<SEC-DOCUMENT>0001493152-22-000830.txt : 20220110
<SEC-HEADER>0001493152-22-000830.hdr.sgml : 20220110
<ACCEPTANCE-DATETIME>20220110164609
ACCESSION NUMBER:		0001493152-22-000830
CONFORMED SUBMISSION TYPE:	POS AM
PUBLIC DOCUMENT COUNT:		70
FILED AS OF DATE:		20220110
DATE AS OF CHANGE:		20220110

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Propanc Biopharma, Inc.
		CENTRAL INDEX KEY:			0001517681
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				300662986
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		POS AM
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-238240
		FILM NUMBER:		22521742

	BUSINESS ADDRESS:	
		STREET 1:		302/6 BUTLER STREET
		CITY:			CAMBERWELL, VICTORIA
		STATE:			C3
		ZIP:			3124
		BUSINESS PHONE:		61-03-9882-0780

	MAIL ADDRESS:	
		STREET 1:		302/6 BUTLER STREET
		CITY:			CAMBERWELL, VICTORIA
		STATE:			C3
		ZIP:			3124

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Propanc Health Group Corp
		DATE OF NAME CHANGE:	20110408
</SEC-HEADER>
<DOCUMENT>
<TYPE>POS AM
<SEQUENCE>1
<FILENAME>formposam.htm
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:us-roles="http://fasb.org/us-roles/2021-01-31" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:PPCB="http://propanc.com/20210930">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02A_US%2DGAAP%2D2021 -->
<!-- Field: Set; Name: xdx; ID: xdx_031_PPCB_propanc.com_20210930 -->
<!-- Field: Set; Name: xdx; ID: xdx_040_20210701_20210930 -->
<!-- Field: Set; Name: xdx; ID: xdx_05C_edei%2D%2DEntityCentralIndexKey_0001517681 -->
<!-- Field: Set; Name: xdx; ID: xdx_055_edei%2D%2DAmendmentFlag_true -->
<!-- Field: Set; Name: xdx; ID: xdx_051_edei%2D%2DDocumentType_POS AM -->
<!-- Field: Set; Name: xdx; ID: xdx_054_edei%2D%2DAmendmentDescription_Post%2DEffective Amendment Number 1 -->
<!-- Field: Set; Name: xdx; ID: xdx_076_XDX_form10%2Dk.xdx -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_069_Pure_4_xbrli%2D%2Dpure -->
<!-- Field: Set; Name: xdx; ID: xdx_064_Integer_5_Integer -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_Euro_0_iso4217%2D%2DEUR -->
<!-- Field: Set; Name: xdx; ID: xdx_063_AUD_0_iso4217%2D%2DAUD -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2021-07-01to2021-09-30" name="dei:EntityCentralIndexKey">0001517681</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2021-07-01to2021-09-30" format="ixt:booleantrue" name="dei:AmendmentFlag">true</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2021-07-01to2021-09-30" name="dei:DocumentType">POS AM</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2021-07-01to2021-09-30" name="dei:AmendmentDescription">Post-Effective Amendment Number 1</ix:nonNumeric>
  <ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="AsOf2021-06-30" id="xdx2ixbrl0043" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2021-06-30" id="xdx2ixbrl0055" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="AsOf2021-06-30" id="xdx2ixbrl0079" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CommitmentsAndContingencies" contextRef="AsOf2021-06-30" id="xdx2ixbrl0100" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2021-06-30_us-gaap_SeriesBPreferredStockMember" id="xdx2ixbrl0133" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2020-06-30_us-gaap_SeriesBPreferredStockMember" id="xdx2ixbrl0134" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:CommonStockIssuable" contextRef="AsOf2021-06-30" id="xdx2ixbrl0174" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:CommonStockIssuable" contextRef="AsOf2020-06-30" id="xdx2ixbrl0175" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquityNoteSubscriptionsReceivable" contextRef="AsOf2021-06-30" id="xdx2ixbrl0184" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquityNoteSubscriptionsReceivable" contextRef="AsOf2020-06-30" id="xdx2ixbrl0185" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2020-07-012021-06-30" id="xdx2ixbrl0209" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2019-07-012020-06-30" id="xdx2ixbrl0210" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherIncome" contextRef="From2020-07-012021-06-30" id="xdx2ixbrl0239" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:GainFromSettlementOfDebtNet" contextRef="From2019-07-012020-06-30" id="xdx2ixbrl0246" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:DeemedDividend" contextRef="From2019-07-012020-06-30" id="xdx2ixbrl0267" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2019-06-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember" id="xdx2ixbrl0294" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2019-06-30_custom_CommonStockIssuableMember" id="xdx2ixbrl0296" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2019-06-30_custom_CommonStockIssuableMember" id="xdx2ixbrl0309" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2019-07-012020-06-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember" id="xdx2ixbrl0311" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2019-07-012020-06-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember" id="xdx2ixbrl0312" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2019-07-012020-06-30_custom_CommonStockIssuableMember" id="xdx2ixbrl0314" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2019-07-012020-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0316" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2019-07-012020-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0317" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2019-07-012020-06-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0318" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2019-07-012020-06-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember" id="xdx2ixbrl0323" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2019-07-012020-06-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember" id="xdx2ixbrl0324" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2019-07-012020-06-30_custom_CommonStockIssuableMember" id="xdx2ixbrl0326" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2019-07-012020-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0328" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2019-07-012020-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0329" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2019-07-012020-06-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0330" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" contextRef="From2019-07-012020-06-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember" id="xdx2ixbrl0333" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" contextRef="From2019-07-012020-06-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember" id="xdx2ixbrl0335" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" contextRef="From2019-07-012020-06-30_custom_CommonStockIssuableMember" id="xdx2ixbrl0339" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:AdjustmentsToAdditionalPaidInCapitalReclassificationOfPremiumUponDebtConversion" contextRef="From2019-07-012020-06-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember" id="xdx2ixbrl0481" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:AdjustmentsToAdditionalPaidInCapitalReclassificationOfPremiumUponDebtConversion" contextRef="From2019-07-012020-06-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember" id="xdx2ixbrl0482" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:AdjustmentsToAdditionalPaidInCapitalReclassificationOfPremiumUponDebtConversion" contextRef="From2019-07-012020-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0483" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:AdjustmentsToAdditionalPaidInCapitalReclassificationOfPremiumUponDebtConversion" contextRef="From2019-07-012020-06-30_custom_CommonStockIssuableMember" id="xdx2ixbrl0484" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:AdjustmentsToAdditionalPaidInCapitalReclassificationOfPremiumUponDebtConversion" contextRef="From2019-07-012020-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0486" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:AdjustmentsToAdditionalPaidInCapitalReclassificationOfPremiumUponDebtConversion" contextRef="From2019-07-012020-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0487" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:AdjustmentsToAdditionalPaidInCapitalReclassificationOfPremiumUponDebtConversion" contextRef="From2019-07-012020-06-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0488" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2019-07-012020-06-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember" id="xdx2ixbrl0491" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2019-07-012020-06-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember" id="xdx2ixbrl0492" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2019-07-012020-06-30_custom_CommonStockIssuableMember" id="xdx2ixbrl0494" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2019-07-012020-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0496" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2019-07-012020-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0497" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2019-07-012020-06-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0498" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:RelativeFairValueOfWarrantsIssuedWithConvertibleDebt" contextRef="From2019-07-012020-06-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember" id="xdx2ixbrl0503" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:RelativeFairValueOfWarrantsIssuedWithConvertibleDebt" contextRef="From2019-07-012020-06-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember" id="xdx2ixbrl0504" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:RelativeFairValueOfWarrantsIssuedWithConvertibleDebt" contextRef="From2019-07-012020-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0505" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:RelativeFairValueOfWarrantsIssuedWithConvertibleDebt" contextRef="From2019-07-012020-06-30_custom_CommonStockIssuableMember" id="xdx2ixbrl0506" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:RelativeFairValueOfWarrantsIssuedWithConvertibleDebt" contextRef="From2019-07-012020-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0508" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:RelativeFairValueOfWarrantsIssuedWithConvertibleDebt" contextRef="From2019-07-012020-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0509" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:RelativeFairValueOfWarrantsIssuedWithConvertibleDebt" contextRef="From2019-07-012020-06-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0510" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2019-07-012020-06-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember" id="xdx2ixbrl0513" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2019-07-012020-06-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember" id="xdx2ixbrl0514" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2019-07-012020-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0515" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2019-07-012020-06-30_custom_CommonStockIssuableMember" id="xdx2ixbrl0516" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2019-07-012020-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0518" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2019-07-012020-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0519" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2019-07-012020-06-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0520" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" contextRef="From2019-07-012020-06-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember" id="xdx2ixbrl0523" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" contextRef="From2019-07-012020-06-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember" id="xdx2ixbrl0524" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" contextRef="From2019-07-012020-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0525" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" contextRef="From2019-07-012020-06-30_custom_CommonStockIssuableMember" id="xdx2ixbrl0526" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" contextRef="From2019-07-012020-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0528" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" contextRef="From2019-07-012020-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0529" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" contextRef="From2019-07-012020-06-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0530" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" contextRef="From2019-07-012020-06-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember" id="xdx2ixbrl0533" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" contextRef="From2019-07-012020-06-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember" id="xdx2ixbrl0534" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" contextRef="From2019-07-012020-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0535" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" contextRef="From2019-07-012020-06-30_custom_CommonStockIssuableMember" id="xdx2ixbrl0536" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" contextRef="From2019-07-012020-06-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0537" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" contextRef="From2019-07-012020-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0538" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2019-07-012020-06-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember" id="xdx2ixbrl0543" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2019-07-012020-06-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember" id="xdx2ixbrl0544" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2019-07-012020-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0545" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2019-07-012020-06-30_custom_CommonStockIssuableMember" id="xdx2ixbrl0546" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2019-07-012020-06-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0547" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2019-07-012020-06-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0550" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-06-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember" id="xdx2ixbrl0554" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-06-30_custom_CommonStockIssuableMember" id="xdx2ixbrl0556" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2020-06-30_custom_CommonStockIssuableMember" id="xdx2ixbrl0569" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2020-07-012021-06-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember" id="xdx2ixbrl0571" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2020-07-012021-06-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember" id="xdx2ixbrl0572" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2020-07-012021-06-30_custom_CommonStockIssuableMember" id="xdx2ixbrl0574" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2020-07-012021-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0576" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2020-07-012021-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0577" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2020-07-012021-06-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0578" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:ReversalOfCommonStockIssuableDueToCancellationOfConversionsOfConvertibleDebtAndAccruedInterest" contextRef="From2020-07-012021-06-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember" id="xdx2ixbrl0583" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:ReversalOfCommonStockIssuableDueToCancellationOfConversionsOfConvertibleDebtAndAccruedInterest" contextRef="From2020-07-012021-06-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember" id="xdx2ixbrl0584" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:ReversalOfCommonStockIssuableDueToCancellationOfConversionsOfConvertibleDebtAndAccruedInterest" contextRef="From2020-07-012021-06-30_custom_CommonStockIssuableMember" id="xdx2ixbrl0586" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:ReversalOfCommonStockIssuableDueToCancellationOfConversionsOfConvertibleDebtAndAccruedInterest" contextRef="From2020-07-012021-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0588" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:ReversalOfCommonStockIssuableDueToCancellationOfConversionsOfConvertibleDebtAndAccruedInterest" contextRef="From2020-07-012021-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0589" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:ReversalOfCommonStockIssuableDueToCancellationOfConversionsOfConvertibleDebtAndAccruedInterest" contextRef="From2020-07-012021-06-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0590" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" contextRef="From2020-07-012021-06-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember" id="xdx2ixbrl0595" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" contextRef="From2020-07-012021-06-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember" id="xdx2ixbrl0596" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0597" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" contextRef="From2020-07-012021-06-30_custom_CommonStockIssuableMember" id="xdx2ixbrl0598" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" contextRef="From2020-07-012021-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0600" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" contextRef="From2020-07-012021-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0601" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" contextRef="From2020-07-012021-06-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0602" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2020-07-012021-06-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember" id="xdx2ixbrl0605" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2020-07-012021-06-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember" id="xdx2ixbrl0606" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2020-07-012021-06-30_custom_CommonStockIssuableMember" id="xdx2ixbrl0608" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2020-07-012021-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0610" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2020-07-012021-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0611" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2020-07-012021-06-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0612" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:StockIssuedDuringPeriodValueExerciseOfWarrants" contextRef="From2020-07-012021-06-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember" id="xdx2ixbrl0617" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:StockIssuedDuringPeriodValueExerciseOfWarrants" contextRef="From2020-07-012021-06-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember" id="xdx2ixbrl0618" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:StockIssuedDuringPeriodValueExerciseOfWarrants" contextRef="From2020-07-012021-06-30_custom_CommonStockIssuableMember" id="xdx2ixbrl0620" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:StockIssuedDuringPeriodValueExerciseOfWarrants" contextRef="From2020-07-012021-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0622" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:StockIssuedDuringPeriodValueExerciseOfWarrants" contextRef="From2020-07-012021-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0623" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:StockIssuedDuringPeriodValueExerciseOfWarrants" contextRef="From2020-07-012021-06-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0624" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:IssuanceOfCommonStockForCashlessExerciseOfWarrants" contextRef="From2020-07-012021-06-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember" id="xdx2ixbrl0629" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:IssuanceOfCommonStockForCashlessExerciseOfWarrants" contextRef="From2020-07-012021-06-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember" id="xdx2ixbrl0630" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:IssuanceOfCommonStockForCashlessExerciseOfWarrants" contextRef="From2020-07-012021-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0634" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:IssuanceOfCommonStockForCashlessExerciseOfWarrants" contextRef="From2020-07-012021-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0635" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:IssuanceOfCommonStockForCashlessExerciseOfWarrants" contextRef="From2020-07-012021-06-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0636" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:IssuanceOfCommonStockForCashlessExerciseOfWarrants" contextRef="From2020-07-012021-06-30" id="xdx2ixbrl0637" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:DeemedDividendUponAlternateCashlessExerciseOfWarrants" contextRef="From2020-07-012021-06-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember" id="xdx2ixbrl0641" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:DeemedDividendUponAlternateCashlessExerciseOfWarrants" contextRef="From2020-07-012021-06-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember" id="xdx2ixbrl0642" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:DeemedDividendUponAlternateCashlessExerciseOfWarrants" contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0643" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:DeemedDividendUponAlternateCashlessExerciseOfWarrants" contextRef="From2020-07-012021-06-30_custom_CommonStockIssuableMember" id="xdx2ixbrl0644" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:DeemedDividendUponAlternateCashlessExerciseOfWarrants" contextRef="From2020-07-012021-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0647" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:DeemedDividendUponAlternateCashlessExerciseOfWarrants" contextRef="From2020-07-012021-06-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0648" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:DeemedDividendUponAlternateCashlessExerciseOfWarrants" contextRef="From2020-07-012021-06-30" id="xdx2ixbrl0649" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:AdjustmentsToAdditionalPaidInCapitalReclassificationOfPremiumUponDebtConversion" contextRef="From2020-07-012021-06-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember" id="xdx2ixbrl0651" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:AdjustmentsToAdditionalPaidInCapitalReclassificationOfPremiumUponDebtConversion" contextRef="From2020-07-012021-06-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember" id="xdx2ixbrl0652" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:AdjustmentsToAdditionalPaidInCapitalReclassificationOfPremiumUponDebtConversion" contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0653" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:AdjustmentsToAdditionalPaidInCapitalReclassificationOfPremiumUponDebtConversion" contextRef="From2020-07-012021-06-30_custom_CommonStockIssuableMember" id="xdx2ixbrl0654" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:AdjustmentsToAdditionalPaidInCapitalReclassificationOfPremiumUponDebtConversion" contextRef="From2020-07-012021-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0656" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:AdjustmentsToAdditionalPaidInCapitalReclassificationOfPremiumUponDebtConversion" contextRef="From2020-07-012021-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0657" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:AdjustmentsToAdditionalPaidInCapitalReclassificationOfPremiumUponDebtConversion" contextRef="From2020-07-012021-06-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0658" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2020-07-012021-06-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember" id="xdx2ixbrl0661" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2020-07-012021-06-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember" id="xdx2ixbrl0662" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0663" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2020-07-012021-06-30_custom_CommonStockIssuableMember" id="xdx2ixbrl0664" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2020-07-012021-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0666" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2020-07-012021-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0667" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2020-07-012021-06-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0668" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" contextRef="From2020-07-012021-06-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember" id="xdx2ixbrl0671" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" contextRef="From2020-07-012021-06-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember" id="xdx2ixbrl0672" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0673" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" contextRef="From2020-07-012021-06-30_custom_CommonStockIssuableMember" id="xdx2ixbrl0674" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" contextRef="From2020-07-012021-06-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0675" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" contextRef="From2020-07-012021-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0676" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" contextRef="From2020-07-012021-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0677" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" contextRef="From2020-07-012021-06-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0678" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" contextRef="From2020-07-012021-06-30" id="xdx2ixbrl0679" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:StockIssuedDuringPeriodValueReverseStockSplits" contextRef="From2020-07-012021-06-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember" id="xdx2ixbrl0683" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:StockIssuedDuringPeriodValueReverseStockSplits" contextRef="From2020-07-012021-06-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember" id="xdx2ixbrl0684" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:StockIssuedDuringPeriodValueReverseStockSplits" contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0685" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:StockIssuedDuringPeriodValueReverseStockSplits" contextRef="From2020-07-012021-06-30_custom_CommonStockIssuableMember" id="xdx2ixbrl0686" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:StockIssuedDuringPeriodValueReverseStockSplits" contextRef="From2020-07-012021-06-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0687" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:StockIssuedDuringPeriodValueReverseStockSplits" contextRef="From2020-07-012021-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0688" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:StockIssuedDuringPeriodValueReverseStockSplits" contextRef="From2020-07-012021-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0689" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:StockIssuedDuringPeriodValueReverseStockSplits" contextRef="From2020-07-012021-06-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0690" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:StockIssuedDuringPeriodValueReverseStockSplits" contextRef="From2020-07-012021-06-30" id="xdx2ixbrl0691" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" contextRef="From2020-07-012021-06-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember" id="xdx2ixbrl0695" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" contextRef="From2020-07-012021-06-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember" id="xdx2ixbrl0696" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0697" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" contextRef="From2020-07-012021-06-30_custom_CommonStockIssuableMember" id="xdx2ixbrl0698" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" contextRef="From2020-07-012021-06-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0699" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" contextRef="From2020-07-012021-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0700" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" contextRef="From2020-07-012021-06-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0702" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2020-07-012021-06-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember" id="xdx2ixbrl0705" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2020-07-012021-06-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember" id="xdx2ixbrl0706" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0707" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2020-07-012021-06-30_custom_CommonStockIssuableMember" id="xdx2ixbrl0708" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2020-07-012021-06-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0709" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2020-07-012021-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0711" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2020-07-012021-06-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0712" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-06-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember" id="xdx2ixbrl0716" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-06-30_custom_CommonStockIssuableMember" id="xdx2ixbrl0718" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:GainFromSettlementOfDebtNet" contextRef="From2019-07-012020-06-30" id="xdx2ixbrl0761" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" contextRef="From2020-07-012021-06-30" id="xdx2ixbrl0778" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:RepaymentsOfConvertibleDebt" contextRef="From2019-07-012020-06-30" id="xdx2ixbrl0806" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="From2020-07-012021-06-30" id="xdx2ixbrl0808" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PaymentsForRepurchaseOfInitialPublicOffering" contextRef="From2020-07-012021-06-30" id="xdx2ixbrl0811" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProceedsFromWarrantExercises" contextRef="From2019-07-012020-06-30" id="xdx2ixbrl0815" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncomeTaxesPaidNet" contextRef="From2020-07-012021-06-30" id="xdx2ixbrl0841" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncomeTaxesPaidNet" contextRef="From2019-07-012020-06-30" id="xdx2ixbrl0842" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:DiscountsRelatedToWarrantsIssuedWithConvertibleNote" contextRef="From2020-07-012021-06-30" id="xdx2ixbrl0853" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:DiscountsRelatedToDerivativeLiability" contextRef="From2020-07-012021-06-30" id="xdx2ixbrl0856" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:OperatingLeaseRightofuseAssetsAndOperatingLeaseLiabilitiesRecordedUponAdoptionOfAsc842" contextRef="From2020-07-012021-06-30" id="xdx2ixbrl0859" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:ReversalOfCommonStockIssuableAndPutPremiumDueToCancellationOfConversionsOfConvertibleDebtAndAccruedInterest" contextRef="From2019-07-012020-06-30" id="xdx2ixbrl0863" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:DeemedDividendUponAlternateCashlessExerciseOfWarrants1" contextRef="From2019-07-012020-06-30" id="xdx2ixbrl0866" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:AccountsPayableReclassToConvertibleNotes" contextRef="From2019-07-012020-06-30" id="xdx2ixbrl0869" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2020-07-012021-06-30" id="xdx2ixbrl0984" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DebtInstrumentConvertibleThresholdTradingDays" contextRef="From2017-08-072017-08-10_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember" id="xdx2ixbrl1215" decimals="INF" unitRef="Integer">10</ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncomeTaxReconciliationTaxCredits" contextRef="From2019-07-012020-06-30_country_US" id="xdx2ixbrl1703" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2020-07-012021-06-30_country_US" id="xdx2ixbrl1708" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2019-07-012020-06-30_country_US" id="xdx2ixbrl1709" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DeferredTaxAssetsLiabilitiesNet" contextRef="AsOf2021-06-30" id="xdx2ixbrl1772" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DeferredTaxAssetsLiabilitiesNet" contextRef="AsOf2020-06-30" id="xdx2ixbrl1773" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" contextRef="From2019-07-012020-06-30" id="xdx2ixbrl1968" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsIssuedInPeriodWeightedAverageExercisePrice" contextRef="From2019-07-012020-06-30" id="xdx2ixbrl1970" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="From2019-07-012020-06-30" id="xdx2ixbrl1972" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" contextRef="From2019-07-012020-06-30" id="xdx2ixbrl1974" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" contextRef="From2019-07-012020-06-30" id="xdx2ixbrl1976" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" contextRef="From2019-07-012020-06-30" id="xdx2ixbrl1978" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" contextRef="From2020-07-012021-06-30" id="xdx2ixbrl1984" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsIssuedInPeriodWeightedAverageExercisePrice" contextRef="From2020-07-012021-06-30" id="xdx2ixbrl1986" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="From2020-07-012021-06-30" id="xdx2ixbrl1988" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" contextRef="From2020-07-012021-06-30" id="xdx2ixbrl1990" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonNumeric contextRef="From2020-07-012021-06-30" id="xdx2ixbrl2006" name="PPCB:WeightedAverageFairValueOfOptionsGrantedDuringPeriod" xs:nil="true"></ix:nonNumeric>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="AsOf2021-06-30" id="xdx2ixbrl2008" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2019-06-30" id="xdx2ixbrl2022" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageOutstanding" contextRef="AsOf2019-06-30" id="xdx2ixbrl2024" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" contextRef="From2019-07-012020-06-30" id="xdx2ixbrl2030" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceExercised" contextRef="From2019-07-012020-06-30" id="xdx2ixbrl2032" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" contextRef="From2019-07-012020-06-30" id="xdx2ixbrl2034" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceExpired" contextRef="From2019-07-012020-06-30" id="xdx2ixbrl2036" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" contextRef="From2019-07-012020-06-30" id="xdx2ixbrl2038" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceForfeited" contextRef="From2019-07-012020-06-30" id="xdx2ixbrl2040" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsIssued" contextRef="From2020-07-012021-06-30" id="xdx2ixbrl2046" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceIssued" contextRef="From2020-07-012021-06-30" id="xdx2ixbrl2048" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" contextRef="From2020-07-012021-06-30" id="xdx2ixbrl2054" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceExpired" contextRef="From2020-07-012021-06-30" id="xdx2ixbrl2056" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" contextRef="From2020-07-012021-06-30" id="xdx2ixbrl2058" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceForfeited" contextRef="From2020-07-012021-06-30" id="xdx2ixbrl2060" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsAggregateIntrinsicValueOutstanding" contextRef="AsOf2021-06-30" id="xdx2ixbrl2072" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonNumeric contextRef="AsOf2016-05-05_custom_NewFiveYearOperatingLeaseAgreementMember" format="ixt-sec:duryear" id="xdx2ixbrl2171" name="us-gaap:LesseeOperatingLeaseTermOfContract">5</ix:nonNumeric>
  <ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2021-06-30" id="xdx2ixbrl2191" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OperatingLeaseLiability" contextRef="AsOf2021-06-30" id="xdx2ixbrl2202" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonNumeric contextRef="AsOf2016-05-05_custom_NorthHorizonPtyLtdMember" format="ixt-sec:duryear" id="xdx2ixbrl2256" name="us-gaap:LessorOperatingLeaseTermOfContract">5</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2019-05-132019-05-14_custom_EmploymentAgreementMember_custom_MrNathanielszMember" format="ixt-sec:duryear" id="xdx2ixbrl2327" name="PPCB:AgreementRenewalTerm">1</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2019-05-132019-05-14_custom_ServicesAgreementMember_custom_DrKenyonMember" format="ixt-sec:duryear" id="xdx2ixbrl2350" name="PPCB:AgreementlTerm">3</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2019-05-132019-05-14_custom_ServicesAgreementMember_custom_DrKenyonMember" format="ixt-sec:duryear" id="xdx2ixbrl2352" name="PPCB:AgreementRenewalTerm">1</ix:nonNumeric>
  <ix:nonFraction name="us-gaap:ProceedsFromConvertibleDebt" contextRef="From2020-07-012021-06-30_custom_LenderTwoMember" id="xdx2ixbrl2392" decimals="0" scale="0" unitRef="USD">200000</ix:nonFraction>
  <ix:nonFraction name="us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" contextRef="AsOf2021-06-30_us-gaap_FairValueInputsLevel1Member" id="xdx2ixbrl2445" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" contextRef="AsOf2021-06-30_us-gaap_FairValueInputsLevel2Member" id="xdx2ixbrl2447" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DerivativeLiabilities" contextRef="AsOf2021-06-30_us-gaap_FairValueInputsLevel1Member" id="xdx2ixbrl2453" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DerivativeLiabilities" contextRef="AsOf2021-06-30_us-gaap_FairValueInputsLevel2Member" id="xdx2ixbrl2455" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" contextRef="AsOf2020-06-30_us-gaap_FairValueInputsLevel1Member" id="xdx2ixbrl2461" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" contextRef="AsOf2020-06-30_us-gaap_FairValueInputsLevel2Member" id="xdx2ixbrl2463" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DerivativeLiabilities" contextRef="AsOf2020-06-30_us-gaap_FairValueInputsLevel1Member" id="xdx2ixbrl2469" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DerivativeLiabilities" contextRef="AsOf2020-06-30_us-gaap_FairValueInputsLevel2Member" id="xdx2ixbrl2471" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="AsOf2021-06-30" id="xdx2ixbrl2567" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CommitmentsAndContingencies" contextRef="AsOf2021-09-30" id="xdx2ixbrl2614" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2021-09-30_us-gaap_SeriesBPreferredStockMember" id="xdx2ixbrl2650" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2021-06-30_us-gaap_SeriesBPreferredStockMember" id="xdx2ixbrl2651" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:CommonStockIssuable" contextRef="AsOf2021-06-30" id="xdx2ixbrl2692" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquityNoteSubscriptionsReceivable" contextRef="AsOf2021-06-30" id="xdx2ixbrl2702" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2021-07-01to2021-09-30" id="xdx2ixbrl2726" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2020-07-012020-09-30" id="xdx2ixbrl2727" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:GainsLossesOnExtinguishmentOfDebt" contextRef="From2021-07-01to2021-09-30" id="xdx2ixbrl2756" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2021-07-01to2021-09-30" id="xdx2ixbrl2768" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2020-07-012020-09-30" id="xdx2ixbrl2769" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:DeemedDividend" contextRef="From2020-07-012020-09-30" id="xdx2ixbrl2775" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-06-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember" id="xdx2ixbrl2802" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-06-30_custom_CommonStockIssuableMember" id="xdx2ixbrl2804" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-06-30_custom_SubscriptionReceivableMember" id="xdx2ixbrl2806" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2020-07-012020-09-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember" id="xdx2ixbrl2818" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2020-07-012020-09-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember" id="xdx2ixbrl2819" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2020-07-012020-09-30_custom_CommonStockIssuableMember" id="xdx2ixbrl2821" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2020-07-012020-09-30_custom_SubscriptionReceivableMember" id="xdx2ixbrl2823" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2020-07-012020-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl2824" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2020-07-012020-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl2825" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2020-07-012020-09-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl2826" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:AdjustmentsToAdditionalPaidInCapitalReclassificationOfPremiumUponDebtConversion" contextRef="From2020-07-012020-09-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember" id="xdx2ixbrl2853" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:AdjustmentsToAdditionalPaidInCapitalReclassificationOfPremiumUponDebtConversion" contextRef="From2020-07-012020-09-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember" id="xdx2ixbrl2854" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:AdjustmentsToAdditionalPaidInCapitalReclassificationOfPremiumUponDebtConversion" contextRef="From2020-07-012020-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl2855" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:AdjustmentsToAdditionalPaidInCapitalReclassificationOfPremiumUponDebtConversion" contextRef="From2020-07-012020-09-30_custom_CommonStockIssuableMember" id="xdx2ixbrl2856" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:AdjustmentsToAdditionalPaidInCapitalReclassificationOfPremiumUponDebtConversion" contextRef="From2020-07-012020-09-30_custom_SubscriptionReceivableMember" id="xdx2ixbrl2858" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:AdjustmentsToAdditionalPaidInCapitalReclassificationOfPremiumUponDebtConversion" contextRef="From2020-07-012020-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl2859" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:AdjustmentsToAdditionalPaidInCapitalReclassificationOfPremiumUponDebtConversion" contextRef="From2020-07-012020-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl2860" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:AdjustmentsToAdditionalPaidInCapitalReclassificationOfPremiumUponDebtConversion" contextRef="From2020-07-012020-09-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl2861" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:StockIssuedDuringPeriodValueExerciseOfWarrants" contextRef="From2020-07-012020-09-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember" id="xdx2ixbrl2886" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:StockIssuedDuringPeriodValueExerciseOfWarrants" contextRef="From2020-07-012020-09-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember" id="xdx2ixbrl2887" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:StockIssuedDuringPeriodValueExerciseOfWarrants" contextRef="From2020-07-012020-09-30_custom_CommonStockIssuableMember" id="xdx2ixbrl2889" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:StockIssuedDuringPeriodValueExerciseOfWarrants" contextRef="From2020-07-012020-09-30_custom_SubscriptionReceivableMember" id="xdx2ixbrl2891" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:StockIssuedDuringPeriodValueExerciseOfWarrants" contextRef="From2020-07-012020-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl2892" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:StockIssuedDuringPeriodValueExerciseOfWarrants" contextRef="From2020-07-012020-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl2893" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:StockIssuedDuringPeriodValueExerciseOfWarrants" contextRef="From2020-07-012020-09-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl2894" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" contextRef="From2020-07-012020-09-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember" id="xdx2ixbrl2921" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" contextRef="From2020-07-012020-09-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember" id="xdx2ixbrl2922" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" contextRef="From2020-07-012020-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl2923" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" contextRef="From2020-07-012020-09-30_custom_CommonStockIssuableMember" id="xdx2ixbrl2924" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" contextRef="From2020-07-012020-09-30_custom_SubscriptionReceivableMember" id="xdx2ixbrl2926" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" contextRef="From2020-07-012020-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl2927" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" contextRef="From2020-07-012020-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl2928" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" contextRef="From2020-07-012020-09-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl2929" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" contextRef="From2020-07-012020-09-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember" id="xdx2ixbrl2932" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" contextRef="From2020-07-012020-09-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember" id="xdx2ixbrl2933" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" contextRef="From2020-07-012020-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl2934" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" contextRef="From2020-07-012020-09-30_custom_CommonStockIssuableMember" id="xdx2ixbrl2935" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" contextRef="From2020-07-012020-09-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl2936" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" contextRef="From2020-07-012020-09-30_custom_SubscriptionReceivableMember" id="xdx2ixbrl2937" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" contextRef="From2020-07-012020-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl2938" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2020-07-012020-09-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember" id="xdx2ixbrl2943" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2020-07-012020-09-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember" id="xdx2ixbrl2944" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2020-07-012020-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl2945" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2020-07-012020-09-30_custom_CommonStockIssuableMember" id="xdx2ixbrl2946" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2020-07-012020-09-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl2947" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2020-07-012020-09-30_custom_SubscriptionReceivableMember" id="xdx2ixbrl2948" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2020-07-012020-09-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl2951" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-09-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember" id="xdx2ixbrl2955" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-09-30_custom_CommonStockIssuableMember" id="xdx2ixbrl2957" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-09-30_custom_SubscriptionReceivableMember" id="xdx2ixbrl2959" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-06-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember" id="xdx2ixbrl2972" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-06-30_custom_CommonStockIssuableMember" id="xdx2ixbrl2974" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-06-30_custom_SubscriptionReceivableMember" id="xdx2ixbrl2976" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2021-07-012021-09-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember" id="xdx2ixbrl2990" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2021-07-012021-09-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember" id="xdx2ixbrl2991" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2021-07-012021-09-30_custom_CommonStockIssuableMember" id="xdx2ixbrl2993" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2021-07-012021-09-30_custom_SubscriptionReceivableMember" id="xdx2ixbrl2995" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2021-07-012021-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl2996" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2021-07-012021-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl2997" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2021-07-012021-09-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl2998" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2021-07-012021-09-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember" id="xdx2ixbrl3003" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2021-07-012021-09-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember" id="xdx2ixbrl3004" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2021-07-012021-09-30_custom_CommonStockIssuableMember" id="xdx2ixbrl3006" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2021-07-012021-09-30_custom_SubscriptionReceivableMember" id="xdx2ixbrl3008" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2021-07-012021-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl3009" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2021-07-012021-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl3010" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2021-07-012021-09-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl3011" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:StockIssuedDuringPeriodValueExerciseOfWarrants" contextRef="From2021-07-012021-09-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember" id="xdx2ixbrl3016" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:StockIssuedDuringPeriodValueExerciseOfWarrants" contextRef="From2021-07-012021-09-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember" id="xdx2ixbrl3017" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:StockIssuedDuringPeriodValueExerciseOfWarrants" contextRef="From2021-07-012021-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl3022" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:StockIssuedDuringPeriodValueExerciseOfWarrants" contextRef="From2021-07-012021-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl3023" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:StockIssuedDuringPeriodValueExerciseOfWarrants" contextRef="From2021-07-012021-09-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl3024" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:IssuanceOfCommonStockForAlternateCashlessExerciseOfWarrants" contextRef="From2021-07-012021-09-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember" id="xdx2ixbrl3031" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:IssuanceOfCommonStockForAlternateCashlessExerciseOfWarrants" contextRef="From2021-07-012021-09-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember" id="xdx2ixbrl3032" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:IssuanceOfCommonStockForAlternateCashlessExerciseOfWarrants" contextRef="From2021-07-012021-09-30_custom_SubscriptionReceivableMember" id="xdx2ixbrl3036" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:IssuanceOfCommonStockForAlternateCashlessExerciseOfWarrants" contextRef="From2021-07-012021-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl3037" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:IssuanceOfCommonStockForAlternateCashlessExerciseOfWarrants" contextRef="From2021-07-012021-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl3038" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:IssuanceOfCommonStockForAlternateCashlessExerciseOfWarrants" contextRef="From2021-07-012021-09-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl3039" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:IssuanceOfCommonStockForAlternateCashlessExerciseOfWarrants" contextRef="From2021-07-01to2021-09-30" id="xdx2ixbrl3040" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:AdjustmentsToAdditionalPaidInCapitalReclassificationOfPremiumUponDebtConversion" contextRef="From2021-07-012021-09-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember" id="xdx2ixbrl3046" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:AdjustmentsToAdditionalPaidInCapitalReclassificationOfPremiumUponDebtConversion" contextRef="From2021-07-012021-09-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember" id="xdx2ixbrl3047" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:AdjustmentsToAdditionalPaidInCapitalReclassificationOfPremiumUponDebtConversion" contextRef="From2021-07-012021-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl3048" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:AdjustmentsToAdditionalPaidInCapitalReclassificationOfPremiumUponDebtConversion" contextRef="From2021-07-012021-09-30_custom_CommonStockIssuableMember" id="xdx2ixbrl3049" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:AdjustmentsToAdditionalPaidInCapitalReclassificationOfPremiumUponDebtConversion" contextRef="From2021-07-012021-09-30_custom_SubscriptionReceivableMember" id="xdx2ixbrl3051" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:AdjustmentsToAdditionalPaidInCapitalReclassificationOfPremiumUponDebtConversion" contextRef="From2021-07-012021-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl3052" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:AdjustmentsToAdditionalPaidInCapitalReclassificationOfPremiumUponDebtConversion" contextRef="From2021-07-012021-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl3053" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:AdjustmentsToAdditionalPaidInCapitalReclassificationOfPremiumUponDebtConversion" contextRef="From2021-07-012021-09-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl3054" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2021-07-012021-09-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember" id="xdx2ixbrl3057" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2021-07-012021-09-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember" id="xdx2ixbrl3058" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2021-07-012021-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl3059" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2021-07-012021-09-30_custom_CommonStockIssuableMember" id="xdx2ixbrl3060" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2021-07-012021-09-30_custom_SubscriptionReceivableMember" id="xdx2ixbrl3062" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2021-07-012021-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl3063" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2021-07-012021-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl3064" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2021-07-012021-09-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl3065" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" contextRef="From2021-07-012021-09-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember" id="xdx2ixbrl3068" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" contextRef="From2021-07-012021-09-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember" id="xdx2ixbrl3069" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" contextRef="From2021-07-012021-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl3070" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" contextRef="From2021-07-012021-09-30_custom_CommonStockIssuableMember" id="xdx2ixbrl3071" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" contextRef="From2021-07-012021-09-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl3072" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" contextRef="From2021-07-012021-09-30_custom_SubscriptionReceivableMember" id="xdx2ixbrl3073" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" contextRef="From2021-07-012021-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl3074" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" contextRef="From2021-07-012021-09-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl3076" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:DeemedDividendUponAlternateCashlessExerciseOfWarrants" contextRef="From2021-07-012021-09-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember" id="xdx2ixbrl3079" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:DeemedDividendUponAlternateCashlessExerciseOfWarrants" contextRef="From2021-07-012021-09-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember" id="xdx2ixbrl3080" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:DeemedDividendUponAlternateCashlessExerciseOfWarrants" contextRef="From2021-07-012021-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl3081" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:DeemedDividendUponAlternateCashlessExerciseOfWarrants" contextRef="From2021-07-012021-09-30_custom_CommonStockIssuableMember" id="xdx2ixbrl3082" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:DeemedDividendUponAlternateCashlessExerciseOfWarrants" contextRef="From2021-07-012021-09-30_custom_SubscriptionReceivableMember" id="xdx2ixbrl3084" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:DeemedDividendUponAlternateCashlessExerciseOfWarrants" contextRef="From2021-07-012021-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl3086" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:DeemedDividendUponAlternateCashlessExerciseOfWarrants" contextRef="From2021-07-012021-09-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl3087" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:DeemedDividendUponAlternateCashlessExerciseOfWarrants" contextRef="From2021-07-01to2021-09-30" id="xdx2ixbrl3088" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2021-07-012021-09-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember" id="xdx2ixbrl3090" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2021-07-012021-09-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember" id="xdx2ixbrl3091" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2021-07-012021-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl3092" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2021-07-012021-09-30_custom_CommonStockIssuableMember" id="xdx2ixbrl3093" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2021-07-012021-09-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl3094" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2021-07-012021-09-30_custom_SubscriptionReceivableMember" id="xdx2ixbrl3095" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2021-07-012021-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl3097" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2021-07-012021-09-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl3098" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-09-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember" id="xdx2ixbrl3102" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims" contextRef="From2020-07-012020-09-30" id="xdx2ixbrl3130" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:GainsLossesOnExtinguishmentOfDebt" contextRef="From2021-07-01to2021-09-30" id="xdx2ixbrl3144" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" contextRef="From2020-07-012020-09-30" id="xdx2ixbrl3154" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" contextRef="From2020-07-012020-09-30" id="xdx2ixbrl3163" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:IncreaseDecreaseInDeferredRent" contextRef="From2021-07-01to2021-09-30" id="xdx2ixbrl3168" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProceedsFromConvertibleDebt" contextRef="From2020-07-012020-09-30" id="xdx2ixbrl3187" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:RepaymentsOfConvertibleDebt" contextRef="From2021-07-01to2021-09-30" id="xdx2ixbrl3189" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:InterestPaidNet" contextRef="From2021-07-01to2021-09-30" id="xdx2ixbrl3216" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncomeTaxesPaidNet" contextRef="From2021-07-01to2021-09-30" id="xdx2ixbrl3219" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncomeTaxesPaidNet" contextRef="From2020-07-012020-09-30" id="xdx2ixbrl3220" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssued1" contextRef="From2020-07-012020-09-30" id="xdx2ixbrl3232" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:DeemedDividendUponAlternateCashlessExerciseOfWarrants1" contextRef="From2020-07-012020-09-30" id="xdx2ixbrl3235" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:SubscriptionReceivable" contextRef="From2020-07-012020-09-30" id="xdx2ixbrl3238" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2020-07-012020-09-30" id="xdx2ixbrl3304" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2021-07-01to2021-09-30" id="xdx2ixbrl3306" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsIssued" contextRef="From2021-07-01to2021-09-30" id="xdx2ixbrl3731" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceIssued" contextRef="From2021-07-01to2021-09-30" id="xdx2ixbrl3733" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" contextRef="From2021-07-01to2021-09-30" id="xdx2ixbrl3739" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceExpired" contextRef="From2021-07-01to2021-09-30" id="xdx2ixbrl3741" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" contextRef="From2021-07-01to2021-09-30" id="xdx2ixbrl3743" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceForfeited" contextRef="From2021-07-01to2021-09-30" id="xdx2ixbrl3745" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="PPCB:SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsAggregateIntrinsicValueOutstanding" contextRef="AsOf2021-09-30" id="xdx2ixbrl3757" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" contextRef="From2021-07-01to2021-09-30" id="xdx2ixbrl3765" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" contextRef="From2021-07-01to2021-09-30" id="xdx2ixbrl3767" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="From2021-07-01to2021-09-30" id="xdx2ixbrl3769" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" contextRef="From2021-07-01to2021-09-30" id="xdx2ixbrl3771" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" contextRef="From2021-07-01to2021-09-30" id="xdx2ixbrl3773" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" contextRef="From2021-07-01to2021-09-30" id="xdx2ixbrl3775" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" contextRef="From2021-07-01to2021-09-30" id="xdx2ixbrl3777" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" contextRef="From2021-07-01to2021-09-30" id="xdx2ixbrl3779" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonNumeric contextRef="From2021-07-01to2021-09-30" id="xdx2ixbrl3791" name="PPCB:WeightedAverageFairValueOfOptionsGrantedDuringPeriod" xs:nil="true"></ix:nonNumeric>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="AsOf2021-09-30" id="xdx2ixbrl3793" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonNumeric contextRef="From2019-05-132019-05-14_custom_EmploymentAgreementMember_custom_MrNathanielszMember" format="ixt-sec:duryear" id="xdx2ixbrl3891" name="PPCB:AgreementRenewalTerm">1</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2019-05-132019-05-14_custom_ServicesAgreementMember_custom_DrKenyonMember" format="ixt-sec:duryear" id="xdx2ixbrl3915" name="PPCB:AgreementlTerm">3</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2019-05-132019-05-14_custom_ServicesAgreementMember_custom_DrKenyonMember" format="ixt-sec:duryear" id="xdx2ixbrl3917" name="PPCB:AgreementRenewalTerm">1</ix:nonNumeric>
  <ix:nonFraction name="us-gaap:ProceedsFromConvertibleDebt" contextRef="From2020-07-012020-09-30" id="xdx2ixbrl3953" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DebtInstrumentMeasurementInput" contextRef="AsOf2021-09-30_us-gaap_MeasurementInputPriceVolatilityMember" id="xdx2ixbrl3968" unitRef="Pure" xs:nil="true"></ix:nonFraction>
  <ix:nonNumeric contextRef="From2021-07-012021-09-30_us-gaap_MeasurementInputExpectedTermMember" id="xdx2ixbrl3972" name="us-gaap:DebtInstrumentTerm" xs:nil="true"></ix:nonNumeric>
  <ix:nonFraction name="us-gaap:DebtInstrumentMeasurementInput" contextRef="AsOf2021-09-30_us-gaap_MeasurementInputRiskFreeInterestRateMember" id="xdx2ixbrl3976" unitRef="Pure" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" contextRef="AsOf2021-09-30_us-gaap_FairValueInputsLevel1Member" id="xdx2ixbrl3988" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" contextRef="AsOf2021-09-30_us-gaap_FairValueInputsLevel2Member" id="xdx2ixbrl3990" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DerivativeLiabilities" contextRef="AsOf2021-09-30_us-gaap_FairValueInputsLevel1Member" id="xdx2ixbrl3996" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DerivativeLiabilities" contextRef="AsOf2021-09-30_us-gaap_FairValueInputsLevel2Member" id="xdx2ixbrl3998" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" contextRef="AsOf2021-06-30_us-gaap_FairValueInputsLevel1Member" id="xdx2ixbrl4004" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" contextRef="AsOf2021-06-30_us-gaap_FairValueInputsLevel2Member" id="xdx2ixbrl4006" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DerivativeLiabilities" contextRef="AsOf2021-06-30_us-gaap_FairValueInputsLevel1Member" id="xdx2ixbrl4012" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DerivativeLiabilities" contextRef="AsOf2021-06-30_us-gaap_FairValueInputsLevel2Member" id="xdx2ixbrl4014" unitRef="USD" xs:nil="true"></ix:nonFraction>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="ppcb-20210930.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2021-07-01to2021-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_SeriesAPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_us-gaap_SeriesAPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_SeriesBPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_us-gaap_SeriesBPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012020-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-06-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-06-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-06-30_custom_CommonStockIssuableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">PPCB:CommonStockIssuableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-06-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-06-30_us-gaap_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012020-06-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012020-06-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012020-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012020-06-30_custom_CommonStockIssuableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">PPCB:CommonStockIssuableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012020-06-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012020-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012020-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012020-06-30_us-gaap_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_custom_CommonStockIssuableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">PPCB:CommonStockIssuableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_us-gaap_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_custom_CommonStockIssuableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">PPCB:CommonStockIssuableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_us-gaap_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_custom_CommonStockIssuableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">PPCB:CommonStockIssuableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-162020-11-17">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-16</xbrli:startDate>
        <xbrli:endDate>2020-11-17</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_custom_IntercompanyLoansMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:IntercompanyLoansMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012020-06-30_custom_IntercompanyLoansMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:IntercompanyLoansMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_srt_WeightedAverageMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_srt_WeightedAverageMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_us-gaap_MachineryAndEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_us-gaap_FurnitureAndFixturesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_us-gaap_EmployeeStockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012020-06-30_us-gaap_EmployeeStockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012020-06-30_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_custom_UnvestedRestrictedStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">PPCB:UnvestedRestrictedStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012020-06-30_custom_UnvestedRestrictedStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">PPCB:UnvestedRestrictedStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_us-gaap_ConvertibleDebtSecuritiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012020-06-30_us-gaap_ConvertibleDebtSecuritiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_custom_DirectorsAndOfficerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">PPCB:DirectorsAndOfficerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_custom_DirectorsAndOfficerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">PPCB:DirectorsAndOfficerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-12-29_custom_DecemberTwentyNineTwoThousandAndSeventeenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_DecemberTwoThousandAndSeventeenEagleNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:DecemberTwentyNineTwoThousandAndSeventeenSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:EagleEquitiesLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:DecemberTwoThousandAndSeventeenEagleNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-12-29</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-12-272017-12-29_custom_DecemberTwentyNineTwoThousandAndSixteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_DecemberTwoThousandAndSeventeenEagleNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:DecemberTwentyNineTwoThousandAndSixteenSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:EagleEquitiesLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:DecemberTwoThousandAndSeventeenEagleNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-12-27</xbrli:startDate>
        <xbrli:endDate>2017-12-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-06-30_custom_DecemberTwentyNineTwoThousandAndSixteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_DecemberTwoThousandAndSeventeenEagleNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:DecemberTwentyNineTwoThousandAndSixteenSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:EagleEquitiesLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:DecemberTwoThousandAndSeventeenEagleNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-07-012019-06-30_custom_DecemberTwentyNineTwoThousandAndSeventeenSecuritiesPurchaseAgreementMember_custom_DecemberTwoThousandAndSeventeenEagleNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:DecemberTwentyNineTwoThousandAndSeventeenSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:DecemberTwoThousandAndSeventeenEagleNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-07-01</xbrli:startDate>
        <xbrli:endDate>2019-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-06-30_custom_DecemberTwentyNineTwoThousandAndSeventeenSecuritiesPurchaseAgreementMember_custom_DecemberTwoThousandAndSeventeenEagleNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:DecemberTwentyNineTwoThousandAndSeventeenSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:DecemberTwoThousandAndSeventeenEagleNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_custom_DecemberTwentyNineTwoThousandAndSeventeenSecuritiesPurchaseAgreementMember_custom_DecemberTwoThousandAndSeventeenEagleNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:DecemberTwentyNineTwoThousandAndSeventeenSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:DecemberTwoThousandAndSeventeenEagleNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012020-06-30_custom_DecemberTwentyNineTwoThousandAndSeventeenSecuritiesPurchaseAgreementMember_custom_DecemberTwoThousandAndSeventeenEagleNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:DecemberTwentyNineTwoThousandAndSeventeenSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:DecemberTwoThousandAndSeventeenEagleNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_custom_DecemberTwentyNineTwoThousandAndSeventeenSecuritiesPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:DecemberTwentyNineTwoThousandAndSeventeenSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_custom_DecemberTwentyNineTwoThousandAndSixteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:DecemberTwentyNineTwoThousandAndSixteenSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:EagleEquitiesLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-07-13_custom_JulyThirteenTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_JulyTwoThousandEighteenEagleNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:JulyThirteenTwoThousandAndEighteenSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:EagleEquitiesLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:JulyTwoThousandEighteenEagleNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-07-13</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-07-182018-07-19_custom_JulyThirteenTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_JulyTwoThousandEighteenEagleNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:JulyThirteenTwoThousandAndEighteenSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:EagleEquitiesLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:JulyTwoThousandEighteenEagleNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-07-18</xbrli:startDate>
        <xbrli:endDate>2018-07-19</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-07-122018-07-13_custom_JulyThirteenTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_JulyTwoThousandEighteenEagleNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:JulyThirteenTwoThousandAndEighteenSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:EagleEquitiesLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:JulyTwoThousandEighteenEagleNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-07-12</xbrli:startDate>
        <xbrli:endDate>2018-07-13</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-06-30_custom_JulyThirteenTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_JulyTwoThousandEighteenEagleNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:JulyThirteenTwoThousandAndEighteenSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:JulyTwoThousandEighteenEagleNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_custom_JulyThirteenTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_JulyTwoThousandEighteenEagleNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:JulyThirteenTwoThousandAndEighteenSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:EagleEquitiesLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:JulyTwoThousandEighteenEagleNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012020-06-30_custom_JulyThirteenTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_JulyTwoThousandEighteenEagleNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:JulyThirteenTwoThousandAndEighteenSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:EagleEquitiesLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:JulyTwoThousandEighteenEagleNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_custom_JuneTwentyNineTwoThousandEighteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:JuneTwentyNineTwoThousandEighteenSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:EagleEquitiesLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-08-29_custom_AugustTwentyNineTwoThousandandEighteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_AugustTwoThousandEighteenEagleNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:AugustTwentyNineTwoThousandandEighteenSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:EagleEquitiesLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:AugustTwoThousandEighteenEagleNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-08-29</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-08-262018-08-29_custom_AugustTwentyNineTwoThousandandEighteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_AugustTwoThousandEighteenEagleNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:AugustTwentyNineTwoThousandandEighteenSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:EagleEquitiesLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:AugustTwoThousandEighteenEagleNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-08-26</xbrli:startDate>
        <xbrli:endDate>2018-08-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-04-012020-04-30_custom_AugustTwentyNineTwoThousandandEighteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_AugustTwoThousandEighteenEagleNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:AugustTwentyNineTwoThousandandEighteenSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:EagleEquitiesLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:AugustTwoThousandEighteenEagleNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-04-01</xbrli:startDate>
        <xbrli:endDate>2020-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-10-02_custom_OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_OctoberTwoTwoThousandAndEighteenEagleNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:EagleEquitiesLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:OctoberTwoTwoThousandAndEighteenEagleNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-10-02</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-09-292018-10-02_custom_OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_OctoberTwoTwoThousandAndEighteenEagleNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:EagleEquitiesLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:OctoberTwoTwoThousandAndEighteenEagleNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-09-29</xbrli:startDate>
        <xbrli:endDate>2018-10-02</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-04-012020-04-30_custom_OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:EagleEquitiesLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-04-01</xbrli:startDate>
        <xbrli:endDate>2020-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-11-30_custom_NovembeThirtyTwoThousandAndEighteenMecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_NovemberTwoThousandAndEighteenEagleNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:NovembeThirtyTwoThousandAndEighteenMecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:EagleEquitiesLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:NovemberTwoThousandAndEighteenEagleNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-11-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-11-262018-11-30_custom_NovembeThirtyTwoThousandAndEighteenMecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_NovemberTwoThousandAndEighteenEagleNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:NovembeThirtyTwoThousandAndEighteenMecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:EagleEquitiesLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:NovemberTwoThousandAndEighteenEagleNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-11-26</xbrli:startDate>
        <xbrli:endDate>2018-11-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-04-012020-04-30_custom_NovembeThirtyTwoThousandAndEighteenMecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_NovemberTwoThousandAndEighteenEagleNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:NovembeThirtyTwoThousandAndEighteenMecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:EagleEquitiesLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:NovemberTwoThousandAndEighteenEagleNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-04-01</xbrli:startDate>
        <xbrli:endDate>2020-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-24_custom_DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_DecembeTwoThousandAndEighteenEagleNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:EagleEquitiesLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:DecembeTwoThousandAndEighteenEagleNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-24</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-12-232018-12-24_custom_DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_DecembeTwoThousandAndEighteenEagleNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:EagleEquitiesLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:DecembeTwoThousandAndEighteenEagleNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-12-23</xbrli:startDate>
        <xbrli:endDate>2018-12-24</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-04-012020-04-30_custom_DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_DecembeTwoThousandAndEighteenEagleNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:EagleEquitiesLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:DecembeTwoThousandAndEighteenEagleNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-04-01</xbrli:startDate>
        <xbrli:endDate>2020-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-12-232018-12-24_custom_DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_DecembeTwoThousandAndEighteenEagleNoteMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:EagleEquitiesLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:DecembeTwoThousandAndEighteenEagleNoteMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-12-23</xbrli:startDate>
        <xbrli:endDate>2018-12-24</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-12-232018-12-24_custom_DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_DecembeTwoThousandAndEighteenEagleNoteMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:EagleEquitiesLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:DecembeTwoThousandAndEighteenEagleNoteMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-12-23</xbrli:startDate>
        <xbrli:endDate>2018-12-24</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-12-232018-12-24_custom_DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_DepositoryTrustCompanyMember_custom_DecembeTwoThousandAndEighteenEagleNoteMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:DepositoryTrustCompanyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:DecembeTwoThousandAndEighteenEagleNoteMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-12-23</xbrli:startDate>
        <xbrli:endDate>2018-12-24</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-12-232018-12-24_custom_DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_DepositoryTrustCompanyMember_custom_DecembeTwoThousandAndEighteenEagleNoteMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:DepositoryTrustCompanyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:DecembeTwoThousandAndEighteenEagleNoteMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-12-23</xbrli:startDate>
        <xbrli:endDate>2018-12-24</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_custom_DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_DecembeTwoThousandAndEighteenEagleNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:EagleEquitiesLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:DecembeTwoThousandAndEighteenEagleNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_custom_DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_DecembeTwoThousandAndEighteenEagleNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:EagleEquitiesLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:DecembeTwoThousandAndEighteenEagleNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_custom_SecuritiesPurchaseAgreementOneMember_custom_EagleEquitiesLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementOneMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:EagleEquitiesLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_custom_SecuritiesPurchaseAgreementOneMember_custom_EagleEquitiesLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementOneMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:EagleEquitiesLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-10-02_custom_OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_GSCapitalPartnersLLCMember_custom_OctoberTwoThousandEighteenGSNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:GSCapitalPartnersLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:OctoberTwoThousandEighteenGSNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-10-02</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-10-03_custom_OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_GSCapitalPartnersLLCMember_custom_OctoberTwoThousandEighteenGSNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:GSCapitalPartnersLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:OctoberTwoThousandEighteenGSNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-10-03</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-09-292018-10-02_custom_OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_GSCapitalPartnersLLCMember_custom_OctoberTwoThousandEighteenGSNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:GSCapitalPartnersLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:OctoberTwoThousandEighteenGSNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-09-29</xbrli:startDate>
        <xbrli:endDate>2018-10-02</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-09-292018-10-02_custom_OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_GSCapitalPartnersLLCMember_custom_OctoberTwoThousandEighteenGSNoteMember_custom_FirstNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:GSCapitalPartnersLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:OctoberTwoThousandEighteenGSNoteMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">PPCB:FirstNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-09-29</xbrli:startDate>
        <xbrli:endDate>2018-10-02</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-09-292018-10-02_custom_OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_GSCapitalPartnersLLCMember_custom_OctoberTwoThousandEighteenGSNoteMember_custom_SecondNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:GSCapitalPartnersLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:OctoberTwoThousandEighteenGSNoteMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">PPCB:SecondNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-09-29</xbrli:startDate>
        <xbrli:endDate>2018-10-02</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-01-22_custom_SecuritiesPurchaseAgreementMember_custom_GSCapitalPartnersLLCMember_custom_JanuaryTwentyTwoTwentyTwentyGSNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:GSCapitalPartnersLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:JanuaryTwentyTwoTwentyTwentyGSNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-01-22</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-212020-01-22_custom_SecuritiesPurchaseAgreementMember_custom_GSCapitalPartnersLLCMember_custom_JanuaryTwentyTwoTwentyTwentyGSNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:GSCapitalPartnersLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:JanuaryTwentyTwoTwentyTwentyGSNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-21</xbrli:startDate>
        <xbrli:endDate>2020-01-22</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-212020-01-22_custom_SecuritiesPurchaseAgreementMember_custom_GSCapitalPartnersLLCMember_custom_JanuaryTwentyTwoTwentyTwentyGSNoteMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:GSCapitalPartnersLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:JanuaryTwentyTwoTwentyTwentyGSNoteMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-21</xbrli:startDate>
        <xbrli:endDate>2020-01-22</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-212020-01-22_custom_SecuritiesPurchaseAgreementMember_custom_GSCapitalPartnersLLCMember_custom_JanuaryTwentyTwoTwentyTwentyGSNoteMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:GSCapitalPartnersLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:JanuaryTwentyTwoTwentyTwentyGSNoteMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-21</xbrli:startDate>
        <xbrli:endDate>2020-01-22</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_custom_SecuritiesPurchaseAgreementMember_custom_GSCapitalPartnersLLCMember_custom_JanuaryTwentyTwoTwentyTwentyGSNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:GSCapitalPartnersLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:JanuaryTwentyTwoTwentyTwentyGSNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_custom_SecuritiesPurchaseAgreementMember_custom_GSCapitalPartnersLLCMember_custom_JanuaryTwentyTwoTwentyTwentyGSNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:GSCapitalPartnersLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:JanuaryTwentyTwoTwentyTwentyGSNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012020-06-30_custom_SecuritiesPurchaseAgreementMember_custom_GSCapitalPartnersLLCMember_custom_JanuaryTwentyTwoTwentyTwentyGSNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:GSCapitalPartnersLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:JanuaryTwentyTwoTwentyTwentyGSNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_custom_SecuritiesPurchaseAgreementMember_custom_GSCapitalPartnersLLCMember_custom_JanuaryTwentyTwoTwentyTwentyGSNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:GSCapitalPartnersLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:JanuaryTwentyTwoTwentyTwentyGSNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-08-10_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:AugustTenTwoThousandAndSeventeenConsultingAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-08-10</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-08-072017-08-10_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:AugustTenTwoThousandAndSeventeenConsultingAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-08-07</xbrli:startDate>
        <xbrli:endDate>2017-08-10</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-06-30_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:AugustTenTwoThousandAndSeventeenConsultingAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-06-30_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:AugustTenTwoThousandAndSeventeenConsultingAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-06-30_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember_custom_ConsultantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:AugustTenTwoThousandAndSeventeenConsultingAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">PPCB:ConsultantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-06-30_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember_custom_ConsultantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:AugustTenTwoThousandAndSeventeenConsultingAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">PPCB:ConsultantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-06-30_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:AugustTenTwoThousandAndSeventeenConsultingAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012020-06-30_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:AugustTenTwoThousandAndSeventeenConsultingAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:AugustTenTwoThousandAndSeventeenConsultingAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-15_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember_custom_SettlementAndMutualReleaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:AugustTenTwoThousandAndSeventeenConsultingAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">PPCB:SettlementAndMutualReleaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-15</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember_custom_SettlementAndMutualReleaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:AugustTenTwoThousandAndSeventeenConsultingAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">PPCB:SettlementAndMutualReleaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember_custom_SettlementAndMutualReleaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:AugustTenTwoThousandAndSeventeenConsultingAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">PPCB:SettlementAndMutualReleaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-11-26_custom_NovemberTwentySixTwoThousandNineteenSecuritiesPurchaseAgreementMember_custom_NovemberTwentySixTwoThousandNineteenPowerUpNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:NovemberTwentySixTwoThousandNineteenSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:NovemberTwentySixTwoThousandNineteenPowerUpNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-11-26</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-11-212019-11-22_custom_NovemberTwentySixTwoThousandNineteenSecuritiesPurchaseAgreementMember_custom_NovemberTwentySixTwoThousandNineteenPowerUpNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:NovemberTwentySixTwoThousandNineteenSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:NovemberTwentySixTwoThousandNineteenPowerUpNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-11-21</xbrli:startDate>
        <xbrli:endDate>2019-11-22</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-11-252019-11-26_custom_NovemberTwentySixTwoThousandNineteenSecuritiesPurchaseAgreementMember_custom_NovemberTwentySixTwoThousandNineteenPowerUpNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:NovemberTwentySixTwoThousandNineteenSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:NovemberTwentySixTwoThousandNineteenPowerUpNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-11-25</xbrli:startDate>
        <xbrli:endDate>2019-11-26</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-01-07_custom_JanuarySevenTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember_custom_JanuarySevenTwoThousandTwentyPowerUpNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:JanuarySevenTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:JanuarySevenTwoThousandTwentyPowerUpNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-01-07</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-122020-01-13_custom_JanuarySevenTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember_custom_JanuarySevenTwoThousandTwentyPowerUpNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:JanuarySevenTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:JanuarySevenTwoThousandTwentyPowerUpNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-12</xbrli:startDate>
        <xbrli:endDate>2020-01-13</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-062020-01-07_custom_JanuarySevenTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember_custom_JanuarySevenTwoThousandTwentyPowerUpNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:JanuarySevenTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:JanuarySevenTwoThousandTwentyPowerUpNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-06</xbrli:startDate>
        <xbrli:endDate>2020-01-07</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-03-12_custom_MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember_custom_MarchTwelveTwoThousandTwentyPowerUpNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:MarchTwelveTwoThousandTwentyPowerUpNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-03-12</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-03-042020-03-05_custom_MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember_custom_MarchTwelveTwoThousandTwentyPowerUpNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:MarchTwelveTwoThousandTwentyPowerUpNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-03-04</xbrli:startDate>
        <xbrli:endDate>2020-03-05</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-03-112020-03-12_custom_MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember_custom_MarchTwelveTwoThousandTwentyPowerUpNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:MarchTwelveTwoThousandTwentyPowerUpNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-03-11</xbrli:startDate>
        <xbrli:endDate>2020-03-12</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-01-07_custom_MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember_custom_MarchTwelveTwoThousandTwentyPowerUpNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:MarchTwelveTwoThousandTwentyPowerUpNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-01-07</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_custom_MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember_custom_MarchTwelveTwoThousandTwentyPowerUpNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:MarchTwelveTwoThousandTwentyPowerUpNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_custom_MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember_custom_MarchTwelveTwoThousandTwentyPowerUpNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:MarchTwelveTwoThousandTwentyPowerUpNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_custom_MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember_custom_MarchTwelveTwoThousandTwentyPowerUpNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:MarchTwelveTwoThousandTwentyPowerUpNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-05-23_custom_RedstartHoldingsCorpFinancingAgreementMember_custom_RedstartHoldingsCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:RedstartHoldingsCorpFinancingAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:RedstartHoldingsCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-05-23</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-05-222019-05-23_custom_RedstartHoldingsCorpFinancingAgreementMember_custom_RedstartHoldingsCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:RedstartHoldingsCorpFinancingAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:RedstartHoldingsCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-05-22</xbrli:startDate>
        <xbrli:endDate>2019-05-23</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-06-30_custom_RedstartHoldingsCorpFinancingAgreementMember_custom_RedstartHoldingsCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:RedstartHoldingsCorpFinancingAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:RedstartHoldingsCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_custom_RedstartHoldingsCorpFinancingAgreementMember_custom_RedstartHoldingsCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:RedstartHoldingsCorpFinancingAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:RedstartHoldingsCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_custom_RedstartHoldingsCorpFinancingAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:RedstartHoldingsCorpFinancingAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-07-30_custom_SecuritiesPurchaseAgreementMember_custom_OdysseyCapitalFundingLLCMember_custom_JulyTwoThousandNineteenOdysseyNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:OdysseyCapitalFundingLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:JulyTwoThousandNineteenOdysseyNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-07-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-08-01_custom_SecuritiesPurchaseAgreementMember_custom_OdysseyCapitalFundingLLCMember_custom_JulyTwoThousandNineteenOdysseyNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:OdysseyCapitalFundingLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:JulyTwoThousandNineteenOdysseyNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-08-01</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-312019-08-01_custom_SecuritiesPurchaseAgreementMember_custom_OdysseyCapitalFundingLLCMember_custom_JulyTwoThousandNineteenOdysseyNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:OdysseyCapitalFundingLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:JulyTwoThousandNineteenOdysseyNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-31</xbrli:startDate>
        <xbrli:endDate>2019-08-01</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-292019-07-30_custom_SecuritiesPurchaseAgreementMember_custom_OdysseyCapitalFundingLLCMember_custom_JulyTwoThousandNineteenOdysseyNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:OdysseyCapitalFundingLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:JulyTwoThousandNineteenOdysseyNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-29</xbrli:startDate>
        <xbrli:endDate>2019-07-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_custom_SecuritiesPurchaseAgreementMember_custom_OdysseyCapitalFundingLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:OdysseyCapitalFundingLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012020-06-30_custom_SecuritiesPurchaseAgreementMember_custom_OdysseyCapitalFundingLLCMember_custom_JulyTwoThousandNineteenOdysseyNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:OdysseyCapitalFundingLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:JulyTwoThousandNineteenOdysseyNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_custom_SecuritiesPurchaseAgreementMember_custom_OdysseyCapitalFundingLLCMember_custom_JulyTwoThousandNineteenOdysseyNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:OdysseyCapitalFundingLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:JulyTwoThousandNineteenOdysseyNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-08-30_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:AuctusFundLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:AugustTwoThousandNineteenAuctusNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-08-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-09-04_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:AuctusFundLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:AugustTwoThousandNineteenAuctusNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-09-04</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-09-032019-09-04_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:AuctusFundLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:AugustTwoThousandNineteenAuctusNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-09-03</xbrli:startDate>
        <xbrli:endDate>2019-09-04</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-08-292019-08-30_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:AuctusFundLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:AugustTwoThousandNineteenAuctusNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-08-29</xbrli:startDate>
        <xbrli:endDate>2019-08-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-08-30_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember_custom_FirstWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:AuctusFundLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:AugustTwoThousandNineteenAuctusNoteMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">PPCB:FirstWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-08-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-08-30_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember_custom_SecondWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:AuctusFundLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:AugustTwoThousandNineteenAuctusNoteMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">PPCB:SecondWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-08-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-08-30_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember_custom_ThirdWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:AuctusFundLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:AugustTwoThousandNineteenAuctusNoteMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">PPCB:ThirdWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-08-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012020-06-30_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:AuctusFundLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:AugustTwoThousandNineteenAuctusNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:AuctusFundLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:AugustTwoThousandNineteenAuctusNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:AuctusFundLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:AugustTwoThousandNineteenAuctusNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:AuctusFundLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:AugustTwoThousandNineteenAuctusNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:AuctusFundLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:AugustTwoThousandNineteenAuctusNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-10-02_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember_custom_OctoberOneTwoThousandNineteenAuctusNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:GWHoldingsGroupLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:OctoberOneTwoThousandNineteenAuctusNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-10-02</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-09-292019-10-02_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember_custom_OctoberOneTwoThousandNineteenAuctusNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:GWHoldingsGroupLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:OctoberOneTwoThousandNineteenAuctusNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-09-29</xbrli:startDate>
        <xbrli:endDate>2019-10-02</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-10_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember_custom_DecemberTenTwoThousandTwentyGWNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:GWHoldingsGroupLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:DecemberTenTwoThousandTwentyGWNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-10</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-12-092020-12-10_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember_custom_DecemberTenTwoThousandTwentyGWNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:GWHoldingsGroupLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:DecemberTenTwoThousandTwentyGWNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-12-09</xbrli:startDate>
        <xbrli:endDate>2020-12-10</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-12-092020-12-10_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember_custom_DecemberTenTwoThousandTwentyGWNoteMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:GWHoldingsGroupLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:DecemberTenTwoThousandTwentyGWNoteMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-12-09</xbrli:startDate>
        <xbrli:endDate>2020-12-10</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-12-092020-12-10_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember_custom_DecemberTenTwoThousandTwentyGWNoteMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:GWHoldingsGroupLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:DecemberTenTwoThousandTwentyGWNoteMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-12-09</xbrli:startDate>
        <xbrli:endDate>2020-12-10</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember_custom_OctoberOneTwoThousandNineteenAuctusNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:GWHoldingsGroupLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:OctoberOneTwoThousandNineteenAuctusNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:GWHoldingsGroupLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember_custom_OctoberOneTwoThousandNineteenAuctusNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:GWHoldingsGroupLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:OctoberOneTwoThousandNineteenAuctusNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:GWHoldingsGroupLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember_custom_DecemberTenTwoThousandTwentyGWNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:GWHoldingsGroupLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:DecemberTenTwoThousandTwentyGWNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember_custom_DecemberTenTwoThousandTwentyGWNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:GWHoldingsGroupLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:DecemberTenTwoThousandTwentyGWNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_custom_SecuritiesPurchaseAgreementMember_custom_DecemberTenTwoThousandTwentyGWNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:DecemberTenTwoThousandTwentyGWNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_custom_SecuritiesPurchaseAgreementMember_custom_DecemberTenTwoThousandTwentyGWNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:DecemberTenTwoThousandTwentyGWNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-10-03_custom_SecuritiesPurchaseAgreementMember_custom_CrownBridgePartnersLLCMember_custom_OctoberThreeTwoThousandNineteenAuctusNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:CrownBridgePartnersLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:OctoberThreeTwoThousandNineteenAuctusNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-10-03</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-10-012019-10-03_custom_SecuritiesPurchaseAgreementMember_custom_CrownBridgePartnersLLCMember_custom_OctoberThreeTwoThousandNineteenAuctusNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:CrownBridgePartnersLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:OctoberThreeTwoThousandNineteenAuctusNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-10-01</xbrli:startDate>
        <xbrli:endDate>2019-10-03</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-10-012019-10-03_custom_SecuritiesPurchaseAgreementMember_custom_CrownBridgePartnersLLCMember_custom_OctoberThreeTwoThousandNineteenAuctusNoteMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:CrownBridgePartnersLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:OctoberThreeTwoThousandNineteenAuctusNoteMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-10-01</xbrli:startDate>
        <xbrli:endDate>2019-10-03</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-10-012019-10-03_custom_SecuritiesPurchaseAgreementMember_custom_CrownBridgePartnersLLCMember_custom_OctoberThreeTwoThousandNineteenAuctusNoteMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:CrownBridgePartnersLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:OctoberThreeTwoThousandNineteenAuctusNoteMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-10-01</xbrli:startDate>
        <xbrli:endDate>2019-10-03</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_custom_SecuritiesPurchaseAgreementMember_custom_CrownBridgePartnersLLCMember_custom_OctoberThreeTwoThousandNineteenAuctusNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:CrownBridgePartnersLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:OctoberThreeTwoThousandNineteenAuctusNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012020-06-30_custom_SecuritiesPurchaseAgreementMember_custom_CrownBridgePartnersLLCMember_custom_OctoberThreeTwoThousandNineteenAuctusNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:CrownBridgePartnersLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:OctoberThreeTwoThousandNineteenAuctusNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_custom_SecuritiesPurchaseAgreementMember_custom_CrownBridgePartnersLLCMember_custom_OctoberThreeTwoThousandNineteenAuctusNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:CrownBridgePartnersLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:OctoberThreeTwoThousandNineteenAuctusNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-09-152020-09-16_custom_SecuritiesPurchaseAgreementMember_custom_CrownBridgePartnersLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:CrownBridgePartnersLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-09-15</xbrli:startDate>
        <xbrli:endDate>2020-09-16</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-11-30_custom_SecuritiesPurchaseAgreementMember_custom_CrownBridgePartnersLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:CrownBridgePartnersLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-11-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-01-13_custom_SecuritiesPurchaseAgreementMember_custom_JanuaryThirteenTwentyTwentyAderAlefNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:JanuaryThirteenTwentyTwentyAderAlefNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-01-13</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-122020-01-13_custom_SecuritiesPurchaseAgreementMember_custom_JanuaryThirteenTwentyTwentyAderAlefNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:JanuaryThirteenTwentyTwentyAderAlefNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-12</xbrli:startDate>
        <xbrli:endDate>2020-01-13</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-122020-01-13_custom_SecuritiesPurchaseAgreementMember_custom_JanuaryThirteenTwentyTwentyAderAlefNoteMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:JanuaryThirteenTwentyTwentyAderAlefNoteMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-12</xbrli:startDate>
        <xbrli:endDate>2020-01-13</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-122020-01-13_custom_SecuritiesPurchaseAgreementMember_custom_JanuaryThirteenTwentyTwentyAderAlefNoteMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:JanuaryThirteenTwentyTwentyAderAlefNoteMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-12</xbrli:startDate>
        <xbrli:endDate>2020-01-13</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_custom_SecuritiesPurchaseAgreementMember_custom_JanuaryThirteenTwentyTwentyAderAlefNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:JanuaryThirteenTwentyTwentyAderAlefNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_custom_SecuritiesPurchaseAgreementMember_custom_JanuaryThirteenTwentyTwentyAderAlefNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:JanuaryThirteenTwentyTwentyAderAlefNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_custom_SecuritiesPurchaseAgreementMember_custom_JanuaryThirteenTwentyTwentyAderAlefNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:JanuaryThirteenTwentyTwentyAderAlefNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-02-19_custom_SecuritiesPurchaseAgreementMember_custom_FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember_custom_LGCapitalFundingLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:LGCapitalFundingLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-02-19</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-02-182020-02-19_custom_SecuritiesPurchaseAgreementMember_custom_FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember_custom_LGCapitalFundingLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:LGCapitalFundingLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-02-18</xbrli:startDate>
        <xbrli:endDate>2020-02-19</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-03-242020-03-25_custom_SecuritiesPurchaseAgreementMember_custom_FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember_custom_LGCapitalFundingLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:LGCapitalFundingLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-03-24</xbrli:startDate>
        <xbrli:endDate>2020-03-25</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-02-182020-02-19_custom_SecuritiesPurchaseAgreementMember_custom_FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember_custom_LGCapitalFundingLLCMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:LGCapitalFundingLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-02-18</xbrli:startDate>
        <xbrli:endDate>2020-02-19</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-02-182020-02-19_custom_SecuritiesPurchaseAgreementMember_custom_FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember_custom_LGCapitalFundingLLCMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:LGCapitalFundingLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-02-18</xbrli:startDate>
        <xbrli:endDate>2020-02-19</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-02-19_custom_SecuritiesPurchaseAgreementMember_custom_LGCapitalFundingLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:LGCapitalFundingLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-02-19</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_custom_SecuritiesPurchaseAgreementMember_custom_FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember_custom_LGCapitalFundingLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:LGCapitalFundingLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_custom_SecuritiesPurchaseAgreementMember_custom_FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember_custom_LGCapitalFundingLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:LGCapitalFundingLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_custom_SecuritiesPurchaseAgreementMember_custom_FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember_custom_LGCapitalFundingLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:LGCapitalFundingLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-09-082020-09-09_custom_SecuritiesPurchaseAgreementMember_custom_LGCapitalFundingLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:LGCapitalFundingLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-09-08</xbrli:startDate>
        <xbrli:endDate>2020-09-09</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-11-30_custom_SecuritiesPurchaseAgreementMember_custom_LGCapitalFundingLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:LGCapitalFundingLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-11-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-292020-11-30_custom_SecuritiesPurchaseAgreementMember_custom_LGCapitalFundingLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:LGCapitalFundingLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-29</xbrli:startDate>
        <xbrli:endDate>2020-11-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-02_custom_SecuritiesPurchaseAgreementMember_custom_DecemberTwoTwoThousandTwentyGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:DecemberTwoTwoThousandTwentyGenevaRothMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:GenevaRothRemarkHoldingsIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-02</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-01-05_custom_SecuritiesPurchaseAgreementMember_custom_JanuaryFiveTwoThousandTwentyOneGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:JanuaryFiveTwoThousandTwentyOneGenevaRothMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:GenevaRothRemarkHoldingsIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-01-05</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-042021-01-05_custom_SecuritiesPurchaseAgreementMember_custom_JanuaryFiveTwoThousandTwentyOneGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:JanuaryFiveTwoThousandTwentyOneGenevaRothMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:GenevaRothRemarkHoldingsIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-04</xbrli:startDate>
        <xbrli:endDate>2021-01-05</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-16_custom_SecuritiesPurchaseAgreementMember_custom_MarchSixteenTwoThousandTwentyOneGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:MarchSixteenTwoThousandTwentyOneGenevaRothMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:GenevaRothRemarkHoldingsIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-16</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-03-132021-03-16_custom_SecuritiesPurchaseAgreementMember_custom_MarchSixteenTwoThousandTwentyOneGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:MarchSixteenTwoThousandTwentyOneGenevaRothMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:GenevaRothRemarkHoldingsIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-03-13</xbrli:startDate>
        <xbrli:endDate>2021-03-16</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-01-05_custom_SecuritiesPurchaseAgreementMember_custom_MarchSixteenTwoThousandTwentyOneGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:MarchSixteenTwoThousandTwentyOneGenevaRothMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:GenevaRothRemarkHoldingsIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-01-05</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-032021-01-05_custom_SecuritiesPurchaseAgreementMember_custom_MarchSixteenTwoThousandTwentyOneGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:MarchSixteenTwoThousandTwentyOneGenevaRothMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:GenevaRothRemarkHoldingsIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-03</xbrli:startDate>
        <xbrli:endDate>2021-01-05</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-12-012020-12-02_custom_SecuritiesPurchaseAgreementMember_custom_DecemberTwoTwoThousandTwentyGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:DecemberTwoTwoThousandTwentyGenevaRothMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:GenevaRothRemarkHoldingsIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-12-01</xbrli:startDate>
        <xbrli:endDate>2020-12-02</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-12-012020-12-02_custom_SecuritiesPurchaseAgreementMember_custom_DecemberTwoTwoThousandTwentyGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:DecemberTwoTwoThousandTwentyGenevaRothMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:GenevaRothRemarkHoldingsIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-12-01</xbrli:startDate>
        <xbrli:endDate>2020-12-02</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-12-012020-12-02_custom_SecuritiesPurchaseAgreementMember_custom_DecemberTwoTwoThousandTwentyGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:DecemberTwoTwoThousandTwentyGenevaRothMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:GenevaRothRemarkHoldingsIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-12-01</xbrli:startDate>
        <xbrli:endDate>2020-12-02</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_custom_SecuritiesPurchaseAgreementMember_custom_DecemberTwoTwoThousandTwentyGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:DecemberTwoTwoThousandTwentyGenevaRothMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:GenevaRothRemarkHoldingsIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_custom_SecuritiesPurchaseAgreementMember_custom_DecemberTwoTwoThousandTwentyGenevaRothMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:DecemberTwoTwoThousandTwentyGenevaRothMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_custom_SecuritiesPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012020-06-30_custom_SecuritiesPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_custom_SecuritiesPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_custom_SecuritiesPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_country_US">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012020-06-30_country_US">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-03-242020-03-27_custom_CaresActMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:CaresActMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-03-24</xbrli:startDate>
        <xbrli:endDate>2020-03-27</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_country_US">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_country_AU_custom_ExpireInTwoThousandTwentyFourMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:AU</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">PPCB:ExpireInTwoThousandTwentyFourMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_country_AU_custom_NotExpireMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:AU</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">PPCB:NotExpireMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012020-06-30_country_AU">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:AU</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_country_AU">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:AU</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_country_AU">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:AU</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-02-03">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-02-03</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-02-04">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-02-04</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-04-022020-04-03_custom_SecurityPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecurityPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-04-02</xbrli:startDate>
        <xbrli:endDate>2020-04-03</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-04-03_custom_SecurityPurchaseAgreementMember_custom_SeriesBWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecurityPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">PPCB:SeriesBWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-04-03</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-04-03_custom_SecurityPurchaseAgreementMember_custom_SeriesCWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecurityPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">PPCB:SeriesCWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-04-03</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-04-03_custom_SecurityPurchaseAgreementMember_custom_SeriesAWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecurityPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">PPCB:SeriesAWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-04-03</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-04-03_custom_SecurityPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecurityPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-04-03</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-04-022020-04-03_custom_SecurityPurchaseAgreementMember_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecurityPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-04-02</xbrli:startDate>
        <xbrli:endDate>2020-04-03</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-04-022020-04-03_custom_SecurityPurchaseAgreementMember_us-gaap_RestrictedStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecurityPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-04-02</xbrli:startDate>
        <xbrli:endDate>2020-04-03</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-04-03_custom_SecurityPurchaseAgreementMember_custom_PrefundedWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecurityPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">PPCB:PrefundedWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-04-03</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012020-06-30_custom_SecurityPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecurityPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_custom_SecurityPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecurityPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_custom_SecurityPurchaseAgreementMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecurityPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_custom_SecurityPurchaseAgreementMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecurityPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_custom_SecurityPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecurityPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_custom_SecurityPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecurityPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_custom_SecurityPurchaseAgreementMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecurityPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_custom_SecurityPurchaseAgreementMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecurityPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-11-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-11-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-292020-11-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-29</xbrli:startDate>
        <xbrli:endDate>2020-11-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_custom_UnderlyingFinancingAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:UnderlyingFinancingAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-182020-07-19_custom_ConsultingAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:ConsultingAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-18</xbrli:startDate>
        <xbrli:endDate>2020-07-19</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-07-19_custom_ConsultingAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:ConsultingAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-07-19</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012020-06-30_custom_ConsultingAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:ConsultingAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-02-022020-02-03_custom_ConsultantMember_custom_EngagementAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">PPCB:ConsultantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:EngagementAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-02-02</xbrli:startDate>
        <xbrli:endDate>2020-02-03</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-06-252020-06-26_custom_ConsultantMember_custom_EngagementAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">PPCB:ConsultantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:EngagementAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-06-25</xbrli:startDate>
        <xbrli:endDate>2020-06-26</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-02-03_custom_ConsultantMember_custom_EngagementAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">PPCB:ConsultantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:EngagementAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-02-03</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-26_custom_ConsultantMember_custom_EngagementAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">PPCB:ConsultantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:EngagementAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-26</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012020-06-30_custom_ConsultantMember_custom_EngagementAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">PPCB:ConsultantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:EngagementAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-03-212021-03-22_custom_ConsultantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">PPCB:ConsultantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-03-21</xbrli:startDate>
        <xbrli:endDate>2021-03-22</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_us-gaap_CommonStockMember_custom_ConsultantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">PPCB:ConsultantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_CommonStockMember_custom_ConsultantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">PPCB:ConsultantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_custom_ConsultantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">PPCB:ConsultantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-03-012021-03-31_custom_ConsultantMember_custom_EngagementAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">PPCB:ConsultantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:EngagementAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-03-01</xbrli:startDate>
        <xbrli:endDate>2021-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-06-012021-06-30_custom_ConsultantMember_custom_EngagementAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">PPCB:ConsultantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:EngagementAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-06-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-31_custom_ConsultantMember_custom_EngagementAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">PPCB:ConsultantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:EngagementAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_custom_ConsultantMember_custom_EngagementAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">PPCB:ConsultantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:EngagementAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_custom_ConsultantMember_custom_EngagementAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">PPCB:ConsultantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:EngagementAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_custom_PrefundedWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">PPCB:PrefundedWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_custom_SeriesBWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">PPCB:SeriesBWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_custom_PrefundedWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">PPCB:PrefundedWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_custom_TwentySeriesAAndOneSeriesCWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">PPCB:TwentySeriesAAndOneSeriesCWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-05-012019-05-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-05-01</xbrli:startDate>
        <xbrli:endDate>2019-05-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-05-012019-05-31_srt_ChiefExecutiveOfficerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-05-01</xbrli:startDate>
        <xbrli:endDate>2019-05-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-05-012019-05-31_us-gaap_RestrictedStockUnitsRSUMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-05-01</xbrli:startDate>
        <xbrli:endDate>2019-05-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_us-gaap_RestrictedStockUnitsRSUMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012020-06-30_us-gaap_RestrictedStockUnitsRSUMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_RestrictedStockUnitsRSUMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_us-gaap_RestrictedStockUnitsRSUMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_custom_TwoThousandNinteenEquityIncentivePlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">PPCB:TwoThousandNinteenEquityIncentivePlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_custom_EmploymentAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:EmploymentAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012020-06-30_custom_EmploymentAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:EmploymentAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-08-31_custom_FirstWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">PPCB:FirstWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-08-31_custom_SecondWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">PPCB:SecondWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-08-31_custom_ThirdWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">PPCB:ThirdWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-09-10">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-09-10</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-09-092019-09-10">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-09-09</xbrli:startDate>
        <xbrli:endDate>2019-09-10</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012020-06-30_us-gaap_WarrantMember17272484">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-04-022020-04-03_custom_SecuritiesPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-04-02</xbrli:startDate>
        <xbrli:endDate>2020-04-03</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-04-03_custom_SecuritiesPurchaseAgreementMember_custom_SeriesBWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">PPCB:SeriesBWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-04-03</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-04-03_custom_SecuritiesPurchaseAgreementMember_custom_SeriesCWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">PPCB:SeriesCWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-04-03</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-04-03_custom_SecuritiesPurchaseAgreementMember_custom_PrefundedWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">PPCB:PrefundedWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-04-03</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-03-20_custom_SecuritiesPurchaseAgreementMember_custom_SeriesAWarrantsMember_us-gaap_InvestorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">PPCB:SeriesAWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-03-20</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-03-20_custom_SecuritiesPurchaseAgreementMember_custom_SeriesBWarrantsMember_us-gaap_InvestorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">PPCB:SeriesBWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-03-20</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-03-192020-03-20_custom_SecuritiesPurchaseAgreementMember_custom_SeriesBWarrantsMember_us-gaap_InvestorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">PPCB:SeriesBWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-03-19</xbrli:startDate>
        <xbrli:endDate>2020-03-20</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-03-192020-03-20_custom_SecuritiesPurchaseAgreementMember_custom_SeriesBWarrantsMember_custom_HolderMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">PPCB:SeriesBWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">PPCB:HolderMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-03-19</xbrli:startDate>
        <xbrli:endDate>2020-03-20</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-03-20_custom_SecuritiesPurchaseAgreementMember_custom_SeriesBWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">PPCB:SeriesBWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-03-20</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-03-20_custom_SecuritiesPurchaseAgreementMember_custom_SeriesCWarrantsMember_us-gaap_InvestorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">PPCB:SeriesCWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-03-20</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-09-252019-09-26_custom_FoleyShechterMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">PPCB:FoleyShechterMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-09-25</xbrli:startDate>
        <xbrli:endDate>2019-09-26</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-03-202021-03-22_custom_SettlementAgreementMember_custom_FoleyShechterMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SettlementAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">PPCB:FoleyShechterMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-03-20</xbrli:startDate>
        <xbrli:endDate>2021-03-22</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-22_custom_SettlementAgreementMember_custom_FoleyShechterMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SettlementAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">PPCB:FoleyShechterMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-22</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_custom_SettlementAgreementMember_custom_FoleyShechterMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SettlementAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">PPCB:FoleyShechterMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_custom_RegalConsultingLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:RegalConsultingLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-05-31_custom_RegalConsultingLLCMember_custom_TwoThousandAndSeventeenNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:RegalConsultingLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:TwoThousandAndSeventeenNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-05-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-05-012017-05-31_custom_RegalConsultingLLCMember_custom_TwoThousandAndSeventeenNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:RegalConsultingLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:TwoThousandAndSeventeenNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-05-01</xbrli:startDate>
        <xbrli:endDate>2017-05-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-08-10_custom_SettlementAndMutualReleaseAgreementMember_custom_RegalConsultingLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SettlementAndMutualReleaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:RegalConsultingLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-08-10</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-15_custom_SettlementAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SettlementAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-15</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_custom_SettlementAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SettlementAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_custom_From2012ThroughThe2014Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">PPCB:From2012ThroughThe2014Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2012-06-012012-06-30_us-gaap_RoyaltyAgreementTermsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:RoyaltyAgreementTermsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2012-06-01</xbrli:startDate>
        <xbrli:endDate>2012-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2012-06-012012-06-30_us-gaap_LicenseAgreementTermsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:LicenseAgreementTermsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2012-06-01</xbrli:startDate>
        <xbrli:endDate>2012-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-05-05_custom_NewFiveYearOperatingLeaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:NewFiveYearOperatingLeaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-05-05</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-05-032016-05-05_custom_NewFiveYearOperatingLeaseAgreementMember_custom_AUDCurrencyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:NewFiveYearOperatingLeaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">PPCB:AUDCurrencyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-05-03</xbrli:startDate>
        <xbrli:endDate>2016-05-05</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-05-032016-05-05_custom_NewFiveYearOperatingLeaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:NewFiveYearOperatingLeaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-05-03</xbrli:startDate>
        <xbrli:endDate>2016-05-05</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-07-02_us-gaap_AccountingStandardsUpdate201602Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-07-02</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012019-07-02_us-gaap_AccountingStandardsUpdate201602Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2019-07-02</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012019-07-02_us-gaap_AccountingStandardsUpdate201602Member_custom_AUDCurrencyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">PPCB:AUDCurrencyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2019-07-02</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-09-102018-09-13_custom_OneYearCollaborationAgreementMember_custom_EurosMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:OneYearCollaborationAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">PPCB:EurosMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-09-10</xbrli:startDate>
        <xbrli:endDate>2018-09-13</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-09-102018-09-13_custom_OneYearCollaborationAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:OneYearCollaborationAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-09-10</xbrli:startDate>
        <xbrli:endDate>2018-09-13</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-09-102018-09-13_custom_TwoYearCollaborationAgreementMember_custom_EurosMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:TwoYearCollaborationAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">PPCB:EurosMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-09-10</xbrli:startDate>
        <xbrli:endDate>2018-09-13</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-09-102018-09-13_custom_TwoYearCollaborationAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:TwoYearCollaborationAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-09-10</xbrli:startDate>
        <xbrli:endDate>2018-09-13</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-07-012019-06-30_custom_EurosMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">PPCB:EurosMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-07-01</xbrli:startDate>
        <xbrli:endDate>2019-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-07-012019-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-07-01</xbrli:startDate>
        <xbrli:endDate>2019-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_custom_EurosMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">PPCB:EurosMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-09-102018-09-13_us-gaap_SalesRevenueNetMember_us-gaap_RevenueFromRightsConcentrationRiskMember_custom_NoCustomerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:RevenueFromRightsConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">PPCB:NoCustomerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-09-10</xbrli:startDate>
        <xbrli:endDate>2018-09-13</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-09-292020-10-02_custom_TwoYearCollaborationAgreementMember_custom_EurosMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:TwoYearCollaborationAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">PPCB:EurosMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-09-29</xbrli:startDate>
        <xbrli:endDate>2020-10-02</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-09-292020-10-02_custom_TwoYearCollaborationAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:TwoYearCollaborationAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-09-29</xbrli:startDate>
        <xbrli:endDate>2020-10-02</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-09-292020-10-02_custom_TwoYearCollaborationAgreementMember_custom_EurosMember_custom_InstallmentOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:TwoYearCollaborationAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">PPCB:EurosMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">PPCB:InstallmentOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-09-29</xbrli:startDate>
        <xbrli:endDate>2020-10-02</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-09-292020-10-02_custom_TwoYearCollaborationAgreementMember_custom_InstallmentTwoMember_custom_EurosMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:TwoYearCollaborationAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">PPCB:InstallmentTwoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">PPCB:EurosMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-09-29</xbrli:startDate>
        <xbrli:endDate>2020-10-02</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-09-292020-10-02_custom_TwoYearCollaborationAgreementMember_custom_InstallmentTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:TwoYearCollaborationAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">PPCB:InstallmentTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-09-29</xbrli:startDate>
        <xbrli:endDate>2020-10-02</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-09-292020-10-02_custom_TwoYearCollaborationAgreementMember_custom_InstallmentThreeMember_custom_EurosMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:TwoYearCollaborationAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">PPCB:InstallmentThreeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">PPCB:EurosMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-09-29</xbrli:startDate>
        <xbrli:endDate>2020-10-02</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-09-292020-10-02_custom_TwoYearCollaborationAgreementMember_custom_InstallmentThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:TwoYearCollaborationAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">PPCB:InstallmentThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-09-29</xbrli:startDate>
        <xbrli:endDate>2020-10-02</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-09-292020-10-02_custom_TwoYearCollaborationAgreementMember_custom_InstallmentFourMember_custom_EurosMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:TwoYearCollaborationAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">PPCB:InstallmentFourMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">PPCB:EurosMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-09-29</xbrli:startDate>
        <xbrli:endDate>2020-10-02</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-09-292020-10-02_custom_TwoYearCollaborationAgreementMember_custom_InstallmentFourMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:TwoYearCollaborationAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">PPCB:InstallmentFourMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-09-29</xbrli:startDate>
        <xbrli:endDate>2020-10-02</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-09-292020-10-02_custom_UniversityOfJaenMember_custom_EurosMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:UniversityOfJaenMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">PPCB:EurosMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-09-29</xbrli:startDate>
        <xbrli:endDate>2020-10-02</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-09-292020-10-02_custom_UniversityOfJaenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:UniversityOfJaenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-09-29</xbrli:startDate>
        <xbrli:endDate>2020-10-02</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-09-292020-10-02_us-gaap_SalesRevenueNetMember_custom_UniversityOfJaenMember_us-gaap_RevenueFromRightsConcentrationRiskMember_custom_NoCustomerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:UniversityOfJaenMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:RevenueFromRightsConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">PPCB:NoCustomerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-09-29</xbrli:startDate>
        <xbrli:endDate>2020-10-02</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_custom_CurrentAndFormerDirectorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">PPCB:CurrentAndFormerDirectorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_custom_CurrentAndFormerDirectorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">PPCB:CurrentAndFormerDirectorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_custom_FormerDirectorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">PPCB:FormerDirectorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_custom_FormerDirectorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">PPCB:FormerDirectorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-05-05_custom_NorthHorizonPtyLtdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:NorthHorizonPtyLtdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-05-05</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-05-032016-05-05_custom_NorthHorizonPtyLtdMember_custom_AUDCurrencyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:NorthHorizonPtyLtdMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">PPCB:AUDCurrencyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-05-03</xbrli:startDate>
        <xbrli:endDate>2016-05-05</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-05-032016-05-05_custom_NorthHorizonPtyLtdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:NorthHorizonPtyLtdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-05-03</xbrli:startDate>
        <xbrli:endDate>2016-05-05</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-05-05_custom_NorthHorizonPtyLtdMember_custom_AUDCurrenryMember_custom_NathanielszMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:NorthHorizonPtyLtdMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">PPCB:AUDCurrenryMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">PPCB:NathanielszMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-05-05</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-05-05_custom_NorthHorizonPtyLtdMember_custom_NathanielszMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:NorthHorizonPtyLtdMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">PPCB:NathanielszMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-05-05</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_custom_NorthHorizonPtyLtdMember_custom_AUDCurrenryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:NorthHorizonPtyLtdMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">PPCB:AUDCurrenryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_custom_NorthHorizonPtyLtdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:NorthHorizonPtyLtdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-02-242015-02-25_custom_NathanielszEmploymentAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:NathanielszEmploymentAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-02-24</xbrli:startDate>
        <xbrli:endDate>2015-02-25</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-02-242015-02-25_custom_NathanielszEmploymentAgreementMember_custom_AUDCurrenryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:NathanielszEmploymentAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">PPCB:AUDCurrenryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-02-24</xbrli:startDate>
        <xbrli:endDate>2015-02-25</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_custom_NathanielszEmploymentAgreementMember_custom_AUDCurrenryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:NathanielszEmploymentAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">PPCB:AUDCurrenryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_custom_NathanielszEmploymentAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:NathanielszEmploymentAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-03-152018-03-16_custom_NathanielszEmploymentAgreementMember_custom_AUDCurrenryMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:NathanielszEmploymentAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">PPCB:AUDCurrenryMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-03-15</xbrli:startDate>
        <xbrli:endDate>2018-03-16</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-03-152018-03-16_custom_NathanielszEmploymentAgreementMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:NathanielszEmploymentAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-03-15</xbrli:startDate>
        <xbrli:endDate>2018-03-16</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-03-152018-03-16_custom_NathanielszEmploymentAgreementMember_custom_AUDCurrenryMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:NathanielszEmploymentAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">PPCB:AUDCurrenryMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-03-15</xbrli:startDate>
        <xbrli:endDate>2018-03-16</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-03-152018-03-16_custom_NathanielszEmploymentAgreementMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:NathanielszEmploymentAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-03-15</xbrli:startDate>
        <xbrli:endDate>2018-03-16</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-282018-02-01_custom_MrsNathanielszMember_custom_AUDCurrencyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">PPCB:MrsNathanielszMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">PPCB:AUDCurrencyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-28</xbrli:startDate>
        <xbrli:endDate>2018-02-01</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-282018-02-01_custom_MrsNathanielszMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">PPCB:MrsNathanielszMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-28</xbrli:startDate>
        <xbrli:endDate>2018-02-01</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-02-242016-02-25_custom_JamesNathanielszMember_custom_AUDCurrenryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">PPCB:JamesNathanielszMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">PPCB:AUDCurrenryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-02-24</xbrli:startDate>
        <xbrli:endDate>2016-02-25</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-02-242016-02-25_custom_JamesNathanielszMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">PPCB:JamesNathanielszMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-02-24</xbrli:startDate>
        <xbrli:endDate>2016-02-25</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012020-06-30_custom_MrsNathanielszMember_custom_AUDCurrenryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">PPCB:MrsNathanielszMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">PPCB:AUDCurrenryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012020-06-30_custom_MrsNathanielszMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">PPCB:MrsNathanielszMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_custom_MrsNathanielszMember_custom_AUDCurrenryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">PPCB:MrsNathanielszMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">PPCB:AUDCurrenryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_custom_MrsNathanielszMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">PPCB:MrsNathanielszMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-05-132019-05-14_custom_MrNathanielszMember_custom_BoardOfDirectorsMember_custom_AUDCurrenryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">PPCB:MrNathanielszMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">PPCB:BoardOfDirectorsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">PPCB:AUDCurrenryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-05-13</xbrli:startDate>
        <xbrli:endDate>2019-05-14</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-05-132019-05-14_custom_MrNathanielszMember_custom_BoardOfDirectorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">PPCB:MrNathanielszMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">PPCB:BoardOfDirectorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-05-13</xbrli:startDate>
        <xbrli:endDate>2019-05-14</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-07-012019-06-30_srt_ChiefExecutiveOfficerMember_custom_AUDCurrenryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">PPCB:AUDCurrenryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-07-01</xbrli:startDate>
        <xbrli:endDate>2019-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-07-012019-06-30_srt_ChiefExecutiveOfficerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-07-01</xbrli:startDate>
        <xbrli:endDate>2019-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-122020-07-13_custom_MrNathanielszMember_custom_BoardOfDirectorsMember_custom_AUDCurrenryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">PPCB:MrNathanielszMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">PPCB:BoardOfDirectorsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">PPCB:AUDCurrenryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-12</xbrli:startDate>
        <xbrli:endDate>2020-07-13</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012020-06-30_srt_ChiefExecutiveOfficerMember_custom_AUDCurrenryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">PPCB:AUDCurrenryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012020-06-30_srt_ChiefExecutiveOfficerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-08-112021-08-12_custom_MrNathanielszMember_custom_BoardOfDirectorsMember_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">PPCB:MrNathanielszMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">PPCB:BoardOfDirectorsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-08-11</xbrli:startDate>
        <xbrli:endDate>2021-08-12</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_srt_ChiefExecutiveOfficerMember_custom_AUDCurrenryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">PPCB:AUDCurrenryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_srt_ChiefExecutiveOfficerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_srt_ChiefExecutiveOfficerMember_custom_MrsNathanielszMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:MrsNathanielszMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-08-112021-08-12_custom_MrNathanielszMember_custom_BoardOfDirectorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">PPCB:MrNathanielszMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">PPCB:BoardOfDirectorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-08-11</xbrli:startDate>
        <xbrli:endDate>2021-08-12</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-05-132019-05-14_custom_EmploymentAgreementMember_custom_MrNathanielszMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:EmploymentAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">PPCB:MrNathanielszMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-05-13</xbrli:startDate>
        <xbrli:endDate>2019-05-14</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-05-132019-05-14_custom_EmploymentAgreementMember_custom_MrNathanielszMember_custom_AUDCurrenryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:EmploymentAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">PPCB:MrNathanielszMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">PPCB:AUDCurrenryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-05-13</xbrli:startDate>
        <xbrli:endDate>2019-05-14</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-05-132019-05-14_custom_EmploymentAgreementMember_custom_RestrictedStocksUnitsRSUMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:EmploymentAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">PPCB:RestrictedStocksUnitsRSUMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-05-13</xbrli:startDate>
        <xbrli:endDate>2019-05-14</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_custom_EmploymentAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:EmploymentAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-05-132019-05-14_custom_EmploymentAgreementMember_custom_AdditionaNathanielszRSUsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:EmploymentAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">PPCB:AdditionaNathanielszRSUsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-05-13</xbrli:startDate>
        <xbrli:endDate>2019-05-14</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-05-132019-05-14_custom_ServicesAgreementMember_custom_DrKenyonMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:ServicesAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">PPCB:DrKenyonMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-05-13</xbrli:startDate>
        <xbrli:endDate>2019-05-14</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-05-132019-05-14_custom_ServicesAgreementMember_custom_DrKenyonMemberMember_custom_AUDCurrenryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:ServicesAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">PPCB:DrKenyonMemberMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">PPCB:AUDCurrenryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-05-13</xbrli:startDate>
        <xbrli:endDate>2019-05-14</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-05-132019-05-14_custom_ServicesAgreementMember_custom_InitialKenyonRSUsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:ServicesAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">PPCB:InitialKenyonRSUsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-05-13</xbrli:startDate>
        <xbrli:endDate>2019-05-14</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-05-132019-05-14_custom_ServicesAgreementMember_custom_AdditionalKenyonRSUsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:ServicesAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">PPCB:AdditionalKenyonRSUsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-05-13</xbrli:startDate>
        <xbrli:endDate>2019-05-14</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_custom_AUDCurrenryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">PPCB:AUDCurrenryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_custom_ServicesAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:ServicesAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-08-12_custom_ServicesAgreementMember_custom_DrKenyonMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:ServicesAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">PPCB:DrKenyonMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-08-12</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-08-112021-08-12_custom_ServicesAgreementMember_custom_DrKenyonMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:ServicesAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">PPCB:DrKenyonMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-08-11</xbrli:startDate>
        <xbrli:endDate>2021-08-12</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012020-06-30_custom_LenderOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">PPCB:LenderOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012020-06-30_custom_LenderTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">PPCB:LenderTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012020-06-30_custom_LenderThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">PPCB:LenderThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_custom_LenderOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">PPCB:LenderOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_custom_LenderTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">PPCB:LenderTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_custom_LenderThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">PPCB:LenderThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_custom_LenderOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">PPCB:LenderOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_custom_LenderTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">PPCB:LenderTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_custom_LenderOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">PPCB:LenderOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_custom_LenderTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">PPCB:LenderTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_ConvertibleDebtMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_us-gaap_ConvertibleDebtMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_us-gaap_MeasurementInputPriceVolatilityMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_us-gaap_MeasurementInputPriceVolatilityMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_MeasurementInputPriceVolatilityMember_us-gaap_ConvertibleDebtMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_us-gaap_MeasurementInputPriceVolatilityMember_us-gaap_ConvertibleDebtMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012020-06-30_us-gaap_MeasurementInputExpectedTermMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_us-gaap_MeasurementInputExpectedTermMember_us-gaap_ConvertibleDebtMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012020-06-30_us-gaap_MeasurementInputExpectedTermMember_us-gaap_ConvertibleDebtMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012020-06-30_us-gaap_MeasurementInputExpectedTermMember_us-gaap_ConvertibleDebtMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_us-gaap_MeasurementInputRiskFreeInterestRateMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_us-gaap_MeasurementInputRiskFreeInterestRateMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_MeasurementInputRiskFreeInterestRateMember_us-gaap_ConvertibleDebtMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_us-gaap_MeasurementInputRiskFreeInterestRateMember_us-gaap_ConvertibleDebtMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_us-gaap_MeasurementInputRiskFreeInterestRateMember_us-gaap_ConvertibleDebtMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_us-gaap_MeasurementInputExpectedDividendRateMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_MeasurementInputExpectedDividendRateMember_us-gaap_ConvertibleDebtMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_us-gaap_MeasurementInputExpectedDividendRateMember_us-gaap_ConvertibleDebtMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_FairValueInputsLevel1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_FairValueInputsLevel2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_FairValueInputsLevel3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_us-gaap_FairValueInputsLevel1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_us-gaap_FairValueInputsLevel2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_us-gaap_FairValueInputsLevel3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-092021-09-07_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-09</xbrli:startDate>
        <xbrli:endDate>2021-09-07</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-092021-09-07_us-gaap_SubsequentEventMember_custom_SeriesBWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">PPCB:SeriesBWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-09</xbrli:startDate>
        <xbrli:endDate>2021-09-07</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-07_us-gaap_SubsequentEventMember_custom_SeriesBWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">PPCB:SeriesBWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-07</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-07_us-gaap_SubsequentEventMember_custom_TwelveSeriesAAndAWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">PPCB:TwelveSeriesAAndAWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-07</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-20_us-gaap_SubsequentEventMember_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-20</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-20_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-20</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-20_us-gaap_SubsequentEventMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-20</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-20_us-gaap_SubsequentEventMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-20</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-23_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-23</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-08-112021-08-12_us-gaap_SubsequentEventMember_custom_NathanielszCancellationAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:NathanielszCancellationAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-08-11</xbrli:startDate>
        <xbrli:endDate>2021-08-12</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-192021-07-20_us-gaap_SubsequentEventMember_custom_MrNathanielszMember_custom_NathanielszCancellationAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">PPCB:MrNathanielszMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:NathanielszCancellationAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-19</xbrli:startDate>
        <xbrli:endDate>2021-07-20</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-08-162021-08-17_us-gaap_SubsequentEventMember_custom_MrNathanielszMember_custom_NathanielszCancellationAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">PPCB:MrNathanielszMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:NathanielszCancellationAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-08-16</xbrli:startDate>
        <xbrli:endDate>2021-08-17</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-08-17_us-gaap_SubsequentEventMember_custom_MrNathanielszMember_custom_NathanielszCancellationAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">PPCB:MrNathanielszMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:NathanielszCancellationAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-08-17</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-08-12_custom_KenyonCancellationAgreementMember_custom_DrKenyonMember_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:KenyonCancellationAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">PPCB:DrKenyonMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-08-12</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-08-112021-08-12_custom_KenyonCancellationAgreementMember_custom_DrKenyonMember_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:KenyonCancellationAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">PPCB:DrKenyonMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-08-11</xbrli:startDate>
        <xbrli:endDate>2021-08-12</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-08-112021-08-12_custom_ZelingerAmendedAndRestatedDirectorAgreementMember_custom_JosefZelingerMember_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:ZelingerAmendedAndRestatedDirectorAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">PPCB:JosefZelingerMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-08-11</xbrli:startDate>
        <xbrli:endDate>2021-08-12</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_custom_ZelingerAmendedAndRestatedDirectorAgreementMember_custom_JosefZelingerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:ZelingerAmendedAndRestatedDirectorAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">PPCB:JosefZelingerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_custom_ZelingerAmendedAndRestatedDirectorAgreementMember_custom_JosefZelingerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:ZelingerAmendedAndRestatedDirectorAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">PPCB:JosefZelingerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-08-12_us-gaap_SubsequentEventMember_custom_CommonStockOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">PPCB:CommonStockOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-08-12</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_custom_CommonStockOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">PPCB:CommonStockOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-08-112021-08-12_us-gaap_SubsequentEventMember_custom_CommonStockOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">PPCB:CommonStockOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-08-11</xbrli:startDate>
        <xbrli:endDate>2021-08-12</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-08-12_us-gaap_SubsequentEventMember_custom_CommonStockTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">PPCB:CommonStockTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-08-12</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-08-112021-08-12_us-gaap_SubsequentEventMember_custom_CommonStockTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">PPCB:CommonStockTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-08-11</xbrli:startDate>
        <xbrli:endDate>2021-08-12</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_us-gaap_SubsequentEventMember_custom_CommonStockThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">PPCB:CommonStockThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-09-012021-09-30_us-gaap_SubsequentEventMember_custom_CommonStockThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">PPCB:CommonStockThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-09-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-08-19_us-gaap_SubsequentEventMember_custom_TwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:TwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-08-19</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-08-182021-08-19_us-gaap_SubsequentEventMember_custom_TwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:TwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-08-18</xbrli:startDate>
        <xbrli:endDate>2021-08-19</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-22_us-gaap_SubsequentEventMember_custom_TwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:TwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-22</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-09-212021-09-22_us-gaap_SubsequentEventMember_custom_TwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:TwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-09-21</xbrli:startDate>
        <xbrli:endDate>2021-09-22</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_us-gaap_SeriesAPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_us-gaap_SeriesBPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_custom_SubscriptionReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">PPCB:SubscriptionReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-09-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-09-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-09-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-09-30_custom_CommonStockIssuableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">PPCB:CommonStockIssuableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-09-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-09-30_custom_SubscriptionReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">PPCB:SubscriptionReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-09-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-09-30_us-gaap_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30_custom_CommonStockIssuableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">PPCB:CommonStockIssuableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30_custom_SubscriptionReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">PPCB:SubscriptionReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30_us-gaap_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_custom_SubscriptionReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">PPCB:SubscriptionReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_custom_CommonStockIssuableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">PPCB:CommonStockIssuableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_custom_SubscriptionReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">PPCB:SubscriptionReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_us-gaap_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_custom_CommonStockIssuableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">PPCB:CommonStockIssuableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_custom_SubscriptionReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">PPCB:SubscriptionReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_us-gaap_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_custom_IntercompanyLoansMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:IntercompanyLoansMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-09-30_custom_IntercompanyLoansMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:IntercompanyLoansMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_srt_WeightedAverageMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_us-gaap_MachineryAndEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_us-gaap_FurnitureAndFixturesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-08-19_custom_TwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:TwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-08-19</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_us-gaap_EmployeeStockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-09-30_us-gaap_EmployeeStockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-09-30_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_custom_UnvestedRestrictedStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">PPCB:UnvestedRestrictedStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-09-30_custom_UnvestedRestrictedStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">PPCB:UnvestedRestrictedStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_us-gaap_ConvertibleDebtSecuritiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-09-30_us-gaap_ConvertibleDebtSecuritiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_custom_DirectorsAndOfficerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">PPCB:DirectorsAndOfficerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember_custom_SettlementAndMutualReleaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:AugustTenTwoThousandAndSeventeenConsultingAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">PPCB:SettlementAndMutualReleaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-06-30_custom_AuctusFinancingAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:AuctusFinancingAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_custom_AuctusFinancingAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:AuctusFinancingAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:AuctusFundLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:AugustTwoThousandNineteenAuctusNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:AuctusFundLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:AugustTwoThousandNineteenAuctusNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_custom_AuctusFinancingAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:AuctusFinancingAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:AuctusFundLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:AugustTwoThousandNineteenAuctusNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:AuctusFundLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:AugustTwoThousandNineteenAuctusNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:AuctusFundLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:AugustTwoThousandNineteenAuctusNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_custom_SecuritiesPurchaseAgreementMember_custom_CrownBridgePartnersLLCMember_custom_OctoberThreeTwoThousandNineteenAuctusNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:CrownBridgePartnersLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:OctoberThreeTwoThousandNineteenAuctusNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-10_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:GWHoldingsGroupLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-10</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember_custom_DecemberTenTwoThousandTwentyGWNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:GWHoldingsGroupLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:DecemberTenTwoThousandTwentyGWNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember_custom_DecemberTenTwoThousandTwentyGWNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:GWHoldingsGroupLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:DecemberTenTwoThousandTwentyGWNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_custom_SecuritiesPurchaseAgreementMember_custom_DecemberTenTwoThousandTwentyGWNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:DecemberTenTwoThousandTwentyGWNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-02_custom_SecuritiesPurchaseAgreementMember_custom_JanuaryFiveTwoThousandTwentyOneGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:JanuaryFiveTwoThousandTwentyOneGenevaRothMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:GenevaRothRemarkHoldingsIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-02</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-03-152021-03-16_custom_SecuritiesPurchaseAgreementMember_custom_MarchSixteenTwoThousandTwentyOneGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:MarchSixteenTwoThousandTwentyOneGenevaRothMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:GenevaRothRemarkHoldingsIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-03-15</xbrli:startDate>
        <xbrli:endDate>2021-03-16</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-08-19_custom_SecuritiesPurchaseAgreementMember_custom_AugustNineteenTwoThousandTwentyOneGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:AugustNineteenTwoThousandTwentyOneGenevaRothMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:GenevaRothRemarkHoldingsIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-08-19</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-08-182021-08-19_custom_SecuritiesPurchaseAgreementMember_custom_AugustNineteenTwoThousandTwentyOneGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:AugustNineteenTwoThousandTwentyOneGenevaRothMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:GenevaRothRemarkHoldingsIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-08-18</xbrli:startDate>
        <xbrli:endDate>2021-08-19</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-22_custom_SecuritiesPurchaseAgreementMember_custom_SeptemberTwentyTwoTwoThousandTwentyOneGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:SeptemberTwentyTwoTwoThousandTwentyOneGenevaRothMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:GenevaRothRemarkHoldingsIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-22</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-09-212021-09-22_custom_SecuritiesPurchaseAgreementMember_custom_SeptemberTwentyTwoTwoThousandTwentyOneGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:SeptemberTwentyTwoTwoThousandTwentyOneGenevaRothMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:GenevaRothRemarkHoldingsIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-09-21</xbrli:startDate>
        <xbrli:endDate>2021-09-22</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-09-212021-09-22_custom_SecuritiesPurchaseAgreementMember_custom_SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:GenevaRothRemarkHoldingsIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-09-21</xbrli:startDate>
        <xbrli:endDate>2021-09-22</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-09-212021-09-22_custom_SecuritiesPurchaseAgreementMember_custom_SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:GenevaRothRemarkHoldingsIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-09-21</xbrli:startDate>
        <xbrli:endDate>2021-09-22</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-09-212021-09-22_custom_SecuritiesPurchaseAgreementMember_custom_SeptemberTwentyTwoTwoThousandTwentyOneGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:SeptemberTwentyTwoTwoThousandTwentyOneGenevaRothMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:GenevaRothRemarkHoldingsIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-09-21</xbrli:startDate>
        <xbrli:endDate>2021-09-22</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-22_custom_SecuritiesPurchaseAgreementMember_custom_SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:GenevaRothRemarkHoldingsIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-22</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-09-212021-09-22_custom_SecuritiesPurchaseAgreementMember_custom_SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:GenevaRothRemarkHoldingsIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-09-21</xbrli:startDate>
        <xbrli:endDate>2021-09-22</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_custom_GenevaRothFinancingAgreementAgreementMember_custom_SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:GenevaRothFinancingAgreementAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:GenevaRothRemarkHoldingsIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_custom_GenevaRothFinancingAgreementAgreementMember_custom_SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:GenevaRothFinancingAgreementAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_custom_SecuritiesPurchaseAgreementMember_custom_SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_custom_GenevaRothFinancingAgreementAgreementMember_custom_SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:GenevaRothFinancingAgreementAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:GenevaRothRemarkHoldingsIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_custom_GenevaRothFinancingAgreementAgreementMember_custom_SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:GenevaRothFinancingAgreementAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_custom_SecuritiesPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-09-30_custom_SecuritiesPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_custom_SecuritiesPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30_custom_SecuritiesPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30_us-gaap_SeriesAPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_custom_SecurityPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecurityPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_custom_SecurityPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecurityPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_custom_SecurityPurchaseAgreementMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecurityPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_custom_SecurityPurchaseAgreementMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecurityPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_custom_UnderlyingFinancingAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:UnderlyingFinancingAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-08-112021-08-12_custom_CommonStockOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">PPCB:CommonStockOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-08-11</xbrli:startDate>
        <xbrli:endDate>2021-08-12</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-08-12_custom_CommonStockOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">PPCB:CommonStockOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-08-12</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_custom_CommonStockOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">PPCB:CommonStockOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-08-112021-08-12_custom_LegalServicesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">PPCB:LegalServicesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-08-11</xbrli:startDate>
        <xbrli:endDate>2021-08-12</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-08-12_custom_LegalServicesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">PPCB:LegalServicesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-08-12</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_custom_LegalServicesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">PPCB:LegalServicesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-09-292021-09-30_custom_ConsultantServicesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">PPCB:ConsultantServicesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-09-29</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-08-12_custom_ConsultantServicesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">PPCB:ConsultantServicesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-08-12</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_custom_ConsultantServicesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">PPCB:ConsultantServicesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-08-112021-08-12_custom_NathanielszCancellationAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:NathanielszCancellationAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-08-11</xbrli:startDate>
        <xbrli:endDate>2021-08-12</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-192021-07-20_custom_MrNathanielszMember_custom_NathanielszCancellationAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">PPCB:MrNathanielszMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:NathanielszCancellationAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-19</xbrli:startDate>
        <xbrli:endDate>2021-07-20</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-08-162021-08-17_custom_MrNathanielszMember_custom_NathanielszCancellationAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">PPCB:MrNathanielszMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:NathanielszCancellationAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-08-16</xbrli:startDate>
        <xbrli:endDate>2021-08-17</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-08-17_custom_MrNathanielszMember_custom_NathanielszCancellationAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">PPCB:MrNathanielszMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:NathanielszCancellationAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-08-17</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-08-112021-08-12_custom_MrNathanielszMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">PPCB:MrNathanielszMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-08-11</xbrli:startDate>
        <xbrli:endDate>2021-08-12</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-08-12_custom_DeferredSalaryMember_custom_CancellationAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis">PPCB:DeferredSalaryMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:CancellationAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-08-12</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-08-112021-08-12_custom_ChiefScientificOfficerandDirectorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">PPCB:ChiefScientificOfficerandDirectorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-08-11</xbrli:startDate>
        <xbrli:endDate>2021-08-12</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-08-12_custom_ChiefScientificOfficerandDirectorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">PPCB:ChiefScientificOfficerandDirectorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-08-12</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_custom_ChiefScientificOfficerandDirectorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">PPCB:ChiefScientificOfficerandDirectorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-08-112021-08-12_custom_ZelingerAmendedAndRestatedDirectorAgreementMember_custom_JosefZelingerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:ZelingerAmendedAndRestatedDirectorAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">PPCB:JosefZelingerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-08-11</xbrli:startDate>
        <xbrli:endDate>2021-08-12</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_custom_ZelingerAmendedAndRestatedDirectorAgreementMember_custom_JosefZelingerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:ZelingerAmendedAndRestatedDirectorAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">PPCB:JosefZelingerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-062021-09-27">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-06</xbrli:startDate>
        <xbrli:endDate>2021-09-27</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-27">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-27</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-062021-09-27_custom_SeriesBWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">PPCB:SeriesBWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-06</xbrli:startDate>
        <xbrli:endDate>2021-09-27</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-27_custom_SeriesBWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">PPCB:SeriesBWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-27</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_custom_SeriesBWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">PPCB:SeriesBWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_custom_From2012ThroughThe2014Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">PPCB:From2012ThroughThe2014Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_custom_CurrentAndFormerDirectorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">PPCB:CurrentAndFormerDirectorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_custom_FormerDirectorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">PPCB:FormerDirectorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-05-032021-05-06_custom_NorthHorizonPtyLtdMember_custom_AUDCurrencyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:NorthHorizonPtyLtdMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">PPCB:AUDCurrencyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-05-03</xbrli:startDate>
        <xbrli:endDate>2021-05-06</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-05-052021-05-06_custom_NorthHorizonPtyLtdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:NorthHorizonPtyLtdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-05-05</xbrli:startDate>
        <xbrli:endDate>2021-05-06</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_custom_NorthHorizonPtyLtdMember_custom_AUDCurrencyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:NorthHorizonPtyLtdMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">PPCB:AUDCurrencyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-09-30_custom_NorthHorizonPtyLtdMember_custom_AUDCurrencyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:NorthHorizonPtyLtdMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">PPCB:AUDCurrencyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_custom_NorthHorizonPtyLtdMember_custom_AUDCurrenryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:NorthHorizonPtyLtdMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">PPCB:AUDCurrenryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_custom_NorthHorizonPtyLtdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:NorthHorizonPtyLtdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_custom_MrsNathanielszMember_custom_AUDCurrenryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">PPCB:MrsNathanielszMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">PPCB:AUDCurrenryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_custom_MrsNathanielszMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">PPCB:MrsNathanielszMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_srt_ChiefExecutiveOfficerMember_custom_AUDCurrenryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">PPCB:AUDCurrenryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_srt_ChiefExecutiveOfficerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_custom_EmploymentAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:EmploymentAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_custom_ServicesAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:ServicesAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_custom_AUDCurrenryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">PPCB:AUDCurrenryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_us-gaap_ConvertibleDebtMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_us-gaap_MeasurementInputPriceVolatilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_us-gaap_MeasurementInputPriceVolatilityMember_us-gaap_ConvertibleDebtMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_us-gaap_MeasurementInputExpectedTermMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_us-gaap_MeasurementInputExpectedTermMember_us-gaap_ConvertibleDebtMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_us-gaap_MeasurementInputRiskFreeInterestRateMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_us-gaap_MeasurementInputRiskFreeInterestRateMember_us-gaap_ConvertibleDebtMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_us-gaap_MeasurementInputExpectedDividendRateMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_us-gaap_MeasurementInputExpectedDividendRateMember_us-gaap_ConvertibleDebtMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_us-gaap_FairValueInputsLevel1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_us-gaap_FairValueInputsLevel2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_us-gaap_FairValueInputsLevel3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_us-gaap_SubsequentEventMember_custom_ElevenSeriesAWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">PPCB:ElevenSeriesAWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-10-012021-10-31_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-10-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-10-192021-10-21_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-10-19</xbrli:startDate>
        <xbrli:endDate>2021-10-21</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-21_us-gaap_SubsequentEventMember_custom_OctoberTwentyOneTwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:OctoberTwentyOneTwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-21</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-10-192021-10-21_us-gaap_SubsequentEventMember_custom_OctoberTwentyOneTwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001517681</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:OctoberTwentyOneTwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-10-19</xbrli:startDate>
        <xbrli:endDate>2021-10-21</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Pure">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Integer">
      <xbrli:measure>PPCB:Integer</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Euro">
      <xbrli:measure>iso4217:EUR</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="AUD">
      <xbrli:measure>iso4217:AUD</xbrli:measure>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As
filed with the Securities and Exchange Commission on January 10, 2022</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Registration
No. 333-238240</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; width: 100%; margin-bottom: 0pt"><div style="border-top: Black 4pt solid; border-bottom: Black 1.5pt solid; margin-top: 0pt; font-size: 1pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>UNITED
STATES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>Washington,
D.C. 20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif"><b>Post-Effective
</b></span><span style="font-family: Times New Roman, Times, Serif"><b>Amendment Number 1 to</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>FORM
S-1</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>REGISTRATION
STATEMENT UNDER THE SECURITIES ACT OF 1933</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b><span id="xdx_90C_edei--EntityRegistrantName_c20210701__20210930_ztuz0URot9Hc"><ix:nonNumeric contextRef="From2021-07-01to2021-09-30" name="dei:EntityRegistrantName">Propanc
Biopharma, Inc.</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact
name of registrant as specified in its charter)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90C_edei--EntityIncorporationStateCountryCode_c20210701__20210930_zGZpIbJpw0Lk"><ix:nonNumeric contextRef="From2021-07-01to2021-09-30" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2834</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_909_edei--EntityTaxIdentificationNumber_c20210701__20210930_zir7rUQlwKnb"><ix:nonNumeric contextRef="From2021-07-01to2021-09-30" name="dei:EntityTaxIdentificationNumber">33-0662986</ix:nonNumeric></span></b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State
                                         of</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incorporation)</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Primary
                                         Standard Industrial</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Classification
        Number)</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(IRS
                                         Employer</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identification
        Number)</span></p></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>James
Nathanielsz</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Chief
Executive Officer</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Propanc
Biopharma, Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90C_edei--EntityAddressAddressLine1_c20210701__20210930" title="Entity Address, Address Line One"><ix:nonNumeric contextRef="From2021-07-01to2021-09-30" name="dei:EntityAddressAddressLine1">302</ix:nonNumeric></span>,
<span id="xdx_90D_edei--EntityAddressAddressLine2_c20210701__20210930" title="Entity Address, Address Line Two"><ix:nonNumeric contextRef="From2021-07-01to2021-09-30" name="dei:EntityAddressAddressLine2">6 Butler Street</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_902_edei--EntityAddressCityOrTown_c20210701__20210930" title="Entity Address, City or Town"><ix:nonNumeric contextRef="From2021-07-01to2021-09-30" name="dei:EntityAddressCityOrTown">Camberwell</ix:nonNumeric></span>,
VIC, <span id="xdx_900_edei--EntityAddressPostalZipCode_c20210701__20210930" title="Entity Address, Postal Zip Code"><ix:nonNumeric contextRef="From2021-07-01to2021-09-30" name="dei:EntityAddressPostalZipCode">3124</ix:nonNumeric></span> Australia</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>+<span id="xdx_90A_edei--CityAreaCode_c20210701__20210930" title="City Area Code"><ix:nonNumeric contextRef="From2021-07-01to2021-09-30" name="dei:CityAreaCode">61-03</ix:nonNumeric></span>-<span id="xdx_904_edei--LocalPhoneNumber_c20210701__20210930" title="Local Phone Number"><ix:nonNumeric contextRef="From2021-07-01to2021-09-30" name="dei:LocalPhoneNumber">9882-0780</ix:nonNumeric></b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address,
including zip code, and telephone number, including area code,</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of
registrant&#8217;s principal executive offices)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please
send copies of all communications to:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>John O&#8217;Leary, Esq.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Patrizio &amp; O&#8217;Leary</b><b> LLP</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>300
Carnegie Center, Suite 150</b></span> </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Princeton,
NJ 08540</b></span> </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Tel.
No.: (609) 786-2525</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address,
including zip code, and telephone, including area code)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Approximate
date of proposed sale to the public:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under
the Securities Act of 1933, check the following box. &#9746;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please
check the following box and list the Securities Act registration statement number of the earlier effective registration statement
for the same offering. &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
this Form is a post-effective amendment filed pursuant to rule 462(c) under the Securities Act, check the following box and list
the Securities Act registration statement number of the earlier effective registration statement for the same offering. &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the
Securities Act registration statement number of the earlier effective registration statement for the same offering.
&#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller
reporting company. See definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting
company&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act. (Check one):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 70%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Large
    accelerated filer &#9744;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accelerated
    filer &#9744;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_edei--EntityFilerCategory_c20210701__20210930_zvSQeZ1zPZhb"><ix:nonNumeric contextRef="From2021-07-01to2021-09-30" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory">Non-accelerated
    filer</ix:nonNumeric></span> &#9746;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Smaller
    reporting company <span id="xdx_907_edei--EntitySmallBusiness_c20210701__20210930_zUjenj0QKTKc"><ix:nonNumeric contextRef="From2021-07-01to2021-09-30" format="ixt:booleantrue" name="dei:EntitySmallBusiness">&#9746;</ix:nonNumeric></span></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
    growth company <span id="xdx_90D_edei--EntityEmergingGrowthCompany_c20210701__20210930_zKAHrg7xcYh6"><ix:nonNumeric contextRef="From2021-07-01to2021-09-30" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by checkmark if the registrant has not elected to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until
the registrant shall file a further amendment which specifically states that this registration statement shall thereafter become
effective in accordance with Section 8(a) of the Securities Act or until the registration statement shall become effective on
such date as the Commission, acting pursuant to said section 8(a), may determine.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt; border-bottom: Black 4pt solid">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>


<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%">&#160;</td><td style="width: 33%">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>EXPLANATORY NOTE</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>On May 13, 2020, Propanc Biopharma, Inc. (the
&#8220;Company&#8221;) filed a Registration Statement on Form S-1 (No. 333-238240) (the &#8220;Registration Statement&#8221;) with the
Securities and Exchange Commission (the &#8220;SEC&#8221;) that was subsequently declared effective on November 12, 2020. The Registration
Statement registered the resale of up to 150,000,000 shares of the Company&#8217;s common stock, $0.001 par value per share by the selling
security holder identified in the prospectus contained therein.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>This Post-Effective Amendment is <span style="background-color: white">being
filed pursuant to the undertakings in Item 16 of the Registration Statement to update and supplement the information t</span>o (i) include
the information in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended June 30, 2021, as filed with the SEC on September
28, 2021, (ii) include the information in the Company&#8217;s Quarterly Report on Form 10-Q for the three-months ended September 30,
2021, as filed with the SEC on November 12, 2021, (iii) include the information in the Company&#8217;s Current Reports filed on Form
8-K with the SEC on December 1, 2021, December 7, 2021, December 13, 2021, respectively, and (iv) make certain other updates as contained
herein.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b>The Registration Statement
originally covered, on an adjusted one-for 1,000 reverse stock split of the common stock, a primary offering of (i) 805 shares of common
stock (ii) 10,445 shares of common stock underlying pre-funded warrants to purchase common stock, (iii) 11,250 shares of common stock
underlying Series A warrants to purchase common stock, (iv) 63,750 shares of common stock underlying Series B warrants to purchase common
stock, and (v) 63,750 shares of common stock underlying Series C warrants to purchase common stock.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b>This Post-Effective
Amendment covers the sale of 53,750 </b>&#160;<b>shares of common stock underlying Series B warrants to purchase common stock.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b>All share and per
share information in this Post-Effective Amendment has been adjusted to reflect a one-for-1,000 reverse stock split of the Company&#8217;s
common stock, which went effective on November 19, 2020.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b>No additional securities
are being registered under this Post-Effective Amendment. All applicable registration fees were paid at the time of the original filing
of the Registration Statement.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b></b></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Red"><b>PRELIMINARY
PROSPECTUS SUBJECT TO COMPLETION DATED JANUARY 10, 2022 </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Red">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Red">The
information in this prospectus is not complete and may be changed. We may not sell these securities until the registration statement
filed with the Securities and Exchange Commission is effective. This prospectus is not an offer to sell these securities and it
is not soliciting offers to buy these securities in any jurisdiction where the offer or sale is not permitted.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Propanc
Biopharma, Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><b>53,750</b><b>
Shares of Common Stock Issuable Upon Exercise of Outstanding Series B Warrants</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">This prospectus relates to the issuance of up
to 53,750 shares of Common Stock underlying warrants (the &#8220;Series B Warrant&#8221;) currently outstanding. Each Series B Warrant
has an exercise price per share equal to $40.00 per share and will expire on the three-year anniversary of its original issuance
date. The Purchaser is not permitted to exercise portion of the Series B Warrants that would result in the Purchaser, together with its
affiliates and certain related parties, beneficially owning more than 4.99% of our outstanding common stock following the consummation
of this offering.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our shares of Common Stock are currently quoted on
the OTC QB market operated by the OTC Markets Group, Inc., under the ticker symbol &#8220;PPCB.&#8221; On January 7, 2022,
the closing price as reported on the OTC QB was $0.03. This price will fluctuate based on the demand for our Common
Stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Investing in our securities involves a high
degree of risk. Before buying any securities, you should read the discussion of material risks of investing in our common stock under
the heading &#8220;Risk Factors&#8221; beginning on page 27 of this prospectus.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Neither the Securities and Exchange Commission
nor any foreign or state securities commission has approved or disapproved of these securities or passed upon the adequacy or accuracy
of this prospectus. Any representation to the contrary is a criminal offense.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Selling Stockholder of the securities and any
of its pledgees, assignees and successors-in-interest may, from time to time, offer common stock at prevailing market prices at the time
of the sale, at fixed prices, at negotiated prices, or at varying prices determined at the time of sale.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
&#8220;Plan of Distribution&#8221; beginning on page 55 of this prospectus for more information.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will not receive any of the proceeds from the sale of shares of common stock by the Selling Stockholder. See &#8220;Use of Proceeds.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus provides a general description of the securities being offered. You should read this prospectus and the registration
statement of which it forms a part before you invest in any securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Investing
in our securities involves a high degree of risk. See &#8220;Risk Factors&#8221; beginning on page 27 of this prospectus for a
discussion of information that should be considered in connection with an investment in our securities.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Neither
the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or
determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>You
should rely only on the information contained in this prospectus or any prospectus supplement or amendment hereto. We have not
authorized anyone to provide you with different information. If anyone provides you with different or inconsistent information,
you should not rely upon it. This prospectus is not an offer to sell, nor is the selling stockholder seeking an offer to buy,
securities in any state where such offer or solicitation is not permitted. The information in this prospectus is complete and
accurate only as of the date on the front cover of this prospectus, regardless of the time of delivery of this prospectus or any
sale of shares of our common stock. Our business, financial condition, results of operations and prospects may have changed since
that date.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
date of this prospectus is January 10, 2022.</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%">&#160;</td><td style="width: 33%">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TABLE
OF CONTENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_001">Prospectus
    Summary</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_002">Risk
    Factors</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">27</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_003">Cautionary
    Note Regarding Forward-Looking Statements</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">52</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_004">Use
    of Proceeds</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">54</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_005">Determination
    of Offering Price</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">54</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_006">Selling
    Stockholder</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">54</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_007">Plan
    of Distribution</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">55</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#v_001">Market
    for Our Common Stock and Related Stockholder Matters</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">57</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#v_002">Management&#8217;s
    Discussion and Analysis of Financial Condition and Results of Operations</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">58</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#arp_007">Directors, Executive Officers and Corporate Governance</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">69</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#arp_008">Executive Compensation</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">75</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#arp_011">Transactions with Related Persons, Promoters and certain Control Persons and Director Independence</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">80</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#arp_009">Security Ownership of Certain Beneficial Owners and Management</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">82</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#arp_012">Description of Capital Stock</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">83</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#arp_013">Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">89</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#arp_014">Where You Can Find More Information</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">89</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#v_009">Index
    to Consolidated Financial Statements</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-1</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Propanc
Biopharma, Inc., the Propanc Biopharma logo, and other trademarks or service marks of Propanc Biopharma appearing in this prospectus
are the property of Propanc Biopharma, Inc. This prospectus also includes trademarks, tradenames and service marks that are the
property of other organizations. Solely for convenience, trademarks and tradenames referred to in this prospectus appear without
the &#174; and &#8482; symbols, but those references are not intended to indicate, in any way, that we will not assert, to the
fullest extent under applicable law, our rights, or that the applicable owner will not assert its rights, to these trademarks
and tradenames.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
should rely only on the information contained in this prospectus or in any related free writing prospectus filed by us with the
Securities and Exchange Commission (the &#8220;SEC&#8221;). We have not authorized anyone to provide you with any information
or to make any representation not contained in this prospectus or incorporated by reference. We do not take any responsibility
for, and can provide no assurance as to the reliability of, any information that others may provide to you. This prospectus is
not an offer to sell or an offer to buy securities in any jurisdiction where offers and sales are not permitted. The information
in this prospectus is accurate only as of its date, regardless of the time of delivery of this prospectus or any sale of securities.
You should not assume that the information contained in this prospectus or any prospectus supplement or free writing prospectus
is accurate as of any date other than the date on the front cover of those documents, or that the information contained in any
document incorporated by reference is accurate as of any date other than the date of the document incorporated by reference, regardless
of the time of delivery of this prospectus or any sale of a security. Our business, financial condition, results of operations
and prospects may have changed since those dates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have not done anything that would permit a public offering of the securities or possession or distribution of this prospectus
in any jurisdiction where action for that purpose is required, other than in the United States. Persons outside the United States
who come into possession of this prospectus must inform themselves about, and observe any restrictions relating to, the offering
of the securities and the distribution of this prospectus outside of the United States.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>


<!-- Field: Page; Sequence: 4 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_001"></span>PROSPECTUS
SUMMARY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
following summary highlights information contained elsewhere or incorporated by reference in this prospectus and does not contain all
of the information you should consider in making your investment decision. You should read this summary together with the more detailed
information, including our consolidated financial statements and the related notes included in this prospectus, contained or incorporated
by reference in this prospectus. You should carefully consider, among other things, the matters discussed under the headings &#8220;Risk
Factors,&#8221; &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; and in our
consolidated financial statements, before making an investment decision. You should also read and consider the information in the documents
to which we have referred you in &#8220;Where You Can Find Additional Information&#8221; And &#8220;Incorporation of Certain Information
by Reference.&#8221;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>As
used in this prospectus, unless the context otherwise requires, references to &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221;
&#8220;our Company,&#8221; the &#8220;Company&#8221; and &#8220;Propanc&#8221; refer to Propanc Biopharma, Inc. and our wholly owned
subsidiary Propanc PPY LTD.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Business
Overview</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Propanc
Biopharma is a biopharmaceutical company developing a novel approach to prevent recurrence and metastasis from solid
tumors by using pancreatic proenzymes that target and eradicate cancer stem cells in patients suffering from pancreatic,
ovarian and colorectal cancers. Our novel proenzyme therapy is based on the science that enzymes stimulate biological reactions in
the body, especially enzymes secreted by the pancreas. These pancreatic enzymes could represent the body&#8217;s primary defense against
cancer.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
lead product candidate, PRP, is a variation upon our novel formulation and involves proenzymes, the inactive precursors of enzymes. As
a result of positive early indications of the anti-cancer effects of our technology, we have conducted successful pre-clinical
studies on PRP and also commenced preparation for a clinical study in advanced cancer patients. Subject to us receiving sufficient financing,
we plan to begin our Investigational Medicinal Product Dossier, study proposal and Investigator&#8217;s Brochure in the 2021 calendar
year. Our plan is to then commence our study preparation process with the contract research organization, analytical lab and trial site(s)
selection and to begin our clinical trial application for PRP (&#8220;CTA&#8221;) compilation in the first calendar quarter of
2022 and complete the CTA compilation and submit the CTA in the first half of 2022. In the second quarter
of 2022, we plan to begin the preparation of logistics and trial site initiation visits. Subject to raising additional sufficient
capital, we subsequently plan to commence a First-In-Human (FIH), Phase Ib study in patients with advanced solid tumors, evaluating the
safety, pharmacokinetics and anti-tumor efficacy of PRP in the second half of 2022 calendar year, which study we hope to
complete within twelve months thereafter. We intend to develop our PRP to treat early-stage cancer and pre-cancerous diseases and as
a preventative measure for patients at risk of developing cancer based on genetic screening.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PRP
is an intravenous injection proenzyme treatment designed as a therapeutic option in cancer treatment and prevention. PRP is a combination
of the pancreatic proenzymes, trypsinogen and chymotrypsinogen. PRP produces multiple effects on cancerous cells intended to inhibit
tumor growth and potentially stop a tumor from spreading through the body.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
received notification from the U.S. Food and Drug Administration (FDA) that PRP had been conferred Orphan Drug Designation for the treatment
of pancreatic cancer. This special status is granted when a rare disease or condition is implicated and a potential treatment qualifies
under the Orphan Drug Act and applicable FDA regulations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
Certificate for Advance Overseas Finding was received from the Board of Innovation and Science Australia to receive up to a 43.5% &#8220;cash
back&#8221; benefit from overseas R&amp;D expenses. The finding relates to the planned Phase 1 clinical trial &#8211; Multiple Ascending
Dose Studies of proteolytic proenzymes for the treatment of advanced cancer patients suffering from solid tumors planned to be conducted
at the Peter MacCallum Center, Melbourne, Australia. Overseas activities to be undertaken include the development of an analytical
assay for the quantification of active pharmaceutical ingredients in the Company&#8217;s lead product candidate, PRP, and its manufacture
of the finished product for the Phase 1 clinical trial.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 5; Options: NewSection; Value: 4 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
POP1 joint research and drug discovery program is designed to produce a backup clinical compound to the lead product candidate, PRP.
With the aim of producing large quantities of trypsinogen and chymotrypsinogen for commercial use, exhibiting minimal variation between
lots and without sourcing the proenzymes from animals, Propanc Biopharma is undertaking a challenging research project in collaboration
with the Universities of Ja&#233;n and Granada. We entered into a second two-year joint research and collaboration agreement with the
University of Ja&#233;n who are undertaking the research activities for the POP1 program.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>OUR
FOCUS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cancer
occurs when cells in the body start to divide quickly and uncontrollably with an ability to migrate from one location and spread to distant
sites. A cell becomes cancerous when it becomes undifferentiated. The cell forgets to do its job and invests all its energy to proliferating.
Unlike normal cells, cancer cells multiply, but do not differentiate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
cancer therapies take advantage of the uncontrolled proliferation of the cancer cells and kill these cells by targeting the cell division
machinery. These therapies are effective but affect healthy cells as well, particularly those with a high rate of cell turnover, inducing
undesirable side effects.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
goal is to stop cancer not by targeting tumor cell death, but inducing cell differentiation. This is known as differentiation therapy.
The key focus is to convince the malignant cells to stop proliferating and return to do their work as a specific cell type. Differentiation
therapy does not target cell death, so healthy cells within the patient will not be compromised, unlike chemotherapeutic drugs or gamma
irradiation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Differentiation
therapy induces the cancer cells into the pathway of terminal differentiation and eventual senescence (i.e., a non-proliferative state).
Differentiation therapy acts not only against cancer cells, but interestingly can turn cancer stem cells (undifferentiated cells) towards
completely differentiated (i.e., normal) cells.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are natural elements within our body that could help us fight against cancer. Enzymes are natural proteins that stimulate and accelerate
biological reactions in the body. Particularly enzymes secreted by the exocrine pancreas that are essential for the digestion of proteins
and fats. More than one hundred years ago, Professor John Beard first proposed that pancreatic enzymes represent the body&#8217;s primary
defense against cancer and would be useful as a cancer treatment. Since then, several scientists have endorsed Beard&#180;s hypothesis
with encouraging data from patient treatment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are developing a long-term therapy based on a pancreatic proenzyme formulation to prevent tumor recurrence and metastasis, the main cause
of patient death from cancer. PRP is a novel, patented, formulation consisting of two proenzymes mixed in a synergetic ratio.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">After
extensive laboratory research and a limited amount of human data, we have evidence that PRP:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reduces
    cancer cell growth via promotion of cell differentiation;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Enhances
    cell adhesion and may suppress metastasis progression;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibited
    no observable serious side effects and improves patient survival.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PRP</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PRP
is a mixture of two proenzymes, trypsinogen and chymotrypsinogen from bovine pancreas administered by intravenous injection. A synergistic
ratio of 1:6 inhibits growth of most tumor cells. Examples include kidney, ovarian, breast, brain, prostate, colorectal, lung liver,
uterine and skin cancers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 6 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Mechanism
Of Action</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Metastasis
occurs because a program inside the cell, called the Epithelial-Mesenchymal Transition (EMT) is activated, which causes epithelial cancer
cells to become invasive and stem cell-like, features which then allow these cancer cells to spread and metastasize. PRP reverses the
conversion from an epithelial to a mesenchymal phenotype and, as such, may reduce the metastatic potential of the tumor cells. PRP also
promotes the acquisition of a less malignant phenotype, in addition to a decrease in proliferation due to lineage (i.e., direct descent)
specific cellular differentiation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Selectivity</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PRP
treatment affects the TGF&#946; pathway, a significant tumor promoter in late-stage cancer. The likely molecular targets are proteinase-activated-receptors
(PARs) type 1 and 2, which are over frequently overexpressed in many types of cancers. Trypsinogen and chymotrypsinogen are activated
by proteases in the extracellular matrix of tumor cells. In turn, trypsin (activated trypsinogen) has a preference to activate PAR-2,
whilst Chymotrypsin (activated chymotrypsinogen) mainly activates PAR-1.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Effects
Against Cancer Stem Cells</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cancer
Stem Cells are resistant to standard treatments because they remain dormant for long periods, then migrate to other organs, and trigger
explosive tumor growth, causing the patient to relapse. Approximately eighty percent of cancers are from solid tumors and metastasis
is the main cause of patient death. Our unique patented approach is designed to target and eradicate cancer stem cells not killed by
radiation or chemotherapy.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PRP
is designed to target and eradicate cancer stem cells not killed by radiation or chemotherapy. Traditional cancer therapies act on tumor
replicating cells, but not cancer stem cells, so they can rebuild the tumor mass and can migrate to start a new tumor in another organ.
PRP stops cancer stem cells so that a tumor loses the ability to generate new cells and therefore the tumor disappears with no option
to form a metastatic tumor elsewhere.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PRP
treatment regulates up to four relevant pathways related to cancer spread and metastasis of cancer stem cells. PRP acts on TGF&#946;,
Hippo, Wnt and Notch pathways. It promotes the up-regulation of RAC1b which avoids the hyper-activation of the p38 pathway induced by
the TGF&#946; pathway, leading to the phosphorylation of YAP, which sequesters B-catenin in the cytoplasm, blocking the canonical Wnt
pathway and inhibiting the Notch pathway. That cascade of reactions implies the disruption of the cancer stem cell phenotype and the
reversal of the malignant epithelial to mesenchymal transition process that leads to tumor invasion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>PRP
Impairs Niche Formation and Tumor Initiation</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
proenzyme treatment inhibits the expression of genes related to the cancer stem cell phenotype, changing these malignant cells toward
a more differentiated and less dangerous cellular condition. PRP interferes with the signals that the primary tumor sends to other tissues
to prepare the pre-metastatic niche.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>In
Vivo Efficacy of PRP In Pancreatic and Ovarian Tumors</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
effect of the pro-enzyme formulation PRP at different doses on tumor weight in orthotopically implanted pancreatic and ovary tumors was
evaluated. In the pancreatic tumor model, there was significant (*P &lt; 0.05) reduction in mean tumor weight in animals
treated for 26 days with trypsinogen/chymotrypsinogen at 83.3/500 mg/kg (30.2 mg; 85.9% inhibition) compared with control (PBS; 214.8
mg). Furthermore, ovary tumor-bearing mice showed a significant (*P &lt; 0.05) reduction in mean tumor weight in animals
treated for 21 days with two different doses of trypsinogen/chymotrypsinogen, 9.1/54 mg/kg and 27.5/165 mg/kg, compared with control
(PBS). The mean weight of control group tumors was 2062.2 mg while the treated groups presented a mean tumor weight of 1074.2 mg and
957.3 respectively, ranging in a 50% tumor inhibition (52&#8211;46%).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 7 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Overview
Of Clinical Studies</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
clinical efficacy of a suppository formulation containing bovine pancreatic pro-enzymes trypsinogen and chymotrypsinogen was
evaluated in the context of a UK Pharmaceuticals Special Scheme and the results were published in a peer reviewed journal, <i>Scientific
Reports</i>. Clinical effects were studied in 46 patients with advanced metastatic cancers of different origin (prostate,
breast, ovarian, pancreatic, colorectal, stomach, non-small cell lung, bowel cancer and melanoma) after treatment with a rectal
formulation of both pancreatic pro-enzymes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
severe or serious adverse events related to the rectal administration were observed. Patients did not experience any hematological side
effects as typically seen with classical chemotherapy regimens. No allergic reactions after rectal administration of suppositories were
observed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to assess the therapeutic activity of rectal administration, overall survival of patients under treatment was compared to the life
expectancy assigned to a patient prior to treatment start. Nineteen from 46 patients (41.3%) with advanced malignant diseases, most of
them suffering from metastases, had a survival time significantly longer than their expected, in fact, for the whole set of cancer types,
mean survival (9.0 months) was significantly higher than mean life expectation (5.6 months). Although the number of patients per cancer
indication is naturally quite low, 3 out of 8 patients with prostate cancer and 5 out of 11 patients with gastrointestinal cancers appear
to particularly benefit from the treatment with the proenzyme suppositories.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PRP
proves to be an in vivo effective and non-toxic anti-tumor treatment, able to inhibit angiogenesis and tumor growth, cancer cell migration
and invasiveness. Furthermore, a suppository formulation containing both pancreatic proenzymes increased the life expectancy of advanced
cancer patients. Consequently, PRP could have relevant oncological clinical applications for the treatment of solid tumors like advanced
pancreatic adenocarcinoma and advanced epithelial ovarian cancer.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 56%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Cancer
    Type</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 20%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Life
                                            Expectation</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(months)</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 20%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Survival
*</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(months)</b></span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td rowspan="4" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pancreatic
    carcinoma (n = 4)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lt;3</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lt;3</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td rowspan="7" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ovarian
    Cancer (n = 7)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lt;12</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">38</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lt;1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td rowspan="6" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Breast
    Cancer (n = 6)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lt;12</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td rowspan="5" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Colon
    Rectal Cancer (n = 5)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">40</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td rowspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gastric
    Cancer (n = 2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lt;3</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td rowspan="8" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prostate
    Cancer (n = 8)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lt;12</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-Hodgkin
    Lymphoma (n = 1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mesothelioma
    (n = 1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td rowspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Melanoma
    (n = 2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lt;3</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neuro-endocrine
    Tumor (n = 1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">24</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td rowspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bladder
    (n = 2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lt;3</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td rowspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NSCLS
    (n = 2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td rowspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bowel
    (n = 2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lt;12</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lt;3</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Small
    Cell Carcinoma (n = 1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lt;12</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Renal
    Cancer (n = 1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lt;3</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Abdomen
    unknown primary (n = 1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lt;12</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Overview
of clinical studies. Patients who met prognosis of life expectation (*). For the whole set of cancer types, mean survival (9.0 months)
was statistically significantly higher than mean life expectation (5.6 months). One way ANOVA (&#945; = 0.05, P &lt; 0.05).</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 8 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>POP1
JOINT RESEARCH AND DRUG DISCOVERY PROGRAM</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
date, both proenzymes were synthesized and purified in the laboratory. Once purified, the proenzymes were lyophilized (freeze dried)
and each formed a stable, dry white powder. The sequence of proteins of each proenzyme were then determined by mass spectrometry. Larger
quantities of the proenzymes were produced with the objective of establishing their combined anti-cancer effects against pancreatic and
colorectal cancers. In addition, research activities were transferred to the MEDINA Foundation Research Center to investigate the potential
to scale up production of the recombinant proenzymes from the expression of the novel expression system, which is currently ongoing.
MEDINA is a Non-Profit Research Organization established in 2008 through a public-private alliance between the Regional Government of
Andalusia, Spain, the pharmaceutical company Merck Sharp &amp; Dohme de Espa&#241;a S.A. (MSD), and the University of Granada. Medina&#8217;s
scientific platforms support the development of multidisciplinary research programs in Microbiology, Natural Product Chemistry and Screening
&amp; Target Validation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are elucidating the molecular pathways involved in the proenzymes anti-tumor efficacy and study how proenzymes interact with the pre-metastatic
tumor niche, focusing on the interaction and suppression of tumor associated cells, like cancer-associated fibroblasts and macrophages.
A pre-metastatic tumor niche is an environment in a secondary organ conducive to the metastasis of a primary tumor. Such a niche provides
favorable conditions for growth, and eventually metastasis, in an otherwise foreign and hostile environment for the primary tumor cells.
Metastasis remains the main cause of patient death from solid tumors for cancer sufferers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
achieve this, we are using integrated tumor models in a microfluidics chip by obtaining 3-dimensional bio-impression samples from patients
with advanced solid tumors, developed at the Centre for Biomedical Research, University of Granada, Granada, Spain. As well as explaining
the mechanism of action by which proenzymes exert their anti-cancer effects, it also confirms whether proenzymes penetrate into the tumor
microenvironment and exert their effects. At the same time, it confirms the selectivity of the drug on solid tumors, by targeting cancer
cells and leaving healthy cells alone.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
date, our investigation has confirmed that proenzyme therapy is effective against cancer stem cells, which are the cells responsible
for the formation of secondary tumors through metastasis. They were also observed to be effective against cancer cells within the primary
tumor, whilst also leaving non-tumor cells alone. The final part of the investigation is to determine the effects of the proenzymes against
both these cancerous cell types within the tumor microenvironment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Joint Research Team successfully published data confirming the anti-tumor potential of a mixture of trypsinogen and chymotrypsinogen.
Treatment with proenzymes sensitizes cancer stem cells, which may allow standard treatment approaches like chemotherapy and radiotherapy
to be more effective.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
vision is to produce a backup product candidate to PRP which can further stabilize and enhance the effects of the proenzymes when administered
to patients. Our scientific researchers are in the process of optimizing conditions to achieve high titers of recombinant trypsinogen
and chymotrypsinogen with this expression system.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PRP
TARGET INDICATIONS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
management of cancer differs widely, with a multitude of factors impacting the choice of treatment strategy. Some of those factors include:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    type of tumor, usually defined by the tissue in the body from which it originated;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    extent to which it has spread beyond its original location;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    availability of treatments, driven by multiple factors including cost, drugs approved, local availability of suitable facilities,
    etc.;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">regional
    and geographic differences;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">whether
    the primary tumor is amenable to surgery, either as a potentially curative procedure, or as a palliative one; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    balance between potential risks and potential benefits from the various treatments and, probably most importantly, the patient&#8217;s
    wishes.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 9 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
many patients with solid cancers, such as breast, ovarian, colorectal, lung and pancreatic cancer, surgery is frequently the first treatment
option, often followed by first line chemotherapy with or without radiotherapy. While hopefully such procedures are curative, in many
instances the tumor returns, and second line treatment strategies are chosen in an effort to achieve a degree of control over the tumor.
In most instances, the benefit is temporary, and eventually the point is reached where the patient&#8217;s tumor either fails to adequately
respond to treatment, or the treatment has unacceptable toxicity which severely limits its usefulness.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Should
the planned Phase I, II and III clinical trials confirm the efficacy of PRP, along with the favorable safety and tolerability profile
suggested by pre-clinical studies conducted to date, we believe our product will have utility in a number of clinical situations including:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
    </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the early-stage management of solid tumors,
    most likely as part of a multi-pronged treatment strategy in combination with existing therapeutic interventions;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a product that can be administered long term
    for patients following standard treatment approaches, such as surgery, or chemotherapy, in order to prevent or delay recurrence;
    and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a preventative measure for patients at risk
    of developing cancer based on genetic screening.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the near term as part of our planned Phase I, II and III clinical trials, we plan to target patients with solid tumors, most likely ovarian
and pancreatic, for whom other treatment options have been exhausted. This is a common approach by which most new drugs for cancer are
initially tested. Once efficacy and safety has been demonstrated in this patient population, exploration of the potential utility of
the drug in earlier stage disease can be undertaken, together with investigation of the drug&#8217;s utility in other types of cancers,
such as gastro-esophageal tumors, colon or rectal carcinoma might be conducted. A Phase II study in a back-up indication, such as advanced
therapy refractant prostate cancer will also be considered. This indication is based on positive preclinical pharmacology studies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Pancreatic
Cancer</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pancreatic
cancer is one of the most lethal malignancies with a median survival of less than 6 months and a 5-year survival rate of less than 5%.
The lethal nature of this disease stems from its propensity to rapidly disseminate to the lymphatic system and distant organs. This aggressive
biology and resistance to conventional and targeted therapeutic agents leads to a typical clinical presentation of incurable disease
at the time of diagnosis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pancreatic
cancer has claimed notoriety over the last decades by proving to be one of the most recalcitrant solid tumors. As an indicator of its
lethality, pancreatic cancer accounts for less than 3% of new cancers diagnosed annually in developed countries, yet it is the third
leading cause of cancer related mortality.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
pancreatic cancer is an essentially fatal condition, disease duration is roughly equivalent with survival time. The median time of survival
of patients with pancreatic cancer depends on the extend of disease at the time of diagnosis and ranges from 11-20 months for patients
who qualified for surgical resection (Stage I/II), to 6-11 months for patients with locally advanced disease (Stage III), and only 2-6
months for patients with metastatic disease (Stage IV) (Amikura 1995, Richter 2003). Taking these low survival times into consideration,
the yearly incidence rates for pancreatic cancer are considered the more relevant measure for this disease.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
year the American Cancer Society estimates the numbers of new cancer cases and deaths that will occur in the United States in the current
year and compiles the most recent data on cancer incidence, mortality, and survival. Incidence data are collected by the National Cancer
Institute (NCI), the Centers for Disease Control and Prevention (CDC), and the North American Association of Central Cancer Registries
(NAACCR). In 2015, a total of more than 1,500,000 new cancer cases and more than 500,000 cancer deaths will occur in the United States.
Amongst these, a total of almost 50.000 new cases of pancreatic cancer (3.33% of new cancer cases) have been estimated, which will result
in more than 40,000 deaths (8% of cancer deaths). This means only 20% survival rate of patients diagnosed with pancreatic cancer.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 10 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Ovarian
Cancer</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ovarian
cancer is a generic term that can be used for any cancer involving the ovaries, arising from one of the several different cell types
of ovaries, including germ cells, specialized gonadal stromal cells and epithelial cells. Epithelial ovarian cancer accounts for 90 percent
of ovarian cancers and is responsible for most ovarian cancer related deaths. Furthermore, several subtypes of ovarian cancer have been
described according to different risk factors, different genetic mutations, different biological behaviors and different prognoses. This
heterogeneity of the disease has impeded progress in the prevention, early detection, treatment and management of ovarian cancer.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ovarian
cancer is the seventh most commonly diagnosed cancer among women in the world and accounts for an estimated 239,000 new cases and 152,000
deaths worldwide annually, of which 21,290 new cases and 14,180 related deaths are estimated to occur in the USA alone. The disease typically
presents at late stage when the 5-year relative survival rate is only 29%. Few cases (15%) are diagnosed with localized tumor (stage
1), when the 5-year survival rate is 92%. Strikingly, the overall 5-year relative survival rate generally ranges between 30%&#8211;40%
across the globe and has seen only very modest increases since 1995.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PRP
DEVELOPMENT STRATEGY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
goal is to undertake early-stage clinical development of PRP through to a significant value inflection point, where the commercial attractiveness
of a drug in development, together with a greater likelihood of achieving market authorization, may attract potential interest from licensees
seeking to acquire new products. Such value inflection points in the context of cancer drugs are typically at the point where formal,
controlled clinical trials have demonstrated either &#8216;efficacy&#8217; or &#8216;proof of concept&#8217; &#8211; typically meaning
that there is controlled clinical trial evidence that the drug is effective in the proposed target patient population, has an acceptable
safety profile, and is suitable for further development. From a &#8216;big picture&#8217; perspective, it is our intention to progress
the development of our technology through the completion of our planned Phase IIa clinical trials and then to seek a licensee for further
development beyond that point.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
part of that commercial strategy, we will:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">continue
    research and development to build our existing intellectual property portfolio, and to seek new, patentable discoveries;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">seek
    to ensure all product development is undertaken in a manner that makes its products approvable in the major pharmaceutical markets,
    including the U.S., Europe, the UK, Australia and Japan;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">aggressively
    pursue the protection of our technology through all means possible, including patents in all major jurisdictions, and potentially
    trade secrets; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">make
    strategic acquisitions to acquire new companies that have intellectual property or products that complement our future goals.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PRP
DEVELOPMENT PLAN AND MILESTONES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
plan to progress PRP down a conventional early-stage clinical development pathway for:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">regulatory
    and/or ethics approval to conduct a Phase Ib study; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phase
    IIa multiple escalating dose studies to investigate the safety, tolerability, and pharmacokinetics of PRP administered intravenously
    to patients.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preclinical
development has been completed, including pharmacology and safety toxicology studies, process development activities and bioanalytical
method development. The full-scale GMP (Good Manufacturing Practice) finished product manufacture of PRP will be completed in preparation
for the FIH Phase Ib study. Validation of the bioanalytical method will also be completed prior to lodging our first clinical trial application
(CTA) which we plan to undertake at the Peter Mac Cancer Center in Melbourne, Victoria, Australia&#8217;s biggest cancer hospital. Propanc
Biopharma is collaborating with contract research organizations, manufacturing partners and consultants to complete activities prior
to preparing the CTA for the Phase Ib study.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 11 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has received expressions of interest to evaluate proenzyme therapy as a method to prevent recurrence and metastasis of solid
tumors in pancreatic and ovarian cancers. The letters of interest were confirmed by medical oncologists specializing in pancreatic and
ovarian cancers, from the University Hospital of Ja&#233;n, in Granada, Spain. The evaluation will most likely be conducted as separate
Phase IIa proof of concept (POC), multi-trial center studies for each target indication. The expressions of interest were confirmed after
their evaluation of Propanc&#8217;s scientific literature supporting the use of proenzymes in pancreatic and ovarian cancers. The Phase
IIa POC studies will be conducted after the Phase Ib dose escalation study investigating the tolerability and activity of proenzyme therapy
in patients with advanced solid tumors is completed at the Peter Mac Cancer Center.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
Australia, we</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> receive up to 43.5% &#8220;cash-back&#8221;
benefit in the form of a refund of their qualified research and development costs and expenses. The Company received a refund of $151,767
AUD ($113,415 USD) and $199,834 AUD ($134,728 USD) for the years ended June 30, 2021 and 2020 respectively. We are
continuing to evaluate all options to conduct our planned clinical trials in the most cost-efficient manner, while striving to minimize
dilution to our stockholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
anticipate reaching the Phase IIa proof of concept milestone in approximately three to four years, subject to regulatory approval in
Europe, and the results from our research and development and licensing activities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
overhead and expenses are likely to increase from its current level as PRP progresses down the development pathway. This increase will
be driven by the need to increase our internal resources in order to effectively manage our research and development activities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Anticipated
timelines</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
second quarter of 2022 calendar year, we anticipate the submission of the Clinical Trial Application for PRP. We
anticipate receiving approval of such application in the first half of 2022. Following the clinical trial application,
we plan to commence our Study Preparation, including CRO Selection and Contracts, Analytical Lab Selection Contracts and Trial Sites
Selection and Contracts. In connection with the Clinical Trial Application, this product will be part of our Investigation Medicinal
Product Dossier, Study Protocol and Investigator&#8217;s Brochure. In the second half of 2022 calendar year, we hope to
complete the Study Preparation together with the Preparation of Logistics and Trial Sites Initiation Visits and complete our clinical
trial application review. Commencing in the second half of 2022 calendar year, we intend to initiate a Phase Ib study in
advanced cancer patients with solid tumors and the anticipated costs will be approximately $6.5 million. We will need to raise additional
financing to fund our planned Phase I, II and III clinical trials and for working capital.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 70%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Research
    Activity</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 28%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Timeline</b>&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Clinical
    Trial Application (CTA)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td rowspan="4" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">November
    2021 - April 2022</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investigational
    Medicinal Product Dossier</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phase
    Ib Clinical Study Protocol</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investigator&#8217;s
    Brochure</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CTA
    Compilation</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March
    - May 2022</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CTA
    submission</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
    2022</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CTA
    Approval</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
    2022</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CTA
    Review</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
    20&#8217;22 &#8211; July 2022</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contract
    Research Organization &amp; Contracts</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td rowspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">January
    &#8211; May 2022</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Analytical
    Laboratory Selection &amp; Contracts</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trial
    Site Selection &amp; Contracts</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preparation
    of Logistics</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td rowspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
    &#8211; September 2022</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trial
    Site Initiation Visits</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">First
    Patient/First Visit</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
    2022</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 12 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>POP1
JOINT RESEARCH AND DRUG DISCOVERY PROGRAM</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
outlined previously, a joint research and drug discovery program has been established with our collaborators at the Universities of Ja&#233;n
and Granada to investigate the changes in genetic and protein expression that occur in cancer cells as a consequence of being exposed
to our proenzyme formulation. The objective of this work is to understand at the molecular level the targets of our proenzyme formulation,
thereby providing the opportunity for new, patentable drugs which can be developed further. We plan to commence a targeted drug discovery
program utilizing the identified molecular target to search for novel anticancer agents.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">One
specific objective of the project is to synthesize both proenzymes by an in vivo system to produce crystalized proteins that could be
maintained for long periods without suffering degradation, even in absence of refrigeration. This will be particularly useful for a longer
shelf life as well as global distribution of the drug product, particularly in warmer climates and developing regions where refrigeration
may not be available.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
POP1 joint research and drug discovery program has produced synthetic recombinant versions of the two proenzymes, trypsinogen and chymotrypsinogen.
Propanc Biopharma&#8217;s joint scientific researchers are developing a novel expression system and are also in the process of optimizing
conditions to achieve high titers of recombinant trypsinogen and chymotrypsinogen. Further, the anticancer effects of the synthetic versions
will be tested against the naturally derived proenzymes from bovine origin.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FINANCIAL
OBJECTIVES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Multiple
factors, many of which are outside of our control, can impact our ability to achieve our target objectives within the planned time and
budgetary constraints. Subject to these caveats, our objective is to complete our planned Phase IIa study for PRP within the proposed
budget.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
primarily outsource services, skills and expertise to third parties as required to achieve our scientific and corporate objectives. As
the business grows and gains more personnel, outsourcing will continue to be the preferred model, where fixed and variable costs are
carefully managed on a project-by-project basis. This means our research and development activities are carried out by third parties.
Additional third parties with specific expertise in research, compound screening and manufacturing (including raw material suppliers)
have been contracted as required.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CORPORATE
STRATEGY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
initial focus is to organize, coordinate and finance the various parts of our drug development pipeline. New personnel will be carefully
introduced into our Company over a period of time as our research and development activities expand. They will have specific expertise
in product development, manufacture and formulation, regulatory affairs, toxicology, clinical operations and business development (including
intellectual property management, licensing and other corporate activities). In the first instance, additional clinical management and
development expertise is likely to be required for our lead product. Therefore, we anticipate an increase in employees in order to effectively
manage our contractors as the projects progress down the development pathway.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
outsourcing strategy is common in the biotechnology sector and is an efficient way to obtain access to the necessary skills required
to progress a project, in particular as the required skills change as the project progresses from discovery, through manufacturing and
non-clinical development and into clinical trials. We anticipate that we will continue to use this model, thereby retaining the flexibility
to contract in the appropriate resource as and when required.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
intend to seek and identify potential licensing partners for our product candidates as they progress through the various development
stages, reaching certain milestones and value inflection points. If a suitable licensee is identified, a potential licensing deal could
consist of payments for certain milestones, plus royalties from future sales if the product is able to receive approval from the relevant
regulatory authorities where future product sales are targeted. We intend to seek and identify potential licensees based on the initial
efficacy data from Phase II clinical trials. To accomplish this objective, we have commenced discussions with potential partners in our
current preclinical phase of development.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 13 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
part of our overall expansion strategy, from time to time, we investigate potential intellectual property acquisition opportunities to
expand our product portfolio. While our initial focus is on the development of PRP as the lead product candidate, potential product candidates
may also be considered for future preclinical and clinical development. These potential opportunities have arisen from other research
and development organizations, which either own existing intellectual property or are currently developing new intellectual property,
which may be of interest to us. These opportunities are possible new cancer treatments that are potentially less toxic than existing
treatment approaches and are able to fill an existing gap in the treatment process, such as a systemic de-bulking method which could
reduce the size and threat of metastases to a more manageable level for late-stage cancer patients.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe these potential treatment approaches will be complementary to existing treatment regimens and our existing product candidate,
PRP. No formal approaches have been made at this stage and it is unknown whether we will engage in this discussion in the near future.
However, as PRP progresses further down the development pathway, we intend to assess future opportunities that may arise
to use the expertise of our management and scientific personnel for future prospective research and development projects.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CURRENT
OPERATIONS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are at a pre-revenue stage. We do not know when, if ever, we will be able to commercialize our products and begin generating revenue.
We are focusing our efforts on organizing, coordinating and financing the various aspects of the drug research and development program
outlined earlier in this document. In order to commercialize our products, we must complete preclinical development, Phase Ib, IIa and
IIb clinical trials in Europe, the U.S., United Kingdom, Australia or elsewhere, and satisfy the applicable regulatory authority that
PRP is safe and effective. If the results from the Phase II trials are convincing, we will seek conditional approval from the regulatory
authorities sooner. Therefore, from the time we commence clinical trials, we estimate that this will take approximately three to four
years if we seek conditional approval upon completion of Phase II trials. As described previously, when we advance our development projects
sufficiently down the development pathway and achieve a major increase in value, such as obtaining interim efficacy data from Phase II
clinical trials, we will seek a suitable licensing partner to complete the remaining development activities, obtain regulatory approval
and market the product.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CURRENT
THERAPIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are developing a therapeutic solution for the treatment of patients with advanced stages of cancer targeting solid tumors, which is cancer
that originates in organs or tissues other than bone marrow or the lymph system. Common cancer types classified as solid tumors include
lung, colorectal, ovarian cancer, pancreatic cancer and liver cancers. In each of these indications, there is a large market opportunity
to capitalize on the limitations of current therapies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current
therapeutic options for the treatment of cancer offer, at most, a few months of extra life or tumor stabilization. Some experts believe
that drugs that kill most tumor cells do not affect cancer stem cells, which can regenerate the tumor (e.g., chemotherapy). Studies
are revealing the genetic changes in cells that cause cancer and spur its growth. This research is providing scientific researchers with
many potential targets for drugs. Tumor cells, however, can develop resistance to drugs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Limitations
of Current Therapies</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PRP
was developed because of the limitation of current cancer therapies. While surgery is often safe and effective for early-stage
cancer, many standard therapies for late-stage cancer urgently need improvement; current treatments generally provide modest benefits,
and frequently cause significant adverse effects. Our focus is to provide oncologists and their patients with therapies for metastatic
cancer which are more effective than current therapies, and which have a substantially reduced side effect profile.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
progress has been made within the oncology sector in developing new treatments, the overall cancer death rate has only improved by 7%
over the last 30 years.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 14 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Most
of these new treatments have some limitations, such as:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">significant
    toxic effects;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">expense;
    and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">limited
    survival benefits.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe that our treatment will provide a competitive advantage over the following treatments:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chemotherapeutics:
    Side effects from chemotherapy can include pain, diarrhea, constipation, mouth sores, hair loss, nausea and vomiting, as well as
    blood-related side effects, which may include a low cell count of infection fighting white blood cells (neutropenia), low red blood
    cell count (anemia), and low platelet count (thrombocytopenia). Our goal is to demonstrate that our treatment will be more effective
    than chemotherapeutic and hormonal therapies with fewer side effects.</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Targeted
    therapies: The most common type is multi-targeted kinase inhibitors (molecules which inhibit a specific class of enzymes called kinases).
    Common side effects include fatigue, rash, hand&#8211;foot reaction, diarrhea, hypertension and dyspnea (shortness of breath). Further,
    tyrosine kinases inhibited by these drugs appear to develop resistance to inhibitors. While the clinical findings with PRP are early
    and subject to confirmation in future clinical trials, no evidence has yet been observed of the development of resistance by the
    cancer to PRP.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Monoclonal
    antibodies: Development of monoclonal antibodies is often difficult due to safety concerns. Side effects that are most common include
    skin and gastro-intestinal toxicities. For example, several serious side effects from Avastin, an anti-angiogenic cancer drug, include
    gastrointestinal perforation and dehiscence (e.g., rupture of the bowel), severe hypertension (often requiring emergency treatment)
    and nephrotic syndrome (protein leakage into the urine). Antibody therapy can be applied to various cancer types, but can also be
    limited to certain genetic sub populations in many instances.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Immunotherapy:
    There is a long history of attempts to develop therapeutic cancer vaccines to stimulate the body&#8217;s own immune system to attack
    cancer cells. While these products generally do not have the poor safety profile of standard therapeutic approaches, only a small
    number of them are FDA-approved and available compared to the number of patients diagnosed with cancer. Furthermore, only a relatively
    small number of the patient population is eligible to receive and subsequently respond to treatment, as defined by preventing tumor
    growth.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>MARKET
OPPORTUNITY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
global metastatic cancer treatment market is predicted to reach $111 Billion by 2027 by Emergen Research. Demand for new cancer products
can largely be attributed to a combination of a rapidly aging population in western countries and changing environmental factors, which
together are resulting in rising cancer incidence rates. Worldwide, the World Health Organization estimated 19.3 million new cancer cases
and almost 10.0 million cancer deaths occurred in 2020. As such, global demand for new cancer treatments which are effective, safe and
easy to administer is rapidly increasing. Our treatment will potentially target many aggressive tumor types for which little or few treatment
options exist.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
plan to target patients with solid tumors, most likely pancreatic and ovarian tumors, for whom other treatment options have been exhausted.
Globally these cancers resulted in over 673,255 deaths in 2020, according to the World Health Organization. With such a high mortality
rate, a substantial unmet medical need exists for new treatments. Once the efficacy and safety of PRP has been demonstrated in late-stage
patient populations, we plan to undertake exploration of the utility of the drug in earlier stage disease, together with investigation
of the drug&#8217;s utility in other types of cancer.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 15 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Anticipated
Market Potential</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
is difficult to estimate the size of the market opportunity for this specific type of product as a clinically proven, pro-enzyme formulated
suppository marketed to oncologists across global territories for specific cancer indications, to the best of management&#8217;s knowledge,
has not been previously available. However, the markets for potential market for pancreatic and ovarian cancers may be characterized
as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    world market for pancreatic cancer drugs is projected to grow to $4.2 billion by the year 2025, according to Grandview Research.
    Major players operating in the pancreatic cancer therapy market include Eli Lilly and Company, F. Hoffmann-La Roche AG, Celgene Corporation,
    Amgen Inc., Novartis AG, Pharmacyte Biotech Inc., Clovis Oncology, Teva Pharmaceutical Industries Ltd., Pfizer Inc., Merck &amp;
    Co., Inc. among others. For instance, in May 2018, Eli Lilly and Company acquired AMRO BioSciences. AMRO BioSciences is engaged into
    number of drugs for cancer. The clinical trial explores a drug (pegilodecakin) which is ongoing for the pancreatic cancer. The developments
    performed by the companies are helping the market to grow in the coming years.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    global market for ovarian cancer drugs expected to reach $10.1 billion by 2027, according to iHealthcareAnalyst. This will be driven
    by continued uptake and expected launches of the approved PARP (poly adenosine diphosphate-ribose polymerase) inhibitors. Major competitors
    operating in the global ovarian cancer treatment market include AbbVie, Inc., AstraZeneca plc (Acerta Pharma), Boehringer Ingelheim
    GmbH, Chugai Pharmaceutical Co., Ltd., Clovis Oncology, Five Prime Therapeutics, Inc., GlaxoSmithKline plc (Tesaro), Gradalis, Inc.,
    Incyte Corporation, MacroGenics, Inc., Mateon Therapeutics, Inc., Merck &amp; Co., Inc., Novartis AG, Novogen Limited, Oasmia Pharmaceuticals,
    Inc., Pfizer, Inc., PharmaMar S.A, and Roche Holding AG.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
products can be defined as addition-in-class, advance-in-class, or first-in-class, depending on their degree of innovation. Addition-in-class
products, defined as new Active Pharmaceutical Ingredients (API) with established mechanisms of action, are often clinically important
and highly commercially successful. Advance-in-class product innovation, defined as significantly differentiated and innovative new APIs,
albeit with established mechanisms of action, remains a highly attractive strategy. However, first-in-class innovation, defined as products
with a molecular target and/or mechanism of action not found in any approved products globally, remains the key product development strategy
in terms of providing the greatest degree of differentiation, extending to a first-mover advantage and potentially the capture of significant
market share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
on the current situation for these two markets, we believe there is an attractive opportunity in both the pancreatic and ovarian cancer
market sectors for the introduction of a first-in-class, clinically proven product which can achieve new benefits for patients in terms
of survival and quality of life. The current concentration of products suggests oncologists may be willing to try newly approved products,
particularly if they can exhibit a favorable safety profile, although substantive R&amp;D activities will be necessary to both obtain
regulatory approval, and to generate the clinical safety and efficacy data needed to convince clinicians to use a new product.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>LICENSE
AGREEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>University
of Bath</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
previously sponsored a collaborative research project at University of Bath to investigate the cellular and molecular mechanisms
underlying the potential clinical approach of our proprietary proenzyme formulation. As a result of this undertaking, we entered into
a Commercialization Agreement with University of Bath (UK), dated November 12, 2009 (the &#8220;Commercialization Agreement&#8221;),
where, initially, we held an exclusive license with Bath University, and where we and University of Bath co-owned the intellectual
property relating to our proenzyme formulations. The Commercialization Agreement originally provided for University of Bath to
assign the Patents (as defined therein) to Propanc in certain specified circumstances, such as successful completion of a clinical trial
and commencement of a Phase II (Proof of Concept) clinical trial.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 16 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 14, 2012, Propanc and University of Bath agreed to an earlier assignment to us of the patents pursuant to an Assignment and
Amendment Deed, on the provision that Bath University retains certain rights arising from the Commercialization Agreement, as
follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">University
    of Bath reserves for itself (and its employees and students and permitted academic sub-licensees with respect to research
    use) the non-exclusive, irrevocable, worldwide, royalty free right to use the patents for research use;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    publication rights of University of Bath specified in the contract relating to the original research made between the parties
    with an effective date of July 18, 2008 shall continue in force;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Propanc
    shall pay to University of Bath a royalty of two percent of any and all net revenues;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Propanc
    shall use all reasonable endeavors to develop and commercially exploit the patents for the mutual benefit of University of Bath
    and Propanc to the maximum extent throughout the covered territory and in any additional territory and to obtain, maintain and/or
    renew any licenses or authorizations that are necessary to enable such development and commercial exploitation. Without prejudice
    to the generality of the foregoing, Propanc shall comply with all relevant regulatory requirements in respect of its sponsoring and/or
    performing clinical trials in humans involving the administration of a product or materials within a claim of the patents; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Propanc
    shall take out with a reputable insurance company and maintain liability insurance coverage prior to the first human trials.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
consideration of such assignment, we agreed to pay royalties of 2% of net revenues to University of Bath. Additionally, we agreed
to pay 5% of each and every license agreement subscribed for. The contract is cancellable at any time by either party. To date, no amounts
are owed under the agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>University
of Ja&#233;n</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have established a collaboration with the University of Ja&#233;n to carry out a Research Project aimed at the synthetic development
of PRP and its subsequent validation. The University of Ja&#233;n is providing scientific research activities the Department of Health
Sciences, which provides the necessary technical and human resources in order to carry out the programmed works. A Collaboration Agreement
(the &#8220;Collaboration Agreement&#8221;) according was established, dated October 1, 2020, with the main objective for the synthetic
development of PRP and its subsequent validation. To that end, there shall be established a pre-clinical protocol of safety evaluation
and antitumor efficacy on cancer stem cells and in orthotopic xenotransplantations derived from cancer stem cells isolated from tumor
cell lines, of a newly developed synthetic formulation based on the two pancreatic zymogens.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
ownership of potential intellectual property rights that may arise as a result of the knowledge obtained through the project will belong
to Propanc. In consideration for payment of the compensation, the University of Ja&#233;n hereby assigns and agrees to do all things
reasonably required to assign to the contracting entity all industrial property rights arising from the Project.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
return for ownership of the entire right and title in all industrial property rights arising from the Project, Propanc agrees to pay
the University of Ja&#233;n two percent (2%) of the net sales of any products sold by the contracting entity which fall within the
scope of the protection of such industrial property rights.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Future
Agreements</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
continue to learn the properties of proenzymes with the long-term aim of screening new compounds for development. We anticipate engaging
in future discussions with several technology companies who are progressing new developments in the oncology field as potential additions
to our product line. Initially targeting the oncology sector, our focus is to identify and develop novel treatments that are highly effective
targeted therapies, with few side effects as a result of toxicity to healthy cells.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 17 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>INTELLECTUAL
PROPERTY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> filed multiple patent applications relating
to its lead product, PRP. The Company&#8217;s lead patent application has been granted and remains in force in the United
States, Belgium, Czech Republic, Denmark, France, Germany, Ireland, Italy, Netherlands, Portugal, Spain, Sweden, Switzerland, Liechtenstein,
Turkey, United Kingdom, Australia, China, Japan, Indonesia, Israel, New Zealand, Singapore, Malaysia, South Africa, Mexico, Republic
of Korea, India and Brazil. In Canada, the patent application remains under examination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
2016 and early 2017, we filed other patent applications. Three applications were filed under the Patent Cooperation
Treaty (the &#8220;PCT&#8221;). The PCT assists applicants in seeking patent protection by filing one international patent application
under the PCT, applicants can simultaneously seek protection for an invention in over 150 countries. Once filed, the application
is placed under the control of the national or regional patent offices, as applicable, in what is called the national phase. One of
the PCT applications filed in November 2016, entered national phase in July 2018 and another PCT application entered
national phase in August 2018. A third PCT application entered national phase in October 2018.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Presently,
there are 35 granted patents and 30 patents&#160;under examination in key global jurisdictions relating to the use of proenzymes against
solid tumors, covering the lead product candidate PRP.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further
patent applications are expected to be filed to capture and protect additional patentable subject matter based on the Company&#8217;s
field of technology relating to pharmaceutical compositions of proenzymes for treating cancer.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>REGULATORY
MATTERS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>United
States</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Government
oversight of the pharmaceutical industry is usually classified into pre-approval and post-approval categories. Most of the therapeutically
significant innovative products marketed today are the subject of New Drug Applications (&#8220;NDA&#8221;). Preapproval activities,
based on these detailed applications, are used to assure the product is safe and effective before marketing. In the United States, The
Center for Drug Evaluation and Research (&#8220;CDER&#8221;), is the FDA organization responsible for over-the- counter and prescription
drugs, including most biological therapeutics, and generic drugs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Before
approval, the FDA may inspect and audit the development facilities, planned production facilities, clinical trials, institutional review
boards and laboratory facilities in which the product was tested in animals. After the product is approved and marketed, the FDA uses
different mechanisms for assuring that firms adhere to the terms and conditions of approval described in the application and that the
product is manufactured in a consistent and controlled manner. This is done by periodic unannounced inspections of production and quality
control facilities by FDA&#8217;s field investigators and analysts.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Federal
Food, Drug and Cosmetic Act and Public Health Service Act</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prescription
drug and biologic products are subject to extensive pre- and post-market regulation by the FDA, including regulations that govern the
testing, manufacturing, safety, efficacy, labelling, storage, record keeping, advertising and promotion of such products under the Federal
Food, Drug and Cosmetic Act, the Public Health Service Act, and their implementing regulations. The process of obtaining FDA approval
and achieving and maintaining compliance with applicable laws and regulations requires the expenditure of substantial time and financial
resources. Failure to comply with applicable FDA or other requirements may result in refusal to approve pending applications, a clinical
hold, warning letters, civil or criminal penalties, recall or seizure of products, partial or total suspension of production or withdrawal
of the product from the market. FDA approval is required before any new drug or biologic, including a new use of a previously approved
drug, can be marketed in the United States. All applications for FDA approval must contain, among other things, information relating
to safety and efficacy, stability, manufacturing, processing, packaging, labelling and quality control.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 18 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>New
Drug Applications (&#8220;NDAs&#8221;)</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
FDA&#8217;s NDA approval process generally involves:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Completion
    of preclinical laboratory and animal testing in compliance with the FDA&#8217;s good laboratory practice, or GLP, regulations;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Submission
    to the FDA of an investigational new drug (&#8220;IND&#8221;) application for human clinical testing, which must become effective
    before human clinical trials may begin in the United States;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Performance
    of adequate and well-controlled human clinical trials to establish the safety, purity and potency of the proposed product for each
    intended use;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Satisfactory
    completion of an FDA pre-approval inspection of the facility or facilities at which the product is manufactured to assess compliance
    with the FDA&#8217;s &#8220;current good manufacturing practice&#8221; (&#8220;CGMP&#8221;) regulations; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Submission
    to and approval by the FDA of an NDA.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preclinical and clinical testing and approval process requires substantial time, effort and financial resources, and we cannot guarantee
that any approvals for our product candidates will be granted on a timely basis, if at all. Preclinical tests include laboratory evaluation
of toxicity and immunogenicity in animals. The results of preclinical tests, together with manufacturing information and analytical data,
are submitted as part of an IND application to the FDA. The IND automatically becomes effective 30 days after receipt by the FDA, unless
the FDA raises concerns or questions about the conduct of the clinical trial, including concerns that human research subjects will be
exposed to unreasonable health risks. In such a case, the IND sponsor and the FDA must resolve any outstanding concerns before clinical
trials can begin. Our submission of an IND may not result in FDA authorization to commence clinical trials. A separate submission to
an existing IND must also be made for each successive clinical trial conducted during product development. Further, an independent institutional
review board (&#8220;IRB&#8221;) covering each medical center proposing to conduct clinical trials must review and approve the plan for
any clinical trial before it commences at that center and it must monitor the study until completed. The FDA, the IRB or the sponsor
may suspend a clinical trial at any time on various grounds, including a finding that the subjects or patients are being exposed to an
unacceptable health risk. Clinical testing also must satisfy extensive &#8220;good clinical practice&#8221; (&#8220;GCP&#8221;) regulations,
which include requirements that all research subjects provide informed consent and that all clinical studies be conducted under the supervision
of one or more qualified investigators.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
purposes of an NDA submission and approval, human clinical trials are typically conducted in the following sequential phases, which may
overlap:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phase
    I: Initially conducted in a limited population to test the product candidate for safety and dose tolerance;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phase
    II: Generally conducted in a limited patient population to identify possible adverse effects and safety risks, to determine the initial
    efficacy of the product for specific targeted indications and to determine optimal dosage. A Phase IIa trial is a non-pivotal, exploratory
    study that assesses biological activity as its primary endpoint. A Phase IIb trial is designed as a definite dose finding study with
    efficacy as the primary endpoint. Multiple Phase II clinical trials may be conducted by the sponsor to obtain information prior to
    beginning larger and more extensive Phase III clinical trials;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phase
    III: Commonly referred to as pivotal studies. When Phase II evaluations demonstrate that a dose range of the product is effective
    and has an acceptable safety profile, Phase III clinical trials are undertaken in large patient populations to further evaluate dosage,
    to provide substantial evidence of clinical efficacy and to further test for safety in an expanded and diverse patient population
    at multiple, geographically-dispersed clinical trial sites. Generally, replicate evidence of safety and effectiveness needs to be
    demonstrated in two adequate and well-controlled Phase III clinical trials of a product candidate for a specific indication. These
    studies are intended to establish the overall risk/benefit ratio of the product and provide adequate basis for product labelling;
    and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phase
    IV: In some cases, the FDA may condition approval of a NDA on the sponsor&#8217;s agreement to conduct additional clinical trials
    to further assess the product&#8217;s safety, purity and potency after NDA approval. Such post-approval trials are typically referred
    to as Phase IV clinical trials.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 19 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Progress
reports detailing the results of the clinical studies must be submitted at least annually to the FDA and safety reports must be submitted
to the FDA and the investigators for serious and unexpected adverse events. Concurrent with clinical studies, sponsors usually complete
additional animal studies and must also develop additional information about the product and finalize a process for manufacturing the
product in commercial quantities in accordance with CGMP requirements. The manufacturing process must be capable of consistently producing
quality batches of the product candidate and, among other things, the manufacturer must develop methods for testing the identity, strength,
quality and purity of the final product. Moreover, appropriate packaging must be selected and tested, and stability studies must
be conducted to demonstrate that the product candidate does not undergo unacceptable deterioration over its shelf life.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
results of product development, preclinical studies and clinical trials, along with the aforementioned manufacturing information, are
submitted to the FDA as part of a NDA. NDA&#8217;s must also contain extensive manufacturing information. Under the Prescription Drug
User Fee Act (&#8220;PDUFA&#8221;), the FDA agrees to specific goals for NDA review time through a two-tiered classification system,
Standard Review and Priority Review. Standard Review is applied to products that offer at most, only minor improvement over existing
marketed therapies. Standard Review NDAs have a goal of being completed within a ten-month timeframe, although a review can take significantly
longer. A Priority Review designation is given to products that offer major advances in treatment, or provide a treatment where no adequate
therapy exists. A Priority Review takes the FDA six months to review a NDA. It is likely that our product candidates will be granted
Standard Reviews. The review process is often significantly extended by FDA requests for additional information or clarification. The
FDA may refer the application to an advisory committee for review, evaluation and recommendation as to whether the application should
be approved. The FDA is not bound by the recommendation of an advisory committee, but it generally follows such recommendations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
FDA may deny approval of a NDA if the applicable regulatory criteria are not satisfied, or it may require additional clinical data or
additional pivotal Phase III clinical trials. Even if such data is submitted, the FDA may ultimately decide that the NDA does not satisfy
the criteria for approval. Data from clinical trials is not always conclusive and the FDA may interpret data differently than Propanc.
Once issued, product approval may be withdrawn by the FDA if ongoing regulatory requirements are not met or if safety problems occur
after the product reaches the market. In addition, the FDA may require testing, including Phase IV clinical trials, Risk Evaluation and
Mitigation Strategies (&#8220;REMS&#8221;), and surveillance programs to monitor the effect of approved products that have been commercialized,
and the FDA has the power to prevent or limit further marketing of a product based on the results of these post-marketing programs. Products
may be marketed only for the approved indications and in accordance with the provisions of the approved label. Further, if there are
any modifications to the drug, including changes in indications, labelling or manufacturing processes or facilities, approval of a new
or supplemental NDA may be required, which may involve conducting additional preclinical studies and clinical trials.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Other
U.S. Regulatory Requirements</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">After
approval, products are subject to extensive continuing regulation by the FDA, which include company obligations to manufacture products
in accordance with GMP, maintain and provide to the FDA updated safety and efficacy information, report adverse experiences with the
product, keep certain records, submit periodic reports, obtain FDA approval of certain manufacturing or labeling changes and comply with
FDA promotion and advertising requirements and restrictions. Failure to meet these obligations can result in various adverse consequences,
both voluntary and FDA-imposed, including product recalls, withdrawal of approval, restrictions on marketing and the imposition of civil
fines and criminal penalties. In addition, later discovery of previously unknown safety or efficacy issues may result in restrictions
on the product, manufacturer or NDA holder.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Propanc,
and any manufacturers of our products, are required to comply with applicable FDA manufacturing requirements contained in the FDA&#8217;s
GMP regulations. GMP regulations require, among other things, quality control and quality assurance as well as the corresponding maintenance
of records and documentation. The manufacturing facilities for our products must meet GMP requirements to the satisfaction of the FDA
pursuant to a pre-approval inspection before Propanc can use them to manufacture products. Propanc and any third-party manufacturers
are also subject to periodic inspections of facilities by the FDA and other authorities, including procedures and operations used in
the testing and manufacture of our products to assess our compliance with applicable regulations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 20 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
respect to post-market product advertising and promotion, the FDA imposes complex regulations on entities that advertise and promote
pharmaceuticals, which include, among others, standards for direct-to-consumer advertising, promoting products for uses or in patient
populations that are not described in the product&#8217;s approved labeling (known as &#8220;off-label use&#8221;), industry-sponsored
scientific and educational activities and promotional activities involving the Internet. Failure to comply with FDA requirements can
have negative consequences, including adverse publicity, enforcement letters from the FDA, mandated corrective advertising or communications
with doctors and civil or criminal penalties. Although physicians may prescribe legally available drugs for off-label uses, manufacturers
may not market or promote such off-label uses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Changes
to some of the conditions established in an approved application, including changes in indications, labeling, or manufacturing processes
or facilities, require submission and FDA approval of a new NDA or NDA supplement before the change can be implemented. A NDA supplement
for a new indication typically requires clinical data similar to that in the original application, and the FDA uses the same procedures
and actions in reviewing NDA supplements as it does in reviewing a NDA.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adverse
event reporting and submission of periodic reports is required following FDA approval of a NDA. The FDA also may require post-marketing
testing, known as Phase IV testing, risk mitigation strategies and surveillance to monitor the effects of an approved product or to place
conditions on an approval that could restrict the distribution or use of the product.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
June 2017, we were notified by the FDA that PRP had been granted orphan drug designation for the treatment of pancreatic cancer. Orphan
drug designation may be granted by the FDA when a rare disease or condition is implicated and a potential treatment qualifies under the
Orphan Drug Act and applicable FDA regulations. This qualifies us for various developmental incentives, including protocol assistance,
the potential for research grants, the waiver of future application fees, and tax credits for clinical testing if we choose to host future
clinical trials in the United States.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
October 2017, we submitted a request for a second orphan drug designation for PRP, this time for ovarian cancer.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 2, 2017, we were notified by the FDA that our request was not granted. The Office of Orphan Products Development (&#8220;OOPD&#8221;)
stated that complete prevalence is used as a measure of disease in ovarian cancer, as this reflects the number of women who have been
diagnosed with disease and may be eligible for treatment with the proposed therapy. Therefore, on the date of the submission of our application,
the OOPD estimated that the prevalence of ovarian cancer was 228,110 cases. Since the prevalence exceeds the threshold of 200,000 to
qualify for orphan drug designation, they could not grant our request. We may consider resubmitting our application if we can identify
a suitable sub population in ovarian cancer, which may meet the target threshold.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>European
Union</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to regulations in the United States, we will be subject to a variety of foreign regulations governing clinical trials, commercial
sales and distribution of our products. Whether or not we obtain FDA approval for a product, we must obtain approval of a product by
the comparable regulatory authorities of foreign countries before we can commence clinical trials or market our product in those countries.
The approval process varies from country to country and the time may differ than that required for FDA approval. The requirements governing
the conduct of clinical trials, product licensing, pricing and reimbursement vary greatly from country to country. Despite these differences,
the clinical trials will be conducted according to international standards such as Good Clinical Practice (GCP), Good Manufacturing Practice
(GMP) and Good Laboratory Practice (GLP), which is recognized by each foreign country under the International Conference of Harmonization
(ICH) Guidelines. We will conduct our trials in each foreign jurisdiction according to these standards, undertaking a First-In-Human
(FIH) Phase I study in patients with advanced solid tumors, evaluating the safety, pharmacokinetics, and anti-tumor efficacy of PRP.
This will be followed by two Phase II studies evaluating the efficacy and safety of PRP. To ensure harmonization between the jurisdictions,
we intend to conduct regulatory meetings in the country where trials are conducted, as well as the FDA and European Medicines Agency.
A pre-IND (Investigational New Drug) meeting will be held with the FDA once initial patient data has been collected from the FIH study
to ensure acceptability of future planned Phase II trials.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 21 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
European Union regulatory systems, we must submit and obtain authorization for a clinical trial application in each member state in which
we intend to conduct a clinical trial. After we have completed clinical trials, we must obtain marketing authorization before it can
market its product. We must submit applications for marketing authorizations for oncology products under a centralized procedure. The
centralized procedure provides for the grant of a single marketing authorization that is valid for all European Union member states.
The European Medicines Agency (the &#8220;EMA&#8221;) is the agency responsible for the scientific evaluation of medicines that are to
be assessed via the centralized procedure.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 23, 2016, the UK government held a referendum to gauge voters&#8217; support to remain or leave the European Union. The referendum
resulted in 51.9% of UK voters in favor of leaving the European Union, commonly referred to as &#8220;Brexit.&#8221; On March 29, 2017,
the UK invoked Article 50 of Lisbon Treaty to initiate complete withdrawal from the European Union, which was effectuated on January
31, 2020. The center for the EMA was based in London but the European Union has relocated the center to The Netherlands.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
impact of Brexit on the drug approval process in the UK is uncertain. Companies based in the UK and operating in the drug industry
are urging the European Union and the UK to reach an agreement to harmonize the regulatory process once the UK officially exits the European
Union.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Australia</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
Australia, the relevant regulatory body responsible for the pharmaceutical industry is the Therapeutics Goods Administration (the &#8220;TGA&#8221;).
Prescription medicines are regulated under the Therapeutic Goods Act 1989. Under the Therapeutic Goods Act, the Therapeutic Goods Administration
evaluates new products for quality, safety and efficacy before being approved for market authorization, according to similar standards
employed by the FDA and EMA in the United States and European Union, respectively. However, receiving market authorization in one or
two regions does not guarantee approval in another.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Third-Party
Payor Coverage and Reimbursement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
none of our product candidates have been commercialized for any indication, if they are approved for marketing, commercial success of
our product candidates will depend, in part, upon the availability of coverage and reimbursement from third-party payors at the federal,
state and private levels. In addition, in many countries outside the United States, a drug must be approved for reimbursement before
it can be approved for sale in that country.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Eligibility
for reimbursement does not imply that any drug will be paid for in all cases or at a rate that covers our costs, including research,
development, manufacture, sale and distribution. Interim reimbursement levels for new drugs, if applicable, may also not be sufficient
to cover costs and may not be made permanent. Reimbursement rates may vary according to the use of the drug and the clinical setting
in which it is used, may be based on reimbursement levels already set for lower cost drugs and may be incorporated into existing payments
for other services. Net prices for drugs may be reduced by mandatory discounts or rebates required by government healthcare programs
or private payors and by any future relaxation of laws that presently restrict imports of drugs from countries where they may be sold
at lower prices than in the United States. Third-party payors often rely upon Medicare coverage policy and payment limitations in setting
their own reimbursement policies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
many countries outside the United States, a drug must be approved for reimbursement before it can be approved for sale in that country.
Approval by the FDA does not ensure approval by regulatory authorities in other countries or jurisdictions, and approval by one foreign
regulatory authority does not ensure approval by regulatory authorities in other foreign countries or by the FDA. The foreign regulatory
approval process may include all of the risks associated with obtaining FDA approval. We may not obtain foreign regulatory approvals
on a timely basis, if at all. We may not be able to file for regulatory approvals and may not receive necessary approvals to commercialize
our products in any foreign market.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 22 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
regulations that govern marketing approvals, pricing and reimbursement for new drug products vary widely from country to country. In
the United States, recently passed legislation may significantly change the approval requirements in ways that could involve additional
costs and cause delays in obtaining approvals. Some countries require approval of the sale price of a drug before it can be marketed.
In many countries, the pricing review period begins after marketing or product licensing approval is granted. In some foreign markets,
prescription pharmaceutical pricing remains subject to continuing governmental control even after initial approval is granted.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Government
authorities and third-party payors, such as private health insurers and health maintenance organizations, decide which medications they
will pay for and establish reimbursement levels. A primary trend in the U.S. healthcare industry and elsewhere is cost containment. Government
authorities and third-party payors have attempted to control costs by limiting coverage and the amount of reimbursement for particular
medications. Increasingly, third-party payors are requiring that drug companies provide them with predetermined discounts from list prices
and are challenging the prices charged for medical products.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Other
Regulations</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are also subject to numerous federal, state and local laws relating to such matters as safe working conditions, manufacturing practices,
environmental protection, fire hazard control, and disposal of hazardous or potentially hazardous substances. We may incur significant
costs to comply with such laws and regulations now or in the future.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>COMPETITION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
biotechnology and pharmaceutical industries are characterized by continuing technological advancement and significant competition. While
we believe that our technology platforms, product candidates, know-how, experience and scientific resources provide us with competitive
advantages, we face competition from major pharmaceutical and biotechnology companies, academic institutions, governmental agencies and
public and private research institutions, among others. Any product candidates that we successfully develop and commercialize will compete
with existing therapies and new therapies that may become available in the future. Key product features that would affect our ability
to effectively compete with other therapeutics include the efficacy, safety and convenience of our products. The level of generic competition
and the availability of reimbursement from government and other third-party payers will also significantly impact the pricing and competitiveness
of our products. Our competitors also may obtain FDA or other regulatory approval for their products more rapidly than we may obtain
approval for ours, which could result in our competitors establishing a strong market position before we are able to enter the market.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Many
of our competitors have significantly greater financial resources and expertise in research and development, manufacturing, preclinical
testing, conducting clinical trials, obtaining regulatory approvals and marketing approved products than we do. Smaller or early-stage
companies may also prove to be significant competitors, particularly through collaborative arrangements with large and established companies.
These competitors also compete with us in recruiting and retaining qualified scientific and management personnel and establishing clinical
trial sites and patient registration for clinical trials, as well as in acquiring technologies complementary to, or necessary for, our
programs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>EMPLOYEES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of January 10, 2022, we have one full-time and one part-time employee. In addition to our employees, we engage key consultants
and utilize the services of independent contractors to perform various services on our behalf. Some of our executive officers and directors
are engaged in outside business activities that we do not believe conflict with our business. Over time, we may be required to hire additional
employees or engage independent contractors to execute various projects that are necessary to grow and develop our business. These decisions
will be made by our officers and directors, if and when appropriate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CORPORATE
INFORMATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
principal executive office is located at 302, 6 Butler Street, Camberwell, VIC, 3124 Australia. Our telephone number is 61 03 9882
0780. Our website is www.propanc.com. We can be contacted by email at www.propanc.com/contact. Our website&#8217;s information is not,
and will not be deemed, a part of this Registration Statement or incorporated into any other filings we make with the SEC.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 23 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>RECENT
DEVELOPMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 26, 2021, the Company entered into a securities purchase agreement (the &#8220;Purchase Agreement&#8221;) with Sixth Street
Lending, LLC (&#8220;Sixth Street&#8221;), pursuant to which Sixth Street purchased a convertible promissory note from the Company in the aggregate principal amount of $53,750, such principal and the interest thereon convertible into shares of the
Company&#8217;s common stock at the option of Sixth Street. The transaction contemplated by the Purchase Agreement closed on or about
December 2, 2021. The Company intends to use the net proceeds ($50,000) from the Note for general working capital purposes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 30, 2021, the Company entered into a Common Stock Purchase Agreement (the &#8220;Purchase Agreement&#8221;) with Dutchess Capital
Growth Fund LP, a Delaware limited partnership, (&#8220;Dutchess&#8221;), providing for an equity financing facility (the &#8220;Equity
Line&#8221;). The Purchase Agreement provides that upon the terms and subject to the conditions in the Purchase Agreement, Dutchess is
committed to purchase up to Five Million Dollars ($5,000,000) of shares of common stock, $0.001 par value per share (the &#8220;Common
Stock&#8221;), over the 36 month term of the Purchase Agreement (the &#8220;Total Commitment&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the terms of the Purchase Agreement, Dutchess will not be obligated to purchase shares of Common Stock unless and until certain conditions
are met, including but not limited to a Registration Statement on Form S-1 (the &#8220;Registration Statement&#8221;) becoming effective
which registers Dutchess&#8217; resale of any Common Stock purchased by Dutchess under the Equity Line. From time to time over the 36-month
term of the Purchase Agreement, commencing on the trading day immediately following the date on which the Registration Statement becomes
effective, the Company, in our sole discretion, may provide Dutchess with a draw down notice (each, a &#8220;Draw Down Notice&#8221;),
to purchase a specified number of shares of Common Stock (each, a &#8220;Draw Down Amount Requested&#8221;), subject to the limitations
discussed below. The actual amount of proceeds the Company will receive pursuant to each Draw Down Notice (each, a &#8220;Draw Down Amount&#8221;)
is to be determined by multiplying the Draw Down Amount Requested by the applicable purchase price. The purchase price of each share
of Common Stock equals 92% of the lowest trading price of the Common Stock during the five (5) business days prior to the Closing Date.
Closing Date shall mean the five (5) business days after the Clearing Date. Clearing Date shall mean the first business day that the
Selling Shareholder holds the Draw Down Amount in its brokerage account and is eligible to trade the shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
maximum number of shares of Common Stock requested to be purchased pursuant to any single Draw Down Notice cannot exceed the lesser of
(i) 300% of the average daily share volume of the Common Stock in the five (5) trading days immediately preceding the Draw Down Notice
or (ii) an aggregate value of $250,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company agreed to pay to Dutchess a commitment fee for entering into the Purchase Agreement of 1,000,000 restricted shares of our common
stock. The shares were issued December 10, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 7, 2021, the Company entered into a securities purchase agreement (the &#8220;Purchase Agreement&#8221;) with ONE44 Capital
LLC, (&#8220;ONE44&#8221;), pursuant to which ONE44 purchased a convertible promissory note the &#8220;Note&#8221;) from the Company
in the aggregate principal amount of $170,000, such principal and the interest thereon convertible into shares of the Company&#8217;s
common stock at the option of ONE44. The transaction contemplated by the Purchase Agreement closed on or about December 13, 2021.
The Company intends to use the net proceeds ($153,000) from the Note for general working capital purposes. The Note contains an original
issue discount amount of $17,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 4, 2022, the Company) entered into a securities purchase agreement (the &#8220;Purchase Agreement&#8221;) with Sixth Street Lending,
LLC (&#8220;Sixth Street&#8221;), pursuant to which Sixth Street purchased a convertible promissory note from the Company in the aggregate
principal amount of $63,750, such principal and the interest thereon convertible into shares of the Company&#8217;s common stock at the
option of Sixth Street. The transaction contemplated by the Purchase Agreement closed on January 6, 2022. The Company intends to use
the net proceeds ($60,000) from the Note for general working capital purposes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 24 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>THE
OFFERING</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 36%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Common
    Stock underlying Series B Warrants to Purchase Common Stock:</b></span></td>
    <td style="width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 62%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Selling Stockholder is offering up to 53,750 shares of common stock underlying Series B warrants
                                            to purchase common stock. Each Series B Warrant has an exercise price per share equal to
                                            $40.00 per share and will expire on the three-year anniversary of its original issuance date.
                                            The Purchaser is not permitted to exercise portion of the Series B Warrants that would result
                                            in the Purchaser, together with its affiliates and certain related parties, beneficially
                                            owning more than 4.99% of our outstanding common stock following the consummation of this
                                            offering.</span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Selling
    Stockholder</b></span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ionic
    Ventures, LLC</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Use
    of proceeds</b></span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    will not receive any proceeds from the sale of common stock by the Selling Stockholder. All of the net proceeds from the sale of
    our common stock will go to the Selling Stockholder as described below in the sections entitled &#8220;Selling Stockholder&#8221;
    and &#8220;Plan of Distribution&#8221;. See &#8220;Use of Proceeds&#8221; on page 54 of this prospectus.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risk
    factors</b></span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investing
    in our securities is highly speculative and involves a high degree of risk. You should carefully consider the information set forth
    in the &#8220;Risk Factors&#8221; section beginning on page 27 before deciding to invest in our securities.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Trading
    symbol</b></span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    common stock is currently quoted on the OTC QB under the trading symbol &#8220;PPCB&#8221;.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Summary
of Risks</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
business is subject to a number of risks and uncertainties that you should understand before making an investment decision. For example,
we have no commercial product, a history of net losses, we expect to continue to incur net losses, we will require significant additional
funding and we may not achieve or maintain profitability. Furthermore, we have no cash flow from operations to sustain our operations.
We have historically relied upon the issuance of equity and/or convertible debt to fund our operations, which debt we are currently unable
to repay in cash. Our ability to ever generate revenues will depend solely on the commercial success of PRP, our only prospective product,
which depends upon its approval by applicable regulatory authorities and then market acceptance by purchasers in the pharmaceutical market
and the future market demand and medical need for products and research utilizing PRP. At present, PRP has only been used for research
and clinical trial purposes in animals, and there is no commercially approved drug product or drug product submitted in a pending marketing
application that incorporates PRP as an ingredient. As a result, no marketing authority has reviewed our drug master file (DMF) for PRP
as a product ingredient or inspected our Company. As of September 30, 2021, we have an accumulated deficit of $58,804,968
since inception. We have incurred substantial net losses since our inception, including net loss of $2,417,696 and $4,740,723
for the fiscal years ended June 30, 2021 and June 30, 2020, respectively. We expect to incur additional losses as we
continue to invest in our research and development programs and move forward with our human clinical trials application, clinical trials
and commercialization activities. Additional risks are discussed more fully in the section entitled &#8220;Risk Factors&#8221; following
this prospectus summary. These risks include, but are not limited to, the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    ability to continue as a going concern absent obtaining adequate new debt and/or equity financings.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 25 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    face risks related to Novel Coronavirus (COVID-19) which could significantly disrupt our research and development, operations, sales,
    and financial results<b><i>.</i></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    have incurred significant losses since our inception, and we expect to incur significant losses for the foreseeable future and may
    never achieve or maintain profitability.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    will continue to need substantial additional funding and raise capital when needed to initiate and continue our product development
    programs and commercialization efforts.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    an early-stage company, it may be difficult for you to evaluate the success of our business to date and to assess our future
    viability.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    currently rely, and may continue to rely for the foreseeable future, on substantial debt financing that we are not able to repay
    in cash.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Raising
    additional capital is highly likely to cause dilution to our stockholders, restrict our operations or require us to relinquish rights
    to our technologies or product candidate.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    conversion of some or all of our currently outstanding convertible notes in shares of our common stock will dilute the ownership
    interests of existing stockholders.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
    may be difficult for you to evaluate the success of our business to date and to assess our future viability.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    only product candidate, PRP, remains in the early stages of development and may never become commercially viable, and therefore,
    you may lose your investment.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PRP
    may cause undesirable side effects that could negatively impact its clinical trial results or limit its use, hindering further development,
    subject us to possible product liability claims, and make it more difficult to commercialize PRP.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    ability to successfully initiate and complete our clinical trials of PRP.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    ability to obtain regulatory approval in jurisdictions in the United States and outside the United States to be able to market PRP
    in those jurisdictions.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    ability in the future to establish sales and marketing capabilities or enter into agreements with third parties to sell and market
    PRP.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    face substantial competition, which may result in others discovering, developing or commercializing products before or more successfully
    than we do.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    ability to seek approval for reimbursement for PRP before it can be marketed, assuming successful commercialization, and us being
    then subject to unfavorable pricing regulations, third-party reimbursement practices or healthcare reform initiatives.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    may depend on collaborations with third parties for the development and commercialization of PRP, and these collaborations may be
    unsuccessful.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    third-party manufacturers of PRP performing satisfactorily or at all, and our reliance on any third-party for the supply of
    PRP.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 26 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    ability to comply with our obligations under any intellectual property licenses with third parties.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    ability to protect our intellectual property rights.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    ability to obtain, or if there are delays in obtaining, required regulatory approvals, to commercialize PRP, and our ability to generate
    revenue.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    ability to obtain marketing approval in international jurisdictions to market PRP in international jurisdictions.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    ability to obtain marketing approval of and commercialize PRP and affect the prices we may obtain.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PRP
    or any other product candidate for which we obtain marketing approval could be subject to restrictions or withdrawal from the market
    and our ability to comply with applicable regulatory requirements.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    rely on the significant experience and specialized expertise of the Chief Executive Officer/Chief Financial Officer, James
    Nathanielsz. </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    have identified material weaknesses in our internal control over financial reporting that, if not properly remediated, could result
    in material misstatements in our consolidated financial statements in future periods.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    ability to implement and maintain an effective system of internal control over financial reporting, and accordingly, our ability
    to accurately report our financial results or prevent fraud.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    market price of our common stock may continue to be highly volatile, and you may not be able to resell your shares at or above the
    public offering price and therefore, you could lose all or part of your investment.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    shares of common stock are thinly traded and there may not be an active, liquid trading market for our common shares.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    Chief Executive Officer/Chief Financial Officer is our controlling shareholder and will continue to control our Company for
    the foreseeable future due to his ownership of super-voting shares, and therefore, it is not likely that you will be able to elect
    directors or have any say in the policies of our Company.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Future
    sales and issuances of our capital stock or rights to purchase capital stock will result in additional dilution of the percentage
    ownership of our stockholders and could cause our stock price to decline.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    are a smaller reporting company, and therefore, we are subject to scaled disclosure requirements that may make it more challenging
    for investors to analyze our results of operations and financial prospects.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 27 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_002"></span>RISK
FACTORS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Investing
in our common stock involves a high degree of risk. You should carefully consider the risks described below, as well as the other information
in this prospectus, including our consolidated financial statements and the related notes and &#8220;Management&#8217;s Discussion and
Analysis of Financial Condition and Results of Operations,&#8221; before deciding whether to invest in our common stock. The occurrence
of any of the events or developments described below could harm our business, financial condition, operating results, and growth prospects.
In such an event, the market price of our common stock could decline, and you may lose all or part of your investment. Additional risks
and uncertainties not presently known to us or that we currently deem immaterial also may impair our business operations.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>RISKS
RELATED TO THIS OFFERING AND OWNERSHIP OF OUR SECURITIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>An
investment in shares of common stock and the warrants are extremely speculative and there can be no assurance of any return on any such
investment.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
investment in the shares of common stock and the warrants is extremely speculative and there is no assurance that investors will obtain
any return on their investment. Investors will be subject to substantial risks involved in an investment in us, including the risk of
losing their entire investment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Holders
of our warrants will have no rights as a common stockholder until they acquire our shares of common stock.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Until
you acquire our shares of common stock upon exercise of your warrants, you will have no rights with respect to our shares of common stock
issuable upon exercise of your warrants. Upon exercise of your warrants, you will be entitled to exercise the rights of a common stockholder
only as to matters for which the record date occurs after the exercise date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
warrants issued in this offering may not have any value.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
53,750 Series B Warrants each have an exercise price equal to $40.00 and will expire on the three (3) year anniversary
of the date they first become exercisable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
our shares of common stock are not listed on a national securities exchange, U.S. holders of the warrants may not be able to exercise
their warrants without compliance with applicable state securities laws and the value of your warrants may be significantly reduced.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
shares of common stock are currently quoted on OTC QB. If our shares of common stock are not listed on a national securities exchange
at the time of the completion of this offering, the exercise of the warrants by U.S. holders may not be exempt from state securities
laws. As a result, depending on the state of residence of a holder of the warrants, a U.S. holder may not be able to exercise its warrants
unless we comply with any state securities law requirements necessary to permit such exercise or an exemption applies. Although we plan
to use our reasonable efforts to assure that U.S. holders will be able to exercise their warrants under applicable state securities laws
if no exemption exists, there is no assurance that we will be able to do so. As a result, in the event that our shares of common stock
are not listed on a national securities exchange at the time of the completion of this offering, your ability to exercise your warrants
may be limited. The value of the warrants may be significantly reduced if U.S. holders are not able to exercise their warrants under
applicable state securities laws.</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 28 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
will require additional financing or financings, which would result in substantial dilution to existing stockholders.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Without
additional financing or curtailing our operations, we may not have the operating capital to continue our operations through 2022.
Management expects to continue incurring losses for the foreseeable future and will need to raise additional capital to pursue our
business plan into 2022. This offering is part of such efforts to raise additional required capital. In addition, we may decide
to expand operations, undertake strategic acquisitions or determine some other business need. Financing could include debt and/or equity
financings, including transactions with strategic customers and partners that may include debt and/or equity arrangements. Such sources
of financing may not be available on acceptable terms, if at all. Failure to obtain such financing may cause us to curtail or cease operations
and/or result in delay or indefinite postponement of research, development and launch of PRP, expansion initiatives, capital expenditures
and other operational priorities. Any transaction involving the issuance of previously authorized but unissued shares of common stock,
or securities convertible into shares of common stock, are likely to result in dilution, possibly substantial, to present and prospective
holders of shares of common stock and may be on unfavorable to us.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
face&#160;risks related to Novel&#160;Coronavirus&#160;(COVID-19) which could significantly disrupt our research and development,
operations, sales, and financial results.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
business will be adversely impacted by the effects of the Novel&#160;Coronavirus&#160;(COVID-19). In addition to global macroeconomic
effects, the Novel&#160;Coronavirus&#160;(COVID-19) outbreak and any other related adverse public health developments will cause disruption
to our operations, research and development, and sales activities. Our third-party manufacturers, third-party distributors, and our customers
have been and will be disrupted by worker absenteeism, quarantines and restrictions on employees&#8217; ability to work, office and&#160;factory
closures, disruptions to ports and other shipping infrastructure, border closures, or other travel or health-related restrictions. Depending
on the magnitude of such effects on our activities or the operations of our third-party manufacturers and third-party distributors, the
supply of our products will be delayed, which could adversely affect our business, operations and customer relationships. In addition,
the Novel&#160;Coronavirus&#160;(COVID-19) or other disease outbreak will in the short-run and may over the longer term adversely affect
the economies and financial markets of many countries, resulting in an economic downturn that will affect demand for our products and
impact our operating results. There can be no assurance that any decrease in sales resulting from the Novel&#160;Coronavirus&#160;(COVID-19)
will be offset by increased sales in subsequent periods. Although the magnitude of the impact of the Novel&#160;Coronavirus&#160;(COVID-19)
outbreak on our business and operations remains uncertain, the continued spread of the Novel&#160;Coronavirus&#160;(COVID-19) or the
occurrence of other epidemics and the imposition of related public health measures and travel and business restrictions will adversely
impact our business, financial condition, operating results and cash flows. In addition, we have experienced and will experience disruptions
to our business operations resulting from quarantines, self-isolations, or other movement and restrictions on the ability of our employees
to perform their jobs that may impact our ability to develop and design our products in a timely manner or meet required milestones or
customer commitments.</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>RISKS
RELATED TO OUR FINANCIAL CONDITION AND OUR NEED FOR ADDITIONAL CAPITAL</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
ability to continue as a going concern is in substantial doubt absent obtaining adequate new debt or equity financings.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt">We have concerns about our
ability to continue as a going concern based on the absence of revenues, recurring losses from operations and our need for additional
financing to fund all of our operations. Working capital limitations continue to impinge on our day-to-day operations, thus contributing
to continued operating losses. For the fiscal years ended June 30, 2021 and June 30, 2020, we had net losses of $2,025,947
and $4,740,723, respectively. Further, as of September 30, 2021, we had $45,817 in cash and had an accumulated
deficit of $58,804,968.</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
upon our current business plan, we will need considerable cash investments to have the opportunity to be successful. Our capital
requirements and cash needs are significant and continuing. We can provide no assurance that we will be able to generate a sufficient
amount of revenue, if any, from our business in order to achieve profitability. It is not possible at this time for us to predict
with assurance the potential success of our business. The revenue and income potential of our proposed business and operations
are unknown. If we cannot continue as a viable entity, we may be unable to continue our operations and you may lose some or all
of your investment in our common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 29 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
have incurred significant losses since our inception. We expect to incur significant losses for the foreseeable future and may
never achieve or maintain profitability.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify">Since inception, we have
incurred significant operating losses. Our net loss was $2,025,947 and $4,740,723, respectively, for the fiscal years ended June
30, 2021 and June 30, 2020, respectively. As of September 30, 2021, we had a deficit accumulated of $58,804,968.
To date, we have not generated any revenues and have financed most of our operations with funds obtained from private financings.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
October 2007, we have devoted substantially all of our efforts to research and development of our product candidates, particularly
PRP, and efforts to protect our intellectual property. Most recently, from January-February 2016, and October 2016-April 2017,
we have contracted with third parties to perform a number of laboratory studies and dose range finding studies designed to examine
the anti-cancer effects of PRP and prepare for human clinical trials. Since mid-2017, we developed a suitable manufacturing process
for each active drug substance in the PRP formulation, capable of producing a full scale GMP manufacture of PRP for human trials.
We were granted Orphan Drug Designation status from the FDA for PRP for the treatment of pancreatic cancer. In March 2018, a scientific
advice meeting was conducted with the MHRA (Medicines and Healthcare Products Regulatory Agency) UK, to assist with preparation
of our first Clinical Trial Application (CTA). We expect that it will be many years, if ever, before we have a product candidate
ready for commercialization. We expect to incur significant expenses and increasing operating losses for the foreseeable future
if and as we progress PRP into clinical trials, continue our research and development, seek regulatory approvals, establish or
contract for a sales and marketing infrastructure, maintain and expand our intellectual property portfolio, and add personnel.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
become profitable, we must develop and eventually commercialize PRP or some other product with significant market potential. This will
require us to successfully complete clinical trials, obtain market approval and market and sell PRP or whatever other product that we
obtain approval for. We might not succeed in any one or a number of these activities, and even if we do, we may never generate revenues
that are significant enough to achieve profitability. Our failure to become and remain profitable would decrease our value and could
impair our ability to raise capital, maintain our research and development efforts, expand our business or continue our operations.</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>As
an early-stage company, it may be difficult for you to evaluate the success of our business to date and to assess our future viability.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Despite
having been founded in 2007, we remain an early-stage company. We commenced active operations in the second half of 2010. Our
operations to date have been mainly limited to establishing our research programs, particularly PRP, building our intellectual
property portfolio and deepening our scientific understanding of our product development. We have not yet initiated, let alone
demonstrated any ability to successfully complete, any clinical trials, including large-scale, pivotal clinical trials, obtain
marketing approvals, manufacture a commercial scale product, or arrange for a third party to do so on our behalf, or conduct sales
and marketing activities necessary for successful product commercialization. It will take a number of years for PRP to be made
available for the treatment of cancer, if it ever is. Given our relatively short operating history compared to the timeline required
to fully develop a new drug, you are cautioned about making any predictions on our future success or viability based on our activities
or results to date. In addition, we may encounter unforeseen expenses, difficulties, complications, delays and other known and
unknown factors. We will eventually need to transition from a company with a research focus to a company capable of supporting
commercial activities. We may not be successful in such a transition.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 30 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
currently rely, and may continue to rely for the foreseeable future, on substantial debt financing that we are not able to repay
in cash.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to maintain our operations, including our research and development efforts and our preclinical development of PRP, we have
over the last few years entered into a number of securities purchase agreements pursuant to which we issued convertible debt in
return for cash. We are not currently able to repay either the current principal or interest on this debt in cash. Our lenders,
therefore, can convert their debt into shares of our common stock, at a discount to current market prices and then attempt to
sell these shares on the open market in order to pay down their loans and receive a return on their investment. These financings
pose the risk that as these debts are converted, our stock price will reflect the reduced prices our lenders are willing to sell
their shares at, given the discount they have received. These financings contain no floor on the price our lenders can convert
their debt into shares of our common stock and they could conceivably reduce the price our common stock to near zero. These types
of financings negatively impact our balance sheet and the appeal of our common stock as an investment. While we are actively exploring
various alternatives to reduce if not eliminate this debt, for the foreseeable future we will continue to carry it on our balance
sheet, and we may have to enter into additional such financings in order to sustain our operations. As a result, the price of
our common stock and our market capitalization are subject to significant declines until our convertible debt is either refinanced
on a favorable basis or is eliminated.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of September 30, 2021, the total amount of debt outstanding under convertible notes, including interest, is $584,608
(not including redemption premium). Please see the section captioned &#8220;Management&#8217;s Discussion of Financial Condition
and Results of Operations - Recent Developments&#8221; for further information</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
will continue to need substantial additional funding. If we are unable to raise capital when needed, we would be forced to delay,
reduce or eliminate our product development programs or commercialization efforts.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
expect our expenses to significantly increase in connection with our ongoing activities, particularly if we initiate clinical
trials of, and ultimately seek marketing approval for, PRP. In addition, even if we ultimately obtain marketing approval for PRP
or any other product candidate, we expect to incur significant commercialization expenses related to product sales, marketing,
manufacturing and distribution. We also hope to continue and expand our research and development activities. Accordingly, we will
need to obtain substantial additional funding in connection with our continuing operations. If we are unable to raise capital
when needed or on attractive terms, we would be forced to delay, reduce or eliminate our future commercialization efforts or any
research and development programs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
future capital requirements will depend on many factors, including, among others, the scope, progress and results of our potential future
clinical trials, the costs, timing and outcome of regulatory review of PRP, the costs of any future commercialization activities, and
the costs of preparing and filing future patent applications, if any. Accordingly, we will continue to rely on additional financing to
achieve our business objectives. Adequate additional financing may not be available to us on acceptable terms, or at all. Even if we
are able to enter into financing agreements, we may be forced to pay higher interest rates, accept default provisions in financing agreements
that we believe are overly punitive, make balloon payments as required, and, as noted below, if we issue convertible debt the price of
our common stock may well be negatively affected and our existing stockholders may suffer dilution.</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Raising
additional capital will cause dilution to our stockholders, restrict our operations or require us to relinquish rights to our
technologies or product candidates.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Until
such time, if ever, as we can generate substantial product revenues, we expect to continue to finance our cash needs through a
combination of equity offerings and additional debt financings, and possibly also through future collaborations, strategic alliances
and licensing arrangements. To the extent that we raise additional capital through the sale of equity or debt securities, including
convertible debt securities, the ownership interest of our existing stockholders will be diluted upon conversion, and the terms
of these securities may include liquidation or other preferences that adversely affect the rights of our existing stockholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 31 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Debt
financing, if available, may also involve agreements that include restrictive covenants limiting or restricting our ability to
take specific actions, such as merging with other companies or consummating certain changes of control, acquiring other companies,
engaging in new lines of business, incurring additional debt, making capital expenditures, making certain investments, paying
dividends, transferring or disposing of assets, amending certain material agreements, incurring additional indebtedness or enter
into various specified transactions. We therefore may not be able to engage in any of the foregoing transactions unless we obtain
the consent of the lender or terminate such debt agreements. Our debt agreements may also contain certain financial covenants,
including achieving certain milestones and may be secured by substantially all of our assets. In the event we enter into such
debt agreements, there is no guarantee that we will be able to generate sufficient cash flow or sales to pay the principal and
interest under our debt agreements or to satisfy all of the financial covenants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we raise additional funds through collaborations, strategic alliances or licensing arrangements with third parties, we may have
to relinquish valuable rights to our technologies, future revenue streams, research programs or product candidates or to grant
licenses on terms that may not be favorable to us. If we are unable to raise additional funds through equity or debt financings
when needed, we may be required to delay, limit, reduce or terminate our product development or future commercialization efforts
or grant rights to develop and market product candidates that we would otherwise prefer to develop and market ourselves.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
conversion of some or all of our currently outstanding convertible notes in shares of our common stock will dilute the ownership
interests of existing stockholders.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify">The conversion of some or
all of our currently outstanding convertible notes into shares of our common stock will dilute the ownership interests of existing
stockholders. As of September 30, 2021, we had 5 outstanding notes convertible into approximately 23,293,971
shares of our common stock (based on then applicable conversion prices). Each holder of the notes has agreed to a 4.99% beneficial
ownership conversion limitation (subject to certain noteholders&#8217; ability to increase such limitation to 9.99% upon 60 days&#8217;
notice to us), and each note may not be converted during the first six-month period from the date of issuance. Any sales in the public
market of the common stock issuable upon such conversion or any anticipated conversion of our convertible notes into shares of our common
stock could adversely affect prevailing market prices of our common stock.</p>
<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
accounting method for convertible debt securities that may be settled in cash could have a material adverse effect on our reported
financial results.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
Financial Accounting Standards Board Accounting Standards Codification 470-20, Debt with Conversion and Other Options (&#8220;ASC 470-20&#8221;),
we are required to separately account for the liability and equity components of our convertible notes because they may be settled entirely
or partially in cash upon conversion in a manner that reflects our economic interest cost. The effect of ASC 470-20 on the accounting
for our convertible notes is that the equity component is required to be included in the additional paid-in capital section of stockholders&#8217;
deficit on our consolidated balance sheet, and the value of the equity component would be treated as a discount for purposes of accounting
for the debt component of our convertible notes. As a result, we will be required to record a greater amount of non-cash interest expense
in current periods presented as a result of the amortization of the discounted carrying value of our convertible debt or notes to their
face amount over the terms. We will report higher net loss in our financial results in part because ASC 470-20 will require interest
to include both the current period&#8217;s amortization of the debt discount and the instrument&#8217;s coupon interest, which could
adversely affect our reported or future financial results, the trading price of our common stock and the trading price of our convertible
notes.</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, because our convertible notes may be settled entirely or partly in cash, under certain circumstances, these are currently
accounted for utilizing the treasury stock method, the effect of which is that the shares issuable upon conversion are not included
in the calculation of diluted earnings per share except to the extent that the conversion value exceeds their principal amount.
Under the treasury stock method, for diluted earnings per share purposes, the transaction is accounted for as if the number of
shares of common stock that would be necessary to settle such excess, if we elected to settle such excess in shares, are issued.
We cannot be sure that the accounting standards in the future will continue to permit the use of the treasury stock method. If
we are unable to use the treasury stock method in accounting for the shares issuable upon conversion of our convertible notes,
then our diluted earnings per share would be adversely affected.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 32 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
maintain our cash in Australian financial institutions that are not insured.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company maintains its cash in banks and financial institutions in Australia. Bank deposits in Australian banks are uninsured.
The Company has not experienced any losses in such accounts through to date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>RISKS
RELATED TO THE DISCOVERY, DEVELOPMENT AND COMMERCIALIZATION OF OUR PRODUCT CANDIDATES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Because
PRP remains in the early stages of development and may never become commercially viable, you may lose your investment.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
present, our only product candidate, PRP, is still in preclinical development. While we are hopeful that the preclinical testing we have
completed will lead to our initiating human clinical trials in 2022 as noted elsewhere we expect that it will be several years,
at least, before PRP can be commercialized. Further, if clinical trials for PRP fail to produce statistically significant results, we
would likely be forced to either spend several more years in development attempting to correct whatever flaws were identified in the
trials, or we would have to abandon PRP altogether. Either of those contingencies, and especially the latter, would dramatically increase
the amount of time before we would be able to generate any product-related revenue, and we may well be forced to cease operations. Under
such circumstances, you may lose at least a portion of, and perhaps your entire, investment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>PRP
may cause undesirable side effects that could negatively impact its clinical trial results or limit its use, hindering further
development, subject us to possible product liability claims, and make it more difficult to commercialize PRP.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to the possibility that the clinical trials we hope to initiate for PRP could demonstrate a lack of efficacy, if we alternatively
identify adverse and undesirable side effects caused by it this will likely interrupt, delay or even halt our further development,
or possibly limit our planned therapeutic uses for it, and may even result in adverse regulatory action by the FDA or other regulatory
authorities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Moreover,
this may subject us to product liability claims by the individuals enrolled in our clinical trials; while we intend to obtain
product liability insurance in connection with our clinical trials, it is possible that the potential liability of any claims
against us could exceed the maximum amount of this coverage, or at least increase our premiums. Either would result in an increase
in our operating expenses, in turn making it more difficult to complete our clinical development, or in the suspension or termination
of the clinical trial. Any negative information concerning PRP, however unrelated to its composition or method of use, could also
damage our chances to obtain regulatory approval.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Even
if we are able to complete PRP&#8217;s development and receive regulatory approvals, undesirable side effects could prevent us
from achieving or maintaining market acceptance of the product or substantially increase the costs and expenses of commercializing
it.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Because
successful development of our products is uncertain, our results of operations may be materially harmed.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
development of PRP and future product candidates is subject to the risks of failure inherent in the development of new pharmaceutical
products that are based on new technologies, including but not limited to delays in product development, clinical testing or manufacturing;
unplanned and higher expenditures; adverse findings relating to safety or efficacy; failure to receive regulatory approvals; the emergence
of superior or equivalent products; an inability by us or one of our collaborators to manufacture our product candidates on a commercial
scale on our own, or in collaboration with third parties; and, ultimately, a failure to achieve market acceptance.</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because
of these risks, our development efforts may not result in PRP, or any other product we attempt to develop, becoming commercially
viable. If even one aspect of these development efforts is not successfully completed, required regulatory approvals will not
be obtained, or if any approved products are not commercialized successfully, our business, financial condition and results of
operations will be materially harmed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i></i></b></span></p>

<!-- Field: Page; Sequence: 33 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>A
variety of factors, either alone or in concert with each other, could result in our clinical trials of PRP being delayed or unsuccessful.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
we have conducted a variety of preclinical studies, which we have concluded provide evidence to support the potential therapeutic
utility of PRP, comprehensive human clinical trials in order to demonstrate the product&#8217;s safety, tolerability and efficacy
will now need to be completed. Clinical testing is expensive, difficult to design and implement, can take many years to complete
and is uncertain as to outcome. A failure of one or more clinical trials can occur at any stage of testing. The outcome of preclinical
testing and even early clinical trials may not be predictive of the success of later clinical trials, and interim results of a
clinical trial do not necessarily predict final results. Moreover, preclinical and clinical data are often susceptible to varying
interpretations and analyses, and many companies that have believed their product candidates performed satisfactorily in preclinical
studies and clinical trials have nonetheless failed to obtain marketing approval of their products.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Among
the numerous unforeseen events that may occur during, or as a result of, clinical trials that alone or in concert with each other
could either delay or prevent our ability to receive marketing approval or commercialize PRP are the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">regulators
    or institutional review boards may not authorize us or our investigators to commence a clinical trial or conduct a clinical
    trial at a prospective trial site;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
    may have delays in reaching or fail to reach an agreement on acceptable clinical trial contracts or clinical trial protocols
    with prospective trial sites;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">as
    noted previously, clinical trials of PRP may produce negative or inconclusive results, and we may decide, or regulators may
    require us, to conduct additional clinical trials or abandon product development altogether;</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    number of patients required for clinical trials may be larger than we anticipate, enrollment in these clinical trials may
    be slower than we anticipate, or participants may drop out of these clinical trials at a higher rate than we anticipate;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    third-party contractors may fail to comply with regulatory requirements or fail to meet their contractual obligations to us
    in a timely manner, or at all;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">regulators
    or institutional review boards may require that we or our investigators suspend or terminate clinical research for various
    reasons, including noncompliance with regulatory requirements or a finding that the participants are being exposed to unacceptable
    health risks;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    cost of clinical trials may be greater than we anticipate;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    supply or quality of PRP or other materials necessary to conduct its clinical trials may be insufficient or inadequate; and</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PRP
    may, as also noted above, have undesirable side effects or other unexpected characteristics, causing us or our investigators,
    regulators or institutional review boards to suspend or terminate the trials.</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 34 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we are required to conduct additional clinical trials or other testing of PRP beyond those that we currently contemplate, if we
are unable to successfully complete clinical trials of PRP or other testing, if the results of these trials or tests are not positive
or are only modestly positive or if there are safety concerns, we may:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">be
    delayed in obtaining marketing approval;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">not
    obtain marketing approval at all;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">obtain
    approval for indications or patient populations that are not as broad as intended or desired;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">obtain
    approval with labeling that includes significant use or distribution restrictions or safety warnings, including boxed warnings;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">be
    subject to additional post-marketing testing requirements; or</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">fail
    to obtain that degree of market acceptance necessary for commercial success.</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
delay in, or termination of, our clinical trials may result in increased development costs, which would very likely cause the
market price of our shares to decline and severely limit our ability to obtain additional financing and, ultimately, our ability
to commercialize our products and generate product revenues. This in turn would likely materially harm our business, financial
condition and operating results, and possibly lead us to cease operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
we fail to obtain regulatory approval in jurisdictions outside the United States, we will not be able to market PRP in those jurisdictions.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
intend to seek regulatory approval for PRP in the United Kingdom, Europe, Australia and/or other countries outside of the United
States and expect that these countries will be important markets for our product, if approved. Marketing our product in these
countries will require separate regulatory approvals in each market and compliance with numerous and varying regulatory requirements.
The regulations that apply to the conduct of clinical trials and approval procedures vary from country to country and may require
additional testing. Moreover, the time required to obtain approval may differ from that required to obtain FDA approval.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If,
in the future, we are unable to establish sales and marketing capabilities or enter into agreements with third parties to sell
and market PRP, we may not be successful in commercializing our product candidates if and when they are approved.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
do not have a sales or marketing infrastructure and have no experience in the sale, marketing or distribution of pharmaceutical
products. To achieve commercial success for PRP or any other approved product, we must either develop a sales and marketing organization
or outsource these functions to third parties. In the future, we may choose to build a focused sales and marketing infrastructure
to market or co-promote some of our product candidates if and when they are approved.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are risks involved with both establishing our own sales and marketing capabilities and entering into arrangements with third parties
to perform these services. For example, recruiting and training a sales force is expensive and time consuming and could delay
any product launch. If the commercial launch of a product candidate for which we recruit a sales force and establish marketing
capabilities is delayed or does not occur for any reason, we would have prematurely or unnecessarily incurred these commercialization
expenses. This may be costly, and our investment would be lost if we cannot retain or reposition our sales and marketing personnel.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 35 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Factors
that may inhibit our efforts to commercialize our products on our own include:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    inability to recruit and retain adequate numbers of effective sales and marketing personnel;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    inability of sales personnel to obtain access to physicians or persuade an adequate number of physicians to prescribe any
    future products;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    lack of complementary products to be offered by sales personnel, which may put us at a competitive disadvantage relative to
    companies with more extensive product lines; and</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">unforeseen
    costs and expenses associated with creating an independent sales and marketing organization.</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we enter into arrangements with third parties to perform sales, marketing and distribution services, our product revenues or the
profitability of these product revenues to us are likely to be lower than if we were to market and sell any products that we develop
ourselves. In addition, we may not be successful in entering into arrangements with third parties to sell and market our product
candidates or may be unable to do so on terms that are favorable to us. We likely will have little control over such third parties,
and any of them may fail to devote the necessary resources and attention to sell and market our products effectively. If we do
not establish sales and marketing capabilities successfully, either on our own or in collaboration with third parties, we will
not be successful in commercializing PRP.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
face substantial competition, which may result in others discovering, developing or commercializing products before or more successfully
than we do.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
development and commercialization of new drug products is highly competitive. We face competition with respect to our current
product candidate and will face competition with respect to any product candidates that we may seek to develop or commercialize
in the future from major pharmaceutical companies, specialty pharmaceutical companies and biotechnology companies worldwide. There
are a number of large pharmaceutical and biotechnology companies that currently market and sell products or are pursuing the development
of products for the treatment of the disease indications for which we are developing our product candidates. Some of these competitive
products and therapies are based on scientific approaches that target and eradicate cancer stem cells to treat metastatic cancer.
Potential competitors also include academic institutions, government agencies and other public and private research organizations
that conduct research, seek patent protection and establish collaborative arrangements for research, development, manufacturing
and commercialization.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are developing PRP for the treatment of pancreatic, ovarian and colorectal cancer. There are a variety of available therapies
marketed for cancer. In many cases, these drugs are administered in combination to enhance efficacy. Some of these drugs are branded
and subject to patent protection, and others are available on a generic basis. Many of these approved drugs are well-established
therapies and are widely accepted by physicians, patients and third-party payors. Insurers and other third-party payors may also
encourage the use of generic products. We expect that if our product candidate is approved, it will be priced at a significant
premium over competitive generic products. This may make it difficult for us to achieve our business strategy of using PRP in
combination with existing therapies or replacing existing therapies with PRP.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are also a number of products in clinical development by other parties to treat and prevent metastatic cancer. Our competitors
may develop products that are more effective, safer, more convenient or less costly than any that we are developing or that would
render our product candidate obsolete or non-competitive. In addition, our competitors may discover biomarkers that more efficiently
measure their effectiveness to treat and prevent metastatic cancer, which may give them a competitive advantage in developing
potential products. Our competitors may also obtain marketing approval from the FDA or other regulatory authorities for their
products more rapidly than we may obtain approval for ours, which could result in our competitors establishing a strong market
position before we are able to enter the market.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 36 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Most
of our competitors have significantly greater financial resources and expertise in research and development, manufacturing, preclinical
testing, conducting clinical trials, obtaining regulatory approvals and marketing approved products than we do. Mergers and acquisitions
in the pharmaceutical and biotechnology industries may result in even more resources being concentrated among a smaller number of our
competitors. Smaller and other early-stage companies may also prove to be significant competitors, particularly through collaborative
arrangements with large and established companies. These third parties compete with us in recruiting and retaining qualified scientific
and management personnel, establishing clinical trial sites and patient registration for clinical trials, as well as in acquiring technologies
complementary to, or necessary for, our programs. In addition, to the extent that product or product candidates of our competitors demonstrate
serious adverse side effects or are determined to be ineffective in clinical trials, the development of our product candidates could
be negatively impacted.</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Even
if we are able to commercialize PRP, we will need to seek approval for reimbursement before it can be marketed, and it may become
subject to unfavorable pricing regulations, third-party reimbursement practices or healthcare reform initiatives, which would
harm our business.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
regulations that govern marketing approvals, pricing and reimbursement for new drug products vary widely from country to country.
In the United States, recently passed legislation may significantly change the approval requirements in ways that could involve
additional costs and cause delays in obtaining approvals. Some countries require approval of the sale price of a drug before it
can be marketed. In many countries, the pricing review period begins after marketing or product licensing approval is granted.
In some foreign markets, prescription pharmaceutical pricing remains subject to continuing governmental control even after initial
approval is granted. As a result, we might obtain marketing approval for PRP in a particular country, but then be subject to price
regulations that delay our commercial launch of it, possibly for lengthy time periods, and negatively impact the revenues we are
able to generate from the sale of PRP in that country. Adverse pricing limitations may hinder our ability to recoup our investment
in PRP, even after it has obtained marketing approval.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
ability to commercialize PRP successfully also will depend in part on the extent to which reimbursement for it will be available
from government health administration authorities, private health insurers and other organizations. Government authorities and
third-party payors, such as private health insurers and health maintenance organizations, decide which medications they will pay
for and establish reimbursement levels. A primary trend in the U.S. healthcare industry and elsewhere is cost containment. Government
authorities and third-party payors have attempted to control costs by limiting coverage and the amount of reimbursement for particular
medications. Increasingly, third-party payors are requiring that drug companies provide them with predetermined discounts from
list prices and are challenging the prices charged for medical products. We cannot be sure that reimbursement will be available
for PRP that we commercialize and, if reimbursement is available, the level of reimbursement. Reimbursement may impact the demand
for, or the price of, PRP. Obtaining reimbursement for it may be particularly difficult because of the higher prices often associated
with drugs administered under the supervision of a physician. If reimbursement is not available or is available only to limited
levels, we may not be able to successfully commercialize PRP.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
may be significant delays in obtaining reimbursement for newly approved drugs, and coverage may be more limited than the purposes
for which the drug is approved by the FDA or similar regulatory authorities outside the United States. Moreover, eligibility for
reimbursement does not imply that any drug will be paid for in all cases or at a rate that covers our costs, including research,
development, manufacture, sale and distribution. Interim reimbursement levels for new drugs, if applicable, may also not be sufficient
to cover our costs and may not be made permanent. Reimbursement rates may vary according to the use of the drug and the clinical
setting in which it is used, may be based on reimbursement levels already set for lower cost drugs and may be incorporated into
existing payments for other services. Net prices for drugs may be reduced by mandatory discounts or rebates required by government
healthcare programs or private payors and by any future relaxation of laws that presently restrict imports of drugs from countries
where they may be sold at lower prices than in the United States. Third-party payors often rely upon Medicare coverage policy
and payment limitations in setting their own reimbursement policies. Our inability to promptly obtain coverage and profitable
payment rates from both government-funded and private payors for any approved products that we develop could have a material adverse
effect on our operating results, our ability to raise capital needed to commercialize products and our overall financial condition.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 37 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>RISKS
RELATED TO OUR DEPENDENCE ON THIRD PARTIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
will depend on collaborations with third parties for the development and commercialization of PRP and other product candidates,
and these collaborations may be unsuccessful.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
currently seek third-party collaborators for the development and commercialization of PRP, contract manufacturers (CMOs), contract research
organizations (CROs), regulatory and development consultants, and hospitals for clinical trial sites. We intend to continue to rely on
third-party collaborators for current and future product candidates for the foreseeable future. Our likely collaborators for any collaboration
arrangements include large and mid-size pharmaceutical companies, regional and national pharmaceutical companies and biotechnology companies.
If we do enter into any such arrangements with any third parties, we will likely have limited control over the amount and timing of resources
that our collaborators dedicate to the development or commercialization of our product candidates. Our ability to generate revenues from
these arrangements will depend on our collaborators&#8217; abilities to successfully perform the functions assigned to them in these
arrangements.</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Collaborations
involving our product candidates would pose the following risks to us:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">collaborators
    have significant discretion in determining the efforts and resources that they will apply to these collaborations;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">collaborators
    may not pursue development and commercialization of our product candidates or may elect not to continue or renew development
    or commercialization programs based on clinical trial results, changes in the collaborator&#8217;s strategic focus or available
    funding or external factors such as an acquisition that diverts resources or creates competing priorities;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">collaborators
    may delay clinical trials, provide insufficient funding for a clinical trial program, stop a clinical trial or abandon a product
    candidate, repeat or conduct new clinical trials or require a new formulation of a product candidate for clinical testing;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">collaborators
    could independently develop, or develop with third parties, products that compete directly or indirectly with our products
    or product candidates if the collaborators believe that competitive products are more likely to be successfully developed
    or can be commercialized under terms that are more economically attractive than ours;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">collaborators
    with marketing and distribution rights to one or more products may not commit sufficient resources to the marketing and distribution
    of such product or products;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">collaborators
    may not properly maintain or defend our intellectual property rights or may use our proprietary information in such a way
    as to invite litigation that could jeopardize or invalidate our proprietary information or expose us to potential litigation;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">disputes
    may arise between the collaborators and us that result in the delay or termination of the research, development or commercialization
    of our products or product candidates or that result in costly litigation or arbitration that diverts management attention
    and resources; and</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">collaborations
    may be terminated and, if terminated, may result in a need for additional capital to pursue further development or commercialization
    of the applicable product candidates.</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Collaboration
agreements may not lead to development or commercialization of product candidates in the most efficient manner or at all. If a
present or future collaborator of ours were to be involved in a business combination, the continued pursuit and emphasis on our
product development or commercialization program could be delayed, diminished or terminated.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 38 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
we are not able to establish collaborations, we may have to alter our development and commercialization plans.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
potential commercialization of PRP will require substantial additional cash to fund clinical trial and other expenses. As noted
above, we may decide to collaborate with other pharmaceutical and biotechnology companies for the development and potential commercialization
of PRP and perhaps future product candidates as well.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
face significant competition in seeking appropriate collaborators. Whether we reach a definitive agreement for collaboration will depend,
among other things, upon our assessment of the collaborator&#8217;s resources and expertise, the terms and conditions of the proposed
collaboration and the proposed collaborator&#8217;s evaluation of a number of factors. Those factors may include the design or results
of clinical trials, the likelihood of approval by the FDA or similar regulatory authorities outside the United States, the potential
market for the subject product candidate, the costs and complexities of manufacturing and delivering such product candidate to patients,
the potential of competing products, the existence of uncertainty with respect to our ownership of technology, which can exist if there
is a challenge to such ownership without regard to the merits of the challenge and industry and market conditions generally. The collaborator
may also consider alternative product candidates or technologies for similar indications that may be available to collaborate on and
whether such collaboration could be more attractive than the one with us for our product candidate. Collaborations are complex and time-consuming
to negotiate and document. In addition, there have been a significant number of recent business combinations among large pharmaceutical
companies that have resulted in a reduced number of potential future collaborators.</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may not be able to negotiate collaborations on a timely basis, on acceptable terms, or at all. If we are unable to do so, we may
have to curtail the development of such product candidate, reduce or delay its development program or one or more of our other
development programs, delay its potential commercialization or reduce the scope of any sales or marketing activities, or increase
our expenditures and undertake development or commercialization activities at our own expense. If we elect to increase our expenditures
to fund development or commercialization activities on our own, we may need to obtain additional capital, which may not be available
to us on acceptable terms or at all. If we do not have sufficient funds, we may not be able to further develop our product candidates
or bring them to market and generate product revenue.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
currently contract with a third party for the manufacture of PRP and this third party may not perform satisfactorily or at all, and our
reliance on any third-party for the supply of PRP carries material risks.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-size: 10pt">We
do not have any manufacturing facilities or personnel. We currently obtain all of our supply of PRP for clinical development through
our Manufacturing Service Agreement (the &#8220;MSA&#8221;) with Amatsigroup, and we expect to continue to rely on Amatsigroup for the
manufacture of clinical and, if necessary, commercial quantities of PRP. We anticipate that our payments to Amatsigroup under the MSA
will range between $2.5 million and $5.0 million over three years, when the finished drug product is manufactured and released for clinical
trials. The Company has spent a total of $1,689,146 of costs to date under this contract of which $49,854 was expensed in fiscal 2019,
$701,973 in fiscal 2018 and $937,319 in fiscal 2017. The MSA shall continue for a term of three years unless extended by mutual agreement
in writing. Either party to the MSA has the right to terminate. The MSA expired in 2019 and it is likely a new agreement to be established
upon mutual satisfaction from both parties.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify">This reliance on a third party includes the
risk that we will not have sufficient quantities of PRP on hand at any given time, which could delay, prevent or impair our development
efforts.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify">PRP and any other product that we may develop may compete with other product
candidates and products for access to manufacturing facilities. Although we believe that there are several potential alternative manufacturers
who could manufacture PRP, we may incur added costs and delays in identifying and qualifying any such replacement, as well as producing
the drug product. In addition, we would then have to enter into technical transfer agreements and share our know-how with the new third-party
manufacturers, which can be time-consuming and may result in delays.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 39 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Even
if we were able to quickly establish agreements with other third-party manufacturers, our general reliance on third-party manufacturers
entails many of the same risks as our agreement with Amatsigroup, including:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reliance
    on the third party for regulatory compliance and quality assurance;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    possible breach of the manufacturing agreement by the third party, including the misappropriation of our proprietary information,
    trade secrets and know-how;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    possible termination or nonrenewal of the agreement by the third party at a time that is costly or inconvenient for us; and</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">disruptions
    to the operations of our manufacturers or suppliers caused by conditions unrelated to our business or operations, including
    the bankruptcy of the manufacturer or supplier or a catastrophic event affecting our manufacturers or suppliers.</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our anticipated future dependence upon others for the manufacture of PRP may adversely affect our future profit margins and our
ability to commercialize any products that receive marketing approval on a timely and competitive basis. We intend to minimize this
risk by tendering our contract agreement with several third-party manufacturers with a plan to engage in a dual supplier strategy for
the contract manufacture of PRP.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>RISKS
RELATED TO OUR INTELLECTUAL PROPERTY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
we fail to comply with our obligations under any intellectual property licenses with third parties, we could lose license rights
that are important to our business.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are currently a party to a joint commercialization agreement with the University of Bath and hope to enter into other license
agreements in the future. If we fail to comply with the obligations included in any future license we may enter into in the future,
such licensors may have the right to terminate these agreements, in which event we might not be able to market any product that
is covered by the agreements, or to convert the exclusive licenses to non-exclusive licenses, which could materially adversely
affect the value of the product candidate being developed under these license agreements. As a general matter, termination of
license agreements or reduction or elimination of our licensed rights may result in our having to negotiate new or reinstated
licenses with less favorable terms.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
we are unable to obtain and maintain patent protection for our technology and products, or if any licensors are unable to obtain and
maintain patent protection for the technology or products that we may license from them in the future, or if the scope of the patent
protection obtained is not sufficiently broad, our competitors could develop and commercialize technology and products similar or identical
to ours, and our ability to successfully commercialize our technology and products may be adversely affected.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="margin: 0pt; text-indent: 0pt; text-align: justify; font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt">We have thirty-five
(35) granted patents and have thirty (30) patent applications</span><span style="font-size: 8pt">&#160;</span><span style="font-size: 10pt">either
pending or under examination in major global jurisdictions. Our future success depends in large part on our and, as applicable, our licensors&#8217;,
ability to obtain and maintain patent protection in the United States and other countries with respect to our proprietary technology.
We cannot be certain that patents will be issued in those countries where our applications are still under examination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
patent process is expensive and time-consuming, and we may not be able to file and prosecute all necessary or desirable patent
applications at a reasonable cost or in a timely manner. It is also possible that we will fail to identify patentable aspects
of our research and development output before it is too late to obtain patent protection.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
patent position of biotechnology and pharmaceutical companies generally is highly uncertain, involves complex legal and factual
questions and has in recent years been the subject of much litigation. As a result, the issuance, scope, validity, enforceability
and commercial value of our patent rights are uncertain. Our pending and future patent applications may not result in patents
being issued which protect our technology or products or which effectively prevent others from commercializing competitive technologies
and products. Changes in either the patent laws or interpretation of the patent laws in the United States and other countries
may diminish the value of our patents or narrow the scope of our patent protection.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 40 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
laws of foreign countries may not protect our rights to the same extent as the laws of the United States. Publications of discoveries
in the scientific literature often lag behind the actual discoveries, and patent applications in the United States and other jurisdictions
are typically not published until 18 months after filing. Therefore, we cannot be certain that we or our licensors were the first to
make the inventions claimed in our owned or licensed patents or pending patent applications, or that we or our licensors were the first
to file for patent protection of such inventions.</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assuming
the other requirements for patentability are met, in the United States, for patents that have an effective filing date prior to
March 15, 2013, the first to make the claimed invention is entitled to the patent, while outside the United States, the first
to file a patent application is entitled to the patent. In March 2013, the United States transitioned to a first inventor to file
system in which, assuming the other requirements for patentability are met, the first inventor to file a patent application will
be entitled to the patent. We may be subject to a third party preissuance submission of prior art to the U.S. Patent and Trademark
Office, or become involved in opposition, derivation, reexamination, inter parties review or interference proceedings challenging
our patent rights or the patent rights of others. An adverse determination in any such submission, proceeding or litigation could
reduce the scope of, or invalidate, our patent rights, allow third parties to commercialize our technology or products and compete
directly with us, without payment to us, or result in our inability to manufacture or commercialize products without infringing
third-party patent rights.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Even
if our owned and licensed patent applications issue as patents, they may not issue in a form that will provide us with any meaningful
protection, prevent competitors from competing with us or otherwise provide us with any competitive advantage. Our competitors
may be able to circumvent our owned or licensed patents by developing similar or alternative technologies or products in a non-infringing
manner.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
issuance of a patent is not conclusive as to its inventorship, scope, validity or enforceability, and our owned and licensed patents
may be challenged in the courts or patent offices in the United States and abroad. Such challenges may result in loss of exclusivity
or freedom to operate or in patent claims being narrowed, invalidated or held unenforceable, which could limit our ability to
stop others from using or commercializing similar or identical technology and products, or limit the duration of the patent protection
of our technology and products. Given the amount of time required for the development, testing and regulatory review of new product
candidates, patents protecting such candidates might expire before or shortly after such candidates are commercialized. As a result,
our owned and licensed patent portfolio may not provide us with sufficient rights to exclude others from commercializing products
similar or identical to ours.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
may become involved in lawsuits to protect or enforce our patents, which could be expensive, time consuming and unsuccessful.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Competitors
may infringe our patents. To counter infringement or unauthorized use, we may be required to file infringement claims, which can
be expensive and time consuming. In addition, in an infringement proceeding, a court may decide that a patent of ours is invalid
or unenforceable or may refuse to stop the other party from using the technology at issue on the grounds that our patents do not
cover the technology in question. An adverse result in any litigation proceeding could put one or more of our patents at risk
of being invalidated or interpreted narrowly. Furthermore, because of the substantial amount of discovery required in connection
with intellectual property litigation, there is a risk that some of our confidential information could be compromised by disclosure
during this type of litigation. In addition, our licensors may have rights to file and prosecute such claims and we are reliant
on them.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 41 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Third
parties may initiate legal proceedings alleging that we are infringing their intellectual property rights, the outcome of which
would be uncertain and could have a material adverse effect on the success of our business.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
commercial success depends upon our ability and the ability of our collaborators to develop, manufacture, market and sell PRP and any
other product candidates and use our proprietary technologies without infringing the proprietary rights of third parties. We have yet
to conduct comprehensive freedom-to-operate searches to determine whether our use of certain of the patent rights owned by or licensed
to us would infringe patents issued to third parties. We may become party to, or threatened with, future adversarial proceedings or litigation
regarding intellectual property rights with respect to our products and technology, including interference proceedings before the U.S.
Patent and Trademark Office and their European Union and global equivalents. Third parties may assert infringement claims against us
based on existing patents or patents that may be granted in the future. If we are found to infringe a third party&#8217;s intellectual
property rights, we could be required to obtain a license from such third party to continue developing and marketing our products and
technology. However, we may not be able to obtain any required license on commercially reasonable terms or at all. Even if we were able
to obtain a license, it could be non-exclusive, thereby giving our competitors access to the same technologies licensed to us. We could
be forced, including by court order, to cease commercializing the infringing technology or product. In addition, we could be found liable
for monetary damages. A finding of infringement could prevent us from commercializing our product candidates or force us to cease some
of our business operations, which could materially harm our business. Claims that we have misappropriated the confidential information
or trade secrets of third parties could have a similar negative impact on our business.</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Intellectual
property litigation could cause us to spend substantial resources and distract our personnel from their normal responsibilities.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Even
if resolved in our favor, litigation or other legal proceedings relating to intellectual property claims may cause us to incur
significant expenses and could distract our personnel from their normal responsibilities. In addition, there could be public
announcements of the results of hearings, motions or other interim proceedings or developments and if securities analysts or investors
perceive these results to be negative, it could have a substantial adverse effect on the price of our common stock. Such litigation
or proceedings could substantially increase our operating losses and reduce the resources available for development activities
or any future sales, marketing or distribution activities. We may not have sufficient financial or other resources to adequately
conduct such litigation or proceedings. Some of our competitors may be able to sustain the costs of such litigation or proceedings
more effectively than we can because of their greater financial resources. Uncertainties resulting from the initiation and continuation
of patent litigation or other proceedings could have a material adverse effect on our ability to compete in the marketplace.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
we are unable to protect the confidentiality of our trade secrets, our business and competitive position would be harmed.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to seeking patents for some of our technology and products, we also rely on trade secrets, including unpatented know-how,
technology and other proprietary information, to maintain our competitive position. We seek to protect these trade secrets, in
part, by entering into non-disclosure and confidentiality agreements with parties who have access to them, such as our employees,
corporate collaborators, outside scientific collaborators, contract manufacturers, consultants, advisors and other third parties.
We also enter into confidentiality and invention or patent assignment agreements with our employees and consultants. Despite these
efforts, any of these parties may breach the agreements and disclose our proprietary information, including our trade secrets,
and we may not be able to obtain adequate remedies for such breaches. Enforcing a claim that a party illegally disclosed or misappropriated
a trade secret is difficult, expensive and time-consuming, and the outcome is unpredictable. In addition, some courts inside and
outside the United States are less willing or unwilling to protect trade secrets. If any of our trade secrets were to be lawfully
obtained or independently developed by a competitor, we would have no right to prevent them from using that technology or information
to compete with us. If any of our trade secrets were to be disclosed to or independently developed by a competitor, our competitive
position would be harmed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 42 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>RISKS
RELATED TO REGULATORY APPROVAL OF OUR PRODUCT CANDIDATES AND OTHER LEGAL COMPLIANCE MATTERS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
we are not able to obtain, or if there are delays in obtaining, required regulatory approvals, we will not be able to commercialize
PRP, and our ability to generate revenue will be materially impaired.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PRP
and the activities associated with its development and commercialization, including design, testing, manufacture, safety, efficacy, recordkeeping,
labeling, storage, approval, advertising, promotion, sale and distribution, are subject to comprehensive regulation by the FDA and other
regulatory agencies in the United States and by comparable authorities in other countries. Failure to obtain marketing approval for PRP
will prevent us from commercializing it. We have not received approval to market PRP or any other product candidate from regulatory authorities
in any jurisdiction. We have only limited experience in filing and supporting the applications necessary to gain marketing approvals
and expect to rely on third-party contract research organizations to assist us in this process. Securing FDA approval requires the submission
of extensive preclinical and clinical data and supporting information to the FDA for each therapeutic indication to establish PRP&#8217;s
safety and efficacy. Securing FDA approval also requires the submission of information about the product manufacturing process to, and
inspection of manufacturing facilities by, the FDA. PRP may not be effective, may be only moderately effective or may prove to have undesirable
or unintended side effects, toxicities or other characteristics that may preclude our obtaining marketing approval or prevent or limit
commercial use.</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
process of obtaining marketing approvals, both in the United States and abroad, is expensive, may take many years if additional
clinical trials are required, if approval is obtained at all, and can vary substantially based upon a variety of factors, including
the type, complexity and novelty of the product candidates involved. Changes in marketing approval policies during the development
period, changes in or the enactment of additional statutes or regulations, or changes in regulatory review for each submitted
product application, may cause delays in the approval or rejection of an application. The FDA has substantial discretion in the
approval process and may refuse to accept any application or may decide that our data is insufficient for approval and require
additional preclinical, clinical or other studies. In addition, varying interpretations of the data obtained from preclinical
and clinical testing could delay, limit or prevent marketing approval of a product candidate. Any marketing approval we ultimately
obtain may be limited or subject to restrictions or post-approval commitments that render the approved product not commercially
viable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we experience delays in obtaining approval or if we fail to obtain approval of PRP, the commercial prospects for PRP may be harmed
and our ability to generate revenues will be materially impaired.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Failure
to obtain marketing approval in international jurisdictions would prevent PRP from being marketed abroad.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
intend to seek regulatory approval for PRP in a number of countries outside of the United States and expect that these countries
will be important markets for it, if approved. In order to market and sell our products in the European Union, the UK, Australia
and many other jurisdictions, we or our third-party collaborators must obtain separate marketing approvals and comply with numerous
and varying regulatory requirements. The approval procedure varies among countries and can involve additional testing. The time
required to obtain approval may differ substantially from that required to obtain FDA approval. The regulatory approval process
outside the United States generally includes all of the risks associated with obtaining FDA approval. In addition, in many countries
outside the United States, it is required that the product be approved for reimbursement before the product can be approved for
sale in that country. We or these third parties may not obtain approvals from regulatory authorities outside the United States
on a timely basis, if at all. Approval by the FDA does not ensure approval by regulatory authorities in other countries or jurisdictions,
and approval by one regulatory authority outside the United States does not ensure approval by regulatory authorities in other
countries or jurisdictions or by the FDA. We may not be able to file for marketing approvals and may not receive necessary approvals
to commercialize our products in any market.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 43 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>PRP
or any other product candidate for which we obtain marketing approval could be subject to restrictions or withdrawal from the
market and we may be subject to penalties if we fail to comply with regulatory requirements or if we experience unanticipated
problems with our products, when and if any of them are approved.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PRP,
or any other product candidate for which we obtain marketing approval, along with the manufacturing processes, post-approval clinical
data, labeling, advertising and promotional activities for such product, will be subject to continual requirements of and review
by the FDA and other regulatory authorities. These requirements include submissions of safety and other post-marketing information
and reports, registration and listing requirements, cGMP requirements relating to quality control, quality assurance and corresponding
maintenance of records and documents, requirements regarding the distribution of samples to physicians and recordkeeping. Even
if marketing approval of a product candidate is granted, the approval may be subject to limitations on the indicated uses for
which the product may be marketed or to the conditions of approval, or contain requirements for costly post-marketing testing
and surveillance to monitor the safety or efficacy of the product. The FDA closely regulates the post-approval marketing and promotion
of drugs to ensure drugs are marketed only for the approved indications and in accordance with the provisions of the approved
labeling. The FDA imposes stringent restrictions on manufacturers&#8217; communications regarding off-label use and if we do not
market our products for their approved indications, we may be subject to enforcement action for off-label marketing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, later discovery of previously unknown problems with our products, manufacturers or manufacturing processes, or failure
to comply with regulatory requirements, may yield various results, including:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">restrictions
    on such products, manufacturers or manufacturing processes;</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">restrictions
    on the labeling or marketing of a product;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">restrictions
    on product distribution or use;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">requirements
    to conduct post-marketing clinical trials;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">warning
    or untitled letters;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">withdrawal
    of the products from the market;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">refusal
    to approve pending applications or supplements to approved applications that we submit;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">recall
    of products;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">fines,
    restitution or disgorgement of profits or revenue;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">suspension
    or withdrawal of marketing approvals;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">refusal
    to permit the import or export of our products;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">product
    seizure; or</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">injunctions
    or the imposition of civil or criminal penalties.</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 44 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
current attempts to both expand our patent protection and seek regulatory approvals from multiple countries, as well as our future
relationships with customers and third-party payors will be subject to applicable anti-kickback, fraud and abuse and other laws
and regulations, which could expose us to criminal sanctions, civil penalties, contractual damages, reputational harm and diminished
profits and future earnings.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
we seek to obtain patent protection from multiple jurisdictions and eventually to seek marketing approval for PRP in those counties,
we are and will continue to be subject to the Foreign Corrupt Practices Act, which makes it illegal for any U.S. business, even
one like Propanc that is physically located in another country, to influence foreign officials with personal payments and rewards.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Moreover,
healthcare providers, physicians and third-party payors will play a primary role in the recommendation and prescription of PRP
and any other product candidate for which we obtain marketing approval. Our future arrangements with third-party payors and customers
may expose us to broadly applicable fraud and abuse and other healthcare laws and regulations that may constrain the business
or financial arrangements and relationships through which we market, sell and distribute our products for which we obtain marketing
approval. Restrictions under applicable federal and state healthcare laws and regulations, include the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    federal healthcare anti-kickback statute prohibits, among other things, persons from knowingly and willfully soliciting, offering,
    receiving or providing remuneration, directly or indirectly, in cash or in kind, to induce or reward either the referral of
    an individual for, or the purchase, order or recommendation of, any good or service, for which payment may be made under federal
    and state healthcare programs such as Medicare and Medicaid;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    federal False Claims Act imposes criminal and civil penalties, including civil whistleblower or qui tam actions, against individuals
    or entities for knowingly presenting, or causing to be presented, to the federal government, claims for payment that are false
    or fraudulent or making a false statement to avoid, decrease or conceal an obligation to pay money to the federal government;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    federal Health Insurance Portability and Accountability Act of 1996, as amended by the Health Information Technology for Economic
    and Clinical Health Act, imposes criminal and civil liability for executing a scheme to defraud any healthcare benefit program
    and also imposes obligations, including mandatory contractual terms, with respect to safeguarding the privacy, security and
    transmission of individually identifiable health information;</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    federal false statements statute prohibits knowingly and willfully falsifying, concealing or covering up a material fact or
    making any materially false statement in connection with the delivery of or payment for healthcare benefits, items or services;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    federal transparency requirements under the Health Care Reform Law requires manufacturers of drugs, devices, biologics and
    medical supplies to report to the Department of Health and Human Services information related to physician payments and other
    transfers of value and physician ownership and investment interests; and</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">analogous
    state laws and regulations, such as state anti-kickback and false claims laws, may apply to sales or marketing arrangements
    and claims involving healthcare items or services reimbursed by non-governmental third-party payors, including private insurers,
    and some state laws require pharmaceutical companies to comply with the pharmaceutical industry&#8217;s voluntary compliance
    guidelines and the relevant compliance guidance promulgated by the federal government in addition to requiring drug manufacturers
    to report information related to payments to physicians and other health care providers or marketing expenditures.</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 45 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Efforts
to ensure that our business arrangements with third parties will comply with applicable healthcare laws and regulations will involve
substantial costs. It is possible that governmental authorities will conclude that our business practices may not comply with
current or future statutes, regulations or case law involving applicable fraud and abuse or other healthcare laws and regulations.
If our operations are found to be in violation of any of these laws or any other governmental regulations that may apply to us,
we may be subject to significant civil, criminal and administrative penalties, damages, fines and exclusion from government funded
healthcare programs, such as Medicare and Medicaid, and the curtailment or restructuring of our operations. If any of the physicians
or other providers or entities with whom we expect to do business are found to be not in compliance with applicable laws, they
may be subject to criminal, civil or administrative sanctions, including exclusions from government funded healthcare programs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Recently
enacted and future legislation, particularly in the United States, may increase the difficulty and cost for us to obtain marketing
approval of and commercialize PRP and affect the prices we may obtain.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the United States and some foreign jurisdictions there have been many legislative and regulatory changes and proposed changes
regarding the healthcare system that could prevent or delay marketing approval of our product candidates, restrict or regulate
post-approval activities and affect our ability to profitably sell any product candidates for which we obtain marketing approval.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the United States, the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (&#8220;Medicare Modernization Act&#8221;),
changed the way Medicare covers and pays for pharmaceutical products. The legislation expanded Medicare coverage for drug purchases
by the elderly and introduced a new reimbursement methodology based on average sales prices for physician-administered drugs.
In addition, this legislation provided authority for limiting the number of drugs that will be covered in any therapeutic class.
Cost reduction initiatives and other provisions of this legislation could decrease the coverage and price that we receive for
any approved products. While the Medicare Modernization Act applies only to drug benefits for Medicare beneficiaries, private
payors often follow Medicare coverage policy and payment limitations in setting their own reimbursement rates. Therefore, any
reduction in reimbursement that results from the Medicare Modernization Act may result in a similar reduction in payments from
private payors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
March 2010, President Obama signed into law the Patient Protection and Affordable Care Act (&#8220;Affordable Care Act&#8221;), a sweeping
law intended to broaden access to health insurance, reduce or constrain the growth of healthcare spending, enhance remedies against fraud
and abuse, add new transparency requirements for health care and health insurance industries, impose new taxes and fees on the health
industry and impose additional health policy reforms. Among other things, the Affordable Care Act revised the definition of &#8220;average
manufacturer price&#8221; for reporting purposes, which could increase the amount of Medicaid drug rebates to states, and it imposed
a significant annual fee on companies that manufacture or import branded prescription drug products.</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
present, the future of the Affordable Care Act is the subject of significant debate in the U.S. Congress, with proposals to either
partially or entirely repeal it being considered and the likelihood that there will be a new law to replace it is uncertain. It
is not yet possible for us to determine the impact, if any, the enactment of any of these proposals will have on our future ability
to obtain approval of or commercialize PRP.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
UK&#8217;s decision to leave the European Union could significantly increase regulatory burdens on obtaining approvals for PRP
within the UK.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 29, 2017, the UK invoked Article 50 of Lisbon Treaty to initiate complete withdrawal from the European Union which was effectuated
on January 31, 2020, and therefore, the regulatory drug approval process in that country may be significantly different from the
current drug regulatory policies in the European Union. We currently are considering holding our clinical trials in the UK, among other
countries, and therefore this event could significantly impact our efforts to successfully bring PRP to market. It is not yet possible
for us to determine the impact of the UK&#8217;s withdrawal from the European Union, but any additional costs or delays in obtaining
approvals may hinder our ability to conduct clinical trials or market PRP in the UK.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 46 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>RISKS
RELATING TO EMPLOYEE MATTERS AND MANAGING GROWTH</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
future success depends on our ability to retain our chief executive officer and our chief scientific officer and, as we continue
to develop and grow as a company, to attract, retain and motivate qualified personnel.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify">We are highly dependent on our management team, specifically Mr. James
Nathanielsz, our Chief Executive Officer, Chief Financial Officer, and Dr. Julian Kenyon, our director who also serves as our chief scientific
officer in a non-executive officer capacity. While we have a current employment agreement with Mr. Nathanielsz and a director agreement
with Dr. Kenyon, both such employment agreement and director agreement permit each of the respective parties thereto to terminate such
agreements upon notice. If we lose this key employee and/or the services of our other director, our business will suffer and we may have
to cease operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recruiting
and retaining qualified scientific, clinical, manufacturing and sales and marketing personnel will also be critical to our future
success, as we continue to develop PRP and attempt to grow as a company. We may not be able to attract and retain these personnel
on acceptable terms given the competition among numerous pharmaceutical and biotechnology companies for similar personnel. We
also experience competition for the hiring of scientific and clinical personnel from universities and research institutions. In
addition, we rely on consultants and advisors, including scientific and clinical advisors, to assist us in formulating our research
and development and commercialization strategy. Our consultants and advisors, including our scientific co-founders, may be employed
by employers other than us and may have commitments under consulting or advisory contracts with other entities that may limit
their availability to us.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
expect to expand our development, regulatory and future sales and marketing capabilities, and as a result, we may encounter difficulties
in managing our growth, which could disrupt our operations.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
expect to experience significant growth in the number of our employees and the scope of our operations, particularly in the areas of
drug development, regulatory affairs and sales and marketing. To manage our anticipated future growth, we must continue to implement
and improve our managerial, operational and financial systems, expand our facilities and continue to recruit and train additional qualified
personnel. Due to our limited financial resources and the limited experience of our management team in managing a company with such anticipated
growth, we may not be able to effectively manage the expansion of our operations or recruit and train additional qualified personnel.
The physical expansion of our operations may lead to significant costs and may divert our management and business development resources.
Any inability to manage growth could delay the execution of our business plans or disrupt our operations.</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
have identified material weaknesses in our internal control over financial reporting that, if not properly remediated, could result
in material misstatements in our consolidated financial statements in future periods.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the audits of our consolidated financial statements for the fiscal years ended June 30, 2021 and 2020,
and in accordance with management&#8217;s assessments of internal controls over financial reporting, we identified certain deficiencies
relating to our internal control over financial reporting that constitute a material weakness under the Internal Control Integrated Framework
issued by COSO in 2013. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting
such that there is a reasonable possibility that a material misstatement of the company&#8217;s annual or interim financial statements
will not be prevented or detected on a timely basis. A deficiency in internal control exists when the design or operation of a control
does not allow management or employees, in the normal course of performing their assigned functions, to prevent or detect misstatements
on a timely basis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 47 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following material weaknesses in our internal control over financial reporting continued to exist at June 30, 2021 and
currently:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
    do not have written documentation of our internal control policies and procedures. Written documentation of key internal controls
    over financial reporting is a requirement of Section 404 of the Sarbanes-Oxley Act of 2002 (the &#8220;Sarbanes-Oxley Act&#8221;);</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
    do not have sufficient segregation of duties within accounting functions, which is a basic internal control. Due to our limited size
    and early-stage nature of operations, segregation of all conflicting duties may not always be possible and may not be economically
    feasible; however, to the extent possible, the initiation of transactions, the custody of assets and the recording of transactions
    should be performed by separate individuals;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">lack
    of independent audit committee of our board of directors; and</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">insufficient
    monitoring and review controls over the financial reporting closing process, including the lack of individuals with current
    knowledge of U.S. GAAP.</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
outsource certain functions that would normally be performed by a principal financial officer to assist us in implementing
the necessary financial controls over the financial reporting and the utilization of internal management and staff to effectuate
these controls.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe that these material weaknesses primarily relate, in part, to our lack of sufficient staff with appropriate training in
U.S. GAAP and U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;) rules and regulations with respect to financial
reporting functions, and the lack of robust accounting systems, as well as the lack of sufficient resources to hire such staff
and implement these accounting systems.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
plan to take a number of actions in the future to correct these material weaknesses including, but not limited to, establishing
an audit committee of our board of directors comprised of at least two independent directors, adding additional experienced
accounting and financial personnel and retaining third-party consultants to review our internal controls and recommend improvements,
subject to receiving sufficient additional capital. If we receive sufficient capital, we hope to increase the chief financial
officer&#8217;s role from part-time to full-time as the next step in building out our accounting department. We will need
to take additional measures to fully mitigate these issues, and the measures we have taken, and expect to take, to improve our
internal controls may not be sufficient to (1) address the issues identified, (2) ensure that our internal controls are effective
or (3) ensure that the identified material weakness or other material weaknesses will not result in a material misstatement of
our annual or interim financial statements. In addition, other material weaknesses may be identified in the future. If we are
unable to correct deficiencies in internal controls in a timely manner, our ability to record, process, summarize and report financial
information accurately and within the time periods specified in the rules and forms of the SEC will be adversely affected. This
failure could negatively affect the market price and trading liquidity of our common stock, cause investors to lose confidence
in our reported financial information, subject us to civil and criminal investigations and penalties, and generally materially
and adversely impact our business and financial condition.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 48 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
we fail to implement and maintain an effective system of internal control over financial reporting, we may not be able to accurately
report our financial results or prevent fraud.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
internal controls over financial reporting are necessary for us to provide reliable financial reports and, together with adequate
disclosure controls and procedures, are designed to prevent fraud. Any failure to implement required new or improved controls,
or difficulties encountered in their implementation could cause us to fail to meet our reporting obligations. In addition, any
testing by us conducted in connection with Section 404 of the Sarbanes-Oxley Act, or the subsequent testing by our independent
registered public accounting firm, if and when required, may reveal additional deficiencies in our internal controls over financial
reporting that are deemed to be material weaknesses or that may require prospective or retroactive changes to our consolidated
financial statements or identify other areas for further attention or improvement. If in the future we identify other material
weaknesses in our internal control over financial reporting, including at some of our acquired companies, if we are unable to
comply with the requirements of Section 404 in a timely manner or assert that our internal control over financial reporting is
effective, or if our independent registered public accounting firm is unable to express an opinion as to the effectiveness of
our internal control over financial reporting, investors may lose confidence in the accuracy and completeness of our financial
reports and the market price of our common stock could be negatively affected, and we could become subject to investigations by
the stock exchange on which our securities are then listed, the SEC, or other regulatory authorities, which could require additional
financial and management resources. Inferior internal controls could also cause investors to lose confidence in our reported financial
information, which could have a negative effect on the trading price of our common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
we currently do not have an internal audit group nor an audit committee of our board of directors, and we will eventually need
to hire additional accounting and financial staff with appropriate public company experience and technical accounting knowledge
to have effective internal controls for financial reporting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
will continue to incur significant increased costs as a result of operating as a public company.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a public company, we will continue to incur significant legal, accounting and other expenses. For example, we are subject to mandatory
reporting requirements of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), which require, among other
things, that we continue to file with the SEC annual, quarterly and current reports with respect to our business and financial condition.
We have incurred and will continue to incur costs associated with the preparation and filing of these SEC reports. In addition, the Sarbanes-Oxley
Act, as well as rules subsequently implemented by the SEC, the Dodd-Frank Wall Street Reform and Consumer Protection Act (the &#8220;Dodd-Frank
Act&#8221;) and national stock exchanges have imposed various other requirements on public companies. Stockholder activism, the current
political environment and the current high level of government intervention and regulatory reform may lead to substantial new regulations
and disclosure obligations, which may lead to additional compliance costs and impact (in ways we cannot currently anticipate) the manner
in which we operate our business. Our management and other personnel will need to devote a substantial amount of time to these compliance
initiatives. Moreover, these rules and regulations have and will continue to increase our legal and financial compliance costs and will
make some activities more time-consuming and costly. For example, we will incur additional expense to increase our director and officer
liability insurance.</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, if and when we cease to be a smaller reporting company and become subject to Section 404(b) of the Sarbanes-Oxley Act,
we will be required to furnish an attestation report on internal control over financial reporting issued by our independent registered
public accounting firm. To achieve compliance with Section 404 within the prescribed time period, we will continue to be engaged
in a process to document and evaluate our internal control over financial reporting, which is both costly and challenging. In
this regard, we will need to dedicate substantially greater internal resources, potentially engage outside consultants and adopt
a detailed work plan to assess and document the adequacy of internal control over financial reporting, continue steps to improve
control processes as appropriate, validate through testing that controls are functioning as documented and implement a continuous
reporting and improvement process for internal control over financial reporting. Despite our efforts, there is a risk that our
independent registered public accounting firm, when required, will not be able to conclude within the prescribed timeframe that
our internal control over financial reporting is effective as required by Section 404. This could result in an adverse reaction
in the financial markets due to a loss of confidence in the reliability of our financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 49 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Judgments
that our stockholders obtain against us may not be enforceable.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Substantially
all of our assets are located outside of the United States. In addition, our Chief Executive Officer/Chief Financial Officer,
James Nathanielsz, and our independent director Josef Zelinger, reside in Australia and our other director, Dr. Julian Kenyon,
resides in the UK. As a result, it may be difficult for you to effect service of process within the United States upon these persons.
It is uncertain whether the courts of Australia or the UK would recognize or enforce judgments of the United States or state courts against
us or such persons predicated upon the civil liability provisions of the laws of the United States or any state.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>RISKS
RELATED TO OUR COMMON STOCK</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
market price of our common stock may continue to be highly volatile, you may not be able to resell your shares at or above the
public offering price and you could lose all or part of your investment.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
trading price of our common stock may continue to be highly volatile. Our stock price could continue to be subject to wide fluctuations
in response to a variety of factors, including the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">actual
    or anticipated results of our clinical trials;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">actions
    of securities analysts who initiate or maintain coverage of us, changes in financial estimates by any securities analysts
    who follow our company, or our failure to meet these estimates or the expectations of investors;</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">issuance
    of our equity and/or debt securities, or disclosure or announcements relating thereto;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">additional
    shares of our common stock being sold into the market by us or our existing stockholders and/or holders of convertible debt
    or the anticipation of such sales;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">stock
    market valuations of companies in our industry;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">price
    and volume fluctuations in the overall stock market, including as a result of trends in the economy as a whole;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">lawsuits
    threatened or filed against us;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">regulatory
    developments in the United States and foreign countries applicable to biotech and biopharma companies; and</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">other
    events or factors, including those resulting from war or incidents of terrorism, or responses to these events.</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
stock markets in general, and the small-cap biotech market, in particular, have experienced extreme price and volume fluctuations
in recent years that have significantly affected the quoted prices of the securities of many companies, including companies in
our industry. The changes often appear to occur without regard to specific operating performance. The price of our shares of common
stock could fluctuate based upon factors that have little or nothing to do with our company and these fluctuations could materially
reduce our share price. Broad market, clinical trial results and industry factors may negatively affect the market price of our
common stock, regardless of our actual operating performance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 50 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Currently
there is a limited public market for our common stock, and we cannot predict the future prices or the amount of liquidity of our
common stock.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Currently,
there is a limited public market for our common stock. Our common stock is quoted on the OTC QB Marketplace under the symbol &#8220;PPCB.&#8221;
However, the OTC QB is not a liquid market in contrast to the major stock exchanges. We cannot assure you as to the liquidity
or the future market prices of our common stock if a market does develop. If an active market for our common stock does not develop,
the fair market value of our common stock could be materially adversely affected. We cannot predict the future prices of our common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
designation of our common stock as a &#8220;penny stock&#8221; would limit the liquidity of our common stock.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
common stock may be deemed a &#8220;penny stock&#8221; (as that term is defined under Rule 3a51-1 of the Exchange Act) in any
market that may develop in the future. Generally, a &#8220;penny stock&#8221; is a common stock that is not listed on a securities
exchange and trades for less than $5.00 a share. Prices often are not available to buyers and sellers and the market may be very
limited. Broker-dealers who sell penny stocks must provide purchasers of these stocks with a standardized risk-disclosure document
prepared by the SEC. The document provides information about penny stocks and the nature and level of risks involved in investing
in the penny stock market. A broker must also provide purchasers with bid and offer quotations and information regarding broker
and salesperson compensation and make a written determination that the penny stock is a suitable investment for the purchaser
and obtain the purchaser&#8217;s written agreement to the purchase. Many brokers choose not to participate in penny stock transactions.
Because of the penny stock rules, there may be less trading activity in any market that develops for our common stock in the future
and stockholders are likely to have difficulty selling their shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Trading
in our common stock on the OTC QB Marketplace has been subject to wide fluctuations.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
common stock is currently quoted for public trading on the OTC QB Marketplace. The trading price of our common stock has been
subject to wide fluctuations. Trading prices of our common stock may fluctuate in response to a number of factors, many of which will
be beyond our control. The stock market has generally experienced extreme price and volume fluctuations that have often been unrelated
or disproportionate to the operating performance of companies with limited business operation. There can be no assurance that trading
prices and price earnings ratios previously experienced by our common stock will be matched or maintained. These broad market and industry
factors may adversely affect the market price of our common stock, regardless of our operating performance. In the past, following periods
of volatility in the market price of a company&#8217;s securities, securities class-action litigation has often been instituted. Such
litigation, if instituted, could result in substantial costs for us and a diversion of management&#8217;s attention and resources.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
common stock is currently quoted only on the OTC QB Marketplace, which may have an unfavorable impact on our stock price and liquidity.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
common stock is quoted on the OTC QB Marketplace. The OTC QB Marketplace is a significantly more limited market than the
New York Stock Exchange or the NASDAQ stock market. The quotation of our shares of common stock on the OTC QB Marketplace may
result in a less liquid market available for existing and potential stockholders to trade shares of our common stock, could depress the
trading price of our common stock and could have a long-term adverse impact on our ability to raise capital in the future.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
can be no assurance that there will be an active market for our shares of common stock either now or in the future. Market liquidity
will depend on the perception of our operating business and any steps that our management might take to bring us to the awareness of
investors. There can be no assurance given that there will be any awareness generated. Consequently, investors may not be able to liquidate
their investment or liquidate at a price that reflects the value of the business. As a result, holders of our securities may not find
purchasers for our securities should they desire to sell them. Consequently, our securities should be purchased only by investors having
no need for liquidity in their investment and who can hold our securities for an indefinite period of time.</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 51 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Because
our directors and officers currently and for the foreseeable future will continue to control our Company, it is not likely that
you will be able to elect directors or have any say in the policies of our Company.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our stockholders are not entitled to cumulative voting rights. Consequently,
the election of directors and all other matters requiring stockholder approval will be decided by majority vote. In addition, our chief
executive officer and chief financial officer beneficially owns all of our preferred stock, which entitles him, as a holder of Series
A preferred stock, to vote on all matters submitted or required to be submitted to a vote of the stockholders, except election and removal
of directors, and each share entitles him to five hundred votes per share of Series A preferred stock, and as a holder of Series B preferred
stock, to voting power equivalent of the number of votes equal to the total number of shares of common stock outstanding as of the record
date for the determination of stockholders entitled to vote at each meeting of our stockholders and entitled to vote on all matters submitted
or required to be submitted to a vote of our stockholders. Due to such a disproportionate voting power, new investors will not be able
to affect a change in our business or management, and therefore, stockholders would have limited recourse as a result of decisions made
by management.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Moreover,
this preferred stock ownership may discourage a potential acquirer from making a tender offer or otherwise attempting to obtain
control of us, which in turn could reduce our stock price or prevent our stockholders from realizing a premium over our stock
price.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Future
sales and issuances of our common stock or rights to purchase common stock could result in additional dilution of the percentage
ownership of our stockholders and could cause our stock price to decline.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are authorized to issue up to 1,000,000,000 shares of our common stock, $0.001 par value per share. We have the right to raise
additional capital or incur borrowings from third parties to finance our business. The board of directors has the authority, without
the consent of any of the shareholders, to cause us to issue more shares of our common stock and/or securities convertible into
our common stock. We will likely issue additional shares of our common stock and/or such securities in the future and such future
sales and issuances of our common stock or rights to purchase our common stock could result in substantial dilution to our existing
stockholders. We may sell common stock, convertible securities and other equity securities in one or more transactions at prices
and in a manner as we may determine from time to time. If we sell any such securities in subsequent transactions, our stockholders
may be materially diluted. New investors in such subsequent transactions could gain rights, preferences and privileges senior
to those of holders of our common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>In
the future, we may issue additional preferred stock without the approval of our stockholders, which could make it more difficult
for a third party to acquire us and could depress our stock price.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are authorized to issue up to 1,500,005 shares of our preferred stock, par value $0.01 per share, having such rights, preferences
and privileges as are determined by our board of directors in their discretion. We have the right to raise additional capital
or incur borrowings from third parties to finance our business. The board of directors has the authority, without the consent
of any of the stockholders, to cause us to issue more shares of our preferred stock. Our board of directors may issue, and has
in the past issued, without a vote of our stockholders, one or more series of our preferred stock with such rights and preferences
as it determines. This could permit our board of directors to issue preferred stock to investors who support us and our management
and permit our management to retain control of our business. Additionally, issuance of preferred stock could block an acquisition
which could result in both a drop in our stock price and a decline in interest of our common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Since
we intend to retain any earnings for development of our business for the foreseeable future, you will likely not receive any dividends
for the foreseeable future, and capital appreciation, if any, will be the source of gain for our stockholders.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have never declared or paid any cash dividends or distributions on our capital stock. We currently intend to retain our future
earnings to support operations and to finance expansion and therefore we do not anticipate paying any cash dividends on our common
stock in the foreseeable future. As a result, capital appreciation, if any, of our common stock will be the sole source of gain
for our stockholders for the foreseeable future.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 52 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
ability to use our net operating loss carryforwards and certain other tax attributes may be limited.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
382 (&#8220;Section 382&#8221;) of the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;), contains rules that
limit the ability of a company that undergoes an ownership change to utilize its net operating losses (&#8220;NOLs&#8221;) and
tax credits existing as of the date of such ownership change. Under the rules, such an ownership change is generally any change
in ownership of more than 50% of a company&#8217;s stock within a rolling three-year period. The rules generally operate by focusing
on changes in ownership among stockholders considered by the rules as owning, directly or indirectly, 5% or more of the stock
of a company and any change in ownership arising from new issuances of stock by the company. As a result of this Section 382 limitation,
any ownership changes as defined by Section 382 may limit the amount of NOL carryforwards that could be utilized annually to offset
future taxable income.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>As
a smaller reporting company, we are subject to scaled disclosure requirements that may make it more challenging for investors
to analyze our results of operations and financial prospects.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a &#8220;smaller reporting company,&#8221; we (i) are able to provide simplified executive compensation disclosures in our filings,
(ii) are exempt from the provisions of Section 404(b) of the Sarbanes-Oxley Act requiring that independent registered public accounting
firms provide an attestation report on the effectiveness of internal control over financial reporting and (iii) have certain other
decreased disclosure obligations in our filings with the SEC, including being required to provide only two years of audited financial
statements in annual reports. Consequently, it may be more challenging for investors to analyze our results of operations and
financial prospects.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will remain a smaller reporting company until the beginning of a fiscal year in which we had a public float of $250 million held
by non-affiliates as of the last business day of the second quarter of the prior fiscal year, assuming our common stock is registered
under Section 12 of the Exchange Act on the applicable evaluation date. Even if we remain a smaller reporting company, if our
public float exceeds $250 million and our annual revenues are greater than $100 million, we will become subject to the
provisions of Section 404(b) of the Sarbanes-Oxley Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">***</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
risks above do not necessarily comprise of all those associated with an investment in our Company. This Registration Statement
contains forward looking statements that involve unknown risks, uncertainties and other factors that may cause our actual results,
financial condition, performance or achievements to be materially different from any future results, performance or achievements
expressed or implied by such forward looking statements. Factors that might cause such a difference include, but are not limited
to, those set out above.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_003"></span>CAUTIONARY
NOTE REGARDING FORWARD-LOOKING STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus may contain certain &#8220;forward-looking&#8221; statements as such term is defined by the SEC in its rules, regulations
and releases, which represent the registrant&#8217;s expectations or beliefs, including but not limited to, statements concerning
our operations, economic performance, financial condition, growth and acquisition strategies, investments, and future operational
plans. For this purpose, any statements contained herein that are not statements of historical fact may be deemed to be forward-looking
statements. Without limiting the generality of the foregoing, words such as &#8220;may,&#8221; &#8220;will,&#8221; &#8220;expect,&#8221;
&#8220;believe,&#8221; &#8220;anticipate,&#8221; &#8220;intent,&#8221; &#8220;could,&#8221; &#8220;would,&#8221; &#8220;should,&#8221;
&#8220;estimate,&#8221; &#8220;might,&#8221; &#8220;plan,&#8221; &#8220;predict&#8221; or &#8220;continue&#8221; or the negative
or other variations thereof or comparable terminology are intended to identify forward-looking statements. These statements by
their nature involve substantial risks and uncertainties, certain of which are beyond our control, and actual results may differ
materially depending on a variety of important factors, including uncertainty related to the discovery, development and commercialization
of our product candidate, protection of our intellectual property, governmental regulation, the operations of our Company and
our subsidiaries, managing and maintaining growth, volatility of our stock price, and any other factors discussed in this and
our other filings with the SEC.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 53 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
risks and uncertainties and other factors include, but are not limited to those set forth under the section captioned <i>&#8220;Risk
Factors&#8221;</i> of this prospectus. Given these risks and uncertainties, readers are cautioned not to place undue reliance on our
forward-looking statements. All subsequent written and oral forward-looking statements attributable to us or to persons acting on our
behalf are expressly qualified in their entirety by these cautionary statements. Except as otherwise required by applicable law, we undertake
no obligation to publicly update or revise any forward-looking statements or the risk factors described in this prospectus or in the
documents we incorporate by reference, whether as a result of new information, future events, changed circumstances or any other reason
after the date of this prospectus.</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus contains forward-looking statements, including statements regarding, among other things:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 72px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to continue as a going concern; </span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    anticipated needs for working capital;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to successfully develop PRP, our lead product candidate;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to reach research and development milestones as planned and within proposed budgets; </span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    current reliance on substantial debt financing;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to repay current debt in cash and obtain adequate new financing;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    dependence on third parties for services;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    dependence on key executives;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to control costs; </span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to successfully implement our expansion strategies; </span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to successfully develop and market our technologies; </span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to obtain and maintain patent protection; </span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to recruit employees with regulatory, accounting and finance expertise; </span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    impact of government regulations, including United States Food and Drug Administration (the &#8220;FDA&#8221;) regulations;
    </span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    impact of any future litigation; </span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    availability of capital; and</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
    in economic, business and competitive conditions;</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 54 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Actual
events or results may differ materially from those discussed in forward-looking statements as a result of various factors, including,
without limitation, the risks, uncertainties and other factors outlined in the section captioned &#8220;Risk Factors&#8221; of this prospectus
and matters described in this prospectus generally. In light of these risks and uncertainties, there can be no assurance that the forward-looking
statements contained in this prospectus will in fact occur. We caution you not to place undue reliance on these forward-looking statements.
In addition to the information expressly required to be included in this prospectus, we will provide such further material information,
if any, as may be necessary to make the required statements, in light of the circumstances under which they are made, not misleading.
All subsequent written and oral forward-looking statements attributable to our Company or to persons acting on our behalf are expressly
qualified in their entirety by these cautionary statements. Except as required by law, we do not intend to update or revise any forward-looking
statements, whether as a result of new information, future events or otherwise.</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_004"></span>USE
OF PROCEEDS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Prospectus relates to shares of our common stock that may be offered and sold from time to time by the Selling Stockholder. We will receive
no proceeds from the sale of shares of common stock by the Selling Stockholder in this registration statement. The proceeds from the
sales will belong to the Selling Stockholder. However, when the warrants are exercised, we will receive proceeds from the sale
of the Purchase Shares to the Selling Stockholder pursuant to the Common Stock Purchase Agreement. The proceeds will be used to support
company operations, including research and development activities as specified in the PRP development plan and also the POP1 joint research
and drug discovery program.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_005"></span>DETERMINATION
OF OFFERING PRICE</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt">The Selling Stockholder of the securities and any
of its pledgees, assignees and successors-in-interest may, from time to time, offer common stock <span style="background-color: white">at
prevailing market prices at the time of the sale, at fixed prices, at negotiated prices, or at varying prices determined at the time
of sale.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_006"></span>SELLING
STOCKHOLDER</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
common stock being offered by the Selling Stockholder are those previously issued to the Selling Stockholder, and those issuable
to the selling shareholders, upon exercise of the warrants. We are registering the shares of common stock in order to permit the
Selling Stockholder to offer the shares for resale from time to time. Except for the ownership of the shares of common stock and
the warrants, the Selling Stockholder has not had any material relationship with us within the past three years.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
table below lists the Selling Stockholder and other information regarding the beneficial ownership of the shares of common stock by the
Selling Stockholder. The second column lists the number of shares of common stock beneficially owned by the Selling Stockholder, based
on its ownership of the shares of common stock and warrants, as of December 31, 2021, assuming exercise of the warrants held by
the Selling Stockholder on that date, without regard to any limitations on exercises.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
third column lists the shares of common stock being offered by this prospectus by the Selling Stockholder.</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with the terms of a registration rights agreement with the Selling Stockholder, this prospectus generally covers the
resale of the sum of (i) the number of shares of common stock issued to the selling shareholders and (ii) the maximum number of
shares of common stock issuable upon exercise of the related warrants, determined as if the outstanding warrants were exercised
in full as of the trading day immediately preceding the date this registration statement was initially filed with the SEC, each
as of the trading day immediately preceding the applicable date of determination and all subject to adjustment as provided in
the registration right agreement, without regard to any limitations on the exercise of the warrants. The fourth column assumes
the sale of all of the shares offered by the Selling Stockholder pursuant to this prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 55 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the terms of the warrants, the Selling Stockholder may not exercise the warrants to the extent such exercise would cause the Selling
Stockholder, together with its affiliates and attribution parties, to beneficially own a number of shares of common stock which
would exceed 4.99% of our then outstanding common stock following such exercise, excluding for purposes of such determination
shares of common stock issuable upon exercise of the warrants which have not been exercised. The number of shares in the second
column does not reflect this limitation. The Selling Stockholder may sell all, some or none of their shares in this offering.
See &#8220;Plan of Distribution.&#8221;</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    of Selling Stockholder</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
    of shares of Common Stock Owned Prior to Offering</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Maximum
    Number of shares of Common Stock to be Sold Pursuant to this Prospectus</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
    of shares of Common Stock Owned After Offering (1)(2)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 28%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ionic
    Ventures LLC (3)</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 20%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 20%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">53,750</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 20%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
Includes shares of Common Stock underlying the Warrants that may held by the Selling Stockholder that are covered by this prospectus,
including any such securities that, due to contractual restrictions, may not be exercisable if such conversion would result in
beneficial ownership greater than 4.99%.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="background-color: white">(2) Assumes that the Selling Stockholder
sells all of the common stock underlying the Warrants offered pursuant to this prospectus.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)
Ionic Ventures, LLC is managed by Brendan O&#8217;Neil and Keith Coulston and they may also be deemed to have investment discretion
and voting power over the shares that it holds. Mr. O&#8217;Neil and Mr. Coulston each disclaims beneficial ownership of the securities
except to the extent of their respective pecuniary interests therein. The business address for Ionic is 3053 Fillmore St., Suite 256,
San Francisco, CA 94123.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_007"></span>PLAN
OF DISTRIBUTION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0 0pt; text-align: justify">The Selling Stockholder of the securities and any
of its pledgees, assignees and successors-in-interest may, from time to time, offer common stock <span style="background-color: white">to
be registered hereunder could be made at prevailing market prices at the time of the sale, at fixed prices, at negotiated prices, or
at varying prices determined at the time of sale.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">The Selling Stockholder
may use any one or more of the following methods when selling securities:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 72px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ordinary
    brokerage transactions and transactions in which the broker-dealer solicits purchasers;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">block
                                                                              trades in which the broker-dealer will attempt to sell the securities as agent but may position and resell a portion of the block as
                                                                              principal to facilitate the transaction;</span></p></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">purchases
    by a broker-dealer as principal and resale by the broker-dealer for its account;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
    exchange distribution in accordance with the rules of the applicable exchange;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">privately
    negotiated transactions;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">settlement
    of short sales;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
                                         transactions through broker-dealers that agree with the Selling Stockholder to sell a
                                         specified number of such securities at a stipulated price per security;</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">through
                                         the writing or settlement of options or other hedging transactions, whether through an
                                         options exchange or otherwise;</span></p></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 56 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 72px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    combination of any such methods of sale; or</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    other method permitted pursuant to applicable law.</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Selling Stockholder may also sell securities under Rule 144 or any other exemption from registration under the Securities Act
of 1933, as amended (the &#8220;<span style="text-decoration: underline">Securities Act</span>&#8221;), if available, rather than under this prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Broker-dealers
engaged by the Selling Stockholders may arrange for other brokers-dealers to participate in sales. Broker-dealers may receive
commissions or discounts from the Selling Stockholders (or, if any broker-dealer acts as agent for the purchaser of securities,
from the purchaser) in amounts to be negotiated, but, except as set forth in a supplement to this Prospectus, in the case of an
agency transaction not in excess of a customary brokerage commission in compliance with FINRA Rule 2440; and in the case of a
principal transaction a markup or markdown in compliance with FINRA IM-2440.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the sale of the securities or interests therein, the Selling Stockholders may enter into hedging transactions
with broker-dealers or other financial institutions, which may in turn engage in short sales of the securities in the course of
hedging the positions they assume. The Selling Stockholders may also sell securities short and deliver these securities to close
out their short positions, or loan or pledge the securities to broker-dealers that in turn may sell these securities. The Selling
Stockholders may also enter into option or other transactions with broker-dealers or other financial institutions or create one
or more derivative securities which require the delivery to such broker-dealer or other financial institution of securities offered
by this prospectus, which securities such broker-dealer or other financial institution may resell pursuant to this prospectus
(as supplemented or amended to reflect such transaction).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Selling Stockholders and any broker-dealers or agents that are involved in selling the securities may be deemed to be &#8220;underwriters&#8221;
within the meaning of the Securities Act in connection with such sales. In such event, any commissions received by such broker-dealers
or agents and any profit on the resale of the securities purchased by them may be deemed to be underwriting commissions or discounts
under the Securities Act. Each Selling Stockholder has informed the Company that it does not have any written or oral agreement
or understanding, directly or indirectly, with any person to distribute the securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is required to pay certain fees and expenses incurred by the Company incident to the registration of the securities. The
Company has agreed to indemnify the Selling Stockholders against certain losses, claims, damages and liabilities, including liabilities
under the Securities Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
agreed to keep this prospectus effective until the earlier of (i) the date on which the securities may be resold by the Selling
Stockholders without registration and without regard to any volume or manner-of-sale limitations by reason of Rule 144, without
the requirement for the Company to be in compliance with the current public information under Rule 144 under the Securities Act
or any other rule of similar effect or (ii) all of the securities have been sold pursuant to this prospectus or Rule 144 under
the Securities Act or any other rule of similar effect. The resale securities will be sold only through registered or licensed
brokers or dealers if required under applicable state securities laws. In addition, in certain states, the resale securities covered
hereby may not be sold unless they have been registered or qualified for sale in the applicable state or an exemption from the
registration or qualification requirement is available and is complied with.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
applicable rules and regulations under the Exchange Act, any person engaged in the distribution of the resale securities may not
simultaneously engage in market making activities with respect to the common stock for the applicable restricted period, as defined
in Regulation M, prior to the commencement of the distribution. In addition, the Selling Stockholders will be subject to applicable
provisions of the Exchange Act and the rules and regulations thereunder, including Regulation M, which may limit the timing of
purchases and sales of the common stock by the Selling Stockholders or any other person. We will make copies of this prospectus
available to the Selling Stockholders and have informed them of the need to deliver a copy of this prospectus to each purchaser
at or prior to the time of the sale (including by compliance with Rule 172 under the Securities Act).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 57 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="v_001"></span>MARKET
PRICE OF AND DIVIDENDS ON OUR COMMON EQUITY AND RELATED STOCKHOLDER MATTERS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Market
Information</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
common stock is quoted under the trading symbol &#8220;PPCB&#8221; on the OTC QB market place. Only a limited market exists for
our common stock. There is no assurance that a regular trading market will develop, or if developed, that it will be sustained. Therefore,
a stockholder may be unable to resell his securities in our Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number
of Holders</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0 0pt; text-align: justify"><span style="background-color: white">As of December
31, 2021, there were approximately 77 stockholders of record holding 53,062,209 shares of our common stock. This number does not include
an indeterminate number of stockholders whose shares are held by brokers in street name. The holders of our common stock are entitled
to one vote for each share held of record on all matters submitted to a vote of stockholders. Holders of our common stock have no preemptive
rights and no right to convert their common stock into any other securities. There are no redemption or sinking fund provisions applicable
to our common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0 0pt; text-align: justify; background-color: white"><b>Dividend Policy</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0 0pt; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0 0pt; text-align: justify; background-color: white">We have never paid any
cash dividends on our common stock and do not anticipate paying any cash dividends on our common stock in the foreseeable future. We
intend to retain future earnings to fund ongoing operations and future capital requirements of our business. Any future determination
to pay cash dividends will be at the discretion of our Board and will be dependent upon our financial condition, results of operations,
capital requirements and such other factors as our Board deems relevant. Our ability to pay cash dividends is subject to limitations
imposed by state law.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify; text-indent: 0pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Penny
Stock</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
SEC has adopted rules that regulate broker-dealer practices in connection with transactions in penny stocks. Penny stocks are generally
equity securities with a market price of less than $5.00, other than securities registered on certain national securities exchanges or
quoted on the NASDAQ system, provided that current price and volume information with respect to transactions in such securities is provided
by the exchange or system. The penny stock rules require a broker-dealer, prior to a transaction in a penny stock, to deliver a standardized
risk disclosure document prepared by the SEC, that: (a) contains a description of the nature and level of risk in the market for penny
stocks in both public offerings and secondary trading; (b) contains a description of the broker&#8217;s or dealer&#8217;s duties to the
customer and of the rights and remedies available to the customer with respect to a violation of such duties or other requirements of
the securities laws; (c) contains a brief, clear, narrative description of a dealer market, including bid and ask prices for penny stocks
and the significance of the spread between the bid and ask price; (d) contains a toll-free telephone number for inquiries on disciplinary
actions; (e) defines significant terms in the disclosure document or in the conduct of trading in penny stocks; and (f) contains such
other information and is in such form, including language, type size and format, as the SEC shall require by rule or regulation.</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
broker-dealer also must provide, prior to effecting any transaction in a penny stock, the customer with (a) bid and offer quotations
for the penny stock; (b) the compensation of the broker-dealer and its salesperson in the transaction; (c) the number of shares
to which such bid and ask prices apply, or other comparable information relating to the depth and liquidity of the market for
such stock; and (d) a monthly account statement showing the market value of each penny stock held in the customer&#8217;s account.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 58 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, the penny stock rules require that prior to a transaction in a penny stock not otherwise exempt from those rules, the
broker-dealer must make a special written determination that the penny stock is a suitable investment for the purchaser and receive
the purchaser&#8217;s written acknowledgment of the receipt of a risk disclosure statement, a written agreement as to transactions
involving penny stocks, and a signed and dated copy of a written suitability statement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
disclosure requirements may have the effect of reducing the trading activity for our common stock. Therefore, stockholders may have difficulty
selling our securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DIVIDEND
POLICY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have not paid any cash dividends to our stockholders. The declaration of any future cash dividends is at the discretion of our
Board and depends upon our earnings, if any, our capital requirements and financial position, and general economic conditions.
It is our present intention not to pay any cash dividends in the foreseeable future, but rather to reinvest earnings, if any,
in our business operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SELECTED
FINANCIAL DATA</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
required for smaller reporting companies.</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>DILUTION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable. The shares registered under this registration statement are not being offered for purchase by the Company. The shares are
being registered on behalf of the Selling Stockholder (the Selling Stockholder identified in this prospectus).</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="v_002"></span>MANAGEMENT&#8217;S
DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
</i></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>following discussion and analysis of the
results of operations and financial condition for the years ended June 30, 2021 and 2020, and for the three month period ended
September 30, 2021 should be read in conjunction with our consolidated financial statements and the notes to those consolidated
financial statements that are included elsewhere in this Registration Statement. Our discussion includes forward-looking
statements based upon current expectations that involve risks and uncertainties, such as our plans, objectives, expectations and
intentions. Actual results and the timing of events could differ materially from those anticipated in these forward-looking
statements as a result of a number of factors. See &#8220;Forward-Looking Statements.&#8221;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management&#8217;s
discussion and analysis of results of operations and financial condition (&#8220;MD&amp;A&#8221;) is a supplement to the accompanying financial statements and provides additional information on Propanc Biopharma, Inc. (&#8220;Propanc&#8221; or the &#8220;Company&#8217;)
business, current developments, financial condition, cash flows and results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
we say &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; &#8220;Company,&#8221; or &#8220;Propanc,&#8221; we mean Propanc Biopharma,
Inc.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Overview</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
were incorporated in the state of Delaware as Propanc Health Group Corporation on November 23, 2010. In January 2011, to reorganize our
Company, we acquired all of the outstanding shares of Propanc PTY LTD, an Australian corporation, on a one-for-one basis and Propanc
PTY LTD became our wholly-owned subsidiary. Effective April 20, 2017, we changed our name to &#8220;Propanc Biopharma, Inc.&#8221; to
better reflect our current stage of operations and development.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 26.2pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 59 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are a development-stage healthcare company that is currently focused on developing new cancer treatments for patients suffering from
pancreatic, ovarian and colorectal cancer. Utilizing our scientific and oncology consultants, we have developed a rational, composite
formulation of anti-cancer compounds, which together exert a number of effects designed to control or prevent tumors from recurring and
spreading through the body. Our lead product candidate, PRP, is a variation upon our novel formulation and involves pro-enzymes, the
inactive precursors of enzymes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Recent
Developments</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 1, 2020, the Company entered into a two-year collaboration agreement with the University of Ja&#233;n (the &#8220;University&#8221;)
to provide certain research services to the Company. In consideration of such services, the Company agreed to pay the University approximately
30,000 Euros ($35,145 USD) which shall be paid in four installment payments of 5,000 Euros in November 2020, 5,000 Euros ($5,858) in
March 2021, 10,000 Euros ($11,715) in December 2021 and 10,000 Euros ($11,715) in September 2022. Additionally, the University shall
hire and train a doctoral student for this project and as such the Company shall pay the University 25,837 Euros ($30,268 USD). In exchange
for full ownership of the intellectual property, the Company agreed to pay royalties of 2% of net revenues to the University.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 26.2pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 11, 2021, the Company&#8217;s scientific researchers with the Universities of Ja&#233;n and Granada, published data in a peer reviewed
journal, <i>Expert Opinion on Biological Therapy</i>, confirming the anti-tumor potential of a mixture of two pancreatic proenzymes trypsinogen
and chymotrypsinogen. Treatment with proenzymes sensitizes cancer stem cells which may allow standard treatment approaches like chemotherapy
and radiotherapy to be more effective.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Between
August 2020 to November 2021, advancements were made with the Company&#8217;s patent portfolio including allowed claims describing a
pharmaceutical composition for treating cancer in Brazil and a divisional application covering additional claims describing a pharmaceutical
composition for treating cancer was granted in China (both covering the Company&#8217;s lead patent application), a first granted patent
describing a method to treat cancer stem cells in Australia, and granted patents in Australia, Indonesia and Singapore, citing higher
doses of a pharmaceutical composition. The advancements represent three of four patent families covering the Company&#8217;s lead product,
PRP.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
November 2021, a Strategic Advisor to the Propanc Biopharma Executive team was appointed to initiate the process of establishing a wholly
owned, US based, R&amp;D operating subsidiary, located in New Jersey. The Strategic Advisor will oversee establishment of the R&amp;D
operating subsidiary and identify strategic partners to assist with financing and resourcing to advance PRP towards a First-In-Human
study for advanced cancer patients suffering from solid tumors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 26, 2021, the Company entered into a securities purchase agreement (the &#8220;Purchase Agreement&#8221;) with Sixth Street
Lending, LLC (&#8220;Sixth Street&#8221;), pursuant to which Sixth Street purchased a convertible promissory note (the &#8220;Note&#8221;)
from the Company in the aggregate principal amount of $53,750, such principal and the interest thereon convertible into shares of the
Company&#8217;s common stock at the option of Sixth Street. The transaction contemplated by the Purchase Agreement closed on or about
December 2, 2021. The Company intends to use the net proceeds ($50.000) from the Note for general working capital purposes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 30, 2021, the Company entered into a Common Stock Purchase Agreement (the &#8220;Purchase Agreement&#8221;) with Dutchess Capital
Growth Fund LP, a Delaware limited partnership, (&#8220;Dutchess&#8221;), providing for an equity financing facility (the &#8220;Equity
Line&#8221;). The Purchase Agreement provides that upon the terms and subject to the conditions in the Purchase Agreement, Dutchess is
committed to purchase up to Five Million Dollars ($5,000,000) of shares of common stock, $0.001 par value per share (the &#8220;Common
Stock&#8221;), over the 36 month term of the Purchase Agreement (the &#8220;Total Commitment&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 60 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the terms of the Purchase Agreement, Dutchess will not be obligated to purchase shares of Common Stock unless and until certain conditions
are met, including but not limited to a Registration Statement on Form S-1 (the &#8220;Registration Statement&#8221;) becoming effective
which registers Dutchess&#8217; resale of any Common Stock purchased by Dutchess under the Equity Line. From time to time over the 36-month
term of the Purchase Agreement, commencing on the trading day immediately following the date on which the Registration Statement becomes
effective, the Company, in our sole discretion, may provide Dutchess with a draw down notice (each, a &#8220;Draw Down Notice&#8221;),
to purchase a specified number of shares of Common Stock (each, a &#8220;Draw Down Amount Requested&#8221;), subject to the limitations
discussed below. The actual amount of proceeds the Company will receive pursuant to each Draw Down Notice (each, a &#8220;Draw Down Amount&#8221;)
is to be determined by multiplying the Draw Down Amount Requested by the applicable purchase price. The purchase price of each share
of Common Stock equals 92% of the lowest trading price of the Common Stock during the five (5) business days prior to the Closing Date.
Closing Date shall mean the five (5) business days after the Clearing Date. Clearing Date shall mean the first business day that the
Selling Shareholder holds the Draw Down Amount in its brokerage account and is eligible to trade the shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
maximum number of shares of Common Stock requested to be purchased pursuant to any single Draw Down Notice cannot exceed the lesser of
(i) 300% of the average daily share volume of the Common Stock in the five (5) trading days immediately preceding the Draw Down Notice
or (ii) an aggregate value of $250,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company agreed to pay to Dutchess a commitment fee for entering into the Purchase Agreement of 1,000,000 restricted shares of our common
stock. The shares were issued December 10, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 7, 2021,</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> the Company entered into a securities
purchase agreement (the &#8220;Purchase Agreement&#8221;) with ONE44 Capital LLC, (&#8220;ONE44&#8221;), pursuant to which
ONE44 purchased a convertible promissory note (the &#8220;Note&#8221;) from the Company in the aggregate principal amount of $170,000,
such principal and the interest thereon convertible into shares of the Company&#8217;s common stock at the option of ONE44.
The transaction contemplated by the Purchase Agreement closed on or about December 13, 2021. The Company intends to
use the net proceeds ($153,000) from the Note for general working capital purposes. The Note contains an original issue discount
amount of $17,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 4, 2022, Propanc Biopharma, Inc. (the &#8220;Company&#8221;) entered into a securities purchase agreement (the &#8220;Purchase
Agreement&#8221;) with Sixth Street Lending, LLC (&#8220;Sixth Street&#8221;), pursuant to which Sixth Street purchased a convertible
promissory note from the Company in the aggregate principal amount of $63,750, such principal and the interest thereon convertible into
shares of the Company&#8217;s common stock at the option of Sixth Street. The transaction contemplated by the Purchase Agreement closed
on January 6, 2022. The Company intends to use the net proceeds ($60,000) from the Note for general working capital purposes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Results
of Operations</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following discussion should be read in conjunction with the Company&#8217;s unaudited consolidated financial statements and notes thereto
included elsewhere in this Registration Statement. The results discussed below are of the Company and its wholly-owned Australian subsidiary,
Propanc PTY LTD.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Three
months ended September 30, 2021, as compared to the Three months ended September 30, 2020</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Revenue</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the three and three months ended September 30, 2021 and 2020, we generated no revenue because we are currently undertaking research and
development activities for market approval and no sales were generated in this period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Administration
Expense</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Administration
expense increased to $431,740 for the three months ended September 30, 2021 as compared to $323,111 for the three months ended September
30, 2020. This decrease of approximately $109,000 is primarily attributable to an increase of approximately $133,000 in stock-based expenses
for services and increase in other general and administrative expenses of approximately $3,000, offset by decrease in general consulting,
legal and investor relation fees of approximately $1,000, decrease in accounting fees of approximately $13,000, and decrease in approximately
$13,000 in employee remuneration expense.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Occupancy
Expense</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Occupancy
expense decreased by $1,468 to $7,736 for the three months ended September 30, 2021. The decrease primarily relates to exchange rate
movements over the period when compared to the same period in 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 61 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->60<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Research
and Development Expenses</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research
and development expenses were $46,554 for the three months ended September 30, 2021, as compared to $50,846 for the three months ended
September 30, 2020, a decrease of approximately $4,000. The research and development expenses incurred are primarily attributable to
research and development expenses incurred in relation to the two-year collaboration agreement we entered with University of Ja&#233;n
in October 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Interest
Expense/Income</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest
expense decreased to $109,853 for the three months ended September 30, 2021, as compared to $159,281 for the three months ended September
30, 2020, respectively. Interest expense is primarily comprised of approximately $6,000 and $90,000 of debt discount amortization and
accretion of put premium for the three months ended September 30, 2021 and interest expense from conversion fees of $2,000 and accrual
of interest expense for approximately $11,000 for the three months ended September 30, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
decrease is primarily attributable to a decrease in amortization of debt discount of approximately $115,000 for three months ended September
30, 2021, decrease in prepayment penalty fees of approximately $13,000 and decrease in conversion fees of $4,000 offset by increases
in accretion of put premium interest expense of approximately $90,000, and accrual of interest expense for a total of $7,000 for the
three months ended September 30, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Change
in Fair Value of Derivative Liabilities</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change
in fair value of derivative liabilities changed by $68,856, to a loss of $3,904 for the three months ended September 30, 2021, as compared
to a gain of $64,952 for the three months ended September 30, 2020. This change is primarily attributable to an increase in fair value
of the principal amount of a convertible note with bifurcated embedded conversion option derivatives during the three months ended September
30, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Gain
(loss) on Extinguishment of Debt, net</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 16.2pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the three months ended September 30, 2020, notes were converted with principal amounts totaling $75,000 and accrued interest of $3,000
contained bifurcated embedded conversion option derivatives. Accordingly, the fair market value of the shares issued was $134,155 resulting
in a loss on extinguishment at the time of conversion of $56,155 and $106,140 of derivative fair value was recorded as a gain on extinguishment
at the time of conversion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 14.55pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the three months ended September 30, 2021, there were no notes converted that contained bifurcated embedded conversion option derivatives.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 16.2pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Foreign
Currency Transaction Gain (Loss)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foreign
currency transaction increased to a gain of $109,129 for the three months ended September 30, 2021 as compared with $1,960 for the three
months ended September 30, 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
foreign currency transaction decreased to a gain is partially attributable to the increase in exchange rates during the three months
ended September 30 2021, as compared to the three months ended September 30, 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Net
loss</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
loss increased to $490,658 for the three months ended September 30, 2021 as compared to a net loss of $425,545 for the three months ended
September 30, 2020. The change relates to the factors discussed above.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 62 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->61<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Deemed
dividend</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognized the value of the effect of a down round feature related to our Series A warrants when triggered. Upon the occurrence
of the triggering event that resulted in a reduction of the strike price, the Company measured the value of the effect of the feature
as the difference between the fair value of the warrants without the down round feature or before the strike price reduction and the
fair value of the warrants with a strike price corresponding to the reduced strike price upon the down round feature being triggered.
Accordingly, the Company recognized deemed dividend of $114,844 and a corresponding reduction of income available to common stockholders
upon the alternate cashless exercise of these warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Net
loss available to common stockholders</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
loss available to common stockholders increased to $605,502 for the three months ended September 30, 2021 as compared to a net loss available
to common stockholders of $425,545 for the three months ended September 30, 2020. The change relates to the factors discussed above.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Liquidity
and Capital Resources</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Current
Financial Condition</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 16.2pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of September 30, 2021, we had total assets of $62,165, comprised primarily of cash of $45,817, GST tax receivable of $2,238, prepaid
expenses and other current assets of $8,353, property and equipment, net, of $3,593 and security deposit of $2,164. As compared to June
30, 2021, we had total assets of $13,101, comprised primarily of cash of $2,255, GST tax receivable of $4,341, property and equipment,
net, of $4,255 and security deposit of $2,250.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
had current liabilities of $2,368,795, primarily comprised of net convertible debt of $584,608, accounts payable and accrued expenses
of $1,233,959, employee benefit liability of $406,644, and embedded conversion option liabilities of $58,124 as of September 30, 2021.
As compared to June 30, 2021, 3,080,674, primarily comprised of net convertible debt of $624,583, accounts payable and accrued expenses
of $1,894,486, employee benefit liability of $418,538, and embedded conversion option liabilities of $54,220 as of June 30, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have funded our operations primarily through the issuance of equity and/or convertible securities for cash. The cash was used primarily
for payments for research and development, administration expenses, occupancy expenses, professional fees, consultants and travel.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the three months ended September 30, 2021 we received proceeds from exercise of warrants of $275,000 and net proceeds from issuance of
convertible notes of $160,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have substantial capital resource requirements and have incurred significant losses since inception. As of September 30, 2021, we had
$45,817 in cash. We depend upon debt and/or equity financing to fund our ongoing operations and to execute our current business plan.
Such capital requirements are in excess of what we have in available cash and for which we currently have commitments. Therefore, we
presently do not have enough available cash to meet our obligations over the next 12 months. If continued funding and capital resources
are unavailable at reasonable terms, we may curtail our plan of operations. We will be required to obtain alternative or additional financing
from financial institutions, investors or otherwise, in order to maintain and expand our existing operations. The failure by us to obtain
such financing would have a material adverse effect upon our business, financial condition and results of operations, and adversely affecting
our ability to complete ongoing activities in connection with our research and development programs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 63 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->62<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Sources
and Uses of Cash</i>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the Three months ended <br />
    September 30,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Net cash used in operating activities</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(486,758</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(179,949</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Net cash used in investing activities</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Net cash provided by financing activities</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">435,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">158,044</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Effect of exchange rate changes on cash</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">95,320</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">6,116</td><td style="text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Net
Cash Flow from Operating Activities</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
cash used in operating activities was $486,758 for the three months ended September 30, 2021, due to our net loss of $490,658 offset
primarily by non-cash charges of amortization of debt discount of $6,074, stock-based compensation of $154,140 non-cash interest expense
of $2,250, accretion of put premium of $90,192, change in fair value of derivatives of $3,904 addback foreign currency transaction gain
of $109,129. Net changes in operating assets and liabilities totaled $144,040, which is primarily attributable to increase in prepaid
expense of $8,353, increase accrued interest of $11,338 offset by decrease in accounts payable of $137,927 and decrease in accrued expenses
of $15,102.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
cash used in operating activities was $179,949 for the three months ended September 30, 2020, due to our net loss of $425,545 offset
primarily by non-cash charges of amortization of debt discount of $121,281, stock-based compensation of $20,718, non-cash interest expense
of $6,750 addback $64,952 of change in fair value of derivatives and $49,985 gain on extinguishment of debt. Net changes in operating
assets and liabilities totaled $213,306, which is primarily attributable to increase in accounts payable of $53,576, employee benefit
liability of $10,544, accrued expenses of $133,046, and accrued interest of $16,262.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Net
Cash Flow from Financing Activities</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
flows provided by financing activities for the three months ended September 30, 2021 were $435,000 as compared to $158,044 for the three
months ended September 30, 2020. During the three months ended September 30, 2021 we received proceeds from the exercise of warrants
of $275,000 and net proceeds from issuance of convertible notes of $160,000. During the three months ended September 30, 2020 we received
proceeds from the exercise of warrants of $201,044 offset by repayments of convertible notes of $43,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Effect
of Exchange Rate</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
effect of the exchange rate on cash resulted in a $95,320 positive adjustment to cash flows in the three months ended September 30, 2021
as compared to an adjustment of $6,116 to cash flows in the three months ended September 30, 2020. The reason for the fluctuation is
due to the application of currency translation rates throughout the cash flow statement, the volume of transactions within each period
and the daily fluctuation in exchange rates</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Going
Concern Qualification</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
did not generate any revenue for the three months ended September 30, 2021 and 2020 and have incurred significant losses and cash used
in operations, and such losses and use of cash are expected to continue. Our independent registered public accounting firm has included
a &#8220;Going Concern Qualification&#8221; in their audit report for each of the fiscal years ended June 30, 2021 and 2020. In addition,
we have negative working capital and convertible debt that is past maturity that we are currently negotiating with lenders in order to
amend the maturity dates. The foregoing raises substantial doubt about our ability to continue as a going concern for a period of 12
months from the issue date of this report. Our ability to continue as a going concern is dependent on our ability to execute our strategy
and on our ability to raise additional funds and/or to consummate a public offering. Management is currently seeking additional funds,
primarily through the issuance of equity and/or debt securities for cash to operate our business. No assurance can be given that any
future financing will be available or, if available, that it will be on terms that are satisfactory to us. Even if we are able to obtain
additional financing, it may contain undue restrictions on our operations, in the case of debt financing or cause substantial dilution
for our stockholders, in case of equity and/or convertible debt financing. The consolidated financial statements do not include any adjustments
that might result from the outcome of this uncertainty. The &#8220;Going Concern Qualification&#8221; might make it substantially more
difficult to raise capital.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fiscal
Year Ended June 30, 2021, as compared to the Fiscal Year Ended June 30, 2020</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Revenue</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the fiscal years 2021 and 2020 we generated no revenue because we are currently undertaking research and development activities for market
approval and no sales were generated in this period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Administration
Expense</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Administration
expense decreased to $1,553,075 for the year ended June 30, 2021 as compared to $3,281,464 for the year ended June 30, 2020.
This decrease of approximately $1,728,000 is primarily attributable to a decrease of approximately $1,190,000
in stock-based expenses for services, decrease of approximately $128,000 of indirect capital raising costs, decrease
in general consulting, legal, and investor relation fees of approximately $265,000, decrease in accounting fees
of approximately $17,000, decrease in insurance expense of approximately $75,000, decrease of approximately $124,000
in marketing and market research expense, decrease in travel expenses of approximately $28,000, decrease of approximately $19,000
of other general and administrative expenses and offset by increase of approximately $118,000 in employee remuneration
expense.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 64 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->63<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Occupancy
Expense</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Occupancy
expense decreased by</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> approximately $4,700 to
$28,112 for the year ended June 30, 2021. The decrease primarily relates to exchange rate movements over the period when compared
to the same period in 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Research
and Development Expenses</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research
and development expenses were $230,956 for the year ended June 30, 2021, as compared to $179,987 for the year ended June 30, 2020. The
increase in research and development expenses is primarily attributable to the two-year collaboration agreement with University Ja&#233;n
which was executed in October 2020 to provide certain research services to the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Interest
Expense/Income</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest
expense decreased to $449,457 for the year ended June 30, 2021, as compared to $1,748,381 for the year ended June 30, 2020. Interest
expense is primarily comprised</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> of approximately
$337,000 of debt discount amortization and accretion of put premium for the year ended June 30, 2021, and interest expense
from conversion fees, prepayment penalty fees and accrual of interest expense for a total of approximately
$113,000 for the year ended June 30, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
decrease of $1,298,924 is primarily attributable to a decrease in the issuance of convertible notes and was further reduced due to the
conversion and repayment of convertible notes</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> during
the year ended June 30, 2021 which resulted to a decrease in accretion of put premium of approximately $636,000 during the year ended
June 30, 2021, and the decrease in amortization of debt discount of approximately $598,000 during the year ended June 30, 2021. Additionally,
interest expense from prepayment penalty fees decreased by approximately $99,000 offset by increase in conversion fees and accrual of
interest expense for a total of $34,000 during the year ended June 30, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Change
in Fair Value of Derivative Liabilities</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change
in fair value of derivative liabilities changed by $393,479, to a loss of $8,186 for the year ended June 30, 2021, as compared
to a gain of $385,293 for the year ended June 30, 2020. This change is primarily attributable to a decrease in the principal
amount of convertible notes with bifurcated embedded conversion option derivatives during the year ended June 30, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Gain
from Settlement of Debt, net</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 14.55pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the year ended June 30, 2021, the Company recorded gain from settlement of debt, net of $49,319 relating to two transactions. On March
22, 2021, the Company entered into a settlement agreement with our former counsel, Foley Shechter, whereby both parties agreed to settle
all claims for professional fees owed for a total of $51,057. The Company paid the settlement amount of $51,057 on March 22, 2021. Prior
to the settlement agreement, the Company recorded total accounts payable and accrued expenses $143,614. Accordingly, the Company recognized
gain from settlement of debt of $92,557 during the year ended June 30, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
on March 15, 2021, the Company entered into a Settlement and Mutual Release Agreement with Regal whereby both parties agreed to settle
all claims and liabilities under the August 10, 2017 Convertible note for a total of $100,000. All other terms of the August 10, 2017
Convertible Note shall remain in full force and effect. Both parties agree that all future penalties under this note are waived unless
the Company fails to authorize to distribute the requested shares upon conversion. The Company has the right to pay off the balance of
any remaining amounts dues under this note in cash at any time more than 60 days after March 15, 2021. Prior to the Settlement Agreement,
the Company recorded total liabilities $56,762 consisting of remaining principal amount of $8,500, accrued interest of $23,262 and accrued
expenses of $25,000. Accordingly, the Company recognized loss from settlement of debt of $43,238 during the year ended June 30, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>


<!-- Field: Page; Sequence: 65 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->64<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Gain
(loss) on Extinguishment of Debt, net</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the year ended June 30, 2020, notes with principal amounts totaling $254,500 and accrued interest of $15,408 contained bifurcated
embedded conversion option derivatives. Accordingly, the fair market value of the shares issued was $565,746 resulting in a loss on
extinguishment at the time of conversion of $295,838 and $362,961 of derivative fair value was recorded as a gain on extinguishment at
the time of conversion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the year ended June 30, 2021, notes with principal amounts totaling $95,000 and accrued interest of $3,000 contained
bifurcated embedded conversion option derivatives. Accordingly, the fair market value of the shares issued was $178,368
resulting in a loss on extinguishment at the time of conversion of $80,368 and $130,975 of derivative
fair value was recorded as a gain on extinguishment at the time of conversion, resulting in a net gain of $50,607.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 14.55pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Foreign
Currency Transaction Gain (Loss)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foreign
currency transaction changed to a gain of $30,497 for the year ended June 30, 2021 as compared with a loss
of $143,808 for the year ended June 30, 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
foreign currency transaction decreased to a gain is partially attributable to the increase in exchange rates during
the year ended June 30 2021, as compared to the year ended June 30, 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Benefit
(provision) for taxes</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the year ended June 30, 2021 and 2020, the Company applied for and received from the Australian Taxation Office a research
and development tax credit in the amount of $113,415 and $134,728, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Net
loss</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
loss decreased to $2,025,947 for the year ended June 30, 2021 as compared to a net loss of $4,740,723 for the year ended June
30, 2020. The change relates to the factors discussed above.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Deemed
dividend</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognized the value of the effect of a down round feature related to our Series A and C warrants when triggered. Upon the occurrence
of the triggering event that resulted in a reduction of the strike price, the Company measured the value of the effect of the feature
as the difference between the fair value of the warrants without the down round feature or before the strike price reduction and the
fair value of the warrants with a strike price corresponding to the reduced strike price upon the down round feature being triggered.
Accordingly, the Company recognized deemed dividend of $391,749 and a corresponding reduction of income available to common stockholders
upon the alternate cashless exercise of these warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Net
loss available to common stockholders</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
loss available to common stockholders decreased to $2,417,696 for the year ended June 30, 2021 as compared to a net loss of $4,740,723
for the year ended June 30, 2020. The change relates to the factors discussed above.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Liquidity
and Capital Resources</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Current
Financial Condition</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of June 30, 2021, we had total assets of $13,101, comprised primarily of cash of $2,255, GST tax receivable of $4,341, property and equipment,
net, of $4,255 and security deposit of $2,250. As compared to</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
June 30, 2020, we had total assets of $98,518, comprised primarily of cash of $67,007, GST tax receivable of $2,015, property and equipment,
net, of $5,747 and operating lease right of use asset, net, $21,682.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 66 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->65<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
had current liabilities of $3,080,674, primarily comprised of net convertible debt of $624,583, accounts payable and accrued expenses
of $1,894,486, employee benefit liability of $418,538, and embedded conversion option liabilities of $54,220</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
as of June 30, 2021. As compared to June 30, 2020, we had current liabilities of $3,739,943, primarily comprised of net convertible
debt of $1,557,734, accounts payable and accrued expenses of $1,544,387, employee benefit liability of $354,109, and embedded
conversion option liabilities of $354,109.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have funded our operations primarily through the issuance of equity and/or convertible securities for cash. The cash was used primarily
for payments for research and development, administration expenses, occupancy expenses, professional fees, consultants and travel.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 29.15pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the year ended June 30, 2021 we received proceeds from exercise of warrants of $776,044 and proceeds from issuance
of convertible notes of $325,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have substantial capital resource requirements and have incurred significant losses since inception.</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
As of June 30, 2021, we had $2,255 in cash. We depend upon debt and/or equity financing to fund our ongoing operations
and to execute our current business plan. Such capital requirements are in excess of what we have in available cash and for which we
currently have commitments. Therefore, we presently do not have enough available cash to meet our obligations over the next 12 months.
If continued funding and capital resources are unavailable at reasonable terms, we may curtail our plan of operations. We will be required
to obtain alternative or additional financing from financial institutions, investors or otherwise, in order to maintain and expand our
existing operations. The failure by us to obtain such financing would have a material adverse effect upon our business, financial condition
and results of operations, and adversely affecting our ability to complete ongoing activities in connection with our research and development
programs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Sources
and Uses of Cash</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the years ended June 30,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 68%; text-align: left">Net cash used in operating activities</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">(1,145,264</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">(1,849,589</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Net cash provided by financing activities</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,058,044</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,890,240</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Effect of exchange rate changes on cash</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">22,468</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">23,962</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Net
Cash Flow from Operating Activities</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
cash used in operating activities was $1,145,264 for the year ended June 30, 2021, due to our net loss of $2,025,947, offset primarily
by non-cash charges of amortization of debt discount of $136,527, stock-based compensation of $208,444, non-cash interest expense of
$16,500, accretion of put premium of $200,410, change in fair value of derivatives of $8,186 addback foreign currency transaction gain
of $30,497, gain from settlement of debt of $48,390 and $50,607 gain on extinguishment of debt. Net changes in operating assets and liabilities
totaled $92,277, which is primarily attributable to increase in accounts payable of $177,382, increase in accrued expenses and other
payables of $152,861, employee benefit liability of $33,134, and accrued interest of $80,582.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
cash used in operating activities was $1,849,589 for the year ended June 30, 2020, due to our net loss of $4,740,723 offset primarily
by non-cash charges of amortization of debt discount of $734,130, stock-based compensation of $1,398,868, accretion of put premium of
$836,724, non-cash interest expense of $15,000, foreign currency transaction loss of $143,808 addback gain on extinguishment of debt
of $67,123 and $385,293 of change in fair value of derivatives. Net changes in operating assets and liabilities totaled $212,547, which
is primarily attributable to decrease in prepaid expenses and other assets of $83,157, increase in employee benefit liability of $35,724,
and accrued interest of $156,417 and offset by decrease in accounts payable of $29,737 and accrued expenses and other payables of $9,740.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 67 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->66<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Net
Cash Flow from Financing Activities</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
flows provided by financing activities for the year ended June 30, 2021 were $1,058,044 as compared to $1,890,240
for the year ended June 30, 2020. During the year ended June 30, 2021 we received proceeds from the exercise of warrants
of $776,044 and proceeds from issuance of convertible notes of $325,000 offset by repayments of convertible notes of $43,000.
During the year ended June 30, 2020, we received proceeds from the sale of convertible promissory notes of $1,465,250 and sale of common
stock of $450,000, net of $25,010 in issue costs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Effect
of Exchange Rate</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
effect of the exchange rate on cash resulted in a $22,468 positive adjustment to cash flows in the year ended June 30, 2021
as compared to an adjustment of $23,962 to cash flows in the year ended June 30, 2020. The reason for the fluctuation
is due to the application of currency translation rates throughout the cash flow statement, the volume of transactions within each period
and the daily fluctuation in exchange rates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Critical
Accounting Estimates</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Below
is a discussion of our more subjective accounting estimation processes for purposes of explaining (i) the methodology used in calculating
the estimates, (ii) the inherent uncertainties pertaining to such estimates, and (iii) the possible effects of a significant variance
in actual experience, from that of the estimate, on our financial condition. Estimates involve numerous assumptions that, if incorrect,
could create a material adverse impact on the Company&#8217;s results of operations and financial condition.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 29.15pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reference
is frequently made herein to the Financial Accounting Standards Board (the &#8220;FASB&#8221;) Accounting Standards Codification (&#8220;ASC&#8221;).
This is the source of authoritative US GAAP recognized by the FASB to be applied to non-governmental entities. Each ASC reference in
this filing is presented with a three-digit number, which represents its Topic. As necessary for explanation and as applicable, an ASC
topic may be followed with a two-digit subtopic, a two-digit section or a two-or-three-digit paragraph.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Foreign
Currency Translation and Comprehensive Income (Loss)</i>: The Company&#8217;s wholly owned subsidiary&#8217;s functional currency is
the AUD. For financial reporting purposes, the Australian Dollar (&#8220;AUD&#8221;) has been translated into USD as the Company&#8217;s
reporting currency. Assets and liabilities are translated at the exchange rate in effect at the balance sheet date. Revenues and expenses
are translated at the average rate of exchange prevailing during the reporting period. Equity transactions are translated at each historical
transaction date spot rate. Translation adjustments arising from the use of different exchange rates from period to period are included
as a component of stockholders&#8217; equity (deficit) as &#8220;accumulated other comprehensive income (loss).&#8221; Gains and losses
resulting from foreign currency transactions are included in the statement of operations and comprehensive loss as other income (expense).
Effective fiscal year 2021, the parent company determined that intercompany loans will not be repaid in the foreseeable future and thus,
per ASC 830-20-35-3, gains and losses from measuring the intercompany balances are recorded within cumulative translation adjustment,
a component of other comprehensive income.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 29.15pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Accounting
for Income Taxes:</i> We are governed by Australian and United States income tax laws, which are administered by the Australian Taxation
Office and the United States Internal Revenue Service, respectively. We follow ASC 740, &#8220;<i>Accounting for Income Taxes,&#8221;
</i>which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets
and liabilities are computed annually for temporary differences between the financial statements and tax bases of assets and liabilities
that will result in taxable or deductible amounts in the future based on enacted tax laws and rates applicable to the periods in which
the differences are expected to affect taxable income. Valuation allowances are established when necessary, to reduce deferred tax assets
to the amount expected to be realized. Income tax expense is the tax payable or refundable for the period plus or minus the change during
the period in deferred tax assets and liabilities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 68 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->67<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company adopted provisions of ASC 740, Sections 25 through 60, &#8220;<i>Accounting for Uncertainty in Income Taxes</i>.&#8221; These
sections provide detailed guidance for the financial statement recognition, measurement and disclosure of uncertain tax positions recognized
in the financial statements. Tax positions must meet a &#8220;more-likely-than-not&#8221; recognition threshold at the effective date
to be recognized upon the adoption of ASC 740 and in subsequent periods.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Accounting
for Stock Based Compensation</i>: We record stock-based compensation in accordance with ASC 718, &#8220;<i>Stock Compensation</i>&#8221;
and Staff Accounting Bulletin No. 107 issued by the SEC in March 2005 regarding its interpretation of ASC 718. ASC 718 requires the fair
value of all stock-based employee compensation awarded to employees to be recorded as an expense over the related requisite service period.
The statement also requires the recognition of compensation expense for the fair value of any unvested stock option awards outstanding
at the date of adoption. We value any employee or non-employee stock-based compensation at fair value using the Black-Scholes Option
Pricing Model.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 29.15pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
account for non-employee share-based awards in accordance with the measurement and recognition criteria of ASC 718.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 29.15pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Derivative
Instruments:</i> ASC 815, &#8220;<i>Derivatives and Hedging,</i>&#8221; establishes accounting and reporting standards for derivative
instruments and for hedging activities by requiring that all derivatives be recognized in the balance sheet and measured at fair value.
Gains or losses resulting from changes in the fair value of derivatives are recognized in earnings. On the date of conversion, or payoff,
of debt, we record the fair value of the conversion shares, remove the fair value of the related derivative liability, remove any discounts
and record a net gain or loss on debt extinguishment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 29.15pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Convertible
Notes with Variable Conversion Options</i>: We have entered into convertible notes, some of which contain variable conversion options,
whereby the outstanding principal and accrued interest may be converted, by the holder, into common shares at or around a fixed discount
to the price of the common stock at the time of conversion. We treat these convertible notes as stock settled debt under ASC 480 and
measure the fair value of the notes at the time of issuance, which is the result of the share price discount at the time of conversion
and record the put premium as accretion to interest expense.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Research
and Development Tax Credits</i>: We may apply for Research and Development tax concessions with the Australian Taxation Office on an
annual basis. Although the amount is possible to estimate at year end, the Australian Taxation Office may reject or materially alter
the claim amount. Accordingly, we do not recognize the benefit of the claim amount until cash receipt since collectability is not certain
until such time. The tax concession is a refundable credit. If we have net income then we can receive the credit which reduces its income
tax liability. If we have net losses, then we may still receive a cash payment for the credit, however, our net operating loss carry
forwards are reduced by the gross equivalent loss that would produce the credit amount when the income tax rate is applied to that gross
amount. The concession is recognized as an income tax benefit, in operations, upon receipt.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 29.15pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Leases:
</i>In February 2016, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued ASU 2016-02, <i>Leases</i> (Topic 842). The
updated guidance requires lessees to recognize lease assets and lease liabilities for most operating leases. In addition, the updated
guidance requires that lessors separate lease and non-lease components in a contract in accordance with the new revenue guidance in ASC
606. This guidance is effective for interim and annual reporting periods beginning after December 15, 2018. The Company adopted this
guidance effective July 1, 2019.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 1, 2019, the Company adopted ASU No. 2016-02, applying the package of practical expedients to leases that commenced before the effective
date whereby the Company elected to not reassess the following: (i) whether any expired or existing contracts contain leases and; (ii)
initial direct costs for any existing leases. For contracts entered into on or after the effective date, at the inception of a contract
the Company assessed whether the contract is, or contains, a lease. The Company&#8217;s assessment is based on: (1) whether the contract
involves the use of a distinct identified asset, (2) whether we obtain the right to substantially all the economic benefit from the use
of the asset throughout the period, and (3) whether it has the right to direct the use of the asset. The Company will allocate the consideration
in the contract to each lease component based on its relative stand-alone price to determine the lease payments.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 69 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->68<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating
lease ROU assets represents the right to use the leased asset for the lease term and operating lease liabilities are recognized based
on the present value of future minimum lease payments over the lease term at commencement date. As most leases do not provide an implicit
rate, the Company use an incremental borrowing rate based on the information available at the adoption date in determining the present
value of future payments. Lease expense for minimum lease payments is amortized on a straight-line basis over the lease term and is included
in general and administrative expenses in the consolidated statements of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Going
Concern Qualification</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying consolidated financial statements have been prepared in conformity with US GAAP, which contemplate continuation of the Company
as a going concern. For the fiscal year ended June 30, 2021, the Company had no revenues, had a net loss of $2,025,947 and had net</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
cash used in operations of $1,145,264. Additionally, as of June 30, 2021, the Company had a working capital deficit, stockholders&#8217;
deficit and accumulated deficit of $3,074,078, $3,067,573, and $58,199,466, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
independent registered public accounting firm has included a &#8220;Going Concern Qualification&#8221; in their audit report for each
of the fiscal years ended June 30, 2021 and 2020. In addition, we have negative working capital and convertible debt that
is past maturity that we are currently negotiating with lenders in order to amend the maturity dates. The foregoing raises substantial
doubt about our ability to continue as a going concern for a period of 12 months from the issue date of this report. Our ability
to continue as a going concern is dependent on our ability to execute our strategy and on our ability to raise additional funds and/or
to consummate a public offering. Management is currently seeking additional funds, primarily through the issuance of equity and/or debt
securities for cash to operate our business. No assurance can be given that any future financing will be available or, if available,
that it will be on terms that are satisfactory to us. Even if we are able to obtain additional financing, it may contain undue restrictions
on our operations, in the case of debt financing or cause substantial dilution for our stockholders, in case of equity and/or convertible
debt financing. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.
The &#8220;Going Concern Qualification&#8221; might make it substantially more difficult to raise capital.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Off-Balance
Sheet Arrangements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
do not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial
condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="arp_007"></span><b>DIRECTORS,
EXECUTIVE OFFICERS AND KEY EMPLOYEES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth certain information regarding our current executive officers and directors as of January 10, 2022:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 28%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Age</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 62%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Position</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">James
    Nathanielsz</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">47</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer, Chief Financial Officer, and Director</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
    Julian Kenyon</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">74</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Josef
    Zelinger</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">70</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Independent
    Director</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 70 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->69<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>James
Nathanielsz</b> has served as Chief Executive Officer and director of our Company since inception, and has served as our Chief
Financial Officer since December, 2020. He also has served as a director and Chief Executive Officer of our Australian subsidiary
since October 2007. From July 2006 until October 2007, Mr. Nathanielsz served as the New Products Manager of Biota Holdings Limited,
an anti- infective drug development company in Australia.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 7.3pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Nathanielsz graduated with a Bachelor of Applied Science, majoring in Biochemistry/Applied Chemistry and with a Master of Entrepreneurship
&amp; Innovation from Swinburne University of Technology in Melbourne, Australia.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
board of directors has concluded that Mr. Nathanielsz is well-qualified to serve on our board of directors and has the requisite qualifications,
skills and perspectives based on, among other factors, him being a Co-Founder of our Australian company and for his experience in research
and development and manufacturing and distribution, as well as him being our controlling stockholder, and his significant business, investment,
finance and public company experience, particularly with biotech companies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Dr.
Julian Kenyon</b> has served as a director of our Company since inception. Dr. Kenyon co-founded our Australian subsidiary and was appointed
as a director of our Australian subsidiary on February 12, 2008. Since 2000, Dr. Kenyon has served as an integrated medical physician
and Medical Director of the Dove Clinic for Integrated Medicine in Winchester and London.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 7.3pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
Kenyon graduated from the University of Liverpool with a Bachelor of Medicine and Surgery and with a research degree, Doctor of Medicine.
Since 1972, he was appointed a Primary Fellow of the Royal College of Surgeons, Edinburgh.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
board of directors has concluded that Dr. Kenyon is well-qualified to serve on our board of directors and has the requisite qualifications,
skills and perspectives based on, among other factors, him being a Co-Founder of our Australian subsidiary and because our business is
based on his initial work at the Dove Clinic.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Josef
Zelinger</b> has served as a director of the Company since December, 2020. He is a Certified Practicing Accountant with 45 years of experience
in tax, auditing, finance, investment and management consulting. Mr. Zelinger also has significant expertise in property management and
import/export businesses. Mr. Zelinger commenced his career as an accountant at L.M. Stanton &amp; Partners - Chartered Accountants,
subsequently joining Caston Pty Ltd in 1980, a steel manufacturer as Chief Financial Officer, and company director, until 1983.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
the mid-1980&#8217;s until current date, Mr. Zelinger serves as director in several private investment companies in a range of businesses
including property portfolio manager of commercial real estate, import/export businesses and a range of commercial and financial investment
companies. Since 1980, Mr. Zelinger also operates as a sole practitioner in accountancy and tax consulting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
1973, Mr. Zelinger graduated in Accounting and was admitted as a Fellow of RMIT University in Business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
board of directors has concluded that Mr. Zelinger is well-qualified to serve on our board of directors and has the requisite
qualifications, skills and perspectives based upon his professional experience.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Term
of Office</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
directors are appointed for a one-year term to hold office until the next annual general meeting of our stockholders or until removed
from office in accordance with our Bylaws and the provisions of the Delaware General Corporation Law. Our directors hold office after
the expiration of his or her term until his or her successor is elected and qualified, or until his or her resignation, death or removal
in accordance with our Bylaws or the Delaware General Corporation Law.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
officers are appointed by our board of directors and hold office until removed by our board of directors at any time for any reason.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 71 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->70<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Family
Relationships</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are no family relationships between or among any of our directors or executive officers or persons nominated or chosen by us to become
directors or executive officers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Director
Independence</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
board of directors has reviewed the independence of our directors and has determined that Josef Zelinger qualifies as an independent
director pursuant to Rule 5605(a)(2) of Nasdaq and applicable SEC rules and regulations. In making this determination, our board of directors
considered the relationships that each of our directors has with us and all other facts and circumstances our board of directors deemed
relevant in determining their independence.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Board
Committees</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
board of directors has no separately designated committees and our board members carry out the functions of both an audit committee
and a compensation committee. We do not have an audit committee financial expert serving on our board of directors. Due to our limited
financial resources, we are not in a position to retain an independent director with the qualifications to serve as an audit committee
financial expert at this time.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Scientific
Advisory Board</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have a Scientific Advisory Board that provides advice to our management relating to the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    identification, assessment, evaluation, selection, conduct and management of research projects, both those which are under review
    and are in progress;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intellectual
    property; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commercialization.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Scientific Advisory Board may also address issues related to improving project selection, formal review processes and management procedures
within our Company. The Scientific Advisory Board will generally be composed of an advisory panel of clinicians with expertise in translational
research.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.3pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of January 10, 2022, the members of our Scientific Advisory Board were:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Professor
    Klaus Kutz (also serving as our acting Chief Medical Officer);</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Professor
    </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Macarena Per&#225;n;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Professor
    </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Juan Antonio Marchal Corrales;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
    Maria Garcia; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
    Ralf Brandt.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
of the members of our Scientific Advisory Board acts as an independent consultant and is compensated on an hourly basis for his or her
services. There is presently no stock based compensation for their services. In addition, we may have relationships with entities with
which the members may be associated.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Professor
Kutz is also acting as Chief Medical Officer for Propanc in a non-executive capacity. His compensation continues to be based on an hourly
rate as per his Advisory Board Agreement. Propanc intends to appoint Professor Kutz as Chief Medical Officer of Propanc in a full-time
executive officer capacity at a time that is mutually agreed upon between both parties.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 72 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->71<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Professor
Klaus Kutz </b>has over 20 years of experience as an independent consultant in Clinical Pharmacology and Safety for pharmaceutical companies
and clinical research organizations. His specialty over the last six years is Oncology, including preparation of multiple NDAs and INDs
for small and medium sized pharmaceutical companies. He has prepared, organized and reported clinical Phase I studies in oncology and
Phase II studies in different cancer indications (prostate, gastric, ovarian, small cell lung cancer) and Non-Hodgkin Lymphomas. Professor
Kutz has more than 13 years of experience as Head of Clinical Pharmacology with world-wide responsibilities for Phase I and Clinical
Pharmacokinetics in two internationally operating pharmaceutical companies, setting up and restructuring international Clinical Pharmacology
departments. His achievements include the successful world-wide registration of multiple important Sandoz&#8217; compounds by preparation
of multiple NDAs (New Drug Applications) and Expert reports (including Written Summary), as well as the preparation of multiple INDs
(Investigational New Drug Applications) for Sandoz Pharma Ltd and Sanofi Research. He is a specialist for Internal Medicine, Gastroenterology,
and Clinical Pharmacology and he is also Professor of Medicine at the University of Bonn, Germany.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Professor
Macarena Per&#225;n</b></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> holds a B.S. in Biology
and an M.S. in Biochemistry and Molecular Biology from the University of M&#225;laga, Spain. Dr. Per&#225;n moved to the Neuroscience
Department at Durham University, UK, where she studied the Cellular Distribution and Immobilization of GABAA Receptors on the
cell membrane and graduated in 2000 with a Ph.D. She moved back to Spain and completed another Ph.D. program in the Faculty of Medicine
focused on Changes in the Behavior of Central Nervous Proteins; she completed a second Ph.D. from Granada University. In 2005/2006, she
attended Bath University, UK, Prof. David Tosh lab, and changed her research interest to the development of new anti-cancer drugs and
cell therapy for regenerative medicine. In 2011, she spent a year as a visiting scientist in the Salk Institute for Biological Studies,
California, Prof. Juan Carlos Izpisua-Belmonte lab. Currently, Dr. Per&#225;n is Reader in Anatomy at University of Ja&#233;n in
Spain and is working with the Institute for Regenerative Medicine and Pathobiology (IBIMER).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Professor
</b></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Juan Antonio Marchal Corrales </b>is Professor
of Anatomy and Embryology at the Faculty of Medicine of University of Granada. He graduated in Medicine and Surgery in 1992, obtaining
the degree &#8220;summa cum laude&#8221;. He defended his doctoral thesis in 1996. Prof. Marchal has worked at three universities in
different educational categories and is responsible for the research group &#8220;Differentiation, Regeneration and Cancer&#8221;. He
has participated in 39 research projects of national and international character, being principal investigator in 13 of them. He has
a total of 145 publications in journals, of which 125 are listed in the Journal Citation Reports. He has spent time at the University
of Sassari (Italy) and as visiting professor. He is inventor of 14 patents, 4 of them licensed. He is a member of the Advisory Board
of the International Graduate School of the University of Granada, member of the standing committee of the Scientific Council and coordinator
of Area Research in the Biosanitary Institute of Granada (ibs.GRANADA) and member of the Governing Board at the Institute of Pathobiology
and Regenerative Medicine (IBIMER). He has recently been named director of the Chair Drs. Galera and Requena of Cancer Stem Cell Research
at the University of Granada.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Dr.
Maria Garcia </b>graduated in Biology from University of Granada (Spain) in 1997, became a Molecular Biologist working in the National
Centre of Biotechnology characterizing the mechanism of action of &#8220;Protein kinase induced by interferon: PKR&#8221;. These studies
gave rise to a PhD title awarded with an Extraordinary Thesis Award by the Autonomous University of Madrid in 2004. In 2002, Dr. Garc&#237;a
completed a 3-months stay at the University of Wyoming with Dr. Roth. During the postdoctoral period, she got major public and private
funding to characterize new activity of the main tumor suppressor genes that are mutated in more than 50% of human cancers such as p53,
ARF and Rb. Dr. Garc&#237;a currently has a competitive research contract from the National Health System to lead translational cancer
research, aiming at the integration of basic, clinical and epidemiological cancer research in the University Hospital Complex of Granada.
She leads a line of research involving new antitumor drugs, biological therapies, biomarkers and cancer stem cell studies. Finally, Dr.
Garc&#237;a has more than 30 peer-reviewed publications in international journals with an average impact factor of 5 and a H-Index
of 14.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 73 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->72<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Dr.
Ralf Brandt</b> is the co-founder of vivoPharm, a global oncology and immuno-oncology discovery services company providing a range of
preclinical services, which merged and became a part of Cancer Genetics, Inc., a Nasdaq listed company enabling precision medicine in
oncology from bench to bedside. Dr. Brandt currently serves as President of Discovery and Early Development of Cancer Genetics. Dr. Brandt
is a biochemist and cell biologist with over 15 years of experience in research programs of experimental oncology. He has immense
experience in in vivo pharmacology and anti-cancer drug profiling. Dr. Brandt received his License (BSc in Biochemistry and Animal
Physiology) in 1986, and his PhD (in Biochemistry) in 1991 from the Martin-Luther University of Halle-Wittenberg, Germany. Dr. Brandt
was employed at research positions at the National Cancer Institute in Bethesda, MD, USA and at Schering AG, Germany. Since 1990, Dr.
Brandt has been active in the field of preclinical oncology. He led the Tumor Biology program at Novartis Pharma AG, Switzerland and
established several transgenic mouse lines developing tumors under the control of oncogenes. During Dr. Brandt&#8217;s long career in
the pharmaceutical industry he has acquired significant knowledge and expertise in leading business units and representation of services
to the pre-clinical research market. Dr. Brandt is also a member of the Scientific Advisory Board at Receptor Inc. in Toronto Canada.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risk
Oversight</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
board of directors will oversee a company-wide approach to risk management. Our board of directors will determine the appropriate risk
level for us generally, assess the specific risks faced by us and review the steps taken by management to manage those risks. While our
board of directors will have ultimate oversight responsibility for the risk management process, its committees will oversee risk in certain
specified areas.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Until
we have established our compensation committee of our board of directors, our board of directors will be responsible for overseeing the
management of risks relating to our executive compensation plans and arrangements, and the incentives created by the compensation awards
it administers. Until we have established our audit committee, our board of directors will oversee management of enterprise risks and
financial risks, as well as potential conflicts of interests. Our board of directors will be responsible for overseeing the management
of risks associated with the independence of our board of directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Code
of Ethics</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board has adopted a Code of Ethics (the &#8220;Code&#8221;) to apply to all of our directors, officers and employees. The Code is intended
to promote ethical conduct and compliance with laws and regulations, to provide guidance with respect to the handling of ethical issues,
to implement mechanisms to report unethical conduct, to foster a culture of honesty and accountability, to deter wrongdoing and to ensure
fair and accurate financial reporting. A copy of the Code is available at our website www.propanc.com.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Compensation
Committee Interlocks and Insider Participation</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None
of our executive officers currently serves, or in the past three years has served, as a member of the board of directors or compensation
committee of another entity that has one or more executive officers serving on our board of directors or the compensation committee.
No member of our compensation committee has any other business relationship or affiliation with us other than his or her service as a
director.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nominations
to the Board of Directors</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>General
</i>&#8212; Our directors take a critical role in guiding our strategic direction and oversee the management of the Company. Our board
of directors&#8217; candidates are considered based upon various criteria, such as their broad-based business and professional skills
and experiences, a global business and social perspective, concern for the long-term interests of the shareholders, diversity,
and personal integrity and judgment. In addition, directors must have time available to devote to our board of directors&#8217; activities
and to enhance their knowledge of our business. Accordingly, we seek to attract and retain highly qualified directors who have sufficient
time to attend to their substantial duties and responsibilities to our Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 74 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->73<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
16(a) Beneficial Ownership Reporting Compliance</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
Section 16(a) of the Exchange Act, our directors and certain of our officers, and persons holding more than 10 percent of our common
stock are required to file forms reporting their beneficial ownership of our common stock and subsequent changes in that ownership with
the United States Securities and Exchange Commission.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
solely upon a review of copies of such forms filed on Forms 3, 4, and 5 furnished to us, we believe that during the year ended June
30, 2021&#160;, our executive officers, directors and greater than 10 percent beneficial owners complied on a timely basis with all Section
16(a) filing requirements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Legal
Proceedings</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the best of our knowledge, none of our directors or executive officers has, during the past ten years:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">been
    convicted in a criminal proceeding or been subject to a pending criminal proceeding (excluding traffic violations and other minor
    offenses);</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">had
    any bankruptcy petition filed by or against the business or property of the person, or of any partnership, corporation or business
    association of which he was a general partner or executive officer, either at the time of the bankruptcy filing or within two years
    prior to that time;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">been
    subject to any order, judgment, or decree, not subsequently reversed, suspended or vacated, of any court of competent jurisdiction
    or federal or state authority, permanently or temporarily enjoining, barring, suspending or otherwise limiting, his involvement in
    any type of business, securities, futures, commodities, investment, banking, savings and loan, or insurance activities, or to be
    associated with persons engaged in any such activity;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">been
    found by a court of competent jurisdiction in a civil action or by the Securities and Exchange Commission or the Commodity Futures
    Trading Commission to have violated a federal or state securities or commodities law, and the judgment has not been reversed, suspended,
    or vacated;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">been
    the subject of, or a party to, any federal or state judicial or administrative order, judgment, decree, or finding, not subsequently
    reversed, suspended or vacated (not including any settlement of a civil proceeding among private litigants), relating to an alleged
    violation of any federal or state securities or commodities law or regulation, any law or regulation respecting financial institutions
    or insurance companies including, but not limited to, a temporary or permanent injunction, order of disgorgement or restitution,
    civil money penalty or temporary or permanent cease-and-desist order, or removal or prohibition order, or any law or regulation prohibiting
    mail or wire fraud or fraud in connection with any business entity; or</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">been
    the subject of, or a party to, any sanction or order, not subsequently reversed, suspended or vacated, of any self-regulatory organization
    (as defined in Section 3(a)(26) of the Exchange Act), any registered entity (as defined in Section 1(a)(29) of the Commodity Exchange
    Act), or any equivalent exchange, association, entity or organization that has disciplinary authority over its members or persons
    associated with a member.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None
of our directors, officers or affiliates, or any beneficial owner of 5% or more of our common stock, or any associate of such persons,
is an adverse party in any material proceeding to, or has a material interest adverse to, us or any of our subsidiaries.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 75 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->74<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="arp_008"></span>EXECUTIVE
COMPENSATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth the compensation paid or accrued by us to our Executive Officers for</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
the fiscal years ended June 30, 2021 and 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.3pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Summary
Compensation Table</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Salary<br /> ($)</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Bonus<br /> ($)</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Option<br /> Awards<br /> ($)</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">All Other<br /> Compensation<br /> ($)</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total<br /> ($)</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 32%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">James Nathanielsz<sup>(1) (5)</sup></span></td><td style="width: 2%">&#160;</td>
    <td style="width: 6%; text-align: center">2020</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">357,988</td><td style="width: 1%; text-align: left"><sup>(2)</sup></td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">165,384</td><td style="width: 1%; text-align: left"><sup>(3)</sup></td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">66,821</td><td style="width: 1%; text-align: left"><sup>(4)</sup></td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">590,193</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-style: italic; text-align: left">Chief Executive Officer</td><td>&#160;</td>
    <td style="text-align: center">2021</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">298,920</td><td style="text-align: left"><sup>(2)</sup></td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">177,840</td><td style="text-align: left"><sup>(5)</sup></td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">64,532</td><td style="text-align: left"><sup>(4)</sup></td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">541,292</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Carlo Campiciano<sup>(6)</sup></td><td>&#160;</td>
    <td style="text-align: center">2020</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">51,222</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">51,222</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-style: italic; text-align: left">Chief Financial Officer</td><td>&#160;</td>
    <td style="text-align: center">2021</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">19,530</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">19,530</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Julian Kenyon<sup>(7)</sup></td><td>&#160;</td>
    <td style="text-align: center">2020</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">37,211</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">37,211</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-style: italic; text-align: left">Chief Scientific Officer</td><td>&#160;</td>
    <td style="text-align: center">2021</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">40,534</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">40,534</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    purposes of the information included in the table, the conversion rates as of June 30, 2021 and 2020, $0.7473 and $0.6891,
    respectively, were used to convert amounts from AUD to USD.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
    the Nathanielsz Employment Agreement (as defined below), Mr. Nathanielsz received a gross annual salary of $400,000 AUD per year
    effective February 1, 2018 as approved by the board of directors. Mr. Nathanielsz has also accrued unused annual and long service
    leave in the amounts of $41,110 (AUD) ($30,722 USD) and $46,187 (AUD) ($31,827 USD) for fiscal years 2021 and 2020,
    respectively, which are included in the total above.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    July 13, 2020 the Board approved a bonus of $240,000 AUD ($165,384 USD) being equal to 60% of Mr. Nathanielsz base salary.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
    the Nathanielsz Employment Agreement, Mr. Nathanielsz receives a 9.5% contribution to a pension of which he is the beneficiary. In
    addition, pursuant to the Nathanielsz Employment Agreement, we may make a monthly payment to cover the costs relating to Mr. Nathanielsz
    use of a vehicle. For the fiscal years ended June 30, 2021 and 2020, $34,476 and $32,757, respectively, was paid to Mr. Nathanielsz
    for use of a vehicle.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    August 12, 2021, the Company entered into a Cancellation Agreement with James Nathanielsz (&#8220;Nathanielsz&#8221;), Chief Executive
    Officer and Director of the Company, whereby Nathanielsz agreed to cancel his cash compensation bonus award for fiscal year 2021,
    ended June 30, 2021, in exchange for common stock of the Company. The Company and Nathanielsz entered into an Amended and Restated
    Employment Agreement dated May 14, 2019 (the &#8220;Agreement&#8221;). Pursuant to the terms of the Agreement, Nathanielsz was eligible
    to earn an annual fiscal year cash performance bonus for each fiscal year of his employment period with the Company with a target
    performance bonus of 200% of his average annualized base salary during the fiscal year for which the performance bonus is earned.
    On July 20, 2021, Nathanielsz was awarded a &#8220;target&#8221; bonus of 78%, or $177,840 USD (the &#8220;Debt&#8221;) for the fiscal
    year ended June 30, 2021, by the Company&#8217;s Board of Directors (the &#8220;Board&#8221;). Pursuant to the Cancellation Agreement,
    Nathanielsz agreed to cancel this Debt in exchange for 5,928,000 shares of the common stock of the Company, valued at approximately
    $0.03 per share, being the closing price of the stock on the date of grant. The shares were issued on August 17, 2021.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 76 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->75<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    December 23, 2020, Carlo Campiciano resigned as the Chief Financial Officer and Secretary of Propanc Biopharma, Inc. (the &#8220;Company&#8221;),
    and effective on that date. James Nathanielsz, the Company&#8217;s Chief Executive Officer, assumed the duties and additional position
    of Chief Financial Officer.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    August 12, 2021, the Company entered into a Cancellation Agreement with Dr. Julian Kenyon (&#8220;Kenyon&#8221;), Chief Scientific
    Officer and Director of the Company, whereby Kenyon agreed to cancel $102,600 USD of accrued salary due him as of June 30, 2021,
    pursuant to that certain Amended and Restated Services Agreement by and between Kenyon and the Company, dated May 14, 2019, in exchange
    for 3,420,000 shares of common stock of the Company, valued at approximately $0.03 per share, being the closing price of the stock
    on the date of grant. The shares were issued on August 17, 2021.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 30.6pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Narrative
to Summary Compensation Table</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Employment
Agreement with James Nathanielsz</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> and James Nathanielsz entered into a
new employment agreement as of May 14, 2019 (the &#8220;Nathanielsz Employment Agreement&#8221;) setting forth the terms and
conditions of Mr. Nathanielsz employment as the Company&#8217;s President and Chief Executive Officer. The Nathanielsz Employment
Agreement also contemplates that Mr. Nathanielsz serves as a member of the Board.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Nathanielsz Employment Agreement provides Mr. Nathanielsz with a base salary of $33,333 AUD per month ($400,000
AUD annually) and a monthly contribution to Mr. Nathanielsz&#8217;s pension equal to 9.5% of his monthly salary. Mr. Nathanielsz has
the ability to convert any accrued but unpaid salary into common stock at the end of each fiscal year at a conversion price to be
determined by Mr. Nathanielsz and the Company, which will in no event be lower than par value or higher than the closing bid price
on the date of conversion. The Company has also agreed to pay Mr. Nathanielsz an annual discretionary bonus in an amount up to
200% of his annual base salary, which bonus shall be determined by the Board and based upon the performance of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Nathanielsz is entitled to 20 days of annual leave and 10 days of paid sick leave. Mr. Nathanielsz is also entitled to participate in
employee benefits plans, fringe benefits and perquisites maintained by the Company to the extent the Company provides similar benefits
or perquisites (or both) to similarly situated executives of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event that the Company provides notice of non-renewal of the Nathanielsz Employment Agreement, the Company terminates Mr. Nathanielsz
without cause (as defined in the Nathanielsz Employment Agreement) or Mr. Nathanielsz terminates his employment for good reason (as defined
in the Nathanielsz Employment Agreement), the Company has agreed to pay Mr. Nathanielsz a severance payment in an amount equal to Mr.
Nathanielsz&#8217;s base salary for the year of termination in addition to accrued but unpaid salary, reimbursement of expenses and certain
other employee benefits as determined under the terms of the applicable plans (&#8220;Accrued Amounts&#8221;). In the event that Mr.
Nathanielsz provides notice of non-renewal of the Nathanielsz Employment Agreement, the Company terminates Mr. Nathanielsz for cause
or Mr. Nathanielsz terminates his employment without good reason, Mr. Nathanielsz is only entitled to the Accrued Amounts.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> agreed to indemnify Mr. Nathanielsz
for any liabilities, costs and expenses incurred in the event that he is made a party to a proceeding due to his roles with the
Company, other than any proceeding initiated by Mr. Nathanielsz or the Company relating to any dispute with respect to the Nathanielsz
Employment Agreement or Mr. Nathanielsz&#8217;s employment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the terms of the Nathanielsz Employment Agreement,
Mr. Nathanielsz is also subject to certain restrictive covenants, including a one-year non-compete.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 77 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->76<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Employment
Agreement with Carlo Campiciano</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with Mr. Campiciano&#8217;s appointment as</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
the Company&#8217;s Chief Financial Officer and Secretary, effective as of June 24, 2019, Propanc PTY entered into an Employment Agreement
with Mr. Campiciano. Pursuant to the Employment Agreement, Mr. Campiciano will be compensated at an hourly rate based on a pro-rated
annual salary for the number of hours of services to be provided to the Company. If Mr. Campiciano&#8217;s employment is terminated by
either party, he will be entitled to certain termination benefits, including payment of accrued but untaken annual leave,
salary payments pro-rated based on applicable notice period required under the Employment Agreement, reimbursement of incurred business
related expenses and such other payments as may be required by the Australian National Employment Standards. The Employment Agreement
contains covenants for the benefit of Propanc PTY relating to non-interference with Propanc PTY&#8217;s business after
termination of employment and protection of Propanc PTY&#8217;s confidential information, certain customary representations and
warranties and standard Propanc PTY indemnification obligations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 23, 2020, Carlo Campiciano resigned as the Chief Financial Officer and Secretary of Propanc Biopharma, Inc. (the &#8220;Company&#8221;),
effective on that date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Amended
and Restated Services Agreement &#8211; Julian Kenyon</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 14, 2019, the Company entered into an Amended and Restated Services Agreement (the &#8220;Services Agreement&#8221;)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
with Dr. Kenyon, the Company&#8217;s Chief Scientific Officer and a director, for a term of three years, subject
to automatic one-year renewals, at an annual salary of $54,000 AUD. In connection with the execution of the Services Agreement,
Dr. Kenyon was designated as an executive officer of the Company and assumed a more active executive role with the Company. Pursuant
to the Services Agreement, Dr. Kenyon was granted options to purchase 20 shares of the Company&#8217;s common stock
(the &#8220;Kenyon Options&#8221;), with an exercise price per share of $4,250 (100% of the closing market price of the
Company&#8217;s common stock on May 14, 2019, the date of approval of such grant by the Company&#8217;s board of directors),
(ii) 20 restricted stock units of the Company (the &#8220;Initial Kenyon RSUs&#8221;), and (iii) an additional 20 restricted
stock units of the Company (the &#8220;Additional Kenyon RSUs&#8221;). Such options and restricted stock units were granted
pursuant to the 2019 Plan approved by the Company&#8217;s board of directors on the Effective Date. The Kenyon Options
have a term of 10 years from the date of grant. 1/3rd of the Kenyon Options shall vest every successive one-year anniversary following
the Effective Date, provided, that on each such vesting date Dr. Kenyon is employed by the Company and subject to the other provisions
of the Services Agreement. The Initial Kenyon RSUs shall vest on the one-year anniversary of the Effective Date, subject to Dr.
Kenyon&#8217;s continued employment with the Company through such vesting date. The Additional Kenyon RSUs will vest as follows, subject
to Dr. Kenyon&#8217;s continued employment with the Company through the applicable vesting date: (i) 5 of the Additional Kenyon
RSUs shall vest upon the Company submitting the CTA for PRP for the Study in an applicable jurisdiction to be selected by the Company,
(ii) 5 of the Additional Kenyon RSUs shall vest upon the Company completing an equity financing in the amount of at least $4,000,000
in gross proceeds, (iii) 5 of the Additional Kenyon RSUs shall vest upon the shares of the Company&#8217;s Common Stock being
listed on a senior stock exchange (NYSE, NYSEMKT or NASDAQ), and (iv) the remaining 5 of the Additional Kenyon RSUs shall vest
upon the Company enrolling its first patient in the Study. Each vested Kenyon RSU shall be settled by delivery to Mr. Kenyon of
one share of the Company&#8217;s common stock and/or the fair market value of one share of common stock in cash, at the sole discretion
of the Company&#8217;s board of directors and subject to the Plan, on the first to occur of: (i) the date of a Change of Control
(as defined in the Services Agreement), (ii) the date that is ten business days following the vesting of such Kenyon RSU, (iii) the date
of Dr. Kenyon&#8217;s death or Disability (as defined in the Services Agreement), and (iv) Dr. Kenyon&#8217;s employment being terminated
either by the Company without Cause or by Dr. Kenyon for Good Reason (as defined in the Services Agreement). In the event of a
Change of Control (as defined in the Services Agreement), 50% of any unvested portion of the Kenyon Options and the Kenyon RSUs
shall vest immediately prior to such event.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 78 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->77<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>2019
Equity Incentive Plan</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 14, 2019, our board of directors adopted our 2019 Equity Incentive Plan (the &#8220;2019 Plan&#8221;), which reserves a total of
234,000 shares of our common stock for issuance under the 2019 Plan (adjusted for the planned Reverse Stock Split). As described below,
incentive awards authorized under the 2019 Plan include, but are not limited to, incentive stock options within the meaning of Section
422 of the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;). If an incentive award granted under the 2019 Plan expires,
terminates, is unexercised or is forfeited, or if any shares are surrendered to us in connection with the exercise of an incentive award,
the shares subject to such award and the surrendered shares will become available for further awards under the 2019 Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Administration
- </i>Our board of directors will administer the 2019 Plan. Subject to the terms of the 2019 Plan, our board of directors has complete
authority and discretion to determine the terms upon which awards may be granted under the 2019 Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Grants
</i>- The 2019 Plan authorizes the grant to participants of nonqualified stock options, incentive stock options, restricted stock awards,
restricted stock units, performance grants intended to comply with Section 162(m) of the Code and stock appreciation rights, as described
below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options
    granted under the 2019 Plan entitle the grantee, upon exercise, to purchase up to a specified number of shares from us at a specified
    exercise price per share. The exercise price for shares of Common Stock covered by an option generally cannot be less than the fair
    market value of Common Stock on the date of grant unless agreed to otherwise at the time of the grant. In addition, in the case of
    an incentive stock option granted to an employee who, at the time the incentive stock option is granted, owns stock representing
    more than 10% of the voting power of all classes of stock of the Company or any parent or subsidiary, the per share exercise price
    will be no less than 110% of the fair market value of Common Stock on the date of grant.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Restricted
    stock awards and restricted stock units may be awarded on terms and conditions established by the compensation committee, which may
    include performance conditions for restricted stock awards and the lapse of restrictions on the achievement of one or more performance
    goals for restricted stock units.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    board of directors may make performance grants, each of which will contain performance goals for the award, including the performance
    criteria, the target and maximum amounts payable, and other terms and conditions.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    2019 Plan authorizes the granting of stock awards. The board of directors will establish the number of shares of our common stock
    to be awarded (subject to the aggregate limit established under the 2019 Plan upon the number of shares of our common stock that
    may be awarded or sold under the 2019 Plan) and the terms applicable to each award, including performance restrictions.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock
    appreciation rights (&#8220;SARs&#8221;) entitle the participant to receive a distribution in an amount not to exceed the number
    of shares of Common Stock subject to the portion of the SAR exercised multiplied by the difference between the market price of a
    share of Common Stock on the date of exercise of the SAR and the market price of a share of our common Stock on the date of grant
    of the SAR.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Duration,
Amendment, and Termination - Our board of directors has the power to amend, suspend or terminate the 2019 Plan without stockholder approval
or ratification at any time or from time to time. No change may be made that increases the total number of shares of Common Stock reserved
for issuance pursuant to incentive awards or reduces the minimum exercise price for options or exchange of options for other incentive
awards, unless such change is authorized by our stockholders within one year of such change. Unless sooner terminated, the 2019 Plan
would terminate ten years after it is adopted.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
awards or any shares of our common stock were issued during the fiscal year 2021 under the 2019 Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 79 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->78<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Outstanding
Equity Awards at Fiscal Year-End</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth certain information with respect to grants of plan-based awards for the fiscal year ended June 30, 2021 to
the Named Executive Officer. Except as set forth below, all of the outstanding equity awards granted to our Named Executive Officer were
fully vested as of June 30, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td colspan="13" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Option awards</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="9" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Stock awards</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Name</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number of Securities Underlying
    Unexercised Options (#) Exercisable</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number of Securities Underlying
    Unexercised Options (#) Unexercisable</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Option Exercise Price ($)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Option Expiration Date</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number of Shares, Units or Other
    Rights That Have Not Vested (#)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Market Value or Payout Value of
    Unearned Shares, Units or Other Rights That Have Not Vested ($)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 20%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">James Nathanielsz
    <sup>(1)</sup></span></td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right">26</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right">13</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">4,675</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 14%; text-align: right">May 13, 2029</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right">39</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right">165,747</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Julian Kenyon <sup>(2)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">13</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">4,250</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: right">May 13, 2029</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">20</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">82,873</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    May 14, 2019, the Board granted Mr. Nathanielsz 39 tenure based stock options at an exercise price of $4,675 per share and 78 performance
    based restricted stock units. The fair value of the 39 options and 78 restricted stock units at the grant date was $165,747 and $331,493,
    respectively. With 39 of such restricted stock vested on May 14, 2020 and the balance subject to performance conditions. </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    May 14, 2019, the Board granted Mr. Kenyon 20 tenure based stock options at an exercise price of $4,250 per share and 40 performance
    based restricted stock units. The fair value of the 20 options and 40 restricted stock units at the grant date was $82,873 and $165,747,
    respectively. With 20 of such restricted stock vested on May 14, 2020 and the balance subject to performance conditions.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Director
Compensation for the Fiscal Year Ended June 30, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Name</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Fees earned or paid in<br /> cash
    ($)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Option
                                            Awards</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>All
                                            Other Compensation</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 44%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Josef Zelinger
    <sup>(1)</sup></span></td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">&#160;&#160;&#160;&#160;&#160;-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right">84,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">84,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Company issued 2,800,000 shares of common stock of the Company for accrued director services of $84,000 as of June 30, 2021. The
    2,800,000 shares of common stock was valued at approximately $0.03 per share, being the closing price of the stock on the date of
    grant. The shares were issued on August 17, 2021.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Amended
and Restated Director Agreement &#8211; Josef Zelinger</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 12, 2021, the Company entered into an Amended and Restated Director Agreement (the &#8220;Director Agreement&#8221;) with Josef
Zelinger (&#8220;Zelinger&#8221;). Pursuant to the terms of the Director Agreement, the Company shall pay Zelinger a base salary of $250.00
AUD per month, payable on the first day of each month. In addition, the Company may compensate Zelinger additional consideration for
advisory services performed by the Director, either in the form of cash or common stock, at the discretion of the Board. The Company
issued 2,800,000 shares of common stock of the Company for accrued director services of $84,000 as of June 30, 2021. The 2,800,000 shares
of common stock was valued at approximately $0.03 per share, being the closing price of the stock on the date of grant. The shares were
issued on August 17, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 80 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->79<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Other
Director Compensation</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Directors
are reimbursed for reasonable expenses incurred in attending meetings and carrying out duties as board members.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Scientific
Advisory Board Members Compensation</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has entered into Scientific Advisory Board Member Agreements with certain members of its Scientific Advisory Board (the &#8220;SAB
Agreements&#8221;). The SAB Agreements contain substantially similar terms and primarily relate to the protection of the Company&#8217;s
intellectual property. The SAB Agreements also include provisions for the members&#8217; compensation for the services performed as a
member of the Scientific Advisory Board. Messrs. Kutz, Brandt and Smyth each are paid a monetary fee for each year of service provided.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Narrative
Disclosure of Compensation Policies and Practices as They Relate to Our Risk Management</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe that our compensation policies and practices for all employees and other individual service providers, including executive officers,
do not create risks that are reasonably likely to have a material adverse effect on us.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="arp_011"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CERTAIN
RELATIONSHIPS AND RELATED PARTY</b></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> TRANSACTIONS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Related-Party
Transactions</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following includes a summary of transactions since July 1, 2019 to which we have been a party, in which the amount involved in
the transaction exceeded $120,000, and in which any of our directors, executive officers or, to our knowledge, beneficial owners of more
than 5% of our capital stock or any member of the immediate family of any of the foregoing persons had or will have a direct or indirect
material interest, other than equity and other compensation, termination, change in control and other arrangements, which are described
above under &#8220;Item 11. Executive Compensation.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.3pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">principal executive office is located at 302,
6 Butler Street, Camberwell, VIC, 3124 Australia, which we lease from Horizon Pty Ltd., a related party, of which Mr. Nathanielsz,
our Chief Executive Officer, Chief Financial Officer and a director, and his wife are owners and directors. The lease has a one-year
term commencing May 6, 2021, and we are currently obligated to pay $3,606 AUD or $2,431 USD (depending on exchange rate),
inclusive of tax, in rent per month</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Nathanielsz&#8217;s wife, Sylvia Nathanielsz, is and has been an employee of our Company since October 2015. Mrs. Nathanielsz receives
an annual salary of $120,000 AUD, or $80,904 USD, and is entitled to benefits customarily expected to be provided to employees of the
Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Employment
and Director Compensation Arrangements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
relationships and related party transactions described herein are in addition to any employment and director compensation arrangements
with our executive officers and directors, which are described above under &#8220;Executive Compensation &#8212; Narrative to Summary
Compensation Table and Director Compensation.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 81 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->80<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Indemnification
Agreements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Certificate of Incorporation provides that none of our officers or directors shall be personally liable for any obligations of our Company
or for any duties or obligations arising out of any acts or conduct of said officer or director performed for or on behalf of our Company,
including without limitation, acts of negligence or contributory negligence. In addition, our Bylaws provide that we shall indemnify
and hold harmless each person and their heirs and administrators who shall serve at any time hereafter as a director or officer of our
Company from and against any and all claims, judgments and liabilities to which such persons shall become subject by reason of their
having heretofore or hereafter been a director or officer of our Company, or by reason of any action alleged to have heretofore or hereafter
taken or omitted to have been taken by him or her as such director or officer, and that we shall reimburse each such person for all legal
and other expenses reasonably incurred by him or her in connection with any such claim, judgment or liability, including our power to
defend such persons from all suits or claims as provided for under the provisions of the Delaware General Corporation Law; provided,
however, that no such persons shall be indemnified against, or be reimbursed for, any expense incurred in connection with any claim or
liability arising out of his (or her) own willful misconduct. In addition, we intend to enter into indemnification agreements with our
directors and officers and some of our executives may have certain indemnification rights arising under their employment agreements with
us. We believe that these bylaw provisions and indemnification agreements are necessary to attract and retain qualified persons
as directors and officers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
limitation of liability and indemnification provisions in our Certificate of Incorporation may discourage stockholders from bringing
a lawsuit against our directors for breach of their fiduciary duties. They may also reduce the likelihood of derivative litigation against
our directors and officers, even though an action, if successful, might benefit us and our stockholders. A stockholder&#8217;s investment
may be harmed to the extent we pay the costs of settlement and damage awards against directors and officers pursuant to these indemnification
provisions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 14, 2019, our board of directors approved a form of Indemnification Agreement (&#8220;Indemnification Agreement&#8221;) for each
of our officers and directors. The Indemnification Agreement requires us to indemnify our directors and officers and to advance expenses
on behalf of such directors or officers to the fullest extent permitted by applicable law and establish the procedures by which a director
or executive officer may request and receive indemnification. The Indemnification Agreement is in addition to other rights to which a
director or officer may be entitled under our Certificate of Incorporation, Bylaws and applicable law.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Director
Independence</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
board of directors has reviewed the independence of our directors and has determined that Josef Zelinger qualifies as an independent
director pursuant to Rule 5605(a)(2) of Nasdaq and applicable SEC rules and regulations. In making this determination, our board of directors
considered the relationships that each of our directors has with us and all other facts and circumstances our board of directors deemed
relevant in determining their independence.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 82 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->81<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="arp_009"></span>SECURITY
OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following sets forth information as of December 31, 2021 regarding the number of shares of our Common Stock beneficially owned
by (i) each person that we know beneficially owns more than 5% of our outstanding Common Stock, (ii) each of our directors and named
executive officer and (iii) all of our directors and named executive officers as a group.</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
amounts and percentages of our Common Stock beneficially owned are reported on the basis of SEC rules governing the determination of
beneficial ownership of securities. Under the SEC rules, a person is deemed to be a &#8220;beneficial owner&#8221; of a security if that
person has or shares &#8220;voting power,&#8221; which includes the power to vote or to direct the voting of such security, or &#8220;investment
power,&#8221; which includes the power to dispose of or to direct the disposition of such security. A person is also deemed to be a beneficial
owner of any securities of which that person has the right to acquire beneficial ownership within 60 days through the exercise of any
stock option, warrant or other right, and the conversion of preferred stock. Under these rules, more than one person may be deemed a
beneficial owner of the same securities and a person may be deemed to be a beneficial owner of securities as to which such person has
no economic interest. Unless otherwise indicated, each of the shareholders named in the table below, or his or her family members, has
sole voting and investment power with respect to such shares of our Common Stock. Except as otherwise indicated, the address of each
of the shareholders listed below is: c/o Propanc Biopharma, Inc., 302, 6 Butler Street, Camberwell, VIC, 3124 Australia.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Common Stock Beneficially Owned</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Series A Preferred Stock Beneficially Owned</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Series B Preferred Stock Beneficially Owned</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; text-align: left; font-weight: bold">Name and Address of Beneficial Owner</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number of Shares Beneficially Owned</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Percentage of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Class<sup>(1)</sup></b></span></p></td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number of Shares Beneficially Owned</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Percentage of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Class<sup>(2)</sup></b></span></p></td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number of Shares Beneficially Owned</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Percentage of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Class <sup>(2)</sup></b></span></p></td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">North Horizon Pty Ltd.<sup>(3)</sup></span></td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">5,928,004</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">11.17</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;500,001</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;100</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%; text-align: right">-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%; text-align: right">-</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">James Nathanielsz<sup>(4)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr. Julian Kenyon<sup>(5)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,420,005</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6.45</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Josef Zelinger</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,800,005</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5.28</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">All directors and executive officers, as a group (3 persons)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12,148,014</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">22.90</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">500,001</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>5% Shareholders</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Sylva International LLC <sup>(6)</sup></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,634,067</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6.85</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Sylvia Nathanielsz <sup>(7)</sup></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,800,005</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5.28</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.4in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
Applicable percentages are based on 53,062,209 shares of our common stock outstanding as of December 31, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.4in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
Applicable percentages are based on 500,000 shares of our Series A Preferred Stock and 1 share of our Series B Preferred Stock outstanding
as of September 21, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.4in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)
North Horizon Pty Ltd. is a Nathanielsz Family Trust. Mr. James Nathanielsz, the Chief Executive Officer and a director of our Company,
has investing and dispositive power of shares beneficially owned by North Horizon Pty Ltd.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.4in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)
Excludes 26 vested stock options, 13 unvested stock options, 39 restricted stock units that vested in May 2020 and 39 restricted
stock units that are subject to certain vesting conditions, as discussed above in the section captioned &#8220;Executive Compensation
- New Employment Agreement with James Nathanielsz,&#8221;.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.4in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)
Excludes 13 vested stock options, 6 unvested stock options, and 20 restricted stock units that vested in May 2020, and 20</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
restricted stock units that are subject to certain vesting conditions, as discussed above in the section captioned &#8220;Executive Compensation
- New Services Agreement with Julian Kenyon&#8221;.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.4in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)
Ross Silver has investing and dispositive power of shares beneficially owned by Sylva International LLC.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.4in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.4in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)
Sylvia Nathanielsz is the wife of James Nathanielsz.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 83 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->82<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="arp_012"></span>DESCRIPTION
OF CAPITAL STOCK</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Authorized
Capital Stock</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
authorized capital stock consists of 1,000,000,000 shares of common stock, $0.001 par value per share, and 1,500,005 shares of preferred
stock, $0.01 par value per share. As of December 31, 2021, there were (i) 53,062,209 shares of our common stock issued
and outstanding and (ii) 500,001 shares of our preferred stock issued and outstanding, consisting of 500,000 preferred shares designated
as our Series A Preferred Stock and one preferred share designated as our Series B Preferred Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Common
Stock</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Voting;
</i></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holders of our common stock are entitled to
one vote for each share held of record on all matters submitted to a vote of the stockholders, including the election of directors, and
do not have cumulative voting rights. Accordingly, the holders of a majority of the shares of our common stock entitled to vote in any
election of directors can elect all of the directors standing for election.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Dividend;
</i></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject to preferences that may be applicable
to any then outstanding preferred stock, the holders of common stock are entitled to receive dividends, if any, as may be declared from
time to time by our board of directors out of legally available funds.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Liquidation;
</i></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the event of our liquidation, dissolution
or winding up, holders of our common stock will be entitled to share ratably in the net assets legally available for distribution to
stockholders after the payment of all of our debts and other liabilities, subject to the satisfaction of any liquidation preference granted
to the holders of any outstanding shares of preferred stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Rights
and Preferences; </i>Holders of our common stock have no preemptive, conversion or subscription rights, and there are no redemption
or sinking fund provisions applicable to our common stock. The rights, preferences and privileges of the holders of our common stock
are subject to, and may be adversely affected by, the rights of the holders of shares of any series of our preferred stock that we may
designate and issue in the future.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Fully
Paid and Nonassessable; </i>All of our outstanding shares of common stock are, and the shares of common stock to be issued in
this offering will be, fully paid and nonassessable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Preferred
Stock</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
board of directors has the authority, without further action by the stockholders, to issue up to 1,500,005 shares of preferred stock
in one or more series, to establish from time to time the number of shares to be included in each such series, to fix the rights, preferences
and privileges of the shares of each wholly unissued series and any qualifications, limitations or restrictions thereon and to increase
or decrease the number of shares of any such series, but not below the number of shares of such series then outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
board of directors may authorize the issuance of preferred stock with voting or conversion rights that could adversely affect the voting
power or other rights of the holders of the common stock. The issuance of preferred stock, while providing flexibility in connection
with possible acquisitions and other corporate purposes, could, among other things, have the effect of delaying, deferring or preventing
a change in our control that may otherwise benefit holders of our common stock and may adversely affect the market price of the common
stock and the voting and other rights of the holders of common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 84 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->83<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of September 30, 2021, 500,001 shares of preferred stock were issued and outstanding, consisting of: (i) 500,000 preferred shares
designated as Series A Preferred Stock (the &#8220;Series A Preferred Stock&#8221;) pursuant to our Certificate of Designation filed
with the Secretary of State of the State of Delaware on December 9, 2014; and (ii) one preferred share designated as Series B Preferred
Stock (the &#8220;Series B Preferred Stock&#8221;) pursuant to our Certificate of Designation filed with the Secretary of State of the
State of Delaware on June 16, 2015. Up to five shares have been designated as Series B Preferred Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Nathanielsz, our Chief Executive Officer, Chairman, Secretary, Treasurer and a director, beneficially owns all of the shares of Series
A Preferred Stock via North Horizon Pty Ltd., which entitles him, as a holder of Series A Preferred Stock, to vote on all matters submitted
or required to be submitted to a vote of our stockholders, except election and removal of directors, and each share of Series A Preferred
Stock entitles him to 0.004 votes per each outstanding share of Series A Preferred Stock. North Horizon Pty Ltd. is a Nathanielsz Family
Trust. Mr. Nathanielsz has voting and investment power over these shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Nathanielsz directly beneficially owns such one share of Series B Preferred Stock. Each holder of outstanding shares of Series B Preferred
Stock is entitled to voting power equivalent to the number of votes equal to the total number of shares of common stock outstanding as
of the record date for the determination of stockholders entitled to vote at each meeting of stockholders of our Company and entitled
to vote on all matters submitted or required to be submitted to a vote of the stockholders of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
of our issued and outstanding shares of preferred stock have no rights to dividends, profit sharing or liquidation preferences.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Authorized
and Unissued Capital Stock</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Delaware
law does not require stockholder approval for any issuance of authorized shares. These additional shares may be used for a variety of
corporate purposes, including future public offerings, to raise additional capital or to facilitate acquisitions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">One
of the effects of the existence of unissued and unreserved common stock or preferred stock may be to enable our board of directors to
issue shares to persons friendly to current management, which issuance could render more difficult or discourage an attempt to obtain
control of our company by means of a merger, tender offer, proxy contest or otherwise, and thereby protect the continuity of our management
and possibly deprive the stockholders of opportunities to sell their shares at prices higher than prevailing market prices.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 85 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->84<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Warrants</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table summarizes warrant activity for the years ended</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
June 30, 2021 and 2020:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Number of</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Weighted Average</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Warrants</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Price Per Share</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Outstanding at June 30, 2019</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 64%">Issued</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">151,170</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">150.00</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Exercised</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Forfeited</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">Expired</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Outstanding at June 30, 2020</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">151,170</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">150.00</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Issued</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Exercised</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(29,841</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">26.15</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Forfeited</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt">Expired</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">Outstanding at June 30, 2021</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">121,329</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">179.63</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">Exercisable at June 30, 2021</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">76,955</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">283.21</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Outstanding and Exercisable:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt">Weighted average remaining contractual term</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1.77</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Outstanding
Warrants</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of September 30, 2021,</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> there were 111,932
warrants outstanding of which 76,933 warrants were exercisable with expiration dates commencing September 2022 and continuing
through August 2024, with a weighted average exercise price per share of $191.32.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Warrants
Included in Offering</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following summary of certain terms and provisions of warrants included that are being offered hereby is not complete and is subject to,
and qualified in its entirety by, the provisions of the warrants, the form of which is filed as an exhibit to the registration statement
of which this prospectus forms a part. Prospective investors should carefully review the terms and provisions of the form of warrant
for a complete description of the terms and conditions of the warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Duration
and Exercise Price</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Series B Warrants have an exercise price equal to $40.00 and will expire on the three (3) year anniversary of the date they first become
exercisable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 86 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->85<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Cashless
Exercise</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If,
at the time a holder exercises Series B Warrants (the &#8220;Warrants&#8221;), a registration statement registering the issuance
of the shares of common stock underlying the Warrants under the Securities Act is not then effective or available for the issuance
of such shares, then in lieu of making the cash payment otherwise contemplated to be made to us upon such exercise in payment of the
aggregate exercise price, the holder may elect instead to receive upon such exercise (either in whole or in part) the net number of shares
of common stock determined according to a formula set forth in the Warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Exercisability</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">warrants will be exercisable, at the option of each
holder, in whole or in part, by delivering to us a duly executed exercise notice accompanied by payment in full for the number of our
shares of common stock purchased upon such exercise (except in the case of a cashless exercise as discussed below). A holder (together
with its affiliates) may not exercise any portion of the warrant to the extent that the holder would own more than 4.99% (or,
at the election of a purchaser prior to issuance of the warrant, 9.99%) of the outstanding shares of common stock immediately after exercise,
except that upon at least 61 days&#8217; prior notice from the holder to us, the holder may increase the amount of ownership of outstanding
shares after exercising the holder&#8217;s warrants up to 9.99% of the number of our shares of common stock outstanding immediately after
giving effect to the exercise, as such percentage ownership is determined in accordance with the terms of the warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Fractional
Shares</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
fractional shares of common stock will be issued upon the exercise of the Warrants. Rather, the number of shares of common stock to be
issued will, at our election, either be rounded up to the nearest whole number or we will pay a cash adjustment in respect of such final
fraction in an amount equal to such fraction multiplied by such warrant&#8217;s exercise price.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Transferability</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to applicable laws, the Warrant may be transferred at the option of the holder upon surrender of the warrant to us together with the
appropriate instruments of transfer.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Exchange
Listing</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
do not intend to list the warrants on any securities exchange or nationally recognized trading system.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Rights
as a Shareholder</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
as otherwise provided in the warrants or by virtue of such holder&#8217;s ownership of our shares of common stock, the holders
of the Warrants do not have the rights or privileges of holders of our shares of common stock, including any voting rights, until they
exercise their warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Fundamental
Transaction</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event of a fundamental transaction which is approved by our Board, the holders of the warrants have the right to require us
or a successor entity to redeem the warrant for cash in the amount of the Black-Scholes value of the unexercised portion of the
warrant on the date of the consummation of the fundamental transaction. In the event of a fundamental transaction which is not approved
by our Board, the holders of the warrants have the right to require us or a successor entity to redeem the Warrant for the consideration
paid in the fundamental transaction in the amount of the Black Scholes value of the unexercised portion of the warrant on the date of
the consummation of the fundamental transaction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 87 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->86<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Options</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
summary of the Company&#8217;s option activity during the years ended June 30, 2021 and 2020 is presented below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Number of</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Weighted Average</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Options</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Price Per Share</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%">Outstanding at June 30, 2019</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">60</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">76,370</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Issued</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Exercised</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt">Expired</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Outstanding at June 30, 2020</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">60</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">76,370</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Issued</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Exercised</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt">Expired</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,750,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">Outstanding at June 30, 2021</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">59</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">13,730</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Exercisable at June 30, 2021</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">40</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">18,193</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Outstanding and Exercisable:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt">Weighted average remaining contractual term</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">7.86</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">Weighted average fair value of options granted during the period</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt">Aggregate intrinsic value</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
the Effective Date, the Company&#8217;s board of directors approved and adopted the Company&#8217;s 2019 Equity Incentive Plan (the &#8220;2019
Plan&#8221;), which reserves a total of 234 shares of the Company&#8217;s common stock for issuance under the 2019 Plan. Incentive awards
authorized under the 2019 Plan include, but are not limited to, incentive stock options, non-qualified stock options, restricted stock
awards and restricted stock units.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the year ended June 30, 2021 and 2020, the Company recognized stock-based compensation of $82,872 and $82,873 related to vested stock
options. There was $72,514 of unvested stock options expense as of June 30, 2021 that will be recognized over a remaining vesting period
of 0.87 year.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
stock options were granted during the years ended June 30, 2021 and 2020. No stock options were granted during the three months ended
September 30, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Restricted
Stock Units</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">to employment agreements dated in May 2019, the
Company granted an aggregate of 78 and 39 restricted stock unit to the Company&#8217;s Chief Executive Officer and Chief Scientific Officer,
respectively. The total 117 restricted stock units are subject to vesting terms as defined in the employment agreements. There are
59 unvested restricted stock units which are subject to various performance conditions which have not yet been met and such restricted
stock units have not yet vested as of June 30, 2021 and 2020. Each vested restricted stock unit shall be settled by delivery to the
holder thereof of one share of our common stock and/or the cash fair market value of such share of common stock on the date of settlement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 88 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->87<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Delaware
Anti-Takeover Statute</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are subject to the provisions of Section 203 of the General Corporation Law of the State of Delaware regulating corporate takeovers.
In general, Section 203 prohibits a publicly held Delaware corporation from engaging, under certain circumstances, in a business combination
with an interested stockholder for a period of three years following the date the person became an interested stockholder unless:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">prior
    to the date of the transaction, our board of directors approved either the business combination or the transaction which resulted
    in the stockholder becoming an interested stockholder; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">upon
    completion of the transaction that resulted in the stockholder becoming an interested stockholder, the interested stockholder owned
    at least 85% of the voting stock of the corporation outstanding at the time the transaction commenced, excluding for purposes of
    determining the voting stock outstanding, but not the outstanding voting stock owned by the interested stockholder, (1) shares owned
    by persons who are directors and also officers and (2) shares owned by employee stock plans in which employee participants do not
    have the right to determine confidentially whether shares held subject to the plan will be tendered in a tender or exchange offer;
    or </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">at
    or subsequent to the date of the transaction, the business combination is approved by our board of directors and authorized at an
    annual or special meeting of stockholders, and not by written consent, by the affirmative vote of at least 66 2/3% of the outstanding
    voting stock which is not owned by the interested stockholder. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Generally,
a business combination includes a merger, asset or stock sale, or other transaction resulting in a financial benefit to the interested
stockholder. An interested stockholder is a person who, together with affiliates and associates, owns or, within three years prior to
the determination of interested stockholder status, did own 15% or more of a corporation&#8217;s outstanding voting stock. We expect
the existence of this provision to have an anti-takeover effect with respect to transactions our board of directors does not approve
in advance. We also anticipate that Section 203 may discourage attempts that might result in a premium over the market price for the
shares of common stock held by stockholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
provisions of Delaware law and the provisions of our Certificate of Incorporation and Bylaws could have the effect of discouraging others
from attempting hostile takeovers and, as a consequence, they might also inhibit temporary fluctuations in the market price of our common
stock that often result from actual or rumored hostile takeover attempts. These provisions might also have the effect of preventing changes
in our management. It is also possible that these provisions could make it more difficult to accomplish transactions that stockholders
might otherwise deem to be in their best interests.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Bylaws</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Provisions
of our Bylaws may delay or discourage transactions involving an actual or potential change in our control or change in our management,
including transactions in which stockholders might otherwise receive a premium for their shares or transactions that our stockholders
might otherwise deem to be in their best interests. Therefore, these provisions could adversely affect the price of our common stock.
Among other things, our Bylaws:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">permit
    our board of directors to issue up to 1,500,005 shares of our preferred stock, with any rights, preferences and privileges as they
    may designate (including the right to approve an acquisition or other change in our control); </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">provide
    that the authorized number of directors may be changed only by resolution of the board of directors; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">provide
    that all vacancies, including newly created directorships, may, except as otherwise required by law, be filled by the affirmative
    vote of a majority of directors then in office, even if less than a quorum; and </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 89 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->88<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">do
    not provide for cumulative voting rights (therefore allowing the holders of a majority of the shares of common stock entitled to
    vote in any election of directors to elect all of the directors standing for election, if they should so choose). </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
amendment of any of these provisions, with the exception of the ability of our board of directors to issue shares of preferred stock
and designate any rights, preferences and privileges thereto, would require approval by the holders of a majority of our then outstanding
common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>EXPERTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
consolidated financial statements as of and for the years ended June 30, 2021 and 2020, appearing in this prospectus and
the registration statement of which it is a part, have been audited by Salberg &amp; Company, P.A., an independent registered public
accounting firm, as set forth in their report dated September 28, 2021(which contains an explanatory paragraph regarding our ability
to continue as a going concern) appearing elsewhere herein, and are included in reliance upon such report given on the authority of such
firm as experts in accounting and auditing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>LEGAL
MATTERS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
validity of the issuance of the Common Stock underlying the Units and Warrants hereby has been passed upon for us by Patrizio
&amp; O&#8217;Leary LLP.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>QUANTITATIVE
AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable to smaller reporting companies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="arp_013"></span>CHANGES
IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
have been no changes in our independent registered public accounting firm during the last two fiscal years, and we have not had any material
disagreements with our independent registered public accounting firm during that time.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="arp_014"></span>WHERE
YOU CAN FIND MORE INFORMATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have filed a registration statement on Form S-1 with the SEC covering the shares and warrants we are offering by this prospectus. This
prospectus does not include all of the information contained in the registration statement. You should refer to the registration statement
and its exhibits for additional information. Whenever we make reference in this prospectus to any of our contracts, agreements or other
documents, the references are not necessarily complete and you should refer to the exhibits filed or documents incorporated by reference
as part of the registration statement for copies of the actual contract, agreement or other document.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
file annual, quarterly and other periodic reports, proxy statements and other information with the SEC. You can read our SEC filings,
including this registration statement, over the Internet at the SEC&#8217;s website at www.sec.gov. You may also read and copy any document
we file with the SEC at its public reference facilities at 100 F Street NE, Washington, D.C. 20549. You may also obtain copies of these
documents at prescribed rates by writing to the Public Reference Section of the SEC at 100 F Street NE, Washington, D.C. 20549. Please
call the SEC at 1-800-SEC-0330 for further information on the operation of the public reference facilities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Internet address is www.propanc.com. There we make available free of charge, on or through the investor relations section of our website,
Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and amendments to those reports filed pursuant
to Section 13(a) or 15(d) of the Exchange Act as soon as reasonably practicable after we electronically file such material with the SEC.
The information found on our website is not part of this prospectus and investors should not rely on any such information in deciding
whether to invest.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 90 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->89<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Statements
contained in this prospectus as to the contents of any contract or other document that we have filed as an exhibit to the registration
statement are qualified in their entirety by reference to the exhibits for a complete statement of their terms and conditions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
representations, warranties and covenants made by us in any agreement that is filed as an exhibit to the registration statement of which
this prospectus is a part were made solely for the benefit of the parties to such agreement, including, in some cases, for the purpose
of allocating risk among the parties to such agreements, and should not be deemed to be a representation, warranty or covenant to you.
Moreover, such representations, warranties or covenants were made as of an earlier date. Accordingly, such representations, warranties
and covenants should not be deemed as accurately representing the current state of our affairs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DISCLOSURE
OF COMMISSION POSITION ON INDEMNIFICATION FOR SECURITIES ACT LIABILITIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Certificate of Incorporation contains provisions that limit the liability of our directors for monetary damages to the fullest extent
permitted by Delaware law. Consequently, our directors will not be personally liable to us or our stockholders for monetary damages for
any breach of fiduciary duties as directors, except liability for:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    breach of the director&#8217;s duty of loyalty to us or our stockholders;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    act or omission not in good faith or that involves intentional misconduct or a knowing violation of law;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">unlawful
    payments of dividends or unlawful stock repurchases or redemptions as provided in Section 174 of the General Corporation Law of the
    State of Delaware; or</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    transaction from which the director derived an improper personal benefit.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Certificate of Incorporation, as amended, provides that we are required to indemnify our directors and officers, in each case to the
fullest extent permitted by Delaware law. Our Certificate of Incorporation also provides that we are obligated to advance expenses incurred
by a director or officer in advance of the final disposition of any action or proceeding, and permit us to secure insurance on behalf
of any officer, director, employee or other agent for any liability arising out of his or her actions in that capacity regardless of
whether we would otherwise be permitted to indemnify him or her under the provisions of Delaware law.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the extent that indemnification for liabilities arising under the Securities Act may be permitted to directors, officers or persons controlling
our company pursuant to the foregoing provisions, we have been informed that, in the opinion of the SEC, such indemnification is against
public policy as expressed in the Securities Act and is therefore unenforceable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 91 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->90<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="v_009"></span>INDEX TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Consolidated Financial Statements</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td>
    <td style="padding-bottom: 1.5pt; width: 0.1in">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Page</b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>



<tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#arp_001">Report of Independent Registered Public Accounting Firm</a></span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-2</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#arp_002">Balance Sheets as of June 30, 2021 and June 30, 2020</a></span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-4</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#arp_003">Statements
    of Operations and Comprehensive Income (Loss) for the Years Ended June 30, 2021 and 2020</a></span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-5</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#arp_004">Statements
    of Changes in Stockholders&#8217; Deficit for the Years Ended June 30, 2021 and 2020</a></span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-6</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#arp_005">Statement
    of Cash Flows for the Years Ended June 30, 2021 and 2020</a></span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-7</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#arp_006">Notes to the Financial Statements</a></span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-8</span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Unaudited
Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td>
    <td style="padding-bottom: 1.5pt; width: 0.1in">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Page</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"><a href="#a_015"><span style="font-size: 10pt">Unaudited
    Balance Sheets as of September 30, 2021 and June 30, 2021</span></a></span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">F-38</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_016">Unaudited
    Statements of Operations and Comprehensive Income (Loss) for the Three Months Ended September 30, 2021 and 2020</a></span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-39</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_017">Unaudited
    Statements of Changes in Stockholders&#8217; Deficit for the Three Months Ended September 30, 2021 and 2020</a></span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-40</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_018">Unaudited
    Statements of Cash Flows for the Three Months Ended September 30, 2021 and 2020</a></span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-41</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"><a href="#a_023"><span style="font-size: 10pt">Notes to the Unaudited Financial Statements</span></a></span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-42</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></p>

<!-- Field: Page; Sequence: 92; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0; margin-bottom: 0"><img src="image_001.jpg" alt="" style="height: 81px; width: 670px" /><span style="font: 10pt Times New Roman, Times, Serif; color: Black"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b><span id="arp_001"></span><span id="kk_001"></span>Report
of Independent Registered Public Accounting Firm</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">To
the Stockholders&#8217; and the Board of Directors of:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Propanc
Biopharma, Inc.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Opinion
on the Financial Statements</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">We
have audited the accompanying consolidated balance sheets Propanc Biopharma, Inc. and Subsidiary (the &#8220;Company&#8221;) as of June
30, 2021 and 2020, the related consolidated statements of operations and comprehensive income (loss), changes in stockholders&#8217;
deficit, and cash flows, for each of the two years in the period ended June 30, 2021, and the related notes (collectively referred to
as the &#8220;consolidated financial statements&#8221;). In our opinion, the consolidated financial statements present fairly, in all
material respects, the consolidated financial position of the Company as of June 30, 2021 and 2020, and the consolidated results of its
operations and its cash flows for each of the two years in the period ended June 30, 2021, in conformity with accounting principles generally
accepted in the United States of America.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Going
Concern</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. As discussed
in Note 2 to the consolidated financial statements, the Company has a net loss of $2,025,947 and net cash used in operating activities
of $1,145,264 for the fiscal year ended June 30, 2021. The Company has a working capital deficit, stockholder&#8217;s deficit, and accumulated
deficit of $3,074,078, $3,067,573, and $58,199,466 respectively, at June 30, 2021. These matters raise substantial doubt about the Company&#8217;s
ability to continue as a going concern. Management&#8217;s Plan regarding these matters is also described in Note 2. The consolidated
financial statements do not include any adjustments that might result from the outcome of this uncertainty.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Basis
for Opinion</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">These
consolidated financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion
on the Company&#8217;s consolidated financial statements based on our audits. We are a public accounting firm registered with the Public
Company Accounting Oversight Board (United States) (&#8220;PCAOB&#8221;) and are required to be independent with respect to the Company
in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission
and the PCAOB.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">We
conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain
reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud.
The Company is not required to have, nor were we engaged to perform, an audit of internal control over financial reporting. As part of
our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing
an opinion on the effectiveness of the Company&#8217;s internal control over financial reporting. Accordingly, we express no such opinion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Our
audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether
due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence
regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles
used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements.
We believe that our audits provide a reasonable basis for our opinion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">2295
NW Corporate Blvd., Suite 240 &#8226; Boca Raton, FL 33431-7328</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Phone:
(561) 995-8270 &#8226; Toll Free: (866) CPA-8500 &#8226; Fax: (561) 995-1920</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">www.salbergco.com
&#8226; info@salbergco.com</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><i>Member
National Association of Certified Valuation Analysts &#8226; Registered with the PCAOB</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><i>Member
CPAConnect with Affiliated Offices Worldwide &#8226; Member AICPA Center for Audit Quality</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 93; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Critical
Audit Matters</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
critical audit matters communicated below are matters arising from the current period audit of the consolidated financial statements
that were communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are
material to the consolidated financial statements and (2) involved our especially challenging, subjective, or complex judgments. The
communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole,
and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the
accounts or disclosures to which they relate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Derivative
Liabilities</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">As
described in Footnote 12 &#8220;Derivative Financial Instruments and Fair Value Measurements&#8221; to the consolidated financial statements,
the Company recorded derivative transactions that resulted primarily in a net
derivative expense from change in fair value of conversion option liability of $8,186, and derivative liabilities of $54,220 at June
30, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">We
identified the evaluation of instruments and contracts to determine whether there are derivatives to be recorded, the analysis of the
accounting treatment and presentation for derivative transactions and the valuation of derivatives as critical audit matters. Auditing
management&#8217;s analysis of the above critical audit matters was complex and involved a high degree of subjectivity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
primary procedures we performed to address these critical audit matters included (a) Reviewed and tested management&#8217;s conclusions
as to whether certain instruments or contracts qualified for derivative treatment by comparing management&#8217;s analysis and conclusions
to authoritative and interpretive literature, (b) Compared the accounting treatment and presentation to that described by the authoritative
and interpretive literature, (c) Tested management&#8217;s process for valuing derivatives by comparing it to generally accepted methodologies
for valuing derivatives, (d) Tested management&#8217;s valuation of the derivatives by testing assumptions and data used in the valuation
model including the term, volatility and interest rate, and (e) Recomputed the derivative valuations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>/s/
Salberg &amp; Company, P.A.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">SALBERG
&amp; COMPANY, P.A.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">We
have served as the Company&#8217;s auditor since 2011</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Boca
Raton, Florida</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">September
28, 2021</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<!-- Field: Page; Sequence: 94; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b><span id="arp_002"></span>PROPANC
BIOPHARMA, INC. AND SUBSIDIARY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b><span id="kk_002"></span>CONSOLIDATED
BALANCE SHEETS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_302_111_zBS2Ga0wI795" summary="xdx: Statement - Condensed Consolidated Balance Sheets" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" id="xdx_494_20210630_z58khBOGEs6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>June
    30, 2021</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" id="xdx_49A_20200630_zg8M4dkewg59" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>June
    30, 2020</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--AssetsAbstract_iB_zxrwRw1wdHbc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-decoration: underline; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>ASSETS</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--AssetsCurrentAbstract_i01B_zi1zWdm2MWze" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>CURRENT
    ASSETS:</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--CashAndCashEquivalentsAtCarryingValue_i02I_maCzR75_zY2NWcX1Mav" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; width: 62%"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Cash</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,255</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">67,007</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_i02I_maCzR75_z5OnpuFljEp1" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt">Prepaid
    expenses and other current assets</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0043">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--ValueAddedTaxReceivableCurrent_i02I_maCzR75_z52ZsYosR3Ph" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">GST
    tax receivable</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:ValueAddedTaxReceivableCurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,341</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:ValueAddedTaxReceivableCurrent" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,015</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--AssetsCurrent_i02TI_mtCzR75_maCzzVv_zcsu4gUmpjH9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>TOTAL
    CURRENT ASSETS</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,596</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">69,022</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--DepositsAssetsNoncurrent_i01I_maCzzVv_zkbZV9jZ711c" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Security
    deposit - related party</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:DepositsAssetsNoncurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,250</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:DepositsAssetsNoncurrent" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,067</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--OperatingLeaseRightOfUseAsset_i01I_maCzzVv_zlkVCwzgEbK6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Operating
    lease right-of-use assets, net - related party</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0055">&#160;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">21,682</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--PropertyPlantAndEquipmentNet_i01I_maCzzVv_zibawbjQ7HCf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Property
    and equipment, net</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,255</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,747</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--Assets_i01TI_mtCzzVv_zfzAbWlR7dN8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>TOTAL
    ASSETS</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">13,101</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">98,518</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--LiabilitiesAndStockholdersEquityAbstract_iB_zU09R4OZZhfh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-decoration: underline; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>LIABILITIES
    AND STOCKHOLDERS&#8217; DEFICIT</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--LiabilitiesCurrentAbstract_i01B_z880GsdpJle7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>CURRENT
    LIABILITIES:</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--AccountsPayableCurrent_i02I_maCzsxH_zKfnmn1dHByf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Accounts
    payable</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,002,335</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">842,156</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--AccountsPayableAndOtherAccruedLiabilitiesCurrent_i02I_maCzsxH_znA1uOuEEI83" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Accrued
    expenses and other payables</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">892,151</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">702,231</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--ConvertibleDebtCurrent_i02I_maCzsxH_zo7peNMN78Ui" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Convertible
    notes and related accrued interest, net of discounts and premiums</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:ConvertibleDebtCurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">624,583</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:ConvertibleDebtCurrent" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,557,734</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--OperatingLeaseLiabilityCurrent_i02I_maCzsxH_zt8Iw0fMgr49" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Operating
    lease liability - related party</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0079">&#160;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25,072</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--DeferredCompensationLiabilityCurrent_i02I_maCzsxH_zzflEuJ1u7Ud" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Embedded
    conversion option liabilities</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:DeferredCompensationLiabilityCurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">54,220</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:DeferredCompensationLiabilityCurrent" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">177,009</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--DueToRelatedPartiesCurrent_i02I_maCzsxH_z8vIqQgViVDh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Due
    to former director - related party</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:DueToRelatedPartiesCurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">33,347</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:DueToRelatedPartiesCurrent" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">30,639</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_409_ecustom--LoanFromFormerDirectorRelatedParty_i02I_pp0p0_maCzsxH_zHkomGH7m9Fj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Loan
    from former director - related party</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="PPCB:LoanFromFormerDirectorRelatedParty" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">55,500</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="PPCB:LoanFromFormerDirectorRelatedParty" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">50,993</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--EmployeeRelatedLiabilitiesCurrent_i02I_maCzsxH_z1uFrbyJvfYh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Employee
    benefit liability</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:EmployeeRelatedLiabilitiesCurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">418,538</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:EmployeeRelatedLiabilitiesCurrent" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">354,109</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--LiabilitiesCurrent_i02TI_mtCzsxH_maCzDzP_z7Owdi6Yzxeg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>TOTAL
    CURRENT LIABILITIES</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,080,674</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,739,943</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--Liabilities_i01I_mtCzDzP_maCzgML_maLASEz4MT_zNgc2o1DDZ4f" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>TOTAL
    LIABILITIES</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,080,674</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,739,943</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--CommitmentsAndContingencies_i01I_maCzgML_maLASEz4MT_zj80shC1WSUf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Commitments
    and Contingencies (See Note 9)</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; display: none">-<span style="color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0100">&#160;</span></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--StockholdersEquityAbstract_i01B_z8tcJIUSEMlb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>STOCKHOLDERS&#8217;
    DEFICIT:</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Preferred
    stock, <span id="xdx_902_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20210630_zNCCOJcrHQAf" title="Preferred stock, shares authorized"><span id="xdx_900_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20200630_zzs0Tw7FTNm6" title="Preferred stock, shares authorized"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,500,005</ix:nonFraction></ix:nonFraction></span></span> shares authorized, $<span id="xdx_904_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20210630_z7EeDINDqEE3" title="Preferred stock, par value"><span id="xdx_900_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20200630_zCloBF8aWFG5" title="Preferred stock, par value"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.01</ix:nonFraction></ix:nonFraction></span></span> par value:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--PreferredStockValue_i02I_pp0p0_hus-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zNHMPY6oLgB8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Series
    A preferred stock, $<span id="xdx_906_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_z8aAfZG8HFm5" title="Preferred stock, par value"><span id="xdx_90C_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20200630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zGFnVZfMpNYa" title="Preferred stock, par value"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2021-06-30_us-gaap_SeriesAPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2020-06-30_us-gaap_SeriesAPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.01</ix:nonFraction></ix:nonFraction></span></span> par value; <span id="xdx_908_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zHiLXV15Odhe" title="Preferred stock, shares authorized"><span id="xdx_90C_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20200630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_ztB0l6Pz0YWd" title="Preferred stock, shares authorized"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2021-06-30_us-gaap_SeriesAPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2020-06-30_us-gaap_SeriesAPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">500,000</ix:nonFraction></ix:nonFraction></span></span> shares authorized; <span id="xdx_903_eus-gaap--PreferredStockSharesIssued_iI_pid_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_z6cYq9uVvKYk" title="Preferred stock, shares issued"><span id="xdx_906_eus-gaap--PreferredStockSharesOutstanding_iI_pid_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zWWusOZ6sAS9" title="Preferred stock, shares outstanding"><span id="xdx_904_eus-gaap--PreferredStockSharesIssued_iI_pid_c20200630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zcaILgMMWoW" title="Preferred stock, shares issued"><span id="xdx_905_eus-gaap--PreferredStockSharesOutstanding_iI_pid_c20200630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_znPtLRuptvhb" title="Preferred stock, shares outstanding"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2021-06-30_us-gaap_SeriesAPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2021-06-30_us-gaap_SeriesAPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2020-06-30_us-gaap_SeriesAPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2020-06-30_us-gaap_SeriesAPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">500,000</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span></span></span></span> shares issued and outstanding as of June 30, 2021 and 2020</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td title="Preferred stock value" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2021-06-30_us-gaap_SeriesAPreferredStockMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,000</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td title="Preferred stock value" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2020-06-30_us-gaap_SeriesAPreferredStockMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,000</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--PreferredStockValue_i02I_pp0p0_hus-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zajjVV54OFne" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Series
    B preferred stock, $<span id="xdx_90A_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zJdSgLM7dbt" title="Preferred stock, par value"><span id="xdx_905_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20200630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zFMqPX5C7T3j" title="Preferred stock, par value"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2021-06-30_us-gaap_SeriesBPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2020-06-30_us-gaap_SeriesBPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.01</ix:nonFraction></ix:nonFraction></span></span> par value; <span id="xdx_90A_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zk3qntTQAd15" title="Preferred stock, shares authorized"><span id="xdx_905_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20200630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zxgEDqEjpYe3" title="Preferred stock, shares authorized"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2021-06-30_us-gaap_SeriesBPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2020-06-30_us-gaap_SeriesBPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5</ix:nonFraction></ix:nonFraction></span></span> shares authorized; <span id="xdx_908_eus-gaap--PreferredStockSharesIssued_iI_pid_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zAxDmBEahpH4" title="Preferred stock, shares issued"><span id="xdx_901_eus-gaap--PreferredStockSharesOutstanding_iI_pid_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zJyW29l0vPrk" title="Preferred stock, shares outstanding"><span id="xdx_900_eus-gaap--PreferredStockSharesIssued_iI_pid_c20200630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zlprHBkoneP8" title="Preferred stock, shares issued"><span id="xdx_903_eus-gaap--PreferredStockSharesOutstanding_iI_pid_c20200630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zbL0phIk0J6d" title="Preferred stock, shares outstanding"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2021-06-30_us-gaap_SeriesBPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2021-06-30_us-gaap_SeriesBPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2020-06-30_us-gaap_SeriesBPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2020-06-30_us-gaap_SeriesBPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span></span></span></span> share issued and outstanding as of June 30, 2021 and 2020</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0133">&#160;</span></span></td>
    <td title="Preferred stock value" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0134">&#160;</span></span></td>
    <td title="Preferred stock value" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--PreferredStockValue_i02I_pp0p0_maSEzNEX_zbZN32aQx0Wf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"><span style="font: 10pt Times New Roman, Times, Serif; display: none">Preferred
    stock value</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td title="Preferred stock value" style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td title="Preferred stock value" style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--CommonStockValue_i02I_pp0p0_maSEzNEX_z16FQdkGvCF8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Common
    stock, $<span id="xdx_90E_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20210630_zygEpX1djCrf" title="Common stock, par value"><span id="xdx_90F_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20200630_zMxrTpiZ64n1" title="Common stock, par value"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.001</ix:nonFraction></ix:nonFraction></span></span> par value; <span id="xdx_90D_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20210630_z7wGRtAFT9Xh" title="Common stock, shares authorized"><span id="xdx_905_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20200630_zzs0zE5LgXS7" title="Common stock, shares authorized"><span title="Common stock, shares authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,000,000,000</ix:nonFraction></ix:nonFraction></span></span></span> shares authorized;<span id="xdx_909_eus-gaap--CommonStockSharesIssued_iI_pid_c20210630_zoscKdtGMW1g" title="Common stock, shares issued"><span id="xdx_905_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20210630_zQbiawzfi2Qd" title="Common stock, shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">14,055,393</ix:nonFraction></ix:nonFraction></span></span> and <span id="xdx_90D_eus-gaap--CommonStockSharesIssued_iI_pid_c20200630_zNxHaLlXhfh3" title="Common stock, shares issued"><span id="xdx_90C_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20200630_zXtQ9UmREFw8" title="Common stock, shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">258,120</ix:nonFraction></ix:nonFraction></span></span> shares issued and outstanding as of June 30, 2021
    and 2020, respectively</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">14,056</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">258</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_403_ecustom--CommonStockIssuable_i02I_pp0p0_maSEzNEX_z4xAY0DnIjY8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Common
    stock issuable (<span id="xdx_90A_ecustom--CommonStockIssuableShares_iI_pid_c20210630_z87Zh8vHBEqf" title="Common stock, shares issuable"><ix:nonFraction name="PPCB:CommonStockIssuableShares" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">59</ix:nonFraction></span> and <span id="xdx_90C_ecustom--CommonStockIssuableShares_iI_pid_c20200630_zhkoL1PMCXK9" title="Common stock, shares issuable"><ix:nonFraction name="PPCB:CommonStockIssuableShares" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">0</ix:nonFraction></span> shares as of June 30, 2021 and 2020, respectively)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0174">&#160;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0175">&#160;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--AdditionalPaidInCapital_i02I_maSEzNEX_zDyivYdMn6vh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Additional
    paid-in capital</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">54,074,110</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">50,913,893</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--StockholdersEquityNoteSubscriptionsReceivable_i02NI_di_msSEzNEX_zYG9DYHZayqk" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Subscription receivable</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0184">&#160;</span></span></td><td style="text-align: right">-</td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0185">&#160;</span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_408_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_i02I_maSEzNEX_zYn3mZwGUsma" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Accumulated
    other comprehensive income</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,085,204</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,267,671</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--RetainedEarningsAccumulatedDeficit_i02I_maSEzNEX_zxB1MYhi8hpd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Accumulated
    deficit</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">58,199,466</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">55,781,770</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td></tr>
  <tr id="xdx_40B_eus-gaap--TreasuryStockValue_i02NI_di_msSEzNEX_zauVb1eEdzkj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Treasury
    stock (<span id="xdx_90C_eus-gaap--TreasuryStockShares_iI_c20210630_z4NrBDaX0C89" title="Treasury stock, shares"><span id="xdx_904_eus-gaap--TreasuryStockShares_iI_c20200630_zn6nGiM6xWR1" title="Treasury stock, shares"><ix:nonFraction name="us-gaap:TreasuryStockShares" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:TreasuryStockShares" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1</ix:nonFraction></ix:nonFraction></span></span> share)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(<ix:nonFraction name="us-gaap:TreasuryStockValue" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">46,477</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(<ix:nonFraction name="us-gaap:TreasuryStockValue" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">46,477</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--StockholdersEquity_i02TI_mtSEzNEX_maLASEz4MT_zRiDhVArtak" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>TOTAL
    STOCKHOLDERS&#8217; DEFICIT</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,067,573</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,641,425</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--LiabilitiesAndStockholdersEquity_i01TI_mtLASEz4MT_zDIiJdwvvgo8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>TOTAL
    LIABILITIES AND STOCKHOLDERS&#8217; DEFICIT</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">13,101</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">98,518</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
accompanying notes are an integral part of these consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<!-- Field: Page; Sequence: 95; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b><span id="arp_003"></span>PROPANC
BIOPHARMA, INC. AND SUBSIDIARY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b><span id="kk_003"></span>CONSOLIDATED
STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_301_113_z1bRalBDPuvf" summary="xdx: Statement - Consolidated Statements of Operations and Comprehensive Income (Loss)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td colspan="2" id="xdx_499_20200701__20210630_ze9dMyjfSvY3" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">2021</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td colspan="2" id="xdx_49C_20190701__20200630_zgvFkxeCofM7" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">2020</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Years
    Ended June 30,</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>2021</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>2020</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--RevenuesAbstract_iB" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>REVENUE</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_i01_pp0p0_maOILzjWh_maOILzCFr_zz3nH1qjH2Rk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; padding-left: 10pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Revenue</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0209">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0210">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--OperatingExpensesAbstract_iB" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>OPERATING
    EXPENSES</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--GeneralAndAdministrativeExpense_i01_pp0p0_maOEzAcK_maOEzU6e_zGfV3FEer3t4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; width: 62%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Administration
    expenses</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,553,075</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,281,464</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--OccupancyNet_i01_pp0p0_maOEzAcK_maOEzU6e_zh7qVUDBKC29" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Occupancy
    expenses</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:OccupancyNet" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">28,112</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:OccupancyNet" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">32,809</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--ResearchAndDevelopmentExpense_i01_pp0p0_maOEzAcK_maOEzU6e_zYKvQdiWxqz4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; padding-left: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Research
    and development</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">230,956</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">179,987</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--OperatingExpenses_i01T_pp0p0_mtOEzAcK_msOILzjWh_mtOEzU6e_zOLBBgfPBnO3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>TOTAL
    OPERATING EXPENSES</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,812,143</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,494,260</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--OperatingIncomeLoss_iT_pp0p0_mtOILzjWh_maILFCOzMZh_z0l6K0pBCa19" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>LOSS
    FROM OPERATIONS</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">1,812,143</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">3,494,260</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--NonoperatingIncomeExpenseAbstract_iB" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>OTHER
    INCOME (EXPENSE)</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--InterestExpense_i01N_pp0p0_di_msNIEzh0L_msNIEzIVM_zMQ3PQRKVUZ4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Interest
    expense</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(<ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">449,457</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(<ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,748,381</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td></tr>
  <tr id="xdx_40B_eus-gaap--InvestmentIncomeInterest_i01_pp0p0_maNIEzh0L_maNIEzIVM_zaNkoPZta12a" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Interest
    income</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:InvestmentIncomeInterest" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:InvestmentIncomeInterest" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">946</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--OtherIncome_i01_pp0p0_maNIEzh0L_maNIEzIVM_zP2pEupAPF78" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Other
    income</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0239">&#160;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:OtherIncome" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">57,636</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--DerivativeGainLossOnDerivativeNet_i01_pp0p0_maNIEzh0L_maNIEzIVM_zQRMVFh8Zs6c" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Change
    in fair value of derivative liabilities</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(<ix:nonFraction name="us-gaap:DerivativeGainLossOnDerivativeNet" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">8,186</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:DerivativeGainLossOnDerivativeNet" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">385,293</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_40A_ecustom--GainFromSettlementOfDebtNet_i01_pp0p0_maNIEzh0L_maNIEzIVM_z7aBGECDhm9c" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Gain
    from settlement of debt, net</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="PPCB:GainFromSettlementOfDebtNet" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">49,319</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0246">&#160;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--GainsLossesOnExtinguishmentOfDebt_i01_pp0p0_maNIEzh0L_maNIEzIVM_zkj7g8RxWKNh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Gain
    on extinguishment of debt, net</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:GainsLossesOnExtinguishmentOfDebt" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">50,607</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:GainsLossesOnExtinguishmentOfDebt" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">67,123</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--ForeignCurrencyTransactionGainLossUnrealized_i01_pp0p0_maNIEzh0L_maNIEzIVM_zGq2jMSfnQa6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; padding-left: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Foreign
    currency transaction gain (loss)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:ForeignCurrencyTransactionGainLossUnrealized" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">30,497</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(<ix:nonFraction name="us-gaap:ForeignCurrencyTransactionGainLossUnrealized" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">143,808</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td></tr>
  <tr id="xdx_406_eus-gaap--NonoperatingIncomeExpense_i01T_pp0p0_mtNIEzh0L_maILFCOzMZh_zsjFay6VFur3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>TOTAL
    OTHER EXPENSE, NET</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(<ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">327,219</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(<ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">1,381,191</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_iT_pp0p0_maNILzpRF_mtILFCOzMZh_z7aBfl3VxlM6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>LOSS
    BEFORE TAXES</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">2,139,362</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">4,875,451</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--IncomeTaxExpenseBenefit_iN_pp0p0_di_msNILzpRF_z9w95yfmaNG2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Tax
    benefit</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">113,415</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">134,728</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--ProfitLoss_iT_pp0p0_mtNILzpRF_maNILATzKc1_zdGYERBzDzmk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>NET
    LOSS</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">2,025,947</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">4,740,723</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--DeemedDividend_maNILATzKc1_zvWRPNRLD858" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">Deemed dividend</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">(<ix:nonFraction name="PPCB:DeemedDividend" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">391,749</ix:nonFraction></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">-<span style="-sec-ix-hidden: xdx2ixbrl0267">&#160;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--NetIncomeLoss_iT_mtNILATzKc1_z10mePvYTN2j" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">NET LOSS AVAILABLE TO COMMON
    STOCKHOLDERS</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">$</p></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,417,696</ix:nonFraction></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">$</p></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">4,740,723</ix:nonFraction></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--EarningsPerShareBasicAndDiluted_pid_z7yMFRWYWPFc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>BASIC
    AND DILUTED NET LOSS PER SHARE AVAILABLE TO COMMON STOCKHOLDERS</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:EarningsPerShareBasicAndDiluted" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.80</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(<ix:nonFraction name="us-gaap:EarningsPerShareBasicAndDiluted" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">192.45</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--WeightedAverageNumberOfShareOutstandingBasicAndDiluted_pid_zejLSmgsKIc7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>BASIC
    AND DILUTED WEIGHTED AVERAGE SHARES OUTSTANDING</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,032,612</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">24,634</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_maCINOTzDDF_zFODEDuibgWf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>NET
    LOSS AVAILABLE TO COMMON STOCKHOLDERS</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"></span><span style="font: 10pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,417,696</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(<ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">4,740,723</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_iB" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>OTHER
    COMPREHENSIVE INCOME (LOSS)</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_i01_pp0p0_maOCILNzCry_zindxOCGxJic" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; padding-left: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Unrealized
    foreign currency translation gain (loss)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">182,467</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">200,673</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_i01T_pp0p0_mtOCILNzCry_maCINOTzDDF_z0NWSV5lKlF6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>TOTAL
    OTHER COMPREHENSIVE INCOME (LOSS)</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">182,467</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">200,673</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--ComprehensiveIncomeNetOfTax_iT_pp0p0_mtCINOTzDDF_zx34utaiSYj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>TOTAL
    COMPREHENSIVE LOSS</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">2,600,163</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(<ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">4,540,050</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
accompanying notes are an integral part of these consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<!-- Field: Page; Sequence: 96; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b><span id="arp_004"></span>PROPANC
BIOPHARMA, INC. AND SUBSIDIARY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b><span id="kk_004"></span>CONSOLIDATED
STATEMENTS OF CHANGES IN STOCKHOLDERS&#8217; DEFICIT FOR THE YEARS ENDED JUNE 30, 2021 and 2020</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_305_114_zdtHy8XdlrS8" summary="xdx: Statement - Consolidated Statements of Changes in Stockholders&apos; Deficit" style="font: 6pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 6pt Times New Roman, Times, Serif; display: none; vertical-align: bottom">
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: center"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 6pt Times New Roman, Times, Serif; text-align: center"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">No.
    of Shares</span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td colspan="2" id="xdx_4B2_us-gaap--StatementClassOfStockAxis_us-gaap--SeriesAPreferredStockMember_us-gaap--StatementEquityComponentsAxis_us-gaap--PreferredStockMember_znMJ6EKKcquc" style="border-bottom: Black 1.5pt solid; font: bold 6pt Times New Roman, Times, Serif; text-align: center"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">Value</span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 6pt Times New Roman, Times, Serif; text-align: center"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">No.
    of Shares</span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td colspan="2" id="xdx_4B1_us-gaap--StatementClassOfStockAxis_us-gaap--SeriesBPreferredStockMember_us-gaap--StatementEquityComponentsAxis_us-gaap--PreferredStockMember_zX9DWnmrPSOd" style="border-bottom: Black 1.5pt solid; font: bold 6pt Times New Roman, Times, Serif; text-align: center"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">Value</span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 6pt Times New Roman, Times, Serif; text-align: center"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">No.
    of Shares</span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td colspan="2" id="xdx_4B3_us-gaap--StatementEquityComponentsAxis_us-gaap--CommonStockMember_zWOTVGbhTZBe" style="border-bottom: Black 1.5pt solid; font: bold 6pt Times New Roman, Times, Serif; text-align: center"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">Value</span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 6pt Times New Roman, Times, Serif; text-align: center"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">No.
    of Shares</span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td colspan="2" id="xdx_4BD_us-gaap--StatementEquityComponentsAxis_custom--CommonStockIssuableMember_zvYSkpM9nyR5" style="border-bottom: Black 1.5pt solid; font: bold 6pt Times New Roman, Times, Serif; text-align: center"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">Value</span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td colspan="2" id="xdx_4BC_us-gaap--StatementEquityComponentsAxis_us-gaap--AdditionalPaidInCapitalMember_zJMxTDNYE8pk" style="border-bottom: Black 1.5pt solid; font: bold 6pt Times New Roman, Times, Serif; text-align: center"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">Capital</span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td colspan="2" id="xdx_4BA_us-gaap--StatementEquityComponentsAxis_us-gaap--RetainedEarningsMember_zlqRhSx0bYf7" style="border-bottom: Black 1.5pt solid; font: bold 6pt Times New Roman, Times, Serif; text-align: center"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">Deficit</span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td colspan="2" id="xdx_4B7_us-gaap--StatementEquityComponentsAxis_us-gaap--AccumulatedOtherComprehensiveIncomeMember_zpGgC40OXDs8" style="border-bottom: Black 1.5pt solid; font: bold 6pt Times New Roman, Times, Serif; text-align: center"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">Income</span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td colspan="2" id="xdx_4BA_us-gaap--StatementEquityComponentsAxis_us-gaap--TreasuryStockMember_zLsLpzNMRdgc" style="border-bottom: Black 1.5pt solid; font: bold 6pt Times New Roman, Times, Serif; text-align: center"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">Stock</span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td colspan="2" id="xdx_4B6_zn0sHbTFHG9d" style="border-bottom: Black 1.5pt solid; font: bold 6pt Times New Roman, Times, Serif; text-align: center"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">Deficit</span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
<tr style="font: 6pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="14" style="font: bold 6pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="6" style="font: bold 6pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="6" style="font: bold 6pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt"><b>Common</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="font: 6pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="font: 6pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="font: bold 6pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>Accumulated</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="font: 6pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="font: 6pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td></tr>
  <tr style="font: 6pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; font: bold 6pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>Preferred
    Stock</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="6" style="font: bold 6pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="6" style="font: bold 6pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>Stock</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>Additional</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="font: 6pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>Other</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="font: 6pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>Total</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td></tr>
  <tr style="font: 6pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 6pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>Series
    A</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 6pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>Series
    B</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 6pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>Common
    Stock</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 6pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt"><b>Issuable</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>Paid-in</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>Accumulated</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>Comprehensive</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>Treasury</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>Stockholders&#8217;</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td></tr>
  <tr style="font: 6pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 6pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>No.
    of Shares</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 6pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>Value</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 6pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>No.
    of Shares</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 6pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>Value</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 6pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>No.
    of Shares</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 6pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>Value</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 6pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>No.
    of Shares</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 6pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>Value</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 6pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>Capital</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 6pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>Deficit</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 6pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>Income</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 6pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>Stock</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 6pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>Deficit</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td></tr>
  <tr style="font: 6pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: center"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td colspan="2" style="font: 6pt Times New Roman, Times, Serif; text-align: center"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td colspan="2" style="font: 6pt Times New Roman, Times, Serif; text-align: center"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td colspan="2" style="font: 6pt Times New Roman, Times, Serif; text-align: center"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td colspan="2" style="font: 6pt Times New Roman, Times, Serif; text-align: center"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td colspan="2" style="font: 6pt Times New Roman, Times, Serif; text-align: center"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td colspan="2" style="font: 6pt Times New Roman, Times, Serif; text-align: center"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td colspan="2" style="font: 6pt Times New Roman, Times, Serif; text-align: center"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td colspan="2" style="font: 6pt Times New Roman, Times, Serif; text-align: center"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td colspan="2" style="font: 6pt Times New Roman, Times, Serif; text-align: center"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td colspan="2" style="font: 6pt Times New Roman, Times, Serif; text-align: center"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td colspan="2" style="font: 6pt Times New Roman, Times, Serif; text-align: center"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td colspan="2" style="font: 6pt Times New Roman, Times, Serif; text-align: center"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td colspan="2" style="font: 6pt Times New Roman, Times, Serif; text-align: center"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 6pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td colspan="2" style="font: 6pt Times New Roman, Times, Serif; text-align: center"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td colspan="2" style="font: 6pt Times New Roman, Times, Serif; text-align: center"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td colspan="2" style="font: 6pt Times New Roman, Times, Serif; text-align: center"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td colspan="2" style="font: 6pt Times New Roman, Times, Serif; text-align: center"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td colspan="2" style="font: 6pt Times New Roman, Times, Serif; text-align: center"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td colspan="2" style="font: 6pt Times New Roman, Times, Serif; text-align: center"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td colspan="2" style="font: 6pt Times New Roman, Times, Serif; text-align: center"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td colspan="2" style="font: 6pt Times New Roman, Times, Serif; text-align: center"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td colspan="2" style="font: 6pt Times New Roman, Times, Serif; text-align: center"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td colspan="2" style="font: 6pt Times New Roman, Times, Serif; text-align: center"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td colspan="2" style="font: 6pt Times New Roman, Times, Serif; text-align: center"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td colspan="2" style="font: 6pt Times New Roman, Times, Serif; text-align: center"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td colspan="2" style="font: 6pt Times New Roman, Times, Serif; text-align: center"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_43A_c20190701__20200630_eus-gaap--StockholdersEquity_iS_zwV4v7nKXIg4" style="font: 6pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 6pt Times New Roman, Times, Serif; width: 48%"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>Balance
    at June 30, 2019</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td id="xdx_980_eus-gaap--SharesOutstanding_iS_c20190701__20200630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zJTMQd9UKN02" title="Beginning balance, shares" style="font: bold 6pt Times New Roman, Times, Serif; width: 1%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2019-06-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">500,000</ix:nonFraction></b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>$</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; width: 1%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2019-06-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,000</ix:nonFraction></b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td id="xdx_989_eus-gaap--SharesOutstanding_iS_pid_c20190701__20200630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zoGp9WROU5A9" title="Beginning balance, shares" style="font: bold 6pt Times New Roman, Times, Serif; width: 1%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2019-06-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1</ix:nonFraction></b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>$</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; width: 1%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b><span style="-sec-ix-hidden: xdx2ixbrl0294">-</span></b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td id="xdx_982_eus-gaap--SharesOutstanding_iS_pid_c20190701__20200630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zypC7OYsSJHa" title="Beginning balance, shares" style="font: bold 6pt Times New Roman, Times, Serif; width: 1%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2019-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">968</ix:nonFraction></b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>$</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; width: 1%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2019-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1</ix:nonFraction></b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td id="xdx_989_eus-gaap--SharesOutstanding_iS_pid_c20190701__20200630__us-gaap--StatementEquityComponentsAxis__custom--CommonStockIssuableMember_zKu4NAUMdHfb" title="Beginning balance, shares" style="font: bold 6pt Times New Roman, Times, Serif; width: 1%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b><span style="-sec-ix-hidden: xdx2ixbrl0309">-</span></b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>$</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; width: 1%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b><span style="-sec-ix-hidden: xdx2ixbrl0296">-</span></b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>$</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; width: 1%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2019-06-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">45,714,289</ix:nonFraction></b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>$</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; width: 1%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2019-06-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">51,041,047</ix:nonFraction></b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>)</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>$</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; width: 1%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2019-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,066,998</ix:nonFraction></b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>$</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; width: 1%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2019-06-30_us-gaap_TreasuryStockMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">46,477</ix:nonFraction></b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>)</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>$</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; width: 1%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2019-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">4,301,236</ix:nonFraction></b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>)</b></span></td></tr>
  <tr style="font: 6pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--StockIssuedDuringPeriodValueNewIssues_zZlUaUaZYfse" style="font: 6pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">Issuance
    of common stock for cash</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0311">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0312">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td id="xdx_986_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20190701__20200630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zTiCJAc6DNs1" title="Issuance of common stock for cash, shares" style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2019-07-012020-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">804</ix:nonFraction></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2019-07-012020-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1</ix:nonFraction></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0314">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2019-07-012020-06-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">424,989</ix:nonFraction></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0316">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0317">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0318">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">424,990</ix:nonFraction></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 6pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_zxQOGsJF2tV7" style="font: 6pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">Issuance
    of common stock for conversion of convertible debt and accrued interest</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td id="xdx_983_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_pid_c20190701__20200630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zugtrZ9JJ5M" title="Issuance of common stock for conversion of convertible debt, conversion fee, and accrued interest, shares" style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0333">-</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0323">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td id="xdx_98B_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_pid_c20190701__20200630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zANb1JUmMQNb" title="Issuance of common stock for conversion of convertible debt, conversion fee, and accrued interest, shares" style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0335">-</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0324">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td id="xdx_981_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_pid_c20190701__20200630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z8xJnpWwlEI9" title="Issuance of common stock for conversion of convertible debt, conversion fee, and accrued interest, shares" style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" contextRef="From2019-07-012020-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">247,619</ix:nonFraction></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2019-07-012020-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">248</ix:nonFraction></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td id="xdx_983_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_pid_c20190701__20200630__us-gaap--StatementEquityComponentsAxis__custom--CommonStockIssuableMember_z7lah05XYnM4" title="Issuance of common stock for conversion of convertible debt, conversion fee, and accrued interest, shares" style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0339">-</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0326">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2019-07-012020-06-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,124,926</ix:nonFraction></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0328">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0329">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0330">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,125,174</ix:nonFraction></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 6pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_401_ecustom--ReversalOfCommonStockIssuableDueToCancellationOfConversionsOfConvertibleDebtAndAccruedInterest_zWi8pm6qxdVc" style="font: 6pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">Reversal of common stock issuable due to cancellation of conversions of convertible debt and accrued interest</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_ecustom--ReversalOfCommonStockIssuableDueToCancellationOfConversionsOfConvertibleDebtAndAccruedInterestShares_pid_zYweklhsRUzg" style="font: 6pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White">
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">Reversal of common stock issuable due to cancellation of conversions of convertible debt and accrued interest, shares</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--StockIssuedDuringPeriodValueExerciseOfWarrants_pid_zlWCTizE1ZG4" style="font: 6pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">Issuance of common stock for exercise of warrants</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--StockIssuedDuringPeriodSharesExerciseOfWarrants_pid_zKETDjYUeJig" style="font: 6pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White">
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">Issuance of common stock for exercise of warrants, shares</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--IssuanceOfCommonStockForCashlessExerciseOfWarrants_pid_zG0TxesZ1a9g" style="font: 6pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">Issuance of common stock for cashless exercise of warrants</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--IssuanceOfCommonStockForCashlessExerciseOfWarrantsShares_pid_ztMY7yzY9Hxl" style="font: 6pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White">
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">Issuance of common stock for cashless exercise of warrants</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature_pid_z2rcD18uMIme" style="font: 6pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">Reversal of put premium upon cancellation of conversions of convertible debt</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_pid_z5wqWUO3jQO3" style="font: 6pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White">
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">Vested restricted stock units</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_pid_zcU0Y6a3DzL6" style="font: 6pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">Vested restricted stock units, shares</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_ecustom--StockIssuedDuringPeriodValueReverseStockSplits_pid_zdBDGReRVQfd" style="font: 6pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White">
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">Fractional difference due to the reverse stock-split</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--StockIssuedDuringPeriodSharesReverseStockSplits_pid_zpljjNTFlNFj" style="font: 6pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">Fractional difference due to the reverse stock-split, shares</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_ecustom--DeemedDividendUponAlternateCashlessExerciseOfWarrants_pid_zFkfoE4njGsf" style="font: 6pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White">
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Deemed
    dividend upon cashless exercise of warrants</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_ecustom--IssuanceOfCommonStockForAlternateCashlessExerciseOfWarrants_pid_zdq1eF4dJon1" style="font: 6pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White">
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">Issuance of common stock for alternate cashless exercise of warrants</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--IssuanceOfCommonStockForAlternateCashlessExerciseOfWarrantsShares_pid_z99CDVXGYbMi" style="font: 6pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White">
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">Issuance of common stock for alternate cashless exercise of warrants, shares</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_ecustom--AdjustmentsToAdditionalPaidInCapitalReclassificationOfPremiumUponDebtConversion_i_pp0p0" style="font: 6pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">Reclassification
    of put premium upon debt conversion</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0481">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0482">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0483">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0484">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="PPCB:AdjustmentsToAdditionalPaidInCapitalReclassificationOfPremiumUponDebtConversion" contextRef="From2019-07-012020-06-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">874,924</ix:nonFraction></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0486">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0487">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0488">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="PPCB:AdjustmentsToAdditionalPaidInCapitalReclassificationOfPremiumUponDebtConversion" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">874,924</ix:nonFraction></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 6pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_i_pp0p0" style="font: 6pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">Issuance
    of common stock for services</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0491">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0492">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td id="xdx_988_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20190701__20200630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z7iGC6PqSUL8" title="Issuance of common stock for services, shares" style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" contextRef="From2019-07-012020-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">8,729</ix:nonFraction></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2019-07-012020-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8</ix:nonFraction></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0494">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2019-07-012020-06-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">113,634</ix:nonFraction></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0496">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0497">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0498">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">113,642</ix:nonFraction></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 6pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_40E_ecustom--RelativeFairValueOfWarrantsIssuedWithConvertibleDebt_i_pp0p0" style="font: 6pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">Relative
    fair value of warrants issued with convertible debt</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0503">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0504">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0505">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0506">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="PPCB:RelativeFairValueOfWarrantsIssuedWithConvertibleDebt" contextRef="From2019-07-012020-06-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">375,905</ix:nonFraction></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0508">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0509">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0510">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="PPCB:RelativeFairValueOfWarrantsIssuedWithConvertibleDebt" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">375,905</ix:nonFraction></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 6pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_i_pp0p0" style="font: 6pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">Stock
    based compensation in connection with stock option grants and restricted stock unit grants</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0513">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0514">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0515">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0516">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2019-07-012020-06-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">300,416</ix:nonFraction></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0518">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0519">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0520">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">300,416</ix:nonFraction></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 6pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--AdjustmentsToAdditionalPaidInCapitalWarrantIssued_i_pp0p0" style="font: 6pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">Stock
    based compensation in connection with fair value of warrants issued for services</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0523">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0524">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0525">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0526">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" contextRef="From2019-07-012020-06-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">984,810</ix:nonFraction></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0528">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0529">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0530">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">984,810</ix:nonFraction></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 6pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--ForeignCurrencyTransactionGainLossBeforeTax_i_pp0p0" style="font: 6pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">Foreign
    currency translation gain</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0533">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0534">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0535">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0536">&#160;</span></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0537">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0538">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" contextRef="From2019-07-012020-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">200,673</ix:nonFraction></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">200,673</ix:nonFraction></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 6pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--ProfitLoss_zOsygbQ6b4V" style="font: 6pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">Net
    loss for the fiscal year ended June 30, 2020</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0543">&#160;</span></span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0544">&#160;</span></span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0545">&#160;</span></span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0546">&#160;</span></span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0547">&#160;</span></span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2019-07-012020-06-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">4,740,723</ix:nonFraction></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">)</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0550">&#160;</span></span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">4,740,723</ix:nonFraction></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">)</span></td></tr>
  <tr style="font: 6pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_43B_c20200701__20210630_eus-gaap--StockholdersEquity_iS_znEMR4A78Ji4" style="font: 6pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 6pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>Balance
    at June 30, 2020</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td id="xdx_98A_eus-gaap--SharesOutstanding_iS_pid_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zrUNZNfNTwo1" title="Beginning balance, shares" style="font: bold 6pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2020-06-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">500,000</ix:nonFraction></b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-06-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,000</ix:nonFraction></b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td id="xdx_98B_eus-gaap--SharesOutstanding_iS_pid_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zGuBBnxqOsWh" title="Beginning balance, shares" style="font: bold 6pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2020-06-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1</ix:nonFraction></b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b><span style="-sec-ix-hidden: xdx2ixbrl0554">&#160;</span></b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>-</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td id="xdx_98A_eus-gaap--SharesOutstanding_iS_pid_c20200701__20210630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z2eEHUb1KKSc" title="Beginning balance, shares" style="font: bold 6pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2020-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">258,120</ix:nonFraction></b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">258</ix:nonFraction></b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td id="xdx_989_eus-gaap--SharesOutstanding_iS_pid_c20200701__20210630__us-gaap--StatementEquityComponentsAxis__custom--CommonStockIssuableMember_zwkojE4Vunvf" title="Beginning balance, shares" style="font: bold 6pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b><span style="-sec-ix-hidden: xdx2ixbrl0569">-</span></b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b><span style="-sec-ix-hidden: xdx2ixbrl0556">&#160;</span></b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>-</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-06-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">50,913,893</ix:nonFraction></b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-06-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">55,781,770</ix:nonFraction></b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>)</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,267,671</ix:nonFraction></b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-06-30_us-gaap_TreasuryStockMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">46,477</ix:nonFraction></b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>)</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,641,425</ix:nonFraction></b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt; color: Black"><b>)</b></span></td></tr>
  <tr style="font: 6pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_zKQ93m21FoE8" style="font: 6pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">Issuance
    of common stock for conversion of convertible debt and accrued interest</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0571">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0572">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td id="xdx_98A_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_pid_c20200701__20210630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zXWQRFdVdlIl" title="Issuance of common stock for conversion of convertible debt, conversion fee, and accrued interest, shares" style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">8,786,113</ix:nonFraction></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,787</ix:nonFraction></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0574">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2020-07-012021-06-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,230,288</ix:nonFraction></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0576">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0577">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0578">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,239,075</ix:nonFraction></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 6pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_40C_ecustom--ReversalOfCommonStockIssuableDueToCancellationOfConversionsOfConvertibleDebtAndAccruedInterest_i_pp0p0" style="font: 6pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">Reversal
    of common stock issuable due to cancellation of conversions of convertible debt and accrued interest</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0583">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0584">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td id="xdx_982_ecustom--ReversalOfCommonStockIssuableDueToCancellationOfConversionsOfConvertibleDebtAndAccruedInterestShares_pid_c20200701__20210630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zZ7B5qAe7PCk" title="Reversal of common stock issuable due to cancellation of conversions of convertible debt and accrued interest, shares" style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">(<ix:nonFraction name="PPCB:ReversalOfCommonStockIssuableDueToCancellationOfConversionsOfConvertibleDebtAndAccruedInterestShares" contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares">24,427</ix:nonFraction></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">)</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">(<ix:nonFraction name="PPCB:ReversalOfCommonStockIssuableDueToCancellationOfConversionsOfConvertibleDebtAndAccruedInterest" contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">24</ix:nonFraction></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">)</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0586">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">(<ix:nonFraction name="PPCB:ReversalOfCommonStockIssuableDueToCancellationOfConversionsOfConvertibleDebtAndAccruedInterest" contextRef="From2020-07-012021-06-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">19,992</ix:nonFraction></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">)</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0588">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0589">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0590">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">(<ix:nonFraction name="PPCB:ReversalOfCommonStockIssuableDueToCancellationOfConversionsOfConvertibleDebtAndAccruedInterest" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">20,016</ix:nonFraction></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">)</span></td></tr>
  <tr style="font: 6pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature_z0w518BQBEva" style="font: 6pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif">Reversal
    of put premium upon cancellation of conversions of convertible debt</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0595">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0596">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0597">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0598">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" contextRef="From2020-07-012021-06-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">11,785</ix:nonFraction></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif">)</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0600">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0601">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0602">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">11,785</ix:nonFraction></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="font: 6pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_zqgDxd5l67ul" style="font: 6pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">Issuance
    of common stock for services</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0605">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0606">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td id="xdx_980_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20200701__20210630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zBLC4vmRxJG8" title="Issuance of common stock for services, shares" style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">805,646</ix:nonFraction></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">806</ix:nonFraction></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0608">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2020-07-012021-06-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">124,766</ix:nonFraction></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0610">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0611">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0612">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">125,572</ix:nonFraction></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 6pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_40C_ecustom--StockIssuedDuringPeriodValueExerciseOfWarrants_zDO15dOht24a" style="font: 6pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">Issuance
    of common stock for exercise of warrants</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0617">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0618">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td id="xdx_98F_ecustom--StockIssuedDuringPeriodSharesExerciseOfWarrants_pid_c20200701__20210630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z2gfkutHiYQ9" title="Issuance of common stock for exercise of warrants, shares" style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="PPCB:StockIssuedDuringPeriodSharesExerciseOfWarrants" contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">29,820</ix:nonFraction></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="PPCB:StockIssuedDuringPeriodValueExerciseOfWarrants" contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">29</ix:nonFraction></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0620">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="PPCB:StockIssuedDuringPeriodValueExerciseOfWarrants" contextRef="From2020-07-012021-06-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">776,015</ix:nonFraction></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0622">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0623">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0624">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="PPCB:StockIssuedDuringPeriodValueExerciseOfWarrants" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">776,044</ix:nonFraction></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 6pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_401_ecustom--IssuanceOfCommonStockForCashlessExerciseOfWarrants_zesjE6uLaqz4" style="font: 6pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">Issuance
    of common stock for cashless exercise of warrants</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0629">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0630">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td id="xdx_981_ecustom--IssuanceOfCommonStockForCashlessExerciseOfWarrantsShares_pid_c20200701__20210630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zKiYVanGySSd" title="Issuance of common stock for cashless exercise of warrants, shares" style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="PPCB:IssuanceOfCommonStockForCashlessExerciseOfWarrantsShares" contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,199,979</ix:nonFraction></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="PPCB:IssuanceOfCommonStockForCashlessExerciseOfWarrants" contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,200</ix:nonFraction></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">(<ix:nonFraction name="PPCB:IssuanceOfCommonStockForCashlessExerciseOfWarrants" contextRef="From2020-07-012021-06-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">4,200</ix:nonFraction></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">)</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0634">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0635">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0636">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0637">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 6pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td title="Issuance of common stock for cashless exercise of warrants, shares" style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--DeemedDividendUponAlternateCashlessExerciseOfWarrants_zEQOqE63wCM6" style="font: 6pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">Deemed dividend upon alternate cashless exercise of warrants</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">-</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0641">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">-</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">-</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0642">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">-</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td title="Issuance of common stock for cashless exercise of warrants, shares" style="font: 6pt Times New Roman, Times, Serif; text-align: right">-</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0643">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">-</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">-</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0644">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">-</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="PPCB:DeemedDividendUponAlternateCashlessExerciseOfWarrants" contextRef="From2020-07-012021-06-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">391,749</ix:nonFraction></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="PPCB:DeemedDividendUponAlternateCashlessExerciseOfWarrants" contextRef="From2020-07-012021-06-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">391,749</ix:nonFraction></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">)</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0647">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">-</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0648">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">-</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0649">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right">-</td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 6pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_405_ecustom--AdjustmentsToAdditionalPaidInCapitalReclassificationOfPremiumUponDebtConversion_zCFQLeDGWFF2" style="font: 6pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">Reclassification
    of put premium upon debt conversion</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0651">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0652">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0653">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0654">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="PPCB:AdjustmentsToAdditionalPaidInCapitalReclassificationOfPremiumUponDebtConversion" contextRef="From2020-07-012021-06-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">590,504</ix:nonFraction></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0656">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0657">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0658">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="PPCB:AdjustmentsToAdditionalPaidInCapitalReclassificationOfPremiumUponDebtConversion" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">590,504</ix:nonFraction></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 6pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_z20EjqKV4uph" style="font: 6pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">Stock
    based compensation in connection with stock option grants</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0661">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0662">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0663">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0664">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2020-07-012021-06-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">82,872</ix:nonFraction></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0666">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0667">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0668">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">82,872</ix:nonFraction></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 6pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_i_pp0p0" style="font: 6pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">Vested
    restricted stock units</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0671">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0672">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0673">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td id="xdx_984_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_pid_c20200701__20210630__us-gaap--StatementEquityComponentsAxis__custom--CommonStockIssuableMember_z4KqL98lLM6g" title="Vested restricted stock units, shares" style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" contextRef="From2020-07-012021-06-30_custom_CommonStockIssuableMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">59</ix:nonFraction></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0674">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0675">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0676">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0677">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0678">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0679">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 6pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_40F_ecustom--StockIssuedDuringPeriodValueReverseStockSplits_i_pp0p0" style="font: 6pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">Fractional
    difference due to the reverse stock-split</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0683">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0684">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td id="xdx_981_eus-gaap--StockIssuedDuringPeriodSharesReverseStockSplits_pid_c20200701__20210630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zKDrRuzvS8Lg" title="Fractional difference due to the reverse stock-split, shares" style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesReverseStockSplits" contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">142</ix:nonFraction></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0685">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0686">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0687">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0688">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0689">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0690">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0691">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 6pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--ForeignCurrencyTransactionGainLossBeforeTax_zwsDqGzAYKB4" style="font: 6pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">Foreign
    currency translation loss</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0695">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0696">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0697">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0698">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0699">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0700">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">(<ix:nonFraction name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" contextRef="From2020-07-012021-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">182,467</ix:nonFraction></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">)</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0702">&#160;</span></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">(<ix:nonFraction name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">182,467</ix:nonFraction></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">)</span></td></tr>
  <tr style="font: 6pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--ProfitLoss_z3O8oX9yHJzk" style="font: 6pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">Net
    loss for the fiscal year ended June 30, 2021</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0705">&#160;</span></span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0706">&#160;</span></span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0707">&#160;</span></span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0708">&#160;</span></span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0709">&#160;</span></span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2020-07-012021-06-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,025,947</ix:nonFraction></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">)</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0711">&#160;</span></span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0712">&#160;</span></span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,025,947</ix:nonFraction></span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">)</span></td></tr>
  <tr style="font: 6pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_437_c20200701__20210630_eus-gaap--StockholdersEquity_iE_pid_zZLfB2LAweDd" style="font: 6pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><b>Balance
    at June 30, 2021</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><b>&#160;</b></span></td>
    <td style="border-bottom: Black 2.5pt double; font: bold 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><b>&#160;</b></span></td>
    <td id="xdx_980_eus-gaap--SharesOutstanding_iE_pid_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zTuLWOCmTpr5" title="Ending balance, shares" style="border-bottom: Black 2.5pt double; font: bold 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><b><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-06-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">500,000</ix:nonFraction></b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><b>&#160;</b></span></td>
    <td style="border-bottom: Black 2.5pt double; font: bold 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><b>$</b></span></td>
    <td style="border-bottom: Black 2.5pt double; font: bold 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><b><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-06-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,000</ix:nonFraction></b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><b>&#160;</b></span></td>
    <td style="border-bottom: Black 2.5pt double; font: bold 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><b>&#160;</b></span></td>
    <td id="xdx_982_eus-gaap--SharesOutstanding_iE_pid_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zDaq5UEnxzv7" title="Ending balance, shares" style="border-bottom: Black 2.5pt double; font: bold 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><b><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-06-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1</ix:nonFraction></b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><b>&#160;</b></span></td>
    <td style="border-bottom: Black 2.5pt double; font: bold 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><b>$</b></span></td>
    <td style="border-bottom: Black 2.5pt double; font: bold 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><b><span style="-sec-ix-hidden: xdx2ixbrl0716">-</span></b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><b>&#160;</b></span></td>
    <td style="border-bottom: Black 2.5pt double; font: bold 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><b>&#160;</b></span></td>
    <td id="xdx_983_eus-gaap--SharesOutstanding_iE_pid_c20200701__20210630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z80LvkI3sjM" title="Ending balance, shares" style="border-bottom: Black 2.5pt double; font: bold 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><b><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">14,055,393</ix:nonFraction></b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><b>&#160;</b></span></td>
    <td style="border-bottom: Black 2.5pt double; font: bold 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><b>$</b></span></td>
    <td style="border-bottom: Black 2.5pt double; font: bold 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><b><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">14,056</ix:nonFraction></b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><b>&#160;</b></span></td>
    <td style="border-bottom: Black 2.5pt double; font: bold 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><b>&#160;</b></span></td>
    <td id="xdx_98A_eus-gaap--SharesOutstanding_iE_pid_c20200701__20210630__us-gaap--StatementEquityComponentsAxis__custom--CommonStockIssuableMember_zygbfjS9qeD3" title="Ending balance, shares" style="border-bottom: Black 2.5pt double; font: bold 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><b><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-06-30_custom_CommonStockIssuableMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">59</ix:nonFraction></b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><b>&#160;</b></span></td>
    <td style="border-bottom: Black 2.5pt double; font: bold 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><b>$</b></span></td>
    <td style="border-bottom: Black 2.5pt double; font: bold 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><b><span style="-sec-ix-hidden: xdx2ixbrl0718">-</span></b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><b>&#160;</b></span></td>
    <td style="border-bottom: Black 2.5pt double; font: bold 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif"><b>$</b></span></td>
    <td style="border-bottom: Black 2.5pt double; font: bold 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif"><b><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-06-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">54,074,110</ix:nonFraction></b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><b>&#160;</b></span></td>
    <td style="border-bottom: Black 2.5pt double; font: bold 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><b>$</b></span></td>
    <td style="border-bottom: Black 2.5pt double; font: bold 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif"><b>(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-06-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">58,199,466</ix:nonFraction></b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><b>)</b></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><b>&#160;</b></span></td>
    <td style="border-bottom: Black 2.5pt double; font: bold 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif"><b>$</b></span></td>
    <td style="border-bottom: Black 2.5pt double; font: bold 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><b><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,085,204</ix:nonFraction></b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><b>&#160;</b></span></td>
    <td style="border-bottom: Black 2.5pt double; font: bold 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><b>$</b></span></td>
    <td style="border-bottom: Black 2.5pt double; font: bold 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><b>(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-06-30_us-gaap_TreasuryStockMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">46,477</ix:nonFraction></b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><b>)</b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><b>&#160;</b></span></td>
    <td style="border-bottom: Black 2.5pt double; font: bold 6pt Times New Roman, Times, Serif; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><b>$</b></span></td>
    <td style="border-bottom: Black 2.5pt double; font: bold 6pt Times New Roman, Times, Serif; text-align: right"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><b>(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,067,573</ix:nonFraction></b></span></td>
    <td style="font: bold 6pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 6pt Times New Roman, Times, Serif; color: Black"><b>)</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
accompanying notes are an integral part of these consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<!-- Field: Page; Sequence: 97; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b><span id="arp_005"></span>PROPANC
BIOPHARMA, INC. AND SUBSIDIARY&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b><span id="kk_005"></span>CONSOLIDATED
STATEMENTS OF CASH FLOWS&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_301_112_zqdnqe6OdGn6" summary="xdx: Statement - Consolidated Statements of Cash Flows" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td colspan="2" id="xdx_494_20200701__20210630_z9xQIvJBeHn5" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>2021</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td colspan="2" id="xdx_49D_20190701__20200630_zjd2fAiwlcig" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">2020</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>Years
Ended June 30, </b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>2021</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>2020</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesAbstract_iB" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>CASH
    FLOWS FROM OPERATING ACTIVITIES:</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--ProfitLoss_i01_pp0p0_maNCPBUznH2_zn1BzTWK4PQc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; width: 66%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Net
    loss</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">2,025,947</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">4,740,723</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td></tr>
  <tr id="xdx_403_eus-gaap--AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_i01B" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-decoration: underline; padding-left: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Adjustments
    to Reconcile Net Loss to Net Cash Used in Operating Activities:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--IssuanceOfStockAndWarrantsForServicesOrClaims_i02_pp0p0_maNCPBUznH2_zcCEQ9rFVYd6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Issuance
    and amortization of common stock for services</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">125,572</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,098,452</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--ForeignCurrencyTransactionGainLossUnrealized_i02N_pp0p0_di_msNCPBUznH2_zfgDtFXHkNl2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Foreign
    currency transaction loss (gain)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(<ix:nonFraction name="us-gaap:ForeignCurrencyTransactionGainLossUnrealized" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">30,497</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:ForeignCurrencyTransactionGainLossUnrealized" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">143,808</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--Depreciation_i02_pp0p0_maNCPBUznH2_zzoXenCOnrT5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Depreciation
    expense</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:Depreciation" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,993</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:Depreciation" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,473</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--AmortizationOfDebtDiscountPremium_i02_pp0p0_maNCPBUznH2_zm9FzzzBeHij" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Amortization
    of debt discounts</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:AmortizationOfDebtDiscountPremium" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">136,527</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:AmortizationOfDebtDiscountPremium" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">734,130</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--DerivativeGainLossOnDerivativeNet_i02N_pp0p0_di_msNCPBUznH2_zVWPaMUckqY7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Change
    in fair value of derivative liabilities</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:DerivativeGainLossOnDerivativeNet" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">8,186</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(<ix:nonFraction name="us-gaap:DerivativeGainLossOnDerivativeNet" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">385,293</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td></tr>
  <tr id="xdx_401_eus-gaap--GainsLossesOnExtinguishmentOfDebt_i02N_pp0p0_di_msNCPBUznH2_zdCj4qMedUMg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Gain
    on extinguishment of debt, net</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(<ix:nonFraction name="us-gaap:GainsLossesOnExtinguishmentOfDebt" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">50,607</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(<ix:nonFraction name="us-gaap:GainsLossesOnExtinguishmentOfDebt" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">67,123</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td></tr>
  <tr id="xdx_40E_ecustom--GainFromSettlementOfDebtNet_i02N_pp0p0_di_msNCPBUznH2_z4xUbe2XBJa8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Gain
    from settlement of debt, net</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(<ix:nonFraction name="PPCB:GainFromSettlementOfDebtNet" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">49,319</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0761">&#160;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--ShareBasedCompensation_i02_pp0p0_maNCPBUznH2_zI8NOVBfFfeb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Stock
    option and restricted stock expense</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">82,872</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">300,416</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--OtherNoncashExpense_i02_pp0p0_maNCPBUznH2_zdTRLE2YzmW5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Non-cash
    interest expense</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:OtherNoncashExpense" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">16,500</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:OtherNoncashExpense" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">15,000</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--AccretionAmortizationOfDiscountsAndPremiumsInvestments_i02N_pp0p0_di_msNCPBUznH2_zolSd00LXKeb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Accretion
    of put premium</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">200,410</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">836,724</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--IncreaseDecreaseInOperatingAssetsAbstract_i02B" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-decoration: underline; padding-left: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Changes
    in Assets and Liabilities:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--IncreaseDecreaseInReceivables_i03N_pp0p0_di_msNCPBUznH2_z5xpjYzpimR" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">GST
    receivable</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInReceivables" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,147</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:IncreaseDecreaseInReceivables" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">3,332</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_i03N_pp0p0_di_msNCPBUznH2_zU3taAeeqI77" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Prepaid
    expenses and other assets</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0778">&#160;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">83,157</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--IncreaseDecreaseInAccountsPayable_i03_pp0p0_maNCPBUznH2_zGRTgpdnqMLl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Accounts
    payable</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayable" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">178,311</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayable" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">59,737</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td></tr>
  <tr id="xdx_40F_ecustom--IncreaseDecreaseInDeferredRent_i03N_pp0p0_di_msNCPBUznH2_zF77VGVckZaj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Deferred
    rent</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(<ix:nonFraction name="PPCB:IncreaseDecreaseInDeferredRent" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,695</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="PPCB:IncreaseDecreaseInDeferredRent" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">3,394</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--IncreaseDecreaseInEmployeeRelatedLiabilities_i03_pp0p0_maNCPBUznH2_zSmPH5alFjdk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Employee
    benefit liability</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">33,134</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">35,724</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_i03_pp0p0_maNCPBUznH2_zFDY7KfW5b36" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Accrued
expenses and other payables</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">152,861</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">9,740</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td></tr>
  <tr id="xdx_40F_eus-gaap--IncreaseDecreaseInInterestPayableNet_i03_pp0p0_maNCPBUznH2_zyxG1tW3JdQi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; padding-left: 20pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Accrued
    interest</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:IncreaseDecreaseInInterestPayableNet" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">80,582</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:IncreaseDecreaseInInterestPayableNet" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">156,417</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--NetCashProvidedByUsedInOperatingActivities_i01T_pp0p0_mtNCPBUznH2_maCCERCzgfp_znYpzcCCVaCg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>NET
    CASH USED IN OPERATING ACTIVITIES</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">1,145,264</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">1,849,589</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--NetCashProvidedByUsedInFinancingActivitiesAbstract_iB" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>CASH
    FLOWS FROM FINANCING ACTIVITIES:</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--ProceedsFromConvertibleDebt_i01_pp0p0_maNCPBUz7qY_zKLHObpqwUP2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Proceeds
    from convertible promissory notes, net of original issue discounts and issue costs</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:ProceedsFromConvertibleDebt" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">325,000</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:ProceedsFromConvertibleDebt" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,465,250</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--RepaymentsOfConvertibleDebt_i01N_pp0p0_di_msNCPBUz7qY_z7wVawoPNGi3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Repayments
    of convertible promissory notes</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(<ix:nonFraction name="us-gaap:RepaymentsOfConvertibleDebt" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">43,000</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0806">&#160;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--ProceedsFromIssuanceOfCommonStock_i01_pp0p0_maNCPBUz7qY_zB7GEP1GXWa" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Proceeds
    from the sale of common stock</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0808">&#160;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">450,000</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--PaymentsForRepurchaseOfInitialPublicOffering_i01N_pp0p0_di_msNCPBUz7qY_zdhMQLSWfF0i" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Fees
    associated with offering costs</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0811">&#160;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(<ix:nonFraction name="us-gaap:PaymentsForRepurchaseOfInitialPublicOffering" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">25,010</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td></tr>
  <tr id="xdx_40D_eus-gaap--ProceedsFromWarrantExercises_i01_pp0p0_maNCPBUz7qY_zeURdDT3e6fh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; padding-left: 20pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Proceeds
    from the exercise of warrants</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:ProceedsFromWarrantExercises" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">776,044</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0815">&#160;</span></span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--NetCashProvidedByUsedInFinancingActivities_i01T_pp0p0_mtNCPBUz7qY_maCCERCzgfp_zUvbIzeNaF69" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>NET
    CASH PROVIDED BY FINANCING ACTIVITIES</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,058,044</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,890,240</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_maCCERCzgfp_zGmZkHghQ0V4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Effect
    of exchange rate changes on cash</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">22,468</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">23,962</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_iT_pp0p0_mtCCERCzgfp_zWaPcDLWfPPe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>NET
    INCREASE (DECREASE) IN CASH</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(<ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">64,752</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">64,613</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_iS_pp0p0" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>CASH
    AT BEGINNING OF YEAR</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">67,007</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2019-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,394</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_iE_pp0p0" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>CASH
    AT END OF YEAR</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,255</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">67,007</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--SupplementalCashFlowInformationAbstract_iB" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-decoration: underline; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Supplemental
    Disclosure of Cash Flow Information</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-decoration: underline"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_40E_ecustom--CashPaidDuringPeriodAbstract_i01B" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Cash
    paid during the year:</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--InterestPaidNet_i02_pp0p0" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; padding-left: 20pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Interest</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:InterestPaidNet" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">13,621</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:InterestPaidNet" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">6,110</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--IncomeTaxesPaidNet_i02_pp0p0" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; padding-left: 20pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Income
Tax</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0841">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0842">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_iB" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-decoration: underline; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Supplemental
    Disclosure of Non-Cash Investing and Financing Activities</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--ConversionOfStockAmountConverted1_i01_pp0p0" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; padding-left: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Reduction
    of put premium related to conversions of convertible notes</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:ConversionOfStockAmountConverted1" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">590,504</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:ConversionOfStockAmountConverted1" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">874,924</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--ConversionOfStockAmountIssued1_i01_pp0p0" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; padding-left: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Conversion
    of convertible notes and accrued interest to common stock</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:ConversionOfStockAmountIssued1" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,142,205</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:ConversionOfStockAmountIssued1" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,814,336</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_408_ecustom--DiscountsRelatedToWarrantsIssuedWithConvertibleNote_i01_pp0p0" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; padding-left: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Discounts
    related to warrants issued with convertible notes</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0853">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="PPCB:DiscountsRelatedToWarrantsIssuedWithConvertibleNote" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">375,905</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_402_ecustom--DiscountsRelatedToDerivativeLiability_i01_pp0p0" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; padding-left: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Discounts
    related to derivative liability</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0856">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="PPCB:DiscountsRelatedToDerivativeLiability" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">227,000</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_404_ecustom--OperatingLeaseRightofuseAssetsAndOperatingLeaseLiabilitiesRecordedUponAdoptionOfAsc842_i01_pp0p0" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; padding-left: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Operating
    lease right-of-use asset and operating lease liability recorded on adoption of ASC 842</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0859">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="PPCB:OperatingLeaseRightofuseAssetsAndOperatingLeaseLiabilitiesRecordedUponAdoptionOfAsc842" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">48,662</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_402_ecustom--ReversalOfCommonStockIssuableAndPutPremiumDueToCancellationOfConversionsOfConvertibleDebtAndAccruedInterest_i01_pp0p0" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; padding-left: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Reversal
    of common stock issuable and put premium due to cancellation of conversions of convertible debt and accrued interest</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="PPCB:ReversalOfCommonStockIssuableAndPutPremiumDueToCancellationOfConversionsOfConvertibleDebtAndAccruedInterest" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">31,801</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0863">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_400_ecustom--DeemedDividendUponAlternateCashlessExerciseOfWarrants1_i01_pp0p0_zOt6SIPuBdO1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; padding-left: 10pt; text-align: left">Deemed dividend
    upon alternate cashless exercise of warrants</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><ix:nonFraction name="PPCB:DeemedDividendUponAlternateCashlessExerciseOfWarrants1" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">391,749</ix:nonFraction></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="-sec-ix-hidden: xdx2ixbrl0866">-</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--AccountsPayableReclassToConvertibleNotes_i01_pp0p0" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; padding-left: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Accounts
    payable reclass to convertible notes</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="PPCB:AccountsPayableReclassToConvertibleNotes" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">25,000</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl0869">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
accompanying notes are an integral part of these consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<!-- Field: Page; Sequence: 98; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b><span id="arp_006"></span>PROPANC
BIOPHARMA, INC. AND SUBSIDIARY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b><span id="kk_006"></span>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p id="xdx_04A_c20200701__20210630_zz2u4fioJ6J3" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>June
30, 2021 and 2020</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>&#160;</b></span></p>

<ix:nonNumeric contextRef="From2020-07-012021-06-30" escape="true" name="us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock"><p id="xdx_800_eus-gaap--OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_zycuyQ5Qj2bl" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>NOTE
1 &#8211; <span id="xdx_825_zzIYbH5HEuLc">NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING AND REPORTING POLICIES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<ix:nonNumeric contextRef="From2020-07-012021-06-30" escape="true" name="PPCB:NatureOfOperationsPolicyTextBlock"><p id="xdx_84D_ecustom--NatureOfOperationsPolicyTextBlock_zUy1ZG0cJ07l" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="text-decoration: underline"><span id="xdx_864_zskNnen1aczd">Nature
of Operations</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Propanc
Biopharma, Inc. (the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;us&#8221; or &#8220;our&#8221;) was originally incorporated in Melbourne,
Victoria Australia on October 15, 2007 as Propanc PTY LTD, and continues to be based in Camberwell, Victoria Australia. Since its inception,
substantially all of the operations of the Company have been focused on the development of new cancer treatments targeting high-risk
patients, particularly cancer survivors, who need a follow-up, non-toxic, long-term therapy designed to prevent the cancer from returning
and spreading. The Company anticipates establishing global markets for its technologies. Our lead product candidate, which we refer to
as PRP, is an enhanced pro-enzyme formulation designed to enhance the anti-cancer effects of multiple enzymes acting synergistically.
It is currently in the preclinical phase of development.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 29.15pt; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">On
<span id="xdx_902_edei--EntityIncorporationDateOfIncorporation_dd_c20200701__20210630_zjsnh70umwD9" title="Entity incorporation, date of incorporation"><ix:nonNumeric contextRef="From2020-07-012021-06-30" format="ixt:datemonthdayyearen" name="dei:EntityIncorporationDateOfIncorporation">November 23, 2010</ix:nonNumeric></span>, the Company was incorporated in the state of Delaware as Propanc Health Group Corporation. In January 2011, to reorganize
the Company, we acquired all of the outstanding shares of Propanc PTY LTD on a one-for-one basis making it a wholly-owned subsidiary
of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">On
July 22, 2016, the Company formed a wholly owned subsidiary, Propanc (UK) Limited under the laws of England and Wales for the purpose
of submitting an orphan drug application to the European Medicines Agency as a small and medium-sized enterprise. As of June 30, 2021,
there has been no activity within this entity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Effective
April 20, 2017, the Company changed its name to &#8220;Propanc Biopharma, Inc.&#8221; to better reflect the Company&#8217;s stage of
operations and development.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">In
July 2020, a world first patent was granted in Australia for the cancer treatment method patent family. Presently, there are 29 granted
patents and 33 patents under examination in key global jurisdictions relating to the use of proenzymes against solid tumors, covering
the lead product candidate PRP.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
Company hopes to capture and protect additional patentable subject matter based on the Company&#8217;s field of technology relating to
pharmaceutical compositions of proenzymes for treating cancer by filing additional patent applications as it advances its lead product
candidate, PRP, through various stages of development.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">On
November 17, 2020, the Company effected a <span id="xdx_90D_eus-gaap--StockholdersEquityReverseStockSplit_c20201116__20201117" title="Reverse stock"><ix:nonNumeric contextRef="From2020-11-162020-11-17" name="us-gaap:StockholdersEquityReverseStockSplit">one-for-one thousand (1:1,000)</ix:nonNumeric></span> reverse stock split of the Company&#8217;s issued and outstanding
shares of common stock (the &#8220;Reverse Stock Split&#8221;). Proportional adjustments for the Reverse Stock Split were made to the
Company&#8217;s outstanding stock options, warrants and equity incentive plans. All share and per-share data and amounts have been retroactively
adjusted as of the earliest period presented in the consolidated financial statements to reflect the Reverse Stock Split.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-07-012021-06-30" escape="true" name="us-gaap:ConsolidationPolicyTextBlock"><p id="xdx_840_eus-gaap--ConsolidationPolicyTextBlock_zTfyfILZC5Xb" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="text-decoration: underline"><span id="xdx_860_z0xpPnCblBPa">Principles
of Consolidation</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
consolidated financial statements include the accounts of Propanc Biopharma, Inc., the parent entity, and its wholly-owned subsidiary,
Propanc PTY LTD. All inter-company balances and transactions have been eliminated in consolidation. Propanc (UK) Limited was an inactive
wholly-owned subsidiary through June 30, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-07-012021-06-30" escape="true" name="us-gaap:UseOfEstimates"><p id="xdx_845_eus-gaap--UseOfEstimates_zzwSrtiWrUj9" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="text-decoration: underline"><span id="xdx_866_zCVztcFqdaWc">Use
of Estimates</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
preparation of financial statements in conformity with the accounting principles generally accepted in the United States of America (&#8220;US
GAAP&#8221;) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure
of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses
during the reporting period. Actual results could differ from these estimates. Significant estimates in the accompanying consolidated
financial statements include the estimates of useful lives for depreciation, valuation of the operating lease liability and related right-of-use
asset, valuation of derivatives, valuation of beneficial conversion features on convertible debt, allowance for uncollectable receivables,
valuation of equity based instruments issued for other than cash, the valuation allowance on deferred tax assets and foreign currency
translation due to certain average exchange rates applied in lieu of spot rates on transaction dates.</span></p>

</ix:nonNumeric><p id="xdx_859_z8T8me2mUWNh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<ix:exclude><!-- Field: Page; Sequence: 99; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>PROPANC
BIOPHARMA, INC. AND SUBSIDIARY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>June
30, 2021 and 2020</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<ix:nonNumeric contextRef="From2020-07-012021-06-30" escape="true" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"><p id="xdx_84C_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_z1sqztQEFLQg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="text-decoration: underline"><span id="xdx_86F_zJUFHRfwNmQ9">Foreign
Currency Translation and Other Comprehensive Income (Loss)</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
Company&#8217;s wholly owned subsidiary&#8217;s functional currency is the Australian dollar (AUD). For financial reporting purposes,
the Australian dollar has been translated into the Company&#8217;s reporting currency which is the United States dollar ($) and/or (USD).
Assets and liabilities are translated at the exchange rate in effect at the balance sheet date. Revenues and expenses are translated
at the average rate of exchange prevailing during the reporting period. Equity transactions are translated at each historical transaction
date spot rate. Translation adjustments arising from the use of different exchange rates from period to period are included as a component
of stockholders&#8217; equity (deficit) as &#8220;Accumulated other comprehensive income (loss).&#8221; Gains and losses resulting from
foreign currency transactions are included in the statements of operations and comprehensive income (loss) as a component of other
comprehensive income (loss). There have been no significant fluctuations in the exchange rate for the conversion of Australian dollars
to USD after the balance sheet date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Other
Comprehensive Income (Loss) for all periods presented includes only foreign currency translation gains (losses).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Assets
and liabilities denominated in foreign currencies are translated into the functional currency at the exchange rates prevailing at
the consolidated balance sheet date with any transaction gains and losses that arise from exchange rate fluctuations on transactions
denominated in a currency other than the functional currency included in the consolidated results of operations as incurred.
Effective fiscal year 2021, the parent company determined that these intercompany loans will not be repaid in the foreseeable future
and thus, per ASC 830-20-35-3, gains and losses from measuring the intercompany balances are recorded within cumulative translation
adjustment, a component of accumulated other comprehensive income (loss). Prior to July 1, 2020, the Company recorded the foreign
currency transaction gains and losses from measuring the intercompany balances as a component of other income (expenses) titled
foreign currency transaction gain (loss). For the year ended June 30, 2021 and 2020, the Company recognized an exchange gain
(loss) of approximately $<span id="xdx_901_eus-gaap--OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_c20200701__20210630__us-gaap--DebtInstrumentAxis__custom--IntercompanyLoansMember_pp0p0"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" contextRef="From2020-07-012021-06-30_custom_IntercompanyLoansMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,005,000</ix:nonFraction> </span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">and
($<span id="xdx_90C_eus-gaap--OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_pp0p0_c20190701__20200630__us-gaap--DebtInstrumentAxis__custom--IntercompanyLoansMember_z9cfuN0kVfSk"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" contextRef="From2019-07-012020-06-30_custom_IntercompanyLoansMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">133,000</ix:nonFraction></span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">),
on intercompany loans made by the parent to the subsidiary which have not been repaid as of June 30, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<ix:nonNumeric contextRef="From2020-07-012021-06-30" escape="true" name="PPCB:ScheduleOfTranslationExchangeRatesTableTextBlock"><p id="xdx_890_ecustom--ScheduleOfTranslationExchangeRatesTableTextBlock_zHWjPfYgXMZa" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">As
of June 30, 2021 and 2020, the exchange rates used to translate amounts in Australian dollars into USD for the purposes of preparing
the consolidated financial statements were as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;<span id="xdx_8BF_zkh7nqNm3XF1" style="display: none">SCHEDULE OF TRANSLATION EXCHANGE RATES</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>June
    30, 2021</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>June
    30, 2020</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Exchange
    rate on balance sheet dates</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 64%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">USD
    : AUD exchange rate</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td id="xdx_98C_eus-gaap--ForeignCurrencyExchangeRateTranslation1_c20210630_pdd" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:ForeignCurrencyExchangeRateTranslation1" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">0.7500</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td id="xdx_98D_eus-gaap--ForeignCurrencyExchangeRateTranslation1_c20200630_pdd" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:ForeignCurrencyExchangeRateTranslation1" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">0.6891</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Average
    exchange rate for the period</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">USD
    : AUD exchange rate</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td id="xdx_981_eus-gaap--ForeignCurrencyExchangeRateTranslation1_c20210630__srt--RangeAxis__srt--WeightedAverageMember_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:ForeignCurrencyExchangeRateTranslation1" contextRef="AsOf2021-06-30_srt_WeightedAverageMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">0.7473</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td id="xdx_980_eus-gaap--ForeignCurrencyExchangeRateTranslation1_c20200630__srt--RangeAxis__srt--WeightedAverageMember_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:ForeignCurrencyExchangeRateTranslation1" contextRef="AsOf2020-06-30_srt_WeightedAverageMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">0.6742</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8A5_zF6IdfJw4yP2" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<ix:nonNumeric contextRef="From2020-07-012021-06-30" escape="true" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"><p id="xdx_89D_eus-gaap--ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_zTTKEp5aN2Mg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Change
in Accumulated Other Comprehensive Income (Loss) by component during the years ended June 30, 2021 and 2020 were as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;<span id="xdx_8BB_z1EztVraTjcc" style="display: none">SCHEDULE OF CHANGE IN ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Foreign<br />
    Currency Items:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 82%"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Beginning
    balance, June 30, 2019</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td id="xdx_982_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iS_pp0p0_c20190701__20200630_zhNUQVDiorwj" title="Beginning balance" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextRef="AsOf2019-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,066,998</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Foreign
    currency translation gain</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td id="xdx_983_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_pp0p0_c20190701__20200630_zybFsKiYr1bg" title="Foreign currency translation gain" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">200,673</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Balance,
    June 30, 2020</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td id="xdx_98A_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iS_pp0p0_c20200701__20210630_z7l1M52ClLwc" title="Beginning balance" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,267,671</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Foreign
    currency translation gain</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td id="xdx_986_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_pp0p0_c20200701__20210630_zDEdRjzTaONi" title="Foreign currency translation gain" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">182,467</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Ending
    balance, June 30, 2021</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td id="xdx_988_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iE_pp0p0_c20200701__20210630_zuP9suUjhKki" title="Ending balance" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,085,204</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8A0_zHuOP9xbxVG" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-07-012021-06-30" escape="true" name="us-gaap:FairValueOfFinancialInstrumentsPolicy"><p id="xdx_84A_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zVxpyFcjsmfb" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="text-decoration: underline"><span id="xdx_869_zSpI6haJjHrj">Fair
Value of Financial Instruments and Fair Value Measurements</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
Company measures its financial assets and liabilities in accordance with US GAAP. For certain financial instruments, including cash and
cash equivalents, accounts receivable, accounts payable and accrued liabilities, the carrying amounts approximate fair value due to their
short maturities. Amounts recorded for notes payable, net of discount, and loans payable also approximate fair value because current
interest rates available for debt with similar terms and maturities are substantially the same.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
Company follows accounting guidance for financial assets and liabilities. This standard defines fair value, provides guidance for measuring
fair value and requires certain disclosures. This standard does not require any new fair value measurements, but rather applies to all
other accounting pronouncements that require or permit fair value measurements. This guidance does not apply to measurements related
to share-based payments. This guidance discusses valuation techniques, such as the market approach (comparable market prices), the income
approach (present value of future income or cash flow), and the cost approach (cost to replace the service capacity of an asset or replacement
cost).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
guidance utilizes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three broad
levels. The following is a brief description of those three levels:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.2in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Level
1: Observable inputs such as quoted prices (unadjusted) in active markets for identical assets or liabilities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.2in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Level
2: Inputs, other than quoted prices that are observable, either directly or indirectly. These include quoted prices for similar assets
or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.2in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Level
3: Unobservable inputs in which little or no market data exists, therefore developed using estimates and assumptions developed by us,
which reflect those that a market participant would use.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Also
see Note 12 - Derivative Financial Instruments and Fair Value Measurements.</span></p>

</ix:nonNumeric><p id="xdx_856_zCAOGM8L5wW4" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<ix:exclude><!-- Field: Page; Sequence: 100; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>PROPANC
BIOPHARMA, INC. AND SUBSIDIARY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>June
30, 2021 and 2020</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<ix:nonNumeric contextRef="From2020-07-012021-06-30" escape="true" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock"><p id="xdx_849_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zbBtLCxM8FT2" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="text-decoration: underline"><span id="xdx_86B_zOfKCWdOLVRd">Cash
and Cash Equivalents</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Cash
and cash equivalents include cash on hand and at banks, short-term deposits with an original maturity of three months or less with financial
institutions, and bank overdrafts. Bank overdrafts, as applicable, are reflected as a current liability on the balance sheets.
There were <span id="xdx_903_eus-gaap--CashEquivalentsAtCarryingValue_iI_pp0p0_do_c20200630_zZ1eOJKYJYr7"><ix:nonFraction name="us-gaap:CashEquivalentsAtCarryingValue" contextRef="AsOf2020-06-30" format="ixt-sec:numwordsen" decimals="0" scale="0" unitRef="USD">no</ix:nonFraction></span></span> <span style="font: 10pt Times New Roman, Times, Serif; color: Black">cash
equivalents as of June 30, 2021 or June 30, 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-07-012021-06-30" escape="true" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock"><p id="xdx_84B_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zfg52EPJexy6" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="text-decoration: underline"><span id="xdx_862_zHWcQfXqSLH3">Property
and Equipment</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Property
and equipment are stated at cost, net of accumulated depreciation. Expenditures for maintenance and repairs are expensed as incurred;
additions, renewals, and betterments are capitalized. When property and equipment are retired or otherwise disposed of, the related cost
and accumulated depreciation are removed from the respective accounts, and any gain or loss is included in operations. Depreciation of
property and equipment is provided using the declining balance method. The depreciable amount is the cost less its residual value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<ix:nonNumeric contextRef="From2020-07-012021-06-30" escape="true" name="PPCB:ScheduleOfPropertyAndEquipmentEstimatedUsefulLivesTableTextBlock"><p id="xdx_892_ecustom--ScheduleOfPropertyAndEquipmentEstimatedUsefulLivesTableTextBlock_z3AwX2Xd0mO4" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
estimated useful lives are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;<span id="xdx_8BA_zTqP1ilC57ma" style="display: none">SCHEDULE OF PROPERTY AND EQUIPMENT ESTIMATED USEFUL LIVES</span></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 28%"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Machinery
    and equipment</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 72%"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">-
    <span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200701__20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_zOXkToZUepQc" title="Property and equipment estimated useful lives"><ix:nonNumeric contextRef="From2020-07-012021-06-30_us-gaap_MachineryAndEquipmentMember" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">5</ix:nonNumeric></span> years</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Furniture</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">-
    <span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200701__20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zW81xzQcQdSg" title="Property and equipment estimated useful lives"><ix:nonNumeric contextRef="From2020-07-012021-06-30_us-gaap_FurnitureAndFixturesMember" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">7</ix:nonNumeric></span> years</span></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8A6_zca7BRRp6xl5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-07-012021-06-30" escape="true" name="us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy"><p id="xdx_841_eus-gaap--GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_zv8lJAmH5La9" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="text-decoration: underline"><span id="xdx_863_zdGUX8vUhRsb">Patents</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 29.15pt; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Patents
are stated at cost and amortized on a straight-line basis over the estimated future periods if and once the patent has been granted by
a regulatory agency. However, the Company will expense any patent costs as long as we are in the startup stage. Accordingly, as the Company&#8217;s
products are not currently approved for market, all patent costs incurred from 2013 through June 30, 2021 were expensed immediately.
This practice of expensing patent costs immediately ends when a product receives market authorization from a government regulatory agency.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-07-012021-06-30" escape="true" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"><p id="xdx_845_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zey8gFOmZPEd" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="text-decoration: underline"><span id="xdx_86C_zgKIFAsI1sVj">Impairment
of Long-Lived Assets</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.45in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">In
accordance with ASC 360-10, &#8220;Long-lived assets,&#8221; which include property and equipment and intangible assets, are reviewed
for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability
of long-lived assets to be held and used is measured by a comparison of the carrying amount of an asset to the estimated undiscounted
future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated undiscounted future
cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the
assets. Fair value is generally determined using the asset&#8217;s expected future discounted cash flows or market value, if readily
determinable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-07-012021-06-30" escape="true" name="us-gaap:EmployeeStockOwnershipPlanESOPPolicy"><p id="xdx_84B_eus-gaap--EmployeeStockOwnershipPlanESOPPolicy_zh3AyswVz5Te" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="text-decoration: underline"><span id="xdx_860_zYj1IsvzQ9N5">Employee
Benefit/Liability</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Liabilities
arising in respect of wages and salaries, accumulated annual leave, accumulated long service leave and any other employee benefits expected
to be settled within twelve months of the reporting date are measured based on the employee&#8217;s remuneration rates applicable at
the reporting date. All other employee benefit liabilities are measured at the present value of the estimated future cash outflow to
be made in respect of services provided by employees up to the reporting date. All employee liabilities are owed within the next twelve
months.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-07-012021-06-30" escape="true" name="PPCB:GoodsAndServiceTaxPolicyTextBlock"><p id="xdx_84B_ecustom--GoodsAndServiceTaxPolicyTextBlock_zXRt2fYMNCde" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="text-decoration: underline"><span id="xdx_861_zXbULMoiEBt1">Australian
Goods and Services Tax (&#8220;GST&#8221;)</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Revenues,
expenses and balance sheet items are recognized net of the amount of GST, except payable and receivable balances which are shown inclusive
of GST. The GST incurred is payable on revenues to, and recoverable on purchases from, the Australian Taxation Office.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Cash
flows are presented in the statements of cash flow on a gross basis, except for the GST component of investing and financing activities,
which are disclosed as operating cash flows.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">As
of June 30, 2021 and 2020, the Company was owed $<span id="xdx_908_eus-gaap--ValueAddedTaxReceivableCurrent_c20210630_pp0p0" title="Value added tax receivable"><ix:nonFraction name="us-gaap:ValueAddedTaxReceivableCurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,341</ix:nonFraction></span> and $<span id="xdx_90B_eus-gaap--ValueAddedTaxReceivableCurrent_c20200630_pp0p0" title="Value added tax receivable"><ix:nonFraction name="us-gaap:ValueAddedTaxReceivableCurrent" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,015</ix:nonFraction></span>, respectively, from the Australian Taxation Office. These amounts were
fully collected subsequent to the balance sheet reporting dates.</span></p>

</ix:nonNumeric><p id="xdx_858_znfh9MJCo1af" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<ix:exclude><!-- Field: Page; Sequence: 101; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>PROPANC
BIOPHARMA, INC. AND SUBSIDIARY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>June
30, 2021 and 2020</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<ix:nonNumeric contextRef="From2020-07-012021-06-30" escape="true" name="us-gaap:DerivativesReportingOfDerivativeActivity"><p id="xdx_84C_eus-gaap--DerivativesReportingOfDerivativeActivity_zPkIWm6mIOdb" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="text-decoration: underline"><span id="xdx_866_z26UFsPBAyH9">Derivative
Instruments</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">ASC
Topic 815, <i>Derivatives and Hedging</i> (&#8220;ASC Topic 815&#8221;), establishes accounting and reporting standards for derivative
instruments and for hedging activities by requiring that all derivatives be recognized in the balance sheet and measured at fair value.
Gains or losses resulting from changes in the fair value of derivatives are recognized in earnings. On the date of conversion or payoff
of debt, the Company records the fair value of the conversion shares, removes the fair value of the related derivative liability, removes
any discounts and records a net gain or loss on debt extinguishment. On July 1, 2019 the Company adopted ASU 2017-11 under which down-round
Features in Financial Instruments will no longer cause derivative treatment. The Company applies the modified prospective method of adoption.
There were no cumulative effects on adoption.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-07-012021-06-30" escape="true" name="PPCB:ConvertibleNotesPolicyTextBlock"><p id="xdx_84D_ecustom--ConvertibleNotesPolicyTextBlock_zxajUQ2alEZ1" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="text-decoration: underline"><span id="xdx_86C_zoAjEhAqQMW4">Convertible
Notes With Variable Conversion Options</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 29.15pt; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
Company has entered into convertible notes, some of which contain variable conversion options, whereby the outstanding principal and
accrued interest may be converted, by the holder, into common shares at a fixed discount to the price of the common stock at or around
the time of conversion. The Company treats these convertible notes as stock settled debt under ASC 480, &#8220;<i>Distinguishing Liabilities
from Equity</i>&#8221; and measures the fair value of the notes at the time of issuance, which is the result of the share price discount
at the time of conversion and records the put premium as interest expense.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-07-012021-06-30" escape="true" name="us-gaap:IncomeTaxPolicyTextBlock"><p id="xdx_843_eus-gaap--IncomeTaxPolicyTextBlock_zN0Zlr1p7J9g" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="text-decoration: underline"><span id="xdx_86C_zPUZwyGp2WM5">Income
Taxes</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 29.15pt; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
Company is governed by Australia and United States income tax laws, which are administered by the Australian Taxation Office and the
United States Internal Revenue Service, respectively. The Company follows ASC 740 &#8220;<i>Accounting for Income Taxes</i>,&#8221; when
accounting for income taxes, which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred
income tax assets and liabilities are computed annually for temporary differences between the financial statements and tax bases of assets
and liabilities that will result in taxable or deductible amounts in the future based on enacted tax laws and rates applicable to the
periods in which the differences are expected to affect taxable income. Valuation allowances are established when necessary to reduce
deferred tax assets to the amount expected to be realized. Income tax expense is the tax payable or refundable for the period plus or
minus the change during the period in deferred tax assets and liabilities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 29.15pt; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
Company follows ASC 740, Sections 25 through 60, &#8220;<i>Accounting for Uncertainty in Income Taxes</i>.&#8221; These sections provide
detailed guidance for the financial statement recognition, measurement and disclosure of uncertain tax positions recognized in the financial
statements. Tax positions must meet a &#8220;more-likely-than-not&#8221; recognition threshold at the effective date to be recognized
upon the adoption of ASC 740 and in subsequent periods.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-07-012021-06-30" escape="true" name="us-gaap:ResearchAndDevelopmentExpensePolicy"><p id="xdx_84F_eus-gaap--ResearchAndDevelopmentExpensePolicy_zQCpNdwyFt72" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="text-decoration: underline"><span id="xdx_861_zChCCKk1NlA1">Research
and Development Costs and Tax Credits</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">In
accordance with ASC 730-10, <i>&#8220;Research and Development-Overall,&#8221;</i> research and development costs are expensed when incurred.
Total research and development costs for the fiscal years ended June 30, 2021 and 2020 were $<span id="xdx_909_eus-gaap--ResearchAndDevelopmentExpense_c20200701__20210630_pp0p0" title="Research and development costs"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">230,956</ix:nonFraction></span> and $<span id="xdx_90A_eus-gaap--ResearchAndDevelopmentExpense_pp0p0_c20190701__20200630_z8D3lSanDVD5" title="Research and development costs"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">179,987</ix:nonFraction></span>, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
Company may apply for research and development tax concessions with the Australian Taxation Office on an annual basis. Although the amount
is possible to estimate at year end, the Australian Taxation Office may reject or materially alter the claim amount. Accordingly, the
Company does not recognize the benefit of the claim amount until cash receipt since collectability is not certain until such time. The
tax concession is a refundable credit. If the Company has net income, then the Company can receive the credit which reduces its income
tax liability. If the Company has net losses, then the Company may still receive a cash payment for the credit, however, the Company&#8217;s
net operating loss carryforwards are reduced by the gross equivalent loss that would produce the credit amount when the income tax rate
is applied to that gross amount. The concession is recognized as tax benefit, in operations, upon receipt.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">During
each of the fiscal years ended June 30, 2021 and 2020, the Company applied for, and received from the Australian Taxation Office, a research
and development tax credit in the amount of $<span id="xdx_905_eus-gaap--IncomeTaxExpenseBenefit_iN_pp0p0_di_c20200701__20210630_zk1027s4V9Fe" title="Tax credits"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">113,415</ix:nonFraction> </span>and $<span id="xdx_901_eus-gaap--IncomeTaxExpenseBenefit_iN_pp0p0_di_c20190701__20200630_zG6ZTffrCXsj"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">134,728</ix:nonFraction></span>, respectively, which is reflected as a tax benefit in the accompanying
consolidated statements of operations and comprehensive income (loss).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-07-012021-06-30" escape="true" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy"><p id="xdx_846_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zaUFPhFSnEja" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="text-decoration: underline"><span id="xdx_861_zBj3dM4Ckci3">Stock
Based Compensation</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
Company records stock-based compensation in accordance with ASC 718, &#8220;<i>Stock Compensation</i>&#8221;. ASC 718 requires the fair
value of all stock-based employee compensation awarded to employees to be recorded as an expense over the shorter of the service period
or the vesting period. The Company values employee and non-employee stock-based compensation at fair value using the Black-Scholes Option
Pricing Model.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<ix:exclude><!-- Field: Page; Sequence: 102; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>PROPANC
BIOPHARMA, INC. AND SUBSIDIARY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>June
30, 2021 and 2020</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
Company adopted ASU 2018-07 and accounts for non-employee share-based awards in accordance with the measurement and recognition criteria
of ASC 718 and recognizes the fair value of such awards over the service period. The Company used the modified prospective method of
adoption. There was no cumulative effect of adoption on July 1, 2019.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-07-012021-06-30" escape="true" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock"><p id="xdx_84A_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zLQNRYxs3VV5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="text-decoration: underline"><span id="xdx_86E_zEV4U1sMubQc">Revenue
Recognition</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
Company adopted and implemented on July 1, 2018, ASC 606 &#8211; Revenue from Contracts with Customers (&#8220;ASC 606&#8221;). ASC 606
did not have a material impact on the consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Upon
implementation of ASC 606, the Company recognizes revenue in accordance with that core principle by applying the following steps:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Step
1: Identify the contract(s) with a customer.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Step
2: Identify the performance obligations in the contract.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Step
3: Determine the transaction price.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Step
4: Allocate the transaction price to the performance obligations in the contract.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Step
5: Recognize revenue when (or as) the entity satisfies a performance obligation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 29.15pt; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Subject
to these criteria, the Company intends to recognize revenue relating to royalties on product sales in the period in which the sale occurs
and the royalty term has begun.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-07-012021-06-30" escape="true" name="us-gaap:LegalCostsPolicyTextBlock"><p id="xdx_846_eus-gaap--LegalCostsPolicyTextBlock_z7Q8kazLnfD2" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="text-decoration: underline"><span id="xdx_86A_zAg6XnkCAfwa">Legal
Expenses</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">All
legal costs for litigation are charged to expense as incurred.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-07-012021-06-30" escape="true" name="us-gaap:LesseeLeasesPolicyTextBlock"><p id="xdx_848_eus-gaap--LesseeLeasesPolicyTextBlock_zdlobmuL7B78" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="text-decoration: underline"><span id="xdx_86D_zjYfYbFZC052">Leases</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">In
February 2016, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued ASU 2016-02, <i>Leases</i> (Topic 842). The updated
guidance requires lessees to recognize lease assets and lease liabilities for most operating leases. In addition, the updated guidance
requires that lessors separate lease and non-lease components in a contract in accordance with the new revenue guidance in ASC 606. This
guidance is effective for interim and annual reporting periods beginning after December 15, 2018. The Company adopted this guidance effective
July 1, 2019.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">On
July 1, 2019, the Company adopted ASU No. 2016-02, applying the package of practical expedients to leases that commenced before the effective
date whereby the Company elected to not reassess the following: (i) whether any expired or existing contracts contain leases and; (ii)
initial direct costs for any existing leases. For contracts entered into on or after the effective date, at the inception of a contract
the Company assessed whether the contract is, or contains, a lease. The Company&#8217;s assessment is based on: (1) whether the contract
involves the use of a distinct identified asset, (2) whether we obtain the right to substantially all the economic benefit from the use
of the asset throughout the period, and (3) whether it has the right to direct the use of the asset. The Company will allocate the consideration
in the contract to each lease component based on its relative stand-alone price to determine the lease payments.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Operating
lease ROU assets represents the right to use the leased asset for the lease term and operating lease liabilities are recognized based
on the present value of future minimum lease payments over the lease term at commencement date. As most leases do not provide an implicit
rate, the Company use an incremental borrowing rate based on the information available at the adoption date in determining the present
value of future payments. Lease expense for minimum lease payments is amortized on a straight-line basis over the lease term and is included
in general and administrative expenses in the consolidated statements of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-07-012021-06-30" escape="true" name="us-gaap:EarningsPerSharePolicyTextBlock"><p id="xdx_844_eus-gaap--EarningsPerSharePolicyTextBlock_zz34xJHutc16" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="text-decoration: underline"><span id="xdx_864_zK6mVblSbdGl">Basic
and Diluted Net Loss Per Common Share</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Basic
net loss per share is computed by dividing the net loss by the weighted average number of common shares outstanding during the period.
Diluted net loss per common share is computed by dividing the net loss by the weighted average number of common shares outstanding for
the period and, if dilutive, potential common shares outstanding during the period. Potentially dilutive securities consist of the incremental
common shares issuable upon exercise of common stock equivalents such as stock options, warrants and convertible debt instruments. Potentially
dilutive securities are excluded from the computation if their effect is anti-dilutive. As a result, the basic and diluted per share
amounts for all periods presented are identical. <span id="xdx_903_eus-gaap--DebtInstrumentConvertibleTermsOfConversionFeature_c20200701__20210630_zq4qmcOL3Smg" title="Debt conversion percentage, description"><ix:nonNumeric contextRef="From2020-07-012021-06-30" name="us-gaap:DebtInstrumentConvertibleTermsOfConversionFeature">Each holder of the notes has agreed to a <span id="xdx_904_eus-gaap--DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_pid_dp_uPure_c20200701__20210630_zzJU4tiDdpIk" title="Debt conversion percentage"><ix:nonFraction name="us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">4.99</ix:nonFraction></span>% beneficial ownership conversion limitation
(subject to certain noteholders&#8217; ability to increase such limitation to 9.99% upon 60 days&#8217; notice to the Company)</ix:nonNumeric></span>, and each
note may not be converted during the first six-month period from the date of issuance. Such securities are considered dilutive securities
which were excluded from the computation since the effect is anti-dilutive.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<ix:exclude><!-- Field: Page; Sequence: 103; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>PROPANC
BIOPHARMA, INC. AND SUBSIDIARY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>June
30, 2021 and 2020</b></span></p>

<ix:nonNumeric contextRef="From2020-07-012021-06-30" escape="true" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"><p id="xdx_898_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zp7ZAEmlQrYd" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span id="xdx_8B9_zWwXX59WoQ27" style="display: none">SCHEDULE OF DILUTIVE SECURITIES EXCLUDED FROM COMPUTATION</span>&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 100%; margin-right: auto">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>June
    30, 2021</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>June
    30, 2020</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 64%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Stock
    Options</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td id="xdx_981_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20200701__20210630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_zRF3jRJ6r1te" title="Antidilutive securities excluded from computation of earnings per share" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2020-07-012021-06-30_us-gaap_EmployeeStockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">59</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td id="xdx_987_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20190701__20200630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_zloQygdbzAlh" title="Antidilutive securities excluded from computation of earnings per share" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2019-07-012020-06-30_us-gaap_EmployeeStockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">60</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Stock
    Warrants</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td id="xdx_98E_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20200701__20210630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zNOzT456LxB6" title="Antidilutive securities excluded from computation of earnings per share" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2020-07-012021-06-30_us-gaap_WarrantMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">121,329</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td id="xdx_98D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20190701__20200630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zNtlaS94tWTe" title="Antidilutive securities excluded from computation of earnings per share" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2019-07-012020-06-30_us-gaap_WarrantMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">151,171</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Unvested
    restricted stock</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td id="xdx_986_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20200701__20210630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--UnvestedRestrictedStockMember_zafhpGNhbIA6" title="Antidilutive securities excluded from computation of earnings per share" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2020-07-012021-06-30_custom_UnvestedRestrictedStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">59</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td id="xdx_982_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20190701__20200630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--UnvestedRestrictedStockMember_zLMxtEOeqQAc" title="Antidilutive securities excluded from computation of earnings per share" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2019-07-012020-06-30_custom_UnvestedRestrictedStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">59</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Convertible
    Debt</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td id="xdx_984_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20200701__20210630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertibleDebtSecuritiesMember_zx6G7fcxhV22" title="Antidilutive securities excluded from computation of earnings per share" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2020-07-012021-06-30_us-gaap_ConvertibleDebtSecuritiesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">12,416,972</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td id="xdx_981_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20190701__20200630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertibleDebtSecuritiesMember_z4ty7l1bgPGc" title="Antidilutive securities excluded from computation of earnings per share" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2019-07-012020-06-30_us-gaap_ConvertibleDebtSecuritiesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">439,113</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Total</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td id="xdx_98D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20200701__20210630_zS2qhAKAAjyf" title="Antidilutive securities excluded from computation of earnings per share" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">12,538,419</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td id="xdx_986_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20190701__20200630_zsjYE0XRyHH4" title="Antidilutive securities excluded from computation of earnings per share" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">590,403</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8A2_z3r805ucvGn" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-07-012021-06-30" escape="true" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock"><p id="xdx_84F_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zaCjb7rqrmle" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="text-decoration: underline"><span id="xdx_864_zqGyiHQTKivb">Recent
Accounting Pronouncements</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">We
have reviewed the FASB issued ASU accounting pronouncements and interpretations thereof that have effectiveness dates during the periods
reported and in future periods. We have carefully considered the new pronouncements that alter previous generally accepted accounting
principles and do not believe that any new or modified principles will have a material impact on the Company&#8217;s reported financial
position or operations in the near term with the exception of those disclosed below. The applicability of any standard is subject
to the formal review of the Company&#8217;s financial management.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In
August 2020, the FASB issued ASU 2020-06, &#8220;Debt &#8211; Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives
and Hedging &#8211; Contracts in Entity&#8217;s Own Equity (Subtopic 815-40)&#8221;. This ASU reduces the number of accounting models
for convertible debt instruments and convertible preferred stock. As well as amend the guidance for the derivatives scope exception for
contracts in an entity&#8217;s own equity to reduce form-over-substance-based accounting conclusions. In addition, this ASU improves
and amends the related EPS guidance. This standard is effective for us on July 1, 2022, including interim periods within those fiscal
years. Adoption is either a modified retrospective method or a fully retrospective method of transition. The Company is currently assessing
the impact the new guidance will have on our consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

</ix:nonNumeric></ix:nonNumeric><ix:nonNumeric contextRef="From2020-07-012021-06-30" escape="true" name="us-gaap:SubstantialDoubtAboutGoingConcernTextBlock"><p id="xdx_808_eus-gaap--SubstantialDoubtAboutGoingConcernTextBlock_zrfc5XGh9z22" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>NOTE
2 &#8211; <span id="xdx_82D_zR4TUUmJtQxb">GOING CONCERN</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
accompanying consolidated financial statements have been prepared in conformity with US GAAP, which contemplate continuation of the Company
as a going concern. For the fiscal year ended June 30, 2021, the Company had <span id="xdx_90E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_doxL_c20200701__20210630_zb0oM1K9Z757" title="::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl0984">no
</span></span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">revenues, had a net loss of $<span id="xdx_904_eus-gaap--ProfitLoss_iN_pp0p0_di_c20200701__20210630_zE5KyvuIa4Tc"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">2,025,947</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">and had net cash used in operations
of $<span id="xdx_90B_eus-gaap--NetCashProvidedByUsedInOperatingActivities_iN_pp0p0_di_c20200701__20210630_zZZ2qqLukVg7"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">1,145,264</ix:nonFraction></span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">.
Additionally, as of June 30, 2021, the Company had a working capital deficit, stockholders&#8217; deficit and accumulated deficit of
$<span id="xdx_90B_ecustom--WorkingCapitalDeficit_c20210630_pp0p0"><ix:nonFraction name="PPCB:WorkingCapitalDeficit" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,074,078</ix:nonFraction></span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">,
$<span id="xdx_90F_eus-gaap--StockholdersEquity_iNI_pp0p0_di_c20210630_zy1eQU64tRIg"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">3,067,573</ix:nonFraction></span></span><span style="font: 10pt Times New Roman, Times, Serif">,
and $<span id="xdx_90B_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_pp0p0_di_c20210630_z63t6FGbdE9k"><ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">58,199,466</ix:nonFraction></span></span><span style="font: 10pt Times New Roman, Times, Serif">,
</span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">respectively. It is management&#8217;s opinion that these
conditions raise substantial doubt about the Company&#8217;s ability to continue as a going concern for a period of at least twelve months
from the date of this filing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
consolidated financial statements do not include any adjustments to reflect the possible future effect on the recoverability and classification
of assets or the amounts and classifications of liabilities that may result from the outcome of this uncertainty.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Successful
completion of the Company&#8217;s development program and, ultimately, the attainment of profitable operations are dependent upon future
events, including obtaining adequate financing to fulfill its development activities, acceptance of the Company&#8217;s patent applications,
obtaining additional sources of suitable and adequate financing and ultimately achieving a level of sales adequate to support the Company&#8217;s
cost structure and business plan. The Company&#8217;s ability to continue as a going concern is also dependent on its ability to further
develop and execute on its business plan. However, there can be no assurances that any or all of these endeavors will be successful.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">In
March 2020, the outbreak of COVID-19 (coronavirus) caused by a novel strain of the coronavirus was recognized as a pandemic by the World
Health Organization, and the outbreak has become increasingly widespread in the United States, Europe and Australia, including in each
of the areas in which the Company operates. The COVID-19 (coronavirus) outbreak has had a notable impact on general economic conditions,
including but not limited to the temporary closures of many businesses, &#8220;shelter in place&#8221; and other governmental regulations,
reduced business and consumer spending due to both job losses, reduced investing activity and M&amp;A transactions, among many other
effects attributable to the COVID-19 (coronavirus), and there continue to be many unknowns. While to date the Company has not been required
to stop operating, management is evaluating its use of its office space, virtual meetings and the like. The Company continues to monitor
the impact of the COVID-19 (coronavirus) outbreak closely. The extent to which the COVID-19 (coronavirus) outbreak will impact our operations,
ability to obtain financing or future financial results is uncertain.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-07-012021-06-30" escape="true" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock"><p id="xdx_803_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zHEs022u6Pnb" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>NOTE
3 &#8211; <span id="xdx_821_zas7Q1BDZ6t1">PROPERTY AND EQUIPMENT</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<ix:nonNumeric contextRef="From2020-07-012021-06-30" escape="true" name="us-gaap:PropertyPlantAndEquipmentTextBlock"><p id="xdx_895_eus-gaap--PropertyPlantAndEquipmentTextBlock_zmgFlYHfXWwc" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Property
and equipment consist of the following as of June 30,</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;<span id="xdx_8BB_zh0whEB5uiQ7" style="display: none">SCHEDULE OF PROPERTY AND EQUIPMENT</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 100%; margin-right: auto">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" id="xdx_490_20210630_zLQ8erGmgJRd" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>2021</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" id="xdx_493_20200630_zCZkbynpGDZc" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>2020</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_maPPAENzBVB_zZKQJHKCiSUf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 64%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Office
    equipment at cost</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">28,623</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">26,299</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_msPPAENzBVB_zh2Xl4FSeynh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Less:
    Accumulated depreciation</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(<ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">24,368</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(<ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">20,552</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--PropertyPlantAndEquipmentNet_iTI_pp0p0_mtPPAENzBVB_zTBB9pS58rT2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Total
    property, plant, and equipment</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,255</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,747</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Depreciation
expense for the years ended June 30, 2021 and 2020 were $<span id="xdx_908_eus-gaap--Depreciation_c20200701__20210630_pp0p0" title="Depreciation expense"><ix:nonFraction name="us-gaap:Depreciation" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,993</ix:nonFraction></span> and $<span id="xdx_908_eus-gaap--Depreciation_pp0p0_c20190701__20200630_zlHMWyp9Oy4" title="Depreciation expense"><ix:nonFraction name="us-gaap:Depreciation" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,473</ix:nonFraction></span>, respectively</span></p>
<!-- Field: Split-Segment; Name: 001 -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<ix:exclude><!-- Field: Page; Sequence: 104; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>PROPANC
BIOPHARMA, INC. AND SUBSIDIARY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>June
30, 2021 and 2020</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

</ix:nonNumeric></ix:nonNumeric><ix:nonNumeric contextRef="From2020-07-012021-06-30" escape="true" name="PPCB:DueToFormerDirectorRelatedPartyDisclosureTextBlock"><p id="xdx_801_ecustom--DueToFormerDirectorRelatedPartyDisclosureTextBlock_zIiAd8JaTtW8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>NOTE
4 &#8211; <span id="xdx_82A_z24o9PK9MNna">DUE TO FORMER DIRECTOR - RELATED PARTY</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Due
to former director - related party represents unsecured advances made primarily by a former director for operating expenses on behalf
of the Company such as intellectual property and formation expenses. The expenses were paid for on behalf of the Company and are due
upon demand. The Company is currently not being charged interest under these advances. The total amount owed the former director at June
30, 2021 and 2020 is <span id="xdx_904_eus-gaap--DueToRelatedPartiesCurrent_c20210630_pp0p0" title="Due to directors - related parties">$<ix:nonFraction name="us-gaap:DueToRelatedPartiesCurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">33,347</ix:nonFraction></span> and <span id="xdx_907_eus-gaap--DueToRelatedPartiesCurrent_c20200630_pp0p0" title="Due to directors - related parties">$<ix:nonFraction name="us-gaap:DueToRelatedPartiesCurrent" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">30,639</ix:nonFraction></span>, respectively. The Company plans to repay the advances as its cash resources allow (see Note
10).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-07-012021-06-30" escape="true" name="PPCB:LoansAndNotesPayableDisclosureTextBlock"><p id="xdx_80C_ecustom--LoansAndNotesPayableDisclosureTextBlock_zOI11SLk00V4" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>NOTE
5 &#8211; <span id="xdx_822_zYKwxJFs54dj">LOANS AND NOTES PAYABLE</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="text-decoration: underline">Loan
from Former Director - Related Party</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Loan
from the Company&#8217;s former director at June 30, 2021 and 2020 were <span id="xdx_909_eus-gaap--LoansPayable_c20210630__srt--TitleOfIndividualAxis__custom--DirectorsAndOfficerMember_pp0p0" title="Loans payable">$<ix:nonFraction name="us-gaap:LoansPayable" contextRef="AsOf2021-06-30_custom_DirectorsAndOfficerMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">55,500</ix:nonFraction></span> and <span id="xdx_908_eus-gaap--LoansPayable_c20200630__srt--TitleOfIndividualAxis__custom--DirectorsAndOfficerMember_pp0p0" title="Loans payable">$<ix:nonFraction name="us-gaap:LoansPayable" contextRef="AsOf2020-06-30_custom_DirectorsAndOfficerMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">50,993</ix:nonFraction></span>, respectively. The loan bear no interest
and is payable on demand. The Company did not repay any amount on this loan during the years ended June 30, 2021 and 2020, respectively,
(see Note 10).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-07-012021-06-30" escape="true" name="us-gaap:DebtDisclosureTextBlock"><p id="xdx_802_eus-gaap--DebtDisclosureTextBlock_zeaWrDcF96f" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>NOTE
6 &#8211; <span id="xdx_82C_zpU7oKjSzdRl">CONVERTIBLE NOTES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<ix:nonNumeric contextRef="From2020-07-012021-06-30" escape="true" name="us-gaap:ConvertibleDebtTableTextBlock"><p id="xdx_89C_eus-gaap--ConvertibleDebtTableTextBlock_ziVRkGrZePIh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
Company&#8217;s convertible notes outstanding at June 30, 2021 and 2020 were as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; display: none; color: Black">&#160;<span id="xdx_8BA_zvU50JaaWwyd">SCHEDULE OF CONVERTIBLE NOTES</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 100%; margin-right: auto">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" id="xdx_494_20210630_zsrmn1iivXZg" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>June
    30, 2021</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" id="xdx_49B_20200630_zuQpL0kHaTa" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>June
    30, 2020</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td></tr>
  <tr id="xdx_403_eus-gaap--DebtInstrumentCarryingAmount_iI_pp0p0_maLTDzcuB_zuxg3RTxe1Li" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 64%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Convertible
    notes and debenture</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:DebtInstrumentCarryingAmount" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">400,128</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:DebtInstrumentCarryingAmount" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,029,496</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--DebtInstrumentUnamortizedDiscount_iNI_pp0p0_di_msLTDzcuB_zuUODCdu4b44" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Unamortized
    discounts</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(<ix:nonFraction name="us-gaap:DebtInstrumentUnamortizedDiscount" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">6,139</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(<ix:nonFraction name="us-gaap:DebtInstrumentUnamortizedDiscount" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">126,667</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td></tr>
  <tr id="xdx_40C_eus-gaap--DepositLiabilitiesAccruedInterest_iI_pp0p0_maLTDzcuB_zPzWSAs6KWd3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Accrued
    interest</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:DepositLiabilitiesAccruedInterest" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">34,098</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:DepositLiabilitiesAccruedInterest" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">80,101</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--DebtInstrumentUnamortizedPremium_iI_pp0p0_maLTDzcuB_zEJVrrhbTgpb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Premium,
    net</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:DebtInstrumentUnamortizedPremium" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">196,496</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:DebtInstrumentUnamortizedPremium" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">574,804</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--LongTermDebt_iTI_pp0p0_mtLTDzcuB_z7Pcz6TEePia" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Convertible
    notes, net</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:LongTermDebt" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">624,583</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:LongTermDebt" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,557,734</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8A9_z1kJBtc4kiUk" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b><i>Eagle
Equities Financing Agreements</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><i>December
29, 2017 Securities Purchase Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
Company entered into an executory contract on December 29, 2017, whereby the Company entered into a securities purchase agreement with
Eagle Equities, pursuant to which Eagle Equities purchased a convertible promissory note (the &#8220;December 2017 Eagle Note&#8221;)
from the Company in the aggregate principal amount of <span id="xdx_902_eus-gaap--DebtInstrumentFaceAmount_c20171229__us-gaap--TypeOfArrangementAxis__custom--DecemberTwentyNineTwoThousandAndSeventeenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--DecemberTwoThousandAndSeventeenEagleNoteMember_pp0p0" title="Convertible debt principal amount">$<ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2017-12-29_custom_DecemberTwentyNineTwoThousandAndSeventeenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_DecemberTwoThousandAndSeventeenEagleNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">532,435</ix:nonFraction></span>, with principal and the interest thereon convertible into shares of the
Company&#8217;s common stock at the option of Eagle Equities at any time. The December 2017 Eagle Note contained an original issue discount
of <span id="xdx_904_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pp0p0_c20171229__us-gaap--TypeOfArrangementAxis__custom--DecemberTwentyNineTwoThousandAndSeventeenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--DecemberTwoThousandAndSeventeenEagleNoteMember_zwtn2dDM4hIj" title="Original issue discount">$<ix:nonFraction name="us-gaap:DebtInstrumentUnamortizedDiscount" contextRef="AsOf2017-12-29_custom_DecemberTwentyNineTwoThousandAndSeventeenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_DecemberTwoThousandAndSeventeenEagleNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">25,354</ix:nonFraction></span> such that the purchase price was <span id="xdx_902_eus-gaap--ProceedsFromConvertibleDebt_c20171227__20171229__us-gaap--TypeOfArrangementAxis__custom--DecemberTwentyNineTwoThousandAndSixteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--DecemberTwoThousandAndSeventeenEagleNoteMember_pp0p0" title="Proceeds from convertible debt">$<ix:nonFraction name="us-gaap:ProceedsFromConvertibleDebt" contextRef="From2017-12-272017-12-29_custom_DecemberTwentyNineTwoThousandAndSixteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_DecemberTwoThousandAndSeventeenEagleNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">507,081</ix:nonFraction></span>. The maturity date of the December 2017 Eagle Note was <span id="xdx_903_eus-gaap--DebtInstrumentMaturityDate_dd_c20171227__20171229__us-gaap--TypeOfArrangementAxis__custom--DecemberTwentyNineTwoThousandAndSixteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--DecemberTwoThousandAndSeventeenEagleNoteMember_z4DqQhh6ygF1" title="Debt maturity date"><ix:nonNumeric contextRef="From2017-12-272017-12-29_custom_DecemberTwentyNineTwoThousandAndSixteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_DecemberTwoThousandAndSeventeenEagleNoteMember" format="ixt:datemonthdayyearen" name="us-gaap:DebtInstrumentMaturityDate">December 29, 2018</ix:nonNumeric></span>. The Company
was in discussions with Eagle Equities to extend the maturity date. The December 2017 Eagle Note bore interest at a rate of <span id="xdx_901_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20171229__us-gaap--TypeOfArrangementAxis__custom--DecemberTwentyNineTwoThousandAndSeventeenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--DecemberTwoThousandAndSeventeenEagleNoteMember_zrEXKmTQfmjl" title="Debt instrument, interest rate, stated percentage"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2017-12-29_custom_DecemberTwentyNineTwoThousandAndSeventeenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_DecemberTwoThousandAndSeventeenEagleNoteMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">8</ix:nonFraction>%</span> per annum,
which interest were to be paid by the Company to Eagle Equities in shares of the Company&#8217;s common stock upon receipt of a notice
of conversion by the Company from Eagle Equities at any time. The Company recorded <span id="xdx_904_eus-gaap--InterestPayableCurrentAndNoncurrent_c20190630__us-gaap--TypeOfArrangementAxis__custom--DecemberTwentyNineTwoThousandAndSixteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--DecemberTwoThousandAndSeventeenEagleNoteMember_pp0p0" title="Accrued interest">$<ix:nonFraction name="us-gaap:InterestPayableCurrentAndNoncurrent" contextRef="AsOf2019-06-30_custom_DecemberTwentyNineTwoThousandAndSixteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_DecemberTwoThousandAndSeventeenEagleNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">20,065</ix:nonFraction></span> of accrued interest for the December 2017
Eagle Note and total principal outstanding as of June 30, 2019 under the December 2017 Eagle Note was <span id="xdx_902_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20180701__20190630__us-gaap--TypeOfArrangementAxis__custom--DecemberTwentyNineTwoThousandAndSeventeenSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--DecemberTwoThousandAndSeventeenEagleNoteMember_pp0p0" title="Debt conversion of converted amount">$<ix:nonFraction name="us-gaap:DebtConversionConvertedInstrumentAmount1" contextRef="From2018-07-012019-06-30_custom_DecemberTwentyNineTwoThousandAndSeventeenSecuritiesPurchaseAgreementMember_custom_DecemberTwoThousandAndSeventeenEagleNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">171,965</ix:nonFraction></span> following conversion of
<span id="xdx_906_eus-gaap--DebtInstrumentFaceAmount_c20190630__us-gaap--TypeOfArrangementAxis__custom--DecemberTwentyNineTwoThousandAndSixteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--DecemberTwoThousandAndSeventeenEagleNoteMember_pp0p0" title="Convertible debt principal amount">$<ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2019-06-30_custom_DecemberTwentyNineTwoThousandAndSixteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_DecemberTwoThousandAndSeventeenEagleNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">360,470</ix:nonFraction></span> of principal and <span id="xdx_903_eus-gaap--InterestPayableCurrentAndNoncurrent_c20190630__us-gaap--TypeOfArrangementAxis__custom--DecemberTwentyNineTwoThousandAndSeventeenSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--DecemberTwoThousandAndSeventeenEagleNoteMember_pp0p0" title="Accrued interest">$<ix:nonFraction name="us-gaap:InterestPayableCurrentAndNoncurrent" contextRef="AsOf2019-06-30_custom_DecemberTwentyNineTwoThousandAndSeventeenSecuritiesPurchaseAgreementMember_custom_DecemberTwoThousandAndSeventeenEagleNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">43,535</ix:nonFraction></span> of accrued interest during the fiscal year ended June 30, 2019. The Company recorded <span id="xdx_90A_eus-gaap--InterestPayableCurrentAndNoncurrent_c20200630__us-gaap--TypeOfArrangementAxis__custom--DecemberTwentyNineTwoThousandAndSeventeenSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--DecemberTwoThousandAndSeventeenEagleNoteMember_pp0p0" title="Accrued interest">$<ix:nonFraction name="us-gaap:InterestPayableCurrentAndNoncurrent" contextRef="AsOf2020-06-30_custom_DecemberTwentyNineTwoThousandAndSeventeenSecuritiesPurchaseAgreementMember_custom_DecemberTwoThousandAndSeventeenEagleNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">0</ix:nonFraction></span> of accrued
interest for the December 2017 Eagle Note and total principal outstanding as of June 30, 2020 under the December 2017 Eagle Note was
<span id="xdx_901_eus-gaap--DebtInstrumentFaceAmount_c20200630__us-gaap--TypeOfArrangementAxis__custom--DecemberTwentyNineTwoThousandAndSeventeenSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--DecemberTwoThousandAndSeventeenEagleNoteMember_pp0p0" title="Convertible debt principal amount">$<ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2020-06-30_custom_DecemberTwentyNineTwoThousandAndSeventeenSecuritiesPurchaseAgreementMember_custom_DecemberTwoThousandAndSeventeenEagleNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">0</ix:nonFraction></span> following conversion of the remaining principal <span id="xdx_90A_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20190701__20200630__us-gaap--TypeOfArrangementAxis__custom--DecemberTwentyNineTwoThousandAndSeventeenSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--DecemberTwoThousandAndSeventeenEagleNoteMember_pp0p0" title="Debt conversion of converted amount">$<ix:nonFraction name="us-gaap:DebtConversionConvertedInstrumentAmount1" contextRef="From2019-07-012020-06-30_custom_DecemberTwentyNineTwoThousandAndSeventeenSecuritiesPurchaseAgreementMember_custom_DecemberTwoThousandAndSeventeenEagleNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">171,965</ix:nonFraction></span> and <span id="xdx_90E_eus-gaap--InterestPayableCurrentAndNoncurrent_c20200630__us-gaap--TypeOfArrangementAxis__custom--DecemberTwentyNineTwoThousandAndSeventeenSecuritiesPurchaseAgreementMember_pp0p0" title="Accrued interest">$<ix:nonFraction name="us-gaap:InterestPayableCurrentAndNoncurrent" contextRef="AsOf2020-06-30_custom_DecemberTwentyNineTwoThousandAndSeventeenSecuritiesPurchaseAgreementMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">24,751</ix:nonFraction></span> of accrued interest during the fiscal year to June 30, 2020.
Accordingly, there was <span id="xdx_909_eus-gaap--ConvertibleNotesPayable_iI_pp0p0_do_c20200630__us-gaap--TypeOfArrangementAxis__custom--DecemberTwentyNineTwoThousandAndSixteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember_zAjzDA5WXnq8" title="Convertible debt outstanding balance"><ix:nonFraction name="us-gaap:ConvertibleNotesPayable" contextRef="AsOf2020-06-30_custom_DecemberTwentyNineTwoThousandAndSixteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember" format="ixt-sec:numwordsen" decimals="0" scale="0" unitRef="USD">no</ix:nonFraction></span> outstanding balance as of June 30, 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><i>July
13, 2018 Securities Purchase Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Effective
July 13, 2018, the Company entered into a securities purchase agreement with Eagle Equities, pursuant to which Eagle Equities purchased
a convertible promissory note (the &#8220;July 2018 Note&#8221;) from the Company in the aggregate principal amount of <span id="xdx_90F_eus-gaap--DebtInstrumentFaceAmount_c20180713__us-gaap--TypeOfArrangementAxis__custom--JulyThirteenTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandEighteenEagleNoteMember_pp0p0" title="Convertible debt principal amount">$<ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2018-07-13_custom_JulyThirteenTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_JulyTwoThousandEighteenEagleNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">75,000</ix:nonFraction></span>, such
principal and the interest thereon convertible into shares of the Company&#8217;s common stock at the option of Eagle Equities any time
after the six month anniversary of the July 2018 Eagle Note. The transaction closed on July 16, 2018 and on July 19, 2018 the Company
received proceeds of <span id="xdx_900_eus-gaap--ProceedsFromConvertibleDebt_pp0p0_c20180718__20180719__us-gaap--TypeOfArrangementAxis__custom--JulyThirteenTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandEighteenEagleNoteMember_zdWkynH66oRd" title="Proceeds from convertible debt">$<ix:nonFraction name="us-gaap:ProceedsFromConvertibleDebt" contextRef="From2018-07-182018-07-19_custom_JulyThirteenTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_JulyTwoThousandEighteenEagleNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">71,250</ix:nonFraction></span> as <span id="xdx_90B_eus-gaap--LegalFees_c20180718__20180719__us-gaap--TypeOfArrangementAxis__custom--JulyThirteenTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandEighteenEagleNoteMember_pp0p0" title="Legal fees">$<ix:nonFraction name="us-gaap:LegalFees" contextRef="From2018-07-182018-07-19_custom_JulyThirteenTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_JulyTwoThousandEighteenEagleNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,750</ix:nonFraction></span> was paid directly to legal fees. The maturity date of the July 2018 Eagle Note was <span id="xdx_902_eus-gaap--DebtInstrumentMaturityDate_dd_c20180712__20180713__us-gaap--TypeOfArrangementAxis__custom--JulyThirteenTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandEighteenEagleNoteMember_zpDA4GM2ucK3" title="Debt maturity date"><ix:nonNumeric contextRef="From2018-07-122018-07-13_custom_JulyThirteenTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_JulyTwoThousandEighteenEagleNoteMember" format="ixt:datemonthdayyearen" name="us-gaap:DebtInstrumentMaturityDate">July 13, 2019</ix:nonNumeric></span>.
The July 2018 Eagle Note bears interest at a rate of <span id="xdx_90E_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20180713__us-gaap--TypeOfArrangementAxis__custom--JulyThirteenTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandEighteenEagleNoteMember_zAmwn9YIE4P4" title="Debt instrument, interest rate, stated percentage"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2018-07-13_custom_JulyThirteenTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_JulyTwoThousandEighteenEagleNoteMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">8</ix:nonFraction>%</span> per annum, which interest shall be paid by the Company to Eagle Equities in shares
of the Company&#8217;s common stock upon receipt of a notice of conversion by the Company from Eagle Equities at any time after the six-month
anniversary of the Note. The Company recorded <span id="xdx_90F_eus-gaap--InterestPayableCurrentAndNoncurrent_c20190630__us-gaap--TypeOfArrangementAxis__custom--JulyThirteenTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandEighteenEagleNoteMember_pp0p0" title="Accrued interest">$<ix:nonFraction name="us-gaap:InterestPayableCurrentAndNoncurrent" contextRef="AsOf2019-06-30_custom_JulyThirteenTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_JulyTwoThousandEighteenEagleNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,786</ix:nonFraction></span> of accrued interest and the total principal outstanding under the July 2018 Eagle
Note was <span id="xdx_905_eus-gaap--DebtInstrumentFaceAmount_c20190630__us-gaap--TypeOfArrangementAxis__custom--JulyThirteenTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandEighteenEagleNoteMember_pp0p0" title="Convertible debt principal amount">$<ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2019-06-30_custom_JulyThirteenTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_JulyTwoThousandEighteenEagleNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">75,000</ix:nonFraction></span> as of June 30, 2019. The Company recorded <span id="xdx_900_eus-gaap--DebtInstrumentFaceAmount_c20200630__us-gaap--TypeOfArrangementAxis__custom--JulyThirteenTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandEighteenEagleNoteMember_pp0p0" title="Convertible debt principal amount">$<ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2020-06-30_custom_JulyThirteenTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_JulyTwoThousandEighteenEagleNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">0</ix:nonFraction></span> of accrued interest and the total principal outstanding under the July
2018 Eagle Note was <span id="xdx_90C_eus-gaap--InterestPayableCurrentAndNoncurrent_c20180713__us-gaap--TypeOfArrangementAxis__custom--JulyThirteenTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandEighteenEagleNoteMember_pp0p0" title="Accrued interest">$<ix:nonFraction name="us-gaap:InterestPayableCurrentAndNoncurrent" contextRef="AsOf2018-07-13_custom_JulyThirteenTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_JulyTwoThousandEighteenEagleNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">0</ix:nonFraction></span> as of June 30, 2020 following conversion of <span id="xdx_909_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20190701__20200630__us-gaap--TypeOfArrangementAxis__custom--JulyThirteenTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandEighteenEagleNoteMember_pp0p0" title="Debt conversion of converted amount">$<ix:nonFraction name="us-gaap:DebtConversionConvertedInstrumentAmount1" contextRef="From2019-07-012020-06-30_custom_JulyThirteenTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_JulyTwoThousandEighteenEagleNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">75,000</ix:nonFraction></span> of principal and <span id="xdx_904_eus-gaap--InterestPayableCurrentAndNoncurrent_c20200630__us-gaap--TypeOfArrangementAxis__custom--JulyThirteenTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandEighteenEagleNoteMember_pp0p0" title="Accrued interest">$<ix:nonFraction name="us-gaap:InterestPayableCurrentAndNoncurrent" contextRef="AsOf2020-06-30_custom_JulyThirteenTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_JulyTwoThousandEighteenEagleNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">9,300</ix:nonFraction></span> of accrued interest during the fiscal
year ended June 30, 2020. Accordingly, there was <span id="xdx_901_eus-gaap--ConvertibleNotesPayable_iI_pp0p0_do_c20200630__us-gaap--TypeOfArrangementAxis__custom--JuneTwentyNineTwoThousandEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember_zuibCjhHE8q6" title="Convertible debt outstanding balance"><ix:nonFraction name="us-gaap:ConvertibleNotesPayable" contextRef="AsOf2020-06-30_custom_JuneTwentyNineTwoThousandEighteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember" format="ixt-sec:numwordsen" decimals="0" scale="0" unitRef="USD">no</ix:nonFraction></span> outstanding balance as of June 30, 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<ix:exclude><!-- Field: Page; Sequence: 105; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>PROPANC
BIOPHARMA, INC. AND SUBSIDIARY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>June
30, 2021 and 2020</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><i>August
29, 2018 Securities Purchase Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Effective
August 29, 2018, the Company entered into a securities purchase agreement with Eagle Equities, pursuant to which Eagle Equities purchased
a convertible promissory note (the &#8220;August 2018 Eagle Note&#8221;) from the Company in the aggregate principal amount of <span id="xdx_903_eus-gaap--DebtInstrumentFaceAmount_c20180829__us-gaap--TypeOfArrangementAxis__custom--AugustTwentyNineTwoThousandandEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandEighteenEagleNoteMember_pp0p0" title="Convertible debt principal amount">$<ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2018-08-29_custom_AugustTwentyNineTwoThousandandEighteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_AugustTwoThousandEighteenEagleNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">105,000</ix:nonFraction></span>,
such principal and the interest thereon convertible into shares of the Company&#8217;s common stock at the option of Eagle Equities any
time after the six-month anniversary of the August 2018 Eagle Note. The transactions contemplated by the agreement closed on August 30,
2018. The maturity date of the August 29, 2018 Eagle Note was <span id="xdx_90F_eus-gaap--DebtInstrumentMaturityDate_dd_c20180826__20180829__us-gaap--TypeOfArrangementAxis__custom--AugustTwentyNineTwoThousandandEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandEighteenEagleNoteMember_zqr0uvzkUBgj"><ix:nonNumeric contextRef="From2018-08-262018-08-29_custom_AugustTwentyNineTwoThousandandEighteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_AugustTwoThousandEighteenEagleNoteMember" format="ixt:datemonthdayyearen" name="us-gaap:DebtInstrumentMaturityDate">August 29, 2019</ix:nonNumeric></span>. The August 2018 Eagle Note bore interest at a rate of
<span id="xdx_903_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20180829__us-gaap--TypeOfArrangementAxis__custom--AugustTwentyNineTwoThousandandEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandEighteenEagleNoteMember_z8BLE0j8JLXf" title="Debt instrument, interest rate, stated percentage"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2018-08-29_custom_AugustTwentyNineTwoThousandandEighteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_AugustTwoThousandEighteenEagleNoteMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">8</ix:nonFraction>%</span> per annum, which interest was paid by the Company to Eagle Equities in shares of the Company&#8217;s common stock upon receipt of
a notice of conversion by the Company from Eagle Equities at any time after the six-month anniversary of the August 2018 Eagle Note.
In April 2020, Eagle Equities agreed to waive the <span id="xdx_90E_ecustom--DebtInstrumentDebtDefaultInterestRate_dp_uPure_c20200401__20200430__us-gaap--TypeOfArrangementAxis__custom--AugustTwentyNineTwoThousandandEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandEighteenEagleNoteMember_zgBWquuwOeDe" title="Debt instrument, default, interest rate"><ix:nonFraction name="PPCB:DebtInstrumentDebtDefaultInterestRate" contextRef="From2020-04-012020-04-30_custom_AugustTwentyNineTwoThousandandEighteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_AugustTwoThousandEighteenEagleNoteMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">24</ix:nonFraction>%</span> default interest on this note. The note was fully converted to common stock in
fiscal 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><i>October
2, 2018 Securities Purchase Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Effective
October 2, 2018, the Company entered into a securities purchase agreement with Eagle Equities, pursuant to which Eagle Equities purchased
a convertible promissory note (the &#8220;October 2018 Eagle Note&#8221;) from the Company in the aggregate principal amount of <span id="xdx_906_eus-gaap--DebtInstrumentFaceAmount_c20181002__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberTwoTwoThousandAndEighteenEagleNoteMember_pp0p0" title="Convertible debt principal amount">$<ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2018-10-02_custom_OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_OctoberTwoTwoThousandAndEighteenEagleNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">210,000</ix:nonFraction></span>,
such principal and the interest thereon convertible into shares of the Company&#8217;s common stock at the option of Eagle Equities any
time after the six-month anniversary of the October 2018 Eagle Note. The transactions contemplated by the purchase agreement closed on
October 3, 2018. Pursuant to the terms of the purchase agreement, Eagle Equities deducted $<span id="xdx_90F_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_c20180929__20181002__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberTwoTwoThousandAndEighteenEagleNoteMember_pp0p0" title="Debt instrument principal payment"><ix:nonFraction name="us-gaap:DebtInstrumentPeriodicPaymentPrincipal" contextRef="From2018-09-292018-10-02_custom_OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_OctoberTwoTwoThousandAndEighteenEagleNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">10,000</ix:nonFraction></span> from the principal payment due under
the October 2018 Eagle Note, at the time of closing, to be applied to its legal expenses. The maturity date of the October 2018 Eagle
Note was <span id="xdx_902_eus-gaap--DebtInstrumentMaturityDate_dd_c20180929__20181002__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberTwoTwoThousandAndEighteenEagleNoteMember_zWGQR2JHUroc" title="Debt maturity date"><ix:nonNumeric contextRef="From2018-09-292018-10-02_custom_OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_OctoberTwoTwoThousandAndEighteenEagleNoteMember" format="ixt:datemonthdayyearen" name="us-gaap:DebtInstrumentMaturityDate">October 2, 2019</ix:nonNumeric></span>. The October 2018 Eagle Note shall bore interest at a rate of <span id="xdx_90B_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20181002__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberTwoTwoThousandAndEighteenEagleNoteMember_zlNz9m1P70B9" title="Debt instrument, interest rate, stated percentage"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2018-10-02_custom_OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_OctoberTwoTwoThousandAndEighteenEagleNoteMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">8</ix:nonFraction>%</span> per annum, which interest was paid by the Company
to Eagle Equities in shares of common stock upon receipt of a notice of conversion by the Company from Eagle Equities at any time after
the six-month anniversary of the October 2018 Eagle Note. In April 2020, Eagle Equities agreed to waive the <span id="xdx_90D_ecustom--DebtInstrumentDebtDefaultInterestRate_dp_uPure_c20200401__20200430__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember_zln5ji2gLDy6" title="Debt instrument, default, interest rate"><ix:nonFraction name="PPCB:DebtInstrumentDebtDefaultInterestRate" contextRef="From2020-04-012020-04-30_custom_OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">24</ix:nonFraction>%</span> default interest on this
note. The note was fully converted to common stock in fiscal 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><i>November
30, 2018 Securities Purchase Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Effective
November 30, 2018, the Company entered into a securities purchase agreement with Eagle Equities, pursuant to which Eagle Equities purchased
a convertible promissory note (the &#8220;November 2018 Eagle Note&#8221;) from the Company in the aggregate principal amount of <span id="xdx_903_eus-gaap--DebtInstrumentFaceAmount_c20181130__us-gaap--TypeOfArrangementAxis__custom--NovembeThirtyTwoThousandAndEighteenMecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--NovemberTwoThousandAndEighteenEagleNoteMember_pp0p0" title="Convertible debt principal amount">$<ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2018-11-30_custom_NovembeThirtyTwoThousandAndEighteenMecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_NovemberTwoThousandAndEighteenEagleNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">105,000</ix:nonFraction></span>,
such principal and the interest thereon convertible into shares of the Company&#8217;s common stock at the option of Eagle Equities any
time after the six-month anniversary of the November 2018 Eagle Note. The transactions contemplated by the purchase agreement closed
on December 3, 2018. Pursuant to the terms of the purchase agreement, Eagle Equities deducted <span id="xdx_906_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_c20181126__20181130__us-gaap--TypeOfArrangementAxis__custom--NovembeThirtyTwoThousandAndEighteenMecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--NovemberTwoThousandAndEighteenEagleNoteMember_pp0p0" title="Debt instrument principal payment">$<ix:nonFraction name="us-gaap:DebtInstrumentPeriodicPaymentPrincipal" contextRef="From2018-11-262018-11-30_custom_NovembeThirtyTwoThousandAndEighteenMecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_NovemberTwoThousandAndEighteenEagleNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,000</ix:nonFraction></span> from the principal payment due under
the November 2018 Eagle Note, at the time of closing, to be applied to its legal expenses. The maturity date of the November 2018 Eagle
Note was <span id="xdx_901_eus-gaap--DebtInstrumentMaturityDate_dd_c20181126__20181130__us-gaap--TypeOfArrangementAxis__custom--NovembeThirtyTwoThousandAndEighteenMecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--NovemberTwoThousandAndEighteenEagleNoteMember_zChtBzkSwcs7" title="Debt maturity date"><ix:nonNumeric contextRef="From2018-11-262018-11-30_custom_NovembeThirtyTwoThousandAndEighteenMecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_NovemberTwoThousandAndEighteenEagleNoteMember" format="ixt:datemonthdayyearen" name="us-gaap:DebtInstrumentMaturityDate">November 30, 2019</ix:nonNumeric></span>. The November 2018 Eagle Note bore interest at a rate of <span id="xdx_90B_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20181130__us-gaap--TypeOfArrangementAxis__custom--NovembeThirtyTwoThousandAndEighteenMecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--NovemberTwoThousandAndEighteenEagleNoteMember_zM0a4tZzTtF6" title="Debt instrument, interest rate, stated percentage"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2018-11-30_custom_NovembeThirtyTwoThousandAndEighteenMecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_NovemberTwoThousandAndEighteenEagleNoteMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">8</ix:nonFraction>%</span> per annum, which interest shall be paid by the
Company to Eagle Equities in shares of common stock upon receipt of a notice of conversion by the Company from Eagle Equities at any
time after the six-month anniversary of the November 2018 Eagle Note. In April 2020, Eagle Equities agreed to waive the <span id="xdx_90A_ecustom--DebtInstrumentDebtDefaultInterestRate_dp_uPure_c20200401__20200430__us-gaap--TypeOfArrangementAxis__custom--NovembeThirtyTwoThousandAndEighteenMecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--NovemberTwoThousandAndEighteenEagleNoteMember_zfKSHWHrSd43" title="Debt instrument, default, interest rate"><ix:nonFraction name="PPCB:DebtInstrumentDebtDefaultInterestRate" contextRef="From2020-04-012020-04-30_custom_NovembeThirtyTwoThousandAndEighteenMecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_NovemberTwoThousandAndEighteenEagleNoteMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">24</ix:nonFraction>%</span> default interest
on this note. The note was fully converted to common stock in fiscal 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><i>December
24, 2018 Securities Purchase Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Effective
December 24, 2018, the Company entered into a securities purchase agreement with Eagle Equities, pursuant to which Eagle Equities purchased
a convertible promissory note (the &#8220;December 2018 Eagle Note&#8221;) from the Company in the aggregate principal amount of <span id="xdx_90B_eus-gaap--DebtInstrumentFaceAmount_c20181224__us-gaap--TypeOfArrangementAxis__custom--DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--DecembeTwoThousandAndEighteenEagleNoteMember_pp0p0" title="Convertible debt principal amount">$<ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2018-12-24_custom_DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_DecembeTwoThousandAndEighteenEagleNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">126,000</ix:nonFraction></span>,
such principal and the interest thereon convertible into shares of the Company&#8217;s common stock at the option of Eagle Equities any
time after the six-month anniversary of the December 2018 Eagle Note. The transactions contemplated by the purchase agreement closed
on December 24, 2018. Pursuant to the terms of the purchase agreement, Eagle Equities deducted <span id="xdx_906_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_c20181223__20181224__us-gaap--TypeOfArrangementAxis__custom--DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--DecembeTwoThousandAndEighteenEagleNoteMember_pp0p0" title="Debt instrument principal payment">$<ix:nonFraction name="us-gaap:DebtInstrumentPeriodicPaymentPrincipal" contextRef="From2018-12-232018-12-24_custom_DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_DecembeTwoThousandAndEighteenEagleNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">6,000</ix:nonFraction></span> from the principal payment due
under the December 2018 Eagle Note, at the time of closing, to be applied to its legal expenses. The Company used the net proceeds from
the December 2018 Eagle Note to repay an outstanding convertible promissory note before such note became convertible. The maturity date
of the December 2018 Eagle Note was <span id="xdx_90A_eus-gaap--DebtInstrumentMaturityDate_dd_c20181223__20181224__us-gaap--TypeOfArrangementAxis__custom--DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--DecembeTwoThousandAndEighteenEagleNoteMember_zIJtjKwc3F6e" title="Debt maturity date"><ix:nonNumeric contextRef="From2018-12-232018-12-24_custom_DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_DecembeTwoThousandAndEighteenEagleNoteMember" format="ixt:datemonthdayyearen" name="us-gaap:DebtInstrumentMaturityDate">December 24, 2019</ix:nonNumeric></span>. The December 2018 Eagle Note bore interest at a rate of <span id="xdx_90E_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20181224__us-gaap--TypeOfArrangementAxis__custom--DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--DecembeTwoThousandAndEighteenEagleNoteMember_zQz2eFDsZRe9" title="Debt instrument, interest rate, stated percentage"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2018-12-24_custom_DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_DecembeTwoThousandAndEighteenEagleNoteMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">8</ix:nonFraction>%</span> per annum, which interest
was paid by the Company to Eagle Equities in shares of common stock upon receipt of a notice of conversion by the Company from Eagle
Equities at any time after the six-month anniversary of the December 2018 Eagle Note. Upon an event of default, principal and accrued
interest would become immediately due and payable under the notes. Additionally, upon an event of default, both notes would accrue interest
at a default interest rate of <span id="xdx_905_ecustom--DebtInstrumentDebtDefaultInterestRate_dp_uPure_c20181223__20181224__us-gaap--TypeOfArrangementAxis__custom--DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--DecembeTwoThousandAndEighteenEagleNoteMember_z6Ts1dycUWZg" title="Debt instrument, default, interest rate"><ix:nonFraction name="PPCB:DebtInstrumentDebtDefaultInterestRate" contextRef="From2018-12-232018-12-24_custom_DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_DecembeTwoThousandAndEighteenEagleNoteMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">24</ix:nonFraction>%</span> per annum or the highest rate of interest permitted by law. In April 2020, Eagle Equities agreed to
waive the <span id="xdx_90E_ecustom--DebtInstrumentDebtDefaultInterestRate_dp_uPure_c20200401__20200430__us-gaap--TypeOfArrangementAxis__custom--DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--DecembeTwoThousandAndEighteenEagleNoteMember_zlZWpPbTdlei" title="Debt instrument, default, interest rate"><ix:nonFraction name="PPCB:DebtInstrumentDebtDefaultInterestRate" contextRef="From2020-04-012020-04-30_custom_DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_DecembeTwoThousandAndEighteenEagleNoteMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">24</ix:nonFraction>%</span> default interest on this note.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Eagle
Equities had the option to convert all or any amount of the principal amount of the notes issued to Eagle Equities above, at any time,
for shares of the Company&#8217;s common stock at a price ranging from <span id="xdx_90B_eus-gaap--DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_dp_uPure_c20181223__20181224__us-gaap--TypeOfArrangementAxis__custom--DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--DecembeTwoThousandAndEighteenEagleNoteMember__srt--RangeAxis__srt--MinimumMember_zfQi4u9wiHai" title="Common stock trading volume, percent"><ix:nonFraction name="us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" contextRef="From2018-12-232018-12-24_custom_DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_DecembeTwoThousandAndEighteenEagleNoteMember_srt_MinimumMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">60</ix:nonFraction>%</span> to <span id="xdx_906_eus-gaap--DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_dp_uPure_c20181223__20181224__us-gaap--TypeOfArrangementAxis__custom--DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--DecembeTwoThousandAndEighteenEagleNoteMember__srt--RangeAxis__srt--MaximumMember_zd2xti7wZbY8" title="Common stock trading volume, percent"><ix:nonFraction name="us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" contextRef="From2018-12-232018-12-24_custom_DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_DecembeTwoThousandAndEighteenEagleNoteMember_srt_MaximumMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">61</ix:nonFraction>%</span> of the lowest closing bid price (the &#8220;Closing
Bid Price&#8221;) of the Company&#8217;s common stock as reported on the OTC Markets Group, Inc. quotation system for the ten prior trading
days, including the day upon which the Company receives a notice of conversion from Eagle Equities (the &#8220;Conversion Price&#8221;).
However, in the event that the Company&#8217;s common stock was restricted by the Depository Trust Company for any reason, the Conversion
Price was to be lowered to from <span id="xdx_903_eus-gaap--DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_dp_uPure_c20181223__20181224__us-gaap--TypeOfArrangementAxis__custom--DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--DepositoryTrustCompanyMember__us-gaap--DebtInstrumentAxis__custom--DecembeTwoThousandAndEighteenEagleNoteMember__srt--RangeAxis__srt--MinimumMember_zCDR7YJTeg13" title="Common stock trading volume, percent"><ix:nonFraction name="us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" contextRef="From2018-12-232018-12-24_custom_DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_DepositoryTrustCompanyMember_custom_DecembeTwoThousandAndEighteenEagleNoteMember_srt_MinimumMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">50</ix:nonFraction>%</span> to <span id="xdx_904_eus-gaap--DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_dp_uPure_c20181223__20181224__us-gaap--TypeOfArrangementAxis__custom--DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--DepositoryTrustCompanyMember__us-gaap--DebtInstrumentAxis__custom--DecembeTwoThousandAndEighteenEagleNoteMember__srt--RangeAxis__srt--MaximumMember_zgAsy2tzpAqe" title="Common stock trading volume, percent"><ix:nonFraction name="us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" contextRef="From2018-12-232018-12-24_custom_DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_DepositoryTrustCompanyMember_custom_DecembeTwoThousandAndEighteenEagleNoteMember_srt_MaximumMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">51</ix:nonFraction>%</span> of the lowest Closing Bid Price for the duration of such restriction. If the Company failed
to maintain a reserve of shares of its common stock at least two and a half times the number of shares issuable upon conversion of all
the Eagle Notes for at least 60 days after the issuance of the notes issued to Eagle Equities, the conversion discount was to be increased
by <span id="xdx_90A_eus-gaap--DebtConversionOriginalDebtInterestRateOfDebt_dp_uPure_c20181223__20181224__us-gaap--TypeOfArrangementAxis__custom--DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--DecembeTwoThousandAndEighteenEagleNoteMember_zOUdDl581VGk" title="Debt original issue discount, rate"><ix:nonFraction name="us-gaap:DebtConversionOriginalDebtInterestRateOfDebt" contextRef="From2018-12-232018-12-24_custom_DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_DecembeTwoThousandAndEighteenEagleNoteMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">10</ix:nonFraction>%</span>. Notwithstanding the foregoing, Eagle Equities was restricted from effecting a conversion if such conversion, along with other
shares of the Company&#8217;s common stock beneficially owned by Eagle Equities and its affiliates, exceeds <span id="xdx_904_ecustom--PercentageOfOutstandingSharesOfCommonStock_dp_uPure_c20181223__20181224__us-gaap--TypeOfArrangementAxis__custom--DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--DecembeTwoThousandAndEighteenEagleNoteMember_ze9mkRXdRss4" title="Percentage of outstanding shares of common stock"><ix:nonFraction name="PPCB:PercentageOfOutstandingSharesOfCommonStock" contextRef="From2018-12-232018-12-24_custom_DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_DecembeTwoThousandAndEighteenEagleNoteMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">4.99</ix:nonFraction>%</span> of the outstanding
shares of the Company&#8217;s common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<ix:exclude><!-- Field: Page; Sequence: 106; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>PROPANC
BIOPHARMA, INC. AND SUBSIDIARY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>June
30, 2021 and 2020</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
above notes issued to Eagle Equities were treated as stock settled debt under ASC 480 and accordingly, the Company recorded a total of
<span id="xdx_908_eus-gaap--DebtInstrumentUnamortizedPremium_c20181224__us-gaap--TypeOfArrangementAxis__custom--DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--DecembeTwoThousandAndEighteenEagleNoteMember_pp0p0" title="Debt premium amount">$<ix:nonFraction name="us-gaap:DebtInstrumentUnamortizedPremium" contextRef="AsOf2018-12-24_custom_DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_DecembeTwoThousandAndEighteenEagleNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">357,688</ix:nonFraction></span> put premium, of which <span id="xdx_904_eus-gaap--AdditionalPaidInCapital_iI_pp0p0_c20210630__us-gaap--TypeOfArrangementAxis__custom--DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--DecembeTwoThousandAndEighteenEagleNoteMember_zH3UbaDWPi5k" title="Additional paid in capital">$<ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2021-06-30_custom_DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_DecembeTwoThousandAndEighteenEagleNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">224,131</ix:nonFraction></span> and <span id="xdx_907_eus-gaap--AdditionalPaidInCapital_iI_pp0p0_c20200630__us-gaap--TypeOfArrangementAxis__custom--DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--DecembeTwoThousandAndEighteenEagleNoteMember_zcmT5xSeF5Q4" title="Additional paid in capital">$<ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2020-06-30_custom_DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_DecembeTwoThousandAndEighteenEagleNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">133,557</ix:nonFraction></span> were released to additional paid in capital following conversion of principal during
the fiscal year to June 30, 2020 and 2021, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
total principal amount outstanding under the above Eagle Equities financing agreements, specifically the August 29, 2018 and the December
24, 2018 agreements was <span id="xdx_902_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementOneMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember_zpGdUj168qPf" title="Convertible debt principal amount">$<ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2020-06-30_custom_SecuritiesPurchaseAgreementOneMember_custom_EagleEquitiesLLCMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">205,500</ix:nonFraction></span> as of June 30, 2020 and accrued interest totaled <span id="xdx_90F_eus-gaap--InterestPayableCurrentAndNoncurrent_c20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementOneMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember_pp0p0" title="Accrued interest">$<ix:nonFraction name="us-gaap:InterestPayableCurrentAndNoncurrent" contextRef="AsOf2020-06-30_custom_SecuritiesPurchaseAgreementOneMember_custom_EagleEquitiesLLCMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">26,990</ix:nonFraction></span>. There were <span id="xdx_900_eus-gaap--ConvertibleNotesPayable_iI_pp0p0_c20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementOneMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember_zvGPnBXv9Zt" title="Convertible debt outstanding balance">$<ix:nonFraction name="us-gaap:ConvertibleNotesPayable" contextRef="AsOf2021-06-30_custom_SecuritiesPurchaseAgreementOneMember_custom_EagleEquitiesLLCMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">0</ix:nonFraction></span> outstanding principal and accrued
interest under the above Eagle Equities financing agreements as of June 30, 2021 as a result of the fiscal 2021 conversions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b><i>GS
Capital Financing Agreements</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><i>October
2, 2018 Securities Purchase Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Effective
October 2, 2018, the Company entered into a securities purchase agreement with GS Capital, pursuant to which GS Capital purchased two
<span id="xdx_90F_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20181002__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberTwoThousandEighteenGSNoteMember_zsBzu4vGlZFh" title="Debt instrument, interest rate, stated percentage"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2018-10-02_custom_OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_GSCapitalPartnersLLCMember_custom_OctoberTwoThousandEighteenGSNoteMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">8</ix:nonFraction>%</span> unsecured convertible redeemable notes (the &#8220;October 2, 2018 GS Notes&#8221;) from the Company in the aggregate principal amount
of <span id="xdx_900_eus-gaap--DebtInstrumentFaceAmount_c20181002__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberTwoThousandEighteenGSNoteMember_pp0p0" title="Convertible debt principal amount">$<ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2018-10-02_custom_OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_GSCapitalPartnersLLCMember_custom_OctoberTwoThousandEighteenGSNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">212,000</ix:nonFraction></span>, such principal and the interest thereon convertible into shares of the Company&#8217;s common stock. The purchase price
of <span id="xdx_90C_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20181003__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberTwoThousandEighteenGSNoteMember_zprsfKSUfdD5" title="Convertible debt principal amount">$<ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2018-10-03_custom_OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_GSCapitalPartnersLLCMember_custom_OctoberTwoThousandEighteenGSNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">106,000</ix:nonFraction></span> of the first note (the &#8220;October 2018 GS Note&#8221;) was paid in cash by GS Capital on October 3, 2018. After payment
of certain legal fees and expenses, net proceeds to the Company from the October 2018 GS Note totaled <span id="xdx_906_eus-gaap--ProceedsFromConvertibleDebt_c20180929__20181002__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberTwoThousandEighteenGSNoteMember_pp0p0" title="Proceeds from convertible debt">$<ix:nonFraction name="us-gaap:ProceedsFromConvertibleDebt" contextRef="From2018-09-292018-10-02_custom_OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_GSCapitalPartnersLLCMember_custom_OctoberTwoThousandEighteenGSNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">100,700</ix:nonFraction></span>. The purchase price of
<span id="xdx_902_eus-gaap--ProceedsFromConvertibleDebt_pp0p0_c20180929__20181002__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberTwoThousandEighteenGSNoteMember__us-gaap--ShortTermDebtTypeAxis__custom--FirstNoteMember_zG1H5PWnaa1" title="Proceeds from convertible debt">$<ix:nonFraction name="us-gaap:ProceedsFromConvertibleDebt" contextRef="From2018-09-292018-10-02_custom_OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_GSCapitalPartnersLLCMember_custom_OctoberTwoThousandEighteenGSNoteMember_custom_FirstNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">106,000</ix:nonFraction></span> of the second note (the &#8220;October 2, 2018 GS Back End Note&#8221;) was initially paid for by GS Capital issuing to the
Company an offsetting <span id="xdx_908_eus-gaap--ProceedsFromConvertibleDebt_c20180929__20181002__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberTwoThousandEighteenGSNoteMember__us-gaap--ShortTermDebtTypeAxis__custom--SecondNoteMember_pp0p0" title="Proceeds from convertible debt">$<ix:nonFraction name="us-gaap:ProceedsFromConvertibleDebt" contextRef="From2018-09-292018-10-02_custom_OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_GSCapitalPartnersLLCMember_custom_OctoberTwoThousandEighteenGSNoteMember_custom_SecondNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">106,000</ix:nonFraction></span> collateralized secured note (the &#8220;October 2, 2018 GS Secured Note&#8221;). The terms of the October
2018 GS Back End Note require cash funding prior to any conversion thereunder, and such cash funding shall occur on or before June 2,
2019.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Both
the October 2, 2018 GS Note and the October 2, 2018 GS Back End Note, which was funded on February 27, 2019, matured on October 2, 2019,
upon which any outstanding principal and interest thereon is due and payable. The amounts cash funded plus accrued interest under both
the October 2018 GS Note and the October 2018 GS Back End Note are convertibles into shares of the Company&#8217;s common stock, at any
time after April 2, 2019, at a conversion price for each share of common stock equal to <span id="xdx_905_eus-gaap--DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_dp_uPure_c20180929__20181002__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberTwoThousandEighteenGSNoteMember_zoEnJjhzaQ3i" title="Common stock trading volume, percent"><ix:nonFraction name="us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" contextRef="From2018-09-292018-10-02_custom_OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_GSCapitalPartnersLLCMember_custom_OctoberTwoThousandEighteenGSNoteMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">61</ix:nonFraction>%</span> of the lowest closing bid price of the Company&#8217;s
common stock for the ten prior trading days including the day upon which a notice of conversion is received by the Company from GS Capital,
subject to adjustment in certain events. The maturity date of the <span id="xdx_90A_eus-gaap--DebtInstrumentMaturityDate_dd_c20180929__20181002__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberTwoThousandEighteenGSNoteMember_zREmxodNjZ6l" title="Debt maturity date"><ix:nonNumeric contextRef="From2018-09-292018-10-02_custom_OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_GSCapitalPartnersLLCMember_custom_OctoberTwoThousandEighteenGSNoteMember" format="ixt:datemonthdayyearen" name="us-gaap:DebtInstrumentMaturityDate">October 2, 2018</ix:nonNumeric></span> GS Back-Note was October 2019 and the notes were fully
converted to common stock in fiscal 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><i>January
22, 2020 GS Capital Securities Purchase Agreements</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Effective
January 22, 2020, the Company entered into a securities purchase agreement with GS Capital, pursuant to which GS Capital purchased a
convertible promissory note (the &#8220;January 22, 2020 GS Note&#8221;) from the Company in the aggregate principal amount of <span id="xdx_905_eus-gaap--DebtInstrumentFaceAmount_c20200122__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--JanuaryTwentyTwoTwentyTwentyGSNoteMember_pp0p0" title="Convertible debt principal amount">$<ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2020-01-22_custom_SecuritiesPurchaseAgreementMember_custom_GSCapitalPartnersLLCMember_custom_JanuaryTwentyTwoTwentyTwentyGSNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">58,000</ix:nonFraction></span>,
such principal and the interest thereon convertible into shares of the Company&#8217;s common stock at the option of GS Capital any time
after the six-month anniversary of the January 22, 2020 GS Capital Note. The January 22, 2020 GS Note contained an original discount
of <span id="xdx_900_eus-gaap--DebtInstrumentUnamortizedDiscount_c20200122__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--JanuaryTwentyTwoTwentyTwentyGSNoteMember_pp0p0" title="Original issue discount">$<ix:nonFraction name="us-gaap:DebtInstrumentUnamortizedDiscount" contextRef="AsOf2020-01-22_custom_SecuritiesPurchaseAgreementMember_custom_GSCapitalPartnersLLCMember_custom_JanuaryTwentyTwoTwentyTwentyGSNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,500</ix:nonFraction></span>. The transactions contemplated by the GS Capital Securities Purchase Agreement closed on January 22, 2020. Pursuant to the
terms of the GS Capital Securities Purchase Agreement, GS Capital deducted <span id="xdx_901_eus-gaap--LegalFees_c20200121__20200122__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--JanuaryTwentyTwoTwentyTwentyGSNoteMember_pp0p0" title="Legal fees">$<ix:nonFraction name="us-gaap:LegalFees" contextRef="From2020-01-212020-01-22_custom_SecuritiesPurchaseAgreementMember_custom_GSCapitalPartnersLLCMember_custom_JanuaryTwentyTwoTwentyTwentyGSNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,500</ix:nonFraction></span> from the principal payment due under the January 22,
2020 GW Note, at the time of closing, to be applied to its legal expenses and received net cash proceeds of <span id="xdx_90D_eus-gaap--ProceedsFromConvertibleDebt_c20200121__20200122__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--JanuaryTwentyTwoTwentyTwentyGSNoteMember__srt--RangeAxis__srt--MinimumMember_pp0p0" title="Proceeds from convertible debt">$<ix:nonFraction name="us-gaap:ProceedsFromConvertibleDebt" contextRef="From2020-01-212020-01-22_custom_SecuritiesPurchaseAgreementMember_custom_GSCapitalPartnersLLCMember_custom_JanuaryTwentyTwoTwentyTwentyGSNoteMember_srt_MinimumMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">52,000</ix:nonFraction></span> on January 28, 2020.
The Company used the net proceeds from the January 22, 2020 GW Note for general working capital purposes. The maturity date of the January
22, 2020 GS Capital was <span id="xdx_90B_eus-gaap--DebtInstrumentMaturityDate_dd_c20200121__20200122__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--JanuaryTwentyTwoTwentyTwentyGSNoteMember_ztHk6HM5YFai" title="Debt maturity date"><ix:nonNumeric contextRef="From2020-01-212020-01-22_custom_SecuritiesPurchaseAgreementMember_custom_GSCapitalPartnersLLCMember_custom_JanuaryTwentyTwoTwentyTwentyGSNoteMember" format="ixt:datemonthdayyearen" name="us-gaap:DebtInstrumentMaturityDate">January 22, 2021</ix:nonNumeric></span>. The January 22, 2020 GS Capital Note bore interest at a rate of 10% per annum, which interest
may be paid by the Company to GS Capital in shares of the Company&#8217;s common stock; but was not payable until the January 22, 2020
GS Capital Note became payable, whether at the maturity date or upon acceleration or by prepayment. The conversion price for the January
22, 2020 GS Capital Note was equal to a <span id="xdx_903_eus-gaap--DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_dp_uPure_c20200121__20200122__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--JanuaryTwentyTwoTwentyTwentyGSNoteMember_zMLHV8tdxRD1" title="Common stock trading volume, percent"><ix:nonFraction name="us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" contextRef="From2020-01-212020-01-22_custom_SecuritiesPurchaseAgreementMember_custom_GSCapitalPartnersLLCMember_custom_JanuaryTwentyTwoTwentyTwentyGSNoteMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">40</ix:nonFraction>%</span> discount of the lowest closing bid price (&#8220;Lowest Trading Price&#8221;) of the Common
Stock for the ten trading days immediately prior to the delivery of a Notice of Conversion, including the day upon which a Notice of
Conversion is received.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Additionally,
GS Capital had the option to convert all or any amount of the principal face amount of the January 22, 2020 GS Capital Note at any time
from the date of issuance and ending on the later of the maturity date or the date the Default Amount was paid if an event of default
occurs, which is an amount between <span id="xdx_909_ecustom--DebtDefaultAmountPercentage_dp_uPure_c20200121__20200122__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--JanuaryTwentyTwoTwentyTwentyGSNoteMember__srt--RangeAxis__srt--MinimumMember_zLhcyB9kReSh" title="Debt default amount percentage"><ix:nonFraction name="PPCB:DebtDefaultAmountPercentage" contextRef="From2020-01-212020-01-22_custom_SecuritiesPurchaseAgreementMember_custom_GSCapitalPartnersLLCMember_custom_JanuaryTwentyTwoTwentyTwentyGSNoteMember_srt_MinimumMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">112</ix:nonFraction>%</span> and <span id="xdx_90A_ecustom--DebtDefaultAmountPercentage_dp_uPure_c20200121__20200122__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--JanuaryTwentyTwoTwentyTwentyGSNoteMember__srt--RangeAxis__srt--MaximumMember_z9sSAd3r7dW1" title="Debt default amount percentage"><ix:nonFraction name="PPCB:DebtDefaultAmountPercentage" contextRef="From2020-01-212020-01-22_custom_SecuritiesPurchaseAgreementMember_custom_GSCapitalPartnersLLCMember_custom_JanuaryTwentyTwoTwentyTwentyGSNoteMember_srt_MaximumMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">130</ix:nonFraction>%</span> of an amount equal to the then outstanding principal amount of the January 22, 2020
GS Capital Note plus any interest accrued, for shares of the Company&#8217;s common stock at the then-applicable conversion price. The
January 22, 2020 GS Note contained certain events of default, upon which principal and accrued interest would become immediately due
and payable. In addition, upon an event of default, interest on the outstanding principal would accrue at a default interest rate of
<span id="xdx_906_ecustom--DebtInstrumentDebtDefaultInterestRate_dp_uPure_c20200121__20200122__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--JanuaryTwentyTwoTwentyTwentyGSNoteMember_zRSiBEyLkQB6" title="Debt instrument, default, interest rate"><ix:nonFraction name="PPCB:DebtInstrumentDebtDefaultInterestRate" contextRef="From2020-01-212020-01-22_custom_SecuritiesPurchaseAgreementMember_custom_GSCapitalPartnersLLCMember_custom_JanuaryTwentyTwoTwentyTwentyGSNoteMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">24</ix:nonFraction>%</span> per annum.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<ix:exclude><!-- Field: Page; Sequence: 107; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>PROPANC
BIOPHARMA, INC. AND SUBSIDIARY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>June
30, 2021 and 2020</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
notes issued to GS capital above were treated as stock settled debt under ASC 480 and accordingly the Company recorded a total of <span id="xdx_90C_eus-gaap--DebtInstrumentUnamortizedPremium_c20200122__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--JanuaryTwentyTwoTwentyTwentyGSNoteMember_pp0p0" title="Debt premium amount">$<ix:nonFraction name="us-gaap:DebtInstrumentUnamortizedPremium" contextRef="AsOf2020-01-22_custom_SecuritiesPurchaseAgreementMember_custom_GSCapitalPartnersLLCMember_custom_JanuaryTwentyTwoTwentyTwentyGSNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">106,438</ix:nonFraction></span>
put premium which was expensed in fiscal 2020 of which <span id="xdx_90F_eus-gaap--AdditionalPaidInCapital_c20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--JanuaryTwentyTwoTwentyTwentyGSNoteMember_pp0p0" title="Additional paid in capital">$<ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2021-06-30_custom_SecuritiesPurchaseAgreementMember_custom_GSCapitalPartnersLLCMember_custom_JanuaryTwentyTwoTwentyTwentyGSNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">22,901</ix:nonFraction></span> and <span id="xdx_90C_eus-gaap--AdditionalPaidInCapital_c20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--JanuaryTwentyTwoTwentyTwentyGSNoteMember_pp0p0" title="Additional paid in capital">$<ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2020-06-30_custom_SecuritiesPurchaseAgreementMember_custom_GSCapitalPartnersLLCMember_custom_JanuaryTwentyTwoTwentyTwentyGSNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">38,667</ix:nonFraction></span> was released to additional paid in capital following conversion
of principal during the year ended June 30, 2020 and 2021, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.45in"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
Company recorded <span id="xdx_90B_eus-gaap--InterestPayableCurrentAndNoncurrent_c20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--JanuaryTwentyTwoTwentyTwentyGSNoteMember_pp0p0" title="Accrued interest">$<ix:nonFraction name="us-gaap:InterestPayableCurrentAndNoncurrent" contextRef="AsOf2020-06-30_custom_SecuritiesPurchaseAgreementMember_custom_GSCapitalPartnersLLCMember_custom_JanuaryTwentyTwoTwentyTwentyGSNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">8,802</ix:nonFraction></span> of accrued interest and the total principal outstanding under the above GS Capital financing agreements was <span id="xdx_901_eus-gaap--ConvertibleNotesPayable_c20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--JanuaryTwentyTwoTwentyTwentyGSNoteMember_pp0p0" title="Convertible debt outstanding balance">$<ix:nonFraction name="us-gaap:ConvertibleNotesPayable" contextRef="AsOf2020-06-30_custom_SecuritiesPurchaseAgreementMember_custom_GSCapitalPartnersLLCMember_custom_JanuaryTwentyTwoTwentyTwentyGSNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">58,000</ix:nonFraction></span>
as of June 30, 2020 following the conversion of <span id="xdx_902_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20190701__20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--JanuaryTwentyTwoTwentyTwentyGSNoteMember_pp0p0" title="Debt conversion of converted amount">$<ix:nonFraction name="us-gaap:DebtConversionConvertedInstrumentAmount1" contextRef="From2019-07-012020-06-30_custom_SecuritiesPurchaseAgreementMember_custom_GSCapitalPartnersLLCMember_custom_JanuaryTwentyTwoTwentyTwentyGSNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">141,820</ix:nonFraction></span> of principal and <span id="xdx_90E_ecustom--DebtConversionConvertedInterestPayable_c20190701__20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--JanuaryTwentyTwoTwentyTwentyGSNoteMember_pp0p0" title="Debt conversion of accrued interest">$<ix:nonFraction name="PPCB:DebtConversionConvertedInterestPayable" contextRef="From2019-07-012020-06-30_custom_SecuritiesPurchaseAgreementMember_custom_GSCapitalPartnersLLCMember_custom_JanuaryTwentyTwoTwentyTwentyGSNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">76,397</ix:nonFraction></span> of accrued interest during the year ended June 30,
2020. The total remaining principal outstanding and accrued interest under the above GS Capital financing agreements was <span id="xdx_902_eus-gaap--ConvertibleNotesPayable_c20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--JanuaryTwentyTwoTwentyTwentyGSNoteMember_pp0p0" title="Convertible debt outstanding balance">$<ix:nonFraction name="us-gaap:ConvertibleNotesPayable" contextRef="AsOf2021-06-30_custom_SecuritiesPurchaseAgreementMember_custom_GSCapitalPartnersLLCMember_custom_JanuaryTwentyTwoTwentyTwentyGSNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">0</ix:nonFraction></span> as of June
30, 2021 following conversion of <span id="xdx_90B_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20200701__20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--JanuaryTwentyTwoTwentyTwentyGSNoteMember_pp0p0" title="Debt conversion of converted amount">$<ix:nonFraction name="us-gaap:DebtConversionConvertedInstrumentAmount1" contextRef="From2020-07-012021-06-30_custom_SecuritiesPurchaseAgreementMember_custom_GSCapitalPartnersLLCMember_custom_JanuaryTwentyTwoTwentyTwentyGSNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">58,000</ix:nonFraction></span> of principal and <span id="xdx_900_ecustom--DebtConversionConvertedInterestPayable_c20200701__20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--JanuaryTwentyTwoTwentyTwentyGSNoteMember_pp0p0" title="Debt conversion of accrued interest">$<ix:nonFraction name="PPCB:DebtConversionConvertedInterestPayable" contextRef="From2020-07-012021-06-30_custom_SecuritiesPurchaseAgreementMember_custom_GSCapitalPartnersLLCMember_custom_JanuaryTwentyTwoTwentyTwentyGSNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">8,508</ix:nonFraction></span> of accrued interest during the year ended June 30, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b><i>Convertible
Note Issued with Consulting Agreement</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><i>August
10, 2017 Consulting Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">On
August 10, 2017, the Company entered into a consulting agreement, retroactive to May 16, 2017, with a certain consultant, pursuant to
which the consultant agreed to provide certain consulting and business advisory services in exchange for a <span id="xdx_90F_eus-gaap--DebtInstrumentFaceAmount_c20170810__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember_pp0p0" title="Convertible debt principal amount">$<ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2017-08-10_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">310,000</ix:nonFraction></span> junior subordinated
convertible note. The maturity date of the August 10, 2017 Convertible Note was August 2019 and is currently past due (see Note 8). The
note accrues interest at a rate of <span id="xdx_90C_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20170810__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember_zGtRbaHUHryg" title="Debt instrument, interest rate, stated percentage"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2017-08-10_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">10</ix:nonFraction>%</span> per annum and is convertible into common stock at the lesser of <span id="xdx_904_eus-gaap--DebtConversionConvertedInstrumentAmount1_pp0p0_c20170807__20170810__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember_zRjQnG0vwOlg" title="Debt conversion of converted amount">$<ix:nonFraction name="us-gaap:DebtConversionConvertedInstrumentAmount1" contextRef="From2017-08-072017-08-10_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">750</ix:nonFraction></span> or <span id="xdx_906_eus-gaap--DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_dp_uPure_c20170807__20170810__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember_za6nPWZA6QU1" title="Common stock trading volume, percent"><ix:nonFraction name="us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" contextRef="From2017-08-072017-08-10_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">65</ix:nonFraction>%</span> of the three lowest
trades in the <span id="xdx_90F_eus-gaap--DebtInstrumentConvertibleThresholdTradingDays_dxL_uInteger_c20170807__20170810__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember_zDWKrjoAjRPh" title="::XDX::10"><span style="-sec-ix-hidden: xdx2ixbrl1215">ten</span></span> trading days prior to the conversion. The note was fully earned upon signing the agreement and matures on <span id="xdx_90E_eus-gaap--DebtInstrumentMaturityDate_dd_c20170807__20170810__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember_zmjK4drtFdhi" title="Debt maturity date"><ix:nonNumeric contextRef="From2017-08-072017-08-10_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember" format="ixt:datemonthdayyearen" name="us-gaap:DebtInstrumentMaturityDate">August 10,
2019</ix:nonNumeric></span>. The Company accrued <span id="xdx_906_eus-gaap--AccruedLiabilitiesCurrentAndNoncurrent_c20170630__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember_pp0p0" title="Accrued expenses">$<ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrentAndNoncurrent" contextRef="AsOf2017-06-30_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">155,000</ix:nonFraction></span> related to this expense at June 30, 2017 and recorded the remaining <span id="xdx_90A_eus-gaap--AccruedLiabilitiesCurrentAndNoncurrent_c20180630__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember_pp0p0" title="Accrued expenses">$<ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrentAndNoncurrent" contextRef="AsOf2018-06-30_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">155,000</ix:nonFraction></span> related to this expense
in fiscal year 2018. Upon an event of default, principal and accrued interest will become immediately due and payable under the note.
Additionally, upon an event of default, at the election of the holder, the note would accrue interest at a default interest rate of <span id="xdx_90E_ecustom--DebtInstrumentDebtDefaultInterestRate_dp_uPure_c20170807__20170810__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember_z0Krvi3m8oVc" title="Debt instrument, default, interest rate"><ix:nonFraction name="PPCB:DebtInstrumentDebtDefaultInterestRate" contextRef="From2017-08-072017-08-10_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">18</ix:nonFraction>%</span>
per annum or the highest rate of interest permitted by law. The consulting agreement had a three-month term and expired on August 16,
2017. An aggregate total of <span id="xdx_903_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_c20170810__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember_pp0p0" title="Embedded derivative, fair value of embedded derivative liability">$<ix:nonFraction name="us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" contextRef="AsOf2017-08-10_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">578,212</ix:nonFraction></span> of this note was bifurcated with the embedded conversion option recorded as a derivative liability
at fair value. During the year ended June 30, 2018, the consultant converted <span id="xdx_902_eus-gaap--DebtInstrumentFaceAmount_c20180630__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ConsultantMember_pp0p0" title="Convertible debt principal amount">$<ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2018-06-30_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember_custom_ConsultantMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">140,000</ix:nonFraction></span> of principal and <span id="xdx_901_eus-gaap--InterestPayableCurrentAndNoncurrent_c20180630__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ConsultantMember_pp0p0" title="Accrued interest">$<ix:nonFraction name="us-gaap:InterestPayableCurrentAndNoncurrent" contextRef="AsOf2018-06-30_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember_custom_ConsultantMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">10,764</ix:nonFraction></span> of interest. During the
year ended June 30, 2019, the consultant converted an additional <span id="xdx_903_eus-gaap--DebtInstrumentFaceAmount_c20190630__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ConsultantMember_pp0p0" title="Convertible debt principal amount">$<ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2019-06-30_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember_custom_ConsultantMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">161,000</ix:nonFraction></span> of principal and <span id="xdx_902_eus-gaap--InterestPayableCurrentAndNoncurrent_c20190630__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ConsultantMember_pp0p0" title="Accrued interest">$<ix:nonFraction name="us-gaap:InterestPayableCurrentAndNoncurrent" contextRef="AsOf2019-06-30_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember_custom_ConsultantMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">19,418</ix:nonFraction></span> of interest leaving a principal balance
owed of <span id="xdx_90D_eus-gaap--DebtInstrumentFaceAmount_c20190630__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember_pp0p0" title="Convertible debt principal amount">$<ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2019-06-30_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">9,000</ix:nonFraction></span> at June 30, 2019. During the year ended June 30, 2020, the consultant converted an additional <span id="xdx_903_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20190701__20200630__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember_pp0p0" title="Debt conversion of converted amount">$<ix:nonFraction name="us-gaap:DebtConversionConvertedInstrumentAmount1" contextRef="From2019-07-012020-06-30_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">500</ix:nonFraction></span> of principal and <span id="xdx_900_eus-gaap--AccruedLiabilitiesCurrentAndNoncurrent_c20200630__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember_pp0p0" title="Accrued expenses">$<ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrentAndNoncurrent" contextRef="AsOf2020-06-30_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,248</ix:nonFraction></span>
of interest such that the remaining principal outstanding and accrued interest under this note as of June 30, 2020 was <span id="xdx_904_eus-gaap--DebtInstrumentFaceAmount_c20200630__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember_pp0p0" title="Convertible debt principal amount">$<ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2020-06-30_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">8,500</ix:nonFraction></span> and <span id="xdx_903_eus-gaap--InterestPayableCurrentAndNoncurrent_c20200630__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember_pp0p0" title="Accrued interest">$<ix:nonFraction name="us-gaap:InterestPayableCurrentAndNoncurrent" contextRef="AsOf2020-06-30_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">22,168</ix:nonFraction></span>,
respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">On
March 15, 2021, the Company entered into a Settlement and Mutual Release Agreement (the &#8220;Settlement Agreement&#8221;) with the
consultant whereby both parties agreed to settle all claims and liabilities under the August 10, 2017 Convertible note for a total of
<span id="xdx_90F_eus-gaap--DebtInstrumentFaceAmount_c20210315__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember__us-gaap--ShortTermDebtTypeAxis__custom--SettlementAndMutualReleaseAgreementMember_pp0p0" title="Convertible debt principal amount">$<ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2021-03-15_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember_custom_SettlementAndMutualReleaseAgreementMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">100,000</ix:nonFraction></span> in the form of a convertible note. All other terms of the August 10, 2017 Convertible Note shall remain in full force and effect.
Both parties agree that all future penalties under this note are waived unless the Company fails to authorize to distribute the requested
shares upon conversion. The Company has the right to pay off the balance of any remaining amounts dues under this note in cash at any
time more than 60 days after March 15, 2021. Prior to the Settlement Agreement, the Company recorded total liabilities <span id="xdx_906_eus-gaap--Liabilities_iI_pp0p0_c20210315__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember__us-gaap--ShortTermDebtTypeAxis__custom--SettlementAndMutualReleaseAgreementMember_zlShDC1Kn4a1" title="Liabilities">$<ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2021-03-15_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember_custom_SettlementAndMutualReleaseAgreementMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">56,762</ix:nonFraction></span> consisting
of remaining principal amount of <span id="xdx_90A_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pp0p0_c20210315__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember__us-gaap--ShortTermDebtTypeAxis__custom--SettlementAndMutualReleaseAgreementMember_zTBqWM6Glnla" title="Original issue discount">$<ix:nonFraction name="us-gaap:DebtInstrumentUnamortizedDiscount" contextRef="AsOf2021-03-15_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember_custom_SettlementAndMutualReleaseAgreementMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">8,500</ix:nonFraction></span>, accrued interest of <span id="xdx_909_eus-gaap--InterestPayableCurrentAndNoncurrent_c20210315__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember__us-gaap--ShortTermDebtTypeAxis__custom--SettlementAndMutualReleaseAgreementMember_pp0p0" title="Accrued interest">$<ix:nonFraction name="us-gaap:InterestPayableCurrentAndNoncurrent" contextRef="AsOf2021-03-15_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember_custom_SettlementAndMutualReleaseAgreementMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">23,262</ix:nonFraction></span> and accrued expenses of <span id="xdx_904_eus-gaap--AccruedLiabilitiesCurrentAndNoncurrent_c20210315__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember__us-gaap--ShortTermDebtTypeAxis__custom--SettlementAndMutualReleaseAgreementMember_pp0p0" title="Accrued expenses">$<ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrentAndNoncurrent" contextRef="AsOf2021-03-15_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember_custom_SettlementAndMutualReleaseAgreementMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">25,000</ix:nonFraction></span>. Accordingly, the Company recognized
loss from settlement of debt of <span id="xdx_90D_eus-gaap--GainsLossesOnExtinguishmentOfDebt_c20200701__20210630__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember__us-gaap--ShortTermDebtTypeAxis__custom--SettlementAndMutualReleaseAgreementMember_pp0p0" title="Loss from settlement of debt">$<ix:nonFraction name="us-gaap:GainsLossesOnExtinguishmentOfDebt" contextRef="From2020-07-012021-06-30_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember_custom_SettlementAndMutualReleaseAgreementMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">43,238</ix:nonFraction></span> during the year ended June 30, 2021 which is included in gain from settlement of debt, net in
the accompanying consolidated statements of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
total principal outstanding after adjustment due to the above-mentioned March 15, 2021 settlement agreement and accrued
interest under the August 10, 2017 Convertible Note was <span id="xdx_90F_eus-gaap--ConvertibleNotesPayable_c20210630__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember__us-gaap--ShortTermDebtTypeAxis__custom--SettlementAndMutualReleaseAgreementMember_pp0p0">$<ix:nonFraction name="us-gaap:ConvertibleNotesPayable" contextRef="AsOf2021-06-30_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember_custom_SettlementAndMutualReleaseAgreementMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">80,000</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">and <span id="xdx_909_eus-gaap--InterestPayableCurrentAndNoncurrent_c20210630__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember__us-gaap--ShortTermDebtTypeAxis__custom--SettlementAndMutualReleaseAgreementMember_pp0p0">$<ix:nonFraction name="us-gaap:InterestPayableCurrentAndNoncurrent" contextRef="AsOf2021-06-30_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember_custom_SettlementAndMutualReleaseAgreementMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,738</ix:nonFraction></span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">,
respectively, as of June 30, 2021 following conversion of <span id="xdx_902_eus-gaap--DebtConversionConvertedInstrumentAmount1_pp0p0_c20200701__20210630__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember__us-gaap--ShortTermDebtTypeAxis__custom--SettlementAndMutualReleaseAgreementMember_zliV7VyKLZJ8">$<ix:nonFraction name="us-gaap:DebtConversionConvertedInstrumentAmount1" contextRef="From2020-07-012021-06-30_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember_custom_SettlementAndMutualReleaseAgreementMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">20,000</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">of principal during the year ended
June 30, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b><i>Power
Up Lending Group Financing Agreements</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><i>November
26, 2019 Securities Purchase Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Effective
November 26, 2019, the Company entered into a securities purchase agreement with Power Up Lending Group Ltd. (&#8220;Power Up&#8221;),
pursuant to which Power Up purchased a convertible promissory note (the &#8220;November 26, 2019 Power Up Note&#8221;) from the Company
in the aggregate principal amount of <span id="xdx_90D_eus-gaap--DebtInstrumentFaceAmount_c20191126__us-gaap--TypeOfArrangementAxis__custom--NovemberTwentySixTwoThousandNineteenSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--NovemberTwentySixTwoThousandNineteenPowerUpNoteMember_pp0p0" title="Convertible debt principal amount">$<ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2019-11-26_custom_NovemberTwentySixTwoThousandNineteenSecuritiesPurchaseAgreementMember_custom_NovemberTwentySixTwoThousandNineteenPowerUpNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">43,000</ix:nonFraction></span>, such principal and the interest thereon convertible into shares of the Company&#8217;s
common stock at the option of Power Up. The transaction closed on November 22, 2019 and the Company received payment on December 3, 2019
in the amount of <span id="xdx_900_ecustom--PrepaymentPenalties_c20191121__20191122__us-gaap--TypeOfArrangementAxis__custom--NovemberTwentySixTwoThousandNineteenSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--NovemberTwentySixTwoThousandNineteenPowerUpNoteMember_pp0p0" title="Prepayment penalty">$<ix:nonFraction name="PPCB:PrepaymentPenalties" contextRef="From2019-11-212019-11-22_custom_NovemberTwentySixTwoThousandNineteenSecuritiesPurchaseAgreementMember_custom_NovemberTwentySixTwoThousandNineteenPowerUpNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">40,000</ix:nonFraction></span>, net of <span id="xdx_90F_eus-gaap--LegalFees_c20191121__20191122__us-gaap--TypeOfArrangementAxis__custom--NovemberTwentySixTwoThousandNineteenSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--NovemberTwentySixTwoThousandNineteenPowerUpNoteMember_pp0p0" title="Legal fees">$<ix:nonFraction name="us-gaap:LegalFees" contextRef="From2019-11-212019-11-22_custom_NovemberTwentySixTwoThousandNineteenSecuritiesPurchaseAgreementMember_custom_NovemberTwentySixTwoThousandNineteenPowerUpNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,500</ix:nonFraction></span> paid directly toward legal fees and <span id="xdx_909_ecustom--DiligenceFees_c20191121__20191122__us-gaap--TypeOfArrangementAxis__custom--NovemberTwentySixTwoThousandNineteenSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--NovemberTwentySixTwoThousandNineteenPowerUpNoteMember_pp0p0" title="Diligence fees">$<ix:nonFraction name="PPCB:DiligenceFees" contextRef="From2019-11-212019-11-22_custom_NovemberTwentySixTwoThousandNineteenSecuritiesPurchaseAgreementMember_custom_NovemberTwentySixTwoThousandNineteenPowerUpNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">500</ix:nonFraction></span> to Power Up for due diligence fees. The maturity date
of the November 26, 2019 Power Up Note was <span id="xdx_90C_eus-gaap--DebtInstrumentMaturityDate_dd_c20191125__20191126__us-gaap--TypeOfArrangementAxis__custom--NovemberTwentySixTwoThousandNineteenSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--NovemberTwentySixTwoThousandNineteenPowerUpNoteMember_zYNvcL22ca51" title="Debt maturity date"><ix:nonNumeric contextRef="From2019-11-252019-11-26_custom_NovemberTwentySixTwoThousandNineteenSecuritiesPurchaseAgreementMember_custom_NovemberTwentySixTwoThousandNineteenPowerUpNoteMember" format="ixt:datemonthdayyearen" name="us-gaap:DebtInstrumentMaturityDate">November 26, 2020</ix:nonNumeric></span>. The November 26, 2019, Power Up Note bore interest at a rate of <span id="xdx_906_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20191126__us-gaap--TypeOfArrangementAxis__custom--NovemberTwentySixTwoThousandNineteenSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--NovemberTwentySixTwoThousandNineteenPowerUpNoteMember_zdNdNDpgTz2" title="Debt instrument, interest rate, stated percentage"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2019-11-26_custom_NovemberTwentySixTwoThousandNineteenSecuritiesPurchaseAgreementMember_custom_NovemberTwentySixTwoThousandNineteenPowerUpNoteMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">8</ix:nonFraction>%</span> per
annum, which interest was paid by the Company to Power Up in shares of the Company&#8217;s common stock but was not payable until the
November 26, 2019 Power Up Note became payable, whether at the maturity date or upon acceleration or by prepayment. The note was fully
converted in fiscal 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><i>January
7, 2020 Power Up Lending Group Securities Purchase Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Effective
January 7, 2020, the Company entered into a securities purchase agreement with Power Up Lending Group Ltd. (&#8220;Power Up&#8221;),
pursuant to which Power Up purchased a convertible promissory note (the &#8220;January 7, 2020 Power Up Note&#8221;) from the Company
in the aggregate principal amount of <span id="xdx_903_eus-gaap--DebtInstrumentFaceAmount_c20200107__us-gaap--TypeOfArrangementAxis__custom--JanuarySevenTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--JanuarySevenTwoThousandTwentyPowerUpNoteMember_pp0p0" title="Convertible debt principal amount">$<ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2020-01-07_custom_JanuarySevenTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember_custom_JanuarySevenTwoThousandTwentyPowerUpNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">75,000</ix:nonFraction></span>, such principal and the interest thereon convertible into shares of the Company&#8217;s
common stock at the option of Power Up. The transaction closed on January 7, 2020 and the Company received payment on January 13, 2020
in the amount of <span id="xdx_90E_ecustom--PrepaymentPenalties_c20200112__20200113__us-gaap--TypeOfArrangementAxis__custom--JanuarySevenTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--JanuarySevenTwoThousandTwentyPowerUpNoteMember_pp0p0" title="Prepayment penalty">$<ix:nonFraction name="PPCB:PrepaymentPenalties" contextRef="From2020-01-122020-01-13_custom_JanuarySevenTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember_custom_JanuarySevenTwoThousandTwentyPowerUpNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">72,000</ix:nonFraction></span>, net of <span id="xdx_908_eus-gaap--LegalFees_c20200112__20200113__us-gaap--TypeOfArrangementAxis__custom--JanuarySevenTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--JanuarySevenTwoThousandTwentyPowerUpNoteMember_pp0p0" title="Legal fees">$<ix:nonFraction name="us-gaap:LegalFees" contextRef="From2020-01-122020-01-13_custom_JanuarySevenTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember_custom_JanuarySevenTwoThousandTwentyPowerUpNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,500</ix:nonFraction></span> paid directly toward legal fees and <span id="xdx_903_ecustom--DiligenceFees_c20200112__20200113__us-gaap--TypeOfArrangementAxis__custom--JanuarySevenTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--JanuarySevenTwoThousandTwentyPowerUpNoteMember_pp0p0" title="Diligence fees">$<ix:nonFraction name="PPCB:DiligenceFees" contextRef="From2020-01-122020-01-13_custom_JanuarySevenTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember_custom_JanuarySevenTwoThousandTwentyPowerUpNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">500</ix:nonFraction></span> to Power Up for due diligence fees. The maturity date
of the January 7, 2020 Power Up Note was <span id="xdx_903_eus-gaap--DebtInstrumentMaturityDate_dd_c20200106__20200107__us-gaap--TypeOfArrangementAxis__custom--JanuarySevenTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--JanuarySevenTwoThousandTwentyPowerUpNoteMember_zjzmYAIZORch" title="Debt maturity date"><ix:nonNumeric contextRef="From2020-01-062020-01-07_custom_JanuarySevenTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember_custom_JanuarySevenTwoThousandTwentyPowerUpNoteMember" format="ixt:datemonthdayyearen" name="us-gaap:DebtInstrumentMaturityDate">January 7, 2021</ix:nonNumeric></span>. The January 7, 2020, Power Up Note bore interest at a rate of <span id="xdx_908_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20200107__us-gaap--TypeOfArrangementAxis__custom--JanuarySevenTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--JanuarySevenTwoThousandTwentyPowerUpNoteMember_ziD8r4iS1J77" title="Debt instrument, interest rate, stated percentage"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2020-01-07_custom_JanuarySevenTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember_custom_JanuarySevenTwoThousandTwentyPowerUpNoteMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">8</ix:nonFraction>%</span> per annum,
which interest was paid by the Company to Power Up in shares of the Company&#8217;s common stock, but not payable until the January 7,
2020 Power Up Note became payable, whether at the maturity date or upon acceleration or by prepayment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<ix:exclude><!-- Field: Page; Sequence: 108; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>PROPANC
BIOPHARMA, INC. AND SUBSIDIARY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>June
30, 2021 and 2020</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><i>March
12, 2020 Power Up Lending Group Securities Purchase Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Effective
March 12, 2020, the Company entered into a securities purchase agreement with Power Up Lending Group Ltd. (&#8220;Power Up&#8221;), pursuant
to which Power Up purchased a convertible promissory note (the &#8220;March 12, 2020 Power Up Note&#8221;) from the Company in the aggregate
principal amount of <span id="xdx_90B_eus-gaap--DebtInstrumentFaceAmount_c20200312__us-gaap--TypeOfArrangementAxis__custom--MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--MarchTwelveTwoThousandTwentyPowerUpNoteMember_pp0p0" title="Convertible debt principal amount">$<ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2020-03-12_custom_MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember_custom_MarchTwelveTwoThousandTwentyPowerUpNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">43,000</ix:nonFraction></span>, such principal and the interest thereon convertible into shares of the Company&#8217;s common stock at the
option of Power Up. The transaction closed on March 12, 2020 and the Company received payment on March 5, 2020 in the amount of <span id="xdx_90A_ecustom--PrepaymentPenalties_c20200304__20200305__us-gaap--TypeOfArrangementAxis__custom--MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--MarchTwelveTwoThousandTwentyPowerUpNoteMember_pp0p0" title="Prepayment penalty">$<ix:nonFraction name="PPCB:PrepaymentPenalties" contextRef="From2020-03-042020-03-05_custom_MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember_custom_MarchTwelveTwoThousandTwentyPowerUpNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">40,000</ix:nonFraction></span>,
net of <span id="xdx_906_eus-gaap--LegalFees_c20200304__20200305__us-gaap--TypeOfArrangementAxis__custom--MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--MarchTwelveTwoThousandTwentyPowerUpNoteMember_pp0p0" title="Legal fees">$<ix:nonFraction name="us-gaap:LegalFees" contextRef="From2020-03-042020-03-05_custom_MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember_custom_MarchTwelveTwoThousandTwentyPowerUpNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,500</ix:nonFraction></span> paid directly toward legal fees and <span id="xdx_903_ecustom--DiligenceFees_c20200304__20200305__us-gaap--TypeOfArrangementAxis__custom--MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--MarchTwelveTwoThousandTwentyPowerUpNoteMember_pp0p0" title="Diligence fees">$<ix:nonFraction name="PPCB:DiligenceFees" contextRef="From2020-03-042020-03-05_custom_MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember_custom_MarchTwelveTwoThousandTwentyPowerUpNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">500</ix:nonFraction></span> to Power Up for due diligence fees. The maturity date of the March 12, 2020 Power
Up Note was <span id="xdx_90D_eus-gaap--DebtInstrumentMaturityDate_dd_c20200311__20200312__us-gaap--TypeOfArrangementAxis__custom--MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--MarchTwelveTwoThousandTwentyPowerUpNoteMember_zm4Ozo2Yvwag" title="Debt maturity date"><ix:nonNumeric contextRef="From2020-03-112020-03-12_custom_MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember_custom_MarchTwelveTwoThousandTwentyPowerUpNoteMember" format="ixt:datemonthdayyearen" name="us-gaap:DebtInstrumentMaturityDate">March 12, 2021</ix:nonNumeric></span>. The March 12, 2020, Power Up Note bore interest at a rate of <span id="xdx_908_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20200312__us-gaap--TypeOfArrangementAxis__custom--MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--MarchTwelveTwoThousandTwentyPowerUpNoteMember_zSjxwDoJzOOc" title="Debt instrument, interest rate, stated percentage"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2020-03-12_custom_MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember_custom_MarchTwelveTwoThousandTwentyPowerUpNoteMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">8</ix:nonFraction>%</span> per annum, which interest may be paid by
the Company to Power Up in shares of the Company&#8217;s common stock but was not payable until the March 12, 2020 Power Up Note became
payable, whether at the maturity date or upon acceleration or by prepayment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">All
the notes issued above to Power Up contained certain events of default, upon which principal and accrued interest would become immediately
due and payable. In addition, upon an event of default, interest on the outstanding principal would accrue at a default interest rate
of <span id="xdx_90F_ecustom--DebtDefaultAmountPercentage_dp_uPure_c20200311__20200312__us-gaap--TypeOfArrangementAxis__custom--MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--MarchTwelveTwoThousandTwentyPowerUpNoteMember_zCkbqUUFvoOa" title="Debt default amount percentage"><ix:nonFraction name="PPCB:DebtDefaultAmountPercentage" contextRef="From2020-03-112020-03-12_custom_MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember_custom_MarchTwelveTwoThousandTwentyPowerUpNoteMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">22</ix:nonFraction>%</span> per annum.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Additionally,
Power Up had the option to convert all or any amount of the principal face amount of the notes issued to Power Up, starting on certain
dates as defined in the note agreements and ending on the later of the maturity date or the date the Default Amount is paid if an event
of default occurs, which was an amount equal to <span id="xdx_904_ecustom--DebtInstrumentDebtDefaultInterestRate_dp_uPure_c20200311__20200312__us-gaap--TypeOfArrangementAxis__custom--MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--MarchTwelveTwoThousandTwentyPowerUpNoteMember_zy0zG934qIS8" title="Debt instrument, default, interest rate"><ix:nonFraction name="PPCB:DebtInstrumentDebtDefaultInterestRate" contextRef="From2020-03-112020-03-12_custom_MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember_custom_MarchTwelveTwoThousandTwentyPowerUpNoteMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">150</ix:nonFraction>%</span> of an amount equal to the then outstanding principal amount of the notes plus any
interest accrued, for shares of the Company&#8217;s common stock at the then-applicable conversion price.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span id="xdx_902_eus-gaap--DebtConversionDescription_c20200311__20200312__us-gaap--TypeOfArrangementAxis__custom--MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--MarchTwelveTwoThousandTwentyPowerUpNoteMember" title="Debt conversion, description"><ix:nonNumeric contextRef="From2020-03-112020-03-12_custom_MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember_custom_MarchTwelveTwoThousandTwentyPowerUpNoteMember" name="us-gaap:DebtConversionDescription">The
conversion price for the above Power Up notes was $3,050, subject to certain Market Price (as defined below) adjustment. If the Market
Price was greater than or equal to $5,000, the conversion price was to be the greater of <span id="xdx_90D_eus-gaap--DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_dp_uPure_c20200311__20200312__us-gaap--TypeOfArrangementAxis__custom--MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--MarchTwelveTwoThousandTwentyPowerUpNoteMember_zAlegf67tQq2" title="Common stock trading volume, percent"><ix:nonFraction name="us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" contextRef="From2020-03-112020-03-12_custom_MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember_custom_MarchTwelveTwoThousandTwentyPowerUpNoteMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">65</ix:nonFraction>%</span> of the Market Price (&#8220;Variable Conversion
Price&#8221;) and $3,050. In the event Market Price was less than $5,000, the conversion price was to be the Variable Conversion Price.
As defined in the note agreements, the &#8220;Market Price&#8221; was the average of the lowest three closing bid prices during the <span id="xdx_904_eus-gaap--DebtInstrumentConvertibleThresholdTradingDays_dc_uInteger_c20200311__20200312__us-gaap--TypeOfArrangementAxis__custom--MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--MarchTwelveTwoThousandTwentyPowerUpNoteMember_zmK9EcdpAoe2" title="Common stock trading days"><ix:nonFraction name="us-gaap:DebtInstrumentConvertibleThresholdTradingDays" contextRef="From2020-03-112020-03-12_custom_MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember_custom_MarchTwelveTwoThousandTwentyPowerUpNoteMember" format="ixt-sec:numwordsen" decimals="INF" unitRef="Integer">ten</ix:nonFraction></span>
day trading period prior to and including the day the Company receives a notice of conversion from Power Up on the electronic quotation
system or applicable principal securities exchange or trading market or, if no closing bid price of such security is available in any
of the foregoing manners, the average of the closing bid prices of any market makers for such security that are listed in the &#8220;pink
sheets&#8221; during the ten prior trading days, including the day upon which the Company receives a notice of conversion from Power
Up. Notwithstanding the foregoing, Power Up was restricted from effecting a conversion if such conversion, along with other shares of
the Company&#8217;s common stock beneficially owned by Power Up and its affiliates, exceeds <span id="xdx_90B_ecustom--PercentageOfOutstandingSharesOfCommonStock_dp_uPure_c20200311__20200312__us-gaap--TypeOfArrangementAxis__custom--MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--MarchTwelveTwoThousandTwentyPowerUpNoteMember_zMMUxQV5ZnF3" title="Percentage of outstanding shares of common stock"><ix:nonFraction name="PPCB:PercentageOfOutstandingSharesOfCommonStock" contextRef="From2020-03-112020-03-12_custom_MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember_custom_MarchTwelveTwoThousandTwentyPowerUpNoteMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">4.99</ix:nonFraction>%</span> of the outstanding shares of the Company&#8217;s
common stock.</ix:nonNumeric></span> An aggregate initial total of <span id="xdx_90F_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_c20200312__us-gaap--TypeOfArrangementAxis__custom--MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--MarchTwelveTwoThousandTwentyPowerUpNoteMember_pp0p0" title="Embedded derivative, fair value of embedded derivative liability">$<ix:nonFraction name="us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" contextRef="AsOf2020-03-12_custom_MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember_custom_MarchTwelveTwoThousandTwentyPowerUpNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">422,557</ix:nonFraction></span> of these notes were bifurcated with the embedded conversion option recorded as derivative
liabilities at fair value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
total principal amount outstanding under the above Power Up financing agreements, specifically the January 7, 2020 and March 12, 2020
Power Up Notes, was <span id="xdx_909_eus-gaap--DebtInstrumentFaceAmount_c20200107__us-gaap--TypeOfArrangementAxis__custom--MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--MarchTwelveTwoThousandTwentyPowerUpNoteMember_pp0p0" title="Convertible debt principal amount"><span id="xdx_908_eus-gaap--DebtInstrumentFaceAmount_c20200630__us-gaap--TypeOfArrangementAxis__custom--MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--MarchTwelveTwoThousandTwentyPowerUpNoteMember_pp0p0" title="Convertible debt principal amount">$<ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2020-01-07_custom_MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember_custom_MarchTwelveTwoThousandTwentyPowerUpNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2020-06-30_custom_MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember_custom_MarchTwelveTwoThousandTwentyPowerUpNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">118,000</ix:nonFraction></ix:nonFraction></span></span> and accrued interest of <span id="xdx_90A_eus-gaap--InterestPayableCurrentAndNoncurrent_c20200107__us-gaap--TypeOfArrangementAxis__custom--MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--MarchTwelveTwoThousandTwentyPowerUpNoteMember_pp0p0" title="Accrued interest"><span id="xdx_905_eus-gaap--InterestPayableCurrentAndNoncurrent_c20200630__us-gaap--TypeOfArrangementAxis__custom--MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--MarchTwelveTwoThousandTwentyPowerUpNoteMember_pp0p0" title="Accrued interest">$<ix:nonFraction name="us-gaap:InterestPayableCurrentAndNoncurrent" contextRef="AsOf2020-01-07_custom_MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember_custom_MarchTwelveTwoThousandTwentyPowerUpNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD"><ix:nonFraction name="us-gaap:InterestPayableCurrentAndNoncurrent" contextRef="AsOf2020-06-30_custom_MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember_custom_MarchTwelveTwoThousandTwentyPowerUpNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,903</ix:nonFraction></ix:nonFraction></span></span> as of June 30, 2020. The total principal amount outstanding under the above
Power Up financing agreement, specifically the January 7, 2020 and March 12, 2020 Power Up Notes, was <span id="xdx_90F_eus-gaap--DebtInstrumentFaceAmount_c20210630__us-gaap--TypeOfArrangementAxis__custom--MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--MarchTwelveTwoThousandTwentyPowerUpNoteMember_pp0p0" title="Convertible debt principal amount">$<ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2021-06-30_custom_MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember_custom_MarchTwelveTwoThousandTwentyPowerUpNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">0</ix:nonFraction></span> and accrued interest of <span id="xdx_904_eus-gaap--InterestPayableCurrentAndNoncurrent_c20210630__us-gaap--TypeOfArrangementAxis__custom--MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--MarchTwelveTwoThousandTwentyPowerUpNoteMember_pp0p0" title="Accrued interest">$<ix:nonFraction name="us-gaap:InterestPayableCurrentAndNoncurrent" contextRef="AsOf2021-06-30_custom_MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember_custom_MarchTwelveTwoThousandTwentyPowerUpNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">0</ix:nonFraction></span> as
of June 30, 2021 following repayment in cash of <span id="xdx_905_eus-gaap--RepaymentsOfDebt_c20200701__20210630__us-gaap--TypeOfArrangementAxis__custom--MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--MarchTwelveTwoThousandTwentyPowerUpNoteMember_pp0p0" title="Repayment in cash">$<ix:nonFraction name="us-gaap:RepaymentsOfDebt" contextRef="From2020-07-012021-06-30_custom_MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember_custom_MarchTwelveTwoThousandTwentyPowerUpNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">43,000</ix:nonFraction></span> of the principal balance and <span id="xdx_904_eus-gaap--InterestPaid_c20200701__20210630__us-gaap--TypeOfArrangementAxis__custom--MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--MarchTwelveTwoThousandTwentyPowerUpNoteMember_pp0p0" title="Repayment of interest">$<ix:nonFraction name="us-gaap:InterestPaid" contextRef="From2020-07-012021-06-30_custom_MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember_custom_MarchTwelveTwoThousandTwentyPowerUpNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,816</ix:nonFraction></span> of accrued interest and conversions into
common stock during the year ended June 30, 2021. Accordingly, there was <span id="xdx_90F_eus-gaap--ConvertibleNotesPayable_iI_pp0p0_do_c20210630__us-gaap--TypeOfArrangementAxis__custom--MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--MarchTwelveTwoThousandTwentyPowerUpNoteMember_z2XBC9mbBouf" title="Convertible debt outstanding balance"><ix:nonFraction name="us-gaap:ConvertibleNotesPayable" contextRef="AsOf2021-06-30_custom_MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember_custom_MarchTwelveTwoThousandTwentyPowerUpNoteMember" format="ixt-sec:numwordsen" decimals="0" scale="0" unitRef="USD">no</ix:nonFraction></span> outstanding principal balance as of June 30, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b><i>Redstart
Holdings Corp Financing Agreement</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><i>May
23, 2019 Securities Purchase Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Effective
May 23, 2019, the Company issued a convertible promissory note (the &#8220;May 23 Redstart Holdings Note&#8221;) to Redstart Holdings
Corp (&#8220;Redstart Holdings&#8221;) in the aggregate principal amount of <span id="xdx_90F_eus-gaap--DebtInstrumentFaceAmount_c20190523__us-gaap--TypeOfArrangementAxis__custom--RedstartHoldingsCorpFinancingAgreementMember__dei--LegalEntityAxis__custom--RedstartHoldingsCorpMember_pp0p0" title="Convertible debt principal amount">$<ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2019-05-23_custom_RedstartHoldingsCorpFinancingAgreementMember_custom_RedstartHoldingsCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">133,000</ix:nonFraction></span>, with principal and the interest thereon convertible
into shares of the Company&#8217;s common stock at the option of Redstart Holdings any time after 180 days of issuance. At the time of
closing on May 31, 2019, Redstart Holdings deducted <span id="xdx_90D_eus-gaap--LegalFees_c20190522__20190523__us-gaap--TypeOfArrangementAxis__custom--RedstartHoldingsCorpFinancingAgreementMember__dei--LegalEntityAxis__custom--RedstartHoldingsCorpMember_pp0p0" title="Legal fees">$<ix:nonFraction name="us-gaap:LegalFees" contextRef="From2019-05-222019-05-23_custom_RedstartHoldingsCorpFinancingAgreementMember_custom_RedstartHoldingsCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,000</ix:nonFraction></span> from the principal payment due under the May 2019 Redstart Holdings Note to
be applied to its legal expenses, such that the Company received aggregate net proceeds of <span id="xdx_90F_eus-gaap--ProceedsFromConvertibleDebt_pp0p0_c20190522__20190523__us-gaap--TypeOfArrangementAxis__custom--RedstartHoldingsCorpFinancingAgreementMember__dei--LegalEntityAxis__custom--RedstartHoldingsCorpMember_zsaJUYDGLanl" title="Proceeds from convertible debt">$<ix:nonFraction name="us-gaap:ProceedsFromConvertibleDebt" contextRef="From2019-05-222019-05-23_custom_RedstartHoldingsCorpFinancingAgreementMember_custom_RedstartHoldingsCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">130,000</ix:nonFraction></span> at closing. The maturity date of
the May 2019 Redstart Holdings Note was <span id="xdx_901_eus-gaap--DebtInstrumentMaturityDate_dd_c20190522__20190523__us-gaap--TypeOfArrangementAxis__custom--RedstartHoldingsCorpFinancingAgreementMember__dei--LegalEntityAxis__custom--RedstartHoldingsCorpMember_zBtTZ0apbbh1" title="Debt maturity date"><ix:nonNumeric contextRef="From2019-05-222019-05-23_custom_RedstartHoldingsCorpFinancingAgreementMember_custom_RedstartHoldingsCorpMember" format="ixt:datemonthdayyearen" name="us-gaap:DebtInstrumentMaturityDate">May 23, 2020</ix:nonNumeric></span> and bore interest at a rate of <span id="xdx_90A_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20190523__us-gaap--TypeOfArrangementAxis__custom--RedstartHoldingsCorpFinancingAgreementMember__dei--LegalEntityAxis__custom--RedstartHoldingsCorpMember_z8zNwVHOEIxb" title="Debt instrument, interest rate, stated percentage"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2019-05-23_custom_RedstartHoldingsCorpFinancingAgreementMember_custom_RedstartHoldingsCorpMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">8</ix:nonFraction>%</span> per annum. The total principal amount outstanding
and accrued interest under the above Redstart Holdings financing agreement, specifically the May 23, 2019 agreement at June 30, 2019
was <span id="xdx_908_eus-gaap--DebtInstrumentFaceAmount_c20190630__us-gaap--TypeOfArrangementAxis__custom--RedstartHoldingsCorpFinancingAgreementMember__dei--LegalEntityAxis__custom--RedstartHoldingsCorpMember_pp0p0" title="Convertible debt principal amount">$<ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2019-06-30_custom_RedstartHoldingsCorpFinancingAgreementMember_custom_RedstartHoldingsCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">133,000</ix:nonFraction></span> and <span id="xdx_901_eus-gaap--InterestPayableCurrentAndNoncurrent_c20190630__us-gaap--TypeOfArrangementAxis__custom--RedstartHoldingsCorpFinancingAgreementMember__dei--LegalEntityAxis__custom--RedstartHoldingsCorpMember_pp0p0" title="Accrued interest">$<ix:nonFraction name="us-gaap:InterestPayableCurrentAndNoncurrent" contextRef="AsOf2019-06-30_custom_RedstartHoldingsCorpFinancingAgreementMember_custom_RedstartHoldingsCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,137</ix:nonFraction></span> respectively and as of June 30, 2020 total principal amount outstanding and accrued interest totaled <span id="xdx_901_eus-gaap--DebtInstrumentFaceAmount_c20200630__us-gaap--TypeOfArrangementAxis__custom--RedstartHoldingsCorpFinancingAgreementMember__dei--LegalEntityAxis__custom--RedstartHoldingsCorpMember_pp0p0" title="Convertible debt principal amount">$<ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2020-06-30_custom_RedstartHoldingsCorpFinancingAgreementMember_custom_RedstartHoldingsCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">0</ix:nonFraction></span> and <span id="xdx_909_eus-gaap--InterestPayableCurrentAndNoncurrent_c20200630__us-gaap--TypeOfArrangementAxis__custom--RedstartHoldingsCorpFinancingAgreementMember__dei--LegalEntityAxis__custom--RedstartHoldingsCorpMember_pp0p0" title="Accrued interest">$<ix:nonFraction name="us-gaap:InterestPayableCurrentAndNoncurrent" contextRef="AsOf2020-06-30_custom_RedstartHoldingsCorpFinancingAgreementMember_custom_RedstartHoldingsCorpMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">0</ix:nonFraction></span>
respectively following conversion of <span id="xdx_900_eus-gaap--DebtInstrumentFaceAmount_c20200630__us-gaap--TypeOfArrangementAxis__custom--RedstartHoldingsCorpFinancingAgreementMember_pp0p0" title="Convertible debt principal amount">$<ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2020-06-30_custom_RedstartHoldingsCorpFinancingAgreementMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">133,000</ix:nonFraction></span> of the principal balance and <span id="xdx_903_eus-gaap--InterestPayableCurrentAndNoncurrent_c20200630__us-gaap--TypeOfArrangementAxis__custom--RedstartHoldingsCorpFinancingAgreementMember_pp0p0" title="Accrued interest">$<ix:nonFraction name="us-gaap:InterestPayableCurrentAndNoncurrent" contextRef="AsOf2020-06-30_custom_RedstartHoldingsCorpFinancingAgreementMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,320</ix:nonFraction></span> of accrued interest during the year ended June 30,
2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<ix:exclude><!-- Field: Page; Sequence: 109; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>PROPANC
BIOPHARMA, INC. AND SUBSIDIARY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>June
30, 2021 and 2020</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b><i>Odyssey
Capital Financing Agreements</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><i>July
30, 2019 Securities Purchase Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Effective
July 30, 2019, the Company entered into a securities purchase agreement with Odyssey Capital Funding LLC, (&#8220;Odyssey&#8221;), pursuant
to which Odyssey purchased a convertible promissory note (the &#8220;July 30, 2019 Odyssey Note&#8221;) from the Company in the aggregate
principal amount of <span id="xdx_906_eus-gaap--DebtInstrumentFaceAmount_c20190730__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OdysseyCapitalFundingLLCMember__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandNineteenOdysseyNoteMember_pp0p0" title="Convertible debt principal amount">$<ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2019-07-30_custom_SecuritiesPurchaseAgreementMember_custom_OdysseyCapitalFundingLLCMember_custom_JulyTwoThousandNineteenOdysseyNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">320,000</ix:nonFraction></span>, such principal and the interest thereon convertible into shares of the Company&#8217;s common stock at
the option of Odyssey. The July 30, 2019 Odyssey Note contains an original discount of <span id="xdx_90A_eus-gaap--DebtInstrumentUnamortizedDiscount_c20190730__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OdysseyCapitalFundingLLCMember__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandNineteenOdysseyNoteMember_pp0p0" title="Original issue discount">$<ix:nonFraction name="us-gaap:DebtInstrumentUnamortizedDiscount" contextRef="AsOf2019-07-30_custom_SecuritiesPurchaseAgreementMember_custom_OdysseyCapitalFundingLLCMember_custom_JulyTwoThousandNineteenOdysseyNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">25,000</ix:nonFraction></span>. The transaction closed on July 30, 2019
and the Company received payment on August 1, 2019 in the amount of <span id="xdx_905_eus-gaap--DebtInstrumentFaceAmount_c20190801__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OdysseyCapitalFundingLLCMember__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandNineteenOdysseyNoteMember_pp0p0" title="Convertible debt principal amount">$<ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2019-08-01_custom_SecuritiesPurchaseAgreementMember_custom_OdysseyCapitalFundingLLCMember_custom_JulyTwoThousandNineteenOdysseyNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">295,000</ix:nonFraction></span>, of which <span id="xdx_90D_eus-gaap--LegalFees_c20190731__20190801__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OdysseyCapitalFundingLLCMember__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandNineteenOdysseyNoteMember_pp0p0" title="Legal fees">$<ix:nonFraction name="us-gaap:LegalFees" contextRef="From2019-07-312019-08-01_custom_SecuritiesPurchaseAgreementMember_custom_OdysseyCapitalFundingLLCMember_custom_JulyTwoThousandNineteenOdysseyNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">10,000</ix:nonFraction></span> was paid directly toward legal fees, resulting
in net cash proceeds of <span id="xdx_90F_eus-gaap--ProceedsFromConvertibleDebt_c20190731__20190801__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OdysseyCapitalFundingLLCMember__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandNineteenOdysseyNoteMember_pp0p0" title="Proceeds from convertible debt">$<ix:nonFraction name="us-gaap:ProceedsFromConvertibleDebt" contextRef="From2019-07-312019-08-01_custom_SecuritiesPurchaseAgreementMember_custom_OdysseyCapitalFundingLLCMember_custom_JulyTwoThousandNineteenOdysseyNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">285,000</ix:nonFraction></span>. The maturity date of the July 30, 2019 Odyssey Note was <span id="xdx_90E_eus-gaap--DebtInstrumentMaturityDate_dd_c20190729__20190730__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OdysseyCapitalFundingLLCMember__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandNineteenOdysseyNoteMember_zWK5JPNAl2Ve" title="Debt maturity date"><ix:nonNumeric contextRef="From2019-07-292019-07-30_custom_SecuritiesPurchaseAgreementMember_custom_OdysseyCapitalFundingLLCMember_custom_JulyTwoThousandNineteenOdysseyNoteMember" format="ixt:datemonthdayyearen" name="us-gaap:DebtInstrumentMaturityDate">July 30, 2020</ix:nonNumeric></span>. The July 2019 Odyssey Note bore
interest at a rate of <span id="xdx_90F_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20190730__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OdysseyCapitalFundingLLCMember__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandNineteenOdysseyNoteMember_zqG7xTnQih53" title="Debt instrument, interest rate, stated percentage"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2019-07-30_custom_SecuritiesPurchaseAgreementMember_custom_OdysseyCapitalFundingLLCMember_custom_JulyTwoThousandNineteenOdysseyNoteMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">10</ix:nonFraction>%</span> per annum, which interest may be paid by the Company to Odyssey in shares of the Company&#8217;s common stock
but was not payable until the July 30, 2019 Odyssey Note became payable, whether at the maturity date or upon acceleration or by prepayment.
The July 30, 2019 Odyssey Note contained certain events of default, upon which principal and accrued interest would become immediately
due and payable. In addition, upon an event of default, interest on the outstanding principal would accrue at a default interest rate
of <span id="xdx_90C_ecustom--DebtInstrumentDebtDefaultInterestRate_dp_uPure_c20190729__20190730__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OdysseyCapitalFundingLLCMember__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandNineteenOdysseyNoteMember_z4GYRD1EAux2" title="Debt instrument, default, interest rate"><ix:nonFraction name="PPCB:DebtInstrumentDebtDefaultInterestRate" contextRef="From2019-07-292019-07-30_custom_SecuritiesPurchaseAgreementMember_custom_OdysseyCapitalFundingLLCMember_custom_JulyTwoThousandNineteenOdysseyNoteMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">24</ix:nonFraction>%</span> per annum. The note was treated as stock settled debt under ASC 480 and accordingly the Company recorded a <span id="xdx_90E_eus-gaap--DebtInstrumentUnamortizedPremium_c20190730__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OdysseyCapitalFundingLLCMember__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandNineteenOdysseyNoteMember_pp0p0" title="Debt premium amount">$<ix:nonFraction name="us-gaap:DebtInstrumentUnamortizedPremium" contextRef="AsOf2019-07-30_custom_SecuritiesPurchaseAgreementMember_custom_OdysseyCapitalFundingLLCMember_custom_JulyTwoThousandNineteenOdysseyNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">172,308</ix:nonFraction></span> put premium.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Additionally,
Odyssey had the option to convert all or any amount of the principal face amount of the July 30, 2019 Odyssey Note, starting on January
31, 2020 and ending on the later of the maturity date or the date the Default Amount was paid if an event of default occurred, which
was an amount equal to <span id="xdx_905_ecustom--PercentageOfOutstandingSharesOfCommonStock_dp_uPure_c20190729__20190730__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OdysseyCapitalFundingLLCMember__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandNineteenOdysseyNoteMember_z1rJRtZ91Hl7" title="Percentage of outstanding shares of common stock"><ix:nonFraction name="PPCB:PercentageOfOutstandingSharesOfCommonStock" contextRef="From2019-07-292019-07-30_custom_SecuritiesPurchaseAgreementMember_custom_OdysseyCapitalFundingLLCMember_custom_JulyTwoThousandNineteenOdysseyNoteMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">120</ix:nonFraction>%</span> of an amount equal to the then outstanding principal amount of the July 30, 2019 Odyssey Note plus any interest
accrued from July 30, 2019 at the default interest rate of <span id="xdx_90C_ecustom--DebtInstrumentDebtDefaultInterestRate_dp_uPure_c20190729__20190730__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OdysseyCapitalFundingLLCMember__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandNineteenOdysseyNoteMember_z6AHBubMbEZc" title="Debt instrument, default, interest rate"><ix:nonFraction name="PPCB:DebtInstrumentDebtDefaultInterestRate" contextRef="From2019-07-292019-07-30_custom_SecuritiesPurchaseAgreementMember_custom_OdysseyCapitalFundingLLCMember_custom_JulyTwoThousandNineteenOdysseyNoteMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">24</ix:nonFraction>%</span> per annum for shares of the Company&#8217;s common stock at the then-applicable
conversion price.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
conversion price for the July 30, 2019 Odyssey Note was equal to <span id="xdx_90D_eus-gaap--DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_dp_uPure_c20190729__20190730__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OdysseyCapitalFundingLLCMember__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandNineteenOdysseyNoteMember_ztZQkrsuCRji" title="Common stock trading volume, percent"><ix:nonFraction name="us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" contextRef="From2019-07-292019-07-30_custom_SecuritiesPurchaseAgreementMember_custom_OdysseyCapitalFundingLLCMember_custom_JulyTwoThousandNineteenOdysseyNoteMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">65</ix:nonFraction>%</span> of the lowest closing bid price of the Common Stock as reported
on the OTC Markets on which the Company&#8217;s shares were then traded or any exchange upon which the Common Stock may be traded in
the future, for the ten prior trading days including the day upon which a Notice of Conversion is received by the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
total principal amount outstanding under the above Odyssey financing agreement, specifically the July 30, 2019 Odyssey Note, was <span id="xdx_907_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OdysseyCapitalFundingLLCMember_zR13FwGy6Ia8" title="Convertible debt principal amount">$<ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2020-06-30_custom_SecuritiesPurchaseAgreementMember_custom_OdysseyCapitalFundingLLCMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">0</ix:nonFraction></span> and
accrued interest of <span id="xdx_90D_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OdysseyCapitalFundingLLCMember_zpqSURkjpol9" title="Accrued interest">$<ix:nonFraction name="us-gaap:InterestPayableCurrentAndNoncurrent" contextRef="AsOf2020-06-30_custom_SecuritiesPurchaseAgreementMember_custom_OdysseyCapitalFundingLLCMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">0</ix:nonFraction></span> as of June 30, 2020 following conversion of <span id="xdx_903_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20190701__20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OdysseyCapitalFundingLLCMember__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandNineteenOdysseyNoteMember_pp0p0" title="Debt conversion of converted amount">$<ix:nonFraction name="us-gaap:DebtConversionConvertedInstrumentAmount1" contextRef="From2019-07-012020-06-30_custom_SecuritiesPurchaseAgreementMember_custom_OdysseyCapitalFundingLLCMember_custom_JulyTwoThousandNineteenOdysseyNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">320,000</ix:nonFraction></span> of the principal balance and <span id="xdx_907_eus-gaap--InterestPayableCurrentAndNoncurrent_c20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OdysseyCapitalFundingLLCMember__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandNineteenOdysseyNoteMember_pp0p0" title="Accrued interest">$<ix:nonFraction name="us-gaap:InterestPayableCurrentAndNoncurrent" contextRef="AsOf2020-06-30_custom_SecuritiesPurchaseAgreementMember_custom_OdysseyCapitalFundingLLCMember_custom_JulyTwoThousandNineteenOdysseyNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">23,220</ix:nonFraction></span> of accrued interest
during the year ended June 30, 2020 resulting in full repayment of the note and a full reduction of the put premium. The note was fully
converted in fiscal 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b><i>Auctus
Fund Financing Agreements</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><i>August
30, 2019 Securities Purchase Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Effective
August 30, 2019, the Company entered into a securities purchase agreement with Auctus Fund, LLC (&#8220;Auctus&#8221;), pursuant to which
Auctus purchased a convertible promissory note (the &#8220;August 30, 2019 Auctus Note&#8221;) from the Company in the aggregate principal
amount of <span id="xdx_90C_eus-gaap--DebtInstrumentFaceAmount_c20190830__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_pp0p0" title="Convertible debt principal amount">$<ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2019-08-30_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">550,000</ix:nonFraction></span>, such principal and the interest thereon convertible into shares of the Company&#8217;s common stock at the option
of Auctus. The transaction closed on August 30, 2019 and the Company received payment on September 4, 2019 in the amount of <span id="xdx_904_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20190904__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_zbGEPw4WPvlj" title="Convertible debt principal amount">$<ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2019-09-04_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">550,000</ix:nonFraction></span>,
of which <span id="xdx_901_eus-gaap--LegalFees_pp0p0_c20190903__20190904__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_zO4UPbfesMyh" title="Legal fees">$<ix:nonFraction name="us-gaap:LegalFees" contextRef="From2019-09-032019-09-04_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,000</ix:nonFraction></span> was paid directly toward legal fees and <span id="xdx_903_ecustom--DiligenceFees_c20190903__20190904__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_pp0p0" title="Diligence fees">$<ix:nonFraction name="PPCB:DiligenceFees" contextRef="From2019-09-032019-09-04_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">40,000</ix:nonFraction></span> to Auctus for due diligence fees resulting in net cash proceeds of <span id="xdx_908_eus-gaap--ProceedsFromConvertibleDebt_c20190903__20190904__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_pp0p0" title="Proceeds from convertible debt">$<ix:nonFraction name="us-gaap:ProceedsFromConvertibleDebt" contextRef="From2019-09-032019-09-04_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">505,000</ix:nonFraction></span>.
The maturity date of the August 30, 2019 Auctus Note was <span id="xdx_90E_eus-gaap--DebtInstrumentMaturityDate_dd_c20190829__20190830__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_zhfCVziB2L77" title="Debt maturity date"><ix:nonNumeric contextRef="From2019-08-292019-08-30_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember" format="ixt:datemonthdayyearen" name="us-gaap:DebtInstrumentMaturityDate">August 30, 2020</ix:nonNumeric></span> and is currently past due. The August 30, 2019 Auctus Note bears
interest at a rate of <span id="xdx_901_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20190830__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_zMKgIwj5n8xf" title="Debt instrument, interest rate, stated percentage"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2019-08-30_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">10</ix:nonFraction>%</span> per annum, but not payable until the August 30, 2019 Auctus Note became payable, whether at the maturity date
or upon acceleration or by prepayment. The note is treated as stock settled debt under ASC 480 and accordingly the Company recorded a
<span id="xdx_904_eus-gaap--DebtInstrumentUnamortizedPremium_c20190830__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_pp0p0" title="Debt premium amount">$<ix:nonFraction name="us-gaap:DebtInstrumentUnamortizedPremium" contextRef="AsOf2019-08-30_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">366,667</ix:nonFraction></span> put premium. The August 30, 2019 Auctus Note may not be prepaid without the written consent of Auctus. Any amount of principal
or interest which is not paid when due shall bear interest at the rate of <span id="xdx_90E_ecustom--DebtInstrumentDebtDefaultInterestRate_dp_uPure_c20190829__20190830__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_zaBaVI3NWg64" title="Debt instrument, default, interest rate"><ix:nonFraction name="PPCB:DebtInstrumentDebtDefaultInterestRate" contextRef="From2019-08-292019-08-30_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">24</ix:nonFraction>%</span> per annum.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Additionally,
Auctus has the option to convert all or any amount of the principal face amount and accrued interest of the August 30, 2019 Auctus Note,
at any time following the issue date and ending on the later of the maturity date or the date of payment of the Default Amount if an
event of default occurs, which is an amount equal to <span id="xdx_90E_ecustom--PercentageOfOutstandingSharesOfCommonStock_dp_uPure_c20190829__20190830__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_z60xIdLxExua" title="Percentage of outstanding shares of common stock"><ix:nonFraction name="PPCB:PercentageOfOutstandingSharesOfCommonStock" contextRef="From2019-08-292019-08-30_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">125</ix:nonFraction>%</span> of an amount equal to the then outstanding principal amount of the August 30,
2019 Auctus Note (but not less than $15,000) plus any interest accrued from August 30, 2019 at the default interest rate of <span id="xdx_90F_ecustom--DebtInstrumentDebtDefaultInterestRate_dp_uPure_c20190829__20190830__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_zSwxjiCA1BAe" title="Debt instrument, default, interest rate"><ix:nonFraction name="PPCB:DebtInstrumentDebtDefaultInterestRate" contextRef="From2019-08-292019-08-30_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">24</ix:nonFraction>%</span> per annum,
for shares of the Company&#8217;s common stock at the then-applicable conversion price. <span id="xdx_900_eus-gaap--DebtInstrumentDescription_c20190829__20190830__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember" title="Debt instrument, description"><ix:nonNumeric contextRef="From2019-08-292019-08-30_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember" name="us-gaap:DebtInstrumentDescription">Upon the holder&#8217;s election to convert accrued
interest, default interest or any penalty amounts as stipulated, the Company may elect to pay those amounts in cash. The note may also
be prepaid by the Company at any time between the date of issuance and August 13, 2020 at 135% multiplied by the sum of (a) the then
outstanding principal amount plus (b) accrued and unpaid interest plus (c) default interests</ix:nonNumeric></span>, if any.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
conversion price for the August 30, 2019 Auctus Note shall be the Variable Conversion Price, being <span id="xdx_90F_eus-gaap--DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_dp_uPure_c20190903__20190904__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_zWk8n9vZwnnc" title="Common stock trading volume, percent"><ix:nonFraction name="us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" contextRef="From2019-09-032019-09-04_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">60</ix:nonFraction>%</span> of the Market Price on the date
of conversion. Notwithstanding the foregoing, Auctus shall be restricted from effecting a conversion if such conversion, along with other
shares of the Company&#8217;s common stock beneficially owned by Auctus and its affiliates, exceeds <span id="xdx_908_ecustom--PercentageOfOutstandingSharesOfCommonStock_dp_uPure_c20190903__20190904__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_zvyXzOqt6ctl" title="Percentage of outstanding shares of common stock"><ix:nonFraction name="PPCB:PercentageOfOutstandingSharesOfCommonStock" contextRef="From2019-09-032019-09-04_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">4.99</ix:nonFraction>%</span> of the outstanding shares of
the Company&#8217;s common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<ix:exclude><!-- Field: Page; Sequence: 110; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>PROPANC
BIOPHARMA, INC. AND SUBSIDIARY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>June
30, 2021 and 2020</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">In
connection with the issuance of the August 2019 Auctus Note, the Company issued common stock purchase warrants to Auctus to purchase
<span id="xdx_900_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_c20190830__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember__us-gaap--StatementEquityComponentsAxis__custom--FirstWarrantMember_pdd" title="Warrants to purchase of common stock, shares"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2019-08-30_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember_custom_FirstWarrantMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">450</ix:nonFraction></span> shares of the Company&#8217;s common stock (the &#8220;First Warrant&#8221;) as a commitment fee upon the terms and subject to the
limitations and conditions set forth in such First Warrant at an &#8220;Exercise Price&#8221; of <span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20190830__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember__us-gaap--StatementEquityComponentsAxis__custom--FirstWarrantMember_pdd" title="Warrants exercise price per share">$<ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2019-08-30_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember_custom_FirstWarrantMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">2,250</ix:nonFraction></span>. In connection with the issuance
of the Note, the Company shall issue a common stock purchase warrant to Buyer to purchase <span id="xdx_905_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_c20190830__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember__us-gaap--StatementEquityComponentsAxis__custom--SecondWarrantMember_pdd" title="Warrants to purchase of common stock, shares"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2019-08-30_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember_custom_SecondWarrantMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">300</ix:nonFraction></span> shares of the Company&#8217;s common stock
(the &#8220;Second Warrant&#8221;) as a commitment fee upon the terms and subject to the limitations and conditions set forth in such
Second Warrant at an &#8220;Exercise Price&#8221; of <span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20190830__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember__us-gaap--StatementEquityComponentsAxis__custom--SecondWarrantMember_pdd" title="Warrants exercise price per share">$<ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2019-08-30_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember_custom_SecondWarrantMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">3,330</ix:nonFraction></span>. In connection with the issuance of the Note, the Company shall issue a common
stock purchase warrant to Buyer to purchase <span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_c20190830__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember__us-gaap--StatementEquityComponentsAxis__custom--ThirdWarrantMember_pdd" title="Warrants to purchase of common stock, shares"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2019-08-30_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember_custom_ThirdWarrantMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">225</ix:nonFraction></span> shares of the Company&#8217;s common stock (the &#8220;Third Warrant&#8221;) as a commitment
fee upon the terms and subject to the limitations and conditions set forth in such Third Warrant at an &#8220;Exercise Price&#8221; of
<span id="xdx_903_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20190830__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember__us-gaap--StatementEquityComponentsAxis__custom--ThirdWarrantMember_pdd" title="Warrants exercise price per share">$<ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2019-08-30_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember_custom_ThirdWarrantMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">4,500</ix:nonFraction></span>. The First Warrant, Second Warrant, and Third Warrant shall collectively be referred as the &#8220;Warrants&#8221;. The Warrants
have an &#8220;Exercise Period&#8221; of five years from the date of issuance being August 30, 2019. Under the terms of the Purchase
Agreement and the Warrants, the Selling Security Holder may not either convert the Notes nor exercise the Warrants to the extent (but
only to the extent) that the Selling Security Holder or any of its affiliates would beneficially own a number of shares of our Common
Stock which would exceed <span id="xdx_908_ecustom--PercentageOfOutstandingSharesOfCommonStock_dp_uPure_c20190701__20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_zvnGDaFAX33d" title="Percentage of outstanding shares of common stock"><ix:nonFraction name="PPCB:PercentageOfOutstandingSharesOfCommonStock" contextRef="From2019-07-012020-06-30_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">4.99</ix:nonFraction>%</span> of our outstanding shares. The Company accounted for the warrants by using the relative fair value method
and recorded debt discount from the relative fair value of the warrants of <span id="xdx_90C_eus-gaap--FairValueAdjustmentOfWarrants_c20190829__20190830__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_pp0p0" title="Fair value of warrants">$<ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="From2019-08-292019-08-30_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">375,905</ix:nonFraction></span> using a simple binomial lattice model.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">In
connection with the Purchase Agreement, the Company and the Purchaser entered into a Registration Rights Agreement (the &#8220;Registration
Rights Agreement&#8221;). Pursuant to the Registration Rights Agreement, the Company agreed to register the shares of Common Stock underlying
the Securities in a Registration Statement with the SEC as well as the Commitment Shares (as defined herein). The Registration Rights
Agreement contains customary representations, warranties, agreements and indemnification rights and obligations of the parties.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
Note is subject to customary default provisions and also includes a cross-default provision which provides that a breach or default by
the Borrower of any covenant or other term or condition contained in any of the Other Agreements (as defined therein), after the passage
of all applicable notice and cure or grace periods, shall, at the option of the Holder, be considered a default under this Note and the
Other Agreements. Upon occurrence of any such event, the Holder shall be entitled (but in no event required) to apply all rights and
remedies of the Holder under the terms of this Note and the Other Agreements by reason of a default under said Other Agreements or the
Note.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
August 30, 2019 Auctus Note contain certain events of default, upon which principal and accrued interest will become immediately due
and payable. In addition, upon an event of default, interest on the outstanding principal shall accrue at a default interest rate of
24% per annum.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
total principal amount outstanding under the above Auctus financing agreement, specifically the August 30, 2019 Auctus Note, was $358,965
and accrued interest of <span id="xdx_90E_eus-gaap--InterestPayableCurrentAndNoncurrent_c20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_pp0p0" title="Accrued interest">$<ix:nonFraction name="us-gaap:InterestPayableCurrentAndNoncurrent" contextRef="AsOf2020-06-30_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">486</ix:nonFraction></span> as of June 30, 2020 following conversion of <span id="xdx_90C_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20190701__20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_pp0p0" title="Debt conversion of converted amount">$<ix:nonFraction name="us-gaap:DebtConversionConvertedInstrumentAmount1" contextRef="From2019-07-012020-06-30_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">191,035</ix:nonFraction></span> of the principal balance and <span id="xdx_90D_eus-gaap--InterestPayableCurrentAndNoncurrent_c20200630__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_pp0p0" title="Accrued interest">$<ix:nonFraction name="us-gaap:InterestPayableCurrentAndNoncurrent" contextRef="AsOf2020-06-30_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">43,176</ix:nonFraction></span> of accrued interest
during the year ended June 30, 2020. Accordingly, <span id="xdx_90A_eus-gaap--DebtInstrumentUnamortizedPremium_c20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_pp0p0" title="Debt premium amount">$<ix:nonFraction name="us-gaap:DebtInstrumentUnamortizedPremium" contextRef="AsOf2020-06-30_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">127,356</ix:nonFraction></span> of the put premium was released in respect of the August 30, 2019 Auctus Note
during the year ended June 30, 2020 following conversion of the principal balance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
total principal amount outstanding under the above Auctus financing agreement, specifically the August 30, 2019 Auctus Note, was <span id="xdx_90D_eus-gaap--DebtInstrumentFaceAmount_c20210630__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_pp0p0" title="Convertible debt principal amount">$<ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2021-06-30_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">32,848</ix:nonFraction></span>
and accrued interest of <span id="xdx_90E_eus-gaap--InterestPayableCurrentAndNoncurrent_c20210630__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_pp0p0" title="Accrued interest">$<ix:nonFraction name="us-gaap:InterestPayableCurrentAndNoncurrent" contextRef="AsOf2021-06-30_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">0</ix:nonFraction></span> as of June 30, 2021 following conversion of <span id="xdx_90D_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20200701__20210630__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_pp0p0" title="Debt conversion of converted amount">$<ix:nonFraction name="us-gaap:DebtConversionConvertedInstrumentAmount1" contextRef="From2020-07-012021-06-30_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">326,117</ix:nonFraction></span> of the principal balance and <span id="xdx_90F_ecustom--DebtConversionConvertedInterestPayable_c20200701__20210630__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_pp0p0" title="Debt conversion of accrued interest">$<ix:nonFraction name="PPCB:DebtConversionConvertedInterestPayable" contextRef="From2020-07-012021-06-30_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">39,536</ix:nonFraction></span> of accrued interest
during the year ended June 30, 2021. Accordingly, <span id="xdx_905_eus-gaap--DebtInstrumentUnamortizedPremium_iI_pp0p0_c20210630__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_zMs1ppsCOrtb" title="Debt premium amount">$<ix:nonFraction name="us-gaap:DebtInstrumentUnamortizedPremium" contextRef="AsOf2021-06-30_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">217,411</ix:nonFraction></span> of the put premium was released in respect of the August 30, 2019 Auctus Note
during the year ended June 30, 2021 following conversion of the principal balance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b><i>GW
Holdings Securities Purchase Agreements</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><i>October
1, 2019 Securities Purchase Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Effective
October 1, 2019, the Company entered into a securities purchase agreement with GW Holdings, pursuant to which GW Holdings purchased a
convertible promissory note (the &#8220;October 1, 2019 GW Note&#8221;) from the Company in the aggregate principal amount of <span id="xdx_90A_eus-gaap--DebtInstrumentFaceAmount_c20191002__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberOneTwoThousandNineteenAuctusNoteMember_pp0p0" title="Convertible debt principal amount">$<ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2019-10-02_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember_custom_OctoberOneTwoThousandNineteenAuctusNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">131,000</ix:nonFraction></span>,
such principal and the interest thereon convertible into shares of the Company&#8217;s common stock at the option of GW Holdings any
time after the six-month anniversary of the October 1, 2019 GW Holdings Note. The transactions contemplated by the GW Holdings Securities
Purchase Agreement closed on October 1, 2019. Pursuant to the terms of the GW Holdings Securities Purchase Agreement, the lender deducted
<span id="xdx_909_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_c20190929__20191002__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberOneTwoThousandNineteenAuctusNoteMember_pp0p0" title="Debt instrument principal payment">$<ix:nonFraction name="us-gaap:DebtInstrumentPeriodicPaymentPrincipal" contextRef="From2019-09-292019-10-02_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember_custom_OctoberOneTwoThousandNineteenAuctusNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">6,000</ix:nonFraction></span> from the principal payment due under the October 1, 2019 GW Note, at the time of closing, to be applied to its legal expenses.
The Company used the net proceeds of <span id="xdx_901_eus-gaap--ProceedsFromConvertibleDebt_pp0p0_c20190929__20191002__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberOneTwoThousandNineteenAuctusNoteMember_zaEB4ud3eO85" title="Proceeds from convertible debt">$<ix:nonFraction name="us-gaap:ProceedsFromConvertibleDebt" contextRef="From2019-09-292019-10-02_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember_custom_OctoberOneTwoThousandNineteenAuctusNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">125,000</ix:nonFraction></span> from the October 1, 2019 GW Note for general working capital purposes. The maturity date
of the October 1, 2019 GW Holdings was <span id="xdx_90A_eus-gaap--DebtInstrumentMaturityDate_dd_c20190929__20191002__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberOneTwoThousandNineteenAuctusNoteMember_zKrndB6pO7Ne" title="Debt maturity date"><ix:nonNumeric contextRef="From2019-09-292019-10-02_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember_custom_OctoberOneTwoThousandNineteenAuctusNoteMember" format="ixt:datemonthdayyearen" name="us-gaap:DebtInstrumentMaturityDate">October 1, 2020</ix:nonNumeric></span> and is currently past due. The October 1, 2019 GW Holdings Note bore interest
at a rate of <span id="xdx_90E_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20191002__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberOneTwoThousandNineteenAuctusNoteMember_zPtct5WsmEEf" title="Debt instrument, interest rate, stated percentage"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2019-10-02_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember_custom_OctoberOneTwoThousandNineteenAuctusNoteMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">8</ix:nonFraction>%</span> per annum, which interest was paid by the Company to GW Holdings in shares of the Company&#8217;s common stock; but was
not payable until the October 1, 2019 GW Holdings Note became payable, whether at the maturity date or upon acceleration or by prepayment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><i>December
10, 2020 Securities Purchase Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Effective
December 10, 2020, the Company entered into a securities purchase agreement with GW Holdings, pursuant to which GW Holdings purchased
a convertible promissory note (the &#8220;December 10, 2020 GW Note&#8221;) from the Company in the aggregate principal amount of <span id="xdx_902_eus-gaap--DebtInstrumentFaceAmount_c20201210__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--DecemberTenTwoThousandTwentyGWNoteMember_pp0p0" title="Convertible debt principal amount">$<ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2020-12-10_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember_custom_DecemberTenTwoThousandTwentyGWNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">131,000</ix:nonFraction></span>,
such principal and the interest thereon convertible into shares of the Company&#8217;s common stock at the option of GW Holdings anytime
from the issuance of the December 10, 2020 GW Holdings Note. The transactions contemplated by the GW Holdings Securities Purchase Agreement
closed on December 10, 2020. Pursuant to the terms of the GW Holdings Securities Purchase Agreement, the lender deducted <span id="xdx_905_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_c20201209__20201210__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--DecemberTenTwoThousandTwentyGWNoteMember_pp0p0" title="Debt instrument principal payment">$<ix:nonFraction name="us-gaap:DebtInstrumentPeriodicPaymentPrincipal" contextRef="From2020-12-092020-12-10_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember_custom_DecemberTenTwoThousandTwentyGWNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">6,000</ix:nonFraction></span> from
the principal payment due under the December 10, 2020 GW Note, at the time of closing, to be applied to its legal expenses. The Company
intends to use the net proceeds of <span id="xdx_90B_eus-gaap--ProceedsFromConvertibleDebt_pp0p0_c20201209__20201210__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--DecemberTenTwoThousandTwentyGWNoteMember_zdGlPC9dx3fg" title="Proceeds from convertible debt">$<ix:nonFraction name="us-gaap:ProceedsFromConvertibleDebt" contextRef="From2020-12-092020-12-10_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember_custom_DecemberTenTwoThousandTwentyGWNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">125,000</ix:nonFraction></span> from the December 10, 2020 GW Note for general working capital purposes. The maturity date
of the December 10, 2020 GW Holdings is <span id="xdx_909_eus-gaap--DebtInstrumentMaturityDate_dd_c20201209__20201210__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--DecemberTenTwoThousandTwentyGWNoteMember_z2vQ7zNJnIve" title="Debt maturity date"><ix:nonNumeric contextRef="From2020-12-092020-12-10_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember_custom_DecemberTenTwoThousandTwentyGWNoteMember" format="ixt:datemonthdayyearen" name="us-gaap:DebtInstrumentMaturityDate">December 10, 2021</ix:nonNumeric></span>. The December 10, 2020 GW Holdings Note bears interest at a rate of <span id="xdx_90B_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20201210__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--DecemberTenTwoThousandTwentyGWNoteMember_zaZ2WjOKzaab" title="Debt instrument, interest rate, stated percentage"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2020-12-10_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember_custom_DecemberTenTwoThousandTwentyGWNoteMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">8</ix:nonFraction>%</span> per
annum, which interest may be paid by the Company to GW Holdings in shares of the Company&#8217;s common stock; but shall not be payable
until the December 10, 2020 GW Holdings Note becomes payable, whether at the maturity date or upon acceleration or by prepayment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<ix:exclude><!-- Field: Page; Sequence: 111; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>PROPANC
BIOPHARMA, INC. AND SUBSIDIARY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>June
30, 2021 and 2020</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
above notes issued to GW Holdings contain certain events of default, upon which principal and accrued interest will become immediately
due and payable. In addition, upon an event of default, interest on the outstanding principal shall accrue at a default interest rate
of <span id="xdx_907_ecustom--DebtInstrumentDebtDefaultInterestRate_dp_uPure_c20201209__20201210__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--DecemberTenTwoThousandTwentyGWNoteMember_zArgRvWfEwje" title="Debt instrument, default, interest rate"><ix:nonFraction name="PPCB:DebtInstrumentDebtDefaultInterestRate" contextRef="From2020-12-092020-12-10_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember_custom_DecemberTenTwoThousandTwentyGWNoteMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">24</ix:nonFraction>%</span> per annum, or if such rate is usurious or not permitted by current law, then at the highest rate of interest permitted by law.
Further, certain events of default may trigger penalty and liquidated damage provisions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Additionally,
GW Holdings has the option to convert all or any amount of the principal face amount of the notes issued to GW Holdings at any time from
the date of issuance and ending on the later of the maturity date or the date the Default Amount is paid if an event of default occurs,
which is an amount between <span id="xdx_905_ecustom--DebtInstrumentDebtDefaultInterestRate_dp_uPure_c20201209__20201210__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--DecemberTenTwoThousandTwentyGWNoteMember__srt--RangeAxis__srt--MinimumMember_zQUE8QLxpFka" title="Debt instrument, default, interest rate"><ix:nonFraction name="PPCB:DebtInstrumentDebtDefaultInterestRate" contextRef="From2020-12-092020-12-10_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember_custom_DecemberTenTwoThousandTwentyGWNoteMember_srt_MinimumMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">110</ix:nonFraction>%</span> and <span id="xdx_905_ecustom--DebtInstrumentDebtDefaultInterestRate_dp_uPure_c20201209__20201210__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--DecemberTenTwoThousandTwentyGWNoteMember__srt--RangeAxis__srt--MaximumMember_zjV9drC6Cubi" title="Debt instrument, default, interest rate"><ix:nonFraction name="PPCB:DebtInstrumentDebtDefaultInterestRate" contextRef="From2020-12-092020-12-10_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember_custom_DecemberTenTwoThousandTwentyGWNoteMember_srt_MaximumMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">150</ix:nonFraction>%</span> of an amount equal to the then outstanding principal amount of such notes plus any interest
accrued, for shares of the Company&#8217;s common stock at the then-applicable conversion price.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
conversion price for the above GW Holdings notes shall be equal to a 40% discount of the lowest closing bid price (&#8220;Lowest Trading
Price&#8221;) of the Common Stock for the ten trading days immediately prior to the delivery of a Notice of Conversion, including the
day upon which a Notice of Conversion is received. Notwithstanding the foregoing, GW Holdings shall be restricted from effecting a conversion
if such conversion, along with other shares of the Company&#8217;s common stock beneficially owned by GW Holdings and its affiliates,
exceeds <span id="xdx_900_ecustom--PercentageOfOutstandingSharesOfCommonStock_dp_uPure_c20201209__20201210__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--DecemberTenTwoThousandTwentyGWNoteMember_zMF2lpDXpXcl" title="Percentage of outstanding shares of common stock"><ix:nonFraction name="PPCB:PercentageOfOutstandingSharesOfCommonStock" contextRef="From2020-12-092020-12-10_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember_custom_DecemberTenTwoThousandTwentyGWNoteMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">4.99</ix:nonFraction>%</span> of the outstanding shares of the Company&#8217;s common stock which may be increased up to 9.99% upon 60 days prior written
notice by the GW Holdings to the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">These
notes are treated as stock settled debt under ASC 480 and accordingly the Company recorded a total of <span id="xdx_904_eus-gaap--DebtInstrumentUnamortizedPremium_c20201210__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--DecemberTenTwoThousandTwentyGWNoteMember_pp0p0" title="Debt premium amount">$<ix:nonFraction name="us-gaap:DebtInstrumentUnamortizedPremium" contextRef="AsOf2020-12-10_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember_custom_DecemberTenTwoThousandTwentyGWNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">174,666</ix:nonFraction></span> put premium.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
total principal amount outstanding under the above October 1, 2019 GW Holdings financing agreement was <span id="xdx_908_eus-gaap--DebtInstrumentFaceAmount_c20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberOneTwoThousandNineteenAuctusNoteMember_pp0p0" title="Convertible debt principal amount">$<ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2020-06-30_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember_custom_OctoberOneTwoThousandNineteenAuctusNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">30,000</ix:nonFraction></span> and accrued interest of
<span id="xdx_903_eus-gaap--InterestPayableCurrentAndNoncurrent_c20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberOneTwoThousandNineteenAuctusNoteMember_pp0p0" title="Accrued interest">$<ix:nonFraction name="us-gaap:InterestPayableCurrentAndNoncurrent" contextRef="AsOf2020-06-30_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember_custom_OctoberOneTwoThousandNineteenAuctusNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,776</ix:nonFraction></span> as of June 30, 2020 following conversion of <span id="xdx_907_eus-gaap--DebtInstrumentFaceAmount_c20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember_pp0p0" title="Convertible debt principal amount">$<ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2020-06-30_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">101,000</ix:nonFraction></span> of the principal balance and <span id="xdx_90F_eus-gaap--InterestPayableCurrentAndNoncurrent_c20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember_pp0p0" title="Accrued interest">$<ix:nonFraction name="us-gaap:InterestPayableCurrentAndNoncurrent" contextRef="AsOf2020-06-30_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,082</ix:nonFraction></span> of accrued interest during the year ended
June 30, 2020. The total principal amount and accrued interest outstanding under the above October 1, 2019 GW Holdings financing agreement
was <span id="xdx_907_eus-gaap--ConvertibleNotesPayable_c20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember_pp0p0" title="Convertible debt outstanding balance">$<ix:nonFraction name="us-gaap:ConvertibleNotesPayable" contextRef="AsOf2020-06-30_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">0</ix:nonFraction></span> as of June 30, 2021 following conversion of <span id="xdx_904_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberOneTwoThousandNineteenAuctusNoteMember_zUKgNk0UCtJ5">$<ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2021-06-30_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember_custom_OctoberOneTwoThousandNineteenAuctusNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">30,000</ix:nonFraction></span> of the principal balance and <span id="xdx_90E_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberOneTwoThousandNineteenAuctusNoteMember_zr1B1KELZycj">$<ix:nonFraction name="us-gaap:InterestPayableCurrentAndNoncurrent" contextRef="AsOf2021-06-30_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember_custom_OctoberOneTwoThousandNineteenAuctusNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,877</ix:nonFraction></span> of accrued interest during the year ended
June 30, 2021. Accordingly, <span id="xdx_902_eus-gaap--DebtInstrumentUnamortizedPremium_iI_pp0p0_c20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember_zQunD2Tm9VOd" title="Debt premium amount">$<ix:nonFraction name="us-gaap:DebtInstrumentUnamortizedPremium" contextRef="AsOf2020-06-30_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">67,333</ix:nonFraction></span> and <span id="xdx_90C_eus-gaap--DebtInstrumentUnamortizedPremium_iI_pp0p0_c20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember_zVc0tgVdJq9b">$<ix:nonFraction name="us-gaap:DebtInstrumentUnamortizedPremium" contextRef="AsOf2021-06-30_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">20,000</ix:nonFraction></span> of the put premium was reclassed to additional paid in capital during the year ended
June 30, 2020 and 2021, respectively, following conversion of the principal balance. This note was fully converted into common stock
in fiscal 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
total principal amount outstanding under the above December 10, 2020 GW Holdings financing agreement, was <span id="xdx_904_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--DecemberTenTwoThousandTwentyGWNoteMember_z4nIBYzF3wx8">$<ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2021-06-30_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember_custom_DecemberTenTwoThousandTwentyGWNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">90,000</ix:nonFraction></span> and accrued interest
of <span id="xdx_905_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--DecemberTenTwoThousandTwentyGWNoteMember_zHF7PjuQZyCh">$<ix:nonFraction name="us-gaap:InterestPayableCurrentAndNoncurrent" contextRef="AsOf2020-06-30_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember_custom_DecemberTenTwoThousandTwentyGWNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,636</ix:nonFraction></span> as of June 30, 2021 following conversion of <span id="xdx_900_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--DecemberTenTwoThousandTwentyGWNoteMember_zxK0GcKj7mR8">$<ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2020-06-30_custom_SecuritiesPurchaseAgreementMember_custom_DecemberTenTwoThousandTwentyGWNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">41,000</ix:nonFraction></span> of the principal balance and <span id="xdx_900_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--DecemberTenTwoThousandTwentyGWNoteMember_zAhI5EC0kXU">$<ix:nonFraction name="us-gaap:InterestPayableCurrentAndNoncurrent" contextRef="AsOf2021-06-30_custom_SecuritiesPurchaseAgreementMember_custom_DecemberTenTwoThousandTwentyGWNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,084</ix:nonFraction></span> of accrued interest during the year
ended June 30, 2021. Accordingly, <span id="xdx_900_eus-gaap--DebtInstrumentUnamortizedPremium_iI_pp0p0_c20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberOneTwoThousandNineteenAuctusNoteMember_zFJPZpaH0zL4">$<ix:nonFraction name="us-gaap:DebtInstrumentUnamortizedPremium" contextRef="AsOf2021-06-30_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember_custom_OctoberOneTwoThousandNineteenAuctusNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">27,333</ix:nonFraction></span> of the put premium was reclassed to additional paid in capital in respect of the October 1,
2019 GW Holdings Note during the year ended June 30, 2021 following conversion of the principal balance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b><i>Crown
Bridge Securities Purchase Agreements</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Effective
October 3, 2019, the Company entered into a securities purchase agreement with Crown Bridge Partners, pursuant to which Crown Bridge
purchased a convertible promissory note (the &#8220;October 3, 2019 Crown Bridge Note&#8221;) from the Company in the aggregate principal
amount of $<span id="xdx_901_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20191003__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember_zwpEHUsBwCU" title="Convertible debt principal amount"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2019-10-03_custom_SecuritiesPurchaseAgreementMember_custom_CrownBridgePartnersLLCMember_custom_OctoberThreeTwoThousandNineteenAuctusNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">108,000</ix:nonFraction></span>, such principal and the interest thereon convertible into shares of the Company&#8217;s common stock at the option
of Crown Bridge any time from the of issuance of the of the October 3, 2019 Crown Bridge Note. The transactions contemplated by the Crown
Bridge Securities Purchase Agreement closed on October 3, 2019. Pursuant to the terms of the Crown Bridge Securities Purchase Agreement,
Crown Bridge deducted $<span id="xdx_90F_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_pp0p0_c20191001__20191003__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember_zeoD6H7WrKf9" title="Debt instrument principal payment"><ix:nonFraction name="us-gaap:DebtInstrumentPeriodicPaymentPrincipal" contextRef="From2019-10-012019-10-03_custom_SecuritiesPurchaseAgreementMember_custom_CrownBridgePartnersLLCMember_custom_OctoberThreeTwoThousandNineteenAuctusNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,000</ix:nonFraction></span> from the principal payment due under the October 3, 2019 Crown Bridge Note, at the time of closing, to be
applied to its legal expenses, and there was a $<span id="xdx_903_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pp0p0_c20191003__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember_zomMnTd7UNx3" title="Original issue discount"><ix:nonFraction name="us-gaap:DebtInstrumentUnamortizedDiscount" contextRef="AsOf2019-10-03_custom_SecuritiesPurchaseAgreementMember_custom_CrownBridgePartnersLLCMember_custom_OctoberThreeTwoThousandNineteenAuctusNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,000</ix:nonFraction></span> original issuance discount resulting in $<span id="xdx_905_eus-gaap--ProceedsFromConvertibleDebt_pp0p0_c20191001__20191003__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember_zzct2UAOe8n4" title="Proceeds from convertible debt"><ix:nonFraction name="us-gaap:ProceedsFromConvertibleDebt" contextRef="From2019-10-012019-10-03_custom_SecuritiesPurchaseAgreementMember_custom_CrownBridgePartnersLLCMember_custom_OctoberThreeTwoThousandNineteenAuctusNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">100,000</ix:nonFraction></span> net proceeds to the Company. The
Company intends to use the net proceeds from the October 3, 2019 Crown Bridge Note for general working capital purposes. The maturity
date of the October 3, 2019 Crown Bridge was October 3, 2020 and is currently past due. The <span id="xdx_90A_eus-gaap--DebtInstrumentMaturityDate_dd_c20191001__20191003__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember_zQwc7KFpP4L3" title="Debt maturity date"><ix:nonNumeric contextRef="From2019-10-012019-10-03_custom_SecuritiesPurchaseAgreementMember_custom_CrownBridgePartnersLLCMember_custom_OctoberThreeTwoThousandNineteenAuctusNoteMember" format="ixt:datemonthdayyearen" name="us-gaap:DebtInstrumentMaturityDate">October 3, 2019</ix:nonNumeric></span> Crown Bridge Note bears interest
at a rate of <span id="xdx_906_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20191003__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember_ztmWQuCkyNLh" title="Debt instrument, interest rate, stated percentage"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2019-10-03_custom_SecuritiesPurchaseAgreementMember_custom_CrownBridgePartnersLLCMember_custom_OctoberThreeTwoThousandNineteenAuctusNoteMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">10</ix:nonFraction></span>% per annum, which interest may be paid by the Company to Crown Bridge in shares of the Company&#8217;s common stock;
but shall not be payable until the October 2019 Crown Bridge Note becomes payable, whether at the maturity date or upon acceleration
or by prepayment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Additionally,
Crown Bridge has the option to convert all or any amount of the principal face amount of the October 3, 2019 Crown Bridge Note at any
time from the date of issuance and ending on the later of the maturity date or the date the Default Amount is paid if an event of default
occurs, which is an amount between <span id="xdx_90B_ecustom--DebtInstrumentDebtDefaultInterestRate_pid_dp_uPure_c20191001__20191003__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember__srt--RangeAxis__srt--MinimumMember_zLvepTZqYK6h" title="Debt instrument, default, interest rate"><ix:nonFraction name="PPCB:DebtInstrumentDebtDefaultInterestRate" contextRef="From2019-10-012019-10-03_custom_SecuritiesPurchaseAgreementMember_custom_CrownBridgePartnersLLCMember_custom_OctoberThreeTwoThousandNineteenAuctusNoteMember_srt_MinimumMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">110</ix:nonFraction></span>% and <span id="xdx_900_ecustom--DebtInstrumentDebtDefaultInterestRate_pid_dp_uPure_c20191001__20191003__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember__srt--RangeAxis__srt--MaximumMember_zEEjcVFQsHy" title="Debt instrument, default, interest rate"><ix:nonFraction name="PPCB:DebtInstrumentDebtDefaultInterestRate" contextRef="From2019-10-012019-10-03_custom_SecuritiesPurchaseAgreementMember_custom_CrownBridgePartnersLLCMember_custom_OctoberThreeTwoThousandNineteenAuctusNoteMember_srt_MaximumMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">150</ix:nonFraction></span>% of an amount equal to the then outstanding principal amount of the October 3, 2019 Crown
Bridge Note plus any interest accrued, for shares of the Company&#8217;s common stock at the then-applicable conversion price.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
conversion price for the October 3, 2019 Crown Bridge Note shall be equal to a 40% discount of the lowest closing bid price (&#8220;Lowest
Trading Price&#8221;) of the Common Stock for the ten trading days immediately prior to the delivery of a Notice of Conversion, including
the day upon which a Notice of Conversion is received. Notwithstanding the foregoing, Crown Bridge shall be restricted from effecting
a conversion if such conversion, along with other shares of the Company&#8217;s common stock beneficially owned by Crown Bridge and its
affiliates, exceeds <span id="xdx_90E_ecustom--PercentageOfOutstandingSharesOfCommonStock_pid_dp_uPure_c20191001__20191003__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember__srt--RangeAxis__srt--MinimumMember_z7lVZvtrX5P5" title="Percentage of outstanding shares of common stock"><ix:nonFraction name="PPCB:PercentageOfOutstandingSharesOfCommonStock" contextRef="From2019-10-012019-10-03_custom_SecuritiesPurchaseAgreementMember_custom_CrownBridgePartnersLLCMember_custom_OctoberThreeTwoThousandNineteenAuctusNoteMember_srt_MinimumMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">4.99</ix:nonFraction></span>% of the outstanding shares of the Company&#8217;s common stock which may be increased up to <span id="xdx_90B_ecustom--PercentageOfOutstandingSharesOfCommonStock_pid_dp_uPure_c20191001__20191003__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember__srt--RangeAxis__srt--MaximumMember_zJktsYMDpp94" title="Percentage of outstanding shares of common stock"><ix:nonFraction name="PPCB:PercentageOfOutstandingSharesOfCommonStock" contextRef="From2019-10-012019-10-03_custom_SecuritiesPurchaseAgreementMember_custom_CrownBridgePartnersLLCMember_custom_OctoberThreeTwoThousandNineteenAuctusNoteMember_srt_MaximumMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">9.99</ix:nonFraction></span>% upon 60 days
prior written notice by the Crown Bridge to the Company. The note is treated as stock settled debt under ASC 480 and accordingly the
Company recorded a $<span id="xdx_904_eus-gaap--DebtInstrumentUnamortizedPremium_iI_pp0p0_c20191003__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember_zHoaM5QgRPfj" title="Debt premium amount"><ix:nonFraction name="us-gaap:DebtInstrumentUnamortizedPremium" contextRef="AsOf2019-10-03_custom_SecuritiesPurchaseAgreementMember_custom_CrownBridgePartnersLLCMember_custom_OctoberThreeTwoThousandNineteenAuctusNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">72,000</ix:nonFraction></span> put premium.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<ix:exclude><!-- Field: Page; Sequence: 112; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>PROPANC
BIOPHARMA, INC. AND SUBSIDIARY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>June
30, 2021 and 2020</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
October 3, 2019 Crown Bridge Note contain certain events of default, upon which principal and accrued interest will become immediately
due and payable. In addition, upon an event of default, interest on the outstanding principal shall accrue at a default interest rate
of <span id="xdx_90F_ecustom--DebtInstrumentDebtDefaultInterestRate_pid_dp_uPure_c20191001__20191003__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember_zv0fjoBojGb7" title="Debt instrument, default, interest rate"><ix:nonFraction name="PPCB:DebtInstrumentDebtDefaultInterestRate" contextRef="From2019-10-012019-10-03_custom_SecuritiesPurchaseAgreementMember_custom_CrownBridgePartnersLLCMember_custom_OctoberThreeTwoThousandNineteenAuctusNoteMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">15</ix:nonFraction></span>% per annum, or if such rate is usurious or not permitted by current law, then at the highest rate of interest permitted by law.
Further, certain events of default may trigger penalty and liquidated damage provisions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
total principal amount outstanding under the above Crown Bridge financing agreement was $<span id="xdx_908_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember_zJbU4yvlAPti" title="Convertible debt principal amount"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2020-06-30_custom_SecuritiesPurchaseAgreementMember_custom_CrownBridgePartnersLLCMember_custom_OctoberThreeTwoThousandNineteenAuctusNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">65,280</ix:nonFraction></span> and accrued interest of $<span id="xdx_902_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember_z2ksPZtm0jBj" title="Accrued interest"><ix:nonFraction name="us-gaap:InterestPayableCurrentAndNoncurrent" contextRef="AsOf2020-06-30_custom_SecuritiesPurchaseAgreementMember_custom_CrownBridgePartnersLLCMember_custom_OctoberThreeTwoThousandNineteenAuctusNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">7,232</ix:nonFraction></span> as of
as of June 30, 2020 following conversion of $<span id="xdx_90D_eus-gaap--DebtConversionConvertedInstrumentAmount1_pp0p0_c20190701__20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember_ziklwtqcVEga" title="Debt conversion of converted amount"><ix:nonFraction name="us-gaap:DebtConversionConvertedInstrumentAmount1" contextRef="From2019-07-012020-06-30_custom_SecuritiesPurchaseAgreementMember_custom_CrownBridgePartnersLLCMember_custom_OctoberThreeTwoThousandNineteenAuctusNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">42,720</ix:nonFraction></span> of the principal balance during the year ended June 30, 2020. Accordingly, $<span id="xdx_901_eus-gaap--DebtInstrumentUnamortizedPremium_iI_pp0p0_c20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember_zySXJNn6cCG1" title="Debt premium amount"><ix:nonFraction name="us-gaap:DebtInstrumentUnamortizedPremium" contextRef="AsOf2020-06-30_custom_SecuritiesPurchaseAgreementMember_custom_CrownBridgePartnersLLCMember_custom_OctoberThreeTwoThousandNineteenAuctusNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">28,480</ix:nonFraction></span>
of the put premium was released in respect of the October 3, 2019 Crown Bridge Note during the year ended June 30, 2020 following conversion
of the principal balance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
total principal amount outstanding under the above Crown Bridge financing agreement was <span id="xdx_900_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember_zCCKsDjlOH51" title="Convertible debt principal amount">$<ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2021-06-30_custom_SecuritiesPurchaseAgreementMember_custom_CrownBridgePartnersLLCMember_custom_OctoberThreeTwoThousandNineteenAuctusNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">65,280</ix:nonFraction></span> and accrued interest of $<span id="xdx_90B_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember_z5eeEhZLWACg" title="Accrued interest"><ix:nonFraction name="us-gaap:InterestPayableCurrentAndNoncurrent" contextRef="AsOf2021-06-30_custom_SecuritiesPurchaseAgreementMember_custom_CrownBridgePartnersLLCMember_custom_OctoberThreeTwoThousandNineteenAuctusNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">16,138</ix:nonFraction></span> as of
as of June 30, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">There
were <span id="xdx_900_ecustom--UnissuedSharesConversion_c20200915__20200916__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember_zCYs7H4vsJf1" title="Unissued shares conversion"><ix:nonFraction name="PPCB:UnissuedSharesConversion" contextRef="From2020-09-152020-09-16_custom_SecuritiesPurchaseAgreementMember_custom_CrownBridgePartnersLLCMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">15,000</ix:nonFraction></span> unissued shares which were considered issuable for accounting purposes during the 1<sup>st</sup> quarter of fiscal 2021 related
to a conversion notice dated and received on September 16, 2020. In November 2020, the Company was notified by the note holder of the
cancellation of this conversion notice as a result of the reverse stock split and as such the Company reversed the effects of this transaction
thereby increasing the principal balance by $<span id="xdx_906_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20201130__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember_zxMfShhyo5H5" title="Convertible debt principal amount"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2020-11-30_custom_SecuritiesPurchaseAgreementMember_custom_CrownBridgePartnersLLCMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">9,600</ix:nonFraction></span> and put premium by $<span id="xdx_908_eus-gaap--DebtInstrumentUnamortizedPremium_iI_pp0p0_c20201130__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember_z3d1u05jFZe8" title="Debt premium amount"><ix:nonFraction name="us-gaap:DebtInstrumentUnamortizedPremium" contextRef="AsOf2020-11-30_custom_SecuritiesPurchaseAgreementMember_custom_CrownBridgePartnersLLCMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">6,400</ix:nonFraction></span> and a corresponding decrease in equity of $<span id="xdx_902_ecustom--DueToEquityConversion_iI_pp0p0_c20201130__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember_zwvoGCxPpSu" title="Due to equity conversion"><ix:nonFraction name="PPCB:DueToEquityConversion" contextRef="AsOf2020-11-30_custom_SecuritiesPurchaseAgreementMember_custom_CrownBridgePartnersLLCMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">16,000</ix:nonFraction></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b><i>Ader
Alef Securities Purchase Agreements</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Effective
January 13, 2020, the Company entered into a securities purchase agreement with Ader Alef, pursuant to which Ader Alef purchased a convertible
promissory note (the &#8220;January 13, 2020 Ader Alef Note&#8221;) from the Company in the aggregate principal amount of $<span id="xdx_908_eus-gaap--DebtInstrumentFaceAmount_c20200113__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--JanuaryThirteenTwentyTwentyAderAlefNoteMember_pp0p0" title="Convertible debt principal amount"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2020-01-13_custom_SecuritiesPurchaseAgreementMember_custom_JanuaryThirteenTwentyTwentyAderAlefNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">110,250</ix:nonFraction></span>, such
principal and the interest thereon convertible into shares of the Company&#8217;s common stock at the option of Ader Alef any time after
the six-month anniversary of the January 13, 2020 Ader Alef Note. The January 13, 2020 Ader Alef Note contained an original discount
of $<span id="xdx_904_eus-gaap--DebtInstrumentUnamortizedDiscount_c20200113__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--JanuaryThirteenTwentyTwentyAderAlefNoteMember_pp0p0" title="Original issue discount"><ix:nonFraction name="us-gaap:DebtInstrumentUnamortizedDiscount" contextRef="AsOf2020-01-13_custom_SecuritiesPurchaseAgreementMember_custom_JanuaryThirteenTwentyTwentyAderAlefNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,250</ix:nonFraction></span>. The transactions contemplated by the Ader Alef Securities Purchase Agreement closed on January 13, 2020. Pursuant to the terms
of the Ader Alef Securities Purchase Agreement, Ader Alef deducted $<span id="xdx_901_eus-gaap--LegalFees_c20200112__20200113__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--JanuaryThirteenTwentyTwentyAderAlefNoteMember_pp0p0" title="Legal fees"><ix:nonFraction name="us-gaap:LegalFees" contextRef="From2020-01-122020-01-13_custom_SecuritiesPurchaseAgreementMember_custom_JanuaryThirteenTwentyTwentyAderAlefNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,000</ix:nonFraction></span> from the principal payment due under the January 13, 2020 Ader
Alef Note at the time of closing, to be applied to its legal expenses and the Company received net cash proceeds of $<span id="xdx_90F_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20200112__20200113__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--JanuaryThirteenTwentyTwentyAderAlefNoteMember_pp0p0" title="Debt conversion of converted amount"><ix:nonFraction name="us-gaap:DebtConversionConvertedInstrumentAmount1" contextRef="From2020-01-122020-01-13_custom_SecuritiesPurchaseAgreementMember_custom_JanuaryThirteenTwentyTwentyAderAlefNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">100,000</ix:nonFraction></span> on January
15, 2020. The Company used the net proceeds from the January 13, 2020 Ader Alef Note for general working capital purposes. The maturity
date of the January 13, 2020 Ader Alef was January 13, 2021. The <span id="xdx_904_eus-gaap--DebtInstrumentMaturityDate_dd_c20200112__20200113__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--JanuaryThirteenTwentyTwentyAderAlefNoteMember_zxQYm58fn5Qk" title="Debt maturity date"><ix:nonNumeric contextRef="From2020-01-122020-01-13_custom_SecuritiesPurchaseAgreementMember_custom_JanuaryThirteenTwentyTwentyAderAlefNoteMember" format="ixt:datemonthdayyearen" name="us-gaap:DebtInstrumentMaturityDate">January 13, 2020</ix:nonNumeric></span> Ader Alef Note bore interest at a rate of <span id="xdx_901_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20200113__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--JanuaryThirteenTwentyTwentyAderAlefNoteMember_zDP149gBzYbc" title="Debt instrument, interest rate, stated percentage"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2020-01-13_custom_SecuritiesPurchaseAgreementMember_custom_JanuaryThirteenTwentyTwentyAderAlefNoteMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">8</ix:nonFraction></span>% per annum,
which interest may be paid by the Company to Ader Alef in shares of the Company&#8217;s common stock; but was not payable until the January
13, 2020 Ader Alef Note became payable, whether at the maturity date or upon acceleration or by prepayment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Additionally,
Ader Alef had the option to convert all or any amount of the principal face amount of the January 13, 2020 Ader Alef Note at any time
from the date of issuance and ending on the later of the maturity date or the date the Default Amount was paid if an event of default
occurs, which was an amount between <span id="xdx_904_ecustom--DebtInstrumentDebtDefaultInterestRate_dp_uPure_c20200112__20200113__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--JanuaryThirteenTwentyTwentyAderAlefNoteMember__srt--RangeAxis__srt--MinimumMember_zr58c3SrdfDc" title="Debt instrument, default, interest rate"><ix:nonFraction name="PPCB:DebtInstrumentDebtDefaultInterestRate" contextRef="From2020-01-122020-01-13_custom_SecuritiesPurchaseAgreementMember_custom_JanuaryThirteenTwentyTwentyAderAlefNoteMember_srt_MinimumMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">120</ix:nonFraction></span>% and <span id="xdx_900_ecustom--DebtInstrumentDebtDefaultInterestRate_dp_uPure_c20200112__20200113__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--JanuaryThirteenTwentyTwentyAderAlefNoteMember__srt--RangeAxis__srt--MaximumMember_zxh5ayER2q3g" title="Debt instrument, default, interest rate"><ix:nonFraction name="PPCB:DebtInstrumentDebtDefaultInterestRate" contextRef="From2020-01-122020-01-13_custom_SecuritiesPurchaseAgreementMember_custom_JanuaryThirteenTwentyTwentyAderAlefNoteMember_srt_MaximumMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">150</ix:nonFraction></span>% of an amount equal to the then outstanding principal amount of the January 13, 2020
Ader Alef Note plus any interest accrued, for shares of the Company&#8217;s common stock at the then-applicable conversion price.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span id="xdx_901_eus-gaap--DebtInstrumentDescription_c20200112__20200113__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--JanuaryThirteenTwentyTwentyAderAlefNoteMember__srt--RangeAxis__srt--MinimumMember_zbMX0id9jcs7" title="Debt instrument, description"><ix:nonNumeric contextRef="From2020-01-122020-01-13_custom_SecuritiesPurchaseAgreementMember_custom_JanuaryThirteenTwentyTwentyAderAlefNoteMember_srt_MinimumMember" name="us-gaap:DebtInstrumentDescription">The
conversion price for the January 13, 2020 Ader Alef Note during the first 6 months the January 13, 2020 Ader Alef Note was fixed at $2.50
and thereafter would be equal to a <span id="xdx_90C_eus-gaap--DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_pid_dp_uPure_c20200112__20200113__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--JanuaryThirteenTwentyTwentyAderAlefNoteMember__srt--RangeAxis__srt--MinimumMember_zT1L8epEdCN9" title="Common stock trading volume, percent"><ix:nonFraction name="us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" contextRef="From2020-01-122020-01-13_custom_SecuritiesPurchaseAgreementMember_custom_JanuaryThirteenTwentyTwentyAderAlefNoteMember_srt_MinimumMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">35</ix:nonFraction></span>% discount of the lowest closing bid price (&#8220;Lowest Trading Price&#8221;) of the Common Stock
for the ten trading days immediately prior to the delivery of a Notice of Conversion, including the day upon which a Notice of Conversion
was received. Notwithstanding the foregoing, Ader Alef was restricted from effecting a conversion if such conversion, along with other
shares of the Company&#8217;s common stock beneficially owned by Ader Alef and its affiliates, exceeds <span id="xdx_907_ecustom--PercentageOfOutstandingSharesOfCommonStock_pid_dp_uPure_c20200112__20200113__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--JanuaryThirteenTwentyTwentyAderAlefNoteMember__srt--RangeAxis__srt--MinimumMember_zdUxPo074Xhg" title="Percentage of outstanding shares of common stock"><ix:nonFraction name="PPCB:PercentageOfOutstandingSharesOfCommonStock" contextRef="From2020-01-122020-01-13_custom_SecuritiesPurchaseAgreementMember_custom_JanuaryThirteenTwentyTwentyAderAlefNoteMember_srt_MinimumMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">4.99</ix:nonFraction></span>% of the outstanding shares
of the Company&#8217;s common stock which may be increased up to <span id="xdx_909_ecustom--PercentageOfOutstandingSharesOfCommonStock_pid_dp_uPure_c20200112__20200113__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--JanuaryThirteenTwentyTwentyAderAlefNoteMember__srt--RangeAxis__srt--MaximumMember_zruzM0e34Bv" title="Percentage of outstanding shares of common stock"><ix:nonFraction name="PPCB:PercentageOfOutstandingSharesOfCommonStock" contextRef="From2020-01-122020-01-13_custom_SecuritiesPurchaseAgreementMember_custom_JanuaryThirteenTwentyTwentyAderAlefNoteMember_srt_MaximumMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">9.99</ix:nonFraction></span>% upon 60 days prior written notice by the Ader Alef to the Company.</ix:nonNumeric></span>
The note was treated as stock settled debt under ASC 480 and accordingly the Company recorded a $<span id="xdx_90E_eus-gaap--DebtInstrumentUnamortizedPremium_iI_pp0p0_c20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--JanuaryThirteenTwentyTwentyAderAlefNoteMember_znVW5pF8JMN9" title="Debt premium amount"><ix:nonFraction name="us-gaap:DebtInstrumentUnamortizedPremium" contextRef="AsOf2021-06-30_custom_SecuritiesPurchaseAgreementMember_custom_JanuaryThirteenTwentyTwentyAderAlefNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">59,365</ix:nonFraction></span> put premium.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
January 13, 2020 Ader Alef Note contained certain events of default, upon which principal and accrued interest would become immediately
due and payable. In addition, upon an event of default, interest on the outstanding principal would accrue at a default interest rate
of 24% per annum, or if such rate was usurious or not permitted by current law, then at the highest rate of interest permitted by law.
Further, certain events of default may trigger penalty and liquidated damage provisions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
total principal amount outstanding under the above Ader Alef financing agreement was $<span id="xdx_909_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--JanuaryThirteenTwentyTwentyAderAlefNoteMember_zrTuhpcSaLr2" title="Convertible debt principal amount"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2020-06-30_custom_SecuritiesPurchaseAgreementMember_custom_JanuaryThirteenTwentyTwentyAderAlefNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">110,250</ix:nonFraction></span> and accrued interest of $<span id="xdx_909_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--JanuaryThirteenTwentyTwentyAderAlefNoteMember_zfnVOaOVSvug" title="Accrued interest"><ix:nonFraction name="us-gaap:InterestPayableCurrentAndNoncurrent" contextRef="AsOf2020-06-30_custom_SecuritiesPurchaseAgreementMember_custom_JanuaryThirteenTwentyTwentyAderAlefNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,073</ix:nonFraction></span> as of June
30, 2020. The total principal amount outstanding and accrued interest under the above Ader Alef financing agreement was $<span id="xdx_906_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--JanuaryThirteenTwentyTwentyAderAlefNoteMember_zewZ1Or5uQyj" title="Convertible debt principal amount"><span id="xdx_90E_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--JanuaryThirteenTwentyTwentyAderAlefNoteMember_zPRKYRsBcAB2" title="Accrued interest"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2021-06-30_custom_SecuritiesPurchaseAgreementMember_custom_JanuaryThirteenTwentyTwentyAderAlefNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD"><ix:nonFraction name="us-gaap:InterestPayableCurrentAndNoncurrent" contextRef="AsOf2021-06-30_custom_SecuritiesPurchaseAgreementMember_custom_JanuaryThirteenTwentyTwentyAderAlefNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">0</ix:nonFraction></ix:nonFraction></span></span> as of as of
June 30, 2021 following conversion of $<span id="xdx_909_eus-gaap--DebtConversionConvertedInstrumentAmount1_pp0p0_c20200701__20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--JanuaryThirteenTwentyTwentyAderAlefNoteMember_zAsiPbM3m5Od" title="Debt conversion of converted amount"><ix:nonFraction name="us-gaap:DebtConversionConvertedInstrumentAmount1" contextRef="From2020-07-012021-06-30_custom_SecuritiesPurchaseAgreementMember_custom_JanuaryThirteenTwentyTwentyAderAlefNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">110,250</ix:nonFraction></span> of the principal balance and $<span id="xdx_907_ecustom--DebtConversionConvertedInterestPayable_pp0p0_c20200701__20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--JanuaryThirteenTwentyTwentyAderAlefNoteMember_ztmxfAe7fDf2" title="Debt conversion of accrued interest"><ix:nonFraction name="PPCB:DebtConversionConvertedInterestPayable" contextRef="From2020-07-012021-06-30_custom_SecuritiesPurchaseAgreementMember_custom_JanuaryThirteenTwentyTwentyAderAlefNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">7,493</ix:nonFraction></span> accrued interest during the year ended June 30, 2021.
Accordingly, $<span id="xdx_903_eus-gaap--DebtInstrumentUnamortizedPremium_iI_pp0p0_c20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--JanuaryThirteenTwentyTwentyAderAlefNoteMember_zf94QUj3cV4d" title="Debt premium amount"><ix:nonFraction name="us-gaap:DebtInstrumentUnamortizedPremium" contextRef="AsOf2021-06-30_custom_SecuritiesPurchaseAgreementMember_custom_JanuaryThirteenTwentyTwentyAderAlefNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">59,365</ix:nonFraction></span> of the put premium was released in respect of the Ader Alef Note during the year ended June 30, 2021 following conversion
of the principal balance. This note was fully converted into common stock in fiscal 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<ix:exclude><!-- Field: Page; Sequence: 113; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>PROPANC
BIOPHARMA, INC. AND SUBSIDIARY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>June
30, 2021 and 2020</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b><i>LG
Capital Securities Purchase Agreements</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Effective
February 19, 2020, the Company entered into a securities purchase agreement with LG Capital Funding, LLC (&#8220;LG Capital&#8221;),
pursuant to which LG Capital purchased a convertible promissory note (the &#8220;February 19, 2020 LG Capital Note&#8221;) from the Company
in the aggregate principal amount of $<span id="xdx_909_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20200219__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember__dei--LegalEntityAxis__custom--LGCapitalFundingLLCMember_zTYL65OQsz78" title="Convertible debt principal amount"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2020-02-19_custom_SecuritiesPurchaseAgreementMember_custom_FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember_custom_LGCapitalFundingLLCMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">75,000</ix:nonFraction></span>, such principal and the interest thereon convertible into shares of the Company&#8217;s
common stock at the option of LG Capital any time after the six month anniversary of the February 19, 2020 LG Capital Note. The February
19, 2020 LG Capital Note contained an original discount of $<span id="xdx_903_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pp0p0_c20200219__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember__dei--LegalEntityAxis__custom--LGCapitalFundingLLCMember_zrW4XhulEQfh" title="Original issue discount"><ix:nonFraction name="us-gaap:DebtInstrumentUnamortizedDiscount" contextRef="AsOf2020-02-19_custom_SecuritiesPurchaseAgreementMember_custom_FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember_custom_LGCapitalFundingLLCMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,750</ix:nonFraction></span>. The transactions contemplated by the LG Capital Securities Purchase
Agreement closed on March 4, 2020. Pursuant to the terms of the LG Capital Securities Purchase Agreement, LG Capital deducted $<span id="xdx_907_eus-gaap--LegalFees_pp0p0_c20200218__20200219__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember__dei--LegalEntityAxis__custom--LGCapitalFundingLLCMember_zAqRY7bZN066" title="Legal fees"><ix:nonFraction name="us-gaap:LegalFees" contextRef="From2020-02-182020-02-19_custom_SecuritiesPurchaseAgreementMember_custom_FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember_custom_LGCapitalFundingLLCMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,500</ix:nonFraction></span>
from the principal payment due under the February 19, 2020 LG Capital Note at the time of closing, to be applied to its legal expenses
and the Company received net cash proceeds of $<span id="xdx_90E_eus-gaap--ProceedsFromConvertibleDebt_pp0p0_c20200324__20200325__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember__dei--LegalEntityAxis__custom--LGCapitalFundingLLCMember_zd2NOwfrQAFi" title="Proceeds from convertible debt"><ix:nonFraction name="us-gaap:ProceedsFromConvertibleDebt" contextRef="From2020-03-242020-03-25_custom_SecuritiesPurchaseAgreementMember_custom_FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember_custom_LGCapitalFundingLLCMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">71,250</ix:nonFraction></span> on March 25, 2020. The Company used the net proceeds from the February 19, 2020
LG Capital Note for general working capital purposes. The maturity date of the February 19, 2020 LG Capital Note was <span id="xdx_902_eus-gaap--DebtInstrumentMaturityDate_c20200218__20200219__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember__dei--LegalEntityAxis__custom--LGCapitalFundingLLCMember" title="Debt maturity date"><ix:nonNumeric contextRef="From2020-02-182020-02-19_custom_SecuritiesPurchaseAgreementMember_custom_FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember_custom_LGCapitalFundingLLCMember" format="ixt:datemonthdayyearen" name="us-gaap:DebtInstrumentMaturityDate">February 19, 2021</ix:nonNumeric></span>.
The February 19, 2020 LG Capital Note bore interest at a rate of <span id="xdx_90A_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20200219__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember__dei--LegalEntityAxis__custom--LGCapitalFundingLLCMember_z2nFpqSgZBM4" title="Debt instrument, interest rate, stated percentage"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2020-02-19_custom_SecuritiesPurchaseAgreementMember_custom_FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember_custom_LGCapitalFundingLLCMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">8</ix:nonFraction></span>% per annum, which interest was paid by the Company to LG Capital in
shares of the Company&#8217;s common stock; but was not payable until the February 19, 2020 LG Capital Note became payable, whether at
the maturity date or upon acceleration or by prepayment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">During
the first 60 to 180 days following the date of the note, the Company had the right to prepay the principal and accrued but unpaid interest
due under the February 19, 2020 LG Capital Note, together with any other amounts that the Company may owe the holder under the terms
of the note, at a premium ranging from <span id="xdx_900_ecustom--DebtInstrumentDebtDefaultInterestRate_pid_dp_uPure_c20200218__20200219__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember__dei--LegalEntityAxis__custom--LGCapitalFundingLLCMember__srt--RangeAxis__srt--MinimumMember_z4523Mnskh12" title="Debt instrument, default, interest rate"><ix:nonFraction name="PPCB:DebtInstrumentDebtDefaultInterestRate" contextRef="From2020-02-182020-02-19_custom_SecuritiesPurchaseAgreementMember_custom_FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember_custom_LGCapitalFundingLLCMember_srt_MinimumMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">112</ix:nonFraction></span>% to <span id="xdx_90B_ecustom--DebtInstrumentDebtDefaultInterestRate_pid_dp_uPure_c20200218__20200219__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember__dei--LegalEntityAxis__custom--LGCapitalFundingLLCMember__srt--RangeAxis__srt--MaximumMember_zHP4hB60Iv01" title="Debt instrument, default, interest rate"><ix:nonFraction name="PPCB:DebtInstrumentDebtDefaultInterestRate" contextRef="From2020-02-182020-02-19_custom_SecuritiesPurchaseAgreementMember_custom_FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember_custom_LGCapitalFundingLLCMember_srt_MaximumMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">135</ix:nonFraction></span>% as defined in the note agreement. After this initial 180-day period, the Company
did not have a right to prepay the February 19, 2020 LG Capital Note.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span id="xdx_902_eus-gaap--DebtInstrumentDescription_c20200218__20200219__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember__dei--LegalEntityAxis__custom--LGCapitalFundingLLCMember__srt--RangeAxis__srt--MinimumMember_zscAo0RkfXK1" title="Debt instrument, description"><ix:nonNumeric contextRef="From2020-02-182020-02-19_custom_SecuritiesPurchaseAgreementMember_custom_FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember_custom_LGCapitalFundingLLCMember_srt_MinimumMember" name="us-gaap:DebtInstrumentDescription">The
conversion price for the February 19, 2020 LG Capital Note during the first 6 months the February 19, 2020 LG Capital Note was fixed
at $500 and thereafter was equal to a 35% discount of the lowest closing bid price (&#8220;Lowest Trading Price&#8221;) of the Common
Stock for the ten trading days immediately prior to the delivery of a Notice of Conversion, including the day upon which a Notice of
Conversion was received. Notwithstanding the foregoing, LG Capital was restricted from effecting a conversion if such conversion, along
with other shares of the Company&#8217;s common stock beneficially owned by LG Capital and its affiliates, exceeds <span id="xdx_90E_ecustom--PercentageOfOutstandingSharesOfCommonStock_uPure_c20200218__20200219__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember__dei--LegalEntityAxis__custom--LGCapitalFundingLLCMember__srt--RangeAxis__srt--MinimumMember_z2n2nkkyJvxi" title="Percentage of outstanding shares of common stock"><ix:nonFraction name="PPCB:PercentageOfOutstandingSharesOfCommonStock" contextRef="From2020-02-182020-02-19_custom_SecuritiesPurchaseAgreementMember_custom_FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember_custom_LGCapitalFundingLLCMember_srt_MinimumMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">9.99</ix:nonFraction></span>% of the outstanding
shares of the Company&#8217;s common stock.</ix:nonNumeric></span> The note was treated as stock settled debt under ASC 480 and accordingly the Company recorded
a $<span id="xdx_905_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pp0p0_c20200219__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--LGCapitalFundingLLCMember_z0U3K57K64Sd" title="Original issue discount"><ix:nonFraction name="us-gaap:DebtInstrumentUnamortizedDiscount" contextRef="AsOf2020-02-19_custom_SecuritiesPurchaseAgreementMember_custom_LGCapitalFundingLLCMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">40,385</ix:nonFraction></span> put premium.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
February 19, 2020 LG Capital Note contained certain events of default, upon which principal and accrued interest would become immediately
due and payable. In addition, upon an event of default, interest on the outstanding principal would accrue at a default interest rate
of <span id="xdx_904_eus-gaap--DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_pid_dp_uPure_c20200218__20200219__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember__dei--LegalEntityAxis__custom--LGCapitalFundingLLCMember_zyn8IJpMpkAh" title="Common stock trading volume, percent"><ix:nonFraction name="us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" contextRef="From2020-02-182020-02-19_custom_SecuritiesPurchaseAgreementMember_custom_FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember_custom_LGCapitalFundingLLCMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">24</ix:nonFraction></span>% per annum, or if such rate was usurious or not permitted by current law, then at the highest rate of interest permitted by law.
Further, certain events of default may trigger penalty and liquidated damage provisions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
total principal amount outstanding under the above LG Capital financing agreement was $<span id="xdx_900_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember__dei--LegalEntityAxis__custom--LGCapitalFundingLLCMember_zTL8mMujcRDg" title="Convertible debt principal amount"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2020-06-30_custom_SecuritiesPurchaseAgreementMember_custom_FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember_custom_LGCapitalFundingLLCMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">75,000</ix:nonFraction></span> and accrued interest of $<span id="xdx_90B_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember__dei--LegalEntityAxis__custom--LGCapitalFundingLLCMember_zHd1HuK4IoK2" title="Accrued interest"><ix:nonFraction name="us-gaap:InterestPayableCurrentAndNoncurrent" contextRef="AsOf2020-06-30_custom_SecuritiesPurchaseAgreementMember_custom_FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember_custom_LGCapitalFundingLLCMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,164</ix:nonFraction></span> as of June
30, 2020. The total principal amount outstanding and accrued interest under the above LG Capital financing agreement was $<span id="xdx_905_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember__dei--LegalEntityAxis__custom--LGCapitalFundingLLCMember_z8qewvbgEe86" title="Convertible debt principal amount"><span id="xdx_903_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember__dei--LegalEntityAxis__custom--LGCapitalFundingLLCMember_z7iiHXaE5ML9" title="Accrued interest"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2021-06-30_custom_SecuritiesPurchaseAgreementMember_custom_FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember_custom_LGCapitalFundingLLCMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD"><ix:nonFraction name="us-gaap:InterestPayableCurrentAndNoncurrent" contextRef="AsOf2021-06-30_custom_SecuritiesPurchaseAgreementMember_custom_FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember_custom_LGCapitalFundingLLCMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">0</ix:nonFraction></ix:nonFraction></span></span> as of June
30 2021 following conversion of $<span id="xdx_901_eus-gaap--DebtConversionConvertedInstrumentAmount1_pp0p0_c20200701__20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember__dei--LegalEntityAxis__custom--LGCapitalFundingLLCMember_zQJcqjX5skTd" title="Debt conversion of converted amount"><ix:nonFraction name="us-gaap:DebtConversionConvertedInstrumentAmount1" contextRef="From2020-07-012021-06-30_custom_SecuritiesPurchaseAgreementMember_custom_FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember_custom_LGCapitalFundingLLCMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">75,000</ix:nonFraction></span> of the principal balance and $<span id="xdx_905_ecustom--DebtConversionConvertedInterestPayable_c20200701__20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember__dei--LegalEntityAxis__custom--LGCapitalFundingLLCMember_pp0p0" title="Debt conversion of accrued interest"><ix:nonFraction name="PPCB:DebtConversionConvertedInterestPayable" contextRef="From2020-07-012021-06-30_custom_SecuritiesPurchaseAgreementMember_custom_FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember_custom_LGCapitalFundingLLCMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,421</ix:nonFraction></span> accrued interest during the year ended June 30, 2021. Accordingly,
$<span id="xdx_90D_eus-gaap--DebtInstrumentUnamortizedPremium_c20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember__dei--LegalEntityAxis__custom--LGCapitalFundingLLCMember_pp0p0" title="Debt premium amount"><ix:nonFraction name="us-gaap:DebtInstrumentUnamortizedPremium" contextRef="AsOf2021-06-30_custom_SecuritiesPurchaseAgreementMember_custom_FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember_custom_LGCapitalFundingLLCMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">40,385</ix:nonFraction></span> of the put premium was released in respect of the February 19, 2020 LG Capital Note during the year ended June 30, 2021 following
conversion of the principal balance. This note was fully converted into common stock in fiscal 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">There
were <span id="xdx_900_ecustom--UnissuedSharesConversion_pid_c20200908__20200909__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--LGCapitalFundingLLCMember_zy8TQj7rLE1l" title="Unissued shares conversion"><ix:nonFraction name="PPCB:UnissuedSharesConversion" contextRef="From2020-09-082020-09-09_custom_SecuritiesPurchaseAgreementMember_custom_LGCapitalFundingLLCMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">9,427</ix:nonFraction></span> unissued shares which were considered issuable for accounting purposes during the first quarter of fiscal 2021 related to
a conversion notice dated and received on September 9, 2020. In November 2020, the Company was notified by the note holder of the cancellation
of this conversion notice as a result of the reverse stock split and as such the Company reversed the effects of this transaction thereby
increasing the principal balance by $<span id="xdx_908_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20201130__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--LGCapitalFundingLLCMember_znSxfxtk5SJi" title="Convertible debt principal amount"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2020-11-30_custom_SecuritiesPurchaseAgreementMember_custom_LGCapitalFundingLLCMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">10,000</ix:nonFraction></span>, accrued interest of $<span id="xdx_90D_eus-gaap--DebtConversionConvertedInstrumentAmount1_pp0p0_c20201129__20201130__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--LGCapitalFundingLLCMember_z106ivN8PpEh" title="Debt conversion of converted amount"><ix:nonFraction name="us-gaap:DebtConversionConvertedInstrumentAmount1" contextRef="From2020-11-292020-11-30_custom_SecuritiesPurchaseAgreementMember_custom_LGCapitalFundingLLCMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">416</ix:nonFraction></span> and put premium by $<span id="xdx_908_eus-gaap--DebtInstrumentUnamortizedPremium_iI_pp0p0_c20201130__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--LGCapitalFundingLLCMember_zOkDmGq34n2k" title="Debt premium amount"><ix:nonFraction name="us-gaap:DebtInstrumentUnamortizedPremium" contextRef="AsOf2020-11-30_custom_SecuritiesPurchaseAgreementMember_custom_LGCapitalFundingLLCMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,385</ix:nonFraction></span> and a corresponding decrease in equity
of $<span id="xdx_90F_ecustom--DueToEquityConversion_iI_pp0p0_c20201130__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--LGCapitalFundingLLCMember_zadObOn7mP04" title="Due to equity conversion"><ix:nonFraction name="PPCB:DueToEquityConversion" contextRef="AsOf2020-11-30_custom_SecuritiesPurchaseAgreementMember_custom_LGCapitalFundingLLCMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">15,801</ix:nonFraction></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b><i>Geneva
Roth Remark Securities Purchase Agreements</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><i>December
2, 2020 Securities Purchase Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Effective
December 2, 2020, the Company entered into a securities purchase agreement with Geneva Roth Remark Holdings, Inc.(&#8220;Geneva Roth&#8221;),
pursuant to which Geneva Roth purchased a convertible promissory note (the &#8220;December 2, 2020 Geneva Roth&#8221;) from the Company
in the aggregate principal amount of $<span id="xdx_908_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20201202__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--DecemberTwoTwoThousandTwentyGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember_zpLyb1jxhG41" title="Convertible debt principal amount"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2020-12-02_custom_SecuritiesPurchaseAgreementMember_custom_DecemberTwoTwoThousandTwentyGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">78,000</ix:nonFraction></span>, such principal and the interest thereon convertible into shares of the Company&#8217;s
common stock at the option of Geneva Roth any time after the six month anniversary of the December 2, 2020 Geneva Roth. The December
2, 2020 Geneva Roth contains an original discount of $<span id="xdx_90F_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pp0p0_c20201202__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--DecemberTwoTwoThousandTwentyGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember_zZB2kgSgjnW1" title="Original issue discount"><ix:nonFraction name="us-gaap:DebtInstrumentUnamortizedDiscount" contextRef="AsOf2020-12-02_custom_SecuritiesPurchaseAgreementMember_custom_DecemberTwoTwoThousandTwentyGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,000</ix:nonFraction></span>. The Company intends to use the net proceeds from the December 2, 2020 Geneva
Roth for general working capital purposes. The maturity date of the December 2, 2020 Geneva Roth Note is December 2, 2021. The December
2, 2020 Geneva Roth Note bears interest at a rate of <span id="xdx_90E_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20201202__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--DecemberTwoTwoThousandTwentyGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember_zxHGRXmSF1E8" title="Debt instrument, interest rate, stated percentage"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2020-12-02_custom_SecuritiesPurchaseAgreementMember_custom_DecemberTwoTwoThousandTwentyGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">8</ix:nonFraction></span>% per annum, which interest may be paid by the Company to Geneva Roth in shares
of the Company&#8217;s common stock; but shall not be payable until the December 2, 2020 Geneva Roth Note becomes payable, whether at
the maturity date or upon acceleration or by prepayment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<ix:exclude><!-- Field: Page; Sequence: 114; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>PROPANC
BIOPHARMA, INC. AND SUBSIDIARY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>June
30, 2021 and 2020</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><i>January
5, 2021 Securities Purchase Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Effective
January 5, 2021, the Company entered into a securities purchase agreement with Geneva Roth Remark Holdings, Inc., pursuant to which Geneva
Roth purchased a convertible promissory note (the &#8220;January 5, 2021 Geneva Roth&#8221;) from the Company in the aggregate principal
amount of $<span id="xdx_901_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20210105__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--JanuaryFiveTwoThousandTwentyOneGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember_zCMSE7NuV6F1" title="Convertible debt principal amount"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2021-01-05_custom_SecuritiesPurchaseAgreementMember_custom_JanuaryFiveTwoThousandTwentyOneGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">68,500</ix:nonFraction></span>, such principal and the interest thereon convertible into shares of the Company&#8217;s common stock at the option
of Geneva Roth any time after the six-month anniversary of the January 5, 2021 Geneva Roth. The January 5, 2021 Geneva Roth contains
an original issue discount of $<span id="xdx_90E_eus-gaap--DebtConversionOriginalDebtAmount1_pp0p0_c20210104__20210105__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--JanuaryFiveTwoThousandTwentyOneGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember_zNzbQ8jepSsb" title="Debt conversion, original debt amount"><ix:nonFraction name="us-gaap:DebtConversionOriginalDebtAmount1" contextRef="From2021-01-042021-01-05_custom_SecuritiesPurchaseAgreementMember_custom_JanuaryFiveTwoThousandTwentyOneGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,500</ix:nonFraction></span>. The Company intends to use the net proceeds from the January 5, 2021 Geneva Roth for general working
capital purposes. The maturity date of the January 5, 2021 Geneva Roth Note is January 5, 2022. The January 5, 2021 Geneva Roth Note
bears interest at a rate of <span id="xdx_904_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20210105__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--JanuaryFiveTwoThousandTwentyOneGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember_zmSE9o74DhGb" title="Debt instrument, interest rate, stated percentage"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2021-01-05_custom_SecuritiesPurchaseAgreementMember_custom_JanuaryFiveTwoThousandTwentyOneGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">8</ix:nonFraction></span>% per annum, which interest may be paid by the Company to Geneva Roth in shares of the Company&#8217;s common
stock; but shall not be payable until the <span id="xdx_90F_eus-gaap--DebtInstrumentMaturityDate_dd_c20210104__20210105__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--JanuaryFiveTwoThousandTwentyOneGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember_z9W72G1n1xIh" title="Debt maturity date"><ix:nonNumeric contextRef="From2021-01-042021-01-05_custom_SecuritiesPurchaseAgreementMember_custom_JanuaryFiveTwoThousandTwentyOneGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember" format="ixt:datemonthdayyearen" name="us-gaap:DebtInstrumentMaturityDate">January 5, 2021</ix:nonNumeric></span> Geneva Roth Note becomes payable, whether at the maturity date or upon acceleration
or by prepayment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><i>March
16, 2021 Securities Purchase Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Effective
March 16, 2021, the Company entered into a securities purchase agreement with Geneva Roth Remark Holdings, Inc., pursuant to which Geneva
Roth purchased a convertible promissory note (the &#8220;March 16, 2021 Geneva Roth&#8221;) from the Company in the aggregate principal
amount of $<span id="xdx_901_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20210316__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--MarchSixteenTwoThousandTwentyOneGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember_zrB2otRYaZxa" title="Convertible debt principal amount"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2021-03-16_custom_SecuritiesPurchaseAgreementMember_custom_MarchSixteenTwoThousandTwentyOneGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">63,500</ix:nonFraction></span>, such principal and the interest thereon convertible into shares of the Company&#8217;s common stock at the option
of Geneva Roth any time after the six-month anniversary of the March 16, 2021 Geneva Roth. The March 16, 2021 Geneva Roth contains an
original discount of $<span id="xdx_904_eus-gaap--DebtConversionOriginalDebtAmount1_pp0p0_c20210313__20210316__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--MarchSixteenTwoThousandTwentyOneGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember_ziPdTQoddlOk" title="Debt conversion, original debt amount"><ix:nonFraction name="us-gaap:DebtConversionOriginalDebtAmount1" contextRef="From2021-03-132021-03-16_custom_SecuritiesPurchaseAgreementMember_custom_MarchSixteenTwoThousandTwentyOneGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,500</ix:nonFraction></span>. The Company intends to use the net proceeds from the March 16, 2021 Geneva Roth for general working capital
purposes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
maturity date of the March 16, 2021 Geneva Roth Note is March 16, 2022. The March 16, 2021 Geneva Roth Note bears interest at a rate
of <span id="xdx_902_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20210105__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--MarchSixteenTwoThousandTwentyOneGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember_zhZipEt2Pqi3" title="Debt instrument, interest rate, stated percentage"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2021-01-05_custom_SecuritiesPurchaseAgreementMember_custom_MarchSixteenTwoThousandTwentyOneGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">8</ix:nonFraction></span>% per annum, which interest may be paid by the Company to Geneva Roth in shares of the Company&#8217;s common stock; but shall not
be payable until the <span id="xdx_908_eus-gaap--DebtInstrumentMaturityDate_dd_c20210103__20210105__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--MarchSixteenTwoThousandTwentyOneGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember_zYkAPffCzota" title="Debt maturity date"><ix:nonNumeric contextRef="From2021-01-032021-01-05_custom_SecuritiesPurchaseAgreementMember_custom_MarchSixteenTwoThousandTwentyOneGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember" format="ixt:datemonthdayyearen" name="us-gaap:DebtInstrumentMaturityDate">March 16, 2021</ix:nonNumeric></span> Geneva Roth Note becomes payable, whether at the maturity date or upon acceleration or by prepayment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">During
the first 60 to 180 days following the date of these notes, the Company has the right to prepay the principal and accrued but unpaid
interest due under the above notes issued to Geneva Roth, together with any other amounts that the Company may owe the holder under the
terms of the note, at a premium ranging from <span id="xdx_90F_ecustom--DebtInstrumentDebtDefaultInterestRate_pid_dp_uPure_c20201201__20201202__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--DecemberTwoTwoThousandTwentyGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember__srt--RangeAxis__srt--MinimumMember_zX5toUXgs6od" title="Debt instrument, default, interest rate"><ix:nonFraction name="PPCB:DebtInstrumentDebtDefaultInterestRate" contextRef="From2020-12-012020-12-02_custom_SecuritiesPurchaseAgreementMember_custom_DecemberTwoTwoThousandTwentyGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember_srt_MinimumMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">110</ix:nonFraction></span>% to <span id="xdx_905_ecustom--DebtInstrumentDebtDefaultInterestRate_pid_dp_uPure_c20201201__20201202__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--DecemberTwoTwoThousandTwentyGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember__srt--RangeAxis__srt--MaximumMember_z5koNVLRd1s9" title="Debt instrument, default, interest rate"><ix:nonFraction name="PPCB:DebtInstrumentDebtDefaultInterestRate" contextRef="From2020-12-012020-12-02_custom_SecuritiesPurchaseAgreementMember_custom_DecemberTwoTwoThousandTwentyGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember_srt_MaximumMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">129</ix:nonFraction></span>% as defined in the note agreement. After this initial 180-day period, the Company
does not have a right to prepay such notes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_905_eus-gaap--DebtInstrumentDescription_c20201201__20201202__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--DecemberTwoTwoThousandTwentyGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember__srt--RangeAxis__srt--MinimumMember" style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonNumeric contextRef="From2020-12-012020-12-02_custom_SecuritiesPurchaseAgreementMember_custom_DecemberTwoTwoThousandTwentyGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember_srt_MinimumMember" name="us-gaap:DebtInstrumentDescription">The
conversion price for the above Geneva Roth notes shall be equal to a</ix:nonNumeric> </span><span id="xdx_908_ecustom--DebtInstrumentDebtDefaultInterestRate_pid_dp_uPure_c20201201__20201202__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--DecemberTwoTwoThousandTwentyGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember_zhmRBdKcKkH6" style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="PPCB:DebtInstrumentDebtDefaultInterestRate" contextRef="From2020-12-012020-12-02_custom_SecuritiesPurchaseAgreementMember_custom_DecemberTwoTwoThousandTwentyGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">35</ix:nonFraction></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">%
discount of the market price based on the average of the lowest three trading prices of the Common Stock for the ten trading days
immediately prior to the delivery of a Notice of Conversion. Notwithstanding the foregoing, Geneva Roth shall be restricted from effecting
a conversion if such conversion, along with other shares of the Company&#8217;s common stock beneficially owned by Geneva Roth and its
affiliates, exceeds </span><span id="xdx_906_ecustom--PercentageOfOutstandingSharesOfCommonStock_pid_dp_uPure_c20201201__20201202__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--DecemberTwoTwoThousandTwentyGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember__srt--RangeAxis__srt--MinimumMember_zBvZ27u0iO91" style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="PPCB:PercentageOfOutstandingSharesOfCommonStock" contextRef="From2020-12-012020-12-02_custom_SecuritiesPurchaseAgreementMember_custom_DecemberTwoTwoThousandTwentyGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember_srt_MinimumMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">9.99</ix:nonFraction></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">%
of the outstanding shares of the Company&#8217;s common stock.</span> <span style="font: 10pt Times New Roman, Times, Serif; color: Black">These
notes are treated as stock settled debt under ASC 480 and accordingly the Company recorded a total of $<span id="xdx_903_eus-gaap--DebtInstrumentUnamortizedPremium_c20201202__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--DecemberTwoTwoThousandTwentyGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember_pp0p0"><ix:nonFraction name="us-gaap:DebtInstrumentUnamortizedPremium" contextRef="AsOf2020-12-02_custom_SecuritiesPurchaseAgreementMember_custom_DecemberTwoTwoThousandTwentyGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">113,077</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">put premium for the three notes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
above Geneva Roth notes contain certain events of default, upon which principal and accrued interest will become immediately due and
payable. In addition, upon an event of default, interest on the outstanding principal shall accrue at a default interest rate of <span id="xdx_909_ecustom--DebtDefaultAmountPercentage_pid_dp_uPure_c20201201__20201202__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--DecemberTwoTwoThousandTwentyGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember_zR9DK8ymxYqi" title="Debt default amount percentage"><ix:nonFraction name="PPCB:DebtDefaultAmountPercentage" contextRef="From2020-12-012020-12-02_custom_SecuritiesPurchaseAgreementMember_custom_DecemberTwoTwoThousandTwentyGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">22</ix:nonFraction></span>%
per annum, or if such rate is usurious or not permitted by current law, then at the highest rate of interest permitted by law. Further,
certain events of default may trigger penalty and liquidated damage provisions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
total principal amounts outstanding under the above Geneva Roth financing agreements were $<span id="xdx_904_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--DecemberTwoTwoThousandTwentyGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember_zFQi7YehIjO8" title="Convertible debt principal amount"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2021-06-30_custom_SecuritiesPurchaseAgreementMember_custom_DecemberTwoTwoThousandTwentyGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">132,000</ix:nonFraction></span> and accrued interest of $<span id="xdx_907_eus-gaap--InterestPayableCurrentAndNoncurrent_c20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--DecemberTwoTwoThousandTwentyGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember_pp0p0" title="Accrued interest"><ix:nonFraction name="us-gaap:InterestPayableCurrentAndNoncurrent" contextRef="AsOf2021-06-30_custom_SecuritiesPurchaseAgreementMember_custom_DecemberTwoTwoThousandTwentyGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,477</ix:nonFraction></span> as
of June 30, 2021 following conversion of $<span id="xdx_904_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--DecemberTwoTwoThousandTwentyGenevaRothMember_zC360zEKOCR5"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2021-06-30_custom_SecuritiesPurchaseAgreementMember_custom_DecemberTwoTwoThousandTwentyGenevaRothMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">78,000</ix:nonFraction></span> of the principal balance and $<span id="xdx_908_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--DecemberTwoTwoThousandTwentyGenevaRothMember_zXRYDWNZ3rce" title="Accrued interest"><ix:nonFraction name="us-gaap:InterestPayableCurrentAndNoncurrent" contextRef="AsOf2021-06-30_custom_SecuritiesPurchaseAgreementMember_custom_DecemberTwoTwoThousandTwentyGenevaRothMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,120</ix:nonFraction></span> accrued interest during the year ended June 30,
2021. Accordingly, $<span id="xdx_906_eus-gaap--DebtInstrumentUnamortizedPremium_iI_pp0p0_c20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--DecemberTwoTwoThousandTwentyGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember_zD3bqIYfPui8" title="Debt premium amount"><ix:nonFraction name="us-gaap:DebtInstrumentUnamortizedPremium" contextRef="AsOf2021-06-30_custom_SecuritiesPurchaseAgreementMember_custom_DecemberTwoTwoThousandTwentyGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">42,000</ix:nonFraction></span> of the put premium was released in respect of the Geneva Roth financing agreements during the year ended June
30, 2021 following conversion of the principal balance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b><i>Amortization
of debt discounts</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
Company recorded $<span id="xdx_907_eus-gaap--AmortizationOfDebtDiscountPremium_pp0p0_c20200701__20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_z97YR7adUCde" title="Amortization of debt discount"><ix:nonFraction name="us-gaap:AmortizationOfDebtDiscountPremium" contextRef="From2020-07-012021-06-30_custom_SecuritiesPurchaseAgreementMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">211,000</ix:nonFraction></span> and $<span id="xdx_90D_eus-gaap--AmortizationOfDebtDiscountPremium_pp0p0_c20190701__20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zGs6lgmrl1q7" title="Amortization of debt discount"><ix:nonFraction name="us-gaap:AmortizationOfDebtDiscountPremium" contextRef="From2019-07-012020-06-30_custom_SecuritiesPurchaseAgreementMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">728,904</ix:nonFraction></span> of debt discounts related to the above note issuances during the years ended June 30, 2021 and
2020, respectively. The Company recorded $<span id="xdx_90F_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pp0p0_c20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zSI8WbWDkQXe" title="Original issue discount"><ix:nonFraction name="us-gaap:DebtInstrumentUnamortizedDiscount" contextRef="AsOf2021-06-30_custom_SecuritiesPurchaseAgreementMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">498,160</ix:nonFraction></span> and $<span id="xdx_904_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pp0p0_c20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zxmpIMrXZTi9" title="Original issue discount"><ix:nonFraction name="us-gaap:DebtInstrumentUnamortizedDiscount" contextRef="AsOf2020-06-30_custom_SecuritiesPurchaseAgreementMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">836,724</ix:nonFraction></span> of put premiums related to the above note issuances during the years ended
June 30, 2021 and 2020, respectively. The debt discounts are being amortized over the term of the debt and the put premiums are expensed
on issuance of the debt with the liability released to additional paid in capital on conversion of the principal.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Amortization
of all debt discounts for the years ended June 30, 2021 and 2020 was $<span id="xdx_909_eus-gaap--AmortizationOfDebtDiscountPremium_pp0p0_c20200701__20210630_zoloR4T28Ki6" title="Amortization of debt discount"><ix:nonFraction name="us-gaap:AmortizationOfDebtDiscountPremium" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">136,527</ix:nonFraction></span> and $<span id="xdx_904_eus-gaap--AmortizationOfDebtDiscountPremium_pp0p0_c20190701__20200630_zED7e8UWunw6" title="Amortization of debt discount"><ix:nonFraction name="us-gaap:AmortizationOfDebtDiscountPremium" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">734,130</ix:nonFraction></span>, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
Company reclassified $<span id="xdx_909_ecustom--ReclassifiedPremiumAmountForAdditionalPaidInCapital_pp0p0_c20200701__20210630_zEz7E5kvysEf" title="Reclassified premium amount for additional paid in capital"><ix:nonFraction name="PPCB:ReclassifiedPremiumAmountForAdditionalPaidInCapital" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">590,504</ix:nonFraction></span> and $<span id="xdx_90F_ecustom--ReclassifiedPremiumAmountForAdditionalPaidInCapital_pp0p0_c20190701__20200630_zkkG58hK8d3d" title="Reclassified premium amount for additional paid in capital"><ix:nonFraction name="PPCB:ReclassifiedPremiumAmountForAdditionalPaidInCapital" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">874,924</ix:nonFraction></span> in put premiums to additional paid in capital following conversions during the year ended
June 30, 2021 and 2020, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<ix:exclude><!-- Field: Page; Sequence: 115; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>PROPANC
BIOPHARMA, INC. AND SUBSIDIARY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>June
30, 2021 and 2020</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-07-012021-06-30" escape="true" name="us-gaap:IncomeTaxDisclosureTextBlock"><p id="xdx_804_eus-gaap--IncomeTaxDisclosureTextBlock_zoUNBWa6TWf9" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>NOTE
7 &#8211; <span id="xdx_82A_zUnPb5Jodezk">INCOME TAXES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
Company follows ASC 740-10-10, under which an entity recognizes deferred tax assets and liabilities for future tax consequences or for
events that were previously recognized in the Company&#8217;s financial statements or tax returns. The measurement of deferred tax assets
and liabilities is based on enacted tax law provisions. The effects of future changes in tax laws or rates are not anticipated. Through
June 30, 2010, the Company operated exclusively in Australia. The Company was wholly subject to Australian income tax laws and regulations,
which are administered by the Australian Taxation Office for the years ended June 30, 2010 and all prior years.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">On
November 23, 2010, the Company was incorporated in the state of Delaware. In January 2011, the Company acquired all of the outstanding
shares of Propanc PTY LTD on a one-for-one basis with Propanc PTY LTD becoming a wholly owned subsidiary of the Company. As a result
of these transactions, the Company is subject to the income tax laws of both the United States and Australia for the years ended June
30, 2013 through June 30, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<ix:nonNumeric contextRef="From2020-07-012021-06-30" escape="true" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"><p id="xdx_898_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zq6pSYl2gst8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
reconciliation of income tax expense computed at the U.S. federal statutory rate of <span id="xdx_903_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPercentage_c20200701__20210630_zcMFKyG8phE7" title="Income tax percentage"><span id="xdx_901_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPercentage_c20190701__20200630_zdBxwBfsNkA" title="Income tax percentage">21</span></span>% to the income tax provision for the years ended
June 30, 2021 and 2020 is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 8.5pt Segoe UI,sans-serif; margin: 0"><span id="xdx_8B8_zxxl79r3HSs9" style="display: none">SCHEDULE OF INCOME TAX PROVISION</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">US</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td colspan="2" id="xdx_49B_20200701__20210630__srt--StatementGeographicalAxis__country--US_zSgCEesLAXfb" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">June
    30, 2021</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td colspan="2" id="xdx_49A_20190701__20200630__srt--StatementGeographicalAxis__country--US_zYj9eqzE26Te" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">June
    30, 2020</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Year
    Ended</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">US</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>June
    30, 2021</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>June
    30, 2020</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_pp0p0_zhUJF5Fi5dNi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Loss
    before Income taxes</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" contextRef="From2020-07-012021-06-30_country_US" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">2,025,947</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" contextRef="From2019-07-012020-06-30_country_US" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">4,740,723</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_maITEBzOQe_zIU9tqeaUh9g" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Taxes
    under statutory US tax rates</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(<ix:nonFraction name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" contextRef="From2020-07-012021-06-30_country_US" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">425,449</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(<ix:nonFraction name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" contextRef="From2019-07-012020-06-30_country_US" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">995,552</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td></tr>
  <tr id="xdx_409_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_maITEBzOQe_z4vI3oRSIpf9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Increase
    (decrease) in valuation allowance</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" contextRef="From2020-07-012021-06-30_country_US" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,146,001</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" contextRef="From2019-07-012020-06-30_country_US" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,137,716</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--IncomeTaxReconciliationPriorYearIncomeTaxes_maITEBzOQe_z9iQbvGBkZa1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Prior
    period adjustment</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(<ix:nonFraction name="us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes" contextRef="From2020-07-012021-06-30_country_US" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,063,710</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(<ix:nonFraction name="us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes" contextRef="From2019-07-012020-06-30_country_US" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">14,624</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--IncomeTaxReconciliationForeignIncomeTaxRateDifferential_maITEBzOQe_z3kFZI11ojl9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Foreign
    tax rate differential</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(<ix:nonFraction name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" contextRef="From2020-07-012021-06-30_country_US" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">51,169</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(<ix:nonFraction name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" contextRef="From2019-07-012020-06-30_country_US" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">128,492</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td></tr>
  <tr id="xdx_40C_eus-gaap--IncomeTaxReconciliationTaxCredits_pp0p0_msITEBzOQe_znRgF8OODJA7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Income
    tax rate change</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationTaxCredits" contextRef="From2020-07-012021-06-30_country_US" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">392,767</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl1703">&#160;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--IncomeTaxReconciliationOtherAdjustments_maITEBzOQe_zLHrjdfb1Frc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Other</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationOtherAdjustments" contextRef="From2020-07-012021-06-30_country_US" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,559</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationOtherAdjustments" contextRef="From2019-07-012020-06-30_country_US" format="ixt:numdotdecimal" decimals="0" unitRef="USD">952</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--IncomeTaxExpenseBenefit_iT_pp0p0_mtITEBzOQe_z8TaVF0Tk2Ql" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Income
    tax (expense) benefit</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl1708">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl1709">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8A8_zxLluA1MdAzc" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company reflects a tax benefit on its consolidated
statement of operations and comprehensive income (loss) in 2021 and 2020 of $<span id="xdx_900_eus-gaap--IncomeTaxExpenseBenefit_iN_pp0p0_di_c20200701__20210630_znGelqCjITDb" title="Tax benefit"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">113,415</ix:nonFraction></span> and $<span id="xdx_90B_eus-gaap--IncomeTaxExpenseBenefit_iN_pp0p0_di_c20190701__20200630_zQTSIGKwbRte" title="Tax benefit"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">134,728</ix:nonFraction></span>, respectively. These amounts are research
and development tax credits and are not considered income tax.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On March 27, 2020, the Coronavirus Aid, Relief, and
Economic Security Act (CARES Act) was enacted in response to the COVID-19 pandemic. <span id="xdx_901_eus-gaap--IncomeTaxExaminationDescription_c20200324__20200327__us-gaap--TypeOfArrangementAxis__custom--CaresActMember_zNICMqUmmFHe"><ix:nonNumeric contextRef="From2020-03-242020-03-27_custom_CaresActMember" name="us-gaap:IncomeTaxExaminationDescription">The
CARES Act, among other things, permits NOL carryovers and carrybacks to offset 100% of taxable income for taxable years beginning before
2021.</ix:nonNumeric></span> In addition, the CARES Act allows NOLs incurred in 2018, 2019, and 2020 to be carried back to each of the five preceding
taxable years to generate a refund of previously paid income taxes. The Company is currently evaluating the impact of the CARES Act,
but due to sustained losses, the NOL carryback provision of the CARES Act would not yield a benefit to us.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Deferred
income taxes reflect the net tax effects of temporary differences between the carrying amount of assets and liabilities for financial
reporting purposes and amounts used for income tax purposes. Significant components of the Company&#8217;s deferred tax assets and liabilities
consist of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<ix:nonNumeric contextRef="From2020-07-012021-06-30" escape="true" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"><p id="xdx_89E_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zV4ys0tVWbi4" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span><span id="xdx_8BF_zUvJ23zA4ce2" style="display: none">SCHEDULE
OF DEFERRED TAX ASSETS AND LIABILITIES</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td colspan="2" id="xdx_493_20210630_zA7OqSLxk0rh" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">June
    30, 2021</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td colspan="2" id="xdx_49F_20200630_z2u0FqruVlw1" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">June
    30, 2020</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Year
    Ended</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>June
    30, 2021</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>June
    30, 2020</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Deferred
    tax assets</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_400_ecustom--DeferredTaxAssetsWarrantDerivativeLiability_iI_pp0p0_maDTAGzhU3_zsIM3aiSPan3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Warrant
    Derivative Liability</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="PPCB:DeferredTaxAssetsWarrantDerivativeLiability" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">7,403</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="PPCB:DeferredTaxAssetsWarrantDerivativeLiability" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">7,403</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_iI_pp0p0_maDTAGzhU3_z39v0JmmRzgh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Accrued
    Expenses</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">342,464</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">297,086</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_404_ecustom--DeferredTaxAssetsPrepaidInvestorServices_iI_pp0p0_maDTAGzhU3_zs5z5qnLjCR7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Prepaid
    Investor Services</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="PPCB:DeferredTaxAssetsPrepaidInvestorServices" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">444,411</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="PPCB:DeferredTaxAssetsPrepaidInvestorServices" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">470,050</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_40A_ecustom--DeferredTaxAssetsNonCashInterest_iI_pp0p0_maDTAGzhU3_zbruP5l38mra" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Non-cash
    interest</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="PPCB:DeferredTaxAssetsNonCashInterest" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">687,529</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="PPCB:DeferredTaxAssetsNonCashInterest" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">596,004</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--DeferredTaxAssetsGoodwillAndIntangibleAssets_iI_pp0p0_maDTAGzhU3_z1IjbyuZlJNf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Intangibles
    (Intellectual Property and Patent Cost)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">259,743</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">240,428</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent_iI_pp0p0_maDTAGzhU3_zlAyguQLKql9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Deferred
    Rent</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,262</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,969</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseOther_iI_pp0p0_maDTAGzhU3_zh29TakOlpN8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Formation
    Expense</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">6,815</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">7,208</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_pp0p0_maDTAGzhU3_zeN7NzTpnym2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Net
    Operating Loss CF</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">8,546,920</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">7,438,911</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_40F_ecustom--DeferredTaxAssetsForeignExchangeLoss_iI_pp0p0_maDTAGzhU3_znhJOjUBv9zc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Foreign
    Exchange Loss (OCI)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(<ix:nonFraction name="PPCB:DeferredTaxAssetsForeignExchangeLoss" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">39,379</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(<ix:nonFraction name="PPCB:DeferredTaxAssetsForeignExchangeLoss" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">39,379</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td></tr>
  <tr id="xdx_40E_ecustom--DeferredTaxAssetsRevalueOfDerivativeLiability_iI_pp0p0_maDTAGzhU3_z2qrS8FEmXae" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Revalue
    of derivative liability</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="PPCB:DeferredTaxAssetsRevalueOfDerivativeLiability" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">439,958</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="PPCB:DeferredTaxAssetsRevalueOfDerivativeLiability" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">438,239</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_iI_pp0p0_maDTAGzhU3_zUq5QwOWluRd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Stock
    Based Compensation</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">51,481</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">51,481</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--DeferredTaxAssetsGross_iTI_pp0p0_mtDTAGzhU3_maDTANz51B_zSomKbWDzIM8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Total
    Deferred tax assets</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DeferredTaxAssetsGross" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">10,751,607</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:DeferredTaxAssetsGross" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">9,509,400</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Deferred
    tax liabilities</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts_iNI_pp0p0_di_maDITLzdtb_zrJP4gkoj7Ib" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">R&amp;D</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(<ix:nonFraction name="us-gaap:DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">197,604</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(<ix:nonFraction name="us-gaap:DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">177,702</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td></tr>
  <tr id="xdx_40F_ecustom--DeferredTaxLiabilitiesGainOnExtinguishmentOfDebt_iNI_pp0p0_di_maDITLzdtb_zSyJS2MFsJx6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Gain
    on extinguishment of debt</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(<ix:nonFraction name="PPCB:DeferredTaxLiabilitiesGainOnExtinguishmentOfDebt" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">277,614</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="PPCB:DeferredTaxLiabilitiesGainOnExtinguishmentOfDebt" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">266,987</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts_iNI_pp0p0_di_maDITLzdtb_zTEacSOpGxXe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Capital
    Raising Costs</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(<ix:nonFraction name="us-gaap:DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">321,291</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(<ix:nonFraction name="us-gaap:DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">255,614</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td></tr>
  <tr id="xdx_403_eus-gaap--DeferredIncomeTaxLiabilities_iNTI_pp0p0_di_mtDITLzdtb_msDTANz51B_zaDntMXslQF1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Total
    deferred tax liabilities</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(<ix:nonFraction name="us-gaap:DeferredIncomeTaxLiabilities" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">796,509</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(<ix:nonFraction name="us-gaap:DeferredIncomeTaxLiabilities" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">700,303</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--DeferredTaxAssetsNet_iI_pp0p0_mtDTANz51B_maDTALNzVhZ_z8gpYprBgWF3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Net
    deferred tax assets (liabilities)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DeferredTaxAssetsNet" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">9,955,098</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:DeferredTaxAssetsNet" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">8,809,097</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pp0p0_di_msDTALNzVhZ_zTERLOTkxohh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Valuation
    allowance</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">9,955,098</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(<ix:nonFraction name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">8,809,097</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td></tr>
  <tr id="xdx_401_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iI_pp0p0_mtDTALNzVhZ_z2rv3BpLnS55" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Net
    deferred tax assets (liabilities)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl1772">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl1773">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8AF_zEoqAdIPi3cg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<ix:exclude><!-- Field: Page; Sequence: 116; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>PROPANC
BIOPHARMA, INC. AND SUBSIDIARY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>June
30, 2021 and 2020</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">At
June 30, 2021, the Company had U.S. net operating loss carry forwards of approximately $<span id="xdx_90E_eus-gaap--OperatingLossCarryforwards_iI_pp0p0_c20210630__srt--StatementGeographicalAxis__country--US_zdRpmeX2B4Qf" title="Operating loss carryforwards"><ix:nonFraction name="us-gaap:OperatingLossCarryforwards" contextRef="AsOf2021-06-30_country_US" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">9,588,164</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">that may be offset against future
taxable income, subject to limitation under IRC Section 382. Of the approximately $<span id="xdx_90A_eus-gaap--OperatingLossCarryforwards_iI_pn5n6_c20210630_zh6iGyk4E8y9" title="Operating loss carryforwards"><ix:nonFraction name="us-gaap:OperatingLossCarryforwards" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">9.6</ix:nonFraction></span> million of net operating loss carryforwards,
$<span id="xdx_909_eus-gaap--OperatingLossCarryforwards_iI_pn5n6_c20210630__srt--StatementGeographicalAxis__country--AU__us-gaap--AwardDateAxis__custom--ExpireInTwoThousandTwentyFourMember_zxpXGaxwDpd" title="Operating loss carryforwards"><ix:nonFraction name="us-gaap:OperatingLossCarryforwards" contextRef="AsOf2021-06-30_country_AU_custom_ExpireInTwoThousandTwentyFourMember" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">7.2</ix:nonFraction></span> million will begin to expire in 2024 and the remaining $<span id="xdx_900_eus-gaap--OperatingLossCarryforwards_iI_pn5n6_c20210630__srt--StatementGeographicalAxis__country--AU__us-gaap--AwardDateAxis__custom--NotExpireMember_zRbswM7wiVji" title="Operating loss carryforwards"><ix:nonFraction name="us-gaap:OperatingLossCarryforwards" contextRef="AsOf2021-06-30_country_AU_custom_NotExpireMember" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">2.4</ix:nonFraction></span> million will not expire. The Australian tax rate changed from <span id="xdx_900_eus-gaap--EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_pid_dp_uPure_c20190701__20200630__srt--StatementGeographicalAxis__country--AU_zSSPzGJCVrOg" title="Income tax rate"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" contextRef="From2019-07-012020-06-30_country_AU" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">27.5</ix:nonFraction>%</span>
in 2020 to <span id="xdx_908_eus-gaap--EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_pid_dp_uPure_c20200701__20210630__srt--StatementGeographicalAxis__country--AU_z6upJzuySn75" title="Income tax rate"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" contextRef="From2020-07-012021-06-30_country_AU" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">26</ix:nonFraction>%</span> in 2021. At June 30, 2021, the Company had Australia net operating loss carry forwards of approximately $<span id="xdx_90F_eus-gaap--OperatingLossCarryforwards_iI_pp0p0_c20210630__srt--StatementGeographicalAxis__country--AU_zqz2R2gp0G7g" title="Operating loss carryforwards"><ix:nonFraction name="us-gaap:OperatingLossCarryforwards" contextRef="AsOf2021-06-30_country_AU" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">25,128,485</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">million which can be carried forward
without expiration. <span id="xdx_906_eus-gaap--IncomeTaxExpenseBenefit_pp0p0_do_c20200701__20210630__srt--StatementGeographicalAxis__country--AU_zff6aukiG5Ok"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2020-07-012021-06-30_country_AU" format="ixt-sec:numwordsen" decimals="0" scale="0" unitRef="USD">No
</ix:nonFraction></span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">tax benefit has been reported in
the June 30, 2021 and 2020 consolidated financial statements due to the uncertainty surrounding the realizability of the benefit, based
on a more likely than not criteria and in consideration of available positive and negative evidence.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
Company applied the &#8220;more-likely-than-not&#8221; recognition threshold to all tax positions taken or expected to be taken in a
tax return, which resulted in <span id="xdx_906_eus-gaap--UnrecognizedTaxBenefits_iI_pp0p0_do_c20210630_zJwGyOocuSw3" title="Unrecognized tax benefits"><span id="xdx_90D_eus-gaap--UnrecognizedTaxBenefits_iI_pp0p0_do_c20200630_zaRtA0qtsLuh" title="Unrecognized tax benefits"><ix:nonFraction name="us-gaap:UnrecognizedTaxBenefits" contextRef="AsOf2021-06-30" format="ixt-sec:numwordsen" decimals="0" scale="0" unitRef="USD"><ix:nonFraction name="us-gaap:UnrecognizedTaxBenefits" contextRef="AsOf2020-06-30" format="ixt-sec:numwordsen" decimals="0" scale="0" unitRef="USD">no</ix:nonFraction></ix:nonFraction></span></span> unrecognized tax benefits as of June 30, 2021 and 2020, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Management
has determined that the realization of the net deferred tax asset is not assured and has created a valuation allowance for the entire
amount of such benefits.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
Company follows ASC 740-10, which provides guidance for the recognition and measurement of certain tax positions in an enterprise&#8217;s
financial statements. Recognition involves a determination whether it is more likely than not that a tax position will be sustained upon
examination with the presumption that the tax position will be examined by the appropriate taxing authority having full knowledge of
all relevant information.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
Company applied the &#8220;more-likely-than-not&#8221; recognition threshold to all tax positions taken or expected to be taken in a
tax return, which resulted in no unrecognized tax benefits as of June 30, 2021 and 2020, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
Company&#8217;s policy is to record interest and penalties associated with unrecognized tax benefits as additional income taxes in the
consolidated statement of operations. As of June 30, 2021, the Company had <span id="xdx_90C_eus-gaap--UnrecognizedTaxBenefits_iI_pp0p0_do_c20210630_zfYqiygoEkHf" title="Unrecognized tax benefits"><ix:nonFraction name="us-gaap:UnrecognizedTaxBenefits" contextRef="AsOf2021-06-30" format="ixt-sec:numwordsen" decimals="0" scale="0" unitRef="USD">no</ix:nonFraction></span> unrecognized tax benefits. There were <span id="xdx_90F_eus-gaap--UnrecognizedTaxBenefitsPeriodIncreaseDecrease_pp0p0_do_c20200701__20210630_zINZpCkISgag" title="Changes in unrecognized tax benefits"><span id="xdx_90A_eus-gaap--UnrecognizedTaxBenefitsPeriodIncreaseDecrease_pp0p0_do_c20190701__20200630_zNM4b7ULrCc5" title="Changes in unrecognized tax benefits"><ix:nonFraction name="us-gaap:UnrecognizedTaxBenefitsPeriodIncreaseDecrease" contextRef="From2020-07-012021-06-30" format="ixt-sec:numwordsen" decimals="0" scale="0" unitRef="USD"><ix:nonFraction name="us-gaap:UnrecognizedTaxBenefitsPeriodIncreaseDecrease" contextRef="From2019-07-012020-06-30" format="ixt-sec:numwordsen" decimals="0" scale="0" unitRef="USD">no</ix:nonFraction></ix:nonFraction></span></span> changes in the
Company&#8217;s unrecognized tax benefits during the years ended June 30, 2021 and 2020. The Company did not recognize any interest or
penalties during fiscal 2021 or 2020 related to unrecognized tax benefits.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
income tax returns filed for the tax years from inception will be subject to examination by the relevant taxing authorities.</span></p>
<!-- Field: Split-Segment; Name: 002 -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-07-012021-06-30" escape="true" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock"><p id="xdx_80A_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zDofS11dMtob" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>NOTE
8 &#8211; <span id="xdx_823_zpbrRbXbhIlk">STOCKHOLDERS&#8217; DEFICIT</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="text-decoration: underline">Increase
in Authorized Shares of Common Stock and Reverse Stock Split</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">On
February 4, 2020 the Directors resolved to increase the Common Stock of the Company from <span id="xdx_90B_eus-gaap--CommonStockSharesAuthorized_iI_c20210203_zEdsVrHBv7C5"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2021-02-03" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">100,000,000</ix:nonFraction></span> authorized shares to <span id="xdx_90B_eus-gaap--CommonStockSharesAuthorized_c20210204_pdd" title="Common stock, shares authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2021-02-04" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,000,000,000</ix:nonFraction></span>
authorized shares and believes that such number of authorized shares of Common Stock will be in the best interests of the Corporation
and its stockholders because the Board believes that the availability of more shares of Common Stock for issuance will allow the Corporation
greater flexibility in pursuing financing from investors, meeting business needs as they arise, taking advantage of favorable opportunities
and responding to a changing corporate environment. The Company filed the necessary documents with the U.S. Securities and Exchange Commission
on February 6, 2020 and with the amendment to the authorized shares being approved by the State of Delaware on March 13, 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">On
November 17, 2020, the Company effected a <span id="xdx_903_eus-gaap--StockholdersEquityReverseStockSplit_c20201116__20201117_zemL0lZyxZzf" title="Reverse stock split"><ix:nonNumeric contextRef="From2020-11-162020-11-17" name="us-gaap:StockholdersEquityReverseStockSplit">one-for-one thousand (1:1,000)</ix:nonNumeric></span> reverse stock split of the Company&#8217;s issued and outstanding
shares of common stock (the &#8220;Reverse Stock Split&#8221;). Proportional adjustments for the Reverse Stock Split were made to the
Company&#8217;s outstanding stock options, warrants and equity incentive plans. All share and per-share data and amounts have been retroactively
adjusted as of the earliest period presented in the consolidated financial statements to reflect the Reverse Stock Split.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b><span style="text-decoration: underline">Preferred
Stock</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
total number of shares of preferred stock that the Company is authorized to issue is <span id="xdx_905_eus-gaap--PreferredStockSharesAuthorized_c20210630_pdd" title="Preferred stock, shares authorized"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,500,005</ix:nonFraction></span>, $<span id="xdx_90D_eus-gaap--PreferredStockParOrStatedValuePerShare_c20210630_pdd" title="Preferred stock, par value"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.01</ix:nonFraction></span> par value per share. These preferred
shares have no rights to dividends, profit sharing or liquidation preferences.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Of
the total preferred shares authorized, <span title="Preferred stock, shares authorized"><span id="xdx_90A_eus-gaap--PreferredStockSharesAuthorized_iI_c20200630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_z8qZZXLoGcSc"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2020-06-30_us-gaap_SeriesAPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">500,000</ix:nonFraction></span></span> have been designated as Series A Preferred Stock (&#8220;Series A Preferred Stock&#8221;),
pursuant to the Certificate of Designation filed with the Secretary of State of the State of Delaware on December 9, 2014. James Nathanielsz,
the Company&#8217;s Chief Executive Officer and Chief Financial Officer, beneficially owns all of the outstanding shares of Series A
Preferred Stock via North Horizon Pty Ltd., which entitles him, as a holder of Series A Preferred Stock, to vote on all matters submitted
or required to be submitted to a vote of the Company&#8217;s stockholders, except election and removal of directors, and each share of
Series A Preferred Stock entitles him to two votes per share of Series A Preferred Stock. North Horizon Pty Ltd. is a Nathanielsz Family
Trust. Mr. James Nathanielsz, the Chief Executive Officer, Chief Financial Officer and a director of our Company, has voting and investment
power over these shares. <span id="xdx_902_eus-gaap--PreferredStockSharesIssued_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_pdd" title="Preferred stock, shares issued"><span id="xdx_903_eus-gaap--PreferredStockSharesOutstanding_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_pdd" title="Preferred stock, shares outstanding"><span id="xdx_903_eus-gaap--PreferredStockSharesIssued_c20200630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_pdd" title="Preferred stock, shares issued"><span id="xdx_900_eus-gaap--PreferredStockSharesOutstanding_c20200630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_pdd" title="Preferred stock, shares outstanding"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2021-06-30_us-gaap_SeriesAPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2021-06-30_us-gaap_SeriesAPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2020-06-30_us-gaap_SeriesAPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2020-06-30_us-gaap_SeriesAPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">500,000</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span></span></span></span> shares of Series A Preferred Stock are issued and outstanding as of June 30, 2021 and 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 29.15pt; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<ix:exclude><!-- Field: Page; Sequence: 117; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>PROPANC
BIOPHARMA, INC. AND SUBSIDIARY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>June
30, 2021 and 2020</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Of
the total preferred shares authorized, pursuant to the Certificate of Designation filed with the Secretary of State of the State of Delaware
on June 16, 2015, up to five shares have been designated as Series B Preferred Stock (&#8220;Series B Preferred Stock&#8221;). Each holder
of outstanding shares of Series B Preferred Stock is entitled to voting power equivalent to the number of votes equal to the total number
of shares of common stock outstanding as of the record date for the determination of stockholders entitled to vote at each meeting of
stockholders of the Company and entitled to vote on all matters submitted or required to be submitted to a vote of the stockholders of
the Company. One share of Series B Preferred Stock is issued and outstanding as of June 30, 2021 and 2020. Mr. Nathanielsz directly beneficially
owns such one share of Series B Preferred Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">No
additional shares of Series A Preferred Stock or Series B Preferred Stock were issued during fiscal year 2021 and 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b><span style="text-decoration: underline">Common
Stock</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b><i>Shares
Issued for Cash</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><i><span style="text-decoration: underline">April
3, 2020 Security Purchase Agreement</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">On
April 3, 2020, <span id="xdx_906_ecustom--EquityPurchaseAgreementDescription_c20200402__20200403__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember_zQzJVOXLplV2" title="Equity purchase agreement description"><ix:nonNumeric contextRef="From2020-04-022020-04-03_custom_SecurityPurchaseAgreementMember" name="PPCB:EquityPurchaseAgreementDescription">the Company closed on a transaction related to a Securities Purchase Agreement (the &#8220;Securities Purchase Agreement&#8221;)
entered into on March 30, 2020, whereby an investor (the &#8220;Investor&#8221;) purchased from the Company, 7,500 units (the &#8220;Units&#8221;),
each consisting of (i) 1.5 shares of the Company&#8217;s common stock (the &#8220;Common Stock&#8221;), or pre-funded warrants (the &#8220;Prefunded
Warrants&#8221;) upon Investor&#8217;s election due to the 4.99% blocker provision as discussed below and (ii) 1.5 warrants to purchase
one share of Common Stock (&#8220;Series A Warrants&#8221;, and collectively with the Common Stock the &#8220;Units&#8221;).</ix:nonNumeric></span> In addition
to the Units, the Investor was issued <span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20200403__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantsMember_zAKVh0VFqBm3" title="Warrants to purchase common stock"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2020-04-03_custom_SecurityPurchaseAgreementMember_custom_SeriesBWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">63,750</ix:nonFraction></span> warrants to purchase one share of Common Stock (the &#8220;Series B Warrants&#8221;) and
an additional <span id="xdx_901_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20200403__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesCWarrantsMember_zkeWadLtjJzb" title="Warrants to purchase common stock"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2020-04-03_custom_SecurityPurchaseAgreementMember_custom_SeriesCWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">63,750</ix:nonFraction></span> warrants to purchase one share of Common Stock, subject to a vesting schedule (the &#8220;Series C Warrants&#8221;
and, together with the Prefunded Warrants, the Series A Warrants, and the Series B Warrants, the &#8220;Warrants&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
aggregate purchase price for the Units, the Series A Warrants with exercise price of $<span id="xdx_906_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20200403__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAWarrantsMember_znkv22AGeQF4" title="Warrant exercise price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2020-04-03_custom_SecurityPurchaseAgreementMember_custom_SeriesAWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">200</ix:nonFraction></span> per share, the Series B Warrants with exercise
price of $<span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20200403__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantsMember_zXFlRpOohsQb" title="Warrant exercise price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2020-04-03_custom_SecurityPurchaseAgreementMember_custom_SeriesBWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">40</ix:nonFraction></span> per share and the Series C Warrants with exercise price of $<span id="xdx_901_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20200403__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesCWarrantsMember_z3yErjs5iHs1" title="Warrant exercise price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2020-04-03_custom_SecurityPurchaseAgreementMember_custom_SeriesCWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">200</ix:nonFraction></span> per share, of $<span id="xdx_90B_eus-gaap--FairValueAdjustmentOfWarrants_pp0p0_c20200402__20200403__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember_zM1MkBaMIzA7" title="Fair value of warrants"><ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="From2020-04-022020-04-03_custom_SecurityPurchaseAgreementMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">450,000</ix:nonFraction></span> was paid at closing (the &#8220;Purchase
Price&#8221;) or $60 per unit purchase price (see Warrants below). The Company received net proceeds of $<span id="xdx_90F_eus-gaap--ProceedsFromIssuanceOfWarrants_pp0p0_c20200402__20200403__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember_zmZ6AYE7zrkc" title="Proceeds from warrants"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfWarrants" contextRef="From2020-04-022020-04-03_custom_SecurityPurchaseAgreementMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">424,990</ix:nonFraction></span>, net of offering cost
of $<span id="xdx_902_eus-gaap--PaymentsOfStockIssuanceCosts_pp0p0_c20200402__20200403__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember_zxXzHfOERk2c" title="Offering cost"><ix:nonFraction name="us-gaap:PaymentsOfStockIssuanceCosts" contextRef="From2020-04-022020-04-03_custom_SecurityPurchaseAgreementMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">25,010</ix:nonFraction></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
Securities Purchase Agreement contains a blocker provision whereby the Investor or any of its affiliates would not beneficially own in
excess of <span id="xdx_90B_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pip0_dp_uPure_c20200403__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember_zkqEarGzUfz1"><ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" contextRef="AsOf2020-04-03_custom_SecurityPurchaseAgreementMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">4.99</ix:nonFraction>%</span> of the outstanding number of shares of Common Stock (&#8220;Beneficial Ownership Limitation&#8221;). As such, the Investor
may elect to purchase Prefunded Warrants equal to the same number of shares of Common Stock that the Company would have been issued.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Due
to the Beneficial Ownership Limitation, the <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20200402__20200403__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zc2NonDYiGfg" title="Common stock issued during period"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2020-04-022020-04-03_custom_SecurityPurchaseAgreementMember_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">11,250</ix:nonFraction></span> shares of Common Stock underlying the Units issuable at closing of the Securities
Purchase Agreement are comprised of <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20200402__20200403__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zzfgAYHtABF6" title="Number of restricted stock, shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" contextRef="From2020-04-022020-04-03_custom_SecurityPurchaseAgreementMember_us-gaap_RestrictedStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">804</ix:nonFraction></span> shares of restricted Common Stock and <span id="xdx_90C_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20200403__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantsMember_zurG6NZFHGPh" title="Warrants to purchase common stock"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2020-04-03_custom_SecurityPurchaseAgreementMember_custom_PrefundedWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">10,446</ix:nonFraction></span> Prefunded Warrants with exercise price of $<span id="xdx_901_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20200403__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantsMember_zPeBk9AvUOvi" title="Warrant exercise price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2020-04-03_custom_SecurityPurchaseAgreementMember_custom_PrefundedWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1</ix:nonFraction></span> (but
can be less than par value). The Prefunded Warrants shall be exercisable immediately and shall expire when exercised in full.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
Securities Purchase Agreement contains such representations, warranties and covenants as are typical for a transaction of this nature.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b><i>Shares
issued for conversion of convertible debt</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">During
the year ended June 30, 2020, the Company issued <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20190701__20200630__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember_zF1o74Iatpdl" title="Common stock issued during period"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2019-07-012020-06-30_custom_SecurityPurchaseAgreementMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">247,619</ix:nonFraction></span> shares of its common stock at an average contractual conversion price of $<span id="xdx_90F_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20200630__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember_zRu1BOZ7gFLl" title="Conversion price"><ix:nonFraction name="us-gaap:DebtInstrumentConvertibleConversionPrice1" contextRef="AsOf2020-06-30_custom_SecurityPurchaseAgreementMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">7</ix:nonFraction></span>,
ranging from $<span id="xdx_902_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20200630__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember__srt--RangeAxis__srt--MinimumMember_zdk4IkfmLyK4" title="Conversion price"><ix:nonFraction name="us-gaap:DebtInstrumentConvertibleConversionPrice1" contextRef="AsOf2020-06-30_custom_SecurityPurchaseAgreementMember_srt_MinimumMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">2</ix:nonFraction></span> to $<span id="xdx_90E_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20200630__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember__srt--RangeAxis__srt--MaximumMember_zTsXQm3Owsbb" title="Conversion price"><ix:nonFraction name="us-gaap:DebtInstrumentConvertibleConversionPrice1" contextRef="AsOf2020-06-30_custom_SecurityPurchaseAgreementMember_srt_MaximumMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">910</ix:nonFraction></span>, as a result of the conversion of principal and interest in the aggregate amount of $<span id="xdx_90D_eus-gaap--DebtConversionConvertedInstrumentAmount1_pp0p0_c20190701__20200630__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember_zEFIa8788IZk" title="Conversion of principal and interest, aggregate amount"><ix:nonFraction name="us-gaap:DebtConversionConvertedInstrumentAmount1" contextRef="From2019-07-012020-06-30_custom_SecurityPurchaseAgreementMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,814,336</ix:nonFraction></span> underlying certain
outstanding principal amount and accrued interest of convertible notes converted during such period, including $<span id="xdx_907_ecustom--ConversionFees_pp0p0_c20190701__20200630__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember_z1Y9Y8O4sjIe" title="Conversion fees"><ix:nonFraction name="PPCB:ConversionFees" contextRef="From2019-07-012020-06-30_custom_SecurityPurchaseAgreementMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">15,000</ix:nonFraction></span> of conversion
fees. The total recorded to equity was $<span id="xdx_901_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20190701__20200630__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember_z4RbqAqFQ8Q9" title="Proceeds from issuance of common stock"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="From2019-07-012020-06-30_custom_SecurityPurchaseAgreementMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,125,174</ix:nonFraction></span>. Notes with principal amounts totaling $<span id="xdx_902_ecustom--ConversionOptionDerivatives_pp0p0_c20190701__20200630__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember_zzfD8Z4BvkT8" title="Conversion option derivatives"><ix:nonFraction name="PPCB:ConversionOptionDerivatives" contextRef="From2019-07-012020-06-30_custom_SecurityPurchaseAgreementMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">254,500</ix:nonFraction></span> and accrued interest of $<span id="xdx_904_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20200630__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember_zhtMhMv9WjYg" title="Accrued interest"><ix:nonFraction name="us-gaap:InterestPayableCurrentAndNoncurrent" contextRef="AsOf2020-06-30_custom_SecurityPurchaseAgreementMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">15,408</ix:nonFraction></span> contained
bifurcated embedded conversion option derivatives. Accordingly, the fair market value of the shares issued was $<span id="xdx_904_ecustom--FairMarketValueOfShares_pp0p0_c20190701__20200630__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember_zsYfcDTrhCIj" title="Fair market value of the shares"><ix:nonFraction name="PPCB:FairMarketValueOfShares" contextRef="From2019-07-012020-06-30_custom_SecurityPurchaseAgreementMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">565,746</ix:nonFraction></span> resulting in
a loss on extinguishment at the time of conversion of $<span id="xdx_90D_eus-gaap--GainsLossesOnExtinguishmentOfDebt_pp0p0_c20190701__20200630__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember_z9JBj30nqpjh" title="Loss on extinguishment"><ix:nonFraction name="us-gaap:GainsLossesOnExtinguishmentOfDebt" contextRef="From2019-07-012020-06-30_custom_SecurityPurchaseAgreementMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">295,838</ix:nonFraction></span> and $<span id="xdx_909_eus-gaap--DerivativeFairValueOfDerivativeNet_iI_pp0p0_c20200630__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember_zDo68gcdGz6b" title="Derivative fair value"><ix:nonFraction name="us-gaap:DerivativeFairValueOfDerivativeNet" contextRef="AsOf2020-06-30_custom_SecurityPurchaseAgreementMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">362,961</ix:nonFraction></span> of derivative fair value was recorded as a gain on extinguishment
at the time of conversion. The Company reclassified $<span id="xdx_908_ecustom--PremiumsToAdditionalPaidInCapital_pp0p0_c20190701__20200630__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember_zm2uY8KckkI" title="Premiums to additional paid in capital"><ix:nonFraction name="PPCB:PremiumsToAdditionalPaidInCapital" contextRef="From2019-07-012020-06-30_custom_SecurityPurchaseAgreementMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">874,924</ix:nonFraction></span> in put premiums to additional paid in capital following conversions during
the year ended June 30, 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">During
the year ended June 30, 2021, the Company issued an aggregate of <span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20200701__20210630__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember_zzmzgt1k6Urk"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2020-07-012021-06-30_custom_SecurityPurchaseAgreementMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">8,786,113</ix:nonFraction></span> shares of its common stock at an average contractual conversion
price of $<span id="xdx_90F_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20210630__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember_zgi5IUtBLy4g"><ix:nonFraction name="us-gaap:DebtInstrumentConvertibleConversionPrice1" contextRef="AsOf2021-06-30_custom_SecurityPurchaseAgreementMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.13</ix:nonFraction></span>, ranging from $<span id="xdx_909_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20210630__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember__srt--RangeAxis__srt--MinimumMember_zKzl3Q22H2M4"><ix:nonFraction name="us-gaap:DebtInstrumentConvertibleConversionPrice1" contextRef="AsOf2021-06-30_custom_SecurityPurchaseAgreementMember_srt_MinimumMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.03</ix:nonFraction></span> to $<span id="xdx_90C_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20210630__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember__srt--RangeAxis__srt--MaximumMember_zQU3yiRITII7"><ix:nonFraction name="us-gaap:DebtInstrumentConvertibleConversionPrice1" contextRef="AsOf2021-06-30_custom_SecurityPurchaseAgreementMember_srt_MaximumMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">2.00</ix:nonFraction></span>, as a result of the conversion of principal of $<span id="xdx_904_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20210630__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember_zawYhep7XYy6"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2021-06-30_custom_SecurityPurchaseAgreementMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,018,867</ix:nonFraction></span>, interest of $<span id="xdx_901_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20210630__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember_z2PXewyj25Pl"><ix:nonFraction name="us-gaap:InterestPayableCurrentAndNoncurrent" contextRef="AsOf2021-06-30_custom_SecurityPurchaseAgreementMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">103,321</ix:nonFraction></span> and conversion
fees $<span id="xdx_901_ecustom--ConversionFees_pp0p0_c20200701__20210630__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember_z8nwnGzWliC8"><ix:nonFraction name="PPCB:ConversionFees" contextRef="From2020-07-012021-06-30_custom_SecurityPurchaseAgreementMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">16,500</ix:nonFraction></span> underlying certain outstanding convertible notes converted during such period. The total recorded to equity was $<span id="xdx_90E_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20200701__20210630__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember_zmLhMoas1V1b"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="From2020-07-012021-06-30_custom_SecurityPurchaseAgreementMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,239,075</ix:nonFraction></span>
prior to the reversal of unissued shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<ix:exclude><!-- Field: Page; Sequence: 118; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>PROPANC
BIOPHARMA, INC. AND SUBSIDIARY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>June
30, 2021 and 2020</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">There
were <span id="xdx_907_eus-gaap--CommonStockSharesSubscribedButUnissued_iI_c20200930_zvwZepU3XH61" title="Common stock, unissued shares"><ix:nonFraction name="us-gaap:CommonStockSharesSubscribedButUnissued" contextRef="AsOf2020-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">24,427</ix:nonFraction></span> unissued shares which were considered issuable for accounting purposes during the first quarter of fiscal 2021 related to
conversion notices dated and received in September 2020. In November 2020, the Company was notified by the note holder of the cancellation
of these conversion notices and as such the Company reversed the effects of these transactions thereby increasing the principal balance
by $<span id="xdx_90B_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20201130_zpFWBVfZZM3i" title="Convertible debt principal amount"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2020-11-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">19,600</ix:nonFraction></span>, accrued interest of $<span id="xdx_904_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20201130_zbIvfesGMJV" title="Accrued interest"><ix:nonFraction name="us-gaap:InterestPayableCurrentAndNoncurrent" contextRef="AsOf2020-11-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">416</ix:nonFraction></span> and put premium by $<span id="xdx_902_eus-gaap--DebtInstrumentUnamortizedPremium_iI_pp0p0_c20201130_zjj3Yf2nNPXh" title="Debt premium amount"><ix:nonFraction name="us-gaap:DebtInstrumentUnamortizedPremium" contextRef="AsOf2020-11-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">11,785</ix:nonFraction></span> and a corresponding decrease in equity of $<span id="xdx_907_ecustom--DecreaseInEquity_pp0p0_c20201129__20201130_zvj9lkT8srN6" title="Amount of decrease in equity"><ix:nonFraction name="PPCB:DecreaseInEquity" contextRef="From2020-11-292020-11-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">31,801</ix:nonFraction></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Converted
notes totaling principal amount of $<span id="xdx_904_eus-gaap--DebtInstrumentFaceAmount_c20210630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_pp0p0"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2021-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">95,000</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">and accrued interest of $<span id="xdx_904_eus-gaap--InterestPayableCurrentAndNoncurrent_c20210630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_pp0p0"><ix:nonFraction name="us-gaap:InterestPayableCurrentAndNoncurrent" contextRef="AsOf2021-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,000</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">contained bifurcated embedded conversion
option derivatives. Accordingly, the fair market value of the shares issued was $<span id="xdx_90C_ecustom--FairMarketValueOfShares_c20200701__20210630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_pp0p0"><ix:nonFraction name="PPCB:FairMarketValueOfShares" contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">178,368</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">resulting in a loss on extinguishment
at the time of conversion of $<span id="xdx_906_eus-gaap--GainsLossesOnExtinguishmentOfDebt_c20200701__20210630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_pp0p0"><ix:nonFraction name="us-gaap:GainsLossesOnExtinguishmentOfDebt" contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">80,368</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">and $<span id="xdx_901_eus-gaap--DerivativeFairValueOfDerivativeNet_c20210630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_pp0p0"><ix:nonFraction name="us-gaap:DerivativeFairValueOfDerivativeNet" contextRef="AsOf2021-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">130,975</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">of derivative fair value was recorded
as a gain on extinguishment at the time of conversion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The Company reclassified $<span id="xdx_90B_ecustom--PremiumsToAdditionalPaidInCapital_c20200701__20210630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_pp0p0"><ix:nonFraction name="PPCB:PremiumsToAdditionalPaidInCapital" contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">590,504</ix:nonFraction>
to additional paid in capital following conversions of notes accounted for as stock settled debt during the year ended June 30,
2021.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
Company has <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20200701__20210630__us-gaap--TypeOfArrangementAxis__custom--UnderlyingFinancingAgreementsMember_pdd" title="Common stock issued during period"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2020-07-012021-06-30_custom_UnderlyingFinancingAgreementsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">197,308,116</ix:nonFraction></span> shares of its common stock reserved for future issuances based on lender reserve requirements pursuant to underlying
financing agreements at June 30, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b><i>Shares
issued for services</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">On
July 19, 2019, the Company entered into an agreement with a certain consultant to provide services over a two-month period beginning
July 1, 2019 and ending September 1, 2019 in exchange for 20 shares of the Company&#8217;s common stock. On July 19, 2019, the Company
issued the <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20200718__20200719__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember_pdd" title="Common stock issued during period"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2020-07-182020-07-19_custom_ConsultingAgreementMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">20</ix:nonFraction></span> shares of the Company&#8217;s common stock valued at $<span id="xdx_90D_eus-gaap--SharesIssuedPricePerShare_c20200719__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember_pdd" title="Share issued price per share"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2020-07-19_custom_ConsultingAgreementMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1,990</ix:nonFraction></span> per share; being the closing price of the stock on the date
of the agreement, to such consultant, or $<span id="xdx_907_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20200718__20200719__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember_pp0p0" title="Proceeds from issuance of common stock"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="From2020-07-182020-07-19_custom_ConsultingAgreementMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">39,800</ix:nonFraction></span>, which will be amortized over the term of the agreement. The Company recorded $<span id="xdx_908_eus-gaap--ProfessionalFees_pp0p0_c20190701__20200630__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember_zskhHC2MpVdj" title="Consulting expenses"><ix:nonFraction name="us-gaap:ProfessionalFees" contextRef="From2019-07-012020-06-30_custom_ConsultingAgreementMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">39,800</ix:nonFraction></span>
of consulting expense with respect to such shares of its common stock during the year ended June 30, 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Between
February 3, 2020 and June 26, 2020, the Company issued an aggregate of <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20200202__20200203__srt--TitleOfIndividualAxis__custom--ConsultantMember__us-gaap--TypeOfArrangementAxis__custom--EngagementAgreementMember_zud6RckbyAIa" title="Stock issued for services, shares"><span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20200625__20200626__srt--TitleOfIndividualAxis__custom--ConsultantMember__us-gaap--TypeOfArrangementAxis__custom--EngagementAgreementMember_zKk11bt134m4" title="Stock issued for services, shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" contextRef="From2020-02-022020-02-03_custom_ConsultantMember_custom_EngagementAgreementMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" contextRef="From2020-06-252020-06-26_custom_ConsultantMember_custom_EngagementAgreementMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">8,709</ix:nonFraction></ix:nonFraction></span></span> shares of the Company&#8217;s common stock to a consultant
for services rendered pursuant to an engagement agreement dated on September 10, 2019 which agreement was later amended in February 2020.
Between February 3, 2020 and June 26, 2020, the Company issued an aggregate of <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20200625__20200626__srt--TitleOfIndividualAxis__custom--ConsultantMember__us-gaap--TypeOfArrangementAxis__custom--EngagementAgreementMember_zS4WwEqgGyM4" title="Stock issued for services, shares"><span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20200625__20200626__srt--TitleOfIndividualAxis__custom--ConsultantMember__us-gaap--TypeOfArrangementAxis__custom--EngagementAgreementMember_zVCOTLx5ebV9" title="Stock issued for services, shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" contextRef="From2020-06-252020-06-26_custom_ConsultantMember_custom_EngagementAgreementMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" contextRef="From2020-06-252020-06-26_custom_ConsultantMember_custom_EngagementAgreementMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">8,709</ix:nonFraction></ix:nonFraction></span></span> shares of the Company&#8217;s common stock valued
at an average price of $<span id="xdx_904_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20200203__srt--TitleOfIndividualAxis__custom--ConsultantMember__us-gaap--TypeOfArrangementAxis__custom--EngagementAgreementMember_zdjrn0McezL9" title="Common stock, par value"><span id="xdx_90C_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20200626__srt--TitleOfIndividualAxis__custom--ConsultantMember__us-gaap--TypeOfArrangementAxis__custom--EngagementAgreementMember_zZ8scAbUaK8j" title="Common stock, par value"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2020-02-03_custom_ConsultantMember_custom_EngagementAgreementMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2020-06-26_custom_ConsultantMember_custom_EngagementAgreementMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">8</ix:nonFraction></ix:nonFraction></span></span> per share; being the closing price of the stock on the date of the agreement, to such consultant, or $<span id="xdx_90B_eus-gaap--ProfessionalFees_pp0p0_c20200202__20200203__srt--TitleOfIndividualAxis__custom--ConsultantMember__us-gaap--TypeOfArrangementAxis__custom--EngagementAgreementMember_z1LUHGxWvIdj" title="Consulting expenses"><span id="xdx_900_eus-gaap--ProfessionalFees_pp0p0_c20200625__20200626__srt--TitleOfIndividualAxis__custom--ConsultantMember__us-gaap--TypeOfArrangementAxis__custom--EngagementAgreementMember_zZrmOY5ch9Nl" title="Consulting expenses"><ix:nonFraction name="us-gaap:ProfessionalFees" contextRef="From2020-02-022020-02-03_custom_ConsultantMember_custom_EngagementAgreementMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD"><ix:nonFraction name="us-gaap:ProfessionalFees" contextRef="From2020-06-252020-06-26_custom_ConsultantMember_custom_EngagementAgreementMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">73,842</ix:nonFraction></ix:nonFraction></span></span>.
The Company recorded $<span id="xdx_903_eus-gaap--ProfessionalFees_pp0p0_c20190701__20200630__srt--TitleOfIndividualAxis__custom--ConsultantMember__us-gaap--TypeOfArrangementAxis__custom--EngagementAgreementMember_zVu3NY8DRQZf" title="Consulting expenses"><ix:nonFraction name="us-gaap:ProfessionalFees" contextRef="From2019-07-012020-06-30_custom_ConsultantMember_custom_EngagementAgreementMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">73,842</ix:nonFraction></span> of consulting expense with respect to such shares of its common stock during the year ended June 30, 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">On
March 22, 2021, the Company issued an aggregate of <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20210321__20210322__srt--TitleOfIndividualAxis__custom--ConsultantMember_zK4ts7pTGyY9" title="Number of shares issued for services"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" contextRef="From2021-03-212021-03-22_custom_ConsultantMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">225,037</ix:nonFraction></span> shares of the Company&#8217;s common stock to a consultant for services rendered
from January 1, 2021 to March 22, 2021. The Company issued <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20200701__20210630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--TitleOfIndividualAxis__custom--ConsultantMember_pdd" title="Number of shares issued for services"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember_custom_ConsultantMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">225,037</ix:nonFraction></span> shares of the Company&#8217;s common stock valued at $<span id="xdx_90A_eus-gaap--SharesIssuedPricePerShare_c20210630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--TitleOfIndividualAxis__custom--ConsultantMember_pdd" title="Shares issued per price"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2021-06-30_us-gaap_CommonStockMember_custom_ConsultantMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.30</ix:nonFraction></span> per share,
being the closing price of the stock on the date of grant to such consultant, or $<span id="xdx_908_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_pp0p0_c20200701__20210630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--TitleOfIndividualAxis__custom--ConsultantMember_zhUF8BYRp3Ih" title="Number of shares issued for services, value"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember_custom_ConsultantMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">67,511</ix:nonFraction></span>. The Company recorded $<span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_pp0p0_c20200701__20210630__srt--TitleOfIndividualAxis__custom--ConsultantMember_zvXvgxYc4jF1" title="Number of shares issued for services, value"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2020-07-012021-06-30_custom_ConsultantMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">67,511</ix:nonFraction></span> of consulting
expense with respect to such shares of its common stock during the year ended June 30, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Between
March 2021 and June 2021, the Company issued an aggregate of <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20210301__20210331__srt--TitleOfIndividualAxis__custom--ConsultantMember__us-gaap--TypeOfArrangementAxis__custom--EngagementAgreementMember_z98v5YphXto8"><span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20210601__20210630__srt--TitleOfIndividualAxis__custom--ConsultantMember__us-gaap--TypeOfArrangementAxis__custom--EngagementAgreementMember_zjqIXel6tOQ1"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" contextRef="From2021-03-012021-03-31_custom_ConsultantMember_custom_EngagementAgreementMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" contextRef="From2021-06-012021-06-30_custom_ConsultantMember_custom_EngagementAgreementMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">580,609</ix:nonFraction></ix:nonFraction></span></span> shares of the Company&#8217;s common stock to a consultant for services
rendered from April 1, 2021 to June 30, 2021. The Company issued <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20210301__20210331__srt--TitleOfIndividualAxis__custom--ConsultantMember__us-gaap--TypeOfArrangementAxis__custom--EngagementAgreementMember_zANCvk6P9mjk"><span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20210601__20210630__srt--TitleOfIndividualAxis__custom--ConsultantMember__us-gaap--TypeOfArrangementAxis__custom--EngagementAgreementMember_zM5PICi8Ffwh"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" contextRef="From2021-03-012021-03-31_custom_ConsultantMember_custom_EngagementAgreementMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" contextRef="From2021-06-012021-06-30_custom_ConsultantMember_custom_EngagementAgreementMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">580,609</ix:nonFraction></ix:nonFraction></span></span> shares of the Company&#8217;s common stock valued at $<span id="xdx_90C_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20210331__srt--TitleOfIndividualAxis__custom--ConsultantMember__us-gaap--TypeOfArrangementAxis__custom--EngagementAgreementMember_zl9v7QU8w19l"><span id="xdx_902_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20210630__srt--TitleOfIndividualAxis__custom--ConsultantMember__us-gaap--TypeOfArrangementAxis__custom--EngagementAgreementMember_zbK4vNipFGil"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2021-03-31_custom_ConsultantMember_custom_EngagementAgreementMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2021-06-30_custom_ConsultantMember_custom_EngagementAgreementMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.10</ix:nonFraction></ix:nonFraction></span></span> per
share, being the closing price of the stock on the date of grant to such consultant, or $<span id="xdx_90E_eus-gaap--ProfessionalFees_pp0p0_c20210301__20210331__srt--TitleOfIndividualAxis__custom--ConsultantMember__us-gaap--TypeOfArrangementAxis__custom--EngagementAgreementMember_zTQTvLKYppKh"><span id="xdx_902_eus-gaap--ProfessionalFees_pp0p0_c20210601__20210630__srt--TitleOfIndividualAxis__custom--ConsultantMember__us-gaap--TypeOfArrangementAxis__custom--EngagementAgreementMember_zqlAs0ioI2c5"><ix:nonFraction name="us-gaap:ProfessionalFees" contextRef="From2021-03-012021-03-31_custom_ConsultantMember_custom_EngagementAgreementMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD"><ix:nonFraction name="us-gaap:ProfessionalFees" contextRef="From2021-06-012021-06-30_custom_ConsultantMember_custom_EngagementAgreementMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">58,061</ix:nonFraction></ix:nonFraction></span></span>. The Company recorded $<span id="xdx_90C_eus-gaap--ProfessionalFees_pp0p0_c20200701__20210630__srt--TitleOfIndividualAxis__custom--ConsultantMember__us-gaap--TypeOfArrangementAxis__custom--EngagementAgreementMember_zPmjyJKaog14"><ix:nonFraction name="us-gaap:ProfessionalFees" contextRef="From2020-07-012021-06-30_custom_ConsultantMember_custom_EngagementAgreementMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">58,061</ix:nonFraction></span> of consulting
expense with respect to such shares of its common stock during the year ended June 30, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b><i>Shares
issued for exercise of warrants</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">During
the year ended June 30, 2021, the Company received aggregate gross proceeds of $<span id="xdx_90D_eus-gaap--ProceedsFromWarrantExercises_c20200701__20210630_pp0p0"><ix:nonFraction name="us-gaap:ProceedsFromWarrantExercises" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">776,044</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">from the exercise of <span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_c20210630__us-gaap--StatementClassOfStockAxis__custom--PrefundedWarrantsMember_pdd"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2021-06-30_custom_PrefundedWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">10,445</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">prefunded warrants and <span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_c20210630__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantsMember_pdd"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2021-06-30_custom_SeriesBWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">19,375</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Series B Warrants resulting in
the issuance of <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20200701__20210630__us-gaap--StatementClassOfStockAxis__custom--PrefundedWarrantsMember_pdd"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2020-07-012021-06-30_custom_PrefundedWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">29,820</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">shares of common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Additionally,
during 2021 the Company issued <span id="xdx_90A_eus-gaap--CommonStockSharesIssued_iI_c20210630__us-gaap--StatementClassOfStockAxis__custom--TwentySeriesAAndOneSeriesCWarrantsMember_z4XiGfAQTBib"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2021-06-30_custom_TwentySeriesAAndOneSeriesCWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,199,979</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">shares of common stock from the
alternate cashless exercise of 20 Series A and 1 Series C warrants. The Company recognized the value of the effect of a down round
feature in such warrants when triggered. Upon the occurrence of the triggering event that resulted in a reduction of the strike price,
the Company measured the value of the effect of the feature as the difference between the fair value of the warrants without the down
round feature or before the strike price reduction and the fair value of the warrants with a strike price corresponding to the reduced
strike price upon the down round feature being triggered. Accordingly, the Company recognized deemed dividend of $<span id="xdx_900_ecustom--DeemedDividend_iN_di_c20200701__20210630_zyNhuYLlIyZh"><ix:nonFraction name="PPCB:DeemedDividend" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">391,749</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">and a corresponding reduction
of income available to common stockholders upon the </span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">alternate
cashless exercise of these warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><i>Restricted
Stock Units</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Pursuant
to employment agreements dated in May 2019, the Company granted an aggregate of <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20190501__20190531_zdMr0ljXcp2i"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" contextRef="From2019-05-012019-05-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">78</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">and <span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20190501__20190531__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zjT4EQM6i0qj"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" contextRef="From2019-05-012019-05-31_srt_ChiefExecutiveOfficerMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">39</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">restricted stock unit to the Company&#8217;s
Chief Executive Officer and Chief Scientific Officer, respectively. The total <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20190501__20190531__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zw6ANGtIJOUc"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" contextRef="From2019-05-012019-05-31_us-gaap_RestrictedStockUnitsRSUMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">117</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">restricted stock units are subject
to vesting terms as defined in the employment agreements. The 117 restricted stock units were valued at the fair value of $<span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20190501__20190531__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zj17rqfAtqfj"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" contextRef="From2019-05-012019-05-31_us-gaap_RestrictedStockUnitsRSUMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">4,250</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">per unit or $<span id="xdx_906_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantDateFairvalue_pp0p0_c20190501__20190531__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zQxy1dO86qna"><ix:nonFraction name="PPCB:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantDateFairvalue" contextRef="From2019-05-012019-05-31_us-gaap_RestrictedStockUnitsRSUMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">497,240</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">based on the quoted trading price
on the date of grant. During the year ended June 30, 2021 and 2020, the Company recognized stock-based compensation of $<span id="xdx_909_eus-gaap--ShareBasedCompensation_c20200701__20210630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_pp0p0"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2020-07-012021-06-30_us-gaap_RestrictedStockUnitsRSUMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">0</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">and $<span id="xdx_900_eus-gaap--ShareBasedCompensation_c20190701__20200630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_pp0p0"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2019-07-012020-06-30_us-gaap_RestrictedStockUnitsRSUMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">217,543</ix:nonFraction></span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">,
respectively, related to vested restricted stock units. There were $<span id="xdx_901_ecustom--UnrecognizedRestrictedStockUnitsExpense_c20200701__20210630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_pp0p0"><ix:nonFraction name="PPCB:UnrecognizedRestrictedStockUnitsExpense" contextRef="From2020-07-012021-06-30_us-gaap_RestrictedStockUnitsRSUMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">248,620</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">unrecognized restricted stock units
expense as of June 30, 2021. There are <span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20200630_z3vqF4UjOqve"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">59</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">unvested restricted stock units
which are subject to various performance conditions which have not yet been met and such restricted stock
units have not yet vested as of June 30, 2021 and 2020 to which the $<span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20210630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zieLyCEmGOui" title="Number of shares not yet vested"><span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20200630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_znngyW9kylEl"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" contextRef="AsOf2021-06-30_us-gaap_RestrictedStockUnitsRSUMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" contextRef="AsOf2020-06-30_us-gaap_RestrictedStockUnitsRSUMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">248,620</ix:nonFraction></ix:nonFraction></span></span> relates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><i>&#160;</i></span></p>

<ix:exclude><!-- Field: Page; Sequence: 119; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>PROPANC
BIOPHARMA, INC. AND SUBSIDIARY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>June
30, 2021 and 2020</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><i>Options</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><i>&#160;</i></span></p>

<ix:nonNumeric contextRef="From2020-07-012021-06-30" escape="true" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"><p id="xdx_893_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zJAtVHqv7Tac" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">A
summary of the Company&#8217;s option activity during the years ended June 30, 2021 and 2020 is presented below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_8B4_z1neiiLP5lU5" style="display: none">SCHEDULE OF STOCK OPTION ACTIVITY</span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="color: Black">&#160;</td><td style="color: Black; font-weight: bold">&#160;</td>
    <td colspan="2" style="color: Black; font-weight: bold; text-align: center">Number of</td><td style="color: Black; font-weight: bold">&#160;</td><td style="color: Black; font-weight: bold">&#160;</td>
    <td colspan="2" style="color: Black; font-weight: bold; text-align: center">Weighted Average</td><td style="color: Black; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="color: Black">&#160;</td><td style="color: Black; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; color: Black; font-weight: bold; text-align: center">Options</td><td style="padding-bottom: 1.5pt; color: Black; font-weight: bold">&#160;</td><td style="color: Black; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; color: Black; font-weight: bold; text-align: center">Price Per Share</td><td style="padding-bottom: 1.5pt; color: Black; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; color: Black">Outstanding at June 30, 2019</td><td style="width: 2%; color: Black">&#160;</td>
    <td style="width: 1%; color: Black; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20190701__20200630_zCvoi2Biml0j" title="Number of Shares, Outstanding, Beginning balance" style="width: 16%; color: Black; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2019-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">60</ix:nonFraction></td><td style="width: 1%; color: Black; text-align: left">&#160;</td><td style="width: 2%; color: Black">&#160;</td>
    <td style="width: 1%; color: Black; text-align: left">$</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20190701__20200630_z4nKrz61JCxb" title="Weighted Average Price Per Share, Outstanding, Beginning balance" style="width: 16%; color: Black; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2019-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">76,370</ix:nonFraction></td><td style="width: 1%; color: Black; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="color: Black">Issued</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_c20190701__20200630_pdd" title="Number of Shares, Issued" style="color: Black; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1968">-</span></td><td style="color: Black; text-align: left">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td id="xdx_986_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsIssuedInPeriodWeightedAverageExercisePrice_c20190701__20200630_pdd" title="Weighted Average Price Per Share, Issued" style="color: Black; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1970">-</span></td><td style="color: Black; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: Black">Exercised</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20190701__20200630_pdd" title="Number of Shares, Exercised" style="color: Black; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1972">-</span></td><td style="color: Black; text-align: left">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20190701__20200630_pdd" title="Weighted Average Price Per Share, Exercised" style="color: Black; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1974">-</span></td><td style="color: Black; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="color: Black; padding-bottom: 1.5pt">Expired</td><td style="color: Black; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; color: Black; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_iN_di_c20190701__20200630_zCAdRgPTA2gj" title="Number of Shares, Expired" style="border-bottom: Black 1.5pt solid; color: Black; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1976">-</span></td><td style="padding-bottom: 1.5pt; color: Black; text-align: left">&#160;</td><td style="color: Black; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; color: Black; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_c20190701__20200630_pdd" title="Weighted Average Price Per Share, Expired" style="border-bottom: Black 1.5pt solid; color: Black; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1978">-</span></td><td style="padding-bottom: 1.5pt; color: Black; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: Black">Outstanding at June 30, 2020</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20200701__20210630_zs4OGeOEO8Zg" title="Number of Shares, Outstanding, Ending balance" style="color: Black; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">60</ix:nonFraction></td><td style="color: Black; text-align: left">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">$</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20200701__20210630_zpvCzXKi2RAi" title="Weighted Average Price Per Share, Outstanding, Ending balance" style="color: Black; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">76,370</ix:nonFraction></td><td style="color: Black; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="color: Black">Issued</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_c20200701__20210630_pdd" title="Number of Shares, Issued" style="color: Black; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1984">-</span></td><td style="color: Black; text-align: left">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td id="xdx_98C_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsIssuedInPeriodWeightedAverageExercisePrice_c20200701__20210630_pdd" title="Weighted Average Price Per Share, Issued" style="color: Black; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1986">-</span></td><td style="color: Black; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: Black">Exercised</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20200701__20210630_pdd" title="Number of Shares, Exercised" style="color: Black; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1988">-</span></td><td style="color: Black; text-align: left">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20200701__20210630_pdd" title="Weighted Average Price Per Share, Exercised" style="color: Black; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1990">-</span></td><td style="color: Black; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="color: Black; padding-bottom: 1.5pt">Expired</td><td style="color: Black; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; color: Black; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_iN_di_c20200701__20210630_z26oJD3Z7ylb" title="Number of Shares, Expired" style="border-bottom: Black 1.5pt solid; color: Black; text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1</ix:nonFraction></td><td style="padding-bottom: 1.5pt; color: Black; text-align: left">)</td><td style="color: Black; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; color: Black; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_c20200701__20210630_pdd" title="Weighted Average Price Per Share, Expired" style="border-bottom: Black 1.5pt solid; color: Black; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">3,750,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; color: Black; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: Black; padding-bottom: 1.5pt">Outstanding at June 30, 2021</td><td style="color: Black; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; color: Black; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20200701__20210630_z8aMmHSwGSKd" title="Number of Shares, Outstanding, Ending balance" style="border-bottom: Black 1.5pt solid; color: Black; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">59</ix:nonFraction></td><td style="padding-bottom: 1.5pt; color: Black; text-align: left">&#160;</td><td style="color: Black; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; color: Black; text-align: left">$</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20200701__20210630_zrYBXYu3bVe4" title="Weighted Average Price Per Share, Outstanding, Ending balance" style="border-bottom: Black 1.5pt solid; color: Black; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">13,730</ix:nonFraction></td><td style="padding-bottom: 1.5pt; color: Black; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="color: Black">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">&#160;</td><td style="color: Black; text-align: left">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">&#160;</td><td style="color: Black; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: Black">Exercisable at June 30, 2021</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20210630_pdd" title="Number of Shares, Exercisable, Ending balance" style="color: Black; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">40</ix:nonFraction></td><td style="color: Black; text-align: left">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">$</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20210630_pdd" title="Weighted Average Price Per Share, Exercisable, Ending balance" style="color: Black; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">18,193</ix:nonFraction></td><td style="color: Black; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="color: Black; text-align: left">Outstanding and Exercisable:</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">&#160;</td><td style="color: Black; text-align: left">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">&#160;</td><td style="color: Black; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: Black">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">&#160;</td><td style="color: Black; text-align: left">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">&#160;</td><td style="color: Black; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="color: Black; padding-bottom: 1.5pt">Weighted average remaining contractual term</td><td style="color: Black; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; color: Black; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; color: Black; text-align: right"><span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20200701__20210630_zQiV9nk5dTk" title="Weighted average remaining contractual term"><ix:nonNumeric contextRef="From2020-07-012021-06-30" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">7.86</ix:nonNumeric></span></td><td style="padding-bottom: 1.5pt; color: Black; text-align: left">&#160;</td><td style="color: Black; padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; color: Black; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; color: Black; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; color: Black; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: Black; padding-bottom: 1.5pt">Weighted average fair value of options granted during the period</td><td style="color: Black; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; color: Black; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; color: Black; text-align: right"><span id="xdx_905_ecustom--WeightedAverageFairValueOfOptionsGrantedDuringPeriod_d0_c20200701__20210630_zcXnUFEhxcJ4" title="Weighted average fair value of options granted during the period"><span style="-sec-ix-hidden: xdx2ixbrl2006">-</span></span></td><td style="padding-bottom: 1.5pt; color: Black; text-align: left">&#160;</td><td style="color: Black; padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; color: Black; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; color: Black; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; color: Black; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="color: Black; padding-bottom: 1.5pt">Aggregate intrinsic value</td><td style="color: Black; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; color: Black; text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_c20210630_pp0p0" title="Aggregate intrinsic value" style="border-bottom: Black 1.5pt solid; color: Black; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2008">-</span></td><td style="padding-bottom: 1.5pt; color: Black; text-align: left">&#160;</td><td style="color: Black; padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; color: Black; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; color: Black; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; color: Black; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A2_zRtgmmXBuksa" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">On
the Effective Date, the Company&#8217;s board of directors approved and adopted the Company&#8217;s 2019 Equity Incentive Plan (the &#8220;2019
Plan&#8221;), which reserves a total of <span id="xdx_902_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_c20210630__us-gaap--PlanNameAxis__custom--TwoThousandNinteenEquityIncentivePlanMember_ziLEvFiYtnC8" title="Number of common shares reserved for future issuance"><ix:nonFraction name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" contextRef="AsOf2021-06-30_custom_TwoThousandNinteenEquityIncentivePlanMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">234</ix:nonFraction></span> shares of the Company&#8217;s common stock for issuance under the 2019 Plan. Incentive awards
authorized under the 2019 Plan include, but are not limited to, incentive stock options, non-qualified stock options, restricted stock
awards and restricted stock units.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">During
the year ended June 30, 2021 and 2020, the Company recognized stock-based compensation of $<span id="xdx_903_eus-gaap--StockOptionPlanExpense_c20200701__20210630__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementsMember_pp0p0"><ix:nonFraction name="us-gaap:StockOptionPlanExpense" contextRef="From2020-07-012021-06-30_custom_EmploymentAgreementsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">82,872</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">and $<span id="xdx_90A_eus-gaap--StockOptionPlanExpense_c20190701__20200630__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementsMember_pp0p0"><ix:nonFraction name="us-gaap:StockOptionPlanExpense" contextRef="From2019-07-012020-06-30_custom_EmploymentAgreementsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">82,873</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">related to vested stock options.
There was $<span id="xdx_90E_ecustom--UnvestedStockOptionsExpense_c20200701__20210630__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementsMember_pp0p0"><ix:nonFraction name="PPCB:UnvestedStockOptionsExpense" contextRef="From2020-07-012021-06-30_custom_EmploymentAgreementsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">72,514</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">of unvested stock options expense
as of June 30, 2021 that will be recognized over a remaining vesting period of <span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_dtY_c20200701__20210630_zoFTWo0hTlDj" title="Vesting period"><ix:nonNumeric contextRef="From2020-07-012021-06-30" format="ixt-sec:duryear" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">0.87</ix:nonNumeric></span> year.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_do_c20200701__20210630_zNcX2trAMrdj" title="Options granted"><span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_do_c20190701__20200630_zo2hqyucXJnc"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" contextRef="From2020-07-012021-06-30" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" contextRef="From2019-07-012020-06-30" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares">No</ix:nonFraction></ix:nonFraction></span></span>
stock options were granted during the years ended June 30, 2021 and 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b><i>Warrants</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b><i>&#160;</i></b></span></p>

<ix:nonNumeric contextRef="From2020-07-012021-06-30" escape="true" name="us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock"><p id="xdx_89C_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zCK2SPds7WP5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
following table summarizes warrant activity for the years ended June 30, 2021 and 2020:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span id="xdx_8BA_zlOH3PPBkAE3" style="display: none">SCHEDULE OF WARRANT ACTIVITY</span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="color: Black">&#160;</td><td style="color: Black; font-weight: bold">&#160;</td>
    <td colspan="2" style="color: Black; font-weight: bold; text-align: center">Number of</td><td style="color: Black; font-weight: bold">&#160;</td><td style="color: Black; font-weight: bold">&#160;</td>
    <td colspan="2" style="color: Black; font-weight: bold; text-align: center">Weighted Average</td><td style="color: Black; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="color: Black">&#160;</td><td style="color: Black; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; color: Black; font-weight: bold; text-align: center">Warrants</td><td style="padding-bottom: 1.5pt; color: Black; font-weight: bold">&#160;</td><td style="color: Black; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; color: Black; font-weight: bold; text-align: center">Price Per Share</td><td style="padding-bottom: 1.5pt; color: Black; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: Black">Outstanding at June 30, 2019</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20190701__20200630_zqxqy7ojzqB3" title="Number of Shares, Outstanding, Beginning balance" style="color: Black; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2022">-</span></td><td style="color: Black; text-align: left">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">$</td><td id="xdx_98F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageOutstanding_iS_c20190701__20200630_zfVXsuFda5Lf" title="Weighted Average Price Per Share, Outstanding, Beginning balance" style="color: Black; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2024">-</span></td><td style="color: Black; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 60%; color: Black">Issued</td><td style="width: 2%; color: Black">&#160;</td>
    <td style="width: 1%; color: Black; text-align: left">&#160;</td><td id="xdx_984_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsIssued_c20190701__20200630_pdd" title="Number of Shares, Issued" style="width: 16%; color: Black; text-align: right"><ix:nonFraction name="PPCB:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsIssued" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">151,170</ix:nonFraction></td><td style="width: 1%; color: Black; text-align: left">&#160;</td><td style="width: 2%; color: Black">&#160;</td>
    <td style="width: 1%; color: Black; text-align: left">&#160;</td><td id="xdx_98F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceIssued_c20190701__20200630_pdd" title="Weighted Average Price Per Share, Issued" style="width: 16%; color: Black; text-align: right"><ix:nonFraction name="PPCB:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceIssued" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">150.00</ix:nonFraction></td><td style="width: 1%; color: Black; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: Black">Exercised</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_di_c20190701__20200630_z6phSP3ACjjb" title="Number of Shares, Exercised" style="color: Black; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2030">-</span></td><td style="color: Black; text-align: left">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td id="xdx_983_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceExercised_c20190701__20200630_pdd" title="Weighted Average Price Per Share, Exercised" style="color: Black; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2032">-</span></td><td style="color: Black; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="color: Black">Forfeited</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_c20190701__20200630_pdd" title="Number of Shares, Forfeited" style="color: Black; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2034">-</span></td><td style="color: Black; text-align: left">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td id="xdx_985_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceExpired_c20190701__20200630_pdd" title="Weighted Average Price Per Share, Forfeited" style="color: Black; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2036">-</span></td><td style="color: Black; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: Black; padding-bottom: 1.5pt">Expired</td><td style="color: Black; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; color: Black; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_c20190701__20200630_pdd" title="Number of Shares, Expired" style="border-bottom: Black 1.5pt solid; color: Black; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2038">-</span></td><td style="padding-bottom: 1.5pt; color: Black; text-align: left">&#160;</td><td style="color: Black; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; color: Black; text-align: left">&#160;</td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceForfeited_c20190701__20200630_pdd" title="Weighted Average Price Per Share, Expired" style="border-bottom: Black 1.5pt solid; color: Black; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2040">-</span></td><td style="padding-bottom: 1.5pt; color: Black; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="color: Black">Outstanding at June 30, 2020</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20200701__20210630_zNSUObxM0a33" title="Number of Shares, Outstanding, Ending balance" style="color: Black; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">151,170</ix:nonFraction></td><td style="color: Black; text-align: left">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">$</td><td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageOutstanding_iS_c20200701__20210630_zsBKJYDHT2Ae" title="Weighted Average Price Per Share, Outstanding, Ending balance" style="color: Black; text-align: right"><ix:nonFraction name="PPCB:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageOutstanding" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">150.00</ix:nonFraction></td><td style="color: Black; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: Black">Issued</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsIssued_c20200701__20210630_pdd" title="Number of Shares, Issued" style="color: Black; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2046">-</span></td><td style="color: Black; text-align: left">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td id="xdx_981_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceIssued_c20200701__20210630_pdd" title="Weighted Average Price Per Share, Issued" style="color: Black; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2048">-</span></td><td style="color: Black; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="color: Black">Exercised</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_di_c20200701__20210630_z3OKGyW1DQB8" title="Number of Shares, Exercised" style="color: Black; text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">29,841</ix:nonFraction></td><td style="color: Black; text-align: left">)</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td id="xdx_984_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceExercised_c20200701__20210630_pdd" title="Weighted Average Price Per Share, Exercised" style="color: Black; text-align: right"><ix:nonFraction name="PPCB:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceExercised" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">26.15</ix:nonFraction></td><td style="color: Black; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: Black">Forfeited</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_c20200701__20210630_pdd" title="Number of Shares, Forfeited" style="color: Black; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2054">-</span></td><td style="color: Black; text-align: left">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td id="xdx_98F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceExpired_c20200701__20210630_pdd" title="Weighted Average Price Per Share, Forfeited" style="color: Black; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2056">-</span></td><td style="color: Black; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="color: Black; padding-bottom: 1.5pt">Expired</td><td style="color: Black; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; color: Black; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_c20200701__20210630_pdd" title="Number of Shares, Expired" style="border-bottom: Black 1.5pt solid; color: Black; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2058">-</span></td><td style="padding-bottom: 1.5pt; color: Black; text-align: left">&#160;</td><td style="color: Black; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; color: Black; text-align: left">&#160;</td><td id="xdx_988_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceForfeited_c20200701__20210630_pdd" title="Weighted Average Price Per Share, Expired" style="border-bottom: Black 1.5pt solid; color: Black; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2060">-</span></td><td style="padding-bottom: 1.5pt; color: Black; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: Black; padding-bottom: 1.5pt">Outstanding at June 30, 2021</td><td style="color: Black; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; color: Black; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_c20200701__20210630_zUi2wA7mVNkl" title="Number of Shares, Outstanding, Ending balance" style="border-bottom: Black 1.5pt solid; color: Black; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">121,329</ix:nonFraction></td><td style="padding-bottom: 1.5pt; color: Black; text-align: left">&#160;</td><td style="color: Black; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; color: Black; text-align: left">$</td><td id="xdx_983_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageOutstanding_iE_c20200701__20210630_zC3AomBZmAta" title="Weighted Average Price Per Share, Outstanding, Ending balance" style="border-bottom: Black 1.5pt solid; color: Black; text-align: right"><ix:nonFraction name="PPCB:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageOutstanding" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">179.63</ix:nonFraction></td><td style="padding-bottom: 1.5pt; color: Black; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="color: Black">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">&#160;</td><td style="color: Black; text-align: left">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">&#160;</td><td style="color: Black; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: Black; padding-bottom: 1.5pt">Exercisable at June 30, 2021</td><td style="color: Black; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; color: Black; text-align: left">&#160;</td><td id="xdx_985_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_c20210630_pdd" title="Number of Shares, Exercisable, Ending balance" style="border-bottom: Black 1.5pt solid; color: Black; text-align: right"><ix:nonFraction name="PPCB:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">76,955</ix:nonFraction></td><td style="padding-bottom: 1.5pt; color: Black; text-align: left">&#160;</td><td style="color: Black; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; color: Black; text-align: left">$</td><td id="xdx_98F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisable_c20210630_pdd" title="Weighted Average Price Per Share, Exercisable, Ending balance" style="border-bottom: Black 1.5pt solid; color: Black; text-align: right"><ix:nonFraction name="PPCB:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisable" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">283.21</ix:nonFraction></td><td style="padding-bottom: 1.5pt; color: Black; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="color: Black; text-align: left">Outstanding and Exercisable:</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">&#160;</td><td style="color: Black; text-align: left">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">&#160;</td><td style="color: Black; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: Black">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">&#160;</td><td style="color: Black; text-align: left">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">&#160;</td><td style="color: Black; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="color: Black; padding-bottom: 1.5pt">Weighted average remaining contractual term</td><td style="color: Black; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; color: Black; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; color: Black; text-align: right"><span id="xdx_90B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20200701__20210630_z78SFcSuOfvh" title="Weighted average remaining contractual term"><ix:nonNumeric contextRef="From2020-07-012021-06-30" format="ixt-sec:duryear" name="PPCB:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerms">1.77</ix:nonNumeric></span></td><td style="padding-bottom: 1.5pt; color: Black; text-align: left">&#160;</td><td style="color: Black; padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; color: Black; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; color: Black; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; color: Black; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: Black; padding-bottom: 1.5pt">Aggregate intrinsic value</td><td style="color: Black; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; color: Black; text-align: left">$</td><td id="xdx_985_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsAggregateIntrinsicValueOutstanding_c20210630_pp0p0" title="Aggregate intrinsic value" style="border-bottom: Black 1.5pt solid; color: Black; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2072">-</span></td><td style="padding-bottom: 1.5pt; color: Black; text-align: left">&#160;</td><td style="color: Black; padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; color: Black; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; color: Black; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; color: Black; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A8_zOMK2q9HwKck" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<ix:exclude><!-- Field: Page; Sequence: 120; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>PROPANC
BIOPHARMA, INC. AND SUBSIDIARY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>June
30, 2021 and 2020</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">In
connection with the issuance of the August 2019 Auctus Note, the Company issued common stock purchase warrants to Auctus to purchase
<span id="xdx_906_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_c20190831__us-gaap--StatementEquityComponentsAxis__custom--FirstWarrantMember_pdd" title="Warrants to purchase common stock"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2019-08-31_custom_FirstWarrantMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">450</ix:nonFraction></span> shares of the Company&#8217;s common stock (the &#8220;First Warrant&#8221;) as a commitment fee upon the terms and subject to the
limitations and conditions set forth in such First Warrant at an &#8220;Exercise Price&#8221; of $<span id="xdx_909_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20190831__us-gaap--StatementEquityComponentsAxis__custom--FirstWarrantMember_pdd" title="Warrant exercise price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2019-08-31_custom_FirstWarrantMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">2,250</ix:nonFraction></span>. In connection with the issuance
of the Note, the Company shall issue a common stock purchase warrant to Buyer to purchase <span id="xdx_907_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_c20190831__us-gaap--StatementEquityComponentsAxis__custom--SecondWarrantMember_pdd" title="Warrants to purchase common stock"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2019-08-31_custom_SecondWarrantMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">300</ix:nonFraction></span> shares of the Company&#8217;s common stock
(the &#8220;Second Warrant&#8221;) as a commitment fee upon the terms and subject to the limitations and conditions set forth in such
Second Warrant at an &#8220;Exercise Price&#8221; of $<span id="xdx_908_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20190831__us-gaap--StatementEquityComponentsAxis__custom--SecondWarrantMember_pdd" title="Warrant exercise price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2019-08-31_custom_SecondWarrantMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">3,330</ix:nonFraction></span>. In connection with the issuance of the Note, the Company shall issue a common
stock purchase warrant to Buyer to purchase <span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_c20190831__us-gaap--StatementEquityComponentsAxis__custom--ThirdWarrantMember_pdd" title="Warrants to purchase common stock"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2019-08-31_custom_ThirdWarrantMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">225</ix:nonFraction></span> shares of the Company&#8217;s common stock (the &#8220;Third Warrant&#8221;) as a commitment
fee upon the terms and subject to the limitations and conditions set forth in such Third Warrant at an &#8220;Exercise Price&#8221; of
$<span id="xdx_906_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20190831__us-gaap--StatementEquityComponentsAxis__custom--ThirdWarrantMember_pdd" title="Warrant exercise price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2019-08-31_custom_ThirdWarrantMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">4,500</ix:nonFraction></span>. The First Warrant, Second Warrant, and Third Warrant shall collectively be referred as the &#8220;Warrants&#8221;. The Warrants
have an &#8220;Exercise Period&#8221; of five years from the date of issuance being August 30, 2019 (see Note 6).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">On
September 10, 2019, the Company entered into an agreement with a certain consultant to provide services over a three-month period beginning
September 10, 2019 and ending December 10, 2019 in exchange for <span id="xdx_907_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_c20190910_pdd" title="Warrants to purchase common stock"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2019-09-10" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,000</ix:nonFraction></span> warrants to purchase the Company&#8217;s common stock at $<span id="xdx_90E_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20190910_pdd" title="Warrant exercise price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2019-09-10" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">2,000</ix:nonFraction></span>
per share with an expiry date of <span id="xdx_900_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20190910_zuOh6KYpd9vg" title="Warrant expiration date"><ix:nonNumeric contextRef="AsOf2019-09-10" format="ixt:datemonthdayyearen" name="us-gaap:WarrantsAndRightsOutstandingMaturityDate">September 10, 2022</ix:nonNumeric></span>. The Fair Market Value of the warrants was $<span id="xdx_90B_eus-gaap--FairValueAdjustmentOfWarrants_c20190909__20190910_pp0p0" title="Fair value of warrants"><ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="From2019-09-092019-09-10" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">984,810</ix:nonFraction></span> on the date of grant as calculated
under the Black Scholes Option Pricing model. The Company recorded $<span id="xdx_90B_eus-gaap--ShareBasedCompensation_pp0p0_c20190701__20200630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zjQlvPqlLwl" title="Share based compensation"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2019-07-012020-06-30_us-gaap_WarrantMember17272484" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">984,810</ix:nonFraction></span> of share-based compensation expenses with respect to the
grant of such warrants during the year ended June 30, 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">In
connection with the issuance of shares on April 3, 2020 as discussed above, <span id="xdx_90C_ecustom--EquityPurchaseAgreementDescription_c20200402__20200403__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember" title="Equity purchase agreement description"><ix:nonNumeric contextRef="From2020-04-022020-04-03_custom_SecuritiesPurchaseAgreementMember" name="PPCB:EquityPurchaseAgreementDescription">the Company closed on a transaction related to a Securities
Purchase Agreement (the &#8220;Securities Purchase Agreement&#8221;) entered into on March 30, 2020, whereby an investor purchased from
the Company, 7,500 units, each consisting of (i) 1.5 shares of the Company&#8217;s common stock, or pre-funded warrants upon Investor&#8217;s
election due to the 4.99% blocker provision and (ii) 1.5 warrants to purchase one share of Common Stock (&#8220;Series A Warrants&#8221;,
and collectively with the Common Stock the &#8220;Units&#8221;)</ix:nonNumeric></span>. In addition to the Units, the Investor was issued <span id="xdx_909_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_c20200403__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantsMember_pdd" title="Warrants to purchase common stock"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2020-04-03_custom_SecuritiesPurchaseAgreementMember_custom_SeriesBWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">63,750</ix:nonFraction></span> warrants to
purchase one share of Common Stock (the &#8220;Series B Warrants&#8221;) and an additional <span id="xdx_908_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_c20200403__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesCWarrantsMember_pdd" title="Warrants to purchase common stock"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2020-04-03_custom_SecuritiesPurchaseAgreementMember_custom_SeriesCWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">63,750</ix:nonFraction></span> warrants to purchase one share of Common
Stock, subject to a vesting schedule (the &#8220;Series C Warrants&#8221; and, together with the Prefunded Warrants, the Series A Warrants,
and the Series B Warrants, the &#8220;Warrants&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Due
to the Beneficial Ownership Limitation, the Company granted <span id="xdx_900_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_c20200403__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantsMember_pdd" title="Warrants to purchase common stock"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2020-04-03_custom_SecuritiesPurchaseAgreementMember_custom_PrefundedWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">10,445</ix:nonFraction></span> Prefunded Warrants with exercise price of $<span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20200403__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantsMember_pdd" title="Warrant exercise price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2020-04-03_custom_SecuritiesPurchaseAgreementMember_custom_PrefundedWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.10</ix:nonFraction></span> (but can be less than
par value). The Prefunded Warrants shall be exercisable immediately and shall expire when exercised in full.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><i><span style="text-decoration: underline">Series
A Warrants</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Pursuant
to the Securities Purchase Agreement entered into March 20, 2020 as discussed above, the Investor purchased Series A Warrants to purchase
up to <span id="xdx_902_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_c20200320__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAWarrantsMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_pdd"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2020-03-20_custom_SecuritiesPurchaseAgreementMember_custom_SeriesAWarrantsMember_us-gaap_InvestorMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">11,250</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">shares of Common Stock, subject
to adjustment as provided therein. The Series A Warrants have a cash exercise price of $<span id="xdx_908_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20200320__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAWarrantsMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_znZkfKlQtxk1"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2020-03-20_custom_SecuritiesPurchaseAgreementMember_custom_SeriesAWarrantsMember_us-gaap_InvestorMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">200</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">per share and are immediately exercisable
and expire in <span id="xdx_906_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20200320__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAWarrantsMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_zl1crbhLsald"><ix:nonNumeric contextRef="AsOf2020-03-20_custom_SecuritiesPurchaseAgreementMember_custom_SeriesAWarrantsMember_us-gaap_InvestorMember" format="ixt-sec:duryear" name="us-gaap:WarrantsAndRightsOutstandingTerm">3</ix:nonNumeric>
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">years. The Series A Warrants contain
a provision for cashless exercise in the event there is no effective registration statement registering the shares underlying the Series
A Warrants calculated based on the difference between the exercise price of the Series A Warrant and the trading price of the stock (the
&#8220;Cashless Exercise&#8221;).Additionally, the Series A Warrants contain a provision for a cashless conversion at the Holder&#8217;s
option should the trading price of the Common Stock fall below $200 per share calculated based on the difference between the exercise
price of the Series A Warrant and 70% of the Market Price, as defined therein (the&#8221; Alternate Cashless Exercise&#8221;). See
above &#8220;Shares issued for exercise of warrants&#8221; for discussion of deemed dividend related to alternate cashless exercise.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><i><span style="text-decoration: underline">Series
B Warrants</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Pursuant
to the Securities Purchase Agreement entered into March 20, 2020 as discussed above, the Investor purchased Series B Warrants to purchase
up to <span id="xdx_901_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_c20200320__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantsMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_pdd" title="Warrants to purchase common stock"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2020-03-20_custom_SecuritiesPurchaseAgreementMember_custom_SeriesBWarrantsMember_us-gaap_InvestorMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">63,750</ix:nonFraction></span> shares of Common Stock, subject to adjustment as provided therein; provided, however, commencing on the 90th day following
the effective date, the Company may reduce the number of Warrant Shares issuable upon exercise thereof by <span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_c20200319__20200320__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantsMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_pdd" title="Warrants exercisable"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" contextRef="From2020-03-192020-03-20_custom_SecuritiesPurchaseAgreementMember_custom_SeriesBWarrantsMember_us-gaap_InvestorMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">37,500</ix:nonFraction></span> upon <span id="xdx_900_eus-gaap--DebtInstrumentConvertibleThresholdTradingDays_uInteger_c20200319__20200320__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantsMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_zDspqr2NeLf9" title="Trading days"><ix:nonFraction name="us-gaap:DebtInstrumentConvertibleThresholdTradingDays" contextRef="From2020-03-192020-03-20_custom_SecuritiesPurchaseAgreementMember_custom_SeriesBWarrantsMember_us-gaap_InvestorMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Integer">10</ix:nonFraction></span> Trading Days&#8217;
prior written notice to the Holder provided that the Company issues to the Holder <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20200319__20200320__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantsMember__srt--TitleOfIndividualAxis__custom--HolderMember_pdd" title="Common stock issued during period"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2020-03-192020-03-20_custom_SecuritiesPurchaseAgreementMember_custom_SeriesBWarrantsMember_custom_HolderMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,750</ix:nonFraction></span> shares of Common Stock (or, at the election of
the Holder, an equivalent number of pre-funded warrants) and Series A Warrants to purchase up to <span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_c20200320__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantsMember_pdd" title="Warrants to purchase common stock"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2020-03-20_custom_SecuritiesPurchaseAgreementMember_custom_SeriesBWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,750</ix:nonFraction></span> shares of Common Stock, which
shares shall be issued pursuant to a registration statement without restrictions on resale. The Series B Warrants have a cash exercise
price of $<span id="xdx_901_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20200320__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantsMember_pdd" title="Warrant exercise price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2020-03-20_custom_SecuritiesPurchaseAgreementMember_custom_SeriesBWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">40</ix:nonFraction></span> per share and expire in <span id="xdx_907_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20200320__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantsMember_zN926UaWdVDf" title="Warrants expiration period"><ix:nonNumeric contextRef="AsOf2020-03-20_custom_SecuritiesPurchaseAgreementMember_custom_SeriesBWarrantsMember" format="ixt-sec:duryear" name="us-gaap:WarrantsAndRightsOutstandingTerm">3</ix:nonNumeric></span> years. The Series B Warrants contain a provision for Cashless Exercise.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><i><span style="text-decoration: underline">Series
C Warrants</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Pursuant
to the Securities Purchase Agreement entered into March 20, 2020 as discussed above, the Investor purchased Series C Warrants to purchase
up to <span id="xdx_900_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_c20200320__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesCWarrantsMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_pdd" title="Warrants to purchase common stock"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2020-03-20_custom_SecuritiesPurchaseAgreementMember_custom_SeriesCWarrantsMember_us-gaap_InvestorMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">63,750</ix:nonFraction></span> shares of Common Stock, subject to adjustment as provided therein and expire in <span id="xdx_902_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20200320__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesCWarrantsMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_z69UHKqI2kwd" title="Warrants expiration period"><ix:nonNumeric contextRef="AsOf2020-03-20_custom_SecuritiesPurchaseAgreementMember_custom_SeriesCWarrantsMember_us-gaap_InvestorMember" format="ixt-sec:duryear" name="us-gaap:WarrantsAndRightsOutstandingTerm">3</ix:nonNumeric></span> years. The Series C Warrants have a cash
exercise price of $<span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20200320__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesCWarrantsMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_pdd" title="Warrant exercise price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2020-03-20_custom_SecuritiesPurchaseAgreementMember_custom_SeriesCWarrantsMember_us-gaap_InvestorMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">200</ix:nonFraction></span> per share, subject to a vesting schedule, which is based on such Holder&#8217;s exercise of the Series B Warrants
(warrants shall be exercisable ratably upon exercise of Series B Warrants). The Series C Warrants contain provisions for Cashless Exercise
and Alternate Cashless Exercise.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<ix:exclude><!-- Field: Page; Sequence: 121; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>PROPANC
BIOPHARMA, INC. AND SUBSIDIARY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>June
30, 2021 and 2020</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><i>Exercise
of Warrants</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">During
the year ended June 30, 2021, the Company received aggregate gross proceeds of $<span id="xdx_904_eus-gaap--ProceedsFromWarrantExercises_pp0p0_c20200701__20210630_z2lmrQItX9F7" title="Proceeds from warrants exercise"><ix:nonFraction name="us-gaap:ProceedsFromWarrantExercises" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">776,044</ix:nonFraction></span> from the exercise of <span id="xdx_906_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20210630__us-gaap--StatementClassOfStockAxis__custom--PrefundedWarrantsMember_zS4wx0bIvvIk" title="Warrants exercised"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2021-06-30_custom_PrefundedWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">10,445</ix:nonFraction></span> prefunded warrants
and <span id="xdx_906_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20210630__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantsMember_zE8DxnoN1jSj" title="Warrants exercised"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2021-06-30_custom_SeriesBWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">19,375</ix:nonFraction></span> Series B Warrants resulting in the issuance of <span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20200701__20210630__us-gaap--StatementClassOfStockAxis__custom--PrefundedWarrantsMember_ziuvGbTAgpK" title="Stock issued during period"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2020-07-012021-06-30_custom_PrefundedWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">29,820</ix:nonFraction></span> shares of common stock. Additionally, the Company issued <span id="xdx_90F_eus-gaap--CommonStockSharesIssued_iI_c20210630__us-gaap--StatementClassOfStockAxis__custom--TwentySeriesAAndOneSeriesCWarrantsMember_zfRYfFir6jVa" title="Common stock, shares issued"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2021-06-30_custom_TwentySeriesAAndOneSeriesCWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,199,979</ix:nonFraction></span> shares
of common stock from the alternate cashless exercise of 20 Series A and 1 Series C warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-07-012021-06-30" escape="true" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock"><p id="xdx_806_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zL2iu8rkR7El" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>NOTE
9 &#8211; <span id="xdx_82D_zoKrhnxDRVm6">COMMITMENTS AND CONTINGENCIES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>Legal
Matters</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">On
September 26, 2019, a complaint was filed against the Company with Supreme Court of the State of New York, County of New York, by Foley
Shechter Ablovatskiy LLP (&#8220;Foley Shechter&#8221;), our former counsel, seeking $<span id="xdx_901_eus-gaap--LegalFees_c20190925__20190926__srt--TitleOfIndividualAxis__custom--FoleyShechterMember_pp0p0"><ix:nonFraction name="us-gaap:LegalFees" contextRef="From2019-09-252019-09-26_custom_FoleyShechterMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">151,031</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">in professional fees allegedly
owed, in addition to interest and costs of suit. The Company filed an answer, together with affirmative defenses and counterclaims. Certain
amounts related to this claim were included in accounts payable and accrued expenses in the accompanying consolidated financial statements
at June 30, 2020. On March 22, 2021, the Company entered into a settlement agreement with Foley Shechter whereby both parties
agreed to settle all claims for professional fees owed for a total of $<span id="xdx_907_eus-gaap--ProfessionalFees_c20210320__20210322__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementMember__srt--TitleOfIndividualAxis__custom--FoleyShechterMember_pp0p0"><ix:nonFraction name="us-gaap:ProfessionalFees" contextRef="From2021-03-202021-03-22_custom_SettlementAgreementMember_custom_FoleyShechterMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">51,032</ix:nonFraction></span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">.
The Company paid the settlement amount of $<span id="xdx_90B_ecustom--SettlementAmount_c20210322__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementMember__srt--TitleOfIndividualAxis__custom--FoleyShechterMember_pp0p0"><ix:nonFraction name="PPCB:SettlementAmount" contextRef="AsOf2021-03-22_custom_SettlementAgreementMember_custom_FoleyShechterMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">51,032</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">on March 22, 2021. Prior to the
settlement agreement, the Company recorded total accounts payable and accrued expenses $<span id="xdx_909_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_iI_pp0p0_c20210322__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementMember__srt--TitleOfIndividualAxis__custom--FoleyShechterMember_zpXBVNIVgbjl"><ix:nonFraction name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" contextRef="AsOf2021-03-22_custom_SettlementAgreementMember_custom_FoleyShechterMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">142,660</ix:nonFraction></span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">.
Accordingly, the Company recognized gain from settlement of debt of <span id="xdx_901_ecustom--GainLossFromSettlementOfDebt_c20200701__20210630__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementMember__srt--TitleOfIndividualAxis__custom--FoleyShechterMember_pp0p0">$<ix:nonFraction name="PPCB:GainLossFromSettlementOfDebt" contextRef="From2020-07-012021-06-30_custom_SettlementAgreementMember_custom_FoleyShechterMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">92,556</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">during the year ended June
30, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Regal
Consulting, LLC (&#8220;Regal&#8221;) initiated litigation against the Company in Clark County District Court, Nevada. Regal was demanding
approximately $<span id="xdx_906_eus-gaap--LossContingencyDamagesSoughtValue_c20200701__20210630__dei--LegalEntityAxis__custom--RegalConsultingLLCMember_pp0p0" title="Loss contingency amount"><ix:nonFraction name="us-gaap:LossContingencyDamagesSoughtValue" contextRef="From2020-07-012021-06-30_custom_RegalConsultingLLCMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">400,000</ix:nonFraction></span> and <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20200701__20210630__dei--LegalEntityAxis__custom--RegalConsultingLLCMember_pdd" title="Number of shares issued for services"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" contextRef="From2020-07-012021-06-30_custom_RegalConsultingLLCMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">60</ix:nonFraction></span> shares of the Company&#8217;s common stock as payment for services that Regal purports to have performed.
Regal additionally claimed that $<span id="xdx_908_eus-gaap--ConvertibleDebt_c20170531__dei--LegalEntityAxis__custom--RegalConsultingLLCMember__us-gaap--DebtInstrumentAxis__custom--TwoThousandAndSeventeenNoteMember_pp0p0" title="Convertible note"><ix:nonFraction name="us-gaap:ConvertibleDebt" contextRef="AsOf2017-05-31_custom_RegalConsultingLLCMember_custom_TwoThousandAndSeventeenNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">106,500</ix:nonFraction></span> remained due on a Convertible Note executed by the Company in May of 2017 and asserted that
it was owed in excess of $<span id="xdx_90C_ecustom--LitigationPenaltyAmount_c20170501__20170531__dei--LegalEntityAxis__custom--RegalConsultingLLCMember__us-gaap--DebtInstrumentAxis__custom--TwoThousandAndSeventeenNoteMember_pp0p0" title="Penalty amount"><ix:nonFraction name="PPCB:LitigationPenaltyAmount" contextRef="From2017-05-012017-05-31_custom_RegalConsultingLLCMember_custom_TwoThousandAndSeventeenNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">100,000</ix:nonFraction></span> in penalties in connection with the Company&#8217;s refusal to honor certain Conversion Notices. The
Company filed an Answer and Counterclaim, denying liability and alleging that Regal procured by fraud the Company&#8217;s execution of
various consulting agreements and additionally failed to provide the consulting services contemplated by said agreements. On December
23, 2020, the parties mediated their dispute and negotiated a settlement agreement. On March 15, 2021, the Company entered into a Settlement
and Mutual Release Agreement with Regal whereby both parties agreed to settle all claims and liabilities under the August 10, 2017 Convertible
note (see Note 6) for a total of $<span id="xdx_909_eus-gaap--ConvertibleDebt_c20170810__us-gaap--TypeOfArrangementAxis__custom--SettlementAndMutualReleaseAgreementMember__dei--LegalEntityAxis__custom--RegalConsultingLLCMember_pp0p0" title="Convertible note"><ix:nonFraction name="us-gaap:ConvertibleDebt" contextRef="AsOf2017-08-10_custom_SettlementAndMutualReleaseAgreementMember_custom_RegalConsultingLLCMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">100,000</ix:nonFraction></span>. All other terms of the August 10, 2017 Convertible Note shall remain in full force and effect.
Both parties agree that all future penalties under this convertible note are waived unless the Company fails to authorize the issuance
of the requested shares upon conversion. The Company has the right to pay off the balance of any remaining amounts dues under this convertible
note in cash at any time 61 days after March 15, 2021. Prior to the Settlement Agreement, the Company recorded total liabilities $<span id="xdx_904_eus-gaap--Liabilities_c20210315__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementMember_pp0p0" title="Liabilities"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2021-03-15_custom_SettlementAgreementMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">56,762</ix:nonFraction></span>
consisting of remaining principal amount of $<span id="xdx_909_ecustom--RemainingPrincipalAmount_c20210315__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementMember_pp0p0" title="Remaining principal amount"><ix:nonFraction name="PPCB:RemainingPrincipalAmount" contextRef="AsOf2021-03-15_custom_SettlementAgreementMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">8,500</ix:nonFraction></span>, accrued interest of $<span id="xdx_90C_eus-gaap--InterestPayableCurrentAndNoncurrent_c20210315__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementMember_pp0p0" title="Accrued interest"><ix:nonFraction name="us-gaap:InterestPayableCurrentAndNoncurrent" contextRef="AsOf2021-03-15_custom_SettlementAgreementMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">23,262</ix:nonFraction></span> and accrued expenses of $<span id="xdx_906_eus-gaap--AccruedLiabilitiesCurrentAndNoncurrent_c20210315__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementMember_pp0p0" title="Accrued expenses"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrentAndNoncurrent" contextRef="AsOf2021-03-15_custom_SettlementAgreementMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">25,000</ix:nonFraction></span>. Accordingly, the Company
recognized loss from settlement of debt of $<span id="xdx_90A_ecustom--GainLossFromSettlementOfDebt_c20200701__20210630__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementMember_pp0p0" title="Gain loss from settlement of debt"><ix:nonFraction name="PPCB:GainLossFromSettlementOfDebt" contextRef="From2020-07-012021-06-30_custom_SettlementAgreementMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">43,238</ix:nonFraction></span> during the year ended June 30, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>IRS
Liability</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">As
part of its requirement for having a foreign operating subsidiary, the Company&#8217;s parent U.S. entity is required to file an informational
Form 5471 to the Internal Revenue Service (the &#8220;IRS&#8221;), which is a form that explains the nature of the relationship between
the foreign subsidiary and the parent company. From 2012 through the 2014, the Company did not file this form in a timely manner. As
a result of the non-timely filings, the Company incurred a penalty from the IRS in the amount of $<span id="xdx_90D_ecustom--LitigationPenaltyAmount_c20200701__20210630__us-gaap--AwardDateAxis__custom--From2012ThroughThe2014Member_pp0p0"><ix:nonFraction name="PPCB:LitigationPenaltyAmount" contextRef="From2020-07-012021-06-30_custom_From2012ThroughThe2014Member" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">10,000</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">per year, or $<span id="xdx_900_ecustom--LitigationPenaltyAmount_c20200701__20210630_pp0p0"><ix:nonFraction name="PPCB:LitigationPenaltyAmount" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">30,000</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">in total, plus accrued interest,
such penalty and interest having been accrued and is included in the accrued expenses and other payable figure in the June
30, 2021 and 2020 consolidated balance sheet. The Company recorded the penalties for all three years during the year ended June 30,
2018. The Company is current on all subsequent filings. The Company&#8217;s tax advisor is awaiting a response from the IRS on this matter.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>Operating
Agreements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 29.15pt; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">In
November 2009, the Company entered into a commercialization agreement with the University of Bath (UK) (the &#8220;University&#8221;)
whereby the Company and the University co-owned the intellectual property relating to the Company&#8217;s pro-enzyme formulations. In
June 2012, the Company and the University entered into an assignment and amendment whereby the Company assumed full ownership of the
intellectual property while agreeing to pay royalties of <span id="xdx_903_ecustom--OperatingLeasesIncomeStatementRevenuePercentage_dp_c20120601__20120630__us-gaap--TypeOfArrangementAxis__us-gaap--RoyaltyAgreementTermsMember_ztXEIiIkqski" title="Operating leases income statement revenue percentage"><ix:nonFraction name="PPCB:OperatingLeasesIncomeStatementRevenuePercentage" contextRef="From2012-06-012012-06-30_us-gaap_RoyaltyAgreementTermsMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">2</ix:nonFraction>%</span> of net revenues to the University. Additionally, the Company agreed to pay
<span id="xdx_90D_ecustom--OperatingLeasesIncomeStatementRevenuePercentage_dp_c20120601__20120630__us-gaap--TypeOfArrangementAxis__us-gaap--LicenseAgreementTermsMember_z9T7IV0czYM7" title="Operating leases income statement revenue percentage"><ix:nonFraction name="PPCB:OperatingLeasesIncomeStatementRevenuePercentage" contextRef="From2012-06-012012-06-30_us-gaap_LicenseAgreementTermsMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">5</ix:nonFraction>%</span> of each and every license agreement subscribed for. The contract is cancellable at any time by either party. To date, no amounts are
owed under the agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>Operating
Leases</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">On
May 5, 2016, the Company entered into a new <span id="xdx_900_eus-gaap--LesseeOperatingLeaseTermOfContract_iI_dtYxL_c20160505__us-gaap--TypeOfArrangementAxis__custom--NewFiveYearOperatingLeaseAgreementMember_z8w18Ofpt9n3" title="::XDX::5"><span style="-sec-ix-hidden: xdx2ixbrl2171">five</span></span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">-year
operating lease agreement with a Horizon Pty Ltd., a related party, of which Mr. Nathanielsz, our CEO, CFO and a director, and his
wife are owners and directors, with monthly rent currently at $<span id="xdx_90A_eus-gaap--PaymentsForRent_pp0p0_uAUD_c20160503__20160505__us-gaap--TypeOfArrangementAxis__custom--NewFiveYearOperatingLeaseAgreementMember__us-gaap--AwardTypeAxis__custom--AUDCurrencyMember_zJAHfK5JtGu7"><ix:nonFraction name="us-gaap:PaymentsForRent" contextRef="From2016-05-032016-05-05_custom_NewFiveYearOperatingLeaseAgreementMember_custom_AUDCurrencyMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="AUD">3,606</ix:nonFraction> </span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">AUD
or $<span id="xdx_906_eus-gaap--PaymentsForRent_c20160503__20160505__us-gaap--TypeOfArrangementAxis__custom--NewFiveYearOperatingLeaseAgreementMember_pp0p0"><ix:nonFraction name="us-gaap:PaymentsForRent" contextRef="From2016-05-032016-05-05_custom_NewFiveYearOperatingLeaseAgreementMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,469</ix:nonFraction> </span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">USD,
inclusive of GST (See Note 10 &#8211; Related Party Transactions). <span id="xdx_906_eus-gaap--LesseeOperatingLeaseDescription_c20160503__20160505__us-gaap--TypeOfArrangementAxis__custom--NewFiveYearOperatingLeaseAgreementMember_zUVwnKDgQfVb" title="Operating lease, description"><ix:nonNumeric contextRef="From2016-05-032016-05-05_custom_NewFiveYearOperatingLeaseAgreementMember" name="us-gaap:LesseeOperatingLeaseDescription">The
initial rental amount was $3,000 AUD and subject to 3% yearly escalation.</ix:nonNumeric></span></span> <span style="font: 10pt Times New Roman, Times, Serif; color: Black">In
adopting ASC Topic 842, Leases (Topic 842), the Company has elected the &#8216;package of practical expedients&#8217;, which permit
it not to reassess under the new standard its prior conclusions about lease identification, lease classification and initial direct
costs. In addition, the Company elected not to apply ASC Topic 842 to arrangements with lease terms of 12 month or less. On July 1,
2019, upon adoption of ASC Topic 842, the Company recorded right-of-use assets $<span id="xdx_901_eus-gaap--OperatingLeaseRightOfUseAsset_c20190702__us-gaap--AdjustmentsForNewAccountingPronouncementsAxis__us-gaap--AccountingStandardsUpdate201602Member_pp0p0"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2019-07-02_us-gaap_AccountingStandardsUpdate201602Member" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">48,662</ix:nonFraction> </span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">and
total lease liabilities of $<span id="xdx_906_eus-gaap--OperatingLeaseLiability_c20190702__us-gaap--AdjustmentsForNewAccountingPronouncementsAxis__us-gaap--AccountingStandardsUpdate201602Member_pp0p0"><ix:nonFraction name="us-gaap:OperatingLeaseLiability" contextRef="AsOf2019-07-02_us-gaap_AccountingStandardsUpdate201602Member" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">48,662</ix:nonFraction> </span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">based
on an incremental borrowing rate of <span id="xdx_90F_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_dp_c20190702__us-gaap--AdjustmentsForNewAccountingPronouncementsAxis__us-gaap--AccountingStandardsUpdate201602Member_zF48AVxpN5Kj"><ix:nonFraction name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" contextRef="AsOf2019-07-02_us-gaap_AccountingStandardsUpdate201602Member" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">6</ix:nonFraction>%</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">. <span><span id="xdx_90F_eus-gaap--LesseeOperatingLeaseDescription_c20190701__20190702__us-gaap--AdjustmentsForNewAccountingPronouncementsAxis__us-gaap--AccountingStandardsUpdate201602Member_zmrqDZpVZnWa"><ix:nonNumeric contextRef="From2019-07-012019-07-02_us-gaap_AccountingStandardsUpdate201602Member" name="us-gaap:LesseeOperatingLeaseDescription">Such lease expired in May 2021 and was renewed for another one-year term from May 2021 to May 2022</ix:nonNumeric></span></span>. The Company is currently obligated to pay $<span id="xdx_90C_eus-gaap--PaymentsForRent_pp0p0_uAUD_c20190701__20190702__us-gaap--AdjustmentsForNewAccountingPronouncementsAxis__us-gaap--AccountingStandardsUpdate201602Member__us-gaap--AwardTypeAxis__custom--AUDCurrencyMember_zFm9VsVr4wvd"><ix:nonFraction name="us-gaap:PaymentsForRent" contextRef="From2019-07-012019-07-02_us-gaap_AccountingStandardsUpdate201602Member_custom_AUDCurrencyMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="AUD">3,606</ix:nonFraction></span>
AUD or $<span id="xdx_905_eus-gaap--PaymentsForRent_pp0p0_c20190701__20190702__us-gaap--AdjustmentsForNewAccountingPronouncementsAxis__us-gaap--AccountingStandardsUpdate201602Member_zMOgPlkTjwcd"><ix:nonFraction name="us-gaap:PaymentsForRent" contextRef="From2019-07-012019-07-02_us-gaap_AccountingStandardsUpdate201602Member" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,431</ix:nonFraction></span>
USD (depending on exchange rate), inclusive of tax, in rent per month.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<ix:exclude><!-- Field: Page; Sequence: 122; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>PROPANC
BIOPHARMA, INC. AND SUBSIDIARY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>June
30, 2021 and 2020</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<ix:nonNumeric contextRef="From2020-07-012021-06-30" escape="true" name="PPCB:ScheduleOfRightUseOfAssetTableTextBlock"><p id="xdx_894_ecustom--ScheduleOfRightUseOfAssetTableTextBlock_zGoPydUjdAul" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">ROU
is summarized below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_8B3_z2t8Ilp9RHCg" style="display: none">SCHEDULE OF RIGHT USE OF ASSET</span><span style="font: 10pt Times New Roman, Times, Serif; color: Black"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" id="xdx_495_20210630_zoufaAcQaxUc" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>June
    30, 2021</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" id="xdx_49F_20200630_zWOmXQOOY9rc" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>June
    30, 2020</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td></tr>
  <tr id="xdx_405_ecustom--OperatingLeaseRightOfUseAssets_iI_pp0p0_maOLROUzHPs_zGh3imgPrtSe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 60%"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Office
    lease (24 months)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="PPCB:OperatingLeaseRightOfUseAssets" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">48,662</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="PPCB:OperatingLeaseRightOfUseAssets" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">48,662</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_406_ecustom--AccumulatedReduction_iI_pp0p0_maOLROUzHPs_zapS6yhxmXci" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Less
    accumulated amortization</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(<ix:nonFraction name="PPCB:AccumulatedReduction" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">48,662</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(<ix:nonFraction name="PPCB:AccumulatedReduction" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">26,980</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td></tr>
  <tr id="xdx_405_eus-gaap--OperatingLeaseRightOfUseAsset_iTI_pp0p0_mtOLROUzHPs_zHMqylvljI8d" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Right-of-use
    asset, net</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl2191">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">21,682</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8A0_zZzvu0PT3Wg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<ix:nonNumeric contextRef="From2020-07-012021-06-30" escape="true" name="us-gaap:OperatingLeaseLeaseIncomeTableTextBlock"><p id="xdx_897_eus-gaap--OperatingLeaseLeaseIncomeTableTextBlock_z19UeNKNN7Qi" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Operating
Lease liabilities are summarized below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span id="xdx_8B0_ztmPtNJAMDuh" style="display: none">SCHEDULE OF OPERATING LEASE LIABILITY</span><span style="font: 10pt Times New Roman, Times, Serif; color: Black"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" id="xdx_49A_20210630_zNY5EJpe1z73" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>June
    30, 2021</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" id="xdx_49A_20200630_zWmUsQuR4raf" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>June
    30, 2020</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td></tr>
  <tr id="xdx_402_ecustom--OfficeLeaseLiability_iI_pp0p0_maOLLzN3P_zkvx3R82HVp5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Office
    lease</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="PPCB:OfficeLeaseLiability" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">48,662</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="PPCB:OfficeLeaseLiability" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">48,662</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_40A_ecustom--ReductionOfLeaseLiability_iI_pp0p0_maOLLzN3P_zEK3QiecFcNb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Reduction
    of lease liability</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(<ix:nonFraction name="PPCB:ReductionOfLeaseLiability" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">48,662</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(<ix:nonFraction name="PPCB:ReductionOfLeaseLiability" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">23,590</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td></tr>
  <tr id="xdx_40A_eus-gaap--OperatingLeaseLiability_iTI_pp0p0_mtOLLzN3P_zKZAcTC4Sz9l" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Long
    term portion of lease liability</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl2202">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:OperatingLeaseLiability" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">25,072</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8A2_zhAaq9TCl825" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>Collaboration
Agreement</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">On
September 13, 2018, the Company entered into a two-year collaboration agreement with the University of Ja&#233;n (the &#8220;University&#8221;)
to provide certain research services to the Company. In consideration of such services, the Company agreed to pay the University approximately
<span id="xdx_90F_ecustom--PaymentForServices_pp0p0_uEuro_c20180910__20180913__us-gaap--TypeOfArrangementAxis__custom--OneYearCollaborationAgreementMember__us-gaap--AwardTypeAxis__custom--EurosMember_z8Esvlqtq8f7" title="Payment for services"><ix:nonFraction name="PPCB:PaymentForServices" contextRef="From2018-09-102018-09-13_custom_OneYearCollaborationAgreementMember_custom_EurosMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="Euro">52,000</ix:nonFraction></span> Euros ($<span id="xdx_90D_ecustom--PaymentForServices_c20180910__20180913__us-gaap--TypeOfArrangementAxis__custom--OneYearCollaborationAgreementMember_pp0p0" title="Payment for services"><ix:nonFraction name="PPCB:PaymentForServices" contextRef="From2018-09-102018-09-13_custom_OneYearCollaborationAgreementMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">59,508</ix:nonFraction></span> USD) in year one and a maximum of <span id="xdx_90C_ecustom--PaymentForServices_pp0p0_uEuro_c20180910__20180913__us-gaap--TypeOfArrangementAxis__custom--TwoYearCollaborationAgreementMember__us-gaap--AwardTypeAxis__custom--EurosMember_zsw8QvfC93n2" title="Payment for services"><ix:nonFraction name="PPCB:PaymentForServices" contextRef="From2018-09-102018-09-13_custom_TwoYearCollaborationAgreementMember_custom_EurosMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="Euro">40,000</ix:nonFraction></span> Euros ($<span id="xdx_907_ecustom--PaymentForServices_c20180910__20180913__us-gaap--TypeOfArrangementAxis__custom--TwoYearCollaborationAgreementMember_pp0p0" title="Payment for services"><ix:nonFraction name="PPCB:PaymentForServices" contextRef="From2018-09-102018-09-13_custom_TwoYearCollaborationAgreementMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">45,775</ix:nonFraction></span> USD) in year two. The Company paid <span id="xdx_90C_ecustom--PaymentForServices_pp0p0_uEuro_c20180701__20190630__us-gaap--AwardTypeAxis__custom--EurosMember_zRObpNRVjqDb" title="Payment for services"><ix:nonFraction name="PPCB:PaymentForServices" contextRef="From2018-07-012019-06-30_custom_EurosMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="Euro">31,754</ix:nonFraction></span> Euros ($<span id="xdx_903_ecustom--PaymentForServices_c20180701__20190630_pp0p0" title="Payment for services"><ix:nonFraction name="PPCB:PaymentForServices" contextRef="From2018-07-012019-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">36,117</ix:nonFraction></span>
USD) in 2019 and has accrued <span id="xdx_90E_ecustom--PaymentForServices_pp0p0_uEuro_c20200701__20210630__us-gaap--AwardTypeAxis__custom--EurosMember_zZtt5T9DIDr8" title="Payment for services"><ix:nonFraction name="PPCB:PaymentForServices" contextRef="From2020-07-012021-06-30_custom_EurosMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="Euro">28,493</ix:nonFraction></span> Euros ($<span id="xdx_904_ecustom--PaymentForServices_c20200701__20210630_pp0p0" title="Payment for services"><ix:nonFraction name="PPCB:PaymentForServices" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">24,043</ix:nonFraction></span> USD) as of June 30, 2021. Additionally, in exchange for full ownership of the intellectual
property the Company agreed to pay royalties of <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_dp_c20180910__20180913__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--RevenueFromRightsConcentrationRiskMember__srt--MajorCustomersAxis__custom--NoCustomerMember_z7mggHXKVhrc" title="Royalties percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2018-09-102018-09-13_us-gaap_SalesRevenueNetMember_us-gaap_RevenueFromRightsConcentrationRiskMember_custom_NoCustomerMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">2</ix:nonFraction>%</span> of net revenues to the University. On October 1, 2020, the Company entered into another
two-year collaboration agreement with the University of Ja&#233;n to provide certain research services to the Company. In consideration
of such services, the Company agreed to pay the University approximately <span id="xdx_90E_ecustom--PaymentForServices_pp0p0_uEuro_c20200929__20201002__us-gaap--TypeOfArrangementAxis__custom--TwoYearCollaborationAgreementMember__us-gaap--AwardTypeAxis__custom--EurosMember_ztP48PuuYROl" title="Payment for services"><ix:nonFraction name="PPCB:PaymentForServices" contextRef="From2020-09-292020-10-02_custom_TwoYearCollaborationAgreementMember_custom_EurosMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="Euro">30,000</ix:nonFraction></span> Euros ($<span id="xdx_904_ecustom--PaymentForServices_c20200929__20201002__us-gaap--TypeOfArrangementAxis__custom--TwoYearCollaborationAgreementMember_pp0p0" title="Payment for services"><ix:nonFraction name="PPCB:PaymentForServices" contextRef="From2020-09-292020-10-02_custom_TwoYearCollaborationAgreementMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">35,145</ix:nonFraction></span> USD) which shall be paid in four installment
payment of <span id="xdx_904_ecustom--PaymentForServices_pp0p0_uEuro_c20200929__20201002__us-gaap--TypeOfArrangementAxis__custom--TwoYearCollaborationAgreementMember__us-gaap--AwardTypeAxis__custom--EurosMember__us-gaap--AwardDateAxis__custom--InstallmentOneMember_zE1rMSMFgGAk" title="Payment for services"><ix:nonFraction name="PPCB:PaymentForServices" contextRef="From2020-09-292020-10-02_custom_TwoYearCollaborationAgreementMember_custom_EurosMember_custom_InstallmentOneMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="Euro">5,000</ix:nonFraction></span> Euros in November 2020, <span id="xdx_90F_ecustom--PaymentForServices_pp0p0_uEuro_c20200929__20201002__us-gaap--TypeOfArrangementAxis__custom--TwoYearCollaborationAgreementMember__us-gaap--AwardDateAxis__custom--InstallmentTwoMember__us-gaap--AwardTypeAxis__custom--EurosMember_ztKvwPExcYt2" title="Payment for services"><ix:nonFraction name="PPCB:PaymentForServices" contextRef="From2020-09-292020-10-02_custom_TwoYearCollaborationAgreementMember_custom_InstallmentTwoMember_custom_EurosMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="Euro">5,000</ix:nonFraction></span> Euros ($<span id="xdx_906_ecustom--PaymentForServices_c20200929__20201002__us-gaap--TypeOfArrangementAxis__custom--TwoYearCollaborationAgreementMember__us-gaap--AwardDateAxis__custom--InstallmentTwoMember_pp0p0" title="Payment for services"><ix:nonFraction name="PPCB:PaymentForServices" contextRef="From2020-09-292020-10-02_custom_TwoYearCollaborationAgreementMember_custom_InstallmentTwoMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,858</ix:nonFraction></span>) in March 2021, <span id="xdx_908_ecustom--PaymentForServices_pp0p0_uEuro_c20200929__20201002__us-gaap--TypeOfArrangementAxis__custom--TwoYearCollaborationAgreementMember__us-gaap--AwardDateAxis__custom--InstallmentThreeMember__us-gaap--AwardTypeAxis__custom--EurosMember_zxu4BWFl0ja" title="Payment for services"><ix:nonFraction name="PPCB:PaymentForServices" contextRef="From2020-09-292020-10-02_custom_TwoYearCollaborationAgreementMember_custom_InstallmentThreeMember_custom_EurosMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="Euro">10,000</ix:nonFraction></span> Euros ($<span id="xdx_909_ecustom--PaymentForServices_c20200929__20201002__us-gaap--TypeOfArrangementAxis__custom--TwoYearCollaborationAgreementMember__us-gaap--AwardDateAxis__custom--InstallmentThreeMember_pp0p0" title="Payment for services"><ix:nonFraction name="PPCB:PaymentForServices" contextRef="From2020-09-292020-10-02_custom_TwoYearCollaborationAgreementMember_custom_InstallmentThreeMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">11,715</ix:nonFraction></span>) in December 2021 and <span id="xdx_902_ecustom--PaymentForServices_pp0p0_uEuro_c20200929__20201002__us-gaap--TypeOfArrangementAxis__custom--TwoYearCollaborationAgreementMember__us-gaap--AwardDateAxis__custom--InstallmentFourMember__us-gaap--AwardTypeAxis__custom--EurosMember_z8iModjJQVl" title="Payment for services"><ix:nonFraction name="PPCB:PaymentForServices" contextRef="From2020-09-292020-10-02_custom_TwoYearCollaborationAgreementMember_custom_InstallmentFourMember_custom_EurosMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="Euro">10,000</ix:nonFraction></span> Euros
($<span id="xdx_900_ecustom--PaymentForServices_c20200929__20201002__us-gaap--TypeOfArrangementAxis__custom--TwoYearCollaborationAgreementMember__us-gaap--AwardDateAxis__custom--InstallmentFourMember_pp0p0" title="Payment for services"><ix:nonFraction name="PPCB:PaymentForServices" contextRef="From2020-09-292020-10-02_custom_TwoYearCollaborationAgreementMember_custom_InstallmentFourMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">11,715</ix:nonFraction></span>) in September 2022. Additionally, the University shall hire and train a doctoral student for this project and as such the Company
shall pay the University <span id="xdx_909_ecustom--PaymentForServices_pp0p0_uEuro_c20200929__20201002__dei--LegalEntityAxis__custom--UniversityOfJaenMember__us-gaap--AwardTypeAxis__custom--EurosMember_zktznTOCKlk2" title="Payment for services"><ix:nonFraction name="PPCB:PaymentForServices" contextRef="From2020-09-292020-10-02_custom_UniversityOfJaenMember_custom_EurosMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="Euro">25,837</ix:nonFraction></span> Euros ($<span id="xdx_900_ecustom--PaymentForServices_c20200929__20201002__dei--LegalEntityAxis__custom--UniversityOfJaenMember_pp0p0" title="Payment for services"><ix:nonFraction name="PPCB:PaymentForServices" contextRef="From2020-09-292020-10-02_custom_UniversityOfJaenMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">30,268</ix:nonFraction></span> USD). In exchange for full ownership of the intellectual property the Company agreed to
pay royalties of <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_dp_c20200929__20201002__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__dei--LegalEntityAxis__custom--UniversityOfJaenMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--RevenueFromRightsConcentrationRiskMember__srt--MajorCustomersAxis__custom--NoCustomerMember_z4ZzunSRlP18" title="Royalties percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2020-09-292020-10-02_us-gaap_SalesRevenueNetMember_custom_UniversityOfJaenMember_us-gaap_RevenueFromRightsConcentrationRiskMember_custom_NoCustomerMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">2</ix:nonFraction>%</span> of net revenues to the University.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-07-012021-06-30" escape="true" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock"><p id="xdx_806_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zzD8WGT4aV38" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>NOTE
10 &#8211; <span id="xdx_82F_zkTUa11D0wZ">RELATED PARTY TRANSACTIONS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Since
its inception, the Company has conducted transactions with its directors and entities related to such directors. These transactions have
included the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">As
of June 30, 2021 and 2020, the Company owed its former director a total of $<span id="xdx_90F_ecustom--LoansFromRelatedParty_c20210630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--CurrentAndFormerDirectorMember_pp0p0" title="Loans from related party"><ix:nonFraction name="PPCB:LoansFromRelatedParty" contextRef="AsOf2021-06-30_custom_CurrentAndFormerDirectorMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">55,500</ix:nonFraction></span> and $<span id="xdx_90E_ecustom--LoansFromRelatedParty_c20200630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--CurrentAndFormerDirectorMember_pp0p0" title="Loans from related party"><ix:nonFraction name="PPCB:LoansFromRelatedParty" contextRef="AsOf2020-06-30_custom_CurrentAndFormerDirectorMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">50,993</ix:nonFraction></span>, respectively, for money loaned to the
Company throughout the years. The total loans balance owed at June 30, 2021 and 2020 is not interest bearing (See Note 5 &#8211; Loans
and Notes Payable).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">As
of June 30, 2021 and 2020, the Company owed its former director a total of $<span id="xdx_90B_eus-gaap--DueToRelatedPartiesCurrent_c20210630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--FormerDirectorMember_pp0p0" title="Due to related parties"><ix:nonFraction name="us-gaap:DueToRelatedPartiesCurrent" contextRef="AsOf2021-06-30_custom_FormerDirectorMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">33,347</ix:nonFraction></span> and $<span id="xdx_90A_eus-gaap--DueToRelatedPartiesCurrent_c20200630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--FormerDirectorMember_pp0p0" title="Due to related parties"><ix:nonFraction name="us-gaap:DueToRelatedPartiesCurrent" contextRef="AsOf2020-06-30_custom_FormerDirectorMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">30,639</ix:nonFraction></span>, respectively, related to expenses paid
on behalf of the Company related to corporate startup costs and intellectual property (See Note 4 &#8211; Due to Former Director &#8211;
Related Party).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Effective
May 5, 2016, the Company entered into an agreement for the lease of its principal executive offices with North Horizon Pty Ltd., a related
party, of which Mr. Nathanielsz, our CEO, CFO and a director, and his wife are owners and directors. The lease has a <span id="xdx_900_eus-gaap--LessorOperatingLeaseTermOfContract_iI_dtYxL_c20160505__dei--LegalEntityAxis__custom--NorthHorizonPtyLtdMember_zcSkroEftsR" title="::XDX::5"><span style="-sec-ix-hidden: xdx2ixbrl2256">five</span></span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">-year
term and provides for annual rental payments of $<span id="xdx_900_eus-gaap--OperatingLeasesRentExpenseMinimumRentals_pp0p0_uAUD_c20160503__20160505__dei--LegalEntityAxis__custom--NorthHorizonPtyLtdMember__us-gaap--AwardTypeAxis__custom--AUDCurrencyMember_ziyfUdJ6SMsc"><ix:nonFraction name="us-gaap:OperatingLeasesRentExpenseMinimumRentals" contextRef="From2016-05-032016-05-05_custom_NorthHorizonPtyLtdMember_custom_AUDCurrencyMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="AUD">39,600</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">AUD or $<span id="xdx_909_eus-gaap--OperatingLeasesRentExpenseMinimumRentals_c20160503__20160505__dei--LegalEntityAxis__custom--NorthHorizonPtyLtdMember_pp0p0"><ix:nonFraction name="us-gaap:OperatingLeasesRentExpenseMinimumRentals" contextRef="From2016-05-032016-05-05_custom_NorthHorizonPtyLtdMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">28,325</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">USD, which includes $<span id="xdx_90F_ecustom--GoodsAndServiceTax_pp0p0_uAUD_c20160503__20160505__dei--LegalEntityAxis__custom--NorthHorizonPtyLtdMember__us-gaap--AwardTypeAxis__custom--AUDCurrencyMember_zYv6xR0CPQ09"><ix:nonFraction name="PPCB:GoodsAndServiceTax" contextRef="From2016-05-032016-05-05_custom_NorthHorizonPtyLtdMember_custom_AUDCurrencyMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="AUD">3,600</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">AUD or $<span id="xdx_904_ecustom--GoodsAndServiceTax_c20160503__20160505__dei--LegalEntityAxis__custom--NorthHorizonPtyLtdMember_pp0p0"><ix:nonFraction name="PPCB:GoodsAndServiceTax" contextRef="From2016-05-032016-05-05_custom_NorthHorizonPtyLtdMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,575</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">USD of goods and service tax for
total payments of $<span id="xdx_90E_eus-gaap--OperatingLeasesFutureMinimumPaymentsDue_iI_pp0p0_uAUD_c20160505__dei--LegalEntityAxis__custom--NorthHorizonPtyLtdMember__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NathanielszMember_zHUUCd1ACDlc"><ix:nonFraction name="us-gaap:OperatingLeasesFutureMinimumPaymentsDue" contextRef="AsOf2016-05-05_custom_NorthHorizonPtyLtdMember_custom_AUDCurrenryMember_custom_NathanielszMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="AUD">198,000</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">AUD or $<span id="xdx_908_eus-gaap--OperatingLeasesFutureMinimumPaymentsDue_c20160505__dei--LegalEntityAxis__custom--NorthHorizonPtyLtdMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NathanielszMember_pp0p0"><ix:nonFraction name="us-gaap:OperatingLeasesFutureMinimumPaymentsDue" contextRef="AsOf2016-05-05_custom_NorthHorizonPtyLtdMember_custom_NathanielszMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">141,629</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">USD during the term of the lease.
As of June 30, 2021, total rent payable of $<span id="xdx_90C_eus-gaap--PaymentsForRent_pp0p0_uAUD_c20200701__20210630__dei--LegalEntityAxis__custom--NorthHorizonPtyLtdMember__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember_zrnorhVlpEih"><ix:nonFraction name="us-gaap:PaymentsForRent" contextRef="From2020-07-012021-06-30_custom_NorthHorizonPtyLtdMember_custom_AUDCurrenryMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="AUD">86,129</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">AUD ($<span id="xdx_907_eus-gaap--PaymentsForRent_c20200701__20210630__dei--LegalEntityAxis__custom--NorthHorizonPtyLtdMember_pp0p0"><ix:nonFraction name="us-gaap:PaymentsForRent" contextRef="From2020-07-012021-06-30_custom_NorthHorizonPtyLtdMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">64,597</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">USD) is included in accrued expenses
in the accompanying consolidated balance sheet. <span><span id="xdx_90F_eus-gaap--LesseeOperatingLeaseDescription_c20190701__20190702__us-gaap--AdjustmentsForNewAccountingPronouncementsAxis__us-gaap--AccountingStandardsUpdate201602Member_zGJRpruMJUSi"><ix:nonNumeric contextRef="From2019-07-012019-07-02_us-gaap_AccountingStandardsUpdate201602Member" name="us-gaap:LesseeOperatingLeaseDescription">Such lease expired in May 2021 and was renewed for another one-year term from May 2021 to May 2022</ix:nonNumeric></span></span> (See Note 9 &#8211; Commitments and Contingencies).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<ix:exclude><!-- Field: Page; Sequence: 123; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>PROPANC
BIOPHARMA, INC. AND SUBSIDIARY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>June
30, 2021 and 2020</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><i>Employment
and Services Agreements with Management</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
Company and Mr. Nathanielsz entered into an employment agreement as of February 25, 2015 (the &#8220;Nathanielsz Employment Agreement&#8221;)
setting forth the terms and conditions of Mr. Nathanielsz employment as the Company&#8217;s President and Chief Executive Officer. The
Nathanielsz Employment Agreement was scheduled to expire on <span id="xdx_904_eus-gaap--RelatedPartyTransactionDate_dd_c20150224__20150225__us-gaap--TypeOfArrangementAxis__custom--NathanielszEmploymentAgreementMember_zL101soAiIPb" title="Expired date"><ix:nonNumeric contextRef="From2015-02-242015-02-25_custom_NathanielszEmploymentAgreementMember" format="ixt:datemonthdayyearen" name="us-gaap:RelatedPartyTransactionDate">February 25, 2019</ix:nonNumeric></span>; however, the term of the Nathanielsz Employment Agreement
automatically renews for successive one-year periods unless either party provides 30 days&#8217; prior written notice of its intent not
to renew. The Nathanielsz Employment Agreement continues in effect as of June 30, 2021 as amended May 14, 2019 (see below). The Nathanielsz
Employment Agreement provides Mr. Nathanielsz with a base salary of $<span id="xdx_909_eus-gaap--SalariesAndWages_pp0p0_uAUD_c20150224__20150225__us-gaap--TypeOfArrangementAxis__custom--NathanielszEmploymentAgreementMember__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember_zYoqbdpF6Lj8" title="Annual salary"><ix:nonFraction name="us-gaap:SalariesAndWages" contextRef="From2015-02-242015-02-25_custom_NathanielszEmploymentAgreementMember_custom_AUDCurrenryMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="AUD">25,000</ix:nonFraction></span> AUD per month ($<span id="xdx_901_eus-gaap--SalariesAndWages_pp0p0_uAUD_c20200701__20210630__us-gaap--TypeOfArrangementAxis__custom--NathanielszEmploymentAgreementMember__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember_zR0jkp8oaqU5" title="Annual salary"><ix:nonFraction name="us-gaap:SalariesAndWages" contextRef="From2020-07-012021-06-30_custom_NathanielszEmploymentAgreementMember_custom_AUDCurrenryMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="AUD">300,000</ix:nonFraction></span> AUD annually or $<span id="xdx_90F_eus-gaap--SalariesAndWages_c20200701__20210630__us-gaap--TypeOfArrangementAxis__custom--NathanielszEmploymentAgreementMember_pp0p0" title="Annual salary"><ix:nonFraction name="us-gaap:SalariesAndWages" contextRef="From2020-07-012021-06-30_custom_NathanielszEmploymentAgreementMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">205,680</ix:nonFraction></span> USD) and
a monthly contribution to Mr. Nathanielsz&#8217;s pension equal to <span id="xdx_904_ecustom--PercentageOfPensionOfMonthlySalary_dp_c20200701__20210630__us-gaap--TypeOfArrangementAxis__custom--NathanielszEmploymentAgreementMember_zc3W4JZ4V5g6" title="Percentage of pension of monthly salary"><ix:nonFraction name="PPCB:PercentageOfPensionOfMonthlySalary" contextRef="From2020-07-012021-06-30_custom_NathanielszEmploymentAgreementMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">9.5</ix:nonFraction>%</span> of his monthly salary. Mr. Nathanielsz has the ability to convert
any accrued but unpaid salary into common stock at the end of each fiscal year at a conversion price to be determined by Mr. Nathanielsz
and the Company, which will in no event be lower than par value or higher than the closing bid price on the date of conversion. Pursuant
to the Nathanielsz Employment Agreement, Mr. Nathanielsz is entitled to an annual discretionary bonus in an amount up to <span id="xdx_90A_ecustom--PercentageOfBonusOfAnnualBaseSalary_dp_uPure_c20200701__20210630__us-gaap--TypeOfArrangementAxis__custom--NathanielszEmploymentAgreementMember_zRkqX1Xzgqc8" title="Percentage of bonus of annual base salary"><ix:nonFraction name="PPCB:PercentageOfBonusOfAnnualBaseSalary" contextRef="From2020-07-012021-06-30_custom_NathanielszEmploymentAgreementMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">200</ix:nonFraction>%</span> of his
annual base salary, which bonus shall be determined by the Company&#8217;s board of directors based upon the performance of the Company.
On March 16, 2018, the Company&#8217;s board of directors approved an increase of Mr. Nathanielsz&#8217;s annual base salary from $<span id="xdx_90F_eus-gaap--SalariesAndWages_pp0p0_uAUD_c20180315__20180316__us-gaap--TypeOfArrangementAxis__custom--NathanielszEmploymentAgreementMember__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember__srt--RangeAxis__srt--MinimumMember_zfz7g8ilDkHa" title="Annual salary"><ix:nonFraction name="us-gaap:SalariesAndWages" contextRef="From2018-03-152018-03-16_custom_NathanielszEmploymentAgreementMember_custom_AUDCurrenryMember_srt_MinimumMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="AUD">300,000</ix:nonFraction></span>
AUD ($<span id="xdx_902_eus-gaap--SalariesAndWages_c20180315__20180316__us-gaap--TypeOfArrangementAxis__custom--NathanielszEmploymentAgreementMember__srt--RangeAxis__srt--MinimumMember_pp0p0" title="Annual salary"><ix:nonFraction name="us-gaap:SalariesAndWages" contextRef="From2018-03-152018-03-16_custom_NathanielszEmploymentAgreementMember_srt_MinimumMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">205,680</ix:nonFraction></span> USD) to $<span id="xdx_902_eus-gaap--SalariesAndWages_pp0p0_uAUD_c20180315__20180316__us-gaap--TypeOfArrangementAxis__custom--NathanielszEmploymentAgreementMember__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember__srt--RangeAxis__srt--MaximumMember_zlk1mxratRg4" title="Annual salary"><ix:nonFraction name="us-gaap:SalariesAndWages" contextRef="From2018-03-152018-03-16_custom_NathanielszEmploymentAgreementMember_custom_AUDCurrenryMember_srt_MaximumMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="AUD">400,000</ix:nonFraction></span> AUD ($<span id="xdx_900_eus-gaap--SalariesAndWages_c20180315__20180316__us-gaap--TypeOfArrangementAxis__custom--NathanielszEmploymentAgreementMember__srt--RangeAxis__srt--MaximumMember_pp0p0" title="Annual salary"><ix:nonFraction name="us-gaap:SalariesAndWages" contextRef="From2018-03-152018-03-16_custom_NathanielszEmploymentAgreementMember_srt_MaximumMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">274,240</ix:nonFraction></span> USD), effective February 2018.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Mr.
Nathanielsz&#8217;s wife, Sylvia Nathanielsz, is and has been a non-executive part-time employee of the Company since October 2015. Effective
February 1, 2018, Mrs. Nathanielsz receives an annual salary of $<span id="xdx_905_eus-gaap--SalariesAndWages_pp0p0_uAUD_c20180128__20180201__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrsNathanielszMember__us-gaap--AwardTypeAxis__custom--AUDCurrencyMember_zHixLQFUIPr7" title="Annual salary"><ix:nonFraction name="us-gaap:SalariesAndWages" contextRef="From2018-01-282018-02-01_custom_MrsNathanielszMember_custom_AUDCurrencyMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="AUD">120,000</ix:nonFraction></span> AUD ($<span id="xdx_90A_eus-gaap--SalariesAndWages_c20180128__20180201__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrsNathanielszMember_pp0p0" title="Annual salary"><ix:nonFraction name="us-gaap:SalariesAndWages" contextRef="From2018-01-282018-02-01_custom_MrsNathanielszMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">80,904</ix:nonFraction></span> USD) and is entitled to customary benefits.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.45in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Pursuant
to a February 25, 2016 board resolution, James Nathanielsz shall be paid $<span id="xdx_900_eus-gaap--RepaymentsOfRelatedPartyDebt_pp0p0_uAUD_c20160224__20160225__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--JamesNathanielszMember__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember_zsc5Uu3BkKMi" title="Payments form related party"><ix:nonFraction name="us-gaap:RepaymentsOfRelatedPartyDebt" contextRef="From2016-02-242016-02-25_custom_JamesNathanielszMember_custom_AUDCurrenryMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="AUD">4,481</ix:nonFraction></span> AUD ($<span id="xdx_90F_eus-gaap--RepaymentsOfRelatedPartyDebt_c20160224__20160225__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--JamesNathanielszMember_pp0p0" title="Payments form related party"><ix:nonFraction name="us-gaap:RepaymentsOfRelatedPartyDebt" contextRef="From2016-02-242016-02-25_custom_JamesNathanielszMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,205</ix:nonFraction></span> USD), on a monthly basis for the purpose
of acquiring and maintaining an automobile. For the year ended June 30, 2020, a total of $<span id="xdx_909_eus-gaap--RepaymentsOfRelatedPartyDebt_pp0p0_uAUD_c20190701__20200630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrsNathanielszMember__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember_z0vnOVOV1umh" title="Payments form related party"><ix:nonFraction name="us-gaap:RepaymentsOfRelatedPartyDebt" contextRef="From2019-07-012020-06-30_custom_MrsNathanielszMember_custom_AUDCurrenryMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="AUD">44,918</ix:nonFraction></span> AUD ($<span id="xdx_906_eus-gaap--RepaymentsOfRelatedPartyDebt_pp0p0_c20190701__20200630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrsNathanielszMember_zuqdo4grtdkc" title="Payments form related party"><ix:nonFraction name="us-gaap:RepaymentsOfRelatedPartyDebt" contextRef="From2019-07-012020-06-30_custom_MrsNathanielszMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">30,284</ix:nonFraction></span> USD) in payments have been
made with respect to Mr. Nathanielsz&#8217;s car allowance. For the year ended June 30, 2021, a total of $<span id="xdx_90A_eus-gaap--RepaymentsOfRelatedPartyDebt_pp0p0_uAUD_c20200701__20210630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrsNathanielszMember__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember_zQuyUSmDfHdd" title="Payments form related party"><ix:nonFraction name="us-gaap:RepaymentsOfRelatedPartyDebt" contextRef="From2020-07-012021-06-30_custom_MrsNathanielszMember_custom_AUDCurrenryMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="AUD">46,135</ix:nonFraction></span> AUD ($<span id="xdx_90F_eus-gaap--RepaymentsOfRelatedPartyDebt_pp0p0_c20200701__20210630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrsNathanielszMember_zsJx3gWyphf7" title="Payments form related party"><ix:nonFraction name="us-gaap:RepaymentsOfRelatedPartyDebt" contextRef="From2020-07-012021-06-30_custom_MrsNathanielszMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">34,476</ix:nonFraction></span> USD) in
payments have been made with respect to Mr. Nathanielsz&#8217;s car allowance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Pursuant
to the approval of the Company&#8217;s board of directors, on May 14, 2019, Mr. Nathanielsz was granted a $<span id="xdx_90D_eus-gaap--OfficersCompensation_pp0p0_uAUD_c20190513__20190514__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsMember__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember_zhr5r6niZC3i"><ix:nonFraction name="us-gaap:OfficersCompensation" contextRef="From2019-05-132019-05-14_custom_MrNathanielszMember_custom_BoardOfDirectorsMember_custom_AUDCurrenryMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="AUD">460,000</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">AUD ($<span id="xdx_907_eus-gaap--OfficersCompensation_c20190513__20190514__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsMember_pp0p0"><ix:nonFraction name="us-gaap:OfficersCompensation" contextRef="From2019-05-132019-05-14_custom_MrNathanielszMember_custom_BoardOfDirectorsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">315,376</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">USD) bonus for accomplishments
achieved while serving as the Company&#8217;s Chief Executive Officer during the fiscal year ended June 30, 2019 with $<span id="xdx_908_ecustom--BonusPayableAmount_pp0p0_uAUD_c20180701__20190630__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember_zrUcMs0KvEzg"><ix:nonFraction name="PPCB:BonusPayableAmount" contextRef="From2018-07-012019-06-30_srt_ChiefExecutiveOfficerMember_custom_AUDCurrenryMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="AUD">200,000</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">AUD ($<span id="xdx_90D_ecustom--BonusPayableAmount_c20180701__20190630__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_pp0p0"><ix:nonFraction name="PPCB:BonusPayableAmount" contextRef="From2018-07-012019-06-30_srt_ChiefExecutiveOfficerMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">137,120</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">USD) of such bonus payable by the
Corporation to the CEO throughout the Corporation&#8217;s 2019 fiscal year as the Corporation&#8217;s cash resources allow, with the
remaining $<span id="xdx_900_ecustom--RemainingBonusAmount_pp0p0_uAUD_c20180701__20190630__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember_zopoISWozugl"><ix:nonFraction name="PPCB:RemainingBonusAmount" contextRef="From2018-07-012019-06-30_srt_ChiefExecutiveOfficerMember_custom_AUDCurrenryMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="AUD">260,000</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">AUD ($<span id="xdx_90C_ecustom--RemainingBonusAmount_c20180701__20190630__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_pp0p0"><ix:nonFraction name="PPCB:RemainingBonusAmount" contextRef="From2018-07-012019-06-30_srt_ChiefExecutiveOfficerMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">178,256</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">USD) of such bonus to be deferred
by the CEO until a future date when the Corporation&#8217;s cash resources allow for such payment, as agreed to by the CEO. A total of
$<span id="xdx_900_eus-gaap--RepaymentsOfRelatedPartyDebt_pp0p0_uAUD_c20180701__20190630__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember_zJKyJ7nmmqnb"><ix:nonFraction name="us-gaap:RepaymentsOfRelatedPartyDebt" contextRef="From2018-07-012019-06-30_srt_ChiefExecutiveOfficerMember_custom_AUDCurrenryMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="AUD">90,000</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">AUD ($<span id="xdx_909_eus-gaap--RepaymentsOfRelatedPartyDebt_c20180701__20190630__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_pp0p0"><ix:nonFraction name="us-gaap:RepaymentsOfRelatedPartyDebt" contextRef="From2018-07-012019-06-30_srt_ChiefExecutiveOfficerMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">64,377</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">USD) in payments were made in the
year ended June 30, 2019. On July 13, 2020, the Board approved a bonus of $<span id="xdx_90C_eus-gaap--OfficersCompensation_pp0p0_uAUD_c20200712__20200713__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsMember__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember_zAfbIS2TyxH4"><ix:nonFraction name="us-gaap:OfficersCompensation" contextRef="From2020-07-122020-07-13_custom_MrNathanielszMember_custom_BoardOfDirectorsMember_custom_AUDCurrenryMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="AUD">240,000</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">AUD being equal to <span id="xdx_908_ecustom--BonusAwardsGrantedPercentage_dp_c20200712__20200713__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsMember__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember_zCFbwsynHeB5"><ix:nonFraction name="PPCB:BonusAwardsGrantedPercentage" contextRef="From2020-07-122020-07-13_custom_MrNathanielszMember_custom_BoardOfDirectorsMember_custom_AUDCurrenryMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">60</ix:nonFraction>%
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">of Mr. Nathanielsz base salary
which was accrued as of June 30, 2020. A total of $<span id="xdx_908_eus-gaap--RepaymentsOfRelatedPartyDebt_pp0p0_uAUD_c20190701__20200630__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember_zHe68DZ7ogVa"><ix:nonFraction name="us-gaap:RepaymentsOfRelatedPartyDebt" contextRef="From2019-07-012020-06-30_srt_ChiefExecutiveOfficerMember_custom_AUDCurrenryMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="AUD">202,620</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">AUD ($<span id="xdx_900_eus-gaap--RepaymentsOfRelatedPartyDebt_c20190701__20200630__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_pp0p0"><ix:nonFraction name="us-gaap:RepaymentsOfRelatedPartyDebt" contextRef="From2019-07-012020-06-30_srt_ChiefExecutiveOfficerMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">136,606</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">USD) in payments were made against
the bonuses during the year ended June 30, 2020 which resulted to a remaining balance of $<span id="xdx_906_ecustom--BonusPayable_pp0p0_uAUD_c20190701__20200630__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember_z6cjrBUkSy06"><ix:nonFraction name="PPCB:BonusPayable" contextRef="From2019-07-012020-06-30_srt_ChiefExecutiveOfficerMember_custom_AUDCurrenryMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="AUD">407,380</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">AUD ($<span id="xdx_907_ecustom--BonusPayable_c20190701__20200630__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_pp0p0"><ix:nonFraction name="PPCB:BonusPayable" contextRef="From2019-07-012020-06-30_srt_ChiefExecutiveOfficerMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">280,726</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">USD) bonus payable as of June 30,
2020. On August 12, 2021, the Board approved a bonus of $<span id="xdx_903_eus-gaap--OfficersCompensation_pp0p0_c20210811__20210812__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zTR9d7GO44Ca"><ix:nonFraction name="us-gaap:OfficersCompensation" contextRef="From2021-08-112021-08-12_custom_MrNathanielszMember_custom_BoardOfDirectorsMember_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">177,840</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">USD. A total of $<span id="xdx_90E_eus-gaap--RepaymentsOfRelatedPartyDebt_pp0p0_uAUD_c20200701__20210630__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember_zIK7GAubQko"><ix:nonFraction name="us-gaap:RepaymentsOfRelatedPartyDebt" contextRef="From2020-07-012021-06-30_srt_ChiefExecutiveOfficerMember_custom_AUDCurrenryMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="AUD">221,890</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">AUD ($<span id="xdx_90D_ecustom--BonusPayable_c20200701__20210630__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_pp0p0"><ix:nonFraction name="PPCB:BonusPayable" contextRef="From2020-07-012021-06-30_srt_ChiefExecutiveOfficerMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">166,418</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">USD) in payments were made against
the bonuses during the year ended June 30, 2021 resulting in a remaining balance of $<span id="xdx_90D_ecustom--BonusPayable_pp0p0_uAUD_c20200701__20210630__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember_zzKb2zutJYC5"><ix:nonFraction name="PPCB:BonusPayable" contextRef="From2020-07-012021-06-30_srt_ChiefExecutiveOfficerMember_custom_AUDCurrenryMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="AUD">422,610</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">AUD ($<span id="xdx_904_ecustom--BonusPayable_pp0p0_c20200701__20210630__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--TypeOfArrangementAxis__custom--MrsNathanielszMember_zw75G6lgrDWj"><ix:nonFraction name="PPCB:BonusPayable" contextRef="From2020-07-012021-06-30_srt_ChiefExecutiveOfficerMember_custom_MrsNathanielszMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">316,957</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">USD) bonus payable as of June 30,
2021 which is included in accrued expenses in the accompanying consolidated balance sheet. On August 12, 2021, pursuant to the Cancellation
Agreement, Mr. Nathanielsz agreed to cancel $<span id="xdx_904_eus-gaap--OfficersCompensation_c20210811__20210812__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsMember_zBqGulXqxETg" title="Officers&apos; compensation"><ix:nonFraction name="us-gaap:OfficersCompensation" contextRef="From2021-08-112021-08-12_custom_MrNathanielszMember_custom_BoardOfDirectorsMember_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">177,840</ix:nonFraction></span> of the bonus payable in exchange for <span id="xdx_908_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_pip0_c20210811__20210812__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsMember_z0ShY2CLgpfi"><ix:nonFraction name="us-gaap:DebtConversionConvertedInstrumentSharesIssued1" contextRef="From2021-08-112021-08-12_custom_MrNathanielszMember_custom_BoardOfDirectorsMember" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">5,928,000</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">shares of the common stock of the
Company (see Note 13).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Amended
and Restated Employment Agreement - On May 14, 2019 (the &#8220;Effective Date&#8221;), the Company entered into an Amended and Restated
Employment Agreement (the &#8220;Employment Agreement&#8221;) with James Nathanielsz, the Company&#8217;s Chief Executive Officer, Chairman,
acting Chief Financial Officer and a director, for a term of <span id="xdx_90B_ecustom--AgreementlTerm_dc_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember_zeNs9QNayR5c" title="Agreement term"><ix:nonNumeric contextRef="From2019-05-132019-05-14_custom_EmploymentAgreementMember_custom_MrNathanielszMember" format="ixt-sec:durwordsen" name="PPCB:AgreementlTerm">three years</ix:nonNumeric></span>, subject to automatic <span id="xdx_909_ecustom--AgreementRenewalTerm_dtYxL_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember_zyg0gxBXOGIa" title="Agreement renewal term::XDX::1"><span style="-sec-ix-hidden: xdx2ixbrl2327">one</span></span>-year renewals, at an annual salary
of $<span id="xdx_908_eus-gaap--SalariesAndWages_pp0p0_uAUD_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember_zRCs20QOpIYd" title="Annual salary"><ix:nonFraction name="us-gaap:SalariesAndWages" contextRef="From2019-05-132019-05-14_custom_EmploymentAgreementMember_custom_MrNathanielszMember_custom_AUDCurrenryMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="AUD">400,000</ix:nonFraction></span> AUD. Pursuant to the Employment Agreement, Mr. Nathanielsz was granted options to purchase <span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember_pdd" title="Option purchase shares"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" contextRef="From2019-05-132019-05-14_custom_EmploymentAgreementMember_custom_MrNathanielszMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">39</ix:nonFraction></span> shares of the Company&#8217;s
common stock (the &#8220;Nathanielsz Options&#8221;), with an exercise price per share of $<span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember_pdd" title="Exercise price"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" contextRef="From2019-05-132019-05-14_custom_EmploymentAgreementMember_custom_MrNathanielszMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">4,675</ix:nonFraction></span> (<span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_dp_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember_zEGYArsbBKx2" title="Market price"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" contextRef="From2019-05-132019-05-14_custom_EmploymentAgreementMember_custom_MrNathanielszMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">110</ix:nonFraction>%</span> of the closing market price of
the Company&#8217;s common stock on May 14, 2019 (or $<span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember_pdd" title="Granted exercise price"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" contextRef="From2019-05-132019-05-14_custom_EmploymentAgreementMember_custom_MrNathanielszMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">4,250</ix:nonFraction></span>), the date of approval of such grant by the Company&#8217;s board of directors),
(ii) <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember__us-gaap--AwardTypeAxis__custom--RestrictedStocksUnitsRSUMember_pdd" title="Restricted stock shares of common stock"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" contextRef="From2019-05-132019-05-14_custom_EmploymentAgreementMember_custom_RestrictedStocksUnitsRSUMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">39</ix:nonFraction></span> restricted stock units of the Company (the &#8220;Initial Nathanielsz RSUs&#8221;), and (iii) an additional <span id="xdx_90C_ecustom--StockToBeIssuedDuringPeriodValueRestrictedStockUnit_c20200701__20210630__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember_pdd" title="Restricted stock unit issuable"><ix:nonFraction name="PPCB:StockToBeIssuedDuringPeriodValueRestrictedStockUnit" contextRef="From2020-07-012021-06-30_custom_EmploymentAgreementMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">39</ix:nonFraction></span> restricted stock
units of the Company (the &#8220;Additional Nathanielsz RSUs&#8221;). Such options and restricted stock units were granted pursuant to
the 2019 Plan approved by the Company&#8217;s board of directors on the Effective Date. <span id="xdx_90E_ecustom--OptionsVestedDescription_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember" title="Options vested, description"><ix:nonNumeric contextRef="From2019-05-132019-05-14_custom_EmploymentAgreementMember_custom_MrNathanielszMember" name="PPCB:OptionsVestedDescription">The Nathanielsz Options have a term of <span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember_ziX0y2aBXc9a"><ix:nonNumeric contextRef="From2019-05-132019-05-14_custom_EmploymentAgreementMember_custom_MrNathanielszMember" format="ixt-sec:durwordsen" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">10 years</ix:nonNumeric></span>
from the date of grant. 1/3rd of the Nathanielsz Options shall vest every successive one-year anniversary following the Effective Date,
provided, that on each such vesting date Mr. Nathanielsz is employed by the Company and subject to the other provisions of the Employment
Agreement. The Initial Nathanielsz RSUs shall vest on the one-year anniversary of the Effective Date, subject to Mr. Nathanielsz&#8217;s
continued employment with the Company through such vesting date. The Additional Nathanielsz RSUs will vest as follows, subject to Mr.
Nathanielsz&#8217;s continued employment with the Company through the applicable vesting date: (i) <span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember__us-gaap--AwardTypeAxis__custom--AdditionaNathanielszRSUsMember_pdd" title="Rsus vest, shares"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" contextRef="From2019-05-132019-05-14_custom_EmploymentAgreementMember_custom_AdditionaNathanielszRSUsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">7.80</ix:nonFraction></span> of the Additional Nathanielsz
RSUs shall vest upon the Company submitting Clinical Trial Application (the &#8220;CTA&#8221;) for PRP, the Company&#8217;s lead product
candidate (&#8220;PRP&#8221;), for a First-In-Human study for PRP (the &#8220;Study&#8221;) in an applicable jurisdiction to be selected
by the Company, (ii) 7.80 of the Additional Nathanielsz RSUs shall vest upon</ix:nonNumeric></span> the CTA being approved in an applicable jurisdiction, (iii)
7.80 of the Additional RSUs shall vest upon the Company completing an equity financing in the amount of at least $<span id="xdx_90A_ecustom--GrossProceedsFromEquityFinancing_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember__us-gaap--AwardTypeAxis__custom--AdditionaNathanielszRSUsMember_pp0p0" title="Gross proceeds from equity financing"><ix:nonFraction name="PPCB:GrossProceedsFromEquityFinancing" contextRef="From2019-05-132019-05-14_custom_EmploymentAgreementMember_custom_AdditionaNathanielszRSUsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,000,000</ix:nonFraction></span> in gross
proceeds, (iv) 7.80 of the Additional Nathanielsz RSUs shall vest upon the shares of the Company&#8217;s Common Stock being listed on
a senior stock exchange (NYSE, NYSEMKT or NASDAQ), and (v) the remaining 7.80 of the Additional Nathanielsz RSUs shall vest upon the
Company enrolling its first patient in the Study. Each vested restricted stock unit shall be settled by delivery to Mr. Nathanielsz of
one share of the Company&#8217;s common stock and/or the fair market value of one share of common stock in cash, at the sole discretion
of the Company&#8217;s board of directors and subject to the 2019 Plan, on the first to occur of: (i) the date of a Change of Control
(as defined in the Employment Agreement), (ii) the date that is ten business days following the vesting of such restricted stock unit,
(iii) the date of Mr. Nathanielsz&#8217;s death or Disability (as defined in the Employment Agreement), and (iv) Mr. Nathanielsz&#8217;s
employment being terminated either by the Company without Cause or by Mr. Nathanielsz for Good Reason (each as defined in the Employment
Agreement). In the event of a Change of Control, any unvested portion of the Nathanielsz Options and such restricted stock units shall
vest immediately prior to such event. The 39 vested restricted stock unit are considered issuable as of June 30, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<ix:exclude><!-- Field: Page; Sequence: 124; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>PROPANC
BIOPHARMA, INC. AND SUBSIDIARY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>June
30, 2021 and 2020</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Amended
and Restated Services Agreement - On May 14, 2019, the Company also entered into an Amended and Restated Services Agreement (the &#8220;Services
Agreement&#8221;) with Dr. Kenyon, the Company&#8217;s Chief Scientific Officer and a director, for a term of <span id="xdx_903_ecustom--AgreementlTerm_dtYxL_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DrKenyonMember_zI7SHQGqEtZk" title="Agreement term::XDX::3"><span style="-sec-ix-hidden: xdx2ixbrl2350">three</span></span> years, subject to
automatic <span id="xdx_90A_ecustom--AgreementRenewalTerm_dtYxL_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DrKenyonMember_zeyfSPX9awp2" title="Agreement renewal term::XDX::1"><span style="-sec-ix-hidden: xdx2ixbrl2352">one</span></span>-year renewals, at an annual salary of $<span id="xdx_903_eus-gaap--SalariesAndWages_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DrKenyonMemberMember__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember_pp0p0" title="Annual salary"><ix:nonFraction name="us-gaap:SalariesAndWages" contextRef="From2019-05-132019-05-14_custom_ServicesAgreementMember_custom_DrKenyonMemberMember_custom_AUDCurrenryMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">54,000</ix:nonFraction></span> AUD. In connection with the execution of the Services Agreement, Dr. Kenyon
was designated as an executive officer of the Company and assumed a more active executive role with the Company. Pursuant to the Services
Agreement, Dr. Kenyon was granted options to purchase <span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DrKenyonMember_pdd" title="Option purchase shares"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" contextRef="From2019-05-132019-05-14_custom_ServicesAgreementMember_custom_DrKenyonMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">20</ix:nonFraction></span> shares of the Company&#8217;s common stock (the &#8220;Kenyon Options&#8221;),
with an exercise price per share of $<span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DrKenyonMember_pdd" title="Exercise price"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" contextRef="From2019-05-132019-05-14_custom_ServicesAgreementMember_custom_DrKenyonMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">4,250</ix:nonFraction></span> (<span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_dp_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DrKenyonMember_zAyY4CSuklcf" title="Market price"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" contextRef="From2019-05-132019-05-14_custom_ServicesAgreementMember_custom_DrKenyonMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction>%</span> of the closing market price of the Company&#8217;s common stock on May 14, 2019, the
date of approval of such grant by the Company&#8217;s board of directors), (ii) <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember__us-gaap--AwardTypeAxis__custom--InitialKenyonRSUsMember_pdd" title="Restricted stock shares of common stock"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" contextRef="From2019-05-132019-05-14_custom_ServicesAgreementMember_custom_InitialKenyonRSUsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">20</ix:nonFraction></span> restricted stock units of the Company (the &#8220;Initial
Kenyon RSUs&#8221;), and (iii) an additional <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember__us-gaap--AwardTypeAxis__custom--AdditionalKenyonRSUsMember_pdd" title="Restricted stock shares of common stock"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" contextRef="From2019-05-132019-05-14_custom_ServicesAgreementMember_custom_AdditionalKenyonRSUsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">20</ix:nonFraction></span> restricted stock units of the Company (the &#8220;Additional Kenyon RSUs&#8221;). Such
options and restricted stock units were granted pursuant to the 2019 Plan approved by the Company&#8217;s board of directors on the Effective
Date. <span id="xdx_90F_ecustom--OptionsVestedDescription_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DrKenyonMember" title="Options vested, description"><ix:nonNumeric contextRef="From2019-05-132019-05-14_custom_ServicesAgreementMember_custom_DrKenyonMember" name="PPCB:OptionsVestedDescription">The Kenyon Options have a term of <span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DrKenyonMember_zbf0Whz1LJM3"><ix:nonNumeric contextRef="From2019-05-132019-05-14_custom_ServicesAgreementMember_custom_DrKenyonMember" format="ixt-sec:durwordsen" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">10 years</ix:nonNumeric></span> from the date of grant. 1/3rd of the Kenyon Options shall vest every successive one-year
anniversary following the Effective Date, provided, that on each such vesting date Dr. Kenyon is employed by the Company and subject
to the other provisions of the Services Agreement. The Initial Kenyon RSUs shall vest on the one-year anniversary of the Effective Date,
subject to Dr. Kenyon&#8217;s continued employment with the Company through such vesting date. The Additional Kenyon RSUs will vest as
follows, subject to Dr. Kenyon&#8217;s continued employment with the Company through the applicable vesting date: (i) <span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember__us-gaap--AwardTypeAxis__custom--AdditionalKenyonRSUsMember_pdd" title="Rsus vest, shares"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" contextRef="From2019-05-132019-05-14_custom_ServicesAgreementMember_custom_AdditionalKenyonRSUsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5</ix:nonFraction></span> of the Additional
Kenyon RSUs shall vest upon the Company submitting the CTA for PRP for the Study in an applicable jurisdiction to be selected by the
Company, (ii) 5 of the Additional Kenyon RSUs shall vest upon the Company completing an equity financing in the amount of at least $<span id="xdx_900_ecustom--GrossProceedsFromEquityFinancing_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember__us-gaap--AwardTypeAxis__custom--AdditionalKenyonRSUsMember_pp0p0" title="Gross proceeds from equity financing"><ix:nonFraction name="PPCB:GrossProceedsFromEquityFinancing" contextRef="From2019-05-132019-05-14_custom_ServicesAgreementMember_custom_AdditionalKenyonRSUsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,000,000</ix:nonFraction></span>
in gross proceeds, (iii) 5 of the Additional Kenyon RSUs shall vest upon the shares o</ix:nonNumeric></span>f the Company&#8217;s Common Stock being listed
on a senior stock exchange (NYSE, NYSEMKT or NASDAQ), and (iv) the remaining 5 of the Additional Kenyon RSUs shall vest upon the Company
enrolling its first patient in the Study. Each vested Kenyon RSU shall be settled by delivery to Mr. Kenyon of one share of the Company&#8217;s
common stock and/or the fair market value of one share of common stock in cash, at the sole discretion of the Company&#8217;s board of
directors and subject to the Plan, on the first to occur of: (i) the date of a Change of Control (as defined in the Services Agreement),
(ii) the date that is ten business days following the vesting of such Kenyon RSU, (iii) the date of Dr. Kenyon&#8217;s death or Disability
(as defined in the Services Agreement), and (iv) Dr. Kenyon&#8217;s employment being terminated either by the Company without Cause or
by Dr. Kenyon for Good Reason (as defined in the Services Agreement). In the event of a Change of Control (as defined in the Services
Agreement), 50% of any unvested portion of the Kenyon Options and the Kenyon RSUs shall vest immediately prior to such event. As of June
30, 2021, total accrued salaries of $<span id="xdx_904_eus-gaap--AccruedSalariesCurrent_iI_pp0p0_uAUD_c20210630__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember_zrdYDlvBc9yl" title="Accrued salaries"><ix:nonFraction name="us-gaap:AccruedSalariesCurrent" contextRef="AsOf2021-06-30_custom_AUDCurrenryMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="AUD">135,000</ix:nonFraction></span> AUD ($<span id="xdx_908_eus-gaap--AccruedSalariesCurrent_c20210630_pp0p0" title="Accrued salaries"><ix:nonFraction name="us-gaap:AccruedSalariesCurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">101,250</ix:nonFraction></span> USD) is included in accrued expenses in the accompanying consolidated balance
sheet. The <span id="xdx_907_ecustom--StockToBeIssuedDuringPeriodValueRestrictedStockUnit_c20200701__20210630__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember_pdd" title="Restricted stock unit issuable"><ix:nonFraction name="PPCB:StockToBeIssuedDuringPeriodValueRestrictedStockUnit" contextRef="From2020-07-012021-06-30_custom_ServicesAgreementMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">20</ix:nonFraction></span> vested restricted stock unit are considered issuable as of June 30, 2021. On August 12, 2021, pursuant to the Cancellation
Agreement, Mr. Kenyon agreed to cancel accrued salaries of $<span id="xdx_90B_ecustom--CancellationOfAccruedSalaries_iI_dtY_c20210812__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DrKenyonMember_zaJwBxkt21Pl" title="Cancellation of accrued salary"><ix:nonFraction name="PPCB:CancellationOfAccruedSalaries" contextRef="AsOf2021-08-12_custom_ServicesAgreementMember_custom_DrKenyonMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">102,600</ix:nonFraction></span> in exchange for <span id="xdx_90D_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_pid_c20210811__20210812__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DrKenyonMember_zqr3diXViojd"><ix:nonFraction name="us-gaap:DebtConversionConvertedInstrumentSharesIssued1" contextRef="From2021-08-112021-08-12_custom_ServicesAgreementMember_custom_DrKenyonMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,420,000</ix:nonFraction></span> shares of the common stock of the Company
(see Note 13).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="text-decoration: underline">Intercompany
Loans</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">All
Intercompany loans were made by the parent to the subsidiary, Propanc PTY LTD, which have not been repaid as of June 30, 2021. Effective
fiscal year 2021, the parent company determined that intercompany loans will not be repaid in the foreseeable future and thus, per ASC
830-20-35-3, gains and losses from measuring the intercompany balances are recorded within cumulative translation adjustment, a component
of other comprehensive income. Prior to July 1, 2020, the Company recorded the foreign currency transaction gains and losses from measuring
the intercompany balances as a component of other income (expenses) as reflected in the consolidated statements of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-07-012021-06-30" escape="true" name="us-gaap:ConcentrationRiskDisclosureTextBlock"><p id="xdx_809_eus-gaap--ConcentrationRiskDisclosureTextBlock_zUlOBh1Ivd83" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>NOTE
11 &#8211; <span id="xdx_826_z7NVN5D24Jra">CONCENTRATIONS AND RISKS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="text-decoration: underline">Concentration
of Credit Risk</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
Company maintains its cash in banks and financial institutions in Australia. Bank deposits in Australian banks are uninsured. The Company
has not experienced any losses in such accounts through June 30, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">In fiscal year 2020,
t<span style="font: 10pt Times New Roman, Times, Serif">he</span><span style="font: 10pt Times New Roman, Times, Serif">
<span style="color: Black">Company currently primarily relied on funding from three convertible debt lenders. Proceeds received
during the year ended June 30, 2020 from each of the three lenders were $<span id="xdx_901_eus-gaap--ProceedsFromConvertibleDebt_pp0p0_c20190701__20200630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LenderOneMember_zjFGEVsziRX5"><ix:nonFraction name="us-gaap:ProceedsFromConvertibleDebt" contextRef="From2019-07-012020-06-30_custom_LenderOneMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">285,000</ix:nonFraction></span></span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">,
$<span id="xdx_90E_eus-gaap--ProceedsFromConvertibleDebt_pp0p0_c20190701__20200630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LenderTwoMember_zPljXdu1OvH2"><ix:nonFraction name="us-gaap:ProceedsFromConvertibleDebt" contextRef="From2019-07-012020-06-30_custom_LenderTwoMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">505,000</ix:nonFraction></span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">,
and $<span id="xdx_909_eus-gaap--ProceedsFromConvertibleDebt_pp0p0_c20190701__20200630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LenderThreeMember_zey8X6YvWZn"><ix:nonFraction name="us-gaap:ProceedsFromConvertibleDebt" contextRef="From2019-07-012020-06-30_custom_LenderThreeMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">227,000</ix:nonFraction></span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">,
respectively, which represents approximately <span id="xdx_90E_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20200630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LenderOneMember_zKzuIYfnun9f"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2020-06-30_custom_LenderOneMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">19</ix:nonFraction>%</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">,
<span id="xdx_90B_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20200630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LenderTwoMember_zXKBdCalnNLb"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2020-06-30_custom_LenderTwoMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">34</ix:nonFraction>%
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">and <span id="xdx_900_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20200630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LenderThreeMember_zRiTLuHUpeml"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2020-06-30_custom_LenderThreeMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">15</ix:nonFraction>%</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">,
respectively of total proceeds received by the Company during fiscal year 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">In fiscal year 2021,
the Company primarily relied on funding from two convertible debt lenders and received net proceeds after
deductions of $<span id="xdx_900_eus-gaap--AmortizationOfFinancingCostsAndDiscounts_pp0p0_c20200701__20210630_zapu3rw2nnQ9" title="Discounts and debt issuance cost"><ix:nonFraction name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">16,000</ix:nonFraction></span> for original issue discounts and debt issue costs during the year ended June 30, 2021 from each of the two
lenders of $<span id="xdx_905_eus-gaap--ProceedsFromConvertibleDebt_pp0p0_c20200701__20210630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LenderOneMember_z0TkhjhwVrB1"><ix:nonFraction name="us-gaap:ProceedsFromConvertibleDebt" contextRef="From2020-07-012021-06-30_custom_LenderOneMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">125,000</ix:nonFraction> </span>and
$<span id="xdx_903_eus-gaap--ProceedsFromConvertibleDebt_pp0p0_c20200701__20210630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LenderTwoMember_zDSyxdHJZdXd"><span style="-sec-ix-hidden: xdx2ixbrl2392">200,000, </span></span>respectively,
which represents approximately <span id="xdx_900_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20210630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LenderOneMember_zsdoBHfYPX4f"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2021-06-30_custom_LenderOneMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">39</ix:nonFraction>%</span>, and <span id="xdx_904_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20210630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LenderTwoMember_zunB0KEfvbt5"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2021-06-30_custom_LenderTwoMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">61</ix:nonFraction>%, </span>respectively
of total proceeds received by the Company during fiscal year 2021.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="text-decoration: underline">Receivable
Concentration</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">As
of June 30, 2021 and 2020, the Company&#8217;s receivables were <span id="xdx_908_ecustom--ReimbursementOnGoodsAndServiceTaxReceivablePercentage_dp_c20200701__20210630_zepQavbUoNN8" title="Reimbursement on goods and service tax receivable percentage"><span id="xdx_90A_ecustom--ReimbursementOnGoodsAndServiceTaxReceivablePercentage_dp_c20190701__20200630_zvXSLqq0YQgb" title="Reimbursement on goods and service tax receivable percentage"><ix:nonFraction name="PPCB:ReimbursementOnGoodsAndServiceTaxReceivablePercentage" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure"><ix:nonFraction name="PPCB:ReimbursementOnGoodsAndServiceTaxReceivablePercentage" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></ix:nonFraction>%</span></span> related to reimbursements on GST taxes paid.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<ix:exclude><!-- Field: Page; Sequence: 125; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>PROPANC
BIOPHARMA, INC. AND SUBSIDIARY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>June
30, 2021 and 2020</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="text-decoration: underline">Patent
and Patent Concentration</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
Company has filed multiple patent applications relating to its lead product, PRP. The Company&#8217;s lead patent application has been
granted and remains in force in the United States, Belgium, Czech Republic, Denmark, France, Germany, Ireland, Italy, Netherlands, Portugal,
Spain, Sweden, Switzerland, Liechtenstein, Turkey, United Kingdom, Australia, China, Japan, Indonesia, Israel, New Zealand, Singapore,
Malaysia, South Africa, Mexico, Republic of Korea, India and Brazil. In  Canada, the patent application remains
under examination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">In
2016 and early 2017, we filed other patent applications. Three applications were filed under the Patent Cooperation Treaty (the &#8220;PCT&#8221;).
The PCT assists applicants in seeking patent protection by filing one international patent application under the PCT, applicants can
simultaneously seek protection for an invention in over 150 countries. Once filed, the application is placed under the control of the
national or regional patent offices, as applicable, in what is called the national phase. One of the PCT applications filed in November
2016, entered national phase in July 2018 and another PCT application is currently entering national phase in August 2018. A third PCT
application entered the national phase in October 2018.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">In
July 2020, a world first patent was granted in Australia for the cancer treatment method patent family. Presently, there are 31
granted patents and 34 patents under examination in key global jurisdictions relating to the use of proenzymes against solid tumors,
covering the lead product candidate PRP.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Further
patent applications are expected to be filed to capture and protect additional patentable subject matter based on the Company&#8217;s
field of technology relating to pharmaceutical compositions of proenzymes for treating cancer.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="text-decoration: underline">Foreign
Operations</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 29.15pt; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">As
of June 30, 2021 and 2020, the Company&#8217;s operations are based in Camberwell, Australia, however the majority of research and development
is being conducted in the European Union.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 29.15pt; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">On
July 22, 2016, the Company formed a wholly owned subsidiary, Propanc (UK) Limited under the laws of England and Wales for the purpose
of submitting an orphan drug application with the European Medicines Agency as a small and medium-sized enterprise. As of June 30, 2021
and 2020, there has been no activity within this entity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-07-012021-06-30" escape="true" name="us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"><p id="xdx_803_eus-gaap--DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_zlYx3T8dti75" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>NOTE
12 - <span id="xdx_82F_zRHtpfFjjGs1">DERIVATIVE FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><i>Derivative
Financial Instruments:</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
Company applies the provisions of ASC 815-40, <i>Contracts in Entity&#8217;s Own Equity</i>, under which convertible instruments and
warrants, which contain terms that protect holders from declines in the stock price (reset provisions), may not be exempt from derivative
accounting treatment. As a result, warrants and embedded conversion options in convertible debt are recorded as a liability and are revalued
at fair value at each reporting date. If the fair value of the warrants exceeds the face value of the related debt, the excess is recorded
as change in fair value in operations on the issuance date. The Company had $<span id="xdx_904_eus-gaap--ConvertibleDebt_c20210630__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--ConvertibleDebtMember_pp0p0" title="Convertible debt"><ix:nonFraction name="us-gaap:ConvertibleDebt" contextRef="AsOf2021-06-30_us-gaap_ConvertibleDebtMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">80,000</ix:nonFraction></span> (1 note) and $<span id="xdx_905_eus-gaap--ConvertibleDebt_c20200630__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--ConvertibleDebtMember_pp0p0" title="Convertible debt"><ix:nonFraction name="us-gaap:ConvertibleDebt" contextRef="AsOf2020-06-30_us-gaap_ConvertibleDebtMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">126,500</ix:nonFraction></span> (3 notes) of convertible debt,
which is treated as derivative instruments outstanding at June 30, 2021 and 2020 respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
Company calculates the estimated fair values of the liabilities for derivative instruments using the Binomial Trees Method. The closing
price of the Company&#8217;s common stock at June 30, 2021, the last trading day of the fiscal year ended June 30, 2021, was $<span id="xdx_90E_eus-gaap--SharePrice_c20210630_pdd"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0517</ix:nonFraction></span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">.
Volatility, expected remaining term and risk-free interest rates used to estimate the fair value of derivative liabilities at June 30,
2021 and 2020 are indicated in the table that follows. The expected term is equal to the remaining term of the warrants or convertible
instruments and the risk free rate is based upon rates for treasury securities with the same term.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<ix:nonNumeric contextRef="From2020-07-012021-06-30" escape="true" name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"><p id="xdx_899_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_zFxlxLM00prd" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_8BA_zmBowUwCLaxi" style="display: none">SCHEDULE OF FAIR VALUE MEASUREMENTS, RECURRING AND NONRECURRING, VALUATION TECHNIQUES</span><span style="font: 10pt Times New Roman, Times, Serif; color: Black"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>Convertible
Debt</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>&#160;</b></span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center"><b>Initial Valuations during the year ended June 30, 2021</b></td>
    <td style="padding-bottom: 1.5pt; text-align: center"><b>&#160;</b></td>
    <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><p style="text-align: center; margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>Initial<br />
                                            Valuations</b></span></p>
                                                                                <p style="text-align: center; margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>during</b></span></p>
                                                                                <p style="text-align: center; margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>the
                                            year ended June 30, 2020</b></span></p></td>
    <td>&#160;</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>June
    30, 2021</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>June
    30, 2020</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>&#160;</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 35%"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Volatility</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="text-align: center; width: 13%">N/A</td>
    <td style="width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 13%; vertical-align: bottom"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90C_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_uPure_c20200630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__srt--RangeAxis__srt--MinimumMember_znsZSskEF4vh" title="Debt instrument, measurement input, percentages"><ix:nonFraction name="us-gaap:DebtInstrumentMeasurementInput" contextRef="AsOf2020-06-30_us-gaap_MeasurementInputPriceVolatilityMember_srt_MinimumMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">227</ix:nonFraction></span>-<span id="xdx_902_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_uPure_c20200630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__srt--RangeAxis__srt--MaximumMember_z19zgrt6LIge" title="Debt instrument, measurement input, percentages"><ix:nonFraction name="us-gaap:DebtInstrumentMeasurementInput" contextRef="AsOf2020-06-30_us-gaap_MeasurementInputPriceVolatilityMember_srt_MaximumMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">279</ix:nonFraction></span></span></td>
    <td style="width: 1%">%</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 13%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span id="xdx_902_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_uPure_c20210630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember_z8qKxb6rq01j" title="Debt instrument, measurement input, percentages"><ix:nonFraction name="us-gaap:DebtInstrumentMeasurementInput" contextRef="AsOf2021-06-30_us-gaap_MeasurementInputPriceVolatilityMember_us-gaap_ConvertibleDebtMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">222</ix:nonFraction></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">%</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 13%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span id="xdx_90A_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_uPure_c20200630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember_zsocWzw9v8mc" title="Debt instrument, measurement input, percentages"><ix:nonFraction name="us-gaap:DebtInstrumentMeasurementInput" contextRef="AsOf2020-06-30_us-gaap_MeasurementInputPriceVolatilityMember_us-gaap_ConvertibleDebtMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">264</ix:nonFraction></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">%</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Expected
    remaining term</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="text-align: center">N/A</td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom"><span id="xdx_90C_eus-gaap--DebtInstrumentTerm_dtY_c20190701__20200630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_zg9nuItaB5A3" title="Debt instrument, measurement input, term"><ix:nonNumeric contextRef="From2019-07-012020-06-30_us-gaap_MeasurementInputExpectedTermMember" format="ixt-sec:duryear" name="us-gaap:DebtInstrumentTerm">1.00</ix:nonNumeric></span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span id="xdx_902_eus-gaap--DebtInstrumentTerm_dtY_c20200701__20210630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember_ziMIM80sCzJ9" title="Debt instrument, measurement input, term"><ix:nonNumeric contextRef="From2020-07-012021-06-30_us-gaap_MeasurementInputExpectedTermMember_us-gaap_ConvertibleDebtMember" format="ixt-sec:duryear" name="us-gaap:DebtInstrumentTerm">0.01</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span id="xdx_904_eus-gaap--DebtInstrumentTerm_dtY_c20190701__20200630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember__srt--RangeAxis__srt--MinimumMember_zQq0IiYT0cn5" title="Debt instrument, measurement input, term"><ix:nonNumeric contextRef="From2019-07-012020-06-30_us-gaap_MeasurementInputExpectedTermMember_us-gaap_ConvertibleDebtMember_srt_MinimumMember" format="ixt-sec:duryear" name="us-gaap:DebtInstrumentTerm">0.01</ix:nonNumeric></span>
    &#8211; <span id="xdx_901_eus-gaap--DebtInstrumentTerm_dtY_c20190701__20200630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember__srt--RangeAxis__srt--MaximumMember_zRzEN0YrwSO1" title="Debt instrument, measurement input, term"><ix:nonNumeric contextRef="From2019-07-012020-06-30_us-gaap_MeasurementInputExpectedTermMember_us-gaap_ConvertibleDebtMember_srt_MaximumMember" format="ixt-sec:duryear" name="us-gaap:DebtInstrumentTerm">0.70</ix:nonNumeric></span> </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Risk-free
    interest rate</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="text-align: center">N/A</td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90D_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_uPure_c20200630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MinimumMember_zG2WLbhXC174" title="Debt instrument, measurement input, percentages"><ix:nonFraction name="us-gaap:DebtInstrumentMeasurementInput" contextRef="AsOf2020-06-30_us-gaap_MeasurementInputRiskFreeInterestRateMember_srt_MinimumMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">1.53</ix:nonFraction></span>
    &#8211; <span id="xdx_905_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_uPure_c20200630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MaximumMember_zeQQCpHn9Oo3" title="Debt instrument, measurement input, percentages"><ix:nonFraction name="us-gaap:DebtInstrumentMeasurementInput" contextRef="AsOf2020-06-30_us-gaap_MeasurementInputRiskFreeInterestRateMember_srt_MaximumMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">1.59</ix:nonFraction></span></span></td>
    <td>%</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span id="xdx_902_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_uPure_c20210630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember_z7Aep2hS9Ss4" title="Debt instrument, measurement input, percentages"><ix:nonFraction name="us-gaap:DebtInstrumentMeasurementInput" contextRef="AsOf2021-06-30_us-gaap_MeasurementInputRiskFreeInterestRateMember_us-gaap_ConvertibleDebtMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">0.05</ix:nonFraction></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">%</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span id="xdx_901_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_uPure_c20200630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember__srt--RangeAxis__srt--MinimumMember_zJYF6qi0vIO4" title="Debt instrument, measurement input, percentages"><ix:nonFraction name="us-gaap:DebtInstrumentMeasurementInput" contextRef="AsOf2020-06-30_us-gaap_MeasurementInputRiskFreeInterestRateMember_us-gaap_ConvertibleDebtMember_srt_MinimumMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">0.13</ix:nonFraction></span>
    &#8211; <span id="xdx_90D_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_uPure_c20200630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember__srt--RangeAxis__srt--MaximumMember_zQagw6Ahxvq1" title="Debt instrument, measurement input, percentages"><ix:nonFraction name="us-gaap:DebtInstrumentMeasurementInput" contextRef="AsOf2020-06-30_us-gaap_MeasurementInputRiskFreeInterestRateMember_us-gaap_ConvertibleDebtMember_srt_MaximumMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">0.18</ix:nonFraction></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">%</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Expected
    dividend yield</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="text-align: center">N/A</td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_904_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_dn_uPure_c20200630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zM4oKsxZoZOi" title="Debt instrument, measurement input, percentages"><ix:nonFraction name="us-gaap:DebtInstrumentMeasurementInput" contextRef="AsOf2020-06-30_us-gaap_MeasurementInputExpectedDividendRateMember" format="ixt-sec:numwordsen" decimals="INF" unitRef="Pure">None</ix:nonFraction></span></span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span id="xdx_901_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_dpn_uPure_c20210630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember_zPYMAAUfdnC9" title="Debt instrument, measurement input, percentages"><ix:nonFraction name="us-gaap:DebtInstrumentMeasurementInput" contextRef="AsOf2021-06-30_us-gaap_MeasurementInputExpectedDividendRateMember_us-gaap_ConvertibleDebtMember" format="ixt-sec:numwordsen" decimals="INF" scale="-2" unitRef="Pure">None</ix:nonFraction></span>
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span id="xdx_907_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_dn_uPure_c20200630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember_zcJ0FN6PYQYf" title="Debt instrument, measurement input, percentages"><ix:nonFraction name="us-gaap:DebtInstrumentMeasurementInput" contextRef="AsOf2020-06-30_us-gaap_MeasurementInputExpectedDividendRateMember_us-gaap_ConvertibleDebtMember" format="ixt-sec:numwordsen" decimals="INF" unitRef="Pure">None</ix:nonFraction></span>
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8AD_zppbwSBc0Qc6" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<ix:exclude><!-- Field: Page; Sequence: 126; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>PROPANC
BIOPHARMA, INC. AND SUBSIDIARY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>June
30, 2021 and 2020</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><i>Fair
Value Measurements:</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
Company measures and reports at fair value the liability for derivative instruments. The fair value liabilities for price adjustable
warrants and embedded conversion options have been recorded as determined utilizing the Binomial Trees model. The following tables summarize
the Company&#8217;s financial assets and liabilities measured at fair value on a recurring basis as of June 30, 2021:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<ix:nonNumeric contextRef="From2020-07-012021-06-30" escape="true" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"><p id="xdx_891_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_zj10hCQnfo2k" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-right: 0; margin-bottom: 0; text-align: left; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span><span id="xdx_8BC_zhgIJsNvoEFe" style="display: none">SCHEDULE OF FAIR VALUE, ASSETS AND LIABILITIES MEASURED ON RECURRING BASIS</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Balance
    at<br /> June 30, 2021</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1.8pt 0 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Quoted</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1.8pt 0 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Prices</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1.8pt 0 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>in
    Active</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1.8pt 0 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Markets
    for</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1.8pt 0 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Identical
    Assets</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1.8pt 0 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Significant</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1.8pt 0 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Other</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1.8pt 0 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Observable
    Inputs</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1.8pt 0 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Significant</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1.8pt 0 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Unobservable
    Inputs</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>(Level
    1)</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>(Level
    2)</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>(Level
    3)</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 36%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Embedded
    conversion option liabilities</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td id="xdx_981_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_c20210630_pp0p0" title="Embedded conversion option liabilities" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">54,220</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td id="xdx_98A_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_c20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_pp0p0" title="Embedded conversion option liabilities" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl2445">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td id="xdx_98B_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_c20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_pp0p0" title="Embedded conversion option liabilities" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl2447">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td id="xdx_98C_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_c20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_pp0p0" title="Embedded conversion option liabilities" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" contextRef="AsOf2021-06-30_us-gaap_FairValueInputsLevel3Member" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">54,220</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Total</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td id="xdx_98D_eus-gaap--DerivativeLiabilities_c20210630_pp0p0" title="Total" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:DerivativeLiabilities" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">54,220</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td id="xdx_98B_eus-gaap--DerivativeLiabilities_c20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_pp0p0" title="Total" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl2453">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td id="xdx_983_eus-gaap--DerivativeLiabilities_c20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_pp0p0" title="Total" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl2455">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td id="xdx_982_eus-gaap--DerivativeLiabilities_c20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_pp0p0" title="Total" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:DerivativeLiabilities" contextRef="AsOf2021-06-30_us-gaap_FairValueInputsLevel3Member" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">54,220</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
following tables summarize the Company&#8217;s financial assets and liabilities measured at fair value on a recurring basis as of June
30, 2020:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Balance
    at<br /> June 30, 2020</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1.8pt 0 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Quoted</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1.8pt 0 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Prices</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1.8pt 0 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>in
    Active</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1.8pt 0 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Markets
    for</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1.8pt 0 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Identical
    Assets</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1.8pt 0 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Significant</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1.8pt 0 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Other</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1.8pt 0 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Observable
    Inputs</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1.8pt 0 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Significant</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1.8pt 0 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Unobservable
    Inputs</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>(Level
    1)</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>(Level
    2)</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>(Level
    3)</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 36%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Embedded
    conversion option liabilities</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td id="xdx_982_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_c20200630_pp0p0" title="Embedded conversion option liabilities" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">177,009</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td id="xdx_989_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_c20200630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_pp0p0" title="Embedded conversion option liabilities" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl2461">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td id="xdx_98A_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_c20200630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_pp0p0" title="Embedded conversion option liabilities" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl2463">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td id="xdx_98B_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_c20200630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_pp0p0" title="Embedded conversion option liabilities" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" contextRef="AsOf2020-06-30_us-gaap_FairValueInputsLevel3Member" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">177,009</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Total</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td id="xdx_98C_eus-gaap--DerivativeLiabilities_c20200630_pp0p0" title="Total" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:DerivativeLiabilities" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">177,009</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td id="xdx_98A_eus-gaap--DerivativeLiabilities_c20200630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_pp0p0" title="Total" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl2469">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td id="xdx_98B_eus-gaap--DerivativeLiabilities_c20200630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_pp0p0" title="Total" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl2471">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td id="xdx_983_eus-gaap--DerivativeLiabilities_c20200630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_pp0p0" title="Total" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:DerivativeLiabilities" contextRef="AsOf2020-06-30_us-gaap_FairValueInputsLevel3Member" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">177,009</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8AA_zSRvajH3Hwag" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<ix:nonNumeric contextRef="From2020-07-012021-06-30" escape="true" name="us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock"><p id="xdx_898_eus-gaap--ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_zwnWqsCQ67Ea" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
following is a roll forward for the years ended June 30, 2021 and 2020 of the fair value liability of price adjustable derivative instruments:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-right: 0; margin-bottom: 0; text-align: left; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span><span id="xdx_8B1_zUG1Rm1Y5kic" style="display: none">SCHEDULE OF DERIVATIVE LIABILITIES AT FAIR VALUE</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Fair
    Value of</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Liability
    for</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Derivative</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Instruments</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; width: 82%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Balance
    at June 30, 2019</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td id="xdx_984_eus-gaap--DerivativeLiabilities_iS_pp0p0_c20190701__20200630_zclpqGLBOnAf" title="Balance at Beginning" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:DerivativeLiabilities" contextRef="AsOf2019-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">698,264</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Reductions
    due to conversions</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td id="xdx_989_ecustom--ReductionsDueToConversions_c20190701__20200630_pp0p0" title="Reductions due to conversions" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(<ix:nonFraction name="PPCB:ReductionsDueToConversions" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">362,962</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Initial
    fair value of embedded conversion option derivative liability recorded as debt discount</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td id="xdx_986_ecustom--FairValueOfWarrantDerivativeLiabilityRecorededAsDebtDiscount_c20190701__20200630_pp0p0" title="Initial fair value of embedded conversion option derivative liability recorded as debt discount" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="PPCB:FairValueOfWarrantDerivativeLiabilityRecorededAsDebtDiscount" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">227,000</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Initial
    fair value of embedded conversion option derivative liability recorded as expense</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td id="xdx_983_ecustom--InitialFairValueOfEmbeddedConversionOptionDerivativeLiabilityRecordedAsExpense_c20190701__20200630_pp0p0" title="Initial fair value of embedded conversion option derivative liability recorded as expense" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="PPCB:InitialFairValueOfEmbeddedConversionOptionDerivativeLiabilityRecordedAsExpense" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">351,461</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Change
    in fair value included in statements of operations</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td id="xdx_98B_eus-gaap--EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet_c20190701__20200630_pp0p0" title="Change in fair value included in statements of operations" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(<ix:nonFraction name="us-gaap:EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet" contextRef="From2019-07-012020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">736,754</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Balance
    at June 30, 2020</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td id="xdx_982_eus-gaap--DerivativeLiabilities_iS_pp0p0_c20200701__20210630_zUMVWyInRydk" title="Balance at Beginning" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:DerivativeLiabilities" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">177,009</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Gain
    on debt extinguishment</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td id="xdx_985_ecustom--GainOnDebtExtinguishment_c20200701__20210630_pp0p0" title="Gain on debt extinguishment" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(<ix:nonFraction name="PPCB:GainOnDebtExtinguishment" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">130,975</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Change
    in fair value included in statements of operations</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td id="xdx_982_eus-gaap--EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet_c20200701__20210630_pp0p0" title="Change in fair value included in statements of operations" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">8,186</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Balance
    at June 30, 2021</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td id="xdx_988_eus-gaap--DerivativeLiabilities_iE_pp0p0_c20200701__20210630_zSqnvtpNZU1f" title="Balance at Ending" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><ix:nonFraction name="us-gaap:DerivativeLiabilities" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">54,220</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8A0_zsQ5mF78ITza" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-07-012021-06-30" escape="true" name="us-gaap:SubsequentEventsTextBlock"><p id="xdx_807_eus-gaap--SubsequentEventsTextBlock_zrHwINm5xEU3" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>NOTE
13 &#8211; <span id="xdx_82D_zExNzAej8vwe">SUBSEQUENT EVENTS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><i>Exercise
of Warrants</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">From
July 9, 2021 through September 7, 2021, the Company received aggregate gross proceeds of $<span id="xdx_907_eus-gaap--ProceedsFromWarrantExercises_pp0p0_c20210709__20210907__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_za2JIYRtppHf"><ix:nonFraction name="us-gaap:ProceedsFromWarrantExercises" contextRef="From2021-07-092021-09-07_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">275,000</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">from the exercise of <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20210709__20210907__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantsMember_zvTZEwTOekzb"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="From2021-07-092021-09-07_us-gaap_SubsequentEventMember_custom_SeriesBWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,875</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Series B Warrants and issued
<span id="xdx_903_eus-gaap--CommonStockSharesIssued_iI_c20210907__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantsMember_z4LaYCMacYo3"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2021-09-07_us-gaap_SubsequentEventMember_custom_SeriesBWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,875</ix:nonFraction></span> shares of common stock. Additionally, the Company issued <span id="xdx_90B_eus-gaap--CommonStockSharesIssued_iI_c20210907__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementClassOfStockAxis__custom--TwelveSeriesAAndAWarrantsMember_zclCoonFaZeg"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2021-09-07_us-gaap_SubsequentEventMember_custom_TwelveSeriesAAndAWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,399,988</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">shares of common stock from the
alternate cashless exercise of 12 Series A warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><i>Note
Conversions</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">From
July 1, 2021 through September 20, 2021, the Company issued an aggregate of <span id="xdx_901_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_pid_c20210701__20210920__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zM9BmClAOoXg"><ix:nonFraction name="us-gaap:DebtConversionConvertedInstrumentSharesIssued1" contextRef="From2021-07-012021-09-20_us-gaap_SubsequentEventMember_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,702,152</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">shares of its common stock
at an average contractual conversion price of $<span id="xdx_90A_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20210920__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zpuhDyv8ks4e"><ix:nonFraction name="us-gaap:DebtInstrumentConvertibleConversionPrice1" contextRef="AsOf2021-09-20_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.02</ix:nonFraction></span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">,
ranging from $<span id="xdx_907_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20210920__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--RangeAxis__srt--MinimumMember_zHKmVoo31Uv1"><ix:nonFraction name="us-gaap:DebtInstrumentConvertibleConversionPrice1" contextRef="AsOf2021-09-20_us-gaap_SubsequentEventMember_srt_MinimumMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.01</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">to $<span id="xdx_906_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20210920__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--RangeAxis__srt--MaximumMember_z0wFtzRzYlCj"><ix:nonFraction name="us-gaap:DebtInstrumentConvertibleConversionPrice1" contextRef="AsOf2021-09-20_us-gaap_SubsequentEventMember_srt_MaximumMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.04</ix:nonFraction></span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">,
as a result of the conversion of principal of $<span id="xdx_90B_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20210920__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zpA0O2qvXElh"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2021-09-20_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">146,348</ix:nonFraction></span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">,
</span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">interest of $<span id="xdx_90F_eus-gaap--InterestPayableCurrent_iI_pp0p0_c20210920__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z0M9VSiaK0D8"><ix:nonFraction name="us-gaap:InterestPayableCurrent" contextRef="AsOf2021-09-20_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,887</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">and conversion fees $<span id="xdx_90E_ecustom--ConversionFees_pp0p0_c20210701__20210920__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zp2IC1QmR0fe"><ix:nonFraction name="PPCB:ConversionFees" contextRef="From2021-07-012021-09-20_us-gaap_SubsequentEventMember_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,250</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">underlying certain outstanding
convertible notes converted during such period. The Company reclassified $<span id="xdx_900_eus-gaap--AdditionalPaidInCapital_iI_pp0p0_c20210923__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z1yVPDDia61c"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2021-09-23_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">86,219</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">in put premiums to additional
paid in capital following conversions between July 2021 and September 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<ix:exclude><!-- Field: Page; Sequence: 127; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>PROPANC
BIOPHARMA, INC. AND SUBSIDIARY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>June
30, 2021 and 2020</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><i>Nathanielsz
Cancellation Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">On
August 12, 2021, the Company entered into a Cancellation Agreement with James Nathanielsz (&#8220;Nathanielsz&#8221;), Chief Executive
Officer and Director of the Company, whereby Nathanielsz agreed to cancel his cash compensation bonus award for fiscal year 2021, ended
June 30, 2021, in exchange for common stock of the Company. The Company and Nathanielsz entered into an Amended and Restated Employment
Agreement dated May 14, 2019 (the &#8220;Agreement&#8221;). Pursuant to the terms of the Agreement, Nathanielsz was eligible to earn
an annual fiscal year cash performance bonus for each fiscal year of his employment period with the Company with a target performance
bonus of <span id="xdx_903_ecustom--PercentageOfBonusOfAnnualBaseSalary_dp_uPure_c20210811__20210812__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--NathanielszCancellationAgreementMember_z0T2IuWy3sub"><ix:nonFraction name="PPCB:PercentageOfBonusOfAnnualBaseSalary" contextRef="From2021-08-112021-08-12_us-gaap_SubsequentEventMember_custom_NathanielszCancellationAgreementMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">200</ix:nonFraction>%</span> of his average annualized base salary during the fiscal year for which the performance bonus is earned. On July 20, 2021,
Nathanielsz was awarded a &#8220;target&#8221; bonus of <span id="xdx_905_ecustom--PercentageOfBonusOfAnnualBaseSalary_pip0_dp_uPure_c20210719__20210720__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember__us-gaap--TypeOfArrangementAxis__custom--NathanielszCancellationAgreementMember_zYc27273q2X4"><ix:nonFraction name="PPCB:PercentageOfBonusOfAnnualBaseSalary" contextRef="From2021-07-192021-07-20_us-gaap_SubsequentEventMember_custom_MrNathanielszMember_custom_NathanielszCancellationAgreementMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">78</ix:nonFraction>%</span>, or $<span id="xdx_90E_eus-gaap--OfficersCompensation_pp0p0_c20210719__20210720__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember__us-gaap--TypeOfArrangementAxis__custom--NathanielszCancellationAgreementMember_zKxr6FEZST98"><ix:nonFraction name="us-gaap:OfficersCompensation" contextRef="From2021-07-192021-07-20_us-gaap_SubsequentEventMember_custom_MrNathanielszMember_custom_NathanielszCancellationAgreementMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">177,840</ix:nonFraction></span> USD (the &#8220;Debt&#8221;) for the fiscal year ended June
30, 2021, by the Company&#8217;s Board of Directors (the &#8220;Board&#8221;). Pursuant to the Cancellation Agreement, Nathanielsz agreed
to cancel this Debt in exchange for <span id="xdx_903_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_pp0p0_c20210816__20210817__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember__us-gaap--TypeOfArrangementAxis__custom--NathanielszCancellationAgreementMember_zlMMchIbnZ5k"><ix:nonFraction name="us-gaap:DebtConversionConvertedInstrumentSharesIssued1" contextRef="From2021-08-162021-08-17_us-gaap_SubsequentEventMember_custom_MrNathanielszMember_custom_NathanielszCancellationAgreementMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="Shares">5,928,000</ix:nonFraction></span> shares of the common stock of the Company (the &#8220;Shares&#8221;), valued at approximately
$<span id="xdx_90C_eus-gaap--SharePrice_iI_pip0_c20210817__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember__us-gaap--TypeOfArrangementAxis__custom--NathanielszCancellationAgreementMember_zktn7yqOiTjj" title="Share price"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2021-08-17_us-gaap_SubsequentEventMember_custom_MrNathanielszMember_custom_NathanielszCancellationAgreementMember" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.03</ix:nonFraction></span> per share, being the closing price of the stock on the date of grant. The shares were issued on August 17, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><i>Kenyon
Cancellation Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; color: #333333; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">On
August 12, 2021, the Company entered into a Cancellation Agreement with Dr. Julian Kenyon (&#8220;Kenyon&#8221;), Chief Scientific Officer
and Director of the Company, whereby Kenyon agreed to cancel of $<span id="xdx_904_ecustom--CancellationOfAccruedSalaries_iI_c20210812__us-gaap--TypeOfArrangementAxis__custom--KenyonCancellationAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DrKenyonMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zmEuFb0Ox5Ec"><ix:nonFraction name="PPCB:CancellationOfAccruedSalaries" contextRef="AsOf2021-08-12_custom_KenyonCancellationAgreementMember_custom_DrKenyonMember_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">102,600</ix:nonFraction> </span>USD of accrued salary due him as of June 30, 2021, pursuant
to that certain Amended and Restated Services Agreement by and between Kenyon and the Company, dated May 14, 2019, in exchange for <span id="xdx_904_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20210811__20210812__us-gaap--TypeOfArrangementAxis__custom--KenyonCancellationAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DrKenyonMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z8XIK8dugdh3"><ix:nonFraction name="us-gaap:DebtConversionConvertedInstrumentSharesIssued1" contextRef="From2021-08-112021-08-12_custom_KenyonCancellationAgreementMember_custom_DrKenyonMember_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,420,000</ix:nonFraction></span>
shares of common stock of the Company (the &#8220;Shares&#8221;), valued at approximately $<span id="xdx_90B_eus-gaap--SharePrice_iI_c20210812__us-gaap--TypeOfArrangementAxis__custom--KenyonCancellationAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DrKenyonMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zyhhb8K4FDg4"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2021-08-12_custom_KenyonCancellationAgreementMember_custom_DrKenyonMember_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.03</ix:nonFraction></span> per share, being the closing price of
the stock on the date of grant. The shares were issued on August 17, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; color: #333333; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><i>Zelinger
Amended and Restated Director Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">On
August 12, 2021, the Company entered into an Amended and Restated Director Agreement (the &#8220;Director Agreement&#8221;) with Josef
Zelinger (&#8220;Zelinger&#8221;). <span id="xdx_903_ecustom--DescriptionOfEmploymentBenefits_c20210811__20210812__us-gaap--TypeOfArrangementAxis__custom--ZelingerAmendedAndRestatedDirectorAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--JosefZelingerMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zNl4i6Kde5w8" title="Description of employment benefits"><ix:nonNumeric contextRef="From2021-08-112021-08-12_custom_ZelingerAmendedAndRestatedDirectorAgreementMember_custom_JosefZelingerMember_us-gaap_SubsequentEventMember" name="PPCB:DescriptionOfEmploymentBenefits">Pursuant to the terms of the Director Agreement, the Company shall pay Zelinger a base salary of $250.00
AUD per month, payable on the first day of each month. In addition, the Company may compensate Zelinger additional consideration for
advisory services performed by the Director, either in the form of cash or common stock, at the discretion of the Board. The Company
issued <span id="xdx_906_ecustom--CommonStockIssuableShares_iI_c20210630__us-gaap--TypeOfArrangementAxis__custom--ZelingerAmendedAndRestatedDirectorAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--JosefZelingerMember_zBon75o6ZXnc"><ix:nonFraction name="PPCB:CommonStockIssuableShares" contextRef="AsOf2021-06-30_custom_ZelingerAmendedAndRestatedDirectorAgreementMember_custom_JosefZelingerMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,800,000</ix:nonFraction></span> shares of common stock of the Company for accrued director services of $<span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20200701__20210630__us-gaap--TypeOfArrangementAxis__custom--ZelingerAmendedAndRestatedDirectorAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--JosefZelingerMember_zdGzrF2eyRAh"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2020-07-012021-06-30_custom_ZelingerAmendedAndRestatedDirectorAgreementMember_custom_JosefZelingerMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">84,000</ix:nonFraction></span> as of June 30, 2021. The <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20200701__20210630__us-gaap--TypeOfArrangementAxis__custom--ZelingerAmendedAndRestatedDirectorAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--JosefZelingerMember_zJJdBMBN9QQe"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2020-07-012021-06-30_custom_ZelingerAmendedAndRestatedDirectorAgreementMember_custom_JosefZelingerMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,800,000</ix:nonFraction></span> shares
of common stock was valued at approximately $<span id="xdx_90E_eus-gaap--SharePrice_iI_c20210630__us-gaap--TypeOfArrangementAxis__custom--ZelingerAmendedAndRestatedDirectorAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--JosefZelingerMember_zgRYESC6Ujbi"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2021-06-30_custom_ZelingerAmendedAndRestatedDirectorAgreementMember_custom_JosefZelingerMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.03</ix:nonFraction></span> per share, being the closing price of the stock on the date of grant.</ix:nonNumeric></span> The shares were
issued on August 17, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><i>Common
Stock Issued for Services</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">On
August 12, 2021, the Board approved the issuance of <span id="xdx_90D_ecustom--CommonStockIssuableShares_iI_c20210812__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementClassOfStockAxis__custom--CommonStockOneMember_zAepDUmVNjb"><ix:nonFraction name="PPCB:CommonStockIssuableShares" contextRef="AsOf2021-08-12_us-gaap_SubsequentEventMember_custom_CommonStockOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,800,000</ix:nonFraction></span> shares of the Company&#8217;s common stock for bonus payable of $<span id="xdx_900_eus-gaap--AccruedBonusesCurrent_iI_c20210630__us-gaap--StatementClassOfStockAxis__custom--CommonStockOneMember_zIC5h5REOc9d" title="Accrued Bonuses"><ix:nonFraction name="us-gaap:AccruedBonusesCurrent" contextRef="AsOf2021-06-30_custom_CommonStockOneMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">84,000</ix:nonFraction></span>
as of June 30, 2021 to an employee who is the wife of the CEO of the Company. The <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210811__20210812__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementClassOfStockAxis__custom--CommonStockOneMember_zEnAQRCCPkya"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2021-08-112021-08-12_us-gaap_SubsequentEventMember_custom_CommonStockOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,800,000</ix:nonFraction></span> shares of common stock was valued at approximately
$<span id="xdx_906_eus-gaap--SharePrice_iI_c20210812__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementClassOfStockAxis__custom--CommonStockOneMember_zdbjW1IUGO11"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2021-08-12_us-gaap_SubsequentEventMember_custom_CommonStockOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.03</ix:nonFraction></span> per share, being the closing price of the stock on the date of grant. The shares were issued on August 17, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">On
August 12, 2021, the Board approved the issuance of <span id="xdx_902_ecustom--CommonStockIssuableShares_iI_c20210812__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementClassOfStockAxis__custom--CommonStockTwoMember_zpWrojFpxwP2" title="Common Stock Issuable Shares"><ix:nonFraction name="PPCB:CommonStockIssuableShares" contextRef="AsOf2021-08-12_us-gaap_SubsequentEventMember_custom_CommonStockTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">166,667</ix:nonFraction></span> shares of the Company&#8217;s common stock for legal services rendered in
August 2021 worth $<span id="xdx_907_eus-gaap--LegalFees_c20210811__20210812__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementClassOfStockAxis__custom--CommonStockTwoMember_zFdllkl1AT64" title="Legal fees"><ix:nonFraction name="us-gaap:LegalFees" contextRef="From2021-08-112021-08-12_us-gaap_SubsequentEventMember_custom_CommonStockTwoMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,000</ix:nonFraction></span>. The <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210811__20210812__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementClassOfStockAxis__custom--CommonStockTwoMember_zLkBE2Ns90yb"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2021-08-112021-08-12_us-gaap_SubsequentEventMember_custom_CommonStockTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,000</ix:nonFraction></span> shares of common stock was valued at approximately $<span id="xdx_908_eus-gaap--SharePrice_iI_pid_c20210812__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementClassOfStockAxis__custom--CommonStockTwoMember_zaxuWj8NaDc5"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2021-08-12_us-gaap_SubsequentEventMember_custom_CommonStockTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.03</ix:nonFraction></span> per share, being the closing price of the
stock on the date of grant. The shares were issued on September 3, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">In
September 2021, the Company issued <span id="xdx_908_ecustom--CommonStockIssuableShares_iI_c20210930__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementClassOfStockAxis__custom--CommonStockThreeMember_zB3RWONnyTXc"><ix:nonFraction name="PPCB:CommonStockIssuableShares" contextRef="AsOf2021-09-30_us-gaap_SubsequentEventMember_custom_CommonStockThreeMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,819,712</ix:nonFraction></span> shares of the Company&#8217;s common stock to a consultant for services rendered from July
2021 to September 2021. The Company issued <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210901__20210930__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementClassOfStockAxis__custom--CommonStockThreeMember_zZ9u46eCp5w3"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2021-09-012021-09-30_us-gaap_SubsequentEventMember_custom_CommonStockThreeMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,819,712</ix:nonFraction></span> shares of the Company&#8217;s common stock valued at approximately $<span id="xdx_904_eus-gaap--SharePrice_iI_c20210930__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementClassOfStockAxis__custom--CommonStockThreeMember_zncTt53fx8H5"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2021-09-30_us-gaap_SubsequentEventMember_custom_CommonStockThreeMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.04</ix:nonFraction></span> per share,
being the closing price of the stock on the date of grant to such consultant, or approximately $<span id="xdx_903_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20210901__20210930__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementClassOfStockAxis__custom--CommonStockThreeMember_zoIb9zEbVEz2"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2021-09-012021-09-30_us-gaap_SubsequentEventMember_custom_CommonStockThreeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">113,000</ix:nonFraction></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><i>August
19, 2021 and September 22, 2021 Securities Purchase Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Effective
August 19, 2021, the Company entered into a securities purchase agreement with Geneva Roth Remark Holdings, Inc., pursuant to which
Geneva Roth purchased a convertible promissory note (the &#8220;August 19, 2021 Geneva Roth&#8221;) from the Company in the
aggregate principal amount of $<span id="xdx_903_eus-gaap--DebtInstrumentFaceAmount_iI_c20210819__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--TwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember_zJxwu8JbUVDh"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2021-08-19_us-gaap_SubsequentEventMember_custom_TwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">103,750</ix:nonFraction></span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">,
such principal and the interest thereon convertible into shares of the Company&#8217;s common stock at the option of Geneva Roth any
time after the six-month anniversary of the August 19, 2021 Geneva Roth. The August 19, 2021 Geneva Roth contains an original
discount of $<span id="xdx_904_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20210819__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--TwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember_zTJl5QYwYr5g"><ix:nonFraction name="us-gaap:DebtInstrumentUnamortizedDiscount" contextRef="AsOf2021-08-19_us-gaap_SubsequentEventMember_custom_TwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,750</ix:nonFraction></span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">.
The Company intends to use the net proceeds from the August 19, 2021 Geneva Roth for general working capital purposes. </span>The
maturity date of the August 19, 2021 Geneva Roth Note is <span id="xdx_90C_eus-gaap--DebtInstrumentMaturityDate_dd_c20210818__20210819__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--TwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember_zaFr17VByOrj"><ix:nonNumeric contextRef="From2021-08-182021-08-19_us-gaap_SubsequentEventMember_custom_TwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember" format="ixt:datemonthdayyearen" name="us-gaap:DebtInstrumentMaturityDate">August
19, 2022</ix:nonNumeric></span>. The August 19, 2021 Geneva Roth Note bears interest at a rate of <span id="xdx_905_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20210818__20210819__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--TwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember_zdxFt8OWQKp4"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateDuringPeriod" contextRef="From2021-08-182021-08-19_us-gaap_SubsequentEventMember_custom_TwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">8</ix:nonFraction>% </span>per
annum, which interest may be paid by the Company to Geneva Roth in shares of the Company&#8217;s common stock; but shall not be
payable until the August 19, 2021 Geneva Roth Note becomes payable, whether at the maturity date or upon acceleration or by
prepayment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Additionally, effective September 22, 2021, the
Company entered into a securities purchase agreement with Geneva Roth Remark Holdings, Inc., pursuant to which Geneva Roth purchased
a convertible promissory note (the &#8220;September 22, 2021 Geneva Roth&#8221;) from the Company in the aggregate principal amount of
$<span id="xdx_907_eus-gaap--DebtInstrumentFaceAmount_iI_c20210922__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--TwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember_zcYCx9VF7F8l"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2021-09-22_us-gaap_SubsequentEventMember_custom_TwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">63,750</ix:nonFraction></span>, such principal and the interest thereon convertible into shares of the Company&#8217;s common stock at the option of Geneva
Roth any time after the six-month anniversary of the September 22, 2021 Geneva Roth. The September 22, 2021 Geneva Roth contains an original
discount of $<span id="xdx_905_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20210922__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--TwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember_zHu6SSH176ua"><ix:nonFraction name="us-gaap:DebtInstrumentUnamortizedDiscount" contextRef="AsOf2021-09-22_us-gaap_SubsequentEventMember_custom_TwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,750</ix:nonFraction></span>. The Company intends to use the net proceeds from the September 22, 2021 Geneva Roth for general working capital purposes.
The maturity date of the <span id="xdx_90A_eus-gaap--DebtInstrumentMaturityDate_dd_c20210921__20210922__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--TwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember_zb91W7EBaEd2"><ix:nonNumeric contextRef="From2021-09-212021-09-22_us-gaap_SubsequentEventMember_custom_TwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember" format="ixt:datemonthdayyearen" name="us-gaap:DebtInstrumentMaturityDate">September 22, 2021</ix:nonNumeric></span> Geneva Roth Note is September 22, 2022. The September 22, 2021 Geneva Roth Note bears interest
at a rate of <span id="xdx_90B_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20210921__20210922__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--TwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember_zzjAhYzJmcJb"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateDuringPeriod" contextRef="From2021-09-212021-09-22_us-gaap_SubsequentEventMember_custom_TwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">8</ix:nonFraction></span>% per annum, which interest may be paid by the Company to Geneva Roth in shares of the Company&#8217;s common stock; but
shall not be payable until the September 22, 2021 Geneva Roth Note becomes payable, whether at the maturity date or upon acceleration
or by prepayment.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span id="xdx_900_eus-gaap--DebtInstrumentDescription_c20210818__20210819__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--TwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember_zG0J5VNzl6Ef" title="Debt description"><ix:nonNumeric contextRef="From2021-08-182021-08-19_us-gaap_SubsequentEventMember_custom_TwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember" name="us-gaap:DebtInstrumentDescription">During
the first 60 to 180 days following the date of these notes, the Company has the right to prepay the principal and accrued but unpaid
interest due under the above notes issued to Geneva Roth, together with any other amounts that the Company may owe the holder under the
terms of the note, at a premium ranging from 110% to 129% as defined in the note agreement. After this initial 180-day period, the Company
does not have a right to prepay such notes.</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
conversion price for the above Geneva Roth notes shall be equal to a <span id="xdx_906_ecustom--DebtCoversionPercentage_dp_c20210818__20210819__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--TwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember_zcSPVFCMNfyc"><ix:nonFraction name="PPCB:DebtCoversionPercentage" contextRef="From2021-08-182021-08-19_us-gaap_SubsequentEventMember_custom_TwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">35</ix:nonFraction>%
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">discount of the market price which
means the average of the lowest three trading prices of the Common Stock for the ten trading days immediately prior to the delivery of
a Notice of Conversion. Notwithstanding the foregoing, Geneva Roth shall be restricted from effecting a conversion if such conversion,
along with other shares of the Company&#8217;s common stock beneficially owned by Geneva Roth and its affiliates, exceeds <span id="xdx_905_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_uPure_c20210819__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--TwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember_zEJqORt1zXC5"><ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" contextRef="AsOf2021-08-19_us-gaap_SubsequentEventMember_custom_TwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">9.99</ix:nonFraction>%
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">of the outstanding shares of the
Company&#8217;s common stock. These notes are treated as stock settled debt under ASC 480 and accordingly the Company recorded a total
of $<span id="xdx_909_ecustom--GainFromSettlementOfDebtNet_c20210818__20210819__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--TwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember_zQ1oTm0LT7ba"><ix:nonFraction name="PPCB:GainFromSettlementOfDebtNet" contextRef="From2021-08-182021-08-19_us-gaap_SubsequentEventMember_custom_TwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">90,192</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">put premium.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
above Geneva Roth notes contain certain events of default, upon which principal and accrued interest will become immediately due and
payable. In addition, upon an event of default, <span id="xdx_909_eus-gaap--DebtInstrumentInterestRateTerms_c20210818__20210819__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--TwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember_zQFItRYrVT9d" title="Debt Instrument, Interest Rate Terms"><ix:nonNumeric contextRef="From2021-08-182021-08-19_us-gaap_SubsequentEventMember_custom_TwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember" name="us-gaap:DebtInstrumentInterestRateTerms">interest on the outstanding principal shall accrue at a default interest rate of 22%
per annum</ix:nonNumeric></span>, or if such rate is usurious or not permitted by current law, then at the highest rate of interest permitted by law. Further,
certain events of default may trigger penalty and liquidated damage provisions.</span></p>

</ix:nonNumeric><p id="xdx_814_zYfTB7ntB1G3" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<!-- Field: Page; Sequence: 128; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>PROPANC
BIOPHARMA, INC. AND SUBSIDIARY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif"><span id="a_015"></span><span style="font-size: 10pt"><b>CONDENSED
CONSOLIDATED BALANCE SHEETS</b></span></span></p>



<p style="text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_300_111_zrA3tn9x9IXg" summary="xdx: Statement - Condensed Consolidated Balance Sheets" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_497_20210930_zddUckBH6wI" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">September
    30, 2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_49A_20210630_zenxaUPGCWej" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">June
    30, 2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Unaudited)</b></span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--AssetsAbstract_iB_zkhYvv1P1xea" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-decoration: underline; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">ASSETS</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--AssetsCurrentAbstract_i01B_zIxd0jJQ9QGc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">CURRENT ASSETS:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--CashAndCashEquivalentsAtCarryingValue_i02I_maCzwoW_zBzORzBUnR13" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; width: 60%"><span style="font-family: Times New Roman, Times, Serif">Cash</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 17%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">45,817</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 15%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,255</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--ValueAddedTaxReceivableCurrent_i02I_maCzwoW_zkEgQwit2ayf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">GST tax receivable</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ValueAddedTaxReceivableCurrent" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,238</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ValueAddedTaxReceivableCurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,341</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_i02I_maCzwoW_zxRSq5QbL4H6" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Prepaid
    expenses and other current assets</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,353</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2567">&#160;</span></span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--AssetsCurrent_i02TI_mtCzwoW_maCzXLq_zEaa2ypSr7eb" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">TOTAL CURRENT ASSETS</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">56,408</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,596</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--DepositsAssetsNoncurrent_i01I_maCzXLq_zUJswUcGcXC4" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Security deposit - related
    party</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DepositsAssetsNoncurrent" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,164</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DepositsAssetsNoncurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,250</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--PropertyPlantAndEquipmentNet_i01I_maCzXLq_zMaUIjbtar66" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Property
    and equipment, net</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,593</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,255</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--Assets_i01TI_mtCzXLq_ztZN9fbJ685b" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">TOTAL
    ASSETS</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">62,165</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">13,101</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--LiabilitiesAndStockholdersEquityAbstract_iB_zM3XgKuqQB93" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-decoration: underline; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">LIABILITIES
    AND STOCKHOLDERS&#8217; DEFICIT</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--LiabilitiesCurrentAbstract_i01B_z4Rl4cZpKEze" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">CURRENT LIABILITIES:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--AccountsPayableCurrent_i02I_maCz6au_z3e9jMCdqC4d" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Accounts payable</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">826,184</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,002,335</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--AccountsPayableAndOtherAccruedLiabilitiesCurrent_i02I_maCz6au_zUhPwysD9uXk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Accrued expenses and other
    payables</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">407,775</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">892,151</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--ConvertibleDebtCurrent_i02I_maCz6au_zzBWC02KXiEc" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Convertible notes and related
    accrued interest, net of discounts and premiums</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ConvertibleDebtCurrent" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">584,608</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ConvertibleDebtCurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">624,583</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--DeferredCompensationLiabilityCurrent_i02I_maCz6au_zH2mixLxUXTj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Embedded conversion option
    liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DeferredCompensationLiabilityCurrent" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">58,124</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DeferredCompensationLiabilityCurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">54,220</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--DueToRelatedPartiesCurrent_i02I_maCz6au_z7EmUV0Oitk2" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Due to former director
    - related party</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DueToRelatedPartiesCurrent" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">32,076</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DueToRelatedPartiesCurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">33,347</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_406_ecustom--LoanFromFormerDirectorRelatedParty_i02I_maCz6au_zQ3kBEFQsuz2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Loan from former director
    - related party</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="PPCB:LoanFromFormerDirectorRelatedParty" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">53,384</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="PPCB:LoanFromFormerDirectorRelatedParty" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">55,500</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--EmployeeRelatedLiabilitiesCurrent_i02I_maCz6au_zdPjki2BLvC4" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Employee
    benefit liability</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:EmployeeRelatedLiabilitiesCurrent" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">406,644</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:EmployeeRelatedLiabilitiesCurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">418,538</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--LiabilitiesCurrent_i02TI_mtCz6au_maCzDLk_zwxXzf6W4VBl" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">TOTAL
    CURRENT LIABILITIES</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,368,795</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,080,674</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--Liabilities_i01I_mtCzDLk_maCzLXL_ztJBEluib0Q1" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">TOTAL
    LIABILITIES</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,368,795</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,080,674</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--CommitmentsAndContingencies_i01I_maCzLXL_zrM58fElC7D3" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Commitments and Contingencies
    (See Note 8)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; display: none">-</span><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2614">&#160;</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--StockholdersEquityAbstract_i01B_z6K0GrfJ019j" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">STOCKHOLDERS&#8217; DEFICIT:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--PreferredStockValue_i02I_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Preferred stock, <span id="xdx_902_eus-gaap--PreferredStockSharesAuthorized_iI_c20210930_zD3hfIV4k0na" title="Preferred stock, shares authorized"><span id="xdx_90D_eus-gaap--PreferredStockSharesAuthorized_iI_c20210630_z3YBCckXC7N3" title="Preferred stock, shares authorized"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,500,005</ix:nonFraction></ix:nonFraction></span></span> shares authorized,
    $<span id="xdx_90A_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20210930_zpVZE9yvc6aa" title="Preferred stock, par value"><span id="xdx_90F_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20210630_zoY1FTvxM2Pc" title="Preferred stock, par value"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.01</ix:nonFraction></ix:nonFraction></span></span> par value:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--PreferredStockValue_i02I_pp0p0_hus-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_z1MmyF3W2ECd" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Series A preferred stock, $<span id="xdx_907_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20210930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zXxcTpRy9Qf2" title="Preferred stock, par value"><span id="xdx_90D_eus-gaap--PreferredStockParOrStatedValuePerShare_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_pdd" title="Preferred stock, par value"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2021-09-30_us-gaap_SeriesAPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2021-06-30_us-gaap_SeriesAPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.01</ix:nonFraction></ix:nonFraction></span></span> par value;
    <span id="xdx_903_eus-gaap--PreferredStockSharesAuthorized_iI_c20210930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_z1Cc7KeB7eK9" title="Preferred stock, shares authorized"><span id="xdx_908_eus-gaap--PreferredStockSharesAuthorized_iI_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zX6R3bd4UBzh" title="Preferred stock, shares authorized"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2021-09-30_us-gaap_SeriesAPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2021-06-30_us-gaap_SeriesAPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">500,000</ix:nonFraction></ix:nonFraction></span></span> shares authorized; <span id="xdx_907_eus-gaap--PreferredStockSharesIssued_iI_c20210930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zY5DcaMah8wa" title="Preferred stock, shares issued"><span id="xdx_90B_eus-gaap--PreferredStockSharesOutstanding_iI_c20210930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zma8dy4nDFoe" title="Preferred stock, shares outstanding"><span id="xdx_903_eus-gaap--PreferredStockSharesIssued_iI_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zK5Ou0dET4U7" title="Preferred stock, shares issued"><span id="xdx_908_eus-gaap--PreferredStockSharesOutstanding_iI_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zUerIBK6uqua" title="Preferred stock, shares outstanding"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2021-09-30_us-gaap_SeriesAPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2021-09-30_us-gaap_SeriesAPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2021-06-30_us-gaap_SeriesAPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2021-06-30_us-gaap_SeriesAPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">500,000</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span></span></span></span> shares issued and outstanding as of September 30, 2021 and June 30, 2021</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2021-09-30_us-gaap_SeriesAPreferredStockMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,000</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2021-06-30_us-gaap_SeriesAPreferredStockMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,000</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--PreferredStockValue_i02I_pp0p0_hus-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_ze7gjWGj3Xd1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Series B preferred stock, $<span id="xdx_905_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20210930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zW0D7rHs5n64" title="Preferred stock, par value"><span id="xdx_90B_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zdV87XP0tu7c" title="Preferred stock, par value"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2021-09-30_us-gaap_SeriesBPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2021-06-30_us-gaap_SeriesBPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.01</ix:nonFraction></ix:nonFraction></span></span> par value;
    <span id="xdx_909_eus-gaap--PreferredStockSharesAuthorized_iI_c20210930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zyNVEP1vgIxi" title="Preferred stock, shares authorized"><span id="xdx_90F_eus-gaap--PreferredStockSharesAuthorized_iI_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_z2HWX7ZHIKnf" title="Preferred stock, shares authorized"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2021-09-30_us-gaap_SeriesBPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2021-06-30_us-gaap_SeriesBPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5</ix:nonFraction></ix:nonFraction></span></span> shares authorized; <span id="xdx_905_eus-gaap--PreferredStockSharesIssued_iI_c20210930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zL4kQsiZH2Ue" title="Preferred stock, shares issued"><span id="xdx_901_eus-gaap--PreferredStockSharesOutstanding_iI_c20210930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zoGsDlzzdsQk" title="Preferred stock, shares outstanding"><span id="xdx_905_eus-gaap--PreferredStockSharesIssued_iI_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zVTTUhIxQcIe" title="Preferred stock, shares issued"><span id="xdx_90D_eus-gaap--PreferredStockSharesOutstanding_iI_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zlCD1j1McEEe" title="Preferred stock, shares outstanding"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2021-09-30_us-gaap_SeriesBPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2021-09-30_us-gaap_SeriesBPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2021-06-30_us-gaap_SeriesBPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2021-06-30_us-gaap_SeriesBPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span></span></span></span> share issued and outstanding as of September 30, 2021 and June 30, 2021</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2650">&#160;</span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2651">&#160;</span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--PreferredStockValue_i02I_pp0p0_maSEzCtH_zmjXmWlRPeu4" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt">Preferred stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--CommonStockValue_i02I_pp0p0_maSEzCtH_zgTptB13Gzci" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Common stock, $<span id="xdx_908_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20210930_zjfdwRAuj2o5" title="Common stock, par value"><span id="xdx_906_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20210630_zecQ1jG4x5Vl" title="Common stock, par value"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.001</ix:nonFraction></ix:nonFraction></span></span> par value; <span id="xdx_90E_eus-gaap--CommonStockSharesAuthorized_iI_c20210930_zDm1auEQTZfi" title="Common stock, shares authorized"><span id="xdx_908_eus-gaap--CommonStockSharesAuthorized_c20210630_pdd" title="Common stock, shares authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,000,000,000</ix:nonFraction></ix:nonFraction></span></span>
    shares authorized;<span id="xdx_90E_eus-gaap--CommonStockSharesIssued_iI_c20210930_zRagegLwOR3d" title="Common stock, shares issued"><span id="xdx_90E_eus-gaap--CommonStockSharesOutstanding_iI_c20210930_zG27ThA9RhX7" title="Common stock, shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">43,841,644</ix:nonFraction></ix:nonFraction></span></span> and <span id="xdx_906_eus-gaap--CommonStockSharesIssued_iI_c20210630_zXvcszaYBfbk" title="Common stock, shares issued"><span id="xdx_90F_eus-gaap--CommonStockSharesOutstanding_c20210630_pdd" title="Common stock, shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">14,055,393</ix:nonFraction></ix:nonFraction></span></span> shares issued and outstanding as of September 30, 2021 and June 30, 2021, respectively</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">43,842</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">14,056</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_404_ecustom--CommonStockIssuable_i02I_pp0p0_maSEzCtH_zRj935exBtMe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Common stock issuable (<span id="xdx_903_ecustom--CommonStockIssuableShares_iI_c20210930_zLmTz1pF0Qk3" title="Common stock, shares issuable"><ix:nonFraction name="PPCB:CommonStockIssuableShares" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,002,549</ix:nonFraction></span> and <span id="xdx_906_ecustom--CommonStockIssuableShares_iI_c20210630_zOHz0raH5Qaa" title="Common stock, shares issuable"><ix:nonFraction name="PPCB:CommonStockIssuableShares" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">59</ix:nonFraction></span> shares
    as of September 30, 2021 and June 30, 2021, respectively)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="PPCB:CommonStockIssuable" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,002</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2692">&#160;</span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--AdditionalPaidInCapital_i02I_maSEzCtH_zBREcbKzGeZ9" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Additional paid-in capital</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">55,444,574</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">54,074,110</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--StockholdersEquityNoteSubscriptionsReceivable_i02NI_di_msSEzCtH_zXfRiDz4Pn99" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Subscription receivable</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockholdersEquityNoteSubscriptionsReceivable" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">100,000</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2702">&#160;</span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_i02I_maSEzCtH_zqNCXEC4RuXf" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Accumulated other comprehensive
    income</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,149,397</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,085,204</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--RetainedEarningsAccumulatedDeficit_i02I_maSEzCtH_zk3lRtciqha4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Accumulated deficit</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">58,804,968</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">58,199,466</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_402_eus-gaap--TreasuryStockValue_i02NI_di_msSEzCtH_z5ehJJZbboCd" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Treasury stock (<span id="xdx_907_eus-gaap--TreasuryStockShares_iI_c20210930_zOQMxhIIzs5" title="Treasury stock, shares"><span id="xdx_904_eus-gaap--TreasuryStockShares_c20210630_pdd" title="Treasury stock, shares"><ix:nonFraction name="us-gaap:TreasuryStockShares" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:TreasuryStockShares" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1</ix:nonFraction></ix:nonFraction></span></span>
    share)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:TreasuryStockValue" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">46,477</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:TreasuryStockValue" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">46,477</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--StockholdersEquity_i02TI_maCzLXL_mtSEzCtH_zlYF51mN9aa3" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">TOTAL
    STOCKHOLDERS&#8217; DEFICIT</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,306,630</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,067,573</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--LiabilitiesAndStockholdersEquity_i01TI_mtCzLXL_zEfCNCYUJRm6" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">TOTAL
    LIABILITIES AND STOCKHOLDERS&#8217; DEFICIT</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">62,165</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">13,101</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
</table>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">The
accompanying unaudited condensed notes are an integral part of these unaudited condensed consolidated financial statements.</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 129; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><b>PROPANC
BIOPHARMA, INC. AND SUBSIDIARY</b> </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><span id="a_016"></span><b>CONDENSED
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)</b> </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Unaudited)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_305_113_zQlPM5PfUMs1" summary="xdx: Statement - Consolidated Statements of Operations and Comprehensive Income (Loss)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_49E_20210701__20210930_zZNTSj7f3rYl" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_49B_20200701__20200930_zAhOeJWcyHn7" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Three
    Months Ended September 30,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--RevenuesAbstract_iB_z9ULz9VXYOWe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">REVENUE</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_i01_pp0p0_maOILzm9A_zbFepLAFq0qk" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Revenue</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2726">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2727">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--OperatingExpensesAbstract_iB_zFNwv8eT77Xh" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">OPERATING EXPENSES</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--GeneralAndAdministrativeExpense_i01_maCz6Ft_zA39dPrDtt8d" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Administration
    expenses</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">431,740</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">323,111</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--OccupancyNet_i01_maCz6Ft_zFQCD1wvypMi" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Occupancy expenses</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OccupancyNet" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,736</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OccupancyNet" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,204</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--ResearchAndDevelopmentExpense_i01_maCz6Ft_zLBss5rYEpT6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Research
    and development</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">46,554</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">50,846</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--OperatingExpenses_i01T_mtCz6Ft_msOILzm9A_zHSBy6cREMfk" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">TOTAL
    OPERATING EXPENSES</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">486,030</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">383,161</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--OperatingIncomeLoss_iT_mtOILzm9A_maILFCOzT02_zL1du25dZMob" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">LOSS
    FROM OPERATIONS</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">486,030</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">383,161</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--NonoperatingIncomeExpenseAbstract_iB_zaef92kutzPe" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">OTHER INCOME (EXPENSE)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--InterestExpense_i01N_di_msCzjrz_zzXKHpst7365" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Interest expense</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">109,853</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">159,281</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_409_eus-gaap--DerivativeGainLossOnDerivativeNet_i01_maCzjrz_zk1GIO91leRk" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Change in fair value of
    derivative liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:DerivativeGainLossOnDerivativeNet" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,904</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DerivativeGainLossOnDerivativeNet" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">64,952</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--GainsLossesOnExtinguishmentOfDebt_i01_maCzjrz_zemuBcXZibLh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Gain on extinguishment
    of debt, net</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2756">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:GainsLossesOnExtinguishmentOfDebt" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">49,985</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--ForeignCurrencyTransactionGainLossUnrealized_i01_maCzjrz_zLtKX1ISa9m2" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Foreign
    currency transaction gain </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ForeignCurrencyTransactionGainLossUnrealized" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">109,129</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ForeignCurrencyTransactionGainLossUnrealized" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,960</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--NonoperatingIncomeExpense_i01T_mtCzjrz_maILFCOzT02_zHkBAmPOirJe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">TOTAL
    OTHER EXPENSE, NET</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">4,628</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">42,384</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_iT_maCz5py_mtILFCOzT02_zOyhn39l33d2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">LOSS BEFORE TAXES</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">490,658</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">425,545</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--IncomeTaxExpenseBenefit_iN_di_msCz5py_zBg6W6VRo8Af" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Tax benefit</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2768">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2769">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--ProfitLoss_iT_mtCz5py_maNILzfVM_z4exyW8GCuDh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">NET LOSS</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">490,658</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">425,545</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_403_ecustom--DeemedDividend_maNILzfVM_zr7G6wODxXsf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Deemed
    Dividend</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="PPCB:DeemedDividend" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">114,844</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2775">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--NetIncomeLoss_iT_mtNILzfVM_ztqLRxfOHNvj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">NET
    LOSS AVAILABLE TO COMMON STOCKHOLDERS</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">605,502</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">425,545</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--EarningsPerShareBasicAndDiluted_pid_zjIoKp65cJxc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">BASIC
    AND DILUTED NET LOSS PER SHARE</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:EarningsPerShareBasicAndDiluted" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.02</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:EarningsPerShareBasicAndDiluted" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.71</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--WeightedAverageNumberOfShareOutstandingBasicAndDiluted_zw7IsZNjOZR6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">BASIC AND DILUTED WEIGHTED
    AVERAGE SHARES OUTSTANDING</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">27,142,519</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">597,314</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_maCINOTzLLn_zIsqh1F1SRw3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">NET LOSS AVAILABLE TO COMMON
    STOCKHOLDERS</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">605,502</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">425,545</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_iB_zygC6A4k4Bc8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">OTHER COMPREHENSIVE INCOME
    (LOSS)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_i01_maCzgUt_zON3pd55S784" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Unrealized
    foreign currency translation gain (loss)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">64,193</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">75,755</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_i01T_mtCzgUt_maCINOTzLLn_zsmEwvFcxFn9" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">TOTAL
    OTHER COMPREHENSIVE INCOME (LOSS)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">64,193</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">75,755</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--ComprehensiveIncomeNetOfTax_iT_mtCINOTzLLn_zPJ7jovXr5ja" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">TOTAL
    COMPREHENSIVE LOSS</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">541,309</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">501,300</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
</table>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">The
accompanying unaudited condensed notes are an integral part of these unaudited condensed consolidated financial statements.</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 130; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PROPANC
BIOPHARMA, INC. AND SUBSIDIARY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="a_017"></span>CONDENSED
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS&#8217; DEFICIT FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2021 AND 2020</b> </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Unaudited)</b></span></p>



<p style="text-align: center; margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0"></p><table cellpadding="0" cellspacing="0" id="xdx_30F_114_zOYYk5IPjsXc" summary="xdx: Statement - Consolidated Statements of Changes in Stockholders&apos; Deficit" style="font: 8pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 8pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White">
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td id="xdx_4BC_us-gaap--StatementClassOfStockAxis_us-gaap--SeriesAPreferredStockMember_us-gaap--StatementEquityComponentsAxis_us-gaap--PreferredStockMember_zxOrq1rKZt6d" style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td id="xdx_4B4_us-gaap--StatementClassOfStockAxis_us-gaap--SeriesBPreferredStockMember_us-gaap--StatementEquityComponentsAxis_us-gaap--PreferredStockMember_zZYp4wjabkA2" style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td id="xdx_4BE_us-gaap--StatementEquityComponentsAxis_us-gaap--CommonStockMember_zmDYNWedSDuk" style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td id="xdx_4B8_us-gaap--StatementEquityComponentsAxis_custom--CommonStockIssuableMember_zMHzs3BCP5q7" style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td id="xdx_4B3_us-gaap--StatementEquityComponentsAxis_us-gaap--AdditionalPaidInCapitalMember_zoxigDV2vL5e" style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td id="xdx_4BF_us-gaap--StatementEquityComponentsAxis_custom--SubscriptionReceivableMember_zBK6XN5GghQg" style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td id="xdx_4B1_us-gaap--StatementEquityComponentsAxis_us-gaap--RetainedEarningsMember_zXX9bgwVwOEk" style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td id="xdx_4B2_us-gaap--StatementEquityComponentsAxis_us-gaap--AccumulatedOtherComprehensiveIncomeMember_zTBUDJGa2Nij" style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td id="xdx_4B4_us-gaap--StatementEquityComponentsAxis_us-gaap--TreasuryStockMember_zxOwxhyN6Joi" style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td id="xdx_4BA_zlBsEncHnnv4" style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Preferred
    Stock</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td colspan="2" style="font: 8pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td colspan="2" style="font: 8pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td colspan="6" style="font: 8pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Common
    Stock</b></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td colspan="2" style="font: 8pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td colspan="2" style="font: 8pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td colspan="2" style="font: 8pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td colspan="2" style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>Accumulated</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td colspan="2" style="font: 8pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td colspan="2" style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td></tr>
  <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Series
    A</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Series
    B</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Common
    Stock</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>Issuable</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td colspan="2" style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Additional</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td colspan="2" style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td colspan="2" style="font: 8pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td colspan="2" style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>Other</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td colspan="2" style="font: 8pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td colspan="2" style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>Total</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td></tr>
  <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>No.
    of Shares</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Value</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>No.
    of Shares</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Value</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>No.
    of Shares</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Value</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>No.
    of Shares</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Value</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Paid-in
    Capital</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Subscription
    Receivable</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Accumulated
    Deficit</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Comprehensive
    Income</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Treasury
    Stock</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Stockholders&#8217;
    Deficit</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td></tr>
  <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: 8pt Times New Roman, Times, Serif; text-align: center"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: 8pt Times New Roman, Times, Serif; text-align: center"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: 8pt Times New Roman, Times, Serif; text-align: center"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: 8pt Times New Roman, Times, Serif; text-align: center"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: 8pt Times New Roman, Times, Serif; text-align: center"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: 8pt Times New Roman, Times, Serif; text-align: center"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: 8pt Times New Roman, Times, Serif; text-align: center"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: 8pt Times New Roman, Times, Serif; text-align: center"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: 8pt Times New Roman, Times, Serif; text-align: center"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: 8pt Times New Roman, Times, Serif; text-align: center"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: 8pt Times New Roman, Times, Serif; text-align: center"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: 8pt Times New Roman, Times, Serif; text-align: center"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: 8pt Times New Roman, Times, Serif; text-align: center"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: 8pt Times New Roman, Times, Serif; text-align: center"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_436_c20200701__20200930_eus-gaap--StockholdersEquity_iS_zzhYC7hxZAQ3" style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 8pt Times New Roman, Times, Serif; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Balance
    at June 30, 2020</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td id="xdx_989_eus-gaap--SharesOutstanding_iS_c20200701__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zmDVomaDfvjh" title="Beginning balance, shares" style="font: bold 8pt Times New Roman, Times, Serif; width: 3%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2020-06-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">500,000</ix:nonFraction></b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>$</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; width: 3%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-06-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,000</ix:nonFraction></b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td id="xdx_98A_eus-gaap--SharesOutstanding_iS_c20200701__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zGWfSDiHC3K7" title="Beginning balance, shares" style="font: bold 8pt Times New Roman, Times, Serif; width: 3%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2020-06-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1</ix:nonFraction></b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>$</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; width: 3%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2802">-</span></b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td id="xdx_985_eus-gaap--SharesOutstanding_iS_c20200701__20200930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zuNo1ZFKbwi2" title="Beginning balance, shares" style="font: bold 8pt Times New Roman, Times, Serif; width: 3%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2020-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">258,120</ix:nonFraction></b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>$</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; width: 3%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">258</ix:nonFraction></b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td title="Balance, shares" style="font: bold 8pt Times New Roman, Times, Serif; width: 3%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>-</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>$</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; width: 3%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2804">-</span></b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>$</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; width: 4%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-06-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">50,913,893</ix:nonFraction></b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>$</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; width: 4%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2806">-</span></b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>$</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; width: 4%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-06-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">55,781,770</ix:nonFraction></b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>)</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>$</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; width: 4%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,267,671</ix:nonFraction></b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>$</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; width: 4%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-06-30_us-gaap_TreasuryStockMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">46,477</ix:nonFraction></b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>)</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>$</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; width: 4%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,641,425</ix:nonFraction></b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>)</b></span></td></tr>
  <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_zrlS36Jzzwpc" style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">Issuance
    of common stock for conversion of convertible debt and accrued interest</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">-</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2818">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">-</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2819">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td id="xdx_981_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20200701__20200930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zxhMQdXPaNm1" title="Issuance of common stock for conversion of convertible debt, conversion fee, and accrued interest, shares" style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" contextRef="From2020-07-012020-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">442,031</ix:nonFraction></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2020-07-012020-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">442</ix:nonFraction></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">-</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2821">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2020-07-012020-09-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">480,133</ix:nonFraction></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2823">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2824">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2825">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2826">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">480,575</ix:nonFraction></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_zflQWkFbsbb7" style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 8pt Times New Roman, Times, Serif; display: none; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">Issuance
    of common stock for services and accrued expenses</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td title="Issuance of common stock for conversion of convertible debt and accrued interest, shares" style="font: 8pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_zGLguKLu88h1" style="font: 8pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">Issuance
    of common stock for services and accrued expenses</span>, shares</td>
    <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td title="Issuance of common stock for conversion of convertible debt and accrued interest, shares" style="font: 8pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_405_ecustom--AdjustmentsToAdditionalPaidInCapitalReclassificationOfPremiumUponDebtConversion_z9XwT6VmUFi9" style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">Reclassification
    of put premium upon debt conversion</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">-</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2853">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">-</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2854">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">-</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2855">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">-</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2856">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><ix:nonFraction name="PPCB:AdjustmentsToAdditionalPaidInCapitalReclassificationOfPremiumUponDebtConversion" contextRef="From2020-07-012020-09-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">204,919</ix:nonFraction></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2858">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2859">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2860">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2861">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><ix:nonFraction name="PPCB:AdjustmentsToAdditionalPaidInCapitalReclassificationOfPremiumUponDebtConversion" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">204,919</ix:nonFraction></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_zYQ74MUBGZxf" style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 8pt Times New Roman, Times, Serif; display: none; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">Stock
    based compensation in connection with stock option grants</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_ecustom--DeemedDividendUponAlternateCashlessExerciseOfWarrants_zC1bPCLhdtl9" style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 8pt Times New Roman, Times, Serif; display: none; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">Deemed
    dividend upon alternate cashless exercise of warrants</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_ecustom--StockIssuedDuringPeriodValueExerciseOfWarrants_zuh90oRrrfrl" style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">Issuance
    of common stock for exercise of warrants</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">-</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2886">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">-</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2887">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td id="xdx_981_ecustom--StockIssuedDuringPeriodSharesExerciseOfWarrants_c20200701__20200930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zuSl0TMzNALg" title="Issuance of common stock for exercise of warrants, shares" style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><ix:nonFraction name="PPCB:StockIssuedDuringPeriodSharesExerciseOfWarrants" contextRef="From2020-07-012020-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">15,445</ix:nonFraction></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><ix:nonFraction name="PPCB:StockIssuedDuringPeriodValueExerciseOfWarrants" contextRef="From2020-07-012020-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">15</ix:nonFraction></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">-</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2889">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><ix:nonFraction name="PPCB:StockIssuedDuringPeriodValueExerciseOfWarrants" contextRef="From2020-07-012020-09-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">201,029</ix:nonFraction></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2891">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2892">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2893">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2894">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><ix:nonFraction name="PPCB:StockIssuedDuringPeriodValueExerciseOfWarrants" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">201,044</ix:nonFraction></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_ecustom--IssuanceOfCommonStockForAlternateCashlessExerciseOfWarrants_zXhwvuc7w5fi" style="font: 8pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">Issuance
    of common stock for alternate cashless exercise of warrants</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td title="Issuance of common stock for exercise of warrants, shares" style="font: 8pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_ecustom--IssuanceOfCommonStockForAlternateCashlessExerciseOfWarrantsShares_zP4WIab7yQC7" style="font: 8pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">Issuance
    of common stock for alternate cashless exercise of warrants</span>, shares</td>
    <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td title="Issuance of common stock for exercise of warrants, shares" style="font: 8pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--AdjustmentsToAdditionalPaidInCapitalWarrantIssued_zU31X7IcD94b" style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">Stock
    based compensation in connection with fair value of warrants issued for services</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">-</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2921">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">-</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2922">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">-</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2923">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">-</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2924">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" contextRef="From2020-07-012020-09-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">20,718</ix:nonFraction></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2926">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2927">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2928">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2929">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">20,718</ix:nonFraction></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--ForeignCurrencyTransactionGainLossBeforeTax_z4JVrDAJSZNb" style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">Foreign
    currency translation gain</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">-</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2932">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">-</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2933">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">-</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2934">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">-</span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2935">-</span></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2936">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2937">-</span></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2938">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" contextRef="From2020-07-012020-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">75,755</ix:nonFraction></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">)</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">75,755</ix:nonFraction></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--ProfitLoss_z3KlWgFpnF3c" style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 8pt Times New Roman, Times, Serif">Net
    loss for the three months ended September 30, 2020</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">-</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2943">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">-</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2944">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">-</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2945">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">-</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2946">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2947">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2948">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2020-07-012020-09-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">425,545</ix:nonFraction></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">)</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2951">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">425,545</ix:nonFraction></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_430_c20200701__20200930_eus-gaap--StockholdersEquity_iE_zxiuHs6hFYKg" style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Balance
    at September 30, 2020</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="border-bottom: Black 2.5pt double; font: bold 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td id="xdx_98A_eus-gaap--SharesOutstanding_iE_c20200701__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_z5oeskOeoiH" title="Ending balance, shares" style="border-bottom: Black 2.5pt double; font: bold 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2020-09-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">500,000</ix:nonFraction></b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="border-bottom: Black 2.5pt double; font: bold 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>$</b></span></td>
    <td style="border-bottom: Black 2.5pt double; font: bold 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-09-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,000</ix:nonFraction></b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="border-bottom: Black 2.5pt double; font: bold 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td id="xdx_983_eus-gaap--SharesOutstanding_iE_c20200701__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_znOUXrMxEzb2" title="Ending balance, shares" style="border-bottom: Black 2.5pt double; font: bold 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2020-09-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1</ix:nonFraction></b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="border-bottom: Black 2.5pt double; font: bold 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>$</b></span></td>
    <td style="border-bottom: Black 2.5pt double; font: bold 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2955">-</span></b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="border-bottom: Black 2.5pt double; font: bold 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td id="xdx_98E_eus-gaap--SharesOutstanding_iE_c20200701__20200930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_ziheCDsmzLn4" title="Ending balance, shares" style="border-bottom: Black 2.5pt double; font: bold 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2020-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">715,596</ix:nonFraction></b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="border-bottom: Black 2.5pt double; font: bold 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>$</b></span></td>
    <td style="border-bottom: Black 2.5pt double; font: bold 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">715</ix:nonFraction></b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="border-bottom: Black 2.5pt double; font: bold 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td title="Balance, shares" style="border-bottom: Black 2.5pt double; font: bold 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>-</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="border-bottom: Black 2.5pt double; font: bold 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>$</b></span></td>
    <td style="border-bottom: Black 2.5pt double; font: bold 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2957">-</span></b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="border-bottom: Black 2.5pt double; font: bold 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>$</b></span></td>
    <td style="border-bottom: Black 2.5pt double; font: bold 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-09-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">51,820,692</ix:nonFraction></b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="border-bottom: Black 2.5pt double; font: bold 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>$</b></span></td>
    <td style="border-bottom: Black 2.5pt double; font: bold 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2959">-</span></b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="border-bottom: Black 2.5pt double; font: bold 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>$</b></span></td>
    <td style="border-bottom: Black 2.5pt double; font: bold 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-09-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">56,207,315</ix:nonFraction></b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>)</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="border-bottom: Black 2.5pt double; font: bold 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>$</b></span></td>
    <td style="border-bottom: Black 2.5pt double; font: bold 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,191,916</ix:nonFraction></b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="border-bottom: Black 2.5pt double; font: bold 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>$</b></span></td>
    <td style="border-bottom: Black 2.5pt double; font: bold 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-09-30_us-gaap_TreasuryStockMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">46,477</ix:nonFraction></b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>)</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="border-bottom: Black 2.5pt double; font: bold 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>$</b></span></td>
    <td style="border-bottom: Black 2.5pt double; font: bold 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,235,469</ix:nonFraction></b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>)</b></span></td></tr>
  <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_435_c20210701__20210930_eus-gaap--StockholdersEquity_iS_zrZcXDTzOSU2" style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Balance
    at June 30, 2021</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td id="xdx_987_eus-gaap--SharesOutstanding_iS_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zUArbDvz9lVb" title="Beginning balance, shares" style="font: bold 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-06-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">500,000</ix:nonFraction></b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>$</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-06-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,000</ix:nonFraction></b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td id="xdx_98E_eus-gaap--SharesOutstanding_iS_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zSteQYC7Io6h" title="Beginning balance, shares" style="font: bold 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-06-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1</ix:nonFraction></b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>$</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2972">-</span></b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td id="xdx_98F_eus-gaap--SharesOutstanding_iS_c20210701__20210930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zBiZhhMjrsyd" title="Beginning balance, shares" style="font: bold 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">14,055,393</ix:nonFraction></b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>$</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">14,056</ix:nonFraction></b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td id="xdx_980_eus-gaap--SharesOutstanding_iS_c20210701__20210930__us-gaap--StatementEquityComponentsAxis__custom--CommonStockIssuableMember_zwG6GrJR3Fbh" title="Beginning balance, shares" style="font: bold 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-06-30_custom_CommonStockIssuableMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">59</ix:nonFraction></b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>$</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2974">-</span></b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>$</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-06-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">54,074,110</ix:nonFraction></b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>$</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2976">-</span></b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>$</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-06-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">58,199,466</ix:nonFraction></b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>)</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>$</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,085,204</ix:nonFraction></b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>$</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-06-30_us-gaap_TreasuryStockMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">46,477</ix:nonFraction></b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>)</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>$</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,067,573</ix:nonFraction></b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>)</b></span></td></tr>
  <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_zY7wdcGWWLj7" style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">Issuance
    of common stock for conversion of convertible debt, conversion fee, and accrued interest</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">-</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2990">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">-</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2991">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td id="xdx_982_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20210701__20210930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z8b0KznVXFga" title="Issuance of common stock for conversion of convertible debt, conversion fee, and accrued interest, shares" style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" contextRef="From2021-07-012021-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">9,445,009</ix:nonFraction></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2021-07-012021-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,445</ix:nonFraction></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">-</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2993">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2021-07-012021-09-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">190,741</ix:nonFraction></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2995">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2996">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2997">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2998">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">200,186</ix:nonFraction></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_zBIECxBSHuYk" style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">Issuance
    of common stock for services and accrued expenses</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">-</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3003">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">-</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3004">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td id="xdx_983_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20210701__20210930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zc2kY1sCCsM" title="Issuance of common stock for services and accrued expenses, shares" style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" contextRef="From2021-07-012021-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">17,934,379</ix:nonFraction></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2021-07-012021-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">17,934</ix:nonFraction></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">-</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3006">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2021-07-012021-09-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">563,927</ix:nonFraction></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3008">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3009">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3010">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3011">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">581,861</ix:nonFraction></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_408_ecustom--StockIssuedDuringPeriodValueExerciseOfWarrants_zAfjMFUMRPMk" style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">Issuance
    of common stock for exercise of warrants</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">-</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3016">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">-</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3017">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td id="xdx_98B_ecustom--StockIssuedDuringPeriodSharesExerciseOfWarrants_c20210701__20210930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zyCQntIlaEZk" title="Issuance of common stock for exercise of warrants, shares" style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><ix:nonFraction name="PPCB:StockIssuedDuringPeriodSharesExerciseOfWarrants" contextRef="From2021-07-012021-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,875</ix:nonFraction></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><ix:nonFraction name="PPCB:StockIssuedDuringPeriodValueExerciseOfWarrants" contextRef="From2021-07-012021-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7</ix:nonFraction></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td id="xdx_980_ecustom--StockIssuedDuringPeriodSharesExerciseOfWarrants_c20210701__20210930__us-gaap--StatementEquityComponentsAxis__custom--CommonStockIssuableMember_zVrmQXK1Cuva" title="Issuance of common stock for exercise of warrants, shares" style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><ix:nonFraction name="PPCB:StockIssuedDuringPeriodSharesExerciseOfWarrants" contextRef="From2021-07-012021-09-30_custom_CommonStockIssuableMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,500</ix:nonFraction></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><ix:nonFraction name="PPCB:StockIssuedDuringPeriodValueExerciseOfWarrants" contextRef="From2021-07-012021-09-30_custom_CommonStockIssuableMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2</ix:nonFraction></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><ix:nonFraction name="PPCB:StockIssuedDuringPeriodValueExerciseOfWarrants" contextRef="From2021-07-012021-09-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">374,991</ix:nonFraction></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">(<ix:nonFraction name="PPCB:StockIssuedDuringPeriodValueExerciseOfWarrants" contextRef="From2021-07-012021-09-30_custom_SubscriptionReceivableMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">100,000</ix:nonFraction></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">)</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3022">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3023">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3024">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><ix:nonFraction name="PPCB:StockIssuedDuringPeriodValueExerciseOfWarrants" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">275,000</ix:nonFraction></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_ecustom--IssuanceOfCommonStockForAlternateCashlessExerciseOfWarrants_z3I645gY6Xvl" style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">Issuance
    of common stock for alternate cashless exercise of warrants</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">-</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3031">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">-</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3032">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td id="xdx_986_ecustom--IssuanceOfCommonStockForAlternateCashlessExerciseOfWarrantsShares_c20210701__20210930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zrvlfHE2jXp1" title="Issuance of common stock for alternate cashless exercise of warrants, shares" style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><ix:nonFraction name="PPCB:IssuanceOfCommonStockForAlternateCashlessExerciseOfWarrantsShares" contextRef="From2021-07-012021-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,399,988</ix:nonFraction></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><ix:nonFraction name="PPCB:IssuanceOfCommonStockForAlternateCashlessExerciseOfWarrants" contextRef="From2021-07-012021-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,400</ix:nonFraction></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td id="xdx_98D_ecustom--IssuanceOfCommonStockForAlternateCashlessExerciseOfWarrantsShares_c20210701__20210930__us-gaap--StatementEquityComponentsAxis__custom--CommonStockIssuableMember_zkd8ajumt0j2" title="Issuance of common stock for alternate cashless exercise of warrants, shares" style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><ix:nonFraction name="PPCB:IssuanceOfCommonStockForAlternateCashlessExerciseOfWarrantsShares" contextRef="From2021-07-012021-09-30_custom_CommonStockIssuableMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,999,990</ix:nonFraction></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><ix:nonFraction name="PPCB:IssuanceOfCommonStockForAlternateCashlessExerciseOfWarrants" contextRef="From2021-07-012021-09-30_custom_CommonStockIssuableMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,000</ix:nonFraction></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">(<ix:nonFraction name="PPCB:IssuanceOfCommonStockForAlternateCashlessExerciseOfWarrants" contextRef="From2021-07-012021-09-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">4,400</ix:nonFraction></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">)</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3036">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3037">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3038">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3039">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3040">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_407_ecustom--AdjustmentsToAdditionalPaidInCapitalReclassificationOfPremiumUponDebtConversion_zE1PYY6C5bn7" style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">Reclassification
    of put premium upon debt conversion</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">-</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3046">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">-</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3047">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">-</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3048">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">-</span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3049">-</span></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><ix:nonFraction name="PPCB:AdjustmentsToAdditionalPaidInCapitalReclassificationOfPremiumUponDebtConversion" contextRef="From2021-07-012021-09-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">109,643</ix:nonFraction></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3051">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3052">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3053">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3054">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><ix:nonFraction name="PPCB:AdjustmentsToAdditionalPaidInCapitalReclassificationOfPremiumUponDebtConversion" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">109,643</ix:nonFraction></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_z79EEXQaRRCj" style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">Stock
    based compensation in connection with stock option grants</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">-</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3057">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">-</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3058">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">-</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3059">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">-</span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3060">-</span></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2021-07-012021-09-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">20,718</ix:nonFraction></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3062">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3063">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3064">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3065">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">20,718</ix:nonFraction></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--ForeignCurrencyTransactionGainLossBeforeTax_z8AONWDZ8XUe" style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">Foreign
    currency translation gain</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">-</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3068">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">-</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3069">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">-</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3070">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">-</span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3071">-</span></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3072">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3073">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3074">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" contextRef="From2021-07-012021-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">64,193</ix:nonFraction></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3076">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">64,193</ix:nonFraction></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_406_ecustom--DeemedDividendUponAlternateCashlessExerciseOfWarrants_zbL6tfKkGDJe" style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">Deemed
    dividend upon alternate cashless exercise of warrants</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">-</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3079">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">-</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3080">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">-</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3081">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">-</span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3082">-</span></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><ix:nonFraction name="PPCB:DeemedDividendUponAlternateCashlessExerciseOfWarrants" contextRef="From2021-07-012021-09-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">114,844</ix:nonFraction></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3084">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">(<ix:nonFraction name="PPCB:DeemedDividendUponAlternateCashlessExerciseOfWarrants" contextRef="From2021-07-012021-09-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">114,844</ix:nonFraction></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">)</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3086">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3087">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3088">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--ProfitLoss_zAGkwyetBAui" style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 8pt Times New Roman, Times, Serif">Net
    loss for the three months ended September 30, 2021</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">-</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3090">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">-</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3091">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">-</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3092">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">-</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3093">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3094">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3095">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2021-07-012021-09-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">490,658</ix:nonFraction></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">)</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3097">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3098">-</span></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">490,658</ix:nonFraction></span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font: 8pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_436_c20210701__20210930_eus-gaap--StockholdersEquity_iE_z18FJB1LbBAk" style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Balance
    at September 30, 2021</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="border-bottom: Black 2.5pt double; font: bold 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td id="xdx_98C_eus-gaap--SharesOutstanding_iE_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zzvO2SF2ncAi" title="Ending balance, shares" style="border-bottom: Black 2.5pt double; font: bold 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-09-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">500,000</ix:nonFraction></b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="border-bottom: Black 2.5pt double; font: bold 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>$</b></span></td>
    <td style="border-bottom: Black 2.5pt double; font: bold 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-09-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,000</ix:nonFraction></b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="border-bottom: Black 2.5pt double; font: bold 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td id="xdx_984_eus-gaap--SharesOutstanding_iE_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zjPumrU7BBN4" title="Ending balance, shares" style="border-bottom: Black 2.5pt double; font: bold 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-09-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1</ix:nonFraction></b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="border-bottom: Black 2.5pt double; font: bold 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>$</b></span></td>
    <td style="border-bottom: Black 2.5pt double; font: bold 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl3102">-</span></b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="border-bottom: Black 2.5pt double; font: bold 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td id="xdx_98C_eus-gaap--SharesOutstanding_iE_c20210701__20210930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zTQcIcUNUxZe" title="Ending balance, shares" style="border-bottom: Black 2.5pt double; font: bold 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">43,841,644</ix:nonFraction></b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="border-bottom: Black 2.5pt double; font: bold 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>$</b></span></td>
    <td style="border-bottom: Black 2.5pt double; font: bold 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">43,842</ix:nonFraction></b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="border-bottom: Black 2.5pt double; font: bold 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td id="xdx_988_eus-gaap--SharesOutstanding_iE_c20210701__20210930__us-gaap--StatementEquityComponentsAxis__custom--CommonStockIssuableMember_zZ9PoKWKOy6d" title="Ending balance, shares" style="border-bottom: Black 2.5pt double; font: bold 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-09-30_custom_CommonStockIssuableMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,002,549</ix:nonFraction></b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="border-bottom: Black 2.5pt double; font: bold 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>$</b></span></td>
    <td style="border-bottom: Black 2.5pt double; font: bold 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-09-30_custom_CommonStockIssuableMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,002</ix:nonFraction></b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="border-bottom: Black 2.5pt double; font: bold 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>$</b></span></td>
    <td style="border-bottom: Black 2.5pt double; font: bold 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-09-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">55,444,574</ix:nonFraction></b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="border-bottom: Black 2.5pt double; font: bold 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>$</b></span></td>
    <td style="border-bottom: Black 2.5pt double; font: bold 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-09-30_custom_SubscriptionReceivableMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">100,000</ix:nonFraction></b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>)</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="border-bottom: Black 2.5pt double; font: bold 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>$</b></span></td>
    <td style="border-bottom: Black 2.5pt double; font: bold 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-09-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">58,804,968</ix:nonFraction></b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>)</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="border-bottom: Black 2.5pt double; font: bold 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>$</b></span></td>
    <td style="border-bottom: Black 2.5pt double; font: bold 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,149,397</ix:nonFraction></b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="border-bottom: Black 2.5pt double; font: bold 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>$</b></span></td>
    <td style="border-bottom: Black 2.5pt double; font: bold 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-09-30_us-gaap_TreasuryStockMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">46,477</ix:nonFraction></b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>)</b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="border-bottom: Black 2.5pt double; font: bold 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>$</b></span></td>
    <td style="border-bottom: Black 2.5pt double; font: bold 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,306,630</ix:nonFraction></b></span></td>
    <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>)</b></span></td></tr>
  </table>

<p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">The
accompanying unaudited condensed notes are an integral part of these unaudited condensed consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 131; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><b>PROPANC
BIOPHARMA, INC. AND SUBSIDIARY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif"><span id="a_018"></span><span style="font-size: 10pt"><b>CONDENSED
CONSOLIDATED STATEMENTS OF CASH FLOWS</b></span></span></p><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Unaudited)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_30F_112_zZBLIGd2HW01" summary="xdx: Statement - Consolidated Statements of Cash Flows" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_491_20210701__20210930_zorwblIGcWV9" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_497_20200701__20200930_z4RvvK6e3yQe" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Three
    Months Ended September 30,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesAbstract_iB_zAaRDTwhgOB2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">CASH FLOWS FROM OPERATING
    ACTIVITIES:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--ProfitLoss_i01_maCzVVM_zEK5tgsc1cpe" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Net loss</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">490,658</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">425,545</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_40C_eus-gaap--AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_i01B_zRrPTQkwFZ87" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-decoration: underline; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Adjustments
    to Reconcile Net Loss to Net Cash Used in Operating Activities:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--IssuanceOfStockAndWarrantsForServicesOrClaims_i02_maCzVVM_zqO8m9KXEfB4" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Issuance and amortization
    of common stock for services</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">133,422</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3130">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--ForeignCurrencyTransactionGainLossUnrealized_i02N_di_msCzVVM_z90jBE995xfh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Foreign currency transaction gain</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:ForeignCurrencyTransactionGainLossUnrealized" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">109,129</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:ForeignCurrencyTransactionGainLossUnrealized" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,960</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_400_eus-gaap--Depreciation_i02_maCzVVM_zvUQfu9swa04" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Depreciation expense</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:Depreciation" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">509</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:Depreciation" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">438</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--AmortizationOfDebtDiscountPremium_i02_maCzVVM_zC6HCde8YSff" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Amortization of debt discounts</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AmortizationOfDebtDiscountPremium" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,074</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AmortizationOfDebtDiscountPremium" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">121,281</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--DerivativeGainLossOnDerivativeNet_i02N_di_msCzVVM_zQfX9NKwvzH1" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Change in fair value of
    derivative liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DerivativeGainLossOnDerivativeNet" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,904</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:DerivativeGainLossOnDerivativeNet" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">64,952</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_405_eus-gaap--GainsLossesOnExtinguishmentOfDebt_i02N_di_msCzVVM_zQpp6r8r29e2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Gain on extinguishment
    of debt, net</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3144">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:GainsLossesOnExtinguishmentOfDebt" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">49,985</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_403_eus-gaap--ShareBasedCompensation_i02_maCzVVM_zDK7zYTrIjWf" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Stock option and restricted
    stock expense</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">20,718</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">20,718</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--OtherNoncashExpense_i02_maCzVVM_zXCTALhMTQU4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Non-cash interest expense</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OtherNoncashExpense" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,250</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OtherNoncashExpense" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,750</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--AccretionAmortizationOfDiscountsAndPremiumsInvestments_i02N_di_msCzVVM_zcMfV70lO5q4" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Accretion of put premium</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">90,192</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3154">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--IncreaseDecreaseInOperatingAssetsAbstract_i02B_zPNIuHZNpy77" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-decoration: underline; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Changes
    in Assets and Liabilities:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--IncreaseDecreaseInReceivables_i03N_di_msCzVVM_zimkK7TDSBQ9" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">GST receivable</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:IncreaseDecreaseInReceivables" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,937</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInReceivables" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">755</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_40A_eus-gaap--IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_i03N_di_msCzVVM_ztG2Bz7pknm6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Prepaid expenses and other
    assets</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,353</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3163">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--IncreaseDecreaseInAccountsPayable_i03_maCzVVM_zh187HODWzNb" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Accounts payable</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayable" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">137,927</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayable" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">53,576</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_ecustom--IncreaseDecreaseInDeferredRent_i03N_di_msCzVVM_zE1DdRdiKUEl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Deferred rent</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3168">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="PPCB:IncreaseDecreaseInDeferredRent" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">633</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--IncreaseDecreaseInEmployeeRelatedLiabilities_i03_maCzVVM_zgZ13dOptiV" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Employee benefit liability</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,067</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,544</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_i03_maCzVVM_z6BMLTrhhMsf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Accrued expenses and other
    payables</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">15,102</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">133,046</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--IncreaseDecreaseInInterestPayableNet_i03_maCzVVM_zDQgxuY2woT4" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt; padding-left: 20pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Accrued
    interest</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:IncreaseDecreaseInInterestPayableNet" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">11,338</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:IncreaseDecreaseInInterestPayableNet" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">16,262</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--NetCashProvidedByUsedInOperatingActivities_i01T_mtCzVVM_maCz5do_zJH7FkPGKSYe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">NET
    CASH USED IN OPERATING ACTIVITIES</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">486,758</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">179,949</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--NetCashProvidedByUsedInFinancingActivitiesAbstract_iB_zWrEAWqTM6Z" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">CASH FLOWS FROM FINANCING
    ACTIVITIES:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--ProceedsFromConvertibleDebt_i01_maCzfp2_zz3qR19XipWa" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Proceeds from convertible
    promissory notes, net of original issue discounts and issue costs</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ProceedsFromConvertibleDebt" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">160,000</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3187">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--RepaymentsOfConvertibleDebt_i01N_di_msCzfp2_zURbBxFflVSe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Repayments of convertible
    promissory notes</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3189">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:RepaymentsOfConvertibleDebt" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">43,000</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_40B_eus-gaap--ProceedsFromWarrantExercises_i01_maCzfp2_z6edD9Lt59dl" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Proceeds from the exercise
    of warrants</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ProceedsFromWarrantExercises" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">275,000</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ProceedsFromWarrantExercises" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">201,044</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--NetCashProvidedByUsedInFinancingActivities_i01T_mtCzfp2_maCz5do_zNoKyzYIc4uf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">NET
    CASH PROVIDED BY FINANCING ACTIVITIES</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">435,000</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">158,044</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_maCz5do_zW4z95Qoi417" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Effect of exchange rate changes on cash</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">95,320</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,116</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_iT_mtCz5do_zk0KWZPC6rM8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">NET INCREASE (DECREASE)
    IN CASH</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">43,562</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">15,789</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_iS_zDFaIFBdIpb5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">CASH AT BEGINNING OF
    PERIOD</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,255</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">67,007</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_iE_zYqUpNoPwmhl" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">CASH AT END OF PERIOD</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">45,817</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2020-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">51,218</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--SupplementalCashFlowInformationAbstract_iB_zVZqb6nQSk93" style="vertical-align: bottom; background-color: White">
    <td style="text-decoration: underline; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Supplemental
    Disclosure of Cash Flow Information</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_400_ecustom--CashPaidDuringPeriodAbstract_i01B_zNbfDXrtRyg5" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Cash paid during the period:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--InterestPaidNet_i02_zyb2RSyxHsqc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; padding-left: 20pt"><span style="font-family: Times New Roman, Times, Serif">Interest</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3216">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:InterestPaidNet" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">13,172</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--IncomeTaxesPaidNet_i02_zdekxhTazQo" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt; padding-left: 20pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Income
    Tax</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3219">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3220">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_iB_zNtWWu74LFQg" style="vertical-align: bottom; background-color: White">
    <td style="text-decoration: underline; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Supplemental
    Disclosure of Non-Cash Investing and Financing Activities</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--ConversionOfStockAmountConverted1_i01_zWWHpKeeSN45" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt; padding-left: 20pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Reduction
    of put premium related to conversions of convertible notes</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ConversionOfStockAmountConverted1" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">109,643</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ConversionOfStockAmountConverted1" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">204,919</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--ConversionOfStockAmountIssued1_i01_zhqMnVrahUb2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; padding-left: 20pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Conversion
    of convertible notes and accrued interest to common stock</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ConversionOfStockAmountIssued1" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">197,936</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ConversionOfStockAmountIssued1" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">417,670</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--StockIssued1_i01_z6ifgwPx8z9i" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt; padding-left: 20pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Common
    stock issued for accrued services</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockIssued1" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">448,440</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3232">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_407_ecustom--DeemedDividendUponAlternateCashlessExerciseOfWarrants1_i01_zak7Ejy11v3g" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; padding-left: 20pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Deemed
    dividend upon alternate cashless exercise of warrants</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="PPCB:DeemedDividendUponAlternateCashlessExerciseOfWarrants1" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">114,844</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3235">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_408_ecustom--SubscriptionReceivable_i01_zITMqGfadZ6h" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt; padding-left: 20pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Subscription
    receivable</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="PPCB:SubscriptionReceivable" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">100,000</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3238">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">The
accompanying unaudited condensed notes are an integral part of these unaudited condensed consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 132; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="a_023"></span>PROPANC
BIOPHARMA, INC. AND SUBSIDIARY<br />
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS<br />
SEPTEMBER 30, 2021</b></span></p>

<p id="xdx_046_c20210701__20210930_zrPq5TuqobGb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Unaudited)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<ix:nonNumeric contextRef="From2021-07-01to2021-09-30" escape="true" name="us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock"><p id="xdx_80D_eus-gaap--OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_zTTe2uwKtJ9f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTE
1 &#8211; <span id="xdx_826_zE9JmaYAHYRh">NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING AND REPORTING POLICIES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-07-01to2021-09-30" escape="true" name="PPCB:NatureOfOperationsPolicyTextBlock"><p id="xdx_842_ecustom--NatureOfOperationsPolicyTextBlock_zyTsCKnZdqck" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_86D_z2tlihvxFFVh">Nature
of Operations</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">Propanc
Biopharma, Inc. (the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;us&#8221; or &#8220;our&#8221;) was originally incorporated in Melbourne,
Victoria Australia on October 15, 2007 as Propanc PTY LTD, and continues to be based in Camberwell, Victoria Australia. Since its inception,
substantially all of the operations of the Company have been focused on the development of new cancer treatments targeting high-risk
patients, particularly cancer survivors, who need a follow-up, non-toxic, long-term therapy designed to prevent the cancer from returning
and spreading. The Company anticipates establishing global markets for its technologies. Our lead product candidate, which we refer to
as PRP, is an enhanced pro-enzyme formulation designed to enhance the anti-cancer effects of multiple enzymes acting synergistically.
It is currently in the preclinical phase of development.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 26.2pt; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">On
<span id="xdx_908_edei--EntityIncorporationDateOfIncorporation_dd_c20210701__20210930_zsFzMpziuoA7" title="Entity incorporation, date of incorporation"><ix:nonNumeric contextRef="From2021-07-01to2021-09-30" format="ixt:datemonthdayyearen" name="dei:EntityIncorporationDateOfIncorporation">November 23, 2010</ix:nonNumeric></span>, the Company was incorporated in the state of Delaware as Propanc Health Group Corporation. In January 2011, to reorganize
the Company, we acquired all of the outstanding shares of Propanc PTY LTD on a one-for-one basis making it a wholly-owned subsidiary
of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">On
July 22, 2016, the Company formed a wholly owned subsidiary, Propanc (UK) Limited under the laws of England and Wales for the purpose
of submitting an orphan drug application to the European Medicines Agency as a small and medium-sized enterprise. As of September 30,
2021, there has been no activity within this entity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">Effective
April 20, 2017, the Company changed its name to &#8220;Propanc Biopharma, Inc.&#8221; to better reflect the Company&#8217;s stage of
operations and development.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">In
July 2020, a world first patent was granted in Australia for the cancer treatment method patent family. Presently, there are 29 granted
patents and 33 patents under examination in key global jurisdictions relating to the use of proenzymes against solid tumors, covering
the lead product candidate PRP.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
Company hopes to capture and protect additional patentable subject matter based on the Company&#8217;s field of technology relating to
pharmaceutical compositions of proenzymes for treating cancer by filing additional patent applications as it advances its lead product
candidate, PRP, through various stages of development.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On
November 17, 2020, the Company effected a <span id="xdx_900_eus-gaap--StockholdersEquityReverseStockSplit_c20201116__20201117_zDGQYeiJ8fv4" title="Reverse stock"><ix:nonNumeric contextRef="From2020-11-162020-11-17" name="us-gaap:StockholdersEquityReverseStockSplit">one-for-one thousand (1:1,000)</ix:nonNumeric></span> reverse stock split of the Company&#8217;s issued and outstanding
shares of common stock (the &#8220;Reverse Stock Split&#8221;). Proportional adjustments for the Reverse Stock Split were made to the
Company&#8217;s outstanding stock options, warrants and equity incentive plans. All share and per-share data and amounts have been retroactively
adjusted as of the earliest period presented in the consolidated financial statements to reflect the Reverse Stock Split.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-07-01to2021-09-30" escape="true" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock"><p id="xdx_848_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zU3e1cFXZ2z2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_86B_zmrKinaSEaT2">Basis
of Presentation</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
Company&#8217;s interim unaudited condensed consolidated financial statements included in this Quarterly Report on Form 10-Q (this &#8220;Quarterly
Report&#8221;) have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;US
GAAP&#8221;) and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;). In the opinion
of the Company&#8217;s management, all adjustments (consisting of normal recurring adjustments and reclassifications and non-recurring
adjustments) necessary to present fairly our results of operations for the three months ended September 30, 2021 and 2020 and cash flows
for the three months ended September 30, 2021 and 2020 and our financial position at September 30, 2021 have been made. The Company&#8217;s
results of operations for the three months ended September 30, 2021 are not necessarily indicative of the operating results to be expected
for the full fiscal year ending June 30, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Certain
information and disclosures normally included in the notes to the Company&#8217;s annual audited consolidated financial statements have
been condensed or omitted from the Company&#8217;s interim unaudited condensed consolidated financial statements included in this Quarterly
Report. Accordingly, these interim unaudited condensed consolidated financial statements should be read in conjunction with the Company&#8217;s
audited consolidated financial statements and notes thereto for the fiscal year ended June 30, 2021. The June 30, 2021 balance sheet
is derived from those statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-07-01to2021-09-30" escape="true" name="us-gaap:ConsolidationPolicyTextBlock"><p id="xdx_84A_eus-gaap--ConsolidationPolicyTextBlock_zUzMhpDH8g1a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_86D_z8DTT4x83H5b">Principles
of Consolidation</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
unaudited condensed consolidated financial statements include the accounts of Propanc Biopharma, Inc., the parent entity, and its wholly-owned
subsidiary, Propanc PTY LTD. All inter-company balances and transactions have been eliminated in consolidation. Propanc (UK) Limited
was an inactive subsidiary at September 30, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 133; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>PROPANC
BIOPHARMA, INC. AND SUBSIDIARY<br />
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS<br />
SEPTEMBER 30, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Unaudited)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-07-01to2021-09-30" escape="true" name="us-gaap:UseOfEstimates"><p id="xdx_840_eus-gaap--UseOfEstimates_zKH5SsGwZ3P6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_86F_zHD6rxWI4vv5">Use
of Estimates</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
preparation of financial statements in conformity with the accounting principles generally accepted in the United States of America (&#8220;US
GAAP&#8221;) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure
of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses
during the reporting period. Actual results could differ from these estimates. Significant estimates in the accompanying consolidated
financial statements include the estimates of useful lives for depreciation, valuation of the operating lease liability and related right-of-use
asset, valuation of derivatives, valuation of beneficial conversion features on convertible debt, allowance for uncollectable receivables,
valuation of equity based instruments issued for other than cash, the valuation allowance on deferred tax assets and foreign currency
translation due to certain average exchange rates applied in lieu of spot rates on transaction dates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-07-01to2021-09-30" escape="true" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"><p id="xdx_84D_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zYtRi38HEaAj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_868_zdZ6QdOvTze2">Foreign
Currency Translation and Other Comprehensive Income (Loss)</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
Company&#8217;s wholly owned subsidiary&#8217;s functional currency is the Australian dollar (AUD). For financial reporting purposes,
the Australian dollar has been translated into the Company&#8217;s reporting currency which is the United States dollar ($) and/or (USD).
Assets and liabilities are translated at the exchange rate in effect at the balance sheet date. Revenues and expenses are translated
at the average rate of exchange prevailing during the reporting period. Equity transactions are translated at each historical transaction
date spot rate. Translation adjustments arising from the use of different exchange rates from period to period are included as a component
of stockholders&#8217; equity (deficit) as &#8220;Accumulated other comprehensive income (loss).&#8221; Gains and losses resulting from
foreign currency transactions are included in the statements of operations and comprehensive income (loss) as a component of other comprehensive
income (loss). There have been no significant fluctuations in the exchange rate for the conversion of Australian dollars to USD after
the balance sheet date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">Other
Comprehensive Income (Loss) for all periods presented includes only foreign currency translation gains (losses).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Assets
and liabilities denominated in foreign currencies are translated into the functional currency at the exchange rates prevailing at the
consolidated balance sheet date with any transaction gains and losses that arise from exchange rate fluctuations on transactions denominated
in a currency other than the functional currency included in the consolidated results of operations as incurred. Effective fiscal year
2021, the parent company determined that these intercompany loans will not be repaid in the foreseeable future and thus, per ASC 830-20-35-3,
gains and losses from measuring the intercompany balances are recorded within cumulative translation adjustment, a component of accumulated
other comprehensive income (loss). Prior to July 1, 2020, the Company recorded the foreign currency transaction gains and losses from
measuring the intercompany balances as a component of other income (expenses) titled foreign currency transaction gain (loss). For the
three months ended September 30, 2021 and 2020, the Company recognized an exchange gain (loss) of approximately $<span id="xdx_909_eus-gaap--OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_pp0p0_c20210701__20210930__us-gaap--DebtInstrumentAxis__custom--IntercompanyLoansMember_zOhbETHOlpbj"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" contextRef="From2021-07-012021-09-30_custom_IntercompanyLoansMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">619,000</ix:nonFraction></span> and ($<span id="xdx_90B_eus-gaap--OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_pp0p0_c20200701__20200930__us-gaap--DebtInstrumentAxis__custom--IntercompanyLoansMember_zKbJ5TpFaGWk"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" contextRef="From2020-07-012020-09-30_custom_IntercompanyLoansMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">583,000</ix:nonFraction></span>),
on intercompany loans made by the parent to the subsidiary which have not been repaid as of September 30, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-07-01to2021-09-30" escape="true" name="PPCB:ScheduleOfTranslationExchangeRatesTableTextBlock"><p id="xdx_89A_ecustom--ScheduleOfTranslationExchangeRatesTableTextBlock_zzNbOSdcA4v" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">As
of September 30, 2021 and June 30, 2021, the exchange rates used to translate amounts in Australian dollars into USD for the purposes
of preparing the consolidated financial statements were as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.45in"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_8B9_z5Jwt3MLbtk1" style="display: none">SCHEDULE
OF TRANSLATION EXCHANGE RATES</span>&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">September
    30, 2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">June
    30, 2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Exchange rate on balance sheet dates</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">USD : AUD exchange rate</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20210930_zAxoaqp5Oof3" style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ForeignCurrencyExchangeRateTranslation1" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">0.7214</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20210630_zAeNeQUILRnf" style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ForeignCurrencyExchangeRateTranslation1" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">0.7500</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Average exchange rate for the period</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">USD : AUD exchange rate</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20210930__srt--RangeAxis__srt--WeightedAverageMember_zyOm6KwP3orf" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ForeignCurrencyExchangeRateTranslation1" contextRef="AsOf2021-09-30_srt_WeightedAverageMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">0.7350</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20210630__srt--RangeAxis__srt--WeightedAverageMember_zvDey7ZbyR65" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ForeignCurrencyExchangeRateTranslation1" contextRef="AsOf2021-06-30_srt_WeightedAverageMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">0.7473</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A8_zfay8WlxJE4a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-07-01to2021-09-30" escape="true" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"><p id="xdx_893_eus-gaap--ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_zWSkwTH6ECU4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
change in Accumulated Other Comprehensive Income (Loss) by component during the three months ended September 30, 2021 was as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8B7_zATgnOSNnnC6" style="display: none">SCHEDULE
OF CHANGE IN ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Foreign<br />
    Currency Items:</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 82%"><span style="font-family: Times New Roman, Times, Serif">Balance, June 30, 2021</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iS_pp0p0_c20210701__20210930_zWQXY0qBZeZ4" title="Beginning balance" style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,085,204</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Unrealized foreign currency
    translation gain</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_pp0p0_c20210701__20210930_zlbQptq6YdTi" title="Foreign currency translation gain" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">64,193</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Ending balance, September 30, 2021</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iE_pp0p0_c20210701__20210930_z94fy1ZvaCCk" title="Ending balance" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,149,397</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A7_zcAa30ZDSqkj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 134; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>PROPANC
BIOPHARMA, INC. AND SUBSIDIARY<br />
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS<br />
SEPTEMBER 30, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Unaudited)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-07-01to2021-09-30" escape="true" name="us-gaap:FairValueOfFinancialInstrumentsPolicy"><p id="xdx_846_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zFC2t1G9CYMj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_864_zKI9KeM2Ukah">Fair
Value of Financial Instruments and Fair Value Measurements</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
Company measures its financial assets and liabilities in accordance with US GAAP. For certain financial instruments, including cash and
cash equivalents, accounts receivable, accounts payable and accrued liabilities, the carrying amounts approximate fair value due to their
short maturities. Amounts recorded for notes payable, net of discount, and loans payable also approximate fair value because current
interest rates available for debt with similar terms and maturities are substantially the same.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
Company follows accounting guidance for financial assets and liabilities. This standard defines fair value, provides guidance for measuring
fair value and requires certain disclosures. This standard does not require any new fair value measurements, but rather applies to all
other accounting pronouncements that require or permit fair value measurements. This guidance does not apply to measurements related
to share-based payments. This guidance discusses valuation techniques, such as the market approach (comparable market prices), the income
approach (present value of future income or cash flow), and the cost approach (cost to replace the service capacity of an asset or replacement
cost).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
guidance utilizes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three broad
levels. The following is a brief description of those three levels:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.95pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Level
1: Observable inputs such as quoted prices (unadjusted) in active markets for identical assets or liabilities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.95pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Level
2: Inputs, other than quoted prices that are observable, either directly or indirectly. These include quoted prices for similar assets
or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.95pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Level
3: Unobservable inputs in which little or no market data exists, therefore developed using estimates and assumptions developed by us,
which reflect those that a market participant would use.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Also
see Note 11 - Derivative Financial Instruments and Fair Value Measurements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-07-01to2021-09-30" escape="true" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock"><p id="xdx_844_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_z9t6VlcKAS8g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_861_zD9uCZl5Cas9">Cash
and Cash Equivalents</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">Cash
and cash equivalents include cash on hand and at banks, short-term deposits with an original maturity of three months or less with financial
institutions, and bank overdrafts. Bank overdrafts are reflected as a current liability on the balance sheets. There were <span id="xdx_907_eus-gaap--CashEquivalentsAtCarryingValue_iI_pp0p0_do_c20200930_zOFhHXa6w5rk"><ix:nonFraction name="us-gaap:CashEquivalentsAtCarryingValue" contextRef="AsOf2020-09-30" format="ixt-sec:numwordsen" decimals="0" scale="0" unitRef="USD">no</ix:nonFraction></span> cash equivalents
as of September 30, 2021 or June 30, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-07-01to2021-09-30" escape="true" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock"><p id="xdx_845_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zACW3ttl00x5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_866_zLBSJMg94jY4">Property
and Equipment</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">Property
and equipment are stated at cost, net of accumulated depreciation. Expenditures for maintenance and repairs are expensed as incurred;
additions, renewals, and betterments are capitalized. When property and equipment are retired or otherwise disposed of, the related cost
and accumulated depreciation are removed from the respective accounts, and any gain or loss is included in operations. Depreciation of
property and equipment is provided using the declining balance method. The depreciable amount is the cost less its residual value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-07-01to2021-09-30" escape="true" name="PPCB:ScheduleOfPropertyAndEquipmentEstimatedUsefulLivesTableTextBlock"><p id="xdx_891_ecustom--ScheduleOfPropertyAndEquipmentEstimatedUsefulLivesTableTextBlock_zt2mxbVoEEWc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
estimated useful lives are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8B4_zrzjwdUOooq6" style="display: none">SCHEDULE
OF PROPERTY AND EQUIPMENT ESTIMATED USEFUL LIVES</span></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 25%"><span style="font: 10pt Times New Roman, Times, Serif">Machinery
    and equipment</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 75%"><span style="font: 10pt Times New Roman, Times, Serif">-
    <span id="xdx_90F_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210701__20210930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_zgVFwUSlH806"><ix:nonNumeric contextRef="From2021-07-012021-09-30_us-gaap_MachineryAndEquipmentMember" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">5</ix:nonNumeric></span> years</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">Furniture</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">-
    <span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210701__20210930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zmrWJFVBDMYc"><ix:nonNumeric contextRef="From2021-07-012021-09-30_us-gaap_FurnitureAndFixturesMember" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">7</ix:nonNumeric></span> years</span></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8A6_zyicsnfsPJy8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-07-01to2021-09-30" escape="true" name="us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy"><p id="xdx_843_eus-gaap--GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_zpLA1iRncFHg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_868_zax2qkWhbWie">Patents</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">Patents
are stated at cost and amortized on a straight-line basis over the estimated future periods if and once the patent has been granted by
a regulatory agency. However, the Company will expense any patent costs as long as we are in the startup stage. Accordingly, as the Company&#8217;s
products are not currently approved for market, all patent costs incurred from 2013 through September 30, 2021 were expensed immediately.
This practice of expensing patent costs immediately ends when a product receives market authorization from a government regulatory agency.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-07-01to2021-09-30" escape="true" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"><p id="xdx_847_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zR7zOXittAmg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_86A_zfgxcl3KPwSa">Impairment
of Long-Lived Assets</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">In
accordance with ASC 360-10, &#8220;<i>Long-lived assets,&#8221;</i> which include property and equipment and intangible assets, are reviewed
for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability
of long-lived assets to be held and used is measured by a comparison of the carrying amount of an asset to the estimated undiscounted
future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated undiscounted future
cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the
assets. Fair value is generally determined using the asset&#8217;s expected future discounted cash flows or market value, if readily
determinable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 135; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>PROPANC
BIOPHARMA, INC. AND SUBSIDIARY<br />
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS<br />
SEPTEMBER 30, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Unaudited)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-07-01to2021-09-30" escape="true" name="us-gaap:EmployeeStockOwnershipPlanESOPPolicy"><p id="xdx_847_eus-gaap--EmployeeStockOwnershipPlanESOPPolicy_zKcRPhz1cmDl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_86B_zKiRtMFzZSlc">Employee
Benefit/Liability</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">Liabilities
arising in respect of wages and salaries, accumulated annual leave, accumulated long service leave and any other employee benefits expected
to be settled within twelve months of the reporting date are measured based on the employee&#8217;s remuneration rates applicable at
the reporting date. All other employee benefit liabilities are measured at the present value of the estimated future cash outflow to
be made in respect of services provided by employees up to the reporting date. All employee liabilities are owed within the next twelve
months.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-07-01to2021-09-30" escape="true" name="PPCB:GoodsAndServiceTaxPolicyTextBlock"><p id="xdx_845_ecustom--GoodsAndServiceTaxPolicyTextBlock_zFkquLvQEsN1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_86E_zAcVIJZd3dT8">Australian
Goods and Services Tax (&#8220;GST&#8221;)</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">Revenues,
expenses and balance sheet items are recognized net of the amount of GST, except payable and receivable balances which are shown inclusive
of GST. The GST incurred is payable on revenues to, and recoverable on purchases from, the Australian Taxation Office.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">Cash
flows are presented in the statements of cash flow on a gross basis, except for the GST component of investing and financing activities,
which are disclosed as operating cash flows.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">As
of September 30, 2021, and June 30, 2021, the Company was owed $<span id="xdx_904_eus-gaap--ValueAddedTaxReceivableCurrent_iI_pp0p0_c20210930_zNHlbbV7dpad" title="Value added tax receivable"><ix:nonFraction name="us-gaap:ValueAddedTaxReceivableCurrent" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,238</ix:nonFraction></span> and $<span id="xdx_90A_eus-gaap--ValueAddedTaxReceivableCurrent_iI_pp0p0_c20200930_zQ4JT5NkFXzk" title="Value added tax receivable"><ix:nonFraction name="us-gaap:ValueAddedTaxReceivableCurrent" contextRef="AsOf2020-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,341</ix:nonFraction></span>, respectively, from the Australian Taxation Office.
These amounts were fully collected subsequent to the balance sheet reporting dates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-07-01to2021-09-30" escape="true" name="us-gaap:DerivativesReportingOfDerivativeActivity"><p id="xdx_847_eus-gaap--DerivativesReportingOfDerivativeActivity_zQ2WlEN1DWE6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_861_zc8e4LzGljd1">Derivative
Instruments</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">ASC
Topic 815, <i>Derivatives and Hedging</i> (&#8220;ASC Topic 815&#8221;), establishes accounting and reporting standards for derivative
instruments and for hedging activities by requiring that all derivatives be recognized in the balance sheet and measured at fair value.
Gains or losses resulting from changes in the fair value of derivatives are recognized in earnings. On the date of conversion or payoff
of debt, the Company records the fair value of the conversion shares, removes the fair value of the related derivative liability, removes
any discounts and records a net gain or loss on debt extinguishment. On July 1, 2019 the Company adopted ASU 2017-11 under which down-round
Features in Financial Instruments will no longer cause derivative treatment. The Company applies the modified prospective method of adoption.
There were no cumulative effects on adoption.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-07-01to2021-09-30" escape="true" name="PPCB:ConvertibleNotesPolicyTextBlock"><p id="xdx_845_ecustom--ConvertibleNotesPolicyTextBlock_zxn5O0pSGSxg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_861_zqNXrYouGBs7">Convertible
Notes With Variable Conversion Options</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
Company has entered into convertible notes, some of which contain variable conversion options, whereby the outstanding principal and
accrued interest may be converted, by the holder, into common shares at a fixed discount to the price of the common stock at or around
the time of conversion. The Company treats these convertible notes as stock settled debt under ASC 480, &#8220;<i>Distinguishing Liabilities
from Equity</i>&#8221; and measures the fair value of the notes at the time of issuance, which is the result of the share price discount
at the time of conversion and records the put premium as interest expense.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-07-01to2021-09-30" escape="true" name="us-gaap:IncomeTaxPolicyTextBlock"><p id="xdx_848_eus-gaap--IncomeTaxPolicyTextBlock_zhOGS6N4HyHb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_86B_z4ulDnTrWbva">Income
Taxes</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
Company is governed by Australia and United States income tax laws, which are administered by the Australian Taxation Office and the
United States Internal Revenue Service, respectively. The Company follows ASC 740 &#8220;<i>Accounting for Income Taxes</i>,&#8221; when
accounting for income taxes, which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred
income tax assets and liabilities are computed annually for temporary differences between the financial statements and tax bases of assets
and liabilities that will result in taxable or deductible amounts in the future based on enacted tax laws and rates applicable to the
periods in which the differences are expected to affect taxable income. Valuation allowances are established when necessary to reduce
deferred tax assets to the amount expected to be realized. Income tax expense is the tax payable or refundable for the period plus or
minus the change during the period in deferred tax assets and liabilities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
Company follows ASC 740, Sections 25 through 60, &#8220;<i>Accounting for Uncertainty in Income Taxes</i>.&#8221; These sections provide
detailed guidance for the financial statement recognition, measurement and disclosure of uncertain tax positions recognized in the financial
statements. Tax positions must meet a &#8220;more-likely-than-not&#8221; recognition threshold at the effective date to be recognized
upon the adoption of ASC 740 and in subsequent periods.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-07-01to2021-09-30" escape="true" name="us-gaap:ResearchAndDevelopmentExpensePolicy"><p id="xdx_842_eus-gaap--ResearchAndDevelopmentExpensePolicy_zhSDwzgwptn3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_864_z7raaBtt59u1">Research
and Development Costs and Tax Credits</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">In
accordance with ASC 730-10, <i>&#8220;Research and Development-Overall,&#8221;</i> research and development costs are expensed when incurred.
Total research and development costs for the three months ended September 30, 2021 and 2020 were $<span id="xdx_901_eus-gaap--ResearchAndDevelopmentExpense_pp0p0_c20210701__20210930_z8IQi4E6xGXk"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">46,554</ix:nonFraction></span> and $<span id="xdx_90B_eus-gaap--ResearchAndDevelopmentExpense_pp0p0_c20200701__20200930_zKalVQgW6Sua"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">50,846</ix:nonFraction></span>, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 136; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>PROPANC
BIOPHARMA, INC. AND SUBSIDIARY<br />
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS<br />
SEPTEMBER 30, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Unaudited)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
Company may apply for research and development tax concessions with the Australian Taxation Office on an annual basis. Although the amount
is possible to estimate at year end, the Australian Taxation Office may reject or materially alter the claim amount. Accordingly, the
Company does not recognize the benefit of the claim amount until cash receipt since collectability is not certain until such time. The
tax concession is a refundable credit. If the Company has net income, then the Company can receive the credit which reduces its income
tax liability. If the Company has net losses, then the Company may still receive a cash payment for the credit, however, the Company&#8217;s
net operating loss carryforwards are reduced by the gross equivalent loss that would produce the credit amount when the income tax rate
is applied to that gross amount. The concession is recognized as tax benefit, in operations, upon receipt.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">During
each of the three months ended September 30, 2021 and 2020, the Company applied for, and received from the Australian Taxation Office,
a research and development tax credit in the amount of $<span id="xdx_900_eus-gaap--IncomeTaxExpenseBenefit_iN_pp0p0_dixL_c20200701__20200930_zfbdkDjR4Lw6" title="::XDX::-"><span id="xdx_90E_eus-gaap--IncomeTaxExpenseBenefit_iN_pp0p0_dixL_c20210701__20210930_zu8lPCnqt6u" title="Tax credits::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl3304"><span style="-sec-ix-hidden: xdx2ixbrl3306">0</span></span></span></span>, which is reflected as a tax benefit in the accompanying unaudited condensed
consolidated statements of operations and comprehensive income (loss).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-07-01to2021-09-30" escape="true" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy"><p id="xdx_847_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_z7ocjmQGNxmd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_86D_zxXe6dOqY3P8">Stock
Based Compensation</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
Company records stock-based compensation in accordance with ASC 718, &#8220;<i>Stock Compensation</i>&#8221;. ASC 718 requires the fair
value of all stock-based employee compensation awarded to employees to be recorded as an expense over the shorter of the service period
or the vesting period. The Company values employee and non-employee stock-based compensation at fair value using the Black-Scholes Option
Pricing Model.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
Company adopted ASU 2018-07 and accounts for non-employee share-based awards in accordance with the measurement and recognition criteria
of ASC 718 and recognizes the fair value of such awards over the service period. The Company used the modified prospective method of
adoption. There was no cumulative effect of adoption on July 1, 2019.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-07-01to2021-09-30" escape="true" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock"><p id="xdx_842_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zoI5lfak5jZ7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_866_zQ0pBQvL2eDf">Revenue
Recognition</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
Company adopted and implemented on July 1, 2018, ASC 606 &#8211; Revenue from Contracts with Customers (&#8220;ASC 606&#8221;). ASC 606
did not have a material impact on the consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Upon
implementation of ASC 606, the Company recognizes revenue in accordance with that core principle by applying the following steps:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Step
1: Identify the contract(s) with a customer.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Step
2: Identify the performance obligations in the contract.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Step
3: Determine the transaction price.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Step
4: Allocate the transaction price to the performance obligations in the contract.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Step
5: Recognize revenue when (or as) the entity satisfies a performance obligation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">Subject
to these criteria, the Company intends to recognize revenue relating to royalties on product sales in the period in which the sale occurs
and the royalty term has begun.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-07-01to2021-09-30" escape="true" name="us-gaap:LegalCostsPolicyTextBlock"><p id="xdx_845_eus-gaap--LegalCostsPolicyTextBlock_zYIGCDDncv8f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_869_zZfv7SoMGD11">Legal
Expenses</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">All
legal costs for litigation are charged to expense as incurred.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-07-01to2021-09-30" escape="true" name="us-gaap:LesseeLeasesPolicyTextBlock"><p id="xdx_84E_eus-gaap--LesseeLeasesPolicyTextBlock_zXunrNvs61Gc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_868_zSbh3EyY4Kej">Leases</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In
February 2016, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued ASU 2016-02, <i>Leases</i> (Topic 842). The updated
guidance requires lessees to recognize lease assets and lease liabilities for most operating leases. In addition, the updated guidance
requires that lessors separate lease and non-lease components in a contract in accordance with the new revenue guidance in ASC 606. This
guidance is effective for interim and annual reporting periods beginning after December 15, 2018. The Company adopted this guidance effective
July 1, 2019.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On
July 1, 2019, the Company adopted ASU No. 2016-02, applying the package of practical expedients to leases that commenced before the effective
date whereby the Company elected to not reassess the following: (i) whether any expired or existing contracts contain leases and; (ii)
initial direct costs for any existing leases. For contracts entered into on or after the effective date, at the inception of a contract
the Company assessed whether the contract is, or contains, a lease. The Company&#8217;s assessment is based on: (1) whether the contract
involves the use of a distinct identified asset, (2) whether we obtain the right to substantially all the economic benefit from the use
of the asset throughout the period, and (3) whether it has the right to direct the use of the asset. The Company will allocate the consideration
in the contract to each lease component based on its relative stand-alone price to determine the lease payments. In addition, the Company
elected not to apply ASC Topic 842 to arrangements with lease terms of 12 months or less.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Operating
lease ROU assets represents the right to use the leased asset for the lease term and operating lease liabilities are recognized based
on the present value of future minimum lease payments over the lease term at commencement date. As most leases do not provide an implicit
rate, the Company use an incremental borrowing rate based on the information available at the adoption date in determining the present
value of future payments. Lease expense for minimum lease payments is amortized on a straight-line basis over the lease term and will
be included in general and administrative expenses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 137; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>PROPANC
BIOPHARMA, INC. AND SUBSIDIARY<br />
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS<br />
SEPTEMBER 30, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Unaudited)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-07-01to2021-09-30" escape="true" name="us-gaap:EarningsPerSharePolicyTextBlock"><p id="xdx_84E_eus-gaap--EarningsPerSharePolicyTextBlock_zpfEBsYvPCak" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_869_zIeaaJNnPy08">Basic
and Diluted Net Loss Per Common Share</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Basic
net loss per share is computed by dividing the net loss by the weighted average number of common shares outstanding during the period.
Diluted net loss per common share is computed by dividing the net loss by the weighted average number of common shares outstanding for
the period and, if dilutive, potential common shares outstanding during the period. Potentially dilutive securities consist of the incremental
common shares issuable upon exercise of common stock equivalents such as stock options, warrants and convertible debt instruments. Potentially
dilutive securities are excluded from the computation if their effect is anti-dilutive. As a result, the basic and diluted per share
amounts for all periods presented are identical. <span id="xdx_902_eus-gaap--DebtInstrumentConvertibleTermsOfConversionFeature_c20210701__20210930_zELEU7ykKkIk" title="Debt conversion percentage, description"><ix:nonNumeric contextRef="From2021-07-01to2021-09-30" name="us-gaap:DebtInstrumentConvertibleTermsOfConversionFeature">Each holder of the notes has agreed to a <span id="xdx_904_eus-gaap--DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_pid_dp_uPure_c20200701__20210630_zhcROCTayfJi" title="Debt conversion percentage"><ix:nonFraction name="us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">4.99</ix:nonFraction></span>% beneficial ownership conversion limitation
(subject to certain noteholders&#8217; ability to increase such limitation to <span id="xdx_906_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_uPure_c20210819__us-gaap--TypeOfArrangementAxis__custom--TwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember_zjDxTQNnQMx6"><ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" contextRef="AsOf2021-08-19_custom_TwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">9.99</ix:nonFraction></span>% upon 60 days&#8217; notice to the Company), and each
note may not be converted during the first six-month period from the date of issuance. The securities for the period ended September
30, 2021 and 2020 were considered dilutive securities which were excluded from the computation since the effect is anti-dilutive.</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span title="Debt conversion percentage, description">&#160;</span></span></p>

<ix:nonNumeric contextRef="From2021-07-01to2021-09-30" escape="true" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"><p id="xdx_89A_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zLusIxCV0JF5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8B8_z5qGGqx37Jgb" style="display: none">SCHEDULE
OF DILUTIVE SECURITIES EXCLUDED FROM COMPUTATION</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 100%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">September
    30, 2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">September
    30, 2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Unaudited)</b></span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Unaudited)</b></span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Stock Options</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20210701__20210930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_zRWorJnhqvNc" style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2021-07-012021-09-30_us-gaap_EmployeeStockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">59</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20200701__20200930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_zlntA9renUm6" style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2020-07-012020-09-30_us-gaap_EmployeeStockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">60</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Stock Warrants</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20210701__20210930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zM5tes7KTZa" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2021-07-012021-09-30_us-gaap_WarrantMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">111,932</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20200701__20200930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zt22Rh7qyBR8" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2020-07-012020-09-30_us-gaap_WarrantMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">135,725</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Unvested restricted stock</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20210701__20210930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--UnvestedRestrictedStockMember_ziQ1XBlUpRa9" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2021-07-012021-09-30_custom_UnvestedRestrictedStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">59</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20200701__20200930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--UnvestedRestrictedStockMember_zaZOZ38j94Hd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2020-07-012020-09-30_custom_UnvestedRestrictedStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">117</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Convertible Debt</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20210701__20210930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertibleDebtSecuritiesMember_zadTQYWGAgi6" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2021-07-012021-09-30_us-gaap_ConvertibleDebtSecuritiesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">23,293,971</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_981_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20200701__20200930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertibleDebtSecuritiesMember_zsFdubolj81a" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2020-07-012020-09-30_us-gaap_ConvertibleDebtSecuritiesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">510,674</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20210701__20210930_zjRj7iczs6t1" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">23,406,021</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20200701__20200930_zQ6W7BJxm8Kh" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">646,576</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A6_ztUc5Ua4Aso2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-07-01to2021-09-30" escape="true" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock"><p id="xdx_841_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zFYh4pSJ2Re4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_863_zJh69seVZbtk">Recent
Accounting Pronouncements</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">We
have reviewed the FASB issued ASU accounting pronouncements and interpretations thereof that have effectiveness dates during the periods
reported and in future periods. We have carefully considered the new pronouncements that alter previous generally accepted accounting
principles and do not believe that any new or modified principles will have a material impact on the Company&#8217;s reported financial
position or operations in the near term. The applicability of any standard is subject to the formal review of the Company&#8217;s financial
management.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In
August 2020, the FASB issued ASU 2020-06, &#8220;Debt &#8211; Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives
and Hedging &#8211; Contracts in Entity&#8217;s Own Equity (Subtopic 815-40)&#8221;. This ASU reduces the number of accounting models
for convertible debt instruments and convertible preferred stock. As well as amend the guidance for the derivatives scope exception for
contracts in an entity&#8217;s own equity to reduce form-over-substance-based accounting conclusions. In addition, this ASU improves
and amends the related EPS guidance. This standard is effective for us on July 1, 2022, including interim periods within those fiscal
years. Adoption is either a modified retrospective method or a fully retrospective method of transition. The Company is currently assessing
the impact the new guidance will have on our consolidated financial statements.</span></p>

</ix:nonNumeric><p id="xdx_859_zwf6AthGWyXc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-07-01to2021-09-30" escape="true" name="us-gaap:SubstantialDoubtAboutGoingConcernTextBlock"><p id="xdx_803_eus-gaap--SubstantialDoubtAboutGoingConcernTextBlock_ziUB31Kjwqvc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTE
2 &#8211; <span id="xdx_82D_z3Eip7SGNUxj">GOING CONCERN</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
accompanying unaudited condensed consolidated financial statements have been prepared in conformity with US GAAP, which contemplate continuation
of the Company as a going concern. For the three months ended September 30, 2021, the Company had no revenues, had a net loss of $<span id="xdx_90C_eus-gaap--ProfitLoss_iN_pp0p0_di_c20210701__20210930_zZ86ZTKlE3f"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">490,658</ix:nonFraction></span>,
and had net cash used in operations of $<span id="xdx_90B_eus-gaap--NetCashProvidedByUsedInOperatingActivities_iN_pp0p0_di_c20210701__20210930_z7zDthEysJmg"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">486,758</ix:nonFraction></span>. Additionally, as of September 30, 2021, the Company had a working capital deficit, stockholders&#8217;
deficit and accumulated deficit of $<span id="xdx_901_ecustom--WorkingCapitalDeficit_iI_pp0p0_c20210930_zmFMtHUfZicd"><ix:nonFraction name="PPCB:WorkingCapitalDeficit" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,312,387</ix:nonFraction></span>, $<span id="xdx_90A_eus-gaap--StockholdersEquity_iNI_pp0p0_di_c20210930_ztn1uKQgbUUb"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">2,306,630</ix:nonFraction></span> and $<span id="xdx_900_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_pp0p0_di_c20210930_zUtdVGNRXych"><ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">58,804,968</ix:nonFraction></span>, respectively. It is management&#8217;s opinion that these
conditions raise substantial doubt about the Company&#8217;s ability to continue as a going concern for a period of at least twelve months
from the issue date of this Quarterly Report.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
unaudited condensed consolidated financial statements do not include any adjustments to reflect the possible future effect on the recoverability
and classification of assets or the amounts and classifications of liabilities that may result from the outcome of this uncertainty.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">Successful
completion of the Company&#8217;s development program and, ultimately, the attainment of profitable operations are dependent upon future
events, including obtaining adequate financing to fulfill its development activities, acceptance of the Company&#8217;s patent applications,
obtaining additional sources of suitable and adequate financing and ultimately achieving a level of sales adequate to support the Company&#8217;s
cost structure and business plan. The Company&#8217;s ability to continue as a going concern is also dependent on its ability to further
develop and execute on its business plan. However, there can be no assurances that any or all of these endeavors will be successful.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 138; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>PROPANC
BIOPHARMA, INC. AND SUBSIDIARY<br />
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS<br />
SEPTEMBER 30, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Unaudited)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">In
March 2020, the outbreak of COVID-19 (coronavirus) caused by a novel strain of the coronavirus was recognized as a pandemic by the World
Health Organization, and the outbreak has become increasingly widespread in the United States, Europe and Australia, including in each
of the areas in which the Company operates. The COVID-19 (coronavirus) outbreak has had a notable impact on general economic conditions,
including but not limited to the temporary closures of many businesses, &#8220;shelter in place&#8221; and other governmental regulations,
reduced business and consumer spending due to both job losses, reduced investing activity and M&amp;A transactions, among many other
effects attributable to the COVID-19 (coronavirus), and there continue to be many unknowns. While to date the Company has not been required
to stop operating, management is evaluating its use of its office space, virtual meetings and the like. The Company continues to monitor
the impact of the COVID-19 (coronavirus) outbreak closely. The extent to which the COVID-19 (coronavirus) outbreak will impact our operations,
ability to obtain financing or future financial results is uncertain.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-07-01to2021-09-30" escape="true" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock"><p id="xdx_80B_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zepSISzbskde" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTE
3 &#8211; <span id="xdx_82B_z2gR3jESkmWk">PROPERTY AND EQUIPMENT</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-07-01to2021-09-30" escape="true" name="us-gaap:PropertyPlantAndEquipmentTextBlock"><p id="xdx_897_eus-gaap--PropertyPlantAndEquipmentTextBlock_zg8Ghbs3Cm4d" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">Property
and equipment consist of the following as of September 30, 2021 and June 30, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8BD_zxaUS1cN4CT3" style="display: none">SCHEDULE
OF PROPERTY AND EQUIPMENT</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_49C_20210930_zAUwbf34Hci3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">September
    30, 2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_49C_20210630_zkfliRIteW57" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">June
    30, 2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(Unaudited)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_maPPAENzBVB_zWa3ZPXSA1sj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Office equipment at cost</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">27,532</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">28,623</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_msPPAENzBVB_zJIDwd7Qqdoa" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Less: Accumulated depreciation</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">23,939</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">24,368</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--PropertyPlantAndEquipmentNet_iTI_pp0p0_mtPPAENzBVB_zCIlyNdbrAOk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total property, plant,
    and equipment</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,593</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,255</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AD_zkLpjrunY5Y2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">Depreciation
expense for the three months ended September 30, 2021 and 2020 were $<span id="xdx_90D_eus-gaap--Depreciation_pp0p0_c20210701__20210930_zRmSWSeRcGnc"><ix:nonFraction name="us-gaap:Depreciation" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">509</ix:nonFraction></span> and $<span id="xdx_90C_eus-gaap--Depreciation_pp0p0_c20200701__20200930_z5geXjYMtJb2"><ix:nonFraction name="us-gaap:Depreciation" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">438</ix:nonFraction></span>, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-07-01to2021-09-30" escape="true" name="PPCB:DueToFormerDirectorRelatedPartyDisclosureTextBlock"><p id="xdx_803_ecustom--DueToFormerDirectorRelatedPartyDisclosureTextBlock_zYCHdB7lkeA7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTE
4 &#8211; <span id="xdx_820_z7yy1mR29q99">DUE TO FORMER DIRECTOR - RELATED PARTY</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">Due
to former director - related party represents unsecured advances made primarily by a former director for operating expenses on behalf
of the Company such as intellectual property and formation expenses. The expenses were paid for on behalf of the Company and are due
upon demand. The Company is currently not being charged interest under these advances. The total amount owed the former director at September
30, 2021 and June 30, 2021 were $<span id="xdx_90E_eus-gaap--DueToRelatedPartiesCurrent_iI_pp0p0_c20210930_zJxA1xS5YYVd"><ix:nonFraction name="us-gaap:DueToRelatedPartiesCurrent" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">32,076</ix:nonFraction></span> and $<span id="xdx_906_eus-gaap--DueToRelatedPartiesCurrent_iI_pp0p0_c20210630_zbE0QKQMtL6g"><ix:nonFraction name="us-gaap:DueToRelatedPartiesCurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">33,347</ix:nonFraction></span>, respectively. The Company plans to repay the advances as its cash resources allow
(see Note 9).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-07-01to2021-09-30" escape="true" name="PPCB:LoansAndNotesPayableDisclosureTextBlock"><p id="xdx_80A_ecustom--LoansAndNotesPayableDisclosureTextBlock_zS4pzWmIuk09" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTE
5 &#8211; <span id="xdx_822_zntXa5mgWi7c">LOANS AND NOTES PAYABLE</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Loan
from Former Director - Related Party</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">Loan
from the Company&#8217;s former director at September 30, 2021 and June 30, 2021 were $<span id="xdx_907_eus-gaap--LoansPayable_iI_pp0p0_c20210930__srt--TitleOfIndividualAxis__custom--DirectorsAndOfficerMember_zjrzMBd5GgQ"><ix:nonFraction name="us-gaap:LoansPayable" contextRef="AsOf2021-09-30_custom_DirectorsAndOfficerMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">53,384</ix:nonFraction></span> and $<span id="xdx_906_eus-gaap--LoansPayable_iI_pp0p0_c20210630__srt--TitleOfIndividualAxis__custom--DirectorsAndOfficerMember_zi5UsTPh9Iy4"><ix:nonFraction name="us-gaap:LoansPayable" contextRef="AsOf2021-06-30_custom_DirectorsAndOfficerMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">55,500</ix:nonFraction></span>, respectively. The loan bears
no interest and is payable on demand. The Company did not repay any amount on this loan during the three months ended September 30, 2021
and 2020, respectively (see Note 9).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-07-01to2021-09-30" escape="true" name="us-gaap:DebtDisclosureTextBlock"><p id="xdx_800_eus-gaap--DebtDisclosureTextBlock_zc2SqHBxedb7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTE
6 &#8211; <span id="xdx_82C_zKhRExlhfXl9">CONVERTIBLE NOTES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-07-01to2021-09-30" escape="true" name="us-gaap:ConvertibleDebtTableTextBlock"><p id="xdx_897_eus-gaap--ConvertibleDebtTableTextBlock_zjBtvrzAXz4j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
Company&#8217;s convertible notes outstanding at September 30, 2021 and June 30, 2021 were as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_8B0_zcA9zJu0m1X9" style="display: none">SCHEDULE
OF CONVERTIBLE NOTES</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_491_20210930_zAp0KEWZ480k" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">September
    30, 2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_497_20210630_zyLLJTngGXul" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">June
    30, 2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(Unaudited)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--DebtInstrumentCarryingAmount_iI_pp0p0_maLTDzcuB_zeR5AoxnitQ" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Convertible notes and debenture</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 17%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DebtInstrumentCarryingAmount" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">377,780</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 15%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DebtInstrumentCarryingAmount" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">400,128</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--DebtInstrumentUnamortizedDiscount_iNI_pp0p0_di_msLTDzcuB_z1VTqFyrK7xb" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Unamortized discounts</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:DebtInstrumentUnamortizedDiscount" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">7,565</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:DebtInstrumentUnamortizedDiscount" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">6,139</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_40C_eus-gaap--DepositLiabilitiesAccruedInterest_iI_pp0p0_maLTDzcuB_zzTn53DC3CG" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Accrued interest</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DepositLiabilitiesAccruedInterest" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">37,348</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DepositLiabilitiesAccruedInterest" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">34,098</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--DebtInstrumentUnamortizedPremium_iI_pp0p0_maLTDzcuB_ztrTE0IiZtYh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Premium, net</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DebtInstrumentUnamortizedPremium" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">177,045</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DebtInstrumentUnamortizedPremium" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">196,496</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--LongTermDebt_iTI_pp0p0_mtLTDzcuB_zuIe10MIoIM4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Convertible notes,
    net</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:LongTermDebt" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">584,608</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:LongTermDebt" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">624,583</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A6_zemr5ZC68yq2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>


<ix:exclude><!-- Field: Page; Sequence: 139; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>PROPANC
BIOPHARMA, INC. AND SUBSIDIARY<br />
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS<br />
SEPTEMBER 30, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Unaudited)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Convertible
Note Issued with Consulting Agreement</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>August
10, 2017 Consulting Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On
August 10, 2017, the Company entered into a consulting agreement, retroactive to May 16, 2017, with a certain consultant, pursuant to
which the consultant agreed to provide certain consulting and business advisory services in exchange for a $<span id="xdx_905_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20170810__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember_zdMEwkoDhrF5" title="Convertible debt principal amount"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2017-08-10_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">310,000</ix:nonFraction></span> junior subordinated
convertible note. The maturity date of the August 10, 2017 Convertible Note was August 2019 and is currently past due (see Note 8). The
note accrues interest at a rate of <span id="xdx_906_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20170810__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember_zHsGPhEkIvh9" title="Debt instrument, interest rate, stated percentage"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2017-08-10_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">10</ix:nonFraction></span>% per annum and is convertible into common stock at the lesser of $<span id="xdx_90E_eus-gaap--DebtConversionConvertedInstrumentAmount1_pp0p0_c20170807__20170810__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember_zBByegCwFfaf" title="Debt conversion of converted amount"><ix:nonFraction name="us-gaap:DebtConversionConvertedInstrumentAmount1" contextRef="From2017-08-072017-08-10_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">750</ix:nonFraction></span> or <span id="xdx_90A_eus-gaap--DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_dp_uPure_c20170807__20170810__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember_zJcps9fyr4oh" title="Common stock trading volume, percent"><ix:nonFraction name="us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" contextRef="From2017-08-072017-08-10_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">65</ix:nonFraction></span>% of the three lowest
trades in the <span id="xdx_906_eus-gaap--DebtInstrumentConvertibleThresholdTradingDays_dc_uInteger_c20170807__20170810__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember_zGmOAN9OUAw9" title="Common stock trading days"><ix:nonFraction name="us-gaap:DebtInstrumentConvertibleThresholdTradingDays" contextRef="From2017-08-072017-08-10_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember" format="ixt-sec:numwordsen" decimals="INF" unitRef="Integer">ten</ix:nonFraction></span> trading days prior to the conversion. The note was fully earned upon signing the agreement and matures on <span id="xdx_909_eus-gaap--DebtInstrumentMaturityDate_dd_c20170807__20170810__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember_zyP7hAcsqzb6" title="Debt maturity date"><ix:nonNumeric contextRef="From2017-08-072017-08-10_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember" format="ixt:datemonthdayyearen" name="us-gaap:DebtInstrumentMaturityDate">August 10,
2019</ix:nonNumeric></span>. The Company accrued $<span id="xdx_906_eus-gaap--AccruedLiabilitiesCurrentAndNoncurrent_iI_pp0p0_c20170630__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember_zaaitofopWHl" title="Accrued expenses"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrentAndNoncurrent" contextRef="AsOf2017-06-30_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">155,000</ix:nonFraction></span> related to this expense at June 30, 2017 and recorded the remaining $<span id="xdx_90A_eus-gaap--AccruedLiabilitiesCurrentAndNoncurrent_iI_pp0p0_c20180630__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember_zRQ09peme5id" title="Accrued expenses"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrentAndNoncurrent" contextRef="AsOf2018-06-30_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">155,000</ix:nonFraction></span> related to this expense
in fiscal year 2018. Upon an event of default, principal and accrued interest will become immediately due and payable under the note.
Additionally, upon an event of default, at the election of the holder, the note would accrue interest at a default interest rate of <span id="xdx_90B_ecustom--DebtInstrumentDebtDefaultInterestRate_dp_uPure_c20170807__20170810__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember_zcUwSkiztpM2" title="Debt instrument, default, interest rate"><ix:nonFraction name="PPCB:DebtInstrumentDebtDefaultInterestRate" contextRef="From2017-08-072017-08-10_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">18</ix:nonFraction></span>%
per annum or the highest rate of interest permitted by law. The consulting agreement had a three-month term and expired on August 16,
2017. An aggregate total of $<span id="xdx_901_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_iI_pp0p0_c20170810__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember_zMHkB6YPayh3" title="Embedded derivative, fair value of embedded derivative liability"><ix:nonFraction name="us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" contextRef="AsOf2017-08-10_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">578,212</ix:nonFraction></span> of this note was bifurcated with the embedded conversion option recorded as a derivative liability
at fair value. During the year ended June 30, 2018, the consultant converted $<span id="xdx_90F_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20180630__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ConsultantMember_zt0fOKSSrOwc" title="Convertible debt principal amount"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2018-06-30_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember_custom_ConsultantMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">140,000</ix:nonFraction></span> of principal and $<span id="xdx_90A_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20180630__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ConsultantMember_zMhXsq0UfDqe" title="Accrued interest"><ix:nonFraction name="us-gaap:InterestPayableCurrentAndNoncurrent" contextRef="AsOf2018-06-30_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember_custom_ConsultantMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">10,764</ix:nonFraction></span> of interest. During the
year ended June 30, 2019, the consultant converted an additional $<span id="xdx_902_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20190630__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ConsultantMember_zvWNRi3Fyayl" title="Convertible debt principal amount"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2019-06-30_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember_custom_ConsultantMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">161,000</ix:nonFraction></span> of principal and $<span id="xdx_90B_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20190630__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ConsultantMember_z9Di3nlU5iTd" title="Accrued interest"><ix:nonFraction name="us-gaap:InterestPayableCurrentAndNoncurrent" contextRef="AsOf2019-06-30_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember_custom_ConsultantMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">19,418</ix:nonFraction> </span>of interest leaving a principal balance
owed of $<span id="xdx_90A_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20190630__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember_znM13bvcFSY8" title="Convertible debt principal amount"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2019-06-30_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">9,000</ix:nonFraction></span> at June 30, 2019. During the year ended June 30, 2020, the consultant converted an additional $<span id="xdx_902_eus-gaap--DebtConversionConvertedInstrumentAmount1_pp0p0_c20190701__20200630__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember_zrkFm4TR9TSb" title="Debt conversion of converted amount"><ix:nonFraction name="us-gaap:DebtConversionConvertedInstrumentAmount1" contextRef="From2019-07-012020-06-30_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">500</ix:nonFraction></span> of principal and $<span id="xdx_903_eus-gaap--AccruedLiabilitiesCurrentAndNoncurrent_iI_pp0p0_c20200630__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember_zViIFvWqXmf1" title="Accrued expenses"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrentAndNoncurrent" contextRef="AsOf2020-06-30_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,248</ix:nonFraction></span>
of interest such that the remaining principal outstanding and accrued interest under this note as of June 30, 2020 was $<span id="xdx_90D_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20200630__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember_zNhyMipK3bs6" title="Convertible debt principal amount"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2020-06-30_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">8,500</ix:nonFraction></span> and $<span id="xdx_900_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20200630__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember_zPMxfvm3VEyh" title="Accrued interest"><ix:nonFraction name="us-gaap:InterestPayableCurrentAndNoncurrent" contextRef="AsOf2020-06-30_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">22,168</ix:nonFraction></span>,
respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On
March 15, 2021, the Company entered into a Settlement and Mutual Release Agreement (the &#8220;Settlement Agreement&#8221;) with the
consultant whereby both parties agreed to settle all claims and liabilities under the August 10, 2017 Convertible note for a total of
$<span id="xdx_901_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20210315__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember__us-gaap--ShortTermDebtTypeAxis__custom--SettlementAndMutualReleaseAgreementMember_zX5bYvBALoPi" title="Convertible debt principal amount"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2021-03-15_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember_custom_SettlementAndMutualReleaseAgreementMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">100,000</ix:nonFraction></span> in the form of a convertible note. All other terms of the August 10, 2017 Convertible Note shall remain in full force and effect.
Both parties agree that all future penalties under this note are waived unless the Company fails to authorize to distribute the requested
shares upon conversion. The Company has the right to pay off the balance of any remaining amounts dues under this note in cash at any
time more than 60 days after March 15, 2021. Prior to the Settlement Agreement, the Company recorded total liabilities $<span id="xdx_901_eus-gaap--Liabilities_iI_pp0p0_c20210315__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember__us-gaap--ShortTermDebtTypeAxis__custom--SettlementAndMutualReleaseAgreementMember_zsfI8VwYYoO8" title="Liabilities"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2021-03-15_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember_custom_SettlementAndMutualReleaseAgreementMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">56,762</ix:nonFraction></span> consisting
of remaining principal amount of $<span id="xdx_901_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pp0p0_c20210315__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember__us-gaap--ShortTermDebtTypeAxis__custom--SettlementAndMutualReleaseAgreementMember_zBR1G1YGjlg7" title="Original issue discount"><ix:nonFraction name="us-gaap:DebtInstrumentUnamortizedDiscount" contextRef="AsOf2021-03-15_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember_custom_SettlementAndMutualReleaseAgreementMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">8,500</ix:nonFraction></span>, accrued interest of $<span id="xdx_90C_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20210315__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember__us-gaap--ShortTermDebtTypeAxis__custom--SettlementAndMutualReleaseAgreementMember_z9lTGAIR1brb" title="Accrued interest"><ix:nonFraction name="us-gaap:InterestPayableCurrentAndNoncurrent" contextRef="AsOf2021-03-15_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember_custom_SettlementAndMutualReleaseAgreementMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">23,262</ix:nonFraction></span> and accrued expenses of $<span id="xdx_902_eus-gaap--AccruedLiabilitiesCurrentAndNoncurrent_iI_pp0p0_c20210315__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember__us-gaap--ShortTermDebtTypeAxis__custom--SettlementAndMutualReleaseAgreementMember_zE7X1tZJDwK8" title="Accrued expenses"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrentAndNoncurrent" contextRef="AsOf2021-03-15_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember_custom_SettlementAndMutualReleaseAgreementMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">25,000</ix:nonFraction></span>. Accordingly, the Company recognized
loss from settlement of debt of $<span id="xdx_902_eus-gaap--GainsLossesOnExtinguishmentOfDebt_pp0p0_c20200701__20210630__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember__us-gaap--ShortTermDebtTypeAxis__custom--SettlementAndMutualReleaseAgreementMember_zoqeBx07G0Ua" title="Loss from settlement of debt"><ix:nonFraction name="us-gaap:GainsLossesOnExtinguishmentOfDebt" contextRef="From2020-07-012021-06-30_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember_custom_SettlementAndMutualReleaseAgreementMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">43,238</ix:nonFraction></span> during the year ended June 30, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
total principal outstanding after adjustment due to the above-mentioned March 15, 2021 settlement agreement and accrued interest under
the August 10, 2017 Convertible Note was $<span id="xdx_907_eus-gaap--ConvertibleNotesPayable_iI_pp0p0_c20210630__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember__us-gaap--ShortTermDebtTypeAxis__custom--SettlementAndMutualReleaseAgreementMember_zMbLpH92Hkg"><ix:nonFraction name="us-gaap:ConvertibleNotesPayable" contextRef="AsOf2021-06-30_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember_custom_SettlementAndMutualReleaseAgreementMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">80,000</ix:nonFraction></span> and $<span id="xdx_906_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20210630__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember__us-gaap--ShortTermDebtTypeAxis__custom--SettlementAndMutualReleaseAgreementMember_zlG84V2LUGeg"><ix:nonFraction name="us-gaap:InterestPayableCurrentAndNoncurrent" contextRef="AsOf2021-06-30_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember_custom_SettlementAndMutualReleaseAgreementMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,738</ix:nonFraction></span>, respectively, as of June 30, 2021 following conversion of $<span id="xdx_902_eus-gaap--DebtConversionConvertedInstrumentAmount1_pp0p0_c20200701__20210630__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember__us-gaap--ShortTermDebtTypeAxis__custom--SettlementAndMutualReleaseAgreementMember_z4opLBtZGvtc"><ix:nonFraction name="us-gaap:DebtConversionConvertedInstrumentAmount1" contextRef="From2020-07-012021-06-30_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember_custom_SettlementAndMutualReleaseAgreementMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">20,000</ix:nonFraction></span> of principal
during the year ended June 30, 2021. The total principal amount outstanding under the August 10, 2017 Convertible Note was $<span id="xdx_900_eus-gaap--ConvertibleNotesPayable_iI_pp0p0_c20210930__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember__us-gaap--ShortTermDebtTypeAxis__custom--SettlementAndMutualReleaseAgreementMember_zrpiKNB5yqQ7"><ix:nonFraction name="us-gaap:ConvertibleNotesPayable" contextRef="AsOf2021-09-30_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember_custom_SettlementAndMutualReleaseAgreementMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">80,000</ix:nonFraction></span> and
accrued interest of $<span id="xdx_900_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20210930__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember__us-gaap--ShortTermDebtTypeAxis__custom--SettlementAndMutualReleaseAgreementMember_zhUGxkUaTiWb"><ix:nonFraction name="us-gaap:InterestPayableCurrentAndNoncurrent" contextRef="AsOf2021-09-30_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember_custom_SettlementAndMutualReleaseAgreementMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">7,381</ix:nonFraction></span> as of as of September 30, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Auctus
Fund Financing Agreements</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>August
30, 2019 Securities Purchase Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Effective
August 30, 2019, the Company entered into a securities purchase agreement with Auctus Fund, LLC (&#8220;Auctus&#8221;), pursuant to which
Auctus purchased a convertible promissory note (the &#8220;August 30, 2019 Auctus Note&#8221;) from the Company in the aggregate principal
amount of $<span id="xdx_90A_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20190830__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_zV8IsENUgnMc" title="Convertible debt principal amount"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2019-08-30_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">550,000</ix:nonFraction></span>, such principal and the interest thereon convertible into shares of the Company&#8217;s common stock at the option
of Auctus. The transaction closed on August 30, 2019 and the Company received payment on September 4, 2019 in the amount of $<span id="xdx_903_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20190904__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_zmX45L2RKm67" title="Convertible debt principal amount"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2019-09-04_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">550,000</ix:nonFraction></span>,
of which $<span id="xdx_909_eus-gaap--LegalFees_pp0p0_c20190903__20190904__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_zM4ZDYGnUbY3" title="Legal fees"><ix:nonFraction name="us-gaap:LegalFees" contextRef="From2019-09-032019-09-04_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,000</ix:nonFraction></span> was paid directly toward legal fees and $<span id="xdx_903_ecustom--DiligenceFees_c20190903__20190904__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_zqsWa63arAJ7" title="Diligence fees"><ix:nonFraction name="PPCB:DiligenceFees" contextRef="From2019-09-032019-09-04_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">40,000</ix:nonFraction></span> to Auctus for due diligence fees resulting in net cash proceeds of $<span id="xdx_90F_eus-gaap--ProceedsFromConvertibleDebt_pp0p0_c20190903__20190904__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_zr4THCD44Xg1" title="Proceeds from convertible debt"><ix:nonFraction name="us-gaap:ProceedsFromConvertibleDebt" contextRef="From2019-09-032019-09-04_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">505,000</ix:nonFraction></span>.
The maturity date of the August 30, 2019 Auctus Note was <span id="xdx_90E_eus-gaap--DebtInstrumentMaturityDate_dd_c20190829__20190830__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_zDR9BpwAdgR3" title="Debt maturity date"><ix:nonNumeric contextRef="From2019-08-292019-08-30_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember" format="ixt:datemonthdayyearen" name="us-gaap:DebtInstrumentMaturityDate">August 30, 2020</ix:nonNumeric></span> and was currently past due. The August 30, 2019 Auctus Note
bore interest at a rate of <span id="xdx_900_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20190830__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_zkdy5Q17THL2" title="Debt instrument, interest rate, stated percentage"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2019-08-30_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">10</ix:nonFraction></span>% per annum, but not payable until the August 30, 2019 Auctus Note became payable, whether at the maturity
date or upon acceleration or by prepayment. The note was treated as stock settled debt under ASC 480 and accordingly the Company recorded
a $<span id="xdx_903_eus-gaap--DebtInstrumentUnamortizedPremium_iI_pp0p0_c20190830__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_zRiHwC088mR2" title="Debt premium amount"><ix:nonFraction name="us-gaap:DebtInstrumentUnamortizedPremium" contextRef="AsOf2019-08-30_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">366,667</ix:nonFraction></span> put premium. The August 30, 2019 Auctus Note may not be prepaid without the written consent of Auctus. Any amount of principal
or interest which was not paid when due shall bear interest at the rate of <span id="xdx_908_ecustom--DebtInstrumentDebtDefaultInterestRate_dp_uPure_c20190829__20190830__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_zHKxsto7eDza" title="Debt instrument, default, interest rate"><ix:nonFraction name="PPCB:DebtInstrumentDebtDefaultInterestRate" contextRef="From2019-08-292019-08-30_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">24</ix:nonFraction></span>% per annum.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Additionally,
Auctus had the option to convert all or any amount of the principal face amount and accrued interest of the August 30, 2019 Auctus Note,
at any time following the issue date and ending on the later of the maturity date or the date of payment of the Default Amount if an
event of default occurs, which was an amount equal to <span id="xdx_90D_ecustom--PercentageOfOutstandingSharesOfCommonStock_dp_uPure_c20190829__20190830__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_zTkSILK2Z3fc" title="Percentage of outstanding shares of common stock"><ix:nonFraction name="PPCB:PercentageOfOutstandingSharesOfCommonStock" contextRef="From2019-08-292019-08-30_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">125</ix:nonFraction></span>% of an amount equal to the then outstanding principal amount of the August
30, 2019 Auctus Note (but not less than $15,000) plus any interest accrued from August 30, 2019 at the default interest rate of <span id="xdx_907_ecustom--DebtInstrumentDebtDefaultInterestRate_dp_uPure_c20190829__20190830__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_zfhrvGYHWUR1" title="Debt instrument, default, interest rate"><ix:nonFraction name="PPCB:DebtInstrumentDebtDefaultInterestRate" contextRef="From2019-08-292019-08-30_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">24</ix:nonFraction></span>% per
annum, for shares of the Company&#8217;s common stock at the then-applicable conversion price. Upon the holder&#8217;s election to convert
accrued interest, default interest or any penalty amounts as stipulated, the Company may elect to pay those amounts in cash. The note
may also be prepaid by the Company at any time between the date of issuance and August 13, 2020 at 135% multiplied by the sum of (a)
the then outstanding principal amount plus (b) accrued and unpaid interest plus (c) default interests, if any.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
conversion price for the August 30, 2019 Auctus Note was equal to the Variable Conversion Price of <span id="xdx_908_eus-gaap--DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_dp_uPure_c20190903__20190904__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_zXKSok3ltqR6" title="Common stock trading volume, percent"><ix:nonFraction name="us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" contextRef="From2019-09-032019-09-04_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">60</ix:nonFraction></span>% of the Market Price on the date
of conversion. Notwithstanding the foregoing, Auctus shall be restricted from effecting a conversion if such conversion, along with other
shares of the Company&#8217;s common stock beneficially owned by Auctus and its affiliates, exceeds <span id="xdx_90E_ecustom--PercentageOfOutstandingSharesOfCommonStock_dp_uPure_c20190903__20190904__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_zH6BNNz0fSne" title="Percentage of outstanding shares of common stock"><ix:nonFraction name="PPCB:PercentageOfOutstandingSharesOfCommonStock" contextRef="From2019-09-032019-09-04_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">4.99</ix:nonFraction></span>% of the outstanding shares of
the Company&#8217;s common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 140; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>PROPANC
BIOPHARMA, INC. AND SUBSIDIARY<br />
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS<br />
SEPTEMBER 30, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Unaudited)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In
connection with the issuance of the August 2019 Auctus Note, the Company issued common stock purchase warrants to Auctus to purchase
<span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20190830__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember__us-gaap--StatementEquityComponentsAxis__custom--FirstWarrantMember_zpcbk22qeGsg" title="Warrants to purchase of common stock, shares"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2019-08-30_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember_custom_FirstWarrantMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">450</ix:nonFraction></span> shares of the Company&#8217;s common stock (the &#8220;First Warrant&#8221;) as a commitment fee upon the terms and subject to the
limitations and conditions set forth in such First Warrant at an &#8220;Exercise Price&#8221; of $<span id="xdx_908_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20190830__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember__us-gaap--StatementEquityComponentsAxis__custom--FirstWarrantMember_zeOwLVNv5Yi7" title="Warrants exercise price per share"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2019-08-30_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember_custom_FirstWarrantMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">2,250</ix:nonFraction></span>. In connection with the issuance
of the Note, the Company issued a common stock purchase warrant to Buyer to purchase <span id="xdx_907_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20190830__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember__us-gaap--StatementEquityComponentsAxis__custom--SecondWarrantMember_zRTJsLcNKxb1" title="Warrants to purchase of common stock, shares"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2019-08-30_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember_custom_SecondWarrantMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">300</ix:nonFraction></span> shares of the Company&#8217;s common stock (the
&#8220;Second Warrant&#8221;) as a commitment fee upon the terms and subject to the limitations and conditions set forth in such Second
Warrant at an &#8220;Exercise Price&#8221; of $<span id="xdx_90C_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20190830__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember__us-gaap--StatementEquityComponentsAxis__custom--SecondWarrantMember_zrIQtzyExSJ" title="Warrants exercise price per share"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2019-08-30_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember_custom_SecondWarrantMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">3,330</ix:nonFraction></span>. In connection with the issuance of the Note, the Company shall issue a common stock
purchase warrant to Buyer to purchase <span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20190830__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember__us-gaap--StatementEquityComponentsAxis__custom--ThirdWarrantMember_zAKe3tNeY5C6" title="Warrants to purchase of common stock, shares"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2019-08-30_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember_custom_ThirdWarrantMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">225</ix:nonFraction></span> shares of the Company&#8217;s common stock (the &#8220;Third Warrant&#8221;) as a commitment
fee upon the terms and subject to the limitations and conditions set forth in such Third Warrant at an &#8220;Exercise Price&#8221; of
$<span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20190830__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember__us-gaap--StatementEquityComponentsAxis__custom--ThirdWarrantMember_zBKfggn3dT37" title="Warrants exercise price per share"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2019-08-30_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember_custom_ThirdWarrantMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">4,500</ix:nonFraction></span>. The First Warrant, Second Warrant, and Third Warrant were collectively be referred as the &#8220;Warrants&#8221;. The Warrants
have an &#8220;Exercise Period&#8221; of five years from the date of issuance being August 30, 2019. Under the terms of the Purchase
Agreement and the Warrants, the Selling Security Holder may not either convert the Notes nor exercise the Warrants to the extent (but
only to the extent) that the Selling Security Holder or any of its affiliates would beneficially own a number of shares of our Common
Stock which would exceed <span id="xdx_904_ecustom--PercentageOfOutstandingSharesOfCommonStock_dp_uPure_c20190701__20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_zhyEK3pmLq55" title="Percentage of outstanding shares of common stock"><ix:nonFraction name="PPCB:PercentageOfOutstandingSharesOfCommonStock" contextRef="From2019-07-012020-06-30_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">4.99</ix:nonFraction></span>% of our outstanding shares. The Company accounted for the warrants by using the relative fair value method
and recorded debt discount from the relative fair value of the warrants of $<span id="xdx_901_eus-gaap--FairValueAdjustmentOfWarrants_pp0p0_c20190829__20190830__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_zHrxPgIwkxO6" title="Fair value of warrants"><ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="From2019-08-292019-08-30_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">375,905</ix:nonFraction></span> using a simple binomial lattice model.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In
connection with the Purchase Agreement, the Company and the Purchaser entered into a Registration Rights Agreement (the &#8220;Registration
Rights Agreement&#8221;). Pursuant to the Registration Rights Agreement, the Company agreed to register the shares of Common Stock underlying
the Securities in a Registration Statement with the SEC as well as the Commitment Shares (as defined herein). The Registration Rights
Agreement contains customary representations, warranties, agreements and indemnification rights and obligations of the parties.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
Note was subject to customary default provisions and also includes a cross-default provision which provides that a breach or default
by the Borrower of any covenant or other term or condition contained in any of the Other Agreements (as defined therein), after the passage
of all applicable notice and cure or grace periods, shall, at the option of the Holder, be considered a default under this Note and the
Other Agreements. Upon occurrence of any such event, the Holder was entitled (but in no event required) to apply all rights and remedies
of the Holder under the terms of this Note and the Other Agreements by reason of a default under said Other Agreements or the Note.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
August 30, 2019 Auctus Note contained certain events of default, upon which principal and accrued interest will become immediately due
and payable. In addition, upon an event of default, interest on the outstanding principal accrued at a default interest rate of 24% per
annum.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
total principal amount outstanding under the above Auctus financing agreement, specifically the August 30, 2019 Auctus Note, was $<span id="xdx_90E_eus-gaap--DebtInstrumentFaceAmount_iI_c20190630__us-gaap--TypeOfArrangementAxis__custom--AuctusFinancingAgreementMember_zu1KVqEJdIm6"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2019-06-30_custom_AuctusFinancingAgreementMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">358,965</ix:nonFraction></span>
and accrued interest of $<span id="xdx_90F_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_zfTyoyOT5roe" title="Accrued interest"><ix:nonFraction name="us-gaap:InterestPayableCurrentAndNoncurrent" contextRef="AsOf2020-06-30_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">486</ix:nonFraction></span> as of June 30, 2020 following conversion of $<span id="xdx_908_eus-gaap--DebtConversionConvertedInstrumentAmount1_pp0p0_c20190701__20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_zYryjWAnVksd" title="Debt conversion of converted amount"><ix:nonFraction name="us-gaap:DebtConversionConvertedInstrumentAmount1" contextRef="From2019-07-012020-06-30_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">191,035</ix:nonFraction></span> of the principal balance and $<span id="xdx_903_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20200630__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_z0TW5PAWVlu" title="Accrued interest"><ix:nonFraction name="us-gaap:InterestPayableCurrentAndNoncurrent" contextRef="AsOf2020-06-30_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">43,176</ix:nonFraction></span> of accrued interest
during the year ended June 30, 2020. Accordingly, $<span id="xdx_90C_eus-gaap--DebtInstrumentUnamortizedPremium_iI_pp0p0_c20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_zerbcq66mLU1" title="Debt premium amount"><ix:nonFraction name="us-gaap:DebtInstrumentUnamortizedPremium" contextRef="AsOf2020-06-30_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">127,356</ix:nonFraction></span> of the put premium was released in respect of the August 30, 2019 Auctus Note
during the year ended June 30, 2020 following conversion of the principal balance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
total principal amount outstanding under the above Auctus financing agreement, specifically the August 30, 2019 Auctus Note, was $<span id="xdx_902_eus-gaap--DebtInstrumentFaceAmount_iI_c20210630__us-gaap--TypeOfArrangementAxis__custom--AuctusFinancingAgreementMember_z204cLvGUN53"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2021-06-30_custom_AuctusFinancingAgreementMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">32,848</ix:nonFraction></span>
and accrued interest of $<span id="xdx_906_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_z1fqVwhhr6Q9"><ix:nonFraction name="us-gaap:InterestPayableCurrentAndNoncurrent" contextRef="AsOf2021-06-30_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">0</ix:nonFraction></span> as of June 30, 2021 following conversion of $<span id="xdx_90C_eus-gaap--DebtConversionConvertedInstrumentAmount1_pp0p0_c20200701__20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_z4cgVEaFq4xf"><ix:nonFraction name="us-gaap:DebtConversionConvertedInstrumentAmount1" contextRef="From2020-07-012021-06-30_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">326,117</ix:nonFraction></span> of the principal balance and $<span id="xdx_90B_ecustom--DebtConversionConvertedInterestPayable_pp0p0_c20200701__20210630__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_zh48bNCa2wFg"><ix:nonFraction name="PPCB:DebtConversionConvertedInterestPayable" contextRef="From2020-07-012021-06-30_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">39,536</ix:nonFraction></span> of accrued interest
during the year ended June 30, 2021. Accordingly, $<span id="xdx_908_eus-gaap--DebtInstrumentUnamortizedPremium_iI_pp0p0_c20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_zG2iHHvRnVEa"><ix:nonFraction name="us-gaap:DebtInstrumentUnamortizedPremium" contextRef="AsOf2021-06-30_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">217,411</ix:nonFraction></span> of the put premium was released in respect of the August 30, 2019 Auctus Note
during the year ended June 30, 2021 following conversion of the principal balance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
total principal amount outstanding under the above Auctus financing agreement, specifically the August 30, 2019 Auctus Note, was $<span id="xdx_903_eus-gaap--DebtInstrumentFaceAmount_iI_c20210930__us-gaap--TypeOfArrangementAxis__custom--AuctusFinancingAgreementMember_zxfOWZcGYCKf" title="Convertible debt principal amount"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2021-09-30_custom_AuctusFinancingAgreementMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">0</ix:nonFraction></span> and
accrued interest of $<span id="xdx_90E_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20210930__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_zFwYUbViB34h" title="Accrued interest"><ix:nonFraction name="us-gaap:InterestPayableCurrentAndNoncurrent" contextRef="AsOf2021-09-30_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">0</ix:nonFraction></span> as of September 30, 2021 following conversion of $<span id="xdx_90A_eus-gaap--DebtConversionConvertedInstrumentAmount1_pp0p0_c20210701__20210930__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_zUicSgLdvtrj" title="Debt conversion of converted amount"><ix:nonFraction name="us-gaap:DebtConversionConvertedInstrumentAmount1" contextRef="From2021-07-012021-09-30_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">32,848</ix:nonFraction></span> of the principal balance and $<span id="xdx_900_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20210930__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_ztM82l9WU34i" title="Debt conversion of accrued interest"><ix:nonFraction name="us-gaap:InterestPayableCurrentAndNoncurrent" contextRef="AsOf2021-09-30_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">716</ix:nonFraction></span> of accrued interest
during the three months ended September 30, 2021. Accordingly, $<span id="xdx_904_eus-gaap--DebtInstrumentUnamortizedPremium_iI_pp0p0_c20210930__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_z55t0Mkeh9v" title="Debt premium amount"><ix:nonFraction name="us-gaap:DebtInstrumentUnamortizedPremium" contextRef="AsOf2021-09-30_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">21,899</ix:nonFraction></span> of the put premium was released in respect of the August 30, 2019
Auctus Note during the three months ended September 30, 2021 following conversion of the principal balance. Accordingly, there was no
outstanding principal balance as of September 30, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Crown
Bridge Securities Purchase Agreements</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Effective
October 3, 2019, the Company entered into a securities purchase agreement with Crown Bridge Partners, pursuant to which Crown Bridge
purchased a convertible promissory note (the &#8220;October 3, 2019 Crown Bridge Note&#8221;) from the Company in the aggregate principal
amount of $<span id="xdx_90F_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20191003__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember_zXZUNdqIui1g" title="Convertible debt principal amount"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2019-10-03_custom_SecuritiesPurchaseAgreementMember_custom_CrownBridgePartnersLLCMember_custom_OctoberThreeTwoThousandNineteenAuctusNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">108,000</ix:nonFraction></span>, such principal and the interest thereon convertible into shares of the Company&#8217;s common stock at the option
of Crown Bridge any time from the of issuance of the of the October 3, 2019 Crown Bridge Note. The transactions contemplated by the Crown
Bridge Securities Purchase Agreement closed on October 3, 2019. Pursuant to the terms of the Crown Bridge Securities Purchase Agreement,
Crown Bridge deducted $<span id="xdx_900_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_pp0p0_c20191001__20191003__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember_zhXRStu3jAN6" title="Debt instrument principal payment"><ix:nonFraction name="us-gaap:DebtInstrumentPeriodicPaymentPrincipal" contextRef="From2019-10-012019-10-03_custom_SecuritiesPurchaseAgreementMember_custom_CrownBridgePartnersLLCMember_custom_OctoberThreeTwoThousandNineteenAuctusNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,000</ix:nonFraction></span> from the principal payment due under the October 3, 2019 Crown Bridge Note, at the time of closing, to be
applied to its legal expenses, and there was a $<span id="xdx_901_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pp0p0_c20191003__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember_zetTnujDFiNf" title="Original issue discount"><ix:nonFraction name="us-gaap:DebtInstrumentUnamortizedDiscount" contextRef="AsOf2019-10-03_custom_SecuritiesPurchaseAgreementMember_custom_CrownBridgePartnersLLCMember_custom_OctoberThreeTwoThousandNineteenAuctusNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,000</ix:nonFraction></span> original issuance discount resulting in $<span id="xdx_903_eus-gaap--ProceedsFromConvertibleDebt_pp0p0_c20191001__20191003__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember_z0CsAu11Ipuf" title="Proceeds from convertible debt"><ix:nonFraction name="us-gaap:ProceedsFromConvertibleDebt" contextRef="From2019-10-012019-10-03_custom_SecuritiesPurchaseAgreementMember_custom_CrownBridgePartnersLLCMember_custom_OctoberThreeTwoThousandNineteenAuctusNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">100,000</ix:nonFraction></span> net proceeds to the Company. The
Company intends to use the net proceeds from the October 3, 2019 Crown Bridge Note for general working capital purposes. The maturity
date of the October 3, 2019 Crown Bridge was October 3, 2020 and is currently past due. The <span id="xdx_903_eus-gaap--DebtInstrumentMaturityDate_dd_c20191001__20191003__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember_zoae1JxdAsQh" title="Debt maturity date"><ix:nonNumeric contextRef="From2019-10-012019-10-03_custom_SecuritiesPurchaseAgreementMember_custom_CrownBridgePartnersLLCMember_custom_OctoberThreeTwoThousandNineteenAuctusNoteMember" format="ixt:datemonthdayyearen" name="us-gaap:DebtInstrumentMaturityDate">October 3, 2019</ix:nonNumeric></span> Crown Bridge Note bears interest
at a rate of <span id="xdx_90B_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20191003__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember_zQQ255xvCjDc" title="Debt instrument, interest rate, stated percentage"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2019-10-03_custom_SecuritiesPurchaseAgreementMember_custom_CrownBridgePartnersLLCMember_custom_OctoberThreeTwoThousandNineteenAuctusNoteMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">10</ix:nonFraction></span>% per annum, which interest may be paid by the Company to Crown Bridge in shares of the Company&#8217;s common stock;
but shall not be payable until the October 2019 Crown Bridge Note becomes payable, whether at the maturity date or upon acceleration
or by prepayment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 141; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>PROPANC
BIOPHARMA, INC. AND SUBSIDIARY<br />
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS<br />
SEPTEMBER 30, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Unaudited)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Additionally,
Crown Bridge has the option to convert all or any amount of the principal face amount of the October 3, 2019 Crown Bridge Note at any
time from the date of issuance and ending on the later of the maturity date or the date the Default Amount is paid if an event of default
occurs, which is an amount between <span id="xdx_90B_ecustom--DebtInstrumentDebtDefaultInterestRate_pid_dp_uPure_c20191001__20191003__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember__srt--RangeAxis__srt--MinimumMember_znQ30TSyPxg2" title="Debt instrument, default, interest rate"><ix:nonFraction name="PPCB:DebtInstrumentDebtDefaultInterestRate" contextRef="From2019-10-012019-10-03_custom_SecuritiesPurchaseAgreementMember_custom_CrownBridgePartnersLLCMember_custom_OctoberThreeTwoThousandNineteenAuctusNoteMember_srt_MinimumMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">110</ix:nonFraction></span>% and <span id="xdx_909_ecustom--DebtInstrumentDebtDefaultInterestRate_pid_dp_uPure_c20191001__20191003__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember__srt--RangeAxis__srt--MaximumMember_zzQvuvFG1Mpb" title="Debt instrument, default, interest rate"><ix:nonFraction name="PPCB:DebtInstrumentDebtDefaultInterestRate" contextRef="From2019-10-012019-10-03_custom_SecuritiesPurchaseAgreementMember_custom_CrownBridgePartnersLLCMember_custom_OctoberThreeTwoThousandNineteenAuctusNoteMember_srt_MaximumMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">150</ix:nonFraction></span>% of an amount equal to the then outstanding principal amount of the October 3, 2019 Crown
Bridge Note plus any interest accrued, for shares of the Company&#8217;s common stock at the then-applicable conversion price.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90A_eus-gaap--DebtInstrumentDescription_c20191001__20191003__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember_zoS7xQeAQNu4"><ix:nonNumeric contextRef="From2019-10-012019-10-03_custom_SecuritiesPurchaseAgreementMember_custom_CrownBridgePartnersLLCMember_custom_OctoberThreeTwoThousandNineteenAuctusNoteMember" name="us-gaap:DebtInstrumentDescription">The
conversion price for the October 3, 2019 Crown Bridge Note shall be equal to a 40% discount of the lowest closing bid price (&#8220;Lowest
Trading Price&#8221;) of the Common Stock for the ten trading days immediately prior to the delivery of a Notice of Conversion, including
the day upon which a Notice of Conversion is received. Notwithstanding the foregoing, Crown Bridge shall be restricted from effecting
a conversion if such conversion, along with other shares of the Company&#8217;s common stock beneficially owned by Crown Bridge and its
affiliates, exceeds <span id="xdx_904_ecustom--PercentageOfOutstandingSharesOfCommonStock_pid_dp_uPure_c20191001__20191003__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember__srt--RangeAxis__srt--MinimumMember_zRdEc6aixyRc" title="Percentage of outstanding shares of common stock"><ix:nonFraction name="PPCB:PercentageOfOutstandingSharesOfCommonStock" contextRef="From2019-10-012019-10-03_custom_SecuritiesPurchaseAgreementMember_custom_CrownBridgePartnersLLCMember_custom_OctoberThreeTwoThousandNineteenAuctusNoteMember_srt_MinimumMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">4.99</ix:nonFraction></span>% of the outstanding shares of the Company&#8217;s common stock which may be increased up to <span id="xdx_90F_ecustom--PercentageOfOutstandingSharesOfCommonStock_pid_dp_uPure_c20191001__20191003__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember__srt--RangeAxis__srt--MaximumMember_zhtu86bdy1Sk" title="Percentage of outstanding shares of common stock"><ix:nonFraction name="PPCB:PercentageOfOutstandingSharesOfCommonStock" contextRef="From2019-10-012019-10-03_custom_SecuritiesPurchaseAgreementMember_custom_CrownBridgePartnersLLCMember_custom_OctoberThreeTwoThousandNineteenAuctusNoteMember_srt_MaximumMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">9.99</ix:nonFraction></span>% upon 60 days
prior written notice by the Crown Bridge to the Company. The note is treated as stock settled debt under ASC 480 and accordingly the
Company recorded a $<span id="xdx_904_eus-gaap--DebtInstrumentUnamortizedPremium_iI_pp0p0_c20191003__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember_zBHIVjm47c4k" title="Debt premium amount"><ix:nonFraction name="us-gaap:DebtInstrumentUnamortizedPremium" contextRef="AsOf2019-10-03_custom_SecuritiesPurchaseAgreementMember_custom_CrownBridgePartnersLLCMember_custom_OctoberThreeTwoThousandNineteenAuctusNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">72,000</ix:nonFraction></span> put premium.</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
October 3, 2019 Crown Bridge Note contain certain events of default, upon which principal and accrued interest will become immediately
due and payable. In addition, upon an event of default, interest on the outstanding principal shall accrue at a default interest rate
of <span id="xdx_90E_ecustom--DebtInstrumentDebtDefaultInterestRate_pid_dp_uPure_c20191001__20191003__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember_zOHqQWtgwzRh" title="Debt instrument, default, interest rate"><ix:nonFraction name="PPCB:DebtInstrumentDebtDefaultInterestRate" contextRef="From2019-10-012019-10-03_custom_SecuritiesPurchaseAgreementMember_custom_CrownBridgePartnersLLCMember_custom_OctoberThreeTwoThousandNineteenAuctusNoteMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">15</ix:nonFraction></span>% per annum, or if such rate is usurious or not permitted by current law, then at the highest rate of interest permitted by law.
Further, certain events of default may trigger penalty and liquidated damage provisions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
total principal amount outstanding under the above Crown Bridge financing agreement was $<span id="xdx_904_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember_zdFkwsqeea91" title="Convertible debt principal amount"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2020-06-30_custom_SecuritiesPurchaseAgreementMember_custom_CrownBridgePartnersLLCMember_custom_OctoberThreeTwoThousandNineteenAuctusNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">65,280</ix:nonFraction></span> and accrued interest of $<span id="xdx_90E_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember_z34GfxgvFSQ" title="Accrued interest"><ix:nonFraction name="us-gaap:InterestPayableCurrentAndNoncurrent" contextRef="AsOf2020-06-30_custom_SecuritiesPurchaseAgreementMember_custom_CrownBridgePartnersLLCMember_custom_OctoberThreeTwoThousandNineteenAuctusNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">7,232</ix:nonFraction></span> as of
as of June 30, 2020 following conversion of $<span id="xdx_905_eus-gaap--DebtConversionConvertedInstrumentAmount1_pp0p0_c20190701__20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember_zEZy8QoDC4Vd" title="Debt conversion of converted amount"><ix:nonFraction name="us-gaap:DebtConversionConvertedInstrumentAmount1" contextRef="From2019-07-012020-06-30_custom_SecuritiesPurchaseAgreementMember_custom_CrownBridgePartnersLLCMember_custom_OctoberThreeTwoThousandNineteenAuctusNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">42,720</ix:nonFraction></span> of the principal balance during the year ended June 30, 2020. Accordingly, $<span id="xdx_908_eus-gaap--DebtInstrumentUnamortizedPremium_iI_pp0p0_c20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember_zded0iHOmySh" title="Debt premium amount"><ix:nonFraction name="us-gaap:DebtInstrumentUnamortizedPremium" contextRef="AsOf2020-06-30_custom_SecuritiesPurchaseAgreementMember_custom_CrownBridgePartnersLLCMember_custom_OctoberThreeTwoThousandNineteenAuctusNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">28,480</ix:nonFraction></span>
of the put premium was released in respect of the October 3, 2019 Crown Bridge Note during the year ended June 30, 2020 following conversion
of the principal balance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">There
were <span id="xdx_909_ecustom--UnissuedSharesConversion_c20200915__20200916__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember_zXlDsNhWk6Je" title="Unissued shares conversion"><ix:nonFraction name="PPCB:UnissuedSharesConversion" contextRef="From2020-09-152020-09-16_custom_SecuritiesPurchaseAgreementMember_custom_CrownBridgePartnersLLCMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">15,000</ix:nonFraction></span> unissued shares which were considered issuable for accounting purposes during the 1<sup>st</sup> quarter of fiscal 2021 related
to a conversion notice dated and received on September 16, 2020. In November 2020, the Company was notified by the note holder of the
cancellation of this conversion notice as a result of the reverse stock split and as such the Company reversed the effects of this transaction
thereby increasing the principal balance by $<span id="xdx_90D_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20201130__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember_zy32wXzjQvLj" title="Convertible debt principal amount"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2020-11-30_custom_SecuritiesPurchaseAgreementMember_custom_CrownBridgePartnersLLCMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">9,600</ix:nonFraction></span> and put premium by $<span id="xdx_907_eus-gaap--DebtInstrumentUnamortizedPremium_iI_pp0p0_c20201130__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember_zq3jN7FvTuX2" title="Debt premium amount"><ix:nonFraction name="us-gaap:DebtInstrumentUnamortizedPremium" contextRef="AsOf2020-11-30_custom_SecuritiesPurchaseAgreementMember_custom_CrownBridgePartnersLLCMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">6,400</ix:nonFraction></span> and a corresponding decrease in equity of $<span id="xdx_90E_ecustom--DueToEquityConversion_iI_pp0p0_c20201130__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember_zUybJvNFcnPb" title="Due to equity conversion"><ix:nonFraction name="PPCB:DueToEquityConversion" contextRef="AsOf2020-11-30_custom_SecuritiesPurchaseAgreementMember_custom_CrownBridgePartnersLLCMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">16,000</ix:nonFraction></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
total principal amount outstanding under the above Crown Bridge financing agreement was $<span id="xdx_90F_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember_zOJBdPnY5H41" title="Convertible debt principal amount"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2021-06-30_custom_SecuritiesPurchaseAgreementMember_custom_CrownBridgePartnersLLCMember_custom_OctoberThreeTwoThousandNineteenAuctusNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">65,280</ix:nonFraction></span> and accrued interest of $<span id="xdx_909_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember_zodzjcK19hV8" title="Accrued interest"><ix:nonFraction name="us-gaap:InterestPayableCurrentAndNoncurrent" contextRef="AsOf2021-06-30_custom_SecuritiesPurchaseAgreementMember_custom_CrownBridgePartnersLLCMember_custom_OctoberThreeTwoThousandNineteenAuctusNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">16,138</ix:nonFraction></span>
as of June 30, 2021. The total principal amount outstanding under the above Crown Bridge financing agreement was $<span id="xdx_902_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20210930__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember_zLpmI8hWX2ka"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2021-09-30_custom_SecuritiesPurchaseAgreementMember_custom_CrownBridgePartnersLLCMember_custom_OctoberThreeTwoThousandNineteenAuctusNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">65,280</ix:nonFraction></span> and accrued
interest of $<span id="xdx_902_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20210930__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember_zOnEQT0IP02c"><ix:nonFraction name="us-gaap:InterestPayableCurrentAndNoncurrent" contextRef="AsOf2021-09-30_custom_SecuritiesPurchaseAgreementMember_custom_CrownBridgePartnersLLCMember_custom_OctoberThreeTwoThousandNineteenAuctusNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">18,606</ix:nonFraction></span> as of as of September 30, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>GW
Holdings Securities Purchase Agreements</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>December
10, 2020 Securities Purchase Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Effective
December 10, 2020, the Company entered into a securities purchase agreement with GW Holdings, pursuant to which GW Holdings purchased
a convertible promissory note (the &#8220;December 10, 2020 GW Note&#8221;) from the Company in the aggregate principal amount of $<span id="xdx_903_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20201210__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--DecemberTenTwoThousandTwentyGWNoteMember_zMtcOjSqoMlg" title="Convertible debt principal amount"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2020-12-10_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember_custom_DecemberTenTwoThousandTwentyGWNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">131,000</ix:nonFraction></span>,
such principal and the interest thereon convertible into shares of the Company&#8217;s common stock at the option of GW Holdings anytime
from the issuance of the December 10, 2020 GW Holdings Note. The transactions contemplated by the GW Holdings Securities Purchase Agreement
closed on December 10, 2020. Pursuant to the terms of the GW Holdings Securities Purchase Agreement, the lender deducted $<span id="xdx_900_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_pp0p0_c20201209__20201210__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--DecemberTenTwoThousandTwentyGWNoteMember_zmu64tgjRdE9" title="Debt instrument principal payment"><ix:nonFraction name="us-gaap:DebtInstrumentPeriodicPaymentPrincipal" contextRef="From2020-12-092020-12-10_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember_custom_DecemberTenTwoThousandTwentyGWNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">6,000</ix:nonFraction></span> from
the principal payment due under the December 10, 2020 GW Note, at the time of closing, to be applied to its legal expenses. The Company
intends to use the net proceeds of $<span id="xdx_90F_eus-gaap--ProceedsFromConvertibleDebt_pp0p0_c20201209__20201210__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--DecemberTenTwoThousandTwentyGWNoteMember_zu5jh9QSR7A2" title="Proceeds from convertible debt"><ix:nonFraction name="us-gaap:ProceedsFromConvertibleDebt" contextRef="From2020-12-092020-12-10_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember_custom_DecemberTenTwoThousandTwentyGWNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">125,000</ix:nonFraction></span> from the December 10, 2020 GW Note for general working capital purposes. The maturity date
of the December 10, 2020 GW Holdings is <span id="xdx_904_eus-gaap--DebtInstrumentMaturityDate_dd_c20201209__20201210__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--DecemberTenTwoThousandTwentyGWNoteMember_zdVj5PT9Jq14" title="Debt maturity date"><ix:nonNumeric contextRef="From2020-12-092020-12-10_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember_custom_DecemberTenTwoThousandTwentyGWNoteMember" format="ixt:datemonthdayyearen" name="us-gaap:DebtInstrumentMaturityDate">December 10, 2021</ix:nonNumeric></span>. The December 10, 2020 GW Holdings Note bears interest at a rate of <span id="xdx_902_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20201210__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--DecemberTenTwoThousandTwentyGWNoteMember_zqOjTWqM9AJk" title="Debt instrument, interest rate, stated percentage"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2020-12-10_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember_custom_DecemberTenTwoThousandTwentyGWNoteMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">8</ix:nonFraction></span>% per
annum, which interest may be paid by the Company to GW Holdings in shares of the Company&#8217;s common stock; but shall not be payable
until the December 10, 2020 GW Holdings Note becomes payable, whether at the maturity date or upon acceleration or by prepayment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
above notes issued to GW Holdings contain certain events of default, upon which principal and accrued interest will become immediately
due and payable. In addition, upon an event of default, interest on the outstanding principal shall accrue at a default interest rate
of <span id="xdx_90B_ecustom--DebtInstrumentDebtDefaultInterestRate_dp_uPure_c20201209__20201210__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--DecemberTenTwoThousandTwentyGWNoteMember_zq1TRF6QimY" title="Debt instrument, default, interest rate"><ix:nonFraction name="PPCB:DebtInstrumentDebtDefaultInterestRate" contextRef="From2020-12-092020-12-10_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember_custom_DecemberTenTwoThousandTwentyGWNoteMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">24</ix:nonFraction></span>% per annum, or if such rate is usurious or not permitted by current law, then at the highest rate of interest permitted by law.
Further, certain events of default may trigger penalty and liquidated damage provisions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Additionally,
GW Holdings has the option to convert all or any amount of the principal face amount of the notes issued to GW Holdings at any time from
the date of issuance and ending on the later of the maturity date or the date the Default Amount is paid if an event of default occurs,
which is an amount between <span id="xdx_906_ecustom--DebtInstrumentDebtDefaultInterestRate_dp_uPure_c20201209__20201210__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--DecemberTenTwoThousandTwentyGWNoteMember__srt--RangeAxis__srt--MinimumMember_z466YXX0CMg6" title="Debt instrument, default, interest rate"><ix:nonFraction name="PPCB:DebtInstrumentDebtDefaultInterestRate" contextRef="From2020-12-092020-12-10_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember_custom_DecemberTenTwoThousandTwentyGWNoteMember_srt_MinimumMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">110</ix:nonFraction></span>% and <span id="xdx_901_ecustom--DebtInstrumentDebtDefaultInterestRate_dp_uPure_c20201209__20201210__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--DecemberTenTwoThousandTwentyGWNoteMember__srt--RangeAxis__srt--MaximumMember_zmnjePezzi72" title="Debt instrument, default, interest rate"><ix:nonFraction name="PPCB:DebtInstrumentDebtDefaultInterestRate" contextRef="From2020-12-092020-12-10_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember_custom_DecemberTenTwoThousandTwentyGWNoteMember_srt_MaximumMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">150</ix:nonFraction></span>% of an amount equal to the then outstanding principal amount of such notes plus any interest
accrued, for shares of the Company&#8217;s common stock at the then-applicable conversion price.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 142; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>PROPANC
BIOPHARMA, INC. AND SUBSIDIARY<br />
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS<br />
SEPTEMBER 30, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Unaudited)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_903_eus-gaap--DebtInstrumentDescription_c20201209__20201210__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--DecemberTenTwoThousandTwentyGWNoteMember"><ix:nonNumeric contextRef="From2020-12-092020-12-10_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember_custom_DecemberTenTwoThousandTwentyGWNoteMember" name="us-gaap:DebtInstrumentDescription">The
conversion price for the above GW Holdings notes shall be equal to a 40% discount of the lowest closing bid price (&#8220;Lowest Trading
Price&#8221;) of the Common Stock for the ten trading days immediately prior to the delivery of a Notice of Conversion, including the
day upon which a Notice of Conversion is received. Notwithstanding the foregoing, GW Holdings shall be restricted from effecting a conversion
if such conversion, along with other shares of the Company&#8217;s common stock beneficially owned by GW Holdings and its affiliates,
exceeds <span id="xdx_908_ecustom--PercentageOfOutstandingSharesOfCommonStock_dp_uPure_c20201209__20201210__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--DecemberTenTwoThousandTwentyGWNoteMember_zfol6OLSWkHl"><ix:nonFraction name="PPCB:PercentageOfOutstandingSharesOfCommonStock" contextRef="From2020-12-092020-12-10_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember_custom_DecemberTenTwoThousandTwentyGWNoteMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">4.99</ix:nonFraction></span>% of the outstanding shares of the Company&#8217;s common stock which may be increased up to 9.99% upon 60 days prior written
notice by the GW Holdings to the Company.</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">These
notes are treated as stock settled debt under ASC 480 and accordingly the Company recorded a total of $<span id="xdx_908_eus-gaap--DebtInstrumentUnamortizedPremium_iI_pp0p0_c20201210__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember_z8VirPDudh83"><ix:nonFraction name="us-gaap:DebtInstrumentUnamortizedPremium" contextRef="AsOf2020-12-10_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">87,333</ix:nonFraction></span> put premium.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
total principal amount outstanding under the above December 10, 2020 GW Holdings financing agreement, was $<span id="xdx_90C_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20200930__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--DecemberTenTwoThousandTwentyGWNoteMember_zvG2tpfICtk5" title="Convertible debt principal amount"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2020-09-30_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember_custom_DecemberTenTwoThousandTwentyGWNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">90,000</ix:nonFraction></span> and accrued interest
of $<span id="xdx_90B_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20200930__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--DecemberTenTwoThousandTwentyGWNoteMember_zwYws47GK557" title="Accrued interest"><ix:nonFraction name="us-gaap:InterestPayableCurrentAndNoncurrent" contextRef="AsOf2020-09-30_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember_custom_DecemberTenTwoThousandTwentyGWNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,636</ix:nonFraction></span> as of June 30, 2021 following conversion of $<span id="xdx_909_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--DecemberTenTwoThousandTwentyGWNoteMember_zXR3wCXR2ii3" title="Convertible debt principal amount"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2021-06-30_custom_SecuritiesPurchaseAgreementMember_custom_DecemberTenTwoThousandTwentyGWNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">41,000</ix:nonFraction></span> of the principal balance and $<span id="xdx_905_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--DecemberTenTwoThousandTwentyGWNoteMember_z1FNGBZ4TcMj" title="Accrued interest"><ix:nonFraction name="us-gaap:InterestPayableCurrentAndNoncurrent" contextRef="AsOf2021-06-30_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember_custom_DecemberTenTwoThousandTwentyGWNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,084</ix:nonFraction></span> of accrued interest during the year
ended June 30, 2021. Accordingly, $<span id="xdx_908_eus-gaap--DebtInstrumentUnamortizedPremium_iI_pp0p0_c20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--DecemberTenTwoThousandTwentyGWNoteMember_zlSogXBHc4dd"><ix:nonFraction name="us-gaap:DebtInstrumentUnamortizedPremium" contextRef="AsOf2021-06-30_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember_custom_DecemberTenTwoThousandTwentyGWNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">27,333</ix:nonFraction></span> of the put premium was reclassed to additional paid in capital in respect of the October 1,
2019 GW Holdings Note during the year ended June 30, 2021 following conversion of the principal balance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
total principal amount outstanding under the above December 10, 2020 GW Holdings financing agreement, was $<span id="xdx_907_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20210930__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--DecemberTenTwoThousandTwentyGWNoteMember_zzpkMkBnkq3l"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2021-09-30_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember_custom_DecemberTenTwoThousandTwentyGWNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">65,000</ix:nonFraction></span> and accrued interest
of $<span id="xdx_90A_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20210930__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--DecemberTenTwoThousandTwentyGWNoteMember_z7eA13hE3B25"><ix:nonFraction name="us-gaap:InterestPayableCurrentAndNoncurrent" contextRef="AsOf2021-09-30_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember_custom_DecemberTenTwoThousandTwentyGWNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,174</ix:nonFraction></span> as of September 30, 2021 following conversion of $<span id="xdx_908_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20210930__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--DecemberTenTwoThousandTwentyGWNoteMember_zVSSWJquEqpe"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2021-09-30_custom_SecuritiesPurchaseAgreementMember_custom_DecemberTenTwoThousandTwentyGWNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">25,000</ix:nonFraction></span> of the principal balance and $<span id="xdx_900_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20210930__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--DecemberTenTwoThousandTwentyGWNoteMember_zxVIWppMhhGa"><ix:nonFraction name="us-gaap:InterestPayableCurrentAndNoncurrent" contextRef="AsOf2021-09-30_custom_SecuritiesPurchaseAgreementMember_custom_DecemberTenTwoThousandTwentyGWNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,091</ix:nonFraction></span> of accrued interest during the
three months ended September 30, 2021. Accordingly, $<span id="xdx_908_eus-gaap--DebtInstrumentUnamortizedPremium_iI_pp0p0_c20210930__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--DecemberTenTwoThousandTwentyGWNoteMember_zbFlv2euddve"><ix:nonFraction name="us-gaap:DebtInstrumentUnamortizedPremium" contextRef="AsOf2021-09-30_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember_custom_DecemberTenTwoThousandTwentyGWNoteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">16,667</ix:nonFraction></span> of the put premium was reclassed to additional paid in capital in respect
of the October 1, 2019 GW Holdings Note during the three months ended September 30, 2021 following conversion of the principal balance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Geneva
Roth Remark Securities Purchase Agreements</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>January
5, 2021 Securities Purchase Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Effective
January 5, 2021, the Company entered into a securities purchase agreement with Geneva Roth Remark Holdings, Inc., pursuant to which Geneva
Roth purchased a convertible promissory note (the &#8220;January 5, 2021 Geneva Roth&#8221;) from the Company in the aggregate principal
amount of $<span id="xdx_905_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20210105__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--JanuaryFiveTwoThousandTwentyOneGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember_zNMXuLqV0FHa" title="Convertible debt principal amount"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2021-01-05_custom_SecuritiesPurchaseAgreementMember_custom_JanuaryFiveTwoThousandTwentyOneGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">68,500</ix:nonFraction></span>, such principal and the interest thereon convertible into shares of the Company&#8217;s common stock at the option
of Geneva Roth any time after the six-month anniversary of the January 5, 2021 Geneva Roth. The January 5, 2021 Geneva Roth contained
an original issue discount of $<span id="xdx_904_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pp0p0_c20210105__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--JanuaryFiveTwoThousandTwentyOneGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember_zxUbSVxlT5Ch"><ix:nonFraction name="us-gaap:DebtInstrumentUnamortizedDiscount" contextRef="AsOf2021-01-05_custom_SecuritiesPurchaseAgreementMember_custom_JanuaryFiveTwoThousandTwentyOneGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,500</ix:nonFraction></span>. The Company intended to use the net proceeds from the January 5, 2021 Geneva Roth for general working
capital purposes. The maturity date of the January 5, 2021 Geneva Roth Note was January 5, 2022. The January 5, 2021 Geneva Roth Note
bore interest at a rate of <span id="xdx_90D_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20201202__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--JanuaryFiveTwoThousandTwentyOneGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember_z8prCVROnlg6"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2020-12-02_custom_SecuritiesPurchaseAgreementMember_custom_JanuaryFiveTwoThousandTwentyOneGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">8</ix:nonFraction></span>% per annum, which interest may be paid by the Company to Geneva Roth in shares of the Company&#8217;s common
stock; but shall not be payable until the January 5, 2021 Geneva Roth Note becomes payable, whether at the maturity date or upon acceleration
or by prepayment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>March
16, 2021 Securities Purchase Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Effective
March 16, 2021, the Company entered into a securities purchase agreement with Geneva Roth Remark Holdings, Inc., pursuant to which Geneva
Roth purchased a convertible promissory note (the &#8220;March 16, 2021 Geneva Roth&#8221;) from the Company in the aggregate principal
amount of $<span id="xdx_902_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20210316__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--MarchSixteenTwoThousandTwentyOneGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember_zRQ6XM5pGns4" title="Convertible debt principal amount"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2021-03-16_custom_SecuritiesPurchaseAgreementMember_custom_MarchSixteenTwoThousandTwentyOneGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">63,500</ix:nonFraction></span>, such principal and the interest thereon convertible into shares of the Company&#8217;s common stock at the option
of Geneva Roth any time after the six-month anniversary of the March 16, 2021 Geneva Roth. The March 16, 2021 Geneva Roth contained an
original discount of $<span id="xdx_906_eus-gaap--DebtConversionOriginalDebtAmount1_pp0p0_c20210315__20210316__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--MarchSixteenTwoThousandTwentyOneGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember_zzskKUm0Wwrd" title="Debt conversion, original debt amount"><ix:nonFraction name="us-gaap:DebtConversionOriginalDebtAmount1" contextRef="From2021-03-152021-03-16_custom_SecuritiesPurchaseAgreementMember_custom_MarchSixteenTwoThousandTwentyOneGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,500</ix:nonFraction></span>. The Company intended to use the net proceeds from the March 16, 2021 Geneva Roth for general working capital
purposes. The maturity date of the March 16, 2021 Geneva Roth Note was March 16, 2022. The March 16, 2021 Geneva Roth Note bears interest
at a rate of <span id="xdx_90B_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20210316__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--MarchSixteenTwoThousandTwentyOneGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember_za2yJLfmOH5c" title="Debt instrument, interest rate, stated percentage"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2021-03-16_custom_SecuritiesPurchaseAgreementMember_custom_MarchSixteenTwoThousandTwentyOneGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">8</ix:nonFraction></span>% per annum, which interest may be paid by the Company to Geneva Roth in shares of the Company&#8217;s common stock; but
shall not be payable until the March 16, 2021 Geneva Roth Note becomes payable, whether at the maturity date or upon acceleration or
by prepayment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>August
19, 2021 Securities Purchase Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Effective
August 19, 2021, the Company entered into a securities purchase agreement with Geneva Roth Remark Holdings, Inc., pursuant to which Geneva
Roth purchased a convertible promissory note (the &#8220;August 19, 2021 Geneva Roth&#8221;) from the Company in the aggregate principal
amount of $<span id="xdx_901_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20210819__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--AugustNineteenTwoThousandTwentyOneGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember_ztnbtalxNhr3"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2021-08-19_custom_SecuritiesPurchaseAgreementMember_custom_AugustNineteenTwoThousandTwentyOneGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">103,750</ix:nonFraction></span>, such principal and the interest thereon convertible into shares of the Company&#8217;s common stock at the option
of Geneva Roth any time after the six-month anniversary of the August 19, 2021 Geneva Roth. The August 19, 2021 Geneva Roth contains
an original discount of $<span id="xdx_901_eus-gaap--DebtConversionOriginalDebtAmount1_pp0p0_c20210818__20210819__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--AugustNineteenTwoThousandTwentyOneGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember_zrlREIRbsh97"><ix:nonFraction name="us-gaap:DebtConversionOriginalDebtAmount1" contextRef="From2021-08-182021-08-19_custom_SecuritiesPurchaseAgreementMember_custom_AugustNineteenTwoThousandTwentyOneGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,750</ix:nonFraction></span>. The Company intends to use the net proceeds from the August 19, 2021 Geneva Roth for general working
capital purposes. The maturity date of the August 19, 2021 Geneva Roth Note is August 19, 2022. The August 19, 2021 Geneva Roth Note
bears interest at a rate of <span id="xdx_901_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20210819__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--AugustNineteenTwoThousandTwentyOneGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember_zPlJepj8LM52"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2021-08-19_custom_SecuritiesPurchaseAgreementMember_custom_AugustNineteenTwoThousandTwentyOneGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">8</ix:nonFraction></span>% per annum, which interest may be paid by the Company to Geneva Roth in shares of the Company&#8217;s common
stock; but shall not be payable until the August 19, 2021 Geneva Roth Note becomes payable, whether at the maturity date or upon acceleration
or by prepayment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 143; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>PROPANC
BIOPHARMA, INC. AND SUBSIDIARY<br />
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS<br />
SEPTEMBER 30, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Unaudited)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>September
22, 2021 Securities Purchase Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Additionally,
effective September 22, 2021, the Company entered into a securities purchase agreement with Geneva Roth Remark Holdings, Inc., pursuant
to which Geneva Roth purchased a convertible promissory note (the &#8220;September 22, 2021 Geneva Roth&#8221;) from the Company in the
aggregate principal amount of $<span id="xdx_90F_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20210922__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeptemberTwentyTwoTwoThousandTwentyOneGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember_zOYq6eOFZ5ek"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2021-09-22_custom_SecuritiesPurchaseAgreementMember_custom_SeptemberTwentyTwoTwoThousandTwentyOneGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">63,750</ix:nonFraction></span>, such principal and the interest thereon convertible into shares of the Company&#8217;s common
stock at the option of Geneva Roth any time after the six-month anniversary of the September 22, 2021 Geneva Roth. The September 22,
2021 Geneva Roth contains an original discount of $<span id="xdx_90E_eus-gaap--DebtConversionOriginalDebtAmount1_pp0p0_c20210921__20210922__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeptemberTwentyTwoTwoThousandTwentyOneGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember_zNZime7T8LN2"><ix:nonFraction name="us-gaap:DebtConversionOriginalDebtAmount1" contextRef="From2021-09-212021-09-22_custom_SecuritiesPurchaseAgreementMember_custom_SeptemberTwentyTwoTwoThousandTwentyOneGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,750</ix:nonFraction></span>. The Company intends to use the net proceeds from the September 22, 2021 Geneva
Roth for general working capital purposes. The maturity date of the September 22, 2021 Geneva Roth Note is September 22, 2022. The September
22, 2021 Geneva Roth Note bears interest at a rate of <span id="xdx_905_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20210922__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeptemberTwentyTwoTwoThousandTwentyOneGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember_zWSiuiI86P3k"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2021-09-22_custom_SecuritiesPurchaseAgreementMember_custom_SeptemberTwentyTwoTwoThousandTwentyOneGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">8</ix:nonFraction></span>% per annum, which interest may be paid by the Company to Geneva Roth in shares
of the Company&#8217;s common stock; but shall not be payable until the September 22, 2021 Geneva Roth Note becomes payable, whether
at the maturity date or upon acceleration or by prepayment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">During
the first 60 to 180 days following the date of these notes, the Company has the right to prepay the principal and accrued but unpaid
interest due under the above notes issued to Geneva Roth, together with any other amounts that the Company may owe the holder under the
terms of the note, at a premium ranging from <span id="xdx_90A_ecustom--DebtInstrumentDebtDefaultInterestRate_pid_dp_uPure_c20210921__20210922__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember__srt--RangeAxis__srt--MinimumMember_zaZJaariTFqc"><ix:nonFraction name="PPCB:DebtInstrumentDebtDefaultInterestRate" contextRef="From2021-09-212021-09-22_custom_SecuritiesPurchaseAgreementMember_custom_SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember_srt_MinimumMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">110</ix:nonFraction></span>% to <span id="xdx_90C_ecustom--DebtInstrumentDebtDefaultInterestRate_pid_dp_uPure_c20210921__20210922__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember__srt--RangeAxis__srt--MaximumMember_zpC4SxPyvNB5"><ix:nonFraction name="PPCB:DebtInstrumentDebtDefaultInterestRate" contextRef="From2021-09-212021-09-22_custom_SecuritiesPurchaseAgreementMember_custom_SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember_srt_MaximumMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">129</ix:nonFraction></span>% as defined in the note agreement. After this initial 180-day period, the Company
does not have a right to prepay such notes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_909_eus-gaap--DebtInstrumentDescription_c20210921__20210922__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeptemberTwentyTwoTwoThousandTwentyOneGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember__srt--RangeAxis__srt--MinimumMember_zHVNcBc1Vpjd"><ix:nonNumeric contextRef="From2021-09-212021-09-22_custom_SecuritiesPurchaseAgreementMember_custom_SeptemberTwentyTwoTwoThousandTwentyOneGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember_srt_MinimumMember" name="us-gaap:DebtInstrumentDescription">The
conversion price for the above Geneva Roth notes shall be equal to a <span id="xdx_902_ecustom--DebtInstrumentDebtDefaultInterestRate_pid_dp_uPure_c20210921__20210922__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeptemberTwentyTwoTwoThousandTwentyOneGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember_zGq3BXUa7Op5"><ix:nonFraction name="PPCB:DebtInstrumentDebtDefaultInterestRate" contextRef="From2021-09-212021-09-22_custom_SecuritiesPurchaseAgreementMember_custom_SeptemberTwentyTwoTwoThousandTwentyOneGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">35</ix:nonFraction></span>% discount of the market price based on the average of the lowest
three trading prices of the Common Stock for the ten trading days immediately prior to the delivery of a Notice of Conversion. Notwithstanding
the foregoing, Geneva Roth shall be restricted from effecting a conversion if such conversion, along with other shares of the Company&#8217;s
common stock beneficially owned by Geneva Roth and its affiliates, exceeds <span id="xdx_90E_ecustom--PercentageOfOutstandingSharesOfCommonStock_pid_dp_uPure_c20210921__20210922__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember__srt--RangeAxis__srt--MinimumMember_z6UGpQRbDf83"><ix:nonFraction name="PPCB:PercentageOfOutstandingSharesOfCommonStock" contextRef="From2021-09-212021-09-22_custom_SecuritiesPurchaseAgreementMember_custom_SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember_srt_MinimumMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">9.99</ix:nonFraction></span>% of the outstanding shares of the Company&#8217;s common
stock. These notes are treated as stock settled debt under ASC 480 and accordingly the Company recorded a total of $<span id="xdx_903_eus-gaap--DebtInstrumentUnamortizedPremium_iI_pp0p0_c20210922__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember_zVrRP5zlDEsi"><ix:nonFraction name="us-gaap:DebtInstrumentUnamortizedPremium" contextRef="AsOf2021-09-22_custom_SecuritiesPurchaseAgreementMember_custom_SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">161,269</ix:nonFraction></span> put premium
for the four notes.</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
above Geneva Roth notes contain certain events of default, upon which principal and accrued interest will become immediately due and
payable. In addition, upon an event of default, interest on the outstanding principal shall accrue at a default interest rate of <span id="xdx_902_ecustom--DebtDefaultAmountPercentage_pid_dp_uPure_c20210921__20210922__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember_zD9LZXItdfcf" title="Debt default amount percentage"><ix:nonFraction name="PPCB:DebtDefaultAmountPercentage" contextRef="From2021-09-212021-09-22_custom_SecuritiesPurchaseAgreementMember_custom_SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">22</ix:nonFraction></span>%
per annum, or if such rate is usurious or not permitted by current law, then at the highest rate of interest permitted by law. Further,
certain events of default may trigger penalty and liquidated damage provisions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
total principal amounts outstanding under the above Geneva Roth financing agreements were $<span id="xdx_907_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20210630__us-gaap--TypeOfArrangementAxis__custom--GenevaRothFinancingAgreementAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember_zm5UdQ7KYNqf"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2021-06-30_custom_GenevaRothFinancingAgreementAgreementMember_custom_SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">132,000</ix:nonFraction></span> and accrued interest of $<span id="xdx_90A_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20210630__us-gaap--TypeOfArrangementAxis__custom--GenevaRothFinancingAgreementAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember_zUsRMblbf2pk"><ix:nonFraction name="us-gaap:InterestPayableCurrentAndNoncurrent" contextRef="AsOf2021-06-30_custom_GenevaRothFinancingAgreementAgreementMember_custom_SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,477</ix:nonFraction></span> as
of June 30, 2021 following conversion of $<span id="xdx_901_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20210630__us-gaap--TypeOfArrangementAxis__custom--GenevaRothFinancingAgreementAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember_zGVdkKYxeGze"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2021-06-30_custom_GenevaRothFinancingAgreementAgreementMember_custom_SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">78,000</ix:nonFraction></span> of the principal balance and $<span id="xdx_904_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember_zJqYyidmnTwf"><ix:nonFraction name="us-gaap:InterestPayableCurrentAndNoncurrent" contextRef="AsOf2021-06-30_custom_SecuritiesPurchaseAgreementMember_custom_SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,120</ix:nonFraction></span> accrued interest during the year ended June 30,
2021. Accordingly, $<span id="xdx_904_eus-gaap--DebtInstrumentUnamortizedPremium_iI_pp0p0_c20210630__us-gaap--TypeOfArrangementAxis__custom--GenevaRothFinancingAgreementAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember_z0OghltJXj4f"><ix:nonFraction name="us-gaap:DebtInstrumentUnamortizedPremium" contextRef="AsOf2021-06-30_custom_GenevaRothFinancingAgreementAgreementMember_custom_SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">42,000</ix:nonFraction></span> of the put premium was released in respect of the Geneva Roth financing agreements during the year ended June
30, 2021 following conversion of the principal balance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
total principal amounts outstanding under the above Geneva Roth financing agreements were $<span id="xdx_900_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20210930__us-gaap--TypeOfArrangementAxis__custom--GenevaRothFinancingAgreementAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember_zSRXj1MFofhf"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2021-09-30_custom_GenevaRothFinancingAgreementAgreementMember_custom_SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">167,500</ix:nonFraction></span> and accrued interest of $<span id="xdx_903_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20210930__us-gaap--TypeOfArrangementAxis__custom--GenevaRothFinancingAgreementAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember_zxEer3i3Ai4b"><ix:nonFraction name="us-gaap:InterestPayableCurrentAndNoncurrent" contextRef="AsOf2021-09-30_custom_GenevaRothFinancingAgreementAgreementMember_custom_SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,081</ix:nonFraction></span> as
of September 30, 2021 following conversion of $<span id="xdx_90C_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20210930__us-gaap--TypeOfArrangementAxis__custom--GenevaRothFinancingAgreementAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember_zfR47ZiJD2Vd"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2021-09-30_custom_GenevaRothFinancingAgreementAgreementMember_custom_SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">132,000</ix:nonFraction></span> of the principal balance and $<span id="xdx_909_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20210930__us-gaap--TypeOfArrangementAxis__custom--GenevaRothFinancingAgreementAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember_zfxIAHXyadMa"><ix:nonFraction name="us-gaap:InterestPayableCurrentAndNoncurrent" contextRef="AsOf2021-09-30_custom_GenevaRothFinancingAgreementAgreementMember_custom_SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,280</ix:nonFraction></span> accrued interest during the three months ended
September 30, 2021. Accordingly, $<span id="xdx_902_eus-gaap--DebtInstrumentUnamortizedPremium_iI_pp0p0_c20210930__us-gaap--TypeOfArrangementAxis__custom--GenevaRothFinancingAgreementAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember_zryCIL9sv5Y7"><ix:nonFraction name="us-gaap:DebtInstrumentUnamortizedPremium" contextRef="AsOf2021-09-30_custom_GenevaRothFinancingAgreementAgreementMember_custom_SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">71,077</ix:nonFraction></span> of the put premium was released in respect of the Geneva Roth financing agreements during the
three months ended September 30, 2021 following conversion of the principal balance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Amortization
of debt discounts</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
Company recorded $<span id="xdx_905_eus-gaap--AmortizationOfDebtDiscountPremium_pp0p0_c20210701__20210930__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zDotonWxHIEg"><ix:nonFraction name="us-gaap:AmortizationOfDebtDiscountPremium" contextRef="From2021-07-012021-09-30_custom_SecuritiesPurchaseAgreementMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">7,500</ix:nonFraction></span> and $<span id="xdx_903_eus-gaap--AmortizationOfDebtDiscountPremium_pp0p0_c20200701__20200930__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zRErArH07Ngi"><ix:nonFraction name="us-gaap:AmortizationOfDebtDiscountPremium" contextRef="From2020-07-012020-09-30_custom_SecuritiesPurchaseAgreementMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">0</ix:nonFraction></span> of debt discounts (including warrants, derivatives, debt issue costs and original issue discounts) related
to the above note issuances during the three months ended September 30, 2021 and 2020, respectively. The Company recorded $<span id="xdx_907_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pp0p0_c20210930__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zoQmvISoyihb"><ix:nonFraction name="us-gaap:DebtInstrumentUnamortizedDiscount" contextRef="AsOf2021-09-30_custom_SecuritiesPurchaseAgreementMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">90,192</ix:nonFraction></span> and
$<span id="xdx_909_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pp0p0_c20200930__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zqYEyVk0Karh"><ix:nonFraction name="us-gaap:DebtInstrumentUnamortizedDiscount" contextRef="AsOf2020-09-30_custom_SecuritiesPurchaseAgreementMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">0</ix:nonFraction></span> of put premiums related to the above note issuances during the three months ended September 30, 2021 and 2020, respectively. The debt
discounts are being amortized over the term of the debt and the put premiums are expensed on issuance of the debt with the liability
released to additional paid in capital on conversion of the principal.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Amortization
of all debt discounts for the three months ended September 30, 2021 and 2020 was $<span id="xdx_900_eus-gaap--AmortizationOfDebtDiscountPremium_pp0p0_c20210701__20210930_z2nbP4cmctd4" title="Amortization of debt discount"><ix:nonFraction name="us-gaap:AmortizationOfDebtDiscountPremium" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">6,074</ix:nonFraction></span> and $<span id="xdx_906_eus-gaap--AmortizationOfDebtDiscountPremium_pp0p0_c20200701__20200930_zBvW04AaEQS9" title="Amortization of debt discount"><ix:nonFraction name="us-gaap:AmortizationOfDebtDiscountPremium" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">121,281</ix:nonFraction></span>, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
Company reclassified $<span id="xdx_909_ecustom--ReclassifiedPremiumAmountForAdditionalPaidInCapital_pp0p0_c20210701__20210930_zoB4cvf8iVJa"><ix:nonFraction name="PPCB:ReclassifiedPremiumAmountForAdditionalPaidInCapital" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">109,643</ix:nonFraction></span> and $<span id="xdx_905_ecustom--ReclassifiedPremiumAmountForAdditionalPaidInCapital_pp0p0_c20200701__20200930_zikr5Gq9GEja"><ix:nonFraction name="PPCB:ReclassifiedPremiumAmountForAdditionalPaidInCapital" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">204,919</ix:nonFraction></span> in put premiums to additional paid in capital following conversions during the three months
ended September 30, 2021 and 2020, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-07-01to2021-09-30" escape="true" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock"><p id="xdx_808_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zMw0pxdAWVcd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTE
7 &#8211; <span id="xdx_822_zMisaHkqg0Q7">STOCKHOLDERS&#8217; DEFICIT</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Increase
in Authorized Shares of Common Stock and Reverse Stock Split</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On
February 4, 2020 the Directors resolved to increase the Common Stock of the Company from <span id="xdx_902_eus-gaap--CommonStockSharesAuthorized_iI_c20210203_zxqwmpDvq0x9"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2021-02-03" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">100,000,000</ix:nonFraction></span> authorized shares to <span id="xdx_904_eus-gaap--CommonStockSharesAuthorized_iI_c20210204_zMJXuOt1cQw6" title="Common stock, shares authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2021-02-04" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,000,000,000</ix:nonFraction></span>
authorized shares and believes that such number of authorized shares of Common Stock will be in the best interests of the Corporation
and its stockholders because the Board believes that the availability of more shares of Common Stock for issuance will allow the Corporation
greater flexibility in pursuing financing from investors, meeting business needs as they arise, taking advantage of favorable opportunities
and responding to a changing corporate environment. The Company filed the necessary documents with the U.S. Securities and Exchange Commission
on February 6, 2020 and with the amendment to the authorized shares being approved by the State of Delaware on March 13, 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On
November 17, 2020, the Company effected a <span id="xdx_903_eus-gaap--StockholdersEquityReverseStockSplit_c20201116__20201117_zCNLsgn52Ge3"><ix:nonNumeric contextRef="From2020-11-162020-11-17" name="us-gaap:StockholdersEquityReverseStockSplit">one-for-one thousand (1:1,000)</ix:nonNumeric></span> reverse stock split of the Company&#8217;s issued and outstanding
shares of common stock (the &#8220;Reverse Stock Split&#8221;). Proportional adjustments for the Reverse Stock Split were made to the
Company&#8217;s outstanding stock options, warrants and equity incentive plans. All share and per-share data and amounts have been retroactively
adjusted as of the earliest period presented in the consolidated financial statements to reflect the Reverse Stock Split.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 144; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><b>PROPANC
BIOPHARMA, INC. AND SUBSIDIARY<br />
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS<br />
SEPTEMBER 30, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Unaudited)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><b><span style="text-decoration: underline">Preferred
Stock</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
total number of shares of preferred stock that the Company is authorized to issue is <span id="xdx_901_eus-gaap--PreferredStockSharesAuthorized_iI_c20210930_zGadqf3imdS2" title="Preferred stock, shares authorized"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,500,005</ix:nonFraction></span>, $<span id="xdx_905_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20210930_zgJ28qgsfvDd" title="Preferred stock, par value"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.01</ix:nonFraction></span> par value per share. These preferred
shares have no rights to dividends, profit sharing or liquidation preferences.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">Of
the total preferred shares authorized, <span id="xdx_90E_eus-gaap--PreferredStockSharesAuthorized_iI_c20210930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zklHtXwcLMRc"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2021-09-30_us-gaap_SeriesAPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">500,000</ix:nonFraction></span> have been designated as Series A Preferred Stock (&#8220;Series A Preferred Stock&#8221;),
pursuant to the Certificate of Designation filed with the Secretary of State of the State of Delaware on December 9, 2014. James Nathanielsz,
the Company&#8217;s Chief Executive Officer and Chief Financial Officer, beneficially owns all of the outstanding shares of Series A
Preferred Stock via North Horizon Pty Ltd., which entitles him, as a holder of Series A Preferred Stock, to vote on all matters submitted
or required to be submitted to a vote of the Company&#8217;s stockholders, except election and removal of directors, and each share of
Series A Preferred Stock entitles him to two votes per share of Series A Preferred Stock. North Horizon Pty Ltd. is a Nathanielsz Family
Trust. Mr. James Nathanielsz, the Chief Executive Officer, Chief Financial Officer and a director of our Company, has voting and investment
power over these shares.  <span id="xdx_908_eus-gaap--PreferredStockSharesIssued_iI_c20210930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zShGRKaqRxR" title="Preferred stock, shares issued"><span id="xdx_903_eus-gaap--PreferredStockSharesOutstanding_iI_c20210930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zWZ0zR9fbVW6" title="Preferred stock, shares outstanding"><span id="xdx_90C_eus-gaap--PreferredStockSharesIssued_iI_c20200930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zhHjKwqXWcAj" title="Preferred stock, shares issued"><span id="xdx_90E_eus-gaap--PreferredStockSharesOutstanding_iI_c20200930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zbNaziOiHu27" title="Preferred stock, shares outstanding"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2021-09-30_us-gaap_SeriesAPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2021-09-30_us-gaap_SeriesAPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2020-09-30_us-gaap_SeriesAPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2020-09-30_us-gaap_SeriesAPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">500,000</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span></span></span></span>  shares of Series A Preferred Stock are issued and outstanding as of September 30, 2021 and June 30,
2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">Of
the total preferred shares authorized, pursuant to the Certificate of Designation filed with the Secretary of State of the State of Delaware
on June 16, 2015, up to five shares have been designated as Series B Preferred Stock (&#8220;Series B Preferred Stock&#8221;). Each holder
of outstanding shares of Series B Preferred Stock is entitled to voting power equivalent to the number of votes equal to the total number
of shares of common stock outstanding as of the record date for the determination of stockholders entitled to vote at each meeting of
stockholders of the Company and entitled to vote on all matters submitted or required to be submitted to a vote of the stockholders of
the Company. One share of Series B Preferred Stock is issued and outstanding as of September 30, 2021 and June 30, 2021. Mr. Nathanielsz
directly beneficially owns such one share of Series B Preferred Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><span>No
additional shares of Series A Preferred Stock or Series B Preferred Stock were issued during the three months ended September 30, 2021
and fiscal year 2021.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><b>Common
Stock:</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Shares
issued for conversion of convertible debt</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">From
July 1, 2021 through September 30, 2021, the Company issued an aggregate of <span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210701__20210930__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember_zrhB06ppwRTb"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2021-07-012021-09-30_custom_SecurityPurchaseAgreementMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">9,445,009</ix:nonFraction> </span>shares of its common stock at an average contractual
conversion price of $<span id="xdx_90A_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20210930__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember_z6oZRlUY1LB6"><ix:nonFraction name="us-gaap:DebtInstrumentConvertibleConversionPrice1" contextRef="AsOf2021-09-30_custom_SecurityPurchaseAgreementMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.02</ix:nonFraction></span>, ranging from $<span id="xdx_905_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20210930__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember__srt--RangeAxis__srt--MinimumMember_zt5sDHz4Y7v1"><ix:nonFraction name="us-gaap:DebtInstrumentConvertibleConversionPrice1" contextRef="AsOf2021-09-30_custom_SecurityPurchaseAgreementMember_srt_MinimumMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.02</ix:nonFraction></span> to $<span id="xdx_901_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20210930__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember__srt--RangeAxis__srt--MaximumMember_zeBaRl8wQ5v8"><ix:nonFraction name="us-gaap:DebtInstrumentConvertibleConversionPrice1" contextRef="AsOf2021-09-30_custom_SecurityPurchaseAgreementMember_srt_MaximumMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.04</ix:nonFraction></span>, as a result of the conversion of principal of $<span id="xdx_90F_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20210930__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember_zmQLQnUkGiG6"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2021-09-30_custom_SecurityPurchaseAgreementMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">189,849</ix:nonFraction></span>, interest of $<span id="xdx_909_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20210930__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember_zkVdbheKEiv1"><ix:nonFraction name="us-gaap:InterestPayableCurrentAndNoncurrent" contextRef="AsOf2021-09-30_custom_SecurityPurchaseAgreementMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">8,087</ix:nonFraction></span> and
conversion fees $<span id="xdx_90C_ecustom--ConversionFees_pp0p0_c20210701__20210930__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember_zsqU4nSbdwIa"><ix:nonFraction name="PPCB:ConversionFees" contextRef="From2021-07-012021-09-30_custom_SecurityPurchaseAgreementMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,250</ix:nonFraction></span> underlying certain outstanding convertible notes converted during such period. The total recorded to equity was
$<span id="xdx_90E_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20210701__20210930__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember_zDJDkDnM7clg"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="From2021-07-012021-09-30_custom_SecurityPurchaseAgreementMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">200,186</ix:nonFraction></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
Company reclassified $<span id="xdx_900_ecustom--PremiumsToAdditionalPaidInCapital_pp0p0_c20210701__20210930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zjihC2NutZa6" title="Premiums to additional paid in capital"><ix:nonFraction name="PPCB:PremiumsToAdditionalPaidInCapital" contextRef="From2021-07-012021-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">109,643</ix:nonFraction></span>, net of reversal of put premium upon cancellation of conversion notices by two lenders discussed above,
to additional paid in capital following conversions during the three months ended September 30, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
Company has <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210701__20210930__us-gaap--TypeOfArrangementAxis__custom--UnderlyingFinancingAgreementsMember_zIDWkVvVbsJ6"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2021-07-012021-09-30_custom_UnderlyingFinancingAgreementsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">197,308,116</ix:nonFraction></span> shares of its common stock reserved for future issuances based on lender reserve requirements pursuant to underlying
financing agreements at September 30, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Shares
issued for services and accrued expenses</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">On
August 12, 2021, the Board approved the issuance of <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesEmployeeBenefitPlan_c20210811__20210812__us-gaap--StatementEquityComponentsAxis__custom--CommonStockOneMember_zDsldrVmkCif" title="Stock issued during the period for services, shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesEmployeeBenefitPlan" contextRef="From2021-08-112021-08-12_custom_CommonStockOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,800,000</ix:nonFraction></span> shares of the Company&#8217;s common stock for bonus payable of $<span id="xdx_905_eus-gaap--StockIssuedDuringPeriodValueEmployeeBenefitPlan_c20210811__20210812__us-gaap--StatementEquityComponentsAxis__custom--CommonStockOneMember_z84Nc7pi4Tmi"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan" contextRef="From2021-08-112021-08-12_custom_CommonStockOneMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">84,000</ix:nonFraction></span>
as of June 30, 2021 to an employee who is the wife of the CEO of the Company. The <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210811__20210812__us-gaap--StatementEquityComponentsAxis__custom--CommonStockOneMember_zJOm4XVVj7g3" title="Issuance of common stock for cash, shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2021-08-112021-08-12_custom_CommonStockOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,800,000</ix:nonFraction></span> shares of common stock were valued
at approximately $<span id="xdx_90C_eus-gaap--SharesIssuedPricePerShare_iI_c20210812__us-gaap--StatementEquityComponentsAxis__custom--CommonStockOneMember_z0mAIG1nJMJ1" title="Shares issued, price per share"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2021-08-12_custom_CommonStockOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.03</ix:nonFraction></span> per share or $<span id="xdx_909_eus-gaap--CommonStockValue_iI_c20210812__us-gaap--StatementEquityComponentsAxis__custom--CommonStockOneMember_zs8vYyqJDiAf" title="Common stock value issued"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2021-08-12_custom_CommonStockOneMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">87,920</ix:nonFraction></span>, being the closing price of the stock on the date of grant. The shares were issued on August
17, 2021. The Company recorded stock-based compensation of $<span id="xdx_90E_eus-gaap--ShareBasedCompensation_c20210701__20210930__us-gaap--StatementEquityComponentsAxis__custom--CommonStockOneMember_ziSzV3C89AQf" title="Share based compensation"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2021-07-012021-09-30_custom_CommonStockOneMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,920</ix:nonFraction></span> during the three months ended September 30, 2021 and reclassified bonus
payable of $<span id="xdx_909_eus-gaap--AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_c20210701__20210930__us-gaap--StatementEquityComponentsAxis__custom--CommonStockOneMember_zf7xE4mgffE8" title="Additional paid in capital upon issuance"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" contextRef="From2021-07-012021-09-30_custom_CommonStockOneMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">84,000</ix:nonFraction></span> to additional paid in capital upon issuance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">On
August 12, 2021, the Board approved the issuance of <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesEmployeeBenefitPlan_c20210811__20210812__srt--ProductOrServiceAxis__custom--LegalServicesMember_zdeAM8QJb4sl"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesEmployeeBenefitPlan" contextRef="From2021-08-112021-08-12_custom_LegalServicesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">166,667</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif">shares of the Company&#8217;s common stock for
legal services rendered for the month of August 2021. The 166,667 shares of common stock were valued at approximately $<span id="xdx_90E_eus-gaap--SharesIssuedPricePerShare_iI_c20210812__srt--ProductOrServiceAxis__custom--LegalServicesMember_zn477kdik1p7"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2021-08-12_custom_LegalServicesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.05</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif">per share or $<span id="xdx_90D_eus-gaap--CommonStockValue_iI_c20210812__srt--ProductOrServiceAxis__custom--LegalServicesMember_zOAYOsBZBqTk"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2021-08-12_custom_LegalServicesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,883</ix:nonFraction></span></span><span style="font: 10pt Times New Roman, Times, Serif">,
being the closing price of the stock on August 31, 2021, the date of grant. The shares were issued on September 3, 2021. The Company
recorded stock-based compensation of $<span id="xdx_90F_eus-gaap--ShareBasedCompensation_c20210701__20210930__srt--ProductOrServiceAxis__custom--LegalServicesMember_zxGb2eDOwmbj"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2021-07-012021-09-30_custom_LegalServicesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,883</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif">during the three months ended September 30, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">In
September 2021, the Company issued <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesEmployeeBenefitPlan_c20210929__20210930__srt--ProductOrServiceAxis__custom--ConsultantServicesMember_zpmqfbe1GZn4"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesEmployeeBenefitPlan" contextRef="From2021-09-292021-09-30_custom_ConsultantServicesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,819,712</ix:nonFraction></span> shares of the Company&#8217;s common stock to a consultant for services rendered from July
2021 to September 2021. The Company issued 2,819,712 shares of the Company&#8217;s common stock valued at approximately $<span id="xdx_90F_eus-gaap--SharesIssuedPricePerShare_iI_c20210812__srt--ProductOrServiceAxis__custom--ConsultantServicesMember_z2GIUXg2Km1h"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2021-08-12_custom_ConsultantServicesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.04</ix:nonFraction></span> per share
or $<span id="xdx_906_eus-gaap--CommonStockValue_iI_c20210812__srt--ProductOrServiceAxis__custom--ConsultantServicesMember_zQBbdMNwTnsj" title="Common stock value issued"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2021-08-12_custom_ConsultantServicesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">104,611</ix:nonFraction></span>, being the closing price of the stock on the date of grant to such consultant. The Company recorded stock-based compensation
of $<span id="xdx_904_eus-gaap--ShareBasedCompensation_c20210701__20210930__srt--ProductOrServiceAxis__custom--ConsultantServicesMember_zThXkNGKffs1"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2021-07-012021-09-30_custom_ConsultantServicesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">104,611</ix:nonFraction></span> during the three months ended September 30, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 145; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><b>PROPANC
BIOPHARMA, INC. AND SUBSIDIARY<br />
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS<br />
SEPTEMBER 30, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Unaudited)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><i>Nathanielsz
Cancellation Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 16.2pt; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">On
August 12, 2021, the Company entered into a Cancellation Agreement with James Nathanielsz (&#8220;Nathanielsz&#8221;), Chief Executive
Officer and Director of the Company, whereby Nathanielsz agreed to cancel his cash compensation bonus award for fiscal year 2021, ended
June 30, 2021, in exchange for common stock of the Company. The Company and Nathanielsz entered into an Amended and Restated Employment
Agreement dated May 14, 2019 (the &#8220;Agreement&#8221;). Pursuant to the terms of the Agreement, Nathanielsz was eligible to earn
an annual fiscal year cash performance bonus for each fiscal year of his employment period with the Company with a target performance
bonus of <span id="xdx_901_ecustom--PercentageOfBonusOfAnnualBaseSalary_dp_uPure_c20210811__20210812__us-gaap--TypeOfArrangementAxis__custom--NathanielszCancellationAgreementMember_zCLC1GCuYMa7" title="Percentage of bonus of annual base salary"><ix:nonFraction name="PPCB:PercentageOfBonusOfAnnualBaseSalary" contextRef="From2021-08-112021-08-12_custom_NathanielszCancellationAgreementMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">200</ix:nonFraction></span>% of his average annualized base salary during the fiscal year for which the performance bonus is earned. On July 20, 2021,
Nathanielsz was awarded a &#8220;target&#8221; bonus of <span id="xdx_908_ecustom--PercentageOfBonusOfAnnualBaseSalary_pip0_dp_uPure_c20210719__20210720__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember__us-gaap--TypeOfArrangementAxis__custom--NathanielszCancellationAgreementMember_zKevKhYlIuFh" title="Percentage of bonus of annual base salary"><ix:nonFraction name="PPCB:PercentageOfBonusOfAnnualBaseSalary" contextRef="From2021-07-192021-07-20_custom_MrNathanielszMember_custom_NathanielszCancellationAgreementMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">78</ix:nonFraction></span>%, or $<span id="xdx_905_eus-gaap--OfficersCompensation_pp0p0_c20210719__20210720__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember__us-gaap--TypeOfArrangementAxis__custom--NathanielszCancellationAgreementMember_zKq0ik4XgMC9" title="Officer compensation"><ix:nonFraction name="us-gaap:OfficersCompensation" contextRef="From2021-07-192021-07-20_custom_MrNathanielszMember_custom_NathanielszCancellationAgreementMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">177,840</ix:nonFraction></span> USD (the &#8220;Debt&#8221;) for the fiscal year ended June
30, 2021, by the Company&#8217;s Board of Directors (the &#8220;Board&#8221;). Pursuant to the Cancellation Agreement, Nathanielsz agreed
to cancel this Debt in exchange for <span id="xdx_901_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_pp0p0_c20210816__20210817__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember__us-gaap--TypeOfArrangementAxis__custom--NathanielszCancellationAgreementMember_zpPnofWvhYb6"><ix:nonFraction name="us-gaap:DebtConversionConvertedInstrumentSharesIssued1" contextRef="From2021-08-162021-08-17_custom_MrNathanielszMember_custom_NathanielszCancellationAgreementMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="Shares">5,928,000</ix:nonFraction></span> shares of the common stock of the Company (the &#8220;Shares&#8221;), valued at approximately
$<span id="xdx_905_eus-gaap--SharePrice_iI_pip0_c20210817__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember__us-gaap--TypeOfArrangementAxis__custom--NathanielszCancellationAgreementMember_zUmi0N2se0X9"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2021-08-17_custom_MrNathanielszMember_custom_NathanielszCancellationAgreementMember" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.03</ix:nonFraction></span> per share or $<span id="xdx_908_eus-gaap--CommonStockValue_iI_pip0_c20210817__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember__us-gaap--TypeOfArrangementAxis__custom--NathanielszCancellationAgreementMember_zbVq3HjJ3BKl" title="Common stock value issued"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2021-08-17_custom_MrNathanielszMember_custom_NathanielszCancellationAgreementMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">186,139</ix:nonFraction></span>, being the closing price of the stock on the date of grant. The shares were issued on August 17, 2021. The
Company recorded stock-based compensation of $<span id="xdx_906_eus-gaap--ShareBasedCompensation_c20210811__20210812__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember_z2hsC7wZ1qEc"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2021-08-112021-08-12_custom_MrNathanielszMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,299</ix:nonFraction></span> during the three months ended September 30, 2021 and reclassified bonus payable of
$<span id="xdx_90E_eus-gaap--AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_c20210811__20210812__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember_zZbHY9PisvJa"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" contextRef="From2021-08-112021-08-12_custom_MrNathanielszMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">177,840</ix:nonFraction></span> to additional paid in capital upon issuance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 16.2pt; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><i>Kenyon
Cancellation Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 16.2pt; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">On
August 12, 2021, the Company entered into a Cancellation Agreement with Dr. Julian Kenyon (&#8220;Kenyon&#8221;), Chief Scientific Officer
and Director of the Company, whereby Kenyon agreed to cancel of $<span id="xdx_90F_eus-gaap--AccruedSalariesCurrent_iI_c20210812__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__custom--DeferredSalaryMember__us-gaap--TypeOfArrangementAxis__custom--CancellationAgreementMember_z2xZEAt3OBL9" title="Acccrued salary cancellation"><ix:nonFraction name="us-gaap:AccruedSalariesCurrent" contextRef="AsOf2021-08-12_custom_DeferredSalaryMember_custom_CancellationAgreementMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">102,600</ix:nonFraction></span> USD of accrued salary due him as of June 30, 2021, pursuant
to that certain Amended and Restated Services Agreement by and between Kenyon and the Company, dated May 14, 2019, in exchange for <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesEmployeeBenefitPlan_c20210811__20210812__srt--TitleOfIndividualAxis__custom--ChiefScientificOfficerandDirectorMember_zLyw61W3dj94"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesEmployeeBenefitPlan" contextRef="From2021-08-112021-08-12_custom_ChiefScientificOfficerandDirectorMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,420,000</ix:nonFraction></span>
shares of common stock of the Company (the &#8220;Shares&#8221;), valued at approximately $<span id="xdx_90F_eus-gaap--SharesIssuedPricePerShare_iI_c20210812__srt--TitleOfIndividualAxis__custom--ChiefScientificOfficerandDirectorMember_zusxu36XXajd"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2021-08-12_custom_ChiefScientificOfficerandDirectorMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.03</ix:nonFraction></span> per share or $<span id="xdx_901_eus-gaap--CommonStockValue_iI_c20210812__srt--TitleOfIndividualAxis__custom--ChiefScientificOfficerandDirectorMember_zliyf6nhtHR6"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2021-08-12_custom_ChiefScientificOfficerandDirectorMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">107,388</ix:nonFraction></span>, being the closing
price of the stock on the date of grant. The shares were issued on August 17, 2021. The Company recorded stock-based compensation of
$<span id="xdx_906_eus-gaap--ShareBasedCompensation_c20210811__20210812__srt--TitleOfIndividualAxis__custom--ChiefScientificOfficerandDirectorMember_zGsvqby85h3c"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2021-08-112021-08-12_custom_ChiefScientificOfficerandDirectorMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,788</ix:nonFraction></span> during the three months ended September 30, 2021 and reclassified accrued expenses of $<span id="xdx_909_eus-gaap--AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_c20210701__20210930__srt--TitleOfIndividualAxis__custom--ChiefScientificOfficerandDirectorMember_z7o5PXxcehH6"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" contextRef="From2021-07-012021-09-30_custom_ChiefScientificOfficerandDirectorMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">102,600</ix:nonFraction></span> to additional paid in capital upon
issuance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 16.2pt; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>Zelinger
Amended and Restated Director Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">On
August 12, 2021, the Company entered into an Amended and Restated Director Agreement (the &#8220;Director Agreement&#8221;) with Josef
Zelinger (&#8220;Zelinger&#8221;). <span id="xdx_908_ecustom--DescriptionOfEmploymentBenefits_c20210811__20210812__us-gaap--TypeOfArrangementAxis__custom--ZelingerAmendedAndRestatedDirectorAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--JosefZelingerMember_zIafOWlVGFbj"><ix:nonNumeric contextRef="From2021-08-112021-08-12_custom_ZelingerAmendedAndRestatedDirectorAgreementMember_custom_JosefZelingerMember" name="PPCB:DescriptionOfEmploymentBenefits">Pursuant
to the terms of the Director Agreement, the Company shall pay Zelinger a base salary of $250.00 AUD ($184 USD) per month, payable
on the first day of each month. In addition, the Company may compensate Zelinger additional consideration for advisory services performed
by the Director, either in the form of cash or common stock, at the discretion of the Board. The Company issued <span id="xdx_906_ecustom--CommonStockIssuableShares_iI_c20210630__us-gaap--TypeOfArrangementAxis__custom--ZelingerAmendedAndRestatedDirectorAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--JosefZelingerMember_z131fYPKaMck"><ix:nonFraction name="PPCB:CommonStockIssuableShares" contextRef="AsOf2021-06-30_custom_ZelingerAmendedAndRestatedDirectorAgreementMember_custom_JosefZelingerMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,800,000</ix:nonFraction></span> shares of common
stock of the Company for accrued director services of $<span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20200701__20210630__us-gaap--TypeOfArrangementAxis__custom--ZelingerAmendedAndRestatedDirectorAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--JosefZelingerMember_zIbg2u8ptUkg"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2020-07-012021-06-30_custom_ZelingerAmendedAndRestatedDirectorAgreementMember_custom_JosefZelingerMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">84,000</ix:nonFraction></span> as of June 30, 2021.</ix:nonNumeric> </span></span><span style="font: 10pt Times New Roman, Times, Serif">The
<span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210701__20210930__us-gaap--TypeOfArrangementAxis__custom--ZelingerAmendedAndRestatedDirectorAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--JosefZelingerMember_zSaHuhy3dBU3"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2021-07-012021-09-30_custom_ZelingerAmendedAndRestatedDirectorAgreementMember_custom_JosefZelingerMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,800,000</ix:nonFraction></span> shares of common stock were valued at approximately $<span id="xdx_90E_eus-gaap--SharePrice_iI_c20210630__us-gaap--TypeOfArrangementAxis__custom--ZelingerAmendedAndRestatedDirectorAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--JosefZelingerMember_zz6ANSdBV52g"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2021-06-30_custom_ZelingerAmendedAndRestatedDirectorAgreementMember_custom_JosefZelingerMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.03</ix:nonFraction></span> per share $<span id="xdx_900_eus-gaap--CommonStockValue_iI_c20210630__us-gaap--TypeOfArrangementAxis__custom--ZelingerAmendedAndRestatedDirectorAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--JosefZelingerMember_zYgCEmlb6eEk" title="Common stock value issued"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2021-06-30_custom_ZelingerAmendedAndRestatedDirectorAgreementMember_custom_JosefZelingerMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">87,920</ix:nonFraction></span>, being the closing price of the stock on
the date of grant. The shares were issued on August 17, 2021. The shares were issued on August 17, 2021. The Company recorded stock-based
compensation of $<span id="xdx_909_eus-gaap--ShareBasedCompensation_c20210811__20210812__us-gaap--TypeOfArrangementAxis__custom--ZelingerAmendedAndRestatedDirectorAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--JosefZelingerMember_z1xSDZC815Fc"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2021-08-112021-08-12_custom_ZelingerAmendedAndRestatedDirectorAgreementMember_custom_JosefZelingerMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,920</ix:nonFraction></span> during the three months ended September 30, 2021 and reclassified accrued expenses of $<span id="xdx_908_eus-gaap--AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_c20210701__20210930__us-gaap--TypeOfArrangementAxis__custom--ZelingerAmendedAndRestatedDirectorAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--JosefZelingerMember_zORHCYFlOc3e"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" contextRef="From2021-07-012021-09-30_custom_ZelingerAmendedAndRestatedDirectorAgreementMember_custom_JosefZelingerMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">84,000</ix:nonFraction></span> to additional paid
in capital upon issuance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Shares
issued for exercise of warrants</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">From
July 9, 2021 through September 27, 2021, the Company received aggregate gross proceeds of $<span id="xdx_904_eus-gaap--ProceedsFromIssuanceOfWarrants_c20210706__20210927_z5sFNnoMpkTi" title="Proceed from issuance of excercise of warrants"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfWarrants" contextRef="From2021-07-062021-09-27" format="ixt:numdotdecimal" decimals="0" unitRef="USD">275,000</ix:nonFraction></span> and subscription receivable of $<span id="xdx_90D_eus-gaap--StockholdersEquityNoteSubscriptionsReceivable_iI_c20210927_zo8TfwJL1jL1"><ix:nonFraction name="us-gaap:StockholdersEquityNoteSubscriptionsReceivable" contextRef="AsOf2021-09-27" format="ixt:numdotdecimal" decimals="0" unitRef="USD">100,000</ix:nonFraction></span>
from the exercise of <span id="xdx_900_eus-gaap--ProceedsFromIssuanceOfWarrants_c20210706__20210927__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantMember_zwQsIV6YL6Cc"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfWarrants" contextRef="From2021-07-062021-09-27_custom_SeriesBWarrantMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,375</ix:nonFraction></span> Series B Warrants and issued <span id="xdx_905_eus-gaap--CommonStockSharesIssued_iI_c20210927__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantMember_zszZpjZ3dgD8" title="Common stock shares issued"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2021-09-27_custom_SeriesBWarrantMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,875</ix:nonFraction></span> shares of common stock and <span id="xdx_907_eus-gaap--CommonStockSharesAuthorized_iI_c20210930__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantMember_zLPnNDXAyZG7" title="Common stock, shares authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2021-09-30_custom_SeriesBWarrantMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,500</ix:nonFraction> </span>shares of common stock issuable
as of September 30, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">During
the three months ended September 30, 2021, additionally, the Company issued <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210701__20210930_zsi5duzQcmTj"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,399,988</ix:nonFraction></span> shares of common stock and <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesOther_c20210701__20210930_zimIlaUtcoaf"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesOther" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,999,990</ix:nonFraction></span> shares
of common stock issuable from the alternate cashless exercise of 22 Series A warrants. The Company recognized the value of the effect
of a down round feature in such warrants when triggered. Upon the occurrence of the triggering event that resulted in a reduction of
the strike price, the Company measured the value of the effect of the feature as the difference between the fair value of the warrants
without the down round feature or before the strike price reduction and the fair value of the warrants with a strike price corresponding
to the reduced strike price upon the down round feature being triggered. Accordingly, the Company recognized deemed dividend of $<span id="xdx_903_ecustom--DeemedDividend_iN_di_c20210701__20210930_zdxR4qPLScJj" title="Deemed dividend"><ix:nonFraction name="PPCB:DeemedDividend" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">114,844</ix:nonFraction></span>
and a corresponding reduction of income available to common stockholders upon the alternate cashless exercise of these warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">A
total of <span id="xdx_903_eus-gaap--CommonStockSharesAuthorized_iI_c20211031_zquk7yMxY55l"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,002,490</ix:nonFraction></span> common stock issuable were issued in October 2021. The Company collected the $<span id="xdx_903_eus-gaap--StockholdersEquityNoteSubscriptionsReceivable_iI_c20211031_zQiFphOIPdbf"><ix:nonFraction name="us-gaap:StockholdersEquityNoteSubscriptionsReceivable" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">100,000</ix:nonFraction></span> subscription receivable in October
2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 146; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><b>PROPANC
BIOPHARMA, INC. AND SUBSIDIARY<br />
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS<br />
SEPTEMBER 30, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Unaudited)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Warrants:</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-07-01to2021-09-30" escape="true" name="us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock"><p id="xdx_896_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zHpSNYZ0bJ83" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
following table summarizes warrant activity for the three months ended September 30, 2021:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8BD_zTCyL2jDJay7" style="display: none">SCHEDULE
OF WARRANT ACTIVITY</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Weighted</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Number of</span></td><td style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Average</span></td><td style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Shares</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Price
    Per Share</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%"><span style="font-family: Times New Roman, Times, Serif">Outstanding at June 30, 2021</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20210701__20210930_zbSgfIZiHED6" title="Number of Shares, Outstanding, Beginning balance" style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">121,329</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageOutstanding_iS_c20210701__20210930_zoMmctVkyGj8" title="Weighted Average Price Per Share, Outstanding, Beginning balance" style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="PPCB:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageOutstanding" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">179.63</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">Issued</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsIssued_c20210701__20210930_ztsKXhp7ND3b" title="Number of Shares, Issued" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3731">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceIssued_c20210701__20210930_zxIyHmTNnHjk" title="Weighted Average Price Per Share, Issued" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3733">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">Exercised</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_di_c20210701__20210930_z2qjat9AzCb5" title="Number of Shares, Exercised" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">9,397</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceExercised_c20210701__20210930_z5aPDFIJ5t9a" title="Weighted Average Price Per Share, Exercised" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="PPCB:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceExercised" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">40.37</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">Forfeited</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_c20210701__20210930_zUF4dPx3cbCj" title="Number of Shares, Forfeited" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3739">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceExpired_c20210701__20210930_zUExwkkX8E9c" title="Weighted Average Price Per Share, Forfeited" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3741">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Expired</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_c20210701__20210930_zRsiiaMbQBUe" title="Number of Shares, Expired" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3743">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceForfeited_c20210701__20210930_zcVGq2jY8Xsl" title="Weighted Average Price Per Share, Expired" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3745">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Outstanding at September 30, 2021</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_c20210701__20210930_zEeLCD9yTkk1" title="Number of Shares, Outstanding, Ending balance" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">111,932</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_981_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageOutstanding_iE_c20210701__20210930_zwi2Nr1IeWxh" title="Weighted Average Price Per Share, Outstanding, Ending balance" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="PPCB:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageOutstanding" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">191.32</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Exercisable at September 30, 2021</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_iE_c20210701__20210930_zrodIa8LyCSj" title="Number of Shares, Exercisable, Ending balance" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="PPCB:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">76,933</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisable_iE_c20210701__20210930_zdX6Ygyia1Ri" title="Weighted Average Price Per Share, Exercisable, Ending balance" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="PPCB:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisable" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">278.36</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Outstanding and Exercisable:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Weighted average remaining contractual
    term</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20210701__20210930_zfPJb5ld6tyk" title="Weighted average remaining contractual term"><ix:nonNumeric contextRef="From2021-07-01to2021-09-30" format="ixt-sec:duryear" name="PPCB:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerms">1.52</ix:nonNumeric></span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Aggregate intrinsic
    value <br /></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_983_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsAggregateIntrinsicValueOutstanding_iE_pp0p0_c20210701__20210930_z7SavXjqef7j" title="Aggregate intrinsic value" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3757">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A6_zjhyyGBCVHqg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">No
stock warrants were granted during the three months ended September 30, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Options:</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-07-01to2021-09-30" escape="true" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"><p id="xdx_89C_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zoqy7CeBTuXf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">A
summary of the Company&#8217;s option activity during the three months ended September 30, 2021 is presented below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8B4_zmh1iYU4qpng" style="display: none">SCHEDULE
OF STOCK OPTION ACTIVITY</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Number of</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Average Exercise</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Shares</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Price
    Per Share</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%"><span style="font-family: Times New Roman, Times, Serif">Outstanding at June 30, 2021</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20210701__20210930_z51ifCEyQQS9" title="Number of Shares, Outstanding, Beginning balance" style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">59</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20210701__20210930_z0rx5Kwkyr14" title="Weighted Average Price Per Share, Outstanding, Beginning balance" style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">13,730</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">Issued</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_c20210701__20210930_zOKcK7k2XQW1" title="Number of Shares, Issued" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3765">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20210701__20210930_zHBULMkZ5u8" title="Weighted Average Price Per Share, Issued" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3767">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">Exercised</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20210701__20210930_zTZzX1tDCJqa" title="Number of Shares, Exercised" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3769">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20210701__20210930_z5HJiarD8QA7" title="Weighted Average Price Per Share, Exercised" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3771">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">Forfeited</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c20210701__20210930_zqSUqZrPkma7" title="Number of Shares, Forfeited" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3773">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20210701__20210930_zzLJvnToAvj9" title="Weighted Average Price Per Share, Forfeited" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3775">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Expired</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_c20210701__20210930_zAfG2knRVrw1" title="Number of Shares, Expired" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3777">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_c20210701__20210930_zKPa4oYA71S5" title="Weighted Average Price Per Share, Expired" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3779">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Outstanding at September 30, 2021</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20210701__20210930_z8Qqg1bHEKp2" title="Number of Shares, Outstanding, Ending balance" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">59</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20210701__20210930_ztHIftIDn6gg" title="Weighted Average Price Per Share, Outstanding, Ending balance" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">4,533.33</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">Exercisable at September 30, 2021</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_c20210701__20210930_z9SXbOqrLe0h" title="Number of Shares, Exercisable, Ending balance" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">39</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_c20210701__20210930_zACMHgTi7J44" title="Weighted Average Price Per Share, Exercisable, Ending balance" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">4,530.93</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Outstanding and Exercisable:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Weighted average remaining contractual
    term</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20210701__20210930_zcgS12ZloSe5" title="Weighted average remaining contractual term"><ix:nonNumeric contextRef="From2021-07-01to2021-09-30" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">7.62</ix:nonNumeric></span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Weighted average fair value of options
    granted during the period</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90C_ecustom--WeightedAverageFairValueOfOptionsGrantedDuringPeriod_c20210701__20210930_zK8ntmlEsHa3" title="Weighted average fair value of options granted during the period"><span style="-sec-ix-hidden: xdx2ixbrl3791">-</span></span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Aggregate intrinsic value</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pp0p0_c20210701__20210930_zKVspuFDvKc6" title="Aggregate intrinsic value" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3793">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A1_zOOS3tjEAv44" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">During
the three months ended September 30, 2021 and 2020, the Company recognized stock-based compensation of $<span id="xdx_908_eus-gaap--ShareBasedCompensation_pp0p0_c20210701__20210930_zn2UUDzW4jE1" title="Share based compensation"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">20,718</ix:nonFraction></span> and $<span id="xdx_907_eus-gaap--ShareBasedCompensation_pp0p0_c20200701__20200930_zT8ZskpYfuei" title="Share based compensation"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">20,718</ix:nonFraction></span>, respectively
related to vested stock options. There was $<span id="xdx_902_eus-gaap--StockOptionPlanExpense_pp0p0_c20210701__20210930_z8rKDxyiF0Bg" title="Stock option expense"><ix:nonFraction name="us-gaap:StockOptionPlanExpense" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">51,796</ix:nonFraction></span> of unvested stock options expense as of September 30, 2021 that will be recognized
through May 2022 or <span id="xdx_908_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20210331_zm4C5sNPiXLf" title="Term of warrant"><ix:nonNumeric contextRef="AsOf2021-03-31" format="ixt-sec:duryear" name="us-gaap:WarrantsAndRightsOutstandingTerm">0.62</ix:nonNumeric></span> years.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">No
stock options were granted during the three months ended September 30, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-07-01to2021-09-30" escape="true" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock"><p id="xdx_802_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zlQYr0RERxR7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTE
8 &#8211; <span id="xdx_822_zCvLoL184dke">COMMITMENTS AND CONTINGENCIES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><b>Legal
Matters </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">From
time to time, the Company may be subject to litigation and claims arising in the ordinary course of business. The Company is not currently
a party to any material legal proceedings and the Company is not aware of any pending or threatened legal proceeding against the Company
that we believe could have a material adverse effect on our business, operating results, cash flows or financial condition.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 147; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>PROPANC
BIOPHARMA, INC. AND SUBSIDIARY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>SEPTEMBER
30, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Unaudited)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>IRS
Liability</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">As
part of its requirement for having a foreign operating subsidiary, the Company&#8217;s parent U.S. entity is required to file an informational
Form 5471 to the Internal Revenue Service (the &#8220;IRS&#8221;), which is a form that explains the nature of the relationship between
the foreign subsidiary and the parent company. From 2012 through the 2014, the Company did not file this form in a timely manner. As
a result of the non-timely filings, the Company incurred a penalty from the IRS in the amount of $<span id="xdx_908_ecustom--LitigationPenaltyAmount_pp0p0_c20210701__20210930__us-gaap--AwardDateAxis__custom--From2012ThroughThe2014Member_zQxZ2XzPp4id"><ix:nonFraction name="PPCB:LitigationPenaltyAmount" contextRef="From2021-07-012021-09-30_custom_From2012ThroughThe2014Member" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">10,000</ix:nonFraction></span> per year, or $<span id="xdx_904_ecustom--LitigationPenaltyAmount_pp0p0_c20210701__20210930_zzLqRmwYUTjb"><ix:nonFraction name="PPCB:LitigationPenaltyAmount" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">30,000</ix:nonFraction></span> in total,
plus accrued interest, such penalty and interest having been accrued and is included in the accrued expenses and other payable figure
in the September 30, 2021 and June 30, 2021 consolidated balance sheet. The Company recorded the penalties for all three years during
the year ended June 30, 2018. The Company is current on all subsequent filings. The Company&#8217;s tax advisor is awaiting a response
from the IRS on this matter.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Operating
Agreements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">In
November 2009, the Company entered into a commercialization agreement with the University of Bath (UK) (the &#8220;University&#8221;)
whereby the Company and the University co-owned the intellectual property relating to the Company&#8217;s pro-enzyme formulations. In
June 2012, the Company and the University entered into an assignment and amendment whereby the Company assumed full ownership of the
intellectual property while agreeing to pay royalties of<span id="xdx_902_ecustom--OperatingLeasesIncomeStatementRevenuePercentage_dp_uPure_c20120601__20120630__us-gaap--TypeOfArrangementAxis__us-gaap--RoyaltyAgreementTermsMember_ztyPmoOVl0m"> <ix:nonFraction name="PPCB:OperatingLeasesIncomeStatementRevenuePercentage" contextRef="From2012-06-012012-06-30_us-gaap_RoyaltyAgreementTermsMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">2</ix:nonFraction></span>% of net revenues to the University. Additionally, the Company agreed to pay
<span id="xdx_90B_ecustom--OperatingLeasesIncomeStatementRevenuePercentage_dp_uPure_c20120601__20120630__us-gaap--TypeOfArrangementAxis__us-gaap--LicenseAgreementTermsMember_zjfHUvOqUBS5"><ix:nonFraction name="PPCB:OperatingLeasesIncomeStatementRevenuePercentage" contextRef="From2012-06-012012-06-30_us-gaap_LicenseAgreementTermsMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">5</ix:nonFraction></span>% of each and every license agreement subscribed for. The contract is cancellable at any time by either party. To date, no amounts are
owed under the agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><b>Collaboration
Agreement</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On
September 13, 2018, the Company entered into a two-year collaboration agreement with the University of Ja&#233;n (the &#8220;University&#8221;)
to provide certain research services to the Company. In consideration of such services, the Company agreed to pay the University approximately
<span id="xdx_90F_ecustom--PaymentForServices_pp0p0_uEuro_c20180910__20180913__us-gaap--TypeOfArrangementAxis__custom--OneYearCollaborationAgreementMember__us-gaap--AwardTypeAxis__custom--EurosMember_zWkpdfYYRu61"><ix:nonFraction name="PPCB:PaymentForServices" contextRef="From2018-09-102018-09-13_custom_OneYearCollaborationAgreementMember_custom_EurosMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="Euro">52,000</ix:nonFraction></span> Euros ($<span id="xdx_900_ecustom--PaymentForServices_pp0p0_c20180910__20180913__us-gaap--TypeOfArrangementAxis__custom--OneYearCollaborationAgreementMember_zUd5vTOCzQ34"><ix:nonFraction name="PPCB:PaymentForServices" contextRef="From2018-09-102018-09-13_custom_OneYearCollaborationAgreementMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">59,508</ix:nonFraction></span> USD) in year one and a maximum of <span id="xdx_900_ecustom--PaymentForServices_pp0p0_uEuro_c20180910__20180913__us-gaap--TypeOfArrangementAxis__custom--TwoYearCollaborationAgreementMember__us-gaap--AwardTypeAxis__custom--EurosMember_zP8v6QHtLfga"><ix:nonFraction name="PPCB:PaymentForServices" contextRef="From2018-09-102018-09-13_custom_TwoYearCollaborationAgreementMember_custom_EurosMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="Euro">40,000</ix:nonFraction></span> Euros ($<span id="xdx_900_ecustom--PaymentForServices_pp0p0_c20180910__20180913__us-gaap--TypeOfArrangementAxis__custom--TwoYearCollaborationAgreementMember_zkNNmUWYmXW5"><ix:nonFraction name="PPCB:PaymentForServices" contextRef="From2018-09-102018-09-13_custom_TwoYearCollaborationAgreementMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">45,775</ix:nonFraction></span> USD) in year two. The Company paid <span id="xdx_90E_ecustom--PaymentForServices_pp0p0_uEuro_c20180701__20190630__us-gaap--AwardTypeAxis__custom--EurosMember_zV6KLypjQpK3"><ix:nonFraction name="PPCB:PaymentForServices" contextRef="From2018-07-012019-06-30_custom_EurosMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="Euro">31,754</ix:nonFraction></span> Euros ($<span id="xdx_907_ecustom--PaymentForServices_pp0p0_c20180701__20190630_z1VrPbRQIVrf"><ix:nonFraction name="PPCB:PaymentForServices" contextRef="From2018-07-012019-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">36,117</ix:nonFraction></span>
USD) in 2019 and has accrued <span id="xdx_90E_ecustom--PaymentForServices_pp0p0_uEuro_c20200701__20210630__us-gaap--AwardTypeAxis__custom--EurosMember_z72xtbmgu1gc"><ix:nonFraction name="PPCB:PaymentForServices" contextRef="From2020-07-012021-06-30_custom_EurosMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="Euro">28,493</ix:nonFraction></span> Euros ($<span id="xdx_90C_ecustom--PaymentForServices_pp0p0_c20200701__20210630_zHpjlYof1Kx6"><ix:nonFraction name="PPCB:PaymentForServices" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">24,043</ix:nonFraction></span> USD) as of June 30, 2021. Additionally, in exchange for full ownership of the intellectual
property the Company agreed to pay royalties of <span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20180910__20180913__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--RevenueFromRightsConcentrationRiskMember__srt--MajorCustomersAxis__custom--NoCustomerMember_zsWXu5YUxfk8"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2018-09-102018-09-13_us-gaap_SalesRevenueNetMember_us-gaap_RevenueFromRightsConcentrationRiskMember_custom_NoCustomerMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">2</ix:nonFraction></span>% of net revenues to the University. On October 1, 2020, the Company entered into another
two-year collaboration agreement with the University of Ja&#233;n to provide certain research services to the Company. In consideration
of such services, the Company agreed to pay the University approximately <span id="xdx_90E_ecustom--PaymentForServices_pp0p0_uEuro_c20200929__20201002__us-gaap--TypeOfArrangementAxis__custom--TwoYearCollaborationAgreementMember__us-gaap--AwardTypeAxis__custom--EurosMember_zD31kIGGvFNg"><ix:nonFraction name="PPCB:PaymentForServices" contextRef="From2020-09-292020-10-02_custom_TwoYearCollaborationAgreementMember_custom_EurosMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="Euro">30,000</ix:nonFraction></span> Euros ($<span id="xdx_90C_ecustom--PaymentForServices_pp0p0_c20200929__20201002__us-gaap--TypeOfArrangementAxis__custom--TwoYearCollaborationAgreementMember_z6moICqqXWrg"><ix:nonFraction name="PPCB:PaymentForServices" contextRef="From2020-09-292020-10-02_custom_TwoYearCollaborationAgreementMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">35,145</ix:nonFraction></span> USD) which shall be paid in four installment
payment of <span id="xdx_90D_ecustom--PaymentForServices_pp0p0_uEuro_c20200929__20201002__us-gaap--TypeOfArrangementAxis__custom--TwoYearCollaborationAgreementMember__us-gaap--AwardTypeAxis__custom--EurosMember__us-gaap--AwardDateAxis__custom--InstallmentOneMember_zasnD79JF5wh"><ix:nonFraction name="PPCB:PaymentForServices" contextRef="From2020-09-292020-10-02_custom_TwoYearCollaborationAgreementMember_custom_EurosMember_custom_InstallmentOneMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="Euro">5,000</ix:nonFraction></span> Euros in November 2020, <span id="xdx_90F_ecustom--PaymentForServices_pp0p0_uEuro_c20200929__20201002__us-gaap--TypeOfArrangementAxis__custom--TwoYearCollaborationAgreementMember__us-gaap--AwardDateAxis__custom--InstallmentTwoMember__us-gaap--AwardTypeAxis__custom--EurosMember_zIeQW14upxB2"><ix:nonFraction name="PPCB:PaymentForServices" contextRef="From2020-09-292020-10-02_custom_TwoYearCollaborationAgreementMember_custom_InstallmentTwoMember_custom_EurosMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="Euro">5,000</ix:nonFraction></span> Euros ($<span id="xdx_908_ecustom--PaymentForServices_pp0p0_c20200929__20201002__us-gaap--TypeOfArrangementAxis__custom--TwoYearCollaborationAgreementMember__us-gaap--AwardDateAxis__custom--InstallmentTwoMember_zxmP75oLG7Ne"><ix:nonFraction name="PPCB:PaymentForServices" contextRef="From2020-09-292020-10-02_custom_TwoYearCollaborationAgreementMember_custom_InstallmentTwoMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,858</ix:nonFraction></span>) in March 2021, <span id="xdx_906_ecustom--PaymentForServices_pp0p0_uEuro_c20200929__20201002__us-gaap--TypeOfArrangementAxis__custom--TwoYearCollaborationAgreementMember__us-gaap--AwardDateAxis__custom--InstallmentThreeMember__us-gaap--AwardTypeAxis__custom--EurosMember_zYSrA2OWPOq7"><ix:nonFraction name="PPCB:PaymentForServices" contextRef="From2020-09-292020-10-02_custom_TwoYearCollaborationAgreementMember_custom_InstallmentThreeMember_custom_EurosMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="Euro">10,000</ix:nonFraction></span> Euros ($<span id="xdx_90B_ecustom--PaymentForServices_pp0p0_c20200929__20201002__us-gaap--TypeOfArrangementAxis__custom--TwoYearCollaborationAgreementMember__us-gaap--AwardDateAxis__custom--InstallmentThreeMember_zQDYB0y5rfZe"><ix:nonFraction name="PPCB:PaymentForServices" contextRef="From2020-09-292020-10-02_custom_TwoYearCollaborationAgreementMember_custom_InstallmentThreeMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">11,715</ix:nonFraction></span>) in December 2021 and <span id="xdx_902_ecustom--PaymentForServices_pp0p0_uEuro_c20200929__20201002__us-gaap--TypeOfArrangementAxis__custom--TwoYearCollaborationAgreementMember__us-gaap--AwardDateAxis__custom--InstallmentFourMember__us-gaap--AwardTypeAxis__custom--EurosMember_zaZTGriMJiI1"><ix:nonFraction name="PPCB:PaymentForServices" contextRef="From2020-09-292020-10-02_custom_TwoYearCollaborationAgreementMember_custom_InstallmentFourMember_custom_EurosMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="Euro">10,000</ix:nonFraction></span> Euros
($<span id="xdx_901_ecustom--PaymentForServices_pp0p0_c20200929__20201002__us-gaap--TypeOfArrangementAxis__custom--TwoYearCollaborationAgreementMember__us-gaap--AwardDateAxis__custom--InstallmentFourMember_zDU0Szg140si"><ix:nonFraction name="PPCB:PaymentForServices" contextRef="From2020-09-292020-10-02_custom_TwoYearCollaborationAgreementMember_custom_InstallmentFourMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">11,715</ix:nonFraction></span>) in September 2022. Additionally, the University shall hire and train a doctoral student for this project and as such the Company
shall pay the University <span id="xdx_90D_ecustom--PaymentForServices_pp0p0_uEuro_c20200929__20201002__dei--LegalEntityAxis__custom--UniversityOfJaenMember__us-gaap--AwardTypeAxis__custom--EurosMember_z2miFiRl7Wj1" title="Payment for services"><ix:nonFraction name="PPCB:PaymentForServices" contextRef="From2020-09-292020-10-02_custom_UniversityOfJaenMember_custom_EurosMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="Euro">25,837</ix:nonFraction></span> Euros ($<span id="xdx_909_ecustom--PaymentForServices_pp0p0_c20200929__20201002__dei--LegalEntityAxis__custom--UniversityOfJaenMember_z20xuqnj98dl" title="Payment for services"><ix:nonFraction name="PPCB:PaymentForServices" contextRef="From2020-09-292020-10-02_custom_UniversityOfJaenMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">30,268</ix:nonFraction></span> USD). In exchange for full ownership of the intellectual property the Company agreed to
pay royalties of<span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20200929__20201002__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__dei--LegalEntityAxis__custom--UniversityOfJaenMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--RevenueFromRightsConcentrationRiskMember__srt--MajorCustomersAxis__custom--NoCustomerMember_zp48BunMv2Bj" title="Royalties percentage"> <ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2020-09-292020-10-02_us-gaap_SalesRevenueNetMember_custom_UniversityOfJaenMember_us-gaap_RevenueFromRightsConcentrationRiskMember_custom_NoCustomerMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">2</ix:nonFraction></span>% of net revenues to the University.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-07-01to2021-09-30" escape="true" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock"><p id="xdx_807_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zKlAkoBh8Ygj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTE 9 &#8211; <span id="xdx_82E_zfYxozwsc66">RELATED PARTY TRANSACTIONS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">Since
its inception, the Company has conducted transactions with its directors and entities related to such directors. These transactions have
included the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">As
of September 30, 2021 and June 30, 2021, the Company owed its former director a total of $<span id="xdx_90B_ecustom--LoansFromRelatedParty_iI_pp0p0_c20210930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--CurrentAndFormerDirectorMember_zu4z5AeLtI9k"><ix:nonFraction name="PPCB:LoansFromRelatedParty" contextRef="AsOf2021-09-30_custom_CurrentAndFormerDirectorMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">53,384</ix:nonFraction></span> and $<span id="xdx_902_ecustom--LoansFromRelatedParty_iI_pp0p0_c20210630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--CurrentAndFormerDirectorMember_z5vSFOs05k61"><ix:nonFraction name="PPCB:LoansFromRelatedParty" contextRef="AsOf2021-06-30_custom_CurrentAndFormerDirectorMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">55,500</ix:nonFraction></span>, respectively, for money
loaned to the Company throughout the years. The total loans balance owed at September 30, 2021 and June 30, 2021 is not interest bearing
(See Note 5 &#8211; Loans and Notes Payable).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">As
of September 30, 2021 and June 30, 2021, the Company owed its former director a total of $<span id="xdx_901_eus-gaap--DueToRelatedPartiesCurrent_iI_pp0p0_c20210930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--FormerDirectorMember_zyDfm48jFJXk"><ix:nonFraction name="us-gaap:DueToRelatedPartiesCurrent" contextRef="AsOf2021-09-30_custom_FormerDirectorMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">32,076</ix:nonFraction> </span>and $<span id="xdx_90F_eus-gaap--DueToRelatedPartiesCurrent_iI_pp0p0_c20210630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--FormerDirectorMember_zJRtMxjGmrnk"><ix:nonFraction name="us-gaap:DueToRelatedPartiesCurrent" contextRef="AsOf2021-06-30_custom_FormerDirectorMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">33,347</ix:nonFraction></span>, respectively, related to
expenses paid on behalf of the Company related to corporate startup costs and intellectual property (See Note 4 &#8211; Due to Former
Director &#8211; Related Party).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On
May 6, 2021, the Company entered into an agreement for the lease of its principal executive offices with North Horizon Pty Ltd., a related
party, of which Mr. Nathanielsz, our CEO, CFO and a director, and his wife are owners and directors. The lease has a one-year term commencing
May 6, 2021, and the Company is currently obligated to pay $<span id="xdx_904_ecustom--OperatingLeasesRentExpenseMinimumRentalsPayable_pp0p0_uAUD_c20210503__20210506__dei--LegalEntityAxis__custom--NorthHorizonPtyLtdMember__us-gaap--AwardTypeAxis__custom--AUDCurrencyMember_zixN4Doi7VDc"><ix:nonFraction name="PPCB:OperatingLeasesRentExpenseMinimumRentalsPayable" contextRef="From2021-05-032021-05-06_custom_NorthHorizonPtyLtdMember_custom_AUDCurrencyMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="AUD">3,606</ix:nonFraction></span> AUD or $<span id="xdx_90B_ecustom--OperatingLeasesRentExpenseMinimumRentalsPayable_pp0p0_c20210505__20210506__dei--LegalEntityAxis__custom--NorthHorizonPtyLtdMember_z9r7nz638Nel"><ix:nonFraction name="PPCB:OperatingLeasesRentExpenseMinimumRentalsPayable" contextRef="From2021-05-052021-05-06_custom_NorthHorizonPtyLtdMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,431</ix:nonFraction></span> USD (depending on exchange rate), inclusive of tax, in
rent per month. During the three months ended September 30, 2021 and 2020, rent expense amounted $<span id="xdx_90F_ecustom--OperatingLeasesRentExpenseMinimumRentalsPayable_pp0p0_uAUD_c20210701__20210930__dei--LegalEntityAxis__custom--NorthHorizonPtyLtdMember__us-gaap--AwardTypeAxis__custom--AUDCurrencyMember_zgF0qADjup7d"><ix:nonFraction name="PPCB:OperatingLeasesRentExpenseMinimumRentalsPayable" contextRef="From2021-07-012021-09-30_custom_NorthHorizonPtyLtdMember_custom_AUDCurrencyMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="AUD">7,735</ix:nonFraction></span> USD and $<span id="xdx_906_ecustom--OperatingLeasesRentExpenseMinimumRentalsPayable_pp0p0_uAUD_c20200701__20210930__dei--LegalEntityAxis__custom--NorthHorizonPtyLtdMember__us-gaap--AwardTypeAxis__custom--AUDCurrencyMember_zsHWq5i1kMUg"><ix:nonFraction name="PPCB:OperatingLeasesRentExpenseMinimumRentalsPayable" contextRef="From2020-07-012021-09-30_custom_NorthHorizonPtyLtdMember_custom_AUDCurrencyMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="AUD">9,204</ix:nonFraction></span> USD. As of September
30, 2021, total rent payable of $<span id="xdx_90A_eus-gaap--PaymentsForRent_pp0p0_uAUD_c20210701__20210930__dei--LegalEntityAxis__custom--NorthHorizonPtyLtdMember__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember_zuGpOsanB7bl"><ix:nonFraction name="us-gaap:PaymentsForRent" contextRef="From2021-07-012021-09-30_custom_NorthHorizonPtyLtdMember_custom_AUDCurrenryMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="AUD">84,000</ix:nonFraction></span>AUD ($<span id="xdx_908_eus-gaap--PaymentsForRent_pp0p0_c20210701__20210930__dei--LegalEntityAxis__custom--NorthHorizonPtyLtdMember_zN2LIz6ibnt3"><ix:nonFraction name="us-gaap:PaymentsForRent" contextRef="From2021-07-012021-09-30_custom_NorthHorizonPtyLtdMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">60,598</ix:nonFraction></span> USD) is included in accrued expenses in the accompanying condensed consolidated balance
sheet.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 148; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>PROPANC
                                            BIOPHARMA, INC. AND SUBSIDIARY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>SEPTEMBER
30, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Unaudited)</b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><i>Employment
and Services Agreements with Management</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
Company and Mr. Nathanielsz entered into an employment agreement as of February 25, 2015 (the &#8220;Nathanielsz Employment Agreement&#8221;)
setting forth the terms and conditions of Mr. Nathanielsz employment as the Company&#8217;s President and Chief Executive Officer. The
Nathanielsz Employment Agreement was scheduled to expire on <span id="xdx_90A_eus-gaap--RelatedPartyTransactionDate_dd_c20150224__20150225__us-gaap--TypeOfArrangementAxis__custom--NathanielszEmploymentAgreementMember_zI4E8tN5aqd3"><ix:nonNumeric contextRef="From2015-02-242015-02-25_custom_NathanielszEmploymentAgreementMember" format="ixt:datemonthdayyearen" name="us-gaap:RelatedPartyTransactionDate">February 25, 2019</ix:nonNumeric></span>; however, the term of the Nathanielsz Employment Agreement
automatically renews for successive one-year periods unless either party provides 30 days&#8217; prior written notice of its intent not
to renew. The Nathanielsz Employment Agreement continues in effect as of September 30, 2021 as amended May 14, 2019 (see below). The
Nathanielsz Employment Agreement provides Mr. Nathanielsz with a base salary of $<span id="xdx_909_eus-gaap--SalariesAndWages_pp0p0_uAUD_c20150224__20150225__us-gaap--TypeOfArrangementAxis__custom--NathanielszEmploymentAgreementMember__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember_zJDZdvgnTkLj"><ix:nonFraction name="us-gaap:SalariesAndWages" contextRef="From2015-02-242015-02-25_custom_NathanielszEmploymentAgreementMember_custom_AUDCurrenryMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="AUD">25,000</ix:nonFraction></span> AUD per month ($<span id="xdx_901_eus-gaap--SalariesAndWages_pp0p0_uAUD_c20200701__20210630__us-gaap--TypeOfArrangementAxis__custom--NathanielszEmploymentAgreementMember__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember_zXJRrgHAZ558"><ix:nonFraction name="us-gaap:SalariesAndWages" contextRef="From2020-07-012021-06-30_custom_NathanielszEmploymentAgreementMember_custom_AUDCurrenryMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="AUD">300,000</ix:nonFraction></span> AUD annually or $<span id="xdx_907_eus-gaap--SalariesAndWages_pp0p0_c20200701__20210630__us-gaap--TypeOfArrangementAxis__custom--NathanielszEmploymentAgreementMember_zstiGJmSWXna"><ix:nonFraction name="us-gaap:SalariesAndWages" contextRef="From2020-07-012021-06-30_custom_NathanielszEmploymentAgreementMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">205,680</ix:nonFraction></span>
USD) and a monthly contribution to Mr. Nathanielsz&#8217;s pension equal to <span id="xdx_90E_ecustom--PercentageOfPensionOfMonthlySalary_dp_uPure_c20200701__20210630__us-gaap--TypeOfArrangementAxis__custom--NathanielszEmploymentAgreementMember_zrBF7nyxe6Vk"><ix:nonFraction name="PPCB:PercentageOfPensionOfMonthlySalary" contextRef="From2020-07-012021-06-30_custom_NathanielszEmploymentAgreementMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">9.5</ix:nonFraction></span>% of his monthly salary. Mr. Nathanielsz has the ability
to convert any accrued but unpaid salary into common stock at the end of each fiscal year at a conversion price to be determined by Mr.
Nathanielsz and the Company, which will in no event be lower than par value or higher than the closing bid price on the date of conversion.
Pursuant to the Nathanielsz Employment Agreement, Mr. Nathanielsz is entitled to an annual discretionary bonus in an amount up to <span id="xdx_908_ecustom--PercentageOfBonusOfAnnualBaseSalary_dp_uPure_c20200701__20210630__us-gaap--TypeOfArrangementAxis__custom--NathanielszEmploymentAgreementMember_zEa6kqt2K3ah"><ix:nonFraction name="PPCB:PercentageOfBonusOfAnnualBaseSalary" contextRef="From2020-07-012021-06-30_custom_NathanielszEmploymentAgreementMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">200</ix:nonFraction></span>%
of his annual base salary, which bonus shall be determined by the Company&#8217;s board of directors based upon the performance of the
Company. On March 16, 2018, the Company&#8217;s board of directors approved an increase of Mr. Nathanielsz&#8217;s annual base salary
from $<span id="xdx_90F_eus-gaap--SalariesAndWages_pp0p0_uAUD_c20180315__20180316__us-gaap--TypeOfArrangementAxis__custom--NathanielszEmploymentAgreementMember__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember__srt--RangeAxis__srt--MinimumMember_zpO1KbgMpXXg"><ix:nonFraction name="us-gaap:SalariesAndWages" contextRef="From2018-03-152018-03-16_custom_NathanielszEmploymentAgreementMember_custom_AUDCurrenryMember_srt_MinimumMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="AUD">300,000</ix:nonFraction></span> AUD ($<span id="xdx_903_eus-gaap--SalariesAndWages_pp0p0_c20180315__20180316__us-gaap--TypeOfArrangementAxis__custom--NathanielszEmploymentAgreementMember__srt--RangeAxis__srt--MinimumMember_z1SrYaSg60oj"><ix:nonFraction name="us-gaap:SalariesAndWages" contextRef="From2018-03-152018-03-16_custom_NathanielszEmploymentAgreementMember_srt_MinimumMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">205,680</ix:nonFraction></span> USD) to $<span id="xdx_90D_eus-gaap--SalariesAndWages_pp0p0_uAUD_c20180315__20180316__us-gaap--TypeOfArrangementAxis__custom--NathanielszEmploymentAgreementMember__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember__srt--RangeAxis__srt--MaximumMember_zPmO0V9mQS5l"><ix:nonFraction name="us-gaap:SalariesAndWages" contextRef="From2018-03-152018-03-16_custom_NathanielszEmploymentAgreementMember_custom_AUDCurrenryMember_srt_MaximumMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="AUD">400,000</ix:nonFraction></span> AUD ($<span id="xdx_90A_eus-gaap--SalariesAndWages_pp0p0_c20180315__20180316__us-gaap--TypeOfArrangementAxis__custom--NathanielszEmploymentAgreementMember__srt--RangeAxis__srt--MaximumMember_zGMywGh0zlDi"><ix:nonFraction name="us-gaap:SalariesAndWages" contextRef="From2018-03-152018-03-16_custom_NathanielszEmploymentAgreementMember_srt_MaximumMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">274,240</ix:nonFraction></span> USD), effective February 2018.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">Mr.
Nathanielsz&#8217;s wife, Sylvia Nathanielsz, is and has been a non-executive part-time employee of the Company since October 2015. Effective
February 1, 2018, Mrs. Nathanielsz receives an annual salary of $<span id="xdx_905_eus-gaap--SalariesAndWages_pp0p0_uAUD_c20180128__20180201__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrsNathanielszMember__us-gaap--AwardTypeAxis__custom--AUDCurrencyMember_zpt8r7SDyqC"><ix:nonFraction name="us-gaap:SalariesAndWages" contextRef="From2018-01-282018-02-01_custom_MrsNathanielszMember_custom_AUDCurrencyMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="AUD">120,000</ix:nonFraction></span> AUD ($<span id="xdx_908_eus-gaap--SalariesAndWages_pp0p0_c20180128__20180201__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrsNathanielszMember_zeFkmrh0GVG7"><ix:nonFraction name="us-gaap:SalariesAndWages" contextRef="From2018-01-282018-02-01_custom_MrsNathanielszMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">80,904</ix:nonFraction></span> USD) and is entitled to customary benefits.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">Pursuant
to a February 25, 2016 board resolution, James Nathanielsz shall be paid $<span id="xdx_900_eus-gaap--RepaymentsOfRelatedPartyDebt_pp0p0_uAUD_c20160224__20160225__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--JamesNathanielszMember__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember_zbKQTZIJ2y6k"><ix:nonFraction name="us-gaap:RepaymentsOfRelatedPartyDebt" contextRef="From2016-02-242016-02-25_custom_JamesNathanielszMember_custom_AUDCurrenryMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="AUD">4,481</ix:nonFraction></span> AUD ($<span id="xdx_905_eus-gaap--RepaymentsOfRelatedPartyDebt_pp0p0_c20160224__20160225__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--JamesNathanielszMember_zKZ9cCX8kI18"><ix:nonFraction name="us-gaap:RepaymentsOfRelatedPartyDebt" contextRef="From2016-02-242016-02-25_custom_JamesNathanielszMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,205</ix:nonFraction></span> USD), on a monthly basis for the purpose
of acquiring and maintaining an automobile. For the three months ended September 30, 2021, a total of $$<span id="xdx_900_eus-gaap--RepaymentsOfRelatedPartyDebt_pp0p0_uAUD_c20210701__20210930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrsNathanielszMember__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember_zTrwbJSefWM7"><ix:nonFraction name="us-gaap:RepaymentsOfRelatedPartyDebt" contextRef="From2021-07-012021-09-30_custom_MrsNathanielszMember_custom_AUDCurrenryMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="AUD">7,689</ix:nonFraction></span> AUD ($<span id="xdx_908_eus-gaap--RepaymentsOfRelatedPartyDebt_pp0p0_c20210701__20210930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrsNathanielszMember_zhIrUC9nNUTa"><ix:nonFraction name="us-gaap:RepaymentsOfRelatedPartyDebt" contextRef="From2021-07-012021-09-30_custom_MrsNathanielszMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,651</ix:nonFraction></span> USD) in payments
have been made with respect to Mr. Nathanielsz&#8217;s car allowance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">Pursuant to the approval of the Company&#8217;s board of directors, on May 14, 2019, Mr. Nathanielsz was granted a $<span id="xdx_90D_eus-gaap--OfficersCompensation_pp0p0_uAUD_c20190513__20190514__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsMember__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember_zTCWArOO88eh"><ix:nonFraction name="us-gaap:OfficersCompensation" contextRef="From2019-05-132019-05-14_custom_MrNathanielszMember_custom_BoardOfDirectorsMember_custom_AUDCurrenryMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="AUD">460,000</ix:nonFraction></span> AUD ($<span id="xdx_90D_eus-gaap--OfficersCompensation_pp0p0_c20190513__20190514__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsMember_ziLfYVoEFR9d"><ix:nonFraction name="us-gaap:OfficersCompensation" contextRef="From2019-05-132019-05-14_custom_MrNathanielszMember_custom_BoardOfDirectorsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">315,376</ix:nonFraction></span> USD) bonus for accomplishments achieved while serving as the Company&#8217;s Chief Executive Officer during the fiscal year ended June 30, 2019 with $<span id="xdx_90A_ecustom--BonusPayableAmount_pp0p0_uAUD_c20180701__20190630__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember_z9peavSiI6S6"><ix:nonFraction name="PPCB:BonusPayableAmount" contextRef="From2018-07-012019-06-30_srt_ChiefExecutiveOfficerMember_custom_AUDCurrenryMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="AUD">200,000</ix:nonFraction></span> AUD ($<span id="xdx_907_ecustom--BonusPayableAmount_pp0p0_c20180701__20190630__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zoZALS8lNCF3"><ix:nonFraction name="PPCB:BonusPayableAmount" contextRef="From2018-07-012019-06-30_srt_ChiefExecutiveOfficerMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">137,120</ix:nonFraction></span> USD) of such bonus payable by the Corporation to the CEO throughout the Corporation&#8217;s 2019 fiscal
year as the Corporation&#8217;s cash resources allow, with the remaining $<span id="xdx_902_ecustom--RemainingBonusAmount_pp0p0_uAUD_c20180701__20190630__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember_zceybiYGVKJd"><ix:nonFraction name="PPCB:RemainingBonusAmount" contextRef="From2018-07-012019-06-30_srt_ChiefExecutiveOfficerMember_custom_AUDCurrenryMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="AUD">260,000</ix:nonFraction></span> AUD ($<span title="[custom:RemainingBonusAmount]"><span id="xdx_906_ecustom--RemainingBonusAmount_pp0p0_c20180701__20190630__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_z3Li8Y1WayYi"><ix:nonFraction name="PPCB:RemainingBonusAmount" contextRef="From2018-07-012019-06-30_srt_ChiefExecutiveOfficerMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">178,256</ix:nonFraction></span></span> USD) of such bonus to be deferred by the CEO until a future date when the Corporation&#8217;s cash resources allow for such payment, as agreed to by the CEO. A total of $<span id="xdx_904_eus-gaap--RepaymentsOfRelatedPartyDebt_pp0p0_uAUD_c20200701__20210630__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember_zV6UgoUEDNii" title="Payments form related party" style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:RepaymentsOfRelatedPartyDebt" contextRef="From2020-07-012021-06-30_srt_ChiefExecutiveOfficerMember_custom_AUDCurrenryMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="AUD">221,890</ix:nonFraction></span>
AUD ($<span id="xdx_904_ecustom--BonusPayable_pp0p0_c20200701__20210630__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zBWdTFd5PPj3" title="Bonus payable"><ix:nonFraction name="PPCB:BonusPayable" contextRef="From2020-07-012021-06-30_srt_ChiefExecutiveOfficerMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">166,418</ix:nonFraction></span> USD) in payments were made against the bonuses during the year ended June 30, 2021 resulting in a remaining balance of $<span id="xdx_905_ecustom--BonusPayable_pp0p0_uAUD_c20200701__20210630__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember_zFN7GNV96Oil" title="Bonus payable"><ix:nonFraction name="PPCB:BonusPayable" contextRef="From2020-07-012021-06-30_srt_ChiefExecutiveOfficerMember_custom_AUDCurrenryMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="AUD">422,610</ix:nonFraction></span> AUD ($<span id="xdx_90F_ecustom--BonusPayable_pp0p0_c20200701__20210630__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--TypeOfArrangementAxis__custom--MrsNathanielszMember_zRsMxqrf9md2" title="Bonus payable"><ix:nonFraction name="PPCB:BonusPayable" contextRef="From2020-07-012021-06-30_srt_ChiefExecutiveOfficerMember_custom_MrsNathanielszMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">316,957</ix:nonFraction></span> USD) bonus payable as of June 30, 2021. On August 12, 2021, the Board approved a bonus of $<span id="xdx_90D_eus-gaap--OfficersCompensation_pp0p0_c20210811__20210812__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember_zSIjyzAeBAf7" title="Officers&apos; compensation"><ix:nonFraction name="us-gaap:OfficersCompensation" contextRef="From2021-08-112021-08-12_custom_MrNathanielszMember_custom_BoardOfDirectorsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">177,840</ix:nonFraction></span> USD. On August 12, 2021, pursuant to the Cancellation Agreement, Mr. Nathanielsz agreed to cancel $<span id="xdx_90F_eus-gaap--OfficersCompensation_pp0p0_c20210811__20210812__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember_zOL3B6kyS4vc" title="Officers&apos; compensation"><ix:nonFraction name="us-gaap:OfficersCompensation" contextRef="From2021-08-112021-08-12_custom_MrNathanielszMember_custom_BoardOfDirectorsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">177,840</ix:nonFraction></span> of the bonus payable in exchange for <span id="xdx_905_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20210811__20210812__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember_z7EORU5fOkxi" title="Debt Conversion, Converted Instrument, Shares Issued"><ix:nonFraction name="us-gaap:DebtConversionConvertedInstrumentSharesIssued1" contextRef="From2021-08-112021-08-12_custom_MrNathanielszMember_custom_BoardOfDirectorsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,928,000</ix:nonFraction></span> shares of the common stock of the Company (see Note 7). A total of $$<span id="xdx_907_eus-gaap--RepaymentsOfRelatedPartyDebt_pp0p0_uAUD_c20210701__20210930__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember_zckpRC2qEJBk" title="Payments form related party"><ix:nonFraction name="us-gaap:RepaymentsOfRelatedPartyDebt" contextRef="From2021-07-012021-09-30_srt_ChiefExecutiveOfficerMember_custom_AUDCurrenryMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="AUD">42,500</ix:nonFraction></span> AUD ($<span id="xdx_90C_eus-gaap--RepaymentsOfRelatedPartyDebt_pp0p0_c20210701__20210930__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zFxDY2HaZEY9" title="Payments form related party"><ix:nonFraction name="us-gaap:RepaymentsOfRelatedPartyDebt" contextRef="From2021-07-012021-09-30_srt_ChiefExecutiveOfficerMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">30,660</ix:nonFraction></span> USD) in payments were made against the bonuses during the three months ended September 30, 2021 which resulted to a remaining balance of $<span id="xdx_906_ecustom--BonusPayable_pp0p0_uAUD_c20210701__20210930__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember_zRiuOG3ZIOJd" title="Bonus payable"><ix:nonFraction name="PPCB:BonusPayable" contextRef="From2021-07-012021-09-30_srt_ChiefExecutiveOfficerMember_custom_AUDCurrenryMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="AUD">142,990</ix:nonFraction></span> AUD ($<span id="xdx_90D_ecustom--BonusPayable_pp0p0_c20210701__20210930__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zOaEh4TI7ixa" title="Bonus payable"><ix:nonFraction name="PPCB:BonusPayable" contextRef="From2021-07-012021-09-30_srt_ChiefExecutiveOfficerMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">103,153</ix:nonFraction></span> USD) bonus payable as of September 30, 2021 which is included in accrued expenses in the accompanying condensed consolidated balance sheet.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Amended
and Restated Employment Agreement - On May 14, 2019 (the &#8220;Effective Date&#8221;), the Company entered into an Amended and Restated
Employment Agreement (the &#8220;Employment Agreement&#8221;) with James Nathanielsz, the Company&#8217;s Chief Executive Officer, Chairman,
acting Chief Financial Officer and a director, for a term of <span id="xdx_90C_ecustom--AgreementlTerm_dc_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember_z3DnwpYc5J9c" title="Agreement term"><ix:nonNumeric contextRef="From2019-05-132019-05-14_custom_EmploymentAgreementMember_custom_MrNathanielszMember" format="ixt-sec:durwordsen" name="PPCB:AgreementlTerm">three years</ix:nonNumeric></span>, subject to automatic <span id="xdx_907_ecustom--AgreementRenewalTerm_dtYxL_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember_zenS2toJ8RTa" title="Agreement renewal term::XDX::1"><span style="-sec-ix-hidden: xdx2ixbrl3891">one</span></span>-year renewals, at an annual salary
of $<span id="xdx_901_eus-gaap--SalariesAndWages_pp0p0_uAUD_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember_zOvUJmTVkEJh" title="Annual salary"><ix:nonFraction name="us-gaap:SalariesAndWages" contextRef="From2019-05-132019-05-14_custom_EmploymentAgreementMember_custom_MrNathanielszMember_custom_AUDCurrenryMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="AUD">400,000</ix:nonFraction></span> AUD. Pursuant to the Employment Agreement, Mr. Nathanielsz was granted options to purchase <span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember_zw2Gfwhnir42" title="Option purchase shares"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" contextRef="From2019-05-132019-05-14_custom_EmploymentAgreementMember_custom_MrNathanielszMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">39</ix:nonFraction></span> shares of the Company&#8217;s
common stock (the &#8220;Nathanielsz Options&#8221;), with an exercise price per share of $<span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember_zUhJwv1Vmi9l" title="Exercise price"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" contextRef="From2019-05-132019-05-14_custom_EmploymentAgreementMember_custom_MrNathanielszMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">4,675</ix:nonFraction></span> (<span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_pid_dp_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember_zdISKL8TIkJe" title="Market price"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" contextRef="From2019-05-132019-05-14_custom_EmploymentAgreementMember_custom_MrNathanielszMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">110</ix:nonFraction>%</span> of the closing market price of
the Company&#8217;s common stock on May 14, 2019 (or $<span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember_znDtkgBG9f65" title="Granted exercise price"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" contextRef="From2019-05-132019-05-14_custom_EmploymentAgreementMember_custom_MrNathanielszMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">4,250</ix:nonFraction></span>), the date of approval of such grant by the Company&#8217;s board of directors),
(ii) <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember__us-gaap--AwardTypeAxis__custom--RestrictedStocksUnitsRSUMember_zWlSMqPlB4G3" title="Restricted stock shares of common stock"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" contextRef="From2019-05-132019-05-14_custom_EmploymentAgreementMember_custom_RestrictedStocksUnitsRSUMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">39</ix:nonFraction></span> restricted stock units of the Company (the &#8220;Initial Nathanielsz RSUs&#8221;), and (iii) an additional <span id="xdx_90A_ecustom--StockToBeIssuedDuringPeriodValueRestrictedStockUnit_c20210701__20210930__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember_z3k96wWhktmi" title="Restricted stock unit issuable"><ix:nonFraction name="PPCB:StockToBeIssuedDuringPeriodValueRestrictedStockUnit" contextRef="From2021-07-012021-09-30_custom_EmploymentAgreementMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">39</ix:nonFraction></span> restricted stock
units of the Company (the &#8220;Additional Nathanielsz RSUs&#8221;). Such options and restricted stock units were granted pursuant to
the 2019 Plan approved by the Company&#8217;s board of directors on the Effective Date. <span id="xdx_90E_ecustom--OptionsVestedDescription_c20190513__20190514__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember" title="Options vested, description"><ix:nonNumeric contextRef="From2019-05-132019-05-14_custom_EmploymentAgreementMember_custom_MrNathanielszMember" name="PPCB:OptionsVestedDescription">The Nathanielsz Options have a term of <span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember_zjXSrkUNxySc" title="Option term"><ix:nonNumeric contextRef="From2019-05-132019-05-14_custom_EmploymentAgreementMember_custom_MrNathanielszMember" format="ixt-sec:durwordsen" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">10 years</ix:nonNumeric></span>
from the date of grant. 1/3rd of the Nathanielsz Options shall vest every successive one-year anniversary following the Effective Date,
provided, that on each such vesting date Mr. Nathanielsz is employed by the Company and subject to the other provisions of the Employment
Agreement. The Initial Nathanielsz RSUs shall vest on the one-year anniversary of the Effective Date, subject to Mr. Nathanielsz&#8217;s
continued employment with the Company through such vesting date. The Additional Nathanielsz RSUs will vest as follows, subject to Mr.
Nathanielsz&#8217;s continued employment with the Company through the applicable vesting date: (i) <span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember__us-gaap--AwardTypeAxis__custom--AdditionaNathanielszRSUsMember_znu8ROG6465k" title="Rsus vest, shares"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" contextRef="From2019-05-132019-05-14_custom_EmploymentAgreementMember_custom_AdditionaNathanielszRSUsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">7.80</ix:nonFraction></span> of the Additional Nathanielsz
RSUs shall vest upon the Company submitting Clinical Trial Application (the &#8220;CTA&#8221;) for PRP, the Company&#8217;s lead product
candidate (&#8220;PRP&#8221;), for a First-In-Human study for PRP (the &#8220;Study&#8221;) in an applicable jurisdiction to be selected
by the Company, (ii) 7.80 of the Additional Nathanielsz RSUs shall vest upon</ix:nonNumeric></span> the CTA being approved in an applicable jurisdiction, (iii)
<span title="Rsus vest, shares">7.80</span> of the Additional RSUs shall vest upon the Company completing an equity financing in the amount of at least $<span id="xdx_904_ecustom--GrossProceedsFromEquityFinancing_pp0p0_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember__us-gaap--AwardTypeAxis__custom--AdditionaNathanielszRSUsMember_zIMnFhIlAV7h" title="Gross proceeds from equity financing"><ix:nonFraction name="PPCB:GrossProceedsFromEquityFinancing" contextRef="From2019-05-132019-05-14_custom_EmploymentAgreementMember_custom_AdditionaNathanielszRSUsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,000,000</ix:nonFraction></span> in gross
proceeds, (iv) 7.80 of the Additional Nathanielsz RSUs shall vest upon the shares of the Company&#8217;s Common Stock being listed on
a senior stock exchange (NYSE, NYSEMKT or NASDAQ), and (v) the remaining 7.80 of the Additional Nathanielsz RSUs shall vest upon the
Company enrolling its first patient in the Study. Each vested restricted stock unit shall be settled by delivery to Mr. Nathanielsz of
one share of the Company&#8217;s common stock and/or the fair market value of one share of common stock in cash, at the sole discretion
of the Company&#8217;s board of directors and subject to the 2019 Plan, on the first to occur of: (i) the date of a Change of Control
(as defined in the Employment Agreement), (ii) the date that is ten business days following the vesting of such restricted stock unit,
(iii) the date of Mr. Nathanielsz&#8217;s death or Disability (as defined in the Employment Agreement), and (iv) Mr. Nathanielsz&#8217;s
employment being terminated either by the Company without Cause or by Mr. Nathanielsz for Good Reason (each as defined in the Employment
Agreement). In the event of a Change of Control, any unvested portion of the Nathanielsz Options and such restricted stock units shall
vest immediately prior to such event. The 39 vested restricted stock unit are considered issuable as of September 30, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 149; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>PROPANC
BIOPHARMA, INC. AND SUBSIDIARY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>SEPTEMBER
30, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Unaudited)</b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">Amended
and Restated Services Agreement - On May 14, 2019, the Company also entered into an Amended and Restated Services Agreement (the &#8220;Services
Agreement&#8221;) with Dr. Kenyon, the Company&#8217;s Chief Scientific Officer and a director, for a term of <span id="xdx_90B_ecustom--AgreementlTerm_dtYxL_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DrKenyonMember_ze0xcu10SeV7" title="Agreement term::XDX::3"><span style="-sec-ix-hidden: xdx2ixbrl3915">three</span></span> years, subject to
automatic <span id="xdx_903_ecustom--AgreementRenewalTerm_dtYxL_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DrKenyonMember_zAtfCXuUlhji" title="Agreement renewal term::XDX::1"><span style="-sec-ix-hidden: xdx2ixbrl3917">one</span></span>-year renewals, at an annual salary of $<span id="xdx_907_eus-gaap--SalariesAndWages_pp0p0_uAUD_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DrKenyonMemberMember__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember_zXf0wu8fePl1" title="Annual salary"><ix:nonFraction name="us-gaap:SalariesAndWages" contextRef="From2019-05-132019-05-14_custom_ServicesAgreementMember_custom_DrKenyonMemberMember_custom_AUDCurrenryMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="AUD">54,000</ix:nonFraction></span> AUD. In connection with the execution of the Services Agreement, Dr. Kenyon
was designated as an executive officer of the Company and assumed a more active executive role with the Company. Pursuant to the Services
Agreement, Dr. Kenyon was granted options to purchase <span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DrKenyonMember_zvS7Ab55s8f9" title="Option purchase shares"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" contextRef="From2019-05-132019-05-14_custom_ServicesAgreementMember_custom_DrKenyonMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">20</ix:nonFraction></span> shares of the Company&#8217;s common stock (the &#8220;Kenyon Options&#8221;),
with an exercise price per share of $<span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DrKenyonMember_zU8nAyBQCwWl" title="Exercise price"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" contextRef="From2019-05-132019-05-14_custom_ServicesAgreementMember_custom_DrKenyonMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">4,250</ix:nonFraction></span> (<span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_dp_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DrKenyonMember_ziNHSOCB8856" title="Market price"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" contextRef="From2019-05-132019-05-14_custom_ServicesAgreementMember_custom_DrKenyonMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction>%</span> of the closing market price of the Company&#8217;s common stock on May 14, 2019, the
date of approval of such grant by the Company&#8217;s board of directors), (ii) <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember__us-gaap--AwardTypeAxis__custom--InitialKenyonRSUsMember_zH0wNjk7LdE" title="Restricted stock shares of common stock"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" contextRef="From2019-05-132019-05-14_custom_ServicesAgreementMember_custom_InitialKenyonRSUsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">20</ix:nonFraction></span> restricted stock units of the Company (the &#8220;Initial
Kenyon RSUs&#8221;), and (iii) an additional <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember__us-gaap--AwardTypeAxis__custom--AdditionalKenyonRSUsMember_zuzPGYxGzvCe" title="Restricted stock shares of common stock"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" contextRef="From2019-05-132019-05-14_custom_ServicesAgreementMember_custom_AdditionalKenyonRSUsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">20</ix:nonFraction></span> restricted stock units of the Company (the &#8220;Additional Kenyon RSUs&#8221;). Such
options and restricted stock units were granted pursuant to the 2019 Plan approved by the Company&#8217;s board of directors on the Effective
Date. The Kenyon Options have a term of <span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DrKenyonMember_zSlJJn86aOja" title="Option term"><ix:nonNumeric contextRef="From2019-05-132019-05-14_custom_ServicesAgreementMember_custom_DrKenyonMember" format="ixt-sec:durwordsen" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">10 years</ix:nonNumeric></span> from the date of grant. 1/3rd of the Kenyon Options shall vest every successive one-year
anniversary following the Effective Date, provided, that on each such vesting date Dr. Kenyon is employed by the Company and subject
to the other provisions of the Services Agreement. The Initial Kenyon RSUs shall vest on the one-year anniversary of the Effective Date,
subject to Dr. Kenyon&#8217;s continued employment with the Company through such vesting date. The Additional Kenyon RSUs will vest as
follows, subject to Dr. Kenyon&#8217;s continued employment with the Company through the applicable vesting date: (i) <span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember__us-gaap--AwardTypeAxis__custom--AdditionalKenyonRSUsMember_zZgAC3z9YhP" title="Rsus vest, shares"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" contextRef="From2019-05-132019-05-14_custom_ServicesAgreementMember_custom_AdditionalKenyonRSUsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5</ix:nonFraction></span> of the Additional
Kenyon RSUs shall vest upon the Company submitting the CTA for PRP for the Study in an applicable jurisdiction to be selected by the
Company, (ii) <span title="Rsus vest, shares">5</span> of the Additional Kenyon RSUs shall vest upon the Company completing an equity financing in the amount of at least $<span id="xdx_90A_ecustom--GrossProceedsFromEquityFinancing_pp0p0_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember__us-gaap--AwardTypeAxis__custom--AdditionalKenyonRSUsMember_zNlEuIx8jIdl" title="Gross proceeds from equity financing"><ix:nonFraction name="PPCB:GrossProceedsFromEquityFinancing" contextRef="From2019-05-132019-05-14_custom_ServicesAgreementMember_custom_AdditionalKenyonRSUsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,000,000</ix:nonFraction></span>
in gross proceeds, (iii) 5 of the Additional Kenyon RSUs shall vest upon the shares of the Company&#8217;s Common Stock being listed
on a senior stock exchange (NYSE, NYSEMKT or NASDAQ), and (iv) the remaining 5 of the Additional Kenyon RSUs shall vest upon the Company
enrolling its first patient in the Study. Each vested Kenyon RSU shall be settled by delivery to Mr. Kenyon of one share of the Company&#8217;s
common stock and/or the fair market value of one share of common stock in cash, at the sole discretion of the Company&#8217;s board of
directors and subject to the Plan, on the first to occur of: (i) the date of a Change of Control (as defined in the Services Agreement),
(ii) the date that is ten business days following the vesting of such Kenyon RSU, (iii) the date of Dr. Kenyon&#8217;s death or Disability
(as defined in the Services Agreement), and (iv) Dr. Kenyon&#8217;s employment being terminated either by the Company without Cause or
by Dr. Kenyon for Good Reason (as defined in the Services Agreement). In the event of a Change of Control (as defined in the Services
Agreement), 50% of any unvested portion of the Kenyon Options and the Kenyon RSUs shall vest immediately prior to such event. The <span id="xdx_90D_ecustom--StockToBeIssuedDuringPeriodValueRestrictedStockUnit_c20210701__20210930__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember_zB17fYlEexz6" title="Restricted stock unit issuable"><ix:nonFraction name="PPCB:StockToBeIssuedDuringPeriodValueRestrictedStockUnit" contextRef="From2021-07-012021-09-30_custom_ServicesAgreementMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">20</ix:nonFraction></span>
vested restricted stock unit are considered issuable as of September 30, 2021. As of June 30, 2021, total accrued salaries of $<span id="xdx_906_eus-gaap--AccruedSalariesCurrent_iI_pp0p0_uAUD_c20210630__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember_zSkbFVtK1Kma" title="Accrued salaries"><ix:nonFraction name="us-gaap:AccruedSalariesCurrent" contextRef="AsOf2021-06-30_custom_AUDCurrenryMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="AUD">135,000</ix:nonFraction></span>
AUD ($<span id="xdx_90C_eus-gaap--AccruedSalariesCurrent_iI_pp0p0_c20210630_zFgxVESQPTOc" title="Accrued salaries"><ix:nonFraction name="us-gaap:AccruedSalariesCurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">101,250</ix:nonFraction></span> USD) was included in accrued expenses. On August 12, 2021, pursuant to the Cancellation Agreement, Mr. Kenyon agreed to
cancel accrued salaries of $<span id="xdx_900_ecustom--CancellationOfAccruedSalaries_iI_dtY_c20210812__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DrKenyonMember_zJ5ujDQKDPC4" title="Cancellation of accrued salary"><ix:nonFraction name="PPCB:CancellationOfAccruedSalaries" contextRef="AsOf2021-08-12_custom_ServicesAgreementMember_custom_DrKenyonMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">102,600</ix:nonFraction></span> in exchange for <span id="xdx_90A_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_pid_c20210811__20210812__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DrKenyonMember_zeayPO4QmVS"><ix:nonFraction name="us-gaap:DebtConversionConvertedInstrumentSharesIssued1" contextRef="From2021-08-112021-08-12_custom_ServicesAgreementMember_custom_DrKenyonMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,420,000</ix:nonFraction></span> shares of the common stock of the Company (see Note 7). As of September
30, 2021, total accrued salaries of $<span id="xdx_901_eus-gaap--AccruedSalariesCurrent_iI_pp0p0_uAUD_c20210930__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember_zkxzMD0F9wGh"><ix:nonFraction name="us-gaap:AccruedSalariesCurrent" contextRef="AsOf2021-09-30_custom_AUDCurrenryMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="AUD">13,500</ix:nonFraction></span> AUD ($<span id="xdx_909_eus-gaap--AccruedSalariesCurrent_iI_pp0p0_c20210930_zYaZ3iRR0tXb"><ix:nonFraction name="us-gaap:AccruedSalariesCurrent" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">9,739</ix:nonFraction></span> USD) was included in accrued expenses in the accompanying condensed consolidated
balance sheet.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Intercompany
Loans</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">All
Intercompany loans were made by the parent to the subsidiary, Propanc PTY LTD, which have not been repaid as of September 30,
2021. Effective fiscal year 2021, the parent company determined that intercompany loans will not be repaid in the foreseeable future
and thus, per ASC 830-20-35-3, gains and losses from measuring the intercompany balances are recorded within cumulative translation adjustment,
a component of other comprehensive income. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-07-01to2021-09-30" escape="true" name="us-gaap:ConcentrationRiskDisclosureTextBlock"><p id="xdx_800_eus-gaap--ConcentrationRiskDisclosureTextBlock_zRlJNNTBEOJ7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTE
10 &#8211; <span id="xdx_825_zh1KlZqvgQEb">CONCENTRATIONS AND RISKS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Concentration
of Credit Risk</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
Company maintains its cash in banks and financial institutions in Australia. Bank deposits in Australian banks are uninsured. The Company
has not experienced any losses in such accounts through September 30, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
Company primarily relied on funding from one convertible debt lender and received proceeds after deductions of $<span id="xdx_90C_eus-gaap--AmortizationOfFinancingCostsAndDiscounts_pp0p0_c20210701__20210930_zvV3ouFXogye" title="Discounts and debt issuance cost"><ix:nonFraction name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">7,500</ix:nonFraction></span> for original issue
discounts and debt issue costs during the three months ended September 30, 2021 from a lender of $<span id="xdx_901_eus-gaap--ProceedsFromConvertibleDebt_pp0p0_c20210701__20210930_zZ5A9lGsQync"><ix:nonFraction name="us-gaap:ProceedsFromConvertibleDebt" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">160,000</ix:nonFraction></span> which represents approximately
<span id="xdx_900_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20210930_zRDKV2Tjny3a"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction>%</span> of total proceeds received by the Company during the three months ended September 30, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
Company did <span id="xdx_909_eus-gaap--ProceedsFromConvertibleDebt_pp0p0_doxL_c20200701__20200930_zLrM3Z83L9M5" title="::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl3953">no</span></span>t receive any funding from lenders during the three months ended September 30, 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Receivable
Concentration</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">As
of September 30, 2021 and June 30, 2021, the Company&#8217;s receivables were <span id="xdx_900_ecustom--ReimbursementOnGoodsAndServiceTaxReceivablePercentage_dp_c20210701__20210930_zCHtZ5g5SYGh" title="Reimbursement on goods and service tax receivable percentage"><span id="xdx_90D_ecustom--ReimbursementOnGoodsAndServiceTaxReceivablePercentage_dp_c20200701__20210630_zWVZomWa1LN6" title="Reimbursement on goods and service tax receivable percentage"><ix:nonFraction name="PPCB:ReimbursementOnGoodsAndServiceTaxReceivablePercentage" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure"><ix:nonFraction name="PPCB:ReimbursementOnGoodsAndServiceTaxReceivablePercentage" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></ix:nonFraction>%</span></span> related to reimbursements on GST taxes paid.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Patent
and Patent Concentration</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
Company has filed multiple patent applications relating to its lead product, PRP. The Company&#8217;s lead patent application has been
granted and remains in force in the United States, Belgium, Czech Republic, Denmark, France, Germany, Ireland, Italy, Netherlands, Portugal,
Spain, Sweden, Switzerland, Liechtenstein, Turkey, United Kingdom, Australia, China, Japan, Indonesia, Israel, New Zealand, Singapore,
Malaysia, South Africa, Mexico, Republic of Korea, India and Brazil. In Canada, the patent application remains under examination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 150; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>PROPANC
BIOPHARMA, INC. AND SUBSIDIARY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>SEPTEMBER
30, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Unaudited)</b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In
2016 and early 2017, we filed other patent applications. Three applications were filed under the Patent Cooperation Treaty (the &#8220;PCT&#8221;).
The PCT assists applicants in seeking patent protection by filing one international patent application under the PCT, applicants can
simultaneously seek protection for an invention in over 150 countries. Once filed, the application is placed under the control of the
national or regional patent offices, as applicable, in what is called the national phase. One of the PCT applications filed in November
2016, entered national phase in July 2018 and another PCT application is currently entering national phase in August 2018. A third PCT
application entered the national phase in October 2018.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">In
July 2020, a world first patent was granted in Australia for the cancer treatment method patent family. Presently, there are 31 granted
patents and 34 patents under examination in key global jurisdictions relating to the use of proenzymes against solid tumors, covering
the lead product candidate PRP.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Further
patent applications are expected to be filed to capture and protect additional patentable subject matter based on the Company&#8217;s
field of technology relating to pharmaceutical compositions of proenzymes for treating cancer.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Foreign
Operations</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 26.2pt; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">As
of September 30, 2021 and June 30, 2021, the Company&#8217;s operations are based in Camberwell, Australia, however the majority of research
and development is being conducted in the European Union.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 26.2pt; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">On
July 22, 2016, the Company formed a wholly owned subsidiary, Propanc (UK) Limited under the laws of England and Wales for the purpose
of submitting an orphan drug application with the European Medicines Agency as a small and medium-sized enterprise. As of September 30,
2021 and June 30, 2021, there has been no activity within this entity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-07-01to2021-09-30" escape="true" name="us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"><p id="xdx_804_eus-gaap--DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_zogQn9ohpdga" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTE
11 - <span id="xdx_82E_z1zpYd1cMdD4">DERIVATIVE FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><i>Derivative
Financial Instruments:</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
Company applies the provisions of ASC 815-40, <i>Contracts in Entity&#8217;s Own Equity</i>, under which convertible instruments and
warrants, which contain terms that protect holders from declines in the stock price (reset provisions), may not be exempt from derivative
accounting treatment. As a result, warrants and embedded conversion options in convertible debt are recorded as a liability and are revalued
at fair value at each reporting date. If the fair value of the warrants exceeds the face value of the related debt, the excess is recorded
as change in fair value in operations on the issuance date. The Company had $<span id="xdx_902_eus-gaap--ConvertibleDebt_iI_pp0p0_c20210930__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--ConvertibleDebtMember_zwH6m3Amf23a" title="Convertible debt"><span id="xdx_903_eus-gaap--ConvertibleDebt_iI_pp0p0_c20210630__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--ConvertibleDebtMember_zwaTAZVdiqi6"><ix:nonFraction name="us-gaap:ConvertibleDebt" contextRef="AsOf2021-09-30_us-gaap_ConvertibleDebtMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD"><ix:nonFraction name="us-gaap:ConvertibleDebt" contextRef="AsOf2021-06-30_us-gaap_ConvertibleDebtMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">80,000</ix:nonFraction></ix:nonFraction></span></span> (1 note) of convertible debt, which is treated as
derivative instruments outstanding at September 30, 2021 and June 30, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
Company calculates the estimated fair values of the liabilities for derivative instruments using the Binomial Trees Method. The closing
price of the Company&#8217;s common stock at September 30, 2021, the last trading day of the period ended September 30, 2021, was $<span id="xdx_90D_eus-gaap--SharePrice_iI_c20210930_zWpDL0RPjJL1" title="Share Price"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.026</ix:nonFraction></span>.
The Volatility, expected remaining term and risk-free interest rates used to estimate the fair value of derivative liabilities at September
30, 2021 are indicated in the table that follows. The expected term is equal to the remaining term of the warrants or convertible instruments
and the risk-free rate is based upon rates for treasury securities with the same term.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Convertible
Debt</b></span></p>

<ix:nonNumeric contextRef="From2021-07-01to2021-09-30" escape="true" name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"><p id="xdx_89C_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_ziVEwM4zVGa4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8B3_zk9Bx8xU2Kvf" style="display: none">SCHEDULE
OF FAIR VALUE MEASUREMENTS, RECURRING AND NONRECURRING, VALUATION TECHNIQUES</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.8pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Initial
                                            Valuations<br /> (on new derivative<br /> instruments entered</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.8pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>into
                                            during the three<br /> months ended<br /> September 30, 2021)</b></span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">September
    30, 2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%"><span style="font-family: Times New Roman, Times, Serif">Volatility</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 18%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_902_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_dp_uPure_c20210930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_z91KrVbagw65" title="Debt instrument, measurement input, percentages"><span style="-sec-ix-hidden: xdx2ixbrl3968">-</span></span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 18%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_902_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_dp_uPure_c20210930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember_znDDVGuM3xK6" title="Debt instrument, measurement input, percentages" style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DebtInstrumentMeasurementInput" contextRef="AsOf2021-09-30_us-gaap_MeasurementInputPriceVolatilityMember_us-gaap_ConvertibleDebtMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">206.00</ix:nonFraction></span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Expected Remaining Term (in years)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90B_eus-gaap--DebtInstrumentTerm_c20210701__20210930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_zcyHeINBsNI9" title="Debt instrument, measurement input, term"><span style="-sec-ix-hidden: xdx2ixbrl3972">-</span></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90C_eus-gaap--DebtInstrumentTerm_dtY_c20210701__20210930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember_zWMN60Ok1IOk" title="Debt instrument, measurement input, term"><ix:nonNumeric contextRef="From2021-07-012021-09-30_us-gaap_MeasurementInputExpectedTermMember_us-gaap_ConvertibleDebtMember" format="ixt-sec:duryear" name="us-gaap:DebtInstrumentTerm">0.01</ix:nonNumeric></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Risk Free Interest Rate</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90D_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_dp_uPure_c20210930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_zTlxnS98e5R5" title="Debt instrument, measurement input, percentages"><span style="-sec-ix-hidden: xdx2ixbrl3976">-</span></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90A_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_dp_uPure_c20210930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember_zBC50CDGAAK1" title="Debt instrument, measurement input, percentages"><ix:nonFraction name="us-gaap:DebtInstrumentMeasurementInput" contextRef="AsOf2021-09-30_us-gaap_MeasurementInputRiskFreeInterestRateMember_us-gaap_ConvertibleDebtMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.07</ix:nonFraction></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Expected dividend yield</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90C_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_dn_uPure_c20210930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zCbCaGbL5Jd7" title="Debt instrument, measurement input, percentages"><ix:nonFraction name="us-gaap:DebtInstrumentMeasurementInput" contextRef="AsOf2021-09-30_us-gaap_MeasurementInputExpectedDividendRateMember" format="ixt-sec:numwordsen" decimals="INF" unitRef="Pure">None</ix:nonFraction></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_901_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_dpn_uPure_c20210930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember_zIiMk9sIpq1" title="Debt instrument, measurement input, percentages"><ix:nonFraction name="us-gaap:DebtInstrumentMeasurementInput" contextRef="AsOf2021-09-30_us-gaap_MeasurementInputExpectedDividendRateMember_us-gaap_ConvertibleDebtMember" format="ixt-sec:numwordsen" decimals="INF" scale="-2" unitRef="Pure">None</ix:nonFraction></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A2_z9QCLngR86Z4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 151; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->60<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>PROPANC
BIOPHARMA, INC. AND SUBSIDIARY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>SEPTEMBER
30, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Unaudited)</b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><i>Fair
Value Measurements:</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-07-01to2021-09-30" escape="true" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"><p id="xdx_89E_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_zQ8Y0zdM2HX4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
Company measures and reports at fair value the liability for derivative instruments. The fair value liabilities for price adjustable
warrants and embedded conversion options have been recorded as determined utilizing the Binomial Trees model. The following tables summarize
the Company&#8217;s financial assets and liabilities measured at fair value on a recurring basis as of September 30, 2021 and June 30,
2021:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_8BF_z92R6udxgfO5" style="display: none">SCHEDULE
OF FAIR VALUE, ASSETS AND LIABILITIES MEASURED ON RECURRING BASIS</span>&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Balance
    at<br /> September&#160;30, 2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Quoted
                                            Prices</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>in
                                            Active</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Markets
                                            for</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Identical<br />
                                            Assets</b></span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Significant</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Other</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Observable<br />
                                            Inputs</b></span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Significant</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Unobservable
                                            Inputs</b></span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">(Level 1)</span></td><td style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">(Level 2)</span></td><td style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">(Level 3)</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 44%; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Embedded
    conversion option liabilities</span></td><td style="width: 2%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_985_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_iI_pp0p0_c20210930_znrDt9zeQUQj" title="Embedded conversion option liabilities" style="border-bottom: Black 1.5pt solid; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">58,124</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98E_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_iI_pdp0_c20210930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zyf9mHFTG7D6" title="Embedded conversion option liabilities" style="border-bottom: Black 1.5pt solid; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3988">&#8212;</span></span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98F_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_iI_pdp0_c20210930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zDR2luvuqBKe" title="Embedded conversion option liabilities" style="border-bottom: Black 1.5pt solid; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3990">&#8212;</span></span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_iI_pp0p0_c20210930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zfYeJvYPLE83" title="Embedded conversion option liabilities" style="border-bottom: Black 1.5pt solid; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" contextRef="AsOf2021-09-30_us-gaap_FairValueInputsLevel3Member" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">58,124</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98F_eus-gaap--DerivativeLiabilities_iI_pp0p0_c20210930_zpZqMmMLg1Nj" title="Total" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DerivativeLiabilities" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">58,124</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_eus-gaap--DerivativeLiabilities_iI_pdp0_c20210930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zI42zixfZpa1" title="Total" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3996">&#8212;</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_983_eus-gaap--DerivativeLiabilities_iI_pdp0_c20210930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z4N9YaP254Ea" title="Total" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3998">&#8212;</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98E_eus-gaap--DerivativeLiabilities_iI_pp0p0_c20210930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zFa2qEvswSgl" title="Total" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DerivativeLiabilities" contextRef="AsOf2021-09-30_us-gaap_FairValueInputsLevel3Member" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">58,124</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Balance
    at<br /> June 30, 2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Quoted
                                            Prices</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>in
                                            Active</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Markets
                                            for</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Identical<br />
                                            Assets</b></span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Significant</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Other</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Observable<br />
                                            Inputs</b></span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Significant</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Unobservable
                                            Inputs</b></span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">(Level 1)</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">(Level 2)</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">(Level 3)</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 44%; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Embedded
    conversion option liabilities</span></td><td style="width: 2%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_iI_pp0p0_c20210630_zxSBZDQIJc8e" title="Embedded conversion option liabilities" style="border-bottom: Black 1.5pt solid; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">54,220</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_c20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_pdp0" title="Embedded conversion option liabilities" style="border-bottom: Black 1.5pt solid; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl4004">&#8212;</span></span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_c20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_pdp0" title="Embedded conversion option liabilities" style="border-bottom: Black 1.5pt solid; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl4006">&#8212;</span></span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_iI_pp0p0_c20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zmZMI2T7dhS3" title="Embedded conversion option liabilities" style="border-bottom: Black 1.5pt solid; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" contextRef="AsOf2021-06-30_us-gaap_FairValueInputsLevel3Member" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">54,220</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eus-gaap--DerivativeLiabilities_iI_pp0p0_c20210630_zY5UsolInuf2" title="Total" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DerivativeLiabilities" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">54,220</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--DerivativeLiabilities_c20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_pdp0" title="Total" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl4012">&#8212;</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_983_eus-gaap--DerivativeLiabilities_c20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_pdp0" title="Total" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl4014">&#8212;</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98E_eus-gaap--DerivativeLiabilities_iI_pp0p0_c20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z8dP5d3YIqD9" title="Total" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DerivativeLiabilities" contextRef="AsOf2021-06-30_us-gaap_FairValueInputsLevel3Member" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">54,220</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

</ix:nonNumeric><p id="xdx_8A7_zWt2ql5TwhZ6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-07-01to2021-09-30" escape="true" name="us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock"><p id="xdx_896_eus-gaap--ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_zCMqAhbosFH6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
following is a roll forward for the three months ended September 30, 2021 of the fair value liability of price adjustable derivative
instruments:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_8B9_z0UpiPSRcN17" style="display: none">SCHEDULE
OF DERIVATIVE LIABILITIES AT FAIR VALUE</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Fair Value
    of</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Liability
    for</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Derivative</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Instruments</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 82%; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Balance at June 30, 2021</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_981_eus-gaap--DerivativeLiabilities_iS_pp0p0_c20210701__20210930_zye6j61g3l84" title="Balance at Beginning" style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DerivativeLiabilities" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">54,220</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Change in fair value
    included in statements of operations</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet_pp0p0_c20210701__20210930_zXS50oq2qLa6" title="Balance at Beginning" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet" contextRef="From2021-07-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,904</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Balance at September
    30, 2021</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_983_eus-gaap--DerivativeLiabilities_iE_pp0p0_c20210701__20210930_zN3IqKOe7TQb" title="Balance at Ending" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DerivativeLiabilities" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">58,124</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A7_z38uRLnE5jX" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-07-01to2021-09-30" escape="true" name="us-gaap:SubsequentEventsTextBlock"><p id="xdx_80E_eus-gaap--SubsequentEventsTextBlock_zBdf9ZOf6jq3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTE
12 &#8211; <span id="xdx_824_zliAKEcZXTY6">SUBSEQUENT EVENTS</span> </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><i>Exercise
of Warrants</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">In
October 2021, the Company issued <span id="xdx_906_eus-gaap--CommonStockSharesIssued_iI_c20211031__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementClassOfStockAxis__custom--ElevenSeriesAWarrantsMember_zTaypf8UVaP3"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2021-10-31_us-gaap_SubsequentEventMember_custom_ElevenSeriesAWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,199,989</ix:nonFraction></span> shares of common stock from the alternate cashless exercise of 11 Series A warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><i>Note
Conversions</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In
October 2021, the Company issued an aggregate of <span id="xdx_90F_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_pid_c20211001__20211031__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z0cEUQXkrEMi"><ix:nonFraction name="us-gaap:DebtConversionConvertedInstrumentSharesIssued1" contextRef="From2021-10-012021-10-31_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,818,097</ix:nonFraction></span> shares of its common stock at an average contractual conversion price of $<span id="xdx_907_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20211031__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zdoPRJX58rwe"><ix:nonFraction name="us-gaap:DebtInstrumentConvertibleConversionPrice1" contextRef="AsOf2021-10-31_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.01</ix:nonFraction></span>,
as a result of the conversion of principal of $<span id="xdx_90D_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20211031__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zurT2Mh9EFfk"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2021-10-31_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">25,000</ix:nonFraction></span>, interest of $<span><span id="xdx_907_eus-gaap--InterestPayableCurrent_iI_pp0p0_c20211031__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_znl6ciVAg1Oj"><ix:nonFraction name="us-gaap:InterestPayableCurrent" contextRef="AsOf2021-10-31_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,726</ix:nonFraction></span></span> and conversion fees $<span id="xdx_902_ecustom--ConversionFees_pp0p0_c20211001__20211031__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zpmLqz6cRsT7"><ix:nonFraction name="PPCB:ConversionFees" contextRef="From2021-10-012021-10-31_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">0</ix:nonFraction></span> underlying certain outstanding convertible
notes converted during such period. The Company reclassified $<span id="xdx_901_eus-gaap--AdditionalPaidInCapital_iI_pp0p0_c20211031__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z1SDhUYOwhUh"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2021-10-31_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">16,667</ix:nonFraction></span> in put premiums to additional paid in capital following these conversions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>Common
Stock Issuable</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
<span id="xdx_908_eus-gaap--CommonStockSharesIssued_iI_c20211031__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z9wgoqHrTdH"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2021-10-31_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,002,490</ix:nonFraction></span> shares of common stock issuable as of September 30, 2021 were issued in October 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>Consulting
Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90E_ecustom--ConsultingAgreementDescription_c20211019__20211021__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z68zps5mSWji" title="Consulting agreement description"><ix:nonNumeric contextRef="From2021-10-192021-10-21_us-gaap_SubsequentEventMember" name="PPCB:ConsultingAgreementDescription">On
October 1, 2021, the Company entered int a consulting agreement (the &#8220;Consulting Agreement&#8221;) with a consultant who will
assist in the development of the Company&#8217;s business and financing activities. The consultant will serve initially as an
independent contractor, and upon certain mutually agreed upon conditions being met, will be appointed Vice Chairman, President and
Interim CFO. The term of the Consulting Agreement shall be for three years commencing on October 1, 2021, and can be terminated by
either party upon 30 day written notice. The monthly payment per the Consulting Agreement is $<span id="xdx_90E_ecustom--ConsultingAgreementMonthlyPayment_c20211019__20211021__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zTgvambp0mw7" title="Consulting agreement, monthly payment"><ix:nonFraction name="PPCB:ConsultingAgreementMonthlyPayment" contextRef="From2021-10-192021-10-21_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,000</ix:nonFraction></span>. The Company will also issue
shares of common stock equal to 1% of the total issued and outstanding shares at the end of each year of service.</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 152; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->61<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>PROPANC
BIOPHARMA, INC. AND SUBSIDIARY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>SEPTEMBER
30, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Unaudited)</b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>October
21, 2021 Securities Purchase Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Effective
October 21, 2021, the Company entered into a securities purchase agreement with Sixth Street Lending LLC (&#8220;Sixth Street&#8221;),
pursuant to which Sixth Street purchased a convertible promissory note (the &#8220;October 21, 2021 Sixth Street&#8221;) from the Company
in the aggregate principal amount of $<span id="xdx_902_eus-gaap--DebtInstrumentFaceAmount_iI_c20211021__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--OctoberTwentyOneTwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember_zc7nWc13krPh"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2021-10-21_us-gaap_SubsequentEventMember_custom_OctoberTwentyOneTwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">63,750</ix:nonFraction></span>, such principal and the interest thereon convertible into shares of the Company&#8217;s
common stock at the option of Sixth Street any time after the six-month anniversary of the October 21, 2021 Sixth Street. The October
21, 2021 Sixth Street contains an original discount of $<span id="xdx_907_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20211021__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--OctoberTwentyOneTwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember_zckIAeInq8A9"><ix:nonFraction name="us-gaap:DebtInstrumentUnamortizedDiscount" contextRef="AsOf2021-10-21_us-gaap_SubsequentEventMember_custom_OctoberTwentyOneTwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,750</ix:nonFraction></span>. The Company intends to use the net proceeds from the October 21, 2021
Sixth Street for general working capital purposes. The maturity date of the October 21, 2021 Sixth Street Note is <span id="xdx_901_eus-gaap--DebtInstrumentMaturityDate_dd_c20211019__20211021__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--OctoberTwentyOneTwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember_zE1DM51b0p48"><ix:nonNumeric contextRef="From2021-10-192021-10-21_us-gaap_SubsequentEventMember_custom_OctoberTwentyOneTwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember" format="ixt:datemonthdayyearen" name="us-gaap:DebtInstrumentMaturityDate">October 21, 2022</ix:nonNumeric></span>. The
October 21, 2021 Sixth Street Note bears interest at a rate of <span id="xdx_90F_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20211019__20211021__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--OctoberTwentyOneTwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember_z6Dh2ArSB0Xf"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateDuringPeriod" contextRef="From2021-10-192021-10-21_us-gaap_SubsequentEventMember_custom_OctoberTwentyOneTwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">8</ix:nonFraction>%</span> per annum, which interest may be paid by the Company to Sixth Street
in shares of the Company&#8217;s common stock; but shall not be payable until the October 21, 2021 Sixth Street Note becomes payable,
whether at the maturity date or upon acceleration or by prepayment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90E_eus-gaap--DebtInstrumentDescription_c20211019__20211021__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--OctoberTwentyOneTwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember_z7EBQht24Kj8" title="Debt description"><ix:nonNumeric contextRef="From2021-10-192021-10-21_us-gaap_SubsequentEventMember_custom_OctoberTwentyOneTwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember" name="us-gaap:DebtInstrumentDescription">During
the first 60 to 180 days following the date of these notes, the Company has the right to prepay the principal and accrued but unpaid
interest due under the above notes issued to Sixth Street, together with any other amounts that the Company may owe the holder under
the terms of the note, at a premium ranging from 110% to 129% as defined in the note agreement. After this initial 180-day period, the
Company does not have a right to prepay such notes.</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
conversion price for the above Sixth Street notes shall be equal to a <span id="xdx_90D_ecustom--DebtCoversionPercentage_dp_c20211019__20211021__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--OctoberTwentyOneTwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember_zilqj1sUw0v"><ix:nonFraction name="PPCB:DebtCoversionPercentage" contextRef="From2021-10-192021-10-21_us-gaap_SubsequentEventMember_custom_OctoberTwentyOneTwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">35</ix:nonFraction>%</span> discount of the market price which means the average of the
lowest three trading prices of the Common Stock for the ten trading days immediately prior to the delivery of a Notice of Conversion.
Notwithstanding the foregoing, Sixth Street shall be restricted from effecting a conversion if such conversion, along with other shares
of the Company&#8217;s common stock beneficially owned by Sixth Street and its affiliates, exceeds <span id="xdx_90E_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_uPure_c20211021__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--OctoberTwentyOneTwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember_zlHWJNKFJQve"><ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" contextRef="AsOf2021-10-21_us-gaap_SubsequentEventMember_custom_OctoberTwentyOneTwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">9.99</ix:nonFraction>%</span> of the outstanding shares of
the Company&#8217;s common stock. These notes are treated as stock settled debt under ASC 480 and accordingly the Company recorded a
total of $<span id="xdx_90E_ecustom--GainFromSettlementOfDebtNet_c20211019__20211021__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--OctoberTwentyOneTwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember_zkIkx4wftODa"><ix:nonFraction name="PPCB:GainFromSettlementOfDebtNet" contextRef="From2021-10-192021-10-21_us-gaap_SubsequentEventMember_custom_OctoberTwentyOneTwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">34,327</ix:nonFraction></span> put premium.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
above Sixth Street notes contain certain events of default, upon which principal and accrued interest will become immediately due and
payable. In addition, upon an event of default, <span id="xdx_903_eus-gaap--DebtInstrumentInterestRateTerms_c20211019__20211021__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--OctoberTwentyOneTwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember_zxb9fpKcrTDh" title="Debt Instrument, Interest Rate Terms"><ix:nonNumeric contextRef="From2021-10-192021-10-21_us-gaap_SubsequentEventMember_custom_OctoberTwentyOneTwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember" name="us-gaap:DebtInstrumentInterestRateTerms">interest on the outstanding principal shall accrue at a default interest rate of 22%
per annum</ix:nonNumeric></span>, or if such rate is usurious or not permitted by current law, then at the highest rate of interest permitted by law. Further,
certain events of default may trigger penalty and liquidated damage provisions.</span></p>

</ix:nonNumeric><p id="xdx_817_zVQpBjx65q1g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 153; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->62<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PART
II</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>INFORMATION
NOT REQUIRED IN PROSPECTUS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
13. Other Expenses of Issuance and Distribution</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth the costs and expenses, other than underwriting discounts and commissions, to be paid by the Registrant
in connection with the issuance and distribution of the securities being registered. All amounts other than the SEC registration
fees  are estimates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 84%; text-align: left">SEC Registration Fee</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">2,336.50</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Accounting Fees and Expenses*</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">10,000.00</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Legal Fees and Expenses*</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">5,000.00</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Transfer Agent and Registrar Fees</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Miscellaneous Fees and Expenses*</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,000.00</td><td style="padding-bottom: 1.5pt; text-align: left"></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; padding-bottom: 2.5pt">Total*</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">18,336.50</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*
Estimated expenses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
14. Indemnification of Directors and Officers</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Certificate of Incorporation contains provisions that limit the liability of our directors for monetary damages to the fullest
extent permitted by Delaware law. Consequently, our directors will not be personally liable to us or our stockholders for monetary
damages for any breach of fiduciary duties as directors, except liability for:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    breach of the director&#8217;s duty of loyalty to us or our stockholders;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    act or omission not in good faith or that involves intentional misconduct or a knowing violation of law;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">unlawful
    payments of dividends or unlawful stock repurchases or redemptions as provided in Section 174 of the Delaware General Corporation
    Law; or</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    transaction from which the director derived an improper personal benefit.</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Certificate of Incorporation provides that we are required to indemnify our directors and officers, in each case to the fullest
extent permitted by Delaware law. Our Certificate of Incorporation also provides that we are obligated to advance expenses incurred
by a director or officer in advance of the final disposition of any action or proceeding, and permit us to secure insurance on
behalf of any officer, director, employee or other agent for any liability arising out of his or her actions in that capacity
regardless of whether we would otherwise be permitted to indemnify him or her under the provisions of Delaware law.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
limitation of liability and indemnification provisions in our Certificate of Incorporation may discourage stockholders from bringing
a lawsuit against our directors and officers for breach of their fiduciary duty. They may also reduce the likelihood of derivative
litigation against our directors and officers, even though an action, if successful, might benefit us and other stockholders.
Further, a stockholder&#8217;s investment may be adversely affected to the extent that we pay the costs of settlement and damage
awards against directors and officers as required by these indemnification provisions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 154; Options: NewSection; Value: 91 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->91<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, in the future, we intend to enter into indemnification agreements with our directors and officers and some of our executives
may have certain indemnification rights arising under their employment agreements with us. These indemnification agreements may
require us, among other things, to indemnify our directors and officers for some expenses, including attorneys&#8217; fees, judgments,
fines and settlement amounts incurred by a director or officer in any action or proceeding arising out of his or her service as
one of our directors or officers, or any of our subsidiaries or any other company or enterprise to which the person provides services
at our request.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
above discussion of our Certificate of Incorporation and Delaware law is not intended to be exhaustive and is respectively qualified
in its entirety by such bylaws and applicable Delaware law.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
indemnification provisions and the indemnification agreements may be sufficiently broad to permit indemnification of our officers and
directors for liabilities, including reimbursement of expenses incurred, arising under the Securities Act. We have been advised that,
in the opinion of the SEC, indemnification of directors or officers for liabilities arising under the Securities Act is against public
policy and, therefore, such indemnification provisions may be unenforceable.</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
maintain a general liability insurance policy that covers certain liabilities of directors and officers of our corporation arising
out of claims based on acts or omissions in their capacities as directors or officers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
15. Recent Sales of Unregistered Securities</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the last three completed fiscal years and to date in the current fiscal year, we sold the following unregistered securities:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shares
Issued for Services</b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 19, 2019, the Company entered into an agreement with a certain consultant to provide services over a two-month period beginning
July 1, 2019 and ending September 1, 2019 in exchange for 20,000 shares of the Company&#8217;s common stock. On July 19, 2019, the Company
issued the 20,000 shares of the Company&#8217;s common stock valued at $1.99 per share; being the closing price of the stock on the date
of the agreement, to such consultant, or $39,800, which will be amortized over the term of the agreement. The Company recorded $39,800
of consulting expense with respect to such shares of its common stock during the three months ended September 30, 2019.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt; background-color: white"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Between
February 3, 2020 and June 26, 2020, the Company issued an aggregate of 8,708,574 shares of the Company&#8217;s common stock to a consultant
for services rendered pursuant to an engagement agreement dated on September 10, 2019 which agreement was later amended in February 2020.
Between February 3, 2020 and June 26, 2020, the Company issued an aggregate of 8,708,574 shares of the Company&#8217;s common stock valued
at an average price of $0.008 per share; being the closing price of the stock on the date of the agreement, to such consultant, or $73,842.
The Company recorded $73,842 of consulting expense with respect to such shares of its common stock during the year ended June 30, 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 17, 2020, the Company effected a one-for-one thousand (1:1,000) reverse stock split of the Company&#8217;s issued and outstanding
shares of common stock (the &#8220;Reverse Stock Split&#8221;). Proportional adjustments for the Reverse Stock Split were made to the
Company&#8217;s outstanding stock options, warrants and equity incentive plans. All share and per-share data and amounts have been retroactively
adjusted as of the earliest period presented in the consolidated financial statements to reflect the Reverse Stock Split.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 22, 2021, the Company issued an aggregate of 225,037 shares of the Company&#8217;s common stock to a consultant for services rendered
from January 1, 2021 to March 22, 2021. The Company issued 225,037 shares of the Company&#8217;s common stock valued at $0.30 per share,
being the closing price of the stock on the date of grant to such consultant, or $67,511. The Company recorded $67,511 of consulting
expense with respect to such shares of its common stock during the year ended June 30, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Between
March 2021 and June 2021, the Company issued an aggregate of 580,609 shares of the Company&#8217;s common stock to a consultant for services
rendered from April 1, 2021 to June 30, 2021. The Company issued 580,609 shares of the Company&#8217;s common stock valued at $0.10 per
share, being the closing price of the stock on the date of grant to such consultant, or $58,061.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 12, 2021, the Board approved the issuance of 2,800,000 shares of the Company&#8217;s common stock for bonus payable of $84,000
as of June 30, 2021 to an employee who is the wife of the CEO of the Company. The 2,800,000 shares of common stock were valued at approximately
$0.03 per share or $87,920, being the closing price of the stock on the date of grant. The shares were issued on August 17, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 12, 2021, the Board approved the issuance of 166,667 shares of the Company&#8217;s common stock for legal services rendered for
the month of August 2021. The 166,667 shares of common stock were valued at approximately $0.05 per share or $7,883, being the closing
price of the stock on August 31, 2021, the date of grant. The shares were issued on September 3, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
September 2021, the Company issued 2,819,712 shares of the Company&#8217;s common stock to a consultant for services rendered from July
2021 to September 2021. The Company issued 2,819,712 shares of the Company&#8217;s common stock valued at approximately $0.04 per share
or $104,611, being the closing price of the stock on the date of grant to such consultant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">On December 10, 2021, the Company issued 1,000,000 shares of the Company&#8217;s common stock to a purchaser as consideration for entering into a common
stock purchase agreement in November 2021. The shares were valued at approximately $0.018 per share or $18,000, being the closing price
of the stock on December 10, 2021.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Issuance
of Shares of Common Stock upon Conversion</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
our first quarter ended September 30, 2018, we issued 258,285 shares of our common stock at an average conversion price of $5 as a result
of the conversion of principal and interest in the aggregate amount of $1,413,317 underlying certain convertible notes converted during
such period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
our second quarter ended December 31, 2018, we issued 127,684 shares of our common stock at an average conversion price of $10 as a result
of the conversion of principal and interest in the aggregate amount of $1,095,100 underlying certain outstanding convertible notes converted
during such period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 155; Value: 91 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->92<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
our third quarter ended March 31, 2019, we issued 140,673 shares of our common stock at an average conversion price of $4.20, as a result
of the conversion of principal and interest in the aggregate amount of $583,331 underlying certain outstanding convertible notes converted
during such period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
our fourth quarter ended June 30, 2019, we issued 177,615 shares of our common stock at an average conversion price of $1.46, as a result
of the conversion of principal and interest in the aggregate amount of $259,034 underlying certain outstanding convertible notes converted
during such period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
our first quarter ended September 30, 2019, we issued 181,939 shares of our common stock at an average conversion price of $0.68 as a
result of the conversion of principal and interest in the aggregate amount of $123,712 underlying certain convertible notes converted
during such period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
our second quarter ended December 31, 2019, we issued 1,064,920 shares of our common stock at an average conversion price of $0.206 as
a result of the conversion of principal and interest in the aggregate amount of $219,466 underlying certain outstanding convertible notes
converted during such period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
our third quarter ended March 31, 2020, we issued 16,096,509 shares of our common stock at an average conversion price of $0.053, as
a result of the conversion of principal and interest in the aggregate amount of $856,338 underlying certain outstanding convertible notes
converted during such period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
our fourth quarter ended June 30, 2020, we issued 230,275,879 shares of our common stock at an average conversion price of $0.004, as
a result of the conversion of principal and interest in the aggregate amount of $925,658 underlying certain outstanding convertible notes
converted during such period. From July 1, 2020 through September 28, 2020, the Company issued an aggregate of 442,031,352 shares of
its common stock at an average contractual conversion price of $0.00096, ranging from $0.00056 to $0.0020, as a result of the conversion
of principal of $391,935, interest of $25,735 and conversion fees $6,750 underlying certain outstanding convertible notes converted during
such period. On September 18, 2020, the Company prepaid an outstanding convertible note in the amount of $57,671 comprising the
note principal of $43,000 plus $1,705 of accrued interest and a prepayment penalty of $12,966.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 17, 2020, the Company effected a one-for-one thousand (1:1,000) reverse stock split of the Company&#8217;s issued and outstanding
shares of common stock (the &#8220;Reverse Stock Split&#8221;). Proportional adjustments for the Reverse Stock Split were made to the
Company&#8217;s outstanding stock options, warrants and equity incentive plans. All share and per-share data and amounts have been retroactively
adjusted as of the earliest period presented in the consolidated financial statements to reflect the Reverse Stock Split.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">During
the year ended June 30, 2021, the Company issued an aggregate of 8,786,113 shares of its common stock at an average contractual conversion
price of $0.13, ranging from $0.03 to $2.00, as a result of the conversion of principal of $1,018,867, interest of $103,321 and conversion
fees $16,500 underlying certain outstanding convertible notes converted during such period. The total recorded to equity was $1,239,075
prior to the reversal of unissued shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">From
July 1, 2021 through September 30, 2021, the Company issued an aggregate of 9,445,009 shares of its common stock at an average contractual
conversion price of $0.02, ranging from $0.02 to $0.04, as a result of the conversion of principal of $189,849, interest of $8,087 and
conversion fees $2,250 underlying certain outstanding convertible notes converted during such period. The total recorded to equity was
$200,186.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">In
October 2021, the Company issued 1,818,097&#160;shares of its common stock at an average contractual conversion price of $0.01 as a result
of the conversion of principal of $25,000 and interest of $1,726&#160;underlying certain outstanding convertible notes converted during
such period. The total recorded to equity was $26,726.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">In
January 2022, the Company issued 2,613,191&#160;shares of its common stock at an average contractual conversion price of $0.01 as a result
of the conversion of principal of $26,000 and interest of $2,222&#160;underlying certain outstanding convertible notes converted during
such period. The total recorded to equity was $28,222.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 156; Value: 91 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->93<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Issuance
of Restricted Stock Units</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to employment agreements dated in May 2019, the Company granted an aggregate of 78,000 and 39,000 restricted stock units to the Company&#8217;s
Chief Executive Officer and Chief Scientific Officer, respectively. The total 117,000 restricted stock units are subject to vesting terms
as defined in the employment agreements. The 117,000 restricted stock units were valued at the fair value of $4.25 per unit or $497,240
based on the quoted trading price on the date of grant. During the year ended June 30, 2020 and 2019, the Company recognized stock-based
compensation of $217,543 and $31,077, respectively, related to vested restricted stock units. There were $248,620 unrecognized restricted
stock units expense as of June 30, 2020 which may be recognized upon achievement of certain performance conditions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Issuance
of Options</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of June 30, 2020, the Company had entered into agreements to grant options to purchase 59,644 shares of its common stock, with a weighted
average exercise price per share of $76.37.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 14, 2019, our board of directors approved a grant of 39,000 stock options to Mr. Nathanielsz, with an exercise price of $4.675 per
share, which shall vest annually over a period of three years from the date of the grant, provided, that on each such vesting date Mr.
Nathanielsz is employed by us and subject to the other provisions of his Amended and Restated Employment Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 14, 2019, our board of directors also approved a grant of 19,500 stock options to Dr. Kenyon, with an exercise price of $4.25 per
share, which shall vest annually over a period of three years from the date of the grant, provided, that on each such vesting date Dr.
Kenyon is employed by us and subject to the other provisions of his Amended and Restated Services Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
stock options were issued during the fiscal year ended June 30, 2020 and 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Issuance
of Warrants</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 30, 2019, pursuant to a Securities Purchase Agreement, we issued to Auctus Fund LLC (i) a Common Stock Purchase Warrant permitting
the holder to purchase 450,000 shares of common stock of the Company for an exercise price of $2.25, (ii) a Common Stock Purchase Warrant
permitting the holder to purchase 300,000 shares of common stock of the Company for an exercise price of $3.33, and (iii) a Common Stock
Purchase Warrant permitting the holder to purchase 225,000 shares of common stock of the Company for an exercise price of $4.50.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 10, 2019, the Company entered into an agreement with a certain consultant to provide services over a three-month period beginning
September 10, 2019 and ending December 10, 2019 in exchange for 1,000,000 warrants to purchase the Company&#8217;s common stock at $2.00
per share with an expiry date of September 10, 2022. The Fair Market Value of the warrants was $984,810 on the date of grant as calculated
under the Black Scholes Option Pricing model. The Company recorded $984,810 of share based compensation expenses with respect to the
grant of such warrants during the six months ended December 31, 2019.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 30, 2020, the Company entered into a Securities Purchase Agreement (the &#8220;Securities Purchase Agreement&#8221;) whereby an
investor (the &#8220;Investor&#8221;) purchased from the Company, 7,500,000 units (the &#8220;Units&#8221;), each consisting of (i) 1.5
shares of the Company&#8217;s common stock (the &#8220;Common Stock&#8221;), or pre-funded warrants (the &#8220;Prefunded Warrants&#8221;)
and (ii) 1.5 warrants to purchase one share of Common Stock (&#8220;Series A Warrants&#8221;, and collectively with the Common Stock
the &#8220;Units&#8221;). In addition to the Units, the Investor was issued 63,750,000 warrants to purchase one share of Common Stock
(the &#8220;Series B Warrants&#8221;) and an additional 63,750,000 warrants to purchase one share of Common Stock, subject to a vesting
schedule (the &#8220;Series C Warrants&#8221; and, together with the Prefunded Warrants, the Series A Warrants, and the Series B Warrants,
the &#8220;Warrants&#8221;). The aggregate purchase price for the Units, the Series A Warrants, the Series B Warrants and the Series
C Warrants of $450,000 was paid at closing (the &#8220;Purchase Price&#8221;). The 11,250,000 shares of Common Stock underlying the Units
issuable at closing of the Securities Purchase Agreement are comprised of 804,518 shares of restricted Common Stock and 10,445,482 Prefunded
Warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 157; Value: 91 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->94<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of June 30, 2021, there were 121,329 warrants outstanding and exercisable with expiration dates commencing September
2022 and continuing through August 2024, with a weighted average exercise price per share of $0.15.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 17, 2020, the Company effected a one-for-one thousand (1:1,000) reverse stock split of the Company&#8217;s issued and outstanding
shares of common stock (the &#8220;Reverse Stock Split&#8221;). Proportional adjustments for the Reverse Stock Split were made to the
Company&#8217;s outstanding stock options, warrants and equity incentive plans. All share and per-share data and amounts have been retroactively
adjusted as of the earliest period presented in the consolidated financial statements to reflect the Reverse Stock Split.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">During
the year ended June 30, 2021, the Company received aggregate gross proceeds of $776,044 from the exercise of 10,445 prefunded warrants
and 19,375 Series B Warrants resulting in the issuance of 29,820 shares of common stock. Additionally, the Company issued 4,199,979 shares
of common stock from the alternate cashless exercise of 20 Series A and 1 Series C warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
July 9, 2021 through September 27, 2021, the Company received aggregate gross proceeds of $275,000 and subscription receivable of $100,000
from the exercise of 9,375 Series B Warrants and issued 6,875 shares of common stock and 2,500 shares of common stock issuable as of
September 30, 2021. During the three months ended September 30, 2021, additionally, the Company issued 2,399,988 shares of common stock
and 1,999,990 shares of common stock issuable from the alternate cashless exercise of 22 Series A warrants. A total of 2,002,490 common
stock issuable were issued in October 2021. The Company collected the $100,000 subscription receivable in October 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 1, 2021, the Company received aggregate gross proceeds of $100,000 from the exercise of 2,500 Series B Warrants and issued 2,500
shares of common stock. Additionally, from October 5, 2021 through December 16, 2021, the Company issued 6,399,968 shares of common stock
from the alternate cashless exercise of 32 Series A warrants.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
as otherwise noted, the securities in the transactions describe above were sold in reliance on the exemption from registration provided
in Section 4(a)(2) of the Securities Act for transactions not involving any public offering. Each of the persons acquiring the foregoing
securities was an accredited investor (as defined in Rule 501(a) of Regulation D) and confirmed the foregoing and acknowledged, in writing,
that the securities must be acquired and held for investment. All certificates evidencing the shares sold bore a restrictive legend.
No underwriter participated in the offer and sale of these securities, and no commission or other remuneration was paid or given directly
or indirectly in connection therewith. The proceeds from these sales were used for general corporate purposes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
15. Exhibits, Financial Statement Schedules</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Exhibits</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 16.9pt; text-align: justify; text-indent: -10.6pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.65in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1517681/000135448811001953/phgc_ex31.htm" style="-sec-extract: exhibit">Certificate of Incorporation of the Company (incorporated by reference to Exhibit 3.1 to the Company&#8217;s Registration Statement on Form S-1, as amended, filed with the SEC on June 23, 2011).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1517681/000135448811001953/phgc_ex32.htm" style="-sec-extract: exhibit">Bylaws of the Company (incorporated by reference to Exhibit 3.2 to the Company&#8217;s Registration Statement on Form S-1, as amended, filed with the SEC on June 23, 2011).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1517681/000114420414074117/v396665_ex3-2.htm" style="-sec-extract: exhibit">Certificate of Amendment to the Certificate of Incorporation of the Company, dated November 11, 2014 (incorporated by reference to Exhibit 3.2 to the Company&#8217;s Current Report on Form 8-K filed on December 16, 2014).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.4</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1517681/000114420415042591/v415484_ex3-1.htm" style="-sec-extract: exhibit">Certificate of Amendment to the Certificate of Incorporation of the Company, dated July 9, 2015 (incorporated by reference to Exhibit 3.1 to the Company&#8217;s Current Report on Form 8-K filed on July 15, 2015).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.5</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1517681/000149315217004418/ex311.htm" style="-sec-extract: exhibit">Certificate of Amendment to the Certificate of Incorporation of the Company, dated April 20, 2017 (incorporated by reference to Exhibit 3.1.1 to the Company&#8217;s Current Report on Form 8-K filed on April 26, 2017).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.6</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1517681/000149315217004418/ex312.htm" style="-sec-extract: exhibit">Certificate of Amendment to the Certificate of Incorporation of the Company, dated April 20, 2017 (incorporated by reference to Exhibit 3.1.2 to the Company&#8217;s Current Report on Form 8-K filed on April 26, 2017).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.7</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1517681/000149315218001103/ex3-1.htm" style="-sec-extract: exhibit">Certificate of Amendment to the Certificate of Incorporation of the Company, dated as of January 23, 2018 (incorporated by reference to Exhibit 3.1 to the Company&#8217;s Current Report on Form 8-K filed on January 26, 2018).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.8</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1517681/000149315219009581/ex3-1.htm" style="-sec-extract: exhibit">Certificate of Amendment, dated as of June 7, 2019 (incorporated by reference to Exhibit 3.1 to the Company&#8217;s Current Report on Form 8-K filed on June 21, 2019).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.9</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1517681/000149315219009581/ex3-2.htm" style="-sec-extract: exhibit">Certificate of Correction, dated as of June 10, 2019 (incorporated by reference to Exhibit 3.2 to the Company&#8217;s Current Report on Form 8-K filed on June 21, 2019).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.10</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1517681/000149315220015435/ex3-10.htm" style="-sec-extract: exhibit">Certificate of Amendment, dated as of March 13, 2019 (incorporated by reference to Exhibit 3.10 to the Company&#8217;s Form S-1/A filed on August 13, 2020).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.11</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1517681/000149315220022006/ex3-1.htm" style="-sec-extract: exhibit">Certificate of Amendment to the Certificate of Incorporation of the Company, dated as of November 17, 2020 (incorporated by reference to Exhibit 3.1 to the Company&#8217;s Current Report on Form 8-K filed on November 19, 2020).</a></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<!-- Field: Page; Sequence: 158; Value: 91 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->95<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.65in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.12</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1517681/000114420414074117/v396665_ex3-1.htm" style="-sec-extract: exhibit">Certificate of Designation of Series A Preferred Stock of the Company, dated December 2, 2014 (incorporated by reference to Exhibit 3.1 to the Company&#8217;s Current Report on Form 8-K filed on December 16, 2014).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.13</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1517681/000114420415042591/v415484_ex4-1.htm" style="-sec-extract: exhibit">Certificate of Designation of Series B Preferred Stock of the Company, dated June 16, 2015 (incorporated by reference to Exhibit 4.1 to the Company&#8217;s Current Report on Form 8-K filed on July 15, 2015).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1517681/000149315218014184/ex4-1.htm" style="-sec-extract: exhibit">8% Convertible Redeemable Note, dated October 2, 2019, issued by the Company to Eagle Equities, LLC (incorporated by reference to Exhibit 4.1 to the Company&#8217;s Current Report on Form 8-K filed on October 5, 2018).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1517681/000149315218014184/ex4-2.htm" style="-sec-extract: exhibit">8% Convertible Redeemable Note, dated October 2, 2019, issued by the Company to GS Capital Partners, LLC (incorporated by reference to Exhibit 4.2 to the Company&#8217;s Current Report on Form 8-K filed on October 5, 2018).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1517681/000149315218014184/ex4-3.htm" style="-sec-extract: exhibit">8% Convertible Redeemable Back End Note, dated October 2, 2019, issued by the Company to GS Capital Partners, LLC (incorporated by reference to Exhibit 4.3 to the Company&#8217;s Current Report on Form 8-K filed on October 5, 2018).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1517681/000149315218014184/ex4-4.htm" style="-sec-extract: exhibit">Collateralized Secured Promissory Note, dated October 2, 2018, issued by GS Capital Partners, LLC to the Company (incorporated by reference to Exhibit 4.4 to the Company&#8217;s Current Report on Form 8-K filed on October 5, 2018).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.5</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1517681/000149315218017138/ex4-1.htm" style="-sec-extract: exhibit">8% Convertible Redeemable Note, dated November 30, 2018, issued by the Company to Eagle Equities, LLC (incorporated by reference to Exhibit 4.1 to the Company&#8217;s Current Report on Form 8-K filed on December 6, 2018).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.6</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1517681/000149315218018073/ex4-1.htm" style="-sec-extract: exhibit">8% Convertible Redeemable Note, dated December 24, 2018, issued by the Company to Eagle Equities, LLC (incorporated by reference to Exhibit 4.1 to the Company&#8217;s Current Report on Form 8-K filed on December 28, 2018).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.7</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1517681/000149315219011734/ex4-1.htm" style="-sec-extract: exhibit">10% Convertible Redeemable Note dated July 30, 2019, by and between the Company and Odyssey Capital Funding LLC. (incorporated by reference to Exhibit 4.1 to the Company&#8217;s Current Report on Form 8-K filed on August 6, 2019).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.8</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1517681/000149315219013872/ex4-1.htm" style="-sec-extract: exhibit">Convertible Redeemable Note, issued to Auctus Fund LLC on August 30, 2019 and effective as of September 3, 2019 (incorporated by reference to Exhibit 4.1 to the Company&#8217;s Current Report on Form 8-K filed on September 9, 2019).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.9</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1517681/000149315219013872/ex4-2.htm" style="-sec-extract: exhibit">Common Stock Purchase Warrant for the purchase of up to 450,000 shares of the Company&#8217;s common stock (incorporated by reference to Exhibit 4.2 to the Company&#8217;s Current Report on Form 8-K filed on September 9, 2019).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.10</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1517681/000149315219013872/ex4-3.htm" style="-sec-extract: exhibit">Common Stock Purchase Warrant for the purchase of up to 300,000 shares of the Company&#8217;s common stock (incorporated by reference to Exhibit 4.3 to the Company&#8217;s Current Report on Form 8-K filed on September 9, 2019).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.11</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1517681/000149315219013872/ex4-4.htm" style="-sec-extract: exhibit">Common Stock Purchase Warrant for the purchase of up to 225,000 shares of the Company&#8217;s common stock (incorporated by reference to Exhibit 4.4 to the Company&#8217;s Current Report on Form 8-K filed on September 9, 2019).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.12</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1517681/000149315219015529/ex4-55.htm" style="-sec-extract: exhibit">Form of Convertible Promissory Note (incorporated by reference to Exhibit 4.55 to the Company&#8217;s Annual Report on Form 10-K filed on October 15, 2019)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.13</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1517681/000149315220000761/ex4-1.htm" style="-sec-extract: exhibit">Form of First Convertible Redeemable Promissory Note (incorporated by reference to Exhibit 4.1 to the Company&#8217;s Current Report on Form 8-K filed on January 17, 2020)</a></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<!-- Field: Page; Sequence: 159; Value: 91 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->96<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.65in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.14</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1517681/000149315220000761/ex4-2.htm" style="-sec-extract: exhibit">Form of Second Convertible Redeemable Promissory Note (incorporated by reference to Exhibit 4.2 to the Company&#8217;s Current Report on Form 8-K filed on January 17, 2020)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.15</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1517681/000149315220023015/ex4-1.htm" style="-sec-extract: exhibit">8% Convertible Promissory Note, dated December 2, 2020, issued by the Company to Geneva Roth Remark Holdings Inc. (incorporated by reference to Exhibit 4.1 to the Company&#8217;s Current Report on Form 8-K filed on December 7, 2020)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.16</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1517681/000149315220023733/ex4-1.htm" style="-sec-extract: exhibit">8% Convertible Redeemable Promissory Note, dated December 10, 2020, issued by the Company to GW Holdings Group, LLC (incorporated by reference to Exhibit 4.1 to the Company&#8217;s Current Report on Form 8-K filed on December 16, 2020)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.17</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1517681/000149315221000709/ex4-1.htm" style="-sec-extract: exhibit">8% Convertible Promissory Note, dated January 5, 2021, issued by the Company to Geneva Roth Remark Holdings, Inc. (incorporated by reference to Exhibit 4.1 to the Company&#8217;s Current Report on Form 8-K filed on January 11, 2021)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.18</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1517681/000149315221006397/ex4-1.htm" style="-sec-extract: exhibit">8% Convertible Promissory Note, dated March 16, 2021, issued by the Company to Geneva Roth Remark Holdings, Inc. (incorporated by reference to Exhibit 4.1 to the Company&#8217;s Current Report on Form 8-K filed on March 19, 2021)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.19</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1517681/000149315221021170/ex4-1.htm" style="-sec-extract: exhibit">8% Convertible Promissory Note, dated August 19, 2021, issued by the Company to Geneva Roth Remark Holdings, Inc. (incorporated by reference to Exhibit 4.1 to the Company&#8217;s Current Report on Form 8-K filed on August 25, 2021)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.20</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1517681/000149315221023930/ex4-1.htm" style="-sec-extract: exhibit">8% Convertible Promissory Note, dated September 22, 2021, issued by the Company to Geneva Roth Remark Holdings, Inc. (incorporated by reference to Exhibit 4.1 to the Company&#8217;s Current Report on Form 8-K filed on September 28, 2021)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.21</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1517681/000149315221026408/ex4-1.htm" style="-sec-extract: exhibit">8% Convertible Promissory Note, dated October 21, 2021, issued by the Company to Sixth Street Lending LLC (incorporated by reference to Exhibit 4.1 to the Company&#8217;s Current Report on Form 8-K filed on October 27, 2021)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.22</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1517681/000149315221030167/ex4-1.htm" style="-sec-extract: exhibit">8% Convertible Promissory Note, dated November 26, 2021, issued by the Company to Sixth Street Lending LLC (incorporated by reference to Exhibit 4.1 to the Company&#8217;s Current Report on Form 8-K filed on December 1, 2021)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.23</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1517681/000149315221031218/ex4-1.htm" style="-sec-extract: exhibit">10% Convertible Promissory Note, dated December 7, issued by the Company to One44 Lending LLC (incorporated by reference to Exhibit 4.1 to the Company&#8217;s Current Report on Form 8-K filed on December 13, 2021)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.24</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1517681/000149315220005802/ex4-1.htm" style="-sec-extract: exhibit">Form of Prefunded Warrant (incorporated by reference to Exhibit 4.1 to the Company&#8217;s Current Report on Form 8-K filed on April 3, 2020)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.25</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1517681/000149315220005802/ex4-2.htm" style="-sec-extract: exhibit">Form of Series A Warrant (incorporated by reference to Exhibit 4.2 to the Company&#8217;s Current Report on Form 8-K filed on April 3, 2020)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.26</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1517681/000149315220005802/ex4-3.htm" style="-sec-extract: exhibit">Form of Series B Warrant (incorporated by reference to Exhibit 4.3 to the Company&#8217;s Current Report on Form 8-K filed on April 3, 2020)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.27</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1517681/000149315220005802/ex4-4.htm" style="-sec-extract: exhibit">Form of Series C Warrant (incorporated by reference to Exhibit 4.4 to the Company&#8217;s Current Report on Form 8-K filed on April 3, 2020)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1517681/000149315220020409/ex5-1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Opinion of Patrizio &amp; O&#8217;Leary LLP (previously filed)</span></a></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<!-- Field: Page; Sequence: 160; Value: 91 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->97<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.65in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1517681/000114420415009533/v401132_ex10-5.htm" style="-sec-extract: exhibit">Debt
    Settlement Agreement between the Company and James Nathanielsz, dated February 4, 2015 (incorporated by reference to Exhibit 10.5
    to the Company&#8217;s Quarterly Report on Form 10-Q filed on February 17, 2015).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1517681/000114420415009533/v401132_ex10-6.htm" style="-sec-extract: exhibit">Debt
    Settlement Agreement between the Company and Julian Kenyon, dated February 4, 2015 (incorporated by reference to Exhibit 10.6 to
    the Company&#8217;s Quarterly Report on Form 10-Q filed on February 17, 2015).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8224;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1517681/000114420416090186/v434961_ex10-10.htm" style="-sec-extract: exhibit">Employment
    Agreement entered into as of February 25, 2015 by and between James Nathanielsz and the Company (incorporated by reference to Exhibit
    10.10 to the Company&#8217;s Registration Statement on Form S-1 filed on March 25, 2016).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.4</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8224;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1517681/000114420416090186/v434961_ex10-11.htm" style="-sec-extract: exhibit">Director
    Agreement entered into as of February 25, 2015 by and between Julian Kenyon and the Company (incorporated by reference to Exhibit
    10.11 to the Company&#8217;s Registration Statement on Form S-1 filed on March 25, 2016).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.5</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8224;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1517681/000114420416090186/v434961_ex10-12.htm" style="-sec-extract: exhibit">Form
    of Scientific Advisory Board Member Agreement, incorporated by reference to Exhibit 10.12 to the Registration Statement on Form S-1
    filed on March 25, 2016.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.6</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8224;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1517681/000114420416102344/v439425_ex10-9.htm" style="-sec-extract: exhibit">Amendment
    No. 1 to Employment Agreement entered into as of April 14, 2016 by and between James Nathanielsz and the Company (incorporated by
    reference to Exhibit 10.9 to the Company&#8217;s Quarterly Report on Form 10-Q filed on May 16, 2016).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.7</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8224;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1517681/000149315217011027/ex10-11.htm" style="-sec-extract: exhibit">Amendment
    No. 2 to Employment Agreement entered into as of September 25, 2017 by and between James Nathanielsz and the Company (incorporated
    by reference to Exhibit 10.11 to the Company&#8217;s Annual Report on Form 10-K filed on September 28, 2017).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.8</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8224;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1517681/000149315219007395/ex10-1.htm" style="-sec-extract: exhibit">Amended
    and Restated Employment Agreement, dated as of May 14, 2019, by and between the James Nathanielsz and the Company (incorporated by
    reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on May 15, 2019).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.9</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8224;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1517681/000149315219007395/ex10-2.htm" style="-sec-extract: exhibit">Amended
    and Restated Services Agreement, by and between Julian Kenyon and the Company, dated as of May 19, 2019 (incorporated by reference
    to Exhibit 10.2 to the Company&#8217;s Current Report on Form 8-K filed on May 15, 2019).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.10</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8224;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1517681/000149315219007395/ex10-4.htm" style="-sec-extract: exhibit">Form
    of Indemnification Agreement (incorporated by reference to Exhibit 10.4 to the Company&#8217;s Current Report on Form 8-K filed on
    May 15, 2019).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.11</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8224;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1517681/000149315220024549/ex10-1.htm" style="-sec-extract: exhibit">Director
    Agreement by and between Josef Zelinger and the Company (incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current
    Report on Form 8-K filed on December 30, 2020).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.12</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8224;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1517681/000149315221020496/ex10-5.htm" style="-sec-extract: exhibit">Amended
    and Restated Director Agreement by and between Josef Zelinger and the Company, dated August 12, 2021 (incorporated by reference to
    Exhibit 10.5 to the Company&#8217;s Current Report on Form 8-K filed on August 18, 2021).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.13</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1517681/000149315221020496/ex10-1.htm" style="-sec-extract: exhibit">Cancellation
    Agreement by and between James Nathanielsz and the Company, dated August 12, 2021 (incorporated by reference to Exhibit 10.1 to the
    Company&#8217;s Current Report on Form 8-K filed on August 18, 2021).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.14</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1517681/000149315221020496/ex10-3.htm" style="-sec-extract: exhibit">Cancellation
    Agreement by and between Julian Kenyon and the Company, dated August 12, 2021 (incorporated by reference to Exhibit 10.3 to the Company&#8217;s
    Current Report on Form 8-K filed on August 18, 2021).</a></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<!-- Field: Page; Sequence: 161; Value: 91 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->98<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.65in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.15</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1517681/000114420416120760/v447520_ex10-1.htm" style="-sec-extract: exhibit">Manufacturing Services Agreement by and between Q-Biologicals NV (now Amatsigroup NV) and the Company, dated August 12, 2016 (incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on August 23, 2016).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.16</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1517681/000114420416120760/v447520_ex10-2.htm" style="-sec-extract: exhibit">Quality Assurance Agreement by and between Q-Biologicals NV (now Amatsigroup NV) and the Company dated August 12, 2016 (incorporated by reference to Exhibit 10.2 to the Company&#8217;s Current Report on Form 8-K filed on August 23, 2016).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.17</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1517681/000114420416136198/v453696_ex10-1.htm" style="-sec-extract: exhibit">Consulting Agreement between the Company and Regal Consulting, LLC, dated November 18, 2016 (incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on November 23, 2016).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.18</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1517681/000149315218012880/ex10-3.htm" style="-sec-extract: exhibit">Securities Purchase Agreement by and between the Company and Eagle Equities, LLC, dated August 29, 2018 (incorporated by reference to Exhibit 10.3 to the Company&#8217;s Current Report on Form 8-K filed on September 4, 2018).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.19</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1517681/000149315219009913/ex10-1.htm" style="-sec-extract: exhibit">Employment Agreement by and between the Company and Carlo Campiciano dated June 24, 2019 (incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on July 1, 2019).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.20</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1517681/000149315218014307/ex10-2.htm" style="-sec-extract: exhibit">Securities Purchase Agreement, dated October 2, 2018, between the Company and GS Capital Partners, LLC (incorporated by reference to Exhibit 10.2 to the Company&#8217;s Current Report on Form 8-K filed on October 10, 2018).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.21</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1517681/000149315218017138/ex10-1.htm" style="-sec-extract: exhibit">Securities Purchase Agreement, dated November 30, 2018, between the Company and Eagle Equities, LLC (incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on December 6, 2018).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.22</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1517681/000149315218018073/ex10-1.htm" style="-sec-extract: exhibit">Securities Purchase Agreement, dated as of December 24, 2018, between the Company and Eagle Equities, LLC (incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on December 28, 2018</a></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.65in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.23</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1517681/000149315220023015/ex10-1.htm" style="-sec-extract: exhibit">Securities Purchase Agreement, dated December 2, 2020, by and between the Company and Geneva Roth Remark Holdings, Inc. (incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on December 7, 2020)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.24</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1517681/000149315220023733/ex10-1.htm" style="-sec-extract: exhibit">Securities Purchase Agreement, dated December 10, 2020, by and between the Company and GW Holdings Group, LLC (incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on December 16, 2020)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.25</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1517681/000149315221000709/ex10-1.htm" style="-sec-extract: exhibit">Securities Purchase Agreement, dated January 5, 2021, by and between the Company and Geneva Roth Remark Holdings, Inc. (incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on January 11, 2021)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.26</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1517681/000149315221006397/ex10-1.htm" style="-sec-extract: exhibit">Securities Purchase Agreement, dated March 16, 2021, by and between the Company and Geneva Roth Remark Holdings, Inc. (incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on March 19, 2021)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.27</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1517681/000149315219007395/ex10-3.htm" style="-sec-extract: exhibit">Propanc Biopharma, Inc.&#8217;s 2019 Equity Incentive Plan (incorporated by reference to Exhibit 10.3 to the Company&#8217;s Current Report on Form 8-K filed on May 15, 2019).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.28</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1517681/000149315219008432/ex10-1.htm" style="-sec-extract: exhibit">Securities Purchase Agreement dated May 23, 2019, by and between the Company and Redstart Holdings Corp (incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on May 30, 2019)</a></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<!-- Field: Page; Sequence: 162; Value: 91 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->99<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.65in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.29</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1517681/000149315219010470/ex10-1.htm" style="-sec-extract: exhibit">Securities Purchase Agreement, dated July 3, 2019, by and between the Company and Power Up Lending Group Ltd. (incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on July 10, 2019).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.30</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1517681/000149315219011734/ex10-1.htm" style="-sec-extract: exhibit">Securities Purchase Agreement dated July 30, 2019, by and between the Company and Odyssey Capital Funding LLC. (incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on August 6, 2019).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.31</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1517681/000149315219013872/ex10-1.htm" style="-sec-extract: exhibit">Securities Purchase Agreement dated August 30, 2019, by and between the Company and Auctus Fund LLC (incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on September 9, 2019).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.32</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1517681/000149315219013872/ex10-2.htm" style="-sec-extract: exhibit">Registration Rights Agreement dated August 30, 2019, by and between the Company and Auctus Fund LLC (incorporated by reference to Exhibit 10.2 to the Company&#8217;s Current Report on Form 8-K filed on September 9, 2019).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.33</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1517681/000149315219015529/ex10-56.htm" style="-sec-extract: exhibit">Form of Securities Purchase Agreement (incorporated by reference to Exhibit 10.56 to the Company&#8217;s Annual Report on Form 10-K filed on October 15, 2019).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.34</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1517681/000149315220000761/ex10-1.htm" style="-sec-extract: exhibit">Form of First Securities Purchase Agreement (incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on January 17, 2020)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.35</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1517681/000149315220000761/ex10-2.htm" style="-sec-extract: exhibit">Form of Second Convertible Redeemable Promissory Note (incorporated by reference to Exhibit 10.2 to the Company&#8217;s Current Report on Form 8-K filed on January 17, 2020)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.36</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1517681/000149315220005802/ex10-1.htm" style="-sec-extract: exhibit">Form of Securities Purchase Agreement (incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on April 3, 2020)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.37</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1517681/000149315220005802/ex10-2.htm" style="-sec-extract: exhibit">Form of Prefunded Warrant (incorporated by reference to Exhibit 10.2 to the Company&#8217;s Current Report on Form 8-K filed on April 3, 2020)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.38</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1517681/000149315221021170/ex10-1.htm" style="-sec-extract: exhibit">Securities Purchase Agreement, dated August 19, 2021, by and between the Company and Geneva Roth Remark Holdings, Inc. (incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on August 25, 2021)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.39</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1517681/000149315221023930/ex10-1.htm" style="-sec-extract: exhibit">Securities Purchase Agreement, dated September 22, 2021, by and between the Company and Geneva Roth Remark Holdings, Inc. (incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on September 28, 2021)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.40</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1517681/000149315221026408/ex10-1.htm" style="-sec-extract: exhibit">Securities Purchase Agreement, dated October 21, 2021, by and between the Company and Sixth Street Lending LLC (incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on October 27, 2021)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.41</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1517681/000149315221030167/ex10-1.htm" style="-sec-extract: exhibit">Securities Purchase Agreement, dated November 26, 2021, by and between the Company and Sixth Street Lending LLC (incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on December 1, 2021)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.42</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1517681/000149315221030703/ex10-1.htm" style="-sec-extract: exhibit">Common Stock Purchase Agreement, dated November 30, 2021, by and between the Company and Dutchess Capital Growth Fund LP (incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on December 7, 2021)</a></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 163; Value: 91 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->100<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.65in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.43</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1517681/000149315221030703/ex10-2.htm" style="-sec-extract: exhibit">Registration Rights Agreement, dated November 30, 2021, by and between the Company and Dutchess Capital Growth Fund LP (incorporated by reference to Exhibit 10.2 to the Company&#8217;s Current Report on Form 8-K filed on December 7, 2021)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.44</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1517681/000149315221031218/ex10-1.htm" style="-sec-extract: exhibit">Securities Purchase Agreement, dated December 7, 2021, by and between the Company and ONE44, Lending LLC (incorporated by reference to Exhibit 10.2 to the Company&#8217;s Current Report on Form 8-K filed on December 13, 2021)</a></span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1517681/000149315219015529/ex21-1.htm" style="-sec-extract: exhibit">List of subsidiaries of the Company (incorporated by reference to Exhibit 21.1 to the Company&#8217;s Annual Report on Form 10-K filed on October 15, 2019).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.1*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex23-1.htm">Consent of Salberg &amp; Company, P.A., independent registered public accounting firm.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1517681/000149315220020409/ex5-1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consent of Patrizio &amp; O&#8217;Leary, LLP (included in Exhibit 5.1)</span></a></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.65in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.1in">*</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed
                                            herewith.</span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#8224;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">Management contract or compensatory plan or arrangement</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(b)
Financial Statement Schedules.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
schedules have been omitted because either they are not required, are not applicable or the information is otherwise set forth
in the financial statements and related notes thereto.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
16. Undertakings</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned registrant hereby undertakes:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    include any prospectus required by Section 10(a)(3) of the Securities Act of 1933;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most
    recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information
    set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered
    (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low
    or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant
    to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than a 20 percent change in the maximum
    aggregate offering price set forth in the &#8220;Calculation of Registration Fee&#8221; table in the effective registration
    statement; and</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    include any material information with respect to the plan of distribution not previously disclosed in the registration statement
    or any material change to such information in the registration statement.</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 164; Value: 91 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->101<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">That
    for the purpose of determining any liability under the Securities Act of 1933 each such post-effective amendment shall be
    deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities
    at that time shall be deemed to be the initial bona fide offering thereof.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold
    at the termination of the offering.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">That,
    for the purpose of determining liability under the Securities Act of 1933 to any purchaser, each prospectus filed pursuant
    to Rule 424(b) as part of a registration statement relating to an offering, other than registration statements relying on
    Rule 430B or other than prospectuses filed in reliance on Rule 430A, shall be deemed to be part of and included in the registration
    statement as of the date it is first used after effectiveness. Provided, however, that no statement made in a registration
    statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated
    by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser
    with a time of contract of sale prior to such first use, supersede or modify any statement that was made in the registration
    statement or prospectus that was part of the registration statement or made in any such document immediately prior to such
    date of first use.</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">That,
    for the purpose of determining liability of the registrant under the Securities Act of 1933 to any purchaser in the initial
    distribution of the securities:</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    undersigned registrant undertakes that in a primary offering of securities of the undersigned registrant pursuant to this
    registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities
    are offered or sold to such purchaser by means of any of the following communications, the undersigned registrant will be
    a seller to the purchaser and will be considered to offer or sell such securities to such purchaser:</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
    preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant
    to Rule 424;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
    free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred
    to by the undersigned registrant;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    portion of any other free writing prospectus relating to the offering containing material information about the undersigned
    registrant or its securities provided by or on behalf of the undersigned registrant; and</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
    other communication that is an offer in the offering made by the undersigned registrant to the purchaser.</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    undersigned Registrant hereby undertakes to provide to the underwriters at the closing specified in the underwriting agreement
    certificates in such denominations and registered in such names as required by the underwriters to permit prompt delivery
    to each purchaser.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Insofar
    as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling
    persons of the Registrant pursuant to the provisions described in Item 14 above, or otherwise, the Registrant has been advised
    that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act and is, therefore,
    unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the Registrant
    of expenses incurred or paid by a director, officer or controlling person of the Registrant in the successful defense of any
    action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities
    being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent,
    submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as
    expressed in the Securities Act and will be governed by the final adjudication of such issue.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    undersigned Registrant hereby undertakes:</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">That
    for purposes of determining any liability under the Securities Act, the information omitted from the form of prospectus filed
    as part of this registration statement in reliance upon Rule 430A and contained in a form of prospectus filed by the Registrant
    pursuant to Rule 424(b)(1) or (4), or 497(h) under the Securities Act shall be deemed to be part of this registration statement
    as of the time it was declared effective.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">That
    for the purpose of determining any liability under the Securities Act, each post-effective amendment that contains a form
    of prospectus shall be deemed to be a new registration statement relating to the securities offered therein, and this offering
    of such securities at that time shall be deemed to be the initial bona fide offering thereof.</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 165; Value: 91 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->102<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SIGNATURES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Act of 1933, the Registrant has duly caused this registration statement to be signed on its behalf
by the undersigned, thereunto duly authorized, in the City of Melbourne, in the State of Victoria, Australia, on January 10, 2022.
</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PROPANC
    BIOPHARMA, INC.</b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 45%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    James Nathanielsz</i></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">James
    Nathanielsz</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer and Chief Financial Officer (Principal Executive Officer and Principal Accounting Officer)</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the
capacities and on the dates indicated:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 28%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Signature</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 23%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Date</b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    James Nathanielsz</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer, Chief Financial Officer (Principal Executive Officer, Principal Accounting Officer), Director</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">January
                                            10, 2022</p></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">James
    Nathanielsz</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Dr. Julian Kenyon</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Technology Officer, Director</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">January
                                            10, 2022</p></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
    Julian Kenyon</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif">/<i>s/ Josef Zelinger</i></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">Director</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center">January 10, 2022</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">Josef Zelinger</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 166; Options: Last -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->103<!-- Field: /Sequence --></td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>2
<FILENAME>ex23-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0"><B>Exhibit 23.1</B></P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Consent of Independent Registered Public Accounting
Firm</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We hereby consent to the use of our report dated September
28, 2021, on the consolidated financial statements of Propanc Biopharma, Inc. and Subsidiary for the years ended June 30, 2021 and 2020,
included herein on the registration statement of Propanc Biopharma, Inc. Post-Effective Amendment No. 1 to Form S-1, and to the reference
to our firm under the heading &ldquo;Experts&rdquo; in the prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><I>/s/ Salberg &amp; Company, P.A.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">SALBERG &amp; COMPANY, P.A.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Boca Raton, Florida</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">January 10, 2022</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_001.jpg
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! @$!+ $L  #_X0J%17AI9@  34T *@    @ !P$2  ,
M   !  $   $:  4    !    8@$;  4    !    :@$H  ,    !  (   $Q
M  (    >    <@$R  (    4    D(=I  0    !    I    -  +<;    G
M$  MQL   "<0061O8F4@4&AO=&]S:&]P($-3-"!-86-I;G1O<V@ ,C Q,#HQ
M,3HP." Q-#HQ.3HS,    Z !  ,    !  $  * "  0    !   %<Z #  0
M   !    J0         & 0,  P    $ !@   1H !0    $   $> 1L !0
M  $   $F 2@  P    $  @   @$ !     $   $N @( !     $   E/
M     $@    !    2     '_V/_@ !!*1DE&  $"  !( $@  /_M  Q!9&]B
M95]#30 !_^X #D%D;V)E &2      ?_; (0 # @(" D(# D)#!$+"@L1%0\,
M# \5&!,3%1,3&!$,# P,# P1# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# $-"PL-#@T0#@X0% X.#A04#@X.#A01# P,# P1$0P,# P,#!$,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,_\  $0@ $P"@ P$B  (1 0,1 ?_=  0
M"O_$ 3\   $% 0$! 0$!          ,  0($!08'" D*"P$  04! 0$! 0$
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M!!D       0    >.$))30/S       )           ! #A"24TG$
M"@ !          $X0DE- _4      $@ +V9F  $ ;&9F  8       $ +V9F
M  $ H9F:  8       $ ,@    $ 6@    8       $ -0    $ +0    8
M      $X0DE- _@      '   /____________________________\#Z
M  #_____________________________ ^@     ____________________
M_________P/H     /____________________________\#Z   .$))300(
M       0     0   D    )      #A"24T$'@      !      X0DE-!!H
M     TT    &              "I   %<P    P <P!A &P 8@!E '( 9P!?
M &P ;P!G &\    !                          $             !7,
M  "I                      $                         $     $
M      !N=6QL     @    9B;W5N9'-/8FIC     0       %)C=#$    $
M     %1O<"!L;VYG          !,969T;&]N9P          0G1O;6QO;F<
M  "I     %)G:'1L;VYG   %<P    9S;&EC97-6;$QS     4]B:F,    !
M       %<VQI8V4    2    !W-L:6-E241L;VYG          =G<F]U<$E$
M;&]N9P         &;W)I9VEN96YU;0    Q%4VQI8V5/<FEG:6X    -875T
M;T=E;F5R871E9     !4>7!E96YU;0    I%4VQI8V54>7!E     $EM9R
M   &8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W @;&]N9P
M        3&5F=&QO;F<          $)T;VUL;VYG    J0    !29VAT;&]N
M9P  !7,    #=7)L5$585     $       !N=6QL5$585     $       !-
M<V=E5$585     $       9A;'1486=415A4     0      #F-E;&Q497AT
M27-(5$U,8F]O; $    (8V5L;%1E>'1415A4     0      "6AO<GI!;&EG
M;F5N=6T    /15-L:6-E2&]R>D%L:6=N    !V1E9F%U;'0    )=F5R=$%L
M:6=N96YU;0    ]%4VQI8V5697)T06QI9VX    '9&5F875L=     MB9T-O
M;&]R5'EP965N=6T    115-L:6-E0D=#;VQO<E1Y<&4     3F]N90    ET
M;W!/=71S971L;VYG          IL969T3W5T<V5T;&]N9P         ,8F]T
M=&]M3W5T<V5T;&]N9P         +<FEG:'1/=71S971L;VYG       X0DE-
M!"@       P    "/_         X0DE-!!0       0    ".$))300,
M  EK     0   *     3   !X   (Z    E/ !@  ?_8_^  $$I&248  0(
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M+?\ 1:LKJ.=AU9PJS7FVS%>/0?LILM:\L]=UK*G4[J*MNQC+_5_27>I[/T:
MHG37=)-!/U#K%C^@XG4:WMQZLM^-]HO8]KVTTW/8V^P7_P W[6N]+U_\#_2/
M\&FZBZO!S,:AF;:RG*LKJRZG6EYK8YMWH9#;;=^1C?:\JJGIWJ>KZ3_6_0>G
MF?IE4'6L7'<^EWKX[+'.-@#,=Q-KG/\ 7;97CL>US_8ZRZS?^D_FZ_6N2IS\
M.MFQK'4X-]37W/:W'+ +'6XU-=S:JO0M9;]G]/\ 1WV_SE7\Y3^F1X2.G?\
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M]?V>^S?^B_3>HH'J&"RNW'M+BRQ[[+:FMHMD[RY[LEEE=6S(]C[+J?TOV?\
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M'\[CGG_7>OEA))3]4#Y<)SR..>_P[+Y6224__]D .$))300A      !5
M 0$    / $$ 9 !O &( 90 @ %  : !O '0 ;P!S &@ ;P!P    $P!! &0
M;P!B &4 ( !0 &@ ;P!T &\ <P!H &\ <  @ $, 4P T     0 X0DE-! 8
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M6B 'S@ "  D !@ Q  !A8W-P35-&5     !)14,@<U)'0@
M 0  ]M8  0    #3+4A0("
M                         !%C<')T   !4    #-D97-C   !A    &QW
M='!T   !\    !1B:W!T   "!    !1R6%E:   "&    !1G6%E:   "+
M !1B6%E:   "0    !1D;6YD   "5    '!D;61D   "Q    (AV=65D   #
M3    (9V:65W   #U    "1L=6UI   #^    !1M96%S   $#    "1T96-H
M   $,     QR5%)#   $/   " QG5%)#   $/   " QB5%)#   $/   " QT
M97AT     $-O<'ER:6=H=" H8RD@,3DY."!(97=L971T+5!A8VMA<F0@0V]M
M<&%N>0  9&5S8P         2<U)'0B!)14,V,3DV-BTR+C$
M !)S4D="($E%0S8Q.38V+3(N,0
M                                6%E:(        /-1  $    !%LQ8
M65H@                     %A96B        !OH@  ./4   .06%E:(
M     &*9  "WA0  &-I865H@        )*    ^$  "VSV1E<V,
M%DE%0R!H='1P.B\O=W=W+FEE8RYC:               %DE%0R!H='1P.B\O
M=W=W+FEE8RYC:
M              !D97-C         "Y)14,@-C$Y-C8M,BXQ($1E9F%U;'0@
M4D="(&-O;&]U<B!S<&%C92 M('-21T(              "Y)14,@-C$Y-C8M
M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92 M('-21T(
M                9&5S8P         L4F5F97)E;F-E(%9I97=I;F<@0V]N
M9&ET:6]N(&EN($E%0S8Q.38V+3(N,0              +%)E9F5R96YC92!6
M:65W:6YG($-O;F1I=&EO;B!I;B!)14,V,3DV-BTR+C$
M                 '9I97<      !.D_@ 47RX $,\4  /MS  $$PL  UR>
M     5A96B       $P)5@!0    5Q_G;65A<P         !
M             H\    "<VEG(     !#4E0@8W5R=@        0     !0 *
M  \ %  9 !X (P H "T ,@ W #L 0 !% $H 3P!4 %D 7@!C &@ ;0!R '<
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M# P,$0P,# P,# P,# P,# P,# P,# P,# P,# P,# S_P  1" "I!7,# 1$
M A$! Q$!_]T ! "O_\0 T@ !  ,! 0$! 0            8'" 4$ P(! 0$
M P$! 0               P0% @8!$  ! P(# @@&"PT%!@0$! <"  $#! 41
M$@8B!R'1,A.351<(,4)28G(C05%A<8*2<X.S%#:QHK+2,T-35'05-188@9'"
M8Z.AP],D--3BE"4W\,&$Q/+C1$6DM.1E=28G$0 " 0(#! 4*!00# 0 " P
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MJ].5$E3(<IM6R,SF3D^'-0<&)+"OXB'C#W?:QMV,S*3C[W]BW5G&@$ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
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MA&$![;-9JR]54=OMT13U,KX" MPO^*(^,1;(KEFA8QD[59:<(-+;O.[A;;0
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M&*3Z#$Z]0>9" U-W6/LU4_MTGT5.L#Q#?CN^UC=L-R>][%+C6::(0! $ 0!
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M@P+9<6C;:-C'X7^3D6A%O%*(:I.GX5WBA->:DZ4C'XFW3/\ K_=G>-#S US
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MC.URON]A&+5EL-FVGCF9W]QB##\)7?#MD^HI^(;8)MW99"+2KL[\ U4K-[V
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MF\'.AESG\X)A\/.2WK"K++IGLF'?4]+8QVBQ.[%?):[3LM#,[O\ 4YW$,?8
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M:*H0! $ 0! $ 0! :F[K'V:J?VZ3Z*G6!XAOQW?:QNV&Y/>]BEQK--$( @"
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M4T.'ES S_P!SDNHI-.R).9J+&V8*[U;WD]/VH"CM6>X5/@;*SA&S^=*;8O\
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MCLKTMU72=$/$G,/FPX"9*.RO2W5=)T0\2<P^;#@)DH[*]+=5TG1#Q)S#YL.
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MCLKTMU72=$/$G,/FPX"9*.RO2W5=)T0\2<P^;#@)DH[*]+=5TG1#Q)S#YL.
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MYZL^DQK^.M'H*16H9AJ;NL?9JI_;I/HJ=8'B&_'=]K&[8;D][V*7&LTT0@"
M( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @"
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M $ 0! $ 0&Y-V<1Q:8M82<KZG _]X"[+RM>>O/>D]10W([L&?N]'<!GU%!3
M^/,4HL7N$12'^!D6QX>N"8_$9%_.+X?@4XM(SC4W=8^S53^W2?14ZP/$-^.[
M[6-VPW)[WL4N-9IHA $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
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M%&SOC@(2$ -B_AV16_2;4L3/NP851=+3$9R<=2$9N+1=5#J73%')4LTL=52
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M[RDL)C$8'=.PT&I-"4M==X J*BFM9'$9XNXES+8FW#RB>(")1:Y2K,+T8O\
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M#,,F0!%I-DB&%AYCS.3M95)5U+271\VDCI835G7\NHL#4^YEI=0V_4.G/J]
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M'V:J?VZ3Z*G6!XAOQW?:QNV&Y/>]BEQK--$( @" ( @" ( @" ( @" ( @"
M( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @"
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M/R;_ /\ *&NH_P#\_E[Y\G[_ )>X6UK>FT_<:4;5J:2G&*I+U832#&1$.&U
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MRK*OZ4M$-'9VFI8U8696?.:86&;1'=:Z M.LJ;ZK=HLSCCS<H\$@._Z,_P#
M6:,O&%34JS4YQ@AJT5J1A)G76/=LOMI,I;.XW"F\+,+L,K-YT9;)_-F6;R!6
MU2OE;>ZICU+)EW>L5=<[-6VJ3F;A!+3R-XLH$#_?LROJT-LG$HLLKM/&NCD_
M441RDP1BY$_@9FQ=T/I-],;E=4:A)N9HRIX7_.U&,8X>W@7K#^;C)5:ETB>?
M])92V=_-^HOW=WN(M&CG:YW$VK*Z-LW.&S#'%APYHP?QA_2R>D'-K'K7;5.B
M.JIK4;1:?3/68X.]/O$TUO [9I8QGJGQ$JEN&,/DO8F/S_R0_P"8IK>RF>E]
MGND->\B.A/U&:ZBHDJ9"GG)SE-W(B)\7=WX2(B?PNZVXC QIG$^:^GP(#4W=
M8^S53^W2?14ZP/$-^.[[6-VPW)[WL4N-9IHA $ 0! $ 0! $ 0! $ 0! $ 0
M! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0
M! $ 0! $ 0! 41KK=OJ'3.HBUCHH>>>8B.:!L'=G+\J+QXCST4Q;>QZP#^":
MUJ-='314,JK19&UH<W45TWA;QH6L+VM[=2F3<\9B<;/E?':DF_-9MK+$)D7G
M+M%I49U8ZSAVJUNKAI+FT?HBDTY8H]/#ZV)HR&4GX,[GCSQ?"S/E\D-E9M6K
M+MJ-*G2A%TE06&@UGNIGJ;9;;>]VM<TCR1$&+NSX9<S\WB0%E$.= @R['JR6
MB\T[B(F9T,9Z14H8Q$:U))NIT->Y;Y5:VU4+0UM2+A%"S\(L^5LSLSED8(P&
M*,"+/RN<VE!<55TQ33=@FMZ3:I=]LGXU=HJ[UN\.W7RGIR.WP!&TDK..#.SR
M9MERS^,/BK[3JK%*5F>L?*E)IJPT1U2X5FFB9YATMKG1&H[E<=/4$59!6R&X
ME(3$V0C>8-D9H)!D'-D+-_XELS4I54B&G3I\LC(BG4I/,K&K42C>WH^\7Z\V
M&NHJ9Y8Z61CJ'%Q9@VX3?E%CXA<G,H+:JJ*T3.]ND]Q39V68C9O$DWUZ?KK_
M *9J+?:XGGJ3.)Q!G9G=A,2+E.(\E06KPCQ,DUTDNF$':W?6VHMFG[?0U@/'
M40T\8&+X/@3#@0[/ HJS0SS,9DE%958B<B"[C='773U=>IKK3E %5-&4+NXO
MF9BJ')]@B_2!RO*5N[JJ\+A.[_U*MK39);'M?]CCZ@TMJ70FIZG4VEJ7Z_0W
M#%YH!X78B?.>R.W^4]9'( EES$!CY4B5$JI"/.EE[1&]-Z3RR1J5A9M,:FU_
MJ2EU#JBE_=UOMSL4,#\HB%^<'9+;_*9"ED(0$@ 0 4:HE%)5)UL_G"H]5X9X
MTJI(-^>[JNU-!2W6Q_Q.WFY +.S.0N[%L$6SSD9@)AF\_P ;*H;2O"3,-NL3
M75&7B)7>4CT][U_K:B?3U1;/W<$PY*JK-G'&/#UC11GAM2\G*/.<K\V.VIH2
ME2G5$Z_=4AEJM6-.&GWF._W>M(W33%IJJ:\0/3RR5&<1)Q?$<@#FV'+V645[
M45VB5Z>@ELZ<HLPV9:BSR^4]O_T5=]2SVD[13E4#3',\KLXME8G@R\LA\/-F
MM*SJJD-JG;A_L9UW29YC"-G_  7"LTT0@*8WQZ,O@7^AUEIV#ZW+2"(R0MPO
MB!$0EDQ8C$QDR%S>T/*6G;55TRC=749MS2;5#KUM)R=84^NMXUKEAGM[6ZDA
M9C&#'UL\C.PB'K'#+&&U)M"'SGBR4II46VZYS]TCJ14K1LTQ]19.[2QUEITE
M2VRNC>*KCAD$HW=G=G<I'%L1?+XRI5WAJDS&PNT$E4B)VE0[N]/:ZW=T\EPI
MK?\ 68IY,DU([LYLP,Q1U$;QD7*YR2/9S\C;#D$M&N]*M.$SA\1GT4J48QB,
M?A.YI;2.I-;:JAU9JJF^I4M%@\,)-@^(.Y1 (%M[,I<\<I\KDAYD52HE)-"3
MJU$M.F]1];QITG<[Q&CKKJ>AHX;-3E4'%,1&PN+8,XX8[9"HK*JM.9U3@27E
M-GB-)V=^>G*_4.G#H+5$\]0\T9,#.S/@S[3[;BRBM'A'QDENDETP@]%OT05T
MT1#IFYB\,I4<<1L^#N$@LQ _!P%S<HB2^-5TU-<>\?8I:J>F?=*VTO<=?[O:
M0M/M:?WA!&1/!(&)".9\S[4?ACS.19#YJ3:Y2NU%I5IU:M/O%*FU6C&G#42[
M<MN_N=GEK=1ZC9ANER+%P9V=P%R>0\V798I#R['YL0'T1KW596P5=U"S;497
M%FWG+46>7BE*'0MZNF\>345SIBCMM.1<R9$+L3 ',0Y1$B/:+UZU)K*M'3$]
M8S8I,U75,=4NM99I%);S]"WIM8T&J;!3%4"'-%/E(6X8RRDSYR'\I!@"U+>L
MO#E&DS*])N)#K!ZM[&[V]!?*?6VDQ:6N@9FEAX,2RLX9VS..<3B?F90S9\O(
M7-O673--]TZN*+:H=-XC^I!UQO1YBRU=M>UT R#)-(;.W@X,WK,KEES;$0#R
M^4:F3AT.M$ZV(7XE?JS&A2QMY.[&/4NFPL-"[1RT;1O3.7@9XQYH0)_)./9^
M*7BJE0KZ'U3VMXN5Z&M-,=G=*^H=6[Q[;:QT\UG,ZJ./F JN%\&9L@GF%^9*
M0!Y,G.9?+$E<FG19M6KY2I%2K$:=/S%@;F=WDFB[)]4K<I5E2;RS,W"PXLP#
M%F\;(+;7GD?BJI=5N*V,;L%NVH\-<)VR5[1Z:U9NJNM2>GJ/]Z6:K+,P#PD.
M#OD' ?6!)'FR<YD..0?.Y%R:B7"QJG0ZE2$>@TZ8UHQZ+3I#4^\'4=-J#5=,
MU!;Z%V*.!^!W<7SL&1]O:/+SQR9<P[ >;RU5**2J3J9NT?5IO5>&>-*J3W?3
MH>IUC8#H:#!ZN&09XA=\&)Q8@<,S\ N02'ES;.;R>4JEK5BF^,[-A;N:4U%P
M@@]BU#O#K:"'34%K:AD",8"K9<68 %N;YT1?9YQA;Q.<VN3&K3I2B=>.KM:"
MJCU9C3AI\VLZ/=]T'==)374+I"44<I0M"1..VP//B6 $67EARO*7%Y66IAA^
M/^IW9TFIXX_A[3^V315WI]Y-7?Y:<AML@$PS8C@[O'&')S9^4/DH]59HPN/6
M"TFBK+8=4D&_/3E?J'3AT%JB>>H>:,F!G9GP9]I]MQ90VCPCXR3722Z80=33
M.G:AM(062J'F:EZ'ZN;/PY2<.;?'+FY*CJ/'$U1[VH[1)T:9]W25?NEM&N]%
MSA9)+=%^[)JII)Y2(2(6)@C,XRCF9N1&/*C-7[EJ56-6/6PZ/+ HVZU*?5PZ
MN/EYSS06+5>[345=6V:WO<K?7$Y-DQ?@<GD#')B<<D68@VPRFNI=*Z1#3H93
MY"/1>96-:L?'5.B-<WJNHM:3TT9U\,P$%$),W-1Q$,L&;,6UGDYSG=O/M#Z,
M?VG5I+$T\>K[_O'RI2J-,/AUO<);OMTS?-7Z<MP4E(Y5^<)9X1(?5N\1<X.8
MR9BR2%D5>TJ+3><9ZO9_J6+I&J)&$=8M*R0'3T%/#*V4PAC$F]IV%F=EGO.,
MR7EC"(*RW&Z.NNGJZ]376G* *J:,H7=Q?,S%4.3[!%^D#E>4K]W55X7"=W_J
M4;6FR2V/:_['&WB:-U50:S#6&FJ4*S"-F9B(<&+FRIC X^<ADY&TQ"I*%5)I
MZ'G3Y:B.M2>*FM8U>6DZ&\/0^H-<Z>M]RDB"GU#1$<CP"[".T7) C.01/U4)
MCGDR\I<4:J4GF/\ ];><[K4FJK$__L4YEQUUO%O%$=GCL;P5,P/$<^#L.!-D
M(@YQ^:#TBE,5(M&DLZM7RG#5:K1AI)_N?W?GHBRM0U),=7,;S3./)8G818!?
MV@ !^%F5.YK<5L8V%JVH\)<))NJI:,[VVR:NW87ZNEL]N>XVZM)W'F\7;*Q$
M<6.3:CDBYP@+.&7R5LL].NL:IT,ICJKT&G3&M6/CJC0NN;K<:'6E12QRU\<P
M$U&!,S0A$0RTXD1'M<X?.\[E/,'PLD?VG6I+$T\>K[_O:A4I5&F'PZWN^[I)
M?OMTS?-7Z<MP4E(Y5^<)9X1(?5N\1<X.8R9BR2%D5>TJ+3><9ZO9_J6+I&J)
M&$=8MFAC*.","; A 6=O=9EG3M+\;"I-P&BKOIJ>['=Z<J<:DX7B=W%\S"\^
M;D$7@YP%HWE57A=,[,?]3/M*3),XQM_Y.3JK26I=$ZJFU7I2F^NTM;B\T(MB
M^)NQ2B0#M[4K<\$@<GDGY\E.HE5-#SITD=2F]-]:1JU''W@Z>UQO&I1N%50?
M58Z8F&"C8FSEG_*SR<X0\C((;63E; <LBEHO3HSA$ZL=YR.LE2M&,QA\)?FE
MZ26CM-'33CDEBIX@,?:(0$2'^]9%2<6F8S-:G&"Q'X'349V47O W;Z@L&HGU
MGHL6E.5W*:!N%\Q-A+ZM\O.Q3<HA$N<&3:'Q2'5HUT=-%0RZU%D?6ARM17K>
M)O!I_P!PM:GM\$KLTQD!QL3-POC+/^:\;+'G,N3F/DJ1$I49U8ZB-VJU8TX:
M2Y] Z.ATA9X+/"^=XV=Y#PY9EM2'_A'S,JS*U6:C:C2HT^&NDJ*#3&J]UEXJ
MI]-T?[RLU86/-#PD+,[N Y1]8$D>8@YS(<9ARMKD:4U$KK$-.AU,^$>@TZ8U
MHQ]J#2>I]XVH:6]:II?W?;*%V*. N!R=GSY&!]OUAB'.R&(>K'*"YFHE%)5)
MU,Q]BF]9H9XTJI+.\%I6Y:FL4%'9X'J)PJPD<6=FP%HY@<MMQ\8Q5>RJ0C8M
M[O\ 8L7E.77!?>_N3K2])+1VFCIIQR2Q4\0&/M$(")#_ 'JK4G%IF,RU3C!8
MC\"N-SNCKK8[[?*RY4Y0P5<V:$G<7S-SDI\&4B\4QY2NW-5758B=TI6U-E9I
MGM'!K=-ZIW=:CK;WIVC_ 'E;KB3F<8\)"Y%SF7*/K!*,R/(>62/FRV]ODRPZ
M5DA6G0R$4H]%Y98UJQYZ_3.K-ZUTI9-0436NT4A.[B7 3L[CS@X%ZPY),F7-
MDCB ?.Y?45*=NLZ9UNQ\E'KS&J-"*3O?IH2LUA8Q@MC,5732M,(.[-G;*0$#
M.6SFV\PYO)52TK13;IV26KJE-1>@BM!J#>%J.D#3SVUK=F!H9ZV1G' ,,AR1
M 3CZW+^CS^;S?*&PR4DG5CK^ @AZKQIPT_&>[NZZ*N^EX*\+S3E3%,<3@Q.+
MXL+'FY!%Y2XO:JU)C3.)U9TF2)U0??1.CKK;]X%VO=53D%!4PR#%*[C@3N<!
M,V5BS\F,_%7RK56:2K$]:/\ L?:5-HJRT[O_ /!Y-\^C-15E]MVI-.4XU1T0
MML.0M@0&\@YA,X\X%F\0LRZM:J0LJTZ=1\N:32T,O3I/)O T?JC7^EX*FX4L
M<%ZI)S+ZN#X,4;MEV'*27UG)+\KXOE95U1JI1?")ZC1O'-:F]5,9CKKV3^0W
M/7VMJ-M-UEO:VPRAS=562,3.\>&$G-QD_+EY.SGY7YL=I)6E2G5$Z_=0:JM6
M-,QH]YCW[@]/ZDTH]38KQ1-#0N1SC49Q+-)ZF'FQRD6P48%(+Y5Q>.E3!EGK
M;NDZM$>GBLQU?>/[N0T5=]/W:[U-TIR@BJ39XB=Q?,V>4O$(O8(>4EW55U6(
MG8+6DR,TS&T=XK15WU1!0!9J<JDH3E<V%Q;!B8,O+(?)2RJK3F=4X"\I,\1I
M@F^]/3-1J;3=;::+!ZB81<&=\&<@,)F',_ V;F\JJV]2$>&DM5TETF((1N=B
MUE:FATY?+?'#:(8Y!YW%G/%W<Q%R"8P=L3+\TK5SPVZRSU_+\"K;<1>JT=3R
M_$CMAM&L=U%954=KM[W:U5!YXW#''@X!+8S'&>3*,F:/)L[!*9VIW$1,SH<A
M1:E"9B(UJ>ZPZ.U-KK4U-JC5=.U!1T+B\,/@)W!^<C'(^8_RNW*<N7-R \SE
MZJ4DE$G5+':4WJO#O&F%+U62:@0'_]'4DM)#,^:4!)_!B[,Z^Q.!\P/Q^[J;
M]%'\5E]U2-,#]W4WZ*/XK)JD:8'[NIOT4?Q635(TP/W=3?HH_BLFJ1I@?NZF
M_11_%9-4C3!A[>&+#J2ZB+8,U=4LS-\J:]31W([J_P#P\Q6WY[S?_2/J8A"
MG6CM].H]+",%-4?6*4<,(9VSBS>T!8M+&WF@>3S54JVJ5-L=/PEJG<NFS_(M
MW3_>HMD^ 7BCEIR\&>)VD'WW8N:,?]19S^'S&[.)H)?Q.]!.K;ONTC<&9X[C
M'&_M2L4>'2B(JJUI4CS%I;I)\YU9-X.EYAR272@(7\+/41.W]SFH^"\>9OTR
M2<9,U_K!Q:W46[X'SSS6HWP\+<R;_>9U)"5?-K_R(I>E\'^)SZC?AH>RL34D
MPD7LC3P%P_"R1Q_?KN+2HVW_ "DYFZIKL_Q@AM_[UD3,X62@(G]@ZDF9F^:B
MS9NF%6D\.]Z?TE9[_P!V/U%0:OWHZ@U9B%SJB>!_S,>Q'\0>7[\F<EHT[=*>
MR#/J5VJ;9(HK!7" ( @-3=UC[-5/[=)]%3K \0WX[OM8W;#<GO>Q2XUFFB$
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
M0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $
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MI_;I/HJ=8'B&_'=]K&[8;D][V*7&LTT0@" ( @" ( @" ( @" ( @" ( @"
M( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @"
M( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @"
M( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @"
M( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" __4M;>I_$X_D!_"
MD5^WV>LHU]I#59*P0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0%I[J_X9)\N7X,
M:H7&WU%ZAL)DJQ9" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @
M" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @
M" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @
M" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @" ( @
8" ( @" ( @" ( @" ( @" ( @" (#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>ppcb-20210930.xsd
<DESCRIPTION>INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.11a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 96Mps7xRiXgen8uDanwsWaiPqbP9z5Z8WekhvWB0bWlqDyUuU+/tcyOAuF1WEQYF -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:srt-types="http://fasb.org/srt-types/2021-01-31" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:PPCB="http://propanc.com/20210930" elementFormDefault="qualified" targetNamespace="http://propanc.com/20210930">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://propanc.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://propanc.com/role/BalanceSheets" id="BalanceSheets">
	  <link:definition>00000002 - Statement - Condensed Consolidated Balance Sheets</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://propanc.com/role/BalanceSheetsParenthetical" id="BalanceSheetsParenthetical">
	  <link:definition>00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://propanc.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss" id="StatementsOfOperationsAndComprehensiveIncomeLoss">
	  <link:definition>00000004 - Statement - Consolidated Statements of Operations and Comprehensive Income (Loss)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://propanc.com/role/StatementsOfChangesInStockholdersDeficit" id="StatementsOfChangesInStockholdersDeficit">
	  <link:definition>00000005 - Statement - Consolidated Statements of Changes in Stockholders' Deficit</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://propanc.com/role/StatementsOfCashFlows" id="StatementsOfCashFlows">
	  <link:definition>00000006 - Statement - Consolidated Statements of Cash Flows</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://propanc.com/role/NatureOfOperationsAndSummaryOfSignificantAccountingAndReportingPolicies" id="NatureOfOperationsAndSummaryOfSignificantAccountingAndReportingPolicies">
	  <link:definition>00000007 - Disclosure - NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING AND REPORTING POLICIES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://propanc.com/role/GoingConcern" id="GoingConcern">
	  <link:definition>00000008 - Disclosure - GOING CONCERN</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://propanc.com/role/PropertyAndEquipment" id="PropertyAndEquipment">
	  <link:definition>00000009 - Disclosure - PROPERTY AND EQUIPMENT</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://propanc.com/role/DueToFormerDirector-RelatedParty" id="DueToFormerDirector-RelatedParty">
	  <link:definition>00000010 - Disclosure - DUE TO FORMER DIRECTOR - RELATED PARTY</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://propanc.com/role/LoansAndNotesPayable" id="LoansAndNotesPayable">
	  <link:definition>00000011 - Disclosure - LOANS AND NOTES PAYABLE</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://propanc.com/role/ConvertibleNotes" id="ConvertibleNotes">
	  <link:definition>00000012 - Disclosure - CONVERTIBLE NOTES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://propanc.com/role/IncomeTaxes" id="IncomeTaxes">
	  <link:definition>00000013 - Disclosure - INCOME TAXES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://propanc.com/role/StockholdersDeficit" id="StockholdersDeficit">
	  <link:definition>00000014 - Disclosure - STOCKHOLDERS&#8217; DEFICIT</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://propanc.com/role/CommitmentsAndContingencies" id="CommitmentsAndContingencies">
	  <link:definition>00000015 - Disclosure - COMMITMENTS AND CONTINGENCIES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://propanc.com/role/RelatedPartyTransactions" id="RelatedPartyTransactions">
	  <link:definition>00000016 - Disclosure - RELATED PARTY TRANSACTIONS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://propanc.com/role/ConcentrationsAndRisks" id="ConcentrationsAndRisks">
	  <link:definition>00000017 - Disclosure - CONCENTRATIONS AND RISKS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://propanc.com/role/DerivativeFinancialInstrumentsAndFairValueMeasurements" id="DerivativeFinancialInstrumentsAndFairValueMeasurements">
	  <link:definition>00000018 - Disclosure - DERIVATIVE FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://propanc.com/role/SubsequentEvents" id="SubsequentEvents">
	  <link:definition>00000019 - Disclosure - SUBSEQUENT EVENTS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://propanc.com/role/NatureOfOperationsAndSummaryOfSignificantAccountingAndReportingPoliciesPolicies" id="NatureOfOperationsAndSummaryOfSignificantAccountingAndReportingPoliciesPolicies">
	  <link:definition>00000020 - Disclosure - NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING AND REPORTING POLICIES (Policies)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://propanc.com/role/NatureOfOperationsAndSummaryOfSignificantAccountingAndReportingPoliciesTables" id="NatureOfOperationsAndSummaryOfSignificantAccountingAndReportingPoliciesTables">
	  <link:definition>00000021 - Disclosure - NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING AND REPORTING POLICIES (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://propanc.com/role/PropertyAndEquipmentTables" id="PropertyAndEquipmentTables">
	  <link:definition>00000022 - Disclosure - PROPERTY AND EQUIPMENT (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://propanc.com/role/ConvertibleNotesTables" id="ConvertibleNotesTables">
	  <link:definition>00000023 - Disclosure - CONVERTIBLE NOTES (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://propanc.com/role/IncomeTaxesTables" id="IncomeTaxesTables">
	  <link:definition>00000024 - Disclosure - INCOME TAXES (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://propanc.com/role/StockholdersDeficitTables" id="StockholdersDeficitTables">
	  <link:definition>00000025 - Disclosure - STOCKHOLDERS&#8217; DEFICIT (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://propanc.com/role/CommitmentsAndContingenciesTables" id="CommitmentsAndContingenciesTables">
	  <link:definition>00000026 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://propanc.com/role/DerivativeFinancialInstrumentsAndFairValueMeasurementsTables" id="DerivativeFinancialInstrumentsAndFairValueMeasurementsTables">
	  <link:definition>00000027 - Disclosure - DERIVATIVE FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://propanc.com/role/ScheduleOfTranslationExchangeRatesDetails" id="ScheduleOfTranslationExchangeRatesDetails">
	  <link:definition>00000028 - Disclosure - SCHEDULE OF TRANSLATION EXCHANGE RATES (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://propanc.com/role/ScheduleOfChangeInAccumulatedOtherComprehensiveIncomeLossDetails" id="ScheduleOfChangeInAccumulatedOtherComprehensiveIncomeLossDetails">
	  <link:definition>00000029 - Disclosure - SCHEDULE OF CHANGE IN ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://propanc.com/role/ScheduleOfPropertyAndEquipmentEstimatedUsefulLivesDetails" id="ScheduleOfPropertyAndEquipmentEstimatedUsefulLivesDetails">
	  <link:definition>00000030 - Disclosure - SCHEDULE OF PROPERTY AND EQUIPMENT ESTIMATED USEFUL LIVES (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://propanc.com/role/ScheduleOfDilutiveSecuritiesExcludedFromComputationDetails" id="ScheduleOfDilutiveSecuritiesExcludedFromComputationDetails">
	  <link:definition>00000031 - Disclosure - SCHEDULE OF DILUTIVE SECURITIES EXCLUDED FROM COMPUTATION (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://propanc.com/role/NatureOfOperationsAndSummaryOfSignificantAccountingAndReportingPoliciesDetailsNarrative" id="NatureOfOperationsAndSummaryOfSignificantAccountingAndReportingPoliciesDetailsNarrative">
	  <link:definition>00000032 - Disclosure - NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING AND REPORTING POLICIES (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://propanc.com/role/GoingConcernDetailsNarrative" id="GoingConcernDetailsNarrative">
	  <link:definition>00000033 - Disclosure - GOING CONCERN (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://propanc.com/role/ScheduleOfPropertyAndEquipmentDetails" id="ScheduleOfPropertyAndEquipmentDetails">
	  <link:definition>00000034 - Disclosure - SCHEDULE OF PROPERTY AND EQUIPMENT (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://propanc.com/role/PropertyAndEquipmentDetailsNarrative" id="PropertyAndEquipmentDetailsNarrative">
	  <link:definition>00000035 - Disclosure - PROPERTY AND EQUIPMENT (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://propanc.com/role/DueToFormerDirector-RelatedPartyDetailsNarrative" id="DueToFormerDirector-RelatedPartyDetailsNarrative">
	  <link:definition>00000036 - Disclosure - DUE TO FORMER DIRECTOR - RELATED PARTY (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://propanc.com/role/LoansAndNotesPayableDetailsNarrative" id="LoansAndNotesPayableDetailsNarrative">
	  <link:definition>00000037 - Disclosure - LOANS AND NOTES PAYABLE (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://propanc.com/role/ScheduleOfConvertibleNotesDetails" id="ScheduleOfConvertibleNotesDetails">
	  <link:definition>00000038 - Disclosure - SCHEDULE OF CONVERTIBLE NOTES (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://propanc.com/role/ConvertibleNotesDetailsNarrative" id="ConvertibleNotesDetailsNarrative">
	  <link:definition>00000039 - Disclosure - CONVERTIBLE NOTES (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://propanc.com/role/ScheduleOfIncomeTaxProvisionDetails" id="ScheduleOfIncomeTaxProvisionDetails">
	  <link:definition>00000040 - Disclosure - SCHEDULE OF INCOME TAX PROVISION (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://propanc.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" id="ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails">
	  <link:definition>00000041 - Disclosure - SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://propanc.com/role/IncomeTaxesDetailsNarrative" id="IncomeTaxesDetailsNarrative">
	  <link:definition>00000042 - Disclosure - INCOME TAXES (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://propanc.com/role/ScheduleOfStockOptionActivityDetails" id="ScheduleOfStockOptionActivityDetails">
	  <link:definition>00000043 - Disclosure - SCHEDULE OF STOCK OPTION ACTIVITY (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://propanc.com/role/ScheduleOfWarrantActivityDetails" id="ScheduleOfWarrantActivityDetails">
	  <link:definition>00000044 - Disclosure - SCHEDULE OF WARRANT ACTIVITY (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://propanc.com/role/StockholdersDeficitDetailsNarrative" id="StockholdersDeficitDetailsNarrative">
	  <link:definition>00000045 - Disclosure - STOCKHOLDERS&#8217; DEFICIT (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://propanc.com/role/ScheduleOfRightUseOfAssetDetails" id="ScheduleOfRightUseOfAssetDetails">
	  <link:definition>00000046 - Disclosure - SCHEDULE OF RIGHT USE OF ASSET (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://propanc.com/role/ScheduleOfOperatingLeaseLiabilityDetails" id="ScheduleOfOperatingLeaseLiabilityDetails">
	  <link:definition>00000047 - Disclosure - SCHEDULE OF OPERATING LEASE LIABILITY (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://propanc.com/role/CommitmentsAndContingenciesDetailsNarrative" id="CommitmentsAndContingenciesDetailsNarrative">
	  <link:definition>00000048 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://propanc.com/role/RelatedPartyTransactionsDetailsNarrative" id="RelatedPartyTransactionsDetailsNarrative">
	  <link:definition>00000049 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://propanc.com/role/ConcentrationsAndRisksDetailsNarrative" id="ConcentrationsAndRisksDetailsNarrative">
	  <link:definition>00000050 - Disclosure - CONCENTRATIONS AND RISKS (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://propanc.com/role/ScheduleOfFairValueMeasurementsRecurringAndNonrecurringValuationTechniquesDetails" id="ScheduleOfFairValueMeasurementsRecurringAndNonrecurringValuationTechniquesDetails">
	  <link:definition>00000051 - Disclosure - SCHEDULE OF FAIR VALUE MEASUREMENTS, RECURRING AND NONRECURRING, VALUATION TECHNIQUES (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://propanc.com/role/ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" id="ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails">
	  <link:definition>00000052 - Disclosure - SCHEDULE OF FAIR VALUE, ASSETS AND LIABILITIES MEASURED ON RECURRING BASIS (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://propanc.com/role/ScheduleOfDerivativeLiabilitiesAtFairValueDetails" id="ScheduleOfDerivativeLiabilitiesAtFairValueDetails">
	  <link:definition>00000053 - Disclosure - SCHEDULE OF DERIVATIVE LIABILITIES AT FAIR VALUE (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://propanc.com/role/DerivativeFinancialInstrumentsAndFairValueMeasurementsDetailsNarrative" id="DerivativeFinancialInstrumentsAndFairValueMeasurementsDetailsNarrative">
	  <link:definition>00000054 - Disclosure - DERIVATIVE FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://propanc.com/role/SubsequentEventsDetailsNarrative" id="SubsequentEventsDetailsNarrative">
	  <link:definition>00000055 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="ppcb-20210930_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="ppcb-20210930_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="ppcb-20210930_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Calculation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="ppcb-20210930_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd" />
    <import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd" />
    <import namespace="http://fasb.org/us-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd" />
    <import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd" />
    <import namespace="http://fasb.org/srt-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd" />
    <element id="PPCB_CommonStockIssuableMember" name="CommonStockIssuableMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_IntercompanyLoansMember" name="IntercompanyLoansMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_UnvestedRestrictedStockMember" name="UnvestedRestrictedStockMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_DirectorsAndOfficerMember" name="DirectorsAndOfficerMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_DecemberTwentyNineTwoThousandAndSeventeenSecuritiesPurchaseAgreementMember" name="DecemberTwentyNineTwoThousandAndSeventeenSecuritiesPurchaseAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_EagleEquitiesLLCMember" name="EagleEquitiesLLCMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_DecemberTwoThousandAndSeventeenEagleNoteMember" name="DecemberTwoThousandAndSeventeenEagleNoteMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_DecemberTwentyNineTwoThousandAndSixteenSecuritiesPurchaseAgreementMember" name="DecemberTwentyNineTwoThousandAndSixteenSecuritiesPurchaseAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_JulyThirteenTwoThousandAndEighteenSecuritiesPurchaseAgreementMember" name="JulyThirteenTwoThousandAndEighteenSecuritiesPurchaseAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_JulyTwoThousandEighteenEagleNoteMember" name="JulyTwoThousandEighteenEagleNoteMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_JuneTwentyNineTwoThousandEighteenSecuritiesPurchaseAgreementMember" name="JuneTwentyNineTwoThousandEighteenSecuritiesPurchaseAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_AugustTwentyNineTwoThousandandEighteenSecuritiesPurchaseAgreementMember" name="AugustTwentyNineTwoThousandandEighteenSecuritiesPurchaseAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_AugustTwoThousandEighteenEagleNoteMember" name="AugustTwoThousandEighteenEagleNoteMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember" name="OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_OctoberTwoTwoThousandAndEighteenEagleNoteMember" name="OctoberTwoTwoThousandAndEighteenEagleNoteMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_NovembeThirtyTwoThousandAndEighteenMecuritiesPurchaseAgreementMember" name="NovembeThirtyTwoThousandAndEighteenMecuritiesPurchaseAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_NovemberTwoThousandAndEighteenEagleNoteMember" name="NovemberTwoThousandAndEighteenEagleNoteMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember" name="DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_DecembeTwoThousandAndEighteenEagleNoteMember" name="DecembeTwoThousandAndEighteenEagleNoteMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_DepositoryTrustCompanyMember" name="DepositoryTrustCompanyMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_SecuritiesPurchaseAgreementOneMember" name="SecuritiesPurchaseAgreementOneMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_GSCapitalPartnersLLCMember" name="GSCapitalPartnersLLCMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_OctoberTwoThousandEighteenGSNoteMember" name="OctoberTwoThousandEighteenGSNoteMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_FirstNoteMember" name="FirstNoteMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_SecondNoteMember" name="SecondNoteMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_SecuritiesPurchaseAgreementMember" name="SecuritiesPurchaseAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_JanuaryTwentyTwoTwentyTwentyGSNoteMember" name="JanuaryTwentyTwoTwentyTwentyGSNoteMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_AugustTenTwoThousandAndSeventeenConsultingAgreementMember" name="AugustTenTwoThousandAndSeventeenConsultingAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_ConsultantMember" name="ConsultantMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_SettlementAndMutualReleaseAgreementMember" name="SettlementAndMutualReleaseAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_NovemberTwentySixTwoThousandNineteenSecuritiesPurchaseAgreementMember" name="NovemberTwentySixTwoThousandNineteenSecuritiesPurchaseAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_NovemberTwentySixTwoThousandNineteenPowerUpNoteMember" name="NovemberTwentySixTwoThousandNineteenPowerUpNoteMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_JanuarySevenTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember" name="JanuarySevenTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_JanuarySevenTwoThousandTwentyPowerUpNoteMember" name="JanuarySevenTwoThousandTwentyPowerUpNoteMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember" name="MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_MarchTwelveTwoThousandTwentyPowerUpNoteMember" name="MarchTwelveTwoThousandTwentyPowerUpNoteMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_RedstartHoldingsCorpFinancingAgreementMember" name="RedstartHoldingsCorpFinancingAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_RedstartHoldingsCorpMember" name="RedstartHoldingsCorpMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_OdysseyCapitalFundingLLCMember" name="OdysseyCapitalFundingLLCMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_JulyTwoThousandNineteenOdysseyNoteMember" name="JulyTwoThousandNineteenOdysseyNoteMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_AuctusFundLLCMember" name="AuctusFundLLCMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_AugustTwoThousandNineteenAuctusNoteMember" name="AugustTwoThousandNineteenAuctusNoteMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_FirstWarrantMember" name="FirstWarrantMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_SecondWarrantMember" name="SecondWarrantMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_ThirdWarrantMember" name="ThirdWarrantMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_GWHoldingsGroupLLCMember" name="GWHoldingsGroupLLCMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_OctoberOneTwoThousandNineteenAuctusNoteMember" name="OctoberOneTwoThousandNineteenAuctusNoteMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_DecemberTenTwoThousandTwentyGWNoteMember" name="DecemberTenTwoThousandTwentyGWNoteMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_CrownBridgePartnersLLCMember" name="CrownBridgePartnersLLCMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_OctoberThreeTwoThousandNineteenAuctusNoteMember" name="OctoberThreeTwoThousandNineteenAuctusNoteMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_JanuaryThirteenTwentyTwentyAderAlefNoteMember" name="JanuaryThirteenTwentyTwentyAderAlefNoteMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember" name="FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_LGCapitalFundingLLCMember" name="LGCapitalFundingLLCMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_DecemberTwoTwoThousandTwentyGenevaRothMember" name="DecemberTwoTwoThousandTwentyGenevaRothMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_GenevaRothRemarkHoldingsIncMember" name="GenevaRothRemarkHoldingsIncMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_JanuaryFiveTwoThousandTwentyOneGenevaRothMember" name="JanuaryFiveTwoThousandTwentyOneGenevaRothMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_MarchSixteenTwoThousandTwentyOneGenevaRothMember" name="MarchSixteenTwoThousandTwentyOneGenevaRothMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_CaresActMember" name="CaresActMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_ExpireInTwoThousandTwentyFourMember" name="ExpireInTwoThousandTwentyFourMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_NotExpireMember" name="NotExpireMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_SecurityPurchaseAgreementMember" name="SecurityPurchaseAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_SeriesBWarrantsMember" name="SeriesBWarrantsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_SeriesCWarrantsMember" name="SeriesCWarrantsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_SeriesAWarrantsMember" name="SeriesAWarrantsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_PrefundedWarrantsMember" name="PrefundedWarrantsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_UnderlyingFinancingAgreementsMember" name="UnderlyingFinancingAgreementsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_ConsultingAgreementMember" name="ConsultingAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_EngagementAgreementMember" name="EngagementAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_TwentySeriesAAndOneSeriesCWarrantsMember" name="TwentySeriesAAndOneSeriesCWarrantsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_TwoThousandNinteenEquityIncentivePlanMember" name="TwoThousandNinteenEquityIncentivePlanMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_EmploymentAgreementsMember" name="EmploymentAgreementsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_HolderMember" name="HolderMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_FoleyShechterMember" name="FoleyShechterMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_SettlementAgreementMember" name="SettlementAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_RegalConsultingLLCMember" name="RegalConsultingLLCMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_TwoThousandAndSeventeenNoteMember" name="TwoThousandAndSeventeenNoteMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_From2012ThroughThe2014Member" name="From2012ThroughThe2014Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_NewFiveYearOperatingLeaseAgreementMember" name="NewFiveYearOperatingLeaseAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_AUDCurrencyMember" name="AUDCurrencyMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_OneYearCollaborationAgreementMember" name="OneYearCollaborationAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_EurosMember" name="EurosMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_TwoYearCollaborationAgreementMember" name="TwoYearCollaborationAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_NoCustomerMember" name="NoCustomerMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_InstallmentOneMember" name="InstallmentOneMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_InstallmentTwoMember" name="InstallmentTwoMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_InstallmentThreeMember" name="InstallmentThreeMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_InstallmentFourMember" name="InstallmentFourMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_UniversityOfJaenMember" name="UniversityOfJaenMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_CurrentAndFormerDirectorMember" name="CurrentAndFormerDirectorMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_FormerDirectorMember" name="FormerDirectorMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_NorthHorizonPtyLtdMember" name="NorthHorizonPtyLtdMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_AUDCurrenryMember" name="AUDCurrenryMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_NathanielszMember" name="NathanielszMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_NathanielszEmploymentAgreementMember" name="NathanielszEmploymentAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_MrsNathanielszMember" name="MrsNathanielszMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_JamesNathanielszMember" name="JamesNathanielszMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_MrNathanielszMember" name="MrNathanielszMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_BoardOfDirectorsMember" name="BoardOfDirectorsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_EmploymentAgreementMember" name="EmploymentAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_RestrictedStocksUnitsRSUMember" name="RestrictedStocksUnitsRSUMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_AdditionaNathanielszRSUsMember" name="AdditionaNathanielszRSUsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_ServicesAgreementMember" name="ServicesAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_DrKenyonMember" name="DrKenyonMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_DrKenyonMemberMember" name="DrKenyonMemberMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_InitialKenyonRSUsMember" name="InitialKenyonRSUsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_AdditionalKenyonRSUsMember" name="AdditionalKenyonRSUsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_LenderOneMember" name="LenderOneMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_LenderTwoMember" name="LenderTwoMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_LenderThreeMember" name="LenderThreeMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_TwelveSeriesAAndAWarrantsMember" name="TwelveSeriesAAndAWarrantsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_NathanielszCancellationAgreementMember" name="NathanielszCancellationAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_KenyonCancellationAgreementMember" name="KenyonCancellationAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_ZelingerAmendedAndRestatedDirectorAgreementMember" name="ZelingerAmendedAndRestatedDirectorAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_JosefZelingerMember" name="JosefZelingerMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_CommonStockOneMember" name="CommonStockOneMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_CommonStockTwoMember" name="CommonStockTwoMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_CommonStockThreeMember" name="CommonStockThreeMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_TwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember" name="TwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_SubscriptionReceivableMember" name="SubscriptionReceivableMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_AuctusFinancingAgreementMember" name="AuctusFinancingAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_AugustNineteenTwoThousandTwentyOneGenevaRothMember" name="AugustNineteenTwoThousandTwentyOneGenevaRothMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_SeptemberTwentyTwoTwoThousandTwentyOneGenevaRothMember" name="SeptemberTwentyTwoTwoThousandTwentyOneGenevaRothMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember" name="SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_GenevaRothFinancingAgreementAgreementMember" name="GenevaRothFinancingAgreementAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_LegalServicesMember" name="LegalServicesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_ConsultantServicesMember" name="ConsultantServicesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_DeferredSalaryMember" name="DeferredSalaryMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_CancellationAgreementMember" name="CancellationAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_ChiefScientificOfficerandDirectorMember" name="ChiefScientificOfficerandDirectorMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_SeriesBWarrantMember" name="SeriesBWarrantMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_ElevenSeriesAWarrantsMember" name="ElevenSeriesAWarrantsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_OctoberTwentyOneTwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember" name="OctoberTwentyOneTwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_LoanFromFormerDirectorRelatedParty" name="LoanFromFormerDirectorRelatedParty" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_CommonStockIssuable" name="CommonStockIssuable" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_CommonStockIssuableShares" name="CommonStockIssuableShares" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_GainFromSettlementOfDebtNet" name="GainFromSettlementOfDebtNet" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_DeemedDividend" name="DeemedDividend" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_ReversalOfCommonStockIssuableDueToCancellationOfConversionsOfConvertibleDebtAndAccruedInterest" name="ReversalOfCommonStockIssuableDueToCancellationOfConversionsOfConvertibleDebtAndAccruedInterest" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_ReversalOfCommonStockIssuableDueToCancellationOfConversionsOfConvertibleDebtAndAccruedInterestShares" name="ReversalOfCommonStockIssuableDueToCancellationOfConversionsOfConvertibleDebtAndAccruedInterestShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_StockIssuedDuringPeriodValueExerciseOfWarrants" name="StockIssuedDuringPeriodValueExerciseOfWarrants" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_StockIssuedDuringPeriodSharesExerciseOfWarrants" name="StockIssuedDuringPeriodSharesExerciseOfWarrants" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_IssuanceOfCommonStockForCashlessExerciseOfWarrants" name="IssuanceOfCommonStockForCashlessExerciseOfWarrants" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_IssuanceOfCommonStockForCashlessExerciseOfWarrantsShares" name="IssuanceOfCommonStockForCashlessExerciseOfWarrantsShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_StockIssuedDuringPeriodValueReverseStockSplits" name="StockIssuedDuringPeriodValueReverseStockSplits" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_DeemedDividendUponAlternateCashlessExerciseOfWarrants" name="DeemedDividendUponAlternateCashlessExerciseOfWarrants" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_IssuanceOfCommonStockForAlternateCashlessExerciseOfWarrants" name="IssuanceOfCommonStockForAlternateCashlessExerciseOfWarrants" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_IssuanceOfCommonStockForAlternateCashlessExerciseOfWarrantsShares" name="IssuanceOfCommonStockForAlternateCashlessExerciseOfWarrantsShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_AdjustmentsToAdditionalPaidInCapitalReclassificationOfPremiumUponDebtConversion" name="AdjustmentsToAdditionalPaidInCapitalReclassificationOfPremiumUponDebtConversion" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_RelativeFairValueOfWarrantsIssuedWithConvertibleDebt" name="RelativeFairValueOfWarrantsIssuedWithConvertibleDebt" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_IncreaseDecreaseInDeferredRent" name="IncreaseDecreaseInDeferredRent" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_CashPaidDuringPeriodAbstract" name="CashPaidDuringPeriodAbstract" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_DiscountsRelatedToWarrantsIssuedWithConvertibleNote" name="DiscountsRelatedToWarrantsIssuedWithConvertibleNote" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_DiscountsRelatedToDerivativeLiability" name="DiscountsRelatedToDerivativeLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_OperatingLeaseRightofuseAssetsAndOperatingLeaseLiabilitiesRecordedUponAdoptionOfAsc842" name="OperatingLeaseRightofuseAssetsAndOperatingLeaseLiabilitiesRecordedUponAdoptionOfAsc842" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_ReversalOfCommonStockIssuableAndPutPremiumDueToCancellationOfConversionsOfConvertibleDebtAndAccruedInterest" name="ReversalOfCommonStockIssuableAndPutPremiumDueToCancellationOfConversionsOfConvertibleDebtAndAccruedInterest" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_DeemedDividendUponAlternateCashlessExerciseOfWarrants1" name="DeemedDividendUponAlternateCashlessExerciseOfWarrants1" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_AccountsPayableReclassToConvertibleNotes" name="AccountsPayableReclassToConvertibleNotes" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_SubscriptionReceivable" name="SubscriptionReceivable" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_DisclosureDueToFormerDirectorRelatedPartyAbstract" name="DisclosureDueToFormerDirectorRelatedPartyAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_DueToFormerDirectorRelatedPartyDisclosureTextBlock" name="DueToFormerDirectorRelatedPartyDisclosureTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_DisclosureLoansAndNotesPayableAbstract" name="DisclosureLoansAndNotesPayableAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_LoansAndNotesPayableDisclosureTextBlock" name="LoansAndNotesPayableDisclosureTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_NatureOfOperationsPolicyTextBlock" name="NatureOfOperationsPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_GoodsAndServiceTaxPolicyTextBlock" name="GoodsAndServiceTaxPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_ConvertibleNotesPolicyTextBlock" name="ConvertibleNotesPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_ScheduleOfTranslationExchangeRatesTableTextBlock" name="ScheduleOfTranslationExchangeRatesTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_ScheduleOfPropertyAndEquipmentEstimatedUsefulLivesTableTextBlock" name="ScheduleOfPropertyAndEquipmentEstimatedUsefulLivesTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_ScheduleOfRightUseOfAssetTableTextBlock" name="ScheduleOfRightUseOfAssetTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_WorkingCapitalDeficit" name="WorkingCapitalDeficit" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_DebtInstrumentDebtDefaultInterestRate" name="DebtInstrumentDebtDefaultInterestRate" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_PercentageOfOutstandingSharesOfCommonStock" name="PercentageOfOutstandingSharesOfCommonStock" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_DebtDefaultAmountPercentage" name="DebtDefaultAmountPercentage" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_DebtConversionConvertedInterestPayable" name="DebtConversionConvertedInterestPayable" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_PrepaymentPenalties" name="PrepaymentPenalties" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_DiligenceFees" name="DiligenceFees" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_UnissuedSharesConversion" name="UnissuedSharesConversion" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_DueToEquityConversion" name="DueToEquityConversion" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_ReclassifiedPremiumAmountForAdditionalPaidInCapital" name="ReclassifiedPremiumAmountForAdditionalPaidInCapital" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_DeferredTaxAssetsWarrantDerivativeLiability" name="DeferredTaxAssetsWarrantDerivativeLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_DeferredTaxAssetsPrepaidInvestorServices" name="DeferredTaxAssetsPrepaidInvestorServices" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_DeferredTaxAssetsNonCashInterest" name="DeferredTaxAssetsNonCashInterest" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_DeferredTaxAssetsForeignExchangeLoss" name="DeferredTaxAssetsForeignExchangeLoss" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_DeferredTaxAssetsRevalueOfDerivativeLiability" name="DeferredTaxAssetsRevalueOfDerivativeLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_DeferredTaxLiabilitiesGainOnExtinguishmentOfDebt" name="DeferredTaxLiabilitiesGainOnExtinguishmentOfDebt" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsIssuedInPeriodWeightedAverageExercisePrice" name="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsIssuedInPeriodWeightedAverageExercisePrice" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_WeightedAverageFairValueOfOptionsGrantedDuringPeriod" name="WeightedAverageFairValueOfOptionsGrantedDuringPeriod" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageOutstanding" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageOutstanding" nillable="true" xbrli:periodType="instant" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsIssued" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsIssued" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceIssued" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceIssued" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceExercised" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceExercised" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceExpired" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceExpired" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceForfeited" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceForfeited" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisable" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisable" nillable="true" xbrli:periodType="instant" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerms" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerms" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsAggregateIntrinsicValueOutstanding" name="SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsAggregateIntrinsicValueOutstanding" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_EquityPurchaseAgreementDescription" name="EquityPurchaseAgreementDescription" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_ConversionFees" name="ConversionFees" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_ConversionOptionDerivatives" name="ConversionOptionDerivatives" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_FairMarketValueOfShares" name="FairMarketValueOfShares" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_PremiumsToAdditionalPaidInCapital" name="PremiumsToAdditionalPaidInCapital" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_DecreaseInEquity" name="DecreaseInEquity" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantDateFairvalue" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantDateFairvalue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_UnrecognizedRestrictedStockUnitsExpense" name="UnrecognizedRestrictedStockUnitsExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_UnvestedStockOptionsExpense" name="UnvestedStockOptionsExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_PercentageOfBonusOfAnnualBaseSalary" name="PercentageOfBonusOfAnnualBaseSalary" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_DescriptionOfEmploymentBenefits" name="DescriptionOfEmploymentBenefits" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_OperatingLeaseRightOfUseAssets" name="OperatingLeaseRightOfUseAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_AccumulatedReduction" name="AccumulatedReduction" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_OfficeLeaseLiability" name="OfficeLeaseLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_ReductionOfLeaseLiability" name="ReductionOfLeaseLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_SettlementAmount" name="SettlementAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_GainLossFromSettlementOfDebt" name="GainLossFromSettlementOfDebt" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_LitigationPenaltyAmount" name="LitigationPenaltyAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_RemainingPrincipalAmount" name="RemainingPrincipalAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_OperatingLeasesIncomeStatementRevenuePercentage" name="OperatingLeasesIncomeStatementRevenuePercentage" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_PaymentForServices" name="PaymentForServices" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_LoansFromRelatedParty" name="LoansFromRelatedParty" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_GoodsAndServiceTax" name="GoodsAndServiceTax" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_PercentageOfPensionOfMonthlySalary" name="PercentageOfPensionOfMonthlySalary" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_BonusPayableAmount" name="BonusPayableAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_RemainingBonusAmount" name="RemainingBonusAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_BonusAwardsGrantedPercentage" name="BonusAwardsGrantedPercentage" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_BonusPayable" name="BonusPayable" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_AgreementlTerm" name="AgreementlTerm" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_AgreementRenewalTerm" name="AgreementRenewalTerm" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_StockToBeIssuedDuringPeriodValueRestrictedStockUnit" name="StockToBeIssuedDuringPeriodValueRestrictedStockUnit" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_OptionsVestedDescription" name="OptionsVestedDescription" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_GrossProceedsFromEquityFinancing" name="GrossProceedsFromEquityFinancing" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_CancellationOfAccruedSalaries" name="CancellationOfAccruedSalaries" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_OperatingLeasesRentExpenseMinimumRentalsPayable" name="OperatingLeasesRentExpenseMinimumRentalsPayable" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_ReimbursementOnGoodsAndServiceTaxReceivablePercentage" name="ReimbursementOnGoodsAndServiceTaxReceivablePercentage" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_ReductionsDueToConversions" name="ReductionsDueToConversions" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_FairValueOfWarrantDerivativeLiabilityRecorededAsDebtDiscount" name="FairValueOfWarrantDerivativeLiabilityRecorededAsDebtDiscount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_InitialFairValueOfEmbeddedConversionOptionDerivativeLiabilityRecordedAsExpense" name="InitialFairValueOfEmbeddedConversionOptionDerivativeLiabilityRecordedAsExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_GainOnDebtExtinguishment" name="GainOnDebtExtinguishment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_DebtCoversionPercentage" name="DebtCoversionPercentage" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_ConsultingAgreementDescription" name="ConsultingAgreementDescription" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_ConsultingAgreementMonthlyPayment" name="ConsultingAgreementMonthlyPayment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_AccumulatedOtherComprehensiveIncomeLossMember" name="AccumulatedOtherComprehensiveIncomeLossMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_PotentialLiabilityReduction" name="PotentialLiabilityReduction" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_LenderFourMember" name="LenderFourMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_LenderFiveMember" name="LenderFiveMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_DebtInstrumentOriginalDiscount" name="DebtInstrumentOriginalDiscount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_DeemedDividendUponAlternateCashlessExerciseOfWarrant" name="DeemedDividendUponAlternateCashlessExerciseOfWarrant" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_CancellationOfBonusPayable" name="CancellationOfBonusPayable" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_ForeignCurrencyTransactionLossBeforeTax1" name="ForeignCurrencyTransactionLossBeforeTax1" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValues" name="AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValues" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="PPCB_AdjustmentsToAdditionalPaidStockBasedCompensationInConnectionWithFairValueOfWarrantsIssuedForServices" name="AdjustmentsToAdditionalPaidStockBasedCompensationInConnectionWithFairValueOfWarrantsIssuedForServices" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>5
<FILENAME>ppcb-20210930_cal.xml
<DESCRIPTION>INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.11a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://propanc.com/role/Cover" xlink:href="ppcb-20210930.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/BalanceSheets" xlink:href="ppcb-20210930.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/BalanceSheetsParenthetical" xlink:href="ppcb-20210930.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss" xlink:href="ppcb-20210930.xsd#StatementsOfOperationsAndComprehensiveIncomeLoss" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/StatementsOfChangesInStockholdersDeficit" xlink:href="ppcb-20210930.xsd#StatementsOfChangesInStockholdersDeficit" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/StatementsOfCashFlows" xlink:href="ppcb-20210930.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/NatureOfOperationsAndSummaryOfSignificantAccountingAndReportingPolicies" xlink:href="ppcb-20210930.xsd#NatureOfOperationsAndSummaryOfSignificantAccountingAndReportingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/GoingConcern" xlink:href="ppcb-20210930.xsd#GoingConcern" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/PropertyAndEquipment" xlink:href="ppcb-20210930.xsd#PropertyAndEquipment" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/DueToFormerDirector-RelatedParty" xlink:href="ppcb-20210930.xsd#DueToFormerDirector-RelatedParty" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/LoansAndNotesPayable" xlink:href="ppcb-20210930.xsd#LoansAndNotesPayable" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/ConvertibleNotes" xlink:href="ppcb-20210930.xsd#ConvertibleNotes" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/IncomeTaxes" xlink:href="ppcb-20210930.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/StockholdersDeficit" xlink:href="ppcb-20210930.xsd#StockholdersDeficit" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/CommitmentsAndContingencies" xlink:href="ppcb-20210930.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/RelatedPartyTransactions" xlink:href="ppcb-20210930.xsd#RelatedPartyTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/ConcentrationsAndRisks" xlink:href="ppcb-20210930.xsd#ConcentrationsAndRisks" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/DerivativeFinancialInstrumentsAndFairValueMeasurements" xlink:href="ppcb-20210930.xsd#DerivativeFinancialInstrumentsAndFairValueMeasurements" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/SubsequentEvents" xlink:href="ppcb-20210930.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/NatureOfOperationsAndSummaryOfSignificantAccountingAndReportingPoliciesPolicies" xlink:href="ppcb-20210930.xsd#NatureOfOperationsAndSummaryOfSignificantAccountingAndReportingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/NatureOfOperationsAndSummaryOfSignificantAccountingAndReportingPoliciesTables" xlink:href="ppcb-20210930.xsd#NatureOfOperationsAndSummaryOfSignificantAccountingAndReportingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/PropertyAndEquipmentTables" xlink:href="ppcb-20210930.xsd#PropertyAndEquipmentTables" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/ConvertibleNotesTables" xlink:href="ppcb-20210930.xsd#ConvertibleNotesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/IncomeTaxesTables" xlink:href="ppcb-20210930.xsd#IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/StockholdersDeficitTables" xlink:href="ppcb-20210930.xsd#StockholdersDeficitTables" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/CommitmentsAndContingenciesTables" xlink:href="ppcb-20210930.xsd#CommitmentsAndContingenciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/DerivativeFinancialInstrumentsAndFairValueMeasurementsTables" xlink:href="ppcb-20210930.xsd#DerivativeFinancialInstrumentsAndFairValueMeasurementsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/ScheduleOfTranslationExchangeRatesDetails" xlink:href="ppcb-20210930.xsd#ScheduleOfTranslationExchangeRatesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/ScheduleOfChangeInAccumulatedOtherComprehensiveIncomeLossDetails" xlink:href="ppcb-20210930.xsd#ScheduleOfChangeInAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/ScheduleOfPropertyAndEquipmentEstimatedUsefulLivesDetails" xlink:href="ppcb-20210930.xsd#ScheduleOfPropertyAndEquipmentEstimatedUsefulLivesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/ScheduleOfDilutiveSecuritiesExcludedFromComputationDetails" xlink:href="ppcb-20210930.xsd#ScheduleOfDilutiveSecuritiesExcludedFromComputationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/NatureOfOperationsAndSummaryOfSignificantAccountingAndReportingPoliciesDetailsNarrative" xlink:href="ppcb-20210930.xsd#NatureOfOperationsAndSummaryOfSignificantAccountingAndReportingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/GoingConcernDetailsNarrative" xlink:href="ppcb-20210930.xsd#GoingConcernDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/ScheduleOfPropertyAndEquipmentDetails" xlink:href="ppcb-20210930.xsd#ScheduleOfPropertyAndEquipmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/PropertyAndEquipmentDetailsNarrative" xlink:href="ppcb-20210930.xsd#PropertyAndEquipmentDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/DueToFormerDirector-RelatedPartyDetailsNarrative" xlink:href="ppcb-20210930.xsd#DueToFormerDirector-RelatedPartyDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/LoansAndNotesPayableDetailsNarrative" xlink:href="ppcb-20210930.xsd#LoansAndNotesPayableDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/ScheduleOfConvertibleNotesDetails" xlink:href="ppcb-20210930.xsd#ScheduleOfConvertibleNotesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/ConvertibleNotesDetailsNarrative" xlink:href="ppcb-20210930.xsd#ConvertibleNotesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/ScheduleOfIncomeTaxProvisionDetails" xlink:href="ppcb-20210930.xsd#ScheduleOfIncomeTaxProvisionDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:href="ppcb-20210930.xsd#ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/IncomeTaxesDetailsNarrative" xlink:href="ppcb-20210930.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/ScheduleOfStockOptionActivityDetails" xlink:href="ppcb-20210930.xsd#ScheduleOfStockOptionActivityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/ScheduleOfWarrantActivityDetails" xlink:href="ppcb-20210930.xsd#ScheduleOfWarrantActivityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/StockholdersDeficitDetailsNarrative" xlink:href="ppcb-20210930.xsd#StockholdersDeficitDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/ScheduleOfRightUseOfAssetDetails" xlink:href="ppcb-20210930.xsd#ScheduleOfRightUseOfAssetDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/ScheduleOfOperatingLeaseLiabilityDetails" xlink:href="ppcb-20210930.xsd#ScheduleOfOperatingLeaseLiabilityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="ppcb-20210930.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:href="ppcb-20210930.xsd#RelatedPartyTransactionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/ConcentrationsAndRisksDetailsNarrative" xlink:href="ppcb-20210930.xsd#ConcentrationsAndRisksDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/ScheduleOfFairValueMeasurementsRecurringAndNonrecurringValuationTechniquesDetails" xlink:href="ppcb-20210930.xsd#ScheduleOfFairValueMeasurementsRecurringAndNonrecurringValuationTechniquesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" xlink:href="ppcb-20210930.xsd#ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/ScheduleOfDerivativeLiabilitiesAtFairValueDetails" xlink:href="ppcb-20210930.xsd#ScheduleOfDerivativeLiabilitiesAtFairValueDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/DerivativeFinancialInstrumentsAndFairValueMeasurementsDetailsNarrative" xlink:href="ppcb-20210930.xsd#DerivativeFinancialInstrumentsAndFairValueMeasurementsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/SubsequentEventsDetailsNarrative" xlink:href="ppcb-20210930.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:calculationLink xlink:type="extended" xlink:role="http://propanc.com/role/Cover" xlink:title="00000001 - Document - Cover" />
    <link:calculationLink xlink:type="extended" xlink:role="http://propanc.com/role/BalanceSheets" xlink:title="00000002 - Statement - Condensed Consolidated Balance Sheets">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValueAddedTaxReceivableCurrent" xlink:label="loc_us-gaapValueAddedTaxReceivableCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapValueAddedTaxReceivableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepositsAssetsNoncurrent" xlink:label="loc_us-gaapDepositsAssetsNoncurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapDepositsAssetsNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndOtherAccruedLiabilitiesCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtCurrent" xlink:label="loc_us-gaapConvertibleDebtCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapConvertibleDebtCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationLiabilityCurrent" xlink:label="loc_us-gaapDeferredCompensationLiabilityCurrent" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapDeferredCompensationLiabilityCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueToRelatedPartiesCurrent" xlink:label="loc_us-gaapDueToRelatedPartiesCurrent" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapDueToRelatedPartiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_LoanFromFormerDirectorRelatedParty" xlink:label="loc_PPCBLoanFromFormerDirectorRelatedParty" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_PPCBLoanFromFormerDirectorRelatedParty" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaapEmployeeRelatedLiabilitiesCurrent" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapEmployeeRelatedLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_CommonStockIssuable" xlink:label="loc_PPCBCommonStockIssuable" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_PPCBCommonStockIssuable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteSubscriptionsReceivable" xlink:label="loc_us-gaapStockholdersEquityNoteSubscriptionsReceivable" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquityNoteSubscriptionsReceivable" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_us-gaapTreasuryStockValue" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapTreasuryStockValue" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaapCommitmentsAndContingencies" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapCommitmentsAndContingencies" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://propanc.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://propanc.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss" xlink:title="00000004 - Statement - Consolidated Statements of Operations and Comprehensive Income (Loss)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OccupancyNet" xlink:label="loc_us-gaapOccupancyNet" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapOccupancyNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapInterestExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="loc_us-gaapInvestmentIncomeInterest" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapInvestmentIncomeInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIncome" xlink:label="loc_us-gaapOtherIncome" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapOtherIncome" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet" xlink:label="loc_us-gaapDerivativeGainLossOnDerivativeNet" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapDerivativeGainLossOnDerivativeNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_GainFromSettlementOfDebtNet" xlink:label="loc_PPCBGainFromSettlementOfDebtNet" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_PPCBGainFromSettlementOfDebtNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:label="loc_us-gaapForeignCurrencyTransactionGainLossUnrealized" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapForeignCurrencyTransactionGainLossUnrealized" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapProfitLoss" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapProfitLoss" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_DeemedDividend" xlink:label="loc_PPCBDeemedDividend" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_PPCBDeemedDividend" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" xlink:label="loc_us-gaapOtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="loc_us-gaapOtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaapComprehensiveIncomeNetOfTax" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapComprehensiveIncomeNetOfTax" xlink:to="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapComprehensiveIncomeNetOfTax" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://propanc.com/role/StatementsOfChangesInStockholdersDeficit" xlink:title="00000005 - Statement - Consolidated Statements of Changes in Stockholders&apos; Deficit" />
    <link:calculationLink xlink:type="extended" xlink:role="http://propanc.com/role/StatementsOfCashFlows" xlink:title="00000006 - Statement - Consolidated Statements of Cash Flows">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:label="loc_us-gaapIssuanceOfStockAndWarrantsForServicesOrClaims" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIssuanceOfStockAndWarrantsForServicesOrClaims" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:label="loc_us-gaapForeignCurrencyTransactionGainLossUnrealized" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapForeignCurrencyTransactionGainLossUnrealized" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaapDepreciation" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapDepreciation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="loc_us-gaapAmortizationOfDebtDiscountPremium" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapAmortizationOfDebtDiscountPremium" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet" xlink:label="loc_us-gaapDerivativeGainLossOnDerivativeNet" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapDerivativeGainLossOnDerivativeNet" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_GainFromSettlementOfDebtNet" xlink:label="loc_PPCBGainFromSettlementOfDebtNet" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_PPCBGainFromSettlementOfDebtNet" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashExpense" xlink:label="loc_us-gaapOtherNoncashExpense" />
      <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapOtherNoncashExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:label="loc_us-gaapAccretionAmortizationOfDiscountsAndPremiumsInvestments" />
      <link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapAccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInReceivables" xlink:label="loc_us-gaapIncreaseDecreaseInReceivables" />
      <link:calculationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInReceivables" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
      <link:calculationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayable" />
      <link:calculationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_IncreaseDecreaseInDeferredRent" xlink:label="loc_PPCBIncreaseDecreaseInDeferredRent" />
      <link:calculationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_PPCBIncreaseDecreaseInDeferredRent" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInEmployeeRelatedLiabilities" />
      <link:calculationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInEmployeeRelatedLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" />
      <link:calculationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInterestPayableNet" xlink:label="loc_us-gaapIncreaseDecreaseInInterestPayableNet" />
      <link:calculationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInInterestPayableNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="loc_us-gaapProceedsFromConvertibleDebt" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromConvertibleDebt" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfConvertibleDebt" xlink:label="loc_us-gaapRepaymentsOfConvertibleDebt" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapRepaymentsOfConvertibleDebt" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfInitialPublicOffering" xlink:label="loc_us-gaapPaymentsForRepurchaseOfInitialPublicOffering" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapPaymentsForRepurchaseOfInitialPublicOffering" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="loc_us-gaapProceedsFromWarrantExercises" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromWarrantExercises" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="loc_us-gaapEffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapEffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://propanc.com/role/NatureOfOperationsAndSummaryOfSignificantAccountingAndReportingPolicies" xlink:title="00000007 - Disclosure - NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING AND REPORTING POLICIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://propanc.com/role/GoingConcern" xlink:title="00000008 - Disclosure - GOING CONCERN" />
    <link:calculationLink xlink:type="extended" xlink:role="http://propanc.com/role/PropertyAndEquipment" xlink:title="00000009 - Disclosure - PROPERTY AND EQUIPMENT" />
    <link:calculationLink xlink:type="extended" xlink:role="http://propanc.com/role/DueToFormerDirector-RelatedParty" xlink:title="00000010 - Disclosure - DUE TO FORMER DIRECTOR - RELATED PARTY" />
    <link:calculationLink xlink:type="extended" xlink:role="http://propanc.com/role/LoansAndNotesPayable" xlink:title="00000011 - Disclosure - LOANS AND NOTES PAYABLE" />
    <link:calculationLink xlink:type="extended" xlink:role="http://propanc.com/role/ConvertibleNotes" xlink:title="00000012 - Disclosure - CONVERTIBLE NOTES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://propanc.com/role/IncomeTaxes" xlink:title="00000013 - Disclosure - INCOME TAXES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://propanc.com/role/StockholdersDeficit" xlink:title="00000014 - Disclosure - STOCKHOLDERS&#8217; DEFICIT" />
    <link:calculationLink xlink:type="extended" xlink:role="http://propanc.com/role/CommitmentsAndContingencies" xlink:title="00000015 - Disclosure - COMMITMENTS AND CONTINGENCIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://propanc.com/role/RelatedPartyTransactions" xlink:title="00000016 - Disclosure - RELATED PARTY TRANSACTIONS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://propanc.com/role/ConcentrationsAndRisks" xlink:title="00000017 - Disclosure - CONCENTRATIONS AND RISKS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://propanc.com/role/DerivativeFinancialInstrumentsAndFairValueMeasurements" xlink:title="00000018 - Disclosure - DERIVATIVE FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://propanc.com/role/SubsequentEvents" xlink:title="00000019 - Disclosure - SUBSEQUENT EVENTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://propanc.com/role/NatureOfOperationsAndSummaryOfSignificantAccountingAndReportingPoliciesPolicies" xlink:title="00000020 - Disclosure - NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING AND REPORTING POLICIES (Policies)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://propanc.com/role/NatureOfOperationsAndSummaryOfSignificantAccountingAndReportingPoliciesTables" xlink:title="00000021 - Disclosure - NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING AND REPORTING POLICIES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://propanc.com/role/PropertyAndEquipmentTables" xlink:title="00000022 - Disclosure - PROPERTY AND EQUIPMENT (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://propanc.com/role/ConvertibleNotesTables" xlink:title="00000023 - Disclosure - CONVERTIBLE NOTES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://propanc.com/role/IncomeTaxesTables" xlink:title="00000024 - Disclosure - INCOME TAXES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://propanc.com/role/StockholdersDeficitTables" xlink:title="00000025 - Disclosure - STOCKHOLDERS&#8217; DEFICIT (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://propanc.com/role/CommitmentsAndContingenciesTables" xlink:title="00000026 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://propanc.com/role/DerivativeFinancialInstrumentsAndFairValueMeasurementsTables" xlink:title="00000027 - Disclosure - DERIVATIVE FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://propanc.com/role/ScheduleOfTranslationExchangeRatesDetails" xlink:title="00000028 - Disclosure - SCHEDULE OF TRANSLATION EXCHANGE RATES (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://propanc.com/role/ScheduleOfChangeInAccumulatedOtherComprehensiveIncomeLossDetails" xlink:title="00000029 - Disclosure - SCHEDULE OF CHANGE IN ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://propanc.com/role/ScheduleOfPropertyAndEquipmentEstimatedUsefulLivesDetails" xlink:title="00000030 - Disclosure - SCHEDULE OF PROPERTY AND EQUIPMENT ESTIMATED USEFUL LIVES (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://propanc.com/role/ScheduleOfDilutiveSecuritiesExcludedFromComputationDetails" xlink:title="00000031 - Disclosure - SCHEDULE OF DILUTIVE SECURITIES EXCLUDED FROM COMPUTATION (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://propanc.com/role/NatureOfOperationsAndSummaryOfSignificantAccountingAndReportingPoliciesDetailsNarrative" xlink:title="00000032 - Disclosure - NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING AND REPORTING POLICIES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://propanc.com/role/GoingConcernDetailsNarrative" xlink:title="00000033 - Disclosure - GOING CONCERN (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://propanc.com/role/ScheduleOfPropertyAndEquipmentDetails" xlink:title="00000034 - Disclosure - SCHEDULE OF PROPERTY AND EQUIPMENT (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://propanc.com/role/PropertyAndEquipmentDetailsNarrative" xlink:title="00000035 - Disclosure - PROPERTY AND EQUIPMENT (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://propanc.com/role/DueToFormerDirector-RelatedPartyDetailsNarrative" xlink:title="00000036 - Disclosure - DUE TO FORMER DIRECTOR - RELATED PARTY (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://propanc.com/role/LoansAndNotesPayableDetailsNarrative" xlink:title="00000037 - Disclosure - LOANS AND NOTES PAYABLE (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://propanc.com/role/ScheduleOfConvertibleNotesDetails" xlink:title="00000038 - Disclosure - SCHEDULE OF CONVERTIBLE NOTES (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt" xlink:label="loc_us-gaapLongTermDebt" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="loc_us-gaapDebtInstrumentCarryingAmount" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLongTermDebt" xlink:to="loc_us-gaapDebtInstrumentCarryingAmount" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:label="loc_us-gaapDebtInstrumentUnamortizedDiscount" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLongTermDebt" xlink:to="loc_us-gaapDebtInstrumentUnamortizedDiscount" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepositLiabilitiesAccruedInterest" xlink:label="loc_us-gaapDepositLiabilitiesAccruedInterest" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLongTermDebt" xlink:to="loc_us-gaapDepositLiabilitiesAccruedInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedPremium" xlink:label="loc_us-gaapDebtInstrumentUnamortizedPremium" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLongTermDebt" xlink:to="loc_us-gaapDebtInstrumentUnamortizedPremium" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://propanc.com/role/ConvertibleNotesDetailsNarrative" xlink:title="00000039 - Disclosure - CONVERTIBLE NOTES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://propanc.com/role/ScheduleOfIncomeTaxProvisionDetails" xlink:title="00000040 - Disclosure - SCHEDULE OF INCOME TAX PROVISION (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaapIncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapIncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapIncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapIncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" xlink:label="loc_us-gaapIncomeTaxReconciliationPriorYearIncomeTaxes" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapIncomeTaxReconciliationPriorYearIncomeTaxes" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:label="loc_us-gaapIncomeTaxReconciliationForeignIncomeTaxRateDifferential" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapIncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxCredits" xlink:label="loc_us-gaapIncomeTaxReconciliationTaxCredits" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapIncomeTaxReconciliationTaxCredits" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:label="loc_us-gaapIncomeTaxReconciliationOtherAdjustments" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapIncomeTaxReconciliationOtherAdjustments" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://propanc.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:title="00000041 - Disclosure - SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaapDeferredTaxAssetsGross" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_DeferredTaxAssetsWarrantDerivativeLiability" xlink:label="loc_PPCBDeferredTaxAssetsWarrantDerivativeLiability" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_PPCBDeferredTaxAssetsWarrantDerivativeLiability" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:label="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_DeferredTaxAssetsPrepaidInvestorServices" xlink:label="loc_PPCBDeferredTaxAssetsPrepaidInvestorServices" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_PPCBDeferredTaxAssetsPrepaidInvestorServices" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_DeferredTaxAssetsNonCashInterest" xlink:label="loc_PPCBDeferredTaxAssetsNonCashInterest" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_PPCBDeferredTaxAssetsNonCashInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:label="loc_us-gaapDeferredTaxAssetsGoodwillAndIntangibleAssets" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent" xlink:label="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" xlink:label="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseOther" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseOther" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_DeferredTaxAssetsForeignExchangeLoss" xlink:label="loc_PPCBDeferredTaxAssetsForeignExchangeLoss" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_PPCBDeferredTaxAssetsForeignExchangeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_DeferredTaxAssetsRevalueOfDerivativeLiability" xlink:label="loc_PPCBDeferredTaxAssetsRevalueOfDerivativeLiability" />
      <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_PPCBDeferredTaxAssetsRevalueOfDerivativeLiability" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" />
      <link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:label="loc_us-gaapDeferredIncomeTaxLiabilities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts" xlink:label="loc_us-gaapDeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredIncomeTaxLiabilities" xlink:to="loc_us-gaapDeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_DeferredTaxLiabilitiesGainOnExtinguishmentOfDebt" xlink:label="loc_PPCBDeferredTaxLiabilitiesGainOnExtinguishmentOfDebt" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredIncomeTaxLiabilities" xlink:to="loc_PPCBDeferredTaxLiabilitiesGainOnExtinguishmentOfDebt" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts" xlink:label="loc_us-gaapDeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredIncomeTaxLiabilities" xlink:to="loc_us-gaapDeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaapDeferredTaxAssetsNet" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsNet" xlink:to="loc_us-gaapDeferredTaxAssetsGross" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsNet" xlink:to="loc_us-gaapDeferredIncomeTaxLiabilities" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="loc_us-gaapDeferredTaxAssetsLiabilitiesNet" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsLiabilitiesNet" xlink:to="loc_us-gaapDeferredTaxAssetsNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapDeferredTaxAssetsValuationAllowance" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsLiabilitiesNet" xlink:to="loc_us-gaapDeferredTaxAssetsValuationAllowance" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://propanc.com/role/IncomeTaxesDetailsNarrative" xlink:title="00000042 - Disclosure - INCOME TAXES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://propanc.com/role/ScheduleOfStockOptionActivityDetails" xlink:title="00000043 - Disclosure - SCHEDULE OF STOCK OPTION ACTIVITY (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://propanc.com/role/ScheduleOfWarrantActivityDetails" xlink:title="00000044 - Disclosure - SCHEDULE OF WARRANT ACTIVITY (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://propanc.com/role/StockholdersDeficitDetailsNarrative" xlink:title="00000045 - Disclosure - STOCKHOLDERS&#8217; DEFICIT (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://propanc.com/role/ScheduleOfRightUseOfAssetDetails" xlink:title="00000046 - Disclosure - SCHEDULE OF RIGHT USE OF ASSET (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_OperatingLeaseRightOfUseAssets" xlink:label="loc_PPCBOperatingLeaseRightOfUseAssets" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingLeaseRightOfUseAsset" xlink:to="loc_PPCBOperatingLeaseRightOfUseAssets" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_AccumulatedReduction" xlink:label="loc_PPCBAccumulatedReduction" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingLeaseRightOfUseAsset" xlink:to="loc_PPCBAccumulatedReduction" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://propanc.com/role/ScheduleOfOperatingLeaseLiabilityDetails" xlink:title="00000047 - Disclosure - SCHEDULE OF OPERATING LEASE LIABILITY (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaapOperatingLeaseLiability" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_OfficeLeaseLiability" xlink:label="loc_PPCBOfficeLeaseLiability" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingLeaseLiability" xlink:to="loc_PPCBOfficeLeaseLiability" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_ReductionOfLeaseLiability" xlink:label="loc_PPCBReductionOfLeaseLiability" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingLeaseLiability" xlink:to="loc_PPCBReductionOfLeaseLiability" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://propanc.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="00000048 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://propanc.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:title="00000049 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://propanc.com/role/ConcentrationsAndRisksDetailsNarrative" xlink:title="00000050 - Disclosure - CONCENTRATIONS AND RISKS (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://propanc.com/role/ScheduleOfFairValueMeasurementsRecurringAndNonrecurringValuationTechniquesDetails" xlink:title="00000051 - Disclosure - SCHEDULE OF FAIR VALUE MEASUREMENTS, RECURRING AND NONRECURRING, VALUATION TECHNIQUES (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://propanc.com/role/ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" xlink:title="00000052 - Disclosure - SCHEDULE OF FAIR VALUE, ASSETS AND LIABILITIES MEASURED ON RECURRING BASIS (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://propanc.com/role/ScheduleOfDerivativeLiabilitiesAtFairValueDetails" xlink:title="00000053 - Disclosure - SCHEDULE OF DERIVATIVE LIABILITIES AT FAIR VALUE (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://propanc.com/role/DerivativeFinancialInstrumentsAndFairValueMeasurementsDetailsNarrative" xlink:title="00000054 - Disclosure - DERIVATIVE FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://propanc.com/role/SubsequentEventsDetailsNarrative" xlink:title="00000055 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>6
<FILENAME>ppcb-20210930_def.xml
<DESCRIPTION>INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.11a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://propanc.com/role/Cover" xlink:href="ppcb-20210930.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/BalanceSheets" xlink:href="ppcb-20210930.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/BalanceSheetsParenthetical" xlink:href="ppcb-20210930.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss" xlink:href="ppcb-20210930.xsd#StatementsOfOperationsAndComprehensiveIncomeLoss" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/StatementsOfChangesInStockholdersDeficit" xlink:href="ppcb-20210930.xsd#StatementsOfChangesInStockholdersDeficit" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/StatementsOfCashFlows" xlink:href="ppcb-20210930.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/NatureOfOperationsAndSummaryOfSignificantAccountingAndReportingPolicies" xlink:href="ppcb-20210930.xsd#NatureOfOperationsAndSummaryOfSignificantAccountingAndReportingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/GoingConcern" xlink:href="ppcb-20210930.xsd#GoingConcern" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/PropertyAndEquipment" xlink:href="ppcb-20210930.xsd#PropertyAndEquipment" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/DueToFormerDirector-RelatedParty" xlink:href="ppcb-20210930.xsd#DueToFormerDirector-RelatedParty" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/LoansAndNotesPayable" xlink:href="ppcb-20210930.xsd#LoansAndNotesPayable" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/ConvertibleNotes" xlink:href="ppcb-20210930.xsd#ConvertibleNotes" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/IncomeTaxes" xlink:href="ppcb-20210930.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/StockholdersDeficit" xlink:href="ppcb-20210930.xsd#StockholdersDeficit" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/CommitmentsAndContingencies" xlink:href="ppcb-20210930.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/RelatedPartyTransactions" xlink:href="ppcb-20210930.xsd#RelatedPartyTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/ConcentrationsAndRisks" xlink:href="ppcb-20210930.xsd#ConcentrationsAndRisks" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/DerivativeFinancialInstrumentsAndFairValueMeasurements" xlink:href="ppcb-20210930.xsd#DerivativeFinancialInstrumentsAndFairValueMeasurements" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/SubsequentEvents" xlink:href="ppcb-20210930.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/NatureOfOperationsAndSummaryOfSignificantAccountingAndReportingPoliciesPolicies" xlink:href="ppcb-20210930.xsd#NatureOfOperationsAndSummaryOfSignificantAccountingAndReportingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/NatureOfOperationsAndSummaryOfSignificantAccountingAndReportingPoliciesTables" xlink:href="ppcb-20210930.xsd#NatureOfOperationsAndSummaryOfSignificantAccountingAndReportingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/PropertyAndEquipmentTables" xlink:href="ppcb-20210930.xsd#PropertyAndEquipmentTables" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/ConvertibleNotesTables" xlink:href="ppcb-20210930.xsd#ConvertibleNotesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/IncomeTaxesTables" xlink:href="ppcb-20210930.xsd#IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/StockholdersDeficitTables" xlink:href="ppcb-20210930.xsd#StockholdersDeficitTables" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/CommitmentsAndContingenciesTables" xlink:href="ppcb-20210930.xsd#CommitmentsAndContingenciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/DerivativeFinancialInstrumentsAndFairValueMeasurementsTables" xlink:href="ppcb-20210930.xsd#DerivativeFinancialInstrumentsAndFairValueMeasurementsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/ScheduleOfTranslationExchangeRatesDetails" xlink:href="ppcb-20210930.xsd#ScheduleOfTranslationExchangeRatesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/ScheduleOfChangeInAccumulatedOtherComprehensiveIncomeLossDetails" xlink:href="ppcb-20210930.xsd#ScheduleOfChangeInAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/ScheduleOfPropertyAndEquipmentEstimatedUsefulLivesDetails" xlink:href="ppcb-20210930.xsd#ScheduleOfPropertyAndEquipmentEstimatedUsefulLivesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/ScheduleOfDilutiveSecuritiesExcludedFromComputationDetails" xlink:href="ppcb-20210930.xsd#ScheduleOfDilutiveSecuritiesExcludedFromComputationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/NatureOfOperationsAndSummaryOfSignificantAccountingAndReportingPoliciesDetailsNarrative" xlink:href="ppcb-20210930.xsd#NatureOfOperationsAndSummaryOfSignificantAccountingAndReportingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/GoingConcernDetailsNarrative" xlink:href="ppcb-20210930.xsd#GoingConcernDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/ScheduleOfPropertyAndEquipmentDetails" xlink:href="ppcb-20210930.xsd#ScheduleOfPropertyAndEquipmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/PropertyAndEquipmentDetailsNarrative" xlink:href="ppcb-20210930.xsd#PropertyAndEquipmentDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/DueToFormerDirector-RelatedPartyDetailsNarrative" xlink:href="ppcb-20210930.xsd#DueToFormerDirector-RelatedPartyDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/LoansAndNotesPayableDetailsNarrative" xlink:href="ppcb-20210930.xsd#LoansAndNotesPayableDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/ScheduleOfConvertibleNotesDetails" xlink:href="ppcb-20210930.xsd#ScheduleOfConvertibleNotesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/ConvertibleNotesDetailsNarrative" xlink:href="ppcb-20210930.xsd#ConvertibleNotesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/ScheduleOfIncomeTaxProvisionDetails" xlink:href="ppcb-20210930.xsd#ScheduleOfIncomeTaxProvisionDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:href="ppcb-20210930.xsd#ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/IncomeTaxesDetailsNarrative" xlink:href="ppcb-20210930.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/ScheduleOfStockOptionActivityDetails" xlink:href="ppcb-20210930.xsd#ScheduleOfStockOptionActivityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/ScheduleOfWarrantActivityDetails" xlink:href="ppcb-20210930.xsd#ScheduleOfWarrantActivityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/StockholdersDeficitDetailsNarrative" xlink:href="ppcb-20210930.xsd#StockholdersDeficitDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/ScheduleOfRightUseOfAssetDetails" xlink:href="ppcb-20210930.xsd#ScheduleOfRightUseOfAssetDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/ScheduleOfOperatingLeaseLiabilityDetails" xlink:href="ppcb-20210930.xsd#ScheduleOfOperatingLeaseLiabilityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="ppcb-20210930.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:href="ppcb-20210930.xsd#RelatedPartyTransactionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/ConcentrationsAndRisksDetailsNarrative" xlink:href="ppcb-20210930.xsd#ConcentrationsAndRisksDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/ScheduleOfFairValueMeasurementsRecurringAndNonrecurringValuationTechniquesDetails" xlink:href="ppcb-20210930.xsd#ScheduleOfFairValueMeasurementsRecurringAndNonrecurringValuationTechniquesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" xlink:href="ppcb-20210930.xsd#ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/ScheduleOfDerivativeLiabilitiesAtFairValueDetails" xlink:href="ppcb-20210930.xsd#ScheduleOfDerivativeLiabilitiesAtFairValueDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/DerivativeFinancialInstrumentsAndFairValueMeasurementsDetailsNarrative" xlink:href="ppcb-20210930.xsd#DerivativeFinancialInstrumentsAndFairValueMeasurementsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/SubsequentEventsDetailsNarrative" xlink:href="ppcb-20210930.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://propanc.com/role/Cover" xlink:title="00000001 - Document - Cover" />
    <link:definitionLink xlink:type="extended" xlink:role="http://propanc.com/role/BalanceSheets" xlink:title="00000002 - Statement - Condensed Consolidated Balance Sheets">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="loc_us-gaapSeriesAPreferredStockMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesAPreferredStockMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="loc_us-gaapSeriesBPreferredStockMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesBPreferredStockMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaapAssetsAbstract_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAssetsAbstract_100" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsAbstract_100" xlink:to="loc_us-gaapAssetsCurrentAbstract_100" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_100" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue_100" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_100" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent_100" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValueAddedTaxReceivableCurrent" xlink:label="loc_us-gaapValueAddedTaxReceivableCurrent_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_100" xlink:to="loc_us-gaapValueAddedTaxReceivableCurrent_100" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_100" xlink:to="loc_us-gaapAssetsCurrent_100" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepositsAssetsNoncurrent" xlink:label="loc_us-gaapDepositsAssetsNoncurrent_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsAbstract_100" xlink:to="loc_us-gaapDepositsAssetsNoncurrent_100" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsAbstract_100" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset_100" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsAbstract_100" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet_100" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsAbstract_100" xlink:to="loc_us-gaapAssets_100" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_100" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_100" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract_100" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_100" xlink:to="loc_us-gaapAccountsPayableCurrent_100" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndOtherAccruedLiabilitiesCurrent_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_100" xlink:to="loc_us-gaapAccountsPayableAndOtherAccruedLiabilitiesCurrent_100" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtCurrent" xlink:label="loc_us-gaapConvertibleDebtCurrent_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_100" xlink:to="loc_us-gaapConvertibleDebtCurrent_100" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_100" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent_100" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationLiabilityCurrent" xlink:label="loc_us-gaapDeferredCompensationLiabilityCurrent_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_100" xlink:to="loc_us-gaapDeferredCompensationLiabilityCurrent_100" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueToRelatedPartiesCurrent" xlink:label="loc_us-gaapDueToRelatedPartiesCurrent_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_100" xlink:to="loc_us-gaapDueToRelatedPartiesCurrent_100" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_LoanFromFormerDirectorRelatedParty" xlink:label="loc_PPCBLoanFromFormerDirectorRelatedParty_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_100" xlink:to="loc_PPCBLoanFromFormerDirectorRelatedParty_100" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaapEmployeeRelatedLiabilitiesCurrent_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_100" xlink:to="loc_us-gaapEmployeeRelatedLiabilitiesCurrent_100" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_100" xlink:to="loc_us-gaapLiabilitiesCurrent_100" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_100" xlink:to="loc_us-gaapLiabilities_100" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaapCommitmentsAndContingencies_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_100" xlink:to="loc_us-gaapCommitmentsAndContingencies_100" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_100" xlink:to="loc_us-gaapStockholdersEquityAbstract_100" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_100" xlink:to="loc_us-gaapPreferredStockValue_100" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_100" xlink:to="loc_us-gaapCommonStockValue_100" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_CommonStockIssuable" xlink:label="loc_PPCBCommonStockIssuable_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_100" xlink:to="loc_PPCBCommonStockIssuable_100" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_100" xlink:to="loc_us-gaapAdditionalPaidInCapital_100" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteSubscriptionsReceivable" xlink:label="loc_us-gaapStockholdersEquityNoteSubscriptionsReceivable_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_100" xlink:to="loc_us-gaapStockholdersEquityNoteSubscriptionsReceivable_100" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_100" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax_100" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_100" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit_100" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_us-gaapTreasuryStockValue_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_100" xlink:to="loc_us-gaapTreasuryStockValue_100" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_100" xlink:to="loc_us-gaapStockholdersEquity_100" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_100" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity_100" xlink:type="arc" order="33" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://propanc.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="loc_us-gaapSeriesAPreferredStockMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesAPreferredStockMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="loc_us-gaapSeriesBPreferredStockMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesBPreferredStockMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized_100" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare_100" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesIssued_100" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesOutstanding_100" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare_100" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized_100" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued_100" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding_100" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_CommonStockIssuableShares" xlink:label="loc_PPCBCommonStockIssuableShares_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_PPCBCommonStockIssuableShares_100" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares" xlink:label="loc_us-gaapTreasuryStockShares_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTreasuryStockShares_100" xlink:type="arc" order="9" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://propanc.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss" xlink:title="00000004 - Statement - Consolidated Statements of Operations and Comprehensive Income (Loss)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://propanc.com/role/StatementsOfChangesInStockholdersDeficit" xlink:title="00000005 - Statement - Consolidated Statements of Changes in Stockholders&apos; Deficit">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="loc_us-gaapSeriesAPreferredStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesAPreferredStockMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="loc_us-gaapSeriesBPreferredStockMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesBPreferredStockMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaapPreferredStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapPreferredStockMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_CommonStockIssuableMember" xlink:label="loc_PPCBCommonStockIssuableMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_PPCBCommonStockIssuableMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapRetainedEarningsMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember" xlink:label="loc_us-gaapTreasuryStockMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapTreasuryStockMember_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_SubscriptionReceivableMember" xlink:label="loc_PPCBSubscriptionReceivableMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_PPCBSubscriptionReceivableMember_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity_110" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding_110" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_110" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_110" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueConversionOfConvertibleSecurities_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueConversionOfConvertibleSecurities_110" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_110" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_ReversalOfCommonStockIssuableDueToCancellationOfConversionsOfConvertibleDebtAndAccruedInterest" xlink:label="loc_PPCBReversalOfCommonStockIssuableDueToCancellationOfConversionsOfConvertibleDebtAndAccruedInterest_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_PPCBReversalOfCommonStockIssuableDueToCancellationOfConversionsOfConvertibleDebtAndAccruedInterest_110" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_ReversalOfCommonStockIssuableDueToCancellationOfConversionsOfConvertibleDebtAndAccruedInterestShares" xlink:label="loc_PPCBReversalOfCommonStockIssuableDueToCancellationOfConversionsOfConvertibleDebtAndAccruedInterestShares_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_PPCBReversalOfCommonStockIssuableDueToCancellationOfConversionsOfConvertibleDebtAndAccruedInterestShares_110" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_StockIssuedDuringPeriodValueExerciseOfWarrants" xlink:label="loc_PPCBStockIssuedDuringPeriodValueExerciseOfWarrants_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_PPCBStockIssuedDuringPeriodValueExerciseOfWarrants_110" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_StockIssuedDuringPeriodSharesExerciseOfWarrants" xlink:label="loc_PPCBStockIssuedDuringPeriodSharesExerciseOfWarrants_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_PPCBStockIssuedDuringPeriodSharesExerciseOfWarrants_110" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_IssuanceOfCommonStockForCashlessExerciseOfWarrants" xlink:label="loc_PPCBIssuanceOfCommonStockForCashlessExerciseOfWarrants_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_PPCBIssuanceOfCommonStockForCashlessExerciseOfWarrants_110" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_IssuanceOfCommonStockForCashlessExerciseOfWarrantsShares" xlink:label="loc_PPCBIssuanceOfCommonStockForCashlessExerciseOfWarrantsShares_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_PPCBIssuanceOfCommonStockForCashlessExerciseOfWarrantsShares_110" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature_110" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_110" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_110" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_StockIssuedDuringPeriodValueReverseStockSplits" xlink:label="loc_PPCBStockIssuedDuringPeriodValueReverseStockSplits_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_PPCBStockIssuedDuringPeriodValueReverseStockSplits_110" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesReverseStockSplits_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesReverseStockSplits_110" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_DeemedDividendUponAlternateCashlessExerciseOfWarrants" xlink:label="loc_PPCBDeemedDividendUponAlternateCashlessExerciseOfWarrants_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_PPCBDeemedDividendUponAlternateCashlessExerciseOfWarrants_110" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_IssuanceOfCommonStockForAlternateCashlessExerciseOfWarrants" xlink:label="loc_PPCBIssuanceOfCommonStockForAlternateCashlessExerciseOfWarrants_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_PPCBIssuanceOfCommonStockForAlternateCashlessExerciseOfWarrants_110" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_IssuanceOfCommonStockForAlternateCashlessExerciseOfWarrantsShares" xlink:label="loc_PPCBIssuanceOfCommonStockForAlternateCashlessExerciseOfWarrantsShares_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_PPCBIssuanceOfCommonStockForAlternateCashlessExerciseOfWarrantsShares_110" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_AdjustmentsToAdditionalPaidInCapitalReclassificationOfPremiumUponDebtConversion" xlink:label="loc_PPCBAdjustmentsToAdditionalPaidInCapitalReclassificationOfPremiumUponDebtConversion_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_PPCBAdjustmentsToAdditionalPaidInCapitalReclassificationOfPremiumUponDebtConversion_110" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices_110" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_110" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_RelativeFairValueOfWarrantsIssuedWithConvertibleDebt" xlink:label="loc_PPCBRelativeFairValueOfWarrantsIssuedWithConvertibleDebt_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_PPCBRelativeFairValueOfWarrantsIssuedWithConvertibleDebt_110" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_110" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalWarrantIssued_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalWarrantIssued_110" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:label="loc_us-gaapForeignCurrencyTransactionGainLossBeforeTax_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapForeignCurrencyTransactionGainLossBeforeTax_110" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProfitLoss_110" xlink:type="arc" order="28" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://propanc.com/role/StatementsOfCashFlows" xlink:title="00000006 - Statement - Consolidated Statements of Cash Flows" />
    <link:definitionLink xlink:type="extended" xlink:role="http://propanc.com/role/NatureOfOperationsAndSummaryOfSignificantAccountingAndReportingPolicies" xlink:title="00000007 - Disclosure - NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING AND REPORTING POLICIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://propanc.com/role/GoingConcern" xlink:title="00000008 - Disclosure - GOING CONCERN" />
    <link:definitionLink xlink:type="extended" xlink:role="http://propanc.com/role/PropertyAndEquipment" xlink:title="00000009 - Disclosure - PROPERTY AND EQUIPMENT" />
    <link:definitionLink xlink:type="extended" xlink:role="http://propanc.com/role/DueToFormerDirector-RelatedParty" xlink:title="00000010 - Disclosure - DUE TO FORMER DIRECTOR - RELATED PARTY" />
    <link:definitionLink xlink:type="extended" xlink:role="http://propanc.com/role/LoansAndNotesPayable" xlink:title="00000011 - Disclosure - LOANS AND NOTES PAYABLE" />
    <link:definitionLink xlink:type="extended" xlink:role="http://propanc.com/role/ConvertibleNotes" xlink:title="00000012 - Disclosure - CONVERTIBLE NOTES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://propanc.com/role/IncomeTaxes" xlink:title="00000013 - Disclosure - INCOME TAXES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://propanc.com/role/StockholdersDeficit" xlink:title="00000014 - Disclosure - STOCKHOLDERS&#8217; DEFICIT" />
    <link:definitionLink xlink:type="extended" xlink:role="http://propanc.com/role/CommitmentsAndContingencies" xlink:title="00000015 - Disclosure - COMMITMENTS AND CONTINGENCIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://propanc.com/role/RelatedPartyTransactions" xlink:title="00000016 - Disclosure - RELATED PARTY TRANSACTIONS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://propanc.com/role/ConcentrationsAndRisks" xlink:title="00000017 - Disclosure - CONCENTRATIONS AND RISKS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://propanc.com/role/DerivativeFinancialInstrumentsAndFairValueMeasurements" xlink:title="00000018 - Disclosure - DERIVATIVE FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://propanc.com/role/SubsequentEvents" xlink:title="00000019 - Disclosure - SUBSEQUENT EVENTS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://propanc.com/role/NatureOfOperationsAndSummaryOfSignificantAccountingAndReportingPoliciesPolicies" xlink:title="00000020 - Disclosure - NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING AND REPORTING POLICIES (Policies)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://propanc.com/role/NatureOfOperationsAndSummaryOfSignificantAccountingAndReportingPoliciesTables" xlink:title="00000021 - Disclosure - NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING AND REPORTING POLICIES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://propanc.com/role/PropertyAndEquipmentTables" xlink:title="00000022 - Disclosure - PROPERTY AND EQUIPMENT (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://propanc.com/role/ConvertibleNotesTables" xlink:title="00000023 - Disclosure - CONVERTIBLE NOTES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://propanc.com/role/IncomeTaxesTables" xlink:title="00000024 - Disclosure - INCOME TAXES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://propanc.com/role/StockholdersDeficitTables" xlink:title="00000025 - Disclosure - STOCKHOLDERS&#8217; DEFICIT (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://propanc.com/role/CommitmentsAndContingenciesTables" xlink:title="00000026 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://propanc.com/role/DerivativeFinancialInstrumentsAndFairValueMeasurementsTables" xlink:title="00000027 - Disclosure - DERIVATIVE FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://propanc.com/role/ScheduleOfTranslationExchangeRatesDetails" xlink:title="00000028 - Disclosure - SCHEDULE OF TRANSLATION EXCHANGE RATES (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_WeightedAverageMember" xlink:label="loc_srtWeightedAverageMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtWeightedAverageMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyExchangeRateTranslation1" xlink:label="loc_us-gaapForeignCurrencyExchangeRateTranslation1_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapForeignCurrencyExchangeRateTranslation1_70" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://propanc.com/role/ScheduleOfChangeInAccumulatedOtherComprehensiveIncomeLossDetails" xlink:title="00000029 - Disclosure - SCHEDULE OF CHANGE IN ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://propanc.com/role/ScheduleOfPropertyAndEquipmentEstimatedUsefulLivesDetails" xlink:title="00000030 - Disclosure - SCHEDULE OF PROPERTY AND EQUIPMENT ESTIMATED USEFUL LIVES (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MachineryAndEquipmentMember" xlink:label="loc_us-gaapMachineryAndEquipmentMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapMachineryAndEquipmentMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaapFurnitureAndFixturesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapFurnitureAndFixturesMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="loc_us-gaapPropertyPlantAndEquipmentUsefulLife_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentUsefulLife_50" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://propanc.com/role/ScheduleOfDilutiveSecuritiesExcludedFromComputationDetails" xlink:title="00000031 - Disclosure - SCHEDULE OF DILUTIVE SECURITIES EXCLUDED FROM COMPUTATION (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaapAntidilutiveSecuritiesNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaapAntidilutiveSecuritiesNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="loc_us-gaapAntidilutiveSecuritiesNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaapEmployeeStockOptionMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_us-gaapEmployeeStockOptionMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_us-gaapWarrantMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_UnvestedRestrictedStockMember" xlink:label="loc_PPCBUnvestedRestrictedStockMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_PPCBUnvestedRestrictedStockMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtSecuritiesMember" xlink:label="loc_us-gaapConvertibleDebtSecuritiesMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_us-gaapConvertibleDebtSecuritiesMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_210" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://propanc.com/role/NatureOfOperationsAndSummaryOfSignificantAccountingAndReportingPoliciesDetailsNarrative" xlink:title="00000032 - Disclosure - NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING AND REPORTING POLICIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtLineItems" xlink:label="loc_us-gaapShortTermDebtLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShortTermDebtTable" xlink:label="loc_us-gaapScheduleOfShortTermDebtTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapScheduleOfShortTermDebtTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapDebtInstrumentAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_IntercompanyLoansMember" xlink:label="loc_PPCBIntercompanyLoansMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_PPCBIntercompanyLoansMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_TwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember" xlink:label="loc_PPCBTwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_PPCBTwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember_130" xlink:type="arc" order="131" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationDateOfIncorporation" xlink:label="loc_deiEntityIncorporationDateOfIncorporation_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_deiEntityIncorporationDateOfIncorporation_150" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityReverseStockSplit" xlink:label="loc_us-gaapStockholdersEquityReverseStockSplit_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapStockholdersEquityReverseStockSplit_150" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" xlink:label="loc_us-gaapOtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapOtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_150" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashEquivalentsAtCarryingValue_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapCashEquivalentsAtCarryingValue_150" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValueAddedTaxReceivableCurrent" xlink:label="loc_us-gaapValueAddedTaxReceivableCurrent_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapValueAddedTaxReceivableCurrent_150" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapResearchAndDevelopmentExpense_150" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit_150" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleTermsOfConversionFeature" xlink:label="loc_us-gaapDebtInstrumentConvertibleTermsOfConversionFeature_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentConvertibleTermsOfConversionFeature_150" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:label="loc_us-gaapDebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_150" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaapEquityMethodInvestmentOwnershipPercentage_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentOwnershipPercentage_150" xlink:type="arc" order="27" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://propanc.com/role/GoingConcernDetailsNarrative" xlink:title="00000033 - Disclosure - GOING CONCERN (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://propanc.com/role/ScheduleOfPropertyAndEquipmentDetails" xlink:title="00000034 - Disclosure - SCHEDULE OF PROPERTY AND EQUIPMENT (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://propanc.com/role/PropertyAndEquipmentDetailsNarrative" xlink:title="00000035 - Disclosure - PROPERTY AND EQUIPMENT (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://propanc.com/role/DueToFormerDirector-RelatedPartyDetailsNarrative" xlink:title="00000036 - Disclosure - DUE TO FORMER DIRECTOR - RELATED PARTY (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://propanc.com/role/LoansAndNotesPayableDetailsNarrative" xlink:title="00000037 - Disclosure - LOANS AND NOTES PAYABLE (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:label="loc_us-gaapDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:label="loc_us-gaapScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="loc_us-gaapScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_DirectorsAndOfficerMember" xlink:label="loc_PPCBDirectorsAndOfficerMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_PPCBDirectorsAndOfficerMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LoansPayable" xlink:label="loc_us-gaapLoansPayable_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="loc_us-gaapLoansPayable_40" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://propanc.com/role/ScheduleOfConvertibleNotesDetails" xlink:title="00000038 - Disclosure - SCHEDULE OF CONVERTIBLE NOTES (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://propanc.com/role/ConvertibleNotesDetailsNarrative" xlink:title="00000039 - Disclosure - CONVERTIBLE NOTES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtLineItems" xlink:label="loc_us-gaapShortTermDebtLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShortTermDebtTable" xlink:label="loc_us-gaapScheduleOfShortTermDebtTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapScheduleOfShortTermDebtTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_DecemberTwentyNineTwoThousandAndSeventeenSecuritiesPurchaseAgreementMember" xlink:label="loc_PPCBDecemberTwentyNineTwoThousandAndSeventeenSecuritiesPurchaseAgreementMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_PPCBDecemberTwentyNineTwoThousandAndSeventeenSecuritiesPurchaseAgreementMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_DecemberTwentyNineTwoThousandAndSixteenSecuritiesPurchaseAgreementMember" xlink:label="loc_PPCBDecemberTwentyNineTwoThousandAndSixteenSecuritiesPurchaseAgreementMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_PPCBDecemberTwentyNineTwoThousandAndSixteenSecuritiesPurchaseAgreementMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_JulyThirteenTwoThousandAndEighteenSecuritiesPurchaseAgreementMember" xlink:label="loc_PPCBJulyThirteenTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_PPCBJulyThirteenTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_JuneTwentyNineTwoThousandEighteenSecuritiesPurchaseAgreementMember" xlink:label="loc_PPCBJuneTwentyNineTwoThousandEighteenSecuritiesPurchaseAgreementMember_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_PPCBJuneTwentyNineTwoThousandEighteenSecuritiesPurchaseAgreementMember_150" xlink:type="arc" order="151" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_AugustTwentyNineTwoThousandandEighteenSecuritiesPurchaseAgreementMember" xlink:label="loc_PPCBAugustTwentyNineTwoThousandandEighteenSecuritiesPurchaseAgreementMember_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_PPCBAugustTwentyNineTwoThousandandEighteenSecuritiesPurchaseAgreementMember_160" xlink:type="arc" order="161" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember" xlink:label="loc_PPCBOctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_PPCBOctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_190" xlink:type="arc" order="191" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_NovembeThirtyTwoThousandAndEighteenMecuritiesPurchaseAgreementMember" xlink:label="loc_PPCBNovembeThirtyTwoThousandAndEighteenMecuritiesPurchaseAgreementMember_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_PPCBNovembeThirtyTwoThousandAndEighteenMecuritiesPurchaseAgreementMember_220" xlink:type="arc" order="221" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember" xlink:label="loc_PPCBDecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_PPCBDecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_250" xlink:type="arc" order="251" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_SecuritiesPurchaseAgreementOneMember" xlink:label="loc_PPCBSecuritiesPurchaseAgreementOneMember_340" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_PPCBSecuritiesPurchaseAgreementOneMember_340" xlink:type="arc" order="341" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_SecuritiesPurchaseAgreementMember" xlink:label="loc_PPCBSecuritiesPurchaseAgreementMember_410" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_PPCBSecuritiesPurchaseAgreementMember_410" xlink:type="arc" order="411" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_AugustTenTwoThousandAndSeventeenConsultingAgreementMember" xlink:label="loc_PPCBAugustTenTwoThousandAndSeventeenConsultingAgreementMember_490" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_PPCBAugustTenTwoThousandAndSeventeenConsultingAgreementMember_490" xlink:type="arc" order="491" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_NovemberTwentySixTwoThousandNineteenSecuritiesPurchaseAgreementMember" xlink:label="loc_PPCBNovemberTwentySixTwoThousandNineteenSecuritiesPurchaseAgreementMember_610" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_PPCBNovemberTwentySixTwoThousandNineteenSecuritiesPurchaseAgreementMember_610" xlink:type="arc" order="611" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_JanuarySevenTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember" xlink:label="loc_PPCBJanuarySevenTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember_640" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_PPCBJanuarySevenTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember_640" xlink:type="arc" order="641" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember" xlink:label="loc_PPCBMarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember_670" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_PPCBMarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember_670" xlink:type="arc" order="671" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_RedstartHoldingsCorpFinancingAgreementMember" xlink:label="loc_PPCBRedstartHoldingsCorpFinancingAgreementMember_740" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_PPCBRedstartHoldingsCorpFinancingAgreementMember_740" xlink:type="arc" order="741" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_AuctusFinancingAgreementMember" xlink:label="loc_PPCBAuctusFinancingAgreementMember_1590" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_PPCBAuctusFinancingAgreementMember_1590" xlink:type="arc" order="1591" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_GenevaRothFinancingAgreementAgreementMember" xlink:label="loc_PPCBGenevaRothFinancingAgreementAgreementMember_1830" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_PPCBGenevaRothFinancingAgreementAgreementMember_1830" xlink:type="arc" order="1831" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_EagleEquitiesLLCMember" xlink:label="loc_PPCBEagleEquitiesLLCMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_PPCBEagleEquitiesLLCMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_DepositoryTrustCompanyMember" xlink:label="loc_PPCBDepositoryTrustCompanyMember_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_PPCBDepositoryTrustCompanyMember_300" xlink:type="arc" order="302" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_GSCapitalPartnersLLCMember" xlink:label="loc_PPCBGSCapitalPartnersLLCMember_360" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_PPCBGSCapitalPartnersLLCMember_360" xlink:type="arc" order="362" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_RedstartHoldingsCorpMember" xlink:label="loc_PPCBRedstartHoldingsCorpMember_740" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_PPCBRedstartHoldingsCorpMember_740" xlink:type="arc" order="742" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_OdysseyCapitalFundingLLCMember" xlink:label="loc_PPCBOdysseyCapitalFundingLLCMember_790" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_PPCBOdysseyCapitalFundingLLCMember_790" xlink:type="arc" order="792" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_AuctusFundLLCMember" xlink:label="loc_PPCBAuctusFundLLCMember_860" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_PPCBAuctusFundLLCMember_860" xlink:type="arc" order="862" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_GWHoldingsGroupLLCMember" xlink:label="loc_PPCBGWHoldingsGroupLLCMember_980" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_PPCBGWHoldingsGroupLLCMember_980" xlink:type="arc" order="982" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_CrownBridgePartnersLLCMember" xlink:label="loc_PPCBCrownBridgePartnersLLCMember_1120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_PPCBCrownBridgePartnersLLCMember_1120" xlink:type="arc" order="1122" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_LGCapitalFundingLLCMember" xlink:label="loc_PPCBLGCapitalFundingLLCMember_1280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_PPCBLGCapitalFundingLLCMember_1280" xlink:type="arc" order="1283" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_GenevaRothRemarkHoldingsIncMember" xlink:label="loc_PPCBGenevaRothRemarkHoldingsIncMember_1400" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_PPCBGenevaRothRemarkHoldingsIncMember_1400" xlink:type="arc" order="1403" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapDebtInstrumentAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_DecemberTwoThousandAndSeventeenEagleNoteMember" xlink:label="loc_PPCBDecemberTwoThousandAndSeventeenEagleNoteMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_PPCBDecemberTwoThousandAndSeventeenEagleNoteMember_0" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_JulyTwoThousandEighteenEagleNoteMember" xlink:label="loc_PPCBJulyTwoThousandEighteenEagleNoteMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_PPCBJulyTwoThousandEighteenEagleNoteMember_90" xlink:type="arc" order="93" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_AugustTwoThousandEighteenEagleNoteMember" xlink:label="loc_PPCBAugustTwoThousandEighteenEagleNoteMember_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_PPCBAugustTwoThousandEighteenEagleNoteMember_160" xlink:type="arc" order="163" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_OctoberTwoTwoThousandAndEighteenEagleNoteMember" xlink:label="loc_PPCBOctoberTwoTwoThousandAndEighteenEagleNoteMember_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_PPCBOctoberTwoTwoThousandAndEighteenEagleNoteMember_190" xlink:type="arc" order="193" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_NovemberTwoThousandAndEighteenEagleNoteMember" xlink:label="loc_PPCBNovemberTwoThousandAndEighteenEagleNoteMember_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_PPCBNovemberTwoThousandAndEighteenEagleNoteMember_220" xlink:type="arc" order="223" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_DecembeTwoThousandAndEighteenEagleNoteMember" xlink:label="loc_PPCBDecembeTwoThousandAndEighteenEagleNoteMember_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_PPCBDecembeTwoThousandAndEighteenEagleNoteMember_250" xlink:type="arc" order="253" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_OctoberTwoThousandEighteenGSNoteMember" xlink:label="loc_PPCBOctoberTwoThousandEighteenGSNoteMember_360" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_PPCBOctoberTwoThousandEighteenGSNoteMember_360" xlink:type="arc" order="363" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_JanuaryTwentyTwoTwentyTwentyGSNoteMember" xlink:label="loc_PPCBJanuaryTwentyTwoTwentyTwentyGSNoteMember_410" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_PPCBJanuaryTwentyTwoTwentyTwentyGSNoteMember_410" xlink:type="arc" order="413" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_NovemberTwentySixTwoThousandNineteenPowerUpNoteMember" xlink:label="loc_PPCBNovemberTwentySixTwoThousandNineteenPowerUpNoteMember_610" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_PPCBNovemberTwentySixTwoThousandNineteenPowerUpNoteMember_610" xlink:type="arc" order="612" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_JanuarySevenTwoThousandTwentyPowerUpNoteMember" xlink:label="loc_PPCBJanuarySevenTwoThousandTwentyPowerUpNoteMember_640" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_PPCBJanuarySevenTwoThousandTwentyPowerUpNoteMember_640" xlink:type="arc" order="642" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_MarchTwelveTwoThousandTwentyPowerUpNoteMember" xlink:label="loc_PPCBMarchTwelveTwoThousandTwentyPowerUpNoteMember_670" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_PPCBMarchTwelveTwoThousandTwentyPowerUpNoteMember_670" xlink:type="arc" order="672" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_JulyTwoThousandNineteenOdysseyNoteMember" xlink:label="loc_PPCBJulyTwoThousandNineteenOdysseyNoteMember_790" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_PPCBJulyTwoThousandNineteenOdysseyNoteMember_790" xlink:type="arc" order="793" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_AugustTwoThousandNineteenAuctusNoteMember" xlink:label="loc_PPCBAugustTwoThousandNineteenAuctusNoteMember_860" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_PPCBAugustTwoThousandNineteenAuctusNoteMember_860" xlink:type="arc" order="863" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_OctoberOneTwoThousandNineteenAuctusNoteMember" xlink:label="loc_PPCBOctoberOneTwoThousandNineteenAuctusNoteMember_980" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_PPCBOctoberOneTwoThousandNineteenAuctusNoteMember_980" xlink:type="arc" order="983" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_DecemberTenTwoThousandTwentyGWNoteMember" xlink:label="loc_PPCBDecemberTenTwoThousandTwentyGWNoteMember_1000" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_PPCBDecemberTenTwoThousandTwentyGWNoteMember_1000" xlink:type="arc" order="1003" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_OctoberThreeTwoThousandNineteenAuctusNoteMember" xlink:label="loc_PPCBOctoberThreeTwoThousandNineteenAuctusNoteMember_1120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_PPCBOctoberThreeTwoThousandNineteenAuctusNoteMember_1120" xlink:type="arc" order="1123" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_JanuaryThirteenTwentyTwentyAderAlefNoteMember" xlink:label="loc_PPCBJanuaryThirteenTwentyTwentyAderAlefNoteMember_1210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_PPCBJanuaryThirteenTwentyTwentyAderAlefNoteMember_1210" xlink:type="arc" order="1212" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember" xlink:label="loc_PPCBFebruaryNineteenTwoThousandTwentyLGCapitalNoteMember_1280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_PPCBFebruaryNineteenTwoThousandTwentyLGCapitalNoteMember_1280" xlink:type="arc" order="1282" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_DecemberTwoTwoThousandTwentyGenevaRothMember" xlink:label="loc_PPCBDecemberTwoTwoThousandTwentyGenevaRothMember_1400" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_PPCBDecemberTwoTwoThousandTwentyGenevaRothMember_1400" xlink:type="arc" order="1402" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_JanuaryFiveTwoThousandTwentyOneGenevaRothMember" xlink:label="loc_PPCBJanuaryFiveTwoThousandTwentyOneGenevaRothMember_1410" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_PPCBJanuaryFiveTwoThousandTwentyOneGenevaRothMember_1410" xlink:type="arc" order="1412" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_MarchSixteenTwoThousandTwentyOneGenevaRothMember" xlink:label="loc_PPCBMarchSixteenTwoThousandTwentyOneGenevaRothMember_1430" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_PPCBMarchSixteenTwoThousandTwentyOneGenevaRothMember_1430" xlink:type="arc" order="1432" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_AugustNineteenTwoThousandTwentyOneGenevaRothMember" xlink:label="loc_PPCBAugustNineteenTwoThousandTwentyOneGenevaRothMember_1740" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_PPCBAugustNineteenTwoThousandTwentyOneGenevaRothMember_1740" xlink:type="arc" order="1742" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_SeptemberTwentyTwoTwoThousandTwentyOneGenevaRothMember" xlink:label="loc_PPCBSeptemberTwentyTwoTwoThousandTwentyOneGenevaRothMember_1760" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_PPCBSeptemberTwentyTwoTwoThousandTwentyOneGenevaRothMember_1760" xlink:type="arc" order="1762" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember" xlink:label="loc_PPCBSeptemberTwentyTwoTwoThousandTwentyGenevaRothMember_1780" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_PPCBSeptemberTwentyTwoTwoThousandTwentyGenevaRothMember_1780" xlink:type="arc" order="1782" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_280" xlink:type="arc" order="284" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_290" xlink:type="arc" order="294" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="loc_us-gaapShortTermDebtTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapShortTermDebtTypeAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="loc_us-gaapShortTermDebtTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapShortTermDebtTypeAxis" xlink:to="loc_us-gaapShortTermDebtTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="loc_us-gaapShortTermDebtTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShortTermDebtTypeAxis" xlink:to="loc_us-gaapShortTermDebtTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_FirstNoteMember" xlink:label="loc_PPCBFirstNoteMember_390" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtTypeDomain" xlink:to="loc_PPCBFirstNoteMember_390" xlink:type="arc" order="394" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_SecondNoteMember" xlink:label="loc_PPCBSecondNoteMember_400" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtTypeDomain" xlink:to="loc_PPCBSecondNoteMember_400" xlink:type="arc" order="404" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_SettlementAndMutualReleaseAgreementMember" xlink:label="loc_PPCBSettlementAndMutualReleaseAgreementMember_580" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtTypeDomain" xlink:to="loc_PPCBSettlementAndMutualReleaseAgreementMember_580" xlink:type="arc" order="582" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_ConsultantMember" xlink:label="loc_PPCBConsultantMember_530" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_PPCBConsultantMember_530" xlink:type="arc" order="532" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_FirstWarrantMember" xlink:label="loc_PPCBFirstWarrantMember_900" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_PPCBFirstWarrantMember_900" xlink:type="arc" order="904" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_SecondWarrantMember" xlink:label="loc_PPCBSecondWarrantMember_910" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_PPCBSecondWarrantMember_910" xlink:type="arc" order="914" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_ThirdWarrantMember" xlink:label="loc_PPCBThirdWarrantMember_920" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_PPCBThirdWarrantMember_920" xlink:type="arc" order="924" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount_1950" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount_1950" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:label="loc_us-gaapDebtInstrumentUnamortizedDiscount_1950" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentUnamortizedDiscount_1950" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="loc_us-gaapProceedsFromConvertibleDebt_1950" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapProceedsFromConvertibleDebt_1950" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_us-gaapDebtInstrumentMaturityDate_1950" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentMaturityDate_1950" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_1950" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_1950" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPayableCurrentAndNoncurrent" xlink:label="loc_us-gaapInterestPayableCurrentAndNoncurrent_1950" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapInterestPayableCurrentAndNoncurrent_1950" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:label="loc_us-gaapDebtConversionConvertedInstrumentAmount1_1950" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtConversionConvertedInstrumentAmount1_1950" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleNotesPayable" xlink:label="loc_us-gaapConvertibleNotesPayable_1950" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapConvertibleNotesPayable_1950" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LegalFees" xlink:label="loc_us-gaapLegalFees_1950" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapLegalFees_1950" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_DebtInstrumentDebtDefaultInterestRate" xlink:label="loc_PPCBDebtInstrumentDebtDefaultInterestRate_1950" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_PPCBDebtInstrumentDebtDefaultInterestRate_1950" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:label="loc_us-gaapDebtInstrumentPeriodicPaymentPrincipal_1950" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentPeriodicPaymentPrincipal_1950" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:label="loc_us-gaapDebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_1950" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_1950" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtConversionOriginalDebtInterestRateOfDebt" xlink:label="loc_us-gaapDebtConversionOriginalDebtInterestRateOfDebt_1950" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtConversionOriginalDebtInterestRateOfDebt_1950" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_PercentageOfOutstandingSharesOfCommonStock" xlink:label="loc_PPCBPercentageOfOutstandingSharesOfCommonStock_1950" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_PPCBPercentageOfOutstandingSharesOfCommonStock_1950" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedPremium" xlink:label="loc_us-gaapDebtInstrumentUnamortizedPremium_1950" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentUnamortizedPremium_1950" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital_1950" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapAdditionalPaidInCapital_1950" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_DebtDefaultAmountPercentage" xlink:label="loc_PPCBDebtDefaultAmountPercentage_1950" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_PPCBDebtDefaultAmountPercentage_1950" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_DebtConversionConvertedInterestPayable" xlink:label="loc_PPCBDebtConversionConvertedInterestPayable_1950" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_PPCBDebtConversionConvertedInterestPayable_1950" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:label="loc_us-gaapDebtInstrumentConvertibleThresholdTradingDays_1950" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentConvertibleThresholdTradingDays_1950" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrentAndNoncurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrentAndNoncurrent_1950" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapAccruedLiabilitiesCurrentAndNoncurrent_1950" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" xlink:label="loc_us-gaapEmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_1950" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapEmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_1950" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities_1950" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapLiabilities_1950" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaapGainsLossesOnExtinguishmentOfDebt_1950" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapGainsLossesOnExtinguishmentOfDebt_1950" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_PrepaymentPenalties" xlink:label="loc_PPCBPrepaymentPenalties_1950" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_PPCBPrepaymentPenalties_1950" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_DiligenceFees" xlink:label="loc_PPCBDiligenceFees_1950" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_PPCBDiligenceFees_1950" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtConversionDescription" xlink:label="loc_us-gaapDebtConversionDescription_1950" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtConversionDescription_1950" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfDebt" xlink:label="loc_us-gaapRepaymentsOfDebt_1950" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapRepaymentsOfDebt_1950" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaid" xlink:label="loc_us-gaapInterestPaid_1950" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapInterestPaid_1950" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentDescription" xlink:label="loc_us-gaapDebtInstrumentDescription_1950" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentDescription_1950" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_1950" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_1950" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_1950" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_1950" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaapFairValueAdjustmentOfWarrants_1950" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapFairValueAdjustmentOfWarrants_1950" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_UnissuedSharesConversion" xlink:label="loc_PPCBUnissuedSharesConversion_1950" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_PPCBUnissuedSharesConversion_1950" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_DueToEquityConversion" xlink:label="loc_PPCBDueToEquityConversion_1950" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_PPCBDueToEquityConversion_1950" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtConversionOriginalDebtAmount1" xlink:label="loc_us-gaapDebtConversionOriginalDebtAmount1_1950" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtConversionOriginalDebtAmount1_1950" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="loc_us-gaapAmortizationOfDebtDiscountPremium_1950" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapAmortizationOfDebtDiscountPremium_1950" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_ReclassifiedPremiumAmountForAdditionalPaidInCapital" xlink:label="loc_PPCBReclassifiedPremiumAmountForAdditionalPaidInCapital_1950" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_PPCBReclassifiedPremiumAmountForAdditionalPaidInCapital_1950" xlink:type="arc" order="36" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://propanc.com/role/ScheduleOfIncomeTaxProvisionDetails" xlink:title="00000040 - Disclosure - SCHEDULE OF INCOME TAX PROVISION (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srtStatementGeographicalAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtStatementGeographicalAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US" xlink:label="loc_countryUS_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryUS_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaapIncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_30" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapIncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_30" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" xlink:label="loc_us-gaapIncomeTaxReconciliationPriorYearIncomeTaxes_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeTaxReconciliationPriorYearIncomeTaxes_30" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:label="loc_us-gaapIncomeTaxReconciliationForeignIncomeTaxRateDifferential_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeTaxReconciliationForeignIncomeTaxRateDifferential_30" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxCredits" xlink:label="loc_us-gaapIncomeTaxReconciliationTaxCredits_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeTaxReconciliationTaxCredits_30" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:label="loc_us-gaapIncomeTaxReconciliationOtherAdjustments_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeTaxReconciliationOtherAdjustments_30" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit_30" xlink:type="arc" order="7" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://propanc.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:title="00000041 - Disclosure - SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://propanc.com/role/IncomeTaxesDetailsNarrative" xlink:title="00000042 - Disclosure - INCOME TAXES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_CaresActMember" xlink:label="loc_PPCBCaresActMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_PPCBCaresActMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srtStatementGeographicalAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_srtStatementGeographicalAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US" xlink:label="loc_countryUS_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryUS_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_AU" xlink:label="loc_countryAU_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryAU_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardDateAxis" xlink:label="loc_us-gaapAwardDateAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapAwardDateAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardDateDomain" xlink:label="loc_us-gaapAwardDateDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardDateAxis" xlink:to="loc_us-gaapAwardDateDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardDateDomain" xlink:label="loc_us-gaapAwardDateDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardDateAxis" xlink:to="loc_us-gaapAwardDateDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_ExpireInTwoThousandTwentyFourMember" xlink:label="loc_PPCBExpireInTwoThousandTwentyFourMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAwardDateDomain" xlink:to="loc_PPCBExpireInTwoThousandTwentyFourMember_50" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_NotExpireMember" xlink:label="loc_PPCBNotExpireMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAwardDateDomain" xlink:to="loc_PPCBNotExpireMember_60" xlink:type="arc" order="62" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit_120" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExaminationDescription" xlink:label="loc_us-gaapIncomeTaxExaminationDescription_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapIncomeTaxExaminationDescription_120" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_us-gaapOperatingLossCarryforwards_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapOperatingLossCarryforwards_120" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_120" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="loc_us-gaapUnrecognizedTaxBenefits_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapUnrecognizedTaxBenefits_120" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease" xlink:label="loc_us-gaapUnrecognizedTaxBenefitsPeriodIncreaseDecrease_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapUnrecognizedTaxBenefitsPeriodIncreaseDecrease_120" xlink:type="arc" order="6" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://propanc.com/role/ScheduleOfStockOptionActivityDetails" xlink:title="00000043 - Disclosure - SCHEDULE OF STOCK OPTION ACTIVITY (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://propanc.com/role/ScheduleOfWarrantActivityDetails" xlink:title="00000044 - Disclosure - SCHEDULE OF WARRANT ACTIVITY (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://propanc.com/role/StockholdersDeficitDetailsNarrative" xlink:title="00000045 - Disclosure - STOCKHOLDERS&#8217; DEFICIT (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="loc_us-gaapClassOfStockLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="loc_us-gaapScheduleOfStockByClassTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapScheduleOfStockByClassTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="loc_us-gaapSeriesAPreferredStockMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesAPreferredStockMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_SeriesBWarrantsMember" xlink:label="loc_PPCBSeriesBWarrantsMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_PPCBSeriesBWarrantsMember_70" xlink:type="arc" order="72" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_SeriesCWarrantsMember" xlink:label="loc_PPCBSeriesCWarrantsMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_PPCBSeriesCWarrantsMember_80" xlink:type="arc" order="82" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_SeriesAWarrantsMember" xlink:label="loc_PPCBSeriesAWarrantsMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_PPCBSeriesAWarrantsMember_90" xlink:type="arc" order="92" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_PrefundedWarrantsMember" xlink:label="loc_PPCBPrefundedWarrantsMember_460" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_PPCBPrefundedWarrantsMember_460" xlink:type="arc" order="461" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_TwentySeriesAAndOneSeriesCWarrantsMember" xlink:label="loc_PPCBTwentySeriesAAndOneSeriesCWarrantsMember_490" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_PPCBTwentySeriesAAndOneSeriesCWarrantsMember_490" xlink:type="arc" order="491" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_SeriesBWarrantMember" xlink:label="loc_PPCBSeriesBWarrantMember_1110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_PPCBSeriesBWarrantMember_1110" xlink:type="arc" order="1111" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_SecurityPurchaseAgreementMember" xlink:label="loc_PPCBSecurityPurchaseAgreementMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_PPCBSecurityPurchaseAgreementMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_UnderlyingFinancingAgreementsMember" xlink:label="loc_PPCBUnderlyingFinancingAgreementsMember_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_PPCBUnderlyingFinancingAgreementsMember_270" xlink:type="arc" order="271" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_ConsultingAgreementMember" xlink:label="loc_PPCBConsultingAgreementMember_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_PPCBConsultingAgreementMember_280" xlink:type="arc" order="281" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_EngagementAgreementMember" xlink:label="loc_PPCBEngagementAgreementMember_310" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_PPCBEngagementAgreementMember_310" xlink:type="arc" order="312" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_EmploymentAgreementsMember" xlink:label="loc_PPCBEmploymentAgreementsMember_590" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_PPCBEmploymentAgreementsMember_590" xlink:type="arc" order="591" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_SecuritiesPurchaseAgreementMember" xlink:label="loc_PPCBSecuritiesPurchaseAgreementMember_680" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_PPCBSecuritiesPurchaseAgreementMember_680" xlink:type="arc" order="681" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_NathanielszCancellationAgreementMember" xlink:label="loc_PPCBNathanielszCancellationAgreementMember_960" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_PPCBNathanielszCancellationAgreementMember_960" xlink:type="arc" order="961" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_CancellationAgreementMember" xlink:label="loc_PPCBCancellationAgreementMember_1010" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_PPCBCancellationAgreementMember_1010" xlink:type="arc" order="1012" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_ZelingerAmendedAndRestatedDirectorAgreementMember" xlink:label="loc_PPCBZelingerAmendedAndRestatedDirectorAgreementMember_1050" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_PPCBZelingerAmendedAndRestatedDirectorAgreementMember_1050" xlink:type="arc" order="1051" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_110" xlink:type="arc" order="112" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_PrefundedWarrantsMember" xlink:label="loc_PPCBPrefundedWarrantsMember_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_PPCBPrefundedWarrantsMember_130" xlink:type="arc" order="132" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_FirstWarrantMember" xlink:label="loc_PPCBFirstWarrantMember_620" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_PPCBFirstWarrantMember_620" xlink:type="arc" order="621" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_SecondWarrantMember" xlink:label="loc_PPCBSecondWarrantMember_630" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_PPCBSecondWarrantMember_630" xlink:type="arc" order="631" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_ThirdWarrantMember" xlink:label="loc_PPCBThirdWarrantMember_640" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_PPCBThirdWarrantMember_640" xlink:type="arc" order="641" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember_670" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapWarrantMember_670" xlink:type="arc" order="671" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_CommonStockOneMember" xlink:label="loc_PPCBCommonStockOneMember_870" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_PPCBCommonStockOneMember_870" xlink:type="arc" order="871" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="loc_us-gaapRestrictedStockMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapRestrictedStockMember_120" xlink:type="arc" order="122" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaapRestrictedStockUnitsRSUMember_520" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapRestrictedStockUnitsRSUMember_520" xlink:type="arc" order="521" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_160" xlink:type="arc" order="162" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_170" xlink:type="arc" order="172" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_ConsultantMember" xlink:label="loc_PPCBConsultantMember_310" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_PPCBConsultantMember_310" xlink:type="arc" order="311" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ChiefExecutiveOfficerMember" xlink:label="loc_srtChiefExecutiveOfficerMember_510" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_srtChiefExecutiveOfficerMember_510" xlink:type="arc" order="511" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestorMember" xlink:label="loc_us-gaapInvestorMember_720" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_us-gaapInvestorMember_720" xlink:type="arc" order="723" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_HolderMember" xlink:label="loc_PPCBHolderMember_750" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_PPCBHolderMember_750" xlink:type="arc" order="753" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_ChiefScientificOfficerandDirectorMember" xlink:label="loc_PPCBChiefScientificOfficerandDirectorMember_1020" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_PPCBChiefScientificOfficerandDirectorMember_1020" xlink:type="arc" order="1021" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapPlanNameAxis" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_TwoThousandNinteenEquityIncentivePlanMember" xlink:label="loc_PPCBTwoThousandNinteenEquityIncentivePlanMember_580" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_PPCBTwoThousandNinteenEquityIncentivePlanMember_580" xlink:type="arc" order="581" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srtProductOrServiceAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_srtProductOrServiceAxis" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_LegalServicesMember" xlink:label="loc_PPCBLegalServicesMember_900" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_PPCBLegalServicesMember_900" xlink:type="arc" order="901" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_ConsultantServicesMember" xlink:label="loc_PPCBConsultantServicesMember_930" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_PPCBConsultantServicesMember_930" xlink:type="arc" order="931" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_MrNathanielszMember" xlink:label="loc_PPCBMrNathanielszMember_970" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_PPCBMrNathanielszMember_970" xlink:type="arc" order="971" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_JosefZelingerMember" xlink:label="loc_PPCBJosefZelingerMember_1050" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_PPCBJosefZelingerMember_1050" xlink:type="arc" order="1052" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis" xlink:label="loc_us-gaapDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredBonusAndProfitSharingArrangementIndividualContractTypeOfDeferredCompensationDomain" xlink:label="loc_us-gaapDeferredBonusAndProfitSharingArrangementIndividualContractTypeOfDeferredCompensationDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis" xlink:to="loc_us-gaapDeferredBonusAndProfitSharingArrangementIndividualContractTypeOfDeferredCompensationDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredBonusAndProfitSharingArrangementIndividualContractTypeOfDeferredCompensationDomain" xlink:label="loc_us-gaapDeferredBonusAndProfitSharingArrangementIndividualContractTypeOfDeferredCompensationDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis" xlink:to="loc_us-gaapDeferredBonusAndProfitSharingArrangementIndividualContractTypeOfDeferredCompensationDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_DeferredSalaryMember" xlink:label="loc_PPCBDeferredSalaryMember_1010" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDeferredBonusAndProfitSharingArrangementIndividualContractTypeOfDeferredCompensationDomain" xlink:to="loc_PPCBDeferredSalaryMember_1010" xlink:type="arc" order="1011" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized_1190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized_1190" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityReverseStockSplit" xlink:label="loc_us-gaapStockholdersEquityReverseStockSplit_1190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapStockholdersEquityReverseStockSplit_1190" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized_1190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized_1190" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare_1190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare_1190" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued_1190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapPreferredStockSharesIssued_1190" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding_1190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapPreferredStockSharesOutstanding_1190" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_EquityPurchaseAgreementDescription" xlink:label="loc_PPCBEquityPurchaseAgreementDescription_1190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_PPCBEquityPurchaseAgreementDescription_1190" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_1190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_1190" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_1190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_1190" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaapFairValueAdjustmentOfWarrants_1190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapFairValueAdjustmentOfWarrants_1190" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="loc_us-gaapProceedsFromIssuanceOfWarrants_1190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfWarrants_1190" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="loc_us-gaapPaymentsOfStockIssuanceCosts_1190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapPaymentsOfStockIssuanceCosts_1190" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaapEquityMethodInvestmentOwnershipPercentage_1190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentOwnershipPercentage_1190" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_1190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_1190" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardGross_1190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardGross_1190" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="loc_us-gaapDebtInstrumentConvertibleConversionPrice1_1190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapDebtInstrumentConvertibleConversionPrice1_1190" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:label="loc_us-gaapDebtConversionConvertedInstrumentAmount1_1190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapDebtConversionConvertedInstrumentAmount1_1190" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_ConversionFees" xlink:label="loc_PPCBConversionFees_1190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_PPCBConversionFees_1190" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock_1190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock_1190" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_ConversionOptionDerivatives" xlink:label="loc_PPCBConversionOptionDerivatives_1190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_PPCBConversionOptionDerivatives_1190" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPayableCurrentAndNoncurrent" xlink:label="loc_us-gaapInterestPayableCurrentAndNoncurrent_1190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapInterestPayableCurrentAndNoncurrent_1190" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_FairMarketValueOfShares" xlink:label="loc_PPCBFairMarketValueOfShares_1190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_PPCBFairMarketValueOfShares_1190" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaapGainsLossesOnExtinguishmentOfDebt_1190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapGainsLossesOnExtinguishmentOfDebt_1190" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeNet" xlink:label="loc_us-gaapDerivativeFairValueOfDerivativeNet_1190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapDerivativeFairValueOfDerivativeNet_1190" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_PremiumsToAdditionalPaidInCapital" xlink:label="loc_PPCBPremiumsToAdditionalPaidInCapital_1190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_PPCBPremiumsToAdditionalPaidInCapital_1190" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount_1190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount_1190" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesSubscribedButUnissued" xlink:label="loc_us-gaapCommonStockSharesSubscribedButUnissued_1190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapCommonStockSharesSubscribedButUnissued_1190" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedPremium" xlink:label="loc_us-gaapDebtInstrumentUnamortizedPremium_1190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapDebtInstrumentUnamortizedPremium_1190" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_DecreaseInEquity" xlink:label="loc_PPCBDecreaseInEquity_1190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_PPCBDecreaseInEquity_1190" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare_1190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare_1190" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfessionalFees" xlink:label="loc_us-gaapProfessionalFees_1190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapProfessionalFees_1190" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_1190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_1190" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare_1190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare_1190" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices_1190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices_1190" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="loc_us-gaapProceedsFromWarrantExercises_1190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapProceedsFromWarrantExercises_1190" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued_1190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued_1190" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_DeemedDividend" xlink:label="loc_PPCBDeemedDividend_1190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_PPCBDeemedDividend_1190" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1190" xlink:type="arc" order="37" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantDateFairvalue" xlink:label="loc_PPCBShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantDateFairvalue_1190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_PPCBShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantDateFairvalue_1190" xlink:type="arc" order="38" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation_1190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapShareBasedCompensation_1190" xlink:type="arc" order="39" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_UnrecognizedRestrictedStockUnitsExpense" xlink:label="loc_PPCBUnrecognizedRestrictedStockUnitsExpense_1190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_PPCBUnrecognizedRestrictedStockUnitsExpense_1190" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_1190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_1190" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_1190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_1190" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance_1190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance_1190" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockOptionPlanExpense" xlink:label="loc_us-gaapStockOptionPlanExpense_1190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapStockOptionPlanExpense_1190" xlink:type="arc" order="44" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_UnvestedStockOptionsExpense" xlink:label="loc_PPCBUnvestedStockOptionsExpense_1190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_PPCBUnvestedStockOptionsExpense_1190" xlink:type="arc" order="45" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_1190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_1190" xlink:type="arc" order="46" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_1190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_1190" xlink:type="arc" order="47" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantsAndRightsOutstandingMaturityDate" xlink:label="loc_us-gaapWarrantsAndRightsOutstandingMaturityDate_1190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstandingMaturityDate_1190" xlink:type="arc" order="48" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="loc_us-gaapWarrantsAndRightsOutstandingTerm_1190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstandingTerm_1190" xlink:type="arc" order="49" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_1190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_1190" xlink:type="arc" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:label="loc_us-gaapDebtInstrumentConvertibleThresholdTradingDays_1190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapDebtInstrumentConvertibleThresholdTradingDays_1190" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesEmployeeBenefitPlan_1190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesEmployeeBenefitPlan_1190" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueEmployeeBenefitPlan_1190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueEmployeeBenefitPlan_1190" xlink:type="arc" order="53" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue_1190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapCommonStockValue_1190" xlink:type="arc" order="54" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_1190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_1190" xlink:type="arc" order="55" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_PercentageOfBonusOfAnnualBaseSalary" xlink:label="loc_PPCBPercentageOfBonusOfAnnualBaseSalary_1190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_PPCBPercentageOfBonusOfAnnualBaseSalary_1190" xlink:type="arc" order="56" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OfficersCompensation" xlink:label="loc_us-gaapOfficersCompensation_1190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapOfficersCompensation_1190" xlink:type="arc" order="57" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:label="loc_us-gaapDebtConversionConvertedInstrumentSharesIssued1_1190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapDebtConversionConvertedInstrumentSharesIssued1_1190" xlink:type="arc" order="58" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice_1190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapSharePrice_1190" xlink:type="arc" order="59" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedSalariesCurrent" xlink:label="loc_us-gaapAccruedSalariesCurrent_1190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapAccruedSalariesCurrent_1190" xlink:type="arc" order="60" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_DescriptionOfEmploymentBenefits" xlink:label="loc_PPCBDescriptionOfEmploymentBenefits_1190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_PPCBDescriptionOfEmploymentBenefits_1190" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_CommonStockIssuableShares" xlink:label="loc_PPCBCommonStockIssuableShares_1190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_PPCBCommonStockIssuableShares_1190" xlink:type="arc" order="62" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_1190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_1190" xlink:type="arc" order="63" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteSubscriptionsReceivable" xlink:label="loc_us-gaapStockholdersEquityNoteSubscriptionsReceivable_1190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapStockholdersEquityNoteSubscriptionsReceivable_1190" xlink:type="arc" order="64" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesOther_1190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesOther_1190" xlink:type="arc" order="65" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://propanc.com/role/ScheduleOfRightUseOfAssetDetails" xlink:title="00000046 - Disclosure - SCHEDULE OF RIGHT USE OF ASSET (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://propanc.com/role/ScheduleOfOperatingLeaseLiabilityDetails" xlink:title="00000047 - Disclosure - SCHEDULE OF OPERATING LEASE LIABILITY (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://propanc.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="00000048 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_FoleyShechterMember" xlink:label="loc_PPCBFoleyShechterMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_PPCBFoleyShechterMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_SettlementAgreementMember" xlink:label="loc_PPCBSettlementAgreementMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_PPCBSettlementAgreementMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_SettlementAndMutualReleaseAgreementMember" xlink:label="loc_PPCBSettlementAndMutualReleaseAgreementMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_PPCBSettlementAndMutualReleaseAgreementMember_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RoyaltyAgreementTermsMember" xlink:label="loc_us-gaapRoyaltyAgreementTermsMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_us-gaapRoyaltyAgreementTermsMember_120" xlink:type="arc" order="121" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LicenseAgreementTermsMember" xlink:label="loc_us-gaapLicenseAgreementTermsMember_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_us-gaapLicenseAgreementTermsMember_130" xlink:type="arc" order="131" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_NewFiveYearOperatingLeaseAgreementMember" xlink:label="loc_PPCBNewFiveYearOperatingLeaseAgreementMember_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_PPCBNewFiveYearOperatingLeaseAgreementMember_140" xlink:type="arc" order="141" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_OneYearCollaborationAgreementMember" xlink:label="loc_PPCBOneYearCollaborationAgreementMember_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_PPCBOneYearCollaborationAgreementMember_200" xlink:type="arc" order="201" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_TwoYearCollaborationAgreementMember" xlink:label="loc_PPCBTwoYearCollaborationAgreementMember_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_PPCBTwoYearCollaborationAgreementMember_220" xlink:type="arc" order="221" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_RegalConsultingLLCMember" xlink:label="loc_PPCBRegalConsultingLLCMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_PPCBRegalConsultingLLCMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_UniversityOfJaenMember" xlink:label="loc_PPCBUniversityOfJaenMember_370" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_PPCBUniversityOfJaenMember_370" xlink:type="arc" order="371" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapDebtInstrumentAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_TwoThousandAndSeventeenNoteMember" xlink:label="loc_PPCBTwoThousandAndSeventeenNoteMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_PPCBTwoThousandAndSeventeenNoteMember_50" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardDateAxis" xlink:label="loc_us-gaapAwardDateAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardDateAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardDateDomain" xlink:label="loc_us-gaapAwardDateDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardDateAxis" xlink:to="loc_us-gaapAwardDateDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardDateDomain" xlink:label="loc_us-gaapAwardDateDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardDateAxis" xlink:to="loc_us-gaapAwardDateDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_From2012ThroughThe2014Member" xlink:label="loc_PPCBFrom2012ThroughThe2014Member_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAwardDateDomain" xlink:to="loc_PPCBFrom2012ThroughThe2014Member_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_InstallmentOneMember" xlink:label="loc_PPCBInstallmentOneMember_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAwardDateDomain" xlink:to="loc_PPCBInstallmentOneMember_300" xlink:type="arc" order="303" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_InstallmentTwoMember" xlink:label="loc_PPCBInstallmentTwoMember_310" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAwardDateDomain" xlink:to="loc_PPCBInstallmentTwoMember_310" xlink:type="arc" order="312" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_InstallmentThreeMember" xlink:label="loc_PPCBInstallmentThreeMember_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAwardDateDomain" xlink:to="loc_PPCBInstallmentThreeMember_330" xlink:type="arc" order="332" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_InstallmentFourMember" xlink:label="loc_PPCBInstallmentFourMember_350" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAwardDateDomain" xlink:to="loc_PPCBInstallmentFourMember_350" xlink:type="arc" order="352" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_AUDCurrencyMember" xlink:label="loc_PPCBAUDCurrencyMember_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_PPCBAUDCurrencyMember_150" xlink:type="arc" order="152" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_EurosMember" xlink:label="loc_PPCBEurosMember_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_PPCBEurosMember_200" xlink:type="arc" order="202" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="loc_us-gaapAdjustmentsForNewAccountingPronouncementsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAdjustmentsForNewAccountingPronouncementsAxis" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="loc_us-gaapTypeOfAdoptionMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAdjustmentsForNewAccountingPronouncementsAxis" xlink:to="loc_us-gaapTypeOfAdoptionMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="loc_us-gaapTypeOfAdoptionMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAdjustmentsForNewAccountingPronouncementsAxis" xlink:to="loc_us-gaapTypeOfAdoptionMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate201602Member" xlink:label="loc_us-gaapAccountingStandardsUpdate201602Member_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTypeOfAdoptionMember" xlink:to="loc_us-gaapAccountingStandardsUpdate201602Member_170" xlink:type="arc" order="171" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaapConcentrationRiskByBenchmarkAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesRevenueNetMember" xlink:label="loc_us-gaapSalesRevenueNetMember_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapSalesRevenueNetMember_270" xlink:type="arc" order="271" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaapConcentrationRiskByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapConcentrationRiskByTypeAxis" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromRightsConcentrationRiskMember" xlink:label="loc_us-gaapRevenueFromRightsConcentrationRiskMember_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_us-gaapRevenueFromRightsConcentrationRiskMember_270" xlink:type="arc" order="272" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis" xlink:label="loc_srtMajorCustomersAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtMajorCustomersAxis" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srtNameOfMajorCustomerDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtMajorCustomersAxis" xlink:to="loc_srtNameOfMajorCustomerDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srtNameOfMajorCustomerDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtMajorCustomersAxis" xlink:to="loc_srtNameOfMajorCustomerDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_NoCustomerMember" xlink:label="loc_PPCBNoCustomerMember_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_PPCBNoCustomerMember_270" xlink:type="arc" order="273" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LegalFees" xlink:label="loc_us-gaapLegalFees_430" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLegalFees_430" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfessionalFees" xlink:label="loc_us-gaapProfessionalFees_430" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProfessionalFees_430" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_SettlementAmount" xlink:label="loc_PPCBSettlementAmount_430" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_PPCBSettlementAmount_430" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_430" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_430" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_GainLossFromSettlementOfDebt" xlink:label="loc_PPCBGainLossFromSettlementOfDebt_430" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_PPCBGainLossFromSettlementOfDebt_430" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyDamagesSoughtValue" xlink:label="loc_us-gaapLossContingencyDamagesSoughtValue_430" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLossContingencyDamagesSoughtValue_430" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_430" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_430" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebt" xlink:label="loc_us-gaapConvertibleDebt_430" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapConvertibleDebt_430" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_LitigationPenaltyAmount" xlink:label="loc_PPCBLitigationPenaltyAmount_430" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_PPCBLitigationPenaltyAmount_430" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities_430" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLiabilities_430" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_RemainingPrincipalAmount" xlink:label="loc_PPCBRemainingPrincipalAmount_430" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_PPCBRemainingPrincipalAmount_430" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPayableCurrentAndNoncurrent" xlink:label="loc_us-gaapInterestPayableCurrentAndNoncurrent_430" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInterestPayableCurrentAndNoncurrent_430" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrentAndNoncurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrentAndNoncurrent_430" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAccruedLiabilitiesCurrentAndNoncurrent_430" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_OperatingLeasesIncomeStatementRevenuePercentage" xlink:label="loc_PPCBOperatingLeasesIncomeStatementRevenuePercentage_430" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_PPCBOperatingLeasesIncomeStatementRevenuePercentage_430" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="loc_us-gaapLesseeOperatingLeaseTermOfContract_430" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseTermOfContract_430" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRent" xlink:label="loc_us-gaapPaymentsForRent_430" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPaymentsForRent_430" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseDescription" xlink:label="loc_us-gaapLesseeOperatingLeaseDescription_430" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseDescription_430" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset_430" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset_430" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaapOperatingLeaseLiability_430" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingLeaseLiability_430" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="loc_us-gaapOperatingLeaseWeightedAverageDiscountRatePercent_430" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingLeaseWeightedAverageDiscountRatePercent_430" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_PaymentForServices" xlink:label="loc_PPCBPaymentForServices_430" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_PPCBPaymentForServices_430" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaapConcentrationRiskPercentage1_430" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapConcentrationRiskPercentage1_430" xlink:type="arc" order="21" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://propanc.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:title="00000049 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="loc_us-gaapRelatedPartyTransactionLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_CurrentAndFormerDirectorMember" xlink:label="loc_PPCBCurrentAndFormerDirectorMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_PPCBCurrentAndFormerDirectorMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_FormerDirectorMember" xlink:label="loc_PPCBFormerDirectorMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_PPCBFormerDirectorMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_NathanielszMember" xlink:label="loc_PPCBNathanielszMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_PPCBNathanielszMember_70" xlink:type="arc" order="73" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_MrsNathanielszMember" xlink:label="loc_PPCBMrsNathanielszMember_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_PPCBMrsNathanielszMember_200" xlink:type="arc" order="201" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_JamesNathanielszMember" xlink:label="loc_PPCBJamesNathanielszMember_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_PPCBJamesNathanielszMember_220" xlink:type="arc" order="221" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_MrNathanielszMember" xlink:label="loc_PPCBMrNathanielszMember_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_PPCBMrNathanielszMember_280" xlink:type="arc" order="281" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_DrKenyonMember" xlink:label="loc_PPCBDrKenyonMember_450" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_PPCBDrKenyonMember_450" xlink:type="arc" order="452" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_DrKenyonMemberMember" xlink:label="loc_PPCBDrKenyonMemberMember_460" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_PPCBDrKenyonMemberMember_460" xlink:type="arc" order="462" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_NorthHorizonPtyLtdMember" xlink:label="loc_PPCBNorthHorizonPtyLtdMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_PPCBNorthHorizonPtyLtdMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_AUDCurrencyMember" xlink:label="loc_PPCBAUDCurrencyMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_PPCBAUDCurrencyMember_50" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_AUDCurrenryMember" xlink:label="loc_PPCBAUDCurrenryMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_PPCBAUDCurrenryMember_70" xlink:type="arc" order="72" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_RestrictedStocksUnitsRSUMember" xlink:label="loc_PPCBRestrictedStocksUnitsRSUMember_420" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_PPCBRestrictedStocksUnitsRSUMember_420" xlink:type="arc" order="422" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_AdditionaNathanielszRSUsMember" xlink:label="loc_PPCBAdditionaNathanielszRSUsMember_440" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_PPCBAdditionaNathanielszRSUsMember_440" xlink:type="arc" order="442" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_InitialKenyonRSUsMember" xlink:label="loc_PPCBInitialKenyonRSUsMember_470" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_PPCBInitialKenyonRSUsMember_470" xlink:type="arc" order="472" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_AdditionalKenyonRSUsMember" xlink:label="loc_PPCBAdditionalKenyonRSUsMember_480" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_PPCBAdditionalKenyonRSUsMember_480" xlink:type="arc" order="482" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="loc_us-gaapAdjustmentsForNewAccountingPronouncementsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapAdjustmentsForNewAccountingPronouncementsAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="loc_us-gaapTypeOfAdoptionMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAdjustmentsForNewAccountingPronouncementsAxis" xlink:to="loc_us-gaapTypeOfAdoptionMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="loc_us-gaapTypeOfAdoptionMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAdjustmentsForNewAccountingPronouncementsAxis" xlink:to="loc_us-gaapTypeOfAdoptionMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate201602Member" xlink:label="loc_us-gaapAccountingStandardsUpdate201602Member_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTypeOfAdoptionMember" xlink:to="loc_us-gaapAccountingStandardsUpdate201602Member_110" xlink:type="arc" order="111" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_NathanielszEmploymentAgreementMember" xlink:label="loc_PPCBNathanielszEmploymentAgreementMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_PPCBNathanielszEmploymentAgreementMember_120" xlink:type="arc" order="121" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_MrsNathanielszMember" xlink:label="loc_PPCBMrsNathanielszMember_380" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_PPCBMrsNathanielszMember_380" xlink:type="arc" order="382" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_EmploymentAgreementMember" xlink:label="loc_PPCBEmploymentAgreementMember_400" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_PPCBEmploymentAgreementMember_400" xlink:type="arc" order="401" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_ServicesAgreementMember" xlink:label="loc_PPCBServicesAgreementMember_450" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_PPCBServicesAgreementMember_450" xlink:type="arc" order="451" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_160" xlink:type="arc" order="163" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_180" xlink:type="arc" order="183" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_BoardOfDirectorsMember" xlink:label="loc_PPCBBoardOfDirectorsMember_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_PPCBBoardOfDirectorsMember_280" xlink:type="arc" order="282" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ChiefExecutiveOfficerMember" xlink:label="loc_srtChiefExecutiveOfficerMember_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_srtChiefExecutiveOfficerMember_300" xlink:type="arc" order="301" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember_350" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember_350" xlink:type="arc" order="353" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_LoansFromRelatedParty" xlink:label="loc_PPCBLoansFromRelatedParty_710" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_PPCBLoansFromRelatedParty_710" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueToRelatedPartiesCurrent" xlink:label="loc_us-gaapDueToRelatedPartiesCurrent_710" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapDueToRelatedPartiesCurrent_710" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LessorOperatingLeaseTermOfContract" xlink:label="loc_us-gaapLessorOperatingLeaseTermOfContract_710" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapLessorOperatingLeaseTermOfContract_710" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesRentExpenseMinimumRentals" xlink:label="loc_us-gaapOperatingLeasesRentExpenseMinimumRentals_710" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapOperatingLeasesRentExpenseMinimumRentals_710" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_GoodsAndServiceTax" xlink:label="loc_PPCBGoodsAndServiceTax_710" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_PPCBGoodsAndServiceTax_710" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDue_710" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDue_710" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRent" xlink:label="loc_us-gaapPaymentsForRent_710" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapPaymentsForRent_710" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseDescription" xlink:label="loc_us-gaapLesseeOperatingLeaseDescription_710" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseDescription_710" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionDate" xlink:label="loc_us-gaapRelatedPartyTransactionDate_710" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapRelatedPartyTransactionDate_710" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalariesAndWages" xlink:label="loc_us-gaapSalariesAndWages_710" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapSalariesAndWages_710" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_PercentageOfPensionOfMonthlySalary" xlink:label="loc_PPCBPercentageOfPensionOfMonthlySalary_710" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_PPCBPercentageOfPensionOfMonthlySalary_710" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_PercentageOfBonusOfAnnualBaseSalary" xlink:label="loc_PPCBPercentageOfBonusOfAnnualBaseSalary_710" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_PPCBPercentageOfBonusOfAnnualBaseSalary_710" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfRelatedPartyDebt" xlink:label="loc_us-gaapRepaymentsOfRelatedPartyDebt_710" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapRepaymentsOfRelatedPartyDebt_710" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OfficersCompensation" xlink:label="loc_us-gaapOfficersCompensation_710" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapOfficersCompensation_710" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_BonusPayableAmount" xlink:label="loc_PPCBBonusPayableAmount_710" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_PPCBBonusPayableAmount_710" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_RemainingBonusAmount" xlink:label="loc_PPCBRemainingBonusAmount_710" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_PPCBRemainingBonusAmount_710" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_BonusAwardsGrantedPercentage" xlink:label="loc_PPCBBonusAwardsGrantedPercentage_710" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_PPCBBonusAwardsGrantedPercentage_710" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_BonusPayable" xlink:label="loc_PPCBBonusPayable_710" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_PPCBBonusPayable_710" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:label="loc_us-gaapDebtConversionConvertedInstrumentSharesIssued1_710" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapDebtConversionConvertedInstrumentSharesIssued1_710" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_AgreementlTerm" xlink:label="loc_PPCBAgreementlTerm_710" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_PPCBAgreementlTerm_710" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_AgreementRenewalTerm" xlink:label="loc_PPCBAgreementRenewalTerm_710" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_PPCBAgreementRenewalTerm_710" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_710" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_710" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_710" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_710" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_710" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_710" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_710" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_710" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardGross_710" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardGross_710" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_StockToBeIssuedDuringPeriodValueRestrictedStockUnit" xlink:label="loc_PPCBStockToBeIssuedDuringPeriodValueRestrictedStockUnit_710" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_PPCBStockToBeIssuedDuringPeriodValueRestrictedStockUnit_710" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_OptionsVestedDescription" xlink:label="loc_PPCBOptionsVestedDescription_710" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_PPCBOptionsVestedDescription_710" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_710" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_710" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_710" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_710" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_GrossProceedsFromEquityFinancing" xlink:label="loc_PPCBGrossProceedsFromEquityFinancing_710" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_PPCBGrossProceedsFromEquityFinancing_710" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedSalariesCurrent" xlink:label="loc_us-gaapAccruedSalariesCurrent_710" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapAccruedSalariesCurrent_710" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_CancellationOfAccruedSalaries" xlink:label="loc_PPCBCancellationOfAccruedSalaries_710" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_PPCBCancellationOfAccruedSalaries_710" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_OperatingLeasesRentExpenseMinimumRentalsPayable" xlink:label="loc_PPCBOperatingLeasesRentExpenseMinimumRentalsPayable_710" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_PPCBOperatingLeasesRentExpenseMinimumRentalsPayable_710" xlink:type="arc" order="42" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://propanc.com/role/ConcentrationsAndRisksDetailsNarrative" xlink:title="00000050 - Disclosure - CONCENTRATIONS AND RISKS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:label="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:label="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_LenderOneMember" xlink:label="loc_PPCBLenderOneMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_PPCBLenderOneMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_LenderTwoMember" xlink:label="loc_PPCBLenderTwoMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_PPCBLenderTwoMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_LenderThreeMember" xlink:label="loc_PPCBLenderThreeMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_PPCBLenderThreeMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="loc_us-gaapProceedsFromConvertibleDebt_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapProceedsFromConvertibleDebt_160" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_160" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:label="loc_us-gaapAmortizationOfFinancingCostsAndDiscounts_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapAmortizationOfFinancingCostsAndDiscounts_160" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_ReimbursementOnGoodsAndServiceTaxReceivablePercentage" xlink:label="loc_PPCBReimbursementOnGoodsAndServiceTaxReceivablePercentage_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_PPCBReimbursementOnGoodsAndServiceTaxReceivablePercentage_160" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://propanc.com/role/ScheduleOfFairValueMeasurementsRecurringAndNonrecurringValuationTechniquesDetails" xlink:title="00000051 - Disclosure - SCHEDULE OF FAIR VALUE MEASUREMENTS, RECURRING AND NONRECURRING, VALUATION TECHNIQUES (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems" xlink:label="loc_us-gaapDerivativeLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable" xlink:label="loc_us-gaapDerivativeTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDerivativeLineItems" xlink:to="loc_us-gaapDerivativeTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaapMeasurementInputTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapDerivativeTable" xlink:to="loc_us-gaapMeasurementInputTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="loc_us-gaapMeasurementInputPriceVolatilityMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputPriceVolatilityMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputExpectedTermMember" xlink:label="loc_us-gaapMeasurementInputExpectedTermMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputExpectedTermMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="loc_us-gaapMeasurementInputRiskFreeInterestRateMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputRiskFreeInterestRateMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputExpectedDividendRateMember" xlink:label="loc_us-gaapMeasurementInputExpectedDividendRateMember_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputExpectedDividendRateMember_130" xlink:type="arc" order="131" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapDerivativeTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="loc_us-gaapShortTermDebtTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapDerivativeTable" xlink:to="loc_us-gaapShortTermDebtTypeAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="loc_us-gaapShortTermDebtTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapShortTermDebtTypeAxis" xlink:to="loc_us-gaapShortTermDebtTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="loc_us-gaapShortTermDebtTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShortTermDebtTypeAxis" xlink:to="loc_us-gaapShortTermDebtTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtMember" xlink:label="loc_us-gaapConvertibleDebtMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtTypeDomain" xlink:to="loc_us-gaapConvertibleDebtMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentMeasurementInput" xlink:label="loc_us-gaapDebtInstrumentMeasurementInput_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeLineItems" xlink:to="loc_us-gaapDebtInstrumentMeasurementInput_250" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTerm" xlink:label="loc_us-gaapDebtInstrumentTerm_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeLineItems" xlink:to="loc_us-gaapDebtInstrumentTerm_250" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://propanc.com/role/ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" xlink:title="00000052 - Disclosure - SCHEDULE OF FAIR VALUE, ASSETS AND LIABILITIES MEASURED ON RECURRING BASIS (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:label="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:label="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaapFairValueInputsLevel1Member_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel1Member_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaapFairValueInputsLevel2Member_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel2Member_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaapFairValueInputsLevel3Member_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel3Member_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" xlink:label="loc_us-gaapEmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapEmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_130" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilities" xlink:label="loc_us-gaapDerivativeLiabilities_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapDerivativeLiabilities_130" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://propanc.com/role/ScheduleOfDerivativeLiabilitiesAtFairValueDetails" xlink:title="00000053 - Disclosure - SCHEDULE OF DERIVATIVE LIABILITIES AT FAIR VALUE (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://propanc.com/role/DerivativeFinancialInstrumentsAndFairValueMeasurementsDetailsNarrative" xlink:title="00000054 - Disclosure - DERIVATIVE FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:label="loc_us-gaapDerivativeInstrumentsGainLossLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:label="loc_us-gaapDerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDerivativeInstrumentsGainLossLineItems" xlink:to="loc_us-gaapDerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaapDerivativeInstrumentRiskAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapDerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:to="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaapDerivativeContractTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:to="loc_us-gaapDerivativeContractTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaapDerivativeContractTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:to="loc_us-gaapDerivativeContractTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtMember" xlink:label="loc_us-gaapConvertibleDebtMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_us-gaapConvertibleDebtMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebt" xlink:label="loc_us-gaapConvertibleDebt_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeInstrumentsGainLossLineItems" xlink:to="loc_us-gaapConvertibleDebt_60" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeInstrumentsGainLossLineItems" xlink:to="loc_us-gaapSharePrice_60" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://propanc.com/role/SubsequentEventsDetailsNarrative" xlink:title="00000055 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventLineItems" xlink:label="loc_us-gaapSubsequentEventLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTable" xlink:label="loc_us-gaapSubsequentEventTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapSubsequentEventTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_SeriesBWarrantsMember" xlink:label="loc_PPCBSeriesBWarrantsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_PPCBSeriesBWarrantsMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_TwelveSeriesAAndAWarrantsMember" xlink:label="loc_PPCBTwelveSeriesAAndAWarrantsMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_PPCBTwelveSeriesAAndAWarrantsMember_30" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_CommonStockOneMember" xlink:label="loc_PPCBCommonStockOneMember_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_PPCBCommonStockOneMember_180" xlink:type="arc" order="182" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_CommonStockTwoMember" xlink:label="loc_PPCBCommonStockTwoMember_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_PPCBCommonStockTwoMember_210" xlink:type="arc" order="212" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_CommonStockThreeMember" xlink:label="loc_PPCBCommonStockThreeMember_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_PPCBCommonStockThreeMember_230" xlink:type="arc" order="232" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_ElevenSeriesAWarrantsMember" xlink:label="loc_PPCBElevenSeriesAWarrantsMember_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_PPCBElevenSeriesAWarrantsMember_290" xlink:type="arc" order="292" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_60" xlink:type="arc" order="62" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_70" xlink:type="arc" order="72" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_NathanielszCancellationAgreementMember" xlink:label="loc_PPCBNathanielszCancellationAgreementMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_PPCBNathanielszCancellationAgreementMember_90" xlink:type="arc" order="92" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_KenyonCancellationAgreementMember" xlink:label="loc_PPCBKenyonCancellationAgreementMember_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_PPCBKenyonCancellationAgreementMember_130" xlink:type="arc" order="131" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_ZelingerAmendedAndRestatedDirectorAgreementMember" xlink:label="loc_PPCBZelingerAmendedAndRestatedDirectorAgreementMember_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_PPCBZelingerAmendedAndRestatedDirectorAgreementMember_150" xlink:type="arc" order="151" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_TwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember" xlink:label="loc_PPCBTwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_PPCBTwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember_250" xlink:type="arc" order="252" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_OctoberTwentyOneTwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember" xlink:label="loc_PPCBOctoberTwentyOneTwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_PPCBOctoberTwentyOneTwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember_330" xlink:type="arc" order="332" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_MrNathanielszMember" xlink:label="loc_PPCBMrNathanielszMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_PPCBMrNathanielszMember_100" xlink:type="arc" order="102" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_DrKenyonMember" xlink:label="loc_PPCBDrKenyonMember_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_PPCBDrKenyonMember_130" xlink:type="arc" order="132" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_JosefZelingerMember" xlink:label="loc_PPCBJosefZelingerMember_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_PPCBJosefZelingerMember_150" xlink:type="arc" order="152" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="loc_us-gaapProceedsFromWarrantExercises_360" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapProceedsFromWarrantExercises_360" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_360" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_360" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued_360" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued_360" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:label="loc_us-gaapDebtConversionConvertedInstrumentSharesIssued1_360" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapDebtConversionConvertedInstrumentSharesIssued1_360" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="loc_us-gaapDebtInstrumentConvertibleConversionPrice1_360" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapDebtInstrumentConvertibleConversionPrice1_360" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount_360" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount_360" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPayableCurrent" xlink:label="loc_us-gaapInterestPayableCurrent_360" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapInterestPayableCurrent_360" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_ConversionFees" xlink:label="loc_PPCBConversionFees_360" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_PPCBConversionFees_360" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital_360" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapAdditionalPaidInCapital_360" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_PercentageOfBonusOfAnnualBaseSalary" xlink:label="loc_PPCBPercentageOfBonusOfAnnualBaseSalary_360" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_PPCBPercentageOfBonusOfAnnualBaseSalary_360" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OfficersCompensation" xlink:label="loc_us-gaapOfficersCompensation_360" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapOfficersCompensation_360" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice_360" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapSharePrice_360" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_CancellationOfAccruedSalaries" xlink:label="loc_PPCBCancellationOfAccruedSalaries_360" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_PPCBCancellationOfAccruedSalaries_360" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_DescriptionOfEmploymentBenefits" xlink:label="loc_PPCBDescriptionOfEmploymentBenefits_360" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_PPCBDescriptionOfEmploymentBenefits_360" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_CommonStockIssuableShares" xlink:label="loc_PPCBCommonStockIssuableShares_360" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_PPCBCommonStockIssuableShares_360" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_360" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_360" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_360" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_360" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedBonusesCurrent" xlink:label="loc_us-gaapAccruedBonusesCurrent_360" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapAccruedBonusesCurrent_360" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LegalFees" xlink:label="loc_us-gaapLegalFees_360" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapLegalFees_360" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:label="loc_us-gaapDebtInstrumentUnamortizedDiscount_360" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapDebtInstrumentUnamortizedDiscount_360" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_us-gaapDebtInstrumentMaturityDate_360" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapDebtInstrumentMaturityDate_360" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:label="loc_us-gaapDebtInstrumentInterestRateDuringPeriod_360" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateDuringPeriod_360" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentDescription" xlink:label="loc_us-gaapDebtInstrumentDescription_360" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapDebtInstrumentDescription_360" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_DebtCoversionPercentage" xlink:label="loc_PPCBDebtCoversionPercentage_360" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_PPCBDebtCoversionPercentage_360" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaapEquityMethodInvestmentOwnershipPercentage_360" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentOwnershipPercentage_360" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_GainFromSettlementOfDebtNet" xlink:label="loc_PPCBGainFromSettlementOfDebtNet_360" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_PPCBGainFromSettlementOfDebtNet_360" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateTerms" xlink:label="loc_us-gaapDebtInstrumentInterestRateTerms_360" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateTerms_360" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_ConsultingAgreementDescription" xlink:label="loc_PPCBConsultingAgreementDescription_360" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_PPCBConsultingAgreementDescription_360" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_ConsultingAgreementMonthlyPayment" xlink:label="loc_PPCBConsultingAgreementMonthlyPayment_360" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_PPCBConsultingAgreementMonthlyPayment_360" xlink:type="arc" order="44" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>7
<FILENAME>ppcb-20210930_lab.xml
<DESCRIPTION>INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.11a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="us-gaap_SeriesAPreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesAPreferredStockMember" xlink:to="us-gaap_SeriesAPreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SeriesAPreferredStockMember_lbl" xml:lang="en-US">Series A Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="us-gaap_SeriesBPreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesBPreferredStockMember" xlink:to="us-gaap_SeriesBPreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SeriesBPreferredStockMember_lbl" xml:lang="en-US">Series B Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US">Equity Components [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockMember" xlink:label="us-gaap_PreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockMember" xlink:to="us-gaap_PreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockMember_lbl" xml:lang="en-US">Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US">Common Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_CommonStockIssuableMember" xlink:label="PPCB_CommonStockIssuableMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_CommonStockIssuableMember" xlink:to="PPCB_CommonStockIssuableMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_CommonStockIssuableMember_lbl" xml:lang="en-US">Common Stock Issuable [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsMember_lbl" xml:lang="en-US">Retained Earnings [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember" xlink:label="us-gaap_TreasuryStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockMember" xlink:to="us-gaap_TreasuryStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TreasuryStockMember_lbl" xml:lang="en-US">Treasury Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentAxis_lbl" xml:lang="en-US">Debt Instrument [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_IntercompanyLoansMember" xlink:label="PPCB_IntercompanyLoansMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_IntercompanyLoansMember" xlink:to="PPCB_IntercompanyLoansMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_IntercompanyLoansMember_lbl" xml:lang="en-US">Intercompany Loans [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeAxis" xlink:to="srt_RangeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RangeAxis_lbl" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_WeightedAverageMember" xlink:label="srt_WeightedAverageMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_WeightedAverageMember" xlink:to="srt_WeightedAverageMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_WeightedAverageMember_lbl" xml:lang="en-US">Weighted Average [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MachineryAndEquipmentMember" xlink:label="us-gaap_MachineryAndEquipmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MachineryAndEquipmentMember" xlink:to="us-gaap_MachineryAndEquipmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MachineryAndEquipmentMember_lbl" xml:lang="en-US">Machinery and Equipment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="us-gaap_FurnitureAndFixturesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FurnitureAndFixturesMember" xlink:to="us-gaap_FurnitureAndFixturesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FurnitureAndFixturesMember_lbl" xml:lang="en-US">Furniture and Fixtures [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeStockOptionMember" xlink:to="us-gaap_EmployeeStockOptionMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeStockOptionMember_lbl" xml:lang="en-US">Share-based Payment Arrangement, Option [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantMember" xlink:to="us-gaap_WarrantMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantMember_lbl" xml:lang="en-US">Warrant [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_UnvestedRestrictedStockMember" xlink:label="PPCB_UnvestedRestrictedStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_UnvestedRestrictedStockMember" xlink:to="PPCB_UnvestedRestrictedStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_UnvestedRestrictedStockMember_lbl" xml:lang="en-US">Unvested Restricted Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtSecuritiesMember" xlink:label="us-gaap_ConvertibleDebtSecuritiesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleDebtSecuritiesMember" xlink:to="us-gaap_ConvertibleDebtSecuritiesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertibleDebtSecuritiesMember_lbl" xml:lang="en-US">Convertible Debt Securities [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_TitleOfIndividualAxis_lbl" xml:lang="en-US">Title of Individual [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_DirectorsAndOfficerMember" xlink:label="PPCB_DirectorsAndOfficerMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_DirectorsAndOfficerMember" xlink:to="PPCB_DirectorsAndOfficerMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_DirectorsAndOfficerMember_lbl" xml:lang="en-US">Directors and Officer [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_TypeOfArrangementAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TypeOfArrangementAxis_lbl" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_DecemberTwentyNineTwoThousandAndSeventeenSecuritiesPurchaseAgreementMember" xlink:label="PPCB_DecemberTwentyNineTwoThousandAndSeventeenSecuritiesPurchaseAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_DecemberTwentyNineTwoThousandAndSeventeenSecuritiesPurchaseAgreementMember" xlink:to="PPCB_DecemberTwentyNineTwoThousandAndSeventeenSecuritiesPurchaseAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_DecemberTwentyNineTwoThousandAndSeventeenSecuritiesPurchaseAgreementMember_lbl" xml:lang="en-US">December 29, 2017 Securities Purchase Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LegalEntityAxis" xlink:to="dei_LegalEntityAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LegalEntityAxis_lbl" xml:lang="en-US">Legal Entity [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_EagleEquitiesLLCMember" xlink:label="PPCB_EagleEquitiesLLCMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_EagleEquitiesLLCMember" xlink:to="PPCB_EagleEquitiesLLCMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_EagleEquitiesLLCMember_lbl" xml:lang="en-US">Eagle Equities, LLC [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_DecemberTwoThousandAndSeventeenEagleNoteMember" xlink:label="PPCB_DecemberTwoThousandAndSeventeenEagleNoteMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_DecemberTwoThousandAndSeventeenEagleNoteMember" xlink:to="PPCB_DecemberTwoThousandAndSeventeenEagleNoteMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_DecemberTwoThousandAndSeventeenEagleNoteMember_lbl" xml:lang="en-US">December 2017 Eagle Note [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_DecemberTwentyNineTwoThousandAndSixteenSecuritiesPurchaseAgreementMember" xlink:label="PPCB_DecemberTwentyNineTwoThousandAndSixteenSecuritiesPurchaseAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_DecemberTwentyNineTwoThousandAndSixteenSecuritiesPurchaseAgreementMember" xlink:to="PPCB_DecemberTwentyNineTwoThousandAndSixteenSecuritiesPurchaseAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_DecemberTwentyNineTwoThousandAndSixteenSecuritiesPurchaseAgreementMember_lbl" xml:lang="en-US">December 21, 2016 Securities Purchase Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_JulyThirteenTwoThousandAndEighteenSecuritiesPurchaseAgreementMember" xlink:label="PPCB_JulyThirteenTwoThousandAndEighteenSecuritiesPurchaseAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_JulyThirteenTwoThousandAndEighteenSecuritiesPurchaseAgreementMember" xlink:to="PPCB_JulyThirteenTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_JulyThirteenTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_lbl" xml:lang="en-US">July 13, 2018 Securities Purchase Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_JulyTwoThousandEighteenEagleNoteMember" xlink:label="PPCB_JulyTwoThousandEighteenEagleNoteMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_JulyTwoThousandEighteenEagleNoteMember" xlink:to="PPCB_JulyTwoThousandEighteenEagleNoteMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_JulyTwoThousandEighteenEagleNoteMember_lbl" xml:lang="en-US">July 2018 Eagle Note [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_JuneTwentyNineTwoThousandEighteenSecuritiesPurchaseAgreementMember" xlink:label="PPCB_JuneTwentyNineTwoThousandEighteenSecuritiesPurchaseAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_JuneTwentyNineTwoThousandEighteenSecuritiesPurchaseAgreementMember" xlink:to="PPCB_JuneTwentyNineTwoThousandEighteenSecuritiesPurchaseAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_JuneTwentyNineTwoThousandEighteenSecuritiesPurchaseAgreementMember_lbl" xml:lang="en-US">June 14, 2018 Securities Purchase Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_AugustTwentyNineTwoThousandandEighteenSecuritiesPurchaseAgreementMember" xlink:label="PPCB_AugustTwentyNineTwoThousandandEighteenSecuritiesPurchaseAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_AugustTwentyNineTwoThousandandEighteenSecuritiesPurchaseAgreementMember" xlink:to="PPCB_AugustTwentyNineTwoThousandandEighteenSecuritiesPurchaseAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_AugustTwentyNineTwoThousandandEighteenSecuritiesPurchaseAgreementMember_lbl" xml:lang="en-US">August 29, 2018 Securities Purchase Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_AugustTwoThousandEighteenEagleNoteMember" xlink:label="PPCB_AugustTwoThousandEighteenEagleNoteMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_AugustTwoThousandEighteenEagleNoteMember" xlink:to="PPCB_AugustTwoThousandEighteenEagleNoteMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_AugustTwoThousandEighteenEagleNoteMember_lbl" xml:lang="en-US">August 2018 Eagle Note [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember" xlink:label="PPCB_OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember" xlink:to="PPCB_OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_lbl" xml:lang="en-US">October 2, 2018 Securities Purchase Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_OctoberTwoTwoThousandAndEighteenEagleNoteMember" xlink:label="PPCB_OctoberTwoTwoThousandAndEighteenEagleNoteMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_OctoberTwoTwoThousandAndEighteenEagleNoteMember" xlink:to="PPCB_OctoberTwoTwoThousandAndEighteenEagleNoteMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_OctoberTwoTwoThousandAndEighteenEagleNoteMember_lbl" xml:lang="en-US">October 2018 Eagle Note [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_NovembeThirtyTwoThousandAndEighteenMecuritiesPurchaseAgreementMember" xlink:label="PPCB_NovembeThirtyTwoThousandAndEighteenMecuritiesPurchaseAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_NovembeThirtyTwoThousandAndEighteenMecuritiesPurchaseAgreementMember" xlink:to="PPCB_NovembeThirtyTwoThousandAndEighteenMecuritiesPurchaseAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_NovembeThirtyTwoThousandAndEighteenMecuritiesPurchaseAgreementMember_lbl" xml:lang="en-US">November 30, 2018 Securities Purchase Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_NovemberTwoThousandAndEighteenEagleNoteMember" xlink:label="PPCB_NovemberTwoThousandAndEighteenEagleNoteMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_NovemberTwoThousandAndEighteenEagleNoteMember" xlink:to="PPCB_NovemberTwoThousandAndEighteenEagleNoteMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_NovemberTwoThousandAndEighteenEagleNoteMember_lbl" xml:lang="en-US">November 2018 Eagle Note [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember" xlink:label="PPCB_DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember" xlink:to="PPCB_DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_lbl" xml:lang="en-US">December 24, 2018 Securities Purchase Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_DecembeTwoThousandAndEighteenEagleNoteMember" xlink:label="PPCB_DecembeTwoThousandAndEighteenEagleNoteMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_DecembeTwoThousandAndEighteenEagleNoteMember" xlink:to="PPCB_DecembeTwoThousandAndEighteenEagleNoteMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_DecembeTwoThousandAndEighteenEagleNoteMember_lbl" xml:lang="en-US">December 2018 Eagle Note [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MinimumMember" xlink:to="srt_MinimumMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MinimumMember_lbl" xml:lang="en-US">Minimum [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MaximumMember" xlink:to="srt_MaximumMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MaximumMember_lbl" xml:lang="en-US">Maximum [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_DepositoryTrustCompanyMember" xlink:label="PPCB_DepositoryTrustCompanyMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_DepositoryTrustCompanyMember" xlink:to="PPCB_DepositoryTrustCompanyMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_DepositoryTrustCompanyMember_lbl" xml:lang="en-US">Depository Trust Company [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_SecuritiesPurchaseAgreementOneMember" xlink:label="PPCB_SecuritiesPurchaseAgreementOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_SecuritiesPurchaseAgreementOneMember" xlink:to="PPCB_SecuritiesPurchaseAgreementOneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_SecuritiesPurchaseAgreementOneMember_lbl" xml:lang="en-US">Securities Purchase Agreement One [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_GSCapitalPartnersLLCMember" xlink:label="PPCB_GSCapitalPartnersLLCMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_GSCapitalPartnersLLCMember" xlink:to="PPCB_GSCapitalPartnersLLCMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_GSCapitalPartnersLLCMember_lbl" xml:lang="en-US">GS Capital Partners, LLC [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_OctoberTwoThousandEighteenGSNoteMember" xlink:label="PPCB_OctoberTwoThousandEighteenGSNoteMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_OctoberTwoThousandEighteenGSNoteMember" xlink:to="PPCB_OctoberTwoThousandEighteenGSNoteMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_OctoberTwoThousandEighteenGSNoteMember_lbl" xml:lang="en-US">October 2018 GS Note [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="us-gaap_ShortTermDebtTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermDebtTypeAxis" xlink:to="us-gaap_ShortTermDebtTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermDebtTypeAxis_lbl" xml:lang="en-US">Short-term Debt, Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_FirstNoteMember" xlink:label="PPCB_FirstNoteMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_FirstNoteMember" xlink:to="PPCB_FirstNoteMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_FirstNoteMember_lbl" xml:lang="en-US">First Note [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_SecondNoteMember" xlink:label="PPCB_SecondNoteMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_SecondNoteMember" xlink:to="PPCB_SecondNoteMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_SecondNoteMember_lbl" xml:lang="en-US">Second Note [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_SecuritiesPurchaseAgreementMember" xlink:label="PPCB_SecuritiesPurchaseAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_SecuritiesPurchaseAgreementMember" xlink:to="PPCB_SecuritiesPurchaseAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_SecuritiesPurchaseAgreementMember_lbl" xml:lang="en-US">Securities Purchase Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_JanuaryTwentyTwoTwentyTwentyGSNoteMember" xlink:label="PPCB_JanuaryTwentyTwoTwentyTwentyGSNoteMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_JanuaryTwentyTwoTwentyTwentyGSNoteMember" xlink:to="PPCB_JanuaryTwentyTwoTwentyTwentyGSNoteMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_JanuaryTwentyTwoTwentyTwentyGSNoteMember_lbl" xml:lang="en-US">January 22, 2020 GS Note [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_AugustTenTwoThousandAndSeventeenConsultingAgreementMember" xlink:label="PPCB_AugustTenTwoThousandAndSeventeenConsultingAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_AugustTenTwoThousandAndSeventeenConsultingAgreementMember" xlink:to="PPCB_AugustTenTwoThousandAndSeventeenConsultingAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_AugustTenTwoThousandAndSeventeenConsultingAgreementMember_lbl" xml:lang="en-US">August 10, 2017 Consulting Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xml:lang="en-US">Related Party [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_ConsultantMember" xlink:label="PPCB_ConsultantMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_ConsultantMember" xlink:to="PPCB_ConsultantMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_ConsultantMember_lbl" xml:lang="en-US">Consultant [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_SettlementAndMutualReleaseAgreementMember" xlink:label="PPCB_SettlementAndMutualReleaseAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_SettlementAndMutualReleaseAgreementMember" xlink:to="PPCB_SettlementAndMutualReleaseAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_SettlementAndMutualReleaseAgreementMember_lbl" xml:lang="en-US">Settlement and Mutual Release Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_NovemberTwentySixTwoThousandNineteenSecuritiesPurchaseAgreementMember" xlink:label="PPCB_NovemberTwentySixTwoThousandNineteenSecuritiesPurchaseAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_NovemberTwentySixTwoThousandNineteenSecuritiesPurchaseAgreementMember" xlink:to="PPCB_NovemberTwentySixTwoThousandNineteenSecuritiesPurchaseAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_NovemberTwentySixTwoThousandNineteenSecuritiesPurchaseAgreementMember_lbl" xml:lang="en-US">November 26, 2019 Securities Purchase Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_NovemberTwentySixTwoThousandNineteenPowerUpNoteMember" xlink:label="PPCB_NovemberTwentySixTwoThousandNineteenPowerUpNoteMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_NovemberTwentySixTwoThousandNineteenPowerUpNoteMember" xlink:to="PPCB_NovemberTwentySixTwoThousandNineteenPowerUpNoteMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_NovemberTwentySixTwoThousandNineteenPowerUpNoteMember_lbl" xml:lang="en-US">November 26, 2019 Power Up Note [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_JanuarySevenTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember" xlink:label="PPCB_JanuarySevenTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_JanuarySevenTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember" xlink:to="PPCB_JanuarySevenTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_JanuarySevenTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember_lbl" xml:lang="en-US">January 7, 2020 Power Up Lending Group Securities Purchase Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_JanuarySevenTwoThousandTwentyPowerUpNoteMember" xlink:label="PPCB_JanuarySevenTwoThousandTwentyPowerUpNoteMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_JanuarySevenTwoThousandTwentyPowerUpNoteMember" xlink:to="PPCB_JanuarySevenTwoThousandTwentyPowerUpNoteMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_JanuarySevenTwoThousandTwentyPowerUpNoteMember_lbl" xml:lang="en-US">January 7, 2020 Power Up Note [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember" xlink:label="PPCB_MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember" xlink:to="PPCB_MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember_lbl" xml:lang="en-US">March 12, 2020 Power Up Lending Group Securities Purchase Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_MarchTwelveTwoThousandTwentyPowerUpNoteMember" xlink:label="PPCB_MarchTwelveTwoThousandTwentyPowerUpNoteMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_MarchTwelveTwoThousandTwentyPowerUpNoteMember" xlink:to="PPCB_MarchTwelveTwoThousandTwentyPowerUpNoteMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_MarchTwelveTwoThousandTwentyPowerUpNoteMember_lbl" xml:lang="en-US">March 12, 2020 Power Up Note [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_RedstartHoldingsCorpFinancingAgreementMember" xlink:label="PPCB_RedstartHoldingsCorpFinancingAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_RedstartHoldingsCorpFinancingAgreementMember" xlink:to="PPCB_RedstartHoldingsCorpFinancingAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_RedstartHoldingsCorpFinancingAgreementMember_lbl" xml:lang="en-US">Redstart Holdings Corp Financing Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_RedstartHoldingsCorpMember" xlink:label="PPCB_RedstartHoldingsCorpMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_RedstartHoldingsCorpMember" xlink:to="PPCB_RedstartHoldingsCorpMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_RedstartHoldingsCorpMember_lbl" xml:lang="en-US">Redstart Holdings Corp [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_OdysseyCapitalFundingLLCMember" xlink:label="PPCB_OdysseyCapitalFundingLLCMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_OdysseyCapitalFundingLLCMember" xlink:to="PPCB_OdysseyCapitalFundingLLCMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_OdysseyCapitalFundingLLCMember_lbl" xml:lang="en-US">Odyssey Capital Funding LLC [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_JulyTwoThousandNineteenOdysseyNoteMember" xlink:label="PPCB_JulyTwoThousandNineteenOdysseyNoteMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_JulyTwoThousandNineteenOdysseyNoteMember" xlink:to="PPCB_JulyTwoThousandNineteenOdysseyNoteMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_JulyTwoThousandNineteenOdysseyNoteMember_lbl" xml:lang="en-US">July 2019 Odyssey Note [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_AuctusFundLLCMember" xlink:label="PPCB_AuctusFundLLCMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_AuctusFundLLCMember" xlink:to="PPCB_AuctusFundLLCMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_AuctusFundLLCMember_lbl" xml:lang="en-US">Auctus Fund, LLC [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_AugustTwoThousandNineteenAuctusNoteMember" xlink:label="PPCB_AugustTwoThousandNineteenAuctusNoteMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_AugustTwoThousandNineteenAuctusNoteMember" xlink:to="PPCB_AugustTwoThousandNineteenAuctusNoteMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_AugustTwoThousandNineteenAuctusNoteMember_lbl" xml:lang="en-US">August 2019 Auctus Note [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_FirstWarrantMember" xlink:label="PPCB_FirstWarrantMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_FirstWarrantMember" xlink:to="PPCB_FirstWarrantMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_FirstWarrantMember_lbl" xml:lang="en-US">First Warrant [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_SecondWarrantMember" xlink:label="PPCB_SecondWarrantMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_SecondWarrantMember" xlink:to="PPCB_SecondWarrantMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_SecondWarrantMember_lbl" xml:lang="en-US">Second Warrant [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_ThirdWarrantMember" xlink:label="PPCB_ThirdWarrantMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_ThirdWarrantMember" xlink:to="PPCB_ThirdWarrantMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_ThirdWarrantMember_lbl" xml:lang="en-US">Third Warrant [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_GWHoldingsGroupLLCMember" xlink:label="PPCB_GWHoldingsGroupLLCMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_GWHoldingsGroupLLCMember" xlink:to="PPCB_GWHoldingsGroupLLCMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_GWHoldingsGroupLLCMember_lbl" xml:lang="en-US">GW Holdings Group, LLC [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_OctoberOneTwoThousandNineteenAuctusNoteMember" xlink:label="PPCB_OctoberOneTwoThousandNineteenAuctusNoteMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_OctoberOneTwoThousandNineteenAuctusNoteMember" xlink:to="PPCB_OctoberOneTwoThousandNineteenAuctusNoteMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_OctoberOneTwoThousandNineteenAuctusNoteMember_lbl" xml:lang="en-US">October 1, 2019 GW Note [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_DecemberTenTwoThousandTwentyGWNoteMember" xlink:label="PPCB_DecemberTenTwoThousandTwentyGWNoteMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_DecemberTenTwoThousandTwentyGWNoteMember" xlink:to="PPCB_DecemberTenTwoThousandTwentyGWNoteMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_DecemberTenTwoThousandTwentyGWNoteMember_lbl" xml:lang="en-US">December 10 2020 GW Note [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_CrownBridgePartnersLLCMember" xlink:label="PPCB_CrownBridgePartnersLLCMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_CrownBridgePartnersLLCMember" xlink:to="PPCB_CrownBridgePartnersLLCMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_CrownBridgePartnersLLCMember_lbl" xml:lang="en-US">Crown Bridge Partners, LLC [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_OctoberThreeTwoThousandNineteenAuctusNoteMember" xlink:label="PPCB_OctoberThreeTwoThousandNineteenAuctusNoteMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_OctoberThreeTwoThousandNineteenAuctusNoteMember" xlink:to="PPCB_OctoberThreeTwoThousandNineteenAuctusNoteMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_OctoberThreeTwoThousandNineteenAuctusNoteMember_lbl" xml:lang="en-US">October 3, 2019 GW Note [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_JanuaryThirteenTwentyTwentyAderAlefNoteMember" xlink:label="PPCB_JanuaryThirteenTwentyTwentyAderAlefNoteMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_JanuaryThirteenTwentyTwentyAderAlefNoteMember" xlink:to="PPCB_JanuaryThirteenTwentyTwentyAderAlefNoteMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_JanuaryThirteenTwentyTwentyAderAlefNoteMember_lbl" xml:lang="en-US">January 13, 2020 Ader Alef Note [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember" xlink:label="PPCB_FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember" xlink:to="PPCB_FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember_lbl" xml:lang="en-US">February19 2020 LG Capital Note [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_LGCapitalFundingLLCMember" xlink:label="PPCB_LGCapitalFundingLLCMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_LGCapitalFundingLLCMember" xlink:to="PPCB_LGCapitalFundingLLCMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_LGCapitalFundingLLCMember_lbl" xml:lang="en-US">LG Capital Funding, LLC [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_DecemberTwoTwoThousandTwentyGenevaRothMember" xlink:label="PPCB_DecemberTwoTwoThousandTwentyGenevaRothMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_DecemberTwoTwoThousandTwentyGenevaRothMember" xlink:to="PPCB_DecemberTwoTwoThousandTwentyGenevaRothMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_DecemberTwoTwoThousandTwentyGenevaRothMember_lbl" xml:lang="en-US">December 02 2020 Geneva Roth [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_GenevaRothRemarkHoldingsIncMember" xlink:label="PPCB_GenevaRothRemarkHoldingsIncMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_GenevaRothRemarkHoldingsIncMember" xlink:to="PPCB_GenevaRothRemarkHoldingsIncMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_GenevaRothRemarkHoldingsIncMember_lbl" xml:lang="en-US">Geneva Roth Remark Holdings Inc [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_JanuaryFiveTwoThousandTwentyOneGenevaRothMember" xlink:label="PPCB_JanuaryFiveTwoThousandTwentyOneGenevaRothMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_JanuaryFiveTwoThousandTwentyOneGenevaRothMember" xlink:to="PPCB_JanuaryFiveTwoThousandTwentyOneGenevaRothMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_JanuaryFiveTwoThousandTwentyOneGenevaRothMember_lbl" xml:lang="en-US">January 05, 2021 One Geneva Roth [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_MarchSixteenTwoThousandTwentyOneGenevaRothMember" xlink:label="PPCB_MarchSixteenTwoThousandTwentyOneGenevaRothMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_MarchSixteenTwoThousandTwentyOneGenevaRothMember" xlink:to="PPCB_MarchSixteenTwoThousandTwentyOneGenevaRothMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_MarchSixteenTwoThousandTwentyOneGenevaRothMember_lbl" xml:lang="en-US">March 16, 2021 Geneva Roth [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis" xlink:label="srt_StatementGeographicalAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_StatementGeographicalAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_StatementGeographicalAxis_lbl" xml:lang="en-US">Geographical [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US" xlink:label="country_US" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_US" xlink:to="country_US_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_US_lbl" xml:lang="en-US">UNITED STATES</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_CaresActMember" xlink:label="PPCB_CaresActMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_CaresActMember" xlink:to="PPCB_CaresActMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_CaresActMember_lbl" xml:lang="en-US">CARES Act [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_AU" xlink:label="country_AU" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_AU" xlink:to="country_AU_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_AU_lbl" xml:lang="en-US">AUSTRALIA</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardDateAxis" xlink:label="us-gaap_AwardDateAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardDateAxis" xlink:to="us-gaap_AwardDateAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AwardDateAxis_lbl" xml:lang="en-US">Award Date [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_ExpireInTwoThousandTwentyFourMember" xlink:label="PPCB_ExpireInTwoThousandTwentyFourMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_ExpireInTwoThousandTwentyFourMember" xlink:to="PPCB_ExpireInTwoThousandTwentyFourMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_ExpireInTwoThousandTwentyFourMember_lbl" xml:lang="en-US">Expire in 2024 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_NotExpireMember" xlink:label="PPCB_NotExpireMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_NotExpireMember" xlink:to="PPCB_NotExpireMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_NotExpireMember_lbl" xml:lang="en-US">Not Expire [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_SecurityPurchaseAgreementMember" xlink:label="PPCB_SecurityPurchaseAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_SecurityPurchaseAgreementMember" xlink:to="PPCB_SecurityPurchaseAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_SecurityPurchaseAgreementMember_lbl" xml:lang="en-US">Security Purchase Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_SeriesBWarrantsMember" xlink:label="PPCB_SeriesBWarrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_SeriesBWarrantsMember" xlink:to="PPCB_SeriesBWarrantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_SeriesBWarrantsMember_lbl" xml:lang="en-US">Series B Warrants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_SeriesCWarrantsMember" xlink:label="PPCB_SeriesCWarrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_SeriesCWarrantsMember" xlink:to="PPCB_SeriesCWarrantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_SeriesCWarrantsMember_lbl" xml:lang="en-US">Series C Warrants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_SeriesAWarrantsMember" xlink:label="PPCB_SeriesAWarrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_SeriesAWarrantsMember" xlink:to="PPCB_SeriesAWarrantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_SeriesAWarrantsMember_lbl" xml:lang="en-US">Series A Warrants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AwardTypeAxis_lbl" xml:lang="en-US">Award Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedStockMember" xlink:to="us-gaap_RestrictedStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestrictedStockMember_lbl" xml:lang="en-US">Restricted Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_PrefundedWarrantsMember" xlink:label="PPCB_PrefundedWarrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_PrefundedWarrantsMember" xlink:to="PPCB_PrefundedWarrantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_PrefundedWarrantsMember_lbl" xml:lang="en-US">Prefunded Warrants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_UnderlyingFinancingAgreementsMember" xlink:label="PPCB_UnderlyingFinancingAgreementsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_UnderlyingFinancingAgreementsMember" xlink:to="PPCB_UnderlyingFinancingAgreementsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_UnderlyingFinancingAgreementsMember_lbl" xml:lang="en-US">Underlying Financing Agreements [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_ConsultingAgreementMember" xlink:label="PPCB_ConsultingAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_ConsultingAgreementMember" xlink:to="PPCB_ConsultingAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_ConsultingAgreementMember_lbl" xml:lang="en-US">Consulting Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_EngagementAgreementMember" xlink:label="PPCB_EngagementAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_EngagementAgreementMember" xlink:to="PPCB_EngagementAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_EngagementAgreementMember_lbl" xml:lang="en-US">Engagement Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_TwentySeriesAAndOneSeriesCWarrantsMember" xlink:label="PPCB_TwentySeriesAAndOneSeriesCWarrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_TwentySeriesAAndOneSeriesCWarrantsMember" xlink:to="PPCB_TwentySeriesAAndOneSeriesCWarrantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_TwentySeriesAAndOneSeriesCWarrantsMember_lbl" xml:lang="en-US">20 Series A and 1 Series C Warrants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ChiefExecutiveOfficerMember" xlink:label="srt_ChiefExecutiveOfficerMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ChiefExecutiveOfficerMember" xlink:to="srt_ChiefExecutiveOfficerMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ChiefExecutiveOfficerMember_lbl" xml:lang="en-US">Chief Executive Officer [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedStockUnitsRSUMember" xlink:to="us-gaap_RestrictedStockUnitsRSUMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestrictedStockUnitsRSUMember_lbl" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PlanNameAxis_lbl" xml:lang="en-US">Plan Name [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_TwoThousandNinteenEquityIncentivePlanMember" xlink:label="PPCB_TwoThousandNinteenEquityIncentivePlanMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_TwoThousandNinteenEquityIncentivePlanMember" xlink:to="PPCB_TwoThousandNinteenEquityIncentivePlanMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_TwoThousandNinteenEquityIncentivePlanMember_lbl" xml:lang="en-US">2019 Equity Incentive Plan [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_EmploymentAgreementsMember" xlink:label="PPCB_EmploymentAgreementsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_EmploymentAgreementsMember" xlink:to="PPCB_EmploymentAgreementsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_EmploymentAgreementsMember_lbl" xml:lang="en-US">Employment Agreements [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestorMember" xlink:label="us-gaap_InvestorMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestorMember" xlink:to="us-gaap_InvestorMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestorMember_lbl" xml:lang="en-US">Investor [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_HolderMember" xlink:label="PPCB_HolderMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_HolderMember" xlink:to="PPCB_HolderMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_HolderMember_lbl" xml:lang="en-US">Holder [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_FoleyShechterMember" xlink:label="PPCB_FoleyShechterMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_FoleyShechterMember" xlink:to="PPCB_FoleyShechterMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_FoleyShechterMember_lbl" xml:lang="en-US">Foley Shechter [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_SettlementAgreementMember" xlink:label="PPCB_SettlementAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_SettlementAgreementMember" xlink:to="PPCB_SettlementAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_SettlementAgreementMember_lbl" xml:lang="en-US">Settlement Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_RegalConsultingLLCMember" xlink:label="PPCB_RegalConsultingLLCMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_RegalConsultingLLCMember" xlink:to="PPCB_RegalConsultingLLCMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_RegalConsultingLLCMember_lbl" xml:lang="en-US">Regal Consulting, LLC [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_TwoThousandAndSeventeenNoteMember" xlink:label="PPCB_TwoThousandAndSeventeenNoteMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_TwoThousandAndSeventeenNoteMember" xlink:to="PPCB_TwoThousandAndSeventeenNoteMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_TwoThousandAndSeventeenNoteMember_lbl" xml:lang="en-US">2017 Note [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_From2012ThroughThe2014Member" xlink:label="PPCB_From2012ThroughThe2014Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_From2012ThroughThe2014Member" xlink:to="PPCB_From2012ThroughThe2014Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_From2012ThroughThe2014Member_lbl" xml:lang="en-US">From 2012 through the 2014 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RoyaltyAgreementTermsMember" xlink:label="us-gaap_RoyaltyAgreementTermsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RoyaltyAgreementTermsMember" xlink:to="us-gaap_RoyaltyAgreementTermsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RoyaltyAgreementTermsMember_lbl" xml:lang="en-US">Royalty Agreement Terms [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LicenseAgreementTermsMember" xlink:label="us-gaap_LicenseAgreementTermsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LicenseAgreementTermsMember" xlink:to="us-gaap_LicenseAgreementTermsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LicenseAgreementTermsMember_lbl" xml:lang="en-US">License Agreement Terms [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_NewFiveYearOperatingLeaseAgreementMember" xlink:label="PPCB_NewFiveYearOperatingLeaseAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_NewFiveYearOperatingLeaseAgreementMember" xlink:to="PPCB_NewFiveYearOperatingLeaseAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_NewFiveYearOperatingLeaseAgreementMember_lbl" xml:lang="en-US">New Five-Year Operating Lease Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_AUDCurrencyMember" xlink:label="PPCB_AUDCurrencyMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_AUDCurrencyMember" xlink:to="PPCB_AUDCurrencyMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_AUDCurrencyMember_lbl" xml:lang="en-US">AUD Currency [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_lbl" xml:lang="en-US">Accounting Standards Update [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate201602Member" xlink:label="us-gaap_AccountingStandardsUpdate201602Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingStandardsUpdate201602Member" xlink:to="us-gaap_AccountingStandardsUpdate201602Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingStandardsUpdate201602Member_lbl" xml:lang="en-US">Accounting Standards Update 2016-02 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_OneYearCollaborationAgreementMember" xlink:label="PPCB_OneYearCollaborationAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_OneYearCollaborationAgreementMember" xlink:to="PPCB_OneYearCollaborationAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_OneYearCollaborationAgreementMember_lbl" xml:lang="en-US">1-Year Collaboration Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_EurosMember" xlink:label="PPCB_EurosMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_EurosMember" xlink:to="PPCB_EurosMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_EurosMember_lbl" xml:lang="en-US">Euros [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_TwoYearCollaborationAgreementMember" xlink:label="PPCB_TwoYearCollaborationAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_TwoYearCollaborationAgreementMember" xlink:to="PPCB_TwoYearCollaborationAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_TwoYearCollaborationAgreementMember_lbl" xml:lang="en-US">2-Year Collaboration Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesRevenueNetMember" xlink:label="us-gaap_SalesRevenueNetMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesRevenueNetMember" xlink:to="us-gaap_SalesRevenueNetMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SalesRevenueNetMember_lbl" xml:lang="en-US">Revenue Benchmark [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="us-gaap_ConcentrationRiskByTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskByTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskByTypeAxis_lbl" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromRightsConcentrationRiskMember" xlink:label="us-gaap_RevenueFromRightsConcentrationRiskMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromRightsConcentrationRiskMember" xlink:to="us-gaap_RevenueFromRightsConcentrationRiskMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueFromRightsConcentrationRiskMember_lbl" xml:lang="en-US">Revenue from Rights Concentration Risk [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis" xlink:label="srt_MajorCustomersAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MajorCustomersAxis" xlink:to="srt_MajorCustomersAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MajorCustomersAxis_lbl" xml:lang="en-US">Customer [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_NoCustomerMember" xlink:label="PPCB_NoCustomerMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_NoCustomerMember" xlink:to="PPCB_NoCustomerMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_NoCustomerMember_lbl" xml:lang="en-US">No Customer [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_InstallmentOneMember" xlink:label="PPCB_InstallmentOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_InstallmentOneMember" xlink:to="PPCB_InstallmentOneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_InstallmentOneMember_lbl" xml:lang="en-US">Installment 1 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_InstallmentTwoMember" xlink:label="PPCB_InstallmentTwoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_InstallmentTwoMember" xlink:to="PPCB_InstallmentTwoMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_InstallmentTwoMember_lbl" xml:lang="en-US">Installment 2 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_InstallmentThreeMember" xlink:label="PPCB_InstallmentThreeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_InstallmentThreeMember" xlink:to="PPCB_InstallmentThreeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_InstallmentThreeMember_lbl" xml:lang="en-US">Installment 3 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_InstallmentFourMember" xlink:label="PPCB_InstallmentFourMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_InstallmentFourMember" xlink:to="PPCB_InstallmentFourMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_InstallmentFourMember_lbl" xml:lang="en-US">Installment 4 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_UniversityOfJaenMember" xlink:label="PPCB_UniversityOfJaenMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_UniversityOfJaenMember" xlink:to="PPCB_UniversityOfJaenMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_UniversityOfJaenMember_lbl" xml:lang="en-US">University of Jaen [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_CurrentAndFormerDirectorMember" xlink:label="PPCB_CurrentAndFormerDirectorMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_CurrentAndFormerDirectorMember" xlink:to="PPCB_CurrentAndFormerDirectorMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_CurrentAndFormerDirectorMember_lbl" xml:lang="en-US">Current and Former Director [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_FormerDirectorMember" xlink:label="PPCB_FormerDirectorMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_FormerDirectorMember" xlink:to="PPCB_FormerDirectorMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_FormerDirectorMember_lbl" xml:lang="en-US">Former Director [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_NorthHorizonPtyLtdMember" xlink:label="PPCB_NorthHorizonPtyLtdMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_NorthHorizonPtyLtdMember" xlink:to="PPCB_NorthHorizonPtyLtdMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_NorthHorizonPtyLtdMember_lbl" xml:lang="en-US">North Horizon Pty Ltd [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_AUDCurrenryMember" xlink:label="PPCB_AUDCurrenryMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_AUDCurrenryMember" xlink:to="PPCB_AUDCurrenryMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="PPCB_AUDCurrenryMember_lbl" xml:lang="en-US">AUD Currency [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_NathanielszMember" xlink:label="PPCB_NathanielszMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_NathanielszMember" xlink:to="PPCB_NathanielszMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_NathanielszMember_lbl" xml:lang="en-US">Nathanielsz [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_NathanielszEmploymentAgreementMember" xlink:label="PPCB_NathanielszEmploymentAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_NathanielszEmploymentAgreementMember" xlink:to="PPCB_NathanielszEmploymentAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_NathanielszEmploymentAgreementMember_lbl" xml:lang="en-US">Nathanielsz Employment Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_MrsNathanielszMember" xlink:label="PPCB_MrsNathanielszMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_MrsNathanielszMember" xlink:to="PPCB_MrsNathanielszMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_MrsNathanielszMember_lbl" xml:lang="en-US">Mrs. Nathanielsz [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_JamesNathanielszMember" xlink:label="PPCB_JamesNathanielszMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_JamesNathanielszMember" xlink:to="PPCB_JamesNathanielszMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_JamesNathanielszMember_lbl" xml:lang="en-US">James Nathanielsz [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_MrNathanielszMember" xlink:label="PPCB_MrNathanielszMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_MrNathanielszMember" xlink:to="PPCB_MrNathanielszMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_MrNathanielszMember_lbl" xml:lang="en-US">Mr. Nathanielsz [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_BoardOfDirectorsMember" xlink:label="PPCB_BoardOfDirectorsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_BoardOfDirectorsMember" xlink:to="PPCB_BoardOfDirectorsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_BoardOfDirectorsMember_lbl" xml:lang="en-US">Board of Directors [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventMember_lbl" xml:lang="en-US">Subsequent Event [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_EmploymentAgreementMember" xlink:label="PPCB_EmploymentAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_EmploymentAgreementMember" xlink:to="PPCB_EmploymentAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_EmploymentAgreementMember_lbl" xml:lang="en-US">Employment Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_RestrictedStocksUnitsRSUMember" xlink:label="PPCB_RestrictedStocksUnitsRSUMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_RestrictedStocksUnitsRSUMember" xlink:to="PPCB_RestrictedStocksUnitsRSUMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_RestrictedStocksUnitsRSUMember_lbl" xml:lang="en-US">Initial Nathanielsz RSUs [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_AdditionaNathanielszRSUsMember" xlink:label="PPCB_AdditionaNathanielszRSUsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_AdditionaNathanielszRSUsMember" xlink:to="PPCB_AdditionaNathanielszRSUsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_AdditionaNathanielszRSUsMember_lbl" xml:lang="en-US">Additional Nathanielsz RSUs [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_ServicesAgreementMember" xlink:label="PPCB_ServicesAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_ServicesAgreementMember" xlink:to="PPCB_ServicesAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_ServicesAgreementMember_lbl" xml:lang="en-US">Services Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_DrKenyonMember" xlink:label="PPCB_DrKenyonMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_DrKenyonMember" xlink:to="PPCB_DrKenyonMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_DrKenyonMember_lbl" xml:lang="en-US">Dr. Kenyon [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_DrKenyonMemberMember" xlink:label="PPCB_DrKenyonMemberMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_DrKenyonMemberMember" xlink:to="PPCB_DrKenyonMemberMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_DrKenyonMemberMember_lbl" xml:lang="en-US">Dr Kenyon [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_InitialKenyonRSUsMember" xlink:label="PPCB_InitialKenyonRSUsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_InitialKenyonRSUsMember" xlink:to="PPCB_InitialKenyonRSUsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_InitialKenyonRSUsMember_lbl" xml:lang="en-US">Initial Kenyon RSUs [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_AdditionalKenyonRSUsMember" xlink:label="PPCB_AdditionalKenyonRSUsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_AdditionalKenyonRSUsMember" xlink:to="PPCB_AdditionalKenyonRSUsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_AdditionalKenyonRSUsMember_lbl" xml:lang="en-US">Additional Kenyon RSUs [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_LenderOneMember" xlink:label="PPCB_LenderOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_LenderOneMember" xlink:to="PPCB_LenderOneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_LenderOneMember_lbl" xml:lang="en-US">Lender One [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_LenderTwoMember" xlink:label="PPCB_LenderTwoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_LenderTwoMember" xlink:to="PPCB_LenderTwoMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_LenderTwoMember_lbl" xml:lang="en-US">Lender Two [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_LenderThreeMember" xlink:label="PPCB_LenderThreeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_LenderThreeMember" xlink:to="PPCB_LenderThreeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_LenderThreeMember_lbl" xml:lang="en-US">Lender Three [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="us-gaap_DerivativeInstrumentRiskAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeInstrumentRiskAxis" xlink:to="us-gaap_DerivativeInstrumentRiskAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeInstrumentRiskAxis_lbl" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtMember" xlink:label="us-gaap_ConvertibleDebtMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleDebtMember" xlink:to="us-gaap_ConvertibleDebtMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertibleDebtMember_lbl" xml:lang="en-US">Convertible Debt [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="us-gaap_MeasurementInputTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputTypeAxis" xlink:to="us-gaap_MeasurementInputTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputTypeAxis_lbl" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="us-gaap_MeasurementInputPriceVolatilityMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputPriceVolatilityMember" xlink:to="us-gaap_MeasurementInputPriceVolatilityMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputPriceVolatilityMember_lbl" xml:lang="en-US">Measurement Input, Price Volatility [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputExpectedTermMember" xlink:label="us-gaap_MeasurementInputExpectedTermMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputExpectedTermMember" xlink:to="us-gaap_MeasurementInputExpectedTermMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputExpectedTermMember_lbl" xml:lang="en-US">Measurement Input, Expected Term [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="us-gaap_MeasurementInputRiskFreeInterestRateMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:to="us-gaap_MeasurementInputRiskFreeInterestRateMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputRiskFreeInterestRateMember_lbl" xml:lang="en-US">Measurement Input, Risk Free Interest Rate [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputExpectedDividendRateMember" xlink:label="us-gaap_MeasurementInputExpectedDividendRateMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputExpectedDividendRateMember" xlink:to="us-gaap_MeasurementInputExpectedDividendRateMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputExpectedDividendRateMember_lbl" xml:lang="en-US">Measurement Input, Expected Dividend Rate [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel1Member" xlink:to="us-gaap_FairValueInputsLevel1Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="us-gaap_FairValueInputsLevel2Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel2Member" xlink:to="us-gaap_FairValueInputsLevel2Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel2Member_lbl" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel3Member" xlink:to="us-gaap_FairValueInputsLevel3Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel3Member_lbl" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_TwelveSeriesAAndAWarrantsMember" xlink:label="PPCB_TwelveSeriesAAndAWarrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_TwelveSeriesAAndAWarrantsMember" xlink:to="PPCB_TwelveSeriesAAndAWarrantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_TwelveSeriesAAndAWarrantsMember_lbl" xml:lang="en-US">12 Series A and A Warrants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_NathanielszCancellationAgreementMember" xlink:label="PPCB_NathanielszCancellationAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_NathanielszCancellationAgreementMember" xlink:to="PPCB_NathanielszCancellationAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_NathanielszCancellationAgreementMember_lbl" xml:lang="en-US">Nathanielsz Cancellation Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_KenyonCancellationAgreementMember" xlink:label="PPCB_KenyonCancellationAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_KenyonCancellationAgreementMember" xlink:to="PPCB_KenyonCancellationAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_KenyonCancellationAgreementMember_lbl" xml:lang="en-US">Kenyon Cancellation Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_ZelingerAmendedAndRestatedDirectorAgreementMember" xlink:label="PPCB_ZelingerAmendedAndRestatedDirectorAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_ZelingerAmendedAndRestatedDirectorAgreementMember" xlink:to="PPCB_ZelingerAmendedAndRestatedDirectorAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_ZelingerAmendedAndRestatedDirectorAgreementMember_lbl" xml:lang="en-US">Zelinger Amended And Restated Director Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_JosefZelingerMember" xlink:label="PPCB_JosefZelingerMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_JosefZelingerMember" xlink:to="PPCB_JosefZelingerMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_JosefZelingerMember_lbl" xml:lang="en-US">Josef Zelinger [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_CommonStockOneMember" xlink:label="PPCB_CommonStockOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_CommonStockOneMember" xlink:to="PPCB_CommonStockOneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_CommonStockOneMember_lbl" xml:lang="en-US">Common Stock One [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_CommonStockTwoMember" xlink:label="PPCB_CommonStockTwoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_CommonStockTwoMember" xlink:to="PPCB_CommonStockTwoMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_CommonStockTwoMember_lbl" xml:lang="en-US">Common Stock Two [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_CommonStockThreeMember" xlink:label="PPCB_CommonStockThreeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_CommonStockThreeMember" xlink:to="PPCB_CommonStockThreeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_CommonStockThreeMember_lbl" xml:lang="en-US">Common Stock Three [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_TwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember" xlink:label="PPCB_TwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_TwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember" xlink:to="PPCB_TwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_TwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember_lbl" xml:lang="en-US">2021 Securities Purchase Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_SubscriptionReceivableMember" xlink:label="PPCB_SubscriptionReceivableMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_SubscriptionReceivableMember" xlink:to="PPCB_SubscriptionReceivableMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_SubscriptionReceivableMember_lbl" xml:lang="en-US">Subscription Receivable [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_AuctusFinancingAgreementMember" xlink:label="PPCB_AuctusFinancingAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_AuctusFinancingAgreementMember" xlink:to="PPCB_AuctusFinancingAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_AuctusFinancingAgreementMember_lbl" xml:lang="en-US">Auctus Financing Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_AugustNineteenTwoThousandTwentyOneGenevaRothMember" xlink:label="PPCB_AugustNineteenTwoThousandTwentyOneGenevaRothMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_AugustNineteenTwoThousandTwentyOneGenevaRothMember" xlink:to="PPCB_AugustNineteenTwoThousandTwentyOneGenevaRothMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_AugustNineteenTwoThousandTwentyOneGenevaRothMember_lbl" xml:lang="en-US">August Nineteen Two Thousand Twenty One Geneva Roth [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_SeptemberTwentyTwoTwoThousandTwentyOneGenevaRothMember" xlink:label="PPCB_SeptemberTwentyTwoTwoThousandTwentyOneGenevaRothMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_SeptemberTwentyTwoTwoThousandTwentyOneGenevaRothMember" xlink:to="PPCB_SeptemberTwentyTwoTwoThousandTwentyOneGenevaRothMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_SeptemberTwentyTwoTwoThousandTwentyOneGenevaRothMember_lbl" xml:lang="en-US">September Twenty Two Two Thousand Twenty One Geneva Roth [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember" xlink:label="PPCB_SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember" xlink:to="PPCB_SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember_lbl" xml:lang="en-US">September Twenty Two Two Thousand Twenty Geneva Roth [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_GenevaRothFinancingAgreementAgreementMember" xlink:label="PPCB_GenevaRothFinancingAgreementAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_GenevaRothFinancingAgreementAgreementMember" xlink:to="PPCB_GenevaRothFinancingAgreementAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_GenevaRothFinancingAgreementAgreementMember_lbl" xml:lang="en-US">Geneva Roth Financing Agreement Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="srt_ProductOrServiceAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductOrServiceAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ProductOrServiceAxis_lbl" xml:lang="en-US">Product and Service [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_LegalServicesMember" xlink:label="PPCB_LegalServicesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_LegalServicesMember" xlink:to="PPCB_LegalServicesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_LegalServicesMember_lbl" xml:lang="en-US">Legal Services [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_ConsultantServicesMember" xlink:label="PPCB_ConsultantServicesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_ConsultantServicesMember" xlink:to="PPCB_ConsultantServicesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_ConsultantServicesMember_lbl" xml:lang="en-US">Consultant Services [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis" xlink:label="us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis" xlink:to="us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis_lbl" xml:lang="en-US">Deferred Bonus and Profit Sharing Arrangements, Individual Contracts, Type of Deferred Compensation [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_DeferredSalaryMember" xlink:label="PPCB_DeferredSalaryMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_DeferredSalaryMember" xlink:to="PPCB_DeferredSalaryMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_DeferredSalaryMember_lbl" xml:lang="en-US">Deferred Salary [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_CancellationAgreementMember" xlink:label="PPCB_CancellationAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_CancellationAgreementMember" xlink:to="PPCB_CancellationAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_CancellationAgreementMember_lbl" xml:lang="en-US">Cancellation Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_ChiefScientificOfficerandDirectorMember" xlink:label="PPCB_ChiefScientificOfficerandDirectorMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_ChiefScientificOfficerandDirectorMember" xlink:to="PPCB_ChiefScientificOfficerandDirectorMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_ChiefScientificOfficerandDirectorMember_lbl" xml:lang="en-US">Chief Scientific Officerand Director [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_SeriesBWarrantMember" xlink:label="PPCB_SeriesBWarrantMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_SeriesBWarrantMember" xlink:to="PPCB_SeriesBWarrantMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_SeriesBWarrantMember_lbl" xml:lang="en-US">Series B Warrant [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_ElevenSeriesAWarrantsMember" xlink:label="PPCB_ElevenSeriesAWarrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_ElevenSeriesAWarrantsMember" xlink:to="PPCB_ElevenSeriesAWarrantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_ElevenSeriesAWarrantsMember_lbl" xml:lang="en-US">Eleven Series A Warrants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_OctoberTwentyOneTwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember" xlink:label="PPCB_OctoberTwentyOneTwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_OctoberTwentyOneTwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember" xlink:to="PPCB_OctoberTwentyOneTwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_OctoberTwentyOneTwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember_lbl" xml:lang="en-US">October Twenty One Two Thousand And Twenty One Securities Purchase Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsAbstract_lbl" xml:lang="en-US">ASSETS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US">CURRENT ASSETS:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US">Cash</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValueAddedTaxReceivableCurrent" xlink:label="us-gaap_ValueAddedTaxReceivableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValueAddedTaxReceivableCurrent" xlink:to="us-gaap_ValueAddedTaxReceivableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ValueAddedTaxReceivableCurrent_lbl" xml:lang="en-US">GST tax receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US">TOTAL CURRENT ASSETS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepositsAssetsNoncurrent" xlink:label="us-gaap_DepositsAssetsNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepositsAssetsNoncurrent" xlink:to="us-gaap_DepositsAssetsNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepositsAssetsNoncurrent_lbl" xml:lang="en-US">Security deposit - related party</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xml:lang="en-US">Operating lease right-of-use assets, net - related party</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xml:lang="en-US">Property and equipment, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US">TOTAL ASSETS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS&#8217; DEFICIT</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US">CURRENT LIABILITIES:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xml:lang="en-US">Accounts payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Accrued expenses and other payables</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtCurrent" xlink:label="us-gaap_ConvertibleDebtCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleDebtCurrent" xlink:to="us-gaap_ConvertibleDebtCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertibleDebtCurrent_lbl" xml:lang="en-US">Convertible notes and related accrued interest, net of discounts and premiums</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xml:lang="en-US">Operating lease liability - related party</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationLiabilityCurrent" xlink:label="us-gaap_DeferredCompensationLiabilityCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredCompensationLiabilityCurrent" xlink:to="us-gaap_DeferredCompensationLiabilityCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredCompensationLiabilityCurrent_lbl" xml:lang="en-US">Embedded conversion option liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueToRelatedPartiesCurrent" xlink:label="us-gaap_DueToRelatedPartiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DueToRelatedPartiesCurrent" xlink:to="us-gaap_DueToRelatedPartiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DueToRelatedPartiesCurrent_lbl" xml:lang="en-US">Due to former director - related party</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_LoanFromFormerDirectorRelatedParty" xlink:label="PPCB_LoanFromFormerDirectorRelatedParty" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_LoanFromFormerDirectorRelatedParty" xlink:to="PPCB_LoanFromFormerDirectorRelatedParty_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_LoanFromFormerDirectorRelatedParty_lbl" xml:lang="en-US">Loan from former director - related party</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xml:lang="en-US">Employee benefit liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US">TOTAL CURRENT LIABILITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Liabilities_lbl" xml:lang="en-US">TOTAL LIABILITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xml:lang="en-US">Commitments and Contingencies (See Note 8)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US">STOCKHOLDERS&#8217; DEFICIT:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockValue_lbl" xml:lang="en-US">Preferred stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US">Common stock, $0.001 par value; 1,000,000,000 shares authorized;43,841,644 and 14,055,393 shares issued and outstanding as of September 30, 2021 and June 30, 2021, respectively</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_CommonStockIssuable" xlink:label="PPCB_CommonStockIssuable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_CommonStockIssuable" xlink:to="PPCB_CommonStockIssuable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_CommonStockIssuable_lbl" xml:lang="en-US">Common stock issuable (2,002,549 and 59 shares as of September 30, 2021 and June 30, 2021, respectively)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xml:lang="en-US">Additional paid-in capital</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteSubscriptionsReceivable" xlink:label="us-gaap_StockholdersEquityNoteSubscriptionsReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteSubscriptionsReceivable" xlink:to="us-gaap_StockholdersEquityNoteSubscriptionsReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_StockholdersEquityNoteSubscriptionsReceivable_lbl" xml:lang="en-US">Subscription receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xml:lang="en-US">Accumulated other comprehensive income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US">Accumulated deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue" xlink:label="us-gaap_TreasuryStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockValue" xlink:to="us-gaap_TreasuryStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_TreasuryStockValue_lbl" xml:lang="en-US">Treasury stock (1 share)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US">TOTAL STOCKHOLDERS&#8217; DEFICIT</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US">TOTAL LIABILITIES AND STOCKHOLDERS&#8217; DEFICIT</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xml:lang="en-US">Preferred stock, shares authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Preferred stock, par value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xml:lang="en-US">Preferred stock, shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xml:lang="en-US">Preferred stock, shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Common stock, par value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US">Common stock, shares authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US">Common stock, shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US">Common stock, shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_CommonStockIssuableShares" xlink:label="PPCB_CommonStockIssuableShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_CommonStockIssuableShares" xlink:to="PPCB_CommonStockIssuableShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_CommonStockIssuableShares_lbl" xml:lang="en-US">Common stock, shares issuable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares" xlink:label="us-gaap_TreasuryStockShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockShares" xlink:to="us-gaap_TreasuryStockShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TreasuryStockShares_lbl" xml:lang="en-US">Treasury stock, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xml:lang="en-US">Income Statement [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract" xlink:label="us-gaap_RevenuesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_RevenuesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenuesAbstract_lbl" xml:lang="en-US">REVENUE</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xml:lang="en-US">Revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xml:lang="en-US">OPERATING EXPENSES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xml:lang="en-US">Administration expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OccupancyNet" xlink:label="us-gaap_OccupancyNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OccupancyNet" xlink:to="us-gaap_OccupancyNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OccupancyNet_lbl" xml:lang="en-US">Occupancy expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xml:lang="en-US">Research and development</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingExpenses_lbl" xml:lang="en-US">TOTAL OPERATING EXPENSES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xml:lang="en-US">LOSS FROM OPERATIONS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_NonoperatingIncomeExpenseAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract_lbl" xml:lang="en-US">OTHER INCOME (EXPENSE)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="us-gaap_InterestExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_InterestExpense_lbl" xml:lang="en-US">Interest expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="us-gaap_InvestmentIncomeInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentIncomeInterest" xlink:to="us-gaap_InvestmentIncomeInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentIncomeInterest_lbl" xml:lang="en-US">Interest income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIncome" xlink:label="us-gaap_OtherIncome" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherIncome" xlink:to="us-gaap_OtherIncome_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherIncome_lbl" xml:lang="en-US">Other income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet" xlink:label="us-gaap_DerivativeGainLossOnDerivativeNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeGainLossOnDerivativeNet" xlink:to="us-gaap_DerivativeGainLossOnDerivativeNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeGainLossOnDerivativeNet_lbl" xml:lang="en-US">Change in fair value of derivative liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_GainFromSettlementOfDebtNet" xlink:label="PPCB_GainFromSettlementOfDebtNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_GainFromSettlementOfDebtNet" xlink:to="PPCB_GainFromSettlementOfDebtNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_GainFromSettlementOfDebtNet_lbl" xml:lang="en-US">Gain from settlement of debt, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl" xml:lang="en-US">Gain on extinguishment of debt, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossUnrealized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:to="us-gaap_ForeignCurrencyTransactionGainLossUnrealized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossUnrealized_lbl" xml:lang="en-US">Foreign currency transaction gain</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl" xml:lang="en-US">TOTAL OTHER EXPENSE, NET</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xml:lang="en-US">LOSS BEFORE TAXES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Tax benefit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_ProfitLoss_lbl" xml:lang="en-US">NET LOSS</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_DeemedDividend" xlink:label="PPCB_DeemedDividend" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_DeemedDividend" xlink:to="PPCB_DeemedDividend_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_DeemedDividend_lbl" xml:lang="en-US">Deemed Dividend</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">NET LOSS AVAILABLE TO COMMON STOCKHOLDERS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasicAndDiluted" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xml:lang="en-US">BASIC AND DILUTED NET LOSS PER SHARE</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xml:lang="en-US">BASIC AND DILUTED WEIGHTED AVERAGE SHARES OUTSTANDING</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xml:lang="en-US">NET LOSS AVAILABLE TO COMMON STOCKHOLDERS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_lbl" xml:lang="en-US">OTHER COMPREHENSIVE INCOME (LOSS)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" xlink:to="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_lbl" xml:lang="en-US">Unrealized foreign currency translation gain (loss)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_lbl" xml:lang="en-US">TOTAL OTHER COMPREHENSIVE INCOME (LOSS)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xml:lang="en-US">TOTAL COMPREHENSIVE LOSS</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_StockholdersEquity_2_lbl" xml:lang="en-US">Beginning balance, value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharesOutstanding_lbl" xml:lang="en-US">Beginning balance, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xml:lang="en-US">Issuance of common stock for cash</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xml:lang="en-US">Issuance of common stock for cash, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl" xml:lang="en-US">Issuance of common stock for conversion of convertible debt, conversion fee, and accrued interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl" xml:lang="en-US">Issuance of common stock for conversion of convertible debt, conversion fee, and accrued interest, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_ReversalOfCommonStockIssuableDueToCancellationOfConversionsOfConvertibleDebtAndAccruedInterest" xlink:label="PPCB_ReversalOfCommonStockIssuableDueToCancellationOfConversionsOfConvertibleDebtAndAccruedInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_ReversalOfCommonStockIssuableDueToCancellationOfConversionsOfConvertibleDebtAndAccruedInterest" xlink:to="PPCB_ReversalOfCommonStockIssuableDueToCancellationOfConversionsOfConvertibleDebtAndAccruedInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_ReversalOfCommonStockIssuableDueToCancellationOfConversionsOfConvertibleDebtAndAccruedInterest_lbl" xml:lang="en-US">Reversal of common stock issuable due to cancellation of conversions of convertible debt and accrued interest</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_ReversalOfCommonStockIssuableDueToCancellationOfConversionsOfConvertibleDebtAndAccruedInterestShares" xlink:label="PPCB_ReversalOfCommonStockIssuableDueToCancellationOfConversionsOfConvertibleDebtAndAccruedInterestShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_ReversalOfCommonStockIssuableDueToCancellationOfConversionsOfConvertibleDebtAndAccruedInterestShares" xlink:to="PPCB_ReversalOfCommonStockIssuableDueToCancellationOfConversionsOfConvertibleDebtAndAccruedInterestShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_ReversalOfCommonStockIssuableDueToCancellationOfConversionsOfConvertibleDebtAndAccruedInterestShares_lbl" xml:lang="en-US">Reversal of common stock issuable due to cancellation of conversions of convertible debt and accrued interest, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_StockIssuedDuringPeriodValueExerciseOfWarrants" xlink:label="PPCB_StockIssuedDuringPeriodValueExerciseOfWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_StockIssuedDuringPeriodValueExerciseOfWarrants" xlink:to="PPCB_StockIssuedDuringPeriodValueExerciseOfWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_StockIssuedDuringPeriodValueExerciseOfWarrants_lbl" xml:lang="en-US">Issuance of common stock for exercise of warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_StockIssuedDuringPeriodSharesExerciseOfWarrants" xlink:label="PPCB_StockIssuedDuringPeriodSharesExerciseOfWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_StockIssuedDuringPeriodSharesExerciseOfWarrants" xlink:to="PPCB_StockIssuedDuringPeriodSharesExerciseOfWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_StockIssuedDuringPeriodSharesExerciseOfWarrants_lbl" xml:lang="en-US">Issuance of common stock for exercise of warrants, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_IssuanceOfCommonStockForCashlessExerciseOfWarrants" xlink:label="PPCB_IssuanceOfCommonStockForCashlessExerciseOfWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_IssuanceOfCommonStockForCashlessExerciseOfWarrants" xlink:to="PPCB_IssuanceOfCommonStockForCashlessExerciseOfWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_IssuanceOfCommonStockForCashlessExerciseOfWarrants_lbl" xml:lang="en-US">Issuance of common stock for cashless exercise of warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_IssuanceOfCommonStockForCashlessExerciseOfWarrantsShares" xlink:label="PPCB_IssuanceOfCommonStockForCashlessExerciseOfWarrantsShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_IssuanceOfCommonStockForCashlessExerciseOfWarrantsShares" xlink:to="PPCB_IssuanceOfCommonStockForCashlessExerciseOfWarrantsShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_IssuanceOfCommonStockForCashlessExerciseOfWarrantsShares_lbl" xml:lang="en-US">Issuance of common stock for cashless exercise of warrants, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature_lbl" xml:lang="en-US">Reversal of put premium upon cancellation of conversions of convertible debt</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:label="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:to="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_lbl" xml:lang="en-US">Vested restricted stock units</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_lbl" xml:lang="en-US">Vested restricted stock units, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_StockIssuedDuringPeriodValueReverseStockSplits" xlink:label="PPCB_StockIssuedDuringPeriodValueReverseStockSplits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_StockIssuedDuringPeriodValueReverseStockSplits" xlink:to="PPCB_StockIssuedDuringPeriodValueReverseStockSplits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_StockIssuedDuringPeriodValueReverseStockSplits_lbl" xml:lang="en-US">Fractional difference due to the reverse stock-split</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits" xlink:label="us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits" xlink:to="us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits_lbl" xml:lang="en-US">Fractional difference due to the reverse stock-split, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_DeemedDividendUponAlternateCashlessExerciseOfWarrants" xlink:label="PPCB_DeemedDividendUponAlternateCashlessExerciseOfWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_DeemedDividendUponAlternateCashlessExerciseOfWarrants" xlink:to="PPCB_DeemedDividendUponAlternateCashlessExerciseOfWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_DeemedDividendUponAlternateCashlessExerciseOfWarrants_lbl" xml:lang="en-US">Deemed dividend upon alternate cashless exercise of warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_IssuanceOfCommonStockForAlternateCashlessExerciseOfWarrants" xlink:label="PPCB_IssuanceOfCommonStockForAlternateCashlessExerciseOfWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_IssuanceOfCommonStockForAlternateCashlessExerciseOfWarrants" xlink:to="PPCB_IssuanceOfCommonStockForAlternateCashlessExerciseOfWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_IssuanceOfCommonStockForAlternateCashlessExerciseOfWarrants_lbl" xml:lang="en-US">Issuance of common stock for alternate cashless exercise of warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_IssuanceOfCommonStockForAlternateCashlessExerciseOfWarrantsShares" xlink:label="PPCB_IssuanceOfCommonStockForAlternateCashlessExerciseOfWarrantsShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_IssuanceOfCommonStockForAlternateCashlessExerciseOfWarrantsShares" xlink:to="PPCB_IssuanceOfCommonStockForAlternateCashlessExerciseOfWarrantsShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_IssuanceOfCommonStockForAlternateCashlessExerciseOfWarrantsShares_lbl" xml:lang="en-US">Issuance of common stock for alternate cashless exercise of warrants, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_AdjustmentsToAdditionalPaidInCapitalReclassificationOfPremiumUponDebtConversion" xlink:label="PPCB_AdjustmentsToAdditionalPaidInCapitalReclassificationOfPremiumUponDebtConversion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_AdjustmentsToAdditionalPaidInCapitalReclassificationOfPremiumUponDebtConversion" xlink:to="PPCB_AdjustmentsToAdditionalPaidInCapitalReclassificationOfPremiumUponDebtConversion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_AdjustmentsToAdditionalPaidInCapitalReclassificationOfPremiumUponDebtConversion_lbl" xml:lang="en-US">Reclassification of put premium upon debt conversion</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_lbl" xml:lang="en-US">Issuance of common stock for services and accrued expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl" xml:lang="en-US">Issuance of common stock for services and accrued expenses, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_RelativeFairValueOfWarrantsIssuedWithConvertibleDebt" xlink:label="PPCB_RelativeFairValueOfWarrantsIssuedWithConvertibleDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_RelativeFairValueOfWarrantsIssuedWithConvertibleDebt" xlink:to="PPCB_RelativeFairValueOfWarrantsIssuedWithConvertibleDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_RelativeFairValueOfWarrantsIssuedWithConvertibleDebt_lbl" xml:lang="en-US">Relative fair value of warrants issued with convertible debt</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xml:lang="en-US">Stock based compensation in connection with stock option grants</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_lbl" xml:lang="en-US">Stock based compensation in connection with fair value of warrants issued for services</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:to="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_lbl" xml:lang="en-US">Foreign currency translation gain</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProfitLoss_2_lbl" xml:lang="en-US">Net loss</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_StockholdersEquity_3_lbl" xml:lang="en-US">Ending balance, value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharesOutstanding_2_lbl" xml:lang="en-US">Ending balance, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">CASH FLOWS FROM OPERATING ACTIVITIES:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Adjustments to Reconcile Net Loss to Net Cash Used in Operating Activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:label="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:to="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_lbl" xml:lang="en-US">Issuance and amortization of common stock for services</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:to="us-gaap_ForeignCurrencyTransactionGainLossUnrealized_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossUnrealized_2_lbl" xml:lang="en-US">Foreign currency transaction gain</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Depreciation" xlink:to="us-gaap_Depreciation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Depreciation_lbl" xml:lang="en-US">Depreciation expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="us-gaap_AmortizationOfDebtDiscountPremium" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfDebtDiscountPremium" xlink:to="us-gaap_AmortizationOfDebtDiscountPremium_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfDebtDiscountPremium_lbl" xml:lang="en-US">Amortization of debt discounts</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeGainLossOnDerivativeNet" xlink:to="us-gaap_DerivativeGainLossOnDerivativeNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DerivativeGainLossOnDerivativeNet_2_lbl" xml:lang="en-US">Change in fair value of derivative liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt_2_lbl" xml:lang="en-US">Gain on extinguishment of debt, net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_GainFromSettlementOfDebtNet" xlink:to="PPCB_GainFromSettlementOfDebtNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="PPCB_GainFromSettlementOfDebtNet_2_lbl" xml:lang="en-US">Gain from settlement of debt, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensation_lbl" xml:lang="en-US">Stock option and restricted stock expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashExpense" xlink:label="us-gaap_OtherNoncashExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNoncashExpense" xlink:to="us-gaap_OtherNoncashExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherNoncashExpense_lbl" xml:lang="en-US">Non-cash interest expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:to="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_lbl" xml:lang="en-US">Accretion of put premium</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_lbl" xml:lang="en-US">Changes in Assets and Liabilities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInReceivables" xlink:label="us-gaap_IncreaseDecreaseInReceivables" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInReceivables" xlink:to="us-gaap_IncreaseDecreaseInReceivables_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInReceivables_lbl" xml:lang="en-US">GST receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xml:lang="en-US">Prepaid expenses and other assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xml:lang="en-US">Accounts payable</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_IncreaseDecreaseInDeferredRent" xlink:label="PPCB_IncreaseDecreaseInDeferredRent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_IncreaseDecreaseInDeferredRent" xlink:to="PPCB_IncreaseDecreaseInDeferredRent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="PPCB_IncreaseDecreaseInDeferredRent_lbl" xml:lang="en-US">Deferred rent</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_lbl" xml:lang="en-US">Employee benefit liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_lbl" xml:lang="en-US">Accrued expenses and other payables</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInterestPayableNet" xlink:label="us-gaap_IncreaseDecreaseInInterestPayableNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInterestPayableNet" xlink:to="us-gaap_IncreaseDecreaseInInterestPayableNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInInterestPayableNet_lbl" xml:lang="en-US">Accrued interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US">NET CASH USED IN OPERATING ACTIVITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US">CASH FLOWS FROM FINANCING ACTIVITIES:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="us-gaap_ProceedsFromConvertibleDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromConvertibleDebt" xlink:to="us-gaap_ProceedsFromConvertibleDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromConvertibleDebt_lbl" xml:lang="en-US">Proceeds from convertible promissory notes, net of original issue discounts and issue costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfConvertibleDebt" xlink:label="us-gaap_RepaymentsOfConvertibleDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfConvertibleDebt" xlink:to="us-gaap_RepaymentsOfConvertibleDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RepaymentsOfConvertibleDebt_lbl" xml:lang="en-US">Repayments of convertible promissory notes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xml:lang="en-US">Proceeds from the sale of common stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfInitialPublicOffering" xlink:label="us-gaap_PaymentsForRepurchaseOfInitialPublicOffering" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForRepurchaseOfInitialPublicOffering" xlink:to="us-gaap_PaymentsForRepurchaseOfInitialPublicOffering_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsForRepurchaseOfInitialPublicOffering_lbl" xml:lang="en-US">Fees associated with offering costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="us-gaap_ProceedsFromWarrantExercises" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromWarrantExercises" xlink:to="us-gaap_ProceedsFromWarrantExercises_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromWarrantExercises_lbl" xml:lang="en-US">Proceeds from the exercise of warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US">NET CASH PROVIDED BY FINANCING ACTIVITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xml:lang="en-US">Effect of exchange rate changes on cash</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xml:lang="en-US">NET INCREASE (DECREASE) IN CASH</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xml:lang="en-US">CASH AT BEGINNING OF PERIOD</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2_lbl" xml:lang="en-US">CASH AT END OF PERIOD</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xml:lang="en-US">Supplemental Disclosure of Cash Flow Information</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_CashPaidDuringPeriodAbstract" xlink:label="PPCB_CashPaidDuringPeriodAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_CashPaidDuringPeriodAbstract" xlink:to="PPCB_CashPaidDuringPeriodAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_CashPaidDuringPeriodAbstract_lbl" xml:lang="en-US">Cash paid during the period:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet" xlink:label="us-gaap_InterestPaidNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaidNet" xlink:to="us-gaap_InterestPaidNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPaidNet_lbl" xml:lang="en-US">Interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaidNet" xlink:label="us-gaap_IncomeTaxesPaidNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxesPaidNet" xlink:to="us-gaap_IncomeTaxesPaidNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxesPaidNet_lbl" xml:lang="en-US">Income Tax</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" xml:lang="en-US">Supplemental Disclosure of Non-Cash Investing and Financing Activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConversionOfStockAmountConverted1" xlink:label="us-gaap_ConversionOfStockAmountConverted1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockAmountConverted1" xlink:to="us-gaap_ConversionOfStockAmountConverted1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConversionOfStockAmountConverted1_lbl" xml:lang="en-US">Reduction of put premium related to conversions of convertible notes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConversionOfStockAmountIssued1" xlink:label="us-gaap_ConversionOfStockAmountIssued1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockAmountIssued1" xlink:to="us-gaap_ConversionOfStockAmountIssued1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConversionOfStockAmountIssued1_lbl" xml:lang="en-US">Conversion of convertible notes and accrued interest to common stock</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_DiscountsRelatedToWarrantsIssuedWithConvertibleNote" xlink:label="PPCB_DiscountsRelatedToWarrantsIssuedWithConvertibleNote" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_DiscountsRelatedToWarrantsIssuedWithConvertibleNote" xlink:to="PPCB_DiscountsRelatedToWarrantsIssuedWithConvertibleNote_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_DiscountsRelatedToWarrantsIssuedWithConvertibleNote_lbl" xml:lang="en-US">Discounts related to warrants issued with convertible notes</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_DiscountsRelatedToDerivativeLiability" xlink:label="PPCB_DiscountsRelatedToDerivativeLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_DiscountsRelatedToDerivativeLiability" xlink:to="PPCB_DiscountsRelatedToDerivativeLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_DiscountsRelatedToDerivativeLiability_lbl" xml:lang="en-US">Discounts related to derivative liability</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_OperatingLeaseRightofuseAssetsAndOperatingLeaseLiabilitiesRecordedUponAdoptionOfAsc842" xlink:label="PPCB_OperatingLeaseRightofuseAssetsAndOperatingLeaseLiabilitiesRecordedUponAdoptionOfAsc842" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_OperatingLeaseRightofuseAssetsAndOperatingLeaseLiabilitiesRecordedUponAdoptionOfAsc842" xlink:to="PPCB_OperatingLeaseRightofuseAssetsAndOperatingLeaseLiabilitiesRecordedUponAdoptionOfAsc842_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_OperatingLeaseRightofuseAssetsAndOperatingLeaseLiabilitiesRecordedUponAdoptionOfAsc842_lbl" xml:lang="en-US">Operating lease right-of-use asset and operating lease liability recorded on adoption of ASC 842</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_ReversalOfCommonStockIssuableAndPutPremiumDueToCancellationOfConversionsOfConvertibleDebtAndAccruedInterest" xlink:label="PPCB_ReversalOfCommonStockIssuableAndPutPremiumDueToCancellationOfConversionsOfConvertibleDebtAndAccruedInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_ReversalOfCommonStockIssuableAndPutPremiumDueToCancellationOfConversionsOfConvertibleDebtAndAccruedInterest" xlink:to="PPCB_ReversalOfCommonStockIssuableAndPutPremiumDueToCancellationOfConversionsOfConvertibleDebtAndAccruedInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_ReversalOfCommonStockIssuableAndPutPremiumDueToCancellationOfConversionsOfConvertibleDebtAndAccruedInterest_lbl" xml:lang="en-US">Reversal of common stock issuable and put premium due to cancellation of conversions of convertible debt and accrued interest</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_DeemedDividendUponAlternateCashlessExerciseOfWarrants1" xlink:label="PPCB_DeemedDividendUponAlternateCashlessExerciseOfWarrants1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_DeemedDividendUponAlternateCashlessExerciseOfWarrants1" xlink:to="PPCB_DeemedDividendUponAlternateCashlessExerciseOfWarrants1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="PPCB_DeemedDividendUponAlternateCashlessExerciseOfWarrants1_lbl" xml:lang="en-US">Deemed dividend upon alternate cashless exercise of warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_AccountsPayableReclassToConvertibleNotes" xlink:label="PPCB_AccountsPayableReclassToConvertibleNotes" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_AccountsPayableReclassToConvertibleNotes" xlink:to="PPCB_AccountsPayableReclassToConvertibleNotes_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_AccountsPayableReclassToConvertibleNotes_lbl" xml:lang="en-US">Accounts payable reclass to convertible notes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssued1" xlink:label="us-gaap_StockIssued1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssued1" xlink:to="us-gaap_StockIssued1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssued1_lbl" xml:lang="en-US">Common stock issued for accrued services</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_SubscriptionReceivable" xlink:label="PPCB_SubscriptionReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_SubscriptionReceivable" xlink:to="PPCB_SubscriptionReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_SubscriptionReceivable_lbl" xml:lang="en-US">Subscription receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:label="us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:to="us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_lbl" xml:lang="en-US">NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING AND REPORTING POLICIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubstantialDoubtAboutGoingConcernTextBlock" xlink:label="us-gaap_SubstantialDoubtAboutGoingConcernTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubstantialDoubtAboutGoingConcernTextBlock" xlink:to="us-gaap_SubstantialDoubtAboutGoingConcernTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubstantialDoubtAboutGoingConcernTextBlock_lbl" xml:lang="en-US">GOING CONCERN</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xml:lang="en-US">PROPERTY AND EQUIPMENT</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_DisclosureDueToFormerDirectorRelatedPartyAbstract" xlink:label="PPCB_DisclosureDueToFormerDirectorRelatedPartyAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_DisclosureDueToFormerDirectorRelatedPartyAbstract" xlink:to="PPCB_DisclosureDueToFormerDirectorRelatedPartyAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_DisclosureDueToFormerDirectorRelatedPartyAbstract_lbl" xml:lang="en-US">Due To Former Director - Related Party</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_DueToFormerDirectorRelatedPartyDisclosureTextBlock" xlink:label="PPCB_DueToFormerDirectorRelatedPartyDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_DueToFormerDirectorRelatedPartyDisclosureTextBlock" xlink:to="PPCB_DueToFormerDirectorRelatedPartyDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_DueToFormerDirectorRelatedPartyDisclosureTextBlock_lbl" xml:lang="en-US">DUE TO FORMER DIRECTOR - RELATED PARTY</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_DisclosureLoansAndNotesPayableAbstract" xlink:label="PPCB_DisclosureLoansAndNotesPayableAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_DisclosureLoansAndNotesPayableAbstract" xlink:to="PPCB_DisclosureLoansAndNotesPayableAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_DisclosureLoansAndNotesPayableAbstract_lbl" xml:lang="en-US">Loans And Notes Payable</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_LoansAndNotesPayableDisclosureTextBlock" xlink:label="PPCB_LoansAndNotesPayableDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_LoansAndNotesPayableDisclosureTextBlock" xlink:to="PPCB_LoansAndNotesPayableDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_LoansAndNotesPayableDisclosureTextBlock_lbl" xml:lang="en-US">LOANS AND NOTES PAYABLE</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtDisclosureAbstract_lbl" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="us-gaap_DebtDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureTextBlock" xlink:to="us-gaap_DebtDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtDisclosureTextBlock_lbl" xml:lang="en-US">CONVERTIBLE NOTES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xml:lang="en-US">INCOME TAXES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_EquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityAbstract_lbl" xml:lang="en-US">Equity [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xml:lang="en-US">STOCKHOLDERS&#8217; DEFICIT</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xml:lang="en-US">COMMITMENTS AND CONTINGENCIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsAbstract_lbl" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xml:lang="en-US">RELATED PARTY TRANSACTIONS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RisksAndUncertaintiesAbstract" xlink:label="us-gaap_RisksAndUncertaintiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RisksAndUncertaintiesAbstract" xlink:to="us-gaap_RisksAndUncertaintiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RisksAndUncertaintiesAbstract_lbl" xml:lang="en-US">Risks and Uncertainties [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:label="us-gaap_ConcentrationRiskDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:to="us-gaap_ConcentrationRiskDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskDisclosureTextBlock_lbl" xml:lang="en-US">CONCENTRATIONS AND RISKS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_lbl" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:label="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:to="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_lbl" xml:lang="en-US">DERIVATIVE FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xml:lang="en-US">SUBSEQUENT EVENTS</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_NatureOfOperationsPolicyTextBlock" xlink:label="PPCB_NatureOfOperationsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_NatureOfOperationsPolicyTextBlock" xlink:to="PPCB_NatureOfOperationsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_NatureOfOperationsPolicyTextBlock_lbl" xml:lang="en-US">Nature of Operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="us-gaap_ConsolidationPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationPolicyTextBlock" xlink:to="us-gaap_ConsolidationPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConsolidationPolicyTextBlock_lbl" xml:lang="en-US">Principles of Consolidation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UseOfEstimates_lbl" xml:lang="en-US">Use of Estimates</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl" xml:lang="en-US">Foreign Currency Translation and Other Comprehensive Income (Loss)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xml:lang="en-US">Fair Value of Financial Instruments and Fair Value Measurements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xml:lang="en-US">Cash and Cash Equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xml:lang="en-US">Property and Equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:label="us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:to="us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_lbl" xml:lang="en-US">Patents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xml:lang="en-US">Impairment of Long-Lived Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOwnershipPlanESOPPolicy" xlink:label="us-gaap_EmployeeStockOwnershipPlanESOPPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeStockOwnershipPlanESOPPolicy" xlink:to="us-gaap_EmployeeStockOwnershipPlanESOPPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeStockOwnershipPlanESOPPolicy_lbl" xml:lang="en-US">Employee Benefit/Liability</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_GoodsAndServiceTaxPolicyTextBlock" xlink:label="PPCB_GoodsAndServiceTaxPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_GoodsAndServiceTaxPolicyTextBlock" xlink:to="PPCB_GoodsAndServiceTaxPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_GoodsAndServiceTaxPolicyTextBlock_lbl" xml:lang="en-US">Australian Goods and Services Tax (&#8220;GST&#8221;)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesReportingOfDerivativeActivity" xlink:label="us-gaap_DerivativesReportingOfDerivativeActivity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativesReportingOfDerivativeActivity" xlink:to="us-gaap_DerivativesReportingOfDerivativeActivity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativesReportingOfDerivativeActivity_lbl" xml:lang="en-US">Derivative Instruments</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_ConvertibleNotesPolicyTextBlock" xlink:label="PPCB_ConvertibleNotesPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_ConvertibleNotesPolicyTextBlock" xlink:to="PPCB_ConvertibleNotesPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_ConvertibleNotesPolicyTextBlock_lbl" xml:lang="en-US">Convertible Notes With Variable Conversion Options</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xml:lang="en-US">Income Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xml:lang="en-US">Research and Development Costs and Tax Credits</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xml:lang="en-US">Stock Based Compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:label="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl" xml:lang="en-US">Revenue Recognition</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LegalCostsPolicyTextBlock" xlink:label="us-gaap_LegalCostsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LegalCostsPolicyTextBlock" xlink:to="us-gaap_LegalCostsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LegalCostsPolicyTextBlock_lbl" xml:lang="en-US">Legal Expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock_lbl" xml:lang="en-US">Leases</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xml:lang="en-US">Basic and Diluted Net Loss Per Common Share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US">Recent Accounting Pronouncements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xml:lang="en-US">Basis of Presentation</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_ScheduleOfTranslationExchangeRatesTableTextBlock" xlink:label="PPCB_ScheduleOfTranslationExchangeRatesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_ScheduleOfTranslationExchangeRatesTableTextBlock" xlink:to="PPCB_ScheduleOfTranslationExchangeRatesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_ScheduleOfTranslationExchangeRatesTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF TRANSLATION EXCHANGE RATES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:label="us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF CHANGE IN ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_ScheduleOfPropertyAndEquipmentEstimatedUsefulLivesTableTextBlock" xlink:label="PPCB_ScheduleOfPropertyAndEquipmentEstimatedUsefulLivesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_ScheduleOfPropertyAndEquipmentEstimatedUsefulLivesTableTextBlock" xlink:to="PPCB_ScheduleOfPropertyAndEquipmentEstimatedUsefulLivesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_ScheduleOfPropertyAndEquipmentEstimatedUsefulLivesTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF PROPERTY AND EQUIPMENT ESTIMATED USEFUL LIVES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" xml:lang="en-US">SCHEDULE OF DILUTIVE SECURITIES EXCLUDED FROM COMPUTATION</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xml:lang="en-US">SCHEDULE OF PROPERTY AND EQUIPMENT</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtTableTextBlock" xlink:label="us-gaap_ConvertibleDebtTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleDebtTableTextBlock" xlink:to="us-gaap_ConvertibleDebtTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertibleDebtTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF CONVERTIBLE NOTES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF INCOME TAX PROVISION</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF STOCK OPTION ACTIVITY</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:to="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl" xml:lang="en-US">SCHEDULE OF WARRANT ACTIVITY</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_ScheduleOfRightUseOfAssetTableTextBlock" xlink:label="PPCB_ScheduleOfRightUseOfAssetTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_ScheduleOfRightUseOfAssetTableTextBlock" xlink:to="PPCB_ScheduleOfRightUseOfAssetTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_ScheduleOfRightUseOfAssetTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF RIGHT USE OF ASSET</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLeaseIncomeTableTextBlock" xlink:label="us-gaap_OperatingLeaseLeaseIncomeTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLeaseIncomeTableTextBlock" xlink:to="us-gaap_OperatingLeaseLeaseIncomeTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLeaseIncomeTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF OPERATING LEASE LIABILITY</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF FAIR VALUE MEASUREMENTS, RECURRING AND NONRECURRING, VALUATION TECHNIQUES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF FAIR VALUE, ASSETS AND LIABILITIES MEASURED ON RECURRING BASIS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" xlink:label="us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" xlink:to="us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF DERIVATIVE LIABILITIES AT FAIR VALUE</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyExchangeRateTranslation1" xlink:label="us-gaap_ForeignCurrencyExchangeRateTranslation1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyExchangeRateTranslation1" xlink:to="us-gaap_ForeignCurrencyExchangeRateTranslation1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ForeignCurrencyExchangeRateTranslation1_lbl" xml:lang="en-US">Foreign Currency Exchange Rate, Translation</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_2_lbl" xml:lang="en-US">Beginning balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_lbl" xml:lang="en-US">Foreign currency translation gain</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_3_lbl" xml:lang="en-US">Ending balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xml:lang="en-US">Property and equipment estimated useful lives</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xml:lang="en-US">Antidilutive securities excluded from computation of earnings per share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShortTermDebtTable" xlink:label="us-gaap_ScheduleOfShortTermDebtTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShortTermDebtTable" xlink:to="us-gaap_ScheduleOfShortTermDebtTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShortTermDebtTable_lbl" xml:lang="en-US">Schedule of Short-term Debt [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtLineItems" xlink:label="us-gaap_ShortTermDebtLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermDebtLineItems" xlink:to="us-gaap_ShortTermDebtLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermDebtLineItems_lbl" xml:lang="en-US">Short-term Debt [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationDateOfIncorporation" xlink:label="dei_EntityIncorporationDateOfIncorporation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationDateOfIncorporation" xlink:to="dei_EntityIncorporationDateOfIncorporation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationDateOfIncorporation_lbl" xml:lang="en-US">Entity incorporation, date of incorporation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityReverseStockSplit" xlink:label="us-gaap_StockholdersEquityReverseStockSplit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityReverseStockSplit" xlink:to="us-gaap_StockholdersEquityReverseStockSplit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityReverseStockSplit_lbl" xml:lang="en-US">Reverse stock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" xlink:to="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_2_lbl" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax, Portion Attributable to Parent</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashEquivalentsAtCarryingValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashEquivalentsAtCarryingValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashEquivalentsAtCarryingValue_lbl" xml:lang="en-US">Cash Equivalents, at Carrying Value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValueAddedTaxReceivableCurrent" xlink:to="us-gaap_ValueAddedTaxReceivableCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ValueAddedTaxReceivableCurrent_2_lbl" xml:lang="en-US">Value added tax receivable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ResearchAndDevelopmentExpense_2_lbl" xml:lang="en-US">Research and development costs</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="us-gaap_IncomeTaxExpenseBenefit_2_lbl" xml:lang="en-US">Tax credits</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleTermsOfConversionFeature" xlink:label="us-gaap_DebtInstrumentConvertibleTermsOfConversionFeature" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentConvertibleTermsOfConversionFeature" xlink:to="us-gaap_DebtInstrumentConvertibleTermsOfConversionFeature_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentConvertibleTermsOfConversionFeature_lbl" xml:lang="en-US">Debt conversion percentage, description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:label="us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:to="us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_lbl" xml:lang="en-US">Debt conversion percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl" xml:lang="en-US">Equity Method Investment, Ownership Percentage</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2_lbl" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ProfitLoss_3_lbl" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_WorkingCapitalDeficit" xlink:label="PPCB_WorkingCapitalDeficit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_WorkingCapitalDeficit" xlink:to="PPCB_WorkingCapitalDeficit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_WorkingCapitalDeficit_lbl" xml:lang="en-US">Working capital deficit</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_StockholdersEquity_4_lbl" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_2_lbl" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xml:lang="en-US">Office equipment at cost</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xml:lang="en-US">Less: Accumulated depreciation</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_2_lbl" xml:lang="en-US">Total property, plant, and equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DueToRelatedPartiesCurrent" xlink:to="us-gaap_DueToRelatedPartiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DueToRelatedPartiesCurrent_2_lbl" xml:lang="en-US">Due to directors - related parties</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:label="us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:to="us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable_lbl" xml:lang="en-US">Schedule of Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits, by Title of Individual and by Type of Deferred Compensation [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:label="us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems_lbl" xml:lang="en-US">Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LoansPayable" xlink:label="us-gaap_LoansPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LoansPayable" xlink:to="us-gaap_LoansPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LoansPayable_lbl" xml:lang="en-US">Loans payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="us-gaap_DebtInstrumentCarryingAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentCarryingAmount" xlink:to="us-gaap_DebtInstrumentCarryingAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentCarryingAmount_lbl" xml:lang="en-US">Convertible notes and debenture</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentUnamortizedDiscount" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount_lbl" xml:lang="en-US">Unamortized discounts</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepositLiabilitiesAccruedInterest" xlink:label="us-gaap_DepositLiabilitiesAccruedInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepositLiabilitiesAccruedInterest" xlink:to="us-gaap_DepositLiabilitiesAccruedInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DepositLiabilitiesAccruedInterest_lbl" xml:lang="en-US">Accrued interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedPremium" xlink:label="us-gaap_DebtInstrumentUnamortizedPremium" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentUnamortizedPremium" xlink:to="us-gaap_DebtInstrumentUnamortizedPremium_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentUnamortizedPremium_lbl" xml:lang="en-US">Premium, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt" xlink:label="us-gaap_LongTermDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebt" xlink:to="us-gaap_LongTermDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LongTermDebt_lbl" xml:lang="en-US">Convertible notes, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl" xml:lang="en-US">Convertible debt principal amount</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentUnamortizedDiscount" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscount_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount_2_lbl" xml:lang="en-US">Original issue discount</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromConvertibleDebt" xlink:to="us-gaap_ProceedsFromConvertibleDebt_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProceedsFromConvertibleDebt_2_lbl" xml:lang="en-US">Proceeds from convertible debt</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="us-gaap_DebtInstrumentMaturityDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentMaturityDate" xlink:to="us-gaap_DebtInstrumentMaturityDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentMaturityDate_lbl" xml:lang="en-US">Debt maturity date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xml:lang="en-US">Debt instrument, interest rate, stated percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPayableCurrentAndNoncurrent" xlink:label="us-gaap_InterestPayableCurrentAndNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPayableCurrentAndNoncurrent" xlink:to="us-gaap_InterestPayableCurrentAndNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_InterestPayableCurrentAndNoncurrent_lbl" xml:lang="en-US">Accrued interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:label="us-gaap_DebtConversionConvertedInstrumentAmount1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:to="us-gaap_DebtConversionConvertedInstrumentAmount1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtConversionConvertedInstrumentAmount1_lbl" xml:lang="en-US">Debt conversion of converted amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleNotesPayable" xlink:label="us-gaap_ConvertibleNotesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleNotesPayable" xlink:to="us-gaap_ConvertibleNotesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertibleNotesPayable_lbl" xml:lang="en-US">Convertible debt outstanding balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LegalFees" xlink:label="us-gaap_LegalFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LegalFees" xlink:to="us-gaap_LegalFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LegalFees_lbl" xml:lang="en-US">Legal fees</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_DebtInstrumentDebtDefaultInterestRate" xlink:label="PPCB_DebtInstrumentDebtDefaultInterestRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_DebtInstrumentDebtDefaultInterestRate" xlink:to="PPCB_DebtInstrumentDebtDefaultInterestRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_DebtInstrumentDebtDefaultInterestRate_lbl" xml:lang="en-US">Debt instrument, default, interest rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:label="us-gaap_DebtInstrumentPeriodicPaymentPrincipal" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:to="us-gaap_DebtInstrumentPeriodicPaymentPrincipal_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentPeriodicPaymentPrincipal_lbl" xml:lang="en-US">Debt instrument principal payment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:to="us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_2_lbl" xml:lang="en-US">Common stock trading volume, percent</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtConversionOriginalDebtInterestRateOfDebt" xlink:label="us-gaap_DebtConversionOriginalDebtInterestRateOfDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionOriginalDebtInterestRateOfDebt" xlink:to="us-gaap_DebtConversionOriginalDebtInterestRateOfDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtConversionOriginalDebtInterestRateOfDebt_lbl" xml:lang="en-US">Debt original issue discount, rate</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_PercentageOfOutstandingSharesOfCommonStock" xlink:label="PPCB_PercentageOfOutstandingSharesOfCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_PercentageOfOutstandingSharesOfCommonStock" xlink:to="PPCB_PercentageOfOutstandingSharesOfCommonStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_PercentageOfOutstandingSharesOfCommonStock_lbl" xml:lang="en-US">Percentage of outstanding shares of common stock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentUnamortizedPremium" xlink:to="us-gaap_DebtInstrumentUnamortizedPremium_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DebtInstrumentUnamortizedPremium_2_lbl" xml:lang="en-US">Debt premium amount</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AdditionalPaidInCapital_2_lbl" xml:lang="en-US">Additional paid in capital</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_DebtDefaultAmountPercentage" xlink:label="PPCB_DebtDefaultAmountPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_DebtDefaultAmountPercentage" xlink:to="PPCB_DebtDefaultAmountPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_DebtDefaultAmountPercentage_lbl" xml:lang="en-US">Debt default amount percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_DebtConversionConvertedInterestPayable" xlink:label="PPCB_DebtConversionConvertedInterestPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_DebtConversionConvertedInterestPayable" xlink:to="PPCB_DebtConversionConvertedInterestPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_DebtConversionConvertedInterestPayable_lbl" xml:lang="en-US">Debt conversion of accrued interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:label="us-gaap_DebtInstrumentConvertibleThresholdTradingDays" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:to="us-gaap_DebtInstrumentConvertibleThresholdTradingDays_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentConvertibleThresholdTradingDays_lbl" xml:lang="en-US">Common stock trading days</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrentAndNoncurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrentAndNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrentAndNoncurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrentAndNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedLiabilitiesCurrentAndNoncurrent_lbl" xml:lang="en-US">Accrued expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" xlink:label="us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" xlink:to="us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_lbl" xml:lang="en-US">Embedded derivative, fair value of embedded derivative liability</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_Liabilities_2_lbl" xml:lang="en-US">Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt_3_lbl" xml:lang="en-US">Loss from settlement of debt</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_PrepaymentPenalties" xlink:label="PPCB_PrepaymentPenalties" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_PrepaymentPenalties" xlink:to="PPCB_PrepaymentPenalties_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_PrepaymentPenalties_lbl" xml:lang="en-US">Prepayment penalty</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_DiligenceFees" xlink:label="PPCB_DiligenceFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_DiligenceFees" xlink:to="PPCB_DiligenceFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_DiligenceFees_lbl" xml:lang="en-US">Diligence fees</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtConversionDescription" xlink:label="us-gaap_DebtConversionDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionDescription" xlink:to="us-gaap_DebtConversionDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtConversionDescription_lbl" xml:lang="en-US">Debt conversion, description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfDebt" xlink:label="us-gaap_RepaymentsOfDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfDebt" xlink:to="us-gaap_RepaymentsOfDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfDebt_lbl" xml:lang="en-US">Repayment in cash</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaid" xlink:label="us-gaap_InterestPaid" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaid" xlink:to="us-gaap_InterestPaid_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPaid_lbl" xml:lang="en-US">Repayment of interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentDescription" xlink:label="us-gaap_DebtInstrumentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentDescription" xlink:to="us-gaap_DebtInstrumentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentDescription_lbl" xml:lang="en-US">Debt instrument, description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xml:lang="en-US">Warrants to purchase of common stock, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xml:lang="en-US">Warrants exercise price per share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="us-gaap_FairValueAdjustmentOfWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAdjustmentOfWarrants" xlink:to="us-gaap_FairValueAdjustmentOfWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAdjustmentOfWarrants_lbl" xml:lang="en-US">Fair value of warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_UnissuedSharesConversion" xlink:label="PPCB_UnissuedSharesConversion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_UnissuedSharesConversion" xlink:to="PPCB_UnissuedSharesConversion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_UnissuedSharesConversion_lbl" xml:lang="en-US">Unissued shares conversion</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_DueToEquityConversion" xlink:label="PPCB_DueToEquityConversion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_DueToEquityConversion" xlink:to="PPCB_DueToEquityConversion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_DueToEquityConversion_lbl" xml:lang="en-US">Due to equity conversion</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtConversionOriginalDebtAmount1" xlink:label="us-gaap_DebtConversionOriginalDebtAmount1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionOriginalDebtAmount1" xlink:to="us-gaap_DebtConversionOriginalDebtAmount1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtConversionOriginalDebtAmount1_lbl" xml:lang="en-US">Debt conversion, original debt amount</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfDebtDiscountPremium" xlink:to="us-gaap_AmortizationOfDebtDiscountPremium_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AmortizationOfDebtDiscountPremium_2_lbl" xml:lang="en-US">Amortization of debt discount</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_ReclassifiedPremiumAmountForAdditionalPaidInCapital" xlink:label="PPCB_ReclassifiedPremiumAmountForAdditionalPaidInCapital" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_ReclassifiedPremiumAmountForAdditionalPaidInCapital" xlink:to="PPCB_ReclassifiedPremiumAmountForAdditionalPaidInCapital_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_ReclassifiedPremiumAmountForAdditionalPaidInCapital_lbl" xml:lang="en-US">Reclassified premium amount for additional paid in capital</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_lbl" xml:lang="en-US">Loss before Income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl" xml:lang="en-US">Taxes under statutory US tax rates</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Increase (decrease) in valuation allowance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" xlink:label="us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" xlink:to="us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_lbl" xml:lang="en-US">Prior period adjustment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:label="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:to="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_lbl" xml:lang="en-US">Foreign tax rate differential</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxCredits" xlink:label="us-gaap_IncomeTaxReconciliationTaxCredits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationTaxCredits" xlink:to="us-gaap_IncomeTaxReconciliationTaxCredits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationTaxCredits_lbl" xml:lang="en-US">Income tax rate change</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:label="us-gaap_IncomeTaxReconciliationOtherAdjustments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:to="us-gaap_IncomeTaxReconciliationOtherAdjustments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationOtherAdjustments_lbl" xml:lang="en-US">Other</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeTaxExpenseBenefit_3_lbl" xml:lang="en-US">Income tax (expense) benefit</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_DeferredTaxAssetsWarrantDerivativeLiability" xlink:label="PPCB_DeferredTaxAssetsWarrantDerivativeLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_DeferredTaxAssetsWarrantDerivativeLiability" xlink:to="PPCB_DeferredTaxAssetsWarrantDerivativeLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_DeferredTaxAssetsWarrantDerivativeLiability_lbl" xml:lang="en-US">Warrant Derivative Liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_lbl" xml:lang="en-US">Accrued Expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_DeferredTaxAssetsPrepaidInvestorServices" xlink:label="PPCB_DeferredTaxAssetsPrepaidInvestorServices" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_DeferredTaxAssetsPrepaidInvestorServices" xlink:to="PPCB_DeferredTaxAssetsPrepaidInvestorServices_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_DeferredTaxAssetsPrepaidInvestorServices_lbl" xml:lang="en-US">Prepaid Investor Services</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_DeferredTaxAssetsNonCashInterest" xlink:label="PPCB_DeferredTaxAssetsNonCashInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_DeferredTaxAssetsNonCashInterest" xlink:to="PPCB_DeferredTaxAssetsNonCashInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_DeferredTaxAssetsNonCashInterest_lbl" xml:lang="en-US">Non-cash interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:label="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:to="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_lbl" xml:lang="en-US">Intangibles (Intellectual Property and Patent Cost)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent_lbl" xml:lang="en-US">Deferred Rent</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther_lbl" xml:lang="en-US">Formation Expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xml:lang="en-US">Net Operating Loss CF</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_DeferredTaxAssetsForeignExchangeLoss" xlink:label="PPCB_DeferredTaxAssetsForeignExchangeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_DeferredTaxAssetsForeignExchangeLoss" xlink:to="PPCB_DeferredTaxAssetsForeignExchangeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_DeferredTaxAssetsForeignExchangeLoss_lbl" xml:lang="en-US">Foreign Exchange Loss (OCI)</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_DeferredTaxAssetsRevalueOfDerivativeLiability" xlink:label="PPCB_DeferredTaxAssetsRevalueOfDerivativeLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_DeferredTaxAssetsRevalueOfDerivativeLiability" xlink:to="PPCB_DeferredTaxAssetsRevalueOfDerivativeLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_DeferredTaxAssetsRevalueOfDerivativeLiability_lbl" xml:lang="en-US">Revalue of derivative liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl" xml:lang="en-US">Stock Based Compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl" xml:lang="en-US">Total Deferred tax assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts" xlink:label="us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts" xlink:to="us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts_lbl" xml:lang="en-US">R&amp;D</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_DeferredTaxLiabilitiesGainOnExtinguishmentOfDebt" xlink:label="PPCB_DeferredTaxLiabilitiesGainOnExtinguishmentOfDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_DeferredTaxLiabilitiesGainOnExtinguishmentOfDebt" xlink:to="PPCB_DeferredTaxLiabilitiesGainOnExtinguishmentOfDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="PPCB_DeferredTaxLiabilitiesGainOnExtinguishmentOfDebt_lbl" xml:lang="en-US">Gain on extinguishment of debt</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts" xlink:label="us-gaap_DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts" xlink:to="us-gaap_DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts_lbl" xml:lang="en-US">Capital Raising Costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:label="us-gaap_DeferredIncomeTaxLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxLiabilities" xlink:to="us-gaap_DeferredIncomeTaxLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="us-gaap_DeferredIncomeTaxLiabilities_lbl" xml:lang="en-US">Total deferred tax liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="us-gaap_DeferredTaxAssetsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsNet_lbl" xml:lang="en-US">Net deferred tax assets (liabilities)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Valuation allowance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl" xml:lang="en-US">Net deferred tax assets (liabilities)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_lbl" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_lbl" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExaminationDescription" xlink:label="us-gaap_IncomeTaxExaminationDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExaminationDescription" xlink:to="us-gaap_IncomeTaxExaminationDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExaminationDescription_lbl" xml:lang="en-US">Income Tax Examination, Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="us-gaap_OperatingLossCarryforwards" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwards" xlink:to="us-gaap_OperatingLossCarryforwards_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLossCarryforwards_lbl" xml:lang="en-US">Operating loss carryforwards</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_lbl" xml:lang="en-US">Income tax rate</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExpenseBenefit_4_lbl" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="us-gaap_UnrecognizedTaxBenefits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefits" xlink:to="us-gaap_UnrecognizedTaxBenefits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl" xml:lang="en-US">Unrecognized tax benefits</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease" xlink:label="us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease" xlink:to="us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease_lbl" xml:lang="en-US">Changes in unrecognized tax benefits</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xml:lang="en-US">Number of Shares, Outstanding, Beginning balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted Average Price Per Share, Outstanding, Beginning balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_lbl" xml:lang="en-US">Number of Shares, Issued</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsIssuedInPeriodWeightedAverageExercisePrice" xlink:label="PPCB_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsIssuedInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsIssuedInPeriodWeightedAverageExercisePrice" xlink:to="PPCB_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsIssuedInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsIssuedInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted Average Price Per Share, Issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xml:lang="en-US">Number of Shares, Exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted Average Price Per Share, Exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_lbl" xml:lang="en-US">Number of Shares, Expired</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted Average Price Per Share, Expired</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2_lbl" xml:lang="en-US">Number of Shares, Outstanding, Ending balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Weighted Average Price Per Share, Outstanding, Ending balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xml:lang="en-US">Number of Shares, Exercisable, Ending balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted Average Price Per Share, Exercisable, Ending balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xml:lang="en-US">Weighted average remaining contractual term</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_WeightedAverageFairValueOfOptionsGrantedDuringPeriod" xlink:label="PPCB_WeightedAverageFairValueOfOptionsGrantedDuringPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_WeightedAverageFairValueOfOptionsGrantedDuringPeriod" xlink:to="PPCB_WeightedAverageFairValueOfOptionsGrantedDuringPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_WeightedAverageFairValueOfOptionsGrantedDuringPeriod_lbl" xml:lang="en-US">Weighted average fair value of options granted during the period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xml:lang="en-US">Aggregate intrinsic value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted Average Price Per Share, Issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xml:lang="en-US">Number of Shares, Forfeited</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted Average Price Per Share, Forfeited</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_2_lbl" xml:lang="en-US">Number of Shares, Expired</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_2_lbl" xml:lang="en-US">Number of Shares, Exercisable, Ending balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Weighted Average Price Per Share, Exercisable, Ending balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_2_lbl" xml:lang="en-US">Aggregate intrinsic value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_lbl" xml:lang="en-US">Number of Shares, Outstanding, Beginning balance</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageOutstanding" xlink:label="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageOutstanding" xlink:to="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageOutstanding_lbl" xml:lang="en-US">Weighted Average Price Per Share, Outstanding, Beginning balance</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsIssued" xlink:label="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsIssued" xlink:to="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsIssued_lbl" xml:lang="en-US">Number of Shares, Issued</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceIssued" xlink:label="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceIssued" xlink:to="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceIssued_lbl" xml:lang="en-US">Weighted Average Price Per Share, Issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_lbl" xml:lang="en-US">Number of Shares, Exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceExercised" xlink:label="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceExercised" xlink:to="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceExercised_lbl" xml:lang="en-US">Weighted Average Price Per Share, Exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_lbl" xml:lang="en-US">Number of Shares, Forfeited</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceExpired" xlink:label="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceExpired" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceExpired" xlink:to="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceExpired_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceExpired_lbl" xml:lang="en-US">Weighted Average Price Per Share, Forfeited</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_lbl" xml:lang="en-US">Number of Shares, Expired</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceForfeited" xlink:label="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceForfeited" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceForfeited" xlink:to="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceForfeited_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceForfeited_lbl" xml:lang="en-US">Weighted Average Price Per Share, Expired</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_2_lbl" xml:lang="en-US">Number of Shares, Outstanding, Ending balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageOutstanding" xlink:to="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageOutstanding_2_lbl" xml:lang="en-US">Weighted Average Price Per Share, Outstanding, Ending balance</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber" xlink:label="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber" xlink:to="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_lbl" xml:lang="en-US">Number of Shares, Exercisable, Ending balance</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisable" xlink:label="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisable" xlink:to="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisable_lbl" xml:lang="en-US">Weighted Average Price Per Share, Exercisable, Ending balance</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerms" xlink:label="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerms" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerms" xlink:to="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerms_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerms_lbl" xml:lang="en-US">Weighted average remaining contractual term</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsAggregateIntrinsicValueOutstanding" xlink:label="PPCB_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsAggregateIntrinsicValueOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsAggregateIntrinsicValueOutstanding" xlink:to="PPCB_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsAggregateIntrinsicValueOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="PPCB_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsAggregateIntrinsicValueOutstanding_lbl" xml:lang="en-US">Aggregate intrinsic value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber" xlink:to="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_2_lbl" xml:lang="en-US">Number of Shares, Exercisable, Ending balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisable" xlink:to="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisable_2_lbl" xml:lang="en-US">Weighted Average Price Per Share, Exercisable, Ending balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsAggregateIntrinsicValueOutstanding" xlink:to="PPCB_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsAggregateIntrinsicValueOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="PPCB_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsAggregateIntrinsicValueOutstanding_2_lbl" xml:lang="en-US">Aggregate intrinsic value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="us-gaap_ScheduleOfStockByClassTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_ScheduleOfStockByClassTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfStockByClassTable_lbl" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="us-gaap_ClassOfStockLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfStockLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfStockLineItems_lbl" xml:lang="en-US">Class of Stock [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityReverseStockSplit" xlink:to="us-gaap_StockholdersEquityReverseStockSplit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockholdersEquityReverseStockSplit_2_lbl" xml:lang="en-US">Reverse stock split</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_EquityPurchaseAgreementDescription" xlink:label="PPCB_EquityPurchaseAgreementDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_EquityPurchaseAgreementDescription" xlink:to="PPCB_EquityPurchaseAgreementDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_EquityPurchaseAgreementDescription_lbl" xml:lang="en-US">Equity purchase agreement description</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_2_lbl" xml:lang="en-US">Warrants exercised</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_2_lbl" xml:lang="en-US">Warrant exercise price</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfWarrants" xlink:to="us-gaap_ProceedsFromIssuanceOfWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants_lbl" xml:lang="en-US">Proceed from issuance of excercise of warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xml:lang="en-US">Offering cost</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_lbl" xml:lang="en-US">Number of restricted stock, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:to="us-gaap_DebtInstrumentConvertibleConversionPrice1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1_lbl" xml:lang="en-US">Conversion price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:to="us-gaap_DebtConversionConvertedInstrumentAmount1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DebtConversionConvertedInstrumentAmount1_2_lbl" xml:lang="en-US">Conversion of principal and interest, aggregate amount</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_ConversionFees" xlink:label="PPCB_ConversionFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_ConversionFees" xlink:to="PPCB_ConversionFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_ConversionFees_lbl" xml:lang="en-US">Conversion fees</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_2_lbl" xml:lang="en-US">Proceeds from issuance of common stock</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_ConversionOptionDerivatives" xlink:label="PPCB_ConversionOptionDerivatives" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_ConversionOptionDerivatives" xlink:to="PPCB_ConversionOptionDerivatives_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_ConversionOptionDerivatives_lbl" xml:lang="en-US">Conversion option derivatives</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_FairMarketValueOfShares" xlink:label="PPCB_FairMarketValueOfShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_FairMarketValueOfShares" xlink:to="PPCB_FairMarketValueOfShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_FairMarketValueOfShares_lbl" xml:lang="en-US">Fair market value of the shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt_4_lbl" xml:lang="en-US">Loss on extinguishment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeNet" xlink:label="us-gaap_DerivativeFairValueOfDerivativeNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeFairValueOfDerivativeNet" xlink:to="us-gaap_DerivativeFairValueOfDerivativeNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeFairValueOfDerivativeNet_lbl" xml:lang="en-US">Derivative fair value</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_PremiumsToAdditionalPaidInCapital" xlink:label="PPCB_PremiumsToAdditionalPaidInCapital" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_PremiumsToAdditionalPaidInCapital" xlink:to="PPCB_PremiumsToAdditionalPaidInCapital_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_PremiumsToAdditionalPaidInCapital_lbl" xml:lang="en-US">Premiums to additional paid in capital</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesSubscribedButUnissued" xlink:label="us-gaap_CommonStockSharesSubscribedButUnissued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesSubscribedButUnissued" xlink:to="us-gaap_CommonStockSharesSubscribedButUnissued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesSubscribedButUnissued_lbl" xml:lang="en-US">Common stock, unissued shares</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_DecreaseInEquity" xlink:label="PPCB_DecreaseInEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_DecreaseInEquity" xlink:to="PPCB_DecreaseInEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_DecreaseInEquity_lbl" xml:lang="en-US">Amount of decrease in equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="us-gaap_SharesIssuedPricePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssuedPricePerShare" xlink:to="us-gaap_SharesIssuedPricePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesIssuedPricePerShare_lbl" xml:lang="en-US">Shares issued, price per share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfessionalFees" xlink:label="us-gaap_ProfessionalFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfessionalFees" xlink:to="us-gaap_ProfessionalFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProfessionalFees_lbl" xml:lang="en-US">Consulting expenses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_2_lbl" xml:lang="en-US">Number of shares issued for services</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_2_lbl" xml:lang="en-US">Number of shares issued for services, value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromWarrantExercises" xlink:to="us-gaap_ProceedsFromWarrantExercises_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProceedsFromWarrantExercises_2_lbl" xml:lang="en-US">Proceeds from warrants exercise</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockSharesIssued_2_lbl" xml:lang="en-US">Common stock shares issued</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_DeemedDividend" xlink:to="PPCB_DeemedDividend_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="PPCB_DeemedDividend_2_lbl" xml:lang="en-US">Deemed dividend</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantDateFairvalue" xlink:label="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantDateFairvalue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantDateFairvalue" xlink:to="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantDateFairvalue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantDateFairvalue_lbl" xml:lang="en-US">[custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantDateFairvalue]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensation_2_lbl" xml:lang="en-US">Share based compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_UnrecognizedRestrictedStockUnitsExpense" xlink:label="PPCB_UnrecognizedRestrictedStockUnitsExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_UnrecognizedRestrictedStockUnitsExpense" xlink:to="PPCB_UnrecognizedRestrictedStockUnitsExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_UnrecognizedRestrictedStockUnitsExpense_lbl" xml:lang="en-US">[custom:UnrecognizedRestrictedStockUnitsExpense]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_lbl" xml:lang="en-US">Number of shares not yet vested</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xml:lang="en-US">Number of common shares reserved for future issuance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockOptionPlanExpense" xlink:label="us-gaap_StockOptionPlanExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockOptionPlanExpense" xlink:to="us-gaap_StockOptionPlanExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockOptionPlanExpense_lbl" xml:lang="en-US">Stock option expense</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_UnvestedStockOptionsExpense" xlink:label="PPCB_UnvestedStockOptionsExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_UnvestedStockOptionsExpense" xlink:to="PPCB_UnvestedStockOptionsExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_UnvestedStockOptionsExpense_lbl" xml:lang="en-US">Unvested stock options expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xml:lang="en-US">Vesting period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_lbl" xml:lang="en-US">Options granted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantsAndRightsOutstandingMaturityDate" xlink:label="us-gaap_WarrantsAndRightsOutstandingMaturityDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstandingMaturityDate" xlink:to="us-gaap_WarrantsAndRightsOutstandingMaturityDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantsAndRightsOutstandingMaturityDate_lbl" xml:lang="en-US">Warrant expiration date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstandingTerm" xlink:to="us-gaap_WarrantsAndRightsOutstandingTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm_lbl" xml:lang="en-US">Term of warrant</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_2_lbl" xml:lang="en-US">Warrants exercisable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:to="us-gaap_DebtInstrumentConvertibleThresholdTradingDays_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DebtInstrumentConvertibleThresholdTradingDays_2_lbl" xml:lang="en-US">Trading days</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan" xlink:to="us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan_lbl" xml:lang="en-US">Stock issued during the period for services, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan" xlink:to="us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan_lbl" xml:lang="en-US">Stock Issued During Period, Value, Employee Benefit Plan</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockValue_2_lbl" xml:lang="en-US">Common stock value issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_lbl" xml:lang="en-US">Additional paid in capital upon issuance</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_PercentageOfBonusOfAnnualBaseSalary" xlink:label="PPCB_PercentageOfBonusOfAnnualBaseSalary" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_PercentageOfBonusOfAnnualBaseSalary" xlink:to="PPCB_PercentageOfBonusOfAnnualBaseSalary_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_PercentageOfBonusOfAnnualBaseSalary_lbl" xml:lang="en-US">Percentage of bonus of annual base salary</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OfficersCompensation" xlink:label="us-gaap_OfficersCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OfficersCompensation" xlink:to="us-gaap_OfficersCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OfficersCompensation_lbl" xml:lang="en-US">Officer compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:label="us-gaap_DebtConversionConvertedInstrumentSharesIssued1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:to="us-gaap_DebtConversionConvertedInstrumentSharesIssued1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtConversionConvertedInstrumentSharesIssued1_lbl" xml:lang="en-US">Debt Conversion, Converted Instrument, Shares Issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharePrice" xlink:to="us-gaap_SharePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharePrice_lbl" xml:lang="en-US">Share Price</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedSalariesCurrent" xlink:label="us-gaap_AccruedSalariesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedSalariesCurrent" xlink:to="us-gaap_AccruedSalariesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedSalariesCurrent_lbl" xml:lang="en-US">Acccrued salary cancellation</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_DescriptionOfEmploymentBenefits" xlink:label="PPCB_DescriptionOfEmploymentBenefits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_DescriptionOfEmploymentBenefits" xlink:to="PPCB_DescriptionOfEmploymentBenefits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_DescriptionOfEmploymentBenefits_lbl" xml:lang="en-US">Description Of Employment Benefits</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_2_lbl" xml:lang="en-US">Stock Issued During Period, Value, New Issues</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteSubscriptionsReceivable" xlink:to="us-gaap_StockholdersEquityNoteSubscriptionsReceivable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteSubscriptionsReceivable_2_lbl" xml:lang="en-US">Stockholders' Equity Note, Subscriptions Receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:to="us-gaap_StockIssuedDuringPeriodSharesOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther_lbl" xml:lang="en-US">Stock Issued During Period, Shares, Other</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_OperatingLeaseRightOfUseAssets" xlink:label="PPCB_OperatingLeaseRightOfUseAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_OperatingLeaseRightOfUseAssets" xlink:to="PPCB_OperatingLeaseRightOfUseAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_OperatingLeaseRightOfUseAssets_lbl" xml:lang="en-US">Office lease (24 months)</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_AccumulatedReduction" xlink:label="PPCB_AccumulatedReduction" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_AccumulatedReduction" xlink:to="PPCB_AccumulatedReduction_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_AccumulatedReduction_lbl" xml:lang="en-US">Less accumulated amortization</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_2_lbl" xml:lang="en-US">Right-of-use asset, net</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_OfficeLeaseLiability" xlink:label="PPCB_OfficeLeaseLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_OfficeLeaseLiability" xlink:to="PPCB_OfficeLeaseLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_OfficeLeaseLiability_lbl" xml:lang="en-US">Office lease</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_ReductionOfLeaseLiability" xlink:label="PPCB_ReductionOfLeaseLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_ReductionOfLeaseLiability" xlink:to="PPCB_ReductionOfLeaseLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_ReductionOfLeaseLiability_lbl" xml:lang="en-US">Reduction of lease liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xml:lang="en-US">Long term portion of lease liability</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LegalFees" xlink:to="us-gaap_LegalFees_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LegalFees_2_lbl" xml:lang="en-US">Legal Fees</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfessionalFees" xlink:to="us-gaap_ProfessionalFees_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProfessionalFees_2_lbl" xml:lang="en-US">Professional Fees</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_SettlementAmount" xlink:label="PPCB_SettlementAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_SettlementAmount" xlink:to="PPCB_SettlementAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_SettlementAmount_lbl" xml:lang="en-US">[custom:SettlementAmount-0]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_lbl" xml:lang="en-US">Accounts Payable and Accrued Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_GainLossFromSettlementOfDebt" xlink:label="PPCB_GainLossFromSettlementOfDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_GainLossFromSettlementOfDebt" xlink:to="PPCB_GainLossFromSettlementOfDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_GainLossFromSettlementOfDebt_lbl" xml:lang="en-US">Gain loss from settlement of debt</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyDamagesSoughtValue" xlink:label="us-gaap_LossContingencyDamagesSoughtValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossContingencyDamagesSoughtValue" xlink:to="us-gaap_LossContingencyDamagesSoughtValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LossContingencyDamagesSoughtValue_lbl" xml:lang="en-US">Loss contingency amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebt" xlink:label="us-gaap_ConvertibleDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleDebt" xlink:to="us-gaap_ConvertibleDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertibleDebt_lbl" xml:lang="en-US">Convertible note</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_LitigationPenaltyAmount" xlink:label="PPCB_LitigationPenaltyAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_LitigationPenaltyAmount" xlink:to="PPCB_LitigationPenaltyAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_LitigationPenaltyAmount_lbl" xml:lang="en-US">Penalty amount</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_RemainingPrincipalAmount" xlink:label="PPCB_RemainingPrincipalAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_RemainingPrincipalAmount" xlink:to="PPCB_RemainingPrincipalAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_RemainingPrincipalAmount_lbl" xml:lang="en-US">Remaining principal amount</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_OperatingLeasesIncomeStatementRevenuePercentage" xlink:label="PPCB_OperatingLeasesIncomeStatementRevenuePercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_OperatingLeasesIncomeStatementRevenuePercentage" xlink:to="PPCB_OperatingLeasesIncomeStatementRevenuePercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_OperatingLeasesIncomeStatementRevenuePercentage_lbl" xml:lang="en-US">Operating leases income statement revenue percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseTermOfContract" xlink:to="us-gaap_LesseeOperatingLeaseTermOfContract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract_lbl" xml:lang="en-US">Lessee, Operating Lease, Term of Contract</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRent" xlink:label="us-gaap_PaymentsForRent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForRent" xlink:to="us-gaap_PaymentsForRent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsForRent_lbl" xml:lang="en-US">Payments for Rent</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseDescription" xlink:label="us-gaap_LesseeOperatingLeaseDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseDescription" xlink:to="us-gaap_LesseeOperatingLeaseDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseDescription_lbl" xml:lang="en-US">Operating lease, description</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_3_lbl" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiability_2_lbl" xml:lang="en-US">Operating Lease, Liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_PaymentForServices" xlink:label="PPCB_PaymentForServices" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_PaymentForServices" xlink:to="PPCB_PaymentForServices_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_PaymentForServices_lbl" xml:lang="en-US">Payment for services</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="us-gaap_ConcentrationRiskPercentage1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskPercentage1" xlink:to="us-gaap_ConcentrationRiskPercentage1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskPercentage1_lbl" xml:lang="en-US">Royalties percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_lbl" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="us-gaap_RelatedPartyTransactionLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_RelatedPartyTransactionLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionLineItems_lbl" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_LoansFromRelatedParty" xlink:label="PPCB_LoansFromRelatedParty" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_LoansFromRelatedParty" xlink:to="PPCB_LoansFromRelatedParty_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_LoansFromRelatedParty_lbl" xml:lang="en-US">Loans from related party</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DueToRelatedPartiesCurrent" xlink:to="us-gaap_DueToRelatedPartiesCurrent_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DueToRelatedPartiesCurrent_3_lbl" xml:lang="en-US">Due to related parties</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LessorOperatingLeaseTermOfContract" xlink:label="us-gaap_LessorOperatingLeaseTermOfContract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LessorOperatingLeaseTermOfContract" xlink:to="us-gaap_LessorOperatingLeaseTermOfContract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LessorOperatingLeaseTermOfContract_lbl" xml:lang="en-US">Lessor, Operating Lease, Term of Contract</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesRentExpenseMinimumRentals" xlink:label="us-gaap_OperatingLeasesRentExpenseMinimumRentals" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesRentExpenseMinimumRentals" xlink:to="us-gaap_OperatingLeasesRentExpenseMinimumRentals_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesRentExpenseMinimumRentals_lbl" xml:lang="en-US">Operating Leases, Rent Expense, Minimum Rentals</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_GoodsAndServiceTax" xlink:label="PPCB_GoodsAndServiceTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_GoodsAndServiceTax" xlink:to="PPCB_GoodsAndServiceTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_GoodsAndServiceTax_lbl" xml:lang="en-US">[custom:GoodsAndServiceTax]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue_lbl" xml:lang="en-US">Operating Leases, Future Minimum Payments Due</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseDescription" xlink:to="us-gaap_LesseeOperatingLeaseDescription_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LesseeOperatingLeaseDescription_2_lbl" xml:lang="en-US">Lessee, Operating Lease, Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionDate" xlink:label="us-gaap_RelatedPartyTransactionDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionDate" xlink:to="us-gaap_RelatedPartyTransactionDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionDate_lbl" xml:lang="en-US">Expired date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalariesAndWages" xlink:label="us-gaap_SalariesAndWages" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalariesAndWages" xlink:to="us-gaap_SalariesAndWages_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SalariesAndWages_lbl" xml:lang="en-US">Annual salary</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_PercentageOfPensionOfMonthlySalary" xlink:label="PPCB_PercentageOfPensionOfMonthlySalary" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_PercentageOfPensionOfMonthlySalary" xlink:to="PPCB_PercentageOfPensionOfMonthlySalary_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_PercentageOfPensionOfMonthlySalary_lbl" xml:lang="en-US">Percentage of pension of monthly salary</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfRelatedPartyDebt" xlink:label="us-gaap_RepaymentsOfRelatedPartyDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfRelatedPartyDebt" xlink:to="us-gaap_RepaymentsOfRelatedPartyDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfRelatedPartyDebt_lbl" xml:lang="en-US">Payments form related party</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OfficersCompensation" xlink:to="us-gaap_OfficersCompensation_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OfficersCompensation_2_lbl" xml:lang="en-US">Officers' compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_BonusPayableAmount" xlink:label="PPCB_BonusPayableAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_BonusPayableAmount" xlink:to="PPCB_BonusPayableAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_BonusPayableAmount_lbl" xml:lang="en-US">Bonus payable amount</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_RemainingBonusAmount" xlink:label="PPCB_RemainingBonusAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_RemainingBonusAmount" xlink:to="PPCB_RemainingBonusAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_RemainingBonusAmount_lbl" xml:lang="en-US">[custom:RemainingBonusAmount]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_BonusAwardsGrantedPercentage" xlink:label="PPCB_BonusAwardsGrantedPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_BonusAwardsGrantedPercentage" xlink:to="PPCB_BonusAwardsGrantedPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_BonusAwardsGrantedPercentage_lbl" xml:lang="en-US">Bonus granted percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_BonusPayable" xlink:label="PPCB_BonusPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_BonusPayable" xlink:to="PPCB_BonusPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_BonusPayable_lbl" xml:lang="en-US">Bonus payable</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_AgreementlTerm" xlink:label="PPCB_AgreementlTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_AgreementlTerm" xlink:to="PPCB_AgreementlTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_AgreementlTerm_lbl" xml:lang="en-US">Agreement term</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_AgreementRenewalTerm" xlink:label="PPCB_AgreementRenewalTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_AgreementRenewalTerm" xlink:to="PPCB_AgreementRenewalTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_AgreementRenewalTerm_lbl" xml:lang="en-US">Agreement renewal term</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_lbl" xml:lang="en-US">Option purchase shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Exercise price</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_lbl" xml:lang="en-US">Market price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_3_lbl" xml:lang="en-US">Granted exercise price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_2_lbl" xml:lang="en-US">Restricted stock shares of common stock</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_StockToBeIssuedDuringPeriodValueRestrictedStockUnit" xlink:label="PPCB_StockToBeIssuedDuringPeriodValueRestrictedStockUnit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_StockToBeIssuedDuringPeriodValueRestrictedStockUnit" xlink:to="PPCB_StockToBeIssuedDuringPeriodValueRestrictedStockUnit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_StockToBeIssuedDuringPeriodValueRestrictedStockUnit_lbl" xml:lang="en-US">Restricted stock unit issuable</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_OptionsVestedDescription" xlink:label="PPCB_OptionsVestedDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_OptionsVestedDescription" xlink:to="PPCB_OptionsVestedDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_OptionsVestedDescription_lbl" xml:lang="en-US">Options vested, description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl" xml:lang="en-US">Option term</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl" xml:lang="en-US">Rsus vest, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_GrossProceedsFromEquityFinancing" xlink:label="PPCB_GrossProceedsFromEquityFinancing" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_GrossProceedsFromEquityFinancing" xlink:to="PPCB_GrossProceedsFromEquityFinancing_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_GrossProceedsFromEquityFinancing_lbl" xml:lang="en-US">Gross proceeds from equity financing</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedSalariesCurrent" xlink:to="us-gaap_AccruedSalariesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AccruedSalariesCurrent_2_lbl" xml:lang="en-US">Accrued salaries</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_CancellationOfAccruedSalaries" xlink:label="PPCB_CancellationOfAccruedSalaries" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_CancellationOfAccruedSalaries" xlink:to="PPCB_CancellationOfAccruedSalaries_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_CancellationOfAccruedSalaries_lbl" xml:lang="en-US">Cancellation of accrued salary</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_OperatingLeasesRentExpenseMinimumRentalsPayable" xlink:label="PPCB_OperatingLeasesRentExpenseMinimumRentalsPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_OperatingLeasesRentExpenseMinimumRentalsPayable" xlink:to="PPCB_OperatingLeasesRentExpenseMinimumRentalsPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_OperatingLeasesRentExpenseMinimumRentalsPayable_lbl" xml:lang="en-US">[custom:OperatingLeasesRentExpenseMinimumRentalsPayable]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:label="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_lbl" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:label="us-gaap_DefinedBenefitPlanDisclosureLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:to="us-gaap_DefinedBenefitPlanDisclosureLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DefinedBenefitPlanDisclosureLineItems_lbl" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromConvertibleDebt" xlink:to="us-gaap_ProceedsFromConvertibleDebt_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromConvertibleDebt_3_lbl" xml:lang="en-US">Proceeds from Convertible Debt</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage_2_lbl" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:label="us-gaap_AmortizationOfFinancingCostsAndDiscounts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:to="us-gaap_AmortizationOfFinancingCostsAndDiscounts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfFinancingCostsAndDiscounts_lbl" xml:lang="en-US">Discounts and debt issuance cost</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_ReimbursementOnGoodsAndServiceTaxReceivablePercentage" xlink:label="PPCB_ReimbursementOnGoodsAndServiceTaxReceivablePercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_ReimbursementOnGoodsAndServiceTaxReceivablePercentage" xlink:to="PPCB_ReimbursementOnGoodsAndServiceTaxReceivablePercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_ReimbursementOnGoodsAndServiceTaxReceivablePercentage_lbl" xml:lang="en-US">Reimbursement on goods and service tax receivable percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable" xlink:label="us-gaap_DerivativeTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeTable" xlink:to="us-gaap_DerivativeTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeTable_lbl" xml:lang="en-US">Derivative [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems" xlink:label="us-gaap_DerivativeLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeLineItems" xlink:to="us-gaap_DerivativeLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeLineItems_lbl" xml:lang="en-US">Derivative [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentMeasurementInput" xlink:label="us-gaap_DebtInstrumentMeasurementInput" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentMeasurementInput" xlink:to="us-gaap_DebtInstrumentMeasurementInput_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentMeasurementInput_lbl" xml:lang="en-US">Debt instrument, measurement input, percentages</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTerm" xlink:label="us-gaap_DebtInstrumentTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentTerm" xlink:to="us-gaap_DebtInstrumentTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentTerm_lbl" xml:lang="en-US">Debt instrument, measurement input, term</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" xlink:to="us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_2_lbl" xml:lang="en-US">Embedded conversion option liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilities" xlink:label="us-gaap_DerivativeLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeLiabilities" xlink:to="us-gaap_DerivativeLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeLiabilities_lbl" xml:lang="en-US">Total</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeLiabilities" xlink:to="us-gaap_DerivativeLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_DerivativeLiabilities_2_lbl" xml:lang="en-US">Balance at Beginning</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_ReductionsDueToConversions" xlink:label="PPCB_ReductionsDueToConversions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_ReductionsDueToConversions" xlink:to="PPCB_ReductionsDueToConversions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_ReductionsDueToConversions_lbl" xml:lang="en-US">Reductions due to conversions</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_FairValueOfWarrantDerivativeLiabilityRecorededAsDebtDiscount" xlink:label="PPCB_FairValueOfWarrantDerivativeLiabilityRecorededAsDebtDiscount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_FairValueOfWarrantDerivativeLiabilityRecorededAsDebtDiscount" xlink:to="PPCB_FairValueOfWarrantDerivativeLiabilityRecorededAsDebtDiscount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_FairValueOfWarrantDerivativeLiabilityRecorededAsDebtDiscount_lbl" xml:lang="en-US">Initial fair value of embedded conversion option derivative liability recorded as debt discount</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_InitialFairValueOfEmbeddedConversionOptionDerivativeLiabilityRecordedAsExpense" xlink:label="PPCB_InitialFairValueOfEmbeddedConversionOptionDerivativeLiabilityRecordedAsExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_InitialFairValueOfEmbeddedConversionOptionDerivativeLiabilityRecordedAsExpense" xlink:to="PPCB_InitialFairValueOfEmbeddedConversionOptionDerivativeLiabilityRecordedAsExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_InitialFairValueOfEmbeddedConversionOptionDerivativeLiabilityRecordedAsExpense_lbl" xml:lang="en-US">Initial fair value of embedded conversion option derivative liability recorded as expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet" xlink:label="us-gaap_EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet" xlink:to="us-gaap_EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet_lbl" xml:lang="en-US">Balance at Beginning</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_GainOnDebtExtinguishment" xlink:label="PPCB_GainOnDebtExtinguishment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_GainOnDebtExtinguishment" xlink:to="PPCB_GainOnDebtExtinguishment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_GainOnDebtExtinguishment_lbl" xml:lang="en-US">Gain on debt extinguishment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeLiabilities" xlink:to="us-gaap_DerivativeLiabilities_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_DerivativeLiabilities_3_lbl" xml:lang="en-US">Balance at Ending</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:label="us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:to="us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_lbl" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:label="us-gaap_DerivativeInstrumentsGainLossLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:to="us-gaap_DerivativeInstrumentsGainLossLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeInstrumentsGainLossLineItems_lbl" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleDebt" xlink:to="us-gaap_ConvertibleDebt_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ConvertibleDebt_2_lbl" xml:lang="en-US">Convertible debt</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTable" xlink:label="us-gaap_SubsequentEventTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTable_lbl" xml:lang="en-US">Subsequent Event [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventLineItems" xlink:label="us-gaap_SubsequentEventLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SubsequentEventLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventLineItems_lbl" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromWarrantExercises" xlink:to="us-gaap_ProceedsFromWarrantExercises_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromWarrantExercises_3_lbl" xml:lang="en-US">Proceeds from Warrant Exercises</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockSharesIssued_3_lbl" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:to="us-gaap_DebtInstrumentConvertibleConversionPrice1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1_2_lbl" xml:lang="en-US">Debt Instrument, Convertible, Conversion Price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DebtInstrumentFaceAmount_2_lbl" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPayableCurrent" xlink:label="us-gaap_InterestPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPayableCurrent" xlink:to="us-gaap_InterestPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPayableCurrent_lbl" xml:lang="en-US">Interest Payable, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AdditionalPaidInCapital_3_lbl" xml:lang="en-US">Additional Paid in Capital</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OfficersCompensation" xlink:to="us-gaap_OfficersCompensation_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OfficersCompensation_3_lbl" xml:lang="en-US">Salary and Wage, Officer, Excluding Cost of Good and Service Sold</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharePrice" xlink:to="us-gaap_SharePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SharePrice_2_lbl" xml:lang="en-US">Share price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_CancellationOfAccruedSalaries" xlink:to="PPCB_CancellationOfAccruedSalaries_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="PPCB_CancellationOfAccruedSalaries_2_lbl" xml:lang="en-US">Cancellation Of Accrued Salaries</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_DescriptionOfEmploymentBenefits" xlink:to="PPCB_DescriptionOfEmploymentBenefits_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="PPCB_DescriptionOfEmploymentBenefits_2_lbl" xml:lang="en-US">Description of employment benefits</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_CommonStockIssuableShares" xlink:to="PPCB_CommonStockIssuableShares_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="PPCB_CommonStockIssuableShares_2_lbl" xml:lang="en-US">Common Stock Issuable Shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_2_lbl" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedBonusesCurrent" xlink:label="us-gaap_AccruedBonusesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedBonusesCurrent" xlink:to="us-gaap_AccruedBonusesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedBonusesCurrent_lbl" xml:lang="en-US">Accrued Bonuses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentUnamortizedDiscount" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscount_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount_3_lbl" xml:lang="en-US">Debt Instrument, Unamortized Discount</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentMaturityDate" xlink:to="us-gaap_DebtInstrumentMaturityDate_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DebtInstrumentMaturityDate_2_lbl" xml:lang="en-US">Debt Instrument, Maturity Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:label="us-gaap_DebtInstrumentInterestRateDuringPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:to="us-gaap_DebtInstrumentInterestRateDuringPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentInterestRateDuringPeriod_lbl" xml:lang="en-US">Debt Instrument, Interest Rate During Period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentDescription" xlink:to="us-gaap_DebtInstrumentDescription_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DebtInstrumentDescription_2_lbl" xml:lang="en-US">Debt description</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_DebtCoversionPercentage" xlink:label="PPCB_DebtCoversionPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_DebtCoversionPercentage" xlink:to="PPCB_DebtCoversionPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_DebtCoversionPercentage_lbl" xml:lang="en-US">Debt Coversion Percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateTerms" xlink:label="us-gaap_DebtInstrumentInterestRateTerms" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateTerms" xlink:to="us-gaap_DebtInstrumentInterestRateTerms_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentInterestRateTerms_lbl" xml:lang="en-US">Debt Instrument, Interest Rate Terms</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_ConsultingAgreementDescription" xlink:label="PPCB_ConsultingAgreementDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_ConsultingAgreementDescription" xlink:to="PPCB_ConsultingAgreementDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_ConsultingAgreementDescription_lbl" xml:lang="en-US">Consulting agreement description</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_ConsultingAgreementMonthlyPayment" xlink:label="PPCB_ConsultingAgreementMonthlyPayment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_ConsultingAgreementMonthlyPayment" xlink:to="PPCB_ConsultingAgreementMonthlyPayment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_ConsultingAgreementMonthlyPayment_lbl" xml:lang="en-US">Consulting agreement, monthly payment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_LoansFromRelatedParty" xlink:to="PPCB_LoansFromRelatedParty_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_LoansFromRelatedParty_doc" xml:lang="en-US">Representing amount borrowed from related parties.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_CommonStockIssuableShares" xlink:to="PPCB_CommonStockIssuableShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_CommonStockIssuableShares_doc" xml:lang="en-US">Common stock, issuable shares.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_DirectorsAndOfficerMember" xlink:to="PPCB_DirectorsAndOfficerMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_DirectorsAndOfficerMember_doc" xml:lang="en-US">Directors and Officer [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_DebtInstrumentDebtDefaultInterestRate" xlink:to="PPCB_DebtInstrumentDebtDefaultInterestRate_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_DebtInstrumentDebtDefaultInterestRate_doc" xml:lang="en-US">It represents interest rate of convertible promissory notes in event of default in payments.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_UnrecognizedRestrictedStockUnitsExpense" xlink:to="PPCB_UnrecognizedRestrictedStockUnitsExpense_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_UnrecognizedRestrictedStockUnitsExpense_doc" xml:lang="en-US">Unrecognized restricted stock units expense.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsIssuedInPeriodWeightedAverageExercisePrice" xlink:to="PPCB_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsIssuedInPeriodWeightedAverageExercisePrice_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsIssuedInPeriodWeightedAverageExercisePrice_doc" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Issued in Period, Weighted Average Exercise Price.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_WeightedAverageFairValueOfOptionsGrantedDuringPeriod" xlink:to="PPCB_WeightedAverageFairValueOfOptionsGrantedDuringPeriod_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_WeightedAverageFairValueOfOptionsGrantedDuringPeriod_doc" xml:lang="en-US">Weighted average fair value of options granted during the period.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsIssued" xlink:to="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsIssued_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsIssued_doc" xml:lang="en-US">Net number of non-option equity instruments issued to participants.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber" xlink:to="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_doc" xml:lang="en-US">Number of equity instruments other than options exercisable, including both vested and non-vested instruments.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerms" xlink:to="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerms_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerms_doc" xml:lang="en-US">Weighted average remaining contractual term.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_SettlementAmount" xlink:to="PPCB_SettlementAmount_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_SettlementAmount_doc" xml:lang="en-US">Settlement amount.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_GainLossFromSettlementOfDebt" xlink:to="PPCB_GainLossFromSettlementOfDebt_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_GainLossFromSettlementOfDebt_doc" xml:lang="en-US">Gain loss from settlement of debt.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_LitigationPenaltyAmount" xlink:to="PPCB_LitigationPenaltyAmount_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_LitigationPenaltyAmount_doc" xml:lang="en-US">Litigation penalty amount.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_RemainingPrincipalAmount" xlink:to="PPCB_RemainingPrincipalAmount_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_RemainingPrincipalAmount_doc" xml:lang="en-US">Remaining principal amount</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_PaymentForServices" xlink:to="PPCB_PaymentForServices_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_PaymentForServices_doc" xml:lang="en-US">Payment for services.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_OperatingLeaseRightOfUseAssets" xlink:to="PPCB_OperatingLeaseRightOfUseAssets_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_OperatingLeaseRightOfUseAssets_doc" xml:lang="en-US">Office lease ROU.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_AccumulatedReduction" xlink:to="PPCB_AccumulatedReduction_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_AccumulatedReduction_doc" xml:lang="en-US">Accumulated reduction.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_OfficeLeaseLiability" xlink:to="PPCB_OfficeLeaseLiability_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_OfficeLeaseLiability_doc" xml:lang="en-US">Office lease liability.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_ReductionOfLeaseLiability" xlink:to="PPCB_ReductionOfLeaseLiability_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_ReductionOfLeaseLiability_doc" xml:lang="en-US">Reduction of lease liability.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_RelativeFairValueOfWarrantsIssuedWithConvertibleDebt" xlink:to="PPCB_RelativeFairValueOfWarrantsIssuedWithConvertibleDebt_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_RelativeFairValueOfWarrantsIssuedWithConvertibleDebt_doc" xml:lang="en-US">Relative fair value of warrants issued with convertible debt.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_RemainingBonusAmount" xlink:to="PPCB_RemainingBonusAmount_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_RemainingBonusAmount_doc" xml:lang="en-US">Remaining bonus amount.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_StockToBeIssuedDuringPeriodValueRestrictedStockUnit" xlink:to="PPCB_StockToBeIssuedDuringPeriodValueRestrictedStockUnit_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_StockToBeIssuedDuringPeriodValueRestrictedStockUnit_doc" xml:lang="en-US">Stock to be issued during period, value, restricted stock unit.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_DecemberTwentyNineTwoThousandAndSeventeenSecuritiesPurchaseAgreementMember" xlink:to="PPCB_DecemberTwentyNineTwoThousandAndSeventeenSecuritiesPurchaseAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_DecemberTwentyNineTwoThousandAndSeventeenSecuritiesPurchaseAgreementMember_doc" xml:lang="en-US">December 29, 2017 Securities Purchase Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_EagleEquitiesLLCMember" xlink:to="PPCB_EagleEquitiesLLCMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_EagleEquitiesLLCMember_doc" xml:lang="en-US">Eagle Equities, LLC [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_DecemberTwoThousandAndSeventeenEagleNoteMember" xlink:to="PPCB_DecemberTwoThousandAndSeventeenEagleNoteMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_DecemberTwoThousandAndSeventeenEagleNoteMember_doc" xml:lang="en-US">December 2017 Eagle Note [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_DecemberTwentyNineTwoThousandAndSixteenSecuritiesPurchaseAgreementMember" xlink:to="PPCB_DecemberTwentyNineTwoThousandAndSixteenSecuritiesPurchaseAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_DecemberTwentyNineTwoThousandAndSixteenSecuritiesPurchaseAgreementMember_doc" xml:lang="en-US">December 21, 2016 Securities Purchase Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_JulyThirteenTwoThousandAndEighteenSecuritiesPurchaseAgreementMember" xlink:to="PPCB_JulyThirteenTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_JulyThirteenTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_doc" xml:lang="en-US">July 13, 2018 Securities Purchase Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_JulyTwoThousandEighteenEagleNoteMember" xlink:to="PPCB_JulyTwoThousandEighteenEagleNoteMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_JulyTwoThousandEighteenEagleNoteMember_doc" xml:lang="en-US">July 2018 Eagle Note [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_JuneTwentyNineTwoThousandEighteenSecuritiesPurchaseAgreementMember" xlink:to="PPCB_JuneTwentyNineTwoThousandEighteenSecuritiesPurchaseAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_JuneTwentyNineTwoThousandEighteenSecuritiesPurchaseAgreementMember_doc" xml:lang="en-US">June 14, 2018 Securities Purchase Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_SeriesBWarrantsMember" xlink:to="PPCB_SeriesBWarrantsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_SeriesBWarrantsMember_doc" xml:lang="en-US">Series B Warrants [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_SeriesCWarrantsMember" xlink:to="PPCB_SeriesCWarrantsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_SeriesCWarrantsMember_doc" xml:lang="en-US">Series C Warrants [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_ReversalOfCommonStockIssuableDueToCancellationOfConversionsOfConvertibleDebtAndAccruedInterest" xlink:to="PPCB_ReversalOfCommonStockIssuableDueToCancellationOfConversionsOfConvertibleDebtAndAccruedInterest_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_ReversalOfCommonStockIssuableDueToCancellationOfConversionsOfConvertibleDebtAndAccruedInterest_doc" xml:lang="en-US">Reversal of common stock issuable due to cancellation of conversions of convertible debt and accrued interest.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_AugustTwentyNineTwoThousandandEighteenSecuritiesPurchaseAgreementMember" xlink:to="PPCB_AugustTwentyNineTwoThousandandEighteenSecuritiesPurchaseAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_AugustTwentyNineTwoThousandandEighteenSecuritiesPurchaseAgreementMember_doc" xml:lang="en-US">August 29, 2018 Securities Purchase Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_AugustTwoThousandEighteenEagleNoteMember" xlink:to="PPCB_AugustTwoThousandEighteenEagleNoteMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_AugustTwoThousandEighteenEagleNoteMember_doc" xml:lang="en-US">August 2018 Eagle Note [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember" xlink:to="PPCB_OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_doc" xml:lang="en-US">October 2, 2018 Securities Purchase Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_OctoberTwoTwoThousandAndEighteenEagleNoteMember" xlink:to="PPCB_OctoberTwoTwoThousandAndEighteenEagleNoteMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_OctoberTwoTwoThousandAndEighteenEagleNoteMember_doc" xml:lang="en-US">October 2018 Eagle Note [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_NovembeThirtyTwoThousandAndEighteenMecuritiesPurchaseAgreementMember" xlink:to="PPCB_NovembeThirtyTwoThousandAndEighteenMecuritiesPurchaseAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_NovembeThirtyTwoThousandAndEighteenMecuritiesPurchaseAgreementMember_doc" xml:lang="en-US">November 30, 2018 Securities Purchase Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_NovemberTwoThousandAndEighteenEagleNoteMember" xlink:to="PPCB_NovemberTwoThousandAndEighteenEagleNoteMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_NovemberTwoThousandAndEighteenEagleNoteMember_doc" xml:lang="en-US">November 2018 Eagle Note [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_ReversalOfCommonStockIssuableDueToCancellationOfConversionsOfConvertibleDebtAndAccruedInterestShares" xlink:to="PPCB_ReversalOfCommonStockIssuableDueToCancellationOfConversionsOfConvertibleDebtAndAccruedInterestShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_ReversalOfCommonStockIssuableDueToCancellationOfConversionsOfConvertibleDebtAndAccruedInterestShares_doc" xml:lang="en-US">Reversal of common stock issuable due to cancellation of conversions of convertible debt and accrued interest, shares.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_ReimbursementOnGoodsAndServiceTaxReceivablePercentage" xlink:to="PPCB_ReimbursementOnGoodsAndServiceTaxReceivablePercentage_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_ReimbursementOnGoodsAndServiceTaxReceivablePercentage_doc" xml:lang="en-US">It represents the percentage of Reimbursement on Goods And Service Tax Receivable.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_StockIssuedDuringPeriodValueReverseStockSplits" xlink:to="PPCB_StockIssuedDuringPeriodValueReverseStockSplits_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_StockIssuedDuringPeriodValueReverseStockSplits_doc" xml:lang="en-US">Fractional difference due to the reverse stock-split.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_ReductionsDueToConversions" xlink:to="PPCB_ReductionsDueToConversions_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_ReductionsDueToConversions_doc" xml:lang="en-US">Reductions due to conversions.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_InitialFairValueOfEmbeddedConversionOptionDerivativeLiabilityRecordedAsExpense" xlink:to="PPCB_InitialFairValueOfEmbeddedConversionOptionDerivativeLiabilityRecordedAsExpense_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_InitialFairValueOfEmbeddedConversionOptionDerivativeLiabilityRecordedAsExpense_doc" xml:lang="en-US">Initial fair value of embedded conversion option derivative liability recorded as expense.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_DebtConversionConvertedInterestPayable" xlink:to="PPCB_DebtConversionConvertedInterestPayable_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_DebtConversionConvertedInterestPayable_doc" xml:lang="en-US">Debt conversion converted interest payable.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_InitialKenyonRSUsMember" xlink:to="PPCB_InitialKenyonRSUsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_InitialKenyonRSUsMember_doc" xml:lang="en-US">Initial Kenyon RSUs [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_GSCapitalPartnersLLCMember" xlink:to="PPCB_GSCapitalPartnersLLCMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_GSCapitalPartnersLLCMember_doc" xml:lang="en-US">GS Capital Partners, LLC [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_OctoberTwoThousandEighteenGSNoteMember" xlink:to="PPCB_OctoberTwoThousandEighteenGSNoteMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_OctoberTwoThousandEighteenGSNoteMember_doc" xml:lang="en-US">October 2018 GS Note [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_FirstNoteMember" xlink:to="PPCB_FirstNoteMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_FirstNoteMember_doc" xml:lang="en-US">First Note [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_JanuaryTwentyTwoTwentyTwentyGSNoteMember" xlink:to="PPCB_JanuaryTwentyTwoTwentyTwentyGSNoteMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_JanuaryTwentyTwoTwentyTwentyGSNoteMember_doc" xml:lang="en-US">January 22, 2020 GS Note [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_AugustTenTwoThousandAndSeventeenConsultingAgreementMember" xlink:to="PPCB_AugustTenTwoThousandAndSeventeenConsultingAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_AugustTenTwoThousandAndSeventeenConsultingAgreementMember_doc" xml:lang="en-US">August 10, 2017 Consulting Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantDateFairvalue" xlink:to="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantDateFairvalue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantDateFairvalue_doc" xml:lang="en-US">The amount of share based compensation arrangement by share based payment award options grant date fair value.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_OperatingLeasesIncomeStatementRevenuePercentage" xlink:to="PPCB_OperatingLeasesIncomeStatementRevenuePercentage_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_OperatingLeasesIncomeStatementRevenuePercentage_doc" xml:lang="en-US">The percentage of operating leases income statement revenue during period.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_GoodsAndServiceTax" xlink:to="PPCB_GoodsAndServiceTax_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_GoodsAndServiceTax_doc" xml:lang="en-US">Amount of goods and service tax which includes in annual lease rent.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_StockIssuedDuringPeriodSharesExerciseOfWarrants" xlink:to="PPCB_StockIssuedDuringPeriodSharesExerciseOfWarrants_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_StockIssuedDuringPeriodSharesExerciseOfWarrants_doc" xml:lang="en-US">Exercise of warrants, shares.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_FairValueOfWarrantDerivativeLiabilityRecorededAsDebtDiscount" xlink:to="PPCB_FairValueOfWarrantDerivativeLiabilityRecorededAsDebtDiscount_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_FairValueOfWarrantDerivativeLiabilityRecorededAsDebtDiscount_doc" xml:lang="en-US">Initial fair value recording of warrant derivative liability as debt discount during the period.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_PercentageOfOutstandingSharesOfCommonStock" xlink:to="PPCB_PercentageOfOutstandingSharesOfCommonStock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_PercentageOfOutstandingSharesOfCommonStock_doc" xml:lang="en-US">It represents Percentage of the outstanding shares of common stock on each closing date the number of shares.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_SecondNoteMember" xlink:to="PPCB_SecondNoteMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_SecondNoteMember_doc" xml:lang="en-US">Second Note [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_DiscountsRelatedToDerivativeLiability" xlink:to="PPCB_DiscountsRelatedToDerivativeLiability_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_DiscountsRelatedToDerivativeLiability_doc" xml:lang="en-US">The discounts related to derivative liability in a noncash (or part noncash) transaction.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_ScheduleOfTranslationExchangeRatesTableTextBlock" xlink:to="PPCB_ScheduleOfTranslationExchangeRatesTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_ScheduleOfTranslationExchangeRatesTableTextBlock_doc" xml:lang="en-US">Schedule of Translation Exchange Rates [Table Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_ScheduleOfPropertyAndEquipmentEstimatedUsefulLivesTableTextBlock" xlink:to="PPCB_ScheduleOfPropertyAndEquipmentEstimatedUsefulLivesTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_ScheduleOfPropertyAndEquipmentEstimatedUsefulLivesTableTextBlock_doc" xml:lang="en-US">Schedule of Property and Equipment Estimated Useful Lives [Table Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_CommonStockIssuable" xlink:to="PPCB_CommonStockIssuable_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_CommonStockIssuable_doc" xml:lang="en-US">Common stock issuable.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_DueToFormerDirectorRelatedPartyDisclosureTextBlock" xlink:to="PPCB_DueToFormerDirectorRelatedPartyDisclosureTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_DueToFormerDirectorRelatedPartyDisclosureTextBlock_doc" xml:lang="en-US">Due to Former Director - Related Party Text Block</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_GainFromSettlementOfDebtNet" xlink:to="PPCB_GainFromSettlementOfDebtNet_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_GainFromSettlementOfDebtNet_doc" xml:lang="en-US">Gain from settlement of debt, net.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_EquityPurchaseAgreementDescription" xlink:to="PPCB_EquityPurchaseAgreementDescription_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_EquityPurchaseAgreementDescription_doc" xml:lang="en-US">Equity purchase agreement description.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_SeriesAWarrantsMember" xlink:to="PPCB_SeriesAWarrantsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_SeriesAWarrantsMember_doc" xml:lang="en-US">Series A Warrants [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_PrefundedWarrantsMember" xlink:to="PPCB_PrefundedWarrantsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_PrefundedWarrantsMember_doc" xml:lang="en-US">Prefunded Warrants [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_ConversionFees" xlink:to="PPCB_ConversionFees_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_ConversionFees_doc" xml:lang="en-US">Conversion fees.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_ConversionOptionDerivatives" xlink:to="PPCB_ConversionOptionDerivatives_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_ConversionOptionDerivatives_doc" xml:lang="en-US">Conversion option derivatives.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_FairMarketValueOfShares" xlink:to="PPCB_FairMarketValueOfShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_FairMarketValueOfShares_doc" xml:lang="en-US">Fair market value of the shares.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_PremiumsToAdditionalPaidInCapital" xlink:to="PPCB_PremiumsToAdditionalPaidInCapital_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_PremiumsToAdditionalPaidInCapital_doc" xml:lang="en-US">Premiums to additional paid in capital.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_UnderlyingFinancingAgreementsMember" xlink:to="PPCB_UnderlyingFinancingAgreementsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_UnderlyingFinancingAgreementsMember_doc" xml:lang="en-US">Underlying Financing Agreements [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_ConsultingAgreementMember" xlink:to="PPCB_ConsultingAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_ConsultingAgreementMember_doc" xml:lang="en-US">Consulting Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_EngagementAgreementMember" xlink:to="PPCB_EngagementAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_EngagementAgreementMember_doc" xml:lang="en-US">Engagement Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_TwentySeriesAAndOneSeriesCWarrantsMember" xlink:to="PPCB_TwentySeriesAAndOneSeriesCWarrantsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_TwentySeriesAAndOneSeriesCWarrantsMember_doc" xml:lang="en-US">20 Series A and 1 Series C Warrants [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_TwoThousandNinteenEquityIncentivePlanMember" xlink:to="PPCB_TwoThousandNinteenEquityIncentivePlanMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_TwoThousandNinteenEquityIncentivePlanMember_doc" xml:lang="en-US">2019 Equity Incentive Plan [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_EmploymentAgreementsMember" xlink:to="PPCB_EmploymentAgreementsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_EmploymentAgreementsMember_doc" xml:lang="en-US">Employment Agreements [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_UnvestedStockOptionsExpense" xlink:to="PPCB_UnvestedStockOptionsExpense_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_UnvestedStockOptionsExpense_doc" xml:lang="en-US">Unvested stock options expense.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_CommonStockIssuableMember" xlink:to="PPCB_CommonStockIssuableMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_CommonStockIssuableMember_doc" xml:lang="en-US">Common Stock Issuable [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_FirstWarrantMember" xlink:to="PPCB_FirstWarrantMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_FirstWarrantMember_doc" xml:lang="en-US">First Warrant [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_ThirdWarrantMember" xlink:to="PPCB_ThirdWarrantMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_ThirdWarrantMember_doc" xml:lang="en-US">Third Warrant [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_AccumulatedOtherComprehensiveIncomeLossMember" xlink:label="PPCB_AccumulatedOtherComprehensiveIncomeLossMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_AccumulatedOtherComprehensiveIncomeLossMember" xlink:to="PPCB_AccumulatedOtherComprehensiveIncomeLossMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_AccumulatedOtherComprehensiveIncomeLossMember_doc" xml:lang="en-US">Accumulated Other Comprehensive Income Loss [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_SecuritiesPurchaseAgreementMember" xlink:to="PPCB_SecuritiesPurchaseAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_SecuritiesPurchaseAgreementMember_doc" xml:lang="en-US">Securities Purchase Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_HolderMember" xlink:to="PPCB_HolderMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_HolderMember_doc" xml:lang="en-US">Holder [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageOutstanding" xlink:to="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageOutstanding_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageOutstanding_doc" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Non-options Equity Instruments, Weighted Average.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceIssued" xlink:to="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceIssued_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceIssued_doc" xml:lang="en-US">Weighted Average Price Per Share Issued.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceExercised" xlink:to="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceExercised_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceExercised_doc" xml:lang="en-US">Weighted Average Price Per Share Exercised.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceExpired" xlink:to="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceExpired_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceExpired_doc" xml:lang="en-US">Weighted Average Price Per Share Expired.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceForfeited" xlink:to="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceForfeited_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceForfeited_doc" xml:lang="en-US">Weighted Average Price Per Share Forfeited.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisable" xlink:to="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisable_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisable_doc" xml:lang="en-US">Weighted Average Price Per Share Outstanding Exercisable, Ending.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsAggregateIntrinsicValueOutstanding" xlink:to="PPCB_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsAggregateIntrinsicValueOutstanding_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsAggregateIntrinsicValueOutstanding_doc" xml:lang="en-US">Aggregate intrinsic value.</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_PotentialLiabilityReduction" xlink:label="PPCB_PotentialLiabilityReduction" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_PotentialLiabilityReduction" xlink:to="PPCB_PotentialLiabilityReduction_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_PotentialLiabilityReduction_doc" xml:lang="en-US">Potential liability reduction.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_SettlementAgreementMember" xlink:to="PPCB_SettlementAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_SettlementAgreementMember_doc" xml:lang="en-US">Settlement Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_TwoThousandAndSeventeenNoteMember" xlink:to="PPCB_TwoThousandAndSeventeenNoteMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_TwoThousandAndSeventeenNoteMember_doc" xml:lang="en-US">2017 Note [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_SettlementAndMutualReleaseAgreementMember" xlink:to="PPCB_SettlementAndMutualReleaseAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_SettlementAndMutualReleaseAgreementMember_doc" xml:lang="en-US">Settlement and Mutual Release Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_From2012ThroughThe2014Member" xlink:to="PPCB_From2012ThroughThe2014Member_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_From2012ThroughThe2014Member_doc" xml:lang="en-US">From 2012 through the 2014 [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_OneYearCollaborationAgreementMember" xlink:to="PPCB_OneYearCollaborationAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_OneYearCollaborationAgreementMember_doc" xml:lang="en-US">1-Year Collaboration Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_TwoYearCollaborationAgreementMember" xlink:to="PPCB_TwoYearCollaborationAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_TwoYearCollaborationAgreementMember_doc" xml:lang="en-US">2-Year Collaboration Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_InstallmentOneMember" xlink:to="PPCB_InstallmentOneMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_InstallmentOneMember_doc" xml:lang="en-US">Installment 1 [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_InstallmentTwoMember" xlink:to="PPCB_InstallmentTwoMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_InstallmentTwoMember_doc" xml:lang="en-US">Installment 2 [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_InstallmentThreeMember" xlink:to="PPCB_InstallmentThreeMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_InstallmentThreeMember_doc" xml:lang="en-US">Installment 3 [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_InstallmentFourMember" xlink:to="PPCB_InstallmentFourMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_InstallmentFourMember_doc" xml:lang="en-US">Installment 4 [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_UniversityOfJaenMember" xlink:to="PPCB_UniversityOfJaenMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_UniversityOfJaenMember_doc" xml:lang="en-US">University of Jaen [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_FormerDirectorMember" xlink:to="PPCB_FormerDirectorMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_FormerDirectorMember_doc" xml:lang="en-US">Former Director [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_NathanielszEmploymentAgreementMember" xlink:to="PPCB_NathanielszEmploymentAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_NathanielszEmploymentAgreementMember_doc" xml:lang="en-US">Nathanielsz Employment Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_PercentageOfPensionOfMonthlySalary" xlink:to="PPCB_PercentageOfPensionOfMonthlySalary_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_PercentageOfPensionOfMonthlySalary_doc" xml:lang="en-US">Percentage of pension of monthly salary.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_JamesNathanielszMember" xlink:to="PPCB_JamesNathanielszMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_JamesNathanielszMember_doc" xml:lang="en-US">James Nathanielsz [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_EmploymentAgreementMember" xlink:to="PPCB_EmploymentAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_EmploymentAgreementMember_doc" xml:lang="en-US">Employment Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_RestrictedStocksUnitsRSUMember" xlink:to="PPCB_RestrictedStocksUnitsRSUMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_RestrictedStocksUnitsRSUMember_doc" xml:lang="en-US">Initial Nathanielsz RSUs [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_ServicesAgreementMember" xlink:to="PPCB_ServicesAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_ServicesAgreementMember_doc" xml:lang="en-US">Services Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_AdditionaNathanielszRSUsMember" xlink:to="PPCB_AdditionaNathanielszRSUsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_AdditionaNathanielszRSUsMember_doc" xml:lang="en-US">Additional Nathanielsz RSUs [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_DrKenyonMember" xlink:to="PPCB_DrKenyonMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_DrKenyonMember_doc" xml:lang="en-US">Dr. Kenyon [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_GrossProceedsFromEquityFinancing" xlink:to="PPCB_GrossProceedsFromEquityFinancing_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_GrossProceedsFromEquityFinancing_doc" xml:lang="en-US">Gross proceeds from equity financing.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_StockIssuedDuringPeriodValueExerciseOfWarrants" xlink:to="PPCB_StockIssuedDuringPeriodValueExerciseOfWarrants_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_StockIssuedDuringPeriodValueExerciseOfWarrants_doc" xml:lang="en-US">Exercise of warrants.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_IssuanceOfCommonStockForCashlessExerciseOfWarrants" xlink:to="PPCB_IssuanceOfCommonStockForCashlessExerciseOfWarrants_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_IssuanceOfCommonStockForCashlessExerciseOfWarrants_doc" xml:lang="en-US">Issuance of common stock for cashless exercise of warrants.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_CancellationOfAccruedSalaries" xlink:to="PPCB_CancellationOfAccruedSalaries_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_CancellationOfAccruedSalaries_doc" xml:lang="en-US">Cancellation Of Accrued Salaries.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_LenderOneMember" xlink:to="PPCB_LenderOneMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_LenderOneMember_doc" xml:lang="en-US">Lender One [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_LenderThreeMember" xlink:to="PPCB_LenderThreeMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_LenderThreeMember_doc" xml:lang="en-US">Lender Three [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_LenderFourMember" xlink:label="PPCB_LenderFourMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_LenderFourMember" xlink:to="PPCB_LenderFourMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_LenderFourMember_doc" xml:lang="en-US">Lender Four [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_LenderFiveMember" xlink:label="PPCB_LenderFiveMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_LenderFiveMember" xlink:to="PPCB_LenderFiveMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_LenderFiveMember_doc" xml:lang="en-US">Lender Five [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_TwelveSeriesAAndAWarrantsMember" xlink:to="PPCB_TwelveSeriesAAndAWarrantsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_TwelveSeriesAAndAWarrantsMember_doc" xml:lang="en-US">12 Series A and A Warrants [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_DescriptionOfEmploymentBenefits" xlink:to="PPCB_DescriptionOfEmploymentBenefits_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_DescriptionOfEmploymentBenefits_doc" xml:lang="en-US">Description Of Employment Benefits.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_NathanielszCancellationAgreementMember" xlink:to="PPCB_NathanielszCancellationAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_NathanielszCancellationAgreementMember_doc" xml:lang="en-US">Nathanielsz Cancellation Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_KenyonCancellationAgreementMember" xlink:to="PPCB_KenyonCancellationAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_KenyonCancellationAgreementMember_doc" xml:lang="en-US">Kenyon Cancellation Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_ZelingerAmendedAndRestatedDirectorAgreementMember" xlink:to="PPCB_ZelingerAmendedAndRestatedDirectorAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_ZelingerAmendedAndRestatedDirectorAgreementMember_doc" xml:lang="en-US">Zelinger Amended And Restated Director Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_JosefZelingerMember" xlink:to="PPCB_JosefZelingerMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_JosefZelingerMember_doc" xml:lang="en-US">Josef Zelinger [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_CommonStockOneMember" xlink:to="PPCB_CommonStockOneMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_CommonStockOneMember_doc" xml:lang="en-US">Common Stock One [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_CommonStockTwoMember" xlink:to="PPCB_CommonStockTwoMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_CommonStockTwoMember_doc" xml:lang="en-US">Common Stock Two [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_CommonStockThreeMember" xlink:to="PPCB_CommonStockThreeMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_CommonStockThreeMember_doc" xml:lang="en-US">Common Stock Three [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_TwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember" xlink:to="PPCB_TwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_TwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember_doc" xml:lang="en-US">2021 Securities Purchase Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_DebtInstrumentOriginalDiscount" xlink:label="PPCB_DebtInstrumentOriginalDiscount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_DebtInstrumentOriginalDiscount" xlink:to="PPCB_DebtInstrumentOriginalDiscount_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_DebtInstrumentOriginalDiscount_doc" xml:lang="en-US">Debt Instrument Original Discount</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_DebtCoversionPercentage" xlink:to="PPCB_DebtCoversionPercentage_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_DebtCoversionPercentage_doc" xml:lang="en-US">Debt Coversion Percentage.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_IssuanceOfCommonStockForCashlessExerciseOfWarrantsShares" xlink:to="PPCB_IssuanceOfCommonStockForCashlessExerciseOfWarrantsShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_IssuanceOfCommonStockForCashlessExerciseOfWarrantsShares_doc" xml:lang="en-US">Issuance Of Common Stock For Cashless Exercise Of Warrants Shares.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_IncreaseDecreaseInDeferredRent" xlink:to="PPCB_IncreaseDecreaseInDeferredRent_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_IncreaseDecreaseInDeferredRent_doc" xml:lang="en-US">Increase Decrease in Deferred rent.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_LoansAndNotesPayableDisclosureTextBlock" xlink:to="PPCB_LoansAndNotesPayableDisclosureTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_LoansAndNotesPayableDisclosureTextBlock_doc" xml:lang="en-US">Loans and Notes Payable Text Block.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_ConsultantMember" xlink:to="PPCB_ConsultantMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_ConsultantMember_doc" xml:lang="en-US">Consultant [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember" xlink:to="PPCB_DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_doc" xml:lang="en-US">December 24, 2018 Securities Purchase Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_DecembeTwoThousandAndEighteenEagleNoteMember" xlink:to="PPCB_DecembeTwoThousandAndEighteenEagleNoteMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_DecembeTwoThousandAndEighteenEagleNoteMember_doc" xml:lang="en-US">December 2018 Eagle Note [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_SecondWarrantMember" xlink:to="PPCB_SecondWarrantMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_SecondWarrantMember_doc" xml:lang="en-US">Second Warrant [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_RegalConsultingLLCMember" xlink:to="PPCB_RegalConsultingLLCMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_RegalConsultingLLCMember_doc" xml:lang="en-US">Regal Consulting, LLC [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_NewFiveYearOperatingLeaseAgreementMember" xlink:to="PPCB_NewFiveYearOperatingLeaseAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_NewFiveYearOperatingLeaseAgreementMember_doc" xml:lang="en-US">New Five-Year Operating Lease Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_AUDCurrencyMember" xlink:to="PPCB_AUDCurrencyMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_AUDCurrencyMember_doc" xml:lang="en-US">AUD Currency [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_EurosMember" xlink:to="PPCB_EurosMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_EurosMember_doc" xml:lang="en-US">Euros [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_DepositoryTrustCompanyMember" xlink:to="PPCB_DepositoryTrustCompanyMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_DepositoryTrustCompanyMember_doc" xml:lang="en-US">Depository Trust Company [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_CurrentAndFormerDirectorMember" xlink:to="PPCB_CurrentAndFormerDirectorMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_CurrentAndFormerDirectorMember_doc" xml:lang="en-US">Current and Former Director [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_NorthHorizonPtyLtdMember" xlink:to="PPCB_NorthHorizonPtyLtdMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_NorthHorizonPtyLtdMember_doc" xml:lang="en-US">North Horizon Pty Ltd [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_AUDCurrenryMember" xlink:to="PPCB_AUDCurrenryMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_AUDCurrenryMember_doc" xml:lang="en-US">AUD Currency [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_NathanielszMember" xlink:to="PPCB_NathanielszMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_NathanielszMember_doc" xml:lang="en-US">Nathanielsz [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_SecuritiesPurchaseAgreementOneMember" xlink:to="PPCB_SecuritiesPurchaseAgreementOneMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_SecuritiesPurchaseAgreementOneMember_doc" xml:lang="en-US">Securities Purchase Agreement One [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_PercentageOfBonusOfAnnualBaseSalary" xlink:to="PPCB_PercentageOfBonusOfAnnualBaseSalary_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_PercentageOfBonusOfAnnualBaseSalary_doc" xml:lang="en-US">Percentage of bonus of annual base salary.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_MrsNathanielszMember" xlink:to="PPCB_MrsNathanielszMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_MrsNathanielszMember_doc" xml:lang="en-US">Mrs. Nathanielsz [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_AdjustmentsToAdditionalPaidInCapitalReclassificationOfPremiumUponDebtConversion" xlink:to="PPCB_AdjustmentsToAdditionalPaidInCapitalReclassificationOfPremiumUponDebtConversion_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_AdjustmentsToAdditionalPaidInCapitalReclassificationOfPremiumUponDebtConversion_doc" xml:lang="en-US">Reclassification of premium upon debt conversion.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_MrNathanielszMember" xlink:to="PPCB_MrNathanielszMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_MrNathanielszMember_doc" xml:lang="en-US">Mr. Nathanielsz [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_BoardOfDirectorsMember" xlink:to="PPCB_BoardOfDirectorsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_BoardOfDirectorsMember_doc" xml:lang="en-US">Board of Directors [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_BonusPayableAmount" xlink:to="PPCB_BonusPayableAmount_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_BonusPayableAmount_doc" xml:lang="en-US">Bonus payable amount.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_BonusAwardsGrantedPercentage" xlink:to="PPCB_BonusAwardsGrantedPercentage_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_BonusAwardsGrantedPercentage_doc" xml:lang="en-US">Bonus granted percentage.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_BonusPayable" xlink:to="PPCB_BonusPayable_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_BonusPayable_doc" xml:lang="en-US">Bonus payable.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_AgreementlTerm" xlink:to="PPCB_AgreementlTerm_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_AgreementlTerm_doc" xml:lang="en-US">Agreement term.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_AgreementRenewalTerm" xlink:to="PPCB_AgreementRenewalTerm_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_AgreementRenewalTerm_doc" xml:lang="en-US">Agreement renewal term.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_OptionsVestedDescription" xlink:to="PPCB_OptionsVestedDescription_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_OptionsVestedDescription_doc" xml:lang="en-US">Options vested, description.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_DrKenyonMemberMember" xlink:to="PPCB_DrKenyonMemberMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_DrKenyonMemberMember_doc" xml:lang="en-US">Dr Kenyon [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_ScheduleOfRightUseOfAssetTableTextBlock" xlink:to="PPCB_ScheduleOfRightUseOfAssetTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_ScheduleOfRightUseOfAssetTableTextBlock_doc" xml:lang="en-US">Schedule of Right Use Of Asset [Table Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_AdditionalKenyonRSUsMember" xlink:to="PPCB_AdditionalKenyonRSUsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_AdditionalKenyonRSUsMember_doc" xml:lang="en-US">Additional Kenyon RSUs [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_GainOnDebtExtinguishment" xlink:to="PPCB_GainOnDebtExtinguishment_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_GainOnDebtExtinguishment_doc" xml:lang="en-US">Gain on debt extinguishment.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_DebtDefaultAmountPercentage" xlink:to="PPCB_DebtDefaultAmountPercentage_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_DebtDefaultAmountPercentage_doc" xml:lang="en-US">Debt default amount percentage.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_FoleyShechterMember" xlink:to="PPCB_FoleyShechterMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_FoleyShechterMember_doc" xml:lang="en-US">Foley Shechter [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_LenderTwoMember" xlink:to="PPCB_LenderTwoMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_LenderTwoMember_doc" xml:lang="en-US">Lender Two [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_CashPaidDuringPeriodAbstract" xlink:to="PPCB_CashPaidDuringPeriodAbstract_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_CashPaidDuringPeriodAbstract_doc" xml:lang="en-US">Cash Paid During Period [Abstract]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_DiscountsRelatedToWarrantsIssuedWithConvertibleNote" xlink:to="PPCB_DiscountsRelatedToWarrantsIssuedWithConvertibleNote_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_DiscountsRelatedToWarrantsIssuedWithConvertibleNote_doc" xml:lang="en-US">Discounts related to warrants issued with convertible notes.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_OperatingLeaseRightofuseAssetsAndOperatingLeaseLiabilitiesRecordedUponAdoptionOfAsc842" xlink:to="PPCB_OperatingLeaseRightofuseAssetsAndOperatingLeaseLiabilitiesRecordedUponAdoptionOfAsc842_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_OperatingLeaseRightofuseAssetsAndOperatingLeaseLiabilitiesRecordedUponAdoptionOfAsc842_doc" xml:lang="en-US">Operating lease right-of-use asset and operating lease liability recorded on adoption of ASC 842.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_ReversalOfCommonStockIssuableAndPutPremiumDueToCancellationOfConversionsOfConvertibleDebtAndAccruedInterest" xlink:to="PPCB_ReversalOfCommonStockIssuableAndPutPremiumDueToCancellationOfConversionsOfConvertibleDebtAndAccruedInterest_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_ReversalOfCommonStockIssuableAndPutPremiumDueToCancellationOfConversionsOfConvertibleDebtAndAccruedInterest_doc" xml:lang="en-US">Reversal of common stock issuable and put premium due to cancellation of conversions of convertible debt and accrued interest.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_AccountsPayableReclassToConvertibleNotes" xlink:to="PPCB_AccountsPayableReclassToConvertibleNotes_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_AccountsPayableReclassToConvertibleNotes_doc" xml:lang="en-US">Accounts payable reclass to convertible notes.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_NatureOfOperationsPolicyTextBlock" xlink:to="PPCB_NatureOfOperationsPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_NatureOfOperationsPolicyTextBlock_doc" xml:lang="en-US">Nature Of Operations [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_GoodsAndServiceTaxPolicyTextBlock" xlink:to="PPCB_GoodsAndServiceTaxPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_GoodsAndServiceTaxPolicyTextBlock_doc" xml:lang="en-US">Goods And Service Tax [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_ConvertibleNotesPolicyTextBlock" xlink:to="PPCB_ConvertibleNotesPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_ConvertibleNotesPolicyTextBlock_doc" xml:lang="en-US">Convertible Notes [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_IntercompanyLoansMember" xlink:to="PPCB_IntercompanyLoansMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_IntercompanyLoansMember_doc" xml:lang="en-US">Intercompany Loans [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_UnvestedRestrictedStockMember" xlink:to="PPCB_UnvestedRestrictedStockMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_UnvestedRestrictedStockMember_doc" xml:lang="en-US">Unvested Restricted Stock [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_WorkingCapitalDeficit" xlink:to="PPCB_WorkingCapitalDeficit_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_WorkingCapitalDeficit_doc" xml:lang="en-US">Amount of Working capital (Deficiency) as of the Balance sheet date.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_NovemberTwentySixTwoThousandNineteenSecuritiesPurchaseAgreementMember" xlink:to="PPCB_NovemberTwentySixTwoThousandNineteenSecuritiesPurchaseAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_NovemberTwentySixTwoThousandNineteenSecuritiesPurchaseAgreementMember_doc" xml:lang="en-US">November 26, 2019 Securities Purchase Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_NovemberTwentySixTwoThousandNineteenPowerUpNoteMember" xlink:to="PPCB_NovemberTwentySixTwoThousandNineteenPowerUpNoteMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_NovemberTwentySixTwoThousandNineteenPowerUpNoteMember_doc" xml:lang="en-US">November 26, 2019 Power Up Note [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_PrepaymentPenalties" xlink:to="PPCB_PrepaymentPenalties_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_PrepaymentPenalties_doc" xml:lang="en-US">Prepayment penalties.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_DiligenceFees" xlink:to="PPCB_DiligenceFees_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_DiligenceFees_doc" xml:lang="en-US">Diligence fees.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_JanuarySevenTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember" xlink:to="PPCB_JanuarySevenTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_JanuarySevenTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember_doc" xml:lang="en-US">January 7, 2020 Power Up Lending Group Securities Purchase Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_JanuarySevenTwoThousandTwentyPowerUpNoteMember" xlink:to="PPCB_JanuarySevenTwoThousandTwentyPowerUpNoteMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_JanuarySevenTwoThousandTwentyPowerUpNoteMember_doc" xml:lang="en-US">January 7, 2020 Power Up Note [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember" xlink:to="PPCB_MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember_doc" xml:lang="en-US">March 12, 2020 Power Up Lending Group Securities Purchase Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_MarchTwelveTwoThousandTwentyPowerUpNoteMember" xlink:to="PPCB_MarchTwelveTwoThousandTwentyPowerUpNoteMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_MarchTwelveTwoThousandTwentyPowerUpNoteMember_doc" xml:lang="en-US">March 12, 2020 Power Up Note [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_RedstartHoldingsCorpFinancingAgreementMember" xlink:to="PPCB_RedstartHoldingsCorpFinancingAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_RedstartHoldingsCorpFinancingAgreementMember_doc" xml:lang="en-US">Redstart Holdings Corp Financing Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_RedstartHoldingsCorpMember" xlink:to="PPCB_RedstartHoldingsCorpMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_RedstartHoldingsCorpMember_doc" xml:lang="en-US">Redstart Holdings Corp [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_OdysseyCapitalFundingLLCMember" xlink:to="PPCB_OdysseyCapitalFundingLLCMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_OdysseyCapitalFundingLLCMember_doc" xml:lang="en-US">Odyssey Capital Funding LLC [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_JulyTwoThousandNineteenOdysseyNoteMember" xlink:to="PPCB_JulyTwoThousandNineteenOdysseyNoteMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_JulyTwoThousandNineteenOdysseyNoteMember_doc" xml:lang="en-US">July 2019 Odyssey Note [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_AuctusFundLLCMember" xlink:to="PPCB_AuctusFundLLCMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_AuctusFundLLCMember_doc" xml:lang="en-US">Auctus Fund, LLC [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_AugustTwoThousandNineteenAuctusNoteMember" xlink:to="PPCB_AugustTwoThousandNineteenAuctusNoteMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_AugustTwoThousandNineteenAuctusNoteMember_doc" xml:lang="en-US">August 2019 Auctus Note [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_GWHoldingsGroupLLCMember" xlink:to="PPCB_GWHoldingsGroupLLCMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_GWHoldingsGroupLLCMember_doc" xml:lang="en-US">GW Holdings Group, LLC [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_OctoberOneTwoThousandNineteenAuctusNoteMember" xlink:to="PPCB_OctoberOneTwoThousandNineteenAuctusNoteMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_OctoberOneTwoThousandNineteenAuctusNoteMember_doc" xml:lang="en-US">October 1, 2019 GW Note [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_DecemberTenTwoThousandTwentyGWNoteMember" xlink:to="PPCB_DecemberTenTwoThousandTwentyGWNoteMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_DecemberTenTwoThousandTwentyGWNoteMember_doc" xml:lang="en-US">December 10 2020 GW Note [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_CrownBridgePartnersLLCMember" xlink:to="PPCB_CrownBridgePartnersLLCMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_CrownBridgePartnersLLCMember_doc" xml:lang="en-US">Crown Bridge Partners, LLC [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_OctoberThreeTwoThousandNineteenAuctusNoteMember" xlink:to="PPCB_OctoberThreeTwoThousandNineteenAuctusNoteMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_OctoberThreeTwoThousandNineteenAuctusNoteMember_doc" xml:lang="en-US">October 3, 2019 GW Note [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_UnissuedSharesConversion" xlink:to="PPCB_UnissuedSharesConversion_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_UnissuedSharesConversion_doc" xml:lang="en-US">Unissued shares conversion.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_DueToEquityConversion" xlink:to="PPCB_DueToEquityConversion_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_DueToEquityConversion_doc" xml:lang="en-US">Due to equity conversion.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_JanuaryThirteenTwentyTwentyAderAlefNoteMember" xlink:to="PPCB_JanuaryThirteenTwentyTwentyAderAlefNoteMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_JanuaryThirteenTwentyTwentyAderAlefNoteMember_doc" xml:lang="en-US">January 13, 2020 Ader Alef Note [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember" xlink:to="PPCB_FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember_doc" xml:lang="en-US">February19 2020 LG Capital Note [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_LGCapitalFundingLLCMember" xlink:to="PPCB_LGCapitalFundingLLCMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_LGCapitalFundingLLCMember_doc" xml:lang="en-US">LG Capital Funding, LLC [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_DecemberTwoTwoThousandTwentyGenevaRothMember" xlink:to="PPCB_DecemberTwoTwoThousandTwentyGenevaRothMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_DecemberTwoTwoThousandTwentyGenevaRothMember_doc" xml:lang="en-US">December 02 2020 Geneva Roth [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_GenevaRothRemarkHoldingsIncMember" xlink:to="PPCB_GenevaRothRemarkHoldingsIncMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_GenevaRothRemarkHoldingsIncMember_doc" xml:lang="en-US">Geneva Roth Remark Holdings Inc [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_JanuaryFiveTwoThousandTwentyOneGenevaRothMember" xlink:to="PPCB_JanuaryFiveTwoThousandTwentyOneGenevaRothMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_JanuaryFiveTwoThousandTwentyOneGenevaRothMember_doc" xml:lang="en-US">January 05, 2021 One Geneva Roth [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_ReclassifiedPremiumAmountForAdditionalPaidInCapital" xlink:to="PPCB_ReclassifiedPremiumAmountForAdditionalPaidInCapital_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_ReclassifiedPremiumAmountForAdditionalPaidInCapital_doc" xml:lang="en-US">Reclassified premium amount for additional paid in capital.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_CaresActMember" xlink:to="PPCB_CaresActMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_CaresActMember_doc" xml:lang="en-US">CARES Act [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_DeferredTaxAssetsWarrantDerivativeLiability" xlink:to="PPCB_DeferredTaxAssetsWarrantDerivativeLiability_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_DeferredTaxAssetsWarrantDerivativeLiability_doc" xml:lang="en-US">Deferred tax assets warrant derivative liability.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_DeferredTaxAssetsPrepaidInvestorServices" xlink:to="PPCB_DeferredTaxAssetsPrepaidInvestorServices_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_DeferredTaxAssetsPrepaidInvestorServices_doc" xml:lang="en-US">Amount, before allocation of valuation allowance, of deferred tax asset attributable to prepaid investor services.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_DeferredTaxAssetsNonCashInterest" xlink:to="PPCB_DeferredTaxAssetsNonCashInterest_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_DeferredTaxAssetsNonCashInterest_doc" xml:lang="en-US">Non-cash interest in deferred tax assets.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_DeferredTaxAssetsForeignExchangeLoss" xlink:to="PPCB_DeferredTaxAssetsForeignExchangeLoss_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_DeferredTaxAssetsForeignExchangeLoss_doc" xml:lang="en-US">Deferred tax assets foreign exchange loss.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_DeferredTaxAssetsRevalueOfDerivativeLiability" xlink:to="PPCB_DeferredTaxAssetsRevalueOfDerivativeLiability_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_DeferredTaxAssetsRevalueOfDerivativeLiability_doc" xml:lang="en-US">Deferred tax assets revalue of derivative liability.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_DeferredTaxLiabilitiesGainOnExtinguishmentOfDebt" xlink:to="PPCB_DeferredTaxLiabilitiesGainOnExtinguishmentOfDebt_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_DeferredTaxLiabilitiesGainOnExtinguishmentOfDebt_doc" xml:lang="en-US">Gain on extinguishment of debt in deferred tax liability.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_NoCustomerMember" xlink:to="PPCB_NoCustomerMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_NoCustomerMember_doc" xml:lang="en-US">No Customer [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_MarchSixteenTwoThousandTwentyOneGenevaRothMember" xlink:to="PPCB_MarchSixteenTwoThousandTwentyOneGenevaRothMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_MarchSixteenTwoThousandTwentyOneGenevaRothMember_doc" xml:lang="en-US">March 16, 2021 Geneva Roth [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_SecurityPurchaseAgreementMember" xlink:to="PPCB_SecurityPurchaseAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_SecurityPurchaseAgreementMember_doc" xml:lang="en-US">Security Purchase Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_DecreaseInEquity" xlink:to="PPCB_DecreaseInEquity_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_DecreaseInEquity_doc" xml:lang="en-US">Decrease in equity.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_DeemedDividend" xlink:to="PPCB_DeemedDividend_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_DeemedDividend_doc" xml:lang="en-US">Deemed dividend.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_DeemedDividendUponAlternateCashlessExerciseOfWarrants" xlink:to="PPCB_DeemedDividendUponAlternateCashlessExerciseOfWarrants_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_DeemedDividendUponAlternateCashlessExerciseOfWarrants_doc" xml:lang="en-US">Deemed dividend upon alternate cashless exercise of warrants.</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_DeemedDividendUponAlternateCashlessExerciseOfWarrant" xlink:label="PPCB_DeemedDividendUponAlternateCashlessExerciseOfWarrant" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_DeemedDividendUponAlternateCashlessExerciseOfWarrant" xlink:to="PPCB_DeemedDividendUponAlternateCashlessExerciseOfWarrant_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_DeemedDividendUponAlternateCashlessExerciseOfWarrant_doc" xml:lang="en-US">Deemed dividend upon alternate cashless exercise of warrants.</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_CancellationOfBonusPayable" xlink:label="PPCB_CancellationOfBonusPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_CancellationOfBonusPayable" xlink:to="PPCB_CancellationOfBonusPayable_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_CancellationOfBonusPayable_doc" xml:lang="en-US">Cancellation of bonus payable.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_ExpireInTwoThousandTwentyFourMember" xlink:to="PPCB_ExpireInTwoThousandTwentyFourMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_ExpireInTwoThousandTwentyFourMember_doc" xml:lang="en-US">Expire in 2024 [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_NotExpireMember" xlink:to="PPCB_NotExpireMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_NotExpireMember_doc" xml:lang="en-US">Not Expire [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_LoanFromFormerDirectorRelatedParty" xlink:to="PPCB_LoanFromFormerDirectorRelatedParty_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_LoanFromFormerDirectorRelatedParty_doc" xml:lang="en-US">Loan from former director related party.</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_ForeignCurrencyTransactionLossBeforeTax1" xlink:label="PPCB_ForeignCurrencyTransactionLossBeforeTax1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_ForeignCurrencyTransactionLossBeforeTax1" xlink:to="PPCB_ForeignCurrencyTransactionLossBeforeTax1_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_ForeignCurrencyTransactionLossBeforeTax1_doc" xml:lang="en-US">Foreign currency transaction loss before tax1.</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValues" xlink:label="PPCB_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValues" xlink:to="PPCB_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValues_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValues_doc" xml:lang="en-US">Stock based compensation in connection with stock option grants.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_IssuanceOfCommonStockForAlternateCashlessExerciseOfWarrants" xlink:to="PPCB_IssuanceOfCommonStockForAlternateCashlessExerciseOfWarrants_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_IssuanceOfCommonStockForAlternateCashlessExerciseOfWarrants_doc" xml:lang="en-US">Issuance of common stock for alternate cashless exercise of warrants.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_IssuanceOfCommonStockForAlternateCashlessExerciseOfWarrantsShares" xlink:to="PPCB_IssuanceOfCommonStockForAlternateCashlessExerciseOfWarrantsShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_IssuanceOfCommonStockForAlternateCashlessExerciseOfWarrantsShares_doc" xml:lang="en-US">Issuance of common stock for alternate cashless exercise of warrants, shares.</link:label>
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_AdjustmentsToAdditionalPaidStockBasedCompensationInConnectionWithFairValueOfWarrantsIssuedForServices" xlink:label="PPCB_AdjustmentsToAdditionalPaidStockBasedCompensationInConnectionWithFairValueOfWarrantsIssuedForServices" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_AdjustmentsToAdditionalPaidStockBasedCompensationInConnectionWithFairValueOfWarrantsIssuedForServices" xlink:to="PPCB_AdjustmentsToAdditionalPaidStockBasedCompensationInConnectionWithFairValueOfWarrantsIssuedForServices_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_AdjustmentsToAdditionalPaidStockBasedCompensationInConnectionWithFairValueOfWarrantsIssuedForServices_doc" xml:lang="en-US">Adjustments to additional paid in capital Stock based compensation in connection with fair value of warrants issued for services.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_OperatingLeasesRentExpenseMinimumRentalsPayable" xlink:to="PPCB_OperatingLeasesRentExpenseMinimumRentalsPayable_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_OperatingLeasesRentExpenseMinimumRentalsPayable_doc" xml:lang="en-US">Operating Leases Rent Expense Minimum Rentals Payable.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_DeemedDividendUponAlternateCashlessExerciseOfWarrants1" xlink:to="PPCB_DeemedDividendUponAlternateCashlessExerciseOfWarrants1_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_DeemedDividendUponAlternateCashlessExerciseOfWarrants1_doc" xml:lang="en-US">Deemed dividend upon alternate cashless exercise of warrants.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_SubscriptionReceivable" xlink:to="PPCB_SubscriptionReceivable_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_SubscriptionReceivable_doc" xml:lang="en-US">Subscription receivable.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_ConsultingAgreementDescription" xlink:to="PPCB_ConsultingAgreementDescription_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_ConsultingAgreementDescription_doc" xml:lang="en-US">Consulting agreement, description.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_ConsultingAgreementMonthlyPayment" xlink:to="PPCB_ConsultingAgreementMonthlyPayment_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PPCB_ConsultingAgreementMonthlyPayment_doc" xml:lang="en-US">Consulting agreement monthly payment.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_AUDCurrenryMember" xlink:to="PPCB_AUDCurrenryMember_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_AUDCurrenryMember_3_lbl" xml:lang="en-US">AUD Currency [Member] [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_2_lbl" xml:lang="en-US">Assets, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_2_lbl" xml:lang="en-US">Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrent_2_lbl" xml:lang="en-US">Liabilities, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockValue" xlink:to="us-gaap_TreasuryStockValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TreasuryStockValue_2_lbl" xml:lang="en-US">Treasury Stock, Value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_5_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_5_lbl" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xml:lang="en-US">Liabilities and Equity</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpenses_2_lbl" xml:lang="en-US">Operating Expenses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingIncomeLoss_2_lbl" xml:lang="en-US">Operating Income (Loss)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="us-gaap_InterestExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestExpense_2_lbl" xml:lang="en-US">Interest Expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonoperatingIncomeExpense_2_lbl" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_lbl" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_2_lbl" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_2_lbl" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_2_lbl" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesOutstanding_3_lbl" xml:lang="en-US">Shares, Outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:to="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_2_lbl" xml:lang="en-US">Accretion (Amortization) of Discounts and Premiums, Investments</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInReceivables" xlink:to="us-gaap_IncreaseDecreaseInReceivables_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInReceivables_2_lbl" xml:lang="en-US">Increase (Decrease) in Receivables</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_lbl" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_2_lbl" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_IncreaseDecreaseInDeferredRent" xlink:to="PPCB_IncreaseDecreaseInDeferredRent_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_IncreaseDecreaseInDeferredRent_3_lbl" xml:lang="en-US">IncreaseDecreaseInDeferredRent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_2_lbl" xml:lang="en-US">Increase (Decrease) in Employee Related Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_2_lbl" xml:lang="en-US">Increase (Decrease) in Other Accounts Payable and Accrued Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_3_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfConvertibleDebt" xlink:to="us-gaap_RepaymentsOfConvertibleDebt_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfConvertibleDebt_2_lbl" xml:lang="en-US">Repayments of Convertible Debt</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForRepurchaseOfInitialPublicOffering" xlink:to="us-gaap_PaymentsForRepurchaseOfInitialPublicOffering_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsForRepurchaseOfInitialPublicOffering_2_lbl" xml:lang="en-US">Payments for Repurchase of Initial Public Offering</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_3_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_DeemedDividendUponAlternateCashlessExerciseOfWarrants1" xlink:to="PPCB_DeemedDividendUponAlternateCashlessExerciseOfWarrants1_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_DeemedDividendUponAlternateCashlessExerciseOfWarrants1_3_lbl" xml:lang="en-US">DeemedDividendUponAlternateCashlessExerciseOfWarrants1</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_2_lbl" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_2_lbl" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepositLiabilitiesAccruedInterest" xlink:to="us-gaap_DepositLiabilitiesAccruedInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepositLiabilitiesAccruedInterest_2_lbl" xml:lang="en-US">Deposit Liabilities, Accrued Interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebt" xlink:to="us-gaap_LongTermDebt_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebt_2_lbl" xml:lang="en-US">Long-term Debt</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPayableCurrentAndNoncurrent" xlink:to="us-gaap_InterestPayableCurrentAndNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPayableCurrentAndNoncurrent_2_lbl" xml:lang="en-US">Interest Payable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_2_lbl" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsGross_2_lbl" xml:lang="en-US">Deferred Tax Assets, Gross</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts" xlink:to="us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts_2_lbl" xml:lang="en-US">Deferred Tax Liabilities, Deferred Expense, Capitalized Research and Development Costs</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_DeferredTaxLiabilitiesGainOnExtinguishmentOfDebt" xlink:to="PPCB_DeferredTaxLiabilitiesGainOnExtinguishmentOfDebt_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_DeferredTaxLiabilitiesGainOnExtinguishmentOfDebt_3_lbl" xml:lang="en-US">DeferredTaxLiabilitiesGainOnExtinguishmentOfDebt</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts" xlink:to="us-gaap_DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts_2_lbl" xml:lang="en-US">Deferred Tax Liabilities, Deferred Expense, Debt Issuance Costs</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxLiabilities" xlink:to="us-gaap_DeferredIncomeTaxLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredIncomeTaxLiabilities_2_lbl" xml:lang="en-US">Deferred Tax Liabilities, Gross</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_2_lbl" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet_2_lbl" xml:lang="en-US">Deferred Tax Assets, Net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_3_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageOutstanding" xlink:to="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageOutstanding_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageOutstanding_4_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Non-options Equity Instruments, Weighted Average</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsIssued" xlink:to="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsIssued_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsIssued_3_lbl" xml:lang="en-US">ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsIssued</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceIssued" xlink:to="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceIssued_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceIssued_3_lbl" xml:lang="en-US">Weighted Average Price Per Share Issued</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceExercised" xlink:to="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceExercised_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceExercised_3_lbl" xml:lang="en-US">Weighted Average Price Per Share Exercised</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_2_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceExpired" xlink:to="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceExpired_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceExpired_3_lbl" xml:lang="en-US">Weighted Average Price Per Share Expired</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_2_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Expirations</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceForfeited" xlink:to="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceForfeited_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceForfeited_3_lbl" xml:lang="en-US">Weighted Average Price Per Share Forfeited</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber" xlink:to="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_4_lbl" xml:lang="en-US">ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisable" xlink:to="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisable_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisable_4_lbl" xml:lang="en-US">Weighted Average Price Per Share Outstanding Exercisable, Ending</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerms" xlink:to="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerms_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerms_3_lbl" xml:lang="en-US">ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerms</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PPCB_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsAggregateIntrinsicValueOutstanding" xlink:to="PPCB_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsAggregateIntrinsicValueOutstanding_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PPCB_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsAggregateIntrinsicValueOutstanding_4_lbl" xml:lang="en-US">Aggregate intrinsic value [Default Label]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>8
<FILENAME>ppcb-20210930_pre.xml
<DESCRIPTION>INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.11a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://propanc.com/role/Cover" xlink:href="ppcb-20210930.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/BalanceSheets" xlink:href="ppcb-20210930.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/BalanceSheetsParenthetical" xlink:href="ppcb-20210930.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss" xlink:href="ppcb-20210930.xsd#StatementsOfOperationsAndComprehensiveIncomeLoss" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/StatementsOfChangesInStockholdersDeficit" xlink:href="ppcb-20210930.xsd#StatementsOfChangesInStockholdersDeficit" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/StatementsOfCashFlows" xlink:href="ppcb-20210930.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/NatureOfOperationsAndSummaryOfSignificantAccountingAndReportingPolicies" xlink:href="ppcb-20210930.xsd#NatureOfOperationsAndSummaryOfSignificantAccountingAndReportingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/GoingConcern" xlink:href="ppcb-20210930.xsd#GoingConcern" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/PropertyAndEquipment" xlink:href="ppcb-20210930.xsd#PropertyAndEquipment" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/DueToFormerDirector-RelatedParty" xlink:href="ppcb-20210930.xsd#DueToFormerDirector-RelatedParty" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/LoansAndNotesPayable" xlink:href="ppcb-20210930.xsd#LoansAndNotesPayable" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/ConvertibleNotes" xlink:href="ppcb-20210930.xsd#ConvertibleNotes" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/IncomeTaxes" xlink:href="ppcb-20210930.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/StockholdersDeficit" xlink:href="ppcb-20210930.xsd#StockholdersDeficit" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/CommitmentsAndContingencies" xlink:href="ppcb-20210930.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/RelatedPartyTransactions" xlink:href="ppcb-20210930.xsd#RelatedPartyTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/ConcentrationsAndRisks" xlink:href="ppcb-20210930.xsd#ConcentrationsAndRisks" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/DerivativeFinancialInstrumentsAndFairValueMeasurements" xlink:href="ppcb-20210930.xsd#DerivativeFinancialInstrumentsAndFairValueMeasurements" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/SubsequentEvents" xlink:href="ppcb-20210930.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/NatureOfOperationsAndSummaryOfSignificantAccountingAndReportingPoliciesPolicies" xlink:href="ppcb-20210930.xsd#NatureOfOperationsAndSummaryOfSignificantAccountingAndReportingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/NatureOfOperationsAndSummaryOfSignificantAccountingAndReportingPoliciesTables" xlink:href="ppcb-20210930.xsd#NatureOfOperationsAndSummaryOfSignificantAccountingAndReportingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/PropertyAndEquipmentTables" xlink:href="ppcb-20210930.xsd#PropertyAndEquipmentTables" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/ConvertibleNotesTables" xlink:href="ppcb-20210930.xsd#ConvertibleNotesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/IncomeTaxesTables" xlink:href="ppcb-20210930.xsd#IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/StockholdersDeficitTables" xlink:href="ppcb-20210930.xsd#StockholdersDeficitTables" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/CommitmentsAndContingenciesTables" xlink:href="ppcb-20210930.xsd#CommitmentsAndContingenciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/DerivativeFinancialInstrumentsAndFairValueMeasurementsTables" xlink:href="ppcb-20210930.xsd#DerivativeFinancialInstrumentsAndFairValueMeasurementsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/ScheduleOfTranslationExchangeRatesDetails" xlink:href="ppcb-20210930.xsd#ScheduleOfTranslationExchangeRatesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/ScheduleOfChangeInAccumulatedOtherComprehensiveIncomeLossDetails" xlink:href="ppcb-20210930.xsd#ScheduleOfChangeInAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/ScheduleOfPropertyAndEquipmentEstimatedUsefulLivesDetails" xlink:href="ppcb-20210930.xsd#ScheduleOfPropertyAndEquipmentEstimatedUsefulLivesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/ScheduleOfDilutiveSecuritiesExcludedFromComputationDetails" xlink:href="ppcb-20210930.xsd#ScheduleOfDilutiveSecuritiesExcludedFromComputationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/NatureOfOperationsAndSummaryOfSignificantAccountingAndReportingPoliciesDetailsNarrative" xlink:href="ppcb-20210930.xsd#NatureOfOperationsAndSummaryOfSignificantAccountingAndReportingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/GoingConcernDetailsNarrative" xlink:href="ppcb-20210930.xsd#GoingConcernDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/ScheduleOfPropertyAndEquipmentDetails" xlink:href="ppcb-20210930.xsd#ScheduleOfPropertyAndEquipmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/PropertyAndEquipmentDetailsNarrative" xlink:href="ppcb-20210930.xsd#PropertyAndEquipmentDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/DueToFormerDirector-RelatedPartyDetailsNarrative" xlink:href="ppcb-20210930.xsd#DueToFormerDirector-RelatedPartyDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/LoansAndNotesPayableDetailsNarrative" xlink:href="ppcb-20210930.xsd#LoansAndNotesPayableDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/ScheduleOfConvertibleNotesDetails" xlink:href="ppcb-20210930.xsd#ScheduleOfConvertibleNotesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/ConvertibleNotesDetailsNarrative" xlink:href="ppcb-20210930.xsd#ConvertibleNotesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/ScheduleOfIncomeTaxProvisionDetails" xlink:href="ppcb-20210930.xsd#ScheduleOfIncomeTaxProvisionDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:href="ppcb-20210930.xsd#ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/IncomeTaxesDetailsNarrative" xlink:href="ppcb-20210930.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/ScheduleOfStockOptionActivityDetails" xlink:href="ppcb-20210930.xsd#ScheduleOfStockOptionActivityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/ScheduleOfWarrantActivityDetails" xlink:href="ppcb-20210930.xsd#ScheduleOfWarrantActivityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/StockholdersDeficitDetailsNarrative" xlink:href="ppcb-20210930.xsd#StockholdersDeficitDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/ScheduleOfRightUseOfAssetDetails" xlink:href="ppcb-20210930.xsd#ScheduleOfRightUseOfAssetDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/ScheduleOfOperatingLeaseLiabilityDetails" xlink:href="ppcb-20210930.xsd#ScheduleOfOperatingLeaseLiabilityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="ppcb-20210930.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:href="ppcb-20210930.xsd#RelatedPartyTransactionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/ConcentrationsAndRisksDetailsNarrative" xlink:href="ppcb-20210930.xsd#ConcentrationsAndRisksDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/ScheduleOfFairValueMeasurementsRecurringAndNonrecurringValuationTechniquesDetails" xlink:href="ppcb-20210930.xsd#ScheduleOfFairValueMeasurementsRecurringAndNonrecurringValuationTechniquesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" xlink:href="ppcb-20210930.xsd#ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/ScheduleOfDerivativeLiabilitiesAtFairValueDetails" xlink:href="ppcb-20210930.xsd#ScheduleOfDerivativeLiabilitiesAtFairValueDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/DerivativeFinancialInstrumentsAndFairValueMeasurementsDetailsNarrative" xlink:href="ppcb-20210930.xsd#DerivativeFinancialInstrumentsAndFairValueMeasurementsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://propanc.com/role/SubsequentEventsDetailsNarrative" xlink:href="ppcb-20210930.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://propanc.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://propanc.com/role/BalanceSheets" xlink:title="00000002 - Statement - Condensed Consolidated Balance Sheets">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="loc_us-gaapSeriesAPreferredStockMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesAPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="loc_us-gaapSeriesBPreferredStockMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesBPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaapAssetsAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAssetsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssetsCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValueAddedTaxReceivableCurrent" xlink:label="loc_us-gaapValueAddedTaxReceivableCurrent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapValueAddedTaxReceivableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepositsAssetsNoncurrent" xlink:label="loc_us-gaapDepositsAssetsNoncurrent" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapDepositsAssetsNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndOtherAccruedLiabilitiesCurrent" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtCurrent" xlink:label="loc_us-gaapConvertibleDebtCurrent" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapConvertibleDebtCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationLiabilityCurrent" xlink:label="loc_us-gaapDeferredCompensationLiabilityCurrent" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapDeferredCompensationLiabilityCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueToRelatedPartiesCurrent" xlink:label="loc_us-gaapDueToRelatedPartiesCurrent" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapDueToRelatedPartiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_LoanFromFormerDirectorRelatedParty" xlink:label="loc_PPCBLoanFromFormerDirectorRelatedParty" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_PPCBLoanFromFormerDirectorRelatedParty" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaapEmployeeRelatedLiabilitiesCurrent" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapEmployeeRelatedLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaapCommitmentsAndContingencies" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapCommitmentsAndContingencies" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_CommonStockIssuable" xlink:label="loc_PPCBCommonStockIssuable" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_PPCBCommonStockIssuable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteSubscriptionsReceivable" xlink:label="loc_us-gaapStockholdersEquityNoteSubscriptionsReceivable" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquityNoteSubscriptionsReceivable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_us-gaapTreasuryStockValue" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapTreasuryStockValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://propanc.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="loc_us-gaapSeriesAPreferredStockMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesAPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="loc_us-gaapSeriesBPreferredStockMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesBPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_CommonStockIssuableShares" xlink:label="loc_PPCBCommonStockIssuableShares" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_PPCBCommonStockIssuableShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares" xlink:label="loc_us-gaapTreasuryStockShares" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTreasuryStockShares" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://propanc.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss" xlink:title="00000004 - Statement - Consolidated Statements of Operations and Comprehensive Income (Loss)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaapIncomeStatementAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract" xlink:label="loc_us-gaapRevenuesAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapRevenuesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesAbstract" xlink:to="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaapOperatingExpensesAbstract" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOperatingExpensesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OccupancyNet" xlink:label="loc_us-gaapOccupancyNet" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapOccupancyNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="loc_us-gaapNonoperatingIncomeExpenseAbstract" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapInterestExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="loc_us-gaapInvestmentIncomeInterest" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapInvestmentIncomeInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIncome" xlink:label="loc_us-gaapOtherIncome" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapOtherIncome" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet" xlink:label="loc_us-gaapDerivativeGainLossOnDerivativeNet" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapDerivativeGainLossOnDerivativeNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_GainFromSettlementOfDebtNet" xlink:label="loc_PPCBGainFromSettlementOfDebtNet" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_PPCBGainFromSettlementOfDebtNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:label="loc_us-gaapForeignCurrencyTransactionGainLossUnrealized" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapForeignCurrencyTransactionGainLossUnrealized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_DeemedDividend" xlink:label="loc_PPCBDeemedDividend" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_PPCBDeemedDividend" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="loc_us-gaapEarningsPerShareBasicAndDiluted" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapEarningsPerShareBasicAndDiluted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="loc_us-gaapWeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" xlink:label="loc_us-gaapOtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:to="loc_us-gaapOtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaapComprehensiveIncomeNetOfTax" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapComprehensiveIncomeNetOfTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://propanc.com/role/StatementsOfChangesInStockholdersDeficit" xlink:title="00000005 - Statement - Consolidated Statements of Changes in Stockholders&apos; Deficit">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaapStatementOfStockholdersEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfStockholdersEquityAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="90" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="loc_us-gaapSeriesAPreferredStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapSeriesAPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="loc_us-gaapSeriesBPreferredStockMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapSeriesBPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="90" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaapPreferredStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_CommonStockIssuableMember" xlink:label="loc_PPCBCommonStockIssuableMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_PPCBCommonStockIssuableMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapRetainedEarningsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember" xlink:label="loc_us-gaapTreasuryStockMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapTreasuryStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_SubscriptionReceivableMember" xlink:label="loc_PPCBSubscriptionReceivableMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_PPCBSubscriptionReceivableMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueConversionOfConvertibleSecurities" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_ReversalOfCommonStockIssuableDueToCancellationOfConversionsOfConvertibleDebtAndAccruedInterest" xlink:label="loc_PPCBReversalOfCommonStockIssuableDueToCancellationOfConversionsOfConvertibleDebtAndAccruedInterest" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_PPCBReversalOfCommonStockIssuableDueToCancellationOfConversionsOfConvertibleDebtAndAccruedInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_ReversalOfCommonStockIssuableDueToCancellationOfConversionsOfConvertibleDebtAndAccruedInterestShares" xlink:label="loc_PPCBReversalOfCommonStockIssuableDueToCancellationOfConversionsOfConvertibleDebtAndAccruedInterestShares" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_PPCBReversalOfCommonStockIssuableDueToCancellationOfConversionsOfConvertibleDebtAndAccruedInterestShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_StockIssuedDuringPeriodValueExerciseOfWarrants" xlink:label="loc_PPCBStockIssuedDuringPeriodValueExerciseOfWarrants" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_PPCBStockIssuedDuringPeriodValueExerciseOfWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_StockIssuedDuringPeriodSharesExerciseOfWarrants" xlink:label="loc_PPCBStockIssuedDuringPeriodSharesExerciseOfWarrants" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_PPCBStockIssuedDuringPeriodSharesExerciseOfWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_IssuanceOfCommonStockForCashlessExerciseOfWarrants" xlink:label="loc_PPCBIssuanceOfCommonStockForCashlessExerciseOfWarrants" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_PPCBIssuanceOfCommonStockForCashlessExerciseOfWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_IssuanceOfCommonStockForCashlessExerciseOfWarrantsShares" xlink:label="loc_PPCBIssuanceOfCommonStockForCashlessExerciseOfWarrantsShares" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_PPCBIssuanceOfCommonStockForCashlessExerciseOfWarrantsShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_StockIssuedDuringPeriodValueReverseStockSplits" xlink:label="loc_PPCBStockIssuedDuringPeriodValueReverseStockSplits" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_PPCBStockIssuedDuringPeriodValueReverseStockSplits" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesReverseStockSplits" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesReverseStockSplits" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_DeemedDividendUponAlternateCashlessExerciseOfWarrants" xlink:label="loc_PPCBDeemedDividendUponAlternateCashlessExerciseOfWarrants" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_PPCBDeemedDividendUponAlternateCashlessExerciseOfWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_IssuanceOfCommonStockForAlternateCashlessExerciseOfWarrants" xlink:label="loc_PPCBIssuanceOfCommonStockForAlternateCashlessExerciseOfWarrants" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_PPCBIssuanceOfCommonStockForAlternateCashlessExerciseOfWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_IssuanceOfCommonStockForAlternateCashlessExerciseOfWarrantsShares" xlink:label="loc_PPCBIssuanceOfCommonStockForAlternateCashlessExerciseOfWarrantsShares" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_PPCBIssuanceOfCommonStockForAlternateCashlessExerciseOfWarrantsShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_AdjustmentsToAdditionalPaidInCapitalReclassificationOfPremiumUponDebtConversion" xlink:label="loc_PPCBAdjustmentsToAdditionalPaidInCapitalReclassificationOfPremiumUponDebtConversion" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_PPCBAdjustmentsToAdditionalPaidInCapitalReclassificationOfPremiumUponDebtConversion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_RelativeFairValueOfWarrantsIssuedWithConvertibleDebt" xlink:label="loc_PPCBRelativeFairValueOfWarrantsIssuedWithConvertibleDebt" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_PPCBRelativeFairValueOfWarrantsIssuedWithConvertibleDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalWarrantIssued" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:label="loc_us-gaapForeignCurrencyTransactionGainLossBeforeTax" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapForeignCurrencyTransactionGainLossBeforeTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_2" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_2" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://propanc.com/role/StatementsOfCashFlows" xlink:title="00000006 - Statement - Consolidated Statements of Cash Flows">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaapStatementOfCashFlowsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:label="loc_us-gaapIssuanceOfStockAndWarrantsForServicesOrClaims" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIssuanceOfStockAndWarrantsForServicesOrClaims" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:label="loc_us-gaapForeignCurrencyTransactionGainLossUnrealized" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapForeignCurrencyTransactionGainLossUnrealized" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaapDepreciation" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapDepreciation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="loc_us-gaapAmortizationOfDebtDiscountPremium" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapAmortizationOfDebtDiscountPremium" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet" xlink:label="loc_us-gaapDerivativeGainLossOnDerivativeNet" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapDerivativeGainLossOnDerivativeNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_GainFromSettlementOfDebtNet" xlink:label="loc_PPCBGainFromSettlementOfDebtNet" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_PPCBGainFromSettlementOfDebtNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashExpense" xlink:label="loc_us-gaapOtherNoncashExpense" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapOtherNoncashExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:label="loc_us-gaapAccretionAmortizationOfDiscountsAndPremiumsInvestments" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapAccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInReceivables" xlink:label="loc_us-gaapIncreaseDecreaseInReceivables" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInReceivables" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayable" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_IncreaseDecreaseInDeferredRent" xlink:label="loc_PPCBIncreaseDecreaseInDeferredRent" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:to="loc_PPCBIncreaseDecreaseInDeferredRent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInEmployeeRelatedLiabilities" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInEmployeeRelatedLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInterestPayableNet" xlink:label="loc_us-gaapIncreaseDecreaseInInterestPayableNet" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInInterestPayableNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="loc_us-gaapProceedsFromConvertibleDebt" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromConvertibleDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfConvertibleDebt" xlink:label="loc_us-gaapRepaymentsOfConvertibleDebt" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapRepaymentsOfConvertibleDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfInitialPublicOffering" xlink:label="loc_us-gaapPaymentsForRepurchaseOfInitialPublicOffering" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsForRepurchaseOfInitialPublicOffering" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="loc_us-gaapProceedsFromWarrantExercises" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromWarrantExercises" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="loc_us-gaapEffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapEffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="loc_us-gaapSupplementalCashFlowInformationAbstract" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_CashPaidDuringPeriodAbstract" xlink:label="loc_PPCBCashPaidDuringPeriodAbstract" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:to="loc_PPCBCashPaidDuringPeriodAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet" xlink:label="loc_us-gaapInterestPaidNet" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_PPCBCashPaidDuringPeriodAbstract" xlink:to="loc_us-gaapInterestPaidNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaidNet" xlink:label="loc_us-gaapIncomeTaxesPaidNet" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_PPCBCashPaidDuringPeriodAbstract" xlink:to="loc_us-gaapIncomeTaxesPaidNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConversionOfStockAmountConverted1" xlink:label="loc_us-gaapConversionOfStockAmountConverted1" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="loc_us-gaapConversionOfStockAmountConverted1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConversionOfStockAmountIssued1" xlink:label="loc_us-gaapConversionOfStockAmountIssued1" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="loc_us-gaapConversionOfStockAmountIssued1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_DiscountsRelatedToWarrantsIssuedWithConvertibleNote" xlink:label="loc_PPCBDiscountsRelatedToWarrantsIssuedWithConvertibleNote" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="loc_PPCBDiscountsRelatedToWarrantsIssuedWithConvertibleNote" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_DiscountsRelatedToDerivativeLiability" xlink:label="loc_PPCBDiscountsRelatedToDerivativeLiability" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="loc_PPCBDiscountsRelatedToDerivativeLiability" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_OperatingLeaseRightofuseAssetsAndOperatingLeaseLiabilitiesRecordedUponAdoptionOfAsc842" xlink:label="loc_PPCBOperatingLeaseRightofuseAssetsAndOperatingLeaseLiabilitiesRecordedUponAdoptionOfAsc842" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="loc_PPCBOperatingLeaseRightofuseAssetsAndOperatingLeaseLiabilitiesRecordedUponAdoptionOfAsc842" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_ReversalOfCommonStockIssuableAndPutPremiumDueToCancellationOfConversionsOfConvertibleDebtAndAccruedInterest" xlink:label="loc_PPCBReversalOfCommonStockIssuableAndPutPremiumDueToCancellationOfConversionsOfConvertibleDebtAndAccruedInterest" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="loc_PPCBReversalOfCommonStockIssuableAndPutPremiumDueToCancellationOfConversionsOfConvertibleDebtAndAccruedInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_DeemedDividendUponAlternateCashlessExerciseOfWarrants1" xlink:label="loc_PPCBDeemedDividendUponAlternateCashlessExerciseOfWarrants1" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="loc_PPCBDeemedDividendUponAlternateCashlessExerciseOfWarrants1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_AccountsPayableReclassToConvertibleNotes" xlink:label="loc_PPCBAccountsPayableReclassToConvertibleNotes" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="loc_PPCBAccountsPayableReclassToConvertibleNotes" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssued1" xlink:label="loc_us-gaapStockIssued1" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="loc_us-gaapStockIssued1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_SubscriptionReceivable" xlink:label="loc_PPCBSubscriptionReceivable" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="loc_PPCBSubscriptionReceivable" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://propanc.com/role/NatureOfOperationsAndSummaryOfSignificantAccountingAndReportingPolicies" xlink:title="00000007 - Disclosure - NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING AND REPORTING POLICIES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:label="loc_us-gaapOrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapOrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://propanc.com/role/GoingConcern" xlink:title="00000008 - Disclosure - GOING CONCERN">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubstantialDoubtAboutGoingConcernTextBlock" xlink:label="loc_us-gaapSubstantialDoubtAboutGoingConcernTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapSubstantialDoubtAboutGoingConcernTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://propanc.com/role/PropertyAndEquipment" xlink:title="00000009 - Disclosure - PROPERTY AND EQUIPMENT">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://propanc.com/role/DueToFormerDirector-RelatedParty" xlink:title="00000010 - Disclosure - DUE TO FORMER DIRECTOR - RELATED PARTY">
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_DisclosureDueToFormerDirectorRelatedPartyAbstract" xlink:label="loc_PPCBDisclosureDueToFormerDirectorRelatedPartyAbstract" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_DueToFormerDirectorRelatedPartyDisclosureTextBlock" xlink:label="loc_PPCBDueToFormerDirectorRelatedPartyDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_PPCBDisclosureDueToFormerDirectorRelatedPartyAbstract" xlink:to="loc_PPCBDueToFormerDirectorRelatedPartyDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://propanc.com/role/LoansAndNotesPayable" xlink:title="00000011 - Disclosure - LOANS AND NOTES PAYABLE">
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_DisclosureLoansAndNotesPayableAbstract" xlink:label="loc_PPCBDisclosureLoansAndNotesPayableAbstract" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_LoansAndNotesPayableDisclosureTextBlock" xlink:label="loc_PPCBLoansAndNotesPayableDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_PPCBDisclosureLoansAndNotesPayableAbstract" xlink:to="loc_PPCBLoansAndNotesPayableDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://propanc.com/role/ConvertibleNotes" xlink:title="00000012 - Disclosure - CONVERTIBLE NOTES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="loc_us-gaapDebtDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapDebtDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://propanc.com/role/IncomeTaxes" xlink:title="00000013 - Disclosure - INCOME TAXES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaapIncomeTaxDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://propanc.com/role/StockholdersDeficit" xlink:title="00000014 - Disclosure - STOCKHOLDERS&#8217; DEFICIT">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://propanc.com/role/CommitmentsAndContingencies" xlink:title="00000015 - Disclosure - COMMITMENTS AND CONTINGENCIES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://propanc.com/role/RelatedPartyTransactions" xlink:title="00000016 - Disclosure - RELATED PARTY TRANSACTIONS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://propanc.com/role/ConcentrationsAndRisks" xlink:title="00000017 - Disclosure - CONCENTRATIONS AND RISKS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RisksAndUncertaintiesAbstract" xlink:label="loc_us-gaapRisksAndUncertaintiesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:label="loc_us-gaapConcentrationRiskDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRisksAndUncertaintiesAbstract" xlink:to="loc_us-gaapConcentrationRiskDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://propanc.com/role/DerivativeFinancialInstrumentsAndFairValueMeasurements" xlink:title="00000018 - Disclosure - DERIVATIVE FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="loc_us-gaapDerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:label="loc_us-gaapDerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="loc_us-gaapDerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://propanc.com/role/SubsequentEvents" xlink:title="00000019 - Disclosure - SUBSEQUENT EVENTS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="loc_us-gaapSubsequentEventsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapSubsequentEventsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://propanc.com/role/NatureOfOperationsAndSummaryOfSignificantAccountingAndReportingPoliciesPolicies" xlink:title="00000020 - Disclosure - NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING AND REPORTING POLICIES (Policies)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_NatureOfOperationsPolicyTextBlock" xlink:label="loc_PPCBNatureOfOperationsPolicyTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_PPCBNatureOfOperationsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="loc_us-gaapConsolidationPolicyTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapConsolidationPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="loc_us-gaapUseOfEstimates" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapUseOfEstimates" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:label="loc_us-gaapForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="loc_us-gaapFairValueOfFinancialInstrumentsPolicy" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapFairValueOfFinancialInstrumentsPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="loc_us-gaapCashAndCashEquivalentsPolicyTextBlock" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentPolicyTextBlock" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsIntangibleAssetsPolicy" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapGoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="loc_us-gaapImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOwnershipPlanESOPPolicy" xlink:label="loc_us-gaapEmployeeStockOwnershipPlanESOPPolicy" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapEmployeeStockOwnershipPlanESOPPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_GoodsAndServiceTaxPolicyTextBlock" xlink:label="loc_PPCBGoodsAndServiceTaxPolicyTextBlock" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_PPCBGoodsAndServiceTaxPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesReportingOfDerivativeActivity" xlink:label="loc_us-gaapDerivativesReportingOfDerivativeActivity" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapDerivativesReportingOfDerivativeActivity" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_ConvertibleNotesPolicyTextBlock" xlink:label="loc_PPCBConvertibleNotesPolicyTextBlock" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_PPCBConvertibleNotesPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="loc_us-gaapIncomeTaxPolicyTextBlock" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapIncomeTaxPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="loc_us-gaapResearchAndDevelopmentExpensePolicy" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapResearchAndDevelopmentExpensePolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="loc_us-gaapShareBasedCompensationOptionAndIncentivePlansPolicy" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:label="loc_us-gaapRevenueFromContractWithCustomerPolicyTextBlock" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapRevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LegalCostsPolicyTextBlock" xlink:label="loc_us-gaapLegalCostsPolicyTextBlock" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapLegalCostsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock" xlink:label="loc_us-gaapLesseeLeasesPolicyTextBlock" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapLesseeLeasesPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="loc_us-gaapEarningsPerSharePolicyTextBlock" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapEarningsPerSharePolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="loc_us-gaapBasisOfAccountingPolicyPolicyTextBlock" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapBasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://propanc.com/role/NatureOfOperationsAndSummaryOfSignificantAccountingAndReportingPoliciesTables" xlink:title="00000021 - Disclosure - NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING AND REPORTING POLICIES (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_ScheduleOfTranslationExchangeRatesTableTextBlock" xlink:label="loc_PPCBScheduleOfTranslationExchangeRatesTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_PPCBScheduleOfTranslationExchangeRatesTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:label="loc_us-gaapScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_ScheduleOfPropertyAndEquipmentEstimatedUsefulLivesTableTextBlock" xlink:label="loc_PPCBScheduleOfPropertyAndEquipmentEstimatedUsefulLivesTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_PPCBScheduleOfPropertyAndEquipmentEstimatedUsefulLivesTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://propanc.com/role/PropertyAndEquipmentTables" xlink:title="00000022 - Disclosure - PROPERTY AND EQUIPMENT (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://propanc.com/role/ConvertibleNotesTables" xlink:title="00000023 - Disclosure - CONVERTIBLE NOTES (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtTableTextBlock" xlink:label="loc_us-gaapConvertibleDebtTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapConvertibleDebtTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://propanc.com/role/IncomeTaxesTables" xlink:title="00000024 - Disclosure - INCOME TAXES (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="loc_us-gaapScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="loc_us-gaapScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://propanc.com/role/StockholdersDeficitTables" xlink:title="00000025 - Disclosure - STOCKHOLDERS&#8217; DEFICIT (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="loc_us-gaapScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://propanc.com/role/CommitmentsAndContingenciesTables" xlink:title="00000026 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_ScheduleOfRightUseOfAssetTableTextBlock" xlink:label="loc_PPCBScheduleOfRightUseOfAssetTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_PPCBScheduleOfRightUseOfAssetTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLeaseIncomeTableTextBlock" xlink:label="loc_us-gaapOperatingLeaseLeaseIncomeTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapOperatingLeaseLeaseIncomeTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://propanc.com/role/DerivativeFinancialInstrumentsAndFairValueMeasurementsTables" xlink:title="00000027 - Disclosure - DERIVATIVE FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="loc_us-gaapDerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:label="loc_us-gaapScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" xlink:label="loc_us-gaapScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://propanc.com/role/ScheduleOfTranslationExchangeRatesDetails" xlink:title="00000028 - Disclosure - SCHEDULE OF TRANSLATION EXCHANGE RATES (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_srtRangeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_WeightedAverageMember" xlink:label="loc_srtWeightedAverageMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtWeightedAverageMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyExchangeRateTranslation1" xlink:label="loc_us-gaapForeignCurrencyExchangeRateTranslation1" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapForeignCurrencyExchangeRateTranslation1" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://propanc.com/role/ScheduleOfChangeInAccumulatedOtherComprehensiveIncomeLossDetails" xlink:title="00000029 - Disclosure - SCHEDULE OF CHANGE IN ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax_2" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://propanc.com/role/ScheduleOfPropertyAndEquipmentEstimatedUsefulLivesDetails" xlink:title="00000030 - Disclosure - SCHEDULE OF PROPERTY AND EQUIPMENT ESTIMATED USEFUL LIVES (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MachineryAndEquipmentMember" xlink:label="loc_us-gaapMachineryAndEquipmentMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapMachineryAndEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaapFurnitureAndFixturesMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapFurnitureAndFixturesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="loc_us-gaapPropertyPlantAndEquipmentUsefulLife" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentUsefulLife" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://propanc.com/role/ScheduleOfDilutiveSecuritiesExcludedFromComputationDetails" xlink:title="00000031 - Disclosure - SCHEDULE OF DILUTIVE SECURITIES EXCLUDED FROM COMPUTATION (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaapAntidilutiveSecuritiesNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="loc_us-gaapAntidilutiveSecuritiesNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaapEmployeeStockOptionMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_us-gaapEmployeeStockOptionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_us-gaapWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_UnvestedRestrictedStockMember" xlink:label="loc_PPCBUnvestedRestrictedStockMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_PPCBUnvestedRestrictedStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtSecuritiesMember" xlink:label="loc_us-gaapConvertibleDebtSecuritiesMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_us-gaapConvertibleDebtSecuritiesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://propanc.com/role/NatureOfOperationsAndSummaryOfSignificantAccountingAndReportingPoliciesDetailsNarrative" xlink:title="00000032 - Disclosure - NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING AND REPORTING POLICIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShortTermDebtTable" xlink:label="loc_us-gaapScheduleOfShortTermDebtTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfShortTermDebtTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtLineItems" xlink:label="loc_us-gaapShortTermDebtLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapShortTermDebtLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapDebtInstrumentAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_IntercompanyLoansMember" xlink:label="loc_PPCBIntercompanyLoansMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_PPCBIntercompanyLoansMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_TwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember" xlink:label="loc_PPCBTwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_PPCBTwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationDateOfIncorporation" xlink:label="loc_deiEntityIncorporationDateOfIncorporation" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_deiEntityIncorporationDateOfIncorporation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityReverseStockSplit" xlink:label="loc_us-gaapStockholdersEquityReverseStockSplit" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapStockholdersEquityReverseStockSplit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" xlink:label="loc_us-gaapOtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapOtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapCashEquivalentsAtCarryingValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValueAddedTaxReceivableCurrent" xlink:label="loc_us-gaapValueAddedTaxReceivableCurrent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapValueAddedTaxReceivableCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleTermsOfConversionFeature" xlink:label="loc_us-gaapDebtInstrumentConvertibleTermsOfConversionFeature" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentConvertibleTermsOfConversionFeature" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:label="loc_us-gaapDebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://propanc.com/role/GoingConcernDetailsNarrative" xlink:title="00000033 - Disclosure - GOING CONCERN (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_WorkingCapitalDeficit" xlink:label="loc_PPCBWorkingCapitalDeficit" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_PPCBWorkingCapitalDeficit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://propanc.com/role/ScheduleOfPropertyAndEquipmentDetails" xlink:title="00000034 - Disclosure - SCHEDULE OF PROPERTY AND EQUIPMENT (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://propanc.com/role/PropertyAndEquipmentDetailsNarrative" xlink:title="00000035 - Disclosure - PROPERTY AND EQUIPMENT (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaapDepreciation" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapDepreciation" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://propanc.com/role/DueToFormerDirector-RelatedPartyDetailsNarrative" xlink:title="00000036 - Disclosure - DUE TO FORMER DIRECTOR - RELATED PARTY (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_DisclosureDueToFormerDirectorRelatedPartyAbstract" xlink:label="loc_PPCBDisclosureDueToFormerDirectorRelatedPartyAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueToRelatedPartiesCurrent" xlink:label="loc_us-gaapDueToRelatedPartiesCurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_PPCBDisclosureDueToFormerDirectorRelatedPartyAbstract" xlink:to="loc_us-gaapDueToRelatedPartiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://propanc.com/role/LoansAndNotesPayableDetailsNarrative" xlink:title="00000037 - Disclosure - LOANS AND NOTES PAYABLE (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_DisclosureLoansAndNotesPayableAbstract" xlink:label="loc_PPCBDisclosureLoansAndNotesPayableAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:label="loc_us-gaapScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_PPCBDisclosureLoansAndNotesPayableAbstract" xlink:to="loc_us-gaapScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:label="loc_us-gaapDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:to="loc_us-gaapDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:to="loc_srtTitleOfIndividualAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_DirectorsAndOfficerMember" xlink:label="loc_PPCBDirectorsAndOfficerMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_PPCBDirectorsAndOfficerMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LoansPayable" xlink:label="loc_us-gaapLoansPayable" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="loc_us-gaapLoansPayable" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://propanc.com/role/ScheduleOfConvertibleNotesDetails" xlink:title="00000038 - Disclosure - SCHEDULE OF CONVERTIBLE NOTES (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="loc_us-gaapDebtInstrumentCarryingAmount" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapDebtInstrumentCarryingAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:label="loc_us-gaapDebtInstrumentUnamortizedDiscount" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapDebtInstrumentUnamortizedDiscount" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepositLiabilitiesAccruedInterest" xlink:label="loc_us-gaapDepositLiabilitiesAccruedInterest" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapDepositLiabilitiesAccruedInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedPremium" xlink:label="loc_us-gaapDebtInstrumentUnamortizedPremium" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapDebtInstrumentUnamortizedPremium" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt" xlink:label="loc_us-gaapLongTermDebt" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapLongTermDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://propanc.com/role/ConvertibleNotesDetailsNarrative" xlink:title="00000039 - Disclosure - CONVERTIBLE NOTES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShortTermDebtTable" xlink:label="loc_us-gaapScheduleOfShortTermDebtTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfShortTermDebtTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtLineItems" xlink:label="loc_us-gaapShortTermDebtLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapShortTermDebtLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_DecemberTwentyNineTwoThousandAndSeventeenSecuritiesPurchaseAgreementMember" xlink:label="loc_PPCBDecemberTwentyNineTwoThousandAndSeventeenSecuritiesPurchaseAgreementMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_PPCBDecemberTwentyNineTwoThousandAndSeventeenSecuritiesPurchaseAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_DecemberTwentyNineTwoThousandAndSixteenSecuritiesPurchaseAgreementMember" xlink:label="loc_PPCBDecemberTwentyNineTwoThousandAndSixteenSecuritiesPurchaseAgreementMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_PPCBDecemberTwentyNineTwoThousandAndSixteenSecuritiesPurchaseAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_JulyThirteenTwoThousandAndEighteenSecuritiesPurchaseAgreementMember" xlink:label="loc_PPCBJulyThirteenTwoThousandAndEighteenSecuritiesPurchaseAgreementMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_PPCBJulyThirteenTwoThousandAndEighteenSecuritiesPurchaseAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_JuneTwentyNineTwoThousandEighteenSecuritiesPurchaseAgreementMember" xlink:label="loc_PPCBJuneTwentyNineTwoThousandEighteenSecuritiesPurchaseAgreementMember" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_PPCBJuneTwentyNineTwoThousandEighteenSecuritiesPurchaseAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_AugustTwentyNineTwoThousandandEighteenSecuritiesPurchaseAgreementMember" xlink:label="loc_PPCBAugustTwentyNineTwoThousandandEighteenSecuritiesPurchaseAgreementMember" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_PPCBAugustTwentyNineTwoThousandandEighteenSecuritiesPurchaseAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember" xlink:label="loc_PPCBOctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_PPCBOctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_NovembeThirtyTwoThousandAndEighteenMecuritiesPurchaseAgreementMember" xlink:label="loc_PPCBNovembeThirtyTwoThousandAndEighteenMecuritiesPurchaseAgreementMember" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_PPCBNovembeThirtyTwoThousandAndEighteenMecuritiesPurchaseAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember" xlink:label="loc_PPCBDecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_PPCBDecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_SecuritiesPurchaseAgreementOneMember" xlink:label="loc_PPCBSecuritiesPurchaseAgreementOneMember" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_PPCBSecuritiesPurchaseAgreementOneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_SecuritiesPurchaseAgreementMember" xlink:label="loc_PPCBSecuritiesPurchaseAgreementMember" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_PPCBSecuritiesPurchaseAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_AugustTenTwoThousandAndSeventeenConsultingAgreementMember" xlink:label="loc_PPCBAugustTenTwoThousandAndSeventeenConsultingAgreementMember" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_PPCBAugustTenTwoThousandAndSeventeenConsultingAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_NovemberTwentySixTwoThousandNineteenSecuritiesPurchaseAgreementMember" xlink:label="loc_PPCBNovemberTwentySixTwoThousandNineteenSecuritiesPurchaseAgreementMember" />
      <link:presentationArc order="620" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_PPCBNovemberTwentySixTwoThousandNineteenSecuritiesPurchaseAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_JanuarySevenTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember" xlink:label="loc_PPCBJanuarySevenTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember" />
      <link:presentationArc order="650" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_PPCBJanuarySevenTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember" xlink:label="loc_PPCBMarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember" />
      <link:presentationArc order="680" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_PPCBMarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_RedstartHoldingsCorpFinancingAgreementMember" xlink:label="loc_PPCBRedstartHoldingsCorpFinancingAgreementMember" />
      <link:presentationArc order="750" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_PPCBRedstartHoldingsCorpFinancingAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_AuctusFinancingAgreementMember" xlink:label="loc_PPCBAuctusFinancingAgreementMember" />
      <link:presentationArc order="1600" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_PPCBAuctusFinancingAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_GenevaRothFinancingAgreementAgreementMember" xlink:label="loc_PPCBGenevaRothFinancingAgreementAgreementMember" />
      <link:presentationArc order="1840" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_PPCBGenevaRothFinancingAgreementAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_deiLegalEntityAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_EagleEquitiesLLCMember" xlink:label="loc_PPCBEagleEquitiesLLCMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_PPCBEagleEquitiesLLCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_DepositoryTrustCompanyMember" xlink:label="loc_PPCBDepositoryTrustCompanyMember" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_PPCBDepositoryTrustCompanyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_GSCapitalPartnersLLCMember" xlink:label="loc_PPCBGSCapitalPartnersLLCMember" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_PPCBGSCapitalPartnersLLCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_RedstartHoldingsCorpMember" xlink:label="loc_PPCBRedstartHoldingsCorpMember" />
      <link:presentationArc order="750" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_PPCBRedstartHoldingsCorpMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_OdysseyCapitalFundingLLCMember" xlink:label="loc_PPCBOdysseyCapitalFundingLLCMember" />
      <link:presentationArc order="800" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_PPCBOdysseyCapitalFundingLLCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_AuctusFundLLCMember" xlink:label="loc_PPCBAuctusFundLLCMember" />
      <link:presentationArc order="870" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_PPCBAuctusFundLLCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_GWHoldingsGroupLLCMember" xlink:label="loc_PPCBGWHoldingsGroupLLCMember" />
      <link:presentationArc order="990" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_PPCBGWHoldingsGroupLLCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_CrownBridgePartnersLLCMember" xlink:label="loc_PPCBCrownBridgePartnersLLCMember" />
      <link:presentationArc order="1130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_PPCBCrownBridgePartnersLLCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_LGCapitalFundingLLCMember" xlink:label="loc_PPCBLGCapitalFundingLLCMember" />
      <link:presentationArc order="1290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_PPCBLGCapitalFundingLLCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_GenevaRothRemarkHoldingsIncMember" xlink:label="loc_PPCBGenevaRothRemarkHoldingsIncMember" />
      <link:presentationArc order="1410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_PPCBGenevaRothRemarkHoldingsIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapDebtInstrumentAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_DecemberTwoThousandAndSeventeenEagleNoteMember" xlink:label="loc_PPCBDecemberTwoThousandAndSeventeenEagleNoteMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_PPCBDecemberTwoThousandAndSeventeenEagleNoteMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_JulyTwoThousandEighteenEagleNoteMember" xlink:label="loc_PPCBJulyTwoThousandEighteenEagleNoteMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_PPCBJulyTwoThousandEighteenEagleNoteMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_AugustTwoThousandEighteenEagleNoteMember" xlink:label="loc_PPCBAugustTwoThousandEighteenEagleNoteMember" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_PPCBAugustTwoThousandEighteenEagleNoteMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_OctoberTwoTwoThousandAndEighteenEagleNoteMember" xlink:label="loc_PPCBOctoberTwoTwoThousandAndEighteenEagleNoteMember" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_PPCBOctoberTwoTwoThousandAndEighteenEagleNoteMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_NovemberTwoThousandAndEighteenEagleNoteMember" xlink:label="loc_PPCBNovemberTwoThousandAndEighteenEagleNoteMember" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_PPCBNovemberTwoThousandAndEighteenEagleNoteMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_DecembeTwoThousandAndEighteenEagleNoteMember" xlink:label="loc_PPCBDecembeTwoThousandAndEighteenEagleNoteMember" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_PPCBDecembeTwoThousandAndEighteenEagleNoteMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_OctoberTwoThousandEighteenGSNoteMember" xlink:label="loc_PPCBOctoberTwoThousandEighteenGSNoteMember" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_PPCBOctoberTwoThousandEighteenGSNoteMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_JanuaryTwentyTwoTwentyTwentyGSNoteMember" xlink:label="loc_PPCBJanuaryTwentyTwoTwentyTwentyGSNoteMember" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_PPCBJanuaryTwentyTwoTwentyTwentyGSNoteMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_NovemberTwentySixTwoThousandNineteenPowerUpNoteMember" xlink:label="loc_PPCBNovemberTwentySixTwoThousandNineteenPowerUpNoteMember" />
      <link:presentationArc order="620" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_PPCBNovemberTwentySixTwoThousandNineteenPowerUpNoteMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_JanuarySevenTwoThousandTwentyPowerUpNoteMember" xlink:label="loc_PPCBJanuarySevenTwoThousandTwentyPowerUpNoteMember" />
      <link:presentationArc order="650" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_PPCBJanuarySevenTwoThousandTwentyPowerUpNoteMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_MarchTwelveTwoThousandTwentyPowerUpNoteMember" xlink:label="loc_PPCBMarchTwelveTwoThousandTwentyPowerUpNoteMember" />
      <link:presentationArc order="680" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_PPCBMarchTwelveTwoThousandTwentyPowerUpNoteMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_JulyTwoThousandNineteenOdysseyNoteMember" xlink:label="loc_PPCBJulyTwoThousandNineteenOdysseyNoteMember" />
      <link:presentationArc order="800" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_PPCBJulyTwoThousandNineteenOdysseyNoteMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_AugustTwoThousandNineteenAuctusNoteMember" xlink:label="loc_PPCBAugustTwoThousandNineteenAuctusNoteMember" />
      <link:presentationArc order="870" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_PPCBAugustTwoThousandNineteenAuctusNoteMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_OctoberOneTwoThousandNineteenAuctusNoteMember" xlink:label="loc_PPCBOctoberOneTwoThousandNineteenAuctusNoteMember" />
      <link:presentationArc order="990" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_PPCBOctoberOneTwoThousandNineteenAuctusNoteMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_DecemberTenTwoThousandTwentyGWNoteMember" xlink:label="loc_PPCBDecemberTenTwoThousandTwentyGWNoteMember" />
      <link:presentationArc order="1010" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_PPCBDecemberTenTwoThousandTwentyGWNoteMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_OctoberThreeTwoThousandNineteenAuctusNoteMember" xlink:label="loc_PPCBOctoberThreeTwoThousandNineteenAuctusNoteMember" />
      <link:presentationArc order="1130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_PPCBOctoberThreeTwoThousandNineteenAuctusNoteMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_JanuaryThirteenTwentyTwentyAderAlefNoteMember" xlink:label="loc_PPCBJanuaryThirteenTwentyTwentyAderAlefNoteMember" />
      <link:presentationArc order="1220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_PPCBJanuaryThirteenTwentyTwentyAderAlefNoteMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember" xlink:label="loc_PPCBFebruaryNineteenTwoThousandTwentyLGCapitalNoteMember" />
      <link:presentationArc order="1290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_PPCBFebruaryNineteenTwoThousandTwentyLGCapitalNoteMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_DecemberTwoTwoThousandTwentyGenevaRothMember" xlink:label="loc_PPCBDecemberTwoTwoThousandTwentyGenevaRothMember" />
      <link:presentationArc order="1410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_PPCBDecemberTwoTwoThousandTwentyGenevaRothMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_JanuaryFiveTwoThousandTwentyOneGenevaRothMember" xlink:label="loc_PPCBJanuaryFiveTwoThousandTwentyOneGenevaRothMember" />
      <link:presentationArc order="1420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_PPCBJanuaryFiveTwoThousandTwentyOneGenevaRothMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_MarchSixteenTwoThousandTwentyOneGenevaRothMember" xlink:label="loc_PPCBMarchSixteenTwoThousandTwentyOneGenevaRothMember" />
      <link:presentationArc order="1440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_PPCBMarchSixteenTwoThousandTwentyOneGenevaRothMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_AugustNineteenTwoThousandTwentyOneGenevaRothMember" xlink:label="loc_PPCBAugustNineteenTwoThousandTwentyOneGenevaRothMember" />
      <link:presentationArc order="1750" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_PPCBAugustNineteenTwoThousandTwentyOneGenevaRothMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_SeptemberTwentyTwoTwoThousandTwentyOneGenevaRothMember" xlink:label="loc_PPCBSeptemberTwentyTwoTwoThousandTwentyOneGenevaRothMember" />
      <link:presentationArc order="1770" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_PPCBSeptemberTwentyTwoTwoThousandTwentyOneGenevaRothMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember" xlink:label="loc_PPCBSeptemberTwentyTwoTwoThousandTwentyGenevaRothMember" />
      <link:presentationArc order="1790" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_PPCBSeptemberTwentyTwoTwoThousandTwentyGenevaRothMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_srtRangeAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="loc_us-gaapShortTermDebtTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapShortTermDebtTypeAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="loc_us-gaapShortTermDebtTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtTypeAxis" xlink:to="loc_us-gaapShortTermDebtTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_FirstNoteMember" xlink:label="loc_PPCBFirstNoteMember" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtTypeDomain" xlink:to="loc_PPCBFirstNoteMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_SecondNoteMember" xlink:label="loc_PPCBSecondNoteMember" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtTypeDomain" xlink:to="loc_PPCBSecondNoteMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_SettlementAndMutualReleaseAgreementMember" xlink:label="loc_PPCBSettlementAndMutualReleaseAgreementMember" />
      <link:presentationArc order="590" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtTypeDomain" xlink:to="loc_PPCBSettlementAndMutualReleaseAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="60" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_ConsultantMember" xlink:label="loc_PPCBConsultantMember" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_PPCBConsultantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="70" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_FirstWarrantMember" xlink:label="loc_PPCBFirstWarrantMember" />
      <link:presentationArc order="910" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_PPCBFirstWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_SecondWarrantMember" xlink:label="loc_PPCBSecondWarrantMember" />
      <link:presentationArc order="920" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_PPCBSecondWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_ThirdWarrantMember" xlink:label="loc_PPCBThirdWarrantMember" />
      <link:presentationArc order="930" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_PPCBThirdWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:label="loc_us-gaapDebtInstrumentUnamortizedDiscount" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentUnamortizedDiscount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="loc_us-gaapProceedsFromConvertibleDebt" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapProceedsFromConvertibleDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_us-gaapDebtInstrumentMaturityDate" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentMaturityDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPayableCurrentAndNoncurrent" xlink:label="loc_us-gaapInterestPayableCurrentAndNoncurrent" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapInterestPayableCurrentAndNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:label="loc_us-gaapDebtConversionConvertedInstrumentAmount1" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtConversionConvertedInstrumentAmount1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleNotesPayable" xlink:label="loc_us-gaapConvertibleNotesPayable" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapConvertibleNotesPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LegalFees" xlink:label="loc_us-gaapLegalFees" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapLegalFees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_DebtInstrumentDebtDefaultInterestRate" xlink:label="loc_PPCBDebtInstrumentDebtDefaultInterestRate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_PPCBDebtInstrumentDebtDefaultInterestRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:label="loc_us-gaapDebtInstrumentPeriodicPaymentPrincipal" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentPeriodicPaymentPrincipal" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:label="loc_us-gaapDebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtConversionOriginalDebtInterestRateOfDebt" xlink:label="loc_us-gaapDebtConversionOriginalDebtInterestRateOfDebt" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtConversionOriginalDebtInterestRateOfDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_PercentageOfOutstandingSharesOfCommonStock" xlink:label="loc_PPCBPercentageOfOutstandingSharesOfCommonStock" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_PPCBPercentageOfOutstandingSharesOfCommonStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedPremium" xlink:label="loc_us-gaapDebtInstrumentUnamortizedPremium" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentUnamortizedPremium" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_DebtDefaultAmountPercentage" xlink:label="loc_PPCBDebtDefaultAmountPercentage" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_PPCBDebtDefaultAmountPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_DebtConversionConvertedInterestPayable" xlink:label="loc_PPCBDebtConversionConvertedInterestPayable" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_PPCBDebtConversionConvertedInterestPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:label="loc_us-gaapDebtInstrumentConvertibleThresholdTradingDays" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentConvertibleThresholdTradingDays" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrentAndNoncurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrentAndNoncurrent" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapAccruedLiabilitiesCurrentAndNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" xlink:label="loc_us-gaapEmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapEmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_PrepaymentPenalties" xlink:label="loc_PPCBPrepaymentPenalties" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_PPCBPrepaymentPenalties" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_DiligenceFees" xlink:label="loc_PPCBDiligenceFees" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_PPCBDiligenceFees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtConversionDescription" xlink:label="loc_us-gaapDebtConversionDescription" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtConversionDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfDebt" xlink:label="loc_us-gaapRepaymentsOfDebt" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapRepaymentsOfDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaid" xlink:label="loc_us-gaapInterestPaid" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapInterestPaid" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentDescription" xlink:label="loc_us-gaapDebtInstrumentDescription" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaapFairValueAdjustmentOfWarrants" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapFairValueAdjustmentOfWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_UnissuedSharesConversion" xlink:label="loc_PPCBUnissuedSharesConversion" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_PPCBUnissuedSharesConversion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_DueToEquityConversion" xlink:label="loc_PPCBDueToEquityConversion" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_PPCBDueToEquityConversion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtConversionOriginalDebtAmount1" xlink:label="loc_us-gaapDebtConversionOriginalDebtAmount1" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtConversionOriginalDebtAmount1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="loc_us-gaapAmortizationOfDebtDiscountPremium" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapAmortizationOfDebtDiscountPremium" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_ReclassifiedPremiumAmountForAdditionalPaidInCapital" xlink:label="loc_PPCBReclassifiedPremiumAmountForAdditionalPaidInCapital" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_PPCBReclassifiedPremiumAmountForAdditionalPaidInCapital" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://propanc.com/role/ScheduleOfIncomeTaxProvisionDetails" xlink:title="00000040 - Disclosure - SCHEDULE OF INCOME TAX PROVISION (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srtStatementGeographicalAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtStatementGeographicalAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US" xlink:label="loc_countryUS" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryUS" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaapIncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapIncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" xlink:label="loc_us-gaapIncomeTaxReconciliationPriorYearIncomeTaxes" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeTaxReconciliationPriorYearIncomeTaxes" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:label="loc_us-gaapIncomeTaxReconciliationForeignIncomeTaxRateDifferential" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxCredits" xlink:label="loc_us-gaapIncomeTaxReconciliationTaxCredits" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeTaxReconciliationTaxCredits" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:label="loc_us-gaapIncomeTaxReconciliationOtherAdjustments" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeTaxReconciliationOtherAdjustments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://propanc.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:title="00000041 - Disclosure - SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_DeferredTaxAssetsWarrantDerivativeLiability" xlink:label="loc_PPCBDeferredTaxAssetsWarrantDerivativeLiability" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_PPCBDeferredTaxAssetsWarrantDerivativeLiability" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:label="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_DeferredTaxAssetsPrepaidInvestorServices" xlink:label="loc_PPCBDeferredTaxAssetsPrepaidInvestorServices" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_PPCBDeferredTaxAssetsPrepaidInvestorServices" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_DeferredTaxAssetsNonCashInterest" xlink:label="loc_PPCBDeferredTaxAssetsNonCashInterest" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_PPCBDeferredTaxAssetsNonCashInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:label="loc_us-gaapDeferredTaxAssetsGoodwillAndIntangibleAssets" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent" xlink:label="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" xlink:label="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseOther" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseOther" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_DeferredTaxAssetsForeignExchangeLoss" xlink:label="loc_PPCBDeferredTaxAssetsForeignExchangeLoss" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_PPCBDeferredTaxAssetsForeignExchangeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_DeferredTaxAssetsRevalueOfDerivativeLiability" xlink:label="loc_PPCBDeferredTaxAssetsRevalueOfDerivativeLiability" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_PPCBDeferredTaxAssetsRevalueOfDerivativeLiability" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaapDeferredTaxAssetsGross" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsGross" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts" xlink:label="loc_us-gaapDeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_DeferredTaxLiabilitiesGainOnExtinguishmentOfDebt" xlink:label="loc_PPCBDeferredTaxLiabilitiesGainOnExtinguishmentOfDebt" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_PPCBDeferredTaxLiabilitiesGainOnExtinguishmentOfDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts" xlink:label="loc_us-gaapDeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:label="loc_us-gaapDeferredIncomeTaxLiabilities" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredIncomeTaxLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaapDeferredTaxAssetsNet" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapDeferredTaxAssetsValuationAllowance" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsValuationAllowance" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="loc_us-gaapDeferredTaxAssetsLiabilitiesNet" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsLiabilitiesNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://propanc.com/role/IncomeTaxesDetailsNarrative" xlink:title="00000042 - Disclosure - INCOME TAXES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_CaresActMember" xlink:label="loc_PPCBCaresActMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_PPCBCaresActMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srtStatementGeographicalAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_srtStatementGeographicalAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US" xlink:label="loc_countryUS" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryUS" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_AU" xlink:label="loc_countryAU" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryAU" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardDateAxis" xlink:label="loc_us-gaapAwardDateAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapAwardDateAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardDateDomain" xlink:label="loc_us-gaapAwardDateDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardDateAxis" xlink:to="loc_us-gaapAwardDateDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_ExpireInTwoThousandTwentyFourMember" xlink:label="loc_PPCBExpireInTwoThousandTwentyFourMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardDateDomain" xlink:to="loc_PPCBExpireInTwoThousandTwentyFourMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_NotExpireMember" xlink:label="loc_PPCBNotExpireMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardDateDomain" xlink:to="loc_PPCBNotExpireMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExaminationDescription" xlink:label="loc_us-gaapIncomeTaxExaminationDescription" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapIncomeTaxExaminationDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_us-gaapOperatingLossCarryforwards" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapOperatingLossCarryforwards" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit_2" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit_2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="loc_us-gaapUnrecognizedTaxBenefits" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapUnrecognizedTaxBenefits" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease" xlink:label="loc_us-gaapUnrecognizedTaxBenefitsPeriodIncreaseDecrease" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapUnrecognizedTaxBenefitsPeriodIncreaseDecrease" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://propanc.com/role/ScheduleOfStockOptionActivityDetails" xlink:title="00000043 - Disclosure - SCHEDULE OF STOCK OPTION ACTIVITY (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsIssuedInPeriodWeightedAverageExercisePrice" xlink:label="loc_PPCBShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsIssuedInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_PPCBShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsIssuedInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_WeightedAverageFairValueOfOptionsGrantedDuringPeriod" xlink:label="loc_PPCBWeightedAverageFairValueOfOptionsGrantedDuringPeriod" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_PPCBWeightedAverageFairValueOfOptionsGrantedDuringPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_2" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_2" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_2" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://propanc.com/role/ScheduleOfWarrantActivityDetails" xlink:title="00000044 - Disclosure - SCHEDULE OF WARRANT ACTIVITY (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageOutstanding" xlink:label="loc_PPCBShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageOutstanding" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_PPCBShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsIssued" xlink:label="loc_PPCBShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsIssued" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_PPCBShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsIssued" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceIssued" xlink:label="loc_PPCBShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceIssued" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_PPCBShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceIssued" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceExercised" xlink:label="loc_PPCBShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceExercised" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_PPCBShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceExercised" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceExpired" xlink:label="loc_PPCBShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceExpired" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_PPCBShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceExpired" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceForfeited" xlink:label="loc_PPCBShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceForfeited" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_PPCBShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceForfeited" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_2" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageOutstanding" xlink:label="loc_PPCBShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageOutstanding_2" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_PPCBShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageOutstanding_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber" xlink:label="loc_PPCBShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_PPCBShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisable" xlink:label="loc_PPCBShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisable" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_PPCBShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerms" xlink:label="loc_PPCBShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerms" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_PPCBShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerms" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsAggregateIntrinsicValueOutstanding" xlink:label="loc_PPCBSharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsAggregateIntrinsicValueOutstanding" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_PPCBSharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsAggregateIntrinsicValueOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber" xlink:label="loc_PPCBShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_2" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_PPCBShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisable" xlink:label="loc_PPCBShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisable_2" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_PPCBShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisable_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsAggregateIntrinsicValueOutstanding" xlink:label="loc_PPCBSharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsAggregateIntrinsicValueOutstanding_2" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_PPCBSharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsAggregateIntrinsicValueOutstanding_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://propanc.com/role/StockholdersDeficitDetailsNarrative" xlink:title="00000045 - Disclosure - STOCKHOLDERS&#8217; DEFICIT (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="loc_us-gaapScheduleOfStockByClassTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapScheduleOfStockByClassTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="loc_us-gaapClassOfStockLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapClassOfStockLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="loc_us-gaapSeriesAPreferredStockMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesAPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_SeriesBWarrantsMember" xlink:label="loc_PPCBSeriesBWarrantsMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_PPCBSeriesBWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_SeriesCWarrantsMember" xlink:label="loc_PPCBSeriesCWarrantsMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_PPCBSeriesCWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_SeriesAWarrantsMember" xlink:label="loc_PPCBSeriesAWarrantsMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_PPCBSeriesAWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_PrefundedWarrantsMember" xlink:label="loc_PPCBPrefundedWarrantsMember" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_PPCBPrefundedWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_TwentySeriesAAndOneSeriesCWarrantsMember" xlink:label="loc_PPCBTwentySeriesAAndOneSeriesCWarrantsMember" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_PPCBTwentySeriesAAndOneSeriesCWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_SeriesBWarrantMember" xlink:label="loc_PPCBSeriesBWarrantMember" />
      <link:presentationArc order="1120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_PPCBSeriesBWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_SecurityPurchaseAgreementMember" xlink:label="loc_PPCBSecurityPurchaseAgreementMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_PPCBSecurityPurchaseAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_UnderlyingFinancingAgreementsMember" xlink:label="loc_PPCBUnderlyingFinancingAgreementsMember" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_PPCBUnderlyingFinancingAgreementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_ConsultingAgreementMember" xlink:label="loc_PPCBConsultingAgreementMember" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_PPCBConsultingAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_EngagementAgreementMember" xlink:label="loc_PPCBEngagementAgreementMember" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_PPCBEngagementAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_EmploymentAgreementsMember" xlink:label="loc_PPCBEmploymentAgreementsMember" />
      <link:presentationArc order="600" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_PPCBEmploymentAgreementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_SecuritiesPurchaseAgreementMember" xlink:label="loc_PPCBSecuritiesPurchaseAgreementMember" />
      <link:presentationArc order="690" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_PPCBSecuritiesPurchaseAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_NathanielszCancellationAgreementMember" xlink:label="loc_PPCBNathanielszCancellationAgreementMember" />
      <link:presentationArc order="970" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_PPCBNathanielszCancellationAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_CancellationAgreementMember" xlink:label="loc_PPCBCancellationAgreementMember" />
      <link:presentationArc order="1020" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_PPCBCancellationAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_ZelingerAmendedAndRestatedDirectorAgreementMember" xlink:label="loc_PPCBZelingerAmendedAndRestatedDirectorAgreementMember" />
      <link:presentationArc order="1060" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_PPCBZelingerAmendedAndRestatedDirectorAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_PrefundedWarrantsMember" xlink:label="loc_PPCBPrefundedWarrantsMember_2" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_PPCBPrefundedWarrantsMember_2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_FirstWarrantMember" xlink:label="loc_PPCBFirstWarrantMember" />
      <link:presentationArc order="630" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_PPCBFirstWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_SecondWarrantMember" xlink:label="loc_PPCBSecondWarrantMember" />
      <link:presentationArc order="640" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_PPCBSecondWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_ThirdWarrantMember" xlink:label="loc_PPCBThirdWarrantMember" />
      <link:presentationArc order="650" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_PPCBThirdWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember" />
      <link:presentationArc order="680" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_CommonStockOneMember" xlink:label="loc_PPCBCommonStockOneMember" />
      <link:presentationArc order="880" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_PPCBCommonStockOneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapAwardTypeAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="loc_us-gaapRestrictedStockMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapRestrictedStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaapRestrictedStockUnitsRSUMember" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapRestrictedStockUnitsRSUMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_srtRangeAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_srtTitleOfIndividualAxis" order="60" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_ConsultantMember" xlink:label="loc_PPCBConsultantMember" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_PPCBConsultantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ChiefExecutiveOfficerMember" xlink:label="loc_srtChiefExecutiveOfficerMember" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_srtChiefExecutiveOfficerMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestorMember" xlink:label="loc_us-gaapInvestorMember" />
      <link:presentationArc order="730" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_us-gaapInvestorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_HolderMember" xlink:label="loc_PPCBHolderMember" />
      <link:presentationArc order="760" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_PPCBHolderMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_ChiefScientificOfficerandDirectorMember" xlink:label="loc_PPCBChiefScientificOfficerandDirectorMember" />
      <link:presentationArc order="1030" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_PPCBChiefScientificOfficerandDirectorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapPlanNameAxis" order="70" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_TwoThousandNinteenEquityIncentivePlanMember" xlink:label="loc_PPCBTwoThousandNinteenEquityIncentivePlanMember" />
      <link:presentationArc order="590" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_PPCBTwoThousandNinteenEquityIncentivePlanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srtProductOrServiceAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_srtProductOrServiceAxis" order="80" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_LegalServicesMember" xlink:label="loc_PPCBLegalServicesMember" />
      <link:presentationArc order="910" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_PPCBLegalServicesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_ConsultantServicesMember" xlink:label="loc_PPCBConsultantServicesMember" />
      <link:presentationArc order="940" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_PPCBConsultantServicesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="90" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_MrNathanielszMember" xlink:label="loc_PPCBMrNathanielszMember" />
      <link:presentationArc order="980" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_PPCBMrNathanielszMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_JosefZelingerMember" xlink:label="loc_PPCBJosefZelingerMember" />
      <link:presentationArc order="1060" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_PPCBJosefZelingerMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis" xlink:label="loc_us-gaapDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredBonusAndProfitSharingArrangementIndividualContractTypeOfDeferredCompensationDomain" xlink:label="loc_us-gaapDeferredBonusAndProfitSharingArrangementIndividualContractTypeOfDeferredCompensationDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis" xlink:to="loc_us-gaapDeferredBonusAndProfitSharingArrangementIndividualContractTypeOfDeferredCompensationDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_DeferredSalaryMember" xlink:label="loc_PPCBDeferredSalaryMember" />
      <link:presentationArc order="1020" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredBonusAndProfitSharingArrangementIndividualContractTypeOfDeferredCompensationDomain" xlink:to="loc_PPCBDeferredSalaryMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityReverseStockSplit" xlink:label="loc_us-gaapStockholdersEquityReverseStockSplit" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapStockholdersEquityReverseStockSplit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapPreferredStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapPreferredStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_EquityPurchaseAgreementDescription" xlink:label="loc_PPCBEquityPurchaseAgreementDescription" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_PPCBEquityPurchaseAgreementDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaapFairValueAdjustmentOfWarrants" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapFairValueAdjustmentOfWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="loc_us-gaapProceedsFromIssuanceOfWarrants" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="loc_us-gaapPaymentsOfStockIssuanceCosts" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapPaymentsOfStockIssuanceCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardGross" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="loc_us-gaapDebtInstrumentConvertibleConversionPrice1" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapDebtInstrumentConvertibleConversionPrice1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:label="loc_us-gaapDebtConversionConvertedInstrumentAmount1" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapDebtConversionConvertedInstrumentAmount1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_ConversionFees" xlink:label="loc_PPCBConversionFees" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_PPCBConversionFees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_ConversionOptionDerivatives" xlink:label="loc_PPCBConversionOptionDerivatives" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_PPCBConversionOptionDerivatives" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPayableCurrentAndNoncurrent" xlink:label="loc_us-gaapInterestPayableCurrentAndNoncurrent" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapInterestPayableCurrentAndNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_FairMarketValueOfShares" xlink:label="loc_PPCBFairMarketValueOfShares" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_PPCBFairMarketValueOfShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeNet" xlink:label="loc_us-gaapDerivativeFairValueOfDerivativeNet" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapDerivativeFairValueOfDerivativeNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_PremiumsToAdditionalPaidInCapital" xlink:label="loc_PPCBPremiumsToAdditionalPaidInCapital" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_PPCBPremiumsToAdditionalPaidInCapital" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesSubscribedButUnissued" xlink:label="loc_us-gaapCommonStockSharesSubscribedButUnissued" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapCommonStockSharesSubscribedButUnissued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedPremium" xlink:label="loc_us-gaapDebtInstrumentUnamortizedPremium" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapDebtInstrumentUnamortizedPremium" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_DecreaseInEquity" xlink:label="loc_PPCBDecreaseInEquity" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_PPCBDecreaseInEquity" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfessionalFees" xlink:label="loc_us-gaapProfessionalFees" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapProfessionalFees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="loc_us-gaapProceedsFromWarrantExercises" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapProceedsFromWarrantExercises" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_DeemedDividend" xlink:label="loc_PPCBDeemedDividend" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_PPCBDeemedDividend" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantDateFairvalue" xlink:label="loc_PPCBShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantDateFairvalue" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_PPCBShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantDateFairvalue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_UnrecognizedRestrictedStockUnitsExpense" xlink:label="loc_PPCBUnrecognizedRestrictedStockUnitsExpense" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_PPCBUnrecognizedRestrictedStockUnitsExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockOptionPlanExpense" xlink:label="loc_us-gaapStockOptionPlanExpense" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapStockOptionPlanExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_UnvestedStockOptionsExpense" xlink:label="loc_PPCBUnvestedStockOptionsExpense" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_PPCBUnvestedStockOptionsExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantsAndRightsOutstandingMaturityDate" xlink:label="loc_us-gaapWarrantsAndRightsOutstandingMaturityDate" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstandingMaturityDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="loc_us-gaapWarrantsAndRightsOutstandingTerm" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstandingTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:label="loc_us-gaapDebtInstrumentConvertibleThresholdTradingDays" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapDebtInstrumentConvertibleThresholdTradingDays" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesEmployeeBenefitPlan" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesEmployeeBenefitPlan" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueEmployeeBenefitPlan" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueEmployeeBenefitPlan" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_PercentageOfBonusOfAnnualBaseSalary" xlink:label="loc_PPCBPercentageOfBonusOfAnnualBaseSalary" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_PPCBPercentageOfBonusOfAnnualBaseSalary" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OfficersCompensation" xlink:label="loc_us-gaapOfficersCompensation" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapOfficersCompensation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:label="loc_us-gaapDebtConversionConvertedInstrumentSharesIssued1" />
      <link:presentationArc order="580" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapDebtConversionConvertedInstrumentSharesIssued1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice" />
      <link:presentationArc order="590" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapSharePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedSalariesCurrent" xlink:label="loc_us-gaapAccruedSalariesCurrent" />
      <link:presentationArc order="600" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapAccruedSalariesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_DescriptionOfEmploymentBenefits" xlink:label="loc_PPCBDescriptionOfEmploymentBenefits" />
      <link:presentationArc order="610" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_PPCBDescriptionOfEmploymentBenefits" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_CommonStockIssuableShares" xlink:label="loc_PPCBCommonStockIssuableShares" />
      <link:presentationArc order="620" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_PPCBCommonStockIssuableShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" />
      <link:presentationArc order="630" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteSubscriptionsReceivable" xlink:label="loc_us-gaapStockholdersEquityNoteSubscriptionsReceivable" />
      <link:presentationArc order="640" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapStockholdersEquityNoteSubscriptionsReceivable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesOther" />
      <link:presentationArc order="650" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesOther" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://propanc.com/role/ScheduleOfRightUseOfAssetDetails" xlink:title="00000046 - Disclosure - SCHEDULE OF RIGHT USE OF ASSET (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_OperatingLeaseRightOfUseAssets" xlink:label="loc_PPCBOperatingLeaseRightOfUseAssets" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_PPCBOperatingLeaseRightOfUseAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_AccumulatedReduction" xlink:label="loc_PPCBAccumulatedReduction" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_PPCBAccumulatedReduction" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://propanc.com/role/ScheduleOfOperatingLeaseLiabilityDetails" xlink:title="00000047 - Disclosure - SCHEDULE OF OPERATING LEASE LIABILITY (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_OfficeLeaseLiability" xlink:label="loc_PPCBOfficeLeaseLiability" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_PPCBOfficeLeaseLiability" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_ReductionOfLeaseLiability" xlink:label="loc_PPCBReductionOfLeaseLiability" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_PPCBReductionOfLeaseLiability" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaapOperatingLeaseLiability" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapOperatingLeaseLiability" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://propanc.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="00000048 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtTitleOfIndividualAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_FoleyShechterMember" xlink:label="loc_PPCBFoleyShechterMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_PPCBFoleyShechterMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_SettlementAgreementMember" xlink:label="loc_PPCBSettlementAgreementMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_PPCBSettlementAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_SettlementAndMutualReleaseAgreementMember" xlink:label="loc_PPCBSettlementAndMutualReleaseAgreementMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_PPCBSettlementAndMutualReleaseAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RoyaltyAgreementTermsMember" xlink:label="loc_us-gaapRoyaltyAgreementTermsMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_us-gaapRoyaltyAgreementTermsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LicenseAgreementTermsMember" xlink:label="loc_us-gaapLicenseAgreementTermsMember" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_us-gaapLicenseAgreementTermsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_NewFiveYearOperatingLeaseAgreementMember" xlink:label="loc_PPCBNewFiveYearOperatingLeaseAgreementMember" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_PPCBNewFiveYearOperatingLeaseAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_OneYearCollaborationAgreementMember" xlink:label="loc_PPCBOneYearCollaborationAgreementMember" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_PPCBOneYearCollaborationAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_TwoYearCollaborationAgreementMember" xlink:label="loc_PPCBTwoYearCollaborationAgreementMember" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_PPCBTwoYearCollaborationAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_RegalConsultingLLCMember" xlink:label="loc_PPCBRegalConsultingLLCMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_PPCBRegalConsultingLLCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_UniversityOfJaenMember" xlink:label="loc_PPCBUniversityOfJaenMember" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_PPCBUniversityOfJaenMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapDebtInstrumentAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_TwoThousandAndSeventeenNoteMember" xlink:label="loc_PPCBTwoThousandAndSeventeenNoteMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_PPCBTwoThousandAndSeventeenNoteMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardDateAxis" xlink:label="loc_us-gaapAwardDateAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardDateAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardDateDomain" xlink:label="loc_us-gaapAwardDateDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardDateAxis" xlink:to="loc_us-gaapAwardDateDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_From2012ThroughThe2014Member" xlink:label="loc_PPCBFrom2012ThroughThe2014Member" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardDateDomain" xlink:to="loc_PPCBFrom2012ThroughThe2014Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_InstallmentOneMember" xlink:label="loc_PPCBInstallmentOneMember" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardDateDomain" xlink:to="loc_PPCBInstallmentOneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_InstallmentTwoMember" xlink:label="loc_PPCBInstallmentTwoMember" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardDateDomain" xlink:to="loc_PPCBInstallmentTwoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_InstallmentThreeMember" xlink:label="loc_PPCBInstallmentThreeMember" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardDateDomain" xlink:to="loc_PPCBInstallmentThreeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_InstallmentFourMember" xlink:label="loc_PPCBInstallmentFourMember" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardDateDomain" xlink:to="loc_PPCBInstallmentFourMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardTypeAxis" order="60" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_AUDCurrencyMember" xlink:label="loc_PPCBAUDCurrencyMember" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_PPCBAUDCurrencyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_EurosMember" xlink:label="loc_PPCBEurosMember" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_PPCBEurosMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="loc_us-gaapAdjustmentsForNewAccountingPronouncementsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAdjustmentsForNewAccountingPronouncementsAxis" order="70" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="loc_us-gaapTypeOfAdoptionMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsForNewAccountingPronouncementsAxis" xlink:to="loc_us-gaapTypeOfAdoptionMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate201602Member" xlink:label="loc_us-gaapAccountingStandardsUpdate201602Member" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfAdoptionMember" xlink:to="loc_us-gaapAccountingStandardsUpdate201602Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaapConcentrationRiskByBenchmarkAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapConcentrationRiskByBenchmarkAxis" order="80" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesRevenueNetMember" xlink:label="loc_us-gaapSalesRevenueNetMember" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapSalesRevenueNetMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaapConcentrationRiskByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapConcentrationRiskByTypeAxis" order="90" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromRightsConcentrationRiskMember" xlink:label="loc_us-gaapRevenueFromRightsConcentrationRiskMember" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_us-gaapRevenueFromRightsConcentrationRiskMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis" xlink:label="loc_srtMajorCustomersAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtMajorCustomersAxis" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srtNameOfMajorCustomerDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtMajorCustomersAxis" xlink:to="loc_srtNameOfMajorCustomerDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_NoCustomerMember" xlink:label="loc_PPCBNoCustomerMember" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_PPCBNoCustomerMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LegalFees" xlink:label="loc_us-gaapLegalFees" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLegalFees" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfessionalFees" xlink:label="loc_us-gaapProfessionalFees" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProfessionalFees" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_SettlementAmount" xlink:label="loc_PPCBSettlementAmount" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_PPCBSettlementAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_GainLossFromSettlementOfDebt" xlink:label="loc_PPCBGainLossFromSettlementOfDebt" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_PPCBGainLossFromSettlementOfDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyDamagesSoughtValue" xlink:label="loc_us-gaapLossContingencyDamagesSoughtValue" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLossContingencyDamagesSoughtValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebt" xlink:label="loc_us-gaapConvertibleDebt" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapConvertibleDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_LitigationPenaltyAmount" xlink:label="loc_PPCBLitigationPenaltyAmount" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_PPCBLitigationPenaltyAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_RemainingPrincipalAmount" xlink:label="loc_PPCBRemainingPrincipalAmount" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_PPCBRemainingPrincipalAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPayableCurrentAndNoncurrent" xlink:label="loc_us-gaapInterestPayableCurrentAndNoncurrent" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInterestPayableCurrentAndNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrentAndNoncurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrentAndNoncurrent" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAccruedLiabilitiesCurrentAndNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_OperatingLeasesIncomeStatementRevenuePercentage" xlink:label="loc_PPCBOperatingLeasesIncomeStatementRevenuePercentage" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_PPCBOperatingLeasesIncomeStatementRevenuePercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="loc_us-gaapLesseeOperatingLeaseTermOfContract" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseTermOfContract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRent" xlink:label="loc_us-gaapPaymentsForRent" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPaymentsForRent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseDescription" xlink:label="loc_us-gaapLesseeOperatingLeaseDescription" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaapOperatingLeaseLiability" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingLeaseLiability" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="loc_us-gaapOperatingLeaseWeightedAverageDiscountRatePercent" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_PaymentForServices" xlink:label="loc_PPCBPaymentForServices" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_PPCBPaymentForServices" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaapConcentrationRiskPercentage1" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapConcentrationRiskPercentage1" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://propanc.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:title="00000049 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="loc_us-gaapRelatedPartyTransactionLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapRelatedPartyTransactionLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_CurrentAndFormerDirectorMember" xlink:label="loc_PPCBCurrentAndFormerDirectorMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_PPCBCurrentAndFormerDirectorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_FormerDirectorMember" xlink:label="loc_PPCBFormerDirectorMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_PPCBFormerDirectorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_NathanielszMember" xlink:label="loc_PPCBNathanielszMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_PPCBNathanielszMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_MrsNathanielszMember" xlink:label="loc_PPCBMrsNathanielszMember" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_PPCBMrsNathanielszMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_JamesNathanielszMember" xlink:label="loc_PPCBJamesNathanielszMember" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_PPCBJamesNathanielszMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_MrNathanielszMember" xlink:label="loc_PPCBMrNathanielszMember" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_PPCBMrNathanielszMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_DrKenyonMember" xlink:label="loc_PPCBDrKenyonMember" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_PPCBDrKenyonMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_DrKenyonMemberMember" xlink:label="loc_PPCBDrKenyonMemberMember" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_PPCBDrKenyonMemberMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_deiLegalEntityAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_NorthHorizonPtyLtdMember" xlink:label="loc_PPCBNorthHorizonPtyLtdMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_PPCBNorthHorizonPtyLtdMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapAwardTypeAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_AUDCurrencyMember" xlink:label="loc_PPCBAUDCurrencyMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_PPCBAUDCurrencyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_AUDCurrenryMember" xlink:label="loc_PPCBAUDCurrenryMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_PPCBAUDCurrenryMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_RestrictedStocksUnitsRSUMember" xlink:label="loc_PPCBRestrictedStocksUnitsRSUMember" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_PPCBRestrictedStocksUnitsRSUMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_AdditionaNathanielszRSUsMember" xlink:label="loc_PPCBAdditionaNathanielszRSUsMember" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_PPCBAdditionaNathanielszRSUsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_InitialKenyonRSUsMember" xlink:label="loc_PPCBInitialKenyonRSUsMember" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_PPCBInitialKenyonRSUsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_AdditionalKenyonRSUsMember" xlink:label="loc_PPCBAdditionalKenyonRSUsMember" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_PPCBAdditionalKenyonRSUsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="loc_us-gaapAdjustmentsForNewAccountingPronouncementsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapAdjustmentsForNewAccountingPronouncementsAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="loc_us-gaapTypeOfAdoptionMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsForNewAccountingPronouncementsAxis" xlink:to="loc_us-gaapTypeOfAdoptionMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate201602Member" xlink:label="loc_us-gaapAccountingStandardsUpdate201602Member" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfAdoptionMember" xlink:to="loc_us-gaapAccountingStandardsUpdate201602Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_NathanielszEmploymentAgreementMember" xlink:label="loc_PPCBNathanielszEmploymentAgreementMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_PPCBNathanielszEmploymentAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_MrsNathanielszMember" xlink:label="loc_PPCBMrsNathanielszMember_2" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_PPCBMrsNathanielszMember_2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_EmploymentAgreementMember" xlink:label="loc_PPCBEmploymentAgreementMember" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_PPCBEmploymentAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_ServicesAgreementMember" xlink:label="loc_PPCBServicesAgreementMember" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_PPCBServicesAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_srtRangeAxis" order="60" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_srtTitleOfIndividualAxis" order="70" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_BoardOfDirectorsMember" xlink:label="loc_PPCBBoardOfDirectorsMember" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_PPCBBoardOfDirectorsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ChiefExecutiveOfficerMember" xlink:label="loc_srtChiefExecutiveOfficerMember" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_srtChiefExecutiveOfficerMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" order="80" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_LoansFromRelatedParty" xlink:label="loc_PPCBLoansFromRelatedParty" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_PPCBLoansFromRelatedParty" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueToRelatedPartiesCurrent" xlink:label="loc_us-gaapDueToRelatedPartiesCurrent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapDueToRelatedPartiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LessorOperatingLeaseTermOfContract" xlink:label="loc_us-gaapLessorOperatingLeaseTermOfContract" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapLessorOperatingLeaseTermOfContract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesRentExpenseMinimumRentals" xlink:label="loc_us-gaapOperatingLeasesRentExpenseMinimumRentals" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapOperatingLeasesRentExpenseMinimumRentals" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_GoodsAndServiceTax" xlink:label="loc_PPCBGoodsAndServiceTax" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_PPCBGoodsAndServiceTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDue" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRent" xlink:label="loc_us-gaapPaymentsForRent" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapPaymentsForRent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseDescription" xlink:label="loc_us-gaapLesseeOperatingLeaseDescription" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseDescription" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionDate" xlink:label="loc_us-gaapRelatedPartyTransactionDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapRelatedPartyTransactionDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalariesAndWages" xlink:label="loc_us-gaapSalariesAndWages" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapSalariesAndWages" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_PercentageOfPensionOfMonthlySalary" xlink:label="loc_PPCBPercentageOfPensionOfMonthlySalary" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_PPCBPercentageOfPensionOfMonthlySalary" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_PercentageOfBonusOfAnnualBaseSalary" xlink:label="loc_PPCBPercentageOfBonusOfAnnualBaseSalary" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_PPCBPercentageOfBonusOfAnnualBaseSalary" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfRelatedPartyDebt" xlink:label="loc_us-gaapRepaymentsOfRelatedPartyDebt" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapRepaymentsOfRelatedPartyDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OfficersCompensation" xlink:label="loc_us-gaapOfficersCompensation" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapOfficersCompensation" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_BonusPayableAmount" xlink:label="loc_PPCBBonusPayableAmount" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_PPCBBonusPayableAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_RemainingBonusAmount" xlink:label="loc_PPCBRemainingBonusAmount" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_PPCBRemainingBonusAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_BonusAwardsGrantedPercentage" xlink:label="loc_PPCBBonusAwardsGrantedPercentage" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_PPCBBonusAwardsGrantedPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_BonusPayable" xlink:label="loc_PPCBBonusPayable" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_PPCBBonusPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:label="loc_us-gaapDebtConversionConvertedInstrumentSharesIssued1" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapDebtConversionConvertedInstrumentSharesIssued1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_AgreementlTerm" xlink:label="loc_PPCBAgreementlTerm" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_PPCBAgreementlTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_AgreementRenewalTerm" xlink:label="loc_PPCBAgreementRenewalTerm" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_PPCBAgreementRenewalTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardGross" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_StockToBeIssuedDuringPeriodValueRestrictedStockUnit" xlink:label="loc_PPCBStockToBeIssuedDuringPeriodValueRestrictedStockUnit" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_PPCBStockToBeIssuedDuringPeriodValueRestrictedStockUnit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_OptionsVestedDescription" xlink:label="loc_PPCBOptionsVestedDescription" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_PPCBOptionsVestedDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_GrossProceedsFromEquityFinancing" xlink:label="loc_PPCBGrossProceedsFromEquityFinancing" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_PPCBGrossProceedsFromEquityFinancing" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedSalariesCurrent" xlink:label="loc_us-gaapAccruedSalariesCurrent" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapAccruedSalariesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_CancellationOfAccruedSalaries" xlink:label="loc_PPCBCancellationOfAccruedSalaries" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_PPCBCancellationOfAccruedSalaries" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_OperatingLeasesRentExpenseMinimumRentalsPayable" xlink:label="loc_PPCBOperatingLeasesRentExpenseMinimumRentalsPayable" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_PPCBOperatingLeasesRentExpenseMinimumRentalsPayable" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://propanc.com/role/ConcentrationsAndRisksDetailsNarrative" xlink:title="00000050 - Disclosure - CONCENTRATIONS AND RISKS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RisksAndUncertaintiesAbstract" xlink:label="loc_us-gaapRisksAndUncertaintiesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:label="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRisksAndUncertaintiesAbstract" xlink:to="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:label="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_LenderOneMember" xlink:label="loc_PPCBLenderOneMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_PPCBLenderOneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_LenderTwoMember" xlink:label="loc_PPCBLenderTwoMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_PPCBLenderTwoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_LenderThreeMember" xlink:label="loc_PPCBLenderThreeMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_PPCBLenderThreeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="loc_us-gaapProceedsFromConvertibleDebt" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapProceedsFromConvertibleDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:label="loc_us-gaapAmortizationOfFinancingCostsAndDiscounts" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapAmortizationOfFinancingCostsAndDiscounts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_ReimbursementOnGoodsAndServiceTaxReceivablePercentage" xlink:label="loc_PPCBReimbursementOnGoodsAndServiceTaxReceivablePercentage" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_PPCBReimbursementOnGoodsAndServiceTaxReceivablePercentage" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://propanc.com/role/ScheduleOfFairValueMeasurementsRecurringAndNonrecurringValuationTechniquesDetails" xlink:title="00000051 - Disclosure - SCHEDULE OF FAIR VALUE MEASUREMENTS, RECURRING AND NONRECURRING, VALUATION TECHNIQUES (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="loc_us-gaapDerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable" xlink:label="loc_us-gaapDerivativeTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="loc_us-gaapDerivativeTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems" xlink:label="loc_us-gaapDerivativeLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeTable" xlink:to="loc_us-gaapDerivativeLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaapMeasurementInputTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeTable" xlink:to="loc_us-gaapMeasurementInputTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="loc_us-gaapMeasurementInputPriceVolatilityMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputPriceVolatilityMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputExpectedTermMember" xlink:label="loc_us-gaapMeasurementInputExpectedTermMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputExpectedTermMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="loc_us-gaapMeasurementInputRiskFreeInterestRateMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputRiskFreeInterestRateMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputExpectedDividendRateMember" xlink:label="loc_us-gaapMeasurementInputExpectedDividendRateMember" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputExpectedDividendRateMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeTable" xlink:to="loc_srtRangeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="loc_us-gaapShortTermDebtTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeTable" xlink:to="loc_us-gaapShortTermDebtTypeAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="loc_us-gaapShortTermDebtTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtTypeAxis" xlink:to="loc_us-gaapShortTermDebtTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtMember" xlink:label="loc_us-gaapConvertibleDebtMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtTypeDomain" xlink:to="loc_us-gaapConvertibleDebtMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentMeasurementInput" xlink:label="loc_us-gaapDebtInstrumentMeasurementInput" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeLineItems" xlink:to="loc_us-gaapDebtInstrumentMeasurementInput" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTerm" xlink:label="loc_us-gaapDebtInstrumentTerm" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeLineItems" xlink:to="loc_us-gaapDebtInstrumentTerm" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://propanc.com/role/ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" xlink:title="00000052 - Disclosure - SCHEDULE OF FAIR VALUE, ASSETS AND LIABILITIES MEASURED ON RECURRING BASIS (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="loc_us-gaapDerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:label="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:label="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaapFairValueInputsLevel1Member" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel1Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaapFairValueInputsLevel2Member" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel2Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaapFairValueInputsLevel3Member" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel3Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" xlink:label="loc_us-gaapEmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapEmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilities" xlink:label="loc_us-gaapDerivativeLiabilities" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapDerivativeLiabilities" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://propanc.com/role/ScheduleOfDerivativeLiabilitiesAtFairValueDetails" xlink:title="00000053 - Disclosure - SCHEDULE OF DERIVATIVE LIABILITIES AT FAIR VALUE (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="loc_us-gaapDerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilities" xlink:label="loc_us-gaapDerivativeLiabilities" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="loc_us-gaapDerivativeLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_ReductionsDueToConversions" xlink:label="loc_PPCBReductionsDueToConversions" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="loc_PPCBReductionsDueToConversions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_FairValueOfWarrantDerivativeLiabilityRecorededAsDebtDiscount" xlink:label="loc_PPCBFairValueOfWarrantDerivativeLiabilityRecorededAsDebtDiscount" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="loc_PPCBFairValueOfWarrantDerivativeLiabilityRecorededAsDebtDiscount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_InitialFairValueOfEmbeddedConversionOptionDerivativeLiabilityRecordedAsExpense" xlink:label="loc_PPCBInitialFairValueOfEmbeddedConversionOptionDerivativeLiabilityRecordedAsExpense" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="loc_PPCBInitialFairValueOfEmbeddedConversionOptionDerivativeLiabilityRecordedAsExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet" xlink:label="loc_us-gaapEmbeddedDerivativeGainLossOnEmbeddedDerivativeNet" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="loc_us-gaapEmbeddedDerivativeGainLossOnEmbeddedDerivativeNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_GainOnDebtExtinguishment" xlink:label="loc_PPCBGainOnDebtExtinguishment" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="loc_PPCBGainOnDebtExtinguishment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilities" xlink:label="loc_us-gaapDerivativeLiabilities_2" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="loc_us-gaapDerivativeLiabilities_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://propanc.com/role/DerivativeFinancialInstrumentsAndFairValueMeasurementsDetailsNarrative" xlink:title="00000054 - Disclosure - DERIVATIVE FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="loc_us-gaapDerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:label="loc_us-gaapDerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="loc_us-gaapDerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:label="loc_us-gaapDerivativeInstrumentsGainLossLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:to="loc_us-gaapDerivativeInstrumentsGainLossLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaapDerivativeInstrumentRiskAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:to="loc_us-gaapDerivativeInstrumentRiskAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaapDerivativeContractTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:to="loc_us-gaapDerivativeContractTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtMember" xlink:label="loc_us-gaapConvertibleDebtMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_us-gaapConvertibleDebtMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebt" xlink:label="loc_us-gaapConvertibleDebt" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeInstrumentsGainLossLineItems" xlink:to="loc_us-gaapConvertibleDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeInstrumentsGainLossLineItems" xlink:to="loc_us-gaapSharePrice" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://propanc.com/role/SubsequentEventsDetailsNarrative" xlink:title="00000055 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTable" xlink:label="loc_us-gaapSubsequentEventTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapSubsequentEventTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventLineItems" xlink:label="loc_us-gaapSubsequentEventLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapSubsequentEventLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_SeriesBWarrantsMember" xlink:label="loc_PPCBSeriesBWarrantsMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_PPCBSeriesBWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_TwelveSeriesAAndAWarrantsMember" xlink:label="loc_PPCBTwelveSeriesAAndAWarrantsMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_PPCBTwelveSeriesAAndAWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_CommonStockOneMember" xlink:label="loc_PPCBCommonStockOneMember" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_PPCBCommonStockOneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_CommonStockTwoMember" xlink:label="loc_PPCBCommonStockTwoMember" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_PPCBCommonStockTwoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_CommonStockThreeMember" xlink:label="loc_PPCBCommonStockThreeMember" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_PPCBCommonStockThreeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_ElevenSeriesAWarrantsMember" xlink:label="loc_PPCBElevenSeriesAWarrantsMember" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_PPCBElevenSeriesAWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_srtRangeAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_NathanielszCancellationAgreementMember" xlink:label="loc_PPCBNathanielszCancellationAgreementMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_PPCBNathanielszCancellationAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_KenyonCancellationAgreementMember" xlink:label="loc_PPCBKenyonCancellationAgreementMember" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_PPCBKenyonCancellationAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_ZelingerAmendedAndRestatedDirectorAgreementMember" xlink:label="loc_PPCBZelingerAmendedAndRestatedDirectorAgreementMember" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_PPCBZelingerAmendedAndRestatedDirectorAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_TwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember" xlink:label="loc_PPCBTwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_PPCBTwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_OctoberTwentyOneTwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember" xlink:label="loc_PPCBOctoberTwentyOneTwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_PPCBOctoberTwentyOneTwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="60" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_MrNathanielszMember" xlink:label="loc_PPCBMrNathanielszMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_PPCBMrNathanielszMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_DrKenyonMember" xlink:label="loc_PPCBDrKenyonMember" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_PPCBDrKenyonMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_JosefZelingerMember" xlink:label="loc_PPCBJosefZelingerMember" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_PPCBJosefZelingerMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="loc_us-gaapProceedsFromWarrantExercises" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapProceedsFromWarrantExercises" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:label="loc_us-gaapDebtConversionConvertedInstrumentSharesIssued1" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapDebtConversionConvertedInstrumentSharesIssued1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="loc_us-gaapDebtInstrumentConvertibleConversionPrice1" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapDebtInstrumentConvertibleConversionPrice1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPayableCurrent" xlink:label="loc_us-gaapInterestPayableCurrent" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapInterestPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_ConversionFees" xlink:label="loc_PPCBConversionFees" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_PPCBConversionFees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_PercentageOfBonusOfAnnualBaseSalary" xlink:label="loc_PPCBPercentageOfBonusOfAnnualBaseSalary" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_PPCBPercentageOfBonusOfAnnualBaseSalary" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OfficersCompensation" xlink:label="loc_us-gaapOfficersCompensation" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapOfficersCompensation" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapSharePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_CancellationOfAccruedSalaries" xlink:label="loc_PPCBCancellationOfAccruedSalaries" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_PPCBCancellationOfAccruedSalaries" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_DescriptionOfEmploymentBenefits" xlink:label="loc_PPCBDescriptionOfEmploymentBenefits" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_PPCBDescriptionOfEmploymentBenefits" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_CommonStockIssuableShares" xlink:label="loc_PPCBCommonStockIssuableShares" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_PPCBCommonStockIssuableShares" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedBonusesCurrent" xlink:label="loc_us-gaapAccruedBonusesCurrent" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapAccruedBonusesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LegalFees" xlink:label="loc_us-gaapLegalFees" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapLegalFees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:label="loc_us-gaapDebtInstrumentUnamortizedDiscount" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapDebtInstrumentUnamortizedDiscount" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_us-gaapDebtInstrumentMaturityDate" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapDebtInstrumentMaturityDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:label="loc_us-gaapDebtInstrumentInterestRateDuringPeriod" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateDuringPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentDescription" xlink:label="loc_us-gaapDebtInstrumentDescription" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapDebtInstrumentDescription" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_DebtCoversionPercentage" xlink:label="loc_PPCBDebtCoversionPercentage" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_PPCBDebtCoversionPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_GainFromSettlementOfDebtNet" xlink:label="loc_PPCBGainFromSettlementOfDebtNet" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_PPCBGainFromSettlementOfDebtNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateTerms" xlink:label="loc_us-gaapDebtInstrumentInterestRateTerms" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateTerms" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_ConsultingAgreementDescription" xlink:label="loc_PPCBConsultingAgreementDescription" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_PPCBConsultingAgreementDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ppcb-20210930.xsd#PPCB_ConsultingAgreementMonthlyPayment" xlink:label="loc_PPCBConsultingAgreementMonthlyPayment" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_PPCBConsultingAgreementMonthlyPayment" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm140460440501880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">POS AM<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentDescription', window );">Amendment Description</a></td>
<td class="text">Post-Effective Amendment Number 1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Propanc
Biopharma, Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001517681<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">33-0662986<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">302<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">6 Butler Street<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Camberwell<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">3124<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">61-03<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">9882-0780<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of changes contained within amended document.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm140460434300376">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>CURRENT ASSETS:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash</a></td>
<td class="nump">$ 45,817<span></span>
</td>
<td class="nump">$ 2,255<span></span>
</td>
<td class="nump">$ 67,007<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">8,353<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValueAddedTaxReceivableCurrent', window );">GST tax receivable</a></td>
<td class="nump">2,238<span></span>
</td>
<td class="nump">4,341<span></span>
</td>
<td class="nump">2,015<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">TOTAL CURRENT ASSETS</a></td>
<td class="nump">56,408<span></span>
</td>
<td class="nump">6,596<span></span>
</td>
<td class="nump">69,022<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepositsAssetsNoncurrent', window );">Security deposit - related party</a></td>
<td class="nump">2,164<span></span>
</td>
<td class="nump">2,250<span></span>
</td>
<td class="nump">2,067<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets, net - related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">21,682<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">3,593<span></span>
</td>
<td class="nump">4,255<span></span>
</td>
<td class="nump">5,747<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">TOTAL ASSETS</a></td>
<td class="nump">62,165<span></span>
</td>
<td class="nump">13,101<span></span>
</td>
<td class="nump">98,518<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>CURRENT LIABILITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">826,184<span></span>
</td>
<td class="nump">1,002,335<span></span>
</td>
<td class="nump">842,156<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent', window );">Accrued expenses and other payables</a></td>
<td class="nump">407,775<span></span>
</td>
<td class="nump">892,151<span></span>
</td>
<td class="nump">702,231<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleDebtCurrent', window );">Convertible notes and related accrued interest, net of discounts and premiums</a></td>
<td class="nump">584,608<span></span>
</td>
<td class="nump">624,583<span></span>
</td>
<td class="nump">1,557,734<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liability - related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">25,072<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationLiabilityCurrent', window );">Embedded conversion option liabilities</a></td>
<td class="nump">58,124<span></span>
</td>
<td class="nump">54,220<span></span>
</td>
<td class="nump">177,009<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueToRelatedPartiesCurrent', window );">Due to former director - related party</a></td>
<td class="nump">32,076<span></span>
</td>
<td class="nump">33,347<span></span>
</td>
<td class="nump">30,639<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_LoanFromFormerDirectorRelatedParty', window );">Loan from former director - related party</a></td>
<td class="nump">53,384<span></span>
</td>
<td class="nump">55,500<span></span>
</td>
<td class="nump">50,993<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Employee benefit liability</a></td>
<td class="nump">406,644<span></span>
</td>
<td class="nump">418,538<span></span>
</td>
<td class="nump">354,109<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">TOTAL CURRENT LIABILITIES</a></td>
<td class="nump">2,368,795<span></span>
</td>
<td class="nump">3,080,674<span></span>
</td>
<td class="nump">3,739,943<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">TOTAL LIABILITIES</a></td>
<td class="nump">2,368,795<span></span>
</td>
<td class="nump">3,080,674<span></span>
</td>
<td class="nump">3,739,943<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and Contingencies (See Note 8)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>STOCKHOLDERS&#8217; DEFICIT:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.001 par value; 1,000,000,000 shares authorized;43,841,644 and 14,055,393 shares issued and outstanding as of September 30, 2021 and June 30, 2021, respectively</a></td>
<td class="nump">43,842<span></span>
</td>
<td class="nump">14,056<span></span>
</td>
<td class="nump">258<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_CommonStockIssuable', window );">Common stock issuable (2,002,549 and 59 shares as of September 30, 2021 and June 30, 2021, respectively)</a></td>
<td class="nump">2,002<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">55,444,574<span></span>
</td>
<td class="nump">54,074,110<span></span>
</td>
<td class="nump">50,913,893<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteSubscriptionsReceivable', window );">Subscription receivable</a></td>
<td class="num">(100,000)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income</a></td>
<td class="nump">1,149,397<span></span>
</td>
<td class="nump">1,085,204<span></span>
</td>
<td class="nump">1,267,671<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(58,804,968)<span></span>
</td>
<td class="num">(58,199,466)<span></span>
</td>
<td class="num">(55,781,770)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury stock (1 share)</a></td>
<td class="num">(46,477)<span></span>
</td>
<td class="num">(46,477)<span></span>
</td>
<td class="num">(46,477)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">TOTAL STOCKHOLDERS&#8217; DEFICIT</a></td>
<td class="num">(2,306,630)<span></span>
</td>
<td class="num">(3,067,573)<span></span>
</td>
<td class="num">(3,641,425)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">TOTAL LIABILITIES AND STOCKHOLDERS&#8217; DEFICIT</a></td>
<td class="nump">62,165<span></span>
</td>
<td class="nump">13,101<span></span>
</td>
<td class="nump">98,518<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember', window );">Series A Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>STOCKHOLDERS&#8217; DEFICIT:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock</a></td>
<td class="nump">5,000<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember', window );">Series B Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>STOCKHOLDERS&#8217; DEFICIT:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_CommonStockIssuable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common stock issuable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_CommonStockIssuable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_LoanFromFormerDirectorRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loan from former director related party.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_LoanFromFormerDirectorRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of the carrying value of long-term convertible debt as of the balance sheet date that is scheduled to be repaid within one year or in the normal operating cycle if longer. Convertible debt is a financial instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable within one year (or the operating cycle, if longer). Represents currently earned compensation under compensation arrangements that is not actually paid until a later date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 710<br> -SubTopic 10<br> -Section 25<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=6409733&amp;loc=d3e19512-108361<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 710<br> -SubTopic 10<br> -Section 30<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6409875&amp;loc=d3e20028-108363<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepositsAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepositsAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueToRelatedPartiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(C))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueToRelatedPartiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteSubscriptionsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Note received instead of cash as contribution to equity. The transaction may be a sale of capital stock or a contribution to paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=65888546&amp;loc=d3e21300-112643<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteSubscriptionsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValueAddedTaxReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of value added taxes due either from customers arising from sales on credit terms, or as previously overpaid to tax authorities. For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValueAddedTaxReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm140460434185752">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="nump">1,500,005<span></span>
</td>
<td class="nump">1,500,005<span></span>
</td>
<td class="nump">1,500,005<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">1,000,000,000<span></span>
</td>
<td class="nump">1,000,000,000<span></span>
</td>
<td class="nump">1,000,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">43,841,644<span></span>
</td>
<td class="nump">14,055,393<span></span>
</td>
<td class="nump">258,120<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="nump">43,841,644<span></span>
</td>
<td class="nump">14,055,393<span></span>
</td>
<td class="nump">258,120<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_CommonStockIssuableShares', window );">Common stock, shares issuable</a></td>
<td class="nump">2,002,549<span></span>
</td>
<td class="nump">59<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury stock, shares</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember', window );">Series A Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="nump">500,000<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="nump">500,000<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="nump">500,000<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember', window );">Series B Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_CommonStockIssuableShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common stock, issuable shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_CommonStockIssuableShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm140460431606312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Operations and Comprehensive Income (Loss) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>REVENUE</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>OPERATING EXPENSES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">Administration expenses</a></td>
<td class="nump">431,740<span></span>
</td>
<td class="nump">323,111<span></span>
</td>
<td class="nump">1,553,075<span></span>
</td>
<td class="nump">3,281,464<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OccupancyNet', window );">Occupancy expenses</a></td>
<td class="nump">7,736<span></span>
</td>
<td class="nump">9,204<span></span>
</td>
<td class="nump">28,112<span></span>
</td>
<td class="nump">32,809<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">46,554<span></span>
</td>
<td class="nump">50,846<span></span>
</td>
<td class="nump">230,956<span></span>
</td>
<td class="nump">179,987<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">TOTAL OPERATING EXPENSES</a></td>
<td class="nump">486,030<span></span>
</td>
<td class="nump">383,161<span></span>
</td>
<td class="nump">1,812,143<span></span>
</td>
<td class="nump">3,494,260<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">LOSS FROM OPERATIONS</a></td>
<td class="num">(486,030)<span></span>
</td>
<td class="num">(383,161)<span></span>
</td>
<td class="num">(1,812,143)<span></span>
</td>
<td class="num">(3,494,260)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>OTHER INCOME (EXPENSE)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(109,853)<span></span>
</td>
<td class="num">(159,281)<span></span>
</td>
<td class="num">(449,457)<span></span>
</td>
<td class="num">(1,748,381)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">946<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Other income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">57,636<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Change in fair value of derivative liabilities</a></td>
<td class="num">(3,904)<span></span>
</td>
<td class="nump">64,952<span></span>
</td>
<td class="num">(8,186)<span></span>
</td>
<td class="nump">385,293<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_GainFromSettlementOfDebtNet', window );">Gain from settlement of debt, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,319<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Gain on extinguishment of debt, net</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">49,985<span></span>
</td>
<td class="nump">50,607<span></span>
</td>
<td class="nump">67,123<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossUnrealized', window );">Foreign currency transaction gain</a></td>
<td class="nump">109,129<span></span>
</td>
<td class="nump">1,960<span></span>
</td>
<td class="nump">30,497<span></span>
</td>
<td class="num">(143,808)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">TOTAL OTHER EXPENSE, NET</a></td>
<td class="num">(4,628)<span></span>
</td>
<td class="num">(42,384)<span></span>
</td>
<td class="num">(327,219)<span></span>
</td>
<td class="num">(1,381,191)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">LOSS BEFORE TAXES</a></td>
<td class="num">(490,658)<span></span>
</td>
<td class="num">(425,545)<span></span>
</td>
<td class="num">(2,139,362)<span></span>
</td>
<td class="num">(4,875,451)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Tax benefit</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">113,415<span></span>
</td>
<td class="nump">134,728<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">NET LOSS</a></td>
<td class="num">(490,658)<span></span>
</td>
<td class="num">(425,545)<span></span>
</td>
<td class="num">(2,025,947)<span></span>
</td>
<td class="num">(4,740,723)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_DeemedDividend', window );">Deemed Dividend</a></td>
<td class="num">(114,844)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(391,749)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">NET LOSS AVAILABLE TO COMMON STOCKHOLDERS</a></td>
<td class="num">$ (605,502)<span></span>
</td>
<td class="num">$ (425,545)<span></span>
</td>
<td class="num">$ (2,417,696)<span></span>
</td>
<td class="num">$ (4,740,723)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">BASIC AND DILUTED NET LOSS PER SHARE</a></td>
<td class="num">$ (0.02)<span></span>
</td>
<td class="num">$ (0.71)<span></span>
</td>
<td class="num">$ (0.80)<span></span>
</td>
<td class="num">$ (192.45)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">BASIC AND DILUTED WEIGHTED AVERAGE SHARES OUTSTANDING</a></td>
<td class="nump">27,142,519<span></span>
</td>
<td class="nump">597,314<span></span>
</td>
<td class="nump">3,032,612<span></span>
</td>
<td class="nump">24,634<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">NET LOSS AVAILABLE TO COMMON STOCKHOLDERS</a></td>
<td class="num">$ (605,502)<span></span>
</td>
<td class="num">$ (425,545)<span></span>
</td>
<td class="num">$ (2,417,696)<span></span>
</td>
<td class="num">$ (4,740,723)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract', window );"><strong>OTHER COMPREHENSIVE INCOME (LOSS)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent', window );">Unrealized foreign currency translation gain (loss)</a></td>
<td class="nump">64,193<span></span>
</td>
<td class="num">(75,755)<span></span>
</td>
<td class="num">(182,467)<span></span>
</td>
<td class="nump">200,673<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">TOTAL OTHER COMPREHENSIVE INCOME (LOSS)</a></td>
<td class="nump">64,193<span></span>
</td>
<td class="num">(75,755)<span></span>
</td>
<td class="num">(182,467)<span></span>
</td>
<td class="nump">200,673<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">TOTAL COMPREHENSIVE LOSS</a></td>
<td class="num">$ (541,309)<span></span>
</td>
<td class="num">$ (501,300)<span></span>
</td>
<td class="num">$ (2,600,163)<span></span>
</td>
<td class="num">$ (4,540,050)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_DeemedDividend">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deemed dividend.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_DeemedDividend</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_GainFromSettlementOfDebtNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gain from settlement of debt, net.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_GainFromSettlementOfDebtNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeGainLossOnDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeGainLossOnDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossUnrealized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of foreign currency transaction unrealized gain (loss) recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124440516&amp;loc=d3e30840-110895<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=125521441&amp;loc=d3e30690-110894<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossUnrealized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1377-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OccupancyNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of net occupancy expense that may include items, such as depreciation of facilities and equipment, lease expenses, property taxes and property and casualty insurance expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.14(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123386454&amp;loc=d3e45280-112737<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.6)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OccupancyNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax, after reclassification adjustments of gain (loss) on foreign currency translation adjustments, on foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue and income classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm140460426833976">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Changes in Stockholders' Deficit - USD ($)<br></strong></div></th>
<th class="th">
<div>Series A Preferred Stock [Member] </div>
<div>Preferred Stock [Member]</div>
</th>
<th class="th">
<div>Series B Preferred Stock [Member] </div>
<div>Preferred Stock [Member]</div>
</th>
<th class="th"><div>Common Stock [Member]</div></th>
<th class="th"><div>Common Stock Issuable [Member]</div></th>
<th class="th"><div>Additional Paid-in Capital [Member]</div></th>
<th class="th"><div>Retained Earnings [Member]</div></th>
<th class="th"><div>AOCI Attributable to Parent [Member]</div></th>
<th class="th"><div>Treasury Stock [Member]</div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Subscription Receivable [Member]</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance, value at Jun. 30, 2019</a></td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 45,714,289<span></span>
</td>
<td class="num">$ (51,041,047)<span></span>
</td>
<td class="nump">$ 1,066,998<span></span>
</td>
<td class="num">$ (46,477)<span></span>
</td>
<td class="num">$ (4,301,236)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance, shares at Jun. 30, 2019</a></td>
<td class="nump">500,000<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">968<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock for cash</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">424,989<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">424,990<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock for cash, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">804<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Issuance of common stock for conversion of convertible debt, conversion fee, and accrued interest</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 248<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">2,124,926<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">2,125,174<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Issuance of common stock for conversion of convertible debt, conversion fee, and accrued interest, shares</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">247,619<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_AdjustmentsToAdditionalPaidInCapitalReclassificationOfPremiumUponDebtConversion', window );">Reclassification of put premium upon debt conversion</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">874,924<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">874,924<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Issuance of common stock for services and accrued expenses</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">113,634<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">113,642<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Issuance of common stock for services and accrued expenses, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,729<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_RelativeFairValueOfWarrantsIssuedWithConvertibleDebt', window );">Relative fair value of warrants issued with convertible debt</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">375,905<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">375,905<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock based compensation in connection with stock option grants</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">300,416<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">300,416<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued', window );">Stock based compensation in connection with fair value of warrants issued for services</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">984,810<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">984,810<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax', window );">Foreign currency translation gain</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">200,673<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,673<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(4,740,723)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(4,740,723)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance, value at Jun. 30, 2020</a></td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 258<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">50,913,893<span></span>
</td>
<td class="num">(55,781,770)<span></span>
</td>
<td class="nump">1,267,671<span></span>
</td>
<td class="num">(46,477)<span></span>
</td>
<td class="num">(3,641,425)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance, shares at Jun. 30, 2020</a></td>
<td class="nump">500,000<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">258,120<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Issuance of common stock for conversion of convertible debt, conversion fee, and accrued interest</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 442<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">480,133<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">480,575<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Issuance of common stock for conversion of convertible debt, conversion fee, and accrued interest, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">442,031<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_StockIssuedDuringPeriodValueExerciseOfWarrants', window );">Issuance of common stock for exercise of warrants</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 15<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">201,029<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">201,044<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_StockIssuedDuringPeriodSharesExerciseOfWarrants', window );">Issuance of common stock for exercise of warrants, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,445<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_AdjustmentsToAdditionalPaidInCapitalReclassificationOfPremiumUponDebtConversion', window );">Reclassification of put premium upon debt conversion</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">204,919<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">204,919<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued', window );">Stock based compensation in connection with fair value of warrants issued for services</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">20,718<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">20,718<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax', window );">Foreign currency translation gain</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(75,755)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(75,755)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(425,545)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(425,545)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance, value at Sep. 30, 2020</a></td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 715<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">51,820,692<span></span>
</td>
<td class="num">(56,207,315)<span></span>
</td>
<td class="nump">1,191,916<span></span>
</td>
<td class="num">(46,477)<span></span>
</td>
<td class="num">(3,235,469)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance, shares at Sep. 30, 2020</a></td>
<td class="nump">500,000<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">715,596<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance, value at Jun. 30, 2020</a></td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 258<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">50,913,893<span></span>
</td>
<td class="num">(55,781,770)<span></span>
</td>
<td class="nump">1,267,671<span></span>
</td>
<td class="num">(46,477)<span></span>
</td>
<td class="num">(3,641,425)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance, shares at Jun. 30, 2020</a></td>
<td class="nump">500,000<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">258,120<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Issuance of common stock for conversion of convertible debt, conversion fee, and accrued interest</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 8,787<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,230,288<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,239,075<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Issuance of common stock for conversion of convertible debt, conversion fee, and accrued interest, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,786,113<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_ReversalOfCommonStockIssuableDueToCancellationOfConversionsOfConvertibleDebtAndAccruedInterest', window );">Reversal of common stock issuable due to cancellation of conversions of convertible debt and accrued interest</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">$ (24)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(19,992)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(20,016)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_ReversalOfCommonStockIssuableDueToCancellationOfConversionsOfConvertibleDebtAndAccruedInterestShares', window );">Reversal of common stock issuable due to cancellation of conversions of convertible debt and accrued interest, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(24,427)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_StockIssuedDuringPeriodValueExerciseOfWarrants', window );">Issuance of common stock for exercise of warrants</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 29<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">776,015<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">776,044<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_StockIssuedDuringPeriodSharesExerciseOfWarrants', window );">Issuance of common stock for exercise of warrants, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,820<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_IssuanceOfCommonStockForCashlessExerciseOfWarrants', window );">Issuance of common stock for cashless exercise of warrants</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 4,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,200)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_IssuanceOfCommonStockForCashlessExerciseOfWarrantsShares', window );">Issuance of common stock for cashless exercise of warrants, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,199,979<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature', window );">Reversal of put premium upon cancellation of conversions of convertible debt</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(11,785)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(11,785)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Vested restricted stock units</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Vested restricted stock units, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">59<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_StockIssuedDuringPeriodValueReverseStockSplits', window );">Fractional difference due to the reverse stock-split</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits', window );">Fractional difference due to the reverse stock-split, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">142<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_DeemedDividendUponAlternateCashlessExerciseOfWarrants', window );">Deemed dividend upon alternate cashless exercise of warrants</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">391,749<span></span>
</td>
<td class="num">(391,749)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_AdjustmentsToAdditionalPaidInCapitalReclassificationOfPremiumUponDebtConversion', window );">Reclassification of put premium upon debt conversion</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">590,504<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">590,504<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Issuance of common stock for services and accrued expenses</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 806<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">124,766<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">125,572<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Issuance of common stock for services and accrued expenses, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">805,646<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock based compensation in connection with stock option grants</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">82,872<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">82,872<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax', window );">Foreign currency translation gain</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(182,467)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(182,467)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(2,025,947)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(2,025,947)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance, value at Jun. 30, 2021</a></td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 14,056<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">54,074,110<span></span>
</td>
<td class="num">(58,199,466)<span></span>
</td>
<td class="nump">1,085,204<span></span>
</td>
<td class="num">(46,477)<span></span>
</td>
<td class="num">$ (3,067,573)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance, shares at Jun. 30, 2021</a></td>
<td class="nump">500,000<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">14,055,393<span></span>
</td>
<td class="nump">59<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock for cash, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,399,988<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Issuance of common stock for conversion of convertible debt, conversion fee, and accrued interest</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 9,445<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">190,741<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 200,186<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Issuance of common stock for conversion of convertible debt, conversion fee, and accrued interest, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,445,009<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_StockIssuedDuringPeriodValueExerciseOfWarrants', window );">Issuance of common stock for exercise of warrants</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 7<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">374,991<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">275,000<span></span>
</td>
<td class="num">(100,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_StockIssuedDuringPeriodSharesExerciseOfWarrants', window );">Issuance of common stock for exercise of warrants, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,875<span></span>
</td>
<td class="nump">2,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_DeemedDividendUponAlternateCashlessExerciseOfWarrants', window );">Deemed dividend upon alternate cashless exercise of warrants</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">114,844<span></span>
</td>
<td class="num">(114,844)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_IssuanceOfCommonStockForAlternateCashlessExerciseOfWarrants', window );">Issuance of common stock for alternate cashless exercise of warrants</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 2,400<span></span>
</td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="num">(4,400)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_IssuanceOfCommonStockForAlternateCashlessExerciseOfWarrantsShares', window );">Issuance of common stock for alternate cashless exercise of warrants, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,399,988<span></span>
</td>
<td class="nump">1,999,990<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_AdjustmentsToAdditionalPaidInCapitalReclassificationOfPremiumUponDebtConversion', window );">Reclassification of put premium upon debt conversion</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">109,643<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">109,643<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Issuance of common stock for services and accrued expenses</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 17,934<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">563,927<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">581,861<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Issuance of common stock for services and accrued expenses, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,934,379<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock based compensation in connection with stock option grants</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">20,718<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">20,718<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax', window );">Foreign currency translation gain</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">64,193<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">64,193<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(490,658)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(490,658)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance, value at Sep. 30, 2021</a></td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 43,842<span></span>
</td>
<td class="nump">$ 2,002<span></span>
</td>
<td class="nump">$ 55,444,574<span></span>
</td>
<td class="num">$ (58,804,968)<span></span>
</td>
<td class="nump">$ 1,149,397<span></span>
</td>
<td class="num">$ (46,477)<span></span>
</td>
<td class="num">$ (2,306,630)<span></span>
</td>
<td class="num">$ (100,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance, shares at Sep. 30, 2021</a></td>
<td class="nump">500,000<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">43,841,644<span></span>
</td>
<td class="nump">2,002,549<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_AdjustmentsToAdditionalPaidInCapitalReclassificationOfPremiumUponDebtConversion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reclassification of premium upon debt conversion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_AdjustmentsToAdditionalPaidInCapitalReclassificationOfPremiumUponDebtConversion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_DeemedDividendUponAlternateCashlessExerciseOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deemed dividend upon alternate cashless exercise of warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_DeemedDividendUponAlternateCashlessExerciseOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_IssuanceOfCommonStockForAlternateCashlessExerciseOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Issuance of common stock for alternate cashless exercise of warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_IssuanceOfCommonStockForAlternateCashlessExerciseOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_IssuanceOfCommonStockForAlternateCashlessExerciseOfWarrantsShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Issuance of common stock for alternate cashless exercise of warrants, shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_IssuanceOfCommonStockForAlternateCashlessExerciseOfWarrantsShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_IssuanceOfCommonStockForCashlessExerciseOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Issuance of common stock for cashless exercise of warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_IssuanceOfCommonStockForCashlessExerciseOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_IssuanceOfCommonStockForCashlessExerciseOfWarrantsShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Issuance Of Common Stock For Cashless Exercise Of Warrants Shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_IssuanceOfCommonStockForCashlessExerciseOfWarrantsShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_RelativeFairValueOfWarrantsIssuedWithConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Relative fair value of warrants issued with convertible debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_RelativeFairValueOfWarrantsIssuedWithConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_ReversalOfCommonStockIssuableDueToCancellationOfConversionsOfConvertibleDebtAndAccruedInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reversal of common stock issuable due to cancellation of conversions of convertible debt and accrued interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_ReversalOfCommonStockIssuableDueToCancellationOfConversionsOfConvertibleDebtAndAccruedInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_ReversalOfCommonStockIssuableDueToCancellationOfConversionsOfConvertibleDebtAndAccruedInterestShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reversal of common stock issuable due to cancellation of conversions of convertible debt and accrued interest, shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_ReversalOfCommonStockIssuableDueToCancellationOfConversionsOfConvertibleDebtAndAccruedInterestShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_StockIssuedDuringPeriodSharesExerciseOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise of warrants, shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_StockIssuedDuringPeriodSharesExerciseOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_StockIssuedDuringPeriodValueExerciseOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise of warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_StockIssuedDuringPeriodValueExerciseOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_StockIssuedDuringPeriodValueReverseStockSplits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fractional difference due to the reverse stock-split.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_StockIssuedDuringPeriodValueReverseStockSplits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in additional paid in capital (APIC) resulting from recognition of deferred taxes for convertible debt with a beneficial conversion feature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 55<br> -Paragraph 51<br> -URI http://asc.fasb.org/extlink&amp;oid=124434304&amp;loc=d3e34017-109320<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123468992&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 25<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123466302&amp;loc=d3e4724-112606<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=125521441&amp;loc=d3e30690-110894<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123602790&amp;loc=d3e30226-110892<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=120253306&amp;loc=d3e28228-110885<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124440516&amp;loc=d3e30840-110895<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reduction in the number of shares during the period as a result of a reverse stock split.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The gross value of stock issued during the period upon the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm140460431352360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>CASH FLOWS FROM OPERATING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="num">$ (490,658)<span></span>
</td>
<td class="num">$ (425,545)<span></span>
</td>
<td class="num">$ (2,025,947)<span></span>
</td>
<td class="num">$ (4,740,723)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to Reconcile Net Loss to Net Cash Used in Operating Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims', window );">Issuance and amortization of common stock for services</a></td>
<td class="nump">133,422<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">125,572<span></span>
</td>
<td class="nump">1,098,452<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossUnrealized', window );">Foreign currency transaction gain</a></td>
<td class="num">(109,129)<span></span>
</td>
<td class="num">(1,960)<span></span>
</td>
<td class="num">(30,497)<span></span>
</td>
<td class="nump">143,808<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="nump">509<span></span>
</td>
<td class="nump">438<span></span>
</td>
<td class="nump">1,993<span></span>
</td>
<td class="nump">2,473<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Amortization of debt discounts</a></td>
<td class="nump">6,074<span></span>
</td>
<td class="nump">121,281<span></span>
</td>
<td class="nump">136,527<span></span>
</td>
<td class="nump">734,130<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Change in fair value of derivative liabilities</a></td>
<td class="nump">3,904<span></span>
</td>
<td class="num">(64,952)<span></span>
</td>
<td class="nump">8,186<span></span>
</td>
<td class="num">(385,293)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Gain on extinguishment of debt, net</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(49,985)<span></span>
</td>
<td class="num">(50,607)<span></span>
</td>
<td class="num">(67,123)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_GainFromSettlementOfDebtNet', window );">Gain from settlement of debt, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(49,319)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock option and restricted stock expense</a></td>
<td class="nump">20,718<span></span>
</td>
<td class="nump">20,718<span></span>
</td>
<td class="nump">82,872<span></span>
</td>
<td class="nump">300,416<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNoncashExpense', window );">Non-cash interest expense</a></td>
<td class="nump">2,250<span></span>
</td>
<td class="nump">6,750<span></span>
</td>
<td class="nump">16,500<span></span>
</td>
<td class="nump">15,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments', window );">Accretion of put premium</a></td>
<td class="nump">90,192<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">200,410<span></span>
</td>
<td class="nump">836,724<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract', window );"><strong>Changes in Assets and Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInReceivables', window );">GST receivable</a></td>
<td class="nump">1,937<span></span>
</td>
<td class="num">(755)<span></span>
</td>
<td class="num">(2,147)<span></span>
</td>
<td class="nump">3,332<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other assets</a></td>
<td class="num">(8,353)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">83,157<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="num">(137,927)<span></span>
</td>
<td class="nump">53,576<span></span>
</td>
<td class="nump">178,311<span></span>
</td>
<td class="num">(59,737)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_IncreaseDecreaseInDeferredRent', window );">Deferred rent</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">633<span></span>
</td>
<td class="num">(3,695)<span></span>
</td>
<td class="nump">3,394<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities', window );">Employee benefit liability</a></td>
<td class="nump">4,067<span></span>
</td>
<td class="nump">10,544<span></span>
</td>
<td class="nump">33,134<span></span>
</td>
<td class="nump">35,724<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities', window );">Accrued expenses and other payables</a></td>
<td class="num">(15,102)<span></span>
</td>
<td class="nump">133,046<span></span>
</td>
<td class="nump">152,861<span></span>
</td>
<td class="num">(9,740)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInterestPayableNet', window );">Accrued interest</a></td>
<td class="nump">11,338<span></span>
</td>
<td class="nump">16,262<span></span>
</td>
<td class="nump">80,582<span></span>
</td>
<td class="nump">156,417<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">NET CASH USED IN OPERATING ACTIVITIES</a></td>
<td class="num">(486,758)<span></span>
</td>
<td class="num">(179,949)<span></span>
</td>
<td class="num">(1,145,264)<span></span>
</td>
<td class="num">(1,849,589)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>CASH FLOWS FROM FINANCING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from convertible promissory notes, net of original issue discounts and issue costs</a></td>
<td class="nump">160,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">325,000<span></span>
</td>
<td class="nump">1,465,250<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfConvertibleDebt', window );">Repayments of convertible promissory notes</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(43,000)<span></span>
</td>
<td class="num">(43,000)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from the sale of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">450,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfInitialPublicOffering', window );">Fees associated with offering costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(25,010)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromWarrantExercises', window );">Proceeds from the exercise of warrants</a></td>
<td class="nump">275,000<span></span>
</td>
<td class="nump">201,044<span></span>
</td>
<td class="nump">776,044<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">NET CASH PROVIDED BY FINANCING ACTIVITIES</a></td>
<td class="nump">435,000<span></span>
</td>
<td class="nump">158,044<span></span>
</td>
<td class="nump">1,058,044<span></span>
</td>
<td class="nump">1,890,240<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Effect of exchange rate changes on cash</a></td>
<td class="nump">95,320<span></span>
</td>
<td class="nump">6,116<span></span>
</td>
<td class="nump">22,468<span></span>
</td>
<td class="nump">23,962<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">NET INCREASE (DECREASE) IN CASH</a></td>
<td class="nump">43,562<span></span>
</td>
<td class="num">(15,789)<span></span>
</td>
<td class="num">(64,752)<span></span>
</td>
<td class="nump">64,613<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">CASH AT BEGINNING OF PERIOD</a></td>
<td class="nump">2,255<span></span>
</td>
<td class="nump">67,007<span></span>
</td>
<td class="nump">67,007<span></span>
</td>
<td class="nump">2,394<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">CASH AT END OF PERIOD</a></td>
<td class="nump">45,817<span></span>
</td>
<td class="nump">51,218<span></span>
</td>
<td class="nump">2,255<span></span>
</td>
<td class="nump">67,007<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental Disclosure of Cash Flow Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">13,172<span></span>
</td>
<td class="nump">13,621<span></span>
</td>
<td class="nump">6,110<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Income Tax</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Supplemental Disclosure of Non-Cash Investing and Financing Activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConversionOfStockAmountConverted1', window );">Reduction of put premium related to conversions of convertible notes</a></td>
<td class="nump">109,643<span></span>
</td>
<td class="nump">204,919<span></span>
</td>
<td class="nump">590,504<span></span>
</td>
<td class="nump">874,924<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConversionOfStockAmountIssued1', window );">Conversion of convertible notes and accrued interest to common stock</a></td>
<td class="nump">197,936<span></span>
</td>
<td class="nump">417,670<span></span>
</td>
<td class="nump">1,142,205<span></span>
</td>
<td class="nump">1,814,336<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_DiscountsRelatedToWarrantsIssuedWithConvertibleNote', window );">Discounts related to warrants issued with convertible notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">375,905<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_DiscountsRelatedToDerivativeLiability', window );">Discounts related to derivative liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">227,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_OperatingLeaseRightofuseAssetsAndOperatingLeaseLiabilitiesRecordedUponAdoptionOfAsc842', window );">Operating lease right-of-use asset and operating lease liability recorded on adoption of ASC 842</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">48,662<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_ReversalOfCommonStockIssuableAndPutPremiumDueToCancellationOfConversionsOfConvertibleDebtAndAccruedInterest', window );">Reversal of common stock issuable and put premium due to cancellation of conversions of convertible debt and accrued interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,801<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_DeemedDividendUponAlternateCashlessExerciseOfWarrants1', window );">Deemed dividend upon alternate cashless exercise of warrants</a></td>
<td class="nump">114,844<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">391,749<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_AccountsPayableReclassToConvertibleNotes', window );">Accounts payable reclass to convertible notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssued1', window );">Common stock issued for accrued services</a></td>
<td class="nump">448,440<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_SubscriptionReceivable', window );">Subscription receivable</a></td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_AccountsPayableReclassToConvertibleNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accounts payable reclass to convertible notes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_AccountsPayableReclassToConvertibleNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_DeemedDividendUponAlternateCashlessExerciseOfWarrants1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deemed dividend upon alternate cashless exercise of warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_DeemedDividendUponAlternateCashlessExerciseOfWarrants1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_DiscountsRelatedToDerivativeLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The discounts related to derivative liability in a noncash (or part noncash) transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_DiscountsRelatedToDerivativeLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_DiscountsRelatedToWarrantsIssuedWithConvertibleNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Discounts related to warrants issued with convertible notes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_DiscountsRelatedToWarrantsIssuedWithConvertibleNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_GainFromSettlementOfDebtNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gain from settlement of debt, net.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_GainFromSettlementOfDebtNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_IncreaseDecreaseInDeferredRent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase Decrease in Deferred rent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_IncreaseDecreaseInDeferredRent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_OperatingLeaseRightofuseAssetsAndOperatingLeaseLiabilitiesRecordedUponAdoptionOfAsc842">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating lease right-of-use asset and operating lease liability recorded on adoption of ASC 842.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_OperatingLeaseRightofuseAssetsAndOperatingLeaseLiabilitiesRecordedUponAdoptionOfAsc842</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_ReversalOfCommonStockIssuableAndPutPremiumDueToCancellationOfConversionsOfConvertibleDebtAndAccruedInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reversal of common stock issuable and put premium due to cancellation of conversions of convertible debt and accrued interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_ReversalOfCommonStockIssuableAndPutPremiumDueToCancellationOfConversionsOfConvertibleDebtAndAccruedInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_SubscriptionReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Subscription receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_SubscriptionReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDebtDiscountPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDebtDiscountPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockAmountConverted1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The value of the stock converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4313-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockAmountConverted1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockAmountIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The value of the financial instrument issued [noncash or part noncash] in the conversion of stock. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockAmountIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeGainLossOnDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeGainLossOnDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossUnrealized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of foreign currency transaction unrealized gain (loss) recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124440516&amp;loc=d3e30840-110895<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=125521441&amp;loc=d3e30690-110894<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossUnrealized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInterestPayableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in interest payable, which represents the amount owed to note holders, bond holders, and other parties for interest earned on loans or credit extended to the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInterestPayableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in other obligations or expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the total amount due within one year (or one operating cycle) from all parties, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense or loss included in net income that result in no cash flow, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the repurchase of amount received from entity's first offering of stock to the public.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromWarrantExercises">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from holders exercising their stock warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromWarrantExercises</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow from the repayment of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value of stock issued in noncash financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4313-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm140460441037816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING AND REPORTING POLICIES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock', window );">NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING AND REPORTING POLICIES</a></td>
<td class="text"><p id="xdx_80D_eus-gaap--OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_zTTe2uwKtJ9f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTE
1 &#8211; <span id="xdx_826_zE9JmaYAHYRh">NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING AND REPORTING POLICIES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_842_ecustom--NatureOfOperationsPolicyTextBlock_zyTsCKnZdqck" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_86D_z2tlihvxFFVh">Nature
of Operations</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">Propanc
Biopharma, Inc. (the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;us&#8221; or &#8220;our&#8221;) was originally incorporated in Melbourne,
Victoria Australia on October 15, 2007 as Propanc PTY LTD, and continues to be based in Camberwell, Victoria Australia. Since its inception,
substantially all of the operations of the Company have been focused on the development of new cancer treatments targeting high-risk
patients, particularly cancer survivors, who need a follow-up, non-toxic, long-term therapy designed to prevent the cancer from returning
and spreading. The Company anticipates establishing global markets for its technologies. Our lead product candidate, which we refer to
as PRP, is an enhanced pro-enzyme formulation designed to enhance the anti-cancer effects of multiple enzymes acting synergistically.
It is currently in the preclinical phase of development.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 26.2pt; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">On
<span id="xdx_908_edei--EntityIncorporationDateOfIncorporation_dd_c20210701__20210930_zsFzMpziuoA7" title="Entity incorporation, date of incorporation">November 23, 2010</span>, the Company was incorporated in the state of Delaware as Propanc Health Group Corporation. In January 2011, to reorganize
the Company, we acquired all of the outstanding shares of Propanc PTY LTD on a one-for-one basis making it a wholly-owned subsidiary
of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">On
July 22, 2016, the Company formed a wholly owned subsidiary, Propanc (UK) Limited under the laws of England and Wales for the purpose
of submitting an orphan drug application to the European Medicines Agency as a small and medium-sized enterprise. As of September 30,
2021, there has been no activity within this entity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">Effective
April 20, 2017, the Company changed its name to &#8220;Propanc Biopharma, Inc.&#8221; to better reflect the Company&#8217;s stage of
operations and development.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">In
July 2020, a world first patent was granted in Australia for the cancer treatment method patent family. Presently, there are 29 granted
patents and 33 patents under examination in key global jurisdictions relating to the use of proenzymes against solid tumors, covering
the lead product candidate PRP.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
Company hopes to capture and protect additional patentable subject matter based on the Company&#8217;s field of technology relating to
pharmaceutical compositions of proenzymes for treating cancer by filing additional patent applications as it advances its lead product
candidate, PRP, through various stages of development.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On
November 17, 2020, the Company effected a <span id="xdx_900_eus-gaap--StockholdersEquityReverseStockSplit_c20201116__20201117_zDGQYeiJ8fv4" title="Reverse stock">one-for-one thousand (1:1,000)</span> reverse stock split of the Company&#8217;s issued and outstanding
shares of common stock (the &#8220;Reverse Stock Split&#8221;). Proportional adjustments for the Reverse Stock Split were made to the
Company&#8217;s outstanding stock options, warrants and equity incentive plans. All share and per-share data and amounts have been retroactively
adjusted as of the earliest period presented in the consolidated financial statements to reflect the Reverse Stock Split.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_848_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zU3e1cFXZ2z2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_86B_zmrKinaSEaT2">Basis
of Presentation</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
Company&#8217;s interim unaudited condensed consolidated financial statements included in this Quarterly Report on Form 10-Q (this &#8220;Quarterly
Report&#8221;) have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;US
GAAP&#8221;) and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;). In the opinion
of the Company&#8217;s management, all adjustments (consisting of normal recurring adjustments and reclassifications and non-recurring
adjustments) necessary to present fairly our results of operations for the three months ended September 30, 2021 and 2020 and cash flows
for the three months ended September 30, 2021 and 2020 and our financial position at September 30, 2021 have been made. The Company&#8217;s
results of operations for the three months ended September 30, 2021 are not necessarily indicative of the operating results to be expected
for the full fiscal year ending June 30, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Certain
information and disclosures normally included in the notes to the Company&#8217;s annual audited consolidated financial statements have
been condensed or omitted from the Company&#8217;s interim unaudited condensed consolidated financial statements included in this Quarterly
Report. Accordingly, these interim unaudited condensed consolidated financial statements should be read in conjunction with the Company&#8217;s
audited consolidated financial statements and notes thereto for the fiscal year ended June 30, 2021. The June 30, 2021 balance sheet
is derived from those statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_84A_eus-gaap--ConsolidationPolicyTextBlock_zUzMhpDH8g1a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_86D_z8DTT4x83H5b">Principles
of Consolidation</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
unaudited condensed consolidated financial statements include the accounts of Propanc Biopharma, Inc., the parent entity, and its wholly-owned
subsidiary, Propanc PTY LTD. All inter-company balances and transactions have been eliminated in consolidation. Propanc (UK) Limited
was an inactive subsidiary at September 30, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>PROPANC
BIOPHARMA, INC. AND SUBSIDIARY<br/>
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS<br/>
SEPTEMBER 30, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Unaudited)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_840_eus-gaap--UseOfEstimates_zKH5SsGwZ3P6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_86F_zHD6rxWI4vv5">Use
of Estimates</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
preparation of financial statements in conformity with the accounting principles generally accepted in the United States of America (&#8220;US
GAAP&#8221;) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure
of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses
during the reporting period. Actual results could differ from these estimates. Significant estimates in the accompanying consolidated
financial statements include the estimates of useful lives for depreciation, valuation of the operating lease liability and related right-of-use
asset, valuation of derivatives, valuation of beneficial conversion features on convertible debt, allowance for uncollectable receivables,
valuation of equity based instruments issued for other than cash, the valuation allowance on deferred tax assets and foreign currency
translation due to certain average exchange rates applied in lieu of spot rates on transaction dates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_84D_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zYtRi38HEaAj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_868_zdZ6QdOvTze2">Foreign
Currency Translation and Other Comprehensive Income (Loss)</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
Company&#8217;s wholly owned subsidiary&#8217;s functional currency is the Australian dollar (AUD). For financial reporting purposes,
the Australian dollar has been translated into the Company&#8217;s reporting currency which is the United States dollar ($) and/or (USD).
Assets and liabilities are translated at the exchange rate in effect at the balance sheet date. Revenues and expenses are translated
at the average rate of exchange prevailing during the reporting period. Equity transactions are translated at each historical transaction
date spot rate. Translation adjustments arising from the use of different exchange rates from period to period are included as a component
of stockholders&#8217; equity (deficit) as &#8220;Accumulated other comprehensive income (loss).&#8221; Gains and losses resulting from
foreign currency transactions are included in the statements of operations and comprehensive income (loss) as a component of other comprehensive
income (loss). There have been no significant fluctuations in the exchange rate for the conversion of Australian dollars to USD after
the balance sheet date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">Other
Comprehensive Income (Loss) for all periods presented includes only foreign currency translation gains (losses).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Assets
and liabilities denominated in foreign currencies are translated into the functional currency at the exchange rates prevailing at the
consolidated balance sheet date with any transaction gains and losses that arise from exchange rate fluctuations on transactions denominated
in a currency other than the functional currency included in the consolidated results of operations as incurred. Effective fiscal year
2021, the parent company determined that these intercompany loans will not be repaid in the foreseeable future and thus, per ASC 830-20-35-3,
gains and losses from measuring the intercompany balances are recorded within cumulative translation adjustment, a component of accumulated
other comprehensive income (loss). Prior to July 1, 2020, the Company recorded the foreign currency transaction gains and losses from
measuring the intercompany balances as a component of other income (expenses) titled foreign currency transaction gain (loss). For the
three months ended September 30, 2021 and 2020, the Company recognized an exchange gain (loss) of approximately $<span id="xdx_909_eus-gaap--OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_pp0p0_c20210701__20210930__us-gaap--DebtInstrumentAxis__custom--IntercompanyLoansMember_zOhbETHOlpbj">619,000</span> and ($<span id="xdx_90B_eus-gaap--OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_pp0p0_c20200701__20200930__us-gaap--DebtInstrumentAxis__custom--IntercompanyLoansMember_zKbJ5TpFaGWk">583,000</span>),
on intercompany loans made by the parent to the subsidiary which have not been repaid as of September 30, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_89A_ecustom--ScheduleOfTranslationExchangeRatesTableTextBlock_zzNbOSdcA4v" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">As
of September 30, 2021 and June 30, 2021, the exchange rates used to translate amounts in Australian dollars into USD for the purposes
of preparing the consolidated financial statements were as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.45in"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_8B9_z5Jwt3MLbtk1" style="display: none">SCHEDULE
OF TRANSLATION EXCHANGE RATES</span>&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">September
    30, 2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">June
    30, 2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Exchange rate on balance sheet dates</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">USD : AUD exchange rate</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20210930_zAxoaqp5Oof3" style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.7214</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20210630_zAeNeQUILRnf" style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.7500</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Average exchange rate for the period</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">USD : AUD exchange rate</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20210930__srt--RangeAxis__srt--WeightedAverageMember_zyOm6KwP3orf" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.7350</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20210630__srt--RangeAxis__srt--WeightedAverageMember_zvDey7ZbyR65" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.7473</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p id="xdx_8A8_zfay8WlxJE4a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_893_eus-gaap--ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_zWSkwTH6ECU4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
change in Accumulated Other Comprehensive Income (Loss) by component during the three months ended September 30, 2021 was as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8B7_zATgnOSNnnC6" style="display: none">SCHEDULE
OF CHANGE IN ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Foreign<br/>
    Currency Items:</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 82%"><span style="font-family: Times New Roman, Times, Serif">Balance, June 30, 2021</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iS_pp0p0_c20210701__20210930_zWQXY0qBZeZ4" style="width: 14%; text-align: right" title="Beginning balance"><span style="font-family: Times New Roman, Times, Serif">1,085,204</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Unrealized foreign currency
    translation gain</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_pp0p0_c20210701__20210930_zlbQptq6YdTi" style="border-bottom: Black 1.5pt solid; text-align: right" title="Foreign currency translation gain"><span style="font-family: Times New Roman, Times, Serif">64,193</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Ending balance, September 30, 2021</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iE_pp0p0_c20210701__20210930_z94fy1ZvaCCk" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending balance"><span style="font-family: Times New Roman, Times, Serif">1,149,397</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p id="xdx_8A7_zcAa30ZDSqkj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>PROPANC
BIOPHARMA, INC. AND SUBSIDIARY<br/>
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS<br/>
SEPTEMBER 30, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Unaudited)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_846_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zFC2t1G9CYMj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_864_zKI9KeM2Ukah">Fair
Value of Financial Instruments and Fair Value Measurements</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
Company measures its financial assets and liabilities in accordance with US GAAP. For certain financial instruments, including cash and
cash equivalents, accounts receivable, accounts payable and accrued liabilities, the carrying amounts approximate fair value due to their
short maturities. Amounts recorded for notes payable, net of discount, and loans payable also approximate fair value because current
interest rates available for debt with similar terms and maturities are substantially the same.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
Company follows accounting guidance for financial assets and liabilities. This standard defines fair value, provides guidance for measuring
fair value and requires certain disclosures. This standard does not require any new fair value measurements, but rather applies to all
other accounting pronouncements that require or permit fair value measurements. This guidance does not apply to measurements related
to share-based payments. This guidance discusses valuation techniques, such as the market approach (comparable market prices), the income
approach (present value of future income or cash flow), and the cost approach (cost to replace the service capacity of an asset or replacement
cost).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
guidance utilizes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three broad
levels. The following is a brief description of those three levels:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.95pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Level
1: Observable inputs such as quoted prices (unadjusted) in active markets for identical assets or liabilities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.95pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Level
2: Inputs, other than quoted prices that are observable, either directly or indirectly. These include quoted prices for similar assets
or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.95pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Level
3: Unobservable inputs in which little or no market data exists, therefore developed using estimates and assumptions developed by us,
which reflect those that a market participant would use.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Also
see Note 11 - Derivative Financial Instruments and Fair Value Measurements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_844_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_z9t6VlcKAS8g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_861_zD9uCZl5Cas9">Cash
and Cash Equivalents</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">Cash
and cash equivalents include cash on hand and at banks, short-term deposits with an original maturity of three months or less with financial
institutions, and bank overdrafts. Bank overdrafts are reflected as a current liability on the balance sheets. There were <span id="xdx_907_eus-gaap--CashEquivalentsAtCarryingValue_iI_pp0p0_do_c20200930_zOFhHXa6w5rk">no</span> cash equivalents
as of September 30, 2021 or June 30, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_845_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zACW3ttl00x5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_866_zLBSJMg94jY4">Property
and Equipment</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">Property
and equipment are stated at cost, net of accumulated depreciation. Expenditures for maintenance and repairs are expensed as incurred;
additions, renewals, and betterments are capitalized. When property and equipment are retired or otherwise disposed of, the related cost
and accumulated depreciation are removed from the respective accounts, and any gain or loss is included in operations. Depreciation of
property and equipment is provided using the declining balance method. The depreciable amount is the cost less its residual value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_891_ecustom--ScheduleOfPropertyAndEquipmentEstimatedUsefulLivesTableTextBlock_zt2mxbVoEEWc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
estimated useful lives are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8B4_zrzjwdUOooq6" style="display: none">SCHEDULE
OF PROPERTY AND EQUIPMENT ESTIMATED USEFUL LIVES</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 25%"><span style="font: 10pt Times New Roman, Times, Serif">Machinery
    and equipment</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 75%"><span style="font: 10pt Times New Roman, Times, Serif">-
    <span id="xdx_90F_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210701__20210930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_zgVFwUSlH806">5</span> years</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">Furniture</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">-
    <span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210701__20210930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zmrWJFVBDMYc">7</span> years</span></td></tr>
  </table>
<p id="xdx_8A6_zyicsnfsPJy8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_843_eus-gaap--GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_zpLA1iRncFHg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_868_zax2qkWhbWie">Patents</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">Patents
are stated at cost and amortized on a straight-line basis over the estimated future periods if and once the patent has been granted by
a regulatory agency. However, the Company will expense any patent costs as long as we are in the startup stage. Accordingly, as the Company&#8217;s
products are not currently approved for market, all patent costs incurred from 2013 through September 30, 2021 were expensed immediately.
This practice of expensing patent costs immediately ends when a product receives market authorization from a government regulatory agency.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_847_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zR7zOXittAmg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_86A_zfgxcl3KPwSa">Impairment
of Long-Lived Assets</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">In
accordance with ASC 360-10, &#8220;<i>Long-lived assets,&#8221;</i> which include property and equipment and intangible assets, are reviewed
for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability
of long-lived assets to be held and used is measured by a comparison of the carrying amount of an asset to the estimated undiscounted
future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated undiscounted future
cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the
assets. Fair value is generally determined using the asset&#8217;s expected future discounted cash flows or market value, if readily
determinable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>PROPANC
BIOPHARMA, INC. AND SUBSIDIARY<br/>
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS<br/>
SEPTEMBER 30, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Unaudited)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_847_eus-gaap--EmployeeStockOwnershipPlanESOPPolicy_zKcRPhz1cmDl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_86B_zKiRtMFzZSlc">Employee
Benefit/Liability</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">Liabilities
arising in respect of wages and salaries, accumulated annual leave, accumulated long service leave and any other employee benefits expected
to be settled within twelve months of the reporting date are measured based on the employee&#8217;s remuneration rates applicable at
the reporting date. All other employee benefit liabilities are measured at the present value of the estimated future cash outflow to
be made in respect of services provided by employees up to the reporting date. All employee liabilities are owed within the next twelve
months.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_845_ecustom--GoodsAndServiceTaxPolicyTextBlock_zFkquLvQEsN1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_86E_zAcVIJZd3dT8">Australian
Goods and Services Tax (&#8220;GST&#8221;)</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">Revenues,
expenses and balance sheet items are recognized net of the amount of GST, except payable and receivable balances which are shown inclusive
of GST. The GST incurred is payable on revenues to, and recoverable on purchases from, the Australian Taxation Office.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">Cash
flows are presented in the statements of cash flow on a gross basis, except for the GST component of investing and financing activities,
which are disclosed as operating cash flows.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">As
of September 30, 2021, and June 30, 2021, the Company was owed $<span id="xdx_904_eus-gaap--ValueAddedTaxReceivableCurrent_iI_pp0p0_c20210930_zNHlbbV7dpad" title="Value added tax receivable">2,238</span> and $<span id="xdx_90A_eus-gaap--ValueAddedTaxReceivableCurrent_iI_pp0p0_c20200930_zQ4JT5NkFXzk" title="Value added tax receivable">4,341</span>, respectively, from the Australian Taxation Office.
These amounts were fully collected subsequent to the balance sheet reporting dates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_847_eus-gaap--DerivativesReportingOfDerivativeActivity_zQ2WlEN1DWE6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_861_zc8e4LzGljd1">Derivative
Instruments</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">ASC
Topic 815, <i>Derivatives and Hedging</i> (&#8220;ASC Topic 815&#8221;), establishes accounting and reporting standards for derivative
instruments and for hedging activities by requiring that all derivatives be recognized in the balance sheet and measured at fair value.
Gains or losses resulting from changes in the fair value of derivatives are recognized in earnings. On the date of conversion or payoff
of debt, the Company records the fair value of the conversion shares, removes the fair value of the related derivative liability, removes
any discounts and records a net gain or loss on debt extinguishment. On July 1, 2019 the Company adopted ASU 2017-11 under which down-round
Features in Financial Instruments will no longer cause derivative treatment. The Company applies the modified prospective method of adoption.
There were no cumulative effects on adoption.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_845_ecustom--ConvertibleNotesPolicyTextBlock_zxn5O0pSGSxg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_861_zqNXrYouGBs7">Convertible
Notes With Variable Conversion Options</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
Company has entered into convertible notes, some of which contain variable conversion options, whereby the outstanding principal and
accrued interest may be converted, by the holder, into common shares at a fixed discount to the price of the common stock at or around
the time of conversion. The Company treats these convertible notes as stock settled debt under ASC 480, &#8220;<i>Distinguishing Liabilities
from Equity</i>&#8221; and measures the fair value of the notes at the time of issuance, which is the result of the share price discount
at the time of conversion and records the put premium as interest expense.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_848_eus-gaap--IncomeTaxPolicyTextBlock_zhOGS6N4HyHb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_86B_z4ulDnTrWbva">Income
Taxes</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
Company is governed by Australia and United States income tax laws, which are administered by the Australian Taxation Office and the
United States Internal Revenue Service, respectively. The Company follows ASC 740 &#8220;<i>Accounting for Income Taxes</i>,&#8221; when
accounting for income taxes, which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred
income tax assets and liabilities are computed annually for temporary differences between the financial statements and tax bases of assets
and liabilities that will result in taxable or deductible amounts in the future based on enacted tax laws and rates applicable to the
periods in which the differences are expected to affect taxable income. Valuation allowances are established when necessary to reduce
deferred tax assets to the amount expected to be realized. Income tax expense is the tax payable or refundable for the period plus or
minus the change during the period in deferred tax assets and liabilities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
Company follows ASC 740, Sections 25 through 60, &#8220;<i>Accounting for Uncertainty in Income Taxes</i>.&#8221; These sections provide
detailed guidance for the financial statement recognition, measurement and disclosure of uncertain tax positions recognized in the financial
statements. Tax positions must meet a &#8220;more-likely-than-not&#8221; recognition threshold at the effective date to be recognized
upon the adoption of ASC 740 and in subsequent periods.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_842_eus-gaap--ResearchAndDevelopmentExpensePolicy_zhSDwzgwptn3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_864_z7raaBtt59u1">Research
and Development Costs and Tax Credits</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">In
accordance with ASC 730-10, <i>&#8220;Research and Development-Overall,&#8221;</i> research and development costs are expensed when incurred.
Total research and development costs for the three months ended September 30, 2021 and 2020 were $<span id="xdx_901_eus-gaap--ResearchAndDevelopmentExpense_pp0p0_c20210701__20210930_z8IQi4E6xGXk">46,554</span> and $<span id="xdx_90B_eus-gaap--ResearchAndDevelopmentExpense_pp0p0_c20200701__20200930_zKalVQgW6Sua">50,846</span>, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>PROPANC
BIOPHARMA, INC. AND SUBSIDIARY<br/>
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS<br/>
SEPTEMBER 30, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Unaudited)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
Company may apply for research and development tax concessions with the Australian Taxation Office on an annual basis. Although the amount
is possible to estimate at year end, the Australian Taxation Office may reject or materially alter the claim amount. Accordingly, the
Company does not recognize the benefit of the claim amount until cash receipt since collectability is not certain until such time. The
tax concession is a refundable credit. If the Company has net income, then the Company can receive the credit which reduces its income
tax liability. If the Company has net losses, then the Company may still receive a cash payment for the credit, however, the Company&#8217;s
net operating loss carryforwards are reduced by the gross equivalent loss that would produce the credit amount when the income tax rate
is applied to that gross amount. The concession is recognized as tax benefit, in operations, upon receipt.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">During
each of the three months ended September 30, 2021 and 2020, the Company applied for, and received from the Australian Taxation Office,
a research and development tax credit in the amount of $<span id="xdx_900_eus-gaap--IncomeTaxExpenseBenefit_iN_pp0p0_dixL_c20200701__20200930_zfbdkDjR4Lw6" title="::XDX::-"><span id="xdx_90E_eus-gaap--IncomeTaxExpenseBenefit_iN_pp0p0_dixL_c20210701__20210930_zu8lPCnqt6u" title="Tax credits::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl3304"><span style="-sec-ix-hidden: xdx2ixbrl3306">0</span></span></span></span>, which is reflected as a tax benefit in the accompanying unaudited condensed
consolidated statements of operations and comprehensive income (loss).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_847_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_z7ocjmQGNxmd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_86D_zxXe6dOqY3P8">Stock
Based Compensation</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
Company records stock-based compensation in accordance with ASC 718, &#8220;<i>Stock Compensation</i>&#8221;. ASC 718 requires the fair
value of all stock-based employee compensation awarded to employees to be recorded as an expense over the shorter of the service period
or the vesting period. The Company values employee and non-employee stock-based compensation at fair value using the Black-Scholes Option
Pricing Model.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
Company adopted ASU 2018-07 and accounts for non-employee share-based awards in accordance with the measurement and recognition criteria
of ASC 718 and recognizes the fair value of such awards over the service period. The Company used the modified prospective method of
adoption. There was no cumulative effect of adoption on July 1, 2019.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_842_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zoI5lfak5jZ7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_866_zQ0pBQvL2eDf">Revenue
Recognition</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
Company adopted and implemented on July 1, 2018, ASC 606 &#8211; Revenue from Contracts with Customers (&#8220;ASC 606&#8221;). ASC 606
did not have a material impact on the consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Upon
implementation of ASC 606, the Company recognizes revenue in accordance with that core principle by applying the following steps:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Step
1: Identify the contract(s) with a customer.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Step
2: Identify the performance obligations in the contract.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Step
3: Determine the transaction price.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Step
4: Allocate the transaction price to the performance obligations in the contract.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Step
5: Recognize revenue when (or as) the entity satisfies a performance obligation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">Subject
to these criteria, the Company intends to recognize revenue relating to royalties on product sales in the period in which the sale occurs
and the royalty term has begun.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_845_eus-gaap--LegalCostsPolicyTextBlock_zYIGCDDncv8f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_869_zZfv7SoMGD11">Legal
Expenses</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">All
legal costs for litigation are charged to expense as incurred.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_84E_eus-gaap--LesseeLeasesPolicyTextBlock_zXunrNvs61Gc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_868_zSbh3EyY4Kej">Leases</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In
February 2016, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued ASU 2016-02, <i>Leases</i> (Topic 842). The updated
guidance requires lessees to recognize lease assets and lease liabilities for most operating leases. In addition, the updated guidance
requires that lessors separate lease and non-lease components in a contract in accordance with the new revenue guidance in ASC 606. This
guidance is effective for interim and annual reporting periods beginning after December 15, 2018. The Company adopted this guidance effective
July 1, 2019.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On
July 1, 2019, the Company adopted ASU No. 2016-02, applying the package of practical expedients to leases that commenced before the effective
date whereby the Company elected to not reassess the following: (i) whether any expired or existing contracts contain leases and; (ii)
initial direct costs for any existing leases. For contracts entered into on or after the effective date, at the inception of a contract
the Company assessed whether the contract is, or contains, a lease. The Company&#8217;s assessment is based on: (1) whether the contract
involves the use of a distinct identified asset, (2) whether we obtain the right to substantially all the economic benefit from the use
of the asset throughout the period, and (3) whether it has the right to direct the use of the asset. The Company will allocate the consideration
in the contract to each lease component based on its relative stand-alone price to determine the lease payments. In addition, the Company
elected not to apply ASC Topic 842 to arrangements with lease terms of 12 months or less.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Operating
lease ROU assets represents the right to use the leased asset for the lease term and operating lease liabilities are recognized based
on the present value of future minimum lease payments over the lease term at commencement date. As most leases do not provide an implicit
rate, the Company use an incremental borrowing rate based on the information available at the adoption date in determining the present
value of future payments. Lease expense for minimum lease payments is amortized on a straight-line basis over the lease term and will
be included in general and administrative expenses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>PROPANC
BIOPHARMA, INC. AND SUBSIDIARY<br/>
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS<br/>
SEPTEMBER 30, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Unaudited)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_84E_eus-gaap--EarningsPerSharePolicyTextBlock_zpfEBsYvPCak" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_869_zIeaaJNnPy08">Basic
and Diluted Net Loss Per Common Share</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Basic
net loss per share is computed by dividing the net loss by the weighted average number of common shares outstanding during the period.
Diluted net loss per common share is computed by dividing the net loss by the weighted average number of common shares outstanding for
the period and, if dilutive, potential common shares outstanding during the period. Potentially dilutive securities consist of the incremental
common shares issuable upon exercise of common stock equivalents such as stock options, warrants and convertible debt instruments. Potentially
dilutive securities are excluded from the computation if their effect is anti-dilutive. As a result, the basic and diluted per share
amounts for all periods presented are identical. <span id="xdx_902_eus-gaap--DebtInstrumentConvertibleTermsOfConversionFeature_c20210701__20210930_zELEU7ykKkIk" title="Debt conversion percentage, description">Each holder of the notes has agreed to a <span id="xdx_904_eus-gaap--DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_pid_dp_uPure_c20200701__20210630_zhcROCTayfJi" title="Debt conversion percentage">4.99</span>% beneficial ownership conversion limitation
(subject to certain noteholders&#8217; ability to increase such limitation to <span id="xdx_906_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_uPure_c20210819__us-gaap--TypeOfArrangementAxis__custom--TwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember_zjDxTQNnQMx6">9.99</span>% upon 60 days&#8217; notice to the Company), and each
note may not be converted during the first six-month period from the date of issuance. The securities for the period ended September
30, 2021 and 2020 were considered dilutive securities which were excluded from the computation since the effect is anti-dilutive.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span title="Debt conversion percentage, description">&#160;</span></span></p>

<p id="xdx_89A_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zLusIxCV0JF5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8B8_z5qGGqx37Jgb" style="display: none">SCHEDULE
OF DILUTIVE SECURITIES EXCLUDED FROM COMPUTATION</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 100%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">September
    30, 2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">September
    30, 2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Unaudited)</b></span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Unaudited)</b></span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Stock Options</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20210701__20210930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_zRWorJnhqvNc" style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">59</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20200701__20200930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_zlntA9renUm6" style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">60</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Stock Warrants</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20210701__20210930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zM5tes7KTZa" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">111,932</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20200701__20200930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zt22Rh7qyBR8" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">135,725</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Unvested restricted stock</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20210701__20210930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--UnvestedRestrictedStockMember_ziQ1XBlUpRa9" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">59</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20200701__20200930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--UnvestedRestrictedStockMember_zaZOZ38j94Hd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">117</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Convertible Debt</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20210701__20210930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertibleDebtSecuritiesMember_zadTQYWGAgi6" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">23,293,971</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_981_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20200701__20200930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertibleDebtSecuritiesMember_zsFdubolj81a" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">510,674</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20210701__20210930_zjRj7iczs6t1" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">23,406,021</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20200701__20200930_zQ6W7BJxm8Kh" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">646,576</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p id="xdx_8A6_ztUc5Ua4Aso2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_841_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zFYh4pSJ2Re4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_863_zJh69seVZbtk">Recent
Accounting Pronouncements</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">We
have reviewed the FASB issued ASU accounting pronouncements and interpretations thereof that have effectiveness dates during the periods
reported and in future periods. We have carefully considered the new pronouncements that alter previous generally accepted accounting
principles and do not believe that any new or modified principles will have a material impact on the Company&#8217;s reported financial
position or operations in the near term. The applicability of any standard is subject to the formal review of the Company&#8217;s financial
management.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In
August 2020, the FASB issued ASU 2020-06, &#8220;Debt &#8211; Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives
and Hedging &#8211; Contracts in Entity&#8217;s Own Equity (Subtopic 815-40)&#8221;. This ASU reduces the number of accounting models
for convertible debt instruments and convertible preferred stock. As well as amend the guidance for the derivatives scope exception for
contracts in an entity&#8217;s own equity to reduce form-over-substance-based accounting conclusions. In addition, this ASU improves
and amends the related EPS guidance. This standard is effective for us on July 1, 2022, including interim periods within those fiscal
years. Adoption is either a modified retrospective method or a fully retrospective method of transition. The Company is currently assessing
the impact the new guidance will have on our consolidated financial statements.</span></p>

<p id="xdx_859_zwf6AthGWyXc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_800_eus-gaap--OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_zycuyQ5Qj2bl" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>NOTE
1 &#8211; <span id="xdx_825_zzIYbH5HEuLc">NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING AND REPORTING POLICIES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p id="xdx_84D_ecustom--NatureOfOperationsPolicyTextBlock_zUy1ZG0cJ07l" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="text-decoration: underline"><span id="xdx_864_zskNnen1aczd">Nature
of Operations</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Propanc
Biopharma, Inc. (the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;us&#8221; or &#8220;our&#8221;) was originally incorporated in Melbourne,
Victoria Australia on October 15, 2007 as Propanc PTY LTD, and continues to be based in Camberwell, Victoria Australia. Since its inception,
substantially all of the operations of the Company have been focused on the development of new cancer treatments targeting high-risk
patients, particularly cancer survivors, who need a follow-up, non-toxic, long-term therapy designed to prevent the cancer from returning
and spreading. The Company anticipates establishing global markets for its technologies. Our lead product candidate, which we refer to
as PRP, is an enhanced pro-enzyme formulation designed to enhance the anti-cancer effects of multiple enzymes acting synergistically.
It is currently in the preclinical phase of development.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 29.15pt; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">On
<span id="xdx_902_edei--EntityIncorporationDateOfIncorporation_dd_c20200701__20210630_zjsnh70umwD9" title="Entity incorporation, date of incorporation">November 23, 2010</span>, the Company was incorporated in the state of Delaware as Propanc Health Group Corporation. In January 2011, to reorganize
the Company, we acquired all of the outstanding shares of Propanc PTY LTD on a one-for-one basis making it a wholly-owned subsidiary
of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">On
July 22, 2016, the Company formed a wholly owned subsidiary, Propanc (UK) Limited under the laws of England and Wales for the purpose
of submitting an orphan drug application to the European Medicines Agency as a small and medium-sized enterprise. As of June 30, 2021,
there has been no activity within this entity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Effective
April 20, 2017, the Company changed its name to &#8220;Propanc Biopharma, Inc.&#8221; to better reflect the Company&#8217;s stage of
operations and development.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">In
July 2020, a world first patent was granted in Australia for the cancer treatment method patent family. Presently, there are 29 granted
patents and 33 patents under examination in key global jurisdictions relating to the use of proenzymes against solid tumors, covering
the lead product candidate PRP.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
Company hopes to capture and protect additional patentable subject matter based on the Company&#8217;s field of technology relating to
pharmaceutical compositions of proenzymes for treating cancer by filing additional patent applications as it advances its lead product
candidate, PRP, through various stages of development.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">On
November 17, 2020, the Company effected a <span id="xdx_90D_eus-gaap--StockholdersEquityReverseStockSplit_c20201116__20201117" title="Reverse stock">one-for-one thousand (1:1,000)</span> reverse stock split of the Company&#8217;s issued and outstanding
shares of common stock (the &#8220;Reverse Stock Split&#8221;). Proportional adjustments for the Reverse Stock Split were made to the
Company&#8217;s outstanding stock options, warrants and equity incentive plans. All share and per-share data and amounts have been retroactively
adjusted as of the earliest period presented in the consolidated financial statements to reflect the Reverse Stock Split.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p id="xdx_840_eus-gaap--ConsolidationPolicyTextBlock_zTfyfILZC5Xb" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="text-decoration: underline"><span id="xdx_860_z0xpPnCblBPa">Principles
of Consolidation</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
consolidated financial statements include the accounts of Propanc Biopharma, Inc., the parent entity, and its wholly-owned subsidiary,
Propanc PTY LTD. All inter-company balances and transactions have been eliminated in consolidation. Propanc (UK) Limited was an inactive
wholly-owned subsidiary through June 30, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p id="xdx_845_eus-gaap--UseOfEstimates_zzwSrtiWrUj9" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="text-decoration: underline"><span id="xdx_866_zCVztcFqdaWc">Use
of Estimates</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
preparation of financial statements in conformity with the accounting principles generally accepted in the United States of America (&#8220;US
GAAP&#8221;) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure
of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses
during the reporting period. Actual results could differ from these estimates. Significant estimates in the accompanying consolidated
financial statements include the estimates of useful lives for depreciation, valuation of the operating lease liability and related right-of-use
asset, valuation of derivatives, valuation of beneficial conversion features on convertible debt, allowance for uncollectable receivables,
valuation of equity based instruments issued for other than cash, the valuation allowance on deferred tax assets and foreign currency
translation due to certain average exchange rates applied in lieu of spot rates on transaction dates.</span></p>

<p id="xdx_859_z8T8me2mUWNh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>PROPANC
BIOPHARMA, INC. AND SUBSIDIARY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>June
30, 2021 and 2020</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p id="xdx_84C_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_z1sqztQEFLQg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="text-decoration: underline"><span id="xdx_86F_zJUFHRfwNmQ9">Foreign
Currency Translation and Other Comprehensive Income (Loss)</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
Company&#8217;s wholly owned subsidiary&#8217;s functional currency is the Australian dollar (AUD). For financial reporting purposes,
the Australian dollar has been translated into the Company&#8217;s reporting currency which is the United States dollar ($) and/or (USD).
Assets and liabilities are translated at the exchange rate in effect at the balance sheet date. Revenues and expenses are translated
at the average rate of exchange prevailing during the reporting period. Equity transactions are translated at each historical transaction
date spot rate. Translation adjustments arising from the use of different exchange rates from period to period are included as a component
of stockholders&#8217; equity (deficit) as &#8220;Accumulated other comprehensive income (loss).&#8221; Gains and losses resulting from
foreign currency transactions are included in the statements of operations and comprehensive income (loss) as a component of other
comprehensive income (loss). There have been no significant fluctuations in the exchange rate for the conversion of Australian dollars
to USD after the balance sheet date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Other
Comprehensive Income (Loss) for all periods presented includes only foreign currency translation gains (losses).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Assets
and liabilities denominated in foreign currencies are translated into the functional currency at the exchange rates prevailing at
the consolidated balance sheet date with any transaction gains and losses that arise from exchange rate fluctuations on transactions
denominated in a currency other than the functional currency included in the consolidated results of operations as incurred.
Effective fiscal year 2021, the parent company determined that these intercompany loans will not be repaid in the foreseeable future
and thus, per ASC 830-20-35-3, gains and losses from measuring the intercompany balances are recorded within cumulative translation
adjustment, a component of accumulated other comprehensive income (loss). Prior to July 1, 2020, the Company recorded the foreign
currency transaction gains and losses from measuring the intercompany balances as a component of other income (expenses) titled
foreign currency transaction gain (loss). For the year ended June 30, 2021 and 2020, the Company recognized an exchange gain
(loss) of approximately $<span id="xdx_901_eus-gaap--OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_c20200701__20210630__us-gaap--DebtInstrumentAxis__custom--IntercompanyLoansMember_pp0p0">1,005,000 </span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">and
($<span id="xdx_90C_eus-gaap--OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_pp0p0_c20190701__20200630__us-gaap--DebtInstrumentAxis__custom--IntercompanyLoansMember_z9cfuN0kVfSk">133,000</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">),
on intercompany loans made by the parent to the subsidiary which have not been repaid as of June 30, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p id="xdx_890_ecustom--ScheduleOfTranslationExchangeRatesTableTextBlock_zHWjPfYgXMZa" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">As
of June 30, 2021 and 2020, the exchange rates used to translate amounts in Australian dollars into USD for the purposes of preparing
the consolidated financial statements were as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;<span id="xdx_8BF_zkh7nqNm3XF1" style="display: none">SCHEDULE OF TRANSLATION EXCHANGE RATES</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>June
    30, 2021</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>June
    30, 2020</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Exchange
    rate on balance sheet dates</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 64%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">USD
    : AUD exchange rate</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td id="xdx_98C_eus-gaap--ForeignCurrencyExchangeRateTranslation1_c20210630_pdd" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">0.7500</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td id="xdx_98D_eus-gaap--ForeignCurrencyExchangeRateTranslation1_c20200630_pdd" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">0.6891</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Average
    exchange rate for the period</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">USD
    : AUD exchange rate</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td id="xdx_981_eus-gaap--ForeignCurrencyExchangeRateTranslation1_c20210630__srt--RangeAxis__srt--WeightedAverageMember_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">0.7473</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td id="xdx_980_eus-gaap--ForeignCurrencyExchangeRateTranslation1_c20200630__srt--RangeAxis__srt--WeightedAverageMember_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">0.6742</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  </table>
<p id="xdx_8A5_zF6IdfJw4yP2" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p id="xdx_89D_eus-gaap--ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_zTTKEp5aN2Mg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Change
in Accumulated Other Comprehensive Income (Loss) by component during the years ended June 30, 2021 and 2020 were as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;<span id="xdx_8BB_z1EztVraTjcc" style="display: none">SCHEDULE OF CHANGE IN ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Foreign<br/>
    Currency Items:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 82%"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Beginning
    balance, June 30, 2019</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td id="xdx_982_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iS_pp0p0_c20190701__20200630_zhNUQVDiorwj" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Beginning balance"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">1,066,998</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Foreign
    currency translation gain</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td id="xdx_983_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_pp0p0_c20190701__20200630_zybFsKiYr1bg" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Foreign currency translation gain"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">200,673</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Balance,
    June 30, 2020</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td id="xdx_98A_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iS_pp0p0_c20200701__20210630_z7l1M52ClLwc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Beginning balance"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">1,267,671</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Foreign
    currency translation gain</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td id="xdx_986_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_pp0p0_c20200701__20210630_zDEdRjzTaONi" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Foreign currency translation gain"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">182,467</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Ending
    balance, June 30, 2021</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td id="xdx_988_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iE_pp0p0_c20200701__20210630_zuP9suUjhKki" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Ending balance"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">1,085,204</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  </table>
<p id="xdx_8A0_zHuOP9xbxVG" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p id="xdx_84A_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zVxpyFcjsmfb" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="text-decoration: underline"><span id="xdx_869_zSpI6haJjHrj">Fair
Value of Financial Instruments and Fair Value Measurements</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
Company measures its financial assets and liabilities in accordance with US GAAP. For certain financial instruments, including cash and
cash equivalents, accounts receivable, accounts payable and accrued liabilities, the carrying amounts approximate fair value due to their
short maturities. Amounts recorded for notes payable, net of discount, and loans payable also approximate fair value because current
interest rates available for debt with similar terms and maturities are substantially the same.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
Company follows accounting guidance for financial assets and liabilities. This standard defines fair value, provides guidance for measuring
fair value and requires certain disclosures. This standard does not require any new fair value measurements, but rather applies to all
other accounting pronouncements that require or permit fair value measurements. This guidance does not apply to measurements related
to share-based payments. This guidance discusses valuation techniques, such as the market approach (comparable market prices), the income
approach (present value of future income or cash flow), and the cost approach (cost to replace the service capacity of an asset or replacement
cost).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
guidance utilizes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three broad
levels. The following is a brief description of those three levels:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.2in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Level
1: Observable inputs such as quoted prices (unadjusted) in active markets for identical assets or liabilities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.2in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Level
2: Inputs, other than quoted prices that are observable, either directly or indirectly. These include quoted prices for similar assets
or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.2in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Level
3: Unobservable inputs in which little or no market data exists, therefore developed using estimates and assumptions developed by us,
which reflect those that a market participant would use.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Also
see Note 12 - Derivative Financial Instruments and Fair Value Measurements.</span></p>

<p id="xdx_856_zCAOGM8L5wW4" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>PROPANC
BIOPHARMA, INC. AND SUBSIDIARY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>June
30, 2021 and 2020</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p id="xdx_849_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zbBtLCxM8FT2" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="text-decoration: underline"><span id="xdx_86B_zOfKCWdOLVRd">Cash
and Cash Equivalents</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Cash
and cash equivalents include cash on hand and at banks, short-term deposits with an original maturity of three months or less with financial
institutions, and bank overdrafts. Bank overdrafts, as applicable, are reflected as a current liability on the balance sheets.
There were <span id="xdx_903_eus-gaap--CashEquivalentsAtCarryingValue_iI_pp0p0_do_c20200630_zZ1eOJKYJYr7">no</span></span> <span style="font: 10pt Times New Roman, Times, Serif; color: Black">cash
equivalents as of June 30, 2021 or June 30, 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p id="xdx_84B_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zfg52EPJexy6" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="text-decoration: underline"><span id="xdx_862_zHWcQfXqSLH3">Property
and Equipment</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Property
and equipment are stated at cost, net of accumulated depreciation. Expenditures for maintenance and repairs are expensed as incurred;
additions, renewals, and betterments are capitalized. When property and equipment are retired or otherwise disposed of, the related cost
and accumulated depreciation are removed from the respective accounts, and any gain or loss is included in operations. Depreciation of
property and equipment is provided using the declining balance method. The depreciable amount is the cost less its residual value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p id="xdx_892_ecustom--ScheduleOfPropertyAndEquipmentEstimatedUsefulLivesTableTextBlock_z3AwX2Xd0mO4" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
estimated useful lives are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;<span id="xdx_8BA_zTqP1ilC57ma" style="display: none">SCHEDULE OF PROPERTY AND EQUIPMENT ESTIMATED USEFUL LIVES</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 28%"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Machinery
    and equipment</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 72%"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">-
    <span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200701__20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_zOXkToZUepQc" title="Property and equipment estimated useful lives">5</span> years</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Furniture</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">-
    <span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200701__20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zW81xzQcQdSg" title="Property and equipment estimated useful lives">7</span> years</span></td></tr>
  </table>
<p id="xdx_8A6_zca7BRRp6xl5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p id="xdx_841_eus-gaap--GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_zv8lJAmH5La9" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="text-decoration: underline"><span id="xdx_863_zdGUX8vUhRsb">Patents</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 29.15pt; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Patents
are stated at cost and amortized on a straight-line basis over the estimated future periods if and once the patent has been granted by
a regulatory agency. However, the Company will expense any patent costs as long as we are in the startup stage. Accordingly, as the Company&#8217;s
products are not currently approved for market, all patent costs incurred from 2013 through June 30, 2021 were expensed immediately.
This practice of expensing patent costs immediately ends when a product receives market authorization from a government regulatory agency.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p id="xdx_845_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zey8gFOmZPEd" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="text-decoration: underline"><span id="xdx_86C_zgKIFAsI1sVj">Impairment
of Long-Lived Assets</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.45in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">In
accordance with ASC 360-10, &#8220;Long-lived assets,&#8221; which include property and equipment and intangible assets, are reviewed
for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability
of long-lived assets to be held and used is measured by a comparison of the carrying amount of an asset to the estimated undiscounted
future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated undiscounted future
cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the
assets. Fair value is generally determined using the asset&#8217;s expected future discounted cash flows or market value, if readily
determinable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p id="xdx_84B_eus-gaap--EmployeeStockOwnershipPlanESOPPolicy_zh3AyswVz5Te" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="text-decoration: underline"><span id="xdx_860_zYj1IsvzQ9N5">Employee
Benefit/Liability</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Liabilities
arising in respect of wages and salaries, accumulated annual leave, accumulated long service leave and any other employee benefits expected
to be settled within twelve months of the reporting date are measured based on the employee&#8217;s remuneration rates applicable at
the reporting date. All other employee benefit liabilities are measured at the present value of the estimated future cash outflow to
be made in respect of services provided by employees up to the reporting date. All employee liabilities are owed within the next twelve
months.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p id="xdx_84B_ecustom--GoodsAndServiceTaxPolicyTextBlock_zXRt2fYMNCde" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="text-decoration: underline"><span id="xdx_861_zXbULMoiEBt1">Australian
Goods and Services Tax (&#8220;GST&#8221;)</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Revenues,
expenses and balance sheet items are recognized net of the amount of GST, except payable and receivable balances which are shown inclusive
of GST. The GST incurred is payable on revenues to, and recoverable on purchases from, the Australian Taxation Office.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Cash
flows are presented in the statements of cash flow on a gross basis, except for the GST component of investing and financing activities,
which are disclosed as operating cash flows.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">As
of June 30, 2021 and 2020, the Company was owed $<span id="xdx_908_eus-gaap--ValueAddedTaxReceivableCurrent_c20210630_pp0p0" title="Value added tax receivable">4,341</span> and $<span id="xdx_90B_eus-gaap--ValueAddedTaxReceivableCurrent_c20200630_pp0p0" title="Value added tax receivable">2,015</span>, respectively, from the Australian Taxation Office. These amounts were
fully collected subsequent to the balance sheet reporting dates.</span></p>

<p id="xdx_858_znfh9MJCo1af" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>PROPANC
BIOPHARMA, INC. AND SUBSIDIARY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>June
30, 2021 and 2020</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p id="xdx_84C_eus-gaap--DerivativesReportingOfDerivativeActivity_zPkIWm6mIOdb" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="text-decoration: underline"><span id="xdx_866_z26UFsPBAyH9">Derivative
Instruments</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">ASC
Topic 815, <i>Derivatives and Hedging</i> (&#8220;ASC Topic 815&#8221;), establishes accounting and reporting standards for derivative
instruments and for hedging activities by requiring that all derivatives be recognized in the balance sheet and measured at fair value.
Gains or losses resulting from changes in the fair value of derivatives are recognized in earnings. On the date of conversion or payoff
of debt, the Company records the fair value of the conversion shares, removes the fair value of the related derivative liability, removes
any discounts and records a net gain or loss on debt extinguishment. On July 1, 2019 the Company adopted ASU 2017-11 under which down-round
Features in Financial Instruments will no longer cause derivative treatment. The Company applies the modified prospective method of adoption.
There were no cumulative effects on adoption.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p id="xdx_84D_ecustom--ConvertibleNotesPolicyTextBlock_zxajUQ2alEZ1" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="text-decoration: underline"><span id="xdx_86C_zoAjEhAqQMW4">Convertible
Notes With Variable Conversion Options</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 29.15pt; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
Company has entered into convertible notes, some of which contain variable conversion options, whereby the outstanding principal and
accrued interest may be converted, by the holder, into common shares at a fixed discount to the price of the common stock at or around
the time of conversion. The Company treats these convertible notes as stock settled debt under ASC 480, &#8220;<i>Distinguishing Liabilities
from Equity</i>&#8221; and measures the fair value of the notes at the time of issuance, which is the result of the share price discount
at the time of conversion and records the put premium as interest expense.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p id="xdx_843_eus-gaap--IncomeTaxPolicyTextBlock_zN0Zlr1p7J9g" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="text-decoration: underline"><span id="xdx_86C_zPUZwyGp2WM5">Income
Taxes</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 29.15pt; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
Company is governed by Australia and United States income tax laws, which are administered by the Australian Taxation Office and the
United States Internal Revenue Service, respectively. The Company follows ASC 740 &#8220;<i>Accounting for Income Taxes</i>,&#8221; when
accounting for income taxes, which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred
income tax assets and liabilities are computed annually for temporary differences between the financial statements and tax bases of assets
and liabilities that will result in taxable or deductible amounts in the future based on enacted tax laws and rates applicable to the
periods in which the differences are expected to affect taxable income. Valuation allowances are established when necessary to reduce
deferred tax assets to the amount expected to be realized. Income tax expense is the tax payable or refundable for the period plus or
minus the change during the period in deferred tax assets and liabilities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 29.15pt; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
Company follows ASC 740, Sections 25 through 60, &#8220;<i>Accounting for Uncertainty in Income Taxes</i>.&#8221; These sections provide
detailed guidance for the financial statement recognition, measurement and disclosure of uncertain tax positions recognized in the financial
statements. Tax positions must meet a &#8220;more-likely-than-not&#8221; recognition threshold at the effective date to be recognized
upon the adoption of ASC 740 and in subsequent periods.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p id="xdx_84F_eus-gaap--ResearchAndDevelopmentExpensePolicy_zQCpNdwyFt72" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="text-decoration: underline"><span id="xdx_861_zChCCKk1NlA1">Research
and Development Costs and Tax Credits</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">In
accordance with ASC 730-10, <i>&#8220;Research and Development-Overall,&#8221;</i> research and development costs are expensed when incurred.
Total research and development costs for the fiscal years ended June 30, 2021 and 2020 were $<span id="xdx_909_eus-gaap--ResearchAndDevelopmentExpense_c20200701__20210630_pp0p0" title="Research and development costs">230,956</span> and $<span id="xdx_90A_eus-gaap--ResearchAndDevelopmentExpense_pp0p0_c20190701__20200630_z8D3lSanDVD5" title="Research and development costs">179,987</span>, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
Company may apply for research and development tax concessions with the Australian Taxation Office on an annual basis. Although the amount
is possible to estimate at year end, the Australian Taxation Office may reject or materially alter the claim amount. Accordingly, the
Company does not recognize the benefit of the claim amount until cash receipt since collectability is not certain until such time. The
tax concession is a refundable credit. If the Company has net income, then the Company can receive the credit which reduces its income
tax liability. If the Company has net losses, then the Company may still receive a cash payment for the credit, however, the Company&#8217;s
net operating loss carryforwards are reduced by the gross equivalent loss that would produce the credit amount when the income tax rate
is applied to that gross amount. The concession is recognized as tax benefit, in operations, upon receipt.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">During
each of the fiscal years ended June 30, 2021 and 2020, the Company applied for, and received from the Australian Taxation Office, a research
and development tax credit in the amount of $<span id="xdx_905_eus-gaap--IncomeTaxExpenseBenefit_iN_pp0p0_di_c20200701__20210630_zk1027s4V9Fe" title="Tax credits">113,415 </span>and $<span id="xdx_901_eus-gaap--IncomeTaxExpenseBenefit_iN_pp0p0_di_c20190701__20200630_zG6ZTffrCXsj">134,728</span>, respectively, which is reflected as a tax benefit in the accompanying
consolidated statements of operations and comprehensive income (loss).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p id="xdx_846_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zaUFPhFSnEja" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="text-decoration: underline"><span id="xdx_861_zBj3dM4Ckci3">Stock
Based Compensation</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
Company records stock-based compensation in accordance with ASC 718, &#8220;<i>Stock Compensation</i>&#8221;. ASC 718 requires the fair
value of all stock-based employee compensation awarded to employees to be recorded as an expense over the shorter of the service period
or the vesting period. The Company values employee and non-employee stock-based compensation at fair value using the Black-Scholes Option
Pricing Model.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>PROPANC
BIOPHARMA, INC. AND SUBSIDIARY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>June
30, 2021 and 2020</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
Company adopted ASU 2018-07 and accounts for non-employee share-based awards in accordance with the measurement and recognition criteria
of ASC 718 and recognizes the fair value of such awards over the service period. The Company used the modified prospective method of
adoption. There was no cumulative effect of adoption on July 1, 2019.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p id="xdx_84A_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zLQNRYxs3VV5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="text-decoration: underline"><span id="xdx_86E_zEV4U1sMubQc">Revenue
Recognition</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
Company adopted and implemented on July 1, 2018, ASC 606 &#8211; Revenue from Contracts with Customers (&#8220;ASC 606&#8221;). ASC 606
did not have a material impact on the consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Upon
implementation of ASC 606, the Company recognizes revenue in accordance with that core principle by applying the following steps:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Step
1: Identify the contract(s) with a customer.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Step
2: Identify the performance obligations in the contract.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Step
3: Determine the transaction price.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Step
4: Allocate the transaction price to the performance obligations in the contract.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Step
5: Recognize revenue when (or as) the entity satisfies a performance obligation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 29.15pt; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Subject
to these criteria, the Company intends to recognize revenue relating to royalties on product sales in the period in which the sale occurs
and the royalty term has begun.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p id="xdx_846_eus-gaap--LegalCostsPolicyTextBlock_z7Q8kazLnfD2" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="text-decoration: underline"><span id="xdx_86A_zAg6XnkCAfwa">Legal
Expenses</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">All
legal costs for litigation are charged to expense as incurred.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p id="xdx_848_eus-gaap--LesseeLeasesPolicyTextBlock_zdlobmuL7B78" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="text-decoration: underline"><span id="xdx_86D_zjYfYbFZC052">Leases</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">In
February 2016, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued ASU 2016-02, <i>Leases</i> (Topic 842). The updated
guidance requires lessees to recognize lease assets and lease liabilities for most operating leases. In addition, the updated guidance
requires that lessors separate lease and non-lease components in a contract in accordance with the new revenue guidance in ASC 606. This
guidance is effective for interim and annual reporting periods beginning after December 15, 2018. The Company adopted this guidance effective
July 1, 2019.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">On
July 1, 2019, the Company adopted ASU No. 2016-02, applying the package of practical expedients to leases that commenced before the effective
date whereby the Company elected to not reassess the following: (i) whether any expired or existing contracts contain leases and; (ii)
initial direct costs for any existing leases. For contracts entered into on or after the effective date, at the inception of a contract
the Company assessed whether the contract is, or contains, a lease. The Company&#8217;s assessment is based on: (1) whether the contract
involves the use of a distinct identified asset, (2) whether we obtain the right to substantially all the economic benefit from the use
of the asset throughout the period, and (3) whether it has the right to direct the use of the asset. The Company will allocate the consideration
in the contract to each lease component based on its relative stand-alone price to determine the lease payments.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Operating
lease ROU assets represents the right to use the leased asset for the lease term and operating lease liabilities are recognized based
on the present value of future minimum lease payments over the lease term at commencement date. As most leases do not provide an implicit
rate, the Company use an incremental borrowing rate based on the information available at the adoption date in determining the present
value of future payments. Lease expense for minimum lease payments is amortized on a straight-line basis over the lease term and is included
in general and administrative expenses in the consolidated statements of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p id="xdx_844_eus-gaap--EarningsPerSharePolicyTextBlock_zz34xJHutc16" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="text-decoration: underline"><span id="xdx_864_zK6mVblSbdGl">Basic
and Diluted Net Loss Per Common Share</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Basic
net loss per share is computed by dividing the net loss by the weighted average number of common shares outstanding during the period.
Diluted net loss per common share is computed by dividing the net loss by the weighted average number of common shares outstanding for
the period and, if dilutive, potential common shares outstanding during the period. Potentially dilutive securities consist of the incremental
common shares issuable upon exercise of common stock equivalents such as stock options, warrants and convertible debt instruments. Potentially
dilutive securities are excluded from the computation if their effect is anti-dilutive. As a result, the basic and diluted per share
amounts for all periods presented are identical. <span id="xdx_903_eus-gaap--DebtInstrumentConvertibleTermsOfConversionFeature_c20200701__20210630_zq4qmcOL3Smg" title="Debt conversion percentage, description">Each holder of the notes has agreed to a <span id="xdx_904_eus-gaap--DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_pid_dp_uPure_c20200701__20210630_zzJU4tiDdpIk" title="Debt conversion percentage">4.99</span>% beneficial ownership conversion limitation
(subject to certain noteholders&#8217; ability to increase such limitation to 9.99% upon 60 days&#8217; notice to the Company)</span>, and each
note may not be converted during the first six-month period from the date of issuance. Such securities are considered dilutive securities
which were excluded from the computation since the effect is anti-dilutive.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>PROPANC
BIOPHARMA, INC. AND SUBSIDIARY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>June
30, 2021 and 2020</b></span></p>

<p id="xdx_898_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zp7ZAEmlQrYd" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span id="xdx_8B9_zWwXX59WoQ27" style="display: none">SCHEDULE OF DILUTIVE SECURITIES EXCLUDED FROM COMPUTATION</span>&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 100%; margin-right: auto">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>June
    30, 2021</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>June
    30, 2020</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 64%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Stock
    Options</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td id="xdx_981_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20200701__20210630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_zRF3jRJ6r1te" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Antidilutive securities excluded from computation of earnings per share"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">59</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td id="xdx_987_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20190701__20200630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_zloQygdbzAlh" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Antidilutive securities excluded from computation of earnings per share"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">60</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Stock
    Warrants</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td id="xdx_98E_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20200701__20210630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zNOzT456LxB6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Antidilutive securities excluded from computation of earnings per share"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">121,329</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td id="xdx_98D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20190701__20200630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zNtlaS94tWTe" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Antidilutive securities excluded from computation of earnings per share"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">151,171</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Unvested
    restricted stock</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td id="xdx_986_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20200701__20210630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--UnvestedRestrictedStockMember_zafhpGNhbIA6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Antidilutive securities excluded from computation of earnings per share"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">59</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td id="xdx_982_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20190701__20200630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--UnvestedRestrictedStockMember_zLMxtEOeqQAc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Antidilutive securities excluded from computation of earnings per share"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">59</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Convertible
    Debt</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td id="xdx_984_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20200701__20210630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertibleDebtSecuritiesMember_zx6G7fcxhV22" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Antidilutive securities excluded from computation of earnings per share"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">12,416,972</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td id="xdx_981_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20190701__20200630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertibleDebtSecuritiesMember_z4ty7l1bgPGc" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Antidilutive securities excluded from computation of earnings per share"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">439,113</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Total</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td id="xdx_98D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20200701__20210630_zS2qhAKAAjyf" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Antidilutive securities excluded from computation of earnings per share"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">12,538,419</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td id="xdx_986_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20190701__20200630_zsjYE0XRyHH4" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Antidilutive securities excluded from computation of earnings per share"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">590,403</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  </table>
<p id="xdx_8A2_z3r805ucvGn" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p id="xdx_84F_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zaCjb7rqrmle" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="text-decoration: underline"><span id="xdx_864_zqGyiHQTKivb">Recent
Accounting Pronouncements</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">We
have reviewed the FASB issued ASU accounting pronouncements and interpretations thereof that have effectiveness dates during the periods
reported and in future periods. We have carefully considered the new pronouncements that alter previous generally accepted accounting
principles and do not believe that any new or modified principles will have a material impact on the Company&#8217;s reported financial
position or operations in the near term with the exception of those disclosed below. The applicability of any standard is subject
to the formal review of the Company&#8217;s financial management.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In
August 2020, the FASB issued ASU 2020-06, &#8220;Debt &#8211; Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives
and Hedging &#8211; Contracts in Entity&#8217;s Own Equity (Subtopic 815-40)&#8221;. This ASU reduces the number of accounting models
for convertible debt instruments and convertible preferred stock. As well as amend the guidance for the derivatives scope exception for
contracts in an entity&#8217;s own equity to reduce form-over-substance-based accounting conclusions. In addition, this ASU improves
and amends the related EPS guidance. This standard is effective for us on July 1, 2022, including interim periods within those fiscal
years. Adoption is either a modified retrospective method or a fully retrospective method of transition. The Company is currently assessing
the impact the new guidance will have on our consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -URI http://asc.fasb.org/topic&amp;trid=2122394<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm140460440291368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOING CONCERN<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubstantialDoubtAboutGoingConcernTextBlock', window );">GOING CONCERN</a></td>
<td class="text"><p id="xdx_803_eus-gaap--SubstantialDoubtAboutGoingConcernTextBlock_ziUB31Kjwqvc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTE
2 &#8211; <span id="xdx_82D_z3Eip7SGNUxj">GOING CONCERN</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
accompanying unaudited condensed consolidated financial statements have been prepared in conformity with US GAAP, which contemplate continuation
of the Company as a going concern. For the three months ended September 30, 2021, the Company had no revenues, had a net loss of $<span id="xdx_90C_eus-gaap--ProfitLoss_iN_pp0p0_di_c20210701__20210930_zZ86ZTKlE3f">490,658</span>,
and had net cash used in operations of $<span id="xdx_90B_eus-gaap--NetCashProvidedByUsedInOperatingActivities_iN_pp0p0_di_c20210701__20210930_z7zDthEysJmg">486,758</span>. Additionally, as of September 30, 2021, the Company had a working capital deficit, stockholders&#8217;
deficit and accumulated deficit of $<span id="xdx_901_ecustom--WorkingCapitalDeficit_iI_pp0p0_c20210930_zmFMtHUfZicd">2,312,387</span>, $<span id="xdx_90A_eus-gaap--StockholdersEquity_iNI_pp0p0_di_c20210930_ztn1uKQgbUUb">2,306,630</span> and $<span id="xdx_900_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_pp0p0_di_c20210930_zUtdVGNRXych">58,804,968</span>, respectively. It is management&#8217;s opinion that these
conditions raise substantial doubt about the Company&#8217;s ability to continue as a going concern for a period of at least twelve months
from the issue date of this Quarterly Report.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
unaudited condensed consolidated financial statements do not include any adjustments to reflect the possible future effect on the recoverability
and classification of assets or the amounts and classifications of liabilities that may result from the outcome of this uncertainty.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">Successful
completion of the Company&#8217;s development program and, ultimately, the attainment of profitable operations are dependent upon future
events, including obtaining adequate financing to fulfill its development activities, acceptance of the Company&#8217;s patent applications,
obtaining additional sources of suitable and adequate financing and ultimately achieving a level of sales adequate to support the Company&#8217;s
cost structure and business plan. The Company&#8217;s ability to continue as a going concern is also dependent on its ability to further
develop and execute on its business plan. However, there can be no assurances that any or all of these endeavors will be successful.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>PROPANC
BIOPHARMA, INC. AND SUBSIDIARY<br/>
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS<br/>
SEPTEMBER 30, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Unaudited)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">In
March 2020, the outbreak of COVID-19 (coronavirus) caused by a novel strain of the coronavirus was recognized as a pandemic by the World
Health Organization, and the outbreak has become increasingly widespread in the United States, Europe and Australia, including in each
of the areas in which the Company operates. The COVID-19 (coronavirus) outbreak has had a notable impact on general economic conditions,
including but not limited to the temporary closures of many businesses, &#8220;shelter in place&#8221; and other governmental regulations,
reduced business and consumer spending due to both job losses, reduced investing activity and M&amp;A transactions, among many other
effects attributable to the COVID-19 (coronavirus), and there continue to be many unknowns. While to date the Company has not been required
to stop operating, management is evaluating its use of its office space, virtual meetings and the like. The Company continues to monitor
the impact of the COVID-19 (coronavirus) outbreak closely. The extent to which the COVID-19 (coronavirus) outbreak will impact our operations,
ability to obtain financing or future financial results is uncertain.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_808_eus-gaap--SubstantialDoubtAboutGoingConcernTextBlock_zrfc5XGh9z22" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>NOTE
2 &#8211; <span id="xdx_82D_zR4TUUmJtQxb">GOING CONCERN</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
accompanying consolidated financial statements have been prepared in conformity with US GAAP, which contemplate continuation of the Company
as a going concern. For the fiscal year ended June 30, 2021, the Company had <span id="xdx_90E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_doxL_c20200701__20210630_zb0oM1K9Z757" title="::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl0984">no
</span></span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">revenues, had a net loss of $<span id="xdx_904_eus-gaap--ProfitLoss_iN_pp0p0_di_c20200701__20210630_zE5KyvuIa4Tc">2,025,947
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">and had net cash used in operations
of $<span id="xdx_90B_eus-gaap--NetCashProvidedByUsedInOperatingActivities_iN_pp0p0_di_c20200701__20210630_zZZ2qqLukVg7">1,145,264</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">.
Additionally, as of June 30, 2021, the Company had a working capital deficit, stockholders&#8217; deficit and accumulated deficit of
$<span id="xdx_90B_ecustom--WorkingCapitalDeficit_c20210630_pp0p0">3,074,078</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">,
$<span id="xdx_90F_eus-gaap--StockholdersEquity_iNI_pp0p0_di_c20210630_zy1eQU64tRIg">3,067,573</span></span><span style="font: 10pt Times New Roman, Times, Serif">,
and $<span id="xdx_90B_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_pp0p0_di_c20210630_z63t6FGbdE9k">58,199,466</span></span><span style="font: 10pt Times New Roman, Times, Serif">,
</span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">respectively. It is management&#8217;s opinion that these
conditions raise substantial doubt about the Company&#8217;s ability to continue as a going concern for a period of at least twelve months
from the date of this filing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
consolidated financial statements do not include any adjustments to reflect the possible future effect on the recoverability and classification
of assets or the amounts and classifications of liabilities that may result from the outcome of this uncertainty.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Successful
completion of the Company&#8217;s development program and, ultimately, the attainment of profitable operations are dependent upon future
events, including obtaining adequate financing to fulfill its development activities, acceptance of the Company&#8217;s patent applications,
obtaining additional sources of suitable and adequate financing and ultimately achieving a level of sales adequate to support the Company&#8217;s
cost structure and business plan. The Company&#8217;s ability to continue as a going concern is also dependent on its ability to further
develop and execute on its business plan. However, there can be no assurances that any or all of these endeavors will be successful.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">In
March 2020, the outbreak of COVID-19 (coronavirus) caused by a novel strain of the coronavirus was recognized as a pandemic by the World
Health Organization, and the outbreak has become increasingly widespread in the United States, Europe and Australia, including in each
of the areas in which the Company operates. The COVID-19 (coronavirus) outbreak has had a notable impact on general economic conditions,
including but not limited to the temporary closures of many businesses, &#8220;shelter in place&#8221; and other governmental regulations,
reduced business and consumer spending due to both job losses, reduced investing activity and M&amp;A transactions, among many other
effects attributable to the COVID-19 (coronavirus), and there continue to be many unknowns. While to date the Company has not been required
to stop operating, management is evaluating its use of its office space, virtual meetings and the like. The Company continues to monitor
the impact of the COVID-19 (coronavirus) outbreak closely. The extent to which the COVID-19 (coronavirus) outbreak will impact our operations,
ability to obtain financing or future financial results is uncertain.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubstantialDoubtAboutGoingConcernTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure when substantial doubt is raised about the ability to continue as a going concern. Includes, but is not limited to, principal conditions or events that raised substantial doubt about the ability to continue as a going concern, management's evaluation of the significance of those conditions or events in relation to the ability to meet its obligations, and management's plans that alleviated or are intended to mitigate the conditions or events that raise substantial doubt about the ability to continue as a going concern.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 40<br> -URI http://asc.fasb.org/subtopic&amp;trid=51888271<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubstantialDoubtAboutGoingConcernTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm140460440244568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">PROPERTY AND EQUIPMENT</a></td>
<td class="text"><p id="xdx_80B_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zepSISzbskde" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTE
3 &#8211; <span id="xdx_82B_z2gR3jESkmWk">PROPERTY AND EQUIPMENT</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_897_eus-gaap--PropertyPlantAndEquipmentTextBlock_zg8Ghbs3Cm4d" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">Property
and equipment consist of the following as of September 30, 2021 and June 30, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8BD_zxaUS1cN4CT3" style="display: none">SCHEDULE
OF PROPERTY AND EQUIPMENT</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_49C_20210930_zAUwbf34Hci3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">September
    30, 2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_49C_20210630_zkfliRIteW57" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">June
    30, 2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(Unaudited)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_maPPAENzBVB_zWa3ZPXSA1sj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Office equipment at cost</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">27,532</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">28,623</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_msPPAENzBVB_zJIDwd7Qqdoa" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Less: Accumulated depreciation</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(23,939</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(24,368</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--PropertyPlantAndEquipmentNet_iTI_pp0p0_mtPPAENzBVB_zCIlyNdbrAOk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total property, plant,
    and equipment</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,593</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,255</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p id="xdx_8AD_zkLpjrunY5Y2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">Depreciation
expense for the three months ended September 30, 2021 and 2020 were $<span id="xdx_90D_eus-gaap--Depreciation_pp0p0_c20210701__20210930_zRmSWSeRcGnc">509</span> and $<span id="xdx_90C_eus-gaap--Depreciation_pp0p0_c20200701__20200930_z5geXjYMtJb2">438</span>, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<span></span>
</td>
<td class="text"><p id="xdx_803_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zHEs022u6Pnb" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>NOTE
3 &#8211; <span id="xdx_821_zas7Q1BDZ6t1">PROPERTY AND EQUIPMENT</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p id="xdx_895_eus-gaap--PropertyPlantAndEquipmentTextBlock_zmgFlYHfXWwc" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Property
and equipment consist of the following as of June 30,</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;<span id="xdx_8BB_zh0whEB5uiQ7" style="display: none">SCHEDULE OF PROPERTY AND EQUIPMENT</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 100%; margin-right: auto">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" id="xdx_490_20210630_zLQ8erGmgJRd" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>2021</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" id="xdx_493_20200630_zCZkbynpGDZc" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>2020</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_maPPAENzBVB_zZKQJHKCiSUf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 64%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Office
    equipment at cost</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">28,623</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">26,299</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_msPPAENzBVB_zh2Xl4FSeynh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Less:
    Accumulated depreciation</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(24,368</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(20,552</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--PropertyPlantAndEquipmentNet_iTI_pp0p0_mtPPAENzBVB_zTBB9pS58rT2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Total
    property, plant, and equipment</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">4,255</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">5,747</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Depreciation
expense for the years ended June 30, 2021 and 2020 were $<span id="xdx_908_eus-gaap--Depreciation_c20200701__20210630_pp0p0" title="Depreciation expense">1,993</span> and $<span id="xdx_908_eus-gaap--Depreciation_pp0p0_c20190701__20200630_zlHMWyp9Oy4" title="Depreciation expense">2,473</span>, respectively</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>PROPANC
BIOPHARMA, INC. AND SUBSIDIARY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>June
30, 2021 and 2020</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI http://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=SL120174063-112916<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm140460432856584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DUE TO FORMER DIRECTOR - RELATED PARTY<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_DisclosureDueToFormerDirectorRelatedPartyAbstract', window );"><strong>Due To Former Director - Related Party</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_DueToFormerDirectorRelatedPartyDisclosureTextBlock', window );">DUE TO FORMER DIRECTOR - RELATED PARTY</a></td>
<td class="text"><p id="xdx_803_ecustom--DueToFormerDirectorRelatedPartyDisclosureTextBlock_zYCHdB7lkeA7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTE
4 &#8211; <span id="xdx_820_z7yy1mR29q99">DUE TO FORMER DIRECTOR - RELATED PARTY</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">Due
to former director - related party represents unsecured advances made primarily by a former director for operating expenses on behalf
of the Company such as intellectual property and formation expenses. The expenses were paid for on behalf of the Company and are due
upon demand. The Company is currently not being charged interest under these advances. The total amount owed the former director at September
30, 2021 and June 30, 2021 were $<span id="xdx_90E_eus-gaap--DueToRelatedPartiesCurrent_iI_pp0p0_c20210930_zJxA1xS5YYVd">32,076</span> and $<span id="xdx_906_eus-gaap--DueToRelatedPartiesCurrent_iI_pp0p0_c20210630_zbE0QKQMtL6g">33,347</span>, respectively. The Company plans to repay the advances as its cash resources allow
(see Note 9).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_801_ecustom--DueToFormerDirectorRelatedPartyDisclosureTextBlock_zIiAd8JaTtW8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>NOTE
4 &#8211; <span id="xdx_82A_z24o9PK9MNna">DUE TO FORMER DIRECTOR - RELATED PARTY</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Due
to former director - related party represents unsecured advances made primarily by a former director for operating expenses on behalf
of the Company such as intellectual property and formation expenses. The expenses were paid for on behalf of the Company and are due
upon demand. The Company is currently not being charged interest under these advances. The total amount owed the former director at June
30, 2021 and 2020 is <span id="xdx_904_eus-gaap--DueToRelatedPartiesCurrent_c20210630_pp0p0" title="Due to directors - related parties">$33,347</span> and <span id="xdx_907_eus-gaap--DueToRelatedPartiesCurrent_c20200630_pp0p0" title="Due to directors - related parties">$30,639</span>, respectively. The Company plans to repay the advances as its cash resources allow (see Note
10).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_DisclosureDueToFormerDirectorRelatedPartyAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_DisclosureDueToFormerDirectorRelatedPartyAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_DueToFormerDirectorRelatedPartyDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Due to Former Director - Related Party Text Block</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_DueToFormerDirectorRelatedPartyDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm140460441994072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LOANS AND NOTES PAYABLE<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_DisclosureLoansAndNotesPayableAbstract', window );"><strong>Loans And Notes Payable</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_LoansAndNotesPayableDisclosureTextBlock', window );">LOANS AND NOTES PAYABLE</a></td>
<td class="text"><p id="xdx_80A_ecustom--LoansAndNotesPayableDisclosureTextBlock_zS4pzWmIuk09" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTE
5 &#8211; <span id="xdx_822_zntXa5mgWi7c">LOANS AND NOTES PAYABLE</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Loan
from Former Director - Related Party</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">Loan
from the Company&#8217;s former director at September 30, 2021 and June 30, 2021 were $<span id="xdx_907_eus-gaap--LoansPayable_iI_pp0p0_c20210930__srt--TitleOfIndividualAxis__custom--DirectorsAndOfficerMember_zjrzMBd5GgQ">53,384</span> and $<span id="xdx_906_eus-gaap--LoansPayable_iI_pp0p0_c20210630__srt--TitleOfIndividualAxis__custom--DirectorsAndOfficerMember_zi5UsTPh9Iy4">55,500</span>, respectively. The loan bears
no interest and is payable on demand. The Company did not repay any amount on this loan during the three months ended September 30, 2021
and 2020, respectively (see Note 9).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_80C_ecustom--LoansAndNotesPayableDisclosureTextBlock_zOI11SLk00V4" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>NOTE
5 &#8211; <span id="xdx_822_zYKwxJFs54dj">LOANS AND NOTES PAYABLE</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="text-decoration: underline">Loan
from Former Director - Related Party</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Loan
from the Company&#8217;s former director at June 30, 2021 and 2020 were <span id="xdx_909_eus-gaap--LoansPayable_c20210630__srt--TitleOfIndividualAxis__custom--DirectorsAndOfficerMember_pp0p0" title="Loans payable">$55,500</span> and <span id="xdx_908_eus-gaap--LoansPayable_c20200630__srt--TitleOfIndividualAxis__custom--DirectorsAndOfficerMember_pp0p0" title="Loans payable">$50,993</span>, respectively. The loan bear no interest
and is payable on demand. The Company did not repay any amount on this loan during the years ended June 30, 2021 and 2020, respectively,
(see Note 10).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_DisclosureLoansAndNotesPayableAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_DisclosureLoansAndNotesPayableAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_LoansAndNotesPayableDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loans and Notes Payable Text Block.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_LoansAndNotesPayableDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm140460440270920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONVERTIBLE NOTES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">CONVERTIBLE NOTES</a></td>
<td class="text"><p id="xdx_800_eus-gaap--DebtDisclosureTextBlock_zc2SqHBxedb7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTE
6 &#8211; <span id="xdx_82C_zKhRExlhfXl9">CONVERTIBLE NOTES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_897_eus-gaap--ConvertibleDebtTableTextBlock_zjBtvrzAXz4j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
Company&#8217;s convertible notes outstanding at September 30, 2021 and June 30, 2021 were as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_8B0_zcA9zJu0m1X9" style="display: none">SCHEDULE
OF CONVERTIBLE NOTES</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_491_20210930_zAp0KEWZ480k" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">September
    30, 2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_497_20210630_zyLLJTngGXul" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">June
    30, 2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(Unaudited)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--DebtInstrumentCarryingAmount_iI_pp0p0_maLTDzcuB_zeR5AoxnitQ" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Convertible notes and debenture</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 17%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">377,780</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 15%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">400,128</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--DebtInstrumentUnamortizedDiscount_iNI_pp0p0_di_msLTDzcuB_z1VTqFyrK7xb" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Unamortized discounts</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(7,565</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(6,139</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_40C_eus-gaap--DepositLiabilitiesAccruedInterest_iI_pp0p0_maLTDzcuB_zzTn53DC3CG" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Accrued interest</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">37,348</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">34,098</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--DebtInstrumentUnamortizedPremium_iI_pp0p0_maLTDzcuB_ztrTE0IiZtYh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Premium, net</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">177,045</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">196,496</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--LongTermDebt_iTI_pp0p0_mtLTDzcuB_zuIe10MIoIM4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Convertible notes,
    net</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">584,608</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">624,583</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p id="xdx_8A6_zemr5ZC68yq2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>PROPANC
BIOPHARMA, INC. AND SUBSIDIARY<br/>
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS<br/>
SEPTEMBER 30, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Unaudited)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Convertible
Note Issued with Consulting Agreement</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>August
10, 2017 Consulting Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On
August 10, 2017, the Company entered into a consulting agreement, retroactive to May 16, 2017, with a certain consultant, pursuant to
which the consultant agreed to provide certain consulting and business advisory services in exchange for a $<span id="xdx_905_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20170810__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember_zdMEwkoDhrF5" title="Convertible debt principal amount">310,000</span> junior subordinated
convertible note. The maturity date of the August 10, 2017 Convertible Note was August 2019 and is currently past due (see Note 8). The
note accrues interest at a rate of <span id="xdx_906_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20170810__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember_zHsGPhEkIvh9" title="Debt instrument, interest rate, stated percentage">10</span>% per annum and is convertible into common stock at the lesser of $<span id="xdx_90E_eus-gaap--DebtConversionConvertedInstrumentAmount1_pp0p0_c20170807__20170810__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember_zBByegCwFfaf" title="Debt conversion of converted amount">750</span> or <span id="xdx_90A_eus-gaap--DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_dp_uPure_c20170807__20170810__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember_zJcps9fyr4oh" title="Common stock trading volume, percent">65</span>% of the three lowest
trades in the <span id="xdx_906_eus-gaap--DebtInstrumentConvertibleThresholdTradingDays_dc_uInteger_c20170807__20170810__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember_zGmOAN9OUAw9" title="Common stock trading days">ten</span> trading days prior to the conversion. The note was fully earned upon signing the agreement and matures on <span id="xdx_909_eus-gaap--DebtInstrumentMaturityDate_dd_c20170807__20170810__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember_zyP7hAcsqzb6" title="Debt maturity date">August 10,
2019</span>. The Company accrued $<span id="xdx_906_eus-gaap--AccruedLiabilitiesCurrentAndNoncurrent_iI_pp0p0_c20170630__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember_zaaitofopWHl" title="Accrued expenses">155,000</span> related to this expense at June 30, 2017 and recorded the remaining $<span id="xdx_90A_eus-gaap--AccruedLiabilitiesCurrentAndNoncurrent_iI_pp0p0_c20180630__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember_zRQ09peme5id" title="Accrued expenses">155,000</span> related to this expense
in fiscal year 2018. Upon an event of default, principal and accrued interest will become immediately due and payable under the note.
Additionally, upon an event of default, at the election of the holder, the note would accrue interest at a default interest rate of <span id="xdx_90B_ecustom--DebtInstrumentDebtDefaultInterestRate_dp_uPure_c20170807__20170810__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember_zcUwSkiztpM2" title="Debt instrument, default, interest rate">18</span>%
per annum or the highest rate of interest permitted by law. The consulting agreement had a three-month term and expired on August 16,
2017. An aggregate total of $<span id="xdx_901_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_iI_pp0p0_c20170810__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember_zMHkB6YPayh3" title="Embedded derivative, fair value of embedded derivative liability">578,212</span> of this note was bifurcated with the embedded conversion option recorded as a derivative liability
at fair value. During the year ended June 30, 2018, the consultant converted $<span id="xdx_90F_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20180630__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ConsultantMember_zt0fOKSSrOwc" title="Convertible debt principal amount">140,000</span> of principal and $<span id="xdx_90A_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20180630__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ConsultantMember_zMhXsq0UfDqe" title="Accrued interest">10,764</span> of interest. During the
year ended June 30, 2019, the consultant converted an additional $<span id="xdx_902_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20190630__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ConsultantMember_zvWNRi3Fyayl" title="Convertible debt principal amount">161,000</span> of principal and $<span id="xdx_90B_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20190630__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ConsultantMember_z9Di3nlU5iTd" title="Accrued interest">19,418 </span>of interest leaving a principal balance
owed of $<span id="xdx_90A_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20190630__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember_znM13bvcFSY8" title="Convertible debt principal amount">9,000</span> at June 30, 2019. During the year ended June 30, 2020, the consultant converted an additional $<span id="xdx_902_eus-gaap--DebtConversionConvertedInstrumentAmount1_pp0p0_c20190701__20200630__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember_zrkFm4TR9TSb" title="Debt conversion of converted amount">500</span> of principal and $<span id="xdx_903_eus-gaap--AccruedLiabilitiesCurrentAndNoncurrent_iI_pp0p0_c20200630__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember_zViIFvWqXmf1" title="Accrued expenses">5,248</span>
of interest such that the remaining principal outstanding and accrued interest under this note as of June 30, 2020 was $<span id="xdx_90D_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20200630__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember_zNhyMipK3bs6" title="Convertible debt principal amount">8,500</span> and $<span id="xdx_900_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20200630__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember_zPMxfvm3VEyh" title="Accrued interest">22,168</span>,
respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On
March 15, 2021, the Company entered into a Settlement and Mutual Release Agreement (the &#8220;Settlement Agreement&#8221;) with the
consultant whereby both parties agreed to settle all claims and liabilities under the August 10, 2017 Convertible note for a total of
$<span id="xdx_901_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20210315__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember__us-gaap--ShortTermDebtTypeAxis__custom--SettlementAndMutualReleaseAgreementMember_zX5bYvBALoPi" title="Convertible debt principal amount">100,000</span> in the form of a convertible note. All other terms of the August 10, 2017 Convertible Note shall remain in full force and effect.
Both parties agree that all future penalties under this note are waived unless the Company fails to authorize to distribute the requested
shares upon conversion. The Company has the right to pay off the balance of any remaining amounts dues under this note in cash at any
time more than 60 days after March 15, 2021. Prior to the Settlement Agreement, the Company recorded total liabilities $<span id="xdx_901_eus-gaap--Liabilities_iI_pp0p0_c20210315__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember__us-gaap--ShortTermDebtTypeAxis__custom--SettlementAndMutualReleaseAgreementMember_zsfI8VwYYoO8" title="Liabilities">56,762</span> consisting
of remaining principal amount of $<span id="xdx_901_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pp0p0_c20210315__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember__us-gaap--ShortTermDebtTypeAxis__custom--SettlementAndMutualReleaseAgreementMember_zBR1G1YGjlg7" title="Original issue discount">8,500</span>, accrued interest of $<span id="xdx_90C_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20210315__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember__us-gaap--ShortTermDebtTypeAxis__custom--SettlementAndMutualReleaseAgreementMember_z9lTGAIR1brb" title="Accrued interest">23,262</span> and accrued expenses of $<span id="xdx_902_eus-gaap--AccruedLiabilitiesCurrentAndNoncurrent_iI_pp0p0_c20210315__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember__us-gaap--ShortTermDebtTypeAxis__custom--SettlementAndMutualReleaseAgreementMember_zE7X1tZJDwK8" title="Accrued expenses">25,000</span>. Accordingly, the Company recognized
loss from settlement of debt of $<span id="xdx_902_eus-gaap--GainsLossesOnExtinguishmentOfDebt_pp0p0_c20200701__20210630__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember__us-gaap--ShortTermDebtTypeAxis__custom--SettlementAndMutualReleaseAgreementMember_zoqeBx07G0Ua" title="Loss from settlement of debt">43,238</span> during the year ended June 30, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
total principal outstanding after adjustment due to the above-mentioned March 15, 2021 settlement agreement and accrued interest under
the August 10, 2017 Convertible Note was $<span id="xdx_907_eus-gaap--ConvertibleNotesPayable_iI_pp0p0_c20210630__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember__us-gaap--ShortTermDebtTypeAxis__custom--SettlementAndMutualReleaseAgreementMember_zMbLpH92Hkg">80,000</span> and $<span id="xdx_906_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20210630__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember__us-gaap--ShortTermDebtTypeAxis__custom--SettlementAndMutualReleaseAgreementMember_zlG84V2LUGeg">3,738</span>, respectively, as of June 30, 2021 following conversion of $<span id="xdx_902_eus-gaap--DebtConversionConvertedInstrumentAmount1_pp0p0_c20200701__20210630__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember__us-gaap--ShortTermDebtTypeAxis__custom--SettlementAndMutualReleaseAgreementMember_z4opLBtZGvtc">20,000</span> of principal
during the year ended June 30, 2021. The total principal amount outstanding under the August 10, 2017 Convertible Note was $<span id="xdx_900_eus-gaap--ConvertibleNotesPayable_iI_pp0p0_c20210930__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember__us-gaap--ShortTermDebtTypeAxis__custom--SettlementAndMutualReleaseAgreementMember_zrpiKNB5yqQ7">80,000</span> and
accrued interest of $<span id="xdx_900_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20210930__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember__us-gaap--ShortTermDebtTypeAxis__custom--SettlementAndMutualReleaseAgreementMember_zhUGxkUaTiWb">7,381</span> as of as of September 30, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Auctus
Fund Financing Agreements</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>August
30, 2019 Securities Purchase Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Effective
August 30, 2019, the Company entered into a securities purchase agreement with Auctus Fund, LLC (&#8220;Auctus&#8221;), pursuant to which
Auctus purchased a convertible promissory note (the &#8220;August 30, 2019 Auctus Note&#8221;) from the Company in the aggregate principal
amount of $<span id="xdx_90A_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20190830__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_zV8IsENUgnMc" title="Convertible debt principal amount">550,000</span>, such principal and the interest thereon convertible into shares of the Company&#8217;s common stock at the option
of Auctus. The transaction closed on August 30, 2019 and the Company received payment on September 4, 2019 in the amount of $<span id="xdx_903_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20190904__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_zmX45L2RKm67" title="Convertible debt principal amount">550,000</span>,
of which $<span id="xdx_909_eus-gaap--LegalFees_pp0p0_c20190903__20190904__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_zM4ZDYGnUbY3" title="Legal fees">5,000</span> was paid directly toward legal fees and $<span id="xdx_903_ecustom--DiligenceFees_c20190903__20190904__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_zqsWa63arAJ7" title="Diligence fees">40,000</span> to Auctus for due diligence fees resulting in net cash proceeds of $<span id="xdx_90F_eus-gaap--ProceedsFromConvertibleDebt_pp0p0_c20190903__20190904__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_zr4THCD44Xg1" title="Proceeds from convertible debt">505,000</span>.
The maturity date of the August 30, 2019 Auctus Note was <span id="xdx_90E_eus-gaap--DebtInstrumentMaturityDate_dd_c20190829__20190830__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_zDR9BpwAdgR3" title="Debt maturity date">August 30, 2020</span> and was currently past due. The August 30, 2019 Auctus Note
bore interest at a rate of <span id="xdx_900_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20190830__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_zkdy5Q17THL2" title="Debt instrument, interest rate, stated percentage">10</span>% per annum, but not payable until the August 30, 2019 Auctus Note became payable, whether at the maturity
date or upon acceleration or by prepayment. The note was treated as stock settled debt under ASC 480 and accordingly the Company recorded
a $<span id="xdx_903_eus-gaap--DebtInstrumentUnamortizedPremium_iI_pp0p0_c20190830__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_zRiHwC088mR2" title="Debt premium amount">366,667</span> put premium. The August 30, 2019 Auctus Note may not be prepaid without the written consent of Auctus. Any amount of principal
or interest which was not paid when due shall bear interest at the rate of <span id="xdx_908_ecustom--DebtInstrumentDebtDefaultInterestRate_dp_uPure_c20190829__20190830__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_zHKxsto7eDza" title="Debt instrument, default, interest rate">24</span>% per annum.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Additionally,
Auctus had the option to convert all or any amount of the principal face amount and accrued interest of the August 30, 2019 Auctus Note,
at any time following the issue date and ending on the later of the maturity date or the date of payment of the Default Amount if an
event of default occurs, which was an amount equal to <span id="xdx_90D_ecustom--PercentageOfOutstandingSharesOfCommonStock_dp_uPure_c20190829__20190830__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_zTkSILK2Z3fc" title="Percentage of outstanding shares of common stock">125</span>% of an amount equal to the then outstanding principal amount of the August
30, 2019 Auctus Note (but not less than $15,000) plus any interest accrued from August 30, 2019 at the default interest rate of <span id="xdx_907_ecustom--DebtInstrumentDebtDefaultInterestRate_dp_uPure_c20190829__20190830__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_zfhrvGYHWUR1" title="Debt instrument, default, interest rate">24</span>% per
annum, for shares of the Company&#8217;s common stock at the then-applicable conversion price. Upon the holder&#8217;s election to convert
accrued interest, default interest or any penalty amounts as stipulated, the Company may elect to pay those amounts in cash. The note
may also be prepaid by the Company at any time between the date of issuance and August 13, 2020 at 135% multiplied by the sum of (a)
the then outstanding principal amount plus (b) accrued and unpaid interest plus (c) default interests, if any.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
conversion price for the August 30, 2019 Auctus Note was equal to the Variable Conversion Price of <span id="xdx_908_eus-gaap--DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_dp_uPure_c20190903__20190904__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_zXKSok3ltqR6" title="Common stock trading volume, percent">60</span>% of the Market Price on the date
of conversion. Notwithstanding the foregoing, Auctus shall be restricted from effecting a conversion if such conversion, along with other
shares of the Company&#8217;s common stock beneficially owned by Auctus and its affiliates, exceeds <span id="xdx_90E_ecustom--PercentageOfOutstandingSharesOfCommonStock_dp_uPure_c20190903__20190904__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_zH6BNNz0fSne" title="Percentage of outstanding shares of common stock">4.99</span>% of the outstanding shares of
the Company&#8217;s common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>PROPANC
BIOPHARMA, INC. AND SUBSIDIARY<br/>
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS<br/>
SEPTEMBER 30, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Unaudited)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In
connection with the issuance of the August 2019 Auctus Note, the Company issued common stock purchase warrants to Auctus to purchase
<span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20190830__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember__us-gaap--StatementEquityComponentsAxis__custom--FirstWarrantMember_zpcbk22qeGsg" title="Warrants to purchase of common stock, shares">450</span> shares of the Company&#8217;s common stock (the &#8220;First Warrant&#8221;) as a commitment fee upon the terms and subject to the
limitations and conditions set forth in such First Warrant at an &#8220;Exercise Price&#8221; of $<span id="xdx_908_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20190830__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember__us-gaap--StatementEquityComponentsAxis__custom--FirstWarrantMember_zeOwLVNv5Yi7" title="Warrants exercise price per share">2,250</span>. In connection with the issuance
of the Note, the Company issued a common stock purchase warrant to Buyer to purchase <span id="xdx_907_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20190830__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember__us-gaap--StatementEquityComponentsAxis__custom--SecondWarrantMember_zRTJsLcNKxb1" title="Warrants to purchase of common stock, shares">300</span> shares of the Company&#8217;s common stock (the
&#8220;Second Warrant&#8221;) as a commitment fee upon the terms and subject to the limitations and conditions set forth in such Second
Warrant at an &#8220;Exercise Price&#8221; of $<span id="xdx_90C_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20190830__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember__us-gaap--StatementEquityComponentsAxis__custom--SecondWarrantMember_zrIQtzyExSJ" title="Warrants exercise price per share">3,330</span>. In connection with the issuance of the Note, the Company shall issue a common stock
purchase warrant to Buyer to purchase <span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20190830__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember__us-gaap--StatementEquityComponentsAxis__custom--ThirdWarrantMember_zAKe3tNeY5C6" title="Warrants to purchase of common stock, shares">225</span> shares of the Company&#8217;s common stock (the &#8220;Third Warrant&#8221;) as a commitment
fee upon the terms and subject to the limitations and conditions set forth in such Third Warrant at an &#8220;Exercise Price&#8221; of
$<span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20190830__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember__us-gaap--StatementEquityComponentsAxis__custom--ThirdWarrantMember_zBKfggn3dT37" title="Warrants exercise price per share">4,500</span>. The First Warrant, Second Warrant, and Third Warrant were collectively be referred as the &#8220;Warrants&#8221;. The Warrants
have an &#8220;Exercise Period&#8221; of five years from the date of issuance being August 30, 2019. Under the terms of the Purchase
Agreement and the Warrants, the Selling Security Holder may not either convert the Notes nor exercise the Warrants to the extent (but
only to the extent) that the Selling Security Holder or any of its affiliates would beneficially own a number of shares of our Common
Stock which would exceed <span id="xdx_904_ecustom--PercentageOfOutstandingSharesOfCommonStock_dp_uPure_c20190701__20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_zhyEK3pmLq55" title="Percentage of outstanding shares of common stock">4.99</span>% of our outstanding shares. The Company accounted for the warrants by using the relative fair value method
and recorded debt discount from the relative fair value of the warrants of $<span id="xdx_901_eus-gaap--FairValueAdjustmentOfWarrants_pp0p0_c20190829__20190830__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_zHrxPgIwkxO6" title="Fair value of warrants">375,905</span> using a simple binomial lattice model.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In
connection with the Purchase Agreement, the Company and the Purchaser entered into a Registration Rights Agreement (the &#8220;Registration
Rights Agreement&#8221;). Pursuant to the Registration Rights Agreement, the Company agreed to register the shares of Common Stock underlying
the Securities in a Registration Statement with the SEC as well as the Commitment Shares (as defined herein). The Registration Rights
Agreement contains customary representations, warranties, agreements and indemnification rights and obligations of the parties.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
Note was subject to customary default provisions and also includes a cross-default provision which provides that a breach or default
by the Borrower of any covenant or other term or condition contained in any of the Other Agreements (as defined therein), after the passage
of all applicable notice and cure or grace periods, shall, at the option of the Holder, be considered a default under this Note and the
Other Agreements. Upon occurrence of any such event, the Holder was entitled (but in no event required) to apply all rights and remedies
of the Holder under the terms of this Note and the Other Agreements by reason of a default under said Other Agreements or the Note.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
August 30, 2019 Auctus Note contained certain events of default, upon which principal and accrued interest will become immediately due
and payable. In addition, upon an event of default, interest on the outstanding principal accrued at a default interest rate of 24% per
annum.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
total principal amount outstanding under the above Auctus financing agreement, specifically the August 30, 2019 Auctus Note, was $<span id="xdx_90E_eus-gaap--DebtInstrumentFaceAmount_iI_c20190630__us-gaap--TypeOfArrangementAxis__custom--AuctusFinancingAgreementMember_zu1KVqEJdIm6">358,965</span>
and accrued interest of $<span id="xdx_90F_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_zfTyoyOT5roe" title="Accrued interest">486</span> as of June 30, 2020 following conversion of $<span id="xdx_908_eus-gaap--DebtConversionConvertedInstrumentAmount1_pp0p0_c20190701__20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_zYryjWAnVksd" title="Debt conversion of converted amount">191,035</span> of the principal balance and $<span id="xdx_903_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20200630__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_z0TW5PAWVlu" title="Accrued interest">43,176</span> of accrued interest
during the year ended June 30, 2020. Accordingly, $<span id="xdx_90C_eus-gaap--DebtInstrumentUnamortizedPremium_iI_pp0p0_c20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_zerbcq66mLU1" title="Debt premium amount">127,356</span> of the put premium was released in respect of the August 30, 2019 Auctus Note
during the year ended June 30, 2020 following conversion of the principal balance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
total principal amount outstanding under the above Auctus financing agreement, specifically the August 30, 2019 Auctus Note, was $<span id="xdx_902_eus-gaap--DebtInstrumentFaceAmount_iI_c20210630__us-gaap--TypeOfArrangementAxis__custom--AuctusFinancingAgreementMember_z204cLvGUN53">32,848</span>
and accrued interest of $<span id="xdx_906_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_z1fqVwhhr6Q9">0</span> as of June 30, 2021 following conversion of $<span id="xdx_90C_eus-gaap--DebtConversionConvertedInstrumentAmount1_pp0p0_c20200701__20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_z4cgVEaFq4xf">326,117</span> of the principal balance and $<span id="xdx_90B_ecustom--DebtConversionConvertedInterestPayable_pp0p0_c20200701__20210630__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_zh48bNCa2wFg">39,536</span> of accrued interest
during the year ended June 30, 2021. Accordingly, $<span id="xdx_908_eus-gaap--DebtInstrumentUnamortizedPremium_iI_pp0p0_c20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_zG2iHHvRnVEa">217,411</span> of the put premium was released in respect of the August 30, 2019 Auctus Note
during the year ended June 30, 2021 following conversion of the principal balance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
total principal amount outstanding under the above Auctus financing agreement, specifically the August 30, 2019 Auctus Note, was $<span id="xdx_903_eus-gaap--DebtInstrumentFaceAmount_iI_c20210930__us-gaap--TypeOfArrangementAxis__custom--AuctusFinancingAgreementMember_zxfOWZcGYCKf" title="Convertible debt principal amount">0</span> and
accrued interest of $<span id="xdx_90E_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20210930__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_zFwYUbViB34h" title="Accrued interest">0</span> as of September 30, 2021 following conversion of $<span id="xdx_90A_eus-gaap--DebtConversionConvertedInstrumentAmount1_pp0p0_c20210701__20210930__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_zUicSgLdvtrj" title="Debt conversion of converted amount">32,848</span> of the principal balance and $<span id="xdx_900_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20210930__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_ztM82l9WU34i" title="Debt conversion of accrued interest">716</span> of accrued interest
during the three months ended September 30, 2021. Accordingly, $<span id="xdx_904_eus-gaap--DebtInstrumentUnamortizedPremium_iI_pp0p0_c20210930__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_z55t0Mkeh9v" title="Debt premium amount">21,899</span> of the put premium was released in respect of the August 30, 2019
Auctus Note during the three months ended September 30, 2021 following conversion of the principal balance. Accordingly, there was no
outstanding principal balance as of September 30, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Crown
Bridge Securities Purchase Agreements</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Effective
October 3, 2019, the Company entered into a securities purchase agreement with Crown Bridge Partners, pursuant to which Crown Bridge
purchased a convertible promissory note (the &#8220;October 3, 2019 Crown Bridge Note&#8221;) from the Company in the aggregate principal
amount of $<span id="xdx_90F_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20191003__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember_zXZUNdqIui1g" title="Convertible debt principal amount">108,000</span>, such principal and the interest thereon convertible into shares of the Company&#8217;s common stock at the option
of Crown Bridge any time from the of issuance of the of the October 3, 2019 Crown Bridge Note. The transactions contemplated by the Crown
Bridge Securities Purchase Agreement closed on October 3, 2019. Pursuant to the terms of the Crown Bridge Securities Purchase Agreement,
Crown Bridge deducted $<span id="xdx_900_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_pp0p0_c20191001__20191003__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember_zhXRStu3jAN6" title="Debt instrument principal payment">3,000</span> from the principal payment due under the October 3, 2019 Crown Bridge Note, at the time of closing, to be
applied to its legal expenses, and there was a $<span id="xdx_901_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pp0p0_c20191003__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember_zetTnujDFiNf" title="Original issue discount">5,000</span> original issuance discount resulting in $<span id="xdx_903_eus-gaap--ProceedsFromConvertibleDebt_pp0p0_c20191001__20191003__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember_z0CsAu11Ipuf" title="Proceeds from convertible debt">100,000</span> net proceeds to the Company. The
Company intends to use the net proceeds from the October 3, 2019 Crown Bridge Note for general working capital purposes. The maturity
date of the October 3, 2019 Crown Bridge was October 3, 2020 and is currently past due. The <span id="xdx_903_eus-gaap--DebtInstrumentMaturityDate_dd_c20191001__20191003__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember_zoae1JxdAsQh" title="Debt maturity date">October 3, 2019</span> Crown Bridge Note bears interest
at a rate of <span id="xdx_90B_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20191003__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember_zQQ255xvCjDc" title="Debt instrument, interest rate, stated percentage">10</span>% per annum, which interest may be paid by the Company to Crown Bridge in shares of the Company&#8217;s common stock;
but shall not be payable until the October 2019 Crown Bridge Note becomes payable, whether at the maturity date or upon acceleration
or by prepayment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>PROPANC
BIOPHARMA, INC. AND SUBSIDIARY<br/>
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS<br/>
SEPTEMBER 30, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Unaudited)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Additionally,
Crown Bridge has the option to convert all or any amount of the principal face amount of the October 3, 2019 Crown Bridge Note at any
time from the date of issuance and ending on the later of the maturity date or the date the Default Amount is paid if an event of default
occurs, which is an amount between <span id="xdx_90B_ecustom--DebtInstrumentDebtDefaultInterestRate_pid_dp_uPure_c20191001__20191003__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember__srt--RangeAxis__srt--MinimumMember_znQ30TSyPxg2" title="Debt instrument, default, interest rate">110</span>% and <span id="xdx_909_ecustom--DebtInstrumentDebtDefaultInterestRate_pid_dp_uPure_c20191001__20191003__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember__srt--RangeAxis__srt--MaximumMember_zzQvuvFG1Mpb" title="Debt instrument, default, interest rate">150</span>% of an amount equal to the then outstanding principal amount of the October 3, 2019 Crown
Bridge Note plus any interest accrued, for shares of the Company&#8217;s common stock at the then-applicable conversion price.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90A_eus-gaap--DebtInstrumentDescription_c20191001__20191003__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember_zoS7xQeAQNu4">The
conversion price for the October 3, 2019 Crown Bridge Note shall be equal to a 40% discount of the lowest closing bid price (&#8220;Lowest
Trading Price&#8221;) of the Common Stock for the ten trading days immediately prior to the delivery of a Notice of Conversion, including
the day upon which a Notice of Conversion is received. Notwithstanding the foregoing, Crown Bridge shall be restricted from effecting
a conversion if such conversion, along with other shares of the Company&#8217;s common stock beneficially owned by Crown Bridge and its
affiliates, exceeds <span id="xdx_904_ecustom--PercentageOfOutstandingSharesOfCommonStock_pid_dp_uPure_c20191001__20191003__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember__srt--RangeAxis__srt--MinimumMember_zRdEc6aixyRc" title="Percentage of outstanding shares of common stock">4.99</span>% of the outstanding shares of the Company&#8217;s common stock which may be increased up to <span id="xdx_90F_ecustom--PercentageOfOutstandingSharesOfCommonStock_pid_dp_uPure_c20191001__20191003__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember__srt--RangeAxis__srt--MaximumMember_zhtu86bdy1Sk" title="Percentage of outstanding shares of common stock">9.99</span>% upon 60 days
prior written notice by the Crown Bridge to the Company. The note is treated as stock settled debt under ASC 480 and accordingly the
Company recorded a $<span id="xdx_904_eus-gaap--DebtInstrumentUnamortizedPremium_iI_pp0p0_c20191003__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember_zBHIVjm47c4k" title="Debt premium amount">72,000</span> put premium.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
October 3, 2019 Crown Bridge Note contain certain events of default, upon which principal and accrued interest will become immediately
due and payable. In addition, upon an event of default, interest on the outstanding principal shall accrue at a default interest rate
of <span id="xdx_90E_ecustom--DebtInstrumentDebtDefaultInterestRate_pid_dp_uPure_c20191001__20191003__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember_zOHqQWtgwzRh" title="Debt instrument, default, interest rate">15</span>% per annum, or if such rate is usurious or not permitted by current law, then at the highest rate of interest permitted by law.
Further, certain events of default may trigger penalty and liquidated damage provisions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
total principal amount outstanding under the above Crown Bridge financing agreement was $<span id="xdx_904_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember_zdFkwsqeea91" title="Convertible debt principal amount">65,280</span> and accrued interest of $<span id="xdx_90E_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember_z34GfxgvFSQ" title="Accrued interest">7,232</span> as of
as of June 30, 2020 following conversion of $<span id="xdx_905_eus-gaap--DebtConversionConvertedInstrumentAmount1_pp0p0_c20190701__20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember_zEZy8QoDC4Vd" title="Debt conversion of converted amount">42,720</span> of the principal balance during the year ended June 30, 2020. Accordingly, $<span id="xdx_908_eus-gaap--DebtInstrumentUnamortizedPremium_iI_pp0p0_c20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember_zded0iHOmySh" title="Debt premium amount">28,480</span>
of the put premium was released in respect of the October 3, 2019 Crown Bridge Note during the year ended June 30, 2020 following conversion
of the principal balance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">There
were <span id="xdx_909_ecustom--UnissuedSharesConversion_c20200915__20200916__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember_zXlDsNhWk6Je" title="Unissued shares conversion">15,000</span> unissued shares which were considered issuable for accounting purposes during the 1<sup>st</sup> quarter of fiscal 2021 related
to a conversion notice dated and received on September 16, 2020. In November 2020, the Company was notified by the note holder of the
cancellation of this conversion notice as a result of the reverse stock split and as such the Company reversed the effects of this transaction
thereby increasing the principal balance by $<span id="xdx_90D_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20201130__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember_zy32wXzjQvLj" title="Convertible debt principal amount">9,600</span> and put premium by $<span id="xdx_907_eus-gaap--DebtInstrumentUnamortizedPremium_iI_pp0p0_c20201130__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember_zq3jN7FvTuX2" title="Debt premium amount">6,400</span> and a corresponding decrease in equity of $<span id="xdx_90E_ecustom--DueToEquityConversion_iI_pp0p0_c20201130__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember_zUybJvNFcnPb" title="Due to equity conversion">16,000</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
total principal amount outstanding under the above Crown Bridge financing agreement was $<span id="xdx_90F_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember_zOJBdPnY5H41" title="Convertible debt principal amount">65,280</span> and accrued interest of $<span id="xdx_909_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember_zodzjcK19hV8" title="Accrued interest">16,138</span>
as of June 30, 2021. The total principal amount outstanding under the above Crown Bridge financing agreement was $<span id="xdx_902_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20210930__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember_zLpmI8hWX2ka">65,280</span> and accrued
interest of $<span id="xdx_902_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20210930__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember_zOnEQT0IP02c">18,606</span> as of as of September 30, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>GW
Holdings Securities Purchase Agreements</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>December
10, 2020 Securities Purchase Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Effective
December 10, 2020, the Company entered into a securities purchase agreement with GW Holdings, pursuant to which GW Holdings purchased
a convertible promissory note (the &#8220;December 10, 2020 GW Note&#8221;) from the Company in the aggregate principal amount of $<span id="xdx_903_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20201210__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--DecemberTenTwoThousandTwentyGWNoteMember_zMtcOjSqoMlg" title="Convertible debt principal amount">131,000</span>,
such principal and the interest thereon convertible into shares of the Company&#8217;s common stock at the option of GW Holdings anytime
from the issuance of the December 10, 2020 GW Holdings Note. The transactions contemplated by the GW Holdings Securities Purchase Agreement
closed on December 10, 2020. Pursuant to the terms of the GW Holdings Securities Purchase Agreement, the lender deducted $<span id="xdx_900_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_pp0p0_c20201209__20201210__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--DecemberTenTwoThousandTwentyGWNoteMember_zmu64tgjRdE9" title="Debt instrument principal payment">6,000</span> from
the principal payment due under the December 10, 2020 GW Note, at the time of closing, to be applied to its legal expenses. The Company
intends to use the net proceeds of $<span id="xdx_90F_eus-gaap--ProceedsFromConvertibleDebt_pp0p0_c20201209__20201210__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--DecemberTenTwoThousandTwentyGWNoteMember_zu5jh9QSR7A2" title="Proceeds from convertible debt">125,000</span> from the December 10, 2020 GW Note for general working capital purposes. The maturity date
of the December 10, 2020 GW Holdings is <span id="xdx_904_eus-gaap--DebtInstrumentMaturityDate_dd_c20201209__20201210__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--DecemberTenTwoThousandTwentyGWNoteMember_zdVj5PT9Jq14" title="Debt maturity date">December 10, 2021</span>. The December 10, 2020 GW Holdings Note bears interest at a rate of <span id="xdx_902_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20201210__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--DecemberTenTwoThousandTwentyGWNoteMember_zqOjTWqM9AJk" title="Debt instrument, interest rate, stated percentage">8</span>% per
annum, which interest may be paid by the Company to GW Holdings in shares of the Company&#8217;s common stock; but shall not be payable
until the December 10, 2020 GW Holdings Note becomes payable, whether at the maturity date or upon acceleration or by prepayment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
above notes issued to GW Holdings contain certain events of default, upon which principal and accrued interest will become immediately
due and payable. In addition, upon an event of default, interest on the outstanding principal shall accrue at a default interest rate
of <span id="xdx_90B_ecustom--DebtInstrumentDebtDefaultInterestRate_dp_uPure_c20201209__20201210__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--DecemberTenTwoThousandTwentyGWNoteMember_zq1TRF6QimY" title="Debt instrument, default, interest rate">24</span>% per annum, or if such rate is usurious or not permitted by current law, then at the highest rate of interest permitted by law.
Further, certain events of default may trigger penalty and liquidated damage provisions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Additionally,
GW Holdings has the option to convert all or any amount of the principal face amount of the notes issued to GW Holdings at any time from
the date of issuance and ending on the later of the maturity date or the date the Default Amount is paid if an event of default occurs,
which is an amount between <span id="xdx_906_ecustom--DebtInstrumentDebtDefaultInterestRate_dp_uPure_c20201209__20201210__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--DecemberTenTwoThousandTwentyGWNoteMember__srt--RangeAxis__srt--MinimumMember_z466YXX0CMg6" title="Debt instrument, default, interest rate">110</span>% and <span id="xdx_901_ecustom--DebtInstrumentDebtDefaultInterestRate_dp_uPure_c20201209__20201210__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--DecemberTenTwoThousandTwentyGWNoteMember__srt--RangeAxis__srt--MaximumMember_zmnjePezzi72" title="Debt instrument, default, interest rate">150</span>% of an amount equal to the then outstanding principal amount of such notes plus any interest
accrued, for shares of the Company&#8217;s common stock at the then-applicable conversion price.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>PROPANC
BIOPHARMA, INC. AND SUBSIDIARY<br/>
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS<br/>
SEPTEMBER 30, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Unaudited)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_903_eus-gaap--DebtInstrumentDescription_c20201209__20201210__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--DecemberTenTwoThousandTwentyGWNoteMember">The
conversion price for the above GW Holdings notes shall be equal to a 40% discount of the lowest closing bid price (&#8220;Lowest Trading
Price&#8221;) of the Common Stock for the ten trading days immediately prior to the delivery of a Notice of Conversion, including the
day upon which a Notice of Conversion is received. Notwithstanding the foregoing, GW Holdings shall be restricted from effecting a conversion
if such conversion, along with other shares of the Company&#8217;s common stock beneficially owned by GW Holdings and its affiliates,
exceeds <span id="xdx_908_ecustom--PercentageOfOutstandingSharesOfCommonStock_dp_uPure_c20201209__20201210__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--DecemberTenTwoThousandTwentyGWNoteMember_zfol6OLSWkHl">4.99</span>% of the outstanding shares of the Company&#8217;s common stock which may be increased up to 9.99% upon 60 days prior written
notice by the GW Holdings to the Company.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">These
notes are treated as stock settled debt under ASC 480 and accordingly the Company recorded a total of $<span id="xdx_908_eus-gaap--DebtInstrumentUnamortizedPremium_iI_pp0p0_c20201210__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember_z8VirPDudh83">87,333</span> put premium.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
total principal amount outstanding under the above December 10, 2020 GW Holdings financing agreement, was $<span id="xdx_90C_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20200930__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--DecemberTenTwoThousandTwentyGWNoteMember_zvG2tpfICtk5" title="Convertible debt principal amount">90,000</span> and accrued interest
of $<span id="xdx_90B_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20200930__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--DecemberTenTwoThousandTwentyGWNoteMember_zwYws47GK557" title="Accrued interest">4,636</span> as of June 30, 2021 following conversion of $<span id="xdx_909_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--DecemberTenTwoThousandTwentyGWNoteMember_zXR3wCXR2ii3" title="Convertible debt principal amount">41,000</span> of the principal balance and $<span id="xdx_905_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--DecemberTenTwoThousandTwentyGWNoteMember_z1FNGBZ4TcMj" title="Accrued interest">1,084</span> of accrued interest during the year
ended June 30, 2021. Accordingly, $<span id="xdx_908_eus-gaap--DebtInstrumentUnamortizedPremium_iI_pp0p0_c20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--DecemberTenTwoThousandTwentyGWNoteMember_zlSogXBHc4dd">27,333</span> of the put premium was reclassed to additional paid in capital in respect of the October 1,
2019 GW Holdings Note during the year ended June 30, 2021 following conversion of the principal balance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
total principal amount outstanding under the above December 10, 2020 GW Holdings financing agreement, was $<span id="xdx_907_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20210930__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--DecemberTenTwoThousandTwentyGWNoteMember_zzpkMkBnkq3l">65,000</span> and accrued interest
of $<span id="xdx_90A_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20210930__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--DecemberTenTwoThousandTwentyGWNoteMember_z7eA13hE3B25">4,174</span> as of September 30, 2021 following conversion of $<span id="xdx_908_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20210930__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--DecemberTenTwoThousandTwentyGWNoteMember_zVSSWJquEqpe">25,000</span> of the principal balance and $<span id="xdx_900_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20210930__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--DecemberTenTwoThousandTwentyGWNoteMember_zxVIWppMhhGa">2,091</span> of accrued interest during the
three months ended September 30, 2021. Accordingly, $<span id="xdx_908_eus-gaap--DebtInstrumentUnamortizedPremium_iI_pp0p0_c20210930__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--DecemberTenTwoThousandTwentyGWNoteMember_zbFlv2euddve">16,667</span> of the put premium was reclassed to additional paid in capital in respect
of the October 1, 2019 GW Holdings Note during the three months ended September 30, 2021 following conversion of the principal balance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Geneva
Roth Remark Securities Purchase Agreements</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>January
5, 2021 Securities Purchase Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Effective
January 5, 2021, the Company entered into a securities purchase agreement with Geneva Roth Remark Holdings, Inc., pursuant to which Geneva
Roth purchased a convertible promissory note (the &#8220;January 5, 2021 Geneva Roth&#8221;) from the Company in the aggregate principal
amount of $<span id="xdx_905_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20210105__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--JanuaryFiveTwoThousandTwentyOneGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember_zNMXuLqV0FHa" title="Convertible debt principal amount">68,500</span>, such principal and the interest thereon convertible into shares of the Company&#8217;s common stock at the option
of Geneva Roth any time after the six-month anniversary of the January 5, 2021 Geneva Roth. The January 5, 2021 Geneva Roth contained
an original issue discount of $<span id="xdx_904_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pp0p0_c20210105__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--JanuaryFiveTwoThousandTwentyOneGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember_zxUbSVxlT5Ch">3,500</span>. The Company intended to use the net proceeds from the January 5, 2021 Geneva Roth for general working
capital purposes. The maturity date of the January 5, 2021 Geneva Roth Note was January 5, 2022. The January 5, 2021 Geneva Roth Note
bore interest at a rate of <span id="xdx_90D_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20201202__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--JanuaryFiveTwoThousandTwentyOneGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember_z8prCVROnlg6">8</span>% per annum, which interest may be paid by the Company to Geneva Roth in shares of the Company&#8217;s common
stock; but shall not be payable until the January 5, 2021 Geneva Roth Note becomes payable, whether at the maturity date or upon acceleration
or by prepayment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>March
16, 2021 Securities Purchase Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Effective
March 16, 2021, the Company entered into a securities purchase agreement with Geneva Roth Remark Holdings, Inc., pursuant to which Geneva
Roth purchased a convertible promissory note (the &#8220;March 16, 2021 Geneva Roth&#8221;) from the Company in the aggregate principal
amount of $<span id="xdx_902_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20210316__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--MarchSixteenTwoThousandTwentyOneGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember_zRQ6XM5pGns4" title="Convertible debt principal amount">63,500</span>, such principal and the interest thereon convertible into shares of the Company&#8217;s common stock at the option
of Geneva Roth any time after the six-month anniversary of the March 16, 2021 Geneva Roth. The March 16, 2021 Geneva Roth contained an
original discount of $<span id="xdx_906_eus-gaap--DebtConversionOriginalDebtAmount1_pp0p0_c20210315__20210316__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--MarchSixteenTwoThousandTwentyOneGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember_zzskKUm0Wwrd" title="Debt conversion, original debt amount">3,500</span>. The Company intended to use the net proceeds from the March 16, 2021 Geneva Roth for general working capital
purposes. The maturity date of the March 16, 2021 Geneva Roth Note was March 16, 2022. The March 16, 2021 Geneva Roth Note bears interest
at a rate of <span id="xdx_90B_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20210316__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--MarchSixteenTwoThousandTwentyOneGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember_za2yJLfmOH5c" title="Debt instrument, interest rate, stated percentage">8</span>% per annum, which interest may be paid by the Company to Geneva Roth in shares of the Company&#8217;s common stock; but
shall not be payable until the March 16, 2021 Geneva Roth Note becomes payable, whether at the maturity date or upon acceleration or
by prepayment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>August
19, 2021 Securities Purchase Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Effective
August 19, 2021, the Company entered into a securities purchase agreement with Geneva Roth Remark Holdings, Inc., pursuant to which Geneva
Roth purchased a convertible promissory note (the &#8220;August 19, 2021 Geneva Roth&#8221;) from the Company in the aggregate principal
amount of $<span id="xdx_901_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20210819__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--AugustNineteenTwoThousandTwentyOneGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember_ztnbtalxNhr3">103,750</span>, such principal and the interest thereon convertible into shares of the Company&#8217;s common stock at the option
of Geneva Roth any time after the six-month anniversary of the August 19, 2021 Geneva Roth. The August 19, 2021 Geneva Roth contains
an original discount of $<span id="xdx_901_eus-gaap--DebtConversionOriginalDebtAmount1_pp0p0_c20210818__20210819__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--AugustNineteenTwoThousandTwentyOneGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember_zrlREIRbsh97">3,750</span>. The Company intends to use the net proceeds from the August 19, 2021 Geneva Roth for general working
capital purposes. The maturity date of the August 19, 2021 Geneva Roth Note is August 19, 2022. The August 19, 2021 Geneva Roth Note
bears interest at a rate of <span id="xdx_901_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20210819__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--AugustNineteenTwoThousandTwentyOneGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember_zPlJepj8LM52">8</span>% per annum, which interest may be paid by the Company to Geneva Roth in shares of the Company&#8217;s common
stock; but shall not be payable until the August 19, 2021 Geneva Roth Note becomes payable, whether at the maturity date or upon acceleration
or by prepayment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>PROPANC
BIOPHARMA, INC. AND SUBSIDIARY<br/>
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS<br/>
SEPTEMBER 30, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Unaudited)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>September
22, 2021 Securities Purchase Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Additionally,
effective September 22, 2021, the Company entered into a securities purchase agreement with Geneva Roth Remark Holdings, Inc., pursuant
to which Geneva Roth purchased a convertible promissory note (the &#8220;September 22, 2021 Geneva Roth&#8221;) from the Company in the
aggregate principal amount of $<span id="xdx_90F_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20210922__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeptemberTwentyTwoTwoThousandTwentyOneGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember_zOYq6eOFZ5ek">63,750</span>, such principal and the interest thereon convertible into shares of the Company&#8217;s common
stock at the option of Geneva Roth any time after the six-month anniversary of the September 22, 2021 Geneva Roth. The September 22,
2021 Geneva Roth contains an original discount of $<span id="xdx_90E_eus-gaap--DebtConversionOriginalDebtAmount1_pp0p0_c20210921__20210922__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeptemberTwentyTwoTwoThousandTwentyOneGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember_zNZime7T8LN2">3,750</span>. The Company intends to use the net proceeds from the September 22, 2021 Geneva
Roth for general working capital purposes. The maturity date of the September 22, 2021 Geneva Roth Note is September 22, 2022. The September
22, 2021 Geneva Roth Note bears interest at a rate of <span id="xdx_905_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20210922__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeptemberTwentyTwoTwoThousandTwentyOneGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember_zWSiuiI86P3k">8</span>% per annum, which interest may be paid by the Company to Geneva Roth in shares
of the Company&#8217;s common stock; but shall not be payable until the September 22, 2021 Geneva Roth Note becomes payable, whether
at the maturity date or upon acceleration or by prepayment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">During
the first 60 to 180 days following the date of these notes, the Company has the right to prepay the principal and accrued but unpaid
interest due under the above notes issued to Geneva Roth, together with any other amounts that the Company may owe the holder under the
terms of the note, at a premium ranging from <span id="xdx_90A_ecustom--DebtInstrumentDebtDefaultInterestRate_pid_dp_uPure_c20210921__20210922__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember__srt--RangeAxis__srt--MinimumMember_zaZJaariTFqc">110</span>% to <span id="xdx_90C_ecustom--DebtInstrumentDebtDefaultInterestRate_pid_dp_uPure_c20210921__20210922__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember__srt--RangeAxis__srt--MaximumMember_zpC4SxPyvNB5">129</span>% as defined in the note agreement. After this initial 180-day period, the Company
does not have a right to prepay such notes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_909_eus-gaap--DebtInstrumentDescription_c20210921__20210922__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeptemberTwentyTwoTwoThousandTwentyOneGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember__srt--RangeAxis__srt--MinimumMember_zHVNcBc1Vpjd">The
conversion price for the above Geneva Roth notes shall be equal to a <span id="xdx_902_ecustom--DebtInstrumentDebtDefaultInterestRate_pid_dp_uPure_c20210921__20210922__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeptemberTwentyTwoTwoThousandTwentyOneGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember_zGq3BXUa7Op5">35</span>% discount of the market price based on the average of the lowest
three trading prices of the Common Stock for the ten trading days immediately prior to the delivery of a Notice of Conversion. Notwithstanding
the foregoing, Geneva Roth shall be restricted from effecting a conversion if such conversion, along with other shares of the Company&#8217;s
common stock beneficially owned by Geneva Roth and its affiliates, exceeds <span id="xdx_90E_ecustom--PercentageOfOutstandingSharesOfCommonStock_pid_dp_uPure_c20210921__20210922__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember__srt--RangeAxis__srt--MinimumMember_z6UGpQRbDf83">9.99</span>% of the outstanding shares of the Company&#8217;s common
stock. These notes are treated as stock settled debt under ASC 480 and accordingly the Company recorded a total of $<span id="xdx_903_eus-gaap--DebtInstrumentUnamortizedPremium_iI_pp0p0_c20210922__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember_zVrRP5zlDEsi">161,269</span> put premium
for the four notes.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
above Geneva Roth notes contain certain events of default, upon which principal and accrued interest will become immediately due and
payable. In addition, upon an event of default, interest on the outstanding principal shall accrue at a default interest rate of <span id="xdx_902_ecustom--DebtDefaultAmountPercentage_pid_dp_uPure_c20210921__20210922__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember_zD9LZXItdfcf" title="Debt default amount percentage">22</span>%
per annum, or if such rate is usurious or not permitted by current law, then at the highest rate of interest permitted by law. Further,
certain events of default may trigger penalty and liquidated damage provisions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
total principal amounts outstanding under the above Geneva Roth financing agreements were $<span id="xdx_907_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20210630__us-gaap--TypeOfArrangementAxis__custom--GenevaRothFinancingAgreementAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember_zm5UdQ7KYNqf">132,000</span> and accrued interest of $<span id="xdx_90A_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20210630__us-gaap--TypeOfArrangementAxis__custom--GenevaRothFinancingAgreementAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember_zUsRMblbf2pk">3,477</span> as
of June 30, 2021 following conversion of $<span id="xdx_901_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20210630__us-gaap--TypeOfArrangementAxis__custom--GenevaRothFinancingAgreementAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember_zGVdkKYxeGze">78,000</span> of the principal balance and $<span id="xdx_904_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember_zJqYyidmnTwf">3,120</span> accrued interest during the year ended June 30,
2021. Accordingly, $<span id="xdx_904_eus-gaap--DebtInstrumentUnamortizedPremium_iI_pp0p0_c20210630__us-gaap--TypeOfArrangementAxis__custom--GenevaRothFinancingAgreementAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember_z0OghltJXj4f">42,000</span> of the put premium was released in respect of the Geneva Roth financing agreements during the year ended June
30, 2021 following conversion of the principal balance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
total principal amounts outstanding under the above Geneva Roth financing agreements were $<span id="xdx_900_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20210930__us-gaap--TypeOfArrangementAxis__custom--GenevaRothFinancingAgreementAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember_zSRXj1MFofhf">167,500</span> and accrued interest of $<span id="xdx_903_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20210930__us-gaap--TypeOfArrangementAxis__custom--GenevaRothFinancingAgreementAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember_zxEer3i3Ai4b">1,081</span> as
of September 30, 2021 following conversion of $<span id="xdx_90C_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20210930__us-gaap--TypeOfArrangementAxis__custom--GenevaRothFinancingAgreementAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember_zfR47ZiJD2Vd">132,000</span> of the principal balance and $<span id="xdx_909_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20210930__us-gaap--TypeOfArrangementAxis__custom--GenevaRothFinancingAgreementAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember_zfxIAHXyadMa">5,280</span> accrued interest during the three months ended
September 30, 2021. Accordingly, $<span id="xdx_902_eus-gaap--DebtInstrumentUnamortizedPremium_iI_pp0p0_c20210930__us-gaap--TypeOfArrangementAxis__custom--GenevaRothFinancingAgreementAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember_zryCIL9sv5Y7">71,077</span> of the put premium was released in respect of the Geneva Roth financing agreements during the
three months ended September 30, 2021 following conversion of the principal balance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Amortization
of debt discounts</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
Company recorded $<span id="xdx_905_eus-gaap--AmortizationOfDebtDiscountPremium_pp0p0_c20210701__20210930__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zDotonWxHIEg">7,500</span> and $<span id="xdx_903_eus-gaap--AmortizationOfDebtDiscountPremium_pp0p0_c20200701__20200930__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zRErArH07Ngi">0</span> of debt discounts (including warrants, derivatives, debt issue costs and original issue discounts) related
to the above note issuances during the three months ended September 30, 2021 and 2020, respectively. The Company recorded $<span id="xdx_907_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pp0p0_c20210930__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zoQmvISoyihb">90,192</span> and
$<span id="xdx_909_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pp0p0_c20200930__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zqYEyVk0Karh">0</span> of put premiums related to the above note issuances during the three months ended September 30, 2021 and 2020, respectively. The debt
discounts are being amortized over the term of the debt and the put premiums are expensed on issuance of the debt with the liability
released to additional paid in capital on conversion of the principal.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Amortization
of all debt discounts for the three months ended September 30, 2021 and 2020 was $<span id="xdx_900_eus-gaap--AmortizationOfDebtDiscountPremium_pp0p0_c20210701__20210930_z2nbP4cmctd4" title="Amortization of debt discount">6,074</span> and $<span id="xdx_906_eus-gaap--AmortizationOfDebtDiscountPremium_pp0p0_c20200701__20200930_zBvW04AaEQS9" title="Amortization of debt discount">121,281</span>, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
Company reclassified $<span id="xdx_909_ecustom--ReclassifiedPremiumAmountForAdditionalPaidInCapital_pp0p0_c20210701__20210930_zoB4cvf8iVJa">109,643</span> and $<span id="xdx_905_ecustom--ReclassifiedPremiumAmountForAdditionalPaidInCapital_pp0p0_c20200701__20200930_zikr5Gq9GEja">204,919</span> in put premiums to additional paid in capital following conversions during the three months
ended September 30, 2021 and 2020, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_802_eus-gaap--DebtDisclosureTextBlock_zeaWrDcF96f" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>NOTE
6 &#8211; <span id="xdx_82C_zpU7oKjSzdRl">CONVERTIBLE NOTES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p id="xdx_89C_eus-gaap--ConvertibleDebtTableTextBlock_ziVRkGrZePIh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
Company&#8217;s convertible notes outstanding at June 30, 2021 and 2020 were as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; display: none; color: Black">&#160;<span id="xdx_8BA_zvU50JaaWwyd">SCHEDULE OF CONVERTIBLE NOTES</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 100%; margin-right: auto">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" id="xdx_494_20210630_zsrmn1iivXZg" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>June
    30, 2021</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" id="xdx_49B_20200630_zuQpL0kHaTa" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>June
    30, 2020</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td></tr>
  <tr id="xdx_403_eus-gaap--DebtInstrumentCarryingAmount_iI_pp0p0_maLTDzcuB_zuxg3RTxe1Li" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 64%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Convertible
    notes and debenture</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">400,128</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">1,029,496</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--DebtInstrumentUnamortizedDiscount_iNI_pp0p0_di_msLTDzcuB_zuUODCdu4b44" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Unamortized
    discounts</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(6,139</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(126,667</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td></tr>
  <tr id="xdx_40C_eus-gaap--DepositLiabilitiesAccruedInterest_iI_pp0p0_maLTDzcuB_zPzWSAs6KWd3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Accrued
    interest</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">34,098</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">80,101</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--DebtInstrumentUnamortizedPremium_iI_pp0p0_maLTDzcuB_zEJVrrhbTgpb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Premium,
    net</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">196,496</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">574,804</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--LongTermDebt_iTI_pp0p0_mtLTDzcuB_z7Pcz6TEePia" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Convertible
    notes, net</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">624,583</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">1,557,734</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  </table>
<p id="xdx_8A9_z1kJBtc4kiUk" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b><i>Eagle
Equities Financing Agreements</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><i>December
29, 2017 Securities Purchase Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
Company entered into an executory contract on December 29, 2017, whereby the Company entered into a securities purchase agreement with
Eagle Equities, pursuant to which Eagle Equities purchased a convertible promissory note (the &#8220;December 2017 Eagle Note&#8221;)
from the Company in the aggregate principal amount of <span id="xdx_902_eus-gaap--DebtInstrumentFaceAmount_c20171229__us-gaap--TypeOfArrangementAxis__custom--DecemberTwentyNineTwoThousandAndSeventeenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--DecemberTwoThousandAndSeventeenEagleNoteMember_pp0p0" title="Convertible debt principal amount">$532,435</span>, with principal and the interest thereon convertible into shares of the
Company&#8217;s common stock at the option of Eagle Equities at any time. The December 2017 Eagle Note contained an original issue discount
of <span id="xdx_904_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pp0p0_c20171229__us-gaap--TypeOfArrangementAxis__custom--DecemberTwentyNineTwoThousandAndSeventeenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--DecemberTwoThousandAndSeventeenEagleNoteMember_zwtn2dDM4hIj" title="Original issue discount">$25,354</span> such that the purchase price was <span id="xdx_902_eus-gaap--ProceedsFromConvertibleDebt_c20171227__20171229__us-gaap--TypeOfArrangementAxis__custom--DecemberTwentyNineTwoThousandAndSixteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--DecemberTwoThousandAndSeventeenEagleNoteMember_pp0p0" title="Proceeds from convertible debt">$507,081</span>. The maturity date of the December 2017 Eagle Note was <span id="xdx_903_eus-gaap--DebtInstrumentMaturityDate_dd_c20171227__20171229__us-gaap--TypeOfArrangementAxis__custom--DecemberTwentyNineTwoThousandAndSixteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--DecemberTwoThousandAndSeventeenEagleNoteMember_z4DqQhh6ygF1" title="Debt maturity date">December 29, 2018</span>. The Company
was in discussions with Eagle Equities to extend the maturity date. The December 2017 Eagle Note bore interest at a rate of <span id="xdx_901_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20171229__us-gaap--TypeOfArrangementAxis__custom--DecemberTwentyNineTwoThousandAndSeventeenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--DecemberTwoThousandAndSeventeenEagleNoteMember_zrEXKmTQfmjl" title="Debt instrument, interest rate, stated percentage">8%</span> per annum,
which interest were to be paid by the Company to Eagle Equities in shares of the Company&#8217;s common stock upon receipt of a notice
of conversion by the Company from Eagle Equities at any time. The Company recorded <span id="xdx_904_eus-gaap--InterestPayableCurrentAndNoncurrent_c20190630__us-gaap--TypeOfArrangementAxis__custom--DecemberTwentyNineTwoThousandAndSixteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--DecemberTwoThousandAndSeventeenEagleNoteMember_pp0p0" title="Accrued interest">$20,065</span> of accrued interest for the December 2017
Eagle Note and total principal outstanding as of June 30, 2019 under the December 2017 Eagle Note was <span id="xdx_902_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20180701__20190630__us-gaap--TypeOfArrangementAxis__custom--DecemberTwentyNineTwoThousandAndSeventeenSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--DecemberTwoThousandAndSeventeenEagleNoteMember_pp0p0" title="Debt conversion of converted amount">$171,965</span> following conversion of
<span id="xdx_906_eus-gaap--DebtInstrumentFaceAmount_c20190630__us-gaap--TypeOfArrangementAxis__custom--DecemberTwentyNineTwoThousandAndSixteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--DecemberTwoThousandAndSeventeenEagleNoteMember_pp0p0" title="Convertible debt principal amount">$360,470</span> of principal and <span id="xdx_903_eus-gaap--InterestPayableCurrentAndNoncurrent_c20190630__us-gaap--TypeOfArrangementAxis__custom--DecemberTwentyNineTwoThousandAndSeventeenSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--DecemberTwoThousandAndSeventeenEagleNoteMember_pp0p0" title="Accrued interest">$43,535</span> of accrued interest during the fiscal year ended June 30, 2019. The Company recorded <span id="xdx_90A_eus-gaap--InterestPayableCurrentAndNoncurrent_c20200630__us-gaap--TypeOfArrangementAxis__custom--DecemberTwentyNineTwoThousandAndSeventeenSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--DecemberTwoThousandAndSeventeenEagleNoteMember_pp0p0" title="Accrued interest">$0</span> of accrued
interest for the December 2017 Eagle Note and total principal outstanding as of June 30, 2020 under the December 2017 Eagle Note was
<span id="xdx_901_eus-gaap--DebtInstrumentFaceAmount_c20200630__us-gaap--TypeOfArrangementAxis__custom--DecemberTwentyNineTwoThousandAndSeventeenSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--DecemberTwoThousandAndSeventeenEagleNoteMember_pp0p0" title="Convertible debt principal amount">$0</span> following conversion of the remaining principal <span id="xdx_90A_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20190701__20200630__us-gaap--TypeOfArrangementAxis__custom--DecemberTwentyNineTwoThousandAndSeventeenSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--DecemberTwoThousandAndSeventeenEagleNoteMember_pp0p0" title="Debt conversion of converted amount">$171,965</span> and <span id="xdx_90E_eus-gaap--InterestPayableCurrentAndNoncurrent_c20200630__us-gaap--TypeOfArrangementAxis__custom--DecemberTwentyNineTwoThousandAndSeventeenSecuritiesPurchaseAgreementMember_pp0p0" title="Accrued interest">$24,751</span> of accrued interest during the fiscal year to June 30, 2020.
Accordingly, there was <span id="xdx_909_eus-gaap--ConvertibleNotesPayable_iI_pp0p0_do_c20200630__us-gaap--TypeOfArrangementAxis__custom--DecemberTwentyNineTwoThousandAndSixteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember_zAjzDA5WXnq8" title="Convertible debt outstanding balance">no</span> outstanding balance as of June 30, 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><i>July
13, 2018 Securities Purchase Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Effective
July 13, 2018, the Company entered into a securities purchase agreement with Eagle Equities, pursuant to which Eagle Equities purchased
a convertible promissory note (the &#8220;July 2018 Note&#8221;) from the Company in the aggregate principal amount of <span id="xdx_90F_eus-gaap--DebtInstrumentFaceAmount_c20180713__us-gaap--TypeOfArrangementAxis__custom--JulyThirteenTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandEighteenEagleNoteMember_pp0p0" title="Convertible debt principal amount">$75,000</span>, such
principal and the interest thereon convertible into shares of the Company&#8217;s common stock at the option of Eagle Equities any time
after the six month anniversary of the July 2018 Eagle Note. The transaction closed on July 16, 2018 and on July 19, 2018 the Company
received proceeds of <span id="xdx_900_eus-gaap--ProceedsFromConvertibleDebt_pp0p0_c20180718__20180719__us-gaap--TypeOfArrangementAxis__custom--JulyThirteenTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandEighteenEagleNoteMember_zdWkynH66oRd" title="Proceeds from convertible debt">$71,250</span> as <span id="xdx_90B_eus-gaap--LegalFees_c20180718__20180719__us-gaap--TypeOfArrangementAxis__custom--JulyThirteenTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandEighteenEagleNoteMember_pp0p0" title="Legal fees">$3,750</span> was paid directly to legal fees. The maturity date of the July 2018 Eagle Note was <span id="xdx_902_eus-gaap--DebtInstrumentMaturityDate_dd_c20180712__20180713__us-gaap--TypeOfArrangementAxis__custom--JulyThirteenTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandEighteenEagleNoteMember_zpDA4GM2ucK3" title="Debt maturity date">July 13, 2019</span>.
The July 2018 Eagle Note bears interest at a rate of <span id="xdx_90E_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20180713__us-gaap--TypeOfArrangementAxis__custom--JulyThirteenTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandEighteenEagleNoteMember_zAmwn9YIE4P4" title="Debt instrument, interest rate, stated percentage">8%</span> per annum, which interest shall be paid by the Company to Eagle Equities in shares
of the Company&#8217;s common stock upon receipt of a notice of conversion by the Company from Eagle Equities at any time after the six-month
anniversary of the Note. The Company recorded <span id="xdx_90F_eus-gaap--InterestPayableCurrentAndNoncurrent_c20190630__us-gaap--TypeOfArrangementAxis__custom--JulyThirteenTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandEighteenEagleNoteMember_pp0p0" title="Accrued interest">$5,786</span> of accrued interest and the total principal outstanding under the July 2018 Eagle
Note was <span id="xdx_905_eus-gaap--DebtInstrumentFaceAmount_c20190630__us-gaap--TypeOfArrangementAxis__custom--JulyThirteenTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandEighteenEagleNoteMember_pp0p0" title="Convertible debt principal amount">$75,000</span> as of June 30, 2019. The Company recorded <span id="xdx_900_eus-gaap--DebtInstrumentFaceAmount_c20200630__us-gaap--TypeOfArrangementAxis__custom--JulyThirteenTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandEighteenEagleNoteMember_pp0p0" title="Convertible debt principal amount">$0</span> of accrued interest and the total principal outstanding under the July
2018 Eagle Note was <span id="xdx_90C_eus-gaap--InterestPayableCurrentAndNoncurrent_c20180713__us-gaap--TypeOfArrangementAxis__custom--JulyThirteenTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandEighteenEagleNoteMember_pp0p0" title="Accrued interest">$0</span> as of June 30, 2020 following conversion of <span id="xdx_909_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20190701__20200630__us-gaap--TypeOfArrangementAxis__custom--JulyThirteenTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandEighteenEagleNoteMember_pp0p0" title="Debt conversion of converted amount">$75,000</span> of principal and <span id="xdx_904_eus-gaap--InterestPayableCurrentAndNoncurrent_c20200630__us-gaap--TypeOfArrangementAxis__custom--JulyThirteenTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandEighteenEagleNoteMember_pp0p0" title="Accrued interest">$9,300</span> of accrued interest during the fiscal
year ended June 30, 2020. Accordingly, there was <span id="xdx_901_eus-gaap--ConvertibleNotesPayable_iI_pp0p0_do_c20200630__us-gaap--TypeOfArrangementAxis__custom--JuneTwentyNineTwoThousandEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember_zuibCjhHE8q6" title="Convertible debt outstanding balance">no</span> outstanding balance as of June 30, 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>PROPANC
BIOPHARMA, INC. AND SUBSIDIARY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>June
30, 2021 and 2020</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><i>August
29, 2018 Securities Purchase Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Effective
August 29, 2018, the Company entered into a securities purchase agreement with Eagle Equities, pursuant to which Eagle Equities purchased
a convertible promissory note (the &#8220;August 2018 Eagle Note&#8221;) from the Company in the aggregate principal amount of <span id="xdx_903_eus-gaap--DebtInstrumentFaceAmount_c20180829__us-gaap--TypeOfArrangementAxis__custom--AugustTwentyNineTwoThousandandEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandEighteenEagleNoteMember_pp0p0" title="Convertible debt principal amount">$105,000</span>,
such principal and the interest thereon convertible into shares of the Company&#8217;s common stock at the option of Eagle Equities any
time after the six-month anniversary of the August 2018 Eagle Note. The transactions contemplated by the agreement closed on August 30,
2018. The maturity date of the August 29, 2018 Eagle Note was <span id="xdx_90F_eus-gaap--DebtInstrumentMaturityDate_dd_c20180826__20180829__us-gaap--TypeOfArrangementAxis__custom--AugustTwentyNineTwoThousandandEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandEighteenEagleNoteMember_zqr0uvzkUBgj">August 29, 2019</span>. The August 2018 Eagle Note bore interest at a rate of
<span id="xdx_903_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20180829__us-gaap--TypeOfArrangementAxis__custom--AugustTwentyNineTwoThousandandEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandEighteenEagleNoteMember_z8BLE0j8JLXf" title="Debt instrument, interest rate, stated percentage">8%</span> per annum, which interest was paid by the Company to Eagle Equities in shares of the Company&#8217;s common stock upon receipt of
a notice of conversion by the Company from Eagle Equities at any time after the six-month anniversary of the August 2018 Eagle Note.
In April 2020, Eagle Equities agreed to waive the <span id="xdx_90E_ecustom--DebtInstrumentDebtDefaultInterestRate_dp_uPure_c20200401__20200430__us-gaap--TypeOfArrangementAxis__custom--AugustTwentyNineTwoThousandandEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandEighteenEagleNoteMember_zgBWquuwOeDe" title="Debt instrument, default, interest rate">24%</span> default interest on this note. The note was fully converted to common stock in
fiscal 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><i>October
2, 2018 Securities Purchase Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Effective
October 2, 2018, the Company entered into a securities purchase agreement with Eagle Equities, pursuant to which Eagle Equities purchased
a convertible promissory note (the &#8220;October 2018 Eagle Note&#8221;) from the Company in the aggregate principal amount of <span id="xdx_906_eus-gaap--DebtInstrumentFaceAmount_c20181002__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberTwoTwoThousandAndEighteenEagleNoteMember_pp0p0" title="Convertible debt principal amount">$210,000</span>,
such principal and the interest thereon convertible into shares of the Company&#8217;s common stock at the option of Eagle Equities any
time after the six-month anniversary of the October 2018 Eagle Note. The transactions contemplated by the purchase agreement closed on
October 3, 2018. Pursuant to the terms of the purchase agreement, Eagle Equities deducted $<span id="xdx_90F_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_c20180929__20181002__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberTwoTwoThousandAndEighteenEagleNoteMember_pp0p0" title="Debt instrument principal payment">10,000</span> from the principal payment due under
the October 2018 Eagle Note, at the time of closing, to be applied to its legal expenses. The maturity date of the October 2018 Eagle
Note was <span id="xdx_902_eus-gaap--DebtInstrumentMaturityDate_dd_c20180929__20181002__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberTwoTwoThousandAndEighteenEagleNoteMember_zWGQR2JHUroc" title="Debt maturity date">October 2, 2019</span>. The October 2018 Eagle Note shall bore interest at a rate of <span id="xdx_90B_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20181002__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberTwoTwoThousandAndEighteenEagleNoteMember_zlNz9m1P70B9" title="Debt instrument, interest rate, stated percentage">8%</span> per annum, which interest was paid by the Company
to Eagle Equities in shares of common stock upon receipt of a notice of conversion by the Company from Eagle Equities at any time after
the six-month anniversary of the October 2018 Eagle Note. In April 2020, Eagle Equities agreed to waive the <span id="xdx_90D_ecustom--DebtInstrumentDebtDefaultInterestRate_dp_uPure_c20200401__20200430__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember_zln5ji2gLDy6" title="Debt instrument, default, interest rate">24%</span> default interest on this
note. The note was fully converted to common stock in fiscal 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><i>November
30, 2018 Securities Purchase Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Effective
November 30, 2018, the Company entered into a securities purchase agreement with Eagle Equities, pursuant to which Eagle Equities purchased
a convertible promissory note (the &#8220;November 2018 Eagle Note&#8221;) from the Company in the aggregate principal amount of <span id="xdx_903_eus-gaap--DebtInstrumentFaceAmount_c20181130__us-gaap--TypeOfArrangementAxis__custom--NovembeThirtyTwoThousandAndEighteenMecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--NovemberTwoThousandAndEighteenEagleNoteMember_pp0p0" title="Convertible debt principal amount">$105,000</span>,
such principal and the interest thereon convertible into shares of the Company&#8217;s common stock at the option of Eagle Equities any
time after the six-month anniversary of the November 2018 Eagle Note. The transactions contemplated by the purchase agreement closed
on December 3, 2018. Pursuant to the terms of the purchase agreement, Eagle Equities deducted <span id="xdx_906_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_c20181126__20181130__us-gaap--TypeOfArrangementAxis__custom--NovembeThirtyTwoThousandAndEighteenMecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--NovemberTwoThousandAndEighteenEagleNoteMember_pp0p0" title="Debt instrument principal payment">$5,000</span> from the principal payment due under
the November 2018 Eagle Note, at the time of closing, to be applied to its legal expenses. The maturity date of the November 2018 Eagle
Note was <span id="xdx_901_eus-gaap--DebtInstrumentMaturityDate_dd_c20181126__20181130__us-gaap--TypeOfArrangementAxis__custom--NovembeThirtyTwoThousandAndEighteenMecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--NovemberTwoThousandAndEighteenEagleNoteMember_zChtBzkSwcs7" title="Debt maturity date">November 30, 2019</span>. The November 2018 Eagle Note bore interest at a rate of <span id="xdx_90B_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20181130__us-gaap--TypeOfArrangementAxis__custom--NovembeThirtyTwoThousandAndEighteenMecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--NovemberTwoThousandAndEighteenEagleNoteMember_zM0a4tZzTtF6" title="Debt instrument, interest rate, stated percentage">8%</span> per annum, which interest shall be paid by the
Company to Eagle Equities in shares of common stock upon receipt of a notice of conversion by the Company from Eagle Equities at any
time after the six-month anniversary of the November 2018 Eagle Note. In April 2020, Eagle Equities agreed to waive the <span id="xdx_90A_ecustom--DebtInstrumentDebtDefaultInterestRate_dp_uPure_c20200401__20200430__us-gaap--TypeOfArrangementAxis__custom--NovembeThirtyTwoThousandAndEighteenMecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--NovemberTwoThousandAndEighteenEagleNoteMember_zfKSHWHrSd43" title="Debt instrument, default, interest rate">24%</span> default interest
on this note. The note was fully converted to common stock in fiscal 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><i>December
24, 2018 Securities Purchase Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Effective
December 24, 2018, the Company entered into a securities purchase agreement with Eagle Equities, pursuant to which Eagle Equities purchased
a convertible promissory note (the &#8220;December 2018 Eagle Note&#8221;) from the Company in the aggregate principal amount of <span id="xdx_90B_eus-gaap--DebtInstrumentFaceAmount_c20181224__us-gaap--TypeOfArrangementAxis__custom--DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--DecembeTwoThousandAndEighteenEagleNoteMember_pp0p0" title="Convertible debt principal amount">$126,000</span>,
such principal and the interest thereon convertible into shares of the Company&#8217;s common stock at the option of Eagle Equities any
time after the six-month anniversary of the December 2018 Eagle Note. The transactions contemplated by the purchase agreement closed
on December 24, 2018. Pursuant to the terms of the purchase agreement, Eagle Equities deducted <span id="xdx_906_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_c20181223__20181224__us-gaap--TypeOfArrangementAxis__custom--DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--DecembeTwoThousandAndEighteenEagleNoteMember_pp0p0" title="Debt instrument principal payment">$6,000</span> from the principal payment due
under the December 2018 Eagle Note, at the time of closing, to be applied to its legal expenses. The Company used the net proceeds from
the December 2018 Eagle Note to repay an outstanding convertible promissory note before such note became convertible. The maturity date
of the December 2018 Eagle Note was <span id="xdx_90A_eus-gaap--DebtInstrumentMaturityDate_dd_c20181223__20181224__us-gaap--TypeOfArrangementAxis__custom--DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--DecembeTwoThousandAndEighteenEagleNoteMember_zIJtjKwc3F6e" title="Debt maturity date">December 24, 2019</span>. The December 2018 Eagle Note bore interest at a rate of <span id="xdx_90E_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20181224__us-gaap--TypeOfArrangementAxis__custom--DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--DecembeTwoThousandAndEighteenEagleNoteMember_zQz2eFDsZRe9" title="Debt instrument, interest rate, stated percentage">8%</span> per annum, which interest
was paid by the Company to Eagle Equities in shares of common stock upon receipt of a notice of conversion by the Company from Eagle
Equities at any time after the six-month anniversary of the December 2018 Eagle Note. Upon an event of default, principal and accrued
interest would become immediately due and payable under the notes. Additionally, upon an event of default, both notes would accrue interest
at a default interest rate of <span id="xdx_905_ecustom--DebtInstrumentDebtDefaultInterestRate_dp_uPure_c20181223__20181224__us-gaap--TypeOfArrangementAxis__custom--DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--DecembeTwoThousandAndEighteenEagleNoteMember_z6Ts1dycUWZg" title="Debt instrument, default, interest rate">24%</span> per annum or the highest rate of interest permitted by law. In April 2020, Eagle Equities agreed to
waive the <span id="xdx_90E_ecustom--DebtInstrumentDebtDefaultInterestRate_dp_uPure_c20200401__20200430__us-gaap--TypeOfArrangementAxis__custom--DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--DecembeTwoThousandAndEighteenEagleNoteMember_zlZWpPbTdlei" title="Debt instrument, default, interest rate">24%</span> default interest on this note.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Eagle
Equities had the option to convert all or any amount of the principal amount of the notes issued to Eagle Equities above, at any time,
for shares of the Company&#8217;s common stock at a price ranging from <span id="xdx_90B_eus-gaap--DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_dp_uPure_c20181223__20181224__us-gaap--TypeOfArrangementAxis__custom--DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--DecembeTwoThousandAndEighteenEagleNoteMember__srt--RangeAxis__srt--MinimumMember_zfQi4u9wiHai" title="Common stock trading volume, percent">60%</span> to <span id="xdx_906_eus-gaap--DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_dp_uPure_c20181223__20181224__us-gaap--TypeOfArrangementAxis__custom--DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--DecembeTwoThousandAndEighteenEagleNoteMember__srt--RangeAxis__srt--MaximumMember_zd2xti7wZbY8" title="Common stock trading volume, percent">61%</span> of the lowest closing bid price (the &#8220;Closing
Bid Price&#8221;) of the Company&#8217;s common stock as reported on the OTC Markets Group, Inc. quotation system for the ten prior trading
days, including the day upon which the Company receives a notice of conversion from Eagle Equities (the &#8220;Conversion Price&#8221;).
However, in the event that the Company&#8217;s common stock was restricted by the Depository Trust Company for any reason, the Conversion
Price was to be lowered to from <span id="xdx_903_eus-gaap--DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_dp_uPure_c20181223__20181224__us-gaap--TypeOfArrangementAxis__custom--DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--DepositoryTrustCompanyMember__us-gaap--DebtInstrumentAxis__custom--DecembeTwoThousandAndEighteenEagleNoteMember__srt--RangeAxis__srt--MinimumMember_zCDR7YJTeg13" title="Common stock trading volume, percent">50%</span> to <span id="xdx_904_eus-gaap--DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_dp_uPure_c20181223__20181224__us-gaap--TypeOfArrangementAxis__custom--DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--DepositoryTrustCompanyMember__us-gaap--DebtInstrumentAxis__custom--DecembeTwoThousandAndEighteenEagleNoteMember__srt--RangeAxis__srt--MaximumMember_zgAsy2tzpAqe" title="Common stock trading volume, percent">51%</span> of the lowest Closing Bid Price for the duration of such restriction. If the Company failed
to maintain a reserve of shares of its common stock at least two and a half times the number of shares issuable upon conversion of all
the Eagle Notes for at least 60 days after the issuance of the notes issued to Eagle Equities, the conversion discount was to be increased
by <span id="xdx_90A_eus-gaap--DebtConversionOriginalDebtInterestRateOfDebt_dp_uPure_c20181223__20181224__us-gaap--TypeOfArrangementAxis__custom--DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--DecembeTwoThousandAndEighteenEagleNoteMember_zOUdDl581VGk" title="Debt original issue discount, rate">10%</span>. Notwithstanding the foregoing, Eagle Equities was restricted from effecting a conversion if such conversion, along with other
shares of the Company&#8217;s common stock beneficially owned by Eagle Equities and its affiliates, exceeds <span id="xdx_904_ecustom--PercentageOfOutstandingSharesOfCommonStock_dp_uPure_c20181223__20181224__us-gaap--TypeOfArrangementAxis__custom--DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--DecembeTwoThousandAndEighteenEagleNoteMember_ze9mkRXdRss4" title="Percentage of outstanding shares of common stock">4.99%</span> of the outstanding
shares of the Company&#8217;s common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>PROPANC
BIOPHARMA, INC. AND SUBSIDIARY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>June
30, 2021 and 2020</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
above notes issued to Eagle Equities were treated as stock settled debt under ASC 480 and accordingly, the Company recorded a total of
<span id="xdx_908_eus-gaap--DebtInstrumentUnamortizedPremium_c20181224__us-gaap--TypeOfArrangementAxis__custom--DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--DecembeTwoThousandAndEighteenEagleNoteMember_pp0p0" title="Debt premium amount">$357,688</span> put premium, of which <span id="xdx_904_eus-gaap--AdditionalPaidInCapital_iI_pp0p0_c20210630__us-gaap--TypeOfArrangementAxis__custom--DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--DecembeTwoThousandAndEighteenEagleNoteMember_zH3UbaDWPi5k" title="Additional paid in capital">$224,131</span> and <span id="xdx_907_eus-gaap--AdditionalPaidInCapital_iI_pp0p0_c20200630__us-gaap--TypeOfArrangementAxis__custom--DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--DecembeTwoThousandAndEighteenEagleNoteMember_zcmT5xSeF5Q4" title="Additional paid in capital">$133,557</span> were released to additional paid in capital following conversion of principal during
the fiscal year to June 30, 2020 and 2021, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
total principal amount outstanding under the above Eagle Equities financing agreements, specifically the August 29, 2018 and the December
24, 2018 agreements was <span id="xdx_902_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementOneMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember_zpGdUj168qPf" title="Convertible debt principal amount">$205,500</span> as of June 30, 2020 and accrued interest totaled <span id="xdx_90F_eus-gaap--InterestPayableCurrentAndNoncurrent_c20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementOneMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember_pp0p0" title="Accrued interest">$26,990</span>. There were <span id="xdx_900_eus-gaap--ConvertibleNotesPayable_iI_pp0p0_c20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementOneMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember_zvGPnBXv9Zt" title="Convertible debt outstanding balance">$0</span> outstanding principal and accrued
interest under the above Eagle Equities financing agreements as of June 30, 2021 as a result of the fiscal 2021 conversions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b><i>GS
Capital Financing Agreements</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><i>October
2, 2018 Securities Purchase Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Effective
October 2, 2018, the Company entered into a securities purchase agreement with GS Capital, pursuant to which GS Capital purchased two
<span id="xdx_90F_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20181002__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberTwoThousandEighteenGSNoteMember_zsBzu4vGlZFh" title="Debt instrument, interest rate, stated percentage">8%</span> unsecured convertible redeemable notes (the &#8220;October 2, 2018 GS Notes&#8221;) from the Company in the aggregate principal amount
of <span id="xdx_900_eus-gaap--DebtInstrumentFaceAmount_c20181002__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberTwoThousandEighteenGSNoteMember_pp0p0" title="Convertible debt principal amount">$212,000</span>, such principal and the interest thereon convertible into shares of the Company&#8217;s common stock. The purchase price
of <span id="xdx_90C_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20181003__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberTwoThousandEighteenGSNoteMember_zprsfKSUfdD5" title="Convertible debt principal amount">$106,000</span> of the first note (the &#8220;October 2018 GS Note&#8221;) was paid in cash by GS Capital on October 3, 2018. After payment
of certain legal fees and expenses, net proceeds to the Company from the October 2018 GS Note totaled <span id="xdx_906_eus-gaap--ProceedsFromConvertibleDebt_c20180929__20181002__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberTwoThousandEighteenGSNoteMember_pp0p0" title="Proceeds from convertible debt">$100,700</span>. The purchase price of
<span id="xdx_902_eus-gaap--ProceedsFromConvertibleDebt_pp0p0_c20180929__20181002__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberTwoThousandEighteenGSNoteMember__us-gaap--ShortTermDebtTypeAxis__custom--FirstNoteMember_zG1H5PWnaa1" title="Proceeds from convertible debt">$106,000</span> of the second note (the &#8220;October 2, 2018 GS Back End Note&#8221;) was initially paid for by GS Capital issuing to the
Company an offsetting <span id="xdx_908_eus-gaap--ProceedsFromConvertibleDebt_c20180929__20181002__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberTwoThousandEighteenGSNoteMember__us-gaap--ShortTermDebtTypeAxis__custom--SecondNoteMember_pp0p0" title="Proceeds from convertible debt">$106,000</span> collateralized secured note (the &#8220;October 2, 2018 GS Secured Note&#8221;). The terms of the October
2018 GS Back End Note require cash funding prior to any conversion thereunder, and such cash funding shall occur on or before June 2,
2019.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Both
the October 2, 2018 GS Note and the October 2, 2018 GS Back End Note, which was funded on February 27, 2019, matured on October 2, 2019,
upon which any outstanding principal and interest thereon is due and payable. The amounts cash funded plus accrued interest under both
the October 2018 GS Note and the October 2018 GS Back End Note are convertibles into shares of the Company&#8217;s common stock, at any
time after April 2, 2019, at a conversion price for each share of common stock equal to <span id="xdx_905_eus-gaap--DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_dp_uPure_c20180929__20181002__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberTwoThousandEighteenGSNoteMember_zoEnJjhzaQ3i" title="Common stock trading volume, percent">61%</span> of the lowest closing bid price of the Company&#8217;s
common stock for the ten prior trading days including the day upon which a notice of conversion is received by the Company from GS Capital,
subject to adjustment in certain events. The maturity date of the <span id="xdx_90A_eus-gaap--DebtInstrumentMaturityDate_dd_c20180929__20181002__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberTwoThousandEighteenGSNoteMember_zREmxodNjZ6l" title="Debt maturity date">October 2, 2018</span> GS Back-Note was October 2019 and the notes were fully
converted to common stock in fiscal 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><i>January
22, 2020 GS Capital Securities Purchase Agreements</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Effective
January 22, 2020, the Company entered into a securities purchase agreement with GS Capital, pursuant to which GS Capital purchased a
convertible promissory note (the &#8220;January 22, 2020 GS Note&#8221;) from the Company in the aggregate principal amount of <span id="xdx_905_eus-gaap--DebtInstrumentFaceAmount_c20200122__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--JanuaryTwentyTwoTwentyTwentyGSNoteMember_pp0p0" title="Convertible debt principal amount">$58,000</span>,
such principal and the interest thereon convertible into shares of the Company&#8217;s common stock at the option of GS Capital any time
after the six-month anniversary of the January 22, 2020 GS Capital Note. The January 22, 2020 GS Note contained an original discount
of <span id="xdx_900_eus-gaap--DebtInstrumentUnamortizedDiscount_c20200122__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--JanuaryTwentyTwoTwentyTwentyGSNoteMember_pp0p0" title="Original issue discount">$3,500</span>. The transactions contemplated by the GS Capital Securities Purchase Agreement closed on January 22, 2020. Pursuant to the
terms of the GS Capital Securities Purchase Agreement, GS Capital deducted <span id="xdx_901_eus-gaap--LegalFees_c20200121__20200122__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--JanuaryTwentyTwoTwentyTwentyGSNoteMember_pp0p0" title="Legal fees">$2,500</span> from the principal payment due under the January 22,
2020 GW Note, at the time of closing, to be applied to its legal expenses and received net cash proceeds of <span id="xdx_90D_eus-gaap--ProceedsFromConvertibleDebt_c20200121__20200122__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--JanuaryTwentyTwoTwentyTwentyGSNoteMember__srt--RangeAxis__srt--MinimumMember_pp0p0" title="Proceeds from convertible debt">$52,000</span> on January 28, 2020.
The Company used the net proceeds from the January 22, 2020 GW Note for general working capital purposes. The maturity date of the January
22, 2020 GS Capital was <span id="xdx_90B_eus-gaap--DebtInstrumentMaturityDate_dd_c20200121__20200122__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--JanuaryTwentyTwoTwentyTwentyGSNoteMember_ztHk6HM5YFai" title="Debt maturity date">January 22, 2021</span>. The January 22, 2020 GS Capital Note bore interest at a rate of 10% per annum, which interest
may be paid by the Company to GS Capital in shares of the Company&#8217;s common stock; but was not payable until the January 22, 2020
GS Capital Note became payable, whether at the maturity date or upon acceleration or by prepayment. The conversion price for the January
22, 2020 GS Capital Note was equal to a <span id="xdx_903_eus-gaap--DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_dp_uPure_c20200121__20200122__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--JanuaryTwentyTwoTwentyTwentyGSNoteMember_zMLHV8tdxRD1" title="Common stock trading volume, percent">40%</span> discount of the lowest closing bid price (&#8220;Lowest Trading Price&#8221;) of the Common
Stock for the ten trading days immediately prior to the delivery of a Notice of Conversion, including the day upon which a Notice of
Conversion is received.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Additionally,
GS Capital had the option to convert all or any amount of the principal face amount of the January 22, 2020 GS Capital Note at any time
from the date of issuance and ending on the later of the maturity date or the date the Default Amount was paid if an event of default
occurs, which is an amount between <span id="xdx_909_ecustom--DebtDefaultAmountPercentage_dp_uPure_c20200121__20200122__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--JanuaryTwentyTwoTwentyTwentyGSNoteMember__srt--RangeAxis__srt--MinimumMember_zLhcyB9kReSh" title="Debt default amount percentage">112%</span> and <span id="xdx_90A_ecustom--DebtDefaultAmountPercentage_dp_uPure_c20200121__20200122__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--JanuaryTwentyTwoTwentyTwentyGSNoteMember__srt--RangeAxis__srt--MaximumMember_z9sSAd3r7dW1" title="Debt default amount percentage">130%</span> of an amount equal to the then outstanding principal amount of the January 22, 2020
GS Capital Note plus any interest accrued, for shares of the Company&#8217;s common stock at the then-applicable conversion price. The
January 22, 2020 GS Note contained certain events of default, upon which principal and accrued interest would become immediately due
and payable. In addition, upon an event of default, interest on the outstanding principal would accrue at a default interest rate of
<span id="xdx_906_ecustom--DebtInstrumentDebtDefaultInterestRate_dp_uPure_c20200121__20200122__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--JanuaryTwentyTwoTwentyTwentyGSNoteMember_zRSiBEyLkQB6" title="Debt instrument, default, interest rate">24%</span> per annum.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>PROPANC
BIOPHARMA, INC. AND SUBSIDIARY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>June
30, 2021 and 2020</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
notes issued to GS capital above were treated as stock settled debt under ASC 480 and accordingly the Company recorded a total of <span id="xdx_90C_eus-gaap--DebtInstrumentUnamortizedPremium_c20200122__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--JanuaryTwentyTwoTwentyTwentyGSNoteMember_pp0p0" title="Debt premium amount">$106,438</span>
put premium which was expensed in fiscal 2020 of which <span id="xdx_90F_eus-gaap--AdditionalPaidInCapital_c20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--JanuaryTwentyTwoTwentyTwentyGSNoteMember_pp0p0" title="Additional paid in capital">$22,901</span> and <span id="xdx_90C_eus-gaap--AdditionalPaidInCapital_c20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--JanuaryTwentyTwoTwentyTwentyGSNoteMember_pp0p0" title="Additional paid in capital">$38,667</span> was released to additional paid in capital following conversion
of principal during the year ended June 30, 2020 and 2021, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.45in"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
Company recorded <span id="xdx_90B_eus-gaap--InterestPayableCurrentAndNoncurrent_c20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--JanuaryTwentyTwoTwentyTwentyGSNoteMember_pp0p0" title="Accrued interest">$8,802</span> of accrued interest and the total principal outstanding under the above GS Capital financing agreements was <span id="xdx_901_eus-gaap--ConvertibleNotesPayable_c20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--JanuaryTwentyTwoTwentyTwentyGSNoteMember_pp0p0" title="Convertible debt outstanding balance">$58,000</span>
as of June 30, 2020 following the conversion of <span id="xdx_902_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20190701__20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--JanuaryTwentyTwoTwentyTwentyGSNoteMember_pp0p0" title="Debt conversion of converted amount">$141,820</span> of principal and <span id="xdx_90E_ecustom--DebtConversionConvertedInterestPayable_c20190701__20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--JanuaryTwentyTwoTwentyTwentyGSNoteMember_pp0p0" title="Debt conversion of accrued interest">$76,397</span> of accrued interest during the year ended June 30,
2020. The total remaining principal outstanding and accrued interest under the above GS Capital financing agreements was <span id="xdx_902_eus-gaap--ConvertibleNotesPayable_c20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--JanuaryTwentyTwoTwentyTwentyGSNoteMember_pp0p0" title="Convertible debt outstanding balance">$0</span> as of June
30, 2021 following conversion of <span id="xdx_90B_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20200701__20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--JanuaryTwentyTwoTwentyTwentyGSNoteMember_pp0p0" title="Debt conversion of converted amount">$58,000</span> of principal and <span id="xdx_900_ecustom--DebtConversionConvertedInterestPayable_c20200701__20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--JanuaryTwentyTwoTwentyTwentyGSNoteMember_pp0p0" title="Debt conversion of accrued interest">$8,508</span> of accrued interest during the year ended June 30, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b><i>Convertible
Note Issued with Consulting Agreement</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><i>August
10, 2017 Consulting Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">On
August 10, 2017, the Company entered into a consulting agreement, retroactive to May 16, 2017, with a certain consultant, pursuant to
which the consultant agreed to provide certain consulting and business advisory services in exchange for a <span id="xdx_90F_eus-gaap--DebtInstrumentFaceAmount_c20170810__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember_pp0p0" title="Convertible debt principal amount">$310,000</span> junior subordinated
convertible note. The maturity date of the August 10, 2017 Convertible Note was August 2019 and is currently past due (see Note 8). The
note accrues interest at a rate of <span id="xdx_90C_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20170810__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember_zGtRbaHUHryg" title="Debt instrument, interest rate, stated percentage">10%</span> per annum and is convertible into common stock at the lesser of <span id="xdx_904_eus-gaap--DebtConversionConvertedInstrumentAmount1_pp0p0_c20170807__20170810__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember_zRjQnG0vwOlg" title="Debt conversion of converted amount">$750</span> or <span id="xdx_906_eus-gaap--DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_dp_uPure_c20170807__20170810__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember_za6nPWZA6QU1" title="Common stock trading volume, percent">65%</span> of the three lowest
trades in the <span id="xdx_90F_eus-gaap--DebtInstrumentConvertibleThresholdTradingDays_dxL_uInteger_c20170807__20170810__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember_zDWKrjoAjRPh" title="::XDX::10"><span style="-sec-ix-hidden: xdx2ixbrl1215">ten</span></span> trading days prior to the conversion. The note was fully earned upon signing the agreement and matures on <span id="xdx_90E_eus-gaap--DebtInstrumentMaturityDate_dd_c20170807__20170810__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember_zmjK4drtFdhi" title="Debt maturity date">August 10,
2019</span>. The Company accrued <span id="xdx_906_eus-gaap--AccruedLiabilitiesCurrentAndNoncurrent_c20170630__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember_pp0p0" title="Accrued expenses">$155,000</span> related to this expense at June 30, 2017 and recorded the remaining <span id="xdx_90A_eus-gaap--AccruedLiabilitiesCurrentAndNoncurrent_c20180630__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember_pp0p0" title="Accrued expenses">$155,000</span> related to this expense
in fiscal year 2018. Upon an event of default, principal and accrued interest will become immediately due and payable under the note.
Additionally, upon an event of default, at the election of the holder, the note would accrue interest at a default interest rate of <span id="xdx_90E_ecustom--DebtInstrumentDebtDefaultInterestRate_dp_uPure_c20170807__20170810__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember_z0Krvi3m8oVc" title="Debt instrument, default, interest rate">18%</span>
per annum or the highest rate of interest permitted by law. The consulting agreement had a three-month term and expired on August 16,
2017. An aggregate total of <span id="xdx_903_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_c20170810__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember_pp0p0" title="Embedded derivative, fair value of embedded derivative liability">$578,212</span> of this note was bifurcated with the embedded conversion option recorded as a derivative liability
at fair value. During the year ended June 30, 2018, the consultant converted <span id="xdx_902_eus-gaap--DebtInstrumentFaceAmount_c20180630__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ConsultantMember_pp0p0" title="Convertible debt principal amount">$140,000</span> of principal and <span id="xdx_901_eus-gaap--InterestPayableCurrentAndNoncurrent_c20180630__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ConsultantMember_pp0p0" title="Accrued interest">$10,764</span> of interest. During the
year ended June 30, 2019, the consultant converted an additional <span id="xdx_903_eus-gaap--DebtInstrumentFaceAmount_c20190630__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ConsultantMember_pp0p0" title="Convertible debt principal amount">$161,000</span> of principal and <span id="xdx_902_eus-gaap--InterestPayableCurrentAndNoncurrent_c20190630__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ConsultantMember_pp0p0" title="Accrued interest">$19,418</span> of interest leaving a principal balance
owed of <span id="xdx_90D_eus-gaap--DebtInstrumentFaceAmount_c20190630__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember_pp0p0" title="Convertible debt principal amount">$9,000</span> at June 30, 2019. During the year ended June 30, 2020, the consultant converted an additional <span id="xdx_903_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20190701__20200630__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember_pp0p0" title="Debt conversion of converted amount">$500</span> of principal and <span id="xdx_900_eus-gaap--AccruedLiabilitiesCurrentAndNoncurrent_c20200630__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember_pp0p0" title="Accrued expenses">$5,248</span>
of interest such that the remaining principal outstanding and accrued interest under this note as of June 30, 2020 was <span id="xdx_904_eus-gaap--DebtInstrumentFaceAmount_c20200630__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember_pp0p0" title="Convertible debt principal amount">$8,500</span> and <span id="xdx_903_eus-gaap--InterestPayableCurrentAndNoncurrent_c20200630__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember_pp0p0" title="Accrued interest">$22,168</span>,
respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">On
March 15, 2021, the Company entered into a Settlement and Mutual Release Agreement (the &#8220;Settlement Agreement&#8221;) with the
consultant whereby both parties agreed to settle all claims and liabilities under the August 10, 2017 Convertible note for a total of
<span id="xdx_90F_eus-gaap--DebtInstrumentFaceAmount_c20210315__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember__us-gaap--ShortTermDebtTypeAxis__custom--SettlementAndMutualReleaseAgreementMember_pp0p0" title="Convertible debt principal amount">$100,000</span> in the form of a convertible note. All other terms of the August 10, 2017 Convertible Note shall remain in full force and effect.
Both parties agree that all future penalties under this note are waived unless the Company fails to authorize to distribute the requested
shares upon conversion. The Company has the right to pay off the balance of any remaining amounts dues under this note in cash at any
time more than 60 days after March 15, 2021. Prior to the Settlement Agreement, the Company recorded total liabilities <span id="xdx_906_eus-gaap--Liabilities_iI_pp0p0_c20210315__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember__us-gaap--ShortTermDebtTypeAxis__custom--SettlementAndMutualReleaseAgreementMember_zlShDC1Kn4a1" title="Liabilities">$56,762</span> consisting
of remaining principal amount of <span id="xdx_90A_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pp0p0_c20210315__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember__us-gaap--ShortTermDebtTypeAxis__custom--SettlementAndMutualReleaseAgreementMember_zTBqWM6Glnla" title="Original issue discount">$8,500</span>, accrued interest of <span id="xdx_909_eus-gaap--InterestPayableCurrentAndNoncurrent_c20210315__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember__us-gaap--ShortTermDebtTypeAxis__custom--SettlementAndMutualReleaseAgreementMember_pp0p0" title="Accrued interest">$23,262</span> and accrued expenses of <span id="xdx_904_eus-gaap--AccruedLiabilitiesCurrentAndNoncurrent_c20210315__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember__us-gaap--ShortTermDebtTypeAxis__custom--SettlementAndMutualReleaseAgreementMember_pp0p0" title="Accrued expenses">$25,000</span>. Accordingly, the Company recognized
loss from settlement of debt of <span id="xdx_90D_eus-gaap--GainsLossesOnExtinguishmentOfDebt_c20200701__20210630__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember__us-gaap--ShortTermDebtTypeAxis__custom--SettlementAndMutualReleaseAgreementMember_pp0p0" title="Loss from settlement of debt">$43,238</span> during the year ended June 30, 2021 which is included in gain from settlement of debt, net in
the accompanying consolidated statements of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
total principal outstanding after adjustment due to the above-mentioned March 15, 2021 settlement agreement and accrued
interest under the August 10, 2017 Convertible Note was <span id="xdx_90F_eus-gaap--ConvertibleNotesPayable_c20210630__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember__us-gaap--ShortTermDebtTypeAxis__custom--SettlementAndMutualReleaseAgreementMember_pp0p0">$80,000
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">and <span id="xdx_909_eus-gaap--InterestPayableCurrentAndNoncurrent_c20210630__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember__us-gaap--ShortTermDebtTypeAxis__custom--SettlementAndMutualReleaseAgreementMember_pp0p0">$3,738</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">,
respectively, as of June 30, 2021 following conversion of <span id="xdx_902_eus-gaap--DebtConversionConvertedInstrumentAmount1_pp0p0_c20200701__20210630__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember__us-gaap--ShortTermDebtTypeAxis__custom--SettlementAndMutualReleaseAgreementMember_zliV7VyKLZJ8">$20,000
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">of principal during the year ended
June 30, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b><i>Power
Up Lending Group Financing Agreements</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><i>November
26, 2019 Securities Purchase Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Effective
November 26, 2019, the Company entered into a securities purchase agreement with Power Up Lending Group Ltd. (&#8220;Power Up&#8221;),
pursuant to which Power Up purchased a convertible promissory note (the &#8220;November 26, 2019 Power Up Note&#8221;) from the Company
in the aggregate principal amount of <span id="xdx_90D_eus-gaap--DebtInstrumentFaceAmount_c20191126__us-gaap--TypeOfArrangementAxis__custom--NovemberTwentySixTwoThousandNineteenSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--NovemberTwentySixTwoThousandNineteenPowerUpNoteMember_pp0p0" title="Convertible debt principal amount">$43,000</span>, such principal and the interest thereon convertible into shares of the Company&#8217;s
common stock at the option of Power Up. The transaction closed on November 22, 2019 and the Company received payment on December 3, 2019
in the amount of <span id="xdx_900_ecustom--PrepaymentPenalties_c20191121__20191122__us-gaap--TypeOfArrangementAxis__custom--NovemberTwentySixTwoThousandNineteenSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--NovemberTwentySixTwoThousandNineteenPowerUpNoteMember_pp0p0" title="Prepayment penalty">$40,000</span>, net of <span id="xdx_90F_eus-gaap--LegalFees_c20191121__20191122__us-gaap--TypeOfArrangementAxis__custom--NovemberTwentySixTwoThousandNineteenSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--NovemberTwentySixTwoThousandNineteenPowerUpNoteMember_pp0p0" title="Legal fees">$2,500</span> paid directly toward legal fees and <span id="xdx_909_ecustom--DiligenceFees_c20191121__20191122__us-gaap--TypeOfArrangementAxis__custom--NovemberTwentySixTwoThousandNineteenSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--NovemberTwentySixTwoThousandNineteenPowerUpNoteMember_pp0p0" title="Diligence fees">$500</span> to Power Up for due diligence fees. The maturity date
of the November 26, 2019 Power Up Note was <span id="xdx_90C_eus-gaap--DebtInstrumentMaturityDate_dd_c20191125__20191126__us-gaap--TypeOfArrangementAxis__custom--NovemberTwentySixTwoThousandNineteenSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--NovemberTwentySixTwoThousandNineteenPowerUpNoteMember_zYNvcL22ca51" title="Debt maturity date">November 26, 2020</span>. The November 26, 2019, Power Up Note bore interest at a rate of <span id="xdx_906_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20191126__us-gaap--TypeOfArrangementAxis__custom--NovemberTwentySixTwoThousandNineteenSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--NovemberTwentySixTwoThousandNineteenPowerUpNoteMember_zdNdNDpgTz2" title="Debt instrument, interest rate, stated percentage">8%</span> per
annum, which interest was paid by the Company to Power Up in shares of the Company&#8217;s common stock but was not payable until the
November 26, 2019 Power Up Note became payable, whether at the maturity date or upon acceleration or by prepayment. The note was fully
converted in fiscal 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><i>January
7, 2020 Power Up Lending Group Securities Purchase Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Effective
January 7, 2020, the Company entered into a securities purchase agreement with Power Up Lending Group Ltd. (&#8220;Power Up&#8221;),
pursuant to which Power Up purchased a convertible promissory note (the &#8220;January 7, 2020 Power Up Note&#8221;) from the Company
in the aggregate principal amount of <span id="xdx_903_eus-gaap--DebtInstrumentFaceAmount_c20200107__us-gaap--TypeOfArrangementAxis__custom--JanuarySevenTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--JanuarySevenTwoThousandTwentyPowerUpNoteMember_pp0p0" title="Convertible debt principal amount">$75,000</span>, such principal and the interest thereon convertible into shares of the Company&#8217;s
common stock at the option of Power Up. The transaction closed on January 7, 2020 and the Company received payment on January 13, 2020
in the amount of <span id="xdx_90E_ecustom--PrepaymentPenalties_c20200112__20200113__us-gaap--TypeOfArrangementAxis__custom--JanuarySevenTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--JanuarySevenTwoThousandTwentyPowerUpNoteMember_pp0p0" title="Prepayment penalty">$72,000</span>, net of <span id="xdx_908_eus-gaap--LegalFees_c20200112__20200113__us-gaap--TypeOfArrangementAxis__custom--JanuarySevenTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--JanuarySevenTwoThousandTwentyPowerUpNoteMember_pp0p0" title="Legal fees">$2,500</span> paid directly toward legal fees and <span id="xdx_903_ecustom--DiligenceFees_c20200112__20200113__us-gaap--TypeOfArrangementAxis__custom--JanuarySevenTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--JanuarySevenTwoThousandTwentyPowerUpNoteMember_pp0p0" title="Diligence fees">$500</span> to Power Up for due diligence fees. The maturity date
of the January 7, 2020 Power Up Note was <span id="xdx_903_eus-gaap--DebtInstrumentMaturityDate_dd_c20200106__20200107__us-gaap--TypeOfArrangementAxis__custom--JanuarySevenTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--JanuarySevenTwoThousandTwentyPowerUpNoteMember_zjzmYAIZORch" title="Debt maturity date">January 7, 2021</span>. The January 7, 2020, Power Up Note bore interest at a rate of <span id="xdx_908_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20200107__us-gaap--TypeOfArrangementAxis__custom--JanuarySevenTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--JanuarySevenTwoThousandTwentyPowerUpNoteMember_ziD8r4iS1J77" title="Debt instrument, interest rate, stated percentage">8%</span> per annum,
which interest was paid by the Company to Power Up in shares of the Company&#8217;s common stock, but not payable until the January 7,
2020 Power Up Note became payable, whether at the maturity date or upon acceleration or by prepayment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>PROPANC
BIOPHARMA, INC. AND SUBSIDIARY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>June
30, 2021 and 2020</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><i>March
12, 2020 Power Up Lending Group Securities Purchase Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Effective
March 12, 2020, the Company entered into a securities purchase agreement with Power Up Lending Group Ltd. (&#8220;Power Up&#8221;), pursuant
to which Power Up purchased a convertible promissory note (the &#8220;March 12, 2020 Power Up Note&#8221;) from the Company in the aggregate
principal amount of <span id="xdx_90B_eus-gaap--DebtInstrumentFaceAmount_c20200312__us-gaap--TypeOfArrangementAxis__custom--MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--MarchTwelveTwoThousandTwentyPowerUpNoteMember_pp0p0" title="Convertible debt principal amount">$43,000</span>, such principal and the interest thereon convertible into shares of the Company&#8217;s common stock at the
option of Power Up. The transaction closed on March 12, 2020 and the Company received payment on March 5, 2020 in the amount of <span id="xdx_90A_ecustom--PrepaymentPenalties_c20200304__20200305__us-gaap--TypeOfArrangementAxis__custom--MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--MarchTwelveTwoThousandTwentyPowerUpNoteMember_pp0p0" title="Prepayment penalty">$40,000</span>,
net of <span id="xdx_906_eus-gaap--LegalFees_c20200304__20200305__us-gaap--TypeOfArrangementAxis__custom--MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--MarchTwelveTwoThousandTwentyPowerUpNoteMember_pp0p0" title="Legal fees">$2,500</span> paid directly toward legal fees and <span id="xdx_903_ecustom--DiligenceFees_c20200304__20200305__us-gaap--TypeOfArrangementAxis__custom--MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--MarchTwelveTwoThousandTwentyPowerUpNoteMember_pp0p0" title="Diligence fees">$500</span> to Power Up for due diligence fees. The maturity date of the March 12, 2020 Power
Up Note was <span id="xdx_90D_eus-gaap--DebtInstrumentMaturityDate_dd_c20200311__20200312__us-gaap--TypeOfArrangementAxis__custom--MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--MarchTwelveTwoThousandTwentyPowerUpNoteMember_zm4Ozo2Yvwag" title="Debt maturity date">March 12, 2021</span>. The March 12, 2020, Power Up Note bore interest at a rate of <span id="xdx_908_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20200312__us-gaap--TypeOfArrangementAxis__custom--MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--MarchTwelveTwoThousandTwentyPowerUpNoteMember_zSjxwDoJzOOc" title="Debt instrument, interest rate, stated percentage">8%</span> per annum, which interest may be paid by
the Company to Power Up in shares of the Company&#8217;s common stock but was not payable until the March 12, 2020 Power Up Note became
payable, whether at the maturity date or upon acceleration or by prepayment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">All
the notes issued above to Power Up contained certain events of default, upon which principal and accrued interest would become immediately
due and payable. In addition, upon an event of default, interest on the outstanding principal would accrue at a default interest rate
of <span id="xdx_90F_ecustom--DebtDefaultAmountPercentage_dp_uPure_c20200311__20200312__us-gaap--TypeOfArrangementAxis__custom--MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--MarchTwelveTwoThousandTwentyPowerUpNoteMember_zCkbqUUFvoOa" title="Debt default amount percentage">22%</span> per annum.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Additionally,
Power Up had the option to convert all or any amount of the principal face amount of the notes issued to Power Up, starting on certain
dates as defined in the note agreements and ending on the later of the maturity date or the date the Default Amount is paid if an event
of default occurs, which was an amount equal to <span id="xdx_904_ecustom--DebtInstrumentDebtDefaultInterestRate_dp_uPure_c20200311__20200312__us-gaap--TypeOfArrangementAxis__custom--MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--MarchTwelveTwoThousandTwentyPowerUpNoteMember_zy0zG934qIS8" title="Debt instrument, default, interest rate">150%</span> of an amount equal to the then outstanding principal amount of the notes plus any
interest accrued, for shares of the Company&#8217;s common stock at the then-applicable conversion price.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span id="xdx_902_eus-gaap--DebtConversionDescription_c20200311__20200312__us-gaap--TypeOfArrangementAxis__custom--MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--MarchTwelveTwoThousandTwentyPowerUpNoteMember" title="Debt conversion, description">The
conversion price for the above Power Up notes was $3,050, subject to certain Market Price (as defined below) adjustment. If the Market
Price was greater than or equal to $5,000, the conversion price was to be the greater of <span id="xdx_90D_eus-gaap--DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_dp_uPure_c20200311__20200312__us-gaap--TypeOfArrangementAxis__custom--MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--MarchTwelveTwoThousandTwentyPowerUpNoteMember_zAlegf67tQq2" title="Common stock trading volume, percent">65%</span> of the Market Price (&#8220;Variable Conversion
Price&#8221;) and $3,050. In the event Market Price was less than $5,000, the conversion price was to be the Variable Conversion Price.
As defined in the note agreements, the &#8220;Market Price&#8221; was the average of the lowest three closing bid prices during the <span id="xdx_904_eus-gaap--DebtInstrumentConvertibleThresholdTradingDays_dc_uInteger_c20200311__20200312__us-gaap--TypeOfArrangementAxis__custom--MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--MarchTwelveTwoThousandTwentyPowerUpNoteMember_zmK9EcdpAoe2" title="Common stock trading days">ten</span>
day trading period prior to and including the day the Company receives a notice of conversion from Power Up on the electronic quotation
system or applicable principal securities exchange or trading market or, if no closing bid price of such security is available in any
of the foregoing manners, the average of the closing bid prices of any market makers for such security that are listed in the &#8220;pink
sheets&#8221; during the ten prior trading days, including the day upon which the Company receives a notice of conversion from Power
Up. Notwithstanding the foregoing, Power Up was restricted from effecting a conversion if such conversion, along with other shares of
the Company&#8217;s common stock beneficially owned by Power Up and its affiliates, exceeds <span id="xdx_90B_ecustom--PercentageOfOutstandingSharesOfCommonStock_dp_uPure_c20200311__20200312__us-gaap--TypeOfArrangementAxis__custom--MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--MarchTwelveTwoThousandTwentyPowerUpNoteMember_zMMUxQV5ZnF3" title="Percentage of outstanding shares of common stock">4.99%</span> of the outstanding shares of the Company&#8217;s
common stock.</span> An aggregate initial total of <span id="xdx_90F_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_c20200312__us-gaap--TypeOfArrangementAxis__custom--MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--MarchTwelveTwoThousandTwentyPowerUpNoteMember_pp0p0" title="Embedded derivative, fair value of embedded derivative liability">$422,557</span> of these notes were bifurcated with the embedded conversion option recorded as derivative
liabilities at fair value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
total principal amount outstanding under the above Power Up financing agreements, specifically the January 7, 2020 and March 12, 2020
Power Up Notes, was <span id="xdx_909_eus-gaap--DebtInstrumentFaceAmount_c20200107__us-gaap--TypeOfArrangementAxis__custom--MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--MarchTwelveTwoThousandTwentyPowerUpNoteMember_pp0p0" title="Convertible debt principal amount"><span id="xdx_908_eus-gaap--DebtInstrumentFaceAmount_c20200630__us-gaap--TypeOfArrangementAxis__custom--MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--MarchTwelveTwoThousandTwentyPowerUpNoteMember_pp0p0" title="Convertible debt principal amount">$118,000</span></span> and accrued interest of <span id="xdx_90A_eus-gaap--InterestPayableCurrentAndNoncurrent_c20200107__us-gaap--TypeOfArrangementAxis__custom--MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--MarchTwelveTwoThousandTwentyPowerUpNoteMember_pp0p0" title="Accrued interest"><span id="xdx_905_eus-gaap--InterestPayableCurrentAndNoncurrent_c20200630__us-gaap--TypeOfArrangementAxis__custom--MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--MarchTwelveTwoThousandTwentyPowerUpNoteMember_pp0p0" title="Accrued interest">$3,903</span></span> as of June 30, 2020. The total principal amount outstanding under the above
Power Up financing agreement, specifically the January 7, 2020 and March 12, 2020 Power Up Notes, was <span id="xdx_90F_eus-gaap--DebtInstrumentFaceAmount_c20210630__us-gaap--TypeOfArrangementAxis__custom--MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--MarchTwelveTwoThousandTwentyPowerUpNoteMember_pp0p0" title="Convertible debt principal amount">$0</span> and accrued interest of <span id="xdx_904_eus-gaap--InterestPayableCurrentAndNoncurrent_c20210630__us-gaap--TypeOfArrangementAxis__custom--MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--MarchTwelveTwoThousandTwentyPowerUpNoteMember_pp0p0" title="Accrued interest">$0</span> as
of June 30, 2021 following repayment in cash of <span id="xdx_905_eus-gaap--RepaymentsOfDebt_c20200701__20210630__us-gaap--TypeOfArrangementAxis__custom--MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--MarchTwelveTwoThousandTwentyPowerUpNoteMember_pp0p0" title="Repayment in cash">$43,000</span> of the principal balance and <span id="xdx_904_eus-gaap--InterestPaid_c20200701__20210630__us-gaap--TypeOfArrangementAxis__custom--MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--MarchTwelveTwoThousandTwentyPowerUpNoteMember_pp0p0" title="Repayment of interest">$1,816</span> of accrued interest and conversions into
common stock during the year ended June 30, 2021. Accordingly, there was <span id="xdx_90F_eus-gaap--ConvertibleNotesPayable_iI_pp0p0_do_c20210630__us-gaap--TypeOfArrangementAxis__custom--MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--MarchTwelveTwoThousandTwentyPowerUpNoteMember_z2XBC9mbBouf" title="Convertible debt outstanding balance">no</span> outstanding principal balance as of June 30, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b><i>Redstart
Holdings Corp Financing Agreement</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><i>May
23, 2019 Securities Purchase Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Effective
May 23, 2019, the Company issued a convertible promissory note (the &#8220;May 23 Redstart Holdings Note&#8221;) to Redstart Holdings
Corp (&#8220;Redstart Holdings&#8221;) in the aggregate principal amount of <span id="xdx_90F_eus-gaap--DebtInstrumentFaceAmount_c20190523__us-gaap--TypeOfArrangementAxis__custom--RedstartHoldingsCorpFinancingAgreementMember__dei--LegalEntityAxis__custom--RedstartHoldingsCorpMember_pp0p0" title="Convertible debt principal amount">$133,000</span>, with principal and the interest thereon convertible
into shares of the Company&#8217;s common stock at the option of Redstart Holdings any time after 180 days of issuance. At the time of
closing on May 31, 2019, Redstart Holdings deducted <span id="xdx_90D_eus-gaap--LegalFees_c20190522__20190523__us-gaap--TypeOfArrangementAxis__custom--RedstartHoldingsCorpFinancingAgreementMember__dei--LegalEntityAxis__custom--RedstartHoldingsCorpMember_pp0p0" title="Legal fees">$3,000</span> from the principal payment due under the May 2019 Redstart Holdings Note to
be applied to its legal expenses, such that the Company received aggregate net proceeds of <span id="xdx_90F_eus-gaap--ProceedsFromConvertibleDebt_pp0p0_c20190522__20190523__us-gaap--TypeOfArrangementAxis__custom--RedstartHoldingsCorpFinancingAgreementMember__dei--LegalEntityAxis__custom--RedstartHoldingsCorpMember_zsaJUYDGLanl" title="Proceeds from convertible debt">$130,000</span> at closing. The maturity date of
the May 2019 Redstart Holdings Note was <span id="xdx_901_eus-gaap--DebtInstrumentMaturityDate_dd_c20190522__20190523__us-gaap--TypeOfArrangementAxis__custom--RedstartHoldingsCorpFinancingAgreementMember__dei--LegalEntityAxis__custom--RedstartHoldingsCorpMember_zBtTZ0apbbh1" title="Debt maturity date">May 23, 2020</span> and bore interest at a rate of <span id="xdx_90A_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20190523__us-gaap--TypeOfArrangementAxis__custom--RedstartHoldingsCorpFinancingAgreementMember__dei--LegalEntityAxis__custom--RedstartHoldingsCorpMember_z8zNwVHOEIxb" title="Debt instrument, interest rate, stated percentage">8%</span> per annum. The total principal amount outstanding
and accrued interest under the above Redstart Holdings financing agreement, specifically the May 23, 2019 agreement at June 30, 2019
was <span id="xdx_908_eus-gaap--DebtInstrumentFaceAmount_c20190630__us-gaap--TypeOfArrangementAxis__custom--RedstartHoldingsCorpFinancingAgreementMember__dei--LegalEntityAxis__custom--RedstartHoldingsCorpMember_pp0p0" title="Convertible debt principal amount">$133,000</span> and <span id="xdx_901_eus-gaap--InterestPayableCurrentAndNoncurrent_c20190630__us-gaap--TypeOfArrangementAxis__custom--RedstartHoldingsCorpFinancingAgreementMember__dei--LegalEntityAxis__custom--RedstartHoldingsCorpMember_pp0p0" title="Accrued interest">$1,137</span> respectively and as of June 30, 2020 total principal amount outstanding and accrued interest totaled <span id="xdx_901_eus-gaap--DebtInstrumentFaceAmount_c20200630__us-gaap--TypeOfArrangementAxis__custom--RedstartHoldingsCorpFinancingAgreementMember__dei--LegalEntityAxis__custom--RedstartHoldingsCorpMember_pp0p0" title="Convertible debt principal amount">$0</span> and <span id="xdx_909_eus-gaap--InterestPayableCurrentAndNoncurrent_c20200630__us-gaap--TypeOfArrangementAxis__custom--RedstartHoldingsCorpFinancingAgreementMember__dei--LegalEntityAxis__custom--RedstartHoldingsCorpMember_pp0p0" title="Accrued interest">$0</span>
respectively following conversion of <span id="xdx_900_eus-gaap--DebtInstrumentFaceAmount_c20200630__us-gaap--TypeOfArrangementAxis__custom--RedstartHoldingsCorpFinancingAgreementMember_pp0p0" title="Convertible debt principal amount">$133,000</span> of the principal balance and <span id="xdx_903_eus-gaap--InterestPayableCurrentAndNoncurrent_c20200630__us-gaap--TypeOfArrangementAxis__custom--RedstartHoldingsCorpFinancingAgreementMember_pp0p0" title="Accrued interest">$5,320</span> of accrued interest during the year ended June 30,
2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>PROPANC
BIOPHARMA, INC. AND SUBSIDIARY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>June
30, 2021 and 2020</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b><i>Odyssey
Capital Financing Agreements</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><i>July
30, 2019 Securities Purchase Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Effective
July 30, 2019, the Company entered into a securities purchase agreement with Odyssey Capital Funding LLC, (&#8220;Odyssey&#8221;), pursuant
to which Odyssey purchased a convertible promissory note (the &#8220;July 30, 2019 Odyssey Note&#8221;) from the Company in the aggregate
principal amount of <span id="xdx_906_eus-gaap--DebtInstrumentFaceAmount_c20190730__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OdysseyCapitalFundingLLCMember__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandNineteenOdysseyNoteMember_pp0p0" title="Convertible debt principal amount">$320,000</span>, such principal and the interest thereon convertible into shares of the Company&#8217;s common stock at
the option of Odyssey. The July 30, 2019 Odyssey Note contains an original discount of <span id="xdx_90A_eus-gaap--DebtInstrumentUnamortizedDiscount_c20190730__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OdysseyCapitalFundingLLCMember__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandNineteenOdysseyNoteMember_pp0p0" title="Original issue discount">$25,000</span>. The transaction closed on July 30, 2019
and the Company received payment on August 1, 2019 in the amount of <span id="xdx_905_eus-gaap--DebtInstrumentFaceAmount_c20190801__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OdysseyCapitalFundingLLCMember__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandNineteenOdysseyNoteMember_pp0p0" title="Convertible debt principal amount">$295,000</span>, of which <span id="xdx_90D_eus-gaap--LegalFees_c20190731__20190801__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OdysseyCapitalFundingLLCMember__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandNineteenOdysseyNoteMember_pp0p0" title="Legal fees">$10,000</span> was paid directly toward legal fees, resulting
in net cash proceeds of <span id="xdx_90F_eus-gaap--ProceedsFromConvertibleDebt_c20190731__20190801__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OdysseyCapitalFundingLLCMember__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandNineteenOdysseyNoteMember_pp0p0" title="Proceeds from convertible debt">$285,000</span>. The maturity date of the July 30, 2019 Odyssey Note was <span id="xdx_90E_eus-gaap--DebtInstrumentMaturityDate_dd_c20190729__20190730__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OdysseyCapitalFundingLLCMember__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandNineteenOdysseyNoteMember_zWK5JPNAl2Ve" title="Debt maturity date">July 30, 2020</span>. The July 2019 Odyssey Note bore
interest at a rate of <span id="xdx_90F_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20190730__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OdysseyCapitalFundingLLCMember__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandNineteenOdysseyNoteMember_zqG7xTnQih53" title="Debt instrument, interest rate, stated percentage">10%</span> per annum, which interest may be paid by the Company to Odyssey in shares of the Company&#8217;s common stock
but was not payable until the July 30, 2019 Odyssey Note became payable, whether at the maturity date or upon acceleration or by prepayment.
The July 30, 2019 Odyssey Note contained certain events of default, upon which principal and accrued interest would become immediately
due and payable. In addition, upon an event of default, interest on the outstanding principal would accrue at a default interest rate
of <span id="xdx_90C_ecustom--DebtInstrumentDebtDefaultInterestRate_dp_uPure_c20190729__20190730__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OdysseyCapitalFundingLLCMember__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandNineteenOdysseyNoteMember_z4GYRD1EAux2" title="Debt instrument, default, interest rate">24%</span> per annum. The note was treated as stock settled debt under ASC 480 and accordingly the Company recorded a <span id="xdx_90E_eus-gaap--DebtInstrumentUnamortizedPremium_c20190730__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OdysseyCapitalFundingLLCMember__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandNineteenOdysseyNoteMember_pp0p0" title="Debt premium amount">$172,308</span> put premium.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Additionally,
Odyssey had the option to convert all or any amount of the principal face amount of the July 30, 2019 Odyssey Note, starting on January
31, 2020 and ending on the later of the maturity date or the date the Default Amount was paid if an event of default occurred, which
was an amount equal to <span id="xdx_905_ecustom--PercentageOfOutstandingSharesOfCommonStock_dp_uPure_c20190729__20190730__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OdysseyCapitalFundingLLCMember__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandNineteenOdysseyNoteMember_z1rJRtZ91Hl7" title="Percentage of outstanding shares of common stock">120%</span> of an amount equal to the then outstanding principal amount of the July 30, 2019 Odyssey Note plus any interest
accrued from July 30, 2019 at the default interest rate of <span id="xdx_90C_ecustom--DebtInstrumentDebtDefaultInterestRate_dp_uPure_c20190729__20190730__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OdysseyCapitalFundingLLCMember__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandNineteenOdysseyNoteMember_z6AHBubMbEZc" title="Debt instrument, default, interest rate">24%</span> per annum for shares of the Company&#8217;s common stock at the then-applicable
conversion price.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
conversion price for the July 30, 2019 Odyssey Note was equal to <span id="xdx_90D_eus-gaap--DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_dp_uPure_c20190729__20190730__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OdysseyCapitalFundingLLCMember__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandNineteenOdysseyNoteMember_ztZQkrsuCRji" title="Common stock trading volume, percent">65%</span> of the lowest closing bid price of the Common Stock as reported
on the OTC Markets on which the Company&#8217;s shares were then traded or any exchange upon which the Common Stock may be traded in
the future, for the ten prior trading days including the day upon which a Notice of Conversion is received by the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
total principal amount outstanding under the above Odyssey financing agreement, specifically the July 30, 2019 Odyssey Note, was <span id="xdx_907_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OdysseyCapitalFundingLLCMember_zR13FwGy6Ia8" title="Convertible debt principal amount">$0</span> and
accrued interest of <span id="xdx_90D_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OdysseyCapitalFundingLLCMember_zpqSURkjpol9" title="Accrued interest">$0</span> as of June 30, 2020 following conversion of <span id="xdx_903_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20190701__20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OdysseyCapitalFundingLLCMember__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandNineteenOdysseyNoteMember_pp0p0" title="Debt conversion of converted amount">$320,000</span> of the principal balance and <span id="xdx_907_eus-gaap--InterestPayableCurrentAndNoncurrent_c20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OdysseyCapitalFundingLLCMember__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandNineteenOdysseyNoteMember_pp0p0" title="Accrued interest">$23,220</span> of accrued interest
during the year ended June 30, 2020 resulting in full repayment of the note and a full reduction of the put premium. The note was fully
converted in fiscal 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b><i>Auctus
Fund Financing Agreements</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><i>August
30, 2019 Securities Purchase Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Effective
August 30, 2019, the Company entered into a securities purchase agreement with Auctus Fund, LLC (&#8220;Auctus&#8221;), pursuant to which
Auctus purchased a convertible promissory note (the &#8220;August 30, 2019 Auctus Note&#8221;) from the Company in the aggregate principal
amount of <span id="xdx_90C_eus-gaap--DebtInstrumentFaceAmount_c20190830__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_pp0p0" title="Convertible debt principal amount">$550,000</span>, such principal and the interest thereon convertible into shares of the Company&#8217;s common stock at the option
of Auctus. The transaction closed on August 30, 2019 and the Company received payment on September 4, 2019 in the amount of <span id="xdx_904_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20190904__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_zbGEPw4WPvlj" title="Convertible debt principal amount">$550,000</span>,
of which <span id="xdx_901_eus-gaap--LegalFees_pp0p0_c20190903__20190904__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_zO4UPbfesMyh" title="Legal fees">$5,000</span> was paid directly toward legal fees and <span id="xdx_903_ecustom--DiligenceFees_c20190903__20190904__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_pp0p0" title="Diligence fees">$40,000</span> to Auctus for due diligence fees resulting in net cash proceeds of <span id="xdx_908_eus-gaap--ProceedsFromConvertibleDebt_c20190903__20190904__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_pp0p0" title="Proceeds from convertible debt">$505,000</span>.
The maturity date of the August 30, 2019 Auctus Note was <span id="xdx_90E_eus-gaap--DebtInstrumentMaturityDate_dd_c20190829__20190830__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_zhfCVziB2L77" title="Debt maturity date">August 30, 2020</span> and is currently past due. The August 30, 2019 Auctus Note bears
interest at a rate of <span id="xdx_901_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20190830__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_zMKgIwj5n8xf" title="Debt instrument, interest rate, stated percentage">10%</span> per annum, but not payable until the August 30, 2019 Auctus Note became payable, whether at the maturity date
or upon acceleration or by prepayment. The note is treated as stock settled debt under ASC 480 and accordingly the Company recorded a
<span id="xdx_904_eus-gaap--DebtInstrumentUnamortizedPremium_c20190830__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_pp0p0" title="Debt premium amount">$366,667</span> put premium. The August 30, 2019 Auctus Note may not be prepaid without the written consent of Auctus. Any amount of principal
or interest which is not paid when due shall bear interest at the rate of <span id="xdx_90E_ecustom--DebtInstrumentDebtDefaultInterestRate_dp_uPure_c20190829__20190830__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_zaBaVI3NWg64" title="Debt instrument, default, interest rate">24%</span> per annum.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Additionally,
Auctus has the option to convert all or any amount of the principal face amount and accrued interest of the August 30, 2019 Auctus Note,
at any time following the issue date and ending on the later of the maturity date or the date of payment of the Default Amount if an
event of default occurs, which is an amount equal to <span id="xdx_90E_ecustom--PercentageOfOutstandingSharesOfCommonStock_dp_uPure_c20190829__20190830__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_z60xIdLxExua" title="Percentage of outstanding shares of common stock">125%</span> of an amount equal to the then outstanding principal amount of the August 30,
2019 Auctus Note (but not less than $15,000) plus any interest accrued from August 30, 2019 at the default interest rate of <span id="xdx_90F_ecustom--DebtInstrumentDebtDefaultInterestRate_dp_uPure_c20190829__20190830__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_zSwxjiCA1BAe" title="Debt instrument, default, interest rate">24%</span> per annum,
for shares of the Company&#8217;s common stock at the then-applicable conversion price. <span id="xdx_900_eus-gaap--DebtInstrumentDescription_c20190829__20190830__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember" title="Debt instrument, description">Upon the holder&#8217;s election to convert accrued
interest, default interest or any penalty amounts as stipulated, the Company may elect to pay those amounts in cash. The note may also
be prepaid by the Company at any time between the date of issuance and August 13, 2020 at 135% multiplied by the sum of (a) the then
outstanding principal amount plus (b) accrued and unpaid interest plus (c) default interests</span>, if any.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"/></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
conversion price for the August 30, 2019 Auctus Note shall be the Variable Conversion Price, being <span id="xdx_90F_eus-gaap--DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_dp_uPure_c20190903__20190904__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_zWk8n9vZwnnc" title="Common stock trading volume, percent">60%</span> of the Market Price on the date
of conversion. Notwithstanding the foregoing, Auctus shall be restricted from effecting a conversion if such conversion, along with other
shares of the Company&#8217;s common stock beneficially owned by Auctus and its affiliates, exceeds <span id="xdx_908_ecustom--PercentageOfOutstandingSharesOfCommonStock_dp_uPure_c20190903__20190904__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_zvyXzOqt6ctl" title="Percentage of outstanding shares of common stock">4.99%</span> of the outstanding shares of
the Company&#8217;s common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>PROPANC
BIOPHARMA, INC. AND SUBSIDIARY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>June
30, 2021 and 2020</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">In
connection with the issuance of the August 2019 Auctus Note, the Company issued common stock purchase warrants to Auctus to purchase
<span id="xdx_900_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_c20190830__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember__us-gaap--StatementEquityComponentsAxis__custom--FirstWarrantMember_pdd" title="Warrants to purchase of common stock, shares">450</span> shares of the Company&#8217;s common stock (the &#8220;First Warrant&#8221;) as a commitment fee upon the terms and subject to the
limitations and conditions set forth in such First Warrant at an &#8220;Exercise Price&#8221; of <span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20190830__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember__us-gaap--StatementEquityComponentsAxis__custom--FirstWarrantMember_pdd" title="Warrants exercise price per share">$2,250</span>. In connection with the issuance
of the Note, the Company shall issue a common stock purchase warrant to Buyer to purchase <span id="xdx_905_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_c20190830__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember__us-gaap--StatementEquityComponentsAxis__custom--SecondWarrantMember_pdd" title="Warrants to purchase of common stock, shares">300</span> shares of the Company&#8217;s common stock
(the &#8220;Second Warrant&#8221;) as a commitment fee upon the terms and subject to the limitations and conditions set forth in such
Second Warrant at an &#8220;Exercise Price&#8221; of <span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20190830__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember__us-gaap--StatementEquityComponentsAxis__custom--SecondWarrantMember_pdd" title="Warrants exercise price per share">$3,330</span>. In connection with the issuance of the Note, the Company shall issue a common
stock purchase warrant to Buyer to purchase <span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_c20190830__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember__us-gaap--StatementEquityComponentsAxis__custom--ThirdWarrantMember_pdd" title="Warrants to purchase of common stock, shares">225</span> shares of the Company&#8217;s common stock (the &#8220;Third Warrant&#8221;) as a commitment
fee upon the terms and subject to the limitations and conditions set forth in such Third Warrant at an &#8220;Exercise Price&#8221; of
<span id="xdx_903_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20190830__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember__us-gaap--StatementEquityComponentsAxis__custom--ThirdWarrantMember_pdd" title="Warrants exercise price per share">$4,500</span>. The First Warrant, Second Warrant, and Third Warrant shall collectively be referred as the &#8220;Warrants&#8221;. The Warrants
have an &#8220;Exercise Period&#8221; of five years from the date of issuance being August 30, 2019. Under the terms of the Purchase
Agreement and the Warrants, the Selling Security Holder may not either convert the Notes nor exercise the Warrants to the extent (but
only to the extent) that the Selling Security Holder or any of its affiliates would beneficially own a number of shares of our Common
Stock which would exceed <span id="xdx_908_ecustom--PercentageOfOutstandingSharesOfCommonStock_dp_uPure_c20190701__20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_zvnGDaFAX33d" title="Percentage of outstanding shares of common stock">4.99%</span> of our outstanding shares. The Company accounted for the warrants by using the relative fair value method
and recorded debt discount from the relative fair value of the warrants of <span id="xdx_90C_eus-gaap--FairValueAdjustmentOfWarrants_c20190829__20190830__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_pp0p0" title="Fair value of warrants">$375,905</span> using a simple binomial lattice model.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">In
connection with the Purchase Agreement, the Company and the Purchaser entered into a Registration Rights Agreement (the &#8220;Registration
Rights Agreement&#8221;). Pursuant to the Registration Rights Agreement, the Company agreed to register the shares of Common Stock underlying
the Securities in a Registration Statement with the SEC as well as the Commitment Shares (as defined herein). The Registration Rights
Agreement contains customary representations, warranties, agreements and indemnification rights and obligations of the parties.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
Note is subject to customary default provisions and also includes a cross-default provision which provides that a breach or default by
the Borrower of any covenant or other term or condition contained in any of the Other Agreements (as defined therein), after the passage
of all applicable notice and cure or grace periods, shall, at the option of the Holder, be considered a default under this Note and the
Other Agreements. Upon occurrence of any such event, the Holder shall be entitled (but in no event required) to apply all rights and
remedies of the Holder under the terms of this Note and the Other Agreements by reason of a default under said Other Agreements or the
Note.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
August 30, 2019 Auctus Note contain certain events of default, upon which principal and accrued interest will become immediately due
and payable. In addition, upon an event of default, interest on the outstanding principal shall accrue at a default interest rate of
24% per annum.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
total principal amount outstanding under the above Auctus financing agreement, specifically the August 30, 2019 Auctus Note, was $358,965
and accrued interest of <span id="xdx_90E_eus-gaap--InterestPayableCurrentAndNoncurrent_c20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_pp0p0" title="Accrued interest">$486</span> as of June 30, 2020 following conversion of <span id="xdx_90C_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20190701__20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_pp0p0" title="Debt conversion of converted amount">$191,035</span> of the principal balance and <span id="xdx_90D_eus-gaap--InterestPayableCurrentAndNoncurrent_c20200630__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_pp0p0" title="Accrued interest">$43,176</span> of accrued interest
during the year ended June 30, 2020. Accordingly, <span id="xdx_90A_eus-gaap--DebtInstrumentUnamortizedPremium_c20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_pp0p0" title="Debt premium amount">$127,356</span> of the put premium was released in respect of the August 30, 2019 Auctus Note
during the year ended June 30, 2020 following conversion of the principal balance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
total principal amount outstanding under the above Auctus financing agreement, specifically the August 30, 2019 Auctus Note, was <span id="xdx_90D_eus-gaap--DebtInstrumentFaceAmount_c20210630__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_pp0p0" title="Convertible debt principal amount">$32,848</span>
and accrued interest of <span id="xdx_90E_eus-gaap--InterestPayableCurrentAndNoncurrent_c20210630__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_pp0p0" title="Accrued interest">$0</span> as of June 30, 2021 following conversion of <span id="xdx_90D_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20200701__20210630__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_pp0p0" title="Debt conversion of converted amount">$326,117</span> of the principal balance and <span id="xdx_90F_ecustom--DebtConversionConvertedInterestPayable_c20200701__20210630__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_pp0p0" title="Debt conversion of accrued interest">$39,536</span> of accrued interest
during the year ended June 30, 2021. Accordingly, <span id="xdx_905_eus-gaap--DebtInstrumentUnamortizedPremium_iI_pp0p0_c20210630__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_zMs1ppsCOrtb" title="Debt premium amount">$217,411</span> of the put premium was released in respect of the August 30, 2019 Auctus Note
during the year ended June 30, 2021 following conversion of the principal balance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b><i>GW
Holdings Securities Purchase Agreements</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><i>October
1, 2019 Securities Purchase Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Effective
October 1, 2019, the Company entered into a securities purchase agreement with GW Holdings, pursuant to which GW Holdings purchased a
convertible promissory note (the &#8220;October 1, 2019 GW Note&#8221;) from the Company in the aggregate principal amount of <span id="xdx_90A_eus-gaap--DebtInstrumentFaceAmount_c20191002__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberOneTwoThousandNineteenAuctusNoteMember_pp0p0" title="Convertible debt principal amount">$131,000</span>,
such principal and the interest thereon convertible into shares of the Company&#8217;s common stock at the option of GW Holdings any
time after the six-month anniversary of the October 1, 2019 GW Holdings Note. The transactions contemplated by the GW Holdings Securities
Purchase Agreement closed on October 1, 2019. Pursuant to the terms of the GW Holdings Securities Purchase Agreement, the lender deducted
<span id="xdx_909_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_c20190929__20191002__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberOneTwoThousandNineteenAuctusNoteMember_pp0p0" title="Debt instrument principal payment">$6,000</span> from the principal payment due under the October 1, 2019 GW Note, at the time of closing, to be applied to its legal expenses.
The Company used the net proceeds of <span id="xdx_901_eus-gaap--ProceedsFromConvertibleDebt_pp0p0_c20190929__20191002__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberOneTwoThousandNineteenAuctusNoteMember_zaEB4ud3eO85" title="Proceeds from convertible debt">$125,000</span> from the October 1, 2019 GW Note for general working capital purposes. The maturity date
of the October 1, 2019 GW Holdings was <span id="xdx_90A_eus-gaap--DebtInstrumentMaturityDate_dd_c20190929__20191002__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberOneTwoThousandNineteenAuctusNoteMember_zKrndB6pO7Ne" title="Debt maturity date">October 1, 2020</span> and is currently past due. The October 1, 2019 GW Holdings Note bore interest
at a rate of <span id="xdx_90E_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20191002__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberOneTwoThousandNineteenAuctusNoteMember_zPtct5WsmEEf" title="Debt instrument, interest rate, stated percentage">8%</span> per annum, which interest was paid by the Company to GW Holdings in shares of the Company&#8217;s common stock; but was
not payable until the October 1, 2019 GW Holdings Note became payable, whether at the maturity date or upon acceleration or by prepayment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><i>December
10, 2020 Securities Purchase Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Effective
December 10, 2020, the Company entered into a securities purchase agreement with GW Holdings, pursuant to which GW Holdings purchased
a convertible promissory note (the &#8220;December 10, 2020 GW Note&#8221;) from the Company in the aggregate principal amount of <span id="xdx_902_eus-gaap--DebtInstrumentFaceAmount_c20201210__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--DecemberTenTwoThousandTwentyGWNoteMember_pp0p0" title="Convertible debt principal amount">$131,000</span>,
such principal and the interest thereon convertible into shares of the Company&#8217;s common stock at the option of GW Holdings anytime
from the issuance of the December 10, 2020 GW Holdings Note. The transactions contemplated by the GW Holdings Securities Purchase Agreement
closed on December 10, 2020. Pursuant to the terms of the GW Holdings Securities Purchase Agreement, the lender deducted <span id="xdx_905_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_c20201209__20201210__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--DecemberTenTwoThousandTwentyGWNoteMember_pp0p0" title="Debt instrument principal payment">$6,000</span> from
the principal payment due under the December 10, 2020 GW Note, at the time of closing, to be applied to its legal expenses. The Company
intends to use the net proceeds of <span id="xdx_90B_eus-gaap--ProceedsFromConvertibleDebt_pp0p0_c20201209__20201210__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--DecemberTenTwoThousandTwentyGWNoteMember_zdGlPC9dx3fg" title="Proceeds from convertible debt">$125,000</span> from the December 10, 2020 GW Note for general working capital purposes. The maturity date
of the December 10, 2020 GW Holdings is <span id="xdx_909_eus-gaap--DebtInstrumentMaturityDate_dd_c20201209__20201210__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--DecemberTenTwoThousandTwentyGWNoteMember_z2vQ7zNJnIve" title="Debt maturity date">December 10, 2021</span>. The December 10, 2020 GW Holdings Note bears interest at a rate of <span id="xdx_90B_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20201210__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--DecemberTenTwoThousandTwentyGWNoteMember_zaZ2WjOKzaab" title="Debt instrument, interest rate, stated percentage">8%</span> per
annum, which interest may be paid by the Company to GW Holdings in shares of the Company&#8217;s common stock; but shall not be payable
until the December 10, 2020 GW Holdings Note becomes payable, whether at the maturity date or upon acceleration or by prepayment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>PROPANC
BIOPHARMA, INC. AND SUBSIDIARY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>June
30, 2021 and 2020</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
above notes issued to GW Holdings contain certain events of default, upon which principal and accrued interest will become immediately
due and payable. In addition, upon an event of default, interest on the outstanding principal shall accrue at a default interest rate
of <span id="xdx_907_ecustom--DebtInstrumentDebtDefaultInterestRate_dp_uPure_c20201209__20201210__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--DecemberTenTwoThousandTwentyGWNoteMember_zArgRvWfEwje" title="Debt instrument, default, interest rate">24%</span> per annum, or if such rate is usurious or not permitted by current law, then at the highest rate of interest permitted by law.
Further, certain events of default may trigger penalty and liquidated damage provisions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Additionally,
GW Holdings has the option to convert all or any amount of the principal face amount of the notes issued to GW Holdings at any time from
the date of issuance and ending on the later of the maturity date or the date the Default Amount is paid if an event of default occurs,
which is an amount between <span id="xdx_905_ecustom--DebtInstrumentDebtDefaultInterestRate_dp_uPure_c20201209__20201210__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--DecemberTenTwoThousandTwentyGWNoteMember__srt--RangeAxis__srt--MinimumMember_zQUE8QLxpFka" title="Debt instrument, default, interest rate">110%</span> and <span id="xdx_905_ecustom--DebtInstrumentDebtDefaultInterestRate_dp_uPure_c20201209__20201210__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--DecemberTenTwoThousandTwentyGWNoteMember__srt--RangeAxis__srt--MaximumMember_zjV9drC6Cubi" title="Debt instrument, default, interest rate">150%</span> of an amount equal to the then outstanding principal amount of such notes plus any interest
accrued, for shares of the Company&#8217;s common stock at the then-applicable conversion price.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
conversion price for the above GW Holdings notes shall be equal to a 40% discount of the lowest closing bid price (&#8220;Lowest Trading
Price&#8221;) of the Common Stock for the ten trading days immediately prior to the delivery of a Notice of Conversion, including the
day upon which a Notice of Conversion is received. Notwithstanding the foregoing, GW Holdings shall be restricted from effecting a conversion
if such conversion, along with other shares of the Company&#8217;s common stock beneficially owned by GW Holdings and its affiliates,
exceeds <span id="xdx_900_ecustom--PercentageOfOutstandingSharesOfCommonStock_dp_uPure_c20201209__20201210__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--DecemberTenTwoThousandTwentyGWNoteMember_zMF2lpDXpXcl" title="Percentage of outstanding shares of common stock">4.99%</span> of the outstanding shares of the Company&#8217;s common stock which may be increased up to 9.99% upon 60 days prior written
notice by the GW Holdings to the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">These
notes are treated as stock settled debt under ASC 480 and accordingly the Company recorded a total of <span id="xdx_904_eus-gaap--DebtInstrumentUnamortizedPremium_c20201210__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--DecemberTenTwoThousandTwentyGWNoteMember_pp0p0" title="Debt premium amount">$174,666</span> put premium.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
total principal amount outstanding under the above October 1, 2019 GW Holdings financing agreement was <span id="xdx_908_eus-gaap--DebtInstrumentFaceAmount_c20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberOneTwoThousandNineteenAuctusNoteMember_pp0p0" title="Convertible debt principal amount">$30,000</span> and accrued interest of
<span id="xdx_903_eus-gaap--InterestPayableCurrentAndNoncurrent_c20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberOneTwoThousandNineteenAuctusNoteMember_pp0p0" title="Accrued interest">$1,776</span> as of June 30, 2020 following conversion of <span id="xdx_907_eus-gaap--DebtInstrumentFaceAmount_c20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember_pp0p0" title="Convertible debt principal amount">$101,000</span> of the principal balance and <span id="xdx_90F_eus-gaap--InterestPayableCurrentAndNoncurrent_c20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember_pp0p0" title="Accrued interest">$5,082</span> of accrued interest during the year ended
June 30, 2020. The total principal amount and accrued interest outstanding under the above October 1, 2019 GW Holdings financing agreement
was <span id="xdx_907_eus-gaap--ConvertibleNotesPayable_c20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember_pp0p0" title="Convertible debt outstanding balance">$0</span> as of June 30, 2021 following conversion of <span id="xdx_904_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberOneTwoThousandNineteenAuctusNoteMember_zUKgNk0UCtJ5">$30,000</span> of the principal balance and <span id="xdx_90E_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberOneTwoThousandNineteenAuctusNoteMember_zr1B1KELZycj">$3,877</span> of accrued interest during the year ended
June 30, 2021. Accordingly, <span id="xdx_902_eus-gaap--DebtInstrumentUnamortizedPremium_iI_pp0p0_c20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember_zQunD2Tm9VOd" title="Debt premium amount">$67,333</span> and <span id="xdx_90C_eus-gaap--DebtInstrumentUnamortizedPremium_iI_pp0p0_c20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember_zVc0tgVdJq9b">$20,000</span> of the put premium was reclassed to additional paid in capital during the year ended
June 30, 2020 and 2021, respectively, following conversion of the principal balance. This note was fully converted into common stock
in fiscal 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
total principal amount outstanding under the above December 10, 2020 GW Holdings financing agreement, was <span id="xdx_904_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--DecemberTenTwoThousandTwentyGWNoteMember_z4nIBYzF3wx8">$90,000</span> and accrued interest
of <span id="xdx_905_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--DecemberTenTwoThousandTwentyGWNoteMember_zHF7PjuQZyCh">$4,636</span> as of June 30, 2021 following conversion of <span id="xdx_900_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--DecemberTenTwoThousandTwentyGWNoteMember_zxK0GcKj7mR8">$41,000</span> of the principal balance and <span id="xdx_900_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--DecemberTenTwoThousandTwentyGWNoteMember_zAhI5EC0kXU">$1,084</span> of accrued interest during the year
ended June 30, 2021. Accordingly, <span id="xdx_900_eus-gaap--DebtInstrumentUnamortizedPremium_iI_pp0p0_c20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberOneTwoThousandNineteenAuctusNoteMember_zFJPZpaH0zL4">$27,333</span> of the put premium was reclassed to additional paid in capital in respect of the October 1,
2019 GW Holdings Note during the year ended June 30, 2021 following conversion of the principal balance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b><i>Crown
Bridge Securities Purchase Agreements</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Effective
October 3, 2019, the Company entered into a securities purchase agreement with Crown Bridge Partners, pursuant to which Crown Bridge
purchased a convertible promissory note (the &#8220;October 3, 2019 Crown Bridge Note&#8221;) from the Company in the aggregate principal
amount of $<span id="xdx_901_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20191003__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember_zwpEHUsBwCU" title="Convertible debt principal amount">108,000</span>, such principal and the interest thereon convertible into shares of the Company&#8217;s common stock at the option
of Crown Bridge any time from the of issuance of the of the October 3, 2019 Crown Bridge Note. The transactions contemplated by the Crown
Bridge Securities Purchase Agreement closed on October 3, 2019. Pursuant to the terms of the Crown Bridge Securities Purchase Agreement,
Crown Bridge deducted $<span id="xdx_90F_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_pp0p0_c20191001__20191003__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember_zeoD6H7WrKf9" title="Debt instrument principal payment">3,000</span> from the principal payment due under the October 3, 2019 Crown Bridge Note, at the time of closing, to be
applied to its legal expenses, and there was a $<span id="xdx_903_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pp0p0_c20191003__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember_zomMnTd7UNx3" title="Original issue discount">5,000</span> original issuance discount resulting in $<span id="xdx_905_eus-gaap--ProceedsFromConvertibleDebt_pp0p0_c20191001__20191003__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember_zzct2UAOe8n4" title="Proceeds from convertible debt">100,000</span> net proceeds to the Company. The
Company intends to use the net proceeds from the October 3, 2019 Crown Bridge Note for general working capital purposes. The maturity
date of the October 3, 2019 Crown Bridge was October 3, 2020 and is currently past due. The <span id="xdx_90A_eus-gaap--DebtInstrumentMaturityDate_dd_c20191001__20191003__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember_zQwc7KFpP4L3" title="Debt maturity date">October 3, 2019</span> Crown Bridge Note bears interest
at a rate of <span id="xdx_906_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20191003__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember_ztmWQuCkyNLh" title="Debt instrument, interest rate, stated percentage">10</span>% per annum, which interest may be paid by the Company to Crown Bridge in shares of the Company&#8217;s common stock;
but shall not be payable until the October 2019 Crown Bridge Note becomes payable, whether at the maturity date or upon acceleration
or by prepayment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Additionally,
Crown Bridge has the option to convert all or any amount of the principal face amount of the October 3, 2019 Crown Bridge Note at any
time from the date of issuance and ending on the later of the maturity date or the date the Default Amount is paid if an event of default
occurs, which is an amount between <span id="xdx_90B_ecustom--DebtInstrumentDebtDefaultInterestRate_pid_dp_uPure_c20191001__20191003__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember__srt--RangeAxis__srt--MinimumMember_zLvepTZqYK6h" title="Debt instrument, default, interest rate">110</span>% and <span id="xdx_900_ecustom--DebtInstrumentDebtDefaultInterestRate_pid_dp_uPure_c20191001__20191003__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember__srt--RangeAxis__srt--MaximumMember_zEEjcVFQsHy" title="Debt instrument, default, interest rate">150</span>% of an amount equal to the then outstanding principal amount of the October 3, 2019 Crown
Bridge Note plus any interest accrued, for shares of the Company&#8217;s common stock at the then-applicable conversion price.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
conversion price for the October 3, 2019 Crown Bridge Note shall be equal to a 40% discount of the lowest closing bid price (&#8220;Lowest
Trading Price&#8221;) of the Common Stock for the ten trading days immediately prior to the delivery of a Notice of Conversion, including
the day upon which a Notice of Conversion is received. Notwithstanding the foregoing, Crown Bridge shall be restricted from effecting
a conversion if such conversion, along with other shares of the Company&#8217;s common stock beneficially owned by Crown Bridge and its
affiliates, exceeds <span id="xdx_90E_ecustom--PercentageOfOutstandingSharesOfCommonStock_pid_dp_uPure_c20191001__20191003__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember__srt--RangeAxis__srt--MinimumMember_z7lVZvtrX5P5" title="Percentage of outstanding shares of common stock">4.99</span>% of the outstanding shares of the Company&#8217;s common stock which may be increased up to <span id="xdx_90B_ecustom--PercentageOfOutstandingSharesOfCommonStock_pid_dp_uPure_c20191001__20191003__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember__srt--RangeAxis__srt--MaximumMember_zJktsYMDpp94" title="Percentage of outstanding shares of common stock">9.99</span>% upon 60 days
prior written notice by the Crown Bridge to the Company. The note is treated as stock settled debt under ASC 480 and accordingly the
Company recorded a $<span id="xdx_904_eus-gaap--DebtInstrumentUnamortizedPremium_iI_pp0p0_c20191003__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember_zHoaM5QgRPfj" title="Debt premium amount">72,000</span> put premium.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>PROPANC
BIOPHARMA, INC. AND SUBSIDIARY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>June
30, 2021 and 2020</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
October 3, 2019 Crown Bridge Note contain certain events of default, upon which principal and accrued interest will become immediately
due and payable. In addition, upon an event of default, interest on the outstanding principal shall accrue at a default interest rate
of <span id="xdx_90F_ecustom--DebtInstrumentDebtDefaultInterestRate_pid_dp_uPure_c20191001__20191003__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember_zv0fjoBojGb7" title="Debt instrument, default, interest rate">15</span>% per annum, or if such rate is usurious or not permitted by current law, then at the highest rate of interest permitted by law.
Further, certain events of default may trigger penalty and liquidated damage provisions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
total principal amount outstanding under the above Crown Bridge financing agreement was $<span id="xdx_908_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember_zJbU4yvlAPti" title="Convertible debt principal amount">65,280</span> and accrued interest of $<span id="xdx_902_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember_z2ksPZtm0jBj" title="Accrued interest">7,232</span> as of
as of June 30, 2020 following conversion of $<span id="xdx_90D_eus-gaap--DebtConversionConvertedInstrumentAmount1_pp0p0_c20190701__20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember_ziklwtqcVEga" title="Debt conversion of converted amount">42,720</span> of the principal balance during the year ended June 30, 2020. Accordingly, $<span id="xdx_901_eus-gaap--DebtInstrumentUnamortizedPremium_iI_pp0p0_c20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember_zySXJNn6cCG1" title="Debt premium amount">28,480</span>
of the put premium was released in respect of the October 3, 2019 Crown Bridge Note during the year ended June 30, 2020 following conversion
of the principal balance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
total principal amount outstanding under the above Crown Bridge financing agreement was <span id="xdx_900_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember_zCCKsDjlOH51" title="Convertible debt principal amount">$65,280</span> and accrued interest of $<span id="xdx_90B_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember_z5eeEhZLWACg" title="Accrued interest">16,138</span> as of
as of June 30, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">There
were <span id="xdx_900_ecustom--UnissuedSharesConversion_c20200915__20200916__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember_zCYs7H4vsJf1" title="Unissued shares conversion">15,000</span> unissued shares which were considered issuable for accounting purposes during the 1<sup>st</sup> quarter of fiscal 2021 related
to a conversion notice dated and received on September 16, 2020. In November 2020, the Company was notified by the note holder of the
cancellation of this conversion notice as a result of the reverse stock split and as such the Company reversed the effects of this transaction
thereby increasing the principal balance by $<span id="xdx_906_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20201130__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember_zxMfShhyo5H5" title="Convertible debt principal amount">9,600</span> and put premium by $<span id="xdx_908_eus-gaap--DebtInstrumentUnamortizedPremium_iI_pp0p0_c20201130__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember_z3d1u05jFZe8" title="Debt premium amount">6,400</span> and a corresponding decrease in equity of $<span id="xdx_902_ecustom--DueToEquityConversion_iI_pp0p0_c20201130__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember_zwvoGCxPpSu" title="Due to equity conversion">16,000</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b><i>Ader
Alef Securities Purchase Agreements</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Effective
January 13, 2020, the Company entered into a securities purchase agreement with Ader Alef, pursuant to which Ader Alef purchased a convertible
promissory note (the &#8220;January 13, 2020 Ader Alef Note&#8221;) from the Company in the aggregate principal amount of $<span id="xdx_908_eus-gaap--DebtInstrumentFaceAmount_c20200113__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--JanuaryThirteenTwentyTwentyAderAlefNoteMember_pp0p0" title="Convertible debt principal amount">110,250</span>, such
principal and the interest thereon convertible into shares of the Company&#8217;s common stock at the option of Ader Alef any time after
the six-month anniversary of the January 13, 2020 Ader Alef Note. The January 13, 2020 Ader Alef Note contained an original discount
of $<span id="xdx_904_eus-gaap--DebtInstrumentUnamortizedDiscount_c20200113__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--JanuaryThirteenTwentyTwentyAderAlefNoteMember_pp0p0" title="Original issue discount">5,250</span>. The transactions contemplated by the Ader Alef Securities Purchase Agreement closed on January 13, 2020. Pursuant to the terms
of the Ader Alef Securities Purchase Agreement, Ader Alef deducted $<span id="xdx_901_eus-gaap--LegalFees_c20200112__20200113__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--JanuaryThirteenTwentyTwentyAderAlefNoteMember_pp0p0" title="Legal fees">5,000</span> from the principal payment due under the January 13, 2020 Ader
Alef Note at the time of closing, to be applied to its legal expenses and the Company received net cash proceeds of $<span id="xdx_90F_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20200112__20200113__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--JanuaryThirteenTwentyTwentyAderAlefNoteMember_pp0p0" title="Debt conversion of converted amount">100,000</span> on January
15, 2020. The Company used the net proceeds from the January 13, 2020 Ader Alef Note for general working capital purposes. The maturity
date of the January 13, 2020 Ader Alef was January 13, 2021. The <span id="xdx_904_eus-gaap--DebtInstrumentMaturityDate_dd_c20200112__20200113__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--JanuaryThirteenTwentyTwentyAderAlefNoteMember_zxQYm58fn5Qk" title="Debt maturity date">January 13, 2020</span> Ader Alef Note bore interest at a rate of <span id="xdx_901_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20200113__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--JanuaryThirteenTwentyTwentyAderAlefNoteMember_zDP149gBzYbc" title="Debt instrument, interest rate, stated percentage">8</span>% per annum,
which interest may be paid by the Company to Ader Alef in shares of the Company&#8217;s common stock; but was not payable until the January
13, 2020 Ader Alef Note became payable, whether at the maturity date or upon acceleration or by prepayment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Additionally,
Ader Alef had the option to convert all or any amount of the principal face amount of the January 13, 2020 Ader Alef Note at any time
from the date of issuance and ending on the later of the maturity date or the date the Default Amount was paid if an event of default
occurs, which was an amount between <span id="xdx_904_ecustom--DebtInstrumentDebtDefaultInterestRate_dp_uPure_c20200112__20200113__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--JanuaryThirteenTwentyTwentyAderAlefNoteMember__srt--RangeAxis__srt--MinimumMember_zr58c3SrdfDc" title="Debt instrument, default, interest rate">120</span>% and <span id="xdx_900_ecustom--DebtInstrumentDebtDefaultInterestRate_dp_uPure_c20200112__20200113__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--JanuaryThirteenTwentyTwentyAderAlefNoteMember__srt--RangeAxis__srt--MaximumMember_zxh5ayER2q3g" title="Debt instrument, default, interest rate">150</span>% of an amount equal to the then outstanding principal amount of the January 13, 2020
Ader Alef Note plus any interest accrued, for shares of the Company&#8217;s common stock at the then-applicable conversion price.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span id="xdx_901_eus-gaap--DebtInstrumentDescription_c20200112__20200113__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--JanuaryThirteenTwentyTwentyAderAlefNoteMember__srt--RangeAxis__srt--MinimumMember_zbMX0id9jcs7" title="Debt instrument, description">The
conversion price for the January 13, 2020 Ader Alef Note during the first 6 months the January 13, 2020 Ader Alef Note was fixed at $2.50
and thereafter would be equal to a <span id="xdx_90C_eus-gaap--DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_pid_dp_uPure_c20200112__20200113__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--JanuaryThirteenTwentyTwentyAderAlefNoteMember__srt--RangeAxis__srt--MinimumMember_zT1L8epEdCN9" title="Common stock trading volume, percent">35</span>% discount of the lowest closing bid price (&#8220;Lowest Trading Price&#8221;) of the Common Stock
for the ten trading days immediately prior to the delivery of a Notice of Conversion, including the day upon which a Notice of Conversion
was received. Notwithstanding the foregoing, Ader Alef was restricted from effecting a conversion if such conversion, along with other
shares of the Company&#8217;s common stock beneficially owned by Ader Alef and its affiliates, exceeds <span id="xdx_907_ecustom--PercentageOfOutstandingSharesOfCommonStock_pid_dp_uPure_c20200112__20200113__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--JanuaryThirteenTwentyTwentyAderAlefNoteMember__srt--RangeAxis__srt--MinimumMember_zdUxPo074Xhg" title="Percentage of outstanding shares of common stock">4.99</span>% of the outstanding shares
of the Company&#8217;s common stock which may be increased up to <span id="xdx_909_ecustom--PercentageOfOutstandingSharesOfCommonStock_pid_dp_uPure_c20200112__20200113__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--JanuaryThirteenTwentyTwentyAderAlefNoteMember__srt--RangeAxis__srt--MaximumMember_zruzM0e34Bv" title="Percentage of outstanding shares of common stock">9.99</span>% upon 60 days prior written notice by the Ader Alef to the Company.</span>
The note was treated as stock settled debt under ASC 480 and accordingly the Company recorded a $<span id="xdx_90E_eus-gaap--DebtInstrumentUnamortizedPremium_iI_pp0p0_c20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--JanuaryThirteenTwentyTwentyAderAlefNoteMember_znVW5pF8JMN9" title="Debt premium amount">59,365</span> put premium.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
January 13, 2020 Ader Alef Note contained certain events of default, upon which principal and accrued interest would become immediately
due and payable. In addition, upon an event of default, interest on the outstanding principal would accrue at a default interest rate
of 24% per annum, or if such rate was usurious or not permitted by current law, then at the highest rate of interest permitted by law.
Further, certain events of default may trigger penalty and liquidated damage provisions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
total principal amount outstanding under the above Ader Alef financing agreement was $<span id="xdx_909_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--JanuaryThirteenTwentyTwentyAderAlefNoteMember_zrTuhpcSaLr2" title="Convertible debt principal amount">110,250</span> and accrued interest of $<span id="xdx_909_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--JanuaryThirteenTwentyTwentyAderAlefNoteMember_zfnVOaOVSvug" title="Accrued interest">4,073</span> as of June
30, 2020. The total principal amount outstanding and accrued interest under the above Ader Alef financing agreement was $<span id="xdx_906_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--JanuaryThirteenTwentyTwentyAderAlefNoteMember_zewZ1Or5uQyj" title="Convertible debt principal amount"><span id="xdx_90E_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--JanuaryThirteenTwentyTwentyAderAlefNoteMember_zPRKYRsBcAB2" title="Accrued interest">0</span></span> as of as of
June 30, 2021 following conversion of $<span id="xdx_909_eus-gaap--DebtConversionConvertedInstrumentAmount1_pp0p0_c20200701__20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--JanuaryThirteenTwentyTwentyAderAlefNoteMember_zAsiPbM3m5Od" title="Debt conversion of converted amount">110,250</span> of the principal balance and $<span id="xdx_907_ecustom--DebtConversionConvertedInterestPayable_pp0p0_c20200701__20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--JanuaryThirteenTwentyTwentyAderAlefNoteMember_ztmxfAe7fDf2" title="Debt conversion of accrued interest">7,493</span> accrued interest during the year ended June 30, 2021.
Accordingly, $<span id="xdx_903_eus-gaap--DebtInstrumentUnamortizedPremium_iI_pp0p0_c20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--JanuaryThirteenTwentyTwentyAderAlefNoteMember_zf94QUj3cV4d" title="Debt premium amount">59,365</span> of the put premium was released in respect of the Ader Alef Note during the year ended June 30, 2021 following conversion
of the principal balance. This note was fully converted into common stock in fiscal 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>PROPANC
BIOPHARMA, INC. AND SUBSIDIARY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>June
30, 2021 and 2020</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b><i>LG
Capital Securities Purchase Agreements</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Effective
February 19, 2020, the Company entered into a securities purchase agreement with LG Capital Funding, LLC (&#8220;LG Capital&#8221;),
pursuant to which LG Capital purchased a convertible promissory note (the &#8220;February 19, 2020 LG Capital Note&#8221;) from the Company
in the aggregate principal amount of $<span id="xdx_909_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20200219__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember__dei--LegalEntityAxis__custom--LGCapitalFundingLLCMember_zTYL65OQsz78" title="Convertible debt principal amount">75,000</span>, such principal and the interest thereon convertible into shares of the Company&#8217;s
common stock at the option of LG Capital any time after the six month anniversary of the February 19, 2020 LG Capital Note. The February
19, 2020 LG Capital Note contained an original discount of $<span id="xdx_903_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pp0p0_c20200219__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember__dei--LegalEntityAxis__custom--LGCapitalFundingLLCMember_zrW4XhulEQfh" title="Original issue discount">3,750</span>. The transactions contemplated by the LG Capital Securities Purchase
Agreement closed on March 4, 2020. Pursuant to the terms of the LG Capital Securities Purchase Agreement, LG Capital deducted $<span id="xdx_907_eus-gaap--LegalFees_pp0p0_c20200218__20200219__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember__dei--LegalEntityAxis__custom--LGCapitalFundingLLCMember_zAqRY7bZN066" title="Legal fees">2,500</span>
from the principal payment due under the February 19, 2020 LG Capital Note at the time of closing, to be applied to its legal expenses
and the Company received net cash proceeds of $<span id="xdx_90E_eus-gaap--ProceedsFromConvertibleDebt_pp0p0_c20200324__20200325__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember__dei--LegalEntityAxis__custom--LGCapitalFundingLLCMember_zd2NOwfrQAFi" title="Proceeds from convertible debt">71,250</span> on March 25, 2020. The Company used the net proceeds from the February 19, 2020
LG Capital Note for general working capital purposes. The maturity date of the February 19, 2020 LG Capital Note was <span id="xdx_902_eus-gaap--DebtInstrumentMaturityDate_c20200218__20200219__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember__dei--LegalEntityAxis__custom--LGCapitalFundingLLCMember" title="Debt maturity date">February 19, 2021</span>.
The February 19, 2020 LG Capital Note bore interest at a rate of <span id="xdx_90A_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20200219__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember__dei--LegalEntityAxis__custom--LGCapitalFundingLLCMember_z2nFpqSgZBM4" title="Debt instrument, interest rate, stated percentage">8</span>% per annum, which interest was paid by the Company to LG Capital in
shares of the Company&#8217;s common stock; but was not payable until the February 19, 2020 LG Capital Note became payable, whether at
the maturity date or upon acceleration or by prepayment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">During
the first 60 to 180 days following the date of the note, the Company had the right to prepay the principal and accrued but unpaid interest
due under the February 19, 2020 LG Capital Note, together with any other amounts that the Company may owe the holder under the terms
of the note, at a premium ranging from <span id="xdx_900_ecustom--DebtInstrumentDebtDefaultInterestRate_pid_dp_uPure_c20200218__20200219__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember__dei--LegalEntityAxis__custom--LGCapitalFundingLLCMember__srt--RangeAxis__srt--MinimumMember_z4523Mnskh12" title="Debt instrument, default, interest rate">112</span>% to <span id="xdx_90B_ecustom--DebtInstrumentDebtDefaultInterestRate_pid_dp_uPure_c20200218__20200219__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember__dei--LegalEntityAxis__custom--LGCapitalFundingLLCMember__srt--RangeAxis__srt--MaximumMember_zHP4hB60Iv01" title="Debt instrument, default, interest rate">135</span>% as defined in the note agreement. After this initial 180-day period, the Company
did not have a right to prepay the February 19, 2020 LG Capital Note.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span id="xdx_902_eus-gaap--DebtInstrumentDescription_c20200218__20200219__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember__dei--LegalEntityAxis__custom--LGCapitalFundingLLCMember__srt--RangeAxis__srt--MinimumMember_zscAo0RkfXK1" title="Debt instrument, description">The
conversion price for the February 19, 2020 LG Capital Note during the first 6 months the February 19, 2020 LG Capital Note was fixed
at $500 and thereafter was equal to a 35% discount of the lowest closing bid price (&#8220;Lowest Trading Price&#8221;) of the Common
Stock for the ten trading days immediately prior to the delivery of a Notice of Conversion, including the day upon which a Notice of
Conversion was received. Notwithstanding the foregoing, LG Capital was restricted from effecting a conversion if such conversion, along
with other shares of the Company&#8217;s common stock beneficially owned by LG Capital and its affiliates, exceeds <span id="xdx_90E_ecustom--PercentageOfOutstandingSharesOfCommonStock_uPure_c20200218__20200219__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember__dei--LegalEntityAxis__custom--LGCapitalFundingLLCMember__srt--RangeAxis__srt--MinimumMember_z2n2nkkyJvxi" title="Percentage of outstanding shares of common stock">9.99</span>% of the outstanding
shares of the Company&#8217;s common stock.</span> The note was treated as stock settled debt under ASC 480 and accordingly the Company recorded
a $<span id="xdx_905_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pp0p0_c20200219__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--LGCapitalFundingLLCMember_z0U3K57K64Sd" title="Original issue discount">40,385</span> put premium.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
February 19, 2020 LG Capital Note contained certain events of default, upon which principal and accrued interest would become immediately
due and payable. In addition, upon an event of default, interest on the outstanding principal would accrue at a default interest rate
of <span id="xdx_904_eus-gaap--DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_pid_dp_uPure_c20200218__20200219__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember__dei--LegalEntityAxis__custom--LGCapitalFundingLLCMember_zyn8IJpMpkAh" title="Common stock trading volume, percent">24</span>% per annum, or if such rate was usurious or not permitted by current law, then at the highest rate of interest permitted by law.
Further, certain events of default may trigger penalty and liquidated damage provisions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
total principal amount outstanding under the above LG Capital financing agreement was $<span id="xdx_900_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember__dei--LegalEntityAxis__custom--LGCapitalFundingLLCMember_zTL8mMujcRDg" title="Convertible debt principal amount">75,000</span> and accrued interest of $<span id="xdx_90B_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember__dei--LegalEntityAxis__custom--LGCapitalFundingLLCMember_zHd1HuK4IoK2" title="Accrued interest">2,164</span> as of June
30, 2020. The total principal amount outstanding and accrued interest under the above LG Capital financing agreement was $<span id="xdx_905_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember__dei--LegalEntityAxis__custom--LGCapitalFundingLLCMember_z8qewvbgEe86" title="Convertible debt principal amount"><span id="xdx_903_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember__dei--LegalEntityAxis__custom--LGCapitalFundingLLCMember_z7iiHXaE5ML9" title="Accrued interest">0</span></span> as of June
30 2021 following conversion of $<span id="xdx_901_eus-gaap--DebtConversionConvertedInstrumentAmount1_pp0p0_c20200701__20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember__dei--LegalEntityAxis__custom--LGCapitalFundingLLCMember_zQJcqjX5skTd" title="Debt conversion of converted amount">75,000</span> of the principal balance and $<span id="xdx_905_ecustom--DebtConversionConvertedInterestPayable_c20200701__20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember__dei--LegalEntityAxis__custom--LGCapitalFundingLLCMember_pp0p0" title="Debt conversion of accrued interest">5,421</span> accrued interest during the year ended June 30, 2021. Accordingly,
$<span id="xdx_90D_eus-gaap--DebtInstrumentUnamortizedPremium_c20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember__dei--LegalEntityAxis__custom--LGCapitalFundingLLCMember_pp0p0" title="Debt premium amount">40,385</span> of the put premium was released in respect of the February 19, 2020 LG Capital Note during the year ended June 30, 2021 following
conversion of the principal balance. This note was fully converted into common stock in fiscal 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">There
were <span id="xdx_900_ecustom--UnissuedSharesConversion_pid_c20200908__20200909__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--LGCapitalFundingLLCMember_zy8TQj7rLE1l" title="Unissued shares conversion">9,427</span> unissued shares which were considered issuable for accounting purposes during the first quarter of fiscal 2021 related to
a conversion notice dated and received on September 9, 2020. In November 2020, the Company was notified by the note holder of the cancellation
of this conversion notice as a result of the reverse stock split and as such the Company reversed the effects of this transaction thereby
increasing the principal balance by $<span id="xdx_908_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20201130__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--LGCapitalFundingLLCMember_znSxfxtk5SJi" title="Convertible debt principal amount">10,000</span>, accrued interest of $<span id="xdx_90D_eus-gaap--DebtConversionConvertedInstrumentAmount1_pp0p0_c20201129__20201130__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--LGCapitalFundingLLCMember_z106ivN8PpEh" title="Debt conversion of converted amount">416</span> and put premium by $<span id="xdx_908_eus-gaap--DebtInstrumentUnamortizedPremium_iI_pp0p0_c20201130__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--LGCapitalFundingLLCMember_zOkDmGq34n2k" title="Debt premium amount">5,385</span> and a corresponding decrease in equity
of $<span id="xdx_90F_ecustom--DueToEquityConversion_iI_pp0p0_c20201130__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--LGCapitalFundingLLCMember_zadObOn7mP04" title="Due to equity conversion">15,801</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b><i>Geneva
Roth Remark Securities Purchase Agreements</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><i>December
2, 2020 Securities Purchase Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Effective
December 2, 2020, the Company entered into a securities purchase agreement with Geneva Roth Remark Holdings, Inc.(&#8220;Geneva Roth&#8221;),
pursuant to which Geneva Roth purchased a convertible promissory note (the &#8220;December 2, 2020 Geneva Roth&#8221;) from the Company
in the aggregate principal amount of $<span id="xdx_908_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20201202__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--DecemberTwoTwoThousandTwentyGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember_zpLyb1jxhG41" title="Convertible debt principal amount">78,000</span>, such principal and the interest thereon convertible into shares of the Company&#8217;s
common stock at the option of Geneva Roth any time after the six month anniversary of the December 2, 2020 Geneva Roth. The December
2, 2020 Geneva Roth contains an original discount of $<span id="xdx_90F_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pp0p0_c20201202__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--DecemberTwoTwoThousandTwentyGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember_zZB2kgSgjnW1" title="Original issue discount">3,000</span>. The Company intends to use the net proceeds from the December 2, 2020 Geneva
Roth for general working capital purposes. The maturity date of the December 2, 2020 Geneva Roth Note is December 2, 2021. The December
2, 2020 Geneva Roth Note bears interest at a rate of <span id="xdx_90E_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20201202__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--DecemberTwoTwoThousandTwentyGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember_zxHGRXmSF1E8" title="Debt instrument, interest rate, stated percentage">8</span>% per annum, which interest may be paid by the Company to Geneva Roth in shares
of the Company&#8217;s common stock; but shall not be payable until the December 2, 2020 Geneva Roth Note becomes payable, whether at
the maturity date or upon acceleration or by prepayment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>PROPANC
BIOPHARMA, INC. AND SUBSIDIARY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>June
30, 2021 and 2020</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><i>January
5, 2021 Securities Purchase Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Effective
January 5, 2021, the Company entered into a securities purchase agreement with Geneva Roth Remark Holdings, Inc., pursuant to which Geneva
Roth purchased a convertible promissory note (the &#8220;January 5, 2021 Geneva Roth&#8221;) from the Company in the aggregate principal
amount of $<span id="xdx_901_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20210105__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--JanuaryFiveTwoThousandTwentyOneGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember_zCMSE7NuV6F1" title="Convertible debt principal amount">68,500</span>, such principal and the interest thereon convertible into shares of the Company&#8217;s common stock at the option
of Geneva Roth any time after the six-month anniversary of the January 5, 2021 Geneva Roth. The January 5, 2021 Geneva Roth contains
an original issue discount of $<span id="xdx_90E_eus-gaap--DebtConversionOriginalDebtAmount1_pp0p0_c20210104__20210105__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--JanuaryFiveTwoThousandTwentyOneGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember_zNzbQ8jepSsb" title="Debt conversion, original debt amount">3,500</span>. The Company intends to use the net proceeds from the January 5, 2021 Geneva Roth for general working
capital purposes. The maturity date of the January 5, 2021 Geneva Roth Note is January 5, 2022. The January 5, 2021 Geneva Roth Note
bears interest at a rate of <span id="xdx_904_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20210105__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--JanuaryFiveTwoThousandTwentyOneGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember_zmSE9o74DhGb" title="Debt instrument, interest rate, stated percentage">8</span>% per annum, which interest may be paid by the Company to Geneva Roth in shares of the Company&#8217;s common
stock; but shall not be payable until the <span id="xdx_90F_eus-gaap--DebtInstrumentMaturityDate_dd_c20210104__20210105__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--JanuaryFiveTwoThousandTwentyOneGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember_z9W72G1n1xIh" title="Debt maturity date">January 5, 2021</span> Geneva Roth Note becomes payable, whether at the maturity date or upon acceleration
or by prepayment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><i>March
16, 2021 Securities Purchase Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Effective
March 16, 2021, the Company entered into a securities purchase agreement with Geneva Roth Remark Holdings, Inc., pursuant to which Geneva
Roth purchased a convertible promissory note (the &#8220;March 16, 2021 Geneva Roth&#8221;) from the Company in the aggregate principal
amount of $<span id="xdx_901_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20210316__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--MarchSixteenTwoThousandTwentyOneGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember_zrB2otRYaZxa" title="Convertible debt principal amount">63,500</span>, such principal and the interest thereon convertible into shares of the Company&#8217;s common stock at the option
of Geneva Roth any time after the six-month anniversary of the March 16, 2021 Geneva Roth. The March 16, 2021 Geneva Roth contains an
original discount of $<span id="xdx_904_eus-gaap--DebtConversionOriginalDebtAmount1_pp0p0_c20210313__20210316__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--MarchSixteenTwoThousandTwentyOneGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember_ziPdTQoddlOk" title="Debt conversion, original debt amount">3,500</span>. The Company intends to use the net proceeds from the March 16, 2021 Geneva Roth for general working capital
purposes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
maturity date of the March 16, 2021 Geneva Roth Note is March 16, 2022. The March 16, 2021 Geneva Roth Note bears interest at a rate
of <span id="xdx_902_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20210105__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--MarchSixteenTwoThousandTwentyOneGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember_zhZipEt2Pqi3" title="Debt instrument, interest rate, stated percentage">8</span>% per annum, which interest may be paid by the Company to Geneva Roth in shares of the Company&#8217;s common stock; but shall not
be payable until the <span id="xdx_908_eus-gaap--DebtInstrumentMaturityDate_dd_c20210103__20210105__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--MarchSixteenTwoThousandTwentyOneGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember_zYkAPffCzota" title="Debt maturity date">March 16, 2021</span> Geneva Roth Note becomes payable, whether at the maturity date or upon acceleration or by prepayment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">During
the first 60 to 180 days following the date of these notes, the Company has the right to prepay the principal and accrued but unpaid
interest due under the above notes issued to Geneva Roth, together with any other amounts that the Company may owe the holder under the
terms of the note, at a premium ranging from <span id="xdx_90F_ecustom--DebtInstrumentDebtDefaultInterestRate_pid_dp_uPure_c20201201__20201202__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--DecemberTwoTwoThousandTwentyGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember__srt--RangeAxis__srt--MinimumMember_zX5toUXgs6od" title="Debt instrument, default, interest rate">110</span>% to <span id="xdx_905_ecustom--DebtInstrumentDebtDefaultInterestRate_pid_dp_uPure_c20201201__20201202__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--DecemberTwoTwoThousandTwentyGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember__srt--RangeAxis__srt--MaximumMember_z5koNVLRd1s9" title="Debt instrument, default, interest rate">129</span>% as defined in the note agreement. After this initial 180-day period, the Company
does not have a right to prepay such notes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_905_eus-gaap--DebtInstrumentDescription_c20201201__20201202__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--DecemberTwoTwoThousandTwentyGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember__srt--RangeAxis__srt--MinimumMember" style="font: 10pt Times New Roman, Times, Serif; color: Black">The
conversion price for the above Geneva Roth notes shall be equal to a </span><span id="xdx_908_ecustom--DebtInstrumentDebtDefaultInterestRate_pid_dp_uPure_c20201201__20201202__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--DecemberTwoTwoThousandTwentyGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember_zhmRBdKcKkH6" style="font: 10pt Times New Roman, Times, Serif; color: Black">35</span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">%
discount of the market price based on the average of the lowest three trading prices of the Common Stock for the ten trading days
immediately prior to the delivery of a Notice of Conversion. Notwithstanding the foregoing, Geneva Roth shall be restricted from effecting
a conversion if such conversion, along with other shares of the Company&#8217;s common stock beneficially owned by Geneva Roth and its
affiliates, exceeds </span><span id="xdx_906_ecustom--PercentageOfOutstandingSharesOfCommonStock_pid_dp_uPure_c20201201__20201202__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--DecemberTwoTwoThousandTwentyGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember__srt--RangeAxis__srt--MinimumMember_zBvZ27u0iO91" style="font: 10pt Times New Roman, Times, Serif; color: Black">9.99</span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">%
of the outstanding shares of the Company&#8217;s common stock.</span> <span style="font: 10pt Times New Roman, Times, Serif; color: Black">These
notes are treated as stock settled debt under ASC 480 and accordingly the Company recorded a total of $<span id="xdx_903_eus-gaap--DebtInstrumentUnamortizedPremium_c20201202__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--DecemberTwoTwoThousandTwentyGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember_pp0p0">113,077
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">put premium for the three notes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
above Geneva Roth notes contain certain events of default, upon which principal and accrued interest will become immediately due and
payable. In addition, upon an event of default, interest on the outstanding principal shall accrue at a default interest rate of <span id="xdx_909_ecustom--DebtDefaultAmountPercentage_pid_dp_uPure_c20201201__20201202__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--DecemberTwoTwoThousandTwentyGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember_zR9DK8ymxYqi" title="Debt default amount percentage">22</span>%
per annum, or if such rate is usurious or not permitted by current law, then at the highest rate of interest permitted by law. Further,
certain events of default may trigger penalty and liquidated damage provisions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
total principal amounts outstanding under the above Geneva Roth financing agreements were $<span id="xdx_904_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--DecemberTwoTwoThousandTwentyGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember_zFQi7YehIjO8" title="Convertible debt principal amount">132,000</span> and accrued interest of $<span id="xdx_907_eus-gaap--InterestPayableCurrentAndNoncurrent_c20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--DecemberTwoTwoThousandTwentyGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember_pp0p0" title="Accrued interest">3,477</span> as
of June 30, 2021 following conversion of $<span id="xdx_904_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--DecemberTwoTwoThousandTwentyGenevaRothMember_zC360zEKOCR5">78,000</span> of the principal balance and $<span id="xdx_908_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--DecemberTwoTwoThousandTwentyGenevaRothMember_zXRYDWNZ3rce" title="Accrued interest">3,120</span> accrued interest during the year ended June 30,
2021. Accordingly, $<span id="xdx_906_eus-gaap--DebtInstrumentUnamortizedPremium_iI_pp0p0_c20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--DecemberTwoTwoThousandTwentyGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember_zD3bqIYfPui8" title="Debt premium amount">42,000</span> of the put premium was released in respect of the Geneva Roth financing agreements during the year ended June
30, 2021 following conversion of the principal balance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b><i>Amortization
of debt discounts</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
Company recorded $<span id="xdx_907_eus-gaap--AmortizationOfDebtDiscountPremium_pp0p0_c20200701__20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_z97YR7adUCde" title="Amortization of debt discount">211,000</span> and $<span id="xdx_90D_eus-gaap--AmortizationOfDebtDiscountPremium_pp0p0_c20190701__20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zGs6lgmrl1q7" title="Amortization of debt discount">728,904</span> of debt discounts related to the above note issuances during the years ended June 30, 2021 and
2020, respectively. The Company recorded $<span id="xdx_90F_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pp0p0_c20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zSI8WbWDkQXe" title="Original issue discount">498,160</span> and $<span id="xdx_904_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pp0p0_c20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zxmpIMrXZTi9" title="Original issue discount">836,724</span> of put premiums related to the above note issuances during the years ended
June 30, 2021 and 2020, respectively. The debt discounts are being amortized over the term of the debt and the put premiums are expensed
on issuance of the debt with the liability released to additional paid in capital on conversion of the principal.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Amortization
of all debt discounts for the years ended June 30, 2021 and 2020 was $<span id="xdx_909_eus-gaap--AmortizationOfDebtDiscountPremium_pp0p0_c20200701__20210630_zoloR4T28Ki6" title="Amortization of debt discount">136,527</span> and $<span id="xdx_904_eus-gaap--AmortizationOfDebtDiscountPremium_pp0p0_c20190701__20200630_zED7e8UWunw6" title="Amortization of debt discount">734,130</span>, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
Company reclassified $<span id="xdx_909_ecustom--ReclassifiedPremiumAmountForAdditionalPaidInCapital_pp0p0_c20200701__20210630_zEz7E5kvysEf" title="Reclassified premium amount for additional paid in capital">590,504</span> and $<span id="xdx_90F_ecustom--ReclassifiedPremiumAmountForAdditionalPaidInCapital_pp0p0_c20190701__20200630_zkkG58hK8d3d" title="Reclassified premium amount for additional paid in capital">874,924</span> in put premiums to additional paid in capital following conversions during the year ended
June 30, 2021 and 2020, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>PROPANC
BIOPHARMA, INC. AND SUBSIDIARY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>June
30, 2021 and 2020</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm140460440632072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">INCOME TAXES</a></td>
<td class="text"><p id="xdx_804_eus-gaap--IncomeTaxDisclosureTextBlock_zoUNBWa6TWf9" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>NOTE
7 &#8211; <span id="xdx_82A_zUnPb5Jodezk">INCOME TAXES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
Company follows ASC 740-10-10, under which an entity recognizes deferred tax assets and liabilities for future tax consequences or for
events that were previously recognized in the Company&#8217;s financial statements or tax returns. The measurement of deferred tax assets
and liabilities is based on enacted tax law provisions. The effects of future changes in tax laws or rates are not anticipated. Through
June 30, 2010, the Company operated exclusively in Australia. The Company was wholly subject to Australian income tax laws and regulations,
which are administered by the Australian Taxation Office for the years ended June 30, 2010 and all prior years.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">On
November 23, 2010, the Company was incorporated in the state of Delaware. In January 2011, the Company acquired all of the outstanding
shares of Propanc PTY LTD on a one-for-one basis with Propanc PTY LTD becoming a wholly owned subsidiary of the Company. As a result
of these transactions, the Company is subject to the income tax laws of both the United States and Australia for the years ended June
30, 2013 through June 30, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p id="xdx_898_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zq6pSYl2gst8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
reconciliation of income tax expense computed at the U.S. federal statutory rate of <span id="xdx_903_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPercentage_c20200701__20210630_zcMFKyG8phE7" title="Income tax percentage"><span id="xdx_901_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPercentage_c20190701__20200630_zdBxwBfsNkA" title="Income tax percentage">21</span></span>% to the income tax provision for the years ended
June 30, 2021 and 2020 is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 8.5pt Segoe UI,sans-serif; margin: 0"><span id="xdx_8B8_zxxl79r3HSs9" style="display: none">SCHEDULE OF INCOME TAX PROVISION</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"/></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">US</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td colspan="2" id="xdx_49B_20200701__20210630__srt--StatementGeographicalAxis__country--US_zSgCEesLAXfb" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">June
    30, 2021</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td colspan="2" id="xdx_49A_20190701__20200630__srt--StatementGeographicalAxis__country--US_zYj9eqzE26Te" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">June
    30, 2020</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Year
    Ended</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">US</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>June
    30, 2021</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>June
    30, 2020</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_pp0p0_zhUJF5Fi5dNi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Loss
    before Income taxes</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(2,025,947</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(4,740,723</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_maITEBzOQe_zIU9tqeaUh9g" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Taxes
    under statutory US tax rates</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(425,449</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(995,552</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td></tr>
  <tr id="xdx_409_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_maITEBzOQe_z4vI3oRSIpf9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Increase
    (decrease) in valuation allowance</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">1,146,001</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">1,137,716</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--IncomeTaxReconciliationPriorYearIncomeTaxes_maITEBzOQe_z9iQbvGBkZa1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Prior
    period adjustment</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(1,063,710</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(14,624</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--IncomeTaxReconciliationForeignIncomeTaxRateDifferential_maITEBzOQe_z3kFZI11ojl9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Foreign
    tax rate differential</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(51,169</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(128,492</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td></tr>
  <tr id="xdx_40C_eus-gaap--IncomeTaxReconciliationTaxCredits_pp0p0_msITEBzOQe_znRgF8OODJA7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Income
    tax rate change</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">392,767</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl1703">&#160;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--IncomeTaxReconciliationOtherAdjustments_maITEBzOQe_zLHrjdfb1Frc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Other</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">1,559</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">952</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--IncomeTaxExpenseBenefit_iT_pp0p0_mtITEBzOQe_z8TaVF0Tk2Ql" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Income
    tax (expense) benefit</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl1708">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl1709">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  </table>
<p id="xdx_8A8_zxLluA1MdAzc" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company reflects a tax benefit on its consolidated
statement of operations and comprehensive income (loss) in 2021 and 2020 of $<span id="xdx_900_eus-gaap--IncomeTaxExpenseBenefit_iN_pp0p0_di_c20200701__20210630_znGelqCjITDb" title="Tax benefit">113,415</span> and $<span id="xdx_90B_eus-gaap--IncomeTaxExpenseBenefit_iN_pp0p0_di_c20190701__20200630_zQTSIGKwbRte" title="Tax benefit">134,728</span>, respectively. These amounts are research
and development tax credits and are not considered income tax.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On March 27, 2020, the Coronavirus Aid, Relief, and
Economic Security Act (CARES Act) was enacted in response to the COVID-19 pandemic. <span id="xdx_901_eus-gaap--IncomeTaxExaminationDescription_c20200324__20200327__us-gaap--TypeOfArrangementAxis__custom--CaresActMember_zNICMqUmmFHe">The
CARES Act, among other things, permits NOL carryovers and carrybacks to offset 100% of taxable income for taxable years beginning before
2021.</span> In addition, the CARES Act allows NOLs incurred in 2018, 2019, and 2020 to be carried back to each of the five preceding
taxable years to generate a refund of previously paid income taxes. The Company is currently evaluating the impact of the CARES Act,
but due to sustained losses, the NOL carryback provision of the CARES Act would not yield a benefit to us.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Deferred
income taxes reflect the net tax effects of temporary differences between the carrying amount of assets and liabilities for financial
reporting purposes and amounts used for income tax purposes. Significant components of the Company&#8217;s deferred tax assets and liabilities
consist of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p id="xdx_89E_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zV4ys0tVWbi4" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span><span id="xdx_8BF_zUvJ23zA4ce2" style="display: none">SCHEDULE
OF DEFERRED TAX ASSETS AND LIABILITIES</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"/></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td colspan="2" id="xdx_493_20210630_zA7OqSLxk0rh" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">June
    30, 2021</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td colspan="2" id="xdx_49F_20200630_z2u0FqruVlw1" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">June
    30, 2020</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Year
    Ended</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>June
    30, 2021</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>June
    30, 2020</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Deferred
    tax assets</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_400_ecustom--DeferredTaxAssetsWarrantDerivativeLiability_iI_pp0p0_maDTAGzhU3_zsIM3aiSPan3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Warrant
    Derivative Liability</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">7,403</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">7,403</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_iI_pp0p0_maDTAGzhU3_z39v0JmmRzgh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Accrued
    Expenses</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">342,464</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">297,086</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_404_ecustom--DeferredTaxAssetsPrepaidInvestorServices_iI_pp0p0_maDTAGzhU3_zs5z5qnLjCR7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Prepaid
    Investor Services</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">444,411</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">470,050</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_40A_ecustom--DeferredTaxAssetsNonCashInterest_iI_pp0p0_maDTAGzhU3_zbruP5l38mra" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Non-cash
    interest</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">687,529</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">596,004</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--DeferredTaxAssetsGoodwillAndIntangibleAssets_iI_pp0p0_maDTAGzhU3_z1IjbyuZlJNf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Intangibles
    (Intellectual Property and Patent Cost)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">259,743</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">240,428</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent_iI_pp0p0_maDTAGzhU3_zlAyguQLKql9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Deferred
    Rent</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">4,262</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">1,969</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseOther_iI_pp0p0_maDTAGzhU3_zh29TakOlpN8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Formation
    Expense</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">6,815</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">7,208</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_pp0p0_maDTAGzhU3_zeN7NzTpnym2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Net
    Operating Loss CF</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">8,546,920</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">7,438,911</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_40F_ecustom--DeferredTaxAssetsForeignExchangeLoss_iI_pp0p0_maDTAGzhU3_znhJOjUBv9zc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Foreign
    Exchange Loss (OCI)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(39,379</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(39,379</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td></tr>
  <tr id="xdx_40E_ecustom--DeferredTaxAssetsRevalueOfDerivativeLiability_iI_pp0p0_maDTAGzhU3_z2qrS8FEmXae" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Revalue
    of derivative liability</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">439,958</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">438,239</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_iI_pp0p0_maDTAGzhU3_zUq5QwOWluRd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Stock
    Based Compensation</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">51,481</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">51,481</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--DeferredTaxAssetsGross_iTI_pp0p0_mtDTAGzhU3_maDTANz51B_zSomKbWDzIM8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Total
    Deferred tax assets</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">10,751,607</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">9,509,400</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Deferred
    tax liabilities</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts_iNI_pp0p0_di_maDITLzdtb_zrJP4gkoj7Ib" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">R&amp;D</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(197,604</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(177,702</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td></tr>
  <tr id="xdx_40F_ecustom--DeferredTaxLiabilitiesGainOnExtinguishmentOfDebt_iNI_pp0p0_di_maDITLzdtb_zSyJS2MFsJx6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Gain
    on extinguishment of debt</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(277,614</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">266,987</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts_iNI_pp0p0_di_maDITLzdtb_zTEacSOpGxXe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Capital
    Raising Costs</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(321,291</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(255,614</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td></tr>
  <tr id="xdx_403_eus-gaap--DeferredIncomeTaxLiabilities_iNTI_pp0p0_di_mtDITLzdtb_msDTANz51B_zaDntMXslQF1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Total
    deferred tax liabilities</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(796,509</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(700,303</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--DeferredTaxAssetsNet_iI_pp0p0_mtDTANz51B_maDTALNzVhZ_z8gpYprBgWF3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Net
    deferred tax assets (liabilities)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">9,955,098</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">8,809,097</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pp0p0_di_msDTALNzVhZ_zTERLOTkxohh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Valuation
    allowance</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(9,955,098</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(8,809,097</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td></tr>
  <tr id="xdx_401_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iI_pp0p0_mtDTALNzVhZ_z2rv3BpLnS55" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Net
    deferred tax assets (liabilities)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl1772">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl1773">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  </table>
<p id="xdx_8AF_zEoqAdIPi3cg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>PROPANC
BIOPHARMA, INC. AND SUBSIDIARY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>June
30, 2021 and 2020</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">At
June 30, 2021, the Company had U.S. net operating loss carry forwards of approximately $<span id="xdx_90E_eus-gaap--OperatingLossCarryforwards_iI_pp0p0_c20210630__srt--StatementGeographicalAxis__country--US_zdRpmeX2B4Qf" title="Operating loss carryforwards">9,588,164
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">that may be offset against future
taxable income, subject to limitation under IRC Section 382. Of the approximately $<span id="xdx_90A_eus-gaap--OperatingLossCarryforwards_iI_pn5n6_c20210630_zh6iGyk4E8y9" title="Operating loss carryforwards">9.6</span> million of net operating loss carryforwards,
$<span id="xdx_909_eus-gaap--OperatingLossCarryforwards_iI_pn5n6_c20210630__srt--StatementGeographicalAxis__country--AU__us-gaap--AwardDateAxis__custom--ExpireInTwoThousandTwentyFourMember_zxpXGaxwDpd" title="Operating loss carryforwards">7.2</span> million will begin to expire in 2024 and the remaining $<span id="xdx_900_eus-gaap--OperatingLossCarryforwards_iI_pn5n6_c20210630__srt--StatementGeographicalAxis__country--AU__us-gaap--AwardDateAxis__custom--NotExpireMember_zRbswM7wiVji" title="Operating loss carryforwards">2.4</span> million will not expire. The Australian tax rate changed from <span id="xdx_900_eus-gaap--EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_pid_dp_uPure_c20190701__20200630__srt--StatementGeographicalAxis__country--AU_zSSPzGJCVrOg" title="Income tax rate">27.5%</span>
in 2020 to <span id="xdx_908_eus-gaap--EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_pid_dp_uPure_c20200701__20210630__srt--StatementGeographicalAxis__country--AU_z6upJzuySn75" title="Income tax rate">26%</span> in 2021. At June 30, 2021, the Company had Australia net operating loss carry forwards of approximately $<span id="xdx_90F_eus-gaap--OperatingLossCarryforwards_iI_pp0p0_c20210630__srt--StatementGeographicalAxis__country--AU_zqz2R2gp0G7g" title="Operating loss carryforwards">25,128,485
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">million which can be carried forward
without expiration. <span id="xdx_906_eus-gaap--IncomeTaxExpenseBenefit_pp0p0_do_c20200701__20210630__srt--StatementGeographicalAxis__country--AU_zff6aukiG5Ok">No
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">tax benefit has been reported in
the June 30, 2021 and 2020 consolidated financial statements due to the uncertainty surrounding the realizability of the benefit, based
on a more likely than not criteria and in consideration of available positive and negative evidence.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
Company applied the &#8220;more-likely-than-not&#8221; recognition threshold to all tax positions taken or expected to be taken in a
tax return, which resulted in <span id="xdx_906_eus-gaap--UnrecognizedTaxBenefits_iI_pp0p0_do_c20210630_zJwGyOocuSw3" title="Unrecognized tax benefits"><span id="xdx_90D_eus-gaap--UnrecognizedTaxBenefits_iI_pp0p0_do_c20200630_zaRtA0qtsLuh" title="Unrecognized tax benefits">no</span></span> unrecognized tax benefits as of June 30, 2021 and 2020, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Management
has determined that the realization of the net deferred tax asset is not assured and has created a valuation allowance for the entire
amount of such benefits.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
Company follows ASC 740-10, which provides guidance for the recognition and measurement of certain tax positions in an enterprise&#8217;s
financial statements. Recognition involves a determination whether it is more likely than not that a tax position will be sustained upon
examination with the presumption that the tax position will be examined by the appropriate taxing authority having full knowledge of
all relevant information.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
Company applied the &#8220;more-likely-than-not&#8221; recognition threshold to all tax positions taken or expected to be taken in a
tax return, which resulted in no unrecognized tax benefits as of June 30, 2021 and 2020, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
Company&#8217;s policy is to record interest and penalties associated with unrecognized tax benefits as additional income taxes in the
consolidated statement of operations. As of June 30, 2021, the Company had <span id="xdx_90C_eus-gaap--UnrecognizedTaxBenefits_iI_pp0p0_do_c20210630_zfYqiygoEkHf" title="Unrecognized tax benefits">no</span> unrecognized tax benefits. There were <span id="xdx_90F_eus-gaap--UnrecognizedTaxBenefitsPeriodIncreaseDecrease_pp0p0_do_c20200701__20210630_zINZpCkISgag" title="Changes in unrecognized tax benefits"><span id="xdx_90A_eus-gaap--UnrecognizedTaxBenefitsPeriodIncreaseDecrease_pp0p0_do_c20190701__20200630_zNM4b7ULrCc5" title="Changes in unrecognized tax benefits">no</span></span> changes in the
Company&#8217;s unrecognized tax benefits during the years ended June 30, 2021 and 2020. The Company did not recognize any interest or
penalties during fiscal 2021 or 2020 related to unrecognized tax benefits.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
income tax returns filed for the tax years from inception will be subject to examination by the relevant taxing authorities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm140460440354456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS&#8217; DEFICIT<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">STOCKHOLDERS&#8217; DEFICIT</a></td>
<td class="text"><p id="xdx_808_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zMw0pxdAWVcd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTE
7 &#8211; <span id="xdx_822_zMisaHkqg0Q7">STOCKHOLDERS&#8217; DEFICIT</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Increase
in Authorized Shares of Common Stock and Reverse Stock Split</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On
February 4, 2020 the Directors resolved to increase the Common Stock of the Company from <span id="xdx_902_eus-gaap--CommonStockSharesAuthorized_iI_c20210203_zxqwmpDvq0x9">100,000,000</span> authorized shares to <span id="xdx_904_eus-gaap--CommonStockSharesAuthorized_iI_c20210204_zMJXuOt1cQw6" title="Common stock, shares authorized">1,000,000,000</span>
authorized shares and believes that such number of authorized shares of Common Stock will be in the best interests of the Corporation
and its stockholders because the Board believes that the availability of more shares of Common Stock for issuance will allow the Corporation
greater flexibility in pursuing financing from investors, meeting business needs as they arise, taking advantage of favorable opportunities
and responding to a changing corporate environment. The Company filed the necessary documents with the U.S. Securities and Exchange Commission
on February 6, 2020 and with the amendment to the authorized shares being approved by the State of Delaware on March 13, 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On
November 17, 2020, the Company effected a <span id="xdx_903_eus-gaap--StockholdersEquityReverseStockSplit_c20201116__20201117_zCNLsgn52Ge3">one-for-one thousand (1:1,000)</span> reverse stock split of the Company&#8217;s issued and outstanding
shares of common stock (the &#8220;Reverse Stock Split&#8221;). Proportional adjustments for the Reverse Stock Split were made to the
Company&#8217;s outstanding stock options, warrants and equity incentive plans. All share and per-share data and amounts have been retroactively
adjusted as of the earliest period presented in the consolidated financial statements to reflect the Reverse Stock Split.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><b>PROPANC
BIOPHARMA, INC. AND SUBSIDIARY<br/>
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS<br/>
SEPTEMBER 30, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Unaudited)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><b><span style="text-decoration: underline">Preferred
Stock</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
total number of shares of preferred stock that the Company is authorized to issue is <span id="xdx_901_eus-gaap--PreferredStockSharesAuthorized_iI_c20210930_zGadqf3imdS2" title="Preferred stock, shares authorized">1,500,005</span>, $<span id="xdx_905_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20210930_zgJ28qgsfvDd" title="Preferred stock, par value">0.01</span> par value per share. These preferred
shares have no rights to dividends, profit sharing or liquidation preferences.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">Of
the total preferred shares authorized, <span id="xdx_90E_eus-gaap--PreferredStockSharesAuthorized_iI_c20210930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zklHtXwcLMRc">500,000</span> have been designated as Series A Preferred Stock (&#8220;Series A Preferred Stock&#8221;),
pursuant to the Certificate of Designation filed with the Secretary of State of the State of Delaware on December 9, 2014. James Nathanielsz,
the Company&#8217;s Chief Executive Officer and Chief Financial Officer, beneficially owns all of the outstanding shares of Series A
Preferred Stock via North Horizon Pty Ltd., which entitles him, as a holder of Series A Preferred Stock, to vote on all matters submitted
or required to be submitted to a vote of the Company&#8217;s stockholders, except election and removal of directors, and each share of
Series A Preferred Stock entitles him to two votes per share of Series A Preferred Stock. North Horizon Pty Ltd. is a Nathanielsz Family
Trust. Mr. James Nathanielsz, the Chief Executive Officer, Chief Financial Officer and a director of our Company, has voting and investment
power over these shares.  <span id="xdx_908_eus-gaap--PreferredStockSharesIssued_iI_c20210930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zShGRKaqRxR" title="Preferred stock, shares issued"><span id="xdx_903_eus-gaap--PreferredStockSharesOutstanding_iI_c20210930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zWZ0zR9fbVW6" title="Preferred stock, shares outstanding"><span id="xdx_90C_eus-gaap--PreferredStockSharesIssued_iI_c20200930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zhHjKwqXWcAj" title="Preferred stock, shares issued"><span id="xdx_90E_eus-gaap--PreferredStockSharesOutstanding_iI_c20200930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zbNaziOiHu27" title="Preferred stock, shares outstanding">500,000</span></span></span></span>  shares of Series A Preferred Stock are issued and outstanding as of September 30, 2021 and June 30,
2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">Of
the total preferred shares authorized, pursuant to the Certificate of Designation filed with the Secretary of State of the State of Delaware
on June 16, 2015, up to five shares have been designated as Series B Preferred Stock (&#8220;Series B Preferred Stock&#8221;). Each holder
of outstanding shares of Series B Preferred Stock is entitled to voting power equivalent to the number of votes equal to the total number
of shares of common stock outstanding as of the record date for the determination of stockholders entitled to vote at each meeting of
stockholders of the Company and entitled to vote on all matters submitted or required to be submitted to a vote of the stockholders of
the Company. One share of Series B Preferred Stock is issued and outstanding as of September 30, 2021 and June 30, 2021. Mr. Nathanielsz
directly beneficially owns such one share of Series B Preferred Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><span>No
additional shares of Series A Preferred Stock or Series B Preferred Stock were issued during the three months ended September 30, 2021
and fiscal year 2021.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><b>Common
Stock:</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Shares
issued for conversion of convertible debt</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">From
July 1, 2021 through September 30, 2021, the Company issued an aggregate of <span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210701__20210930__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember_zrhB06ppwRTb">9,445,009 </span>shares of its common stock at an average contractual
conversion price of $<span id="xdx_90A_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20210930__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember_z6oZRlUY1LB6">0.02</span>, ranging from $<span id="xdx_905_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20210930__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember__srt--RangeAxis__srt--MinimumMember_zt5sDHz4Y7v1">0.02</span> to $<span id="xdx_901_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20210930__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember__srt--RangeAxis__srt--MaximumMember_zeBaRl8wQ5v8">0.04</span>, as a result of the conversion of principal of $<span id="xdx_90F_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20210930__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember_zmQLQnUkGiG6">189,849</span>, interest of $<span id="xdx_909_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20210930__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember_zkVdbheKEiv1">8,087</span> and
conversion fees $<span id="xdx_90C_ecustom--ConversionFees_pp0p0_c20210701__20210930__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember_zsqU4nSbdwIa">2,250</span> underlying certain outstanding convertible notes converted during such period. The total recorded to equity was
$<span id="xdx_90E_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20210701__20210930__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember_zDJDkDnM7clg">200,186</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
Company reclassified $<span id="xdx_900_ecustom--PremiumsToAdditionalPaidInCapital_pp0p0_c20210701__20210930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zjihC2NutZa6" title="Premiums to additional paid in capital">109,643</span>, net of reversal of put premium upon cancellation of conversion notices by two lenders discussed above,
to additional paid in capital following conversions during the three months ended September 30, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
Company has <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210701__20210930__us-gaap--TypeOfArrangementAxis__custom--UnderlyingFinancingAgreementsMember_zIDWkVvVbsJ6">197,308,116</span> shares of its common stock reserved for future issuances based on lender reserve requirements pursuant to underlying
financing agreements at September 30, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Shares
issued for services and accrued expenses</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">On
August 12, 2021, the Board approved the issuance of <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesEmployeeBenefitPlan_c20210811__20210812__us-gaap--StatementEquityComponentsAxis__custom--CommonStockOneMember_zDsldrVmkCif" title="Stock issued during the period for services, shares">2,800,000</span> shares of the Company&#8217;s common stock for bonus payable of $<span id="xdx_905_eus-gaap--StockIssuedDuringPeriodValueEmployeeBenefitPlan_c20210811__20210812__us-gaap--StatementEquityComponentsAxis__custom--CommonStockOneMember_z84Nc7pi4Tmi">84,000</span>
as of June 30, 2021 to an employee who is the wife of the CEO of the Company. The <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210811__20210812__us-gaap--StatementEquityComponentsAxis__custom--CommonStockOneMember_zJOm4XVVj7g3" title="Issuance of common stock for cash, shares">2,800,000</span> shares of common stock were valued
at approximately $<span id="xdx_90C_eus-gaap--SharesIssuedPricePerShare_iI_c20210812__us-gaap--StatementEquityComponentsAxis__custom--CommonStockOneMember_z0mAIG1nJMJ1" title="Shares issued, price per share">0.03</span> per share or $<span id="xdx_909_eus-gaap--CommonStockValue_iI_c20210812__us-gaap--StatementEquityComponentsAxis__custom--CommonStockOneMember_zs8vYyqJDiAf" title="Common stock value issued">87,920</span>, being the closing price of the stock on the date of grant. The shares were issued on August
17, 2021. The Company recorded stock-based compensation of $<span id="xdx_90E_eus-gaap--ShareBasedCompensation_c20210701__20210930__us-gaap--StatementEquityComponentsAxis__custom--CommonStockOneMember_ziSzV3C89AQf" title="Share based compensation">3,920</span> during the three months ended September 30, 2021 and reclassified bonus
payable of $<span id="xdx_909_eus-gaap--AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_c20210701__20210930__us-gaap--StatementEquityComponentsAxis__custom--CommonStockOneMember_zf7xE4mgffE8" title="Additional paid in capital upon issuance">84,000</span> to additional paid in capital upon issuance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">On
August 12, 2021, the Board approved the issuance of <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesEmployeeBenefitPlan_c20210811__20210812__srt--ProductOrServiceAxis__custom--LegalServicesMember_zdeAM8QJb4sl">166,667
</span></span><span style="font: 10pt Times New Roman, Times, Serif">shares of the Company&#8217;s common stock for
legal services rendered for the month of August 2021. The 166,667 shares of common stock were valued at approximately $<span id="xdx_90E_eus-gaap--SharesIssuedPricePerShare_iI_c20210812__srt--ProductOrServiceAxis__custom--LegalServicesMember_zn477kdik1p7">0.05
</span></span><span style="font: 10pt Times New Roman, Times, Serif">per share or $<span id="xdx_90D_eus-gaap--CommonStockValue_iI_c20210812__srt--ProductOrServiceAxis__custom--LegalServicesMember_zOAYOsBZBqTk">7,883</span></span><span style="font: 10pt Times New Roman, Times, Serif">,
being the closing price of the stock on August 31, 2021, the date of grant. The shares were issued on September 3, 2021. The Company
recorded stock-based compensation of $<span id="xdx_90F_eus-gaap--ShareBasedCompensation_c20210701__20210930__srt--ProductOrServiceAxis__custom--LegalServicesMember_zxGb2eDOwmbj">7,883
</span></span><span style="font: 10pt Times New Roman, Times, Serif">during the three months ended September 30, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">In
September 2021, the Company issued <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesEmployeeBenefitPlan_c20210929__20210930__srt--ProductOrServiceAxis__custom--ConsultantServicesMember_zpmqfbe1GZn4">2,819,712</span> shares of the Company&#8217;s common stock to a consultant for services rendered from July
2021 to September 2021. The Company issued 2,819,712 shares of the Company&#8217;s common stock valued at approximately $<span id="xdx_90F_eus-gaap--SharesIssuedPricePerShare_iI_c20210812__srt--ProductOrServiceAxis__custom--ConsultantServicesMember_z2GIUXg2Km1h">0.04</span> per share
or $<span id="xdx_906_eus-gaap--CommonStockValue_iI_c20210812__srt--ProductOrServiceAxis__custom--ConsultantServicesMember_zQBbdMNwTnsj" title="Common stock value issued">104,611</span>, being the closing price of the stock on the date of grant to such consultant. The Company recorded stock-based compensation
of $<span id="xdx_904_eus-gaap--ShareBasedCompensation_c20210701__20210930__srt--ProductOrServiceAxis__custom--ConsultantServicesMember_zThXkNGKffs1">104,611</span> during the three months ended September 30, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><b>PROPANC
BIOPHARMA, INC. AND SUBSIDIARY<br/>
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS<br/>
SEPTEMBER 30, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Unaudited)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><i>Nathanielsz
Cancellation Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 16.2pt; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">On
August 12, 2021, the Company entered into a Cancellation Agreement with James Nathanielsz (&#8220;Nathanielsz&#8221;), Chief Executive
Officer and Director of the Company, whereby Nathanielsz agreed to cancel his cash compensation bonus award for fiscal year 2021, ended
June 30, 2021, in exchange for common stock of the Company. The Company and Nathanielsz entered into an Amended and Restated Employment
Agreement dated May 14, 2019 (the &#8220;Agreement&#8221;). Pursuant to the terms of the Agreement, Nathanielsz was eligible to earn
an annual fiscal year cash performance bonus for each fiscal year of his employment period with the Company with a target performance
bonus of <span id="xdx_901_ecustom--PercentageOfBonusOfAnnualBaseSalary_dp_uPure_c20210811__20210812__us-gaap--TypeOfArrangementAxis__custom--NathanielszCancellationAgreementMember_zCLC1GCuYMa7" title="Percentage of bonus of annual base salary">200</span>% of his average annualized base salary during the fiscal year for which the performance bonus is earned. On July 20, 2021,
Nathanielsz was awarded a &#8220;target&#8221; bonus of <span id="xdx_908_ecustom--PercentageOfBonusOfAnnualBaseSalary_pip0_dp_uPure_c20210719__20210720__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember__us-gaap--TypeOfArrangementAxis__custom--NathanielszCancellationAgreementMember_zKevKhYlIuFh" title="Percentage of bonus of annual base salary">78</span>%, or $<span id="xdx_905_eus-gaap--OfficersCompensation_pp0p0_c20210719__20210720__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember__us-gaap--TypeOfArrangementAxis__custom--NathanielszCancellationAgreementMember_zKq0ik4XgMC9" title="Officer compensation">177,840</span> USD (the &#8220;Debt&#8221;) for the fiscal year ended June
30, 2021, by the Company&#8217;s Board of Directors (the &#8220;Board&#8221;). Pursuant to the Cancellation Agreement, Nathanielsz agreed
to cancel this Debt in exchange for <span id="xdx_901_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_pp0p0_c20210816__20210817__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember__us-gaap--TypeOfArrangementAxis__custom--NathanielszCancellationAgreementMember_zpPnofWvhYb6">5,928,000</span> shares of the common stock of the Company (the &#8220;Shares&#8221;), valued at approximately
$<span id="xdx_905_eus-gaap--SharePrice_iI_pip0_c20210817__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember__us-gaap--TypeOfArrangementAxis__custom--NathanielszCancellationAgreementMember_zUmi0N2se0X9">0.03</span> per share or $<span id="xdx_908_eus-gaap--CommonStockValue_iI_pip0_c20210817__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember__us-gaap--TypeOfArrangementAxis__custom--NathanielszCancellationAgreementMember_zbVq3HjJ3BKl" title="Common stock value issued">186,139</span>, being the closing price of the stock on the date of grant. The shares were issued on August 17, 2021. The
Company recorded stock-based compensation of $<span id="xdx_906_eus-gaap--ShareBasedCompensation_c20210811__20210812__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember_z2hsC7wZ1qEc">8,299</span> during the three months ended September 30, 2021 and reclassified bonus payable of
$<span id="xdx_90E_eus-gaap--AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_c20210811__20210812__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember_zZbHY9PisvJa">177,840</span> to additional paid in capital upon issuance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 16.2pt; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><i>Kenyon
Cancellation Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 16.2pt; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">On
August 12, 2021, the Company entered into a Cancellation Agreement with Dr. Julian Kenyon (&#8220;Kenyon&#8221;), Chief Scientific Officer
and Director of the Company, whereby Kenyon agreed to cancel of $<span id="xdx_90F_eus-gaap--AccruedSalariesCurrent_iI_c20210812__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__custom--DeferredSalaryMember__us-gaap--TypeOfArrangementAxis__custom--CancellationAgreementMember_z2xZEAt3OBL9" title="Acccrued salary cancellation">102,600</span> USD of accrued salary due him as of June 30, 2021, pursuant
to that certain Amended and Restated Services Agreement by and between Kenyon and the Company, dated May 14, 2019, in exchange for <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesEmployeeBenefitPlan_c20210811__20210812__srt--TitleOfIndividualAxis__custom--ChiefScientificOfficerandDirectorMember_zLyw61W3dj94">3,420,000</span>
shares of common stock of the Company (the &#8220;Shares&#8221;), valued at approximately $<span id="xdx_90F_eus-gaap--SharesIssuedPricePerShare_iI_c20210812__srt--TitleOfIndividualAxis__custom--ChiefScientificOfficerandDirectorMember_zusxu36XXajd">0.03</span> per share or $<span id="xdx_901_eus-gaap--CommonStockValue_iI_c20210812__srt--TitleOfIndividualAxis__custom--ChiefScientificOfficerandDirectorMember_zliyf6nhtHR6">107,388</span>, being the closing
price of the stock on the date of grant. The shares were issued on August 17, 2021. The Company recorded stock-based compensation of
$<span id="xdx_906_eus-gaap--ShareBasedCompensation_c20210811__20210812__srt--TitleOfIndividualAxis__custom--ChiefScientificOfficerandDirectorMember_zGsvqby85h3c">4,788</span> during the three months ended September 30, 2021 and reclassified accrued expenses of $<span id="xdx_909_eus-gaap--AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_c20210701__20210930__srt--TitleOfIndividualAxis__custom--ChiefScientificOfficerandDirectorMember_z7o5PXxcehH6">102,600</span> to additional paid in capital upon
issuance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 16.2pt; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>Zelinger
Amended and Restated Director Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 16.2pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">On
August 12, 2021, the Company entered into an Amended and Restated Director Agreement (the &#8220;Director Agreement&#8221;) with Josef
Zelinger (&#8220;Zelinger&#8221;). <span id="xdx_908_ecustom--DescriptionOfEmploymentBenefits_c20210811__20210812__us-gaap--TypeOfArrangementAxis__custom--ZelingerAmendedAndRestatedDirectorAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--JosefZelingerMember_zIafOWlVGFbj">Pursuant
to the terms of the Director Agreement, the Company shall pay Zelinger a base salary of $250.00 AUD ($184 USD) per month, payable
on the first day of each month. In addition, the Company may compensate Zelinger additional consideration for advisory services performed
by the Director, either in the form of cash or common stock, at the discretion of the Board. The Company issued <span id="xdx_906_ecustom--CommonStockIssuableShares_iI_c20210630__us-gaap--TypeOfArrangementAxis__custom--ZelingerAmendedAndRestatedDirectorAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--JosefZelingerMember_z131fYPKaMck">2,800,000</span> shares of common
stock of the Company for accrued director services of $<span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20200701__20210630__us-gaap--TypeOfArrangementAxis__custom--ZelingerAmendedAndRestatedDirectorAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--JosefZelingerMember_zIbg2u8ptUkg">84,000</span> as of June 30, 2021. </span></span><span style="font: 10pt Times New Roman, Times, Serif">The
<span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210701__20210930__us-gaap--TypeOfArrangementAxis__custom--ZelingerAmendedAndRestatedDirectorAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--JosefZelingerMember_zSaHuhy3dBU3">2,800,000</span> shares of common stock were valued at approximately $<span id="xdx_90E_eus-gaap--SharePrice_iI_c20210630__us-gaap--TypeOfArrangementAxis__custom--ZelingerAmendedAndRestatedDirectorAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--JosefZelingerMember_zz6ANSdBV52g">0.03</span> per share $<span id="xdx_900_eus-gaap--CommonStockValue_iI_c20210630__us-gaap--TypeOfArrangementAxis__custom--ZelingerAmendedAndRestatedDirectorAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--JosefZelingerMember_zYgCEmlb6eEk" title="Common stock value issued">87,920</span>, being the closing price of the stock on
the date of grant. The shares were issued on August 17, 2021. The shares were issued on August 17, 2021. The Company recorded stock-based
compensation of $<span id="xdx_909_eus-gaap--ShareBasedCompensation_c20210811__20210812__us-gaap--TypeOfArrangementAxis__custom--ZelingerAmendedAndRestatedDirectorAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--JosefZelingerMember_z1xSDZC815Fc">3,920</span> during the three months ended September 30, 2021 and reclassified accrued expenses of $<span id="xdx_908_eus-gaap--AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_c20210701__20210930__us-gaap--TypeOfArrangementAxis__custom--ZelingerAmendedAndRestatedDirectorAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--JosefZelingerMember_zORHCYFlOc3e">84,000</span> to additional paid
in capital upon issuance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Shares
issued for exercise of warrants</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">From
July 9, 2021 through September 27, 2021, the Company received aggregate gross proceeds of $<span id="xdx_904_eus-gaap--ProceedsFromIssuanceOfWarrants_c20210706__20210927_z5sFNnoMpkTi" title="Proceed from issuance of excercise of warrants">275,000</span> and subscription receivable of $<span id="xdx_90D_eus-gaap--StockholdersEquityNoteSubscriptionsReceivable_iI_c20210927_zo8TfwJL1jL1">100,000</span>
from the exercise of <span id="xdx_900_eus-gaap--ProceedsFromIssuanceOfWarrants_c20210706__20210927__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantMember_zwQsIV6YL6Cc">9,375</span> Series B Warrants and issued <span id="xdx_905_eus-gaap--CommonStockSharesIssued_iI_c20210927__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantMember_zszZpjZ3dgD8" title="Common stock shares issued">6,875</span> shares of common stock and <span id="xdx_907_eus-gaap--CommonStockSharesAuthorized_iI_c20210930__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantMember_zLPnNDXAyZG7" title="Common stock, shares authorized">2,500 </span>shares of common stock issuable
as of September 30, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">During
the three months ended September 30, 2021, additionally, the Company issued <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210701__20210930_zsi5duzQcmTj">2,399,988</span> shares of common stock and <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesOther_c20210701__20210930_zimIlaUtcoaf">1,999,990</span> shares
of common stock issuable from the alternate cashless exercise of 22 Series A warrants. The Company recognized the value of the effect
of a down round feature in such warrants when triggered. Upon the occurrence of the triggering event that resulted in a reduction of
the strike price, the Company measured the value of the effect of the feature as the difference between the fair value of the warrants
without the down round feature or before the strike price reduction and the fair value of the warrants with a strike price corresponding
to the reduced strike price upon the down round feature being triggered. Accordingly, the Company recognized deemed dividend of $<span id="xdx_903_ecustom--DeemedDividend_iN_di_c20210701__20210930_zdxR4qPLScJj" title="Deemed dividend">114,844</span>
and a corresponding reduction of income available to common stockholders upon the alternate cashless exercise of these warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">A
total of <span id="xdx_903_eus-gaap--CommonStockSharesAuthorized_iI_c20211031_zquk7yMxY55l">2,002,490</span> common stock issuable were issued in October 2021. The Company collected the $<span id="xdx_903_eus-gaap--StockholdersEquityNoteSubscriptionsReceivable_iI_c20211031_zQiFphOIPdbf">100,000</span> subscription receivable in October
2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><b>PROPANC
BIOPHARMA, INC. AND SUBSIDIARY<br/>
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS<br/>
SEPTEMBER 30, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Unaudited)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Warrants:</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_896_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zHpSNYZ0bJ83" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
following table summarizes warrant activity for the three months ended September 30, 2021:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8BD_zTCyL2jDJay7" style="display: none">SCHEDULE
OF WARRANT ACTIVITY</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Weighted</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Number of</span></td><td style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Average</span></td><td style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Shares</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Price
    Per Share</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%"><span style="font-family: Times New Roman, Times, Serif">Outstanding at June 30, 2021</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20210701__20210930_zbSgfIZiHED6" style="width: 14%; text-align: right" title="Number of Shares, Outstanding, Beginning balance"><span style="font-family: Times New Roman, Times, Serif">121,329</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageOutstanding_iS_c20210701__20210930_zoMmctVkyGj8" style="width: 14%; text-align: right" title="Weighted Average Price Per Share, Outstanding, Beginning balance"><span style="font-family: Times New Roman, Times, Serif">179.63</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">Issued</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsIssued_c20210701__20210930_ztsKXhp7ND3b" style="text-align: right" title="Number of Shares, Issued"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3731">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceIssued_c20210701__20210930_zxIyHmTNnHjk" style="text-align: right" title="Weighted Average Price Per Share, Issued"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3733">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">Exercised</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_di_c20210701__20210930_z2qjat9AzCb5" style="text-align: right" title="Number of Shares, Exercised"><span style="font-family: Times New Roman, Times, Serif">(9,397</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceExercised_c20210701__20210930_z5aPDFIJ5t9a" style="text-align: right" title="Weighted Average Price Per Share, Exercised"><span style="font-family: Times New Roman, Times, Serif">40.37</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">Forfeited</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_c20210701__20210930_zUF4dPx3cbCj" style="text-align: right" title="Number of Shares, Forfeited"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3739">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceExpired_c20210701__20210930_zUExwkkX8E9c" style="text-align: right" title="Weighted Average Price Per Share, Forfeited"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3741">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Expired</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_c20210701__20210930_zRsiiaMbQBUe" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Shares, Expired"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3743">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceForfeited_c20210701__20210930_zcVGq2jY8Xsl" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Price Per Share, Expired"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3745">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Outstanding at September 30, 2021</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_c20210701__20210930_zEeLCD9yTkk1" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Shares, Outstanding, Ending balance"><span style="font-family: Times New Roman, Times, Serif">111,932</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_981_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageOutstanding_iE_c20210701__20210930_zwi2Nr1IeWxh" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Price Per Share, Outstanding, Ending balance"><span style="font-family: Times New Roman, Times, Serif">191.32</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Exercisable at September 30, 2021</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_iE_c20210701__20210930_zrodIa8LyCSj" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Shares, Exercisable, Ending balance"><span style="font-family: Times New Roman, Times, Serif">76,933</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisable_iE_c20210701__20210930_zdX6Ygyia1Ri" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Price Per Share, Exercisable, Ending balance"><span style="font-family: Times New Roman, Times, Serif">278.36</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Outstanding and Exercisable:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Weighted average remaining contractual
    term</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20210701__20210930_zfPJb5ld6tyk" title="Weighted average remaining contractual term">1.52</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Aggregate intrinsic
    value <br/></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_983_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsAggregateIntrinsicValueOutstanding_iE_pp0p0_c20210701__20210930_z7SavXjqef7j" style="border-bottom: Black 1.5pt solid; text-align: right" title="Aggregate intrinsic value"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3757">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p id="xdx_8A6_zjhyyGBCVHqg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">No
stock warrants were granted during the three months ended September 30, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Options:</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_89C_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zoqy7CeBTuXf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">A
summary of the Company&#8217;s option activity during the three months ended September 30, 2021 is presented below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8B4_zmh1iYU4qpng" style="display: none">SCHEDULE
OF STOCK OPTION ACTIVITY</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Number of</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Average Exercise</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Shares</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Price
    Per Share</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%"><span style="font-family: Times New Roman, Times, Serif">Outstanding at June 30, 2021</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20210701__20210930_z51ifCEyQQS9" style="width: 14%; text-align: right" title="Number of Shares, Outstanding, Beginning balance"><span style="font-family: Times New Roman, Times, Serif">59</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20210701__20210930_z0rx5Kwkyr14" style="width: 14%; text-align: right" title="Weighted Average Price Per Share, Outstanding, Beginning balance"><span style="font-family: Times New Roman, Times, Serif">13,730</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">Issued</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_c20210701__20210930_zOKcK7k2XQW1" style="text-align: right" title="Number of Shares, Issued"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3765">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20210701__20210930_zHBULMkZ5u8" style="text-align: right" title="Weighted Average Price Per Share, Issued"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3767">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">Exercised</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20210701__20210930_zTZzX1tDCJqa" style="text-align: right" title="Number of Shares, Exercised"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3769">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20210701__20210930_z5HJiarD8QA7" style="text-align: right" title="Weighted Average Price Per Share, Exercised"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3771">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">Forfeited</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c20210701__20210930_zqSUqZrPkma7" style="text-align: right" title="Number of Shares, Forfeited"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3773">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20210701__20210930_zzLJvnToAvj9" style="text-align: right" title="Weighted Average Price Per Share, Forfeited"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3775">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Expired</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_c20210701__20210930_zAfG2knRVrw1" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Shares, Expired"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3777">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_c20210701__20210930_zKPa4oYA71S5" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Price Per Share, Expired"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3779">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Outstanding at September 30, 2021</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20210701__20210930_z8Qqg1bHEKp2" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Shares, Outstanding, Ending balance"><span style="font-family: Times New Roman, Times, Serif">59</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20210701__20210930_ztHIftIDn6gg" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Price Per Share, Outstanding, Ending balance"><span style="font-family: Times New Roman, Times, Serif">4,533.33</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">Exercisable at September 30, 2021</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_c20210701__20210930_z9SXbOqrLe0h" style="text-align: right" title="Number of Shares, Exercisable, Ending balance"><span style="font-family: Times New Roman, Times, Serif">39</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_c20210701__20210930_zACMHgTi7J44" style="text-align: right" title="Weighted Average Price Per Share, Exercisable, Ending balance"><span style="font-family: Times New Roman, Times, Serif">4,530.93</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Outstanding and Exercisable:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Weighted average remaining contractual
    term</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20210701__20210930_zcgS12ZloSe5" title="Weighted average remaining contractual term">7.62</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Weighted average fair value of options
    granted during the period</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90C_ecustom--WeightedAverageFairValueOfOptionsGrantedDuringPeriod_c20210701__20210930_zK8ntmlEsHa3" title="Weighted average fair value of options granted during the period"><span style="-sec-ix-hidden: xdx2ixbrl3791">-</span></span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Aggregate intrinsic value</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pp0p0_c20210701__20210930_zKVspuFDvKc6" style="border-bottom: Black 1.5pt solid; text-align: right" title="Aggregate intrinsic value"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3793">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p id="xdx_8A1_zOOS3tjEAv44" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">During
the three months ended September 30, 2021 and 2020, the Company recognized stock-based compensation of $<span id="xdx_908_eus-gaap--ShareBasedCompensation_pp0p0_c20210701__20210930_zn2UUDzW4jE1" title="Share based compensation">20,718</span> and $<span id="xdx_907_eus-gaap--ShareBasedCompensation_pp0p0_c20200701__20200930_zT8ZskpYfuei" title="Share based compensation">20,718</span>, respectively
related to vested stock options. There was $<span id="xdx_902_eus-gaap--StockOptionPlanExpense_pp0p0_c20210701__20210930_z8rKDxyiF0Bg" title="Stock option expense">51,796</span> of unvested stock options expense as of September 30, 2021 that will be recognized
through May 2022 or <span id="xdx_908_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20210331_zm4C5sNPiXLf" title="Term of warrant">0.62</span> years.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">No
stock options were granted during the three months ended September 30, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_80A_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zDofS11dMtob" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>NOTE
8 &#8211; <span id="xdx_823_zpbrRbXbhIlk">STOCKHOLDERS&#8217; DEFICIT</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="text-decoration: underline">Increase
in Authorized Shares of Common Stock and Reverse Stock Split</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">On
February 4, 2020 the Directors resolved to increase the Common Stock of the Company from <span id="xdx_90B_eus-gaap--CommonStockSharesAuthorized_iI_c20210203_zEdsVrHBv7C5">100,000,000</span> authorized shares to <span id="xdx_90B_eus-gaap--CommonStockSharesAuthorized_c20210204_pdd" title="Common stock, shares authorized">1,000,000,000</span>
authorized shares and believes that such number of authorized shares of Common Stock will be in the best interests of the Corporation
and its stockholders because the Board believes that the availability of more shares of Common Stock for issuance will allow the Corporation
greater flexibility in pursuing financing from investors, meeting business needs as they arise, taking advantage of favorable opportunities
and responding to a changing corporate environment. The Company filed the necessary documents with the U.S. Securities and Exchange Commission
on February 6, 2020 and with the amendment to the authorized shares being approved by the State of Delaware on March 13, 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">On
November 17, 2020, the Company effected a <span id="xdx_903_eus-gaap--StockholdersEquityReverseStockSplit_c20201116__20201117_zemL0lZyxZzf" title="Reverse stock split">one-for-one thousand (1:1,000)</span> reverse stock split of the Company&#8217;s issued and outstanding
shares of common stock (the &#8220;Reverse Stock Split&#8221;). Proportional adjustments for the Reverse Stock Split were made to the
Company&#8217;s outstanding stock options, warrants and equity incentive plans. All share and per-share data and amounts have been retroactively
adjusted as of the earliest period presented in the consolidated financial statements to reflect the Reverse Stock Split.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b><span style="text-decoration: underline">Preferred
Stock</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
total number of shares of preferred stock that the Company is authorized to issue is <span id="xdx_905_eus-gaap--PreferredStockSharesAuthorized_c20210630_pdd" title="Preferred stock, shares authorized">1,500,005</span>, $<span id="xdx_90D_eus-gaap--PreferredStockParOrStatedValuePerShare_c20210630_pdd" title="Preferred stock, par value">0.01</span> par value per share. These preferred
shares have no rights to dividends, profit sharing or liquidation preferences.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Of
the total preferred shares authorized, <span title="Preferred stock, shares authorized"><span id="xdx_90A_eus-gaap--PreferredStockSharesAuthorized_iI_c20200630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_z8qZZXLoGcSc">500,000</span></span> have been designated as Series A Preferred Stock (&#8220;Series A Preferred Stock&#8221;),
pursuant to the Certificate of Designation filed with the Secretary of State of the State of Delaware on December 9, 2014. James Nathanielsz,
the Company&#8217;s Chief Executive Officer and Chief Financial Officer, beneficially owns all of the outstanding shares of Series A
Preferred Stock via North Horizon Pty Ltd., which entitles him, as a holder of Series A Preferred Stock, to vote on all matters submitted
or required to be submitted to a vote of the Company&#8217;s stockholders, except election and removal of directors, and each share of
Series A Preferred Stock entitles him to two votes per share of Series A Preferred Stock. North Horizon Pty Ltd. is a Nathanielsz Family
Trust. Mr. James Nathanielsz, the Chief Executive Officer, Chief Financial Officer and a director of our Company, has voting and investment
power over these shares. <span id="xdx_902_eus-gaap--PreferredStockSharesIssued_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_pdd" title="Preferred stock, shares issued"><span id="xdx_903_eus-gaap--PreferredStockSharesOutstanding_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_pdd" title="Preferred stock, shares outstanding"><span id="xdx_903_eus-gaap--PreferredStockSharesIssued_c20200630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_pdd" title="Preferred stock, shares issued"><span id="xdx_900_eus-gaap--PreferredStockSharesOutstanding_c20200630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_pdd" title="Preferred stock, shares outstanding">500,000</span></span></span></span> shares of Series A Preferred Stock are issued and outstanding as of June 30, 2021 and 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 29.15pt; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>PROPANC
BIOPHARMA, INC. AND SUBSIDIARY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>June
30, 2021 and 2020</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Of
the total preferred shares authorized, pursuant to the Certificate of Designation filed with the Secretary of State of the State of Delaware
on June 16, 2015, up to five shares have been designated as Series B Preferred Stock (&#8220;Series B Preferred Stock&#8221;). Each holder
of outstanding shares of Series B Preferred Stock is entitled to voting power equivalent to the number of votes equal to the total number
of shares of common stock outstanding as of the record date for the determination of stockholders entitled to vote at each meeting of
stockholders of the Company and entitled to vote on all matters submitted or required to be submitted to a vote of the stockholders of
the Company. One share of Series B Preferred Stock is issued and outstanding as of June 30, 2021 and 2020. Mr. Nathanielsz directly beneficially
owns such one share of Series B Preferred Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">No
additional shares of Series A Preferred Stock or Series B Preferred Stock were issued during fiscal year 2021 and 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b><span style="text-decoration: underline">Common
Stock</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b><i>Shares
Issued for Cash</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><i><span style="text-decoration: underline">April
3, 2020 Security Purchase Agreement</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">On
April 3, 2020, <span id="xdx_906_ecustom--EquityPurchaseAgreementDescription_c20200402__20200403__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember_zQzJVOXLplV2" title="Equity purchase agreement description">the Company closed on a transaction related to a Securities Purchase Agreement (the &#8220;Securities Purchase Agreement&#8221;)
entered into on March 30, 2020, whereby an investor (the &#8220;Investor&#8221;) purchased from the Company, 7,500 units (the &#8220;Units&#8221;),
each consisting of (i) 1.5 shares of the Company&#8217;s common stock (the &#8220;Common Stock&#8221;), or pre-funded warrants (the &#8220;Prefunded
Warrants&#8221;) upon Investor&#8217;s election due to the 4.99% blocker provision as discussed below and (ii) 1.5 warrants to purchase
one share of Common Stock (&#8220;Series A Warrants&#8221;, and collectively with the Common Stock the &#8220;Units&#8221;).</span> In addition
to the Units, the Investor was issued <span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20200403__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantsMember_zAKVh0VFqBm3" title="Warrants to purchase common stock">63,750</span> warrants to purchase one share of Common Stock (the &#8220;Series B Warrants&#8221;) and
an additional <span id="xdx_901_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20200403__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesCWarrantsMember_zkeWadLtjJzb" title="Warrants to purchase common stock">63,750</span> warrants to purchase one share of Common Stock, subject to a vesting schedule (the &#8220;Series C Warrants&#8221;
and, together with the Prefunded Warrants, the Series A Warrants, and the Series B Warrants, the &#8220;Warrants&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
aggregate purchase price for the Units, the Series A Warrants with exercise price of $<span id="xdx_906_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20200403__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAWarrantsMember_znkv22AGeQF4" title="Warrant exercise price">200</span> per share, the Series B Warrants with exercise
price of $<span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20200403__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantsMember_zXFlRpOohsQb" title="Warrant exercise price">40</span> per share and the Series C Warrants with exercise price of $<span id="xdx_901_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20200403__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesCWarrantsMember_z3yErjs5iHs1" title="Warrant exercise price">200</span> per share, of $<span id="xdx_90B_eus-gaap--FairValueAdjustmentOfWarrants_pp0p0_c20200402__20200403__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember_zM1MkBaMIzA7" title="Fair value of warrants">450,000</span> was paid at closing (the &#8220;Purchase
Price&#8221;) or $60 per unit purchase price (see Warrants below). The Company received net proceeds of $<span id="xdx_90F_eus-gaap--ProceedsFromIssuanceOfWarrants_pp0p0_c20200402__20200403__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember_zmZ6AYE7zrkc" title="Proceeds from warrants">424,990</span>, net of offering cost
of $<span id="xdx_902_eus-gaap--PaymentsOfStockIssuanceCosts_pp0p0_c20200402__20200403__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember_zxXzHfOERk2c" title="Offering cost">25,010</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
Securities Purchase Agreement contains a blocker provision whereby the Investor or any of its affiliates would not beneficially own in
excess of <span id="xdx_90B_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pip0_dp_uPure_c20200403__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember_zkqEarGzUfz1">4.99%</span> of the outstanding number of shares of Common Stock (&#8220;Beneficial Ownership Limitation&#8221;). As such, the Investor
may elect to purchase Prefunded Warrants equal to the same number of shares of Common Stock that the Company would have been issued.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Due
to the Beneficial Ownership Limitation, the <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20200402__20200403__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zc2NonDYiGfg" title="Common stock issued during period">11,250</span> shares of Common Stock underlying the Units issuable at closing of the Securities
Purchase Agreement are comprised of <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20200402__20200403__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zzfgAYHtABF6" title="Number of restricted stock, shares">804</span> shares of restricted Common Stock and <span id="xdx_90C_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20200403__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantsMember_zurG6NZFHGPh" title="Warrants to purchase common stock">10,446</span> Prefunded Warrants with exercise price of $<span id="xdx_901_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20200403__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantsMember_zPeBk9AvUOvi" title="Warrant exercise price">1</span> (but
can be less than par value). The Prefunded Warrants shall be exercisable immediately and shall expire when exercised in full.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
Securities Purchase Agreement contains such representations, warranties and covenants as are typical for a transaction of this nature.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b><i>Shares
issued for conversion of convertible debt</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">During
the year ended June 30, 2020, the Company issued <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20190701__20200630__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember_zF1o74Iatpdl" title="Common stock issued during period">247,619</span> shares of its common stock at an average contractual conversion price of $<span id="xdx_90F_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20200630__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember_zRu1BOZ7gFLl" title="Conversion price">7</span>,
ranging from $<span id="xdx_902_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20200630__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember__srt--RangeAxis__srt--MinimumMember_zdk4IkfmLyK4" title="Conversion price">2</span> to $<span id="xdx_90E_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20200630__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember__srt--RangeAxis__srt--MaximumMember_zTsXQm3Owsbb" title="Conversion price">910</span>, as a result of the conversion of principal and interest in the aggregate amount of $<span id="xdx_90D_eus-gaap--DebtConversionConvertedInstrumentAmount1_pp0p0_c20190701__20200630__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember_zEFIa8788IZk" title="Conversion of principal and interest, aggregate amount">1,814,336</span> underlying certain
outstanding principal amount and accrued interest of convertible notes converted during such period, including $<span id="xdx_907_ecustom--ConversionFees_pp0p0_c20190701__20200630__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember_z1Y9Y8O4sjIe" title="Conversion fees">15,000</span> of conversion
fees. The total recorded to equity was $<span id="xdx_901_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20190701__20200630__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember_z4RbqAqFQ8Q9" title="Proceeds from issuance of common stock">2,125,174</span>. Notes with principal amounts totaling $<span id="xdx_902_ecustom--ConversionOptionDerivatives_pp0p0_c20190701__20200630__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember_zzfD8Z4BvkT8" title="Conversion option derivatives">254,500</span> and accrued interest of $<span id="xdx_904_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20200630__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember_zhtMhMv9WjYg" title="Accrued interest">15,408</span> contained
bifurcated embedded conversion option derivatives. Accordingly, the fair market value of the shares issued was $<span id="xdx_904_ecustom--FairMarketValueOfShares_pp0p0_c20190701__20200630__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember_zsYfcDTrhCIj" title="Fair market value of the shares">565,746</span> resulting in
a loss on extinguishment at the time of conversion of $<span id="xdx_90D_eus-gaap--GainsLossesOnExtinguishmentOfDebt_pp0p0_c20190701__20200630__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember_z9JBj30nqpjh" title="Loss on extinguishment">295,838</span> and $<span id="xdx_909_eus-gaap--DerivativeFairValueOfDerivativeNet_iI_pp0p0_c20200630__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember_zDo68gcdGz6b" title="Derivative fair value">362,961</span> of derivative fair value was recorded as a gain on extinguishment
at the time of conversion. The Company reclassified $<span id="xdx_908_ecustom--PremiumsToAdditionalPaidInCapital_pp0p0_c20190701__20200630__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember_zm2uY8KckkI" title="Premiums to additional paid in capital">874,924</span> in put premiums to additional paid in capital following conversions during
the year ended June 30, 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">During
the year ended June 30, 2021, the Company issued an aggregate of <span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20200701__20210630__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember_zzmzgt1k6Urk">8,786,113</span> shares of its common stock at an average contractual conversion
price of $<span id="xdx_90F_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20210630__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember_zgi5IUtBLy4g">0.13</span>, ranging from $<span id="xdx_909_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20210630__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember__srt--RangeAxis__srt--MinimumMember_zKzl3Q22H2M4">0.03</span> to $<span id="xdx_90C_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20210630__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember__srt--RangeAxis__srt--MaximumMember_zQU3yiRITII7">2.00</span>, as a result of the conversion of principal of $<span id="xdx_904_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20210630__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember_zawYhep7XYy6">1,018,867</span>, interest of $<span id="xdx_901_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20210630__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember_z2PXewyj25Pl">103,321</span> and conversion
fees $<span id="xdx_901_ecustom--ConversionFees_pp0p0_c20200701__20210630__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember_z8nwnGzWliC8">16,500</span> underlying certain outstanding convertible notes converted during such period. The total recorded to equity was $<span id="xdx_90E_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20200701__20210630__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember_zmLhMoas1V1b">1,239,075</span>
prior to the reversal of unissued shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>PROPANC
BIOPHARMA, INC. AND SUBSIDIARY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>June
30, 2021 and 2020</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">There
were <span id="xdx_907_eus-gaap--CommonStockSharesSubscribedButUnissued_iI_c20200930_zvwZepU3XH61" title="Common stock, unissued shares">24,427</span> unissued shares which were considered issuable for accounting purposes during the first quarter of fiscal 2021 related to
conversion notices dated and received in September 2020. In November 2020, the Company was notified by the note holder of the cancellation
of these conversion notices and as such the Company reversed the effects of these transactions thereby increasing the principal balance
by $<span id="xdx_90B_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20201130_zpFWBVfZZM3i" title="Convertible debt principal amount">19,600</span>, accrued interest of $<span id="xdx_904_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20201130_zbIvfesGMJV" title="Accrued interest">416</span> and put premium by $<span id="xdx_902_eus-gaap--DebtInstrumentUnamortizedPremium_iI_pp0p0_c20201130_zjj3Yf2nNPXh" title="Debt premium amount">11,785</span> and a corresponding decrease in equity of $<span id="xdx_907_ecustom--DecreaseInEquity_pp0p0_c20201129__20201130_zvj9lkT8srN6" title="Amount of decrease in equity">31,801</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Converted
notes totaling principal amount of $<span id="xdx_904_eus-gaap--DebtInstrumentFaceAmount_c20210630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_pp0p0">95,000
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">and accrued interest of $<span id="xdx_904_eus-gaap--InterestPayableCurrentAndNoncurrent_c20210630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_pp0p0">3,000
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">contained bifurcated embedded conversion
option derivatives. Accordingly, the fair market value of the shares issued was $<span id="xdx_90C_ecustom--FairMarketValueOfShares_c20200701__20210630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_pp0p0">178,368
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">resulting in a loss on extinguishment
at the time of conversion of $<span id="xdx_906_eus-gaap--GainsLossesOnExtinguishmentOfDebt_c20200701__20210630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_pp0p0">80,368
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">and $<span id="xdx_901_eus-gaap--DerivativeFairValueOfDerivativeNet_c20210630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_pp0p0">130,975
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">of derivative fair value was recorded
as a gain on extinguishment at the time of conversion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The Company reclassified $<span id="xdx_90B_ecustom--PremiumsToAdditionalPaidInCapital_c20200701__20210630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_pp0p0">590,504
to additional paid in capital following conversions of notes accounted for as stock settled debt during the year ended June 30,
2021.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
Company has <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20200701__20210630__us-gaap--TypeOfArrangementAxis__custom--UnderlyingFinancingAgreementsMember_pdd" title="Common stock issued during period">197,308,116</span> shares of its common stock reserved for future issuances based on lender reserve requirements pursuant to underlying
financing agreements at June 30, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b><i>Shares
issued for services</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">On
July 19, 2019, the Company entered into an agreement with a certain consultant to provide services over a two-month period beginning
July 1, 2019 and ending September 1, 2019 in exchange for 20 shares of the Company&#8217;s common stock. On July 19, 2019, the Company
issued the <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20200718__20200719__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember_pdd" title="Common stock issued during period">20</span> shares of the Company&#8217;s common stock valued at $<span id="xdx_90D_eus-gaap--SharesIssuedPricePerShare_c20200719__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember_pdd" title="Share issued price per share">1,990</span> per share; being the closing price of the stock on the date
of the agreement, to such consultant, or $<span id="xdx_907_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20200718__20200719__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember_pp0p0" title="Proceeds from issuance of common stock">39,800</span>, which will be amortized over the term of the agreement. The Company recorded $<span id="xdx_908_eus-gaap--ProfessionalFees_pp0p0_c20190701__20200630__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember_zskhHC2MpVdj" title="Consulting expenses">39,800</span>
of consulting expense with respect to such shares of its common stock during the year ended June 30, 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Between
February 3, 2020 and June 26, 2020, the Company issued an aggregate of <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20200202__20200203__srt--TitleOfIndividualAxis__custom--ConsultantMember__us-gaap--TypeOfArrangementAxis__custom--EngagementAgreementMember_zud6RckbyAIa" title="Stock issued for services, shares"><span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20200625__20200626__srt--TitleOfIndividualAxis__custom--ConsultantMember__us-gaap--TypeOfArrangementAxis__custom--EngagementAgreementMember_zKk11bt134m4" title="Stock issued for services, shares">8,709</span></span> shares of the Company&#8217;s common stock to a consultant
for services rendered pursuant to an engagement agreement dated on September 10, 2019 which agreement was later amended in February 2020.
Between February 3, 2020 and June 26, 2020, the Company issued an aggregate of <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20200625__20200626__srt--TitleOfIndividualAxis__custom--ConsultantMember__us-gaap--TypeOfArrangementAxis__custom--EngagementAgreementMember_zS4WwEqgGyM4" title="Stock issued for services, shares"><span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20200625__20200626__srt--TitleOfIndividualAxis__custom--ConsultantMember__us-gaap--TypeOfArrangementAxis__custom--EngagementAgreementMember_zVCOTLx5ebV9" title="Stock issued for services, shares">8,709</span></span> shares of the Company&#8217;s common stock valued
at an average price of $<span id="xdx_904_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20200203__srt--TitleOfIndividualAxis__custom--ConsultantMember__us-gaap--TypeOfArrangementAxis__custom--EngagementAgreementMember_zdjrn0McezL9" title="Common stock, par value"><span id="xdx_90C_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20200626__srt--TitleOfIndividualAxis__custom--ConsultantMember__us-gaap--TypeOfArrangementAxis__custom--EngagementAgreementMember_zZ8scAbUaK8j" title="Common stock, par value">8</span></span> per share; being the closing price of the stock on the date of the agreement, to such consultant, or $<span id="xdx_90B_eus-gaap--ProfessionalFees_pp0p0_c20200202__20200203__srt--TitleOfIndividualAxis__custom--ConsultantMember__us-gaap--TypeOfArrangementAxis__custom--EngagementAgreementMember_z1LUHGxWvIdj" title="Consulting expenses"><span id="xdx_900_eus-gaap--ProfessionalFees_pp0p0_c20200625__20200626__srt--TitleOfIndividualAxis__custom--ConsultantMember__us-gaap--TypeOfArrangementAxis__custom--EngagementAgreementMember_zZrmOY5ch9Nl" title="Consulting expenses">73,842</span></span>.
The Company recorded $<span id="xdx_903_eus-gaap--ProfessionalFees_pp0p0_c20190701__20200630__srt--TitleOfIndividualAxis__custom--ConsultantMember__us-gaap--TypeOfArrangementAxis__custom--EngagementAgreementMember_zVu3NY8DRQZf" title="Consulting expenses">73,842</span> of consulting expense with respect to such shares of its common stock during the year ended June 30, 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">On
March 22, 2021, the Company issued an aggregate of <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20210321__20210322__srt--TitleOfIndividualAxis__custom--ConsultantMember_zK4ts7pTGyY9" title="Number of shares issued for services">225,037</span> shares of the Company&#8217;s common stock to a consultant for services rendered
from January 1, 2021 to March 22, 2021. The Company issued <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20200701__20210630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--TitleOfIndividualAxis__custom--ConsultantMember_pdd" title="Number of shares issued for services">225,037</span> shares of the Company&#8217;s common stock valued at $<span id="xdx_90A_eus-gaap--SharesIssuedPricePerShare_c20210630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--TitleOfIndividualAxis__custom--ConsultantMember_pdd" title="Shares issued per price">0.30</span> per share,
being the closing price of the stock on the date of grant to such consultant, or $<span id="xdx_908_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_pp0p0_c20200701__20210630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--TitleOfIndividualAxis__custom--ConsultantMember_zhUF8BYRp3Ih" title="Number of shares issued for services, value">67,511</span>. The Company recorded $<span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_pp0p0_c20200701__20210630__srt--TitleOfIndividualAxis__custom--ConsultantMember_zvXvgxYc4jF1" title="Number of shares issued for services, value">67,511</span> of consulting
expense with respect to such shares of its common stock during the year ended June 30, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Between
March 2021 and June 2021, the Company issued an aggregate of <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20210301__20210331__srt--TitleOfIndividualAxis__custom--ConsultantMember__us-gaap--TypeOfArrangementAxis__custom--EngagementAgreementMember_z98v5YphXto8"><span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20210601__20210630__srt--TitleOfIndividualAxis__custom--ConsultantMember__us-gaap--TypeOfArrangementAxis__custom--EngagementAgreementMember_zjqIXel6tOQ1">580,609</span></span> shares of the Company&#8217;s common stock to a consultant for services
rendered from April 1, 2021 to June 30, 2021. The Company issued <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20210301__20210331__srt--TitleOfIndividualAxis__custom--ConsultantMember__us-gaap--TypeOfArrangementAxis__custom--EngagementAgreementMember_zANCvk6P9mjk"><span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20210601__20210630__srt--TitleOfIndividualAxis__custom--ConsultantMember__us-gaap--TypeOfArrangementAxis__custom--EngagementAgreementMember_zM5PICi8Ffwh">580,609</span></span> shares of the Company&#8217;s common stock valued at $<span id="xdx_90C_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20210331__srt--TitleOfIndividualAxis__custom--ConsultantMember__us-gaap--TypeOfArrangementAxis__custom--EngagementAgreementMember_zl9v7QU8w19l"><span id="xdx_902_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20210630__srt--TitleOfIndividualAxis__custom--ConsultantMember__us-gaap--TypeOfArrangementAxis__custom--EngagementAgreementMember_zbK4vNipFGil">0.10</span></span> per
share, being the closing price of the stock on the date of grant to such consultant, or $<span id="xdx_90E_eus-gaap--ProfessionalFees_pp0p0_c20210301__20210331__srt--TitleOfIndividualAxis__custom--ConsultantMember__us-gaap--TypeOfArrangementAxis__custom--EngagementAgreementMember_zTQTvLKYppKh"><span id="xdx_902_eus-gaap--ProfessionalFees_pp0p0_c20210601__20210630__srt--TitleOfIndividualAxis__custom--ConsultantMember__us-gaap--TypeOfArrangementAxis__custom--EngagementAgreementMember_zqlAs0ioI2c5">58,061</span></span>. The Company recorded $<span id="xdx_90C_eus-gaap--ProfessionalFees_pp0p0_c20200701__20210630__srt--TitleOfIndividualAxis__custom--ConsultantMember__us-gaap--TypeOfArrangementAxis__custom--EngagementAgreementMember_zPmjyJKaog14">58,061</span> of consulting
expense with respect to such shares of its common stock during the year ended June 30, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b><i>Shares
issued for exercise of warrants</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">During
the year ended June 30, 2021, the Company received aggregate gross proceeds of $<span id="xdx_90D_eus-gaap--ProceedsFromWarrantExercises_c20200701__20210630_pp0p0">776,044
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">from the exercise of <span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_c20210630__us-gaap--StatementClassOfStockAxis__custom--PrefundedWarrantsMember_pdd">10,445
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">prefunded warrants and <span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_c20210630__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantsMember_pdd">19,375
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Series B Warrants resulting in
the issuance of <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20200701__20210630__us-gaap--StatementClassOfStockAxis__custom--PrefundedWarrantsMember_pdd">29,820
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">shares of common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Additionally,
during 2021 the Company issued <span id="xdx_90A_eus-gaap--CommonStockSharesIssued_iI_c20210630__us-gaap--StatementClassOfStockAxis__custom--TwentySeriesAAndOneSeriesCWarrantsMember_z4XiGfAQTBib">4,199,979
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">shares of common stock from the
alternate cashless exercise of 20 Series A and 1 Series C warrants. The Company recognized the value of the effect of a down round
feature in such warrants when triggered. Upon the occurrence of the triggering event that resulted in a reduction of the strike price,
the Company measured the value of the effect of the feature as the difference between the fair value of the warrants without the down
round feature or before the strike price reduction and the fair value of the warrants with a strike price corresponding to the reduced
strike price upon the down round feature being triggered. Accordingly, the Company recognized deemed dividend of $<span id="xdx_900_ecustom--DeemedDividend_iN_di_c20200701__20210630_zyNhuYLlIyZh">391,749
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">and a corresponding reduction
of income available to common stockholders upon the </span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">alternate
cashless exercise of these warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><i>Restricted
Stock Units</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Pursuant
to employment agreements dated in May 2019, the Company granted an aggregate of <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20190501__20190531_zdMr0ljXcp2i">78
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">and <span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20190501__20190531__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zjT4EQM6i0qj">39
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">restricted stock unit to the Company&#8217;s
Chief Executive Officer and Chief Scientific Officer, respectively. The total <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20190501__20190531__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zw6ANGtIJOUc">117
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">restricted stock units are subject
to vesting terms as defined in the employment agreements. The 117 restricted stock units were valued at the fair value of $<span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20190501__20190531__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zj17rqfAtqfj">4,250
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">per unit or $<span id="xdx_906_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantDateFairvalue_pp0p0_c20190501__20190531__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zQxy1dO86qna">497,240
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">based on the quoted trading price
on the date of grant. During the year ended June 30, 2021 and 2020, the Company recognized stock-based compensation of $<span id="xdx_909_eus-gaap--ShareBasedCompensation_c20200701__20210630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_pp0p0">0
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">and $<span id="xdx_900_eus-gaap--ShareBasedCompensation_c20190701__20200630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_pp0p0">217,543</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">,
respectively, related to vested restricted stock units. There were $<span id="xdx_901_ecustom--UnrecognizedRestrictedStockUnitsExpense_c20200701__20210630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_pp0p0">248,620
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">unrecognized restricted stock units
expense as of June 30, 2021. There are <span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20200630_z3vqF4UjOqve">59
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">unvested restricted stock units
which are subject to various performance conditions which have not yet been met and such restricted stock
units have not yet vested as of June 30, 2021 and 2020 to which the $<span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20210630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zieLyCEmGOui" title="Number of shares not yet vested"><span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20200630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_znngyW9kylEl">248,620</span></span> relates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>PROPANC
BIOPHARMA, INC. AND SUBSIDIARY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>June
30, 2021 and 2020</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><i>Options</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><i>&#160;</i></span></p>

<p id="xdx_893_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zJAtVHqv7Tac" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">A
summary of the Company&#8217;s option activity during the years ended June 30, 2021 and 2020 is presented below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_8B4_z1neiiLP5lU5" style="display: none">SCHEDULE OF STOCK OPTION ACTIVITY</span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="color: Black">&#160;</td><td style="color: Black; font-weight: bold">&#160;</td>
    <td colspan="2" style="color: Black; font-weight: bold; text-align: center">Number of</td><td style="color: Black; font-weight: bold">&#160;</td><td style="color: Black; font-weight: bold">&#160;</td>
    <td colspan="2" style="color: Black; font-weight: bold; text-align: center">Weighted Average</td><td style="color: Black; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="color: Black">&#160;</td><td style="color: Black; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; color: Black; font-weight: bold; text-align: center">Options</td><td style="padding-bottom: 1.5pt; color: Black; font-weight: bold">&#160;</td><td style="color: Black; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; color: Black; font-weight: bold; text-align: center">Price Per Share</td><td style="padding-bottom: 1.5pt; color: Black; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; color: Black">Outstanding at June 30, 2019</td><td style="width: 2%; color: Black">&#160;</td>
    <td style="width: 1%; color: Black; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20190701__20200630_zCvoi2Biml0j" style="width: 16%; color: Black; text-align: right" title="Number of Shares, Outstanding, Beginning balance">60</td><td style="width: 1%; color: Black; text-align: left">&#160;</td><td style="width: 2%; color: Black">&#160;</td>
    <td style="width: 1%; color: Black; text-align: left">$</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20190701__20200630_z4nKrz61JCxb" style="width: 16%; color: Black; text-align: right" title="Weighted Average Price Per Share, Outstanding, Beginning balance">76,370</td><td style="width: 1%; color: Black; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="color: Black">Issued</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_c20190701__20200630_pdd" style="color: Black; text-align: right" title="Number of Shares, Issued"><span style="-sec-ix-hidden: xdx2ixbrl1968">-</span></td><td style="color: Black; text-align: left">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td id="xdx_986_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsIssuedInPeriodWeightedAverageExercisePrice_c20190701__20200630_pdd" style="color: Black; text-align: right" title="Weighted Average Price Per Share, Issued"><span style="-sec-ix-hidden: xdx2ixbrl1970">-</span></td><td style="color: Black; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: Black">Exercised</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20190701__20200630_pdd" style="color: Black; text-align: right" title="Number of Shares, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl1972">-</span></td><td style="color: Black; text-align: left">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20190701__20200630_pdd" style="color: Black; text-align: right" title="Weighted Average Price Per Share, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl1974">-</span></td><td style="color: Black; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="color: Black; padding-bottom: 1.5pt">Expired</td><td style="color: Black; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; color: Black; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_iN_di_c20190701__20200630_zCAdRgPTA2gj" style="border-bottom: Black 1.5pt solid; color: Black; text-align: right" title="Number of Shares, Expired"><span style="-sec-ix-hidden: xdx2ixbrl1976">-</span></td><td style="padding-bottom: 1.5pt; color: Black; text-align: left">&#160;</td><td style="color: Black; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; color: Black; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_c20190701__20200630_pdd" style="border-bottom: Black 1.5pt solid; color: Black; text-align: right" title="Weighted Average Price Per Share, Expired"><span style="-sec-ix-hidden: xdx2ixbrl1978">-</span></td><td style="padding-bottom: 1.5pt; color: Black; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: Black">Outstanding at June 30, 2020</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20200701__20210630_zs4OGeOEO8Zg" style="color: Black; text-align: right" title="Number of Shares, Outstanding, Ending balance">60</td><td style="color: Black; text-align: left">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">$</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20200701__20210630_zpvCzXKi2RAi" style="color: Black; text-align: right" title="Weighted Average Price Per Share, Outstanding, Ending balance">76,370</td><td style="color: Black; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="color: Black">Issued</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_c20200701__20210630_pdd" style="color: Black; text-align: right" title="Number of Shares, Issued"><span style="-sec-ix-hidden: xdx2ixbrl1984">-</span></td><td style="color: Black; text-align: left">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td id="xdx_98C_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsIssuedInPeriodWeightedAverageExercisePrice_c20200701__20210630_pdd" style="color: Black; text-align: right" title="Weighted Average Price Per Share, Issued"><span style="-sec-ix-hidden: xdx2ixbrl1986">-</span></td><td style="color: Black; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: Black">Exercised</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20200701__20210630_pdd" style="color: Black; text-align: right" title="Number of Shares, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl1988">-</span></td><td style="color: Black; text-align: left">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20200701__20210630_pdd" style="color: Black; text-align: right" title="Weighted Average Price Per Share, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl1990">-</span></td><td style="color: Black; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="color: Black; padding-bottom: 1.5pt">Expired</td><td style="color: Black; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; color: Black; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_iN_di_c20200701__20210630_z26oJD3Z7ylb" style="border-bottom: Black 1.5pt solid; color: Black; text-align: right" title="Number of Shares, Expired">(1</td><td style="padding-bottom: 1.5pt; color: Black; text-align: left">)</td><td style="color: Black; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; color: Black; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_c20200701__20210630_pdd" style="border-bottom: Black 1.5pt solid; color: Black; text-align: right" title="Weighted Average Price Per Share, Expired">3,750,000</td><td style="padding-bottom: 1.5pt; color: Black; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: Black; padding-bottom: 1.5pt">Outstanding at June 30, 2021</td><td style="color: Black; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; color: Black; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20200701__20210630_z8aMmHSwGSKd" style="border-bottom: Black 1.5pt solid; color: Black; text-align: right" title="Number of Shares, Outstanding, Ending balance">59</td><td style="padding-bottom: 1.5pt; color: Black; text-align: left">&#160;</td><td style="color: Black; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; color: Black; text-align: left">$</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20200701__20210630_zrYBXYu3bVe4" style="border-bottom: Black 1.5pt solid; color: Black; text-align: right" title="Weighted Average Price Per Share, Outstanding, Ending balance">13,730</td><td style="padding-bottom: 1.5pt; color: Black; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="color: Black">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">&#160;</td><td style="color: Black; text-align: left">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">&#160;</td><td style="color: Black; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: Black">Exercisable at June 30, 2021</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20210630_pdd" style="color: Black; text-align: right" title="Number of Shares, Exercisable, Ending balance">40</td><td style="color: Black; text-align: left">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">$</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20210630_pdd" style="color: Black; text-align: right" title="Weighted Average Price Per Share, Exercisable, Ending balance">18,193</td><td style="color: Black; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="color: Black; text-align: left">Outstanding and Exercisable:</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">&#160;</td><td style="color: Black; text-align: left">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">&#160;</td><td style="color: Black; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: Black">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">&#160;</td><td style="color: Black; text-align: left">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">&#160;</td><td style="color: Black; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="color: Black; padding-bottom: 1.5pt">Weighted average remaining contractual term</td><td style="color: Black; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; color: Black; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; color: Black; text-align: right"><span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20200701__20210630_zQiV9nk5dTk" title="Weighted average remaining contractual term">7.86</span></td><td style="padding-bottom: 1.5pt; color: Black; text-align: left">&#160;</td><td style="color: Black; padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; color: Black; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; color: Black; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; color: Black; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: Black; padding-bottom: 1.5pt">Weighted average fair value of options granted during the period</td><td style="color: Black; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; color: Black; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; color: Black; text-align: right"><span id="xdx_905_ecustom--WeightedAverageFairValueOfOptionsGrantedDuringPeriod_d0_c20200701__20210630_zcXnUFEhxcJ4" title="Weighted average fair value of options granted during the period"><span style="-sec-ix-hidden: xdx2ixbrl2006">-</span></span></td><td style="padding-bottom: 1.5pt; color: Black; text-align: left">&#160;</td><td style="color: Black; padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; color: Black; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; color: Black; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; color: Black; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="color: Black; padding-bottom: 1.5pt">Aggregate intrinsic value</td><td style="color: Black; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; color: Black; text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_c20210630_pp0p0" style="border-bottom: Black 1.5pt solid; color: Black; text-align: right" title="Aggregate intrinsic value"><span style="-sec-ix-hidden: xdx2ixbrl2008">-</span></td><td style="padding-bottom: 1.5pt; color: Black; text-align: left">&#160;</td><td style="color: Black; padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; color: Black; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; color: Black; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; color: Black; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A2_zRtgmmXBuksa" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">On
the Effective Date, the Company&#8217;s board of directors approved and adopted the Company&#8217;s 2019 Equity Incentive Plan (the &#8220;2019
Plan&#8221;), which reserves a total of <span id="xdx_902_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_c20210630__us-gaap--PlanNameAxis__custom--TwoThousandNinteenEquityIncentivePlanMember_ziLEvFiYtnC8" title="Number of common shares reserved for future issuance">234</span> shares of the Company&#8217;s common stock for issuance under the 2019 Plan. Incentive awards
authorized under the 2019 Plan include, but are not limited to, incentive stock options, non-qualified stock options, restricted stock
awards and restricted stock units.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">During
the year ended June 30, 2021 and 2020, the Company recognized stock-based compensation of $<span id="xdx_903_eus-gaap--StockOptionPlanExpense_c20200701__20210630__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementsMember_pp0p0">82,872
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">and $<span id="xdx_90A_eus-gaap--StockOptionPlanExpense_c20190701__20200630__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementsMember_pp0p0">82,873
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">related to vested stock options.
There was $<span id="xdx_90E_ecustom--UnvestedStockOptionsExpense_c20200701__20210630__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementsMember_pp0p0">72,514
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">of unvested stock options expense
as of June 30, 2021 that will be recognized over a remaining vesting period of <span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_dtY_c20200701__20210630_zoFTWo0hTlDj" title="Vesting period">0.87</span> year.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_do_c20200701__20210630_zNcX2trAMrdj" title="Options granted"><span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_do_c20190701__20200630_zo2hqyucXJnc">No</span></span>
stock options were granted during the years ended June 30, 2021 and 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b><i>Warrants</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b><i>&#160;</i></b></span></p>

<p id="xdx_89C_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zCK2SPds7WP5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
following table summarizes warrant activity for the years ended June 30, 2021 and 2020:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span id="xdx_8BA_zlOH3PPBkAE3" style="display: none">SCHEDULE OF WARRANT ACTIVITY</span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="color: Black">&#160;</td><td style="color: Black; font-weight: bold">&#160;</td>
    <td colspan="2" style="color: Black; font-weight: bold; text-align: center">Number of</td><td style="color: Black; font-weight: bold">&#160;</td><td style="color: Black; font-weight: bold">&#160;</td>
    <td colspan="2" style="color: Black; font-weight: bold; text-align: center">Weighted Average</td><td style="color: Black; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="color: Black">&#160;</td><td style="color: Black; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; color: Black; font-weight: bold; text-align: center">Warrants</td><td style="padding-bottom: 1.5pt; color: Black; font-weight: bold">&#160;</td><td style="color: Black; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; color: Black; font-weight: bold; text-align: center">Price Per Share</td><td style="padding-bottom: 1.5pt; color: Black; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: Black">Outstanding at June 30, 2019</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20190701__20200630_zqxqy7ojzqB3" style="color: Black; text-align: right" title="Number of Shares, Outstanding, Beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl2022">-</span></td><td style="color: Black; text-align: left">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">$</td><td id="xdx_98F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageOutstanding_iS_c20190701__20200630_zfVXsuFda5Lf" style="color: Black; text-align: right" title="Weighted Average Price Per Share, Outstanding, Beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl2024">-</span></td><td style="color: Black; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 60%; color: Black">Issued</td><td style="width: 2%; color: Black">&#160;</td>
    <td style="width: 1%; color: Black; text-align: left">&#160;</td><td id="xdx_984_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsIssued_c20190701__20200630_pdd" style="width: 16%; color: Black; text-align: right" title="Number of Shares, Issued">151,170</td><td style="width: 1%; color: Black; text-align: left">&#160;</td><td style="width: 2%; color: Black">&#160;</td>
    <td style="width: 1%; color: Black; text-align: left">&#160;</td><td id="xdx_98F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceIssued_c20190701__20200630_pdd" style="width: 16%; color: Black; text-align: right" title="Weighted Average Price Per Share, Issued">150.00</td><td style="width: 1%; color: Black; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: Black">Exercised</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_di_c20190701__20200630_z6phSP3ACjjb" style="color: Black; text-align: right" title="Number of Shares, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl2030">-</span></td><td style="color: Black; text-align: left">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td id="xdx_983_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceExercised_c20190701__20200630_pdd" style="color: Black; text-align: right" title="Weighted Average Price Per Share, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl2032">-</span></td><td style="color: Black; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="color: Black">Forfeited</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_c20190701__20200630_pdd" style="color: Black; text-align: right" title="Number of Shares, Forfeited"><span style="-sec-ix-hidden: xdx2ixbrl2034">-</span></td><td style="color: Black; text-align: left">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td id="xdx_985_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceExpired_c20190701__20200630_pdd" style="color: Black; text-align: right" title="Weighted Average Price Per Share, Forfeited"><span style="-sec-ix-hidden: xdx2ixbrl2036">-</span></td><td style="color: Black; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: Black; padding-bottom: 1.5pt">Expired</td><td style="color: Black; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; color: Black; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_c20190701__20200630_pdd" style="border-bottom: Black 1.5pt solid; color: Black; text-align: right" title="Number of Shares, Expired"><span style="-sec-ix-hidden: xdx2ixbrl2038">-</span></td><td style="padding-bottom: 1.5pt; color: Black; text-align: left">&#160;</td><td style="color: Black; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; color: Black; text-align: left">&#160;</td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceForfeited_c20190701__20200630_pdd" style="border-bottom: Black 1.5pt solid; color: Black; text-align: right" title="Weighted Average Price Per Share, Expired"><span style="-sec-ix-hidden: xdx2ixbrl2040">-</span></td><td style="padding-bottom: 1.5pt; color: Black; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="color: Black">Outstanding at June 30, 2020</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20200701__20210630_zNSUObxM0a33" style="color: Black; text-align: right" title="Number of Shares, Outstanding, Ending balance">151,170</td><td style="color: Black; text-align: left">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">$</td><td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageOutstanding_iS_c20200701__20210630_zsBKJYDHT2Ae" style="color: Black; text-align: right" title="Weighted Average Price Per Share, Outstanding, Ending balance">150.00</td><td style="color: Black; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: Black">Issued</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsIssued_c20200701__20210630_pdd" style="color: Black; text-align: right" title="Number of Shares, Issued"><span style="-sec-ix-hidden: xdx2ixbrl2046">-</span></td><td style="color: Black; text-align: left">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td id="xdx_981_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceIssued_c20200701__20210630_pdd" style="color: Black; text-align: right" title="Weighted Average Price Per Share, Issued"><span style="-sec-ix-hidden: xdx2ixbrl2048">-</span></td><td style="color: Black; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="color: Black">Exercised</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_di_c20200701__20210630_z3OKGyW1DQB8" style="color: Black; text-align: right" title="Number of Shares, Exercised">(29,841</td><td style="color: Black; text-align: left">)</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td id="xdx_984_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceExercised_c20200701__20210630_pdd" style="color: Black; text-align: right" title="Weighted Average Price Per Share, Exercised">26.15</td><td style="color: Black; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: Black">Forfeited</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_c20200701__20210630_pdd" style="color: Black; text-align: right" title="Number of Shares, Forfeited"><span style="-sec-ix-hidden: xdx2ixbrl2054">-</span></td><td style="color: Black; text-align: left">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td id="xdx_98F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceExpired_c20200701__20210630_pdd" style="color: Black; text-align: right" title="Weighted Average Price Per Share, Forfeited"><span style="-sec-ix-hidden: xdx2ixbrl2056">-</span></td><td style="color: Black; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="color: Black; padding-bottom: 1.5pt">Expired</td><td style="color: Black; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; color: Black; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_c20200701__20210630_pdd" style="border-bottom: Black 1.5pt solid; color: Black; text-align: right" title="Number of Shares, Expired"><span style="-sec-ix-hidden: xdx2ixbrl2058">-</span></td><td style="padding-bottom: 1.5pt; color: Black; text-align: left">&#160;</td><td style="color: Black; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; color: Black; text-align: left">&#160;</td><td id="xdx_988_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceForfeited_c20200701__20210630_pdd" style="border-bottom: Black 1.5pt solid; color: Black; text-align: right" title="Weighted Average Price Per Share, Expired"><span style="-sec-ix-hidden: xdx2ixbrl2060">-</span></td><td style="padding-bottom: 1.5pt; color: Black; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: Black; padding-bottom: 1.5pt">Outstanding at June 30, 2021</td><td style="color: Black; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; color: Black; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_c20200701__20210630_zUi2wA7mVNkl" style="border-bottom: Black 1.5pt solid; color: Black; text-align: right" title="Number of Shares, Outstanding, Ending balance">121,329</td><td style="padding-bottom: 1.5pt; color: Black; text-align: left">&#160;</td><td style="color: Black; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; color: Black; text-align: left">$</td><td id="xdx_983_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageOutstanding_iE_c20200701__20210630_zC3AomBZmAta" style="border-bottom: Black 1.5pt solid; color: Black; text-align: right" title="Weighted Average Price Per Share, Outstanding, Ending balance">179.63</td><td style="padding-bottom: 1.5pt; color: Black; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="color: Black">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">&#160;</td><td style="color: Black; text-align: left">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">&#160;</td><td style="color: Black; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: Black; padding-bottom: 1.5pt">Exercisable at June 30, 2021</td><td style="color: Black; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; color: Black; text-align: left">&#160;</td><td id="xdx_985_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_c20210630_pdd" style="border-bottom: Black 1.5pt solid; color: Black; text-align: right" title="Number of Shares, Exercisable, Ending balance">76,955</td><td style="padding-bottom: 1.5pt; color: Black; text-align: left">&#160;</td><td style="color: Black; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; color: Black; text-align: left">$</td><td id="xdx_98F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisable_c20210630_pdd" style="border-bottom: Black 1.5pt solid; color: Black; text-align: right" title="Weighted Average Price Per Share, Exercisable, Ending balance">283.21</td><td style="padding-bottom: 1.5pt; color: Black; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="color: Black; text-align: left">Outstanding and Exercisable:</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">&#160;</td><td style="color: Black; text-align: left">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">&#160;</td><td style="color: Black; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: Black">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">&#160;</td><td style="color: Black; text-align: left">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">&#160;</td><td style="color: Black; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="color: Black; padding-bottom: 1.5pt">Weighted average remaining contractual term</td><td style="color: Black; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; color: Black; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; color: Black; text-align: right"><span id="xdx_90B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20200701__20210630_z78SFcSuOfvh" title="Weighted average remaining contractual term">1.77</span></td><td style="padding-bottom: 1.5pt; color: Black; text-align: left">&#160;</td><td style="color: Black; padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; color: Black; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; color: Black; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; color: Black; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: Black; padding-bottom: 1.5pt">Aggregate intrinsic value</td><td style="color: Black; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; color: Black; text-align: left">$</td><td id="xdx_985_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsAggregateIntrinsicValueOutstanding_c20210630_pp0p0" style="border-bottom: Black 1.5pt solid; color: Black; text-align: right" title="Aggregate intrinsic value"><span style="-sec-ix-hidden: xdx2ixbrl2072">-</span></td><td style="padding-bottom: 1.5pt; color: Black; text-align: left">&#160;</td><td style="color: Black; padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; color: Black; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; color: Black; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; color: Black; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A8_zOMK2q9HwKck" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>PROPANC
BIOPHARMA, INC. AND SUBSIDIARY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>June
30, 2021 and 2020</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">In
connection with the issuance of the August 2019 Auctus Note, the Company issued common stock purchase warrants to Auctus to purchase
<span id="xdx_906_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_c20190831__us-gaap--StatementEquityComponentsAxis__custom--FirstWarrantMember_pdd" title="Warrants to purchase common stock">450</span> shares of the Company&#8217;s common stock (the &#8220;First Warrant&#8221;) as a commitment fee upon the terms and subject to the
limitations and conditions set forth in such First Warrant at an &#8220;Exercise Price&#8221; of $<span id="xdx_909_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20190831__us-gaap--StatementEquityComponentsAxis__custom--FirstWarrantMember_pdd" title="Warrant exercise price">2,250</span>. In connection with the issuance
of the Note, the Company shall issue a common stock purchase warrant to Buyer to purchase <span id="xdx_907_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_c20190831__us-gaap--StatementEquityComponentsAxis__custom--SecondWarrantMember_pdd" title="Warrants to purchase common stock">300</span> shares of the Company&#8217;s common stock
(the &#8220;Second Warrant&#8221;) as a commitment fee upon the terms and subject to the limitations and conditions set forth in such
Second Warrant at an &#8220;Exercise Price&#8221; of $<span id="xdx_908_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20190831__us-gaap--StatementEquityComponentsAxis__custom--SecondWarrantMember_pdd" title="Warrant exercise price">3,330</span>. In connection with the issuance of the Note, the Company shall issue a common
stock purchase warrant to Buyer to purchase <span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_c20190831__us-gaap--StatementEquityComponentsAxis__custom--ThirdWarrantMember_pdd" title="Warrants to purchase common stock">225</span> shares of the Company&#8217;s common stock (the &#8220;Third Warrant&#8221;) as a commitment
fee upon the terms and subject to the limitations and conditions set forth in such Third Warrant at an &#8220;Exercise Price&#8221; of
$<span id="xdx_906_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20190831__us-gaap--StatementEquityComponentsAxis__custom--ThirdWarrantMember_pdd" title="Warrant exercise price">4,500</span>. The First Warrant, Second Warrant, and Third Warrant shall collectively be referred as the &#8220;Warrants&#8221;. The Warrants
have an &#8220;Exercise Period&#8221; of five years from the date of issuance being August 30, 2019 (see Note 6).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">On
September 10, 2019, the Company entered into an agreement with a certain consultant to provide services over a three-month period beginning
September 10, 2019 and ending December 10, 2019 in exchange for <span id="xdx_907_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_c20190910_pdd" title="Warrants to purchase common stock">1,000</span> warrants to purchase the Company&#8217;s common stock at $<span id="xdx_90E_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20190910_pdd" title="Warrant exercise price">2,000</span>
per share with an expiry date of <span id="xdx_900_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20190910_zuOh6KYpd9vg" title="Warrant expiration date">September 10, 2022</span>. The Fair Market Value of the warrants was $<span id="xdx_90B_eus-gaap--FairValueAdjustmentOfWarrants_c20190909__20190910_pp0p0" title="Fair value of warrants">984,810</span> on the date of grant as calculated
under the Black Scholes Option Pricing model. The Company recorded $<span id="xdx_90B_eus-gaap--ShareBasedCompensation_pp0p0_c20190701__20200630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zjQlvPqlLwl" title="Share based compensation">984,810</span> of share-based compensation expenses with respect to the
grant of such warrants during the year ended June 30, 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">In
connection with the issuance of shares on April 3, 2020 as discussed above, <span id="xdx_90C_ecustom--EquityPurchaseAgreementDescription_c20200402__20200403__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember" title="Equity purchase agreement description">the Company closed on a transaction related to a Securities
Purchase Agreement (the &#8220;Securities Purchase Agreement&#8221;) entered into on March 30, 2020, whereby an investor purchased from
the Company, 7,500 units, each consisting of (i) 1.5 shares of the Company&#8217;s common stock, or pre-funded warrants upon Investor&#8217;s
election due to the 4.99% blocker provision and (ii) 1.5 warrants to purchase one share of Common Stock (&#8220;Series A Warrants&#8221;,
and collectively with the Common Stock the &#8220;Units&#8221;)</span>. In addition to the Units, the Investor was issued <span id="xdx_909_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_c20200403__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantsMember_pdd" title="Warrants to purchase common stock">63,750</span> warrants to
purchase one share of Common Stock (the &#8220;Series B Warrants&#8221;) and an additional <span id="xdx_908_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_c20200403__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesCWarrantsMember_pdd" title="Warrants to purchase common stock">63,750</span> warrants to purchase one share of Common
Stock, subject to a vesting schedule (the &#8220;Series C Warrants&#8221; and, together with the Prefunded Warrants, the Series A Warrants,
and the Series B Warrants, the &#8220;Warrants&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Due
to the Beneficial Ownership Limitation, the Company granted <span id="xdx_900_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_c20200403__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantsMember_pdd" title="Warrants to purchase common stock">10,445</span> Prefunded Warrants with exercise price of $<span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20200403__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantsMember_pdd" title="Warrant exercise price">0.10</span> (but can be less than
par value). The Prefunded Warrants shall be exercisable immediately and shall expire when exercised in full.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><i><span style="text-decoration: underline">Series
A Warrants</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Pursuant
to the Securities Purchase Agreement entered into March 20, 2020 as discussed above, the Investor purchased Series A Warrants to purchase
up to <span id="xdx_902_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_c20200320__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAWarrantsMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_pdd">11,250
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">shares of Common Stock, subject
to adjustment as provided therein. The Series A Warrants have a cash exercise price of $<span id="xdx_908_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20200320__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAWarrantsMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_znZkfKlQtxk1">200
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">per share and are immediately exercisable
and expire in <span id="xdx_906_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20200320__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAWarrantsMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_zl1crbhLsald">3
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">years. The Series A Warrants contain
a provision for cashless exercise in the event there is no effective registration statement registering the shares underlying the Series
A Warrants calculated based on the difference between the exercise price of the Series A Warrant and the trading price of the stock (the
&#8220;Cashless Exercise&#8221;).Additionally, the Series A Warrants contain a provision for a cashless conversion at the Holder&#8217;s
option should the trading price of the Common Stock fall below $200 per share calculated based on the difference between the exercise
price of the Series A Warrant and 70% of the Market Price, as defined therein (the&#8221; Alternate Cashless Exercise&#8221;). See
above &#8220;Shares issued for exercise of warrants&#8221; for discussion of deemed dividend related to alternate cashless exercise.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><i><span style="text-decoration: underline">Series
B Warrants</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Pursuant
to the Securities Purchase Agreement entered into March 20, 2020 as discussed above, the Investor purchased Series B Warrants to purchase
up to <span id="xdx_901_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_c20200320__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantsMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_pdd" title="Warrants to purchase common stock">63,750</span> shares of Common Stock, subject to adjustment as provided therein; provided, however, commencing on the 90th day following
the effective date, the Company may reduce the number of Warrant Shares issuable upon exercise thereof by <span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_c20200319__20200320__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantsMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_pdd" title="Warrants exercisable">37,500</span> upon <span id="xdx_900_eus-gaap--DebtInstrumentConvertibleThresholdTradingDays_uInteger_c20200319__20200320__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantsMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_zDspqr2NeLf9" title="Trading days">10</span> Trading Days&#8217;
prior written notice to the Holder provided that the Company issues to the Holder <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20200319__20200320__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantsMember__srt--TitleOfIndividualAxis__custom--HolderMember_pdd" title="Common stock issued during period">3,750</span> shares of Common Stock (or, at the election of
the Holder, an equivalent number of pre-funded warrants) and Series A Warrants to purchase up to <span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_c20200320__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantsMember_pdd" title="Warrants to purchase common stock">3,750</span> shares of Common Stock, which
shares shall be issued pursuant to a registration statement without restrictions on resale. The Series B Warrants have a cash exercise
price of $<span id="xdx_901_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20200320__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantsMember_pdd" title="Warrant exercise price">40</span> per share and expire in <span id="xdx_907_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20200320__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantsMember_zN926UaWdVDf" title="Warrants expiration period">3</span> years. The Series B Warrants contain a provision for Cashless Exercise.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><i><span style="text-decoration: underline">Series
C Warrants</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Pursuant
to the Securities Purchase Agreement entered into March 20, 2020 as discussed above, the Investor purchased Series C Warrants to purchase
up to <span id="xdx_900_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_c20200320__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesCWarrantsMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_pdd" title="Warrants to purchase common stock">63,750</span> shares of Common Stock, subject to adjustment as provided therein and expire in <span id="xdx_902_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20200320__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesCWarrantsMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_z69UHKqI2kwd" title="Warrants expiration period">3</span> years. The Series C Warrants have a cash
exercise price of $<span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20200320__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesCWarrantsMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_pdd" title="Warrant exercise price">200</span> per share, subject to a vesting schedule, which is based on such Holder&#8217;s exercise of the Series B Warrants
(warrants shall be exercisable ratably upon exercise of Series B Warrants). The Series C Warrants contain provisions for Cashless Exercise
and Alternate Cashless Exercise.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>PROPANC
BIOPHARMA, INC. AND SUBSIDIARY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>June
30, 2021 and 2020</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><i>Exercise
of Warrants</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">During
the year ended June 30, 2021, the Company received aggregate gross proceeds of $<span id="xdx_904_eus-gaap--ProceedsFromWarrantExercises_pp0p0_c20200701__20210630_z2lmrQItX9F7" title="Proceeds from warrants exercise">776,044</span> from the exercise of <span id="xdx_906_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20210630__us-gaap--StatementClassOfStockAxis__custom--PrefundedWarrantsMember_zS4wx0bIvvIk" title="Warrants exercised">10,445</span> prefunded warrants
and <span id="xdx_906_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20210630__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantsMember_zE8DxnoN1jSj" title="Warrants exercised">19,375</span> Series B Warrants resulting in the issuance of <span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20200701__20210630__us-gaap--StatementClassOfStockAxis__custom--PrefundedWarrantsMember_ziuvGbTAgpK" title="Stock issued during period">29,820</span> shares of common stock. Additionally, the Company issued <span id="xdx_90F_eus-gaap--CommonStockSharesIssued_iI_c20210630__us-gaap--StatementClassOfStockAxis__custom--TwentySeriesAAndOneSeriesCWarrantsMember_zfRYfFir6jVa" title="Common stock, shares issued">4,199,979</span> shares
of common stock from the alternate cashless exercise of 20 Series A and 1 Series C warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm140460440375800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">COMMITMENTS AND CONTINGENCIES</a></td>
<td class="text"><p id="xdx_802_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zlQYr0RERxR7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTE
8 &#8211; <span id="xdx_822_zCvLoL184dke">COMMITMENTS AND CONTINGENCIES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><b>Legal
Matters </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">From
time to time, the Company may be subject to litigation and claims arising in the ordinary course of business. The Company is not currently
a party to any material legal proceedings and the Company is not aware of any pending or threatened legal proceeding against the Company
that we believe could have a material adverse effect on our business, operating results, cash flows or financial condition.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>PROPANC
BIOPHARMA, INC. AND SUBSIDIARY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>SEPTEMBER
30, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Unaudited)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>IRS
Liability</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">As
part of its requirement for having a foreign operating subsidiary, the Company&#8217;s parent U.S. entity is required to file an informational
Form 5471 to the Internal Revenue Service (the &#8220;IRS&#8221;), which is a form that explains the nature of the relationship between
the foreign subsidiary and the parent company. From 2012 through the 2014, the Company did not file this form in a timely manner. As
a result of the non-timely filings, the Company incurred a penalty from the IRS in the amount of $<span id="xdx_908_ecustom--LitigationPenaltyAmount_pp0p0_c20210701__20210930__us-gaap--AwardDateAxis__custom--From2012ThroughThe2014Member_zQxZ2XzPp4id">10,000</span> per year, or $<span id="xdx_904_ecustom--LitigationPenaltyAmount_pp0p0_c20210701__20210930_zzLqRmwYUTjb">30,000</span> in total,
plus accrued interest, such penalty and interest having been accrued and is included in the accrued expenses and other payable figure
in the September 30, 2021 and June 30, 2021 consolidated balance sheet. The Company recorded the penalties for all three years during
the year ended June 30, 2018. The Company is current on all subsequent filings. The Company&#8217;s tax advisor is awaiting a response
from the IRS on this matter.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Operating
Agreements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">In
November 2009, the Company entered into a commercialization agreement with the University of Bath (UK) (the &#8220;University&#8221;)
whereby the Company and the University co-owned the intellectual property relating to the Company&#8217;s pro-enzyme formulations. In
June 2012, the Company and the University entered into an assignment and amendment whereby the Company assumed full ownership of the
intellectual property while agreeing to pay royalties of<span id="xdx_902_ecustom--OperatingLeasesIncomeStatementRevenuePercentage_dp_uPure_c20120601__20120630__us-gaap--TypeOfArrangementAxis__us-gaap--RoyaltyAgreementTermsMember_ztyPmoOVl0m"> 2</span>% of net revenues to the University. Additionally, the Company agreed to pay
<span id="xdx_90B_ecustom--OperatingLeasesIncomeStatementRevenuePercentage_dp_uPure_c20120601__20120630__us-gaap--TypeOfArrangementAxis__us-gaap--LicenseAgreementTermsMember_zjfHUvOqUBS5">5</span>% of each and every license agreement subscribed for. The contract is cancellable at any time by either party. To date, no amounts are
owed under the agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><b>Collaboration
Agreement</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On
September 13, 2018, the Company entered into a two-year collaboration agreement with the University of Ja&#233;n (the &#8220;University&#8221;)
to provide certain research services to the Company. In consideration of such services, the Company agreed to pay the University approximately
<span id="xdx_90F_ecustom--PaymentForServices_pp0p0_uEuro_c20180910__20180913__us-gaap--TypeOfArrangementAxis__custom--OneYearCollaborationAgreementMember__us-gaap--AwardTypeAxis__custom--EurosMember_zWkpdfYYRu61">52,000</span> Euros ($<span id="xdx_900_ecustom--PaymentForServices_pp0p0_c20180910__20180913__us-gaap--TypeOfArrangementAxis__custom--OneYearCollaborationAgreementMember_zUd5vTOCzQ34">59,508</span> USD) in year one and a maximum of <span id="xdx_900_ecustom--PaymentForServices_pp0p0_uEuro_c20180910__20180913__us-gaap--TypeOfArrangementAxis__custom--TwoYearCollaborationAgreementMember__us-gaap--AwardTypeAxis__custom--EurosMember_zP8v6QHtLfga">40,000</span> Euros ($<span id="xdx_900_ecustom--PaymentForServices_pp0p0_c20180910__20180913__us-gaap--TypeOfArrangementAxis__custom--TwoYearCollaborationAgreementMember_zkNNmUWYmXW5">45,775</span> USD) in year two. The Company paid <span id="xdx_90E_ecustom--PaymentForServices_pp0p0_uEuro_c20180701__20190630__us-gaap--AwardTypeAxis__custom--EurosMember_zV6KLypjQpK3">31,754</span> Euros ($<span id="xdx_907_ecustom--PaymentForServices_pp0p0_c20180701__20190630_z1VrPbRQIVrf">36,117</span>
USD) in 2019 and has accrued <span id="xdx_90E_ecustom--PaymentForServices_pp0p0_uEuro_c20200701__20210630__us-gaap--AwardTypeAxis__custom--EurosMember_z72xtbmgu1gc">28,493</span> Euros ($<span id="xdx_90C_ecustom--PaymentForServices_pp0p0_c20200701__20210630_zHpjlYof1Kx6">24,043</span> USD) as of June 30, 2021. Additionally, in exchange for full ownership of the intellectual
property the Company agreed to pay royalties of <span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20180910__20180913__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--RevenueFromRightsConcentrationRiskMember__srt--MajorCustomersAxis__custom--NoCustomerMember_zsWXu5YUxfk8">2</span>% of net revenues to the University. On October 1, 2020, the Company entered into another
two-year collaboration agreement with the University of Ja&#233;n to provide certain research services to the Company. In consideration
of such services, the Company agreed to pay the University approximately <span id="xdx_90E_ecustom--PaymentForServices_pp0p0_uEuro_c20200929__20201002__us-gaap--TypeOfArrangementAxis__custom--TwoYearCollaborationAgreementMember__us-gaap--AwardTypeAxis__custom--EurosMember_zD31kIGGvFNg">30,000</span> Euros ($<span id="xdx_90C_ecustom--PaymentForServices_pp0p0_c20200929__20201002__us-gaap--TypeOfArrangementAxis__custom--TwoYearCollaborationAgreementMember_z6moICqqXWrg">35,145</span> USD) which shall be paid in four installment
payment of <span id="xdx_90D_ecustom--PaymentForServices_pp0p0_uEuro_c20200929__20201002__us-gaap--TypeOfArrangementAxis__custom--TwoYearCollaborationAgreementMember__us-gaap--AwardTypeAxis__custom--EurosMember__us-gaap--AwardDateAxis__custom--InstallmentOneMember_zasnD79JF5wh">5,000</span> Euros in November 2020, <span id="xdx_90F_ecustom--PaymentForServices_pp0p0_uEuro_c20200929__20201002__us-gaap--TypeOfArrangementAxis__custom--TwoYearCollaborationAgreementMember__us-gaap--AwardDateAxis__custom--InstallmentTwoMember__us-gaap--AwardTypeAxis__custom--EurosMember_zIeQW14upxB2">5,000</span> Euros ($<span id="xdx_908_ecustom--PaymentForServices_pp0p0_c20200929__20201002__us-gaap--TypeOfArrangementAxis__custom--TwoYearCollaborationAgreementMember__us-gaap--AwardDateAxis__custom--InstallmentTwoMember_zxmP75oLG7Ne">5,858</span>) in March 2021, <span id="xdx_906_ecustom--PaymentForServices_pp0p0_uEuro_c20200929__20201002__us-gaap--TypeOfArrangementAxis__custom--TwoYearCollaborationAgreementMember__us-gaap--AwardDateAxis__custom--InstallmentThreeMember__us-gaap--AwardTypeAxis__custom--EurosMember_zYSrA2OWPOq7">10,000</span> Euros ($<span id="xdx_90B_ecustom--PaymentForServices_pp0p0_c20200929__20201002__us-gaap--TypeOfArrangementAxis__custom--TwoYearCollaborationAgreementMember__us-gaap--AwardDateAxis__custom--InstallmentThreeMember_zQDYB0y5rfZe">11,715</span>) in December 2021 and <span id="xdx_902_ecustom--PaymentForServices_pp0p0_uEuro_c20200929__20201002__us-gaap--TypeOfArrangementAxis__custom--TwoYearCollaborationAgreementMember__us-gaap--AwardDateAxis__custom--InstallmentFourMember__us-gaap--AwardTypeAxis__custom--EurosMember_zaZTGriMJiI1">10,000</span> Euros
($<span id="xdx_901_ecustom--PaymentForServices_pp0p0_c20200929__20201002__us-gaap--TypeOfArrangementAxis__custom--TwoYearCollaborationAgreementMember__us-gaap--AwardDateAxis__custom--InstallmentFourMember_zDU0Szg140si">11,715</span>) in September 2022. Additionally, the University shall hire and train a doctoral student for this project and as such the Company
shall pay the University <span id="xdx_90D_ecustom--PaymentForServices_pp0p0_uEuro_c20200929__20201002__dei--LegalEntityAxis__custom--UniversityOfJaenMember__us-gaap--AwardTypeAxis__custom--EurosMember_z2miFiRl7Wj1" title="Payment for services">25,837</span> Euros ($<span id="xdx_909_ecustom--PaymentForServices_pp0p0_c20200929__20201002__dei--LegalEntityAxis__custom--UniversityOfJaenMember_z20xuqnj98dl" title="Payment for services">30,268</span> USD). In exchange for full ownership of the intellectual property the Company agreed to
pay royalties of<span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20200929__20201002__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__dei--LegalEntityAxis__custom--UniversityOfJaenMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--RevenueFromRightsConcentrationRiskMember__srt--MajorCustomersAxis__custom--NoCustomerMember_zp48BunMv2Bj" title="Royalties percentage"> 2</span>% of net revenues to the University.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_806_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zL2iu8rkR7El" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>NOTE
9 &#8211; <span id="xdx_82D_zoKrhnxDRVm6">COMMITMENTS AND CONTINGENCIES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>Legal
Matters</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">On
September 26, 2019, a complaint was filed against the Company with Supreme Court of the State of New York, County of New York, by Foley
Shechter Ablovatskiy LLP (&#8220;Foley Shechter&#8221;), our former counsel, seeking $<span id="xdx_901_eus-gaap--LegalFees_c20190925__20190926__srt--TitleOfIndividualAxis__custom--FoleyShechterMember_pp0p0">151,031
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">in professional fees allegedly
owed, in addition to interest and costs of suit. The Company filed an answer, together with affirmative defenses and counterclaims. Certain
amounts related to this claim were included in accounts payable and accrued expenses in the accompanying consolidated financial statements
at June 30, 2020. On March 22, 2021, the Company entered into a settlement agreement with Foley Shechter whereby both parties
agreed to settle all claims for professional fees owed for a total of $<span id="xdx_907_eus-gaap--ProfessionalFees_c20210320__20210322__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementMember__srt--TitleOfIndividualAxis__custom--FoleyShechterMember_pp0p0">51,032</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">.
The Company paid the settlement amount of $<span id="xdx_90B_ecustom--SettlementAmount_c20210322__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementMember__srt--TitleOfIndividualAxis__custom--FoleyShechterMember_pp0p0">51,032
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">on March 22, 2021. Prior to the
settlement agreement, the Company recorded total accounts payable and accrued expenses $<span id="xdx_909_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_iI_pp0p0_c20210322__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementMember__srt--TitleOfIndividualAxis__custom--FoleyShechterMember_zpXBVNIVgbjl">142,660</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">.
Accordingly, the Company recognized gain from settlement of debt of <span id="xdx_901_ecustom--GainLossFromSettlementOfDebt_c20200701__20210630__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementMember__srt--TitleOfIndividualAxis__custom--FoleyShechterMember_pp0p0">$92,556
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">during the year ended June
30, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Regal
Consulting, LLC (&#8220;Regal&#8221;) initiated litigation against the Company in Clark County District Court, Nevada. Regal was demanding
approximately $<span id="xdx_906_eus-gaap--LossContingencyDamagesSoughtValue_c20200701__20210630__dei--LegalEntityAxis__custom--RegalConsultingLLCMember_pp0p0" title="Loss contingency amount">400,000</span> and <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20200701__20210630__dei--LegalEntityAxis__custom--RegalConsultingLLCMember_pdd" title="Number of shares issued for services">60</span> shares of the Company&#8217;s common stock as payment for services that Regal purports to have performed.
Regal additionally claimed that $<span id="xdx_908_eus-gaap--ConvertibleDebt_c20170531__dei--LegalEntityAxis__custom--RegalConsultingLLCMember__us-gaap--DebtInstrumentAxis__custom--TwoThousandAndSeventeenNoteMember_pp0p0" title="Convertible note">106,500</span> remained due on a Convertible Note executed by the Company in May of 2017 and asserted that
it was owed in excess of $<span id="xdx_90C_ecustom--LitigationPenaltyAmount_c20170501__20170531__dei--LegalEntityAxis__custom--RegalConsultingLLCMember__us-gaap--DebtInstrumentAxis__custom--TwoThousandAndSeventeenNoteMember_pp0p0" title="Penalty amount">100,000</span> in penalties in connection with the Company&#8217;s refusal to honor certain Conversion Notices. The
Company filed an Answer and Counterclaim, denying liability and alleging that Regal procured by fraud the Company&#8217;s execution of
various consulting agreements and additionally failed to provide the consulting services contemplated by said agreements. On December
23, 2020, the parties mediated their dispute and negotiated a settlement agreement. On March 15, 2021, the Company entered into a Settlement
and Mutual Release Agreement with Regal whereby both parties agreed to settle all claims and liabilities under the August 10, 2017 Convertible
note (see Note 6) for a total of $<span id="xdx_909_eus-gaap--ConvertibleDebt_c20170810__us-gaap--TypeOfArrangementAxis__custom--SettlementAndMutualReleaseAgreementMember__dei--LegalEntityAxis__custom--RegalConsultingLLCMember_pp0p0" title="Convertible note">100,000</span>. All other terms of the August 10, 2017 Convertible Note shall remain in full force and effect.
Both parties agree that all future penalties under this convertible note are waived unless the Company fails to authorize the issuance
of the requested shares upon conversion. The Company has the right to pay off the balance of any remaining amounts dues under this convertible
note in cash at any time 61 days after March 15, 2021. Prior to the Settlement Agreement, the Company recorded total liabilities $<span id="xdx_904_eus-gaap--Liabilities_c20210315__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementMember_pp0p0" title="Liabilities">56,762</span>
consisting of remaining principal amount of $<span id="xdx_909_ecustom--RemainingPrincipalAmount_c20210315__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementMember_pp0p0" title="Remaining principal amount">8,500</span>, accrued interest of $<span id="xdx_90C_eus-gaap--InterestPayableCurrentAndNoncurrent_c20210315__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementMember_pp0p0" title="Accrued interest">23,262</span> and accrued expenses of $<span id="xdx_906_eus-gaap--AccruedLiabilitiesCurrentAndNoncurrent_c20210315__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementMember_pp0p0" title="Accrued expenses">25,000</span>. Accordingly, the Company
recognized loss from settlement of debt of $<span id="xdx_90A_ecustom--GainLossFromSettlementOfDebt_c20200701__20210630__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementMember_pp0p0" title="Gain loss from settlement of debt">43,238</span> during the year ended June 30, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>IRS
Liability</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">As
part of its requirement for having a foreign operating subsidiary, the Company&#8217;s parent U.S. entity is required to file an informational
Form 5471 to the Internal Revenue Service (the &#8220;IRS&#8221;), which is a form that explains the nature of the relationship between
the foreign subsidiary and the parent company. From 2012 through the 2014, the Company did not file this form in a timely manner. As
a result of the non-timely filings, the Company incurred a penalty from the IRS in the amount of $<span id="xdx_90D_ecustom--LitigationPenaltyAmount_c20200701__20210630__us-gaap--AwardDateAxis__custom--From2012ThroughThe2014Member_pp0p0">10,000
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">per year, or $<span id="xdx_900_ecustom--LitigationPenaltyAmount_c20200701__20210630_pp0p0">30,000
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">in total, plus accrued interest,
such penalty and interest having been accrued and is included in the accrued expenses and other payable figure in the June
30, 2021 and 2020 consolidated balance sheet. The Company recorded the penalties for all three years during the year ended June 30,
2018. The Company is current on all subsequent filings. The Company&#8217;s tax advisor is awaiting a response from the IRS on this matter.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>Operating
Agreements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 29.15pt; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">In
November 2009, the Company entered into a commercialization agreement with the University of Bath (UK) (the &#8220;University&#8221;)
whereby the Company and the University co-owned the intellectual property relating to the Company&#8217;s pro-enzyme formulations. In
June 2012, the Company and the University entered into an assignment and amendment whereby the Company assumed full ownership of the
intellectual property while agreeing to pay royalties of <span id="xdx_903_ecustom--OperatingLeasesIncomeStatementRevenuePercentage_dp_c20120601__20120630__us-gaap--TypeOfArrangementAxis__us-gaap--RoyaltyAgreementTermsMember_ztXEIiIkqski" title="Operating leases income statement revenue percentage">2%</span> of net revenues to the University. Additionally, the Company agreed to pay
<span id="xdx_90D_ecustom--OperatingLeasesIncomeStatementRevenuePercentage_dp_c20120601__20120630__us-gaap--TypeOfArrangementAxis__us-gaap--LicenseAgreementTermsMember_z9T7IV0czYM7" title="Operating leases income statement revenue percentage">5%</span> of each and every license agreement subscribed for. The contract is cancellable at any time by either party. To date, no amounts are
owed under the agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>Operating
Leases</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">On
May 5, 2016, the Company entered into a new <span id="xdx_900_eus-gaap--LesseeOperatingLeaseTermOfContract_iI_dtYxL_c20160505__us-gaap--TypeOfArrangementAxis__custom--NewFiveYearOperatingLeaseAgreementMember_z8w18Ofpt9n3" title="::XDX::5"><span style="-sec-ix-hidden: xdx2ixbrl2171">five</span></span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">-year
operating lease agreement with a Horizon Pty Ltd., a related party, of which Mr. Nathanielsz, our CEO, CFO and a director, and his
wife are owners and directors, with monthly rent currently at $<span id="xdx_90A_eus-gaap--PaymentsForRent_pp0p0_uAUD_c20160503__20160505__us-gaap--TypeOfArrangementAxis__custom--NewFiveYearOperatingLeaseAgreementMember__us-gaap--AwardTypeAxis__custom--AUDCurrencyMember_zJAHfK5JtGu7">3,606 </span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">AUD
or $<span id="xdx_906_eus-gaap--PaymentsForRent_c20160503__20160505__us-gaap--TypeOfArrangementAxis__custom--NewFiveYearOperatingLeaseAgreementMember_pp0p0">2,469 </span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">USD,
inclusive of GST (See Note 10 &#8211; Related Party Transactions). <span id="xdx_906_eus-gaap--LesseeOperatingLeaseDescription_c20160503__20160505__us-gaap--TypeOfArrangementAxis__custom--NewFiveYearOperatingLeaseAgreementMember_zUVwnKDgQfVb" title="Operating lease, description">The
initial rental amount was $3,000 AUD and subject to 3% yearly escalation.</span></span> <span style="font: 10pt Times New Roman, Times, Serif; color: Black">In
adopting ASC Topic 842, Leases (Topic 842), the Company has elected the &#8216;package of practical expedients&#8217;, which permit
it not to reassess under the new standard its prior conclusions about lease identification, lease classification and initial direct
costs. In addition, the Company elected not to apply ASC Topic 842 to arrangements with lease terms of 12 month or less. On July 1,
2019, upon adoption of ASC Topic 842, the Company recorded right-of-use assets $<span id="xdx_901_eus-gaap--OperatingLeaseRightOfUseAsset_c20190702__us-gaap--AdjustmentsForNewAccountingPronouncementsAxis__us-gaap--AccountingStandardsUpdate201602Member_pp0p0">48,662 </span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">and
total lease liabilities of $<span id="xdx_906_eus-gaap--OperatingLeaseLiability_c20190702__us-gaap--AdjustmentsForNewAccountingPronouncementsAxis__us-gaap--AccountingStandardsUpdate201602Member_pp0p0">48,662 </span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">based
on an incremental borrowing rate of <span id="xdx_90F_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_dp_c20190702__us-gaap--AdjustmentsForNewAccountingPronouncementsAxis__us-gaap--AccountingStandardsUpdate201602Member_zF48AVxpN5Kj">6%</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">. <span><span id="xdx_90F_eus-gaap--LesseeOperatingLeaseDescription_c20190701__20190702__us-gaap--AdjustmentsForNewAccountingPronouncementsAxis__us-gaap--AccountingStandardsUpdate201602Member_zmrqDZpVZnWa">Such lease expired in May 2021 and was renewed for another one-year term from May 2021 to May 2022</span></span>. The Company is currently obligated to pay $<span id="xdx_90C_eus-gaap--PaymentsForRent_pp0p0_uAUD_c20190701__20190702__us-gaap--AdjustmentsForNewAccountingPronouncementsAxis__us-gaap--AccountingStandardsUpdate201602Member__us-gaap--AwardTypeAxis__custom--AUDCurrencyMember_zFm9VsVr4wvd">3,606</span>
AUD or $<span id="xdx_905_eus-gaap--PaymentsForRent_pp0p0_c20190701__20190702__us-gaap--AdjustmentsForNewAccountingPronouncementsAxis__us-gaap--AccountingStandardsUpdate201602Member_zMOgPlkTjwcd">2,431</span>
USD (depending on exchange rate), inclusive of tax, in rent per month.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>PROPANC
BIOPHARMA, INC. AND SUBSIDIARY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>June
30, 2021 and 2020</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p id="xdx_894_ecustom--ScheduleOfRightUseOfAssetTableTextBlock_zGoPydUjdAul" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">ROU
is summarized below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_8B3_z2t8Ilp9RHCg" style="display: none">SCHEDULE OF RIGHT USE OF ASSET</span><span style="font: 10pt Times New Roman, Times, Serif; color: Black"/></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" id="xdx_495_20210630_zoufaAcQaxUc" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>June
    30, 2021</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" id="xdx_49F_20200630_zWOmXQOOY9rc" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>June
    30, 2020</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td></tr>
  <tr id="xdx_405_ecustom--OperatingLeaseRightOfUseAssets_iI_pp0p0_maOLROUzHPs_zGh3imgPrtSe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 60%"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Office
    lease (24 months)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">48,662</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">48,662</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_406_ecustom--AccumulatedReduction_iI_pp0p0_maOLROUzHPs_zapS6yhxmXci" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Less
    accumulated amortization</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(48,662</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(26,980</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td></tr>
  <tr id="xdx_405_eus-gaap--OperatingLeaseRightOfUseAsset_iTI_pp0p0_mtOLROUzHPs_zHMqylvljI8d" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Right-of-use
    asset, net</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl2191">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">21,682</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  </table>
<p id="xdx_8A0_zZzvu0PT3Wg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p id="xdx_897_eus-gaap--OperatingLeaseLeaseIncomeTableTextBlock_z19UeNKNN7Qi" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Operating
Lease liabilities are summarized below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span id="xdx_8B0_ztmPtNJAMDuh" style="display: none">SCHEDULE OF OPERATING LEASE LIABILITY</span><span style="font: 10pt Times New Roman, Times, Serif; color: Black"/></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" id="xdx_49A_20210630_zNY5EJpe1z73" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>June
    30, 2021</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" id="xdx_49A_20200630_zWmUsQuR4raf" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>June
    30, 2020</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td></tr>
  <tr id="xdx_402_ecustom--OfficeLeaseLiability_iI_pp0p0_maOLLzN3P_zkvx3R82HVp5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Office
    lease</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">48,662</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">48,662</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_40A_ecustom--ReductionOfLeaseLiability_iI_pp0p0_maOLLzN3P_zEK3QiecFcNb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Reduction
    of lease liability</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(48,662</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(23,590</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td></tr>
  <tr id="xdx_40A_eus-gaap--OperatingLeaseLiability_iTI_pp0p0_mtOLLzN3P_zKZAcTC4Sz9l" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Long
    term portion of lease liability</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl2202">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">25,072</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  </table>
<p id="xdx_8A2_zhAaq9TCl825" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>Collaboration
Agreement</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">On
September 13, 2018, the Company entered into a two-year collaboration agreement with the University of Ja&#233;n (the &#8220;University&#8221;)
to provide certain research services to the Company. In consideration of such services, the Company agreed to pay the University approximately
<span id="xdx_90F_ecustom--PaymentForServices_pp0p0_uEuro_c20180910__20180913__us-gaap--TypeOfArrangementAxis__custom--OneYearCollaborationAgreementMember__us-gaap--AwardTypeAxis__custom--EurosMember_z8Esvlqtq8f7" title="Payment for services">52,000</span> Euros ($<span id="xdx_90D_ecustom--PaymentForServices_c20180910__20180913__us-gaap--TypeOfArrangementAxis__custom--OneYearCollaborationAgreementMember_pp0p0" title="Payment for services">59,508</span> USD) in year one and a maximum of <span id="xdx_90C_ecustom--PaymentForServices_pp0p0_uEuro_c20180910__20180913__us-gaap--TypeOfArrangementAxis__custom--TwoYearCollaborationAgreementMember__us-gaap--AwardTypeAxis__custom--EurosMember_zsw8QvfC93n2" title="Payment for services">40,000</span> Euros ($<span id="xdx_907_ecustom--PaymentForServices_c20180910__20180913__us-gaap--TypeOfArrangementAxis__custom--TwoYearCollaborationAgreementMember_pp0p0" title="Payment for services">45,775</span> USD) in year two. The Company paid <span id="xdx_90C_ecustom--PaymentForServices_pp0p0_uEuro_c20180701__20190630__us-gaap--AwardTypeAxis__custom--EurosMember_zRObpNRVjqDb" title="Payment for services">31,754</span> Euros ($<span id="xdx_903_ecustom--PaymentForServices_c20180701__20190630_pp0p0" title="Payment for services">36,117</span>
USD) in 2019 and has accrued <span id="xdx_90E_ecustom--PaymentForServices_pp0p0_uEuro_c20200701__20210630__us-gaap--AwardTypeAxis__custom--EurosMember_zZtt5T9DIDr8" title="Payment for services">28,493</span> Euros ($<span id="xdx_904_ecustom--PaymentForServices_c20200701__20210630_pp0p0" title="Payment for services">24,043</span> USD) as of June 30, 2021. Additionally, in exchange for full ownership of the intellectual
property the Company agreed to pay royalties of <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_dp_c20180910__20180913__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--RevenueFromRightsConcentrationRiskMember__srt--MajorCustomersAxis__custom--NoCustomerMember_z7mggHXKVhrc" title="Royalties percentage">2%</span> of net revenues to the University. On October 1, 2020, the Company entered into another
two-year collaboration agreement with the University of Ja&#233;n to provide certain research services to the Company. In consideration
of such services, the Company agreed to pay the University approximately <span id="xdx_90E_ecustom--PaymentForServices_pp0p0_uEuro_c20200929__20201002__us-gaap--TypeOfArrangementAxis__custom--TwoYearCollaborationAgreementMember__us-gaap--AwardTypeAxis__custom--EurosMember_ztP48PuuYROl" title="Payment for services">30,000</span> Euros ($<span id="xdx_904_ecustom--PaymentForServices_c20200929__20201002__us-gaap--TypeOfArrangementAxis__custom--TwoYearCollaborationAgreementMember_pp0p0" title="Payment for services">35,145</span> USD) which shall be paid in four installment
payment of <span id="xdx_904_ecustom--PaymentForServices_pp0p0_uEuro_c20200929__20201002__us-gaap--TypeOfArrangementAxis__custom--TwoYearCollaborationAgreementMember__us-gaap--AwardTypeAxis__custom--EurosMember__us-gaap--AwardDateAxis__custom--InstallmentOneMember_zE1rMSMFgGAk" title="Payment for services">5,000</span> Euros in November 2020, <span id="xdx_90F_ecustom--PaymentForServices_pp0p0_uEuro_c20200929__20201002__us-gaap--TypeOfArrangementAxis__custom--TwoYearCollaborationAgreementMember__us-gaap--AwardDateAxis__custom--InstallmentTwoMember__us-gaap--AwardTypeAxis__custom--EurosMember_ztKvwPExcYt2" title="Payment for services">5,000</span> Euros ($<span id="xdx_906_ecustom--PaymentForServices_c20200929__20201002__us-gaap--TypeOfArrangementAxis__custom--TwoYearCollaborationAgreementMember__us-gaap--AwardDateAxis__custom--InstallmentTwoMember_pp0p0" title="Payment for services">5,858</span>) in March 2021, <span id="xdx_908_ecustom--PaymentForServices_pp0p0_uEuro_c20200929__20201002__us-gaap--TypeOfArrangementAxis__custom--TwoYearCollaborationAgreementMember__us-gaap--AwardDateAxis__custom--InstallmentThreeMember__us-gaap--AwardTypeAxis__custom--EurosMember_zxu4BWFl0ja" title="Payment for services">10,000</span> Euros ($<span id="xdx_909_ecustom--PaymentForServices_c20200929__20201002__us-gaap--TypeOfArrangementAxis__custom--TwoYearCollaborationAgreementMember__us-gaap--AwardDateAxis__custom--InstallmentThreeMember_pp0p0" title="Payment for services">11,715</span>) in December 2021 and <span id="xdx_902_ecustom--PaymentForServices_pp0p0_uEuro_c20200929__20201002__us-gaap--TypeOfArrangementAxis__custom--TwoYearCollaborationAgreementMember__us-gaap--AwardDateAxis__custom--InstallmentFourMember__us-gaap--AwardTypeAxis__custom--EurosMember_z8iModjJQVl" title="Payment for services">10,000</span> Euros
($<span id="xdx_900_ecustom--PaymentForServices_c20200929__20201002__us-gaap--TypeOfArrangementAxis__custom--TwoYearCollaborationAgreementMember__us-gaap--AwardDateAxis__custom--InstallmentFourMember_pp0p0" title="Payment for services">11,715</span>) in September 2022. Additionally, the University shall hire and train a doctoral student for this project and as such the Company
shall pay the University <span id="xdx_909_ecustom--PaymentForServices_pp0p0_uEuro_c20200929__20201002__dei--LegalEntityAxis__custom--UniversityOfJaenMember__us-gaap--AwardTypeAxis__custom--EurosMember_zktznTOCKlk2" title="Payment for services">25,837</span> Euros ($<span id="xdx_900_ecustom--PaymentForServices_c20200929__20201002__dei--LegalEntityAxis__custom--UniversityOfJaenMember_pp0p0" title="Payment for services">30,268</span> USD). In exchange for full ownership of the intellectual property the Company agreed to
pay royalties of <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_dp_c20200929__20201002__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__dei--LegalEntityAxis__custom--UniversityOfJaenMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--RevenueFromRightsConcentrationRiskMember__srt--MajorCustomersAxis__custom--NoCustomerMember_z4ZzunSRlP18" title="Royalties percentage">2%</span> of net revenues to the University.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm140460432849096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RELATED PARTY TRANSACTIONS<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">RELATED PARTY TRANSACTIONS</a></td>
<td class="text"><p id="xdx_807_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zKlAkoBh8Ygj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTE 9 &#8211; <span id="xdx_82E_zfYxozwsc66">RELATED PARTY TRANSACTIONS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">Since
its inception, the Company has conducted transactions with its directors and entities related to such directors. These transactions have
included the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">As
of September 30, 2021 and June 30, 2021, the Company owed its former director a total of $<span id="xdx_90B_ecustom--LoansFromRelatedParty_iI_pp0p0_c20210930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--CurrentAndFormerDirectorMember_zu4z5AeLtI9k">53,384</span> and $<span id="xdx_902_ecustom--LoansFromRelatedParty_iI_pp0p0_c20210630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--CurrentAndFormerDirectorMember_z5vSFOs05k61">55,500</span>, respectively, for money
loaned to the Company throughout the years. The total loans balance owed at September 30, 2021 and June 30, 2021 is not interest bearing
(See Note 5 &#8211; Loans and Notes Payable).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">As
of September 30, 2021 and June 30, 2021, the Company owed its former director a total of $<span id="xdx_901_eus-gaap--DueToRelatedPartiesCurrent_iI_pp0p0_c20210930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--FormerDirectorMember_zyDfm48jFJXk">32,076 </span>and $<span id="xdx_90F_eus-gaap--DueToRelatedPartiesCurrent_iI_pp0p0_c20210630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--FormerDirectorMember_zJRtMxjGmrnk">33,347</span>, respectively, related to
expenses paid on behalf of the Company related to corporate startup costs and intellectual property (See Note 4 &#8211; Due to Former
Director &#8211; Related Party).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On
May 6, 2021, the Company entered into an agreement for the lease of its principal executive offices with North Horizon Pty Ltd., a related
party, of which Mr. Nathanielsz, our CEO, CFO and a director, and his wife are owners and directors. The lease has a one-year term commencing
May 6, 2021, and the Company is currently obligated to pay $<span id="xdx_904_ecustom--OperatingLeasesRentExpenseMinimumRentalsPayable_pp0p0_uAUD_c20210503__20210506__dei--LegalEntityAxis__custom--NorthHorizonPtyLtdMember__us-gaap--AwardTypeAxis__custom--AUDCurrencyMember_zixN4Doi7VDc">3,606</span> AUD or $<span id="xdx_90B_ecustom--OperatingLeasesRentExpenseMinimumRentalsPayable_pp0p0_c20210505__20210506__dei--LegalEntityAxis__custom--NorthHorizonPtyLtdMember_z9r7nz638Nel">2,431</span> USD (depending on exchange rate), inclusive of tax, in
rent per month. During the three months ended September 30, 2021 and 2020, rent expense amounted $<span id="xdx_90F_ecustom--OperatingLeasesRentExpenseMinimumRentalsPayable_pp0p0_uAUD_c20210701__20210930__dei--LegalEntityAxis__custom--NorthHorizonPtyLtdMember__us-gaap--AwardTypeAxis__custom--AUDCurrencyMember_zgF0qADjup7d">7,735</span> USD and $<span id="xdx_906_ecustom--OperatingLeasesRentExpenseMinimumRentalsPayable_pp0p0_uAUD_c20200701__20210930__dei--LegalEntityAxis__custom--NorthHorizonPtyLtdMember__us-gaap--AwardTypeAxis__custom--AUDCurrencyMember_zsHWq5i1kMUg">9,204</span> USD. As of September
30, 2021, total rent payable of $<span id="xdx_90A_eus-gaap--PaymentsForRent_pp0p0_uAUD_c20210701__20210930__dei--LegalEntityAxis__custom--NorthHorizonPtyLtdMember__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember_zuGpOsanB7bl">84,000</span>AUD ($<span id="xdx_908_eus-gaap--PaymentsForRent_pp0p0_c20210701__20210930__dei--LegalEntityAxis__custom--NorthHorizonPtyLtdMember_zN2LIz6ibnt3">60,598</span> USD) is included in accrued expenses in the accompanying condensed consolidated balance
sheet.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>PROPANC
                                            BIOPHARMA, INC. AND SUBSIDIARY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>SEPTEMBER
30, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Unaudited)</b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><i>Employment
and Services Agreements with Management</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
Company and Mr. Nathanielsz entered into an employment agreement as of February 25, 2015 (the &#8220;Nathanielsz Employment Agreement&#8221;)
setting forth the terms and conditions of Mr. Nathanielsz employment as the Company&#8217;s President and Chief Executive Officer. The
Nathanielsz Employment Agreement was scheduled to expire on <span id="xdx_90A_eus-gaap--RelatedPartyTransactionDate_dd_c20150224__20150225__us-gaap--TypeOfArrangementAxis__custom--NathanielszEmploymentAgreementMember_zI4E8tN5aqd3">February 25, 2019</span>; however, the term of the Nathanielsz Employment Agreement
automatically renews for successive one-year periods unless either party provides 30 days&#8217; prior written notice of its intent not
to renew. The Nathanielsz Employment Agreement continues in effect as of September 30, 2021 as amended May 14, 2019 (see below). The
Nathanielsz Employment Agreement provides Mr. Nathanielsz with a base salary of $<span id="xdx_909_eus-gaap--SalariesAndWages_pp0p0_uAUD_c20150224__20150225__us-gaap--TypeOfArrangementAxis__custom--NathanielszEmploymentAgreementMember__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember_zJDZdvgnTkLj">25,000</span> AUD per month ($<span id="xdx_901_eus-gaap--SalariesAndWages_pp0p0_uAUD_c20200701__20210630__us-gaap--TypeOfArrangementAxis__custom--NathanielszEmploymentAgreementMember__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember_zXJRrgHAZ558">300,000</span> AUD annually or $<span id="xdx_907_eus-gaap--SalariesAndWages_pp0p0_c20200701__20210630__us-gaap--TypeOfArrangementAxis__custom--NathanielszEmploymentAgreementMember_zstiGJmSWXna">205,680</span>
USD) and a monthly contribution to Mr. Nathanielsz&#8217;s pension equal to <span id="xdx_90E_ecustom--PercentageOfPensionOfMonthlySalary_dp_uPure_c20200701__20210630__us-gaap--TypeOfArrangementAxis__custom--NathanielszEmploymentAgreementMember_zrBF7nyxe6Vk">9.5</span>% of his monthly salary. Mr. Nathanielsz has the ability
to convert any accrued but unpaid salary into common stock at the end of each fiscal year at a conversion price to be determined by Mr.
Nathanielsz and the Company, which will in no event be lower than par value or higher than the closing bid price on the date of conversion.
Pursuant to the Nathanielsz Employment Agreement, Mr. Nathanielsz is entitled to an annual discretionary bonus in an amount up to <span id="xdx_908_ecustom--PercentageOfBonusOfAnnualBaseSalary_dp_uPure_c20200701__20210630__us-gaap--TypeOfArrangementAxis__custom--NathanielszEmploymentAgreementMember_zEa6kqt2K3ah">200</span>%
of his annual base salary, which bonus shall be determined by the Company&#8217;s board of directors based upon the performance of the
Company. On March 16, 2018, the Company&#8217;s board of directors approved an increase of Mr. Nathanielsz&#8217;s annual base salary
from $<span id="xdx_90F_eus-gaap--SalariesAndWages_pp0p0_uAUD_c20180315__20180316__us-gaap--TypeOfArrangementAxis__custom--NathanielszEmploymentAgreementMember__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember__srt--RangeAxis__srt--MinimumMember_zpO1KbgMpXXg">300,000</span> AUD ($<span id="xdx_903_eus-gaap--SalariesAndWages_pp0p0_c20180315__20180316__us-gaap--TypeOfArrangementAxis__custom--NathanielszEmploymentAgreementMember__srt--RangeAxis__srt--MinimumMember_z1SrYaSg60oj">205,680</span> USD) to $<span id="xdx_90D_eus-gaap--SalariesAndWages_pp0p0_uAUD_c20180315__20180316__us-gaap--TypeOfArrangementAxis__custom--NathanielszEmploymentAgreementMember__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember__srt--RangeAxis__srt--MaximumMember_zPmO0V9mQS5l">400,000</span> AUD ($<span id="xdx_90A_eus-gaap--SalariesAndWages_pp0p0_c20180315__20180316__us-gaap--TypeOfArrangementAxis__custom--NathanielszEmploymentAgreementMember__srt--RangeAxis__srt--MaximumMember_zGMywGh0zlDi">274,240</span> USD), effective February 2018.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">Mr.
Nathanielsz&#8217;s wife, Sylvia Nathanielsz, is and has been a non-executive part-time employee of the Company since October 2015. Effective
February 1, 2018, Mrs. Nathanielsz receives an annual salary of $<span id="xdx_905_eus-gaap--SalariesAndWages_pp0p0_uAUD_c20180128__20180201__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrsNathanielszMember__us-gaap--AwardTypeAxis__custom--AUDCurrencyMember_zpt8r7SDyqC">120,000</span> AUD ($<span id="xdx_908_eus-gaap--SalariesAndWages_pp0p0_c20180128__20180201__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrsNathanielszMember_zeFkmrh0GVG7">80,904</span> USD) and is entitled to customary benefits.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">Pursuant
to a February 25, 2016 board resolution, James Nathanielsz shall be paid $<span id="xdx_900_eus-gaap--RepaymentsOfRelatedPartyDebt_pp0p0_uAUD_c20160224__20160225__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--JamesNathanielszMember__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember_zbKQTZIJ2y6k">4,481</span> AUD ($<span id="xdx_905_eus-gaap--RepaymentsOfRelatedPartyDebt_pp0p0_c20160224__20160225__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--JamesNathanielszMember_zKZ9cCX8kI18">3,205</span> USD), on a monthly basis for the purpose
of acquiring and maintaining an automobile. For the three months ended September 30, 2021, a total of $$<span id="xdx_900_eus-gaap--RepaymentsOfRelatedPartyDebt_pp0p0_uAUD_c20210701__20210930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrsNathanielszMember__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember_zTrwbJSefWM7">7,689</span> AUD ($<span id="xdx_908_eus-gaap--RepaymentsOfRelatedPartyDebt_pp0p0_c20210701__20210930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrsNathanielszMember_zhIrUC9nNUTa">5,651</span> USD) in payments
have been made with respect to Mr. Nathanielsz&#8217;s car allowance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">Pursuant to the approval of the Company&#8217;s board of directors, on May 14, 2019, Mr. Nathanielsz was granted a $<span id="xdx_90D_eus-gaap--OfficersCompensation_pp0p0_uAUD_c20190513__20190514__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsMember__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember_zTCWArOO88eh">460,000</span> AUD ($<span id="xdx_90D_eus-gaap--OfficersCompensation_pp0p0_c20190513__20190514__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsMember_ziLfYVoEFR9d">315,376</span> USD) bonus for accomplishments achieved while serving as the Company&#8217;s Chief Executive Officer during the fiscal year ended June 30, 2019 with $<span id="xdx_90A_ecustom--BonusPayableAmount_pp0p0_uAUD_c20180701__20190630__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember_z9peavSiI6S6">200,000</span> AUD ($<span id="xdx_907_ecustom--BonusPayableAmount_pp0p0_c20180701__20190630__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zoZALS8lNCF3">137,120</span> USD) of such bonus payable by the Corporation to the CEO throughout the Corporation&#8217;s 2019 fiscal
year as the Corporation&#8217;s cash resources allow, with the remaining $<span id="xdx_902_ecustom--RemainingBonusAmount_pp0p0_uAUD_c20180701__20190630__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember_zceybiYGVKJd">260,000</span> AUD ($<span title="[custom:RemainingBonusAmount]"><span id="xdx_906_ecustom--RemainingBonusAmount_pp0p0_c20180701__20190630__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_z3Li8Y1WayYi">178,256</span></span> USD) of such bonus to be deferred by the CEO until a future date when the Corporation&#8217;s cash resources allow for such payment, as agreed to by the CEO. A total of $<span id="xdx_904_eus-gaap--RepaymentsOfRelatedPartyDebt_pp0p0_uAUD_c20200701__20210630__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember_zV6UgoUEDNii" style="font: 10pt Times New Roman, Times, Serif" title="Payments form related party">221,890</span>
AUD ($<span id="xdx_904_ecustom--BonusPayable_pp0p0_c20200701__20210630__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zBWdTFd5PPj3" title="Bonus payable">166,418</span> USD) in payments were made against the bonuses during the year ended June 30, 2021 resulting in a remaining balance of $<span id="xdx_905_ecustom--BonusPayable_pp0p0_uAUD_c20200701__20210630__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember_zFN7GNV96Oil" title="Bonus payable">422,610</span> AUD ($<span id="xdx_90F_ecustom--BonusPayable_pp0p0_c20200701__20210630__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--TypeOfArrangementAxis__custom--MrsNathanielszMember_zRsMxqrf9md2" title="Bonus payable">316,957</span> USD) bonus payable as of June 30, 2021. On August 12, 2021, the Board approved a bonus of $<span id="xdx_90D_eus-gaap--OfficersCompensation_pp0p0_c20210811__20210812__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember_zSIjyzAeBAf7" title="Officers' compensation">177,840</span> USD. On August 12, 2021, pursuant to the Cancellation Agreement, Mr. Nathanielsz agreed to cancel $<span id="xdx_90F_eus-gaap--OfficersCompensation_pp0p0_c20210811__20210812__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember_zOL3B6kyS4vc" title="Officers' compensation">177,840</span> of the bonus payable in exchange for <span id="xdx_905_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20210811__20210812__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember_z7EORU5fOkxi" title="Debt Conversion, Converted Instrument, Shares Issued">5,928,000</span> shares of the common stock of the Company (see Note 7). A total of $$<span id="xdx_907_eus-gaap--RepaymentsOfRelatedPartyDebt_pp0p0_uAUD_c20210701__20210930__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember_zckpRC2qEJBk" title="Payments form related party">42,500</span> AUD ($<span id="xdx_90C_eus-gaap--RepaymentsOfRelatedPartyDebt_pp0p0_c20210701__20210930__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zFxDY2HaZEY9" title="Payments form related party">30,660</span> USD) in payments were made against the bonuses during the three months ended September 30, 2021 which resulted to a remaining balance of $<span id="xdx_906_ecustom--BonusPayable_pp0p0_uAUD_c20210701__20210930__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember_zRiuOG3ZIOJd" title="Bonus payable">142,990</span> AUD ($<span id="xdx_90D_ecustom--BonusPayable_pp0p0_c20210701__20210930__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zOaEh4TI7ixa" title="Bonus payable">103,153</span> USD) bonus payable as of September 30, 2021 which is included in accrued expenses in the accompanying condensed consolidated balance sheet.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Amended
and Restated Employment Agreement - On May 14, 2019 (the &#8220;Effective Date&#8221;), the Company entered into an Amended and Restated
Employment Agreement (the &#8220;Employment Agreement&#8221;) with James Nathanielsz, the Company&#8217;s Chief Executive Officer, Chairman,
acting Chief Financial Officer and a director, for a term of <span id="xdx_90C_ecustom--AgreementlTerm_dc_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember_z3DnwpYc5J9c" title="Agreement term">three years</span>, subject to automatic <span id="xdx_907_ecustom--AgreementRenewalTerm_dtYxL_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember_zenS2toJ8RTa" title="Agreement renewal term::XDX::1"><span style="-sec-ix-hidden: xdx2ixbrl3891">one</span></span>-year renewals, at an annual salary
of $<span id="xdx_901_eus-gaap--SalariesAndWages_pp0p0_uAUD_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember_zOvUJmTVkEJh" title="Annual salary">400,000</span> AUD. Pursuant to the Employment Agreement, Mr. Nathanielsz was granted options to purchase <span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember_zw2Gfwhnir42" title="Option purchase shares">39</span> shares of the Company&#8217;s
common stock (the &#8220;Nathanielsz Options&#8221;), with an exercise price per share of $<span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember_zUhJwv1Vmi9l" title="Exercise price">4,675</span> (<span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_pid_dp_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember_zdISKL8TIkJe" title="Market price">110%</span> of the closing market price of
the Company&#8217;s common stock on May 14, 2019 (or $<span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember_znDtkgBG9f65" title="Granted exercise price">4,250</span>), the date of approval of such grant by the Company&#8217;s board of directors),
(ii) <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember__us-gaap--AwardTypeAxis__custom--RestrictedStocksUnitsRSUMember_zWlSMqPlB4G3" title="Restricted stock shares of common stock">39</span> restricted stock units of the Company (the &#8220;Initial Nathanielsz RSUs&#8221;), and (iii) an additional <span id="xdx_90A_ecustom--StockToBeIssuedDuringPeriodValueRestrictedStockUnit_c20210701__20210930__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember_z3k96wWhktmi" title="Restricted stock unit issuable">39</span> restricted stock
units of the Company (the &#8220;Additional Nathanielsz RSUs&#8221;). Such options and restricted stock units were granted pursuant to
the 2019 Plan approved by the Company&#8217;s board of directors on the Effective Date. <span id="xdx_90E_ecustom--OptionsVestedDescription_c20190513__20190514__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember" title="Options vested, description">The Nathanielsz Options have a term of <span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember_zjXSrkUNxySc" title="Option term">10 years</span>
from the date of grant. 1/3rd of the Nathanielsz Options shall vest every successive one-year anniversary following the Effective Date,
provided, that on each such vesting date Mr. Nathanielsz is employed by the Company and subject to the other provisions of the Employment
Agreement. The Initial Nathanielsz RSUs shall vest on the one-year anniversary of the Effective Date, subject to Mr. Nathanielsz&#8217;s
continued employment with the Company through such vesting date. The Additional Nathanielsz RSUs will vest as follows, subject to Mr.
Nathanielsz&#8217;s continued employment with the Company through the applicable vesting date: (i) <span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember__us-gaap--AwardTypeAxis__custom--AdditionaNathanielszRSUsMember_znu8ROG6465k" title="Rsus vest, shares">7.80</span> of the Additional Nathanielsz
RSUs shall vest upon the Company submitting Clinical Trial Application (the &#8220;CTA&#8221;) for PRP, the Company&#8217;s lead product
candidate (&#8220;PRP&#8221;), for a First-In-Human study for PRP (the &#8220;Study&#8221;) in an applicable jurisdiction to be selected
by the Company, (ii) 7.80 of the Additional Nathanielsz RSUs shall vest upon</span> the CTA being approved in an applicable jurisdiction, (iii)
<span title="Rsus vest, shares">7.80</span> of the Additional RSUs shall vest upon the Company completing an equity financing in the amount of at least $<span id="xdx_904_ecustom--GrossProceedsFromEquityFinancing_pp0p0_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember__us-gaap--AwardTypeAxis__custom--AdditionaNathanielszRSUsMember_zIMnFhIlAV7h" title="Gross proceeds from equity financing">4,000,000</span> in gross
proceeds, (iv) 7.80 of the Additional Nathanielsz RSUs shall vest upon the shares of the Company&#8217;s Common Stock being listed on
a senior stock exchange (NYSE, NYSEMKT or NASDAQ), and (v) the remaining 7.80 of the Additional Nathanielsz RSUs shall vest upon the
Company enrolling its first patient in the Study. Each vested restricted stock unit shall be settled by delivery to Mr. Nathanielsz of
one share of the Company&#8217;s common stock and/or the fair market value of one share of common stock in cash, at the sole discretion
of the Company&#8217;s board of directors and subject to the 2019 Plan, on the first to occur of: (i) the date of a Change of Control
(as defined in the Employment Agreement), (ii) the date that is ten business days following the vesting of such restricted stock unit,
(iii) the date of Mr. Nathanielsz&#8217;s death or Disability (as defined in the Employment Agreement), and (iv) Mr. Nathanielsz&#8217;s
employment being terminated either by the Company without Cause or by Mr. Nathanielsz for Good Reason (each as defined in the Employment
Agreement). In the event of a Change of Control, any unvested portion of the Nathanielsz Options and such restricted stock units shall
vest immediately prior to such event. The 39 vested restricted stock unit are considered issuable as of September 30, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>PROPANC
BIOPHARMA, INC. AND SUBSIDIARY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>SEPTEMBER
30, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Unaudited)</b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">Amended
and Restated Services Agreement - On May 14, 2019, the Company also entered into an Amended and Restated Services Agreement (the &#8220;Services
Agreement&#8221;) with Dr. Kenyon, the Company&#8217;s Chief Scientific Officer and a director, for a term of <span id="xdx_90B_ecustom--AgreementlTerm_dtYxL_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DrKenyonMember_ze0xcu10SeV7" title="Agreement term::XDX::3"><span style="-sec-ix-hidden: xdx2ixbrl3915">three</span></span> years, subject to
automatic <span id="xdx_903_ecustom--AgreementRenewalTerm_dtYxL_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DrKenyonMember_zAtfCXuUlhji" title="Agreement renewal term::XDX::1"><span style="-sec-ix-hidden: xdx2ixbrl3917">one</span></span>-year renewals, at an annual salary of $<span id="xdx_907_eus-gaap--SalariesAndWages_pp0p0_uAUD_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DrKenyonMemberMember__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember_zXf0wu8fePl1" title="Annual salary">54,000</span> AUD. In connection with the execution of the Services Agreement, Dr. Kenyon
was designated as an executive officer of the Company and assumed a more active executive role with the Company. Pursuant to the Services
Agreement, Dr. Kenyon was granted options to purchase <span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DrKenyonMember_zvS7Ab55s8f9" title="Option purchase shares">20</span> shares of the Company&#8217;s common stock (the &#8220;Kenyon Options&#8221;),
with an exercise price per share of $<span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DrKenyonMember_zU8nAyBQCwWl" title="Exercise price">4,250</span> (<span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_dp_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DrKenyonMember_ziNHSOCB8856" title="Market price">100%</span> of the closing market price of the Company&#8217;s common stock on May 14, 2019, the
date of approval of such grant by the Company&#8217;s board of directors), (ii) <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember__us-gaap--AwardTypeAxis__custom--InitialKenyonRSUsMember_zH0wNjk7LdE" title="Restricted stock shares of common stock">20</span> restricted stock units of the Company (the &#8220;Initial
Kenyon RSUs&#8221;), and (iii) an additional <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember__us-gaap--AwardTypeAxis__custom--AdditionalKenyonRSUsMember_zuzPGYxGzvCe" title="Restricted stock shares of common stock">20</span> restricted stock units of the Company (the &#8220;Additional Kenyon RSUs&#8221;). Such
options and restricted stock units were granted pursuant to the 2019 Plan approved by the Company&#8217;s board of directors on the Effective
Date. The Kenyon Options have a term of <span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DrKenyonMember_zSlJJn86aOja" title="Option term">10 years</span> from the date of grant. 1/3rd of the Kenyon Options shall vest every successive one-year
anniversary following the Effective Date, provided, that on each such vesting date Dr. Kenyon is employed by the Company and subject
to the other provisions of the Services Agreement. The Initial Kenyon RSUs shall vest on the one-year anniversary of the Effective Date,
subject to Dr. Kenyon&#8217;s continued employment with the Company through such vesting date. The Additional Kenyon RSUs will vest as
follows, subject to Dr. Kenyon&#8217;s continued employment with the Company through the applicable vesting date: (i) <span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember__us-gaap--AwardTypeAxis__custom--AdditionalKenyonRSUsMember_zZgAC3z9YhP" title="Rsus vest, shares">5</span> of the Additional
Kenyon RSUs shall vest upon the Company submitting the CTA for PRP for the Study in an applicable jurisdiction to be selected by the
Company, (ii) <span title="Rsus vest, shares">5</span> of the Additional Kenyon RSUs shall vest upon the Company completing an equity financing in the amount of at least $<span id="xdx_90A_ecustom--GrossProceedsFromEquityFinancing_pp0p0_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember__us-gaap--AwardTypeAxis__custom--AdditionalKenyonRSUsMember_zNlEuIx8jIdl" title="Gross proceeds from equity financing">4,000,000</span>
in gross proceeds, (iii) 5 of the Additional Kenyon RSUs shall vest upon the shares of the Company&#8217;s Common Stock being listed
on a senior stock exchange (NYSE, NYSEMKT or NASDAQ), and (iv) the remaining 5 of the Additional Kenyon RSUs shall vest upon the Company
enrolling its first patient in the Study. Each vested Kenyon RSU shall be settled by delivery to Mr. Kenyon of one share of the Company&#8217;s
common stock and/or the fair market value of one share of common stock in cash, at the sole discretion of the Company&#8217;s board of
directors and subject to the Plan, on the first to occur of: (i) the date of a Change of Control (as defined in the Services Agreement),
(ii) the date that is ten business days following the vesting of such Kenyon RSU, (iii) the date of Dr. Kenyon&#8217;s death or Disability
(as defined in the Services Agreement), and (iv) Dr. Kenyon&#8217;s employment being terminated either by the Company without Cause or
by Dr. Kenyon for Good Reason (as defined in the Services Agreement). In the event of a Change of Control (as defined in the Services
Agreement), 50% of any unvested portion of the Kenyon Options and the Kenyon RSUs shall vest immediately prior to such event. The <span id="xdx_90D_ecustom--StockToBeIssuedDuringPeriodValueRestrictedStockUnit_c20210701__20210930__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember_zB17fYlEexz6" title="Restricted stock unit issuable">20</span>
vested restricted stock unit are considered issuable as of September 30, 2021. As of June 30, 2021, total accrued salaries of $<span id="xdx_906_eus-gaap--AccruedSalariesCurrent_iI_pp0p0_uAUD_c20210630__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember_zSkbFVtK1Kma" title="Accrued salaries">135,000</span>
AUD ($<span id="xdx_90C_eus-gaap--AccruedSalariesCurrent_iI_pp0p0_c20210630_zFgxVESQPTOc" title="Accrued salaries">101,250</span> USD) was included in accrued expenses. On August 12, 2021, pursuant to the Cancellation Agreement, Mr. Kenyon agreed to
cancel accrued salaries of $<span id="xdx_900_ecustom--CancellationOfAccruedSalaries_iI_dtY_c20210812__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DrKenyonMember_zJ5ujDQKDPC4" title="Cancellation of accrued salary">102,600</span> in exchange for <span id="xdx_90A_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_pid_c20210811__20210812__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DrKenyonMember_zeayPO4QmVS">3,420,000</span> shares of the common stock of the Company (see Note 7). As of September
30, 2021, total accrued salaries of $<span id="xdx_901_eus-gaap--AccruedSalariesCurrent_iI_pp0p0_uAUD_c20210930__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember_zkxzMD0F9wGh">13,500</span> AUD ($<span id="xdx_909_eus-gaap--AccruedSalariesCurrent_iI_pp0p0_c20210930_zYaZ3iRR0tXb">9,739</span> USD) was included in accrued expenses in the accompanying condensed consolidated
balance sheet.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Intercompany
Loans</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">All
Intercompany loans were made by the parent to the subsidiary, Propanc PTY LTD, which have not been repaid as of September 30,
2021. Effective fiscal year 2021, the parent company determined that intercompany loans will not be repaid in the foreseeable future
and thus, per ASC 830-20-35-3, gains and losses from measuring the intercompany balances are recorded within cumulative translation adjustment,
a component of other comprehensive income. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<span></span>
</td>
<td class="text"><p id="xdx_806_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zzD8WGT4aV38" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>NOTE
10 &#8211; <span id="xdx_82F_zkTUa11D0wZ">RELATED PARTY TRANSACTIONS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Since
its inception, the Company has conducted transactions with its directors and entities related to such directors. These transactions have
included the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">As
of June 30, 2021 and 2020, the Company owed its former director a total of $<span id="xdx_90F_ecustom--LoansFromRelatedParty_c20210630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--CurrentAndFormerDirectorMember_pp0p0" title="Loans from related party">55,500</span> and $<span id="xdx_90E_ecustom--LoansFromRelatedParty_c20200630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--CurrentAndFormerDirectorMember_pp0p0" title="Loans from related party">50,993</span>, respectively, for money loaned to the
Company throughout the years. The total loans balance owed at June 30, 2021 and 2020 is not interest bearing (See Note 5 &#8211; Loans
and Notes Payable).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">As
of June 30, 2021 and 2020, the Company owed its former director a total of $<span id="xdx_90B_eus-gaap--DueToRelatedPartiesCurrent_c20210630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--FormerDirectorMember_pp0p0" title="Due to related parties">33,347</span> and $<span id="xdx_90A_eus-gaap--DueToRelatedPartiesCurrent_c20200630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--FormerDirectorMember_pp0p0" title="Due to related parties">30,639</span>, respectively, related to expenses paid
on behalf of the Company related to corporate startup costs and intellectual property (See Note 4 &#8211; Due to Former Director &#8211;
Related Party).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Effective
May 5, 2016, the Company entered into an agreement for the lease of its principal executive offices with North Horizon Pty Ltd., a related
party, of which Mr. Nathanielsz, our CEO, CFO and a director, and his wife are owners and directors. The lease has a <span id="xdx_900_eus-gaap--LessorOperatingLeaseTermOfContract_iI_dtYxL_c20160505__dei--LegalEntityAxis__custom--NorthHorizonPtyLtdMember_zcSkroEftsR" title="::XDX::5"><span style="-sec-ix-hidden: xdx2ixbrl2256">five</span></span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">-year
term and provides for annual rental payments of $<span id="xdx_900_eus-gaap--OperatingLeasesRentExpenseMinimumRentals_pp0p0_uAUD_c20160503__20160505__dei--LegalEntityAxis__custom--NorthHorizonPtyLtdMember__us-gaap--AwardTypeAxis__custom--AUDCurrencyMember_ziyfUdJ6SMsc">39,600
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">AUD or $<span id="xdx_909_eus-gaap--OperatingLeasesRentExpenseMinimumRentals_c20160503__20160505__dei--LegalEntityAxis__custom--NorthHorizonPtyLtdMember_pp0p0">28,325
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">USD, which includes $<span id="xdx_90F_ecustom--GoodsAndServiceTax_pp0p0_uAUD_c20160503__20160505__dei--LegalEntityAxis__custom--NorthHorizonPtyLtdMember__us-gaap--AwardTypeAxis__custom--AUDCurrencyMember_zYv6xR0CPQ09">3,600
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">AUD or $<span id="xdx_904_ecustom--GoodsAndServiceTax_c20160503__20160505__dei--LegalEntityAxis__custom--NorthHorizonPtyLtdMember_pp0p0">2,575
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">USD of goods and service tax for
total payments of $<span id="xdx_90E_eus-gaap--OperatingLeasesFutureMinimumPaymentsDue_iI_pp0p0_uAUD_c20160505__dei--LegalEntityAxis__custom--NorthHorizonPtyLtdMember__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NathanielszMember_zHUUCd1ACDlc">198,000
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">AUD or $<span id="xdx_908_eus-gaap--OperatingLeasesFutureMinimumPaymentsDue_c20160505__dei--LegalEntityAxis__custom--NorthHorizonPtyLtdMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NathanielszMember_pp0p0">141,629
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">USD during the term of the lease.
As of June 30, 2021, total rent payable of $<span id="xdx_90C_eus-gaap--PaymentsForRent_pp0p0_uAUD_c20200701__20210630__dei--LegalEntityAxis__custom--NorthHorizonPtyLtdMember__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember_zrnorhVlpEih">86,129
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">AUD ($<span id="xdx_907_eus-gaap--PaymentsForRent_c20200701__20210630__dei--LegalEntityAxis__custom--NorthHorizonPtyLtdMember_pp0p0">64,597
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">USD) is included in accrued expenses
in the accompanying consolidated balance sheet. <span><span id="xdx_90F_eus-gaap--LesseeOperatingLeaseDescription_c20190701__20190702__us-gaap--AdjustmentsForNewAccountingPronouncementsAxis__us-gaap--AccountingStandardsUpdate201602Member_zGJRpruMJUSi">Such lease expired in May 2021 and was renewed for another one-year term from May 2021 to May 2022</span></span> (See Note 9 &#8211; Commitments and Contingencies).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>PROPANC
BIOPHARMA, INC. AND SUBSIDIARY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>June
30, 2021 and 2020</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><i>Employment
and Services Agreements with Management</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
Company and Mr. Nathanielsz entered into an employment agreement as of February 25, 2015 (the &#8220;Nathanielsz Employment Agreement&#8221;)
setting forth the terms and conditions of Mr. Nathanielsz employment as the Company&#8217;s President and Chief Executive Officer. The
Nathanielsz Employment Agreement was scheduled to expire on <span id="xdx_904_eus-gaap--RelatedPartyTransactionDate_dd_c20150224__20150225__us-gaap--TypeOfArrangementAxis__custom--NathanielszEmploymentAgreementMember_zL101soAiIPb" title="Expired date">February 25, 2019</span>; however, the term of the Nathanielsz Employment Agreement
automatically renews for successive one-year periods unless either party provides 30 days&#8217; prior written notice of its intent not
to renew. The Nathanielsz Employment Agreement continues in effect as of June 30, 2021 as amended May 14, 2019 (see below). The Nathanielsz
Employment Agreement provides Mr. Nathanielsz with a base salary of $<span id="xdx_909_eus-gaap--SalariesAndWages_pp0p0_uAUD_c20150224__20150225__us-gaap--TypeOfArrangementAxis__custom--NathanielszEmploymentAgreementMember__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember_zYoqbdpF6Lj8" title="Annual salary">25,000</span> AUD per month ($<span id="xdx_901_eus-gaap--SalariesAndWages_pp0p0_uAUD_c20200701__20210630__us-gaap--TypeOfArrangementAxis__custom--NathanielszEmploymentAgreementMember__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember_zR0jkp8oaqU5" title="Annual salary">300,000</span> AUD annually or $<span id="xdx_90F_eus-gaap--SalariesAndWages_c20200701__20210630__us-gaap--TypeOfArrangementAxis__custom--NathanielszEmploymentAgreementMember_pp0p0" title="Annual salary">205,680</span> USD) and
a monthly contribution to Mr. Nathanielsz&#8217;s pension equal to <span id="xdx_904_ecustom--PercentageOfPensionOfMonthlySalary_dp_c20200701__20210630__us-gaap--TypeOfArrangementAxis__custom--NathanielszEmploymentAgreementMember_zc3W4JZ4V5g6" title="Percentage of pension of monthly salary">9.5%</span> of his monthly salary. Mr. Nathanielsz has the ability to convert
any accrued but unpaid salary into common stock at the end of each fiscal year at a conversion price to be determined by Mr. Nathanielsz
and the Company, which will in no event be lower than par value or higher than the closing bid price on the date of conversion. Pursuant
to the Nathanielsz Employment Agreement, Mr. Nathanielsz is entitled to an annual discretionary bonus in an amount up to <span id="xdx_90A_ecustom--PercentageOfBonusOfAnnualBaseSalary_dp_uPure_c20200701__20210630__us-gaap--TypeOfArrangementAxis__custom--NathanielszEmploymentAgreementMember_zRkqX1Xzgqc8" title="Percentage of bonus of annual base salary">200%</span> of his
annual base salary, which bonus shall be determined by the Company&#8217;s board of directors based upon the performance of the Company.
On March 16, 2018, the Company&#8217;s board of directors approved an increase of Mr. Nathanielsz&#8217;s annual base salary from $<span id="xdx_90F_eus-gaap--SalariesAndWages_pp0p0_uAUD_c20180315__20180316__us-gaap--TypeOfArrangementAxis__custom--NathanielszEmploymentAgreementMember__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember__srt--RangeAxis__srt--MinimumMember_zfz7g8ilDkHa" title="Annual salary">300,000</span>
AUD ($<span id="xdx_902_eus-gaap--SalariesAndWages_c20180315__20180316__us-gaap--TypeOfArrangementAxis__custom--NathanielszEmploymentAgreementMember__srt--RangeAxis__srt--MinimumMember_pp0p0" title="Annual salary">205,680</span> USD) to $<span id="xdx_902_eus-gaap--SalariesAndWages_pp0p0_uAUD_c20180315__20180316__us-gaap--TypeOfArrangementAxis__custom--NathanielszEmploymentAgreementMember__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember__srt--RangeAxis__srt--MaximumMember_zlk1mxratRg4" title="Annual salary">400,000</span> AUD ($<span id="xdx_900_eus-gaap--SalariesAndWages_c20180315__20180316__us-gaap--TypeOfArrangementAxis__custom--NathanielszEmploymentAgreementMember__srt--RangeAxis__srt--MaximumMember_pp0p0" title="Annual salary">274,240</span> USD), effective February 2018.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Mr.
Nathanielsz&#8217;s wife, Sylvia Nathanielsz, is and has been a non-executive part-time employee of the Company since October 2015. Effective
February 1, 2018, Mrs. Nathanielsz receives an annual salary of $<span id="xdx_905_eus-gaap--SalariesAndWages_pp0p0_uAUD_c20180128__20180201__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrsNathanielszMember__us-gaap--AwardTypeAxis__custom--AUDCurrencyMember_zHixLQFUIPr7" title="Annual salary">120,000</span> AUD ($<span id="xdx_90A_eus-gaap--SalariesAndWages_c20180128__20180201__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrsNathanielszMember_pp0p0" title="Annual salary">80,904</span> USD) and is entitled to customary benefits.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.45in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Pursuant
to a February 25, 2016 board resolution, James Nathanielsz shall be paid $<span id="xdx_900_eus-gaap--RepaymentsOfRelatedPartyDebt_pp0p0_uAUD_c20160224__20160225__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--JamesNathanielszMember__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember_zsc5Uu3BkKMi" title="Payments form related party">4,481</span> AUD ($<span id="xdx_90F_eus-gaap--RepaymentsOfRelatedPartyDebt_c20160224__20160225__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--JamesNathanielszMember_pp0p0" title="Payments form related party">3,205</span> USD), on a monthly basis for the purpose
of acquiring and maintaining an automobile. For the year ended June 30, 2020, a total of $<span id="xdx_909_eus-gaap--RepaymentsOfRelatedPartyDebt_pp0p0_uAUD_c20190701__20200630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrsNathanielszMember__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember_z0vnOVOV1umh" title="Payments form related party">44,918</span> AUD ($<span id="xdx_906_eus-gaap--RepaymentsOfRelatedPartyDebt_pp0p0_c20190701__20200630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrsNathanielszMember_zuqdo4grtdkc" title="Payments form related party">30,284</span> USD) in payments have been
made with respect to Mr. Nathanielsz&#8217;s car allowance. For the year ended June 30, 2021, a total of $<span id="xdx_90A_eus-gaap--RepaymentsOfRelatedPartyDebt_pp0p0_uAUD_c20200701__20210630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrsNathanielszMember__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember_zQuyUSmDfHdd" title="Payments form related party">46,135</span> AUD ($<span id="xdx_90F_eus-gaap--RepaymentsOfRelatedPartyDebt_pp0p0_c20200701__20210630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrsNathanielszMember_zsJx3gWyphf7" title="Payments form related party">34,476</span> USD) in
payments have been made with respect to Mr. Nathanielsz&#8217;s car allowance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Pursuant
to the approval of the Company&#8217;s board of directors, on May 14, 2019, Mr. Nathanielsz was granted a $<span id="xdx_90D_eus-gaap--OfficersCompensation_pp0p0_uAUD_c20190513__20190514__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsMember__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember_zhr5r6niZC3i">460,000
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">AUD ($<span id="xdx_907_eus-gaap--OfficersCompensation_c20190513__20190514__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsMember_pp0p0">315,376
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">USD) bonus for accomplishments
achieved while serving as the Company&#8217;s Chief Executive Officer during the fiscal year ended June 30, 2019 with $<span id="xdx_908_ecustom--BonusPayableAmount_pp0p0_uAUD_c20180701__20190630__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember_zrUcMs0KvEzg">200,000
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">AUD ($<span id="xdx_90D_ecustom--BonusPayableAmount_c20180701__20190630__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_pp0p0">137,120
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">USD) of such bonus payable by the
Corporation to the CEO throughout the Corporation&#8217;s 2019 fiscal year as the Corporation&#8217;s cash resources allow, with the
remaining $<span id="xdx_900_ecustom--RemainingBonusAmount_pp0p0_uAUD_c20180701__20190630__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember_zopoISWozugl">260,000
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">AUD ($<span id="xdx_90C_ecustom--RemainingBonusAmount_c20180701__20190630__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_pp0p0">178,256
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">USD) of such bonus to be deferred
by the CEO until a future date when the Corporation&#8217;s cash resources allow for such payment, as agreed to by the CEO. A total of
$<span id="xdx_900_eus-gaap--RepaymentsOfRelatedPartyDebt_pp0p0_uAUD_c20180701__20190630__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember_zJKyJ7nmmqnb">90,000
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">AUD ($<span id="xdx_909_eus-gaap--RepaymentsOfRelatedPartyDebt_c20180701__20190630__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_pp0p0">64,377
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">USD) in payments were made in the
year ended June 30, 2019. On July 13, 2020, the Board approved a bonus of $<span id="xdx_90C_eus-gaap--OfficersCompensation_pp0p0_uAUD_c20200712__20200713__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsMember__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember_zAfbIS2TyxH4">240,000
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">AUD being equal to <span id="xdx_908_ecustom--BonusAwardsGrantedPercentage_dp_c20200712__20200713__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsMember__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember_zCFbwsynHeB5">60%
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">of Mr. Nathanielsz base salary
which was accrued as of June 30, 2020. A total of $<span id="xdx_908_eus-gaap--RepaymentsOfRelatedPartyDebt_pp0p0_uAUD_c20190701__20200630__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember_zHe68DZ7ogVa">202,620
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">AUD ($<span id="xdx_900_eus-gaap--RepaymentsOfRelatedPartyDebt_c20190701__20200630__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_pp0p0">136,606
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">USD) in payments were made against
the bonuses during the year ended June 30, 2020 which resulted to a remaining balance of $<span id="xdx_906_ecustom--BonusPayable_pp0p0_uAUD_c20190701__20200630__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember_z6cjrBUkSy06">407,380
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">AUD ($<span id="xdx_907_ecustom--BonusPayable_c20190701__20200630__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_pp0p0">280,726
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">USD) bonus payable as of June 30,
2020. On August 12, 2021, the Board approved a bonus of $<span id="xdx_903_eus-gaap--OfficersCompensation_pp0p0_c20210811__20210812__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zTR9d7GO44Ca">177,840
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">USD. A total of $<span id="xdx_90E_eus-gaap--RepaymentsOfRelatedPartyDebt_pp0p0_uAUD_c20200701__20210630__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember_zIK7GAubQko">221,890
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">AUD ($<span id="xdx_90D_ecustom--BonusPayable_c20200701__20210630__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_pp0p0">166,418
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">USD) in payments were made against
the bonuses during the year ended June 30, 2021 resulting in a remaining balance of $<span id="xdx_90D_ecustom--BonusPayable_pp0p0_uAUD_c20200701__20210630__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember_zzKb2zutJYC5">422,610
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">AUD ($<span id="xdx_904_ecustom--BonusPayable_pp0p0_c20200701__20210630__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--TypeOfArrangementAxis__custom--MrsNathanielszMember_zw75G6lgrDWj">316,957
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">USD) bonus payable as of June 30,
2021 which is included in accrued expenses in the accompanying consolidated balance sheet. On August 12, 2021, pursuant to the Cancellation
Agreement, Mr. Nathanielsz agreed to cancel $<span id="xdx_904_eus-gaap--OfficersCompensation_c20210811__20210812__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsMember_zBqGulXqxETg" title="Officers' compensation">177,840</span> of the bonus payable in exchange for <span id="xdx_908_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_pip0_c20210811__20210812__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsMember_z0ShY2CLgpfi">5,928,000
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">shares of the common stock of the
Company (see Note 13).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Amended
and Restated Employment Agreement - On May 14, 2019 (the &#8220;Effective Date&#8221;), the Company entered into an Amended and Restated
Employment Agreement (the &#8220;Employment Agreement&#8221;) with James Nathanielsz, the Company&#8217;s Chief Executive Officer, Chairman,
acting Chief Financial Officer and a director, for a term of <span id="xdx_90B_ecustom--AgreementlTerm_dc_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember_zeNs9QNayR5c" title="Agreement term">three years</span>, subject to automatic <span id="xdx_909_ecustom--AgreementRenewalTerm_dtYxL_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember_zyg0gxBXOGIa" title="Agreement renewal term::XDX::1"><span style="-sec-ix-hidden: xdx2ixbrl2327">one</span></span>-year renewals, at an annual salary
of $<span id="xdx_908_eus-gaap--SalariesAndWages_pp0p0_uAUD_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember_zRCs20QOpIYd" title="Annual salary">400,000</span> AUD. Pursuant to the Employment Agreement, Mr. Nathanielsz was granted options to purchase <span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember_pdd" title="Option purchase shares">39</span> shares of the Company&#8217;s
common stock (the &#8220;Nathanielsz Options&#8221;), with an exercise price per share of $<span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember_pdd" title="Exercise price">4,675</span> (<span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_dp_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember_zEGYArsbBKx2" title="Market price">110%</span> of the closing market price of
the Company&#8217;s common stock on May 14, 2019 (or $<span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember_pdd" title="Granted exercise price">4,250</span>), the date of approval of such grant by the Company&#8217;s board of directors),
(ii) <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember__us-gaap--AwardTypeAxis__custom--RestrictedStocksUnitsRSUMember_pdd" title="Restricted stock shares of common stock">39</span> restricted stock units of the Company (the &#8220;Initial Nathanielsz RSUs&#8221;), and (iii) an additional <span id="xdx_90C_ecustom--StockToBeIssuedDuringPeriodValueRestrictedStockUnit_c20200701__20210630__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember_pdd" title="Restricted stock unit issuable">39</span> restricted stock
units of the Company (the &#8220;Additional Nathanielsz RSUs&#8221;). Such options and restricted stock units were granted pursuant to
the 2019 Plan approved by the Company&#8217;s board of directors on the Effective Date. <span id="xdx_90E_ecustom--OptionsVestedDescription_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember" title="Options vested, description">The Nathanielsz Options have a term of <span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember_ziX0y2aBXc9a">10 years</span>
from the date of grant. 1/3rd of the Nathanielsz Options shall vest every successive one-year anniversary following the Effective Date,
provided, that on each such vesting date Mr. Nathanielsz is employed by the Company and subject to the other provisions of the Employment
Agreement. The Initial Nathanielsz RSUs shall vest on the one-year anniversary of the Effective Date, subject to Mr. Nathanielsz&#8217;s
continued employment with the Company through such vesting date. The Additional Nathanielsz RSUs will vest as follows, subject to Mr.
Nathanielsz&#8217;s continued employment with the Company through the applicable vesting date: (i) <span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember__us-gaap--AwardTypeAxis__custom--AdditionaNathanielszRSUsMember_pdd" title="Rsus vest, shares">7.80</span> of the Additional Nathanielsz
RSUs shall vest upon the Company submitting Clinical Trial Application (the &#8220;CTA&#8221;) for PRP, the Company&#8217;s lead product
candidate (&#8220;PRP&#8221;), for a First-In-Human study for PRP (the &#8220;Study&#8221;) in an applicable jurisdiction to be selected
by the Company, (ii) 7.80 of the Additional Nathanielsz RSUs shall vest upon</span> the CTA being approved in an applicable jurisdiction, (iii)
7.80 of the Additional RSUs shall vest upon the Company completing an equity financing in the amount of at least $<span id="xdx_90A_ecustom--GrossProceedsFromEquityFinancing_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember__us-gaap--AwardTypeAxis__custom--AdditionaNathanielszRSUsMember_pp0p0" title="Gross proceeds from equity financing">4,000,000</span> in gross
proceeds, (iv) 7.80 of the Additional Nathanielsz RSUs shall vest upon the shares of the Company&#8217;s Common Stock being listed on
a senior stock exchange (NYSE, NYSEMKT or NASDAQ), and (v) the remaining 7.80 of the Additional Nathanielsz RSUs shall vest upon the
Company enrolling its first patient in the Study. Each vested restricted stock unit shall be settled by delivery to Mr. Nathanielsz of
one share of the Company&#8217;s common stock and/or the fair market value of one share of common stock in cash, at the sole discretion
of the Company&#8217;s board of directors and subject to the 2019 Plan, on the first to occur of: (i) the date of a Change of Control
(as defined in the Employment Agreement), (ii) the date that is ten business days following the vesting of such restricted stock unit,
(iii) the date of Mr. Nathanielsz&#8217;s death or Disability (as defined in the Employment Agreement), and (iv) Mr. Nathanielsz&#8217;s
employment being terminated either by the Company without Cause or by Mr. Nathanielsz for Good Reason (each as defined in the Employment
Agreement). In the event of a Change of Control, any unvested portion of the Nathanielsz Options and such restricted stock units shall
vest immediately prior to such event. The 39 vested restricted stock unit are considered issuable as of June 30, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>PROPANC
BIOPHARMA, INC. AND SUBSIDIARY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>June
30, 2021 and 2020</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Amended
and Restated Services Agreement - On May 14, 2019, the Company also entered into an Amended and Restated Services Agreement (the &#8220;Services
Agreement&#8221;) with Dr. Kenyon, the Company&#8217;s Chief Scientific Officer and a director, for a term of <span id="xdx_903_ecustom--AgreementlTerm_dtYxL_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DrKenyonMember_zI7SHQGqEtZk" title="Agreement term::XDX::3"><span style="-sec-ix-hidden: xdx2ixbrl2350">three</span></span> years, subject to
automatic <span id="xdx_90A_ecustom--AgreementRenewalTerm_dtYxL_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DrKenyonMember_zeyfSPX9awp2" title="Agreement renewal term::XDX::1"><span style="-sec-ix-hidden: xdx2ixbrl2352">one</span></span>-year renewals, at an annual salary of $<span id="xdx_903_eus-gaap--SalariesAndWages_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DrKenyonMemberMember__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember_pp0p0" title="Annual salary">54,000</span> AUD. In connection with the execution of the Services Agreement, Dr. Kenyon
was designated as an executive officer of the Company and assumed a more active executive role with the Company. Pursuant to the Services
Agreement, Dr. Kenyon was granted options to purchase <span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DrKenyonMember_pdd" title="Option purchase shares">20</span> shares of the Company&#8217;s common stock (the &#8220;Kenyon Options&#8221;),
with an exercise price per share of $<span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DrKenyonMember_pdd" title="Exercise price">4,250</span> (<span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_dp_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DrKenyonMember_zAyY4CSuklcf" title="Market price">100%</span> of the closing market price of the Company&#8217;s common stock on May 14, 2019, the
date of approval of such grant by the Company&#8217;s board of directors), (ii) <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember__us-gaap--AwardTypeAxis__custom--InitialKenyonRSUsMember_pdd" title="Restricted stock shares of common stock">20</span> restricted stock units of the Company (the &#8220;Initial
Kenyon RSUs&#8221;), and (iii) an additional <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember__us-gaap--AwardTypeAxis__custom--AdditionalKenyonRSUsMember_pdd" title="Restricted stock shares of common stock">20</span> restricted stock units of the Company (the &#8220;Additional Kenyon RSUs&#8221;). Such
options and restricted stock units were granted pursuant to the 2019 Plan approved by the Company&#8217;s board of directors on the Effective
Date. <span id="xdx_90F_ecustom--OptionsVestedDescription_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DrKenyonMember" title="Options vested, description">The Kenyon Options have a term of <span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DrKenyonMember_zbf0Whz1LJM3">10 years</span> from the date of grant. 1/3rd of the Kenyon Options shall vest every successive one-year
anniversary following the Effective Date, provided, that on each such vesting date Dr. Kenyon is employed by the Company and subject
to the other provisions of the Services Agreement. The Initial Kenyon RSUs shall vest on the one-year anniversary of the Effective Date,
subject to Dr. Kenyon&#8217;s continued employment with the Company through such vesting date. The Additional Kenyon RSUs will vest as
follows, subject to Dr. Kenyon&#8217;s continued employment with the Company through the applicable vesting date: (i) <span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember__us-gaap--AwardTypeAxis__custom--AdditionalKenyonRSUsMember_pdd" title="Rsus vest, shares">5</span> of the Additional
Kenyon RSUs shall vest upon the Company submitting the CTA for PRP for the Study in an applicable jurisdiction to be selected by the
Company, (ii) 5 of the Additional Kenyon RSUs shall vest upon the Company completing an equity financing in the amount of at least $<span id="xdx_900_ecustom--GrossProceedsFromEquityFinancing_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember__us-gaap--AwardTypeAxis__custom--AdditionalKenyonRSUsMember_pp0p0" title="Gross proceeds from equity financing">4,000,000</span>
in gross proceeds, (iii) 5 of the Additional Kenyon RSUs shall vest upon the shares o</span>f the Company&#8217;s Common Stock being listed
on a senior stock exchange (NYSE, NYSEMKT or NASDAQ), and (iv) the remaining 5 of the Additional Kenyon RSUs shall vest upon the Company
enrolling its first patient in the Study. Each vested Kenyon RSU shall be settled by delivery to Mr. Kenyon of one share of the Company&#8217;s
common stock and/or the fair market value of one share of common stock in cash, at the sole discretion of the Company&#8217;s board of
directors and subject to the Plan, on the first to occur of: (i) the date of a Change of Control (as defined in the Services Agreement),
(ii) the date that is ten business days following the vesting of such Kenyon RSU, (iii) the date of Dr. Kenyon&#8217;s death or Disability
(as defined in the Services Agreement), and (iv) Dr. Kenyon&#8217;s employment being terminated either by the Company without Cause or
by Dr. Kenyon for Good Reason (as defined in the Services Agreement). In the event of a Change of Control (as defined in the Services
Agreement), 50% of any unvested portion of the Kenyon Options and the Kenyon RSUs shall vest immediately prior to such event. As of June
30, 2021, total accrued salaries of $<span id="xdx_904_eus-gaap--AccruedSalariesCurrent_iI_pp0p0_uAUD_c20210630__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember_zrdYDlvBc9yl" title="Accrued salaries">135,000</span> AUD ($<span id="xdx_908_eus-gaap--AccruedSalariesCurrent_c20210630_pp0p0" title="Accrued salaries">101,250</span> USD) is included in accrued expenses in the accompanying consolidated balance
sheet. The <span id="xdx_907_ecustom--StockToBeIssuedDuringPeriodValueRestrictedStockUnit_c20200701__20210630__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember_pdd" title="Restricted stock unit issuable">20</span> vested restricted stock unit are considered issuable as of June 30, 2021. On August 12, 2021, pursuant to the Cancellation
Agreement, Mr. Kenyon agreed to cancel accrued salaries of $<span id="xdx_90B_ecustom--CancellationOfAccruedSalaries_iI_dtY_c20210812__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DrKenyonMember_zaJwBxkt21Pl" title="Cancellation of accrued salary">102,600</span> in exchange for <span id="xdx_90D_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_pid_c20210811__20210812__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DrKenyonMember_zqr3diXViojd">3,420,000</span> shares of the common stock of the Company
(see Note 13).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="text-decoration: underline">Intercompany
Loans</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">All
Intercompany loans were made by the parent to the subsidiary, Propanc PTY LTD, which have not been repaid as of June 30, 2021. Effective
fiscal year 2021, the parent company determined that intercompany loans will not be repaid in the foreseeable future and thus, per ASC
830-20-35-3, gains and losses from measuring the intercompany balances are recorded within cumulative translation adjustment, a component
of other comprehensive income. Prior to July 1, 2020, the Company recorded the foreign currency transaction gains and losses from measuring
the intercompany balances as a component of other income (expenses) as reflected in the consolidated statements of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -URI http://asc.fasb.org/topic&amp;trid=2122745<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39691-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm140460432843176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONCENTRATIONS AND RISKS<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RisksAndUncertaintiesAbstract', window );"><strong>Risks and Uncertainties [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskDisclosureTextBlock', window );">CONCENTRATIONS AND RISKS</a></td>
<td class="text"><p id="xdx_800_eus-gaap--ConcentrationRiskDisclosureTextBlock_zRlJNNTBEOJ7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTE
10 &#8211; <span id="xdx_825_zh1KlZqvgQEb">CONCENTRATIONS AND RISKS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Concentration
of Credit Risk</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
Company maintains its cash in banks and financial institutions in Australia. Bank deposits in Australian banks are uninsured. The Company
has not experienced any losses in such accounts through September 30, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
Company primarily relied on funding from one convertible debt lender and received proceeds after deductions of $<span id="xdx_90C_eus-gaap--AmortizationOfFinancingCostsAndDiscounts_pp0p0_c20210701__20210930_zvV3ouFXogye" title="Discounts and debt issuance cost">7,500</span> for original issue
discounts and debt issue costs during the three months ended September 30, 2021 from a lender of $<span id="xdx_901_eus-gaap--ProceedsFromConvertibleDebt_pp0p0_c20210701__20210930_zZ5A9lGsQync">160,000</span> which represents approximately
<span id="xdx_900_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20210930_zRDKV2Tjny3a">100%</span> of total proceeds received by the Company during the three months ended September 30, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
Company did <span id="xdx_909_eus-gaap--ProceedsFromConvertibleDebt_pp0p0_doxL_c20200701__20200930_zLrM3Z83L9M5" title="::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl3953">no</span></span>t receive any funding from lenders during the three months ended September 30, 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Receivable
Concentration</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">As
of September 30, 2021 and June 30, 2021, the Company&#8217;s receivables were <span id="xdx_900_ecustom--ReimbursementOnGoodsAndServiceTaxReceivablePercentage_dp_c20210701__20210930_zCHtZ5g5SYGh" title="Reimbursement on goods and service tax receivable percentage"><span id="xdx_90D_ecustom--ReimbursementOnGoodsAndServiceTaxReceivablePercentage_dp_c20200701__20210630_zWVZomWa1LN6" title="Reimbursement on goods and service tax receivable percentage">100%</span></span> related to reimbursements on GST taxes paid.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Patent
and Patent Concentration</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
Company has filed multiple patent applications relating to its lead product, PRP. The Company&#8217;s lead patent application has been
granted and remains in force in the United States, Belgium, Czech Republic, Denmark, France, Germany, Ireland, Italy, Netherlands, Portugal,
Spain, Sweden, Switzerland, Liechtenstein, Turkey, United Kingdom, Australia, China, Japan, Indonesia, Israel, New Zealand, Singapore,
Malaysia, South Africa, Mexico, Republic of Korea, India and Brazil. In Canada, the patent application remains under examination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>PROPANC
BIOPHARMA, INC. AND SUBSIDIARY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>SEPTEMBER
30, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Unaudited)</b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In
2016 and early 2017, we filed other patent applications. Three applications were filed under the Patent Cooperation Treaty (the &#8220;PCT&#8221;).
The PCT assists applicants in seeking patent protection by filing one international patent application under the PCT, applicants can
simultaneously seek protection for an invention in over 150 countries. Once filed, the application is placed under the control of the
national or regional patent offices, as applicable, in what is called the national phase. One of the PCT applications filed in November
2016, entered national phase in July 2018 and another PCT application is currently entering national phase in August 2018. A third PCT
application entered the national phase in October 2018.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">In
July 2020, a world first patent was granted in Australia for the cancer treatment method patent family. Presently, there are 31 granted
patents and 34 patents under examination in key global jurisdictions relating to the use of proenzymes against solid tumors, covering
the lead product candidate PRP.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Further
patent applications are expected to be filed to capture and protect additional patentable subject matter based on the Company&#8217;s
field of technology relating to pharmaceutical compositions of proenzymes for treating cancer.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Foreign
Operations</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 26.2pt; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">As
of September 30, 2021 and June 30, 2021, the Company&#8217;s operations are based in Camberwell, Australia, however the majority of research
and development is being conducted in the European Union.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 26.2pt; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">On
July 22, 2016, the Company formed a wholly owned subsidiary, Propanc (UK) Limited under the laws of England and Wales for the purpose
of submitting an orphan drug application with the European Medicines Agency as a small and medium-sized enterprise. As of September 30,
2021 and June 30, 2021, there has been no activity within this entity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_809_eus-gaap--ConcentrationRiskDisclosureTextBlock_zUlOBh1Ivd83" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>NOTE
11 &#8211; <span id="xdx_826_z7NVN5D24Jra">CONCENTRATIONS AND RISKS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="text-decoration: underline">Concentration
of Credit Risk</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
Company maintains its cash in banks and financial institutions in Australia. Bank deposits in Australian banks are uninsured. The Company
has not experienced any losses in such accounts through June 30, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">In fiscal year 2020,
t<span style="font: 10pt Times New Roman, Times, Serif">he</span><span style="font: 10pt Times New Roman, Times, Serif">
<span style="color: Black">Company currently primarily relied on funding from three convertible debt lenders. Proceeds received
during the year ended June 30, 2020 from each of the three lenders were $<span id="xdx_901_eus-gaap--ProceedsFromConvertibleDebt_pp0p0_c20190701__20200630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LenderOneMember_zjFGEVsziRX5">285,000</span></span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">,
$<span id="xdx_90E_eus-gaap--ProceedsFromConvertibleDebt_pp0p0_c20190701__20200630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LenderTwoMember_zPljXdu1OvH2">505,000</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">,
and $<span id="xdx_909_eus-gaap--ProceedsFromConvertibleDebt_pp0p0_c20190701__20200630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LenderThreeMember_zey8X6YvWZn">227,000</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">,
respectively, which represents approximately <span id="xdx_90E_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20200630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LenderOneMember_zKzuIYfnun9f">19%</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">,
<span id="xdx_90B_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20200630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LenderTwoMember_zXKBdCalnNLb">34%
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">and <span id="xdx_900_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20200630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LenderThreeMember_zRiTLuHUpeml">15%</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">,
respectively of total proceeds received by the Company during fiscal year 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">In fiscal year 2021,
the Company primarily relied on funding from two convertible debt lenders and received net proceeds after
deductions of $<span id="xdx_900_eus-gaap--AmortizationOfFinancingCostsAndDiscounts_pp0p0_c20200701__20210630_zapu3rw2nnQ9" title="Discounts and debt issuance cost">16,000</span> for original issue discounts and debt issue costs during the year ended June 30, 2021 from each of the two
lenders of $<span id="xdx_905_eus-gaap--ProceedsFromConvertibleDebt_pp0p0_c20200701__20210630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LenderOneMember_z0TkhjhwVrB1">125,000 </span>and
$<span id="xdx_903_eus-gaap--ProceedsFromConvertibleDebt_pp0p0_c20200701__20210630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LenderTwoMember_zDSyxdHJZdXd"><span style="-sec-ix-hidden: xdx2ixbrl2392">200,000, </span></span>respectively,
which represents approximately <span id="xdx_900_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20210630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LenderOneMember_zsdoBHfYPX4f">39%</span>, and <span id="xdx_904_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20210630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LenderTwoMember_zunB0KEfvbt5">61%, </span>respectively
of total proceeds received by the Company during fiscal year 2021.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="text-decoration: underline">Receivable
Concentration</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">As
of June 30, 2021 and 2020, the Company&#8217;s receivables were <span id="xdx_908_ecustom--ReimbursementOnGoodsAndServiceTaxReceivablePercentage_dp_c20200701__20210630_zepQavbUoNN8" title="Reimbursement on goods and service tax receivable percentage"><span id="xdx_90A_ecustom--ReimbursementOnGoodsAndServiceTaxReceivablePercentage_dp_c20190701__20200630_zvXSLqq0YQgb" title="Reimbursement on goods and service tax receivable percentage">100%</span></span> related to reimbursements on GST taxes paid.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>PROPANC
BIOPHARMA, INC. AND SUBSIDIARY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>June
30, 2021 and 2020</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="text-decoration: underline">Patent
and Patent Concentration</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
Company has filed multiple patent applications relating to its lead product, PRP. The Company&#8217;s lead patent application has been
granted and remains in force in the United States, Belgium, Czech Republic, Denmark, France, Germany, Ireland, Italy, Netherlands, Portugal,
Spain, Sweden, Switzerland, Liechtenstein, Turkey, United Kingdom, Australia, China, Japan, Indonesia, Israel, New Zealand, Singapore,
Malaysia, South Africa, Mexico, Republic of Korea, India and Brazil. In  Canada, the patent application remains
under examination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">In
2016 and early 2017, we filed other patent applications. Three applications were filed under the Patent Cooperation Treaty (the &#8220;PCT&#8221;).
The PCT assists applicants in seeking patent protection by filing one international patent application under the PCT, applicants can
simultaneously seek protection for an invention in over 150 countries. Once filed, the application is placed under the control of the
national or regional patent offices, as applicable, in what is called the national phase. One of the PCT applications filed in November
2016, entered national phase in July 2018 and another PCT application is currently entering national phase in August 2018. A third PCT
application entered the national phase in October 2018.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">In
July 2020, a world first patent was granted in Australia for the cancer treatment method patent family. Presently, there are 31
granted patents and 34 patents under examination in key global jurisdictions relating to the use of proenzymes against solid tumors,
covering the lead product candidate PRP.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Further
patent applications are expected to be filed to capture and protect additional patentable subject matter based on the Company&#8217;s
field of technology relating to pharmaceutical compositions of proenzymes for treating cancer.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="text-decoration: underline">Foreign
Operations</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 29.15pt; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">As
of June 30, 2021 and 2020, the Company&#8217;s operations are based in Camberwell, Australia, however the majority of research and development
is being conducted in the European Union.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 29.15pt; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">On
July 22, 2016, the Company formed a wholly owned subsidiary, Propanc (UK) Limited under the laws of England and Wales for the purpose
of submitting an orphan drug application with the European Medicines Agency as a small and medium-sized enterprise. As of June 30, 2021
and 2020, there has been no activity within this entity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RisksAndUncertaintiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RisksAndUncertaintiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm140460440390088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DERIVATIVE FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock', window );">DERIVATIVE FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS</a></td>
<td class="text"><p id="xdx_804_eus-gaap--DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_zogQn9ohpdga" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTE
11 - <span id="xdx_82E_z1zpYd1cMdD4">DERIVATIVE FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><i>Derivative
Financial Instruments:</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
Company applies the provisions of ASC 815-40, <i>Contracts in Entity&#8217;s Own Equity</i>, under which convertible instruments and
warrants, which contain terms that protect holders from declines in the stock price (reset provisions), may not be exempt from derivative
accounting treatment. As a result, warrants and embedded conversion options in convertible debt are recorded as a liability and are revalued
at fair value at each reporting date. If the fair value of the warrants exceeds the face value of the related debt, the excess is recorded
as change in fair value in operations on the issuance date. The Company had $<span id="xdx_902_eus-gaap--ConvertibleDebt_iI_pp0p0_c20210930__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--ConvertibleDebtMember_zwH6m3Amf23a" title="Convertible debt"><span id="xdx_903_eus-gaap--ConvertibleDebt_iI_pp0p0_c20210630__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--ConvertibleDebtMember_zwaTAZVdiqi6">80,000</span></span> (1 note) of convertible debt, which is treated as
derivative instruments outstanding at September 30, 2021 and June 30, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
Company calculates the estimated fair values of the liabilities for derivative instruments using the Binomial Trees Method. The closing
price of the Company&#8217;s common stock at September 30, 2021, the last trading day of the period ended September 30, 2021, was $<span id="xdx_90D_eus-gaap--SharePrice_iI_c20210930_zWpDL0RPjJL1" title="Share Price">0.026</span>.
The Volatility, expected remaining term and risk-free interest rates used to estimate the fair value of derivative liabilities at September
30, 2021 are indicated in the table that follows. The expected term is equal to the remaining term of the warrants or convertible instruments
and the risk-free rate is based upon rates for treasury securities with the same term.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Convertible
Debt</b></span></p>

<p id="xdx_89C_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_ziVEwM4zVGa4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8B3_zk9Bx8xU2Kvf" style="display: none">SCHEDULE
OF FAIR VALUE MEASUREMENTS, RECURRING AND NONRECURRING, VALUATION TECHNIQUES</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.8pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Initial
                                            Valuations<br/> (on new derivative<br/> instruments entered</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.8pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>into
                                            during the three<br/> months ended<br/> September 30, 2021)</b></span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">September
    30, 2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%"><span style="font-family: Times New Roman, Times, Serif">Volatility</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 18%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_902_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_dp_uPure_c20210930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_z91KrVbagw65" title="Debt instrument, measurement input, percentages"><span style="-sec-ix-hidden: xdx2ixbrl3968">-</span></span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 18%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_902_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_dp_uPure_c20210930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember_znDDVGuM3xK6" style="font: 10pt Times New Roman, Times, Serif" title="Debt instrument, measurement input, percentages">206.00</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Expected Remaining Term (in years)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90B_eus-gaap--DebtInstrumentTerm_c20210701__20210930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_zcyHeINBsNI9" title="Debt instrument, measurement input, term"><span style="-sec-ix-hidden: xdx2ixbrl3972">-</span></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90C_eus-gaap--DebtInstrumentTerm_dtY_c20210701__20210930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember_zWMN60Ok1IOk" title="Debt instrument, measurement input, term">0.01</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Risk Free Interest Rate</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90D_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_dp_uPure_c20210930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_zTlxnS98e5R5" title="Debt instrument, measurement input, percentages"><span style="-sec-ix-hidden: xdx2ixbrl3976">-</span></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90A_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_dp_uPure_c20210930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember_zBC50CDGAAK1" title="Debt instrument, measurement input, percentages">0.07</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Expected dividend yield</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90C_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_dn_uPure_c20210930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zCbCaGbL5Jd7" title="Debt instrument, measurement input, percentages">None</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_901_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_dpn_uPure_c20210930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember_zIiMk9sIpq1" title="Debt instrument, measurement input, percentages">None</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p id="xdx_8A2_z9QCLngR86Z4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>PROPANC
BIOPHARMA, INC. AND SUBSIDIARY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>SEPTEMBER
30, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Unaudited)</b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><i>Fair
Value Measurements:</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_89E_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_zQ8Y0zdM2HX4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
Company measures and reports at fair value the liability for derivative instruments. The fair value liabilities for price adjustable
warrants and embedded conversion options have been recorded as determined utilizing the Binomial Trees model. The following tables summarize
the Company&#8217;s financial assets and liabilities measured at fair value on a recurring basis as of September 30, 2021 and June 30,
2021:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_8BF_z92R6udxgfO5" style="display: none">SCHEDULE
OF FAIR VALUE, ASSETS AND LIABILITIES MEASURED ON RECURRING BASIS</span>&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Balance
    at<br/> September&#160;30, 2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Quoted
                                            Prices</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>in
                                            Active</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Markets
                                            for</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Identical<br/>
                                            Assets</b></span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Significant</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Other</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Observable<br/>
                                            Inputs</b></span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Significant</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Unobservable
                                            Inputs</b></span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">(Level 1)</span></td><td style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">(Level 2)</span></td><td style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">(Level 3)</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 44%; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Embedded
    conversion option liabilities</span></td><td style="width: 2%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_985_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_iI_pp0p0_c20210930_znrDt9zeQUQj" style="border-bottom: Black 1.5pt solid; width: 10%; text-align: right" title="Embedded conversion option liabilities"><span style="font-family: Times New Roman, Times, Serif">58,124</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98E_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_iI_pdp0_c20210930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zyf9mHFTG7D6" style="border-bottom: Black 1.5pt solid; width: 10%; text-align: right" title="Embedded conversion option liabilities"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3988">&#8212;</span></span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98F_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_iI_pdp0_c20210930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zDR2luvuqBKe" style="border-bottom: Black 1.5pt solid; width: 10%; text-align: right" title="Embedded conversion option liabilities"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3990">&#8212;</span></span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_iI_pp0p0_c20210930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zfYeJvYPLE83" style="border-bottom: Black 1.5pt solid; width: 10%; text-align: right" title="Embedded conversion option liabilities"><span style="font-family: Times New Roman, Times, Serif">58,124</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98F_eus-gaap--DerivativeLiabilities_iI_pp0p0_c20210930_zpZqMmMLg1Nj" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total"><span style="font-family: Times New Roman, Times, Serif">58,124</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_eus-gaap--DerivativeLiabilities_iI_pdp0_c20210930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zI42zixfZpa1" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3996">&#8212;</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_983_eus-gaap--DerivativeLiabilities_iI_pdp0_c20210930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z4N9YaP254Ea" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3998">&#8212;</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98E_eus-gaap--DerivativeLiabilities_iI_pp0p0_c20210930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zFa2qEvswSgl" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total"><span style="font-family: Times New Roman, Times, Serif">58,124</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Balance
    at<br/> June 30, 2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Quoted
                                            Prices</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>in
                                            Active</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Markets
                                            for</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Identical<br/>
                                            Assets</b></span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Significant</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Other</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Observable<br/>
                                            Inputs</b></span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Significant</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Unobservable
                                            Inputs</b></span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">(Level 1)</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">(Level 2)</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">(Level 3)</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 44%; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Embedded
    conversion option liabilities</span></td><td style="width: 2%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_iI_pp0p0_c20210630_zxSBZDQIJc8e" style="border-bottom: Black 1.5pt solid; width: 10%; text-align: right" title="Embedded conversion option liabilities"><span style="font-family: Times New Roman, Times, Serif">54,220</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_c20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_pdp0" style="border-bottom: Black 1.5pt solid; width: 10%; text-align: right" title="Embedded conversion option liabilities"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl4004">&#8212;</span></span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_c20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_pdp0" style="border-bottom: Black 1.5pt solid; width: 10%; text-align: right" title="Embedded conversion option liabilities"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl4006">&#8212;</span></span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_iI_pp0p0_c20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zmZMI2T7dhS3" style="border-bottom: Black 1.5pt solid; width: 10%; text-align: right" title="Embedded conversion option liabilities"><span style="font-family: Times New Roman, Times, Serif">54,220</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eus-gaap--DerivativeLiabilities_iI_pp0p0_c20210630_zY5UsolInuf2" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total"><span style="font-family: Times New Roman, Times, Serif">54,220</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--DerivativeLiabilities_c20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_pdp0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl4012">&#8212;</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_983_eus-gaap--DerivativeLiabilities_c20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_pdp0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl4014">&#8212;</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98E_eus-gaap--DerivativeLiabilities_iI_pp0p0_c20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z8dP5d3YIqD9" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total"><span style="font-family: Times New Roman, Times, Serif">54,220</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/>

<p id="xdx_8A7_zWt2ql5TwhZ6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_896_eus-gaap--ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_zCMqAhbosFH6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
following is a roll forward for the three months ended September 30, 2021 of the fair value liability of price adjustable derivative
instruments:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_8B9_z0UpiPSRcN17" style="display: none">SCHEDULE
OF DERIVATIVE LIABILITIES AT FAIR VALUE</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"/>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Fair Value
    of</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Liability
    for</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Derivative</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Instruments</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 82%; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Balance at June 30, 2021</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_981_eus-gaap--DerivativeLiabilities_iS_pp0p0_c20210701__20210930_zye6j61g3l84" style="width: 14%; text-align: right" title="Balance at Beginning"><span style="font-family: Times New Roman, Times, Serif">54,220</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Change in fair value
    included in statements of operations</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet_pp0p0_c20210701__20210930_zXS50oq2qLa6" style="border-bottom: Black 1.5pt solid; text-align: right" title="Balance at Beginning"><span style="font-family: Times New Roman, Times, Serif">3,904</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Balance at September
    30, 2021</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_983_eus-gaap--DerivativeLiabilities_iE_pp0p0_c20210701__20210930_zN3IqKOe7TQb" style="border-bottom: Black 2.5pt double; text-align: right" title="Balance at Ending"><span style="font-family: Times New Roman, Times, Serif">58,124</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p id="xdx_8A7_z38uRLnE5jX" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"/>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"/>

<span></span>
</td>
<td class="text"><p id="xdx_803_eus-gaap--DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_zlYx3T8dti75" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>NOTE
12 - <span id="xdx_82F_zRHtpfFjjGs1">DERIVATIVE FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><i>Derivative
Financial Instruments:</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
Company applies the provisions of ASC 815-40, <i>Contracts in Entity&#8217;s Own Equity</i>, under which convertible instruments and
warrants, which contain terms that protect holders from declines in the stock price (reset provisions), may not be exempt from derivative
accounting treatment. As a result, warrants and embedded conversion options in convertible debt are recorded as a liability and are revalued
at fair value at each reporting date. If the fair value of the warrants exceeds the face value of the related debt, the excess is recorded
as change in fair value in operations on the issuance date. The Company had $<span id="xdx_904_eus-gaap--ConvertibleDebt_c20210630__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--ConvertibleDebtMember_pp0p0" title="Convertible debt">80,000</span> (1 note) and $<span id="xdx_905_eus-gaap--ConvertibleDebt_c20200630__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--ConvertibleDebtMember_pp0p0" title="Convertible debt">126,500</span> (3 notes) of convertible debt,
which is treated as derivative instruments outstanding at June 30, 2021 and 2020 respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
Company calculates the estimated fair values of the liabilities for derivative instruments using the Binomial Trees Method. The closing
price of the Company&#8217;s common stock at June 30, 2021, the last trading day of the fiscal year ended June 30, 2021, was $<span id="xdx_90E_eus-gaap--SharePrice_c20210630_pdd">0.0517</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">.
Volatility, expected remaining term and risk-free interest rates used to estimate the fair value of derivative liabilities at June 30,
2021 and 2020 are indicated in the table that follows. The expected term is equal to the remaining term of the warrants or convertible
instruments and the risk free rate is based upon rates for treasury securities with the same term.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p id="xdx_899_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_zFxlxLM00prd" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_8BA_zmBowUwCLaxi" style="display: none">SCHEDULE OF FAIR VALUE MEASUREMENTS, RECURRING AND NONRECURRING, VALUATION TECHNIQUES</span><span style="font: 10pt Times New Roman, Times, Serif; color: Black"/></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>Convertible
Debt</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>&#160;</b></span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center"><b>Initial Valuations during the year ended June 30, 2021</b></td>
    <td style="padding-bottom: 1.5pt; text-align: center"><b>&#160;</b></td>
    <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><p style="text-align: center; margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>Initial<br/>
                                            Valuations</b></span></p>
                                                                                <p style="text-align: center; margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>during</b></span></p>
                                                                                <p style="text-align: center; margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>the
                                            year ended June 30, 2020</b></span></p></td>
    <td>&#160;</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>June
    30, 2021</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>June
    30, 2020</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>&#160;</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 35%"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Volatility</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="text-align: center; width: 13%">N/A</td>
    <td style="width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 13%; vertical-align: bottom"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90C_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_uPure_c20200630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__srt--RangeAxis__srt--MinimumMember_znsZSskEF4vh" title="Debt instrument, measurement input, percentages">227</span>-<span id="xdx_902_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_uPure_c20200630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__srt--RangeAxis__srt--MaximumMember_z19zgrt6LIge" title="Debt instrument, measurement input, percentages">279</span></span></td>
    <td style="width: 1%">%</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 13%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span id="xdx_902_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_uPure_c20210630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember_z8qKxb6rq01j" title="Debt instrument, measurement input, percentages">222</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">%</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 13%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span id="xdx_90A_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_uPure_c20200630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember_zsocWzw9v8mc" title="Debt instrument, measurement input, percentages">264</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">%</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Expected
    remaining term</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="text-align: center">N/A</td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom"><span id="xdx_90C_eus-gaap--DebtInstrumentTerm_dtY_c20190701__20200630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_zg9nuItaB5A3" title="Debt instrument, measurement input, term">1.00</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span id="xdx_902_eus-gaap--DebtInstrumentTerm_dtY_c20200701__20210630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember_ziMIM80sCzJ9" title="Debt instrument, measurement input, term">0.01</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span id="xdx_904_eus-gaap--DebtInstrumentTerm_dtY_c20190701__20200630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember__srt--RangeAxis__srt--MinimumMember_zQq0IiYT0cn5" title="Debt instrument, measurement input, term">0.01</span>
    &#8211; <span id="xdx_901_eus-gaap--DebtInstrumentTerm_dtY_c20190701__20200630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember__srt--RangeAxis__srt--MaximumMember_zRzEN0YrwSO1" title="Debt instrument, measurement input, term">0.70</span> </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Risk-free
    interest rate</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="text-align: center">N/A</td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90D_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_uPure_c20200630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MinimumMember_zG2WLbhXC174" title="Debt instrument, measurement input, percentages">1.53</span>
    &#8211; <span id="xdx_905_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_uPure_c20200630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MaximumMember_zeQQCpHn9Oo3" title="Debt instrument, measurement input, percentages">1.59</span></span></td>
    <td>%</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span id="xdx_902_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_uPure_c20210630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember_z7Aep2hS9Ss4" title="Debt instrument, measurement input, percentages">0.05</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">%</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span id="xdx_901_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_uPure_c20200630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember__srt--RangeAxis__srt--MinimumMember_zJYF6qi0vIO4" title="Debt instrument, measurement input, percentages">0.13</span>
    &#8211; <span id="xdx_90D_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_uPure_c20200630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember__srt--RangeAxis__srt--MaximumMember_zQagw6Ahxvq1" title="Debt instrument, measurement input, percentages">0.18</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">%</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Expected
    dividend yield</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="text-align: center">N/A</td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_904_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_dn_uPure_c20200630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zM4oKsxZoZOi" title="Debt instrument, measurement input, percentages">None</span></span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span id="xdx_901_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_dpn_uPure_c20210630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember_zPYMAAUfdnC9" title="Debt instrument, measurement input, percentages">None</span>
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span id="xdx_907_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_dn_uPure_c20200630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember_zcJ0FN6PYQYf" title="Debt instrument, measurement input, percentages">None</span>
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  </table>
<p id="xdx_8AD_zppbwSBc0Qc6" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>PROPANC
BIOPHARMA, INC. AND SUBSIDIARY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>June
30, 2021 and 2020</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><i>Fair
Value Measurements:</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
Company measures and reports at fair value the liability for derivative instruments. The fair value liabilities for price adjustable
warrants and embedded conversion options have been recorded as determined utilizing the Binomial Trees model. The following tables summarize
the Company&#8217;s financial assets and liabilities measured at fair value on a recurring basis as of June 30, 2021:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p id="xdx_891_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_zj10hCQnfo2k" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-right: 0; margin-bottom: 0; text-align: left; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span><span id="xdx_8BC_zhgIJsNvoEFe" style="display: none">SCHEDULE OF FAIR VALUE, ASSETS AND LIABILITIES MEASURED ON RECURRING BASIS</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Balance
    at<br/> June 30, 2021</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1.8pt 0 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Quoted</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1.8pt 0 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Prices</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1.8pt 0 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>in
    Active</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1.8pt 0 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Markets
    for</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1.8pt 0 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Identical
    Assets</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1.8pt 0 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Significant</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1.8pt 0 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Other</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1.8pt 0 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Observable
    Inputs</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1.8pt 0 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Significant</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1.8pt 0 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Unobservable
    Inputs</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>(Level
    1)</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>(Level
    2)</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>(Level
    3)</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 36%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Embedded
    conversion option liabilities</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td id="xdx_981_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_c20210630_pp0p0" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Embedded conversion option liabilities"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">54,220</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td id="xdx_98A_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_c20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_pp0p0" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Embedded conversion option liabilities"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl2445">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td id="xdx_98B_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_c20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_pp0p0" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Embedded conversion option liabilities"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl2447">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td id="xdx_98C_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_c20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_pp0p0" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Embedded conversion option liabilities"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">54,220</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Total</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td id="xdx_98D_eus-gaap--DerivativeLiabilities_c20210630_pp0p0" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">54,220</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td id="xdx_98B_eus-gaap--DerivativeLiabilities_c20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_pp0p0" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl2453">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td id="xdx_983_eus-gaap--DerivativeLiabilities_c20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_pp0p0" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl2455">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td id="xdx_982_eus-gaap--DerivativeLiabilities_c20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_pp0p0" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">54,220</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
following tables summarize the Company&#8217;s financial assets and liabilities measured at fair value on a recurring basis as of June
30, 2020:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Balance
    at<br/> June 30, 2020</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1.8pt 0 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Quoted</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1.8pt 0 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Prices</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1.8pt 0 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>in
    Active</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1.8pt 0 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Markets
    for</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1.8pt 0 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Identical
    Assets</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1.8pt 0 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Significant</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1.8pt 0 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Other</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1.8pt 0 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Observable
    Inputs</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1.8pt 0 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Significant</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1.8pt 0 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Unobservable
    Inputs</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>(Level
    1)</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>(Level
    2)</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>(Level
    3)</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 36%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Embedded
    conversion option liabilities</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td id="xdx_982_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_c20200630_pp0p0" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Embedded conversion option liabilities"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">177,009</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td id="xdx_989_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_c20200630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_pp0p0" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Embedded conversion option liabilities"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl2461">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td id="xdx_98A_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_c20200630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_pp0p0" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Embedded conversion option liabilities"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl2463">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td id="xdx_98B_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_c20200630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_pp0p0" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Embedded conversion option liabilities"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">177,009</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Total</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td id="xdx_98C_eus-gaap--DerivativeLiabilities_c20200630_pp0p0" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">177,009</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td id="xdx_98A_eus-gaap--DerivativeLiabilities_c20200630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_pp0p0" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl2469">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td id="xdx_98B_eus-gaap--DerivativeLiabilities_c20200630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_pp0p0" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl2471">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td id="xdx_983_eus-gaap--DerivativeLiabilities_c20200630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_pp0p0" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">177,009</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  </table>
<p id="xdx_8AA_zSRvajH3Hwag" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p id="xdx_898_eus-gaap--ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_zwnWqsCQ67Ea" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
following is a roll forward for the years ended June 30, 2021 and 2020 of the fair value liability of price adjustable derivative instruments:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-right: 0; margin-bottom: 0; text-align: left; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span><span id="xdx_8B1_zUG1Rm1Y5kic" style="display: none">SCHEDULE OF DERIVATIVE LIABILITIES AT FAIR VALUE</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Fair
    Value of</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Liability
    for</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Derivative</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Instruments</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; width: 82%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Balance
    at June 30, 2019</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td id="xdx_984_eus-gaap--DerivativeLiabilities_iS_pp0p0_c20190701__20200630_zclpqGLBOnAf" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Balance at Beginning"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">698,264</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Reductions
    due to conversions</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td id="xdx_989_ecustom--ReductionsDueToConversions_c20190701__20200630_pp0p0" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Reductions due to conversions"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(362,962</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Initial
    fair value of embedded conversion option derivative liability recorded as debt discount</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td id="xdx_986_ecustom--FairValueOfWarrantDerivativeLiabilityRecorededAsDebtDiscount_c20190701__20200630_pp0p0" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Initial fair value of embedded conversion option derivative liability recorded as debt discount"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">227,000</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Initial
    fair value of embedded conversion option derivative liability recorded as expense</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td id="xdx_983_ecustom--InitialFairValueOfEmbeddedConversionOptionDerivativeLiabilityRecordedAsExpense_c20190701__20200630_pp0p0" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Initial fair value of embedded conversion option derivative liability recorded as expense"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">351,461</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Change
    in fair value included in statements of operations</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td id="xdx_98B_eus-gaap--EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet_c20190701__20200630_pp0p0" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Change in fair value included in statements of operations"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(736,754</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Balance
    at June 30, 2020</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td id="xdx_982_eus-gaap--DerivativeLiabilities_iS_pp0p0_c20200701__20210630_zUMVWyInRydk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Balance at Beginning"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">177,009</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Gain
    on debt extinguishment</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td id="xdx_985_ecustom--GainOnDebtExtinguishment_c20200701__20210630_pp0p0" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Gain on debt extinguishment"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(130,975</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Change
    in fair value included in statements of operations</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td id="xdx_982_eus-gaap--EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet_c20200701__20210630_pp0p0" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Change in fair value included in statements of operations"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">8,186</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Balance
    at June 30, 2021</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td id="xdx_988_eus-gaap--DerivativeLiabilities_iE_pp0p0_c20200701__20210630_zSqnvtpNZU1f" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Balance at Ending"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">54,220</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  </table>
<p id="xdx_8A0_zsQ5mF78ITza" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -URI http://asc.fasb.org/topic&amp;trid=2229140<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123477628&amp;loc=d3e90205-114008<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm140460440350584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUBSEQUENT EVENTS<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">SUBSEQUENT EVENTS</a></td>
<td class="text"><p id="xdx_80E_eus-gaap--SubsequentEventsTextBlock_zBdf9ZOf6jq3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTE
12 &#8211; <span id="xdx_824_zliAKEcZXTY6">SUBSEQUENT EVENTS</span> </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><i>Exercise
of Warrants</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">In
October 2021, the Company issued <span id="xdx_906_eus-gaap--CommonStockSharesIssued_iI_c20211031__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementClassOfStockAxis__custom--ElevenSeriesAWarrantsMember_zTaypf8UVaP3">2,199,989</span> shares of common stock from the alternate cashless exercise of 11 Series A warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><i>Note
Conversions</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In
October 2021, the Company issued an aggregate of <span id="xdx_90F_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_pid_c20211001__20211031__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z0cEUQXkrEMi">1,818,097</span> shares of its common stock at an average contractual conversion price of $<span id="xdx_907_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20211031__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zdoPRJX58rwe">0.01</span>,
as a result of the conversion of principal of $<span id="xdx_90D_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20211031__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zurT2Mh9EFfk">25,000</span>, interest of $<span><span id="xdx_907_eus-gaap--InterestPayableCurrent_iI_pp0p0_c20211031__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_znl6ciVAg1Oj">1,726</span></span> and conversion fees $<span id="xdx_902_ecustom--ConversionFees_pp0p0_c20211001__20211031__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zpmLqz6cRsT7">0</span> underlying certain outstanding convertible
notes converted during such period. The Company reclassified $<span id="xdx_901_eus-gaap--AdditionalPaidInCapital_iI_pp0p0_c20211031__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z1SDhUYOwhUh">16,667</span> in put premiums to additional paid in capital following these conversions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>Common
Stock Issuable</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
<span id="xdx_908_eus-gaap--CommonStockSharesIssued_iI_c20211031__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z9wgoqHrTdH">2,002,490</span> shares of common stock issuable as of September 30, 2021 were issued in October 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>Consulting
Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90E_ecustom--ConsultingAgreementDescription_c20211019__20211021__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z68zps5mSWji" title="Consulting agreement description">On
October 1, 2021, the Company entered int a consulting agreement (the &#8220;Consulting Agreement&#8221;) with a consultant who will
assist in the development of the Company&#8217;s business and financing activities. The consultant will serve initially as an
independent contractor, and upon certain mutually agreed upon conditions being met, will be appointed Vice Chairman, President and
Interim CFO. The term of the Consulting Agreement shall be for three years commencing on October 1, 2021, and can be terminated by
either party upon 30 day written notice. The monthly payment per the Consulting Agreement is $<span id="xdx_90E_ecustom--ConsultingAgreementMonthlyPayment_c20211019__20211021__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zTgvambp0mw7" title="Consulting agreement, monthly payment">7,000</span>. The Company will also issue
shares of common stock equal to 1% of the total issued and outstanding shares at the end of each year of service.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>PROPANC
BIOPHARMA, INC. AND SUBSIDIARY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>SEPTEMBER
30, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Unaudited)</b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>October
21, 2021 Securities Purchase Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Effective
October 21, 2021, the Company entered into a securities purchase agreement with Sixth Street Lending LLC (&#8220;Sixth Street&#8221;),
pursuant to which Sixth Street purchased a convertible promissory note (the &#8220;October 21, 2021 Sixth Street&#8221;) from the Company
in the aggregate principal amount of $<span id="xdx_902_eus-gaap--DebtInstrumentFaceAmount_iI_c20211021__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--OctoberTwentyOneTwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember_zc7nWc13krPh">63,750</span>, such principal and the interest thereon convertible into shares of the Company&#8217;s
common stock at the option of Sixth Street any time after the six-month anniversary of the October 21, 2021 Sixth Street. The October
21, 2021 Sixth Street contains an original discount of $<span id="xdx_907_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20211021__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--OctoberTwentyOneTwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember_zckIAeInq8A9">3,750</span>. The Company intends to use the net proceeds from the October 21, 2021
Sixth Street for general working capital purposes. The maturity date of the October 21, 2021 Sixth Street Note is <span id="xdx_901_eus-gaap--DebtInstrumentMaturityDate_dd_c20211019__20211021__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--OctoberTwentyOneTwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember_zE1DM51b0p48">October 21, 2022</span>. The
October 21, 2021 Sixth Street Note bears interest at a rate of <span id="xdx_90F_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20211019__20211021__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--OctoberTwentyOneTwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember_z6Dh2ArSB0Xf">8%</span> per annum, which interest may be paid by the Company to Sixth Street
in shares of the Company&#8217;s common stock; but shall not be payable until the October 21, 2021 Sixth Street Note becomes payable,
whether at the maturity date or upon acceleration or by prepayment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90E_eus-gaap--DebtInstrumentDescription_c20211019__20211021__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--OctoberTwentyOneTwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember_z7EBQht24Kj8" title="Debt description">During
the first 60 to 180 days following the date of these notes, the Company has the right to prepay the principal and accrued but unpaid
interest due under the above notes issued to Sixth Street, together with any other amounts that the Company may owe the holder under
the terms of the note, at a premium ranging from 110% to 129% as defined in the note agreement. After this initial 180-day period, the
Company does not have a right to prepay such notes.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
conversion price for the above Sixth Street notes shall be equal to a <span id="xdx_90D_ecustom--DebtCoversionPercentage_dp_c20211019__20211021__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--OctoberTwentyOneTwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember_zilqj1sUw0v">35%</span> discount of the market price which means the average of the
lowest three trading prices of the Common Stock for the ten trading days immediately prior to the delivery of a Notice of Conversion.
Notwithstanding the foregoing, Sixth Street shall be restricted from effecting a conversion if such conversion, along with other shares
of the Company&#8217;s common stock beneficially owned by Sixth Street and its affiliates, exceeds <span id="xdx_90E_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_uPure_c20211021__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--OctoberTwentyOneTwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember_zlHWJNKFJQve">9.99%</span> of the outstanding shares of
the Company&#8217;s common stock. These notes are treated as stock settled debt under ASC 480 and accordingly the Company recorded a
total of $<span id="xdx_90E_ecustom--GainFromSettlementOfDebtNet_c20211019__20211021__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--OctoberTwentyOneTwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember_zkIkx4wftODa">34,327</span> put premium.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
above Sixth Street notes contain certain events of default, upon which principal and accrued interest will become immediately due and
payable. In addition, upon an event of default, <span id="xdx_903_eus-gaap--DebtInstrumentInterestRateTerms_c20211019__20211021__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--OctoberTwentyOneTwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember_zxb9fpKcrTDh" title="Debt Instrument, Interest Rate Terms">interest on the outstanding principal shall accrue at a default interest rate of 22%
per annum</span>, or if such rate is usurious or not permitted by current law, then at the highest rate of interest permitted by law. Further,
certain events of default may trigger penalty and liquidated damage provisions.</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_807_eus-gaap--SubsequentEventsTextBlock_zrHwINm5xEU3" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>NOTE
13 &#8211; <span id="xdx_82D_zExNzAej8vwe">SUBSEQUENT EVENTS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><i>Exercise
of Warrants</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">From
July 9, 2021 through September 7, 2021, the Company received aggregate gross proceeds of $<span id="xdx_907_eus-gaap--ProceedsFromWarrantExercises_pp0p0_c20210709__20210907__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_za2JIYRtppHf">275,000
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">from the exercise of <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20210709__20210907__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantsMember_zvTZEwTOekzb">6,875
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Series B Warrants and issued
<span id="xdx_903_eus-gaap--CommonStockSharesIssued_iI_c20210907__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantsMember_z4LaYCMacYo3">6,875</span> shares of common stock. Additionally, the Company issued <span id="xdx_90B_eus-gaap--CommonStockSharesIssued_iI_c20210907__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementClassOfStockAxis__custom--TwelveSeriesAAndAWarrantsMember_zclCoonFaZeg">2,399,988
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">shares of common stock from the
alternate cashless exercise of 12 Series A warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><i>Note
Conversions</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">From
July 1, 2021 through September 20, 2021, the Company issued an aggregate of <span id="xdx_901_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_pid_c20210701__20210920__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zM9BmClAOoXg">6,702,152
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">shares of its common stock
at an average contractual conversion price of $<span id="xdx_90A_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20210920__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zpuhDyv8ks4e">0.02</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">,
ranging from $<span id="xdx_907_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20210920__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--RangeAxis__srt--MinimumMember_zHKmVoo31Uv1">0.01
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">to $<span id="xdx_906_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20210920__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--RangeAxis__srt--MaximumMember_z0wFtzRzYlCj">0.04</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">,
as a result of the conversion of principal of $<span id="xdx_90B_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20210920__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zpA0O2qvXElh">146,348</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">,
</span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">interest of $<span id="xdx_90F_eus-gaap--InterestPayableCurrent_iI_pp0p0_c20210920__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z0M9VSiaK0D8">4,887
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">and conversion fees $<span id="xdx_90E_ecustom--ConversionFees_pp0p0_c20210701__20210920__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zp2IC1QmR0fe">2,250
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">underlying certain outstanding
convertible notes converted during such period. The Company reclassified $<span id="xdx_900_eus-gaap--AdditionalPaidInCapital_iI_pp0p0_c20210923__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z1yVPDDia61c">86,219
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">in put premiums to additional
paid in capital following conversions between July 2021 and September 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>PROPANC
BIOPHARMA, INC. AND SUBSIDIARY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>June
30, 2021 and 2020</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><i>Nathanielsz
Cancellation Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">On
August 12, 2021, the Company entered into a Cancellation Agreement with James Nathanielsz (&#8220;Nathanielsz&#8221;), Chief Executive
Officer and Director of the Company, whereby Nathanielsz agreed to cancel his cash compensation bonus award for fiscal year 2021, ended
June 30, 2021, in exchange for common stock of the Company. The Company and Nathanielsz entered into an Amended and Restated Employment
Agreement dated May 14, 2019 (the &#8220;Agreement&#8221;). Pursuant to the terms of the Agreement, Nathanielsz was eligible to earn
an annual fiscal year cash performance bonus for each fiscal year of his employment period with the Company with a target performance
bonus of <span id="xdx_903_ecustom--PercentageOfBonusOfAnnualBaseSalary_dp_uPure_c20210811__20210812__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--NathanielszCancellationAgreementMember_z0T2IuWy3sub">200%</span> of his average annualized base salary during the fiscal year for which the performance bonus is earned. On July 20, 2021,
Nathanielsz was awarded a &#8220;target&#8221; bonus of <span id="xdx_905_ecustom--PercentageOfBonusOfAnnualBaseSalary_pip0_dp_uPure_c20210719__20210720__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember__us-gaap--TypeOfArrangementAxis__custom--NathanielszCancellationAgreementMember_zYc27273q2X4">78%</span>, or $<span id="xdx_90E_eus-gaap--OfficersCompensation_pp0p0_c20210719__20210720__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember__us-gaap--TypeOfArrangementAxis__custom--NathanielszCancellationAgreementMember_zKxr6FEZST98">177,840</span> USD (the &#8220;Debt&#8221;) for the fiscal year ended June
30, 2021, by the Company&#8217;s Board of Directors (the &#8220;Board&#8221;). Pursuant to the Cancellation Agreement, Nathanielsz agreed
to cancel this Debt in exchange for <span id="xdx_903_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_pp0p0_c20210816__20210817__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember__us-gaap--TypeOfArrangementAxis__custom--NathanielszCancellationAgreementMember_zlMMchIbnZ5k">5,928,000</span> shares of the common stock of the Company (the &#8220;Shares&#8221;), valued at approximately
$<span id="xdx_90C_eus-gaap--SharePrice_iI_pip0_c20210817__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember__us-gaap--TypeOfArrangementAxis__custom--NathanielszCancellationAgreementMember_zktn7yqOiTjj" title="Share price">0.03</span> per share, being the closing price of the stock on the date of grant. The shares were issued on August 17, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><i>Kenyon
Cancellation Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; color: #333333; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">On
August 12, 2021, the Company entered into a Cancellation Agreement with Dr. Julian Kenyon (&#8220;Kenyon&#8221;), Chief Scientific Officer
and Director of the Company, whereby Kenyon agreed to cancel of $<span id="xdx_904_ecustom--CancellationOfAccruedSalaries_iI_c20210812__us-gaap--TypeOfArrangementAxis__custom--KenyonCancellationAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DrKenyonMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zmEuFb0Ox5Ec">102,600 </span>USD of accrued salary due him as of June 30, 2021, pursuant
to that certain Amended and Restated Services Agreement by and between Kenyon and the Company, dated May 14, 2019, in exchange for <span id="xdx_904_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20210811__20210812__us-gaap--TypeOfArrangementAxis__custom--KenyonCancellationAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DrKenyonMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z8XIK8dugdh3">3,420,000</span>
shares of common stock of the Company (the &#8220;Shares&#8221;), valued at approximately $<span id="xdx_90B_eus-gaap--SharePrice_iI_c20210812__us-gaap--TypeOfArrangementAxis__custom--KenyonCancellationAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DrKenyonMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zyhhb8K4FDg4">0.03</span> per share, being the closing price of
the stock on the date of grant. The shares were issued on August 17, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; color: #333333; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><i>Zelinger
Amended and Restated Director Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">On
August 12, 2021, the Company entered into an Amended and Restated Director Agreement (the &#8220;Director Agreement&#8221;) with Josef
Zelinger (&#8220;Zelinger&#8221;). <span id="xdx_903_ecustom--DescriptionOfEmploymentBenefits_c20210811__20210812__us-gaap--TypeOfArrangementAxis__custom--ZelingerAmendedAndRestatedDirectorAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--JosefZelingerMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zNl4i6Kde5w8" title="Description of employment benefits">Pursuant to the terms of the Director Agreement, the Company shall pay Zelinger a base salary of $250.00
AUD per month, payable on the first day of each month. In addition, the Company may compensate Zelinger additional consideration for
advisory services performed by the Director, either in the form of cash or common stock, at the discretion of the Board. The Company
issued <span id="xdx_906_ecustom--CommonStockIssuableShares_iI_c20210630__us-gaap--TypeOfArrangementAxis__custom--ZelingerAmendedAndRestatedDirectorAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--JosefZelingerMember_zBon75o6ZXnc">2,800,000</span> shares of common stock of the Company for accrued director services of $<span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20200701__20210630__us-gaap--TypeOfArrangementAxis__custom--ZelingerAmendedAndRestatedDirectorAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--JosefZelingerMember_zdGzrF2eyRAh">84,000</span> as of June 30, 2021. The <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20200701__20210630__us-gaap--TypeOfArrangementAxis__custom--ZelingerAmendedAndRestatedDirectorAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--JosefZelingerMember_zJJdBMBN9QQe">2,800,000</span> shares
of common stock was valued at approximately $<span id="xdx_90E_eus-gaap--SharePrice_iI_c20210630__us-gaap--TypeOfArrangementAxis__custom--ZelingerAmendedAndRestatedDirectorAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--JosefZelingerMember_zgRYESC6Ujbi">0.03</span> per share, being the closing price of the stock on the date of grant.</span> The shares were
issued on August 17, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><i>Common
Stock Issued for Services</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">On
August 12, 2021, the Board approved the issuance of <span id="xdx_90D_ecustom--CommonStockIssuableShares_iI_c20210812__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementClassOfStockAxis__custom--CommonStockOneMember_zAepDUmVNjb">2,800,000</span> shares of the Company&#8217;s common stock for bonus payable of $<span id="xdx_900_eus-gaap--AccruedBonusesCurrent_iI_c20210630__us-gaap--StatementClassOfStockAxis__custom--CommonStockOneMember_zIC5h5REOc9d" title="Accrued Bonuses">84,000</span>
as of June 30, 2021 to an employee who is the wife of the CEO of the Company. The <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210811__20210812__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementClassOfStockAxis__custom--CommonStockOneMember_zEnAQRCCPkya">2,800,000</span> shares of common stock was valued at approximately
$<span id="xdx_906_eus-gaap--SharePrice_iI_c20210812__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementClassOfStockAxis__custom--CommonStockOneMember_zdbjW1IUGO11">0.03</span> per share, being the closing price of the stock on the date of grant. The shares were issued on August 17, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">On
August 12, 2021, the Board approved the issuance of <span id="xdx_902_ecustom--CommonStockIssuableShares_iI_c20210812__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementClassOfStockAxis__custom--CommonStockTwoMember_zpWrojFpxwP2" title="Common Stock Issuable Shares">166,667</span> shares of the Company&#8217;s common stock for legal services rendered in
August 2021 worth $<span id="xdx_907_eus-gaap--LegalFees_c20210811__20210812__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementClassOfStockAxis__custom--CommonStockTwoMember_zFdllkl1AT64" title="Legal fees">5,000</span>. The <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210811__20210812__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementClassOfStockAxis__custom--CommonStockTwoMember_zLkBE2Ns90yb">5,000</span> shares of common stock was valued at approximately $<span id="xdx_908_eus-gaap--SharePrice_iI_pid_c20210812__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementClassOfStockAxis__custom--CommonStockTwoMember_zaxuWj8NaDc5">0.03</span> per share, being the closing price of the
stock on the date of grant. The shares were issued on September 3, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">In
September 2021, the Company issued <span id="xdx_908_ecustom--CommonStockIssuableShares_iI_c20210930__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementClassOfStockAxis__custom--CommonStockThreeMember_zB3RWONnyTXc">2,819,712</span> shares of the Company&#8217;s common stock to a consultant for services rendered from July
2021 to September 2021. The Company issued <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210901__20210930__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementClassOfStockAxis__custom--CommonStockThreeMember_zZ9u46eCp5w3">2,819,712</span> shares of the Company&#8217;s common stock valued at approximately $<span id="xdx_904_eus-gaap--SharePrice_iI_c20210930__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementClassOfStockAxis__custom--CommonStockThreeMember_zncTt53fx8H5">0.04</span> per share,
being the closing price of the stock on the date of grant to such consultant, or approximately $<span id="xdx_903_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20210901__20210930__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementClassOfStockAxis__custom--CommonStockThreeMember_zoIb9zEbVEz2">113,000</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><i>August
19, 2021 and September 22, 2021 Securities Purchase Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Effective
August 19, 2021, the Company entered into a securities purchase agreement with Geneva Roth Remark Holdings, Inc., pursuant to which
Geneva Roth purchased a convertible promissory note (the &#8220;August 19, 2021 Geneva Roth&#8221;) from the Company in the
aggregate principal amount of $<span id="xdx_903_eus-gaap--DebtInstrumentFaceAmount_iI_c20210819__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--TwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember_zJxwu8JbUVDh">103,750</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">,
such principal and the interest thereon convertible into shares of the Company&#8217;s common stock at the option of Geneva Roth any
time after the six-month anniversary of the August 19, 2021 Geneva Roth. The August 19, 2021 Geneva Roth contains an original
discount of $<span id="xdx_904_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20210819__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--TwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember_zTJl5QYwYr5g">3,750</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">.
The Company intends to use the net proceeds from the August 19, 2021 Geneva Roth for general working capital purposes. </span>The
maturity date of the August 19, 2021 Geneva Roth Note is <span id="xdx_90C_eus-gaap--DebtInstrumentMaturityDate_dd_c20210818__20210819__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--TwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember_zaFr17VByOrj">August
19, 2022</span>. The August 19, 2021 Geneva Roth Note bears interest at a rate of <span id="xdx_905_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20210818__20210819__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--TwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember_zdxFt8OWQKp4">8% </span>per
annum, which interest may be paid by the Company to Geneva Roth in shares of the Company&#8217;s common stock; but shall not be
payable until the August 19, 2021 Geneva Roth Note becomes payable, whether at the maturity date or upon acceleration or by
prepayment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"/></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Additionally, effective September 22, 2021, the
Company entered into a securities purchase agreement with Geneva Roth Remark Holdings, Inc., pursuant to which Geneva Roth purchased
a convertible promissory note (the &#8220;September 22, 2021 Geneva Roth&#8221;) from the Company in the aggregate principal amount of
$<span id="xdx_907_eus-gaap--DebtInstrumentFaceAmount_iI_c20210922__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--TwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember_zcYCx9VF7F8l">63,750</span>, such principal and the interest thereon convertible into shares of the Company&#8217;s common stock at the option of Geneva
Roth any time after the six-month anniversary of the September 22, 2021 Geneva Roth. The September 22, 2021 Geneva Roth contains an original
discount of $<span id="xdx_905_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20210922__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--TwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember_zHu6SSH176ua">3,750</span>. The Company intends to use the net proceeds from the September 22, 2021 Geneva Roth for general working capital purposes.
The maturity date of the <span id="xdx_90A_eus-gaap--DebtInstrumentMaturityDate_dd_c20210921__20210922__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--TwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember_zb91W7EBaEd2">September 22, 2021</span> Geneva Roth Note is September 22, 2022. The September 22, 2021 Geneva Roth Note bears interest
at a rate of <span id="xdx_90B_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20210921__20210922__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--TwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember_zzjAhYzJmcJb">8</span>% per annum, which interest may be paid by the Company to Geneva Roth in shares of the Company&#8217;s common stock; but
shall not be payable until the September 22, 2021 Geneva Roth Note becomes payable, whether at the maturity date or upon acceleration
or by prepayment.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span id="xdx_900_eus-gaap--DebtInstrumentDescription_c20210818__20210819__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--TwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember_zG0J5VNzl6Ef" title="Debt description">During
the first 60 to 180 days following the date of these notes, the Company has the right to prepay the principal and accrued but unpaid
interest due under the above notes issued to Geneva Roth, together with any other amounts that the Company may owe the holder under the
terms of the note, at a premium ranging from 110% to 129% as defined in the note agreement. After this initial 180-day period, the Company
does not have a right to prepay such notes.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
conversion price for the above Geneva Roth notes shall be equal to a <span id="xdx_906_ecustom--DebtCoversionPercentage_dp_c20210818__20210819__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--TwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember_zcSPVFCMNfyc">35%
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">discount of the market price which
means the average of the lowest three trading prices of the Common Stock for the ten trading days immediately prior to the delivery of
a Notice of Conversion. Notwithstanding the foregoing, Geneva Roth shall be restricted from effecting a conversion if such conversion,
along with other shares of the Company&#8217;s common stock beneficially owned by Geneva Roth and its affiliates, exceeds <span id="xdx_905_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_uPure_c20210819__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--TwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember_zEJqORt1zXC5">9.99%
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">of the outstanding shares of the
Company&#8217;s common stock. These notes are treated as stock settled debt under ASC 480 and accordingly the Company recorded a total
of $<span id="xdx_909_ecustom--GainFromSettlementOfDebtNet_c20210818__20210819__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--TwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember_zQ1oTm0LT7ba">90,192
</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">put premium.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
above Geneva Roth notes contain certain events of default, upon which principal and accrued interest will become immediately due and
payable. In addition, upon an event of default, <span id="xdx_909_eus-gaap--DebtInstrumentInterestRateTerms_c20210818__20210819__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--TwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember_zQFItRYrVT9d" title="Debt Instrument, Interest Rate Terms">interest on the outstanding principal shall accrue at a default interest rate of 22%
per annum</span>, or if such rate is usurious or not permitted by current law, then at the highest rate of interest permitted by law. Further,
certain events of default may trigger penalty and liquidated damage provisions.</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI http://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm140460432863064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING AND REPORTING POLICIES (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_NatureOfOperationsPolicyTextBlock', window );">Nature of Operations</a></td>
<td class="text"><p id="xdx_842_ecustom--NatureOfOperationsPolicyTextBlock_zyTsCKnZdqck" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_86D_z2tlihvxFFVh">Nature
of Operations</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">Propanc
Biopharma, Inc. (the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;us&#8221; or &#8220;our&#8221;) was originally incorporated in Melbourne,
Victoria Australia on October 15, 2007 as Propanc PTY LTD, and continues to be based in Camberwell, Victoria Australia. Since its inception,
substantially all of the operations of the Company have been focused on the development of new cancer treatments targeting high-risk
patients, particularly cancer survivors, who need a follow-up, non-toxic, long-term therapy designed to prevent the cancer from returning
and spreading. The Company anticipates establishing global markets for its technologies. Our lead product candidate, which we refer to
as PRP, is an enhanced pro-enzyme formulation designed to enhance the anti-cancer effects of multiple enzymes acting synergistically.
It is currently in the preclinical phase of development.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 26.2pt; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">On
<span id="xdx_908_edei--EntityIncorporationDateOfIncorporation_dd_c20210701__20210930_zsFzMpziuoA7" title="Entity incorporation, date of incorporation">November 23, 2010</span>, the Company was incorporated in the state of Delaware as Propanc Health Group Corporation. In January 2011, to reorganize
the Company, we acquired all of the outstanding shares of Propanc PTY LTD on a one-for-one basis making it a wholly-owned subsidiary
of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">On
July 22, 2016, the Company formed a wholly owned subsidiary, Propanc (UK) Limited under the laws of England and Wales for the purpose
of submitting an orphan drug application to the European Medicines Agency as a small and medium-sized enterprise. As of September 30,
2021, there has been no activity within this entity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">Effective
April 20, 2017, the Company changed its name to &#8220;Propanc Biopharma, Inc.&#8221; to better reflect the Company&#8217;s stage of
operations and development.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">In
July 2020, a world first patent was granted in Australia for the cancer treatment method patent family. Presently, there are 29 granted
patents and 33 patents under examination in key global jurisdictions relating to the use of proenzymes against solid tumors, covering
the lead product candidate PRP.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
Company hopes to capture and protect additional patentable subject matter based on the Company&#8217;s field of technology relating to
pharmaceutical compositions of proenzymes for treating cancer by filing additional patent applications as it advances its lead product
candidate, PRP, through various stages of development.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On
November 17, 2020, the Company effected a <span id="xdx_900_eus-gaap--StockholdersEquityReverseStockSplit_c20201116__20201117_zDGQYeiJ8fv4" title="Reverse stock">one-for-one thousand (1:1,000)</span> reverse stock split of the Company&#8217;s issued and outstanding
shares of common stock (the &#8220;Reverse Stock Split&#8221;). Proportional adjustments for the Reverse Stock Split were made to the
Company&#8217;s outstanding stock options, warrants and equity incentive plans. All share and per-share data and amounts have been retroactively
adjusted as of the earliest period presented in the consolidated financial statements to reflect the Reverse Stock Split.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_84D_ecustom--NatureOfOperationsPolicyTextBlock_zUy1ZG0cJ07l" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="text-decoration: underline"><span id="xdx_864_zskNnen1aczd">Nature
of Operations</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Propanc
Biopharma, Inc. (the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;us&#8221; or &#8220;our&#8221;) was originally incorporated in Melbourne,
Victoria Australia on October 15, 2007 as Propanc PTY LTD, and continues to be based in Camberwell, Victoria Australia. Since its inception,
substantially all of the operations of the Company have been focused on the development of new cancer treatments targeting high-risk
patients, particularly cancer survivors, who need a follow-up, non-toxic, long-term therapy designed to prevent the cancer from returning
and spreading. The Company anticipates establishing global markets for its technologies. Our lead product candidate, which we refer to
as PRP, is an enhanced pro-enzyme formulation designed to enhance the anti-cancer effects of multiple enzymes acting synergistically.
It is currently in the preclinical phase of development.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 29.15pt; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">On
<span id="xdx_902_edei--EntityIncorporationDateOfIncorporation_dd_c20200701__20210630_zjsnh70umwD9" title="Entity incorporation, date of incorporation">November 23, 2010</span>, the Company was incorporated in the state of Delaware as Propanc Health Group Corporation. In January 2011, to reorganize
the Company, we acquired all of the outstanding shares of Propanc PTY LTD on a one-for-one basis making it a wholly-owned subsidiary
of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">On
July 22, 2016, the Company formed a wholly owned subsidiary, Propanc (UK) Limited under the laws of England and Wales for the purpose
of submitting an orphan drug application to the European Medicines Agency as a small and medium-sized enterprise. As of June 30, 2021,
there has been no activity within this entity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Effective
April 20, 2017, the Company changed its name to &#8220;Propanc Biopharma, Inc.&#8221; to better reflect the Company&#8217;s stage of
operations and development.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">In
July 2020, a world first patent was granted in Australia for the cancer treatment method patent family. Presently, there are 29 granted
patents and 33 patents under examination in key global jurisdictions relating to the use of proenzymes against solid tumors, covering
the lead product candidate PRP.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
Company hopes to capture and protect additional patentable subject matter based on the Company&#8217;s field of technology relating to
pharmaceutical compositions of proenzymes for treating cancer by filing additional patent applications as it advances its lead product
candidate, PRP, through various stages of development.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">On
November 17, 2020, the Company effected a <span id="xdx_90D_eus-gaap--StockholdersEquityReverseStockSplit_c20201116__20201117" title="Reverse stock">one-for-one thousand (1:1,000)</span> reverse stock split of the Company&#8217;s issued and outstanding
shares of common stock (the &#8220;Reverse Stock Split&#8221;). Proportional adjustments for the Reverse Stock Split were made to the
Company&#8217;s outstanding stock options, warrants and equity incentive plans. All share and per-share data and amounts have been retroactively
adjusted as of the earliest period presented in the consolidated financial statements to reflect the Reverse Stock Split.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of Consolidation</a></td>
<td class="text"><p id="xdx_84A_eus-gaap--ConsolidationPolicyTextBlock_zUzMhpDH8g1a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_86D_z8DTT4x83H5b">Principles
of Consolidation</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
unaudited condensed consolidated financial statements include the accounts of Propanc Biopharma, Inc., the parent entity, and its wholly-owned
subsidiary, Propanc PTY LTD. All inter-company balances and transactions have been eliminated in consolidation. Propanc (UK) Limited
was an inactive subsidiary at September 30, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>PROPANC
BIOPHARMA, INC. AND SUBSIDIARY<br/>
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS<br/>
SEPTEMBER 30, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Unaudited)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_840_eus-gaap--ConsolidationPolicyTextBlock_zTfyfILZC5Xb" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="text-decoration: underline"><span id="xdx_860_z0xpPnCblBPa">Principles
of Consolidation</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
consolidated financial statements include the accounts of Propanc Biopharma, Inc., the parent entity, and its wholly-owned subsidiary,
Propanc PTY LTD. All inter-company balances and transactions have been eliminated in consolidation. Propanc (UK) Limited was an inactive
wholly-owned subsidiary through June 30, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><p id="xdx_840_eus-gaap--UseOfEstimates_zKH5SsGwZ3P6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_86F_zHD6rxWI4vv5">Use
of Estimates</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
preparation of financial statements in conformity with the accounting principles generally accepted in the United States of America (&#8220;US
GAAP&#8221;) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure
of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses
during the reporting period. Actual results could differ from these estimates. Significant estimates in the accompanying consolidated
financial statements include the estimates of useful lives for depreciation, valuation of the operating lease liability and related right-of-use
asset, valuation of derivatives, valuation of beneficial conversion features on convertible debt, allowance for uncollectable receivables,
valuation of equity based instruments issued for other than cash, the valuation allowance on deferred tax assets and foreign currency
translation due to certain average exchange rates applied in lieu of spot rates on transaction dates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_845_eus-gaap--UseOfEstimates_zzwSrtiWrUj9" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="text-decoration: underline"><span id="xdx_866_zCVztcFqdaWc">Use
of Estimates</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
preparation of financial statements in conformity with the accounting principles generally accepted in the United States of America (&#8220;US
GAAP&#8221;) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure
of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses
during the reporting period. Actual results could differ from these estimates. Significant estimates in the accompanying consolidated
financial statements include the estimates of useful lives for depreciation, valuation of the operating lease liability and related right-of-use
asset, valuation of derivatives, valuation of beneficial conversion features on convertible debt, allowance for uncollectable receivables,
valuation of equity based instruments issued for other than cash, the valuation allowance on deferred tax assets and foreign currency
translation due to certain average exchange rates applied in lieu of spot rates on transaction dates.</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Foreign Currency Translation and Other Comprehensive Income (Loss)</a></td>
<td class="text"><p id="xdx_84D_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zYtRi38HEaAj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_868_zdZ6QdOvTze2">Foreign
Currency Translation and Other Comprehensive Income (Loss)</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
Company&#8217;s wholly owned subsidiary&#8217;s functional currency is the Australian dollar (AUD). For financial reporting purposes,
the Australian dollar has been translated into the Company&#8217;s reporting currency which is the United States dollar ($) and/or (USD).
Assets and liabilities are translated at the exchange rate in effect at the balance sheet date. Revenues and expenses are translated
at the average rate of exchange prevailing during the reporting period. Equity transactions are translated at each historical transaction
date spot rate. Translation adjustments arising from the use of different exchange rates from period to period are included as a component
of stockholders&#8217; equity (deficit) as &#8220;Accumulated other comprehensive income (loss).&#8221; Gains and losses resulting from
foreign currency transactions are included in the statements of operations and comprehensive income (loss) as a component of other comprehensive
income (loss). There have been no significant fluctuations in the exchange rate for the conversion of Australian dollars to USD after
the balance sheet date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">Other
Comprehensive Income (Loss) for all periods presented includes only foreign currency translation gains (losses).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Assets
and liabilities denominated in foreign currencies are translated into the functional currency at the exchange rates prevailing at the
consolidated balance sheet date with any transaction gains and losses that arise from exchange rate fluctuations on transactions denominated
in a currency other than the functional currency included in the consolidated results of operations as incurred. Effective fiscal year
2021, the parent company determined that these intercompany loans will not be repaid in the foreseeable future and thus, per ASC 830-20-35-3,
gains and losses from measuring the intercompany balances are recorded within cumulative translation adjustment, a component of accumulated
other comprehensive income (loss). Prior to July 1, 2020, the Company recorded the foreign currency transaction gains and losses from
measuring the intercompany balances as a component of other income (expenses) titled foreign currency transaction gain (loss). For the
three months ended September 30, 2021 and 2020, the Company recognized an exchange gain (loss) of approximately $<span id="xdx_909_eus-gaap--OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_pp0p0_c20210701__20210930__us-gaap--DebtInstrumentAxis__custom--IntercompanyLoansMember_zOhbETHOlpbj">619,000</span> and ($<span id="xdx_90B_eus-gaap--OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_pp0p0_c20200701__20200930__us-gaap--DebtInstrumentAxis__custom--IntercompanyLoansMember_zKbJ5TpFaGWk">583,000</span>),
on intercompany loans made by the parent to the subsidiary which have not been repaid as of September 30, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_89A_ecustom--ScheduleOfTranslationExchangeRatesTableTextBlock_zzNbOSdcA4v" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">As
of September 30, 2021 and June 30, 2021, the exchange rates used to translate amounts in Australian dollars into USD for the purposes
of preparing the consolidated financial statements were as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.45in"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_8B9_z5Jwt3MLbtk1" style="display: none">SCHEDULE
OF TRANSLATION EXCHANGE RATES</span>&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">September
    30, 2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">June
    30, 2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Exchange rate on balance sheet dates</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">USD : AUD exchange rate</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20210930_zAxoaqp5Oof3" style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.7214</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20210630_zAeNeQUILRnf" style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.7500</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Average exchange rate for the period</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">USD : AUD exchange rate</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20210930__srt--RangeAxis__srt--WeightedAverageMember_zyOm6KwP3orf" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.7350</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20210630__srt--RangeAxis__srt--WeightedAverageMember_zvDey7ZbyR65" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.7473</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p id="xdx_8A8_zfay8WlxJE4a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_893_eus-gaap--ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_zWSkwTH6ECU4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
change in Accumulated Other Comprehensive Income (Loss) by component during the three months ended September 30, 2021 was as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8B7_zATgnOSNnnC6" style="display: none">SCHEDULE
OF CHANGE IN ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Foreign<br/>
    Currency Items:</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 82%"><span style="font-family: Times New Roman, Times, Serif">Balance, June 30, 2021</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iS_pp0p0_c20210701__20210930_zWQXY0qBZeZ4" style="width: 14%; text-align: right" title="Beginning balance"><span style="font-family: Times New Roman, Times, Serif">1,085,204</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Unrealized foreign currency
    translation gain</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_pp0p0_c20210701__20210930_zlbQptq6YdTi" style="border-bottom: Black 1.5pt solid; text-align: right" title="Foreign currency translation gain"><span style="font-family: Times New Roman, Times, Serif">64,193</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Ending balance, September 30, 2021</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iE_pp0p0_c20210701__20210930_z94fy1ZvaCCk" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending balance"><span style="font-family: Times New Roman, Times, Serif">1,149,397</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p id="xdx_8A7_zcAa30ZDSqkj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>PROPANC
BIOPHARMA, INC. AND SUBSIDIARY<br/>
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS<br/>
SEPTEMBER 30, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Unaudited)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_84C_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_z1sqztQEFLQg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="text-decoration: underline"><span id="xdx_86F_zJUFHRfwNmQ9">Foreign
Currency Translation and Other Comprehensive Income (Loss)</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
Company&#8217;s wholly owned subsidiary&#8217;s functional currency is the Australian dollar (AUD). For financial reporting purposes,
the Australian dollar has been translated into the Company&#8217;s reporting currency which is the United States dollar ($) and/or (USD).
Assets and liabilities are translated at the exchange rate in effect at the balance sheet date. Revenues and expenses are translated
at the average rate of exchange prevailing during the reporting period. Equity transactions are translated at each historical transaction
date spot rate. Translation adjustments arising from the use of different exchange rates from period to period are included as a component
of stockholders&#8217; equity (deficit) as &#8220;Accumulated other comprehensive income (loss).&#8221; Gains and losses resulting from
foreign currency transactions are included in the statements of operations and comprehensive income (loss) as a component of other
comprehensive income (loss). There have been no significant fluctuations in the exchange rate for the conversion of Australian dollars
to USD after the balance sheet date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Other
Comprehensive Income (Loss) for all periods presented includes only foreign currency translation gains (losses).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Assets
and liabilities denominated in foreign currencies are translated into the functional currency at the exchange rates prevailing at
the consolidated balance sheet date with any transaction gains and losses that arise from exchange rate fluctuations on transactions
denominated in a currency other than the functional currency included in the consolidated results of operations as incurred.
Effective fiscal year 2021, the parent company determined that these intercompany loans will not be repaid in the foreseeable future
and thus, per ASC 830-20-35-3, gains and losses from measuring the intercompany balances are recorded within cumulative translation
adjustment, a component of accumulated other comprehensive income (loss). Prior to July 1, 2020, the Company recorded the foreign
currency transaction gains and losses from measuring the intercompany balances as a component of other income (expenses) titled
foreign currency transaction gain (loss). For the year ended June 30, 2021 and 2020, the Company recognized an exchange gain
(loss) of approximately $<span id="xdx_901_eus-gaap--OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_c20200701__20210630__us-gaap--DebtInstrumentAxis__custom--IntercompanyLoansMember_pp0p0">1,005,000 </span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">and
($<span id="xdx_90C_eus-gaap--OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_pp0p0_c20190701__20200630__us-gaap--DebtInstrumentAxis__custom--IntercompanyLoansMember_z9cfuN0kVfSk">133,000</span></span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">),
on intercompany loans made by the parent to the subsidiary which have not been repaid as of June 30, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p id="xdx_890_ecustom--ScheduleOfTranslationExchangeRatesTableTextBlock_zHWjPfYgXMZa" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">As
of June 30, 2021 and 2020, the exchange rates used to translate amounts in Australian dollars into USD for the purposes of preparing
the consolidated financial statements were as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;<span id="xdx_8BF_zkh7nqNm3XF1" style="display: none">SCHEDULE OF TRANSLATION EXCHANGE RATES</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>June
    30, 2021</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>June
    30, 2020</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Exchange
    rate on balance sheet dates</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 64%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">USD
    : AUD exchange rate</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td id="xdx_98C_eus-gaap--ForeignCurrencyExchangeRateTranslation1_c20210630_pdd" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">0.7500</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td id="xdx_98D_eus-gaap--ForeignCurrencyExchangeRateTranslation1_c20200630_pdd" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">0.6891</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Average
    exchange rate for the period</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">USD
    : AUD exchange rate</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td id="xdx_981_eus-gaap--ForeignCurrencyExchangeRateTranslation1_c20210630__srt--RangeAxis__srt--WeightedAverageMember_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">0.7473</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td id="xdx_980_eus-gaap--ForeignCurrencyExchangeRateTranslation1_c20200630__srt--RangeAxis__srt--WeightedAverageMember_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">0.6742</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  </table>
<p id="xdx_8A5_zF6IdfJw4yP2" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p id="xdx_89D_eus-gaap--ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_zTTKEp5aN2Mg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Change
in Accumulated Other Comprehensive Income (Loss) by component during the years ended June 30, 2021 and 2020 were as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;<span id="xdx_8BB_z1EztVraTjcc" style="display: none">SCHEDULE OF CHANGE IN ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Foreign<br/>
    Currency Items:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 82%"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Beginning
    balance, June 30, 2019</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td id="xdx_982_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iS_pp0p0_c20190701__20200630_zhNUQVDiorwj" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Beginning balance"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">1,066,998</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Foreign
    currency translation gain</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td id="xdx_983_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_pp0p0_c20190701__20200630_zybFsKiYr1bg" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Foreign currency translation gain"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">200,673</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Balance,
    June 30, 2020</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td id="xdx_98A_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iS_pp0p0_c20200701__20210630_z7l1M52ClLwc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Beginning balance"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">1,267,671</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Foreign
    currency translation gain</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td id="xdx_986_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_pp0p0_c20200701__20210630_zDEdRjzTaONi" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Foreign currency translation gain"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">182,467</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Ending
    balance, June 30, 2021</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td id="xdx_988_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iE_pp0p0_c20200701__20210630_zuP9suUjhKki" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Ending balance"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">1,085,204</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  </table>
<p id="xdx_8A0_zHuOP9xbxVG" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value of Financial Instruments and Fair Value Measurements</a></td>
<td class="text"><p id="xdx_846_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zFC2t1G9CYMj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_864_zKI9KeM2Ukah">Fair
Value of Financial Instruments and Fair Value Measurements</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
Company measures its financial assets and liabilities in accordance with US GAAP. For certain financial instruments, including cash and
cash equivalents, accounts receivable, accounts payable and accrued liabilities, the carrying amounts approximate fair value due to their
short maturities. Amounts recorded for notes payable, net of discount, and loans payable also approximate fair value because current
interest rates available for debt with similar terms and maturities are substantially the same.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
Company follows accounting guidance for financial assets and liabilities. This standard defines fair value, provides guidance for measuring
fair value and requires certain disclosures. This standard does not require any new fair value measurements, but rather applies to all
other accounting pronouncements that require or permit fair value measurements. This guidance does not apply to measurements related
to share-based payments. This guidance discusses valuation techniques, such as the market approach (comparable market prices), the income
approach (present value of future income or cash flow), and the cost approach (cost to replace the service capacity of an asset or replacement
cost).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
guidance utilizes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three broad
levels. The following is a brief description of those three levels:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.95pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Level
1: Observable inputs such as quoted prices (unadjusted) in active markets for identical assets or liabilities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.95pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Level
2: Inputs, other than quoted prices that are observable, either directly or indirectly. These include quoted prices for similar assets
or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.95pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Level
3: Unobservable inputs in which little or no market data exists, therefore developed using estimates and assumptions developed by us,
which reflect those that a market participant would use.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Also
see Note 11 - Derivative Financial Instruments and Fair Value Measurements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_84A_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zVxpyFcjsmfb" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="text-decoration: underline"><span id="xdx_869_zSpI6haJjHrj">Fair
Value of Financial Instruments and Fair Value Measurements</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
Company measures its financial assets and liabilities in accordance with US GAAP. For certain financial instruments, including cash and
cash equivalents, accounts receivable, accounts payable and accrued liabilities, the carrying amounts approximate fair value due to their
short maturities. Amounts recorded for notes payable, net of discount, and loans payable also approximate fair value because current
interest rates available for debt with similar terms and maturities are substantially the same.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
Company follows accounting guidance for financial assets and liabilities. This standard defines fair value, provides guidance for measuring
fair value and requires certain disclosures. This standard does not require any new fair value measurements, but rather applies to all
other accounting pronouncements that require or permit fair value measurements. This guidance does not apply to measurements related
to share-based payments. This guidance discusses valuation techniques, such as the market approach (comparable market prices), the income
approach (present value of future income or cash flow), and the cost approach (cost to replace the service capacity of an asset or replacement
cost).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
guidance utilizes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three broad
levels. The following is a brief description of those three levels:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.2in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Level
1: Observable inputs such as quoted prices (unadjusted) in active markets for identical assets or liabilities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.2in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Level
2: Inputs, other than quoted prices that are observable, either directly or indirectly. These include quoted prices for similar assets
or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.2in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Level
3: Unobservable inputs in which little or no market data exists, therefore developed using estimates and assumptions developed by us,
which reflect those that a market participant would use.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Also
see Note 12 - Derivative Financial Instruments and Fair Value Measurements.</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text"><p id="xdx_844_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_z9t6VlcKAS8g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_861_zD9uCZl5Cas9">Cash
and Cash Equivalents</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">Cash
and cash equivalents include cash on hand and at banks, short-term deposits with an original maturity of three months or less with financial
institutions, and bank overdrafts. Bank overdrafts are reflected as a current liability on the balance sheets. There were <span id="xdx_907_eus-gaap--CashEquivalentsAtCarryingValue_iI_pp0p0_do_c20200930_zOFhHXa6w5rk">no</span> cash equivalents
as of September 30, 2021 or June 30, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_849_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zbBtLCxM8FT2" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="text-decoration: underline"><span id="xdx_86B_zOfKCWdOLVRd">Cash
and Cash Equivalents</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Cash
and cash equivalents include cash on hand and at banks, short-term deposits with an original maturity of three months or less with financial
institutions, and bank overdrafts. Bank overdrafts, as applicable, are reflected as a current liability on the balance sheets.
There were <span id="xdx_903_eus-gaap--CashEquivalentsAtCarryingValue_iI_pp0p0_do_c20200630_zZ1eOJKYJYr7">no</span></span> <span style="font: 10pt Times New Roman, Times, Serif; color: Black">cash
equivalents as of June 30, 2021 or June 30, 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and Equipment</a></td>
<td class="text"><p id="xdx_845_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zACW3ttl00x5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_866_zLBSJMg94jY4">Property
and Equipment</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">Property
and equipment are stated at cost, net of accumulated depreciation. Expenditures for maintenance and repairs are expensed as incurred;
additions, renewals, and betterments are capitalized. When property and equipment are retired or otherwise disposed of, the related cost
and accumulated depreciation are removed from the respective accounts, and any gain or loss is included in operations. Depreciation of
property and equipment is provided using the declining balance method. The depreciable amount is the cost less its residual value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_891_ecustom--ScheduleOfPropertyAndEquipmentEstimatedUsefulLivesTableTextBlock_zt2mxbVoEEWc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
estimated useful lives are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8B4_zrzjwdUOooq6" style="display: none">SCHEDULE
OF PROPERTY AND EQUIPMENT ESTIMATED USEFUL LIVES</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 25%"><span style="font: 10pt Times New Roman, Times, Serif">Machinery
    and equipment</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 75%"><span style="font: 10pt Times New Roman, Times, Serif">-
    <span id="xdx_90F_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210701__20210930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_zgVFwUSlH806">5</span> years</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">Furniture</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">-
    <span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210701__20210930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zmrWJFVBDMYc">7</span> years</span></td></tr>
  </table>
<p id="xdx_8A6_zyicsnfsPJy8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_84B_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zfg52EPJexy6" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="text-decoration: underline"><span id="xdx_862_zHWcQfXqSLH3">Property
and Equipment</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Property
and equipment are stated at cost, net of accumulated depreciation. Expenditures for maintenance and repairs are expensed as incurred;
additions, renewals, and betterments are capitalized. When property and equipment are retired or otherwise disposed of, the related cost
and accumulated depreciation are removed from the respective accounts, and any gain or loss is included in operations. Depreciation of
property and equipment is provided using the declining balance method. The depreciable amount is the cost less its residual value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p id="xdx_892_ecustom--ScheduleOfPropertyAndEquipmentEstimatedUsefulLivesTableTextBlock_z3AwX2Xd0mO4" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
estimated useful lives are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;<span id="xdx_8BA_zTqP1ilC57ma" style="display: none">SCHEDULE OF PROPERTY AND EQUIPMENT ESTIMATED USEFUL LIVES</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 28%"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Machinery
    and equipment</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 72%"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">-
    <span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200701__20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_zOXkToZUepQc" title="Property and equipment estimated useful lives">5</span> years</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Furniture</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">-
    <span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200701__20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zW81xzQcQdSg" title="Property and equipment estimated useful lives">7</span> years</span></td></tr>
  </table>
<p id="xdx_8A6_zca7BRRp6xl5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy', window );">Patents</a></td>
<td class="text"><p id="xdx_843_eus-gaap--GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_zpLA1iRncFHg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_868_zax2qkWhbWie">Patents</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">Patents
are stated at cost and amortized on a straight-line basis over the estimated future periods if and once the patent has been granted by
a regulatory agency. However, the Company will expense any patent costs as long as we are in the startup stage. Accordingly, as the Company&#8217;s
products are not currently approved for market, all patent costs incurred from 2013 through September 30, 2021 were expensed immediately.
This practice of expensing patent costs immediately ends when a product receives market authorization from a government regulatory agency.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_841_eus-gaap--GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_zv8lJAmH5La9" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="text-decoration: underline"><span id="xdx_863_zdGUX8vUhRsb">Patents</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 29.15pt; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Patents
are stated at cost and amortized on a straight-line basis over the estimated future periods if and once the patent has been granted by
a regulatory agency. However, the Company will expense any patent costs as long as we are in the startup stage. Accordingly, as the Company&#8217;s
products are not currently approved for market, all patent costs incurred from 2013 through June 30, 2021 were expensed immediately.
This practice of expensing patent costs immediately ends when a product receives market authorization from a government regulatory agency.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Impairment of Long-Lived Assets</a></td>
<td class="text"><p id="xdx_847_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zR7zOXittAmg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_86A_zfgxcl3KPwSa">Impairment
of Long-Lived Assets</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">In
accordance with ASC 360-10, &#8220;<i>Long-lived assets,&#8221;</i> which include property and equipment and intangible assets, are reviewed
for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability
of long-lived assets to be held and used is measured by a comparison of the carrying amount of an asset to the estimated undiscounted
future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated undiscounted future
cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the
assets. Fair value is generally determined using the asset&#8217;s expected future discounted cash flows or market value, if readily
determinable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>PROPANC
BIOPHARMA, INC. AND SUBSIDIARY<br/>
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS<br/>
SEPTEMBER 30, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Unaudited)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_845_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zey8gFOmZPEd" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="text-decoration: underline"><span id="xdx_86C_zgKIFAsI1sVj">Impairment
of Long-Lived Assets</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.45in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">In
accordance with ASC 360-10, &#8220;Long-lived assets,&#8221; which include property and equipment and intangible assets, are reviewed
for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability
of long-lived assets to be held and used is measured by a comparison of the carrying amount of an asset to the estimated undiscounted
future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated undiscounted future
cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the
assets. Fair value is generally determined using the asset&#8217;s expected future discounted cash flows or market value, if readily
determinable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeStockOwnershipPlanESOPPolicy', window );">Employee Benefit/Liability</a></td>
<td class="text"><p id="xdx_847_eus-gaap--EmployeeStockOwnershipPlanESOPPolicy_zKcRPhz1cmDl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_86B_zKiRtMFzZSlc">Employee
Benefit/Liability</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">Liabilities
arising in respect of wages and salaries, accumulated annual leave, accumulated long service leave and any other employee benefits expected
to be settled within twelve months of the reporting date are measured based on the employee&#8217;s remuneration rates applicable at
the reporting date. All other employee benefit liabilities are measured at the present value of the estimated future cash outflow to
be made in respect of services provided by employees up to the reporting date. All employee liabilities are owed within the next twelve
months.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_84B_eus-gaap--EmployeeStockOwnershipPlanESOPPolicy_zh3AyswVz5Te" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="text-decoration: underline"><span id="xdx_860_zYj1IsvzQ9N5">Employee
Benefit/Liability</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Liabilities
arising in respect of wages and salaries, accumulated annual leave, accumulated long service leave and any other employee benefits expected
to be settled within twelve months of the reporting date are measured based on the employee&#8217;s remuneration rates applicable at
the reporting date. All other employee benefit liabilities are measured at the present value of the estimated future cash outflow to
be made in respect of services provided by employees up to the reporting date. All employee liabilities are owed within the next twelve
months.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_GoodsAndServiceTaxPolicyTextBlock', window );">Australian Goods and Services Tax (&#8220;GST&#8221;)</a></td>
<td class="text"><p id="xdx_845_ecustom--GoodsAndServiceTaxPolicyTextBlock_zFkquLvQEsN1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_86E_zAcVIJZd3dT8">Australian
Goods and Services Tax (&#8220;GST&#8221;)</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">Revenues,
expenses and balance sheet items are recognized net of the amount of GST, except payable and receivable balances which are shown inclusive
of GST. The GST incurred is payable on revenues to, and recoverable on purchases from, the Australian Taxation Office.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">Cash
flows are presented in the statements of cash flow on a gross basis, except for the GST component of investing and financing activities,
which are disclosed as operating cash flows.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">As
of September 30, 2021, and June 30, 2021, the Company was owed $<span id="xdx_904_eus-gaap--ValueAddedTaxReceivableCurrent_iI_pp0p0_c20210930_zNHlbbV7dpad" title="Value added tax receivable">2,238</span> and $<span id="xdx_90A_eus-gaap--ValueAddedTaxReceivableCurrent_iI_pp0p0_c20200930_zQ4JT5NkFXzk" title="Value added tax receivable">4,341</span>, respectively, from the Australian Taxation Office.
These amounts were fully collected subsequent to the balance sheet reporting dates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_84B_ecustom--GoodsAndServiceTaxPolicyTextBlock_zXRt2fYMNCde" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="text-decoration: underline"><span id="xdx_861_zXbULMoiEBt1">Australian
Goods and Services Tax (&#8220;GST&#8221;)</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Revenues,
expenses and balance sheet items are recognized net of the amount of GST, except payable and receivable balances which are shown inclusive
of GST. The GST incurred is payable on revenues to, and recoverable on purchases from, the Australian Taxation Office.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Cash
flows are presented in the statements of cash flow on a gross basis, except for the GST component of investing and financing activities,
which are disclosed as operating cash flows.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">As
of June 30, 2021 and 2020, the Company was owed $<span id="xdx_908_eus-gaap--ValueAddedTaxReceivableCurrent_c20210630_pp0p0" title="Value added tax receivable">4,341</span> and $<span id="xdx_90B_eus-gaap--ValueAddedTaxReceivableCurrent_c20200630_pp0p0" title="Value added tax receivable">2,015</span>, respectively, from the Australian Taxation Office. These amounts were
fully collected subsequent to the balance sheet reporting dates.</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesReportingOfDerivativeActivity', window );">Derivative Instruments</a></td>
<td class="text"><p id="xdx_847_eus-gaap--DerivativesReportingOfDerivativeActivity_zQ2WlEN1DWE6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_861_zc8e4LzGljd1">Derivative
Instruments</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">ASC
Topic 815, <i>Derivatives and Hedging</i> (&#8220;ASC Topic 815&#8221;), establishes accounting and reporting standards for derivative
instruments and for hedging activities by requiring that all derivatives be recognized in the balance sheet and measured at fair value.
Gains or losses resulting from changes in the fair value of derivatives are recognized in earnings. On the date of conversion or payoff
of debt, the Company records the fair value of the conversion shares, removes the fair value of the related derivative liability, removes
any discounts and records a net gain or loss on debt extinguishment. On July 1, 2019 the Company adopted ASU 2017-11 under which down-round
Features in Financial Instruments will no longer cause derivative treatment. The Company applies the modified prospective method of adoption.
There were no cumulative effects on adoption.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_84C_eus-gaap--DerivativesReportingOfDerivativeActivity_zPkIWm6mIOdb" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="text-decoration: underline"><span id="xdx_866_z26UFsPBAyH9">Derivative
Instruments</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">ASC
Topic 815, <i>Derivatives and Hedging</i> (&#8220;ASC Topic 815&#8221;), establishes accounting and reporting standards for derivative
instruments and for hedging activities by requiring that all derivatives be recognized in the balance sheet and measured at fair value.
Gains or losses resulting from changes in the fair value of derivatives are recognized in earnings. On the date of conversion or payoff
of debt, the Company records the fair value of the conversion shares, removes the fair value of the related derivative liability, removes
any discounts and records a net gain or loss on debt extinguishment. On July 1, 2019 the Company adopted ASU 2017-11 under which down-round
Features in Financial Instruments will no longer cause derivative treatment. The Company applies the modified prospective method of adoption.
There were no cumulative effects on adoption.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_ConvertibleNotesPolicyTextBlock', window );">Convertible Notes With Variable Conversion Options</a></td>
<td class="text"><p id="xdx_845_ecustom--ConvertibleNotesPolicyTextBlock_zxn5O0pSGSxg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_861_zqNXrYouGBs7">Convertible
Notes With Variable Conversion Options</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
Company has entered into convertible notes, some of which contain variable conversion options, whereby the outstanding principal and
accrued interest may be converted, by the holder, into common shares at a fixed discount to the price of the common stock at or around
the time of conversion. The Company treats these convertible notes as stock settled debt under ASC 480, &#8220;<i>Distinguishing Liabilities
from Equity</i>&#8221; and measures the fair value of the notes at the time of issuance, which is the result of the share price discount
at the time of conversion and records the put premium as interest expense.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_84D_ecustom--ConvertibleNotesPolicyTextBlock_zxajUQ2alEZ1" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="text-decoration: underline"><span id="xdx_86C_zoAjEhAqQMW4">Convertible
Notes With Variable Conversion Options</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 29.15pt; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
Company has entered into convertible notes, some of which contain variable conversion options, whereby the outstanding principal and
accrued interest may be converted, by the holder, into common shares at a fixed discount to the price of the common stock at or around
the time of conversion. The Company treats these convertible notes as stock settled debt under ASC 480, &#8220;<i>Distinguishing Liabilities
from Equity</i>&#8221; and measures the fair value of the notes at the time of issuance, which is the result of the share price discount
at the time of conversion and records the put premium as interest expense.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><p id="xdx_848_eus-gaap--IncomeTaxPolicyTextBlock_zhOGS6N4HyHb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_86B_z4ulDnTrWbva">Income
Taxes</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
Company is governed by Australia and United States income tax laws, which are administered by the Australian Taxation Office and the
United States Internal Revenue Service, respectively. The Company follows ASC 740 &#8220;<i>Accounting for Income Taxes</i>,&#8221; when
accounting for income taxes, which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred
income tax assets and liabilities are computed annually for temporary differences between the financial statements and tax bases of assets
and liabilities that will result in taxable or deductible amounts in the future based on enacted tax laws and rates applicable to the
periods in which the differences are expected to affect taxable income. Valuation allowances are established when necessary to reduce
deferred tax assets to the amount expected to be realized. Income tax expense is the tax payable or refundable for the period plus or
minus the change during the period in deferred tax assets and liabilities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
Company follows ASC 740, Sections 25 through 60, &#8220;<i>Accounting for Uncertainty in Income Taxes</i>.&#8221; These sections provide
detailed guidance for the financial statement recognition, measurement and disclosure of uncertain tax positions recognized in the financial
statements. Tax positions must meet a &#8220;more-likely-than-not&#8221; recognition threshold at the effective date to be recognized
upon the adoption of ASC 740 and in subsequent periods.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_843_eus-gaap--IncomeTaxPolicyTextBlock_zN0Zlr1p7J9g" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="text-decoration: underline"><span id="xdx_86C_zPUZwyGp2WM5">Income
Taxes</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 29.15pt; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
Company is governed by Australia and United States income tax laws, which are administered by the Australian Taxation Office and the
United States Internal Revenue Service, respectively. The Company follows ASC 740 &#8220;<i>Accounting for Income Taxes</i>,&#8221; when
accounting for income taxes, which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred
income tax assets and liabilities are computed annually for temporary differences between the financial statements and tax bases of assets
and liabilities that will result in taxable or deductible amounts in the future based on enacted tax laws and rates applicable to the
periods in which the differences are expected to affect taxable income. Valuation allowances are established when necessary to reduce
deferred tax assets to the amount expected to be realized. Income tax expense is the tax payable or refundable for the period plus or
minus the change during the period in deferred tax assets and liabilities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 29.15pt; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
Company follows ASC 740, Sections 25 through 60, &#8220;<i>Accounting for Uncertainty in Income Taxes</i>.&#8221; These sections provide
detailed guidance for the financial statement recognition, measurement and disclosure of uncertain tax positions recognized in the financial
statements. Tax positions must meet a &#8220;more-likely-than-not&#8221; recognition threshold at the effective date to be recognized
upon the adoption of ASC 740 and in subsequent periods.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and Development Costs and Tax Credits</a></td>
<td class="text"><p id="xdx_842_eus-gaap--ResearchAndDevelopmentExpensePolicy_zhSDwzgwptn3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_864_z7raaBtt59u1">Research
and Development Costs and Tax Credits</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">In
accordance with ASC 730-10, <i>&#8220;Research and Development-Overall,&#8221;</i> research and development costs are expensed when incurred.
Total research and development costs for the three months ended September 30, 2021 and 2020 were $<span id="xdx_901_eus-gaap--ResearchAndDevelopmentExpense_pp0p0_c20210701__20210930_z8IQi4E6xGXk">46,554</span> and $<span id="xdx_90B_eus-gaap--ResearchAndDevelopmentExpense_pp0p0_c20200701__20200930_zKalVQgW6Sua">50,846</span>, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>PROPANC
BIOPHARMA, INC. AND SUBSIDIARY<br/>
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS<br/>
SEPTEMBER 30, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Unaudited)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
Company may apply for research and development tax concessions with the Australian Taxation Office on an annual basis. Although the amount
is possible to estimate at year end, the Australian Taxation Office may reject or materially alter the claim amount. Accordingly, the
Company does not recognize the benefit of the claim amount until cash receipt since collectability is not certain until such time. The
tax concession is a refundable credit. If the Company has net income, then the Company can receive the credit which reduces its income
tax liability. If the Company has net losses, then the Company may still receive a cash payment for the credit, however, the Company&#8217;s
net operating loss carryforwards are reduced by the gross equivalent loss that would produce the credit amount when the income tax rate
is applied to that gross amount. The concession is recognized as tax benefit, in operations, upon receipt.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">During
each of the three months ended September 30, 2021 and 2020, the Company applied for, and received from the Australian Taxation Office,
a research and development tax credit in the amount of $<span id="xdx_900_eus-gaap--IncomeTaxExpenseBenefit_iN_pp0p0_dixL_c20200701__20200930_zfbdkDjR4Lw6" title="::XDX::-"><span id="xdx_90E_eus-gaap--IncomeTaxExpenseBenefit_iN_pp0p0_dixL_c20210701__20210930_zu8lPCnqt6u" title="Tax credits::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl3304"><span style="-sec-ix-hidden: xdx2ixbrl3306">0</span></span></span></span>, which is reflected as a tax benefit in the accompanying unaudited condensed
consolidated statements of operations and comprehensive income (loss).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_84F_eus-gaap--ResearchAndDevelopmentExpensePolicy_zQCpNdwyFt72" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="text-decoration: underline"><span id="xdx_861_zChCCKk1NlA1">Research
and Development Costs and Tax Credits</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">In
accordance with ASC 730-10, <i>&#8220;Research and Development-Overall,&#8221;</i> research and development costs are expensed when incurred.
Total research and development costs for the fiscal years ended June 30, 2021 and 2020 were $<span id="xdx_909_eus-gaap--ResearchAndDevelopmentExpense_c20200701__20210630_pp0p0" title="Research and development costs">230,956</span> and $<span id="xdx_90A_eus-gaap--ResearchAndDevelopmentExpense_pp0p0_c20190701__20200630_z8D3lSanDVD5" title="Research and development costs">179,987</span>, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
Company may apply for research and development tax concessions with the Australian Taxation Office on an annual basis. Although the amount
is possible to estimate at year end, the Australian Taxation Office may reject or materially alter the claim amount. Accordingly, the
Company does not recognize the benefit of the claim amount until cash receipt since collectability is not certain until such time. The
tax concession is a refundable credit. If the Company has net income, then the Company can receive the credit which reduces its income
tax liability. If the Company has net losses, then the Company may still receive a cash payment for the credit, however, the Company&#8217;s
net operating loss carryforwards are reduced by the gross equivalent loss that would produce the credit amount when the income tax rate
is applied to that gross amount. The concession is recognized as tax benefit, in operations, upon receipt.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">During
each of the fiscal years ended June 30, 2021 and 2020, the Company applied for, and received from the Australian Taxation Office, a research
and development tax credit in the amount of $<span id="xdx_905_eus-gaap--IncomeTaxExpenseBenefit_iN_pp0p0_di_c20200701__20210630_zk1027s4V9Fe" title="Tax credits">113,415 </span>and $<span id="xdx_901_eus-gaap--IncomeTaxExpenseBenefit_iN_pp0p0_di_c20190701__20200630_zG6ZTffrCXsj">134,728</span>, respectively, which is reflected as a tax benefit in the accompanying
consolidated statements of operations and comprehensive income (loss).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Stock Based Compensation</a></td>
<td class="text"><p id="xdx_847_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_z7ocjmQGNxmd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_86D_zxXe6dOqY3P8">Stock
Based Compensation</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
Company records stock-based compensation in accordance with ASC 718, &#8220;<i>Stock Compensation</i>&#8221;. ASC 718 requires the fair
value of all stock-based employee compensation awarded to employees to be recorded as an expense over the shorter of the service period
or the vesting period. The Company values employee and non-employee stock-based compensation at fair value using the Black-Scholes Option
Pricing Model.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
Company adopted ASU 2018-07 and accounts for non-employee share-based awards in accordance with the measurement and recognition criteria
of ASC 718 and recognizes the fair value of such awards over the service period. The Company used the modified prospective method of
adoption. There was no cumulative effect of adoption on July 1, 2019.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_846_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zaUFPhFSnEja" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="text-decoration: underline"><span id="xdx_861_zBj3dM4Ckci3">Stock
Based Compensation</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
Company records stock-based compensation in accordance with ASC 718, &#8220;<i>Stock Compensation</i>&#8221;. ASC 718 requires the fair
value of all stock-based employee compensation awarded to employees to be recorded as an expense over the shorter of the service period
or the vesting period. The Company values employee and non-employee stock-based compensation at fair value using the Black-Scholes Option
Pricing Model.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>PROPANC
BIOPHARMA, INC. AND SUBSIDIARY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>June
30, 2021 and 2020</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
Company adopted ASU 2018-07 and accounts for non-employee share-based awards in accordance with the measurement and recognition criteria
of ASC 718 and recognizes the fair value of such awards over the service period. The Company used the modified prospective method of
adoption. There was no cumulative effect of adoption on July 1, 2019.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><p id="xdx_842_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zoI5lfak5jZ7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_866_zQ0pBQvL2eDf">Revenue
Recognition</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
Company adopted and implemented on July 1, 2018, ASC 606 &#8211; Revenue from Contracts with Customers (&#8220;ASC 606&#8221;). ASC 606
did not have a material impact on the consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Upon
implementation of ASC 606, the Company recognizes revenue in accordance with that core principle by applying the following steps:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Step
1: Identify the contract(s) with a customer.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Step
2: Identify the performance obligations in the contract.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Step
3: Determine the transaction price.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Step
4: Allocate the transaction price to the performance obligations in the contract.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Step
5: Recognize revenue when (or as) the entity satisfies a performance obligation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">Subject
to these criteria, the Company intends to recognize revenue relating to royalties on product sales in the period in which the sale occurs
and the royalty term has begun.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_84A_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zLQNRYxs3VV5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="text-decoration: underline"><span id="xdx_86E_zEV4U1sMubQc">Revenue
Recognition</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
Company adopted and implemented on July 1, 2018, ASC 606 &#8211; Revenue from Contracts with Customers (&#8220;ASC 606&#8221;). ASC 606
did not have a material impact on the consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Upon
implementation of ASC 606, the Company recognizes revenue in accordance with that core principle by applying the following steps:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Step
1: Identify the contract(s) with a customer.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Step
2: Identify the performance obligations in the contract.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Step
3: Determine the transaction price.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Step
4: Allocate the transaction price to the performance obligations in the contract.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Step
5: Recognize revenue when (or as) the entity satisfies a performance obligation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 29.15pt; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Subject
to these criteria, the Company intends to recognize revenue relating to royalties on product sales in the period in which the sale occurs
and the royalty term has begun.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LegalCostsPolicyTextBlock', window );">Legal Expenses</a></td>
<td class="text"><p id="xdx_845_eus-gaap--LegalCostsPolicyTextBlock_zYIGCDDncv8f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_869_zZfv7SoMGD11">Legal
Expenses</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">All
legal costs for litigation are charged to expense as incurred.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_846_eus-gaap--LegalCostsPolicyTextBlock_z7Q8kazLnfD2" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="text-decoration: underline"><span id="xdx_86A_zAg6XnkCAfwa">Legal
Expenses</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">All
legal costs for litigation are charged to expense as incurred.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text"><p id="xdx_84E_eus-gaap--LesseeLeasesPolicyTextBlock_zXunrNvs61Gc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_868_zSbh3EyY4Kej">Leases</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In
February 2016, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued ASU 2016-02, <i>Leases</i> (Topic 842). The updated
guidance requires lessees to recognize lease assets and lease liabilities for most operating leases. In addition, the updated guidance
requires that lessors separate lease and non-lease components in a contract in accordance with the new revenue guidance in ASC 606. This
guidance is effective for interim and annual reporting periods beginning after December 15, 2018. The Company adopted this guidance effective
July 1, 2019.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On
July 1, 2019, the Company adopted ASU No. 2016-02, applying the package of practical expedients to leases that commenced before the effective
date whereby the Company elected to not reassess the following: (i) whether any expired or existing contracts contain leases and; (ii)
initial direct costs for any existing leases. For contracts entered into on or after the effective date, at the inception of a contract
the Company assessed whether the contract is, or contains, a lease. The Company&#8217;s assessment is based on: (1) whether the contract
involves the use of a distinct identified asset, (2) whether we obtain the right to substantially all the economic benefit from the use
of the asset throughout the period, and (3) whether it has the right to direct the use of the asset. The Company will allocate the consideration
in the contract to each lease component based on its relative stand-alone price to determine the lease payments. In addition, the Company
elected not to apply ASC Topic 842 to arrangements with lease terms of 12 months or less.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Operating
lease ROU assets represents the right to use the leased asset for the lease term and operating lease liabilities are recognized based
on the present value of future minimum lease payments over the lease term at commencement date. As most leases do not provide an implicit
rate, the Company use an incremental borrowing rate based on the information available at the adoption date in determining the present
value of future payments. Lease expense for minimum lease payments is amortized on a straight-line basis over the lease term and will
be included in general and administrative expenses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>PROPANC
BIOPHARMA, INC. AND SUBSIDIARY<br/>
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS<br/>
SEPTEMBER 30, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Unaudited)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_848_eus-gaap--LesseeLeasesPolicyTextBlock_zdlobmuL7B78" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="text-decoration: underline"><span id="xdx_86D_zjYfYbFZC052">Leases</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">In
February 2016, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued ASU 2016-02, <i>Leases</i> (Topic 842). The updated
guidance requires lessees to recognize lease assets and lease liabilities for most operating leases. In addition, the updated guidance
requires that lessors separate lease and non-lease components in a contract in accordance with the new revenue guidance in ASC 606. This
guidance is effective for interim and annual reporting periods beginning after December 15, 2018. The Company adopted this guidance effective
July 1, 2019.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">On
July 1, 2019, the Company adopted ASU No. 2016-02, applying the package of practical expedients to leases that commenced before the effective
date whereby the Company elected to not reassess the following: (i) whether any expired or existing contracts contain leases and; (ii)
initial direct costs for any existing leases. For contracts entered into on or after the effective date, at the inception of a contract
the Company assessed whether the contract is, or contains, a lease. The Company&#8217;s assessment is based on: (1) whether the contract
involves the use of a distinct identified asset, (2) whether we obtain the right to substantially all the economic benefit from the use
of the asset throughout the period, and (3) whether it has the right to direct the use of the asset. The Company will allocate the consideration
in the contract to each lease component based on its relative stand-alone price to determine the lease payments.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Operating
lease ROU assets represents the right to use the leased asset for the lease term and operating lease liabilities are recognized based
on the present value of future minimum lease payments over the lease term at commencement date. As most leases do not provide an implicit
rate, the Company use an incremental borrowing rate based on the information available at the adoption date in determining the present
value of future payments. Lease expense for minimum lease payments is amortized on a straight-line basis over the lease term and is included
in general and administrative expenses in the consolidated statements of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Basic and Diluted Net Loss Per Common Share</a></td>
<td class="text"><p id="xdx_84E_eus-gaap--EarningsPerSharePolicyTextBlock_zpfEBsYvPCak" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_869_zIeaaJNnPy08">Basic
and Diluted Net Loss Per Common Share</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Basic
net loss per share is computed by dividing the net loss by the weighted average number of common shares outstanding during the period.
Diluted net loss per common share is computed by dividing the net loss by the weighted average number of common shares outstanding for
the period and, if dilutive, potential common shares outstanding during the period. Potentially dilutive securities consist of the incremental
common shares issuable upon exercise of common stock equivalents such as stock options, warrants and convertible debt instruments. Potentially
dilutive securities are excluded from the computation if their effect is anti-dilutive. As a result, the basic and diluted per share
amounts for all periods presented are identical. <span id="xdx_902_eus-gaap--DebtInstrumentConvertibleTermsOfConversionFeature_c20210701__20210930_zELEU7ykKkIk" title="Debt conversion percentage, description">Each holder of the notes has agreed to a <span id="xdx_904_eus-gaap--DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_pid_dp_uPure_c20200701__20210630_zhcROCTayfJi" title="Debt conversion percentage">4.99</span>% beneficial ownership conversion limitation
(subject to certain noteholders&#8217; ability to increase such limitation to <span id="xdx_906_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_uPure_c20210819__us-gaap--TypeOfArrangementAxis__custom--TwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember_zjDxTQNnQMx6">9.99</span>% upon 60 days&#8217; notice to the Company), and each
note may not be converted during the first six-month period from the date of issuance. The securities for the period ended September
30, 2021 and 2020 were considered dilutive securities which were excluded from the computation since the effect is anti-dilutive.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span title="Debt conversion percentage, description">&#160;</span></span></p>

<p id="xdx_89A_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zLusIxCV0JF5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8B8_z5qGGqx37Jgb" style="display: none">SCHEDULE
OF DILUTIVE SECURITIES EXCLUDED FROM COMPUTATION</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 100%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">September
    30, 2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">September
    30, 2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Unaudited)</b></span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Unaudited)</b></span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Stock Options</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20210701__20210930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_zRWorJnhqvNc" style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">59</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20200701__20200930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_zlntA9renUm6" style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">60</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Stock Warrants</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20210701__20210930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zM5tes7KTZa" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">111,932</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20200701__20200930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zt22Rh7qyBR8" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">135,725</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Unvested restricted stock</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20210701__20210930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--UnvestedRestrictedStockMember_ziQ1XBlUpRa9" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">59</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20200701__20200930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--UnvestedRestrictedStockMember_zaZOZ38j94Hd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">117</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Convertible Debt</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20210701__20210930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertibleDebtSecuritiesMember_zadTQYWGAgi6" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">23,293,971</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_981_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20200701__20200930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertibleDebtSecuritiesMember_zsFdubolj81a" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">510,674</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20210701__20210930_zjRj7iczs6t1" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">23,406,021</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20200701__20200930_zQ6W7BJxm8Kh" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">646,576</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p id="xdx_8A6_ztUc5Ua4Aso2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_844_eus-gaap--EarningsPerSharePolicyTextBlock_zz34xJHutc16" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="text-decoration: underline"><span id="xdx_864_zK6mVblSbdGl">Basic
and Diluted Net Loss Per Common Share</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Basic
net loss per share is computed by dividing the net loss by the weighted average number of common shares outstanding during the period.
Diluted net loss per common share is computed by dividing the net loss by the weighted average number of common shares outstanding for
the period and, if dilutive, potential common shares outstanding during the period. Potentially dilutive securities consist of the incremental
common shares issuable upon exercise of common stock equivalents such as stock options, warrants and convertible debt instruments. Potentially
dilutive securities are excluded from the computation if their effect is anti-dilutive. As a result, the basic and diluted per share
amounts for all periods presented are identical. <span id="xdx_903_eus-gaap--DebtInstrumentConvertibleTermsOfConversionFeature_c20200701__20210630_zq4qmcOL3Smg" title="Debt conversion percentage, description">Each holder of the notes has agreed to a <span id="xdx_904_eus-gaap--DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_pid_dp_uPure_c20200701__20210630_zzJU4tiDdpIk" title="Debt conversion percentage">4.99</span>% beneficial ownership conversion limitation
(subject to certain noteholders&#8217; ability to increase such limitation to 9.99% upon 60 days&#8217; notice to the Company)</span>, and each
note may not be converted during the first six-month period from the date of issuance. Such securities are considered dilutive securities
which were excluded from the computation since the effect is anti-dilutive.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>PROPANC
BIOPHARMA, INC. AND SUBSIDIARY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>June
30, 2021 and 2020</b></span></p>

<p id="xdx_898_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zp7ZAEmlQrYd" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span id="xdx_8B9_zWwXX59WoQ27" style="display: none">SCHEDULE OF DILUTIVE SECURITIES EXCLUDED FROM COMPUTATION</span>&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 100%; margin-right: auto">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>June
    30, 2021</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>June
    30, 2020</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 64%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Stock
    Options</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td id="xdx_981_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20200701__20210630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_zRF3jRJ6r1te" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Antidilutive securities excluded from computation of earnings per share"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">59</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td id="xdx_987_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20190701__20200630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_zloQygdbzAlh" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Antidilutive securities excluded from computation of earnings per share"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">60</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Stock
    Warrants</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td id="xdx_98E_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20200701__20210630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zNOzT456LxB6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Antidilutive securities excluded from computation of earnings per share"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">121,329</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td id="xdx_98D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20190701__20200630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zNtlaS94tWTe" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Antidilutive securities excluded from computation of earnings per share"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">151,171</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Unvested
    restricted stock</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td id="xdx_986_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20200701__20210630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--UnvestedRestrictedStockMember_zafhpGNhbIA6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Antidilutive securities excluded from computation of earnings per share"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">59</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td id="xdx_982_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20190701__20200630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--UnvestedRestrictedStockMember_zLMxtEOeqQAc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Antidilutive securities excluded from computation of earnings per share"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">59</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Convertible
    Debt</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td id="xdx_984_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20200701__20210630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertibleDebtSecuritiesMember_zx6G7fcxhV22" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Antidilutive securities excluded from computation of earnings per share"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">12,416,972</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td id="xdx_981_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20190701__20200630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertibleDebtSecuritiesMember_z4ty7l1bgPGc" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Antidilutive securities excluded from computation of earnings per share"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">439,113</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Total</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td id="xdx_98D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20200701__20210630_zS2qhAKAAjyf" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Antidilutive securities excluded from computation of earnings per share"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">12,538,419</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td id="xdx_986_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20190701__20200630_zsjYE0XRyHH4" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Antidilutive securities excluded from computation of earnings per share"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">590,403</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  </table>
<p id="xdx_8A2_z3r805ucvGn" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Pronouncements</a></td>
<td class="text"><p id="xdx_841_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zFYh4pSJ2Re4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_863_zJh69seVZbtk">Recent
Accounting Pronouncements</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">We
have reviewed the FASB issued ASU accounting pronouncements and interpretations thereof that have effectiveness dates during the periods
reported and in future periods. We have carefully considered the new pronouncements that alter previous generally accepted accounting
principles and do not believe that any new or modified principles will have a material impact on the Company&#8217;s reported financial
position or operations in the near term. The applicability of any standard is subject to the formal review of the Company&#8217;s financial
management.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In
August 2020, the FASB issued ASU 2020-06, &#8220;Debt &#8211; Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives
and Hedging &#8211; Contracts in Entity&#8217;s Own Equity (Subtopic 815-40)&#8221;. This ASU reduces the number of accounting models
for convertible debt instruments and convertible preferred stock. As well as amend the guidance for the derivatives scope exception for
contracts in an entity&#8217;s own equity to reduce form-over-substance-based accounting conclusions. In addition, this ASU improves
and amends the related EPS guidance. This standard is effective for us on July 1, 2022, including interim periods within those fiscal
years. Adoption is either a modified retrospective method or a fully retrospective method of transition. The Company is currently assessing
the impact the new guidance will have on our consolidated financial statements.</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_84F_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zaCjb7rqrmle" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="text-decoration: underline"><span id="xdx_864_zqGyiHQTKivb">Recent
Accounting Pronouncements</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">We
have reviewed the FASB issued ASU accounting pronouncements and interpretations thereof that have effectiveness dates during the periods
reported and in future periods. We have carefully considered the new pronouncements that alter previous generally accepted accounting
principles and do not believe that any new or modified principles will have a material impact on the Company&#8217;s reported financial
position or operations in the near term with the exception of those disclosed below. The applicability of any standard is subject
to the formal review of the Company&#8217;s financial management.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In
August 2020, the FASB issued ASU 2020-06, &#8220;Debt &#8211; Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives
and Hedging &#8211; Contracts in Entity&#8217;s Own Equity (Subtopic 815-40)&#8221;. This ASU reduces the number of accounting models
for convertible debt instruments and convertible preferred stock. As well as amend the guidance for the derivatives scope exception for
contracts in an entity&#8217;s own equity to reduce form-over-substance-based accounting conclusions. In addition, this ASU improves
and amends the related EPS guidance. This standard is effective for us on July 1, 2022, including interim periods within those fiscal
years. Adoption is either a modified retrospective method or a fully retrospective method of transition. The Company is currently assessing
the impact the new guidance will have on our consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><p id="xdx_848_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zU3e1cFXZ2z2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_86B_zmrKinaSEaT2">Basis
of Presentation</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
Company&#8217;s interim unaudited condensed consolidated financial statements included in this Quarterly Report on Form 10-Q (this &#8220;Quarterly
Report&#8221;) have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;US
GAAP&#8221;) and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;). In the opinion
of the Company&#8217;s management, all adjustments (consisting of normal recurring adjustments and reclassifications and non-recurring
adjustments) necessary to present fairly our results of operations for the three months ended September 30, 2021 and 2020 and cash flows
for the three months ended September 30, 2021 and 2020 and our financial position at September 30, 2021 have been made. The Company&#8217;s
results of operations for the three months ended September 30, 2021 are not necessarily indicative of the operating results to be expected
for the full fiscal year ending June 30, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Certain
information and disclosures normally included in the notes to the Company&#8217;s annual audited consolidated financial statements have
been condensed or omitted from the Company&#8217;s interim unaudited condensed consolidated financial statements included in this Quarterly
Report. Accordingly, these interim unaudited condensed consolidated financial statements should be read in conjunction with the Company&#8217;s
audited consolidated financial statements and notes thereto for the fiscal year ended June 30, 2021. The June 30, 2021 balance sheet
is derived from those statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_ConvertibleNotesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Convertible Notes [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_ConvertibleNotesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_GoodsAndServiceTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Goods And Service Tax [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_GoodsAndServiceTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_NatureOfOperationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nature Of Operations [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_NatureOfOperationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4273-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesReportingOfDerivativeActivity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for derivatives entered into for trading purposes and those entered into for purposes other than trading including where and when derivative financial instruments and derivative commodity instruments and their related gains or losses are reported in the entity's statements of financial position, cash flows, and results of operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579240-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesReportingOfDerivativeActivity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeStockOwnershipPlanESOPPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for ESOP transactions, including the method of measuring compensation, the classification of dividends on ESOP shares, and the treatment of ESOP shares for EPS computations. If the employer has both old ESOP shares for which it does not adopt new guidance and new ESOP shares for which new guidance is required, these disclosures are required for both blocks of shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 40<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109244661&amp;loc=d3e17540-113929<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeStockOwnershipPlanESOPPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 60<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=7493716&amp;loc=d3e21868-110260<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13279-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -URI http://asc.fasb.org/topic&amp;trid=2175825<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for intangible assets. This accounting policy may address both intangible assets subject to amortization and those that are not. The following also may be disclosed: (1) a description of intangible assets (2) the estimated useful lives of those assets (3) the amortization method used (4) how the entity assesses and measures impairment of such assets (5) how future cash flows are estimated (6) how the fair values of such asset are determined.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109226317&amp;loc=d3e202-110218<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011434&amp;loc=d3e125687-122742<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32847-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL116659661-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32280-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LegalCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for legal costs incurred to protect or defend the entity's assets and rights, or to obtain assets, including monetary damages, or to obtain rights.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section S99<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=27011672&amp;loc=d3e149975-122751<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LegalCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918666-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130561-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130563-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130563-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130564-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm140460441788120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING AND REPORTING POLICIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_ScheduleOfTranslationExchangeRatesTableTextBlock', window );">SCHEDULE OF TRANSLATION EXCHANGE RATES</a></td>
<td class="text"><p id="xdx_89A_ecustom--ScheduleOfTranslationExchangeRatesTableTextBlock_zzNbOSdcA4v" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">As
of September 30, 2021 and June 30, 2021, the exchange rates used to translate amounts in Australian dollars into USD for the purposes
of preparing the consolidated financial statements were as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.45in"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_8B9_z5Jwt3MLbtk1" style="display: none">SCHEDULE
OF TRANSLATION EXCHANGE RATES</span>&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">September
    30, 2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">June
    30, 2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Exchange rate on balance sheet dates</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">USD : AUD exchange rate</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20210930_zAxoaqp5Oof3" style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.7214</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20210630_zAeNeQUILRnf" style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.7500</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Average exchange rate for the period</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">USD : AUD exchange rate</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20210930__srt--RangeAxis__srt--WeightedAverageMember_zyOm6KwP3orf" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.7350</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20210630__srt--RangeAxis__srt--WeightedAverageMember_zvDey7ZbyR65" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.7473</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<span></span>
</td>
<td class="text"><p id="xdx_890_ecustom--ScheduleOfTranslationExchangeRatesTableTextBlock_zHWjPfYgXMZa" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">As
of June 30, 2021 and 2020, the exchange rates used to translate amounts in Australian dollars into USD for the purposes of preparing
the consolidated financial statements were as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;<span id="xdx_8BF_zkh7nqNm3XF1" style="display: none">SCHEDULE OF TRANSLATION EXCHANGE RATES</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>June
    30, 2021</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>June
    30, 2020</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Exchange
    rate on balance sheet dates</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 64%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">USD
    : AUD exchange rate</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td id="xdx_98C_eus-gaap--ForeignCurrencyExchangeRateTranslation1_c20210630_pdd" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">0.7500</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td id="xdx_98D_eus-gaap--ForeignCurrencyExchangeRateTranslation1_c20200630_pdd" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">0.6891</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Average
    exchange rate for the period</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">USD
    : AUD exchange rate</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td id="xdx_981_eus-gaap--ForeignCurrencyExchangeRateTranslation1_c20210630__srt--RangeAxis__srt--WeightedAverageMember_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">0.7473</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td id="xdx_980_eus-gaap--ForeignCurrencyExchangeRateTranslation1_c20200630__srt--RangeAxis__srt--WeightedAverageMember_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">0.6742</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  </table>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">SCHEDULE OF CHANGE IN ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)</a></td>
<td class="text"><p id="xdx_893_eus-gaap--ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_zWSkwTH6ECU4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
change in Accumulated Other Comprehensive Income (Loss) by component during the three months ended September 30, 2021 was as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8B7_zATgnOSNnnC6" style="display: none">SCHEDULE
OF CHANGE IN ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Foreign<br/>
    Currency Items:</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 82%"><span style="font-family: Times New Roman, Times, Serif">Balance, June 30, 2021</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iS_pp0p0_c20210701__20210930_zWQXY0qBZeZ4" style="width: 14%; text-align: right" title="Beginning balance"><span style="font-family: Times New Roman, Times, Serif">1,085,204</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Unrealized foreign currency
    translation gain</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_pp0p0_c20210701__20210930_zlbQptq6YdTi" style="border-bottom: Black 1.5pt solid; text-align: right" title="Foreign currency translation gain"><span style="font-family: Times New Roman, Times, Serif">64,193</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Ending balance, September 30, 2021</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iE_pp0p0_c20210701__20210930_z94fy1ZvaCCk" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending balance"><span style="font-family: Times New Roman, Times, Serif">1,149,397</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<span></span>
</td>
<td class="text"><p id="xdx_89D_eus-gaap--ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_zTTKEp5aN2Mg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Change
in Accumulated Other Comprehensive Income (Loss) by component during the years ended June 30, 2021 and 2020 were as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;<span id="xdx_8BB_z1EztVraTjcc" style="display: none">SCHEDULE OF CHANGE IN ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Foreign<br/>
    Currency Items:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 82%"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Beginning
    balance, June 30, 2019</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td id="xdx_982_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iS_pp0p0_c20190701__20200630_zhNUQVDiorwj" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Beginning balance"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">1,066,998</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Foreign
    currency translation gain</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td id="xdx_983_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_pp0p0_c20190701__20200630_zybFsKiYr1bg" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Foreign currency translation gain"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">200,673</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Balance,
    June 30, 2020</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td id="xdx_98A_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iS_pp0p0_c20200701__20210630_z7l1M52ClLwc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Beginning balance"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">1,267,671</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Foreign
    currency translation gain</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td id="xdx_986_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_pp0p0_c20200701__20210630_zDEdRjzTaONi" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Foreign currency translation gain"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">182,467</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Ending
    balance, June 30, 2021</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td id="xdx_988_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iE_pp0p0_c20200701__20210630_zuP9suUjhKki" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Ending balance"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">1,085,204</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  </table>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_ScheduleOfPropertyAndEquipmentEstimatedUsefulLivesTableTextBlock', window );">SCHEDULE OF PROPERTY AND EQUIPMENT ESTIMATED USEFUL LIVES</a></td>
<td class="text"><p id="xdx_891_ecustom--ScheduleOfPropertyAndEquipmentEstimatedUsefulLivesTableTextBlock_zt2mxbVoEEWc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
estimated useful lives are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8B4_zrzjwdUOooq6" style="display: none">SCHEDULE
OF PROPERTY AND EQUIPMENT ESTIMATED USEFUL LIVES</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 25%"><span style="font: 10pt Times New Roman, Times, Serif">Machinery
    and equipment</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 75%"><span style="font: 10pt Times New Roman, Times, Serif">-
    <span id="xdx_90F_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210701__20210930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_zgVFwUSlH806">5</span> years</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">Furniture</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">-
    <span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210701__20210930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zmrWJFVBDMYc">7</span> years</span></td></tr>
  </table>
<span></span>
</td>
<td class="text"><p id="xdx_892_ecustom--ScheduleOfPropertyAndEquipmentEstimatedUsefulLivesTableTextBlock_z3AwX2Xd0mO4" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
estimated useful lives are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;<span id="xdx_8BA_zTqP1ilC57ma" style="display: none">SCHEDULE OF PROPERTY AND EQUIPMENT ESTIMATED USEFUL LIVES</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 28%"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Machinery
    and equipment</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 72%"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">-
    <span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200701__20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_zOXkToZUepQc" title="Property and equipment estimated useful lives">5</span> years</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Furniture</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">-
    <span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200701__20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zW81xzQcQdSg" title="Property and equipment estimated useful lives">7</span> years</span></td></tr>
  </table>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">SCHEDULE OF DILUTIVE SECURITIES EXCLUDED FROM COMPUTATION</a></td>
<td class="text"><p id="xdx_89A_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zLusIxCV0JF5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8B8_z5qGGqx37Jgb" style="display: none">SCHEDULE
OF DILUTIVE SECURITIES EXCLUDED FROM COMPUTATION</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 100%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">September
    30, 2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">September
    30, 2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Unaudited)</b></span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Unaudited)</b></span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Stock Options</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20210701__20210930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_zRWorJnhqvNc" style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">59</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20200701__20200930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_zlntA9renUm6" style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">60</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Stock Warrants</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20210701__20210930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zM5tes7KTZa" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">111,932</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20200701__20200930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zt22Rh7qyBR8" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">135,725</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Unvested restricted stock</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20210701__20210930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--UnvestedRestrictedStockMember_ziQ1XBlUpRa9" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">59</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20200701__20200930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--UnvestedRestrictedStockMember_zaZOZ38j94Hd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">117</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Convertible Debt</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20210701__20210930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertibleDebtSecuritiesMember_zadTQYWGAgi6" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">23,293,971</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_981_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20200701__20200930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertibleDebtSecuritiesMember_zsFdubolj81a" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">510,674</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20210701__20210930_zjRj7iczs6t1" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">23,406,021</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20200701__20200930_zQ6W7BJxm8Kh" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">646,576</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<span></span>
</td>
<td class="text"><p id="xdx_898_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zp7ZAEmlQrYd" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span id="xdx_8B9_zWwXX59WoQ27" style="display: none">SCHEDULE OF DILUTIVE SECURITIES EXCLUDED FROM COMPUTATION</span>&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 100%; margin-right: auto">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>June
    30, 2021</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>June
    30, 2020</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 64%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Stock
    Options</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td id="xdx_981_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20200701__20210630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_zRF3jRJ6r1te" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Antidilutive securities excluded from computation of earnings per share"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">59</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td id="xdx_987_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20190701__20200630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_zloQygdbzAlh" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Antidilutive securities excluded from computation of earnings per share"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">60</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Stock
    Warrants</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td id="xdx_98E_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20200701__20210630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zNOzT456LxB6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Antidilutive securities excluded from computation of earnings per share"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">121,329</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td id="xdx_98D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20190701__20200630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zNtlaS94tWTe" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Antidilutive securities excluded from computation of earnings per share"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">151,171</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Unvested
    restricted stock</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td id="xdx_986_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20200701__20210630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--UnvestedRestrictedStockMember_zafhpGNhbIA6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Antidilutive securities excluded from computation of earnings per share"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">59</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td id="xdx_982_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20190701__20200630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--UnvestedRestrictedStockMember_zLMxtEOeqQAc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Antidilutive securities excluded from computation of earnings per share"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">59</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Convertible
    Debt</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td id="xdx_984_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20200701__20210630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertibleDebtSecuritiesMember_zx6G7fcxhV22" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Antidilutive securities excluded from computation of earnings per share"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">12,416,972</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td id="xdx_981_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20190701__20200630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertibleDebtSecuritiesMember_z4ty7l1bgPGc" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Antidilutive securities excluded from computation of earnings per share"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">439,113</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Total</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td id="xdx_98D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20200701__20210630_zS2qhAKAAjyf" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Antidilutive securities excluded from computation of earnings per share"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">12,538,419</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td id="xdx_986_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20190701__20200630_zsjYE0XRyHH4" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Antidilutive securities excluded from computation of earnings per share"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">590,403</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  </table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_ScheduleOfPropertyAndEquipmentEstimatedUsefulLivesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of Property and Equipment Estimated Useful Lives [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_ScheduleOfPropertyAndEquipmentEstimatedUsefulLivesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_ScheduleOfTranslationExchangeRatesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of Translation Exchange Rates [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_ScheduleOfTranslationExchangeRatesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm140460440613960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">SCHEDULE OF PROPERTY AND EQUIPMENT</a></td>
<td class="text"><p id="xdx_897_eus-gaap--PropertyPlantAndEquipmentTextBlock_zg8Ghbs3Cm4d" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">Property
and equipment consist of the following as of September 30, 2021 and June 30, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8BD_zxaUS1cN4CT3" style="display: none">SCHEDULE
OF PROPERTY AND EQUIPMENT</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_49C_20210930_zAUwbf34Hci3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">September
    30, 2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_49C_20210630_zkfliRIteW57" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">June
    30, 2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(Unaudited)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_maPPAENzBVB_zWa3ZPXSA1sj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Office equipment at cost</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">27,532</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">28,623</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_msPPAENzBVB_zJIDwd7Qqdoa" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Less: Accumulated depreciation</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(23,939</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(24,368</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--PropertyPlantAndEquipmentNet_iTI_pp0p0_mtPPAENzBVB_zCIlyNdbrAOk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total property, plant,
    and equipment</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,593</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,255</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<span></span>
</td>
<td class="text"><p id="xdx_895_eus-gaap--PropertyPlantAndEquipmentTextBlock_zmgFlYHfXWwc" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Property
and equipment consist of the following as of June 30,</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;<span id="xdx_8BB_zh0whEB5uiQ7" style="display: none">SCHEDULE OF PROPERTY AND EQUIPMENT</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 100%; margin-right: auto">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" id="xdx_490_20210630_zLQ8erGmgJRd" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>2021</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" id="xdx_493_20200630_zCZkbynpGDZc" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>2020</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_maPPAENzBVB_zZKQJHKCiSUf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 64%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Office
    equipment at cost</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">28,623</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">26,299</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_msPPAENzBVB_zh2Xl4FSeynh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Less:
    Accumulated depreciation</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(24,368</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(20,552</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--PropertyPlantAndEquipmentNet_iTI_pp0p0_mtPPAENzBVB_zTBB9pS58rT2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Total
    property, plant, and equipment</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">4,255</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">5,747</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Depreciation
expense for the years ended June 30, 2021 and 2020 were $<span id="xdx_908_eus-gaap--Depreciation_c20200701__20210630_pp0p0" title="Depreciation expense">1,993</span> and $<span id="xdx_908_eus-gaap--Depreciation_pp0p0_c20190701__20200630_zlHMWyp9Oy4" title="Depreciation expense">2,473</span>, respectively</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>PROPANC
BIOPHARMA, INC. AND SUBSIDIARY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>June
30, 2021 and 2020</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm140460440388248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONVERTIBLE NOTES (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleDebtTableTextBlock', window );">SCHEDULE OF CONVERTIBLE NOTES</a></td>
<td class="text"><p id="xdx_897_eus-gaap--ConvertibleDebtTableTextBlock_zjBtvrzAXz4j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
Company&#8217;s convertible notes outstanding at September 30, 2021 and June 30, 2021 were as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_8B0_zcA9zJu0m1X9" style="display: none">SCHEDULE
OF CONVERTIBLE NOTES</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_491_20210930_zAp0KEWZ480k" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">September
    30, 2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_497_20210630_zyLLJTngGXul" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">June
    30, 2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(Unaudited)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--DebtInstrumentCarryingAmount_iI_pp0p0_maLTDzcuB_zeR5AoxnitQ" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Convertible notes and debenture</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 17%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">377,780</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 15%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">400,128</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--DebtInstrumentUnamortizedDiscount_iNI_pp0p0_di_msLTDzcuB_z1VTqFyrK7xb" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Unamortized discounts</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(7,565</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(6,139</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_40C_eus-gaap--DepositLiabilitiesAccruedInterest_iI_pp0p0_maLTDzcuB_zzTn53DC3CG" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Accrued interest</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">37,348</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">34,098</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--DebtInstrumentUnamortizedPremium_iI_pp0p0_maLTDzcuB_ztrTE0IiZtYh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Premium, net</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">177,045</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">196,496</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--LongTermDebt_iTI_pp0p0_mtLTDzcuB_zuIe10MIoIM4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Convertible notes,
    net</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">584,608</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">624,583</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<span></span>
</td>
<td class="text"><p id="xdx_89C_eus-gaap--ConvertibleDebtTableTextBlock_ziVRkGrZePIh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
Company&#8217;s convertible notes outstanding at June 30, 2021 and 2020 were as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; display: none; color: Black">&#160;<span id="xdx_8BA_zvU50JaaWwyd">SCHEDULE OF CONVERTIBLE NOTES</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 100%; margin-right: auto">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" id="xdx_494_20210630_zsrmn1iivXZg" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>June
    30, 2021</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" id="xdx_49B_20200630_zuQpL0kHaTa" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>June
    30, 2020</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td></tr>
  <tr id="xdx_403_eus-gaap--DebtInstrumentCarryingAmount_iI_pp0p0_maLTDzcuB_zuxg3RTxe1Li" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 64%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Convertible
    notes and debenture</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">400,128</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">1,029,496</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--DebtInstrumentUnamortizedDiscount_iNI_pp0p0_di_msLTDzcuB_zuUODCdu4b44" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Unamortized
    discounts</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(6,139</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(126,667</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td></tr>
  <tr id="xdx_40C_eus-gaap--DepositLiabilitiesAccruedInterest_iI_pp0p0_maLTDzcuB_zPzWSAs6KWd3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Accrued
    interest</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">34,098</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">80,101</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--DebtInstrumentUnamortizedPremium_iI_pp0p0_maLTDzcuB_zEJVrrhbTgpb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Premium,
    net</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">196,496</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">574,804</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--LongTermDebt_iTI_pp0p0_mtLTDzcuB_z7Pcz6TEePia" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Convertible
    notes, net</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">624,583</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">1,557,734</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  </table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of convertible debt instrument. Includes, but is not limited to, principal amount and amortized premium or discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm140460440246984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">SCHEDULE OF INCOME TAX PROVISION</a></td>
<td class="text"><p id="xdx_898_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zq6pSYl2gst8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
reconciliation of income tax expense computed at the U.S. federal statutory rate of <span id="xdx_903_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPercentage_c20200701__20210630_zcMFKyG8phE7" title="Income tax percentage"><span id="xdx_901_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPercentage_c20190701__20200630_zdBxwBfsNkA" title="Income tax percentage">21</span></span>% to the income tax provision for the years ended
June 30, 2021 and 2020 is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 8.5pt Segoe UI,sans-serif; margin: 0"><span id="xdx_8B8_zxxl79r3HSs9" style="display: none">SCHEDULE OF INCOME TAX PROVISION</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"/></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">US</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td colspan="2" id="xdx_49B_20200701__20210630__srt--StatementGeographicalAxis__country--US_zSgCEesLAXfb" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">June
    30, 2021</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td colspan="2" id="xdx_49A_20190701__20200630__srt--StatementGeographicalAxis__country--US_zYj9eqzE26Te" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">June
    30, 2020</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Year
    Ended</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">US</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>June
    30, 2021</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>June
    30, 2020</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_pp0p0_zhUJF5Fi5dNi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Loss
    before Income taxes</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(2,025,947</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(4,740,723</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_maITEBzOQe_zIU9tqeaUh9g" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Taxes
    under statutory US tax rates</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(425,449</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(995,552</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td></tr>
  <tr id="xdx_409_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_maITEBzOQe_z4vI3oRSIpf9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Increase
    (decrease) in valuation allowance</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">1,146,001</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">1,137,716</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--IncomeTaxReconciliationPriorYearIncomeTaxes_maITEBzOQe_z9iQbvGBkZa1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Prior
    period adjustment</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(1,063,710</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(14,624</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--IncomeTaxReconciliationForeignIncomeTaxRateDifferential_maITEBzOQe_z3kFZI11ojl9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Foreign
    tax rate differential</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(51,169</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(128,492</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td></tr>
  <tr id="xdx_40C_eus-gaap--IncomeTaxReconciliationTaxCredits_pp0p0_msITEBzOQe_znRgF8OODJA7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Income
    tax rate change</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">392,767</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl1703">&#160;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">-</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--IncomeTaxReconciliationOtherAdjustments_maITEBzOQe_zLHrjdfb1Frc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Other</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">1,559</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">952</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--IncomeTaxExpenseBenefit_iT_pp0p0_mtITEBzOQe_z8TaVF0Tk2Ql" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Income
    tax (expense) benefit</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl1708">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl1709">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  </table>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES</a></td>
<td class="text"><p id="xdx_89E_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zV4ys0tVWbi4" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span><span id="xdx_8BF_zUvJ23zA4ce2" style="display: none">SCHEDULE
OF DEFERRED TAX ASSETS AND LIABILITIES</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"/></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td colspan="2" id="xdx_493_20210630_zA7OqSLxk0rh" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">June
    30, 2021</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td colspan="2" id="xdx_49F_20200630_z2u0FqruVlw1" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">June
    30, 2020</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Year
    Ended</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>June
    30, 2021</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>June
    30, 2020</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Deferred
    tax assets</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_400_ecustom--DeferredTaxAssetsWarrantDerivativeLiability_iI_pp0p0_maDTAGzhU3_zsIM3aiSPan3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Warrant
    Derivative Liability</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">7,403</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">7,403</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_iI_pp0p0_maDTAGzhU3_z39v0JmmRzgh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Accrued
    Expenses</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">342,464</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">297,086</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_404_ecustom--DeferredTaxAssetsPrepaidInvestorServices_iI_pp0p0_maDTAGzhU3_zs5z5qnLjCR7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Prepaid
    Investor Services</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">444,411</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">470,050</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_40A_ecustom--DeferredTaxAssetsNonCashInterest_iI_pp0p0_maDTAGzhU3_zbruP5l38mra" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Non-cash
    interest</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">687,529</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">596,004</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--DeferredTaxAssetsGoodwillAndIntangibleAssets_iI_pp0p0_maDTAGzhU3_z1IjbyuZlJNf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Intangibles
    (Intellectual Property and Patent Cost)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">259,743</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">240,428</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent_iI_pp0p0_maDTAGzhU3_zlAyguQLKql9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Deferred
    Rent</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">4,262</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">1,969</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseOther_iI_pp0p0_maDTAGzhU3_zh29TakOlpN8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Formation
    Expense</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">6,815</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">7,208</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_pp0p0_maDTAGzhU3_zeN7NzTpnym2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Net
    Operating Loss CF</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">8,546,920</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">7,438,911</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_40F_ecustom--DeferredTaxAssetsForeignExchangeLoss_iI_pp0p0_maDTAGzhU3_znhJOjUBv9zc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Foreign
    Exchange Loss (OCI)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(39,379</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(39,379</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td></tr>
  <tr id="xdx_40E_ecustom--DeferredTaxAssetsRevalueOfDerivativeLiability_iI_pp0p0_maDTAGzhU3_z2qrS8FEmXae" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Revalue
    of derivative liability</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">439,958</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">438,239</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_iI_pp0p0_maDTAGzhU3_zUq5QwOWluRd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Stock
    Based Compensation</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">51,481</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">51,481</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--DeferredTaxAssetsGross_iTI_pp0p0_mtDTAGzhU3_maDTANz51B_zSomKbWDzIM8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Total
    Deferred tax assets</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">10,751,607</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">9,509,400</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Deferred
    tax liabilities</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts_iNI_pp0p0_di_maDITLzdtb_zrJP4gkoj7Ib" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">R&amp;D</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(197,604</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(177,702</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td></tr>
  <tr id="xdx_40F_ecustom--DeferredTaxLiabilitiesGainOnExtinguishmentOfDebt_iNI_pp0p0_di_maDITLzdtb_zSyJS2MFsJx6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Gain
    on extinguishment of debt</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(277,614</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">266,987</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts_iNI_pp0p0_di_maDITLzdtb_zTEacSOpGxXe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Capital
    Raising Costs</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(321,291</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(255,614</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td></tr>
  <tr id="xdx_403_eus-gaap--DeferredIncomeTaxLiabilities_iNTI_pp0p0_di_mtDITLzdtb_msDTANz51B_zaDntMXslQF1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Total
    deferred tax liabilities</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(796,509</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(700,303</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--DeferredTaxAssetsNet_iI_pp0p0_mtDTANz51B_maDTALNzVhZ_z8gpYprBgWF3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Net
    deferred tax assets (liabilities)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">9,955,098</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">8,809,097</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pp0p0_di_msDTALNzVhZ_zTERLOTkxohh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Valuation
    allowance</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(9,955,098</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(8,809,097</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td></tr>
  <tr id="xdx_401_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iI_pp0p0_mtDTALNzVhZ_z2rv3BpLnS55" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Net
    deferred tax assets (liabilities)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl1772">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl1773">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  </table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm140460430479912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS&#8217; DEFICIT (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">SCHEDULE OF STOCK OPTION ACTIVITY</a></td>
<td class="text"><p id="xdx_89C_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zoqy7CeBTuXf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">A
summary of the Company&#8217;s option activity during the three months ended September 30, 2021 is presented below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8B4_zmh1iYU4qpng" style="display: none">SCHEDULE
OF STOCK OPTION ACTIVITY</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Number of</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Average Exercise</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Shares</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Price
    Per Share</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%"><span style="font-family: Times New Roman, Times, Serif">Outstanding at June 30, 2021</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20210701__20210930_z51ifCEyQQS9" style="width: 14%; text-align: right" title="Number of Shares, Outstanding, Beginning balance"><span style="font-family: Times New Roman, Times, Serif">59</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20210701__20210930_z0rx5Kwkyr14" style="width: 14%; text-align: right" title="Weighted Average Price Per Share, Outstanding, Beginning balance"><span style="font-family: Times New Roman, Times, Serif">13,730</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">Issued</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_c20210701__20210930_zOKcK7k2XQW1" style="text-align: right" title="Number of Shares, Issued"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3765">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20210701__20210930_zHBULMkZ5u8" style="text-align: right" title="Weighted Average Price Per Share, Issued"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3767">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">Exercised</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20210701__20210930_zTZzX1tDCJqa" style="text-align: right" title="Number of Shares, Exercised"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3769">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20210701__20210930_z5HJiarD8QA7" style="text-align: right" title="Weighted Average Price Per Share, Exercised"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3771">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">Forfeited</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c20210701__20210930_zqSUqZrPkma7" style="text-align: right" title="Number of Shares, Forfeited"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3773">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20210701__20210930_zzLJvnToAvj9" style="text-align: right" title="Weighted Average Price Per Share, Forfeited"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3775">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Expired</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_c20210701__20210930_zAfG2knRVrw1" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Shares, Expired"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3777">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_c20210701__20210930_zKPa4oYA71S5" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Price Per Share, Expired"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3779">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Outstanding at September 30, 2021</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20210701__20210930_z8Qqg1bHEKp2" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Shares, Outstanding, Ending balance"><span style="font-family: Times New Roman, Times, Serif">59</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20210701__20210930_ztHIftIDn6gg" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Price Per Share, Outstanding, Ending balance"><span style="font-family: Times New Roman, Times, Serif">4,533.33</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">Exercisable at September 30, 2021</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_c20210701__20210930_z9SXbOqrLe0h" style="text-align: right" title="Number of Shares, Exercisable, Ending balance"><span style="font-family: Times New Roman, Times, Serif">39</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_c20210701__20210930_zACMHgTi7J44" style="text-align: right" title="Weighted Average Price Per Share, Exercisable, Ending balance"><span style="font-family: Times New Roman, Times, Serif">4,530.93</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Outstanding and Exercisable:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Weighted average remaining contractual
    term</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20210701__20210930_zcgS12ZloSe5" title="Weighted average remaining contractual term">7.62</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Weighted average fair value of options
    granted during the period</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90C_ecustom--WeightedAverageFairValueOfOptionsGrantedDuringPeriod_c20210701__20210930_zK8ntmlEsHa3" title="Weighted average fair value of options granted during the period"><span style="-sec-ix-hidden: xdx2ixbrl3791">-</span></span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Aggregate intrinsic value</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pp0p0_c20210701__20210930_zKVspuFDvKc6" style="border-bottom: Black 1.5pt solid; text-align: right" title="Aggregate intrinsic value"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3793">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<span></span>
</td>
<td class="text"><p id="xdx_893_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zJAtVHqv7Tac" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">A
summary of the Company&#8217;s option activity during the years ended June 30, 2021 and 2020 is presented below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_8B4_z1neiiLP5lU5" style="display: none">SCHEDULE OF STOCK OPTION ACTIVITY</span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="color: Black">&#160;</td><td style="color: Black; font-weight: bold">&#160;</td>
    <td colspan="2" style="color: Black; font-weight: bold; text-align: center">Number of</td><td style="color: Black; font-weight: bold">&#160;</td><td style="color: Black; font-weight: bold">&#160;</td>
    <td colspan="2" style="color: Black; font-weight: bold; text-align: center">Weighted Average</td><td style="color: Black; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="color: Black">&#160;</td><td style="color: Black; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; color: Black; font-weight: bold; text-align: center">Options</td><td style="padding-bottom: 1.5pt; color: Black; font-weight: bold">&#160;</td><td style="color: Black; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; color: Black; font-weight: bold; text-align: center">Price Per Share</td><td style="padding-bottom: 1.5pt; color: Black; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; color: Black">Outstanding at June 30, 2019</td><td style="width: 2%; color: Black">&#160;</td>
    <td style="width: 1%; color: Black; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20190701__20200630_zCvoi2Biml0j" style="width: 16%; color: Black; text-align: right" title="Number of Shares, Outstanding, Beginning balance">60</td><td style="width: 1%; color: Black; text-align: left">&#160;</td><td style="width: 2%; color: Black">&#160;</td>
    <td style="width: 1%; color: Black; text-align: left">$</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20190701__20200630_z4nKrz61JCxb" style="width: 16%; color: Black; text-align: right" title="Weighted Average Price Per Share, Outstanding, Beginning balance">76,370</td><td style="width: 1%; color: Black; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="color: Black">Issued</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_c20190701__20200630_pdd" style="color: Black; text-align: right" title="Number of Shares, Issued"><span style="-sec-ix-hidden: xdx2ixbrl1968">-</span></td><td style="color: Black; text-align: left">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td id="xdx_986_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsIssuedInPeriodWeightedAverageExercisePrice_c20190701__20200630_pdd" style="color: Black; text-align: right" title="Weighted Average Price Per Share, Issued"><span style="-sec-ix-hidden: xdx2ixbrl1970">-</span></td><td style="color: Black; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: Black">Exercised</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20190701__20200630_pdd" style="color: Black; text-align: right" title="Number of Shares, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl1972">-</span></td><td style="color: Black; text-align: left">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20190701__20200630_pdd" style="color: Black; text-align: right" title="Weighted Average Price Per Share, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl1974">-</span></td><td style="color: Black; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="color: Black; padding-bottom: 1.5pt">Expired</td><td style="color: Black; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; color: Black; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_iN_di_c20190701__20200630_zCAdRgPTA2gj" style="border-bottom: Black 1.5pt solid; color: Black; text-align: right" title="Number of Shares, Expired"><span style="-sec-ix-hidden: xdx2ixbrl1976">-</span></td><td style="padding-bottom: 1.5pt; color: Black; text-align: left">&#160;</td><td style="color: Black; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; color: Black; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_c20190701__20200630_pdd" style="border-bottom: Black 1.5pt solid; color: Black; text-align: right" title="Weighted Average Price Per Share, Expired"><span style="-sec-ix-hidden: xdx2ixbrl1978">-</span></td><td style="padding-bottom: 1.5pt; color: Black; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: Black">Outstanding at June 30, 2020</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20200701__20210630_zs4OGeOEO8Zg" style="color: Black; text-align: right" title="Number of Shares, Outstanding, Ending balance">60</td><td style="color: Black; text-align: left">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">$</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20200701__20210630_zpvCzXKi2RAi" style="color: Black; text-align: right" title="Weighted Average Price Per Share, Outstanding, Ending balance">76,370</td><td style="color: Black; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="color: Black">Issued</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_c20200701__20210630_pdd" style="color: Black; text-align: right" title="Number of Shares, Issued"><span style="-sec-ix-hidden: xdx2ixbrl1984">-</span></td><td style="color: Black; text-align: left">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td id="xdx_98C_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsIssuedInPeriodWeightedAverageExercisePrice_c20200701__20210630_pdd" style="color: Black; text-align: right" title="Weighted Average Price Per Share, Issued"><span style="-sec-ix-hidden: xdx2ixbrl1986">-</span></td><td style="color: Black; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: Black">Exercised</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20200701__20210630_pdd" style="color: Black; text-align: right" title="Number of Shares, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl1988">-</span></td><td style="color: Black; text-align: left">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20200701__20210630_pdd" style="color: Black; text-align: right" title="Weighted Average Price Per Share, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl1990">-</span></td><td style="color: Black; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="color: Black; padding-bottom: 1.5pt">Expired</td><td style="color: Black; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; color: Black; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_iN_di_c20200701__20210630_z26oJD3Z7ylb" style="border-bottom: Black 1.5pt solid; color: Black; text-align: right" title="Number of Shares, Expired">(1</td><td style="padding-bottom: 1.5pt; color: Black; text-align: left">)</td><td style="color: Black; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; color: Black; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_c20200701__20210630_pdd" style="border-bottom: Black 1.5pt solid; color: Black; text-align: right" title="Weighted Average Price Per Share, Expired">3,750,000</td><td style="padding-bottom: 1.5pt; color: Black; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: Black; padding-bottom: 1.5pt">Outstanding at June 30, 2021</td><td style="color: Black; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; color: Black; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20200701__20210630_z8aMmHSwGSKd" style="border-bottom: Black 1.5pt solid; color: Black; text-align: right" title="Number of Shares, Outstanding, Ending balance">59</td><td style="padding-bottom: 1.5pt; color: Black; text-align: left">&#160;</td><td style="color: Black; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; color: Black; text-align: left">$</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20200701__20210630_zrYBXYu3bVe4" style="border-bottom: Black 1.5pt solid; color: Black; text-align: right" title="Weighted Average Price Per Share, Outstanding, Ending balance">13,730</td><td style="padding-bottom: 1.5pt; color: Black; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="color: Black">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">&#160;</td><td style="color: Black; text-align: left">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">&#160;</td><td style="color: Black; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: Black">Exercisable at June 30, 2021</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20210630_pdd" style="color: Black; text-align: right" title="Number of Shares, Exercisable, Ending balance">40</td><td style="color: Black; text-align: left">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">$</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20210630_pdd" style="color: Black; text-align: right" title="Weighted Average Price Per Share, Exercisable, Ending balance">18,193</td><td style="color: Black; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="color: Black; text-align: left">Outstanding and Exercisable:</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">&#160;</td><td style="color: Black; text-align: left">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">&#160;</td><td style="color: Black; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: Black">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">&#160;</td><td style="color: Black; text-align: left">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">&#160;</td><td style="color: Black; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="color: Black; padding-bottom: 1.5pt">Weighted average remaining contractual term</td><td style="color: Black; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; color: Black; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; color: Black; text-align: right"><span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20200701__20210630_zQiV9nk5dTk" title="Weighted average remaining contractual term">7.86</span></td><td style="padding-bottom: 1.5pt; color: Black; text-align: left">&#160;</td><td style="color: Black; padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; color: Black; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; color: Black; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; color: Black; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: Black; padding-bottom: 1.5pt">Weighted average fair value of options granted during the period</td><td style="color: Black; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; color: Black; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; color: Black; text-align: right"><span id="xdx_905_ecustom--WeightedAverageFairValueOfOptionsGrantedDuringPeriod_d0_c20200701__20210630_zcXnUFEhxcJ4" title="Weighted average fair value of options granted during the period"><span style="-sec-ix-hidden: xdx2ixbrl2006">-</span></span></td><td style="padding-bottom: 1.5pt; color: Black; text-align: left">&#160;</td><td style="color: Black; padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; color: Black; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; color: Black; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; color: Black; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="color: Black; padding-bottom: 1.5pt">Aggregate intrinsic value</td><td style="color: Black; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; color: Black; text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_c20210630_pp0p0" style="border-bottom: Black 1.5pt solid; color: Black; text-align: right" title="Aggregate intrinsic value"><span style="-sec-ix-hidden: xdx2ixbrl2008">-</span></td><td style="padding-bottom: 1.5pt; color: Black; text-align: left">&#160;</td><td style="color: Black; padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; color: Black; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; color: Black; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; color: Black; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock', window );">SCHEDULE OF WARRANT ACTIVITY</a></td>
<td class="text"><p id="xdx_896_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zHpSNYZ0bJ83" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
following table summarizes warrant activity for the three months ended September 30, 2021:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8BD_zTCyL2jDJay7" style="display: none">SCHEDULE
OF WARRANT ACTIVITY</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Weighted</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Number of</span></td><td style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Average</span></td><td style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Shares</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Price
    Per Share</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%"><span style="font-family: Times New Roman, Times, Serif">Outstanding at June 30, 2021</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20210701__20210930_zbSgfIZiHED6" style="width: 14%; text-align: right" title="Number of Shares, Outstanding, Beginning balance"><span style="font-family: Times New Roman, Times, Serif">121,329</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageOutstanding_iS_c20210701__20210930_zoMmctVkyGj8" style="width: 14%; text-align: right" title="Weighted Average Price Per Share, Outstanding, Beginning balance"><span style="font-family: Times New Roman, Times, Serif">179.63</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">Issued</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsIssued_c20210701__20210930_ztsKXhp7ND3b" style="text-align: right" title="Number of Shares, Issued"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3731">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceIssued_c20210701__20210930_zxIyHmTNnHjk" style="text-align: right" title="Weighted Average Price Per Share, Issued"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3733">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">Exercised</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_di_c20210701__20210930_z2qjat9AzCb5" style="text-align: right" title="Number of Shares, Exercised"><span style="font-family: Times New Roman, Times, Serif">(9,397</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceExercised_c20210701__20210930_z5aPDFIJ5t9a" style="text-align: right" title="Weighted Average Price Per Share, Exercised"><span style="font-family: Times New Roman, Times, Serif">40.37</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">Forfeited</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_c20210701__20210930_zUF4dPx3cbCj" style="text-align: right" title="Number of Shares, Forfeited"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3739">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceExpired_c20210701__20210930_zUExwkkX8E9c" style="text-align: right" title="Weighted Average Price Per Share, Forfeited"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3741">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Expired</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_c20210701__20210930_zRsiiaMbQBUe" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Shares, Expired"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3743">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceForfeited_c20210701__20210930_zcVGq2jY8Xsl" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Price Per Share, Expired"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3745">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Outstanding at September 30, 2021</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_c20210701__20210930_zEeLCD9yTkk1" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Shares, Outstanding, Ending balance"><span style="font-family: Times New Roman, Times, Serif">111,932</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_981_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageOutstanding_iE_c20210701__20210930_zwi2Nr1IeWxh" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Price Per Share, Outstanding, Ending balance"><span style="font-family: Times New Roman, Times, Serif">191.32</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Exercisable at September 30, 2021</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_iE_c20210701__20210930_zrodIa8LyCSj" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Shares, Exercisable, Ending balance"><span style="font-family: Times New Roman, Times, Serif">76,933</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisable_iE_c20210701__20210930_zdX6Ygyia1Ri" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Price Per Share, Exercisable, Ending balance"><span style="font-family: Times New Roman, Times, Serif">278.36</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Outstanding and Exercisable:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Weighted average remaining contractual
    term</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20210701__20210930_zfPJb5ld6tyk" title="Weighted average remaining contractual term">1.52</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Aggregate intrinsic
    value <br/></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_983_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsAggregateIntrinsicValueOutstanding_iE_pp0p0_c20210701__20210930_z7SavXjqef7j" style="border-bottom: Black 1.5pt solid; text-align: right" title="Aggregate intrinsic value"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3757">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<span></span>
</td>
<td class="text"><p id="xdx_89C_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zCK2SPds7WP5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
following table summarizes warrant activity for the years ended June 30, 2021 and 2020:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span id="xdx_8BA_zlOH3PPBkAE3" style="display: none">SCHEDULE OF WARRANT ACTIVITY</span><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="color: Black">&#160;</td><td style="color: Black; font-weight: bold">&#160;</td>
    <td colspan="2" style="color: Black; font-weight: bold; text-align: center">Number of</td><td style="color: Black; font-weight: bold">&#160;</td><td style="color: Black; font-weight: bold">&#160;</td>
    <td colspan="2" style="color: Black; font-weight: bold; text-align: center">Weighted Average</td><td style="color: Black; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="color: Black">&#160;</td><td style="color: Black; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; color: Black; font-weight: bold; text-align: center">Warrants</td><td style="padding-bottom: 1.5pt; color: Black; font-weight: bold">&#160;</td><td style="color: Black; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; color: Black; font-weight: bold; text-align: center">Price Per Share</td><td style="padding-bottom: 1.5pt; color: Black; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: Black">Outstanding at June 30, 2019</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20190701__20200630_zqxqy7ojzqB3" style="color: Black; text-align: right" title="Number of Shares, Outstanding, Beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl2022">-</span></td><td style="color: Black; text-align: left">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">$</td><td id="xdx_98F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageOutstanding_iS_c20190701__20200630_zfVXsuFda5Lf" style="color: Black; text-align: right" title="Weighted Average Price Per Share, Outstanding, Beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl2024">-</span></td><td style="color: Black; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 60%; color: Black">Issued</td><td style="width: 2%; color: Black">&#160;</td>
    <td style="width: 1%; color: Black; text-align: left">&#160;</td><td id="xdx_984_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsIssued_c20190701__20200630_pdd" style="width: 16%; color: Black; text-align: right" title="Number of Shares, Issued">151,170</td><td style="width: 1%; color: Black; text-align: left">&#160;</td><td style="width: 2%; color: Black">&#160;</td>
    <td style="width: 1%; color: Black; text-align: left">&#160;</td><td id="xdx_98F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceIssued_c20190701__20200630_pdd" style="width: 16%; color: Black; text-align: right" title="Weighted Average Price Per Share, Issued">150.00</td><td style="width: 1%; color: Black; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: Black">Exercised</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_di_c20190701__20200630_z6phSP3ACjjb" style="color: Black; text-align: right" title="Number of Shares, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl2030">-</span></td><td style="color: Black; text-align: left">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td id="xdx_983_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceExercised_c20190701__20200630_pdd" style="color: Black; text-align: right" title="Weighted Average Price Per Share, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl2032">-</span></td><td style="color: Black; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="color: Black">Forfeited</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_c20190701__20200630_pdd" style="color: Black; text-align: right" title="Number of Shares, Forfeited"><span style="-sec-ix-hidden: xdx2ixbrl2034">-</span></td><td style="color: Black; text-align: left">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td id="xdx_985_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceExpired_c20190701__20200630_pdd" style="color: Black; text-align: right" title="Weighted Average Price Per Share, Forfeited"><span style="-sec-ix-hidden: xdx2ixbrl2036">-</span></td><td style="color: Black; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: Black; padding-bottom: 1.5pt">Expired</td><td style="color: Black; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; color: Black; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_c20190701__20200630_pdd" style="border-bottom: Black 1.5pt solid; color: Black; text-align: right" title="Number of Shares, Expired"><span style="-sec-ix-hidden: xdx2ixbrl2038">-</span></td><td style="padding-bottom: 1.5pt; color: Black; text-align: left">&#160;</td><td style="color: Black; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; color: Black; text-align: left">&#160;</td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceForfeited_c20190701__20200630_pdd" style="border-bottom: Black 1.5pt solid; color: Black; text-align: right" title="Weighted Average Price Per Share, Expired"><span style="-sec-ix-hidden: xdx2ixbrl2040">-</span></td><td style="padding-bottom: 1.5pt; color: Black; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="color: Black">Outstanding at June 30, 2020</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20200701__20210630_zNSUObxM0a33" style="color: Black; text-align: right" title="Number of Shares, Outstanding, Ending balance">151,170</td><td style="color: Black; text-align: left">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">$</td><td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageOutstanding_iS_c20200701__20210630_zsBKJYDHT2Ae" style="color: Black; text-align: right" title="Weighted Average Price Per Share, Outstanding, Ending balance">150.00</td><td style="color: Black; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: Black">Issued</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsIssued_c20200701__20210630_pdd" style="color: Black; text-align: right" title="Number of Shares, Issued"><span style="-sec-ix-hidden: xdx2ixbrl2046">-</span></td><td style="color: Black; text-align: left">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td id="xdx_981_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceIssued_c20200701__20210630_pdd" style="color: Black; text-align: right" title="Weighted Average Price Per Share, Issued"><span style="-sec-ix-hidden: xdx2ixbrl2048">-</span></td><td style="color: Black; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="color: Black">Exercised</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_di_c20200701__20210630_z3OKGyW1DQB8" style="color: Black; text-align: right" title="Number of Shares, Exercised">(29,841</td><td style="color: Black; text-align: left">)</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td id="xdx_984_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceExercised_c20200701__20210630_pdd" style="color: Black; text-align: right" title="Weighted Average Price Per Share, Exercised">26.15</td><td style="color: Black; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: Black">Forfeited</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_c20200701__20210630_pdd" style="color: Black; text-align: right" title="Number of Shares, Forfeited"><span style="-sec-ix-hidden: xdx2ixbrl2054">-</span></td><td style="color: Black; text-align: left">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td id="xdx_98F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceExpired_c20200701__20210630_pdd" style="color: Black; text-align: right" title="Weighted Average Price Per Share, Forfeited"><span style="-sec-ix-hidden: xdx2ixbrl2056">-</span></td><td style="color: Black; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="color: Black; padding-bottom: 1.5pt">Expired</td><td style="color: Black; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; color: Black; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_c20200701__20210630_pdd" style="border-bottom: Black 1.5pt solid; color: Black; text-align: right" title="Number of Shares, Expired"><span style="-sec-ix-hidden: xdx2ixbrl2058">-</span></td><td style="padding-bottom: 1.5pt; color: Black; text-align: left">&#160;</td><td style="color: Black; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; color: Black; text-align: left">&#160;</td><td id="xdx_988_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceForfeited_c20200701__20210630_pdd" style="border-bottom: Black 1.5pt solid; color: Black; text-align: right" title="Weighted Average Price Per Share, Expired"><span style="-sec-ix-hidden: xdx2ixbrl2060">-</span></td><td style="padding-bottom: 1.5pt; color: Black; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: Black; padding-bottom: 1.5pt">Outstanding at June 30, 2021</td><td style="color: Black; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; color: Black; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_c20200701__20210630_zUi2wA7mVNkl" style="border-bottom: Black 1.5pt solid; color: Black; text-align: right" title="Number of Shares, Outstanding, Ending balance">121,329</td><td style="padding-bottom: 1.5pt; color: Black; text-align: left">&#160;</td><td style="color: Black; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; color: Black; text-align: left">$</td><td id="xdx_983_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageOutstanding_iE_c20200701__20210630_zC3AomBZmAta" style="border-bottom: Black 1.5pt solid; color: Black; text-align: right" title="Weighted Average Price Per Share, Outstanding, Ending balance">179.63</td><td style="padding-bottom: 1.5pt; color: Black; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="color: Black">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">&#160;</td><td style="color: Black; text-align: left">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">&#160;</td><td style="color: Black; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: Black; padding-bottom: 1.5pt">Exercisable at June 30, 2021</td><td style="color: Black; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; color: Black; text-align: left">&#160;</td><td id="xdx_985_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_c20210630_pdd" style="border-bottom: Black 1.5pt solid; color: Black; text-align: right" title="Number of Shares, Exercisable, Ending balance">76,955</td><td style="padding-bottom: 1.5pt; color: Black; text-align: left">&#160;</td><td style="color: Black; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; color: Black; text-align: left">$</td><td id="xdx_98F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisable_c20210630_pdd" style="border-bottom: Black 1.5pt solid; color: Black; text-align: right" title="Weighted Average Price Per Share, Exercisable, Ending balance">283.21</td><td style="padding-bottom: 1.5pt; color: Black; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="color: Black; text-align: left">Outstanding and Exercisable:</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">&#160;</td><td style="color: Black; text-align: left">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">&#160;</td><td style="color: Black; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: Black">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">&#160;</td><td style="color: Black; text-align: left">&#160;</td><td style="color: Black">&#160;</td>
    <td style="color: Black; text-align: left">&#160;</td><td style="color: Black; text-align: right">&#160;</td><td style="color: Black; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="color: Black; padding-bottom: 1.5pt">Weighted average remaining contractual term</td><td style="color: Black; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; color: Black; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; color: Black; text-align: right"><span id="xdx_90B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20200701__20210630_z78SFcSuOfvh" title="Weighted average remaining contractual term">1.77</span></td><td style="padding-bottom: 1.5pt; color: Black; text-align: left">&#160;</td><td style="color: Black; padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; color: Black; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; color: Black; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; color: Black; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: Black; padding-bottom: 1.5pt">Aggregate intrinsic value</td><td style="color: Black; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; color: Black; text-align: left">$</td><td id="xdx_985_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsAggregateIntrinsicValueOutstanding_c20210630_pp0p0" style="border-bottom: Black 1.5pt solid; color: Black; text-align: right" title="Aggregate intrinsic value"><span style="-sec-ix-hidden: xdx2ixbrl2072">-</span></td><td style="padding-bottom: 1.5pt; color: Black; text-align: left">&#160;</td><td style="color: Black; padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; color: Black; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; color: Black; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; color: Black; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 50<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6784392&amp;loc=d3e188667-122775<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm140460440329704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_ScheduleOfRightUseOfAssetTableTextBlock', window );">SCHEDULE OF RIGHT USE OF ASSET</a></td>
<td class="text"><p id="xdx_894_ecustom--ScheduleOfRightUseOfAssetTableTextBlock_zGoPydUjdAul" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">ROU
is summarized below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_8B3_z2t8Ilp9RHCg" style="display: none">SCHEDULE OF RIGHT USE OF ASSET</span><span style="font: 10pt Times New Roman, Times, Serif; color: Black"/></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" id="xdx_495_20210630_zoufaAcQaxUc" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>June
    30, 2021</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" id="xdx_49F_20200630_zWOmXQOOY9rc" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>June
    30, 2020</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td></tr>
  <tr id="xdx_405_ecustom--OperatingLeaseRightOfUseAssets_iI_pp0p0_maOLROUzHPs_zGh3imgPrtSe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 60%"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Office
    lease (24 months)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">48,662</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">48,662</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_406_ecustom--AccumulatedReduction_iI_pp0p0_maOLROUzHPs_zapS6yhxmXci" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Less
    accumulated amortization</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(48,662</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(26,980</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td></tr>
  <tr id="xdx_405_eus-gaap--OperatingLeaseRightOfUseAsset_iTI_pp0p0_mtOLROUzHPs_zHMqylvljI8d" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Right-of-use
    asset, net</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl2191">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">21,682</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  </table>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLeaseIncomeTableTextBlock', window );">SCHEDULE OF OPERATING LEASE LIABILITY</a></td>
<td class="text"><p id="xdx_897_eus-gaap--OperatingLeaseLeaseIncomeTableTextBlock_z19UeNKNN7Qi" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Operating
Lease liabilities are summarized below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span id="xdx_8B0_ztmPtNJAMDuh" style="display: none">SCHEDULE OF OPERATING LEASE LIABILITY</span><span style="font: 10pt Times New Roman, Times, Serif; color: Black"/></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" id="xdx_49A_20210630_zNY5EJpe1z73" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>June
    30, 2021</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" id="xdx_49A_20200630_zWmUsQuR4raf" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>June
    30, 2020</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td></tr>
  <tr id="xdx_402_ecustom--OfficeLeaseLiability_iI_pp0p0_maOLLzN3P_zkvx3R82HVp5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Office
    lease</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">48,662</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">48,662</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr id="xdx_40A_ecustom--ReductionOfLeaseLiability_iI_pp0p0_maOLLzN3P_zEK3QiecFcNb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Reduction
    of lease liability</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(48,662</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(23,590</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td></tr>
  <tr id="xdx_40A_eus-gaap--OperatingLeaseLiability_iTI_pp0p0_mtOLLzN3P_zKZAcTC4Sz9l" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Long
    term portion of lease liability</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl2202">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">25,072</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  </table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_ScheduleOfRightUseOfAssetTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of Right Use Of Asset [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_ScheduleOfRightUseOfAssetTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLeaseIncomeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of components of income from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919372-209981<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6A<br> -URI http://asc.fasb.org/extlink&amp;oid=124502072&amp;loc=SL77927221-108306<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLeaseIncomeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm140460440498824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DERIVATIVE FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock', window );">SCHEDULE OF FAIR VALUE MEASUREMENTS, RECURRING AND NONRECURRING, VALUATION TECHNIQUES</a></td>
<td class="text"><p id="xdx_89C_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_ziVEwM4zVGa4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8B3_zk9Bx8xU2Kvf" style="display: none">SCHEDULE
OF FAIR VALUE MEASUREMENTS, RECURRING AND NONRECURRING, VALUATION TECHNIQUES</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.8pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Initial
                                            Valuations<br/> (on new derivative<br/> instruments entered</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.8pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>into
                                            during the three<br/> months ended<br/> September 30, 2021)</b></span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">September
    30, 2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%"><span style="font-family: Times New Roman, Times, Serif">Volatility</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 18%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_902_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_dp_uPure_c20210930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_z91KrVbagw65" title="Debt instrument, measurement input, percentages"><span style="-sec-ix-hidden: xdx2ixbrl3968">-</span></span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 18%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_902_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_dp_uPure_c20210930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember_znDDVGuM3xK6" style="font: 10pt Times New Roman, Times, Serif" title="Debt instrument, measurement input, percentages">206.00</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Expected Remaining Term (in years)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90B_eus-gaap--DebtInstrumentTerm_c20210701__20210930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_zcyHeINBsNI9" title="Debt instrument, measurement input, term"><span style="-sec-ix-hidden: xdx2ixbrl3972">-</span></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90C_eus-gaap--DebtInstrumentTerm_dtY_c20210701__20210930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember_zWMN60Ok1IOk" title="Debt instrument, measurement input, term">0.01</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Risk Free Interest Rate</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90D_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_dp_uPure_c20210930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_zTlxnS98e5R5" title="Debt instrument, measurement input, percentages"><span style="-sec-ix-hidden: xdx2ixbrl3976">-</span></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90A_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_dp_uPure_c20210930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember_zBC50CDGAAK1" title="Debt instrument, measurement input, percentages">0.07</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Expected dividend yield</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90C_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_dn_uPure_c20210930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zCbCaGbL5Jd7" title="Debt instrument, measurement input, percentages">None</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_901_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_dpn_uPure_c20210930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember_zIiMk9sIpq1" title="Debt instrument, measurement input, percentages">None</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<span></span>
</td>
<td class="text"><p id="xdx_899_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_zFxlxLM00prd" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_8BA_zmBowUwCLaxi" style="display: none">SCHEDULE OF FAIR VALUE MEASUREMENTS, RECURRING AND NONRECURRING, VALUATION TECHNIQUES</span><span style="font: 10pt Times New Roman, Times, Serif; color: Black"/></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>Convertible
Debt</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>&#160;</b></span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center"><b>Initial Valuations during the year ended June 30, 2021</b></td>
    <td style="padding-bottom: 1.5pt; text-align: center"><b>&#160;</b></td>
    <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><p style="text-align: center; margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>Initial<br/>
                                            Valuations</b></span></p>
                                                                                <p style="text-align: center; margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>during</b></span></p>
                                                                                <p style="text-align: center; margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>the
                                            year ended June 30, 2020</b></span></p></td>
    <td>&#160;</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>June
    30, 2021</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>June
    30, 2020</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><b>&#160;</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 35%"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Volatility</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="text-align: center; width: 13%">N/A</td>
    <td style="width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 13%; vertical-align: bottom"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90C_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_uPure_c20200630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__srt--RangeAxis__srt--MinimumMember_znsZSskEF4vh" title="Debt instrument, measurement input, percentages">227</span>-<span id="xdx_902_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_uPure_c20200630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__srt--RangeAxis__srt--MaximumMember_z19zgrt6LIge" title="Debt instrument, measurement input, percentages">279</span></span></td>
    <td style="width: 1%">%</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 13%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span id="xdx_902_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_uPure_c20210630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember_z8qKxb6rq01j" title="Debt instrument, measurement input, percentages">222</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">%</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 13%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span id="xdx_90A_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_uPure_c20200630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember_zsocWzw9v8mc" title="Debt instrument, measurement input, percentages">264</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">%</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Expected
    remaining term</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="text-align: center">N/A</td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom"><span id="xdx_90C_eus-gaap--DebtInstrumentTerm_dtY_c20190701__20200630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_zg9nuItaB5A3" title="Debt instrument, measurement input, term">1.00</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span id="xdx_902_eus-gaap--DebtInstrumentTerm_dtY_c20200701__20210630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember_ziMIM80sCzJ9" title="Debt instrument, measurement input, term">0.01</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span id="xdx_904_eus-gaap--DebtInstrumentTerm_dtY_c20190701__20200630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember__srt--RangeAxis__srt--MinimumMember_zQq0IiYT0cn5" title="Debt instrument, measurement input, term">0.01</span>
    &#8211; <span id="xdx_901_eus-gaap--DebtInstrumentTerm_dtY_c20190701__20200630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember__srt--RangeAxis__srt--MaximumMember_zRzEN0YrwSO1" title="Debt instrument, measurement input, term">0.70</span> </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Risk-free
    interest rate</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="text-align: center">N/A</td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90D_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_uPure_c20200630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MinimumMember_zG2WLbhXC174" title="Debt instrument, measurement input, percentages">1.53</span>
    &#8211; <span id="xdx_905_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_uPure_c20200630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MaximumMember_zeQQCpHn9Oo3" title="Debt instrument, measurement input, percentages">1.59</span></span></td>
    <td>%</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span id="xdx_902_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_uPure_c20210630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember_z7Aep2hS9Ss4" title="Debt instrument, measurement input, percentages">0.05</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">%</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span id="xdx_901_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_uPure_c20200630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember__srt--RangeAxis__srt--MinimumMember_zJYF6qi0vIO4" title="Debt instrument, measurement input, percentages">0.13</span>
    &#8211; <span id="xdx_90D_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_uPure_c20200630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember__srt--RangeAxis__srt--MaximumMember_zQagw6Ahxvq1" title="Debt instrument, measurement input, percentages">0.18</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">%</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Expected
    dividend yield</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="text-align: center">N/A</td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_904_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_dn_uPure_c20200630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zM4oKsxZoZOi" title="Debt instrument, measurement input, percentages">None</span></span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span id="xdx_901_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_dpn_uPure_c20210630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember_zPYMAAUfdnC9" title="Debt instrument, measurement input, percentages">None</span>
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span id="xdx_907_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_dn_uPure_c20200630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember_zcJ0FN6PYQYf" title="Debt instrument, measurement input, percentages">None</span>
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  </table>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">SCHEDULE OF FAIR VALUE, ASSETS AND LIABILITIES MEASURED ON RECURRING BASIS</a></td>
<td class="text"><p id="xdx_89E_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_zQ8Y0zdM2HX4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
Company measures and reports at fair value the liability for derivative instruments. The fair value liabilities for price adjustable
warrants and embedded conversion options have been recorded as determined utilizing the Binomial Trees model. The following tables summarize
the Company&#8217;s financial assets and liabilities measured at fair value on a recurring basis as of September 30, 2021 and June 30,
2021:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_8BF_z92R6udxgfO5" style="display: none">SCHEDULE
OF FAIR VALUE, ASSETS AND LIABILITIES MEASURED ON RECURRING BASIS</span>&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Balance
    at<br/> September&#160;30, 2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Quoted
                                            Prices</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>in
                                            Active</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Markets
                                            for</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Identical<br/>
                                            Assets</b></span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Significant</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Other</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Observable<br/>
                                            Inputs</b></span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Significant</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Unobservable
                                            Inputs</b></span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">(Level 1)</span></td><td style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">(Level 2)</span></td><td style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">(Level 3)</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 44%; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Embedded
    conversion option liabilities</span></td><td style="width: 2%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_985_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_iI_pp0p0_c20210930_znrDt9zeQUQj" style="border-bottom: Black 1.5pt solid; width: 10%; text-align: right" title="Embedded conversion option liabilities"><span style="font-family: Times New Roman, Times, Serif">58,124</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98E_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_iI_pdp0_c20210930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zyf9mHFTG7D6" style="border-bottom: Black 1.5pt solid; width: 10%; text-align: right" title="Embedded conversion option liabilities"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3988">&#8212;</span></span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98F_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_iI_pdp0_c20210930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zDR2luvuqBKe" style="border-bottom: Black 1.5pt solid; width: 10%; text-align: right" title="Embedded conversion option liabilities"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3990">&#8212;</span></span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_iI_pp0p0_c20210930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zfYeJvYPLE83" style="border-bottom: Black 1.5pt solid; width: 10%; text-align: right" title="Embedded conversion option liabilities"><span style="font-family: Times New Roman, Times, Serif">58,124</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98F_eus-gaap--DerivativeLiabilities_iI_pp0p0_c20210930_zpZqMmMLg1Nj" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total"><span style="font-family: Times New Roman, Times, Serif">58,124</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_eus-gaap--DerivativeLiabilities_iI_pdp0_c20210930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zI42zixfZpa1" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3996">&#8212;</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_983_eus-gaap--DerivativeLiabilities_iI_pdp0_c20210930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z4N9YaP254Ea" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3998">&#8212;</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98E_eus-gaap--DerivativeLiabilities_iI_pp0p0_c20210930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zFa2qEvswSgl" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total"><span style="font-family: Times New Roman, Times, Serif">58,124</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Balance
    at<br/> June 30, 2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Quoted
                                            Prices</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>in
                                            Active</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Markets
                                            for</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Identical<br/>
                                            Assets</b></span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Significant</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Other</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Observable<br/>
                                            Inputs</b></span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Significant</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Unobservable
                                            Inputs</b></span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">(Level 1)</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">(Level 2)</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">(Level 3)</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 44%; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Embedded
    conversion option liabilities</span></td><td style="width: 2%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_iI_pp0p0_c20210630_zxSBZDQIJc8e" style="border-bottom: Black 1.5pt solid; width: 10%; text-align: right" title="Embedded conversion option liabilities"><span style="font-family: Times New Roman, Times, Serif">54,220</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_c20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_pdp0" style="border-bottom: Black 1.5pt solid; width: 10%; text-align: right" title="Embedded conversion option liabilities"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl4004">&#8212;</span></span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_c20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_pdp0" style="border-bottom: Black 1.5pt solid; width: 10%; text-align: right" title="Embedded conversion option liabilities"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl4006">&#8212;</span></span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_iI_pp0p0_c20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zmZMI2T7dhS3" style="border-bottom: Black 1.5pt solid; width: 10%; text-align: right" title="Embedded conversion option liabilities"><span style="font-family: Times New Roman, Times, Serif">54,220</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eus-gaap--DerivativeLiabilities_iI_pp0p0_c20210630_zY5UsolInuf2" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total"><span style="font-family: Times New Roman, Times, Serif">54,220</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--DerivativeLiabilities_c20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_pdp0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl4012">&#8212;</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_983_eus-gaap--DerivativeLiabilities_c20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_pdp0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl4014">&#8212;</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98E_eus-gaap--DerivativeLiabilities_iI_pp0p0_c20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z8dP5d3YIqD9" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total"><span style="font-family: Times New Roman, Times, Serif">54,220</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/>

<span></span>
</td>
<td class="text"><p id="xdx_891_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_zj10hCQnfo2k" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-right: 0; margin-bottom: 0; text-align: left; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span><span id="xdx_8BC_zhgIJsNvoEFe" style="display: none">SCHEDULE OF FAIR VALUE, ASSETS AND LIABILITIES MEASURED ON RECURRING BASIS</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Balance
    at<br/> June 30, 2021</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1.8pt 0 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Quoted</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1.8pt 0 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Prices</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1.8pt 0 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>in
    Active</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1.8pt 0 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Markets
    for</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1.8pt 0 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Identical
    Assets</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1.8pt 0 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Significant</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1.8pt 0 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Other</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1.8pt 0 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Observable
    Inputs</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1.8pt 0 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Significant</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1.8pt 0 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Unobservable
    Inputs</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>(Level
    1)</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>(Level
    2)</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>(Level
    3)</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 36%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Embedded
    conversion option liabilities</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td id="xdx_981_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_c20210630_pp0p0" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Embedded conversion option liabilities"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">54,220</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td id="xdx_98A_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_c20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_pp0p0" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Embedded conversion option liabilities"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl2445">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td id="xdx_98B_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_c20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_pp0p0" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Embedded conversion option liabilities"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl2447">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td id="xdx_98C_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_c20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_pp0p0" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Embedded conversion option liabilities"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">54,220</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Total</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td id="xdx_98D_eus-gaap--DerivativeLiabilities_c20210630_pp0p0" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">54,220</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td id="xdx_98B_eus-gaap--DerivativeLiabilities_c20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_pp0p0" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl2453">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td id="xdx_983_eus-gaap--DerivativeLiabilities_c20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_pp0p0" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl2455">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td id="xdx_982_eus-gaap--DerivativeLiabilities_c20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_pp0p0" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">54,220</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
following tables summarize the Company&#8217;s financial assets and liabilities measured at fair value on a recurring basis as of June
30, 2020:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Balance
    at<br/> June 30, 2020</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1.8pt 0 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Quoted</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1.8pt 0 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Prices</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1.8pt 0 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>in
    Active</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1.8pt 0 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Markets
    for</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1.8pt 0 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Identical
    Assets</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1.8pt 0 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Significant</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1.8pt 0 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Other</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1.8pt 0 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Observable
    Inputs</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1.8pt 0 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Significant</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1.8pt 0 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Unobservable
    Inputs</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>(Level
    1)</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>(Level
    2)</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>(Level
    3)</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 36%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Embedded
    conversion option liabilities</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td id="xdx_982_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_c20200630_pp0p0" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Embedded conversion option liabilities"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">177,009</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td id="xdx_989_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_c20200630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_pp0p0" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Embedded conversion option liabilities"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl2461">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td id="xdx_98A_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_c20200630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_pp0p0" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Embedded conversion option liabilities"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl2463">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td id="xdx_98B_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_c20200630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_pp0p0" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Embedded conversion option liabilities"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">177,009</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Total</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td id="xdx_98C_eus-gaap--DerivativeLiabilities_c20200630_pp0p0" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">177,009</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td id="xdx_98A_eus-gaap--DerivativeLiabilities_c20200630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_pp0p0" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl2469">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td id="xdx_98B_eus-gaap--DerivativeLiabilities_c20200630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_pp0p0" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total"><span style="font: 10pt Times New Roman, Times, Serif; color: Black"><span style="-sec-ix-hidden: xdx2ixbrl2471">&#8212;</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td id="xdx_983_eus-gaap--DerivativeLiabilities_c20200630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_pp0p0" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">177,009</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  </table>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock', window );">SCHEDULE OF DERIVATIVE LIABILITIES AT FAIR VALUE</a></td>
<td class="text"><p id="xdx_896_eus-gaap--ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_zCMqAhbosFH6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
following is a roll forward for the three months ended September 30, 2021 of the fair value liability of price adjustable derivative
instruments:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_8B9_z0UpiPSRcN17" style="display: none">SCHEDULE
OF DERIVATIVE LIABILITIES AT FAIR VALUE</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"/>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Fair Value
    of</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Liability
    for</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Derivative</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Instruments</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 82%; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Balance at June 30, 2021</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_981_eus-gaap--DerivativeLiabilities_iS_pp0p0_c20210701__20210930_zye6j61g3l84" style="width: 14%; text-align: right" title="Balance at Beginning"><span style="font-family: Times New Roman, Times, Serif">54,220</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Change in fair value
    included in statements of operations</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet_pp0p0_c20210701__20210930_zXS50oq2qLa6" style="border-bottom: Black 1.5pt solid; text-align: right" title="Balance at Beginning"><span style="font-family: Times New Roman, Times, Serif">3,904</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Balance at September
    30, 2021</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_983_eus-gaap--DerivativeLiabilities_iE_pp0p0_c20210701__20210930_zN3IqKOe7TQb" style="border-bottom: Black 2.5pt double; text-align: right" title="Balance at Ending"><span style="font-family: Times New Roman, Times, Serif">58,124</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<span></span>
</td>
<td class="text"><p id="xdx_898_eus-gaap--ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_zwnWqsCQ67Ea" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">The
following is a roll forward for the years ended June 30, 2021 and 2020 of the fair value liability of price adjustable derivative instruments:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-right: 0; margin-bottom: 0; text-align: left; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span><span id="xdx_8B1_zUG1Rm1Y5kic" style="display: none">SCHEDULE OF DERIVATIVE LIABILITIES AT FAIR VALUE</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Fair
    Value of</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Liability
    for</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Derivative</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Instruments</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>&#160;</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; width: 82%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Balance
    at June 30, 2019</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td id="xdx_984_eus-gaap--DerivativeLiabilities_iS_pp0p0_c20190701__20200630_zclpqGLBOnAf" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Balance at Beginning"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">698,264</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Reductions
    due to conversions</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td id="xdx_989_ecustom--ReductionsDueToConversions_c20190701__20200630_pp0p0" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Reductions due to conversions"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(362,962</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Initial
    fair value of embedded conversion option derivative liability recorded as debt discount</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td id="xdx_986_ecustom--FairValueOfWarrantDerivativeLiabilityRecorededAsDebtDiscount_c20190701__20200630_pp0p0" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Initial fair value of embedded conversion option derivative liability recorded as debt discount"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">227,000</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Initial
    fair value of embedded conversion option derivative liability recorded as expense</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td id="xdx_983_ecustom--InitialFairValueOfEmbeddedConversionOptionDerivativeLiabilityRecordedAsExpense_c20190701__20200630_pp0p0" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Initial fair value of embedded conversion option derivative liability recorded as expense"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">351,461</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Change
    in fair value included in statements of operations</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td id="xdx_98B_eus-gaap--EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet_c20190701__20200630_pp0p0" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Change in fair value included in statements of operations"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(736,754</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Balance
    at June 30, 2020</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td id="xdx_982_eus-gaap--DerivativeLiabilities_iS_pp0p0_c20200701__20210630_zUMVWyInRydk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Balance at Beginning"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">177,009</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Gain
    on debt extinguishment</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td id="xdx_985_ecustom--GainOnDebtExtinguishment_c20200701__20210630_pp0p0" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Gain on debt extinguishment"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">(130,975</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">Change
    in fair value included in statements of operations</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td id="xdx_982_eus-gaap--EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet_c20200701__20210630_pp0p0" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Change in fair value included in statements of operations"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">8,186</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Balance
    at June 30, 2021</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">$</span></td>
    <td id="xdx_988_eus-gaap--DerivativeLiabilities_iE_pp0p0_c20200701__20210630_zSqnvtpNZU1f" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Balance at Ending"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">54,220</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; color: Black">&#160;</span></td></tr>
  </table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of derivative liabilities at fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm140460436449192">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SCHEDULE OF TRANSLATION EXCHANGE RATES (Details)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyExchangeRateTranslation1', window );">Foreign Currency Exchange Rate, Translation</a></td>
<td class="nump">0.7214<span></span>
</td>
<td class="nump">0.7500<span></span>
</td>
<td class="nump">0.6891<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_WeightedAverageMember', window );">Weighted Average [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyExchangeRateTranslation1', window );">Foreign Currency Exchange Rate, Translation</a></td>
<td class="nump">0.7350<span></span>
</td>
<td class="nump">0.7473<span></span>
</td>
<td class="nump">0.6742<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyExchangeRateTranslation1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Foreign exchange rate used to translate amounts denominated in functional currency to reporting currency.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6897108&amp;loc=SL6897125-166521<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32618-110901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyExchangeRateTranslation1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_WeightedAverageMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_WeightedAverageMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm140460441895000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE OF CHANGE IN ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Beginning balance</a></td>
<td class="nump">$ 1,085,204<span></span>
</td>
<td class="nump">$ 1,267,671<span></span>
</td>
<td class="nump">$ 1,066,998<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax', window );">Foreign currency translation gain</a></td>
<td class="nump">64,193<span></span>
</td>
<td class="nump">182,467<span></span>
</td>
<td class="nump">200,673<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Ending balance</a></td>
<td class="nump">$ 1,149,397<span></span>
</td>
<td class="nump">$ 1,085,204<span></span>
</td>
<td class="nump">$ 1,267,671<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax, after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm140460440475768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE OF PROPERTY AND EQUIPMENT ESTIMATED USEFUL LIVES (Details)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property and equipment estimated useful lives</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and Fixtures [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property and equipment estimated useful lives</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">7 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm140460434315400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE OF DILUTIVE SECURITIES EXCLUDED FROM COMPUTATION (Details) - shares<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share</a></td>
<td class="nump">23,406,021<span></span>
</td>
<td class="nump">646,576<span></span>
</td>
<td class="nump">12,538,419<span></span>
</td>
<td class="nump">590,403<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Share-based Payment Arrangement, Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share</a></td>
<td class="nump">59<span></span>
</td>
<td class="nump">60<span></span>
</td>
<td class="nump">59<span></span>
</td>
<td class="nump">60<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember', window );">Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share</a></td>
<td class="nump">111,932<span></span>
</td>
<td class="nump">135,725<span></span>
</td>
<td class="nump">121,329<span></span>
</td>
<td class="nump">151,171<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=PPCB_UnvestedRestrictedStockMember', window );">Unvested Restricted Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share</a></td>
<td class="nump">59<span></span>
</td>
<td class="nump">117<span></span>
</td>
<td class="nump">59<span></span>
</td>
<td class="nump">59<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertibleDebtSecuritiesMember', window );">Convertible Debt Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share</a></td>
<td class="nump">23,293,971<span></span>
</td>
<td class="nump">510,674<span></span>
</td>
<td class="nump">12,416,972<span></span>
</td>
<td class="nump">439,113<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=PPCB_UnvestedRestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=PPCB_UnvestedRestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertibleDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertibleDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm140460428098568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING AND REPORTING POLICIES (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Nov. 17, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Aug. 19, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationDateOfIncorporation', window );">Entity incorporation, date of incorporation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Nov. 23,  2010<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Nov. 23,  2010<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityReverseStockSplit', window );">Reverse stock</a></td>
<td class="text">one-for-one thousand (1:1,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent', window );">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax, Portion Attributable to Parent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 64,193<span></span>
</td>
<td class="num">$ (75,755)<span></span>
</td>
<td class="num">$ (182,467)<span></span>
</td>
<td class="nump">$ 200,673<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Cash Equivalents, at Carrying Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValueAddedTaxReceivableCurrent', window );">Value added tax receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,238<span></span>
</td>
<td class="nump">4,341<span></span>
</td>
<td class="nump">4,341<span></span>
</td>
<td class="nump">2,015<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">46,554<span></span>
</td>
<td class="nump">50,846<span></span>
</td>
<td class="nump">230,956<span></span>
</td>
<td class="nump">179,987<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Tax credits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 113,415<span></span>
</td>
<td class="nump">134,728<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleTermsOfConversionFeature', window );">Debt conversion percentage, description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Each holder of the notes has agreed to a 4.99% beneficial ownership conversion limitation
(subject to certain noteholders&#8217; ability to increase such limitation to 9.99% upon 60 days&#8217; notice to the Company), and each
note may not be converted during the first six-month period from the date of issuance. The securities for the period ended September
30, 2021 and 2020 were considered dilutive securities which were excluded from the computation since the effect is anti-dilutive.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Each holder of the notes has agreed to a 4.99% beneficial ownership conversion limitation
(subject to certain noteholders&#8217; ability to increase such limitation to 9.99% upon 60 days&#8217; notice to the Company)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger', window );">Debt conversion percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PPCB_TwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember', window );">2021 Securities Purchase Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity Method Investment, Ownership Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.99%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=PPCB_IntercompanyLoansMember', window );">Intercompany Loans [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent', window );">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax, Portion Attributable to Parent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 619,000<span></span>
</td>
<td class="nump">$ 583,000<span></span>
</td>
<td class="nump">$ 1,005,000<span></span>
</td>
<td class="nump">$ 133,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationDateOfIncorporation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date when an entity was incorporated</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationDateOfIncorporation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleTermsOfConversionFeature">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of conversion terms for debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21506-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21521-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleTermsOfConversionFeature</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum percentage of common stock price to conversion price of convertible debt instruments to determine eligibility of conversion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax, after reclassification adjustments of gain (loss) on foreign currency translation adjustments, on foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityReverseStockSplit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB Topic 4.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187143-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityReverseStockSplit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValueAddedTaxReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of value added taxes due either from customers arising from sales on credit terms, or as previously overpaid to tax authorities. For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValueAddedTaxReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=PPCB_TwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=PPCB_TwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=PPCB_IntercompanyLoansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=PPCB_IntercompanyLoansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm140460441883064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOING CONCERN (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Contract with Customer, Excluding Assessed Tax</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</a></td>
<td class="nump">490,658<span></span>
</td>
<td class="nump">425,545<span></span>
</td>
<td class="nump">2,025,947<span></span>
</td>
<td class="nump">4,740,723<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net Cash Provided by (Used in) Operating Activities</a></td>
<td class="nump">486,758<span></span>
</td>
<td class="nump">179,949<span></span>
</td>
<td class="nump">1,145,264<span></span>
</td>
<td class="nump">1,849,589<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_WorkingCapitalDeficit', window );">Working capital deficit</a></td>
<td class="nump">2,312,387<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,074,078<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' Equity Attributable to Parent</a></td>
<td class="nump">2,306,630<span></span>
</td>
<td class="nump">$ 3,235,469<span></span>
</td>
<td class="nump">3,067,573<span></span>
</td>
<td class="nump">3,641,425<span></span>
</td>
<td class="nump">$ 4,301,236<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained Earnings (Accumulated Deficit)</a></td>
<td class="nump">$ 58,804,968<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 58,199,466<span></span>
</td>
<td class="nump">$ 55,781,770<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_WorkingCapitalDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Working capital (Deficiency) as of the Balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_WorkingCapitalDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm140460436508680">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SCHEDULE OF PROPERTY AND EQUIPMENT (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Office equipment at cost</a></td>
<td class="nump">$ 27,532<span></span>
</td>
<td class="nump">$ 28,623<span></span>
</td>
<td class="nump">$ 26,299<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less: Accumulated depreciation</a></td>
<td class="num">(23,939)<span></span>
</td>
<td class="num">(24,368)<span></span>
</td>
<td class="num">(20,552)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Total property, plant, and equipment</a></td>
<td class="nump">$ 3,593<span></span>
</td>
<td class="nump">$ 4,255<span></span>
</td>
<td class="nump">$ 5,747<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm140460536072824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="nump">$ 509<span></span>
</td>
<td class="nump">$ 438<span></span>
</td>
<td class="nump">$ 1,993<span></span>
</td>
<td class="nump">$ 2,473<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm140460436234600">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>DUE TO FORMER DIRECTOR - RELATED PARTY (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_DisclosureDueToFormerDirectorRelatedPartyAbstract', window );"><strong>Due To Former Director - Related Party</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueToRelatedPartiesCurrent', window );">Due to directors - related parties</a></td>
<td class="nump">$ 32,076<span></span>
</td>
<td class="nump">$ 33,347<span></span>
</td>
<td class="nump">$ 30,639<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_DisclosureDueToFormerDirectorRelatedPartyAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_DisclosureDueToFormerDirectorRelatedPartyAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueToRelatedPartiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(C))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueToRelatedPartiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm140460520453688">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>LOANS AND NOTES PAYABLE (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=PPCB_DirectorsAndOfficerMember', window );">Directors and Officer [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems', window );"><strong>Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LoansPayable', window );">Loans payable</a></td>
<td class="nump">$ 53,384<span></span>
</td>
<td class="nump">$ 55,500<span></span>
</td>
<td class="nump">$ 50,993<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LoansPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, aggregate carrying value as of the balance sheet date of loans payable (with maturities initially due after one year or beyond the operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16)(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LoansPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=PPCB_DirectorsAndOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=PPCB_DirectorsAndOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm140460440421688">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SCHEDULE OF CONVERTIBLE NOTES (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Nov. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Convertible notes and debenture</a></td>
<td class="nump">$ 377,780<span></span>
</td>
<td class="nump">$ 400,128<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,029,496<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Unamortized discounts</a></td>
<td class="num">(7,565)<span></span>
</td>
<td class="num">(6,139)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(126,667)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepositLiabilitiesAccruedInterest', window );">Accrued interest</a></td>
<td class="nump">37,348<span></span>
</td>
<td class="nump">34,098<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80,101<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedPremium', window );">Premium, net</a></td>
<td class="nump">177,045<span></span>
</td>
<td class="nump">196,496<span></span>
</td>
<td class="nump">$ 11,785<span></span>
</td>
<td class="nump">574,804<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Convertible notes, net</a></td>
<td class="nump">$ 584,608<span></span>
</td>
<td class="nump">$ 624,583<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,557,734<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt premium.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepositLiabilitiesAccruedInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accrued but unpaid interest on deposit liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepositLiabilitiesAccruedInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm140460273570152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONVERTIBLE NOTES (Details Narrative)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Sep. 22, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Aug. 19, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 16, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 16, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 05, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 05, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 10, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 02, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Nov. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 16, 2020 </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 09, 2020 </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 25, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 12, 2020 </div>
<div>USD ($) </div>
<div>Integer</div>
</th>
<th class="th">
<div>Mar. 05, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Feb. 19, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 22, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 13, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 07, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Nov. 26, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Nov. 22, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 03, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 02, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 10, 2019 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 04, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Aug. 30, 2019 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Aug. 01, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 23, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 24, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Nov. 30, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 02, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Aug. 29, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 19, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 13, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 29, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Aug. 10, 2017 </div>
<div>USD ($) </div>
<div>Integer</div>
</th>
<th class="th"><div>Apr. 30, 2020</div></th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 15, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Aug. 31, 2019 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Oct. 03, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2017 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Convertible debt principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Original issue discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,565<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,139<span></span>
</td>
<td class="nump">$ 126,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from convertible debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 160,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 325,000<span></span>
</td>
<td class="nump">1,465,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate, stated percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPayableCurrentAndNoncurrent', window );">Accrued interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">416<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger', window );">Common stock trading volume, percent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedPremium', window );">Debt premium amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,785<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 177,045<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 196,496<span></span>
</td>
<td class="nump">574,804<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55,444,574<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">54,074,110<span></span>
</td>
<td class="nump">50,913,893<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability', window );">Embedded derivative, fair value of embedded derivative liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58,124<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">54,220<span></span>
</td>
<td class="nump">177,009<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,368,795<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,080,674<span></span>
</td>
<td class="nump">3,739,943<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss from settlement of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">49,985<span></span>
</td>
<td class="nump">50,607<span></span>
</td>
<td class="nump">67,123<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants to purchase of common stock, shares | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrants exercise price per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Fair value of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 984,810<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Amortization of debt discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,074<span></span>
</td>
<td class="nump">121,281<span></span>
</td>
<td class="nump">136,527<span></span>
</td>
<td class="nump">734,130<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_ReclassifiedPremiumAmountForAdditionalPaidInCapital', window );">Reclassified premium amount for additional paid in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">109,643<span></span>
</td>
<td class="nump">204,919<span></span>
</td>
<td class="nump">590,504<span></span>
</td>
<td class="nump">874,924<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=PPCB_FirstWarrantMember', window );">First Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants to purchase of common stock, shares | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrants exercise price per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=PPCB_SecondWarrantMember', window );">Second Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants to purchase of common stock, shares | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrants exercise price per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,330<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=PPCB_ThirdWarrantMember', window );">Third Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants to purchase of common stock, shares | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">225<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrants exercise price per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=PPCB_AuctusFundLLCMember', window );">Auctus Fund, LLC [Member] | August 2019 Auctus Note [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Convertible debt principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32,848<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPayableCurrentAndNoncurrent', window );">Accrued interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">716<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">43,176<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentAmount1', window );">Debt conversion of converted amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">326,117<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedPremium', window );">Debt premium amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">217,411<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_DebtConversionConvertedInterestPayable', window );">Debt conversion of accrued interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39,536<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PPCB_DecemberTwentyNineTwoThousandAndSeventeenSecuritiesPurchaseAgreementMember', window );">December 29, 2017 Securities Purchase Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPayableCurrentAndNoncurrent', window );">Accrued interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,751<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PPCB_DecemberTwentyNineTwoThousandAndSeventeenSecuritiesPurchaseAgreementMember', window );">December 29, 2017 Securities Purchase Agreement [Member] | December 2017 Eagle Note [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Convertible debt principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPayableCurrentAndNoncurrent', window );">Accrued interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 43,535<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentAmount1', window );">Debt conversion of converted amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">171,965<span></span>
</td>
<td class="nump">171,965<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PPCB_DecemberTwentyNineTwoThousandAndSeventeenSecuritiesPurchaseAgreementMember', window );">December 29, 2017 Securities Purchase Agreement [Member] | Eagle Equities, LLC [Member] | December 2017 Eagle Note [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Convertible debt principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 532,435<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Original issue discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,354<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate, stated percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PPCB_DecemberTwentyNineTwoThousandAndSixteenSecuritiesPurchaseAgreementMember', window );">December 21, 2016 Securities Purchase Agreement [Member] | Eagle Equities, LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayable', window );">Convertible debt outstanding balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PPCB_DecemberTwentyNineTwoThousandAndSixteenSecuritiesPurchaseAgreementMember', window );">December 21, 2016 Securities Purchase Agreement [Member] | Eagle Equities, LLC [Member] | December 2017 Eagle Note [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Convertible debt principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">360,470<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from convertible debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 507,081<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Dec. 29,  2018<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPayableCurrentAndNoncurrent', window );">Accrued interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,065<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PPCB_JulyThirteenTwoThousandAndEighteenSecuritiesPurchaseAgreementMember', window );">July 13, 2018 Securities Purchase Agreement [Member] | July 2018 Eagle Note [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Convertible debt principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPayableCurrentAndNoncurrent', window );">Accrued interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,786<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PPCB_JulyThirteenTwoThousandAndEighteenSecuritiesPurchaseAgreementMember', window );">July 13, 2018 Securities Purchase Agreement [Member] | Eagle Equities, LLC [Member] | July 2018 Eagle Note [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Convertible debt principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from convertible debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 71,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jul. 13,  2019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate, stated percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPayableCurrentAndNoncurrent', window );">Accrued interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentAmount1', window );">Debt conversion of converted amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LegalFees', window );">Legal fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PPCB_JuneTwentyNineTwoThousandEighteenSecuritiesPurchaseAgreementMember', window );">June 14, 2018 Securities Purchase Agreement [Member] | Eagle Equities, LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayable', window );">Convertible debt outstanding balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PPCB_AugustTwentyNineTwoThousandandEighteenSecuritiesPurchaseAgreementMember', window );">August 29, 2018 Securities Purchase Agreement [Member] | Eagle Equities, LLC [Member] | August 2018 Eagle Note [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Convertible debt principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 105,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Aug. 29,  2019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate, stated percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_DebtInstrumentDebtDefaultInterestRate', window );">Debt instrument, default, interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PPCB_OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember', window );">October 2, 2018 Securities Purchase Agreement [Member] | Eagle Equities, LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_DebtInstrumentDebtDefaultInterestRate', window );">Debt instrument, default, interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PPCB_OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember', window );">October 2, 2018 Securities Purchase Agreement [Member] | Eagle Equities, LLC [Member] | October 2018 Eagle Note [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Convertible debt principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 210,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Oct.  02,  2019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate, stated percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPaymentPrincipal', window );">Debt instrument principal payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PPCB_OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember', window );">October 2, 2018 Securities Purchase Agreement [Member] | GS Capital Partners, LLC [Member] | October 2018 GS Note [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Convertible debt principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">212,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 106,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from convertible debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Oct.  02,  2018<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate, stated percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger', window );">Common stock trading volume, percent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">61.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PPCB_OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember', window );">October 2, 2018 Securities Purchase Agreement [Member] | GS Capital Partners, LLC [Member] | October 2018 GS Note [Member] | First Note [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from convertible debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 106,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PPCB_OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember', window );">October 2, 2018 Securities Purchase Agreement [Member] | GS Capital Partners, LLC [Member] | October 2018 GS Note [Member] | Second Note [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from convertible debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 106,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PPCB_NovembeThirtyTwoThousandAndEighteenMecuritiesPurchaseAgreementMember', window );">November 30, 2018 Securities Purchase Agreement [Member] | Eagle Equities, LLC [Member] | November 2018 Eagle Note [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Convertible debt principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 105,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Nov. 30,  2019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate, stated percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_DebtInstrumentDebtDefaultInterestRate', window );">Debt instrument, default, interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPaymentPrincipal', window );">Debt instrument principal payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PPCB_DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember', window );">December 24, 2018 Securities Purchase Agreement [Member] | Eagle Equities, LLC [Member] | December 2018 Eagle Note [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Convertible debt principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 126,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Dec. 24,  2019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate, stated percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_DebtInstrumentDebtDefaultInterestRate', window );">Debt instrument, default, interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPaymentPrincipal', window );">Debt instrument principal payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionOriginalDebtInterestRateOfDebt', window );">Debt original issue discount, rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_PercentageOfOutstandingSharesOfCommonStock', window );">Percentage of outstanding shares of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedPremium', window );">Debt premium amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 357,688<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">224,131<span></span>
</td>
<td class="nump">133,557<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PPCB_DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember', window );">December 24, 2018 Securities Purchase Agreement [Member] | Eagle Equities, LLC [Member] | December 2018 Eagle Note [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger', window );">Common stock trading volume, percent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PPCB_DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember', window );">December 24, 2018 Securities Purchase Agreement [Member] | Eagle Equities, LLC [Member] | December 2018 Eagle Note [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger', window );">Common stock trading volume, percent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">61.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PPCB_DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember', window );">December 24, 2018 Securities Purchase Agreement [Member] | Depository Trust Company [Member] | December 2018 Eagle Note [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger', window );">Common stock trading volume, percent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PPCB_DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember', window );">December 24, 2018 Securities Purchase Agreement [Member] | Depository Trust Company [Member] | December 2018 Eagle Note [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger', window );">Common stock trading volume, percent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PPCB_SecuritiesPurchaseAgreementOneMember', window );">Securities Purchase Agreement One [Member] | Eagle Equities, LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Convertible debt principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">205,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPayableCurrentAndNoncurrent', window );">Accrued interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,990<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayable', window );">Convertible debt outstanding balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PPCB_SecuritiesPurchaseAgreementMember', window );">Securities Purchase Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Original issue discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90,192<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">498,160<span></span>
</td>
<td class="nump">836,724<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Amortization of debt discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,500<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">211,000<span></span>
</td>
<td class="nump">728,904<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PPCB_SecuritiesPurchaseAgreementMember', window );">Securities Purchase Agreement [Member] | December 10 2020 GW Note [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Convertible debt principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41,000<span></span>
</td>
<td class="nump">41,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPayableCurrentAndNoncurrent', window );">Accrued interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,091<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,084<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PPCB_SecuritiesPurchaseAgreementMember', window );">Securities Purchase Agreement [Member] | January 13, 2020 Ader Alef Note [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Convertible debt principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 110,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">110,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Original issue discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jan. 13,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate, stated percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPayableCurrentAndNoncurrent', window );">Accrued interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,073<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentAmount1', window );">Debt conversion of converted amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">110,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LegalFees', window );">Legal fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedPremium', window );">Debt premium amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">59,365<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_DebtConversionConvertedInterestPayable', window );">Debt conversion of accrued interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,493<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PPCB_SecuritiesPurchaseAgreementMember', window );">Securities Purchase Agreement [Member] | January 13, 2020 Ader Alef Note [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_DebtInstrumentDebtDefaultInterestRate', window );">Debt instrument, default, interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">120.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger', window );">Common stock trading volume, percent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_PercentageOfOutstandingSharesOfCommonStock', window );">Percentage of outstanding shares of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentDescription', window );">Debt instrument, description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The
conversion price for the January 13, 2020 Ader Alef Note during the first 6 months the January 13, 2020 Ader Alef Note was fixed at $2.50
and thereafter would be equal to a 35% discount of the lowest closing bid price (&#8220;Lowest Trading Price&#8221;) of the Common Stock
for the ten trading days immediately prior to the delivery of a Notice of Conversion, including the day upon which a Notice of Conversion
was received. Notwithstanding the foregoing, Ader Alef was restricted from effecting a conversion if such conversion, along with other
shares of the Company&#8217;s common stock beneficially owned by Ader Alef and its affiliates, exceeds 4.99% of the outstanding shares
of the Company&#8217;s common stock which may be increased up to 9.99% upon 60 days prior written notice by the Ader Alef to the Company.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PPCB_SecuritiesPurchaseAgreementMember', window );">Securities Purchase Agreement [Member] | January 13, 2020 Ader Alef Note [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_DebtInstrumentDebtDefaultInterestRate', window );">Debt instrument, default, interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_PercentageOfOutstandingSharesOfCommonStock', window );">Percentage of outstanding shares of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PPCB_SecuritiesPurchaseAgreementMember', window );">Securities Purchase Agreement [Member] | December 02 2020 Geneva Roth [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Convertible debt principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">78,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPayableCurrentAndNoncurrent', window );">Accrued interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,120<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PPCB_SecuritiesPurchaseAgreementMember', window );">Securities Purchase Agreement [Member] | September Twenty Two Two Thousand Twenty Geneva Roth [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPayableCurrentAndNoncurrent', window );">Accrued interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,120<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PPCB_SecuritiesPurchaseAgreementMember', window );">Securities Purchase Agreement [Member] | GS Capital Partners, LLC [Member] | January 22, 2020 GS Note [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Convertible debt principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 58,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Original issue discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jan. 22,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPayableCurrentAndNoncurrent', window );">Accrued interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,802<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentAmount1', window );">Debt conversion of converted amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58,000<span></span>
</td>
<td class="nump">141,820<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayable', window );">Convertible debt outstanding balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">58,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LegalFees', window );">Legal fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_DebtInstrumentDebtDefaultInterestRate', window );">Debt instrument, default, interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger', window );">Common stock trading volume, percent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedPremium', window );">Debt premium amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 106,438<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,901<span></span>
</td>
<td class="nump">38,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_DebtConversionConvertedInterestPayable', window );">Debt conversion of accrued interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,508<span></span>
</td>
<td class="nump">76,397<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PPCB_SecuritiesPurchaseAgreementMember', window );">Securities Purchase Agreement [Member] | GS Capital Partners, LLC [Member] | January 22, 2020 GS Note [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from convertible debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 52,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_DebtDefaultAmountPercentage', window );">Debt default amount percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">112.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PPCB_SecuritiesPurchaseAgreementMember', window );">Securities Purchase Agreement [Member] | GS Capital Partners, LLC [Member] | January 22, 2020 GS Note [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_DebtDefaultAmountPercentage', window );">Debt default amount percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PPCB_SecuritiesPurchaseAgreementMember', window );">Securities Purchase Agreement [Member] | Odyssey Capital Funding LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Convertible debt principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPayableCurrentAndNoncurrent', window );">Accrued interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PPCB_SecuritiesPurchaseAgreementMember', window );">Securities Purchase Agreement [Member] | Odyssey Capital Funding LLC [Member] | July 2019 Odyssey Note [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Convertible debt principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 295,000<span></span>
</td>
<td class="nump">$ 320,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Original issue discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from convertible debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">285,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jul. 30,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate, stated percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPayableCurrentAndNoncurrent', window );">Accrued interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,220<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentAmount1', window );">Debt conversion of converted amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">320,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LegalFees', window );">Legal fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_DebtInstrumentDebtDefaultInterestRate', window );">Debt instrument, default, interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger', window );">Common stock trading volume, percent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_PercentageOfOutstandingSharesOfCommonStock', window );">Percentage of outstanding shares of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">120.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedPremium', window );">Debt premium amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 172,308<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PPCB_SecuritiesPurchaseAgreementMember', window );">Securities Purchase Agreement [Member] | Auctus Fund, LLC [Member] | August 2019 Auctus Note [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Convertible debt principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 550,000<span></span>
</td>
<td class="nump">$ 550,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from convertible debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">505,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Aug. 30,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate, stated percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPayableCurrentAndNoncurrent', window );">Accrued interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">486<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentAmount1', window );">Debt conversion of converted amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32,848<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">326,117<span></span>
</td>
<td class="nump">$ 191,035<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LegalFees', window );">Legal fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_DebtInstrumentDebtDefaultInterestRate', window );">Debt instrument, default, interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger', window );">Common stock trading volume, percent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_PercentageOfOutstandingSharesOfCommonStock', window );">Percentage of outstanding shares of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.99%<span></span>
</td>
<td class="nump">125.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedPremium', window );">Debt premium amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 366,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,899<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">217,411<span></span>
</td>
<td class="nump">$ 127,356<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_DiligenceFees', window );">Diligence fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 40,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentDescription', window );">Debt instrument, description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Upon the holder&#8217;s election to convert accrued
interest, default interest or any penalty amounts as stipulated, the Company may elect to pay those amounts in cash. The note may also
be prepaid by the Company at any time between the date of issuance and August 13, 2020 at 135% multiplied by the sum of (a) the then
outstanding principal amount plus (b) accrued and unpaid interest plus (c) default interests<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Fair value of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 375,905<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PPCB_SecuritiesPurchaseAgreementMember', window );">Securities Purchase Agreement [Member] | Auctus Fund, LLC [Member] | August 2019 Auctus Note [Member] | First Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants to purchase of common stock, shares | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrants exercise price per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PPCB_SecuritiesPurchaseAgreementMember', window );">Securities Purchase Agreement [Member] | Auctus Fund, LLC [Member] | August 2019 Auctus Note [Member] | Second Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants to purchase of common stock, shares | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrants exercise price per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,330<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PPCB_SecuritiesPurchaseAgreementMember', window );">Securities Purchase Agreement [Member] | Auctus Fund, LLC [Member] | August 2019 Auctus Note [Member] | Third Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants to purchase of common stock, shares | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">225<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrants exercise price per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PPCB_SecuritiesPurchaseAgreementMember', window );">Securities Purchase Agreement [Member] | GW Holdings Group, LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Convertible debt principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">101,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPayableCurrentAndNoncurrent', window );">Accrued interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,082<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayable', window );">Convertible debt outstanding balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedPremium', window );">Debt premium amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 87,333<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,000<span></span>
</td>
<td class="nump">67,333<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PPCB_SecuritiesPurchaseAgreementMember', window );">Securities Purchase Agreement [Member] | GW Holdings Group, LLC [Member] | October 1, 2019 GW Note [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Convertible debt principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 131,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,000<span></span>
</td>
<td class="nump">30,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from convertible debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 125,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Oct.  01,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate, stated percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPayableCurrentAndNoncurrent', window );">Accrued interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,877<span></span>
</td>
<td class="nump">1,776<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPaymentPrincipal', window );">Debt instrument principal payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedPremium', window );">Debt premium amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,333<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PPCB_SecuritiesPurchaseAgreementMember', window );">Securities Purchase Agreement [Member] | GW Holdings Group, LLC [Member] | December 10 2020 GW Note [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Convertible debt principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">131,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65,000<span></span>
</td>
<td class="nump">90,000<span></span>
</td>
<td class="nump">90,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from convertible debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 125,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Dec. 10,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate, stated percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPayableCurrentAndNoncurrent', window );">Accrued interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,174<span></span>
</td>
<td class="nump">$ 4,636<span></span>
</td>
<td class="nump">1,084<span></span>
</td>
<td class="nump">4,636<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_DebtInstrumentDebtDefaultInterestRate', window );">Debt instrument, default, interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPaymentPrincipal', window );">Debt instrument principal payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_PercentageOfOutstandingSharesOfCommonStock', window );">Percentage of outstanding shares of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedPremium', window );">Debt premium amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 174,666<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,333<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentDescription', window );">Debt instrument, description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The
conversion price for the above GW Holdings notes shall be equal to a 40% discount of the lowest closing bid price (&#8220;Lowest Trading
Price&#8221;) of the Common Stock for the ten trading days immediately prior to the delivery of a Notice of Conversion, including the
day upon which a Notice of Conversion is received. Notwithstanding the foregoing, GW Holdings shall be restricted from effecting a conversion
if such conversion, along with other shares of the Company&#8217;s common stock beneficially owned by GW Holdings and its affiliates,
exceeds 4.99% of the outstanding shares of the Company&#8217;s common stock which may be increased up to 9.99% upon 60 days prior written
notice by the GW Holdings to the Company.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PPCB_SecuritiesPurchaseAgreementMember', window );">Securities Purchase Agreement [Member] | GW Holdings Group, LLC [Member] | December 10 2020 GW Note [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_DebtInstrumentDebtDefaultInterestRate', window );">Debt instrument, default, interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">110.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PPCB_SecuritiesPurchaseAgreementMember', window );">Securities Purchase Agreement [Member] | GW Holdings Group, LLC [Member] | December 10 2020 GW Note [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_DebtInstrumentDebtDefaultInterestRate', window );">Debt instrument, default, interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PPCB_SecuritiesPurchaseAgreementMember', window );">Securities Purchase Agreement [Member] | Crown Bridge Partners, LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Convertible debt principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedPremium', window );">Debt premium amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_UnissuedSharesConversion', window );">Unissued shares conversion | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_DueToEquityConversion', window );">Due to equity conversion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PPCB_SecuritiesPurchaseAgreementMember', window );">Securities Purchase Agreement [Member] | Crown Bridge Partners, LLC [Member] | October 3, 2019 GW Note [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Convertible debt principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 108,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65,280<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65,280<span></span>
</td>
<td class="nump">65,280<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Original issue discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from convertible debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Oct.  03,  2019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate, stated percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPayableCurrentAndNoncurrent', window );">Accrued interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,606<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,138<span></span>
</td>
<td class="nump">7,232<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentAmount1', window );">Debt conversion of converted amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,720<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_DebtInstrumentDebtDefaultInterestRate', window );">Debt instrument, default, interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPaymentPrincipal', window );">Debt instrument principal payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedPremium', window );">Debt premium amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 72,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,480<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentDescription', window );">Debt instrument, description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The
conversion price for the October 3, 2019 Crown Bridge Note shall be equal to a 40% discount of the lowest closing bid price (&#8220;Lowest
Trading Price&#8221;) of the Common Stock for the ten trading days immediately prior to the delivery of a Notice of Conversion, including
the day upon which a Notice of Conversion is received. Notwithstanding the foregoing, Crown Bridge shall be restricted from effecting
a conversion if such conversion, along with other shares of the Company&#8217;s common stock beneficially owned by Crown Bridge and its
affiliates, exceeds 4.99% of the outstanding shares of the Company&#8217;s common stock which may be increased up to 9.99% upon 60 days
prior written notice by the Crown Bridge to the Company. The note is treated as stock settled debt under ASC 480 and accordingly the
Company recorded a $72,000 put premium.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PPCB_SecuritiesPurchaseAgreementMember', window );">Securities Purchase Agreement [Member] | Crown Bridge Partners, LLC [Member] | October 3, 2019 GW Note [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_DebtInstrumentDebtDefaultInterestRate', window );">Debt instrument, default, interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">110.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_PercentageOfOutstandingSharesOfCommonStock', window );">Percentage of outstanding shares of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PPCB_SecuritiesPurchaseAgreementMember', window );">Securities Purchase Agreement [Member] | Crown Bridge Partners, LLC [Member] | October 3, 2019 GW Note [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_DebtInstrumentDebtDefaultInterestRate', window );">Debt instrument, default, interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_PercentageOfOutstandingSharesOfCommonStock', window );">Percentage of outstanding shares of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PPCB_SecuritiesPurchaseAgreementMember', window );">Securities Purchase Agreement [Member] | LG Capital Funding, LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Convertible debt principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Original issue discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 40,385<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentAmount1', window );">Debt conversion of converted amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">416<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedPremium', window );">Debt premium amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,385<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_UnissuedSharesConversion', window );">Unissued shares conversion | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,427<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_DueToEquityConversion', window );">Due to equity conversion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,801<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PPCB_SecuritiesPurchaseAgreementMember', window );">Securities Purchase Agreement [Member] | LG Capital Funding, LLC [Member] | February19 2020 LG Capital Note [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Convertible debt principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">75,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Original issue discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from convertible debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 71,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Feb. 19,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate, stated percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPayableCurrentAndNoncurrent', window );">Accrued interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,164<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentAmount1', window );">Debt conversion of converted amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LegalFees', window );">Legal fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger', window );">Common stock trading volume, percent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedPremium', window );">Debt premium amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,385<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_DebtConversionConvertedInterestPayable', window );">Debt conversion of accrued interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,421<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PPCB_SecuritiesPurchaseAgreementMember', window );">Securities Purchase Agreement [Member] | LG Capital Funding, LLC [Member] | February19 2020 LG Capital Note [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_DebtInstrumentDebtDefaultInterestRate', window );">Debt instrument, default, interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">112.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_PercentageOfOutstandingSharesOfCommonStock', window );">Percentage of outstanding shares of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">999.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentDescription', window );">Debt instrument, description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The
conversion price for the February 19, 2020 LG Capital Note during the first 6 months the February 19, 2020 LG Capital Note was fixed
at $500 and thereafter was equal to a 35% discount of the lowest closing bid price (&#8220;Lowest Trading Price&#8221;) of the Common
Stock for the ten trading days immediately prior to the delivery of a Notice of Conversion, including the day upon which a Notice of
Conversion was received. Notwithstanding the foregoing, LG Capital was restricted from effecting a conversion if such conversion, along
with other shares of the Company&#8217;s common stock beneficially owned by LG Capital and its affiliates, exceeds 9.99% of the outstanding
shares of the Company&#8217;s common stock.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PPCB_SecuritiesPurchaseAgreementMember', window );">Securities Purchase Agreement [Member] | LG Capital Funding, LLC [Member] | February19 2020 LG Capital Note [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_DebtInstrumentDebtDefaultInterestRate', window );">Debt instrument, default, interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">135.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PPCB_SecuritiesPurchaseAgreementMember', window );">Securities Purchase Agreement [Member] | Geneva Roth Remark Holdings Inc [Member] | December 02 2020 Geneva Roth [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Convertible debt principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 78,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">132,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Original issue discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate, stated percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPayableCurrentAndNoncurrent', window );">Accrued interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,477<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_DebtInstrumentDebtDefaultInterestRate', window );">Debt instrument, default, interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedPremium', window );">Debt premium amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 113,077<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_DebtDefaultAmountPercentage', window );">Debt default amount percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PPCB_SecuritiesPurchaseAgreementMember', window );">Securities Purchase Agreement [Member] | Geneva Roth Remark Holdings Inc [Member] | December 02 2020 Geneva Roth [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_DebtInstrumentDebtDefaultInterestRate', window );">Debt instrument, default, interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">110.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_PercentageOfOutstandingSharesOfCommonStock', window );">Percentage of outstanding shares of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentDescription', window );">Debt instrument, description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The
conversion price for the above Geneva Roth notes shall be equal to a<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PPCB_SecuritiesPurchaseAgreementMember', window );">Securities Purchase Agreement [Member] | Geneva Roth Remark Holdings Inc [Member] | December 02 2020 Geneva Roth [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_DebtInstrumentDebtDefaultInterestRate', window );">Debt instrument, default, interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">129.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PPCB_SecuritiesPurchaseAgreementMember', window );">Securities Purchase Agreement [Member] | Geneva Roth Remark Holdings Inc [Member] | January 05, 2021 One Geneva Roth [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Convertible debt principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 68,500<span></span>
</td>
<td class="nump">$ 68,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Original issue discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,500<span></span>
</td>
<td class="nump">$ 3,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jan.  05,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate, stated percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionOriginalDebtAmount1', window );">Debt conversion, original debt amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PPCB_SecuritiesPurchaseAgreementMember', window );">Securities Purchase Agreement [Member] | Geneva Roth Remark Holdings Inc [Member] | March 16, 2021 Geneva Roth [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Convertible debt principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 63,500<span></span>
</td>
<td class="nump">$ 63,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Mar. 16,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate, stated percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionOriginalDebtAmount1', window );">Debt conversion, original debt amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,500<span></span>
</td>
<td class="nump">$ 3,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PPCB_SecuritiesPurchaseAgreementMember', window );">Securities Purchase Agreement [Member] | Geneva Roth Remark Holdings Inc [Member] | August Nineteen Two Thousand Twenty One Geneva Roth [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Convertible debt principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 103,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate, stated percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionOriginalDebtAmount1', window );">Debt conversion, original debt amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PPCB_SecuritiesPurchaseAgreementMember', window );">Securities Purchase Agreement [Member] | Geneva Roth Remark Holdings Inc [Member] | September Twenty Two Two Thousand Twenty One Geneva Roth [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Convertible debt principal amount</a></td>
<td class="nump">$ 63,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate, stated percentage</a></td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_DebtInstrumentDebtDefaultInterestRate', window );">Debt instrument, default, interest rate</a></td>
<td class="nump">35.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionOriginalDebtAmount1', window );">Debt conversion, original debt amount</a></td>
<td class="nump">$ 3,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PPCB_SecuritiesPurchaseAgreementMember', window );">Securities Purchase Agreement [Member] | Geneva Roth Remark Holdings Inc [Member] | September Twenty Two Two Thousand Twenty One Geneva Roth [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentDescription', window );">Debt instrument, description</a></td>
<td class="text">The
conversion price for the above Geneva Roth notes shall be equal to a 35% discount of the market price based on the average of the lowest
three trading prices of the Common Stock for the ten trading days immediately prior to the delivery of a Notice of Conversion. Notwithstanding
the foregoing, Geneva Roth shall be restricted from effecting a conversion if such conversion, along with other shares of the Company&#8217;s
common stock beneficially owned by Geneva Roth and its affiliates, exceeds 9.99% of the outstanding shares of the Company&#8217;s common
stock. These notes are treated as stock settled debt under ASC 480 and accordingly the Company recorded a total of $161,269 put premium
for the four notes.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PPCB_SecuritiesPurchaseAgreementMember', window );">Securities Purchase Agreement [Member] | Geneva Roth Remark Holdings Inc [Member] | September Twenty Two Two Thousand Twenty Geneva Roth [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedPremium', window );">Debt premium amount</a></td>
<td class="nump">$ 161,269<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_DebtDefaultAmountPercentage', window );">Debt default amount percentage</a></td>
<td class="nump">22.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PPCB_SecuritiesPurchaseAgreementMember', window );">Securities Purchase Agreement [Member] | Geneva Roth Remark Holdings Inc [Member] | September Twenty Two Two Thousand Twenty Geneva Roth [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_DebtInstrumentDebtDefaultInterestRate', window );">Debt instrument, default, interest rate</a></td>
<td class="nump">110.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_PercentageOfOutstandingSharesOfCommonStock', window );">Percentage of outstanding shares of common stock</a></td>
<td class="nump">9.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PPCB_SecuritiesPurchaseAgreementMember', window );">Securities Purchase Agreement [Member] | Geneva Roth Remark Holdings Inc [Member] | September Twenty Two Two Thousand Twenty Geneva Roth [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_DebtInstrumentDebtDefaultInterestRate', window );">Debt instrument, default, interest rate</a></td>
<td class="nump">129.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PPCB_AugustTenTwoThousandAndSeventeenConsultingAgreementMember', window );">August 10, 2017 Consulting Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Convertible debt principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 310,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,500<span></span>
</td>
<td class="nump">9,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Aug. 10,  2019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate, stated percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPayableCurrentAndNoncurrent', window );">Accrued interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,168<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentAmount1', window );">Debt conversion of converted amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_DebtInstrumentDebtDefaultInterestRate', window );">Debt instrument, default, interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger', window );">Common stock trading volume, percent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdTradingDays', window );">Common stock trading days | Integer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent', window );">Accrued expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,248<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 155,000<span></span>
</td>
<td class="nump">$ 155,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability', window );">Embedded derivative, fair value of embedded derivative liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 578,212<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PPCB_AugustTenTwoThousandAndSeventeenConsultingAgreementMember', window );">August 10, 2017 Consulting Agreement [Member] | Consultant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Convertible debt principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">161,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">140,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPayableCurrentAndNoncurrent', window );">Accrued interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,418<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,764<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PPCB_AugustTenTwoThousandAndSeventeenConsultingAgreementMember', window );">August 10, 2017 Consulting Agreement [Member] | Settlement and Mutual Release Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Convertible debt principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Original issue discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPayableCurrentAndNoncurrent', window );">Accrued interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,381<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,738<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,262<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentAmount1', window );">Debt conversion of converted amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayable', window );">Convertible debt outstanding balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent', window );">Accrued expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 56,762<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss from settlement of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43,238<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PPCB_NovemberTwentySixTwoThousandNineteenSecuritiesPurchaseAgreementMember', window );">November 26, 2019 Securities Purchase Agreement [Member] | November 26, 2019 Power Up Note [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Convertible debt principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 43,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Nov. 26,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate, stated percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LegalFees', window );">Legal fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_PrepaymentPenalties', window );">Prepayment penalty</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_DiligenceFees', window );">Diligence fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PPCB_JanuarySevenTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember', window );">January 7, 2020 Power Up Lending Group Securities Purchase Agreement [Member] | January 7, 2020 Power Up Note [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Convertible debt principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jan.  07,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate, stated percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LegalFees', window );">Legal fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_PrepaymentPenalties', window );">Prepayment penalty</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">72,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_DiligenceFees', window );">Diligence fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PPCB_MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember', window );">March 12, 2020 Power Up Lending Group Securities Purchase Agreement [Member] | March 12, 2020 Power Up Note [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Convertible debt principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 43,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 118,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">118,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Mar. 12,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate, stated percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPayableCurrentAndNoncurrent', window );">Accrued interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,903<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,903<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayable', window );">Convertible debt outstanding balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LegalFees', window );">Legal fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_DebtInstrumentDebtDefaultInterestRate', window );">Debt instrument, default, interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger', window );">Common stock trading volume, percent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_PercentageOfOutstandingSharesOfCommonStock', window );">Percentage of outstanding shares of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_DebtDefaultAmountPercentage', window );">Debt default amount percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdTradingDays', window );">Common stock trading days | Integer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability', window );">Embedded derivative, fair value of embedded derivative liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 422,557<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_PrepaymentPenalties', window );">Prepayment penalty</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_DiligenceFees', window );">Diligence fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionDescription', window );">Debt conversion, description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The
conversion price for the above Power Up notes was $3,050, subject to certain Market Price (as defined below) adjustment. If the Market
Price was greater than or equal to $5,000, the conversion price was to be the greater of 65% of the Market Price (&#8220;Variable Conversion
Price&#8221;) and $3,050. In the event Market Price was less than $5,000, the conversion price was to be the Variable Conversion Price.
As defined in the note agreements, the &#8220;Market Price&#8221; was the average of the lowest three closing bid prices during the ten
day trading period prior to and including the day the Company receives a notice of conversion from Power Up on the electronic quotation
system or applicable principal securities exchange or trading market or, if no closing bid price of such security is available in any
of the foregoing manners, the average of the closing bid prices of any market makers for such security that are listed in the &#8220;pink
sheets&#8221; during the ten prior trading days, including the day upon which the Company receives a notice of conversion from Power
Up. Notwithstanding the foregoing, Power Up was restricted from effecting a conversion if such conversion, along with other shares of
the Company&#8217;s common stock beneficially owned by Power Up and its affiliates, exceeds 4.99% of the outstanding shares of the Company&#8217;s
common stock.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayment in cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaid', window );">Repayment of interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,816<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PPCB_RedstartHoldingsCorpFinancingAgreementMember', window );">Redstart Holdings Corp Financing Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Convertible debt principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">133,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPayableCurrentAndNoncurrent', window );">Accrued interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,320<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PPCB_RedstartHoldingsCorpFinancingAgreementMember', window );">Redstart Holdings Corp Financing Agreement [Member] | Redstart Holdings Corp [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Convertible debt principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 133,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">133,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from convertible debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 130,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">May 23,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate, stated percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPayableCurrentAndNoncurrent', window );">Accrued interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">1,137<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LegalFees', window );">Legal fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PPCB_AuctusFinancingAgreementMember', window );">Auctus Financing Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Convertible debt principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32,848<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 358,965<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PPCB_GenevaRothFinancingAgreementAgreementMember', window );">Geneva Roth Financing Agreement Agreement [Member] | September Twenty Two Two Thousand Twenty Geneva Roth [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Convertible debt principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">132,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">78,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPayableCurrentAndNoncurrent', window );">Accrued interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,280<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PPCB_GenevaRothFinancingAgreementAgreementMember', window );">Geneva Roth Financing Agreement Agreement [Member] | Geneva Roth Remark Holdings Inc [Member] | September Twenty Two Two Thousand Twenty Geneva Roth [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Convertible debt principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">167,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">132,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPayableCurrentAndNoncurrent', window );">Accrued interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,081<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,477<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedPremium', window );">Debt premium amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 71,077<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 42,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_DebtConversionConvertedInterestPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt conversion converted interest payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_DebtConversionConvertedInterestPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_DebtDefaultAmountPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt default amount percentage.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_DebtDefaultAmountPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_DebtInstrumentDebtDefaultInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>It represents interest rate of convertible promissory notes in event of default in payments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_DebtInstrumentDebtDefaultInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_DiligenceFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Diligence fees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_DiligenceFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_DueToEquityConversion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Due to equity conversion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_DueToEquityConversion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_PercentageOfOutstandingSharesOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>It represents Percentage of the outstanding shares of common stock on each closing date the number of shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_PercentageOfOutstandingSharesOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_PrepaymentPenalties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Prepayment penalties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_PrepaymentPenalties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_ReclassifiedPremiumAmountForAdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reclassified premium amount for additional paid in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_ReclassifiedPremiumAmountForAdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_UnissuedSharesConversion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unissued shares conversion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_UnissuedSharesConversion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDebtDiscountPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDebtDiscountPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120401414&amp;loc=d3e603758-122996<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The name of the original debt issue that has been converted in a noncash (or part noncash) transaction during the accounting period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionOriginalDebtAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of the original debt being converted in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionOriginalDebtAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionOriginalDebtInterestRateOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The rate of interest that was being paid on the original debt issue that is being converted in the noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionOriginalDebtInterestRateOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum percentage of common stock price to conversion price of convertible debt instruments to determine eligibility of conversion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Threshold number of specified trading days that common stock price to conversion price of convertible debt instruments must exceed threshold percentage within a specified consecutive trading period to trigger conversion feature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Identification of the lender and information about a contractual promise to repay a short-term or long-term obligation, which includes borrowings under lines of credit, notes payable, commercial paper, bonds payable, debentures, and other contractual obligations for payment. This may include rationale for entering into the arrangement, significant terms of the arrangement, which may include amount, repayment terms, priority, collateral required, debt covenants, borrowing capacity, call features, participation rights, conversion provisions, sinking-fund requirements, voting rights, basis for conversion if convertible and remarketing provisions. The description may be provided for individual debt instruments, rational groupings of debt instruments, or by debt in total.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentPeriodicPaymentPrincipal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the required periodic payments applied to principal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentPeriodicPaymentPrincipal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt premium.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value as of the balance sheet date of the embedded derivative or group of embedded derivatives classified as a liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAdjustmentOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to adjustment to fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section 25<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=109262497&amp;loc=d3e20148-110875<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAdjustmentOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, including, but not limited to, capitalized interest and payment to settle zero-coupon bond attributable to accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount; classified as operating and investing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPayableCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest payable on debt, including, but not limited to, trade payables.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPayableCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LegalFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LegalFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=PPCB_FirstWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=PPCB_FirstWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=PPCB_SecondWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=PPCB_SecondWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=PPCB_ThirdWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=PPCB_ThirdWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=PPCB_AuctusFundLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=PPCB_AuctusFundLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=PPCB_AugustTwoThousandNineteenAuctusNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=PPCB_AugustTwoThousandNineteenAuctusNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=PPCB_DecemberTwentyNineTwoThousandAndSeventeenSecuritiesPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=PPCB_DecemberTwentyNineTwoThousandAndSeventeenSecuritiesPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=PPCB_DecemberTwoThousandAndSeventeenEagleNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=PPCB_DecemberTwoThousandAndSeventeenEagleNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=PPCB_EagleEquitiesLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=PPCB_EagleEquitiesLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=PPCB_DecemberTwentyNineTwoThousandAndSixteenSecuritiesPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=PPCB_DecemberTwentyNineTwoThousandAndSixteenSecuritiesPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=PPCB_JulyThirteenTwoThousandAndEighteenSecuritiesPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=PPCB_JulyThirteenTwoThousandAndEighteenSecuritiesPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=PPCB_JulyTwoThousandEighteenEagleNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=PPCB_JulyTwoThousandEighteenEagleNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=PPCB_JuneTwentyNineTwoThousandEighteenSecuritiesPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=PPCB_JuneTwentyNineTwoThousandEighteenSecuritiesPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=PPCB_AugustTwentyNineTwoThousandandEighteenSecuritiesPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=PPCB_AugustTwentyNineTwoThousandandEighteenSecuritiesPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=PPCB_AugustTwoThousandEighteenEagleNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=PPCB_AugustTwoThousandEighteenEagleNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=PPCB_OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=PPCB_OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=PPCB_OctoberTwoTwoThousandAndEighteenEagleNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=PPCB_OctoberTwoTwoThousandAndEighteenEagleNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=PPCB_GSCapitalPartnersLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=PPCB_GSCapitalPartnersLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=PPCB_OctoberTwoThousandEighteenGSNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=PPCB_OctoberTwoThousandEighteenGSNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=PPCB_FirstNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=PPCB_FirstNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=PPCB_SecondNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=PPCB_SecondNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=PPCB_NovembeThirtyTwoThousandAndEighteenMecuritiesPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=PPCB_NovembeThirtyTwoThousandAndEighteenMecuritiesPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=PPCB_NovemberTwoThousandAndEighteenEagleNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=PPCB_NovemberTwoThousandAndEighteenEagleNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=PPCB_DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=PPCB_DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=PPCB_DecembeTwoThousandAndEighteenEagleNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=PPCB_DecembeTwoThousandAndEighteenEagleNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=PPCB_DepositoryTrustCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=PPCB_DepositoryTrustCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=PPCB_SecuritiesPurchaseAgreementOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=PPCB_SecuritiesPurchaseAgreementOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=PPCB_SecuritiesPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=PPCB_SecuritiesPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=PPCB_DecemberTenTwoThousandTwentyGWNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=PPCB_DecemberTenTwoThousandTwentyGWNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=PPCB_JanuaryThirteenTwentyTwentyAderAlefNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=PPCB_JanuaryThirteenTwentyTwentyAderAlefNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=PPCB_DecemberTwoTwoThousandTwentyGenevaRothMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=PPCB_DecemberTwoTwoThousandTwentyGenevaRothMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=PPCB_SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=PPCB_SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=PPCB_JanuaryTwentyTwoTwentyTwentyGSNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=PPCB_JanuaryTwentyTwoTwentyTwentyGSNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=PPCB_OdysseyCapitalFundingLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=PPCB_OdysseyCapitalFundingLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=PPCB_JulyTwoThousandNineteenOdysseyNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=PPCB_JulyTwoThousandNineteenOdysseyNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=PPCB_GWHoldingsGroupLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=PPCB_GWHoldingsGroupLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=PPCB_OctoberOneTwoThousandNineteenAuctusNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=PPCB_OctoberOneTwoThousandNineteenAuctusNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=PPCB_CrownBridgePartnersLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=PPCB_CrownBridgePartnersLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=PPCB_OctoberThreeTwoThousandNineteenAuctusNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=PPCB_OctoberThreeTwoThousandNineteenAuctusNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=PPCB_LGCapitalFundingLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=PPCB_LGCapitalFundingLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=PPCB_FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=PPCB_FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=PPCB_GenevaRothRemarkHoldingsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=PPCB_GenevaRothRemarkHoldingsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=PPCB_JanuaryFiveTwoThousandTwentyOneGenevaRothMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=PPCB_JanuaryFiveTwoThousandTwentyOneGenevaRothMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=PPCB_MarchSixteenTwoThousandTwentyOneGenevaRothMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=PPCB_MarchSixteenTwoThousandTwentyOneGenevaRothMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=PPCB_AugustNineteenTwoThousandTwentyOneGenevaRothMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=PPCB_AugustNineteenTwoThousandTwentyOneGenevaRothMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=PPCB_SeptemberTwentyTwoTwoThousandTwentyOneGenevaRothMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=PPCB_SeptemberTwentyTwoTwoThousandTwentyOneGenevaRothMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=PPCB_AugustTenTwoThousandAndSeventeenConsultingAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=PPCB_AugustTenTwoThousandAndSeventeenConsultingAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=PPCB_ConsultantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=PPCB_ConsultantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=PPCB_SettlementAndMutualReleaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=PPCB_SettlementAndMutualReleaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=PPCB_NovemberTwentySixTwoThousandNineteenSecuritiesPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=PPCB_NovemberTwentySixTwoThousandNineteenSecuritiesPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=PPCB_NovemberTwentySixTwoThousandNineteenPowerUpNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=PPCB_NovemberTwentySixTwoThousandNineteenPowerUpNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=PPCB_JanuarySevenTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=PPCB_JanuarySevenTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=PPCB_JanuarySevenTwoThousandTwentyPowerUpNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=PPCB_JanuarySevenTwoThousandTwentyPowerUpNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=PPCB_MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=PPCB_MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=PPCB_MarchTwelveTwoThousandTwentyPowerUpNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=PPCB_MarchTwelveTwoThousandTwentyPowerUpNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=PPCB_RedstartHoldingsCorpFinancingAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=PPCB_RedstartHoldingsCorpFinancingAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=PPCB_RedstartHoldingsCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=PPCB_RedstartHoldingsCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=PPCB_AuctusFinancingAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=PPCB_AuctusFinancingAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=PPCB_GenevaRothFinancingAgreementAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=PPCB_GenevaRothFinancingAgreementAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm140460426719864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE OF INCOME TAX PROVISION (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax (expense) benefit</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">$ (113,415)<span></span>
</td>
<td class="num">$ (134,728)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">UNITED STATES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic', window );">Loss before Income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,025,947)<span></span>
</td>
<td class="num">(4,740,723)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate', window );">Taxes under statutory US tax rates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(425,449)<span></span>
</td>
<td class="num">(995,552)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Increase (decrease) in valuation allowance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,146,001<span></span>
</td>
<td class="nump">1,137,716<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes', window );">Prior period adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,063,710)<span></span>
</td>
<td class="num">(14,624)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential', window );">Foreign tax rate differential</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(51,169)<span></span>
</td>
<td class="num">(128,492)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationTaxCredits', window );">Income tax rate change</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">392,767<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationOtherAdjustments', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,559<span></span>
</td>
<td class="nump">952<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax (expense) benefit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to revisions of previously reported income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationTaxCredits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax credits. Including, but not limited to, research credit, foreign tax credit, investment tax credit, and other tax credits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationTaxCredits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm140460431518648">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_DeferredTaxAssetsWarrantDerivativeLiability', window );">Warrant Derivative Liability</a></td>
<td class="nump">$ 7,403<span></span>
</td>
<td class="nump">$ 7,403<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities', window );">Accrued Expenses</a></td>
<td class="nump">342,464<span></span>
</td>
<td class="nump">297,086<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_DeferredTaxAssetsPrepaidInvestorServices', window );">Prepaid Investor Services</a></td>
<td class="nump">444,411<span></span>
</td>
<td class="nump">470,050<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_DeferredTaxAssetsNonCashInterest', window );">Non-cash interest</a></td>
<td class="nump">687,529<span></span>
</td>
<td class="nump">596,004<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets', window );">Intangibles (Intellectual Property and Patent Cost)</a></td>
<td class="nump">259,743<span></span>
</td>
<td class="nump">240,428<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent', window );">Deferred Rent</a></td>
<td class="nump">4,262<span></span>
</td>
<td class="nump">1,969<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther', window );">Formation Expense</a></td>
<td class="nump">6,815<span></span>
</td>
<td class="nump">7,208<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net Operating Loss CF</a></td>
<td class="nump">8,546,920<span></span>
</td>
<td class="nump">7,438,911<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_DeferredTaxAssetsForeignExchangeLoss', window );">Foreign Exchange Loss (OCI)</a></td>
<td class="num">(39,379)<span></span>
</td>
<td class="num">(39,379)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_DeferredTaxAssetsRevalueOfDerivativeLiability', window );">Revalue of derivative liability</a></td>
<td class="nump">439,958<span></span>
</td>
<td class="nump">438,239<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost', window );">Stock Based Compensation</a></td>
<td class="nump">51,481<span></span>
</td>
<td class="nump">51,481<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Total Deferred tax assets</a></td>
<td class="nump">10,751,607<span></span>
</td>
<td class="nump">9,509,400<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts', window );">R&amp;D</a></td>
<td class="num">(197,604)<span></span>
</td>
<td class="num">(177,702)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_DeferredTaxLiabilitiesGainOnExtinguishmentOfDebt', window );">Gain on extinguishment of debt</a></td>
<td class="num">(277,614)<span></span>
</td>
<td class="nump">266,987<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts', window );">Capital Raising Costs</a></td>
<td class="num">(321,291)<span></span>
</td>
<td class="num">(255,614)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Total deferred tax liabilities</a></td>
<td class="num">(796,509)<span></span>
</td>
<td class="num">(700,303)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Net deferred tax assets (liabilities)</a></td>
<td class="nump">9,955,098<span></span>
</td>
<td class="nump">8,809,097<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(9,955,098)<span></span>
</td>
<td class="num">(8,809,097)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Net deferred tax assets (liabilities)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_DeferredTaxAssetsForeignExchangeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred tax assets foreign exchange loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_DeferredTaxAssetsForeignExchangeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_DeferredTaxAssetsNonCashInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Non-cash interest in deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_DeferredTaxAssetsNonCashInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_DeferredTaxAssetsPrepaidInvestorServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to prepaid investor services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_DeferredTaxAssetsPrepaidInvestorServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_DeferredTaxAssetsRevalueOfDerivativeLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred tax assets revalue of derivative liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_DeferredTaxAssetsRevalueOfDerivativeLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_DeferredTaxAssetsWarrantDerivativeLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred tax assets warrant derivative liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_DeferredTaxAssetsWarrantDerivativeLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_DeferredTaxLiabilitiesGainOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gain on extinguishment of debt in deferred tax liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_DeferredTaxLiabilitiesGainOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(15)(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from intangible assets including goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from provisions, reserves, allowances, and accruals, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from deferred rent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from research and development costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm140460430430104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 27, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Tax benefit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 113,415<span></span>
</td>
<td class="nump">$ 134,728<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income Tax Expense (Benefit)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(113,415)<span></span>
</td>
<td class="num">(134,728)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease', window );">Changes in unrecognized tax benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">UNITED STATES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Tax benefit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,588,164<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income Tax Expense (Benefit)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_AU', window );">AUSTRALIA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Tax benefit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,128,485<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential', window );">Income tax rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26.00%<span></span>
</td>
<td class="nump">27.50%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income Tax Expense (Benefit)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_AU', window );">AUSTRALIA | Expire in 2024 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_AU', window );">AUSTRALIA | Not Expire [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PPCB_CaresActMember', window );">CARES Act [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationDescription', window );">Income Tax Examination, Description</a></td>
<td class="text">The
CARES Act, among other things, permits NOL carryovers and carrybacks to offset 100% of taxable income for taxable years beginning before
2021.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExaminationDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A brief description of status of the tax examination, significant findings to date, and the entity's position with respect to the findings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExaminationDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in unrecognized tax benefits attributable to uncertain tax positions taken in tax returns.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_AU">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_AU</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardDateAxis=PPCB_ExpireInTwoThousandTwentyFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardDateAxis=PPCB_ExpireInTwoThousandTwentyFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardDateAxis=PPCB_NotExpireMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardDateAxis=PPCB_NotExpireMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=PPCB_CaresActMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=PPCB_CaresActMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm140460434949960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE OF STOCK OPTION ACTIVITY (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of Shares, Outstanding, Beginning balance</a></td>
<td class="nump">59<span></span>
</td>
<td class="nump">60<span></span>
</td>
<td class="nump">60<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Price Per Share, Outstanding, Beginning balance</a></td>
<td class="nump">$ 13,730<span></span>
</td>
<td class="nump">$ 76,370<span></span>
</td>
<td class="nump">$ 76,370<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod', window );">Number of Shares, Issued</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsIssuedInPeriodWeightedAverageExercisePrice', window );">Weighted Average Price Per Share, Issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Number of Shares, Exercised</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Weighted Average Price Per Share, Exercised</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod', window );">Number of Shares, Expired</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice', window );">Weighted Average Price Per Share, Expired</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 3,750,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of Shares, Outstanding, Ending balance</a></td>
<td class="nump">59<span></span>
</td>
<td class="nump">59<span></span>
</td>
<td class="nump">60<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Price Per Share, Outstanding, Ending balance</a></td>
<td class="nump">$ 4,533.33<span></span>
</td>
<td class="nump">$ 13,730<span></span>
</td>
<td class="nump">$ 76,370<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Number of Shares, Exercisable, Ending balance</a></td>
<td class="nump">39<span></span>
</td>
<td class="nump">40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Weighted Average Price Per Share, Exercisable, Ending balance</a></td>
<td class="nump">$ 4,530.93<span></span>
</td>
<td class="nump">$ 18,193<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted average remaining contractual term</a></td>
<td class="text">7 years 7 months 13 days<span></span>
</td>
<td class="text">7 years 10 months 9 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_WeightedAverageFairValueOfOptionsGrantedDuringPeriod', window );">Weighted average fair value of options granted during the period</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate intrinsic value</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Weighted Average Price Per Share, Issued</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Number of Shares, Forfeited</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Weighted Average Price Per Share, Forfeited</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod', window );">Number of Shares, Expired</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Number of Shares, Exercisable, Ending balance</a></td>
<td class="nump">39<span></span>
</td>
<td class="nump">40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Weighted Average Price Per Share, Exercisable, Ending balance</a></td>
<td class="nump">$ 4,530.93<span></span>
</td>
<td class="nump">$ 18,193<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate intrinsic value</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsIssuedInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangements by Share-based Payment Award, Options, Issued in Period, Weighted Average Exercise Price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsIssuedInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_WeightedAverageFairValueOfOptionsGrantedDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value of options granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_WeightedAverageFairValueOfOptionsGrantedDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm140460434169720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE OF WARRANT ACTIVITY (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber', window );">Number of Shares, Outstanding, Beginning balance</a></td>
<td class="nump">121,329<span></span>
</td>
<td class="nump">151,170<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageOutstanding', window );">Weighted Average Price Per Share, Outstanding, Beginning balance</a></td>
<td class="nump">$ 179.63<span></span>
</td>
<td class="nump">$ 150.00<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsIssued', window );">Number of Shares, Issued</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">151,170<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceIssued', window );">Weighted Average Price Per Share, Issued</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 150.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised', window );">Number of Shares, Exercised</a></td>
<td class="num">(9,397)<span></span>
</td>
<td class="num">(29,841)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceExercised', window );">Weighted Average Price Per Share, Exercised</a></td>
<td class="nump">$ 40.37<span></span>
</td>
<td class="nump">$ 26.15<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures', window );">Number of Shares, Forfeited</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceExpired', window );">Weighted Average Price Per Share, Forfeited</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations', window );">Number of Shares, Expired</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceForfeited', window );">Weighted Average Price Per Share, Expired</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber', window );">Number of Shares, Outstanding, Ending balance</a></td>
<td class="nump">111,932<span></span>
</td>
<td class="nump">121,329<span></span>
</td>
<td class="nump">151,170<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageOutstanding', window );">Weighted Average Price Per Share, Outstanding, Ending balance</a></td>
<td class="nump">$ 191.32<span></span>
</td>
<td class="nump">$ 179.63<span></span>
</td>
<td class="nump">$ 150.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber', window );">Number of Shares, Exercisable, Ending balance</a></td>
<td class="nump">76,933<span></span>
</td>
<td class="nump">76,955<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisable', window );">Weighted Average Price Per Share, Exercisable, Ending balance</a></td>
<td class="nump">$ 278.36<span></span>
</td>
<td class="nump">$ 283.21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerms', window );">Weighted average remaining contractual term</a></td>
<td class="text">1 year 6 months 7 days<span></span>
</td>
<td class="text">1 year 9 months 7 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsAggregateIntrinsicValueOutstanding', window );">Aggregate intrinsic value</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber', window );">Number of Shares, Exercisable, Ending balance</a></td>
<td class="nump">76,933<span></span>
</td>
<td class="nump">76,955<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisable', window );">Weighted Average Price Per Share, Exercisable, Ending balance</a></td>
<td class="nump">$ 278.36<span></span>
</td>
<td class="nump">$ 283.21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsAggregateIntrinsicValueOutstanding', window );">Aggregate intrinsic value</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of equity instruments other than options exercisable, including both vested and non-vested instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net number of non-option equity instruments issued to participants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Price Per Share Outstanding Exercisable, Ending.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Non-options Equity Instruments, Weighted Average.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Price Per Share Exercised.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceExpired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Price Per Share Expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceExpired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceForfeited">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Price Per Share Forfeited.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceForfeited</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Price Per Share Issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsAggregateIntrinsicValueOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate intrinsic value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsAggregateIntrinsicValueOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of non-option equity instruments exercised by participants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares under non-option equity instrument agreements for which rights to exercise lapsed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares under non-option equity instrument agreements that were cancelled as a result of occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of equity instruments other than options outstanding, including both vested and non-vested instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm140460298129800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS&#8217; DEFICIT (Details Narrative)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">1 Months Ended</th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Aug. 17, 2021 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Aug. 12, 2021 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jul. 20, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 22, 2021 </div>
<div>shares</div>
</th>
<th class="th">
<div>Nov. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Nov. 17, 2020</div></th>
<th class="th">
<div>Jul. 19, 2020 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 26, 2020 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Apr. 03, 2020 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 20, 2020 </div>
<div>Integer </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Feb. 03, 2020 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 10, 2019 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>May 31, 2019 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 27, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Oct. 31, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Feb. 04, 2021 </div>
<div>shares</div>
</th>
<th class="th">
<div>Feb. 03, 2021 </div>
<div>shares</div>
</th>
<th class="th">
<div>Aug. 31, 2019 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized | shares</a></td>
<td class="nump">1,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000,000<span></span>
</td>
<td class="nump">1,000,000,000<span></span>
</td>
<td class="nump">2,002,490<span></span>
</td>
<td class="nump">1,000,000,000<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityReverseStockSplit', window );">Reverse stock split</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">one-for-one thousand (1:1,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized | shares</a></td>
<td class="nump">1,500,005<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500,005<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500,005<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500,005<span></span>
</td>
<td class="nump">1,500,005<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value | $ / shares</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants exercised | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Fair value of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 984,810<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Proceed from issuance of excercise of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 275,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock for cash, shares | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,399,988<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Number of restricted stock, shares | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">78<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 450,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPayableCurrentAndNoncurrent', window );">Accrued interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 416<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 49,985<span></span>
</td>
<td class="nump">50,607<span></span>
</td>
<td class="nump">67,123<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Convertible debt principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesSubscribedButUnissued', window );">Common stock, unissued shares | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,427<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedPremium', window );">Debt premium amount</a></td>
<td class="nump">$ 177,045<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,785<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 196,496<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 177,045<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 196,496<span></span>
</td>
<td class="nump">$ 574,804<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_DecreaseInEquity', window );">Amount of decrease in equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 31,801<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value | $ / shares</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Number of shares issued for services, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 581,861<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 125,572<span></span>
</td>
<td class="nump">$ 113,642<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromWarrantExercises', window );">Proceeds from warrants exercise</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 275,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 201,044<span></span>
</td>
<td class="nump">$ 776,044<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock shares issued | shares</a></td>
<td class="nump">43,841,644<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,055,393<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43,841,644<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,055,393<span></span>
</td>
<td class="nump">258,120<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_DeemedDividend', window );">Deemed dividend</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 114,844<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 391,749<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,718<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,718<span></span>
</td>
<td class="nump">$ 82,872<span></span>
</td>
<td class="nump">$ 300,416<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">59<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockOptionPlanExpense', window );">Stock option expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 51,796<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 months 13 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Options granted | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMaturityDate', window );">Warrant expiration date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Sep. 10,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Term of warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 months 13 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised', window );">Warrants exercisable | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,397<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,841<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock value issued</a></td>
<td class="nump">$ 43,842<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,056<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 43,842<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,056<span></span>
</td>
<td class="nump">$ 258<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share Price | $ / shares</a></td>
<td class="nump">$ 0.026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0517<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0517<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedSalariesCurrent', window );">Acccrued salary cancellation</a></td>
<td class="nump">$ 9,739<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 101,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,739<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 101,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_CommonStockIssuableShares', window );">Common stock, shares issuable | shares</a></td>
<td class="nump">2,002,549<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">59<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,002,549<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">59<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Stock Issued During Period, Value, New Issues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 424,990<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteSubscriptionsReceivable', window );">Stockholders' Equity Note, Subscriptions Receivable</a></td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesOther', window );">Stock Issued During Period, Shares, Other | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,999,990<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=PPCB_MrNathanielszMember', window );">Mr. Nathanielsz [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,299<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Additional paid in capital upon issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 177,840<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=PPCB_LegalServicesMember', window );">Legal Services [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Shares issued, price per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.05<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,883<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan', window );">Stock issued during the period for services, shares | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">166,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock value issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,883<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=PPCB_ConsultantServicesMember', window );">Consultant Services [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Shares issued, price per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.04<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">104,611<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan', window );">Stock issued during the period for services, shares | shares</a></td>
<td class="nump">2,819,712<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock value issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 104,611<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=PPCB_TwoThousandNinteenEquityIncentivePlanMember', window );">2019 Equity Incentive Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Number of common shares reserved for future issuance | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">234<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">234<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=PPCB_ConsultantMember', window );">Consultant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Number of shares issued for services | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">225,037<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Number of shares issued for services, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 67,511<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember', window );">Chief Executive Officer [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Number of restricted stock, shares | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=PPCB_ChiefScientificOfficerandDirectorMember', window );">Chief Scientific Officerand Director [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Shares issued, price per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.03<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,788<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan', window );">Stock issued during the period for services, shares | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,420,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock value issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 107,388<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Additional paid in capital upon issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">102,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Number of restricted stock, shares | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">117<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantDateFairvalue', window );">[custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantDateFairvalue]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 497,240<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 217,543<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_UnrecognizedRestrictedStockUnitsExpense', window );">[custom:UnrecognizedRestrictedStockUnitsExpense]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 248,620<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares', window );">Number of shares not yet vested | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">248,620<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">248,620<span></span>
</td>
<td class="nump">248,620<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock for cash, shares | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">804<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPayableCurrentAndNoncurrent', window );">Accrued interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_FairMarketValueOfShares', window );">Fair market value of the shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">178,368<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80,368<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Derivative fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130,975<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130,975<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_PremiumsToAdditionalPaidInCapital', window );">Premiums to additional paid in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 109,643<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">590,504<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Convertible debt principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 95,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 95,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Number of shares issued for services | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,934,379<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">805,646<span></span>
</td>
<td class="nump">8,729<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Number of shares issued for services, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17,934<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 806<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Stock Issued During Period, Value, New Issues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member] | Consultant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Shares issued, price per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Number of shares issued for services | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">225,037<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Number of shares issued for services, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 67,511<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=PPCB_FirstWarrantMember', window );">First Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants exercised | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">450<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,250<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=PPCB_SecondWarrantMember', window );">Second Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants exercised | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,330<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=PPCB_ThirdWarrantMember', window );">Third Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants exercised | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">225<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember', window );">Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 984,810<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=PPCB_CommonStockOneMember', window );">Common Stock One [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock for cash, shares | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Shares issued, price per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.03<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,920<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan', window );">Stock issued during the period for services, shares | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan', window );">Stock Issued During Period, Value, Employee Benefit Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 84,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock value issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 87,920<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Additional paid in capital upon issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 84,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PPCB_SecurityPurchaseAgreementMember', window );">Security Purchase Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_EquityPurchaseAgreementDescription', window );">Equity purchase agreement description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">the Company closed on a transaction related to a Securities Purchase Agreement (the &#8220;Securities Purchase Agreement&#8221;)
entered into on March 30, 2020, whereby an investor (the &#8220;Investor&#8221;) purchased from the Company, 7,500 units (the &#8220;Units&#8221;),
each consisting of (i) 1.5 shares of the Company&#8217;s common stock (the &#8220;Common Stock&#8221;), or pre-funded warrants (the &#8220;Prefunded
Warrants&#8221;) upon Investor&#8217;s election due to the 4.99% blocker provision as discussed below and (ii) 1.5 warrants to purchase
one share of Common Stock (&#8220;Series A Warrants&#8221;, and collectively with the Common Stock the &#8220;Units&#8221;).<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Fair value of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 450,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Proceed from issuance of excercise of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">424,990<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Offering cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,010<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity Method Investment, Ownership Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock for cash, shares | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,445,009<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,786,113<span></span>
</td>
<td class="nump">247,619<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price | $ / shares</a></td>
<td class="nump">$ 0.02<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.02<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.13<span></span>
</td>
<td class="nump">$ 7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentAmount1', window );">Conversion of principal and interest, aggregate amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,814,336<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_ConversionFees', window );">Conversion fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,500<span></span>
</td>
<td class="nump">15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,186<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,239,075<span></span>
</td>
<td class="nump">2,125,174<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_ConversionOptionDerivatives', window );">Conversion option derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">254,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPayableCurrentAndNoncurrent', window );">Accrued interest</a></td>
<td class="nump">$ 8,087<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 103,321<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,087<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">103,321<span></span>
</td>
<td class="nump">15,408<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_FairMarketValueOfShares', window );">Fair market value of the shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">565,746<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">295,838<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Derivative fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">362,961<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_PremiumsToAdditionalPaidInCapital', window );">Premiums to additional paid in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 874,924<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Convertible debt principal amount</a></td>
<td class="nump">$ 189,849<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,018,867<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 189,849<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,018,867<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PPCB_SecurityPurchaseAgreementMember', window );">Security Purchase Agreement [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price | $ / shares</a></td>
<td class="nump">$ 0.02<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.03<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.02<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.03<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PPCB_SecurityPurchaseAgreementMember', window );">Security Purchase Agreement [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price | $ / shares</a></td>
<td class="nump">$ 0.04<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.04<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.00<span></span>
</td>
<td class="nump">$ 910<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PPCB_SecurityPurchaseAgreementMember', window );">Security Purchase Agreement [Member] | Restricted Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Number of restricted stock, shares | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">804<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PPCB_SecurityPurchaseAgreementMember', window );">Security Purchase Agreement [Member] | Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock for cash, shares | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PPCB_SecurityPurchaseAgreementMember', window );">Security Purchase Agreement [Member] | Prefunded Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants exercised | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,446<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PPCB_UnderlyingFinancingAgreementsMember', window );">Underlying Financing Agreements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock for cash, shares | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">197,308,116<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">197,308,116<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PPCB_ConsultingAgreementMember', window );">Consulting Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock for cash, shares | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 39,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Shares issued, price per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,990<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfessionalFees', window );">Consulting expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 39,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PPCB_EngagementAgreementMember', window );">Engagement Agreement [Member] | Consultant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfessionalFees', window );">Consulting expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 73,842<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 73,842<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 58,061<span></span>
</td>
<td class="nump">$ 58,061<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 58,061<span></span>
</td>
<td class="nump">73,842<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Number of shares issued for services | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,709<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,709<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">580,609<span></span>
</td>
<td class="nump">580,609<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.10<span></span>
</td>
<td class="nump">$ 0.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PPCB_EmploymentAgreementsMember', window );">Employment Agreements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockOptionPlanExpense', window );">Stock option expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 82,872<span></span>
</td>
<td class="nump">$ 82,873<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_UnvestedStockOptionsExpense', window );">Unvested stock options expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 72,514<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PPCB_SecuritiesPurchaseAgreementMember', window );">Securities Purchase Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_EquityPurchaseAgreementDescription', window );">Equity purchase agreement description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">the Company closed on a transaction related to a Securities
Purchase Agreement (the &#8220;Securities Purchase Agreement&#8221;) entered into on March 30, 2020, whereby an investor purchased from
the Company, 7,500 units, each consisting of (i) 1.5 shares of the Company&#8217;s common stock, or pre-funded warrants upon Investor&#8217;s
election due to the 4.99% blocker provision and (ii) 1.5 warrants to purchase one share of Common Stock (&#8220;Series A Warrants&#8221;,
and collectively with the Common Stock the &#8220;Units&#8221;)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PPCB_SecuritiesPurchaseAgreementMember', window );">Securities Purchase Agreement [Member] | Prefunded Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants exercised | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,445<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PPCB_NathanielszCancellationAgreementMember', window );">Nathanielsz Cancellation Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_PercentageOfBonusOfAnnualBaseSalary', window );">Percentage of bonus of annual base salary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PPCB_NathanielszCancellationAgreementMember', window );">Nathanielsz Cancellation Agreement [Member] | Mr. Nathanielsz [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock value issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 186,139<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_PercentageOfBonusOfAnnualBaseSalary', window );">Percentage of bonus of annual base salary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">78.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OfficersCompensation', window );">Officer compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 177,840<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1', window );">Debt Conversion, Converted Instrument, Shares Issued | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,928,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share Price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.03<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PPCB_CancellationAgreementMember', window );">Cancellation Agreement [Member] | Deferred Salary [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedSalariesCurrent', window );">Acccrued salary cancellation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 102,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PPCB_ZelingerAmendedAndRestatedDirectorAgreementMember', window );">Zelinger Amended And Restated Director Agreement [Member] | Josef Zelinger [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock for cash, shares | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,920<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock value issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 87,920<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 87,920<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Additional paid in capital upon issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 84,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share Price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.03<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.03<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_DescriptionOfEmploymentBenefits', window );">Description Of Employment Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Pursuant
to the terms of the Director Agreement, the Company shall pay Zelinger a base salary of $250.00 AUD ($184 USD) per month, payable
on the first day of each month. In addition, the Company may compensate Zelinger additional consideration for advisory services performed
by the Director, either in the form of cash or common stock, at the discretion of the Board. The Company issued 2,800,000 shares of common
stock of the Company for accrued director services of $84,000 as of June 30, 2021.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_CommonStockIssuableShares', window );">Common stock, shares issuable | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Stock Issued During Period, Value, New Issues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 84,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember', window );">Series A Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized | shares</a></td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value | $ / shares</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued | shares</a></td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding | shares</a></td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=PPCB_SeriesBWarrantsMember', window );">Series B Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants exercised | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,375<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,375<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=PPCB_SeriesBWarrantsMember', window );">Series B Warrants [Member] | Security Purchase Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants exercised | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">63,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=PPCB_SeriesBWarrantsMember', window );">Series B Warrants [Member] | Securities Purchase Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants exercised | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">63,750<span></span>
</td>
<td class="nump">3,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Term of warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=PPCB_SeriesBWarrantsMember', window );">Series B Warrants [Member] | Securities Purchase Agreement [Member] | Investor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants exercised | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">63,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised', window );">Warrants exercisable | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdTradingDays', window );">Trading days | Integer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=PPCB_SeriesBWarrantsMember', window );">Series B Warrants [Member] | Securities Purchase Agreement [Member] | Holder [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock for cash, shares | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=PPCB_SeriesCWarrantsMember', window );">Series C Warrants [Member] | Security Purchase Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants exercised | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">63,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=PPCB_SeriesCWarrantsMember', window );">Series C Warrants [Member] | Securities Purchase Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants exercised | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">63,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=PPCB_SeriesCWarrantsMember', window );">Series C Warrants [Member] | Securities Purchase Agreement [Member] | Investor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants exercised | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">63,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Term of warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=PPCB_SeriesAWarrantsMember', window );">Series A Warrants [Member] | Security Purchase Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=PPCB_SeriesAWarrantsMember', window );">Series A Warrants [Member] | Securities Purchase Agreement [Member] | Investor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants exercised | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Term of warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=PPCB_PrefundedWarrantsMember', window );">Prefunded Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants exercised | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,445<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,445<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock for cash, shares | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,820<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=PPCB_TwentySeriesAAndOneSeriesCWarrantsMember', window );">20 Series A and 1 Series C Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock shares issued | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,199,979<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,199,979<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=PPCB_SeriesBWarrantMember', window );">Series B Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized | shares</a></td>
<td class="nump">2,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Proceed from issuance of excercise of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,375<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock shares issued | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,875<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_CommonStockIssuableShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common stock, issuable shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_CommonStockIssuableShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_ConversionFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Conversion fees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_ConversionFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_ConversionOptionDerivatives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Conversion option derivatives.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_ConversionOptionDerivatives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_DecreaseInEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Decrease in equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_DecreaseInEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_DeemedDividend">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deemed dividend.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_DeemedDividend</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_DescriptionOfEmploymentBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description Of Employment Benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_DescriptionOfEmploymentBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_EquityPurchaseAgreementDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity purchase agreement description.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_EquityPurchaseAgreementDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_FairMarketValueOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair market value of the shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_FairMarketValueOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_PercentageOfBonusOfAnnualBaseSalary">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of bonus of annual base salary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_PercentageOfBonusOfAnnualBaseSalary</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_PremiumsToAdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Premiums to additional paid in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_PremiumsToAdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantDateFairvalue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of share based compensation arrangement by share based payment award options grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantDateFairvalue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_UnrecognizedRestrictedStockUnitsExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unrecognized restricted stock units expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_UnrecognizedRestrictedStockUnitsExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_UnvestedStockOptionsExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unvested stock options expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_UnvestedStockOptionsExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedSalariesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedSalariesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesSubscribedButUnissued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of common stock allocated to investors to buy shares of a new issue of common stock before they are offered to the public. When stock is sold on a subscription basis, the issuer does not initially receive the total proceeds. In general, the issuer does not issue the shares to the investor until it receives the entire proceeds.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesSubscribedButUnissued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentSharesIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031898-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Threshold number of specified trading days that common stock price to conversion price of convertible debt instruments must exceed threshold percentage within a specified consecutive trading period to trigger conversion feature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt premium.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of the assets less the liabilities of a derivative or group of derivatives.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAdjustmentOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to adjustment to fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section 25<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=109262497&amp;loc=d3e20148-110875<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAdjustmentOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPayableCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest payable on debt, including, but not limited to, trade payables.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPayableCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OfficersCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for salary and wage arising from service rendered by officer. Excludes allocated cost, labor-related nonsalary expense, and direct and overhead labor cost included in cost of good and service sold.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OfficersCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromWarrantExercises">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from holders exercising their stock warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromWarrantExercises</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfessionalFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07.2(a),(b),(c),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120401555&amp;loc=SL114874292-224272<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 220<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (k)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433917&amp;loc=SL114874205-224268<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfessionalFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of non-option equity instruments exercised by participants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of non-vested options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period to an employee benefit plan, such as a defined contribution or defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued attributable to transactions classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of shares issued during the period to an employee benefit plan, such as a defined contribution or defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockOptionPlanExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockOptionPlanExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteSubscriptionsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Note received instead of cash as contribution to equity. The transaction may be a sale of capital stock or a contribution to paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=65888546&amp;loc=d3e21300-112643<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteSubscriptionsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityReverseStockSplit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB Topic 4.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187143-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityReverseStockSplit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expiration date of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=PPCB_MrNathanielszMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=PPCB_MrNathanielszMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=PPCB_LegalServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=PPCB_LegalServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=PPCB_ConsultantServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=PPCB_ConsultantServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=PPCB_TwoThousandNinteenEquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=PPCB_TwoThousandNinteenEquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=PPCB_ConsultantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=PPCB_ConsultantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=PPCB_ChiefScientificOfficerandDirectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=PPCB_ChiefScientificOfficerandDirectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=PPCB_FirstWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=PPCB_FirstWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=PPCB_SecondWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=PPCB_SecondWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=PPCB_ThirdWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=PPCB_ThirdWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=PPCB_CommonStockOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=PPCB_CommonStockOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=PPCB_SecurityPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=PPCB_SecurityPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=PPCB_PrefundedWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=PPCB_PrefundedWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=PPCB_UnderlyingFinancingAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=PPCB_UnderlyingFinancingAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=PPCB_ConsultingAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=PPCB_ConsultingAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=PPCB_EngagementAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=PPCB_EngagementAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=PPCB_EmploymentAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=PPCB_EmploymentAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=PPCB_SecuritiesPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=PPCB_SecuritiesPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=PPCB_NathanielszCancellationAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=PPCB_NathanielszCancellationAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=PPCB_CancellationAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=PPCB_CancellationAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis=PPCB_DeferredSalaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis=PPCB_DeferredSalaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=PPCB_ZelingerAmendedAndRestatedDirectorAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=PPCB_ZelingerAmendedAndRestatedDirectorAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=PPCB_JosefZelingerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=PPCB_JosefZelingerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=PPCB_SeriesBWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=PPCB_SeriesBWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=us-gaap_InvestorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=us-gaap_InvestorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=PPCB_HolderMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=PPCB_HolderMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=PPCB_SeriesCWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=PPCB_SeriesCWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=PPCB_SeriesAWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=PPCB_SeriesAWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=PPCB_PrefundedWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=PPCB_PrefundedWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=PPCB_TwentySeriesAAndOneSeriesCWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=PPCB_TwentySeriesAAndOneSeriesCWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=PPCB_SeriesBWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=PPCB_SeriesBWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm140460521710104">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SCHEDULE OF RIGHT USE OF ASSET (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_OperatingLeaseRightOfUseAssets', window );">Office lease (24 months)</a></td>
<td class="nump">$ 48,662<span></span>
</td>
<td class="nump">$ 48,662<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_AccumulatedReduction', window );">Less accumulated amortization</a></td>
<td class="num">(48,662)<span></span>
</td>
<td class="num">(26,980)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right-of-use asset, net</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 21,682<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_AccumulatedReduction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated reduction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_AccumulatedReduction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_OperatingLeaseRightOfUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Office lease ROU.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_OperatingLeaseRightOfUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm140460520352104">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SCHEDULE OF OPERATING LEASE LIABILITY (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_OfficeLeaseLiability', window );">Office lease</a></td>
<td class="nump">$ 48,662<span></span>
</td>
<td class="nump">$ 48,662<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_ReductionOfLeaseLiability', window );">Reduction of lease liability</a></td>
<td class="num">(48,662)<span></span>
</td>
<td class="num">(23,590)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Long term portion of lease liability</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 25,072<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_OfficeLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Office lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_OfficeLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_ReductionOfLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reduction of lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_ReductionOfLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm140460264048360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES (Details Narrative)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="4">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 22, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 02, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 02, 2020 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Sep. 26, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 02, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 02, 2019 </div>
<div>AUD ($)</div>
</th>
<th class="th">
<div>Sep. 13, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 13, 2018 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>May 05, 2016 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 05, 2016 </div>
<div>AUD ($)</div>
</th>
<th class="th">
<div>May 31, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Jun. 30, 2012</div></th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>EUR (&#8364;) </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2019 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Mar. 15, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Nov. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Aug. 10, 2017 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_LitigationPenaltyAmount', window );">Penalty amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,000<span></span>
</td>
<td class="nump">$ 30,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,368,795<span></span>
</td>
<td class="nump">3,080,674<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,739,943<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPayableCurrentAndNoncurrent', window );">Accrued interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 416<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating Lease, Right-of-Use Asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,682<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating Lease, Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,072<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_PaymentForServices', window );">Payment for services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,043<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 36,117<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Revenue Benchmark [Member] | Revenue from Rights Concentration Risk [Member] | No Customer [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Royalties percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member', window );">Accounting Standards Update 2016-02 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRent', window );">Payments for Rent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,431<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseDescription', window );">Operating lease, description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Such lease expired in May 2021 and was renewed for another one-year term from May 2021 to May 2022<span></span>
</td>
<td class="text">Such lease expired in May 2021 and was renewed for another one-year term from May 2021 to May 2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating Lease, Right-of-Use Asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 48,662<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating Lease, Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 48,662<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Operating Lease, Weighted Average Discount Rate, Percent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=PPCB_AUDCurrencyMember', window );">AUD Currency [Member] | Accounting Standards Update 2016-02 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRent', window );">Payments for Rent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,606<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=PPCB_EurosMember', window );">Euros [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_PaymentForServices', window );">Payment for services | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 28,493<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 31,754<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardDateAxis=PPCB_From2012ThroughThe2014Member', window );">From 2012 through the 2014 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_LitigationPenaltyAmount', window );">Penalty amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=PPCB_RegalConsultingLLCMember', window );">Regal Consulting, LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesSoughtValue', window );">Loss contingency amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Number of shares issued for services | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60<span></span>
</td>
<td class="nump">60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=PPCB_RegalConsultingLLCMember', window );">Regal Consulting, LLC [Member] | 2017 Note [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleDebt', window );">Convertible note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 106,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_LitigationPenaltyAmount', window );">Penalty amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=PPCB_UniversityOfJaenMember', window );">University of Jaen [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_PaymentForServices', window );">Payment for services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,268<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=PPCB_UniversityOfJaenMember', window );">University of Jaen [Member] | Revenue Benchmark [Member] | Revenue from Rights Concentration Risk [Member] | No Customer [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Royalties percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=PPCB_UniversityOfJaenMember', window );">University of Jaen [Member] | Euros [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_PaymentForServices', window );">Payment for services | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 25,837<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PPCB_SettlementAgreementMember', window );">Settlement Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_GainLossFromSettlementOfDebt', window );">Gain loss from settlement of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 43,238<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 56,762<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_RemainingPrincipalAmount', window );">Remaining principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPayableCurrentAndNoncurrent', window );">Accrued interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,262<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent', window );">Accrued expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PPCB_SettlementAndMutualReleaseAgreementMember', window );">Settlement and Mutual Release Agreement [Member] | Regal Consulting, LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleDebt', window );">Convertible note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=us-gaap_RoyaltyAgreementTermsMember', window );">Royalty Agreement Terms [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_OperatingLeasesIncomeStatementRevenuePercentage', window );">Operating leases income statement revenue percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=us-gaap_LicenseAgreementTermsMember', window );">License Agreement Terms [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_OperatingLeasesIncomeStatementRevenuePercentage', window );">Operating leases income statement revenue percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PPCB_NewFiveYearOperatingLeaseAgreementMember', window );">New Five-Year Operating Lease Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lessee, Operating Lease, Term of Contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRent', window );">Payments for Rent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,469<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseDescription', window );">Operating lease, description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The
initial rental amount was $3,000 AUD and subject to 3% yearly escalation.<span></span>
</td>
<td class="text">The
initial rental amount was $3,000 AUD and subject to 3% yearly escalation.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PPCB_NewFiveYearOperatingLeaseAgreementMember', window );">New Five-Year Operating Lease Agreement [Member] | AUD Currency [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRent', window );">Payments for Rent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,606<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PPCB_OneYearCollaborationAgreementMember', window );">1-Year Collaboration Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_PaymentForServices', window );">Payment for services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 59,508<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PPCB_OneYearCollaborationAgreementMember', window );">1-Year Collaboration Agreement [Member] | Euros [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_PaymentForServices', window );">Payment for services | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 52,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PPCB_TwoYearCollaborationAgreementMember', window );">2-Year Collaboration Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_PaymentForServices', window );">Payment for services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 35,145<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 45,775<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PPCB_TwoYearCollaborationAgreementMember', window );">2-Year Collaboration Agreement [Member] | Euros [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_PaymentForServices', window );">Payment for services | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 40,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PPCB_TwoYearCollaborationAgreementMember', window );">2-Year Collaboration Agreement [Member] | Installment 1 [Member] | Euros [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_PaymentForServices', window );">Payment for services | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PPCB_TwoYearCollaborationAgreementMember', window );">2-Year Collaboration Agreement [Member] | Installment 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_PaymentForServices', window );">Payment for services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,858<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PPCB_TwoYearCollaborationAgreementMember', window );">2-Year Collaboration Agreement [Member] | Installment 2 [Member] | Euros [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_PaymentForServices', window );">Payment for services | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PPCB_TwoYearCollaborationAgreementMember', window );">2-Year Collaboration Agreement [Member] | Installment 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_PaymentForServices', window );">Payment for services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,715<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PPCB_TwoYearCollaborationAgreementMember', window );">2-Year Collaboration Agreement [Member] | Installment 3 [Member] | Euros [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_PaymentForServices', window );">Payment for services | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PPCB_TwoYearCollaborationAgreementMember', window );">2-Year Collaboration Agreement [Member] | Installment 4 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_PaymentForServices', window );">Payment for services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,715<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PPCB_TwoYearCollaborationAgreementMember', window );">2-Year Collaboration Agreement [Member] | Installment 4 [Member] | Euros [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_PaymentForServices', window );">Payment for services | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=PPCB_FoleyShechterMember', window );">Foley Shechter [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LegalFees', window );">Legal Fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 151,031<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=PPCB_FoleyShechterMember', window );">Foley Shechter [Member] | Settlement Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfessionalFees', window );">Professional Fees</a></td>
<td class="nump">$ 51,032<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_SettlementAmount', window );">[custom:SettlementAmount-0]</a></td>
<td class="nump">51,032<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent', window );">Accounts Payable and Accrued Liabilities</a></td>
<td class="nump">$ 142,660<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_GainLossFromSettlementOfDebt', window );">Gain loss from settlement of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 92,556<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_GainLossFromSettlementOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gain loss from settlement of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_GainLossFromSettlementOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_LitigationPenaltyAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Litigation penalty amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_LitigationPenaltyAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_OperatingLeasesIncomeStatementRevenuePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of operating leases income statement revenue during period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_OperatingLeasesIncomeStatementRevenuePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_PaymentForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payment for services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_PaymentForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_RemainingPrincipalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Remaining principal amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_RemainingPrincipalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_SettlementAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Settlement amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_SettlementAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date, including liabilities incurred and payable to vendors for goods and services received, taxes, interest, rent and utilities, compensation costs, payroll taxes and fringe benefits (other than pension and postretirement obligations), contractual rights and obligations, and statutory obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(1),(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying amount of debt identified as being convertible into another form of financial instrument (typically the entity's common stock) as of the balance sheet date, which originally required full repayment more than twelve months after issuance or greater than the normal operating cycle of the company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPayableCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest payable on debt, including, but not limited to, trade payables.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPayableCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LegalFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LegalFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of lessee's operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyDamagesSoughtValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The value (monetary amount) of the award the plaintiff seeks in the legal matter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyDamagesSoughtValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash payments to lessor's for use of assets under operating leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfessionalFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07.2(a),(b),(c),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120401555&amp;loc=SL114874292-224272<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 220<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (k)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433917&amp;loc=SL114874205-224268<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfessionalFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_RevenueFromRightsConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_RevenueFromRightsConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=PPCB_NoCustomerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=PPCB_NoCustomerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=PPCB_AUDCurrencyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=PPCB_AUDCurrencyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=PPCB_EurosMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=PPCB_EurosMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardDateAxis=PPCB_From2012ThroughThe2014Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardDateAxis=PPCB_From2012ThroughThe2014Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=PPCB_RegalConsultingLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=PPCB_RegalConsultingLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=PPCB_TwoThousandAndSeventeenNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=PPCB_TwoThousandAndSeventeenNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=PPCB_UniversityOfJaenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=PPCB_UniversityOfJaenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=PPCB_SettlementAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=PPCB_SettlementAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=PPCB_SettlementAndMutualReleaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=PPCB_SettlementAndMutualReleaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=us-gaap_RoyaltyAgreementTermsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=us-gaap_RoyaltyAgreementTermsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=us-gaap_LicenseAgreementTermsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=us-gaap_LicenseAgreementTermsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=PPCB_NewFiveYearOperatingLeaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=PPCB_NewFiveYearOperatingLeaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=PPCB_OneYearCollaborationAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=PPCB_OneYearCollaborationAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=PPCB_TwoYearCollaborationAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=PPCB_TwoYearCollaborationAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardDateAxis=PPCB_InstallmentOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardDateAxis=PPCB_InstallmentOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardDateAxis=PPCB_InstallmentTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardDateAxis=PPCB_InstallmentTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardDateAxis=PPCB_InstallmentThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardDateAxis=PPCB_InstallmentThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardDateAxis=PPCB_InstallmentFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardDateAxis=PPCB_InstallmentFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=PPCB_FoleyShechterMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=PPCB_FoleyShechterMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm140460265692376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RELATED PARTY TRANSACTIONS (Details Narrative)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="6">12 Months Ended</th>
<th class="th" colspan="1">15 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Aug. 12, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>May 06, 2021 </div>
<div>AUD ($)</div>
</th>
<th class="th">
<div>May 06, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 13, 2020 </div>
<div>AUD ($)</div>
</th>
<th class="th">
<div>Jul. 02, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 02, 2019 </div>
<div>AUD ($)</div>
</th>
<th class="th">
<div>May 14, 2019 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>May 14, 2019 </div>
<div>AUD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 16, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 16, 2018 </div>
<div>AUD ($)</div>
</th>
<th class="th">
<div>Feb. 01, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Feb. 01, 2018 </div>
<div>AUD ($)</div>
</th>
<th class="th">
<div>May 05, 2016 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 05, 2016 </div>
<div>AUD ($)</div>
</th>
<th class="th">
<div>Feb. 25, 2016 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Feb. 25, 2016 </div>
<div>AUD ($)</div>
</th>
<th class="th">
<div>Feb. 25, 2015 </div>
<div>AUD ($)</div>
</th>
<th class="th">
<div>Oct. 31, 2021 </div>
<div>shares</div>
</th>
<th class="th">
<div>May 31, 2019 </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>AUD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>AUD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>AUD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2019 </div>
<div>AUD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>AUD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>AUD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>AUD ($)</div>
</th>
<th class="th">
<div>May 05, 2016 </div>
<div>AUD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueToRelatedPartiesCurrent', window );">Due to related parties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 32,076<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 33,347<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,639<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercise price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted exercise price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Restricted stock shares of common stock | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">78<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedSalariesCurrent', window );">Accrued salaries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,739<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 101,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1', window );">Debt Conversion, Converted Instrument, Shares Issued | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,818,097<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember', window );">Chief Executive Officer [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfRelatedPartyDebt', window );">Payments form related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,660<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 136,606<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 64,377<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_BonusPayableAmount', window );">Bonus payable amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">137,120<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_RemainingBonusAmount', window );">[custom:RemainingBonusAmount]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 178,256<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_BonusPayable', window );">Bonus payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 103,153<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">166,418<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">280,726<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Restricted stock shares of common stock | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PPCB_NathanielszEmploymentAgreementMember', window );">Nathanielsz Employment Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionDate', window );">Expired date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Feb. 25,  2019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalariesAndWages', window );">Annual salary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 205,680<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_PercentageOfPensionOfMonthlySalary', window );">Percentage of pension of monthly salary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.50%<span></span>
</td>
<td class="nump">9.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_PercentageOfBonusOfAnnualBaseSalary', window );">Percentage of bonus of annual base salary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200.00%<span></span>
</td>
<td class="nump">200.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PPCB_NathanielszEmploymentAgreementMember', window );">Nathanielsz Employment Agreement [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalariesAndWages', window );">Annual salary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 205,680<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PPCB_NathanielszEmploymentAgreementMember', window );">Nathanielsz Employment Agreement [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalariesAndWages', window );">Annual salary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 274,240<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PPCB_MrsNathanielszMember', window );">Mrs. Nathanielsz [Member] | Chief Executive Officer [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_BonusPayable', window );">Bonus payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 316,957<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PPCB_EmploymentAgreementMember', window );">Employment Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_StockToBeIssuedDuringPeriodValueRestrictedStockUnit', window );">Restricted stock unit issuable | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39<span></span>
</td>
<td class="nump">39<span></span>
</td>
<td class="nump">39<span></span>
</td>
<td class="nump">39<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PPCB_ServicesAgreementMember', window );">Services Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_StockToBeIssuedDuringPeriodValueRestrictedStockUnit', window );">Restricted stock unit issuable | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member', window );">Accounting Standards Update 2016-02 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRent', window );">Payments for Rent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,431<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseDescription', window );">Lessee, Operating Lease, Description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Such lease expired in May 2021 and was renewed for another one-year term from May 2021 to May 2022<span></span>
</td>
<td class="text">Such lease expired in May 2021 and was renewed for another one-year term from May 2021 to May 2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=PPCB_AUDCurrencyMember', window );">AUD Currency [Member] | Accounting Standards Update 2016-02 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRent', window );">Payments for Rent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,606<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=PPCB_AUDCurrenryMember', window );">AUD Currency [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedSalariesCurrent', window );">Accrued salaries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,500<span></span>
</td>
<td class="nump">$ 135,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=PPCB_AUDCurrenryMember', window );">AUD Currency [Member] | Chief Executive Officer [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfRelatedPartyDebt', window );">Payments form related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 42,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 221,890<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 202,620<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 90,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_BonusPayableAmount', window );">Bonus payable amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_RemainingBonusAmount', window );">[custom:RemainingBonusAmount]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 260,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_BonusPayable', window );">Bonus payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">142,990<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">422,610<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">407,380<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=PPCB_AUDCurrenryMember', window );">AUD Currency [Member] | Nathanielsz Employment Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalariesAndWages', window );">Annual salary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=PPCB_AUDCurrenryMember', window );">AUD Currency [Member] | Nathanielsz Employment Agreement [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalariesAndWages', window );">Annual salary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=PPCB_AUDCurrenryMember', window );">AUD Currency [Member] | Nathanielsz Employment Agreement [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalariesAndWages', window );">Annual salary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=PPCB_RestrictedStocksUnitsRSUMember', window );">Initial Nathanielsz RSUs [Member] | Employment Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Restricted stock shares of common stock | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39<span></span>
</td>
<td class="nump">39<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=PPCB_AdditionaNathanielszRSUsMember', window );">Additional Nathanielsz RSUs [Member] | Employment Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Rsus vest, shares | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.80<span></span>
</td>
<td class="nump">7.80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_GrossProceedsFromEquityFinancing', window );">Gross proceeds from equity financing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=PPCB_InitialKenyonRSUsMember', window );">Initial Kenyon RSUs [Member] | Services Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Restricted stock shares of common stock | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=PPCB_AdditionalKenyonRSUsMember', window );">Additional Kenyon RSUs [Member] | Services Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Restricted stock shares of common stock | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Rsus vest, shares | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_GrossProceedsFromEquityFinancing', window );">Gross proceeds from equity financing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=PPCB_NorthHorizonPtyLtdMember', window );">North Horizon Pty Ltd [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LessorOperatingLeaseTermOfContract', window );">Lessor, Operating Lease, Term of Contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesRentExpenseMinimumRentals', window );">Operating Leases, Rent Expense, Minimum Rentals</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 28,325<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_GoodsAndServiceTax', window );">[custom:GoodsAndServiceTax]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,575<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRent', window );">Payments for Rent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 60,598<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 64,597<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_OperatingLeasesRentExpenseMinimumRentalsPayable', window );">[custom:OperatingLeasesRentExpenseMinimumRentalsPayable]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,431<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=PPCB_NorthHorizonPtyLtdMember', window );">North Horizon Pty Ltd [Member] | AUD Currency [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesRentExpenseMinimumRentals', window );">Operating Leases, Rent Expense, Minimum Rentals</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 39,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_GoodsAndServiceTax', window );">[custom:GoodsAndServiceTax]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_OperatingLeasesRentExpenseMinimumRentalsPayable', window );">[custom:OperatingLeasesRentExpenseMinimumRentalsPayable]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,606<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,735<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,204<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=PPCB_NorthHorizonPtyLtdMember', window );">North Horizon Pty Ltd [Member] | AUD Currency [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRent', window );">Payments for Rent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">84,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">86,129<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=PPCB_CurrentAndFormerDirectorMember', window );">Current and Former Director [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_LoansFromRelatedParty', window );">Loans from related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">53,384<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,993<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=PPCB_FormerDirectorMember', window );">Former Director [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueToRelatedPartiesCurrent', window );">Due to related parties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32,076<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,347<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,639<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=PPCB_NathanielszMember', window );">Nathanielsz [Member] | North Horizon Pty Ltd [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDue', window );">Operating Leases, Future Minimum Payments Due</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 141,629<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=PPCB_NathanielszMember', window );">Nathanielsz [Member] | North Horizon Pty Ltd [Member] | AUD Currency [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDue', window );">Operating Leases, Future Minimum Payments Due</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 198,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=PPCB_MrsNathanielszMember', window );">Mrs. Nathanielsz [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalariesAndWages', window );">Annual salary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 80,904<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfRelatedPartyDebt', window );">Payments form related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,651<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 34,476<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,284<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=PPCB_MrsNathanielszMember', window );">Mrs. Nathanielsz [Member] | AUD Currency [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalariesAndWages', window );">Annual salary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 120,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=PPCB_MrsNathanielszMember', window );">Mrs. Nathanielsz [Member] | AUD Currency [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfRelatedPartyDebt', window );">Payments form related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,689<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 46,135<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 44,918<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=PPCB_JamesNathanielszMember', window );">James Nathanielsz [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfRelatedPartyDebt', window );">Payments form related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,205<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=PPCB_JamesNathanielszMember', window );">James Nathanielsz [Member] | AUD Currency [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfRelatedPartyDebt', window );">Payments form related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,481<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=PPCB_MrNathanielszMember', window );">Mr. Nathanielsz [Member] | Board of Directors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OfficersCompensation', window );">Officers' compensation</a></td>
<td class="nump">$ 177,840<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 315,376<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1', window );">Debt Conversion, Converted Instrument, Shares Issued | shares</a></td>
<td class="nump">5,928,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=PPCB_MrNathanielszMember', window );">Mr. Nathanielsz [Member] | Board of Directors [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OfficersCompensation', window );">Officers' compensation</a></td>
<td class="nump">$ 177,840<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=PPCB_MrNathanielszMember', window );">Mr. Nathanielsz [Member] | Employment Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_AgreementlTerm', window );">Agreement term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_AgreementRenewalTerm', window );">Agreement renewal term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward', window );">Option purchase shares | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39<span></span>
</td>
<td class="nump">39<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercise price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,675<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent', window );">Market price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">110.00%<span></span>
</td>
<td class="nump">110.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted exercise price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_OptionsVestedDescription', window );">Options vested, description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The Nathanielsz Options have a term of 10 years
from the date of grant. 1/3rd of the Nathanielsz Options shall vest every successive one-year anniversary following the Effective Date,
provided, that on each such vesting date Mr. Nathanielsz is employed by the Company and subject to the other provisions of the Employment
Agreement. The Initial Nathanielsz RSUs shall vest on the one-year anniversary of the Effective Date, subject to Mr. Nathanielsz&#8217;s
continued employment with the Company through such vesting date. The Additional Nathanielsz RSUs will vest as follows, subject to Mr.
Nathanielsz&#8217;s continued employment with the Company through the applicable vesting date: (i) 7.80 of the Additional Nathanielsz
RSUs shall vest upon the Company submitting Clinical Trial Application (the &#8220;CTA&#8221;) for PRP, the Company&#8217;s lead product
candidate (&#8220;PRP&#8221;), for a First-In-Human study for PRP (the &#8220;Study&#8221;) in an applicable jurisdiction to be selected
by the Company, (ii) 7.80 of the Additional Nathanielsz RSUs shall vest upon<span></span>
</td>
<td class="text">The Nathanielsz Options have a term of 10 years
from the date of grant. 1/3rd of the Nathanielsz Options shall vest every successive one-year anniversary following the Effective Date,
provided, that on each such vesting date Mr. Nathanielsz is employed by the Company and subject to the other provisions of the Employment
Agreement. The Initial Nathanielsz RSUs shall vest on the one-year anniversary of the Effective Date, subject to Mr. Nathanielsz&#8217;s
continued employment with the Company through such vesting date. The Additional Nathanielsz RSUs will vest as follows, subject to Mr.
Nathanielsz&#8217;s continued employment with the Company through the applicable vesting date: (i) 7.80 of the Additional Nathanielsz
RSUs shall vest upon the Company submitting Clinical Trial Application (the &#8220;CTA&#8221;) for PRP, the Company&#8217;s lead product
candidate (&#8220;PRP&#8221;), for a First-In-Human study for PRP (the &#8220;Study&#8221;) in an applicable jurisdiction to be selected
by the Company, (ii) 7.80 of the Additional Nathanielsz RSUs shall vest upon<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Option term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=PPCB_MrNathanielszMember', window );">Mr. Nathanielsz [Member] | AUD Currency [Member] | Board of Directors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OfficersCompensation', window );">Officers' compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 240,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 460,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_BonusAwardsGrantedPercentage', window );">Bonus granted percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=PPCB_MrNathanielszMember', window );">Mr. Nathanielsz [Member] | AUD Currency [Member] | Employment Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalariesAndWages', window );">Annual salary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=PPCB_DrKenyonMember', window );">Dr. Kenyon [Member] | Services Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1', window );">Debt Conversion, Converted Instrument, Shares Issued | shares</a></td>
<td class="nump">3,420,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_AgreementlTerm', window );">Agreement term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_AgreementRenewalTerm', window );">Agreement renewal term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward', window );">Option purchase shares | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercise price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent', window );">Market price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_OptionsVestedDescription', window );">Options vested, description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The Kenyon Options have a term of 10 years from the date of grant. 1/3rd of the Kenyon Options shall vest every successive one-year
anniversary following the Effective Date, provided, that on each such vesting date Dr. Kenyon is employed by the Company and subject
to the other provisions of the Services Agreement. The Initial Kenyon RSUs shall vest on the one-year anniversary of the Effective Date,
subject to Dr. Kenyon&#8217;s continued employment with the Company through such vesting date. The Additional Kenyon RSUs will vest as
follows, subject to Dr. Kenyon&#8217;s continued employment with the Company through the applicable vesting date: (i) 5 of the Additional
Kenyon RSUs shall vest upon the Company submitting the CTA for PRP for the Study in an applicable jurisdiction to be selected by the
Company, (ii) 5 of the Additional Kenyon RSUs shall vest upon the Company completing an equity financing in the amount of at least $4,000,000
in gross proceeds, (iii) 5 of the Additional Kenyon RSUs shall vest upon the shares o<span></span>
</td>
<td class="text">The Kenyon Options have a term of 10 years from the date of grant. 1/3rd of the Kenyon Options shall vest every successive one-year
anniversary following the Effective Date, provided, that on each such vesting date Dr. Kenyon is employed by the Company and subject
to the other provisions of the Services Agreement. The Initial Kenyon RSUs shall vest on the one-year anniversary of the Effective Date,
subject to Dr. Kenyon&#8217;s continued employment with the Company through such vesting date. The Additional Kenyon RSUs will vest as
follows, subject to Dr. Kenyon&#8217;s continued employment with the Company through the applicable vesting date: (i) 5 of the Additional
Kenyon RSUs shall vest upon the Company submitting the CTA for PRP for the Study in an applicable jurisdiction to be selected by the
Company, (ii) 5 of the Additional Kenyon RSUs shall vest upon the Company completing an equity financing in the amount of at least $4,000,000
in gross proceeds, (iii) 5 of the Additional Kenyon RSUs shall vest upon the shares o<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Option term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_CancellationOfAccruedSalaries', window );">Cancellation of accrued salary</a></td>
<td class="nump">$ 102,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=PPCB_DrKenyonMemberMember', window );">Dr Kenyon [Member] | AUD Currency [Member] | Services Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalariesAndWages', window );">Annual salary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 54,000<span></span>
</td>
<td class="nump">$ 54,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_AgreementRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Agreement renewal term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_AgreementRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_AgreementlTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Agreement term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_AgreementlTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_BonusAwardsGrantedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Bonus granted percentage.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_BonusAwardsGrantedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_BonusPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Bonus payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_BonusPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_BonusPayableAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Bonus payable amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_BonusPayableAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_CancellationOfAccruedSalaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cancellation Of Accrued Salaries.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_CancellationOfAccruedSalaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_GoodsAndServiceTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of goods and service tax which includes in annual lease rent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_GoodsAndServiceTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_GrossProceedsFromEquityFinancing">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross proceeds from equity financing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_GrossProceedsFromEquityFinancing</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_LoansFromRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Representing amount borrowed from related parties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_LoansFromRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_OperatingLeasesRentExpenseMinimumRentalsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Leases Rent Expense Minimum Rentals Payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_OperatingLeasesRentExpenseMinimumRentalsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_OptionsVestedDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Options vested, description.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_OptionsVestedDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_PercentageOfBonusOfAnnualBaseSalary">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of bonus of annual base salary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_PercentageOfBonusOfAnnualBaseSalary</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_PercentageOfPensionOfMonthlySalary">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of pension of monthly salary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_PercentageOfPensionOfMonthlySalary</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_RemainingBonusAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Remaining bonus amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_RemainingBonusAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_StockToBeIssuedDuringPeriodValueRestrictedStockUnit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock to be issued during period, value, restricted stock unit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_StockToBeIssuedDuringPeriodValueRestrictedStockUnit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedSalariesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedSalariesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentSharesIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueToRelatedPartiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(C))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueToRelatedPartiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of lessee's operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LessorOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessor's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919359-209981<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LessorOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OfficersCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for salary and wage arising from service rendered by officer. Excludes allocated cost, labor-related nonsalary expense, and direct and overhead labor cost included in cost of good and service sold.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OfficersCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for leases having an initial or remaining non-cancelable letter-terms in excess of one year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406913&amp;loc=d3e41502-112717<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123403562&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesRentExpenseMinimumRentals">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the payments that the lessee is obligated to make or can be required to make in connection with a property under the terms of an agreement classified as an operating lease, excluding contingent rentals and a guarantee by the lessee of the lessor's debt and the lessee's obligation to pay (apart from the rental payments) executory costs such as insurance, maintenance, and taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 25<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123403832&amp;loc=d3e34039-112682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123403562&amp;loc=d3e38371-112697<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123406913&amp;loc=d3e41499-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesRentExpenseMinimumRentals</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash payments to lessor's for use of assets under operating leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date of maturity or expiration of arrangements with a related party (for example, but not limited to, leasing and debt arrangements between related parties), in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfRelatedPartyDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfRelatedPartyDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalariesAndWages">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for salary and wage arising from service rendered by nonofficer employee. Excludes allocated cost, labor-related nonsalary expense, and direct and overhead labor cost included in cost of good and service sold.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalariesAndWages</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares purchased for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Purchase price of common stock expressed as a percentage of its fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=PPCB_NathanielszEmploymentAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=PPCB_NathanielszEmploymentAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=PPCB_MrsNathanielszMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=PPCB_MrsNathanielszMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=PPCB_EmploymentAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=PPCB_EmploymentAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=PPCB_ServicesAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=PPCB_ServicesAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=PPCB_AUDCurrencyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=PPCB_AUDCurrencyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=PPCB_AUDCurrenryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=PPCB_AUDCurrenryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=PPCB_RestrictedStocksUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=PPCB_RestrictedStocksUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=PPCB_AdditionaNathanielszRSUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=PPCB_AdditionaNathanielszRSUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=PPCB_InitialKenyonRSUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=PPCB_InitialKenyonRSUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=PPCB_AdditionalKenyonRSUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=PPCB_AdditionalKenyonRSUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=PPCB_NorthHorizonPtyLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=PPCB_NorthHorizonPtyLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=PPCB_CurrentAndFormerDirectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=PPCB_CurrentAndFormerDirectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=PPCB_FormerDirectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=PPCB_FormerDirectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=PPCB_NathanielszMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=PPCB_NathanielszMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=PPCB_MrsNathanielszMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=PPCB_MrsNathanielszMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=PPCB_JamesNathanielszMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=PPCB_JamesNathanielszMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=PPCB_MrNathanielszMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=PPCB_MrNathanielszMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=PPCB_BoardOfDirectorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=PPCB_BoardOfDirectorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=PPCB_DrKenyonMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=PPCB_DrKenyonMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=PPCB_DrKenyonMemberMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=PPCB_DrKenyonMemberMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm140460431512904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONCENTRATIONS AND RISKS (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from Convertible Debt</a></td>
<td class="nump">$ 160,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 325,000<span></span>
</td>
<td class="nump">$ 1,465,250<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts', window );">Discounts and debt issuance cost</a></td>
<td class="nump">$ 7,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_ReimbursementOnGoodsAndServiceTaxReceivablePercentage', window );">Reimbursement on goods and service tax receivable percentage</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=PPCB_LenderOneMember', window );">Lender One [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from Convertible Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 125,000<span></span>
</td>
<td class="nump">$ 285,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39.00%<span></span>
</td>
<td class="nump">19.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=PPCB_LenderTwoMember', window );">Lender Two [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from Convertible Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="nump">$ 505,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">61.00%<span></span>
</td>
<td class="nump">34.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=PPCB_LenderThreeMember', window );">Lender Three [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from Convertible Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 227,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_ReimbursementOnGoodsAndServiceTaxReceivablePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>It represents the percentage of Reimbursement on Goods And Service Tax Receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_ReimbursementOnGoodsAndServiceTaxReceivablePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCostsAndDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=PPCB_LenderOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=PPCB_LenderOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=PPCB_LenderTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=PPCB_LenderTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=PPCB_LenderThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=PPCB_LenderThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm140460273406648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE OF FAIR VALUE MEASUREMENTS, RECURRING AND NONRECURRING, VALUATION TECHNIQUES (Details)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember', window );">Measurement Input, Price Volatility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMeasurementInput', window );">Debt instrument, measurement input, percentages</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember', window );">Measurement Input, Price Volatility [Member] | Convertible Debt [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMeasurementInput', window );">Debt instrument, measurement input, percentages</a></td>
<td class="nump">2.0600<span></span>
</td>
<td class="nump">222<span></span>
</td>
<td class="nump">264<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember', window );">Measurement Input, Price Volatility [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMeasurementInput', window );">Debt instrument, measurement input, percentages</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">227<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember', window );">Measurement Input, Price Volatility [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMeasurementInput', window );">Debt instrument, measurement input, percentages</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">279<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember', window );">Measurement Input, Expected Term [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Debt instrument, measurement input, term</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember', window );">Measurement Input, Expected Term [Member] | Convertible Debt [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Debt instrument, measurement input, term</a></td>
<td class="text">3 days<span></span>
</td>
<td class="text">3 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember', window );">Measurement Input, Expected Term [Member] | Minimum [Member] | Convertible Debt [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Debt instrument, measurement input, term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember', window );">Measurement Input, Expected Term [Member] | Maximum [Member] | Convertible Debt [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Debt instrument, measurement input, term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">8 months 12 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember', window );">Measurement Input, Risk Free Interest Rate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMeasurementInput', window );">Debt instrument, measurement input, percentages</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember', window );">Measurement Input, Risk Free Interest Rate [Member] | Convertible Debt [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMeasurementInput', window );">Debt instrument, measurement input, percentages</a></td>
<td class="nump">0.0007<span></span>
</td>
<td class="nump">0.05<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember', window );">Measurement Input, Risk Free Interest Rate [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMeasurementInput', window );">Debt instrument, measurement input, percentages</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.53<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember', window );">Measurement Input, Risk Free Interest Rate [Member] | Minimum [Member] | Convertible Debt [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMeasurementInput', window );">Debt instrument, measurement input, percentages</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.13<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember', window );">Measurement Input, Risk Free Interest Rate [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMeasurementInput', window );">Debt instrument, measurement input, percentages</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.59<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember', window );">Measurement Input, Risk Free Interest Rate [Member] | Maximum [Member] | Convertible Debt [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMeasurementInput', window );">Debt instrument, measurement input, percentages</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.18<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember', window );">Measurement Input, Expected Dividend Rate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMeasurementInput', window );">Debt instrument, measurement input, percentages</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember', window );">Measurement Input, Expected Dividend Rate [Member] | Convertible Debt [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMeasurementInput', window );">Debt instrument, measurement input, percentages</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure debt instrument, including, but not limited to, convertible and non-convertible debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_ConvertibleDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=us-gaap_ConvertibleDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm140460434266712">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SCHEDULE OF FAIR VALUE, ASSETS AND LIABILITIES MEASURED ON RECURRING BASIS (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability', window );">Embedded conversion option liabilities</a></td>
<td class="nump">$ 58,124<span></span>
</td>
<td class="nump">$ 54,220<span></span>
</td>
<td class="nump">$ 177,009<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Total</a></td>
<td class="nump">58,124<span></span>
</td>
<td class="nump">54,220<span></span>
</td>
<td class="nump">177,009<span></span>
</td>
<td class="nump">$ 698,264<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Fair Value, Inputs, Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability', window );">Embedded conversion option liabilities</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Total</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Fair Value, Inputs, Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability', window );">Embedded conversion option liabilities</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Total</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability', window );">Embedded conversion option liabilities</a></td>
<td class="nump">58,124<span></span>
</td>
<td class="nump">54,220<span></span>
</td>
<td class="nump">177,009<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Total</a></td>
<td class="nump">$ 58,124<span></span>
</td>
<td class="nump">$ 54,220<span></span>
</td>
<td class="nump">$ 177,009<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value as of the balance sheet date of the embedded derivative or group of embedded derivatives classified as a liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm140460441077016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE OF DERIVATIVE LIABILITIES AT FAIR VALUE (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Balance at Beginning</a></td>
<td class="nump">$ 54,220<span></span>
</td>
<td class="nump">$ 177,009<span></span>
</td>
<td class="nump">$ 698,264<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_ReductionsDueToConversions', window );">Reductions due to conversions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(362,962)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_FairValueOfWarrantDerivativeLiabilityRecorededAsDebtDiscount', window );">Initial fair value of embedded conversion option derivative liability recorded as debt discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">227,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_InitialFairValueOfEmbeddedConversionOptionDerivativeLiabilityRecordedAsExpense', window );">Initial fair value of embedded conversion option derivative liability recorded as expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">351,461<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet', window );">Balance at Beginning</a></td>
<td class="nump">3,904<span></span>
</td>
<td class="nump">8,186<span></span>
</td>
<td class="num">(736,754)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_GainOnDebtExtinguishment', window );">Gain on debt extinguishment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(130,975)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Balance at Ending</a></td>
<td class="nump">$ 58,124<span></span>
</td>
<td class="nump">$ 54,220<span></span>
</td>
<td class="nump">$ 177,009<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_FairValueOfWarrantDerivativeLiabilityRecorededAsDebtDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Initial fair value recording of warrant derivative liability as debt discount during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_FairValueOfWarrantDerivativeLiabilityRecorededAsDebtDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_GainOnDebtExtinguishment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gain on debt extinguishment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_GainOnDebtExtinguishment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_InitialFairValueOfEmbeddedConversionOptionDerivativeLiabilityRecordedAsExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Initial fair value of embedded conversion option derivative liability recorded as expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_InitialFairValueOfEmbeddedConversionOptionDerivativeLiabilityRecordedAsExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_ReductionsDueToConversions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reductions due to conversions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_ReductionsDueToConversions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net Increase or Decrease in the fair value of the embedded derivative or group of embedded derivatives included in earnings in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 15<br> -URI http://asc.fasb.org/subtopic&amp;trid=2229187<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm140460436345224">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>DERIVATIVE FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share Price</a></td>
<td class="nump">$ 0.026<span></span>
</td>
<td class="nump">$ 0.0517<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Debt [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleDebt', window );">Convertible debt</a></td>
<td class="nump">$ 80,000<span></span>
</td>
<td class="nump">$ 80,000<span></span>
</td>
<td class="nump">$ 126,500<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying amount of debt identified as being convertible into another form of financial instrument (typically the entity's common stock) as of the balance sheet date, which originally required full repayment more than twelve months after issuance or greater than the normal operating cycle of the company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ConvertibleDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ConvertibleDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm140460299130264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUBSEQUENT EVENTS (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="1">2 Months Ended</th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Oct. 21, 2021</div></th>
<th class="th"><div>Sep. 22, 2021</div></th>
<th class="th"><div>Aug. 19, 2021</div></th>
<th class="th"><div>Aug. 17, 2021</div></th>
<th class="th"><div>Aug. 12, 2021</div></th>
<th class="th"><div>Jul. 20, 2021</div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 07, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 20, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Sep. 23, 2021</div></th>
<th class="th"><div>Nov. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromWarrantExercises', window );">Proceeds from Warrant Exercises</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 275,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 201,044<span></span>
</td>
<td class="nump">$ 776,044<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common Stock, Shares, Issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43,841,644<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43,841,644<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,055,393<span></span>
</td>
<td class="nump">258,120<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt Instrument, Face Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,600<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional Paid in Capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 55,444,574<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 55,444,574<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 54,074,110<span></span>
</td>
<td class="nump">$ 50,913,893<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0517<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_CommonStockIssuableShares', window );">Common Stock Issuable Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,002,549<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,002,549<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">59<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Stock Issued During Period, Value, New Issues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 424,990<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock Issued During Period, Shares, New Issues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,399,988<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Debt Instrument, Unamortized Discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,565<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,565<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,139<span></span>
</td>
<td class="nump">126,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_GainFromSettlementOfDebtNet', window );">Gain from settlement of debt, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 49,319<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PPCB_NathanielszCancellationAgreementMember', window );">Nathanielsz Cancellation Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_PercentageOfBonusOfAnnualBaseSalary', window );">Percentage of bonus of annual base salary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PPCB_NathanielszCancellationAgreementMember', window );">Nathanielsz Cancellation Agreement [Member] | Mr. Nathanielsz [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1', window );">Debt Conversion, Converted Instrument, Shares Issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,928,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_PercentageOfBonusOfAnnualBaseSalary', window );">Percentage of bonus of annual base salary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">78.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OfficersCompensation', window );">Salary and Wage, Officer, Excluding Cost of Good and Service Sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 177,840<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.03<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PPCB_ZelingerAmendedAndRestatedDirectorAgreementMember', window );">Zelinger Amended And Restated Director Agreement [Member] | Josef Zelinger [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.03<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_DescriptionOfEmploymentBenefits', window );">Description of employment benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Pursuant
to the terms of the Director Agreement, the Company shall pay Zelinger a base salary of $250.00 AUD ($184 USD) per month, payable
on the first day of each month. In addition, the Company may compensate Zelinger additional consideration for advisory services performed
by the Director, either in the form of cash or common stock, at the discretion of the Board. The Company issued 2,800,000 shares of common
stock of the Company for accrued director services of $84,000 as of June 30, 2021.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_CommonStockIssuableShares', window );">Common Stock Issuable Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Stock Issued During Period, Value, New Issues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 84,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock Issued During Period, Shares, New Issues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PPCB_TwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember', window );">2021 Securities Purchase Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity Method Investment, Ownership Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt Instrument, Face Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 95,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Stock Issued During Period, Value, New Issues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock Issued During Period, Shares, New Issues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">804<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=PPCB_CommonStockOneMember', window );">Common Stock One [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedBonusesCurrent', window );">Accrued Bonuses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 84,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromWarrantExercises', window );">Proceeds from Warrant Exercises</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 275,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common Stock, Shares, Issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,002,490<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1', window );">Debt Conversion, Converted Instrument, Shares Issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,818,097<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Debt Instrument, Convertible, Conversion Price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.02<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt Instrument, Face Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 146,348<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPayableCurrent', window );">Interest Payable, Current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,726<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,887<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_ConversionFees', window );">Conversion fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional Paid in Capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 86,219<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_ConsultingAgreementDescription', window );">Consulting agreement description</a></td>
<td class="text">On
October 1, 2021, the Company entered int a consulting agreement (the &#8220;Consulting Agreement&#8221;) with a consultant who will
assist in the development of the Company&#8217;s business and financing activities. The consultant will serve initially as an
independent contractor, and upon certain mutually agreed upon conditions being met, will be appointed Vice Chairman, President and
Interim CFO. The term of the Consulting Agreement shall be for three years commencing on October 1, 2021, and can be terminated by
either party upon 30 day written notice. The monthly payment per the Consulting Agreement is $7,000. The Company will also issue
shares of common stock equal to 1% of the total issued and outstanding shares at the end of each year of service.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_ConsultingAgreementMonthlyPayment', window );">Consulting agreement, monthly payment</a></td>
<td class="nump">$ 7,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Nathanielsz Cancellation Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_PercentageOfBonusOfAnnualBaseSalary', window );">Percentage of bonus of annual base salary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Nathanielsz Cancellation Agreement [Member] | Mr. Nathanielsz [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1', window );">Debt Conversion, Converted Instrument, Shares Issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,928,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_PercentageOfBonusOfAnnualBaseSalary', window );">Percentage of bonus of annual base salary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">78.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OfficersCompensation', window );">Salary and Wage, Officer, Excluding Cost of Good and Service Sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 177,840<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.03<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Kenyon Cancellation Agreement [Member] | Dr. Kenyon [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1', window );">Debt Conversion, Converted Instrument, Shares Issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,420,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.03<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_CancellationOfAccruedSalaries', window );">Cancellation Of Accrued Salaries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 102,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Zelinger Amended And Restated Director Agreement [Member] | Josef Zelinger [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_DescriptionOfEmploymentBenefits', window );">Description of employment benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Pursuant to the terms of the Director Agreement, the Company shall pay Zelinger a base salary of $250.00
AUD per month, payable on the first day of each month. In addition, the Company may compensate Zelinger additional consideration for
advisory services performed by the Director, either in the form of cash or common stock, at the discretion of the Board. The Company
issued 2,800,000 shares of common stock of the Company for accrued director services of $84,000 as of June 30, 2021. The 2,800,000 shares
of common stock was valued at approximately $0.03 per share, being the closing price of the stock on the date of grant.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | 2021 Securities Purchase Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt Instrument, Face Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 63,750<span></span>
</td>
<td class="nump">$ 103,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Debt Instrument, Unamortized Discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,750<span></span>
</td>
<td class="nump">$ 3,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt Instrument, Maturity Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Sep. 22,  2021<span></span>
</td>
<td class="text">Aug. 19,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Debt Instrument, Interest Rate During Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentDescription', window );">Debt description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">During
the first 60 to 180 days following the date of these notes, the Company has the right to prepay the principal and accrued but unpaid
interest due under the above notes issued to Geneva Roth, together with any other amounts that the Company may owe the holder under the
terms of the note, at a premium ranging from 110% to 129% as defined in the note agreement. After this initial 180-day period, the Company
does not have a right to prepay such notes.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_DebtCoversionPercentage', window );">Debt Coversion Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity Method Investment, Ownership Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_GainFromSettlementOfDebtNet', window );">Gain from settlement of debt, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 90,192<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateTerms', window );">Debt Instrument, Interest Rate Terms</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">interest on the outstanding principal shall accrue at a default interest rate of 22%
per annum<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | October Twenty One Two Thousand And Twenty One Securities Purchase Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt Instrument, Face Amount</a></td>
<td class="nump">63,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Debt Instrument, Unamortized Discount</a></td>
<td class="nump">$ 3,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt Instrument, Maturity Date</a></td>
<td class="text">Oct. 21,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Debt Instrument, Interest Rate During Period</a></td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentDescription', window );">Debt description</a></td>
<td class="text">During
the first 60 to 180 days following the date of these notes, the Company has the right to prepay the principal and accrued but unpaid
interest due under the above notes issued to Sixth Street, together with any other amounts that the Company may owe the holder under
the terms of the note, at a premium ranging from 110% to 129% as defined in the note agreement. After this initial 180-day period, the
Company does not have a right to prepay such notes.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_DebtCoversionPercentage', window );">Debt Coversion Percentage</a></td>
<td class="nump">35.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity Method Investment, Ownership Percentage</a></td>
<td class="nump">9.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_GainFromSettlementOfDebtNet', window );">Gain from settlement of debt, net</a></td>
<td class="nump">$ 34,327<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateTerms', window );">Debt Instrument, Interest Rate Terms</a></td>
<td class="text">interest on the outstanding principal shall accrue at a default interest rate of 22%
per annum<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Debt Instrument, Convertible, Conversion Price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Debt Instrument, Convertible, Conversion Price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.04<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1', window );">Debt Conversion, Converted Instrument, Shares Issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,702,152<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_ConversionFees', window );">Conversion fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Series B Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,875<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common Stock, Shares, Issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,875<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | 12 Series A and A Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common Stock, Shares, Issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,399,988<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Common Stock One [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.03<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_CommonStockIssuableShares', window );">Common Stock Issuable Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock Issued During Period, Shares, New Issues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Common Stock Two [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.03<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_CommonStockIssuableShares', window );">Common Stock Issuable Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">166,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock Issued During Period, Shares, New Issues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LegalFees', window );">Legal fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Common Stock Three [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.04<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.04<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PPCB_CommonStockIssuableShares', window );">Common Stock Issuable Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,819,712<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,819,712<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Stock Issued During Period, Value, New Issues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 113,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock Issued During Period, Shares, New Issues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,819,712<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Eleven Series A Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common Stock, Shares, Issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,199,989<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_CancellationOfAccruedSalaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cancellation Of Accrued Salaries.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_CancellationOfAccruedSalaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_CommonStockIssuableShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common stock, issuable shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_CommonStockIssuableShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_ConsultingAgreementDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Consulting agreement, description.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_ConsultingAgreementDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_ConsultingAgreementMonthlyPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Consulting agreement monthly payment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_ConsultingAgreementMonthlyPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_ConversionFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Conversion fees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_ConversionFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_DebtCoversionPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Coversion Percentage.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_DebtCoversionPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_DescriptionOfEmploymentBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description Of Employment Benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_DescriptionOfEmploymentBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_GainFromSettlementOfDebtNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gain from settlement of debt, net.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_GainFromSettlementOfDebtNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PPCB_PercentageOfBonusOfAnnualBaseSalary">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of bonus of annual base salary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PPCB_PercentageOfBonusOfAnnualBaseSalary</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PPCB_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedBonusesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for incentive compensation awarded to employees and directors or earned by them based on the terms of one or more relevant arrangements. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedBonusesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentSharesIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031898-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Identification of the lender and information about a contractual promise to repay a short-term or long-term obligation, which includes borrowings under lines of credit, notes payable, commercial paper, bonds payable, debentures, and other contractual obligations for payment. This may include rationale for entering into the arrangement, significant terms of the arrangement, which may include amount, repayment terms, priority, collateral required, debt covenants, borrowing capacity, call features, participation rights, conversion provisions, sinking-fund requirements, voting rights, basis for conversion if convertible and remarketing provisions. The description may be provided for individual debt instruments, rational groupings of debt instruments, or by debt in total.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average effective interest rate during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of the interest rate as being fixed or variable, and, if variable, identification of the index or rate on which the interest rate is based and the number of points or percentage added to that index or rate to set the rate, and other pertinent information, such as frequency of rate resets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e7018-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LegalFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LegalFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OfficersCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for salary and wage arising from service rendered by officer. Excludes allocated cost, labor-related nonsalary expense, and direct and overhead labor cost included in cost of good and service sold.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OfficersCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromWarrantExercises">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from holders exercising their stock warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromWarrantExercises</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=PPCB_NathanielszCancellationAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=PPCB_NathanielszCancellationAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=PPCB_MrNathanielszMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=PPCB_MrNathanielszMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=PPCB_ZelingerAmendedAndRestatedDirectorAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=PPCB_ZelingerAmendedAndRestatedDirectorAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=PPCB_JosefZelingerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=PPCB_JosefZelingerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=PPCB_TwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=PPCB_TwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=PPCB_CommonStockOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=PPCB_CommonStockOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=PPCB_KenyonCancellationAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=PPCB_KenyonCancellationAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=PPCB_DrKenyonMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=PPCB_DrKenyonMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=PPCB_OctoberTwentyOneTwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=PPCB_OctoberTwentyOneTwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=PPCB_SeriesBWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=PPCB_SeriesBWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=PPCB_TwelveSeriesAAndAWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=PPCB_TwelveSeriesAAndAWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=PPCB_CommonStockTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=PPCB_CommonStockTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=PPCB_CommonStockThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=PPCB_CommonStockThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=PPCB_ElevenSeriesAWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=PPCB_ElevenSeriesAWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>formposam_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:PPCB="http://propanc.com/20210930"
  xmlns:country="http://xbrl.sec.gov/country/2021"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2021-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="ppcb-20210930.xsd" xlink:type="simple"/>
    <context id="From2021-07-01to2021-09-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2021-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_SeriesAPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30_us-gaap_SeriesAPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_SeriesBPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30_us-gaap_SeriesBPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="From2020-07-012021-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2019-07-012020-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2019-06-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="AsOf2019-06-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="AsOf2019-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="AsOf2019-06-30_custom_CommonStockIssuableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">PPCB:CommonStockIssuableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="AsOf2019-06-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="AsOf2019-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="AsOf2019-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="AsOf2019-06-30_us-gaap_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="AsOf2019-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="From2019-07-012020-06-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="From2019-07-012020-06-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="From2019-07-012020-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="From2019-07-012020-06-30_custom_CommonStockIssuableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">PPCB:CommonStockIssuableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="From2019-07-012020-06-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="From2019-07-012020-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="From2019-07-012020-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="From2019-07-012020-06-30_us-gaap_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2020-06-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30_custom_CommonStockIssuableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">PPCB:CommonStockIssuableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30_us-gaap_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_custom_CommonStockIssuableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">PPCB:CommonStockIssuableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_us-gaap_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_custom_CommonStockIssuableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">PPCB:CommonStockIssuableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="From2020-11-162020-11-17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
        </entity>
        <period>
            <startDate>2020-11-16</startDate>
            <endDate>2020-11-17</endDate>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_custom_IntercompanyLoansMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:IntercompanyLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2019-07-012020-06-30_custom_IntercompanyLoansMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:IntercompanyLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2021-06-30_srt_WeightedAverageMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30_srt_WeightedAverageMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_us-gaap_MachineryAndEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_us-gaap_FurnitureAndFixturesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_us-gaap_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2019-07-012020-06-30_us-gaap_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_us-gaap_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2019-07-012020-06-30_us-gaap_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_custom_UnvestedRestrictedStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">PPCB:UnvestedRestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2019-07-012020-06-30_custom_UnvestedRestrictedStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">PPCB:UnvestedRestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_us-gaap_ConvertibleDebtSecuritiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2019-07-012020-06-30_us-gaap_ConvertibleDebtSecuritiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2021-06-30_custom_DirectorsAndOfficerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">PPCB:DirectorsAndOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30_custom_DirectorsAndOfficerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">PPCB:DirectorsAndOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="AsOf2017-12-29_custom_DecemberTwentyNineTwoThousandAndSeventeenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_DecemberTwoThousandAndSeventeenEagleNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:DecemberTwoThousandAndSeventeenEagleNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:DecemberTwentyNineTwoThousandAndSeventeenSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:EagleEquitiesLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-29</instant>
        </period>
    </context>
    <context id="From2017-12-272017-12-29_custom_DecemberTwentyNineTwoThousandAndSixteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_DecemberTwoThousandAndSeventeenEagleNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:DecemberTwoThousandAndSeventeenEagleNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:DecemberTwentyNineTwoThousandAndSixteenSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:EagleEquitiesLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-12-27</startDate>
            <endDate>2017-12-29</endDate>
        </period>
    </context>
    <context id="AsOf2019-06-30_custom_DecemberTwentyNineTwoThousandAndSixteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_DecemberTwoThousandAndSeventeenEagleNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:DecemberTwoThousandAndSeventeenEagleNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:DecemberTwentyNineTwoThousandAndSixteenSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:EagleEquitiesLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="From2018-07-012019-06-30_custom_DecemberTwentyNineTwoThousandAndSeventeenSecuritiesPurchaseAgreementMember_custom_DecemberTwoThousandAndSeventeenEagleNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:DecemberTwoThousandAndSeventeenEagleNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:DecemberTwentyNineTwoThousandAndSeventeenSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2019-06-30_custom_DecemberTwentyNineTwoThousandAndSeventeenSecuritiesPurchaseAgreementMember_custom_DecemberTwoThousandAndSeventeenEagleNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:DecemberTwoThousandAndSeventeenEagleNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:DecemberTwentyNineTwoThousandAndSeventeenSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30_custom_DecemberTwentyNineTwoThousandAndSeventeenSecuritiesPurchaseAgreementMember_custom_DecemberTwoThousandAndSeventeenEagleNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:DecemberTwoThousandAndSeventeenEagleNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:DecemberTwentyNineTwoThousandAndSeventeenSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="From2019-07-012020-06-30_custom_DecemberTwentyNineTwoThousandAndSeventeenSecuritiesPurchaseAgreementMember_custom_DecemberTwoThousandAndSeventeenEagleNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:DecemberTwoThousandAndSeventeenEagleNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:DecemberTwentyNineTwoThousandAndSeventeenSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2020-06-30_custom_DecemberTwentyNineTwoThousandAndSeventeenSecuritiesPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:DecemberTwentyNineTwoThousandAndSeventeenSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30_custom_DecemberTwentyNineTwoThousandAndSixteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:DecemberTwentyNineTwoThousandAndSixteenSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:EagleEquitiesLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="AsOf2018-07-13_custom_JulyThirteenTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_JulyTwoThousandEighteenEagleNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:JulyTwoThousandEighteenEagleNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:JulyThirteenTwoThousandAndEighteenSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:EagleEquitiesLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-07-13</instant>
        </period>
    </context>
    <context id="From2018-07-182018-07-19_custom_JulyThirteenTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_JulyTwoThousandEighteenEagleNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:JulyTwoThousandEighteenEagleNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:JulyThirteenTwoThousandAndEighteenSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:EagleEquitiesLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-18</startDate>
            <endDate>2018-07-19</endDate>
        </period>
    </context>
    <context id="From2018-07-122018-07-13_custom_JulyThirteenTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_JulyTwoThousandEighteenEagleNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:JulyTwoThousandEighteenEagleNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:JulyThirteenTwoThousandAndEighteenSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:EagleEquitiesLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-12</startDate>
            <endDate>2018-07-13</endDate>
        </period>
    </context>
    <context id="AsOf2019-06-30_custom_JulyThirteenTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_JulyTwoThousandEighteenEagleNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:JulyTwoThousandEighteenEagleNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:JulyThirteenTwoThousandAndEighteenSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30_custom_JulyThirteenTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_JulyTwoThousandEighteenEagleNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:JulyTwoThousandEighteenEagleNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:JulyThirteenTwoThousandAndEighteenSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:EagleEquitiesLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="From2019-07-012020-06-30_custom_JulyThirteenTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_JulyTwoThousandEighteenEagleNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:JulyTwoThousandEighteenEagleNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:JulyThirteenTwoThousandAndEighteenSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:EagleEquitiesLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2020-06-30_custom_JuneTwentyNineTwoThousandEighteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:JuneTwentyNineTwoThousandEighteenSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:EagleEquitiesLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="AsOf2018-08-29_custom_AugustTwentyNineTwoThousandandEighteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_AugustTwoThousandEighteenEagleNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:AugustTwoThousandEighteenEagleNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:AugustTwentyNineTwoThousandandEighteenSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:EagleEquitiesLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-08-29</instant>
        </period>
    </context>
    <context id="From2018-08-262018-08-29_custom_AugustTwentyNineTwoThousandandEighteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_AugustTwoThousandEighteenEagleNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:AugustTwoThousandEighteenEagleNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:AugustTwentyNineTwoThousandandEighteenSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:EagleEquitiesLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-08-26</startDate>
            <endDate>2018-08-29</endDate>
        </period>
    </context>
    <context id="From2020-04-012020-04-30_custom_AugustTwentyNineTwoThousandandEighteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_AugustTwoThousandEighteenEagleNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:AugustTwoThousandEighteenEagleNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:AugustTwentyNineTwoThousandandEighteenSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:EagleEquitiesLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="AsOf2018-10-02_custom_OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_OctoberTwoTwoThousandAndEighteenEagleNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:OctoberTwoTwoThousandAndEighteenEagleNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:EagleEquitiesLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-10-02</instant>
        </period>
    </context>
    <context id="From2018-09-292018-10-02_custom_OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_OctoberTwoTwoThousandAndEighteenEagleNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:OctoberTwoTwoThousandAndEighteenEagleNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:EagleEquitiesLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-29</startDate>
            <endDate>2018-10-02</endDate>
        </period>
    </context>
    <context id="From2020-04-012020-04-30_custom_OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:EagleEquitiesLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="AsOf2018-11-30_custom_NovembeThirtyTwoThousandAndEighteenMecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_NovemberTwoThousandAndEighteenEagleNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:NovemberTwoThousandAndEighteenEagleNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:NovembeThirtyTwoThousandAndEighteenMecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:EagleEquitiesLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-11-30</instant>
        </period>
    </context>
    <context id="From2018-11-262018-11-30_custom_NovembeThirtyTwoThousandAndEighteenMecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_NovemberTwoThousandAndEighteenEagleNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:NovemberTwoThousandAndEighteenEagleNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:NovembeThirtyTwoThousandAndEighteenMecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:EagleEquitiesLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-11-26</startDate>
            <endDate>2018-11-30</endDate>
        </period>
    </context>
    <context id="From2020-04-012020-04-30_custom_NovembeThirtyTwoThousandAndEighteenMecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_NovemberTwoThousandAndEighteenEagleNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:NovemberTwoThousandAndEighteenEagleNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:NovembeThirtyTwoThousandAndEighteenMecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:EagleEquitiesLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="AsOf2018-12-24_custom_DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_DecembeTwoThousandAndEighteenEagleNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:DecembeTwoThousandAndEighteenEagleNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:EagleEquitiesLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-24</instant>
        </period>
    </context>
    <context id="From2018-12-232018-12-24_custom_DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_DecembeTwoThousandAndEighteenEagleNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:DecembeTwoThousandAndEighteenEagleNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:EagleEquitiesLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-23</startDate>
            <endDate>2018-12-24</endDate>
        </period>
    </context>
    <context id="From2020-04-012020-04-30_custom_DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_DecembeTwoThousandAndEighteenEagleNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:DecembeTwoThousandAndEighteenEagleNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:EagleEquitiesLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="From2018-12-232018-12-24_custom_DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_DecembeTwoThousandAndEighteenEagleNoteMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:DecembeTwoThousandAndEighteenEagleNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:EagleEquitiesLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-23</startDate>
            <endDate>2018-12-24</endDate>
        </period>
    </context>
    <context id="From2018-12-232018-12-24_custom_DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_DecembeTwoThousandAndEighteenEagleNoteMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:DecembeTwoThousandAndEighteenEagleNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:EagleEquitiesLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-23</startDate>
            <endDate>2018-12-24</endDate>
        </period>
    </context>
    <context id="From2018-12-232018-12-24_custom_DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_DepositoryTrustCompanyMember_custom_DecembeTwoThousandAndEighteenEagleNoteMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:DecembeTwoThousandAndEighteenEagleNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:DepositoryTrustCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-23</startDate>
            <endDate>2018-12-24</endDate>
        </period>
    </context>
    <context id="From2018-12-232018-12-24_custom_DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_DepositoryTrustCompanyMember_custom_DecembeTwoThousandAndEighteenEagleNoteMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:DecembeTwoThousandAndEighteenEagleNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:DepositoryTrustCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-23</startDate>
            <endDate>2018-12-24</endDate>
        </period>
    </context>
    <context id="AsOf2021-06-30_custom_DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_DecembeTwoThousandAndEighteenEagleNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:DecembeTwoThousandAndEighteenEagleNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:EagleEquitiesLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30_custom_DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_DecembeTwoThousandAndEighteenEagleNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:DecembeTwoThousandAndEighteenEagleNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:EagleEquitiesLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30_custom_SecuritiesPurchaseAgreementOneMember_custom_EagleEquitiesLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:EagleEquitiesLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_custom_SecuritiesPurchaseAgreementOneMember_custom_EagleEquitiesLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:EagleEquitiesLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2018-10-02_custom_OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_GSCapitalPartnersLLCMember_custom_OctoberTwoThousandEighteenGSNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:OctoberTwoThousandEighteenGSNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:GSCapitalPartnersLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-10-02</instant>
        </period>
    </context>
    <context id="AsOf2018-10-03_custom_OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_GSCapitalPartnersLLCMember_custom_OctoberTwoThousandEighteenGSNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:OctoberTwoThousandEighteenGSNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:GSCapitalPartnersLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-10-03</instant>
        </period>
    </context>
    <context id="From2018-09-292018-10-02_custom_OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_GSCapitalPartnersLLCMember_custom_OctoberTwoThousandEighteenGSNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:OctoberTwoThousandEighteenGSNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:GSCapitalPartnersLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-29</startDate>
            <endDate>2018-10-02</endDate>
        </period>
    </context>
    <context id="From2018-09-292018-10-02_custom_OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_GSCapitalPartnersLLCMember_custom_OctoberTwoThousandEighteenGSNoteMember_custom_FirstNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:OctoberTwoThousandEighteenGSNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">PPCB:FirstNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:GSCapitalPartnersLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-29</startDate>
            <endDate>2018-10-02</endDate>
        </period>
    </context>
    <context id="From2018-09-292018-10-02_custom_OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_GSCapitalPartnersLLCMember_custom_OctoberTwoThousandEighteenGSNoteMember_custom_SecondNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:OctoberTwoThousandEighteenGSNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">PPCB:SecondNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:GSCapitalPartnersLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-29</startDate>
            <endDate>2018-10-02</endDate>
        </period>
    </context>
    <context id="AsOf2020-01-22_custom_SecuritiesPurchaseAgreementMember_custom_GSCapitalPartnersLLCMember_custom_JanuaryTwentyTwoTwentyTwentyGSNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:JanuaryTwentyTwoTwentyTwentyGSNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:GSCapitalPartnersLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-01-22</instant>
        </period>
    </context>
    <context id="From2020-01-212020-01-22_custom_SecuritiesPurchaseAgreementMember_custom_GSCapitalPartnersLLCMember_custom_JanuaryTwentyTwoTwentyTwentyGSNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:JanuaryTwentyTwoTwentyTwentyGSNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:GSCapitalPartnersLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-21</startDate>
            <endDate>2020-01-22</endDate>
        </period>
    </context>
    <context id="From2020-01-212020-01-22_custom_SecuritiesPurchaseAgreementMember_custom_GSCapitalPartnersLLCMember_custom_JanuaryTwentyTwoTwentyTwentyGSNoteMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:JanuaryTwentyTwoTwentyTwentyGSNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:GSCapitalPartnersLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-21</startDate>
            <endDate>2020-01-22</endDate>
        </period>
    </context>
    <context id="From2020-01-212020-01-22_custom_SecuritiesPurchaseAgreementMember_custom_GSCapitalPartnersLLCMember_custom_JanuaryTwentyTwoTwentyTwentyGSNoteMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:JanuaryTwentyTwoTwentyTwentyGSNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:GSCapitalPartnersLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-21</startDate>
            <endDate>2020-01-22</endDate>
        </period>
    </context>
    <context id="AsOf2021-06-30_custom_SecuritiesPurchaseAgreementMember_custom_GSCapitalPartnersLLCMember_custom_JanuaryTwentyTwoTwentyTwentyGSNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:JanuaryTwentyTwoTwentyTwentyGSNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:GSCapitalPartnersLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30_custom_SecuritiesPurchaseAgreementMember_custom_GSCapitalPartnersLLCMember_custom_JanuaryTwentyTwoTwentyTwentyGSNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:JanuaryTwentyTwoTwentyTwentyGSNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:GSCapitalPartnersLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="From2019-07-012020-06-30_custom_SecuritiesPurchaseAgreementMember_custom_GSCapitalPartnersLLCMember_custom_JanuaryTwentyTwoTwentyTwentyGSNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:JanuaryTwentyTwoTwentyTwentyGSNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:GSCapitalPartnersLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_custom_SecuritiesPurchaseAgreementMember_custom_GSCapitalPartnersLLCMember_custom_JanuaryTwentyTwoTwentyTwentyGSNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:JanuaryTwentyTwoTwentyTwentyGSNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:GSCapitalPartnersLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2017-08-10_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:AugustTenTwoThousandAndSeventeenConsultingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-08-10</instant>
        </period>
    </context>
    <context id="From2017-08-072017-08-10_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:AugustTenTwoThousandAndSeventeenConsultingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-08-07</startDate>
            <endDate>2017-08-10</endDate>
        </period>
    </context>
    <context id="AsOf2017-06-30_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:AugustTenTwoThousandAndSeventeenConsultingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-06-30</instant>
        </period>
    </context>
    <context id="AsOf2018-06-30_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:AugustTenTwoThousandAndSeventeenConsultingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-06-30</instant>
        </period>
    </context>
    <context id="AsOf2018-06-30_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember_custom_ConsultantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">PPCB:ConsultantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:AugustTenTwoThousandAndSeventeenConsultingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-06-30</instant>
        </period>
    </context>
    <context id="AsOf2019-06-30_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember_custom_ConsultantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">PPCB:ConsultantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:AugustTenTwoThousandAndSeventeenConsultingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="AsOf2019-06-30_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:AugustTenTwoThousandAndSeventeenConsultingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="From2019-07-012020-06-30_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:AugustTenTwoThousandAndSeventeenConsultingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2020-06-30_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:AugustTenTwoThousandAndSeventeenConsultingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-03-15_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember_custom_SettlementAndMutualReleaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">PPCB:SettlementAndMutualReleaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:AugustTenTwoThousandAndSeventeenConsultingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-15</instant>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember_custom_SettlementAndMutualReleaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">PPCB:SettlementAndMutualReleaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:AugustTenTwoThousandAndSeventeenConsultingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2021-06-30_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember_custom_SettlementAndMutualReleaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">PPCB:SettlementAndMutualReleaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:AugustTenTwoThousandAndSeventeenConsultingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2019-11-26_custom_NovemberTwentySixTwoThousandNineteenSecuritiesPurchaseAgreementMember_custom_NovemberTwentySixTwoThousandNineteenPowerUpNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:NovemberTwentySixTwoThousandNineteenPowerUpNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:NovemberTwentySixTwoThousandNineteenSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-11-26</instant>
        </period>
    </context>
    <context id="From2019-11-212019-11-22_custom_NovemberTwentySixTwoThousandNineteenSecuritiesPurchaseAgreementMember_custom_NovemberTwentySixTwoThousandNineteenPowerUpNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:NovemberTwentySixTwoThousandNineteenPowerUpNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:NovemberTwentySixTwoThousandNineteenSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-11-21</startDate>
            <endDate>2019-11-22</endDate>
        </period>
    </context>
    <context id="From2019-11-252019-11-26_custom_NovemberTwentySixTwoThousandNineteenSecuritiesPurchaseAgreementMember_custom_NovemberTwentySixTwoThousandNineteenPowerUpNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:NovemberTwentySixTwoThousandNineteenPowerUpNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:NovemberTwentySixTwoThousandNineteenSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-11-25</startDate>
            <endDate>2019-11-26</endDate>
        </period>
    </context>
    <context id="AsOf2020-01-07_custom_JanuarySevenTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember_custom_JanuarySevenTwoThousandTwentyPowerUpNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:JanuarySevenTwoThousandTwentyPowerUpNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:JanuarySevenTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-01-07</instant>
        </period>
    </context>
    <context id="From2020-01-122020-01-13_custom_JanuarySevenTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember_custom_JanuarySevenTwoThousandTwentyPowerUpNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:JanuarySevenTwoThousandTwentyPowerUpNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:JanuarySevenTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-12</startDate>
            <endDate>2020-01-13</endDate>
        </period>
    </context>
    <context id="From2020-01-062020-01-07_custom_JanuarySevenTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember_custom_JanuarySevenTwoThousandTwentyPowerUpNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:JanuarySevenTwoThousandTwentyPowerUpNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:JanuarySevenTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-06</startDate>
            <endDate>2020-01-07</endDate>
        </period>
    </context>
    <context id="AsOf2020-03-12_custom_MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember_custom_MarchTwelveTwoThousandTwentyPowerUpNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:MarchTwelveTwoThousandTwentyPowerUpNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-12</instant>
        </period>
    </context>
    <context id="From2020-03-042020-03-05_custom_MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember_custom_MarchTwelveTwoThousandTwentyPowerUpNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:MarchTwelveTwoThousandTwentyPowerUpNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-04</startDate>
            <endDate>2020-03-05</endDate>
        </period>
    </context>
    <context id="From2020-03-112020-03-12_custom_MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember_custom_MarchTwelveTwoThousandTwentyPowerUpNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:MarchTwelveTwoThousandTwentyPowerUpNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-11</startDate>
            <endDate>2020-03-12</endDate>
        </period>
    </context>
    <context id="AsOf2020-01-07_custom_MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember_custom_MarchTwelveTwoThousandTwentyPowerUpNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:MarchTwelveTwoThousandTwentyPowerUpNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-01-07</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30_custom_MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember_custom_MarchTwelveTwoThousandTwentyPowerUpNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:MarchTwelveTwoThousandTwentyPowerUpNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_custom_MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember_custom_MarchTwelveTwoThousandTwentyPowerUpNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:MarchTwelveTwoThousandTwentyPowerUpNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_custom_MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember_custom_MarchTwelveTwoThousandTwentyPowerUpNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:MarchTwelveTwoThousandTwentyPowerUpNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2019-05-23_custom_RedstartHoldingsCorpFinancingAgreementMember_custom_RedstartHoldingsCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:RedstartHoldingsCorpFinancingAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:RedstartHoldingsCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-05-23</instant>
        </period>
    </context>
    <context id="From2019-05-222019-05-23_custom_RedstartHoldingsCorpFinancingAgreementMember_custom_RedstartHoldingsCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:RedstartHoldingsCorpFinancingAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:RedstartHoldingsCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-05-22</startDate>
            <endDate>2019-05-23</endDate>
        </period>
    </context>
    <context id="AsOf2019-06-30_custom_RedstartHoldingsCorpFinancingAgreementMember_custom_RedstartHoldingsCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:RedstartHoldingsCorpFinancingAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:RedstartHoldingsCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30_custom_RedstartHoldingsCorpFinancingAgreementMember_custom_RedstartHoldingsCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:RedstartHoldingsCorpFinancingAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:RedstartHoldingsCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30_custom_RedstartHoldingsCorpFinancingAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:RedstartHoldingsCorpFinancingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="AsOf2019-07-30_custom_SecuritiesPurchaseAgreementMember_custom_OdysseyCapitalFundingLLCMember_custom_JulyTwoThousandNineteenOdysseyNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:JulyTwoThousandNineteenOdysseyNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:OdysseyCapitalFundingLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-07-30</instant>
        </period>
    </context>
    <context id="AsOf2019-08-01_custom_SecuritiesPurchaseAgreementMember_custom_OdysseyCapitalFundingLLCMember_custom_JulyTwoThousandNineteenOdysseyNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:JulyTwoThousandNineteenOdysseyNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:OdysseyCapitalFundingLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-01</instant>
        </period>
    </context>
    <context id="From2019-07-312019-08-01_custom_SecuritiesPurchaseAgreementMember_custom_OdysseyCapitalFundingLLCMember_custom_JulyTwoThousandNineteenOdysseyNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:JulyTwoThousandNineteenOdysseyNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:OdysseyCapitalFundingLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-31</startDate>
            <endDate>2019-08-01</endDate>
        </period>
    </context>
    <context id="From2019-07-292019-07-30_custom_SecuritiesPurchaseAgreementMember_custom_OdysseyCapitalFundingLLCMember_custom_JulyTwoThousandNineteenOdysseyNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:JulyTwoThousandNineteenOdysseyNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:OdysseyCapitalFundingLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-29</startDate>
            <endDate>2019-07-30</endDate>
        </period>
    </context>
    <context id="AsOf2020-06-30_custom_SecuritiesPurchaseAgreementMember_custom_OdysseyCapitalFundingLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:OdysseyCapitalFundingLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="From2019-07-012020-06-30_custom_SecuritiesPurchaseAgreementMember_custom_OdysseyCapitalFundingLLCMember_custom_JulyTwoThousandNineteenOdysseyNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:JulyTwoThousandNineteenOdysseyNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:OdysseyCapitalFundingLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2020-06-30_custom_SecuritiesPurchaseAgreementMember_custom_OdysseyCapitalFundingLLCMember_custom_JulyTwoThousandNineteenOdysseyNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:JulyTwoThousandNineteenOdysseyNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:OdysseyCapitalFundingLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="AsOf2019-08-30_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:AugustTwoThousandNineteenAuctusNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:AuctusFundLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-30</instant>
        </period>
    </context>
    <context id="AsOf2019-09-04_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:AugustTwoThousandNineteenAuctusNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:AuctusFundLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-04</instant>
        </period>
    </context>
    <context id="From2019-09-032019-09-04_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:AugustTwoThousandNineteenAuctusNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:AuctusFundLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-03</startDate>
            <endDate>2019-09-04</endDate>
        </period>
    </context>
    <context id="From2019-08-292019-08-30_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:AugustTwoThousandNineteenAuctusNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:AuctusFundLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-08-29</startDate>
            <endDate>2019-08-30</endDate>
        </period>
    </context>
    <context id="AsOf2019-08-30_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember_custom_FirstWarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:AugustTwoThousandNineteenAuctusNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">PPCB:FirstWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:AuctusFundLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-30</instant>
        </period>
    </context>
    <context id="AsOf2019-08-30_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember_custom_SecondWarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:AugustTwoThousandNineteenAuctusNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">PPCB:SecondWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:AuctusFundLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-30</instant>
        </period>
    </context>
    <context id="AsOf2019-08-30_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember_custom_ThirdWarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:AugustTwoThousandNineteenAuctusNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">PPCB:ThirdWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:AuctusFundLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-30</instant>
        </period>
    </context>
    <context id="From2019-07-012020-06-30_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:AugustTwoThousandNineteenAuctusNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:AuctusFundLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2020-06-30_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:AugustTwoThousandNineteenAuctusNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:AuctusFundLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:AugustTwoThousandNineteenAuctusNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:AuctusFundLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:AugustTwoThousandNineteenAuctusNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:AuctusFundLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:AugustTwoThousandNineteenAuctusNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:AuctusFundLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2019-10-02_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember_custom_OctoberOneTwoThousandNineteenAuctusNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:OctoberOneTwoThousandNineteenAuctusNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:GWHoldingsGroupLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-10-02</instant>
        </period>
    </context>
    <context id="From2019-09-292019-10-02_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember_custom_OctoberOneTwoThousandNineteenAuctusNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:OctoberOneTwoThousandNineteenAuctusNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:GWHoldingsGroupLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-10-02</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-10_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember_custom_DecemberTenTwoThousandTwentyGWNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:DecemberTenTwoThousandTwentyGWNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:GWHoldingsGroupLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-10</instant>
        </period>
    </context>
    <context id="From2020-12-092020-12-10_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember_custom_DecemberTenTwoThousandTwentyGWNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:DecemberTenTwoThousandTwentyGWNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:GWHoldingsGroupLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-09</startDate>
            <endDate>2020-12-10</endDate>
        </period>
    </context>
    <context id="From2020-12-092020-12-10_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember_custom_DecemberTenTwoThousandTwentyGWNoteMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:DecemberTenTwoThousandTwentyGWNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:GWHoldingsGroupLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-09</startDate>
            <endDate>2020-12-10</endDate>
        </period>
    </context>
    <context id="From2020-12-092020-12-10_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember_custom_DecemberTenTwoThousandTwentyGWNoteMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:DecemberTenTwoThousandTwentyGWNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:GWHoldingsGroupLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-09</startDate>
            <endDate>2020-12-10</endDate>
        </period>
    </context>
    <context id="AsOf2020-06-30_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember_custom_OctoberOneTwoThousandNineteenAuctusNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:OctoberOneTwoThousandNineteenAuctusNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:GWHoldingsGroupLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:GWHoldingsGroupLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember_custom_OctoberOneTwoThousandNineteenAuctusNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:OctoberOneTwoThousandNineteenAuctusNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:GWHoldingsGroupLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:GWHoldingsGroupLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember_custom_DecemberTenTwoThousandTwentyGWNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:DecemberTenTwoThousandTwentyGWNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:GWHoldingsGroupLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember_custom_DecemberTenTwoThousandTwentyGWNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:DecemberTenTwoThousandTwentyGWNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:GWHoldingsGroupLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30_custom_SecuritiesPurchaseAgreementMember_custom_DecemberTenTwoThousandTwentyGWNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:DecemberTenTwoThousandTwentyGWNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_custom_SecuritiesPurchaseAgreementMember_custom_DecemberTenTwoThousandTwentyGWNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:DecemberTenTwoThousandTwentyGWNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2019-10-03_custom_SecuritiesPurchaseAgreementMember_custom_CrownBridgePartnersLLCMember_custom_OctoberThreeTwoThousandNineteenAuctusNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:OctoberThreeTwoThousandNineteenAuctusNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:CrownBridgePartnersLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-10-03</instant>
        </period>
    </context>
    <context id="From2019-10-012019-10-03_custom_SecuritiesPurchaseAgreementMember_custom_CrownBridgePartnersLLCMember_custom_OctoberThreeTwoThousandNineteenAuctusNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:OctoberThreeTwoThousandNineteenAuctusNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:CrownBridgePartnersLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-10-03</endDate>
        </period>
    </context>
    <context id="From2019-10-012019-10-03_custom_SecuritiesPurchaseAgreementMember_custom_CrownBridgePartnersLLCMember_custom_OctoberThreeTwoThousandNineteenAuctusNoteMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:OctoberThreeTwoThousandNineteenAuctusNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:CrownBridgePartnersLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-10-03</endDate>
        </period>
    </context>
    <context id="From2019-10-012019-10-03_custom_SecuritiesPurchaseAgreementMember_custom_CrownBridgePartnersLLCMember_custom_OctoberThreeTwoThousandNineteenAuctusNoteMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:OctoberThreeTwoThousandNineteenAuctusNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:CrownBridgePartnersLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-10-03</endDate>
        </period>
    </context>
    <context id="AsOf2020-06-30_custom_SecuritiesPurchaseAgreementMember_custom_CrownBridgePartnersLLCMember_custom_OctoberThreeTwoThousandNineteenAuctusNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:OctoberThreeTwoThousandNineteenAuctusNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:CrownBridgePartnersLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="From2019-07-012020-06-30_custom_SecuritiesPurchaseAgreementMember_custom_CrownBridgePartnersLLCMember_custom_OctoberThreeTwoThousandNineteenAuctusNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:OctoberThreeTwoThousandNineteenAuctusNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:CrownBridgePartnersLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2021-06-30_custom_SecuritiesPurchaseAgreementMember_custom_CrownBridgePartnersLLCMember_custom_OctoberThreeTwoThousandNineteenAuctusNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:OctoberThreeTwoThousandNineteenAuctusNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:CrownBridgePartnersLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="From2020-09-152020-09-16_custom_SecuritiesPurchaseAgreementMember_custom_CrownBridgePartnersLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:CrownBridgePartnersLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-15</startDate>
            <endDate>2020-09-16</endDate>
        </period>
    </context>
    <context id="AsOf2020-11-30_custom_SecuritiesPurchaseAgreementMember_custom_CrownBridgePartnersLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:CrownBridgePartnersLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-11-30</instant>
        </period>
    </context>
    <context id="AsOf2020-01-13_custom_SecuritiesPurchaseAgreementMember_custom_JanuaryThirteenTwentyTwentyAderAlefNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:JanuaryThirteenTwentyTwentyAderAlefNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-01-13</instant>
        </period>
    </context>
    <context id="From2020-01-122020-01-13_custom_SecuritiesPurchaseAgreementMember_custom_JanuaryThirteenTwentyTwentyAderAlefNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:JanuaryThirteenTwentyTwentyAderAlefNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-12</startDate>
            <endDate>2020-01-13</endDate>
        </period>
    </context>
    <context id="From2020-01-122020-01-13_custom_SecuritiesPurchaseAgreementMember_custom_JanuaryThirteenTwentyTwentyAderAlefNoteMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:JanuaryThirteenTwentyTwentyAderAlefNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-12</startDate>
            <endDate>2020-01-13</endDate>
        </period>
    </context>
    <context id="From2020-01-122020-01-13_custom_SecuritiesPurchaseAgreementMember_custom_JanuaryThirteenTwentyTwentyAderAlefNoteMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:JanuaryThirteenTwentyTwentyAderAlefNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-12</startDate>
            <endDate>2020-01-13</endDate>
        </period>
    </context>
    <context id="AsOf2021-06-30_custom_SecuritiesPurchaseAgreementMember_custom_JanuaryThirteenTwentyTwentyAderAlefNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:JanuaryThirteenTwentyTwentyAderAlefNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30_custom_SecuritiesPurchaseAgreementMember_custom_JanuaryThirteenTwentyTwentyAderAlefNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:JanuaryThirteenTwentyTwentyAderAlefNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_custom_SecuritiesPurchaseAgreementMember_custom_JanuaryThirteenTwentyTwentyAderAlefNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:JanuaryThirteenTwentyTwentyAderAlefNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2020-02-19_custom_SecuritiesPurchaseAgreementMember_custom_FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember_custom_LGCapitalFundingLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:LGCapitalFundingLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-02-19</instant>
        </period>
    </context>
    <context id="From2020-02-182020-02-19_custom_SecuritiesPurchaseAgreementMember_custom_FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember_custom_LGCapitalFundingLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:LGCapitalFundingLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-18</startDate>
            <endDate>2020-02-19</endDate>
        </period>
    </context>
    <context id="From2020-03-242020-03-25_custom_SecuritiesPurchaseAgreementMember_custom_FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember_custom_LGCapitalFundingLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:LGCapitalFundingLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-24</startDate>
            <endDate>2020-03-25</endDate>
        </period>
    </context>
    <context id="From2020-02-182020-02-19_custom_SecuritiesPurchaseAgreementMember_custom_FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember_custom_LGCapitalFundingLLCMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:LGCapitalFundingLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-18</startDate>
            <endDate>2020-02-19</endDate>
        </period>
    </context>
    <context id="From2020-02-182020-02-19_custom_SecuritiesPurchaseAgreementMember_custom_FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember_custom_LGCapitalFundingLLCMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:LGCapitalFundingLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-18</startDate>
            <endDate>2020-02-19</endDate>
        </period>
    </context>
    <context id="AsOf2020-02-19_custom_SecuritiesPurchaseAgreementMember_custom_LGCapitalFundingLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:LGCapitalFundingLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-02-19</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30_custom_SecuritiesPurchaseAgreementMember_custom_FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember_custom_LGCapitalFundingLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:LGCapitalFundingLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_custom_SecuritiesPurchaseAgreementMember_custom_FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember_custom_LGCapitalFundingLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:LGCapitalFundingLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_custom_SecuritiesPurchaseAgreementMember_custom_FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember_custom_LGCapitalFundingLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:LGCapitalFundingLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2020-09-082020-09-09_custom_SecuritiesPurchaseAgreementMember_custom_LGCapitalFundingLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:LGCapitalFundingLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-08</startDate>
            <endDate>2020-09-09</endDate>
        </period>
    </context>
    <context id="AsOf2020-11-30_custom_SecuritiesPurchaseAgreementMember_custom_LGCapitalFundingLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:LGCapitalFundingLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-11-30</instant>
        </period>
    </context>
    <context id="From2020-11-292020-11-30_custom_SecuritiesPurchaseAgreementMember_custom_LGCapitalFundingLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:LGCapitalFundingLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-29</startDate>
            <endDate>2020-11-30</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-02_custom_SecuritiesPurchaseAgreementMember_custom_DecemberTwoTwoThousandTwentyGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:DecemberTwoTwoThousandTwentyGenevaRothMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:GenevaRothRemarkHoldingsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-02</instant>
        </period>
    </context>
    <context id="AsOf2021-01-05_custom_SecuritiesPurchaseAgreementMember_custom_JanuaryFiveTwoThousandTwentyOneGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:JanuaryFiveTwoThousandTwentyOneGenevaRothMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:GenevaRothRemarkHoldingsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-05</instant>
        </period>
    </context>
    <context id="From2021-01-042021-01-05_custom_SecuritiesPurchaseAgreementMember_custom_JanuaryFiveTwoThousandTwentyOneGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:JanuaryFiveTwoThousandTwentyOneGenevaRothMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:GenevaRothRemarkHoldingsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-04</startDate>
            <endDate>2021-01-05</endDate>
        </period>
    </context>
    <context id="AsOf2021-03-16_custom_SecuritiesPurchaseAgreementMember_custom_MarchSixteenTwoThousandTwentyOneGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:MarchSixteenTwoThousandTwentyOneGenevaRothMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:GenevaRothRemarkHoldingsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-16</instant>
        </period>
    </context>
    <context id="From2021-03-132021-03-16_custom_SecuritiesPurchaseAgreementMember_custom_MarchSixteenTwoThousandTwentyOneGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:MarchSixteenTwoThousandTwentyOneGenevaRothMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:GenevaRothRemarkHoldingsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-13</startDate>
            <endDate>2021-03-16</endDate>
        </period>
    </context>
    <context id="AsOf2021-01-05_custom_SecuritiesPurchaseAgreementMember_custom_MarchSixteenTwoThousandTwentyOneGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:MarchSixteenTwoThousandTwentyOneGenevaRothMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:GenevaRothRemarkHoldingsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-05</instant>
        </period>
    </context>
    <context id="From2021-01-032021-01-05_custom_SecuritiesPurchaseAgreementMember_custom_MarchSixteenTwoThousandTwentyOneGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:MarchSixteenTwoThousandTwentyOneGenevaRothMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:GenevaRothRemarkHoldingsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-03</startDate>
            <endDate>2021-01-05</endDate>
        </period>
    </context>
    <context id="From2020-12-012020-12-02_custom_SecuritiesPurchaseAgreementMember_custom_DecemberTwoTwoThousandTwentyGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:DecemberTwoTwoThousandTwentyGenevaRothMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:GenevaRothRemarkHoldingsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-01</startDate>
            <endDate>2020-12-02</endDate>
        </period>
    </context>
    <context id="From2020-12-012020-12-02_custom_SecuritiesPurchaseAgreementMember_custom_DecemberTwoTwoThousandTwentyGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:DecemberTwoTwoThousandTwentyGenevaRothMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:GenevaRothRemarkHoldingsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-01</startDate>
            <endDate>2020-12-02</endDate>
        </period>
    </context>
    <context id="From2020-12-012020-12-02_custom_SecuritiesPurchaseAgreementMember_custom_DecemberTwoTwoThousandTwentyGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:DecemberTwoTwoThousandTwentyGenevaRothMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:GenevaRothRemarkHoldingsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-01</startDate>
            <endDate>2020-12-02</endDate>
        </period>
    </context>
    <context id="AsOf2021-06-30_custom_SecuritiesPurchaseAgreementMember_custom_DecemberTwoTwoThousandTwentyGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:DecemberTwoTwoThousandTwentyGenevaRothMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:GenevaRothRemarkHoldingsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_custom_SecuritiesPurchaseAgreementMember_custom_DecemberTwoTwoThousandTwentyGenevaRothMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:DecemberTwoTwoThousandTwentyGenevaRothMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_custom_SecuritiesPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2019-07-012020-06-30_custom_SecuritiesPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2021-06-30_custom_SecuritiesPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30_custom_SecuritiesPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_country_US">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2019-07-012020-06-30_country_US">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="From2020-03-242020-03-27_custom_CaresActMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:CaresActMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-24</startDate>
            <endDate>2020-03-27</endDate>
        </period>
    </context>
    <context id="AsOf2021-06-30_country_US">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_country_AU_custom_ExpireInTwoThousandTwentyFourMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:AU</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">PPCB:ExpireInTwoThousandTwentyFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_country_AU_custom_NotExpireMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:AU</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">PPCB:NotExpireMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="From2019-07-012020-06-30_country_AU">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:AU</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_country_AU">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:AU</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2021-06-30_country_AU">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:AU</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-02-03">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
        </entity>
        <period>
            <instant>2021-02-03</instant>
        </period>
    </context>
    <context id="AsOf2021-02-04">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
        </entity>
        <period>
            <instant>2021-02-04</instant>
        </period>
    </context>
    <context id="From2020-04-022020-04-03_custom_SecurityPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecurityPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-02</startDate>
            <endDate>2020-04-03</endDate>
        </period>
    </context>
    <context id="AsOf2020-04-03_custom_SecurityPurchaseAgreementMember_custom_SeriesBWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">PPCB:SeriesBWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecurityPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-03</instant>
        </period>
    </context>
    <context id="AsOf2020-04-03_custom_SecurityPurchaseAgreementMember_custom_SeriesCWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">PPCB:SeriesCWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecurityPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-03</instant>
        </period>
    </context>
    <context id="AsOf2020-04-03_custom_SecurityPurchaseAgreementMember_custom_SeriesAWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">PPCB:SeriesAWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecurityPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-03</instant>
        </period>
    </context>
    <context id="AsOf2020-04-03_custom_SecurityPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecurityPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-03</instant>
        </period>
    </context>
    <context id="From2020-04-022020-04-03_custom_SecurityPurchaseAgreementMember_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecurityPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-02</startDate>
            <endDate>2020-04-03</endDate>
        </period>
    </context>
    <context id="From2020-04-022020-04-03_custom_SecurityPurchaseAgreementMember_us-gaap_RestrictedStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecurityPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-02</startDate>
            <endDate>2020-04-03</endDate>
        </period>
    </context>
    <context id="AsOf2020-04-03_custom_SecurityPurchaseAgreementMember_custom_PrefundedWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">PPCB:PrefundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecurityPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-03</instant>
        </period>
    </context>
    <context id="From2019-07-012020-06-30_custom_SecurityPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecurityPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2020-06-30_custom_SecurityPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecurityPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30_custom_SecurityPurchaseAgreementMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecurityPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30_custom_SecurityPurchaseAgreementMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecurityPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_custom_SecurityPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecurityPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2021-06-30_custom_SecurityPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecurityPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_custom_SecurityPurchaseAgreementMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecurityPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_custom_SecurityPurchaseAgreementMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecurityPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-09-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="AsOf2020-11-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
        </entity>
        <period>
            <instant>2020-11-30</instant>
        </period>
    </context>
    <context id="From2020-11-292020-11-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
        </entity>
        <period>
            <startDate>2020-11-29</startDate>
            <endDate>2020-11-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_custom_UnderlyingFinancingAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:UnderlyingFinancingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2020-07-182020-07-19_custom_ConsultingAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:ConsultingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-18</startDate>
            <endDate>2020-07-19</endDate>
        </period>
    </context>
    <context id="AsOf2020-07-19_custom_ConsultingAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:ConsultingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-19</instant>
        </period>
    </context>
    <context id="From2019-07-012020-06-30_custom_ConsultingAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:ConsultingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="From2020-02-022020-02-03_custom_ConsultantMember_custom_EngagementAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">PPCB:ConsultantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:EngagementAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-02</startDate>
            <endDate>2020-02-03</endDate>
        </period>
    </context>
    <context id="From2020-06-252020-06-26_custom_ConsultantMember_custom_EngagementAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">PPCB:ConsultantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:EngagementAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-25</startDate>
            <endDate>2020-06-26</endDate>
        </period>
    </context>
    <context id="AsOf2020-02-03_custom_ConsultantMember_custom_EngagementAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">PPCB:ConsultantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:EngagementAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-02-03</instant>
        </period>
    </context>
    <context id="AsOf2020-06-26_custom_ConsultantMember_custom_EngagementAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">PPCB:ConsultantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:EngagementAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-26</instant>
        </period>
    </context>
    <context id="From2019-07-012020-06-30_custom_ConsultantMember_custom_EngagementAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">PPCB:ConsultantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:EngagementAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="From2021-03-212021-03-22_custom_ConsultantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">PPCB:ConsultantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-21</startDate>
            <endDate>2021-03-22</endDate>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_us-gaap_CommonStockMember_custom_ConsultantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">PPCB:ConsultantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_CommonStockMember_custom_ConsultantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">PPCB:ConsultantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_custom_ConsultantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">PPCB:ConsultantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-03-012021-03-31_custom_ConsultantMember_custom_EngagementAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">PPCB:ConsultantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:EngagementAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="From2021-06-012021-06-30_custom_ConsultantMember_custom_EngagementAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">PPCB:ConsultantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:EngagementAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2021-03-31_custom_ConsultantMember_custom_EngagementAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">PPCB:ConsultantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:EngagementAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_custom_ConsultantMember_custom_EngagementAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">PPCB:ConsultantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:EngagementAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_custom_ConsultantMember_custom_EngagementAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">PPCB:ConsultantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:EngagementAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2021-06-30_custom_PrefundedWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">PPCB:PrefundedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_custom_SeriesBWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">PPCB:SeriesBWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_custom_PrefundedWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">PPCB:PrefundedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2021-06-30_custom_TwentySeriesAAndOneSeriesCWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">PPCB:TwentySeriesAAndOneSeriesCWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="From2019-05-012019-05-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
        </entity>
        <period>
            <startDate>2019-05-01</startDate>
            <endDate>2019-05-31</endDate>
        </period>
    </context>
    <context id="From2019-05-012019-05-31_srt_ChiefExecutiveOfficerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-05-01</startDate>
            <endDate>2019-05-31</endDate>
        </period>
    </context>
    <context id="From2019-05-012019-05-31_us-gaap_RestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-05-01</startDate>
            <endDate>2019-05-31</endDate>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_us-gaap_RestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2019-07-012020-06-30_us-gaap_RestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_RestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30_us-gaap_RestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_custom_TwoThousandNinteenEquityIncentivePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">PPCB:TwoThousandNinteenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_custom_EmploymentAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:EmploymentAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2019-07-012020-06-30_custom_EmploymentAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:EmploymentAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2019-08-31_custom_FirstWarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">PPCB:FirstWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-31</instant>
        </period>
    </context>
    <context id="AsOf2019-08-31_custom_SecondWarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">PPCB:SecondWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-31</instant>
        </period>
    </context>
    <context id="AsOf2019-08-31_custom_ThirdWarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">PPCB:ThirdWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-31</instant>
        </period>
    </context>
    <context id="AsOf2019-09-10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
        </entity>
        <period>
            <instant>2019-09-10</instant>
        </period>
    </context>
    <context id="From2019-09-092019-09-10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
        </entity>
        <period>
            <startDate>2019-09-09</startDate>
            <endDate>2019-09-10</endDate>
        </period>
    </context>
    <context id="From2019-07-012020-06-30_us-gaap_WarrantMember17272484">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="From2020-04-022020-04-03_custom_SecuritiesPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-02</startDate>
            <endDate>2020-04-03</endDate>
        </period>
    </context>
    <context id="AsOf2020-04-03_custom_SecuritiesPurchaseAgreementMember_custom_SeriesBWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">PPCB:SeriesBWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-03</instant>
        </period>
    </context>
    <context id="AsOf2020-04-03_custom_SecuritiesPurchaseAgreementMember_custom_SeriesCWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">PPCB:SeriesCWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-03</instant>
        </period>
    </context>
    <context id="AsOf2020-04-03_custom_SecuritiesPurchaseAgreementMember_custom_PrefundedWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">PPCB:PrefundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-03</instant>
        </period>
    </context>
    <context id="AsOf2020-03-20_custom_SecuritiesPurchaseAgreementMember_custom_SeriesAWarrantsMember_us-gaap_InvestorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">PPCB:SeriesAWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-20</instant>
        </period>
    </context>
    <context id="AsOf2020-03-20_custom_SecuritiesPurchaseAgreementMember_custom_SeriesBWarrantsMember_us-gaap_InvestorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">PPCB:SeriesBWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-20</instant>
        </period>
    </context>
    <context id="From2020-03-192020-03-20_custom_SecuritiesPurchaseAgreementMember_custom_SeriesBWarrantsMember_us-gaap_InvestorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">PPCB:SeriesBWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-19</startDate>
            <endDate>2020-03-20</endDate>
        </period>
    </context>
    <context id="From2020-03-192020-03-20_custom_SecuritiesPurchaseAgreementMember_custom_SeriesBWarrantsMember_custom_HolderMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">PPCB:HolderMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">PPCB:SeriesBWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-19</startDate>
            <endDate>2020-03-20</endDate>
        </period>
    </context>
    <context id="AsOf2020-03-20_custom_SecuritiesPurchaseAgreementMember_custom_SeriesBWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">PPCB:SeriesBWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-20</instant>
        </period>
    </context>
    <context id="AsOf2020-03-20_custom_SecuritiesPurchaseAgreementMember_custom_SeriesCWarrantsMember_us-gaap_InvestorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">PPCB:SeriesCWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-20</instant>
        </period>
    </context>
    <context id="From2019-09-252019-09-26_custom_FoleyShechterMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">PPCB:FoleyShechterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-25</startDate>
            <endDate>2019-09-26</endDate>
        </period>
    </context>
    <context id="From2021-03-202021-03-22_custom_SettlementAgreementMember_custom_FoleyShechterMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">PPCB:FoleyShechterMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SettlementAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-20</startDate>
            <endDate>2021-03-22</endDate>
        </period>
    </context>
    <context id="AsOf2021-03-22_custom_SettlementAgreementMember_custom_FoleyShechterMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">PPCB:FoleyShechterMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SettlementAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-22</instant>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_custom_SettlementAgreementMember_custom_FoleyShechterMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">PPCB:FoleyShechterMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SettlementAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_custom_RegalConsultingLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:RegalConsultingLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2017-05-31_custom_RegalConsultingLLCMember_custom_TwoThousandAndSeventeenNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:TwoThousandAndSeventeenNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:RegalConsultingLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-05-31</instant>
        </period>
    </context>
    <context id="From2017-05-012017-05-31_custom_RegalConsultingLLCMember_custom_TwoThousandAndSeventeenNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:TwoThousandAndSeventeenNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:RegalConsultingLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-05-01</startDate>
            <endDate>2017-05-31</endDate>
        </period>
    </context>
    <context id="AsOf2017-08-10_custom_SettlementAndMutualReleaseAgreementMember_custom_RegalConsultingLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SettlementAndMutualReleaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:RegalConsultingLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-08-10</instant>
        </period>
    </context>
    <context id="AsOf2021-03-15_custom_SettlementAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SettlementAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-15</instant>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_custom_SettlementAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SettlementAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_custom_From2012ThroughThe2014Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">PPCB:From2012ThroughThe2014Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2012-06-012012-06-30_us-gaap_RoyaltyAgreementTermsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:RoyaltyAgreementTermsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2012-06-01</startDate>
            <endDate>2012-06-30</endDate>
        </period>
    </context>
    <context id="From2012-06-012012-06-30_us-gaap_LicenseAgreementTermsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:LicenseAgreementTermsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2012-06-01</startDate>
            <endDate>2012-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2016-05-05_custom_NewFiveYearOperatingLeaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:NewFiveYearOperatingLeaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-05-05</instant>
        </period>
    </context>
    <context id="From2016-05-032016-05-05_custom_NewFiveYearOperatingLeaseAgreementMember_custom_AUDCurrencyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">PPCB:AUDCurrencyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:NewFiveYearOperatingLeaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-03</startDate>
            <endDate>2016-05-05</endDate>
        </period>
    </context>
    <context id="From2016-05-032016-05-05_custom_NewFiveYearOperatingLeaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:NewFiveYearOperatingLeaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-03</startDate>
            <endDate>2016-05-05</endDate>
        </period>
    </context>
    <context id="AsOf2019-07-02_us-gaap_AccountingStandardsUpdate201602Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-07-02</instant>
        </period>
    </context>
    <context id="From2019-07-012019-07-02_us-gaap_AccountingStandardsUpdate201602Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-07-02</endDate>
        </period>
    </context>
    <context id="From2019-07-012019-07-02_us-gaap_AccountingStandardsUpdate201602Member_custom_AUDCurrencyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">PPCB:AUDCurrencyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-07-02</endDate>
        </period>
    </context>
    <context id="From2018-09-102018-09-13_custom_OneYearCollaborationAgreementMember_custom_EurosMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">PPCB:EurosMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:OneYearCollaborationAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-10</startDate>
            <endDate>2018-09-13</endDate>
        </period>
    </context>
    <context id="From2018-09-102018-09-13_custom_OneYearCollaborationAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:OneYearCollaborationAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-10</startDate>
            <endDate>2018-09-13</endDate>
        </period>
    </context>
    <context id="From2018-09-102018-09-13_custom_TwoYearCollaborationAgreementMember_custom_EurosMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">PPCB:EurosMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:TwoYearCollaborationAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-10</startDate>
            <endDate>2018-09-13</endDate>
        </period>
    </context>
    <context id="From2018-09-102018-09-13_custom_TwoYearCollaborationAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:TwoYearCollaborationAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-10</startDate>
            <endDate>2018-09-13</endDate>
        </period>
    </context>
    <context id="From2018-07-012019-06-30_custom_EurosMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">PPCB:EurosMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="From2018-07-012019-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_custom_EurosMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">PPCB:EurosMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2018-09-102018-09-13_us-gaap_SalesRevenueNetMember_us-gaap_RevenueFromRightsConcentrationRiskMember_custom_NoCustomerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">PPCB:NoCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:RevenueFromRightsConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-10</startDate>
            <endDate>2018-09-13</endDate>
        </period>
    </context>
    <context id="From2020-09-292020-10-02_custom_TwoYearCollaborationAgreementMember_custom_EurosMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">PPCB:EurosMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:TwoYearCollaborationAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-29</startDate>
            <endDate>2020-10-02</endDate>
        </period>
    </context>
    <context id="From2020-09-292020-10-02_custom_TwoYearCollaborationAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:TwoYearCollaborationAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-29</startDate>
            <endDate>2020-10-02</endDate>
        </period>
    </context>
    <context id="From2020-09-292020-10-02_custom_TwoYearCollaborationAgreementMember_custom_EurosMember_custom_InstallmentOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">PPCB:InstallmentOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">PPCB:EurosMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:TwoYearCollaborationAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-29</startDate>
            <endDate>2020-10-02</endDate>
        </period>
    </context>
    <context id="From2020-09-292020-10-02_custom_TwoYearCollaborationAgreementMember_custom_InstallmentTwoMember_custom_EurosMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">PPCB:InstallmentTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">PPCB:EurosMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:TwoYearCollaborationAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-29</startDate>
            <endDate>2020-10-02</endDate>
        </period>
    </context>
    <context id="From2020-09-292020-10-02_custom_TwoYearCollaborationAgreementMember_custom_InstallmentTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">PPCB:InstallmentTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:TwoYearCollaborationAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-29</startDate>
            <endDate>2020-10-02</endDate>
        </period>
    </context>
    <context id="From2020-09-292020-10-02_custom_TwoYearCollaborationAgreementMember_custom_InstallmentThreeMember_custom_EurosMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">PPCB:InstallmentThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">PPCB:EurosMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:TwoYearCollaborationAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-29</startDate>
            <endDate>2020-10-02</endDate>
        </period>
    </context>
    <context id="From2020-09-292020-10-02_custom_TwoYearCollaborationAgreementMember_custom_InstallmentThreeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">PPCB:InstallmentThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:TwoYearCollaborationAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-29</startDate>
            <endDate>2020-10-02</endDate>
        </period>
    </context>
    <context id="From2020-09-292020-10-02_custom_TwoYearCollaborationAgreementMember_custom_InstallmentFourMember_custom_EurosMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">PPCB:InstallmentFourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">PPCB:EurosMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:TwoYearCollaborationAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-29</startDate>
            <endDate>2020-10-02</endDate>
        </period>
    </context>
    <context id="From2020-09-292020-10-02_custom_TwoYearCollaborationAgreementMember_custom_InstallmentFourMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">PPCB:InstallmentFourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:TwoYearCollaborationAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-29</startDate>
            <endDate>2020-10-02</endDate>
        </period>
    </context>
    <context id="From2020-09-292020-10-02_custom_UniversityOfJaenMember_custom_EurosMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">PPCB:EurosMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:UniversityOfJaenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-29</startDate>
            <endDate>2020-10-02</endDate>
        </period>
    </context>
    <context id="From2020-09-292020-10-02_custom_UniversityOfJaenMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:UniversityOfJaenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-29</startDate>
            <endDate>2020-10-02</endDate>
        </period>
    </context>
    <context id="From2020-09-292020-10-02_us-gaap_SalesRevenueNetMember_custom_UniversityOfJaenMember_us-gaap_RevenueFromRightsConcentrationRiskMember_custom_NoCustomerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">PPCB:NoCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:RevenueFromRightsConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:UniversityOfJaenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-29</startDate>
            <endDate>2020-10-02</endDate>
        </period>
    </context>
    <context id="AsOf2021-06-30_custom_CurrentAndFormerDirectorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">PPCB:CurrentAndFormerDirectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30_custom_CurrentAndFormerDirectorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">PPCB:CurrentAndFormerDirectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_custom_FormerDirectorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">PPCB:FormerDirectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30_custom_FormerDirectorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">PPCB:FormerDirectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="AsOf2016-05-05_custom_NorthHorizonPtyLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:NorthHorizonPtyLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-05-05</instant>
        </period>
    </context>
    <context id="From2016-05-032016-05-05_custom_NorthHorizonPtyLtdMember_custom_AUDCurrencyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">PPCB:AUDCurrencyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:NorthHorizonPtyLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-03</startDate>
            <endDate>2016-05-05</endDate>
        </period>
    </context>
    <context id="From2016-05-032016-05-05_custom_NorthHorizonPtyLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:NorthHorizonPtyLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-03</startDate>
            <endDate>2016-05-05</endDate>
        </period>
    </context>
    <context id="AsOf2016-05-05_custom_NorthHorizonPtyLtdMember_custom_AUDCurrenryMember_custom_NathanielszMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">PPCB:AUDCurrenryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">PPCB:NathanielszMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:NorthHorizonPtyLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-05-05</instant>
        </period>
    </context>
    <context id="AsOf2016-05-05_custom_NorthHorizonPtyLtdMember_custom_NathanielszMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">PPCB:NathanielszMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:NorthHorizonPtyLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-05-05</instant>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_custom_NorthHorizonPtyLtdMember_custom_AUDCurrenryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">PPCB:AUDCurrenryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:NorthHorizonPtyLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_custom_NorthHorizonPtyLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:NorthHorizonPtyLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2015-02-242015-02-25_custom_NathanielszEmploymentAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:NathanielszEmploymentAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2015-02-24</startDate>
            <endDate>2015-02-25</endDate>
        </period>
    </context>
    <context id="From2015-02-242015-02-25_custom_NathanielszEmploymentAgreementMember_custom_AUDCurrenryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">PPCB:AUDCurrenryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:NathanielszEmploymentAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2015-02-24</startDate>
            <endDate>2015-02-25</endDate>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_custom_NathanielszEmploymentAgreementMember_custom_AUDCurrenryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">PPCB:AUDCurrenryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:NathanielszEmploymentAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_custom_NathanielszEmploymentAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:NathanielszEmploymentAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2018-03-152018-03-16_custom_NathanielszEmploymentAgreementMember_custom_AUDCurrenryMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">PPCB:AUDCurrenryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:NathanielszEmploymentAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-03-15</startDate>
            <endDate>2018-03-16</endDate>
        </period>
    </context>
    <context id="From2018-03-152018-03-16_custom_NathanielszEmploymentAgreementMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:NathanielszEmploymentAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-03-15</startDate>
            <endDate>2018-03-16</endDate>
        </period>
    </context>
    <context id="From2018-03-152018-03-16_custom_NathanielszEmploymentAgreementMember_custom_AUDCurrenryMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">PPCB:AUDCurrenryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:NathanielszEmploymentAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-03-15</startDate>
            <endDate>2018-03-16</endDate>
        </period>
    </context>
    <context id="From2018-03-152018-03-16_custom_NathanielszEmploymentAgreementMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:NathanielszEmploymentAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-03-15</startDate>
            <endDate>2018-03-16</endDate>
        </period>
    </context>
    <context id="From2018-01-282018-02-01_custom_MrsNathanielszMember_custom_AUDCurrencyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">PPCB:AUDCurrencyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">PPCB:MrsNathanielszMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-28</startDate>
            <endDate>2018-02-01</endDate>
        </period>
    </context>
    <context id="From2018-01-282018-02-01_custom_MrsNathanielszMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">PPCB:MrsNathanielszMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-28</startDate>
            <endDate>2018-02-01</endDate>
        </period>
    </context>
    <context id="From2016-02-242016-02-25_custom_JamesNathanielszMember_custom_AUDCurrenryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">PPCB:AUDCurrenryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">PPCB:JamesNathanielszMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-02-24</startDate>
            <endDate>2016-02-25</endDate>
        </period>
    </context>
    <context id="From2016-02-242016-02-25_custom_JamesNathanielszMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">PPCB:JamesNathanielszMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-02-24</startDate>
            <endDate>2016-02-25</endDate>
        </period>
    </context>
    <context id="From2019-07-012020-06-30_custom_MrsNathanielszMember_custom_AUDCurrenryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">PPCB:AUDCurrenryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">PPCB:MrsNathanielszMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="From2019-07-012020-06-30_custom_MrsNathanielszMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">PPCB:MrsNathanielszMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_custom_MrsNathanielszMember_custom_AUDCurrenryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">PPCB:AUDCurrenryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">PPCB:MrsNathanielszMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_custom_MrsNathanielszMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">PPCB:MrsNathanielszMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2019-05-132019-05-14_custom_MrNathanielszMember_custom_BoardOfDirectorsMember_custom_AUDCurrenryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">PPCB:BoardOfDirectorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">PPCB:AUDCurrenryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">PPCB:MrNathanielszMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-05-13</startDate>
            <endDate>2019-05-14</endDate>
        </period>
    </context>
    <context id="From2019-05-132019-05-14_custom_MrNathanielszMember_custom_BoardOfDirectorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">PPCB:BoardOfDirectorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">PPCB:MrNathanielszMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-05-13</startDate>
            <endDate>2019-05-14</endDate>
        </period>
    </context>
    <context id="From2018-07-012019-06-30_srt_ChiefExecutiveOfficerMember_custom_AUDCurrenryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">PPCB:AUDCurrenryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="From2018-07-012019-06-30_srt_ChiefExecutiveOfficerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="From2020-07-122020-07-13_custom_MrNathanielszMember_custom_BoardOfDirectorsMember_custom_AUDCurrenryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">PPCB:BoardOfDirectorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">PPCB:AUDCurrenryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">PPCB:MrNathanielszMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-12</startDate>
            <endDate>2020-07-13</endDate>
        </period>
    </context>
    <context id="From2019-07-012020-06-30_srt_ChiefExecutiveOfficerMember_custom_AUDCurrenryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">PPCB:AUDCurrenryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="From2019-07-012020-06-30_srt_ChiefExecutiveOfficerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="From2021-08-112021-08-12_custom_MrNathanielszMember_custom_BoardOfDirectorsMember_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">PPCB:BoardOfDirectorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">PPCB:MrNathanielszMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-11</startDate>
            <endDate>2021-08-12</endDate>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_srt_ChiefExecutiveOfficerMember_custom_AUDCurrenryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">PPCB:AUDCurrenryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_srt_ChiefExecutiveOfficerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_srt_ChiefExecutiveOfficerMember_custom_MrsNathanielszMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:MrsNathanielszMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-08-112021-08-12_custom_MrNathanielszMember_custom_BoardOfDirectorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">PPCB:BoardOfDirectorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">PPCB:MrNathanielszMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-11</startDate>
            <endDate>2021-08-12</endDate>
        </period>
    </context>
    <context id="From2019-05-132019-05-14_custom_EmploymentAgreementMember_custom_MrNathanielszMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">PPCB:MrNathanielszMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:EmploymentAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-05-13</startDate>
            <endDate>2019-05-14</endDate>
        </period>
    </context>
    <context id="From2019-05-132019-05-14_custom_EmploymentAgreementMember_custom_MrNathanielszMember_custom_AUDCurrenryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">PPCB:AUDCurrenryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">PPCB:MrNathanielszMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:EmploymentAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-05-13</startDate>
            <endDate>2019-05-14</endDate>
        </period>
    </context>
    <context id="From2019-05-132019-05-14_custom_EmploymentAgreementMember_custom_RestrictedStocksUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">PPCB:RestrictedStocksUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:EmploymentAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-05-13</startDate>
            <endDate>2019-05-14</endDate>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_custom_EmploymentAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:EmploymentAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2019-05-132019-05-14_custom_EmploymentAgreementMember_custom_AdditionaNathanielszRSUsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">PPCB:AdditionaNathanielszRSUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:EmploymentAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-05-13</startDate>
            <endDate>2019-05-14</endDate>
        </period>
    </context>
    <context id="From2019-05-132019-05-14_custom_ServicesAgreementMember_custom_DrKenyonMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">PPCB:DrKenyonMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:ServicesAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-05-13</startDate>
            <endDate>2019-05-14</endDate>
        </period>
    </context>
    <context id="From2019-05-132019-05-14_custom_ServicesAgreementMember_custom_DrKenyonMemberMember_custom_AUDCurrenryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">PPCB:AUDCurrenryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">PPCB:DrKenyonMemberMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:ServicesAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-05-13</startDate>
            <endDate>2019-05-14</endDate>
        </period>
    </context>
    <context id="From2019-05-132019-05-14_custom_ServicesAgreementMember_custom_InitialKenyonRSUsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">PPCB:InitialKenyonRSUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:ServicesAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-05-13</startDate>
            <endDate>2019-05-14</endDate>
        </period>
    </context>
    <context id="From2019-05-132019-05-14_custom_ServicesAgreementMember_custom_AdditionalKenyonRSUsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">PPCB:AdditionalKenyonRSUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:ServicesAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-05-13</startDate>
            <endDate>2019-05-14</endDate>
        </period>
    </context>
    <context id="AsOf2021-06-30_custom_AUDCurrenryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">PPCB:AUDCurrenryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_custom_ServicesAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:ServicesAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2021-08-12_custom_ServicesAgreementMember_custom_DrKenyonMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">PPCB:DrKenyonMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:ServicesAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-12</instant>
        </period>
    </context>
    <context id="From2021-08-112021-08-12_custom_ServicesAgreementMember_custom_DrKenyonMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">PPCB:DrKenyonMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:ServicesAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-11</startDate>
            <endDate>2021-08-12</endDate>
        </period>
    </context>
    <context id="From2019-07-012020-06-30_custom_LenderOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">PPCB:LenderOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="From2019-07-012020-06-30_custom_LenderTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">PPCB:LenderTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="From2019-07-012020-06-30_custom_LenderThreeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">PPCB:LenderThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2020-06-30_custom_LenderOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">PPCB:LenderOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30_custom_LenderTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">PPCB:LenderTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30_custom_LenderThreeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">PPCB:LenderThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_custom_LenderOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">PPCB:LenderOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_custom_LenderTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">PPCB:LenderTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2021-06-30_custom_LenderOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">PPCB:LenderOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_custom_LenderTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">PPCB:LenderTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_ConvertibleDebtMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30_us-gaap_ConvertibleDebtMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30_us-gaap_MeasurementInputPriceVolatilityMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30_us-gaap_MeasurementInputPriceVolatilityMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_MeasurementInputPriceVolatilityMember_us-gaap_ConvertibleDebtMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30_us-gaap_MeasurementInputPriceVolatilityMember_us-gaap_ConvertibleDebtMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="From2019-07-012020-06-30_us-gaap_MeasurementInputExpectedTermMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_us-gaap_MeasurementInputExpectedTermMember_us-gaap_ConvertibleDebtMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2019-07-012020-06-30_us-gaap_MeasurementInputExpectedTermMember_us-gaap_ConvertibleDebtMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="From2019-07-012020-06-30_us-gaap_MeasurementInputExpectedTermMember_us-gaap_ConvertibleDebtMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2020-06-30_us-gaap_MeasurementInputRiskFreeInterestRateMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30_us-gaap_MeasurementInputRiskFreeInterestRateMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_MeasurementInputRiskFreeInterestRateMember_us-gaap_ConvertibleDebtMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30_us-gaap_MeasurementInputRiskFreeInterestRateMember_us-gaap_ConvertibleDebtMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30_us-gaap_MeasurementInputRiskFreeInterestRateMember_us-gaap_ConvertibleDebtMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30_us-gaap_MeasurementInputExpectedDividendRateMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_MeasurementInputExpectedDividendRateMember_us-gaap_ConvertibleDebtMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30_us-gaap_MeasurementInputExpectedDividendRateMember_us-gaap_ConvertibleDebtMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_FairValueInputsLevel1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_FairValueInputsLevel2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_FairValueInputsLevel3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30_us-gaap_FairValueInputsLevel1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30_us-gaap_FairValueInputsLevel2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30_us-gaap_FairValueInputsLevel3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="From2021-07-092021-09-07_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-09</startDate>
            <endDate>2021-09-07</endDate>
        </period>
    </context>
    <context id="From2021-07-092021-09-07_us-gaap_SubsequentEventMember_custom_SeriesBWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">PPCB:SeriesBWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-09</startDate>
            <endDate>2021-09-07</endDate>
        </period>
    </context>
    <context id="AsOf2021-09-07_us-gaap_SubsequentEventMember_custom_SeriesBWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">PPCB:SeriesBWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-07</instant>
        </period>
    </context>
    <context id="AsOf2021-09-07_us-gaap_SubsequentEventMember_custom_TwelveSeriesAAndAWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">PPCB:TwelveSeriesAAndAWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-07</instant>
        </period>
    </context>
    <context id="From2021-07-012021-09-20_us-gaap_SubsequentEventMember_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-20</endDate>
        </period>
    </context>
    <context id="AsOf2021-09-20_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-20</instant>
        </period>
    </context>
    <context id="AsOf2021-09-20_us-gaap_SubsequentEventMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-20</instant>
        </period>
    </context>
    <context id="AsOf2021-09-20_us-gaap_SubsequentEventMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-20</instant>
        </period>
    </context>
    <context id="AsOf2021-09-23_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-23</instant>
        </period>
    </context>
    <context id="From2021-08-112021-08-12_us-gaap_SubsequentEventMember_custom_NathanielszCancellationAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:NathanielszCancellationAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-11</startDate>
            <endDate>2021-08-12</endDate>
        </period>
    </context>
    <context id="From2021-07-192021-07-20_us-gaap_SubsequentEventMember_custom_MrNathanielszMember_custom_NathanielszCancellationAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">PPCB:MrNathanielszMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:NathanielszCancellationAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-19</startDate>
            <endDate>2021-07-20</endDate>
        </period>
    </context>
    <context id="From2021-08-162021-08-17_us-gaap_SubsequentEventMember_custom_MrNathanielszMember_custom_NathanielszCancellationAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">PPCB:MrNathanielszMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:NathanielszCancellationAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-16</startDate>
            <endDate>2021-08-17</endDate>
        </period>
    </context>
    <context id="AsOf2021-08-17_us-gaap_SubsequentEventMember_custom_MrNathanielszMember_custom_NathanielszCancellationAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">PPCB:MrNathanielszMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:NathanielszCancellationAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-17</instant>
        </period>
    </context>
    <context id="AsOf2021-08-12_custom_KenyonCancellationAgreementMember_custom_DrKenyonMember_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">PPCB:DrKenyonMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:KenyonCancellationAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-12</instant>
        </period>
    </context>
    <context id="From2021-08-112021-08-12_custom_KenyonCancellationAgreementMember_custom_DrKenyonMember_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">PPCB:DrKenyonMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:KenyonCancellationAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-11</startDate>
            <endDate>2021-08-12</endDate>
        </period>
    </context>
    <context id="From2021-08-112021-08-12_custom_ZelingerAmendedAndRestatedDirectorAgreementMember_custom_JosefZelingerMember_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">PPCB:JosefZelingerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:ZelingerAmendedAndRestatedDirectorAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-11</startDate>
            <endDate>2021-08-12</endDate>
        </period>
    </context>
    <context id="AsOf2021-06-30_custom_ZelingerAmendedAndRestatedDirectorAgreementMember_custom_JosefZelingerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">PPCB:JosefZelingerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:ZelingerAmendedAndRestatedDirectorAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_custom_ZelingerAmendedAndRestatedDirectorAgreementMember_custom_JosefZelingerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">PPCB:JosefZelingerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:ZelingerAmendedAndRestatedDirectorAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2021-08-12_us-gaap_SubsequentEventMember_custom_CommonStockOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">PPCB:CommonStockOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-12</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_custom_CommonStockOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">PPCB:CommonStockOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="From2021-08-112021-08-12_us-gaap_SubsequentEventMember_custom_CommonStockOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">PPCB:CommonStockOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-11</startDate>
            <endDate>2021-08-12</endDate>
        </period>
    </context>
    <context id="AsOf2021-08-12_us-gaap_SubsequentEventMember_custom_CommonStockTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">PPCB:CommonStockTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-12</instant>
        </period>
    </context>
    <context id="From2021-08-112021-08-12_us-gaap_SubsequentEventMember_custom_CommonStockTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">PPCB:CommonStockTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-11</startDate>
            <endDate>2021-08-12</endDate>
        </period>
    </context>
    <context id="AsOf2021-09-30_us-gaap_SubsequentEventMember_custom_CommonStockThreeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">PPCB:CommonStockThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="From2021-09-012021-09-30_us-gaap_SubsequentEventMember_custom_CommonStockThreeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">PPCB:CommonStockThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2021-08-19_us-gaap_SubsequentEventMember_custom_TwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:TwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-19</instant>
        </period>
    </context>
    <context id="From2021-08-182021-08-19_us-gaap_SubsequentEventMember_custom_TwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:TwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-18</startDate>
            <endDate>2021-08-19</endDate>
        </period>
    </context>
    <context id="AsOf2021-09-22_us-gaap_SubsequentEventMember_custom_TwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:TwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-22</instant>
        </period>
    </context>
    <context id="From2021-09-212021-09-22_us-gaap_SubsequentEventMember_custom_TwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:TwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-21</startDate>
            <endDate>2021-09-22</endDate>
        </period>
    </context>
    <context id="AsOf2021-09-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30_us-gaap_SeriesAPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30_us-gaap_SeriesBPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="From2020-07-012020-09-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2020-06-30_custom_SubscriptionReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">PPCB:SubscriptionReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="From2020-07-012020-09-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012020-09-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012020-09-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012020-09-30_custom_CommonStockIssuableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">PPCB:CommonStockIssuableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012020-09-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012020-09-30_custom_SubscriptionReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">PPCB:SubscriptionReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012020-09-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012020-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012020-09-30_us-gaap_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2020-09-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="AsOf2020-09-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="AsOf2020-09-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="AsOf2020-09-30_custom_CommonStockIssuableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">PPCB:CommonStockIssuableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="AsOf2020-09-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="AsOf2020-09-30_custom_SubscriptionReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">PPCB:SubscriptionReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="AsOf2020-09-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="AsOf2020-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="AsOf2020-09-30_us-gaap_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_custom_SubscriptionReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">PPCB:SubscriptionReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_custom_CommonStockIssuableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">PPCB:CommonStockIssuableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_custom_SubscriptionReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">PPCB:SubscriptionReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_us-gaap_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2021-09-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30_custom_CommonStockIssuableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">PPCB:CommonStockIssuableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30_custom_SubscriptionReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">PPCB:SubscriptionReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30_us-gaap_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_custom_IntercompanyLoansMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:IntercompanyLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012020-09-30_custom_IntercompanyLoansMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:IntercompanyLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2021-09-30_srt_WeightedAverageMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_us-gaap_MachineryAndEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_us-gaap_FurnitureAndFixturesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2021-08-19_custom_TwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:TwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-19</instant>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_us-gaap_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012020-09-30_us-gaap_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_us-gaap_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012020-09-30_us-gaap_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_custom_UnvestedRestrictedStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">PPCB:UnvestedRestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012020-09-30_custom_UnvestedRestrictedStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">PPCB:UnvestedRestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_us-gaap_ConvertibleDebtSecuritiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012020-09-30_us-gaap_ConvertibleDebtSecuritiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2021-09-30_custom_DirectorsAndOfficerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">PPCB:DirectorsAndOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember_custom_SettlementAndMutualReleaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">PPCB:SettlementAndMutualReleaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:AugustTenTwoThousandAndSeventeenConsultingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2019-06-30_custom_AuctusFinancingAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:AuctusFinancingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_custom_AuctusFinancingAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:AuctusFinancingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:AugustTwoThousandNineteenAuctusNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:AuctusFundLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:AugustTwoThousandNineteenAuctusNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:AuctusFundLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2021-09-30_custom_AuctusFinancingAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:AuctusFinancingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:AugustTwoThousandNineteenAuctusNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:AuctusFundLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:AugustTwoThousandNineteenAuctusNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:AuctusFundLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2021-09-30_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:AugustTwoThousandNineteenAuctusNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:AuctusFundLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30_custom_SecuritiesPurchaseAgreementMember_custom_CrownBridgePartnersLLCMember_custom_OctoberThreeTwoThousandNineteenAuctusNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:OctoberThreeTwoThousandNineteenAuctusNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:CrownBridgePartnersLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2020-12-10_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:GWHoldingsGroupLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-10</instant>
        </period>
    </context>
    <context id="AsOf2020-09-30_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember_custom_DecemberTenTwoThousandTwentyGWNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:DecemberTenTwoThousandTwentyGWNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:GWHoldingsGroupLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember_custom_DecemberTenTwoThousandTwentyGWNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:DecemberTenTwoThousandTwentyGWNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:GWHoldingsGroupLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30_custom_SecuritiesPurchaseAgreementMember_custom_DecemberTenTwoThousandTwentyGWNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:DecemberTenTwoThousandTwentyGWNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2020-12-02_custom_SecuritiesPurchaseAgreementMember_custom_JanuaryFiveTwoThousandTwentyOneGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:JanuaryFiveTwoThousandTwentyOneGenevaRothMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:GenevaRothRemarkHoldingsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-02</instant>
        </period>
    </context>
    <context id="From2021-03-152021-03-16_custom_SecuritiesPurchaseAgreementMember_custom_MarchSixteenTwoThousandTwentyOneGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:MarchSixteenTwoThousandTwentyOneGenevaRothMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:GenevaRothRemarkHoldingsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-15</startDate>
            <endDate>2021-03-16</endDate>
        </period>
    </context>
    <context id="AsOf2021-08-19_custom_SecuritiesPurchaseAgreementMember_custom_AugustNineteenTwoThousandTwentyOneGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:AugustNineteenTwoThousandTwentyOneGenevaRothMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:GenevaRothRemarkHoldingsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-19</instant>
        </period>
    </context>
    <context id="From2021-08-182021-08-19_custom_SecuritiesPurchaseAgreementMember_custom_AugustNineteenTwoThousandTwentyOneGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:AugustNineteenTwoThousandTwentyOneGenevaRothMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:GenevaRothRemarkHoldingsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-18</startDate>
            <endDate>2021-08-19</endDate>
        </period>
    </context>
    <context id="AsOf2021-09-22_custom_SecuritiesPurchaseAgreementMember_custom_SeptemberTwentyTwoTwoThousandTwentyOneGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:SeptemberTwentyTwoTwoThousandTwentyOneGenevaRothMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:GenevaRothRemarkHoldingsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-22</instant>
        </period>
    </context>
    <context id="From2021-09-212021-09-22_custom_SecuritiesPurchaseAgreementMember_custom_SeptemberTwentyTwoTwoThousandTwentyOneGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:SeptemberTwentyTwoTwoThousandTwentyOneGenevaRothMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:GenevaRothRemarkHoldingsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-21</startDate>
            <endDate>2021-09-22</endDate>
        </period>
    </context>
    <context id="From2021-09-212021-09-22_custom_SecuritiesPurchaseAgreementMember_custom_SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:GenevaRothRemarkHoldingsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-21</startDate>
            <endDate>2021-09-22</endDate>
        </period>
    </context>
    <context id="From2021-09-212021-09-22_custom_SecuritiesPurchaseAgreementMember_custom_SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:GenevaRothRemarkHoldingsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-21</startDate>
            <endDate>2021-09-22</endDate>
        </period>
    </context>
    <context id="From2021-09-212021-09-22_custom_SecuritiesPurchaseAgreementMember_custom_SeptemberTwentyTwoTwoThousandTwentyOneGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:SeptemberTwentyTwoTwoThousandTwentyOneGenevaRothMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:GenevaRothRemarkHoldingsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-21</startDate>
            <endDate>2021-09-22</endDate>
        </period>
    </context>
    <context id="AsOf2021-09-22_custom_SecuritiesPurchaseAgreementMember_custom_SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:GenevaRothRemarkHoldingsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-22</instant>
        </period>
    </context>
    <context id="From2021-09-212021-09-22_custom_SecuritiesPurchaseAgreementMember_custom_SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:GenevaRothRemarkHoldingsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-21</startDate>
            <endDate>2021-09-22</endDate>
        </period>
    </context>
    <context id="AsOf2021-06-30_custom_GenevaRothFinancingAgreementAgreementMember_custom_SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:GenevaRothFinancingAgreementAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:GenevaRothRemarkHoldingsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_custom_GenevaRothFinancingAgreementAgreementMember_custom_SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:GenevaRothFinancingAgreementAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_custom_SecuritiesPurchaseAgreementMember_custom_SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30_custom_GenevaRothFinancingAgreementAgreementMember_custom_SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:GenevaRothFinancingAgreementAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:GenevaRothRemarkHoldingsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30_custom_GenevaRothFinancingAgreementAgreementMember_custom_SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PPCB:SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:GenevaRothFinancingAgreementAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_custom_SecuritiesPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012020-09-30_custom_SecuritiesPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2021-09-30_custom_SecuritiesPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2020-09-30_custom_SecuritiesPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="AsOf2020-09-30_us-gaap_SeriesAPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_custom_SecurityPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecurityPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2021-09-30_custom_SecurityPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecurityPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30_custom_SecurityPurchaseAgreementMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecurityPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30_custom_SecurityPurchaseAgreementMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:SecurityPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_custom_UnderlyingFinancingAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:UnderlyingFinancingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2021-08-112021-08-12_custom_CommonStockOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">PPCB:CommonStockOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-11</startDate>
            <endDate>2021-08-12</endDate>
        </period>
    </context>
    <context id="AsOf2021-08-12_custom_CommonStockOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">PPCB:CommonStockOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-12</instant>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_custom_CommonStockOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">PPCB:CommonStockOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2021-08-112021-08-12_custom_LegalServicesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">PPCB:LegalServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-11</startDate>
            <endDate>2021-08-12</endDate>
        </period>
    </context>
    <context id="AsOf2021-08-12_custom_LegalServicesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">PPCB:LegalServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-12</instant>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_custom_LegalServicesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">PPCB:LegalServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2021-09-292021-09-30_custom_ConsultantServicesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">PPCB:ConsultantServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-29</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2021-08-12_custom_ConsultantServicesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">PPCB:ConsultantServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-12</instant>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_custom_ConsultantServicesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">PPCB:ConsultantServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2021-08-112021-08-12_custom_NathanielszCancellationAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:NathanielszCancellationAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-11</startDate>
            <endDate>2021-08-12</endDate>
        </period>
    </context>
    <context id="From2021-07-192021-07-20_custom_MrNathanielszMember_custom_NathanielszCancellationAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">PPCB:MrNathanielszMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:NathanielszCancellationAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-19</startDate>
            <endDate>2021-07-20</endDate>
        </period>
    </context>
    <context id="From2021-08-162021-08-17_custom_MrNathanielszMember_custom_NathanielszCancellationAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">PPCB:MrNathanielszMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:NathanielszCancellationAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-16</startDate>
            <endDate>2021-08-17</endDate>
        </period>
    </context>
    <context id="AsOf2021-08-17_custom_MrNathanielszMember_custom_NathanielszCancellationAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">PPCB:MrNathanielszMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:NathanielszCancellationAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-17</instant>
        </period>
    </context>
    <context id="From2021-08-112021-08-12_custom_MrNathanielszMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">PPCB:MrNathanielszMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-11</startDate>
            <endDate>2021-08-12</endDate>
        </period>
    </context>
    <context id="AsOf2021-08-12_custom_DeferredSalaryMember_custom_CancellationAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis">PPCB:DeferredSalaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:CancellationAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-12</instant>
        </period>
    </context>
    <context id="From2021-08-112021-08-12_custom_ChiefScientificOfficerandDirectorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">PPCB:ChiefScientificOfficerandDirectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-11</startDate>
            <endDate>2021-08-12</endDate>
        </period>
    </context>
    <context id="AsOf2021-08-12_custom_ChiefScientificOfficerandDirectorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">PPCB:ChiefScientificOfficerandDirectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-12</instant>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_custom_ChiefScientificOfficerandDirectorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">PPCB:ChiefScientificOfficerandDirectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2021-08-112021-08-12_custom_ZelingerAmendedAndRestatedDirectorAgreementMember_custom_JosefZelingerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">PPCB:JosefZelingerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:ZelingerAmendedAndRestatedDirectorAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-11</startDate>
            <endDate>2021-08-12</endDate>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_custom_ZelingerAmendedAndRestatedDirectorAgreementMember_custom_JosefZelingerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">PPCB:JosefZelingerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:ZelingerAmendedAndRestatedDirectorAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2021-07-062021-09-27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
        </entity>
        <period>
            <startDate>2021-07-06</startDate>
            <endDate>2021-09-27</endDate>
        </period>
    </context>
    <context id="AsOf2021-09-27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
        </entity>
        <period>
            <instant>2021-09-27</instant>
        </period>
    </context>
    <context id="From2021-07-062021-09-27_custom_SeriesBWarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">PPCB:SeriesBWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-06</startDate>
            <endDate>2021-09-27</endDate>
        </period>
    </context>
    <context id="AsOf2021-09-27_custom_SeriesBWarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">PPCB:SeriesBWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-27</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30_custom_SeriesBWarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">PPCB:SeriesBWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2021-10-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="AsOf2021-03-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_custom_From2012ThroughThe2014Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">PPCB:From2012ThroughThe2014Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2021-09-30_custom_CurrentAndFormerDirectorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">PPCB:CurrentAndFormerDirectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30_custom_FormerDirectorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">PPCB:FormerDirectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="From2021-05-032021-05-06_custom_NorthHorizonPtyLtdMember_custom_AUDCurrencyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">PPCB:AUDCurrencyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:NorthHorizonPtyLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-03</startDate>
            <endDate>2021-05-06</endDate>
        </period>
    </context>
    <context id="From2021-05-052021-05-06_custom_NorthHorizonPtyLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:NorthHorizonPtyLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-05</startDate>
            <endDate>2021-05-06</endDate>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_custom_NorthHorizonPtyLtdMember_custom_AUDCurrencyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">PPCB:AUDCurrencyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:NorthHorizonPtyLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012021-09-30_custom_NorthHorizonPtyLtdMember_custom_AUDCurrencyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">PPCB:AUDCurrencyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:NorthHorizonPtyLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_custom_NorthHorizonPtyLtdMember_custom_AUDCurrenryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">PPCB:AUDCurrenryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:NorthHorizonPtyLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_custom_NorthHorizonPtyLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">PPCB:NorthHorizonPtyLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_custom_MrsNathanielszMember_custom_AUDCurrenryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">PPCB:AUDCurrenryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">PPCB:MrsNathanielszMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_custom_MrsNathanielszMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">PPCB:MrsNathanielszMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_srt_ChiefExecutiveOfficerMember_custom_AUDCurrenryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">PPCB:AUDCurrenryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_srt_ChiefExecutiveOfficerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_custom_EmploymentAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:EmploymentAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_custom_ServicesAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:ServicesAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2021-09-30_custom_AUDCurrenryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">PPCB:AUDCurrenryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30_us-gaap_ConvertibleDebtMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30_us-gaap_MeasurementInputPriceVolatilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30_us-gaap_MeasurementInputPriceVolatilityMember_us-gaap_ConvertibleDebtMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_us-gaap_MeasurementInputExpectedTermMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_us-gaap_MeasurementInputExpectedTermMember_us-gaap_ConvertibleDebtMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2021-09-30_us-gaap_MeasurementInputRiskFreeInterestRateMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30_us-gaap_MeasurementInputRiskFreeInterestRateMember_us-gaap_ConvertibleDebtMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30_us-gaap_MeasurementInputExpectedDividendRateMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30_us-gaap_MeasurementInputExpectedDividendRateMember_us-gaap_ConvertibleDebtMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30_us-gaap_FairValueInputsLevel1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30_us-gaap_FairValueInputsLevel2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30_us-gaap_FairValueInputsLevel3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2021-10-31_us-gaap_SubsequentEventMember_custom_ElevenSeriesAWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">PPCB:ElevenSeriesAWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="From2021-10-012021-10-31_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-10-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-10-31_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="From2021-10-192021-10-21_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-19</startDate>
            <endDate>2021-10-21</endDate>
        </period>
    </context>
    <context id="AsOf2021-10-21_us-gaap_SubsequentEventMember_custom_OctoberTwentyOneTwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:OctoberTwentyOneTwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-21</instant>
        </period>
    </context>
    <context id="From2021-10-192021-10-21_us-gaap_SubsequentEventMember_custom_OctoberTwentyOneTwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001517681</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PPCB:OctoberTwentyOneTwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-19</startDate>
            <endDate>2021-10-21</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Pure">
        <measure>pure</measure>
    </unit>
    <unit id="Integer">
        <measure>PPCB:Integer</measure>
    </unit>
    <unit id="Euro">
        <measure>iso4217:EUR</measure>
    </unit>
    <unit id="AUD">
        <measure>iso4217:AUD</measure>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2021-07-01to2021-09-30">0001517681</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2021-07-01to2021-09-30">true</dei:AmendmentFlag>
    <dei:DocumentType contextRef="From2021-07-01to2021-09-30">POS AM</dei:DocumentType>
    <dei:AmendmentDescription contextRef="From2021-07-01to2021-09-30">Post-Effective Amendment Number 1</dei:AmendmentDescription>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="AsOf2021-06-30"
      id="xdx2ixbrl0043"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="AsOf2021-06-30"
      id="xdx2ixbrl0055"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="AsOf2021-06-30"
      id="xdx2ixbrl0079"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="AsOf2021-06-30"
      id="xdx2ixbrl0100"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2021-06-30_us-gaap_SeriesBPreferredStockMember"
      id="xdx2ixbrl0133"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2020-06-30_us-gaap_SeriesBPreferredStockMember"
      id="xdx2ixbrl0134"
      unitRef="USD"
      xsi:nil="true"/>
    <PPCB:CommonStockIssuable
      contextRef="AsOf2021-06-30"
      id="xdx2ixbrl0174"
      unitRef="USD"
      xsi:nil="true"/>
    <PPCB:CommonStockIssuable
      contextRef="AsOf2020-06-30"
      id="xdx2ixbrl0175"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquityNoteSubscriptionsReceivable
      contextRef="AsOf2021-06-30"
      id="xdx2ixbrl0184"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquityNoteSubscriptionsReceivable
      contextRef="AsOf2020-06-30"
      id="xdx2ixbrl0185"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2020-07-012021-06-30"
      id="xdx2ixbrl0209"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2019-07-012020-06-30"
      id="xdx2ixbrl0210"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherIncome
      contextRef="From2020-07-012021-06-30"
      id="xdx2ixbrl0239"
      unitRef="USD"
      xsi:nil="true"/>
    <PPCB:GainFromSettlementOfDebtNet
      contextRef="From2019-07-012020-06-30"
      id="xdx2ixbrl0246"
      unitRef="USD"
      xsi:nil="true"/>
    <PPCB:DeemedDividend
      contextRef="From2019-07-012020-06-30"
      id="xdx2ixbrl0267"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2019-06-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0294"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2019-06-30_custom_CommonStockIssuableMember"
      id="xdx2ixbrl0296"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2019-06-30_custom_CommonStockIssuableMember"
      id="xdx2ixbrl0309"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2019-07-012020-06-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0311"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2019-07-012020-06-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0312"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2019-07-012020-06-30_custom_CommonStockIssuableMember"
      id="xdx2ixbrl0314"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2019-07-012020-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0316"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2019-07-012020-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0317"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2019-07-012020-06-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0318"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2019-07-012020-06-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0323"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2019-07-012020-06-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0324"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2019-07-012020-06-30_custom_CommonStockIssuableMember"
      id="xdx2ixbrl0326"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2019-07-012020-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0328"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2019-07-012020-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0329"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2019-07-012020-06-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0330"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="From2019-07-012020-06-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0333"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="From2019-07-012020-06-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0335"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="From2019-07-012020-06-30_custom_CommonStockIssuableMember"
      id="xdx2ixbrl0339"
      unitRef="Shares"
      xsi:nil="true"/>
    <PPCB:AdjustmentsToAdditionalPaidInCapitalReclassificationOfPremiumUponDebtConversion
      contextRef="From2019-07-012020-06-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0481"
      unitRef="USD"
      xsi:nil="true"/>
    <PPCB:AdjustmentsToAdditionalPaidInCapitalReclassificationOfPremiumUponDebtConversion
      contextRef="From2019-07-012020-06-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0482"
      unitRef="USD"
      xsi:nil="true"/>
    <PPCB:AdjustmentsToAdditionalPaidInCapitalReclassificationOfPremiumUponDebtConversion
      contextRef="From2019-07-012020-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0483"
      unitRef="USD"
      xsi:nil="true"/>
    <PPCB:AdjustmentsToAdditionalPaidInCapitalReclassificationOfPremiumUponDebtConversion
      contextRef="From2019-07-012020-06-30_custom_CommonStockIssuableMember"
      id="xdx2ixbrl0484"
      unitRef="USD"
      xsi:nil="true"/>
    <PPCB:AdjustmentsToAdditionalPaidInCapitalReclassificationOfPremiumUponDebtConversion
      contextRef="From2019-07-012020-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0486"
      unitRef="USD"
      xsi:nil="true"/>
    <PPCB:AdjustmentsToAdditionalPaidInCapitalReclassificationOfPremiumUponDebtConversion
      contextRef="From2019-07-012020-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0487"
      unitRef="USD"
      xsi:nil="true"/>
    <PPCB:AdjustmentsToAdditionalPaidInCapitalReclassificationOfPremiumUponDebtConversion
      contextRef="From2019-07-012020-06-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0488"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2019-07-012020-06-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0491"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2019-07-012020-06-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0492"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2019-07-012020-06-30_custom_CommonStockIssuableMember"
      id="xdx2ixbrl0494"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2019-07-012020-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0496"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2019-07-012020-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0497"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2019-07-012020-06-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0498"
      unitRef="USD"
      xsi:nil="true"/>
    <PPCB:RelativeFairValueOfWarrantsIssuedWithConvertibleDebt
      contextRef="From2019-07-012020-06-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0503"
      unitRef="USD"
      xsi:nil="true"/>
    <PPCB:RelativeFairValueOfWarrantsIssuedWithConvertibleDebt
      contextRef="From2019-07-012020-06-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0504"
      unitRef="USD"
      xsi:nil="true"/>
    <PPCB:RelativeFairValueOfWarrantsIssuedWithConvertibleDebt
      contextRef="From2019-07-012020-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0505"
      unitRef="USD"
      xsi:nil="true"/>
    <PPCB:RelativeFairValueOfWarrantsIssuedWithConvertibleDebt
      contextRef="From2019-07-012020-06-30_custom_CommonStockIssuableMember"
      id="xdx2ixbrl0506"
      unitRef="USD"
      xsi:nil="true"/>
    <PPCB:RelativeFairValueOfWarrantsIssuedWithConvertibleDebt
      contextRef="From2019-07-012020-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0508"
      unitRef="USD"
      xsi:nil="true"/>
    <PPCB:RelativeFairValueOfWarrantsIssuedWithConvertibleDebt
      contextRef="From2019-07-012020-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0509"
      unitRef="USD"
      xsi:nil="true"/>
    <PPCB:RelativeFairValueOfWarrantsIssuedWithConvertibleDebt
      contextRef="From2019-07-012020-06-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0510"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2019-07-012020-06-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0513"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2019-07-012020-06-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0514"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2019-07-012020-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0515"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2019-07-012020-06-30_custom_CommonStockIssuableMember"
      id="xdx2ixbrl0516"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2019-07-012020-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0518"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2019-07-012020-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0519"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2019-07-012020-06-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0520"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="From2019-07-012020-06-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0523"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="From2019-07-012020-06-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0524"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="From2019-07-012020-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0525"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="From2019-07-012020-06-30_custom_CommonStockIssuableMember"
      id="xdx2ixbrl0526"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="From2019-07-012020-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0528"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="From2019-07-012020-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0529"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="From2019-07-012020-06-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0530"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="From2019-07-012020-06-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0533"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="From2019-07-012020-06-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0534"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="From2019-07-012020-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0535"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="From2019-07-012020-06-30_custom_CommonStockIssuableMember"
      id="xdx2ixbrl0536"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="From2019-07-012020-06-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0537"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="From2019-07-012020-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0538"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2019-07-012020-06-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0543"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2019-07-012020-06-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0544"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2019-07-012020-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0545"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2019-07-012020-06-30_custom_CommonStockIssuableMember"
      id="xdx2ixbrl0546"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2019-07-012020-06-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0547"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2019-07-012020-06-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0550"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-06-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0554"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-06-30_custom_CommonStockIssuableMember"
      id="xdx2ixbrl0556"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2020-06-30_custom_CommonStockIssuableMember"
      id="xdx2ixbrl0569"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2020-07-012021-06-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0571"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2020-07-012021-06-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0572"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2020-07-012021-06-30_custom_CommonStockIssuableMember"
      id="xdx2ixbrl0574"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2020-07-012021-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0576"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2020-07-012021-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0577"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2020-07-012021-06-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0578"
      unitRef="USD"
      xsi:nil="true"/>
    <PPCB:ReversalOfCommonStockIssuableDueToCancellationOfConversionsOfConvertibleDebtAndAccruedInterest
      contextRef="From2020-07-012021-06-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0583"
      unitRef="USD"
      xsi:nil="true"/>
    <PPCB:ReversalOfCommonStockIssuableDueToCancellationOfConversionsOfConvertibleDebtAndAccruedInterest
      contextRef="From2020-07-012021-06-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0584"
      unitRef="USD"
      xsi:nil="true"/>
    <PPCB:ReversalOfCommonStockIssuableDueToCancellationOfConversionsOfConvertibleDebtAndAccruedInterest
      contextRef="From2020-07-012021-06-30_custom_CommonStockIssuableMember"
      id="xdx2ixbrl0586"
      unitRef="USD"
      xsi:nil="true"/>
    <PPCB:ReversalOfCommonStockIssuableDueToCancellationOfConversionsOfConvertibleDebtAndAccruedInterest
      contextRef="From2020-07-012021-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0588"
      unitRef="USD"
      xsi:nil="true"/>
    <PPCB:ReversalOfCommonStockIssuableDueToCancellationOfConversionsOfConvertibleDebtAndAccruedInterest
      contextRef="From2020-07-012021-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0589"
      unitRef="USD"
      xsi:nil="true"/>
    <PPCB:ReversalOfCommonStockIssuableDueToCancellationOfConversionsOfConvertibleDebtAndAccruedInterest
      contextRef="From2020-07-012021-06-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0590"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
      contextRef="From2020-07-012021-06-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0595"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
      contextRef="From2020-07-012021-06-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0596"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
      contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0597"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
      contextRef="From2020-07-012021-06-30_custom_CommonStockIssuableMember"
      id="xdx2ixbrl0598"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
      contextRef="From2020-07-012021-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0600"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
      contextRef="From2020-07-012021-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0601"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
      contextRef="From2020-07-012021-06-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0602"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2020-07-012021-06-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0605"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2020-07-012021-06-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0606"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2020-07-012021-06-30_custom_CommonStockIssuableMember"
      id="xdx2ixbrl0608"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2020-07-012021-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0610"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2020-07-012021-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0611"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2020-07-012021-06-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0612"
      unitRef="USD"
      xsi:nil="true"/>
    <PPCB:StockIssuedDuringPeriodValueExerciseOfWarrants
      contextRef="From2020-07-012021-06-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0617"
      unitRef="USD"
      xsi:nil="true"/>
    <PPCB:StockIssuedDuringPeriodValueExerciseOfWarrants
      contextRef="From2020-07-012021-06-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0618"
      unitRef="USD"
      xsi:nil="true"/>
    <PPCB:StockIssuedDuringPeriodValueExerciseOfWarrants
      contextRef="From2020-07-012021-06-30_custom_CommonStockIssuableMember"
      id="xdx2ixbrl0620"
      unitRef="USD"
      xsi:nil="true"/>
    <PPCB:StockIssuedDuringPeriodValueExerciseOfWarrants
      contextRef="From2020-07-012021-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0622"
      unitRef="USD"
      xsi:nil="true"/>
    <PPCB:StockIssuedDuringPeriodValueExerciseOfWarrants
      contextRef="From2020-07-012021-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0623"
      unitRef="USD"
      xsi:nil="true"/>
    <PPCB:StockIssuedDuringPeriodValueExerciseOfWarrants
      contextRef="From2020-07-012021-06-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0624"
      unitRef="USD"
      xsi:nil="true"/>
    <PPCB:IssuanceOfCommonStockForCashlessExerciseOfWarrants
      contextRef="From2020-07-012021-06-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0629"
      unitRef="USD"
      xsi:nil="true"/>
    <PPCB:IssuanceOfCommonStockForCashlessExerciseOfWarrants
      contextRef="From2020-07-012021-06-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0630"
      unitRef="USD"
      xsi:nil="true"/>
    <PPCB:IssuanceOfCommonStockForCashlessExerciseOfWarrants
      contextRef="From2020-07-012021-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0634"
      unitRef="USD"
      xsi:nil="true"/>
    <PPCB:IssuanceOfCommonStockForCashlessExerciseOfWarrants
      contextRef="From2020-07-012021-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0635"
      unitRef="USD"
      xsi:nil="true"/>
    <PPCB:IssuanceOfCommonStockForCashlessExerciseOfWarrants
      contextRef="From2020-07-012021-06-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0636"
      unitRef="USD"
      xsi:nil="true"/>
    <PPCB:IssuanceOfCommonStockForCashlessExerciseOfWarrants
      contextRef="From2020-07-012021-06-30"
      id="xdx2ixbrl0637"
      unitRef="USD"
      xsi:nil="true"/>
    <PPCB:DeemedDividendUponAlternateCashlessExerciseOfWarrants
      contextRef="From2020-07-012021-06-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0641"
      unitRef="USD"
      xsi:nil="true"/>
    <PPCB:DeemedDividendUponAlternateCashlessExerciseOfWarrants
      contextRef="From2020-07-012021-06-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0642"
      unitRef="USD"
      xsi:nil="true"/>
    <PPCB:DeemedDividendUponAlternateCashlessExerciseOfWarrants
      contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0643"
      unitRef="USD"
      xsi:nil="true"/>
    <PPCB:DeemedDividendUponAlternateCashlessExerciseOfWarrants
      contextRef="From2020-07-012021-06-30_custom_CommonStockIssuableMember"
      id="xdx2ixbrl0644"
      unitRef="USD"
      xsi:nil="true"/>
    <PPCB:DeemedDividendUponAlternateCashlessExerciseOfWarrants
      contextRef="From2020-07-012021-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0647"
      unitRef="USD"
      xsi:nil="true"/>
    <PPCB:DeemedDividendUponAlternateCashlessExerciseOfWarrants
      contextRef="From2020-07-012021-06-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0648"
      unitRef="USD"
      xsi:nil="true"/>
    <PPCB:DeemedDividendUponAlternateCashlessExerciseOfWarrants
      contextRef="From2020-07-012021-06-30"
      id="xdx2ixbrl0649"
      unitRef="USD"
      xsi:nil="true"/>
    <PPCB:AdjustmentsToAdditionalPaidInCapitalReclassificationOfPremiumUponDebtConversion
      contextRef="From2020-07-012021-06-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0651"
      unitRef="USD"
      xsi:nil="true"/>
    <PPCB:AdjustmentsToAdditionalPaidInCapitalReclassificationOfPremiumUponDebtConversion
      contextRef="From2020-07-012021-06-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0652"
      unitRef="USD"
      xsi:nil="true"/>
    <PPCB:AdjustmentsToAdditionalPaidInCapitalReclassificationOfPremiumUponDebtConversion
      contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0653"
      unitRef="USD"
      xsi:nil="true"/>
    <PPCB:AdjustmentsToAdditionalPaidInCapitalReclassificationOfPremiumUponDebtConversion
      contextRef="From2020-07-012021-06-30_custom_CommonStockIssuableMember"
      id="xdx2ixbrl0654"
      unitRef="USD"
      xsi:nil="true"/>
    <PPCB:AdjustmentsToAdditionalPaidInCapitalReclassificationOfPremiumUponDebtConversion
      contextRef="From2020-07-012021-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0656"
      unitRef="USD"
      xsi:nil="true"/>
    <PPCB:AdjustmentsToAdditionalPaidInCapitalReclassificationOfPremiumUponDebtConversion
      contextRef="From2020-07-012021-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0657"
      unitRef="USD"
      xsi:nil="true"/>
    <PPCB:AdjustmentsToAdditionalPaidInCapitalReclassificationOfPremiumUponDebtConversion
      contextRef="From2020-07-012021-06-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0658"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2020-07-012021-06-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0661"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2020-07-012021-06-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0662"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0663"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2020-07-012021-06-30_custom_CommonStockIssuableMember"
      id="xdx2ixbrl0664"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2020-07-012021-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0666"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2020-07-012021-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0667"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2020-07-012021-06-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0668"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="From2020-07-012021-06-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0671"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="From2020-07-012021-06-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0672"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0673"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="From2020-07-012021-06-30_custom_CommonStockIssuableMember"
      id="xdx2ixbrl0674"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="From2020-07-012021-06-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0675"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="From2020-07-012021-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0676"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="From2020-07-012021-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0677"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="From2020-07-012021-06-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0678"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="From2020-07-012021-06-30"
      id="xdx2ixbrl0679"
      unitRef="USD"
      xsi:nil="true"/>
    <PPCB:StockIssuedDuringPeriodValueReverseStockSplits
      contextRef="From2020-07-012021-06-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0683"
      unitRef="USD"
      xsi:nil="true"/>
    <PPCB:StockIssuedDuringPeriodValueReverseStockSplits
      contextRef="From2020-07-012021-06-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0684"
      unitRef="USD"
      xsi:nil="true"/>
    <PPCB:StockIssuedDuringPeriodValueReverseStockSplits
      contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0685"
      unitRef="USD"
      xsi:nil="true"/>
    <PPCB:StockIssuedDuringPeriodValueReverseStockSplits
      contextRef="From2020-07-012021-06-30_custom_CommonStockIssuableMember"
      id="xdx2ixbrl0686"
      unitRef="USD"
      xsi:nil="true"/>
    <PPCB:StockIssuedDuringPeriodValueReverseStockSplits
      contextRef="From2020-07-012021-06-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0687"
      unitRef="USD"
      xsi:nil="true"/>
    <PPCB:StockIssuedDuringPeriodValueReverseStockSplits
      contextRef="From2020-07-012021-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0688"
      unitRef="USD"
      xsi:nil="true"/>
    <PPCB:StockIssuedDuringPeriodValueReverseStockSplits
      contextRef="From2020-07-012021-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0689"
      unitRef="USD"
      xsi:nil="true"/>
    <PPCB:StockIssuedDuringPeriodValueReverseStockSplits
      contextRef="From2020-07-012021-06-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0690"
      unitRef="USD"
      xsi:nil="true"/>
    <PPCB:StockIssuedDuringPeriodValueReverseStockSplits
      contextRef="From2020-07-012021-06-30"
      id="xdx2ixbrl0691"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="From2020-07-012021-06-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0695"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="From2020-07-012021-06-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0696"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0697"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="From2020-07-012021-06-30_custom_CommonStockIssuableMember"
      id="xdx2ixbrl0698"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="From2020-07-012021-06-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0699"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="From2020-07-012021-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0700"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="From2020-07-012021-06-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0702"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2020-07-012021-06-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0705"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2020-07-012021-06-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0706"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0707"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2020-07-012021-06-30_custom_CommonStockIssuableMember"
      id="xdx2ixbrl0708"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2020-07-012021-06-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0709"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2020-07-012021-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0711"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2020-07-012021-06-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0712"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-06-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0716"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-06-30_custom_CommonStockIssuableMember"
      id="xdx2ixbrl0718"
      unitRef="USD"
      xsi:nil="true"/>
    <PPCB:GainFromSettlementOfDebtNet
      contextRef="From2019-07-012020-06-30"
      id="xdx2ixbrl0761"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="From2020-07-012021-06-30"
      id="xdx2ixbrl0778"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RepaymentsOfConvertibleDebt
      contextRef="From2019-07-012020-06-30"
      id="xdx2ixbrl0806"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="From2020-07-012021-06-30"
      id="xdx2ixbrl0808"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PaymentsForRepurchaseOfInitialPublicOffering
      contextRef="From2020-07-012021-06-30"
      id="xdx2ixbrl0811"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromWarrantExercises
      contextRef="From2019-07-012020-06-30"
      id="xdx2ixbrl0815"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="From2020-07-012021-06-30"
      id="xdx2ixbrl0841"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="From2019-07-012020-06-30"
      id="xdx2ixbrl0842"
      unitRef="USD"
      xsi:nil="true"/>
    <PPCB:DiscountsRelatedToWarrantsIssuedWithConvertibleNote
      contextRef="From2020-07-012021-06-30"
      id="xdx2ixbrl0853"
      unitRef="USD"
      xsi:nil="true"/>
    <PPCB:DiscountsRelatedToDerivativeLiability
      contextRef="From2020-07-012021-06-30"
      id="xdx2ixbrl0856"
      unitRef="USD"
      xsi:nil="true"/>
    <PPCB:OperatingLeaseRightofuseAssetsAndOperatingLeaseLiabilitiesRecordedUponAdoptionOfAsc842
      contextRef="From2020-07-012021-06-30"
      id="xdx2ixbrl0859"
      unitRef="USD"
      xsi:nil="true"/>
    <PPCB:ReversalOfCommonStockIssuableAndPutPremiumDueToCancellationOfConversionsOfConvertibleDebtAndAccruedInterest
      contextRef="From2019-07-012020-06-30"
      id="xdx2ixbrl0863"
      unitRef="USD"
      xsi:nil="true"/>
    <PPCB:DeemedDividendUponAlternateCashlessExerciseOfWarrants1
      contextRef="From2019-07-012020-06-30"
      id="xdx2ixbrl0866"
      unitRef="USD"
      xsi:nil="true"/>
    <PPCB:AccountsPayableReclassToConvertibleNotes
      contextRef="From2019-07-012020-06-30"
      id="xdx2ixbrl0869"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2020-07-012021-06-30"
      id="xdx2ixbrl0984"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DebtInstrumentConvertibleThresholdTradingDays
      contextRef="From2017-08-072017-08-10_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember"
      decimals="INF"
      id="xdx2ixbrl1215"
      unitRef="Integer">10</us-gaap:DebtInstrumentConvertibleThresholdTradingDays>
    <us-gaap:IncomeTaxReconciliationTaxCredits
      contextRef="From2019-07-012020-06-30_country_US"
      id="xdx2ixbrl1703"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2020-07-012021-06-30_country_US"
      id="xdx2ixbrl1708"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2019-07-012020-06-30_country_US"
      id="xdx2ixbrl1709"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="AsOf2021-06-30"
      id="xdx2ixbrl1772"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="AsOf2020-06-30"
      id="xdx2ixbrl1773"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
      contextRef="From2019-07-012020-06-30"
      id="xdx2ixbrl1968"
      unitRef="Shares"
      xsi:nil="true"/>
    <PPCB:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsIssuedInPeriodWeightedAverageExercisePrice
      contextRef="From2019-07-012020-06-30"
      id="xdx2ixbrl1970"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2019-07-012020-06-30"
      id="xdx2ixbrl1972"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="From2019-07-012020-06-30"
      id="xdx2ixbrl1974"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
      contextRef="From2019-07-012020-06-30"
      id="xdx2ixbrl1976"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="From2019-07-012020-06-30"
      id="xdx2ixbrl1978"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
      contextRef="From2020-07-012021-06-30"
      id="xdx2ixbrl1984"
      unitRef="Shares"
      xsi:nil="true"/>
    <PPCB:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsIssuedInPeriodWeightedAverageExercisePrice
      contextRef="From2020-07-012021-06-30"
      id="xdx2ixbrl1986"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2020-07-012021-06-30"
      id="xdx2ixbrl1988"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="From2020-07-012021-06-30"
      id="xdx2ixbrl1990"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <PPCB:WeightedAverageFairValueOfOptionsGrantedDuringPeriod
      contextRef="From2020-07-012021-06-30"
      id="xdx2ixbrl2006"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="AsOf2021-06-30"
      id="xdx2ixbrl2008"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="AsOf2019-06-30"
      id="xdx2ixbrl2022"
      unitRef="Shares"
      xsi:nil="true"/>
    <PPCB:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageOutstanding
      contextRef="AsOf2019-06-30"
      id="xdx2ixbrl2024"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
      contextRef="From2019-07-012020-06-30"
      id="xdx2ixbrl2030"
      unitRef="Shares"
      xsi:nil="true"/>
    <PPCB:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceExercised
      contextRef="From2019-07-012020-06-30"
      id="xdx2ixbrl2032"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures
      contextRef="From2019-07-012020-06-30"
      id="xdx2ixbrl2034"
      unitRef="Shares"
      xsi:nil="true"/>
    <PPCB:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceExpired
      contextRef="From2019-07-012020-06-30"
      id="xdx2ixbrl2036"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations
      contextRef="From2019-07-012020-06-30"
      id="xdx2ixbrl2038"
      unitRef="Shares"
      xsi:nil="true"/>
    <PPCB:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceForfeited
      contextRef="From2019-07-012020-06-30"
      id="xdx2ixbrl2040"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <PPCB:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsIssued
      contextRef="From2020-07-012021-06-30"
      id="xdx2ixbrl2046"
      unitRef="Shares"
      xsi:nil="true"/>
    <PPCB:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceIssued
      contextRef="From2020-07-012021-06-30"
      id="xdx2ixbrl2048"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures
      contextRef="From2020-07-012021-06-30"
      id="xdx2ixbrl2054"
      unitRef="Shares"
      xsi:nil="true"/>
    <PPCB:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceExpired
      contextRef="From2020-07-012021-06-30"
      id="xdx2ixbrl2056"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations
      contextRef="From2020-07-012021-06-30"
      id="xdx2ixbrl2058"
      unitRef="Shares"
      xsi:nil="true"/>
    <PPCB:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceForfeited
      contextRef="From2020-07-012021-06-30"
      id="xdx2ixbrl2060"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <PPCB:SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsAggregateIntrinsicValueOutstanding
      contextRef="AsOf2021-06-30"
      id="xdx2ixbrl2072"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="AsOf2016-05-05_custom_NewFiveYearOperatingLeaseAgreementMember"
      id="xdx2ixbrl2171">P5Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="AsOf2021-06-30"
      id="xdx2ixbrl2191"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OperatingLeaseLiability
      contextRef="AsOf2021-06-30"
      id="xdx2ixbrl2202"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LessorOperatingLeaseTermOfContract
      contextRef="AsOf2016-05-05_custom_NorthHorizonPtyLtdMember"
      id="xdx2ixbrl2256">P5Y</us-gaap:LessorOperatingLeaseTermOfContract>
    <PPCB:AgreementRenewalTerm
      contextRef="From2019-05-132019-05-14_custom_EmploymentAgreementMember_custom_MrNathanielszMember"
      id="xdx2ixbrl2327">P1Y</PPCB:AgreementRenewalTerm>
    <PPCB:AgreementlTerm
      contextRef="From2019-05-132019-05-14_custom_ServicesAgreementMember_custom_DrKenyonMember"
      id="xdx2ixbrl2350">P3Y</PPCB:AgreementlTerm>
    <PPCB:AgreementRenewalTerm
      contextRef="From2019-05-132019-05-14_custom_ServicesAgreementMember_custom_DrKenyonMember"
      id="xdx2ixbrl2352">P1Y</PPCB:AgreementRenewalTerm>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="From2020-07-012021-06-30_custom_LenderTwoMember"
      decimals="0"
      id="xdx2ixbrl2392"
      unitRef="USD">200000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
      contextRef="AsOf2021-06-30_us-gaap_FairValueInputsLevel1Member"
      id="xdx2ixbrl2445"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
      contextRef="AsOf2021-06-30_us-gaap_FairValueInputsLevel2Member"
      id="xdx2ixbrl2447"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DerivativeLiabilities
      contextRef="AsOf2021-06-30_us-gaap_FairValueInputsLevel1Member"
      id="xdx2ixbrl2453"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DerivativeLiabilities
      contextRef="AsOf2021-06-30_us-gaap_FairValueInputsLevel2Member"
      id="xdx2ixbrl2455"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
      contextRef="AsOf2020-06-30_us-gaap_FairValueInputsLevel1Member"
      id="xdx2ixbrl2461"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
      contextRef="AsOf2020-06-30_us-gaap_FairValueInputsLevel2Member"
      id="xdx2ixbrl2463"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DerivativeLiabilities
      contextRef="AsOf2020-06-30_us-gaap_FairValueInputsLevel1Member"
      id="xdx2ixbrl2469"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DerivativeLiabilities
      contextRef="AsOf2020-06-30_us-gaap_FairValueInputsLevel2Member"
      id="xdx2ixbrl2471"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="AsOf2021-06-30"
      id="xdx2ixbrl2567"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="AsOf2021-09-30"
      id="xdx2ixbrl2614"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2021-09-30_us-gaap_SeriesBPreferredStockMember"
      id="xdx2ixbrl2650"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2021-06-30_us-gaap_SeriesBPreferredStockMember"
      id="xdx2ixbrl2651"
      unitRef="USD"
      xsi:nil="true"/>
    <PPCB:CommonStockIssuable
      contextRef="AsOf2021-06-30"
      id="xdx2ixbrl2692"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquityNoteSubscriptionsReceivable
      contextRef="AsOf2021-06-30"
      id="xdx2ixbrl2702"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2021-07-01to2021-09-30"
      id="xdx2ixbrl2726"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2020-07-012020-09-30"
      id="xdx2ixbrl2727"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="From2021-07-01to2021-09-30"
      id="xdx2ixbrl2756"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2021-07-01to2021-09-30"
      id="xdx2ixbrl2768"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2020-07-012020-09-30"
      id="xdx2ixbrl2769"
      unitRef="USD"
      xsi:nil="true"/>
    <PPCB:DeemedDividend
      contextRef="From2020-07-012020-09-30"
      id="xdx2ixbrl2775"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-06-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl2802"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-06-30_custom_CommonStockIssuableMember"
      id="xdx2ixbrl2804"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-06-30_custom_SubscriptionReceivableMember"
      id="xdx2ixbrl2806"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2020-07-012020-09-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl2818"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2020-07-012020-09-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl2819"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2020-07-012020-09-30_custom_CommonStockIssuableMember"
      id="xdx2ixbrl2821"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2020-07-012020-09-30_custom_SubscriptionReceivableMember"
      id="xdx2ixbrl2823"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2020-07-012020-09-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl2824"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2020-07-012020-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl2825"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2020-07-012020-09-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl2826"
      unitRef="USD"
      xsi:nil="true"/>
    <PPCB:AdjustmentsToAdditionalPaidInCapitalReclassificationOfPremiumUponDebtConversion
      contextRef="From2020-07-012020-09-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl2853"
      unitRef="USD"
      xsi:nil="true"/>
    <PPCB:AdjustmentsToAdditionalPaidInCapitalReclassificationOfPremiumUponDebtConversion
      contextRef="From2020-07-012020-09-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl2854"
      unitRef="USD"
      xsi:nil="true"/>
    <PPCB:AdjustmentsToAdditionalPaidInCapitalReclassificationOfPremiumUponDebtConversion
      contextRef="From2020-07-012020-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl2855"
      unitRef="USD"
      xsi:nil="true"/>
    <PPCB:AdjustmentsToAdditionalPaidInCapitalReclassificationOfPremiumUponDebtConversion
      contextRef="From2020-07-012020-09-30_custom_CommonStockIssuableMember"
      id="xdx2ixbrl2856"
      unitRef="USD"
      xsi:nil="true"/>
    <PPCB:AdjustmentsToAdditionalPaidInCapitalReclassificationOfPremiumUponDebtConversion
      contextRef="From2020-07-012020-09-30_custom_SubscriptionReceivableMember"
      id="xdx2ixbrl2858"
      unitRef="USD"
      xsi:nil="true"/>
    <PPCB:AdjustmentsToAdditionalPaidInCapitalReclassificationOfPremiumUponDebtConversion
      contextRef="From2020-07-012020-09-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl2859"
      unitRef="USD"
      xsi:nil="true"/>
    <PPCB:AdjustmentsToAdditionalPaidInCapitalReclassificationOfPremiumUponDebtConversion
      contextRef="From2020-07-012020-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl2860"
      unitRef="USD"
      xsi:nil="true"/>
    <PPCB:AdjustmentsToAdditionalPaidInCapitalReclassificationOfPremiumUponDebtConversion
      contextRef="From2020-07-012020-09-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl2861"
      unitRef="USD"
      xsi:nil="true"/>
    <PPCB:StockIssuedDuringPeriodValueExerciseOfWarrants
      contextRef="From2020-07-012020-09-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl2886"
      unitRef="USD"
      xsi:nil="true"/>
    <PPCB:StockIssuedDuringPeriodValueExerciseOfWarrants
      contextRef="From2020-07-012020-09-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl2887"
      unitRef="USD"
      xsi:nil="true"/>
    <PPCB:StockIssuedDuringPeriodValueExerciseOfWarrants
      contextRef="From2020-07-012020-09-30_custom_CommonStockIssuableMember"
      id="xdx2ixbrl2889"
      unitRef="USD"
      xsi:nil="true"/>
    <PPCB:StockIssuedDuringPeriodValueExerciseOfWarrants
      contextRef="From2020-07-012020-09-30_custom_SubscriptionReceivableMember"
      id="xdx2ixbrl2891"
      unitRef="USD"
      xsi:nil="true"/>
    <PPCB:StockIssuedDuringPeriodValueExerciseOfWarrants
      contextRef="From2020-07-012020-09-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl2892"
      unitRef="USD"
      xsi:nil="true"/>
    <PPCB:StockIssuedDuringPeriodValueExerciseOfWarrants
      contextRef="From2020-07-012020-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl2893"
      unitRef="USD"
      xsi:nil="true"/>
    <PPCB:StockIssuedDuringPeriodValueExerciseOfWarrants
      contextRef="From2020-07-012020-09-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl2894"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="From2020-07-012020-09-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl2921"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="From2020-07-012020-09-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl2922"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="From2020-07-012020-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl2923"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="From2020-07-012020-09-30_custom_CommonStockIssuableMember"
      id="xdx2ixbrl2924"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="From2020-07-012020-09-30_custom_SubscriptionReceivableMember"
      id="xdx2ixbrl2926"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="From2020-07-012020-09-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl2927"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="From2020-07-012020-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl2928"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="From2020-07-012020-09-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl2929"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="From2020-07-012020-09-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl2932"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="From2020-07-012020-09-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl2933"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="From2020-07-012020-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl2934"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="From2020-07-012020-09-30_custom_CommonStockIssuableMember"
      id="xdx2ixbrl2935"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="From2020-07-012020-09-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl2936"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="From2020-07-012020-09-30_custom_SubscriptionReceivableMember"
      id="xdx2ixbrl2937"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="From2020-07-012020-09-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl2938"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2020-07-012020-09-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl2943"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2020-07-012020-09-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl2944"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2020-07-012020-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl2945"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2020-07-012020-09-30_custom_CommonStockIssuableMember"
      id="xdx2ixbrl2946"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2020-07-012020-09-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl2947"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2020-07-012020-09-30_custom_SubscriptionReceivableMember"
      id="xdx2ixbrl2948"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2020-07-012020-09-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl2951"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-09-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl2955"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-09-30_custom_CommonStockIssuableMember"
      id="xdx2ixbrl2957"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-09-30_custom_SubscriptionReceivableMember"
      id="xdx2ixbrl2959"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-06-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl2972"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-06-30_custom_CommonStockIssuableMember"
      id="xdx2ixbrl2974"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-06-30_custom_SubscriptionReceivableMember"
      id="xdx2ixbrl2976"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2021-07-012021-09-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl2990"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2021-07-012021-09-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl2991"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2021-07-012021-09-30_custom_CommonStockIssuableMember"
      id="xdx2ixbrl2993"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2021-07-012021-09-30_custom_SubscriptionReceivableMember"
      id="xdx2ixbrl2995"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2021-07-012021-09-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl2996"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2021-07-012021-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl2997"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2021-07-012021-09-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl2998"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2021-07-012021-09-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3003"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2021-07-012021-09-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3004"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2021-07-012021-09-30_custom_CommonStockIssuableMember"
      id="xdx2ixbrl3006"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2021-07-012021-09-30_custom_SubscriptionReceivableMember"
      id="xdx2ixbrl3008"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2021-07-012021-09-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl3009"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2021-07-012021-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl3010"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2021-07-012021-09-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl3011"
      unitRef="USD"
      xsi:nil="true"/>
    <PPCB:StockIssuedDuringPeriodValueExerciseOfWarrants
      contextRef="From2021-07-012021-09-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3016"
      unitRef="USD"
      xsi:nil="true"/>
    <PPCB:StockIssuedDuringPeriodValueExerciseOfWarrants
      contextRef="From2021-07-012021-09-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3017"
      unitRef="USD"
      xsi:nil="true"/>
    <PPCB:StockIssuedDuringPeriodValueExerciseOfWarrants
      contextRef="From2021-07-012021-09-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl3022"
      unitRef="USD"
      xsi:nil="true"/>
    <PPCB:StockIssuedDuringPeriodValueExerciseOfWarrants
      contextRef="From2021-07-012021-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl3023"
      unitRef="USD"
      xsi:nil="true"/>
    <PPCB:StockIssuedDuringPeriodValueExerciseOfWarrants
      contextRef="From2021-07-012021-09-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl3024"
      unitRef="USD"
      xsi:nil="true"/>
    <PPCB:IssuanceOfCommonStockForAlternateCashlessExerciseOfWarrants
      contextRef="From2021-07-012021-09-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3031"
      unitRef="USD"
      xsi:nil="true"/>
    <PPCB:IssuanceOfCommonStockForAlternateCashlessExerciseOfWarrants
      contextRef="From2021-07-012021-09-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3032"
      unitRef="USD"
      xsi:nil="true"/>
    <PPCB:IssuanceOfCommonStockForAlternateCashlessExerciseOfWarrants
      contextRef="From2021-07-012021-09-30_custom_SubscriptionReceivableMember"
      id="xdx2ixbrl3036"
      unitRef="USD"
      xsi:nil="true"/>
    <PPCB:IssuanceOfCommonStockForAlternateCashlessExerciseOfWarrants
      contextRef="From2021-07-012021-09-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl3037"
      unitRef="USD"
      xsi:nil="true"/>
    <PPCB:IssuanceOfCommonStockForAlternateCashlessExerciseOfWarrants
      contextRef="From2021-07-012021-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl3038"
      unitRef="USD"
      xsi:nil="true"/>
    <PPCB:IssuanceOfCommonStockForAlternateCashlessExerciseOfWarrants
      contextRef="From2021-07-012021-09-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl3039"
      unitRef="USD"
      xsi:nil="true"/>
    <PPCB:IssuanceOfCommonStockForAlternateCashlessExerciseOfWarrants
      contextRef="From2021-07-01to2021-09-30"
      id="xdx2ixbrl3040"
      unitRef="USD"
      xsi:nil="true"/>
    <PPCB:AdjustmentsToAdditionalPaidInCapitalReclassificationOfPremiumUponDebtConversion
      contextRef="From2021-07-012021-09-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3046"
      unitRef="USD"
      xsi:nil="true"/>
    <PPCB:AdjustmentsToAdditionalPaidInCapitalReclassificationOfPremiumUponDebtConversion
      contextRef="From2021-07-012021-09-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3047"
      unitRef="USD"
      xsi:nil="true"/>
    <PPCB:AdjustmentsToAdditionalPaidInCapitalReclassificationOfPremiumUponDebtConversion
      contextRef="From2021-07-012021-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl3048"
      unitRef="USD"
      xsi:nil="true"/>
    <PPCB:AdjustmentsToAdditionalPaidInCapitalReclassificationOfPremiumUponDebtConversion
      contextRef="From2021-07-012021-09-30_custom_CommonStockIssuableMember"
      id="xdx2ixbrl3049"
      unitRef="USD"
      xsi:nil="true"/>
    <PPCB:AdjustmentsToAdditionalPaidInCapitalReclassificationOfPremiumUponDebtConversion
      contextRef="From2021-07-012021-09-30_custom_SubscriptionReceivableMember"
      id="xdx2ixbrl3051"
      unitRef="USD"
      xsi:nil="true"/>
    <PPCB:AdjustmentsToAdditionalPaidInCapitalReclassificationOfPremiumUponDebtConversion
      contextRef="From2021-07-012021-09-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl3052"
      unitRef="USD"
      xsi:nil="true"/>
    <PPCB:AdjustmentsToAdditionalPaidInCapitalReclassificationOfPremiumUponDebtConversion
      contextRef="From2021-07-012021-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl3053"
      unitRef="USD"
      xsi:nil="true"/>
    <PPCB:AdjustmentsToAdditionalPaidInCapitalReclassificationOfPremiumUponDebtConversion
      contextRef="From2021-07-012021-09-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl3054"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2021-07-012021-09-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3057"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2021-07-012021-09-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3058"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2021-07-012021-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl3059"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2021-07-012021-09-30_custom_CommonStockIssuableMember"
      id="xdx2ixbrl3060"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2021-07-012021-09-30_custom_SubscriptionReceivableMember"
      id="xdx2ixbrl3062"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2021-07-012021-09-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl3063"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2021-07-012021-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl3064"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2021-07-012021-09-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl3065"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="From2021-07-012021-09-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3068"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="From2021-07-012021-09-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3069"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="From2021-07-012021-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl3070"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="From2021-07-012021-09-30_custom_CommonStockIssuableMember"
      id="xdx2ixbrl3071"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="From2021-07-012021-09-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl3072"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="From2021-07-012021-09-30_custom_SubscriptionReceivableMember"
      id="xdx2ixbrl3073"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="From2021-07-012021-09-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl3074"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="From2021-07-012021-09-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl3076"
      unitRef="USD"
      xsi:nil="true"/>
    <PPCB:DeemedDividendUponAlternateCashlessExerciseOfWarrants
      contextRef="From2021-07-012021-09-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3079"
      unitRef="USD"
      xsi:nil="true"/>
    <PPCB:DeemedDividendUponAlternateCashlessExerciseOfWarrants
      contextRef="From2021-07-012021-09-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3080"
      unitRef="USD"
      xsi:nil="true"/>
    <PPCB:DeemedDividendUponAlternateCashlessExerciseOfWarrants
      contextRef="From2021-07-012021-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl3081"
      unitRef="USD"
      xsi:nil="true"/>
    <PPCB:DeemedDividendUponAlternateCashlessExerciseOfWarrants
      contextRef="From2021-07-012021-09-30_custom_CommonStockIssuableMember"
      id="xdx2ixbrl3082"
      unitRef="USD"
      xsi:nil="true"/>
    <PPCB:DeemedDividendUponAlternateCashlessExerciseOfWarrants
      contextRef="From2021-07-012021-09-30_custom_SubscriptionReceivableMember"
      id="xdx2ixbrl3084"
      unitRef="USD"
      xsi:nil="true"/>
    <PPCB:DeemedDividendUponAlternateCashlessExerciseOfWarrants
      contextRef="From2021-07-012021-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl3086"
      unitRef="USD"
      xsi:nil="true"/>
    <PPCB:DeemedDividendUponAlternateCashlessExerciseOfWarrants
      contextRef="From2021-07-012021-09-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl3087"
      unitRef="USD"
      xsi:nil="true"/>
    <PPCB:DeemedDividendUponAlternateCashlessExerciseOfWarrants
      contextRef="From2021-07-01to2021-09-30"
      id="xdx2ixbrl3088"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2021-07-012021-09-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3090"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2021-07-012021-09-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3091"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2021-07-012021-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl3092"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2021-07-012021-09-30_custom_CommonStockIssuableMember"
      id="xdx2ixbrl3093"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2021-07-012021-09-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl3094"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2021-07-012021-09-30_custom_SubscriptionReceivableMember"
      id="xdx2ixbrl3095"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2021-07-012021-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl3097"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2021-07-012021-09-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl3098"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-09-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl3102"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims
      contextRef="From2020-07-012020-09-30"
      id="xdx2ixbrl3130"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="From2021-07-01to2021-09-30"
      id="xdx2ixbrl3144"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments
      contextRef="From2020-07-012020-09-30"
      id="xdx2ixbrl3154"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="From2020-07-012020-09-30"
      id="xdx2ixbrl3163"
      unitRef="USD"
      xsi:nil="true"/>
    <PPCB:IncreaseDecreaseInDeferredRent
      contextRef="From2021-07-01to2021-09-30"
      id="xdx2ixbrl3168"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="From2020-07-012020-09-30"
      id="xdx2ixbrl3187"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RepaymentsOfConvertibleDebt
      contextRef="From2021-07-01to2021-09-30"
      id="xdx2ixbrl3189"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:InterestPaidNet
      contextRef="From2021-07-01to2021-09-30"
      id="xdx2ixbrl3216"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="From2021-07-01to2021-09-30"
      id="xdx2ixbrl3219"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="From2020-07-012020-09-30"
      id="xdx2ixbrl3220"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssued1
      contextRef="From2020-07-012020-09-30"
      id="xdx2ixbrl3232"
      unitRef="USD"
      xsi:nil="true"/>
    <PPCB:DeemedDividendUponAlternateCashlessExerciseOfWarrants1
      contextRef="From2020-07-012020-09-30"
      id="xdx2ixbrl3235"
      unitRef="USD"
      xsi:nil="true"/>
    <PPCB:SubscriptionReceivable
      contextRef="From2020-07-012020-09-30"
      id="xdx2ixbrl3238"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2020-07-012020-09-30"
      id="xdx2ixbrl3304"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2021-07-01to2021-09-30"
      id="xdx2ixbrl3306"
      unitRef="USD"
      xsi:nil="true"/>
    <PPCB:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsIssued
      contextRef="From2021-07-01to2021-09-30"
      id="xdx2ixbrl3731"
      unitRef="Shares"
      xsi:nil="true"/>
    <PPCB:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceIssued
      contextRef="From2021-07-01to2021-09-30"
      id="xdx2ixbrl3733"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures
      contextRef="From2021-07-01to2021-09-30"
      id="xdx2ixbrl3739"
      unitRef="Shares"
      xsi:nil="true"/>
    <PPCB:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceExpired
      contextRef="From2021-07-01to2021-09-30"
      id="xdx2ixbrl3741"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations
      contextRef="From2021-07-01to2021-09-30"
      id="xdx2ixbrl3743"
      unitRef="Shares"
      xsi:nil="true"/>
    <PPCB:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceForfeited
      contextRef="From2021-07-01to2021-09-30"
      id="xdx2ixbrl3745"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <PPCB:SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsAggregateIntrinsicValueOutstanding
      contextRef="AsOf2021-09-30"
      id="xdx2ixbrl3757"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
      contextRef="From2021-07-01to2021-09-30"
      id="xdx2ixbrl3765"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="From2021-07-01to2021-09-30"
      id="xdx2ixbrl3767"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2021-07-01to2021-09-30"
      id="xdx2ixbrl3769"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="From2021-07-01to2021-09-30"
      id="xdx2ixbrl3771"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="From2021-07-01to2021-09-30"
      id="xdx2ixbrl3773"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="From2021-07-01to2021-09-30"
      id="xdx2ixbrl3775"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
      contextRef="From2021-07-01to2021-09-30"
      id="xdx2ixbrl3777"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="From2021-07-01to2021-09-30"
      id="xdx2ixbrl3779"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <PPCB:WeightedAverageFairValueOfOptionsGrantedDuringPeriod
      contextRef="From2021-07-01to2021-09-30"
      id="xdx2ixbrl3791"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="AsOf2021-09-30"
      id="xdx2ixbrl3793"
      unitRef="USD"
      xsi:nil="true"/>
    <PPCB:AgreementRenewalTerm
      contextRef="From2019-05-132019-05-14_custom_EmploymentAgreementMember_custom_MrNathanielszMember"
      id="xdx2ixbrl3891">P1Y</PPCB:AgreementRenewalTerm>
    <PPCB:AgreementlTerm
      contextRef="From2019-05-132019-05-14_custom_ServicesAgreementMember_custom_DrKenyonMember"
      id="xdx2ixbrl3915">P3Y</PPCB:AgreementlTerm>
    <PPCB:AgreementRenewalTerm
      contextRef="From2019-05-132019-05-14_custom_ServicesAgreementMember_custom_DrKenyonMember"
      id="xdx2ixbrl3917">P1Y</PPCB:AgreementRenewalTerm>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="From2020-07-012020-09-30"
      id="xdx2ixbrl3953"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DebtInstrumentMeasurementInput
      contextRef="AsOf2021-09-30_us-gaap_MeasurementInputPriceVolatilityMember"
      id="xdx2ixbrl3968"
      unitRef="Pure"
      xsi:nil="true"/>
    <us-gaap:DebtInstrumentTerm
      contextRef="From2021-07-012021-09-30_us-gaap_MeasurementInputExpectedTermMember"
      id="xdx2ixbrl3972"
      xsi:nil="true"/>
    <us-gaap:DebtInstrumentMeasurementInput
      contextRef="AsOf2021-09-30_us-gaap_MeasurementInputRiskFreeInterestRateMember"
      id="xdx2ixbrl3976"
      unitRef="Pure"
      xsi:nil="true"/>
    <us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
      contextRef="AsOf2021-09-30_us-gaap_FairValueInputsLevel1Member"
      id="xdx2ixbrl3988"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
      contextRef="AsOf2021-09-30_us-gaap_FairValueInputsLevel2Member"
      id="xdx2ixbrl3990"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DerivativeLiabilities
      contextRef="AsOf2021-09-30_us-gaap_FairValueInputsLevel1Member"
      id="xdx2ixbrl3996"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DerivativeLiabilities
      contextRef="AsOf2021-09-30_us-gaap_FairValueInputsLevel2Member"
      id="xdx2ixbrl3998"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
      contextRef="AsOf2021-06-30_us-gaap_FairValueInputsLevel1Member"
      id="xdx2ixbrl4004"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
      contextRef="AsOf2021-06-30_us-gaap_FairValueInputsLevel2Member"
      id="xdx2ixbrl4006"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DerivativeLiabilities
      contextRef="AsOf2021-06-30_us-gaap_FairValueInputsLevel1Member"
      id="xdx2ixbrl4012"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DerivativeLiabilities
      contextRef="AsOf2021-06-30_us-gaap_FairValueInputsLevel2Member"
      id="xdx2ixbrl4014"
      unitRef="USD"
      xsi:nil="true"/>
    <dei:EntityRegistrantName contextRef="From2021-07-01to2021-09-30">Propanc Biopharma, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2021-07-01to2021-09-30">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="From2021-07-01to2021-09-30">33-0662986</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2021-07-01to2021-09-30">302</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2021-07-01to2021-09-30">6 Butler Street</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="From2021-07-01to2021-09-30">Camberwell</dei:EntityAddressCityOrTown>
    <dei:EntityAddressPostalZipCode contextRef="From2021-07-01to2021-09-30">3124</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2021-07-01to2021-09-30">61-03</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2021-07-01to2021-09-30">9882-0780</dei:LocalPhoneNumber>
    <dei:EntityFilerCategory contextRef="From2021-07-01to2021-09-30">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="From2021-07-01to2021-09-30">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="From2021-07-01to2021-09-30">false</dei:EntityEmergingGrowthCompany>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">2255</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">67007</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:ValueAddedTaxReceivableCurrent contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">4341</us-gaap:ValueAddedTaxReceivableCurrent>
    <us-gaap:ValueAddedTaxReceivableCurrent contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">2015</us-gaap:ValueAddedTaxReceivableCurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">6596</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">69022</us-gaap:AssetsCurrent>
    <us-gaap:DepositsAssetsNoncurrent contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">2250</us-gaap:DepositsAssetsNoncurrent>
    <us-gaap:DepositsAssetsNoncurrent contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">2067</us-gaap:DepositsAssetsNoncurrent>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">21682</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">4255</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">5747</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Assets contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">13101</us-gaap:Assets>
    <us-gaap:Assets contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">98518</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">1002335</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">842156</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">892151</us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">702231</us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent>
    <us-gaap:ConvertibleDebtCurrent contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">624583</us-gaap:ConvertibleDebtCurrent>
    <us-gaap:ConvertibleDebtCurrent contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">1557734</us-gaap:ConvertibleDebtCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">25072</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:DeferredCompensationLiabilityCurrent contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">54220</us-gaap:DeferredCompensationLiabilityCurrent>
    <us-gaap:DeferredCompensationLiabilityCurrent contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">177009</us-gaap:DeferredCompensationLiabilityCurrent>
    <us-gaap:DueToRelatedPartiesCurrent contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">33347</us-gaap:DueToRelatedPartiesCurrent>
    <us-gaap:DueToRelatedPartiesCurrent contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">30639</us-gaap:DueToRelatedPartiesCurrent>
    <PPCB:LoanFromFormerDirectorRelatedParty contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">55500</PPCB:LoanFromFormerDirectorRelatedParty>
    <PPCB:LoanFromFormerDirectorRelatedParty contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">50993</PPCB:LoanFromFormerDirectorRelatedParty>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">418538</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">354109</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">3080674</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">3739943</us-gaap:LiabilitiesCurrent>
    <us-gaap:Liabilities contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">3080674</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">3739943</us-gaap:Liabilities>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2021-06-30" decimals="INF" unitRef="Shares">1500005</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2020-06-30" decimals="INF" unitRef="Shares">1500005</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2021-06-30"
      decimals="INF"
      unitRef="USDPShares">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2020-06-30"
      decimals="INF"
      unitRef="USDPShares">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2021-06-30_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      unitRef="USDPShares">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2020-06-30_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      unitRef="USDPShares">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2021-06-30_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      unitRef="Shares">500000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2020-06-30_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      unitRef="Shares">500000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2021-06-30_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      unitRef="Shares">500000</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2021-06-30_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      unitRef="Shares">500000</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2020-06-30_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      unitRef="Shares">500000</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2020-06-30_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      unitRef="Shares">500000</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2021-06-30_us-gaap_SeriesAPreferredStockMember"
      decimals="0"
      unitRef="USD">5000</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2020-06-30_us-gaap_SeriesAPreferredStockMember"
      decimals="0"
      unitRef="USD">5000</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2021-06-30_us-gaap_SeriesBPreferredStockMember"
      decimals="INF"
      unitRef="USDPShares">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2020-06-30_us-gaap_SeriesBPreferredStockMember"
      decimals="INF"
      unitRef="USDPShares">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2021-06-30_us-gaap_SeriesBPreferredStockMember"
      decimals="INF"
      unitRef="Shares">5</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2020-06-30_us-gaap_SeriesBPreferredStockMember"
      decimals="INF"
      unitRef="Shares">5</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2021-06-30_us-gaap_SeriesBPreferredStockMember"
      decimals="INF"
      unitRef="Shares">1</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2021-06-30_us-gaap_SeriesBPreferredStockMember"
      decimals="INF"
      unitRef="Shares">1</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2020-06-30_us-gaap_SeriesBPreferredStockMember"
      decimals="INF"
      unitRef="Shares">1</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2020-06-30_us-gaap_SeriesBPreferredStockMember"
      decimals="INF"
      unitRef="Shares">1</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2021-06-30"
      decimals="INF"
      unitRef="USDPShares">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2020-06-30"
      decimals="INF"
      unitRef="USDPShares">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2021-06-30" decimals="INF" unitRef="Shares">1000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2020-06-30" decimals="INF" unitRef="Shares">1000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2021-06-30" decimals="INF" unitRef="Shares">14055393</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2021-06-30" decimals="INF" unitRef="Shares">14055393</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2020-06-30" decimals="INF" unitRef="Shares">258120</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2020-06-30" decimals="INF" unitRef="Shares">258120</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">14056</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">258</us-gaap:CommonStockValue>
    <PPCB:CommonStockIssuableShares contextRef="AsOf2021-06-30" decimals="INF" unitRef="Shares">59</PPCB:CommonStockIssuableShares>
    <PPCB:CommonStockIssuableShares contextRef="AsOf2020-06-30" decimals="INF" unitRef="Shares">0</PPCB:CommonStockIssuableShares>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">54074110</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">50913893</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">1085204</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">1267671</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">-58199466</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">-55781770</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:TreasuryStockShares contextRef="AsOf2021-06-30" decimals="INF" unitRef="Shares">1</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockShares contextRef="AsOf2020-06-30" decimals="INF" unitRef="Shares">1</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">46477</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">46477</us-gaap:TreasuryStockValue>
    <us-gaap:StockholdersEquity contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">-3067573</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">-3641425</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">13101</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">98518</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">1553075</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">3281464</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OccupancyNet
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">28112</us-gaap:OccupancyNet>
    <us-gaap:OccupancyNet
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">32809</us-gaap:OccupancyNet>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">230956</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">179987</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:OperatingExpenses
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">1812143</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">3494260</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">-1812143</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">-3494260</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpense
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">449457</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">1748381</us-gaap:InterestExpense>
    <us-gaap:InvestmentIncomeInterest
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">1</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">946</us-gaap:InvestmentIncomeInterest>
    <us-gaap:OtherIncome
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">57636</us-gaap:OtherIncome>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">-8186</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">385293</us-gaap:DerivativeGainLossOnDerivativeNet>
    <PPCB:GainFromSettlementOfDebtNet
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">49319</PPCB:GainFromSettlementOfDebtNet>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">50607</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">67123</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:ForeignCurrencyTransactionGainLossUnrealized
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">30497</us-gaap:ForeignCurrencyTransactionGainLossUnrealized>
    <us-gaap:ForeignCurrencyTransactionGainLossUnrealized
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">-143808</us-gaap:ForeignCurrencyTransactionGainLossUnrealized>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">-327219</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">-1381191</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">-2139362</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">-4875451</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">-113415</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">-134728</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">-2025947</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">-4740723</us-gaap:ProfitLoss>
    <PPCB:DeemedDividend
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">-391749</PPCB:DeemedDividend>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">-2417696</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">-4740723</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="From2020-07-012021-06-30"
      decimals="INF"
      unitRef="USDPShares">-0.80</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="From2019-07-012020-06-30"
      decimals="INF"
      unitRef="USDPShares">-192.45</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="From2020-07-012021-06-30"
      decimals="INF"
      unitRef="Shares">3032612</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="From2019-07-012020-06-30"
      decimals="INF"
      unitRef="Shares">24634</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">-2417696</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">-4740723</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">-182467</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">200673</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">-182467</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">200673</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">-2600163</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">-4540050</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2019-06-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember"
      decimals="INF"
      unitRef="Shares">500000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2019-06-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember"
      decimals="0"
      unitRef="USD">5000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2019-06-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember"
      decimals="INF"
      unitRef="Shares">1</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2019-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">968</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2019-06-30_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">1</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2019-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">45714289</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2019-06-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-51041047</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2019-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      unitRef="USD">1066998</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2019-06-30_us-gaap_TreasuryStockMember"
      decimals="0"
      unitRef="USD">-46477</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2019-06-30" decimals="0" unitRef="USD">-4301236</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2019-07-012020-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">804</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2019-07-012020-06-30_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">1</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2019-07-012020-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">424989</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">424990</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="From2019-07-012020-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">247619</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2019-07-012020-06-30_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">248</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2019-07-012020-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">2124926</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">2125174</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <PPCB:AdjustmentsToAdditionalPaidInCapitalReclassificationOfPremiumUponDebtConversion
      contextRef="From2019-07-012020-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">874924</PPCB:AdjustmentsToAdditionalPaidInCapitalReclassificationOfPremiumUponDebtConversion>
    <PPCB:AdjustmentsToAdditionalPaidInCapitalReclassificationOfPremiumUponDebtConversion
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">874924</PPCB:AdjustmentsToAdditionalPaidInCapitalReclassificationOfPremiumUponDebtConversion>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2019-07-012020-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">8729</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2019-07-012020-06-30_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">8</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2019-07-012020-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">113634</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">113642</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <PPCB:RelativeFairValueOfWarrantsIssuedWithConvertibleDebt
      contextRef="From2019-07-012020-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">375905</PPCB:RelativeFairValueOfWarrantsIssuedWithConvertibleDebt>
    <PPCB:RelativeFairValueOfWarrantsIssuedWithConvertibleDebt
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">375905</PPCB:RelativeFairValueOfWarrantsIssuedWithConvertibleDebt>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2019-07-012020-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">300416</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">300416</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="From2019-07-012020-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">984810</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">984810</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="From2019-07-012020-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      unitRef="USD">200673</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">200673</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ProfitLoss
      contextRef="From2019-07-012020-06-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-4740723</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">-4740723</us-gaap:ProfitLoss>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2020-06-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember"
      decimals="INF"
      unitRef="Shares">500000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-06-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember"
      decimals="0"
      unitRef="USD">5000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2020-06-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember"
      decimals="INF"
      unitRef="Shares">1</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2020-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">258120</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-06-30_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">258</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">50913893</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-06-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-55781770</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      unitRef="USD">1267671</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-06-30_us-gaap_TreasuryStockMember"
      decimals="0"
      unitRef="USD">-46477</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">-3641425</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">8786113</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">8787</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2020-07-012021-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">1230288</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">1239075</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <PPCB:ReversalOfCommonStockIssuableDueToCancellationOfConversionsOfConvertibleDebtAndAccruedInterestShares
      contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">-24427</PPCB:ReversalOfCommonStockIssuableDueToCancellationOfConversionsOfConvertibleDebtAndAccruedInterestShares>
    <PPCB:ReversalOfCommonStockIssuableDueToCancellationOfConversionsOfConvertibleDebtAndAccruedInterest
      contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">-24</PPCB:ReversalOfCommonStockIssuableDueToCancellationOfConversionsOfConvertibleDebtAndAccruedInterest>
    <PPCB:ReversalOfCommonStockIssuableDueToCancellationOfConversionsOfConvertibleDebtAndAccruedInterest
      contextRef="From2020-07-012021-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">-19992</PPCB:ReversalOfCommonStockIssuableDueToCancellationOfConversionsOfConvertibleDebtAndAccruedInterest>
    <PPCB:ReversalOfCommonStockIssuableDueToCancellationOfConversionsOfConvertibleDebtAndAccruedInterest
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">-20016</PPCB:ReversalOfCommonStockIssuableDueToCancellationOfConversionsOfConvertibleDebtAndAccruedInterest>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
      contextRef="From2020-07-012021-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">-11785</us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">-11785</us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">805646</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">806</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2020-07-012021-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">124766</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">125572</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <PPCB:StockIssuedDuringPeriodSharesExerciseOfWarrants
      contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">29820</PPCB:StockIssuedDuringPeriodSharesExerciseOfWarrants>
    <PPCB:StockIssuedDuringPeriodValueExerciseOfWarrants
      contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">29</PPCB:StockIssuedDuringPeriodValueExerciseOfWarrants>
    <PPCB:StockIssuedDuringPeriodValueExerciseOfWarrants
      contextRef="From2020-07-012021-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">776015</PPCB:StockIssuedDuringPeriodValueExerciseOfWarrants>
    <PPCB:StockIssuedDuringPeriodValueExerciseOfWarrants
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">776044</PPCB:StockIssuedDuringPeriodValueExerciseOfWarrants>
    <PPCB:IssuanceOfCommonStockForCashlessExerciseOfWarrantsShares
      contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">4199979</PPCB:IssuanceOfCommonStockForCashlessExerciseOfWarrantsShares>
    <PPCB:IssuanceOfCommonStockForCashlessExerciseOfWarrants
      contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">4200</PPCB:IssuanceOfCommonStockForCashlessExerciseOfWarrants>
    <PPCB:IssuanceOfCommonStockForCashlessExerciseOfWarrants
      contextRef="From2020-07-012021-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">-4200</PPCB:IssuanceOfCommonStockForCashlessExerciseOfWarrants>
    <PPCB:DeemedDividendUponAlternateCashlessExerciseOfWarrants
      contextRef="From2020-07-012021-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">391749</PPCB:DeemedDividendUponAlternateCashlessExerciseOfWarrants>
    <PPCB:DeemedDividendUponAlternateCashlessExerciseOfWarrants
      contextRef="From2020-07-012021-06-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-391749</PPCB:DeemedDividendUponAlternateCashlessExerciseOfWarrants>
    <PPCB:AdjustmentsToAdditionalPaidInCapitalReclassificationOfPremiumUponDebtConversion
      contextRef="From2020-07-012021-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">590504</PPCB:AdjustmentsToAdditionalPaidInCapitalReclassificationOfPremiumUponDebtConversion>
    <PPCB:AdjustmentsToAdditionalPaidInCapitalReclassificationOfPremiumUponDebtConversion
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">590504</PPCB:AdjustmentsToAdditionalPaidInCapitalReclassificationOfPremiumUponDebtConversion>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2020-07-012021-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">82872</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">82872</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="From2020-07-012021-06-30_custom_CommonStockIssuableMember"
      decimals="INF"
      unitRef="Shares">59</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodSharesReverseStockSplits
      contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">142</us-gaap:StockIssuedDuringPeriodSharesReverseStockSplits>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="From2020-07-012021-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      unitRef="USD">-182467</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">-182467</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ProfitLoss
      contextRef="From2020-07-012021-06-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-2025947</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">-2025947</us-gaap:ProfitLoss>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2021-06-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember"
      decimals="INF"
      unitRef="Shares">500000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-06-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember"
      decimals="0"
      unitRef="USD">5000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2021-06-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember"
      decimals="INF"
      unitRef="Shares">1</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2021-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">14055393</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-06-30_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">14056</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2021-06-30_custom_CommonStockIssuableMember"
      decimals="INF"
      unitRef="Shares">59</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">54074110</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-06-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-58199466</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      unitRef="USD">1085204</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-06-30_us-gaap_TreasuryStockMember"
      decimals="0"
      unitRef="USD">-46477</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">-3067573</us-gaap:StockholdersEquity>
    <us-gaap:ProfitLoss
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">-2025947</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">-4740723</us-gaap:ProfitLoss>
    <us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">125572</us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims>
    <us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">1098452</us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims>
    <us-gaap:ForeignCurrencyTransactionGainLossUnrealized
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">30497</us-gaap:ForeignCurrencyTransactionGainLossUnrealized>
    <us-gaap:ForeignCurrencyTransactionGainLossUnrealized
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">-143808</us-gaap:ForeignCurrencyTransactionGainLossUnrealized>
    <us-gaap:Depreciation
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">1993</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">2473</us-gaap:Depreciation>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">136527</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">734130</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">-8186</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">385293</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">50607</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">67123</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <PPCB:GainFromSettlementOfDebtNet
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">49319</PPCB:GainFromSettlementOfDebtNet>
    <us-gaap:ShareBasedCompensation
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">82872</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">300416</us-gaap:ShareBasedCompensation>
    <us-gaap:OtherNoncashExpense
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">16500</us-gaap:OtherNoncashExpense>
    <us-gaap:OtherNoncashExpense
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">15000</us-gaap:OtherNoncashExpense>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">-200410</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">-836724</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:IncreaseDecreaseInReceivables
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">2147</us-gaap:IncreaseDecreaseInReceivables>
    <us-gaap:IncreaseDecreaseInReceivables
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">-3332</us-gaap:IncreaseDecreaseInReceivables>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">-83157</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">178311</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">-59737</us-gaap:IncreaseDecreaseInAccountsPayable>
    <PPCB:IncreaseDecreaseInDeferredRent
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">3695</PPCB:IncreaseDecreaseInDeferredRent>
    <PPCB:IncreaseDecreaseInDeferredRent
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">-3394</PPCB:IncreaseDecreaseInDeferredRent>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">33134</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">35724</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">152861</us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">-9740</us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInInterestPayableNet
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">80582</us-gaap:IncreaseDecreaseInInterestPayableNet>
    <us-gaap:IncreaseDecreaseInInterestPayableNet
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">156417</us-gaap:IncreaseDecreaseInInterestPayableNet>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">-1145264</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">-1849589</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">325000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">1465250</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:RepaymentsOfConvertibleDebt
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">43000</us-gaap:RepaymentsOfConvertibleDebt>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">450000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfInitialPublicOffering
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">25010</us-gaap:PaymentsForRepurchaseOfInitialPublicOffering>
    <us-gaap:ProceedsFromWarrantExercises
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">776044</us-gaap:ProceedsFromWarrantExercises>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">1058044</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">1890240</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">22468</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">23962</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">-64752</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">64613</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">67007</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="AsOf2019-06-30" decimals="0" unitRef="USD">2394</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">2255</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">67007</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:InterestPaidNet
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">13621</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">6110</us-gaap:InterestPaidNet>
    <us-gaap:ConversionOfStockAmountConverted1
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">590504</us-gaap:ConversionOfStockAmountConverted1>
    <us-gaap:ConversionOfStockAmountConverted1
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">874924</us-gaap:ConversionOfStockAmountConverted1>
    <us-gaap:ConversionOfStockAmountIssued1
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">1142205</us-gaap:ConversionOfStockAmountIssued1>
    <us-gaap:ConversionOfStockAmountIssued1
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">1814336</us-gaap:ConversionOfStockAmountIssued1>
    <PPCB:DiscountsRelatedToWarrantsIssuedWithConvertibleNote
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">375905</PPCB:DiscountsRelatedToWarrantsIssuedWithConvertibleNote>
    <PPCB:DiscountsRelatedToDerivativeLiability
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">227000</PPCB:DiscountsRelatedToDerivativeLiability>
    <PPCB:OperatingLeaseRightofuseAssetsAndOperatingLeaseLiabilitiesRecordedUponAdoptionOfAsc842
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">48662</PPCB:OperatingLeaseRightofuseAssetsAndOperatingLeaseLiabilitiesRecordedUponAdoptionOfAsc842>
    <PPCB:ReversalOfCommonStockIssuableAndPutPremiumDueToCancellationOfConversionsOfConvertibleDebtAndAccruedInterest
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">31801</PPCB:ReversalOfCommonStockIssuableAndPutPremiumDueToCancellationOfConversionsOfConvertibleDebtAndAccruedInterest>
    <PPCB:DeemedDividendUponAlternateCashlessExerciseOfWarrants1
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">391749</PPCB:DeemedDividendUponAlternateCashlessExerciseOfWarrants1>
    <PPCB:AccountsPayableReclassToConvertibleNotes
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">25000</PPCB:AccountsPayableReclassToConvertibleNotes>
    <us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock contextRef="From2020-07-012021-06-30">&lt;p id="xdx_800_eus-gaap--OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_zycuyQ5Qj2bl" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;NOTE
1 &#x2013; &lt;span id="xdx_825_zzIYbH5HEuLc"&gt;NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING AND REPORTING POLICIES&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84D_ecustom--NatureOfOperationsPolicyTextBlock_zUy1ZG0cJ07l" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_864_zskNnen1aczd"&gt;Nature
of Operations&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Propanc
Biopharma, Inc. (the &#x201c;Company,&#x201d; &#x201c;we,&#x201d; &#x201c;us&#x201d; or &#x201c;our&#x201d;) was originally incorporated in Melbourne,
Victoria Australia on October 15, 2007 as Propanc PTY LTD, and continues to be based in Camberwell, Victoria Australia. Since its inception,
substantially all of the operations of the Company have been focused on the development of new cancer treatments targeting high-risk
patients, particularly cancer survivors, who need a follow-up, non-toxic, long-term therapy designed to prevent the cancer from returning
and spreading. The Company anticipates establishing global markets for its technologies. Our lead product candidate, which we refer to
as PRP, is an enhanced pro-enzyme formulation designed to enhance the anti-cancer effects of multiple enzymes acting synergistically.
It is currently in the preclinical phase of development.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 29.15pt; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;On
&lt;span id="xdx_902_edei--EntityIncorporationDateOfIncorporation_dd_c20200701__20210630_zjsnh70umwD9" title="Entity incorporation, date of incorporation"&gt;November 23, 2010&lt;/span&gt;, the Company was incorporated in the state of Delaware as Propanc Health Group Corporation. In January 2011, to reorganize
the Company, we acquired all of the outstanding shares of Propanc PTY LTD on a one-for-one basis making it a wholly-owned subsidiary
of the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;On
July 22, 2016, the Company formed a wholly owned subsidiary, Propanc (UK) Limited under the laws of England and Wales for the purpose
of submitting an orphan drug application to the European Medicines Agency as a small and medium-sized enterprise. As of June 30, 2021,
there has been no activity within this entity.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Effective
April 20, 2017, the Company changed its name to &#x201c;Propanc Biopharma, Inc.&#x201d; to better reflect the Company&#x2019;s stage of
operations and development.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;In
July 2020, a world first patent was granted in Australia for the cancer treatment method patent family. Presently, there are 29 granted
patents and 33 patents under examination in key global jurisdictions relating to the use of proenzymes against solid tumors, covering
the lead product candidate PRP.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;The
Company hopes to capture and protect additional patentable subject matter based on the Company&#x2019;s field of technology relating to
pharmaceutical compositions of proenzymes for treating cancer by filing additional patent applications as it advances its lead product
candidate, PRP, through various stages of development.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;On
November 17, 2020, the Company effected a &lt;span id="xdx_90D_eus-gaap--StockholdersEquityReverseStockSplit_c20201116__20201117" title="Reverse stock"&gt;one-for-one thousand (1:1,000)&lt;/span&gt; reverse stock split of the Company&#x2019;s issued and outstanding
shares of common stock (the &#x201c;Reverse Stock Split&#x201d;). Proportional adjustments for the Reverse Stock Split were made to the
Company&#x2019;s outstanding stock options, warrants and equity incentive plans. All share and per-share data and amounts have been retroactively
adjusted as of the earliest period presented in the consolidated financial statements to reflect the Reverse Stock Split.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_840_eus-gaap--ConsolidationPolicyTextBlock_zTfyfILZC5Xb" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_860_z0xpPnCblBPa"&gt;Principles
of Consolidation&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;The
consolidated financial statements include the accounts of Propanc Biopharma, Inc., the parent entity, and its wholly-owned subsidiary,
Propanc PTY LTD. All inter-company balances and transactions have been eliminated in consolidation. Propanc (UK) Limited was an inactive
wholly-owned subsidiary through June 30, 2021.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_845_eus-gaap--UseOfEstimates_zzwSrtiWrUj9" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_866_zCVztcFqdaWc"&gt;Use
of Estimates&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;The
preparation of financial statements in conformity with the accounting principles generally accepted in the United States of America (&#x201c;US
GAAP&#x201d;) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure
of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses
during the reporting period. Actual results could differ from these estimates. Significant estimates in the accompanying consolidated
financial statements include the estimates of useful lives for depreciation, valuation of the operating lease liability and related right-of-use
asset, valuation of derivatives, valuation of beneficial conversion features on convertible debt, allowance for uncollectable receivables,
valuation of equity based instruments issued for other than cash, the valuation allowance on deferred tax assets and foreign currency
translation due to certain average exchange rates applied in lieu of spot rates on transaction dates.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_859_z8T8me2mUWNh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;PROPANC
BIOPHARMA, INC. AND SUBSIDIARY&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;June
30, 2021 and 2020&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84C_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_z1sqztQEFLQg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86F_zJUFHRfwNmQ9"&gt;Foreign
Currency Translation and Other Comprehensive Income (Loss)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;The
Company&#x2019;s wholly owned subsidiary&#x2019;s functional currency is the Australian dollar (AUD). For financial reporting purposes,
the Australian dollar has been translated into the Company&#x2019;s reporting currency which is the United States dollar ($) and/or (USD).
Assets and liabilities are translated at the exchange rate in effect at the balance sheet date. Revenues and expenses are translated
at the average rate of exchange prevailing during the reporting period. Equity transactions are translated at each historical transaction
date spot rate. Translation adjustments arising from the use of different exchange rates from period to period are included as a component
of stockholders&#x2019; equity (deficit) as &#x201c;Accumulated other comprehensive income (loss).&#x201d; Gains and losses resulting from
foreign currency transactions are included in the statements of operations and comprehensive income (loss) as a component of other
comprehensive income (loss). There have been no significant fluctuations in the exchange rate for the conversion of Australian dollars
to USD after the balance sheet date.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Other
Comprehensive Income (Loss) for all periods presented includes only foreign currency translation gains (losses).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Assets
and liabilities denominated in foreign currencies are translated into the functional currency at the exchange rates prevailing at
the consolidated balance sheet date with any transaction gains and losses that arise from exchange rate fluctuations on transactions
denominated in a currency other than the functional currency included in the consolidated results of operations as incurred.
Effective fiscal year 2021, the parent company determined that these intercompany loans will not be repaid in the foreseeable future
and thus, per ASC 830-20-35-3, gains and losses from measuring the intercompany balances are recorded within cumulative translation
adjustment, a component of accumulated other comprehensive income (loss). Prior to July 1, 2020, the Company recorded the foreign
currency transaction gains and losses from measuring the intercompany balances as a component of other income (expenses) titled
foreign currency transaction gain (loss). For the year ended June 30, 2021 and 2020, the Company recognized an exchange gain
(loss) of approximately $&lt;span id="xdx_901_eus-gaap--OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_c20200701__20210630__us-gaap--DebtInstrumentAxis__custom--IntercompanyLoansMember_pp0p0"&gt;1,005,000 &lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;and
($&lt;span id="xdx_90C_eus-gaap--OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_pp0p0_c20190701__20200630__us-gaap--DebtInstrumentAxis__custom--IntercompanyLoansMember_z9cfuN0kVfSk"&gt;133,000&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;),
on intercompany loans made by the parent to the subsidiary which have not been repaid as of June 30, 2021.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_890_ecustom--ScheduleOfTranslationExchangeRatesTableTextBlock_zHWjPfYgXMZa" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;As
of June 30, 2021 and 2020, the exchange rates used to translate amounts in Australian dollars into USD for the purposes of preparing
the consolidated financial statements were as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;span id="xdx_8BF_zkh7nqNm3XF1" style="display: none"&gt;SCHEDULE OF TRANSLATION EXCHANGE RATES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;June
    30, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;June
    30, 2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Exchange
    rate on balance sheet dates&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 64%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;USD
    : AUD exchange rate&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eus-gaap--ForeignCurrencyExchangeRateTranslation1_c20210630_pdd" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;0.7500&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eus-gaap--ForeignCurrencyExchangeRateTranslation1_c20200630_pdd" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;0.6891&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Average
    exchange rate for the period&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;USD
    : AUD exchange rate&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--ForeignCurrencyExchangeRateTranslation1_c20210630__srt--RangeAxis__srt--WeightedAverageMember_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;0.7473&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eus-gaap--ForeignCurrencyExchangeRateTranslation1_c20200630__srt--RangeAxis__srt--WeightedAverageMember_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;0.6742&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A5_zF6IdfJw4yP2" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89D_eus-gaap--ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_zTTKEp5aN2Mg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Change
in Accumulated Other Comprehensive Income (Loss) by component during the years ended June 30, 2021 and 2020 were as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;span id="xdx_8BB_z1EztVraTjcc" style="display: none"&gt;SCHEDULE OF CHANGE IN ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Foreign&lt;br/&gt;
    Currency Items:&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 82%"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Beginning
    balance, June 30, 2019&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iS_pp0p0_c20190701__20200630_zhNUQVDiorwj" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Beginning balance"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;1,066,998&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Foreign
    currency translation gain&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_pp0p0_c20190701__20200630_zybFsKiYr1bg" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Foreign currency translation gain"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;200,673&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Balance,
    June 30, 2020&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iS_pp0p0_c20200701__20210630_z7l1M52ClLwc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Beginning balance"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;1,267,671&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Foreign
    currency translation gain&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_pp0p0_c20200701__20210630_zDEdRjzTaONi" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Foreign currency translation gain"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;182,467&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Ending
    balance, June 30, 2021&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iE_pp0p0_c20200701__20210630_zuP9suUjhKki" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Ending balance"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;1,085,204&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A0_zHuOP9xbxVG" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84A_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zVxpyFcjsmfb" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_869_zSpI6haJjHrj"&gt;Fair
Value of Financial Instruments and Fair Value Measurements&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;The
Company measures its financial assets and liabilities in accordance with US GAAP. For certain financial instruments, including cash and
cash equivalents, accounts receivable, accounts payable and accrued liabilities, the carrying amounts approximate fair value due to their
short maturities. Amounts recorded for notes payable, net of discount, and loans payable also approximate fair value because current
interest rates available for debt with similar terms and maturities are substantially the same.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;The
Company follows accounting guidance for financial assets and liabilities. This standard defines fair value, provides guidance for measuring
fair value and requires certain disclosures. This standard does not require any new fair value measurements, but rather applies to all
other accounting pronouncements that require or permit fair value measurements. This guidance does not apply to measurements related
to share-based payments. This guidance discusses valuation techniques, such as the market approach (comparable market prices), the income
approach (present value of future income or cash flow), and the cost approach (cost to replace the service capacity of an asset or replacement
cost).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;The
guidance utilizes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three broad
levels. The following is a brief description of those three levels:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.2in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Level
1: Observable inputs such as quoted prices (unadjusted) in active markets for identical assets or liabilities.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.2in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Level
2: Inputs, other than quoted prices that are observable, either directly or indirectly. These include quoted prices for similar assets
or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.2in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Level
3: Unobservable inputs in which little or no market data exists, therefore developed using estimates and assumptions developed by us,
which reflect those that a market participant would use.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Also
see Note 12 - Derivative Financial Instruments and Fair Value Measurements.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_856_zCAOGM8L5wW4" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;PROPANC
BIOPHARMA, INC. AND SUBSIDIARY&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;June
30, 2021 and 2020&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_849_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zbBtLCxM8FT2" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86B_zOfKCWdOLVRd"&gt;Cash
and Cash Equivalents&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Cash
and cash equivalents include cash on hand and at banks, short-term deposits with an original maturity of three months or less with financial
institutions, and bank overdrafts. Bank overdrafts, as applicable, are reflected as a current liability on the balance sheets.
There were &lt;span id="xdx_903_eus-gaap--CashEquivalentsAtCarryingValue_iI_pp0p0_do_c20200630_zZ1eOJKYJYr7"&gt;no&lt;/span&gt;&lt;/span&gt; &lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;cash
equivalents as of June 30, 2021 or June 30, 2020.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84B_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zfg52EPJexy6" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_862_zHWcQfXqSLH3"&gt;Property
and Equipment&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Property
and equipment are stated at cost, net of accumulated depreciation. Expenditures for maintenance and repairs are expensed as incurred;
additions, renewals, and betterments are capitalized. When property and equipment are retired or otherwise disposed of, the related cost
and accumulated depreciation are removed from the respective accounts, and any gain or loss is included in operations. Depreciation of
property and equipment is provided using the declining balance method. The depreciable amount is the cost less its residual value.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_892_ecustom--ScheduleOfPropertyAndEquipmentEstimatedUsefulLivesTableTextBlock_z3AwX2Xd0mO4" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;The
estimated useful lives are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;span id="xdx_8BA_zTqP1ilC57ma" style="display: none"&gt;SCHEDULE OF PROPERTY AND EQUIPMENT ESTIMATED USEFUL LIVES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 28%"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Machinery
    and equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 72%"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;-
    &lt;span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200701__20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_zOXkToZUepQc" title="Property and equipment estimated useful lives"&gt;5&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Furniture&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;-
    &lt;span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200701__20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zW81xzQcQdSg" title="Property and equipment estimated useful lives"&gt;7&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A6_zca7BRRp6xl5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_841_eus-gaap--GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_zv8lJAmH5La9" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_863_zdGUX8vUhRsb"&gt;Patents&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 29.15pt; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Patents
are stated at cost and amortized on a straight-line basis over the estimated future periods if and once the patent has been granted by
a regulatory agency. However, the Company will expense any patent costs as long as we are in the startup stage. Accordingly, as the Company&#x2019;s
products are not currently approved for market, all patent costs incurred from 2013 through June 30, 2021 were expensed immediately.
This practice of expensing patent costs immediately ends when a product receives market authorization from a government regulatory agency.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_845_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zey8gFOmZPEd" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86C_zgKIFAsI1sVj"&gt;Impairment
of Long-Lived Assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.45in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;In
accordance with ASC 360-10, &#x201c;Long-lived assets,&#x201d; which include property and equipment and intangible assets, are reviewed
for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability
of long-lived assets to be held and used is measured by a comparison of the carrying amount of an asset to the estimated undiscounted
future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated undiscounted future
cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the
assets. Fair value is generally determined using the asset&#x2019;s expected future discounted cash flows or market value, if readily
determinable.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84B_eus-gaap--EmployeeStockOwnershipPlanESOPPolicy_zh3AyswVz5Te" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_860_zYj1IsvzQ9N5"&gt;Employee
Benefit/Liability&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Liabilities
arising in respect of wages and salaries, accumulated annual leave, accumulated long service leave and any other employee benefits expected
to be settled within twelve months of the reporting date are measured based on the employee&#x2019;s remuneration rates applicable at
the reporting date. All other employee benefit liabilities are measured at the present value of the estimated future cash outflow to
be made in respect of services provided by employees up to the reporting date. All employee liabilities are owed within the next twelve
months.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84B_ecustom--GoodsAndServiceTaxPolicyTextBlock_zXRt2fYMNCde" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_861_zXbULMoiEBt1"&gt;Australian
Goods and Services Tax (&#x201c;GST&#x201d;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Revenues,
expenses and balance sheet items are recognized net of the amount of GST, except payable and receivable balances which are shown inclusive
of GST. The GST incurred is payable on revenues to, and recoverable on purchases from, the Australian Taxation Office.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Cash
flows are presented in the statements of cash flow on a gross basis, except for the GST component of investing and financing activities,
which are disclosed as operating cash flows.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;As
of June 30, 2021 and 2020, the Company was owed $&lt;span id="xdx_908_eus-gaap--ValueAddedTaxReceivableCurrent_c20210630_pp0p0" title="Value added tax receivable"&gt;4,341&lt;/span&gt; and $&lt;span id="xdx_90B_eus-gaap--ValueAddedTaxReceivableCurrent_c20200630_pp0p0" title="Value added tax receivable"&gt;2,015&lt;/span&gt;, respectively, from the Australian Taxation Office. These amounts were
fully collected subsequent to the balance sheet reporting dates.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_858_znfh9MJCo1af" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;PROPANC
BIOPHARMA, INC. AND SUBSIDIARY&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;June
30, 2021 and 2020&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84C_eus-gaap--DerivativesReportingOfDerivativeActivity_zPkIWm6mIOdb" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_866_z26UFsPBAyH9"&gt;Derivative
Instruments&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;ASC
Topic 815, &lt;i&gt;Derivatives and Hedging&lt;/i&gt; (&#x201c;ASC Topic 815&#x201d;), establishes accounting and reporting standards for derivative
instruments and for hedging activities by requiring that all derivatives be recognized in the balance sheet and measured at fair value.
Gains or losses resulting from changes in the fair value of derivatives are recognized in earnings. On the date of conversion or payoff
of debt, the Company records the fair value of the conversion shares, removes the fair value of the related derivative liability, removes
any discounts and records a net gain or loss on debt extinguishment. On July 1, 2019 the Company adopted ASU 2017-11 under which down-round
Features in Financial Instruments will no longer cause derivative treatment. The Company applies the modified prospective method of adoption.
There were no cumulative effects on adoption.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84D_ecustom--ConvertibleNotesPolicyTextBlock_zxajUQ2alEZ1" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86C_zoAjEhAqQMW4"&gt;Convertible
Notes With Variable Conversion Options&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 29.15pt; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;The
Company has entered into convertible notes, some of which contain variable conversion options, whereby the outstanding principal and
accrued interest may be converted, by the holder, into common shares at a fixed discount to the price of the common stock at or around
the time of conversion. The Company treats these convertible notes as stock settled debt under ASC 480, &#x201c;&lt;i&gt;Distinguishing Liabilities
from Equity&lt;/i&gt;&#x201d; and measures the fair value of the notes at the time of issuance, which is the result of the share price discount
at the time of conversion and records the put premium as interest expense.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_843_eus-gaap--IncomeTaxPolicyTextBlock_zN0Zlr1p7J9g" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86C_zPUZwyGp2WM5"&gt;Income
Taxes&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 29.15pt; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;The
Company is governed by Australia and United States income tax laws, which are administered by the Australian Taxation Office and the
United States Internal Revenue Service, respectively. The Company follows ASC 740 &#x201c;&lt;i&gt;Accounting for Income Taxes&lt;/i&gt;,&#x201d; when
accounting for income taxes, which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred
income tax assets and liabilities are computed annually for temporary differences between the financial statements and tax bases of assets
and liabilities that will result in taxable or deductible amounts in the future based on enacted tax laws and rates applicable to the
periods in which the differences are expected to affect taxable income. Valuation allowances are established when necessary to reduce
deferred tax assets to the amount expected to be realized. Income tax expense is the tax payable or refundable for the period plus or
minus the change during the period in deferred tax assets and liabilities.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 29.15pt; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;The
Company follows ASC 740, Sections 25 through 60, &#x201c;&lt;i&gt;Accounting for Uncertainty in Income Taxes&lt;/i&gt;.&#x201d; These sections provide
detailed guidance for the financial statement recognition, measurement and disclosure of uncertain tax positions recognized in the financial
statements. Tax positions must meet a &#x201c;more-likely-than-not&#x201d; recognition threshold at the effective date to be recognized
upon the adoption of ASC 740 and in subsequent periods.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84F_eus-gaap--ResearchAndDevelopmentExpensePolicy_zQCpNdwyFt72" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_861_zChCCKk1NlA1"&gt;Research
and Development Costs and Tax Credits&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;In
accordance with ASC 730-10, &lt;i&gt;&#x201c;Research and Development-Overall,&#x201d;&lt;/i&gt; research and development costs are expensed when incurred.
Total research and development costs for the fiscal years ended June 30, 2021 and 2020 were $&lt;span id="xdx_909_eus-gaap--ResearchAndDevelopmentExpense_c20200701__20210630_pp0p0" title="Research and development costs"&gt;230,956&lt;/span&gt; and $&lt;span id="xdx_90A_eus-gaap--ResearchAndDevelopmentExpense_pp0p0_c20190701__20200630_z8D3lSanDVD5" title="Research and development costs"&gt;179,987&lt;/span&gt;, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;The
Company may apply for research and development tax concessions with the Australian Taxation Office on an annual basis. Although the amount
is possible to estimate at year end, the Australian Taxation Office may reject or materially alter the claim amount. Accordingly, the
Company does not recognize the benefit of the claim amount until cash receipt since collectability is not certain until such time. The
tax concession is a refundable credit. If the Company has net income, then the Company can receive the credit which reduces its income
tax liability. If the Company has net losses, then the Company may still receive a cash payment for the credit, however, the Company&#x2019;s
net operating loss carryforwards are reduced by the gross equivalent loss that would produce the credit amount when the income tax rate
is applied to that gross amount. The concession is recognized as tax benefit, in operations, upon receipt.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;During
each of the fiscal years ended June 30, 2021 and 2020, the Company applied for, and received from the Australian Taxation Office, a research
and development tax credit in the amount of $&lt;span id="xdx_905_eus-gaap--IncomeTaxExpenseBenefit_iN_pp0p0_di_c20200701__20210630_zk1027s4V9Fe" title="Tax credits"&gt;113,415 &lt;/span&gt;and $&lt;span id="xdx_901_eus-gaap--IncomeTaxExpenseBenefit_iN_pp0p0_di_c20190701__20200630_zG6ZTffrCXsj"&gt;134,728&lt;/span&gt;, respectively, which is reflected as a tax benefit in the accompanying
consolidated statements of operations and comprehensive income (loss).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_846_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zaUFPhFSnEja" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_861_zBj3dM4Ckci3"&gt;Stock
Based Compensation&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;The
Company records stock-based compensation in accordance with ASC 718, &#x201c;&lt;i&gt;Stock Compensation&lt;/i&gt;&#x201d;. ASC 718 requires the fair
value of all stock-based employee compensation awarded to employees to be recorded as an expense over the shorter of the service period
or the vesting period. The Company values employee and non-employee stock-based compensation at fair value using the Black-Scholes Option
Pricing Model.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;PROPANC
BIOPHARMA, INC. AND SUBSIDIARY&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;June
30, 2021 and 2020&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;The
Company adopted ASU 2018-07 and accounts for non-employee share-based awards in accordance with the measurement and recognition criteria
of ASC 718 and recognizes the fair value of such awards over the service period. The Company used the modified prospective method of
adoption. There was no cumulative effect of adoption on July 1, 2019.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84A_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zLQNRYxs3VV5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86E_zEV4U1sMubQc"&gt;Revenue
Recognition&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;The
Company adopted and implemented on July 1, 2018, ASC 606 &#x2013; Revenue from Contracts with Customers (&#x201c;ASC 606&#x201d;). ASC 606
did not have a material impact on the consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Upon
implementation of ASC 606, the Company recognizes revenue in accordance with that core principle by applying the following steps:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Step
1: Identify the contract(s) with a customer.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Step
2: Identify the performance obligations in the contract.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Step
3: Determine the transaction price.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Step
4: Allocate the transaction price to the performance obligations in the contract.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Step
5: Recognize revenue when (or as) the entity satisfies a performance obligation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 29.15pt; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Subject
to these criteria, the Company intends to recognize revenue relating to royalties on product sales in the period in which the sale occurs
and the royalty term has begun.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_846_eus-gaap--LegalCostsPolicyTextBlock_z7Q8kazLnfD2" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86A_zAg6XnkCAfwa"&gt;Legal
Expenses&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;All
legal costs for litigation are charged to expense as incurred.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_848_eus-gaap--LesseeLeasesPolicyTextBlock_zdlobmuL7B78" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86D_zjYfYbFZC052"&gt;Leases&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;In
February 2016, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued ASU 2016-02, &lt;i&gt;Leases&lt;/i&gt; (Topic 842). The updated
guidance requires lessees to recognize lease assets and lease liabilities for most operating leases. In addition, the updated guidance
requires that lessors separate lease and non-lease components in a contract in accordance with the new revenue guidance in ASC 606. This
guidance is effective for interim and annual reporting periods beginning after December 15, 2018. The Company adopted this guidance effective
July 1, 2019.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;On
July 1, 2019, the Company adopted ASU No. 2016-02, applying the package of practical expedients to leases that commenced before the effective
date whereby the Company elected to not reassess the following: (i) whether any expired or existing contracts contain leases and; (ii)
initial direct costs for any existing leases. For contracts entered into on or after the effective date, at the inception of a contract
the Company assessed whether the contract is, or contains, a lease. The Company&#x2019;s assessment is based on: (1) whether the contract
involves the use of a distinct identified asset, (2) whether we obtain the right to substantially all the economic benefit from the use
of the asset throughout the period, and (3) whether it has the right to direct the use of the asset. The Company will allocate the consideration
in the contract to each lease component based on its relative stand-alone price to determine the lease payments.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Operating
lease ROU assets represents the right to use the leased asset for the lease term and operating lease liabilities are recognized based
on the present value of future minimum lease payments over the lease term at commencement date. As most leases do not provide an implicit
rate, the Company use an incremental borrowing rate based on the information available at the adoption date in determining the present
value of future payments. Lease expense for minimum lease payments is amortized on a straight-line basis over the lease term and is included
in general and administrative expenses in the consolidated statements of operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_844_eus-gaap--EarningsPerSharePolicyTextBlock_zz34xJHutc16" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_864_zK6mVblSbdGl"&gt;Basic
and Diluted Net Loss Per Common Share&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Basic
net loss per share is computed by dividing the net loss by the weighted average number of common shares outstanding during the period.
Diluted net loss per common share is computed by dividing the net loss by the weighted average number of common shares outstanding for
the period and, if dilutive, potential common shares outstanding during the period. Potentially dilutive securities consist of the incremental
common shares issuable upon exercise of common stock equivalents such as stock options, warrants and convertible debt instruments. Potentially
dilutive securities are excluded from the computation if their effect is anti-dilutive. As a result, the basic and diluted per share
amounts for all periods presented are identical. &lt;span id="xdx_903_eus-gaap--DebtInstrumentConvertibleTermsOfConversionFeature_c20200701__20210630_zq4qmcOL3Smg" title="Debt conversion percentage, description"&gt;Each holder of the notes has agreed to a &lt;span id="xdx_904_eus-gaap--DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_pid_dp_uPure_c20200701__20210630_zzJU4tiDdpIk" title="Debt conversion percentage"&gt;4.99&lt;/span&gt;% beneficial ownership conversion limitation
(subject to certain noteholders&#x2019; ability to increase such limitation to 9.99% upon 60 days&#x2019; notice to the Company)&lt;/span&gt;, and each
note may not be converted during the first six-month period from the date of issuance. Such securities are considered dilutive securities
which were excluded from the computation since the effect is anti-dilutive.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;PROPANC
BIOPHARMA, INC. AND SUBSIDIARY&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;June
30, 2021 and 2020&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_898_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zp7ZAEmlQrYd" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;span id="xdx_8B9_zWwXX59WoQ27" style="display: none"&gt;SCHEDULE OF DILUTIVE SECURITIES EXCLUDED FROM COMPUTATION&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 100%; margin-right: auto"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;June
    30, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;June
    30, 2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 64%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Stock
    Options&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20200701__20210630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_zRF3jRJ6r1te" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Antidilutive securities excluded from computation of earnings per share"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;59&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20190701__20200630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_zloQygdbzAlh" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Antidilutive securities excluded from computation of earnings per share"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;60&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Stock
    Warrants&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20200701__20210630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zNOzT456LxB6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Antidilutive securities excluded from computation of earnings per share"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;121,329&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20190701__20200630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zNtlaS94tWTe" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Antidilutive securities excluded from computation of earnings per share"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;151,171&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Unvested
    restricted stock&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20200701__20210630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--UnvestedRestrictedStockMember_zafhpGNhbIA6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Antidilutive securities excluded from computation of earnings per share"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;59&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20190701__20200630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--UnvestedRestrictedStockMember_zLMxtEOeqQAc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Antidilutive securities excluded from computation of earnings per share"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;59&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Convertible
    Debt&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20200701__20210630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertibleDebtSecuritiesMember_zx6G7fcxhV22" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Antidilutive securities excluded from computation of earnings per share"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;12,416,972&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20190701__20200630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertibleDebtSecuritiesMember_z4ty7l1bgPGc" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Antidilutive securities excluded from computation of earnings per share"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;439,113&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Total&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20200701__20210630_zS2qhAKAAjyf" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Antidilutive securities excluded from computation of earnings per share"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;12,538,419&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20190701__20200630_zsjYE0XRyHH4" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Antidilutive securities excluded from computation of earnings per share"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;590,403&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A2_z3r805ucvGn" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84F_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zaCjb7rqrmle" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_864_zqGyiHQTKivb"&gt;Recent
Accounting Pronouncements&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;We
have reviewed the FASB issued ASU accounting pronouncements and interpretations thereof that have effectiveness dates during the periods
reported and in future periods. We have carefully considered the new pronouncements that alter previous generally accepted accounting
principles and do not believe that any new or modified principles will have a material impact on the Company&#x2019;s reported financial
position or operations in the near term with the exception of those disclosed below. The applicability of any standard is subject
to the formal review of the Company&#x2019;s financial management.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;In
August 2020, the FASB issued ASU 2020-06, &#x201c;Debt &#x2013; Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives
and Hedging &#x2013; Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40)&#x201d;. This ASU reduces the number of accounting models
for convertible debt instruments and convertible preferred stock. As well as amend the guidance for the derivatives scope exception for
contracts in an entity&#x2019;s own equity to reduce form-over-substance-based accounting conclusions. In addition, this ASU improves
and amends the related EPS guidance. This standard is effective for us on July 1, 2022, including interim periods within those fiscal
years. Adoption is either a modified retrospective method or a fully retrospective method of transition. The Company is currently assessing
the impact the new guidance will have on our consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock>
    <PPCB:NatureOfOperationsPolicyTextBlock contextRef="From2020-07-012021-06-30">&lt;p id="xdx_84D_ecustom--NatureOfOperationsPolicyTextBlock_zUy1ZG0cJ07l" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_864_zskNnen1aczd"&gt;Nature
of Operations&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Propanc
Biopharma, Inc. (the &#x201c;Company,&#x201d; &#x201c;we,&#x201d; &#x201c;us&#x201d; or &#x201c;our&#x201d;) was originally incorporated in Melbourne,
Victoria Australia on October 15, 2007 as Propanc PTY LTD, and continues to be based in Camberwell, Victoria Australia. Since its inception,
substantially all of the operations of the Company have been focused on the development of new cancer treatments targeting high-risk
patients, particularly cancer survivors, who need a follow-up, non-toxic, long-term therapy designed to prevent the cancer from returning
and spreading. The Company anticipates establishing global markets for its technologies. Our lead product candidate, which we refer to
as PRP, is an enhanced pro-enzyme formulation designed to enhance the anti-cancer effects of multiple enzymes acting synergistically.
It is currently in the preclinical phase of development.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 29.15pt; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;On
&lt;span id="xdx_902_edei--EntityIncorporationDateOfIncorporation_dd_c20200701__20210630_zjsnh70umwD9" title="Entity incorporation, date of incorporation"&gt;November 23, 2010&lt;/span&gt;, the Company was incorporated in the state of Delaware as Propanc Health Group Corporation. In January 2011, to reorganize
the Company, we acquired all of the outstanding shares of Propanc PTY LTD on a one-for-one basis making it a wholly-owned subsidiary
of the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;On
July 22, 2016, the Company formed a wholly owned subsidiary, Propanc (UK) Limited under the laws of England and Wales for the purpose
of submitting an orphan drug application to the European Medicines Agency as a small and medium-sized enterprise. As of June 30, 2021,
there has been no activity within this entity.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Effective
April 20, 2017, the Company changed its name to &#x201c;Propanc Biopharma, Inc.&#x201d; to better reflect the Company&#x2019;s stage of
operations and development.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;In
July 2020, a world first patent was granted in Australia for the cancer treatment method patent family. Presently, there are 29 granted
patents and 33 patents under examination in key global jurisdictions relating to the use of proenzymes against solid tumors, covering
the lead product candidate PRP.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;The
Company hopes to capture and protect additional patentable subject matter based on the Company&#x2019;s field of technology relating to
pharmaceutical compositions of proenzymes for treating cancer by filing additional patent applications as it advances its lead product
candidate, PRP, through various stages of development.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;On
November 17, 2020, the Company effected a &lt;span id="xdx_90D_eus-gaap--StockholdersEquityReverseStockSplit_c20201116__20201117" title="Reverse stock"&gt;one-for-one thousand (1:1,000)&lt;/span&gt; reverse stock split of the Company&#x2019;s issued and outstanding
shares of common stock (the &#x201c;Reverse Stock Split&#x201d;). Proportional adjustments for the Reverse Stock Split were made to the
Company&#x2019;s outstanding stock options, warrants and equity incentive plans. All share and per-share data and amounts have been retroactively
adjusted as of the earliest period presented in the consolidated financial statements to reflect the Reverse Stock Split.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</PPCB:NatureOfOperationsPolicyTextBlock>
    <dei:EntityIncorporationDateOfIncorporation contextRef="From2020-07-012021-06-30">2010-11-23</dei:EntityIncorporationDateOfIncorporation>
    <us-gaap:StockholdersEquityReverseStockSplit contextRef="From2020-11-162020-11-17">one-for-one thousand (1:1,000)</us-gaap:StockholdersEquityReverseStockSplit>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="From2020-07-012021-06-30">&lt;p id="xdx_840_eus-gaap--ConsolidationPolicyTextBlock_zTfyfILZC5Xb" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_860_z0xpPnCblBPa"&gt;Principles
of Consolidation&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;The
consolidated financial statements include the accounts of Propanc Biopharma, Inc., the parent entity, and its wholly-owned subsidiary,
Propanc PTY LTD. All inter-company balances and transactions have been eliminated in consolidation. Propanc (UK) Limited was an inactive
wholly-owned subsidiary through June 30, 2021.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:UseOfEstimates contextRef="From2020-07-012021-06-30">&lt;p id="xdx_845_eus-gaap--UseOfEstimates_zzwSrtiWrUj9" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_866_zCVztcFqdaWc"&gt;Use
of Estimates&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;The
preparation of financial statements in conformity with the accounting principles generally accepted in the United States of America (&#x201c;US
GAAP&#x201d;) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure
of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses
during the reporting period. Actual results could differ from these estimates. Significant estimates in the accompanying consolidated
financial statements include the estimates of useful lives for depreciation, valuation of the operating lease liability and related right-of-use
asset, valuation of derivatives, valuation of beneficial conversion features on convertible debt, allowance for uncollectable receivables,
valuation of equity based instruments issued for other than cash, the valuation allowance on deferred tax assets and foreign currency
translation due to certain average exchange rates applied in lieu of spot rates on transaction dates.&lt;/span&gt;&lt;/p&gt;

</us-gaap:UseOfEstimates>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock contextRef="From2020-07-012021-06-30">&lt;p id="xdx_84C_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_z1sqztQEFLQg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86F_zJUFHRfwNmQ9"&gt;Foreign
Currency Translation and Other Comprehensive Income (Loss)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;The
Company&#x2019;s wholly owned subsidiary&#x2019;s functional currency is the Australian dollar (AUD). For financial reporting purposes,
the Australian dollar has been translated into the Company&#x2019;s reporting currency which is the United States dollar ($) and/or (USD).
Assets and liabilities are translated at the exchange rate in effect at the balance sheet date. Revenues and expenses are translated
at the average rate of exchange prevailing during the reporting period. Equity transactions are translated at each historical transaction
date spot rate. Translation adjustments arising from the use of different exchange rates from period to period are included as a component
of stockholders&#x2019; equity (deficit) as &#x201c;Accumulated other comprehensive income (loss).&#x201d; Gains and losses resulting from
foreign currency transactions are included in the statements of operations and comprehensive income (loss) as a component of other
comprehensive income (loss). There have been no significant fluctuations in the exchange rate for the conversion of Australian dollars
to USD after the balance sheet date.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Other
Comprehensive Income (Loss) for all periods presented includes only foreign currency translation gains (losses).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Assets
and liabilities denominated in foreign currencies are translated into the functional currency at the exchange rates prevailing at
the consolidated balance sheet date with any transaction gains and losses that arise from exchange rate fluctuations on transactions
denominated in a currency other than the functional currency included in the consolidated results of operations as incurred.
Effective fiscal year 2021, the parent company determined that these intercompany loans will not be repaid in the foreseeable future
and thus, per ASC 830-20-35-3, gains and losses from measuring the intercompany balances are recorded within cumulative translation
adjustment, a component of accumulated other comprehensive income (loss). Prior to July 1, 2020, the Company recorded the foreign
currency transaction gains and losses from measuring the intercompany balances as a component of other income (expenses) titled
foreign currency transaction gain (loss). For the year ended June 30, 2021 and 2020, the Company recognized an exchange gain
(loss) of approximately $&lt;span id="xdx_901_eus-gaap--OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_c20200701__20210630__us-gaap--DebtInstrumentAxis__custom--IntercompanyLoansMember_pp0p0"&gt;1,005,000 &lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;and
($&lt;span id="xdx_90C_eus-gaap--OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_pp0p0_c20190701__20200630__us-gaap--DebtInstrumentAxis__custom--IntercompanyLoansMember_z9cfuN0kVfSk"&gt;133,000&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;),
on intercompany loans made by the parent to the subsidiary which have not been repaid as of June 30, 2021.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_890_ecustom--ScheduleOfTranslationExchangeRatesTableTextBlock_zHWjPfYgXMZa" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;As
of June 30, 2021 and 2020, the exchange rates used to translate amounts in Australian dollars into USD for the purposes of preparing
the consolidated financial statements were as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;span id="xdx_8BF_zkh7nqNm3XF1" style="display: none"&gt;SCHEDULE OF TRANSLATION EXCHANGE RATES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;June
    30, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;June
    30, 2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Exchange
    rate on balance sheet dates&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 64%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;USD
    : AUD exchange rate&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eus-gaap--ForeignCurrencyExchangeRateTranslation1_c20210630_pdd" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;0.7500&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eus-gaap--ForeignCurrencyExchangeRateTranslation1_c20200630_pdd" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;0.6891&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Average
    exchange rate for the period&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;USD
    : AUD exchange rate&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--ForeignCurrencyExchangeRateTranslation1_c20210630__srt--RangeAxis__srt--WeightedAverageMember_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;0.7473&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eus-gaap--ForeignCurrencyExchangeRateTranslation1_c20200630__srt--RangeAxis__srt--WeightedAverageMember_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;0.6742&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A5_zF6IdfJw4yP2" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89D_eus-gaap--ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_zTTKEp5aN2Mg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Change
in Accumulated Other Comprehensive Income (Loss) by component during the years ended June 30, 2021 and 2020 were as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;span id="xdx_8BB_z1EztVraTjcc" style="display: none"&gt;SCHEDULE OF CHANGE IN ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Foreign&lt;br/&gt;
    Currency Items:&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 82%"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Beginning
    balance, June 30, 2019&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iS_pp0p0_c20190701__20200630_zhNUQVDiorwj" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Beginning balance"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;1,066,998&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Foreign
    currency translation gain&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_pp0p0_c20190701__20200630_zybFsKiYr1bg" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Foreign currency translation gain"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;200,673&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Balance,
    June 30, 2020&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iS_pp0p0_c20200701__20210630_z7l1M52ClLwc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Beginning balance"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;1,267,671&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Foreign
    currency translation gain&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_pp0p0_c20200701__20210630_zDEdRjzTaONi" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Foreign currency translation gain"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;182,467&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Ending
    balance, June 30, 2021&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iE_pp0p0_c20200701__20210630_zuP9suUjhKki" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Ending balance"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;1,085,204&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A0_zHuOP9xbxVG" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
      contextRef="From2020-07-012021-06-30_custom_IntercompanyLoansMember"
      decimals="0"
      unitRef="USD">1005000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
      contextRef="From2019-07-012020-06-30_custom_IntercompanyLoansMember"
      decimals="0"
      unitRef="USD">133000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent>
    <PPCB:ScheduleOfTranslationExchangeRatesTableTextBlock contextRef="From2020-07-012021-06-30">&lt;p id="xdx_890_ecustom--ScheduleOfTranslationExchangeRatesTableTextBlock_zHWjPfYgXMZa" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;As
of June 30, 2021 and 2020, the exchange rates used to translate amounts in Australian dollars into USD for the purposes of preparing
the consolidated financial statements were as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;span id="xdx_8BF_zkh7nqNm3XF1" style="display: none"&gt;SCHEDULE OF TRANSLATION EXCHANGE RATES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;June
    30, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;June
    30, 2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Exchange
    rate on balance sheet dates&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 64%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;USD
    : AUD exchange rate&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eus-gaap--ForeignCurrencyExchangeRateTranslation1_c20210630_pdd" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;0.7500&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eus-gaap--ForeignCurrencyExchangeRateTranslation1_c20200630_pdd" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;0.6891&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Average
    exchange rate for the period&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;USD
    : AUD exchange rate&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--ForeignCurrencyExchangeRateTranslation1_c20210630__srt--RangeAxis__srt--WeightedAverageMember_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;0.7473&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eus-gaap--ForeignCurrencyExchangeRateTranslation1_c20200630__srt--RangeAxis__srt--WeightedAverageMember_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;0.6742&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</PPCB:ScheduleOfTranslationExchangeRatesTableTextBlock>
    <us-gaap:ForeignCurrencyExchangeRateTranslation1 contextRef="AsOf2021-06-30" decimals="INF" unitRef="Pure">0.7500</us-gaap:ForeignCurrencyExchangeRateTranslation1>
    <us-gaap:ForeignCurrencyExchangeRateTranslation1 contextRef="AsOf2020-06-30" decimals="INF" unitRef="Pure">0.6891</us-gaap:ForeignCurrencyExchangeRateTranslation1>
    <us-gaap:ForeignCurrencyExchangeRateTranslation1
      contextRef="AsOf2021-06-30_srt_WeightedAverageMember"
      decimals="INF"
      unitRef="Pure">0.7473</us-gaap:ForeignCurrencyExchangeRateTranslation1>
    <us-gaap:ForeignCurrencyExchangeRateTranslation1
      contextRef="AsOf2020-06-30_srt_WeightedAverageMember"
      decimals="INF"
      unitRef="Pure">0.6742</us-gaap:ForeignCurrencyExchangeRateTranslation1>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock contextRef="From2020-07-012021-06-30">&lt;p id="xdx_89D_eus-gaap--ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_zTTKEp5aN2Mg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Change
in Accumulated Other Comprehensive Income (Loss) by component during the years ended June 30, 2021 and 2020 were as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;span id="xdx_8BB_z1EztVraTjcc" style="display: none"&gt;SCHEDULE OF CHANGE IN ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Foreign&lt;br/&gt;
    Currency Items:&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 82%"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Beginning
    balance, June 30, 2019&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iS_pp0p0_c20190701__20200630_zhNUQVDiorwj" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Beginning balance"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;1,066,998&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Foreign
    currency translation gain&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_pp0p0_c20190701__20200630_zybFsKiYr1bg" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Foreign currency translation gain"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;200,673&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Balance,
    June 30, 2020&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iS_pp0p0_c20200701__20210630_z7l1M52ClLwc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Beginning balance"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;1,267,671&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Foreign
    currency translation gain&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_pp0p0_c20200701__20210630_zDEdRjzTaONi" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Foreign currency translation gain"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;182,467&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Ending
    balance, June 30, 2021&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iE_pp0p0_c20200701__20210630_zuP9suUjhKki" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Ending balance"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;1,085,204&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="AsOf2019-06-30" decimals="0" unitRef="USD">1066998</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">200673</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">1267671</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">182467</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">1085204</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="From2020-07-012021-06-30">&lt;p id="xdx_84A_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zVxpyFcjsmfb" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_869_zSpI6haJjHrj"&gt;Fair
Value of Financial Instruments and Fair Value Measurements&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;The
Company measures its financial assets and liabilities in accordance with US GAAP. For certain financial instruments, including cash and
cash equivalents, accounts receivable, accounts payable and accrued liabilities, the carrying amounts approximate fair value due to their
short maturities. Amounts recorded for notes payable, net of discount, and loans payable also approximate fair value because current
interest rates available for debt with similar terms and maturities are substantially the same.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;The
Company follows accounting guidance for financial assets and liabilities. This standard defines fair value, provides guidance for measuring
fair value and requires certain disclosures. This standard does not require any new fair value measurements, but rather applies to all
other accounting pronouncements that require or permit fair value measurements. This guidance does not apply to measurements related
to share-based payments. This guidance discusses valuation techniques, such as the market approach (comparable market prices), the income
approach (present value of future income or cash flow), and the cost approach (cost to replace the service capacity of an asset or replacement
cost).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;The
guidance utilizes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three broad
levels. The following is a brief description of those three levels:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.2in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Level
1: Observable inputs such as quoted prices (unadjusted) in active markets for identical assets or liabilities.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.2in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Level
2: Inputs, other than quoted prices that are observable, either directly or indirectly. These include quoted prices for similar assets
or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.2in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Level
3: Unobservable inputs in which little or no market data exists, therefore developed using estimates and assumptions developed by us,
which reflect those that a market participant would use.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Also
see Note 12 - Derivative Financial Instruments and Fair Value Measurements.&lt;/span&gt;&lt;/p&gt;

</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="From2020-07-012021-06-30">&lt;p id="xdx_849_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zbBtLCxM8FT2" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86B_zOfKCWdOLVRd"&gt;Cash
and Cash Equivalents&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Cash
and cash equivalents include cash on hand and at banks, short-term deposits with an original maturity of three months or less with financial
institutions, and bank overdrafts. Bank overdrafts, as applicable, are reflected as a current liability on the balance sheets.
There were &lt;span id="xdx_903_eus-gaap--CashEquivalentsAtCarryingValue_iI_pp0p0_do_c20200630_zZ1eOJKYJYr7"&gt;no&lt;/span&gt;&lt;/span&gt; &lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;cash
equivalents as of June 30, 2021 or June 30, 2020.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:CashEquivalentsAtCarryingValue contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">0</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="From2020-07-012021-06-30">&lt;p id="xdx_84B_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zfg52EPJexy6" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_862_zHWcQfXqSLH3"&gt;Property
and Equipment&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Property
and equipment are stated at cost, net of accumulated depreciation. Expenditures for maintenance and repairs are expensed as incurred;
additions, renewals, and betterments are capitalized. When property and equipment are retired or otherwise disposed of, the related cost
and accumulated depreciation are removed from the respective accounts, and any gain or loss is included in operations. Depreciation of
property and equipment is provided using the declining balance method. The depreciable amount is the cost less its residual value.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_892_ecustom--ScheduleOfPropertyAndEquipmentEstimatedUsefulLivesTableTextBlock_z3AwX2Xd0mO4" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;The
estimated useful lives are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;span id="xdx_8BA_zTqP1ilC57ma" style="display: none"&gt;SCHEDULE OF PROPERTY AND EQUIPMENT ESTIMATED USEFUL LIVES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 28%"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Machinery
    and equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 72%"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;-
    &lt;span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200701__20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_zOXkToZUepQc" title="Property and equipment estimated useful lives"&gt;5&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Furniture&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;-
    &lt;span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200701__20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zW81xzQcQdSg" title="Property and equipment estimated useful lives"&gt;7&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A6_zca7BRRp6xl5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <PPCB:ScheduleOfPropertyAndEquipmentEstimatedUsefulLivesTableTextBlock contextRef="From2020-07-012021-06-30">&lt;p id="xdx_892_ecustom--ScheduleOfPropertyAndEquipmentEstimatedUsefulLivesTableTextBlock_z3AwX2Xd0mO4" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;The
estimated useful lives are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;span id="xdx_8BA_zTqP1ilC57ma" style="display: none"&gt;SCHEDULE OF PROPERTY AND EQUIPMENT ESTIMATED USEFUL LIVES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 28%"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Machinery
    and equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 72%"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;-
    &lt;span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200701__20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_zOXkToZUepQc" title="Property and equipment estimated useful lives"&gt;5&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Furniture&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;-
    &lt;span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200701__20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zW81xzQcQdSg" title="Property and equipment estimated useful lives"&gt;7&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</PPCB:ScheduleOfPropertyAndEquipmentEstimatedUsefulLivesTableTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="From2020-07-012021-06-30_us-gaap_MachineryAndEquipmentMember">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="From2020-07-012021-06-30_us-gaap_FurnitureAndFixturesMember">P7Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy contextRef="From2020-07-012021-06-30">&lt;p id="xdx_841_eus-gaap--GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_zv8lJAmH5La9" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_863_zdGUX8vUhRsb"&gt;Patents&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 29.15pt; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Patents
are stated at cost and amortized on a straight-line basis over the estimated future periods if and once the patent has been granted by
a regulatory agency. However, the Company will expense any patent costs as long as we are in the startup stage. Accordingly, as the Company&#x2019;s
products are not currently approved for market, all patent costs incurred from 2013 through June 30, 2021 were expensed immediately.
This practice of expensing patent costs immediately ends when a product receives market authorization from a government regulatory agency.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock contextRef="From2020-07-012021-06-30">&lt;p id="xdx_845_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zey8gFOmZPEd" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86C_zgKIFAsI1sVj"&gt;Impairment
of Long-Lived Assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.45in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;In
accordance with ASC 360-10, &#x201c;Long-lived assets,&#x201d; which include property and equipment and intangible assets, are reviewed
for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability
of long-lived assets to be held and used is measured by a comparison of the carrying amount of an asset to the estimated undiscounted
future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated undiscounted future
cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the
assets. Fair value is generally determined using the asset&#x2019;s expected future discounted cash flows or market value, if readily
determinable.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <us-gaap:EmployeeStockOwnershipPlanESOPPolicy contextRef="From2020-07-012021-06-30">&lt;p id="xdx_84B_eus-gaap--EmployeeStockOwnershipPlanESOPPolicy_zh3AyswVz5Te" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_860_zYj1IsvzQ9N5"&gt;Employee
Benefit/Liability&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Liabilities
arising in respect of wages and salaries, accumulated annual leave, accumulated long service leave and any other employee benefits expected
to be settled within twelve months of the reporting date are measured based on the employee&#x2019;s remuneration rates applicable at
the reporting date. All other employee benefit liabilities are measured at the present value of the estimated future cash outflow to
be made in respect of services provided by employees up to the reporting date. All employee liabilities are owed within the next twelve
months.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:EmployeeStockOwnershipPlanESOPPolicy>
    <PPCB:GoodsAndServiceTaxPolicyTextBlock contextRef="From2020-07-012021-06-30">&lt;p id="xdx_84B_ecustom--GoodsAndServiceTaxPolicyTextBlock_zXRt2fYMNCde" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_861_zXbULMoiEBt1"&gt;Australian
Goods and Services Tax (&#x201c;GST&#x201d;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Revenues,
expenses and balance sheet items are recognized net of the amount of GST, except payable and receivable balances which are shown inclusive
of GST. The GST incurred is payable on revenues to, and recoverable on purchases from, the Australian Taxation Office.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Cash
flows are presented in the statements of cash flow on a gross basis, except for the GST component of investing and financing activities,
which are disclosed as operating cash flows.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;As
of June 30, 2021 and 2020, the Company was owed $&lt;span id="xdx_908_eus-gaap--ValueAddedTaxReceivableCurrent_c20210630_pp0p0" title="Value added tax receivable"&gt;4,341&lt;/span&gt; and $&lt;span id="xdx_90B_eus-gaap--ValueAddedTaxReceivableCurrent_c20200630_pp0p0" title="Value added tax receivable"&gt;2,015&lt;/span&gt;, respectively, from the Australian Taxation Office. These amounts were
fully collected subsequent to the balance sheet reporting dates.&lt;/span&gt;&lt;/p&gt;

</PPCB:GoodsAndServiceTaxPolicyTextBlock>
    <us-gaap:ValueAddedTaxReceivableCurrent contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">4341</us-gaap:ValueAddedTaxReceivableCurrent>
    <us-gaap:ValueAddedTaxReceivableCurrent contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">2015</us-gaap:ValueAddedTaxReceivableCurrent>
    <us-gaap:DerivativesReportingOfDerivativeActivity contextRef="From2020-07-012021-06-30">&lt;p id="xdx_84C_eus-gaap--DerivativesReportingOfDerivativeActivity_zPkIWm6mIOdb" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_866_z26UFsPBAyH9"&gt;Derivative
Instruments&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;ASC
Topic 815, &lt;i&gt;Derivatives and Hedging&lt;/i&gt; (&#x201c;ASC Topic 815&#x201d;), establishes accounting and reporting standards for derivative
instruments and for hedging activities by requiring that all derivatives be recognized in the balance sheet and measured at fair value.
Gains or losses resulting from changes in the fair value of derivatives are recognized in earnings. On the date of conversion or payoff
of debt, the Company records the fair value of the conversion shares, removes the fair value of the related derivative liability, removes
any discounts and records a net gain or loss on debt extinguishment. On July 1, 2019 the Company adopted ASU 2017-11 under which down-round
Features in Financial Instruments will no longer cause derivative treatment. The Company applies the modified prospective method of adoption.
There were no cumulative effects on adoption.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:DerivativesReportingOfDerivativeActivity>
    <PPCB:ConvertibleNotesPolicyTextBlock contextRef="From2020-07-012021-06-30">&lt;p id="xdx_84D_ecustom--ConvertibleNotesPolicyTextBlock_zxajUQ2alEZ1" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86C_zoAjEhAqQMW4"&gt;Convertible
Notes With Variable Conversion Options&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 29.15pt; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;The
Company has entered into convertible notes, some of which contain variable conversion options, whereby the outstanding principal and
accrued interest may be converted, by the holder, into common shares at a fixed discount to the price of the common stock at or around
the time of conversion. The Company treats these convertible notes as stock settled debt under ASC 480, &#x201c;&lt;i&gt;Distinguishing Liabilities
from Equity&lt;/i&gt;&#x201d; and measures the fair value of the notes at the time of issuance, which is the result of the share price discount
at the time of conversion and records the put premium as interest expense.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</PPCB:ConvertibleNotesPolicyTextBlock>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="From2020-07-012021-06-30">&lt;p id="xdx_843_eus-gaap--IncomeTaxPolicyTextBlock_zN0Zlr1p7J9g" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86C_zPUZwyGp2WM5"&gt;Income
Taxes&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 29.15pt; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;The
Company is governed by Australia and United States income tax laws, which are administered by the Australian Taxation Office and the
United States Internal Revenue Service, respectively. The Company follows ASC 740 &#x201c;&lt;i&gt;Accounting for Income Taxes&lt;/i&gt;,&#x201d; when
accounting for income taxes, which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred
income tax assets and liabilities are computed annually for temporary differences between the financial statements and tax bases of assets
and liabilities that will result in taxable or deductible amounts in the future based on enacted tax laws and rates applicable to the
periods in which the differences are expected to affect taxable income. Valuation allowances are established when necessary to reduce
deferred tax assets to the amount expected to be realized. Income tax expense is the tax payable or refundable for the period plus or
minus the change during the period in deferred tax assets and liabilities.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 29.15pt; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;The
Company follows ASC 740, Sections 25 through 60, &#x201c;&lt;i&gt;Accounting for Uncertainty in Income Taxes&lt;/i&gt;.&#x201d; These sections provide
detailed guidance for the financial statement recognition, measurement and disclosure of uncertain tax positions recognized in the financial
statements. Tax positions must meet a &#x201c;more-likely-than-not&#x201d; recognition threshold at the effective date to be recognized
upon the adoption of ASC 740 and in subsequent periods.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:ResearchAndDevelopmentExpensePolicy contextRef="From2020-07-012021-06-30">&lt;p id="xdx_84F_eus-gaap--ResearchAndDevelopmentExpensePolicy_zQCpNdwyFt72" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_861_zChCCKk1NlA1"&gt;Research
and Development Costs and Tax Credits&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;In
accordance with ASC 730-10, &lt;i&gt;&#x201c;Research and Development-Overall,&#x201d;&lt;/i&gt; research and development costs are expensed when incurred.
Total research and development costs for the fiscal years ended June 30, 2021 and 2020 were $&lt;span id="xdx_909_eus-gaap--ResearchAndDevelopmentExpense_c20200701__20210630_pp0p0" title="Research and development costs"&gt;230,956&lt;/span&gt; and $&lt;span id="xdx_90A_eus-gaap--ResearchAndDevelopmentExpense_pp0p0_c20190701__20200630_z8D3lSanDVD5" title="Research and development costs"&gt;179,987&lt;/span&gt;, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;The
Company may apply for research and development tax concessions with the Australian Taxation Office on an annual basis. Although the amount
is possible to estimate at year end, the Australian Taxation Office may reject or materially alter the claim amount. Accordingly, the
Company does not recognize the benefit of the claim amount until cash receipt since collectability is not certain until such time. The
tax concession is a refundable credit. If the Company has net income, then the Company can receive the credit which reduces its income
tax liability. If the Company has net losses, then the Company may still receive a cash payment for the credit, however, the Company&#x2019;s
net operating loss carryforwards are reduced by the gross equivalent loss that would produce the credit amount when the income tax rate
is applied to that gross amount. The concession is recognized as tax benefit, in operations, upon receipt.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;During
each of the fiscal years ended June 30, 2021 and 2020, the Company applied for, and received from the Australian Taxation Office, a research
and development tax credit in the amount of $&lt;span id="xdx_905_eus-gaap--IncomeTaxExpenseBenefit_iN_pp0p0_di_c20200701__20210630_zk1027s4V9Fe" title="Tax credits"&gt;113,415 &lt;/span&gt;and $&lt;span id="xdx_901_eus-gaap--IncomeTaxExpenseBenefit_iN_pp0p0_di_c20190701__20200630_zG6ZTffrCXsj"&gt;134,728&lt;/span&gt;, respectively, which is reflected as a tax benefit in the accompanying
consolidated statements of operations and comprehensive income (loss).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">230956</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">179987</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">-113415</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">-134728</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy contextRef="From2020-07-012021-06-30">&lt;p id="xdx_846_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zaUFPhFSnEja" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_861_zBj3dM4Ckci3"&gt;Stock
Based Compensation&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;The
Company records stock-based compensation in accordance with ASC 718, &#x201c;&lt;i&gt;Stock Compensation&lt;/i&gt;&#x201d;. ASC 718 requires the fair
value of all stock-based employee compensation awarded to employees to be recorded as an expense over the shorter of the service period
or the vesting period. The Company values employee and non-employee stock-based compensation at fair value using the Black-Scholes Option
Pricing Model.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;PROPANC
BIOPHARMA, INC. AND SUBSIDIARY&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;June
30, 2021 and 2020&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;The
Company adopted ASU 2018-07 and accounts for non-employee share-based awards in accordance with the measurement and recognition criteria
of ASC 718 and recognizes the fair value of such awards over the service period. The Company used the modified prospective method of
adoption. There was no cumulative effect of adoption on July 1, 2019.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock contextRef="From2020-07-012021-06-30">&lt;p id="xdx_84A_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zLQNRYxs3VV5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86E_zEV4U1sMubQc"&gt;Revenue
Recognition&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;The
Company adopted and implemented on July 1, 2018, ASC 606 &#x2013; Revenue from Contracts with Customers (&#x201c;ASC 606&#x201d;). ASC 606
did not have a material impact on the consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Upon
implementation of ASC 606, the Company recognizes revenue in accordance with that core principle by applying the following steps:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Step
1: Identify the contract(s) with a customer.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Step
2: Identify the performance obligations in the contract.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Step
3: Determine the transaction price.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Step
4: Allocate the transaction price to the performance obligations in the contract.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Step
5: Recognize revenue when (or as) the entity satisfies a performance obligation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 29.15pt; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Subject
to these criteria, the Company intends to recognize revenue relating to royalties on product sales in the period in which the sale occurs
and the royalty term has begun.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:LegalCostsPolicyTextBlock contextRef="From2020-07-012021-06-30">&lt;p id="xdx_846_eus-gaap--LegalCostsPolicyTextBlock_z7Q8kazLnfD2" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86A_zAg6XnkCAfwa"&gt;Legal
Expenses&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;All
legal costs for litigation are charged to expense as incurred.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:LegalCostsPolicyTextBlock>
    <us-gaap:LesseeLeasesPolicyTextBlock contextRef="From2020-07-012021-06-30">&lt;p id="xdx_848_eus-gaap--LesseeLeasesPolicyTextBlock_zdlobmuL7B78" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86D_zjYfYbFZC052"&gt;Leases&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;In
February 2016, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued ASU 2016-02, &lt;i&gt;Leases&lt;/i&gt; (Topic 842). The updated
guidance requires lessees to recognize lease assets and lease liabilities for most operating leases. In addition, the updated guidance
requires that lessors separate lease and non-lease components in a contract in accordance with the new revenue guidance in ASC 606. This
guidance is effective for interim and annual reporting periods beginning after December 15, 2018. The Company adopted this guidance effective
July 1, 2019.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;On
July 1, 2019, the Company adopted ASU No. 2016-02, applying the package of practical expedients to leases that commenced before the effective
date whereby the Company elected to not reassess the following: (i) whether any expired or existing contracts contain leases and; (ii)
initial direct costs for any existing leases. For contracts entered into on or after the effective date, at the inception of a contract
the Company assessed whether the contract is, or contains, a lease. The Company&#x2019;s assessment is based on: (1) whether the contract
involves the use of a distinct identified asset, (2) whether we obtain the right to substantially all the economic benefit from the use
of the asset throughout the period, and (3) whether it has the right to direct the use of the asset. The Company will allocate the consideration
in the contract to each lease component based on its relative stand-alone price to determine the lease payments.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Operating
lease ROU assets represents the right to use the leased asset for the lease term and operating lease liabilities are recognized based
on the present value of future minimum lease payments over the lease term at commencement date. As most leases do not provide an implicit
rate, the Company use an incremental borrowing rate based on the information available at the adoption date in determining the present
value of future payments. Lease expense for minimum lease payments is amortized on a straight-line basis over the lease term and is included
in general and administrative expenses in the consolidated statements of operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="From2020-07-012021-06-30">&lt;p id="xdx_844_eus-gaap--EarningsPerSharePolicyTextBlock_zz34xJHutc16" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_864_zK6mVblSbdGl"&gt;Basic
and Diluted Net Loss Per Common Share&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Basic
net loss per share is computed by dividing the net loss by the weighted average number of common shares outstanding during the period.
Diluted net loss per common share is computed by dividing the net loss by the weighted average number of common shares outstanding for
the period and, if dilutive, potential common shares outstanding during the period. Potentially dilutive securities consist of the incremental
common shares issuable upon exercise of common stock equivalents such as stock options, warrants and convertible debt instruments. Potentially
dilutive securities are excluded from the computation if their effect is anti-dilutive. As a result, the basic and diluted per share
amounts for all periods presented are identical. &lt;span id="xdx_903_eus-gaap--DebtInstrumentConvertibleTermsOfConversionFeature_c20200701__20210630_zq4qmcOL3Smg" title="Debt conversion percentage, description"&gt;Each holder of the notes has agreed to a &lt;span id="xdx_904_eus-gaap--DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_pid_dp_uPure_c20200701__20210630_zzJU4tiDdpIk" title="Debt conversion percentage"&gt;4.99&lt;/span&gt;% beneficial ownership conversion limitation
(subject to certain noteholders&#x2019; ability to increase such limitation to 9.99% upon 60 days&#x2019; notice to the Company)&lt;/span&gt;, and each
note may not be converted during the first six-month period from the date of issuance. Such securities are considered dilutive securities
which were excluded from the computation since the effect is anti-dilutive.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;PROPANC
BIOPHARMA, INC. AND SUBSIDIARY&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;June
30, 2021 and 2020&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_898_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zp7ZAEmlQrYd" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;span id="xdx_8B9_zWwXX59WoQ27" style="display: none"&gt;SCHEDULE OF DILUTIVE SECURITIES EXCLUDED FROM COMPUTATION&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 100%; margin-right: auto"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;June
    30, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;June
    30, 2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 64%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Stock
    Options&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20200701__20210630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_zRF3jRJ6r1te" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Antidilutive securities excluded from computation of earnings per share"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;59&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20190701__20200630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_zloQygdbzAlh" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Antidilutive securities excluded from computation of earnings per share"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;60&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Stock
    Warrants&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20200701__20210630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zNOzT456LxB6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Antidilutive securities excluded from computation of earnings per share"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;121,329&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20190701__20200630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zNtlaS94tWTe" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Antidilutive securities excluded from computation of earnings per share"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;151,171&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Unvested
    restricted stock&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20200701__20210630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--UnvestedRestrictedStockMember_zafhpGNhbIA6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Antidilutive securities excluded from computation of earnings per share"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;59&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20190701__20200630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--UnvestedRestrictedStockMember_zLMxtEOeqQAc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Antidilutive securities excluded from computation of earnings per share"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;59&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Convertible
    Debt&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20200701__20210630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertibleDebtSecuritiesMember_zx6G7fcxhV22" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Antidilutive securities excluded from computation of earnings per share"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;12,416,972&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20190701__20200630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertibleDebtSecuritiesMember_z4ty7l1bgPGc" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Antidilutive securities excluded from computation of earnings per share"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;439,113&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Total&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20200701__20210630_zS2qhAKAAjyf" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Antidilutive securities excluded from computation of earnings per share"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;12,538,419&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20190701__20200630_zsjYE0XRyHH4" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Antidilutive securities excluded from computation of earnings per share"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;590,403&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A2_z3r805ucvGn" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:DebtInstrumentConvertibleTermsOfConversionFeature contextRef="From2020-07-012021-06-30">Each holder of the notes has agreed to a 4.99% beneficial ownership conversion limitation
(subject to certain noteholders&#x2019; ability to increase such limitation to 9.99% upon 60 days&#x2019; notice to the Company)</us-gaap:DebtInstrumentConvertibleTermsOfConversionFeature>
    <us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
      contextRef="From2020-07-012021-06-30"
      decimals="INF"
      unitRef="Pure">0.0499</us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock contextRef="From2020-07-012021-06-30">&lt;p id="xdx_898_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zp7ZAEmlQrYd" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;span id="xdx_8B9_zWwXX59WoQ27" style="display: none"&gt;SCHEDULE OF DILUTIVE SECURITIES EXCLUDED FROM COMPUTATION&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 100%; margin-right: auto"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;June
    30, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;June
    30, 2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 64%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Stock
    Options&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20200701__20210630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_zRF3jRJ6r1te" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Antidilutive securities excluded from computation of earnings per share"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;59&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20190701__20200630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_zloQygdbzAlh" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Antidilutive securities excluded from computation of earnings per share"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;60&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Stock
    Warrants&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20200701__20210630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zNOzT456LxB6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Antidilutive securities excluded from computation of earnings per share"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;121,329&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20190701__20200630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zNtlaS94tWTe" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Antidilutive securities excluded from computation of earnings per share"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;151,171&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Unvested
    restricted stock&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20200701__20210630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--UnvestedRestrictedStockMember_zafhpGNhbIA6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Antidilutive securities excluded from computation of earnings per share"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;59&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20190701__20200630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--UnvestedRestrictedStockMember_zLMxtEOeqQAc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Antidilutive securities excluded from computation of earnings per share"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;59&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Convertible
    Debt&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20200701__20210630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertibleDebtSecuritiesMember_zx6G7fcxhV22" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Antidilutive securities excluded from computation of earnings per share"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;12,416,972&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20190701__20200630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertibleDebtSecuritiesMember_z4ty7l1bgPGc" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Antidilutive securities excluded from computation of earnings per share"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;439,113&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Total&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20200701__20210630_zS2qhAKAAjyf" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Antidilutive securities excluded from computation of earnings per share"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;12,538,419&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20190701__20200630_zsjYE0XRyHH4" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Antidilutive securities excluded from computation of earnings per share"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;590,403&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2020-07-012021-06-30_us-gaap_EmployeeStockOptionMember"
      decimals="INF"
      unitRef="Shares">59</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2019-07-012020-06-30_us-gaap_EmployeeStockOptionMember"
      decimals="INF"
      unitRef="Shares">60</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2020-07-012021-06-30_us-gaap_WarrantMember"
      decimals="INF"
      unitRef="Shares">121329</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2019-07-012020-06-30_us-gaap_WarrantMember"
      decimals="INF"
      unitRef="Shares">151171</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2020-07-012021-06-30_custom_UnvestedRestrictedStockMember"
      decimals="INF"
      unitRef="Shares">59</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2019-07-012020-06-30_custom_UnvestedRestrictedStockMember"
      decimals="INF"
      unitRef="Shares">59</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2020-07-012021-06-30_us-gaap_ConvertibleDebtSecuritiesMember"
      decimals="INF"
      unitRef="Shares">12416972</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2019-07-012020-06-30_us-gaap_ConvertibleDebtSecuritiesMember"
      decimals="INF"
      unitRef="Shares">439113</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2020-07-012021-06-30"
      decimals="INF"
      unitRef="Shares">12538419</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2019-07-012020-06-30"
      decimals="INF"
      unitRef="Shares">590403</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="From2020-07-012021-06-30">&lt;p id="xdx_84F_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zaCjb7rqrmle" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_864_zqGyiHQTKivb"&gt;Recent
Accounting Pronouncements&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;We
have reviewed the FASB issued ASU accounting pronouncements and interpretations thereof that have effectiveness dates during the periods
reported and in future periods. We have carefully considered the new pronouncements that alter previous generally accepted accounting
principles and do not believe that any new or modified principles will have a material impact on the Company&#x2019;s reported financial
position or operations in the near term with the exception of those disclosed below. The applicability of any standard is subject
to the formal review of the Company&#x2019;s financial management.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;In
August 2020, the FASB issued ASU 2020-06, &#x201c;Debt &#x2013; Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives
and Hedging &#x2013; Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40)&#x201d;. This ASU reduces the number of accounting models
for convertible debt instruments and convertible preferred stock. As well as amend the guidance for the derivatives scope exception for
contracts in an entity&#x2019;s own equity to reduce form-over-substance-based accounting conclusions. In addition, this ASU improves
and amends the related EPS guidance. This standard is effective for us on July 1, 2022, including interim periods within those fiscal
years. Adoption is either a modified retrospective method or a fully retrospective method of transition. The Company is currently assessing
the impact the new guidance will have on our consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:SubstantialDoubtAboutGoingConcernTextBlock contextRef="From2020-07-012021-06-30">&lt;p id="xdx_808_eus-gaap--SubstantialDoubtAboutGoingConcernTextBlock_zrfc5XGh9z22" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;NOTE
2 &#x2013; &lt;span id="xdx_82D_zR4TUUmJtQxb"&gt;GOING CONCERN&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;The
accompanying consolidated financial statements have been prepared in conformity with US GAAP, which contemplate continuation of the Company
as a going concern. For the fiscal year ended June 30, 2021, the Company had &lt;span id="xdx_90E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_doxL_c20200701__20210630_zb0oM1K9Z757" title="::XDX::-"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0984"&gt;no
&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;revenues, had a net loss of $&lt;span id="xdx_904_eus-gaap--ProfitLoss_iN_pp0p0_di_c20200701__20210630_zE5KyvuIa4Tc"&gt;2,025,947
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;and had net cash used in operations
of $&lt;span id="xdx_90B_eus-gaap--NetCashProvidedByUsedInOperatingActivities_iN_pp0p0_di_c20200701__20210630_zZZ2qqLukVg7"&gt;1,145,264&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;.
Additionally, as of June 30, 2021, the Company had a working capital deficit, stockholders&#x2019; deficit and accumulated deficit of
$&lt;span id="xdx_90B_ecustom--WorkingCapitalDeficit_c20210630_pp0p0"&gt;3,074,078&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;,
$&lt;span id="xdx_90F_eus-gaap--StockholdersEquity_iNI_pp0p0_di_c20210630_zy1eQU64tRIg"&gt;3,067,573&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;,
and $&lt;span id="xdx_90B_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_pp0p0_di_c20210630_z63t6FGbdE9k"&gt;58,199,466&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;,
&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;respectively. It is management&#x2019;s opinion that these
conditions raise substantial doubt about the Company&#x2019;s ability to continue as a going concern for a period of at least twelve months
from the date of this filing.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;The
consolidated financial statements do not include any adjustments to reflect the possible future effect on the recoverability and classification
of assets or the amounts and classifications of liabilities that may result from the outcome of this uncertainty.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Successful
completion of the Company&#x2019;s development program and, ultimately, the attainment of profitable operations are dependent upon future
events, including obtaining adequate financing to fulfill its development activities, acceptance of the Company&#x2019;s patent applications,
obtaining additional sources of suitable and adequate financing and ultimately achieving a level of sales adequate to support the Company&#x2019;s
cost structure and business plan. The Company&#x2019;s ability to continue as a going concern is also dependent on its ability to further
develop and execute on its business plan. However, there can be no assurances that any or all of these endeavors will be successful.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;In
March 2020, the outbreak of COVID-19 (coronavirus) caused by a novel strain of the coronavirus was recognized as a pandemic by the World
Health Organization, and the outbreak has become increasingly widespread in the United States, Europe and Australia, including in each
of the areas in which the Company operates. The COVID-19 (coronavirus) outbreak has had a notable impact on general economic conditions,
including but not limited to the temporary closures of many businesses, &#x201c;shelter in place&#x201d; and other governmental regulations,
reduced business and consumer spending due to both job losses, reduced investing activity and M&amp;amp;A transactions, among many other
effects attributable to the COVID-19 (coronavirus), and there continue to be many unknowns. While to date the Company has not been required
to stop operating, management is evaluating its use of its office space, virtual meetings and the like. The Company continues to monitor
the impact of the COVID-19 (coronavirus) outbreak closely. The extent to which the COVID-19 (coronavirus) outbreak will impact our operations,
ability to obtain financing or future financial results is uncertain.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:SubstantialDoubtAboutGoingConcernTextBlock>
    <us-gaap:ProfitLoss
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">-2025947</us-gaap:ProfitLoss>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">-1145264</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <PPCB:WorkingCapitalDeficit contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">3074078</PPCB:WorkingCapitalDeficit>
    <us-gaap:StockholdersEquity contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">-3067573</us-gaap:StockholdersEquity>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">-58199466</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef="From2020-07-012021-06-30">&lt;p id="xdx_803_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zHEs022u6Pnb" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;NOTE
3 &#x2013; &lt;span id="xdx_821_zas7Q1BDZ6t1"&gt;PROPERTY AND EQUIPMENT&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_895_eus-gaap--PropertyPlantAndEquipmentTextBlock_zmgFlYHfXWwc" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Property
and equipment consist of the following as of June 30,&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;span id="xdx_8BB_zh0whEB5uiQ7" style="display: none"&gt;SCHEDULE OF PROPERTY AND EQUIPMENT&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 100%; margin-right: auto"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_490_20210630_zLQ8erGmgJRd" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_493_20200630_zCZkbynpGDZc" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_maPPAENzBVB_zZKQJHKCiSUf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 64%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Office
    equipment at cost&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;28,623&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;26,299&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_msPPAENzBVB_zh2Xl4FSeynh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Less:
    Accumulated depreciation&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;(24,368&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;(20,552&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--PropertyPlantAndEquipmentNet_iTI_pp0p0_mtPPAENzBVB_zTBB9pS58rT2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Total
    property, plant, and equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;4,255&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;5,747&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Depreciation
expense for the years ended June 30, 2021 and 2020 were $&lt;span id="xdx_908_eus-gaap--Depreciation_c20200701__20210630_pp0p0" title="Depreciation expense"&gt;1,993&lt;/span&gt; and $&lt;span id="xdx_908_eus-gaap--Depreciation_pp0p0_c20190701__20200630_zlHMWyp9Oy4" title="Depreciation expense"&gt;2,473&lt;/span&gt;, respectively&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;PROPANC
BIOPHARMA, INC. AND SUBSIDIARY&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;June
30, 2021 and 2020&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="From2020-07-012021-06-30">&lt;p id="xdx_895_eus-gaap--PropertyPlantAndEquipmentTextBlock_zmgFlYHfXWwc" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Property
and equipment consist of the following as of June 30,&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;span id="xdx_8BB_zh0whEB5uiQ7" style="display: none"&gt;SCHEDULE OF PROPERTY AND EQUIPMENT&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 100%; margin-right: auto"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_490_20210630_zLQ8erGmgJRd" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_493_20200630_zCZkbynpGDZc" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_maPPAENzBVB_zZKQJHKCiSUf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 64%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Office
    equipment at cost&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;28,623&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;26,299&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_msPPAENzBVB_zh2Xl4FSeynh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Less:
    Accumulated depreciation&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;(24,368&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;(20,552&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--PropertyPlantAndEquipmentNet_iTI_pp0p0_mtPPAENzBVB_zTBB9pS58rT2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Total
    property, plant, and equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;4,255&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;5,747&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Depreciation
expense for the years ended June 30, 2021 and 2020 were $&lt;span id="xdx_908_eus-gaap--Depreciation_c20200701__20210630_pp0p0" title="Depreciation expense"&gt;1,993&lt;/span&gt; and $&lt;span id="xdx_908_eus-gaap--Depreciation_pp0p0_c20190701__20200630_zlHMWyp9Oy4" title="Depreciation expense"&gt;2,473&lt;/span&gt;, respectively&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;PROPANC
BIOPHARMA, INC. AND SUBSIDIARY&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;June
30, 2021 and 2020&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">28623</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">26299</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">24368</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">20552</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">4255</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">5747</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Depreciation
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">1993</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">2473</us-gaap:Depreciation>
    <PPCB:DueToFormerDirectorRelatedPartyDisclosureTextBlock contextRef="From2020-07-012021-06-30">&lt;p id="xdx_801_ecustom--DueToFormerDirectorRelatedPartyDisclosureTextBlock_zIiAd8JaTtW8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;NOTE
4 &#x2013; &lt;span id="xdx_82A_z24o9PK9MNna"&gt;DUE TO FORMER DIRECTOR - RELATED PARTY&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Due
to former director - related party represents unsecured advances made primarily by a former director for operating expenses on behalf
of the Company such as intellectual property and formation expenses. The expenses were paid for on behalf of the Company and are due
upon demand. The Company is currently not being charged interest under these advances. The total amount owed the former director at June
30, 2021 and 2020 is &lt;span id="xdx_904_eus-gaap--DueToRelatedPartiesCurrent_c20210630_pp0p0" title="Due to directors - related parties"&gt;$33,347&lt;/span&gt; and &lt;span id="xdx_907_eus-gaap--DueToRelatedPartiesCurrent_c20200630_pp0p0" title="Due to directors - related parties"&gt;$30,639&lt;/span&gt;, respectively. The Company plans to repay the advances as its cash resources allow (see Note
10).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</PPCB:DueToFormerDirectorRelatedPartyDisclosureTextBlock>
    <us-gaap:DueToRelatedPartiesCurrent contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">33347</us-gaap:DueToRelatedPartiesCurrent>
    <us-gaap:DueToRelatedPartiesCurrent contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">30639</us-gaap:DueToRelatedPartiesCurrent>
    <PPCB:LoansAndNotesPayableDisclosureTextBlock contextRef="From2020-07-012021-06-30">&lt;p id="xdx_80C_ecustom--LoansAndNotesPayableDisclosureTextBlock_zOI11SLk00V4" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;NOTE
5 &#x2013; &lt;span id="xdx_822_zYKwxJFs54dj"&gt;LOANS AND NOTES PAYABLE&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;span style="text-decoration: underline"&gt;Loan
from Former Director - Related Party&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Loan
from the Company&#x2019;s former director at June 30, 2021 and 2020 were &lt;span id="xdx_909_eus-gaap--LoansPayable_c20210630__srt--TitleOfIndividualAxis__custom--DirectorsAndOfficerMember_pp0p0" title="Loans payable"&gt;$55,500&lt;/span&gt; and &lt;span id="xdx_908_eus-gaap--LoansPayable_c20200630__srt--TitleOfIndividualAxis__custom--DirectorsAndOfficerMember_pp0p0" title="Loans payable"&gt;$50,993&lt;/span&gt;, respectively. The loan bear no interest
and is payable on demand. The Company did not repay any amount on this loan during the years ended June 30, 2021 and 2020, respectively,
(see Note 10).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</PPCB:LoansAndNotesPayableDisclosureTextBlock>
    <us-gaap:LoansPayable
      contextRef="AsOf2021-06-30_custom_DirectorsAndOfficerMember"
      decimals="0"
      unitRef="USD">55500</us-gaap:LoansPayable>
    <us-gaap:LoansPayable
      contextRef="AsOf2020-06-30_custom_DirectorsAndOfficerMember"
      decimals="0"
      unitRef="USD">50993</us-gaap:LoansPayable>
    <us-gaap:DebtDisclosureTextBlock contextRef="From2020-07-012021-06-30">&lt;p id="xdx_802_eus-gaap--DebtDisclosureTextBlock_zeaWrDcF96f" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;NOTE
6 &#x2013; &lt;span id="xdx_82C_zpU7oKjSzdRl"&gt;CONVERTIBLE NOTES&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89C_eus-gaap--ConvertibleDebtTableTextBlock_ziVRkGrZePIh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;The
Company&#x2019;s convertible notes outstanding at June 30, 2021 and 2020 were as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; display: none; color: Black"&gt;&#160;&lt;span id="xdx_8BA_zvU50JaaWwyd"&gt;SCHEDULE OF CONVERTIBLE NOTES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 100%; margin-right: auto"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_494_20210630_zsrmn1iivXZg" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;June
    30, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20200630_zuQpL0kHaTa" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;June
    30, 2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--DebtInstrumentCarryingAmount_iI_pp0p0_maLTDzcuB_zuxg3RTxe1Li" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 64%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Convertible
    notes and debenture&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;400,128&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;1,029,496&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--DebtInstrumentUnamortizedDiscount_iNI_pp0p0_di_msLTDzcuB_zuUODCdu4b44" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Unamortized
    discounts&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;(6,139&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;(126,667&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--DepositLiabilitiesAccruedInterest_iI_pp0p0_maLTDzcuB_zPzWSAs6KWd3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Accrued
    interest&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;34,098&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;80,101&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--DebtInstrumentUnamortizedPremium_iI_pp0p0_maLTDzcuB_zEJVrrhbTgpb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Premium,
    net&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;196,496&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;574,804&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--LongTermDebt_iTI_pp0p0_mtLTDzcuB_z7Pcz6TEePia" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Convertible
    notes, net&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;624,583&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;1,557,734&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A9_z1kJBtc4kiUk" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;&lt;i&gt;Eagle
Equities Financing Agreements&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;i&gt;December
29, 2017 Securities Purchase Agreement&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;The
Company entered into an executory contract on December 29, 2017, whereby the Company entered into a securities purchase agreement with
Eagle Equities, pursuant to which Eagle Equities purchased a convertible promissory note (the &#x201c;December 2017 Eagle Note&#x201d;)
from the Company in the aggregate principal amount of &lt;span id="xdx_902_eus-gaap--DebtInstrumentFaceAmount_c20171229__us-gaap--TypeOfArrangementAxis__custom--DecemberTwentyNineTwoThousandAndSeventeenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--DecemberTwoThousandAndSeventeenEagleNoteMember_pp0p0" title="Convertible debt principal amount"&gt;$532,435&lt;/span&gt;, with principal and the interest thereon convertible into shares of the
Company&#x2019;s common stock at the option of Eagle Equities at any time. The December 2017 Eagle Note contained an original issue discount
of &lt;span id="xdx_904_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pp0p0_c20171229__us-gaap--TypeOfArrangementAxis__custom--DecemberTwentyNineTwoThousandAndSeventeenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--DecemberTwoThousandAndSeventeenEagleNoteMember_zwtn2dDM4hIj" title="Original issue discount"&gt;$25,354&lt;/span&gt; such that the purchase price was &lt;span id="xdx_902_eus-gaap--ProceedsFromConvertibleDebt_c20171227__20171229__us-gaap--TypeOfArrangementAxis__custom--DecemberTwentyNineTwoThousandAndSixteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--DecemberTwoThousandAndSeventeenEagleNoteMember_pp0p0" title="Proceeds from convertible debt"&gt;$507,081&lt;/span&gt;. The maturity date of the December 2017 Eagle Note was &lt;span id="xdx_903_eus-gaap--DebtInstrumentMaturityDate_dd_c20171227__20171229__us-gaap--TypeOfArrangementAxis__custom--DecemberTwentyNineTwoThousandAndSixteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--DecemberTwoThousandAndSeventeenEagleNoteMember_z4DqQhh6ygF1" title="Debt maturity date"&gt;December 29, 2018&lt;/span&gt;. The Company
was in discussions with Eagle Equities to extend the maturity date. The December 2017 Eagle Note bore interest at a rate of &lt;span id="xdx_901_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20171229__us-gaap--TypeOfArrangementAxis__custom--DecemberTwentyNineTwoThousandAndSeventeenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--DecemberTwoThousandAndSeventeenEagleNoteMember_zrEXKmTQfmjl" title="Debt instrument, interest rate, stated percentage"&gt;8%&lt;/span&gt; per annum,
which interest were to be paid by the Company to Eagle Equities in shares of the Company&#x2019;s common stock upon receipt of a notice
of conversion by the Company from Eagle Equities at any time. The Company recorded &lt;span id="xdx_904_eus-gaap--InterestPayableCurrentAndNoncurrent_c20190630__us-gaap--TypeOfArrangementAxis__custom--DecemberTwentyNineTwoThousandAndSixteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--DecemberTwoThousandAndSeventeenEagleNoteMember_pp0p0" title="Accrued interest"&gt;$20,065&lt;/span&gt; of accrued interest for the December 2017
Eagle Note and total principal outstanding as of June 30, 2019 under the December 2017 Eagle Note was &lt;span id="xdx_902_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20180701__20190630__us-gaap--TypeOfArrangementAxis__custom--DecemberTwentyNineTwoThousandAndSeventeenSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--DecemberTwoThousandAndSeventeenEagleNoteMember_pp0p0" title="Debt conversion of converted amount"&gt;$171,965&lt;/span&gt; following conversion of
&lt;span id="xdx_906_eus-gaap--DebtInstrumentFaceAmount_c20190630__us-gaap--TypeOfArrangementAxis__custom--DecemberTwentyNineTwoThousandAndSixteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--DecemberTwoThousandAndSeventeenEagleNoteMember_pp0p0" title="Convertible debt principal amount"&gt;$360,470&lt;/span&gt; of principal and &lt;span id="xdx_903_eus-gaap--InterestPayableCurrentAndNoncurrent_c20190630__us-gaap--TypeOfArrangementAxis__custom--DecemberTwentyNineTwoThousandAndSeventeenSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--DecemberTwoThousandAndSeventeenEagleNoteMember_pp0p0" title="Accrued interest"&gt;$43,535&lt;/span&gt; of accrued interest during the fiscal year ended June 30, 2019. The Company recorded &lt;span id="xdx_90A_eus-gaap--InterestPayableCurrentAndNoncurrent_c20200630__us-gaap--TypeOfArrangementAxis__custom--DecemberTwentyNineTwoThousandAndSeventeenSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--DecemberTwoThousandAndSeventeenEagleNoteMember_pp0p0" title="Accrued interest"&gt;$0&lt;/span&gt; of accrued
interest for the December 2017 Eagle Note and total principal outstanding as of June 30, 2020 under the December 2017 Eagle Note was
&lt;span id="xdx_901_eus-gaap--DebtInstrumentFaceAmount_c20200630__us-gaap--TypeOfArrangementAxis__custom--DecemberTwentyNineTwoThousandAndSeventeenSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--DecemberTwoThousandAndSeventeenEagleNoteMember_pp0p0" title="Convertible debt principal amount"&gt;$0&lt;/span&gt; following conversion of the remaining principal &lt;span id="xdx_90A_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20190701__20200630__us-gaap--TypeOfArrangementAxis__custom--DecemberTwentyNineTwoThousandAndSeventeenSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--DecemberTwoThousandAndSeventeenEagleNoteMember_pp0p0" title="Debt conversion of converted amount"&gt;$171,965&lt;/span&gt; and &lt;span id="xdx_90E_eus-gaap--InterestPayableCurrentAndNoncurrent_c20200630__us-gaap--TypeOfArrangementAxis__custom--DecemberTwentyNineTwoThousandAndSeventeenSecuritiesPurchaseAgreementMember_pp0p0" title="Accrued interest"&gt;$24,751&lt;/span&gt; of accrued interest during the fiscal year to June 30, 2020.
Accordingly, there was &lt;span id="xdx_909_eus-gaap--ConvertibleNotesPayable_iI_pp0p0_do_c20200630__us-gaap--TypeOfArrangementAxis__custom--DecemberTwentyNineTwoThousandAndSixteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember_zAjzDA5WXnq8" title="Convertible debt outstanding balance"&gt;no&lt;/span&gt; outstanding balance as of June 30, 2020.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;i&gt;July
13, 2018 Securities Purchase Agreement&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Effective
July 13, 2018, the Company entered into a securities purchase agreement with Eagle Equities, pursuant to which Eagle Equities purchased
a convertible promissory note (the &#x201c;July 2018 Note&#x201d;) from the Company in the aggregate principal amount of &lt;span id="xdx_90F_eus-gaap--DebtInstrumentFaceAmount_c20180713__us-gaap--TypeOfArrangementAxis__custom--JulyThirteenTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandEighteenEagleNoteMember_pp0p0" title="Convertible debt principal amount"&gt;$75,000&lt;/span&gt;, such
principal and the interest thereon convertible into shares of the Company&#x2019;s common stock at the option of Eagle Equities any time
after the six month anniversary of the July 2018 Eagle Note. The transaction closed on July 16, 2018 and on July 19, 2018 the Company
received proceeds of &lt;span id="xdx_900_eus-gaap--ProceedsFromConvertibleDebt_pp0p0_c20180718__20180719__us-gaap--TypeOfArrangementAxis__custom--JulyThirteenTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandEighteenEagleNoteMember_zdWkynH66oRd" title="Proceeds from convertible debt"&gt;$71,250&lt;/span&gt; as &lt;span id="xdx_90B_eus-gaap--LegalFees_c20180718__20180719__us-gaap--TypeOfArrangementAxis__custom--JulyThirteenTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandEighteenEagleNoteMember_pp0p0" title="Legal fees"&gt;$3,750&lt;/span&gt; was paid directly to legal fees. The maturity date of the July 2018 Eagle Note was &lt;span id="xdx_902_eus-gaap--DebtInstrumentMaturityDate_dd_c20180712__20180713__us-gaap--TypeOfArrangementAxis__custom--JulyThirteenTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandEighteenEagleNoteMember_zpDA4GM2ucK3" title="Debt maturity date"&gt;July 13, 2019&lt;/span&gt;.
The July 2018 Eagle Note bears interest at a rate of &lt;span id="xdx_90E_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20180713__us-gaap--TypeOfArrangementAxis__custom--JulyThirteenTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandEighteenEagleNoteMember_zAmwn9YIE4P4" title="Debt instrument, interest rate, stated percentage"&gt;8%&lt;/span&gt; per annum, which interest shall be paid by the Company to Eagle Equities in shares
of the Company&#x2019;s common stock upon receipt of a notice of conversion by the Company from Eagle Equities at any time after the six-month
anniversary of the Note. The Company recorded &lt;span id="xdx_90F_eus-gaap--InterestPayableCurrentAndNoncurrent_c20190630__us-gaap--TypeOfArrangementAxis__custom--JulyThirteenTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandEighteenEagleNoteMember_pp0p0" title="Accrued interest"&gt;$5,786&lt;/span&gt; of accrued interest and the total principal outstanding under the July 2018 Eagle
Note was &lt;span id="xdx_905_eus-gaap--DebtInstrumentFaceAmount_c20190630__us-gaap--TypeOfArrangementAxis__custom--JulyThirteenTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandEighteenEagleNoteMember_pp0p0" title="Convertible debt principal amount"&gt;$75,000&lt;/span&gt; as of June 30, 2019. The Company recorded &lt;span id="xdx_900_eus-gaap--DebtInstrumentFaceAmount_c20200630__us-gaap--TypeOfArrangementAxis__custom--JulyThirteenTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandEighteenEagleNoteMember_pp0p0" title="Convertible debt principal amount"&gt;$0&lt;/span&gt; of accrued interest and the total principal outstanding under the July
2018 Eagle Note was &lt;span id="xdx_90C_eus-gaap--InterestPayableCurrentAndNoncurrent_c20180713__us-gaap--TypeOfArrangementAxis__custom--JulyThirteenTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandEighteenEagleNoteMember_pp0p0" title="Accrued interest"&gt;$0&lt;/span&gt; as of June 30, 2020 following conversion of &lt;span id="xdx_909_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20190701__20200630__us-gaap--TypeOfArrangementAxis__custom--JulyThirteenTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandEighteenEagleNoteMember_pp0p0" title="Debt conversion of converted amount"&gt;$75,000&lt;/span&gt; of principal and &lt;span id="xdx_904_eus-gaap--InterestPayableCurrentAndNoncurrent_c20200630__us-gaap--TypeOfArrangementAxis__custom--JulyThirteenTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandEighteenEagleNoteMember_pp0p0" title="Accrued interest"&gt;$9,300&lt;/span&gt; of accrued interest during the fiscal
year ended June 30, 2020. Accordingly, there was &lt;span id="xdx_901_eus-gaap--ConvertibleNotesPayable_iI_pp0p0_do_c20200630__us-gaap--TypeOfArrangementAxis__custom--JuneTwentyNineTwoThousandEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember_zuibCjhHE8q6" title="Convertible debt outstanding balance"&gt;no&lt;/span&gt; outstanding balance as of June 30, 2020.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;PROPANC
BIOPHARMA, INC. AND SUBSIDIARY&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;June
30, 2021 and 2020&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;i&gt;August
29, 2018 Securities Purchase Agreement&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Effective
August 29, 2018, the Company entered into a securities purchase agreement with Eagle Equities, pursuant to which Eagle Equities purchased
a convertible promissory note (the &#x201c;August 2018 Eagle Note&#x201d;) from the Company in the aggregate principal amount of &lt;span id="xdx_903_eus-gaap--DebtInstrumentFaceAmount_c20180829__us-gaap--TypeOfArrangementAxis__custom--AugustTwentyNineTwoThousandandEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandEighteenEagleNoteMember_pp0p0" title="Convertible debt principal amount"&gt;$105,000&lt;/span&gt;,
such principal and the interest thereon convertible into shares of the Company&#x2019;s common stock at the option of Eagle Equities any
time after the six-month anniversary of the August 2018 Eagle Note. The transactions contemplated by the agreement closed on August 30,
2018. The maturity date of the August 29, 2018 Eagle Note was &lt;span id="xdx_90F_eus-gaap--DebtInstrumentMaturityDate_dd_c20180826__20180829__us-gaap--TypeOfArrangementAxis__custom--AugustTwentyNineTwoThousandandEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandEighteenEagleNoteMember_zqr0uvzkUBgj"&gt;August 29, 2019&lt;/span&gt;. The August 2018 Eagle Note bore interest at a rate of
&lt;span id="xdx_903_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20180829__us-gaap--TypeOfArrangementAxis__custom--AugustTwentyNineTwoThousandandEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandEighteenEagleNoteMember_z8BLE0j8JLXf" title="Debt instrument, interest rate, stated percentage"&gt;8%&lt;/span&gt; per annum, which interest was paid by the Company to Eagle Equities in shares of the Company&#x2019;s common stock upon receipt of
a notice of conversion by the Company from Eagle Equities at any time after the six-month anniversary of the August 2018 Eagle Note.
In April 2020, Eagle Equities agreed to waive the &lt;span id="xdx_90E_ecustom--DebtInstrumentDebtDefaultInterestRate_dp_uPure_c20200401__20200430__us-gaap--TypeOfArrangementAxis__custom--AugustTwentyNineTwoThousandandEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandEighteenEagleNoteMember_zgBWquuwOeDe" title="Debt instrument, default, interest rate"&gt;24%&lt;/span&gt; default interest on this note. The note was fully converted to common stock in
fiscal 2021.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;i&gt;October
2, 2018 Securities Purchase Agreement&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Effective
October 2, 2018, the Company entered into a securities purchase agreement with Eagle Equities, pursuant to which Eagle Equities purchased
a convertible promissory note (the &#x201c;October 2018 Eagle Note&#x201d;) from the Company in the aggregate principal amount of &lt;span id="xdx_906_eus-gaap--DebtInstrumentFaceAmount_c20181002__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberTwoTwoThousandAndEighteenEagleNoteMember_pp0p0" title="Convertible debt principal amount"&gt;$210,000&lt;/span&gt;,
such principal and the interest thereon convertible into shares of the Company&#x2019;s common stock at the option of Eagle Equities any
time after the six-month anniversary of the October 2018 Eagle Note. The transactions contemplated by the purchase agreement closed on
October 3, 2018. Pursuant to the terms of the purchase agreement, Eagle Equities deducted $&lt;span id="xdx_90F_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_c20180929__20181002__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberTwoTwoThousandAndEighteenEagleNoteMember_pp0p0" title="Debt instrument principal payment"&gt;10,000&lt;/span&gt; from the principal payment due under
the October 2018 Eagle Note, at the time of closing, to be applied to its legal expenses. The maturity date of the October 2018 Eagle
Note was &lt;span id="xdx_902_eus-gaap--DebtInstrumentMaturityDate_dd_c20180929__20181002__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberTwoTwoThousandAndEighteenEagleNoteMember_zWGQR2JHUroc" title="Debt maturity date"&gt;October 2, 2019&lt;/span&gt;. The October 2018 Eagle Note shall bore interest at a rate of &lt;span id="xdx_90B_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20181002__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberTwoTwoThousandAndEighteenEagleNoteMember_zlNz9m1P70B9" title="Debt instrument, interest rate, stated percentage"&gt;8%&lt;/span&gt; per annum, which interest was paid by the Company
to Eagle Equities in shares of common stock upon receipt of a notice of conversion by the Company from Eagle Equities at any time after
the six-month anniversary of the October 2018 Eagle Note. In April 2020, Eagle Equities agreed to waive the &lt;span id="xdx_90D_ecustom--DebtInstrumentDebtDefaultInterestRate_dp_uPure_c20200401__20200430__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember_zln5ji2gLDy6" title="Debt instrument, default, interest rate"&gt;24%&lt;/span&gt; default interest on this
note. The note was fully converted to common stock in fiscal 2020.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;i&gt;November
30, 2018 Securities Purchase Agreement&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Effective
November 30, 2018, the Company entered into a securities purchase agreement with Eagle Equities, pursuant to which Eagle Equities purchased
a convertible promissory note (the &#x201c;November 2018 Eagle Note&#x201d;) from the Company in the aggregate principal amount of &lt;span id="xdx_903_eus-gaap--DebtInstrumentFaceAmount_c20181130__us-gaap--TypeOfArrangementAxis__custom--NovembeThirtyTwoThousandAndEighteenMecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--NovemberTwoThousandAndEighteenEagleNoteMember_pp0p0" title="Convertible debt principal amount"&gt;$105,000&lt;/span&gt;,
such principal and the interest thereon convertible into shares of the Company&#x2019;s common stock at the option of Eagle Equities any
time after the six-month anniversary of the November 2018 Eagle Note. The transactions contemplated by the purchase agreement closed
on December 3, 2018. Pursuant to the terms of the purchase agreement, Eagle Equities deducted &lt;span id="xdx_906_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_c20181126__20181130__us-gaap--TypeOfArrangementAxis__custom--NovembeThirtyTwoThousandAndEighteenMecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--NovemberTwoThousandAndEighteenEagleNoteMember_pp0p0" title="Debt instrument principal payment"&gt;$5,000&lt;/span&gt; from the principal payment due under
the November 2018 Eagle Note, at the time of closing, to be applied to its legal expenses. The maturity date of the November 2018 Eagle
Note was &lt;span id="xdx_901_eus-gaap--DebtInstrumentMaturityDate_dd_c20181126__20181130__us-gaap--TypeOfArrangementAxis__custom--NovembeThirtyTwoThousandAndEighteenMecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--NovemberTwoThousandAndEighteenEagleNoteMember_zChtBzkSwcs7" title="Debt maturity date"&gt;November 30, 2019&lt;/span&gt;. The November 2018 Eagle Note bore interest at a rate of &lt;span id="xdx_90B_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20181130__us-gaap--TypeOfArrangementAxis__custom--NovembeThirtyTwoThousandAndEighteenMecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--NovemberTwoThousandAndEighteenEagleNoteMember_zM0a4tZzTtF6" title="Debt instrument, interest rate, stated percentage"&gt;8%&lt;/span&gt; per annum, which interest shall be paid by the
Company to Eagle Equities in shares of common stock upon receipt of a notice of conversion by the Company from Eagle Equities at any
time after the six-month anniversary of the November 2018 Eagle Note. In April 2020, Eagle Equities agreed to waive the &lt;span id="xdx_90A_ecustom--DebtInstrumentDebtDefaultInterestRate_dp_uPure_c20200401__20200430__us-gaap--TypeOfArrangementAxis__custom--NovembeThirtyTwoThousandAndEighteenMecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--NovemberTwoThousandAndEighteenEagleNoteMember_zfKSHWHrSd43" title="Debt instrument, default, interest rate"&gt;24%&lt;/span&gt; default interest
on this note. The note was fully converted to common stock in fiscal 2020.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;i&gt;December
24, 2018 Securities Purchase Agreement&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Effective
December 24, 2018, the Company entered into a securities purchase agreement with Eagle Equities, pursuant to which Eagle Equities purchased
a convertible promissory note (the &#x201c;December 2018 Eagle Note&#x201d;) from the Company in the aggregate principal amount of &lt;span id="xdx_90B_eus-gaap--DebtInstrumentFaceAmount_c20181224__us-gaap--TypeOfArrangementAxis__custom--DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--DecembeTwoThousandAndEighteenEagleNoteMember_pp0p0" title="Convertible debt principal amount"&gt;$126,000&lt;/span&gt;,
such principal and the interest thereon convertible into shares of the Company&#x2019;s common stock at the option of Eagle Equities any
time after the six-month anniversary of the December 2018 Eagle Note. The transactions contemplated by the purchase agreement closed
on December 24, 2018. Pursuant to the terms of the purchase agreement, Eagle Equities deducted &lt;span id="xdx_906_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_c20181223__20181224__us-gaap--TypeOfArrangementAxis__custom--DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--DecembeTwoThousandAndEighteenEagleNoteMember_pp0p0" title="Debt instrument principal payment"&gt;$6,000&lt;/span&gt; from the principal payment due
under the December 2018 Eagle Note, at the time of closing, to be applied to its legal expenses. The Company used the net proceeds from
the December 2018 Eagle Note to repay an outstanding convertible promissory note before such note became convertible. The maturity date
of the December 2018 Eagle Note was &lt;span id="xdx_90A_eus-gaap--DebtInstrumentMaturityDate_dd_c20181223__20181224__us-gaap--TypeOfArrangementAxis__custom--DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--DecembeTwoThousandAndEighteenEagleNoteMember_zIJtjKwc3F6e" title="Debt maturity date"&gt;December 24, 2019&lt;/span&gt;. The December 2018 Eagle Note bore interest at a rate of &lt;span id="xdx_90E_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20181224__us-gaap--TypeOfArrangementAxis__custom--DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--DecembeTwoThousandAndEighteenEagleNoteMember_zQz2eFDsZRe9" title="Debt instrument, interest rate, stated percentage"&gt;8%&lt;/span&gt; per annum, which interest
was paid by the Company to Eagle Equities in shares of common stock upon receipt of a notice of conversion by the Company from Eagle
Equities at any time after the six-month anniversary of the December 2018 Eagle Note. Upon an event of default, principal and accrued
interest would become immediately due and payable under the notes. Additionally, upon an event of default, both notes would accrue interest
at a default interest rate of &lt;span id="xdx_905_ecustom--DebtInstrumentDebtDefaultInterestRate_dp_uPure_c20181223__20181224__us-gaap--TypeOfArrangementAxis__custom--DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--DecembeTwoThousandAndEighteenEagleNoteMember_z6Ts1dycUWZg" title="Debt instrument, default, interest rate"&gt;24%&lt;/span&gt; per annum or the highest rate of interest permitted by law. In April 2020, Eagle Equities agreed to
waive the &lt;span id="xdx_90E_ecustom--DebtInstrumentDebtDefaultInterestRate_dp_uPure_c20200401__20200430__us-gaap--TypeOfArrangementAxis__custom--DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--DecembeTwoThousandAndEighteenEagleNoteMember_zlZWpPbTdlei" title="Debt instrument, default, interest rate"&gt;24%&lt;/span&gt; default interest on this note.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Eagle
Equities had the option to convert all or any amount of the principal amount of the notes issued to Eagle Equities above, at any time,
for shares of the Company&#x2019;s common stock at a price ranging from &lt;span id="xdx_90B_eus-gaap--DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_dp_uPure_c20181223__20181224__us-gaap--TypeOfArrangementAxis__custom--DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--DecembeTwoThousandAndEighteenEagleNoteMember__srt--RangeAxis__srt--MinimumMember_zfQi4u9wiHai" title="Common stock trading volume, percent"&gt;60%&lt;/span&gt; to &lt;span id="xdx_906_eus-gaap--DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_dp_uPure_c20181223__20181224__us-gaap--TypeOfArrangementAxis__custom--DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--DecembeTwoThousandAndEighteenEagleNoteMember__srt--RangeAxis__srt--MaximumMember_zd2xti7wZbY8" title="Common stock trading volume, percent"&gt;61%&lt;/span&gt; of the lowest closing bid price (the &#x201c;Closing
Bid Price&#x201d;) of the Company&#x2019;s common stock as reported on the OTC Markets Group, Inc. quotation system for the ten prior trading
days, including the day upon which the Company receives a notice of conversion from Eagle Equities (the &#x201c;Conversion Price&#x201d;).
However, in the event that the Company&#x2019;s common stock was restricted by the Depository Trust Company for any reason, the Conversion
Price was to be lowered to from &lt;span id="xdx_903_eus-gaap--DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_dp_uPure_c20181223__20181224__us-gaap--TypeOfArrangementAxis__custom--DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--DepositoryTrustCompanyMember__us-gaap--DebtInstrumentAxis__custom--DecembeTwoThousandAndEighteenEagleNoteMember__srt--RangeAxis__srt--MinimumMember_zCDR7YJTeg13" title="Common stock trading volume, percent"&gt;50%&lt;/span&gt; to &lt;span id="xdx_904_eus-gaap--DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_dp_uPure_c20181223__20181224__us-gaap--TypeOfArrangementAxis__custom--DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--DepositoryTrustCompanyMember__us-gaap--DebtInstrumentAxis__custom--DecembeTwoThousandAndEighteenEagleNoteMember__srt--RangeAxis__srt--MaximumMember_zgAsy2tzpAqe" title="Common stock trading volume, percent"&gt;51%&lt;/span&gt; of the lowest Closing Bid Price for the duration of such restriction. If the Company failed
to maintain a reserve of shares of its common stock at least two and a half times the number of shares issuable upon conversion of all
the Eagle Notes for at least 60 days after the issuance of the notes issued to Eagle Equities, the conversion discount was to be increased
by &lt;span id="xdx_90A_eus-gaap--DebtConversionOriginalDebtInterestRateOfDebt_dp_uPure_c20181223__20181224__us-gaap--TypeOfArrangementAxis__custom--DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--DecembeTwoThousandAndEighteenEagleNoteMember_zOUdDl581VGk" title="Debt original issue discount, rate"&gt;10%&lt;/span&gt;. Notwithstanding the foregoing, Eagle Equities was restricted from effecting a conversion if such conversion, along with other
shares of the Company&#x2019;s common stock beneficially owned by Eagle Equities and its affiliates, exceeds &lt;span id="xdx_904_ecustom--PercentageOfOutstandingSharesOfCommonStock_dp_uPure_c20181223__20181224__us-gaap--TypeOfArrangementAxis__custom--DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--DecembeTwoThousandAndEighteenEagleNoteMember_ze9mkRXdRss4" title="Percentage of outstanding shares of common stock"&gt;4.99%&lt;/span&gt; of the outstanding
shares of the Company&#x2019;s common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;PROPANC
BIOPHARMA, INC. AND SUBSIDIARY&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;June
30, 2021 and 2020&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;The
above notes issued to Eagle Equities were treated as stock settled debt under ASC 480 and accordingly, the Company recorded a total of
&lt;span id="xdx_908_eus-gaap--DebtInstrumentUnamortizedPremium_c20181224__us-gaap--TypeOfArrangementAxis__custom--DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--DecembeTwoThousandAndEighteenEagleNoteMember_pp0p0" title="Debt premium amount"&gt;$357,688&lt;/span&gt; put premium, of which &lt;span id="xdx_904_eus-gaap--AdditionalPaidInCapital_iI_pp0p0_c20210630__us-gaap--TypeOfArrangementAxis__custom--DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--DecembeTwoThousandAndEighteenEagleNoteMember_zH3UbaDWPi5k" title="Additional paid in capital"&gt;$224,131&lt;/span&gt; and &lt;span id="xdx_907_eus-gaap--AdditionalPaidInCapital_iI_pp0p0_c20200630__us-gaap--TypeOfArrangementAxis__custom--DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember__us-gaap--DebtInstrumentAxis__custom--DecembeTwoThousandAndEighteenEagleNoteMember_zcmT5xSeF5Q4" title="Additional paid in capital"&gt;$133,557&lt;/span&gt; were released to additional paid in capital following conversion of principal during
the fiscal year to June 30, 2020 and 2021, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;The
total principal amount outstanding under the above Eagle Equities financing agreements, specifically the August 29, 2018 and the December
24, 2018 agreements was &lt;span id="xdx_902_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementOneMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember_zpGdUj168qPf" title="Convertible debt principal amount"&gt;$205,500&lt;/span&gt; as of June 30, 2020 and accrued interest totaled &lt;span id="xdx_90F_eus-gaap--InterestPayableCurrentAndNoncurrent_c20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementOneMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember_pp0p0" title="Accrued interest"&gt;$26,990&lt;/span&gt;. There were &lt;span id="xdx_900_eus-gaap--ConvertibleNotesPayable_iI_pp0p0_c20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementOneMember__dei--LegalEntityAxis__custom--EagleEquitiesLLCMember_zvGPnBXv9Zt" title="Convertible debt outstanding balance"&gt;$0&lt;/span&gt; outstanding principal and accrued
interest under the above Eagle Equities financing agreements as of June 30, 2021 as a result of the fiscal 2021 conversions.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;&lt;i&gt;GS
Capital Financing Agreements&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;i&gt;October
2, 2018 Securities Purchase Agreement&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Effective
October 2, 2018, the Company entered into a securities purchase agreement with GS Capital, pursuant to which GS Capital purchased two
&lt;span id="xdx_90F_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20181002__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberTwoThousandEighteenGSNoteMember_zsBzu4vGlZFh" title="Debt instrument, interest rate, stated percentage"&gt;8%&lt;/span&gt; unsecured convertible redeemable notes (the &#x201c;October 2, 2018 GS Notes&#x201d;) from the Company in the aggregate principal amount
of &lt;span id="xdx_900_eus-gaap--DebtInstrumentFaceAmount_c20181002__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberTwoThousandEighteenGSNoteMember_pp0p0" title="Convertible debt principal amount"&gt;$212,000&lt;/span&gt;, such principal and the interest thereon convertible into shares of the Company&#x2019;s common stock. The purchase price
of &lt;span id="xdx_90C_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20181003__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberTwoThousandEighteenGSNoteMember_zprsfKSUfdD5" title="Convertible debt principal amount"&gt;$106,000&lt;/span&gt; of the first note (the &#x201c;October 2018 GS Note&#x201d;) was paid in cash by GS Capital on October 3, 2018. After payment
of certain legal fees and expenses, net proceeds to the Company from the October 2018 GS Note totaled &lt;span id="xdx_906_eus-gaap--ProceedsFromConvertibleDebt_c20180929__20181002__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberTwoThousandEighteenGSNoteMember_pp0p0" title="Proceeds from convertible debt"&gt;$100,700&lt;/span&gt;. The purchase price of
&lt;span id="xdx_902_eus-gaap--ProceedsFromConvertibleDebt_pp0p0_c20180929__20181002__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberTwoThousandEighteenGSNoteMember__us-gaap--ShortTermDebtTypeAxis__custom--FirstNoteMember_zG1H5PWnaa1" title="Proceeds from convertible debt"&gt;$106,000&lt;/span&gt; of the second note (the &#x201c;October 2, 2018 GS Back End Note&#x201d;) was initially paid for by GS Capital issuing to the
Company an offsetting &lt;span id="xdx_908_eus-gaap--ProceedsFromConvertibleDebt_c20180929__20181002__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberTwoThousandEighteenGSNoteMember__us-gaap--ShortTermDebtTypeAxis__custom--SecondNoteMember_pp0p0" title="Proceeds from convertible debt"&gt;$106,000&lt;/span&gt; collateralized secured note (the &#x201c;October 2, 2018 GS Secured Note&#x201d;). The terms of the October
2018 GS Back End Note require cash funding prior to any conversion thereunder, and such cash funding shall occur on or before June 2,
2019.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Both
the October 2, 2018 GS Note and the October 2, 2018 GS Back End Note, which was funded on February 27, 2019, matured on October 2, 2019,
upon which any outstanding principal and interest thereon is due and payable. The amounts cash funded plus accrued interest under both
the October 2018 GS Note and the October 2018 GS Back End Note are convertibles into shares of the Company&#x2019;s common stock, at any
time after April 2, 2019, at a conversion price for each share of common stock equal to &lt;span id="xdx_905_eus-gaap--DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_dp_uPure_c20180929__20181002__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberTwoThousandEighteenGSNoteMember_zoEnJjhzaQ3i" title="Common stock trading volume, percent"&gt;61%&lt;/span&gt; of the lowest closing bid price of the Company&#x2019;s
common stock for the ten prior trading days including the day upon which a notice of conversion is received by the Company from GS Capital,
subject to adjustment in certain events. The maturity date of the &lt;span id="xdx_90A_eus-gaap--DebtInstrumentMaturityDate_dd_c20180929__20181002__us-gaap--TypeOfArrangementAxis__custom--OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberTwoThousandEighteenGSNoteMember_zREmxodNjZ6l" title="Debt maturity date"&gt;October 2, 2018&lt;/span&gt; GS Back-Note was October 2019 and the notes were fully
converted to common stock in fiscal 2020.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;i&gt;January
22, 2020 GS Capital Securities Purchase Agreements&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Effective
January 22, 2020, the Company entered into a securities purchase agreement with GS Capital, pursuant to which GS Capital purchased a
convertible promissory note (the &#x201c;January 22, 2020 GS Note&#x201d;) from the Company in the aggregate principal amount of &lt;span id="xdx_905_eus-gaap--DebtInstrumentFaceAmount_c20200122__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--JanuaryTwentyTwoTwentyTwentyGSNoteMember_pp0p0" title="Convertible debt principal amount"&gt;$58,000&lt;/span&gt;,
such principal and the interest thereon convertible into shares of the Company&#x2019;s common stock at the option of GS Capital any time
after the six-month anniversary of the January 22, 2020 GS Capital Note. The January 22, 2020 GS Note contained an original discount
of &lt;span id="xdx_900_eus-gaap--DebtInstrumentUnamortizedDiscount_c20200122__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--JanuaryTwentyTwoTwentyTwentyGSNoteMember_pp0p0" title="Original issue discount"&gt;$3,500&lt;/span&gt;. The transactions contemplated by the GS Capital Securities Purchase Agreement closed on January 22, 2020. Pursuant to the
terms of the GS Capital Securities Purchase Agreement, GS Capital deducted &lt;span id="xdx_901_eus-gaap--LegalFees_c20200121__20200122__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--JanuaryTwentyTwoTwentyTwentyGSNoteMember_pp0p0" title="Legal fees"&gt;$2,500&lt;/span&gt; from the principal payment due under the January 22,
2020 GW Note, at the time of closing, to be applied to its legal expenses and received net cash proceeds of &lt;span id="xdx_90D_eus-gaap--ProceedsFromConvertibleDebt_c20200121__20200122__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--JanuaryTwentyTwoTwentyTwentyGSNoteMember__srt--RangeAxis__srt--MinimumMember_pp0p0" title="Proceeds from convertible debt"&gt;$52,000&lt;/span&gt; on January 28, 2020.
The Company used the net proceeds from the January 22, 2020 GW Note for general working capital purposes. The maturity date of the January
22, 2020 GS Capital was &lt;span id="xdx_90B_eus-gaap--DebtInstrumentMaturityDate_dd_c20200121__20200122__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--JanuaryTwentyTwoTwentyTwentyGSNoteMember_ztHk6HM5YFai" title="Debt maturity date"&gt;January 22, 2021&lt;/span&gt;. The January 22, 2020 GS Capital Note bore interest at a rate of 10% per annum, which interest
may be paid by the Company to GS Capital in shares of the Company&#x2019;s common stock; but was not payable until the January 22, 2020
GS Capital Note became payable, whether at the maturity date or upon acceleration or by prepayment. The conversion price for the January
22, 2020 GS Capital Note was equal to a &lt;span id="xdx_903_eus-gaap--DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_dp_uPure_c20200121__20200122__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--JanuaryTwentyTwoTwentyTwentyGSNoteMember_zMLHV8tdxRD1" title="Common stock trading volume, percent"&gt;40%&lt;/span&gt; discount of the lowest closing bid price (&#x201c;Lowest Trading Price&#x201d;) of the Common
Stock for the ten trading days immediately prior to the delivery of a Notice of Conversion, including the day upon which a Notice of
Conversion is received.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Additionally,
GS Capital had the option to convert all or any amount of the principal face amount of the January 22, 2020 GS Capital Note at any time
from the date of issuance and ending on the later of the maturity date or the date the Default Amount was paid if an event of default
occurs, which is an amount between &lt;span id="xdx_909_ecustom--DebtDefaultAmountPercentage_dp_uPure_c20200121__20200122__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--JanuaryTwentyTwoTwentyTwentyGSNoteMember__srt--RangeAxis__srt--MinimumMember_zLhcyB9kReSh" title="Debt default amount percentage"&gt;112%&lt;/span&gt; and &lt;span id="xdx_90A_ecustom--DebtDefaultAmountPercentage_dp_uPure_c20200121__20200122__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--JanuaryTwentyTwoTwentyTwentyGSNoteMember__srt--RangeAxis__srt--MaximumMember_z9sSAd3r7dW1" title="Debt default amount percentage"&gt;130%&lt;/span&gt; of an amount equal to the then outstanding principal amount of the January 22, 2020
GS Capital Note plus any interest accrued, for shares of the Company&#x2019;s common stock at the then-applicable conversion price. The
January 22, 2020 GS Note contained certain events of default, upon which principal and accrued interest would become immediately due
and payable. In addition, upon an event of default, interest on the outstanding principal would accrue at a default interest rate of
&lt;span id="xdx_906_ecustom--DebtInstrumentDebtDefaultInterestRate_dp_uPure_c20200121__20200122__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--JanuaryTwentyTwoTwentyTwentyGSNoteMember_zRSiBEyLkQB6" title="Debt instrument, default, interest rate"&gt;24%&lt;/span&gt; per annum.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;PROPANC
BIOPHARMA, INC. AND SUBSIDIARY&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;June
30, 2021 and 2020&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;The
notes issued to GS capital above were treated as stock settled debt under ASC 480 and accordingly the Company recorded a total of &lt;span id="xdx_90C_eus-gaap--DebtInstrumentUnamortizedPremium_c20200122__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--JanuaryTwentyTwoTwentyTwentyGSNoteMember_pp0p0" title="Debt premium amount"&gt;$106,438&lt;/span&gt;
put premium which was expensed in fiscal 2020 of which &lt;span id="xdx_90F_eus-gaap--AdditionalPaidInCapital_c20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--JanuaryTwentyTwoTwentyTwentyGSNoteMember_pp0p0" title="Additional paid in capital"&gt;$22,901&lt;/span&gt; and &lt;span id="xdx_90C_eus-gaap--AdditionalPaidInCapital_c20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--JanuaryTwentyTwoTwentyTwentyGSNoteMember_pp0p0" title="Additional paid in capital"&gt;$38,667&lt;/span&gt; was released to additional paid in capital following conversion
of principal during the year ended June 30, 2020 and 2021, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.45in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;The
Company recorded &lt;span id="xdx_90B_eus-gaap--InterestPayableCurrentAndNoncurrent_c20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--JanuaryTwentyTwoTwentyTwentyGSNoteMember_pp0p0" title="Accrued interest"&gt;$8,802&lt;/span&gt; of accrued interest and the total principal outstanding under the above GS Capital financing agreements was &lt;span id="xdx_901_eus-gaap--ConvertibleNotesPayable_c20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--JanuaryTwentyTwoTwentyTwentyGSNoteMember_pp0p0" title="Convertible debt outstanding balance"&gt;$58,000&lt;/span&gt;
as of June 30, 2020 following the conversion of &lt;span id="xdx_902_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20190701__20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--JanuaryTwentyTwoTwentyTwentyGSNoteMember_pp0p0" title="Debt conversion of converted amount"&gt;$141,820&lt;/span&gt; of principal and &lt;span id="xdx_90E_ecustom--DebtConversionConvertedInterestPayable_c20190701__20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--JanuaryTwentyTwoTwentyTwentyGSNoteMember_pp0p0" title="Debt conversion of accrued interest"&gt;$76,397&lt;/span&gt; of accrued interest during the year ended June 30,
2020. The total remaining principal outstanding and accrued interest under the above GS Capital financing agreements was &lt;span id="xdx_902_eus-gaap--ConvertibleNotesPayable_c20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--JanuaryTwentyTwoTwentyTwentyGSNoteMember_pp0p0" title="Convertible debt outstanding balance"&gt;$0&lt;/span&gt; as of June
30, 2021 following conversion of &lt;span id="xdx_90B_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20200701__20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--JanuaryTwentyTwoTwentyTwentyGSNoteMember_pp0p0" title="Debt conversion of converted amount"&gt;$58,000&lt;/span&gt; of principal and &lt;span id="xdx_900_ecustom--DebtConversionConvertedInterestPayable_c20200701__20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--JanuaryTwentyTwoTwentyTwentyGSNoteMember_pp0p0" title="Debt conversion of accrued interest"&gt;$8,508&lt;/span&gt; of accrued interest during the year ended June 30, 2021.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;&lt;i&gt;Convertible
Note Issued with Consulting Agreement&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;i&gt;August
10, 2017 Consulting Agreement&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;On
August 10, 2017, the Company entered into a consulting agreement, retroactive to May 16, 2017, with a certain consultant, pursuant to
which the consultant agreed to provide certain consulting and business advisory services in exchange for a &lt;span id="xdx_90F_eus-gaap--DebtInstrumentFaceAmount_c20170810__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember_pp0p0" title="Convertible debt principal amount"&gt;$310,000&lt;/span&gt; junior subordinated
convertible note. The maturity date of the August 10, 2017 Convertible Note was August 2019 and is currently past due (see Note 8). The
note accrues interest at a rate of &lt;span id="xdx_90C_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20170810__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember_zGtRbaHUHryg" title="Debt instrument, interest rate, stated percentage"&gt;10%&lt;/span&gt; per annum and is convertible into common stock at the lesser of &lt;span id="xdx_904_eus-gaap--DebtConversionConvertedInstrumentAmount1_pp0p0_c20170807__20170810__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember_zRjQnG0vwOlg" title="Debt conversion of converted amount"&gt;$750&lt;/span&gt; or &lt;span id="xdx_906_eus-gaap--DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_dp_uPure_c20170807__20170810__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember_za6nPWZA6QU1" title="Common stock trading volume, percent"&gt;65%&lt;/span&gt; of the three lowest
trades in the &lt;span id="xdx_90F_eus-gaap--DebtInstrumentConvertibleThresholdTradingDays_dxL_uInteger_c20170807__20170810__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember_zDWKrjoAjRPh" title="::XDX::10"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1215"&gt;ten&lt;/span&gt;&lt;/span&gt; trading days prior to the conversion. The note was fully earned upon signing the agreement and matures on &lt;span id="xdx_90E_eus-gaap--DebtInstrumentMaturityDate_dd_c20170807__20170810__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember_zmjK4drtFdhi" title="Debt maturity date"&gt;August 10,
2019&lt;/span&gt;. The Company accrued &lt;span id="xdx_906_eus-gaap--AccruedLiabilitiesCurrentAndNoncurrent_c20170630__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember_pp0p0" title="Accrued expenses"&gt;$155,000&lt;/span&gt; related to this expense at June 30, 2017 and recorded the remaining &lt;span id="xdx_90A_eus-gaap--AccruedLiabilitiesCurrentAndNoncurrent_c20180630__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember_pp0p0" title="Accrued expenses"&gt;$155,000&lt;/span&gt; related to this expense
in fiscal year 2018. Upon an event of default, principal and accrued interest will become immediately due and payable under the note.
Additionally, upon an event of default, at the election of the holder, the note would accrue interest at a default interest rate of &lt;span id="xdx_90E_ecustom--DebtInstrumentDebtDefaultInterestRate_dp_uPure_c20170807__20170810__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember_z0Krvi3m8oVc" title="Debt instrument, default, interest rate"&gt;18%&lt;/span&gt;
per annum or the highest rate of interest permitted by law. The consulting agreement had a three-month term and expired on August 16,
2017. An aggregate total of &lt;span id="xdx_903_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_c20170810__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember_pp0p0" title="Embedded derivative, fair value of embedded derivative liability"&gt;$578,212&lt;/span&gt; of this note was bifurcated with the embedded conversion option recorded as a derivative liability
at fair value. During the year ended June 30, 2018, the consultant converted &lt;span id="xdx_902_eus-gaap--DebtInstrumentFaceAmount_c20180630__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ConsultantMember_pp0p0" title="Convertible debt principal amount"&gt;$140,000&lt;/span&gt; of principal and &lt;span id="xdx_901_eus-gaap--InterestPayableCurrentAndNoncurrent_c20180630__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ConsultantMember_pp0p0" title="Accrued interest"&gt;$10,764&lt;/span&gt; of interest. During the
year ended June 30, 2019, the consultant converted an additional &lt;span id="xdx_903_eus-gaap--DebtInstrumentFaceAmount_c20190630__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ConsultantMember_pp0p0" title="Convertible debt principal amount"&gt;$161,000&lt;/span&gt; of principal and &lt;span id="xdx_902_eus-gaap--InterestPayableCurrentAndNoncurrent_c20190630__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ConsultantMember_pp0p0" title="Accrued interest"&gt;$19,418&lt;/span&gt; of interest leaving a principal balance
owed of &lt;span id="xdx_90D_eus-gaap--DebtInstrumentFaceAmount_c20190630__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember_pp0p0" title="Convertible debt principal amount"&gt;$9,000&lt;/span&gt; at June 30, 2019. During the year ended June 30, 2020, the consultant converted an additional &lt;span id="xdx_903_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20190701__20200630__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember_pp0p0" title="Debt conversion of converted amount"&gt;$500&lt;/span&gt; of principal and &lt;span id="xdx_900_eus-gaap--AccruedLiabilitiesCurrentAndNoncurrent_c20200630__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember_pp0p0" title="Accrued expenses"&gt;$5,248&lt;/span&gt;
of interest such that the remaining principal outstanding and accrued interest under this note as of June 30, 2020 was &lt;span id="xdx_904_eus-gaap--DebtInstrumentFaceAmount_c20200630__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember_pp0p0" title="Convertible debt principal amount"&gt;$8,500&lt;/span&gt; and &lt;span id="xdx_903_eus-gaap--InterestPayableCurrentAndNoncurrent_c20200630__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember_pp0p0" title="Accrued interest"&gt;$22,168&lt;/span&gt;,
respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;On
March 15, 2021, the Company entered into a Settlement and Mutual Release Agreement (the &#x201c;Settlement Agreement&#x201d;) with the
consultant whereby both parties agreed to settle all claims and liabilities under the August 10, 2017 Convertible note for a total of
&lt;span id="xdx_90F_eus-gaap--DebtInstrumentFaceAmount_c20210315__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember__us-gaap--ShortTermDebtTypeAxis__custom--SettlementAndMutualReleaseAgreementMember_pp0p0" title="Convertible debt principal amount"&gt;$100,000&lt;/span&gt; in the form of a convertible note. All other terms of the August 10, 2017 Convertible Note shall remain in full force and effect.
Both parties agree that all future penalties under this note are waived unless the Company fails to authorize to distribute the requested
shares upon conversion. The Company has the right to pay off the balance of any remaining amounts dues under this note in cash at any
time more than 60 days after March 15, 2021. Prior to the Settlement Agreement, the Company recorded total liabilities &lt;span id="xdx_906_eus-gaap--Liabilities_iI_pp0p0_c20210315__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember__us-gaap--ShortTermDebtTypeAxis__custom--SettlementAndMutualReleaseAgreementMember_zlShDC1Kn4a1" title="Liabilities"&gt;$56,762&lt;/span&gt; consisting
of remaining principal amount of &lt;span id="xdx_90A_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pp0p0_c20210315__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember__us-gaap--ShortTermDebtTypeAxis__custom--SettlementAndMutualReleaseAgreementMember_zTBqWM6Glnla" title="Original issue discount"&gt;$8,500&lt;/span&gt;, accrued interest of &lt;span id="xdx_909_eus-gaap--InterestPayableCurrentAndNoncurrent_c20210315__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember__us-gaap--ShortTermDebtTypeAxis__custom--SettlementAndMutualReleaseAgreementMember_pp0p0" title="Accrued interest"&gt;$23,262&lt;/span&gt; and accrued expenses of &lt;span id="xdx_904_eus-gaap--AccruedLiabilitiesCurrentAndNoncurrent_c20210315__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember__us-gaap--ShortTermDebtTypeAxis__custom--SettlementAndMutualReleaseAgreementMember_pp0p0" title="Accrued expenses"&gt;$25,000&lt;/span&gt;. Accordingly, the Company recognized
loss from settlement of debt of &lt;span id="xdx_90D_eus-gaap--GainsLossesOnExtinguishmentOfDebt_c20200701__20210630__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember__us-gaap--ShortTermDebtTypeAxis__custom--SettlementAndMutualReleaseAgreementMember_pp0p0" title="Loss from settlement of debt"&gt;$43,238&lt;/span&gt; during the year ended June 30, 2021 which is included in gain from settlement of debt, net in
the accompanying consolidated statements of operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;The
total principal outstanding after adjustment due to the above-mentioned March 15, 2021 settlement agreement and accrued
interest under the August 10, 2017 Convertible Note was &lt;span id="xdx_90F_eus-gaap--ConvertibleNotesPayable_c20210630__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember__us-gaap--ShortTermDebtTypeAxis__custom--SettlementAndMutualReleaseAgreementMember_pp0p0"&gt;$80,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;and &lt;span id="xdx_909_eus-gaap--InterestPayableCurrentAndNoncurrent_c20210630__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember__us-gaap--ShortTermDebtTypeAxis__custom--SettlementAndMutualReleaseAgreementMember_pp0p0"&gt;$3,738&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;,
respectively, as of June 30, 2021 following conversion of &lt;span id="xdx_902_eus-gaap--DebtConversionConvertedInstrumentAmount1_pp0p0_c20200701__20210630__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember__us-gaap--ShortTermDebtTypeAxis__custom--SettlementAndMutualReleaseAgreementMember_zliV7VyKLZJ8"&gt;$20,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;of principal during the year ended
June 30, 2021.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;&lt;i&gt;Power
Up Lending Group Financing Agreements&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;i&gt;November
26, 2019 Securities Purchase Agreement&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Effective
November 26, 2019, the Company entered into a securities purchase agreement with Power Up Lending Group Ltd. (&#x201c;Power Up&#x201d;),
pursuant to which Power Up purchased a convertible promissory note (the &#x201c;November 26, 2019 Power Up Note&#x201d;) from the Company
in the aggregate principal amount of &lt;span id="xdx_90D_eus-gaap--DebtInstrumentFaceAmount_c20191126__us-gaap--TypeOfArrangementAxis__custom--NovemberTwentySixTwoThousandNineteenSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--NovemberTwentySixTwoThousandNineteenPowerUpNoteMember_pp0p0" title="Convertible debt principal amount"&gt;$43,000&lt;/span&gt;, such principal and the interest thereon convertible into shares of the Company&#x2019;s
common stock at the option of Power Up. The transaction closed on November 22, 2019 and the Company received payment on December 3, 2019
in the amount of &lt;span id="xdx_900_ecustom--PrepaymentPenalties_c20191121__20191122__us-gaap--TypeOfArrangementAxis__custom--NovemberTwentySixTwoThousandNineteenSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--NovemberTwentySixTwoThousandNineteenPowerUpNoteMember_pp0p0" title="Prepayment penalty"&gt;$40,000&lt;/span&gt;, net of &lt;span id="xdx_90F_eus-gaap--LegalFees_c20191121__20191122__us-gaap--TypeOfArrangementAxis__custom--NovemberTwentySixTwoThousandNineteenSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--NovemberTwentySixTwoThousandNineteenPowerUpNoteMember_pp0p0" title="Legal fees"&gt;$2,500&lt;/span&gt; paid directly toward legal fees and &lt;span id="xdx_909_ecustom--DiligenceFees_c20191121__20191122__us-gaap--TypeOfArrangementAxis__custom--NovemberTwentySixTwoThousandNineteenSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--NovemberTwentySixTwoThousandNineteenPowerUpNoteMember_pp0p0" title="Diligence fees"&gt;$500&lt;/span&gt; to Power Up for due diligence fees. The maturity date
of the November 26, 2019 Power Up Note was &lt;span id="xdx_90C_eus-gaap--DebtInstrumentMaturityDate_dd_c20191125__20191126__us-gaap--TypeOfArrangementAxis__custom--NovemberTwentySixTwoThousandNineteenSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--NovemberTwentySixTwoThousandNineteenPowerUpNoteMember_zYNvcL22ca51" title="Debt maturity date"&gt;November 26, 2020&lt;/span&gt;. The November 26, 2019, Power Up Note bore interest at a rate of &lt;span id="xdx_906_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20191126__us-gaap--TypeOfArrangementAxis__custom--NovemberTwentySixTwoThousandNineteenSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--NovemberTwentySixTwoThousandNineteenPowerUpNoteMember_zdNdNDpgTz2" title="Debt instrument, interest rate, stated percentage"&gt;8%&lt;/span&gt; per
annum, which interest was paid by the Company to Power Up in shares of the Company&#x2019;s common stock but was not payable until the
November 26, 2019 Power Up Note became payable, whether at the maturity date or upon acceleration or by prepayment. The note was fully
converted in fiscal 2020.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;i&gt;January
7, 2020 Power Up Lending Group Securities Purchase Agreement&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Effective
January 7, 2020, the Company entered into a securities purchase agreement with Power Up Lending Group Ltd. (&#x201c;Power Up&#x201d;),
pursuant to which Power Up purchased a convertible promissory note (the &#x201c;January 7, 2020 Power Up Note&#x201d;) from the Company
in the aggregate principal amount of &lt;span id="xdx_903_eus-gaap--DebtInstrumentFaceAmount_c20200107__us-gaap--TypeOfArrangementAxis__custom--JanuarySevenTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--JanuarySevenTwoThousandTwentyPowerUpNoteMember_pp0p0" title="Convertible debt principal amount"&gt;$75,000&lt;/span&gt;, such principal and the interest thereon convertible into shares of the Company&#x2019;s
common stock at the option of Power Up. The transaction closed on January 7, 2020 and the Company received payment on January 13, 2020
in the amount of &lt;span id="xdx_90E_ecustom--PrepaymentPenalties_c20200112__20200113__us-gaap--TypeOfArrangementAxis__custom--JanuarySevenTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--JanuarySevenTwoThousandTwentyPowerUpNoteMember_pp0p0" title="Prepayment penalty"&gt;$72,000&lt;/span&gt;, net of &lt;span id="xdx_908_eus-gaap--LegalFees_c20200112__20200113__us-gaap--TypeOfArrangementAxis__custom--JanuarySevenTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--JanuarySevenTwoThousandTwentyPowerUpNoteMember_pp0p0" title="Legal fees"&gt;$2,500&lt;/span&gt; paid directly toward legal fees and &lt;span id="xdx_903_ecustom--DiligenceFees_c20200112__20200113__us-gaap--TypeOfArrangementAxis__custom--JanuarySevenTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--JanuarySevenTwoThousandTwentyPowerUpNoteMember_pp0p0" title="Diligence fees"&gt;$500&lt;/span&gt; to Power Up for due diligence fees. The maturity date
of the January 7, 2020 Power Up Note was &lt;span id="xdx_903_eus-gaap--DebtInstrumentMaturityDate_dd_c20200106__20200107__us-gaap--TypeOfArrangementAxis__custom--JanuarySevenTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--JanuarySevenTwoThousandTwentyPowerUpNoteMember_zjzmYAIZORch" title="Debt maturity date"&gt;January 7, 2021&lt;/span&gt;. The January 7, 2020, Power Up Note bore interest at a rate of &lt;span id="xdx_908_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20200107__us-gaap--TypeOfArrangementAxis__custom--JanuarySevenTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--JanuarySevenTwoThousandTwentyPowerUpNoteMember_ziD8r4iS1J77" title="Debt instrument, interest rate, stated percentage"&gt;8%&lt;/span&gt; per annum,
which interest was paid by the Company to Power Up in shares of the Company&#x2019;s common stock, but not payable until the January 7,
2020 Power Up Note became payable, whether at the maturity date or upon acceleration or by prepayment.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;PROPANC
BIOPHARMA, INC. AND SUBSIDIARY&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;June
30, 2021 and 2020&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;i&gt;March
12, 2020 Power Up Lending Group Securities Purchase Agreement&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Effective
March 12, 2020, the Company entered into a securities purchase agreement with Power Up Lending Group Ltd. (&#x201c;Power Up&#x201d;), pursuant
to which Power Up purchased a convertible promissory note (the &#x201c;March 12, 2020 Power Up Note&#x201d;) from the Company in the aggregate
principal amount of &lt;span id="xdx_90B_eus-gaap--DebtInstrumentFaceAmount_c20200312__us-gaap--TypeOfArrangementAxis__custom--MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--MarchTwelveTwoThousandTwentyPowerUpNoteMember_pp0p0" title="Convertible debt principal amount"&gt;$43,000&lt;/span&gt;, such principal and the interest thereon convertible into shares of the Company&#x2019;s common stock at the
option of Power Up. The transaction closed on March 12, 2020 and the Company received payment on March 5, 2020 in the amount of &lt;span id="xdx_90A_ecustom--PrepaymentPenalties_c20200304__20200305__us-gaap--TypeOfArrangementAxis__custom--MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--MarchTwelveTwoThousandTwentyPowerUpNoteMember_pp0p0" title="Prepayment penalty"&gt;$40,000&lt;/span&gt;,
net of &lt;span id="xdx_906_eus-gaap--LegalFees_c20200304__20200305__us-gaap--TypeOfArrangementAxis__custom--MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--MarchTwelveTwoThousandTwentyPowerUpNoteMember_pp0p0" title="Legal fees"&gt;$2,500&lt;/span&gt; paid directly toward legal fees and &lt;span id="xdx_903_ecustom--DiligenceFees_c20200304__20200305__us-gaap--TypeOfArrangementAxis__custom--MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--MarchTwelveTwoThousandTwentyPowerUpNoteMember_pp0p0" title="Diligence fees"&gt;$500&lt;/span&gt; to Power Up for due diligence fees. The maturity date of the March 12, 2020 Power
Up Note was &lt;span id="xdx_90D_eus-gaap--DebtInstrumentMaturityDate_dd_c20200311__20200312__us-gaap--TypeOfArrangementAxis__custom--MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--MarchTwelveTwoThousandTwentyPowerUpNoteMember_zm4Ozo2Yvwag" title="Debt maturity date"&gt;March 12, 2021&lt;/span&gt;. The March 12, 2020, Power Up Note bore interest at a rate of &lt;span id="xdx_908_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20200312__us-gaap--TypeOfArrangementAxis__custom--MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--MarchTwelveTwoThousandTwentyPowerUpNoteMember_zSjxwDoJzOOc" title="Debt instrument, interest rate, stated percentage"&gt;8%&lt;/span&gt; per annum, which interest may be paid by
the Company to Power Up in shares of the Company&#x2019;s common stock but was not payable until the March 12, 2020 Power Up Note became
payable, whether at the maturity date or upon acceleration or by prepayment.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;All
the notes issued above to Power Up contained certain events of default, upon which principal and accrued interest would become immediately
due and payable. In addition, upon an event of default, interest on the outstanding principal would accrue at a default interest rate
of &lt;span id="xdx_90F_ecustom--DebtDefaultAmountPercentage_dp_uPure_c20200311__20200312__us-gaap--TypeOfArrangementAxis__custom--MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--MarchTwelveTwoThousandTwentyPowerUpNoteMember_zCkbqUUFvoOa" title="Debt default amount percentage"&gt;22%&lt;/span&gt; per annum.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Additionally,
Power Up had the option to convert all or any amount of the principal face amount of the notes issued to Power Up, starting on certain
dates as defined in the note agreements and ending on the later of the maturity date or the date the Default Amount is paid if an event
of default occurs, which was an amount equal to &lt;span id="xdx_904_ecustom--DebtInstrumentDebtDefaultInterestRate_dp_uPure_c20200311__20200312__us-gaap--TypeOfArrangementAxis__custom--MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--MarchTwelveTwoThousandTwentyPowerUpNoteMember_zy0zG934qIS8" title="Debt instrument, default, interest rate"&gt;150%&lt;/span&gt; of an amount equal to the then outstanding principal amount of the notes plus any
interest accrued, for shares of the Company&#x2019;s common stock at the then-applicable conversion price.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;span id="xdx_902_eus-gaap--DebtConversionDescription_c20200311__20200312__us-gaap--TypeOfArrangementAxis__custom--MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--MarchTwelveTwoThousandTwentyPowerUpNoteMember" title="Debt conversion, description"&gt;The
conversion price for the above Power Up notes was $3,050, subject to certain Market Price (as defined below) adjustment. If the Market
Price was greater than or equal to $5,000, the conversion price was to be the greater of &lt;span id="xdx_90D_eus-gaap--DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_dp_uPure_c20200311__20200312__us-gaap--TypeOfArrangementAxis__custom--MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--MarchTwelveTwoThousandTwentyPowerUpNoteMember_zAlegf67tQq2" title="Common stock trading volume, percent"&gt;65%&lt;/span&gt; of the Market Price (&#x201c;Variable Conversion
Price&#x201d;) and $3,050. In the event Market Price was less than $5,000, the conversion price was to be the Variable Conversion Price.
As defined in the note agreements, the &#x201c;Market Price&#x201d; was the average of the lowest three closing bid prices during the &lt;span id="xdx_904_eus-gaap--DebtInstrumentConvertibleThresholdTradingDays_dc_uInteger_c20200311__20200312__us-gaap--TypeOfArrangementAxis__custom--MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--MarchTwelveTwoThousandTwentyPowerUpNoteMember_zmK9EcdpAoe2" title="Common stock trading days"&gt;ten&lt;/span&gt;
day trading period prior to and including the day the Company receives a notice of conversion from Power Up on the electronic quotation
system or applicable principal securities exchange or trading market or, if no closing bid price of such security is available in any
of the foregoing manners, the average of the closing bid prices of any market makers for such security that are listed in the &#x201c;pink
sheets&#x201d; during the ten prior trading days, including the day upon which the Company receives a notice of conversion from Power
Up. Notwithstanding the foregoing, Power Up was restricted from effecting a conversion if such conversion, along with other shares of
the Company&#x2019;s common stock beneficially owned by Power Up and its affiliates, exceeds &lt;span id="xdx_90B_ecustom--PercentageOfOutstandingSharesOfCommonStock_dp_uPure_c20200311__20200312__us-gaap--TypeOfArrangementAxis__custom--MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--MarchTwelveTwoThousandTwentyPowerUpNoteMember_zMMUxQV5ZnF3" title="Percentage of outstanding shares of common stock"&gt;4.99%&lt;/span&gt; of the outstanding shares of the Company&#x2019;s
common stock.&lt;/span&gt; An aggregate initial total of &lt;span id="xdx_90F_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_c20200312__us-gaap--TypeOfArrangementAxis__custom--MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--MarchTwelveTwoThousandTwentyPowerUpNoteMember_pp0p0" title="Embedded derivative, fair value of embedded derivative liability"&gt;$422,557&lt;/span&gt; of these notes were bifurcated with the embedded conversion option recorded as derivative
liabilities at fair value.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;The
total principal amount outstanding under the above Power Up financing agreements, specifically the January 7, 2020 and March 12, 2020
Power Up Notes, was &lt;span id="xdx_909_eus-gaap--DebtInstrumentFaceAmount_c20200107__us-gaap--TypeOfArrangementAxis__custom--MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--MarchTwelveTwoThousandTwentyPowerUpNoteMember_pp0p0" title="Convertible debt principal amount"&gt;&lt;span id="xdx_908_eus-gaap--DebtInstrumentFaceAmount_c20200630__us-gaap--TypeOfArrangementAxis__custom--MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--MarchTwelveTwoThousandTwentyPowerUpNoteMember_pp0p0" title="Convertible debt principal amount"&gt;$118,000&lt;/span&gt;&lt;/span&gt; and accrued interest of &lt;span id="xdx_90A_eus-gaap--InterestPayableCurrentAndNoncurrent_c20200107__us-gaap--TypeOfArrangementAxis__custom--MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--MarchTwelveTwoThousandTwentyPowerUpNoteMember_pp0p0" title="Accrued interest"&gt;&lt;span id="xdx_905_eus-gaap--InterestPayableCurrentAndNoncurrent_c20200630__us-gaap--TypeOfArrangementAxis__custom--MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--MarchTwelveTwoThousandTwentyPowerUpNoteMember_pp0p0" title="Accrued interest"&gt;$3,903&lt;/span&gt;&lt;/span&gt; as of June 30, 2020. The total principal amount outstanding under the above
Power Up financing agreement, specifically the January 7, 2020 and March 12, 2020 Power Up Notes, was &lt;span id="xdx_90F_eus-gaap--DebtInstrumentFaceAmount_c20210630__us-gaap--TypeOfArrangementAxis__custom--MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--MarchTwelveTwoThousandTwentyPowerUpNoteMember_pp0p0" title="Convertible debt principal amount"&gt;$0&lt;/span&gt; and accrued interest of &lt;span id="xdx_904_eus-gaap--InterestPayableCurrentAndNoncurrent_c20210630__us-gaap--TypeOfArrangementAxis__custom--MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--MarchTwelveTwoThousandTwentyPowerUpNoteMember_pp0p0" title="Accrued interest"&gt;$0&lt;/span&gt; as
of June 30, 2021 following repayment in cash of &lt;span id="xdx_905_eus-gaap--RepaymentsOfDebt_c20200701__20210630__us-gaap--TypeOfArrangementAxis__custom--MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--MarchTwelveTwoThousandTwentyPowerUpNoteMember_pp0p0" title="Repayment in cash"&gt;$43,000&lt;/span&gt; of the principal balance and &lt;span id="xdx_904_eus-gaap--InterestPaid_c20200701__20210630__us-gaap--TypeOfArrangementAxis__custom--MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--MarchTwelveTwoThousandTwentyPowerUpNoteMember_pp0p0" title="Repayment of interest"&gt;$1,816&lt;/span&gt; of accrued interest and conversions into
common stock during the year ended June 30, 2021. Accordingly, there was &lt;span id="xdx_90F_eus-gaap--ConvertibleNotesPayable_iI_pp0p0_do_c20210630__us-gaap--TypeOfArrangementAxis__custom--MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--MarchTwelveTwoThousandTwentyPowerUpNoteMember_z2XBC9mbBouf" title="Convertible debt outstanding balance"&gt;no&lt;/span&gt; outstanding principal balance as of June 30, 2021.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;&lt;i&gt;Redstart
Holdings Corp Financing Agreement&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;i&gt;May
23, 2019 Securities Purchase Agreement&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Effective
May 23, 2019, the Company issued a convertible promissory note (the &#x201c;May 23 Redstart Holdings Note&#x201d;) to Redstart Holdings
Corp (&#x201c;Redstart Holdings&#x201d;) in the aggregate principal amount of &lt;span id="xdx_90F_eus-gaap--DebtInstrumentFaceAmount_c20190523__us-gaap--TypeOfArrangementAxis__custom--RedstartHoldingsCorpFinancingAgreementMember__dei--LegalEntityAxis__custom--RedstartHoldingsCorpMember_pp0p0" title="Convertible debt principal amount"&gt;$133,000&lt;/span&gt;, with principal and the interest thereon convertible
into shares of the Company&#x2019;s common stock at the option of Redstart Holdings any time after 180 days of issuance. At the time of
closing on May 31, 2019, Redstart Holdings deducted &lt;span id="xdx_90D_eus-gaap--LegalFees_c20190522__20190523__us-gaap--TypeOfArrangementAxis__custom--RedstartHoldingsCorpFinancingAgreementMember__dei--LegalEntityAxis__custom--RedstartHoldingsCorpMember_pp0p0" title="Legal fees"&gt;$3,000&lt;/span&gt; from the principal payment due under the May 2019 Redstart Holdings Note to
be applied to its legal expenses, such that the Company received aggregate net proceeds of &lt;span id="xdx_90F_eus-gaap--ProceedsFromConvertibleDebt_pp0p0_c20190522__20190523__us-gaap--TypeOfArrangementAxis__custom--RedstartHoldingsCorpFinancingAgreementMember__dei--LegalEntityAxis__custom--RedstartHoldingsCorpMember_zsaJUYDGLanl" title="Proceeds from convertible debt"&gt;$130,000&lt;/span&gt; at closing. The maturity date of
the May 2019 Redstart Holdings Note was &lt;span id="xdx_901_eus-gaap--DebtInstrumentMaturityDate_dd_c20190522__20190523__us-gaap--TypeOfArrangementAxis__custom--RedstartHoldingsCorpFinancingAgreementMember__dei--LegalEntityAxis__custom--RedstartHoldingsCorpMember_zBtTZ0apbbh1" title="Debt maturity date"&gt;May 23, 2020&lt;/span&gt; and bore interest at a rate of &lt;span id="xdx_90A_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20190523__us-gaap--TypeOfArrangementAxis__custom--RedstartHoldingsCorpFinancingAgreementMember__dei--LegalEntityAxis__custom--RedstartHoldingsCorpMember_z8zNwVHOEIxb" title="Debt instrument, interest rate, stated percentage"&gt;8%&lt;/span&gt; per annum. The total principal amount outstanding
and accrued interest under the above Redstart Holdings financing agreement, specifically the May 23, 2019 agreement at June 30, 2019
was &lt;span id="xdx_908_eus-gaap--DebtInstrumentFaceAmount_c20190630__us-gaap--TypeOfArrangementAxis__custom--RedstartHoldingsCorpFinancingAgreementMember__dei--LegalEntityAxis__custom--RedstartHoldingsCorpMember_pp0p0" title="Convertible debt principal amount"&gt;$133,000&lt;/span&gt; and &lt;span id="xdx_901_eus-gaap--InterestPayableCurrentAndNoncurrent_c20190630__us-gaap--TypeOfArrangementAxis__custom--RedstartHoldingsCorpFinancingAgreementMember__dei--LegalEntityAxis__custom--RedstartHoldingsCorpMember_pp0p0" title="Accrued interest"&gt;$1,137&lt;/span&gt; respectively and as of June 30, 2020 total principal amount outstanding and accrued interest totaled &lt;span id="xdx_901_eus-gaap--DebtInstrumentFaceAmount_c20200630__us-gaap--TypeOfArrangementAxis__custom--RedstartHoldingsCorpFinancingAgreementMember__dei--LegalEntityAxis__custom--RedstartHoldingsCorpMember_pp0p0" title="Convertible debt principal amount"&gt;$0&lt;/span&gt; and &lt;span id="xdx_909_eus-gaap--InterestPayableCurrentAndNoncurrent_c20200630__us-gaap--TypeOfArrangementAxis__custom--RedstartHoldingsCorpFinancingAgreementMember__dei--LegalEntityAxis__custom--RedstartHoldingsCorpMember_pp0p0" title="Accrued interest"&gt;$0&lt;/span&gt;
respectively following conversion of &lt;span id="xdx_900_eus-gaap--DebtInstrumentFaceAmount_c20200630__us-gaap--TypeOfArrangementAxis__custom--RedstartHoldingsCorpFinancingAgreementMember_pp0p0" title="Convertible debt principal amount"&gt;$133,000&lt;/span&gt; of the principal balance and &lt;span id="xdx_903_eus-gaap--InterestPayableCurrentAndNoncurrent_c20200630__us-gaap--TypeOfArrangementAxis__custom--RedstartHoldingsCorpFinancingAgreementMember_pp0p0" title="Accrued interest"&gt;$5,320&lt;/span&gt; of accrued interest during the year ended June 30,
2020.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;PROPANC
BIOPHARMA, INC. AND SUBSIDIARY&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;June
30, 2021 and 2020&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;&lt;i&gt;Odyssey
Capital Financing Agreements&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;i&gt;July
30, 2019 Securities Purchase Agreement&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Effective
July 30, 2019, the Company entered into a securities purchase agreement with Odyssey Capital Funding LLC, (&#x201c;Odyssey&#x201d;), pursuant
to which Odyssey purchased a convertible promissory note (the &#x201c;July 30, 2019 Odyssey Note&#x201d;) from the Company in the aggregate
principal amount of &lt;span id="xdx_906_eus-gaap--DebtInstrumentFaceAmount_c20190730__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OdysseyCapitalFundingLLCMember__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandNineteenOdysseyNoteMember_pp0p0" title="Convertible debt principal amount"&gt;$320,000&lt;/span&gt;, such principal and the interest thereon convertible into shares of the Company&#x2019;s common stock at
the option of Odyssey. The July 30, 2019 Odyssey Note contains an original discount of &lt;span id="xdx_90A_eus-gaap--DebtInstrumentUnamortizedDiscount_c20190730__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OdysseyCapitalFundingLLCMember__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandNineteenOdysseyNoteMember_pp0p0" title="Original issue discount"&gt;$25,000&lt;/span&gt;. The transaction closed on July 30, 2019
and the Company received payment on August 1, 2019 in the amount of &lt;span id="xdx_905_eus-gaap--DebtInstrumentFaceAmount_c20190801__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OdysseyCapitalFundingLLCMember__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandNineteenOdysseyNoteMember_pp0p0" title="Convertible debt principal amount"&gt;$295,000&lt;/span&gt;, of which &lt;span id="xdx_90D_eus-gaap--LegalFees_c20190731__20190801__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OdysseyCapitalFundingLLCMember__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandNineteenOdysseyNoteMember_pp0p0" title="Legal fees"&gt;$10,000&lt;/span&gt; was paid directly toward legal fees, resulting
in net cash proceeds of &lt;span id="xdx_90F_eus-gaap--ProceedsFromConvertibleDebt_c20190731__20190801__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OdysseyCapitalFundingLLCMember__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandNineteenOdysseyNoteMember_pp0p0" title="Proceeds from convertible debt"&gt;$285,000&lt;/span&gt;. The maturity date of the July 30, 2019 Odyssey Note was &lt;span id="xdx_90E_eus-gaap--DebtInstrumentMaturityDate_dd_c20190729__20190730__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OdysseyCapitalFundingLLCMember__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandNineteenOdysseyNoteMember_zWK5JPNAl2Ve" title="Debt maturity date"&gt;July 30, 2020&lt;/span&gt;. The July 2019 Odyssey Note bore
interest at a rate of &lt;span id="xdx_90F_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20190730__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OdysseyCapitalFundingLLCMember__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandNineteenOdysseyNoteMember_zqG7xTnQih53" title="Debt instrument, interest rate, stated percentage"&gt;10%&lt;/span&gt; per annum, which interest may be paid by the Company to Odyssey in shares of the Company&#x2019;s common stock
but was not payable until the July 30, 2019 Odyssey Note became payable, whether at the maturity date or upon acceleration or by prepayment.
The July 30, 2019 Odyssey Note contained certain events of default, upon which principal and accrued interest would become immediately
due and payable. In addition, upon an event of default, interest on the outstanding principal would accrue at a default interest rate
of &lt;span id="xdx_90C_ecustom--DebtInstrumentDebtDefaultInterestRate_dp_uPure_c20190729__20190730__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OdysseyCapitalFundingLLCMember__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandNineteenOdysseyNoteMember_z4GYRD1EAux2" title="Debt instrument, default, interest rate"&gt;24%&lt;/span&gt; per annum. The note was treated as stock settled debt under ASC 480 and accordingly the Company recorded a &lt;span id="xdx_90E_eus-gaap--DebtInstrumentUnamortizedPremium_c20190730__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OdysseyCapitalFundingLLCMember__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandNineteenOdysseyNoteMember_pp0p0" title="Debt premium amount"&gt;$172,308&lt;/span&gt; put premium.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Additionally,
Odyssey had the option to convert all or any amount of the principal face amount of the July 30, 2019 Odyssey Note, starting on January
31, 2020 and ending on the later of the maturity date or the date the Default Amount was paid if an event of default occurred, which
was an amount equal to &lt;span id="xdx_905_ecustom--PercentageOfOutstandingSharesOfCommonStock_dp_uPure_c20190729__20190730__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OdysseyCapitalFundingLLCMember__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandNineteenOdysseyNoteMember_z1rJRtZ91Hl7" title="Percentage of outstanding shares of common stock"&gt;120%&lt;/span&gt; of an amount equal to the then outstanding principal amount of the July 30, 2019 Odyssey Note plus any interest
accrued from July 30, 2019 at the default interest rate of &lt;span id="xdx_90C_ecustom--DebtInstrumentDebtDefaultInterestRate_dp_uPure_c20190729__20190730__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OdysseyCapitalFundingLLCMember__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandNineteenOdysseyNoteMember_z6AHBubMbEZc" title="Debt instrument, default, interest rate"&gt;24%&lt;/span&gt; per annum for shares of the Company&#x2019;s common stock at the then-applicable
conversion price.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;The
conversion price for the July 30, 2019 Odyssey Note was equal to &lt;span id="xdx_90D_eus-gaap--DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_dp_uPure_c20190729__20190730__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OdysseyCapitalFundingLLCMember__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandNineteenOdysseyNoteMember_ztZQkrsuCRji" title="Common stock trading volume, percent"&gt;65%&lt;/span&gt; of the lowest closing bid price of the Common Stock as reported
on the OTC Markets on which the Company&#x2019;s shares were then traded or any exchange upon which the Common Stock may be traded in
the future, for the ten prior trading days including the day upon which a Notice of Conversion is received by the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;The
total principal amount outstanding under the above Odyssey financing agreement, specifically the July 30, 2019 Odyssey Note, was &lt;span id="xdx_907_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OdysseyCapitalFundingLLCMember_zR13FwGy6Ia8" title="Convertible debt principal amount"&gt;$0&lt;/span&gt; and
accrued interest of &lt;span id="xdx_90D_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OdysseyCapitalFundingLLCMember_zpqSURkjpol9" title="Accrued interest"&gt;$0&lt;/span&gt; as of June 30, 2020 following conversion of &lt;span id="xdx_903_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20190701__20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OdysseyCapitalFundingLLCMember__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandNineteenOdysseyNoteMember_pp0p0" title="Debt conversion of converted amount"&gt;$320,000&lt;/span&gt; of the principal balance and &lt;span id="xdx_907_eus-gaap--InterestPayableCurrentAndNoncurrent_c20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OdysseyCapitalFundingLLCMember__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandNineteenOdysseyNoteMember_pp0p0" title="Accrued interest"&gt;$23,220&lt;/span&gt; of accrued interest
during the year ended June 30, 2020 resulting in full repayment of the note and a full reduction of the put premium. The note was fully
converted in fiscal 2020.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;&lt;i&gt;Auctus
Fund Financing Agreements&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;i&gt;August
30, 2019 Securities Purchase Agreement&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Effective
August 30, 2019, the Company entered into a securities purchase agreement with Auctus Fund, LLC (&#x201c;Auctus&#x201d;), pursuant to which
Auctus purchased a convertible promissory note (the &#x201c;August 30, 2019 Auctus Note&#x201d;) from the Company in the aggregate principal
amount of &lt;span id="xdx_90C_eus-gaap--DebtInstrumentFaceAmount_c20190830__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_pp0p0" title="Convertible debt principal amount"&gt;$550,000&lt;/span&gt;, such principal and the interest thereon convertible into shares of the Company&#x2019;s common stock at the option
of Auctus. The transaction closed on August 30, 2019 and the Company received payment on September 4, 2019 in the amount of &lt;span id="xdx_904_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20190904__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_zbGEPw4WPvlj" title="Convertible debt principal amount"&gt;$550,000&lt;/span&gt;,
of which &lt;span id="xdx_901_eus-gaap--LegalFees_pp0p0_c20190903__20190904__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_zO4UPbfesMyh" title="Legal fees"&gt;$5,000&lt;/span&gt; was paid directly toward legal fees and &lt;span id="xdx_903_ecustom--DiligenceFees_c20190903__20190904__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_pp0p0" title="Diligence fees"&gt;$40,000&lt;/span&gt; to Auctus for due diligence fees resulting in net cash proceeds of &lt;span id="xdx_908_eus-gaap--ProceedsFromConvertibleDebt_c20190903__20190904__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_pp0p0" title="Proceeds from convertible debt"&gt;$505,000&lt;/span&gt;.
The maturity date of the August 30, 2019 Auctus Note was &lt;span id="xdx_90E_eus-gaap--DebtInstrumentMaturityDate_dd_c20190829__20190830__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_zhfCVziB2L77" title="Debt maturity date"&gt;August 30, 2020&lt;/span&gt; and is currently past due. The August 30, 2019 Auctus Note bears
interest at a rate of &lt;span id="xdx_901_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20190830__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_zMKgIwj5n8xf" title="Debt instrument, interest rate, stated percentage"&gt;10%&lt;/span&gt; per annum, but not payable until the August 30, 2019 Auctus Note became payable, whether at the maturity date
or upon acceleration or by prepayment. The note is treated as stock settled debt under ASC 480 and accordingly the Company recorded a
&lt;span id="xdx_904_eus-gaap--DebtInstrumentUnamortizedPremium_c20190830__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_pp0p0" title="Debt premium amount"&gt;$366,667&lt;/span&gt; put premium. The August 30, 2019 Auctus Note may not be prepaid without the written consent of Auctus. Any amount of principal
or interest which is not paid when due shall bear interest at the rate of &lt;span id="xdx_90E_ecustom--DebtInstrumentDebtDefaultInterestRate_dp_uPure_c20190829__20190830__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_zaBaVI3NWg64" title="Debt instrument, default, interest rate"&gt;24%&lt;/span&gt; per annum.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Additionally,
Auctus has the option to convert all or any amount of the principal face amount and accrued interest of the August 30, 2019 Auctus Note,
at any time following the issue date and ending on the later of the maturity date or the date of payment of the Default Amount if an
event of default occurs, which is an amount equal to &lt;span id="xdx_90E_ecustom--PercentageOfOutstandingSharesOfCommonStock_dp_uPure_c20190829__20190830__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_z60xIdLxExua" title="Percentage of outstanding shares of common stock"&gt;125%&lt;/span&gt; of an amount equal to the then outstanding principal amount of the August 30,
2019 Auctus Note (but not less than $15,000) plus any interest accrued from August 30, 2019 at the default interest rate of &lt;span id="xdx_90F_ecustom--DebtInstrumentDebtDefaultInterestRate_dp_uPure_c20190829__20190830__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_zSwxjiCA1BAe" title="Debt instrument, default, interest rate"&gt;24%&lt;/span&gt; per annum,
for shares of the Company&#x2019;s common stock at the then-applicable conversion price. &lt;span id="xdx_900_eus-gaap--DebtInstrumentDescription_c20190829__20190830__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember" title="Debt instrument, description"&gt;Upon the holder&#x2019;s election to convert accrued
interest, default interest or any penalty amounts as stipulated, the Company may elect to pay those amounts in cash. The note may also
be prepaid by the Company at any time between the date of issuance and August 13, 2020 at 135% multiplied by the sum of (a) the then
outstanding principal amount plus (b) accrued and unpaid interest plus (c) default interests&lt;/span&gt;, if any.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"/&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;The
conversion price for the August 30, 2019 Auctus Note shall be the Variable Conversion Price, being &lt;span id="xdx_90F_eus-gaap--DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_dp_uPure_c20190903__20190904__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_zWk8n9vZwnnc" title="Common stock trading volume, percent"&gt;60%&lt;/span&gt; of the Market Price on the date
of conversion. Notwithstanding the foregoing, Auctus shall be restricted from effecting a conversion if such conversion, along with other
shares of the Company&#x2019;s common stock beneficially owned by Auctus and its affiliates, exceeds &lt;span id="xdx_908_ecustom--PercentageOfOutstandingSharesOfCommonStock_dp_uPure_c20190903__20190904__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_zvyXzOqt6ctl" title="Percentage of outstanding shares of common stock"&gt;4.99%&lt;/span&gt; of the outstanding shares of
the Company&#x2019;s common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;PROPANC
BIOPHARMA, INC. AND SUBSIDIARY&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;June
30, 2021 and 2020&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;In
connection with the issuance of the August 2019 Auctus Note, the Company issued common stock purchase warrants to Auctus to purchase
&lt;span id="xdx_900_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_c20190830__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember__us-gaap--StatementEquityComponentsAxis__custom--FirstWarrantMember_pdd" title="Warrants to purchase of common stock, shares"&gt;450&lt;/span&gt; shares of the Company&#x2019;s common stock (the &#x201c;First Warrant&#x201d;) as a commitment fee upon the terms and subject to the
limitations and conditions set forth in such First Warrant at an &#x201c;Exercise Price&#x201d; of &lt;span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20190830__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember__us-gaap--StatementEquityComponentsAxis__custom--FirstWarrantMember_pdd" title="Warrants exercise price per share"&gt;$2,250&lt;/span&gt;. In connection with the issuance
of the Note, the Company shall issue a common stock purchase warrant to Buyer to purchase &lt;span id="xdx_905_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_c20190830__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember__us-gaap--StatementEquityComponentsAxis__custom--SecondWarrantMember_pdd" title="Warrants to purchase of common stock, shares"&gt;300&lt;/span&gt; shares of the Company&#x2019;s common stock
(the &#x201c;Second Warrant&#x201d;) as a commitment fee upon the terms and subject to the limitations and conditions set forth in such
Second Warrant at an &#x201c;Exercise Price&#x201d; of &lt;span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20190830__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember__us-gaap--StatementEquityComponentsAxis__custom--SecondWarrantMember_pdd" title="Warrants exercise price per share"&gt;$3,330&lt;/span&gt;. In connection with the issuance of the Note, the Company shall issue a common
stock purchase warrant to Buyer to purchase &lt;span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_c20190830__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember__us-gaap--StatementEquityComponentsAxis__custom--ThirdWarrantMember_pdd" title="Warrants to purchase of common stock, shares"&gt;225&lt;/span&gt; shares of the Company&#x2019;s common stock (the &#x201c;Third Warrant&#x201d;) as a commitment
fee upon the terms and subject to the limitations and conditions set forth in such Third Warrant at an &#x201c;Exercise Price&#x201d; of
&lt;span id="xdx_903_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20190830__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember__us-gaap--StatementEquityComponentsAxis__custom--ThirdWarrantMember_pdd" title="Warrants exercise price per share"&gt;$4,500&lt;/span&gt;. The First Warrant, Second Warrant, and Third Warrant shall collectively be referred as the &#x201c;Warrants&#x201d;. The Warrants
have an &#x201c;Exercise Period&#x201d; of five years from the date of issuance being August 30, 2019. Under the terms of the Purchase
Agreement and the Warrants, the Selling Security Holder may not either convert the Notes nor exercise the Warrants to the extent (but
only to the extent) that the Selling Security Holder or any of its affiliates would beneficially own a number of shares of our Common
Stock which would exceed &lt;span id="xdx_908_ecustom--PercentageOfOutstandingSharesOfCommonStock_dp_uPure_c20190701__20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_zvnGDaFAX33d" title="Percentage of outstanding shares of common stock"&gt;4.99%&lt;/span&gt; of our outstanding shares. The Company accounted for the warrants by using the relative fair value method
and recorded debt discount from the relative fair value of the warrants of &lt;span id="xdx_90C_eus-gaap--FairValueAdjustmentOfWarrants_c20190829__20190830__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_pp0p0" title="Fair value of warrants"&gt;$375,905&lt;/span&gt; using a simple binomial lattice model.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;In
connection with the Purchase Agreement, the Company and the Purchaser entered into a Registration Rights Agreement (the &#x201c;Registration
Rights Agreement&#x201d;). Pursuant to the Registration Rights Agreement, the Company agreed to register the shares of Common Stock underlying
the Securities in a Registration Statement with the SEC as well as the Commitment Shares (as defined herein). The Registration Rights
Agreement contains customary representations, warranties, agreements and indemnification rights and obligations of the parties.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;The
Note is subject to customary default provisions and also includes a cross-default provision which provides that a breach or default by
the Borrower of any covenant or other term or condition contained in any of the Other Agreements (as defined therein), after the passage
of all applicable notice and cure or grace periods, shall, at the option of the Holder, be considered a default under this Note and the
Other Agreements. Upon occurrence of any such event, the Holder shall be entitled (but in no event required) to apply all rights and
remedies of the Holder under the terms of this Note and the Other Agreements by reason of a default under said Other Agreements or the
Note.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;The
August 30, 2019 Auctus Note contain certain events of default, upon which principal and accrued interest will become immediately due
and payable. In addition, upon an event of default, interest on the outstanding principal shall accrue at a default interest rate of
24% per annum.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;The
total principal amount outstanding under the above Auctus financing agreement, specifically the August 30, 2019 Auctus Note, was $358,965
and accrued interest of &lt;span id="xdx_90E_eus-gaap--InterestPayableCurrentAndNoncurrent_c20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_pp0p0" title="Accrued interest"&gt;$486&lt;/span&gt; as of June 30, 2020 following conversion of &lt;span id="xdx_90C_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20190701__20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_pp0p0" title="Debt conversion of converted amount"&gt;$191,035&lt;/span&gt; of the principal balance and &lt;span id="xdx_90D_eus-gaap--InterestPayableCurrentAndNoncurrent_c20200630__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_pp0p0" title="Accrued interest"&gt;$43,176&lt;/span&gt; of accrued interest
during the year ended June 30, 2020. Accordingly, &lt;span id="xdx_90A_eus-gaap--DebtInstrumentUnamortizedPremium_c20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_pp0p0" title="Debt premium amount"&gt;$127,356&lt;/span&gt; of the put premium was released in respect of the August 30, 2019 Auctus Note
during the year ended June 30, 2020 following conversion of the principal balance.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;The
total principal amount outstanding under the above Auctus financing agreement, specifically the August 30, 2019 Auctus Note, was &lt;span id="xdx_90D_eus-gaap--DebtInstrumentFaceAmount_c20210630__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_pp0p0" title="Convertible debt principal amount"&gt;$32,848&lt;/span&gt;
and accrued interest of &lt;span id="xdx_90E_eus-gaap--InterestPayableCurrentAndNoncurrent_c20210630__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_pp0p0" title="Accrued interest"&gt;$0&lt;/span&gt; as of June 30, 2021 following conversion of &lt;span id="xdx_90D_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20200701__20210630__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_pp0p0" title="Debt conversion of converted amount"&gt;$326,117&lt;/span&gt; of the principal balance and &lt;span id="xdx_90F_ecustom--DebtConversionConvertedInterestPayable_c20200701__20210630__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_pp0p0" title="Debt conversion of accrued interest"&gt;$39,536&lt;/span&gt; of accrued interest
during the year ended June 30, 2021. Accordingly, &lt;span id="xdx_905_eus-gaap--DebtInstrumentUnamortizedPremium_iI_pp0p0_c20210630__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_zMs1ppsCOrtb" title="Debt premium amount"&gt;$217,411&lt;/span&gt; of the put premium was released in respect of the August 30, 2019 Auctus Note
during the year ended June 30, 2021 following conversion of the principal balance.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;&lt;i&gt;GW
Holdings Securities Purchase Agreements&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;i&gt;October
1, 2019 Securities Purchase Agreement&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Effective
October 1, 2019, the Company entered into a securities purchase agreement with GW Holdings, pursuant to which GW Holdings purchased a
convertible promissory note (the &#x201c;October 1, 2019 GW Note&#x201d;) from the Company in the aggregate principal amount of &lt;span id="xdx_90A_eus-gaap--DebtInstrumentFaceAmount_c20191002__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberOneTwoThousandNineteenAuctusNoteMember_pp0p0" title="Convertible debt principal amount"&gt;$131,000&lt;/span&gt;,
such principal and the interest thereon convertible into shares of the Company&#x2019;s common stock at the option of GW Holdings any
time after the six-month anniversary of the October 1, 2019 GW Holdings Note. The transactions contemplated by the GW Holdings Securities
Purchase Agreement closed on October 1, 2019. Pursuant to the terms of the GW Holdings Securities Purchase Agreement, the lender deducted
&lt;span id="xdx_909_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_c20190929__20191002__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberOneTwoThousandNineteenAuctusNoteMember_pp0p0" title="Debt instrument principal payment"&gt;$6,000&lt;/span&gt; from the principal payment due under the October 1, 2019 GW Note, at the time of closing, to be applied to its legal expenses.
The Company used the net proceeds of &lt;span id="xdx_901_eus-gaap--ProceedsFromConvertibleDebt_pp0p0_c20190929__20191002__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberOneTwoThousandNineteenAuctusNoteMember_zaEB4ud3eO85" title="Proceeds from convertible debt"&gt;$125,000&lt;/span&gt; from the October 1, 2019 GW Note for general working capital purposes. The maturity date
of the October 1, 2019 GW Holdings was &lt;span id="xdx_90A_eus-gaap--DebtInstrumentMaturityDate_dd_c20190929__20191002__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberOneTwoThousandNineteenAuctusNoteMember_zKrndB6pO7Ne" title="Debt maturity date"&gt;October 1, 2020&lt;/span&gt; and is currently past due. The October 1, 2019 GW Holdings Note bore interest
at a rate of &lt;span id="xdx_90E_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20191002__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberOneTwoThousandNineteenAuctusNoteMember_zPtct5WsmEEf" title="Debt instrument, interest rate, stated percentage"&gt;8%&lt;/span&gt; per annum, which interest was paid by the Company to GW Holdings in shares of the Company&#x2019;s common stock; but was
not payable until the October 1, 2019 GW Holdings Note became payable, whether at the maturity date or upon acceleration or by prepayment.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;i&gt;December
10, 2020 Securities Purchase Agreement&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Effective
December 10, 2020, the Company entered into a securities purchase agreement with GW Holdings, pursuant to which GW Holdings purchased
a convertible promissory note (the &#x201c;December 10, 2020 GW Note&#x201d;) from the Company in the aggregate principal amount of &lt;span id="xdx_902_eus-gaap--DebtInstrumentFaceAmount_c20201210__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--DecemberTenTwoThousandTwentyGWNoteMember_pp0p0" title="Convertible debt principal amount"&gt;$131,000&lt;/span&gt;,
such principal and the interest thereon convertible into shares of the Company&#x2019;s common stock at the option of GW Holdings anytime
from the issuance of the December 10, 2020 GW Holdings Note. The transactions contemplated by the GW Holdings Securities Purchase Agreement
closed on December 10, 2020. Pursuant to the terms of the GW Holdings Securities Purchase Agreement, the lender deducted &lt;span id="xdx_905_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_c20201209__20201210__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--DecemberTenTwoThousandTwentyGWNoteMember_pp0p0" title="Debt instrument principal payment"&gt;$6,000&lt;/span&gt; from
the principal payment due under the December 10, 2020 GW Note, at the time of closing, to be applied to its legal expenses. The Company
intends to use the net proceeds of &lt;span id="xdx_90B_eus-gaap--ProceedsFromConvertibleDebt_pp0p0_c20201209__20201210__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--DecemberTenTwoThousandTwentyGWNoteMember_zdGlPC9dx3fg" title="Proceeds from convertible debt"&gt;$125,000&lt;/span&gt; from the December 10, 2020 GW Note for general working capital purposes. The maturity date
of the December 10, 2020 GW Holdings is &lt;span id="xdx_909_eus-gaap--DebtInstrumentMaturityDate_dd_c20201209__20201210__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--DecemberTenTwoThousandTwentyGWNoteMember_z2vQ7zNJnIve" title="Debt maturity date"&gt;December 10, 2021&lt;/span&gt;. The December 10, 2020 GW Holdings Note bears interest at a rate of &lt;span id="xdx_90B_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20201210__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--DecemberTenTwoThousandTwentyGWNoteMember_zaZ2WjOKzaab" title="Debt instrument, interest rate, stated percentage"&gt;8%&lt;/span&gt; per
annum, which interest may be paid by the Company to GW Holdings in shares of the Company&#x2019;s common stock; but shall not be payable
until the December 10, 2020 GW Holdings Note becomes payable, whether at the maturity date or upon acceleration or by prepayment.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;PROPANC
BIOPHARMA, INC. AND SUBSIDIARY&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;June
30, 2021 and 2020&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;The
above notes issued to GW Holdings contain certain events of default, upon which principal and accrued interest will become immediately
due and payable. In addition, upon an event of default, interest on the outstanding principal shall accrue at a default interest rate
of &lt;span id="xdx_907_ecustom--DebtInstrumentDebtDefaultInterestRate_dp_uPure_c20201209__20201210__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--DecemberTenTwoThousandTwentyGWNoteMember_zArgRvWfEwje" title="Debt instrument, default, interest rate"&gt;24%&lt;/span&gt; per annum, or if such rate is usurious or not permitted by current law, then at the highest rate of interest permitted by law.
Further, certain events of default may trigger penalty and liquidated damage provisions.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Additionally,
GW Holdings has the option to convert all or any amount of the principal face amount of the notes issued to GW Holdings at any time from
the date of issuance and ending on the later of the maturity date or the date the Default Amount is paid if an event of default occurs,
which is an amount between &lt;span id="xdx_905_ecustom--DebtInstrumentDebtDefaultInterestRate_dp_uPure_c20201209__20201210__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--DecemberTenTwoThousandTwentyGWNoteMember__srt--RangeAxis__srt--MinimumMember_zQUE8QLxpFka" title="Debt instrument, default, interest rate"&gt;110%&lt;/span&gt; and &lt;span id="xdx_905_ecustom--DebtInstrumentDebtDefaultInterestRate_dp_uPure_c20201209__20201210__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--DecemberTenTwoThousandTwentyGWNoteMember__srt--RangeAxis__srt--MaximumMember_zjV9drC6Cubi" title="Debt instrument, default, interest rate"&gt;150%&lt;/span&gt; of an amount equal to the then outstanding principal amount of such notes plus any interest
accrued, for shares of the Company&#x2019;s common stock at the then-applicable conversion price.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;The
conversion price for the above GW Holdings notes shall be equal to a 40% discount of the lowest closing bid price (&#x201c;Lowest Trading
Price&#x201d;) of the Common Stock for the ten trading days immediately prior to the delivery of a Notice of Conversion, including the
day upon which a Notice of Conversion is received. Notwithstanding the foregoing, GW Holdings shall be restricted from effecting a conversion
if such conversion, along with other shares of the Company&#x2019;s common stock beneficially owned by GW Holdings and its affiliates,
exceeds &lt;span id="xdx_900_ecustom--PercentageOfOutstandingSharesOfCommonStock_dp_uPure_c20201209__20201210__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--DecemberTenTwoThousandTwentyGWNoteMember_zMF2lpDXpXcl" title="Percentage of outstanding shares of common stock"&gt;4.99%&lt;/span&gt; of the outstanding shares of the Company&#x2019;s common stock which may be increased up to 9.99% upon 60 days prior written
notice by the GW Holdings to the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;These
notes are treated as stock settled debt under ASC 480 and accordingly the Company recorded a total of &lt;span id="xdx_904_eus-gaap--DebtInstrumentUnamortizedPremium_c20201210__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--DecemberTenTwoThousandTwentyGWNoteMember_pp0p0" title="Debt premium amount"&gt;$174,666&lt;/span&gt; put premium.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;The
total principal amount outstanding under the above October 1, 2019 GW Holdings financing agreement was &lt;span id="xdx_908_eus-gaap--DebtInstrumentFaceAmount_c20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberOneTwoThousandNineteenAuctusNoteMember_pp0p0" title="Convertible debt principal amount"&gt;$30,000&lt;/span&gt; and accrued interest of
&lt;span id="xdx_903_eus-gaap--InterestPayableCurrentAndNoncurrent_c20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberOneTwoThousandNineteenAuctusNoteMember_pp0p0" title="Accrued interest"&gt;$1,776&lt;/span&gt; as of June 30, 2020 following conversion of &lt;span id="xdx_907_eus-gaap--DebtInstrumentFaceAmount_c20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember_pp0p0" title="Convertible debt principal amount"&gt;$101,000&lt;/span&gt; of the principal balance and &lt;span id="xdx_90F_eus-gaap--InterestPayableCurrentAndNoncurrent_c20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember_pp0p0" title="Accrued interest"&gt;$5,082&lt;/span&gt; of accrued interest during the year ended
June 30, 2020. The total principal amount and accrued interest outstanding under the above October 1, 2019 GW Holdings financing agreement
was &lt;span id="xdx_907_eus-gaap--ConvertibleNotesPayable_c20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember_pp0p0" title="Convertible debt outstanding balance"&gt;$0&lt;/span&gt; as of June 30, 2021 following conversion of &lt;span id="xdx_904_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberOneTwoThousandNineteenAuctusNoteMember_zUKgNk0UCtJ5"&gt;$30,000&lt;/span&gt; of the principal balance and &lt;span id="xdx_90E_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberOneTwoThousandNineteenAuctusNoteMember_zr1B1KELZycj"&gt;$3,877&lt;/span&gt; of accrued interest during the year ended
June 30, 2021. Accordingly, &lt;span id="xdx_902_eus-gaap--DebtInstrumentUnamortizedPremium_iI_pp0p0_c20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember_zQunD2Tm9VOd" title="Debt premium amount"&gt;$67,333&lt;/span&gt; and &lt;span id="xdx_90C_eus-gaap--DebtInstrumentUnamortizedPremium_iI_pp0p0_c20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember_zVc0tgVdJq9b"&gt;$20,000&lt;/span&gt; of the put premium was reclassed to additional paid in capital during the year ended
June 30, 2020 and 2021, respectively, following conversion of the principal balance. This note was fully converted into common stock
in fiscal 2021.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;The
total principal amount outstanding under the above December 10, 2020 GW Holdings financing agreement, was &lt;span id="xdx_904_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--DecemberTenTwoThousandTwentyGWNoteMember_z4nIBYzF3wx8"&gt;$90,000&lt;/span&gt; and accrued interest
of &lt;span id="xdx_905_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--DecemberTenTwoThousandTwentyGWNoteMember_zHF7PjuQZyCh"&gt;$4,636&lt;/span&gt; as of June 30, 2021 following conversion of &lt;span id="xdx_900_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--DecemberTenTwoThousandTwentyGWNoteMember_zxK0GcKj7mR8"&gt;$41,000&lt;/span&gt; of the principal balance and &lt;span id="xdx_900_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--DecemberTenTwoThousandTwentyGWNoteMember_zAhI5EC0kXU"&gt;$1,084&lt;/span&gt; of accrued interest during the year
ended June 30, 2021. Accordingly, &lt;span id="xdx_900_eus-gaap--DebtInstrumentUnamortizedPremium_iI_pp0p0_c20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberOneTwoThousandNineteenAuctusNoteMember_zFJPZpaH0zL4"&gt;$27,333&lt;/span&gt; of the put premium was reclassed to additional paid in capital in respect of the October 1,
2019 GW Holdings Note during the year ended June 30, 2021 following conversion of the principal balance.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;&lt;i&gt;Crown
Bridge Securities Purchase Agreements&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Effective
October 3, 2019, the Company entered into a securities purchase agreement with Crown Bridge Partners, pursuant to which Crown Bridge
purchased a convertible promissory note (the &#x201c;October 3, 2019 Crown Bridge Note&#x201d;) from the Company in the aggregate principal
amount of $&lt;span id="xdx_901_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20191003__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember_zwpEHUsBwCU" title="Convertible debt principal amount"&gt;108,000&lt;/span&gt;, such principal and the interest thereon convertible into shares of the Company&#x2019;s common stock at the option
of Crown Bridge any time from the of issuance of the of the October 3, 2019 Crown Bridge Note. The transactions contemplated by the Crown
Bridge Securities Purchase Agreement closed on October 3, 2019. Pursuant to the terms of the Crown Bridge Securities Purchase Agreement,
Crown Bridge deducted $&lt;span id="xdx_90F_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_pp0p0_c20191001__20191003__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember_zeoD6H7WrKf9" title="Debt instrument principal payment"&gt;3,000&lt;/span&gt; from the principal payment due under the October 3, 2019 Crown Bridge Note, at the time of closing, to be
applied to its legal expenses, and there was a $&lt;span id="xdx_903_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pp0p0_c20191003__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember_zomMnTd7UNx3" title="Original issue discount"&gt;5,000&lt;/span&gt; original issuance discount resulting in $&lt;span id="xdx_905_eus-gaap--ProceedsFromConvertibleDebt_pp0p0_c20191001__20191003__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember_zzct2UAOe8n4" title="Proceeds from convertible debt"&gt;100,000&lt;/span&gt; net proceeds to the Company. The
Company intends to use the net proceeds from the October 3, 2019 Crown Bridge Note for general working capital purposes. The maturity
date of the October 3, 2019 Crown Bridge was October 3, 2020 and is currently past due. The &lt;span id="xdx_90A_eus-gaap--DebtInstrumentMaturityDate_dd_c20191001__20191003__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember_zQwc7KFpP4L3" title="Debt maturity date"&gt;October 3, 2019&lt;/span&gt; Crown Bridge Note bears interest
at a rate of &lt;span id="xdx_906_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20191003__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember_ztmWQuCkyNLh" title="Debt instrument, interest rate, stated percentage"&gt;10&lt;/span&gt;% per annum, which interest may be paid by the Company to Crown Bridge in shares of the Company&#x2019;s common stock;
but shall not be payable until the October 2019 Crown Bridge Note becomes payable, whether at the maturity date or upon acceleration
or by prepayment.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Additionally,
Crown Bridge has the option to convert all or any amount of the principal face amount of the October 3, 2019 Crown Bridge Note at any
time from the date of issuance and ending on the later of the maturity date or the date the Default Amount is paid if an event of default
occurs, which is an amount between &lt;span id="xdx_90B_ecustom--DebtInstrumentDebtDefaultInterestRate_pid_dp_uPure_c20191001__20191003__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember__srt--RangeAxis__srt--MinimumMember_zLvepTZqYK6h" title="Debt instrument, default, interest rate"&gt;110&lt;/span&gt;% and &lt;span id="xdx_900_ecustom--DebtInstrumentDebtDefaultInterestRate_pid_dp_uPure_c20191001__20191003__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember__srt--RangeAxis__srt--MaximumMember_zEEjcVFQsHy" title="Debt instrument, default, interest rate"&gt;150&lt;/span&gt;% of an amount equal to the then outstanding principal amount of the October 3, 2019 Crown
Bridge Note plus any interest accrued, for shares of the Company&#x2019;s common stock at the then-applicable conversion price.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;The
conversion price for the October 3, 2019 Crown Bridge Note shall be equal to a 40% discount of the lowest closing bid price (&#x201c;Lowest
Trading Price&#x201d;) of the Common Stock for the ten trading days immediately prior to the delivery of a Notice of Conversion, including
the day upon which a Notice of Conversion is received. Notwithstanding the foregoing, Crown Bridge shall be restricted from effecting
a conversion if such conversion, along with other shares of the Company&#x2019;s common stock beneficially owned by Crown Bridge and its
affiliates, exceeds &lt;span id="xdx_90E_ecustom--PercentageOfOutstandingSharesOfCommonStock_pid_dp_uPure_c20191001__20191003__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember__srt--RangeAxis__srt--MinimumMember_z7lVZvtrX5P5" title="Percentage of outstanding shares of common stock"&gt;4.99&lt;/span&gt;% of the outstanding shares of the Company&#x2019;s common stock which may be increased up to &lt;span id="xdx_90B_ecustom--PercentageOfOutstandingSharesOfCommonStock_pid_dp_uPure_c20191001__20191003__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember__srt--RangeAxis__srt--MaximumMember_zJktsYMDpp94" title="Percentage of outstanding shares of common stock"&gt;9.99&lt;/span&gt;% upon 60 days
prior written notice by the Crown Bridge to the Company. The note is treated as stock settled debt under ASC 480 and accordingly the
Company recorded a $&lt;span id="xdx_904_eus-gaap--DebtInstrumentUnamortizedPremium_iI_pp0p0_c20191003__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember_zHoaM5QgRPfj" title="Debt premium amount"&gt;72,000&lt;/span&gt; put premium.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;PROPANC
BIOPHARMA, INC. AND SUBSIDIARY&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;June
30, 2021 and 2020&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;The
October 3, 2019 Crown Bridge Note contain certain events of default, upon which principal and accrued interest will become immediately
due and payable. In addition, upon an event of default, interest on the outstanding principal shall accrue at a default interest rate
of &lt;span id="xdx_90F_ecustom--DebtInstrumentDebtDefaultInterestRate_pid_dp_uPure_c20191001__20191003__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember_zv0fjoBojGb7" title="Debt instrument, default, interest rate"&gt;15&lt;/span&gt;% per annum, or if such rate is usurious or not permitted by current law, then at the highest rate of interest permitted by law.
Further, certain events of default may trigger penalty and liquidated damage provisions.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;The
total principal amount outstanding under the above Crown Bridge financing agreement was $&lt;span id="xdx_908_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember_zJbU4yvlAPti" title="Convertible debt principal amount"&gt;65,280&lt;/span&gt; and accrued interest of $&lt;span id="xdx_902_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember_z2ksPZtm0jBj" title="Accrued interest"&gt;7,232&lt;/span&gt; as of
as of June 30, 2020 following conversion of $&lt;span id="xdx_90D_eus-gaap--DebtConversionConvertedInstrumentAmount1_pp0p0_c20190701__20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember_ziklwtqcVEga" title="Debt conversion of converted amount"&gt;42,720&lt;/span&gt; of the principal balance during the year ended June 30, 2020. Accordingly, $&lt;span id="xdx_901_eus-gaap--DebtInstrumentUnamortizedPremium_iI_pp0p0_c20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember_zySXJNn6cCG1" title="Debt premium amount"&gt;28,480&lt;/span&gt;
of the put premium was released in respect of the October 3, 2019 Crown Bridge Note during the year ended June 30, 2020 following conversion
of the principal balance.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;The
total principal amount outstanding under the above Crown Bridge financing agreement was &lt;span id="xdx_900_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember_zCCKsDjlOH51" title="Convertible debt principal amount"&gt;$65,280&lt;/span&gt; and accrued interest of $&lt;span id="xdx_90B_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember_z5eeEhZLWACg" title="Accrued interest"&gt;16,138&lt;/span&gt; as of
as of June 30, 2021.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;There
were &lt;span id="xdx_900_ecustom--UnissuedSharesConversion_c20200915__20200916__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember_zCYs7H4vsJf1" title="Unissued shares conversion"&gt;15,000&lt;/span&gt; unissued shares which were considered issuable for accounting purposes during the 1&lt;sup&gt;st&lt;/sup&gt; quarter of fiscal 2021 related
to a conversion notice dated and received on September 16, 2020. In November 2020, the Company was notified by the note holder of the
cancellation of this conversion notice as a result of the reverse stock split and as such the Company reversed the effects of this transaction
thereby increasing the principal balance by $&lt;span id="xdx_906_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20201130__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember_zxMfShhyo5H5" title="Convertible debt principal amount"&gt;9,600&lt;/span&gt; and put premium by $&lt;span id="xdx_908_eus-gaap--DebtInstrumentUnamortizedPremium_iI_pp0p0_c20201130__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember_z3d1u05jFZe8" title="Debt premium amount"&gt;6,400&lt;/span&gt; and a corresponding decrease in equity of $&lt;span id="xdx_902_ecustom--DueToEquityConversion_iI_pp0p0_c20201130__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember_zwvoGCxPpSu" title="Due to equity conversion"&gt;16,000&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;&lt;i&gt;Ader
Alef Securities Purchase Agreements&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Effective
January 13, 2020, the Company entered into a securities purchase agreement with Ader Alef, pursuant to which Ader Alef purchased a convertible
promissory note (the &#x201c;January 13, 2020 Ader Alef Note&#x201d;) from the Company in the aggregate principal amount of $&lt;span id="xdx_908_eus-gaap--DebtInstrumentFaceAmount_c20200113__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--JanuaryThirteenTwentyTwentyAderAlefNoteMember_pp0p0" title="Convertible debt principal amount"&gt;110,250&lt;/span&gt;, such
principal and the interest thereon convertible into shares of the Company&#x2019;s common stock at the option of Ader Alef any time after
the six-month anniversary of the January 13, 2020 Ader Alef Note. The January 13, 2020 Ader Alef Note contained an original discount
of $&lt;span id="xdx_904_eus-gaap--DebtInstrumentUnamortizedDiscount_c20200113__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--JanuaryThirteenTwentyTwentyAderAlefNoteMember_pp0p0" title="Original issue discount"&gt;5,250&lt;/span&gt;. The transactions contemplated by the Ader Alef Securities Purchase Agreement closed on January 13, 2020. Pursuant to the terms
of the Ader Alef Securities Purchase Agreement, Ader Alef deducted $&lt;span id="xdx_901_eus-gaap--LegalFees_c20200112__20200113__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--JanuaryThirteenTwentyTwentyAderAlefNoteMember_pp0p0" title="Legal fees"&gt;5,000&lt;/span&gt; from the principal payment due under the January 13, 2020 Ader
Alef Note at the time of closing, to be applied to its legal expenses and the Company received net cash proceeds of $&lt;span id="xdx_90F_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20200112__20200113__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--JanuaryThirteenTwentyTwentyAderAlefNoteMember_pp0p0" title="Debt conversion of converted amount"&gt;100,000&lt;/span&gt; on January
15, 2020. The Company used the net proceeds from the January 13, 2020 Ader Alef Note for general working capital purposes. The maturity
date of the January 13, 2020 Ader Alef was January 13, 2021. The &lt;span id="xdx_904_eus-gaap--DebtInstrumentMaturityDate_dd_c20200112__20200113__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--JanuaryThirteenTwentyTwentyAderAlefNoteMember_zxQYm58fn5Qk" title="Debt maturity date"&gt;January 13, 2020&lt;/span&gt; Ader Alef Note bore interest at a rate of &lt;span id="xdx_901_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20200113__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--JanuaryThirteenTwentyTwentyAderAlefNoteMember_zDP149gBzYbc" title="Debt instrument, interest rate, stated percentage"&gt;8&lt;/span&gt;% per annum,
which interest may be paid by the Company to Ader Alef in shares of the Company&#x2019;s common stock; but was not payable until the January
13, 2020 Ader Alef Note became payable, whether at the maturity date or upon acceleration or by prepayment.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Additionally,
Ader Alef had the option to convert all or any amount of the principal face amount of the January 13, 2020 Ader Alef Note at any time
from the date of issuance and ending on the later of the maturity date or the date the Default Amount was paid if an event of default
occurs, which was an amount between &lt;span id="xdx_904_ecustom--DebtInstrumentDebtDefaultInterestRate_dp_uPure_c20200112__20200113__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--JanuaryThirteenTwentyTwentyAderAlefNoteMember__srt--RangeAxis__srt--MinimumMember_zr58c3SrdfDc" title="Debt instrument, default, interest rate"&gt;120&lt;/span&gt;% and &lt;span id="xdx_900_ecustom--DebtInstrumentDebtDefaultInterestRate_dp_uPure_c20200112__20200113__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--JanuaryThirteenTwentyTwentyAderAlefNoteMember__srt--RangeAxis__srt--MaximumMember_zxh5ayER2q3g" title="Debt instrument, default, interest rate"&gt;150&lt;/span&gt;% of an amount equal to the then outstanding principal amount of the January 13, 2020
Ader Alef Note plus any interest accrued, for shares of the Company&#x2019;s common stock at the then-applicable conversion price.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;span id="xdx_901_eus-gaap--DebtInstrumentDescription_c20200112__20200113__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--JanuaryThirteenTwentyTwentyAderAlefNoteMember__srt--RangeAxis__srt--MinimumMember_zbMX0id9jcs7" title="Debt instrument, description"&gt;The
conversion price for the January 13, 2020 Ader Alef Note during the first 6 months the January 13, 2020 Ader Alef Note was fixed at $2.50
and thereafter would be equal to a &lt;span id="xdx_90C_eus-gaap--DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_pid_dp_uPure_c20200112__20200113__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--JanuaryThirteenTwentyTwentyAderAlefNoteMember__srt--RangeAxis__srt--MinimumMember_zT1L8epEdCN9" title="Common stock trading volume, percent"&gt;35&lt;/span&gt;% discount of the lowest closing bid price (&#x201c;Lowest Trading Price&#x201d;) of the Common Stock
for the ten trading days immediately prior to the delivery of a Notice of Conversion, including the day upon which a Notice of Conversion
was received. Notwithstanding the foregoing, Ader Alef was restricted from effecting a conversion if such conversion, along with other
shares of the Company&#x2019;s common stock beneficially owned by Ader Alef and its affiliates, exceeds &lt;span id="xdx_907_ecustom--PercentageOfOutstandingSharesOfCommonStock_pid_dp_uPure_c20200112__20200113__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--JanuaryThirteenTwentyTwentyAderAlefNoteMember__srt--RangeAxis__srt--MinimumMember_zdUxPo074Xhg" title="Percentage of outstanding shares of common stock"&gt;4.99&lt;/span&gt;% of the outstanding shares
of the Company&#x2019;s common stock which may be increased up to &lt;span id="xdx_909_ecustom--PercentageOfOutstandingSharesOfCommonStock_pid_dp_uPure_c20200112__20200113__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--JanuaryThirteenTwentyTwentyAderAlefNoteMember__srt--RangeAxis__srt--MaximumMember_zruzM0e34Bv" title="Percentage of outstanding shares of common stock"&gt;9.99&lt;/span&gt;% upon 60 days prior written notice by the Ader Alef to the Company.&lt;/span&gt;
The note was treated as stock settled debt under ASC 480 and accordingly the Company recorded a $&lt;span id="xdx_90E_eus-gaap--DebtInstrumentUnamortizedPremium_iI_pp0p0_c20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--JanuaryThirteenTwentyTwentyAderAlefNoteMember_znVW5pF8JMN9" title="Debt premium amount"&gt;59,365&lt;/span&gt; put premium.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;The
January 13, 2020 Ader Alef Note contained certain events of default, upon which principal and accrued interest would become immediately
due and payable. In addition, upon an event of default, interest on the outstanding principal would accrue at a default interest rate
of 24% per annum, or if such rate was usurious or not permitted by current law, then at the highest rate of interest permitted by law.
Further, certain events of default may trigger penalty and liquidated damage provisions.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;The
total principal amount outstanding under the above Ader Alef financing agreement was $&lt;span id="xdx_909_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--JanuaryThirteenTwentyTwentyAderAlefNoteMember_zrTuhpcSaLr2" title="Convertible debt principal amount"&gt;110,250&lt;/span&gt; and accrued interest of $&lt;span id="xdx_909_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--JanuaryThirteenTwentyTwentyAderAlefNoteMember_zfnVOaOVSvug" title="Accrued interest"&gt;4,073&lt;/span&gt; as of June
30, 2020. The total principal amount outstanding and accrued interest under the above Ader Alef financing agreement was $&lt;span id="xdx_906_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--JanuaryThirteenTwentyTwentyAderAlefNoteMember_zewZ1Or5uQyj" title="Convertible debt principal amount"&gt;&lt;span id="xdx_90E_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--JanuaryThirteenTwentyTwentyAderAlefNoteMember_zPRKYRsBcAB2" title="Accrued interest"&gt;0&lt;/span&gt;&lt;/span&gt; as of as of
June 30, 2021 following conversion of $&lt;span id="xdx_909_eus-gaap--DebtConversionConvertedInstrumentAmount1_pp0p0_c20200701__20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--JanuaryThirteenTwentyTwentyAderAlefNoteMember_zAsiPbM3m5Od" title="Debt conversion of converted amount"&gt;110,250&lt;/span&gt; of the principal balance and $&lt;span id="xdx_907_ecustom--DebtConversionConvertedInterestPayable_pp0p0_c20200701__20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--JanuaryThirteenTwentyTwentyAderAlefNoteMember_ztmxfAe7fDf2" title="Debt conversion of accrued interest"&gt;7,493&lt;/span&gt; accrued interest during the year ended June 30, 2021.
Accordingly, $&lt;span id="xdx_903_eus-gaap--DebtInstrumentUnamortizedPremium_iI_pp0p0_c20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--JanuaryThirteenTwentyTwentyAderAlefNoteMember_zf94QUj3cV4d" title="Debt premium amount"&gt;59,365&lt;/span&gt; of the put premium was released in respect of the Ader Alef Note during the year ended June 30, 2021 following conversion
of the principal balance. This note was fully converted into common stock in fiscal 2021.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;PROPANC
BIOPHARMA, INC. AND SUBSIDIARY&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;June
30, 2021 and 2020&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;&lt;i&gt;LG
Capital Securities Purchase Agreements&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Effective
February 19, 2020, the Company entered into a securities purchase agreement with LG Capital Funding, LLC (&#x201c;LG Capital&#x201d;),
pursuant to which LG Capital purchased a convertible promissory note (the &#x201c;February 19, 2020 LG Capital Note&#x201d;) from the Company
in the aggregate principal amount of $&lt;span id="xdx_909_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20200219__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember__dei--LegalEntityAxis__custom--LGCapitalFundingLLCMember_zTYL65OQsz78" title="Convertible debt principal amount"&gt;75,000&lt;/span&gt;, such principal and the interest thereon convertible into shares of the Company&#x2019;s
common stock at the option of LG Capital any time after the six month anniversary of the February 19, 2020 LG Capital Note. The February
19, 2020 LG Capital Note contained an original discount of $&lt;span id="xdx_903_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pp0p0_c20200219__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember__dei--LegalEntityAxis__custom--LGCapitalFundingLLCMember_zrW4XhulEQfh" title="Original issue discount"&gt;3,750&lt;/span&gt;. The transactions contemplated by the LG Capital Securities Purchase
Agreement closed on March 4, 2020. Pursuant to the terms of the LG Capital Securities Purchase Agreement, LG Capital deducted $&lt;span id="xdx_907_eus-gaap--LegalFees_pp0p0_c20200218__20200219__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember__dei--LegalEntityAxis__custom--LGCapitalFundingLLCMember_zAqRY7bZN066" title="Legal fees"&gt;2,500&lt;/span&gt;
from the principal payment due under the February 19, 2020 LG Capital Note at the time of closing, to be applied to its legal expenses
and the Company received net cash proceeds of $&lt;span id="xdx_90E_eus-gaap--ProceedsFromConvertibleDebt_pp0p0_c20200324__20200325__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember__dei--LegalEntityAxis__custom--LGCapitalFundingLLCMember_zd2NOwfrQAFi" title="Proceeds from convertible debt"&gt;71,250&lt;/span&gt; on March 25, 2020. The Company used the net proceeds from the February 19, 2020
LG Capital Note for general working capital purposes. The maturity date of the February 19, 2020 LG Capital Note was &lt;span id="xdx_902_eus-gaap--DebtInstrumentMaturityDate_c20200218__20200219__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember__dei--LegalEntityAxis__custom--LGCapitalFundingLLCMember" title="Debt maturity date"&gt;February 19, 2021&lt;/span&gt;.
The February 19, 2020 LG Capital Note bore interest at a rate of &lt;span id="xdx_90A_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20200219__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember__dei--LegalEntityAxis__custom--LGCapitalFundingLLCMember_z2nFpqSgZBM4" title="Debt instrument, interest rate, stated percentage"&gt;8&lt;/span&gt;% per annum, which interest was paid by the Company to LG Capital in
shares of the Company&#x2019;s common stock; but was not payable until the February 19, 2020 LG Capital Note became payable, whether at
the maturity date or upon acceleration or by prepayment.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;During
the first 60 to 180 days following the date of the note, the Company had the right to prepay the principal and accrued but unpaid interest
due under the February 19, 2020 LG Capital Note, together with any other amounts that the Company may owe the holder under the terms
of the note, at a premium ranging from &lt;span id="xdx_900_ecustom--DebtInstrumentDebtDefaultInterestRate_pid_dp_uPure_c20200218__20200219__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember__dei--LegalEntityAxis__custom--LGCapitalFundingLLCMember__srt--RangeAxis__srt--MinimumMember_z4523Mnskh12" title="Debt instrument, default, interest rate"&gt;112&lt;/span&gt;% to &lt;span id="xdx_90B_ecustom--DebtInstrumentDebtDefaultInterestRate_pid_dp_uPure_c20200218__20200219__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember__dei--LegalEntityAxis__custom--LGCapitalFundingLLCMember__srt--RangeAxis__srt--MaximumMember_zHP4hB60Iv01" title="Debt instrument, default, interest rate"&gt;135&lt;/span&gt;% as defined in the note agreement. After this initial 180-day period, the Company
did not have a right to prepay the February 19, 2020 LG Capital Note.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;span id="xdx_902_eus-gaap--DebtInstrumentDescription_c20200218__20200219__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember__dei--LegalEntityAxis__custom--LGCapitalFundingLLCMember__srt--RangeAxis__srt--MinimumMember_zscAo0RkfXK1" title="Debt instrument, description"&gt;The
conversion price for the February 19, 2020 LG Capital Note during the first 6 months the February 19, 2020 LG Capital Note was fixed
at $500 and thereafter was equal to a 35% discount of the lowest closing bid price (&#x201c;Lowest Trading Price&#x201d;) of the Common
Stock for the ten trading days immediately prior to the delivery of a Notice of Conversion, including the day upon which a Notice of
Conversion was received. Notwithstanding the foregoing, LG Capital was restricted from effecting a conversion if such conversion, along
with other shares of the Company&#x2019;s common stock beneficially owned by LG Capital and its affiliates, exceeds &lt;span id="xdx_90E_ecustom--PercentageOfOutstandingSharesOfCommonStock_uPure_c20200218__20200219__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember__dei--LegalEntityAxis__custom--LGCapitalFundingLLCMember__srt--RangeAxis__srt--MinimumMember_z2n2nkkyJvxi" title="Percentage of outstanding shares of common stock"&gt;9.99&lt;/span&gt;% of the outstanding
shares of the Company&#x2019;s common stock.&lt;/span&gt; The note was treated as stock settled debt under ASC 480 and accordingly the Company recorded
a $&lt;span id="xdx_905_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pp0p0_c20200219__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--LGCapitalFundingLLCMember_z0U3K57K64Sd" title="Original issue discount"&gt;40,385&lt;/span&gt; put premium.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;The
February 19, 2020 LG Capital Note contained certain events of default, upon which principal and accrued interest would become immediately
due and payable. In addition, upon an event of default, interest on the outstanding principal would accrue at a default interest rate
of &lt;span id="xdx_904_eus-gaap--DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_pid_dp_uPure_c20200218__20200219__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember__dei--LegalEntityAxis__custom--LGCapitalFundingLLCMember_zyn8IJpMpkAh" title="Common stock trading volume, percent"&gt;24&lt;/span&gt;% per annum, or if such rate was usurious or not permitted by current law, then at the highest rate of interest permitted by law.
Further, certain events of default may trigger penalty and liquidated damage provisions.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;The
total principal amount outstanding under the above LG Capital financing agreement was $&lt;span id="xdx_900_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember__dei--LegalEntityAxis__custom--LGCapitalFundingLLCMember_zTL8mMujcRDg" title="Convertible debt principal amount"&gt;75,000&lt;/span&gt; and accrued interest of $&lt;span id="xdx_90B_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember__dei--LegalEntityAxis__custom--LGCapitalFundingLLCMember_zHd1HuK4IoK2" title="Accrued interest"&gt;2,164&lt;/span&gt; as of June
30, 2020. The total principal amount outstanding and accrued interest under the above LG Capital financing agreement was $&lt;span id="xdx_905_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember__dei--LegalEntityAxis__custom--LGCapitalFundingLLCMember_z8qewvbgEe86" title="Convertible debt principal amount"&gt;&lt;span id="xdx_903_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember__dei--LegalEntityAxis__custom--LGCapitalFundingLLCMember_z7iiHXaE5ML9" title="Accrued interest"&gt;0&lt;/span&gt;&lt;/span&gt; as of June
30 2021 following conversion of $&lt;span id="xdx_901_eus-gaap--DebtConversionConvertedInstrumentAmount1_pp0p0_c20200701__20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember__dei--LegalEntityAxis__custom--LGCapitalFundingLLCMember_zQJcqjX5skTd" title="Debt conversion of converted amount"&gt;75,000&lt;/span&gt; of the principal balance and $&lt;span id="xdx_905_ecustom--DebtConversionConvertedInterestPayable_c20200701__20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember__dei--LegalEntityAxis__custom--LGCapitalFundingLLCMember_pp0p0" title="Debt conversion of accrued interest"&gt;5,421&lt;/span&gt; accrued interest during the year ended June 30, 2021. Accordingly,
$&lt;span id="xdx_90D_eus-gaap--DebtInstrumentUnamortizedPremium_c20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember__dei--LegalEntityAxis__custom--LGCapitalFundingLLCMember_pp0p0" title="Debt premium amount"&gt;40,385&lt;/span&gt; of the put premium was released in respect of the February 19, 2020 LG Capital Note during the year ended June 30, 2021 following
conversion of the principal balance. This note was fully converted into common stock in fiscal 2021.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;There
were &lt;span id="xdx_900_ecustom--UnissuedSharesConversion_pid_c20200908__20200909__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--LGCapitalFundingLLCMember_zy8TQj7rLE1l" title="Unissued shares conversion"&gt;9,427&lt;/span&gt; unissued shares which were considered issuable for accounting purposes during the first quarter of fiscal 2021 related to
a conversion notice dated and received on September 9, 2020. In November 2020, the Company was notified by the note holder of the cancellation
of this conversion notice as a result of the reverse stock split and as such the Company reversed the effects of this transaction thereby
increasing the principal balance by $&lt;span id="xdx_908_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20201130__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--LGCapitalFundingLLCMember_znSxfxtk5SJi" title="Convertible debt principal amount"&gt;10,000&lt;/span&gt;, accrued interest of $&lt;span id="xdx_90D_eus-gaap--DebtConversionConvertedInstrumentAmount1_pp0p0_c20201129__20201130__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--LGCapitalFundingLLCMember_z106ivN8PpEh" title="Debt conversion of converted amount"&gt;416&lt;/span&gt; and put premium by $&lt;span id="xdx_908_eus-gaap--DebtInstrumentUnamortizedPremium_iI_pp0p0_c20201130__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--LGCapitalFundingLLCMember_zOkDmGq34n2k" title="Debt premium amount"&gt;5,385&lt;/span&gt; and a corresponding decrease in equity
of $&lt;span id="xdx_90F_ecustom--DueToEquityConversion_iI_pp0p0_c20201130__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--LGCapitalFundingLLCMember_zadObOn7mP04" title="Due to equity conversion"&gt;15,801&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;&lt;i&gt;Geneva
Roth Remark Securities Purchase Agreements&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;i&gt;December
2, 2020 Securities Purchase Agreement&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Effective
December 2, 2020, the Company entered into a securities purchase agreement with Geneva Roth Remark Holdings, Inc.(&#x201c;Geneva Roth&#x201d;),
pursuant to which Geneva Roth purchased a convertible promissory note (the &#x201c;December 2, 2020 Geneva Roth&#x201d;) from the Company
in the aggregate principal amount of $&lt;span id="xdx_908_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20201202__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--DecemberTwoTwoThousandTwentyGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember_zpLyb1jxhG41" title="Convertible debt principal amount"&gt;78,000&lt;/span&gt;, such principal and the interest thereon convertible into shares of the Company&#x2019;s
common stock at the option of Geneva Roth any time after the six month anniversary of the December 2, 2020 Geneva Roth. The December
2, 2020 Geneva Roth contains an original discount of $&lt;span id="xdx_90F_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pp0p0_c20201202__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--DecemberTwoTwoThousandTwentyGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember_zZB2kgSgjnW1" title="Original issue discount"&gt;3,000&lt;/span&gt;. The Company intends to use the net proceeds from the December 2, 2020 Geneva
Roth for general working capital purposes. The maturity date of the December 2, 2020 Geneva Roth Note is December 2, 2021. The December
2, 2020 Geneva Roth Note bears interest at a rate of &lt;span id="xdx_90E_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20201202__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--DecemberTwoTwoThousandTwentyGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember_zxHGRXmSF1E8" title="Debt instrument, interest rate, stated percentage"&gt;8&lt;/span&gt;% per annum, which interest may be paid by the Company to Geneva Roth in shares
of the Company&#x2019;s common stock; but shall not be payable until the December 2, 2020 Geneva Roth Note becomes payable, whether at
the maturity date or upon acceleration or by prepayment.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;PROPANC
BIOPHARMA, INC. AND SUBSIDIARY&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;June
30, 2021 and 2020&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;i&gt;January
5, 2021 Securities Purchase Agreement&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Effective
January 5, 2021, the Company entered into a securities purchase agreement with Geneva Roth Remark Holdings, Inc., pursuant to which Geneva
Roth purchased a convertible promissory note (the &#x201c;January 5, 2021 Geneva Roth&#x201d;) from the Company in the aggregate principal
amount of $&lt;span id="xdx_901_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20210105__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--JanuaryFiveTwoThousandTwentyOneGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember_zCMSE7NuV6F1" title="Convertible debt principal amount"&gt;68,500&lt;/span&gt;, such principal and the interest thereon convertible into shares of the Company&#x2019;s common stock at the option
of Geneva Roth any time after the six-month anniversary of the January 5, 2021 Geneva Roth. The January 5, 2021 Geneva Roth contains
an original issue discount of $&lt;span id="xdx_90E_eus-gaap--DebtConversionOriginalDebtAmount1_pp0p0_c20210104__20210105__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--JanuaryFiveTwoThousandTwentyOneGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember_zNzbQ8jepSsb" title="Debt conversion, original debt amount"&gt;3,500&lt;/span&gt;. The Company intends to use the net proceeds from the January 5, 2021 Geneva Roth for general working
capital purposes. The maturity date of the January 5, 2021 Geneva Roth Note is January 5, 2022. The January 5, 2021 Geneva Roth Note
bears interest at a rate of &lt;span id="xdx_904_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20210105__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--JanuaryFiveTwoThousandTwentyOneGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember_zmSE9o74DhGb" title="Debt instrument, interest rate, stated percentage"&gt;8&lt;/span&gt;% per annum, which interest may be paid by the Company to Geneva Roth in shares of the Company&#x2019;s common
stock; but shall not be payable until the &lt;span id="xdx_90F_eus-gaap--DebtInstrumentMaturityDate_dd_c20210104__20210105__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--JanuaryFiveTwoThousandTwentyOneGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember_z9W72G1n1xIh" title="Debt maturity date"&gt;January 5, 2021&lt;/span&gt; Geneva Roth Note becomes payable, whether at the maturity date or upon acceleration
or by prepayment.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;i&gt;March
16, 2021 Securities Purchase Agreement&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Effective
March 16, 2021, the Company entered into a securities purchase agreement with Geneva Roth Remark Holdings, Inc., pursuant to which Geneva
Roth purchased a convertible promissory note (the &#x201c;March 16, 2021 Geneva Roth&#x201d;) from the Company in the aggregate principal
amount of $&lt;span id="xdx_901_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20210316__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--MarchSixteenTwoThousandTwentyOneGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember_zrB2otRYaZxa" title="Convertible debt principal amount"&gt;63,500&lt;/span&gt;, such principal and the interest thereon convertible into shares of the Company&#x2019;s common stock at the option
of Geneva Roth any time after the six-month anniversary of the March 16, 2021 Geneva Roth. The March 16, 2021 Geneva Roth contains an
original discount of $&lt;span id="xdx_904_eus-gaap--DebtConversionOriginalDebtAmount1_pp0p0_c20210313__20210316__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--MarchSixteenTwoThousandTwentyOneGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember_ziPdTQoddlOk" title="Debt conversion, original debt amount"&gt;3,500&lt;/span&gt;. The Company intends to use the net proceeds from the March 16, 2021 Geneva Roth for general working capital
purposes.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;The
maturity date of the March 16, 2021 Geneva Roth Note is March 16, 2022. The March 16, 2021 Geneva Roth Note bears interest at a rate
of &lt;span id="xdx_902_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20210105__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--MarchSixteenTwoThousandTwentyOneGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember_zhZipEt2Pqi3" title="Debt instrument, interest rate, stated percentage"&gt;8&lt;/span&gt;% per annum, which interest may be paid by the Company to Geneva Roth in shares of the Company&#x2019;s common stock; but shall not
be payable until the &lt;span id="xdx_908_eus-gaap--DebtInstrumentMaturityDate_dd_c20210103__20210105__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--MarchSixteenTwoThousandTwentyOneGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember_zYkAPffCzota" title="Debt maturity date"&gt;March 16, 2021&lt;/span&gt; Geneva Roth Note becomes payable, whether at the maturity date or upon acceleration or by prepayment.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;During
the first 60 to 180 days following the date of these notes, the Company has the right to prepay the principal and accrued but unpaid
interest due under the above notes issued to Geneva Roth, together with any other amounts that the Company may owe the holder under the
terms of the note, at a premium ranging from &lt;span id="xdx_90F_ecustom--DebtInstrumentDebtDefaultInterestRate_pid_dp_uPure_c20201201__20201202__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--DecemberTwoTwoThousandTwentyGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember__srt--RangeAxis__srt--MinimumMember_zX5toUXgs6od" title="Debt instrument, default, interest rate"&gt;110&lt;/span&gt;% to &lt;span id="xdx_905_ecustom--DebtInstrumentDebtDefaultInterestRate_pid_dp_uPure_c20201201__20201202__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--DecemberTwoTwoThousandTwentyGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember__srt--RangeAxis__srt--MaximumMember_z5koNVLRd1s9" title="Debt instrument, default, interest rate"&gt;129&lt;/span&gt;% as defined in the note agreement. After this initial 180-day period, the Company
does not have a right to prepay such notes.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_905_eus-gaap--DebtInstrumentDescription_c20201201__20201202__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--DecemberTwoTwoThousandTwentyGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember__srt--RangeAxis__srt--MinimumMember" style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;The
conversion price for the above Geneva Roth notes shall be equal to a &lt;/span&gt;&lt;span id="xdx_908_ecustom--DebtInstrumentDebtDefaultInterestRate_pid_dp_uPure_c20201201__20201202__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--DecemberTwoTwoThousandTwentyGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember_zhmRBdKcKkH6" style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;35&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;%
discount of the market price based on the average of the lowest three trading prices of the Common Stock for the ten trading days
immediately prior to the delivery of a Notice of Conversion. Notwithstanding the foregoing, Geneva Roth shall be restricted from effecting
a conversion if such conversion, along with other shares of the Company&#x2019;s common stock beneficially owned by Geneva Roth and its
affiliates, exceeds &lt;/span&gt;&lt;span id="xdx_906_ecustom--PercentageOfOutstandingSharesOfCommonStock_pid_dp_uPure_c20201201__20201202__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--DecemberTwoTwoThousandTwentyGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember__srt--RangeAxis__srt--MinimumMember_zBvZ27u0iO91" style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;9.99&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;%
of the outstanding shares of the Company&#x2019;s common stock.&lt;/span&gt; &lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;These
notes are treated as stock settled debt under ASC 480 and accordingly the Company recorded a total of $&lt;span id="xdx_903_eus-gaap--DebtInstrumentUnamortizedPremium_c20201202__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--DecemberTwoTwoThousandTwentyGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember_pp0p0"&gt;113,077
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;put premium for the three notes.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;The
above Geneva Roth notes contain certain events of default, upon which principal and accrued interest will become immediately due and
payable. In addition, upon an event of default, interest on the outstanding principal shall accrue at a default interest rate of &lt;span id="xdx_909_ecustom--DebtDefaultAmountPercentage_pid_dp_uPure_c20201201__20201202__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--DecemberTwoTwoThousandTwentyGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember_zR9DK8ymxYqi" title="Debt default amount percentage"&gt;22&lt;/span&gt;%
per annum, or if such rate is usurious or not permitted by current law, then at the highest rate of interest permitted by law. Further,
certain events of default may trigger penalty and liquidated damage provisions.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;The
total principal amounts outstanding under the above Geneva Roth financing agreements were $&lt;span id="xdx_904_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--DecemberTwoTwoThousandTwentyGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember_zFQi7YehIjO8" title="Convertible debt principal amount"&gt;132,000&lt;/span&gt; and accrued interest of $&lt;span id="xdx_907_eus-gaap--InterestPayableCurrentAndNoncurrent_c20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--DecemberTwoTwoThousandTwentyGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember_pp0p0" title="Accrued interest"&gt;3,477&lt;/span&gt; as
of June 30, 2021 following conversion of $&lt;span id="xdx_904_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--DecemberTwoTwoThousandTwentyGenevaRothMember_zC360zEKOCR5"&gt;78,000&lt;/span&gt; of the principal balance and $&lt;span id="xdx_908_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--DecemberTwoTwoThousandTwentyGenevaRothMember_zXRYDWNZ3rce" title="Accrued interest"&gt;3,120&lt;/span&gt; accrued interest during the year ended June 30,
2021. Accordingly, $&lt;span id="xdx_906_eus-gaap--DebtInstrumentUnamortizedPremium_iI_pp0p0_c20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--DecemberTwoTwoThousandTwentyGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember_zD3bqIYfPui8" title="Debt premium amount"&gt;42,000&lt;/span&gt; of the put premium was released in respect of the Geneva Roth financing agreements during the year ended June
30, 2021 following conversion of the principal balance.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;&lt;i&gt;Amortization
of debt discounts&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;The
Company recorded $&lt;span id="xdx_907_eus-gaap--AmortizationOfDebtDiscountPremium_pp0p0_c20200701__20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_z97YR7adUCde" title="Amortization of debt discount"&gt;211,000&lt;/span&gt; and $&lt;span id="xdx_90D_eus-gaap--AmortizationOfDebtDiscountPremium_pp0p0_c20190701__20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zGs6lgmrl1q7" title="Amortization of debt discount"&gt;728,904&lt;/span&gt; of debt discounts related to the above note issuances during the years ended June 30, 2021 and
2020, respectively. The Company recorded $&lt;span id="xdx_90F_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pp0p0_c20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zSI8WbWDkQXe" title="Original issue discount"&gt;498,160&lt;/span&gt; and $&lt;span id="xdx_904_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pp0p0_c20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zxmpIMrXZTi9" title="Original issue discount"&gt;836,724&lt;/span&gt; of put premiums related to the above note issuances during the years ended
June 30, 2021 and 2020, respectively. The debt discounts are being amortized over the term of the debt and the put premiums are expensed
on issuance of the debt with the liability released to additional paid in capital on conversion of the principal.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Amortization
of all debt discounts for the years ended June 30, 2021 and 2020 was $&lt;span id="xdx_909_eus-gaap--AmortizationOfDebtDiscountPremium_pp0p0_c20200701__20210630_zoloR4T28Ki6" title="Amortization of debt discount"&gt;136,527&lt;/span&gt; and $&lt;span id="xdx_904_eus-gaap--AmortizationOfDebtDiscountPremium_pp0p0_c20190701__20200630_zED7e8UWunw6" title="Amortization of debt discount"&gt;734,130&lt;/span&gt;, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;The
Company reclassified $&lt;span id="xdx_909_ecustom--ReclassifiedPremiumAmountForAdditionalPaidInCapital_pp0p0_c20200701__20210630_zEz7E5kvysEf" title="Reclassified premium amount for additional paid in capital"&gt;590,504&lt;/span&gt; and $&lt;span id="xdx_90F_ecustom--ReclassifiedPremiumAmountForAdditionalPaidInCapital_pp0p0_c20190701__20200630_zkkG58hK8d3d" title="Reclassified premium amount for additional paid in capital"&gt;874,924&lt;/span&gt; in put premiums to additional paid in capital following conversions during the year ended
June 30, 2021 and 2020, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;PROPANC
BIOPHARMA, INC. AND SUBSIDIARY&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;June
30, 2021 and 2020&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ConvertibleDebtTableTextBlock contextRef="From2020-07-012021-06-30">&lt;p id="xdx_89C_eus-gaap--ConvertibleDebtTableTextBlock_ziVRkGrZePIh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;The
Company&#x2019;s convertible notes outstanding at June 30, 2021 and 2020 were as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; display: none; color: Black"&gt;&#160;&lt;span id="xdx_8BA_zvU50JaaWwyd"&gt;SCHEDULE OF CONVERTIBLE NOTES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 100%; margin-right: auto"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_494_20210630_zsrmn1iivXZg" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;June
    30, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20200630_zuQpL0kHaTa" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;June
    30, 2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--DebtInstrumentCarryingAmount_iI_pp0p0_maLTDzcuB_zuxg3RTxe1Li" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 64%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Convertible
    notes and debenture&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;400,128&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;1,029,496&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--DebtInstrumentUnamortizedDiscount_iNI_pp0p0_di_msLTDzcuB_zuUODCdu4b44" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Unamortized
    discounts&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;(6,139&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;(126,667&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--DepositLiabilitiesAccruedInterest_iI_pp0p0_maLTDzcuB_zPzWSAs6KWd3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Accrued
    interest&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;34,098&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;80,101&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--DebtInstrumentUnamortizedPremium_iI_pp0p0_maLTDzcuB_zEJVrrhbTgpb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Premium,
    net&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;196,496&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;574,804&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--LongTermDebt_iTI_pp0p0_mtLTDzcuB_z7Pcz6TEePia" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Convertible
    notes, net&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;624,583&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;1,557,734&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</us-gaap:ConvertibleDebtTableTextBlock>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">400128</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">1029496</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscount contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">6139</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentUnamortizedDiscount contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">126667</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DepositLiabilitiesAccruedInterest contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">34098</us-gaap:DepositLiabilitiesAccruedInterest>
    <us-gaap:DepositLiabilitiesAccruedInterest contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">80101</us-gaap:DepositLiabilitiesAccruedInterest>
    <us-gaap:DebtInstrumentUnamortizedPremium contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">196496</us-gaap:DebtInstrumentUnamortizedPremium>
    <us-gaap:DebtInstrumentUnamortizedPremium contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">574804</us-gaap:DebtInstrumentUnamortizedPremium>
    <us-gaap:LongTermDebt contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">624583</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">1557734</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2017-12-29_custom_DecemberTwentyNineTwoThousandAndSeventeenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_DecemberTwoThousandAndSeventeenEagleNoteMember"
      decimals="0"
      unitRef="USD">532435</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="AsOf2017-12-29_custom_DecemberTwentyNineTwoThousandAndSeventeenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_DecemberTwoThousandAndSeventeenEagleNoteMember"
      decimals="0"
      unitRef="USD">25354</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="From2017-12-272017-12-29_custom_DecemberTwentyNineTwoThousandAndSixteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_DecemberTwoThousandAndSeventeenEagleNoteMember"
      decimals="0"
      unitRef="USD">507081</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:DebtInstrumentMaturityDate contextRef="From2017-12-272017-12-29_custom_DecemberTwentyNineTwoThousandAndSixteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_DecemberTwoThousandAndSeventeenEagleNoteMember">2018-12-29</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2017-12-29_custom_DecemberTwentyNineTwoThousandAndSeventeenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_DecemberTwoThousandAndSeventeenEagleNoteMember"
      decimals="INF"
      unitRef="Pure">0.08</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="AsOf2019-06-30_custom_DecemberTwentyNineTwoThousandAndSixteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_DecemberTwoThousandAndSeventeenEagleNoteMember"
      decimals="0"
      unitRef="USD">20065</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:DebtConversionConvertedInstrumentAmount1
      contextRef="From2018-07-012019-06-30_custom_DecemberTwentyNineTwoThousandAndSeventeenSecuritiesPurchaseAgreementMember_custom_DecemberTwoThousandAndSeventeenEagleNoteMember"
      decimals="0"
      unitRef="USD">171965</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2019-06-30_custom_DecemberTwentyNineTwoThousandAndSixteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_DecemberTwoThousandAndSeventeenEagleNoteMember"
      decimals="0"
      unitRef="USD">360470</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="AsOf2019-06-30_custom_DecemberTwentyNineTwoThousandAndSeventeenSecuritiesPurchaseAgreementMember_custom_DecemberTwoThousandAndSeventeenEagleNoteMember"
      decimals="0"
      unitRef="USD">43535</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="AsOf2020-06-30_custom_DecemberTwentyNineTwoThousandAndSeventeenSecuritiesPurchaseAgreementMember_custom_DecemberTwoThousandAndSeventeenEagleNoteMember"
      decimals="0"
      unitRef="USD">0</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2020-06-30_custom_DecemberTwentyNineTwoThousandAndSeventeenSecuritiesPurchaseAgreementMember_custom_DecemberTwoThousandAndSeventeenEagleNoteMember"
      decimals="0"
      unitRef="USD">0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtConversionConvertedInstrumentAmount1
      contextRef="From2019-07-012020-06-30_custom_DecemberTwentyNineTwoThousandAndSeventeenSecuritiesPurchaseAgreementMember_custom_DecemberTwoThousandAndSeventeenEagleNoteMember"
      decimals="0"
      unitRef="USD">171965</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="AsOf2020-06-30_custom_DecemberTwentyNineTwoThousandAndSeventeenSecuritiesPurchaseAgreementMember"
      decimals="0"
      unitRef="USD">24751</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:ConvertibleNotesPayable
      contextRef="AsOf2020-06-30_custom_DecemberTwentyNineTwoThousandAndSixteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember"
      decimals="0"
      unitRef="USD">0</us-gaap:ConvertibleNotesPayable>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2018-07-13_custom_JulyThirteenTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_JulyTwoThousandEighteenEagleNoteMember"
      decimals="0"
      unitRef="USD">75000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="From2018-07-182018-07-19_custom_JulyThirteenTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_JulyTwoThousandEighteenEagleNoteMember"
      decimals="0"
      unitRef="USD">71250</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:LegalFees
      contextRef="From2018-07-182018-07-19_custom_JulyThirteenTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_JulyTwoThousandEighteenEagleNoteMember"
      decimals="0"
      unitRef="USD">3750</us-gaap:LegalFees>
    <us-gaap:DebtInstrumentMaturityDate contextRef="From2018-07-122018-07-13_custom_JulyThirteenTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_JulyTwoThousandEighteenEagleNoteMember">2019-07-13</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2018-07-13_custom_JulyThirteenTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_JulyTwoThousandEighteenEagleNoteMember"
      decimals="INF"
      unitRef="Pure">0.08</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="AsOf2019-06-30_custom_JulyThirteenTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_JulyTwoThousandEighteenEagleNoteMember"
      decimals="0"
      unitRef="USD">5786</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2019-06-30_custom_JulyThirteenTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_JulyTwoThousandEighteenEagleNoteMember"
      decimals="0"
      unitRef="USD">75000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2020-06-30_custom_JulyThirteenTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_JulyTwoThousandEighteenEagleNoteMember"
      decimals="0"
      unitRef="USD">0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="AsOf2018-07-13_custom_JulyThirteenTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_JulyTwoThousandEighteenEagleNoteMember"
      decimals="0"
      unitRef="USD">0</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:DebtConversionConvertedInstrumentAmount1
      contextRef="From2019-07-012020-06-30_custom_JulyThirteenTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_JulyTwoThousandEighteenEagleNoteMember"
      decimals="0"
      unitRef="USD">75000</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="AsOf2020-06-30_custom_JulyThirteenTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_JulyTwoThousandEighteenEagleNoteMember"
      decimals="0"
      unitRef="USD">9300</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:ConvertibleNotesPayable
      contextRef="AsOf2020-06-30_custom_JuneTwentyNineTwoThousandEighteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember"
      decimals="0"
      unitRef="USD">0</us-gaap:ConvertibleNotesPayable>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2018-08-29_custom_AugustTwentyNineTwoThousandandEighteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_AugustTwoThousandEighteenEagleNoteMember"
      decimals="0"
      unitRef="USD">105000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentMaturityDate contextRef="From2018-08-262018-08-29_custom_AugustTwentyNineTwoThousandandEighteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_AugustTwoThousandEighteenEagleNoteMember">2019-08-29</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2018-08-29_custom_AugustTwentyNineTwoThousandandEighteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_AugustTwoThousandEighteenEagleNoteMember"
      decimals="INF"
      unitRef="Pure">0.08</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <PPCB:DebtInstrumentDebtDefaultInterestRate
      contextRef="From2020-04-012020-04-30_custom_AugustTwentyNineTwoThousandandEighteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_AugustTwoThousandEighteenEagleNoteMember"
      decimals="INF"
      unitRef="Pure">0.24</PPCB:DebtInstrumentDebtDefaultInterestRate>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2018-10-02_custom_OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_OctoberTwoTwoThousandAndEighteenEagleNoteMember"
      decimals="0"
      unitRef="USD">210000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentPeriodicPaymentPrincipal
      contextRef="From2018-09-292018-10-02_custom_OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_OctoberTwoTwoThousandAndEighteenEagleNoteMember"
      decimals="0"
      unitRef="USD">10000</us-gaap:DebtInstrumentPeriodicPaymentPrincipal>
    <us-gaap:DebtInstrumentMaturityDate contextRef="From2018-09-292018-10-02_custom_OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_OctoberTwoTwoThousandAndEighteenEagleNoteMember">2019-10-02</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2018-10-02_custom_OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_OctoberTwoTwoThousandAndEighteenEagleNoteMember"
      decimals="INF"
      unitRef="Pure">0.08</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <PPCB:DebtInstrumentDebtDefaultInterestRate
      contextRef="From2020-04-012020-04-30_custom_OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember"
      decimals="INF"
      unitRef="Pure">0.24</PPCB:DebtInstrumentDebtDefaultInterestRate>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2018-11-30_custom_NovembeThirtyTwoThousandAndEighteenMecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_NovemberTwoThousandAndEighteenEagleNoteMember"
      decimals="0"
      unitRef="USD">105000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentPeriodicPaymentPrincipal
      contextRef="From2018-11-262018-11-30_custom_NovembeThirtyTwoThousandAndEighteenMecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_NovemberTwoThousandAndEighteenEagleNoteMember"
      decimals="0"
      unitRef="USD">5000</us-gaap:DebtInstrumentPeriodicPaymentPrincipal>
    <us-gaap:DebtInstrumentMaturityDate contextRef="From2018-11-262018-11-30_custom_NovembeThirtyTwoThousandAndEighteenMecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_NovemberTwoThousandAndEighteenEagleNoteMember">2019-11-30</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2018-11-30_custom_NovembeThirtyTwoThousandAndEighteenMecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_NovemberTwoThousandAndEighteenEagleNoteMember"
      decimals="INF"
      unitRef="Pure">0.08</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <PPCB:DebtInstrumentDebtDefaultInterestRate
      contextRef="From2020-04-012020-04-30_custom_NovembeThirtyTwoThousandAndEighteenMecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_NovemberTwoThousandAndEighteenEagleNoteMember"
      decimals="INF"
      unitRef="Pure">0.24</PPCB:DebtInstrumentDebtDefaultInterestRate>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2018-12-24_custom_DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_DecembeTwoThousandAndEighteenEagleNoteMember"
      decimals="0"
      unitRef="USD">126000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentPeriodicPaymentPrincipal
      contextRef="From2018-12-232018-12-24_custom_DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_DecembeTwoThousandAndEighteenEagleNoteMember"
      decimals="0"
      unitRef="USD">6000</us-gaap:DebtInstrumentPeriodicPaymentPrincipal>
    <us-gaap:DebtInstrumentMaturityDate contextRef="From2018-12-232018-12-24_custom_DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_DecembeTwoThousandAndEighteenEagleNoteMember">2019-12-24</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2018-12-24_custom_DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_DecembeTwoThousandAndEighteenEagleNoteMember"
      decimals="INF"
      unitRef="Pure">0.08</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <PPCB:DebtInstrumentDebtDefaultInterestRate
      contextRef="From2018-12-232018-12-24_custom_DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_DecembeTwoThousandAndEighteenEagleNoteMember"
      decimals="INF"
      unitRef="Pure">0.24</PPCB:DebtInstrumentDebtDefaultInterestRate>
    <PPCB:DebtInstrumentDebtDefaultInterestRate
      contextRef="From2020-04-012020-04-30_custom_DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_DecembeTwoThousandAndEighteenEagleNoteMember"
      decimals="INF"
      unitRef="Pure">0.24</PPCB:DebtInstrumentDebtDefaultInterestRate>
    <us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
      contextRef="From2018-12-232018-12-24_custom_DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_DecembeTwoThousandAndEighteenEagleNoteMember_srt_MinimumMember"
      decimals="INF"
      unitRef="Pure">0.60</us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger>
    <us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
      contextRef="From2018-12-232018-12-24_custom_DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_DecembeTwoThousandAndEighteenEagleNoteMember_srt_MaximumMember"
      decimals="INF"
      unitRef="Pure">0.61</us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger>
    <us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
      contextRef="From2018-12-232018-12-24_custom_DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_DepositoryTrustCompanyMember_custom_DecembeTwoThousandAndEighteenEagleNoteMember_srt_MinimumMember"
      decimals="INF"
      unitRef="Pure">0.50</us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger>
    <us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
      contextRef="From2018-12-232018-12-24_custom_DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_DepositoryTrustCompanyMember_custom_DecembeTwoThousandAndEighteenEagleNoteMember_srt_MaximumMember"
      decimals="INF"
      unitRef="Pure">0.51</us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger>
    <us-gaap:DebtConversionOriginalDebtInterestRateOfDebt
      contextRef="From2018-12-232018-12-24_custom_DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_DecembeTwoThousandAndEighteenEagleNoteMember"
      decimals="INF"
      unitRef="Pure">0.10</us-gaap:DebtConversionOriginalDebtInterestRateOfDebt>
    <PPCB:PercentageOfOutstandingSharesOfCommonStock
      contextRef="From2018-12-232018-12-24_custom_DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_DecembeTwoThousandAndEighteenEagleNoteMember"
      decimals="INF"
      unitRef="Pure">0.0499</PPCB:PercentageOfOutstandingSharesOfCommonStock>
    <us-gaap:DebtInstrumentUnamortizedPremium
      contextRef="AsOf2018-12-24_custom_DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_DecembeTwoThousandAndEighteenEagleNoteMember"
      decimals="0"
      unitRef="USD">357688</us-gaap:DebtInstrumentUnamortizedPremium>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2021-06-30_custom_DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_DecembeTwoThousandAndEighteenEagleNoteMember"
      decimals="0"
      unitRef="USD">224131</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2020-06-30_custom_DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_EagleEquitiesLLCMember_custom_DecembeTwoThousandAndEighteenEagleNoteMember"
      decimals="0"
      unitRef="USD">133557</us-gaap:AdditionalPaidInCapital>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2020-06-30_custom_SecuritiesPurchaseAgreementOneMember_custom_EagleEquitiesLLCMember"
      decimals="0"
      unitRef="USD">205500</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="AsOf2020-06-30_custom_SecuritiesPurchaseAgreementOneMember_custom_EagleEquitiesLLCMember"
      decimals="0"
      unitRef="USD">26990</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:ConvertibleNotesPayable
      contextRef="AsOf2021-06-30_custom_SecuritiesPurchaseAgreementOneMember_custom_EagleEquitiesLLCMember"
      decimals="0"
      unitRef="USD">0</us-gaap:ConvertibleNotesPayable>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2018-10-02_custom_OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_GSCapitalPartnersLLCMember_custom_OctoberTwoThousandEighteenGSNoteMember"
      decimals="INF"
      unitRef="Pure">0.08</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2018-10-02_custom_OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_GSCapitalPartnersLLCMember_custom_OctoberTwoThousandEighteenGSNoteMember"
      decimals="0"
      unitRef="USD">212000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2018-10-03_custom_OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_GSCapitalPartnersLLCMember_custom_OctoberTwoThousandEighteenGSNoteMember"
      decimals="0"
      unitRef="USD">106000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="From2018-09-292018-10-02_custom_OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_GSCapitalPartnersLLCMember_custom_OctoberTwoThousandEighteenGSNoteMember"
      decimals="0"
      unitRef="USD">100700</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="From2018-09-292018-10-02_custom_OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_GSCapitalPartnersLLCMember_custom_OctoberTwoThousandEighteenGSNoteMember_custom_FirstNoteMember"
      decimals="0"
      unitRef="USD">106000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="From2018-09-292018-10-02_custom_OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_GSCapitalPartnersLLCMember_custom_OctoberTwoThousandEighteenGSNoteMember_custom_SecondNoteMember"
      decimals="0"
      unitRef="USD">106000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
      contextRef="From2018-09-292018-10-02_custom_OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_GSCapitalPartnersLLCMember_custom_OctoberTwoThousandEighteenGSNoteMember"
      decimals="INF"
      unitRef="Pure">0.61</us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger>
    <us-gaap:DebtInstrumentMaturityDate contextRef="From2018-09-292018-10-02_custom_OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember_custom_GSCapitalPartnersLLCMember_custom_OctoberTwoThousandEighteenGSNoteMember">2018-10-02</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2020-01-22_custom_SecuritiesPurchaseAgreementMember_custom_GSCapitalPartnersLLCMember_custom_JanuaryTwentyTwoTwentyTwentyGSNoteMember"
      decimals="0"
      unitRef="USD">58000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="AsOf2020-01-22_custom_SecuritiesPurchaseAgreementMember_custom_GSCapitalPartnersLLCMember_custom_JanuaryTwentyTwoTwentyTwentyGSNoteMember"
      decimals="0"
      unitRef="USD">3500</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:LegalFees
      contextRef="From2020-01-212020-01-22_custom_SecuritiesPurchaseAgreementMember_custom_GSCapitalPartnersLLCMember_custom_JanuaryTwentyTwoTwentyTwentyGSNoteMember"
      decimals="0"
      unitRef="USD">2500</us-gaap:LegalFees>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="From2020-01-212020-01-22_custom_SecuritiesPurchaseAgreementMember_custom_GSCapitalPartnersLLCMember_custom_JanuaryTwentyTwoTwentyTwentyGSNoteMember_srt_MinimumMember"
      decimals="0"
      unitRef="USD">52000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:DebtInstrumentMaturityDate contextRef="From2020-01-212020-01-22_custom_SecuritiesPurchaseAgreementMember_custom_GSCapitalPartnersLLCMember_custom_JanuaryTwentyTwoTwentyTwentyGSNoteMember">2021-01-22</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
      contextRef="From2020-01-212020-01-22_custom_SecuritiesPurchaseAgreementMember_custom_GSCapitalPartnersLLCMember_custom_JanuaryTwentyTwoTwentyTwentyGSNoteMember"
      decimals="INF"
      unitRef="Pure">0.40</us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger>
    <PPCB:DebtDefaultAmountPercentage
      contextRef="From2020-01-212020-01-22_custom_SecuritiesPurchaseAgreementMember_custom_GSCapitalPartnersLLCMember_custom_JanuaryTwentyTwoTwentyTwentyGSNoteMember_srt_MinimumMember"
      decimals="INF"
      unitRef="Pure">1.12</PPCB:DebtDefaultAmountPercentage>
    <PPCB:DebtDefaultAmountPercentage
      contextRef="From2020-01-212020-01-22_custom_SecuritiesPurchaseAgreementMember_custom_GSCapitalPartnersLLCMember_custom_JanuaryTwentyTwoTwentyTwentyGSNoteMember_srt_MaximumMember"
      decimals="INF"
      unitRef="Pure">1.30</PPCB:DebtDefaultAmountPercentage>
    <PPCB:DebtInstrumentDebtDefaultInterestRate
      contextRef="From2020-01-212020-01-22_custom_SecuritiesPurchaseAgreementMember_custom_GSCapitalPartnersLLCMember_custom_JanuaryTwentyTwoTwentyTwentyGSNoteMember"
      decimals="INF"
      unitRef="Pure">0.24</PPCB:DebtInstrumentDebtDefaultInterestRate>
    <us-gaap:DebtInstrumentUnamortizedPremium
      contextRef="AsOf2020-01-22_custom_SecuritiesPurchaseAgreementMember_custom_GSCapitalPartnersLLCMember_custom_JanuaryTwentyTwoTwentyTwentyGSNoteMember"
      decimals="0"
      unitRef="USD">106438</us-gaap:DebtInstrumentUnamortizedPremium>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2021-06-30_custom_SecuritiesPurchaseAgreementMember_custom_GSCapitalPartnersLLCMember_custom_JanuaryTwentyTwoTwentyTwentyGSNoteMember"
      decimals="0"
      unitRef="USD">22901</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2020-06-30_custom_SecuritiesPurchaseAgreementMember_custom_GSCapitalPartnersLLCMember_custom_JanuaryTwentyTwoTwentyTwentyGSNoteMember"
      decimals="0"
      unitRef="USD">38667</us-gaap:AdditionalPaidInCapital>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="AsOf2020-06-30_custom_SecuritiesPurchaseAgreementMember_custom_GSCapitalPartnersLLCMember_custom_JanuaryTwentyTwoTwentyTwentyGSNoteMember"
      decimals="0"
      unitRef="USD">8802</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:ConvertibleNotesPayable
      contextRef="AsOf2020-06-30_custom_SecuritiesPurchaseAgreementMember_custom_GSCapitalPartnersLLCMember_custom_JanuaryTwentyTwoTwentyTwentyGSNoteMember"
      decimals="0"
      unitRef="USD">58000</us-gaap:ConvertibleNotesPayable>
    <us-gaap:DebtConversionConvertedInstrumentAmount1
      contextRef="From2019-07-012020-06-30_custom_SecuritiesPurchaseAgreementMember_custom_GSCapitalPartnersLLCMember_custom_JanuaryTwentyTwoTwentyTwentyGSNoteMember"
      decimals="0"
      unitRef="USD">141820</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <PPCB:DebtConversionConvertedInterestPayable
      contextRef="From2019-07-012020-06-30_custom_SecuritiesPurchaseAgreementMember_custom_GSCapitalPartnersLLCMember_custom_JanuaryTwentyTwoTwentyTwentyGSNoteMember"
      decimals="0"
      unitRef="USD">76397</PPCB:DebtConversionConvertedInterestPayable>
    <us-gaap:ConvertibleNotesPayable
      contextRef="AsOf2021-06-30_custom_SecuritiesPurchaseAgreementMember_custom_GSCapitalPartnersLLCMember_custom_JanuaryTwentyTwoTwentyTwentyGSNoteMember"
      decimals="0"
      unitRef="USD">0</us-gaap:ConvertibleNotesPayable>
    <us-gaap:DebtConversionConvertedInstrumentAmount1
      contextRef="From2020-07-012021-06-30_custom_SecuritiesPurchaseAgreementMember_custom_GSCapitalPartnersLLCMember_custom_JanuaryTwentyTwoTwentyTwentyGSNoteMember"
      decimals="0"
      unitRef="USD">58000</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <PPCB:DebtConversionConvertedInterestPayable
      contextRef="From2020-07-012021-06-30_custom_SecuritiesPurchaseAgreementMember_custom_GSCapitalPartnersLLCMember_custom_JanuaryTwentyTwoTwentyTwentyGSNoteMember"
      decimals="0"
      unitRef="USD">8508</PPCB:DebtConversionConvertedInterestPayable>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2017-08-10_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember"
      decimals="0"
      unitRef="USD">310000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2017-08-10_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember"
      decimals="INF"
      unitRef="Pure">0.10</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtConversionConvertedInstrumentAmount1
      contextRef="From2017-08-072017-08-10_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember"
      decimals="0"
      unitRef="USD">750</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
      contextRef="From2017-08-072017-08-10_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember"
      decimals="INF"
      unitRef="Pure">0.65</us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger>
    <us-gaap:DebtInstrumentMaturityDate contextRef="From2017-08-072017-08-10_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember">2019-08-10</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:AccruedLiabilitiesCurrentAndNoncurrent
      contextRef="AsOf2017-06-30_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember"
      decimals="0"
      unitRef="USD">155000</us-gaap:AccruedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:AccruedLiabilitiesCurrentAndNoncurrent
      contextRef="AsOf2018-06-30_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember"
      decimals="0"
      unitRef="USD">155000</us-gaap:AccruedLiabilitiesCurrentAndNoncurrent>
    <PPCB:DebtInstrumentDebtDefaultInterestRate
      contextRef="From2017-08-072017-08-10_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember"
      decimals="INF"
      unitRef="Pure">0.18</PPCB:DebtInstrumentDebtDefaultInterestRate>
    <us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
      contextRef="AsOf2017-08-10_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember"
      decimals="0"
      unitRef="USD">578212</us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2018-06-30_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember_custom_ConsultantMember"
      decimals="0"
      unitRef="USD">140000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="AsOf2018-06-30_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember_custom_ConsultantMember"
      decimals="0"
      unitRef="USD">10764</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2019-06-30_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember_custom_ConsultantMember"
      decimals="0"
      unitRef="USD">161000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="AsOf2019-06-30_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember_custom_ConsultantMember"
      decimals="0"
      unitRef="USD">19418</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2019-06-30_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember"
      decimals="0"
      unitRef="USD">9000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtConversionConvertedInstrumentAmount1
      contextRef="From2019-07-012020-06-30_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember"
      decimals="0"
      unitRef="USD">500</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <us-gaap:AccruedLiabilitiesCurrentAndNoncurrent
      contextRef="AsOf2020-06-30_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember"
      decimals="0"
      unitRef="USD">5248</us-gaap:AccruedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2020-06-30_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember"
      decimals="0"
      unitRef="USD">8500</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="AsOf2020-06-30_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember"
      decimals="0"
      unitRef="USD">22168</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2021-03-15_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember_custom_SettlementAndMutualReleaseAgreementMember"
      decimals="0"
      unitRef="USD">100000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:Liabilities
      contextRef="AsOf2021-03-15_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember_custom_SettlementAndMutualReleaseAgreementMember"
      decimals="0"
      unitRef="USD">56762</us-gaap:Liabilities>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="AsOf2021-03-15_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember_custom_SettlementAndMutualReleaseAgreementMember"
      decimals="0"
      unitRef="USD">8500</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="AsOf2021-03-15_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember_custom_SettlementAndMutualReleaseAgreementMember"
      decimals="0"
      unitRef="USD">23262</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:AccruedLiabilitiesCurrentAndNoncurrent
      contextRef="AsOf2021-03-15_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember_custom_SettlementAndMutualReleaseAgreementMember"
      decimals="0"
      unitRef="USD">25000</us-gaap:AccruedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="From2020-07-012021-06-30_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember_custom_SettlementAndMutualReleaseAgreementMember"
      decimals="0"
      unitRef="USD">43238</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:ConvertibleNotesPayable
      contextRef="AsOf2021-06-30_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember_custom_SettlementAndMutualReleaseAgreementMember"
      decimals="0"
      unitRef="USD">80000</us-gaap:ConvertibleNotesPayable>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="AsOf2021-06-30_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember_custom_SettlementAndMutualReleaseAgreementMember"
      decimals="0"
      unitRef="USD">3738</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:DebtConversionConvertedInstrumentAmount1
      contextRef="From2020-07-012021-06-30_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember_custom_SettlementAndMutualReleaseAgreementMember"
      decimals="0"
      unitRef="USD">20000</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2019-11-26_custom_NovemberTwentySixTwoThousandNineteenSecuritiesPurchaseAgreementMember_custom_NovemberTwentySixTwoThousandNineteenPowerUpNoteMember"
      decimals="0"
      unitRef="USD">43000</us-gaap:DebtInstrumentFaceAmount>
    <PPCB:PrepaymentPenalties
      contextRef="From2019-11-212019-11-22_custom_NovemberTwentySixTwoThousandNineteenSecuritiesPurchaseAgreementMember_custom_NovemberTwentySixTwoThousandNineteenPowerUpNoteMember"
      decimals="0"
      unitRef="USD">40000</PPCB:PrepaymentPenalties>
    <us-gaap:LegalFees
      contextRef="From2019-11-212019-11-22_custom_NovemberTwentySixTwoThousandNineteenSecuritiesPurchaseAgreementMember_custom_NovemberTwentySixTwoThousandNineteenPowerUpNoteMember"
      decimals="0"
      unitRef="USD">2500</us-gaap:LegalFees>
    <PPCB:DiligenceFees
      contextRef="From2019-11-212019-11-22_custom_NovemberTwentySixTwoThousandNineteenSecuritiesPurchaseAgreementMember_custom_NovemberTwentySixTwoThousandNineteenPowerUpNoteMember"
      decimals="0"
      unitRef="USD">500</PPCB:DiligenceFees>
    <us-gaap:DebtInstrumentMaturityDate contextRef="From2019-11-252019-11-26_custom_NovemberTwentySixTwoThousandNineteenSecuritiesPurchaseAgreementMember_custom_NovemberTwentySixTwoThousandNineteenPowerUpNoteMember">2020-11-26</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2019-11-26_custom_NovemberTwentySixTwoThousandNineteenSecuritiesPurchaseAgreementMember_custom_NovemberTwentySixTwoThousandNineteenPowerUpNoteMember"
      decimals="INF"
      unitRef="Pure">0.08</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2020-01-07_custom_JanuarySevenTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember_custom_JanuarySevenTwoThousandTwentyPowerUpNoteMember"
      decimals="0"
      unitRef="USD">75000</us-gaap:DebtInstrumentFaceAmount>
    <PPCB:PrepaymentPenalties
      contextRef="From2020-01-122020-01-13_custom_JanuarySevenTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember_custom_JanuarySevenTwoThousandTwentyPowerUpNoteMember"
      decimals="0"
      unitRef="USD">72000</PPCB:PrepaymentPenalties>
    <us-gaap:LegalFees
      contextRef="From2020-01-122020-01-13_custom_JanuarySevenTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember_custom_JanuarySevenTwoThousandTwentyPowerUpNoteMember"
      decimals="0"
      unitRef="USD">2500</us-gaap:LegalFees>
    <PPCB:DiligenceFees
      contextRef="From2020-01-122020-01-13_custom_JanuarySevenTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember_custom_JanuarySevenTwoThousandTwentyPowerUpNoteMember"
      decimals="0"
      unitRef="USD">500</PPCB:DiligenceFees>
    <us-gaap:DebtInstrumentMaturityDate contextRef="From2020-01-062020-01-07_custom_JanuarySevenTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember_custom_JanuarySevenTwoThousandTwentyPowerUpNoteMember">2021-01-07</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2020-01-07_custom_JanuarySevenTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember_custom_JanuarySevenTwoThousandTwentyPowerUpNoteMember"
      decimals="INF"
      unitRef="Pure">0.08</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2020-03-12_custom_MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember_custom_MarchTwelveTwoThousandTwentyPowerUpNoteMember"
      decimals="0"
      unitRef="USD">43000</us-gaap:DebtInstrumentFaceAmount>
    <PPCB:PrepaymentPenalties
      contextRef="From2020-03-042020-03-05_custom_MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember_custom_MarchTwelveTwoThousandTwentyPowerUpNoteMember"
      decimals="0"
      unitRef="USD">40000</PPCB:PrepaymentPenalties>
    <us-gaap:LegalFees
      contextRef="From2020-03-042020-03-05_custom_MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember_custom_MarchTwelveTwoThousandTwentyPowerUpNoteMember"
      decimals="0"
      unitRef="USD">2500</us-gaap:LegalFees>
    <PPCB:DiligenceFees
      contextRef="From2020-03-042020-03-05_custom_MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember_custom_MarchTwelveTwoThousandTwentyPowerUpNoteMember"
      decimals="0"
      unitRef="USD">500</PPCB:DiligenceFees>
    <us-gaap:DebtInstrumentMaturityDate contextRef="From2020-03-112020-03-12_custom_MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember_custom_MarchTwelveTwoThousandTwentyPowerUpNoteMember">2021-03-12</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2020-03-12_custom_MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember_custom_MarchTwelveTwoThousandTwentyPowerUpNoteMember"
      decimals="INF"
      unitRef="Pure">0.08</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <PPCB:DebtDefaultAmountPercentage
      contextRef="From2020-03-112020-03-12_custom_MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember_custom_MarchTwelveTwoThousandTwentyPowerUpNoteMember"
      decimals="INF"
      unitRef="Pure">0.22</PPCB:DebtDefaultAmountPercentage>
    <PPCB:DebtInstrumentDebtDefaultInterestRate
      contextRef="From2020-03-112020-03-12_custom_MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember_custom_MarchTwelveTwoThousandTwentyPowerUpNoteMember"
      decimals="INF"
      unitRef="Pure">1.50</PPCB:DebtInstrumentDebtDefaultInterestRate>
    <us-gaap:DebtConversionDescription contextRef="From2020-03-112020-03-12_custom_MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember_custom_MarchTwelveTwoThousandTwentyPowerUpNoteMember">The
conversion price for the above Power Up notes was $3,050, subject to certain Market Price (as defined below) adjustment. If the Market
Price was greater than or equal to $5,000, the conversion price was to be the greater of 65% of the Market Price (&#x201c;Variable Conversion
Price&#x201d;) and $3,050. In the event Market Price was less than $5,000, the conversion price was to be the Variable Conversion Price.
As defined in the note agreements, the &#x201c;Market Price&#x201d; was the average of the lowest three closing bid prices during the ten
day trading period prior to and including the day the Company receives a notice of conversion from Power Up on the electronic quotation
system or applicable principal securities exchange or trading market or, if no closing bid price of such security is available in any
of the foregoing manners, the average of the closing bid prices of any market makers for such security that are listed in the &#x201c;pink
sheets&#x201d; during the ten prior trading days, including the day upon which the Company receives a notice of conversion from Power
Up. Notwithstanding the foregoing, Power Up was restricted from effecting a conversion if such conversion, along with other shares of
the Company&#x2019;s common stock beneficially owned by Power Up and its affiliates, exceeds 4.99% of the outstanding shares of the Company&#x2019;s
common stock.</us-gaap:DebtConversionDescription>
    <us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
      contextRef="From2020-03-112020-03-12_custom_MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember_custom_MarchTwelveTwoThousandTwentyPowerUpNoteMember"
      decimals="INF"
      unitRef="Pure">0.65</us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger>
    <us-gaap:DebtInstrumentConvertibleThresholdTradingDays
      contextRef="From2020-03-112020-03-12_custom_MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember_custom_MarchTwelveTwoThousandTwentyPowerUpNoteMember"
      decimals="INF"
      unitRef="Integer">10</us-gaap:DebtInstrumentConvertibleThresholdTradingDays>
    <PPCB:PercentageOfOutstandingSharesOfCommonStock
      contextRef="From2020-03-112020-03-12_custom_MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember_custom_MarchTwelveTwoThousandTwentyPowerUpNoteMember"
      decimals="INF"
      unitRef="Pure">0.0499</PPCB:PercentageOfOutstandingSharesOfCommonStock>
    <us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
      contextRef="AsOf2020-03-12_custom_MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember_custom_MarchTwelveTwoThousandTwentyPowerUpNoteMember"
      decimals="0"
      unitRef="USD">422557</us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2020-01-07_custom_MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember_custom_MarchTwelveTwoThousandTwentyPowerUpNoteMember"
      decimals="0"
      unitRef="USD">118000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2020-06-30_custom_MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember_custom_MarchTwelveTwoThousandTwentyPowerUpNoteMember"
      decimals="0"
      unitRef="USD">118000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="AsOf2020-01-07_custom_MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember_custom_MarchTwelveTwoThousandTwentyPowerUpNoteMember"
      decimals="0"
      unitRef="USD">3903</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="AsOf2020-06-30_custom_MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember_custom_MarchTwelveTwoThousandTwentyPowerUpNoteMember"
      decimals="0"
      unitRef="USD">3903</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2021-06-30_custom_MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember_custom_MarchTwelveTwoThousandTwentyPowerUpNoteMember"
      decimals="0"
      unitRef="USD">0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="AsOf2021-06-30_custom_MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember_custom_MarchTwelveTwoThousandTwentyPowerUpNoteMember"
      decimals="0"
      unitRef="USD">0</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:RepaymentsOfDebt
      contextRef="From2020-07-012021-06-30_custom_MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember_custom_MarchTwelveTwoThousandTwentyPowerUpNoteMember"
      decimals="0"
      unitRef="USD">43000</us-gaap:RepaymentsOfDebt>
    <us-gaap:InterestPaid
      contextRef="From2020-07-012021-06-30_custom_MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember_custom_MarchTwelveTwoThousandTwentyPowerUpNoteMember"
      decimals="0"
      unitRef="USD">1816</us-gaap:InterestPaid>
    <us-gaap:ConvertibleNotesPayable
      contextRef="AsOf2021-06-30_custom_MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember_custom_MarchTwelveTwoThousandTwentyPowerUpNoteMember"
      decimals="0"
      unitRef="USD">0</us-gaap:ConvertibleNotesPayable>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2019-05-23_custom_RedstartHoldingsCorpFinancingAgreementMember_custom_RedstartHoldingsCorpMember"
      decimals="0"
      unitRef="USD">133000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:LegalFees
      contextRef="From2019-05-222019-05-23_custom_RedstartHoldingsCorpFinancingAgreementMember_custom_RedstartHoldingsCorpMember"
      decimals="0"
      unitRef="USD">3000</us-gaap:LegalFees>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="From2019-05-222019-05-23_custom_RedstartHoldingsCorpFinancingAgreementMember_custom_RedstartHoldingsCorpMember"
      decimals="0"
      unitRef="USD">130000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:DebtInstrumentMaturityDate contextRef="From2019-05-222019-05-23_custom_RedstartHoldingsCorpFinancingAgreementMember_custom_RedstartHoldingsCorpMember">2020-05-23</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2019-05-23_custom_RedstartHoldingsCorpFinancingAgreementMember_custom_RedstartHoldingsCorpMember"
      decimals="INF"
      unitRef="Pure">0.08</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2019-06-30_custom_RedstartHoldingsCorpFinancingAgreementMember_custom_RedstartHoldingsCorpMember"
      decimals="0"
      unitRef="USD">133000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="AsOf2019-06-30_custom_RedstartHoldingsCorpFinancingAgreementMember_custom_RedstartHoldingsCorpMember"
      decimals="0"
      unitRef="USD">1137</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2020-06-30_custom_RedstartHoldingsCorpFinancingAgreementMember_custom_RedstartHoldingsCorpMember"
      decimals="0"
      unitRef="USD">0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="AsOf2020-06-30_custom_RedstartHoldingsCorpFinancingAgreementMember_custom_RedstartHoldingsCorpMember"
      decimals="0"
      unitRef="USD">0</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2020-06-30_custom_RedstartHoldingsCorpFinancingAgreementMember"
      decimals="0"
      unitRef="USD">133000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="AsOf2020-06-30_custom_RedstartHoldingsCorpFinancingAgreementMember"
      decimals="0"
      unitRef="USD">5320</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2019-07-30_custom_SecuritiesPurchaseAgreementMember_custom_OdysseyCapitalFundingLLCMember_custom_JulyTwoThousandNineteenOdysseyNoteMember"
      decimals="0"
      unitRef="USD">320000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="AsOf2019-07-30_custom_SecuritiesPurchaseAgreementMember_custom_OdysseyCapitalFundingLLCMember_custom_JulyTwoThousandNineteenOdysseyNoteMember"
      decimals="0"
      unitRef="USD">25000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2019-08-01_custom_SecuritiesPurchaseAgreementMember_custom_OdysseyCapitalFundingLLCMember_custom_JulyTwoThousandNineteenOdysseyNoteMember"
      decimals="0"
      unitRef="USD">295000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:LegalFees
      contextRef="From2019-07-312019-08-01_custom_SecuritiesPurchaseAgreementMember_custom_OdysseyCapitalFundingLLCMember_custom_JulyTwoThousandNineteenOdysseyNoteMember"
      decimals="0"
      unitRef="USD">10000</us-gaap:LegalFees>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="From2019-07-312019-08-01_custom_SecuritiesPurchaseAgreementMember_custom_OdysseyCapitalFundingLLCMember_custom_JulyTwoThousandNineteenOdysseyNoteMember"
      decimals="0"
      unitRef="USD">285000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:DebtInstrumentMaturityDate contextRef="From2019-07-292019-07-30_custom_SecuritiesPurchaseAgreementMember_custom_OdysseyCapitalFundingLLCMember_custom_JulyTwoThousandNineteenOdysseyNoteMember">2020-07-30</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2019-07-30_custom_SecuritiesPurchaseAgreementMember_custom_OdysseyCapitalFundingLLCMember_custom_JulyTwoThousandNineteenOdysseyNoteMember"
      decimals="INF"
      unitRef="Pure">0.10</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <PPCB:DebtInstrumentDebtDefaultInterestRate
      contextRef="From2019-07-292019-07-30_custom_SecuritiesPurchaseAgreementMember_custom_OdysseyCapitalFundingLLCMember_custom_JulyTwoThousandNineteenOdysseyNoteMember"
      decimals="INF"
      unitRef="Pure">0.24</PPCB:DebtInstrumentDebtDefaultInterestRate>
    <us-gaap:DebtInstrumentUnamortizedPremium
      contextRef="AsOf2019-07-30_custom_SecuritiesPurchaseAgreementMember_custom_OdysseyCapitalFundingLLCMember_custom_JulyTwoThousandNineteenOdysseyNoteMember"
      decimals="0"
      unitRef="USD">172308</us-gaap:DebtInstrumentUnamortizedPremium>
    <PPCB:PercentageOfOutstandingSharesOfCommonStock
      contextRef="From2019-07-292019-07-30_custom_SecuritiesPurchaseAgreementMember_custom_OdysseyCapitalFundingLLCMember_custom_JulyTwoThousandNineteenOdysseyNoteMember"
      decimals="INF"
      unitRef="Pure">1.20</PPCB:PercentageOfOutstandingSharesOfCommonStock>
    <PPCB:DebtInstrumentDebtDefaultInterestRate
      contextRef="From2019-07-292019-07-30_custom_SecuritiesPurchaseAgreementMember_custom_OdysseyCapitalFundingLLCMember_custom_JulyTwoThousandNineteenOdysseyNoteMember"
      decimals="INF"
      unitRef="Pure">0.24</PPCB:DebtInstrumentDebtDefaultInterestRate>
    <us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
      contextRef="From2019-07-292019-07-30_custom_SecuritiesPurchaseAgreementMember_custom_OdysseyCapitalFundingLLCMember_custom_JulyTwoThousandNineteenOdysseyNoteMember"
      decimals="INF"
      unitRef="Pure">0.65</us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2020-06-30_custom_SecuritiesPurchaseAgreementMember_custom_OdysseyCapitalFundingLLCMember"
      decimals="0"
      unitRef="USD">0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="AsOf2020-06-30_custom_SecuritiesPurchaseAgreementMember_custom_OdysseyCapitalFundingLLCMember"
      decimals="0"
      unitRef="USD">0</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:DebtConversionConvertedInstrumentAmount1
      contextRef="From2019-07-012020-06-30_custom_SecuritiesPurchaseAgreementMember_custom_OdysseyCapitalFundingLLCMember_custom_JulyTwoThousandNineteenOdysseyNoteMember"
      decimals="0"
      unitRef="USD">320000</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="AsOf2020-06-30_custom_SecuritiesPurchaseAgreementMember_custom_OdysseyCapitalFundingLLCMember_custom_JulyTwoThousandNineteenOdysseyNoteMember"
      decimals="0"
      unitRef="USD">23220</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2019-08-30_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember"
      decimals="0"
      unitRef="USD">550000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2019-09-04_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember"
      decimals="0"
      unitRef="USD">550000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:LegalFees
      contextRef="From2019-09-032019-09-04_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember"
      decimals="0"
      unitRef="USD">5000</us-gaap:LegalFees>
    <PPCB:DiligenceFees
      contextRef="From2019-09-032019-09-04_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember"
      decimals="0"
      unitRef="USD">40000</PPCB:DiligenceFees>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="From2019-09-032019-09-04_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember"
      decimals="0"
      unitRef="USD">505000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:DebtInstrumentMaturityDate contextRef="From2019-08-292019-08-30_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember">2020-08-30</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2019-08-30_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember"
      decimals="INF"
      unitRef="Pure">0.10</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentUnamortizedPremium
      contextRef="AsOf2019-08-30_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember"
      decimals="0"
      unitRef="USD">366667</us-gaap:DebtInstrumentUnamortizedPremium>
    <PPCB:DebtInstrumentDebtDefaultInterestRate
      contextRef="From2019-08-292019-08-30_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember"
      decimals="INF"
      unitRef="Pure">0.24</PPCB:DebtInstrumentDebtDefaultInterestRate>
    <PPCB:PercentageOfOutstandingSharesOfCommonStock
      contextRef="From2019-08-292019-08-30_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember"
      decimals="INF"
      unitRef="Pure">1.25</PPCB:PercentageOfOutstandingSharesOfCommonStock>
    <PPCB:DebtInstrumentDebtDefaultInterestRate
      contextRef="From2019-08-292019-08-30_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember"
      decimals="INF"
      unitRef="Pure">0.24</PPCB:DebtInstrumentDebtDefaultInterestRate>
    <us-gaap:DebtInstrumentDescription contextRef="From2019-08-292019-08-30_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember">Upon the holder&#x2019;s election to convert accrued
interest, default interest or any penalty amounts as stipulated, the Company may elect to pay those amounts in cash. The note may also
be prepaid by the Company at any time between the date of issuance and August 13, 2020 at 135% multiplied by the sum of (a) the then
outstanding principal amount plus (b) accrued and unpaid interest plus (c) default interests</us-gaap:DebtInstrumentDescription>
    <us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
      contextRef="From2019-09-032019-09-04_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember"
      decimals="INF"
      unitRef="Pure">0.60</us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger>
    <PPCB:PercentageOfOutstandingSharesOfCommonStock
      contextRef="From2019-09-032019-09-04_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember"
      decimals="INF"
      unitRef="Pure">0.0499</PPCB:PercentageOfOutstandingSharesOfCommonStock>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2019-08-30_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember_custom_FirstWarrantMember"
      decimals="INF"
      unitRef="Shares">450</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2019-08-30_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember_custom_FirstWarrantMember"
      decimals="INF"
      unitRef="USDPShares">2250</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2019-08-30_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember_custom_SecondWarrantMember"
      decimals="INF"
      unitRef="Shares">300</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2019-08-30_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember_custom_SecondWarrantMember"
      decimals="INF"
      unitRef="USDPShares">3330</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2019-08-30_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember_custom_ThirdWarrantMember"
      decimals="INF"
      unitRef="Shares">225</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2019-08-30_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember_custom_ThirdWarrantMember"
      decimals="INF"
      unitRef="USDPShares">4500</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <PPCB:PercentageOfOutstandingSharesOfCommonStock
      contextRef="From2019-07-012020-06-30_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember"
      decimals="INF"
      unitRef="Pure">0.0499</PPCB:PercentageOfOutstandingSharesOfCommonStock>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2019-08-292019-08-30_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember"
      decimals="0"
      unitRef="USD">375905</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="AsOf2020-06-30_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember"
      decimals="0"
      unitRef="USD">486</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:DebtConversionConvertedInstrumentAmount1
      contextRef="From2019-07-012020-06-30_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember"
      decimals="0"
      unitRef="USD">191035</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="AsOf2020-06-30_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember"
      decimals="0"
      unitRef="USD">43176</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:DebtInstrumentUnamortizedPremium
      contextRef="AsOf2020-06-30_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember"
      decimals="0"
      unitRef="USD">127356</us-gaap:DebtInstrumentUnamortizedPremium>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2021-06-30_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember"
      decimals="0"
      unitRef="USD">32848</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="AsOf2021-06-30_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember"
      decimals="0"
      unitRef="USD">0</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:DebtConversionConvertedInstrumentAmount1
      contextRef="From2020-07-012021-06-30_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember"
      decimals="0"
      unitRef="USD">326117</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <PPCB:DebtConversionConvertedInterestPayable
      contextRef="From2020-07-012021-06-30_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember"
      decimals="0"
      unitRef="USD">39536</PPCB:DebtConversionConvertedInterestPayable>
    <us-gaap:DebtInstrumentUnamortizedPremium
      contextRef="AsOf2021-06-30_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember"
      decimals="0"
      unitRef="USD">217411</us-gaap:DebtInstrumentUnamortizedPremium>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2019-10-02_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember_custom_OctoberOneTwoThousandNineteenAuctusNoteMember"
      decimals="0"
      unitRef="USD">131000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentPeriodicPaymentPrincipal
      contextRef="From2019-09-292019-10-02_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember_custom_OctoberOneTwoThousandNineteenAuctusNoteMember"
      decimals="0"
      unitRef="USD">6000</us-gaap:DebtInstrumentPeriodicPaymentPrincipal>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="From2019-09-292019-10-02_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember_custom_OctoberOneTwoThousandNineteenAuctusNoteMember"
      decimals="0"
      unitRef="USD">125000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:DebtInstrumentMaturityDate contextRef="From2019-09-292019-10-02_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember_custom_OctoberOneTwoThousandNineteenAuctusNoteMember">2020-10-01</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2019-10-02_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember_custom_OctoberOneTwoThousandNineteenAuctusNoteMember"
      decimals="INF"
      unitRef="Pure">0.08</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2020-12-10_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember_custom_DecemberTenTwoThousandTwentyGWNoteMember"
      decimals="0"
      unitRef="USD">131000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentPeriodicPaymentPrincipal
      contextRef="From2020-12-092020-12-10_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember_custom_DecemberTenTwoThousandTwentyGWNoteMember"
      decimals="0"
      unitRef="USD">6000</us-gaap:DebtInstrumentPeriodicPaymentPrincipal>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="From2020-12-092020-12-10_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember_custom_DecemberTenTwoThousandTwentyGWNoteMember"
      decimals="0"
      unitRef="USD">125000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:DebtInstrumentMaturityDate contextRef="From2020-12-092020-12-10_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember_custom_DecemberTenTwoThousandTwentyGWNoteMember">2021-12-10</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2020-12-10_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember_custom_DecemberTenTwoThousandTwentyGWNoteMember"
      decimals="INF"
      unitRef="Pure">0.08</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <PPCB:DebtInstrumentDebtDefaultInterestRate
      contextRef="From2020-12-092020-12-10_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember_custom_DecemberTenTwoThousandTwentyGWNoteMember"
      decimals="INF"
      unitRef="Pure">0.24</PPCB:DebtInstrumentDebtDefaultInterestRate>
    <PPCB:DebtInstrumentDebtDefaultInterestRate
      contextRef="From2020-12-092020-12-10_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember_custom_DecemberTenTwoThousandTwentyGWNoteMember_srt_MinimumMember"
      decimals="INF"
      unitRef="Pure">1.10</PPCB:DebtInstrumentDebtDefaultInterestRate>
    <PPCB:DebtInstrumentDebtDefaultInterestRate
      contextRef="From2020-12-092020-12-10_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember_custom_DecemberTenTwoThousandTwentyGWNoteMember_srt_MaximumMember"
      decimals="INF"
      unitRef="Pure">1.50</PPCB:DebtInstrumentDebtDefaultInterestRate>
    <PPCB:PercentageOfOutstandingSharesOfCommonStock
      contextRef="From2020-12-092020-12-10_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember_custom_DecemberTenTwoThousandTwentyGWNoteMember"
      decimals="INF"
      unitRef="Pure">0.0499</PPCB:PercentageOfOutstandingSharesOfCommonStock>
    <us-gaap:DebtInstrumentUnamortizedPremium
      contextRef="AsOf2020-12-10_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember_custom_DecemberTenTwoThousandTwentyGWNoteMember"
      decimals="0"
      unitRef="USD">174666</us-gaap:DebtInstrumentUnamortizedPremium>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2020-06-30_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember_custom_OctoberOneTwoThousandNineteenAuctusNoteMember"
      decimals="0"
      unitRef="USD">30000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="AsOf2020-06-30_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember_custom_OctoberOneTwoThousandNineteenAuctusNoteMember"
      decimals="0"
      unitRef="USD">1776</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2020-06-30_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember"
      decimals="0"
      unitRef="USD">101000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="AsOf2020-06-30_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember"
      decimals="0"
      unitRef="USD">5082</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:ConvertibleNotesPayable
      contextRef="AsOf2020-06-30_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember"
      decimals="0"
      unitRef="USD">0</us-gaap:ConvertibleNotesPayable>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2021-06-30_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember_custom_OctoberOneTwoThousandNineteenAuctusNoteMember"
      decimals="0"
      unitRef="USD">30000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="AsOf2021-06-30_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember_custom_OctoberOneTwoThousandNineteenAuctusNoteMember"
      decimals="0"
      unitRef="USD">3877</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:DebtInstrumentUnamortizedPremium
      contextRef="AsOf2020-06-30_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember"
      decimals="0"
      unitRef="USD">67333</us-gaap:DebtInstrumentUnamortizedPremium>
    <us-gaap:DebtInstrumentUnamortizedPremium
      contextRef="AsOf2021-06-30_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember"
      decimals="0"
      unitRef="USD">20000</us-gaap:DebtInstrumentUnamortizedPremium>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2021-06-30_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember_custom_DecemberTenTwoThousandTwentyGWNoteMember"
      decimals="0"
      unitRef="USD">90000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="AsOf2020-06-30_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember_custom_DecemberTenTwoThousandTwentyGWNoteMember"
      decimals="0"
      unitRef="USD">4636</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2020-06-30_custom_SecuritiesPurchaseAgreementMember_custom_DecemberTenTwoThousandTwentyGWNoteMember"
      decimals="0"
      unitRef="USD">41000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="AsOf2021-06-30_custom_SecuritiesPurchaseAgreementMember_custom_DecemberTenTwoThousandTwentyGWNoteMember"
      decimals="0"
      unitRef="USD">1084</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:DebtInstrumentUnamortizedPremium
      contextRef="AsOf2021-06-30_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember_custom_OctoberOneTwoThousandNineteenAuctusNoteMember"
      decimals="0"
      unitRef="USD">27333</us-gaap:DebtInstrumentUnamortizedPremium>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2019-10-03_custom_SecuritiesPurchaseAgreementMember_custom_CrownBridgePartnersLLCMember_custom_OctoberThreeTwoThousandNineteenAuctusNoteMember"
      decimals="0"
      unitRef="USD">108000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentPeriodicPaymentPrincipal
      contextRef="From2019-10-012019-10-03_custom_SecuritiesPurchaseAgreementMember_custom_CrownBridgePartnersLLCMember_custom_OctoberThreeTwoThousandNineteenAuctusNoteMember"
      decimals="0"
      unitRef="USD">3000</us-gaap:DebtInstrumentPeriodicPaymentPrincipal>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="AsOf2019-10-03_custom_SecuritiesPurchaseAgreementMember_custom_CrownBridgePartnersLLCMember_custom_OctoberThreeTwoThousandNineteenAuctusNoteMember"
      decimals="0"
      unitRef="USD">5000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="From2019-10-012019-10-03_custom_SecuritiesPurchaseAgreementMember_custom_CrownBridgePartnersLLCMember_custom_OctoberThreeTwoThousandNineteenAuctusNoteMember"
      decimals="0"
      unitRef="USD">100000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:DebtInstrumentMaturityDate contextRef="From2019-10-012019-10-03_custom_SecuritiesPurchaseAgreementMember_custom_CrownBridgePartnersLLCMember_custom_OctoberThreeTwoThousandNineteenAuctusNoteMember">2019-10-03</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2019-10-03_custom_SecuritiesPurchaseAgreementMember_custom_CrownBridgePartnersLLCMember_custom_OctoberThreeTwoThousandNineteenAuctusNoteMember"
      decimals="INF"
      unitRef="Pure">0.10</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <PPCB:DebtInstrumentDebtDefaultInterestRate
      contextRef="From2019-10-012019-10-03_custom_SecuritiesPurchaseAgreementMember_custom_CrownBridgePartnersLLCMember_custom_OctoberThreeTwoThousandNineteenAuctusNoteMember_srt_MinimumMember"
      decimals="INF"
      unitRef="Pure">1.10</PPCB:DebtInstrumentDebtDefaultInterestRate>
    <PPCB:DebtInstrumentDebtDefaultInterestRate
      contextRef="From2019-10-012019-10-03_custom_SecuritiesPurchaseAgreementMember_custom_CrownBridgePartnersLLCMember_custom_OctoberThreeTwoThousandNineteenAuctusNoteMember_srt_MaximumMember"
      decimals="INF"
      unitRef="Pure">1.50</PPCB:DebtInstrumentDebtDefaultInterestRate>
    <PPCB:PercentageOfOutstandingSharesOfCommonStock
      contextRef="From2019-10-012019-10-03_custom_SecuritiesPurchaseAgreementMember_custom_CrownBridgePartnersLLCMember_custom_OctoberThreeTwoThousandNineteenAuctusNoteMember_srt_MinimumMember"
      decimals="INF"
      unitRef="Pure">0.0499</PPCB:PercentageOfOutstandingSharesOfCommonStock>
    <PPCB:PercentageOfOutstandingSharesOfCommonStock
      contextRef="From2019-10-012019-10-03_custom_SecuritiesPurchaseAgreementMember_custom_CrownBridgePartnersLLCMember_custom_OctoberThreeTwoThousandNineteenAuctusNoteMember_srt_MaximumMember"
      decimals="INF"
      unitRef="Pure">0.0999</PPCB:PercentageOfOutstandingSharesOfCommonStock>
    <us-gaap:DebtInstrumentUnamortizedPremium
      contextRef="AsOf2019-10-03_custom_SecuritiesPurchaseAgreementMember_custom_CrownBridgePartnersLLCMember_custom_OctoberThreeTwoThousandNineteenAuctusNoteMember"
      decimals="0"
      unitRef="USD">72000</us-gaap:DebtInstrumentUnamortizedPremium>
    <PPCB:DebtInstrumentDebtDefaultInterestRate
      contextRef="From2019-10-012019-10-03_custom_SecuritiesPurchaseAgreementMember_custom_CrownBridgePartnersLLCMember_custom_OctoberThreeTwoThousandNineteenAuctusNoteMember"
      decimals="INF"
      unitRef="Pure">0.15</PPCB:DebtInstrumentDebtDefaultInterestRate>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2020-06-30_custom_SecuritiesPurchaseAgreementMember_custom_CrownBridgePartnersLLCMember_custom_OctoberThreeTwoThousandNineteenAuctusNoteMember"
      decimals="0"
      unitRef="USD">65280</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="AsOf2020-06-30_custom_SecuritiesPurchaseAgreementMember_custom_CrownBridgePartnersLLCMember_custom_OctoberThreeTwoThousandNineteenAuctusNoteMember"
      decimals="0"
      unitRef="USD">7232</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:DebtConversionConvertedInstrumentAmount1
      contextRef="From2019-07-012020-06-30_custom_SecuritiesPurchaseAgreementMember_custom_CrownBridgePartnersLLCMember_custom_OctoberThreeTwoThousandNineteenAuctusNoteMember"
      decimals="0"
      unitRef="USD">42720</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <us-gaap:DebtInstrumentUnamortizedPremium
      contextRef="AsOf2020-06-30_custom_SecuritiesPurchaseAgreementMember_custom_CrownBridgePartnersLLCMember_custom_OctoberThreeTwoThousandNineteenAuctusNoteMember"
      decimals="0"
      unitRef="USD">28480</us-gaap:DebtInstrumentUnamortizedPremium>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2021-06-30_custom_SecuritiesPurchaseAgreementMember_custom_CrownBridgePartnersLLCMember_custom_OctoberThreeTwoThousandNineteenAuctusNoteMember"
      decimals="0"
      unitRef="USD">65280</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="AsOf2021-06-30_custom_SecuritiesPurchaseAgreementMember_custom_CrownBridgePartnersLLCMember_custom_OctoberThreeTwoThousandNineteenAuctusNoteMember"
      decimals="0"
      unitRef="USD">16138</us-gaap:InterestPayableCurrentAndNoncurrent>
    <PPCB:UnissuedSharesConversion
      contextRef="From2020-09-152020-09-16_custom_SecuritiesPurchaseAgreementMember_custom_CrownBridgePartnersLLCMember"
      decimals="INF"
      unitRef="Shares">15000</PPCB:UnissuedSharesConversion>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2020-11-30_custom_SecuritiesPurchaseAgreementMember_custom_CrownBridgePartnersLLCMember"
      decimals="0"
      unitRef="USD">9600</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentUnamortizedPremium
      contextRef="AsOf2020-11-30_custom_SecuritiesPurchaseAgreementMember_custom_CrownBridgePartnersLLCMember"
      decimals="0"
      unitRef="USD">6400</us-gaap:DebtInstrumentUnamortizedPremium>
    <PPCB:DueToEquityConversion
      contextRef="AsOf2020-11-30_custom_SecuritiesPurchaseAgreementMember_custom_CrownBridgePartnersLLCMember"
      decimals="0"
      unitRef="USD">16000</PPCB:DueToEquityConversion>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2020-01-13_custom_SecuritiesPurchaseAgreementMember_custom_JanuaryThirteenTwentyTwentyAderAlefNoteMember"
      decimals="0"
      unitRef="USD">110250</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="AsOf2020-01-13_custom_SecuritiesPurchaseAgreementMember_custom_JanuaryThirteenTwentyTwentyAderAlefNoteMember"
      decimals="0"
      unitRef="USD">5250</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:LegalFees
      contextRef="From2020-01-122020-01-13_custom_SecuritiesPurchaseAgreementMember_custom_JanuaryThirteenTwentyTwentyAderAlefNoteMember"
      decimals="0"
      unitRef="USD">5000</us-gaap:LegalFees>
    <us-gaap:DebtConversionConvertedInstrumentAmount1
      contextRef="From2020-01-122020-01-13_custom_SecuritiesPurchaseAgreementMember_custom_JanuaryThirteenTwentyTwentyAderAlefNoteMember"
      decimals="0"
      unitRef="USD">100000</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <us-gaap:DebtInstrumentMaturityDate contextRef="From2020-01-122020-01-13_custom_SecuritiesPurchaseAgreementMember_custom_JanuaryThirteenTwentyTwentyAderAlefNoteMember">2020-01-13</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2020-01-13_custom_SecuritiesPurchaseAgreementMember_custom_JanuaryThirteenTwentyTwentyAderAlefNoteMember"
      decimals="INF"
      unitRef="Pure">0.08</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <PPCB:DebtInstrumentDebtDefaultInterestRate
      contextRef="From2020-01-122020-01-13_custom_SecuritiesPurchaseAgreementMember_custom_JanuaryThirteenTwentyTwentyAderAlefNoteMember_srt_MinimumMember"
      decimals="INF"
      unitRef="Pure">1.20</PPCB:DebtInstrumentDebtDefaultInterestRate>
    <PPCB:DebtInstrumentDebtDefaultInterestRate
      contextRef="From2020-01-122020-01-13_custom_SecuritiesPurchaseAgreementMember_custom_JanuaryThirteenTwentyTwentyAderAlefNoteMember_srt_MaximumMember"
      decimals="INF"
      unitRef="Pure">1.50</PPCB:DebtInstrumentDebtDefaultInterestRate>
    <us-gaap:DebtInstrumentDescription contextRef="From2020-01-122020-01-13_custom_SecuritiesPurchaseAgreementMember_custom_JanuaryThirteenTwentyTwentyAderAlefNoteMember_srt_MinimumMember">The
conversion price for the January 13, 2020 Ader Alef Note during the first 6 months the January 13, 2020 Ader Alef Note was fixed at $2.50
and thereafter would be equal to a 35% discount of the lowest closing bid price (&#x201c;Lowest Trading Price&#x201d;) of the Common Stock
for the ten trading days immediately prior to the delivery of a Notice of Conversion, including the day upon which a Notice of Conversion
was received. Notwithstanding the foregoing, Ader Alef was restricted from effecting a conversion if such conversion, along with other
shares of the Company&#x2019;s common stock beneficially owned by Ader Alef and its affiliates, exceeds 4.99% of the outstanding shares
of the Company&#x2019;s common stock which may be increased up to 9.99% upon 60 days prior written notice by the Ader Alef to the Company.</us-gaap:DebtInstrumentDescription>
    <us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
      contextRef="From2020-01-122020-01-13_custom_SecuritiesPurchaseAgreementMember_custom_JanuaryThirteenTwentyTwentyAderAlefNoteMember_srt_MinimumMember"
      decimals="INF"
      unitRef="Pure">0.35</us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger>
    <PPCB:PercentageOfOutstandingSharesOfCommonStock
      contextRef="From2020-01-122020-01-13_custom_SecuritiesPurchaseAgreementMember_custom_JanuaryThirteenTwentyTwentyAderAlefNoteMember_srt_MinimumMember"
      decimals="INF"
      unitRef="Pure">0.0499</PPCB:PercentageOfOutstandingSharesOfCommonStock>
    <PPCB:PercentageOfOutstandingSharesOfCommonStock
      contextRef="From2020-01-122020-01-13_custom_SecuritiesPurchaseAgreementMember_custom_JanuaryThirteenTwentyTwentyAderAlefNoteMember_srt_MaximumMember"
      decimals="INF"
      unitRef="Pure">0.0999</PPCB:PercentageOfOutstandingSharesOfCommonStock>
    <us-gaap:DebtInstrumentUnamortizedPremium
      contextRef="AsOf2021-06-30_custom_SecuritiesPurchaseAgreementMember_custom_JanuaryThirteenTwentyTwentyAderAlefNoteMember"
      decimals="0"
      unitRef="USD">59365</us-gaap:DebtInstrumentUnamortizedPremium>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2020-06-30_custom_SecuritiesPurchaseAgreementMember_custom_JanuaryThirteenTwentyTwentyAderAlefNoteMember"
      decimals="0"
      unitRef="USD">110250</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="AsOf2020-06-30_custom_SecuritiesPurchaseAgreementMember_custom_JanuaryThirteenTwentyTwentyAderAlefNoteMember"
      decimals="0"
      unitRef="USD">4073</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2021-06-30_custom_SecuritiesPurchaseAgreementMember_custom_JanuaryThirteenTwentyTwentyAderAlefNoteMember"
      decimals="0"
      unitRef="USD">0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="AsOf2021-06-30_custom_SecuritiesPurchaseAgreementMember_custom_JanuaryThirteenTwentyTwentyAderAlefNoteMember"
      decimals="0"
      unitRef="USD">0</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:DebtConversionConvertedInstrumentAmount1
      contextRef="From2020-07-012021-06-30_custom_SecuritiesPurchaseAgreementMember_custom_JanuaryThirteenTwentyTwentyAderAlefNoteMember"
      decimals="0"
      unitRef="USD">110250</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <PPCB:DebtConversionConvertedInterestPayable
      contextRef="From2020-07-012021-06-30_custom_SecuritiesPurchaseAgreementMember_custom_JanuaryThirteenTwentyTwentyAderAlefNoteMember"
      decimals="0"
      unitRef="USD">7493</PPCB:DebtConversionConvertedInterestPayable>
    <us-gaap:DebtInstrumentUnamortizedPremium
      contextRef="AsOf2021-06-30_custom_SecuritiesPurchaseAgreementMember_custom_JanuaryThirteenTwentyTwentyAderAlefNoteMember"
      decimals="0"
      unitRef="USD">59365</us-gaap:DebtInstrumentUnamortizedPremium>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2020-02-19_custom_SecuritiesPurchaseAgreementMember_custom_FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember_custom_LGCapitalFundingLLCMember"
      decimals="0"
      unitRef="USD">75000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="AsOf2020-02-19_custom_SecuritiesPurchaseAgreementMember_custom_FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember_custom_LGCapitalFundingLLCMember"
      decimals="0"
      unitRef="USD">3750</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:LegalFees
      contextRef="From2020-02-182020-02-19_custom_SecuritiesPurchaseAgreementMember_custom_FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember_custom_LGCapitalFundingLLCMember"
      decimals="0"
      unitRef="USD">2500</us-gaap:LegalFees>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="From2020-03-242020-03-25_custom_SecuritiesPurchaseAgreementMember_custom_FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember_custom_LGCapitalFundingLLCMember"
      decimals="0"
      unitRef="USD">71250</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:DebtInstrumentMaturityDate contextRef="From2020-02-182020-02-19_custom_SecuritiesPurchaseAgreementMember_custom_FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember_custom_LGCapitalFundingLLCMember">2021-02-19</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2020-02-19_custom_SecuritiesPurchaseAgreementMember_custom_FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember_custom_LGCapitalFundingLLCMember"
      decimals="INF"
      unitRef="Pure">0.08</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <PPCB:DebtInstrumentDebtDefaultInterestRate
      contextRef="From2020-02-182020-02-19_custom_SecuritiesPurchaseAgreementMember_custom_FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember_custom_LGCapitalFundingLLCMember_srt_MinimumMember"
      decimals="INF"
      unitRef="Pure">1.12</PPCB:DebtInstrumentDebtDefaultInterestRate>
    <PPCB:DebtInstrumentDebtDefaultInterestRate
      contextRef="From2020-02-182020-02-19_custom_SecuritiesPurchaseAgreementMember_custom_FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember_custom_LGCapitalFundingLLCMember_srt_MaximumMember"
      decimals="INF"
      unitRef="Pure">1.35</PPCB:DebtInstrumentDebtDefaultInterestRate>
    <us-gaap:DebtInstrumentDescription contextRef="From2020-02-182020-02-19_custom_SecuritiesPurchaseAgreementMember_custom_FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember_custom_LGCapitalFundingLLCMember_srt_MinimumMember">The
conversion price for the February 19, 2020 LG Capital Note during the first 6 months the February 19, 2020 LG Capital Note was fixed
at $500 and thereafter was equal to a 35% discount of the lowest closing bid price (&#x201c;Lowest Trading Price&#x201d;) of the Common
Stock for the ten trading days immediately prior to the delivery of a Notice of Conversion, including the day upon which a Notice of
Conversion was received. Notwithstanding the foregoing, LG Capital was restricted from effecting a conversion if such conversion, along
with other shares of the Company&#x2019;s common stock beneficially owned by LG Capital and its affiliates, exceeds 9.99% of the outstanding
shares of the Company&#x2019;s common stock.</us-gaap:DebtInstrumentDescription>
    <PPCB:PercentageOfOutstandingSharesOfCommonStock
      contextRef="From2020-02-182020-02-19_custom_SecuritiesPurchaseAgreementMember_custom_FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember_custom_LGCapitalFundingLLCMember_srt_MinimumMember"
      decimals="INF"
      unitRef="Pure">9.99</PPCB:PercentageOfOutstandingSharesOfCommonStock>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="AsOf2020-02-19_custom_SecuritiesPurchaseAgreementMember_custom_LGCapitalFundingLLCMember"
      decimals="0"
      unitRef="USD">40385</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
      contextRef="From2020-02-182020-02-19_custom_SecuritiesPurchaseAgreementMember_custom_FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember_custom_LGCapitalFundingLLCMember"
      decimals="INF"
      unitRef="Pure">0.24</us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2020-06-30_custom_SecuritiesPurchaseAgreementMember_custom_FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember_custom_LGCapitalFundingLLCMember"
      decimals="0"
      unitRef="USD">75000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="AsOf2020-06-30_custom_SecuritiesPurchaseAgreementMember_custom_FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember_custom_LGCapitalFundingLLCMember"
      decimals="0"
      unitRef="USD">2164</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2021-06-30_custom_SecuritiesPurchaseAgreementMember_custom_FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember_custom_LGCapitalFundingLLCMember"
      decimals="0"
      unitRef="USD">0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="AsOf2021-06-30_custom_SecuritiesPurchaseAgreementMember_custom_FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember_custom_LGCapitalFundingLLCMember"
      decimals="0"
      unitRef="USD">0</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:DebtConversionConvertedInstrumentAmount1
      contextRef="From2020-07-012021-06-30_custom_SecuritiesPurchaseAgreementMember_custom_FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember_custom_LGCapitalFundingLLCMember"
      decimals="0"
      unitRef="USD">75000</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <PPCB:DebtConversionConvertedInterestPayable
      contextRef="From2020-07-012021-06-30_custom_SecuritiesPurchaseAgreementMember_custom_FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember_custom_LGCapitalFundingLLCMember"
      decimals="0"
      unitRef="USD">5421</PPCB:DebtConversionConvertedInterestPayable>
    <us-gaap:DebtInstrumentUnamortizedPremium
      contextRef="AsOf2021-06-30_custom_SecuritiesPurchaseAgreementMember_custom_FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember_custom_LGCapitalFundingLLCMember"
      decimals="0"
      unitRef="USD">40385</us-gaap:DebtInstrumentUnamortizedPremium>
    <PPCB:UnissuedSharesConversion
      contextRef="From2020-09-082020-09-09_custom_SecuritiesPurchaseAgreementMember_custom_LGCapitalFundingLLCMember"
      decimals="INF"
      unitRef="Shares">9427</PPCB:UnissuedSharesConversion>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2020-11-30_custom_SecuritiesPurchaseAgreementMember_custom_LGCapitalFundingLLCMember"
      decimals="0"
      unitRef="USD">10000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtConversionConvertedInstrumentAmount1
      contextRef="From2020-11-292020-11-30_custom_SecuritiesPurchaseAgreementMember_custom_LGCapitalFundingLLCMember"
      decimals="0"
      unitRef="USD">416</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <us-gaap:DebtInstrumentUnamortizedPremium
      contextRef="AsOf2020-11-30_custom_SecuritiesPurchaseAgreementMember_custom_LGCapitalFundingLLCMember"
      decimals="0"
      unitRef="USD">5385</us-gaap:DebtInstrumentUnamortizedPremium>
    <PPCB:DueToEquityConversion
      contextRef="AsOf2020-11-30_custom_SecuritiesPurchaseAgreementMember_custom_LGCapitalFundingLLCMember"
      decimals="0"
      unitRef="USD">15801</PPCB:DueToEquityConversion>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2020-12-02_custom_SecuritiesPurchaseAgreementMember_custom_DecemberTwoTwoThousandTwentyGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember"
      decimals="0"
      unitRef="USD">78000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="AsOf2020-12-02_custom_SecuritiesPurchaseAgreementMember_custom_DecemberTwoTwoThousandTwentyGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember"
      decimals="0"
      unitRef="USD">3000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2020-12-02_custom_SecuritiesPurchaseAgreementMember_custom_DecemberTwoTwoThousandTwentyGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember"
      decimals="INF"
      unitRef="Pure">0.08</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2021-01-05_custom_SecuritiesPurchaseAgreementMember_custom_JanuaryFiveTwoThousandTwentyOneGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember"
      decimals="0"
      unitRef="USD">68500</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtConversionOriginalDebtAmount1
      contextRef="From2021-01-042021-01-05_custom_SecuritiesPurchaseAgreementMember_custom_JanuaryFiveTwoThousandTwentyOneGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember"
      decimals="0"
      unitRef="USD">3500</us-gaap:DebtConversionOriginalDebtAmount1>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2021-01-05_custom_SecuritiesPurchaseAgreementMember_custom_JanuaryFiveTwoThousandTwentyOneGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember"
      decimals="INF"
      unitRef="Pure">0.08</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentMaturityDate contextRef="From2021-01-042021-01-05_custom_SecuritiesPurchaseAgreementMember_custom_JanuaryFiveTwoThousandTwentyOneGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember">2021-01-05</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2021-03-16_custom_SecuritiesPurchaseAgreementMember_custom_MarchSixteenTwoThousandTwentyOneGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember"
      decimals="0"
      unitRef="USD">63500</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtConversionOriginalDebtAmount1
      contextRef="From2021-03-132021-03-16_custom_SecuritiesPurchaseAgreementMember_custom_MarchSixteenTwoThousandTwentyOneGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember"
      decimals="0"
      unitRef="USD">3500</us-gaap:DebtConversionOriginalDebtAmount1>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2021-01-05_custom_SecuritiesPurchaseAgreementMember_custom_MarchSixteenTwoThousandTwentyOneGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember"
      decimals="INF"
      unitRef="Pure">0.08</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentMaturityDate contextRef="From2021-01-032021-01-05_custom_SecuritiesPurchaseAgreementMember_custom_MarchSixteenTwoThousandTwentyOneGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember">2021-03-16</us-gaap:DebtInstrumentMaturityDate>
    <PPCB:DebtInstrumentDebtDefaultInterestRate
      contextRef="From2020-12-012020-12-02_custom_SecuritiesPurchaseAgreementMember_custom_DecemberTwoTwoThousandTwentyGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember_srt_MinimumMember"
      decimals="INF"
      unitRef="Pure">1.10</PPCB:DebtInstrumentDebtDefaultInterestRate>
    <PPCB:DebtInstrumentDebtDefaultInterestRate
      contextRef="From2020-12-012020-12-02_custom_SecuritiesPurchaseAgreementMember_custom_DecemberTwoTwoThousandTwentyGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember_srt_MaximumMember"
      decimals="INF"
      unitRef="Pure">1.29</PPCB:DebtInstrumentDebtDefaultInterestRate>
    <us-gaap:DebtInstrumentDescription contextRef="From2020-12-012020-12-02_custom_SecuritiesPurchaseAgreementMember_custom_DecemberTwoTwoThousandTwentyGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember_srt_MinimumMember">The
conversion price for the above Geneva Roth notes shall be equal to a</us-gaap:DebtInstrumentDescription>
    <PPCB:DebtInstrumentDebtDefaultInterestRate
      contextRef="From2020-12-012020-12-02_custom_SecuritiesPurchaseAgreementMember_custom_DecemberTwoTwoThousandTwentyGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember"
      decimals="INF"
      unitRef="Pure">0.35</PPCB:DebtInstrumentDebtDefaultInterestRate>
    <PPCB:PercentageOfOutstandingSharesOfCommonStock
      contextRef="From2020-12-012020-12-02_custom_SecuritiesPurchaseAgreementMember_custom_DecemberTwoTwoThousandTwentyGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember_srt_MinimumMember"
      decimals="INF"
      unitRef="Pure">0.0999</PPCB:PercentageOfOutstandingSharesOfCommonStock>
    <us-gaap:DebtInstrumentUnamortizedPremium
      contextRef="AsOf2020-12-02_custom_SecuritiesPurchaseAgreementMember_custom_DecemberTwoTwoThousandTwentyGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember"
      decimals="0"
      unitRef="USD">113077</us-gaap:DebtInstrumentUnamortizedPremium>
    <PPCB:DebtDefaultAmountPercentage
      contextRef="From2020-12-012020-12-02_custom_SecuritiesPurchaseAgreementMember_custom_DecemberTwoTwoThousandTwentyGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember"
      decimals="INF"
      unitRef="Pure">0.22</PPCB:DebtDefaultAmountPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2021-06-30_custom_SecuritiesPurchaseAgreementMember_custom_DecemberTwoTwoThousandTwentyGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember"
      decimals="0"
      unitRef="USD">132000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="AsOf2021-06-30_custom_SecuritiesPurchaseAgreementMember_custom_DecemberTwoTwoThousandTwentyGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember"
      decimals="0"
      unitRef="USD">3477</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2021-06-30_custom_SecuritiesPurchaseAgreementMember_custom_DecemberTwoTwoThousandTwentyGenevaRothMember"
      decimals="0"
      unitRef="USD">78000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="AsOf2021-06-30_custom_SecuritiesPurchaseAgreementMember_custom_DecemberTwoTwoThousandTwentyGenevaRothMember"
      decimals="0"
      unitRef="USD">3120</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:DebtInstrumentUnamortizedPremium
      contextRef="AsOf2021-06-30_custom_SecuritiesPurchaseAgreementMember_custom_DecemberTwoTwoThousandTwentyGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember"
      decimals="0"
      unitRef="USD">42000</us-gaap:DebtInstrumentUnamortizedPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="From2020-07-012021-06-30_custom_SecuritiesPurchaseAgreementMember"
      decimals="0"
      unitRef="USD">211000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="From2019-07-012020-06-30_custom_SecuritiesPurchaseAgreementMember"
      decimals="0"
      unitRef="USD">728904</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="AsOf2021-06-30_custom_SecuritiesPurchaseAgreementMember"
      decimals="0"
      unitRef="USD">498160</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="AsOf2020-06-30_custom_SecuritiesPurchaseAgreementMember"
      decimals="0"
      unitRef="USD">836724</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">136527</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">734130</us-gaap:AmortizationOfDebtDiscountPremium>
    <PPCB:ReclassifiedPremiumAmountForAdditionalPaidInCapital
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">590504</PPCB:ReclassifiedPremiumAmountForAdditionalPaidInCapital>
    <PPCB:ReclassifiedPremiumAmountForAdditionalPaidInCapital
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">874924</PPCB:ReclassifiedPremiumAmountForAdditionalPaidInCapital>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="From2020-07-012021-06-30">&lt;p id="xdx_804_eus-gaap--IncomeTaxDisclosureTextBlock_zoUNBWa6TWf9" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;NOTE
7 &#x2013; &lt;span id="xdx_82A_zUnPb5Jodezk"&gt;INCOME TAXES&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;The
Company follows ASC 740-10-10, under which an entity recognizes deferred tax assets and liabilities for future tax consequences or for
events that were previously recognized in the Company&#x2019;s financial statements or tax returns. The measurement of deferred tax assets
and liabilities is based on enacted tax law provisions. The effects of future changes in tax laws or rates are not anticipated. Through
June 30, 2010, the Company operated exclusively in Australia. The Company was wholly subject to Australian income tax laws and regulations,
which are administered by the Australian Taxation Office for the years ended June 30, 2010 and all prior years.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;On
November 23, 2010, the Company was incorporated in the state of Delaware. In January 2011, the Company acquired all of the outstanding
shares of Propanc PTY LTD on a one-for-one basis with Propanc PTY LTD becoming a wholly owned subsidiary of the Company. As a result
of these transactions, the Company is subject to the income tax laws of both the United States and Australia for the years ended June
30, 2013 through June 30, 2021.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_898_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zq6pSYl2gst8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;The
reconciliation of income tax expense computed at the U.S. federal statutory rate of &lt;span id="xdx_903_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPercentage_c20200701__20210630_zcMFKyG8phE7" title="Income tax percentage"&gt;&lt;span id="xdx_901_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPercentage_c20190701__20200630_zdBxwBfsNkA" title="Income tax percentage"&gt;21&lt;/span&gt;&lt;/span&gt;% to the income tax provision for the years ended
June 30, 2021 and 2020 is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 8.5pt Segoe UI,sans-serif; margin: 0"&gt;&lt;span id="xdx_8B8_zxxl79r3HSs9" style="display: none"&gt;SCHEDULE OF INCOME TAX PROVISION&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"/&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;US&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20200701__20210630__srt--StatementGeographicalAxis__country--US_zSgCEesLAXfb" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;June
    30, 2021&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49A_20190701__20200630__srt--StatementGeographicalAxis__country--US_zYj9eqzE26Te" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;June
    30, 2020&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;Year
    Ended&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;US&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;June
    30, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;June
    30, 2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_pp0p0_zhUJF5Fi5dNi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Loss
    before Income taxes&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;(2,025,947&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;(4,740,723&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_maITEBzOQe_zIU9tqeaUh9g" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Taxes
    under statutory US tax rates&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;(425,449&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;(995,552&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_maITEBzOQe_z4vI3oRSIpf9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Increase
    (decrease) in valuation allowance&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;1,146,001&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;1,137,716&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--IncomeTaxReconciliationPriorYearIncomeTaxes_maITEBzOQe_z9iQbvGBkZa1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Prior
    period adjustment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;(1,063,710&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;(14,624&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--IncomeTaxReconciliationForeignIncomeTaxRateDifferential_maITEBzOQe_z3kFZI11ojl9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Foreign
    tax rate differential&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;(51,169&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;(128,492&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--IncomeTaxReconciliationTaxCredits_pp0p0_msITEBzOQe_znRgF8OODJA7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Income
    tax rate change&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;392,767&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1703"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--IncomeTaxReconciliationOtherAdjustments_maITEBzOQe_zLHrjdfb1Frc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Other&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;1,559&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;952&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--IncomeTaxExpenseBenefit_iT_pp0p0_mtITEBzOQe_z8TaVF0Tk2Ql" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Income
    tax (expense) benefit&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1708"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1709"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A8_zxLluA1MdAzc" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company reflects a tax benefit on its consolidated
statement of operations and comprehensive income (loss) in 2021 and 2020 of $&lt;span id="xdx_900_eus-gaap--IncomeTaxExpenseBenefit_iN_pp0p0_di_c20200701__20210630_znGelqCjITDb" title="Tax benefit"&gt;113,415&lt;/span&gt; and $&lt;span id="xdx_90B_eus-gaap--IncomeTaxExpenseBenefit_iN_pp0p0_di_c20190701__20200630_zQTSIGKwbRte" title="Tax benefit"&gt;134,728&lt;/span&gt;, respectively. These amounts are research
and development tax credits and are not considered income tax.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On March 27, 2020, the Coronavirus Aid, Relief, and
Economic Security Act (CARES Act) was enacted in response to the COVID-19 pandemic. &lt;span id="xdx_901_eus-gaap--IncomeTaxExaminationDescription_c20200324__20200327__us-gaap--TypeOfArrangementAxis__custom--CaresActMember_zNICMqUmmFHe"&gt;The
CARES Act, among other things, permits NOL carryovers and carrybacks to offset 100% of taxable income for taxable years beginning before
2021.&lt;/span&gt; In addition, the CARES Act allows NOLs incurred in 2018, 2019, and 2020 to be carried back to each of the five preceding
taxable years to generate a refund of previously paid income taxes. The Company is currently evaluating the impact of the CARES Act,
but due to sustained losses, the NOL carryback provision of the CARES Act would not yield a benefit to us.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Deferred
income taxes reflect the net tax effects of temporary differences between the carrying amount of assets and liabilities for financial
reporting purposes and amounts used for income tax purposes. Significant components of the Company&#x2019;s deferred tax assets and liabilities
consist of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89E_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zV4ys0tVWbi4" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8BF_zUvJ23zA4ce2" style="display: none"&gt;SCHEDULE
OF DEFERRED TAX ASSETS AND LIABILITIES&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"/&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_493_20210630_zA7OqSLxk0rh" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;June
    30, 2021&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49F_20200630_z2u0FqruVlw1" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;June
    30, 2020&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;Year
    Ended&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;June
    30, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;June
    30, 2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;Deferred
    tax assets&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--DeferredTaxAssetsWarrantDerivativeLiability_iI_pp0p0_maDTAGzhU3_zsIM3aiSPan3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Warrant
    Derivative Liability&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;7,403&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;7,403&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_iI_pp0p0_maDTAGzhU3_z39v0JmmRzgh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Accrued
    Expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;342,464&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;297,086&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--DeferredTaxAssetsPrepaidInvestorServices_iI_pp0p0_maDTAGzhU3_zs5z5qnLjCR7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Prepaid
    Investor Services&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;444,411&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;470,050&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--DeferredTaxAssetsNonCashInterest_iI_pp0p0_maDTAGzhU3_zbruP5l38mra" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Non-cash
    interest&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;687,529&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;596,004&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--DeferredTaxAssetsGoodwillAndIntangibleAssets_iI_pp0p0_maDTAGzhU3_z1IjbyuZlJNf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Intangibles
    (Intellectual Property and Patent Cost)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;259,743&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;240,428&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent_iI_pp0p0_maDTAGzhU3_zlAyguQLKql9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Deferred
    Rent&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;4,262&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;1,969&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseOther_iI_pp0p0_maDTAGzhU3_zh29TakOlpN8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Formation
    Expense&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;6,815&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;7,208&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_pp0p0_maDTAGzhU3_zeN7NzTpnym2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Net
    Operating Loss CF&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;8,546,920&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;7,438,911&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--DeferredTaxAssetsForeignExchangeLoss_iI_pp0p0_maDTAGzhU3_znhJOjUBv9zc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Foreign
    Exchange Loss (OCI)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;(39,379&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;(39,379&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--DeferredTaxAssetsRevalueOfDerivativeLiability_iI_pp0p0_maDTAGzhU3_z2qrS8FEmXae" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Revalue
    of derivative liability&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;439,958&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;438,239&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_iI_pp0p0_maDTAGzhU3_zUq5QwOWluRd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Stock
    Based Compensation&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;51,481&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;51,481&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--DeferredTaxAssetsGross_iTI_pp0p0_mtDTAGzhU3_maDTANz51B_zSomKbWDzIM8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Total
    Deferred tax assets&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;10,751,607&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;9,509,400&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;Deferred
    tax liabilities&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts_iNI_pp0p0_di_maDITLzdtb_zrJP4gkoj7Ib" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;R&amp;amp;D&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;(197,604&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;(177,702&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--DeferredTaxLiabilitiesGainOnExtinguishmentOfDebt_iNI_pp0p0_di_maDITLzdtb_zSyJS2MFsJx6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Gain
    on extinguishment of debt&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;(277,614&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;266,987&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts_iNI_pp0p0_di_maDITLzdtb_zTEacSOpGxXe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Capital
    Raising Costs&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;(321,291&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;(255,614&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--DeferredIncomeTaxLiabilities_iNTI_pp0p0_di_mtDITLzdtb_msDTANz51B_zaDntMXslQF1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Total
    deferred tax liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;(796,509&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;(700,303&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--DeferredTaxAssetsNet_iI_pp0p0_mtDTANz51B_maDTALNzVhZ_z8gpYprBgWF3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Net
    deferred tax assets (liabilities)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;9,955,098&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;8,809,097&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pp0p0_di_msDTALNzVhZ_zTERLOTkxohh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;Valuation
    allowance&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(9,955,098&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;(8,809,097&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iI_pp0p0_mtDTALNzVhZ_z2rv3BpLnS55" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Net
    deferred tax assets (liabilities)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1772"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1773"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8AF_zEoqAdIPi3cg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;PROPANC
BIOPHARMA, INC. AND SUBSIDIARY&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;June
30, 2021 and 2020&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;At
June 30, 2021, the Company had U.S. net operating loss carry forwards of approximately $&lt;span id="xdx_90E_eus-gaap--OperatingLossCarryforwards_iI_pp0p0_c20210630__srt--StatementGeographicalAxis__country--US_zdRpmeX2B4Qf" title="Operating loss carryforwards"&gt;9,588,164
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;that may be offset against future
taxable income, subject to limitation under IRC Section 382. Of the approximately $&lt;span id="xdx_90A_eus-gaap--OperatingLossCarryforwards_iI_pn5n6_c20210630_zh6iGyk4E8y9" title="Operating loss carryforwards"&gt;9.6&lt;/span&gt; million of net operating loss carryforwards,
$&lt;span id="xdx_909_eus-gaap--OperatingLossCarryforwards_iI_pn5n6_c20210630__srt--StatementGeographicalAxis__country--AU__us-gaap--AwardDateAxis__custom--ExpireInTwoThousandTwentyFourMember_zxpXGaxwDpd" title="Operating loss carryforwards"&gt;7.2&lt;/span&gt; million will begin to expire in 2024 and the remaining $&lt;span id="xdx_900_eus-gaap--OperatingLossCarryforwards_iI_pn5n6_c20210630__srt--StatementGeographicalAxis__country--AU__us-gaap--AwardDateAxis__custom--NotExpireMember_zRbswM7wiVji" title="Operating loss carryforwards"&gt;2.4&lt;/span&gt; million will not expire. The Australian tax rate changed from &lt;span id="xdx_900_eus-gaap--EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_pid_dp_uPure_c20190701__20200630__srt--StatementGeographicalAxis__country--AU_zSSPzGJCVrOg" title="Income tax rate"&gt;27.5%&lt;/span&gt;
in 2020 to &lt;span id="xdx_908_eus-gaap--EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_pid_dp_uPure_c20200701__20210630__srt--StatementGeographicalAxis__country--AU_z6upJzuySn75" title="Income tax rate"&gt;26%&lt;/span&gt; in 2021. At June 30, 2021, the Company had Australia net operating loss carry forwards of approximately $&lt;span id="xdx_90F_eus-gaap--OperatingLossCarryforwards_iI_pp0p0_c20210630__srt--StatementGeographicalAxis__country--AU_zqz2R2gp0G7g" title="Operating loss carryforwards"&gt;25,128,485
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;million which can be carried forward
without expiration. &lt;span id="xdx_906_eus-gaap--IncomeTaxExpenseBenefit_pp0p0_do_c20200701__20210630__srt--StatementGeographicalAxis__country--AU_zff6aukiG5Ok"&gt;No
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;tax benefit has been reported in
the June 30, 2021 and 2020 consolidated financial statements due to the uncertainty surrounding the realizability of the benefit, based
on a more likely than not criteria and in consideration of available positive and negative evidence.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;The
Company applied the &#x201c;more-likely-than-not&#x201d; recognition threshold to all tax positions taken or expected to be taken in a
tax return, which resulted in &lt;span id="xdx_906_eus-gaap--UnrecognizedTaxBenefits_iI_pp0p0_do_c20210630_zJwGyOocuSw3" title="Unrecognized tax benefits"&gt;&lt;span id="xdx_90D_eus-gaap--UnrecognizedTaxBenefits_iI_pp0p0_do_c20200630_zaRtA0qtsLuh" title="Unrecognized tax benefits"&gt;no&lt;/span&gt;&lt;/span&gt; unrecognized tax benefits as of June 30, 2021 and 2020, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Management
has determined that the realization of the net deferred tax asset is not assured and has created a valuation allowance for the entire
amount of such benefits.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;The
Company follows ASC 740-10, which provides guidance for the recognition and measurement of certain tax positions in an enterprise&#x2019;s
financial statements. Recognition involves a determination whether it is more likely than not that a tax position will be sustained upon
examination with the presumption that the tax position will be examined by the appropriate taxing authority having full knowledge of
all relevant information.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;The
Company applied the &#x201c;more-likely-than-not&#x201d; recognition threshold to all tax positions taken or expected to be taken in a
tax return, which resulted in no unrecognized tax benefits as of June 30, 2021 and 2020, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;The
Company&#x2019;s policy is to record interest and penalties associated with unrecognized tax benefits as additional income taxes in the
consolidated statement of operations. As of June 30, 2021, the Company had &lt;span id="xdx_90C_eus-gaap--UnrecognizedTaxBenefits_iI_pp0p0_do_c20210630_zfYqiygoEkHf" title="Unrecognized tax benefits"&gt;no&lt;/span&gt; unrecognized tax benefits. There were &lt;span id="xdx_90F_eus-gaap--UnrecognizedTaxBenefitsPeriodIncreaseDecrease_pp0p0_do_c20200701__20210630_zINZpCkISgag" title="Changes in unrecognized tax benefits"&gt;&lt;span id="xdx_90A_eus-gaap--UnrecognizedTaxBenefitsPeriodIncreaseDecrease_pp0p0_do_c20190701__20200630_zNM4b7ULrCc5" title="Changes in unrecognized tax benefits"&gt;no&lt;/span&gt;&lt;/span&gt; changes in the
Company&#x2019;s unrecognized tax benefits during the years ended June 30, 2021 and 2020. The Company did not recognize any interest or
penalties during fiscal 2021 or 2020 related to unrecognized tax benefits.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;The
income tax returns filed for the tax years from inception will be subject to examination by the relevant taxing authorities.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock contextRef="From2020-07-012021-06-30">&lt;p id="xdx_898_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zq6pSYl2gst8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;The
reconciliation of income tax expense computed at the U.S. federal statutory rate of &lt;span id="xdx_903_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPercentage_c20200701__20210630_zcMFKyG8phE7" title="Income tax percentage"&gt;&lt;span id="xdx_901_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPercentage_c20190701__20200630_zdBxwBfsNkA" title="Income tax percentage"&gt;21&lt;/span&gt;&lt;/span&gt;% to the income tax provision for the years ended
June 30, 2021 and 2020 is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 8.5pt Segoe UI,sans-serif; margin: 0"&gt;&lt;span id="xdx_8B8_zxxl79r3HSs9" style="display: none"&gt;SCHEDULE OF INCOME TAX PROVISION&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"/&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;US&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20200701__20210630__srt--StatementGeographicalAxis__country--US_zSgCEesLAXfb" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;June
    30, 2021&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49A_20190701__20200630__srt--StatementGeographicalAxis__country--US_zYj9eqzE26Te" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;June
    30, 2020&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;Year
    Ended&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;US&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;June
    30, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;June
    30, 2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_pp0p0_zhUJF5Fi5dNi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Loss
    before Income taxes&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;(2,025,947&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;(4,740,723&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_maITEBzOQe_zIU9tqeaUh9g" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Taxes
    under statutory US tax rates&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;(425,449&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;(995,552&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_maITEBzOQe_z4vI3oRSIpf9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Increase
    (decrease) in valuation allowance&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;1,146,001&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;1,137,716&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--IncomeTaxReconciliationPriorYearIncomeTaxes_maITEBzOQe_z9iQbvGBkZa1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Prior
    period adjustment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;(1,063,710&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;(14,624&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--IncomeTaxReconciliationForeignIncomeTaxRateDifferential_maITEBzOQe_z3kFZI11ojl9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Foreign
    tax rate differential&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;(51,169&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;(128,492&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--IncomeTaxReconciliationTaxCredits_pp0p0_msITEBzOQe_znRgF8OODJA7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Income
    tax rate change&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;392,767&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1703"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--IncomeTaxReconciliationOtherAdjustments_maITEBzOQe_zLHrjdfb1Frc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Other&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;1,559&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;952&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--IncomeTaxExpenseBenefit_iT_pp0p0_mtITEBzOQe_z8TaVF0Tk2Ql" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Income
    tax (expense) benefit&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1708"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1709"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="From2020-07-012021-06-30_country_US"
      decimals="0"
      unitRef="USD">-2025947</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="From2019-07-012020-06-30_country_US"
      decimals="0"
      unitRef="USD">-4740723</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="From2020-07-012021-06-30_country_US"
      decimals="0"
      unitRef="USD">-425449</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="From2019-07-012020-06-30_country_US"
      decimals="0"
      unitRef="USD">-995552</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="From2020-07-012021-06-30_country_US"
      decimals="0"
      unitRef="USD">1146001</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="From2019-07-012020-06-30_country_US"
      decimals="0"
      unitRef="USD">1137716</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes
      contextRef="From2020-07-012021-06-30_country_US"
      decimals="0"
      unitRef="USD">-1063710</us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes
      contextRef="From2019-07-012020-06-30_country_US"
      decimals="0"
      unitRef="USD">-14624</us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential
      contextRef="From2020-07-012021-06-30_country_US"
      decimals="0"
      unitRef="USD">-51169</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential
      contextRef="From2019-07-012020-06-30_country_US"
      decimals="0"
      unitRef="USD">-128492</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationTaxCredits
      contextRef="From2020-07-012021-06-30_country_US"
      decimals="0"
      unitRef="USD">392767</us-gaap:IncomeTaxReconciliationTaxCredits>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="From2020-07-012021-06-30_country_US"
      decimals="0"
      unitRef="USD">1559</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="From2019-07-012020-06-30_country_US"
      decimals="0"
      unitRef="USD">952</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">-113415</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">-134728</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExaminationDescription contextRef="From2020-03-242020-03-27_custom_CaresActMember">The
CARES Act, among other things, permits NOL carryovers and carrybacks to offset 100% of taxable income for taxable years beginning before
2021.</us-gaap:IncomeTaxExaminationDescription>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="From2020-07-012021-06-30">&lt;p id="xdx_89E_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zV4ys0tVWbi4" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8BF_zUvJ23zA4ce2" style="display: none"&gt;SCHEDULE
OF DEFERRED TAX ASSETS AND LIABILITIES&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"/&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_493_20210630_zA7OqSLxk0rh" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;June
    30, 2021&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49F_20200630_z2u0FqruVlw1" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;June
    30, 2020&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;Year
    Ended&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;June
    30, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;June
    30, 2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;Deferred
    tax assets&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--DeferredTaxAssetsWarrantDerivativeLiability_iI_pp0p0_maDTAGzhU3_zsIM3aiSPan3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Warrant
    Derivative Liability&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;7,403&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;7,403&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_iI_pp0p0_maDTAGzhU3_z39v0JmmRzgh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Accrued
    Expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;342,464&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;297,086&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--DeferredTaxAssetsPrepaidInvestorServices_iI_pp0p0_maDTAGzhU3_zs5z5qnLjCR7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Prepaid
    Investor Services&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;444,411&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;470,050&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--DeferredTaxAssetsNonCashInterest_iI_pp0p0_maDTAGzhU3_zbruP5l38mra" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Non-cash
    interest&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;687,529&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;596,004&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--DeferredTaxAssetsGoodwillAndIntangibleAssets_iI_pp0p0_maDTAGzhU3_z1IjbyuZlJNf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Intangibles
    (Intellectual Property and Patent Cost)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;259,743&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;240,428&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent_iI_pp0p0_maDTAGzhU3_zlAyguQLKql9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Deferred
    Rent&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;4,262&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;1,969&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseOther_iI_pp0p0_maDTAGzhU3_zh29TakOlpN8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Formation
    Expense&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;6,815&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;7,208&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_pp0p0_maDTAGzhU3_zeN7NzTpnym2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Net
    Operating Loss CF&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;8,546,920&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;7,438,911&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--DeferredTaxAssetsForeignExchangeLoss_iI_pp0p0_maDTAGzhU3_znhJOjUBv9zc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Foreign
    Exchange Loss (OCI)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;(39,379&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;(39,379&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--DeferredTaxAssetsRevalueOfDerivativeLiability_iI_pp0p0_maDTAGzhU3_z2qrS8FEmXae" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Revalue
    of derivative liability&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;439,958&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;438,239&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_iI_pp0p0_maDTAGzhU3_zUq5QwOWluRd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Stock
    Based Compensation&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;51,481&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;51,481&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--DeferredTaxAssetsGross_iTI_pp0p0_mtDTAGzhU3_maDTANz51B_zSomKbWDzIM8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Total
    Deferred tax assets&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;10,751,607&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;9,509,400&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;Deferred
    tax liabilities&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts_iNI_pp0p0_di_maDITLzdtb_zrJP4gkoj7Ib" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;R&amp;amp;D&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;(197,604&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;(177,702&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--DeferredTaxLiabilitiesGainOnExtinguishmentOfDebt_iNI_pp0p0_di_maDITLzdtb_zSyJS2MFsJx6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Gain
    on extinguishment of debt&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;(277,614&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;266,987&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts_iNI_pp0p0_di_maDITLzdtb_zTEacSOpGxXe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Capital
    Raising Costs&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;(321,291&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;(255,614&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--DeferredIncomeTaxLiabilities_iNTI_pp0p0_di_mtDITLzdtb_msDTANz51B_zaDntMXslQF1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Total
    deferred tax liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;(796,509&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;(700,303&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--DeferredTaxAssetsNet_iI_pp0p0_mtDTANz51B_maDTALNzVhZ_z8gpYprBgWF3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Net
    deferred tax assets (liabilities)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;9,955,098&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;8,809,097&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pp0p0_di_msDTALNzVhZ_zTERLOTkxohh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;Valuation
    allowance&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(9,955,098&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;(8,809,097&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iI_pp0p0_mtDTALNzVhZ_z2rv3BpLnS55" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Net
    deferred tax assets (liabilities)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1772"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1773"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <PPCB:DeferredTaxAssetsWarrantDerivativeLiability contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">7403</PPCB:DeferredTaxAssetsWarrantDerivativeLiability>
    <PPCB:DeferredTaxAssetsWarrantDerivativeLiability contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">7403</PPCB:DeferredTaxAssetsWarrantDerivativeLiability>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">342464</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">297086</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities>
    <PPCB:DeferredTaxAssetsPrepaidInvestorServices contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">444411</PPCB:DeferredTaxAssetsPrepaidInvestorServices>
    <PPCB:DeferredTaxAssetsPrepaidInvestorServices contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">470050</PPCB:DeferredTaxAssetsPrepaidInvestorServices>
    <PPCB:DeferredTaxAssetsNonCashInterest contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">687529</PPCB:DeferredTaxAssetsNonCashInterest>
    <PPCB:DeferredTaxAssetsNonCashInterest contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">596004</PPCB:DeferredTaxAssetsNonCashInterest>
    <us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">259743</us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets>
    <us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">240428</us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">4262</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">1969</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">6815</us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">7208</us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">8546920</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">7438911</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <PPCB:DeferredTaxAssetsForeignExchangeLoss contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">-39379</PPCB:DeferredTaxAssetsForeignExchangeLoss>
    <PPCB:DeferredTaxAssetsForeignExchangeLoss contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">-39379</PPCB:DeferredTaxAssetsForeignExchangeLoss>
    <PPCB:DeferredTaxAssetsRevalueOfDerivativeLiability contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">439958</PPCB:DeferredTaxAssetsRevalueOfDerivativeLiability>
    <PPCB:DeferredTaxAssetsRevalueOfDerivativeLiability contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">438239</PPCB:DeferredTaxAssetsRevalueOfDerivativeLiability>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">51481</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">51481</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsGross contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">10751607</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">9509400</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">197604</us-gaap:DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts>
    <us-gaap:DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">177702</us-gaap:DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts>
    <PPCB:DeferredTaxLiabilitiesGainOnExtinguishmentOfDebt contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">277614</PPCB:DeferredTaxLiabilitiesGainOnExtinguishmentOfDebt>
    <PPCB:DeferredTaxLiabilitiesGainOnExtinguishmentOfDebt contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">-266987</PPCB:DeferredTaxLiabilitiesGainOnExtinguishmentOfDebt>
    <us-gaap:DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">321291</us-gaap:DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts>
    <us-gaap:DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">255614</us-gaap:DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts>
    <us-gaap:DeferredIncomeTaxLiabilities contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">796509</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredIncomeTaxLiabilities contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">700303</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredTaxAssetsNet contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">9955098</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">8809097</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">9955098</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">8809097</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:OperatingLossCarryforwards
      contextRef="AsOf2021-06-30_country_US"
      decimals="0"
      unitRef="USD">9588164</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards contextRef="AsOf2021-06-30" decimals="-5" unitRef="USD">9600000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="AsOf2021-06-30_country_AU_custom_ExpireInTwoThousandTwentyFourMember"
      decimals="-5"
      unitRef="USD">7200000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="AsOf2021-06-30_country_AU_custom_NotExpireMember"
      decimals="-5"
      unitRef="USD">2400000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="From2019-07-012020-06-30_country_AU"
      decimals="INF"
      unitRef="Pure">0.275</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="From2020-07-012021-06-30_country_AU"
      decimals="INF"
      unitRef="Pure">0.26</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:OperatingLossCarryforwards
      contextRef="AsOf2021-06-30_country_AU"
      decimals="0"
      unitRef="USD">25128485</us-gaap:OperatingLossCarryforwards>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2020-07-012021-06-30_country_AU"
      decimals="0"
      unitRef="USD">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:UnrecognizedTaxBenefits contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">0</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">0</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">0</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsPeriodIncreaseDecrease
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">0</us-gaap:UnrecognizedTaxBenefitsPeriodIncreaseDecrease>
    <us-gaap:UnrecognizedTaxBenefitsPeriodIncreaseDecrease
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">0</us-gaap:UnrecognizedTaxBenefitsPeriodIncreaseDecrease>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="From2020-07-012021-06-30">&lt;p id="xdx_80A_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zDofS11dMtob" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;NOTE
8 &#x2013; &lt;span id="xdx_823_zpbrRbXbhIlk"&gt;STOCKHOLDERS&#x2019; DEFICIT&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;span style="text-decoration: underline"&gt;Increase
in Authorized Shares of Common Stock and Reverse Stock Split&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;On
February 4, 2020 the Directors resolved to increase the Common Stock of the Company from &lt;span id="xdx_90B_eus-gaap--CommonStockSharesAuthorized_iI_c20210203_zEdsVrHBv7C5"&gt;100,000,000&lt;/span&gt; authorized shares to &lt;span id="xdx_90B_eus-gaap--CommonStockSharesAuthorized_c20210204_pdd" title="Common stock, shares authorized"&gt;1,000,000,000&lt;/span&gt;
authorized shares and believes that such number of authorized shares of Common Stock will be in the best interests of the Corporation
and its stockholders because the Board believes that the availability of more shares of Common Stock for issuance will allow the Corporation
greater flexibility in pursuing financing from investors, meeting business needs as they arise, taking advantage of favorable opportunities
and responding to a changing corporate environment. The Company filed the necessary documents with the U.S. Securities and Exchange Commission
on February 6, 2020 and with the amendment to the authorized shares being approved by the State of Delaware on March 13, 2020.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;On
November 17, 2020, the Company effected a &lt;span id="xdx_903_eus-gaap--StockholdersEquityReverseStockSplit_c20201116__20201117_zemL0lZyxZzf" title="Reverse stock split"&gt;one-for-one thousand (1:1,000)&lt;/span&gt; reverse stock split of the Company&#x2019;s issued and outstanding
shares of common stock (the &#x201c;Reverse Stock Split&#x201d;). Proportional adjustments for the Reverse Stock Split were made to the
Company&#x2019;s outstanding stock options, warrants and equity incentive plans. All share and per-share data and amounts have been retroactively
adjusted as of the earliest period presented in the consolidated financial statements to reflect the Reverse Stock Split.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;&lt;span style="text-decoration: underline"&gt;Preferred
Stock&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;The
total number of shares of preferred stock that the Company is authorized to issue is &lt;span id="xdx_905_eus-gaap--PreferredStockSharesAuthorized_c20210630_pdd" title="Preferred stock, shares authorized"&gt;1,500,005&lt;/span&gt;, $&lt;span id="xdx_90D_eus-gaap--PreferredStockParOrStatedValuePerShare_c20210630_pdd" title="Preferred stock, par value"&gt;0.01&lt;/span&gt; par value per share. These preferred
shares have no rights to dividends, profit sharing or liquidation preferences.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Of
the total preferred shares authorized, &lt;span title="Preferred stock, shares authorized"&gt;&lt;span id="xdx_90A_eus-gaap--PreferredStockSharesAuthorized_iI_c20200630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_z8qZZXLoGcSc"&gt;500,000&lt;/span&gt;&lt;/span&gt; have been designated as Series A Preferred Stock (&#x201c;Series A Preferred Stock&#x201d;),
pursuant to the Certificate of Designation filed with the Secretary of State of the State of Delaware on December 9, 2014. James Nathanielsz,
the Company&#x2019;s Chief Executive Officer and Chief Financial Officer, beneficially owns all of the outstanding shares of Series A
Preferred Stock via North Horizon Pty Ltd., which entitles him, as a holder of Series A Preferred Stock, to vote on all matters submitted
or required to be submitted to a vote of the Company&#x2019;s stockholders, except election and removal of directors, and each share of
Series A Preferred Stock entitles him to two votes per share of Series A Preferred Stock. North Horizon Pty Ltd. is a Nathanielsz Family
Trust. Mr. James Nathanielsz, the Chief Executive Officer, Chief Financial Officer and a director of our Company, has voting and investment
power over these shares. &lt;span id="xdx_902_eus-gaap--PreferredStockSharesIssued_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_pdd" title="Preferred stock, shares issued"&gt;&lt;span id="xdx_903_eus-gaap--PreferredStockSharesOutstanding_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_pdd" title="Preferred stock, shares outstanding"&gt;&lt;span id="xdx_903_eus-gaap--PreferredStockSharesIssued_c20200630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_pdd" title="Preferred stock, shares issued"&gt;&lt;span id="xdx_900_eus-gaap--PreferredStockSharesOutstanding_c20200630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_pdd" title="Preferred stock, shares outstanding"&gt;500,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt; shares of Series A Preferred Stock are issued and outstanding as of June 30, 2021 and 2020.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 29.15pt; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;PROPANC
BIOPHARMA, INC. AND SUBSIDIARY&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;June
30, 2021 and 2020&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Of
the total preferred shares authorized, pursuant to the Certificate of Designation filed with the Secretary of State of the State of Delaware
on June 16, 2015, up to five shares have been designated as Series B Preferred Stock (&#x201c;Series B Preferred Stock&#x201d;). Each holder
of outstanding shares of Series B Preferred Stock is entitled to voting power equivalent to the number of votes equal to the total number
of shares of common stock outstanding as of the record date for the determination of stockholders entitled to vote at each meeting of
stockholders of the Company and entitled to vote on all matters submitted or required to be submitted to a vote of the stockholders of
the Company. One share of Series B Preferred Stock is issued and outstanding as of June 30, 2021 and 2020. Mr. Nathanielsz directly beneficially
owns such one share of Series B Preferred Stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;No
additional shares of Series A Preferred Stock or Series B Preferred Stock were issued during fiscal year 2021 and 2020.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;&lt;span style="text-decoration: underline"&gt;Common
Stock&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;&lt;i&gt;Shares
Issued for Cash&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;April
3, 2020 Security Purchase Agreement&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;On
April 3, 2020, &lt;span id="xdx_906_ecustom--EquityPurchaseAgreementDescription_c20200402__20200403__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember_zQzJVOXLplV2" title="Equity purchase agreement description"&gt;the Company closed on a transaction related to a Securities Purchase Agreement (the &#x201c;Securities Purchase Agreement&#x201d;)
entered into on March 30, 2020, whereby an investor (the &#x201c;Investor&#x201d;) purchased from the Company, 7,500 units (the &#x201c;Units&#x201d;),
each consisting of (i) 1.5 shares of the Company&#x2019;s common stock (the &#x201c;Common Stock&#x201d;), or pre-funded warrants (the &#x201c;Prefunded
Warrants&#x201d;) upon Investor&#x2019;s election due to the 4.99% blocker provision as discussed below and (ii) 1.5 warrants to purchase
one share of Common Stock (&#x201c;Series A Warrants&#x201d;, and collectively with the Common Stock the &#x201c;Units&#x201d;).&lt;/span&gt; In addition
to the Units, the Investor was issued &lt;span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20200403__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantsMember_zAKVh0VFqBm3" title="Warrants to purchase common stock"&gt;63,750&lt;/span&gt; warrants to purchase one share of Common Stock (the &#x201c;Series B Warrants&#x201d;) and
an additional &lt;span id="xdx_901_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20200403__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesCWarrantsMember_zkeWadLtjJzb" title="Warrants to purchase common stock"&gt;63,750&lt;/span&gt; warrants to purchase one share of Common Stock, subject to a vesting schedule (the &#x201c;Series C Warrants&#x201d;
and, together with the Prefunded Warrants, the Series A Warrants, and the Series B Warrants, the &#x201c;Warrants&#x201d;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;The
aggregate purchase price for the Units, the Series A Warrants with exercise price of $&lt;span id="xdx_906_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20200403__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAWarrantsMember_znkv22AGeQF4" title="Warrant exercise price"&gt;200&lt;/span&gt; per share, the Series B Warrants with exercise
price of $&lt;span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20200403__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantsMember_zXFlRpOohsQb" title="Warrant exercise price"&gt;40&lt;/span&gt; per share and the Series C Warrants with exercise price of $&lt;span id="xdx_901_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20200403__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesCWarrantsMember_z3yErjs5iHs1" title="Warrant exercise price"&gt;200&lt;/span&gt; per share, of $&lt;span id="xdx_90B_eus-gaap--FairValueAdjustmentOfWarrants_pp0p0_c20200402__20200403__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember_zM1MkBaMIzA7" title="Fair value of warrants"&gt;450,000&lt;/span&gt; was paid at closing (the &#x201c;Purchase
Price&#x201d;) or $60 per unit purchase price (see Warrants below). The Company received net proceeds of $&lt;span id="xdx_90F_eus-gaap--ProceedsFromIssuanceOfWarrants_pp0p0_c20200402__20200403__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember_zmZ6AYE7zrkc" title="Proceeds from warrants"&gt;424,990&lt;/span&gt;, net of offering cost
of $&lt;span id="xdx_902_eus-gaap--PaymentsOfStockIssuanceCosts_pp0p0_c20200402__20200403__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember_zxXzHfOERk2c" title="Offering cost"&gt;25,010&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;The
Securities Purchase Agreement contains a blocker provision whereby the Investor or any of its affiliates would not beneficially own in
excess of &lt;span id="xdx_90B_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pip0_dp_uPure_c20200403__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember_zkqEarGzUfz1"&gt;4.99%&lt;/span&gt; of the outstanding number of shares of Common Stock (&#x201c;Beneficial Ownership Limitation&#x201d;). As such, the Investor
may elect to purchase Prefunded Warrants equal to the same number of shares of Common Stock that the Company would have been issued.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Due
to the Beneficial Ownership Limitation, the &lt;span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20200402__20200403__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zc2NonDYiGfg" title="Common stock issued during period"&gt;11,250&lt;/span&gt; shares of Common Stock underlying the Units issuable at closing of the Securities
Purchase Agreement are comprised of &lt;span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20200402__20200403__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zzfgAYHtABF6" title="Number of restricted stock, shares"&gt;804&lt;/span&gt; shares of restricted Common Stock and &lt;span id="xdx_90C_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20200403__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantsMember_zurG6NZFHGPh" title="Warrants to purchase common stock"&gt;10,446&lt;/span&gt; Prefunded Warrants with exercise price of $&lt;span id="xdx_901_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20200403__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantsMember_zPeBk9AvUOvi" title="Warrant exercise price"&gt;1&lt;/span&gt; (but
can be less than par value). The Prefunded Warrants shall be exercisable immediately and shall expire when exercised in full.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;The
Securities Purchase Agreement contains such representations, warranties and covenants as are typical for a transaction of this nature.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;&lt;i&gt;Shares
issued for conversion of convertible debt&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;During
the year ended June 30, 2020, the Company issued &lt;span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20190701__20200630__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember_zF1o74Iatpdl" title="Common stock issued during period"&gt;247,619&lt;/span&gt; shares of its common stock at an average contractual conversion price of $&lt;span id="xdx_90F_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20200630__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember_zRu1BOZ7gFLl" title="Conversion price"&gt;7&lt;/span&gt;,
ranging from $&lt;span id="xdx_902_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20200630__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember__srt--RangeAxis__srt--MinimumMember_zdk4IkfmLyK4" title="Conversion price"&gt;2&lt;/span&gt; to $&lt;span id="xdx_90E_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20200630__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember__srt--RangeAxis__srt--MaximumMember_zTsXQm3Owsbb" title="Conversion price"&gt;910&lt;/span&gt;, as a result of the conversion of principal and interest in the aggregate amount of $&lt;span id="xdx_90D_eus-gaap--DebtConversionConvertedInstrumentAmount1_pp0p0_c20190701__20200630__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember_zEFIa8788IZk" title="Conversion of principal and interest, aggregate amount"&gt;1,814,336&lt;/span&gt; underlying certain
outstanding principal amount and accrued interest of convertible notes converted during such period, including $&lt;span id="xdx_907_ecustom--ConversionFees_pp0p0_c20190701__20200630__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember_z1Y9Y8O4sjIe" title="Conversion fees"&gt;15,000&lt;/span&gt; of conversion
fees. The total recorded to equity was $&lt;span id="xdx_901_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20190701__20200630__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember_z4RbqAqFQ8Q9" title="Proceeds from issuance of common stock"&gt;2,125,174&lt;/span&gt;. Notes with principal amounts totaling $&lt;span id="xdx_902_ecustom--ConversionOptionDerivatives_pp0p0_c20190701__20200630__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember_zzfD8Z4BvkT8" title="Conversion option derivatives"&gt;254,500&lt;/span&gt; and accrued interest of $&lt;span id="xdx_904_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20200630__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember_zhtMhMv9WjYg" title="Accrued interest"&gt;15,408&lt;/span&gt; contained
bifurcated embedded conversion option derivatives. Accordingly, the fair market value of the shares issued was $&lt;span id="xdx_904_ecustom--FairMarketValueOfShares_pp0p0_c20190701__20200630__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember_zsYfcDTrhCIj" title="Fair market value of the shares"&gt;565,746&lt;/span&gt; resulting in
a loss on extinguishment at the time of conversion of $&lt;span id="xdx_90D_eus-gaap--GainsLossesOnExtinguishmentOfDebt_pp0p0_c20190701__20200630__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember_z9JBj30nqpjh" title="Loss on extinguishment"&gt;295,838&lt;/span&gt; and $&lt;span id="xdx_909_eus-gaap--DerivativeFairValueOfDerivativeNet_iI_pp0p0_c20200630__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember_zDo68gcdGz6b" title="Derivative fair value"&gt;362,961&lt;/span&gt; of derivative fair value was recorded as a gain on extinguishment
at the time of conversion. The Company reclassified $&lt;span id="xdx_908_ecustom--PremiumsToAdditionalPaidInCapital_pp0p0_c20190701__20200630__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember_zm2uY8KckkI" title="Premiums to additional paid in capital"&gt;874,924&lt;/span&gt; in put premiums to additional paid in capital following conversions during
the year ended June 30, 2020.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;During
the year ended June 30, 2021, the Company issued an aggregate of &lt;span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20200701__20210630__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember_zzmzgt1k6Urk"&gt;8,786,113&lt;/span&gt; shares of its common stock at an average contractual conversion
price of $&lt;span id="xdx_90F_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20210630__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember_zgi5IUtBLy4g"&gt;0.13&lt;/span&gt;, ranging from $&lt;span id="xdx_909_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20210630__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember__srt--RangeAxis__srt--MinimumMember_zKzl3Q22H2M4"&gt;0.03&lt;/span&gt; to $&lt;span id="xdx_90C_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20210630__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember__srt--RangeAxis__srt--MaximumMember_zQU3yiRITII7"&gt;2.00&lt;/span&gt;, as a result of the conversion of principal of $&lt;span id="xdx_904_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20210630__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember_zawYhep7XYy6"&gt;1,018,867&lt;/span&gt;, interest of $&lt;span id="xdx_901_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20210630__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember_z2PXewyj25Pl"&gt;103,321&lt;/span&gt; and conversion
fees $&lt;span id="xdx_901_ecustom--ConversionFees_pp0p0_c20200701__20210630__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember_z8nwnGzWliC8"&gt;16,500&lt;/span&gt; underlying certain outstanding convertible notes converted during such period. The total recorded to equity was $&lt;span id="xdx_90E_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20200701__20210630__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember_zmLhMoas1V1b"&gt;1,239,075&lt;/span&gt;
prior to the reversal of unissued shares.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;PROPANC
BIOPHARMA, INC. AND SUBSIDIARY&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;June
30, 2021 and 2020&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;There
were &lt;span id="xdx_907_eus-gaap--CommonStockSharesSubscribedButUnissued_iI_c20200930_zvwZepU3XH61" title="Common stock, unissued shares"&gt;24,427&lt;/span&gt; unissued shares which were considered issuable for accounting purposes during the first quarter of fiscal 2021 related to
conversion notices dated and received in September 2020. In November 2020, the Company was notified by the note holder of the cancellation
of these conversion notices and as such the Company reversed the effects of these transactions thereby increasing the principal balance
by $&lt;span id="xdx_90B_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20201130_zpFWBVfZZM3i" title="Convertible debt principal amount"&gt;19,600&lt;/span&gt;, accrued interest of $&lt;span id="xdx_904_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20201130_zbIvfesGMJV" title="Accrued interest"&gt;416&lt;/span&gt; and put premium by $&lt;span id="xdx_902_eus-gaap--DebtInstrumentUnamortizedPremium_iI_pp0p0_c20201130_zjj3Yf2nNPXh" title="Debt premium amount"&gt;11,785&lt;/span&gt; and a corresponding decrease in equity of $&lt;span id="xdx_907_ecustom--DecreaseInEquity_pp0p0_c20201129__20201130_zvj9lkT8srN6" title="Amount of decrease in equity"&gt;31,801&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Converted
notes totaling principal amount of $&lt;span id="xdx_904_eus-gaap--DebtInstrumentFaceAmount_c20210630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_pp0p0"&gt;95,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;and accrued interest of $&lt;span id="xdx_904_eus-gaap--InterestPayableCurrentAndNoncurrent_c20210630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_pp0p0"&gt;3,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;contained bifurcated embedded conversion
option derivatives. Accordingly, the fair market value of the shares issued was $&lt;span id="xdx_90C_ecustom--FairMarketValueOfShares_c20200701__20210630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_pp0p0"&gt;178,368
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;resulting in a loss on extinguishment
at the time of conversion of $&lt;span id="xdx_906_eus-gaap--GainsLossesOnExtinguishmentOfDebt_c20200701__20210630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_pp0p0"&gt;80,368
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;and $&lt;span id="xdx_901_eus-gaap--DerivativeFairValueOfDerivativeNet_c20210630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_pp0p0"&gt;130,975
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;of derivative fair value was recorded
as a gain on extinguishment at the time of conversion.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;The Company reclassified $&lt;span id="xdx_90B_ecustom--PremiumsToAdditionalPaidInCapital_c20200701__20210630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_pp0p0"&gt;590,504
to additional paid in capital following conversions of notes accounted for as stock settled debt during the year ended June 30,
2021.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;The
Company has &lt;span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20200701__20210630__us-gaap--TypeOfArrangementAxis__custom--UnderlyingFinancingAgreementsMember_pdd" title="Common stock issued during period"&gt;197,308,116&lt;/span&gt; shares of its common stock reserved for future issuances based on lender reserve requirements pursuant to underlying
financing agreements at June 30, 2021.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;&lt;i&gt;Shares
issued for services&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;On
July 19, 2019, the Company entered into an agreement with a certain consultant to provide services over a two-month period beginning
July 1, 2019 and ending September 1, 2019 in exchange for 20 shares of the Company&#x2019;s common stock. On July 19, 2019, the Company
issued the &lt;span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20200718__20200719__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember_pdd" title="Common stock issued during period"&gt;20&lt;/span&gt; shares of the Company&#x2019;s common stock valued at $&lt;span id="xdx_90D_eus-gaap--SharesIssuedPricePerShare_c20200719__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember_pdd" title="Share issued price per share"&gt;1,990&lt;/span&gt; per share; being the closing price of the stock on the date
of the agreement, to such consultant, or $&lt;span id="xdx_907_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20200718__20200719__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember_pp0p0" title="Proceeds from issuance of common stock"&gt;39,800&lt;/span&gt;, which will be amortized over the term of the agreement. The Company recorded $&lt;span id="xdx_908_eus-gaap--ProfessionalFees_pp0p0_c20190701__20200630__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember_zskhHC2MpVdj" title="Consulting expenses"&gt;39,800&lt;/span&gt;
of consulting expense with respect to such shares of its common stock during the year ended June 30, 2020.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Between
February 3, 2020 and June 26, 2020, the Company issued an aggregate of &lt;span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20200202__20200203__srt--TitleOfIndividualAxis__custom--ConsultantMember__us-gaap--TypeOfArrangementAxis__custom--EngagementAgreementMember_zud6RckbyAIa" title="Stock issued for services, shares"&gt;&lt;span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20200625__20200626__srt--TitleOfIndividualAxis__custom--ConsultantMember__us-gaap--TypeOfArrangementAxis__custom--EngagementAgreementMember_zKk11bt134m4" title="Stock issued for services, shares"&gt;8,709&lt;/span&gt;&lt;/span&gt; shares of the Company&#x2019;s common stock to a consultant
for services rendered pursuant to an engagement agreement dated on September 10, 2019 which agreement was later amended in February 2020.
Between February 3, 2020 and June 26, 2020, the Company issued an aggregate of &lt;span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20200625__20200626__srt--TitleOfIndividualAxis__custom--ConsultantMember__us-gaap--TypeOfArrangementAxis__custom--EngagementAgreementMember_zS4WwEqgGyM4" title="Stock issued for services, shares"&gt;&lt;span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20200625__20200626__srt--TitleOfIndividualAxis__custom--ConsultantMember__us-gaap--TypeOfArrangementAxis__custom--EngagementAgreementMember_zVCOTLx5ebV9" title="Stock issued for services, shares"&gt;8,709&lt;/span&gt;&lt;/span&gt; shares of the Company&#x2019;s common stock valued
at an average price of $&lt;span id="xdx_904_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20200203__srt--TitleOfIndividualAxis__custom--ConsultantMember__us-gaap--TypeOfArrangementAxis__custom--EngagementAgreementMember_zdjrn0McezL9" title="Common stock, par value"&gt;&lt;span id="xdx_90C_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20200626__srt--TitleOfIndividualAxis__custom--ConsultantMember__us-gaap--TypeOfArrangementAxis__custom--EngagementAgreementMember_zZ8scAbUaK8j" title="Common stock, par value"&gt;8&lt;/span&gt;&lt;/span&gt; per share; being the closing price of the stock on the date of the agreement, to such consultant, or $&lt;span id="xdx_90B_eus-gaap--ProfessionalFees_pp0p0_c20200202__20200203__srt--TitleOfIndividualAxis__custom--ConsultantMember__us-gaap--TypeOfArrangementAxis__custom--EngagementAgreementMember_z1LUHGxWvIdj" title="Consulting expenses"&gt;&lt;span id="xdx_900_eus-gaap--ProfessionalFees_pp0p0_c20200625__20200626__srt--TitleOfIndividualAxis__custom--ConsultantMember__us-gaap--TypeOfArrangementAxis__custom--EngagementAgreementMember_zZrmOY5ch9Nl" title="Consulting expenses"&gt;73,842&lt;/span&gt;&lt;/span&gt;.
The Company recorded $&lt;span id="xdx_903_eus-gaap--ProfessionalFees_pp0p0_c20190701__20200630__srt--TitleOfIndividualAxis__custom--ConsultantMember__us-gaap--TypeOfArrangementAxis__custom--EngagementAgreementMember_zVu3NY8DRQZf" title="Consulting expenses"&gt;73,842&lt;/span&gt; of consulting expense with respect to such shares of its common stock during the year ended June 30, 2020.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;On
March 22, 2021, the Company issued an aggregate of &lt;span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20210321__20210322__srt--TitleOfIndividualAxis__custom--ConsultantMember_zK4ts7pTGyY9" title="Number of shares issued for services"&gt;225,037&lt;/span&gt; shares of the Company&#x2019;s common stock to a consultant for services rendered
from January 1, 2021 to March 22, 2021. The Company issued &lt;span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20200701__20210630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--TitleOfIndividualAxis__custom--ConsultantMember_pdd" title="Number of shares issued for services"&gt;225,037&lt;/span&gt; shares of the Company&#x2019;s common stock valued at $&lt;span id="xdx_90A_eus-gaap--SharesIssuedPricePerShare_c20210630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--TitleOfIndividualAxis__custom--ConsultantMember_pdd" title="Shares issued per price"&gt;0.30&lt;/span&gt; per share,
being the closing price of the stock on the date of grant to such consultant, or $&lt;span id="xdx_908_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_pp0p0_c20200701__20210630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--TitleOfIndividualAxis__custom--ConsultantMember_zhUF8BYRp3Ih" title="Number of shares issued for services, value"&gt;67,511&lt;/span&gt;. The Company recorded $&lt;span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_pp0p0_c20200701__20210630__srt--TitleOfIndividualAxis__custom--ConsultantMember_zvXvgxYc4jF1" title="Number of shares issued for services, value"&gt;67,511&lt;/span&gt; of consulting
expense with respect to such shares of its common stock during the year ended June 30, 2021.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Between
March 2021 and June 2021, the Company issued an aggregate of &lt;span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20210301__20210331__srt--TitleOfIndividualAxis__custom--ConsultantMember__us-gaap--TypeOfArrangementAxis__custom--EngagementAgreementMember_z98v5YphXto8"&gt;&lt;span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20210601__20210630__srt--TitleOfIndividualAxis__custom--ConsultantMember__us-gaap--TypeOfArrangementAxis__custom--EngagementAgreementMember_zjqIXel6tOQ1"&gt;580,609&lt;/span&gt;&lt;/span&gt; shares of the Company&#x2019;s common stock to a consultant for services
rendered from April 1, 2021 to June 30, 2021. The Company issued &lt;span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20210301__20210331__srt--TitleOfIndividualAxis__custom--ConsultantMember__us-gaap--TypeOfArrangementAxis__custom--EngagementAgreementMember_zANCvk6P9mjk"&gt;&lt;span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20210601__20210630__srt--TitleOfIndividualAxis__custom--ConsultantMember__us-gaap--TypeOfArrangementAxis__custom--EngagementAgreementMember_zM5PICi8Ffwh"&gt;580,609&lt;/span&gt;&lt;/span&gt; shares of the Company&#x2019;s common stock valued at $&lt;span id="xdx_90C_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20210331__srt--TitleOfIndividualAxis__custom--ConsultantMember__us-gaap--TypeOfArrangementAxis__custom--EngagementAgreementMember_zl9v7QU8w19l"&gt;&lt;span id="xdx_902_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20210630__srt--TitleOfIndividualAxis__custom--ConsultantMember__us-gaap--TypeOfArrangementAxis__custom--EngagementAgreementMember_zbK4vNipFGil"&gt;0.10&lt;/span&gt;&lt;/span&gt; per
share, being the closing price of the stock on the date of grant to such consultant, or $&lt;span id="xdx_90E_eus-gaap--ProfessionalFees_pp0p0_c20210301__20210331__srt--TitleOfIndividualAxis__custom--ConsultantMember__us-gaap--TypeOfArrangementAxis__custom--EngagementAgreementMember_zTQTvLKYppKh"&gt;&lt;span id="xdx_902_eus-gaap--ProfessionalFees_pp0p0_c20210601__20210630__srt--TitleOfIndividualAxis__custom--ConsultantMember__us-gaap--TypeOfArrangementAxis__custom--EngagementAgreementMember_zqlAs0ioI2c5"&gt;58,061&lt;/span&gt;&lt;/span&gt;. The Company recorded $&lt;span id="xdx_90C_eus-gaap--ProfessionalFees_pp0p0_c20200701__20210630__srt--TitleOfIndividualAxis__custom--ConsultantMember__us-gaap--TypeOfArrangementAxis__custom--EngagementAgreementMember_zPmjyJKaog14"&gt;58,061&lt;/span&gt; of consulting
expense with respect to such shares of its common stock during the year ended June 30, 2021.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;&lt;i&gt;Shares
issued for exercise of warrants&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;During
the year ended June 30, 2021, the Company received aggregate gross proceeds of $&lt;span id="xdx_90D_eus-gaap--ProceedsFromWarrantExercises_c20200701__20210630_pp0p0"&gt;776,044
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;from the exercise of &lt;span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_c20210630__us-gaap--StatementClassOfStockAxis__custom--PrefundedWarrantsMember_pdd"&gt;10,445
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;prefunded warrants and &lt;span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_c20210630__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantsMember_pdd"&gt;19,375
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Series B Warrants resulting in
the issuance of &lt;span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20200701__20210630__us-gaap--StatementClassOfStockAxis__custom--PrefundedWarrantsMember_pdd"&gt;29,820
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;shares of common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Additionally,
during 2021 the Company issued &lt;span id="xdx_90A_eus-gaap--CommonStockSharesIssued_iI_c20210630__us-gaap--StatementClassOfStockAxis__custom--TwentySeriesAAndOneSeriesCWarrantsMember_z4XiGfAQTBib"&gt;4,199,979
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;shares of common stock from the
alternate cashless exercise of 20 Series A and 1 Series C warrants. The Company recognized the value of the effect of a down round
feature in such warrants when triggered. Upon the occurrence of the triggering event that resulted in a reduction of the strike price,
the Company measured the value of the effect of the feature as the difference between the fair value of the warrants without the down
round feature or before the strike price reduction and the fair value of the warrants with a strike price corresponding to the reduced
strike price upon the down round feature being triggered. Accordingly, the Company recognized deemed dividend of $&lt;span id="xdx_900_ecustom--DeemedDividend_iN_di_c20200701__20210630_zyNhuYLlIyZh"&gt;391,749
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;and a corresponding reduction
of income available to common stockholders upon the &lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;alternate
cashless exercise of these warrants.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;i&gt;Restricted
Stock Units&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Pursuant
to employment agreements dated in May 2019, the Company granted an aggregate of &lt;span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20190501__20190531_zdMr0ljXcp2i"&gt;78
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;and &lt;span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20190501__20190531__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zjT4EQM6i0qj"&gt;39
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;restricted stock unit to the Company&#x2019;s
Chief Executive Officer and Chief Scientific Officer, respectively. The total &lt;span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20190501__20190531__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zw6ANGtIJOUc"&gt;117
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;restricted stock units are subject
to vesting terms as defined in the employment agreements. The 117 restricted stock units were valued at the fair value of $&lt;span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20190501__20190531__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zj17rqfAtqfj"&gt;4,250
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;per unit or $&lt;span id="xdx_906_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantDateFairvalue_pp0p0_c20190501__20190531__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zQxy1dO86qna"&gt;497,240
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;based on the quoted trading price
on the date of grant. During the year ended June 30, 2021 and 2020, the Company recognized stock-based compensation of $&lt;span id="xdx_909_eus-gaap--ShareBasedCompensation_c20200701__20210630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_pp0p0"&gt;0
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;and $&lt;span id="xdx_900_eus-gaap--ShareBasedCompensation_c20190701__20200630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_pp0p0"&gt;217,543&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;,
respectively, related to vested restricted stock units. There were $&lt;span id="xdx_901_ecustom--UnrecognizedRestrictedStockUnitsExpense_c20200701__20210630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_pp0p0"&gt;248,620
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;unrecognized restricted stock units
expense as of June 30, 2021. There are &lt;span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20200630_z3vqF4UjOqve"&gt;59
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;unvested restricted stock units
which are subject to various performance conditions which have not yet been met and such restricted stock
units have not yet vested as of June 30, 2021 and 2020 to which the $&lt;span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20210630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zieLyCEmGOui" title="Number of shares not yet vested"&gt;&lt;span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20200630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_znngyW9kylEl"&gt;248,620&lt;/span&gt;&lt;/span&gt; relates.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;PROPANC
BIOPHARMA, INC. AND SUBSIDIARY&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;June
30, 2021 and 2020&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;i&gt;Options&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_893_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zJAtVHqv7Tac" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;A
summary of the Company&#x2019;s option activity during the years ended June 30, 2021 and 2020 is presented below:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_8B4_z1neiiLP5lU5" style="display: none"&gt;SCHEDULE OF STOCK OPTION ACTIVITY&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="color: Black"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="color: Black; font-weight: bold; text-align: center"&gt;Number of&lt;/td&gt;&lt;td style="color: Black; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="color: Black; font-weight: bold; text-align: center"&gt;Weighted Average&lt;/td&gt;&lt;td style="color: Black; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="color: Black"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; color: Black; font-weight: bold; text-align: center"&gt;Options&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; color: Black; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; color: Black; font-weight: bold; text-align: center"&gt;Price Per Share&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; color: Black; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; color: Black"&gt;Outstanding at June 30, 2019&lt;/td&gt;&lt;td style="width: 2%; color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20190701__20200630_zCvoi2Biml0j" style="width: 16%; color: Black; text-align: right" title="Number of Shares, Outstanding, Beginning balance"&gt;60&lt;/td&gt;&lt;td style="width: 1%; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: Black; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20190701__20200630_z4nKrz61JCxb" style="width: 16%; color: Black; text-align: right" title="Weighted Average Price Per Share, Outstanding, Beginning balance"&gt;76,370&lt;/td&gt;&lt;td style="width: 1%; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="color: Black"&gt;Issued&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_c20190701__20200630_pdd" style="color: Black; text-align: right" title="Number of Shares, Issued"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1968"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsIssuedInPeriodWeightedAverageExercisePrice_c20190701__20200630_pdd" style="color: Black; text-align: right" title="Weighted Average Price Per Share, Issued"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1970"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="color: Black"&gt;Exercised&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20190701__20200630_pdd" style="color: Black; text-align: right" title="Number of Shares, Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1972"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20190701__20200630_pdd" style="color: Black; text-align: right" title="Weighted Average Price Per Share, Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1974"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="color: Black; padding-bottom: 1.5pt"&gt;Expired&lt;/td&gt;&lt;td style="color: Black; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_iN_di_c20190701__20200630_zCAdRgPTA2gj" style="border-bottom: Black 1.5pt solid; color: Black; text-align: right" title="Number of Shares, Expired"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1976"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_c20190701__20200630_pdd" style="border-bottom: Black 1.5pt solid; color: Black; text-align: right" title="Weighted Average Price Per Share, Expired"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1978"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="color: Black"&gt;Outstanding at June 30, 2020&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20200701__20210630_zs4OGeOEO8Zg" style="color: Black; text-align: right" title="Number of Shares, Outstanding, Ending balance"&gt;60&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20200701__20210630_zpvCzXKi2RAi" style="color: Black; text-align: right" title="Weighted Average Price Per Share, Outstanding, Ending balance"&gt;76,370&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="color: Black"&gt;Issued&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_c20200701__20210630_pdd" style="color: Black; text-align: right" title="Number of Shares, Issued"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1984"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsIssuedInPeriodWeightedAverageExercisePrice_c20200701__20210630_pdd" style="color: Black; text-align: right" title="Weighted Average Price Per Share, Issued"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1986"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="color: Black"&gt;Exercised&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20200701__20210630_pdd" style="color: Black; text-align: right" title="Number of Shares, Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1988"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20200701__20210630_pdd" style="color: Black; text-align: right" title="Weighted Average Price Per Share, Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1990"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="color: Black; padding-bottom: 1.5pt"&gt;Expired&lt;/td&gt;&lt;td style="color: Black; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_iN_di_c20200701__20210630_z26oJD3Z7ylb" style="border-bottom: Black 1.5pt solid; color: Black; text-align: right" title="Number of Shares, Expired"&gt;(1&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; color: Black; text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: Black; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_c20200701__20210630_pdd" style="border-bottom: Black 1.5pt solid; color: Black; text-align: right" title="Weighted Average Price Per Share, Expired"&gt;3,750,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="color: Black; padding-bottom: 1.5pt"&gt;Outstanding at June 30, 2021&lt;/td&gt;&lt;td style="color: Black; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20200701__20210630_z8aMmHSwGSKd" style="border-bottom: Black 1.5pt solid; color: Black; text-align: right" title="Number of Shares, Outstanding, Ending balance"&gt;59&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; color: Black; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20200701__20210630_zrYBXYu3bVe4" style="border-bottom: Black 1.5pt solid; color: Black; text-align: right" title="Weighted Average Price Per Share, Outstanding, Ending balance"&gt;13,730&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="color: Black"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="color: Black"&gt;Exercisable at June 30, 2021&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20210630_pdd" style="color: Black; text-align: right" title="Number of Shares, Exercisable, Ending balance"&gt;40&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20210630_pdd" style="color: Black; text-align: right" title="Weighted Average Price Per Share, Exercisable, Ending balance"&gt;18,193&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="color: Black; text-align: left"&gt;Outstanding and Exercisable:&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="color: Black"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="color: Black; padding-bottom: 1.5pt"&gt;Weighted average remaining contractual term&lt;/td&gt;&lt;td style="color: Black; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; color: Black; text-align: right"&gt;&lt;span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20200701__20210630_zQiV9nk5dTk" title="Weighted average remaining contractual term"&gt;7.86&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; color: Black; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="color: Black; padding-bottom: 1.5pt"&gt;Weighted average fair value of options granted during the period&lt;/td&gt;&lt;td style="color: Black; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; color: Black; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; color: Black; text-align: right"&gt;&lt;span id="xdx_905_ecustom--WeightedAverageFairValueOfOptionsGrantedDuringPeriod_d0_c20200701__20210630_zcXnUFEhxcJ4" title="Weighted average fair value of options granted during the period"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2006"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; color: Black; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="color: Black; padding-bottom: 1.5pt"&gt;Aggregate intrinsic value&lt;/td&gt;&lt;td style="color: Black; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; color: Black; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_c20210630_pp0p0" style="border-bottom: Black 1.5pt solid; color: Black; text-align: right" title="Aggregate intrinsic value"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2008"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; color: Black; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A2_zRtgmmXBuksa" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;On
the Effective Date, the Company&#x2019;s board of directors approved and adopted the Company&#x2019;s 2019 Equity Incentive Plan (the &#x201c;2019
Plan&#x201d;), which reserves a total of &lt;span id="xdx_902_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_c20210630__us-gaap--PlanNameAxis__custom--TwoThousandNinteenEquityIncentivePlanMember_ziLEvFiYtnC8" title="Number of common shares reserved for future issuance"&gt;234&lt;/span&gt; shares of the Company&#x2019;s common stock for issuance under the 2019 Plan. Incentive awards
authorized under the 2019 Plan include, but are not limited to, incentive stock options, non-qualified stock options, restricted stock
awards and restricted stock units.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;During
the year ended June 30, 2021 and 2020, the Company recognized stock-based compensation of $&lt;span id="xdx_903_eus-gaap--StockOptionPlanExpense_c20200701__20210630__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementsMember_pp0p0"&gt;82,872
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;and $&lt;span id="xdx_90A_eus-gaap--StockOptionPlanExpense_c20190701__20200630__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementsMember_pp0p0"&gt;82,873
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;related to vested stock options.
There was $&lt;span id="xdx_90E_ecustom--UnvestedStockOptionsExpense_c20200701__20210630__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementsMember_pp0p0"&gt;72,514
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;of unvested stock options expense
as of June 30, 2021 that will be recognized over a remaining vesting period of &lt;span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_dtY_c20200701__20210630_zoFTWo0hTlDj" title="Vesting period"&gt;0.87&lt;/span&gt; year.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_do_c20200701__20210630_zNcX2trAMrdj" title="Options granted"&gt;&lt;span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_do_c20190701__20200630_zo2hqyucXJnc"&gt;No&lt;/span&gt;&lt;/span&gt;
stock options were granted during the years ended June 30, 2021 and 2020.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;&lt;i&gt;Warrants&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89C_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zCK2SPds7WP5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;The
following table summarizes warrant activity for the years ended June 30, 2021 and 2020:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span id="xdx_8BA_zlOH3PPBkAE3" style="display: none"&gt;SCHEDULE OF WARRANT ACTIVITY&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="color: Black"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="color: Black; font-weight: bold; text-align: center"&gt;Number of&lt;/td&gt;&lt;td style="color: Black; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="color: Black; font-weight: bold; text-align: center"&gt;Weighted Average&lt;/td&gt;&lt;td style="color: Black; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="color: Black"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; color: Black; font-weight: bold; text-align: center"&gt;Warrants&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; color: Black; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; color: Black; font-weight: bold; text-align: center"&gt;Price Per Share&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; color: Black; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="color: Black"&gt;Outstanding at June 30, 2019&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20190701__20200630_zqxqy7ojzqB3" style="color: Black; text-align: right" title="Number of Shares, Outstanding, Beginning balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2022"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageOutstanding_iS_c20190701__20200630_zfVXsuFda5Lf" style="color: Black; text-align: right" title="Weighted Average Price Per Share, Outstanding, Beginning balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2024"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 60%; color: Black"&gt;Issued&lt;/td&gt;&lt;td style="width: 2%; color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsIssued_c20190701__20200630_pdd" style="width: 16%; color: Black; text-align: right" title="Number of Shares, Issued"&gt;151,170&lt;/td&gt;&lt;td style="width: 1%; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceIssued_c20190701__20200630_pdd" style="width: 16%; color: Black; text-align: right" title="Weighted Average Price Per Share, Issued"&gt;150.00&lt;/td&gt;&lt;td style="width: 1%; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="color: Black"&gt;Exercised&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_di_c20190701__20200630_z6phSP3ACjjb" style="color: Black; text-align: right" title="Number of Shares, Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2030"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceExercised_c20190701__20200630_pdd" style="color: Black; text-align: right" title="Weighted Average Price Per Share, Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2032"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="color: Black"&gt;Forfeited&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_c20190701__20200630_pdd" style="color: Black; text-align: right" title="Number of Shares, Forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2034"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceExpired_c20190701__20200630_pdd" style="color: Black; text-align: right" title="Weighted Average Price Per Share, Forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2036"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="color: Black; padding-bottom: 1.5pt"&gt;Expired&lt;/td&gt;&lt;td style="color: Black; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_c20190701__20200630_pdd" style="border-bottom: Black 1.5pt solid; color: Black; text-align: right" title="Number of Shares, Expired"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2038"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceForfeited_c20190701__20200630_pdd" style="border-bottom: Black 1.5pt solid; color: Black; text-align: right" title="Weighted Average Price Per Share, Expired"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2040"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="color: Black"&gt;Outstanding at June 30, 2020&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20200701__20210630_zNSUObxM0a33" style="color: Black; text-align: right" title="Number of Shares, Outstanding, Ending balance"&gt;151,170&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageOutstanding_iS_c20200701__20210630_zsBKJYDHT2Ae" style="color: Black; text-align: right" title="Weighted Average Price Per Share, Outstanding, Ending balance"&gt;150.00&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="color: Black"&gt;Issued&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsIssued_c20200701__20210630_pdd" style="color: Black; text-align: right" title="Number of Shares, Issued"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2046"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceIssued_c20200701__20210630_pdd" style="color: Black; text-align: right" title="Weighted Average Price Per Share, Issued"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2048"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="color: Black"&gt;Exercised&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_di_c20200701__20210630_z3OKGyW1DQB8" style="color: Black; text-align: right" title="Number of Shares, Exercised"&gt;(29,841&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceExercised_c20200701__20210630_pdd" style="color: Black; text-align: right" title="Weighted Average Price Per Share, Exercised"&gt;26.15&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="color: Black"&gt;Forfeited&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_c20200701__20210630_pdd" style="color: Black; text-align: right" title="Number of Shares, Forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2054"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceExpired_c20200701__20210630_pdd" style="color: Black; text-align: right" title="Weighted Average Price Per Share, Forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2056"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="color: Black; padding-bottom: 1.5pt"&gt;Expired&lt;/td&gt;&lt;td style="color: Black; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_c20200701__20210630_pdd" style="border-bottom: Black 1.5pt solid; color: Black; text-align: right" title="Number of Shares, Expired"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2058"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceForfeited_c20200701__20210630_pdd" style="border-bottom: Black 1.5pt solid; color: Black; text-align: right" title="Weighted Average Price Per Share, Expired"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2060"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="color: Black; padding-bottom: 1.5pt"&gt;Outstanding at June 30, 2021&lt;/td&gt;&lt;td style="color: Black; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_c20200701__20210630_zUi2wA7mVNkl" style="border-bottom: Black 1.5pt solid; color: Black; text-align: right" title="Number of Shares, Outstanding, Ending balance"&gt;121,329&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; color: Black; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageOutstanding_iE_c20200701__20210630_zC3AomBZmAta" style="border-bottom: Black 1.5pt solid; color: Black; text-align: right" title="Weighted Average Price Per Share, Outstanding, Ending balance"&gt;179.63&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="color: Black"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="color: Black; padding-bottom: 1.5pt"&gt;Exercisable at June 30, 2021&lt;/td&gt;&lt;td style="color: Black; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_c20210630_pdd" style="border-bottom: Black 1.5pt solid; color: Black; text-align: right" title="Number of Shares, Exercisable, Ending balance"&gt;76,955&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; color: Black; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisable_c20210630_pdd" style="border-bottom: Black 1.5pt solid; color: Black; text-align: right" title="Weighted Average Price Per Share, Exercisable, Ending balance"&gt;283.21&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="color: Black; text-align: left"&gt;Outstanding and Exercisable:&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="color: Black"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="color: Black; padding-bottom: 1.5pt"&gt;Weighted average remaining contractual term&lt;/td&gt;&lt;td style="color: Black; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; color: Black; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20200701__20210630_z78SFcSuOfvh" title="Weighted average remaining contractual term"&gt;1.77&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; color: Black; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="color: Black; padding-bottom: 1.5pt"&gt;Aggregate intrinsic value&lt;/td&gt;&lt;td style="color: Black; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; color: Black; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsAggregateIntrinsicValueOutstanding_c20210630_pp0p0" style="border-bottom: Black 1.5pt solid; color: Black; text-align: right" title="Aggregate intrinsic value"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2072"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; color: Black; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A8_zOMK2q9HwKck" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;PROPANC
BIOPHARMA, INC. AND SUBSIDIARY&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;June
30, 2021 and 2020&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;In
connection with the issuance of the August 2019 Auctus Note, the Company issued common stock purchase warrants to Auctus to purchase
&lt;span id="xdx_906_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_c20190831__us-gaap--StatementEquityComponentsAxis__custom--FirstWarrantMember_pdd" title="Warrants to purchase common stock"&gt;450&lt;/span&gt; shares of the Company&#x2019;s common stock (the &#x201c;First Warrant&#x201d;) as a commitment fee upon the terms and subject to the
limitations and conditions set forth in such First Warrant at an &#x201c;Exercise Price&#x201d; of $&lt;span id="xdx_909_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20190831__us-gaap--StatementEquityComponentsAxis__custom--FirstWarrantMember_pdd" title="Warrant exercise price"&gt;2,250&lt;/span&gt;. In connection with the issuance
of the Note, the Company shall issue a common stock purchase warrant to Buyer to purchase &lt;span id="xdx_907_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_c20190831__us-gaap--StatementEquityComponentsAxis__custom--SecondWarrantMember_pdd" title="Warrants to purchase common stock"&gt;300&lt;/span&gt; shares of the Company&#x2019;s common stock
(the &#x201c;Second Warrant&#x201d;) as a commitment fee upon the terms and subject to the limitations and conditions set forth in such
Second Warrant at an &#x201c;Exercise Price&#x201d; of $&lt;span id="xdx_908_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20190831__us-gaap--StatementEquityComponentsAxis__custom--SecondWarrantMember_pdd" title="Warrant exercise price"&gt;3,330&lt;/span&gt;. In connection with the issuance of the Note, the Company shall issue a common
stock purchase warrant to Buyer to purchase &lt;span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_c20190831__us-gaap--StatementEquityComponentsAxis__custom--ThirdWarrantMember_pdd" title="Warrants to purchase common stock"&gt;225&lt;/span&gt; shares of the Company&#x2019;s common stock (the &#x201c;Third Warrant&#x201d;) as a commitment
fee upon the terms and subject to the limitations and conditions set forth in such Third Warrant at an &#x201c;Exercise Price&#x201d; of
$&lt;span id="xdx_906_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20190831__us-gaap--StatementEquityComponentsAxis__custom--ThirdWarrantMember_pdd" title="Warrant exercise price"&gt;4,500&lt;/span&gt;. The First Warrant, Second Warrant, and Third Warrant shall collectively be referred as the &#x201c;Warrants&#x201d;. The Warrants
have an &#x201c;Exercise Period&#x201d; of five years from the date of issuance being August 30, 2019 (see Note 6).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;On
September 10, 2019, the Company entered into an agreement with a certain consultant to provide services over a three-month period beginning
September 10, 2019 and ending December 10, 2019 in exchange for &lt;span id="xdx_907_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_c20190910_pdd" title="Warrants to purchase common stock"&gt;1,000&lt;/span&gt; warrants to purchase the Company&#x2019;s common stock at $&lt;span id="xdx_90E_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20190910_pdd" title="Warrant exercise price"&gt;2,000&lt;/span&gt;
per share with an expiry date of &lt;span id="xdx_900_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20190910_zuOh6KYpd9vg" title="Warrant expiration date"&gt;September 10, 2022&lt;/span&gt;. The Fair Market Value of the warrants was $&lt;span id="xdx_90B_eus-gaap--FairValueAdjustmentOfWarrants_c20190909__20190910_pp0p0" title="Fair value of warrants"&gt;984,810&lt;/span&gt; on the date of grant as calculated
under the Black Scholes Option Pricing model. The Company recorded $&lt;span id="xdx_90B_eus-gaap--ShareBasedCompensation_pp0p0_c20190701__20200630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zjQlvPqlLwl" title="Share based compensation"&gt;984,810&lt;/span&gt; of share-based compensation expenses with respect to the
grant of such warrants during the year ended June 30, 2020.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;In
connection with the issuance of shares on April 3, 2020 as discussed above, &lt;span id="xdx_90C_ecustom--EquityPurchaseAgreementDescription_c20200402__20200403__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember" title="Equity purchase agreement description"&gt;the Company closed on a transaction related to a Securities
Purchase Agreement (the &#x201c;Securities Purchase Agreement&#x201d;) entered into on March 30, 2020, whereby an investor purchased from
the Company, 7,500 units, each consisting of (i) 1.5 shares of the Company&#x2019;s common stock, or pre-funded warrants upon Investor&#x2019;s
election due to the 4.99% blocker provision and (ii) 1.5 warrants to purchase one share of Common Stock (&#x201c;Series A Warrants&#x201d;,
and collectively with the Common Stock the &#x201c;Units&#x201d;)&lt;/span&gt;. In addition to the Units, the Investor was issued &lt;span id="xdx_909_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_c20200403__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantsMember_pdd" title="Warrants to purchase common stock"&gt;63,750&lt;/span&gt; warrants to
purchase one share of Common Stock (the &#x201c;Series B Warrants&#x201d;) and an additional &lt;span id="xdx_908_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_c20200403__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesCWarrantsMember_pdd" title="Warrants to purchase common stock"&gt;63,750&lt;/span&gt; warrants to purchase one share of Common
Stock, subject to a vesting schedule (the &#x201c;Series C Warrants&#x201d; and, together with the Prefunded Warrants, the Series A Warrants,
and the Series B Warrants, the &#x201c;Warrants&#x201d;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Due
to the Beneficial Ownership Limitation, the Company granted &lt;span id="xdx_900_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_c20200403__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantsMember_pdd" title="Warrants to purchase common stock"&gt;10,445&lt;/span&gt; Prefunded Warrants with exercise price of $&lt;span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20200403__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantsMember_pdd" title="Warrant exercise price"&gt;0.10&lt;/span&gt; (but can be less than
par value). The Prefunded Warrants shall be exercisable immediately and shall expire when exercised in full.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Series
A Warrants&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Pursuant
to the Securities Purchase Agreement entered into March 20, 2020 as discussed above, the Investor purchased Series A Warrants to purchase
up to &lt;span id="xdx_902_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_c20200320__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAWarrantsMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_pdd"&gt;11,250
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;shares of Common Stock, subject
to adjustment as provided therein. The Series A Warrants have a cash exercise price of $&lt;span id="xdx_908_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20200320__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAWarrantsMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_znZkfKlQtxk1"&gt;200
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;per share and are immediately exercisable
and expire in &lt;span id="xdx_906_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20200320__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAWarrantsMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_zl1crbhLsald"&gt;3
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;years. The Series A Warrants contain
a provision for cashless exercise in the event there is no effective registration statement registering the shares underlying the Series
A Warrants calculated based on the difference between the exercise price of the Series A Warrant and the trading price of the stock (the
&#x201c;Cashless Exercise&#x201d;).Additionally, the Series A Warrants contain a provision for a cashless conversion at the Holder&#x2019;s
option should the trading price of the Common Stock fall below $200 per share calculated based on the difference between the exercise
price of the Series A Warrant and 70% of the Market Price, as defined therein (the&#x201d; Alternate Cashless Exercise&#x201d;). See
above &#x201c;Shares issued for exercise of warrants&#x201d; for discussion of deemed dividend related to alternate cashless exercise.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Series
B Warrants&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Pursuant
to the Securities Purchase Agreement entered into March 20, 2020 as discussed above, the Investor purchased Series B Warrants to purchase
up to &lt;span id="xdx_901_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_c20200320__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantsMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_pdd" title="Warrants to purchase common stock"&gt;63,750&lt;/span&gt; shares of Common Stock, subject to adjustment as provided therein; provided, however, commencing on the 90th day following
the effective date, the Company may reduce the number of Warrant Shares issuable upon exercise thereof by &lt;span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_c20200319__20200320__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantsMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_pdd" title="Warrants exercisable"&gt;37,500&lt;/span&gt; upon &lt;span id="xdx_900_eus-gaap--DebtInstrumentConvertibleThresholdTradingDays_uInteger_c20200319__20200320__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantsMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_zDspqr2NeLf9" title="Trading days"&gt;10&lt;/span&gt; Trading Days&#x2019;
prior written notice to the Holder provided that the Company issues to the Holder &lt;span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20200319__20200320__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantsMember__srt--TitleOfIndividualAxis__custom--HolderMember_pdd" title="Common stock issued during period"&gt;3,750&lt;/span&gt; shares of Common Stock (or, at the election of
the Holder, an equivalent number of pre-funded warrants) and Series A Warrants to purchase up to &lt;span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_c20200320__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantsMember_pdd" title="Warrants to purchase common stock"&gt;3,750&lt;/span&gt; shares of Common Stock, which
shares shall be issued pursuant to a registration statement without restrictions on resale. The Series B Warrants have a cash exercise
price of $&lt;span id="xdx_901_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20200320__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantsMember_pdd" title="Warrant exercise price"&gt;40&lt;/span&gt; per share and expire in &lt;span id="xdx_907_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20200320__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantsMember_zN926UaWdVDf" title="Warrants expiration period"&gt;3&lt;/span&gt; years. The Series B Warrants contain a provision for Cashless Exercise.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Series
C Warrants&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Pursuant
to the Securities Purchase Agreement entered into March 20, 2020 as discussed above, the Investor purchased Series C Warrants to purchase
up to &lt;span id="xdx_900_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_c20200320__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesCWarrantsMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_pdd" title="Warrants to purchase common stock"&gt;63,750&lt;/span&gt; shares of Common Stock, subject to adjustment as provided therein and expire in &lt;span id="xdx_902_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20200320__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesCWarrantsMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_z69UHKqI2kwd" title="Warrants expiration period"&gt;3&lt;/span&gt; years. The Series C Warrants have a cash
exercise price of $&lt;span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20200320__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesCWarrantsMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_pdd" title="Warrant exercise price"&gt;200&lt;/span&gt; per share, subject to a vesting schedule, which is based on such Holder&#x2019;s exercise of the Series B Warrants
(warrants shall be exercisable ratably upon exercise of Series B Warrants). The Series C Warrants contain provisions for Cashless Exercise
and Alternate Cashless Exercise.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;PROPANC
BIOPHARMA, INC. AND SUBSIDIARY&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;June
30, 2021 and 2020&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;i&gt;Exercise
of Warrants&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;During
the year ended June 30, 2021, the Company received aggregate gross proceeds of $&lt;span id="xdx_904_eus-gaap--ProceedsFromWarrantExercises_pp0p0_c20200701__20210630_z2lmrQItX9F7" title="Proceeds from warrants exercise"&gt;776,044&lt;/span&gt; from the exercise of &lt;span id="xdx_906_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20210630__us-gaap--StatementClassOfStockAxis__custom--PrefundedWarrantsMember_zS4wx0bIvvIk" title="Warrants exercised"&gt;10,445&lt;/span&gt; prefunded warrants
and &lt;span id="xdx_906_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20210630__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantsMember_zE8DxnoN1jSj" title="Warrants exercised"&gt;19,375&lt;/span&gt; Series B Warrants resulting in the issuance of &lt;span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20200701__20210630__us-gaap--StatementClassOfStockAxis__custom--PrefundedWarrantsMember_ziuvGbTAgpK" title="Stock issued during period"&gt;29,820&lt;/span&gt; shares of common stock. Additionally, the Company issued &lt;span id="xdx_90F_eus-gaap--CommonStockSharesIssued_iI_c20210630__us-gaap--StatementClassOfStockAxis__custom--TwentySeriesAAndOneSeriesCWarrantsMember_zfRYfFir6jVa" title="Common stock, shares issued"&gt;4,199,979&lt;/span&gt; shares
of common stock from the alternate cashless exercise of 20 Series A and 1 Series C warrants.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2021-02-03" decimals="INF" unitRef="Shares">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2021-02-04" decimals="INF" unitRef="Shares">1000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:StockholdersEquityReverseStockSplit contextRef="From2020-11-162020-11-17">one-for-one thousand (1:1,000)</us-gaap:StockholdersEquityReverseStockSplit>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2021-06-30" decimals="INF" unitRef="Shares">1500005</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2021-06-30"
      decimals="INF"
      unitRef="USDPShares">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2020-06-30_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      unitRef="Shares">500000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2021-06-30_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      unitRef="Shares">500000</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2021-06-30_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      unitRef="Shares">500000</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2020-06-30_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      unitRef="Shares">500000</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2020-06-30_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      unitRef="Shares">500000</us-gaap:PreferredStockSharesOutstanding>
    <PPCB:EquityPurchaseAgreementDescription contextRef="From2020-04-022020-04-03_custom_SecurityPurchaseAgreementMember">the Company closed on a transaction related to a Securities Purchase Agreement (the &#x201c;Securities Purchase Agreement&#x201d;)
entered into on March 30, 2020, whereby an investor (the &#x201c;Investor&#x201d;) purchased from the Company, 7,500 units (the &#x201c;Units&#x201d;),
each consisting of (i) 1.5 shares of the Company&#x2019;s common stock (the &#x201c;Common Stock&#x201d;), or pre-funded warrants (the &#x201c;Prefunded
Warrants&#x201d;) upon Investor&#x2019;s election due to the 4.99% blocker provision as discussed below and (ii) 1.5 warrants to purchase
one share of Common Stock (&#x201c;Series A Warrants&#x201d;, and collectively with the Common Stock the &#x201c;Units&#x201d;).</PPCB:EquityPurchaseAgreementDescription>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2020-04-03_custom_SecurityPurchaseAgreementMember_custom_SeriesBWarrantsMember"
      decimals="INF"
      unitRef="Shares">63750</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2020-04-03_custom_SecurityPurchaseAgreementMember_custom_SeriesCWarrantsMember"
      decimals="INF"
      unitRef="Shares">63750</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2020-04-03_custom_SecurityPurchaseAgreementMember_custom_SeriesAWarrantsMember"
      decimals="INF"
      unitRef="USDPShares">200</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2020-04-03_custom_SecurityPurchaseAgreementMember_custom_SeriesBWarrantsMember"
      decimals="INF"
      unitRef="USDPShares">40</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2020-04-03_custom_SecurityPurchaseAgreementMember_custom_SeriesCWarrantsMember"
      decimals="INF"
      unitRef="USDPShares">200</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2020-04-022020-04-03_custom_SecurityPurchaseAgreementMember"
      decimals="0"
      unitRef="USD">450000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:ProceedsFromIssuanceOfWarrants
      contextRef="From2020-04-022020-04-03_custom_SecurityPurchaseAgreementMember"
      decimals="0"
      unitRef="USD">424990</us-gaap:ProceedsFromIssuanceOfWarrants>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="From2020-04-022020-04-03_custom_SecurityPurchaseAgreementMember"
      decimals="0"
      unitRef="USD">25010</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="AsOf2020-04-03_custom_SecurityPurchaseAgreementMember"
      decimals="INF"
      unitRef="Pure">0.0499</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2020-04-022020-04-03_custom_SecurityPurchaseAgreementMember_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">11250</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="From2020-04-022020-04-03_custom_SecurityPurchaseAgreementMember_us-gaap_RestrictedStockMember"
      decimals="INF"
      unitRef="Shares">804</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2020-04-03_custom_SecurityPurchaseAgreementMember_custom_PrefundedWarrantsMember"
      decimals="INF"
      unitRef="Shares">10446</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2020-04-03_custom_SecurityPurchaseAgreementMember_custom_PrefundedWarrantsMember"
      decimals="INF"
      unitRef="USDPShares">1</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2019-07-012020-06-30_custom_SecurityPurchaseAgreementMember"
      decimals="INF"
      unitRef="Shares">247619</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="AsOf2020-06-30_custom_SecurityPurchaseAgreementMember"
      decimals="INF"
      unitRef="USDPShares">7</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="AsOf2020-06-30_custom_SecurityPurchaseAgreementMember_srt_MinimumMember"
      decimals="INF"
      unitRef="USDPShares">2</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="AsOf2020-06-30_custom_SecurityPurchaseAgreementMember_srt_MaximumMember"
      decimals="INF"
      unitRef="USDPShares">910</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DebtConversionConvertedInstrumentAmount1
      contextRef="From2019-07-012020-06-30_custom_SecurityPurchaseAgreementMember"
      decimals="0"
      unitRef="USD">1814336</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <PPCB:ConversionFees
      contextRef="From2019-07-012020-06-30_custom_SecurityPurchaseAgreementMember"
      decimals="0"
      unitRef="USD">15000</PPCB:ConversionFees>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="From2019-07-012020-06-30_custom_SecurityPurchaseAgreementMember"
      decimals="0"
      unitRef="USD">2125174</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <PPCB:ConversionOptionDerivatives
      contextRef="From2019-07-012020-06-30_custom_SecurityPurchaseAgreementMember"
      decimals="0"
      unitRef="USD">254500</PPCB:ConversionOptionDerivatives>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="AsOf2020-06-30_custom_SecurityPurchaseAgreementMember"
      decimals="0"
      unitRef="USD">15408</us-gaap:InterestPayableCurrentAndNoncurrent>
    <PPCB:FairMarketValueOfShares
      contextRef="From2019-07-012020-06-30_custom_SecurityPurchaseAgreementMember"
      decimals="0"
      unitRef="USD">565746</PPCB:FairMarketValueOfShares>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="From2019-07-012020-06-30_custom_SecurityPurchaseAgreementMember"
      decimals="0"
      unitRef="USD">295838</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="AsOf2020-06-30_custom_SecurityPurchaseAgreementMember"
      decimals="0"
      unitRef="USD">362961</us-gaap:DerivativeFairValueOfDerivativeNet>
    <PPCB:PremiumsToAdditionalPaidInCapital
      contextRef="From2019-07-012020-06-30_custom_SecurityPurchaseAgreementMember"
      decimals="0"
      unitRef="USD">874924</PPCB:PremiumsToAdditionalPaidInCapital>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2020-07-012021-06-30_custom_SecurityPurchaseAgreementMember"
      decimals="INF"
      unitRef="Shares">8786113</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="AsOf2021-06-30_custom_SecurityPurchaseAgreementMember"
      decimals="INF"
      unitRef="USDPShares">0.13</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="AsOf2021-06-30_custom_SecurityPurchaseAgreementMember_srt_MinimumMember"
      decimals="INF"
      unitRef="USDPShares">0.03</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="AsOf2021-06-30_custom_SecurityPurchaseAgreementMember_srt_MaximumMember"
      decimals="INF"
      unitRef="USDPShares">2.00</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2021-06-30_custom_SecurityPurchaseAgreementMember"
      decimals="0"
      unitRef="USD">1018867</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="AsOf2021-06-30_custom_SecurityPurchaseAgreementMember"
      decimals="0"
      unitRef="USD">103321</us-gaap:InterestPayableCurrentAndNoncurrent>
    <PPCB:ConversionFees
      contextRef="From2020-07-012021-06-30_custom_SecurityPurchaseAgreementMember"
      decimals="0"
      unitRef="USD">16500</PPCB:ConversionFees>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="From2020-07-012021-06-30_custom_SecurityPurchaseAgreementMember"
      decimals="0"
      unitRef="USD">1239075</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:CommonStockSharesSubscribedButUnissued contextRef="AsOf2020-09-30" decimals="INF" unitRef="Shares">24427</us-gaap:CommonStockSharesSubscribedButUnissued>
    <us-gaap:DebtInstrumentFaceAmount contextRef="AsOf2020-11-30" decimals="0" unitRef="USD">19600</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:InterestPayableCurrentAndNoncurrent contextRef="AsOf2020-11-30" decimals="0" unitRef="USD">416</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:DebtInstrumentUnamortizedPremium contextRef="AsOf2020-11-30" decimals="0" unitRef="USD">11785</us-gaap:DebtInstrumentUnamortizedPremium>
    <PPCB:DecreaseInEquity
      contextRef="From2020-11-292020-11-30"
      decimals="0"
      unitRef="USD">31801</PPCB:DecreaseInEquity>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2021-06-30_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">95000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="AsOf2021-06-30_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">3000</us-gaap:InterestPayableCurrentAndNoncurrent>
    <PPCB:FairMarketValueOfShares
      contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">178368</PPCB:FairMarketValueOfShares>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">80368</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="AsOf2021-06-30_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">130975</us-gaap:DerivativeFairValueOfDerivativeNet>
    <PPCB:PremiumsToAdditionalPaidInCapital
      contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">590504</PPCB:PremiumsToAdditionalPaidInCapital>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2020-07-012021-06-30_custom_UnderlyingFinancingAgreementsMember"
      decimals="INF"
      unitRef="Shares">197308116</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2020-07-182020-07-19_custom_ConsultingAgreementMember"
      decimals="INF"
      unitRef="Shares">20</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2020-07-19_custom_ConsultingAgreementMember"
      decimals="INF"
      unitRef="USDPShares">1990</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="From2020-07-182020-07-19_custom_ConsultingAgreementMember"
      decimals="0"
      unitRef="USD">39800</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProfessionalFees
      contextRef="From2019-07-012020-06-30_custom_ConsultingAgreementMember"
      decimals="0"
      unitRef="USD">39800</us-gaap:ProfessionalFees>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2020-02-022020-02-03_custom_ConsultantMember_custom_EngagementAgreementMember"
      decimals="INF"
      unitRef="Shares">8709</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2020-06-252020-06-26_custom_ConsultantMember_custom_EngagementAgreementMember"
      decimals="INF"
      unitRef="Shares">8709</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2020-06-252020-06-26_custom_ConsultantMember_custom_EngagementAgreementMember"
      decimals="INF"
      unitRef="Shares">8709</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2020-06-252020-06-26_custom_ConsultantMember_custom_EngagementAgreementMember"
      decimals="INF"
      unitRef="Shares">8709</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2020-02-03_custom_ConsultantMember_custom_EngagementAgreementMember"
      decimals="INF"
      unitRef="USDPShares">8</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2020-06-26_custom_ConsultantMember_custom_EngagementAgreementMember"
      decimals="INF"
      unitRef="USDPShares">8</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:ProfessionalFees
      contextRef="From2020-02-022020-02-03_custom_ConsultantMember_custom_EngagementAgreementMember"
      decimals="0"
      unitRef="USD">73842</us-gaap:ProfessionalFees>
    <us-gaap:ProfessionalFees
      contextRef="From2020-06-252020-06-26_custom_ConsultantMember_custom_EngagementAgreementMember"
      decimals="0"
      unitRef="USD">73842</us-gaap:ProfessionalFees>
    <us-gaap:ProfessionalFees
      contextRef="From2019-07-012020-06-30_custom_ConsultantMember_custom_EngagementAgreementMember"
      decimals="0"
      unitRef="USD">73842</us-gaap:ProfessionalFees>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2021-03-212021-03-22_custom_ConsultantMember"
      decimals="INF"
      unitRef="Shares">225037</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember_custom_ConsultantMember"
      decimals="INF"
      unitRef="Shares">225037</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2021-06-30_us-gaap_CommonStockMember_custom_ConsultantMember"
      decimals="INF"
      unitRef="USDPShares">0.30</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember_custom_ConsultantMember"
      decimals="0"
      unitRef="USD">67511</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2020-07-012021-06-30_custom_ConsultantMember"
      decimals="0"
      unitRef="USD">67511</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2021-03-012021-03-31_custom_ConsultantMember_custom_EngagementAgreementMember"
      decimals="INF"
      unitRef="Shares">580609</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2021-06-012021-06-30_custom_ConsultantMember_custom_EngagementAgreementMember"
      decimals="INF"
      unitRef="Shares">580609</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2021-03-012021-03-31_custom_ConsultantMember_custom_EngagementAgreementMember"
      decimals="INF"
      unitRef="Shares">580609</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2021-06-012021-06-30_custom_ConsultantMember_custom_EngagementAgreementMember"
      decimals="INF"
      unitRef="Shares">580609</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2021-03-31_custom_ConsultantMember_custom_EngagementAgreementMember"
      decimals="INF"
      unitRef="USDPShares">0.10</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2021-06-30_custom_ConsultantMember_custom_EngagementAgreementMember"
      decimals="INF"
      unitRef="USDPShares">0.10</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:ProfessionalFees
      contextRef="From2021-03-012021-03-31_custom_ConsultantMember_custom_EngagementAgreementMember"
      decimals="0"
      unitRef="USD">58061</us-gaap:ProfessionalFees>
    <us-gaap:ProfessionalFees
      contextRef="From2021-06-012021-06-30_custom_ConsultantMember_custom_EngagementAgreementMember"
      decimals="0"
      unitRef="USD">58061</us-gaap:ProfessionalFees>
    <us-gaap:ProfessionalFees
      contextRef="From2020-07-012021-06-30_custom_ConsultantMember_custom_EngagementAgreementMember"
      decimals="0"
      unitRef="USD">58061</us-gaap:ProfessionalFees>
    <us-gaap:ProceedsFromWarrantExercises
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">776044</us-gaap:ProceedsFromWarrantExercises>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2021-06-30_custom_PrefundedWarrantsMember"
      decimals="INF"
      unitRef="Shares">10445</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2021-06-30_custom_SeriesBWarrantsMember"
      decimals="INF"
      unitRef="Shares">19375</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2020-07-012021-06-30_custom_PrefundedWarrantsMember"
      decimals="INF"
      unitRef="Shares">29820</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2021-06-30_custom_TwentySeriesAAndOneSeriesCWarrantsMember"
      decimals="INF"
      unitRef="Shares">4199979</us-gaap:CommonStockSharesIssued>
    <PPCB:DeemedDividend
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">-391749</PPCB:DeemedDividend>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="From2019-05-012019-05-31"
      decimals="INF"
      unitRef="Shares">78</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="From2019-05-012019-05-31_srt_ChiefExecutiveOfficerMember"
      decimals="INF"
      unitRef="Shares">39</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="From2019-05-012019-05-31_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="INF"
      unitRef="Shares">117</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="From2019-05-012019-05-31_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="INF"
      unitRef="USDPShares">4250</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <PPCB:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantDateFairvalue
      contextRef="From2019-05-012019-05-31_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="0"
      unitRef="USD">497240</PPCB:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantDateFairvalue>
    <us-gaap:ShareBasedCompensation
      contextRef="From2020-07-012021-06-30_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="0"
      unitRef="USD">0</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="From2019-07-012020-06-30_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="0"
      unitRef="USD">217543</us-gaap:ShareBasedCompensation>
    <PPCB:UnrecognizedRestrictedStockUnitsExpense
      contextRef="From2020-07-012021-06-30_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="0"
      unitRef="USD">248620</PPCB:UnrecognizedRestrictedStockUnitsExpense>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber contextRef="AsOf2020-06-30" decimals="INF" unitRef="Shares">59</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
      contextRef="AsOf2021-06-30_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="INF"
      unitRef="Shares">248620</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
      contextRef="AsOf2020-06-30_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="INF"
      unitRef="Shares">248620</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="From2020-07-012021-06-30">&lt;p id="xdx_893_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zJAtVHqv7Tac" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;A
summary of the Company&#x2019;s option activity during the years ended June 30, 2021 and 2020 is presented below:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_8B4_z1neiiLP5lU5" style="display: none"&gt;SCHEDULE OF STOCK OPTION ACTIVITY&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="color: Black"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="color: Black; font-weight: bold; text-align: center"&gt;Number of&lt;/td&gt;&lt;td style="color: Black; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="color: Black; font-weight: bold; text-align: center"&gt;Weighted Average&lt;/td&gt;&lt;td style="color: Black; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="color: Black"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; color: Black; font-weight: bold; text-align: center"&gt;Options&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; color: Black; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; color: Black; font-weight: bold; text-align: center"&gt;Price Per Share&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; color: Black; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; color: Black"&gt;Outstanding at June 30, 2019&lt;/td&gt;&lt;td style="width: 2%; color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20190701__20200630_zCvoi2Biml0j" style="width: 16%; color: Black; text-align: right" title="Number of Shares, Outstanding, Beginning balance"&gt;60&lt;/td&gt;&lt;td style="width: 1%; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: Black; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20190701__20200630_z4nKrz61JCxb" style="width: 16%; color: Black; text-align: right" title="Weighted Average Price Per Share, Outstanding, Beginning balance"&gt;76,370&lt;/td&gt;&lt;td style="width: 1%; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="color: Black"&gt;Issued&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_c20190701__20200630_pdd" style="color: Black; text-align: right" title="Number of Shares, Issued"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1968"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsIssuedInPeriodWeightedAverageExercisePrice_c20190701__20200630_pdd" style="color: Black; text-align: right" title="Weighted Average Price Per Share, Issued"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1970"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="color: Black"&gt;Exercised&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20190701__20200630_pdd" style="color: Black; text-align: right" title="Number of Shares, Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1972"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20190701__20200630_pdd" style="color: Black; text-align: right" title="Weighted Average Price Per Share, Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1974"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="color: Black; padding-bottom: 1.5pt"&gt;Expired&lt;/td&gt;&lt;td style="color: Black; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_iN_di_c20190701__20200630_zCAdRgPTA2gj" style="border-bottom: Black 1.5pt solid; color: Black; text-align: right" title="Number of Shares, Expired"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1976"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_c20190701__20200630_pdd" style="border-bottom: Black 1.5pt solid; color: Black; text-align: right" title="Weighted Average Price Per Share, Expired"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1978"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="color: Black"&gt;Outstanding at June 30, 2020&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20200701__20210630_zs4OGeOEO8Zg" style="color: Black; text-align: right" title="Number of Shares, Outstanding, Ending balance"&gt;60&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20200701__20210630_zpvCzXKi2RAi" style="color: Black; text-align: right" title="Weighted Average Price Per Share, Outstanding, Ending balance"&gt;76,370&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="color: Black"&gt;Issued&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_c20200701__20210630_pdd" style="color: Black; text-align: right" title="Number of Shares, Issued"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1984"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsIssuedInPeriodWeightedAverageExercisePrice_c20200701__20210630_pdd" style="color: Black; text-align: right" title="Weighted Average Price Per Share, Issued"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1986"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="color: Black"&gt;Exercised&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20200701__20210630_pdd" style="color: Black; text-align: right" title="Number of Shares, Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1988"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20200701__20210630_pdd" style="color: Black; text-align: right" title="Weighted Average Price Per Share, Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1990"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="color: Black; padding-bottom: 1.5pt"&gt;Expired&lt;/td&gt;&lt;td style="color: Black; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_iN_di_c20200701__20210630_z26oJD3Z7ylb" style="border-bottom: Black 1.5pt solid; color: Black; text-align: right" title="Number of Shares, Expired"&gt;(1&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; color: Black; text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: Black; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_c20200701__20210630_pdd" style="border-bottom: Black 1.5pt solid; color: Black; text-align: right" title="Weighted Average Price Per Share, Expired"&gt;3,750,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="color: Black; padding-bottom: 1.5pt"&gt;Outstanding at June 30, 2021&lt;/td&gt;&lt;td style="color: Black; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20200701__20210630_z8aMmHSwGSKd" style="border-bottom: Black 1.5pt solid; color: Black; text-align: right" title="Number of Shares, Outstanding, Ending balance"&gt;59&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; color: Black; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20200701__20210630_zrYBXYu3bVe4" style="border-bottom: Black 1.5pt solid; color: Black; text-align: right" title="Weighted Average Price Per Share, Outstanding, Ending balance"&gt;13,730&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="color: Black"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="color: Black"&gt;Exercisable at June 30, 2021&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20210630_pdd" style="color: Black; text-align: right" title="Number of Shares, Exercisable, Ending balance"&gt;40&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20210630_pdd" style="color: Black; text-align: right" title="Weighted Average Price Per Share, Exercisable, Ending balance"&gt;18,193&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="color: Black; text-align: left"&gt;Outstanding and Exercisable:&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="color: Black"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="color: Black; padding-bottom: 1.5pt"&gt;Weighted average remaining contractual term&lt;/td&gt;&lt;td style="color: Black; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; color: Black; text-align: right"&gt;&lt;span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20200701__20210630_zQiV9nk5dTk" title="Weighted average remaining contractual term"&gt;7.86&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; color: Black; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="color: Black; padding-bottom: 1.5pt"&gt;Weighted average fair value of options granted during the period&lt;/td&gt;&lt;td style="color: Black; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; color: Black; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; color: Black; text-align: right"&gt;&lt;span id="xdx_905_ecustom--WeightedAverageFairValueOfOptionsGrantedDuringPeriod_d0_c20200701__20210630_zcXnUFEhxcJ4" title="Weighted average fair value of options granted during the period"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2006"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; color: Black; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="color: Black; padding-bottom: 1.5pt"&gt;Aggregate intrinsic value&lt;/td&gt;&lt;td style="color: Black; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; color: Black; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_c20210630_pp0p0" style="border-bottom: Black 1.5pt solid; color: Black; text-align: right" title="Aggregate intrinsic value"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2008"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; color: Black; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2019-06-30" decimals="INF" unitRef="Shares">60</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2019-06-30"
      decimals="INF"
      unitRef="USDPShares">76370</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2020-06-30" decimals="INF" unitRef="Shares">60</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2020-06-30"
      decimals="INF"
      unitRef="USDPShares">76370</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
      contextRef="From2020-07-012021-06-30"
      decimals="INF"
      unitRef="Shares">1</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="From2020-07-012021-06-30"
      decimals="INF"
      unitRef="USDPShares">3750000</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2021-06-30" decimals="INF" unitRef="Shares">59</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2021-06-30"
      decimals="INF"
      unitRef="USDPShares">13730</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber contextRef="AsOf2021-06-30" decimals="INF" unitRef="Shares">40</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="AsOf2021-06-30"
      decimals="INF"
      unitRef="USDPShares">18193</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2020-07-012021-06-30">P7Y10M9D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="AsOf2021-06-30_custom_TwoThousandNinteenEquityIncentivePlanMember"
      decimals="INF"
      unitRef="Shares">234</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:StockOptionPlanExpense
      contextRef="From2020-07-012021-06-30_custom_EmploymentAgreementsMember"
      decimals="0"
      unitRef="USD">82872</us-gaap:StockOptionPlanExpense>
    <us-gaap:StockOptionPlanExpense
      contextRef="From2019-07-012020-06-30_custom_EmploymentAgreementsMember"
      decimals="0"
      unitRef="USD">82873</us-gaap:StockOptionPlanExpense>
    <PPCB:UnvestedStockOptionsExpense
      contextRef="From2020-07-012021-06-30_custom_EmploymentAgreementsMember"
      decimals="0"
      unitRef="USD">72514</PPCB:UnvestedStockOptionsExpense>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="From2020-07-012021-06-30">P0Y10M13D</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="From2020-07-012021-06-30"
      decimals="INF"
      unitRef="Shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="From2019-07-012020-06-30"
      decimals="INF"
      unitRef="Shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock contextRef="From2020-07-012021-06-30">&lt;p id="xdx_89C_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zCK2SPds7WP5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;The
following table summarizes warrant activity for the years ended June 30, 2021 and 2020:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span id="xdx_8BA_zlOH3PPBkAE3" style="display: none"&gt;SCHEDULE OF WARRANT ACTIVITY&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="color: Black"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="color: Black; font-weight: bold; text-align: center"&gt;Number of&lt;/td&gt;&lt;td style="color: Black; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="color: Black; font-weight: bold; text-align: center"&gt;Weighted Average&lt;/td&gt;&lt;td style="color: Black; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="color: Black"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; color: Black; font-weight: bold; text-align: center"&gt;Warrants&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; color: Black; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; color: Black; font-weight: bold; text-align: center"&gt;Price Per Share&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; color: Black; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="color: Black"&gt;Outstanding at June 30, 2019&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20190701__20200630_zqxqy7ojzqB3" style="color: Black; text-align: right" title="Number of Shares, Outstanding, Beginning balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2022"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageOutstanding_iS_c20190701__20200630_zfVXsuFda5Lf" style="color: Black; text-align: right" title="Weighted Average Price Per Share, Outstanding, Beginning balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2024"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 60%; color: Black"&gt;Issued&lt;/td&gt;&lt;td style="width: 2%; color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsIssued_c20190701__20200630_pdd" style="width: 16%; color: Black; text-align: right" title="Number of Shares, Issued"&gt;151,170&lt;/td&gt;&lt;td style="width: 1%; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceIssued_c20190701__20200630_pdd" style="width: 16%; color: Black; text-align: right" title="Weighted Average Price Per Share, Issued"&gt;150.00&lt;/td&gt;&lt;td style="width: 1%; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="color: Black"&gt;Exercised&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_di_c20190701__20200630_z6phSP3ACjjb" style="color: Black; text-align: right" title="Number of Shares, Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2030"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceExercised_c20190701__20200630_pdd" style="color: Black; text-align: right" title="Weighted Average Price Per Share, Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2032"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="color: Black"&gt;Forfeited&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_c20190701__20200630_pdd" style="color: Black; text-align: right" title="Number of Shares, Forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2034"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceExpired_c20190701__20200630_pdd" style="color: Black; text-align: right" title="Weighted Average Price Per Share, Forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2036"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="color: Black; padding-bottom: 1.5pt"&gt;Expired&lt;/td&gt;&lt;td style="color: Black; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_c20190701__20200630_pdd" style="border-bottom: Black 1.5pt solid; color: Black; text-align: right" title="Number of Shares, Expired"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2038"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceForfeited_c20190701__20200630_pdd" style="border-bottom: Black 1.5pt solid; color: Black; text-align: right" title="Weighted Average Price Per Share, Expired"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2040"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="color: Black"&gt;Outstanding at June 30, 2020&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20200701__20210630_zNSUObxM0a33" style="color: Black; text-align: right" title="Number of Shares, Outstanding, Ending balance"&gt;151,170&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageOutstanding_iS_c20200701__20210630_zsBKJYDHT2Ae" style="color: Black; text-align: right" title="Weighted Average Price Per Share, Outstanding, Ending balance"&gt;150.00&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="color: Black"&gt;Issued&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsIssued_c20200701__20210630_pdd" style="color: Black; text-align: right" title="Number of Shares, Issued"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2046"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceIssued_c20200701__20210630_pdd" style="color: Black; text-align: right" title="Weighted Average Price Per Share, Issued"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2048"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="color: Black"&gt;Exercised&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_di_c20200701__20210630_z3OKGyW1DQB8" style="color: Black; text-align: right" title="Number of Shares, Exercised"&gt;(29,841&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;)&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceExercised_c20200701__20210630_pdd" style="color: Black; text-align: right" title="Weighted Average Price Per Share, Exercised"&gt;26.15&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="color: Black"&gt;Forfeited&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_c20200701__20210630_pdd" style="color: Black; text-align: right" title="Number of Shares, Forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2054"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceExpired_c20200701__20210630_pdd" style="color: Black; text-align: right" title="Weighted Average Price Per Share, Forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2056"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="color: Black; padding-bottom: 1.5pt"&gt;Expired&lt;/td&gt;&lt;td style="color: Black; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_c20200701__20210630_pdd" style="border-bottom: Black 1.5pt solid; color: Black; text-align: right" title="Number of Shares, Expired"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2058"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceForfeited_c20200701__20210630_pdd" style="border-bottom: Black 1.5pt solid; color: Black; text-align: right" title="Weighted Average Price Per Share, Expired"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2060"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="color: Black; padding-bottom: 1.5pt"&gt;Outstanding at June 30, 2021&lt;/td&gt;&lt;td style="color: Black; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_c20200701__20210630_zUi2wA7mVNkl" style="border-bottom: Black 1.5pt solid; color: Black; text-align: right" title="Number of Shares, Outstanding, Ending balance"&gt;121,329&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; color: Black; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageOutstanding_iE_c20200701__20210630_zC3AomBZmAta" style="border-bottom: Black 1.5pt solid; color: Black; text-align: right" title="Weighted Average Price Per Share, Outstanding, Ending balance"&gt;179.63&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="color: Black"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="color: Black; padding-bottom: 1.5pt"&gt;Exercisable at June 30, 2021&lt;/td&gt;&lt;td style="color: Black; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_c20210630_pdd" style="border-bottom: Black 1.5pt solid; color: Black; text-align: right" title="Number of Shares, Exercisable, Ending balance"&gt;76,955&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; color: Black; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisable_c20210630_pdd" style="border-bottom: Black 1.5pt solid; color: Black; text-align: right" title="Weighted Average Price Per Share, Exercisable, Ending balance"&gt;283.21&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="color: Black; text-align: left"&gt;Outstanding and Exercisable:&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="color: Black"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="color: Black; padding-bottom: 1.5pt"&gt;Weighted average remaining contractual term&lt;/td&gt;&lt;td style="color: Black; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; color: Black; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20200701__20210630_z78SFcSuOfvh" title="Weighted average remaining contractual term"&gt;1.77&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; color: Black; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="color: Black; padding-bottom: 1.5pt"&gt;Aggregate intrinsic value&lt;/td&gt;&lt;td style="color: Black; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; color: Black; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsAggregateIntrinsicValueOutstanding_c20210630_pp0p0" style="border-bottom: Black 1.5pt solid; color: Black; text-align: right" title="Aggregate intrinsic value"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2072"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="color: Black; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; color: Black; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; color: Black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock>
    <PPCB:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsIssued
      contextRef="From2019-07-012020-06-30"
      decimals="INF"
      unitRef="Shares">151170</PPCB:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsIssued>
    <PPCB:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceIssued
      contextRef="From2019-07-012020-06-30"
      decimals="INF"
      unitRef="USDPShares">150.00</PPCB:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceIssued>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber contextRef="AsOf2020-06-30" decimals="INF" unitRef="Shares">151170</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <PPCB:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageOutstanding
      contextRef="AsOf2020-06-30"
      decimals="INF"
      unitRef="USDPShares">150.00</PPCB:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageOutstanding>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
      contextRef="From2020-07-012021-06-30"
      decimals="INF"
      unitRef="Shares">29841</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised>
    <PPCB:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceExercised
      contextRef="From2020-07-012021-06-30"
      decimals="INF"
      unitRef="USDPShares">26.15</PPCB:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceExercised>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber contextRef="AsOf2021-06-30" decimals="INF" unitRef="Shares">121329</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <PPCB:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageOutstanding
      contextRef="AsOf2021-06-30"
      decimals="INF"
      unitRef="USDPShares">179.63</PPCB:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageOutstanding>
    <PPCB:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber contextRef="AsOf2021-06-30" decimals="INF" unitRef="Shares">76955</PPCB:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber>
    <PPCB:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisable
      contextRef="AsOf2021-06-30"
      decimals="INF"
      unitRef="USDPShares">283.21</PPCB:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisable>
    <PPCB:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerms contextRef="From2020-07-012021-06-30">P1Y9M7D</PPCB:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerms>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2019-08-31_custom_FirstWarrantMember"
      decimals="INF"
      unitRef="Shares">450</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2019-08-31_custom_FirstWarrantMember"
      decimals="INF"
      unitRef="USDPShares">2250</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2019-08-31_custom_SecondWarrantMember"
      decimals="INF"
      unitRef="Shares">300</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2019-08-31_custom_SecondWarrantMember"
      decimals="INF"
      unitRef="USDPShares">3330</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2019-08-31_custom_ThirdWarrantMember"
      decimals="INF"
      unitRef="Shares">225</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2019-08-31_custom_ThirdWarrantMember"
      decimals="INF"
      unitRef="USDPShares">4500</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="AsOf2019-09-10" decimals="INF" unitRef="Shares">1000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2019-09-10"
      decimals="INF"
      unitRef="USDPShares">2000</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstandingMaturityDate contextRef="AsOf2019-09-10">2022-09-10</us-gaap:WarrantsAndRightsOutstandingMaturityDate>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2019-09-092019-09-10"
      decimals="0"
      unitRef="USD">984810</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:ShareBasedCompensation
      contextRef="From2019-07-012020-06-30_us-gaap_WarrantMember17272484"
      decimals="0"
      unitRef="USD">984810</us-gaap:ShareBasedCompensation>
    <PPCB:EquityPurchaseAgreementDescription contextRef="From2020-04-022020-04-03_custom_SecuritiesPurchaseAgreementMember">the Company closed on a transaction related to a Securities
Purchase Agreement (the &#x201c;Securities Purchase Agreement&#x201d;) entered into on March 30, 2020, whereby an investor purchased from
the Company, 7,500 units, each consisting of (i) 1.5 shares of the Company&#x2019;s common stock, or pre-funded warrants upon Investor&#x2019;s
election due to the 4.99% blocker provision and (ii) 1.5 warrants to purchase one share of Common Stock (&#x201c;Series A Warrants&#x201d;,
and collectively with the Common Stock the &#x201c;Units&#x201d;)</PPCB:EquityPurchaseAgreementDescription>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2020-04-03_custom_SecuritiesPurchaseAgreementMember_custom_SeriesBWarrantsMember"
      decimals="INF"
      unitRef="Shares">63750</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2020-04-03_custom_SecuritiesPurchaseAgreementMember_custom_SeriesCWarrantsMember"
      decimals="INF"
      unitRef="Shares">63750</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2020-04-03_custom_SecuritiesPurchaseAgreementMember_custom_PrefundedWarrantsMember"
      decimals="INF"
      unitRef="Shares">10445</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2020-04-03_custom_SecuritiesPurchaseAgreementMember_custom_PrefundedWarrantsMember"
      decimals="INF"
      unitRef="USDPShares">0.10</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2020-03-20_custom_SecuritiesPurchaseAgreementMember_custom_SeriesAWarrantsMember_us-gaap_InvestorMember"
      decimals="INF"
      unitRef="Shares">11250</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2020-03-20_custom_SecuritiesPurchaseAgreementMember_custom_SeriesAWarrantsMember_us-gaap_InvestorMember"
      decimals="INF"
      unitRef="USDPShares">200</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="AsOf2020-03-20_custom_SecuritiesPurchaseAgreementMember_custom_SeriesAWarrantsMember_us-gaap_InvestorMember">P3Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2020-03-20_custom_SecuritiesPurchaseAgreementMember_custom_SeriesBWarrantsMember_us-gaap_InvestorMember"
      decimals="INF"
      unitRef="Shares">63750</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
      contextRef="From2020-03-192020-03-20_custom_SecuritiesPurchaseAgreementMember_custom_SeriesBWarrantsMember_us-gaap_InvestorMember"
      decimals="INF"
      unitRef="Shares">37500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised>
    <us-gaap:DebtInstrumentConvertibleThresholdTradingDays
      contextRef="From2020-03-192020-03-20_custom_SecuritiesPurchaseAgreementMember_custom_SeriesBWarrantsMember_us-gaap_InvestorMember"
      decimals="INF"
      unitRef="Integer">10</us-gaap:DebtInstrumentConvertibleThresholdTradingDays>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2020-03-192020-03-20_custom_SecuritiesPurchaseAgreementMember_custom_SeriesBWarrantsMember_custom_HolderMember"
      decimals="INF"
      unitRef="Shares">3750</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2020-03-20_custom_SecuritiesPurchaseAgreementMember_custom_SeriesBWarrantsMember"
      decimals="INF"
      unitRef="Shares">3750</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2020-03-20_custom_SecuritiesPurchaseAgreementMember_custom_SeriesBWarrantsMember"
      decimals="INF"
      unitRef="USDPShares">40</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="AsOf2020-03-20_custom_SecuritiesPurchaseAgreementMember_custom_SeriesBWarrantsMember">P3Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2020-03-20_custom_SecuritiesPurchaseAgreementMember_custom_SeriesCWarrantsMember_us-gaap_InvestorMember"
      decimals="INF"
      unitRef="Shares">63750</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="AsOf2020-03-20_custom_SecuritiesPurchaseAgreementMember_custom_SeriesCWarrantsMember_us-gaap_InvestorMember">P3Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2020-03-20_custom_SecuritiesPurchaseAgreementMember_custom_SeriesCWarrantsMember_us-gaap_InvestorMember"
      decimals="INF"
      unitRef="USDPShares">200</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ProceedsFromWarrantExercises
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">776044</us-gaap:ProceedsFromWarrantExercises>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2021-06-30_custom_PrefundedWarrantsMember"
      decimals="INF"
      unitRef="Shares">10445</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2021-06-30_custom_SeriesBWarrantsMember"
      decimals="INF"
      unitRef="Shares">19375</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2020-07-012021-06-30_custom_PrefundedWarrantsMember"
      decimals="INF"
      unitRef="Shares">29820</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2021-06-30_custom_TwentySeriesAAndOneSeriesCWarrantsMember"
      decimals="INF"
      unitRef="Shares">4199979</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="From2020-07-012021-06-30">&lt;p id="xdx_806_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zL2iu8rkR7El" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;NOTE
9 &#x2013; &lt;span id="xdx_82D_zoKrhnxDRVm6"&gt;COMMITMENTS AND CONTINGENCIES&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;Legal
Matters&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;On
September 26, 2019, a complaint was filed against the Company with Supreme Court of the State of New York, County of New York, by Foley
Shechter Ablovatskiy LLP (&#x201c;Foley Shechter&#x201d;), our former counsel, seeking $&lt;span id="xdx_901_eus-gaap--LegalFees_c20190925__20190926__srt--TitleOfIndividualAxis__custom--FoleyShechterMember_pp0p0"&gt;151,031
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;in professional fees allegedly
owed, in addition to interest and costs of suit. The Company filed an answer, together with affirmative defenses and counterclaims. Certain
amounts related to this claim were included in accounts payable and accrued expenses in the accompanying consolidated financial statements
at June 30, 2020. On March 22, 2021, the Company entered into a settlement agreement with Foley Shechter whereby both parties
agreed to settle all claims for professional fees owed for a total of $&lt;span id="xdx_907_eus-gaap--ProfessionalFees_c20210320__20210322__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementMember__srt--TitleOfIndividualAxis__custom--FoleyShechterMember_pp0p0"&gt;51,032&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;.
The Company paid the settlement amount of $&lt;span id="xdx_90B_ecustom--SettlementAmount_c20210322__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementMember__srt--TitleOfIndividualAxis__custom--FoleyShechterMember_pp0p0"&gt;51,032
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;on March 22, 2021. Prior to the
settlement agreement, the Company recorded total accounts payable and accrued expenses $&lt;span id="xdx_909_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_iI_pp0p0_c20210322__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementMember__srt--TitleOfIndividualAxis__custom--FoleyShechterMember_zpXBVNIVgbjl"&gt;142,660&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;.
Accordingly, the Company recognized gain from settlement of debt of &lt;span id="xdx_901_ecustom--GainLossFromSettlementOfDebt_c20200701__20210630__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementMember__srt--TitleOfIndividualAxis__custom--FoleyShechterMember_pp0p0"&gt;$92,556
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;during the year ended June
30, 2021.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Regal
Consulting, LLC (&#x201c;Regal&#x201d;) initiated litigation against the Company in Clark County District Court, Nevada. Regal was demanding
approximately $&lt;span id="xdx_906_eus-gaap--LossContingencyDamagesSoughtValue_c20200701__20210630__dei--LegalEntityAxis__custom--RegalConsultingLLCMember_pp0p0" title="Loss contingency amount"&gt;400,000&lt;/span&gt; and &lt;span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20200701__20210630__dei--LegalEntityAxis__custom--RegalConsultingLLCMember_pdd" title="Number of shares issued for services"&gt;60&lt;/span&gt; shares of the Company&#x2019;s common stock as payment for services that Regal purports to have performed.
Regal additionally claimed that $&lt;span id="xdx_908_eus-gaap--ConvertibleDebt_c20170531__dei--LegalEntityAxis__custom--RegalConsultingLLCMember__us-gaap--DebtInstrumentAxis__custom--TwoThousandAndSeventeenNoteMember_pp0p0" title="Convertible note"&gt;106,500&lt;/span&gt; remained due on a Convertible Note executed by the Company in May of 2017 and asserted that
it was owed in excess of $&lt;span id="xdx_90C_ecustom--LitigationPenaltyAmount_c20170501__20170531__dei--LegalEntityAxis__custom--RegalConsultingLLCMember__us-gaap--DebtInstrumentAxis__custom--TwoThousandAndSeventeenNoteMember_pp0p0" title="Penalty amount"&gt;100,000&lt;/span&gt; in penalties in connection with the Company&#x2019;s refusal to honor certain Conversion Notices. The
Company filed an Answer and Counterclaim, denying liability and alleging that Regal procured by fraud the Company&#x2019;s execution of
various consulting agreements and additionally failed to provide the consulting services contemplated by said agreements. On December
23, 2020, the parties mediated their dispute and negotiated a settlement agreement. On March 15, 2021, the Company entered into a Settlement
and Mutual Release Agreement with Regal whereby both parties agreed to settle all claims and liabilities under the August 10, 2017 Convertible
note (see Note 6) for a total of $&lt;span id="xdx_909_eus-gaap--ConvertibleDebt_c20170810__us-gaap--TypeOfArrangementAxis__custom--SettlementAndMutualReleaseAgreementMember__dei--LegalEntityAxis__custom--RegalConsultingLLCMember_pp0p0" title="Convertible note"&gt;100,000&lt;/span&gt;. All other terms of the August 10, 2017 Convertible Note shall remain in full force and effect.
Both parties agree that all future penalties under this convertible note are waived unless the Company fails to authorize the issuance
of the requested shares upon conversion. The Company has the right to pay off the balance of any remaining amounts dues under this convertible
note in cash at any time 61 days after March 15, 2021. Prior to the Settlement Agreement, the Company recorded total liabilities $&lt;span id="xdx_904_eus-gaap--Liabilities_c20210315__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementMember_pp0p0" title="Liabilities"&gt;56,762&lt;/span&gt;
consisting of remaining principal amount of $&lt;span id="xdx_909_ecustom--RemainingPrincipalAmount_c20210315__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementMember_pp0p0" title="Remaining principal amount"&gt;8,500&lt;/span&gt;, accrued interest of $&lt;span id="xdx_90C_eus-gaap--InterestPayableCurrentAndNoncurrent_c20210315__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementMember_pp0p0" title="Accrued interest"&gt;23,262&lt;/span&gt; and accrued expenses of $&lt;span id="xdx_906_eus-gaap--AccruedLiabilitiesCurrentAndNoncurrent_c20210315__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementMember_pp0p0" title="Accrued expenses"&gt;25,000&lt;/span&gt;. Accordingly, the Company
recognized loss from settlement of debt of $&lt;span id="xdx_90A_ecustom--GainLossFromSettlementOfDebt_c20200701__20210630__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementMember_pp0p0" title="Gain loss from settlement of debt"&gt;43,238&lt;/span&gt; during the year ended June 30, 2021.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;IRS
Liability&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;As
part of its requirement for having a foreign operating subsidiary, the Company&#x2019;s parent U.S. entity is required to file an informational
Form 5471 to the Internal Revenue Service (the &#x201c;IRS&#x201d;), which is a form that explains the nature of the relationship between
the foreign subsidiary and the parent company. From 2012 through the 2014, the Company did not file this form in a timely manner. As
a result of the non-timely filings, the Company incurred a penalty from the IRS in the amount of $&lt;span id="xdx_90D_ecustom--LitigationPenaltyAmount_c20200701__20210630__us-gaap--AwardDateAxis__custom--From2012ThroughThe2014Member_pp0p0"&gt;10,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;per year, or $&lt;span id="xdx_900_ecustom--LitigationPenaltyAmount_c20200701__20210630_pp0p0"&gt;30,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;in total, plus accrued interest,
such penalty and interest having been accrued and is included in the accrued expenses and other payable figure in the June
30, 2021 and 2020 consolidated balance sheet. The Company recorded the penalties for all three years during the year ended June 30,
2018. The Company is current on all subsequent filings. The Company&#x2019;s tax advisor is awaiting a response from the IRS on this matter.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;Operating
Agreements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 29.15pt; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;In
November 2009, the Company entered into a commercialization agreement with the University of Bath (UK) (the &#x201c;University&#x201d;)
whereby the Company and the University co-owned the intellectual property relating to the Company&#x2019;s pro-enzyme formulations. In
June 2012, the Company and the University entered into an assignment and amendment whereby the Company assumed full ownership of the
intellectual property while agreeing to pay royalties of &lt;span id="xdx_903_ecustom--OperatingLeasesIncomeStatementRevenuePercentage_dp_c20120601__20120630__us-gaap--TypeOfArrangementAxis__us-gaap--RoyaltyAgreementTermsMember_ztXEIiIkqski" title="Operating leases income statement revenue percentage"&gt;2%&lt;/span&gt; of net revenues to the University. Additionally, the Company agreed to pay
&lt;span id="xdx_90D_ecustom--OperatingLeasesIncomeStatementRevenuePercentage_dp_c20120601__20120630__us-gaap--TypeOfArrangementAxis__us-gaap--LicenseAgreementTermsMember_z9T7IV0czYM7" title="Operating leases income statement revenue percentage"&gt;5%&lt;/span&gt; of each and every license agreement subscribed for. The contract is cancellable at any time by either party. To date, no amounts are
owed under the agreement.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;Operating
Leases&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;On
May 5, 2016, the Company entered into a new &lt;span id="xdx_900_eus-gaap--LesseeOperatingLeaseTermOfContract_iI_dtYxL_c20160505__us-gaap--TypeOfArrangementAxis__custom--NewFiveYearOperatingLeaseAgreementMember_z8w18Ofpt9n3" title="::XDX::5"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2171"&gt;five&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;-year
operating lease agreement with a Horizon Pty Ltd., a related party, of which Mr. Nathanielsz, our CEO, CFO and a director, and his
wife are owners and directors, with monthly rent currently at $&lt;span id="xdx_90A_eus-gaap--PaymentsForRent_pp0p0_uAUD_c20160503__20160505__us-gaap--TypeOfArrangementAxis__custom--NewFiveYearOperatingLeaseAgreementMember__us-gaap--AwardTypeAxis__custom--AUDCurrencyMember_zJAHfK5JtGu7"&gt;3,606 &lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;AUD
or $&lt;span id="xdx_906_eus-gaap--PaymentsForRent_c20160503__20160505__us-gaap--TypeOfArrangementAxis__custom--NewFiveYearOperatingLeaseAgreementMember_pp0p0"&gt;2,469 &lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;USD,
inclusive of GST (See Note 10 &#x2013; Related Party Transactions). &lt;span id="xdx_906_eus-gaap--LesseeOperatingLeaseDescription_c20160503__20160505__us-gaap--TypeOfArrangementAxis__custom--NewFiveYearOperatingLeaseAgreementMember_zUVwnKDgQfVb" title="Operating lease, description"&gt;The
initial rental amount was $3,000 AUD and subject to 3% yearly escalation.&lt;/span&gt;&lt;/span&gt; &lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;In
adopting ASC Topic 842, Leases (Topic 842), the Company has elected the &#x2018;package of practical expedients&#x2019;, which permit
it not to reassess under the new standard its prior conclusions about lease identification, lease classification and initial direct
costs. In addition, the Company elected not to apply ASC Topic 842 to arrangements with lease terms of 12 month or less. On July 1,
2019, upon adoption of ASC Topic 842, the Company recorded right-of-use assets $&lt;span id="xdx_901_eus-gaap--OperatingLeaseRightOfUseAsset_c20190702__us-gaap--AdjustmentsForNewAccountingPronouncementsAxis__us-gaap--AccountingStandardsUpdate201602Member_pp0p0"&gt;48,662 &lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;and
total lease liabilities of $&lt;span id="xdx_906_eus-gaap--OperatingLeaseLiability_c20190702__us-gaap--AdjustmentsForNewAccountingPronouncementsAxis__us-gaap--AccountingStandardsUpdate201602Member_pp0p0"&gt;48,662 &lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;based
on an incremental borrowing rate of &lt;span id="xdx_90F_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_dp_c20190702__us-gaap--AdjustmentsForNewAccountingPronouncementsAxis__us-gaap--AccountingStandardsUpdate201602Member_zF48AVxpN5Kj"&gt;6%&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;. &lt;span&gt;&lt;span id="xdx_90F_eus-gaap--LesseeOperatingLeaseDescription_c20190701__20190702__us-gaap--AdjustmentsForNewAccountingPronouncementsAxis__us-gaap--AccountingStandardsUpdate201602Member_zmrqDZpVZnWa"&gt;Such lease expired in May 2021 and was renewed for another one-year term from May 2021 to May 2022&lt;/span&gt;&lt;/span&gt;. The Company is currently obligated to pay $&lt;span id="xdx_90C_eus-gaap--PaymentsForRent_pp0p0_uAUD_c20190701__20190702__us-gaap--AdjustmentsForNewAccountingPronouncementsAxis__us-gaap--AccountingStandardsUpdate201602Member__us-gaap--AwardTypeAxis__custom--AUDCurrencyMember_zFm9VsVr4wvd"&gt;3,606&lt;/span&gt;
AUD or $&lt;span id="xdx_905_eus-gaap--PaymentsForRent_pp0p0_c20190701__20190702__us-gaap--AdjustmentsForNewAccountingPronouncementsAxis__us-gaap--AccountingStandardsUpdate201602Member_zMOgPlkTjwcd"&gt;2,431&lt;/span&gt;
USD (depending on exchange rate), inclusive of tax, in rent per month.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;PROPANC
BIOPHARMA, INC. AND SUBSIDIARY&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;June
30, 2021 and 2020&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_894_ecustom--ScheduleOfRightUseOfAssetTableTextBlock_zGoPydUjdAul" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;ROU
is summarized below:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_8B3_z2t8Ilp9RHCg" style="display: none"&gt;SCHEDULE OF RIGHT USE OF ASSET&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"/&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20210630_zoufaAcQaxUc" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;June
    30, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49F_20200630_zWOmXQOOY9rc" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;June
    30, 2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--OperatingLeaseRightOfUseAssets_iI_pp0p0_maOLROUzHPs_zGh3imgPrtSe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 60%"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Office
    lease (24 months)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;48,662&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;48,662&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--AccumulatedReduction_iI_pp0p0_maOLROUzHPs_zapS6yhxmXci" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Less
    accumulated amortization&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;(48,662&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;(26,980&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--OperatingLeaseRightOfUseAsset_iTI_pp0p0_mtOLROUzHPs_zHMqylvljI8d" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Right-of-use
    asset, net&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2191"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;21,682&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A0_zZzvu0PT3Wg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_897_eus-gaap--OperatingLeaseLeaseIncomeTableTextBlock_z19UeNKNN7Qi" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Operating
Lease liabilities are summarized below:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span id="xdx_8B0_ztmPtNJAMDuh" style="display: none"&gt;SCHEDULE OF OPERATING LEASE LIABILITY&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"/&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49A_20210630_zNY5EJpe1z73" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;June
    30, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49A_20200630_zWmUsQuR4raf" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;June
    30, 2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--OfficeLeaseLiability_iI_pp0p0_maOLLzN3P_zkvx3R82HVp5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Office
    lease&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;48,662&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;48,662&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--ReductionOfLeaseLiability_iI_pp0p0_maOLLzN3P_zEK3QiecFcNb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Reduction
    of lease liability&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;(48,662&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;(23,590&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--OperatingLeaseLiability_iTI_pp0p0_mtOLLzN3P_zKZAcTC4Sz9l" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Long
    term portion of lease liability&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2202"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;25,072&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A2_zhAaq9TCl825" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;Collaboration
Agreement&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;On
September 13, 2018, the Company entered into a two-year collaboration agreement with the University of Ja&#xe9;n (the &#x201c;University&#x201d;)
to provide certain research services to the Company. In consideration of such services, the Company agreed to pay the University approximately
&lt;span id="xdx_90F_ecustom--PaymentForServices_pp0p0_uEuro_c20180910__20180913__us-gaap--TypeOfArrangementAxis__custom--OneYearCollaborationAgreementMember__us-gaap--AwardTypeAxis__custom--EurosMember_z8Esvlqtq8f7" title="Payment for services"&gt;52,000&lt;/span&gt; Euros ($&lt;span id="xdx_90D_ecustom--PaymentForServices_c20180910__20180913__us-gaap--TypeOfArrangementAxis__custom--OneYearCollaborationAgreementMember_pp0p0" title="Payment for services"&gt;59,508&lt;/span&gt; USD) in year one and a maximum of &lt;span id="xdx_90C_ecustom--PaymentForServices_pp0p0_uEuro_c20180910__20180913__us-gaap--TypeOfArrangementAxis__custom--TwoYearCollaborationAgreementMember__us-gaap--AwardTypeAxis__custom--EurosMember_zsw8QvfC93n2" title="Payment for services"&gt;40,000&lt;/span&gt; Euros ($&lt;span id="xdx_907_ecustom--PaymentForServices_c20180910__20180913__us-gaap--TypeOfArrangementAxis__custom--TwoYearCollaborationAgreementMember_pp0p0" title="Payment for services"&gt;45,775&lt;/span&gt; USD) in year two. The Company paid &lt;span id="xdx_90C_ecustom--PaymentForServices_pp0p0_uEuro_c20180701__20190630__us-gaap--AwardTypeAxis__custom--EurosMember_zRObpNRVjqDb" title="Payment for services"&gt;31,754&lt;/span&gt; Euros ($&lt;span id="xdx_903_ecustom--PaymentForServices_c20180701__20190630_pp0p0" title="Payment for services"&gt;36,117&lt;/span&gt;
USD) in 2019 and has accrued &lt;span id="xdx_90E_ecustom--PaymentForServices_pp0p0_uEuro_c20200701__20210630__us-gaap--AwardTypeAxis__custom--EurosMember_zZtt5T9DIDr8" title="Payment for services"&gt;28,493&lt;/span&gt; Euros ($&lt;span id="xdx_904_ecustom--PaymentForServices_c20200701__20210630_pp0p0" title="Payment for services"&gt;24,043&lt;/span&gt; USD) as of June 30, 2021. Additionally, in exchange for full ownership of the intellectual
property the Company agreed to pay royalties of &lt;span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_dp_c20180910__20180913__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--RevenueFromRightsConcentrationRiskMember__srt--MajorCustomersAxis__custom--NoCustomerMember_z7mggHXKVhrc" title="Royalties percentage"&gt;2%&lt;/span&gt; of net revenues to the University. On October 1, 2020, the Company entered into another
two-year collaboration agreement with the University of Ja&#xe9;n to provide certain research services to the Company. In consideration
of such services, the Company agreed to pay the University approximately &lt;span id="xdx_90E_ecustom--PaymentForServices_pp0p0_uEuro_c20200929__20201002__us-gaap--TypeOfArrangementAxis__custom--TwoYearCollaborationAgreementMember__us-gaap--AwardTypeAxis__custom--EurosMember_ztP48PuuYROl" title="Payment for services"&gt;30,000&lt;/span&gt; Euros ($&lt;span id="xdx_904_ecustom--PaymentForServices_c20200929__20201002__us-gaap--TypeOfArrangementAxis__custom--TwoYearCollaborationAgreementMember_pp0p0" title="Payment for services"&gt;35,145&lt;/span&gt; USD) which shall be paid in four installment
payment of &lt;span id="xdx_904_ecustom--PaymentForServices_pp0p0_uEuro_c20200929__20201002__us-gaap--TypeOfArrangementAxis__custom--TwoYearCollaborationAgreementMember__us-gaap--AwardTypeAxis__custom--EurosMember__us-gaap--AwardDateAxis__custom--InstallmentOneMember_zE1rMSMFgGAk" title="Payment for services"&gt;5,000&lt;/span&gt; Euros in November 2020, &lt;span id="xdx_90F_ecustom--PaymentForServices_pp0p0_uEuro_c20200929__20201002__us-gaap--TypeOfArrangementAxis__custom--TwoYearCollaborationAgreementMember__us-gaap--AwardDateAxis__custom--InstallmentTwoMember__us-gaap--AwardTypeAxis__custom--EurosMember_ztKvwPExcYt2" title="Payment for services"&gt;5,000&lt;/span&gt; Euros ($&lt;span id="xdx_906_ecustom--PaymentForServices_c20200929__20201002__us-gaap--TypeOfArrangementAxis__custom--TwoYearCollaborationAgreementMember__us-gaap--AwardDateAxis__custom--InstallmentTwoMember_pp0p0" title="Payment for services"&gt;5,858&lt;/span&gt;) in March 2021, &lt;span id="xdx_908_ecustom--PaymentForServices_pp0p0_uEuro_c20200929__20201002__us-gaap--TypeOfArrangementAxis__custom--TwoYearCollaborationAgreementMember__us-gaap--AwardDateAxis__custom--InstallmentThreeMember__us-gaap--AwardTypeAxis__custom--EurosMember_zxu4BWFl0ja" title="Payment for services"&gt;10,000&lt;/span&gt; Euros ($&lt;span id="xdx_909_ecustom--PaymentForServices_c20200929__20201002__us-gaap--TypeOfArrangementAxis__custom--TwoYearCollaborationAgreementMember__us-gaap--AwardDateAxis__custom--InstallmentThreeMember_pp0p0" title="Payment for services"&gt;11,715&lt;/span&gt;) in December 2021 and &lt;span id="xdx_902_ecustom--PaymentForServices_pp0p0_uEuro_c20200929__20201002__us-gaap--TypeOfArrangementAxis__custom--TwoYearCollaborationAgreementMember__us-gaap--AwardDateAxis__custom--InstallmentFourMember__us-gaap--AwardTypeAxis__custom--EurosMember_z8iModjJQVl" title="Payment for services"&gt;10,000&lt;/span&gt; Euros
($&lt;span id="xdx_900_ecustom--PaymentForServices_c20200929__20201002__us-gaap--TypeOfArrangementAxis__custom--TwoYearCollaborationAgreementMember__us-gaap--AwardDateAxis__custom--InstallmentFourMember_pp0p0" title="Payment for services"&gt;11,715&lt;/span&gt;) in September 2022. Additionally, the University shall hire and train a doctoral student for this project and as such the Company
shall pay the University &lt;span id="xdx_909_ecustom--PaymentForServices_pp0p0_uEuro_c20200929__20201002__dei--LegalEntityAxis__custom--UniversityOfJaenMember__us-gaap--AwardTypeAxis__custom--EurosMember_zktznTOCKlk2" title="Payment for services"&gt;25,837&lt;/span&gt; Euros ($&lt;span id="xdx_900_ecustom--PaymentForServices_c20200929__20201002__dei--LegalEntityAxis__custom--UniversityOfJaenMember_pp0p0" title="Payment for services"&gt;30,268&lt;/span&gt; USD). In exchange for full ownership of the intellectual property the Company agreed to
pay royalties of &lt;span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_dp_c20200929__20201002__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__dei--LegalEntityAxis__custom--UniversityOfJaenMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--RevenueFromRightsConcentrationRiskMember__srt--MajorCustomersAxis__custom--NoCustomerMember_z4ZzunSRlP18" title="Royalties percentage"&gt;2%&lt;/span&gt; of net revenues to the University.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:LegalFees
      contextRef="From2019-09-252019-09-26_custom_FoleyShechterMember"
      decimals="0"
      unitRef="USD">151031</us-gaap:LegalFees>
    <us-gaap:ProfessionalFees
      contextRef="From2021-03-202021-03-22_custom_SettlementAgreementMember_custom_FoleyShechterMember"
      decimals="0"
      unitRef="USD">51032</us-gaap:ProfessionalFees>
    <PPCB:SettlementAmount
      contextRef="AsOf2021-03-22_custom_SettlementAgreementMember_custom_FoleyShechterMember"
      decimals="0"
      unitRef="USD">51032</PPCB:SettlementAmount>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
      contextRef="AsOf2021-03-22_custom_SettlementAgreementMember_custom_FoleyShechterMember"
      decimals="0"
      unitRef="USD">142660</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent>
    <PPCB:GainLossFromSettlementOfDebt
      contextRef="From2020-07-012021-06-30_custom_SettlementAgreementMember_custom_FoleyShechterMember"
      decimals="0"
      unitRef="USD">92556</PPCB:GainLossFromSettlementOfDebt>
    <us-gaap:LossContingencyDamagesSoughtValue
      contextRef="From2020-07-012021-06-30_custom_RegalConsultingLLCMember"
      decimals="0"
      unitRef="USD">400000</us-gaap:LossContingencyDamagesSoughtValue>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2020-07-012021-06-30_custom_RegalConsultingLLCMember"
      decimals="INF"
      unitRef="Shares">60</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:ConvertibleDebt
      contextRef="AsOf2017-05-31_custom_RegalConsultingLLCMember_custom_TwoThousandAndSeventeenNoteMember"
      decimals="0"
      unitRef="USD">106500</us-gaap:ConvertibleDebt>
    <PPCB:LitigationPenaltyAmount
      contextRef="From2017-05-012017-05-31_custom_RegalConsultingLLCMember_custom_TwoThousandAndSeventeenNoteMember"
      decimals="0"
      unitRef="USD">100000</PPCB:LitigationPenaltyAmount>
    <us-gaap:ConvertibleDebt
      contextRef="AsOf2017-08-10_custom_SettlementAndMutualReleaseAgreementMember_custom_RegalConsultingLLCMember"
      decimals="0"
      unitRef="USD">100000</us-gaap:ConvertibleDebt>
    <us-gaap:Liabilities
      contextRef="AsOf2021-03-15_custom_SettlementAgreementMember"
      decimals="0"
      unitRef="USD">56762</us-gaap:Liabilities>
    <PPCB:RemainingPrincipalAmount
      contextRef="AsOf2021-03-15_custom_SettlementAgreementMember"
      decimals="0"
      unitRef="USD">8500</PPCB:RemainingPrincipalAmount>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="AsOf2021-03-15_custom_SettlementAgreementMember"
      decimals="0"
      unitRef="USD">23262</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:AccruedLiabilitiesCurrentAndNoncurrent
      contextRef="AsOf2021-03-15_custom_SettlementAgreementMember"
      decimals="0"
      unitRef="USD">25000</us-gaap:AccruedLiabilitiesCurrentAndNoncurrent>
    <PPCB:GainLossFromSettlementOfDebt
      contextRef="From2020-07-012021-06-30_custom_SettlementAgreementMember"
      decimals="0"
      unitRef="USD">43238</PPCB:GainLossFromSettlementOfDebt>
    <PPCB:LitigationPenaltyAmount
      contextRef="From2020-07-012021-06-30_custom_From2012ThroughThe2014Member"
      decimals="0"
      unitRef="USD">10000</PPCB:LitigationPenaltyAmount>
    <PPCB:LitigationPenaltyAmount
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">30000</PPCB:LitigationPenaltyAmount>
    <PPCB:OperatingLeasesIncomeStatementRevenuePercentage
      contextRef="From2012-06-012012-06-30_us-gaap_RoyaltyAgreementTermsMember"
      decimals="INF"
      unitRef="Pure">0.02</PPCB:OperatingLeasesIncomeStatementRevenuePercentage>
    <PPCB:OperatingLeasesIncomeStatementRevenuePercentage
      contextRef="From2012-06-012012-06-30_us-gaap_LicenseAgreementTermsMember"
      decimals="INF"
      unitRef="Pure">0.05</PPCB:OperatingLeasesIncomeStatementRevenuePercentage>
    <us-gaap:PaymentsForRent
      contextRef="From2016-05-032016-05-05_custom_NewFiveYearOperatingLeaseAgreementMember_custom_AUDCurrencyMember"
      decimals="0"
      unitRef="AUD">3606</us-gaap:PaymentsForRent>
    <us-gaap:PaymentsForRent
      contextRef="From2016-05-032016-05-05_custom_NewFiveYearOperatingLeaseAgreementMember"
      decimals="0"
      unitRef="USD">2469</us-gaap:PaymentsForRent>
    <us-gaap:LesseeOperatingLeaseDescription contextRef="From2016-05-032016-05-05_custom_NewFiveYearOperatingLeaseAgreementMember">The
initial rental amount was $3,000 AUD and subject to 3% yearly escalation.</us-gaap:LesseeOperatingLeaseDescription>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="AsOf2019-07-02_us-gaap_AccountingStandardsUpdate201602Member"
      decimals="0"
      unitRef="USD">48662</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiability
      contextRef="AsOf2019-07-02_us-gaap_AccountingStandardsUpdate201602Member"
      decimals="0"
      unitRef="USD">48662</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="AsOf2019-07-02_us-gaap_AccountingStandardsUpdate201602Member"
      decimals="INF"
      unitRef="Pure">0.06</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:LesseeOperatingLeaseDescription contextRef="From2019-07-012019-07-02_us-gaap_AccountingStandardsUpdate201602Member">Such lease expired in May 2021 and was renewed for another one-year term from May 2021 to May 2022</us-gaap:LesseeOperatingLeaseDescription>
    <us-gaap:PaymentsForRent
      contextRef="From2019-07-012019-07-02_us-gaap_AccountingStandardsUpdate201602Member_custom_AUDCurrencyMember"
      decimals="0"
      unitRef="AUD">3606</us-gaap:PaymentsForRent>
    <us-gaap:PaymentsForRent
      contextRef="From2019-07-012019-07-02_us-gaap_AccountingStandardsUpdate201602Member"
      decimals="0"
      unitRef="USD">2431</us-gaap:PaymentsForRent>
    <PPCB:ScheduleOfRightUseOfAssetTableTextBlock contextRef="From2020-07-012021-06-30">&lt;p id="xdx_894_ecustom--ScheduleOfRightUseOfAssetTableTextBlock_zGoPydUjdAul" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;ROU
is summarized below:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_8B3_z2t8Ilp9RHCg" style="display: none"&gt;SCHEDULE OF RIGHT USE OF ASSET&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"/&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20210630_zoufaAcQaxUc" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;June
    30, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49F_20200630_zWOmXQOOY9rc" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;June
    30, 2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--OperatingLeaseRightOfUseAssets_iI_pp0p0_maOLROUzHPs_zGh3imgPrtSe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 60%"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Office
    lease (24 months)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;48,662&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;48,662&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--AccumulatedReduction_iI_pp0p0_maOLROUzHPs_zapS6yhxmXci" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Less
    accumulated amortization&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;(48,662&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;(26,980&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--OperatingLeaseRightOfUseAsset_iTI_pp0p0_mtOLROUzHPs_zHMqylvljI8d" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Right-of-use
    asset, net&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2191"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;21,682&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</PPCB:ScheduleOfRightUseOfAssetTableTextBlock>
    <PPCB:OperatingLeaseRightOfUseAssets contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">48662</PPCB:OperatingLeaseRightOfUseAssets>
    <PPCB:OperatingLeaseRightOfUseAssets contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">48662</PPCB:OperatingLeaseRightOfUseAssets>
    <PPCB:AccumulatedReduction contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">-48662</PPCB:AccumulatedReduction>
    <PPCB:AccumulatedReduction contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">-26980</PPCB:AccumulatedReduction>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">21682</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLeaseIncomeTableTextBlock contextRef="From2020-07-012021-06-30">&lt;p id="xdx_897_eus-gaap--OperatingLeaseLeaseIncomeTableTextBlock_z19UeNKNN7Qi" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Operating
Lease liabilities are summarized below:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span id="xdx_8B0_ztmPtNJAMDuh" style="display: none"&gt;SCHEDULE OF OPERATING LEASE LIABILITY&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"/&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49A_20210630_zNY5EJpe1z73" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;June
    30, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49A_20200630_zWmUsQuR4raf" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;June
    30, 2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--OfficeLeaseLiability_iI_pp0p0_maOLLzN3P_zkvx3R82HVp5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Office
    lease&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;48,662&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;48,662&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--ReductionOfLeaseLiability_iI_pp0p0_maOLLzN3P_zEK3QiecFcNb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Reduction
    of lease liability&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;(48,662&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;(23,590&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--OperatingLeaseLiability_iTI_pp0p0_mtOLLzN3P_zKZAcTC4Sz9l" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Long
    term portion of lease liability&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2202"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;25,072&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</us-gaap:OperatingLeaseLeaseIncomeTableTextBlock>
    <PPCB:OfficeLeaseLiability contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">48662</PPCB:OfficeLeaseLiability>
    <PPCB:OfficeLeaseLiability contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">48662</PPCB:OfficeLeaseLiability>
    <PPCB:ReductionOfLeaseLiability contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">-48662</PPCB:ReductionOfLeaseLiability>
    <PPCB:ReductionOfLeaseLiability contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">-23590</PPCB:ReductionOfLeaseLiability>
    <us-gaap:OperatingLeaseLiability contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">25072</us-gaap:OperatingLeaseLiability>
    <PPCB:PaymentForServices
      contextRef="From2018-09-102018-09-13_custom_OneYearCollaborationAgreementMember_custom_EurosMember"
      decimals="0"
      unitRef="Euro">52000</PPCB:PaymentForServices>
    <PPCB:PaymentForServices
      contextRef="From2018-09-102018-09-13_custom_OneYearCollaborationAgreementMember"
      decimals="0"
      unitRef="USD">59508</PPCB:PaymentForServices>
    <PPCB:PaymentForServices
      contextRef="From2018-09-102018-09-13_custom_TwoYearCollaborationAgreementMember_custom_EurosMember"
      decimals="0"
      unitRef="Euro">40000</PPCB:PaymentForServices>
    <PPCB:PaymentForServices
      contextRef="From2018-09-102018-09-13_custom_TwoYearCollaborationAgreementMember"
      decimals="0"
      unitRef="USD">45775</PPCB:PaymentForServices>
    <PPCB:PaymentForServices
      contextRef="From2018-07-012019-06-30_custom_EurosMember"
      decimals="0"
      unitRef="Euro">31754</PPCB:PaymentForServices>
    <PPCB:PaymentForServices
      contextRef="From2018-07-012019-06-30"
      decimals="0"
      unitRef="USD">36117</PPCB:PaymentForServices>
    <PPCB:PaymentForServices
      contextRef="From2020-07-012021-06-30_custom_EurosMember"
      decimals="0"
      unitRef="Euro">28493</PPCB:PaymentForServices>
    <PPCB:PaymentForServices
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">24043</PPCB:PaymentForServices>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2018-09-102018-09-13_us-gaap_SalesRevenueNetMember_us-gaap_RevenueFromRightsConcentrationRiskMember_custom_NoCustomerMember"
      decimals="INF"
      unitRef="Pure">0.02</us-gaap:ConcentrationRiskPercentage1>
    <PPCB:PaymentForServices
      contextRef="From2020-09-292020-10-02_custom_TwoYearCollaborationAgreementMember_custom_EurosMember"
      decimals="0"
      unitRef="Euro">30000</PPCB:PaymentForServices>
    <PPCB:PaymentForServices
      contextRef="From2020-09-292020-10-02_custom_TwoYearCollaborationAgreementMember"
      decimals="0"
      unitRef="USD">35145</PPCB:PaymentForServices>
    <PPCB:PaymentForServices
      contextRef="From2020-09-292020-10-02_custom_TwoYearCollaborationAgreementMember_custom_EurosMember_custom_InstallmentOneMember"
      decimals="0"
      unitRef="Euro">5000</PPCB:PaymentForServices>
    <PPCB:PaymentForServices
      contextRef="From2020-09-292020-10-02_custom_TwoYearCollaborationAgreementMember_custom_InstallmentTwoMember_custom_EurosMember"
      decimals="0"
      unitRef="Euro">5000</PPCB:PaymentForServices>
    <PPCB:PaymentForServices
      contextRef="From2020-09-292020-10-02_custom_TwoYearCollaborationAgreementMember_custom_InstallmentTwoMember"
      decimals="0"
      unitRef="USD">5858</PPCB:PaymentForServices>
    <PPCB:PaymentForServices
      contextRef="From2020-09-292020-10-02_custom_TwoYearCollaborationAgreementMember_custom_InstallmentThreeMember_custom_EurosMember"
      decimals="0"
      unitRef="Euro">10000</PPCB:PaymentForServices>
    <PPCB:PaymentForServices
      contextRef="From2020-09-292020-10-02_custom_TwoYearCollaborationAgreementMember_custom_InstallmentThreeMember"
      decimals="0"
      unitRef="USD">11715</PPCB:PaymentForServices>
    <PPCB:PaymentForServices
      contextRef="From2020-09-292020-10-02_custom_TwoYearCollaborationAgreementMember_custom_InstallmentFourMember_custom_EurosMember"
      decimals="0"
      unitRef="Euro">10000</PPCB:PaymentForServices>
    <PPCB:PaymentForServices
      contextRef="From2020-09-292020-10-02_custom_TwoYearCollaborationAgreementMember_custom_InstallmentFourMember"
      decimals="0"
      unitRef="USD">11715</PPCB:PaymentForServices>
    <PPCB:PaymentForServices
      contextRef="From2020-09-292020-10-02_custom_UniversityOfJaenMember_custom_EurosMember"
      decimals="0"
      unitRef="Euro">25837</PPCB:PaymentForServices>
    <PPCB:PaymentForServices
      contextRef="From2020-09-292020-10-02_custom_UniversityOfJaenMember"
      decimals="0"
      unitRef="USD">30268</PPCB:PaymentForServices>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2020-09-292020-10-02_us-gaap_SalesRevenueNetMember_custom_UniversityOfJaenMember_us-gaap_RevenueFromRightsConcentrationRiskMember_custom_NoCustomerMember"
      decimals="INF"
      unitRef="Pure">0.02</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="From2020-07-012021-06-30">&lt;p id="xdx_806_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zzD8WGT4aV38" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;NOTE
10 &#x2013; &lt;span id="xdx_82F_zkTUa11D0wZ"&gt;RELATED PARTY TRANSACTIONS&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Since
its inception, the Company has conducted transactions with its directors and entities related to such directors. These transactions have
included the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;As
of June 30, 2021 and 2020, the Company owed its former director a total of $&lt;span id="xdx_90F_ecustom--LoansFromRelatedParty_c20210630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--CurrentAndFormerDirectorMember_pp0p0" title="Loans from related party"&gt;55,500&lt;/span&gt; and $&lt;span id="xdx_90E_ecustom--LoansFromRelatedParty_c20200630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--CurrentAndFormerDirectorMember_pp0p0" title="Loans from related party"&gt;50,993&lt;/span&gt;, respectively, for money loaned to the
Company throughout the years. The total loans balance owed at June 30, 2021 and 2020 is not interest bearing (See Note 5 &#x2013; Loans
and Notes Payable).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;As
of June 30, 2021 and 2020, the Company owed its former director a total of $&lt;span id="xdx_90B_eus-gaap--DueToRelatedPartiesCurrent_c20210630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--FormerDirectorMember_pp0p0" title="Due to related parties"&gt;33,347&lt;/span&gt; and $&lt;span id="xdx_90A_eus-gaap--DueToRelatedPartiesCurrent_c20200630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--FormerDirectorMember_pp0p0" title="Due to related parties"&gt;30,639&lt;/span&gt;, respectively, related to expenses paid
on behalf of the Company related to corporate startup costs and intellectual property (See Note 4 &#x2013; Due to Former Director &#x2013;
Related Party).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Effective
May 5, 2016, the Company entered into an agreement for the lease of its principal executive offices with North Horizon Pty Ltd., a related
party, of which Mr. Nathanielsz, our CEO, CFO and a director, and his wife are owners and directors. The lease has a &lt;span id="xdx_900_eus-gaap--LessorOperatingLeaseTermOfContract_iI_dtYxL_c20160505__dei--LegalEntityAxis__custom--NorthHorizonPtyLtdMember_zcSkroEftsR" title="::XDX::5"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2256"&gt;five&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;-year
term and provides for annual rental payments of $&lt;span id="xdx_900_eus-gaap--OperatingLeasesRentExpenseMinimumRentals_pp0p0_uAUD_c20160503__20160505__dei--LegalEntityAxis__custom--NorthHorizonPtyLtdMember__us-gaap--AwardTypeAxis__custom--AUDCurrencyMember_ziyfUdJ6SMsc"&gt;39,600
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;AUD or $&lt;span id="xdx_909_eus-gaap--OperatingLeasesRentExpenseMinimumRentals_c20160503__20160505__dei--LegalEntityAxis__custom--NorthHorizonPtyLtdMember_pp0p0"&gt;28,325
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;USD, which includes $&lt;span id="xdx_90F_ecustom--GoodsAndServiceTax_pp0p0_uAUD_c20160503__20160505__dei--LegalEntityAxis__custom--NorthHorizonPtyLtdMember__us-gaap--AwardTypeAxis__custom--AUDCurrencyMember_zYv6xR0CPQ09"&gt;3,600
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;AUD or $&lt;span id="xdx_904_ecustom--GoodsAndServiceTax_c20160503__20160505__dei--LegalEntityAxis__custom--NorthHorizonPtyLtdMember_pp0p0"&gt;2,575
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;USD of goods and service tax for
total payments of $&lt;span id="xdx_90E_eus-gaap--OperatingLeasesFutureMinimumPaymentsDue_iI_pp0p0_uAUD_c20160505__dei--LegalEntityAxis__custom--NorthHorizonPtyLtdMember__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NathanielszMember_zHUUCd1ACDlc"&gt;198,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;AUD or $&lt;span id="xdx_908_eus-gaap--OperatingLeasesFutureMinimumPaymentsDue_c20160505__dei--LegalEntityAxis__custom--NorthHorizonPtyLtdMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NathanielszMember_pp0p0"&gt;141,629
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;USD during the term of the lease.
As of June 30, 2021, total rent payable of $&lt;span id="xdx_90C_eus-gaap--PaymentsForRent_pp0p0_uAUD_c20200701__20210630__dei--LegalEntityAxis__custom--NorthHorizonPtyLtdMember__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember_zrnorhVlpEih"&gt;86,129
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;AUD ($&lt;span id="xdx_907_eus-gaap--PaymentsForRent_c20200701__20210630__dei--LegalEntityAxis__custom--NorthHorizonPtyLtdMember_pp0p0"&gt;64,597
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;USD) is included in accrued expenses
in the accompanying consolidated balance sheet. &lt;span&gt;&lt;span id="xdx_90F_eus-gaap--LesseeOperatingLeaseDescription_c20190701__20190702__us-gaap--AdjustmentsForNewAccountingPronouncementsAxis__us-gaap--AccountingStandardsUpdate201602Member_zGJRpruMJUSi"&gt;Such lease expired in May 2021 and was renewed for another one-year term from May 2021 to May 2022&lt;/span&gt;&lt;/span&gt; (See Note 9 &#x2013; Commitments and Contingencies).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;PROPANC
BIOPHARMA, INC. AND SUBSIDIARY&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;June
30, 2021 and 2020&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;i&gt;Employment
and Services Agreements with Management&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;The
Company and Mr. Nathanielsz entered into an employment agreement as of February 25, 2015 (the &#x201c;Nathanielsz Employment Agreement&#x201d;)
setting forth the terms and conditions of Mr. Nathanielsz employment as the Company&#x2019;s President and Chief Executive Officer. The
Nathanielsz Employment Agreement was scheduled to expire on &lt;span id="xdx_904_eus-gaap--RelatedPartyTransactionDate_dd_c20150224__20150225__us-gaap--TypeOfArrangementAxis__custom--NathanielszEmploymentAgreementMember_zL101soAiIPb" title="Expired date"&gt;February 25, 2019&lt;/span&gt;; however, the term of the Nathanielsz Employment Agreement
automatically renews for successive one-year periods unless either party provides 30 days&#x2019; prior written notice of its intent not
to renew. The Nathanielsz Employment Agreement continues in effect as of June 30, 2021 as amended May 14, 2019 (see below). The Nathanielsz
Employment Agreement provides Mr. Nathanielsz with a base salary of $&lt;span id="xdx_909_eus-gaap--SalariesAndWages_pp0p0_uAUD_c20150224__20150225__us-gaap--TypeOfArrangementAxis__custom--NathanielszEmploymentAgreementMember__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember_zYoqbdpF6Lj8" title="Annual salary"&gt;25,000&lt;/span&gt; AUD per month ($&lt;span id="xdx_901_eus-gaap--SalariesAndWages_pp0p0_uAUD_c20200701__20210630__us-gaap--TypeOfArrangementAxis__custom--NathanielszEmploymentAgreementMember__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember_zR0jkp8oaqU5" title="Annual salary"&gt;300,000&lt;/span&gt; AUD annually or $&lt;span id="xdx_90F_eus-gaap--SalariesAndWages_c20200701__20210630__us-gaap--TypeOfArrangementAxis__custom--NathanielszEmploymentAgreementMember_pp0p0" title="Annual salary"&gt;205,680&lt;/span&gt; USD) and
a monthly contribution to Mr. Nathanielsz&#x2019;s pension equal to &lt;span id="xdx_904_ecustom--PercentageOfPensionOfMonthlySalary_dp_c20200701__20210630__us-gaap--TypeOfArrangementAxis__custom--NathanielszEmploymentAgreementMember_zc3W4JZ4V5g6" title="Percentage of pension of monthly salary"&gt;9.5%&lt;/span&gt; of his monthly salary. Mr. Nathanielsz has the ability to convert
any accrued but unpaid salary into common stock at the end of each fiscal year at a conversion price to be determined by Mr. Nathanielsz
and the Company, which will in no event be lower than par value or higher than the closing bid price on the date of conversion. Pursuant
to the Nathanielsz Employment Agreement, Mr. Nathanielsz is entitled to an annual discretionary bonus in an amount up to &lt;span id="xdx_90A_ecustom--PercentageOfBonusOfAnnualBaseSalary_dp_uPure_c20200701__20210630__us-gaap--TypeOfArrangementAxis__custom--NathanielszEmploymentAgreementMember_zRkqX1Xzgqc8" title="Percentage of bonus of annual base salary"&gt;200%&lt;/span&gt; of his
annual base salary, which bonus shall be determined by the Company&#x2019;s board of directors based upon the performance of the Company.
On March 16, 2018, the Company&#x2019;s board of directors approved an increase of Mr. Nathanielsz&#x2019;s annual base salary from $&lt;span id="xdx_90F_eus-gaap--SalariesAndWages_pp0p0_uAUD_c20180315__20180316__us-gaap--TypeOfArrangementAxis__custom--NathanielszEmploymentAgreementMember__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember__srt--RangeAxis__srt--MinimumMember_zfz7g8ilDkHa" title="Annual salary"&gt;300,000&lt;/span&gt;
AUD ($&lt;span id="xdx_902_eus-gaap--SalariesAndWages_c20180315__20180316__us-gaap--TypeOfArrangementAxis__custom--NathanielszEmploymentAgreementMember__srt--RangeAxis__srt--MinimumMember_pp0p0" title="Annual salary"&gt;205,680&lt;/span&gt; USD) to $&lt;span id="xdx_902_eus-gaap--SalariesAndWages_pp0p0_uAUD_c20180315__20180316__us-gaap--TypeOfArrangementAxis__custom--NathanielszEmploymentAgreementMember__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember__srt--RangeAxis__srt--MaximumMember_zlk1mxratRg4" title="Annual salary"&gt;400,000&lt;/span&gt; AUD ($&lt;span id="xdx_900_eus-gaap--SalariesAndWages_c20180315__20180316__us-gaap--TypeOfArrangementAxis__custom--NathanielszEmploymentAgreementMember__srt--RangeAxis__srt--MaximumMember_pp0p0" title="Annual salary"&gt;274,240&lt;/span&gt; USD), effective February 2018.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Mr.
Nathanielsz&#x2019;s wife, Sylvia Nathanielsz, is and has been a non-executive part-time employee of the Company since October 2015. Effective
February 1, 2018, Mrs. Nathanielsz receives an annual salary of $&lt;span id="xdx_905_eus-gaap--SalariesAndWages_pp0p0_uAUD_c20180128__20180201__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrsNathanielszMember__us-gaap--AwardTypeAxis__custom--AUDCurrencyMember_zHixLQFUIPr7" title="Annual salary"&gt;120,000&lt;/span&gt; AUD ($&lt;span id="xdx_90A_eus-gaap--SalariesAndWages_c20180128__20180201__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrsNathanielszMember_pp0p0" title="Annual salary"&gt;80,904&lt;/span&gt; USD) and is entitled to customary benefits.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.45in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Pursuant
to a February 25, 2016 board resolution, James Nathanielsz shall be paid $&lt;span id="xdx_900_eus-gaap--RepaymentsOfRelatedPartyDebt_pp0p0_uAUD_c20160224__20160225__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--JamesNathanielszMember__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember_zsc5Uu3BkKMi" title="Payments form related party"&gt;4,481&lt;/span&gt; AUD ($&lt;span id="xdx_90F_eus-gaap--RepaymentsOfRelatedPartyDebt_c20160224__20160225__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--JamesNathanielszMember_pp0p0" title="Payments form related party"&gt;3,205&lt;/span&gt; USD), on a monthly basis for the purpose
of acquiring and maintaining an automobile. For the year ended June 30, 2020, a total of $&lt;span id="xdx_909_eus-gaap--RepaymentsOfRelatedPartyDebt_pp0p0_uAUD_c20190701__20200630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrsNathanielszMember__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember_z0vnOVOV1umh" title="Payments form related party"&gt;44,918&lt;/span&gt; AUD ($&lt;span id="xdx_906_eus-gaap--RepaymentsOfRelatedPartyDebt_pp0p0_c20190701__20200630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrsNathanielszMember_zuqdo4grtdkc" title="Payments form related party"&gt;30,284&lt;/span&gt; USD) in payments have been
made with respect to Mr. Nathanielsz&#x2019;s car allowance. For the year ended June 30, 2021, a total of $&lt;span id="xdx_90A_eus-gaap--RepaymentsOfRelatedPartyDebt_pp0p0_uAUD_c20200701__20210630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrsNathanielszMember__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember_zQuyUSmDfHdd" title="Payments form related party"&gt;46,135&lt;/span&gt; AUD ($&lt;span id="xdx_90F_eus-gaap--RepaymentsOfRelatedPartyDebt_pp0p0_c20200701__20210630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrsNathanielszMember_zsJx3gWyphf7" title="Payments form related party"&gt;34,476&lt;/span&gt; USD) in
payments have been made with respect to Mr. Nathanielsz&#x2019;s car allowance.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Pursuant
to the approval of the Company&#x2019;s board of directors, on May 14, 2019, Mr. Nathanielsz was granted a $&lt;span id="xdx_90D_eus-gaap--OfficersCompensation_pp0p0_uAUD_c20190513__20190514__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsMember__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember_zhr5r6niZC3i"&gt;460,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;AUD ($&lt;span id="xdx_907_eus-gaap--OfficersCompensation_c20190513__20190514__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsMember_pp0p0"&gt;315,376
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;USD) bonus for accomplishments
achieved while serving as the Company&#x2019;s Chief Executive Officer during the fiscal year ended June 30, 2019 with $&lt;span id="xdx_908_ecustom--BonusPayableAmount_pp0p0_uAUD_c20180701__20190630__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember_zrUcMs0KvEzg"&gt;200,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;AUD ($&lt;span id="xdx_90D_ecustom--BonusPayableAmount_c20180701__20190630__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_pp0p0"&gt;137,120
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;USD) of such bonus payable by the
Corporation to the CEO throughout the Corporation&#x2019;s 2019 fiscal year as the Corporation&#x2019;s cash resources allow, with the
remaining $&lt;span id="xdx_900_ecustom--RemainingBonusAmount_pp0p0_uAUD_c20180701__20190630__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember_zopoISWozugl"&gt;260,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;AUD ($&lt;span id="xdx_90C_ecustom--RemainingBonusAmount_c20180701__20190630__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_pp0p0"&gt;178,256
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;USD) of such bonus to be deferred
by the CEO until a future date when the Corporation&#x2019;s cash resources allow for such payment, as agreed to by the CEO. A total of
$&lt;span id="xdx_900_eus-gaap--RepaymentsOfRelatedPartyDebt_pp0p0_uAUD_c20180701__20190630__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember_zJKyJ7nmmqnb"&gt;90,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;AUD ($&lt;span id="xdx_909_eus-gaap--RepaymentsOfRelatedPartyDebt_c20180701__20190630__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_pp0p0"&gt;64,377
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;USD) in payments were made in the
year ended June 30, 2019. On July 13, 2020, the Board approved a bonus of $&lt;span id="xdx_90C_eus-gaap--OfficersCompensation_pp0p0_uAUD_c20200712__20200713__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsMember__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember_zAfbIS2TyxH4"&gt;240,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;AUD being equal to &lt;span id="xdx_908_ecustom--BonusAwardsGrantedPercentage_dp_c20200712__20200713__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsMember__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember_zCFbwsynHeB5"&gt;60%
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;of Mr. Nathanielsz base salary
which was accrued as of June 30, 2020. A total of $&lt;span id="xdx_908_eus-gaap--RepaymentsOfRelatedPartyDebt_pp0p0_uAUD_c20190701__20200630__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember_zHe68DZ7ogVa"&gt;202,620
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;AUD ($&lt;span id="xdx_900_eus-gaap--RepaymentsOfRelatedPartyDebt_c20190701__20200630__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_pp0p0"&gt;136,606
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;USD) in payments were made against
the bonuses during the year ended June 30, 2020 which resulted to a remaining balance of $&lt;span id="xdx_906_ecustom--BonusPayable_pp0p0_uAUD_c20190701__20200630__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember_z6cjrBUkSy06"&gt;407,380
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;AUD ($&lt;span id="xdx_907_ecustom--BonusPayable_c20190701__20200630__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_pp0p0"&gt;280,726
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;USD) bonus payable as of June 30,
2020. On August 12, 2021, the Board approved a bonus of $&lt;span id="xdx_903_eus-gaap--OfficersCompensation_pp0p0_c20210811__20210812__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zTR9d7GO44Ca"&gt;177,840
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;USD. A total of $&lt;span id="xdx_90E_eus-gaap--RepaymentsOfRelatedPartyDebt_pp0p0_uAUD_c20200701__20210630__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember_zIK7GAubQko"&gt;221,890
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;AUD ($&lt;span id="xdx_90D_ecustom--BonusPayable_c20200701__20210630__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_pp0p0"&gt;166,418
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;USD) in payments were made against
the bonuses during the year ended June 30, 2021 resulting in a remaining balance of $&lt;span id="xdx_90D_ecustom--BonusPayable_pp0p0_uAUD_c20200701__20210630__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember_zzKb2zutJYC5"&gt;422,610
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;AUD ($&lt;span id="xdx_904_ecustom--BonusPayable_pp0p0_c20200701__20210630__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--TypeOfArrangementAxis__custom--MrsNathanielszMember_zw75G6lgrDWj"&gt;316,957
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;USD) bonus payable as of June 30,
2021 which is included in accrued expenses in the accompanying consolidated balance sheet. On August 12, 2021, pursuant to the Cancellation
Agreement, Mr. Nathanielsz agreed to cancel $&lt;span id="xdx_904_eus-gaap--OfficersCompensation_c20210811__20210812__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsMember_zBqGulXqxETg" title="Officers' compensation"&gt;177,840&lt;/span&gt; of the bonus payable in exchange for &lt;span id="xdx_908_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_pip0_c20210811__20210812__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsMember_z0ShY2CLgpfi"&gt;5,928,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;shares of the common stock of the
Company (see Note 13).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Amended
and Restated Employment Agreement - On May 14, 2019 (the &#x201c;Effective Date&#x201d;), the Company entered into an Amended and Restated
Employment Agreement (the &#x201c;Employment Agreement&#x201d;) with James Nathanielsz, the Company&#x2019;s Chief Executive Officer, Chairman,
acting Chief Financial Officer and a director, for a term of &lt;span id="xdx_90B_ecustom--AgreementlTerm_dc_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember_zeNs9QNayR5c" title="Agreement term"&gt;three years&lt;/span&gt;, subject to automatic &lt;span id="xdx_909_ecustom--AgreementRenewalTerm_dtYxL_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember_zyg0gxBXOGIa" title="Agreement renewal term::XDX::1"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2327"&gt;one&lt;/span&gt;&lt;/span&gt;-year renewals, at an annual salary
of $&lt;span id="xdx_908_eus-gaap--SalariesAndWages_pp0p0_uAUD_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember_zRCs20QOpIYd" title="Annual salary"&gt;400,000&lt;/span&gt; AUD. Pursuant to the Employment Agreement, Mr. Nathanielsz was granted options to purchase &lt;span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember_pdd" title="Option purchase shares"&gt;39&lt;/span&gt; shares of the Company&#x2019;s
common stock (the &#x201c;Nathanielsz Options&#x201d;), with an exercise price per share of $&lt;span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember_pdd" title="Exercise price"&gt;4,675&lt;/span&gt; (&lt;span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_dp_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember_zEGYArsbBKx2" title="Market price"&gt;110%&lt;/span&gt; of the closing market price of
the Company&#x2019;s common stock on May 14, 2019 (or $&lt;span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember_pdd" title="Granted exercise price"&gt;4,250&lt;/span&gt;), the date of approval of such grant by the Company&#x2019;s board of directors),
(ii) &lt;span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember__us-gaap--AwardTypeAxis__custom--RestrictedStocksUnitsRSUMember_pdd" title="Restricted stock shares of common stock"&gt;39&lt;/span&gt; restricted stock units of the Company (the &#x201c;Initial Nathanielsz RSUs&#x201d;), and (iii) an additional &lt;span id="xdx_90C_ecustom--StockToBeIssuedDuringPeriodValueRestrictedStockUnit_c20200701__20210630__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember_pdd" title="Restricted stock unit issuable"&gt;39&lt;/span&gt; restricted stock
units of the Company (the &#x201c;Additional Nathanielsz RSUs&#x201d;). Such options and restricted stock units were granted pursuant to
the 2019 Plan approved by the Company&#x2019;s board of directors on the Effective Date. &lt;span id="xdx_90E_ecustom--OptionsVestedDescription_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember" title="Options vested, description"&gt;The Nathanielsz Options have a term of &lt;span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember_ziX0y2aBXc9a"&gt;10 years&lt;/span&gt;
from the date of grant. 1/3rd of the Nathanielsz Options shall vest every successive one-year anniversary following the Effective Date,
provided, that on each such vesting date Mr. Nathanielsz is employed by the Company and subject to the other provisions of the Employment
Agreement. The Initial Nathanielsz RSUs shall vest on the one-year anniversary of the Effective Date, subject to Mr. Nathanielsz&#x2019;s
continued employment with the Company through such vesting date. The Additional Nathanielsz RSUs will vest as follows, subject to Mr.
Nathanielsz&#x2019;s continued employment with the Company through the applicable vesting date: (i) &lt;span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember__us-gaap--AwardTypeAxis__custom--AdditionaNathanielszRSUsMember_pdd" title="Rsus vest, shares"&gt;7.80&lt;/span&gt; of the Additional Nathanielsz
RSUs shall vest upon the Company submitting Clinical Trial Application (the &#x201c;CTA&#x201d;) for PRP, the Company&#x2019;s lead product
candidate (&#x201c;PRP&#x201d;), for a First-In-Human study for PRP (the &#x201c;Study&#x201d;) in an applicable jurisdiction to be selected
by the Company, (ii) 7.80 of the Additional Nathanielsz RSUs shall vest upon&lt;/span&gt; the CTA being approved in an applicable jurisdiction, (iii)
7.80 of the Additional RSUs shall vest upon the Company completing an equity financing in the amount of at least $&lt;span id="xdx_90A_ecustom--GrossProceedsFromEquityFinancing_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember__us-gaap--AwardTypeAxis__custom--AdditionaNathanielszRSUsMember_pp0p0" title="Gross proceeds from equity financing"&gt;4,000,000&lt;/span&gt; in gross
proceeds, (iv) 7.80 of the Additional Nathanielsz RSUs shall vest upon the shares of the Company&#x2019;s Common Stock being listed on
a senior stock exchange (NYSE, NYSEMKT or NASDAQ), and (v) the remaining 7.80 of the Additional Nathanielsz RSUs shall vest upon the
Company enrolling its first patient in the Study. Each vested restricted stock unit shall be settled by delivery to Mr. Nathanielsz of
one share of the Company&#x2019;s common stock and/or the fair market value of one share of common stock in cash, at the sole discretion
of the Company&#x2019;s board of directors and subject to the 2019 Plan, on the first to occur of: (i) the date of a Change of Control
(as defined in the Employment Agreement), (ii) the date that is ten business days following the vesting of such restricted stock unit,
(iii) the date of Mr. Nathanielsz&#x2019;s death or Disability (as defined in the Employment Agreement), and (iv) Mr. Nathanielsz&#x2019;s
employment being terminated either by the Company without Cause or by Mr. Nathanielsz for Good Reason (each as defined in the Employment
Agreement). In the event of a Change of Control, any unvested portion of the Nathanielsz Options and such restricted stock units shall
vest immediately prior to such event. The 39 vested restricted stock unit are considered issuable as of June 30, 2021.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;PROPANC
BIOPHARMA, INC. AND SUBSIDIARY&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;June
30, 2021 and 2020&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Amended
and Restated Services Agreement - On May 14, 2019, the Company also entered into an Amended and Restated Services Agreement (the &#x201c;Services
Agreement&#x201d;) with Dr. Kenyon, the Company&#x2019;s Chief Scientific Officer and a director, for a term of &lt;span id="xdx_903_ecustom--AgreementlTerm_dtYxL_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DrKenyonMember_zI7SHQGqEtZk" title="Agreement term::XDX::3"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2350"&gt;three&lt;/span&gt;&lt;/span&gt; years, subject to
automatic &lt;span id="xdx_90A_ecustom--AgreementRenewalTerm_dtYxL_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DrKenyonMember_zeyfSPX9awp2" title="Agreement renewal term::XDX::1"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2352"&gt;one&lt;/span&gt;&lt;/span&gt;-year renewals, at an annual salary of $&lt;span id="xdx_903_eus-gaap--SalariesAndWages_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DrKenyonMemberMember__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember_pp0p0" title="Annual salary"&gt;54,000&lt;/span&gt; AUD. In connection with the execution of the Services Agreement, Dr. Kenyon
was designated as an executive officer of the Company and assumed a more active executive role with the Company. Pursuant to the Services
Agreement, Dr. Kenyon was granted options to purchase &lt;span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DrKenyonMember_pdd" title="Option purchase shares"&gt;20&lt;/span&gt; shares of the Company&#x2019;s common stock (the &#x201c;Kenyon Options&#x201d;),
with an exercise price per share of $&lt;span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DrKenyonMember_pdd" title="Exercise price"&gt;4,250&lt;/span&gt; (&lt;span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_dp_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DrKenyonMember_zAyY4CSuklcf" title="Market price"&gt;100%&lt;/span&gt; of the closing market price of the Company&#x2019;s common stock on May 14, 2019, the
date of approval of such grant by the Company&#x2019;s board of directors), (ii) &lt;span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember__us-gaap--AwardTypeAxis__custom--InitialKenyonRSUsMember_pdd" title="Restricted stock shares of common stock"&gt;20&lt;/span&gt; restricted stock units of the Company (the &#x201c;Initial
Kenyon RSUs&#x201d;), and (iii) an additional &lt;span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember__us-gaap--AwardTypeAxis__custom--AdditionalKenyonRSUsMember_pdd" title="Restricted stock shares of common stock"&gt;20&lt;/span&gt; restricted stock units of the Company (the &#x201c;Additional Kenyon RSUs&#x201d;). Such
options and restricted stock units were granted pursuant to the 2019 Plan approved by the Company&#x2019;s board of directors on the Effective
Date. &lt;span id="xdx_90F_ecustom--OptionsVestedDescription_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DrKenyonMember" title="Options vested, description"&gt;The Kenyon Options have a term of &lt;span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DrKenyonMember_zbf0Whz1LJM3"&gt;10 years&lt;/span&gt; from the date of grant. 1/3rd of the Kenyon Options shall vest every successive one-year
anniversary following the Effective Date, provided, that on each such vesting date Dr. Kenyon is employed by the Company and subject
to the other provisions of the Services Agreement. The Initial Kenyon RSUs shall vest on the one-year anniversary of the Effective Date,
subject to Dr. Kenyon&#x2019;s continued employment with the Company through such vesting date. The Additional Kenyon RSUs will vest as
follows, subject to Dr. Kenyon&#x2019;s continued employment with the Company through the applicable vesting date: (i) &lt;span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember__us-gaap--AwardTypeAxis__custom--AdditionalKenyonRSUsMember_pdd" title="Rsus vest, shares"&gt;5&lt;/span&gt; of the Additional
Kenyon RSUs shall vest upon the Company submitting the CTA for PRP for the Study in an applicable jurisdiction to be selected by the
Company, (ii) 5 of the Additional Kenyon RSUs shall vest upon the Company completing an equity financing in the amount of at least $&lt;span id="xdx_900_ecustom--GrossProceedsFromEquityFinancing_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember__us-gaap--AwardTypeAxis__custom--AdditionalKenyonRSUsMember_pp0p0" title="Gross proceeds from equity financing"&gt;4,000,000&lt;/span&gt;
in gross proceeds, (iii) 5 of the Additional Kenyon RSUs shall vest upon the shares o&lt;/span&gt;f the Company&#x2019;s Common Stock being listed
on a senior stock exchange (NYSE, NYSEMKT or NASDAQ), and (iv) the remaining 5 of the Additional Kenyon RSUs shall vest upon the Company
enrolling its first patient in the Study. Each vested Kenyon RSU shall be settled by delivery to Mr. Kenyon of one share of the Company&#x2019;s
common stock and/or the fair market value of one share of common stock in cash, at the sole discretion of the Company&#x2019;s board of
directors and subject to the Plan, on the first to occur of: (i) the date of a Change of Control (as defined in the Services Agreement),
(ii) the date that is ten business days following the vesting of such Kenyon RSU, (iii) the date of Dr. Kenyon&#x2019;s death or Disability
(as defined in the Services Agreement), and (iv) Dr. Kenyon&#x2019;s employment being terminated either by the Company without Cause or
by Dr. Kenyon for Good Reason (as defined in the Services Agreement). In the event of a Change of Control (as defined in the Services
Agreement), 50% of any unvested portion of the Kenyon Options and the Kenyon RSUs shall vest immediately prior to such event. As of June
30, 2021, total accrued salaries of $&lt;span id="xdx_904_eus-gaap--AccruedSalariesCurrent_iI_pp0p0_uAUD_c20210630__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember_zrdYDlvBc9yl" title="Accrued salaries"&gt;135,000&lt;/span&gt; AUD ($&lt;span id="xdx_908_eus-gaap--AccruedSalariesCurrent_c20210630_pp0p0" title="Accrued salaries"&gt;101,250&lt;/span&gt; USD) is included in accrued expenses in the accompanying consolidated balance
sheet. The &lt;span id="xdx_907_ecustom--StockToBeIssuedDuringPeriodValueRestrictedStockUnit_c20200701__20210630__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember_pdd" title="Restricted stock unit issuable"&gt;20&lt;/span&gt; vested restricted stock unit are considered issuable as of June 30, 2021. On August 12, 2021, pursuant to the Cancellation
Agreement, Mr. Kenyon agreed to cancel accrued salaries of $&lt;span id="xdx_90B_ecustom--CancellationOfAccruedSalaries_iI_dtY_c20210812__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DrKenyonMember_zaJwBxkt21Pl" title="Cancellation of accrued salary"&gt;102,600&lt;/span&gt; in exchange for &lt;span id="xdx_90D_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_pid_c20210811__20210812__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DrKenyonMember_zqr3diXViojd"&gt;3,420,000&lt;/span&gt; shares of the common stock of the Company
(see Note 13).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;span style="text-decoration: underline"&gt;Intercompany
Loans&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;All
Intercompany loans were made by the parent to the subsidiary, Propanc PTY LTD, which have not been repaid as of June 30, 2021. Effective
fiscal year 2021, the parent company determined that intercompany loans will not be repaid in the foreseeable future and thus, per ASC
830-20-35-3, gains and losses from measuring the intercompany balances are recorded within cumulative translation adjustment, a component
of other comprehensive income. Prior to July 1, 2020, the Company recorded the foreign currency transaction gains and losses from measuring
the intercompany balances as a component of other income (expenses) as reflected in the consolidated statements of operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <PPCB:LoansFromRelatedParty
      contextRef="AsOf2021-06-30_custom_CurrentAndFormerDirectorMember"
      decimals="0"
      unitRef="USD">55500</PPCB:LoansFromRelatedParty>
    <PPCB:LoansFromRelatedParty
      contextRef="AsOf2020-06-30_custom_CurrentAndFormerDirectorMember"
      decimals="0"
      unitRef="USD">50993</PPCB:LoansFromRelatedParty>
    <us-gaap:DueToRelatedPartiesCurrent
      contextRef="AsOf2021-06-30_custom_FormerDirectorMember"
      decimals="0"
      unitRef="USD">33347</us-gaap:DueToRelatedPartiesCurrent>
    <us-gaap:DueToRelatedPartiesCurrent
      contextRef="AsOf2020-06-30_custom_FormerDirectorMember"
      decimals="0"
      unitRef="USD">30639</us-gaap:DueToRelatedPartiesCurrent>
    <us-gaap:OperatingLeasesRentExpenseMinimumRentals
      contextRef="From2016-05-032016-05-05_custom_NorthHorizonPtyLtdMember_custom_AUDCurrencyMember"
      decimals="0"
      unitRef="AUD">39600</us-gaap:OperatingLeasesRentExpenseMinimumRentals>
    <us-gaap:OperatingLeasesRentExpenseMinimumRentals
      contextRef="From2016-05-032016-05-05_custom_NorthHorizonPtyLtdMember"
      decimals="0"
      unitRef="USD">28325</us-gaap:OperatingLeasesRentExpenseMinimumRentals>
    <PPCB:GoodsAndServiceTax
      contextRef="From2016-05-032016-05-05_custom_NorthHorizonPtyLtdMember_custom_AUDCurrencyMember"
      decimals="0"
      unitRef="AUD">3600</PPCB:GoodsAndServiceTax>
    <PPCB:GoodsAndServiceTax
      contextRef="From2016-05-032016-05-05_custom_NorthHorizonPtyLtdMember"
      decimals="0"
      unitRef="USD">2575</PPCB:GoodsAndServiceTax>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDue
      contextRef="AsOf2016-05-05_custom_NorthHorizonPtyLtdMember_custom_AUDCurrenryMember_custom_NathanielszMember"
      decimals="0"
      unitRef="AUD">198000</us-gaap:OperatingLeasesFutureMinimumPaymentsDue>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDue
      contextRef="AsOf2016-05-05_custom_NorthHorizonPtyLtdMember_custom_NathanielszMember"
      decimals="0"
      unitRef="USD">141629</us-gaap:OperatingLeasesFutureMinimumPaymentsDue>
    <us-gaap:PaymentsForRent
      contextRef="From2020-07-012021-06-30_custom_NorthHorizonPtyLtdMember_custom_AUDCurrenryMember"
      decimals="0"
      unitRef="AUD">86129</us-gaap:PaymentsForRent>
    <us-gaap:PaymentsForRent
      contextRef="From2020-07-012021-06-30_custom_NorthHorizonPtyLtdMember"
      decimals="0"
      unitRef="USD">64597</us-gaap:PaymentsForRent>
    <us-gaap:LesseeOperatingLeaseDescription contextRef="From2019-07-012019-07-02_us-gaap_AccountingStandardsUpdate201602Member">Such lease expired in May 2021 and was renewed for another one-year term from May 2021 to May 2022</us-gaap:LesseeOperatingLeaseDescription>
    <us-gaap:RelatedPartyTransactionDate contextRef="From2015-02-242015-02-25_custom_NathanielszEmploymentAgreementMember">2019-02-25</us-gaap:RelatedPartyTransactionDate>
    <us-gaap:SalariesAndWages
      contextRef="From2015-02-242015-02-25_custom_NathanielszEmploymentAgreementMember_custom_AUDCurrenryMember"
      decimals="0"
      unitRef="AUD">25000</us-gaap:SalariesAndWages>
    <us-gaap:SalariesAndWages
      contextRef="From2020-07-012021-06-30_custom_NathanielszEmploymentAgreementMember_custom_AUDCurrenryMember"
      decimals="0"
      unitRef="AUD">300000</us-gaap:SalariesAndWages>
    <us-gaap:SalariesAndWages
      contextRef="From2020-07-012021-06-30_custom_NathanielszEmploymentAgreementMember"
      decimals="0"
      unitRef="USD">205680</us-gaap:SalariesAndWages>
    <PPCB:PercentageOfPensionOfMonthlySalary
      contextRef="From2020-07-012021-06-30_custom_NathanielszEmploymentAgreementMember"
      decimals="INF"
      unitRef="Pure">0.095</PPCB:PercentageOfPensionOfMonthlySalary>
    <PPCB:PercentageOfBonusOfAnnualBaseSalary
      contextRef="From2020-07-012021-06-30_custom_NathanielszEmploymentAgreementMember"
      decimals="INF"
      unitRef="Pure">2</PPCB:PercentageOfBonusOfAnnualBaseSalary>
    <us-gaap:SalariesAndWages
      contextRef="From2018-03-152018-03-16_custom_NathanielszEmploymentAgreementMember_custom_AUDCurrenryMember_srt_MinimumMember"
      decimals="0"
      unitRef="AUD">300000</us-gaap:SalariesAndWages>
    <us-gaap:SalariesAndWages
      contextRef="From2018-03-152018-03-16_custom_NathanielszEmploymentAgreementMember_srt_MinimumMember"
      decimals="0"
      unitRef="USD">205680</us-gaap:SalariesAndWages>
    <us-gaap:SalariesAndWages
      contextRef="From2018-03-152018-03-16_custom_NathanielszEmploymentAgreementMember_custom_AUDCurrenryMember_srt_MaximumMember"
      decimals="0"
      unitRef="AUD">400000</us-gaap:SalariesAndWages>
    <us-gaap:SalariesAndWages
      contextRef="From2018-03-152018-03-16_custom_NathanielszEmploymentAgreementMember_srt_MaximumMember"
      decimals="0"
      unitRef="USD">274240</us-gaap:SalariesAndWages>
    <us-gaap:SalariesAndWages
      contextRef="From2018-01-282018-02-01_custom_MrsNathanielszMember_custom_AUDCurrencyMember"
      decimals="0"
      unitRef="AUD">120000</us-gaap:SalariesAndWages>
    <us-gaap:SalariesAndWages
      contextRef="From2018-01-282018-02-01_custom_MrsNathanielszMember"
      decimals="0"
      unitRef="USD">80904</us-gaap:SalariesAndWages>
    <us-gaap:RepaymentsOfRelatedPartyDebt
      contextRef="From2016-02-242016-02-25_custom_JamesNathanielszMember_custom_AUDCurrenryMember"
      decimals="0"
      unitRef="AUD">4481</us-gaap:RepaymentsOfRelatedPartyDebt>
    <us-gaap:RepaymentsOfRelatedPartyDebt
      contextRef="From2016-02-242016-02-25_custom_JamesNathanielszMember"
      decimals="0"
      unitRef="USD">3205</us-gaap:RepaymentsOfRelatedPartyDebt>
    <us-gaap:RepaymentsOfRelatedPartyDebt
      contextRef="From2019-07-012020-06-30_custom_MrsNathanielszMember_custom_AUDCurrenryMember"
      decimals="0"
      unitRef="AUD">44918</us-gaap:RepaymentsOfRelatedPartyDebt>
    <us-gaap:RepaymentsOfRelatedPartyDebt
      contextRef="From2019-07-012020-06-30_custom_MrsNathanielszMember"
      decimals="0"
      unitRef="USD">30284</us-gaap:RepaymentsOfRelatedPartyDebt>
    <us-gaap:RepaymentsOfRelatedPartyDebt
      contextRef="From2020-07-012021-06-30_custom_MrsNathanielszMember_custom_AUDCurrenryMember"
      decimals="0"
      unitRef="AUD">46135</us-gaap:RepaymentsOfRelatedPartyDebt>
    <us-gaap:RepaymentsOfRelatedPartyDebt
      contextRef="From2020-07-012021-06-30_custom_MrsNathanielszMember"
      decimals="0"
      unitRef="USD">34476</us-gaap:RepaymentsOfRelatedPartyDebt>
    <us-gaap:OfficersCompensation
      contextRef="From2019-05-132019-05-14_custom_MrNathanielszMember_custom_BoardOfDirectorsMember_custom_AUDCurrenryMember"
      decimals="0"
      unitRef="AUD">460000</us-gaap:OfficersCompensation>
    <us-gaap:OfficersCompensation
      contextRef="From2019-05-132019-05-14_custom_MrNathanielszMember_custom_BoardOfDirectorsMember"
      decimals="0"
      unitRef="USD">315376</us-gaap:OfficersCompensation>
    <PPCB:BonusPayableAmount
      contextRef="From2018-07-012019-06-30_srt_ChiefExecutiveOfficerMember_custom_AUDCurrenryMember"
      decimals="0"
      unitRef="AUD">200000</PPCB:BonusPayableAmount>
    <PPCB:BonusPayableAmount
      contextRef="From2018-07-012019-06-30_srt_ChiefExecutiveOfficerMember"
      decimals="0"
      unitRef="USD">137120</PPCB:BonusPayableAmount>
    <PPCB:RemainingBonusAmount
      contextRef="From2018-07-012019-06-30_srt_ChiefExecutiveOfficerMember_custom_AUDCurrenryMember"
      decimals="0"
      unitRef="AUD">260000</PPCB:RemainingBonusAmount>
    <PPCB:RemainingBonusAmount
      contextRef="From2018-07-012019-06-30_srt_ChiefExecutiveOfficerMember"
      decimals="0"
      unitRef="USD">178256</PPCB:RemainingBonusAmount>
    <us-gaap:RepaymentsOfRelatedPartyDebt
      contextRef="From2018-07-012019-06-30_srt_ChiefExecutiveOfficerMember_custom_AUDCurrenryMember"
      decimals="0"
      unitRef="AUD">90000</us-gaap:RepaymentsOfRelatedPartyDebt>
    <us-gaap:RepaymentsOfRelatedPartyDebt
      contextRef="From2018-07-012019-06-30_srt_ChiefExecutiveOfficerMember"
      decimals="0"
      unitRef="USD">64377</us-gaap:RepaymentsOfRelatedPartyDebt>
    <us-gaap:OfficersCompensation
      contextRef="From2020-07-122020-07-13_custom_MrNathanielszMember_custom_BoardOfDirectorsMember_custom_AUDCurrenryMember"
      decimals="0"
      unitRef="AUD">240000</us-gaap:OfficersCompensation>
    <PPCB:BonusAwardsGrantedPercentage
      contextRef="From2020-07-122020-07-13_custom_MrNathanielszMember_custom_BoardOfDirectorsMember_custom_AUDCurrenryMember"
      decimals="INF"
      unitRef="Pure">0.60</PPCB:BonusAwardsGrantedPercentage>
    <us-gaap:RepaymentsOfRelatedPartyDebt
      contextRef="From2019-07-012020-06-30_srt_ChiefExecutiveOfficerMember_custom_AUDCurrenryMember"
      decimals="0"
      unitRef="AUD">202620</us-gaap:RepaymentsOfRelatedPartyDebt>
    <us-gaap:RepaymentsOfRelatedPartyDebt
      contextRef="From2019-07-012020-06-30_srt_ChiefExecutiveOfficerMember"
      decimals="0"
      unitRef="USD">136606</us-gaap:RepaymentsOfRelatedPartyDebt>
    <PPCB:BonusPayable
      contextRef="From2019-07-012020-06-30_srt_ChiefExecutiveOfficerMember_custom_AUDCurrenryMember"
      decimals="0"
      unitRef="AUD">407380</PPCB:BonusPayable>
    <PPCB:BonusPayable
      contextRef="From2019-07-012020-06-30_srt_ChiefExecutiveOfficerMember"
      decimals="0"
      unitRef="USD">280726</PPCB:BonusPayable>
    <us-gaap:OfficersCompensation
      contextRef="From2021-08-112021-08-12_custom_MrNathanielszMember_custom_BoardOfDirectorsMember_us-gaap_SubsequentEventMember"
      decimals="0"
      unitRef="USD">177840</us-gaap:OfficersCompensation>
    <us-gaap:RepaymentsOfRelatedPartyDebt
      contextRef="From2020-07-012021-06-30_srt_ChiefExecutiveOfficerMember_custom_AUDCurrenryMember"
      decimals="0"
      unitRef="AUD">221890</us-gaap:RepaymentsOfRelatedPartyDebt>
    <PPCB:BonusPayable
      contextRef="From2020-07-012021-06-30_srt_ChiefExecutiveOfficerMember"
      decimals="0"
      unitRef="USD">166418</PPCB:BonusPayable>
    <PPCB:BonusPayable
      contextRef="From2020-07-012021-06-30_srt_ChiefExecutiveOfficerMember_custom_AUDCurrenryMember"
      decimals="0"
      unitRef="AUD">422610</PPCB:BonusPayable>
    <PPCB:BonusPayable
      contextRef="From2020-07-012021-06-30_srt_ChiefExecutiveOfficerMember_custom_MrsNathanielszMember"
      decimals="0"
      unitRef="USD">316957</PPCB:BonusPayable>
    <us-gaap:OfficersCompensation
      contextRef="From2021-08-112021-08-12_custom_MrNathanielszMember_custom_BoardOfDirectorsMember_us-gaap_SubsequentEventMember"
      decimals="0"
      unitRef="USD">177840</us-gaap:OfficersCompensation>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1
      contextRef="From2021-08-112021-08-12_custom_MrNathanielszMember_custom_BoardOfDirectorsMember"
      decimals="INF"
      unitRef="Shares">5928000</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <PPCB:AgreementlTerm contextRef="From2019-05-132019-05-14_custom_EmploymentAgreementMember_custom_MrNathanielszMember">P3Y</PPCB:AgreementlTerm>
    <us-gaap:SalariesAndWages
      contextRef="From2019-05-132019-05-14_custom_EmploymentAgreementMember_custom_MrNathanielszMember_custom_AUDCurrenryMember"
      decimals="0"
      unitRef="AUD">400000</us-gaap:SalariesAndWages>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward
      contextRef="From2019-05-132019-05-14_custom_EmploymentAgreementMember_custom_MrNathanielszMember"
      decimals="INF"
      unitRef="Shares">39</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="From2019-05-132019-05-14_custom_EmploymentAgreementMember_custom_MrNathanielszMember"
      decimals="INF"
      unitRef="USDPShares">4675</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
      contextRef="From2019-05-132019-05-14_custom_EmploymentAgreementMember_custom_MrNathanielszMember"
      decimals="INF"
      unitRef="Pure">1.10</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="From2019-05-132019-05-14_custom_EmploymentAgreementMember_custom_MrNathanielszMember"
      decimals="INF"
      unitRef="USDPShares">4250</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="From2019-05-132019-05-14_custom_EmploymentAgreementMember_custom_RestrictedStocksUnitsRSUMember"
      decimals="INF"
      unitRef="Shares">39</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <PPCB:StockToBeIssuedDuringPeriodValueRestrictedStockUnit
      contextRef="From2020-07-012021-06-30_custom_EmploymentAgreementMember"
      decimals="INF"
      unitRef="Shares">39</PPCB:StockToBeIssuedDuringPeriodValueRestrictedStockUnit>
    <PPCB:OptionsVestedDescription contextRef="From2019-05-132019-05-14_custom_EmploymentAgreementMember_custom_MrNathanielszMember">The Nathanielsz Options have a term of 10 years
from the date of grant. 1/3rd of the Nathanielsz Options shall vest every successive one-year anniversary following the Effective Date,
provided, that on each such vesting date Mr. Nathanielsz is employed by the Company and subject to the other provisions of the Employment
Agreement. The Initial Nathanielsz RSUs shall vest on the one-year anniversary of the Effective Date, subject to Mr. Nathanielsz&#x2019;s
continued employment with the Company through such vesting date. The Additional Nathanielsz RSUs will vest as follows, subject to Mr.
Nathanielsz&#x2019;s continued employment with the Company through the applicable vesting date: (i) 7.80 of the Additional Nathanielsz
RSUs shall vest upon the Company submitting Clinical Trial Application (the &#x201c;CTA&#x201d;) for PRP, the Company&#x2019;s lead product
candidate (&#x201c;PRP&#x201d;), for a First-In-Human study for PRP (the &#x201c;Study&#x201d;) in an applicable jurisdiction to be selected
by the Company, (ii) 7.80 of the Additional Nathanielsz RSUs shall vest upon</PPCB:OptionsVestedDescription>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod contextRef="From2019-05-132019-05-14_custom_EmploymentAgreementMember_custom_MrNathanielszMember">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="From2019-05-132019-05-14_custom_EmploymentAgreementMember_custom_AdditionaNathanielszRSUsMember"
      decimals="INF"
      unitRef="Shares">7.80</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <PPCB:GrossProceedsFromEquityFinancing
      contextRef="From2019-05-132019-05-14_custom_EmploymentAgreementMember_custom_AdditionaNathanielszRSUsMember"
      decimals="0"
      unitRef="USD">4000000</PPCB:GrossProceedsFromEquityFinancing>
    <us-gaap:SalariesAndWages
      contextRef="From2019-05-132019-05-14_custom_ServicesAgreementMember_custom_DrKenyonMemberMember_custom_AUDCurrenryMember"
      decimals="0"
      unitRef="USD">54000</us-gaap:SalariesAndWages>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward
      contextRef="From2019-05-132019-05-14_custom_ServicesAgreementMember_custom_DrKenyonMember"
      decimals="INF"
      unitRef="Shares">20</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="From2019-05-132019-05-14_custom_ServicesAgreementMember_custom_DrKenyonMember"
      decimals="INF"
      unitRef="USDPShares">4250</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
      contextRef="From2019-05-132019-05-14_custom_ServicesAgreementMember_custom_DrKenyonMember"
      decimals="INF"
      unitRef="Pure">1</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="From2019-05-132019-05-14_custom_ServicesAgreementMember_custom_InitialKenyonRSUsMember"
      decimals="INF"
      unitRef="Shares">20</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="From2019-05-132019-05-14_custom_ServicesAgreementMember_custom_AdditionalKenyonRSUsMember"
      decimals="INF"
      unitRef="Shares">20</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <PPCB:OptionsVestedDescription contextRef="From2019-05-132019-05-14_custom_ServicesAgreementMember_custom_DrKenyonMember">The Kenyon Options have a term of 10 years from the date of grant. 1/3rd of the Kenyon Options shall vest every successive one-year
anniversary following the Effective Date, provided, that on each such vesting date Dr. Kenyon is employed by the Company and subject
to the other provisions of the Services Agreement. The Initial Kenyon RSUs shall vest on the one-year anniversary of the Effective Date,
subject to Dr. Kenyon&#x2019;s continued employment with the Company through such vesting date. The Additional Kenyon RSUs will vest as
follows, subject to Dr. Kenyon&#x2019;s continued employment with the Company through the applicable vesting date: (i) 5 of the Additional
Kenyon RSUs shall vest upon the Company submitting the CTA for PRP for the Study in an applicable jurisdiction to be selected by the
Company, (ii) 5 of the Additional Kenyon RSUs shall vest upon the Company completing an equity financing in the amount of at least $4,000,000
in gross proceeds, (iii) 5 of the Additional Kenyon RSUs shall vest upon the shares o</PPCB:OptionsVestedDescription>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod contextRef="From2019-05-132019-05-14_custom_ServicesAgreementMember_custom_DrKenyonMember">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="From2019-05-132019-05-14_custom_ServicesAgreementMember_custom_AdditionalKenyonRSUsMember"
      decimals="INF"
      unitRef="Shares">5</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <PPCB:GrossProceedsFromEquityFinancing
      contextRef="From2019-05-132019-05-14_custom_ServicesAgreementMember_custom_AdditionalKenyonRSUsMember"
      decimals="0"
      unitRef="USD">4000000</PPCB:GrossProceedsFromEquityFinancing>
    <us-gaap:AccruedSalariesCurrent
      contextRef="AsOf2021-06-30_custom_AUDCurrenryMember"
      decimals="0"
      unitRef="AUD">135000</us-gaap:AccruedSalariesCurrent>
    <us-gaap:AccruedSalariesCurrent contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">101250</us-gaap:AccruedSalariesCurrent>
    <PPCB:StockToBeIssuedDuringPeriodValueRestrictedStockUnit
      contextRef="From2020-07-012021-06-30_custom_ServicesAgreementMember"
      decimals="INF"
      unitRef="Shares">20</PPCB:StockToBeIssuedDuringPeriodValueRestrictedStockUnit>
    <PPCB:CancellationOfAccruedSalaries
      contextRef="AsOf2021-08-12_custom_ServicesAgreementMember_custom_DrKenyonMember"
      decimals="0"
      unitRef="USD">102600</PPCB:CancellationOfAccruedSalaries>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1
      contextRef="From2021-08-112021-08-12_custom_ServicesAgreementMember_custom_DrKenyonMember"
      decimals="INF"
      unitRef="Shares">3420000</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <us-gaap:ConcentrationRiskDisclosureTextBlock contextRef="From2020-07-012021-06-30">&lt;p id="xdx_809_eus-gaap--ConcentrationRiskDisclosureTextBlock_zUlOBh1Ivd83" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;NOTE
11 &#x2013; &lt;span id="xdx_826_z7NVN5D24Jra"&gt;CONCENTRATIONS AND RISKS&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;span style="text-decoration: underline"&gt;Concentration
of Credit Risk&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;The
Company maintains its cash in banks and financial institutions in Australia. Bank deposits in Australian banks are uninsured. The Company
has not experienced any losses in such accounts through June 30, 2021.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;In fiscal year 2020,
t&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;he&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;
&lt;span style="color: Black"&gt;Company currently primarily relied on funding from three convertible debt lenders. Proceeds received
during the year ended June 30, 2020 from each of the three lenders were $&lt;span id="xdx_901_eus-gaap--ProceedsFromConvertibleDebt_pp0p0_c20190701__20200630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LenderOneMember_zjFGEVsziRX5"&gt;285,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;,
$&lt;span id="xdx_90E_eus-gaap--ProceedsFromConvertibleDebt_pp0p0_c20190701__20200630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LenderTwoMember_zPljXdu1OvH2"&gt;505,000&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;,
and $&lt;span id="xdx_909_eus-gaap--ProceedsFromConvertibleDebt_pp0p0_c20190701__20200630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LenderThreeMember_zey8X6YvWZn"&gt;227,000&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;,
respectively, which represents approximately &lt;span id="xdx_90E_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20200630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LenderOneMember_zKzuIYfnun9f"&gt;19%&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;,
&lt;span id="xdx_90B_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20200630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LenderTwoMember_zXKBdCalnNLb"&gt;34%
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;and &lt;span id="xdx_900_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20200630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LenderThreeMember_zRiTLuHUpeml"&gt;15%&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;,
respectively of total proceeds received by the Company during fiscal year 2020.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;In fiscal year 2021,
the Company primarily relied on funding from two convertible debt lenders and received net proceeds after
deductions of $&lt;span id="xdx_900_eus-gaap--AmortizationOfFinancingCostsAndDiscounts_pp0p0_c20200701__20210630_zapu3rw2nnQ9" title="Discounts and debt issuance cost"&gt;16,000&lt;/span&gt; for original issue discounts and debt issue costs during the year ended June 30, 2021 from each of the two
lenders of $&lt;span id="xdx_905_eus-gaap--ProceedsFromConvertibleDebt_pp0p0_c20200701__20210630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LenderOneMember_z0TkhjhwVrB1"&gt;125,000 &lt;/span&gt;and
$&lt;span id="xdx_903_eus-gaap--ProceedsFromConvertibleDebt_pp0p0_c20200701__20210630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LenderTwoMember_zDSyxdHJZdXd"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2392"&gt;200,000, &lt;/span&gt;&lt;/span&gt;respectively,
which represents approximately &lt;span id="xdx_900_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20210630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LenderOneMember_zsdoBHfYPX4f"&gt;39%&lt;/span&gt;, and &lt;span id="xdx_904_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20210630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LenderTwoMember_zunB0KEfvbt5"&gt;61%, &lt;/span&gt;respectively
of total proceeds received by the Company during fiscal year 2021.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;span style="text-decoration: underline"&gt;Receivable
Concentration&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;As
of June 30, 2021 and 2020, the Company&#x2019;s receivables were &lt;span id="xdx_908_ecustom--ReimbursementOnGoodsAndServiceTaxReceivablePercentage_dp_c20200701__20210630_zepQavbUoNN8" title="Reimbursement on goods and service tax receivable percentage"&gt;&lt;span id="xdx_90A_ecustom--ReimbursementOnGoodsAndServiceTaxReceivablePercentage_dp_c20190701__20200630_zvXSLqq0YQgb" title="Reimbursement on goods and service tax receivable percentage"&gt;100%&lt;/span&gt;&lt;/span&gt; related to reimbursements on GST taxes paid.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;PROPANC
BIOPHARMA, INC. AND SUBSIDIARY&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;June
30, 2021 and 2020&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;span style="text-decoration: underline"&gt;Patent
and Patent Concentration&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;The
Company has filed multiple patent applications relating to its lead product, PRP. The Company&#x2019;s lead patent application has been
granted and remains in force in the United States, Belgium, Czech Republic, Denmark, France, Germany, Ireland, Italy, Netherlands, Portugal,
Spain, Sweden, Switzerland, Liechtenstein, Turkey, United Kingdom, Australia, China, Japan, Indonesia, Israel, New Zealand, Singapore,
Malaysia, South Africa, Mexico, Republic of Korea, India and Brazil. In  Canada, the patent application remains
under examination.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;In
2016 and early 2017, we filed other patent applications. Three applications were filed under the Patent Cooperation Treaty (the &#x201c;PCT&#x201d;).
The PCT assists applicants in seeking patent protection by filing one international patent application under the PCT, applicants can
simultaneously seek protection for an invention in over 150 countries. Once filed, the application is placed under the control of the
national or regional patent offices, as applicable, in what is called the national phase. One of the PCT applications filed in November
2016, entered national phase in July 2018 and another PCT application is currently entering national phase in August 2018. A third PCT
application entered the national phase in October 2018.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;In
July 2020, a world first patent was granted in Australia for the cancer treatment method patent family. Presently, there are 31
granted patents and 34 patents under examination in key global jurisdictions relating to the use of proenzymes against solid tumors,
covering the lead product candidate PRP.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Further
patent applications are expected to be filed to capture and protect additional patentable subject matter based on the Company&#x2019;s
field of technology relating to pharmaceutical compositions of proenzymes for treating cancer.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;span style="text-decoration: underline"&gt;Foreign
Operations&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 29.15pt; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;As
of June 30, 2021 and 2020, the Company&#x2019;s operations are based in Camberwell, Australia, however the majority of research and development
is being conducted in the European Union.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 29.15pt; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;On
July 22, 2016, the Company formed a wholly owned subsidiary, Propanc (UK) Limited under the laws of England and Wales for the purpose
of submitting an orphan drug application with the European Medicines Agency as a small and medium-sized enterprise. As of June 30, 2021
and 2020, there has been no activity within this entity.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ConcentrationRiskDisclosureTextBlock>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="From2019-07-012020-06-30_custom_LenderOneMember"
      decimals="0"
      unitRef="USD">285000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="From2019-07-012020-06-30_custom_LenderTwoMember"
      decimals="0"
      unitRef="USD">505000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="From2019-07-012020-06-30_custom_LenderThreeMember"
      decimals="0"
      unitRef="USD">227000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2020-06-30_custom_LenderOneMember"
      decimals="INF"
      unitRef="Pure">0.19</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2020-06-30_custom_LenderTwoMember"
      decimals="INF"
      unitRef="Pure">0.34</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2020-06-30_custom_LenderThreeMember"
      decimals="INF"
      unitRef="Pure">0.15</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">16000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="From2020-07-012021-06-30_custom_LenderOneMember"
      decimals="0"
      unitRef="USD">125000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2021-06-30_custom_LenderOneMember"
      decimals="INF"
      unitRef="Pure">0.39</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2021-06-30_custom_LenderTwoMember"
      decimals="INF"
      unitRef="Pure">0.61</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <PPCB:ReimbursementOnGoodsAndServiceTaxReceivablePercentage
      contextRef="From2020-07-012021-06-30"
      decimals="INF"
      unitRef="Pure">1</PPCB:ReimbursementOnGoodsAndServiceTaxReceivablePercentage>
    <PPCB:ReimbursementOnGoodsAndServiceTaxReceivablePercentage
      contextRef="From2019-07-012020-06-30"
      decimals="INF"
      unitRef="Pure">1</PPCB:ReimbursementOnGoodsAndServiceTaxReceivablePercentage>
    <us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock contextRef="From2020-07-012021-06-30">&lt;p id="xdx_803_eus-gaap--DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_zlYx3T8dti75" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;NOTE
12 - &lt;span id="xdx_82F_zRHtpfFjjGs1"&gt;DERIVATIVE FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;i&gt;Derivative
Financial Instruments:&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;The
Company applies the provisions of ASC 815-40, &lt;i&gt;Contracts in Entity&#x2019;s Own Equity&lt;/i&gt;, under which convertible instruments and
warrants, which contain terms that protect holders from declines in the stock price (reset provisions), may not be exempt from derivative
accounting treatment. As a result, warrants and embedded conversion options in convertible debt are recorded as a liability and are revalued
at fair value at each reporting date. If the fair value of the warrants exceeds the face value of the related debt, the excess is recorded
as change in fair value in operations on the issuance date. The Company had $&lt;span id="xdx_904_eus-gaap--ConvertibleDebt_c20210630__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--ConvertibleDebtMember_pp0p0" title="Convertible debt"&gt;80,000&lt;/span&gt; (1 note) and $&lt;span id="xdx_905_eus-gaap--ConvertibleDebt_c20200630__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--ConvertibleDebtMember_pp0p0" title="Convertible debt"&gt;126,500&lt;/span&gt; (3 notes) of convertible debt,
which is treated as derivative instruments outstanding at June 30, 2021 and 2020 respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;The
Company calculates the estimated fair values of the liabilities for derivative instruments using the Binomial Trees Method. The closing
price of the Company&#x2019;s common stock at June 30, 2021, the last trading day of the fiscal year ended June 30, 2021, was $&lt;span id="xdx_90E_eus-gaap--SharePrice_c20210630_pdd"&gt;0.0517&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;.
Volatility, expected remaining term and risk-free interest rates used to estimate the fair value of derivative liabilities at June 30,
2021 and 2020 are indicated in the table that follows. The expected term is equal to the remaining term of the warrants or convertible
instruments and the risk free rate is based upon rates for treasury securities with the same term.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_899_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_zFxlxLM00prd" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_8BA_zmBowUwCLaxi" style="display: none"&gt;SCHEDULE OF FAIR VALUE MEASUREMENTS, RECURRING AND NONRECURRING, VALUATION TECHNIQUES&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"/&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;Convertible
Debt&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;Initial Valuations during the year ended June 30, 2021&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"&gt;&lt;p style="text-align: center; margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Initial&lt;br/&gt;
                                            Valuations&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="text-align: center; margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;during&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="text-align: center; margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;the
                                            year ended June 30, 2020&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;June
    30, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;June
    30, 2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 35%"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Volatility&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; width: 13%"&gt;N/A&lt;/td&gt;
    &lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 13%; vertical-align: bottom"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90C_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_uPure_c20200630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__srt--RangeAxis__srt--MinimumMember_znsZSskEF4vh" title="Debt instrument, measurement input, percentages"&gt;227&lt;/span&gt;-&lt;span id="xdx_902_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_uPure_c20200630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__srt--RangeAxis__srt--MaximumMember_z19zgrt6LIge" title="Debt instrument, measurement input, percentages"&gt;279&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;%&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 13%; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;span id="xdx_902_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_uPure_c20210630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember_z8qKxb6rq01j" title="Debt instrument, measurement input, percentages"&gt;222&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 13%; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;span id="xdx_90A_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_uPure_c20200630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember_zsocWzw9v8mc" title="Debt instrument, measurement input, percentages"&gt;264&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Expected
    remaining term&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;N/A&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom"&gt;&lt;span id="xdx_90C_eus-gaap--DebtInstrumentTerm_dtY_c20190701__20200630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_zg9nuItaB5A3" title="Debt instrument, measurement input, term"&gt;1.00&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;span id="xdx_902_eus-gaap--DebtInstrumentTerm_dtY_c20200701__20210630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember_ziMIM80sCzJ9" title="Debt instrument, measurement input, term"&gt;0.01&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;span id="xdx_904_eus-gaap--DebtInstrumentTerm_dtY_c20190701__20200630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember__srt--RangeAxis__srt--MinimumMember_zQq0IiYT0cn5" title="Debt instrument, measurement input, term"&gt;0.01&lt;/span&gt;
    &#x2013; &lt;span id="xdx_901_eus-gaap--DebtInstrumentTerm_dtY_c20190701__20200630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember__srt--RangeAxis__srt--MaximumMember_zRzEN0YrwSO1" title="Debt instrument, measurement input, term"&gt;0.70&lt;/span&gt; &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Risk-free
    interest rate&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;N/A&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90D_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_uPure_c20200630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MinimumMember_zG2WLbhXC174" title="Debt instrument, measurement input, percentages"&gt;1.53&lt;/span&gt;
    &#x2013; &lt;span id="xdx_905_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_uPure_c20200630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MaximumMember_zeQQCpHn9Oo3" title="Debt instrument, measurement input, percentages"&gt;1.59&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;%&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;span id="xdx_902_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_uPure_c20210630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember_z7Aep2hS9Ss4" title="Debt instrument, measurement input, percentages"&gt;0.05&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;span id="xdx_901_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_uPure_c20200630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember__srt--RangeAxis__srt--MinimumMember_zJYF6qi0vIO4" title="Debt instrument, measurement input, percentages"&gt;0.13&lt;/span&gt;
    &#x2013; &lt;span id="xdx_90D_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_uPure_c20200630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember__srt--RangeAxis__srt--MaximumMember_zQagw6Ahxvq1" title="Debt instrument, measurement input, percentages"&gt;0.18&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Expected
    dividend yield&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;N/A&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_904_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_dn_uPure_c20200630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zM4oKsxZoZOi" title="Debt instrument, measurement input, percentages"&gt;None&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;span id="xdx_901_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_dpn_uPure_c20210630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember_zPYMAAUfdnC9" title="Debt instrument, measurement input, percentages"&gt;None&lt;/span&gt;
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;span id="xdx_907_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_dn_uPure_c20200630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember_zcJ0FN6PYQYf" title="Debt instrument, measurement input, percentages"&gt;None&lt;/span&gt;
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8AD_zppbwSBc0Qc6" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;PROPANC
BIOPHARMA, INC. AND SUBSIDIARY&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;June
30, 2021 and 2020&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;i&gt;Fair
Value Measurements:&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;The
Company measures and reports at fair value the liability for derivative instruments. The fair value liabilities for price adjustable
warrants and embedded conversion options have been recorded as determined utilizing the Binomial Trees model. The following tables summarize
the Company&#x2019;s financial assets and liabilities measured at fair value on a recurring basis as of June 30, 2021:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_891_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_zj10hCQnfo2k" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-right: 0; margin-bottom: 0; text-align: left; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8BC_zhgIJsNvoEFe" style="display: none"&gt;SCHEDULE OF FAIR VALUE, ASSETS AND LIABILITIES MEASURED ON RECURRING BASIS&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;Balance
    at&lt;br/&gt; June 30, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1.8pt 0 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;Quoted&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1.8pt 0 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;Prices&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1.8pt 0 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;in
    Active&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1.8pt 0 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;Markets
    for&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1.8pt 0 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;Identical
    Assets&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1.8pt 0 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;Significant&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1.8pt 0 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;Other&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1.8pt 0 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;Observable
    Inputs&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1.8pt 0 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;Significant&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1.8pt 0 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;Unobservable
    Inputs&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;(Level
    1)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;(Level
    2)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;(Level
    3)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 36%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Embedded
    conversion option liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_c20210630_pp0p0" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Embedded conversion option liabilities"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;54,220&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_c20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_pp0p0" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Embedded conversion option liabilities"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2445"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_c20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_pp0p0" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Embedded conversion option liabilities"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2447"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_c20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_pp0p0" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Embedded conversion option liabilities"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;54,220&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Total&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eus-gaap--DerivativeLiabilities_c20210630_pp0p0" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;54,220&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--DerivativeLiabilities_c20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_pp0p0" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2453"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eus-gaap--DerivativeLiabilities_c20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_pp0p0" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2455"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--DerivativeLiabilities_c20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_pp0p0" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;54,220&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;The
following tables summarize the Company&#x2019;s financial assets and liabilities measured at fair value on a recurring basis as of June
30, 2020:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;Balance
    at&lt;br/&gt; June 30, 2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1.8pt 0 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;Quoted&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1.8pt 0 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;Prices&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1.8pt 0 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;in
    Active&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1.8pt 0 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;Markets
    for&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1.8pt 0 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;Identical
    Assets&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1.8pt 0 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;Significant&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1.8pt 0 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;Other&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1.8pt 0 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;Observable
    Inputs&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1.8pt 0 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;Significant&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1.8pt 0 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;Unobservable
    Inputs&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;(Level
    1)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;(Level
    2)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;(Level
    3)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 36%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Embedded
    conversion option liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_c20200630_pp0p0" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Embedded conversion option liabilities"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;177,009&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_c20200630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_pp0p0" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Embedded conversion option liabilities"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2461"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_c20200630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_pp0p0" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Embedded conversion option liabilities"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2463"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_c20200630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_pp0p0" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Embedded conversion option liabilities"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;177,009&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Total&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eus-gaap--DerivativeLiabilities_c20200630_pp0p0" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;177,009&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--DerivativeLiabilities_c20200630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_pp0p0" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2469"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--DerivativeLiabilities_c20200630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_pp0p0" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2471"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eus-gaap--DerivativeLiabilities_c20200630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_pp0p0" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;177,009&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8AA_zSRvajH3Hwag" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_898_eus-gaap--ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_zwnWqsCQ67Ea" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;The
following is a roll forward for the years ended June 30, 2021 and 2020 of the fair value liability of price adjustable derivative instruments:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-right: 0; margin-bottom: 0; text-align: left; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B1_zUG1Rm1Y5kic" style="display: none"&gt;SCHEDULE OF DERIVATIVE LIABILITIES AT FAIR VALUE&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;Fair
    Value of&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;Liability
    for&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;Derivative&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;Instruments&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; width: 82%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;Balance
    at June 30, 2019&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--DerivativeLiabilities_iS_pp0p0_c20190701__20200630_zclpqGLBOnAf" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Balance at Beginning"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;698,264&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Reductions
    due to conversions&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--ReductionsDueToConversions_c20190701__20200630_pp0p0" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Reductions due to conversions"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;(362,962&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Initial
    fair value of embedded conversion option derivative liability recorded as debt discount&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--FairValueOfWarrantDerivativeLiabilityRecorededAsDebtDiscount_c20190701__20200630_pp0p0" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Initial fair value of embedded conversion option derivative liability recorded as debt discount"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;227,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Initial
    fair value of embedded conversion option derivative liability recorded as expense&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--InitialFairValueOfEmbeddedConversionOptionDerivativeLiabilityRecordedAsExpense_c20190701__20200630_pp0p0" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Initial fair value of embedded conversion option derivative liability recorded as expense"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;351,461&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Change
    in fair value included in statements of operations&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet_c20190701__20200630_pp0p0" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Change in fair value included in statements of operations"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;(736,754&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;Balance
    at June 30, 2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--DerivativeLiabilities_iS_pp0p0_c20200701__20210630_zUMVWyInRydk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Balance at Beginning"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;177,009&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Gain
    on debt extinguishment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--GainOnDebtExtinguishment_c20200701__20210630_pp0p0" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Gain on debt extinguishment"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;(130,975&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Change
    in fair value included in statements of operations&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet_c20200701__20210630_pp0p0" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Change in fair value included in statements of operations"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;8,186&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;Balance
    at June 30, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eus-gaap--DerivativeLiabilities_iE_pp0p0_c20200701__20210630_zSqnvtpNZU1f" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Balance at Ending"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;54,220&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A0_zsQ5mF78ITza" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
    <us-gaap:ConvertibleDebt
      contextRef="AsOf2021-06-30_us-gaap_ConvertibleDebtMember"
      decimals="0"
      unitRef="USD">80000</us-gaap:ConvertibleDebt>
    <us-gaap:ConvertibleDebt
      contextRef="AsOf2020-06-30_us-gaap_ConvertibleDebtMember"
      decimals="0"
      unitRef="USD">126500</us-gaap:ConvertibleDebt>
    <us-gaap:SharePrice
      contextRef="AsOf2021-06-30"
      decimals="INF"
      unitRef="USDPShares">0.0517</us-gaap:SharePrice>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock contextRef="From2020-07-012021-06-30">&lt;p id="xdx_899_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_zFxlxLM00prd" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_8BA_zmBowUwCLaxi" style="display: none"&gt;SCHEDULE OF FAIR VALUE MEASUREMENTS, RECURRING AND NONRECURRING, VALUATION TECHNIQUES&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"/&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;Convertible
Debt&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;Initial Valuations during the year ended June 30, 2021&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"&gt;&lt;p style="text-align: center; margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Initial&lt;br/&gt;
                                            Valuations&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="text-align: center; margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;during&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="text-align: center; margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;the
                                            year ended June 30, 2020&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;June
    30, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;June
    30, 2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 35%"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Volatility&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; width: 13%"&gt;N/A&lt;/td&gt;
    &lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 13%; vertical-align: bottom"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90C_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_uPure_c20200630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__srt--RangeAxis__srt--MinimumMember_znsZSskEF4vh" title="Debt instrument, measurement input, percentages"&gt;227&lt;/span&gt;-&lt;span id="xdx_902_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_uPure_c20200630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__srt--RangeAxis__srt--MaximumMember_z19zgrt6LIge" title="Debt instrument, measurement input, percentages"&gt;279&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;%&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 13%; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;span id="xdx_902_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_uPure_c20210630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember_z8qKxb6rq01j" title="Debt instrument, measurement input, percentages"&gt;222&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 13%; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;span id="xdx_90A_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_uPure_c20200630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember_zsocWzw9v8mc" title="Debt instrument, measurement input, percentages"&gt;264&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Expected
    remaining term&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;N/A&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom"&gt;&lt;span id="xdx_90C_eus-gaap--DebtInstrumentTerm_dtY_c20190701__20200630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_zg9nuItaB5A3" title="Debt instrument, measurement input, term"&gt;1.00&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;span id="xdx_902_eus-gaap--DebtInstrumentTerm_dtY_c20200701__20210630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember_ziMIM80sCzJ9" title="Debt instrument, measurement input, term"&gt;0.01&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;span id="xdx_904_eus-gaap--DebtInstrumentTerm_dtY_c20190701__20200630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember__srt--RangeAxis__srt--MinimumMember_zQq0IiYT0cn5" title="Debt instrument, measurement input, term"&gt;0.01&lt;/span&gt;
    &#x2013; &lt;span id="xdx_901_eus-gaap--DebtInstrumentTerm_dtY_c20190701__20200630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember__srt--RangeAxis__srt--MaximumMember_zRzEN0YrwSO1" title="Debt instrument, measurement input, term"&gt;0.70&lt;/span&gt; &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Risk-free
    interest rate&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;N/A&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90D_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_uPure_c20200630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MinimumMember_zG2WLbhXC174" title="Debt instrument, measurement input, percentages"&gt;1.53&lt;/span&gt;
    &#x2013; &lt;span id="xdx_905_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_uPure_c20200630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MaximumMember_zeQQCpHn9Oo3" title="Debt instrument, measurement input, percentages"&gt;1.59&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;%&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;span id="xdx_902_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_uPure_c20210630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember_z7Aep2hS9Ss4" title="Debt instrument, measurement input, percentages"&gt;0.05&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;span id="xdx_901_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_uPure_c20200630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember__srt--RangeAxis__srt--MinimumMember_zJYF6qi0vIO4" title="Debt instrument, measurement input, percentages"&gt;0.13&lt;/span&gt;
    &#x2013; &lt;span id="xdx_90D_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_uPure_c20200630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember__srt--RangeAxis__srt--MaximumMember_zQagw6Ahxvq1" title="Debt instrument, measurement input, percentages"&gt;0.18&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Expected
    dividend yield&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;N/A&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_904_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_dn_uPure_c20200630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zM4oKsxZoZOi" title="Debt instrument, measurement input, percentages"&gt;None&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;span id="xdx_901_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_dpn_uPure_c20210630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember_zPYMAAUfdnC9" title="Debt instrument, measurement input, percentages"&gt;None&lt;/span&gt;
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;span id="xdx_907_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_dn_uPure_c20200630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember_zcJ0FN6PYQYf" title="Debt instrument, measurement input, percentages"&gt;None&lt;/span&gt;
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock>
    <us-gaap:DebtInstrumentMeasurementInput
      contextRef="AsOf2020-06-30_us-gaap_MeasurementInputPriceVolatilityMember_srt_MinimumMember"
      decimals="INF"
      unitRef="Pure">227</us-gaap:DebtInstrumentMeasurementInput>
    <us-gaap:DebtInstrumentMeasurementInput
      contextRef="AsOf2020-06-30_us-gaap_MeasurementInputPriceVolatilityMember_srt_MaximumMember"
      decimals="INF"
      unitRef="Pure">279</us-gaap:DebtInstrumentMeasurementInput>
    <us-gaap:DebtInstrumentMeasurementInput
      contextRef="AsOf2021-06-30_us-gaap_MeasurementInputPriceVolatilityMember_us-gaap_ConvertibleDebtMember"
      decimals="INF"
      unitRef="Pure">222</us-gaap:DebtInstrumentMeasurementInput>
    <us-gaap:DebtInstrumentMeasurementInput
      contextRef="AsOf2020-06-30_us-gaap_MeasurementInputPriceVolatilityMember_us-gaap_ConvertibleDebtMember"
      decimals="INF"
      unitRef="Pure">264</us-gaap:DebtInstrumentMeasurementInput>
    <us-gaap:DebtInstrumentTerm contextRef="From2019-07-012020-06-30_us-gaap_MeasurementInputExpectedTermMember">P1Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentTerm contextRef="From2020-07-012021-06-30_us-gaap_MeasurementInputExpectedTermMember_us-gaap_ConvertibleDebtMember">P0Y3D</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentTerm contextRef="From2019-07-012020-06-30_us-gaap_MeasurementInputExpectedTermMember_us-gaap_ConvertibleDebtMember_srt_MinimumMember">P0Y3D</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentTerm contextRef="From2019-07-012020-06-30_us-gaap_MeasurementInputExpectedTermMember_us-gaap_ConvertibleDebtMember_srt_MaximumMember">P0Y8M12D</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentMeasurementInput
      contextRef="AsOf2020-06-30_us-gaap_MeasurementInputRiskFreeInterestRateMember_srt_MinimumMember"
      decimals="INF"
      unitRef="Pure">1.53</us-gaap:DebtInstrumentMeasurementInput>
    <us-gaap:DebtInstrumentMeasurementInput
      contextRef="AsOf2020-06-30_us-gaap_MeasurementInputRiskFreeInterestRateMember_srt_MaximumMember"
      decimals="INF"
      unitRef="Pure">1.59</us-gaap:DebtInstrumentMeasurementInput>
    <us-gaap:DebtInstrumentMeasurementInput
      contextRef="AsOf2021-06-30_us-gaap_MeasurementInputRiskFreeInterestRateMember_us-gaap_ConvertibleDebtMember"
      decimals="INF"
      unitRef="Pure">0.05</us-gaap:DebtInstrumentMeasurementInput>
    <us-gaap:DebtInstrumentMeasurementInput
      contextRef="AsOf2020-06-30_us-gaap_MeasurementInputRiskFreeInterestRateMember_us-gaap_ConvertibleDebtMember_srt_MinimumMember"
      decimals="INF"
      unitRef="Pure">0.13</us-gaap:DebtInstrumentMeasurementInput>
    <us-gaap:DebtInstrumentMeasurementInput
      contextRef="AsOf2020-06-30_us-gaap_MeasurementInputRiskFreeInterestRateMember_us-gaap_ConvertibleDebtMember_srt_MaximumMember"
      decimals="INF"
      unitRef="Pure">0.18</us-gaap:DebtInstrumentMeasurementInput>
    <us-gaap:DebtInstrumentMeasurementInput
      contextRef="AsOf2020-06-30_us-gaap_MeasurementInputExpectedDividendRateMember"
      decimals="INF"
      unitRef="Pure">0</us-gaap:DebtInstrumentMeasurementInput>
    <us-gaap:DebtInstrumentMeasurementInput
      contextRef="AsOf2021-06-30_us-gaap_MeasurementInputExpectedDividendRateMember_us-gaap_ConvertibleDebtMember"
      decimals="INF"
      unitRef="Pure">0</us-gaap:DebtInstrumentMeasurementInput>
    <us-gaap:DebtInstrumentMeasurementInput
      contextRef="AsOf2020-06-30_us-gaap_MeasurementInputExpectedDividendRateMember_us-gaap_ConvertibleDebtMember"
      decimals="INF"
      unitRef="Pure">0</us-gaap:DebtInstrumentMeasurementInput>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock contextRef="From2020-07-012021-06-30">&lt;p id="xdx_891_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_zj10hCQnfo2k" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-right: 0; margin-bottom: 0; text-align: left; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8BC_zhgIJsNvoEFe" style="display: none"&gt;SCHEDULE OF FAIR VALUE, ASSETS AND LIABILITIES MEASURED ON RECURRING BASIS&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;Balance
    at&lt;br/&gt; June 30, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1.8pt 0 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;Quoted&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1.8pt 0 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;Prices&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1.8pt 0 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;in
    Active&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1.8pt 0 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;Markets
    for&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1.8pt 0 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;Identical
    Assets&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1.8pt 0 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;Significant&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1.8pt 0 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;Other&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1.8pt 0 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;Observable
    Inputs&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1.8pt 0 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;Significant&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1.8pt 0 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;Unobservable
    Inputs&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;(Level
    1)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;(Level
    2)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;(Level
    3)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 36%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Embedded
    conversion option liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_c20210630_pp0p0" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Embedded conversion option liabilities"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;54,220&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_c20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_pp0p0" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Embedded conversion option liabilities"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2445"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_c20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_pp0p0" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Embedded conversion option liabilities"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2447"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_c20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_pp0p0" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Embedded conversion option liabilities"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;54,220&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Total&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eus-gaap--DerivativeLiabilities_c20210630_pp0p0" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;54,220&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--DerivativeLiabilities_c20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_pp0p0" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2453"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eus-gaap--DerivativeLiabilities_c20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_pp0p0" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2455"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--DerivativeLiabilities_c20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_pp0p0" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;54,220&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;The
following tables summarize the Company&#x2019;s financial assets and liabilities measured at fair value on a recurring basis as of June
30, 2020:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;Balance
    at&lt;br/&gt; June 30, 2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1.8pt 0 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;Quoted&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1.8pt 0 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;Prices&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1.8pt 0 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;in
    Active&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1.8pt 0 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;Markets
    for&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1.8pt 0 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;Identical
    Assets&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1.8pt 0 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;Significant&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1.8pt 0 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;Other&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1.8pt 0 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;Observable
    Inputs&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1.8pt 0 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;Significant&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1.8pt 0 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;Unobservable
    Inputs&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;(Level
    1)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;(Level
    2)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;(Level
    3)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 36%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Embedded
    conversion option liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_c20200630_pp0p0" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Embedded conversion option liabilities"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;177,009&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_c20200630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_pp0p0" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Embedded conversion option liabilities"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2461"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_c20200630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_pp0p0" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Embedded conversion option liabilities"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2463"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_c20200630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_pp0p0" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Embedded conversion option liabilities"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;177,009&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Total&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eus-gaap--DerivativeLiabilities_c20200630_pp0p0" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;177,009&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--DerivativeLiabilities_c20200630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_pp0p0" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2469"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--DerivativeLiabilities_c20200630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_pp0p0" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2471"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eus-gaap--DerivativeLiabilities_c20200630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_pp0p0" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;177,009&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">54220</us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability>
    <us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
      contextRef="AsOf2021-06-30_us-gaap_FairValueInputsLevel3Member"
      decimals="0"
      unitRef="USD">54220</us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability>
    <us-gaap:DerivativeLiabilities contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">54220</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="AsOf2021-06-30_us-gaap_FairValueInputsLevel3Member"
      decimals="0"
      unitRef="USD">54220</us-gaap:DerivativeLiabilities>
    <us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">177009</us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability>
    <us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
      contextRef="AsOf2020-06-30_us-gaap_FairValueInputsLevel3Member"
      decimals="0"
      unitRef="USD">177009</us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability>
    <us-gaap:DerivativeLiabilities contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">177009</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="AsOf2020-06-30_us-gaap_FairValueInputsLevel3Member"
      decimals="0"
      unitRef="USD">177009</us-gaap:DerivativeLiabilities>
    <us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock contextRef="From2020-07-012021-06-30">&lt;p id="xdx_898_eus-gaap--ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_zwnWqsCQ67Ea" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;The
following is a roll forward for the years ended June 30, 2021 and 2020 of the fair value liability of price adjustable derivative instruments:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-right: 0; margin-bottom: 0; text-align: left; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B1_zUG1Rm1Y5kic" style="display: none"&gt;SCHEDULE OF DERIVATIVE LIABILITIES AT FAIR VALUE&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;Fair
    Value of&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;Liability
    for&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;Derivative&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;Instruments&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; width: 82%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;Balance
    at June 30, 2019&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--DerivativeLiabilities_iS_pp0p0_c20190701__20200630_zclpqGLBOnAf" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Balance at Beginning"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;698,264&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Reductions
    due to conversions&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--ReductionsDueToConversions_c20190701__20200630_pp0p0" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Reductions due to conversions"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;(362,962&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Initial
    fair value of embedded conversion option derivative liability recorded as debt discount&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--FairValueOfWarrantDerivativeLiabilityRecorededAsDebtDiscount_c20190701__20200630_pp0p0" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Initial fair value of embedded conversion option derivative liability recorded as debt discount"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;227,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Initial
    fair value of embedded conversion option derivative liability recorded as expense&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--InitialFairValueOfEmbeddedConversionOptionDerivativeLiabilityRecordedAsExpense_c20190701__20200630_pp0p0" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Initial fair value of embedded conversion option derivative liability recorded as expense"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;351,461&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Change
    in fair value included in statements of operations&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet_c20190701__20200630_pp0p0" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Change in fair value included in statements of operations"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;(736,754&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;Balance
    at June 30, 2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--DerivativeLiabilities_iS_pp0p0_c20200701__20210630_zUMVWyInRydk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Balance at Beginning"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;177,009&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Gain
    on debt extinguishment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--GainOnDebtExtinguishment_c20200701__20210630_pp0p0" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Gain on debt extinguishment"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;(130,975&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Change
    in fair value included in statements of operations&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet_c20200701__20210630_pp0p0" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Change in fair value included in statements of operations"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;8,186&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;&lt;b&gt;Balance
    at June 30, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eus-gaap--DerivativeLiabilities_iE_pp0p0_c20200701__20210630_zSqnvtpNZU1f" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Balance at Ending"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;54,220&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock>
    <us-gaap:DerivativeLiabilities contextRef="AsOf2019-06-30" decimals="0" unitRef="USD">698264</us-gaap:DerivativeLiabilities>
    <PPCB:ReductionsDueToConversions
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">-362962</PPCB:ReductionsDueToConversions>
    <PPCB:FairValueOfWarrantDerivativeLiabilityRecorededAsDebtDiscount
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">227000</PPCB:FairValueOfWarrantDerivativeLiabilityRecorededAsDebtDiscount>
    <PPCB:InitialFairValueOfEmbeddedConversionOptionDerivativeLiabilityRecordedAsExpense
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">351461</PPCB:InitialFairValueOfEmbeddedConversionOptionDerivativeLiabilityRecordedAsExpense>
    <us-gaap:EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
      contextRef="From2019-07-012020-06-30"
      decimals="0"
      unitRef="USD">-736754</us-gaap:EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet>
    <us-gaap:DerivativeLiabilities contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">177009</us-gaap:DerivativeLiabilities>
    <PPCB:GainOnDebtExtinguishment
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">-130975</PPCB:GainOnDebtExtinguishment>
    <us-gaap:EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">8186</us-gaap:EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet>
    <us-gaap:DerivativeLiabilities contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">54220</us-gaap:DerivativeLiabilities>
    <us-gaap:SubsequentEventsTextBlock contextRef="From2020-07-012021-06-30">&lt;p id="xdx_807_eus-gaap--SubsequentEventsTextBlock_zrHwINm5xEU3" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;NOTE
13 &#x2013; &lt;span id="xdx_82D_zExNzAej8vwe"&gt;SUBSEQUENT EVENTS&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;i&gt;Exercise
of Warrants&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;From
July 9, 2021 through September 7, 2021, the Company received aggregate gross proceeds of $&lt;span id="xdx_907_eus-gaap--ProceedsFromWarrantExercises_pp0p0_c20210709__20210907__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_za2JIYRtppHf"&gt;275,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;from the exercise of &lt;span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20210709__20210907__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantsMember_zvTZEwTOekzb"&gt;6,875
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Series B Warrants and issued
&lt;span id="xdx_903_eus-gaap--CommonStockSharesIssued_iI_c20210907__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantsMember_z4LaYCMacYo3"&gt;6,875&lt;/span&gt; shares of common stock. Additionally, the Company issued &lt;span id="xdx_90B_eus-gaap--CommonStockSharesIssued_iI_c20210907__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementClassOfStockAxis__custom--TwelveSeriesAAndAWarrantsMember_zclCoonFaZeg"&gt;2,399,988
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;shares of common stock from the
alternate cashless exercise of 12 Series A warrants.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;i&gt;Note
Conversions&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;From
July 1, 2021 through September 20, 2021, the Company issued an aggregate of &lt;span id="xdx_901_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_pid_c20210701__20210920__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zM9BmClAOoXg"&gt;6,702,152
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;shares of its common stock
at an average contractual conversion price of $&lt;span id="xdx_90A_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20210920__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zpuhDyv8ks4e"&gt;0.02&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;,
ranging from $&lt;span id="xdx_907_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20210920__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--RangeAxis__srt--MinimumMember_zHKmVoo31Uv1"&gt;0.01
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;to $&lt;span id="xdx_906_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20210920__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--RangeAxis__srt--MaximumMember_z0wFtzRzYlCj"&gt;0.04&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;,
as a result of the conversion of principal of $&lt;span id="xdx_90B_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20210920__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zpA0O2qvXElh"&gt;146,348&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;,
&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;interest of $&lt;span id="xdx_90F_eus-gaap--InterestPayableCurrent_iI_pp0p0_c20210920__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z0M9VSiaK0D8"&gt;4,887
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;and conversion fees $&lt;span id="xdx_90E_ecustom--ConversionFees_pp0p0_c20210701__20210920__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zp2IC1QmR0fe"&gt;2,250
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;underlying certain outstanding
convertible notes converted during such period. The Company reclassified $&lt;span id="xdx_900_eus-gaap--AdditionalPaidInCapital_iI_pp0p0_c20210923__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z1yVPDDia61c"&gt;86,219
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;in put premiums to additional
paid in capital following conversions between July 2021 and September 2021.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;PROPANC
BIOPHARMA, INC. AND SUBSIDIARY&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;June
30, 2021 and 2020&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;i&gt;Nathanielsz
Cancellation Agreement&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;On
August 12, 2021, the Company entered into a Cancellation Agreement with James Nathanielsz (&#x201c;Nathanielsz&#x201d;), Chief Executive
Officer and Director of the Company, whereby Nathanielsz agreed to cancel his cash compensation bonus award for fiscal year 2021, ended
June 30, 2021, in exchange for common stock of the Company. The Company and Nathanielsz entered into an Amended and Restated Employment
Agreement dated May 14, 2019 (the &#x201c;Agreement&#x201d;). Pursuant to the terms of the Agreement, Nathanielsz was eligible to earn
an annual fiscal year cash performance bonus for each fiscal year of his employment period with the Company with a target performance
bonus of &lt;span id="xdx_903_ecustom--PercentageOfBonusOfAnnualBaseSalary_dp_uPure_c20210811__20210812__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--NathanielszCancellationAgreementMember_z0T2IuWy3sub"&gt;200%&lt;/span&gt; of his average annualized base salary during the fiscal year for which the performance bonus is earned. On July 20, 2021,
Nathanielsz was awarded a &#x201c;target&#x201d; bonus of &lt;span id="xdx_905_ecustom--PercentageOfBonusOfAnnualBaseSalary_pip0_dp_uPure_c20210719__20210720__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember__us-gaap--TypeOfArrangementAxis__custom--NathanielszCancellationAgreementMember_zYc27273q2X4"&gt;78%&lt;/span&gt;, or $&lt;span id="xdx_90E_eus-gaap--OfficersCompensation_pp0p0_c20210719__20210720__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember__us-gaap--TypeOfArrangementAxis__custom--NathanielszCancellationAgreementMember_zKxr6FEZST98"&gt;177,840&lt;/span&gt; USD (the &#x201c;Debt&#x201d;) for the fiscal year ended June
30, 2021, by the Company&#x2019;s Board of Directors (the &#x201c;Board&#x201d;). Pursuant to the Cancellation Agreement, Nathanielsz agreed
to cancel this Debt in exchange for &lt;span id="xdx_903_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_pp0p0_c20210816__20210817__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember__us-gaap--TypeOfArrangementAxis__custom--NathanielszCancellationAgreementMember_zlMMchIbnZ5k"&gt;5,928,000&lt;/span&gt; shares of the common stock of the Company (the &#x201c;Shares&#x201d;), valued at approximately
$&lt;span id="xdx_90C_eus-gaap--SharePrice_iI_pip0_c20210817__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember__us-gaap--TypeOfArrangementAxis__custom--NathanielszCancellationAgreementMember_zktn7yqOiTjj" title="Share price"&gt;0.03&lt;/span&gt; per share, being the closing price of the stock on the date of grant. The shares were issued on August 17, 2021.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;i&gt;Kenyon
Cancellation Agreement&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; color: #333333; text-align: justify; text-indent: 0.25in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;On
August 12, 2021, the Company entered into a Cancellation Agreement with Dr. Julian Kenyon (&#x201c;Kenyon&#x201d;), Chief Scientific Officer
and Director of the Company, whereby Kenyon agreed to cancel of $&lt;span id="xdx_904_ecustom--CancellationOfAccruedSalaries_iI_c20210812__us-gaap--TypeOfArrangementAxis__custom--KenyonCancellationAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DrKenyonMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zmEuFb0Ox5Ec"&gt;102,600 &lt;/span&gt;USD of accrued salary due him as of June 30, 2021, pursuant
to that certain Amended and Restated Services Agreement by and between Kenyon and the Company, dated May 14, 2019, in exchange for &lt;span id="xdx_904_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20210811__20210812__us-gaap--TypeOfArrangementAxis__custom--KenyonCancellationAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DrKenyonMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z8XIK8dugdh3"&gt;3,420,000&lt;/span&gt;
shares of common stock of the Company (the &#x201c;Shares&#x201d;), valued at approximately $&lt;span id="xdx_90B_eus-gaap--SharePrice_iI_c20210812__us-gaap--TypeOfArrangementAxis__custom--KenyonCancellationAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DrKenyonMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zyhhb8K4FDg4"&gt;0.03&lt;/span&gt; per share, being the closing price of
the stock on the date of grant. The shares were issued on August 17, 2021.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; color: #333333; text-align: justify; text-indent: 0.25in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;i&gt;Zelinger
Amended and Restated Director Agreement&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;On
August 12, 2021, the Company entered into an Amended and Restated Director Agreement (the &#x201c;Director Agreement&#x201d;) with Josef
Zelinger (&#x201c;Zelinger&#x201d;). &lt;span id="xdx_903_ecustom--DescriptionOfEmploymentBenefits_c20210811__20210812__us-gaap--TypeOfArrangementAxis__custom--ZelingerAmendedAndRestatedDirectorAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--JosefZelingerMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zNl4i6Kde5w8" title="Description of employment benefits"&gt;Pursuant to the terms of the Director Agreement, the Company shall pay Zelinger a base salary of $250.00
AUD per month, payable on the first day of each month. In addition, the Company may compensate Zelinger additional consideration for
advisory services performed by the Director, either in the form of cash or common stock, at the discretion of the Board. The Company
issued &lt;span id="xdx_906_ecustom--CommonStockIssuableShares_iI_c20210630__us-gaap--TypeOfArrangementAxis__custom--ZelingerAmendedAndRestatedDirectorAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--JosefZelingerMember_zBon75o6ZXnc"&gt;2,800,000&lt;/span&gt; shares of common stock of the Company for accrued director services of $&lt;span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20200701__20210630__us-gaap--TypeOfArrangementAxis__custom--ZelingerAmendedAndRestatedDirectorAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--JosefZelingerMember_zdGzrF2eyRAh"&gt;84,000&lt;/span&gt; as of June 30, 2021. The &lt;span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20200701__20210630__us-gaap--TypeOfArrangementAxis__custom--ZelingerAmendedAndRestatedDirectorAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--JosefZelingerMember_zJJdBMBN9QQe"&gt;2,800,000&lt;/span&gt; shares
of common stock was valued at approximately $&lt;span id="xdx_90E_eus-gaap--SharePrice_iI_c20210630__us-gaap--TypeOfArrangementAxis__custom--ZelingerAmendedAndRestatedDirectorAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--JosefZelingerMember_zgRYESC6Ujbi"&gt;0.03&lt;/span&gt; per share, being the closing price of the stock on the date of grant.&lt;/span&gt; The shares were
issued on August 17, 2021.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;i&gt;Common
Stock Issued for Services&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;On
August 12, 2021, the Board approved the issuance of &lt;span id="xdx_90D_ecustom--CommonStockIssuableShares_iI_c20210812__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementClassOfStockAxis__custom--CommonStockOneMember_zAepDUmVNjb"&gt;2,800,000&lt;/span&gt; shares of the Company&#x2019;s common stock for bonus payable of $&lt;span id="xdx_900_eus-gaap--AccruedBonusesCurrent_iI_c20210630__us-gaap--StatementClassOfStockAxis__custom--CommonStockOneMember_zIC5h5REOc9d" title="Accrued Bonuses"&gt;84,000&lt;/span&gt;
as of June 30, 2021 to an employee who is the wife of the CEO of the Company. The &lt;span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210811__20210812__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementClassOfStockAxis__custom--CommonStockOneMember_zEnAQRCCPkya"&gt;2,800,000&lt;/span&gt; shares of common stock was valued at approximately
$&lt;span id="xdx_906_eus-gaap--SharePrice_iI_c20210812__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementClassOfStockAxis__custom--CommonStockOneMember_zdbjW1IUGO11"&gt;0.03&lt;/span&gt; per share, being the closing price of the stock on the date of grant. The shares were issued on August 17, 2021.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;On
August 12, 2021, the Board approved the issuance of &lt;span id="xdx_902_ecustom--CommonStockIssuableShares_iI_c20210812__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementClassOfStockAxis__custom--CommonStockTwoMember_zpWrojFpxwP2" title="Common Stock Issuable Shares"&gt;166,667&lt;/span&gt; shares of the Company&#x2019;s common stock for legal services rendered in
August 2021 worth $&lt;span id="xdx_907_eus-gaap--LegalFees_c20210811__20210812__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementClassOfStockAxis__custom--CommonStockTwoMember_zFdllkl1AT64" title="Legal fees"&gt;5,000&lt;/span&gt;. The &lt;span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210811__20210812__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementClassOfStockAxis__custom--CommonStockTwoMember_zLkBE2Ns90yb"&gt;5,000&lt;/span&gt; shares of common stock was valued at approximately $&lt;span id="xdx_908_eus-gaap--SharePrice_iI_pid_c20210812__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementClassOfStockAxis__custom--CommonStockTwoMember_zaxuWj8NaDc5"&gt;0.03&lt;/span&gt; per share, being the closing price of the
stock on the date of grant. The shares were issued on September 3, 2021.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;In
September 2021, the Company issued &lt;span id="xdx_908_ecustom--CommonStockIssuableShares_iI_c20210930__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementClassOfStockAxis__custom--CommonStockThreeMember_zB3RWONnyTXc"&gt;2,819,712&lt;/span&gt; shares of the Company&#x2019;s common stock to a consultant for services rendered from July
2021 to September 2021. The Company issued &lt;span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210901__20210930__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementClassOfStockAxis__custom--CommonStockThreeMember_zZ9u46eCp5w3"&gt;2,819,712&lt;/span&gt; shares of the Company&#x2019;s common stock valued at approximately $&lt;span id="xdx_904_eus-gaap--SharePrice_iI_c20210930__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementClassOfStockAxis__custom--CommonStockThreeMember_zncTt53fx8H5"&gt;0.04&lt;/span&gt; per share,
being the closing price of the stock on the date of grant to such consultant, or approximately $&lt;span id="xdx_903_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20210901__20210930__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementClassOfStockAxis__custom--CommonStockThreeMember_zoIb9zEbVEz2"&gt;113,000&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;i&gt;August
19, 2021 and September 22, 2021 Securities Purchase Agreement&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;Effective
August 19, 2021, the Company entered into a securities purchase agreement with Geneva Roth Remark Holdings, Inc., pursuant to which
Geneva Roth purchased a convertible promissory note (the &#x201c;August 19, 2021 Geneva Roth&#x201d;) from the Company in the
aggregate principal amount of $&lt;span id="xdx_903_eus-gaap--DebtInstrumentFaceAmount_iI_c20210819__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--TwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember_zJxwu8JbUVDh"&gt;103,750&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;,
such principal and the interest thereon convertible into shares of the Company&#x2019;s common stock at the option of Geneva Roth any
time after the six-month anniversary of the August 19, 2021 Geneva Roth. The August 19, 2021 Geneva Roth contains an original
discount of $&lt;span id="xdx_904_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20210819__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--TwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember_zTJl5QYwYr5g"&gt;3,750&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;.
The Company intends to use the net proceeds from the August 19, 2021 Geneva Roth for general working capital purposes. &lt;/span&gt;The
maturity date of the August 19, 2021 Geneva Roth Note is &lt;span id="xdx_90C_eus-gaap--DebtInstrumentMaturityDate_dd_c20210818__20210819__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--TwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember_zaFr17VByOrj"&gt;August
19, 2022&lt;/span&gt;. The August 19, 2021 Geneva Roth Note bears interest at a rate of &lt;span id="xdx_905_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20210818__20210819__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--TwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember_zdxFt8OWQKp4"&gt;8% &lt;/span&gt;per
annum, which interest may be paid by the Company to Geneva Roth in shares of the Company&#x2019;s common stock; but shall not be
payable until the August 19, 2021 Geneva Roth Note becomes payable, whether at the maturity date or upon acceleration or by
prepayment.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"/&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Additionally, effective September 22, 2021, the
Company entered into a securities purchase agreement with Geneva Roth Remark Holdings, Inc., pursuant to which Geneva Roth purchased
a convertible promissory note (the &#x201c;September 22, 2021 Geneva Roth&#x201d;) from the Company in the aggregate principal amount of
$&lt;span id="xdx_907_eus-gaap--DebtInstrumentFaceAmount_iI_c20210922__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--TwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember_zcYCx9VF7F8l"&gt;63,750&lt;/span&gt;, such principal and the interest thereon convertible into shares of the Company&#x2019;s common stock at the option of Geneva
Roth any time after the six-month anniversary of the September 22, 2021 Geneva Roth. The September 22, 2021 Geneva Roth contains an original
discount of $&lt;span id="xdx_905_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20210922__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--TwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember_zHu6SSH176ua"&gt;3,750&lt;/span&gt;. The Company intends to use the net proceeds from the September 22, 2021 Geneva Roth for general working capital purposes.
The maturity date of the &lt;span id="xdx_90A_eus-gaap--DebtInstrumentMaturityDate_dd_c20210921__20210922__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--TwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember_zb91W7EBaEd2"&gt;September 22, 2021&lt;/span&gt; Geneva Roth Note is September 22, 2022. The September 22, 2021 Geneva Roth Note bears interest
at a rate of &lt;span id="xdx_90B_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20210921__20210922__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--TwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember_zzjAhYzJmcJb"&gt;8&lt;/span&gt;% per annum, which interest may be paid by the Company to Geneva Roth in shares of the Company&#x2019;s common stock; but
shall not be payable until the September 22, 2021 Geneva Roth Note becomes payable, whether at the maturity date or upon acceleration
or by prepayment.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&lt;span id="xdx_900_eus-gaap--DebtInstrumentDescription_c20210818__20210819__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--TwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember_zG0J5VNzl6Ef" title="Debt description"&gt;During
the first 60 to 180 days following the date of these notes, the Company has the right to prepay the principal and accrued but unpaid
interest due under the above notes issued to Geneva Roth, together with any other amounts that the Company may owe the holder under the
terms of the note, at a premium ranging from 110% to 129% as defined in the note agreement. After this initial 180-day period, the Company
does not have a right to prepay such notes.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;The
conversion price for the above Geneva Roth notes shall be equal to a &lt;span id="xdx_906_ecustom--DebtCoversionPercentage_dp_c20210818__20210819__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--TwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember_zcSPVFCMNfyc"&gt;35%
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;discount of the market price which
means the average of the lowest three trading prices of the Common Stock for the ten trading days immediately prior to the delivery of
a Notice of Conversion. Notwithstanding the foregoing, Geneva Roth shall be restricted from effecting a conversion if such conversion,
along with other shares of the Company&#x2019;s common stock beneficially owned by Geneva Roth and its affiliates, exceeds &lt;span id="xdx_905_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_uPure_c20210819__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--TwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember_zEJqORt1zXC5"&gt;9.99%
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;of the outstanding shares of the
Company&#x2019;s common stock. These notes are treated as stock settled debt under ASC 480 and accordingly the Company recorded a total
of $&lt;span id="xdx_909_ecustom--GainFromSettlementOfDebtNet_c20210818__20210819__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--TwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember_zQ1oTm0LT7ba"&gt;90,192
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;put premium.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; color: Black"&gt;The
above Geneva Roth notes contain certain events of default, upon which principal and accrued interest will become immediately due and
payable. In addition, upon an event of default, &lt;span id="xdx_909_eus-gaap--DebtInstrumentInterestRateTerms_c20210818__20210819__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--TwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember_zQFItRYrVT9d" title="Debt Instrument, Interest Rate Terms"&gt;interest on the outstanding principal shall accrue at a default interest rate of 22%
per annum&lt;/span&gt;, or if such rate is usurious or not permitted by current law, then at the highest rate of interest permitted by law. Further,
certain events of default may trigger penalty and liquidated damage provisions.&lt;/span&gt;&lt;/p&gt;

</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:ProceedsFromWarrantExercises
      contextRef="From2021-07-092021-09-07_us-gaap_SubsequentEventMember"
      decimals="0"
      unitRef="USD">275000</us-gaap:ProceedsFromWarrantExercises>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2021-07-092021-09-07_us-gaap_SubsequentEventMember_custom_SeriesBWarrantsMember"
      decimals="INF"
      unitRef="Shares">6875</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2021-09-07_us-gaap_SubsequentEventMember_custom_SeriesBWarrantsMember"
      decimals="INF"
      unitRef="Shares">6875</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2021-09-07_us-gaap_SubsequentEventMember_custom_TwelveSeriesAAndAWarrantsMember"
      decimals="INF"
      unitRef="Shares">2399988</us-gaap:CommonStockSharesIssued>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1
      contextRef="From2021-07-012021-09-20_us-gaap_SubsequentEventMember_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">6702152</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="AsOf2021-09-20_us-gaap_SubsequentEventMember"
      decimals="INF"
      unitRef="USDPShares">0.02</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="AsOf2021-09-20_us-gaap_SubsequentEventMember_srt_MinimumMember"
      decimals="INF"
      unitRef="USDPShares">0.01</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="AsOf2021-09-20_us-gaap_SubsequentEventMember_srt_MaximumMember"
      decimals="INF"
      unitRef="USDPShares">0.04</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2021-09-20_us-gaap_SubsequentEventMember"
      decimals="0"
      unitRef="USD">146348</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:InterestPayableCurrent
      contextRef="AsOf2021-09-20_us-gaap_SubsequentEventMember"
      decimals="0"
      unitRef="USD">4887</us-gaap:InterestPayableCurrent>
    <PPCB:ConversionFees
      contextRef="From2021-07-012021-09-20_us-gaap_SubsequentEventMember_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">2250</PPCB:ConversionFees>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2021-09-23_us-gaap_SubsequentEventMember"
      decimals="0"
      unitRef="USD">86219</us-gaap:AdditionalPaidInCapital>
    <PPCB:PercentageOfBonusOfAnnualBaseSalary
      contextRef="From2021-08-112021-08-12_us-gaap_SubsequentEventMember_custom_NathanielszCancellationAgreementMember"
      decimals="INF"
      unitRef="Pure">2</PPCB:PercentageOfBonusOfAnnualBaseSalary>
    <PPCB:PercentageOfBonusOfAnnualBaseSalary
      contextRef="From2021-07-192021-07-20_us-gaap_SubsequentEventMember_custom_MrNathanielszMember_custom_NathanielszCancellationAgreementMember"
      decimals="INF"
      unitRef="Pure">0.78</PPCB:PercentageOfBonusOfAnnualBaseSalary>
    <us-gaap:OfficersCompensation
      contextRef="From2021-07-192021-07-20_us-gaap_SubsequentEventMember_custom_MrNathanielszMember_custom_NathanielszCancellationAgreementMember"
      decimals="0"
      unitRef="USD">177840</us-gaap:OfficersCompensation>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1
      contextRef="From2021-08-162021-08-17_us-gaap_SubsequentEventMember_custom_MrNathanielszMember_custom_NathanielszCancellationAgreementMember"
      decimals="0"
      unitRef="Shares">5928000</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <us-gaap:SharePrice
      contextRef="AsOf2021-08-17_us-gaap_SubsequentEventMember_custom_MrNathanielszMember_custom_NathanielszCancellationAgreementMember"
      decimals="INF"
      unitRef="USDPShares">0.03</us-gaap:SharePrice>
    <PPCB:CancellationOfAccruedSalaries
      contextRef="AsOf2021-08-12_custom_KenyonCancellationAgreementMember_custom_DrKenyonMember_us-gaap_SubsequentEventMember"
      decimals="0"
      unitRef="USD">102600</PPCB:CancellationOfAccruedSalaries>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1
      contextRef="From2021-08-112021-08-12_custom_KenyonCancellationAgreementMember_custom_DrKenyonMember_us-gaap_SubsequentEventMember"
      decimals="INF"
      unitRef="Shares">3420000</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <us-gaap:SharePrice
      contextRef="AsOf2021-08-12_custom_KenyonCancellationAgreementMember_custom_DrKenyonMember_us-gaap_SubsequentEventMember"
      decimals="INF"
      unitRef="USDPShares">0.03</us-gaap:SharePrice>
    <PPCB:DescriptionOfEmploymentBenefits contextRef="From2021-08-112021-08-12_custom_ZelingerAmendedAndRestatedDirectorAgreementMember_custom_JosefZelingerMember_us-gaap_SubsequentEventMember">Pursuant to the terms of the Director Agreement, the Company shall pay Zelinger a base salary of $250.00
AUD per month, payable on the first day of each month. In addition, the Company may compensate Zelinger additional consideration for
advisory services performed by the Director, either in the form of cash or common stock, at the discretion of the Board. The Company
issued 2,800,000 shares of common stock of the Company for accrued director services of $84,000 as of June 30, 2021. The 2,800,000 shares
of common stock was valued at approximately $0.03 per share, being the closing price of the stock on the date of grant.</PPCB:DescriptionOfEmploymentBenefits>
    <PPCB:CommonStockIssuableShares
      contextRef="AsOf2021-06-30_custom_ZelingerAmendedAndRestatedDirectorAgreementMember_custom_JosefZelingerMember"
      decimals="INF"
      unitRef="Shares">2800000</PPCB:CommonStockIssuableShares>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2020-07-012021-06-30_custom_ZelingerAmendedAndRestatedDirectorAgreementMember_custom_JosefZelingerMember"
      decimals="0"
      unitRef="USD">84000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2020-07-012021-06-30_custom_ZelingerAmendedAndRestatedDirectorAgreementMember_custom_JosefZelingerMember"
      decimals="INF"
      unitRef="Shares">2800000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharePrice
      contextRef="AsOf2021-06-30_custom_ZelingerAmendedAndRestatedDirectorAgreementMember_custom_JosefZelingerMember"
      decimals="INF"
      unitRef="USDPShares">0.03</us-gaap:SharePrice>
    <PPCB:CommonStockIssuableShares
      contextRef="AsOf2021-08-12_us-gaap_SubsequentEventMember_custom_CommonStockOneMember"
      decimals="INF"
      unitRef="Shares">2800000</PPCB:CommonStockIssuableShares>
    <us-gaap:AccruedBonusesCurrent
      contextRef="AsOf2021-06-30_custom_CommonStockOneMember"
      decimals="0"
      unitRef="USD">84000</us-gaap:AccruedBonusesCurrent>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2021-08-112021-08-12_us-gaap_SubsequentEventMember_custom_CommonStockOneMember"
      decimals="INF"
      unitRef="Shares">2800000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharePrice
      contextRef="AsOf2021-08-12_us-gaap_SubsequentEventMember_custom_CommonStockOneMember"
      decimals="INF"
      unitRef="USDPShares">0.03</us-gaap:SharePrice>
    <PPCB:CommonStockIssuableShares
      contextRef="AsOf2021-08-12_us-gaap_SubsequentEventMember_custom_CommonStockTwoMember"
      decimals="INF"
      unitRef="Shares">166667</PPCB:CommonStockIssuableShares>
    <us-gaap:LegalFees
      contextRef="From2021-08-112021-08-12_us-gaap_SubsequentEventMember_custom_CommonStockTwoMember"
      decimals="0"
      unitRef="USD">5000</us-gaap:LegalFees>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2021-08-112021-08-12_us-gaap_SubsequentEventMember_custom_CommonStockTwoMember"
      decimals="INF"
      unitRef="Shares">5000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharePrice
      contextRef="AsOf2021-08-12_us-gaap_SubsequentEventMember_custom_CommonStockTwoMember"
      decimals="INF"
      unitRef="USDPShares">0.03</us-gaap:SharePrice>
    <PPCB:CommonStockIssuableShares
      contextRef="AsOf2021-09-30_us-gaap_SubsequentEventMember_custom_CommonStockThreeMember"
      decimals="INF"
      unitRef="Shares">2819712</PPCB:CommonStockIssuableShares>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2021-09-012021-09-30_us-gaap_SubsequentEventMember_custom_CommonStockThreeMember"
      decimals="INF"
      unitRef="Shares">2819712</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharePrice
      contextRef="AsOf2021-09-30_us-gaap_SubsequentEventMember_custom_CommonStockThreeMember"
      decimals="INF"
      unitRef="USDPShares">0.04</us-gaap:SharePrice>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2021-09-012021-09-30_us-gaap_SubsequentEventMember_custom_CommonStockThreeMember"
      decimals="0"
      unitRef="USD">113000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2021-08-19_us-gaap_SubsequentEventMember_custom_TwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember"
      decimals="0"
      unitRef="USD">103750</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="AsOf2021-08-19_us-gaap_SubsequentEventMember_custom_TwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember"
      decimals="0"
      unitRef="USD">3750</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentMaturityDate contextRef="From2021-08-182021-08-19_us-gaap_SubsequentEventMember_custom_TwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember">2022-08-19</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="From2021-08-182021-08-19_us-gaap_SubsequentEventMember_custom_TwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember"
      decimals="INF"
      unitRef="Pure">0.08</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2021-09-22_us-gaap_SubsequentEventMember_custom_TwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember"
      decimals="0"
      unitRef="USD">63750</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="AsOf2021-09-22_us-gaap_SubsequentEventMember_custom_TwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember"
      decimals="0"
      unitRef="USD">3750</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentMaturityDate contextRef="From2021-09-212021-09-22_us-gaap_SubsequentEventMember_custom_TwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember">2021-09-22</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="From2021-09-212021-09-22_us-gaap_SubsequentEventMember_custom_TwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember"
      decimals="INF"
      unitRef="Pure">0.08</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:DebtInstrumentDescription contextRef="From2021-08-182021-08-19_us-gaap_SubsequentEventMember_custom_TwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember">During
the first 60 to 180 days following the date of these notes, the Company has the right to prepay the principal and accrued but unpaid
interest due under the above notes issued to Geneva Roth, together with any other amounts that the Company may owe the holder under the
terms of the note, at a premium ranging from 110% to 129% as defined in the note agreement. After this initial 180-day period, the Company
does not have a right to prepay such notes.</us-gaap:DebtInstrumentDescription>
    <PPCB:DebtCoversionPercentage
      contextRef="From2021-08-182021-08-19_us-gaap_SubsequentEventMember_custom_TwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember"
      decimals="INF"
      unitRef="Pure">0.35</PPCB:DebtCoversionPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="AsOf2021-08-19_us-gaap_SubsequentEventMember_custom_TwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember"
      decimals="INF"
      unitRef="Pure">0.0999</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <PPCB:GainFromSettlementOfDebtNet
      contextRef="From2021-08-182021-08-19_us-gaap_SubsequentEventMember_custom_TwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember"
      decimals="0"
      unitRef="USD">90192</PPCB:GainFromSettlementOfDebtNet>
    <us-gaap:DebtInstrumentInterestRateTerms contextRef="From2021-08-182021-08-19_us-gaap_SubsequentEventMember_custom_TwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember">interest on the outstanding principal shall accrue at a default interest rate of 22%
per annum</us-gaap:DebtInstrumentInterestRateTerms>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2021-09-30" decimals="0" unitRef="USD">45817</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">2255</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:ValueAddedTaxReceivableCurrent contextRef="AsOf2021-09-30" decimals="0" unitRef="USD">2238</us-gaap:ValueAddedTaxReceivableCurrent>
    <us-gaap:ValueAddedTaxReceivableCurrent contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">4341</us-gaap:ValueAddedTaxReceivableCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="AsOf2021-09-30" decimals="0" unitRef="USD">8353</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2021-09-30" decimals="0" unitRef="USD">56408</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">6596</us-gaap:AssetsCurrent>
    <us-gaap:DepositsAssetsNoncurrent contextRef="AsOf2021-09-30" decimals="0" unitRef="USD">2164</us-gaap:DepositsAssetsNoncurrent>
    <us-gaap:DepositsAssetsNoncurrent contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">2250</us-gaap:DepositsAssetsNoncurrent>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2021-09-30" decimals="0" unitRef="USD">3593</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">4255</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Assets contextRef="AsOf2021-09-30" decimals="0" unitRef="USD">62165</us-gaap:Assets>
    <us-gaap:Assets contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">13101</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent contextRef="AsOf2021-09-30" decimals="0" unitRef="USD">826184</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">1002335</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent contextRef="AsOf2021-09-30" decimals="0" unitRef="USD">407775</us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">892151</us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent>
    <us-gaap:ConvertibleDebtCurrent contextRef="AsOf2021-09-30" decimals="0" unitRef="USD">584608</us-gaap:ConvertibleDebtCurrent>
    <us-gaap:ConvertibleDebtCurrent contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">624583</us-gaap:ConvertibleDebtCurrent>
    <us-gaap:DeferredCompensationLiabilityCurrent contextRef="AsOf2021-09-30" decimals="0" unitRef="USD">58124</us-gaap:DeferredCompensationLiabilityCurrent>
    <us-gaap:DeferredCompensationLiabilityCurrent contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">54220</us-gaap:DeferredCompensationLiabilityCurrent>
    <us-gaap:DueToRelatedPartiesCurrent contextRef="AsOf2021-09-30" decimals="0" unitRef="USD">32076</us-gaap:DueToRelatedPartiesCurrent>
    <us-gaap:DueToRelatedPartiesCurrent contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">33347</us-gaap:DueToRelatedPartiesCurrent>
    <PPCB:LoanFromFormerDirectorRelatedParty contextRef="AsOf2021-09-30" decimals="0" unitRef="USD">53384</PPCB:LoanFromFormerDirectorRelatedParty>
    <PPCB:LoanFromFormerDirectorRelatedParty contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">55500</PPCB:LoanFromFormerDirectorRelatedParty>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="AsOf2021-09-30" decimals="0" unitRef="USD">406644</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">418538</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2021-09-30" decimals="0" unitRef="USD">2368795</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">3080674</us-gaap:LiabilitiesCurrent>
    <us-gaap:Liabilities contextRef="AsOf2021-09-30" decimals="0" unitRef="USD">2368795</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">3080674</us-gaap:Liabilities>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2021-09-30" decimals="INF" unitRef="Shares">1500005</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2021-06-30" decimals="INF" unitRef="Shares">1500005</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2021-09-30"
      decimals="INF"
      unitRef="USDPShares">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2021-06-30"
      decimals="INF"
      unitRef="USDPShares">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2021-09-30_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      unitRef="USDPShares">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2021-06-30_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      unitRef="USDPShares">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2021-09-30_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      unitRef="Shares">500000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2021-06-30_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      unitRef="Shares">500000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2021-09-30_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      unitRef="Shares">500000</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2021-09-30_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      unitRef="Shares">500000</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2021-06-30_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      unitRef="Shares">500000</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2021-06-30_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      unitRef="Shares">500000</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2021-09-30_us-gaap_SeriesAPreferredStockMember"
      decimals="0"
      unitRef="USD">5000</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2021-06-30_us-gaap_SeriesAPreferredStockMember"
      decimals="0"
      unitRef="USD">5000</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2021-09-30_us-gaap_SeriesBPreferredStockMember"
      decimals="INF"
      unitRef="USDPShares">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2021-06-30_us-gaap_SeriesBPreferredStockMember"
      decimals="INF"
      unitRef="USDPShares">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2021-09-30_us-gaap_SeriesBPreferredStockMember"
      decimals="INF"
      unitRef="Shares">5</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2021-06-30_us-gaap_SeriesBPreferredStockMember"
      decimals="INF"
      unitRef="Shares">5</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2021-09-30_us-gaap_SeriesBPreferredStockMember"
      decimals="INF"
      unitRef="Shares">1</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2021-09-30_us-gaap_SeriesBPreferredStockMember"
      decimals="INF"
      unitRef="Shares">1</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2021-06-30_us-gaap_SeriesBPreferredStockMember"
      decimals="INF"
      unitRef="Shares">1</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2021-06-30_us-gaap_SeriesBPreferredStockMember"
      decimals="INF"
      unitRef="Shares">1</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2021-09-30"
      decimals="INF"
      unitRef="USDPShares">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2021-06-30"
      decimals="INF"
      unitRef="USDPShares">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2021-09-30" decimals="INF" unitRef="Shares">1000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2021-06-30" decimals="INF" unitRef="Shares">1000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2021-09-30" decimals="INF" unitRef="Shares">43841644</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2021-09-30" decimals="INF" unitRef="Shares">43841644</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2021-06-30" decimals="INF" unitRef="Shares">14055393</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2021-06-30" decimals="INF" unitRef="Shares">14055393</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue contextRef="AsOf2021-09-30" decimals="0" unitRef="USD">43842</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">14056</us-gaap:CommonStockValue>
    <PPCB:CommonStockIssuableShares contextRef="AsOf2021-09-30" decimals="INF" unitRef="Shares">2002549</PPCB:CommonStockIssuableShares>
    <PPCB:CommonStockIssuableShares contextRef="AsOf2021-06-30" decimals="INF" unitRef="Shares">59</PPCB:CommonStockIssuableShares>
    <PPCB:CommonStockIssuable contextRef="AsOf2021-09-30" decimals="0" unitRef="USD">2002</PPCB:CommonStockIssuable>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2021-09-30" decimals="0" unitRef="USD">55444574</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">54074110</us-gaap:AdditionalPaidInCapital>
    <us-gaap:StockholdersEquityNoteSubscriptionsReceivable contextRef="AsOf2021-09-30" decimals="0" unitRef="USD">100000</us-gaap:StockholdersEquityNoteSubscriptionsReceivable>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="AsOf2021-09-30" decimals="0" unitRef="USD">1149397</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">1085204</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2021-09-30" decimals="0" unitRef="USD">-58804968</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">-58199466</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:TreasuryStockShares contextRef="AsOf2021-09-30" decimals="INF" unitRef="Shares">1</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockShares contextRef="AsOf2021-06-30" decimals="INF" unitRef="Shares">1</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue contextRef="AsOf2021-09-30" decimals="0" unitRef="USD">46477</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">46477</us-gaap:TreasuryStockValue>
    <us-gaap:StockholdersEquity contextRef="AsOf2021-09-30" decimals="0" unitRef="USD">-2306630</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">-3067573</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2021-09-30" decimals="0" unitRef="USD">62165</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">13101</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2021-07-01to2021-09-30"
      decimals="0"
      unitRef="USD">431740</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2020-07-012020-09-30"
      decimals="0"
      unitRef="USD">323111</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OccupancyNet
      contextRef="From2021-07-01to2021-09-30"
      decimals="0"
      unitRef="USD">7736</us-gaap:OccupancyNet>
    <us-gaap:OccupancyNet
      contextRef="From2020-07-012020-09-30"
      decimals="0"
      unitRef="USD">9204</us-gaap:OccupancyNet>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2021-07-01to2021-09-30"
      decimals="0"
      unitRef="USD">46554</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2020-07-012020-09-30"
      decimals="0"
      unitRef="USD">50846</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:OperatingExpenses
      contextRef="From2021-07-01to2021-09-30"
      decimals="0"
      unitRef="USD">486030</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="From2020-07-012020-09-30"
      decimals="0"
      unitRef="USD">383161</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2021-07-01to2021-09-30"
      decimals="0"
      unitRef="USD">-486030</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2020-07-012020-09-30"
      decimals="0"
      unitRef="USD">-383161</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpense
      contextRef="From2021-07-01to2021-09-30"
      decimals="0"
      unitRef="USD">109853</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="From2020-07-012020-09-30"
      decimals="0"
      unitRef="USD">159281</us-gaap:InterestExpense>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="From2021-07-01to2021-09-30"
      decimals="0"
      unitRef="USD">-3904</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="From2020-07-012020-09-30"
      decimals="0"
      unitRef="USD">64952</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="From2020-07-012020-09-30"
      decimals="0"
      unitRef="USD">49985</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:ForeignCurrencyTransactionGainLossUnrealized
      contextRef="From2021-07-01to2021-09-30"
      decimals="0"
      unitRef="USD">109129</us-gaap:ForeignCurrencyTransactionGainLossUnrealized>
    <us-gaap:ForeignCurrencyTransactionGainLossUnrealized
      contextRef="From2020-07-012020-09-30"
      decimals="0"
      unitRef="USD">1960</us-gaap:ForeignCurrencyTransactionGainLossUnrealized>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2021-07-01to2021-09-30"
      decimals="0"
      unitRef="USD">-4628</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2020-07-012020-09-30"
      decimals="0"
      unitRef="USD">-42384</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2021-07-01to2021-09-30"
      decimals="0"
      unitRef="USD">-490658</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2020-07-012020-09-30"
      decimals="0"
      unitRef="USD">-425545</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="From2021-07-01to2021-09-30"
      decimals="0"
      unitRef="USD">-490658</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2020-07-012020-09-30"
      decimals="0"
      unitRef="USD">-425545</us-gaap:ProfitLoss>
    <PPCB:DeemedDividend
      contextRef="From2021-07-01to2021-09-30"
      decimals="0"
      unitRef="USD">-114844</PPCB:DeemedDividend>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-07-01to2021-09-30"
      decimals="0"
      unitRef="USD">-605502</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-07-012020-09-30"
      decimals="0"
      unitRef="USD">-425545</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="From2021-07-01to2021-09-30"
      decimals="INF"
      unitRef="USDPShares">-0.02</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="From2020-07-012020-09-30"
      decimals="INF"
      unitRef="USDPShares">-0.71</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="From2021-07-01to2021-09-30"
      decimals="INF"
      unitRef="Shares">27142519</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="From2020-07-012020-09-30"
      decimals="INF"
      unitRef="Shares">597314</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2021-07-01to2021-09-30"
      decimals="0"
      unitRef="USD">-605502</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2020-07-012020-09-30"
      decimals="0"
      unitRef="USD">-425545</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
      contextRef="From2021-07-01to2021-09-30"
      decimals="0"
      unitRef="USD">64193</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
      contextRef="From2020-07-012020-09-30"
      decimals="0"
      unitRef="USD">-75755</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="From2021-07-01to2021-09-30"
      decimals="0"
      unitRef="USD">64193</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="From2020-07-012020-09-30"
      decimals="0"
      unitRef="USD">-75755</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="From2021-07-01to2021-09-30"
      decimals="0"
      unitRef="USD">-541309</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="From2020-07-012020-09-30"
      decimals="0"
      unitRef="USD">-501300</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2020-06-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember"
      decimals="INF"
      unitRef="Shares">500000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-06-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember"
      decimals="0"
      unitRef="USD">5000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2020-06-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember"
      decimals="INF"
      unitRef="Shares">1</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2020-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">258120</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-06-30_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">258</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">50913893</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-06-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-55781770</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      unitRef="USD">1267671</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-06-30_us-gaap_TreasuryStockMember"
      decimals="0"
      unitRef="USD">-46477</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">-3641425</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="From2020-07-012020-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">442031</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2020-07-012020-09-30_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">442</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2020-07-012020-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">480133</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2020-07-012020-09-30"
      decimals="0"
      unitRef="USD">480575</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <PPCB:AdjustmentsToAdditionalPaidInCapitalReclassificationOfPremiumUponDebtConversion
      contextRef="From2020-07-012020-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">204919</PPCB:AdjustmentsToAdditionalPaidInCapitalReclassificationOfPremiumUponDebtConversion>
    <PPCB:AdjustmentsToAdditionalPaidInCapitalReclassificationOfPremiumUponDebtConversion
      contextRef="From2020-07-012020-09-30"
      decimals="0"
      unitRef="USD">204919</PPCB:AdjustmentsToAdditionalPaidInCapitalReclassificationOfPremiumUponDebtConversion>
    <PPCB:StockIssuedDuringPeriodSharesExerciseOfWarrants
      contextRef="From2020-07-012020-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">15445</PPCB:StockIssuedDuringPeriodSharesExerciseOfWarrants>
    <PPCB:StockIssuedDuringPeriodValueExerciseOfWarrants
      contextRef="From2020-07-012020-09-30_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">15</PPCB:StockIssuedDuringPeriodValueExerciseOfWarrants>
    <PPCB:StockIssuedDuringPeriodValueExerciseOfWarrants
      contextRef="From2020-07-012020-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">201029</PPCB:StockIssuedDuringPeriodValueExerciseOfWarrants>
    <PPCB:StockIssuedDuringPeriodValueExerciseOfWarrants
      contextRef="From2020-07-012020-09-30"
      decimals="0"
      unitRef="USD">201044</PPCB:StockIssuedDuringPeriodValueExerciseOfWarrants>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="From2020-07-012020-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">20718</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="From2020-07-012020-09-30"
      decimals="0"
      unitRef="USD">20718</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="From2020-07-012020-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      unitRef="USD">-75755</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="From2020-07-012020-09-30"
      decimals="0"
      unitRef="USD">-75755</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ProfitLoss
      contextRef="From2020-07-012020-09-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-425545</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2020-07-012020-09-30"
      decimals="0"
      unitRef="USD">-425545</us-gaap:ProfitLoss>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2020-09-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember"
      decimals="INF"
      unitRef="Shares">500000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-09-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember"
      decimals="0"
      unitRef="USD">5000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2020-09-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember"
      decimals="INF"
      unitRef="Shares">1</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2020-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">715596</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-09-30_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">715</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">51820692</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-09-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-56207315</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      unitRef="USD">1191916</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-09-30_us-gaap_TreasuryStockMember"
      decimals="0"
      unitRef="USD">-46477</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2020-09-30" decimals="0" unitRef="USD">-3235469</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2021-06-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember"
      decimals="INF"
      unitRef="Shares">500000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-06-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember"
      decimals="0"
      unitRef="USD">5000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2021-06-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember"
      decimals="INF"
      unitRef="Shares">1</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2021-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">14055393</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-06-30_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">14056</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2021-06-30_custom_CommonStockIssuableMember"
      decimals="INF"
      unitRef="Shares">59</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">54074110</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-06-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-58199466</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      unitRef="USD">1085204</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-06-30_us-gaap_TreasuryStockMember"
      decimals="0"
      unitRef="USD">-46477</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">-3067573</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="From2021-07-012021-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">9445009</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2021-07-012021-09-30_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">9445</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2021-07-012021-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">190741</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2021-07-01to2021-09-30"
      decimals="0"
      unitRef="USD">200186</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2021-07-012021-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">17934379</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2021-07-012021-09-30_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">17934</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2021-07-012021-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">563927</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2021-07-01to2021-09-30"
      decimals="0"
      unitRef="USD">581861</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <PPCB:StockIssuedDuringPeriodSharesExerciseOfWarrants
      contextRef="From2021-07-012021-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">6875</PPCB:StockIssuedDuringPeriodSharesExerciseOfWarrants>
    <PPCB:StockIssuedDuringPeriodValueExerciseOfWarrants
      contextRef="From2021-07-012021-09-30_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">7</PPCB:StockIssuedDuringPeriodValueExerciseOfWarrants>
    <PPCB:StockIssuedDuringPeriodSharesExerciseOfWarrants
      contextRef="From2021-07-012021-09-30_custom_CommonStockIssuableMember"
      decimals="INF"
      unitRef="Shares">2500</PPCB:StockIssuedDuringPeriodSharesExerciseOfWarrants>
    <PPCB:StockIssuedDuringPeriodValueExerciseOfWarrants
      contextRef="From2021-07-012021-09-30_custom_CommonStockIssuableMember"
      decimals="0"
      unitRef="USD">2</PPCB:StockIssuedDuringPeriodValueExerciseOfWarrants>
    <PPCB:StockIssuedDuringPeriodValueExerciseOfWarrants
      contextRef="From2021-07-012021-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">374991</PPCB:StockIssuedDuringPeriodValueExerciseOfWarrants>
    <PPCB:StockIssuedDuringPeriodValueExerciseOfWarrants
      contextRef="From2021-07-012021-09-30_custom_SubscriptionReceivableMember"
      decimals="0"
      unitRef="USD">-100000</PPCB:StockIssuedDuringPeriodValueExerciseOfWarrants>
    <PPCB:StockIssuedDuringPeriodValueExerciseOfWarrants
      contextRef="From2021-07-01to2021-09-30"
      decimals="0"
      unitRef="USD">275000</PPCB:StockIssuedDuringPeriodValueExerciseOfWarrants>
    <PPCB:IssuanceOfCommonStockForAlternateCashlessExerciseOfWarrantsShares
      contextRef="From2021-07-012021-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">2399988</PPCB:IssuanceOfCommonStockForAlternateCashlessExerciseOfWarrantsShares>
    <PPCB:IssuanceOfCommonStockForAlternateCashlessExerciseOfWarrants
      contextRef="From2021-07-012021-09-30_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">2400</PPCB:IssuanceOfCommonStockForAlternateCashlessExerciseOfWarrants>
    <PPCB:IssuanceOfCommonStockForAlternateCashlessExerciseOfWarrantsShares
      contextRef="From2021-07-012021-09-30_custom_CommonStockIssuableMember"
      decimals="INF"
      unitRef="Shares">1999990</PPCB:IssuanceOfCommonStockForAlternateCashlessExerciseOfWarrantsShares>
    <PPCB:IssuanceOfCommonStockForAlternateCashlessExerciseOfWarrants
      contextRef="From2021-07-012021-09-30_custom_CommonStockIssuableMember"
      decimals="0"
      unitRef="USD">2000</PPCB:IssuanceOfCommonStockForAlternateCashlessExerciseOfWarrants>
    <PPCB:IssuanceOfCommonStockForAlternateCashlessExerciseOfWarrants
      contextRef="From2021-07-012021-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">-4400</PPCB:IssuanceOfCommonStockForAlternateCashlessExerciseOfWarrants>
    <PPCB:AdjustmentsToAdditionalPaidInCapitalReclassificationOfPremiumUponDebtConversion
      contextRef="From2021-07-012021-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">109643</PPCB:AdjustmentsToAdditionalPaidInCapitalReclassificationOfPremiumUponDebtConversion>
    <PPCB:AdjustmentsToAdditionalPaidInCapitalReclassificationOfPremiumUponDebtConversion
      contextRef="From2021-07-01to2021-09-30"
      decimals="0"
      unitRef="USD">109643</PPCB:AdjustmentsToAdditionalPaidInCapitalReclassificationOfPremiumUponDebtConversion>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2021-07-012021-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">20718</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2021-07-01to2021-09-30"
      decimals="0"
      unitRef="USD">20718</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="From2021-07-012021-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      unitRef="USD">64193</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="From2021-07-01to2021-09-30"
      decimals="0"
      unitRef="USD">64193</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <PPCB:DeemedDividendUponAlternateCashlessExerciseOfWarrants
      contextRef="From2021-07-012021-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">114844</PPCB:DeemedDividendUponAlternateCashlessExerciseOfWarrants>
    <PPCB:DeemedDividendUponAlternateCashlessExerciseOfWarrants
      contextRef="From2021-07-012021-09-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-114844</PPCB:DeemedDividendUponAlternateCashlessExerciseOfWarrants>
    <us-gaap:ProfitLoss
      contextRef="From2021-07-012021-09-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-490658</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2021-07-01to2021-09-30"
      decimals="0"
      unitRef="USD">-490658</us-gaap:ProfitLoss>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2021-09-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember"
      decimals="INF"
      unitRef="Shares">500000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-09-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember"
      decimals="0"
      unitRef="USD">5000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2021-09-30_us-gaap_SeriesBPreferredStockMember_us-gaap_PreferredStockMember"
      decimals="INF"
      unitRef="Shares">1</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2021-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">43841644</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-09-30_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">43842</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2021-09-30_custom_CommonStockIssuableMember"
      decimals="INF"
      unitRef="Shares">2002549</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-09-30_custom_CommonStockIssuableMember"
      decimals="0"
      unitRef="USD">2002</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">55444574</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-09-30_custom_SubscriptionReceivableMember"
      decimals="0"
      unitRef="USD">-100000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-09-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-58804968</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      unitRef="USD">1149397</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-09-30_us-gaap_TreasuryStockMember"
      decimals="0"
      unitRef="USD">-46477</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2021-09-30" decimals="0" unitRef="USD">-2306630</us-gaap:StockholdersEquity>
    <us-gaap:ProfitLoss
      contextRef="From2021-07-01to2021-09-30"
      decimals="0"
      unitRef="USD">-490658</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2020-07-012020-09-30"
      decimals="0"
      unitRef="USD">-425545</us-gaap:ProfitLoss>
    <us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims
      contextRef="From2021-07-01to2021-09-30"
      decimals="0"
      unitRef="USD">133422</us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims>
    <us-gaap:ForeignCurrencyTransactionGainLossUnrealized
      contextRef="From2021-07-01to2021-09-30"
      decimals="0"
      unitRef="USD">109129</us-gaap:ForeignCurrencyTransactionGainLossUnrealized>
    <us-gaap:ForeignCurrencyTransactionGainLossUnrealized
      contextRef="From2020-07-012020-09-30"
      decimals="0"
      unitRef="USD">1960</us-gaap:ForeignCurrencyTransactionGainLossUnrealized>
    <us-gaap:Depreciation
      contextRef="From2021-07-01to2021-09-30"
      decimals="0"
      unitRef="USD">509</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="From2020-07-012020-09-30"
      decimals="0"
      unitRef="USD">438</us-gaap:Depreciation>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="From2021-07-01to2021-09-30"
      decimals="0"
      unitRef="USD">6074</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="From2020-07-012020-09-30"
      decimals="0"
      unitRef="USD">121281</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="From2021-07-01to2021-09-30"
      decimals="0"
      unitRef="USD">-3904</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="From2020-07-012020-09-30"
      decimals="0"
      unitRef="USD">64952</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="From2020-07-012020-09-30"
      decimals="0"
      unitRef="USD">49985</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:ShareBasedCompensation
      contextRef="From2021-07-01to2021-09-30"
      decimals="0"
      unitRef="USD">20718</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="From2020-07-012020-09-30"
      decimals="0"
      unitRef="USD">20718</us-gaap:ShareBasedCompensation>
    <us-gaap:OtherNoncashExpense
      contextRef="From2021-07-01to2021-09-30"
      decimals="0"
      unitRef="USD">2250</us-gaap:OtherNoncashExpense>
    <us-gaap:OtherNoncashExpense
      contextRef="From2020-07-012020-09-30"
      decimals="0"
      unitRef="USD">6750</us-gaap:OtherNoncashExpense>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments
      contextRef="From2021-07-01to2021-09-30"
      decimals="0"
      unitRef="USD">-90192</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:IncreaseDecreaseInReceivables
      contextRef="From2021-07-01to2021-09-30"
      decimals="0"
      unitRef="USD">-1937</us-gaap:IncreaseDecreaseInReceivables>
    <us-gaap:IncreaseDecreaseInReceivables
      contextRef="From2020-07-012020-09-30"
      decimals="0"
      unitRef="USD">755</us-gaap:IncreaseDecreaseInReceivables>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="From2021-07-01to2021-09-30"
      decimals="0"
      unitRef="USD">8353</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="From2021-07-01to2021-09-30"
      decimals="0"
      unitRef="USD">-137927</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="From2020-07-012020-09-30"
      decimals="0"
      unitRef="USD">53576</us-gaap:IncreaseDecreaseInAccountsPayable>
    <PPCB:IncreaseDecreaseInDeferredRent
      contextRef="From2020-07-012020-09-30"
      decimals="0"
      unitRef="USD">-633</PPCB:IncreaseDecreaseInDeferredRent>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities
      contextRef="From2021-07-01to2021-09-30"
      decimals="0"
      unitRef="USD">4067</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities
      contextRef="From2020-07-012020-09-30"
      decimals="0"
      unitRef="USD">10544</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
      contextRef="From2021-07-01to2021-09-30"
      decimals="0"
      unitRef="USD">-15102</us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
      contextRef="From2020-07-012020-09-30"
      decimals="0"
      unitRef="USD">133046</us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInInterestPayableNet
      contextRef="From2021-07-01to2021-09-30"
      decimals="0"
      unitRef="USD">11338</us-gaap:IncreaseDecreaseInInterestPayableNet>
    <us-gaap:IncreaseDecreaseInInterestPayableNet
      contextRef="From2020-07-012020-09-30"
      decimals="0"
      unitRef="USD">16262</us-gaap:IncreaseDecreaseInInterestPayableNet>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2021-07-01to2021-09-30"
      decimals="0"
      unitRef="USD">-486758</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2020-07-012020-09-30"
      decimals="0"
      unitRef="USD">-179949</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="From2021-07-01to2021-09-30"
      decimals="0"
      unitRef="USD">160000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:RepaymentsOfConvertibleDebt
      contextRef="From2020-07-012020-09-30"
      decimals="0"
      unitRef="USD">43000</us-gaap:RepaymentsOfConvertibleDebt>
    <us-gaap:ProceedsFromWarrantExercises
      contextRef="From2021-07-01to2021-09-30"
      decimals="0"
      unitRef="USD">275000</us-gaap:ProceedsFromWarrantExercises>
    <us-gaap:ProceedsFromWarrantExercises
      contextRef="From2020-07-012020-09-30"
      decimals="0"
      unitRef="USD">201044</us-gaap:ProceedsFromWarrantExercises>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2021-07-01to2021-09-30"
      decimals="0"
      unitRef="USD">435000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2020-07-012020-09-30"
      decimals="0"
      unitRef="USD">158044</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="From2021-07-01to2021-09-30"
      decimals="0"
      unitRef="USD">95320</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="From2020-07-012020-09-30"
      decimals="0"
      unitRef="USD">6116</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="From2021-07-01to2021-09-30"
      decimals="0"
      unitRef="USD">43562</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="From2020-07-012020-09-30"
      decimals="0"
      unitRef="USD">-15789</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">2255</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">67007</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="AsOf2021-09-30" decimals="0" unitRef="USD">45817</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="AsOf2020-09-30" decimals="0" unitRef="USD">51218</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:InterestPaidNet
      contextRef="From2020-07-012020-09-30"
      decimals="0"
      unitRef="USD">13172</us-gaap:InterestPaidNet>
    <us-gaap:ConversionOfStockAmountConverted1
      contextRef="From2021-07-01to2021-09-30"
      decimals="0"
      unitRef="USD">109643</us-gaap:ConversionOfStockAmountConverted1>
    <us-gaap:ConversionOfStockAmountConverted1
      contextRef="From2020-07-012020-09-30"
      decimals="0"
      unitRef="USD">204919</us-gaap:ConversionOfStockAmountConverted1>
    <us-gaap:ConversionOfStockAmountIssued1
      contextRef="From2021-07-01to2021-09-30"
      decimals="0"
      unitRef="USD">197936</us-gaap:ConversionOfStockAmountIssued1>
    <us-gaap:ConversionOfStockAmountIssued1
      contextRef="From2020-07-012020-09-30"
      decimals="0"
      unitRef="USD">417670</us-gaap:ConversionOfStockAmountIssued1>
    <us-gaap:StockIssued1
      contextRef="From2021-07-01to2021-09-30"
      decimals="0"
      unitRef="USD">448440</us-gaap:StockIssued1>
    <PPCB:DeemedDividendUponAlternateCashlessExerciseOfWarrants1
      contextRef="From2021-07-01to2021-09-30"
      decimals="0"
      unitRef="USD">114844</PPCB:DeemedDividendUponAlternateCashlessExerciseOfWarrants1>
    <PPCB:SubscriptionReceivable
      contextRef="From2021-07-01to2021-09-30"
      decimals="0"
      unitRef="USD">100000</PPCB:SubscriptionReceivable>
    <us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock contextRef="From2021-07-01to2021-09-30">&lt;p id="xdx_80D_eus-gaap--OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_zTTe2uwKtJ9f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTE
1 &#x2013; &lt;span id="xdx_826_zE9JmaYAHYRh"&gt;NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING AND REPORTING POLICIES&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_842_ecustom--NatureOfOperationsPolicyTextBlock_zyTsCKnZdqck" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86D_z2tlihvxFFVh"&gt;Nature
of Operations&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Propanc
Biopharma, Inc. (the &#x201c;Company,&#x201d; &#x201c;we,&#x201d; &#x201c;us&#x201d; or &#x201c;our&#x201d;) was originally incorporated in Melbourne,
Victoria Australia on October 15, 2007 as Propanc PTY LTD, and continues to be based in Camberwell, Victoria Australia. Since its inception,
substantially all of the operations of the Company have been focused on the development of new cancer treatments targeting high-risk
patients, particularly cancer survivors, who need a follow-up, non-toxic, long-term therapy designed to prevent the cancer from returning
and spreading. The Company anticipates establishing global markets for its technologies. Our lead product candidate, which we refer to
as PRP, is an enhanced pro-enzyme formulation designed to enhance the anti-cancer effects of multiple enzymes acting synergistically.
It is currently in the preclinical phase of development.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 26.2pt; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;On
&lt;span id="xdx_908_edei--EntityIncorporationDateOfIncorporation_dd_c20210701__20210930_zsFzMpziuoA7" title="Entity incorporation, date of incorporation"&gt;November 23, 2010&lt;/span&gt;, the Company was incorporated in the state of Delaware as Propanc Health Group Corporation. In January 2011, to reorganize
the Company, we acquired all of the outstanding shares of Propanc PTY LTD on a one-for-one basis making it a wholly-owned subsidiary
of the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;On
July 22, 2016, the Company formed a wholly owned subsidiary, Propanc (UK) Limited under the laws of England and Wales for the purpose
of submitting an orphan drug application to the European Medicines Agency as a small and medium-sized enterprise. As of September 30,
2021, there has been no activity within this entity.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Effective
April 20, 2017, the Company changed its name to &#x201c;Propanc Biopharma, Inc.&#x201d; to better reflect the Company&#x2019;s stage of
operations and development.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;In
July 2020, a world first patent was granted in Australia for the cancer treatment method patent family. Presently, there are 29 granted
patents and 33 patents under examination in key global jurisdictions relating to the use of proenzymes against solid tumors, covering
the lead product candidate PRP.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company hopes to capture and protect additional patentable subject matter based on the Company&#x2019;s field of technology relating to
pharmaceutical compositions of proenzymes for treating cancer by filing additional patent applications as it advances its lead product
candidate, PRP, through various stages of development.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;On
November 17, 2020, the Company effected a &lt;span id="xdx_900_eus-gaap--StockholdersEquityReverseStockSplit_c20201116__20201117_zDGQYeiJ8fv4" title="Reverse stock"&gt;one-for-one thousand (1:1,000)&lt;/span&gt; reverse stock split of the Company&#x2019;s issued and outstanding
shares of common stock (the &#x201c;Reverse Stock Split&#x201d;). Proportional adjustments for the Reverse Stock Split were made to the
Company&#x2019;s outstanding stock options, warrants and equity incentive plans. All share and per-share data and amounts have been retroactively
adjusted as of the earliest period presented in the consolidated financial statements to reflect the Reverse Stock Split.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_848_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zU3e1cFXZ2z2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86B_zmrKinaSEaT2"&gt;Basis
of Presentation&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company&#x2019;s interim unaudited condensed consolidated financial statements included in this Quarterly Report on Form 10-Q (this &#x201c;Quarterly
Report&#x201d;) have been prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;US
GAAP&#x201d;) and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (&#x201c;SEC&#x201d;). In the opinion
of the Company&#x2019;s management, all adjustments (consisting of normal recurring adjustments and reclassifications and non-recurring
adjustments) necessary to present fairly our results of operations for the three months ended September 30, 2021 and 2020 and cash flows
for the three months ended September 30, 2021 and 2020 and our financial position at September 30, 2021 have been made. The Company&#x2019;s
results of operations for the three months ended September 30, 2021 are not necessarily indicative of the operating results to be expected
for the full fiscal year ending June 30, 2022.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Certain
information and disclosures normally included in the notes to the Company&#x2019;s annual audited consolidated financial statements have
been condensed or omitted from the Company&#x2019;s interim unaudited condensed consolidated financial statements included in this Quarterly
Report. Accordingly, these interim unaudited condensed consolidated financial statements should be read in conjunction with the Company&#x2019;s
audited consolidated financial statements and notes thereto for the fiscal year ended June 30, 2021. The June 30, 2021 balance sheet
is derived from those statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84A_eus-gaap--ConsolidationPolicyTextBlock_zUzMhpDH8g1a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86D_z8DTT4x83H5b"&gt;Principles
of Consolidation&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
unaudited condensed consolidated financial statements include the accounts of Propanc Biopharma, Inc., the parent entity, and its wholly-owned
subsidiary, Propanc PTY LTD. All inter-company balances and transactions have been eliminated in consolidation. Propanc (UK) Limited
was an inactive subsidiary at September 30, 2021.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;PROPANC
BIOPHARMA, INC. AND SUBSIDIARY&lt;br/&gt;
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&lt;br/&gt;
SEPTEMBER 30, 2021&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;(Unaudited)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_840_eus-gaap--UseOfEstimates_zKH5SsGwZ3P6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86F_zHD6rxWI4vv5"&gt;Use
of Estimates&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
preparation of financial statements in conformity with the accounting principles generally accepted in the United States of America (&#x201c;US
GAAP&#x201d;) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure
of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses
during the reporting period. Actual results could differ from these estimates. Significant estimates in the accompanying consolidated
financial statements include the estimates of useful lives for depreciation, valuation of the operating lease liability and related right-of-use
asset, valuation of derivatives, valuation of beneficial conversion features on convertible debt, allowance for uncollectable receivables,
valuation of equity based instruments issued for other than cash, the valuation allowance on deferred tax assets and foreign currency
translation due to certain average exchange rates applied in lieu of spot rates on transaction dates.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84D_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zYtRi38HEaAj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_868_zdZ6QdOvTze2"&gt;Foreign
Currency Translation and Other Comprehensive Income (Loss)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company&#x2019;s wholly owned subsidiary&#x2019;s functional currency is the Australian dollar (AUD). For financial reporting purposes,
the Australian dollar has been translated into the Company&#x2019;s reporting currency which is the United States dollar ($) and/or (USD).
Assets and liabilities are translated at the exchange rate in effect at the balance sheet date. Revenues and expenses are translated
at the average rate of exchange prevailing during the reporting period. Equity transactions are translated at each historical transaction
date spot rate. Translation adjustments arising from the use of different exchange rates from period to period are included as a component
of stockholders&#x2019; equity (deficit) as &#x201c;Accumulated other comprehensive income (loss).&#x201d; Gains and losses resulting from
foreign currency transactions are included in the statements of operations and comprehensive income (loss) as a component of other comprehensive
income (loss). There have been no significant fluctuations in the exchange rate for the conversion of Australian dollars to USD after
the balance sheet date.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Other
Comprehensive Income (Loss) for all periods presented includes only foreign currency translation gains (losses).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Assets
and liabilities denominated in foreign currencies are translated into the functional currency at the exchange rates prevailing at the
consolidated balance sheet date with any transaction gains and losses that arise from exchange rate fluctuations on transactions denominated
in a currency other than the functional currency included in the consolidated results of operations as incurred. Effective fiscal year
2021, the parent company determined that these intercompany loans will not be repaid in the foreseeable future and thus, per ASC 830-20-35-3,
gains and losses from measuring the intercompany balances are recorded within cumulative translation adjustment, a component of accumulated
other comprehensive income (loss). Prior to July 1, 2020, the Company recorded the foreign currency transaction gains and losses from
measuring the intercompany balances as a component of other income (expenses) titled foreign currency transaction gain (loss). For the
three months ended September 30, 2021 and 2020, the Company recognized an exchange gain (loss) of approximately $&lt;span id="xdx_909_eus-gaap--OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_pp0p0_c20210701__20210930__us-gaap--DebtInstrumentAxis__custom--IntercompanyLoansMember_zOhbETHOlpbj"&gt;619,000&lt;/span&gt; and ($&lt;span id="xdx_90B_eus-gaap--OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_pp0p0_c20200701__20200930__us-gaap--DebtInstrumentAxis__custom--IntercompanyLoansMember_zKbJ5TpFaGWk"&gt;583,000&lt;/span&gt;),
on intercompany loans made by the parent to the subsidiary which have not been repaid as of September 30, 2021.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89A_ecustom--ScheduleOfTranslationExchangeRatesTableTextBlock_zzNbOSdcA4v" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;As
of September 30, 2021 and June 30, 2021, the exchange rates used to translate amounts in Australian dollars into USD for the purposes
of preparing the consolidated financial statements were as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.45in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_8B9_z5Jwt3MLbtk1" style="display: none"&gt;SCHEDULE
OF TRANSLATION EXCHANGE RATES&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;September
    30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;June
    30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Exchange rate on balance sheet dates&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;USD : AUD exchange rate&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20210930_zAxoaqp5Oof3" style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0.7214&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20210630_zAeNeQUILRnf" style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0.7500&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Average exchange rate for the period&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;USD : AUD exchange rate&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20210930__srt--RangeAxis__srt--WeightedAverageMember_zyOm6KwP3orf" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0.7350&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20210630__srt--RangeAxis__srt--WeightedAverageMember_zvDey7ZbyR65" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0.7473&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A8_zfay8WlxJE4a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_893_eus-gaap--ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_zWSkwTH6ECU4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
change in Accumulated Other Comprehensive Income (Loss) by component during the three months ended September 30, 2021 was as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;span id="xdx_8B7_zATgnOSNnnC6" style="display: none"&gt;SCHEDULE
OF CHANGE IN ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Foreign&lt;br/&gt;
    Currency Items:&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 82%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Balance, June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iS_pp0p0_c20210701__20210930_zWQXY0qBZeZ4" style="width: 14%; text-align: right" title="Beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,085,204&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Unrealized foreign currency
    translation gain&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_pp0p0_c20210701__20210930_zlbQptq6YdTi" style="border-bottom: Black 1.5pt solid; text-align: right" title="Foreign currency translation gain"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;64,193&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Ending balance, September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iE_pp0p0_c20210701__20210930_z94fy1ZvaCCk" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,149,397&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A7_zcAa30ZDSqkj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;PROPANC
BIOPHARMA, INC. AND SUBSIDIARY&lt;br/&gt;
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&lt;br/&gt;
SEPTEMBER 30, 2021&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;(Unaudited)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_846_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zFC2t1G9CYMj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_864_zKI9KeM2Ukah"&gt;Fair
Value of Financial Instruments and Fair Value Measurements&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company measures its financial assets and liabilities in accordance with US GAAP. For certain financial instruments, including cash and
cash equivalents, accounts receivable, accounts payable and accrued liabilities, the carrying amounts approximate fair value due to their
short maturities. Amounts recorded for notes payable, net of discount, and loans payable also approximate fair value because current
interest rates available for debt with similar terms and maturities are substantially the same.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company follows accounting guidance for financial assets and liabilities. This standard defines fair value, provides guidance for measuring
fair value and requires certain disclosures. This standard does not require any new fair value measurements, but rather applies to all
other accounting pronouncements that require or permit fair value measurements. This guidance does not apply to measurements related
to share-based payments. This guidance discusses valuation techniques, such as the market approach (comparable market prices), the income
approach (present value of future income or cash flow), and the cost approach (cost to replace the service capacity of an asset or replacement
cost).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
guidance utilizes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three broad
levels. The following is a brief description of those three levels:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.95pt; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Level
1: Observable inputs such as quoted prices (unadjusted) in active markets for identical assets or liabilities.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.95pt; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Level
2: Inputs, other than quoted prices that are observable, either directly or indirectly. These include quoted prices for similar assets
or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.95pt; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Level
3: Unobservable inputs in which little or no market data exists, therefore developed using estimates and assumptions developed by us,
which reflect those that a market participant would use.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Also
see Note 11 - Derivative Financial Instruments and Fair Value Measurements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_844_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_z9t6VlcKAS8g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_861_zD9uCZl5Cas9"&gt;Cash
and Cash Equivalents&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Cash
and cash equivalents include cash on hand and at banks, short-term deposits with an original maturity of three months or less with financial
institutions, and bank overdrafts. Bank overdrafts are reflected as a current liability on the balance sheets. There were &lt;span id="xdx_907_eus-gaap--CashEquivalentsAtCarryingValue_iI_pp0p0_do_c20200930_zOFhHXa6w5rk"&gt;no&lt;/span&gt; cash equivalents
as of September 30, 2021 or June 30, 2021.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_845_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zACW3ttl00x5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_866_zLBSJMg94jY4"&gt;Property
and Equipment&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Property
and equipment are stated at cost, net of accumulated depreciation. Expenditures for maintenance and repairs are expensed as incurred;
additions, renewals, and betterments are capitalized. When property and equipment are retired or otherwise disposed of, the related cost
and accumulated depreciation are removed from the respective accounts, and any gain or loss is included in operations. Depreciation of
property and equipment is provided using the declining balance method. The depreciable amount is the cost less its residual value.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_891_ecustom--ScheduleOfPropertyAndEquipmentEstimatedUsefulLivesTableTextBlock_zt2mxbVoEEWc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
estimated useful lives are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;span id="xdx_8B4_zrzjwdUOooq6" style="display: none"&gt;SCHEDULE
OF PROPERTY AND EQUIPMENT ESTIMATED USEFUL LIVES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 25%"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Machinery
    and equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 75%"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;-
    &lt;span id="xdx_90F_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210701__20210930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_zgVFwUSlH806"&gt;5&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Furniture&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;-
    &lt;span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210701__20210930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zmrWJFVBDMYc"&gt;7&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A6_zyicsnfsPJy8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_843_eus-gaap--GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_zpLA1iRncFHg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_868_zax2qkWhbWie"&gt;Patents&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Patents
are stated at cost and amortized on a straight-line basis over the estimated future periods if and once the patent has been granted by
a regulatory agency. However, the Company will expense any patent costs as long as we are in the startup stage. Accordingly, as the Company&#x2019;s
products are not currently approved for market, all patent costs incurred from 2013 through September 30, 2021 were expensed immediately.
This practice of expensing patent costs immediately ends when a product receives market authorization from a government regulatory agency.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_847_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zR7zOXittAmg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86A_zfgxcl3KPwSa"&gt;Impairment
of Long-Lived Assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;In
accordance with ASC 360-10, &#x201c;&lt;i&gt;Long-lived assets,&#x201d;&lt;/i&gt; which include property and equipment and intangible assets, are reviewed
for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability
of long-lived assets to be held and used is measured by a comparison of the carrying amount of an asset to the estimated undiscounted
future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated undiscounted future
cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the
assets. Fair value is generally determined using the asset&#x2019;s expected future discounted cash flows or market value, if readily
determinable.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;PROPANC
BIOPHARMA, INC. AND SUBSIDIARY&lt;br/&gt;
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&lt;br/&gt;
SEPTEMBER 30, 2021&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;(Unaudited)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_847_eus-gaap--EmployeeStockOwnershipPlanESOPPolicy_zKcRPhz1cmDl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86B_zKiRtMFzZSlc"&gt;Employee
Benefit/Liability&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Liabilities
arising in respect of wages and salaries, accumulated annual leave, accumulated long service leave and any other employee benefits expected
to be settled within twelve months of the reporting date are measured based on the employee&#x2019;s remuneration rates applicable at
the reporting date. All other employee benefit liabilities are measured at the present value of the estimated future cash outflow to
be made in respect of services provided by employees up to the reporting date. All employee liabilities are owed within the next twelve
months.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_845_ecustom--GoodsAndServiceTaxPolicyTextBlock_zFkquLvQEsN1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86E_zAcVIJZd3dT8"&gt;Australian
Goods and Services Tax (&#x201c;GST&#x201d;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Revenues,
expenses and balance sheet items are recognized net of the amount of GST, except payable and receivable balances which are shown inclusive
of GST. The GST incurred is payable on revenues to, and recoverable on purchases from, the Australian Taxation Office.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Cash
flows are presented in the statements of cash flow on a gross basis, except for the GST component of investing and financing activities,
which are disclosed as operating cash flows.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;As
of September 30, 2021, and June 30, 2021, the Company was owed $&lt;span id="xdx_904_eus-gaap--ValueAddedTaxReceivableCurrent_iI_pp0p0_c20210930_zNHlbbV7dpad" title="Value added tax receivable"&gt;2,238&lt;/span&gt; and $&lt;span id="xdx_90A_eus-gaap--ValueAddedTaxReceivableCurrent_iI_pp0p0_c20200930_zQ4JT5NkFXzk" title="Value added tax receivable"&gt;4,341&lt;/span&gt;, respectively, from the Australian Taxation Office.
These amounts were fully collected subsequent to the balance sheet reporting dates.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_847_eus-gaap--DerivativesReportingOfDerivativeActivity_zQ2WlEN1DWE6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_861_zc8e4LzGljd1"&gt;Derivative
Instruments&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;ASC
Topic 815, &lt;i&gt;Derivatives and Hedging&lt;/i&gt; (&#x201c;ASC Topic 815&#x201d;), establishes accounting and reporting standards for derivative
instruments and for hedging activities by requiring that all derivatives be recognized in the balance sheet and measured at fair value.
Gains or losses resulting from changes in the fair value of derivatives are recognized in earnings. On the date of conversion or payoff
of debt, the Company records the fair value of the conversion shares, removes the fair value of the related derivative liability, removes
any discounts and records a net gain or loss on debt extinguishment. On July 1, 2019 the Company adopted ASU 2017-11 under which down-round
Features in Financial Instruments will no longer cause derivative treatment. The Company applies the modified prospective method of adoption.
There were no cumulative effects on adoption.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_845_ecustom--ConvertibleNotesPolicyTextBlock_zxn5O0pSGSxg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_861_zqNXrYouGBs7"&gt;Convertible
Notes With Variable Conversion Options&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company has entered into convertible notes, some of which contain variable conversion options, whereby the outstanding principal and
accrued interest may be converted, by the holder, into common shares at a fixed discount to the price of the common stock at or around
the time of conversion. The Company treats these convertible notes as stock settled debt under ASC 480, &#x201c;&lt;i&gt;Distinguishing Liabilities
from Equity&lt;/i&gt;&#x201d; and measures the fair value of the notes at the time of issuance, which is the result of the share price discount
at the time of conversion and records the put premium as interest expense.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_848_eus-gaap--IncomeTaxPolicyTextBlock_zhOGS6N4HyHb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86B_z4ulDnTrWbva"&gt;Income
Taxes&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company is governed by Australia and United States income tax laws, which are administered by the Australian Taxation Office and the
United States Internal Revenue Service, respectively. The Company follows ASC 740 &#x201c;&lt;i&gt;Accounting for Income Taxes&lt;/i&gt;,&#x201d; when
accounting for income taxes, which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred
income tax assets and liabilities are computed annually for temporary differences between the financial statements and tax bases of assets
and liabilities that will result in taxable or deductible amounts in the future based on enacted tax laws and rates applicable to the
periods in which the differences are expected to affect taxable income. Valuation allowances are established when necessary to reduce
deferred tax assets to the amount expected to be realized. Income tax expense is the tax payable or refundable for the period plus or
minus the change during the period in deferred tax assets and liabilities.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company follows ASC 740, Sections 25 through 60, &#x201c;&lt;i&gt;Accounting for Uncertainty in Income Taxes&lt;/i&gt;.&#x201d; These sections provide
detailed guidance for the financial statement recognition, measurement and disclosure of uncertain tax positions recognized in the financial
statements. Tax positions must meet a &#x201c;more-likely-than-not&#x201d; recognition threshold at the effective date to be recognized
upon the adoption of ASC 740 and in subsequent periods.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_842_eus-gaap--ResearchAndDevelopmentExpensePolicy_zhSDwzgwptn3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_864_z7raaBtt59u1"&gt;Research
and Development Costs and Tax Credits&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;In
accordance with ASC 730-10, &lt;i&gt;&#x201c;Research and Development-Overall,&#x201d;&lt;/i&gt; research and development costs are expensed when incurred.
Total research and development costs for the three months ended September 30, 2021 and 2020 were $&lt;span id="xdx_901_eus-gaap--ResearchAndDevelopmentExpense_pp0p0_c20210701__20210930_z8IQi4E6xGXk"&gt;46,554&lt;/span&gt; and $&lt;span id="xdx_90B_eus-gaap--ResearchAndDevelopmentExpense_pp0p0_c20200701__20200930_zKalVQgW6Sua"&gt;50,846&lt;/span&gt;, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;PROPANC
BIOPHARMA, INC. AND SUBSIDIARY&lt;br/&gt;
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&lt;br/&gt;
SEPTEMBER 30, 2021&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;(Unaudited)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company may apply for research and development tax concessions with the Australian Taxation Office on an annual basis. Although the amount
is possible to estimate at year end, the Australian Taxation Office may reject or materially alter the claim amount. Accordingly, the
Company does not recognize the benefit of the claim amount until cash receipt since collectability is not certain until such time. The
tax concession is a refundable credit. If the Company has net income, then the Company can receive the credit which reduces its income
tax liability. If the Company has net losses, then the Company may still receive a cash payment for the credit, however, the Company&#x2019;s
net operating loss carryforwards are reduced by the gross equivalent loss that would produce the credit amount when the income tax rate
is applied to that gross amount. The concession is recognized as tax benefit, in operations, upon receipt.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;During
each of the three months ended September 30, 2021 and 2020, the Company applied for, and received from the Australian Taxation Office,
a research and development tax credit in the amount of $&lt;span id="xdx_900_eus-gaap--IncomeTaxExpenseBenefit_iN_pp0p0_dixL_c20200701__20200930_zfbdkDjR4Lw6" title="::XDX::-"&gt;&lt;span id="xdx_90E_eus-gaap--IncomeTaxExpenseBenefit_iN_pp0p0_dixL_c20210701__20210930_zu8lPCnqt6u" title="Tax credits::XDX::-"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3304"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3306"&gt;0&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;, which is reflected as a tax benefit in the accompanying unaudited condensed
consolidated statements of operations and comprehensive income (loss).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_847_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_z7ocjmQGNxmd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86D_zxXe6dOqY3P8"&gt;Stock
Based Compensation&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company records stock-based compensation in accordance with ASC 718, &#x201c;&lt;i&gt;Stock Compensation&lt;/i&gt;&#x201d;. ASC 718 requires the fair
value of all stock-based employee compensation awarded to employees to be recorded as an expense over the shorter of the service period
or the vesting period. The Company values employee and non-employee stock-based compensation at fair value using the Black-Scholes Option
Pricing Model.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company adopted ASU 2018-07 and accounts for non-employee share-based awards in accordance with the measurement and recognition criteria
of ASC 718 and recognizes the fair value of such awards over the service period. The Company used the modified prospective method of
adoption. There was no cumulative effect of adoption on July 1, 2019.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_842_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zoI5lfak5jZ7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_866_zQ0pBQvL2eDf"&gt;Revenue
Recognition&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company adopted and implemented on July 1, 2018, ASC 606 &#x2013; Revenue from Contracts with Customers (&#x201c;ASC 606&#x201d;). ASC 606
did not have a material impact on the consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Upon
implementation of ASC 606, the Company recognizes revenue in accordance with that core principle by applying the following steps:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Step
1: Identify the contract(s) with a customer.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Step
2: Identify the performance obligations in the contract.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Step
3: Determine the transaction price.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Step
4: Allocate the transaction price to the performance obligations in the contract.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Step
5: Recognize revenue when (or as) the entity satisfies a performance obligation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Subject
to these criteria, the Company intends to recognize revenue relating to royalties on product sales in the period in which the sale occurs
and the royalty term has begun.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_845_eus-gaap--LegalCostsPolicyTextBlock_zYIGCDDncv8f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_869_zZfv7SoMGD11"&gt;Legal
Expenses&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;All
legal costs for litigation are charged to expense as incurred.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84E_eus-gaap--LesseeLeasesPolicyTextBlock_zXunrNvs61Gc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_868_zSbh3EyY4Kej"&gt;Leases&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;In
February 2016, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued ASU 2016-02, &lt;i&gt;Leases&lt;/i&gt; (Topic 842). The updated
guidance requires lessees to recognize lease assets and lease liabilities for most operating leases. In addition, the updated guidance
requires that lessors separate lease and non-lease components in a contract in accordance with the new revenue guidance in ASC 606. This
guidance is effective for interim and annual reporting periods beginning after December 15, 2018. The Company adopted this guidance effective
July 1, 2019.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;On
July 1, 2019, the Company adopted ASU No. 2016-02, applying the package of practical expedients to leases that commenced before the effective
date whereby the Company elected to not reassess the following: (i) whether any expired or existing contracts contain leases and; (ii)
initial direct costs for any existing leases. For contracts entered into on or after the effective date, at the inception of a contract
the Company assessed whether the contract is, or contains, a lease. The Company&#x2019;s assessment is based on: (1) whether the contract
involves the use of a distinct identified asset, (2) whether we obtain the right to substantially all the economic benefit from the use
of the asset throughout the period, and (3) whether it has the right to direct the use of the asset. The Company will allocate the consideration
in the contract to each lease component based on its relative stand-alone price to determine the lease payments. In addition, the Company
elected not to apply ASC Topic 842 to arrangements with lease terms of 12 months or less.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Operating
lease ROU assets represents the right to use the leased asset for the lease term and operating lease liabilities are recognized based
on the present value of future minimum lease payments over the lease term at commencement date. As most leases do not provide an implicit
rate, the Company use an incremental borrowing rate based on the information available at the adoption date in determining the present
value of future payments. Lease expense for minimum lease payments is amortized on a straight-line basis over the lease term and will
be included in general and administrative expenses.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;PROPANC
BIOPHARMA, INC. AND SUBSIDIARY&lt;br/&gt;
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&lt;br/&gt;
SEPTEMBER 30, 2021&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;(Unaudited)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84E_eus-gaap--EarningsPerSharePolicyTextBlock_zpfEBsYvPCak" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_869_zIeaaJNnPy08"&gt;Basic
and Diluted Net Loss Per Common Share&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Basic
net loss per share is computed by dividing the net loss by the weighted average number of common shares outstanding during the period.
Diluted net loss per common share is computed by dividing the net loss by the weighted average number of common shares outstanding for
the period and, if dilutive, potential common shares outstanding during the period. Potentially dilutive securities consist of the incremental
common shares issuable upon exercise of common stock equivalents such as stock options, warrants and convertible debt instruments. Potentially
dilutive securities are excluded from the computation if their effect is anti-dilutive. As a result, the basic and diluted per share
amounts for all periods presented are identical. &lt;span id="xdx_902_eus-gaap--DebtInstrumentConvertibleTermsOfConversionFeature_c20210701__20210930_zELEU7ykKkIk" title="Debt conversion percentage, description"&gt;Each holder of the notes has agreed to a &lt;span id="xdx_904_eus-gaap--DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_pid_dp_uPure_c20200701__20210630_zhcROCTayfJi" title="Debt conversion percentage"&gt;4.99&lt;/span&gt;% beneficial ownership conversion limitation
(subject to certain noteholders&#x2019; ability to increase such limitation to &lt;span id="xdx_906_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_uPure_c20210819__us-gaap--TypeOfArrangementAxis__custom--TwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember_zjDxTQNnQMx6"&gt;9.99&lt;/span&gt;% upon 60 days&#x2019; notice to the Company), and each
note may not be converted during the first six-month period from the date of issuance. The securities for the period ended September
30, 2021 and 2020 were considered dilutive securities which were excluded from the computation since the effect is anti-dilutive.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span title="Debt conversion percentage, description"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89A_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zLusIxCV0JF5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;span id="xdx_8B8_z5qGGqx37Jgb" style="display: none"&gt;SCHEDULE
OF DILUTIVE SECURITIES EXCLUDED FROM COMPUTATION&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 100%; margin-right: auto"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;September
    30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;September
    30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;(Unaudited)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;(Unaudited)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Stock Options&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20210701__20210930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_zRWorJnhqvNc" style="width: 14%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;59&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20200701__20200930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_zlntA9renUm6" style="width: 14%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;60&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Stock Warrants&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20210701__20210930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zM5tes7KTZa" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;111,932&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20200701__20200930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zt22Rh7qyBR8" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;135,725&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Unvested restricted stock&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20210701__20210930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--UnvestedRestrictedStockMember_ziQ1XBlUpRa9" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;59&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20200701__20200930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--UnvestedRestrictedStockMember_zaZOZ38j94Hd" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;117&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Convertible Debt&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20210701__20210930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertibleDebtSecuritiesMember_zadTQYWGAgi6" style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;23,293,971&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20200701__20200930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertibleDebtSecuritiesMember_zsFdubolj81a" style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;510,674&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20210701__20210930_zjRj7iczs6t1" style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;23,406,021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20200701__20200930_zQ6W7BJxm8Kh" style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;646,576&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A6_ztUc5Ua4Aso2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_841_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zFYh4pSJ2Re4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_863_zJh69seVZbtk"&gt;Recent
Accounting Pronouncements&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;We
have reviewed the FASB issued ASU accounting pronouncements and interpretations thereof that have effectiveness dates during the periods
reported and in future periods. We have carefully considered the new pronouncements that alter previous generally accepted accounting
principles and do not believe that any new or modified principles will have a material impact on the Company&#x2019;s reported financial
position or operations in the near term. The applicability of any standard is subject to the formal review of the Company&#x2019;s financial
management.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;In
August 2020, the FASB issued ASU 2020-06, &#x201c;Debt &#x2013; Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives
and Hedging &#x2013; Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40)&#x201d;. This ASU reduces the number of accounting models
for convertible debt instruments and convertible preferred stock. As well as amend the guidance for the derivatives scope exception for
contracts in an entity&#x2019;s own equity to reduce form-over-substance-based accounting conclusions. In addition, this ASU improves
and amends the related EPS guidance. This standard is effective for us on July 1, 2022, including interim periods within those fiscal
years. Adoption is either a modified retrospective method or a fully retrospective method of transition. The Company is currently assessing
the impact the new guidance will have on our consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_859_zwf6AthGWyXc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock>
    <PPCB:NatureOfOperationsPolicyTextBlock contextRef="From2021-07-01to2021-09-30">&lt;p id="xdx_842_ecustom--NatureOfOperationsPolicyTextBlock_zyTsCKnZdqck" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86D_z2tlihvxFFVh"&gt;Nature
of Operations&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Propanc
Biopharma, Inc. (the &#x201c;Company,&#x201d; &#x201c;we,&#x201d; &#x201c;us&#x201d; or &#x201c;our&#x201d;) was originally incorporated in Melbourne,
Victoria Australia on October 15, 2007 as Propanc PTY LTD, and continues to be based in Camberwell, Victoria Australia. Since its inception,
substantially all of the operations of the Company have been focused on the development of new cancer treatments targeting high-risk
patients, particularly cancer survivors, who need a follow-up, non-toxic, long-term therapy designed to prevent the cancer from returning
and spreading. The Company anticipates establishing global markets for its technologies. Our lead product candidate, which we refer to
as PRP, is an enhanced pro-enzyme formulation designed to enhance the anti-cancer effects of multiple enzymes acting synergistically.
It is currently in the preclinical phase of development.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 26.2pt; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;On
&lt;span id="xdx_908_edei--EntityIncorporationDateOfIncorporation_dd_c20210701__20210930_zsFzMpziuoA7" title="Entity incorporation, date of incorporation"&gt;November 23, 2010&lt;/span&gt;, the Company was incorporated in the state of Delaware as Propanc Health Group Corporation. In January 2011, to reorganize
the Company, we acquired all of the outstanding shares of Propanc PTY LTD on a one-for-one basis making it a wholly-owned subsidiary
of the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;On
July 22, 2016, the Company formed a wholly owned subsidiary, Propanc (UK) Limited under the laws of England and Wales for the purpose
of submitting an orphan drug application to the European Medicines Agency as a small and medium-sized enterprise. As of September 30,
2021, there has been no activity within this entity.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Effective
April 20, 2017, the Company changed its name to &#x201c;Propanc Biopharma, Inc.&#x201d; to better reflect the Company&#x2019;s stage of
operations and development.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;In
July 2020, a world first patent was granted in Australia for the cancer treatment method patent family. Presently, there are 29 granted
patents and 33 patents under examination in key global jurisdictions relating to the use of proenzymes against solid tumors, covering
the lead product candidate PRP.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company hopes to capture and protect additional patentable subject matter based on the Company&#x2019;s field of technology relating to
pharmaceutical compositions of proenzymes for treating cancer by filing additional patent applications as it advances its lead product
candidate, PRP, through various stages of development.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;On
November 17, 2020, the Company effected a &lt;span id="xdx_900_eus-gaap--StockholdersEquityReverseStockSplit_c20201116__20201117_zDGQYeiJ8fv4" title="Reverse stock"&gt;one-for-one thousand (1:1,000)&lt;/span&gt; reverse stock split of the Company&#x2019;s issued and outstanding
shares of common stock (the &#x201c;Reverse Stock Split&#x201d;). Proportional adjustments for the Reverse Stock Split were made to the
Company&#x2019;s outstanding stock options, warrants and equity incentive plans. All share and per-share data and amounts have been retroactively
adjusted as of the earliest period presented in the consolidated financial statements to reflect the Reverse Stock Split.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</PPCB:NatureOfOperationsPolicyTextBlock>
    <dei:EntityIncorporationDateOfIncorporation contextRef="From2021-07-01to2021-09-30">2010-11-23</dei:EntityIncorporationDateOfIncorporation>
    <us-gaap:StockholdersEquityReverseStockSplit contextRef="From2020-11-162020-11-17">one-for-one thousand (1:1,000)</us-gaap:StockholdersEquityReverseStockSplit>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="From2021-07-01to2021-09-30">&lt;p id="xdx_848_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zU3e1cFXZ2z2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86B_zmrKinaSEaT2"&gt;Basis
of Presentation&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company&#x2019;s interim unaudited condensed consolidated financial statements included in this Quarterly Report on Form 10-Q (this &#x201c;Quarterly
Report&#x201d;) have been prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;US
GAAP&#x201d;) and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (&#x201c;SEC&#x201d;). In the opinion
of the Company&#x2019;s management, all adjustments (consisting of normal recurring adjustments and reclassifications and non-recurring
adjustments) necessary to present fairly our results of operations for the three months ended September 30, 2021 and 2020 and cash flows
for the three months ended September 30, 2021 and 2020 and our financial position at September 30, 2021 have been made. The Company&#x2019;s
results of operations for the three months ended September 30, 2021 are not necessarily indicative of the operating results to be expected
for the full fiscal year ending June 30, 2022.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Certain
information and disclosures normally included in the notes to the Company&#x2019;s annual audited consolidated financial statements have
been condensed or omitted from the Company&#x2019;s interim unaudited condensed consolidated financial statements included in this Quarterly
Report. Accordingly, these interim unaudited condensed consolidated financial statements should be read in conjunction with the Company&#x2019;s
audited consolidated financial statements and notes thereto for the fiscal year ended June 30, 2021. The June 30, 2021 balance sheet
is derived from those statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="From2021-07-01to2021-09-30">&lt;p id="xdx_84A_eus-gaap--ConsolidationPolicyTextBlock_zUzMhpDH8g1a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86D_z8DTT4x83H5b"&gt;Principles
of Consolidation&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
unaudited condensed consolidated financial statements include the accounts of Propanc Biopharma, Inc., the parent entity, and its wholly-owned
subsidiary, Propanc PTY LTD. All inter-company balances and transactions have been eliminated in consolidation. Propanc (UK) Limited
was an inactive subsidiary at September 30, 2021.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;PROPANC
BIOPHARMA, INC. AND SUBSIDIARY&lt;br/&gt;
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&lt;br/&gt;
SEPTEMBER 30, 2021&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;(Unaudited)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:UseOfEstimates contextRef="From2021-07-01to2021-09-30">&lt;p id="xdx_840_eus-gaap--UseOfEstimates_zKH5SsGwZ3P6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86F_zHD6rxWI4vv5"&gt;Use
of Estimates&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
preparation of financial statements in conformity with the accounting principles generally accepted in the United States of America (&#x201c;US
GAAP&#x201d;) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure
of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses
during the reporting period. Actual results could differ from these estimates. Significant estimates in the accompanying consolidated
financial statements include the estimates of useful lives for depreciation, valuation of the operating lease liability and related right-of-use
asset, valuation of derivatives, valuation of beneficial conversion features on convertible debt, allowance for uncollectable receivables,
valuation of equity based instruments issued for other than cash, the valuation allowance on deferred tax assets and foreign currency
translation due to certain average exchange rates applied in lieu of spot rates on transaction dates.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:UseOfEstimates>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock contextRef="From2021-07-01to2021-09-30">&lt;p id="xdx_84D_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zYtRi38HEaAj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_868_zdZ6QdOvTze2"&gt;Foreign
Currency Translation and Other Comprehensive Income (Loss)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company&#x2019;s wholly owned subsidiary&#x2019;s functional currency is the Australian dollar (AUD). For financial reporting purposes,
the Australian dollar has been translated into the Company&#x2019;s reporting currency which is the United States dollar ($) and/or (USD).
Assets and liabilities are translated at the exchange rate in effect at the balance sheet date. Revenues and expenses are translated
at the average rate of exchange prevailing during the reporting period. Equity transactions are translated at each historical transaction
date spot rate. Translation adjustments arising from the use of different exchange rates from period to period are included as a component
of stockholders&#x2019; equity (deficit) as &#x201c;Accumulated other comprehensive income (loss).&#x201d; Gains and losses resulting from
foreign currency transactions are included in the statements of operations and comprehensive income (loss) as a component of other comprehensive
income (loss). There have been no significant fluctuations in the exchange rate for the conversion of Australian dollars to USD after
the balance sheet date.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Other
Comprehensive Income (Loss) for all periods presented includes only foreign currency translation gains (losses).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Assets
and liabilities denominated in foreign currencies are translated into the functional currency at the exchange rates prevailing at the
consolidated balance sheet date with any transaction gains and losses that arise from exchange rate fluctuations on transactions denominated
in a currency other than the functional currency included in the consolidated results of operations as incurred. Effective fiscal year
2021, the parent company determined that these intercompany loans will not be repaid in the foreseeable future and thus, per ASC 830-20-35-3,
gains and losses from measuring the intercompany balances are recorded within cumulative translation adjustment, a component of accumulated
other comprehensive income (loss). Prior to July 1, 2020, the Company recorded the foreign currency transaction gains and losses from
measuring the intercompany balances as a component of other income (expenses) titled foreign currency transaction gain (loss). For the
three months ended September 30, 2021 and 2020, the Company recognized an exchange gain (loss) of approximately $&lt;span id="xdx_909_eus-gaap--OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_pp0p0_c20210701__20210930__us-gaap--DebtInstrumentAxis__custom--IntercompanyLoansMember_zOhbETHOlpbj"&gt;619,000&lt;/span&gt; and ($&lt;span id="xdx_90B_eus-gaap--OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_pp0p0_c20200701__20200930__us-gaap--DebtInstrumentAxis__custom--IntercompanyLoansMember_zKbJ5TpFaGWk"&gt;583,000&lt;/span&gt;),
on intercompany loans made by the parent to the subsidiary which have not been repaid as of September 30, 2021.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89A_ecustom--ScheduleOfTranslationExchangeRatesTableTextBlock_zzNbOSdcA4v" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;As
of September 30, 2021 and June 30, 2021, the exchange rates used to translate amounts in Australian dollars into USD for the purposes
of preparing the consolidated financial statements were as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.45in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_8B9_z5Jwt3MLbtk1" style="display: none"&gt;SCHEDULE
OF TRANSLATION EXCHANGE RATES&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;September
    30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;June
    30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Exchange rate on balance sheet dates&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;USD : AUD exchange rate&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20210930_zAxoaqp5Oof3" style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0.7214&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20210630_zAeNeQUILRnf" style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0.7500&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Average exchange rate for the period&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;USD : AUD exchange rate&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20210930__srt--RangeAxis__srt--WeightedAverageMember_zyOm6KwP3orf" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0.7350&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20210630__srt--RangeAxis__srt--WeightedAverageMember_zvDey7ZbyR65" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0.7473&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A8_zfay8WlxJE4a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_893_eus-gaap--ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_zWSkwTH6ECU4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
change in Accumulated Other Comprehensive Income (Loss) by component during the three months ended September 30, 2021 was as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;span id="xdx_8B7_zATgnOSNnnC6" style="display: none"&gt;SCHEDULE
OF CHANGE IN ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Foreign&lt;br/&gt;
    Currency Items:&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 82%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Balance, June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iS_pp0p0_c20210701__20210930_zWQXY0qBZeZ4" style="width: 14%; text-align: right" title="Beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,085,204&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Unrealized foreign currency
    translation gain&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_pp0p0_c20210701__20210930_zlbQptq6YdTi" style="border-bottom: Black 1.5pt solid; text-align: right" title="Foreign currency translation gain"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;64,193&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Ending balance, September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iE_pp0p0_c20210701__20210930_z94fy1ZvaCCk" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,149,397&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A7_zcAa30ZDSqkj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;PROPANC
BIOPHARMA, INC. AND SUBSIDIARY&lt;br/&gt;
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&lt;br/&gt;
SEPTEMBER 30, 2021&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;(Unaudited)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
      contextRef="From2021-07-012021-09-30_custom_IntercompanyLoansMember"
      decimals="0"
      unitRef="USD">619000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
      contextRef="From2020-07-012020-09-30_custom_IntercompanyLoansMember"
      decimals="0"
      unitRef="USD">583000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent>
    <PPCB:ScheduleOfTranslationExchangeRatesTableTextBlock contextRef="From2021-07-01to2021-09-30">&lt;p id="xdx_89A_ecustom--ScheduleOfTranslationExchangeRatesTableTextBlock_zzNbOSdcA4v" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;As
of September 30, 2021 and June 30, 2021, the exchange rates used to translate amounts in Australian dollars into USD for the purposes
of preparing the consolidated financial statements were as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.45in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_8B9_z5Jwt3MLbtk1" style="display: none"&gt;SCHEDULE
OF TRANSLATION EXCHANGE RATES&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;September
    30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;June
    30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Exchange rate on balance sheet dates&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;USD : AUD exchange rate&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20210930_zAxoaqp5Oof3" style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0.7214&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20210630_zAeNeQUILRnf" style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0.7500&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Average exchange rate for the period&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;USD : AUD exchange rate&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20210930__srt--RangeAxis__srt--WeightedAverageMember_zyOm6KwP3orf" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0.7350&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20210630__srt--RangeAxis__srt--WeightedAverageMember_zvDey7ZbyR65" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0.7473&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</PPCB:ScheduleOfTranslationExchangeRatesTableTextBlock>
    <us-gaap:ForeignCurrencyExchangeRateTranslation1 contextRef="AsOf2021-09-30" decimals="INF" unitRef="Pure">0.7214</us-gaap:ForeignCurrencyExchangeRateTranslation1>
    <us-gaap:ForeignCurrencyExchangeRateTranslation1 contextRef="AsOf2021-06-30" decimals="INF" unitRef="Pure">0.7500</us-gaap:ForeignCurrencyExchangeRateTranslation1>
    <us-gaap:ForeignCurrencyExchangeRateTranslation1
      contextRef="AsOf2021-09-30_srt_WeightedAverageMember"
      decimals="INF"
      unitRef="Pure">0.7350</us-gaap:ForeignCurrencyExchangeRateTranslation1>
    <us-gaap:ForeignCurrencyExchangeRateTranslation1
      contextRef="AsOf2021-06-30_srt_WeightedAverageMember"
      decimals="INF"
      unitRef="Pure">0.7473</us-gaap:ForeignCurrencyExchangeRateTranslation1>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock contextRef="From2021-07-01to2021-09-30">&lt;p id="xdx_893_eus-gaap--ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_zWSkwTH6ECU4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
change in Accumulated Other Comprehensive Income (Loss) by component during the three months ended September 30, 2021 was as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;span id="xdx_8B7_zATgnOSNnnC6" style="display: none"&gt;SCHEDULE
OF CHANGE IN ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Foreign&lt;br/&gt;
    Currency Items:&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 82%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Balance, June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iS_pp0p0_c20210701__20210930_zWQXY0qBZeZ4" style="width: 14%; text-align: right" title="Beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,085,204&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Unrealized foreign currency
    translation gain&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_pp0p0_c20210701__20210930_zlbQptq6YdTi" style="border-bottom: Black 1.5pt solid; text-align: right" title="Foreign currency translation gain"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;64,193&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Ending balance, September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iE_pp0p0_c20210701__20210930_z94fy1ZvaCCk" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,149,397&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">1085204</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
      contextRef="From2021-07-01to2021-09-30"
      decimals="0"
      unitRef="USD">64193</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="AsOf2021-09-30" decimals="0" unitRef="USD">1149397</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="From2021-07-01to2021-09-30">&lt;p id="xdx_846_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zFC2t1G9CYMj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_864_zKI9KeM2Ukah"&gt;Fair
Value of Financial Instruments and Fair Value Measurements&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company measures its financial assets and liabilities in accordance with US GAAP. For certain financial instruments, including cash and
cash equivalents, accounts receivable, accounts payable and accrued liabilities, the carrying amounts approximate fair value due to their
short maturities. Amounts recorded for notes payable, net of discount, and loans payable also approximate fair value because current
interest rates available for debt with similar terms and maturities are substantially the same.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company follows accounting guidance for financial assets and liabilities. This standard defines fair value, provides guidance for measuring
fair value and requires certain disclosures. This standard does not require any new fair value measurements, but rather applies to all
other accounting pronouncements that require or permit fair value measurements. This guidance does not apply to measurements related
to share-based payments. This guidance discusses valuation techniques, such as the market approach (comparable market prices), the income
approach (present value of future income or cash flow), and the cost approach (cost to replace the service capacity of an asset or replacement
cost).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
guidance utilizes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three broad
levels. The following is a brief description of those three levels:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.95pt; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Level
1: Observable inputs such as quoted prices (unadjusted) in active markets for identical assets or liabilities.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.95pt; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Level
2: Inputs, other than quoted prices that are observable, either directly or indirectly. These include quoted prices for similar assets
or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.95pt; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Level
3: Unobservable inputs in which little or no market data exists, therefore developed using estimates and assumptions developed by us,
which reflect those that a market participant would use.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Also
see Note 11 - Derivative Financial Instruments and Fair Value Measurements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="From2021-07-01to2021-09-30">&lt;p id="xdx_844_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_z9t6VlcKAS8g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_861_zD9uCZl5Cas9"&gt;Cash
and Cash Equivalents&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Cash
and cash equivalents include cash on hand and at banks, short-term deposits with an original maturity of three months or less with financial
institutions, and bank overdrafts. Bank overdrafts are reflected as a current liability on the balance sheets. There were &lt;span id="xdx_907_eus-gaap--CashEquivalentsAtCarryingValue_iI_pp0p0_do_c20200930_zOFhHXa6w5rk"&gt;no&lt;/span&gt; cash equivalents
as of September 30, 2021 or June 30, 2021.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:CashEquivalentsAtCarryingValue contextRef="AsOf2020-09-30" decimals="0" unitRef="USD">0</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="From2021-07-01to2021-09-30">&lt;p id="xdx_845_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zACW3ttl00x5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_866_zLBSJMg94jY4"&gt;Property
and Equipment&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Property
and equipment are stated at cost, net of accumulated depreciation. Expenditures for maintenance and repairs are expensed as incurred;
additions, renewals, and betterments are capitalized. When property and equipment are retired or otherwise disposed of, the related cost
and accumulated depreciation are removed from the respective accounts, and any gain or loss is included in operations. Depreciation of
property and equipment is provided using the declining balance method. The depreciable amount is the cost less its residual value.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_891_ecustom--ScheduleOfPropertyAndEquipmentEstimatedUsefulLivesTableTextBlock_zt2mxbVoEEWc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
estimated useful lives are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;span id="xdx_8B4_zrzjwdUOooq6" style="display: none"&gt;SCHEDULE
OF PROPERTY AND EQUIPMENT ESTIMATED USEFUL LIVES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 25%"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Machinery
    and equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 75%"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;-
    &lt;span id="xdx_90F_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210701__20210930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_zgVFwUSlH806"&gt;5&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Furniture&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;-
    &lt;span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210701__20210930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zmrWJFVBDMYc"&gt;7&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A6_zyicsnfsPJy8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <PPCB:ScheduleOfPropertyAndEquipmentEstimatedUsefulLivesTableTextBlock contextRef="From2021-07-01to2021-09-30">&lt;p id="xdx_891_ecustom--ScheduleOfPropertyAndEquipmentEstimatedUsefulLivesTableTextBlock_zt2mxbVoEEWc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
estimated useful lives are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;span id="xdx_8B4_zrzjwdUOooq6" style="display: none"&gt;SCHEDULE
OF PROPERTY AND EQUIPMENT ESTIMATED USEFUL LIVES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 25%"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Machinery
    and equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 75%"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;-
    &lt;span id="xdx_90F_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210701__20210930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_zgVFwUSlH806"&gt;5&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Furniture&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;-
    &lt;span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210701__20210930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zmrWJFVBDMYc"&gt;7&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</PPCB:ScheduleOfPropertyAndEquipmentEstimatedUsefulLivesTableTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="From2021-07-012021-09-30_us-gaap_MachineryAndEquipmentMember">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="From2021-07-012021-09-30_us-gaap_FurnitureAndFixturesMember">P7Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy contextRef="From2021-07-01to2021-09-30">&lt;p id="xdx_843_eus-gaap--GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_zpLA1iRncFHg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_868_zax2qkWhbWie"&gt;Patents&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Patents
are stated at cost and amortized on a straight-line basis over the estimated future periods if and once the patent has been granted by
a regulatory agency. However, the Company will expense any patent costs as long as we are in the startup stage. Accordingly, as the Company&#x2019;s
products are not currently approved for market, all patent costs incurred from 2013 through September 30, 2021 were expensed immediately.
This practice of expensing patent costs immediately ends when a product receives market authorization from a government regulatory agency.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock contextRef="From2021-07-01to2021-09-30">&lt;p id="xdx_847_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zR7zOXittAmg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86A_zfgxcl3KPwSa"&gt;Impairment
of Long-Lived Assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;In
accordance with ASC 360-10, &#x201c;&lt;i&gt;Long-lived assets,&#x201d;&lt;/i&gt; which include property and equipment and intangible assets, are reviewed
for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability
of long-lived assets to be held and used is measured by a comparison of the carrying amount of an asset to the estimated undiscounted
future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated undiscounted future
cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the
assets. Fair value is generally determined using the asset&#x2019;s expected future discounted cash flows or market value, if readily
determinable.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;PROPANC
BIOPHARMA, INC. AND SUBSIDIARY&lt;br/&gt;
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&lt;br/&gt;
SEPTEMBER 30, 2021&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;(Unaudited)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <us-gaap:EmployeeStockOwnershipPlanESOPPolicy contextRef="From2021-07-01to2021-09-30">&lt;p id="xdx_847_eus-gaap--EmployeeStockOwnershipPlanESOPPolicy_zKcRPhz1cmDl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86B_zKiRtMFzZSlc"&gt;Employee
Benefit/Liability&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Liabilities
arising in respect of wages and salaries, accumulated annual leave, accumulated long service leave and any other employee benefits expected
to be settled within twelve months of the reporting date are measured based on the employee&#x2019;s remuneration rates applicable at
the reporting date. All other employee benefit liabilities are measured at the present value of the estimated future cash outflow to
be made in respect of services provided by employees up to the reporting date. All employee liabilities are owed within the next twelve
months.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:EmployeeStockOwnershipPlanESOPPolicy>
    <PPCB:GoodsAndServiceTaxPolicyTextBlock contextRef="From2021-07-01to2021-09-30">&lt;p id="xdx_845_ecustom--GoodsAndServiceTaxPolicyTextBlock_zFkquLvQEsN1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86E_zAcVIJZd3dT8"&gt;Australian
Goods and Services Tax (&#x201c;GST&#x201d;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Revenues,
expenses and balance sheet items are recognized net of the amount of GST, except payable and receivable balances which are shown inclusive
of GST. The GST incurred is payable on revenues to, and recoverable on purchases from, the Australian Taxation Office.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Cash
flows are presented in the statements of cash flow on a gross basis, except for the GST component of investing and financing activities,
which are disclosed as operating cash flows.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;As
of September 30, 2021, and June 30, 2021, the Company was owed $&lt;span id="xdx_904_eus-gaap--ValueAddedTaxReceivableCurrent_iI_pp0p0_c20210930_zNHlbbV7dpad" title="Value added tax receivable"&gt;2,238&lt;/span&gt; and $&lt;span id="xdx_90A_eus-gaap--ValueAddedTaxReceivableCurrent_iI_pp0p0_c20200930_zQ4JT5NkFXzk" title="Value added tax receivable"&gt;4,341&lt;/span&gt;, respectively, from the Australian Taxation Office.
These amounts were fully collected subsequent to the balance sheet reporting dates.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</PPCB:GoodsAndServiceTaxPolicyTextBlock>
    <us-gaap:ValueAddedTaxReceivableCurrent contextRef="AsOf2021-09-30" decimals="0" unitRef="USD">2238</us-gaap:ValueAddedTaxReceivableCurrent>
    <us-gaap:ValueAddedTaxReceivableCurrent contextRef="AsOf2020-09-30" decimals="0" unitRef="USD">4341</us-gaap:ValueAddedTaxReceivableCurrent>
    <us-gaap:DerivativesReportingOfDerivativeActivity contextRef="From2021-07-01to2021-09-30">&lt;p id="xdx_847_eus-gaap--DerivativesReportingOfDerivativeActivity_zQ2WlEN1DWE6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_861_zc8e4LzGljd1"&gt;Derivative
Instruments&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;ASC
Topic 815, &lt;i&gt;Derivatives and Hedging&lt;/i&gt; (&#x201c;ASC Topic 815&#x201d;), establishes accounting and reporting standards for derivative
instruments and for hedging activities by requiring that all derivatives be recognized in the balance sheet and measured at fair value.
Gains or losses resulting from changes in the fair value of derivatives are recognized in earnings. On the date of conversion or payoff
of debt, the Company records the fair value of the conversion shares, removes the fair value of the related derivative liability, removes
any discounts and records a net gain or loss on debt extinguishment. On July 1, 2019 the Company adopted ASU 2017-11 under which down-round
Features in Financial Instruments will no longer cause derivative treatment. The Company applies the modified prospective method of adoption.
There were no cumulative effects on adoption.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:DerivativesReportingOfDerivativeActivity>
    <PPCB:ConvertibleNotesPolicyTextBlock contextRef="From2021-07-01to2021-09-30">&lt;p id="xdx_845_ecustom--ConvertibleNotesPolicyTextBlock_zxn5O0pSGSxg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_861_zqNXrYouGBs7"&gt;Convertible
Notes With Variable Conversion Options&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company has entered into convertible notes, some of which contain variable conversion options, whereby the outstanding principal and
accrued interest may be converted, by the holder, into common shares at a fixed discount to the price of the common stock at or around
the time of conversion. The Company treats these convertible notes as stock settled debt under ASC 480, &#x201c;&lt;i&gt;Distinguishing Liabilities
from Equity&lt;/i&gt;&#x201d; and measures the fair value of the notes at the time of issuance, which is the result of the share price discount
at the time of conversion and records the put premium as interest expense.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</PPCB:ConvertibleNotesPolicyTextBlock>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="From2021-07-01to2021-09-30">&lt;p id="xdx_848_eus-gaap--IncomeTaxPolicyTextBlock_zhOGS6N4HyHb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86B_z4ulDnTrWbva"&gt;Income
Taxes&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company is governed by Australia and United States income tax laws, which are administered by the Australian Taxation Office and the
United States Internal Revenue Service, respectively. The Company follows ASC 740 &#x201c;&lt;i&gt;Accounting for Income Taxes&lt;/i&gt;,&#x201d; when
accounting for income taxes, which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred
income tax assets and liabilities are computed annually for temporary differences between the financial statements and tax bases of assets
and liabilities that will result in taxable or deductible amounts in the future based on enacted tax laws and rates applicable to the
periods in which the differences are expected to affect taxable income. Valuation allowances are established when necessary to reduce
deferred tax assets to the amount expected to be realized. Income tax expense is the tax payable or refundable for the period plus or
minus the change during the period in deferred tax assets and liabilities.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company follows ASC 740, Sections 25 through 60, &#x201c;&lt;i&gt;Accounting for Uncertainty in Income Taxes&lt;/i&gt;.&#x201d; These sections provide
detailed guidance for the financial statement recognition, measurement and disclosure of uncertain tax positions recognized in the financial
statements. Tax positions must meet a &#x201c;more-likely-than-not&#x201d; recognition threshold at the effective date to be recognized
upon the adoption of ASC 740 and in subsequent periods.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:ResearchAndDevelopmentExpensePolicy contextRef="From2021-07-01to2021-09-30">&lt;p id="xdx_842_eus-gaap--ResearchAndDevelopmentExpensePolicy_zhSDwzgwptn3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_864_z7raaBtt59u1"&gt;Research
and Development Costs and Tax Credits&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;In
accordance with ASC 730-10, &lt;i&gt;&#x201c;Research and Development-Overall,&#x201d;&lt;/i&gt; research and development costs are expensed when incurred.
Total research and development costs for the three months ended September 30, 2021 and 2020 were $&lt;span id="xdx_901_eus-gaap--ResearchAndDevelopmentExpense_pp0p0_c20210701__20210930_z8IQi4E6xGXk"&gt;46,554&lt;/span&gt; and $&lt;span id="xdx_90B_eus-gaap--ResearchAndDevelopmentExpense_pp0p0_c20200701__20200930_zKalVQgW6Sua"&gt;50,846&lt;/span&gt;, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;PROPANC
BIOPHARMA, INC. AND SUBSIDIARY&lt;br/&gt;
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&lt;br/&gt;
SEPTEMBER 30, 2021&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;(Unaudited)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company may apply for research and development tax concessions with the Australian Taxation Office on an annual basis. Although the amount
is possible to estimate at year end, the Australian Taxation Office may reject or materially alter the claim amount. Accordingly, the
Company does not recognize the benefit of the claim amount until cash receipt since collectability is not certain until such time. The
tax concession is a refundable credit. If the Company has net income, then the Company can receive the credit which reduces its income
tax liability. If the Company has net losses, then the Company may still receive a cash payment for the credit, however, the Company&#x2019;s
net operating loss carryforwards are reduced by the gross equivalent loss that would produce the credit amount when the income tax rate
is applied to that gross amount. The concession is recognized as tax benefit, in operations, upon receipt.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;During
each of the three months ended September 30, 2021 and 2020, the Company applied for, and received from the Australian Taxation Office,
a research and development tax credit in the amount of $&lt;span id="xdx_900_eus-gaap--IncomeTaxExpenseBenefit_iN_pp0p0_dixL_c20200701__20200930_zfbdkDjR4Lw6" title="::XDX::-"&gt;&lt;span id="xdx_90E_eus-gaap--IncomeTaxExpenseBenefit_iN_pp0p0_dixL_c20210701__20210930_zu8lPCnqt6u" title="Tax credits::XDX::-"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3304"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3306"&gt;0&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;, which is reflected as a tax benefit in the accompanying unaudited condensed
consolidated statements of operations and comprehensive income (loss).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2021-07-01to2021-09-30"
      decimals="0"
      unitRef="USD">46554</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2020-07-012020-09-30"
      decimals="0"
      unitRef="USD">50846</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy contextRef="From2021-07-01to2021-09-30">&lt;p id="xdx_847_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_z7ocjmQGNxmd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86D_zxXe6dOqY3P8"&gt;Stock
Based Compensation&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company records stock-based compensation in accordance with ASC 718, &#x201c;&lt;i&gt;Stock Compensation&lt;/i&gt;&#x201d;. ASC 718 requires the fair
value of all stock-based employee compensation awarded to employees to be recorded as an expense over the shorter of the service period
or the vesting period. The Company values employee and non-employee stock-based compensation at fair value using the Black-Scholes Option
Pricing Model.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company adopted ASU 2018-07 and accounts for non-employee share-based awards in accordance with the measurement and recognition criteria
of ASC 718 and recognizes the fair value of such awards over the service period. The Company used the modified prospective method of
adoption. There was no cumulative effect of adoption on July 1, 2019.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock contextRef="From2021-07-01to2021-09-30">&lt;p id="xdx_842_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zoI5lfak5jZ7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_866_zQ0pBQvL2eDf"&gt;Revenue
Recognition&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company adopted and implemented on July 1, 2018, ASC 606 &#x2013; Revenue from Contracts with Customers (&#x201c;ASC 606&#x201d;). ASC 606
did not have a material impact on the consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Upon
implementation of ASC 606, the Company recognizes revenue in accordance with that core principle by applying the following steps:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Step
1: Identify the contract(s) with a customer.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Step
2: Identify the performance obligations in the contract.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Step
3: Determine the transaction price.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Step
4: Allocate the transaction price to the performance obligations in the contract.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Step
5: Recognize revenue when (or as) the entity satisfies a performance obligation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Subject
to these criteria, the Company intends to recognize revenue relating to royalties on product sales in the period in which the sale occurs
and the royalty term has begun.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:LegalCostsPolicyTextBlock contextRef="From2021-07-01to2021-09-30">&lt;p id="xdx_845_eus-gaap--LegalCostsPolicyTextBlock_zYIGCDDncv8f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_869_zZfv7SoMGD11"&gt;Legal
Expenses&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;All
legal costs for litigation are charged to expense as incurred.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:LegalCostsPolicyTextBlock>
    <us-gaap:LesseeLeasesPolicyTextBlock contextRef="From2021-07-01to2021-09-30">&lt;p id="xdx_84E_eus-gaap--LesseeLeasesPolicyTextBlock_zXunrNvs61Gc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_868_zSbh3EyY4Kej"&gt;Leases&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;In
February 2016, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued ASU 2016-02, &lt;i&gt;Leases&lt;/i&gt; (Topic 842). The updated
guidance requires lessees to recognize lease assets and lease liabilities for most operating leases. In addition, the updated guidance
requires that lessors separate lease and non-lease components in a contract in accordance with the new revenue guidance in ASC 606. This
guidance is effective for interim and annual reporting periods beginning after December 15, 2018. The Company adopted this guidance effective
July 1, 2019.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;On
July 1, 2019, the Company adopted ASU No. 2016-02, applying the package of practical expedients to leases that commenced before the effective
date whereby the Company elected to not reassess the following: (i) whether any expired or existing contracts contain leases and; (ii)
initial direct costs for any existing leases. For contracts entered into on or after the effective date, at the inception of a contract
the Company assessed whether the contract is, or contains, a lease. The Company&#x2019;s assessment is based on: (1) whether the contract
involves the use of a distinct identified asset, (2) whether we obtain the right to substantially all the economic benefit from the use
of the asset throughout the period, and (3) whether it has the right to direct the use of the asset. The Company will allocate the consideration
in the contract to each lease component based on its relative stand-alone price to determine the lease payments. In addition, the Company
elected not to apply ASC Topic 842 to arrangements with lease terms of 12 months or less.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Operating
lease ROU assets represents the right to use the leased asset for the lease term and operating lease liabilities are recognized based
on the present value of future minimum lease payments over the lease term at commencement date. As most leases do not provide an implicit
rate, the Company use an incremental borrowing rate based on the information available at the adoption date in determining the present
value of future payments. Lease expense for minimum lease payments is amortized on a straight-line basis over the lease term and will
be included in general and administrative expenses.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;PROPANC
BIOPHARMA, INC. AND SUBSIDIARY&lt;br/&gt;
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&lt;br/&gt;
SEPTEMBER 30, 2021&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;(Unaudited)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="From2021-07-01to2021-09-30">&lt;p id="xdx_84E_eus-gaap--EarningsPerSharePolicyTextBlock_zpfEBsYvPCak" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_869_zIeaaJNnPy08"&gt;Basic
and Diluted Net Loss Per Common Share&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Basic
net loss per share is computed by dividing the net loss by the weighted average number of common shares outstanding during the period.
Diluted net loss per common share is computed by dividing the net loss by the weighted average number of common shares outstanding for
the period and, if dilutive, potential common shares outstanding during the period. Potentially dilutive securities consist of the incremental
common shares issuable upon exercise of common stock equivalents such as stock options, warrants and convertible debt instruments. Potentially
dilutive securities are excluded from the computation if their effect is anti-dilutive. As a result, the basic and diluted per share
amounts for all periods presented are identical. &lt;span id="xdx_902_eus-gaap--DebtInstrumentConvertibleTermsOfConversionFeature_c20210701__20210930_zELEU7ykKkIk" title="Debt conversion percentage, description"&gt;Each holder of the notes has agreed to a &lt;span id="xdx_904_eus-gaap--DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_pid_dp_uPure_c20200701__20210630_zhcROCTayfJi" title="Debt conversion percentage"&gt;4.99&lt;/span&gt;% beneficial ownership conversion limitation
(subject to certain noteholders&#x2019; ability to increase such limitation to &lt;span id="xdx_906_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_uPure_c20210819__us-gaap--TypeOfArrangementAxis__custom--TwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember_zjDxTQNnQMx6"&gt;9.99&lt;/span&gt;% upon 60 days&#x2019; notice to the Company), and each
note may not be converted during the first six-month period from the date of issuance. The securities for the period ended September
30, 2021 and 2020 were considered dilutive securities which were excluded from the computation since the effect is anti-dilutive.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span title="Debt conversion percentage, description"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89A_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zLusIxCV0JF5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;span id="xdx_8B8_z5qGGqx37Jgb" style="display: none"&gt;SCHEDULE
OF DILUTIVE SECURITIES EXCLUDED FROM COMPUTATION&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 100%; margin-right: auto"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;September
    30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;September
    30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;(Unaudited)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;(Unaudited)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Stock Options&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20210701__20210930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_zRWorJnhqvNc" style="width: 14%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;59&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20200701__20200930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_zlntA9renUm6" style="width: 14%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;60&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Stock Warrants&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20210701__20210930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zM5tes7KTZa" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;111,932&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20200701__20200930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zt22Rh7qyBR8" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;135,725&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Unvested restricted stock&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20210701__20210930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--UnvestedRestrictedStockMember_ziQ1XBlUpRa9" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;59&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20200701__20200930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--UnvestedRestrictedStockMember_zaZOZ38j94Hd" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;117&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Convertible Debt&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20210701__20210930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertibleDebtSecuritiesMember_zadTQYWGAgi6" style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;23,293,971&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20200701__20200930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertibleDebtSecuritiesMember_zsFdubolj81a" style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;510,674&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20210701__20210930_zjRj7iczs6t1" style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;23,406,021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20200701__20200930_zQ6W7BJxm8Kh" style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;646,576&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A6_ztUc5Ua4Aso2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:DebtInstrumentConvertibleTermsOfConversionFeature contextRef="From2021-07-01to2021-09-30">Each holder of the notes has agreed to a 4.99% beneficial ownership conversion limitation
(subject to certain noteholders&#x2019; ability to increase such limitation to 9.99% upon 60 days&#x2019; notice to the Company), and each
note may not be converted during the first six-month period from the date of issuance. The securities for the period ended September
30, 2021 and 2020 were considered dilutive securities which were excluded from the computation since the effect is anti-dilutive.</us-gaap:DebtInstrumentConvertibleTermsOfConversionFeature>
    <us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
      contextRef="From2020-07-012021-06-30"
      decimals="INF"
      unitRef="Pure">0.0499</us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="AsOf2021-08-19_custom_TwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember"
      decimals="INF"
      unitRef="Pure">0.0999</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock contextRef="From2021-07-01to2021-09-30">&lt;p id="xdx_89A_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zLusIxCV0JF5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;span id="xdx_8B8_z5qGGqx37Jgb" style="display: none"&gt;SCHEDULE
OF DILUTIVE SECURITIES EXCLUDED FROM COMPUTATION&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 100%; margin-right: auto"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;September
    30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;September
    30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;(Unaudited)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;(Unaudited)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Stock Options&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20210701__20210930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_zRWorJnhqvNc" style="width: 14%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;59&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20200701__20200930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_zlntA9renUm6" style="width: 14%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;60&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Stock Warrants&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20210701__20210930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zM5tes7KTZa" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;111,932&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20200701__20200930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zt22Rh7qyBR8" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;135,725&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Unvested restricted stock&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20210701__20210930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--UnvestedRestrictedStockMember_ziQ1XBlUpRa9" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;59&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20200701__20200930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--UnvestedRestrictedStockMember_zaZOZ38j94Hd" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;117&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Convertible Debt&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20210701__20210930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertibleDebtSecuritiesMember_zadTQYWGAgi6" style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;23,293,971&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20200701__20200930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertibleDebtSecuritiesMember_zsFdubolj81a" style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;510,674&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20210701__20210930_zjRj7iczs6t1" style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;23,406,021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20200701__20200930_zQ6W7BJxm8Kh" style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;646,576&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2021-07-012021-09-30_us-gaap_EmployeeStockOptionMember"
      decimals="INF"
      unitRef="Shares">59</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2020-07-012020-09-30_us-gaap_EmployeeStockOptionMember"
      decimals="INF"
      unitRef="Shares">60</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2021-07-012021-09-30_us-gaap_WarrantMember"
      decimals="INF"
      unitRef="Shares">111932</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2020-07-012020-09-30_us-gaap_WarrantMember"
      decimals="INF"
      unitRef="Shares">135725</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2021-07-012021-09-30_custom_UnvestedRestrictedStockMember"
      decimals="INF"
      unitRef="Shares">59</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2020-07-012020-09-30_custom_UnvestedRestrictedStockMember"
      decimals="INF"
      unitRef="Shares">117</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2021-07-012021-09-30_us-gaap_ConvertibleDebtSecuritiesMember"
      decimals="INF"
      unitRef="Shares">23293971</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2020-07-012020-09-30_us-gaap_ConvertibleDebtSecuritiesMember"
      decimals="INF"
      unitRef="Shares">510674</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2021-07-01to2021-09-30"
      decimals="INF"
      unitRef="Shares">23406021</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2020-07-012020-09-30"
      decimals="INF"
      unitRef="Shares">646576</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="From2021-07-01to2021-09-30">&lt;p id="xdx_841_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zFYh4pSJ2Re4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_863_zJh69seVZbtk"&gt;Recent
Accounting Pronouncements&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;We
have reviewed the FASB issued ASU accounting pronouncements and interpretations thereof that have effectiveness dates during the periods
reported and in future periods. We have carefully considered the new pronouncements that alter previous generally accepted accounting
principles and do not believe that any new or modified principles will have a material impact on the Company&#x2019;s reported financial
position or operations in the near term. The applicability of any standard is subject to the formal review of the Company&#x2019;s financial
management.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;In
August 2020, the FASB issued ASU 2020-06, &#x201c;Debt &#x2013; Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives
and Hedging &#x2013; Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40)&#x201d;. This ASU reduces the number of accounting models
for convertible debt instruments and convertible preferred stock. As well as amend the guidance for the derivatives scope exception for
contracts in an entity&#x2019;s own equity to reduce form-over-substance-based accounting conclusions. In addition, this ASU improves
and amends the related EPS guidance. This standard is effective for us on July 1, 2022, including interim periods within those fiscal
years. Adoption is either a modified retrospective method or a fully retrospective method of transition. The Company is currently assessing
the impact the new guidance will have on our consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:SubstantialDoubtAboutGoingConcernTextBlock contextRef="From2021-07-01to2021-09-30">&lt;p id="xdx_803_eus-gaap--SubstantialDoubtAboutGoingConcernTextBlock_ziUB31Kjwqvc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTE
2 &#x2013; &lt;span id="xdx_82D_z3Eip7SGNUxj"&gt;GOING CONCERN&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
accompanying unaudited condensed consolidated financial statements have been prepared in conformity with US GAAP, which contemplate continuation
of the Company as a going concern. For the three months ended September 30, 2021, the Company had no revenues, had a net loss of $&lt;span id="xdx_90C_eus-gaap--ProfitLoss_iN_pp0p0_di_c20210701__20210930_zZ86ZTKlE3f"&gt;490,658&lt;/span&gt;,
and had net cash used in operations of $&lt;span id="xdx_90B_eus-gaap--NetCashProvidedByUsedInOperatingActivities_iN_pp0p0_di_c20210701__20210930_z7zDthEysJmg"&gt;486,758&lt;/span&gt;. Additionally, as of September 30, 2021, the Company had a working capital deficit, stockholders&#x2019;
deficit and accumulated deficit of $&lt;span id="xdx_901_ecustom--WorkingCapitalDeficit_iI_pp0p0_c20210930_zmFMtHUfZicd"&gt;2,312,387&lt;/span&gt;, $&lt;span id="xdx_90A_eus-gaap--StockholdersEquity_iNI_pp0p0_di_c20210930_ztn1uKQgbUUb"&gt;2,306,630&lt;/span&gt; and $&lt;span id="xdx_900_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_pp0p0_di_c20210930_zUtdVGNRXych"&gt;58,804,968&lt;/span&gt;, respectively. It is management&#x2019;s opinion that these
conditions raise substantial doubt about the Company&#x2019;s ability to continue as a going concern for a period of at least twelve months
from the issue date of this Quarterly Report.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
unaudited condensed consolidated financial statements do not include any adjustments to reflect the possible future effect on the recoverability
and classification of assets or the amounts and classifications of liabilities that may result from the outcome of this uncertainty.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Successful
completion of the Company&#x2019;s development program and, ultimately, the attainment of profitable operations are dependent upon future
events, including obtaining adequate financing to fulfill its development activities, acceptance of the Company&#x2019;s patent applications,
obtaining additional sources of suitable and adequate financing and ultimately achieving a level of sales adequate to support the Company&#x2019;s
cost structure and business plan. The Company&#x2019;s ability to continue as a going concern is also dependent on its ability to further
develop and execute on its business plan. However, there can be no assurances that any or all of these endeavors will be successful.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;PROPANC
BIOPHARMA, INC. AND SUBSIDIARY&lt;br/&gt;
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&lt;br/&gt;
SEPTEMBER 30, 2021&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;(Unaudited)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;In
March 2020, the outbreak of COVID-19 (coronavirus) caused by a novel strain of the coronavirus was recognized as a pandemic by the World
Health Organization, and the outbreak has become increasingly widespread in the United States, Europe and Australia, including in each
of the areas in which the Company operates. The COVID-19 (coronavirus) outbreak has had a notable impact on general economic conditions,
including but not limited to the temporary closures of many businesses, &#x201c;shelter in place&#x201d; and other governmental regulations,
reduced business and consumer spending due to both job losses, reduced investing activity and M&amp;amp;A transactions, among many other
effects attributable to the COVID-19 (coronavirus), and there continue to be many unknowns. While to date the Company has not been required
to stop operating, management is evaluating its use of its office space, virtual meetings and the like. The Company continues to monitor
the impact of the COVID-19 (coronavirus) outbreak closely. The extent to which the COVID-19 (coronavirus) outbreak will impact our operations,
ability to obtain financing or future financial results is uncertain.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:SubstantialDoubtAboutGoingConcernTextBlock>
    <us-gaap:ProfitLoss
      contextRef="From2021-07-01to2021-09-30"
      decimals="0"
      unitRef="USD">-490658</us-gaap:ProfitLoss>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2021-07-01to2021-09-30"
      decimals="0"
      unitRef="USD">-486758</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <PPCB:WorkingCapitalDeficit contextRef="AsOf2021-09-30" decimals="0" unitRef="USD">2312387</PPCB:WorkingCapitalDeficit>
    <us-gaap:StockholdersEquity contextRef="AsOf2021-09-30" decimals="0" unitRef="USD">-2306630</us-gaap:StockholdersEquity>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2021-09-30" decimals="0" unitRef="USD">-58804968</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef="From2021-07-01to2021-09-30">&lt;p id="xdx_80B_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zepSISzbskde" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTE
3 &#x2013; &lt;span id="xdx_82B_z2gR3jESkmWk"&gt;PROPERTY AND EQUIPMENT&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_897_eus-gaap--PropertyPlantAndEquipmentTextBlock_zg8Ghbs3Cm4d" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Property
and equipment consist of the following as of September 30, 2021 and June 30, 2021.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;span id="xdx_8BD_zxaUS1cN4CT3" style="display: none"&gt;SCHEDULE
OF PROPERTY AND EQUIPMENT&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49C_20210930_zAUwbf34Hci3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;September
    30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49C_20210630_zkfliRIteW57" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;June
    30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(Unaudited)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_maPPAENzBVB_zWa3ZPXSA1sj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Office equipment at cost&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;27,532&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;28,623&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_msPPAENzBVB_zJIDwd7Qqdoa" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Less: Accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(23,939&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(24,368&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--PropertyPlantAndEquipmentNet_iTI_pp0p0_mtPPAENzBVB_zCIlyNdbrAOk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total property, plant,
    and equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,593&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,255&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AD_zkLpjrunY5Y2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Depreciation
expense for the three months ended September 30, 2021 and 2020 were $&lt;span id="xdx_90D_eus-gaap--Depreciation_pp0p0_c20210701__20210930_zRmSWSeRcGnc"&gt;509&lt;/span&gt; and $&lt;span id="xdx_90C_eus-gaap--Depreciation_pp0p0_c20200701__20200930_z5geXjYMtJb2"&gt;438&lt;/span&gt;, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="From2021-07-01to2021-09-30">&lt;p id="xdx_897_eus-gaap--PropertyPlantAndEquipmentTextBlock_zg8Ghbs3Cm4d" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Property
and equipment consist of the following as of September 30, 2021 and June 30, 2021.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;span id="xdx_8BD_zxaUS1cN4CT3" style="display: none"&gt;SCHEDULE
OF PROPERTY AND EQUIPMENT&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49C_20210930_zAUwbf34Hci3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;September
    30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49C_20210630_zkfliRIteW57" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;June
    30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(Unaudited)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_maPPAENzBVB_zWa3ZPXSA1sj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Office equipment at cost&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;27,532&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;28,623&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_msPPAENzBVB_zJIDwd7Qqdoa" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Less: Accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(23,939&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(24,368&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--PropertyPlantAndEquipmentNet_iTI_pp0p0_mtPPAENzBVB_zCIlyNdbrAOk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total property, plant,
    and equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,593&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,255&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2021-09-30" decimals="0" unitRef="USD">27532</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">28623</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="AsOf2021-09-30" decimals="0" unitRef="USD">23939</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">24368</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2021-09-30" decimals="0" unitRef="USD">3593</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">4255</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Depreciation
      contextRef="From2021-07-01to2021-09-30"
      decimals="0"
      unitRef="USD">509</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="From2020-07-012020-09-30"
      decimals="0"
      unitRef="USD">438</us-gaap:Depreciation>
    <PPCB:DueToFormerDirectorRelatedPartyDisclosureTextBlock contextRef="From2021-07-01to2021-09-30">&lt;p id="xdx_803_ecustom--DueToFormerDirectorRelatedPartyDisclosureTextBlock_zYCHdB7lkeA7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTE
4 &#x2013; &lt;span id="xdx_820_z7yy1mR29q99"&gt;DUE TO FORMER DIRECTOR - RELATED PARTY&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Due
to former director - related party represents unsecured advances made primarily by a former director for operating expenses on behalf
of the Company such as intellectual property and formation expenses. The expenses were paid for on behalf of the Company and are due
upon demand. The Company is currently not being charged interest under these advances. The total amount owed the former director at September
30, 2021 and June 30, 2021 were $&lt;span id="xdx_90E_eus-gaap--DueToRelatedPartiesCurrent_iI_pp0p0_c20210930_zJxA1xS5YYVd"&gt;32,076&lt;/span&gt; and $&lt;span id="xdx_906_eus-gaap--DueToRelatedPartiesCurrent_iI_pp0p0_c20210630_zbE0QKQMtL6g"&gt;33,347&lt;/span&gt;, respectively. The Company plans to repay the advances as its cash resources allow
(see Note 9).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</PPCB:DueToFormerDirectorRelatedPartyDisclosureTextBlock>
    <us-gaap:DueToRelatedPartiesCurrent contextRef="AsOf2021-09-30" decimals="0" unitRef="USD">32076</us-gaap:DueToRelatedPartiesCurrent>
    <us-gaap:DueToRelatedPartiesCurrent contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">33347</us-gaap:DueToRelatedPartiesCurrent>
    <PPCB:LoansAndNotesPayableDisclosureTextBlock contextRef="From2021-07-01to2021-09-30">&lt;p id="xdx_80A_ecustom--LoansAndNotesPayableDisclosureTextBlock_zS4pzWmIuk09" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTE
5 &#x2013; &lt;span id="xdx_822_zntXa5mgWi7c"&gt;LOANS AND NOTES PAYABLE&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;Loan
from Former Director - Related Party&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Loan
from the Company&#x2019;s former director at September 30, 2021 and June 30, 2021 were $&lt;span id="xdx_907_eus-gaap--LoansPayable_iI_pp0p0_c20210930__srt--TitleOfIndividualAxis__custom--DirectorsAndOfficerMember_zjrzMBd5GgQ"&gt;53,384&lt;/span&gt; and $&lt;span id="xdx_906_eus-gaap--LoansPayable_iI_pp0p0_c20210630__srt--TitleOfIndividualAxis__custom--DirectorsAndOfficerMember_zi5UsTPh9Iy4"&gt;55,500&lt;/span&gt;, respectively. The loan bears
no interest and is payable on demand. The Company did not repay any amount on this loan during the three months ended September 30, 2021
and 2020, respectively (see Note 9).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</PPCB:LoansAndNotesPayableDisclosureTextBlock>
    <us-gaap:LoansPayable
      contextRef="AsOf2021-09-30_custom_DirectorsAndOfficerMember"
      decimals="0"
      unitRef="USD">53384</us-gaap:LoansPayable>
    <us-gaap:LoansPayable
      contextRef="AsOf2021-06-30_custom_DirectorsAndOfficerMember"
      decimals="0"
      unitRef="USD">55500</us-gaap:LoansPayable>
    <us-gaap:DebtDisclosureTextBlock contextRef="From2021-07-01to2021-09-30">&lt;p id="xdx_800_eus-gaap--DebtDisclosureTextBlock_zc2SqHBxedb7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTE
6 &#x2013; &lt;span id="xdx_82C_zKhRExlhfXl9"&gt;CONVERTIBLE NOTES&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_897_eus-gaap--ConvertibleDebtTableTextBlock_zjBtvrzAXz4j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company&#x2019;s convertible notes outstanding at September 30, 2021 and June 30, 2021 were as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_8B0_zcA9zJu0m1X9" style="display: none"&gt;SCHEDULE
OF CONVERTIBLE NOTES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20210930_zAp0KEWZ480k" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;September
    30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20210630_zyLLJTngGXul" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;June
    30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(Unaudited)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--DebtInstrumentCarryingAmount_iI_pp0p0_maLTDzcuB_zeR5AoxnitQ" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Convertible notes and debenture&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 17%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;377,780&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 15%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;400,128&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--DebtInstrumentUnamortizedDiscount_iNI_pp0p0_di_msLTDzcuB_z1VTqFyrK7xb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Unamortized discounts&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(7,565&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(6,139&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--DepositLiabilitiesAccruedInterest_iI_pp0p0_maLTDzcuB_zzTn53DC3CG" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Accrued interest&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;37,348&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;34,098&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--DebtInstrumentUnamortizedPremium_iI_pp0p0_maLTDzcuB_ztrTE0IiZtYh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Premium, net&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;177,045&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;196,496&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--LongTermDebt_iTI_pp0p0_mtLTDzcuB_zuIe10MIoIM4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Convertible notes,
    net&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;584,608&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;624,583&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A6_zemr5ZC68yq2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;PROPANC
BIOPHARMA, INC. AND SUBSIDIARY&lt;br/&gt;
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&lt;br/&gt;
SEPTEMBER 30, 2021&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;(Unaudited)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Convertible
Note Issued with Consulting Agreement&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;i&gt;August
10, 2017 Consulting Agreement&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;On
August 10, 2017, the Company entered into a consulting agreement, retroactive to May 16, 2017, with a certain consultant, pursuant to
which the consultant agreed to provide certain consulting and business advisory services in exchange for a $&lt;span id="xdx_905_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20170810__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember_zdMEwkoDhrF5" title="Convertible debt principal amount"&gt;310,000&lt;/span&gt; junior subordinated
convertible note. The maturity date of the August 10, 2017 Convertible Note was August 2019 and is currently past due (see Note 8). The
note accrues interest at a rate of &lt;span id="xdx_906_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20170810__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember_zHsGPhEkIvh9" title="Debt instrument, interest rate, stated percentage"&gt;10&lt;/span&gt;% per annum and is convertible into common stock at the lesser of $&lt;span id="xdx_90E_eus-gaap--DebtConversionConvertedInstrumentAmount1_pp0p0_c20170807__20170810__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember_zBByegCwFfaf" title="Debt conversion of converted amount"&gt;750&lt;/span&gt; or &lt;span id="xdx_90A_eus-gaap--DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_dp_uPure_c20170807__20170810__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember_zJcps9fyr4oh" title="Common stock trading volume, percent"&gt;65&lt;/span&gt;% of the three lowest
trades in the &lt;span id="xdx_906_eus-gaap--DebtInstrumentConvertibleThresholdTradingDays_dc_uInteger_c20170807__20170810__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember_zGmOAN9OUAw9" title="Common stock trading days"&gt;ten&lt;/span&gt; trading days prior to the conversion. The note was fully earned upon signing the agreement and matures on &lt;span id="xdx_909_eus-gaap--DebtInstrumentMaturityDate_dd_c20170807__20170810__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember_zyP7hAcsqzb6" title="Debt maturity date"&gt;August 10,
2019&lt;/span&gt;. The Company accrued $&lt;span id="xdx_906_eus-gaap--AccruedLiabilitiesCurrentAndNoncurrent_iI_pp0p0_c20170630__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember_zaaitofopWHl" title="Accrued expenses"&gt;155,000&lt;/span&gt; related to this expense at June 30, 2017 and recorded the remaining $&lt;span id="xdx_90A_eus-gaap--AccruedLiabilitiesCurrentAndNoncurrent_iI_pp0p0_c20180630__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember_zRQ09peme5id" title="Accrued expenses"&gt;155,000&lt;/span&gt; related to this expense
in fiscal year 2018. Upon an event of default, principal and accrued interest will become immediately due and payable under the note.
Additionally, upon an event of default, at the election of the holder, the note would accrue interest at a default interest rate of &lt;span id="xdx_90B_ecustom--DebtInstrumentDebtDefaultInterestRate_dp_uPure_c20170807__20170810__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember_zcUwSkiztpM2" title="Debt instrument, default, interest rate"&gt;18&lt;/span&gt;%
per annum or the highest rate of interest permitted by law. The consulting agreement had a three-month term and expired on August 16,
2017. An aggregate total of $&lt;span id="xdx_901_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_iI_pp0p0_c20170810__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember_zMHkB6YPayh3" title="Embedded derivative, fair value of embedded derivative liability"&gt;578,212&lt;/span&gt; of this note was bifurcated with the embedded conversion option recorded as a derivative liability
at fair value. During the year ended June 30, 2018, the consultant converted $&lt;span id="xdx_90F_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20180630__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ConsultantMember_zt0fOKSSrOwc" title="Convertible debt principal amount"&gt;140,000&lt;/span&gt; of principal and $&lt;span id="xdx_90A_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20180630__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ConsultantMember_zMhXsq0UfDqe" title="Accrued interest"&gt;10,764&lt;/span&gt; of interest. During the
year ended June 30, 2019, the consultant converted an additional $&lt;span id="xdx_902_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20190630__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ConsultantMember_zvWNRi3Fyayl" title="Convertible debt principal amount"&gt;161,000&lt;/span&gt; of principal and $&lt;span id="xdx_90B_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20190630__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ConsultantMember_z9Di3nlU5iTd" title="Accrued interest"&gt;19,418 &lt;/span&gt;of interest leaving a principal balance
owed of $&lt;span id="xdx_90A_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20190630__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember_znM13bvcFSY8" title="Convertible debt principal amount"&gt;9,000&lt;/span&gt; at June 30, 2019. During the year ended June 30, 2020, the consultant converted an additional $&lt;span id="xdx_902_eus-gaap--DebtConversionConvertedInstrumentAmount1_pp0p0_c20190701__20200630__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember_zrkFm4TR9TSb" title="Debt conversion of converted amount"&gt;500&lt;/span&gt; of principal and $&lt;span id="xdx_903_eus-gaap--AccruedLiabilitiesCurrentAndNoncurrent_iI_pp0p0_c20200630__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember_zViIFvWqXmf1" title="Accrued expenses"&gt;5,248&lt;/span&gt;
of interest such that the remaining principal outstanding and accrued interest under this note as of June 30, 2020 was $&lt;span id="xdx_90D_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20200630__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember_zNhyMipK3bs6" title="Convertible debt principal amount"&gt;8,500&lt;/span&gt; and $&lt;span id="xdx_900_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20200630__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember_zPMxfvm3VEyh" title="Accrued interest"&gt;22,168&lt;/span&gt;,
respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;On
March 15, 2021, the Company entered into a Settlement and Mutual Release Agreement (the &#x201c;Settlement Agreement&#x201d;) with the
consultant whereby both parties agreed to settle all claims and liabilities under the August 10, 2017 Convertible note for a total of
$&lt;span id="xdx_901_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20210315__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember__us-gaap--ShortTermDebtTypeAxis__custom--SettlementAndMutualReleaseAgreementMember_zX5bYvBALoPi" title="Convertible debt principal amount"&gt;100,000&lt;/span&gt; in the form of a convertible note. All other terms of the August 10, 2017 Convertible Note shall remain in full force and effect.
Both parties agree that all future penalties under this note are waived unless the Company fails to authorize to distribute the requested
shares upon conversion. The Company has the right to pay off the balance of any remaining amounts dues under this note in cash at any
time more than 60 days after March 15, 2021. Prior to the Settlement Agreement, the Company recorded total liabilities $&lt;span id="xdx_901_eus-gaap--Liabilities_iI_pp0p0_c20210315__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember__us-gaap--ShortTermDebtTypeAxis__custom--SettlementAndMutualReleaseAgreementMember_zsfI8VwYYoO8" title="Liabilities"&gt;56,762&lt;/span&gt; consisting
of remaining principal amount of $&lt;span id="xdx_901_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pp0p0_c20210315__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember__us-gaap--ShortTermDebtTypeAxis__custom--SettlementAndMutualReleaseAgreementMember_zBR1G1YGjlg7" title="Original issue discount"&gt;8,500&lt;/span&gt;, accrued interest of $&lt;span id="xdx_90C_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20210315__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember__us-gaap--ShortTermDebtTypeAxis__custom--SettlementAndMutualReleaseAgreementMember_z9lTGAIR1brb" title="Accrued interest"&gt;23,262&lt;/span&gt; and accrued expenses of $&lt;span id="xdx_902_eus-gaap--AccruedLiabilitiesCurrentAndNoncurrent_iI_pp0p0_c20210315__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember__us-gaap--ShortTermDebtTypeAxis__custom--SettlementAndMutualReleaseAgreementMember_zE7X1tZJDwK8" title="Accrued expenses"&gt;25,000&lt;/span&gt;. Accordingly, the Company recognized
loss from settlement of debt of $&lt;span id="xdx_902_eus-gaap--GainsLossesOnExtinguishmentOfDebt_pp0p0_c20200701__20210630__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember__us-gaap--ShortTermDebtTypeAxis__custom--SettlementAndMutualReleaseAgreementMember_zoqeBx07G0Ua" title="Loss from settlement of debt"&gt;43,238&lt;/span&gt; during the year ended June 30, 2021.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
total principal outstanding after adjustment due to the above-mentioned March 15, 2021 settlement agreement and accrued interest under
the August 10, 2017 Convertible Note was $&lt;span id="xdx_907_eus-gaap--ConvertibleNotesPayable_iI_pp0p0_c20210630__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember__us-gaap--ShortTermDebtTypeAxis__custom--SettlementAndMutualReleaseAgreementMember_zMbLpH92Hkg"&gt;80,000&lt;/span&gt; and $&lt;span id="xdx_906_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20210630__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember__us-gaap--ShortTermDebtTypeAxis__custom--SettlementAndMutualReleaseAgreementMember_zlG84V2LUGeg"&gt;3,738&lt;/span&gt;, respectively, as of June 30, 2021 following conversion of $&lt;span id="xdx_902_eus-gaap--DebtConversionConvertedInstrumentAmount1_pp0p0_c20200701__20210630__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember__us-gaap--ShortTermDebtTypeAxis__custom--SettlementAndMutualReleaseAgreementMember_z4opLBtZGvtc"&gt;20,000&lt;/span&gt; of principal
during the year ended June 30, 2021. The total principal amount outstanding under the August 10, 2017 Convertible Note was $&lt;span id="xdx_900_eus-gaap--ConvertibleNotesPayable_iI_pp0p0_c20210930__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember__us-gaap--ShortTermDebtTypeAxis__custom--SettlementAndMutualReleaseAgreementMember_zrpiKNB5yqQ7"&gt;80,000&lt;/span&gt; and
accrued interest of $&lt;span id="xdx_900_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20210930__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember__us-gaap--ShortTermDebtTypeAxis__custom--SettlementAndMutualReleaseAgreementMember_zhUGxkUaTiWb"&gt;7,381&lt;/span&gt; as of as of September 30, 2021.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Auctus
Fund Financing Agreements&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;i&gt;August
30, 2019 Securities Purchase Agreement&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Effective
August 30, 2019, the Company entered into a securities purchase agreement with Auctus Fund, LLC (&#x201c;Auctus&#x201d;), pursuant to which
Auctus purchased a convertible promissory note (the &#x201c;August 30, 2019 Auctus Note&#x201d;) from the Company in the aggregate principal
amount of $&lt;span id="xdx_90A_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20190830__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_zV8IsENUgnMc" title="Convertible debt principal amount"&gt;550,000&lt;/span&gt;, such principal and the interest thereon convertible into shares of the Company&#x2019;s common stock at the option
of Auctus. The transaction closed on August 30, 2019 and the Company received payment on September 4, 2019 in the amount of $&lt;span id="xdx_903_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20190904__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_zmX45L2RKm67" title="Convertible debt principal amount"&gt;550,000&lt;/span&gt;,
of which $&lt;span id="xdx_909_eus-gaap--LegalFees_pp0p0_c20190903__20190904__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_zM4ZDYGnUbY3" title="Legal fees"&gt;5,000&lt;/span&gt; was paid directly toward legal fees and $&lt;span id="xdx_903_ecustom--DiligenceFees_c20190903__20190904__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_zqsWa63arAJ7" title="Diligence fees"&gt;40,000&lt;/span&gt; to Auctus for due diligence fees resulting in net cash proceeds of $&lt;span id="xdx_90F_eus-gaap--ProceedsFromConvertibleDebt_pp0p0_c20190903__20190904__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_zr4THCD44Xg1" title="Proceeds from convertible debt"&gt;505,000&lt;/span&gt;.
The maturity date of the August 30, 2019 Auctus Note was &lt;span id="xdx_90E_eus-gaap--DebtInstrumentMaturityDate_dd_c20190829__20190830__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_zDR9BpwAdgR3" title="Debt maturity date"&gt;August 30, 2020&lt;/span&gt; and was currently past due. The August 30, 2019 Auctus Note
bore interest at a rate of &lt;span id="xdx_900_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20190830__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_zkdy5Q17THL2" title="Debt instrument, interest rate, stated percentage"&gt;10&lt;/span&gt;% per annum, but not payable until the August 30, 2019 Auctus Note became payable, whether at the maturity
date or upon acceleration or by prepayment. The note was treated as stock settled debt under ASC 480 and accordingly the Company recorded
a $&lt;span id="xdx_903_eus-gaap--DebtInstrumentUnamortizedPremium_iI_pp0p0_c20190830__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_zRiHwC088mR2" title="Debt premium amount"&gt;366,667&lt;/span&gt; put premium. The August 30, 2019 Auctus Note may not be prepaid without the written consent of Auctus. Any amount of principal
or interest which was not paid when due shall bear interest at the rate of &lt;span id="xdx_908_ecustom--DebtInstrumentDebtDefaultInterestRate_dp_uPure_c20190829__20190830__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_zHKxsto7eDza" title="Debt instrument, default, interest rate"&gt;24&lt;/span&gt;% per annum.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Additionally,
Auctus had the option to convert all or any amount of the principal face amount and accrued interest of the August 30, 2019 Auctus Note,
at any time following the issue date and ending on the later of the maturity date or the date of payment of the Default Amount if an
event of default occurs, which was an amount equal to &lt;span id="xdx_90D_ecustom--PercentageOfOutstandingSharesOfCommonStock_dp_uPure_c20190829__20190830__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_zTkSILK2Z3fc" title="Percentage of outstanding shares of common stock"&gt;125&lt;/span&gt;% of an amount equal to the then outstanding principal amount of the August
30, 2019 Auctus Note (but not less than $15,000) plus any interest accrued from August 30, 2019 at the default interest rate of &lt;span id="xdx_907_ecustom--DebtInstrumentDebtDefaultInterestRate_dp_uPure_c20190829__20190830__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_zfhrvGYHWUR1" title="Debt instrument, default, interest rate"&gt;24&lt;/span&gt;% per
annum, for shares of the Company&#x2019;s common stock at the then-applicable conversion price. Upon the holder&#x2019;s election to convert
accrued interest, default interest or any penalty amounts as stipulated, the Company may elect to pay those amounts in cash. The note
may also be prepaid by the Company at any time between the date of issuance and August 13, 2020 at 135% multiplied by the sum of (a)
the then outstanding principal amount plus (b) accrued and unpaid interest plus (c) default interests, if any.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
conversion price for the August 30, 2019 Auctus Note was equal to the Variable Conversion Price of &lt;span id="xdx_908_eus-gaap--DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_dp_uPure_c20190903__20190904__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_zXKSok3ltqR6" title="Common stock trading volume, percent"&gt;60&lt;/span&gt;% of the Market Price on the date
of conversion. Notwithstanding the foregoing, Auctus shall be restricted from effecting a conversion if such conversion, along with other
shares of the Company&#x2019;s common stock beneficially owned by Auctus and its affiliates, exceeds &lt;span id="xdx_90E_ecustom--PercentageOfOutstandingSharesOfCommonStock_dp_uPure_c20190903__20190904__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_zH6BNNz0fSne" title="Percentage of outstanding shares of common stock"&gt;4.99&lt;/span&gt;% of the outstanding shares of
the Company&#x2019;s common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;PROPANC
BIOPHARMA, INC. AND SUBSIDIARY&lt;br/&gt;
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&lt;br/&gt;
SEPTEMBER 30, 2021&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;(Unaudited)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;In
connection with the issuance of the August 2019 Auctus Note, the Company issued common stock purchase warrants to Auctus to purchase
&lt;span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20190830__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember__us-gaap--StatementEquityComponentsAxis__custom--FirstWarrantMember_zpcbk22qeGsg" title="Warrants to purchase of common stock, shares"&gt;450&lt;/span&gt; shares of the Company&#x2019;s common stock (the &#x201c;First Warrant&#x201d;) as a commitment fee upon the terms and subject to the
limitations and conditions set forth in such First Warrant at an &#x201c;Exercise Price&#x201d; of $&lt;span id="xdx_908_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20190830__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember__us-gaap--StatementEquityComponentsAxis__custom--FirstWarrantMember_zeOwLVNv5Yi7" title="Warrants exercise price per share"&gt;2,250&lt;/span&gt;. In connection with the issuance
of the Note, the Company issued a common stock purchase warrant to Buyer to purchase &lt;span id="xdx_907_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20190830__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember__us-gaap--StatementEquityComponentsAxis__custom--SecondWarrantMember_zRTJsLcNKxb1" title="Warrants to purchase of common stock, shares"&gt;300&lt;/span&gt; shares of the Company&#x2019;s common stock (the
&#x201c;Second Warrant&#x201d;) as a commitment fee upon the terms and subject to the limitations and conditions set forth in such Second
Warrant at an &#x201c;Exercise Price&#x201d; of $&lt;span id="xdx_90C_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20190830__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember__us-gaap--StatementEquityComponentsAxis__custom--SecondWarrantMember_zrIQtzyExSJ" title="Warrants exercise price per share"&gt;3,330&lt;/span&gt;. In connection with the issuance of the Note, the Company shall issue a common stock
purchase warrant to Buyer to purchase &lt;span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20190830__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember__us-gaap--StatementEquityComponentsAxis__custom--ThirdWarrantMember_zAKe3tNeY5C6" title="Warrants to purchase of common stock, shares"&gt;225&lt;/span&gt; shares of the Company&#x2019;s common stock (the &#x201c;Third Warrant&#x201d;) as a commitment
fee upon the terms and subject to the limitations and conditions set forth in such Third Warrant at an &#x201c;Exercise Price&#x201d; of
$&lt;span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20190830__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember__us-gaap--StatementEquityComponentsAxis__custom--ThirdWarrantMember_zBKfggn3dT37" title="Warrants exercise price per share"&gt;4,500&lt;/span&gt;. The First Warrant, Second Warrant, and Third Warrant were collectively be referred as the &#x201c;Warrants&#x201d;. The Warrants
have an &#x201c;Exercise Period&#x201d; of five years from the date of issuance being August 30, 2019. Under the terms of the Purchase
Agreement and the Warrants, the Selling Security Holder may not either convert the Notes nor exercise the Warrants to the extent (but
only to the extent) that the Selling Security Holder or any of its affiliates would beneficially own a number of shares of our Common
Stock which would exceed &lt;span id="xdx_904_ecustom--PercentageOfOutstandingSharesOfCommonStock_dp_uPure_c20190701__20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_zhyEK3pmLq55" title="Percentage of outstanding shares of common stock"&gt;4.99&lt;/span&gt;% of our outstanding shares. The Company accounted for the warrants by using the relative fair value method
and recorded debt discount from the relative fair value of the warrants of $&lt;span id="xdx_901_eus-gaap--FairValueAdjustmentOfWarrants_pp0p0_c20190829__20190830__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_zHrxPgIwkxO6" title="Fair value of warrants"&gt;375,905&lt;/span&gt; using a simple binomial lattice model.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;In
connection with the Purchase Agreement, the Company and the Purchaser entered into a Registration Rights Agreement (the &#x201c;Registration
Rights Agreement&#x201d;). Pursuant to the Registration Rights Agreement, the Company agreed to register the shares of Common Stock underlying
the Securities in a Registration Statement with the SEC as well as the Commitment Shares (as defined herein). The Registration Rights
Agreement contains customary representations, warranties, agreements and indemnification rights and obligations of the parties.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Note was subject to customary default provisions and also includes a cross-default provision which provides that a breach or default
by the Borrower of any covenant or other term or condition contained in any of the Other Agreements (as defined therein), after the passage
of all applicable notice and cure or grace periods, shall, at the option of the Holder, be considered a default under this Note and the
Other Agreements. Upon occurrence of any such event, the Holder was entitled (but in no event required) to apply all rights and remedies
of the Holder under the terms of this Note and the Other Agreements by reason of a default under said Other Agreements or the Note.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
August 30, 2019 Auctus Note contained certain events of default, upon which principal and accrued interest will become immediately due
and payable. In addition, upon an event of default, interest on the outstanding principal accrued at a default interest rate of 24% per
annum.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
total principal amount outstanding under the above Auctus financing agreement, specifically the August 30, 2019 Auctus Note, was $&lt;span id="xdx_90E_eus-gaap--DebtInstrumentFaceAmount_iI_c20190630__us-gaap--TypeOfArrangementAxis__custom--AuctusFinancingAgreementMember_zu1KVqEJdIm6"&gt;358,965&lt;/span&gt;
and accrued interest of $&lt;span id="xdx_90F_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_zfTyoyOT5roe" title="Accrued interest"&gt;486&lt;/span&gt; as of June 30, 2020 following conversion of $&lt;span id="xdx_908_eus-gaap--DebtConversionConvertedInstrumentAmount1_pp0p0_c20190701__20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_zYryjWAnVksd" title="Debt conversion of converted amount"&gt;191,035&lt;/span&gt; of the principal balance and $&lt;span id="xdx_903_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20200630__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_z0TW5PAWVlu" title="Accrued interest"&gt;43,176&lt;/span&gt; of accrued interest
during the year ended June 30, 2020. Accordingly, $&lt;span id="xdx_90C_eus-gaap--DebtInstrumentUnamortizedPremium_iI_pp0p0_c20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_zerbcq66mLU1" title="Debt premium amount"&gt;127,356&lt;/span&gt; of the put premium was released in respect of the August 30, 2019 Auctus Note
during the year ended June 30, 2020 following conversion of the principal balance.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
total principal amount outstanding under the above Auctus financing agreement, specifically the August 30, 2019 Auctus Note, was $&lt;span id="xdx_902_eus-gaap--DebtInstrumentFaceAmount_iI_c20210630__us-gaap--TypeOfArrangementAxis__custom--AuctusFinancingAgreementMember_z204cLvGUN53"&gt;32,848&lt;/span&gt;
and accrued interest of $&lt;span id="xdx_906_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_z1fqVwhhr6Q9"&gt;0&lt;/span&gt; as of June 30, 2021 following conversion of $&lt;span id="xdx_90C_eus-gaap--DebtConversionConvertedInstrumentAmount1_pp0p0_c20200701__20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_z4cgVEaFq4xf"&gt;326,117&lt;/span&gt; of the principal balance and $&lt;span id="xdx_90B_ecustom--DebtConversionConvertedInterestPayable_pp0p0_c20200701__20210630__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_zh48bNCa2wFg"&gt;39,536&lt;/span&gt; of accrued interest
during the year ended June 30, 2021. Accordingly, $&lt;span id="xdx_908_eus-gaap--DebtInstrumentUnamortizedPremium_iI_pp0p0_c20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_zG2iHHvRnVEa"&gt;217,411&lt;/span&gt; of the put premium was released in respect of the August 30, 2019 Auctus Note
during the year ended June 30, 2021 following conversion of the principal balance.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
total principal amount outstanding under the above Auctus financing agreement, specifically the August 30, 2019 Auctus Note, was $&lt;span id="xdx_903_eus-gaap--DebtInstrumentFaceAmount_iI_c20210930__us-gaap--TypeOfArrangementAxis__custom--AuctusFinancingAgreementMember_zxfOWZcGYCKf" title="Convertible debt principal amount"&gt;0&lt;/span&gt; and
accrued interest of $&lt;span id="xdx_90E_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20210930__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_zFwYUbViB34h" title="Accrued interest"&gt;0&lt;/span&gt; as of September 30, 2021 following conversion of $&lt;span id="xdx_90A_eus-gaap--DebtConversionConvertedInstrumentAmount1_pp0p0_c20210701__20210930__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_zUicSgLdvtrj" title="Debt conversion of converted amount"&gt;32,848&lt;/span&gt; of the principal balance and $&lt;span id="xdx_900_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20210930__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_ztM82l9WU34i" title="Debt conversion of accrued interest"&gt;716&lt;/span&gt; of accrued interest
during the three months ended September 30, 2021. Accordingly, $&lt;span id="xdx_904_eus-gaap--DebtInstrumentUnamortizedPremium_iI_pp0p0_c20210930__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_z55t0Mkeh9v" title="Debt premium amount"&gt;21,899&lt;/span&gt; of the put premium was released in respect of the August 30, 2019
Auctus Note during the three months ended September 30, 2021 following conversion of the principal balance. Accordingly, there was no
outstanding principal balance as of September 30, 2021.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Crown
Bridge Securities Purchase Agreements&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Effective
October 3, 2019, the Company entered into a securities purchase agreement with Crown Bridge Partners, pursuant to which Crown Bridge
purchased a convertible promissory note (the &#x201c;October 3, 2019 Crown Bridge Note&#x201d;) from the Company in the aggregate principal
amount of $&lt;span id="xdx_90F_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20191003__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember_zXZUNdqIui1g" title="Convertible debt principal amount"&gt;108,000&lt;/span&gt;, such principal and the interest thereon convertible into shares of the Company&#x2019;s common stock at the option
of Crown Bridge any time from the of issuance of the of the October 3, 2019 Crown Bridge Note. The transactions contemplated by the Crown
Bridge Securities Purchase Agreement closed on October 3, 2019. Pursuant to the terms of the Crown Bridge Securities Purchase Agreement,
Crown Bridge deducted $&lt;span id="xdx_900_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_pp0p0_c20191001__20191003__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember_zhXRStu3jAN6" title="Debt instrument principal payment"&gt;3,000&lt;/span&gt; from the principal payment due under the October 3, 2019 Crown Bridge Note, at the time of closing, to be
applied to its legal expenses, and there was a $&lt;span id="xdx_901_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pp0p0_c20191003__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember_zetTnujDFiNf" title="Original issue discount"&gt;5,000&lt;/span&gt; original issuance discount resulting in $&lt;span id="xdx_903_eus-gaap--ProceedsFromConvertibleDebt_pp0p0_c20191001__20191003__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember_z0CsAu11Ipuf" title="Proceeds from convertible debt"&gt;100,000&lt;/span&gt; net proceeds to the Company. The
Company intends to use the net proceeds from the October 3, 2019 Crown Bridge Note for general working capital purposes. The maturity
date of the October 3, 2019 Crown Bridge was October 3, 2020 and is currently past due. The &lt;span id="xdx_903_eus-gaap--DebtInstrumentMaturityDate_dd_c20191001__20191003__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember_zoae1JxdAsQh" title="Debt maturity date"&gt;October 3, 2019&lt;/span&gt; Crown Bridge Note bears interest
at a rate of &lt;span id="xdx_90B_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20191003__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember_zQQ255xvCjDc" title="Debt instrument, interest rate, stated percentage"&gt;10&lt;/span&gt;% per annum, which interest may be paid by the Company to Crown Bridge in shares of the Company&#x2019;s common stock;
but shall not be payable until the October 2019 Crown Bridge Note becomes payable, whether at the maturity date or upon acceleration
or by prepayment.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;PROPANC
BIOPHARMA, INC. AND SUBSIDIARY&lt;br/&gt;
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&lt;br/&gt;
SEPTEMBER 30, 2021&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;(Unaudited)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Additionally,
Crown Bridge has the option to convert all or any amount of the principal face amount of the October 3, 2019 Crown Bridge Note at any
time from the date of issuance and ending on the later of the maturity date or the date the Default Amount is paid if an event of default
occurs, which is an amount between &lt;span id="xdx_90B_ecustom--DebtInstrumentDebtDefaultInterestRate_pid_dp_uPure_c20191001__20191003__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember__srt--RangeAxis__srt--MinimumMember_znQ30TSyPxg2" title="Debt instrument, default, interest rate"&gt;110&lt;/span&gt;% and &lt;span id="xdx_909_ecustom--DebtInstrumentDebtDefaultInterestRate_pid_dp_uPure_c20191001__20191003__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember__srt--RangeAxis__srt--MaximumMember_zzQvuvFG1Mpb" title="Debt instrument, default, interest rate"&gt;150&lt;/span&gt;% of an amount equal to the then outstanding principal amount of the October 3, 2019 Crown
Bridge Note plus any interest accrued, for shares of the Company&#x2019;s common stock at the then-applicable conversion price.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90A_eus-gaap--DebtInstrumentDescription_c20191001__20191003__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember_zoS7xQeAQNu4"&gt;The
conversion price for the October 3, 2019 Crown Bridge Note shall be equal to a 40% discount of the lowest closing bid price (&#x201c;Lowest
Trading Price&#x201d;) of the Common Stock for the ten trading days immediately prior to the delivery of a Notice of Conversion, including
the day upon which a Notice of Conversion is received. Notwithstanding the foregoing, Crown Bridge shall be restricted from effecting
a conversion if such conversion, along with other shares of the Company&#x2019;s common stock beneficially owned by Crown Bridge and its
affiliates, exceeds &lt;span id="xdx_904_ecustom--PercentageOfOutstandingSharesOfCommonStock_pid_dp_uPure_c20191001__20191003__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember__srt--RangeAxis__srt--MinimumMember_zRdEc6aixyRc" title="Percentage of outstanding shares of common stock"&gt;4.99&lt;/span&gt;% of the outstanding shares of the Company&#x2019;s common stock which may be increased up to &lt;span id="xdx_90F_ecustom--PercentageOfOutstandingSharesOfCommonStock_pid_dp_uPure_c20191001__20191003__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember__srt--RangeAxis__srt--MaximumMember_zhtu86bdy1Sk" title="Percentage of outstanding shares of common stock"&gt;9.99&lt;/span&gt;% upon 60 days
prior written notice by the Crown Bridge to the Company. The note is treated as stock settled debt under ASC 480 and accordingly the
Company recorded a $&lt;span id="xdx_904_eus-gaap--DebtInstrumentUnamortizedPremium_iI_pp0p0_c20191003__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember_zBHIVjm47c4k" title="Debt premium amount"&gt;72,000&lt;/span&gt; put premium.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
October 3, 2019 Crown Bridge Note contain certain events of default, upon which principal and accrued interest will become immediately
due and payable. In addition, upon an event of default, interest on the outstanding principal shall accrue at a default interest rate
of &lt;span id="xdx_90E_ecustom--DebtInstrumentDebtDefaultInterestRate_pid_dp_uPure_c20191001__20191003__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember_zOHqQWtgwzRh" title="Debt instrument, default, interest rate"&gt;15&lt;/span&gt;% per annum, or if such rate is usurious or not permitted by current law, then at the highest rate of interest permitted by law.
Further, certain events of default may trigger penalty and liquidated damage provisions.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
total principal amount outstanding under the above Crown Bridge financing agreement was $&lt;span id="xdx_904_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember_zdFkwsqeea91" title="Convertible debt principal amount"&gt;65,280&lt;/span&gt; and accrued interest of $&lt;span id="xdx_90E_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember_z34GfxgvFSQ" title="Accrued interest"&gt;7,232&lt;/span&gt; as of
as of June 30, 2020 following conversion of $&lt;span id="xdx_905_eus-gaap--DebtConversionConvertedInstrumentAmount1_pp0p0_c20190701__20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember_zEZy8QoDC4Vd" title="Debt conversion of converted amount"&gt;42,720&lt;/span&gt; of the principal balance during the year ended June 30, 2020. Accordingly, $&lt;span id="xdx_908_eus-gaap--DebtInstrumentUnamortizedPremium_iI_pp0p0_c20200630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember_zded0iHOmySh" title="Debt premium amount"&gt;28,480&lt;/span&gt;
of the put premium was released in respect of the October 3, 2019 Crown Bridge Note during the year ended June 30, 2020 following conversion
of the principal balance.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;There
were &lt;span id="xdx_909_ecustom--UnissuedSharesConversion_c20200915__20200916__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember_zXlDsNhWk6Je" title="Unissued shares conversion"&gt;15,000&lt;/span&gt; unissued shares which were considered issuable for accounting purposes during the 1&lt;sup&gt;st&lt;/sup&gt; quarter of fiscal 2021 related
to a conversion notice dated and received on September 16, 2020. In November 2020, the Company was notified by the note holder of the
cancellation of this conversion notice as a result of the reverse stock split and as such the Company reversed the effects of this transaction
thereby increasing the principal balance by $&lt;span id="xdx_90D_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20201130__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember_zy32wXzjQvLj" title="Convertible debt principal amount"&gt;9,600&lt;/span&gt; and put premium by $&lt;span id="xdx_907_eus-gaap--DebtInstrumentUnamortizedPremium_iI_pp0p0_c20201130__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember_zq3jN7FvTuX2" title="Debt premium amount"&gt;6,400&lt;/span&gt; and a corresponding decrease in equity of $&lt;span id="xdx_90E_ecustom--DueToEquityConversion_iI_pp0p0_c20201130__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember_zUybJvNFcnPb" title="Due to equity conversion"&gt;16,000&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
total principal amount outstanding under the above Crown Bridge financing agreement was $&lt;span id="xdx_90F_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember_zOJBdPnY5H41" title="Convertible debt principal amount"&gt;65,280&lt;/span&gt; and accrued interest of $&lt;span id="xdx_909_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember_zodzjcK19hV8" title="Accrued interest"&gt;16,138&lt;/span&gt;
as of June 30, 2021. The total principal amount outstanding under the above Crown Bridge financing agreement was $&lt;span id="xdx_902_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20210930__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember_zLpmI8hWX2ka"&gt;65,280&lt;/span&gt; and accrued
interest of $&lt;span id="xdx_902_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20210930__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberThreeTwoThousandNineteenAuctusNoteMember_zOnEQT0IP02c"&gt;18,606&lt;/span&gt; as of as of September 30, 2021.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;GW
Holdings Securities Purchase Agreements&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;i&gt;December
10, 2020 Securities Purchase Agreement&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Effective
December 10, 2020, the Company entered into a securities purchase agreement with GW Holdings, pursuant to which GW Holdings purchased
a convertible promissory note (the &#x201c;December 10, 2020 GW Note&#x201d;) from the Company in the aggregate principal amount of $&lt;span id="xdx_903_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20201210__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--DecemberTenTwoThousandTwentyGWNoteMember_zMtcOjSqoMlg" title="Convertible debt principal amount"&gt;131,000&lt;/span&gt;,
such principal and the interest thereon convertible into shares of the Company&#x2019;s common stock at the option of GW Holdings anytime
from the issuance of the December 10, 2020 GW Holdings Note. The transactions contemplated by the GW Holdings Securities Purchase Agreement
closed on December 10, 2020. Pursuant to the terms of the GW Holdings Securities Purchase Agreement, the lender deducted $&lt;span id="xdx_900_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_pp0p0_c20201209__20201210__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--DecemberTenTwoThousandTwentyGWNoteMember_zmu64tgjRdE9" title="Debt instrument principal payment"&gt;6,000&lt;/span&gt; from
the principal payment due under the December 10, 2020 GW Note, at the time of closing, to be applied to its legal expenses. The Company
intends to use the net proceeds of $&lt;span id="xdx_90F_eus-gaap--ProceedsFromConvertibleDebt_pp0p0_c20201209__20201210__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--DecemberTenTwoThousandTwentyGWNoteMember_zu5jh9QSR7A2" title="Proceeds from convertible debt"&gt;125,000&lt;/span&gt; from the December 10, 2020 GW Note for general working capital purposes. The maturity date
of the December 10, 2020 GW Holdings is &lt;span id="xdx_904_eus-gaap--DebtInstrumentMaturityDate_dd_c20201209__20201210__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--DecemberTenTwoThousandTwentyGWNoteMember_zdVj5PT9Jq14" title="Debt maturity date"&gt;December 10, 2021&lt;/span&gt;. The December 10, 2020 GW Holdings Note bears interest at a rate of &lt;span id="xdx_902_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20201210__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--DecemberTenTwoThousandTwentyGWNoteMember_zqOjTWqM9AJk" title="Debt instrument, interest rate, stated percentage"&gt;8&lt;/span&gt;% per
annum, which interest may be paid by the Company to GW Holdings in shares of the Company&#x2019;s common stock; but shall not be payable
until the December 10, 2020 GW Holdings Note becomes payable, whether at the maturity date or upon acceleration or by prepayment.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
above notes issued to GW Holdings contain certain events of default, upon which principal and accrued interest will become immediately
due and payable. In addition, upon an event of default, interest on the outstanding principal shall accrue at a default interest rate
of &lt;span id="xdx_90B_ecustom--DebtInstrumentDebtDefaultInterestRate_dp_uPure_c20201209__20201210__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--DecemberTenTwoThousandTwentyGWNoteMember_zq1TRF6QimY" title="Debt instrument, default, interest rate"&gt;24&lt;/span&gt;% per annum, or if such rate is usurious or not permitted by current law, then at the highest rate of interest permitted by law.
Further, certain events of default may trigger penalty and liquidated damage provisions.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Additionally,
GW Holdings has the option to convert all or any amount of the principal face amount of the notes issued to GW Holdings at any time from
the date of issuance and ending on the later of the maturity date or the date the Default Amount is paid if an event of default occurs,
which is an amount between &lt;span id="xdx_906_ecustom--DebtInstrumentDebtDefaultInterestRate_dp_uPure_c20201209__20201210__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--DecemberTenTwoThousandTwentyGWNoteMember__srt--RangeAxis__srt--MinimumMember_z466YXX0CMg6" title="Debt instrument, default, interest rate"&gt;110&lt;/span&gt;% and &lt;span id="xdx_901_ecustom--DebtInstrumentDebtDefaultInterestRate_dp_uPure_c20201209__20201210__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--DecemberTenTwoThousandTwentyGWNoteMember__srt--RangeAxis__srt--MaximumMember_zmnjePezzi72" title="Debt instrument, default, interest rate"&gt;150&lt;/span&gt;% of an amount equal to the then outstanding principal amount of such notes plus any interest
accrued, for shares of the Company&#x2019;s common stock at the then-applicable conversion price.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;PROPANC
BIOPHARMA, INC. AND SUBSIDIARY&lt;br/&gt;
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&lt;br/&gt;
SEPTEMBER 30, 2021&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;(Unaudited)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_903_eus-gaap--DebtInstrumentDescription_c20201209__20201210__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--DecemberTenTwoThousandTwentyGWNoteMember"&gt;The
conversion price for the above GW Holdings notes shall be equal to a 40% discount of the lowest closing bid price (&#x201c;Lowest Trading
Price&#x201d;) of the Common Stock for the ten trading days immediately prior to the delivery of a Notice of Conversion, including the
day upon which a Notice of Conversion is received. Notwithstanding the foregoing, GW Holdings shall be restricted from effecting a conversion
if such conversion, along with other shares of the Company&#x2019;s common stock beneficially owned by GW Holdings and its affiliates,
exceeds &lt;span id="xdx_908_ecustom--PercentageOfOutstandingSharesOfCommonStock_dp_uPure_c20201209__20201210__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--DecemberTenTwoThousandTwentyGWNoteMember_zfol6OLSWkHl"&gt;4.99&lt;/span&gt;% of the outstanding shares of the Company&#x2019;s common stock which may be increased up to 9.99% upon 60 days prior written
notice by the GW Holdings to the Company.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;These
notes are treated as stock settled debt under ASC 480 and accordingly the Company recorded a total of $&lt;span id="xdx_908_eus-gaap--DebtInstrumentUnamortizedPremium_iI_pp0p0_c20201210__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember_z8VirPDudh83"&gt;87,333&lt;/span&gt; put premium.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
total principal amount outstanding under the above December 10, 2020 GW Holdings financing agreement, was $&lt;span id="xdx_90C_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20200930__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--DecemberTenTwoThousandTwentyGWNoteMember_zvG2tpfICtk5" title="Convertible debt principal amount"&gt;90,000&lt;/span&gt; and accrued interest
of $&lt;span id="xdx_90B_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20200930__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--DecemberTenTwoThousandTwentyGWNoteMember_zwYws47GK557" title="Accrued interest"&gt;4,636&lt;/span&gt; as of June 30, 2021 following conversion of $&lt;span id="xdx_909_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--DecemberTenTwoThousandTwentyGWNoteMember_zXR3wCXR2ii3" title="Convertible debt principal amount"&gt;41,000&lt;/span&gt; of the principal balance and $&lt;span id="xdx_905_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--DecemberTenTwoThousandTwentyGWNoteMember_z1FNGBZ4TcMj" title="Accrued interest"&gt;1,084&lt;/span&gt; of accrued interest during the year
ended June 30, 2021. Accordingly, $&lt;span id="xdx_908_eus-gaap--DebtInstrumentUnamortizedPremium_iI_pp0p0_c20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--DecemberTenTwoThousandTwentyGWNoteMember_zlSogXBHc4dd"&gt;27,333&lt;/span&gt; of the put premium was reclassed to additional paid in capital in respect of the October 1,
2019 GW Holdings Note during the year ended June 30, 2021 following conversion of the principal balance.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
total principal amount outstanding under the above December 10, 2020 GW Holdings financing agreement, was $&lt;span id="xdx_907_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20210930__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--DecemberTenTwoThousandTwentyGWNoteMember_zzpkMkBnkq3l"&gt;65,000&lt;/span&gt; and accrued interest
of $&lt;span id="xdx_90A_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20210930__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--DecemberTenTwoThousandTwentyGWNoteMember_z7eA13hE3B25"&gt;4,174&lt;/span&gt; as of September 30, 2021 following conversion of $&lt;span id="xdx_908_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20210930__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--DecemberTenTwoThousandTwentyGWNoteMember_zVSSWJquEqpe"&gt;25,000&lt;/span&gt; of the principal balance and $&lt;span id="xdx_900_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20210930__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--DecemberTenTwoThousandTwentyGWNoteMember_zxVIWppMhhGa"&gt;2,091&lt;/span&gt; of accrued interest during the
three months ended September 30, 2021. Accordingly, $&lt;span id="xdx_908_eus-gaap--DebtInstrumentUnamortizedPremium_iI_pp0p0_c20210930__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GWHoldingsGroupLLCMember__us-gaap--DebtInstrumentAxis__custom--DecemberTenTwoThousandTwentyGWNoteMember_zbFlv2euddve"&gt;16,667&lt;/span&gt; of the put premium was reclassed to additional paid in capital in respect
of the October 1, 2019 GW Holdings Note during the three months ended September 30, 2021 following conversion of the principal balance.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Geneva
Roth Remark Securities Purchase Agreements&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;i&gt;January
5, 2021 Securities Purchase Agreement&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Effective
January 5, 2021, the Company entered into a securities purchase agreement with Geneva Roth Remark Holdings, Inc., pursuant to which Geneva
Roth purchased a convertible promissory note (the &#x201c;January 5, 2021 Geneva Roth&#x201d;) from the Company in the aggregate principal
amount of $&lt;span id="xdx_905_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20210105__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--JanuaryFiveTwoThousandTwentyOneGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember_zNMXuLqV0FHa" title="Convertible debt principal amount"&gt;68,500&lt;/span&gt;, such principal and the interest thereon convertible into shares of the Company&#x2019;s common stock at the option
of Geneva Roth any time after the six-month anniversary of the January 5, 2021 Geneva Roth. The January 5, 2021 Geneva Roth contained
an original issue discount of $&lt;span id="xdx_904_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pp0p0_c20210105__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--JanuaryFiveTwoThousandTwentyOneGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember_zxUbSVxlT5Ch"&gt;3,500&lt;/span&gt;. The Company intended to use the net proceeds from the January 5, 2021 Geneva Roth for general working
capital purposes. The maturity date of the January 5, 2021 Geneva Roth Note was January 5, 2022. The January 5, 2021 Geneva Roth Note
bore interest at a rate of &lt;span id="xdx_90D_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20201202__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--JanuaryFiveTwoThousandTwentyOneGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember_z8prCVROnlg6"&gt;8&lt;/span&gt;% per annum, which interest may be paid by the Company to Geneva Roth in shares of the Company&#x2019;s common
stock; but shall not be payable until the January 5, 2021 Geneva Roth Note becomes payable, whether at the maturity date or upon acceleration
or by prepayment.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;i&gt;March
16, 2021 Securities Purchase Agreement&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Effective
March 16, 2021, the Company entered into a securities purchase agreement with Geneva Roth Remark Holdings, Inc., pursuant to which Geneva
Roth purchased a convertible promissory note (the &#x201c;March 16, 2021 Geneva Roth&#x201d;) from the Company in the aggregate principal
amount of $&lt;span id="xdx_902_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20210316__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--MarchSixteenTwoThousandTwentyOneGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember_zRQ6XM5pGns4" title="Convertible debt principal amount"&gt;63,500&lt;/span&gt;, such principal and the interest thereon convertible into shares of the Company&#x2019;s common stock at the option
of Geneva Roth any time after the six-month anniversary of the March 16, 2021 Geneva Roth. The March 16, 2021 Geneva Roth contained an
original discount of $&lt;span id="xdx_906_eus-gaap--DebtConversionOriginalDebtAmount1_pp0p0_c20210315__20210316__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--MarchSixteenTwoThousandTwentyOneGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember_zzskKUm0Wwrd" title="Debt conversion, original debt amount"&gt;3,500&lt;/span&gt;. The Company intended to use the net proceeds from the March 16, 2021 Geneva Roth for general working capital
purposes. The maturity date of the March 16, 2021 Geneva Roth Note was March 16, 2022. The March 16, 2021 Geneva Roth Note bears interest
at a rate of &lt;span id="xdx_90B_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20210316__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--MarchSixteenTwoThousandTwentyOneGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember_za2yJLfmOH5c" title="Debt instrument, interest rate, stated percentage"&gt;8&lt;/span&gt;% per annum, which interest may be paid by the Company to Geneva Roth in shares of the Company&#x2019;s common stock; but
shall not be payable until the March 16, 2021 Geneva Roth Note becomes payable, whether at the maturity date or upon acceleration or
by prepayment.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;i&gt;August
19, 2021 Securities Purchase Agreement&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Effective
August 19, 2021, the Company entered into a securities purchase agreement with Geneva Roth Remark Holdings, Inc., pursuant to which Geneva
Roth purchased a convertible promissory note (the &#x201c;August 19, 2021 Geneva Roth&#x201d;) from the Company in the aggregate principal
amount of $&lt;span id="xdx_901_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20210819__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--AugustNineteenTwoThousandTwentyOneGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember_ztnbtalxNhr3"&gt;103,750&lt;/span&gt;, such principal and the interest thereon convertible into shares of the Company&#x2019;s common stock at the option
of Geneva Roth any time after the six-month anniversary of the August 19, 2021 Geneva Roth. The August 19, 2021 Geneva Roth contains
an original discount of $&lt;span id="xdx_901_eus-gaap--DebtConversionOriginalDebtAmount1_pp0p0_c20210818__20210819__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--AugustNineteenTwoThousandTwentyOneGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember_zrlREIRbsh97"&gt;3,750&lt;/span&gt;. The Company intends to use the net proceeds from the August 19, 2021 Geneva Roth for general working
capital purposes. The maturity date of the August 19, 2021 Geneva Roth Note is August 19, 2022. The August 19, 2021 Geneva Roth Note
bears interest at a rate of &lt;span id="xdx_901_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20210819__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--AugustNineteenTwoThousandTwentyOneGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember_zPlJepj8LM52"&gt;8&lt;/span&gt;% per annum, which interest may be paid by the Company to Geneva Roth in shares of the Company&#x2019;s common
stock; but shall not be payable until the August 19, 2021 Geneva Roth Note becomes payable, whether at the maturity date or upon acceleration
or by prepayment.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;PROPANC
BIOPHARMA, INC. AND SUBSIDIARY&lt;br/&gt;
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&lt;br/&gt;
SEPTEMBER 30, 2021&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;(Unaudited)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;i&gt;September
22, 2021 Securities Purchase Agreement&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Additionally,
effective September 22, 2021, the Company entered into a securities purchase agreement with Geneva Roth Remark Holdings, Inc., pursuant
to which Geneva Roth purchased a convertible promissory note (the &#x201c;September 22, 2021 Geneva Roth&#x201d;) from the Company in the
aggregate principal amount of $&lt;span id="xdx_90F_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20210922__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeptemberTwentyTwoTwoThousandTwentyOneGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember_zOYq6eOFZ5ek"&gt;63,750&lt;/span&gt;, such principal and the interest thereon convertible into shares of the Company&#x2019;s common
stock at the option of Geneva Roth any time after the six-month anniversary of the September 22, 2021 Geneva Roth. The September 22,
2021 Geneva Roth contains an original discount of $&lt;span id="xdx_90E_eus-gaap--DebtConversionOriginalDebtAmount1_pp0p0_c20210921__20210922__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeptemberTwentyTwoTwoThousandTwentyOneGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember_zNZime7T8LN2"&gt;3,750&lt;/span&gt;. The Company intends to use the net proceeds from the September 22, 2021 Geneva
Roth for general working capital purposes. The maturity date of the September 22, 2021 Geneva Roth Note is September 22, 2022. The September
22, 2021 Geneva Roth Note bears interest at a rate of &lt;span id="xdx_905_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20210922__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeptemberTwentyTwoTwoThousandTwentyOneGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember_zWSiuiI86P3k"&gt;8&lt;/span&gt;% per annum, which interest may be paid by the Company to Geneva Roth in shares
of the Company&#x2019;s common stock; but shall not be payable until the September 22, 2021 Geneva Roth Note becomes payable, whether
at the maturity date or upon acceleration or by prepayment.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;During
the first 60 to 180 days following the date of these notes, the Company has the right to prepay the principal and accrued but unpaid
interest due under the above notes issued to Geneva Roth, together with any other amounts that the Company may owe the holder under the
terms of the note, at a premium ranging from &lt;span id="xdx_90A_ecustom--DebtInstrumentDebtDefaultInterestRate_pid_dp_uPure_c20210921__20210922__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember__srt--RangeAxis__srt--MinimumMember_zaZJaariTFqc"&gt;110&lt;/span&gt;% to &lt;span id="xdx_90C_ecustom--DebtInstrumentDebtDefaultInterestRate_pid_dp_uPure_c20210921__20210922__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember__srt--RangeAxis__srt--MaximumMember_zpC4SxPyvNB5"&gt;129&lt;/span&gt;% as defined in the note agreement. After this initial 180-day period, the Company
does not have a right to prepay such notes.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_909_eus-gaap--DebtInstrumentDescription_c20210921__20210922__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeptemberTwentyTwoTwoThousandTwentyOneGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember__srt--RangeAxis__srt--MinimumMember_zHVNcBc1Vpjd"&gt;The
conversion price for the above Geneva Roth notes shall be equal to a &lt;span id="xdx_902_ecustom--DebtInstrumentDebtDefaultInterestRate_pid_dp_uPure_c20210921__20210922__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeptemberTwentyTwoTwoThousandTwentyOneGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember_zGq3BXUa7Op5"&gt;35&lt;/span&gt;% discount of the market price based on the average of the lowest
three trading prices of the Common Stock for the ten trading days immediately prior to the delivery of a Notice of Conversion. Notwithstanding
the foregoing, Geneva Roth shall be restricted from effecting a conversion if such conversion, along with other shares of the Company&#x2019;s
common stock beneficially owned by Geneva Roth and its affiliates, exceeds &lt;span id="xdx_90E_ecustom--PercentageOfOutstandingSharesOfCommonStock_pid_dp_uPure_c20210921__20210922__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember__srt--RangeAxis__srt--MinimumMember_z6UGpQRbDf83"&gt;9.99&lt;/span&gt;% of the outstanding shares of the Company&#x2019;s common
stock. These notes are treated as stock settled debt under ASC 480 and accordingly the Company recorded a total of $&lt;span id="xdx_903_eus-gaap--DebtInstrumentUnamortizedPremium_iI_pp0p0_c20210922__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember_zVrRP5zlDEsi"&gt;161,269&lt;/span&gt; put premium
for the four notes.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
above Geneva Roth notes contain certain events of default, upon which principal and accrued interest will become immediately due and
payable. In addition, upon an event of default, interest on the outstanding principal shall accrue at a default interest rate of &lt;span id="xdx_902_ecustom--DebtDefaultAmountPercentage_pid_dp_uPure_c20210921__20210922__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember_zD9LZXItdfcf" title="Debt default amount percentage"&gt;22&lt;/span&gt;%
per annum, or if such rate is usurious or not permitted by current law, then at the highest rate of interest permitted by law. Further,
certain events of default may trigger penalty and liquidated damage provisions.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
total principal amounts outstanding under the above Geneva Roth financing agreements were $&lt;span id="xdx_907_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20210630__us-gaap--TypeOfArrangementAxis__custom--GenevaRothFinancingAgreementAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember_zm5UdQ7KYNqf"&gt;132,000&lt;/span&gt; and accrued interest of $&lt;span id="xdx_90A_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20210630__us-gaap--TypeOfArrangementAxis__custom--GenevaRothFinancingAgreementAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember_zUsRMblbf2pk"&gt;3,477&lt;/span&gt; as
of June 30, 2021 following conversion of $&lt;span id="xdx_901_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20210630__us-gaap--TypeOfArrangementAxis__custom--GenevaRothFinancingAgreementAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember_zGVdkKYxeGze"&gt;78,000&lt;/span&gt; of the principal balance and $&lt;span id="xdx_904_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20210630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember_zJqYyidmnTwf"&gt;3,120&lt;/span&gt; accrued interest during the year ended June 30,
2021. Accordingly, $&lt;span id="xdx_904_eus-gaap--DebtInstrumentUnamortizedPremium_iI_pp0p0_c20210630__us-gaap--TypeOfArrangementAxis__custom--GenevaRothFinancingAgreementAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember_z0OghltJXj4f"&gt;42,000&lt;/span&gt; of the put premium was released in respect of the Geneva Roth financing agreements during the year ended June
30, 2021 following conversion of the principal balance.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
total principal amounts outstanding under the above Geneva Roth financing agreements were $&lt;span id="xdx_900_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20210930__us-gaap--TypeOfArrangementAxis__custom--GenevaRothFinancingAgreementAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember_zSRXj1MFofhf"&gt;167,500&lt;/span&gt; and accrued interest of $&lt;span id="xdx_903_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20210930__us-gaap--TypeOfArrangementAxis__custom--GenevaRothFinancingAgreementAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember_zxEer3i3Ai4b"&gt;1,081&lt;/span&gt; as
of September 30, 2021 following conversion of $&lt;span id="xdx_90C_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20210930__us-gaap--TypeOfArrangementAxis__custom--GenevaRothFinancingAgreementAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember_zfR47ZiJD2Vd"&gt;132,000&lt;/span&gt; of the principal balance and $&lt;span id="xdx_909_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20210930__us-gaap--TypeOfArrangementAxis__custom--GenevaRothFinancingAgreementAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember_zfxIAHXyadMa"&gt;5,280&lt;/span&gt; accrued interest during the three months ended
September 30, 2021. Accordingly, $&lt;span id="xdx_902_eus-gaap--DebtInstrumentUnamortizedPremium_iI_pp0p0_c20210930__us-gaap--TypeOfArrangementAxis__custom--GenevaRothFinancingAgreementAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember__dei--LegalEntityAxis__custom--GenevaRothRemarkHoldingsIncMember_zryCIL9sv5Y7"&gt;71,077&lt;/span&gt; of the put premium was released in respect of the Geneva Roth financing agreements during the
three months ended September 30, 2021 following conversion of the principal balance.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Amortization
of debt discounts&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company recorded $&lt;span id="xdx_905_eus-gaap--AmortizationOfDebtDiscountPremium_pp0p0_c20210701__20210930__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zDotonWxHIEg"&gt;7,500&lt;/span&gt; and $&lt;span id="xdx_903_eus-gaap--AmortizationOfDebtDiscountPremium_pp0p0_c20200701__20200930__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zRErArH07Ngi"&gt;0&lt;/span&gt; of debt discounts (including warrants, derivatives, debt issue costs and original issue discounts) related
to the above note issuances during the three months ended September 30, 2021 and 2020, respectively. The Company recorded $&lt;span id="xdx_907_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pp0p0_c20210930__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zoQmvISoyihb"&gt;90,192&lt;/span&gt; and
$&lt;span id="xdx_909_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pp0p0_c20200930__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zqYEyVk0Karh"&gt;0&lt;/span&gt; of put premiums related to the above note issuances during the three months ended September 30, 2021 and 2020, respectively. The debt
discounts are being amortized over the term of the debt and the put premiums are expensed on issuance of the debt with the liability
released to additional paid in capital on conversion of the principal.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Amortization
of all debt discounts for the three months ended September 30, 2021 and 2020 was $&lt;span id="xdx_900_eus-gaap--AmortizationOfDebtDiscountPremium_pp0p0_c20210701__20210930_z2nbP4cmctd4" title="Amortization of debt discount"&gt;6,074&lt;/span&gt; and $&lt;span id="xdx_906_eus-gaap--AmortizationOfDebtDiscountPremium_pp0p0_c20200701__20200930_zBvW04AaEQS9" title="Amortization of debt discount"&gt;121,281&lt;/span&gt;, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company reclassified $&lt;span id="xdx_909_ecustom--ReclassifiedPremiumAmountForAdditionalPaidInCapital_pp0p0_c20210701__20210930_zoB4cvf8iVJa"&gt;109,643&lt;/span&gt; and $&lt;span id="xdx_905_ecustom--ReclassifiedPremiumAmountForAdditionalPaidInCapital_pp0p0_c20200701__20200930_zikr5Gq9GEja"&gt;204,919&lt;/span&gt; in put premiums to additional paid in capital following conversions during the three months
ended September 30, 2021 and 2020, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ConvertibleDebtTableTextBlock contextRef="From2021-07-01to2021-09-30">&lt;p id="xdx_897_eus-gaap--ConvertibleDebtTableTextBlock_zjBtvrzAXz4j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company&#x2019;s convertible notes outstanding at September 30, 2021 and June 30, 2021 were as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_8B0_zcA9zJu0m1X9" style="display: none"&gt;SCHEDULE
OF CONVERTIBLE NOTES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20210930_zAp0KEWZ480k" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;September
    30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20210630_zyLLJTngGXul" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;June
    30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(Unaudited)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--DebtInstrumentCarryingAmount_iI_pp0p0_maLTDzcuB_zeR5AoxnitQ" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Convertible notes and debenture&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 17%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;377,780&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 15%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;400,128&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--DebtInstrumentUnamortizedDiscount_iNI_pp0p0_di_msLTDzcuB_z1VTqFyrK7xb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Unamortized discounts&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(7,565&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(6,139&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--DepositLiabilitiesAccruedInterest_iI_pp0p0_maLTDzcuB_zzTn53DC3CG" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Accrued interest&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;37,348&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;34,098&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--DebtInstrumentUnamortizedPremium_iI_pp0p0_maLTDzcuB_ztrTE0IiZtYh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Premium, net&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;177,045&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;196,496&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--LongTermDebt_iTI_pp0p0_mtLTDzcuB_zuIe10MIoIM4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Convertible notes,
    net&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;584,608&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;624,583&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ConvertibleDebtTableTextBlock>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="AsOf2021-09-30" decimals="0" unitRef="USD">377780</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">400128</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscount contextRef="AsOf2021-09-30" decimals="0" unitRef="USD">7565</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentUnamortizedDiscount contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">6139</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DepositLiabilitiesAccruedInterest contextRef="AsOf2021-09-30" decimals="0" unitRef="USD">37348</us-gaap:DepositLiabilitiesAccruedInterest>
    <us-gaap:DepositLiabilitiesAccruedInterest contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">34098</us-gaap:DepositLiabilitiesAccruedInterest>
    <us-gaap:DebtInstrumentUnamortizedPremium contextRef="AsOf2021-09-30" decimals="0" unitRef="USD">177045</us-gaap:DebtInstrumentUnamortizedPremium>
    <us-gaap:DebtInstrumentUnamortizedPremium contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">196496</us-gaap:DebtInstrumentUnamortizedPremium>
    <us-gaap:LongTermDebt contextRef="AsOf2021-09-30" decimals="0" unitRef="USD">584608</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">624583</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2017-08-10_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember"
      decimals="0"
      unitRef="USD">310000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2017-08-10_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember"
      decimals="INF"
      unitRef="Pure">0.10</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtConversionConvertedInstrumentAmount1
      contextRef="From2017-08-072017-08-10_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember"
      decimals="0"
      unitRef="USD">750</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
      contextRef="From2017-08-072017-08-10_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember"
      decimals="INF"
      unitRef="Pure">0.65</us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger>
    <us-gaap:DebtInstrumentConvertibleThresholdTradingDays
      contextRef="From2017-08-072017-08-10_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember"
      decimals="INF"
      unitRef="Integer">10</us-gaap:DebtInstrumentConvertibleThresholdTradingDays>
    <us-gaap:DebtInstrumentMaturityDate contextRef="From2017-08-072017-08-10_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember">2019-08-10</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:AccruedLiabilitiesCurrentAndNoncurrent
      contextRef="AsOf2017-06-30_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember"
      decimals="0"
      unitRef="USD">155000</us-gaap:AccruedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:AccruedLiabilitiesCurrentAndNoncurrent
      contextRef="AsOf2018-06-30_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember"
      decimals="0"
      unitRef="USD">155000</us-gaap:AccruedLiabilitiesCurrentAndNoncurrent>
    <PPCB:DebtInstrumentDebtDefaultInterestRate
      contextRef="From2017-08-072017-08-10_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember"
      decimals="INF"
      unitRef="Pure">0.18</PPCB:DebtInstrumentDebtDefaultInterestRate>
    <us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
      contextRef="AsOf2017-08-10_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember"
      decimals="0"
      unitRef="USD">578212</us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2018-06-30_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember_custom_ConsultantMember"
      decimals="0"
      unitRef="USD">140000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="AsOf2018-06-30_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember_custom_ConsultantMember"
      decimals="0"
      unitRef="USD">10764</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2019-06-30_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember_custom_ConsultantMember"
      decimals="0"
      unitRef="USD">161000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="AsOf2019-06-30_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember_custom_ConsultantMember"
      decimals="0"
      unitRef="USD">19418</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2019-06-30_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember"
      decimals="0"
      unitRef="USD">9000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtConversionConvertedInstrumentAmount1
      contextRef="From2019-07-012020-06-30_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember"
      decimals="0"
      unitRef="USD">500</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <us-gaap:AccruedLiabilitiesCurrentAndNoncurrent
      contextRef="AsOf2020-06-30_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember"
      decimals="0"
      unitRef="USD">5248</us-gaap:AccruedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2020-06-30_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember"
      decimals="0"
      unitRef="USD">8500</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="AsOf2020-06-30_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember"
      decimals="0"
      unitRef="USD">22168</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2021-03-15_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember_custom_SettlementAndMutualReleaseAgreementMember"
      decimals="0"
      unitRef="USD">100000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:Liabilities
      contextRef="AsOf2021-03-15_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember_custom_SettlementAndMutualReleaseAgreementMember"
      decimals="0"
      unitRef="USD">56762</us-gaap:Liabilities>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="AsOf2021-03-15_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember_custom_SettlementAndMutualReleaseAgreementMember"
      decimals="0"
      unitRef="USD">8500</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="AsOf2021-03-15_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember_custom_SettlementAndMutualReleaseAgreementMember"
      decimals="0"
      unitRef="USD">23262</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:AccruedLiabilitiesCurrentAndNoncurrent
      contextRef="AsOf2021-03-15_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember_custom_SettlementAndMutualReleaseAgreementMember"
      decimals="0"
      unitRef="USD">25000</us-gaap:AccruedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="From2020-07-012021-06-30_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember_custom_SettlementAndMutualReleaseAgreementMember"
      decimals="0"
      unitRef="USD">43238</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:ConvertibleNotesPayable
      contextRef="AsOf2021-06-30_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember_custom_SettlementAndMutualReleaseAgreementMember"
      decimals="0"
      unitRef="USD">80000</us-gaap:ConvertibleNotesPayable>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="AsOf2021-06-30_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember_custom_SettlementAndMutualReleaseAgreementMember"
      decimals="0"
      unitRef="USD">3738</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:DebtConversionConvertedInstrumentAmount1
      contextRef="From2020-07-012021-06-30_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember_custom_SettlementAndMutualReleaseAgreementMember"
      decimals="0"
      unitRef="USD">20000</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <us-gaap:ConvertibleNotesPayable
      contextRef="AsOf2021-09-30_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember_custom_SettlementAndMutualReleaseAgreementMember"
      decimals="0"
      unitRef="USD">80000</us-gaap:ConvertibleNotesPayable>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="AsOf2021-09-30_custom_AugustTenTwoThousandAndSeventeenConsultingAgreementMember_custom_SettlementAndMutualReleaseAgreementMember"
      decimals="0"
      unitRef="USD">7381</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2019-08-30_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember"
      decimals="0"
      unitRef="USD">550000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2019-09-04_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember"
      decimals="0"
      unitRef="USD">550000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:LegalFees
      contextRef="From2019-09-032019-09-04_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember"
      decimals="0"
      unitRef="USD">5000</us-gaap:LegalFees>
    <PPCB:DiligenceFees
      contextRef="From2019-09-032019-09-04_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember"
      decimals="0"
      unitRef="USD">40000</PPCB:DiligenceFees>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="From2019-09-032019-09-04_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember"
      decimals="0"
      unitRef="USD">505000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:DebtInstrumentMaturityDate contextRef="From2019-08-292019-08-30_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember">2020-08-30</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2019-08-30_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember"
      decimals="INF"
      unitRef="Pure">0.10</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentUnamortizedPremium
      contextRef="AsOf2019-08-30_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember"
      decimals="0"
      unitRef="USD">366667</us-gaap:DebtInstrumentUnamortizedPremium>
    <PPCB:DebtInstrumentDebtDefaultInterestRate
      contextRef="From2019-08-292019-08-30_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember"
      decimals="INF"
      unitRef="Pure">0.24</PPCB:DebtInstrumentDebtDefaultInterestRate>
    <PPCB:PercentageOfOutstandingSharesOfCommonStock
      contextRef="From2019-08-292019-08-30_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember"
      decimals="INF"
      unitRef="Pure">1.25</PPCB:PercentageOfOutstandingSharesOfCommonStock>
    <PPCB:DebtInstrumentDebtDefaultInterestRate
      contextRef="From2019-08-292019-08-30_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember"
      decimals="INF"
      unitRef="Pure">0.24</PPCB:DebtInstrumentDebtDefaultInterestRate>
    <us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
      contextRef="From2019-09-032019-09-04_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember"
      decimals="INF"
      unitRef="Pure">0.60</us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger>
    <PPCB:PercentageOfOutstandingSharesOfCommonStock
      contextRef="From2019-09-032019-09-04_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember"
      decimals="INF"
      unitRef="Pure">0.0499</PPCB:PercentageOfOutstandingSharesOfCommonStock>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2019-08-30_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember_custom_FirstWarrantMember"
      decimals="INF"
      unitRef="Shares">450</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2019-08-30_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember_custom_FirstWarrantMember"
      decimals="INF"
      unitRef="USDPShares">2250</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2019-08-30_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember_custom_SecondWarrantMember"
      decimals="INF"
      unitRef="Shares">300</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2019-08-30_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember_custom_SecondWarrantMember"
      decimals="INF"
      unitRef="USDPShares">3330</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2019-08-30_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember_custom_ThirdWarrantMember"
      decimals="INF"
      unitRef="Shares">225</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2019-08-30_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember_custom_ThirdWarrantMember"
      decimals="INF"
      unitRef="USDPShares">4500</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <PPCB:PercentageOfOutstandingSharesOfCommonStock
      contextRef="From2019-07-012020-06-30_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember"
      decimals="INF"
      unitRef="Pure">0.0499</PPCB:PercentageOfOutstandingSharesOfCommonStock>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2019-08-292019-08-30_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember"
      decimals="0"
      unitRef="USD">375905</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2019-06-30_custom_AuctusFinancingAgreementMember"
      decimals="0"
      unitRef="USD">358965</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="AsOf2020-06-30_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember"
      decimals="0"
      unitRef="USD">486</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:DebtConversionConvertedInstrumentAmount1
      contextRef="From2019-07-012020-06-30_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember"
      decimals="0"
      unitRef="USD">191035</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="AsOf2020-06-30_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember"
      decimals="0"
      unitRef="USD">43176</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:DebtInstrumentUnamortizedPremium
      contextRef="AsOf2020-06-30_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember"
      decimals="0"
      unitRef="USD">127356</us-gaap:DebtInstrumentUnamortizedPremium>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2021-06-30_custom_AuctusFinancingAgreementMember"
      decimals="0"
      unitRef="USD">32848</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="AsOf2021-06-30_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember"
      decimals="0"
      unitRef="USD">0</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:DebtConversionConvertedInstrumentAmount1
      contextRef="From2020-07-012021-06-30_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember"
      decimals="0"
      unitRef="USD">326117</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <PPCB:DebtConversionConvertedInterestPayable
      contextRef="From2020-07-012021-06-30_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember"
      decimals="0"
      unitRef="USD">39536</PPCB:DebtConversionConvertedInterestPayable>
    <us-gaap:DebtInstrumentUnamortizedPremium
      contextRef="AsOf2021-06-30_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember"
      decimals="0"
      unitRef="USD">217411</us-gaap:DebtInstrumentUnamortizedPremium>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2021-09-30_custom_AuctusFinancingAgreementMember"
      decimals="0"
      unitRef="USD">0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="AsOf2021-09-30_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember"
      decimals="0"
      unitRef="USD">0</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:DebtConversionConvertedInstrumentAmount1
      contextRef="From2021-07-012021-09-30_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember"
      decimals="0"
      unitRef="USD">32848</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="AsOf2021-09-30_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember"
      decimals="0"
      unitRef="USD">716</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:DebtInstrumentUnamortizedPremium
      contextRef="AsOf2021-09-30_custom_SecuritiesPurchaseAgreementMember_custom_AuctusFundLLCMember_custom_AugustTwoThousandNineteenAuctusNoteMember"
      decimals="0"
      unitRef="USD">21899</us-gaap:DebtInstrumentUnamortizedPremium>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2019-10-03_custom_SecuritiesPurchaseAgreementMember_custom_CrownBridgePartnersLLCMember_custom_OctoberThreeTwoThousandNineteenAuctusNoteMember"
      decimals="0"
      unitRef="USD">108000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentPeriodicPaymentPrincipal
      contextRef="From2019-10-012019-10-03_custom_SecuritiesPurchaseAgreementMember_custom_CrownBridgePartnersLLCMember_custom_OctoberThreeTwoThousandNineteenAuctusNoteMember"
      decimals="0"
      unitRef="USD">3000</us-gaap:DebtInstrumentPeriodicPaymentPrincipal>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="AsOf2019-10-03_custom_SecuritiesPurchaseAgreementMember_custom_CrownBridgePartnersLLCMember_custom_OctoberThreeTwoThousandNineteenAuctusNoteMember"
      decimals="0"
      unitRef="USD">5000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="From2019-10-012019-10-03_custom_SecuritiesPurchaseAgreementMember_custom_CrownBridgePartnersLLCMember_custom_OctoberThreeTwoThousandNineteenAuctusNoteMember"
      decimals="0"
      unitRef="USD">100000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:DebtInstrumentMaturityDate contextRef="From2019-10-012019-10-03_custom_SecuritiesPurchaseAgreementMember_custom_CrownBridgePartnersLLCMember_custom_OctoberThreeTwoThousandNineteenAuctusNoteMember">2019-10-03</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2019-10-03_custom_SecuritiesPurchaseAgreementMember_custom_CrownBridgePartnersLLCMember_custom_OctoberThreeTwoThousandNineteenAuctusNoteMember"
      decimals="INF"
      unitRef="Pure">0.10</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <PPCB:DebtInstrumentDebtDefaultInterestRate
      contextRef="From2019-10-012019-10-03_custom_SecuritiesPurchaseAgreementMember_custom_CrownBridgePartnersLLCMember_custom_OctoberThreeTwoThousandNineteenAuctusNoteMember_srt_MinimumMember"
      decimals="INF"
      unitRef="Pure">1.10</PPCB:DebtInstrumentDebtDefaultInterestRate>
    <PPCB:DebtInstrumentDebtDefaultInterestRate
      contextRef="From2019-10-012019-10-03_custom_SecuritiesPurchaseAgreementMember_custom_CrownBridgePartnersLLCMember_custom_OctoberThreeTwoThousandNineteenAuctusNoteMember_srt_MaximumMember"
      decimals="INF"
      unitRef="Pure">1.50</PPCB:DebtInstrumentDebtDefaultInterestRate>
    <us-gaap:DebtInstrumentDescription contextRef="From2019-10-012019-10-03_custom_SecuritiesPurchaseAgreementMember_custom_CrownBridgePartnersLLCMember_custom_OctoberThreeTwoThousandNineteenAuctusNoteMember">The
conversion price for the October 3, 2019 Crown Bridge Note shall be equal to a 40% discount of the lowest closing bid price (&#x201c;Lowest
Trading Price&#x201d;) of the Common Stock for the ten trading days immediately prior to the delivery of a Notice of Conversion, including
the day upon which a Notice of Conversion is received. Notwithstanding the foregoing, Crown Bridge shall be restricted from effecting
a conversion if such conversion, along with other shares of the Company&#x2019;s common stock beneficially owned by Crown Bridge and its
affiliates, exceeds 4.99% of the outstanding shares of the Company&#x2019;s common stock which may be increased up to 9.99% upon 60 days
prior written notice by the Crown Bridge to the Company. The note is treated as stock settled debt under ASC 480 and accordingly the
Company recorded a $72,000 put premium.</us-gaap:DebtInstrumentDescription>
    <PPCB:PercentageOfOutstandingSharesOfCommonStock
      contextRef="From2019-10-012019-10-03_custom_SecuritiesPurchaseAgreementMember_custom_CrownBridgePartnersLLCMember_custom_OctoberThreeTwoThousandNineteenAuctusNoteMember_srt_MinimumMember"
      decimals="INF"
      unitRef="Pure">0.0499</PPCB:PercentageOfOutstandingSharesOfCommonStock>
    <PPCB:PercentageOfOutstandingSharesOfCommonStock
      contextRef="From2019-10-012019-10-03_custom_SecuritiesPurchaseAgreementMember_custom_CrownBridgePartnersLLCMember_custom_OctoberThreeTwoThousandNineteenAuctusNoteMember_srt_MaximumMember"
      decimals="INF"
      unitRef="Pure">0.0999</PPCB:PercentageOfOutstandingSharesOfCommonStock>
    <us-gaap:DebtInstrumentUnamortizedPremium
      contextRef="AsOf2019-10-03_custom_SecuritiesPurchaseAgreementMember_custom_CrownBridgePartnersLLCMember_custom_OctoberThreeTwoThousandNineteenAuctusNoteMember"
      decimals="0"
      unitRef="USD">72000</us-gaap:DebtInstrumentUnamortizedPremium>
    <PPCB:DebtInstrumentDebtDefaultInterestRate
      contextRef="From2019-10-012019-10-03_custom_SecuritiesPurchaseAgreementMember_custom_CrownBridgePartnersLLCMember_custom_OctoberThreeTwoThousandNineteenAuctusNoteMember"
      decimals="INF"
      unitRef="Pure">0.15</PPCB:DebtInstrumentDebtDefaultInterestRate>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2020-06-30_custom_SecuritiesPurchaseAgreementMember_custom_CrownBridgePartnersLLCMember_custom_OctoberThreeTwoThousandNineteenAuctusNoteMember"
      decimals="0"
      unitRef="USD">65280</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="AsOf2020-06-30_custom_SecuritiesPurchaseAgreementMember_custom_CrownBridgePartnersLLCMember_custom_OctoberThreeTwoThousandNineteenAuctusNoteMember"
      decimals="0"
      unitRef="USD">7232</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:DebtConversionConvertedInstrumentAmount1
      contextRef="From2019-07-012020-06-30_custom_SecuritiesPurchaseAgreementMember_custom_CrownBridgePartnersLLCMember_custom_OctoberThreeTwoThousandNineteenAuctusNoteMember"
      decimals="0"
      unitRef="USD">42720</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <us-gaap:DebtInstrumentUnamortizedPremium
      contextRef="AsOf2020-06-30_custom_SecuritiesPurchaseAgreementMember_custom_CrownBridgePartnersLLCMember_custom_OctoberThreeTwoThousandNineteenAuctusNoteMember"
      decimals="0"
      unitRef="USD">28480</us-gaap:DebtInstrumentUnamortizedPremium>
    <PPCB:UnissuedSharesConversion
      contextRef="From2020-09-152020-09-16_custom_SecuritiesPurchaseAgreementMember_custom_CrownBridgePartnersLLCMember"
      decimals="INF"
      unitRef="Shares">15000</PPCB:UnissuedSharesConversion>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2020-11-30_custom_SecuritiesPurchaseAgreementMember_custom_CrownBridgePartnersLLCMember"
      decimals="0"
      unitRef="USD">9600</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentUnamortizedPremium
      contextRef="AsOf2020-11-30_custom_SecuritiesPurchaseAgreementMember_custom_CrownBridgePartnersLLCMember"
      decimals="0"
      unitRef="USD">6400</us-gaap:DebtInstrumentUnamortizedPremium>
    <PPCB:DueToEquityConversion
      contextRef="AsOf2020-11-30_custom_SecuritiesPurchaseAgreementMember_custom_CrownBridgePartnersLLCMember"
      decimals="0"
      unitRef="USD">16000</PPCB:DueToEquityConversion>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2021-06-30_custom_SecuritiesPurchaseAgreementMember_custom_CrownBridgePartnersLLCMember_custom_OctoberThreeTwoThousandNineteenAuctusNoteMember"
      decimals="0"
      unitRef="USD">65280</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="AsOf2021-06-30_custom_SecuritiesPurchaseAgreementMember_custom_CrownBridgePartnersLLCMember_custom_OctoberThreeTwoThousandNineteenAuctusNoteMember"
      decimals="0"
      unitRef="USD">16138</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2021-09-30_custom_SecuritiesPurchaseAgreementMember_custom_CrownBridgePartnersLLCMember_custom_OctoberThreeTwoThousandNineteenAuctusNoteMember"
      decimals="0"
      unitRef="USD">65280</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="AsOf2021-09-30_custom_SecuritiesPurchaseAgreementMember_custom_CrownBridgePartnersLLCMember_custom_OctoberThreeTwoThousandNineteenAuctusNoteMember"
      decimals="0"
      unitRef="USD">18606</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2020-12-10_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember_custom_DecemberTenTwoThousandTwentyGWNoteMember"
      decimals="0"
      unitRef="USD">131000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentPeriodicPaymentPrincipal
      contextRef="From2020-12-092020-12-10_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember_custom_DecemberTenTwoThousandTwentyGWNoteMember"
      decimals="0"
      unitRef="USD">6000</us-gaap:DebtInstrumentPeriodicPaymentPrincipal>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="From2020-12-092020-12-10_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember_custom_DecemberTenTwoThousandTwentyGWNoteMember"
      decimals="0"
      unitRef="USD">125000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:DebtInstrumentMaturityDate contextRef="From2020-12-092020-12-10_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember_custom_DecemberTenTwoThousandTwentyGWNoteMember">2021-12-10</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2020-12-10_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember_custom_DecemberTenTwoThousandTwentyGWNoteMember"
      decimals="INF"
      unitRef="Pure">0.08</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <PPCB:DebtInstrumentDebtDefaultInterestRate
      contextRef="From2020-12-092020-12-10_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember_custom_DecemberTenTwoThousandTwentyGWNoteMember"
      decimals="INF"
      unitRef="Pure">0.24</PPCB:DebtInstrumentDebtDefaultInterestRate>
    <PPCB:DebtInstrumentDebtDefaultInterestRate
      contextRef="From2020-12-092020-12-10_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember_custom_DecemberTenTwoThousandTwentyGWNoteMember_srt_MinimumMember"
      decimals="INF"
      unitRef="Pure">1.10</PPCB:DebtInstrumentDebtDefaultInterestRate>
    <PPCB:DebtInstrumentDebtDefaultInterestRate
      contextRef="From2020-12-092020-12-10_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember_custom_DecemberTenTwoThousandTwentyGWNoteMember_srt_MaximumMember"
      decimals="INF"
      unitRef="Pure">1.50</PPCB:DebtInstrumentDebtDefaultInterestRate>
    <us-gaap:DebtInstrumentDescription contextRef="From2020-12-092020-12-10_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember_custom_DecemberTenTwoThousandTwentyGWNoteMember">The
conversion price for the above GW Holdings notes shall be equal to a 40% discount of the lowest closing bid price (&#x201c;Lowest Trading
Price&#x201d;) of the Common Stock for the ten trading days immediately prior to the delivery of a Notice of Conversion, including the
day upon which a Notice of Conversion is received. Notwithstanding the foregoing, GW Holdings shall be restricted from effecting a conversion
if such conversion, along with other shares of the Company&#x2019;s common stock beneficially owned by GW Holdings and its affiliates,
exceeds 4.99% of the outstanding shares of the Company&#x2019;s common stock which may be increased up to 9.99% upon 60 days prior written
notice by the GW Holdings to the Company.</us-gaap:DebtInstrumentDescription>
    <PPCB:PercentageOfOutstandingSharesOfCommonStock
      contextRef="From2020-12-092020-12-10_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember_custom_DecemberTenTwoThousandTwentyGWNoteMember"
      decimals="INF"
      unitRef="Pure">0.0499</PPCB:PercentageOfOutstandingSharesOfCommonStock>
    <us-gaap:DebtInstrumentUnamortizedPremium
      contextRef="AsOf2020-12-10_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember"
      decimals="0"
      unitRef="USD">87333</us-gaap:DebtInstrumentUnamortizedPremium>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2020-09-30_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember_custom_DecemberTenTwoThousandTwentyGWNoteMember"
      decimals="0"
      unitRef="USD">90000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="AsOf2020-09-30_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember_custom_DecemberTenTwoThousandTwentyGWNoteMember"
      decimals="0"
      unitRef="USD">4636</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2021-06-30_custom_SecuritiesPurchaseAgreementMember_custom_DecemberTenTwoThousandTwentyGWNoteMember"
      decimals="0"
      unitRef="USD">41000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="AsOf2021-06-30_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember_custom_DecemberTenTwoThousandTwentyGWNoteMember"
      decimals="0"
      unitRef="USD">1084</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:DebtInstrumentUnamortizedPremium
      contextRef="AsOf2021-06-30_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember_custom_DecemberTenTwoThousandTwentyGWNoteMember"
      decimals="0"
      unitRef="USD">27333</us-gaap:DebtInstrumentUnamortizedPremium>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2021-09-30_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember_custom_DecemberTenTwoThousandTwentyGWNoteMember"
      decimals="0"
      unitRef="USD">65000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="AsOf2021-09-30_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember_custom_DecemberTenTwoThousandTwentyGWNoteMember"
      decimals="0"
      unitRef="USD">4174</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2021-09-30_custom_SecuritiesPurchaseAgreementMember_custom_DecemberTenTwoThousandTwentyGWNoteMember"
      decimals="0"
      unitRef="USD">25000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="AsOf2021-09-30_custom_SecuritiesPurchaseAgreementMember_custom_DecemberTenTwoThousandTwentyGWNoteMember"
      decimals="0"
      unitRef="USD">2091</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:DebtInstrumentUnamortizedPremium
      contextRef="AsOf2021-09-30_custom_SecuritiesPurchaseAgreementMember_custom_GWHoldingsGroupLLCMember_custom_DecemberTenTwoThousandTwentyGWNoteMember"
      decimals="0"
      unitRef="USD">16667</us-gaap:DebtInstrumentUnamortizedPremium>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2021-01-05_custom_SecuritiesPurchaseAgreementMember_custom_JanuaryFiveTwoThousandTwentyOneGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember"
      decimals="0"
      unitRef="USD">68500</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="AsOf2021-01-05_custom_SecuritiesPurchaseAgreementMember_custom_JanuaryFiveTwoThousandTwentyOneGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember"
      decimals="0"
      unitRef="USD">3500</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2020-12-02_custom_SecuritiesPurchaseAgreementMember_custom_JanuaryFiveTwoThousandTwentyOneGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember"
      decimals="INF"
      unitRef="Pure">0.08</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2021-03-16_custom_SecuritiesPurchaseAgreementMember_custom_MarchSixteenTwoThousandTwentyOneGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember"
      decimals="0"
      unitRef="USD">63500</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtConversionOriginalDebtAmount1
      contextRef="From2021-03-152021-03-16_custom_SecuritiesPurchaseAgreementMember_custom_MarchSixteenTwoThousandTwentyOneGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember"
      decimals="0"
      unitRef="USD">3500</us-gaap:DebtConversionOriginalDebtAmount1>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2021-03-16_custom_SecuritiesPurchaseAgreementMember_custom_MarchSixteenTwoThousandTwentyOneGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember"
      decimals="INF"
      unitRef="Pure">0.08</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2021-08-19_custom_SecuritiesPurchaseAgreementMember_custom_AugustNineteenTwoThousandTwentyOneGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember"
      decimals="0"
      unitRef="USD">103750</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtConversionOriginalDebtAmount1
      contextRef="From2021-08-182021-08-19_custom_SecuritiesPurchaseAgreementMember_custom_AugustNineteenTwoThousandTwentyOneGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember"
      decimals="0"
      unitRef="USD">3750</us-gaap:DebtConversionOriginalDebtAmount1>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2021-08-19_custom_SecuritiesPurchaseAgreementMember_custom_AugustNineteenTwoThousandTwentyOneGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember"
      decimals="INF"
      unitRef="Pure">0.08</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2021-09-22_custom_SecuritiesPurchaseAgreementMember_custom_SeptemberTwentyTwoTwoThousandTwentyOneGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember"
      decimals="0"
      unitRef="USD">63750</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtConversionOriginalDebtAmount1
      contextRef="From2021-09-212021-09-22_custom_SecuritiesPurchaseAgreementMember_custom_SeptemberTwentyTwoTwoThousandTwentyOneGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember"
      decimals="0"
      unitRef="USD">3750</us-gaap:DebtConversionOriginalDebtAmount1>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2021-09-22_custom_SecuritiesPurchaseAgreementMember_custom_SeptemberTwentyTwoTwoThousandTwentyOneGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember"
      decimals="INF"
      unitRef="Pure">0.08</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <PPCB:DebtInstrumentDebtDefaultInterestRate
      contextRef="From2021-09-212021-09-22_custom_SecuritiesPurchaseAgreementMember_custom_SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember_srt_MinimumMember"
      decimals="INF"
      unitRef="Pure">1.10</PPCB:DebtInstrumentDebtDefaultInterestRate>
    <PPCB:DebtInstrumentDebtDefaultInterestRate
      contextRef="From2021-09-212021-09-22_custom_SecuritiesPurchaseAgreementMember_custom_SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember_srt_MaximumMember"
      decimals="INF"
      unitRef="Pure">1.29</PPCB:DebtInstrumentDebtDefaultInterestRate>
    <us-gaap:DebtInstrumentDescription contextRef="From2021-09-212021-09-22_custom_SecuritiesPurchaseAgreementMember_custom_SeptemberTwentyTwoTwoThousandTwentyOneGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember_srt_MinimumMember">The
conversion price for the above Geneva Roth notes shall be equal to a 35% discount of the market price based on the average of the lowest
three trading prices of the Common Stock for the ten trading days immediately prior to the delivery of a Notice of Conversion. Notwithstanding
the foregoing, Geneva Roth shall be restricted from effecting a conversion if such conversion, along with other shares of the Company&#x2019;s
common stock beneficially owned by Geneva Roth and its affiliates, exceeds 9.99% of the outstanding shares of the Company&#x2019;s common
stock. These notes are treated as stock settled debt under ASC 480 and accordingly the Company recorded a total of $161,269 put premium
for the four notes.</us-gaap:DebtInstrumentDescription>
    <PPCB:DebtInstrumentDebtDefaultInterestRate
      contextRef="From2021-09-212021-09-22_custom_SecuritiesPurchaseAgreementMember_custom_SeptemberTwentyTwoTwoThousandTwentyOneGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember"
      decimals="INF"
      unitRef="Pure">0.35</PPCB:DebtInstrumentDebtDefaultInterestRate>
    <PPCB:PercentageOfOutstandingSharesOfCommonStock
      contextRef="From2021-09-212021-09-22_custom_SecuritiesPurchaseAgreementMember_custom_SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember_srt_MinimumMember"
      decimals="INF"
      unitRef="Pure">0.0999</PPCB:PercentageOfOutstandingSharesOfCommonStock>
    <us-gaap:DebtInstrumentUnamortizedPremium
      contextRef="AsOf2021-09-22_custom_SecuritiesPurchaseAgreementMember_custom_SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember"
      decimals="0"
      unitRef="USD">161269</us-gaap:DebtInstrumentUnamortizedPremium>
    <PPCB:DebtDefaultAmountPercentage
      contextRef="From2021-09-212021-09-22_custom_SecuritiesPurchaseAgreementMember_custom_SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember"
      decimals="INF"
      unitRef="Pure">0.22</PPCB:DebtDefaultAmountPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2021-06-30_custom_GenevaRothFinancingAgreementAgreementMember_custom_SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember"
      decimals="0"
      unitRef="USD">132000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="AsOf2021-06-30_custom_GenevaRothFinancingAgreementAgreementMember_custom_SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember"
      decimals="0"
      unitRef="USD">3477</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2021-06-30_custom_GenevaRothFinancingAgreementAgreementMember_custom_SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember"
      decimals="0"
      unitRef="USD">78000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="AsOf2021-06-30_custom_SecuritiesPurchaseAgreementMember_custom_SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember"
      decimals="0"
      unitRef="USD">3120</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:DebtInstrumentUnamortizedPremium
      contextRef="AsOf2021-06-30_custom_GenevaRothFinancingAgreementAgreementMember_custom_SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember"
      decimals="0"
      unitRef="USD">42000</us-gaap:DebtInstrumentUnamortizedPremium>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2021-09-30_custom_GenevaRothFinancingAgreementAgreementMember_custom_SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember"
      decimals="0"
      unitRef="USD">167500</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="AsOf2021-09-30_custom_GenevaRothFinancingAgreementAgreementMember_custom_SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember"
      decimals="0"
      unitRef="USD">1081</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2021-09-30_custom_GenevaRothFinancingAgreementAgreementMember_custom_SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember"
      decimals="0"
      unitRef="USD">132000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="AsOf2021-09-30_custom_GenevaRothFinancingAgreementAgreementMember_custom_SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember"
      decimals="0"
      unitRef="USD">5280</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:DebtInstrumentUnamortizedPremium
      contextRef="AsOf2021-09-30_custom_GenevaRothFinancingAgreementAgreementMember_custom_SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember_custom_GenevaRothRemarkHoldingsIncMember"
      decimals="0"
      unitRef="USD">71077</us-gaap:DebtInstrumentUnamortizedPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="From2021-07-012021-09-30_custom_SecuritiesPurchaseAgreementMember"
      decimals="0"
      unitRef="USD">7500</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="From2020-07-012020-09-30_custom_SecuritiesPurchaseAgreementMember"
      decimals="0"
      unitRef="USD">0</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="AsOf2021-09-30_custom_SecuritiesPurchaseAgreementMember"
      decimals="0"
      unitRef="USD">90192</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="AsOf2020-09-30_custom_SecuritiesPurchaseAgreementMember"
      decimals="0"
      unitRef="USD">0</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="From2021-07-01to2021-09-30"
      decimals="0"
      unitRef="USD">6074</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="From2020-07-012020-09-30"
      decimals="0"
      unitRef="USD">121281</us-gaap:AmortizationOfDebtDiscountPremium>
    <PPCB:ReclassifiedPremiumAmountForAdditionalPaidInCapital
      contextRef="From2021-07-01to2021-09-30"
      decimals="0"
      unitRef="USD">109643</PPCB:ReclassifiedPremiumAmountForAdditionalPaidInCapital>
    <PPCB:ReclassifiedPremiumAmountForAdditionalPaidInCapital
      contextRef="From2020-07-012020-09-30"
      decimals="0"
      unitRef="USD">204919</PPCB:ReclassifiedPremiumAmountForAdditionalPaidInCapital>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="From2021-07-01to2021-09-30">&lt;p id="xdx_808_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zMw0pxdAWVcd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTE
7 &#x2013; &lt;span id="xdx_822_zMisaHkqg0Q7"&gt;STOCKHOLDERS&#x2019; DEFICIT&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;Increase
in Authorized Shares of Common Stock and Reverse Stock Split&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;On
February 4, 2020 the Directors resolved to increase the Common Stock of the Company from &lt;span id="xdx_902_eus-gaap--CommonStockSharesAuthorized_iI_c20210203_zxqwmpDvq0x9"&gt;100,000,000&lt;/span&gt; authorized shares to &lt;span id="xdx_904_eus-gaap--CommonStockSharesAuthorized_iI_c20210204_zMJXuOt1cQw6" title="Common stock, shares authorized"&gt;1,000,000,000&lt;/span&gt;
authorized shares and believes that such number of authorized shares of Common Stock will be in the best interests of the Corporation
and its stockholders because the Board believes that the availability of more shares of Common Stock for issuance will allow the Corporation
greater flexibility in pursuing financing from investors, meeting business needs as they arise, taking advantage of favorable opportunities
and responding to a changing corporate environment. The Company filed the necessary documents with the U.S. Securities and Exchange Commission
on February 6, 2020 and with the amendment to the authorized shares being approved by the State of Delaware on March 13, 2020.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;On
November 17, 2020, the Company effected a &lt;span id="xdx_903_eus-gaap--StockholdersEquityReverseStockSplit_c20201116__20201117_zCNLsgn52Ge3"&gt;one-for-one thousand (1:1,000)&lt;/span&gt; reverse stock split of the Company&#x2019;s issued and outstanding
shares of common stock (the &#x201c;Reverse Stock Split&#x201d;). Proportional adjustments for the Reverse Stock Split were made to the
Company&#x2019;s outstanding stock options, warrants and equity incentive plans. All share and per-share data and amounts have been retroactively
adjusted as of the earliest period presented in the consolidated financial statements to reflect the Reverse Stock Split.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;PROPANC
BIOPHARMA, INC. AND SUBSIDIARY&lt;br/&gt;
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&lt;br/&gt;
SEPTEMBER 30, 2021&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;(Unaudited)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;span style="text-decoration: underline"&gt;Preferred
Stock&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
total number of shares of preferred stock that the Company is authorized to issue is &lt;span id="xdx_901_eus-gaap--PreferredStockSharesAuthorized_iI_c20210930_zGadqf3imdS2" title="Preferred stock, shares authorized"&gt;1,500,005&lt;/span&gt;, $&lt;span id="xdx_905_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20210930_zgJ28qgsfvDd" title="Preferred stock, par value"&gt;0.01&lt;/span&gt; par value per share. These preferred
shares have no rights to dividends, profit sharing or liquidation preferences.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Of
the total preferred shares authorized, &lt;span id="xdx_90E_eus-gaap--PreferredStockSharesAuthorized_iI_c20210930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zklHtXwcLMRc"&gt;500,000&lt;/span&gt; have been designated as Series A Preferred Stock (&#x201c;Series A Preferred Stock&#x201d;),
pursuant to the Certificate of Designation filed with the Secretary of State of the State of Delaware on December 9, 2014. James Nathanielsz,
the Company&#x2019;s Chief Executive Officer and Chief Financial Officer, beneficially owns all of the outstanding shares of Series A
Preferred Stock via North Horizon Pty Ltd., which entitles him, as a holder of Series A Preferred Stock, to vote on all matters submitted
or required to be submitted to a vote of the Company&#x2019;s stockholders, except election and removal of directors, and each share of
Series A Preferred Stock entitles him to two votes per share of Series A Preferred Stock. North Horizon Pty Ltd. is a Nathanielsz Family
Trust. Mr. James Nathanielsz, the Chief Executive Officer, Chief Financial Officer and a director of our Company, has voting and investment
power over these shares.  &lt;span id="xdx_908_eus-gaap--PreferredStockSharesIssued_iI_c20210930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zShGRKaqRxR" title="Preferred stock, shares issued"&gt;&lt;span id="xdx_903_eus-gaap--PreferredStockSharesOutstanding_iI_c20210930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zWZ0zR9fbVW6" title="Preferred stock, shares outstanding"&gt;&lt;span id="xdx_90C_eus-gaap--PreferredStockSharesIssued_iI_c20200930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zhHjKwqXWcAj" title="Preferred stock, shares issued"&gt;&lt;span id="xdx_90E_eus-gaap--PreferredStockSharesOutstanding_iI_c20200930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zbNaziOiHu27" title="Preferred stock, shares outstanding"&gt;500,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;  shares of Series A Preferred Stock are issued and outstanding as of September 30, 2021 and June 30,
2021.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Of
the total preferred shares authorized, pursuant to the Certificate of Designation filed with the Secretary of State of the State of Delaware
on June 16, 2015, up to five shares have been designated as Series B Preferred Stock (&#x201c;Series B Preferred Stock&#x201d;). Each holder
of outstanding shares of Series B Preferred Stock is entitled to voting power equivalent to the number of votes equal to the total number
of shares of common stock outstanding as of the record date for the determination of stockholders entitled to vote at each meeting of
stockholders of the Company and entitled to vote on all matters submitted or required to be submitted to a vote of the stockholders of
the Company. One share of Series B Preferred Stock is issued and outstanding as of September 30, 2021 and June 30, 2021. Mr. Nathanielsz
directly beneficially owns such one share of Series B Preferred Stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span&gt;No
additional shares of Series A Preferred Stock or Series B Preferred Stock were issued during the three months ended September 30, 2021
and fiscal year 2021.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Common
Stock:&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Shares
issued for conversion of convertible debt&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;From
July 1, 2021 through September 30, 2021, the Company issued an aggregate of &lt;span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210701__20210930__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember_zrhB06ppwRTb"&gt;9,445,009 &lt;/span&gt;shares of its common stock at an average contractual
conversion price of $&lt;span id="xdx_90A_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20210930__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember_z6oZRlUY1LB6"&gt;0.02&lt;/span&gt;, ranging from $&lt;span id="xdx_905_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20210930__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember__srt--RangeAxis__srt--MinimumMember_zt5sDHz4Y7v1"&gt;0.02&lt;/span&gt; to $&lt;span id="xdx_901_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20210930__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember__srt--RangeAxis__srt--MaximumMember_zeBaRl8wQ5v8"&gt;0.04&lt;/span&gt;, as a result of the conversion of principal of $&lt;span id="xdx_90F_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20210930__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember_zmQLQnUkGiG6"&gt;189,849&lt;/span&gt;, interest of $&lt;span id="xdx_909_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20210930__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember_zkVdbheKEiv1"&gt;8,087&lt;/span&gt; and
conversion fees $&lt;span id="xdx_90C_ecustom--ConversionFees_pp0p0_c20210701__20210930__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember_zsqU4nSbdwIa"&gt;2,250&lt;/span&gt; underlying certain outstanding convertible notes converted during such period. The total recorded to equity was
$&lt;span id="xdx_90E_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20210701__20210930__us-gaap--TypeOfArrangementAxis__custom--SecurityPurchaseAgreementMember_zDJDkDnM7clg"&gt;200,186&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company reclassified $&lt;span id="xdx_900_ecustom--PremiumsToAdditionalPaidInCapital_pp0p0_c20210701__20210930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zjihC2NutZa6" title="Premiums to additional paid in capital"&gt;109,643&lt;/span&gt;, net of reversal of put premium upon cancellation of conversion notices by two lenders discussed above,
to additional paid in capital following conversions during the three months ended September 30, 2021.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company has &lt;span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210701__20210930__us-gaap--TypeOfArrangementAxis__custom--UnderlyingFinancingAgreementsMember_zIDWkVvVbsJ6"&gt;197,308,116&lt;/span&gt; shares of its common stock reserved for future issuances based on lender reserve requirements pursuant to underlying
financing agreements at September 30, 2021.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Shares
issued for services and accrued expenses&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;On
August 12, 2021, the Board approved the issuance of &lt;span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesEmployeeBenefitPlan_c20210811__20210812__us-gaap--StatementEquityComponentsAxis__custom--CommonStockOneMember_zDsldrVmkCif" title="Stock issued during the period for services, shares"&gt;2,800,000&lt;/span&gt; shares of the Company&#x2019;s common stock for bonus payable of $&lt;span id="xdx_905_eus-gaap--StockIssuedDuringPeriodValueEmployeeBenefitPlan_c20210811__20210812__us-gaap--StatementEquityComponentsAxis__custom--CommonStockOneMember_z84Nc7pi4Tmi"&gt;84,000&lt;/span&gt;
as of June 30, 2021 to an employee who is the wife of the CEO of the Company. The &lt;span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210811__20210812__us-gaap--StatementEquityComponentsAxis__custom--CommonStockOneMember_zJOm4XVVj7g3" title="Issuance of common stock for cash, shares"&gt;2,800,000&lt;/span&gt; shares of common stock were valued
at approximately $&lt;span id="xdx_90C_eus-gaap--SharesIssuedPricePerShare_iI_c20210812__us-gaap--StatementEquityComponentsAxis__custom--CommonStockOneMember_z0mAIG1nJMJ1" title="Shares issued, price per share"&gt;0.03&lt;/span&gt; per share or $&lt;span id="xdx_909_eus-gaap--CommonStockValue_iI_c20210812__us-gaap--StatementEquityComponentsAxis__custom--CommonStockOneMember_zs8vYyqJDiAf" title="Common stock value issued"&gt;87,920&lt;/span&gt;, being the closing price of the stock on the date of grant. The shares were issued on August
17, 2021. The Company recorded stock-based compensation of $&lt;span id="xdx_90E_eus-gaap--ShareBasedCompensation_c20210701__20210930__us-gaap--StatementEquityComponentsAxis__custom--CommonStockOneMember_ziSzV3C89AQf" title="Share based compensation"&gt;3,920&lt;/span&gt; during the three months ended September 30, 2021 and reclassified bonus
payable of $&lt;span id="xdx_909_eus-gaap--AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_c20210701__20210930__us-gaap--StatementEquityComponentsAxis__custom--CommonStockOneMember_zf7xE4mgffE8" title="Additional paid in capital upon issuance"&gt;84,000&lt;/span&gt; to additional paid in capital upon issuance.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;On
August 12, 2021, the Board approved the issuance of &lt;span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesEmployeeBenefitPlan_c20210811__20210812__srt--ProductOrServiceAxis__custom--LegalServicesMember_zdeAM8QJb4sl"&gt;166,667
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;shares of the Company&#x2019;s common stock for
legal services rendered for the month of August 2021. The 166,667 shares of common stock were valued at approximately $&lt;span id="xdx_90E_eus-gaap--SharesIssuedPricePerShare_iI_c20210812__srt--ProductOrServiceAxis__custom--LegalServicesMember_zn477kdik1p7"&gt;0.05
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;per share or $&lt;span id="xdx_90D_eus-gaap--CommonStockValue_iI_c20210812__srt--ProductOrServiceAxis__custom--LegalServicesMember_zOAYOsBZBqTk"&gt;7,883&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;,
being the closing price of the stock on August 31, 2021, the date of grant. The shares were issued on September 3, 2021. The Company
recorded stock-based compensation of $&lt;span id="xdx_90F_eus-gaap--ShareBasedCompensation_c20210701__20210930__srt--ProductOrServiceAxis__custom--LegalServicesMember_zxGb2eDOwmbj"&gt;7,883
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;during the three months ended September 30, 2021.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;In
September 2021, the Company issued &lt;span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesEmployeeBenefitPlan_c20210929__20210930__srt--ProductOrServiceAxis__custom--ConsultantServicesMember_zpmqfbe1GZn4"&gt;2,819,712&lt;/span&gt; shares of the Company&#x2019;s common stock to a consultant for services rendered from July
2021 to September 2021. The Company issued 2,819,712 shares of the Company&#x2019;s common stock valued at approximately $&lt;span id="xdx_90F_eus-gaap--SharesIssuedPricePerShare_iI_c20210812__srt--ProductOrServiceAxis__custom--ConsultantServicesMember_z2GIUXg2Km1h"&gt;0.04&lt;/span&gt; per share
or $&lt;span id="xdx_906_eus-gaap--CommonStockValue_iI_c20210812__srt--ProductOrServiceAxis__custom--ConsultantServicesMember_zQBbdMNwTnsj" title="Common stock value issued"&gt;104,611&lt;/span&gt;, being the closing price of the stock on the date of grant to such consultant. The Company recorded stock-based compensation
of $&lt;span id="xdx_904_eus-gaap--ShareBasedCompensation_c20210701__20210930__srt--ProductOrServiceAxis__custom--ConsultantServicesMember_zThXkNGKffs1"&gt;104,611&lt;/span&gt; during the three months ended September 30, 2021.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;PROPANC
BIOPHARMA, INC. AND SUBSIDIARY&lt;br/&gt;
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&lt;br/&gt;
SEPTEMBER 30, 2021&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;(Unaudited)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;i&gt;Nathanielsz
Cancellation Agreement&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 16.2pt; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;On
August 12, 2021, the Company entered into a Cancellation Agreement with James Nathanielsz (&#x201c;Nathanielsz&#x201d;), Chief Executive
Officer and Director of the Company, whereby Nathanielsz agreed to cancel his cash compensation bonus award for fiscal year 2021, ended
June 30, 2021, in exchange for common stock of the Company. The Company and Nathanielsz entered into an Amended and Restated Employment
Agreement dated May 14, 2019 (the &#x201c;Agreement&#x201d;). Pursuant to the terms of the Agreement, Nathanielsz was eligible to earn
an annual fiscal year cash performance bonus for each fiscal year of his employment period with the Company with a target performance
bonus of &lt;span id="xdx_901_ecustom--PercentageOfBonusOfAnnualBaseSalary_dp_uPure_c20210811__20210812__us-gaap--TypeOfArrangementAxis__custom--NathanielszCancellationAgreementMember_zCLC1GCuYMa7" title="Percentage of bonus of annual base salary"&gt;200&lt;/span&gt;% of his average annualized base salary during the fiscal year for which the performance bonus is earned. On July 20, 2021,
Nathanielsz was awarded a &#x201c;target&#x201d; bonus of &lt;span id="xdx_908_ecustom--PercentageOfBonusOfAnnualBaseSalary_pip0_dp_uPure_c20210719__20210720__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember__us-gaap--TypeOfArrangementAxis__custom--NathanielszCancellationAgreementMember_zKevKhYlIuFh" title="Percentage of bonus of annual base salary"&gt;78&lt;/span&gt;%, or $&lt;span id="xdx_905_eus-gaap--OfficersCompensation_pp0p0_c20210719__20210720__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember__us-gaap--TypeOfArrangementAxis__custom--NathanielszCancellationAgreementMember_zKq0ik4XgMC9" title="Officer compensation"&gt;177,840&lt;/span&gt; USD (the &#x201c;Debt&#x201d;) for the fiscal year ended June
30, 2021, by the Company&#x2019;s Board of Directors (the &#x201c;Board&#x201d;). Pursuant to the Cancellation Agreement, Nathanielsz agreed
to cancel this Debt in exchange for &lt;span id="xdx_901_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_pp0p0_c20210816__20210817__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember__us-gaap--TypeOfArrangementAxis__custom--NathanielszCancellationAgreementMember_zpPnofWvhYb6"&gt;5,928,000&lt;/span&gt; shares of the common stock of the Company (the &#x201c;Shares&#x201d;), valued at approximately
$&lt;span id="xdx_905_eus-gaap--SharePrice_iI_pip0_c20210817__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember__us-gaap--TypeOfArrangementAxis__custom--NathanielszCancellationAgreementMember_zUmi0N2se0X9"&gt;0.03&lt;/span&gt; per share or $&lt;span id="xdx_908_eus-gaap--CommonStockValue_iI_pip0_c20210817__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember__us-gaap--TypeOfArrangementAxis__custom--NathanielszCancellationAgreementMember_zbVq3HjJ3BKl" title="Common stock value issued"&gt;186,139&lt;/span&gt;, being the closing price of the stock on the date of grant. The shares were issued on August 17, 2021. The
Company recorded stock-based compensation of $&lt;span id="xdx_906_eus-gaap--ShareBasedCompensation_c20210811__20210812__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember_z2hsC7wZ1qEc"&gt;8,299&lt;/span&gt; during the three months ended September 30, 2021 and reclassified bonus payable of
$&lt;span id="xdx_90E_eus-gaap--AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_c20210811__20210812__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember_zZbHY9PisvJa"&gt;177,840&lt;/span&gt; to additional paid in capital upon issuance.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 16.2pt; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;i&gt;Kenyon
Cancellation Agreement&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 16.2pt; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;On
August 12, 2021, the Company entered into a Cancellation Agreement with Dr. Julian Kenyon (&#x201c;Kenyon&#x201d;), Chief Scientific Officer
and Director of the Company, whereby Kenyon agreed to cancel of $&lt;span id="xdx_90F_eus-gaap--AccruedSalariesCurrent_iI_c20210812__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__custom--DeferredSalaryMember__us-gaap--TypeOfArrangementAxis__custom--CancellationAgreementMember_z2xZEAt3OBL9" title="Acccrued salary cancellation"&gt;102,600&lt;/span&gt; USD of accrued salary due him as of June 30, 2021, pursuant
to that certain Amended and Restated Services Agreement by and between Kenyon and the Company, dated May 14, 2019, in exchange for &lt;span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesEmployeeBenefitPlan_c20210811__20210812__srt--TitleOfIndividualAxis__custom--ChiefScientificOfficerandDirectorMember_zLyw61W3dj94"&gt;3,420,000&lt;/span&gt;
shares of common stock of the Company (the &#x201c;Shares&#x201d;), valued at approximately $&lt;span id="xdx_90F_eus-gaap--SharesIssuedPricePerShare_iI_c20210812__srt--TitleOfIndividualAxis__custom--ChiefScientificOfficerandDirectorMember_zusxu36XXajd"&gt;0.03&lt;/span&gt; per share or $&lt;span id="xdx_901_eus-gaap--CommonStockValue_iI_c20210812__srt--TitleOfIndividualAxis__custom--ChiefScientificOfficerandDirectorMember_zliyf6nhtHR6"&gt;107,388&lt;/span&gt;, being the closing
price of the stock on the date of grant. The shares were issued on August 17, 2021. The Company recorded stock-based compensation of
$&lt;span id="xdx_906_eus-gaap--ShareBasedCompensation_c20210811__20210812__srt--TitleOfIndividualAxis__custom--ChiefScientificOfficerandDirectorMember_zGsvqby85h3c"&gt;4,788&lt;/span&gt; during the three months ended September 30, 2021 and reclassified accrued expenses of $&lt;span id="xdx_909_eus-gaap--AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_c20210701__20210930__srt--TitleOfIndividualAxis__custom--ChiefScientificOfficerandDirectorMember_z7o5PXxcehH6"&gt;102,600&lt;/span&gt; to additional paid in capital upon
issuance.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 16.2pt; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;i&gt;Zelinger
Amended and Restated Director Agreement&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;On
August 12, 2021, the Company entered into an Amended and Restated Director Agreement (the &#x201c;Director Agreement&#x201d;) with Josef
Zelinger (&#x201c;Zelinger&#x201d;). &lt;span id="xdx_908_ecustom--DescriptionOfEmploymentBenefits_c20210811__20210812__us-gaap--TypeOfArrangementAxis__custom--ZelingerAmendedAndRestatedDirectorAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--JosefZelingerMember_zIafOWlVGFbj"&gt;Pursuant
to the terms of the Director Agreement, the Company shall pay Zelinger a base salary of $250.00 AUD ($184 USD) per month, payable
on the first day of each month. In addition, the Company may compensate Zelinger additional consideration for advisory services performed
by the Director, either in the form of cash or common stock, at the discretion of the Board. The Company issued &lt;span id="xdx_906_ecustom--CommonStockIssuableShares_iI_c20210630__us-gaap--TypeOfArrangementAxis__custom--ZelingerAmendedAndRestatedDirectorAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--JosefZelingerMember_z131fYPKaMck"&gt;2,800,000&lt;/span&gt; shares of common
stock of the Company for accrued director services of $&lt;span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20200701__20210630__us-gaap--TypeOfArrangementAxis__custom--ZelingerAmendedAndRestatedDirectorAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--JosefZelingerMember_zIbg2u8ptUkg"&gt;84,000&lt;/span&gt; as of June 30, 2021. &lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
&lt;span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210701__20210930__us-gaap--TypeOfArrangementAxis__custom--ZelingerAmendedAndRestatedDirectorAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--JosefZelingerMember_zSaHuhy3dBU3"&gt;2,800,000&lt;/span&gt; shares of common stock were valued at approximately $&lt;span id="xdx_90E_eus-gaap--SharePrice_iI_c20210630__us-gaap--TypeOfArrangementAxis__custom--ZelingerAmendedAndRestatedDirectorAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--JosefZelingerMember_zz6ANSdBV52g"&gt;0.03&lt;/span&gt; per share $&lt;span id="xdx_900_eus-gaap--CommonStockValue_iI_c20210630__us-gaap--TypeOfArrangementAxis__custom--ZelingerAmendedAndRestatedDirectorAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--JosefZelingerMember_zYgCEmlb6eEk" title="Common stock value issued"&gt;87,920&lt;/span&gt;, being the closing price of the stock on
the date of grant. The shares were issued on August 17, 2021. The shares were issued on August 17, 2021. The Company recorded stock-based
compensation of $&lt;span id="xdx_909_eus-gaap--ShareBasedCompensation_c20210811__20210812__us-gaap--TypeOfArrangementAxis__custom--ZelingerAmendedAndRestatedDirectorAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--JosefZelingerMember_z1xSDZC815Fc"&gt;3,920&lt;/span&gt; during the three months ended September 30, 2021 and reclassified accrued expenses of $&lt;span id="xdx_908_eus-gaap--AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_c20210701__20210930__us-gaap--TypeOfArrangementAxis__custom--ZelingerAmendedAndRestatedDirectorAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--JosefZelingerMember_zORHCYFlOc3e"&gt;84,000&lt;/span&gt; to additional paid
in capital upon issuance.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Shares
issued for exercise of warrants&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;From
July 9, 2021 through September 27, 2021, the Company received aggregate gross proceeds of $&lt;span id="xdx_904_eus-gaap--ProceedsFromIssuanceOfWarrants_c20210706__20210927_z5sFNnoMpkTi" title="Proceed from issuance of excercise of warrants"&gt;275,000&lt;/span&gt; and subscription receivable of $&lt;span id="xdx_90D_eus-gaap--StockholdersEquityNoteSubscriptionsReceivable_iI_c20210927_zo8TfwJL1jL1"&gt;100,000&lt;/span&gt;
from the exercise of &lt;span id="xdx_900_eus-gaap--ProceedsFromIssuanceOfWarrants_c20210706__20210927__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantMember_zwQsIV6YL6Cc"&gt;9,375&lt;/span&gt; Series B Warrants and issued &lt;span id="xdx_905_eus-gaap--CommonStockSharesIssued_iI_c20210927__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantMember_zszZpjZ3dgD8" title="Common stock shares issued"&gt;6,875&lt;/span&gt; shares of common stock and &lt;span id="xdx_907_eus-gaap--CommonStockSharesAuthorized_iI_c20210930__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantMember_zLPnNDXAyZG7" title="Common stock, shares authorized"&gt;2,500 &lt;/span&gt;shares of common stock issuable
as of September 30, 2021.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;During
the three months ended September 30, 2021, additionally, the Company issued &lt;span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210701__20210930_zsi5duzQcmTj"&gt;2,399,988&lt;/span&gt; shares of common stock and &lt;span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesOther_c20210701__20210930_zimIlaUtcoaf"&gt;1,999,990&lt;/span&gt; shares
of common stock issuable from the alternate cashless exercise of 22 Series A warrants. The Company recognized the value of the effect
of a down round feature in such warrants when triggered. Upon the occurrence of the triggering event that resulted in a reduction of
the strike price, the Company measured the value of the effect of the feature as the difference between the fair value of the warrants
without the down round feature or before the strike price reduction and the fair value of the warrants with a strike price corresponding
to the reduced strike price upon the down round feature being triggered. Accordingly, the Company recognized deemed dividend of $&lt;span id="xdx_903_ecustom--DeemedDividend_iN_di_c20210701__20210930_zdxR4qPLScJj" title="Deemed dividend"&gt;114,844&lt;/span&gt;
and a corresponding reduction of income available to common stockholders upon the alternate cashless exercise of these warrants.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;A
total of &lt;span id="xdx_903_eus-gaap--CommonStockSharesAuthorized_iI_c20211031_zquk7yMxY55l"&gt;2,002,490&lt;/span&gt; common stock issuable were issued in October 2021. The Company collected the $&lt;span id="xdx_903_eus-gaap--StockholdersEquityNoteSubscriptionsReceivable_iI_c20211031_zQiFphOIPdbf"&gt;100,000&lt;/span&gt; subscription receivable in October
2021.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;PROPANC
BIOPHARMA, INC. AND SUBSIDIARY&lt;br/&gt;
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&lt;br/&gt;
SEPTEMBER 30, 2021&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;(Unaudited)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Warrants:&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_896_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zHpSNYZ0bJ83" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
following table summarizes warrant activity for the three months ended September 30, 2021:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;span id="xdx_8BD_zTCyL2jDJay7" style="display: none"&gt;SCHEDULE
OF WARRANT ACTIVITY&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Weighted&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Number of&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Average&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Price
    Per Share&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Outstanding at June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20210701__20210930_zbSgfIZiHED6" style="width: 14%; text-align: right" title="Number of Shares, Outstanding, Beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;121,329&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageOutstanding_iS_c20210701__20210930_zoMmctVkyGj8" style="width: 14%; text-align: right" title="Weighted Average Price Per Share, Outstanding, Beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;179.63&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Issued&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsIssued_c20210701__20210930_ztsKXhp7ND3b" style="text-align: right" title="Number of Shares, Issued"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3731"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceIssued_c20210701__20210930_zxIyHmTNnHjk" style="text-align: right" title="Weighted Average Price Per Share, Issued"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3733"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_di_c20210701__20210930_z2qjat9AzCb5" style="text-align: right" title="Number of Shares, Exercised"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(9,397&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceExercised_c20210701__20210930_z5aPDFIJ5t9a" style="text-align: right" title="Weighted Average Price Per Share, Exercised"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;40.37&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_c20210701__20210930_zUF4dPx3cbCj" style="text-align: right" title="Number of Shares, Forfeited"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3739"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceExpired_c20210701__20210930_zUExwkkX8E9c" style="text-align: right" title="Weighted Average Price Per Share, Forfeited"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3741"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Expired&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_c20210701__20210930_zRsiiaMbQBUe" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Shares, Expired"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3743"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceForfeited_c20210701__20210930_zcVGq2jY8Xsl" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Price Per Share, Expired"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3745"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Outstanding at September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_c20210701__20210930_zEeLCD9yTkk1" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Shares, Outstanding, Ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;111,932&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageOutstanding_iE_c20210701__20210930_zwi2Nr1IeWxh" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Price Per Share, Outstanding, Ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;191.32&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Exercisable at September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_iE_c20210701__20210930_zrodIa8LyCSj" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Shares, Exercisable, Ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;76,933&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisable_iE_c20210701__20210930_zdX6Ygyia1Ri" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Price Per Share, Exercisable, Ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;278.36&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Outstanding and Exercisable:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Weighted average remaining contractual
    term&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20210701__20210930_zfPJb5ld6tyk" title="Weighted average remaining contractual term"&gt;1.52&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Aggregate intrinsic
    value &lt;br/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsAggregateIntrinsicValueOutstanding_iE_pp0p0_c20210701__20210930_z7SavXjqef7j" style="border-bottom: Black 1.5pt solid; text-align: right" title="Aggregate intrinsic value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3757"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A6_zjhyyGBCVHqg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;No
stock warrants were granted during the three months ended September 30, 2021.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Options:&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89C_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zoqy7CeBTuXf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;A
summary of the Company&#x2019;s option activity during the three months ended September 30, 2021 is presented below:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;span id="xdx_8B4_zmh1iYU4qpng" style="display: none"&gt;SCHEDULE
OF STOCK OPTION ACTIVITY&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Weighted&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Number of&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Average Exercise&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Price
    Per Share&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Outstanding at June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20210701__20210930_z51ifCEyQQS9" style="width: 14%; text-align: right" title="Number of Shares, Outstanding, Beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;59&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20210701__20210930_z0rx5Kwkyr14" style="width: 14%; text-align: right" title="Weighted Average Price Per Share, Outstanding, Beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;13,730&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Issued&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_c20210701__20210930_zOKcK7k2XQW1" style="text-align: right" title="Number of Shares, Issued"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3765"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20210701__20210930_zHBULMkZ5u8" style="text-align: right" title="Weighted Average Price Per Share, Issued"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3767"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20210701__20210930_zTZzX1tDCJqa" style="text-align: right" title="Number of Shares, Exercised"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3769"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20210701__20210930_z5HJiarD8QA7" style="text-align: right" title="Weighted Average Price Per Share, Exercised"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3771"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c20210701__20210930_zqSUqZrPkma7" style="text-align: right" title="Number of Shares, Forfeited"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3773"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20210701__20210930_zzLJvnToAvj9" style="text-align: right" title="Weighted Average Price Per Share, Forfeited"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3775"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Expired&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_c20210701__20210930_zAfG2knRVrw1" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Shares, Expired"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3777"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_c20210701__20210930_zKPa4oYA71S5" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Price Per Share, Expired"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3779"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Outstanding at September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20210701__20210930_z8Qqg1bHEKp2" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Shares, Outstanding, Ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;59&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20210701__20210930_ztHIftIDn6gg" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Price Per Share, Outstanding, Ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,533.33&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Exercisable at September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_c20210701__20210930_z9SXbOqrLe0h" style="text-align: right" title="Number of Shares, Exercisable, Ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;39&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_c20210701__20210930_zACMHgTi7J44" style="text-align: right" title="Weighted Average Price Per Share, Exercisable, Ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,530.93&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Outstanding and Exercisable:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Weighted average remaining contractual
    term&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20210701__20210930_zcgS12ZloSe5" title="Weighted average remaining contractual term"&gt;7.62&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Weighted average fair value of options
    granted during the period&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90C_ecustom--WeightedAverageFairValueOfOptionsGrantedDuringPeriod_c20210701__20210930_zK8ntmlEsHa3" title="Weighted average fair value of options granted during the period"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3791"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Aggregate intrinsic value&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pp0p0_c20210701__20210930_zKVspuFDvKc6" style="border-bottom: Black 1.5pt solid; text-align: right" title="Aggregate intrinsic value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3793"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A1_zOOS3tjEAv44" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;During
the three months ended September 30, 2021 and 2020, the Company recognized stock-based compensation of $&lt;span id="xdx_908_eus-gaap--ShareBasedCompensation_pp0p0_c20210701__20210930_zn2UUDzW4jE1" title="Share based compensation"&gt;20,718&lt;/span&gt; and $&lt;span id="xdx_907_eus-gaap--ShareBasedCompensation_pp0p0_c20200701__20200930_zT8ZskpYfuei" title="Share based compensation"&gt;20,718&lt;/span&gt;, respectively
related to vested stock options. There was $&lt;span id="xdx_902_eus-gaap--StockOptionPlanExpense_pp0p0_c20210701__20210930_z8rKDxyiF0Bg" title="Stock option expense"&gt;51,796&lt;/span&gt; of unvested stock options expense as of September 30, 2021 that will be recognized
through May 2022 or &lt;span id="xdx_908_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20210331_zm4C5sNPiXLf" title="Term of warrant"&gt;0.62&lt;/span&gt; years.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;No
stock options were granted during the three months ended September 30, 2021.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2021-02-03" decimals="INF" unitRef="Shares">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2021-02-04" decimals="INF" unitRef="Shares">1000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:StockholdersEquityReverseStockSplit contextRef="From2020-11-162020-11-17">one-for-one thousand (1:1,000)</us-gaap:StockholdersEquityReverseStockSplit>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2021-09-30" decimals="INF" unitRef="Shares">1500005</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2021-09-30"
      decimals="INF"
      unitRef="USDPShares">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2021-09-30_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      unitRef="Shares">500000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2021-09-30_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      unitRef="Shares">500000</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2021-09-30_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      unitRef="Shares">500000</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2020-09-30_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      unitRef="Shares">500000</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2020-09-30_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      unitRef="Shares">500000</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2021-07-012021-09-30_custom_SecurityPurchaseAgreementMember"
      decimals="INF"
      unitRef="Shares">9445009</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="AsOf2021-09-30_custom_SecurityPurchaseAgreementMember"
      decimals="INF"
      unitRef="USDPShares">0.02</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="AsOf2021-09-30_custom_SecurityPurchaseAgreementMember_srt_MinimumMember"
      decimals="INF"
      unitRef="USDPShares">0.02</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="AsOf2021-09-30_custom_SecurityPurchaseAgreementMember_srt_MaximumMember"
      decimals="INF"
      unitRef="USDPShares">0.04</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2021-09-30_custom_SecurityPurchaseAgreementMember"
      decimals="0"
      unitRef="USD">189849</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="AsOf2021-09-30_custom_SecurityPurchaseAgreementMember"
      decimals="0"
      unitRef="USD">8087</us-gaap:InterestPayableCurrentAndNoncurrent>
    <PPCB:ConversionFees
      contextRef="From2021-07-012021-09-30_custom_SecurityPurchaseAgreementMember"
      decimals="0"
      unitRef="USD">2250</PPCB:ConversionFees>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="From2021-07-012021-09-30_custom_SecurityPurchaseAgreementMember"
      decimals="0"
      unitRef="USD">200186</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <PPCB:PremiumsToAdditionalPaidInCapital
      contextRef="From2021-07-012021-09-30_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">109643</PPCB:PremiumsToAdditionalPaidInCapital>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2021-07-012021-09-30_custom_UnderlyingFinancingAgreementsMember"
      decimals="INF"
      unitRef="Shares">197308116</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeBenefitPlan
      contextRef="From2021-08-112021-08-12_custom_CommonStockOneMember"
      decimals="INF"
      unitRef="Shares">2800000</us-gaap:StockIssuedDuringPeriodSharesEmployeeBenefitPlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan
      contextRef="From2021-08-112021-08-12_custom_CommonStockOneMember"
      decimals="0"
      unitRef="USD">84000</us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2021-08-112021-08-12_custom_CommonStockOneMember"
      decimals="INF"
      unitRef="Shares">2800000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2021-08-12_custom_CommonStockOneMember"
      decimals="INF"
      unitRef="USDPShares">0.03</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:CommonStockValue
      contextRef="AsOf2021-08-12_custom_CommonStockOneMember"
      decimals="0"
      unitRef="USD">87920</us-gaap:CommonStockValue>
    <us-gaap:ShareBasedCompensation
      contextRef="From2021-07-012021-09-30_custom_CommonStockOneMember"
      decimals="0"
      unitRef="USD">3920</us-gaap:ShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="From2021-07-012021-09-30_custom_CommonStockOneMember"
      decimals="0"
      unitRef="USD">84000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeBenefitPlan
      contextRef="From2021-08-112021-08-12_custom_LegalServicesMember"
      decimals="INF"
      unitRef="Shares">166667</us-gaap:StockIssuedDuringPeriodSharesEmployeeBenefitPlan>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2021-08-12_custom_LegalServicesMember"
      decimals="INF"
      unitRef="USDPShares">0.05</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:CommonStockValue
      contextRef="AsOf2021-08-12_custom_LegalServicesMember"
      decimals="0"
      unitRef="USD">7883</us-gaap:CommonStockValue>
    <us-gaap:ShareBasedCompensation
      contextRef="From2021-07-012021-09-30_custom_LegalServicesMember"
      decimals="0"
      unitRef="USD">7883</us-gaap:ShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeBenefitPlan
      contextRef="From2021-09-292021-09-30_custom_ConsultantServicesMember"
      decimals="INF"
      unitRef="Shares">2819712</us-gaap:StockIssuedDuringPeriodSharesEmployeeBenefitPlan>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2021-08-12_custom_ConsultantServicesMember"
      decimals="INF"
      unitRef="USDPShares">0.04</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:CommonStockValue
      contextRef="AsOf2021-08-12_custom_ConsultantServicesMember"
      decimals="0"
      unitRef="USD">104611</us-gaap:CommonStockValue>
    <us-gaap:ShareBasedCompensation
      contextRef="From2021-07-012021-09-30_custom_ConsultantServicesMember"
      decimals="0"
      unitRef="USD">104611</us-gaap:ShareBasedCompensation>
    <PPCB:PercentageOfBonusOfAnnualBaseSalary
      contextRef="From2021-08-112021-08-12_custom_NathanielszCancellationAgreementMember"
      decimals="INF"
      unitRef="Pure">2</PPCB:PercentageOfBonusOfAnnualBaseSalary>
    <PPCB:PercentageOfBonusOfAnnualBaseSalary
      contextRef="From2021-07-192021-07-20_custom_MrNathanielszMember_custom_NathanielszCancellationAgreementMember"
      decimals="INF"
      unitRef="Pure">0.78</PPCB:PercentageOfBonusOfAnnualBaseSalary>
    <us-gaap:OfficersCompensation
      contextRef="From2021-07-192021-07-20_custom_MrNathanielszMember_custom_NathanielszCancellationAgreementMember"
      decimals="0"
      unitRef="USD">177840</us-gaap:OfficersCompensation>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1
      contextRef="From2021-08-162021-08-17_custom_MrNathanielszMember_custom_NathanielszCancellationAgreementMember"
      decimals="0"
      unitRef="Shares">5928000</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <us-gaap:SharePrice
      contextRef="AsOf2021-08-17_custom_MrNathanielszMember_custom_NathanielszCancellationAgreementMember"
      decimals="INF"
      unitRef="USDPShares">0.03</us-gaap:SharePrice>
    <us-gaap:CommonStockValue
      contextRef="AsOf2021-08-17_custom_MrNathanielszMember_custom_NathanielszCancellationAgreementMember"
      decimals="0"
      unitRef="USD">186139</us-gaap:CommonStockValue>
    <us-gaap:ShareBasedCompensation
      contextRef="From2021-08-112021-08-12_custom_MrNathanielszMember"
      decimals="0"
      unitRef="USD">8299</us-gaap:ShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="From2021-08-112021-08-12_custom_MrNathanielszMember"
      decimals="0"
      unitRef="USD">177840</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:AccruedSalariesCurrent
      contextRef="AsOf2021-08-12_custom_DeferredSalaryMember_custom_CancellationAgreementMember"
      decimals="0"
      unitRef="USD">102600</us-gaap:AccruedSalariesCurrent>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeBenefitPlan
      contextRef="From2021-08-112021-08-12_custom_ChiefScientificOfficerandDirectorMember"
      decimals="INF"
      unitRef="Shares">3420000</us-gaap:StockIssuedDuringPeriodSharesEmployeeBenefitPlan>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2021-08-12_custom_ChiefScientificOfficerandDirectorMember"
      decimals="INF"
      unitRef="USDPShares">0.03</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:CommonStockValue
      contextRef="AsOf2021-08-12_custom_ChiefScientificOfficerandDirectorMember"
      decimals="0"
      unitRef="USD">107388</us-gaap:CommonStockValue>
    <us-gaap:ShareBasedCompensation
      contextRef="From2021-08-112021-08-12_custom_ChiefScientificOfficerandDirectorMember"
      decimals="0"
      unitRef="USD">4788</us-gaap:ShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="From2021-07-012021-09-30_custom_ChiefScientificOfficerandDirectorMember"
      decimals="0"
      unitRef="USD">102600</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <PPCB:DescriptionOfEmploymentBenefits contextRef="From2021-08-112021-08-12_custom_ZelingerAmendedAndRestatedDirectorAgreementMember_custom_JosefZelingerMember">Pursuant
to the terms of the Director Agreement, the Company shall pay Zelinger a base salary of $250.00 AUD ($184 USD) per month, payable
on the first day of each month. In addition, the Company may compensate Zelinger additional consideration for advisory services performed
by the Director, either in the form of cash or common stock, at the discretion of the Board. The Company issued 2,800,000 shares of common
stock of the Company for accrued director services of $84,000 as of June 30, 2021.</PPCB:DescriptionOfEmploymentBenefits>
    <PPCB:CommonStockIssuableShares
      contextRef="AsOf2021-06-30_custom_ZelingerAmendedAndRestatedDirectorAgreementMember_custom_JosefZelingerMember"
      decimals="INF"
      unitRef="Shares">2800000</PPCB:CommonStockIssuableShares>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2020-07-012021-06-30_custom_ZelingerAmendedAndRestatedDirectorAgreementMember_custom_JosefZelingerMember"
      decimals="0"
      unitRef="USD">84000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2021-07-012021-09-30_custom_ZelingerAmendedAndRestatedDirectorAgreementMember_custom_JosefZelingerMember"
      decimals="INF"
      unitRef="Shares">2800000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharePrice
      contextRef="AsOf2021-06-30_custom_ZelingerAmendedAndRestatedDirectorAgreementMember_custom_JosefZelingerMember"
      decimals="INF"
      unitRef="USDPShares">0.03</us-gaap:SharePrice>
    <us-gaap:CommonStockValue
      contextRef="AsOf2021-06-30_custom_ZelingerAmendedAndRestatedDirectorAgreementMember_custom_JosefZelingerMember"
      decimals="0"
      unitRef="USD">87920</us-gaap:CommonStockValue>
    <us-gaap:ShareBasedCompensation
      contextRef="From2021-08-112021-08-12_custom_ZelingerAmendedAndRestatedDirectorAgreementMember_custom_JosefZelingerMember"
      decimals="0"
      unitRef="USD">3920</us-gaap:ShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="From2021-07-012021-09-30_custom_ZelingerAmendedAndRestatedDirectorAgreementMember_custom_JosefZelingerMember"
      decimals="0"
      unitRef="USD">84000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:ProceedsFromIssuanceOfWarrants
      contextRef="From2021-07-062021-09-27"
      decimals="0"
      unitRef="USD">275000</us-gaap:ProceedsFromIssuanceOfWarrants>
    <us-gaap:StockholdersEquityNoteSubscriptionsReceivable contextRef="AsOf2021-09-27" decimals="0" unitRef="USD">100000</us-gaap:StockholdersEquityNoteSubscriptionsReceivable>
    <us-gaap:ProceedsFromIssuanceOfWarrants
      contextRef="From2021-07-062021-09-27_custom_SeriesBWarrantMember"
      decimals="0"
      unitRef="USD">9375</us-gaap:ProceedsFromIssuanceOfWarrants>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2021-09-27_custom_SeriesBWarrantMember"
      decimals="INF"
      unitRef="Shares">6875</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2021-09-30_custom_SeriesBWarrantMember"
      decimals="INF"
      unitRef="Shares">2500</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2021-07-01to2021-09-30"
      decimals="INF"
      unitRef="Shares">2399988</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesOther
      contextRef="From2021-07-01to2021-09-30"
      decimals="INF"
      unitRef="Shares">1999990</us-gaap:StockIssuedDuringPeriodSharesOther>
    <PPCB:DeemedDividend
      contextRef="From2021-07-01to2021-09-30"
      decimals="0"
      unitRef="USD">-114844</PPCB:DeemedDividend>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2021-10-31" decimals="INF" unitRef="Shares">2002490</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:StockholdersEquityNoteSubscriptionsReceivable contextRef="AsOf2021-10-31" decimals="0" unitRef="USD">100000</us-gaap:StockholdersEquityNoteSubscriptionsReceivable>
    <us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock contextRef="From2021-07-01to2021-09-30">&lt;p id="xdx_896_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zHpSNYZ0bJ83" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
following table summarizes warrant activity for the three months ended September 30, 2021:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;span id="xdx_8BD_zTCyL2jDJay7" style="display: none"&gt;SCHEDULE
OF WARRANT ACTIVITY&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Weighted&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Number of&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Average&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Price
    Per Share&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Outstanding at June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20210701__20210930_zbSgfIZiHED6" style="width: 14%; text-align: right" title="Number of Shares, Outstanding, Beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;121,329&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageOutstanding_iS_c20210701__20210930_zoMmctVkyGj8" style="width: 14%; text-align: right" title="Weighted Average Price Per Share, Outstanding, Beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;179.63&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Issued&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsIssued_c20210701__20210930_ztsKXhp7ND3b" style="text-align: right" title="Number of Shares, Issued"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3731"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceIssued_c20210701__20210930_zxIyHmTNnHjk" style="text-align: right" title="Weighted Average Price Per Share, Issued"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3733"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_di_c20210701__20210930_z2qjat9AzCb5" style="text-align: right" title="Number of Shares, Exercised"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(9,397&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceExercised_c20210701__20210930_z5aPDFIJ5t9a" style="text-align: right" title="Weighted Average Price Per Share, Exercised"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;40.37&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_c20210701__20210930_zUF4dPx3cbCj" style="text-align: right" title="Number of Shares, Forfeited"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3739"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceExpired_c20210701__20210930_zUExwkkX8E9c" style="text-align: right" title="Weighted Average Price Per Share, Forfeited"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3741"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Expired&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_c20210701__20210930_zRsiiaMbQBUe" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Shares, Expired"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3743"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceForfeited_c20210701__20210930_zcVGq2jY8Xsl" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Price Per Share, Expired"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3745"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Outstanding at September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_c20210701__20210930_zEeLCD9yTkk1" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Shares, Outstanding, Ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;111,932&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageOutstanding_iE_c20210701__20210930_zwi2Nr1IeWxh" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Price Per Share, Outstanding, Ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;191.32&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Exercisable at September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_iE_c20210701__20210930_zrodIa8LyCSj" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Shares, Exercisable, Ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;76,933&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisable_iE_c20210701__20210930_zdX6Ygyia1Ri" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Price Per Share, Exercisable, Ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;278.36&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Outstanding and Exercisable:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Weighted average remaining contractual
    term&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20210701__20210930_zfPJb5ld6tyk" title="Weighted average remaining contractual term"&gt;1.52&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Aggregate intrinsic
    value &lt;br/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsAggregateIntrinsicValueOutstanding_iE_pp0p0_c20210701__20210930_z7SavXjqef7j" style="border-bottom: Black 1.5pt solid; text-align: right" title="Aggregate intrinsic value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3757"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber contextRef="AsOf2021-06-30" decimals="INF" unitRef="Shares">121329</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <PPCB:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageOutstanding
      contextRef="AsOf2021-06-30"
      decimals="INF"
      unitRef="USDPShares">179.63</PPCB:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageOutstanding>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
      contextRef="From2021-07-01to2021-09-30"
      decimals="INF"
      unitRef="Shares">9397</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised>
    <PPCB:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceExercised
      contextRef="From2021-07-01to2021-09-30"
      decimals="INF"
      unitRef="USDPShares">40.37</PPCB:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceExercised>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber contextRef="AsOf2021-09-30" decimals="INF" unitRef="Shares">111932</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <PPCB:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageOutstanding
      contextRef="AsOf2021-09-30"
      decimals="INF"
      unitRef="USDPShares">191.32</PPCB:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageOutstanding>
    <PPCB:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber contextRef="AsOf2021-09-30" decimals="INF" unitRef="Shares">76933</PPCB:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber>
    <PPCB:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisable
      contextRef="AsOf2021-09-30"
      decimals="INF"
      unitRef="USDPShares">278.36</PPCB:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisable>
    <PPCB:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerms contextRef="From2021-07-01to2021-09-30">P1Y6M7D</PPCB:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerms>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="From2021-07-01to2021-09-30">&lt;p id="xdx_89C_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zoqy7CeBTuXf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;A
summary of the Company&#x2019;s option activity during the three months ended September 30, 2021 is presented below:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;span id="xdx_8B4_zmh1iYU4qpng" style="display: none"&gt;SCHEDULE
OF STOCK OPTION ACTIVITY&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Weighted&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Number of&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Average Exercise&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Price
    Per Share&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Outstanding at June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20210701__20210930_z51ifCEyQQS9" style="width: 14%; text-align: right" title="Number of Shares, Outstanding, Beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;59&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20210701__20210930_z0rx5Kwkyr14" style="width: 14%; text-align: right" title="Weighted Average Price Per Share, Outstanding, Beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;13,730&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Issued&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_c20210701__20210930_zOKcK7k2XQW1" style="text-align: right" title="Number of Shares, Issued"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3765"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20210701__20210930_zHBULMkZ5u8" style="text-align: right" title="Weighted Average Price Per Share, Issued"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3767"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20210701__20210930_zTZzX1tDCJqa" style="text-align: right" title="Number of Shares, Exercised"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3769"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20210701__20210930_z5HJiarD8QA7" style="text-align: right" title="Weighted Average Price Per Share, Exercised"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3771"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c20210701__20210930_zqSUqZrPkma7" style="text-align: right" title="Number of Shares, Forfeited"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3773"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20210701__20210930_zzLJvnToAvj9" style="text-align: right" title="Weighted Average Price Per Share, Forfeited"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3775"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Expired&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_c20210701__20210930_zAfG2knRVrw1" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Shares, Expired"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3777"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_c20210701__20210930_zKPa4oYA71S5" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Price Per Share, Expired"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3779"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Outstanding at September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20210701__20210930_z8Qqg1bHEKp2" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Shares, Outstanding, Ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;59&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20210701__20210930_ztHIftIDn6gg" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Price Per Share, Outstanding, Ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,533.33&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Exercisable at September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_c20210701__20210930_z9SXbOqrLe0h" style="text-align: right" title="Number of Shares, Exercisable, Ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;39&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_c20210701__20210930_zACMHgTi7J44" style="text-align: right" title="Weighted Average Price Per Share, Exercisable, Ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,530.93&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Outstanding and Exercisable:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Weighted average remaining contractual
    term&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20210701__20210930_zcgS12ZloSe5" title="Weighted average remaining contractual term"&gt;7.62&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Weighted average fair value of options
    granted during the period&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90C_ecustom--WeightedAverageFairValueOfOptionsGrantedDuringPeriod_c20210701__20210930_zK8ntmlEsHa3" title="Weighted average fair value of options granted during the period"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3791"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Aggregate intrinsic value&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pp0p0_c20210701__20210930_zKVspuFDvKc6" style="border-bottom: Black 1.5pt solid; text-align: right" title="Aggregate intrinsic value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3793"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2021-06-30" decimals="INF" unitRef="Shares">59</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2021-06-30"
      decimals="INF"
      unitRef="USDPShares">13730</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2021-09-30" decimals="INF" unitRef="Shares">59</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2021-09-30"
      decimals="INF"
      unitRef="USDPShares">4533.33</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber contextRef="AsOf2021-09-30" decimals="INF" unitRef="Shares">39</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="AsOf2021-09-30"
      decimals="INF"
      unitRef="USDPShares">4530.93</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2021-07-01to2021-09-30">P7Y7M13D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensation
      contextRef="From2021-07-01to2021-09-30"
      decimals="0"
      unitRef="USD">20718</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="From2020-07-012020-09-30"
      decimals="0"
      unitRef="USD">20718</us-gaap:ShareBasedCompensation>
    <us-gaap:StockOptionPlanExpense
      contextRef="From2021-07-01to2021-09-30"
      decimals="0"
      unitRef="USD">51796</us-gaap:StockOptionPlanExpense>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="AsOf2021-03-31">P0Y7M13D</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="From2021-07-01to2021-09-30">&lt;p id="xdx_802_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zlQYr0RERxR7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTE
8 &#x2013; &lt;span id="xdx_822_zCvLoL184dke"&gt;COMMITMENTS AND CONTINGENCIES&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Legal
Matters &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;From
time to time, the Company may be subject to litigation and claims arising in the ordinary course of business. The Company is not currently
a party to any material legal proceedings and the Company is not aware of any pending or threatened legal proceeding against the Company
that we believe could have a material adverse effect on our business, operating results, cash flows or financial condition.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;PROPANC
BIOPHARMA, INC. AND SUBSIDIARY&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;SEPTEMBER
30, 2021&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;(Unaudited)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;IRS
Liability&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;As
part of its requirement for having a foreign operating subsidiary, the Company&#x2019;s parent U.S. entity is required to file an informational
Form 5471 to the Internal Revenue Service (the &#x201c;IRS&#x201d;), which is a form that explains the nature of the relationship between
the foreign subsidiary and the parent company. From 2012 through the 2014, the Company did not file this form in a timely manner. As
a result of the non-timely filings, the Company incurred a penalty from the IRS in the amount of $&lt;span id="xdx_908_ecustom--LitigationPenaltyAmount_pp0p0_c20210701__20210930__us-gaap--AwardDateAxis__custom--From2012ThroughThe2014Member_zQxZ2XzPp4id"&gt;10,000&lt;/span&gt; per year, or $&lt;span id="xdx_904_ecustom--LitigationPenaltyAmount_pp0p0_c20210701__20210930_zzLqRmwYUTjb"&gt;30,000&lt;/span&gt; in total,
plus accrued interest, such penalty and interest having been accrued and is included in the accrued expenses and other payable figure
in the September 30, 2021 and June 30, 2021 consolidated balance sheet. The Company recorded the penalties for all three years during
the year ended June 30, 2018. The Company is current on all subsequent filings. The Company&#x2019;s tax advisor is awaiting a response
from the IRS on this matter.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Operating
Agreements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;In
November 2009, the Company entered into a commercialization agreement with the University of Bath (UK) (the &#x201c;University&#x201d;)
whereby the Company and the University co-owned the intellectual property relating to the Company&#x2019;s pro-enzyme formulations. In
June 2012, the Company and the University entered into an assignment and amendment whereby the Company assumed full ownership of the
intellectual property while agreeing to pay royalties of&lt;span id="xdx_902_ecustom--OperatingLeasesIncomeStatementRevenuePercentage_dp_uPure_c20120601__20120630__us-gaap--TypeOfArrangementAxis__us-gaap--RoyaltyAgreementTermsMember_ztyPmoOVl0m"&gt; 2&lt;/span&gt;% of net revenues to the University. Additionally, the Company agreed to pay
&lt;span id="xdx_90B_ecustom--OperatingLeasesIncomeStatementRevenuePercentage_dp_uPure_c20120601__20120630__us-gaap--TypeOfArrangementAxis__us-gaap--LicenseAgreementTermsMember_zjfHUvOqUBS5"&gt;5&lt;/span&gt;% of each and every license agreement subscribed for. The contract is cancellable at any time by either party. To date, no amounts are
owed under the agreement.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Collaboration
Agreement&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;On
September 13, 2018, the Company entered into a two-year collaboration agreement with the University of Ja&#xe9;n (the &#x201c;University&#x201d;)
to provide certain research services to the Company. In consideration of such services, the Company agreed to pay the University approximately
&lt;span id="xdx_90F_ecustom--PaymentForServices_pp0p0_uEuro_c20180910__20180913__us-gaap--TypeOfArrangementAxis__custom--OneYearCollaborationAgreementMember__us-gaap--AwardTypeAxis__custom--EurosMember_zWkpdfYYRu61"&gt;52,000&lt;/span&gt; Euros ($&lt;span id="xdx_900_ecustom--PaymentForServices_pp0p0_c20180910__20180913__us-gaap--TypeOfArrangementAxis__custom--OneYearCollaborationAgreementMember_zUd5vTOCzQ34"&gt;59,508&lt;/span&gt; USD) in year one and a maximum of &lt;span id="xdx_900_ecustom--PaymentForServices_pp0p0_uEuro_c20180910__20180913__us-gaap--TypeOfArrangementAxis__custom--TwoYearCollaborationAgreementMember__us-gaap--AwardTypeAxis__custom--EurosMember_zP8v6QHtLfga"&gt;40,000&lt;/span&gt; Euros ($&lt;span id="xdx_900_ecustom--PaymentForServices_pp0p0_c20180910__20180913__us-gaap--TypeOfArrangementAxis__custom--TwoYearCollaborationAgreementMember_zkNNmUWYmXW5"&gt;45,775&lt;/span&gt; USD) in year two. The Company paid &lt;span id="xdx_90E_ecustom--PaymentForServices_pp0p0_uEuro_c20180701__20190630__us-gaap--AwardTypeAxis__custom--EurosMember_zV6KLypjQpK3"&gt;31,754&lt;/span&gt; Euros ($&lt;span id="xdx_907_ecustom--PaymentForServices_pp0p0_c20180701__20190630_z1VrPbRQIVrf"&gt;36,117&lt;/span&gt;
USD) in 2019 and has accrued &lt;span id="xdx_90E_ecustom--PaymentForServices_pp0p0_uEuro_c20200701__20210630__us-gaap--AwardTypeAxis__custom--EurosMember_z72xtbmgu1gc"&gt;28,493&lt;/span&gt; Euros ($&lt;span id="xdx_90C_ecustom--PaymentForServices_pp0p0_c20200701__20210630_zHpjlYof1Kx6"&gt;24,043&lt;/span&gt; USD) as of June 30, 2021. Additionally, in exchange for full ownership of the intellectual
property the Company agreed to pay royalties of &lt;span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20180910__20180913__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--RevenueFromRightsConcentrationRiskMember__srt--MajorCustomersAxis__custom--NoCustomerMember_zsWXu5YUxfk8"&gt;2&lt;/span&gt;% of net revenues to the University. On October 1, 2020, the Company entered into another
two-year collaboration agreement with the University of Ja&#xe9;n to provide certain research services to the Company. In consideration
of such services, the Company agreed to pay the University approximately &lt;span id="xdx_90E_ecustom--PaymentForServices_pp0p0_uEuro_c20200929__20201002__us-gaap--TypeOfArrangementAxis__custom--TwoYearCollaborationAgreementMember__us-gaap--AwardTypeAxis__custom--EurosMember_zD31kIGGvFNg"&gt;30,000&lt;/span&gt; Euros ($&lt;span id="xdx_90C_ecustom--PaymentForServices_pp0p0_c20200929__20201002__us-gaap--TypeOfArrangementAxis__custom--TwoYearCollaborationAgreementMember_z6moICqqXWrg"&gt;35,145&lt;/span&gt; USD) which shall be paid in four installment
payment of &lt;span id="xdx_90D_ecustom--PaymentForServices_pp0p0_uEuro_c20200929__20201002__us-gaap--TypeOfArrangementAxis__custom--TwoYearCollaborationAgreementMember__us-gaap--AwardTypeAxis__custom--EurosMember__us-gaap--AwardDateAxis__custom--InstallmentOneMember_zasnD79JF5wh"&gt;5,000&lt;/span&gt; Euros in November 2020, &lt;span id="xdx_90F_ecustom--PaymentForServices_pp0p0_uEuro_c20200929__20201002__us-gaap--TypeOfArrangementAxis__custom--TwoYearCollaborationAgreementMember__us-gaap--AwardDateAxis__custom--InstallmentTwoMember__us-gaap--AwardTypeAxis__custom--EurosMember_zIeQW14upxB2"&gt;5,000&lt;/span&gt; Euros ($&lt;span id="xdx_908_ecustom--PaymentForServices_pp0p0_c20200929__20201002__us-gaap--TypeOfArrangementAxis__custom--TwoYearCollaborationAgreementMember__us-gaap--AwardDateAxis__custom--InstallmentTwoMember_zxmP75oLG7Ne"&gt;5,858&lt;/span&gt;) in March 2021, &lt;span id="xdx_906_ecustom--PaymentForServices_pp0p0_uEuro_c20200929__20201002__us-gaap--TypeOfArrangementAxis__custom--TwoYearCollaborationAgreementMember__us-gaap--AwardDateAxis__custom--InstallmentThreeMember__us-gaap--AwardTypeAxis__custom--EurosMember_zYSrA2OWPOq7"&gt;10,000&lt;/span&gt; Euros ($&lt;span id="xdx_90B_ecustom--PaymentForServices_pp0p0_c20200929__20201002__us-gaap--TypeOfArrangementAxis__custom--TwoYearCollaborationAgreementMember__us-gaap--AwardDateAxis__custom--InstallmentThreeMember_zQDYB0y5rfZe"&gt;11,715&lt;/span&gt;) in December 2021 and &lt;span id="xdx_902_ecustom--PaymentForServices_pp0p0_uEuro_c20200929__20201002__us-gaap--TypeOfArrangementAxis__custom--TwoYearCollaborationAgreementMember__us-gaap--AwardDateAxis__custom--InstallmentFourMember__us-gaap--AwardTypeAxis__custom--EurosMember_zaZTGriMJiI1"&gt;10,000&lt;/span&gt; Euros
($&lt;span id="xdx_901_ecustom--PaymentForServices_pp0p0_c20200929__20201002__us-gaap--TypeOfArrangementAxis__custom--TwoYearCollaborationAgreementMember__us-gaap--AwardDateAxis__custom--InstallmentFourMember_zDU0Szg140si"&gt;11,715&lt;/span&gt;) in September 2022. Additionally, the University shall hire and train a doctoral student for this project and as such the Company
shall pay the University &lt;span id="xdx_90D_ecustom--PaymentForServices_pp0p0_uEuro_c20200929__20201002__dei--LegalEntityAxis__custom--UniversityOfJaenMember__us-gaap--AwardTypeAxis__custom--EurosMember_z2miFiRl7Wj1" title="Payment for services"&gt;25,837&lt;/span&gt; Euros ($&lt;span id="xdx_909_ecustom--PaymentForServices_pp0p0_c20200929__20201002__dei--LegalEntityAxis__custom--UniversityOfJaenMember_z20xuqnj98dl" title="Payment for services"&gt;30,268&lt;/span&gt; USD). In exchange for full ownership of the intellectual property the Company agreed to
pay royalties of&lt;span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20200929__20201002__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__dei--LegalEntityAxis__custom--UniversityOfJaenMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--RevenueFromRightsConcentrationRiskMember__srt--MajorCustomersAxis__custom--NoCustomerMember_zp48BunMv2Bj" title="Royalties percentage"&gt; 2&lt;/span&gt;% of net revenues to the University.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <PPCB:LitigationPenaltyAmount
      contextRef="From2021-07-012021-09-30_custom_From2012ThroughThe2014Member"
      decimals="0"
      unitRef="USD">10000</PPCB:LitigationPenaltyAmount>
    <PPCB:LitigationPenaltyAmount
      contextRef="From2021-07-01to2021-09-30"
      decimals="0"
      unitRef="USD">30000</PPCB:LitigationPenaltyAmount>
    <PPCB:OperatingLeasesIncomeStatementRevenuePercentage
      contextRef="From2012-06-012012-06-30_us-gaap_RoyaltyAgreementTermsMember"
      decimals="INF"
      unitRef="Pure">0.02</PPCB:OperatingLeasesIncomeStatementRevenuePercentage>
    <PPCB:OperatingLeasesIncomeStatementRevenuePercentage
      contextRef="From2012-06-012012-06-30_us-gaap_LicenseAgreementTermsMember"
      decimals="INF"
      unitRef="Pure">0.05</PPCB:OperatingLeasesIncomeStatementRevenuePercentage>
    <PPCB:PaymentForServices
      contextRef="From2018-09-102018-09-13_custom_OneYearCollaborationAgreementMember_custom_EurosMember"
      decimals="0"
      unitRef="Euro">52000</PPCB:PaymentForServices>
    <PPCB:PaymentForServices
      contextRef="From2018-09-102018-09-13_custom_OneYearCollaborationAgreementMember"
      decimals="0"
      unitRef="USD">59508</PPCB:PaymentForServices>
    <PPCB:PaymentForServices
      contextRef="From2018-09-102018-09-13_custom_TwoYearCollaborationAgreementMember_custom_EurosMember"
      decimals="0"
      unitRef="Euro">40000</PPCB:PaymentForServices>
    <PPCB:PaymentForServices
      contextRef="From2018-09-102018-09-13_custom_TwoYearCollaborationAgreementMember"
      decimals="0"
      unitRef="USD">45775</PPCB:PaymentForServices>
    <PPCB:PaymentForServices
      contextRef="From2018-07-012019-06-30_custom_EurosMember"
      decimals="0"
      unitRef="Euro">31754</PPCB:PaymentForServices>
    <PPCB:PaymentForServices
      contextRef="From2018-07-012019-06-30"
      decimals="0"
      unitRef="USD">36117</PPCB:PaymentForServices>
    <PPCB:PaymentForServices
      contextRef="From2020-07-012021-06-30_custom_EurosMember"
      decimals="0"
      unitRef="Euro">28493</PPCB:PaymentForServices>
    <PPCB:PaymentForServices
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">24043</PPCB:PaymentForServices>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2018-09-102018-09-13_us-gaap_SalesRevenueNetMember_us-gaap_RevenueFromRightsConcentrationRiskMember_custom_NoCustomerMember"
      decimals="INF"
      unitRef="Pure">0.02</us-gaap:ConcentrationRiskPercentage1>
    <PPCB:PaymentForServices
      contextRef="From2020-09-292020-10-02_custom_TwoYearCollaborationAgreementMember_custom_EurosMember"
      decimals="0"
      unitRef="Euro">30000</PPCB:PaymentForServices>
    <PPCB:PaymentForServices
      contextRef="From2020-09-292020-10-02_custom_TwoYearCollaborationAgreementMember"
      decimals="0"
      unitRef="USD">35145</PPCB:PaymentForServices>
    <PPCB:PaymentForServices
      contextRef="From2020-09-292020-10-02_custom_TwoYearCollaborationAgreementMember_custom_EurosMember_custom_InstallmentOneMember"
      decimals="0"
      unitRef="Euro">5000</PPCB:PaymentForServices>
    <PPCB:PaymentForServices
      contextRef="From2020-09-292020-10-02_custom_TwoYearCollaborationAgreementMember_custom_InstallmentTwoMember_custom_EurosMember"
      decimals="0"
      unitRef="Euro">5000</PPCB:PaymentForServices>
    <PPCB:PaymentForServices
      contextRef="From2020-09-292020-10-02_custom_TwoYearCollaborationAgreementMember_custom_InstallmentTwoMember"
      decimals="0"
      unitRef="USD">5858</PPCB:PaymentForServices>
    <PPCB:PaymentForServices
      contextRef="From2020-09-292020-10-02_custom_TwoYearCollaborationAgreementMember_custom_InstallmentThreeMember_custom_EurosMember"
      decimals="0"
      unitRef="Euro">10000</PPCB:PaymentForServices>
    <PPCB:PaymentForServices
      contextRef="From2020-09-292020-10-02_custom_TwoYearCollaborationAgreementMember_custom_InstallmentThreeMember"
      decimals="0"
      unitRef="USD">11715</PPCB:PaymentForServices>
    <PPCB:PaymentForServices
      contextRef="From2020-09-292020-10-02_custom_TwoYearCollaborationAgreementMember_custom_InstallmentFourMember_custom_EurosMember"
      decimals="0"
      unitRef="Euro">10000</PPCB:PaymentForServices>
    <PPCB:PaymentForServices
      contextRef="From2020-09-292020-10-02_custom_TwoYearCollaborationAgreementMember_custom_InstallmentFourMember"
      decimals="0"
      unitRef="USD">11715</PPCB:PaymentForServices>
    <PPCB:PaymentForServices
      contextRef="From2020-09-292020-10-02_custom_UniversityOfJaenMember_custom_EurosMember"
      decimals="0"
      unitRef="Euro">25837</PPCB:PaymentForServices>
    <PPCB:PaymentForServices
      contextRef="From2020-09-292020-10-02_custom_UniversityOfJaenMember"
      decimals="0"
      unitRef="USD">30268</PPCB:PaymentForServices>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2020-09-292020-10-02_us-gaap_SalesRevenueNetMember_custom_UniversityOfJaenMember_us-gaap_RevenueFromRightsConcentrationRiskMember_custom_NoCustomerMember"
      decimals="INF"
      unitRef="Pure">0.02</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="From2021-07-01to2021-09-30">&lt;p id="xdx_807_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zKlAkoBh8Ygj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTE 9 &#x2013; &lt;span id="xdx_82E_zfYxozwsc66"&gt;RELATED PARTY TRANSACTIONS&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Since
its inception, the Company has conducted transactions with its directors and entities related to such directors. These transactions have
included the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;As
of September 30, 2021 and June 30, 2021, the Company owed its former director a total of $&lt;span id="xdx_90B_ecustom--LoansFromRelatedParty_iI_pp0p0_c20210930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--CurrentAndFormerDirectorMember_zu4z5AeLtI9k"&gt;53,384&lt;/span&gt; and $&lt;span id="xdx_902_ecustom--LoansFromRelatedParty_iI_pp0p0_c20210630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--CurrentAndFormerDirectorMember_z5vSFOs05k61"&gt;55,500&lt;/span&gt;, respectively, for money
loaned to the Company throughout the years. The total loans balance owed at September 30, 2021 and June 30, 2021 is not interest bearing
(See Note 5 &#x2013; Loans and Notes Payable).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;As
of September 30, 2021 and June 30, 2021, the Company owed its former director a total of $&lt;span id="xdx_901_eus-gaap--DueToRelatedPartiesCurrent_iI_pp0p0_c20210930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--FormerDirectorMember_zyDfm48jFJXk"&gt;32,076 &lt;/span&gt;and $&lt;span id="xdx_90F_eus-gaap--DueToRelatedPartiesCurrent_iI_pp0p0_c20210630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--FormerDirectorMember_zJRtMxjGmrnk"&gt;33,347&lt;/span&gt;, respectively, related to
expenses paid on behalf of the Company related to corporate startup costs and intellectual property (See Note 4 &#x2013; Due to Former
Director &#x2013; Related Party).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;On
May 6, 2021, the Company entered into an agreement for the lease of its principal executive offices with North Horizon Pty Ltd., a related
party, of which Mr. Nathanielsz, our CEO, CFO and a director, and his wife are owners and directors. The lease has a one-year term commencing
May 6, 2021, and the Company is currently obligated to pay $&lt;span id="xdx_904_ecustom--OperatingLeasesRentExpenseMinimumRentalsPayable_pp0p0_uAUD_c20210503__20210506__dei--LegalEntityAxis__custom--NorthHorizonPtyLtdMember__us-gaap--AwardTypeAxis__custom--AUDCurrencyMember_zixN4Doi7VDc"&gt;3,606&lt;/span&gt; AUD or $&lt;span id="xdx_90B_ecustom--OperatingLeasesRentExpenseMinimumRentalsPayable_pp0p0_c20210505__20210506__dei--LegalEntityAxis__custom--NorthHorizonPtyLtdMember_z9r7nz638Nel"&gt;2,431&lt;/span&gt; USD (depending on exchange rate), inclusive of tax, in
rent per month. During the three months ended September 30, 2021 and 2020, rent expense amounted $&lt;span id="xdx_90F_ecustom--OperatingLeasesRentExpenseMinimumRentalsPayable_pp0p0_uAUD_c20210701__20210930__dei--LegalEntityAxis__custom--NorthHorizonPtyLtdMember__us-gaap--AwardTypeAxis__custom--AUDCurrencyMember_zgF0qADjup7d"&gt;7,735&lt;/span&gt; USD and $&lt;span id="xdx_906_ecustom--OperatingLeasesRentExpenseMinimumRentalsPayable_pp0p0_uAUD_c20200701__20210930__dei--LegalEntityAxis__custom--NorthHorizonPtyLtdMember__us-gaap--AwardTypeAxis__custom--AUDCurrencyMember_zsHWq5i1kMUg"&gt;9,204&lt;/span&gt; USD. As of September
30, 2021, total rent payable of $&lt;span id="xdx_90A_eus-gaap--PaymentsForRent_pp0p0_uAUD_c20210701__20210930__dei--LegalEntityAxis__custom--NorthHorizonPtyLtdMember__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember_zuGpOsanB7bl"&gt;84,000&lt;/span&gt;AUD ($&lt;span id="xdx_908_eus-gaap--PaymentsForRent_pp0p0_c20210701__20210930__dei--LegalEntityAxis__custom--NorthHorizonPtyLtdMember_zN2LIz6ibnt3"&gt;60,598&lt;/span&gt; USD) is included in accrued expenses in the accompanying condensed consolidated balance
sheet.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;PROPANC
                                            BIOPHARMA, INC. AND SUBSIDIARY&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;SEPTEMBER
30, 2021&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;(Unaudited)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;i&gt;Employment
and Services Agreements with Management&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company and Mr. Nathanielsz entered into an employment agreement as of February 25, 2015 (the &#x201c;Nathanielsz Employment Agreement&#x201d;)
setting forth the terms and conditions of Mr. Nathanielsz employment as the Company&#x2019;s President and Chief Executive Officer. The
Nathanielsz Employment Agreement was scheduled to expire on &lt;span id="xdx_90A_eus-gaap--RelatedPartyTransactionDate_dd_c20150224__20150225__us-gaap--TypeOfArrangementAxis__custom--NathanielszEmploymentAgreementMember_zI4E8tN5aqd3"&gt;February 25, 2019&lt;/span&gt;; however, the term of the Nathanielsz Employment Agreement
automatically renews for successive one-year periods unless either party provides 30 days&#x2019; prior written notice of its intent not
to renew. The Nathanielsz Employment Agreement continues in effect as of September 30, 2021 as amended May 14, 2019 (see below). The
Nathanielsz Employment Agreement provides Mr. Nathanielsz with a base salary of $&lt;span id="xdx_909_eus-gaap--SalariesAndWages_pp0p0_uAUD_c20150224__20150225__us-gaap--TypeOfArrangementAxis__custom--NathanielszEmploymentAgreementMember__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember_zJDZdvgnTkLj"&gt;25,000&lt;/span&gt; AUD per month ($&lt;span id="xdx_901_eus-gaap--SalariesAndWages_pp0p0_uAUD_c20200701__20210630__us-gaap--TypeOfArrangementAxis__custom--NathanielszEmploymentAgreementMember__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember_zXJRrgHAZ558"&gt;300,000&lt;/span&gt; AUD annually or $&lt;span id="xdx_907_eus-gaap--SalariesAndWages_pp0p0_c20200701__20210630__us-gaap--TypeOfArrangementAxis__custom--NathanielszEmploymentAgreementMember_zstiGJmSWXna"&gt;205,680&lt;/span&gt;
USD) and a monthly contribution to Mr. Nathanielsz&#x2019;s pension equal to &lt;span id="xdx_90E_ecustom--PercentageOfPensionOfMonthlySalary_dp_uPure_c20200701__20210630__us-gaap--TypeOfArrangementAxis__custom--NathanielszEmploymentAgreementMember_zrBF7nyxe6Vk"&gt;9.5&lt;/span&gt;% of his monthly salary. Mr. Nathanielsz has the ability
to convert any accrued but unpaid salary into common stock at the end of each fiscal year at a conversion price to be determined by Mr.
Nathanielsz and the Company, which will in no event be lower than par value or higher than the closing bid price on the date of conversion.
Pursuant to the Nathanielsz Employment Agreement, Mr. Nathanielsz is entitled to an annual discretionary bonus in an amount up to &lt;span id="xdx_908_ecustom--PercentageOfBonusOfAnnualBaseSalary_dp_uPure_c20200701__20210630__us-gaap--TypeOfArrangementAxis__custom--NathanielszEmploymentAgreementMember_zEa6kqt2K3ah"&gt;200&lt;/span&gt;%
of his annual base salary, which bonus shall be determined by the Company&#x2019;s board of directors based upon the performance of the
Company. On March 16, 2018, the Company&#x2019;s board of directors approved an increase of Mr. Nathanielsz&#x2019;s annual base salary
from $&lt;span id="xdx_90F_eus-gaap--SalariesAndWages_pp0p0_uAUD_c20180315__20180316__us-gaap--TypeOfArrangementAxis__custom--NathanielszEmploymentAgreementMember__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember__srt--RangeAxis__srt--MinimumMember_zpO1KbgMpXXg"&gt;300,000&lt;/span&gt; AUD ($&lt;span id="xdx_903_eus-gaap--SalariesAndWages_pp0p0_c20180315__20180316__us-gaap--TypeOfArrangementAxis__custom--NathanielszEmploymentAgreementMember__srt--RangeAxis__srt--MinimumMember_z1SrYaSg60oj"&gt;205,680&lt;/span&gt; USD) to $&lt;span id="xdx_90D_eus-gaap--SalariesAndWages_pp0p0_uAUD_c20180315__20180316__us-gaap--TypeOfArrangementAxis__custom--NathanielszEmploymentAgreementMember__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember__srt--RangeAxis__srt--MaximumMember_zPmO0V9mQS5l"&gt;400,000&lt;/span&gt; AUD ($&lt;span id="xdx_90A_eus-gaap--SalariesAndWages_pp0p0_c20180315__20180316__us-gaap--TypeOfArrangementAxis__custom--NathanielszEmploymentAgreementMember__srt--RangeAxis__srt--MaximumMember_zGMywGh0zlDi"&gt;274,240&lt;/span&gt; USD), effective February 2018.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Mr.
Nathanielsz&#x2019;s wife, Sylvia Nathanielsz, is and has been a non-executive part-time employee of the Company since October 2015. Effective
February 1, 2018, Mrs. Nathanielsz receives an annual salary of $&lt;span id="xdx_905_eus-gaap--SalariesAndWages_pp0p0_uAUD_c20180128__20180201__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrsNathanielszMember__us-gaap--AwardTypeAxis__custom--AUDCurrencyMember_zpt8r7SDyqC"&gt;120,000&lt;/span&gt; AUD ($&lt;span id="xdx_908_eus-gaap--SalariesAndWages_pp0p0_c20180128__20180201__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrsNathanielszMember_zeFkmrh0GVG7"&gt;80,904&lt;/span&gt; USD) and is entitled to customary benefits.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Pursuant
to a February 25, 2016 board resolution, James Nathanielsz shall be paid $&lt;span id="xdx_900_eus-gaap--RepaymentsOfRelatedPartyDebt_pp0p0_uAUD_c20160224__20160225__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--JamesNathanielszMember__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember_zbKQTZIJ2y6k"&gt;4,481&lt;/span&gt; AUD ($&lt;span id="xdx_905_eus-gaap--RepaymentsOfRelatedPartyDebt_pp0p0_c20160224__20160225__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--JamesNathanielszMember_zKZ9cCX8kI18"&gt;3,205&lt;/span&gt; USD), on a monthly basis for the purpose
of acquiring and maintaining an automobile. For the three months ended September 30, 2021, a total of $$&lt;span id="xdx_900_eus-gaap--RepaymentsOfRelatedPartyDebt_pp0p0_uAUD_c20210701__20210930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrsNathanielszMember__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember_zTrwbJSefWM7"&gt;7,689&lt;/span&gt; AUD ($&lt;span id="xdx_908_eus-gaap--RepaymentsOfRelatedPartyDebt_pp0p0_c20210701__20210930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrsNathanielszMember_zhIrUC9nNUTa"&gt;5,651&lt;/span&gt; USD) in payments
have been made with respect to Mr. Nathanielsz&#x2019;s car allowance.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Pursuant to the approval of the Company&#x2019;s board of directors, on May 14, 2019, Mr. Nathanielsz was granted a $&lt;span id="xdx_90D_eus-gaap--OfficersCompensation_pp0p0_uAUD_c20190513__20190514__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsMember__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember_zTCWArOO88eh"&gt;460,000&lt;/span&gt; AUD ($&lt;span id="xdx_90D_eus-gaap--OfficersCompensation_pp0p0_c20190513__20190514__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsMember_ziLfYVoEFR9d"&gt;315,376&lt;/span&gt; USD) bonus for accomplishments achieved while serving as the Company&#x2019;s Chief Executive Officer during the fiscal year ended June 30, 2019 with $&lt;span id="xdx_90A_ecustom--BonusPayableAmount_pp0p0_uAUD_c20180701__20190630__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember_z9peavSiI6S6"&gt;200,000&lt;/span&gt; AUD ($&lt;span id="xdx_907_ecustom--BonusPayableAmount_pp0p0_c20180701__20190630__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zoZALS8lNCF3"&gt;137,120&lt;/span&gt; USD) of such bonus payable by the Corporation to the CEO throughout the Corporation&#x2019;s 2019 fiscal
year as the Corporation&#x2019;s cash resources allow, with the remaining $&lt;span id="xdx_902_ecustom--RemainingBonusAmount_pp0p0_uAUD_c20180701__20190630__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember_zceybiYGVKJd"&gt;260,000&lt;/span&gt; AUD ($&lt;span title="[custom:RemainingBonusAmount]"&gt;&lt;span id="xdx_906_ecustom--RemainingBonusAmount_pp0p0_c20180701__20190630__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_z3Li8Y1WayYi"&gt;178,256&lt;/span&gt;&lt;/span&gt; USD) of such bonus to be deferred by the CEO until a future date when the Corporation&#x2019;s cash resources allow for such payment, as agreed to by the CEO. A total of $&lt;span id="xdx_904_eus-gaap--RepaymentsOfRelatedPartyDebt_pp0p0_uAUD_c20200701__20210630__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember_zV6UgoUEDNii" style="font: 10pt Times New Roman, Times, Serif" title="Payments form related party"&gt;221,890&lt;/span&gt;
AUD ($&lt;span id="xdx_904_ecustom--BonusPayable_pp0p0_c20200701__20210630__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zBWdTFd5PPj3" title="Bonus payable"&gt;166,418&lt;/span&gt; USD) in payments were made against the bonuses during the year ended June 30, 2021 resulting in a remaining balance of $&lt;span id="xdx_905_ecustom--BonusPayable_pp0p0_uAUD_c20200701__20210630__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember_zFN7GNV96Oil" title="Bonus payable"&gt;422,610&lt;/span&gt; AUD ($&lt;span id="xdx_90F_ecustom--BonusPayable_pp0p0_c20200701__20210630__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--TypeOfArrangementAxis__custom--MrsNathanielszMember_zRsMxqrf9md2" title="Bonus payable"&gt;316,957&lt;/span&gt; USD) bonus payable as of June 30, 2021. On August 12, 2021, the Board approved a bonus of $&lt;span id="xdx_90D_eus-gaap--OfficersCompensation_pp0p0_c20210811__20210812__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember_zSIjyzAeBAf7" title="Officers' compensation"&gt;177,840&lt;/span&gt; USD. On August 12, 2021, pursuant to the Cancellation Agreement, Mr. Nathanielsz agreed to cancel $&lt;span id="xdx_90F_eus-gaap--OfficersCompensation_pp0p0_c20210811__20210812__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember_zOL3B6kyS4vc" title="Officers' compensation"&gt;177,840&lt;/span&gt; of the bonus payable in exchange for &lt;span id="xdx_905_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20210811__20210812__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember_z7EORU5fOkxi" title="Debt Conversion, Converted Instrument, Shares Issued"&gt;5,928,000&lt;/span&gt; shares of the common stock of the Company (see Note 7). A total of $$&lt;span id="xdx_907_eus-gaap--RepaymentsOfRelatedPartyDebt_pp0p0_uAUD_c20210701__20210930__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember_zckpRC2qEJBk" title="Payments form related party"&gt;42,500&lt;/span&gt; AUD ($&lt;span id="xdx_90C_eus-gaap--RepaymentsOfRelatedPartyDebt_pp0p0_c20210701__20210930__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zFxDY2HaZEY9" title="Payments form related party"&gt;30,660&lt;/span&gt; USD) in payments were made against the bonuses during the three months ended September 30, 2021 which resulted to a remaining balance of $&lt;span id="xdx_906_ecustom--BonusPayable_pp0p0_uAUD_c20210701__20210930__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember_zRiuOG3ZIOJd" title="Bonus payable"&gt;142,990&lt;/span&gt; AUD ($&lt;span id="xdx_90D_ecustom--BonusPayable_pp0p0_c20210701__20210930__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zOaEh4TI7ixa" title="Bonus payable"&gt;103,153&lt;/span&gt; USD) bonus payable as of September 30, 2021 which is included in accrued expenses in the accompanying condensed consolidated balance sheet.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Amended
and Restated Employment Agreement - On May 14, 2019 (the &#x201c;Effective Date&#x201d;), the Company entered into an Amended and Restated
Employment Agreement (the &#x201c;Employment Agreement&#x201d;) with James Nathanielsz, the Company&#x2019;s Chief Executive Officer, Chairman,
acting Chief Financial Officer and a director, for a term of &lt;span id="xdx_90C_ecustom--AgreementlTerm_dc_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember_z3DnwpYc5J9c" title="Agreement term"&gt;three years&lt;/span&gt;, subject to automatic &lt;span id="xdx_907_ecustom--AgreementRenewalTerm_dtYxL_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember_zenS2toJ8RTa" title="Agreement renewal term::XDX::1"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3891"&gt;one&lt;/span&gt;&lt;/span&gt;-year renewals, at an annual salary
of $&lt;span id="xdx_901_eus-gaap--SalariesAndWages_pp0p0_uAUD_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember_zOvUJmTVkEJh" title="Annual salary"&gt;400,000&lt;/span&gt; AUD. Pursuant to the Employment Agreement, Mr. Nathanielsz was granted options to purchase &lt;span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember_zw2Gfwhnir42" title="Option purchase shares"&gt;39&lt;/span&gt; shares of the Company&#x2019;s
common stock (the &#x201c;Nathanielsz Options&#x201d;), with an exercise price per share of $&lt;span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember_zUhJwv1Vmi9l" title="Exercise price"&gt;4,675&lt;/span&gt; (&lt;span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_pid_dp_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember_zdISKL8TIkJe" title="Market price"&gt;110%&lt;/span&gt; of the closing market price of
the Company&#x2019;s common stock on May 14, 2019 (or $&lt;span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember_znDtkgBG9f65" title="Granted exercise price"&gt;4,250&lt;/span&gt;), the date of approval of such grant by the Company&#x2019;s board of directors),
(ii) &lt;span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember__us-gaap--AwardTypeAxis__custom--RestrictedStocksUnitsRSUMember_zWlSMqPlB4G3" title="Restricted stock shares of common stock"&gt;39&lt;/span&gt; restricted stock units of the Company (the &#x201c;Initial Nathanielsz RSUs&#x201d;), and (iii) an additional &lt;span id="xdx_90A_ecustom--StockToBeIssuedDuringPeriodValueRestrictedStockUnit_c20210701__20210930__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember_z3k96wWhktmi" title="Restricted stock unit issuable"&gt;39&lt;/span&gt; restricted stock
units of the Company (the &#x201c;Additional Nathanielsz RSUs&#x201d;). Such options and restricted stock units were granted pursuant to
the 2019 Plan approved by the Company&#x2019;s board of directors on the Effective Date. &lt;span id="xdx_90E_ecustom--OptionsVestedDescription_c20190513__20190514__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember" title="Options vested, description"&gt;The Nathanielsz Options have a term of &lt;span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember_zjXSrkUNxySc" title="Option term"&gt;10 years&lt;/span&gt;
from the date of grant. 1/3rd of the Nathanielsz Options shall vest every successive one-year anniversary following the Effective Date,
provided, that on each such vesting date Mr. Nathanielsz is employed by the Company and subject to the other provisions of the Employment
Agreement. The Initial Nathanielsz RSUs shall vest on the one-year anniversary of the Effective Date, subject to Mr. Nathanielsz&#x2019;s
continued employment with the Company through such vesting date. The Additional Nathanielsz RSUs will vest as follows, subject to Mr.
Nathanielsz&#x2019;s continued employment with the Company through the applicable vesting date: (i) &lt;span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember__us-gaap--AwardTypeAxis__custom--AdditionaNathanielszRSUsMember_znu8ROG6465k" title="Rsus vest, shares"&gt;7.80&lt;/span&gt; of the Additional Nathanielsz
RSUs shall vest upon the Company submitting Clinical Trial Application (the &#x201c;CTA&#x201d;) for PRP, the Company&#x2019;s lead product
candidate (&#x201c;PRP&#x201d;), for a First-In-Human study for PRP (the &#x201c;Study&#x201d;) in an applicable jurisdiction to be selected
by the Company, (ii) 7.80 of the Additional Nathanielsz RSUs shall vest upon&lt;/span&gt; the CTA being approved in an applicable jurisdiction, (iii)
&lt;span title="Rsus vest, shares"&gt;7.80&lt;/span&gt; of the Additional RSUs shall vest upon the Company completing an equity financing in the amount of at least $&lt;span id="xdx_904_ecustom--GrossProceedsFromEquityFinancing_pp0p0_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember__us-gaap--AwardTypeAxis__custom--AdditionaNathanielszRSUsMember_zIMnFhIlAV7h" title="Gross proceeds from equity financing"&gt;4,000,000&lt;/span&gt; in gross
proceeds, (iv) 7.80 of the Additional Nathanielsz RSUs shall vest upon the shares of the Company&#x2019;s Common Stock being listed on
a senior stock exchange (NYSE, NYSEMKT or NASDAQ), and (v) the remaining 7.80 of the Additional Nathanielsz RSUs shall vest upon the
Company enrolling its first patient in the Study. Each vested restricted stock unit shall be settled by delivery to Mr. Nathanielsz of
one share of the Company&#x2019;s common stock and/or the fair market value of one share of common stock in cash, at the sole discretion
of the Company&#x2019;s board of directors and subject to the 2019 Plan, on the first to occur of: (i) the date of a Change of Control
(as defined in the Employment Agreement), (ii) the date that is ten business days following the vesting of such restricted stock unit,
(iii) the date of Mr. Nathanielsz&#x2019;s death or Disability (as defined in the Employment Agreement), and (iv) Mr. Nathanielsz&#x2019;s
employment being terminated either by the Company without Cause or by Mr. Nathanielsz for Good Reason (each as defined in the Employment
Agreement). In the event of a Change of Control, any unvested portion of the Nathanielsz Options and such restricted stock units shall
vest immediately prior to such event. The 39 vested restricted stock unit are considered issuable as of September 30, 2021.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;PROPANC
BIOPHARMA, INC. AND SUBSIDIARY&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;SEPTEMBER
30, 2021&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;(Unaudited)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Amended
and Restated Services Agreement - On May 14, 2019, the Company also entered into an Amended and Restated Services Agreement (the &#x201c;Services
Agreement&#x201d;) with Dr. Kenyon, the Company&#x2019;s Chief Scientific Officer and a director, for a term of &lt;span id="xdx_90B_ecustom--AgreementlTerm_dtYxL_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DrKenyonMember_ze0xcu10SeV7" title="Agreement term::XDX::3"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3915"&gt;three&lt;/span&gt;&lt;/span&gt; years, subject to
automatic &lt;span id="xdx_903_ecustom--AgreementRenewalTerm_dtYxL_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DrKenyonMember_zAtfCXuUlhji" title="Agreement renewal term::XDX::1"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3917"&gt;one&lt;/span&gt;&lt;/span&gt;-year renewals, at an annual salary of $&lt;span id="xdx_907_eus-gaap--SalariesAndWages_pp0p0_uAUD_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DrKenyonMemberMember__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember_zXf0wu8fePl1" title="Annual salary"&gt;54,000&lt;/span&gt; AUD. In connection with the execution of the Services Agreement, Dr. Kenyon
was designated as an executive officer of the Company and assumed a more active executive role with the Company. Pursuant to the Services
Agreement, Dr. Kenyon was granted options to purchase &lt;span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DrKenyonMember_zvS7Ab55s8f9" title="Option purchase shares"&gt;20&lt;/span&gt; shares of the Company&#x2019;s common stock (the &#x201c;Kenyon Options&#x201d;),
with an exercise price per share of $&lt;span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DrKenyonMember_zU8nAyBQCwWl" title="Exercise price"&gt;4,250&lt;/span&gt; (&lt;span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_dp_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DrKenyonMember_ziNHSOCB8856" title="Market price"&gt;100%&lt;/span&gt; of the closing market price of the Company&#x2019;s common stock on May 14, 2019, the
date of approval of such grant by the Company&#x2019;s board of directors), (ii) &lt;span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember__us-gaap--AwardTypeAxis__custom--InitialKenyonRSUsMember_zH0wNjk7LdE" title="Restricted stock shares of common stock"&gt;20&lt;/span&gt; restricted stock units of the Company (the &#x201c;Initial
Kenyon RSUs&#x201d;), and (iii) an additional &lt;span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember__us-gaap--AwardTypeAxis__custom--AdditionalKenyonRSUsMember_zuzPGYxGzvCe" title="Restricted stock shares of common stock"&gt;20&lt;/span&gt; restricted stock units of the Company (the &#x201c;Additional Kenyon RSUs&#x201d;). Such
options and restricted stock units were granted pursuant to the 2019 Plan approved by the Company&#x2019;s board of directors on the Effective
Date. The Kenyon Options have a term of &lt;span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DrKenyonMember_zSlJJn86aOja" title="Option term"&gt;10 years&lt;/span&gt; from the date of grant. 1/3rd of the Kenyon Options shall vest every successive one-year
anniversary following the Effective Date, provided, that on each such vesting date Dr. Kenyon is employed by the Company and subject
to the other provisions of the Services Agreement. The Initial Kenyon RSUs shall vest on the one-year anniversary of the Effective Date,
subject to Dr. Kenyon&#x2019;s continued employment with the Company through such vesting date. The Additional Kenyon RSUs will vest as
follows, subject to Dr. Kenyon&#x2019;s continued employment with the Company through the applicable vesting date: (i) &lt;span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember__us-gaap--AwardTypeAxis__custom--AdditionalKenyonRSUsMember_zZgAC3z9YhP" title="Rsus vest, shares"&gt;5&lt;/span&gt; of the Additional
Kenyon RSUs shall vest upon the Company submitting the CTA for PRP for the Study in an applicable jurisdiction to be selected by the
Company, (ii) &lt;span title="Rsus vest, shares"&gt;5&lt;/span&gt; of the Additional Kenyon RSUs shall vest upon the Company completing an equity financing in the amount of at least $&lt;span id="xdx_90A_ecustom--GrossProceedsFromEquityFinancing_pp0p0_c20190513__20190514__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember__us-gaap--AwardTypeAxis__custom--AdditionalKenyonRSUsMember_zNlEuIx8jIdl" title="Gross proceeds from equity financing"&gt;4,000,000&lt;/span&gt;
in gross proceeds, (iii) 5 of the Additional Kenyon RSUs shall vest upon the shares of the Company&#x2019;s Common Stock being listed
on a senior stock exchange (NYSE, NYSEMKT or NASDAQ), and (iv) the remaining 5 of the Additional Kenyon RSUs shall vest upon the Company
enrolling its first patient in the Study. Each vested Kenyon RSU shall be settled by delivery to Mr. Kenyon of one share of the Company&#x2019;s
common stock and/or the fair market value of one share of common stock in cash, at the sole discretion of the Company&#x2019;s board of
directors and subject to the Plan, on the first to occur of: (i) the date of a Change of Control (as defined in the Services Agreement),
(ii) the date that is ten business days following the vesting of such Kenyon RSU, (iii) the date of Dr. Kenyon&#x2019;s death or Disability
(as defined in the Services Agreement), and (iv) Dr. Kenyon&#x2019;s employment being terminated either by the Company without Cause or
by Dr. Kenyon for Good Reason (as defined in the Services Agreement). In the event of a Change of Control (as defined in the Services
Agreement), 50% of any unvested portion of the Kenyon Options and the Kenyon RSUs shall vest immediately prior to such event. The &lt;span id="xdx_90D_ecustom--StockToBeIssuedDuringPeriodValueRestrictedStockUnit_c20210701__20210930__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember_zB17fYlEexz6" title="Restricted stock unit issuable"&gt;20&lt;/span&gt;
vested restricted stock unit are considered issuable as of September 30, 2021. As of June 30, 2021, total accrued salaries of $&lt;span id="xdx_906_eus-gaap--AccruedSalariesCurrent_iI_pp0p0_uAUD_c20210630__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember_zSkbFVtK1Kma" title="Accrued salaries"&gt;135,000&lt;/span&gt;
AUD ($&lt;span id="xdx_90C_eus-gaap--AccruedSalariesCurrent_iI_pp0p0_c20210630_zFgxVESQPTOc" title="Accrued salaries"&gt;101,250&lt;/span&gt; USD) was included in accrued expenses. On August 12, 2021, pursuant to the Cancellation Agreement, Mr. Kenyon agreed to
cancel accrued salaries of $&lt;span id="xdx_900_ecustom--CancellationOfAccruedSalaries_iI_dtY_c20210812__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DrKenyonMember_zJ5ujDQKDPC4" title="Cancellation of accrued salary"&gt;102,600&lt;/span&gt; in exchange for &lt;span id="xdx_90A_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_pid_c20210811__20210812__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DrKenyonMember_zeayPO4QmVS"&gt;3,420,000&lt;/span&gt; shares of the common stock of the Company (see Note 7). As of September
30, 2021, total accrued salaries of $&lt;span id="xdx_901_eus-gaap--AccruedSalariesCurrent_iI_pp0p0_uAUD_c20210930__us-gaap--AwardTypeAxis__custom--AUDCurrenryMember_zkxzMD0F9wGh"&gt;13,500&lt;/span&gt; AUD ($&lt;span id="xdx_909_eus-gaap--AccruedSalariesCurrent_iI_pp0p0_c20210930_zYaZ3iRR0tXb"&gt;9,739&lt;/span&gt; USD) was included in accrued expenses in the accompanying condensed consolidated
balance sheet.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;Intercompany
Loans&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;All
Intercompany loans were made by the parent to the subsidiary, Propanc PTY LTD, which have not been repaid as of September 30,
2021. Effective fiscal year 2021, the parent company determined that intercompany loans will not be repaid in the foreseeable future
and thus, per ASC 830-20-35-3, gains and losses from measuring the intercompany balances are recorded within cumulative translation adjustment,
a component of other comprehensive income. &lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <PPCB:LoansFromRelatedParty
      contextRef="AsOf2021-09-30_custom_CurrentAndFormerDirectorMember"
      decimals="0"
      unitRef="USD">53384</PPCB:LoansFromRelatedParty>
    <PPCB:LoansFromRelatedParty
      contextRef="AsOf2021-06-30_custom_CurrentAndFormerDirectorMember"
      decimals="0"
      unitRef="USD">55500</PPCB:LoansFromRelatedParty>
    <us-gaap:DueToRelatedPartiesCurrent
      contextRef="AsOf2021-09-30_custom_FormerDirectorMember"
      decimals="0"
      unitRef="USD">32076</us-gaap:DueToRelatedPartiesCurrent>
    <us-gaap:DueToRelatedPartiesCurrent
      contextRef="AsOf2021-06-30_custom_FormerDirectorMember"
      decimals="0"
      unitRef="USD">33347</us-gaap:DueToRelatedPartiesCurrent>
    <PPCB:OperatingLeasesRentExpenseMinimumRentalsPayable
      contextRef="From2021-05-032021-05-06_custom_NorthHorizonPtyLtdMember_custom_AUDCurrencyMember"
      decimals="0"
      unitRef="AUD">3606</PPCB:OperatingLeasesRentExpenseMinimumRentalsPayable>
    <PPCB:OperatingLeasesRentExpenseMinimumRentalsPayable
      contextRef="From2021-05-052021-05-06_custom_NorthHorizonPtyLtdMember"
      decimals="0"
      unitRef="USD">2431</PPCB:OperatingLeasesRentExpenseMinimumRentalsPayable>
    <PPCB:OperatingLeasesRentExpenseMinimumRentalsPayable
      contextRef="From2021-07-012021-09-30_custom_NorthHorizonPtyLtdMember_custom_AUDCurrencyMember"
      decimals="0"
      unitRef="AUD">7735</PPCB:OperatingLeasesRentExpenseMinimumRentalsPayable>
    <PPCB:OperatingLeasesRentExpenseMinimumRentalsPayable
      contextRef="From2020-07-012021-09-30_custom_NorthHorizonPtyLtdMember_custom_AUDCurrencyMember"
      decimals="0"
      unitRef="AUD">9204</PPCB:OperatingLeasesRentExpenseMinimumRentalsPayable>
    <us-gaap:PaymentsForRent
      contextRef="From2021-07-012021-09-30_custom_NorthHorizonPtyLtdMember_custom_AUDCurrenryMember"
      decimals="0"
      unitRef="AUD">84000</us-gaap:PaymentsForRent>
    <us-gaap:PaymentsForRent
      contextRef="From2021-07-012021-09-30_custom_NorthHorizonPtyLtdMember"
      decimals="0"
      unitRef="USD">60598</us-gaap:PaymentsForRent>
    <us-gaap:RelatedPartyTransactionDate contextRef="From2015-02-242015-02-25_custom_NathanielszEmploymentAgreementMember">2019-02-25</us-gaap:RelatedPartyTransactionDate>
    <us-gaap:SalariesAndWages
      contextRef="From2015-02-242015-02-25_custom_NathanielszEmploymentAgreementMember_custom_AUDCurrenryMember"
      decimals="0"
      unitRef="AUD">25000</us-gaap:SalariesAndWages>
    <us-gaap:SalariesAndWages
      contextRef="From2020-07-012021-06-30_custom_NathanielszEmploymentAgreementMember_custom_AUDCurrenryMember"
      decimals="0"
      unitRef="AUD">300000</us-gaap:SalariesAndWages>
    <us-gaap:SalariesAndWages
      contextRef="From2020-07-012021-06-30_custom_NathanielszEmploymentAgreementMember"
      decimals="0"
      unitRef="USD">205680</us-gaap:SalariesAndWages>
    <PPCB:PercentageOfPensionOfMonthlySalary
      contextRef="From2020-07-012021-06-30_custom_NathanielszEmploymentAgreementMember"
      decimals="INF"
      unitRef="Pure">0.095</PPCB:PercentageOfPensionOfMonthlySalary>
    <PPCB:PercentageOfBonusOfAnnualBaseSalary
      contextRef="From2020-07-012021-06-30_custom_NathanielszEmploymentAgreementMember"
      decimals="INF"
      unitRef="Pure">2</PPCB:PercentageOfBonusOfAnnualBaseSalary>
    <us-gaap:SalariesAndWages
      contextRef="From2018-03-152018-03-16_custom_NathanielszEmploymentAgreementMember_custom_AUDCurrenryMember_srt_MinimumMember"
      decimals="0"
      unitRef="AUD">300000</us-gaap:SalariesAndWages>
    <us-gaap:SalariesAndWages
      contextRef="From2018-03-152018-03-16_custom_NathanielszEmploymentAgreementMember_srt_MinimumMember"
      decimals="0"
      unitRef="USD">205680</us-gaap:SalariesAndWages>
    <us-gaap:SalariesAndWages
      contextRef="From2018-03-152018-03-16_custom_NathanielszEmploymentAgreementMember_custom_AUDCurrenryMember_srt_MaximumMember"
      decimals="0"
      unitRef="AUD">400000</us-gaap:SalariesAndWages>
    <us-gaap:SalariesAndWages
      contextRef="From2018-03-152018-03-16_custom_NathanielszEmploymentAgreementMember_srt_MaximumMember"
      decimals="0"
      unitRef="USD">274240</us-gaap:SalariesAndWages>
    <us-gaap:SalariesAndWages
      contextRef="From2018-01-282018-02-01_custom_MrsNathanielszMember_custom_AUDCurrencyMember"
      decimals="0"
      unitRef="AUD">120000</us-gaap:SalariesAndWages>
    <us-gaap:SalariesAndWages
      contextRef="From2018-01-282018-02-01_custom_MrsNathanielszMember"
      decimals="0"
      unitRef="USD">80904</us-gaap:SalariesAndWages>
    <us-gaap:RepaymentsOfRelatedPartyDebt
      contextRef="From2016-02-242016-02-25_custom_JamesNathanielszMember_custom_AUDCurrenryMember"
      decimals="0"
      unitRef="AUD">4481</us-gaap:RepaymentsOfRelatedPartyDebt>
    <us-gaap:RepaymentsOfRelatedPartyDebt
      contextRef="From2016-02-242016-02-25_custom_JamesNathanielszMember"
      decimals="0"
      unitRef="USD">3205</us-gaap:RepaymentsOfRelatedPartyDebt>
    <us-gaap:RepaymentsOfRelatedPartyDebt
      contextRef="From2021-07-012021-09-30_custom_MrsNathanielszMember_custom_AUDCurrenryMember"
      decimals="0"
      unitRef="AUD">7689</us-gaap:RepaymentsOfRelatedPartyDebt>
    <us-gaap:RepaymentsOfRelatedPartyDebt
      contextRef="From2021-07-012021-09-30_custom_MrsNathanielszMember"
      decimals="0"
      unitRef="USD">5651</us-gaap:RepaymentsOfRelatedPartyDebt>
    <us-gaap:OfficersCompensation
      contextRef="From2019-05-132019-05-14_custom_MrNathanielszMember_custom_BoardOfDirectorsMember_custom_AUDCurrenryMember"
      decimals="0"
      unitRef="AUD">460000</us-gaap:OfficersCompensation>
    <us-gaap:OfficersCompensation
      contextRef="From2019-05-132019-05-14_custom_MrNathanielszMember_custom_BoardOfDirectorsMember"
      decimals="0"
      unitRef="USD">315376</us-gaap:OfficersCompensation>
    <PPCB:BonusPayableAmount
      contextRef="From2018-07-012019-06-30_srt_ChiefExecutiveOfficerMember_custom_AUDCurrenryMember"
      decimals="0"
      unitRef="AUD">200000</PPCB:BonusPayableAmount>
    <PPCB:BonusPayableAmount
      contextRef="From2018-07-012019-06-30_srt_ChiefExecutiveOfficerMember"
      decimals="0"
      unitRef="USD">137120</PPCB:BonusPayableAmount>
    <PPCB:RemainingBonusAmount
      contextRef="From2018-07-012019-06-30_srt_ChiefExecutiveOfficerMember_custom_AUDCurrenryMember"
      decimals="0"
      unitRef="AUD">260000</PPCB:RemainingBonusAmount>
    <PPCB:RemainingBonusAmount
      contextRef="From2018-07-012019-06-30_srt_ChiefExecutiveOfficerMember"
      decimals="0"
      unitRef="USD">178256</PPCB:RemainingBonusAmount>
    <us-gaap:RepaymentsOfRelatedPartyDebt
      contextRef="From2020-07-012021-06-30_srt_ChiefExecutiveOfficerMember_custom_AUDCurrenryMember"
      decimals="0"
      unitRef="AUD">221890</us-gaap:RepaymentsOfRelatedPartyDebt>
    <PPCB:BonusPayable
      contextRef="From2020-07-012021-06-30_srt_ChiefExecutiveOfficerMember"
      decimals="0"
      unitRef="USD">166418</PPCB:BonusPayable>
    <PPCB:BonusPayable
      contextRef="From2020-07-012021-06-30_srt_ChiefExecutiveOfficerMember_custom_AUDCurrenryMember"
      decimals="0"
      unitRef="AUD">422610</PPCB:BonusPayable>
    <PPCB:BonusPayable
      contextRef="From2020-07-012021-06-30_srt_ChiefExecutiveOfficerMember_custom_MrsNathanielszMember"
      decimals="0"
      unitRef="USD">316957</PPCB:BonusPayable>
    <us-gaap:OfficersCompensation
      contextRef="From2021-08-112021-08-12_custom_MrNathanielszMember_custom_BoardOfDirectorsMember"
      decimals="0"
      unitRef="USD">177840</us-gaap:OfficersCompensation>
    <us-gaap:OfficersCompensation
      contextRef="From2021-08-112021-08-12_custom_MrNathanielszMember_custom_BoardOfDirectorsMember"
      decimals="0"
      unitRef="USD">177840</us-gaap:OfficersCompensation>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1
      contextRef="From2021-08-112021-08-12_custom_MrNathanielszMember_custom_BoardOfDirectorsMember"
      decimals="INF"
      unitRef="Shares">5928000</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <us-gaap:RepaymentsOfRelatedPartyDebt
      contextRef="From2021-07-012021-09-30_srt_ChiefExecutiveOfficerMember_custom_AUDCurrenryMember"
      decimals="0"
      unitRef="AUD">42500</us-gaap:RepaymentsOfRelatedPartyDebt>
    <us-gaap:RepaymentsOfRelatedPartyDebt
      contextRef="From2021-07-012021-09-30_srt_ChiefExecutiveOfficerMember"
      decimals="0"
      unitRef="USD">30660</us-gaap:RepaymentsOfRelatedPartyDebt>
    <PPCB:BonusPayable
      contextRef="From2021-07-012021-09-30_srt_ChiefExecutiveOfficerMember_custom_AUDCurrenryMember"
      decimals="0"
      unitRef="AUD">142990</PPCB:BonusPayable>
    <PPCB:BonusPayable
      contextRef="From2021-07-012021-09-30_srt_ChiefExecutiveOfficerMember"
      decimals="0"
      unitRef="USD">103153</PPCB:BonusPayable>
    <PPCB:AgreementlTerm contextRef="From2019-05-132019-05-14_custom_EmploymentAgreementMember_custom_MrNathanielszMember">P3Y</PPCB:AgreementlTerm>
    <us-gaap:SalariesAndWages
      contextRef="From2019-05-132019-05-14_custom_EmploymentAgreementMember_custom_MrNathanielszMember_custom_AUDCurrenryMember"
      decimals="0"
      unitRef="AUD">400000</us-gaap:SalariesAndWages>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward
      contextRef="From2019-05-132019-05-14_custom_EmploymentAgreementMember_custom_MrNathanielszMember"
      decimals="INF"
      unitRef="Shares">39</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="From2019-05-132019-05-14_custom_EmploymentAgreementMember_custom_MrNathanielszMember"
      decimals="INF"
      unitRef="USDPShares">4675</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
      contextRef="From2019-05-132019-05-14_custom_EmploymentAgreementMember_custom_MrNathanielszMember"
      decimals="INF"
      unitRef="Pure">1.10</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="From2019-05-132019-05-14_custom_EmploymentAgreementMember_custom_MrNathanielszMember"
      decimals="INF"
      unitRef="USDPShares">4250</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="From2019-05-132019-05-14_custom_EmploymentAgreementMember_custom_RestrictedStocksUnitsRSUMember"
      decimals="INF"
      unitRef="Shares">39</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <PPCB:StockToBeIssuedDuringPeriodValueRestrictedStockUnit
      contextRef="From2021-07-012021-09-30_custom_EmploymentAgreementMember"
      decimals="INF"
      unitRef="Shares">39</PPCB:StockToBeIssuedDuringPeriodValueRestrictedStockUnit>
    <PPCB:OptionsVestedDescription contextRef="From2019-05-132019-05-14_custom_EmploymentAgreementMember_custom_MrNathanielszMember">The Nathanielsz Options have a term of 10 years
from the date of grant. 1/3rd of the Nathanielsz Options shall vest every successive one-year anniversary following the Effective Date,
provided, that on each such vesting date Mr. Nathanielsz is employed by the Company and subject to the other provisions of the Employment
Agreement. The Initial Nathanielsz RSUs shall vest on the one-year anniversary of the Effective Date, subject to Mr. Nathanielsz&#x2019;s
continued employment with the Company through such vesting date. The Additional Nathanielsz RSUs will vest as follows, subject to Mr.
Nathanielsz&#x2019;s continued employment with the Company through the applicable vesting date: (i) 7.80 of the Additional Nathanielsz
RSUs shall vest upon the Company submitting Clinical Trial Application (the &#x201c;CTA&#x201d;) for PRP, the Company&#x2019;s lead product
candidate (&#x201c;PRP&#x201d;), for a First-In-Human study for PRP (the &#x201c;Study&#x201d;) in an applicable jurisdiction to be selected
by the Company, (ii) 7.80 of the Additional Nathanielsz RSUs shall vest upon</PPCB:OptionsVestedDescription>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod contextRef="From2019-05-132019-05-14_custom_EmploymentAgreementMember_custom_MrNathanielszMember">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="From2019-05-132019-05-14_custom_EmploymentAgreementMember_custom_AdditionaNathanielszRSUsMember"
      decimals="INF"
      unitRef="Shares">7.80</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <PPCB:GrossProceedsFromEquityFinancing
      contextRef="From2019-05-132019-05-14_custom_EmploymentAgreementMember_custom_AdditionaNathanielszRSUsMember"
      decimals="0"
      unitRef="USD">4000000</PPCB:GrossProceedsFromEquityFinancing>
    <us-gaap:SalariesAndWages
      contextRef="From2019-05-132019-05-14_custom_ServicesAgreementMember_custom_DrKenyonMemberMember_custom_AUDCurrenryMember"
      decimals="0"
      unitRef="AUD">54000</us-gaap:SalariesAndWages>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward
      contextRef="From2019-05-132019-05-14_custom_ServicesAgreementMember_custom_DrKenyonMember"
      decimals="INF"
      unitRef="Shares">20</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="From2019-05-132019-05-14_custom_ServicesAgreementMember_custom_DrKenyonMember"
      decimals="INF"
      unitRef="USDPShares">4250</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
      contextRef="From2019-05-132019-05-14_custom_ServicesAgreementMember_custom_DrKenyonMember"
      decimals="INF"
      unitRef="Pure">1</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="From2019-05-132019-05-14_custom_ServicesAgreementMember_custom_InitialKenyonRSUsMember"
      decimals="INF"
      unitRef="Shares">20</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="From2019-05-132019-05-14_custom_ServicesAgreementMember_custom_AdditionalKenyonRSUsMember"
      decimals="INF"
      unitRef="Shares">20</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod contextRef="From2019-05-132019-05-14_custom_ServicesAgreementMember_custom_DrKenyonMember">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="From2019-05-132019-05-14_custom_ServicesAgreementMember_custom_AdditionalKenyonRSUsMember"
      decimals="INF"
      unitRef="Shares">5</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <PPCB:GrossProceedsFromEquityFinancing
      contextRef="From2019-05-132019-05-14_custom_ServicesAgreementMember_custom_AdditionalKenyonRSUsMember"
      decimals="0"
      unitRef="USD">4000000</PPCB:GrossProceedsFromEquityFinancing>
    <PPCB:StockToBeIssuedDuringPeriodValueRestrictedStockUnit
      contextRef="From2021-07-012021-09-30_custom_ServicesAgreementMember"
      decimals="INF"
      unitRef="Shares">20</PPCB:StockToBeIssuedDuringPeriodValueRestrictedStockUnit>
    <us-gaap:AccruedSalariesCurrent
      contextRef="AsOf2021-06-30_custom_AUDCurrenryMember"
      decimals="0"
      unitRef="AUD">135000</us-gaap:AccruedSalariesCurrent>
    <us-gaap:AccruedSalariesCurrent contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">101250</us-gaap:AccruedSalariesCurrent>
    <PPCB:CancellationOfAccruedSalaries
      contextRef="AsOf2021-08-12_custom_ServicesAgreementMember_custom_DrKenyonMember"
      decimals="0"
      unitRef="USD">102600</PPCB:CancellationOfAccruedSalaries>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1
      contextRef="From2021-08-112021-08-12_custom_ServicesAgreementMember_custom_DrKenyonMember"
      decimals="INF"
      unitRef="Shares">3420000</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <us-gaap:AccruedSalariesCurrent
      contextRef="AsOf2021-09-30_custom_AUDCurrenryMember"
      decimals="0"
      unitRef="AUD">13500</us-gaap:AccruedSalariesCurrent>
    <us-gaap:AccruedSalariesCurrent contextRef="AsOf2021-09-30" decimals="0" unitRef="USD">9739</us-gaap:AccruedSalariesCurrent>
    <us-gaap:ConcentrationRiskDisclosureTextBlock contextRef="From2021-07-01to2021-09-30">&lt;p id="xdx_800_eus-gaap--ConcentrationRiskDisclosureTextBlock_zRlJNNTBEOJ7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTE
10 &#x2013; &lt;span id="xdx_825_zh1KlZqvgQEb"&gt;CONCENTRATIONS AND RISKS&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;Concentration
of Credit Risk&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company maintains its cash in banks and financial institutions in Australia. Bank deposits in Australian banks are uninsured. The Company
has not experienced any losses in such accounts through September 30, 2021.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company primarily relied on funding from one convertible debt lender and received proceeds after deductions of $&lt;span id="xdx_90C_eus-gaap--AmortizationOfFinancingCostsAndDiscounts_pp0p0_c20210701__20210930_zvV3ouFXogye" title="Discounts and debt issuance cost"&gt;7,500&lt;/span&gt; for original issue
discounts and debt issue costs during the three months ended September 30, 2021 from a lender of $&lt;span id="xdx_901_eus-gaap--ProceedsFromConvertibleDebt_pp0p0_c20210701__20210930_zZ5A9lGsQync"&gt;160,000&lt;/span&gt; which represents approximately
&lt;span id="xdx_900_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20210930_zRDKV2Tjny3a"&gt;100%&lt;/span&gt; of total proceeds received by the Company during the three months ended September 30, 2021.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company did &lt;span id="xdx_909_eus-gaap--ProceedsFromConvertibleDebt_pp0p0_doxL_c20200701__20200930_zLrM3Z83L9M5" title="::XDX::-"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3953"&gt;no&lt;/span&gt;&lt;/span&gt;t receive any funding from lenders during the three months ended September 30, 2020.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;Receivable
Concentration&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;As
of September 30, 2021 and June 30, 2021, the Company&#x2019;s receivables were &lt;span id="xdx_900_ecustom--ReimbursementOnGoodsAndServiceTaxReceivablePercentage_dp_c20210701__20210930_zCHtZ5g5SYGh" title="Reimbursement on goods and service tax receivable percentage"&gt;&lt;span id="xdx_90D_ecustom--ReimbursementOnGoodsAndServiceTaxReceivablePercentage_dp_c20200701__20210630_zWVZomWa1LN6" title="Reimbursement on goods and service tax receivable percentage"&gt;100%&lt;/span&gt;&lt;/span&gt; related to reimbursements on GST taxes paid.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;Patent
and Patent Concentration&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company has filed multiple patent applications relating to its lead product, PRP. The Company&#x2019;s lead patent application has been
granted and remains in force in the United States, Belgium, Czech Republic, Denmark, France, Germany, Ireland, Italy, Netherlands, Portugal,
Spain, Sweden, Switzerland, Liechtenstein, Turkey, United Kingdom, Australia, China, Japan, Indonesia, Israel, New Zealand, Singapore,
Malaysia, South Africa, Mexico, Republic of Korea, India and Brazil. In Canada, the patent application remains under examination.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;PROPANC
BIOPHARMA, INC. AND SUBSIDIARY&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;SEPTEMBER
30, 2021&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;(Unaudited)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;In
2016 and early 2017, we filed other patent applications. Three applications were filed under the Patent Cooperation Treaty (the &#x201c;PCT&#x201d;).
The PCT assists applicants in seeking patent protection by filing one international patent application under the PCT, applicants can
simultaneously seek protection for an invention in over 150 countries. Once filed, the application is placed under the control of the
national or regional patent offices, as applicable, in what is called the national phase. One of the PCT applications filed in November
2016, entered national phase in July 2018 and another PCT application is currently entering national phase in August 2018. A third PCT
application entered the national phase in October 2018.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;In
July 2020, a world first patent was granted in Australia for the cancer treatment method patent family. Presently, there are 31 granted
patents and 34 patents under examination in key global jurisdictions relating to the use of proenzymes against solid tumors, covering
the lead product candidate PRP.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Further
patent applications are expected to be filed to capture and protect additional patentable subject matter based on the Company&#x2019;s
field of technology relating to pharmaceutical compositions of proenzymes for treating cancer.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;Foreign
Operations&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 26.2pt; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;As
of September 30, 2021 and June 30, 2021, the Company&#x2019;s operations are based in Camberwell, Australia, however the majority of research
and development is being conducted in the European Union.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 26.2pt; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;On
July 22, 2016, the Company formed a wholly owned subsidiary, Propanc (UK) Limited under the laws of England and Wales for the purpose
of submitting an orphan drug application with the European Medicines Agency as a small and medium-sized enterprise. As of September 30,
2021 and June 30, 2021, there has been no activity within this entity.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ConcentrationRiskDisclosureTextBlock>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="From2021-07-01to2021-09-30"
      decimals="0"
      unitRef="USD">7500</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="From2021-07-01to2021-09-30"
      decimals="0"
      unitRef="USD">160000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="AsOf2021-09-30" decimals="INF" unitRef="Pure">1</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <PPCB:ReimbursementOnGoodsAndServiceTaxReceivablePercentage
      contextRef="From2021-07-01to2021-09-30"
      decimals="INF"
      unitRef="Pure">1</PPCB:ReimbursementOnGoodsAndServiceTaxReceivablePercentage>
    <PPCB:ReimbursementOnGoodsAndServiceTaxReceivablePercentage
      contextRef="From2020-07-012021-06-30"
      decimals="INF"
      unitRef="Pure">1</PPCB:ReimbursementOnGoodsAndServiceTaxReceivablePercentage>
    <us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock contextRef="From2021-07-01to2021-09-30">&lt;p id="xdx_804_eus-gaap--DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_zogQn9ohpdga" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTE
11 - &lt;span id="xdx_82E_z1zpYd1cMdD4"&gt;DERIVATIVE FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;i&gt;Derivative
Financial Instruments:&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company applies the provisions of ASC 815-40, &lt;i&gt;Contracts in Entity&#x2019;s Own Equity&lt;/i&gt;, under which convertible instruments and
warrants, which contain terms that protect holders from declines in the stock price (reset provisions), may not be exempt from derivative
accounting treatment. As a result, warrants and embedded conversion options in convertible debt are recorded as a liability and are revalued
at fair value at each reporting date. If the fair value of the warrants exceeds the face value of the related debt, the excess is recorded
as change in fair value in operations on the issuance date. The Company had $&lt;span id="xdx_902_eus-gaap--ConvertibleDebt_iI_pp0p0_c20210930__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--ConvertibleDebtMember_zwH6m3Amf23a" title="Convertible debt"&gt;&lt;span id="xdx_903_eus-gaap--ConvertibleDebt_iI_pp0p0_c20210630__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--ConvertibleDebtMember_zwaTAZVdiqi6"&gt;80,000&lt;/span&gt;&lt;/span&gt; (1 note) of convertible debt, which is treated as
derivative instruments outstanding at September 30, 2021 and June 30, 2021.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company calculates the estimated fair values of the liabilities for derivative instruments using the Binomial Trees Method. The closing
price of the Company&#x2019;s common stock at September 30, 2021, the last trading day of the period ended September 30, 2021, was $&lt;span id="xdx_90D_eus-gaap--SharePrice_iI_c20210930_zWpDL0RPjJL1" title="Share Price"&gt;0.026&lt;/span&gt;.
The Volatility, expected remaining term and risk-free interest rates used to estimate the fair value of derivative liabilities at September
30, 2021 are indicated in the table that follows. The expected term is equal to the remaining term of the warrants or convertible instruments
and the risk-free rate is based upon rates for treasury securities with the same term.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Convertible
Debt&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89C_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_ziVEwM4zVGa4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;span id="xdx_8B3_zk9Bx8xU2Kvf" style="display: none"&gt;SCHEDULE
OF FAIR VALUE MEASUREMENTS, RECURRING AND NONRECURRING, VALUATION TECHNIQUES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.8pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Initial
                                            Valuations&lt;br/&gt; (on new derivative&lt;br/&gt; instruments entered&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.8pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;into
                                            during the three&lt;br/&gt; months ended&lt;br/&gt; September 30, 2021)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;September
    30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Volatility&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 18%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_902_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_dp_uPure_c20210930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_z91KrVbagw65" title="Debt instrument, measurement input, percentages"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3968"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 18%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_902_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_dp_uPure_c20210930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember_znDDVGuM3xK6" style="font: 10pt Times New Roman, Times, Serif" title="Debt instrument, measurement input, percentages"&gt;206.00&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Expected Remaining Term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90B_eus-gaap--DebtInstrumentTerm_c20210701__20210930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_zcyHeINBsNI9" title="Debt instrument, measurement input, term"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3972"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90C_eus-gaap--DebtInstrumentTerm_dtY_c20210701__20210930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember_zWMN60Ok1IOk" title="Debt instrument, measurement input, term"&gt;0.01&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Risk Free Interest Rate&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90D_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_dp_uPure_c20210930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_zTlxnS98e5R5" title="Debt instrument, measurement input, percentages"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3976"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90A_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_dp_uPure_c20210930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember_zBC50CDGAAK1" title="Debt instrument, measurement input, percentages"&gt;0.07&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90C_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_dn_uPure_c20210930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zCbCaGbL5Jd7" title="Debt instrument, measurement input, percentages"&gt;None&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_901_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_dpn_uPure_c20210930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember_zIiMk9sIpq1" title="Debt instrument, measurement input, percentages"&gt;None&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A2_z9QCLngR86Z4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;PROPANC
BIOPHARMA, INC. AND SUBSIDIARY&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;SEPTEMBER
30, 2021&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;(Unaudited)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;i&gt;Fair
Value Measurements:&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89E_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_zQ8Y0zdM2HX4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company measures and reports at fair value the liability for derivative instruments. The fair value liabilities for price adjustable
warrants and embedded conversion options have been recorded as determined utilizing the Binomial Trees model. The following tables summarize
the Company&#x2019;s financial assets and liabilities measured at fair value on a recurring basis as of September 30, 2021 and June 30,
2021:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_8BF_z92R6udxgfO5" style="display: none"&gt;SCHEDULE
OF FAIR VALUE, ASSETS AND LIABILITIES MEASURED ON RECURRING BASIS&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Balance
    at&lt;br/&gt; September&#160;30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Quoted
                                            Prices&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;in
                                            Active&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Markets
                                            for&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Identical&lt;br/&gt;
                                            Assets&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Significant&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Other&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Observable&lt;br/&gt;
                                            Inputs&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Significant&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Unobservable
                                            Inputs&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(Level 1)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(Level 2)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(Level 3)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 44%; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Embedded
    conversion option liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_iI_pp0p0_c20210930_znrDt9zeQUQj" style="border-bottom: Black 1.5pt solid; width: 10%; text-align: right" title="Embedded conversion option liabilities"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;58,124&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_iI_pdp0_c20210930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zyf9mHFTG7D6" style="border-bottom: Black 1.5pt solid; width: 10%; text-align: right" title="Embedded conversion option liabilities"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3988"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_iI_pdp0_c20210930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zDR2luvuqBKe" style="border-bottom: Black 1.5pt solid; width: 10%; text-align: right" title="Embedded conversion option liabilities"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3990"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_iI_pp0p0_c20210930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zfYeJvYPLE83" style="border-bottom: Black 1.5pt solid; width: 10%; text-align: right" title="Embedded conversion option liabilities"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;58,124&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--DerivativeLiabilities_iI_pp0p0_c20210930_zpZqMmMLg1Nj" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;58,124&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--DerivativeLiabilities_iI_pdp0_c20210930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zI42zixfZpa1" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3996"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--DerivativeLiabilities_iI_pdp0_c20210930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z4N9YaP254Ea" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3998"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--DerivativeLiabilities_iI_pp0p0_c20210930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zFa2qEvswSgl" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;58,124&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Balance
    at&lt;br/&gt; June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Quoted
                                            Prices&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;in
                                            Active&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Markets
                                            for&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Identical&lt;br/&gt;
                                            Assets&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Significant&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Other&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Observable&lt;br/&gt;
                                            Inputs&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Significant&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Unobservable
                                            Inputs&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(Level 1)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(Level 2)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(Level 3)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 44%; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Embedded
    conversion option liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_iI_pp0p0_c20210630_zxSBZDQIJc8e" style="border-bottom: Black 1.5pt solid; width: 10%; text-align: right" title="Embedded conversion option liabilities"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;54,220&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_c20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_pdp0" style="border-bottom: Black 1.5pt solid; width: 10%; text-align: right" title="Embedded conversion option liabilities"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4004"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_c20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_pdp0" style="border-bottom: Black 1.5pt solid; width: 10%; text-align: right" title="Embedded conversion option liabilities"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4006"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_iI_pp0p0_c20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zmZMI2T7dhS3" style="border-bottom: Black 1.5pt solid; width: 10%; text-align: right" title="Embedded conversion option liabilities"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;54,220&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--DerivativeLiabilities_iI_pp0p0_c20210630_zY5UsolInuf2" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;54,220&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--DerivativeLiabilities_c20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_pdp0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4012"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--DerivativeLiabilities_c20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_pdp0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4014"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--DerivativeLiabilities_iI_pp0p0_c20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z8dP5d3YIqD9" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;54,220&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/&gt;

&lt;p id="xdx_8A7_zWt2ql5TwhZ6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_896_eus-gaap--ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_zCMqAhbosFH6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
following is a roll forward for the three months ended September 30, 2021 of the fair value liability of price adjustable derivative
instruments:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_8B9_z0UpiPSRcN17" style="display: none"&gt;SCHEDULE
OF DERIVATIVE LIABILITIES AT FAIR VALUE&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"/&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Fair Value
    of&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Liability
    for&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Derivative&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Instruments&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 82%; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Balance at June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--DerivativeLiabilities_iS_pp0p0_c20210701__20210930_zye6j61g3l84" style="width: 14%; text-align: right" title="Balance at Beginning"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;54,220&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Change in fair value
    included in statements of operations&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet_pp0p0_c20210701__20210930_zXS50oq2qLa6" style="border-bottom: Black 1.5pt solid; text-align: right" title="Balance at Beginning"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,904&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Balance at September
    30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--DerivativeLiabilities_iE_pp0p0_c20210701__20210930_zN3IqKOe7TQb" style="border-bottom: Black 2.5pt double; text-align: right" title="Balance at Ending"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;58,124&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A7_z38uRLnE5jX" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"/&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"/&gt;

</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
    <us-gaap:ConvertibleDebt
      contextRef="AsOf2021-09-30_us-gaap_ConvertibleDebtMember"
      decimals="0"
      unitRef="USD">80000</us-gaap:ConvertibleDebt>
    <us-gaap:ConvertibleDebt
      contextRef="AsOf2021-06-30_us-gaap_ConvertibleDebtMember"
      decimals="0"
      unitRef="USD">80000</us-gaap:ConvertibleDebt>
    <us-gaap:SharePrice
      contextRef="AsOf2021-09-30"
      decimals="INF"
      unitRef="USDPShares">0.026</us-gaap:SharePrice>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock contextRef="From2021-07-01to2021-09-30">&lt;p id="xdx_89C_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_ziVEwM4zVGa4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;span id="xdx_8B3_zk9Bx8xU2Kvf" style="display: none"&gt;SCHEDULE
OF FAIR VALUE MEASUREMENTS, RECURRING AND NONRECURRING, VALUATION TECHNIQUES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.8pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Initial
                                            Valuations&lt;br/&gt; (on new derivative&lt;br/&gt; instruments entered&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.8pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;into
                                            during the three&lt;br/&gt; months ended&lt;br/&gt; September 30, 2021)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;September
    30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Volatility&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 18%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_902_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_dp_uPure_c20210930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_z91KrVbagw65" title="Debt instrument, measurement input, percentages"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3968"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 18%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_902_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_dp_uPure_c20210930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember_znDDVGuM3xK6" style="font: 10pt Times New Roman, Times, Serif" title="Debt instrument, measurement input, percentages"&gt;206.00&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Expected Remaining Term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90B_eus-gaap--DebtInstrumentTerm_c20210701__20210930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_zcyHeINBsNI9" title="Debt instrument, measurement input, term"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3972"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90C_eus-gaap--DebtInstrumentTerm_dtY_c20210701__20210930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember_zWMN60Ok1IOk" title="Debt instrument, measurement input, term"&gt;0.01&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Risk Free Interest Rate&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90D_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_dp_uPure_c20210930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_zTlxnS98e5R5" title="Debt instrument, measurement input, percentages"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3976"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90A_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_dp_uPure_c20210930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember_zBC50CDGAAK1" title="Debt instrument, measurement input, percentages"&gt;0.07&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90C_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_dn_uPure_c20210930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zCbCaGbL5Jd7" title="Debt instrument, measurement input, percentages"&gt;None&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_901_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_dpn_uPure_c20210930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember_zIiMk9sIpq1" title="Debt instrument, measurement input, percentages"&gt;None&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock>
    <us-gaap:DebtInstrumentMeasurementInput
      contextRef="AsOf2021-09-30_us-gaap_MeasurementInputPriceVolatilityMember_us-gaap_ConvertibleDebtMember"
      decimals="INF"
      unitRef="Pure">2.0600</us-gaap:DebtInstrumentMeasurementInput>
    <us-gaap:DebtInstrumentTerm contextRef="From2021-07-012021-09-30_us-gaap_MeasurementInputExpectedTermMember_us-gaap_ConvertibleDebtMember">P0Y3D</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentMeasurementInput
      contextRef="AsOf2021-09-30_us-gaap_MeasurementInputRiskFreeInterestRateMember_us-gaap_ConvertibleDebtMember"
      decimals="INF"
      unitRef="Pure">0.0007</us-gaap:DebtInstrumentMeasurementInput>
    <us-gaap:DebtInstrumentMeasurementInput
      contextRef="AsOf2021-09-30_us-gaap_MeasurementInputExpectedDividendRateMember"
      decimals="INF"
      unitRef="Pure">0</us-gaap:DebtInstrumentMeasurementInput>
    <us-gaap:DebtInstrumentMeasurementInput
      contextRef="AsOf2021-09-30_us-gaap_MeasurementInputExpectedDividendRateMember_us-gaap_ConvertibleDebtMember"
      decimals="INF"
      unitRef="Pure">0</us-gaap:DebtInstrumentMeasurementInput>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock contextRef="From2021-07-01to2021-09-30">&lt;p id="xdx_89E_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_zQ8Y0zdM2HX4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company measures and reports at fair value the liability for derivative instruments. The fair value liabilities for price adjustable
warrants and embedded conversion options have been recorded as determined utilizing the Binomial Trees model. The following tables summarize
the Company&#x2019;s financial assets and liabilities measured at fair value on a recurring basis as of September 30, 2021 and June 30,
2021:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_8BF_z92R6udxgfO5" style="display: none"&gt;SCHEDULE
OF FAIR VALUE, ASSETS AND LIABILITIES MEASURED ON RECURRING BASIS&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Balance
    at&lt;br/&gt; September&#160;30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Quoted
                                            Prices&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;in
                                            Active&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Markets
                                            for&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Identical&lt;br/&gt;
                                            Assets&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Significant&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Other&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Observable&lt;br/&gt;
                                            Inputs&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Significant&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Unobservable
                                            Inputs&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(Level 1)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(Level 2)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(Level 3)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 44%; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Embedded
    conversion option liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_iI_pp0p0_c20210930_znrDt9zeQUQj" style="border-bottom: Black 1.5pt solid; width: 10%; text-align: right" title="Embedded conversion option liabilities"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;58,124&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_iI_pdp0_c20210930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zyf9mHFTG7D6" style="border-bottom: Black 1.5pt solid; width: 10%; text-align: right" title="Embedded conversion option liabilities"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3988"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_iI_pdp0_c20210930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zDR2luvuqBKe" style="border-bottom: Black 1.5pt solid; width: 10%; text-align: right" title="Embedded conversion option liabilities"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3990"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_iI_pp0p0_c20210930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zfYeJvYPLE83" style="border-bottom: Black 1.5pt solid; width: 10%; text-align: right" title="Embedded conversion option liabilities"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;58,124&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--DerivativeLiabilities_iI_pp0p0_c20210930_zpZqMmMLg1Nj" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;58,124&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--DerivativeLiabilities_iI_pdp0_c20210930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zI42zixfZpa1" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3996"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--DerivativeLiabilities_iI_pdp0_c20210930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z4N9YaP254Ea" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3998"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--DerivativeLiabilities_iI_pp0p0_c20210930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zFa2qEvswSgl" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;58,124&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Balance
    at&lt;br/&gt; June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Quoted
                                            Prices&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;in
                                            Active&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Markets
                                            for&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Identical&lt;br/&gt;
                                            Assets&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Significant&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Other&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Observable&lt;br/&gt;
                                            Inputs&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Significant&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Unobservable
                                            Inputs&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(Level 1)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(Level 2)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(Level 3)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 44%; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Embedded
    conversion option liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_iI_pp0p0_c20210630_zxSBZDQIJc8e" style="border-bottom: Black 1.5pt solid; width: 10%; text-align: right" title="Embedded conversion option liabilities"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;54,220&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_c20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_pdp0" style="border-bottom: Black 1.5pt solid; width: 10%; text-align: right" title="Embedded conversion option liabilities"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4004"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_c20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_pdp0" style="border-bottom: Black 1.5pt solid; width: 10%; text-align: right" title="Embedded conversion option liabilities"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4006"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_iI_pp0p0_c20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zmZMI2T7dhS3" style="border-bottom: Black 1.5pt solid; width: 10%; text-align: right" title="Embedded conversion option liabilities"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;54,220&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--DerivativeLiabilities_iI_pp0p0_c20210630_zY5UsolInuf2" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;54,220&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--DerivativeLiabilities_c20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_pdp0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4012"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--DerivativeLiabilities_c20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_pdp0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4014"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--DerivativeLiabilities_iI_pp0p0_c20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z8dP5d3YIqD9" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;54,220&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/&gt;

</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability contextRef="AsOf2021-09-30" decimals="0" unitRef="USD">58124</us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability>
    <us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
      contextRef="AsOf2021-09-30_us-gaap_FairValueInputsLevel3Member"
      decimals="0"
      unitRef="USD">58124</us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability>
    <us-gaap:DerivativeLiabilities contextRef="AsOf2021-09-30" decimals="0" unitRef="USD">58124</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="AsOf2021-09-30_us-gaap_FairValueInputsLevel3Member"
      decimals="0"
      unitRef="USD">58124</us-gaap:DerivativeLiabilities>
    <us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">54220</us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability>
    <us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
      contextRef="AsOf2021-06-30_us-gaap_FairValueInputsLevel3Member"
      decimals="0"
      unitRef="USD">54220</us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability>
    <us-gaap:DerivativeLiabilities contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">54220</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="AsOf2021-06-30_us-gaap_FairValueInputsLevel3Member"
      decimals="0"
      unitRef="USD">54220</us-gaap:DerivativeLiabilities>
    <us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock contextRef="From2021-07-01to2021-09-30">&lt;p id="xdx_896_eus-gaap--ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_zCMqAhbosFH6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
following is a roll forward for the three months ended September 30, 2021 of the fair value liability of price adjustable derivative
instruments:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_8B9_z0UpiPSRcN17" style="display: none"&gt;SCHEDULE
OF DERIVATIVE LIABILITIES AT FAIR VALUE&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"/&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Fair Value
    of&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Liability
    for&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Derivative&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Instruments&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 82%; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Balance at June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--DerivativeLiabilities_iS_pp0p0_c20210701__20210930_zye6j61g3l84" style="width: 14%; text-align: right" title="Balance at Beginning"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;54,220&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Change in fair value
    included in statements of operations&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet_pp0p0_c20210701__20210930_zXS50oq2qLa6" style="border-bottom: Black 1.5pt solid; text-align: right" title="Balance at Beginning"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,904&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Balance at September
    30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--DerivativeLiabilities_iE_pp0p0_c20210701__20210930_zN3IqKOe7TQb" style="border-bottom: Black 2.5pt double; text-align: right" title="Balance at Ending"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;58,124&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock>
    <us-gaap:DerivativeLiabilities contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">54220</us-gaap:DerivativeLiabilities>
    <us-gaap:EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
      contextRef="From2021-07-01to2021-09-30"
      decimals="0"
      unitRef="USD">3904</us-gaap:EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet>
    <us-gaap:DerivativeLiabilities contextRef="AsOf2021-09-30" decimals="0" unitRef="USD">58124</us-gaap:DerivativeLiabilities>
    <us-gaap:SubsequentEventsTextBlock contextRef="From2021-07-01to2021-09-30">&lt;p id="xdx_80E_eus-gaap--SubsequentEventsTextBlock_zBdf9ZOf6jq3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTE
12 &#x2013; &lt;span id="xdx_824_zliAKEcZXTY6"&gt;SUBSEQUENT EVENTS&lt;/span&gt; &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;i&gt;Exercise
of Warrants&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;In
October 2021, the Company issued &lt;span id="xdx_906_eus-gaap--CommonStockSharesIssued_iI_c20211031__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementClassOfStockAxis__custom--ElevenSeriesAWarrantsMember_zTaypf8UVaP3"&gt;2,199,989&lt;/span&gt; shares of common stock from the alternate cashless exercise of 11 Series A warrants.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;i&gt;Note
Conversions&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;In
October 2021, the Company issued an aggregate of &lt;span id="xdx_90F_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_pid_c20211001__20211031__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z0cEUQXkrEMi"&gt;1,818,097&lt;/span&gt; shares of its common stock at an average contractual conversion price of $&lt;span id="xdx_907_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20211031__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zdoPRJX58rwe"&gt;0.01&lt;/span&gt;,
as a result of the conversion of principal of $&lt;span id="xdx_90D_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20211031__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zurT2Mh9EFfk"&gt;25,000&lt;/span&gt;, interest of $&lt;span&gt;&lt;span id="xdx_907_eus-gaap--InterestPayableCurrent_iI_pp0p0_c20211031__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_znl6ciVAg1Oj"&gt;1,726&lt;/span&gt;&lt;/span&gt; and conversion fees $&lt;span id="xdx_902_ecustom--ConversionFees_pp0p0_c20211001__20211031__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zpmLqz6cRsT7"&gt;0&lt;/span&gt; underlying certain outstanding convertible
notes converted during such period. The Company reclassified $&lt;span id="xdx_901_eus-gaap--AdditionalPaidInCapital_iI_pp0p0_c20211031__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z1SDhUYOwhUh"&gt;16,667&lt;/span&gt; in put premiums to additional paid in capital following these conversions.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;i&gt;Common
Stock Issuable&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
&lt;span id="xdx_908_eus-gaap--CommonStockSharesIssued_iI_c20211031__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z9wgoqHrTdH"&gt;2,002,490&lt;/span&gt; shares of common stock issuable as of September 30, 2021 were issued in October 2021.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;i&gt;Consulting
Agreement&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90E_ecustom--ConsultingAgreementDescription_c20211019__20211021__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z68zps5mSWji" title="Consulting agreement description"&gt;On
October 1, 2021, the Company entered int a consulting agreement (the &#x201c;Consulting Agreement&#x201d;) with a consultant who will
assist in the development of the Company&#x2019;s business and financing activities. The consultant will serve initially as an
independent contractor, and upon certain mutually agreed upon conditions being met, will be appointed Vice Chairman, President and
Interim CFO. The term of the Consulting Agreement shall be for three years commencing on October 1, 2021, and can be terminated by
either party upon 30 day written notice. The monthly payment per the Consulting Agreement is $&lt;span id="xdx_90E_ecustom--ConsultingAgreementMonthlyPayment_c20211019__20211021__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zTgvambp0mw7" title="Consulting agreement, monthly payment"&gt;7,000&lt;/span&gt;. The Company will also issue
shares of common stock equal to 1% of the total issued and outstanding shares at the end of each year of service.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;PROPANC
BIOPHARMA, INC. AND SUBSIDIARY&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;SEPTEMBER
30, 2021&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;(Unaudited)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;i&gt;October
21, 2021 Securities Purchase Agreement&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Effective
October 21, 2021, the Company entered into a securities purchase agreement with Sixth Street Lending LLC (&#x201c;Sixth Street&#x201d;),
pursuant to which Sixth Street purchased a convertible promissory note (the &#x201c;October 21, 2021 Sixth Street&#x201d;) from the Company
in the aggregate principal amount of $&lt;span id="xdx_902_eus-gaap--DebtInstrumentFaceAmount_iI_c20211021__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--OctoberTwentyOneTwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember_zc7nWc13krPh"&gt;63,750&lt;/span&gt;, such principal and the interest thereon convertible into shares of the Company&#x2019;s
common stock at the option of Sixth Street any time after the six-month anniversary of the October 21, 2021 Sixth Street. The October
21, 2021 Sixth Street contains an original discount of $&lt;span id="xdx_907_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20211021__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--OctoberTwentyOneTwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember_zckIAeInq8A9"&gt;3,750&lt;/span&gt;. The Company intends to use the net proceeds from the October 21, 2021
Sixth Street for general working capital purposes. The maturity date of the October 21, 2021 Sixth Street Note is &lt;span id="xdx_901_eus-gaap--DebtInstrumentMaturityDate_dd_c20211019__20211021__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--OctoberTwentyOneTwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember_zE1DM51b0p48"&gt;October 21, 2022&lt;/span&gt;. The
October 21, 2021 Sixth Street Note bears interest at a rate of &lt;span id="xdx_90F_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20211019__20211021__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--OctoberTwentyOneTwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember_z6Dh2ArSB0Xf"&gt;8%&lt;/span&gt; per annum, which interest may be paid by the Company to Sixth Street
in shares of the Company&#x2019;s common stock; but shall not be payable until the October 21, 2021 Sixth Street Note becomes payable,
whether at the maturity date or upon acceleration or by prepayment.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90E_eus-gaap--DebtInstrumentDescription_c20211019__20211021__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--OctoberTwentyOneTwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember_z7EBQht24Kj8" title="Debt description"&gt;During
the first 60 to 180 days following the date of these notes, the Company has the right to prepay the principal and accrued but unpaid
interest due under the above notes issued to Sixth Street, together with any other amounts that the Company may owe the holder under
the terms of the note, at a premium ranging from 110% to 129% as defined in the note agreement. After this initial 180-day period, the
Company does not have a right to prepay such notes.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
conversion price for the above Sixth Street notes shall be equal to a &lt;span id="xdx_90D_ecustom--DebtCoversionPercentage_dp_c20211019__20211021__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--OctoberTwentyOneTwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember_zilqj1sUw0v"&gt;35%&lt;/span&gt; discount of the market price which means the average of the
lowest three trading prices of the Common Stock for the ten trading days immediately prior to the delivery of a Notice of Conversion.
Notwithstanding the foregoing, Sixth Street shall be restricted from effecting a conversion if such conversion, along with other shares
of the Company&#x2019;s common stock beneficially owned by Sixth Street and its affiliates, exceeds &lt;span id="xdx_90E_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_uPure_c20211021__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--OctoberTwentyOneTwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember_zlHWJNKFJQve"&gt;9.99%&lt;/span&gt; of the outstanding shares of
the Company&#x2019;s common stock. These notes are treated as stock settled debt under ASC 480 and accordingly the Company recorded a
total of $&lt;span id="xdx_90E_ecustom--GainFromSettlementOfDebtNet_c20211019__20211021__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--OctoberTwentyOneTwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember_zkIkx4wftODa"&gt;34,327&lt;/span&gt; put premium.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
above Sixth Street notes contain certain events of default, upon which principal and accrued interest will become immediately due and
payable. In addition, upon an event of default, &lt;span id="xdx_903_eus-gaap--DebtInstrumentInterestRateTerms_c20211019__20211021__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--OctoberTwentyOneTwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember_zxb9fpKcrTDh" title="Debt Instrument, Interest Rate Terms"&gt;interest on the outstanding principal shall accrue at a default interest rate of 22%
per annum&lt;/span&gt;, or if such rate is usurious or not permitted by current law, then at the highest rate of interest permitted by law. Further,
certain events of default may trigger penalty and liquidated damage provisions.&lt;/span&gt;&lt;/p&gt;

</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2021-10-31_us-gaap_SubsequentEventMember_custom_ElevenSeriesAWarrantsMember"
      decimals="INF"
      unitRef="Shares">2199989</us-gaap:CommonStockSharesIssued>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1
      contextRef="From2021-10-012021-10-31_us-gaap_SubsequentEventMember"
      decimals="INF"
      unitRef="Shares">1818097</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="AsOf2021-10-31_us-gaap_SubsequentEventMember"
      decimals="INF"
      unitRef="USDPShares">0.01</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2021-10-31_us-gaap_SubsequentEventMember"
      decimals="0"
      unitRef="USD">25000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:InterestPayableCurrent
      contextRef="AsOf2021-10-31_us-gaap_SubsequentEventMember"
      decimals="0"
      unitRef="USD">1726</us-gaap:InterestPayableCurrent>
    <PPCB:ConversionFees
      contextRef="From2021-10-012021-10-31_us-gaap_SubsequentEventMember"
      decimals="0"
      unitRef="USD">0</PPCB:ConversionFees>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2021-10-31_us-gaap_SubsequentEventMember"
      decimals="0"
      unitRef="USD">16667</us-gaap:AdditionalPaidInCapital>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2021-10-31_us-gaap_SubsequentEventMember"
      decimals="INF"
      unitRef="Shares">2002490</us-gaap:CommonStockSharesIssued>
    <PPCB:ConsultingAgreementDescription contextRef="From2021-10-192021-10-21_us-gaap_SubsequentEventMember">On
October 1, 2021, the Company entered int a consulting agreement (the &#x201c;Consulting Agreement&#x201d;) with a consultant who will
assist in the development of the Company&#x2019;s business and financing activities. The consultant will serve initially as an
independent contractor, and upon certain mutually agreed upon conditions being met, will be appointed Vice Chairman, President and
Interim CFO. The term of the Consulting Agreement shall be for three years commencing on October 1, 2021, and can be terminated by
either party upon 30 day written notice. The monthly payment per the Consulting Agreement is $7,000. The Company will also issue
shares of common stock equal to 1% of the total issued and outstanding shares at the end of each year of service.</PPCB:ConsultingAgreementDescription>
    <PPCB:ConsultingAgreementMonthlyPayment
      contextRef="From2021-10-192021-10-21_us-gaap_SubsequentEventMember"
      decimals="0"
      unitRef="USD">7000</PPCB:ConsultingAgreementMonthlyPayment>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2021-10-21_us-gaap_SubsequentEventMember_custom_OctoberTwentyOneTwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember"
      decimals="0"
      unitRef="USD">63750</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="AsOf2021-10-21_us-gaap_SubsequentEventMember_custom_OctoberTwentyOneTwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember"
      decimals="0"
      unitRef="USD">3750</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentMaturityDate contextRef="From2021-10-192021-10-21_us-gaap_SubsequentEventMember_custom_OctoberTwentyOneTwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember">2022-10-21</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="From2021-10-192021-10-21_us-gaap_SubsequentEventMember_custom_OctoberTwentyOneTwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember"
      decimals="INF"
      unitRef="Pure">0.08</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:DebtInstrumentDescription contextRef="From2021-10-192021-10-21_us-gaap_SubsequentEventMember_custom_OctoberTwentyOneTwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember">During
the first 60 to 180 days following the date of these notes, the Company has the right to prepay the principal and accrued but unpaid
interest due under the above notes issued to Sixth Street, together with any other amounts that the Company may owe the holder under
the terms of the note, at a premium ranging from 110% to 129% as defined in the note agreement. After this initial 180-day period, the
Company does not have a right to prepay such notes.</us-gaap:DebtInstrumentDescription>
    <PPCB:DebtCoversionPercentage
      contextRef="From2021-10-192021-10-21_us-gaap_SubsequentEventMember_custom_OctoberTwentyOneTwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember"
      decimals="INF"
      unitRef="Pure">0.35</PPCB:DebtCoversionPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="AsOf2021-10-21_us-gaap_SubsequentEventMember_custom_OctoberTwentyOneTwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember"
      decimals="INF"
      unitRef="Pure">0.0999</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <PPCB:GainFromSettlementOfDebtNet
      contextRef="From2021-10-192021-10-21_us-gaap_SubsequentEventMember_custom_OctoberTwentyOneTwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember"
      decimals="0"
      unitRef="USD">34327</PPCB:GainFromSettlementOfDebtNet>
    <us-gaap:DebtInstrumentInterestRateTerms contextRef="From2021-10-192021-10-21_us-gaap_SubsequentEventMember_custom_OctoberTwentyOneTwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember">interest on the outstanding principal shall accrue at a default interest rate of 22%
per annum</us-gaap:DebtInstrumentInterestRateTerms>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>65
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M(J H54?PI=[PCGU:**$+QV;-@O(>)&G=C;*!ZZ*2ITWNSH0M\"RB@:4L#ER
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M34!45:9&J>J L,3+.6<GP+5:9=.-JIA5M,*GA9[WC>3J*%5Q<KEB1:)FD21
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M"2T.U]@FKFQ#X0VVH=#$-FW9IH]-&=YF5]?9=#B,( CC:';!-=3%%Q(TE-R
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MYWE27_(D./CY'1<* _\E"(,L@,^IJH'3Y>3*A]  @%F&:U)YP@%L#G'DC1N
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M!N]%-*R(3I8480:1;^,@'#-LVK)8:)/)J#Z3B76!\AD#V@4E)W"20$!PD@!
MBJGI&O+V %**NV6[;8^D31BC^C VY.)(7*)A< B6/((>KO6IFK0N"#$<0XX$
M^J9^9R( +3)7Q$]YYWB'%D]]:X(BU0?%MZF">L^]T7VO?R_VEPD2]PD/DS&:
MS2>#?^XF]T-O"L^EDML\UF=AT\14=A0 PG,) %*#V)8K)RV04CN7FNQ)]=FS
MWYN-!J@W'J+AZ/YI[@U1[9*X>42SN][4 ^TH:>WC+N'/JAD@S)9O<6"8(]L
MH(A+/Q\Y>^I"DSBI/G&J+GSU1K=W^9?>L[B'OO5*)V9H\C2?S05P-+X%;5%3
M*+6)&'[Y !T 2-.U&9%/9 #',*.6\NP(:MJP6,MS,MKD5JK/K7^V:NQS5PT
MA%<- &Q9-1"E=M4T*94Z9SQC$!X\3KT[D<]&SU[]Q"'W2O>X@38YD.ISX%.4
M<#\,_A-[_0J,Q:%?QV+T(<Q?V8!CH$8URR"N_#P"@%W8IFTJ P E/T=,->4$
M5('Y>TZ[Q7W6!$2F#XC'^?CL,2B]8&IT@[P 8* 7$ [T @!JO6@"(_M%8"R\
M.'6A+0Y55"<+PC0(P_+>! *Q ,JW2A"06A@32W[@!R$-T\#8E!_X=8_>>FYY
MLBY>-Z=H$>^CK'S!55^M7VGWBA>YTO4^N1P0X/J07'KE"^N&OGQ__N GZR!*
M4<A7HBEQ3HGN)N4KZ?)'%N^*=ZXO<9;%V^+KAOM+GN0 \?=5'&=O/_(&ZO\8
M</,_4$L#!!0    ( ,&%*E1V<<BO10\  &^1   8    >&PO=V]R:W-H965T
M<R]S:&5E=#4N>&ULS5UM;^.X&?PK0E"@+7"YB!3U=L@&V(TE2S*N7>SVKA^*
M?E!L)A'6ME))3G;_?2G':UDD15OQ;*^'Q25.R!F*FD>DA@^9ZY>R^E(_<MY8
M7U?+=?WNXK%IGGZYNJKGCWR5US^73WPM?G-?5JN\$1^KAZOZJ>+Y8EMIM;RB
MMNU=K?)B?7%SO?W9Q^KFNMPTRV+-/U96O5FM\NK;![XL7]Y=D(OO/_A4/#PV
M[0^N;JZ?\@?^F3>_/7VLQ*>K/<JB6/%U791KJ^+W[R[>DU]FGM]6V);XO> O
M]<'W5GLI=V7YI?V0+MY=V&V+^)+/FQ8B%U^>^2U?+ELDT8[_[$ O]IQMQ</O
MOZ/'VXL7%W.7U_RV7/ZS6#2/[RZ""VO![_/-LOE4OB1\=T%NBS<OE_7V_];+
MKJQ]8<TW=5.N=I5%"U;%^O5K_G77$0<5W&"@ MU5H*=6<'85'*D"I0,5V*X"
MDRHX9*""NZO@RA6\@0K>KH(G-\D?J.#O*O@RPU"%8%<AD!G80(5P5R&4*A!G
MZ,;9W^^<+3=JL,K^9K^*[E4E6XE-\B:_N:[*%ZMJRPN\]INM3K?UA;**=1M2
MGYM*_+80]9J;VW)=E\MBD3=\87UNQ!<1+TUME??6[6.^?N"U5:S%+\KYE\=R
MN>!5_6=KPN^+>=%8E]9OGR?67_[TU^NK1C2E!;R:[V@_O-+2 =K/O"H$]'OK
MHX@@7E5;<L%A_>M7OKKCU;^'?JZANCV)Z@.":F*FNBU7JW)]'"8: 9/6]2:_
M6W(37FS&>[]8%.WS*U]:'_-B<2ENZ&W^5#3BLP%T:@;]Q!OQP!:=%N75NE@_
MU":LY$@#_WZ;6N^;IBKN-LWV8IM2-+422C2AIF;4?X@AIMY4WX[?C^P(4"FZ
M2E-M=D1XF[MZ7A5/VZ'C$Y_SXMEP(Z]$X.ZCE^ZCEVXIV #%!_Y0K-O>%\/*
M,E_/^4_6<[[<<"MOK&RS_MER[)\L:I-0%Z&OT.X6NAUYGV]<V[:OKYX/8\O(
MWX[WO]1/^9R_NQ #>LVK9WYQ8^D"1R4C?:8(Q!2K3,SU":-!V"><J@4O76(S
M\<_OETPTC;<]+PR#?KE4@\@\YDMPF:Z88Q/J>/N"/34X>S4X8]50/XHHJD^2
MPRNV)\E!$81:3+J1$[5$Z$D]%1DOY*2;W>LAMN\A9NRA[<-4=$P[O,U?G[+U
M]N$@YJ;6/*\?=1UCA#Q=F+<@G D[&DH@II@I=Y)1%BJ!!*)+0#@I""?37WYH
MZZ/4W6O0/4^#WZ-6=^]=I4F!S?3M\?;M\<YH3[E^%G.^=@3;_KK]U!3M*+;@
M=\U/A[^_Y^)YDZ\7XBUI7FW$Q*!8-UQ<1J.+*6.31L04"&?B*3%%F?S, G'%
MGG(/*1&ZHIX45B"^!(23@G R[?6[Q!_0L;_7L?_'ZM@0EQ^,31NA9Q#.Q%?[
MF/D>D9[<T?ETO5L5[&]58+Q58C*\S.NZ$*^1>;.[)T^;QA(LJV*SLC9/XF?M
MC3FX+[I>-[*,Z'40S@2$$X%PXD =+7SQH&'2@P9$EX!P4A!.=O3R>^(-]^(-
MW_Z<:9M3S-L9]\$#A']]XNM:_^ P<HV0, AG$BH#H3P,@ICB4'V1(([GR.($
MT24@G!2$D^DOGU&].(G=^7GV#Y*G:=ZY(^W'$@T'&GM@/I(C \$R;RUUZSXO
MJIUU(=K]DE=5WKJ0A;@8T<*7HGE4!FVMZ6BD&Q%.** )"BA" <4[H,-;Z?AN
M:+M2X*$($Q10B@+*CG=!7\^='4?,?MRKT]@N\2S:X&OCZG6"4ZQ;_:YWZTA;
M/;]&9?EJ#SYL]:Z5-,@7NT4!35! $0HHW@'U[J=M,R*_4:$($Q10B@+*CG=!
M7]*=ITC,IN(829N?XH<#D%;IYYN".Z6#@"8HH @%%!.-N1JP@-BRTD&$"0HH
M10%EQ[N@K_3.&R9F<S@N*UX\"%5OJHJOY]^L1LBW7KZJ_2$OM*^@9LPQHD79
MPRB@" 44HX"F**"$J-9NFX/B.])*S?%R?:UU'C QF\!_XXVU+&O]<]!8=8RD
M0$ 3%%"$ HI10%.B.NJ7S&>V3R4MI"C*[!3*OJPZ*Y^8O?QHO3BZ&$QMK>A4
M!URS&FRF'Z,HC>'NRDX#BBTFJN7LVB%Q@M"1QTVUY*7K^@'Q?:DO$DU10CW?
M\XDL' VF;EE85\[Q&&%4>C6; 3JF+[#.8R=FDUT6F'9]>4!AJB>M76#6E)-7
MF#5%A'H(M64!@?UMTAG<Q.QP_R&+:N8VC1DX4(;X#JB7C'%@<>WN$LKN)JKA
MRP*;.$J0HPQO%%"* LKT7>#ZRA/D?,)^9'3N.3G#/O_!RW03HKJN0H^V0_0#
M+^U<5WJ&Z\J_\FI>U+V78FU"EI%C1/RB@"8[H%ZNB22E"$464]5CIC:QJ9*W
M!2),4$ I"B@;Z (F+8K, (1]H7>./34[]J.%;@I'JOJPQ&5LP(:E!UF19AL6
MM;YLIAD3D+ T2I3WB@**J6H\4IN%<JK!%$68H(!2%%!V8A?, (3]@.A,7/K_
M8N*:&S(F9% F+@HH0@'%5'4PJ>V30(X8E(>+ DI10-EI/3 #\/4#IO."Z0_P
M@LV88[2/\H)10!$**$8!35% "54]WDM?O#%)\]SLQ'(S0,/ZHNU,9?IV4]E<
M=8PV4:8R"BA" <4HH"G5.;S4=9FDE13%F)W*. ,P]M79>=/TC=[T9_YD=@[I
M2=ZTF7Z,,%4Z7WWK17G35.--DX#:7DCE^8#.F_;$N.G(K4LT10D1$U(Y(R+5
M86JW+.F\:>JXS%,FN6!OFG;>-'VK-WU<82=ZTYIRLC>M*2+4XX8#B1BTLY2I
MV5(^<:_?P 6J1JPNA%"^KX9.7=Y!L<54-3T'EG<T)8>6=S1%]<L[.DQM"&G*
MZ9=W !W3UUAGSE*S.7OJ#L(!D:GNJCZ*-+FO<A2I1;0K/.;K&=]53N?X.F<X
MOC]JA<?<IA&S.!30Q%$=XL /).U'*+K840U20AV;!O++,XHQ00&E**!,WP>A
M[0_XIDYG[CIGF+L_>FW&4<U@H22/D(&L"*>S@YUC=G#;L'RI7%;Q_6R%Q69[
MY,"\O?CE<N\9=Y=4ZZ[Y]+!%^<@HH(FCV8,N[PN*4&RQHQJDER0,E1DNBC!!
M :4HH$S7!=2VA_)SG8,]_V9K]W\J;F/\JIZ>D!2C_L 5=EZ<8_;B(&NK9HXQ
M(8CRYG9 O3FRO#\3118[JGGE^YXMOSA.480)"BA% 64#7< &M@,ZG>WFG+&A
M?^R2J*,:.30,Z$!RL].Y+\XYN_SS^G')Z_KT:$+MWT<!31S5M&%4?O.('9W=
MH12;HEJ5H(!2%% & .HKL+-GG'/VYYL4:(P7U6YA[=3"']B;Z'1^BW-LDWHW
ML"K) R,'4VT,H;+U4$ 3%%"$ HH=C6="B!\HPQ8JHP\%E** LN-=T-=WY_4X
M9J_G=S&?$U.[=EI7%?/VV]=PW*R+@8<^:J\Z"FB" HI00#$*:(H"2E! *0HH
M P#U#__J/#MF]NR,DC>,,A%3+1=W8(!AG=O"S&Y+7.7SW;&,B^+^GK>)!ONW
MM>:1BW:V8PI_;>1E_;0LM .)F69$7** )BB@" 44HX"F** $!92B@#( 4#\2
M.H..F0VZMT2":5+(5+.%#)VLP3JGA9F=E@GG*_'(6!3/Q8*O%Z\3P7S9\&J=
M-WS\2Y29;DS<HE+E4$ 1"BAFJJGDA,1GRA&$&O-)5S!!M2Q% 64 H+Z@#P[#
M-!MKJ#1I,\T8(:.\-110A **F>H^M0>.V/)Q1RC"! 64HH"RXUW0UW%GP+$S
M#+COR<HGG\AE)ANC9E2FW ZHM\9J2YD\$8HM9JH#2=K# ^7#5%"$"0HH10%E
MVBYP77]H"M&YL.P,%]:H5.-T1W4U ]OUV,#:$NLL.V:V['[ <49FQC'1A3HJ
M$P44H8!BIGJ: 0U\>;44Q9>@@%(44':T!_J"[CQ=9O9TWY36;\8<(UF448L"
MBE! ,0IHB@)*F,XW#2CSI-RD%,68G<#8EVUGU3*S56M*[#=7':-.E"N+ HI0
M0#$*:,K4M,1+:E,W5/YD!(HR10%EI[2]?Z!]YZNZ9E_UI&-GB$Z]KIH^J,E+
M-M./D*:&CC Q59+FTBB^V-7XQLSV&5$.;-.4O'0#$H9,GG@GFJ+$#EPJOTNF
M.DQ=9K*F5RX=V_-=^3RL&:!C^A+KS'+7;):?=O",7F-J8J$V+5E33DY+UA41
M^G$=.=,\TI$.K!BXG4_JFGW2<_YT1.9J=BD[81@>I,[VF]49HZ[9&/U#4J'-
M;1HQ[J& )CN@PS *F;P!*T+1Q:[F+_&$[;-%?K*@MA&C@%(44*;I\3:G,O#D
MQQ;88G4[B]4](W?Q1V=4NZKAU@K2MH<>1 =_P@:<\J:-8)31A@*:N*K1)N]D
MT!21WLMC5W6/')^%H1*8* ,-!92B@#)-%U!?G=C--.4N27]L[BNT<]K<,YRV
ML4EFKFJP>8%\IE:D*47=P2OI3#C7;,*AEQW-=&/"#N7 H8 B%%#L:O9Y$A;(
MYS!-->4N=0435,M2%%"& IH!@/J1T;EY[AF'+)X3(2C##P4T<37[:9G\-(UT
MI91G;NSJ]JLJ8%-4VQ,44(H"RE! ,P!07_J=(^B><8KBB=(WCGB:_;?2R^).
M<YJ]O&'[W\"XYW6FDF<VE5#9"6::$=&, IJ@@"(44.SI+*708_+^>11A@@)*
M44#9B5TP Q#V Z*SP+PS=N>.3G,PDXT)"U36Z ZH9\[ZH?P'P2(47^QI+#K/
M":DOBQZ5\HD"2E% F:X+ A)X1!8].#74ZRQ/[PS+\\T9$YXF0;25FC.T;<CK
MS% /=]3BB3D39L8QH8JR.E% $0HH]DX[4Q'%EZ" 4A10=EH/S !\_<CHO%#/
M[(6^*?G"C#E&^ZC<4A10A **44!3%%#BJ<ZSQXB\2):B^++3^&8 OK[V.\/<
M>_O1C.:J8R2.\L%10!$**$8!33W=08FA[<FGDR4HQA0%E)W:]!F L2_SSG7W
M &<\:A?IO9/.>#33CU&XYK@ )U#^-(FF&+5M><%'UW:7,>;ZLE^L*7GI!H'-
M0D_1GUJ4$!8ZH9R_IL/497GHRE'']CQ'7I71E32MRGC=6H:'.*)1+Y 3CVC4
ME).S.#1%VIM//-FVCS0EV_OO,ODUX:I^Y+R9Y$U^<_V4/_!?\^JA6-?6DM^+
MFO;/ONC,JGAXW']HRJ=W%^*MZJYLFG*U_?:1YPM>M07$[^_+LOG^X4K@OY35
MERW'S7\!4$L#!!0    ( ,&%*E3N%",3 0L  .0R   8    >&PO=V]R:W-H
M965T<R]S:&5E=#8N>&ULK5O;4N-($OV5"F(?9B*&MNJB&P%$&$OT>*(;"$SW
MQ#X*N0#MR))7DKGLUV^69"R[*E78';R +9^ZY%%FY:E4Z?2EK/ZIGZ1LR.LB
M+^JSHZ>F69Z,1G7Z)!=)_:5<R@)^>2BK1=+ U^IQ5"\KF<S;1HM\Q!S'&RV2
MK#@Z/VVOW53GI^6JR;-"WE2D7BT62?5V(?/RY>R('KU?N,T>GQIU871^NDP>
MY4PV/Y8W%7P;;7J99PM9U%E9D$H^G!V-Z4DL0M6@1?S,Y$N]]9DH4^[+\A_U
M93H_.W+4C&0NTT9UD<"_9SF1>:YZ@GG\=]WIT69,U7#[\WOOEZWQ8,Q]4LM)
MF?^=S9NGLZ/@B,SE0[+*F]ORY4^Y-LA5_:5E7K=_R<L:ZQR1=%4WY6+=&&:P
MR(KN?_*Z)F*K ?2#-V#K!DQO( 8:\'4#KC?P!AJ(=0.Q[PCNND%K^JBSO24N
M2IKD_+0J7TBET-";^M"RW[8&OK)".<JLJ>#7#-HUYY.RJ,L\FR>-G)-9 __
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M))N_1U?':-D\R8HD+<6H^:82.@ZXRW7[K4,?XGB?U%&,3#S@U/4'6.Q%'/U
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MQ554XOJQCF$VW)6.IG*A4)DBLC*!9W]S'4A=P+)2I5,$EL:V5/K;XTSA*C-
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M(% 0+X4Y>,OFNS&)E7(/AQEE!E9C18%--&.)&Z(&-VC##0ER@XM;O<?("Q,
M/%>%D>EV=V*9WU?1NVRD>X*ZZ9YP"'XC2$L8H,&KVQ#-;2!74QC0FD)I)@M/
MU8R3"E45 V  ;-*QBYC5\ADMA67V)+<#F 84/5AG8A/!DQ@23XDA7 _]9J:!
MPGJQA#]")(K Y'%%T$I?T%*\C'&@$ O,QV*9C\'8S3S#<&G*-9SNY,TZP;=.
M#!0^=_(+HF&-K"+)Q$[2!BF9'7ETR%851H&9>Y9.S3_7ILIH;%N@&JJWX&G
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M!+/9!2<5F)&0;+ 6"%[0"D-U193K>1T$Q&0"S\!C7\H+_"NZ+^75/:*#3L6
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M-3#)(LQC:P?A)IR,8N5?QYIX&$7&. C&CDP#&^8X%W8WGEA$FQ<)U58'DNJ
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MRLR\4V8][R;C'/,*^%4'O*I7NQ30;?BO^^P:_%TX?EEHW_#YUPHMZ.0)]>;
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M1FB] >]OC*'#Q#OHGUJ3OP%02P,$%     @ P84J5 OIG32) @  O08  !D
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M=@"-B)QQ!$(6;%#!B7+\1$Y=F[G2YT+WFI:L 8H$@V\212+=-9?:V/4/D?$
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MSBKT+6E^*6,6QC/UV^).2-^<=1F,W3O"%KB=M43#80!4-LC@DU6GH"8>JB)
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M^40OW96GYWX4T4@=I3M@A_GNF@.;/4$01EQGH3'I:'CD01-\"6"=B&Q0D8;
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M.S8?IV4I5+((TI3 I_=<*$U4<&B8#H9F/;PJMFYVAVY'Y,,LQ^6TEM.<)QB
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M@WTF/^ $]UG^E8/W[O\ 4$L#!!0    ( ,&%*E1+E/3N>0L  ,,9   9
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MQG/WDX&[*/36OJ9?Z*+0&_MU+05:!!'@^5+KHKZ@ PZ_VWS\#U!+ P04
M" #!A2I4?3+L@)$4  !K2@  &0   'AL+W=O<FMS:&5E=',O<VAE970Q-"YX
M;6SM/&MOVTB2W_M7-'S90P(P,E\2R4P20'X$X]F);<3.#O8.]X&B6A)W*%+#
MAQ7/K[^JZFZRJ5=D)Q?L ?/!HDAV5U=5U[O:>KLNRM^KA1 U_[+,\NK=R:*N
M5V].3ZMD(99Q-2A6(H<WLZ)<QC7<EO/3:E6*>$J3EMFI:]NCTV6<YB?OW]*S
MV_+]VZ*ILS07MR6OFN4R+A_/1%:LWYTX)_K!IW2^J/'!Z?NWJW@N[D3]>75;
MPMUI"V6:+D5>I47.2S%[=S)VWIS[.)X&_",5Z\KXSI&225'\CC=7TW<G-B(D
M,I'4""&&RX,X%UF&@ "-/Q3,DW9)G&A^U] _$.U RR2NQ'F1_99.Z\6[D_"$
M3\4L;K+Z4['^62AZA@@O*;**/OE:CG7=$YXT55TLU63 8)GF\AI_47PP)H3V
MG@FNFN >.\%3$SPB5&)&9%W$=?S^;5FL>8FC 1I^(=[0;* FS7$7[^H2WJ8P
MKWY_=W]S_O>?;WZ]N/QT]Y__$;I.\!._N/QP=7YU__:TA@5PV&FB@)U)8.X>
M8![_6.3UHN*7^51,=\P_/SS?<0\ . 7*6O)<3=Z9>Q#BG5@-N&=;W+5=9Q="
MAZ?_TN3[IO?0\5IN>P3/VP/O\H\FK1_Y?X\G55V"!/_/ 9A^"],GF/[WV<&#
MP-!FO*E6<2+>G8!1J$3Y($[>7]_<7[* $W#G)WY@07Z5)V!+*L'2G(^;>E&4
MZ9]BRN\6,4#CQ8R?%\LE:.]=722_\SB?\D_B09254$_N5EE:\YN<?1"3L@&S
MPGUBOLWKA> 7:0G:7Y05V(^JR!X <EWP5*U)0WKP83WU;!7GCWQ6%DONV+9E
MRS_NZ&]T!ZM>%P]B.1$E=P*YK-4#(&8S6!]6C7F1B]=@0U_#%884386TO'3>
M$,A7_/;3S>WX^IR=7=W<_CS^]'%L\:OK\P$?7U_PN\]G=U<75^-/_^0O/^=Q
M,TT!)$P!^R7*4DR91/Y^(5A=U''&\X9P FJJEH\K/9I7-+I>Q'4/U[3B<;<!
MR*:J:@0^=JPA43SD]L!V^,V,X3RYE %6+M7!L/A0,4I?CY^Y:LJJB?,:\2 D
M15FGLS2):X'$7(@JG><QV?59F@&,=5HO:.2=@,VM41!@W%VM)M";NIV=Q6M8
MDL%L4%C!G1%NGC.T>+/"%6?@*#16BQB^3X3(P=;+17$[*UBG3.'U6;<-2H9>
MHHB[]D_[!M!KYZ=7 WX9)PN^*+*I*!F@!2ZSJD$JTGQN[-O>=6!C1%ZG=29W
MZZ&H<>*J6,/."S ;#W$F.@9V(@$# 1Z,@#U0+TVI83VI2:1V2)$Q$8PKS5;0
ML**<\BDR%P2<GDU%+4IP/G*'$"("D*1NH2TX2*) 7BS!*2'P8L9Z$S;4$C5G
M"P9Z^"P#3U?7.*5J)LNTQKT"E$KD1RD'3X3Q#NYC-5TNL;$L,Y8=@+XKJ?C:
MOI#F3 G/;9Z!AZFES=!^@@:2(.HG _ZQ'/#K&)0T3T56_<FF9,FR1\ _%Z (
M*1 +(K[.D51@77$,;@"R8/$4[ =L"^SXEI2-MZ@![NVE%"1-:%JG38DDDC0M
M2B'X4OIE@7YY!\T,:9ZE50)H/(JX5&1+:RP-VAOE!9A: H4K*7*T_DJJY%V=
M3C(4N4G-/X#!9K\TP!E'L1:0*9KY8@<&UH;U4UO&X_F\%'-E*B++]X=@NR(T
M?6[[X7,GC*S0CWAHV6' 7<L=V@#5MIQP1(98PX5=R^*J ML%T%^ ,XFLD>_U
MABQ +IPHL#P[M!QGM(-J=*MI@B82F!8G28DOQ!<(S"MX"&YHW,PA\N..:Y)V
M5L2@E_%J51;D^!9RL^(\(=)<*U1F.?3ITCT "CT>!E8$;M2C3S7DF4LYHY$U
M&@6LDS>#]2HBJ/JV!LAF&6Q#UA%?HBR5BB4(@$0,H2F<I @!:_6"^PP9"2[8
M1]KQ6N+])073(4!R7B#Y0[8"45$*5<*SP I#CUML(K28)UE1D<4MTZ1O/] 6
M*90\QV335$G5O 37)C%5&)JJA-%()ZV609;B&),F5[ORUYB53)%"%(C6Y"J<
MV5,U<P Q&>L>[U45$!<GL@)'*X3M6R/'::_/"&A,>W>.LI-EDIHQ:*18HC?;
M)X!MP)77)")I3J9]#Q0*%GZ)E\!X8\W6<QO/M+.V^/DB%3-^^44D#>:1[&8&
M5ACX@RJIP\P-R;;X>@'83!Y[J\2(!KF>A+#C"_ 825PM^CLX*?(&%'Z-BH4"
MOVDK+;F!K.<W+" <#$,"B\V%,IBF ^^AUY,IHL-$L\])X-Y2"HP,P:N:XJ#+
MY2HK'I&GK./NE%Y]C,$(4RSN1/PE+JNXVP[L J';C6@/@X?63+3CK1Y^:[":
M(DOG9/QA'O E9VB^\QPC&Y-=Q%S09RIAH$F2O$7V4-AACH5%<3]$2QA.3 LC
MP-0,HP<QAU!S+FH3/)/@T<2"R0Q"R U $WT(@\&4AIV!!5=A.1ZZ$#>*VD%_
M%_DC>,#_>_F_@ @#7&4*/)-KMO(O;S=%_RY),>@"J>=*]ME1LJ^ ;XD]F2C'
M=JV1C5[&=PW?X]C@#L,0<KD /O6@_X+]!KDNV4Y9;!%Y+K?VR/@.N*8X;[_6
MC%-FIJC$C&G46Q[K!]M*P'8IP?8J?4K C4#PNP*=:U>*J5K%JSA3R= +B%$&
MP,;QYPO^\H43^OSSW<4KE%SI$BR<'X,Z85Z$P&=I6:$ZTVP9H.,X=!!<1Y%]
M-)8PMK5BPL"EBSDA9JM2\.,J>2OPY4-:%8!CZ^F5,H%U _DQR0>C!SP%@*G"
M$$:1=T<-W[!V%E<)[A34&U)"Y1;;<*5O_CJGU@^*,% [(C#:CMG$%U$F:47^
M'HPX>OS*B$^CO?&I&^P25:!?I!A;=>'IO"PJX%59)*!8E=0G-QC*0H5".+*\
M8,A'5@B?+J;Q_(+" 79T.& 9FY<][HD$O"BR(M14*\)O$2  MC_T?3Y6)0D*
M.&U09#_JL'M&C/";8N4;VIE9D67%FL(;%%Q56D[_Q(A*#I1E7ZRAZ:CQ**HA
M]SC_^?+B\Z^7[.8#_VW\Z=/X^IZ/S^^O_G%U_T_V&Q5[03ZOV[1Z#)E(/!=,
M5:YN,2IDM_".'K ;,P^L^]D>6"?'\MP([6$0#48>NY*,?<U?LTLE1U/^$C8S
M"O@K[ML#+V ?BG(FD"EJV(HR7/R^L=:.A--Q8*<\%Q>,G('GZE6(B;NG!".8
MX9&(A0-OU%\$[*4!X4W+'QY+KH#X8H, QX+^4R43G#1#$\>=P="%Z$%+-=AB
M$- J31@%Z+#@:\Q:5>"N%8GB90JCGY%[0B:_0H$&(1HSU8W8EY04JZYY@%+T
MU+6P'$"%4<)T@DV0OFQ1<93?W-Y?W5P?(V":T<^3M"$)F6<%GKU;R/#N6R2+
M%O"MH><-/.\(L?+T>'L0>=]/J(+!R-V>,(O34N9]R%"YM17;(48JY@/9VR69
MO)/,IUI3HFJ[3HP)W3RGPNOAE XF!DZH+T/'"J(1>*61V^F((NM;5617[^.Y
MK8#PKU; 4UH!_^_J^D?Z<92%.W9_P\]OKN]N?KVZ&-]?7O /5]<P]VK\*P@'
M//AX>7U_1U:+;2G-7PV$OQH(?S40^AY=Z\96RX#O;!FP?[N6P69ARZ#([ ;H
M%.NJ2['.,>L;K\HT8YZR]*"\ !7B-,BFDP4:]GXU  >KFNJ&?<9RKBR^QAQB
M"?"Z\MA(";K>[K0"C[3M6, L"QP<J368]0H0L-C'&(;JO;6[&DJ<PY '46$%
MP%SE2CUL2PXKM=94.JQ>02:@_*_)4XB?32"?\4E;[6&D2)2E5TJ7^,OT%8;I
M_ GU>W,!TZ]V524@!2SXZUE#(4@;V9L347KH-=-I7TMHLP*()OF$0GO89]H(
M;9O\013]C4\R6%S@DL5#2OTC4":L##15I0-SDKR7J2*VQ0C@:+:RGL[TXH4-
MJSWF&RA;!#V!A%700:3LL5=2[ #MVYD!'T'</K3U!<."KAB@,53M"&U'"8*E
M_-H&8G+]MD[1]C%>4-W2M^5E*%V\[_J4U[M#RW;DXH>5 4-RB,XKK$-M\5[+
M->*E-Q$% A41,$ )C6?@E],87<VZ:+(ISXMZJ_D)6L'$ET14))1RIR\:H4MH
M9^UP?K/.P2(OTA7_-07;'7>U*TB%L7D74@_#\OT1=YY"'IG24J@<C^ "PY7P
MI*IGET!LF!//0>I0>NK'58I6C^I?/7M#R@4N %Q?4XK!TWN@1DI"-E6&^*;3
ML'=7<?S &CD1#[C+(P<#W-#Q+<\#?@Q5?]"!W7<"'X3 )UL"+WP;TI#1T J
M;VXTM$(OY-[(M:*1P\, 9,;UC\#HN&9L: 58,G<\B%?IP_:X.Y"QN!-:X2B
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MN+>)X-TR@<,N58==\6+)LT2D^6]X4RHV.AO;;/1VK,W!&RUM?;],B-E<,*[
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M&&6V1;;+)$"1M9:E2J5:L:71.?:")5I]AB_(128@P,*Q3,#[C1?=B$0@QZ5
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M2&'(\5RET1.R:"B+)7(-3@<+T-5RK]"_ F2 ")6O@+Q53XX),A#W)>,$A+9
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M$.*V%DJ1K3.K7-RZ7%1XJ ?K'4]/Y?&HOS?L[XT.]D:!>(9LPO 2S+E:OC9
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MS$W<=(!.><Y(!GOH%>^9T%+D\O3J=6+R,G:/($]V[>C"X J(&[LX\I;0&DQ
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M1E%GMK\^'+5S<I]0US;43HKBTJ]FQ(GQ-;^:<=B3IUPF*QH'CVGL7PYIZ(;
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M@RVW>UOL)VQQ8,1RN1'@YTNZK)#OU<M;=HV")@)3HF,?T;FU:S4&=/L6'-,
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MW-!H2;E:@/,KQN2QHS8HO_+<_ =02P,$%     @ P84J5$V&%OQW P  <0@
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M&R+<L")1<[Y_P8.>EN8+>2+-$_;EV";-&!92\?0 IG8:9^6;O1]\. $\U"\
MO / ^Z\ _P#PC= R,R-KR!3K=P7?@]"CB4T'QAN#)C5QIE=QH01]C0FG^K/Y
M=#::+[]!,!G"Z/?5>/8VFBSA=LG6"<J[KJMH$CW4#0^$3R6A=X'0AS>>J9V$
M419A= 8_N(YO>%<(7%)72?2.$I^\JXP+S&O@UQWPZE[C7$+7X;\5V27XIW3\
MRG'?\/F7'!=T!(7Z<&"6L$P!RR(8_2CBG,Z&@K^"M52"-O??5Z9J5E,US53-
M2\H'+Z/AZG4$TV<XO]#GUO<JIZXJCS)G(?9L*AL2Q4^T*TV6%H.5F)#3:9<*
M^ ;4#F'#$RH:<;8%)G4?+8S"=(VBLM>8089CU5.#HPCKH@BK(K(J(DU2M:S;
M5<:**%88W5G3S28.\21+IA.E+&_ :SLMW]/!@W/O^=8K2OD(01@6:9$P0E.!
M(-%AS$P)NO5\I^-WX(ZBIN/?/\"=M>2*)9!7:YSK-7:^^'(#OM/J^/1N.EZK
M!><VY?^V"I7=_[Y;+&,M/>H'%ZVS+AKS='#O>)U.Z:)UQ<6#=Q35G5;+.[IH
M?741OKI8NG<#+:?=;,/PA-7"=[KGI%8KC.H/9$("ZI+R>8,94BT)]BB0R!I.
MAY;&<YIMW]@03 ;6TW@Z>PGF;X$#X\F@9EQ9K)X6X^$XF'^#R70Y6EC+*0RF
MD\7T=3P,EJ,A/(\GA!T'K[!84H<V</%Y7_Z:^]QA=T^J>HIB:RX[22X7F2H+
M?-5;W:>!N4;<7\/+R_B-B6V<24AP0]!ZK=VR09077-E0/#=WQ)HKNG%,N*-_
M A1Z 'W?<*Z.#3U!]9?1_P=02P,$%     @ P84J5+5KD*U6 P  . @  !D
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M).:;'25_"*Y)70'?D[Q5QI"EP*DB8-Q"%P9^@B[S*(N\+$S@S&U#+PFIE[
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M<-#C[ "XME9L>F"2:=!*/J;ZV%/)U2Y6.#E(HW$2+^X3,/T*HO'PX5L"[A[
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M,JG*KAEN52=%7!NH_35C\CC1#JK>//@#4$L#!!0    ( ,&%*E1*W7%3G0(
M * '   9    >&PO=V]R:W-H965T<R]S:&5E=#,P+GAM;+5576_:,!3]*U:>
M-JEJ("D?J@")0E"9H,T(=)JF/1AR(58=.[6=4?[];"=DM()HJM27Q';N.><>
MW]BWM^?B628 "KVFE,F^DRB5W;JNW"208GG-,V#ZRY:+%"L]%3M79@)P;$$I
M=;U&H^VFF#!GT+-KH1CT>*XH81 *)/,TQ>)P!Y3O^T[3.2XLR"Y19L$=]#*\
M@PC4*@N%GKD52TQ28))PA@1L^\ZP>3OJFG@;\$1@+T_&R#A9<_YL)M.X[S1,
M0D!AHPP#UJ\_, )*#9%.XZ7D="I) SP=']DGUKOVLL821IS^(+%*^D[703%L
M<4[5@N_OH?33,GP;3J5]HGT1V];!FUPJGI9@G4%*6/'&K^4^G  TSWF 5P*\
M]X#V!8!? GQKM,C,VAICA0<]P?=(F&C-9@9V;RQ:NR',5#%20G\E&J<&T>@^
M&*]F 7J<H'#Q& :+Y4\T?!BCX/MJ&LZ#AR4*HN5T/EP&8[2*@LEJAF;3IR!"
M7\:@,*'R:\]5.A%#YVY*T;M"U+L@ZJ,Y9RJ1*& QQ&?PHWI\TZLA</4.5-O@
M';?ASJMEC""[1G[C"GD-KWDNH7KXMYQ=@K])QZ^JXEN^FPM\<[Q)])(X(,QB
M%+SD)-,G1Z%?<TC7('[72-Q4$C=6PK\@$0I]$PAUN$(AQ9KZG=!,AZ.I@E36
MB;4JL5:MGZ.858%*!:0B^B1"C'()VYPBJH^T//<_U=.WT &P. <<?0#XQF&[
M<MBN99KD@A&5"[ 6)^35C.7_%*Q3*70^OV#=2JS[N06KI^]<+M@'@(5#]^02
M3$'L;&^0:,-SIHK[L%JMVL_0WKKNO_"B=\VQV!$F$86MAC:N._HO$D4_*":*
M9_9*77.E+V@[3'0+!6$"]/<MY^HX,0)54Q[\!5!+ P04    " #!A2I4"DF8
M<M0#  "=#P  &0   'AL+W=O<FMS:&5E=',O<VAE970S,2YX;6S-5UUOXC@4
M_2M6GG:EF29VODH%2#1)-:S*@J#,K#2:!Q,,1$UBQG9*Y]^O;4* D*:\M2_$
M,?><>WU\$N=V=Y0]\PTA KQF:<Y[QD:([9UI\GA#,LQOZ);D\I\591D6\I:M
M3;YE!"\U*$M-9%F>F>$D-_I=/3=A_2XM1)KD9,( +[(,LS_W)*6[G@&-P\0T
M66^$FC#[W2U>DQD1\^V$R3NS8EDF&<EY0G/ R*IG#.!=!#T%T!'?$[+C)V.@
MEK*@]%G=#)<]PU(5D93$0E%@>7DA 4E3Q23K^%V2&E5.!3P=']@?].+E8A:8
MDX"F/Y*EV/2,6P,LR0H7J9C2W3=2+LA5?#%-N?X%NS+6,D!<<$&S$BPKR))\
M?\6OI1 G ,G3#$ E -4!SAL NP38=8#W!L I <ZU&=P2H)=N[M>NA0NQP/TN
MHSO 5+1D4P.MOD9+O9)<&64FF/PWD3C1GP7?HG#^&('Q PB'C_.GX?<(S*)@
M/AT^#:,9B/X+'N=A%(*'Z7@$@O%H,G\:/ W'_X*_0B)PDO*_P5? -Y@1WC6%
MK$CQFG&9_7Z?';V1W08CFHL-!U&^),L&?-B.AZB%P)125'J@@Q[WJ)5Q1K8W
MP+:^ &0AV%!0<#W<:EI/._R?(F_-'ET/MUK$L"MSV)K/?H-OD(MDF:2%>I;!
MC,0%2T1"I-BO<5I(O<&*T0P$--L6 NOGGJY A%F>Y&L.)H2!F3(&^/DHB<%0
MD(S_:BG+J<IR=%G.-67Q8UGDK*SXO"QR*&LKR])^;;+K/K&G$ZMW[$L?V8[E
MZ=UX.;7!9:#G>*[OG8>%EV$0N?:M SOG@=%EH-NQ',NNPLZ4<BNEW%:EM/Q?
MU8MT"2;XCWS!"S!@#.=KHL9?P'BK]?DY(MF"L+;-\:J4WF?RC%^5Y7^49_R&
MK:NYY3+$LVI.>9\E:F4Y4^6V4N6V594?6)E!7+/_G8JR\YGV'UK'@\[Z* >4
MF<\><P@[-JK9H"G.=GWDUKS0%(>@C>J&:(IS(?1ALRO@R4<!;-5JGK\0+J0F
M4WEA2:R&,T'CYVN< M$Q#?I47CF>>]#^,*_8[[\N&F+DKM9-\CY1U!YS+L[Q
M](7MQV] I3N82!8I 2%9B-.=N\8>Q\,+NI_*'L<C#GH?9@^OX0L$=>R.7_\"
M:8ATH>7Y3MTGEW$0.=#K^*CNELM(Q^Y 6/\(,4_:C8RPM>[SN%QOD8O]QV4U
M6_62 ]U!U>;OX5T &^9#U7OJ]N9(OV]<1YBMDYR#E*QD*NO&EPYB^UYP?R/H
M5C<["RIDZZ2'&]D_$Z8"Y/\K2L7A1B6H.O+^_U!+ P04    " #!A2I48\74
MZ/\%  !&%   &0   'AL+W=O<FMS:&5E=',O<VAE970S,BYX;6SE6%MOXC@4
M?I[^"HN]J)5HB1/"I=LB,12ZK%I T,YJ-=H'DYC&,TF<L1UH__T>FS3<TA3M
M[D@K[0O$R?G.S<?G?,G5BHNO,J!4H><HC.5U)5 JN:S5I!?0B,@+GM 8GBRX
MB(B"I7BJR410XAM0%-9LRVK4(L+B2N?*W)N(SA5/5<AB.A%(IE%$Q,M'&O+5
M=0577F],V5.@](U:YRHA3W1&U6,R$;"JY5I\%M%8,AXC01?7E2Z^O,5-#3 2
MGQA=R:UKI$.9<_Y5+X;^=<72'M&0>DJK(/"WI#T:AEH3^/$M4UK);6K@]O6K
M]H$)'H*9$TE[//R=^2JXKK0JR*<+DH9JRE>_TBP@5^OS>"C-+UIELE8%>:E4
M/,K X$'$XO4_><X2L05P\!L .P/8>X W+3@9P-D#X/H;@'H&J!]KP<T [K$6
M&AF@<2R@F0',[M?6V35;<T,4Z5P)OD)"2X,V?6'VUZ!A1UBL2W&F!#QE@%.=
M4??A<=I'XP$:3_K3[L-P/)JA[N@&S1[O[[O3/_23V?!V-!P,>]W1 ^KV>N/'
MT<-P=&NDIOW)>&I6D_'=L#?LS]#I#56$A1*-B!!$%]H9.D>/LQMT^N/954V!
MT]ITS<L<_+AVT'[+0;Z\0+A91;9E6P7P7CE\1I,+Y%@&C@O@-\?#BZSWR^&_
MI7&I]<'Q\"+KM^7P;OH$J6L76:]!F>2U8N>U8AM]SEO)"+A0YXJ*"-W0N4*?
M[T  #16-Y)\EZIU<O6/4U]]0WX\54R^(Q1X7"=>EP^,J\HFBB"]V;Q?50;ER
M4T:V4SWY\,&V<.%6_@,%._'6\WCKI1JG=$F%I C.N/>UZ&"4PWE,SV$4G<,_
M4@%/)8E]=(HO<=6RK+,2_]S</[?4P%@%5* >CV#&!7KX+&&S81<BBD[ON)1G
M5033 'I]C'JI$#3V7M"#(+$DV90!?\PZ-'N&NOX7Z&<PQE05S2FX3M$#>:ZB
M"525>:Z48/-4D7D($7$T(:!3%6WUVF_7^*UG[;+3J..V<U5;;I_L0ZGSIMMT
MW5VQ?H$8;MGU1G-7;G HI\=]<V-U)\F-/,F-TB3WB Q0_UO*EB2$:&45$85Z
MT#E?6/R$/I$PI45=:ZVTL>6,M>=NF<2.I\W<TV:II\871'R?^DB19^ A'@6O
M8;.*MJAY8-ZVG=;>#AT*U9TZWMN?8X0&!>8L[!8'W,H#;KUS/B4EP@M,(?MP
M6$.>Z.I%'I=*%@7=.G2UX;KUO:@/I5RK56_LA7TH93M6V]T3&QR*X6:[W6H6
MA][.0V^7A@[G$GF"^JPXSE*P)L^7,B$>O:Y YY!4+&FE@XJJ^%_2TV\?'$V,
MH4;V3OJ@?9@KI]ZT6\6YPM:&0EFEV3+#T..Q;N>ZD254>% GP.1A?%'I"9:\
M-;3>T=PG4'X!#WUHQ# #H2&CF"LJ44 D(D^"ZK/($4'UBW;[)^BJ,5TPCY$0
M\54,W@0LV78L9!%3IAF?G,IT_@5>!S3<HP(86VQ4KXW)GW]HV;CY"R)S%NJA
M#%(P@.%=1\^K%)S:J-+/VL9\FL"J8<'(?LD5@$[FF7:NG=?#A,0O,#GTF:(0
MW8DV"H3V14M" )F["@+S4Z%[H,8MF) *2?9\'O%8!3K#C/MH(7ADGN<D0<J4
MQ!Z]0 ]P5U(/5"@&^8)I8P0S((UU%P-R!]QE3L7)*T4S;FFRA594&%\D@W1H
M9UB8:BZ[K705,,B$D:3/7IAJG;E+,">3-,N0A-Q1<Y<N%CKI#'8/V,[YJ]:+
M0FKY_ZR-$N:"M]YJ\-\\DH69+E=F$ECFUH9 8[M4DZFQV::")BG,%YVWKMXO
M,UP^WYN2+"/4>,.HL?,]&#O>4%A<3D(U<X$2N*? 0'U@ATOZRO#&>9%-RG)_
M^XZ!]GNYW[!97$YGAS'DP5L7&;KCP$N/RO6&R.'&=\GUAG_A<@+VW^7CF>,[
MA!RWX35DC_D4R+DMYT"N7R"'+<L]$!P4"3H["M>YKFU](-%?V.Z)>&)0 "%=
M -"Z:((&L?YHM5XHGIAO)G.N%(_,94 )=#\M ,\7'/IAMM"?8?)/AYV_ %!+
M P04    " #!A2I4-VWO3"0$  #;#   &0   'AL+W=O<FMS:&5E=',O<VAE
M970S,RYX;6RM5VUOZC84_BM6-&FMU#7O;Q4@4:!WG78I*NONAVD?3&+ NHG-
MM1UH]^MWG*09#2ZWTJZ$(';.\YQ7'Q\&!RZ^RBTA"CV7!9-#:ZO4[L:V9;8E
M)9;7?$<8O%ES46(%2[&QY4X0G->@LK ]QXGL$E-FC0;UWD*,!KQ2!65D(9"L
MRA*+EUM2\,/0<JW7C4>ZV2J]88\&.[PA2Z*>=@L!*[MCR6E)F*2<(4'60VOL
MWMRE6KX6^).2@SQZ1MJ3%>=?]>(^'UJ.-H@4)%.: <//GDQ(46@B,.-;RVEU
M*C7P^/F5_:[V'7Q984DFO/A"<[4=6HF%<K+&5:$>^>%7TOH3:KZ,%[+^1H=6
MUK%05DG%RQ8,%I24-;_XN8W#$0!XS "O!7A]0/ .P&\!?A\0O0,(6D#P40UA
M"P@_"HA:0%3'O@E6'>DI5G@T$/R A)8&-OU0IZM&0X ITX6U5 +>4L"IT:>'
M^_DG-'F83V:/<W0Q)0K30J(Y%@+KG%^B7]#3<HHN?KH<V H4:IB=M>2W#;GW
M#KF//G.FMA+-6$YR WYZ'N]Z9PAL\+1SUWMU]]8[R[@DNVOD.U?(<SS78-#D
MXW#'Y,]Y^&\5.ZM]]G&X2?O=A^%N>B:6?E<Z?LWGO\/W(#:8T7^P[A!7:,*9
MY 7-<=,P6(X6@DC"5+/!U^B.,LPRB@NTA$T"W4E)]-=X)96 _O+W&8N"SJ*@
MMBAXQZ)'LB>L(F@M>*D-JHGA0*DMFM1'B8@K-'O.BBJG;(/&4A+XY.@/_&PJ
M[K/*=,>_D3N<D:&UTYZ*/;%&R%13/XAG^H-X9O^?YTUVPBX[X=GLS.&:O&<9
M9 %=_,ZEO+S2RS87"R[J.ADK)>BJ4GA5$*0XFG- 0")Y46BQ>Z8(&*5,Z6JT
M1[5V?9_N1T'J1&$RL/?'V3"(>6$8A&_%IJ=B<.K"-(C?RLT,=''@Q)[?R;T)
M5M0%*_INL"98;N$4\3V%YH=6+^CB25<K99?H84=T?]9%K*]FJBB1IIA$I]8E
M47P2DU,Q-T[3(.W%Q"#F!J$7!;V8&.22( V3U!R3N(M)?#8F7V!&T2YG>$<5
MM!$8(&A&C;40GV;/=ST_Z65O>BKG.SI]B=G2I+,T.6OI4O'LZY87.1'R9S3[
M5E'U<E+:"RR@!9JL3PS6.U'D.[VT-7+AL?6>'P91/V^G?$ 7A['?RYM!+@I<
M.!YOY>Y.]0:^ ^&-S%%+NZBEWVG?,'PPJ/ 9%@P2+='%.,NJLBK@NLC1M$FW
M<0Y)3RP*D\0)TJA7Z5.3H NE'D6]6!@$PSAQX]CI.6D?#5]PP6SJ,5FBC%=,
M-9=IM]M-XN-Z .WMW[HW$]>P/W5O9LV@_1]],_9_QF)#F40%68,JYSH&<T4S
M2C<+Q7?UZ+?B"FZ_^G$+_SZ(T +P?LVY>EUH!=W_F=&_4$L#!!0    ( ,&%
M*E0"PN:AF@(  +<&   9    >&PO=V]R:W-H965T<R]S:&5E=#,T+GAM;(U5
M;4^K,!C]*PVY'S11804V9QC)'#-J?.%N[M[<W-P/'92ML5!LB]-_?]N"9$ZV
M^ 7Z<LYY>IZV3X,-X\]BC;$$;SDMQ,A:2UE>V+9(UCA'XHR5N% S&>,YDJK+
M5[8H.4:I(>74AH[3MW-$"BL,S%C,PX!5DI("QQR(*L\1?[_$E&U&5L_Z&)B1
MU5KJ 3L,2K3"<RP79<Q5SVY54I+C0A!6 (ZSD37N742^QAO +X(W8JL-M),E
M8\^Z<Y..+$<O"%.<2*V U.\53S"E6D@MXZ71M-J0FKC=_E"_,MZ5ER42>,+H
M;Y+*]<@ZMT"*,U11.6.;:]SX,0M,&!7F"S8UUO<MD%1"LKPAJQ7DI*C_Z*W)
MPQ:AY^TAP(8 OTMP&X+[78+7$#R3F=J*R4.$) H#SC: :[12TPV33,-6]DFA
MMWTNN9HEBB?#^>1Z&BWNIN#Q"L2SQW@Z>_H#Q@\1F/Y<W,3WTX<G<!1AB0@5
MQ^ 4+.81./IQ'-A2Q=8*=M+$N:SCP'UQ<'D&7.<$0 ?V.NB3P_3;JCA(C[Y/
M=S[3;96P-FNPS1HT>NX>O9BK>\?E^PF(*2HD0$4*IB\5*=6%D.#O>"DD5R?Z
MWX%0;AO*-:&\/:$>LXPD&.!6'4F0,"&[MJ!6\HV2ON^O(1SX+@SLU^U,=Z#.
M^]#]C(HZ4'TX'+:H3V:\UHQWT,P=%N("C).DRBN*)$[5%575*B%(%X$N2[5>
M?VL9I] =NL,=3UTPS^V?[YCJ@CF^#[M=^:TK_Z"K)R81!65[)DI])D[,H6BW
MK<N;_R7%KC_<V8?)5Y '?7_'UU>0/_ &.Z[LK2JA2_H]XBM2"$!QIFC.V4#Q
M>5TFZXYDI2D<2R95&3+-M7I9,-< -9\Q)C\ZNA:U;U7X'U!+ P04    " #!
MA2I4SL /-($"  "2!@  &0   'AL+W=O<FMS:&5E=',O<VAE970S-2YX;6R-
M55UOFS 4_2L6VD,K=>4S_1)!2@+3-JD=2]I-T[0'!VZ"5;"I;9KVW\\VA*9M
M@OH"]O4]Y_A>[$.X8?Q>%  2/54E%6.KD+*^LFV1%5!A<<IJH&IEQ7B%I9KR
MM2UJ#C@WH*JT/<<YLRM,J!6%)I;R*&2-+ F%E"/15!7FSU,HV69LN=8V,"?K
M0NJ '84U7L,"Y%V=<C6S>Y:<5$ %811Q6(VMB7N5!#K?)/PBL!$[8Z0K63)V
MKR??\K'EZ U!"9G4#%B]'F$&9:F)U#8>.DZKE]3 W?&6_8NI7=6RQ )FK/Q-
M<EF,K0L+Y;#"32GG;/,5NGI&FB]CI3!/M&ES1[Z%LD9(5G5@M8.*T/:-G[H^
M[  4SWZ UP&\MX#@ ,#O /Y;P-D!0- !@H\JC#J *=UN:S>-B['$4<C9!G&=
MK=CTP'3?H%6_"-7G9"&Y6B4*)Z-T_B--YK=_T.0F1LG/NV_I=7)SBXYBD)B4
M MU@SK'^EL?H,[I;Q.CHTW%H2Z6L\7;6J4Q;%>^ BH^N&96%0 G-(=^#CX?Q
MKC= 8*N2^[J];=U3;Y!Q ?4I\IT3Y#F>NV=#LX_#G7WU#,._-W10/?DXW!EH
MAM\? M_P^8<. 5>^P^7S"4I+3"7"-$?)0T-J90@2_9TLA>3J1O\;D IZJ<!(
M!0>D8E!VEA%L7 *>E-T)V'>>6I:18=%>]QB-G,O0?MS]1.]S O_B=4[\/L>]
MO/1?)R7OD[S@_"6I+=3>N605\+5Q-X$RUE#9MKJ/]@8Z,;[Q)CYUKV;NGGBL
M#+?UQQ?ZUJVO,5\3*E )*R7EG)ZKK?+6 =N)9+6YXDLFE6&88:%^&L!U@EI?
M,2:W$RW0_X:B_U!+ P04    " #!A2I4MVN.>C$"   A!0  &0   'AL+W=O
M<FMS:&5E=',O<VAE970S-BYX;6R-5%MOVC 4_BM'T1Y::2,AH;!6(1(E5&NU
M#A1@TQX-.1"K3IS9#K3_?K83(BH!XH7X\EU\/A\<[KEXDQFB@O><%7+H9$J5
M#ZXKUQGF1'9XB87>V7"1$Z6G8NO*4B!)+2EGKN]Y?3<GM'"BT*[-1!3R2C%:
MX$R K/*<B(]'9'P_=+K.82&AVTR9!3<*2[+%.:IE.1-ZYK8J*<VQD)07(' S
M=$;=AS@P> OX37$OC\9@*EEQ_F8FS^G0\<R!D.%:&06B/SL<(V-&2!_C7Z/I
MM):&>#P^J#_9VG4M*R)QS-D?FJILZ'QW(,4-J9A*^/X'-O7<&;TU9]+^PK[&
M]N\=6%=2\;PAZQ/DM*B_Y+W)X8C0[9TA^ W!OY80-(3@6D*O(?1L,G4I-H>8
M*!*%@N]!&+16,P,;IF7K\FEAKGVNA-ZEFJ>B>#F!Q12>ILGK)('X.9F,%],$
MOD$R^3E:3&*8C9+%7[B)41'*)/PB0A!S5;<:LYS'<//E-G25/HG1<]>-ZV/M
MZI]QG6/9@<#["K[G=T_0QY?I+U5QD1Y?3_<^TUT=7YNAWV;H6[W@7(85PH*#
MZ4,4$%.A>YH+DR$RHC"%&1'JXX)1T!H%UJAWP4AQ2!L'J2U$8U%J"XKRU%74
MFG=6T[P"NRCPO4$_='?'B9] !4%O\!D5GT!Y_>"^1=5EN4?]:!Z/5R*VM)#
M<*-Y7F>@!43]AZPGBI>V15=<Z8:WPTR_82@,0.]O.%>'B>GZ]E6,_@-02P,$
M%     @ P84J5!%?W!)W @  L@4  !D   !X;"]W;W)K<VAE971S+W-H965T
M,S<N>&ULC5113]LP$/XKIV@/( %)DW8#U$9J&Z:!2JGHV#2A/;C)I;%P[,QV
M6OCWLYT0%:FM>$E\]GW?=W?VW7 KY(LJ$#6\EHRKD5=H75W[ODH++(FZ$!5R
M<Y(+61)M3+GV52619 Y4,C\,@J]^22CWXJ';6\AX*&K-*,>%!%67)9%O$V1B
M._)ZWOO&(UT7VF[X\; B:URB?JH6TEA^QY+1$KFB@H/$?.2->]=)W_H[AU\4
MMVIG#3:3E1 OUKC-1EY@ T*&J;8,Q/PV.$7&+)$)XU_+Z762%KB[?F?_[G(W
MN:R(PJE@OVFFBY%WZ4&&.:F9?A3;']CF,[!\J6#*?6';^@8>I+72HFS!)H*2
M\N9/7MLZ[ !Z_0. L 6$GP5$+2#Z+*#? ERI_2855X>$:!(/I=B"M-Z&S2Y<
M,1W:I$^YO?:EEN:4&IR.9P_C^1+&\P3F#S]OEK 8_QE/9C=PDJ FE"F8$RF)
MO9M3.(>G90(G7TZ'OC;2EL!/6YE)(Q,>D%EB=0%1< 9A$/;VP*?'X7<U/PI/
M/@\//L)]4Z^N:&%7M-#Q]0_P)52:9RND L(S>,ASFJ*$YWLL5RC_'A&(.H'(
M"42'!#!'*3&#J2A-@ROB>F1L;H*OT32=-J]$%W#+,[JA64W8&=R\IJS.*%_#
MLB 2SVTS9+ @;]:]"70AE):H3?".8H(<<VK.GF=&'FXUENI8\/TN^/[1ZLP$
MX0HJ\D96#/<]E08^<' [EC;Q((HN^T-_L_LB]G@-!D'PT2O9XQ5<746=5Y.!
MO],@=IK=$[FF)DB&N<$%%]\,@6PF1&-H4;F>60EM.M M"S-445H'<YX+H=\-
MVX;=F([_ U!+ P04    " #!A2I4),3(8?("  "]"   &0   'AL+W=O<FMS
M:&5E=',O<VAE970S."YX;6R5EE]OFS 4Q;^*A?;02FTQ_TF51&H3JG;:VJAI
MNH=I#X3<)%;!SFR3=/OTLX&B%$B4O208SCF7WS7&]'>,OXDU@$3O64K%P%A+
MN;DV39&L(8O%%=L 55>6C&>Q5$.^,L6&0[PH3%EJVAC[9A83:@S[Q;D)'_99
M+E-"8<*1R+,LYG]N(66[@6$9'R>>R6HM]0ESV-_$*YB"G&TF7(W,.F5!,J""
M,(HX+ ?&C74=!5I?"%X)[,3>,=(D<\;>].!A,3"POB%((9$Z(59_6QA!FNH@
M=1N_JTRC+JF-^\<?Z7<%NV*9QP)&+/U!%G(],$(#+6 9YZE\9KM[J'@\G9>P
M5!2_:%=J/6R@)!>29959W4%&:/D?OU=]V#-8[@&#71GL4PU.97!.-;B5P3W5
MX%6& MTLV8O&C6,9#_N<[1#7:I6F#XKN%V[5+T+U<S*57%TERB>'T]%]-)Y]
MB]#3'1H]/;Y&SR\/MVKX^/023='9&&1,4G&.+M%L.D9G7\[[IE1EM=E,JA*W
M90G[4 G87"$'7R ;VU:'?73<_C6G1^WCX_9'MJWMN,,>G5Z]83=5J^M^VW6_
M[2+/.9 WAKE$8R*2E(F< _IY,Q>2J^7RZTBX4X<[1;A[('S$Z!:X)/,4$&42
M!(KI0BV;.5"IBG5-71GH%8'ZG;(=.D$0A IUNS]%;9F+L66'GV516V9AN^?V
M_%KWB<NMN=RC7#,:9TQQ_05%HWK'<BI%%TT9X^_5OPP\WVO =*A\R^DU6#I4
MENW[?M#-XM4LWE&6FR3AN>(@5 ('(;LPO%9I)W#<1K-''2H7]YI3TE:%V,)6
M-X1?0_A'(28<,I)G%XA")X#?*FH% 7:;$]$AZ_G[3TNYP/WV4V4%82,L:H=Y
M@1MBMYLTJ$F#_UM2!YF#UEUZH>OCYJRU9;[M>J'3H&G++,\+U%/0P#'W7OUZ
M8_\>\Q6A J6P5$Y\%:@(7FZ6Y4"R3;$;S)E4>TMQN%;?%\"U0%U?,D59#?0&
M4W^Q#/\!4$L#!!0    ( ,&%*E1NY\7&)2L  .I+ 0 9    >&PO=V]R:W-H
M965T<R]S:&5E=#,Y+GAM;,U]6W/<.++F\]&O8'A[-KHCO#9QX6VFNR,DR[+E
ML:2R?#O=)_:!*E$23Y>*-466U=HX/WY!%E%,%@$D2)'N>9AIR0(2(!+X$DAD
M?OCY(5O_D=\E2>'\>;]8YK\\NRN*U=]?OLSG=\E]G+_(5LE2_.4F6]_'A?AU
M??LR7ZV3^+JJ=+]X25W7?WD?I\MGO_Y<_=ML_>O/V:98I,MDMG;RS?U]O'X\
M2A;9PR_/R#/Y#Y?I[5U1_L/+7W]>Q;?)QZ3XO)JMQ6\O=U*NT_MDF:?9TEDG
M-[\\.R1_/_S" [>L4I7YDB8/.?C9*3_F*LO^*'\YO?[EF5OV*5DD\Z(4$HO_
M?$M>)8M%*4OTY%^UV&>[5LN*\&<I_:3Z?/$Y5W&>O,H67]/KXNZ79^$SYSJY
MB3>+XC)[>)O4G^25\N;9(J_^WWFHR[K/G/DF+[+[NK+HP7VZW/XW_K,>"IL*
MM*Y ]RI0HJG Z@K,M@*O*W#;"EY=P;.MX-<5?-L*05TAL!VEL*X0[E4(F*9"
M5%>(;+M$7*DY=[^*5M<[9>]K6U]%JIM8ZYM(A9-]C>LGH50YL=8YD4HG^UK7
MMR+53JSU3J3BB;7FB50]V=>]OA6I?&*M?2JU3SO:UU:1VJ?V:WVWV*VU3Z7V
MZ;[V6:"K(K5/K;5/I?:IM?:IU#ZUUCZ5VJ?[VM=7D=JG'>UK.R:U3ZVUSZ3V
MF;7VF=0^ZZQ];16I?6:/]3NPMT9[)K7/K+7/I/:9->(SJ7W6T7ZHJR*US_:U
M7\*5NHK4/K->^TQJGUEKGTOM<VOM<ZE];JU]+K7/K;7/I?:YO:W?&?M][3/=
M>N%2^]Q:^UQJGUNO?2ZUSZW7/I?:YY7V7VXW8=4.[C@NXE]_7F</SKHL+^25
M/U3;P*J^V+BERW+/^K%8B[^FHE[QZZN+\R^O+S^='KU_[9Q??'K]T?GQ."GB
M=)$[Y_%Z'9?[R9]^?EF(ILH*+^>UV*.M6*H1^S%9O7 H?>Y0EY+/'X^='W]0
M27EEEG*XN7WAD B3<FR6<A:OA10?D_)Z%"DG9BGOXN4+Q_4P*6]&D?+6+.4X
MF8LO<BLIKE[*J844EV)2WIFEG&??7C@,[<L_+69=K2,WOXO72:X0\MY"B!LA
M0LXL9@OUL.\YMYES[;$]71;);;)6"+NP$.:B79J9I9PD5[LE:9#RP6("4W32
M7%I((0R3\M%F,068E$\6$YA64X]$>BF?;:103,H7LY2+>2&^B&%2OMI(0?OR
MGS9+TFU)^<%YZ6P7EG9Y_6:S1CG6M]\MS OKW;?#0PNQ+L$Z=XB8T'>;1:=W
M*C&(#3V+'QV*SH5#Q(96*$^W QX:Q"!&%,"\40QB1>'4-(E!S&BE*!JA8A [
M6BF*X&(00[H5PU QB"7=:FK;F\ @!C&EVZV7VQ*C-SV'B$T]7*T;\ZZJCYC3
M:KW7]0T;GD/$GD(Q!J@_1"SIN\W2JC>(*85B3+W!;&DCQKC"$6.ZW6N@>\I#
MQ)IN,;4&/QLP1>PJM&6F58$85CA()C&(985BU(OKI3A_[0YA='<(HY58IIN7
M=]FZ^#]%LKYWCI.KPOFO]Z* <UHD]_G_-8AG._&L$L]U9[QL^2U9%^G5(G&N
M2_FK=;J<IZMXX<3WV699J/;K6Y%>);*\^/CV*XE\5RS>;XJ>\%U/N+$G%^OT
M-EV*=M,\WXC.I/E<T_[A&>]T(/!\;]=^O5*[I7S"HKU2LVXI0GW?#]1?X^V^
MQC-^S6R=S9/D.G=NUMF],]\;9>5'>=V.B$$%PUKCF+'A\A[K[_DJGB>_/%N)
M996LOR7/?G642-9MD%&OV^!L6\Z''>.^)XJJA\C?#9%O'*)J.J?+O%AO[I-E
M\5S\+*9YDA?..BZ2YTY>B/]<.ZMD/1=_CF\3Y:B9VR"N^\)U_V98*,&NMX%1
MTN%\OMZ([LA.JM9%T!DH3GSU((6[9D-D?=[?9TLQ%MG\#Z=8Q]?I\M;YEBW$
MD#V70Z-4KEDL?Q%%IE&)=MV+<!V*>7:?;NX-@!%U9Q )POT%>Q9U5T 0N+RS
ML!7E(I]'_O[$[3;K!3QTN5HEQ&W\8JYY+EQ?I^6=J@"K59R6<\*9QZNTB!?J
M_8O;[8?'.1>=V?\R55'N!IR0SJI4%74CPL*(:;X/^/V(\?M>WU\EU]=BLE\G
MZ_1;Y>=[[MS$Z=KY%B\$-F<W3M(MXBS2^"I=I,6C>A1(M[\AH=TA4)3CE':_
MOUNNG"UNI/GZQN 2:OSZ]_5GI.I-R5E='39,F1\&46>>*DHR-W3]CMYGJI(!
MBR*NTV5CWXG9P+_/\MH(Y4E1+)(2:DL%:LV065X/^W)>2VKA811UEOV%HISG
M^F[0&:1N.3\@5#=$S<:#F'<>7TMG]K+(G2)S5IOU_"[.JSD^!]C[O-ZL.O_C
M:/>K_UFWTYJ2KFY?1)JM!#'O)7;]2_X4@)^*SHE-VCPIX7_;&=&I9CNM[%C7
MU%-]QQH#3LS6]:0%"0]U-Y4=\#L=B$(>$ET7&JM,$+-\+[;'Z?^+JQ"7>EJ;
M]XZD:Z7%7-M?D>>*8H02&I+.[%449&)[U)V^W8(!XX3IQJ#9(A"S,;],YHLX
MS].;M-PNM8RQ<Y.MG;BGN0H5LUC85]89HFY!ZO*([&^Q+Q0%O<CUW"X,=@N&
M 8^HSF(WVQ1BWJ><I&NQKZP7DO-?9Z7Y6IO.3[39#%!WB@,:;:PQ-5OCL>#I
M\"/MFDRNV\53<$ UV\LGPY/H&.WBD_9\01O;1\VV[V,B#E[7O=3>& W*)U%[
M@_K4$O6?KO;N 8[IP)\VX$_-X#^&VKM6@3$='M+&)E"S3?ATEZ[[:;V!6AI.
MHO4&J*@9J$;4>O?T(]:4>FQ9@W;,?/090>MU"UX;A31:9PU,,C-,'F[FQ29W
M3C;+Z^?.^_>O=HH7/3K<W&X$_I=^1Z<N=YX5B<W<8 T.LFD\=<!5-[ZO[O""
M=7?-C(J]EV:\&P!DYEVSA4/D\(QU=\0!V3^G7RA*=8Y[BC*<D4#C7F$-S#(S
MS%:JVOKG\GH/67OKQ+>9AE4!JM0G1.,W9 VN,@NW&.I2$1WPN^N;E)X"30<:
M^&1F^%2,2&RAZPO6W=^RR&,Z#368R\S;V^-D7JW2W<V5(^SZ9ET=T)V9Q,C#
MVW6R/=S:+.H&CUDTQ:+F#:!RQ)=D,;0SWO7U4!YX&E7S!C.Y&3.'#JV U*9J
M6>UU?"M R193>8.I?!),Y0VF\@DP=<:[F*J[_0#7'T_'TQG'D?(#[]YH<.8Q
MC>GG#5+R29!RQA7W!P&).O<U'_""[9XWD,HQ2!T\S;<3^_6_-E7ASL;B2:N@
M060>3+(*&HCEV"W#@%7PKA8*)YK'*-?.M 9TN7D3W.,J\!WO7@90,=DU'@.O
MP67/C,NCW$Z]0QH)D<LIKT%RSQ;)M_?K_CA3W-2W!L2]24#<:T#<ZPGBV:80
M^EE6EV57\2)>SI7JF7G6..XU..Z9<7PB33P1;#QP<>U-HJT&C3TS&@\"FP]>
M=[O+?)<'.GTUX.J9M[O];^K?U1);P.<&;JC9CWD-#GO85E<,QWU<E-/ET;D6
M"*-N']TP5V%>!__Q'V5(BTEI#21[9DBVV9U\\!0N!]?5V6^_P6+?#)/O-HO'
M7?B;_7*JJE55^JT5OT%=GTRQ5OP&.GVS;W786O&[MXF!I[WO\1N<]<TX:S4)
M?,5M7A!J3H%^ ZN^&58'S@$$4@=/D09._4G@U =1-!/ Z:G?=;T&JM@?OPN[
MNFG4(*X_-N*^];N(&Q!]!%(#N/X8@'N*2)'AN5O C4QJ;0#7MXBL>>K^\Q1I
M!-M_!@U$!T]W8YP&7<]O9\(%75='I+VM"!JD#K#]\;##:]"],C- :=  >X $
MF22W8H'>)&H?^=N@>R'& MUT#QH #\P _FXCL(?P,4'4-'L:< \FN4P+&A0.
MS+Z+P2>$H.N3T&FA0>S C-CR-B(:V9@UMQQ]S5D HB G<44$#2('$[@BW@1=
M5P1Q#>NT@>'  H91 _$&D2*S27 #$3:(&WX'!\4;I!',0(0- (<6  R[6U/'
M[/5;F4""B*8<ZV4#RZ$9EB_F15:=L+\31(8-=(=LBH47-A@<8GZ+)RC(+!I7
M4 /DH1G()U&0^/-.;G_P#!O@#_U)=-B@<VC>60\"SY.PN[FFQ-6"9PABU\?8
M79\@4JHT'VJ#G0VJA]]A<WV"-()A9]1 ?=0+ZH%65_'CO28#X"3J[K8-6HT:
M)(_,<#MX";[YZ+S:QATZLWA=+,56W+P.107;11@U$!]-XHV.&J2.)KA2/(FZ
M;A-*:/=$_BE29%^YOEZOC0&(S"C=_UA^$BF2IUPWT/:E@?G(XJX11PY$2@LY
M3'[0J('PZ#LD+9T@C:#(T1B$"#,(P]*'3A"Y/L&ZV!B)"(7WOPA.Q-^W<<'6
M( /2HB8)&Q&+9]="^?/(RU6*M,4.XH*4(???U2J(O]>!OK9Z)"Y(!G(G,1?$
M!1DZKME@#-)D/RM 7) -XYKMP'GV;7O-*'.B1]MD[R0/V&6+XSSX@DE\[F(
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MU(\:WB\MA'SULT_B%P%Y]R28)KXA@,\1C)^!^4$*;1W*3:L6P">23F_O0/M
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M(3:^<\!M0!%N@S%\YU^Q1C R!@J(#BA"=&"51$(59 4L#+I.8Q6I01#H'$F
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MLV_H6]N#RN2/[ @ZL":GG=H1=&!-3MO+$=0:0=P3=-";H_;IGJ!6%VM7T,$
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M-%4%.R=E7-K>UP%T1EA?^D"5@OB%!;KD. 9H7QA"^]+;GWDF);:<#$2;J<<
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M>Z(EK/74E&Q1OE98I]F0B!O6&^N'9J>H!Y$B[2KUF&MH4M72UZ#<3"FNK2)
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M7!.P(9RRZHFZ)=\X:0&H+$OA'*'9.HY7*TY66!) U5"@D:"+5)1*OFTYQQ:
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MP;;V /,4V0 S:QMED!KBJ_^HV37P$++=)K(!-M966]W=0-9_U&R]UG23=0@
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M$4 H(PVP>'/949H1HQWB:<VP%>*VD:=BLO;0KLVXC<VX36JR1E:]3$8@,M+
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M2)OPRH"P)1/@331H[AV?&_A4\Q7##&HY:&E&-4WK#J4C 0.JL8ZJ)23@#C5
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M/,KE>77P<NI8[-]Q_Z4>OFU7[4S.V4[.T4[N)O2?PBC,0FE0C@MA7!O3=O#
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MVKLZ_G!V"5[LXRP(9RDX"Y(DH(;RY>N=C(Q)>^Z,2_J[!7TDH3]:WFT#B+8
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M3Z.<(;-"&RO0VP94F-*[GYP "+<Y<=&TJP'J\^7Y:LSH/__R$'1_3C?&,:W
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M!KG2?JBI[=\G"BCK$IY<D@"YPG\X=.4_Y$K_H:;V__E3P%;["1?34IUF<D\
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M'VZ5P(/:<+MS##?5N12'XQ2'XV1\C1-\/BS5R@(-(5$CB>XH3I!/Q)PRL>:
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MVU=.\;)K*2>2'<P[OF92=05FN%>='G)MH+YO&9-O$[U!W3M._@-02P,$%
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MU=\#N0:H\PUC\CW0\Z;^'P5_ %!+ P04    " #!A2I4M3E_I\L0   =7@
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M[^.K 8TK_+V[905].T!SJF"O B:N<"-N#S>BJ$ZJ6/R_ I/[X!M@$!@*9;7
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MTP8>6!R(]&=KC6<;KY#]=8#E=%^%8#/%*Q&;*;[6@/C7#3R2Q)]M+ YX8%G
M:@?B^^- 3?E]H@BRBFG#GF <21(,@5KTUV@<(ZL3P\N?'^PIB:(D\2. ^15$
M$8; TX@CF +0@"%15.V#._M1N-ZGPO:?P-%O4$L#!!0    ( ,&%*E27BKL<
MP    !,"   +    7W)E;',O+G)E;'.=DKENPS ,0'_%T)XP!] AB#-E\18$
M^0%6H@_8$@6*19V_K]JE<9 +&7D]/!+<'FE [3BDMHNI&/T04FE:U;@!2+8E
MCVG.D4*NU"P>-8?20$3;8T.P6BP^0"X99K>]9!:G<Z17B%S7G:4]VR]/06^
MKSI,<4)I2$LS#O#-TG\R]_,,-47E2B.56QIXT^7^=N!)T:$B6!::1<G3HAVE
M?QW']I#3Z:]C(K1Z6^CY<6A4"H[<8R6,<6*T_C6"R0_L?@!02P,$%     @
MP84J5,8D/]/G!   TB0   \   !X;"]W;W)K8F]O:RYX;6S%FFUOFT@0@/_*
MRI]RTMW9O*5M5%<BL$Y6Q>#CQ==^JHA9UZ@8+"!)K[_^%FPK0\X>W9=Q/L6
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M2P$"% ,4    " #!A2I4!T%-8H$   "Q    $               @ $
M9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( ,&%*E085%<;[P   "L"   1
M              "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    (
M ,&%*E297)PC$ 8  )PG   3              "  <T!  !X;"]T:&5M92]T
M:&5M93$N>&UL4$L! A0#%     @ P84J5%'G6/RK P  0 T  !@
M     ("!#@@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    (
M ,&%*E1JDJ:,N0<  *@A   8              " @>\+  !X;"]W;W)K<VAE
M971S+W-H965T,BYX;6Q02P$"% ,4    " #!A2I41*4CUZT#  #L$0  &
M            @('>$P  >&PO=V]R:W-H965T<R]S:&5E=#,N>&UL4$L! A0#
M%     @ P84J5*!);/96!P  )"   !@              ("!P1<  'AL+W=O
M<FMS:&5E=',O<VAE970T+GAM;%!+ 0(4 Q0    ( ,&%*E1V<<BO10\  &^1
M   8              " @4T?  !X;"]W;W)K<VAE971S+W-H965T-2YX;6Q0
M2P$"% ,4    " #!A2I4[A0C$P$+  #D,@  &               @('(+@
M>&PO=V]R:W-H965T<R]S:&5E=#8N>&UL4$L! A0#%     @ P84J5!]QL+U%
M)   XJT  !@              ("!_SD  'AL+W=O<FMS:&5E=',O<VAE970W
M+GAM;%!+ 0(4 Q0    ( ,&%*E3B@X6TU@<  ,T:   8              "
M@7I>  !X;"]W;W)K<VAE971S+W-H965T."YX;6Q02P$"% ,4    " #!A2I4
M6XDV.)$#   #"0  &               @(&&9@  >&PO=V]R:W-H965T<R]S
M:&5E=#DN>&UL4$L! A0#%     @ P84J5 .;]TP] P  =@D  !D
M     ("!36H  'AL+W=O<FMS:&5E=',O<VAE970Q,"YX;6Q02P$"% ,4
M" #!A2I4"^F=-(D"  "]!@  &0              @('!;0  >&PO=V]R:W-H
M965T<R]S:&5E=#$Q+GAM;%!+ 0(4 Q0    ( ,&%*E2RY4O;)QD  $^3   9
M              " @8%P  !X;"]W;W)K<VAE971S+W-H965T,3(N>&UL4$L!
M A0#%     @ P84J5$N4].YY"P  PQD  !D              ("!WXD  'AL
M+W=O<FMS:&5E=',O<VAE970Q,RYX;6Q02P$"% ,4    " #!A2I4?3+L@)$4
M  !K2@  &0              @(&/E0  >&PO=V]R:W-H965T<R]S:&5E=#$T
M+GAM;%!+ 0(4 Q0    ( ,&%*E0#':P;N0L  -\@   9              "
M@5>J  !X;"]W;W)K<VAE971S+W-H965T,34N>&UL4$L! A0#%     @ P84J
M5"LS"#E%"P  ]B<  !D              ("!1[8  'AL+W=O<FMS:&5E=',O
M<VAE970Q-BYX;6Q02P$"% ,4    " #!A2I4N"W$%ND(  #X'@  &0
M        @('#P0  >&PO=V]R:W-H965T<R]S:&5E=#$W+GAM;%!+ 0(4 Q0
M   ( ,&%*E2QT9H>#@@   @<   9              " @>/*  !X;"]W;W)K
M<VAE971S+W-H965T,3@N>&UL4$L! A0#%     @ P84J5"?_D8#+"P  2",
M !D              ("!*-,  'AL+W=O<FMS:&5E=',O<VAE970Q.2YX;6Q0
M2P$"% ,4    " #!A2I4F.338]$F  #JO@  &0              @($JWP
M>&PO=V]R:W-H965T<R]S:&5E=#(P+GAM;%!+ 0(4 Q0    ( ,&%*E020YW&
MZ04  /$1   9              " @3(& 0!X;"]W;W)K<VAE971S+W-H965T
M,C$N>&UL4$L! A0#%     @ P84J5$V&%OQW P  <0@  !D
M ("!4@P! 'AL+W=O<FMS:&5E=',O<VAE970R,BYX;6Q02P$"% ,4    " #!
MA2I4M6N0K58#   X"   &0              @($ $ $ >&PO=V]R:W-H965T
M<R]S:&5E=#(S+GAM;%!+ 0(4 Q0    ( ,&%*E3_BPIF0@4  $$+   9
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M970R."YX;6Q02P$"% ,4    " #!A2I4+X!&9-X"  "G!P  &0
M    @(%Z*@$ >&PO=V]R:W-H965T<R]S:&5E=#(Y+GAM;%!+ 0(4 Q0    (
M ,&%*E1*W7%3G0(  * '   9              " @8\M 0!X;"]W;W)K<VAE
M971S+W-H965T,S N>&UL4$L! A0#%     @ P84J5 I)F'+4 P  G0\  !D
M             ("!8S ! 'AL+W=O<FMS:&5E=',O<VAE970S,2YX;6Q02P$"
M% ,4    " #!A2I48\74Z/\%  !&%   &0              @(%N- $ >&PO
M=V]R:W-H965T<R]S:&5E=#,R+GAM;%!+ 0(4 Q0    ( ,&%*E0W;>],) 0
M -L,   9              " @:0Z 0!X;"]W;W)K<VAE971S+W-H965T,S,N
M>&UL4$L! A0#%     @ P84J5 +"YJ&: @  MP8  !D              ("!
M_SX! 'AL+W=O<FMS:&5E=',O<VAE970S-"YX;6Q02P$"% ,4    " #!A2I4
MSL /-($"  "2!@  &0              @('000$ >&PO=V]R:W-H965T<R]S
M:&5E=#,U+GAM;%!+ 0(4 Q0    ( ,&%*E2W:XYZ,0(  "$%   9
M      " @8A$ 0!X;"]W;W)K<VAE971S+W-H965T,S8N>&UL4$L! A0#%
M  @ P84J5!%?W!)W @  L@4  !D              ("!\$8! 'AL+W=O<FMS
M:&5E=',O<VAE970S-RYX;6Q02P$"% ,4    " #!A2I4),3(8?("  "]"
M&0              @(&>20$ >&PO=V]R:W-H965T<R]S:&5E=#,X+GAM;%!+
M 0(4 Q0    ( ,&%*E1NY\7&)2L  .I+ 0 9              " @<=, 0!X
M;"]W;W)K<VAE971S+W-H965T,SDN>&UL4$L! A0#%     @ P84J5-JLYH&Y
M P  F@P  !D              ("!(W@! 'AL+W=O<FMS:&5E=',O<VAE970T
M,"YX;6Q02P$"% ,4    " #!A2I4A T?]^($  #I$   &0
M@($3? $ >&PO=V]R:W-H965T<R]S:&5E=#0Q+GAM;%!+ 0(4 Q0    ( ,&%
M*E0Y1QO>BP0   (5   9              " @2R! 0!X;"]W;W)K<VAE971S
M+W-H965T-#(N>&UL4$L! A0#%     @ P84J5,OE4Z+(!   VQD  !D
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M=#0W+GAM;%!+ 0(4 Q0    ( ,&%*E0!>(,F7 H  &8Y   9
M  " @0FQ 0!X;"]W;W)K<VAE971S+W-H965T-#@N>&UL4$L! A0#%     @
MP84J5,67PL(Z$@  VWL  !D              ("!G+L! 'AL+W=O<FMS:&5E
M=',O<VAE970T.2YX;6Q02P$"% ,4    " #!A2I4..A2?OH#   =$   &0
M            @($-S@$ >&PO=V]R:W-H965T<R]S:&5E=#4P+GAM;%!+ 0(4
M Q0    ( ,&%*E0'VFK@'04  +P>   9              " @3[2 0!X;"]W
M;W)K<VAE971S+W-H965T-3$N>&UL4$L! A0#%     @ P84J5/D1E;1Y P
MC@\  !D              ("!DM<! 'AL+W=O<FMS:&5E=',O<VAE970U,BYX
M;6Q02P$"% ,4    " #!A2I4VQENL8$#  !'"@  &0              @(%"
MVP$ >&PO=V]R:W-H965T<R]S:&5E=#4S+GAM;%!+ 0(4 Q0    ( ,&%*E3J
M[DV>A@(  )L&   9              " @?K> 0!X;"]W;W)K<VAE971S+W-H
M965T-30N>&UL4$L! A0#%     @ P84J5+4Y?Z?+$   '5X  !D
M     ("!M^$! 'AL+W=O<FMS:&5E=',O<VAE970U-2YX;6Q02P$"% ,4
M" #!A2I4]^4EIC\#   6%   #0              @ &Y\@$ >&PO<W1Y;&5S
M+GAM;%!+ 0(4 Q0    ( ,&%*E27BKL<P    !,"   +              "
M 2/V 0!?<F5L<R\N<F5L<U!+ 0(4 Q0    ( ,&%*E3&)#_3YP0  -(D   /
M              "  0SW 0!X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " #!
MA2I4O '6P> !  #L(   &@              @ $@_ $ >&PO7W)E;',O=V]R
M:V)O;VLN>&UL+G)E;'-02P$"% ,4    " #!A2I4%-1QY- !  "M(   $P
M            @ $X_@$ 6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     /P _
+ # 1   Y  (    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>613</ContextCount>
  <ElementCount>502</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>175</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>7</UnitCount>
  <MyReports>
    <Report instance="formposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://propanc.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="formposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>00000002 - Statement - Condensed Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://propanc.com/role/BalanceSheets</Role>
      <ShortName>Condensed Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="formposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://propanc.com/role/BalanceSheetsParenthetical</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="formposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>00000004 - Statement - Consolidated Statements of Operations and Comprehensive Income (Loss)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://propanc.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss</Role>
      <ShortName>Consolidated Statements of Operations and Comprehensive Income (Loss)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="formposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>00000005 - Statement - Consolidated Statements of Changes in Stockholders' Deficit</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://propanc.com/role/StatementsOfChangesInStockholdersDeficit</Role>
      <ShortName>Consolidated Statements of Changes in Stockholders' Deficit</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="formposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>00000006 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://propanc.com/role/StatementsOfCashFlows</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="formposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>00000007 - Disclosure - NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING AND REPORTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://propanc.com/role/NatureOfOperationsAndSummaryOfSignificantAccountingAndReportingPolicies</Role>
      <ShortName>NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING AND REPORTING POLICIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="formposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>00000008 - Disclosure - GOING CONCERN</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://propanc.com/role/GoingConcern</Role>
      <ShortName>GOING CONCERN</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="formposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>00000009 - Disclosure - PROPERTY AND EQUIPMENT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://propanc.com/role/PropertyAndEquipment</Role>
      <ShortName>PROPERTY AND EQUIPMENT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="formposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>00000010 - Disclosure - DUE TO FORMER DIRECTOR - RELATED PARTY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://propanc.com/role/DueToFormerDirector-RelatedParty</Role>
      <ShortName>DUE TO FORMER DIRECTOR - RELATED PARTY</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="formposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>00000011 - Disclosure - LOANS AND NOTES PAYABLE</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://propanc.com/role/LoansAndNotesPayable</Role>
      <ShortName>LOANS AND NOTES PAYABLE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="formposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>00000012 - Disclosure - CONVERTIBLE NOTES</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://propanc.com/role/ConvertibleNotes</Role>
      <ShortName>CONVERTIBLE NOTES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="formposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>00000013 - Disclosure - INCOME TAXES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://propanc.com/role/IncomeTaxes</Role>
      <ShortName>INCOME TAXES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="formposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>00000014 - Disclosure - STOCKHOLDERS??? DEFICIT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://propanc.com/role/StockholdersDeficit</Role>
      <ShortName>STOCKHOLDERS??? DEFICIT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="formposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>00000015 - Disclosure - COMMITMENTS AND CONTINGENCIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://propanc.com/role/CommitmentsAndContingencies</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="formposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>00000016 - Disclosure - RELATED PARTY TRANSACTIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://propanc.com/role/RelatedPartyTransactions</Role>
      <ShortName>RELATED PARTY TRANSACTIONS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="formposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>00000017 - Disclosure - CONCENTRATIONS AND RISKS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://propanc.com/role/ConcentrationsAndRisks</Role>
      <ShortName>CONCENTRATIONS AND RISKS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="formposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>00000018 - Disclosure - DERIVATIVE FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://propanc.com/role/DerivativeFinancialInstrumentsAndFairValueMeasurements</Role>
      <ShortName>DERIVATIVE FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="formposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>00000019 - Disclosure - SUBSEQUENT EVENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://propanc.com/role/SubsequentEvents</Role>
      <ShortName>SUBSEQUENT EVENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="formposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>00000020 - Disclosure - NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING AND REPORTING POLICIES (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://propanc.com/role/NatureOfOperationsAndSummaryOfSignificantAccountingAndReportingPoliciesPolicies</Role>
      <ShortName>NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING AND REPORTING POLICIES (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="formposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>00000021 - Disclosure - NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING AND REPORTING POLICIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://propanc.com/role/NatureOfOperationsAndSummaryOfSignificantAccountingAndReportingPoliciesTables</Role>
      <ShortName>NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING AND REPORTING POLICIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://propanc.com/role/NatureOfOperationsAndSummaryOfSignificantAccountingAndReportingPolicies</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="formposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>00000022 - Disclosure - PROPERTY AND EQUIPMENT (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://propanc.com/role/PropertyAndEquipmentTables</Role>
      <ShortName>PROPERTY AND EQUIPMENT (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://propanc.com/role/PropertyAndEquipment</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="formposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>00000023 - Disclosure - CONVERTIBLE NOTES (Tables)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://propanc.com/role/ConvertibleNotesTables</Role>
      <ShortName>CONVERTIBLE NOTES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://propanc.com/role/ConvertibleNotes</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="formposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>00000024 - Disclosure - INCOME TAXES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://propanc.com/role/IncomeTaxesTables</Role>
      <ShortName>INCOME TAXES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://propanc.com/role/IncomeTaxes</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="formposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>00000025 - Disclosure - STOCKHOLDERS??? DEFICIT (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://propanc.com/role/StockholdersDeficitTables</Role>
      <ShortName>STOCKHOLDERS??? DEFICIT (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://propanc.com/role/StockholdersDeficit</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="formposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>00000026 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://propanc.com/role/CommitmentsAndContingenciesTables</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://propanc.com/role/CommitmentsAndContingencies</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="formposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>00000027 - Disclosure - DERIVATIVE FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://propanc.com/role/DerivativeFinancialInstrumentsAndFairValueMeasurementsTables</Role>
      <ShortName>DERIVATIVE FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://propanc.com/role/DerivativeFinancialInstrumentsAndFairValueMeasurements</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="formposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>00000028 - Disclosure - SCHEDULE OF TRANSLATION EXCHANGE RATES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://propanc.com/role/ScheduleOfTranslationExchangeRatesDetails</Role>
      <ShortName>SCHEDULE OF TRANSLATION EXCHANGE RATES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="formposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>00000029 - Disclosure - SCHEDULE OF CHANGE IN ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://propanc.com/role/ScheduleOfChangeInAccumulatedOtherComprehensiveIncomeLossDetails</Role>
      <ShortName>SCHEDULE OF CHANGE IN ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="formposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>00000030 - Disclosure - SCHEDULE OF PROPERTY AND EQUIPMENT ESTIMATED USEFUL LIVES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://propanc.com/role/ScheduleOfPropertyAndEquipmentEstimatedUsefulLivesDetails</Role>
      <ShortName>SCHEDULE OF PROPERTY AND EQUIPMENT ESTIMATED USEFUL LIVES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="formposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>00000031 - Disclosure - SCHEDULE OF DILUTIVE SECURITIES EXCLUDED FROM COMPUTATION (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://propanc.com/role/ScheduleOfDilutiveSecuritiesExcludedFromComputationDetails</Role>
      <ShortName>SCHEDULE OF DILUTIVE SECURITIES EXCLUDED FROM COMPUTATION (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="formposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>00000032 - Disclosure - NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING AND REPORTING POLICIES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://propanc.com/role/NatureOfOperationsAndSummaryOfSignificantAccountingAndReportingPoliciesDetailsNarrative</Role>
      <ShortName>NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING AND REPORTING POLICIES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://propanc.com/role/NatureOfOperationsAndSummaryOfSignificantAccountingAndReportingPoliciesTables</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="formposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>00000033 - Disclosure - GOING CONCERN (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://propanc.com/role/GoingConcernDetailsNarrative</Role>
      <ShortName>GOING CONCERN (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://propanc.com/role/GoingConcern</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="formposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>00000034 - Disclosure - SCHEDULE OF PROPERTY AND EQUIPMENT (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://propanc.com/role/ScheduleOfPropertyAndEquipmentDetails</Role>
      <ShortName>SCHEDULE OF PROPERTY AND EQUIPMENT (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="formposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>00000035 - Disclosure - PROPERTY AND EQUIPMENT (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://propanc.com/role/PropertyAndEquipmentDetailsNarrative</Role>
      <ShortName>PROPERTY AND EQUIPMENT (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://propanc.com/role/PropertyAndEquipmentTables</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="formposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>00000036 - Disclosure - DUE TO FORMER DIRECTOR - RELATED PARTY (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://propanc.com/role/DueToFormerDirector-RelatedPartyDetailsNarrative</Role>
      <ShortName>DUE TO FORMER DIRECTOR - RELATED PARTY (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://propanc.com/role/DueToFormerDirector-RelatedParty</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="formposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>00000037 - Disclosure - LOANS AND NOTES PAYABLE (Details Narrative)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://propanc.com/role/LoansAndNotesPayableDetailsNarrative</Role>
      <ShortName>LOANS AND NOTES PAYABLE (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://propanc.com/role/LoansAndNotesPayable</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="formposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>00000038 - Disclosure - SCHEDULE OF CONVERTIBLE NOTES (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://propanc.com/role/ScheduleOfConvertibleNotesDetails</Role>
      <ShortName>SCHEDULE OF CONVERTIBLE NOTES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="formposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>00000039 - Disclosure - CONVERTIBLE NOTES (Details Narrative)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://propanc.com/role/ConvertibleNotesDetailsNarrative</Role>
      <ShortName>CONVERTIBLE NOTES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://propanc.com/role/ConvertibleNotesTables</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="formposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>00000040 - Disclosure - SCHEDULE OF INCOME TAX PROVISION (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://propanc.com/role/ScheduleOfIncomeTaxProvisionDetails</Role>
      <ShortName>SCHEDULE OF INCOME TAX PROVISION (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="formposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>00000041 - Disclosure - SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://propanc.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails</Role>
      <ShortName>SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="formposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>00000042 - Disclosure - INCOME TAXES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://propanc.com/role/IncomeTaxesDetailsNarrative</Role>
      <ShortName>INCOME TAXES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://propanc.com/role/IncomeTaxesTables</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="formposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>00000043 - Disclosure - SCHEDULE OF STOCK OPTION ACTIVITY (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://propanc.com/role/ScheduleOfStockOptionActivityDetails</Role>
      <ShortName>SCHEDULE OF STOCK OPTION ACTIVITY (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="formposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>00000044 - Disclosure - SCHEDULE OF WARRANT ACTIVITY (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://propanc.com/role/ScheduleOfWarrantActivityDetails</Role>
      <ShortName>SCHEDULE OF WARRANT ACTIVITY (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="formposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>00000045 - Disclosure - STOCKHOLDERS??? DEFICIT (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://propanc.com/role/StockholdersDeficitDetailsNarrative</Role>
      <ShortName>STOCKHOLDERS??? DEFICIT (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://propanc.com/role/StockholdersDeficitTables</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="formposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>00000046 - Disclosure - SCHEDULE OF RIGHT USE OF ASSET (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://propanc.com/role/ScheduleOfRightUseOfAssetDetails</Role>
      <ShortName>SCHEDULE OF RIGHT USE OF ASSET (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="formposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>00000047 - Disclosure - SCHEDULE OF OPERATING LEASE LIABILITY (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://propanc.com/role/ScheduleOfOperatingLeaseLiabilityDetails</Role>
      <ShortName>SCHEDULE OF OPERATING LEASE LIABILITY (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="formposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>00000048 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://propanc.com/role/CommitmentsAndContingenciesDetailsNarrative</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://propanc.com/role/CommitmentsAndContingenciesTables</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="formposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>00000049 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://propanc.com/role/RelatedPartyTransactionsDetailsNarrative</Role>
      <ShortName>RELATED PARTY TRANSACTIONS (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://propanc.com/role/RelatedPartyTransactions</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="formposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>00000050 - Disclosure - CONCENTRATIONS AND RISKS (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://propanc.com/role/ConcentrationsAndRisksDetailsNarrative</Role>
      <ShortName>CONCENTRATIONS AND RISKS (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://propanc.com/role/ConcentrationsAndRisks</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="formposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>00000051 - Disclosure - SCHEDULE OF FAIR VALUE MEASUREMENTS, RECURRING AND NONRECURRING, VALUATION TECHNIQUES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://propanc.com/role/ScheduleOfFairValueMeasurementsRecurringAndNonrecurringValuationTechniquesDetails</Role>
      <ShortName>SCHEDULE OF FAIR VALUE MEASUREMENTS, RECURRING AND NONRECURRING, VALUATION TECHNIQUES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="formposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>00000052 - Disclosure - SCHEDULE OF FAIR VALUE, ASSETS AND LIABILITIES MEASURED ON RECURRING BASIS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://propanc.com/role/ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails</Role>
      <ShortName>SCHEDULE OF FAIR VALUE, ASSETS AND LIABILITIES MEASURED ON RECURRING BASIS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="formposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>00000053 - Disclosure - SCHEDULE OF DERIVATIVE LIABILITIES AT FAIR VALUE (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://propanc.com/role/ScheduleOfDerivativeLiabilitiesAtFairValueDetails</Role>
      <ShortName>SCHEDULE OF DERIVATIVE LIABILITIES AT FAIR VALUE (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="formposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>00000054 - Disclosure - DERIVATIVE FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://propanc.com/role/DerivativeFinancialInstrumentsAndFairValueMeasurementsDetailsNarrative</Role>
      <ShortName>DERIVATIVE FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://propanc.com/role/DerivativeFinancialInstrumentsAndFairValueMeasurementsTables</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="formposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>00000055 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://propanc.com/role/SubsequentEventsDetailsNarrative</Role>
      <ShortName>SUBSEQUENT EVENTS (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://propanc.com/role/SubsequentEvents</ParentRole>
      <Position>55</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="POS AM" original="formposam.htm">formposam.htm</File>
    <File>ex23-1.htm</File>
    <File>ppcb-20210930.xsd</File>
    <File>ppcb-20210930_cal.xml</File>
    <File>ppcb-20210930_def.xml</File>
    <File>ppcb-20210930_lab.xml</File>
    <File>ppcb-20210930_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>image_001.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy>http://fasb.org/srt/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/us-gaap/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/country/2021</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>71
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "formposam.htm": {
   "axisCustom": 0,
   "axisStandard": 25,
   "contextCount": 613,
   "dts": {
    "calculationLink": {
     "local": [
      "ppcb-20210930_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "ppcb-20210930_def.xml"
     ]
    },
    "inline": {
     "local": [
      "formposam.htm"
     ]
    },
    "labelLink": {
     "local": [
      "ppcb-20210930_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "ppcb-20210930_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "ppcb-20210930.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 713,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2021-01-31": 279,
    "http://propanc.com/20210930": 138,
    "http://xbrl.sec.gov/dei/2021q4": 4,
    "total": 421
   },
   "keyCustom": 104,
   "keyStandard": 398,
   "memberCustom": 132,
   "memberStandard": 36,
   "nsprefix": "PPCB",
   "nsuri": "http://propanc.com/20210930",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "formposam.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "role": "http://propanc.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "formposam.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "formposam.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "PPCB:DueToFormerDirectorRelatedPartyDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000010 - Disclosure - DUE TO FORMER DIRECTOR - RELATED PARTY",
     "role": "http://propanc.com/role/DueToFormerDirector-RelatedParty",
     "shortName": "DUE TO FORMER DIRECTOR - RELATED PARTY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "formposam.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "PPCB:DueToFormerDirectorRelatedPartyDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "formposam.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "PPCB:LoansAndNotesPayableDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000011 - Disclosure - LOANS AND NOTES PAYABLE",
     "role": "http://propanc.com/role/LoansAndNotesPayable",
     "shortName": "LOANS AND NOTES PAYABLE",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "formposam.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "PPCB:LoansAndNotesPayableDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "formposam.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000012 - Disclosure - CONVERTIBLE NOTES",
     "role": "http://propanc.com/role/ConvertibleNotes",
     "shortName": "CONVERTIBLE NOTES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "formposam.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "formposam.htm",
      "contextRef": "From2020-07-012021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000013 - Disclosure - INCOME TAXES",
     "role": "http://propanc.com/role/IncomeTaxes",
     "shortName": "INCOME TAXES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "formposam.htm",
      "contextRef": "From2020-07-012021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "formposam.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000014 - Disclosure - STOCKHOLDERS\u2019 DEFICIT",
     "role": "http://propanc.com/role/StockholdersDeficit",
     "shortName": "STOCKHOLDERS\u2019 DEFICIT",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "formposam.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "formposam.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000015 - Disclosure - COMMITMENTS AND CONTINGENCIES",
     "role": "http://propanc.com/role/CommitmentsAndContingencies",
     "shortName": "COMMITMENTS AND CONTINGENCIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "formposam.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "formposam.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000016 - Disclosure - RELATED PARTY TRANSACTIONS",
     "role": "http://propanc.com/role/RelatedPartyTransactions",
     "shortName": "RELATED PARTY TRANSACTIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "formposam.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "formposam.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000017 - Disclosure - CONCENTRATIONS AND RISKS",
     "role": "http://propanc.com/role/ConcentrationsAndRisks",
     "shortName": "CONCENTRATIONS AND RISKS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "formposam.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "formposam.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000018 - Disclosure - DERIVATIVE FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS",
     "role": "http://propanc.com/role/DerivativeFinancialInstrumentsAndFairValueMeasurements",
     "shortName": "DERIVATIVE FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "formposam.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "formposam.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000019 - Disclosure - SUBSEQUENT EVENTS",
     "role": "http://propanc.com/role/SubsequentEvents",
     "shortName": "SUBSEQUENT EVENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "formposam.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "formposam.htm",
      "contextRef": "AsOf2021-09-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000002 - Statement - Condensed Consolidated Balance Sheets",
     "role": "http://propanc.com/role/BalanceSheets",
     "shortName": "Condensed Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "formposam.htm",
      "contextRef": "AsOf2021-09-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "formposam.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "PPCB:NatureOfOperationsPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000020 - Disclosure - NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING AND REPORTING POLICIES (Policies)",
     "role": "http://propanc.com/role/NatureOfOperationsAndSummaryOfSignificantAccountingAndReportingPoliciesPolicies",
     "shortName": "NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING AND REPORTING POLICIES (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "formposam.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "PPCB:NatureOfOperationsPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
       "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "formposam.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "PPCB:ScheduleOfTranslationExchangeRatesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000021 - Disclosure - NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING AND REPORTING POLICIES (Tables)",
     "role": "http://propanc.com/role/NatureOfOperationsAndSummaryOfSignificantAccountingAndReportingPoliciesTables",
     "shortName": "NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING AND REPORTING POLICIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
       "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "formposam.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "PPCB:ScheduleOfTranslationExchangeRatesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "formposam.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000022 - Disclosure - PROPERTY AND EQUIPMENT (Tables)",
     "role": "http://propanc.com/role/PropertyAndEquipmentTables",
     "shortName": "PROPERTY AND EQUIPMENT (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "formposam.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "formposam.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConvertibleDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000023 - Disclosure - CONVERTIBLE NOTES (Tables)",
     "role": "http://propanc.com/role/ConvertibleNotesTables",
     "shortName": "CONVERTIBLE NOTES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "formposam.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConvertibleDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "formposam.htm",
      "contextRef": "From2020-07-012021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000024 - Disclosure - INCOME TAXES (Tables)",
     "role": "http://propanc.com/role/IncomeTaxesTables",
     "shortName": "INCOME TAXES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "formposam.htm",
      "contextRef": "From2020-07-012021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "formposam.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000025 - Disclosure - STOCKHOLDERS\u2019 DEFICIT (Tables)",
     "role": "http://propanc.com/role/StockholdersDeficitTables",
     "shortName": "STOCKHOLDERS\u2019 DEFICIT (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "formposam.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "formposam.htm",
      "contextRef": "From2020-07-012021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "PPCB:ScheduleOfRightUseOfAssetTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000026 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables)",
     "role": "http://propanc.com/role/CommitmentsAndContingenciesTables",
     "shortName": "COMMITMENTS AND CONTINGENCIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "formposam.htm",
      "contextRef": "From2020-07-012021-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "PPCB:ScheduleOfRightUseOfAssetTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "formposam.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000027 - Disclosure - DERIVATIVE FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Tables)",
     "role": "http://propanc.com/role/DerivativeFinancialInstrumentsAndFairValueMeasurementsTables",
     "shortName": "DERIVATIVE FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "formposam.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "PPCB:ScheduleOfTranslationExchangeRatesTableTextBlock",
       "us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
       "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "formposam.htm",
      "contextRef": "AsOf2021-09-30",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ForeignCurrencyExchangeRateTranslation1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000028 - Disclosure - SCHEDULE OF TRANSLATION EXCHANGE RATES (Details)",
     "role": "http://propanc.com/role/ScheduleOfTranslationExchangeRatesDetails",
     "shortName": "SCHEDULE OF TRANSLATION EXCHANGE RATES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "PPCB:ScheduleOfTranslationExchangeRatesTableTextBlock",
       "us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
       "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "formposam.htm",
      "contextRef": "AsOf2021-09-30",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ForeignCurrencyExchangeRateTranslation1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "formposam.htm",
      "contextRef": "AsOf2021-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000029 - Disclosure - SCHEDULE OF CHANGE IN ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) (Details)",
     "role": "http://propanc.com/role/ScheduleOfChangeInAccumulatedOtherComprehensiveIncomeLossDetails",
     "shortName": "SCHEDULE OF CHANGE IN ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
       "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "formposam.htm",
      "contextRef": "AsOf2019-06-30",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "formposam.htm",
      "contextRef": "AsOf2021-09-30",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:PreferredStockSharesAuthorized",
      "reportCount": 1,
      "unitRef": "Shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)",
     "role": "http://propanc.com/role/BalanceSheetsParenthetical",
     "shortName": "Condensed Consolidated Balance Sheets (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:CommonStockSharesIssued",
       "span",
       "span",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "formposam.htm",
      "contextRef": "AsOf2021-09-30",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "PPCB:ScheduleOfPropertyAndEquipmentEstimatedUsefulLivesTableTextBlock",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "formposam.htm",
      "contextRef": "From2021-07-012021-09-30_us-gaap_MachineryAndEquipmentMember",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000030 - Disclosure - SCHEDULE OF PROPERTY AND EQUIPMENT ESTIMATED USEFUL LIVES (Details)",
     "role": "http://propanc.com/role/ScheduleOfPropertyAndEquipmentEstimatedUsefulLivesDetails",
     "shortName": "SCHEDULE OF PROPERTY AND EQUIPMENT ESTIMATED USEFUL LIVES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "PPCB:ScheduleOfPropertyAndEquipmentEstimatedUsefulLivesTableTextBlock",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "formposam.htm",
      "contextRef": "From2021-07-012021-09-30_us-gaap_MachineryAndEquipmentMember",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "formposam.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000031 - Disclosure - SCHEDULE OF DILUTIVE SECURITIES EXCLUDED FROM COMPUTATION (Details)",
     "role": "http://propanc.com/role/ScheduleOfDilutiveSecuritiesExcludedFromComputationDetails",
     "shortName": "SCHEDULE OF DILUTIVE SECURITIES EXCLUDED FROM COMPUTATION (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "formposam.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "PPCB:NatureOfOperationsPolicyTextBlock",
       "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "formposam.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityIncorporationDateOfIncorporation",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000032 - Disclosure - NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING AND REPORTING POLICIES (Details Narrative)",
     "role": "http://propanc.com/role/NatureOfOperationsAndSummaryOfSignificantAccountingAndReportingPoliciesDetailsNarrative",
     "shortName": "NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING AND REPORTING POLICIES (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "PPCB:NatureOfOperationsPolicyTextBlock",
       "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "formposam.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityIncorporationDateOfIncorporation",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "formposam.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000033 - Disclosure - GOING CONCERN (Details Narrative)",
     "role": "http://propanc.com/role/GoingConcernDetailsNarrative",
     "shortName": "GOING CONCERN (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock",
       "body",
       "html"
      ],
      "baseRef": "formposam.htm",
      "contextRef": "AsOf2021-09-30",
      "decimals": "0",
      "lang": null,
      "name": "PPCB:WorkingCapitalDeficit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "formposam.htm",
      "contextRef": "AsOf2021-09-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000034 - Disclosure - SCHEDULE OF PROPERTY AND EQUIPMENT (Details)",
     "role": "http://propanc.com/role/ScheduleOfPropertyAndEquipmentDetails",
     "shortName": "SCHEDULE OF PROPERTY AND EQUIPMENT (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "formposam.htm",
      "contextRef": "AsOf2021-09-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "formposam.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000035 - Disclosure - PROPERTY AND EQUIPMENT (Details Narrative)",
     "role": "http://propanc.com/role/PropertyAndEquipmentDetailsNarrative",
     "shortName": "PROPERTY AND EQUIPMENT (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "formposam.htm",
      "contextRef": "AsOf2021-09-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:DueToRelatedPartiesCurrent",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000036 - Disclosure - DUE TO FORMER DIRECTOR - RELATED PARTY (Details Narrative)",
     "role": "http://propanc.com/role/DueToFormerDirector-RelatedPartyDetailsNarrative",
     "shortName": "DUE TO FORMER DIRECTOR - RELATED PARTY (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "PPCB:LoansAndNotesPayableDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "formposam.htm",
      "contextRef": "AsOf2021-09-30_custom_DirectorsAndOfficerMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:LoansPayable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000037 - Disclosure - LOANS AND NOTES PAYABLE (Details Narrative)",
     "role": "http://propanc.com/role/LoansAndNotesPayableDetailsNarrative",
     "shortName": "LOANS AND NOTES PAYABLE (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "PPCB:LoansAndNotesPayableDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "formposam.htm",
      "contextRef": "AsOf2021-09-30_custom_DirectorsAndOfficerMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:LoansPayable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ConvertibleDebtTableTextBlock",
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "formposam.htm",
      "contextRef": "AsOf2021-09-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000038 - Disclosure - SCHEDULE OF CONVERTIBLE NOTES (Details)",
     "role": "http://propanc.com/role/ScheduleOfConvertibleNotesDetails",
     "shortName": "SCHEDULE OF CONVERTIBLE NOTES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ConvertibleDebtTableTextBlock",
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "formposam.htm",
      "contextRef": "AsOf2021-09-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "formposam.htm",
      "contextRef": "AsOf2020-11-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000039 - Disclosure - CONVERTIBLE NOTES (Details Narrative)",
     "role": "http://propanc.com/role/ConvertibleNotesDetailsNarrative",
     "shortName": "CONVERTIBLE NOTES (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "formposam.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": "0",
      "lang": null,
      "name": "PPCB:ReclassifiedPremiumAmountForAdditionalPaidInCapital",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "formposam.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:GeneralAndAdministrativeExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000004 - Statement - Consolidated Statements of Operations and Comprehensive Income (Loss)",
     "role": "http://propanc.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss",
     "shortName": "Consolidated Statements of Operations and Comprehensive Income (Loss)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "formposam.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:GeneralAndAdministrativeExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "formposam.htm",
      "contextRef": "From2020-07-012021-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncomeTaxExpenseBenefit",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000040 - Disclosure - SCHEDULE OF INCOME TAX PROVISION (Details)",
     "role": "http://propanc.com/role/ScheduleOfIncomeTaxProvisionDetails",
     "shortName": "SCHEDULE OF INCOME TAX PROVISION (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "formposam.htm",
      "contextRef": "From2020-07-012021-06-30_country_US",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "formposam.htm",
      "contextRef": "AsOf2021-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "PPCB:DeferredTaxAssetsWarrantDerivativeLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000041 - Disclosure - SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES (Details)",
     "role": "http://propanc.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails",
     "shortName": "SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "formposam.htm",
      "contextRef": "AsOf2021-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "PPCB:DeferredTaxAssetsWarrantDerivativeLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "formposam.htm",
      "contextRef": "From2020-07-012021-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncomeTaxExpenseBenefit",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000042 - Disclosure - INCOME TAXES (Details Narrative)",
     "role": "http://propanc.com/role/IncomeTaxesDetailsNarrative",
     "shortName": "INCOME TAXES (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "formposam.htm",
      "contextRef": "AsOf2021-06-30",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:OperatingLossCarryforwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "formposam.htm",
      "contextRef": "AsOf2021-06-30",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unitRef": "Shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000043 - Disclosure - SCHEDULE OF STOCK OPTION ACTIVITY (Details)",
     "role": "http://propanc.com/role/ScheduleOfStockOptionActivityDetails",
     "shortName": "SCHEDULE OF STOCK OPTION ACTIVITY (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "formposam.htm",
      "contextRef": "AsOf2019-06-30",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "formposam.htm",
      "contextRef": "AsOf2021-06-30",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber",
      "reportCount": 1,
      "unitRef": "Shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000044 - Disclosure - SCHEDULE OF WARRANT ACTIVITY (Details)",
     "role": "http://propanc.com/role/ScheduleOfWarrantActivityDetails",
     "shortName": "SCHEDULE OF WARRANT ACTIVITY (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "formposam.htm",
      "contextRef": "From2019-07-012020-06-30",
      "decimals": "INF",
      "lang": null,
      "name": "PPCB:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "formposam.htm",
      "contextRef": "AsOf2021-09-30",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:CommonStockSharesAuthorized",
      "reportCount": 1,
      "unitRef": "Shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000045 - Disclosure - STOCKHOLDERS\u2019 DEFICIT (Details Narrative)",
     "role": "http://propanc.com/role/StockholdersDeficitDetailsNarrative",
     "shortName": "STOCKHOLDERS\u2019 DEFICIT (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "formposam.htm",
      "contextRef": "AsOf2021-10-31",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:CommonStockSharesAuthorized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "PPCB:ScheduleOfRightUseOfAssetTableTextBlock",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "formposam.htm",
      "contextRef": "AsOf2021-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "PPCB:OperatingLeaseRightOfUseAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000046 - Disclosure - SCHEDULE OF RIGHT USE OF ASSET (Details)",
     "role": "http://propanc.com/role/ScheduleOfRightUseOfAssetDetails",
     "shortName": "SCHEDULE OF RIGHT USE OF ASSET (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "PPCB:ScheduleOfRightUseOfAssetTableTextBlock",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "formposam.htm",
      "contextRef": "AsOf2021-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "PPCB:OperatingLeaseRightOfUseAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:OperatingLeaseLeaseIncomeTableTextBlock",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "formposam.htm",
      "contextRef": "AsOf2021-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "PPCB:OfficeLeaseLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000047 - Disclosure - SCHEDULE OF OPERATING LEASE LIABILITY (Details)",
     "role": "http://propanc.com/role/ScheduleOfOperatingLeaseLiabilityDetails",
     "shortName": "SCHEDULE OF OPERATING LEASE LIABILITY (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:OperatingLeaseLeaseIncomeTableTextBlock",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "formposam.htm",
      "contextRef": "AsOf2021-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "PPCB:OfficeLeaseLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "formposam.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "PPCB:LitigationPenaltyAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000048 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)",
     "role": "http://propanc.com/role/CommitmentsAndContingenciesDetailsNarrative",
     "shortName": "COMMITMENTS AND CONTINGENCIES (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "formposam.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "PPCB:LitigationPenaltyAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "formposam.htm",
      "contextRef": "AsOf2021-09-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:DueToRelatedPartiesCurrent",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000049 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)",
     "role": "http://propanc.com/role/RelatedPartyTransactionsDetailsNarrative",
     "shortName": "RELATED PARTY TRANSACTIONS (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "formposam.htm",
      "contextRef": "From2021-07-012021-09-30_srt_ChiefExecutiveOfficerMember",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:RepaymentsOfRelatedPartyDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "b",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "formposam.htm",
      "contextRef": "AsOf2019-06-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000005 - Statement - Consolidated Statements of Changes in Stockholders' Deficit",
     "role": "http://propanc.com/role/StatementsOfChangesInStockholdersDeficit",
     "shortName": "Consolidated Statements of Changes in Stockholders' Deficit",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "b",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "formposam.htm",
      "contextRef": "AsOf2019-06-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "formposam.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProceedsFromConvertibleDebt",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000050 - Disclosure - CONCENTRATIONS AND RISKS (Details Narrative)",
     "role": "http://propanc.com/role/ConcentrationsAndRisksDetailsNarrative",
     "shortName": "CONCENTRATIONS AND RISKS (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:ConcentrationRiskDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "formposam.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:AmortizationOfFinancingCostsAndDiscounts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
       "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "formposam.htm",
      "contextRef": "AsOf2021-09-30_us-gaap_MeasurementInputPriceVolatilityMember_us-gaap_ConvertibleDebtMember",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:DebtInstrumentMeasurementInput",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000051 - Disclosure - SCHEDULE OF FAIR VALUE MEASUREMENTS, RECURRING AND NONRECURRING, VALUATION TECHNIQUES (Details)",
     "role": "http://propanc.com/role/ScheduleOfFairValueMeasurementsRecurringAndNonrecurringValuationTechniquesDetails",
     "shortName": "SCHEDULE OF FAIR VALUE MEASUREMENTS, RECURRING AND NONRECURRING, VALUATION TECHNIQUES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
       "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "formposam.htm",
      "contextRef": "AsOf2021-09-30_us-gaap_MeasurementInputPriceVolatilityMember_us-gaap_ConvertibleDebtMember",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:DebtInstrumentMeasurementInput",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "formposam.htm",
      "contextRef": "AsOf2021-09-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000052 - Disclosure - SCHEDULE OF FAIR VALUE, ASSETS AND LIABILITIES MEASURED ON RECURRING BASIS (Details)",
     "role": "http://propanc.com/role/ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails",
     "shortName": "SCHEDULE OF FAIR VALUE, ASSETS AND LIABILITIES MEASURED ON RECURRING BASIS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "formposam.htm",
      "contextRef": "AsOf2021-09-30_us-gaap_FairValueInputsLevel3Member",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "formposam.htm",
      "contextRef": "AsOf2021-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:DerivativeLiabilities",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000053 - Disclosure - SCHEDULE OF DERIVATIVE LIABILITIES AT FAIR VALUE (Details)",
     "role": "http://propanc.com/role/ScheduleOfDerivativeLiabilitiesAtFairValueDetails",
     "shortName": "SCHEDULE OF DERIVATIVE LIABILITIES AT FAIR VALUE (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock",
       "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "formposam.htm",
      "contextRef": "From2019-07-012020-06-30",
      "decimals": "0",
      "lang": null,
      "name": "PPCB:ReductionsDueToConversions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "formposam.htm",
      "contextRef": "AsOf2021-09-30",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:SharePrice",
      "reportCount": 1,
      "unitRef": "USDPShares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000054 - Disclosure - DERIVATIVE FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Details Narrative)",
     "role": "http://propanc.com/role/DerivativeFinancialInstrumentsAndFairValueMeasurementsDetailsNarrative",
     "shortName": "DERIVATIVE FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "span",
       "p",
       "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "formposam.htm",
      "contextRef": "AsOf2021-09-30_us-gaap_ConvertibleDebtMember",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:ConvertibleDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "formposam.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProceedsFromWarrantExercises",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000055 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)",
     "role": "http://propanc.com/role/SubsequentEventsDetailsNarrative",
     "shortName": "SUBSEQUENT EVENTS (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:SubsequentEventsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "formposam.htm",
      "contextRef": "AsOf2021-06-30_custom_CommonStockOneMember",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:AccruedBonusesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "formposam.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000006 - Statement - Consolidated Statements of Cash Flows",
     "role": "http://propanc.com/role/StatementsOfCashFlows",
     "shortName": "Consolidated Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "formposam.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "formposam.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000007 - Disclosure - NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING AND REPORTING POLICIES",
     "role": "http://propanc.com/role/NatureOfOperationsAndSummaryOfSignificantAccountingAndReportingPolicies",
     "shortName": "NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING AND REPORTING POLICIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "formposam.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "formposam.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000008 - Disclosure - GOING CONCERN",
     "role": "http://propanc.com/role/GoingConcern",
     "shortName": "GOING CONCERN",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "formposam.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "formposam.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000009 - Disclosure - PROPERTY AND EQUIPMENT",
     "role": "http://propanc.com/role/PropertyAndEquipment",
     "shortName": "PROPERTY AND EQUIPMENT",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "formposam.htm",
      "contextRef": "From2021-07-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 175,
   "tag": {
    "PPCB_AUDCurrencyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "AUD Currency [Member]",
        "label": "AUD Currency [Member]"
       }
      }
     },
     "localname": "AUDCurrencyMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://propanc.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_AUDCurrenryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "AUD Currency [Member]",
        "label": "AUD Currency [Member] [Default Label]",
        "verboseLabel": "AUD Currency [Member]"
       }
      }
     },
     "localname": "AUDCurrenryMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_AccountsPayableReclassToConvertibleNotes": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounts payable reclass to convertible notes.",
        "label": "Accounts payable reclass to convertible notes"
       }
      }
     },
     "localname": "AccountsPayableReclassToConvertibleNotes",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "PPCB_AccumulatedReduction": {
     "auth_ref": [],
     "calculation": {
      "http://propanc.com/role/ScheduleOfRightUseOfAssetDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingLeaseRightOfUseAsset",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated reduction.",
        "label": "Less accumulated amortization"
       }
      }
     },
     "localname": "AccumulatedReduction",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/ScheduleOfRightUseOfAssetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "PPCB_AdditionaNathanielszRSUsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional Nathanielsz RSUs [Member]",
        "label": "Additional Nathanielsz RSUs [Member]"
       }
      }
     },
     "localname": "AdditionaNathanielszRSUsMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_AdditionalKenyonRSUsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional Kenyon RSUs [Member]",
        "label": "Additional Kenyon RSUs [Member]"
       }
      }
     },
     "localname": "AdditionalKenyonRSUsMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_AdjustmentsToAdditionalPaidInCapitalReclassificationOfPremiumUponDebtConversion": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reclassification of premium upon debt conversion.",
        "label": "Reclassification of put premium upon debt conversion"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalReclassificationOfPremiumUponDebtConversion",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/StatementsOfChangesInStockholdersDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "PPCB_AgreementRenewalTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreement renewal term.",
        "label": "Agreement renewal term"
       }
      }
     },
     "localname": "AgreementRenewalTerm",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "durationItemType"
    },
    "PPCB_AgreementlTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreement term.",
        "label": "Agreement term"
       }
      }
     },
     "localname": "AgreementlTerm",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "durationItemType"
    },
    "PPCB_AuctusFinancingAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auctus Financing Agreement [Member]"
       }
      }
     },
     "localname": "AuctusFinancingAgreementMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/ConvertibleNotesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_AuctusFundLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Auctus Fund, LLC [Member]",
        "label": "Auctus Fund, LLC [Member]"
       }
      }
     },
     "localname": "AuctusFundLLCMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/ConvertibleNotesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_AugustNineteenTwoThousandTwentyOneGenevaRothMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "August Nineteen Two Thousand Twenty One Geneva Roth [Member]"
       }
      }
     },
     "localname": "AugustNineteenTwoThousandTwentyOneGenevaRothMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/ConvertibleNotesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_AugustTenTwoThousandAndSeventeenConsultingAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "August 10, 2017 Consulting Agreement [Member]",
        "label": "August 10, 2017 Consulting Agreement [Member]"
       }
      }
     },
     "localname": "AugustTenTwoThousandAndSeventeenConsultingAgreementMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/ConvertibleNotesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_AugustTwentyNineTwoThousandandEighteenSecuritiesPurchaseAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "August 29, 2018 Securities Purchase Agreement [Member]",
        "label": "August 29, 2018 Securities Purchase Agreement [Member]"
       }
      }
     },
     "localname": "AugustTwentyNineTwoThousandandEighteenSecuritiesPurchaseAgreementMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/ConvertibleNotesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_AugustTwoThousandEighteenEagleNoteMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "August 2018 Eagle Note [Member]",
        "label": "August 2018 Eagle Note [Member]"
       }
      }
     },
     "localname": "AugustTwoThousandEighteenEagleNoteMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/ConvertibleNotesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_AugustTwoThousandNineteenAuctusNoteMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "August 2019 Auctus Note [Member]",
        "label": "August 2019 Auctus Note [Member]"
       }
      }
     },
     "localname": "AugustTwoThousandNineteenAuctusNoteMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/ConvertibleNotesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_BoardOfDirectorsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Board of Directors [Member]",
        "label": "Board of Directors [Member]"
       }
      }
     },
     "localname": "BoardOfDirectorsMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_BonusAwardsGrantedPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bonus granted percentage.",
        "label": "Bonus granted percentage"
       }
      }
     },
     "localname": "BonusAwardsGrantedPercentage",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "PPCB_BonusPayable": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bonus payable.",
        "label": "Bonus payable"
       }
      }
     },
     "localname": "BonusPayable",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "PPCB_BonusPayableAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bonus payable amount.",
        "label": "Bonus payable amount"
       }
      }
     },
     "localname": "BonusPayableAmount",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "PPCB_CancellationAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cancellation Agreement [Member]"
       }
      }
     },
     "localname": "CancellationAgreementMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_CancellationOfAccruedSalaries": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cancellation Of Accrued Salaries.",
        "label": "Cancellation of accrued salary",
        "verboseLabel": "Cancellation Of Accrued Salaries"
       }
      }
     },
     "localname": "CancellationOfAccruedSalaries",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://propanc.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "PPCB_CaresActMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "CARES Act [Member]",
        "label": "CARES Act [Member]"
       }
      }
     },
     "localname": "CaresActMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_CashPaidDuringPeriodAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash Paid During Period [Abstract]",
        "label": "Cash paid during the period:"
       }
      }
     },
     "localname": "CashPaidDuringPeriodAbstract",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "PPCB_ChiefScientificOfficerandDirectorMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Chief Scientific Officerand Director [Member]"
       }
      }
     },
     "localname": "ChiefScientificOfficerandDirectorMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_CommonStockIssuable": {
     "auth_ref": [],
     "calculation": {
      "http://propanc.com/role/BalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common stock issuable.",
        "label": "Common stock issuable (2,002,549 and 59 shares as of September 30, 2021 and June 30, 2021, respectively)"
       }
      }
     },
     "localname": "CommonStockIssuable",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "PPCB_CommonStockIssuableMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Stock Issuable [Member]",
        "label": "Common Stock Issuable [Member]"
       }
      }
     },
     "localname": "CommonStockIssuableMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/StatementsOfChangesInStockholdersDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_CommonStockIssuableShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common stock, issuable shares.",
        "label": "Common stock, shares issuable",
        "verboseLabel": "Common Stock Issuable Shares"
       }
      }
     },
     "localname": "CommonStockIssuableShares",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/BalanceSheetsParenthetical",
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative",
      "http://propanc.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "PPCB_CommonStockOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Stock One [Member]",
        "label": "Common Stock One [Member]"
       }
      }
     },
     "localname": "CommonStockOneMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative",
      "http://propanc.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_CommonStockThreeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Stock Three [Member]",
        "label": "Common Stock Three [Member]"
       }
      }
     },
     "localname": "CommonStockThreeMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_CommonStockTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Stock Two [Member]",
        "label": "Common Stock Two [Member]"
       }
      }
     },
     "localname": "CommonStockTwoMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_ConsultantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Consultant [Member]",
        "label": "Consultant [Member]"
       }
      }
     },
     "localname": "ConsultantMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/ConvertibleNotesDetailsNarrative",
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_ConsultantServicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consultant Services [Member]"
       }
      }
     },
     "localname": "ConsultantServicesMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_ConsultingAgreementDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Consulting agreement, description.",
        "label": "Consulting agreement description"
       }
      }
     },
     "localname": "ConsultingAgreementDescription",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "PPCB_ConsultingAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Consulting Agreement [Member]",
        "label": "Consulting Agreement [Member]"
       }
      }
     },
     "localname": "ConsultingAgreementMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_ConsultingAgreementMonthlyPayment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Consulting agreement monthly payment.",
        "label": "Consulting agreement, monthly payment"
       }
      }
     },
     "localname": "ConsultingAgreementMonthlyPayment",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "PPCB_ConversionFees": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Conversion fees.",
        "label": "Conversion fees"
       }
      }
     },
     "localname": "ConversionFees",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative",
      "http://propanc.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "PPCB_ConversionOptionDerivatives": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Conversion option derivatives.",
        "label": "Conversion option derivatives"
       }
      }
     },
     "localname": "ConversionOptionDerivatives",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "PPCB_ConvertibleNotesPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Convertible Notes [Policy Text Block]",
        "label": "Convertible Notes With Variable Conversion Options"
       }
      }
     },
     "localname": "ConvertibleNotesPolicyTextBlock",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/NatureOfOperationsAndSummaryOfSignificantAccountingAndReportingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "PPCB_CrownBridgePartnersLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Crown Bridge Partners, LLC [Member]",
        "label": "Crown Bridge Partners, LLC [Member]"
       }
      }
     },
     "localname": "CrownBridgePartnersLLCMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/ConvertibleNotesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_CurrentAndFormerDirectorMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Current and Former Director [Member]",
        "label": "Current and Former Director [Member]"
       }
      }
     },
     "localname": "CurrentAndFormerDirectorMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_DebtConversionConvertedInterestPayable": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt conversion converted interest payable.",
        "label": "Debt conversion of accrued interest"
       }
      }
     },
     "localname": "DebtConversionConvertedInterestPayable",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/ConvertibleNotesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "PPCB_DebtCoversionPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Coversion Percentage.",
        "label": "Debt Coversion Percentage"
       }
      }
     },
     "localname": "DebtCoversionPercentage",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "PPCB_DebtDefaultAmountPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt default amount percentage.",
        "label": "Debt default amount percentage"
       }
      }
     },
     "localname": "DebtDefaultAmountPercentage",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/ConvertibleNotesDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "PPCB_DebtInstrumentDebtDefaultInterestRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents interest rate of convertible promissory notes in event of default in payments.",
        "label": "Debt instrument, default, interest rate"
       }
      }
     },
     "localname": "DebtInstrumentDebtDefaultInterestRate",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/ConvertibleNotesDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "PPCB_DecembeTwoThousandAndEighteenEagleNoteMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "December 2018 Eagle Note [Member]",
        "label": "December 2018 Eagle Note [Member]"
       }
      }
     },
     "localname": "DecembeTwoThousandAndEighteenEagleNoteMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/ConvertibleNotesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_DecemberTenTwoThousandTwentyGWNoteMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "December 10 2020 GW Note [Member]",
        "label": "December 10 2020 GW Note [Member]"
       }
      }
     },
     "localname": "DecemberTenTwoThousandTwentyGWNoteMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/ConvertibleNotesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "December 24, 2018 Securities Purchase Agreement [Member]",
        "label": "December 24, 2018 Securities Purchase Agreement [Member]"
       }
      }
     },
     "localname": "DecemberTwentyFourTwoThousandAndEighteenSecuritiesPurchaseAgreementMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/ConvertibleNotesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_DecemberTwentyNineTwoThousandAndSeventeenSecuritiesPurchaseAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "December 29, 2017 Securities Purchase Agreement [Member]",
        "label": "December 29, 2017 Securities Purchase Agreement [Member]"
       }
      }
     },
     "localname": "DecemberTwentyNineTwoThousandAndSeventeenSecuritiesPurchaseAgreementMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/ConvertibleNotesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_DecemberTwentyNineTwoThousandAndSixteenSecuritiesPurchaseAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "December 21, 2016 Securities Purchase Agreement [Member]",
        "label": "December 21, 2016 Securities Purchase Agreement [Member]"
       }
      }
     },
     "localname": "DecemberTwentyNineTwoThousandAndSixteenSecuritiesPurchaseAgreementMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/ConvertibleNotesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_DecemberTwoThousandAndSeventeenEagleNoteMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "December 2017 Eagle Note [Member]",
        "label": "December 2017 Eagle Note [Member]"
       }
      }
     },
     "localname": "DecemberTwoThousandAndSeventeenEagleNoteMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/ConvertibleNotesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_DecemberTwoTwoThousandTwentyGenevaRothMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "December 02 2020 Geneva Roth [Member]",
        "label": "December 02 2020 Geneva Roth [Member]"
       }
      }
     },
     "localname": "DecemberTwoTwoThousandTwentyGenevaRothMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/ConvertibleNotesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_DecreaseInEquity": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Decrease in equity.",
        "label": "Amount of decrease in equity"
       }
      }
     },
     "localname": "DecreaseInEquity",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "PPCB_DeemedDividend": {
     "auth_ref": [],
     "calculation": {
      "http://propanc.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deemed dividend.",
        "label": "Deemed Dividend",
        "negatedLabel": "Deemed dividend"
       }
      }
     },
     "localname": "DeemedDividend",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss",
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "PPCB_DeemedDividendUponAlternateCashlessExerciseOfWarrants": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deemed dividend upon alternate cashless exercise of warrants.",
        "label": "Deemed dividend upon alternate cashless exercise of warrants"
       }
      }
     },
     "localname": "DeemedDividendUponAlternateCashlessExerciseOfWarrants",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/StatementsOfChangesInStockholdersDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "PPCB_DeemedDividendUponAlternateCashlessExerciseOfWarrants1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deemed dividend upon alternate cashless exercise of warrants.",
        "label": "DeemedDividendUponAlternateCashlessExerciseOfWarrants1",
        "verboseLabel": "Deemed dividend upon alternate cashless exercise of warrants"
       }
      }
     },
     "localname": "DeemedDividendUponAlternateCashlessExerciseOfWarrants1",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "PPCB_DeferredSalaryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Salary [Member]"
       }
      }
     },
     "localname": "DeferredSalaryMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_DeferredTaxAssetsForeignExchangeLoss": {
     "auth_ref": [],
     "calculation": {
      "http://propanc.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred tax assets foreign exchange loss.",
        "label": "Foreign Exchange Loss (OCI)"
       }
      }
     },
     "localname": "DeferredTaxAssetsForeignExchangeLoss",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "PPCB_DeferredTaxAssetsNonCashInterest": {
     "auth_ref": [],
     "calculation": {
      "http://propanc.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non-cash interest in deferred tax assets.",
        "label": "Non-cash interest"
       }
      }
     },
     "localname": "DeferredTaxAssetsNonCashInterest",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "PPCB_DeferredTaxAssetsPrepaidInvestorServices": {
     "auth_ref": [],
     "calculation": {
      "http://propanc.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to prepaid investor services.",
        "label": "Prepaid Investor Services"
       }
      }
     },
     "localname": "DeferredTaxAssetsPrepaidInvestorServices",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "PPCB_DeferredTaxAssetsRevalueOfDerivativeLiability": {
     "auth_ref": [],
     "calculation": {
      "http://propanc.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 10.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred tax assets revalue of derivative liability.",
        "label": "Revalue of derivative liability"
       }
      }
     },
     "localname": "DeferredTaxAssetsRevalueOfDerivativeLiability",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "PPCB_DeferredTaxAssetsWarrantDerivativeLiability": {
     "auth_ref": [],
     "calculation": {
      "http://propanc.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred tax assets warrant derivative liability.",
        "label": "Warrant Derivative Liability"
       }
      }
     },
     "localname": "DeferredTaxAssetsWarrantDerivativeLiability",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "PPCB_DeferredTaxLiabilitiesGainOnExtinguishmentOfDebt": {
     "auth_ref": [],
     "calculation": {
      "http://propanc.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gain on extinguishment of debt in deferred tax liability.",
        "label": "DeferredTaxLiabilitiesGainOnExtinguishmentOfDebt",
        "negatedLabel": "Gain on extinguishment of debt"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesGainOnExtinguishmentOfDebt",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "PPCB_DepositoryTrustCompanyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Depository Trust Company [Member]",
        "label": "Depository Trust Company [Member]"
       }
      }
     },
     "localname": "DepositoryTrustCompanyMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/ConvertibleNotesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_DescriptionOfEmploymentBenefits": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description Of Employment Benefits.",
        "label": "Description Of Employment Benefits",
        "verboseLabel": "Description of employment benefits"
       }
      }
     },
     "localname": "DescriptionOfEmploymentBenefits",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative",
      "http://propanc.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "PPCB_DiligenceFees": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Diligence fees.",
        "label": "Diligence fees"
       }
      }
     },
     "localname": "DiligenceFees",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/ConvertibleNotesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "PPCB_DirectorsAndOfficerMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Directors and Officer [Member]",
        "label": "Directors and Officer [Member]"
       }
      }
     },
     "localname": "DirectorsAndOfficerMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/LoansAndNotesPayableDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_DisclosureDueToFormerDirectorRelatedPartyAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Due To Former Director - Related Party"
       }
      }
     },
     "localname": "DisclosureDueToFormerDirectorRelatedPartyAbstract",
     "nsuri": "http://propanc.com/20210930",
     "xbrltype": "stringItemType"
    },
    "PPCB_DisclosureLoansAndNotesPayableAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loans And Notes Payable"
       }
      }
     },
     "localname": "DisclosureLoansAndNotesPayableAbstract",
     "nsuri": "http://propanc.com/20210930",
     "xbrltype": "stringItemType"
    },
    "PPCB_DiscountsRelatedToDerivativeLiability": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The discounts related to derivative liability in a noncash (or part noncash) transaction.",
        "label": "Discounts related to derivative liability"
       }
      }
     },
     "localname": "DiscountsRelatedToDerivativeLiability",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "PPCB_DiscountsRelatedToWarrantsIssuedWithConvertibleNote": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discounts related to warrants issued with convertible notes.",
        "label": "Discounts related to warrants issued with convertible notes"
       }
      }
     },
     "localname": "DiscountsRelatedToWarrantsIssuedWithConvertibleNote",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "PPCB_DrKenyonMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Dr. Kenyon [Member]",
        "label": "Dr. Kenyon [Member]"
       }
      }
     },
     "localname": "DrKenyonMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://propanc.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_DrKenyonMemberMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Dr Kenyon [Member]",
        "label": "Dr Kenyon [Member]"
       }
      }
     },
     "localname": "DrKenyonMemberMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_DueToEquityConversion": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Due to equity conversion.",
        "label": "Due to equity conversion"
       }
      }
     },
     "localname": "DueToEquityConversion",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/ConvertibleNotesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "PPCB_DueToFormerDirectorRelatedPartyDisclosureTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Due to Former Director - Related Party Text Block",
        "label": "DUE TO FORMER DIRECTOR - RELATED PARTY"
       }
      }
     },
     "localname": "DueToFormerDirectorRelatedPartyDisclosureTextBlock",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/DueToFormerDirector-RelatedParty"
     ],
     "xbrltype": "textBlockItemType"
    },
    "PPCB_EagleEquitiesLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Eagle Equities, LLC [Member]",
        "label": "Eagle Equities, LLC [Member]"
       }
      }
     },
     "localname": "EagleEquitiesLLCMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/ConvertibleNotesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_ElevenSeriesAWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Eleven Series A Warrants [Member]"
       }
      }
     },
     "localname": "ElevenSeriesAWarrantsMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_EmploymentAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employment Agreement [Member]",
        "label": "Employment Agreement [Member]"
       }
      }
     },
     "localname": "EmploymentAgreementMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_EmploymentAgreementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employment Agreements [Member]",
        "label": "Employment Agreements [Member]"
       }
      }
     },
     "localname": "EmploymentAgreementsMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_EngagementAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Engagement Agreement [Member]",
        "label": "Engagement Agreement [Member]"
       }
      }
     },
     "localname": "EngagementAgreementMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_EquityPurchaseAgreementDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity purchase agreement description.",
        "label": "Equity purchase agreement description"
       }
      }
     },
     "localname": "EquityPurchaseAgreementDescription",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "PPCB_EurosMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Euros [Member]",
        "label": "Euros [Member]"
       }
      }
     },
     "localname": "EurosMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_ExpireInTwoThousandTwentyFourMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expire in 2024 [Member]",
        "label": "Expire in 2024 [Member]"
       }
      }
     },
     "localname": "ExpireInTwoThousandTwentyFourMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_FairMarketValueOfShares": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair market value of the shares.",
        "label": "Fair market value of the shares"
       }
      }
     },
     "localname": "FairMarketValueOfShares",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "PPCB_FairValueOfWarrantDerivativeLiabilityRecorededAsDebtDiscount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Initial fair value recording of warrant derivative liability as debt discount during the period.",
        "label": "Initial fair value of embedded conversion option derivative liability recorded as debt discount"
       }
      }
     },
     "localname": "FairValueOfWarrantDerivativeLiabilityRecorededAsDebtDiscount",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/ScheduleOfDerivativeLiabilitiesAtFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "PPCB_FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "February19 2020 LG Capital Note [Member]",
        "label": "February19 2020 LG Capital Note [Member]"
       }
      }
     },
     "localname": "FebruaryNineteenTwoThousandTwentyLGCapitalNoteMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/ConvertibleNotesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_FirstNoteMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "First Note [Member]",
        "label": "First Note [Member]"
       }
      }
     },
     "localname": "FirstNoteMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/ConvertibleNotesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_FirstWarrantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "First Warrant [Member]",
        "label": "First Warrant [Member]"
       }
      }
     },
     "localname": "FirstWarrantMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/ConvertibleNotesDetailsNarrative",
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_FoleyShechterMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foley Shechter [Member]",
        "label": "Foley Shechter [Member]"
       }
      }
     },
     "localname": "FoleyShechterMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_FormerDirectorMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Former Director [Member]",
        "label": "Former Director [Member]"
       }
      }
     },
     "localname": "FormerDirectorMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_From2012ThroughThe2014Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "From 2012 through the 2014 [Member]",
        "label": "From 2012 through the 2014 [Member]"
       }
      }
     },
     "localname": "From2012ThroughThe2014Member",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_GSCapitalPartnersLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "GS Capital Partners, LLC [Member]",
        "label": "GS Capital Partners, LLC [Member]"
       }
      }
     },
     "localname": "GSCapitalPartnersLLCMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/ConvertibleNotesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_GWHoldingsGroupLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "GW Holdings Group, LLC [Member]",
        "label": "GW Holdings Group, LLC [Member]"
       }
      }
     },
     "localname": "GWHoldingsGroupLLCMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/ConvertibleNotesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_GainFromSettlementOfDebtNet": {
     "auth_ref": [],
     "calculation": {
      "http://propanc.com/role/StatementsOfCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://propanc.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": {
       "order": 5.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gain from settlement of debt, net.",
        "label": "Gain from settlement of debt, net",
        "negatedLabel": "Gain from settlement of debt, net"
       }
      }
     },
     "localname": "GainFromSettlementOfDebtNet",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/StatementsOfCashFlows",
      "http://propanc.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss",
      "http://propanc.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "PPCB_GainLossFromSettlementOfDebt": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gain loss from settlement of debt.",
        "label": "Gain loss from settlement of debt"
       }
      }
     },
     "localname": "GainLossFromSettlementOfDebt",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "PPCB_GainOnDebtExtinguishment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gain on debt extinguishment.",
        "label": "Gain on debt extinguishment"
       }
      }
     },
     "localname": "GainOnDebtExtinguishment",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/ScheduleOfDerivativeLiabilitiesAtFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "PPCB_GenevaRothFinancingAgreementAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geneva Roth Financing Agreement Agreement [Member]"
       }
      }
     },
     "localname": "GenevaRothFinancingAgreementAgreementMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/ConvertibleNotesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_GenevaRothRemarkHoldingsIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Geneva Roth Remark Holdings Inc [Member]",
        "label": "Geneva Roth Remark Holdings Inc [Member]"
       }
      }
     },
     "localname": "GenevaRothRemarkHoldingsIncMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/ConvertibleNotesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_GoodsAndServiceTax": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of goods and service tax which includes in annual lease rent.",
        "label": "[custom:GoodsAndServiceTax]"
       }
      }
     },
     "localname": "GoodsAndServiceTax",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "PPCB_GoodsAndServiceTaxPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Goods And Service Tax [Policy Text Block]",
        "label": "Australian Goods and Services Tax (\u201cGST\u201d)"
       }
      }
     },
     "localname": "GoodsAndServiceTaxPolicyTextBlock",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/NatureOfOperationsAndSummaryOfSignificantAccountingAndReportingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "PPCB_GrossProceedsFromEquityFinancing": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross proceeds from equity financing.",
        "label": "Gross proceeds from equity financing"
       }
      }
     },
     "localname": "GrossProceedsFromEquityFinancing",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "PPCB_HolderMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Holder [Member]",
        "label": "Holder [Member]"
       }
      }
     },
     "localname": "HolderMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_IncreaseDecreaseInDeferredRent": {
     "auth_ref": [],
     "calculation": {
      "http://propanc.com/role/StatementsOfCashFlows": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase Decrease in Deferred rent.",
        "label": "IncreaseDecreaseInDeferredRent",
        "negatedLabel": "Deferred rent"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeferredRent",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "PPCB_InitialFairValueOfEmbeddedConversionOptionDerivativeLiabilityRecordedAsExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Initial fair value of embedded conversion option derivative liability recorded as expense.",
        "label": "Initial fair value of embedded conversion option derivative liability recorded as expense"
       }
      }
     },
     "localname": "InitialFairValueOfEmbeddedConversionOptionDerivativeLiabilityRecordedAsExpense",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/ScheduleOfDerivativeLiabilitiesAtFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "PPCB_InitialKenyonRSUsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Initial Kenyon RSUs [Member]",
        "label": "Initial Kenyon RSUs [Member]"
       }
      }
     },
     "localname": "InitialKenyonRSUsMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_InstallmentFourMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Installment 4 [Member]",
        "label": "Installment 4 [Member]"
       }
      }
     },
     "localname": "InstallmentFourMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_InstallmentOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Installment 1 [Member]",
        "label": "Installment 1 [Member]"
       }
      }
     },
     "localname": "InstallmentOneMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_InstallmentThreeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Installment 3 [Member]",
        "label": "Installment 3 [Member]"
       }
      }
     },
     "localname": "InstallmentThreeMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_InstallmentTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Installment 2 [Member]",
        "label": "Installment 2 [Member]"
       }
      }
     },
     "localname": "InstallmentTwoMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_IntercompanyLoansMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intercompany Loans [Member]",
        "label": "Intercompany Loans [Member]"
       }
      }
     },
     "localname": "IntercompanyLoansMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/NatureOfOperationsAndSummaryOfSignificantAccountingAndReportingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_IssuanceOfCommonStockForAlternateCashlessExerciseOfWarrants": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Issuance of common stock for alternate cashless exercise of warrants.",
        "label": "Issuance of common stock for alternate cashless exercise of warrants"
       }
      }
     },
     "localname": "IssuanceOfCommonStockForAlternateCashlessExerciseOfWarrants",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/StatementsOfChangesInStockholdersDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "PPCB_IssuanceOfCommonStockForAlternateCashlessExerciseOfWarrantsShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Issuance of common stock for alternate cashless exercise of warrants, shares.",
        "label": "Issuance of common stock for alternate cashless exercise of warrants, shares"
       }
      }
     },
     "localname": "IssuanceOfCommonStockForAlternateCashlessExerciseOfWarrantsShares",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/StatementsOfChangesInStockholdersDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "PPCB_IssuanceOfCommonStockForCashlessExerciseOfWarrants": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Issuance of common stock for cashless exercise of warrants.",
        "label": "Issuance of common stock for cashless exercise of warrants"
       }
      }
     },
     "localname": "IssuanceOfCommonStockForCashlessExerciseOfWarrants",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/StatementsOfChangesInStockholdersDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "PPCB_IssuanceOfCommonStockForCashlessExerciseOfWarrantsShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Issuance Of Common Stock For Cashless Exercise Of Warrants Shares.",
        "label": "Issuance of common stock for cashless exercise of warrants, shares"
       }
      }
     },
     "localname": "IssuanceOfCommonStockForCashlessExerciseOfWarrantsShares",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/StatementsOfChangesInStockholdersDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "PPCB_JamesNathanielszMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "James Nathanielsz [Member]",
        "label": "James Nathanielsz [Member]"
       }
      }
     },
     "localname": "JamesNathanielszMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_JanuaryFiveTwoThousandTwentyOneGenevaRothMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "January 05, 2021 One Geneva Roth [Member]",
        "label": "January 05, 2021 One Geneva Roth [Member]"
       }
      }
     },
     "localname": "JanuaryFiveTwoThousandTwentyOneGenevaRothMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/ConvertibleNotesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_JanuarySevenTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "January 7, 2020 Power Up Lending Group Securities Purchase Agreement [Member]",
        "label": "January 7, 2020 Power Up Lending Group Securities Purchase Agreement [Member]"
       }
      }
     },
     "localname": "JanuarySevenTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/ConvertibleNotesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_JanuarySevenTwoThousandTwentyPowerUpNoteMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "January 7, 2020 Power Up Note [Member]",
        "label": "January 7, 2020 Power Up Note [Member]"
       }
      }
     },
     "localname": "JanuarySevenTwoThousandTwentyPowerUpNoteMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/ConvertibleNotesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_JanuaryThirteenTwentyTwentyAderAlefNoteMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "January 13, 2020 Ader Alef Note [Member]",
        "label": "January 13, 2020 Ader Alef Note [Member]"
       }
      }
     },
     "localname": "JanuaryThirteenTwentyTwentyAderAlefNoteMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/ConvertibleNotesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_JanuaryTwentyTwoTwentyTwentyGSNoteMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "January 22, 2020 GS Note [Member]",
        "label": "January 22, 2020 GS Note [Member]"
       }
      }
     },
     "localname": "JanuaryTwentyTwoTwentyTwentyGSNoteMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/ConvertibleNotesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_JosefZelingerMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Josef Zelinger [Member]",
        "label": "Josef Zelinger [Member]"
       }
      }
     },
     "localname": "JosefZelingerMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative",
      "http://propanc.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_JulyThirteenTwoThousandAndEighteenSecuritiesPurchaseAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "July 13, 2018 Securities Purchase Agreement [Member]",
        "label": "July 13, 2018 Securities Purchase Agreement [Member]"
       }
      }
     },
     "localname": "JulyThirteenTwoThousandAndEighteenSecuritiesPurchaseAgreementMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/ConvertibleNotesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_JulyTwoThousandEighteenEagleNoteMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "July 2018 Eagle Note [Member]",
        "label": "July 2018 Eagle Note [Member]"
       }
      }
     },
     "localname": "JulyTwoThousandEighteenEagleNoteMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/ConvertibleNotesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_JulyTwoThousandNineteenOdysseyNoteMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "July 2019 Odyssey Note [Member]",
        "label": "July 2019 Odyssey Note [Member]"
       }
      }
     },
     "localname": "JulyTwoThousandNineteenOdysseyNoteMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/ConvertibleNotesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_JuneTwentyNineTwoThousandEighteenSecuritiesPurchaseAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "June 14, 2018 Securities Purchase Agreement [Member]",
        "label": "June 14, 2018 Securities Purchase Agreement [Member]"
       }
      }
     },
     "localname": "JuneTwentyNineTwoThousandEighteenSecuritiesPurchaseAgreementMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/ConvertibleNotesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_KenyonCancellationAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Kenyon Cancellation Agreement [Member]",
        "label": "Kenyon Cancellation Agreement [Member]"
       }
      }
     },
     "localname": "KenyonCancellationAgreementMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_LGCapitalFundingLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "LG Capital Funding, LLC [Member]",
        "label": "LG Capital Funding, LLC [Member]"
       }
      }
     },
     "localname": "LGCapitalFundingLLCMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/ConvertibleNotesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_LegalServicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Services [Member]"
       }
      }
     },
     "localname": "LegalServicesMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_LenderOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lender One [Member]",
        "label": "Lender One [Member]"
       }
      }
     },
     "localname": "LenderOneMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/ConcentrationsAndRisksDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_LenderThreeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lender Three [Member]",
        "label": "Lender Three [Member]"
       }
      }
     },
     "localname": "LenderThreeMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/ConcentrationsAndRisksDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_LenderTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lender Two [Member]",
        "label": "Lender Two [Member]"
       }
      }
     },
     "localname": "LenderTwoMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/ConcentrationsAndRisksDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_LitigationPenaltyAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Litigation penalty amount.",
        "label": "Penalty amount"
       }
      }
     },
     "localname": "LitigationPenaltyAmount",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "PPCB_LoanFromFormerDirectorRelatedParty": {
     "auth_ref": [],
     "calculation": {
      "http://propanc.com/role/BalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loan from former director related party.",
        "label": "Loan from former director - related party"
       }
      }
     },
     "localname": "LoanFromFormerDirectorRelatedParty",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "PPCB_LoansAndNotesPayableDisclosureTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loans and Notes Payable Text Block.",
        "label": "LOANS AND NOTES PAYABLE"
       }
      }
     },
     "localname": "LoansAndNotesPayableDisclosureTextBlock",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/LoansAndNotesPayable"
     ],
     "xbrltype": "textBlockItemType"
    },
    "PPCB_LoansFromRelatedParty": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Representing amount borrowed from related parties.",
        "label": "Loans from related party"
       }
      }
     },
     "localname": "LoansFromRelatedParty",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "PPCB_MarchSixteenTwoThousandTwentyOneGenevaRothMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "March 16, 2021 Geneva Roth [Member]",
        "label": "March 16, 2021 Geneva Roth [Member]"
       }
      }
     },
     "localname": "MarchSixteenTwoThousandTwentyOneGenevaRothMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/ConvertibleNotesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "March 12, 2020 Power Up Lending Group Securities Purchase Agreement [Member]",
        "label": "March 12, 2020 Power Up Lending Group Securities Purchase Agreement [Member]"
       }
      }
     },
     "localname": "MarchTwelveTwoThousandTwentyPowerUpLendingGroupSecuritiesPurchaseAgreementMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/ConvertibleNotesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_MarchTwelveTwoThousandTwentyPowerUpNoteMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "March 12, 2020 Power Up Note [Member]",
        "label": "March 12, 2020 Power Up Note [Member]"
       }
      }
     },
     "localname": "MarchTwelveTwoThousandTwentyPowerUpNoteMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/ConvertibleNotesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_MrNathanielszMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mr. Nathanielsz [Member]",
        "label": "Mr. Nathanielsz [Member]"
       }
      }
     },
     "localname": "MrNathanielszMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative",
      "http://propanc.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_MrsNathanielszMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mrs. Nathanielsz [Member]",
        "label": "Mrs. Nathanielsz [Member]"
       }
      }
     },
     "localname": "MrsNathanielszMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_NathanielszCancellationAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nathanielsz Cancellation Agreement [Member]",
        "label": "Nathanielsz Cancellation Agreement [Member]"
       }
      }
     },
     "localname": "NathanielszCancellationAgreementMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative",
      "http://propanc.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_NathanielszEmploymentAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nathanielsz Employment Agreement [Member]",
        "label": "Nathanielsz Employment Agreement [Member]"
       }
      }
     },
     "localname": "NathanielszEmploymentAgreementMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_NathanielszMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nathanielsz [Member]",
        "label": "Nathanielsz [Member]"
       }
      }
     },
     "localname": "NathanielszMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_NatureOfOperationsPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nature Of Operations [Policy Text Block]",
        "label": "Nature of Operations"
       }
      }
     },
     "localname": "NatureOfOperationsPolicyTextBlock",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/NatureOfOperationsAndSummaryOfSignificantAccountingAndReportingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "PPCB_NewFiveYearOperatingLeaseAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "New Five-Year Operating Lease Agreement [Member]",
        "label": "New Five-Year Operating Lease Agreement [Member]"
       }
      }
     },
     "localname": "NewFiveYearOperatingLeaseAgreementMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_NoCustomerMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "No Customer [Member]",
        "label": "No Customer [Member]"
       }
      }
     },
     "localname": "NoCustomerMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_NorthHorizonPtyLtdMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "North Horizon Pty Ltd [Member]",
        "label": "North Horizon Pty Ltd [Member]"
       }
      }
     },
     "localname": "NorthHorizonPtyLtdMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_NotExpireMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Not Expire [Member]",
        "label": "Not Expire [Member]"
       }
      }
     },
     "localname": "NotExpireMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_NovembeThirtyTwoThousandAndEighteenMecuritiesPurchaseAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "November 30, 2018 Securities Purchase Agreement [Member]",
        "label": "November 30, 2018 Securities Purchase Agreement [Member]"
       }
      }
     },
     "localname": "NovembeThirtyTwoThousandAndEighteenMecuritiesPurchaseAgreementMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/ConvertibleNotesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_NovemberTwentySixTwoThousandNineteenPowerUpNoteMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "November 26, 2019 Power Up Note [Member]",
        "label": "November 26, 2019 Power Up Note [Member]"
       }
      }
     },
     "localname": "NovemberTwentySixTwoThousandNineteenPowerUpNoteMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/ConvertibleNotesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_NovemberTwentySixTwoThousandNineteenSecuritiesPurchaseAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "November 26, 2019 Securities Purchase Agreement [Member]",
        "label": "November 26, 2019 Securities Purchase Agreement [Member]"
       }
      }
     },
     "localname": "NovemberTwentySixTwoThousandNineteenSecuritiesPurchaseAgreementMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/ConvertibleNotesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_NovemberTwoThousandAndEighteenEagleNoteMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "November 2018 Eagle Note [Member]",
        "label": "November 2018 Eagle Note [Member]"
       }
      }
     },
     "localname": "NovemberTwoThousandAndEighteenEagleNoteMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/ConvertibleNotesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_OctoberOneTwoThousandNineteenAuctusNoteMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "October 1, 2019 GW Note [Member]",
        "label": "October 1, 2019 GW Note [Member]"
       }
      }
     },
     "localname": "OctoberOneTwoThousandNineteenAuctusNoteMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/ConvertibleNotesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_OctoberThreeTwoThousandNineteenAuctusNoteMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "October 3, 2019 GW Note [Member]",
        "label": "October 3, 2019 GW Note [Member]"
       }
      }
     },
     "localname": "OctoberThreeTwoThousandNineteenAuctusNoteMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/ConvertibleNotesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_OctoberTwentyOneTwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "October Twenty One Two Thousand And Twenty One Securities Purchase Agreement [Member]"
       }
      }
     },
     "localname": "OctoberTwentyOneTwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_OctoberTwoThousandEighteenGSNoteMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "October 2018 GS Note [Member]",
        "label": "October 2018 GS Note [Member]"
       }
      }
     },
     "localname": "OctoberTwoThousandEighteenGSNoteMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/ConvertibleNotesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_OctoberTwoTwoThousandAndEighteenEagleNoteMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "October 2018 Eagle Note [Member]",
        "label": "October 2018 Eagle Note [Member]"
       }
      }
     },
     "localname": "OctoberTwoTwoThousandAndEighteenEagleNoteMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/ConvertibleNotesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "October 2, 2018 Securities Purchase Agreement [Member]",
        "label": "October 2, 2018 Securities Purchase Agreement [Member]"
       }
      }
     },
     "localname": "OctoberTwoTwoThousandAndEighteenSecuritiesPurchaseAgreementMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/ConvertibleNotesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_OdysseyCapitalFundingLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Odyssey Capital Funding LLC [Member]",
        "label": "Odyssey Capital Funding LLC [Member]"
       }
      }
     },
     "localname": "OdysseyCapitalFundingLLCMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/ConvertibleNotesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_OfficeLeaseLiability": {
     "auth_ref": [],
     "calculation": {
      "http://propanc.com/role/ScheduleOfOperatingLeaseLiabilityDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Office lease liability.",
        "label": "Office lease"
       }
      }
     },
     "localname": "OfficeLeaseLiability",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/ScheduleOfOperatingLeaseLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "PPCB_OneYearCollaborationAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "1-Year Collaboration Agreement [Member]",
        "label": "1-Year Collaboration Agreement [Member]"
       }
      }
     },
     "localname": "OneYearCollaborationAgreementMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_OperatingLeaseRightOfUseAssets": {
     "auth_ref": [],
     "calculation": {
      "http://propanc.com/role/ScheduleOfRightUseOfAssetDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingLeaseRightOfUseAsset",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Office lease ROU.",
        "label": "Office lease (24 months)"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAssets",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/ScheduleOfRightUseOfAssetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "PPCB_OperatingLeaseRightofuseAssetsAndOperatingLeaseLiabilitiesRecordedUponAdoptionOfAsc842": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating lease right-of-use asset and operating lease liability recorded on adoption of ASC 842.",
        "label": "Operating lease right-of-use asset and operating lease liability recorded on adoption of ASC 842"
       }
      }
     },
     "localname": "OperatingLeaseRightofuseAssetsAndOperatingLeaseLiabilitiesRecordedUponAdoptionOfAsc842",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "PPCB_OperatingLeasesIncomeStatementRevenuePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of operating leases income statement revenue during period.",
        "label": "Operating leases income statement revenue percentage"
       }
      }
     },
     "localname": "OperatingLeasesIncomeStatementRevenuePercentage",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "PPCB_OperatingLeasesRentExpenseMinimumRentalsPayable": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Leases Rent Expense Minimum Rentals Payable.",
        "label": "[custom:OperatingLeasesRentExpenseMinimumRentalsPayable]"
       }
      }
     },
     "localname": "OperatingLeasesRentExpenseMinimumRentalsPayable",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "PPCB_OptionsVestedDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Options vested, description.",
        "label": "Options vested, description"
       }
      }
     },
     "localname": "OptionsVestedDescription",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "PPCB_PaymentForServices": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payment for services.",
        "label": "Payment for services"
       }
      }
     },
     "localname": "PaymentForServices",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "PPCB_PercentageOfBonusOfAnnualBaseSalary": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of bonus of annual base salary.",
        "label": "Percentage of bonus of annual base salary"
       }
      }
     },
     "localname": "PercentageOfBonusOfAnnualBaseSalary",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative",
      "http://propanc.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "PPCB_PercentageOfOutstandingSharesOfCommonStock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents Percentage of the outstanding shares of common stock on each closing date the number of shares.",
        "label": "Percentage of outstanding shares of common stock"
       }
      }
     },
     "localname": "PercentageOfOutstandingSharesOfCommonStock",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/ConvertibleNotesDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "PPCB_PercentageOfPensionOfMonthlySalary": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of pension of monthly salary.",
        "label": "Percentage of pension of monthly salary"
       }
      }
     },
     "localname": "PercentageOfPensionOfMonthlySalary",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "PPCB_PrefundedWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prefunded Warrants [Member]",
        "label": "Prefunded Warrants [Member]"
       }
      }
     },
     "localname": "PrefundedWarrantsMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_PremiumsToAdditionalPaidInCapital": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Premiums to additional paid in capital.",
        "label": "Premiums to additional paid in capital"
       }
      }
     },
     "localname": "PremiumsToAdditionalPaidInCapital",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "PPCB_PrepaymentPenalties": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prepayment penalties.",
        "label": "Prepayment penalty"
       }
      }
     },
     "localname": "PrepaymentPenalties",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/ConvertibleNotesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "PPCB_ReclassifiedPremiumAmountForAdditionalPaidInCapital": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reclassified premium amount for additional paid in capital.",
        "label": "Reclassified premium amount for additional paid in capital"
       }
      }
     },
     "localname": "ReclassifiedPremiumAmountForAdditionalPaidInCapital",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/ConvertibleNotesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "PPCB_RedstartHoldingsCorpFinancingAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Redstart Holdings Corp Financing Agreement [Member]",
        "label": "Redstart Holdings Corp Financing Agreement [Member]"
       }
      }
     },
     "localname": "RedstartHoldingsCorpFinancingAgreementMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/ConvertibleNotesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_RedstartHoldingsCorpMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Redstart Holdings Corp [Member]",
        "label": "Redstart Holdings Corp [Member]"
       }
      }
     },
     "localname": "RedstartHoldingsCorpMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/ConvertibleNotesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_ReductionOfLeaseLiability": {
     "auth_ref": [],
     "calculation": {
      "http://propanc.com/role/ScheduleOfOperatingLeaseLiabilityDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reduction of lease liability.",
        "label": "Reduction of lease liability"
       }
      }
     },
     "localname": "ReductionOfLeaseLiability",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/ScheduleOfOperatingLeaseLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "PPCB_ReductionsDueToConversions": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reductions due to conversions.",
        "label": "Reductions due to conversions"
       }
      }
     },
     "localname": "ReductionsDueToConversions",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/ScheduleOfDerivativeLiabilitiesAtFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "PPCB_RegalConsultingLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Regal Consulting, LLC [Member]",
        "label": "Regal Consulting, LLC [Member]"
       }
      }
     },
     "localname": "RegalConsultingLLCMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_ReimbursementOnGoodsAndServiceTaxReceivablePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents the percentage of Reimbursement on Goods And Service Tax Receivable.",
        "label": "Reimbursement on goods and service tax receivable percentage"
       }
      }
     },
     "localname": "ReimbursementOnGoodsAndServiceTaxReceivablePercentage",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/ConcentrationsAndRisksDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "PPCB_RelativeFairValueOfWarrantsIssuedWithConvertibleDebt": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Relative fair value of warrants issued with convertible debt.",
        "label": "Relative fair value of warrants issued with convertible debt"
       }
      }
     },
     "localname": "RelativeFairValueOfWarrantsIssuedWithConvertibleDebt",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/StatementsOfChangesInStockholdersDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "PPCB_RemainingBonusAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Remaining bonus amount.",
        "label": "[custom:RemainingBonusAmount]"
       }
      }
     },
     "localname": "RemainingBonusAmount",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "PPCB_RemainingPrincipalAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Remaining principal amount",
        "label": "Remaining principal amount"
       }
      }
     },
     "localname": "RemainingPrincipalAmount",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "PPCB_RestrictedStocksUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Initial Nathanielsz RSUs [Member]",
        "label": "Initial Nathanielsz RSUs [Member]"
       }
      }
     },
     "localname": "RestrictedStocksUnitsRSUMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_ReversalOfCommonStockIssuableAndPutPremiumDueToCancellationOfConversionsOfConvertibleDebtAndAccruedInterest": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reversal of common stock issuable and put premium due to cancellation of conversions of convertible debt and accrued interest.",
        "label": "Reversal of common stock issuable and put premium due to cancellation of conversions of convertible debt and accrued interest"
       }
      }
     },
     "localname": "ReversalOfCommonStockIssuableAndPutPremiumDueToCancellationOfConversionsOfConvertibleDebtAndAccruedInterest",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "PPCB_ReversalOfCommonStockIssuableDueToCancellationOfConversionsOfConvertibleDebtAndAccruedInterest": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reversal of common stock issuable due to cancellation of conversions of convertible debt and accrued interest.",
        "label": "Reversal of common stock issuable due to cancellation of conversions of convertible debt and accrued interest"
       }
      }
     },
     "localname": "ReversalOfCommonStockIssuableDueToCancellationOfConversionsOfConvertibleDebtAndAccruedInterest",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/StatementsOfChangesInStockholdersDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "PPCB_ReversalOfCommonStockIssuableDueToCancellationOfConversionsOfConvertibleDebtAndAccruedInterestShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reversal of common stock issuable due to cancellation of conversions of convertible debt and accrued interest, shares.",
        "label": "Reversal of common stock issuable due to cancellation of conversions of convertible debt and accrued interest, shares"
       }
      }
     },
     "localname": "ReversalOfCommonStockIssuableDueToCancellationOfConversionsOfConvertibleDebtAndAccruedInterestShares",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/StatementsOfChangesInStockholdersDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "PPCB_ScheduleOfPropertyAndEquipmentEstimatedUsefulLivesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Property and Equipment Estimated Useful Lives [Table Text Block]",
        "label": "SCHEDULE OF PROPERTY AND EQUIPMENT ESTIMATED USEFUL LIVES"
       }
      }
     },
     "localname": "ScheduleOfPropertyAndEquipmentEstimatedUsefulLivesTableTextBlock",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/NatureOfOperationsAndSummaryOfSignificantAccountingAndReportingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "PPCB_ScheduleOfRightUseOfAssetTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Right Use Of Asset [Table Text Block]",
        "label": "SCHEDULE OF RIGHT USE OF ASSET"
       }
      }
     },
     "localname": "ScheduleOfRightUseOfAssetTableTextBlock",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/CommitmentsAndContingenciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "PPCB_ScheduleOfTranslationExchangeRatesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Translation Exchange Rates [Table Text Block]",
        "label": "SCHEDULE OF TRANSLATION EXCHANGE RATES"
       }
      }
     },
     "localname": "ScheduleOfTranslationExchangeRatesTableTextBlock",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/NatureOfOperationsAndSummaryOfSignificantAccountingAndReportingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "PPCB_SecondNoteMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Second Note [Member]",
        "label": "Second Note [Member]"
       }
      }
     },
     "localname": "SecondNoteMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/ConvertibleNotesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_SecondWarrantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Second Warrant [Member]",
        "label": "Second Warrant [Member]"
       }
      }
     },
     "localname": "SecondWarrantMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/ConvertibleNotesDetailsNarrative",
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_SecuritiesPurchaseAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities Purchase Agreement [Member]",
        "label": "Securities Purchase Agreement [Member]"
       }
      }
     },
     "localname": "SecuritiesPurchaseAgreementMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/ConvertibleNotesDetailsNarrative",
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_SecuritiesPurchaseAgreementOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities Purchase Agreement One [Member]",
        "label": "Securities Purchase Agreement One [Member]"
       }
      }
     },
     "localname": "SecuritiesPurchaseAgreementOneMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/ConvertibleNotesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_SecurityPurchaseAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Security Purchase Agreement [Member]",
        "label": "Security Purchase Agreement [Member]"
       }
      }
     },
     "localname": "SecurityPurchaseAgreementMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "September Twenty Two Two Thousand Twenty Geneva Roth [Member]"
       }
      }
     },
     "localname": "SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/ConvertibleNotesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_SeptemberTwentyTwoTwoThousandTwentyOneGenevaRothMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "September Twenty Two Two Thousand Twenty One Geneva Roth [Member]"
       }
      }
     },
     "localname": "SeptemberTwentyTwoTwoThousandTwentyOneGenevaRothMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/ConvertibleNotesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_SeriesAWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series A Warrants [Member]",
        "label": "Series A Warrants [Member]"
       }
      }
     },
     "localname": "SeriesAWarrantsMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_SeriesBWarrantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series B Warrant [Member]"
       }
      }
     },
     "localname": "SeriesBWarrantMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_SeriesBWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series B Warrants [Member]",
        "label": "Series B Warrants [Member]"
       }
      }
     },
     "localname": "SeriesBWarrantsMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative",
      "http://propanc.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_SeriesCWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series C Warrants [Member]",
        "label": "Series C Warrants [Member]"
       }
      }
     },
     "localname": "SeriesCWarrantsMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_ServicesAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Services Agreement [Member]",
        "label": "Services Agreement [Member]"
       }
      }
     },
     "localname": "ServicesAgreementMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_SettlementAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Settlement Agreement [Member]",
        "label": "Settlement Agreement [Member]"
       }
      }
     },
     "localname": "SettlementAgreementMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_SettlementAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Settlement amount.",
        "label": "[custom:SettlementAmount-0]"
       }
      }
     },
     "localname": "SettlementAmount",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "PPCB_SettlementAndMutualReleaseAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Settlement and Mutual Release Agreement [Member]",
        "label": "Settlement and Mutual Release Agreement [Member]"
       }
      }
     },
     "localname": "SettlementAndMutualReleaseAgreementMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://propanc.com/role/ConvertibleNotesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of equity instruments other than options exercisable, including both vested and non-vested instruments.",
        "label": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber",
        "periodEndLabel": "Number of Shares, Exercisable, Ending balance",
        "verboseLabel": "Number of Shares, Exercisable, Ending balance"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/ScheduleOfWarrantActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsIssued": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net number of non-option equity instruments issued to participants.",
        "label": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsIssued",
        "verboseLabel": "Number of Shares, Issued"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsIssued",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/ScheduleOfWarrantActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted Average Price Per Share Outstanding Exercisable, Ending.",
        "label": "Weighted Average Price Per Share Outstanding Exercisable, Ending",
        "periodEndLabel": "Weighted Average Price Per Share, Exercisable, Ending balance",
        "verboseLabel": "Weighted Average Price Per Share, Exercisable, Ending balance"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisable",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/ScheduleOfWarrantActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Non-options Equity Instruments, Weighted Average.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Non-options Equity Instruments, Weighted Average",
        "periodEndLabel": "Weighted Average Price Per Share, Outstanding, Ending balance",
        "periodStartLabel": "Weighted Average Price Per Share, Outstanding, Beginning balance"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageOutstanding",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/ScheduleOfWarrantActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceExercised": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted Average Price Per Share Exercised.",
        "label": "Weighted Average Price Per Share Exercised",
        "verboseLabel": "Weighted Average Price Per Share, Exercised"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceExercised",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/ScheduleOfWarrantActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceExpired": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted Average Price Per Share Expired.",
        "label": "Weighted Average Price Per Share Expired",
        "verboseLabel": "Weighted Average Price Per Share, Forfeited"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceExpired",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/ScheduleOfWarrantActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceForfeited": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted Average Price Per Share Forfeited.",
        "label": "Weighted Average Price Per Share Forfeited",
        "verboseLabel": "Weighted Average Price Per Share, Expired"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceForfeited",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/ScheduleOfWarrantActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceIssued": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted Average Price Per Share Issued.",
        "label": "Weighted Average Price Per Share Issued",
        "verboseLabel": "Weighted Average Price Per Share, Issued"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceIssued",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/ScheduleOfWarrantActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerms": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term.",
        "label": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerms",
        "verboseLabel": "Weighted average remaining contractual term"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerms",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/ScheduleOfWarrantActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "PPCB_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantDateFairvalue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of share based compensation arrangement by share based payment award options grant date fair value.",
        "label": "[custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantDateFairvalue]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantDateFairvalue",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "PPCB_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsIssuedInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Issued in Period, Weighted Average Exercise Price.",
        "label": "Weighted Average Price Per Share, Issued"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsIssuedInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/ScheduleOfStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "PPCB_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsAggregateIntrinsicValueOutstanding": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate intrinsic value.",
        "label": "Aggregate intrinsic value [Default Label]",
        "periodEndLabel": "Aggregate intrinsic value",
        "verboseLabel": "Aggregate intrinsic value"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsAggregateIntrinsicValueOutstanding",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/ScheduleOfWarrantActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "PPCB_StockIssuedDuringPeriodSharesExerciseOfWarrants": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise of warrants, shares.",
        "label": "Issuance of common stock for exercise of warrants, shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesExerciseOfWarrants",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/StatementsOfChangesInStockholdersDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "PPCB_StockIssuedDuringPeriodValueExerciseOfWarrants": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise of warrants.",
        "label": "Issuance of common stock for exercise of warrants"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueExerciseOfWarrants",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/StatementsOfChangesInStockholdersDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "PPCB_StockIssuedDuringPeriodValueReverseStockSplits": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fractional difference due to the reverse stock-split.",
        "label": "Fractional difference due to the reverse stock-split"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueReverseStockSplits",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/StatementsOfChangesInStockholdersDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "PPCB_StockToBeIssuedDuringPeriodValueRestrictedStockUnit": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock to be issued during period, value, restricted stock unit.",
        "label": "Restricted stock unit issuable"
       }
      }
     },
     "localname": "StockToBeIssuedDuringPeriodValueRestrictedStockUnit",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "PPCB_SubscriptionReceivable": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Subscription receivable.",
        "label": "Subscription receivable"
       }
      }
     },
     "localname": "SubscriptionReceivable",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "PPCB_SubscriptionReceivableMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subscription Receivable [Member]"
       }
      }
     },
     "localname": "SubscriptionReceivableMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/StatementsOfChangesInStockholdersDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_ThirdWarrantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Third Warrant [Member]",
        "label": "Third Warrant [Member]"
       }
      }
     },
     "localname": "ThirdWarrantMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/ConvertibleNotesDetailsNarrative",
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_TwelveSeriesAAndAWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "12 Series A and A Warrants [Member]",
        "label": "12 Series A and A Warrants [Member]"
       }
      }
     },
     "localname": "TwelveSeriesAAndAWarrantsMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_TwentySeriesAAndOneSeriesCWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "20 Series A and 1 Series C Warrants [Member]",
        "label": "20 Series A and 1 Series C Warrants [Member]"
       }
      }
     },
     "localname": "TwentySeriesAAndOneSeriesCWarrantsMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_TwoThousandAndSeventeenNoteMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2017 Note [Member]",
        "label": "2017 Note [Member]"
       }
      }
     },
     "localname": "TwoThousandAndSeventeenNoteMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_TwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2021 Securities Purchase Agreement [Member]",
        "label": "2021 Securities Purchase Agreement [Member]"
       }
      }
     },
     "localname": "TwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/NatureOfOperationsAndSummaryOfSignificantAccountingAndReportingPoliciesDetailsNarrative",
      "http://propanc.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_TwoThousandNinteenEquityIncentivePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2019 Equity Incentive Plan [Member]",
        "label": "2019 Equity Incentive Plan [Member]"
       }
      }
     },
     "localname": "TwoThousandNinteenEquityIncentivePlanMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_TwoYearCollaborationAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2-Year Collaboration Agreement [Member]",
        "label": "2-Year Collaboration Agreement [Member]"
       }
      }
     },
     "localname": "TwoYearCollaborationAgreementMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_UnderlyingFinancingAgreementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Underlying Financing Agreements [Member]",
        "label": "Underlying Financing Agreements [Member]"
       }
      }
     },
     "localname": "UnderlyingFinancingAgreementsMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_UnissuedSharesConversion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unissued shares conversion.",
        "label": "Unissued shares conversion"
       }
      }
     },
     "localname": "UnissuedSharesConversion",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/ConvertibleNotesDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "PPCB_UniversityOfJaenMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "University of Jaen [Member]",
        "label": "University of Jaen [Member]"
       }
      }
     },
     "localname": "UniversityOfJaenMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_UnrecognizedRestrictedStockUnitsExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unrecognized restricted stock units expense.",
        "label": "[custom:UnrecognizedRestrictedStockUnitsExpense]"
       }
      }
     },
     "localname": "UnrecognizedRestrictedStockUnitsExpense",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "PPCB_UnvestedRestrictedStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unvested Restricted Stock [Member]",
        "label": "Unvested Restricted Stock [Member]"
       }
      }
     },
     "localname": "UnvestedRestrictedStockMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/ScheduleOfDilutiveSecuritiesExcludedFromComputationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "PPCB_UnvestedStockOptionsExpense": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unvested stock options expense.",
        "label": "Unvested stock options expense"
       }
      }
     },
     "localname": "UnvestedStockOptionsExpense",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "PPCB_WeightedAverageFairValueOfOptionsGrantedDuringPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value of options granted during the period.",
        "label": "Weighted average fair value of options granted during the period"
       }
      }
     },
     "localname": "WeightedAverageFairValueOfOptionsGrantedDuringPeriod",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/ScheduleOfStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "PPCB_WorkingCapitalDeficit": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Working capital (Deficiency) as of the Balance sheet date.",
        "label": "Working capital deficit"
       }
      }
     },
     "localname": "WorkingCapitalDeficit",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/GoingConcernDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "PPCB_ZelingerAmendedAndRestatedDirectorAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Zelinger Amended And Restated Director Agreement [Member]",
        "label": "Zelinger Amended And Restated Director Agreement [Member]"
       }
      }
     },
     "localname": "ZelingerAmendedAndRestatedDirectorAgreementMember",
     "nsuri": "http://propanc.com/20210930",
     "presentation": [
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative",
      "http://propanc.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "country_AU": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "AUSTRALIA"
       }
      }
     },
     "localname": "AU",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://propanc.com/role/IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://propanc.com/role/IncomeTaxesDetailsNarrative",
      "http://propanc.com/role/ScheduleOfIncomeTaxProvisionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://propanc.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://propanc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r632"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://propanc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r632"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://propanc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://propanc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://propanc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://propanc.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r631"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://propanc.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r629",
      "r631",
      "r632"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://propanc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://propanc.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://propanc.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://propanc.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://propanc.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r630"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://propanc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r618"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://propanc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r631"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://propanc.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r631"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://propanc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r633"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://propanc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://propanc.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r621"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://propanc.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://propanc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://propanc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://propanc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://propanc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://propanc.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://propanc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://propanc.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r624"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://propanc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r620"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://propanc.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://propanc.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://propanc.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://propanc.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://propanc.com/role/ConvertibleNotesDetailsNarrative",
      "http://propanc.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r620"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://propanc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r638"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://propanc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://propanc.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r620"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://propanc.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationDateOfIncorporation": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date when an entity was incorporated",
        "label": "Entity incorporation, date of incorporation"
       }
      }
     },
     "localname": "EntityIncorporationDateOfIncorporation",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://propanc.com/role/NatureOfOperationsAndSummaryOfSignificantAccountingAndReportingPoliciesDetailsNarrative"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://propanc.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r635"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://propanc.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r632"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://propanc.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://propanc.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r620"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://propanc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r620"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://propanc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r620"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://propanc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r620"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://propanc.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://propanc.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r636"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://propanc.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://propanc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://propanc.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://propanc.com/role/ConvertibleNotesDetailsNarrative",
      "http://propanc.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://propanc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://propanc.com/role/Cover"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r631"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://propanc.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r625"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://propanc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r626"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://propanc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r619"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://propanc.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r623"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://propanc.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r622"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://propanc.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r627"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://propanc.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r628"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://propanc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://propanc.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r637"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://propanc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "srt_ChiefExecutiveOfficerMember": {
     "auth_ref": [
      "r181"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Chief Executive Officer [Member]"
       }
      }
     },
     "localname": "ChiefExecutiveOfficerMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://propanc.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MajorCustomersAxis": {
     "auth_ref": [
      "r180",
      "r304",
      "r307",
      "r582"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Axis]"
       }
      }
     },
     "localname": "MajorCustomersAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://propanc.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r228",
      "r268",
      "r327",
      "r328",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r579",
      "r583",
      "r615",
      "r616"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ConvertibleNotesDetailsNarrative",
      "http://propanc.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://propanc.com/role/ScheduleOfFairValueMeasurementsRecurringAndNonrecurringValuationTechniquesDetails",
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative",
      "http://propanc.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r228",
      "r268",
      "r327",
      "r328",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r579",
      "r583",
      "r615",
      "r616"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ConvertibleNotesDetailsNarrative",
      "http://propanc.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://propanc.com/role/ScheduleOfFairValueMeasurementsRecurringAndNonrecurringValuationTechniquesDetails",
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative",
      "http://propanc.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_NameOfMajorCustomerDomain": {
     "auth_ref": [
      "r180",
      "r304",
      "r307",
      "r582"
     ],
     "localname": "NameOfMajorCustomerDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://propanc.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r177",
      "r304",
      "r305",
      "r527",
      "r578",
      "r580"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r177",
      "r304",
      "r305",
      "r527",
      "r578",
      "r580"
     ],
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r228",
      "r268",
      "r313",
      "r327",
      "r328",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r579",
      "r583",
      "r615",
      "r616"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ConvertibleNotesDetailsNarrative",
      "http://propanc.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://propanc.com/role/ScheduleOfFairValueMeasurementsRecurringAndNonrecurringValuationTechniquesDetails",
      "http://propanc.com/role/ScheduleOfTranslationExchangeRatesDetails",
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative",
      "http://propanc.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r228",
      "r268",
      "r313",
      "r327",
      "r328",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r579",
      "r583",
      "r615",
      "r616"
     ],
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ConvertibleNotesDetailsNarrative",
      "http://propanc.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://propanc.com/role/ScheduleOfFairValueMeasurementsRecurringAndNonrecurringValuationTechniquesDetails",
      "http://propanc.com/role/ScheduleOfTranslationExchangeRatesDetails",
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative",
      "http://propanc.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r178",
      "r179",
      "r304",
      "r306",
      "r581",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613",
      "r614"
     ],
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://propanc.com/role/IncomeTaxesDetailsNarrative",
      "http://propanc.com/role/ScheduleOfIncomeTaxProvisionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r178",
      "r179",
      "r304",
      "r306",
      "r581",
      "r600",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613",
      "r614"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://propanc.com/role/IncomeTaxesDetailsNarrative",
      "http://propanc.com/role/ScheduleOfIncomeTaxProvisionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualAxis": {
     "auth_ref": [
      "r181",
      "r506"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Axis]"
       }
      }
     },
     "localname": "TitleOfIndividualAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://propanc.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://propanc.com/role/LoansAndNotesPayableDetailsNarrative",
      "http://propanc.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "auth_ref": [],
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://propanc.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://propanc.com/role/LoansAndNotesPayableDetailsNarrative",
      "http://propanc.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_WeightedAverageMember": {
     "auth_ref": [
      "r519",
      "r521",
      "r524",
      "r615",
      "r616"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average [Member]"
       }
      }
     },
     "localname": "WeightedAverageMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ScheduleOfTranslationExchangeRatesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingStandardsUpdate201602Member": {
     "auth_ref": [
      "r490"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounting Standards Update 2016-02 Leases (Topic 842).",
        "label": "Accounting Standards Update 2016-02 [Member]"
       }
      }
     },
     "localname": "AccountingStandardsUpdate201602Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://propanc.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent": {
     "auth_ref": [
      "r549",
      "r572"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date, including liabilities incurred and payable to vendors for goods and services received, taxes, interest, rent and utilities, compensation costs, payroll taxes and fringe benefits (other than pension and postretirement obligations), contractual rights and obligations, and statutory obligations.",
        "label": "Accounts Payable and Accrued Liabilities"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://propanc.com/role/BalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer.",
        "label": "Accrued expenses and other payables"
       }
      }
     },
     "localname": "AccountsPayableAndOtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r37",
      "r512"
     ],
     "calculation": {
      "http://propanc.com/role/BalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments": {
     "auth_ref": [
      "r96"
     ],
     "calculation": {
      "http://propanc.com/role/StatementsOfCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Accretion (Amortization) of Discounts and Premiums, Investments",
        "negatedLabel": "Accretion of put premium"
       }
      }
     },
     "localname": "AccretionAmortizationOfDiscountsAndPremiumsInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedBonusesCurrent": {
     "auth_ref": [
      "r10",
      "r11",
      "r40"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for incentive compensation awarded to employees and directors or earned by them based on the terms of one or more relevant arrangements. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Bonuses"
       }
      }
     },
     "localname": "AccruedBonusesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrentAndNoncurrent": {
     "auth_ref": [
      "r550",
      "r571"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities.",
        "label": "Accrued expenses"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://propanc.com/role/ConvertibleNotesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedSalariesCurrent": {
     "auth_ref": [
      "r10",
      "r11",
      "r40"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Acccrued salary cancellation",
        "verboseLabel": "Accrued salaries"
       }
      }
     },
     "localname": "AccruedSalariesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r35",
      "r197"
     ],
     "calculation": {
      "http://propanc.com/role/ScheduleOfPropertyAndEquipmentDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedLabel": "Less: Accumulated depreciation"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ScheduleOfPropertyAndEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r26",
      "r59",
      "r60",
      "r61",
      "r566",
      "r591",
      "r595"
     ],
     "calculation": {
      "http://propanc.com/role/BalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated other comprehensive income",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/BalanceSheets",
      "http://propanc.com/role/ScheduleOfChangeInAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r58",
      "r61",
      "r69",
      "r70",
      "r71",
      "r117",
      "r118",
      "r119",
      "r409",
      "r586",
      "r587",
      "r643"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/StatementsOfChangesInStockholdersDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r24",
      "r359",
      "r512"
     ],
     "calculation": {
      "http://propanc.com/role/BalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional paid-in capital",
        "terseLabel": "Additional Paid in Capital",
        "verboseLabel": "Additional paid in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/BalanceSheets",
      "http://propanc.com/role/ConvertibleNotesDetailsNarrative",
      "http://propanc.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r117",
      "r118",
      "r119",
      "r356",
      "r357",
      "r358",
      "r442"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/StatementsOfChangesInStockholdersDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r120",
      "r121",
      "r122",
      "r123",
      "r131",
      "r183",
      "r184",
      "r187",
      "r188",
      "r189",
      "r190",
      "r191",
      "r192",
      "r209",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r387",
      "r388",
      "r389",
      "r390",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r500",
      "r528",
      "r529",
      "r530",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r639",
      "r640",
      "r641",
      "r642",
      "r643"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by amendment to accounting standards.",
        "label": "Accounting Standards Update [Axis]"
       }
      }
     },
     "localname": "AdjustmentsForNewAccountingPronouncementsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://propanc.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature": {
     "auth_ref": [
      "r282",
      "r289",
      "r386"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in additional paid in capital (APIC) resulting from recognition of deferred taxes for convertible debt with a beneficial conversion feature.",
        "label": "Reversal of put premium upon cancellation of conversions of convertible debt"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/StatementsOfChangesInStockholdersDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r329",
      "r331",
      "r360",
      "r361"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "Stock based compensation in connection with stock option grants"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/StatementsOfChangesInStockholdersDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts": {
     "auth_ref": [
      "r282",
      "r289"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration.",
        "label": "Additional paid in capital upon issuance"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued": {
     "auth_ref": [
      "r224",
      "r282",
      "r289"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.",
        "label": "Stock based compensation in connection with fair value of warrants issued for services"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalWarrantIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/StatementsOfChangesInStockholdersDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Loss to Net Cash Used in Operating Activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AmortizationOfDebtDiscountPremium": {
     "auth_ref": [
      "r82",
      "r95",
      "r248",
      "r480"
     ],
     "calculation": {
      "http://propanc.com/role/StatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.",
        "label": "Amortization of debt discounts",
        "verboseLabel": "Amortization of debt discount"
       }
      }
     },
     "localname": "AmortizationOfDebtDiscountPremium",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ConvertibleNotesDetailsNarrative",
      "http://propanc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfFinancingCostsAndDiscounts": {
     "auth_ref": [
      "r95",
      "r248",
      "r257",
      "r258",
      "r482"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.",
        "label": "Discounts and debt issuance cost"
       }
      }
     },
     "localname": "AmortizationOfFinancingCostsAndDiscounts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ConcentrationsAndRisksDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r143"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive securities excluded from computation of earnings per share"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ScheduleOfDilutiveSecuritiesExcludedFromComputationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r143"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ScheduleOfDilutiveSecuritiesExcludedFromComputationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ScheduleOfDilutiveSecuritiesExcludedFromComputationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r143"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented."
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ScheduleOfDilutiveSecuritiesExcludedFromComputationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://propanc.com/role/ConvertibleNotesDetailsNarrative",
      "http://propanc.com/role/IncomeTaxesDetailsNarrative",
      "http://propanc.com/role/NatureOfOperationsAndSummaryOfSignificantAccountingAndReportingPoliciesDetailsNarrative",
      "http://propanc.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative",
      "http://propanc.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r110",
      "r166",
      "r169",
      "r175",
      "r186",
      "r210",
      "r211",
      "r212",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r221",
      "r222",
      "r403",
      "r410",
      "r455",
      "r510",
      "r512",
      "r544",
      "r563"
     ],
     "calculation": {
      "http://propanc.com/role/BalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "TOTAL ASSETS"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/BalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r8",
      "r9",
      "r53",
      "r110",
      "r186",
      "r210",
      "r211",
      "r212",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r221",
      "r222",
      "r403",
      "r410",
      "r455",
      "r510",
      "r512"
     ],
     "calculation": {
      "http://propanc.com/role/BalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "TOTAL CURRENT ASSETS"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CURRENT ASSETS:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/BalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AwardDateAxis": {
     "auth_ref": [
      "r332",
      "r351"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by date or year award under share-based payment arrangement is granted.",
        "label": "Award Date [Axis]"
       }
      }
     },
     "localname": "AwardDateAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://propanc.com/role/IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AwardDateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date or year award under share-based payment arrangement is granted."
       }
      }
     },
     "localname": "AwardDateDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://propanc.com/role/IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r332",
      "r351"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://propanc.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/NatureOfOperationsAndSummaryOfSignificantAccountingAndReportingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r7",
      "r32",
      "r97"
     ],
     "calculation": {
      "http://propanc.com/role/BalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r13",
      "r98"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and Cash Equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/NatureOfOperationsAndSummaryOfSignificantAccountingAndReportingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": {
     "auth_ref": [
      "r90",
      "r97",
      "r103"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations",
        "periodEndLabel": "CASH AT END OF PERIOD",
        "periodStartLabel": "CASH AT BEGINNING OF PERIOD"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r90",
      "r468"
     ],
     "calculation": {
      "http://propanc.com/role/StatementsOfCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "NET INCREASE (DECREASE) IN CASH"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r32"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash Equivalents, at Carrying Value"
       }
      }
     },
     "localname": "CashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/NatureOfOperationsAndSummaryOfSignificantAccountingAndReportingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Disclosure of Non-Cash Investing and Financing Activities"
       }
      }
     },
     "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r107",
      "r110",
      "r135",
      "r136",
      "r137",
      "r140",
      "r142",
      "r147",
      "r148",
      "r149",
      "r186",
      "r210",
      "r215",
      "r216",
      "r217",
      "r221",
      "r222",
      "r266",
      "r267",
      "r271",
      "r275",
      "r455",
      "r634"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock."
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/BalanceSheets",
      "http://propanc.com/role/BalanceSheetsParenthetical",
      "http://propanc.com/role/StatementsOfChangesInStockholdersDeficit",
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative",
      "http://propanc.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class of Stock [Line Items]"
       }
      }
     },
     "localname": "ClassOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "auth_ref": [
      "r283"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding.",
        "label": "Warrants exercise price per share",
        "verboseLabel": "Warrant exercise price"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ConvertibleNotesDetailsNarrative",
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": {
     "auth_ref": [
      "r283"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.",
        "label": "Warrants to purchase of common stock, shares",
        "verboseLabel": "Warrants exercised"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ConvertibleNotesDetailsNarrative",
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]"
       }
      }
     },
     "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r46",
      "r204",
      "r551",
      "r570"
     ],
     "calculation": {
      "http://propanc.com/role/BalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies (See Note 8)"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r201",
      "r202",
      "r203",
      "r208",
      "r602"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "COMMITMENTS AND CONTINGENCIES"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/CommitmentsAndContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "auth_ref": [
      "r48"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate number of common shares reserved for future issuance.",
        "label": "Number of common shares reserved for future issuance"
       }
      }
     },
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r117",
      "r118",
      "r442"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/StatementsOfChangesInStockholdersDeficit",
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative",
      "http://propanc.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r23"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common stock, par value"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/BalanceSheetsParenthetical",
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r23"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common stock, shares authorized"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/BalanceSheetsParenthetical",
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r23"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common stock, shares issued",
        "terseLabel": "Common Stock, Shares, Issued",
        "verboseLabel": "Common stock shares issued"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/BalanceSheetsParenthetical",
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative",
      "http://propanc.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r23",
      "r282"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common stock, shares outstanding"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/BalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesSubscribedButUnissued": {
     "auth_ref": [
      "r23"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of common stock allocated to investors to buy shares of a new issue of common stock before they are offered to the public. When stock is sold on a subscription basis, the issuer does not initially receive the total proceeds. In general, the issuer does not issue the shares to the investor until it receives the entire proceeds.",
        "label": "Common stock, unissued shares"
       }
      }
     },
     "localname": "CommonStockSharesSubscribedButUnissued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r23",
      "r512"
     ],
     "calculation": {
      "http://propanc.com/role/BalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common stock, $0.001 par value; 1,000,000,000 shares authorized;43,841,644 and 14,055,393 shares issued and outstanding as of September 30, 2021 and June 30, 2021, respectively",
        "verboseLabel": "Common stock value issued"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/BalanceSheets",
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r64",
      "r66",
      "r67",
      "r75",
      "r554",
      "r574"
     ],
     "calculation": {
      "http://propanc.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "TOTAL COMPREHENSIVE LOSS"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "auth_ref": [
      "r155",
      "r156",
      "r180",
      "r453",
      "r454",
      "r601"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage."
       }
      }
     },
     "localname": "ConcentrationRiskBenchmarkDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "auth_ref": [
      "r155",
      "r156",
      "r180",
      "r453",
      "r454",
      "r596",
      "r601"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by benchmark of concentration risk.",
        "label": "Concentration Risk Benchmark [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "auth_ref": [
      "r155",
      "r156",
      "r180",
      "r453",
      "r454",
      "r596",
      "r601"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.",
        "label": "Concentration Risk Type [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskDisclosureTextBlock": {
     "auth_ref": [
      "r160"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.",
        "label": "CONCENTRATIONS AND RISKS"
       }
      }
     },
     "localname": "ConcentrationRiskDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ConcentrationsAndRisks"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "auth_ref": [
      "r155",
      "r156",
      "r180",
      "r453",
      "r454"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
        "label": "Royalties percentage"
       }
      }
     },
     "localname": "ConcentrationRiskPercentage1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "auth_ref": [
      "r155",
      "r156",
      "r180",
      "r453",
      "r454",
      "r601"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration."
       }
      }
     },
     "localname": "ConcentrationRiskTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r104",
      "r405"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Principles of Consolidation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/NatureOfOperationsAndSummaryOfSignificantAccountingAndReportingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConversionOfStockAmountConverted1": {
     "auth_ref": [
      "r100",
      "r101",
      "r102"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The value of the stock converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Reduction of put premium related to conversions of convertible notes"
       }
      }
     },
     "localname": "ConversionOfStockAmountConverted1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConversionOfStockAmountIssued1": {
     "auth_ref": [
      "r100",
      "r101",
      "r102"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The value of the financial instrument issued [noncash or part noncash] in the conversion of stock. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Conversion of convertible notes and accrued interest to common stock"
       }
      }
     },
     "localname": "ConversionOfStockAmountIssued1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConvertibleDebt": {
     "auth_ref": [
      "r18",
      "r547",
      "r565"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Including the current and noncurrent portions, carrying amount of debt identified as being convertible into another form of financial instrument (typically the entity's common stock) as of the balance sheet date, which originally required full repayment more than twelve months after issuance or greater than the normal operating cycle of the company.",
        "label": "Convertible note",
        "verboseLabel": "Convertible debt"
       }
      }
     },
     "localname": "ConvertibleDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://propanc.com/role/DerivativeFinancialInstrumentsAndFairValueMeasurementsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConvertibleDebtCurrent": {
     "auth_ref": [
      "r16"
     ],
     "calculation": {
      "http://propanc.com/role/BalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of the carrying value of long-term convertible debt as of the balance sheet date that is scheduled to be repaid within one year or in the normal operating cycle if longer. Convertible debt is a financial instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.",
        "label": "Convertible notes and related accrued interest, net of discounts and premiums"
       }
      }
     },
     "localname": "ConvertibleDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConvertibleDebtMember": {
     "auth_ref": [
      "r223",
      "r225",
      "r226",
      "r228",
      "r238",
      "r239",
      "r240",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r255",
      "r256",
      "r257",
      "r258"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.",
        "label": "Convertible Debt [Member]"
       }
      }
     },
     "localname": "ConvertibleDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/DerivativeFinancialInstrumentsAndFairValueMeasurementsDetailsNarrative",
      "http://propanc.com/role/ScheduleOfFairValueMeasurementsRecurringAndNonrecurringValuationTechniquesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConvertibleDebtSecuritiesMember": {
     "auth_ref": [
      "r314"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities that can be exchanged for equity of the debt issuer at the option of the issuer or the holder.",
        "label": "Convertible Debt Securities [Member]"
       }
      }
     },
     "localname": "ConvertibleDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ScheduleOfDilutiveSecuritiesExcludedFromComputationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConvertibleDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of convertible debt instrument. Includes, but is not limited to, principal amount and amortized premium or discount.",
        "label": "SCHEDULE OF CONVERTIBLE NOTES"
       }
      }
     },
     "localname": "ConvertibleDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ConvertibleNotesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConvertibleNotesPayable": {
     "auth_ref": [
      "r18",
      "r547",
      "r564",
      "r597"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder.",
        "label": "Convertible debt outstanding balance"
       }
      }
     },
     "localname": "ConvertibleNotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ConvertibleNotesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtConversionConvertedInstrumentAmount1": {
     "auth_ref": [
      "r100",
      "r102"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Debt conversion of converted amount",
        "verboseLabel": "Conversion of principal and interest, aggregate amount"
       }
      }
     },
     "localname": "DebtConversionConvertedInstrumentAmount1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ConvertibleNotesDetailsNarrative",
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtConversionConvertedInstrumentSharesIssued1": {
     "auth_ref": [
      "r100",
      "r102"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or payments in the period.",
        "label": "Debt Conversion, Converted Instrument, Shares Issued"
       }
      }
     },
     "localname": "DebtConversionConvertedInstrumentSharesIssued1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative",
      "http://propanc.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_DebtConversionDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name of the original debt issue that has been converted in a noncash (or part noncash) transaction during the accounting period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Debt conversion, description"
       }
      }
     },
     "localname": "DebtConversionDescription",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ConvertibleNotesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtConversionOriginalDebtAmount1": {
     "auth_ref": [
      "r100",
      "r102"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Debt conversion, original debt amount"
       }
      }
     },
     "localname": "DebtConversionOriginalDebtAmount1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ConvertibleNotesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtConversionOriginalDebtInterestRateOfDebt": {
     "auth_ref": [
      "r100",
      "r102"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The rate of interest that was being paid on the original debt issue that is being converted in the noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Debt original issue discount, rate"
       }
      }
     },
     "localname": "DebtConversionOriginalDebtInterestRateOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ConvertibleNotesDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r106",
      "r231",
      "r232",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r242",
      "r249",
      "r250",
      "r251",
      "r261"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "CONVERTIBLE NOTES"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ConvertibleNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r16",
      "r17",
      "r18",
      "r109",
      "r115",
      "r225",
      "r226",
      "r227",
      "r228",
      "r229",
      "r230",
      "r232",
      "r238",
      "r239",
      "r240",
      "r241",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r255",
      "r256",
      "r257",
      "r258",
      "r483",
      "r545",
      "r547",
      "r562"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://propanc.com/role/ConvertibleNotesDetailsNarrative",
      "http://propanc.com/role/NatureOfOperationsAndSummaryOfSignificantAccountingAndReportingPoliciesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "auth_ref": [
      "r18",
      "r252",
      "r547",
      "r562"
     ],
     "calculation": {
      "http://propanc.com/role/ScheduleOfConvertibleNotesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Convertible notes and debenture"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ScheduleOfConvertibleNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentConvertibleConversionPrice1": {
     "auth_ref": [
      "r227",
      "r254"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The price per share of the conversion feature embedded in the debt instrument.",
        "label": "Conversion price",
        "verboseLabel": "Debt Instrument, Convertible, Conversion Price"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleConversionPrice1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative",
      "http://propanc.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_DebtInstrumentConvertibleTermsOfConversionFeature": {
     "auth_ref": [
      "r44",
      "r283",
      "r286",
      "r287"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of conversion terms for debt instrument.",
        "label": "Debt conversion percentage, description"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleTermsOfConversionFeature",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/NatureOfOperationsAndSummaryOfSignificantAccountingAndReportingPoliciesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum percentage of common stock price to conversion price of convertible debt instruments to determine eligibility of conversion.",
        "label": "Debt conversion percentage",
        "verboseLabel": "Common stock trading volume, percent"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ConvertibleNotesDetailsNarrative",
      "http://propanc.com/role/NatureOfOperationsAndSummaryOfSignificantAccountingAndReportingPoliciesDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentConvertibleThresholdTradingDays": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Threshold number of specified trading days that common stock price to conversion price of convertible debt instruments must exceed threshold percentage within a specified consecutive trading period to trigger conversion feature.",
        "label": "Common stock trading days",
        "verboseLabel": "Trading days"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleThresholdTradingDays",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ConvertibleNotesDetailsNarrative",
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DebtInstrumentDescription": {
     "auth_ref": [
      "r16",
      "r18",
      "r283",
      "r545",
      "r547",
      "r559",
      "r562"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the lender and information about a contractual promise to repay a short-term or long-term obligation, which includes borrowings under lines of credit, notes payable, commercial paper, bonds payable, debentures, and other contractual obligations for payment. This may include rationale for entering into the arrangement, significant terms of the arrangement, which may include amount, repayment terms, priority, collateral required, debt covenants, borrowing capacity, call features, participation rights, conversion provisions, sinking-fund requirements, voting rights, basis for conversion if convertible and remarketing provisions. The description may be provided for individual debt instruments, rational groupings of debt instruments, or by debt in total.",
        "label": "Debt instrument, description",
        "verboseLabel": "Debt description"
       }
      }
     },
     "localname": "DebtInstrumentDescription",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ConvertibleNotesDetailsNarrative",
      "http://propanc.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r225",
      "r255",
      "r256",
      "r481",
      "r483",
      "r484"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Convertible debt principal amount",
        "verboseLabel": "Debt Instrument, Face Amount"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ConvertibleNotesDetailsNarrative",
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative",
      "http://propanc.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateDuringPeriod": {
     "auth_ref": [
      "r42",
      "r245",
      "r481"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average effective interest rate during the reporting period.",
        "label": "Debt Instrument, Interest Rate During Period"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r42",
      "r226"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt instrument, interest rate, stated percentage",
        "verboseLabel": "Debt Instrument, Interest Rate, Stated Percentage"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ConcentrationsAndRisksDetailsNarrative",
      "http://propanc.com/role/ConvertibleNotesDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentInterestRateTerms": {
     "auth_ref": [
      "r42"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of the interest rate as being fixed or variable, and, if variable, identification of the index or rate on which the interest rate is based and the number of points or percentage added to that index or rate to set the rate, and other pertinent information, such as frequency of rate resets.",
        "label": "Debt Instrument, Interest Rate Terms"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateTerms",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentMaturityDate": {
     "auth_ref": [
      "r43",
      "r228",
      "r449"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.",
        "label": "Debt maturity date",
        "verboseLabel": "Debt Instrument, Maturity Date"
       }
      }
     },
     "localname": "DebtInstrumentMaturityDate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ConvertibleNotesDetailsNarrative",
      "http://propanc.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_DebtInstrumentMeasurementInput": {
     "auth_ref": [
      "r449"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of input used to measure debt instrument, including, but not limited to, convertible and non-convertible debt.",
        "label": "Debt instrument, measurement input, percentages"
       }
      }
     },
     "localname": "DebtInstrumentMeasurementInput",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ScheduleOfFairValueMeasurementsRecurringAndNonrecurringValuationTechniquesDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r45",
      "r109",
      "r115",
      "r225",
      "r226",
      "r227",
      "r228",
      "r229",
      "r230",
      "r232",
      "r238",
      "r239",
      "r240",
      "r241",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r255",
      "r256",
      "r257",
      "r258",
      "r483"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities."
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://propanc.com/role/ConvertibleNotesDetailsNarrative",
      "http://propanc.com/role/NatureOfOperationsAndSummaryOfSignificantAccountingAndReportingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentPeriodicPaymentPrincipal": {
     "auth_ref": [
      "r45"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the required periodic payments applied to principal.",
        "label": "Debt instrument principal payment"
       }
      }
     },
     "localname": "DebtInstrumentPeriodicPaymentPrincipal",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ConvertibleNotesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Debt instrument, measurement input, term"
       }
      }
     },
     "localname": "DebtInstrumentTerm",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ScheduleOfFairValueMeasurementsRecurringAndNonrecurringValuationTechniquesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscount": {
     "auth_ref": [
      "r238",
      "r480",
      "r484"
     ],
     "calculation": {
      "http://propanc.com/role/ScheduleOfConvertibleNotesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt discount.",
        "label": "Original issue discount",
        "negatedLabel": "Unamortized discounts",
        "verboseLabel": "Debt Instrument, Unamortized Discount"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ConvertibleNotesDetailsNarrative",
      "http://propanc.com/role/ScheduleOfConvertibleNotesDetails",
      "http://propanc.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedPremium": {
     "auth_ref": [
      "r238",
      "r480",
      "r484"
     ],
     "calculation": {
      "http://propanc.com/role/ScheduleOfConvertibleNotesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt premium.",
        "label": "Premium, net",
        "verboseLabel": "Debt premium amount"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedPremium",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ConvertibleNotesDetailsNarrative",
      "http://propanc.com/role/ScheduleOfConvertibleNotesDetails",
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredBonusAndProfitSharingArrangementIndividualContractTypeOfDeferredCompensationDomain": {
     "auth_ref": [
      "r309",
      "r311"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred compensation that is not equivalent to a defined benefit pension plan or a defined benefit other postretirement benefit plan. Includes, but is not limited to, employment contracts with one or more selected officers or key employees. Excludes equity-based compensation plans, defined benefit pension plans and defined benefit other postretirement benefit plans."
       }
      }
     },
     "localname": "DeferredBonusAndProfitSharingArrangementIndividualContractTypeOfDeferredCompensationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis": {
     "auth_ref": [
      "r309",
      "r311"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of deferred compensation that is not equivalent to a defined benefit pension plan or a defined benefit other postretirement benefit plan. Includes, but is not limited to, employment contracts with one or more selected officers or key employees. Excludes equity-based compensation plans, defined benefit pension plans and defined benefit other postretirement benefit plans.",
        "label": "Deferred Bonus and Profit Sharing Arrangements, Individual Contracts, Type of Deferred Compensation [Axis]"
       }
      }
     },
     "localname": "DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]"
       }
      }
     },
     "localname": "DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/LoansAndNotesPayableDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredCompensationLiabilityCurrent": {
     "auth_ref": [
      "r310",
      "r312"
     ],
     "calculation": {
      "http://propanc.com/role/BalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable within one year (or the operating cycle, if longer). Represents currently earned compensation under compensation arrangements that is not actually paid until a later date.",
        "label": "Embedded conversion option liabilities"
       }
      }
     },
     "localname": "DeferredCompensationLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilities": {
     "auth_ref": [
      "r19",
      "r20",
      "r376",
      "r546",
      "r560"
     ],
     "calculation": {
      "http://propanc.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.",
        "label": "Deferred Tax Liabilities, Gross",
        "negatedTotalLabel": "Total deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets": {
     "auth_ref": [],
     "calculation": {
      "http://propanc.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from intangible assets including goodwill.",
        "label": "Intangibles (Intellectual Property and Patent Cost)"
       }
      }
     },
     "localname": "DeferredTaxAssetsGoodwillAndIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "auth_ref": [
      "r377"
     ],
     "calculation": {
      "http://propanc.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Gross",
        "totalLabel": "Total Deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsLiabilitiesNet": {
     "auth_ref": [
      "r379"
     ],
     "calculation": {
      "http://propanc.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.",
        "label": "Deferred Tax Assets, Net",
        "verboseLabel": "Net deferred tax assets (liabilities)"
       }
      }
     },
     "localname": "DeferredTaxAssetsLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "auth_ref": [
      "r379"
     ],
     "calculation": {
      "http://propanc.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Net deferred tax assets (liabilities)"
       }
      }
     },
     "localname": "DeferredTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "auth_ref": [
      "r383",
      "r384"
     ],
     "calculation": {
      "http://propanc.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.",
        "label": "Net Operating Loss CF"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": {
     "auth_ref": [
      "r383",
      "r384"
     ],
     "calculation": {
      "http://propanc.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 11.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost",
        "verboseLabel": "Stock Based Compensation"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther": {
     "auth_ref": [
      "r383",
      "r384"
     ],
     "calculation": {
      "http://propanc.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from provisions, reserves, allowances, and accruals, classified as other.",
        "label": "Formation Expense"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities": {
     "auth_ref": [
      "r383",
      "r384"
     ],
     "calculation": {
      "http://propanc.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities.",
        "label": "Accrued Expenses"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent": {
     "auth_ref": [
      "r383",
      "r384"
     ],
     "calculation": {
      "http://propanc.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from deferred rent.",
        "label": "Deferred Rent"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r378"
     ],
     "calculation": {
      "http://propanc.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "negatedLabel": "Valuation allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts": {
     "auth_ref": [
      "r383",
      "r384"
     ],
     "calculation": {
      "http://propanc.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from research and development costs.",
        "label": "Deferred Tax Liabilities, Deferred Expense, Capitalized Research and Development Costs",
        "negatedLabel": "R&amp;D"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts": {
     "auth_ref": [
      "r383",
      "r384"
     ],
     "calculation": {
      "http://propanc.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from debt issuance costs.",
        "label": "Deferred Tax Liabilities, Deferred Expense, Debt Issuance Costs",
        "negatedLabel": "Capital Raising Costs"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Defined Benefit Plan Disclosure [Line Items]"
       }
      }
     },
     "localname": "DefinedBenefitPlanDisclosureLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ConcentrationsAndRisksDetailsNarrative",
      "http://propanc.com/role/ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DepositLiabilitiesAccruedInterest": {
     "auth_ref": [
      "r550"
     ],
     "calculation": {
      "http://propanc.com/role/ScheduleOfConvertibleNotesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accrued but unpaid interest on deposit liabilities.",
        "label": "Deposit Liabilities, Accrued Interest",
        "verboseLabel": "Accrued interest"
       }
      }
     },
     "localname": "DepositLiabilitiesAccruedInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ScheduleOfConvertibleNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepositsAssetsNoncurrent": {
     "auth_ref": [
      "r36"
     ],
     "calculation": {
      "http://propanc.com/role/BalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment after one year or beyond the operating cycle, if longer.",
        "label": "Security deposit - related party"
       }
      }
     },
     "localname": "DepositsAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r95",
      "r195"
     ],
     "calculation": {
      "http://propanc.com/role/StatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation expense"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/PropertyAndEquipmentDetailsNarrative",
      "http://propanc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset."
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/DerivativeFinancialInstrumentsAndFairValueMeasurementsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeNet": {
     "auth_ref": [
      "r452"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of the assets less the liabilities of a derivative or group of derivatives.",
        "label": "Derivative fair value"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeGainLossOnDerivativeNet": {
     "auth_ref": [
      "r421"
     ],
     "calculation": {
      "http://propanc.com/role/StatementsOfCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://propanc.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": {
       "order": 4.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.",
        "label": "Change in fair value of derivative liabilities",
        "negatedLabel": "Change in fair value of derivative liabilities"
       }
      }
     },
     "localname": "DerivativeGainLossOnDerivativeNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/StatementsOfCashFlows",
      "http://propanc.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r56",
      "r420",
      "r423",
      "r425",
      "r426"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/DerivativeFinancialInstrumentsAndFairValueMeasurementsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r433",
      "r445"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.",
        "label": "DERIVATIVE FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/DerivativeFinancialInstrumentsAndFairValueMeasurements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": {
     "auth_ref": [
      "r418",
      "r420",
      "r425",
      "r426",
      "r427",
      "r430",
      "r432"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/DerivativeFinancialInstrumentsAndFairValueMeasurementsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative Instruments, Gain (Loss) [Line Items]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/DerivativeFinancialInstrumentsAndFairValueMeasurementsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeLiabilities": {
     "auth_ref": [
      "r54",
      "r55",
      "r56",
      "r452"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.",
        "label": "Total",
        "periodEndLabel": "Balance at Ending",
        "periodStartLabel": "Balance at Beginning"
       }
      }
     },
     "localname": "DerivativeLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ScheduleOfDerivativeLiabilitiesAtFairValueDetails",
      "http://propanc.com/role/ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative [Line Items]"
       }
      }
     },
     "localname": "DerivativeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ScheduleOfFairValueMeasurementsRecurringAndNonrecurringValuationTechniquesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeTable": {
     "auth_ref": [
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r424",
      "r425",
      "r428",
      "r429",
      "r432",
      "r433"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Derivative [Table]"
       }
      }
     },
     "localname": "DerivativeTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ScheduleOfFairValueMeasurementsRecurringAndNonrecurringValuationTechniquesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativesReportingOfDerivativeActivity": {
     "auth_ref": [
      "r415"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for derivatives entered into for trading purposes and those entered into for purposes other than trading including where and when derivative financial instruments and derivative commodity instruments and their related gains or losses are reported in the entity's statements of financial position, cash flows, and results of operations.",
        "label": "Derivative Instruments"
       }
      }
     },
     "localname": "DerivativesReportingOfDerivativeActivity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/NatureOfOperationsAndSummaryOfSignificantAccountingAndReportingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DueToRelatedPartiesCurrent": {
     "auth_ref": [
      "r37",
      "r114",
      "r213",
      "r215",
      "r216",
      "r220",
      "r221",
      "r222",
      "r504"
     ],
     "calculation": {
      "http://propanc.com/role/BalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Due to former director - related party",
        "terseLabel": "Due to related parties",
        "verboseLabel": "Due to directors - related parties"
       }
      }
     },
     "localname": "DueToRelatedPartiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/BalanceSheets",
      "http://propanc.com/role/DueToFormerDirector-RelatedPartyDetailsNarrative",
      "http://propanc.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDiluted": {
     "auth_ref": [
      "r141"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "BASIC AND DILUTED NET LOSS PER SHARE"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r143",
      "r144"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Basic and Diluted Net Loss Per Common Share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/NatureOfOperationsAndSummaryOfSignificantAccountingAndReportingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": {
     "auth_ref": [
      "r468"
     ],
     "calculation": {
      "http://propanc.com/role/StatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of exchange rate changes on cash"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential": {
     "auth_ref": [
      "r370",
      "r394"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.",
        "label": "Income tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability": {
     "auth_ref": [
      "r422"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value as of the balance sheet date of the embedded derivative or group of embedded derivatives classified as a liability.",
        "label": "Embedded derivative, fair value of embedded derivative liability",
        "verboseLabel": "Embedded conversion option liabilities"
       }
      }
     },
     "localname": "EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ConvertibleNotesDetailsNarrative",
      "http://propanc.com/role/ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet": {
     "auth_ref": [
      "r431"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net Increase or Decrease in the fair value of the embedded derivative or group of embedded derivatives included in earnings in the period.",
        "label": "Balance at Beginning"
       }
      }
     },
     "localname": "EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ScheduleOfDerivativeLiabilitiesAtFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r40"
     ],
     "calculation": {
      "http://propanc.com/role/BalanceSheets": {
       "order": 8.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee benefit liability"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [
      "r350"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-based Payment Arrangement, Option [Member]"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ScheduleOfDilutiveSecuritiesExcludedFromComputationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EmployeeStockOwnershipPlanESOPPolicy": {
     "auth_ref": [
      "r362"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for ESOP transactions, including the method of measuring compensation, the classification of dividends on ESOP shares, and the treatment of ESOP shares for EPS computations. If the employer has both old ESOP shares for which it does not adopt new guidance and new ESOP shares for which new guidance is required, these disclosures are required for both blocks of shares.",
        "label": "Employee Benefit/Liability"
       }
      }
     },
     "localname": "EmployeeStockOwnershipPlanESOPPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/NatureOfOperationsAndSummaryOfSignificantAccountingAndReportingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r2",
      "r69",
      "r70",
      "r71",
      "r117",
      "r118",
      "r119",
      "r121",
      "r128",
      "r130",
      "r146",
      "r190",
      "r282",
      "r289",
      "r356",
      "r357",
      "r358",
      "r389",
      "r390",
      "r442",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r475",
      "r586",
      "r587",
      "r588",
      "r643"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ConvertibleNotesDetailsNarrative",
      "http://propanc.com/role/StatementsOfChangesInStockholdersDeficit",
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative",
      "http://propanc.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentOwnershipPercentage": {
     "auth_ref": [
      "r185"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.",
        "label": "Equity Method Investment, Ownership Percentage"
       }
      }
     },
     "localname": "EquityMethodInvestmentOwnershipPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/NatureOfOperationsAndSummaryOfSignificantAccountingAndReportingPoliciesDetailsNarrative",
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative",
      "http://propanc.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_FairValueAdjustmentOfWarrants": {
     "auth_ref": [
      "r95",
      "r262"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (income) related to adjustment to fair value of warrant liability.",
        "label": "Fair value of warrants"
       }
      }
     },
     "localname": "FairValueAdjustmentOfWarrants",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ConvertibleNotesDetailsNarrative",
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": {
     "auth_ref": [
      "r448"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.",
        "label": "SCHEDULE OF FAIR VALUE MEASUREMENTS, RECURRING AND NONRECURRING, VALUATION TECHNIQUES"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/DerivativeFinancialInstrumentsAndFairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r240",
      "r255",
      "r256",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r326",
      "r447",
      "r516",
      "r517",
      "r518"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r240",
      "r314",
      "r315",
      "r320",
      "r326",
      "r447",
      "r516"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r240",
      "r255",
      "r256",
      "r314",
      "r315",
      "r320",
      "r326",
      "r447",
      "r517"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r240",
      "r255",
      "r256",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r326",
      "r447",
      "r518"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r240",
      "r255",
      "r256",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r326",
      "r516",
      "r517",
      "r518"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value."
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "auth_ref": [
      "r450",
      "r451"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.",
        "label": "Fair Value of Financial Instruments and Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/NatureOfOperationsAndSummaryOfSignificantAccountingAndReportingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ForeignCurrencyExchangeRateTranslation1": {
     "auth_ref": [
      "r476",
      "r477"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign exchange rate used to translate amounts denominated in functional currency to reporting currency.",
        "label": "Foreign Currency Exchange Rate, Translation"
       }
      }
     },
     "localname": "ForeignCurrencyExchangeRateTranslation1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ScheduleOfTranslationExchangeRatesDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": {
     "auth_ref": [
      "r464",
      "r465",
      "r466",
      "r467"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.",
        "label": "Foreign currency translation gain"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionGainLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/StatementsOfChangesInStockholdersDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyTransactionGainLossUnrealized": {
     "auth_ref": [
      "r96",
      "r466",
      "r467"
     ],
     "calculation": {
      "http://propanc.com/role/StatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://propanc.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": {
       "order": 7.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of foreign currency transaction unrealized gain (loss) recognized in the income statement.",
        "label": "Foreign currency transaction gain",
        "negatedLabel": "Foreign currency transaction gain"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionGainLossUnrealized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/StatementsOfCashFlows",
      "http://propanc.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "auth_ref": [
      "r478"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.",
        "label": "Foreign Currency Translation and Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/NatureOfOperationsAndSummaryOfSignificantAccountingAndReportingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture and Fixtures [Member]"
       }
      }
     },
     "localname": "FurnitureAndFixturesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ScheduleOfPropertyAndEquipmentEstimatedUsefulLivesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "auth_ref": [
      "r95",
      "r259",
      "r260"
     ],
     "calculation": {
      "http://propanc.com/role/StatementsOfCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://propanc.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": {
       "order": 6.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.",
        "label": "Gain on extinguishment of debt, net",
        "negatedLabel": "Gain on extinguishment of debt, net",
        "terseLabel": "Loss on extinguishment",
        "verboseLabel": "Loss from settlement of debt"
       }
      }
     },
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ConvertibleNotesDetailsNarrative",
      "http://propanc.com/role/StatementsOfCashFlows",
      "http://propanc.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss",
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r78"
     ],
     "calculation": {
      "http://propanc.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "Administration expenses"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy": {
     "auth_ref": [
      "r193"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for intangible assets. This accounting policy may address both intangible assets subject to amortization and those that are not. The following also may be disclosed: (1) a description of intangible assets (2) the estimated useful lives of those assets (3) the amortization method used (4) how the entity assesses and measures impairment of such assets (5) how future cash flows are estimated (6) how the fair values of such asset are determined.",
        "label": "Patents"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsIntangibleAssetsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/NatureOfOperationsAndSummaryOfSignificantAccountingAndReportingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": {
     "auth_ref": [
      "r194",
      "r199"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.",
        "label": "Impairment of Long-Lived Assets"
       }
      }
     },
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/NatureOfOperationsAndSummaryOfSignificantAccountingAndReportingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": {
     "auth_ref": [
      "r111",
      "r393"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.",
        "label": "Loss before Income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ScheduleOfIncomeTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r73",
      "r166",
      "r168",
      "r171",
      "r174",
      "r176",
      "r543",
      "r552",
      "r557",
      "r575"
     ],
     "calculation": {
      "http://propanc.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "LOSS BEFORE TAXES"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r112",
      "r371",
      "r374",
      "r381",
      "r391",
      "r395",
      "r397",
      "r398",
      "r399"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "INCOME TAXES"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExaminationDescription": {
     "auth_ref": [
      "r372"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A brief description of status of the tax examination, significant findings to date, and the entity's position with respect to the findings.",
        "label": "Income Tax Examination, Description"
       }
      }
     },
     "localname": "IncomeTaxExaminationDescription",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r113",
      "r129",
      "r130",
      "r165",
      "r369",
      "r392",
      "r396",
      "r576"
     ],
     "calculation": {
      "http://propanc.com/role/ScheduleOfIncomeTaxProvisionDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://propanc.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "negatedLabel": "Tax benefit",
        "negatedTerseLabel": "Tax credits",
        "totalLabel": "Income tax (expense) benefit"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/IncomeTaxesDetailsNarrative",
      "http://propanc.com/role/NatureOfOperationsAndSummaryOfSignificantAccountingAndReportingPoliciesDetailsNarrative",
      "http://propanc.com/role/ScheduleOfIncomeTaxProvisionDetails",
      "http://propanc.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r68",
      "r367",
      "r368",
      "r374",
      "r375",
      "r380",
      "r385"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/NatureOfOperationsAndSummaryOfSignificantAccountingAndReportingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r370"
     ],
     "calculation": {
      "http://propanc.com/role/ScheduleOfIncomeTaxProvisionDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.",
        "label": "Increase (decrease) in valuation allowance"
       }
      }
     },
     "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ScheduleOfIncomeTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential": {
     "auth_ref": [
      "r370"
     ],
     "calculation": {
      "http://propanc.com/role/ScheduleOfIncomeTaxProvisionDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).",
        "label": "Foreign tax rate differential"
       }
      }
     },
     "localname": "IncomeTaxReconciliationForeignIncomeTaxRateDifferential",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ScheduleOfIncomeTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r370"
     ],
     "calculation": {
      "http://propanc.com/role/ScheduleOfIncomeTaxProvisionDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Taxes under statutory US tax rates"
       }
      }
     },
     "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ScheduleOfIncomeTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationOtherAdjustments": {
     "auth_ref": [
      "r370"
     ],
     "calculation": {
      "http://propanc.com/role/ScheduleOfIncomeTaxProvisionDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.",
        "label": "Other"
       }
      }
     },
     "localname": "IncomeTaxReconciliationOtherAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ScheduleOfIncomeTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes": {
     "auth_ref": [
      "r370"
     ],
     "calculation": {
      "http://propanc.com/role/ScheduleOfIncomeTaxProvisionDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to revisions of previously reported income tax expense (benefit).",
        "label": "Prior period adjustment"
       }
      }
     },
     "localname": "IncomeTaxReconciliationPriorYearIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ScheduleOfIncomeTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationTaxCredits": {
     "auth_ref": [
      "r370"
     ],
     "calculation": {
      "http://propanc.com/role/ScheduleOfIncomeTaxProvisionDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax credits. Including, but not limited to, research credit, foreign tax credit, investment tax credit, and other tax credits.",
        "label": "Income tax rate change"
       }
      }
     },
     "localname": "IncomeTaxReconciliationTaxCredits",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ScheduleOfIncomeTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "auth_ref": [
      "r99"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.",
        "label": "Income Tax"
       }
      }
     },
     "localname": "IncomeTaxesPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r94"
     ],
     "calculation": {
      "http://propanc.com/role/StatementsOfCashFlows": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "verboseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities": {
     "auth_ref": [
      "r94"
     ],
     "calculation": {
      "http://propanc.com/role/StatementsOfCashFlows": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.",
        "label": "Increase (Decrease) in Employee Related Liabilities",
        "verboseLabel": "Employee benefit liability"
       }
      }
     },
     "localname": "IncreaseDecreaseInEmployeeRelatedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInterestPayableNet": {
     "auth_ref": [
      "r94"
     ],
     "calculation": {
      "http://propanc.com/role/StatementsOfCashFlows": {
       "order": 18.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in interest payable, which represents the amount owed to note holders, bond holders, and other parties for interest earned on loans or credit extended to the reporting entity.",
        "label": "Accrued interest"
       }
      }
     },
     "localname": "IncreaseDecreaseInInterestPayableNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changes in Assets and Liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingAssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r94"
     ],
     "calculation": {
      "http://propanc.com/role/StatementsOfCashFlows": {
       "order": 17.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in other obligations or expenses incurred but not yet paid.",
        "label": "Increase (Decrease) in Other Accounts Payable and Accrued Liabilities",
        "verboseLabel": "Accrued expenses and other payables"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r94"
     ],
     "calculation": {
      "http://propanc.com/role/StatementsOfCashFlows": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedLabel": "Prepaid expenses and other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInReceivables": {
     "auth_ref": [
      "r94"
     ],
     "calculation": {
      "http://propanc.com/role/StatementsOfCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the total amount due within one year (or one operating cycle) from all parties, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Receivables",
        "negatedLabel": "GST receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInReceivables",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r72",
      "r164",
      "r479",
      "r482",
      "r556"
     ],
     "calculation": {
      "http://propanc.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaid": {
     "auth_ref": [
      "r99"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, including, but not limited to, capitalized interest and payment to settle zero-coupon bond attributable to accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount; classified as operating and investing activities.",
        "label": "Repayment of interest"
       }
      }
     },
     "localname": "InterestPaid",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ConvertibleNotesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r88",
      "r91",
      "r99"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPayableCurrent": {
     "auth_ref": [
      "r11",
      "r12",
      "r40"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Interest Payable, Current"
       }
      }
     },
     "localname": "InterestPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPayableCurrentAndNoncurrent": {
     "auth_ref": [
      "r550",
      "r571"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest payable on debt, including, but not limited to, trade payables.",
        "label": "Interest Payable",
        "verboseLabel": "Accrued interest"
       }
      }
     },
     "localname": "InterestPayableCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://propanc.com/role/ConvertibleNotesDetailsNarrative",
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeInterest": {
     "auth_ref": [
      "r80",
      "r163"
     ],
     "calculation": {
      "http://propanc.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.",
        "label": "Interest income"
       }
      }
     },
     "localname": "InvestmentIncomeInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestorMember": {
     "auth_ref": [
      "r503",
      "r504"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business entity or individual that puts money, by purchase or expenditure, in something offering potential profitable returns, such as interest income or appreciation in value.",
        "label": "Investor [Member]"
       }
      }
     },
     "localname": "InvestorMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims": {
     "auth_ref": [
      "r95"
     ],
     "calculation": {
      "http://propanc.com/role/StatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims.",
        "label": "Issuance and amortization of common stock for services"
       }
      }
     },
     "localname": "IssuanceOfStockAndWarrantsForServicesOrClaims",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LegalCostsPolicyTextBlock": {
     "auth_ref": [
      "r207"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for legal costs incurred to protect or defend the entity's assets and rights, or to obtain assets, including monetary damages, or to obtain rights.",
        "label": "Legal Expenses"
       }
      }
     },
     "localname": "LegalCostsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/NatureOfOperationsAndSummaryOfSignificantAccountingAndReportingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LegalFees": {
     "auth_ref": [
      "r77"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings.",
        "label": "Legal fees",
        "verboseLabel": "Legal Fees"
       }
      }
     },
     "localname": "LegalFees",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://propanc.com/role/ConvertibleNotesDetailsNarrative",
      "http://propanc.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "auth_ref": [
      "r493"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.",
        "label": "Leases"
       }
      }
     },
     "localname": "LesseeLeasesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/NatureOfOperationsAndSummaryOfSignificantAccountingAndReportingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseDescription": {
     "auth_ref": [
      "r494"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of lessee's operating lease.",
        "label": "Operating lease, description",
        "verboseLabel": "Lessee, Operating Lease, Description"
       }
      }
     },
     "localname": "LesseeOperatingLeaseDescription",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://propanc.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeOperatingLeaseTermOfContract": {
     "auth_ref": [
      "r495"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Term of Contract"
       }
      }
     },
     "localname": "LesseeOperatingLeaseTermOfContract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LessorOperatingLeaseTermOfContract": {
     "auth_ref": [
      "r498"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessor's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessor, Operating Lease, Term of Contract"
       }
      }
     },
     "localname": "LessorOperatingLeaseTermOfContract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r39",
      "r110",
      "r170",
      "r186",
      "r210",
      "r211",
      "r212",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r221",
      "r222",
      "r404",
      "r410",
      "r411",
      "r455",
      "r510",
      "r511"
     ],
     "calculation": {
      "http://propanc.com/role/BalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "TOTAL LIABILITIES",
        "verboseLabel": "Liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/BalanceSheets",
      "http://propanc.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://propanc.com/role/ConvertibleNotesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r29",
      "r110",
      "r186",
      "r455",
      "r512",
      "r548",
      "r568"
     ],
     "calculation": {
      "http://propanc.com/role/BalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "TOTAL LIABILITIES AND STOCKHOLDERS\u2019 DEFICIT"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "LIABILITIES AND STOCKHOLDERS\u2019 DEFICIT"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/BalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r41",
      "r110",
      "r186",
      "r210",
      "r211",
      "r212",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r221",
      "r222",
      "r404",
      "r410",
      "r411",
      "r455",
      "r510",
      "r511",
      "r512"
     ],
     "calculation": {
      "http://propanc.com/role/BalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "TOTAL CURRENT LIABILITIES"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CURRENT LIABILITIES:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/BalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LicenseAgreementTermsMember": {
     "auth_ref": [
      "r364",
      "r365"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Terms of the license agreements under research and development arrangements accounted for as a contract to perform research and development for others.",
        "label": "License Agreement Terms [Member]"
       }
      }
     },
     "localname": "LicenseAgreementTermsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LoansPayable": {
     "auth_ref": [
      "r18",
      "r547",
      "r561"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Including the current and noncurrent portions, aggregate carrying value as of the balance sheet date of loans payable (with maturities initially due after one year or beyond the operating cycle if longer).",
        "label": "Loans payable"
       }
      }
     },
     "localname": "LoansPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/LoansAndNotesPayableDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r18",
      "r239",
      "r253",
      "r255",
      "r256",
      "r547",
      "r565"
     ],
     "calculation": {
      "http://propanc.com/role/ScheduleOfConvertibleNotesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt",
        "totalLabel": "Convertible notes, net"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ScheduleOfConvertibleNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyDamagesSoughtValue": {
     "auth_ref": [
      "r204",
      "r205",
      "r206"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The value (monetary amount) of the award the plaintiff seeks in the legal matter.",
        "label": "Loss contingency amount"
       }
      }
     },
     "localname": "LossContingencyDamagesSoughtValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MachineryAndEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.",
        "label": "Machinery and Equipment [Member]"
       }
      }
     },
     "localname": "MachineryAndEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ScheduleOfPropertyAndEquipmentEstimatedUsefulLivesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputExpectedDividendRateMember": {
     "auth_ref": [
      "r448"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using expected dividend rate to be paid to holder of share per year.",
        "label": "Measurement Input, Expected Dividend Rate [Member]"
       }
      }
     },
     "localname": "MeasurementInputExpectedDividendRateMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ScheduleOfFairValueMeasurementsRecurringAndNonrecurringValuationTechniquesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputExpectedTermMember": {
     "auth_ref": [
      "r448"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using period financial instrument is expected to be outstanding. Excludes maturity date.",
        "label": "Measurement Input, Expected Term [Member]"
       }
      }
     },
     "localname": "MeasurementInputExpectedTermMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ScheduleOfFairValueMeasurementsRecurringAndNonrecurringValuationTechniquesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputPriceVolatilityMember": {
     "auth_ref": [
      "r448"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using rate at which price of security will increase (decrease) for given set of returns.",
        "label": "Measurement Input, Price Volatility [Member]"
       }
      }
     },
     "localname": "MeasurementInputPriceVolatilityMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ScheduleOfFairValueMeasurementsRecurringAndNonrecurringValuationTechniquesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputRiskFreeInterestRateMember": {
     "auth_ref": [
      "r448"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using interest rate on instrument with zero risk of financial loss.",
        "label": "Measurement Input, Risk Free Interest Rate [Member]"
       }
      }
     },
     "localname": "MeasurementInputRiskFreeInterestRateMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ScheduleOfFairValueMeasurementsRecurringAndNonrecurringValuationTechniquesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputTypeAxis": {
     "auth_ref": [
      "r448"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Axis]"
       }
      }
     },
     "localname": "MeasurementInputTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ScheduleOfFairValueMeasurementsRecurringAndNonrecurringValuationTechniquesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MeasurementInputTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input used to determine value of asset and liability."
       }
      }
     },
     "localname": "MeasurementInputTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ScheduleOfFairValueMeasurementsRecurringAndNonrecurringValuationTechniquesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r90"
     ],
     "calculation": {
      "http://propanc.com/role/StatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "NET CASH PROVIDED BY FINANCING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CASH FLOWS FROM FINANCING ACTIVITIES:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r90",
      "r93",
      "r96"
     ],
     "calculation": {
      "http://propanc.com/role/StatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "negatedLabel": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "NET CASH USED IN OPERATING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/GoingConcernDetailsNarrative",
      "http://propanc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CASH FLOWS FROM OPERATING ACTIVITIES:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r5",
      "r62",
      "r65",
      "r71",
      "r74",
      "r96",
      "r110",
      "r120",
      "r124",
      "r125",
      "r126",
      "r127",
      "r129",
      "r130",
      "r138",
      "r166",
      "r168",
      "r171",
      "r174",
      "r176",
      "r186",
      "r210",
      "r211",
      "r212",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r221",
      "r222",
      "r444",
      "r455",
      "r553",
      "r573"
     ],
     "calculation": {
      "http://propanc.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "totalLabel": "NET LOSS AVAILABLE TO COMMON STOCKHOLDERS"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "auth_ref": [
      "r124",
      "r125",
      "r126",
      "r127",
      "r133",
      "r134",
      "r139",
      "r142",
      "r166",
      "r168",
      "r171",
      "r174",
      "r176"
     ],
     "calculation": {
      "http://propanc.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.",
        "label": "NET LOSS AVAILABLE TO COMMON STOCKHOLDERS"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "Recent Accounting Pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/NatureOfOperationsAndSummaryOfSignificantAccountingAndReportingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r81"
     ],
     "calculation": {
      "http://propanc.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "totalLabel": "TOTAL OTHER EXPENSE, NET"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "OTHER INCOME (EXPENSE)"
       }
      }
     },
     "localname": "NonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OccupancyNet": {
     "auth_ref": [
      "r79",
      "r489",
      "r555"
     ],
     "calculation": {
      "http://propanc.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of net occupancy expense that may include items, such as depreciation of facilities and equipment, lease expenses, property taxes and property and casualty insurance expense.",
        "label": "Occupancy expenses"
       }
      }
     },
     "localname": "OccupancyNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OfficersCompensation": {
     "auth_ref": [
      "r76"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for salary and wage arising from service rendered by officer. Excludes allocated cost, labor-related nonsalary expense, and direct and overhead labor cost included in cost of good and service sold.",
        "label": "Officer compensation",
        "terseLabel": "Salary and Wage, Officer, Excluding Cost of Good and Service Sold",
        "verboseLabel": "Officers' compensation"
       }
      }
     },
     "localname": "OfficersCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative",
      "http://propanc.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://propanc.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "TOTAL OPERATING EXPENSES"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "OPERATING EXPENSES"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r166",
      "r168",
      "r171",
      "r174",
      "r176"
     ],
     "calculation": {
      "http://propanc.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "LOSS FROM OPERATIONS"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLeaseIncomeTableTextBlock": {
     "auth_ref": [
      "r145",
      "r499"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of components of income from operating lease.",
        "label": "SCHEDULE OF OPERATING LEASE LIABILITY"
       }
      }
     },
     "localname": "OperatingLeaseLeaseIncomeTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/CommitmentsAndContingenciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r492"
     ],
     "calculation": {
      "http://propanc.com/role/ScheduleOfOperatingLeaseLiabilityDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "totalLabel": "Long term portion of lease liability"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://propanc.com/role/ScheduleOfOperatingLeaseLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r492"
     ],
     "calculation": {
      "http://propanc.com/role/BalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating lease liability - related party"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r491"
     ],
     "calculation": {
      "http://propanc.com/role/BalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://propanc.com/role/ScheduleOfRightUseOfAssetDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating lease right-of-use assets, net - related party",
        "totalLabel": "Right-of-use asset, net",
        "verboseLabel": "Operating Lease, Right-of-Use Asset"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/BalanceSheets",
      "http://propanc.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://propanc.com/role/ScheduleOfRightUseOfAssetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r496",
      "r497"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDue": {
     "auth_ref": [
      "r486",
      "r488"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of required minimum rental payments for leases having an initial or remaining non-cancelable letter-terms in excess of one year.",
        "label": "Operating Leases, Future Minimum Payments Due"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesRentExpenseMinimumRentals": {
     "auth_ref": [
      "r485",
      "r486",
      "r487"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the payments that the lessee is obligated to make or can be required to make in connection with a property under the terms of an agreement classified as an operating lease, excluding contingent rentals and a guarantee by the lessee of the lessor's debt and the lessee's obligation to pay (apart from the rental payments) executory costs such as insurance, maintenance, and taxes.",
        "label": "Operating Leases, Rent Expense, Minimum Rentals"
       }
      }
     },
     "localname": "OperatingLeasesRentExpenseMinimumRentals",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLossCarryforwards": {
     "auth_ref": [
      "r382"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Operating loss carryforwards"
       }
      }
     },
     "localname": "OperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r116",
      "r132",
      "r160",
      "r414"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles.",
        "label": "NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING AND REPORTING POLICIES"
       }
      }
     },
     "localname": "OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/NatureOfOperationsAndSummaryOfSignificantAccountingAndReportingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent": {
     "auth_ref": [
      "r401",
      "r402",
      "r408"
     ],
     "calculation": {
      "http://propanc.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax, after reclassification adjustments of gain (loss) on foreign currency translation adjustments, on foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.",
        "label": "Unrealized foreign currency translation gain (loss)",
        "verboseLabel": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax, Portion Attributable to Parent"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/NatureOfOperationsAndSummaryOfSignificantAccountingAndReportingPoliciesDetailsNarrative",
      "http://propanc.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax": {
     "auth_ref": [
      "r57",
      "r59"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax, after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax",
        "verboseLabel": "Foreign currency translation gain"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ScheduleOfChangeInAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r63",
      "r66",
      "r401",
      "r402",
      "r408"
     ],
     "calculation": {
      "http://propanc.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent",
        "totalLabel": "TOTAL OTHER COMPREHENSIVE INCOME (LOSS)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "OTHER COMPREHENSIVE INCOME (LOSS)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherIncome": {
     "auth_ref": [
      "r577"
     ],
     "calculation": {
      "http://propanc.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": {
       "order": 3.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue and income classified as other.",
        "label": "Other income"
       }
      }
     },
     "localname": "OtherIncome",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncashExpense": {
     "auth_ref": [
      "r96"
     ],
     "calculation": {
      "http://propanc.com/role/StatementsOfCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense or loss included in net income that result in no cash flow, classified as other.",
        "label": "Non-cash interest expense"
       }
      }
     },
     "localname": "OtherNoncashExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRent": {
     "auth_ref": [
      "r92"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash payments to lessor's for use of assets under operating leases.",
        "label": "Payments for Rent"
       }
      }
     },
     "localname": "PaymentsForRent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://propanc.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfInitialPublicOffering": {
     "auth_ref": [
      "r85"
     ],
     "calculation": {
      "http://propanc.com/role/StatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the repurchase of amount received from entity's first offering of stock to the public.",
        "label": "Payments for Repurchase of Initial Public Offering",
        "negatedLabel": "Fees associated with offering costs"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfInitialPublicOffering",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfStockIssuanceCosts": {
     "auth_ref": [
      "r87"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security.",
        "label": "Offering cost"
       }
      }
     },
     "localname": "PaymentsOfStockIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r332",
      "r351"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement."
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company.",
        "label": "Preferred Stock [Member]"
       }
      }
     },
     "localname": "PreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/StatementsOfChangesInStockholdersDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r22",
      "r266"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred stock, par value"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/BalanceSheetsParenthetical",
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r22"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred stock, shares authorized"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/BalanceSheetsParenthetical",
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r22",
      "r266"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred stock, shares issued"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/BalanceSheetsParenthetical",
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r22"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred stock, shares outstanding"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/BalanceSheetsParenthetical",
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r22",
      "r512"
     ],
     "calculation": {
      "http://propanc.com/role/BalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred stock"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r8",
      "r30",
      "r31"
     ],
     "calculation": {
      "http://propanc.com/role/BalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromConvertibleDebt": {
     "auth_ref": [
      "r84"
     ],
     "calculation": {
      "http://propanc.com/role/StatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.",
        "label": "Proceeds from convertible promissory notes, net of original issue discounts and issue costs",
        "terseLabel": "Proceeds from Convertible Debt",
        "verboseLabel": "Proceeds from convertible debt"
       }
      }
     },
     "localname": "ProceedsFromConvertibleDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ConcentrationsAndRisksDetailsNarrative",
      "http://propanc.com/role/ConvertibleNotesDetailsNarrative",
      "http://propanc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "auth_ref": [
      "r83"
     ],
     "calculation": {
      "http://propanc.com/role/StatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the additional capital contribution to the entity.",
        "label": "Proceeds from the sale of common stock",
        "verboseLabel": "Proceeds from issuance of common stock"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/StatementsOfCashFlows",
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfWarrants": {
     "auth_ref": [
      "r83"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).",
        "label": "Proceed from issuance of excercise of warrants"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfWarrants",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromWarrantExercises": {
     "auth_ref": [
      "r83"
     ],
     "calculation": {
      "http://propanc.com/role/StatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from holders exercising their stock warrants.",
        "label": "Proceeds from the exercise of warrants",
        "terseLabel": "Proceeds from Warrant Exercises",
        "verboseLabel": "Proceeds from warrants exercise"
       }
      }
     },
     "localname": "ProceedsFromWarrantExercises",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/StatementsOfCashFlows",
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative",
      "http://propanc.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfessionalFees": {
     "auth_ref": [
      "r598",
      "r599"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.",
        "label": "Consulting expenses",
        "verboseLabel": "Professional Fees"
       }
      }
     },
     "localname": "ProfessionalFees",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r5",
      "r62",
      "r65",
      "r71",
      "r89",
      "r110",
      "r120",
      "r129",
      "r130",
      "r166",
      "r168",
      "r171",
      "r174",
      "r176",
      "r186",
      "r210",
      "r211",
      "r212",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r221",
      "r222",
      "r401",
      "r406",
      "r407",
      "r412",
      "r413",
      "r444",
      "r455",
      "r557"
     ],
     "calculation": {
      "http://propanc.com/role/StatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://propanc.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net loss",
        "negatedLabel": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "NET LOSS"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/GoingConcernDetailsNarrative",
      "http://propanc.com/role/StatementsOfCashFlows",
      "http://propanc.com/role/StatementsOfChangesInStockholdersDeficit",
      "http://propanc.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r35",
      "r198"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ScheduleOfPropertyAndEquipmentEstimatedUsefulLivesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "auth_ref": [
      "r200",
      "r603",
      "r604",
      "r605"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "PROPERTY AND EQUIPMENT"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/PropertyAndEquipment"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r34",
      "r196"
     ],
     "calculation": {
      "http://propanc.com/role/ScheduleOfPropertyAndEquipmentDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Office equipment at cost"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ScheduleOfPropertyAndEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ScheduleOfPropertyAndEquipmentEstimatedUsefulLivesDetails",
      "http://propanc.com/role/ScheduleOfTranslationExchangeRatesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r14",
      "r15",
      "r198",
      "r512",
      "r558",
      "r569"
     ],
     "calculation": {
      "http://propanc.com/role/BalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://propanc.com/role/ScheduleOfPropertyAndEquipmentDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property and equipment, net",
        "totalLabel": "Total property, plant, and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/BalanceSheets",
      "http://propanc.com/role/ScheduleOfPropertyAndEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r33",
      "r198",
      "r603",
      "r604"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/NatureOfOperationsAndSummaryOfSignificantAccountingAndReportingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r14",
      "r198"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "SCHEDULE OF PROPERTY AND EQUIPMENT"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/PropertyAndEquipmentTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r14",
      "r196"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software."
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ScheduleOfPropertyAndEquipmentEstimatedUsefulLivesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property and equipment estimated useful lives"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ScheduleOfPropertyAndEquipmentEstimatedUsefulLivesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_RelatedPartyDomain": {
     "auth_ref": [
      "r321",
      "r503",
      "r504"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests."
       }
      }
     },
     "localname": "RelatedPartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ConcentrationsAndRisksDetailsNarrative",
      "http://propanc.com/role/ConvertibleNotesDetailsNarrative",
      "http://propanc.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative",
      "http://propanc.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of maturity or expiration of arrangements with a related party (for example, but not limited to, leasing and debt arrangements between related parties), in YYYY-MM-DD format.",
        "label": "Expired date"
       }
      }
     },
     "localname": "RelatedPartyTransactionDate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_RelatedPartyTransactionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Related Party Transaction [Line Items]"
       }
      }
     },
     "localname": "RelatedPartyTransactionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "auth_ref": [
      "r321",
      "r503",
      "r507",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ConcentrationsAndRisksDetailsNarrative",
      "http://propanc.com/role/ConvertibleNotesDetailsNarrative",
      "http://propanc.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative",
      "http://propanc.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "auth_ref": [
      "r501",
      "r502",
      "r504",
      "r508",
      "r509"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "RELATED PARTY TRANSACTIONS"
       }
      }
     },
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/RelatedPartyTransactions"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RepaymentsOfConvertibleDebt": {
     "auth_ref": [
      "r86"
     ],
     "calculation": {
      "http://propanc.com/role/StatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow from the repayment of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.",
        "label": "Repayments of Convertible Debt",
        "negatedLabel": "Repayments of convertible promissory notes"
       }
      }
     },
     "localname": "RepaymentsOfConvertibleDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfDebt": {
     "auth_ref": [
      "r86"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.",
        "label": "Repayment in cash"
       }
      }
     },
     "localname": "RepaymentsOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ConvertibleNotesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfRelatedPartyDebt": {
     "auth_ref": [
      "r86"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates.",
        "label": "Payments form related party"
       }
      }
     },
     "localname": "RepaymentsOfRelatedPartyDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r363",
      "r526",
      "r617"
     ],
     "calculation": {
      "http://propanc.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and development",
        "verboseLabel": "Research and development costs"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/NatureOfOperationsAndSummaryOfSignificantAccountingAndReportingPoliciesDetailsNarrative",
      "http://propanc.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "auth_ref": [
      "r363"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.",
        "label": "Research and Development Costs and Tax Credits"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/NatureOfOperationsAndSummaryOfSignificantAccountingAndReportingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestrictedStockMember": {
     "auth_ref": [
      "r143"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.",
        "label": "Restricted Stock [Member]"
       }
      }
     },
     "localname": "RestrictedStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r25",
      "r289",
      "r359",
      "r512",
      "r567",
      "r590",
      "r595"
     ],
     "calculation": {
      "http://propanc.com/role/BalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Accumulated deficit",
        "negatedLabel": "Retained Earnings (Accumulated Deficit)"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/BalanceSheets",
      "http://propanc.com/role/GoingConcernDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r2",
      "r117",
      "r118",
      "r119",
      "r121",
      "r128",
      "r130",
      "r190",
      "r356",
      "r357",
      "r358",
      "r389",
      "r390",
      "r442",
      "r586",
      "r588"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/StatementsOfChangesInStockholdersDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r161",
      "r162",
      "r167",
      "r172",
      "r173",
      "r177",
      "r178",
      "r180",
      "r303",
      "r304",
      "r527"
     ],
     "calculation": {
      "http://propanc.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue",
        "verboseLabel": "Revenue from Contract with Customer, Excluding Assessed Tax"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/GoingConcernDetailsNarrative",
      "http://propanc.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "auth_ref": [
      "r105",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r308"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue from contract with customer.",
        "label": "Revenue Recognition"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/NatureOfOperationsAndSummaryOfSignificantAccountingAndReportingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueFromRightsConcentrationRiskMember": {
     "auth_ref": [
      "r154"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that license fee or royalty revenues during the period from other parties from use of a specified patent, trademark, or other form of right granted to such parties are to a specified benchmark, such as total license fees, total revenues, segment revenues or product line revenues. May also reflect the percentage contribution the revenue made to operating results. Risk is materially adverse effects of a loss of such revenues, which could occur upon loss of rights to sell, distribute or license others; loss of patent or copyright protection; or technological obsolescence.",
        "label": "Revenue from Rights Concentration Risk [Member]"
       }
      }
     },
     "localname": "RevenueFromRightsConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenuesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "REVENUE"
       }
      }
     },
     "localname": "RevenuesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RisksAndUncertaintiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risks and Uncertainties [Abstract]"
       }
      }
     },
     "localname": "RisksAndUncertaintiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RoyaltyAgreementTermsMember": {
     "auth_ref": [
      "r364",
      "r365"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Terms of the royalty agreement under research and development arrangements.",
        "label": "Royalty Agreement Terms [Member]"
       }
      }
     },
     "localname": "RoyaltyAgreementTermsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SalariesAndWages": {
     "auth_ref": [
      "r76"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for salary and wage arising from service rendered by nonofficer employee. Excludes allocated cost, labor-related nonsalary expense, and direct and overhead labor cost included in cost of good and service sold.",
        "label": "Annual salary"
       }
      }
     },
     "localname": "SalariesAndWages",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SalesRevenueNetMember": {
     "auth_ref": [
      "r155",
      "r180"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.",
        "label": "Revenue Benchmark [Member]"
       }
      }
     },
     "localname": "SalesRevenueNetMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r61",
      "r474",
      "r475"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "SCHEDULE OF CHANGE IN ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/NatureOfOperationsAndSummaryOfSignificantAccountingAndReportingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r143"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ScheduleOfDilutiveSecuritiesExcludedFromComputationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "auth_ref": [
      "r143"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.",
        "label": "SCHEDULE OF DILUTIVE SECURITIES EXCLUDED FROM COMPUTATION"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/NatureOfOperationsAndSummaryOfSignificantAccountingAndReportingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": {
     "auth_ref": [
      "r400"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]"
       }
      }
     },
     "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "auth_ref": [
      "r385"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.",
        "label": "SCHEDULE OF INCOME TAX PROVISION"
       }
      }
     },
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable": {
     "auth_ref": [
      "r309",
      "r311"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule, table or text reflecting arrangements that are not equity-based payments, or pension and other postretirement benefits, with individual employees. The arrangements (for example, profit sharing, deferred bonuses or certain split-dollar life insurance arrangements) are generally based on employment contracts between the entity and one or more selected officers or key employees, and which contain a promise by the employer to pay certain amounts at designated future dates, sometimes including a period after retirement, upon compliance with stipulated requirements. This type of arrangement is distinguished from broader based employee benefit plans as it is usually tailored to the employee. Disclosure also typically includes the amount of related compensation expense recognized during the reporting period and the carrying amount as of the balance sheet date of the related liability.",
        "label": "Schedule of Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits, by Title of Individual and by Type of Deferred Compensation [Table]"
       }
      }
     },
     "localname": "ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/LoansAndNotesPayableDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r379"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": {
     "auth_ref": [
      "r322",
      "r323",
      "r324",
      "r325",
      "r326"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans.  Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Defined Benefit Plans Disclosures [Table]"
       }
      }
     },
     "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ConcentrationsAndRisksDetailsNarrative",
      "http://propanc.com/role/ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of derivative liabilities at fair value.",
        "label": "SCHEDULE OF DERIVATIVE LIABILITIES AT FAIR VALUE"
       }
      }
     },
     "localname": "ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/DerivativeFinancialInstrumentsAndFairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "auth_ref": [
      "r446",
      "r447"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "SCHEDULE OF FAIR VALUE, ASSETS AND LIABILITIES MEASURED ON RECURRING BASIS"
       }
      }
     },
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/DerivativeFinancialInstrumentsAndFairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r35",
      "r198"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ScheduleOfPropertyAndEquipmentEstimatedUsefulLivesDetails",
      "http://propanc.com/role/ScheduleOfTranslationExchangeRatesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": {
     "auth_ref": [
      "r505",
      "r507"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Schedule of Related Party Transactions, by Related Party [Table]"
       }
      }
     },
     "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r337",
      "r347",
      "r348"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "SCHEDULE OF STOCK OPTION ACTIVITY"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/StockholdersDeficitTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShortTermDebtTable": {
     "auth_ref": [
      "r38"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to borrowings under which repayment was required in less than twelve months (or normal operating cycle, if longer) after its issuance. It may include: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date and measures of the maximum and average amount outstanding during the period; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation.",
        "label": "Schedule of Short-term Debt [Table]"
       }
      }
     },
     "localname": "ScheduleOfShortTermDebtTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ConvertibleNotesDetailsNarrative",
      "http://propanc.com/role/NatureOfOperationsAndSummaryOfSignificantAccountingAndReportingPoliciesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "auth_ref": [
      "r47",
      "r107",
      "r147",
      "r148",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r271",
      "r275",
      "r280",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.",
        "label": "Schedule of Stock by Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfStockByClassTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock": {
     "auth_ref": [
      "r293",
      "r330"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.",
        "label": "SCHEDULE OF WARRANT ACTIVITY"
       }
      }
     },
     "localname": "ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/StockholdersDeficitTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SeriesAPreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Outstanding nonredeemable series A preferred stock or outstanding series A preferred stock. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Series A Preferred Stock [Member]"
       }
      }
     },
     "localname": "SeriesAPreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/BalanceSheets",
      "http://propanc.com/role/BalanceSheetsParenthetical",
      "http://propanc.com/role/StatementsOfChangesInStockholdersDeficit",
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeriesBPreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Outstanding nonredeemable series B preferred stock or outstanding series B preferred stock. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Series B Preferred Stock [Member]"
       }
      }
     },
     "localname": "SeriesBPreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/BalanceSheets",
      "http://propanc.com/role/BalanceSheetsParenthetical",
      "http://propanc.com/role/StatementsOfChangesInStockholdersDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r94"
     ],
     "calculation": {
      "http://propanc.com/role/StatementsOfCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Stock option and restricted stock expense",
        "verboseLabel": "Share based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/StatementsOfCashFlows",
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r333"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Vesting period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r346"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Rsus vest, shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised": {
     "auth_ref": [
      "r343"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of non-option equity instruments exercised by participants.",
        "label": "Warrants exercisable",
        "negatedLabel": "Number of Shares, Exercised"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ScheduleOfWarrantActivityDetails",
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations": {
     "auth_ref": [
      "r345"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares under non-option equity instrument agreements for which rights to exercise lapsed.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Expirations",
        "verboseLabel": "Number of Shares, Expired"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ScheduleOfWarrantActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures": {
     "auth_ref": [
      "r344"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares under non-option equity instrument agreements that were cancelled as a result of occurrence of a terminating event.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures",
        "verboseLabel": "Number of Shares, Forfeited"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ScheduleOfWarrantActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber": {
     "auth_ref": [
      "r338",
      "r340"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of equity instruments other than options outstanding, including both vested and non-vested instruments.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number",
        "periodEndLabel": "Number of Shares, Outstanding, Ending balance",
        "periodStartLabel": "Number of Shares, Outstanding, Beginning balance"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ScheduleOfWarrantActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r341"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Number of Shares, Exercisable, Ending balance",
        "periodEndLabel": "Number of Shares, Exercisable, Ending balance"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ScheduleOfStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r341"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Weighted Average Price Per Share, Exercisable, Ending balance",
        "periodEndLabel": "Weighted Average Price Per Share, Exercisable, Ending balance"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ScheduleOfStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod": {
     "auth_ref": [
      "r345"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.",
        "label": "Number of Shares, Expired",
        "negatedLabel": "Number of Shares, Expired"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ScheduleOfStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "auth_ref": [
      "r344"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.",
        "label": "Number of Shares, Forfeited"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ScheduleOfStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": {
     "auth_ref": [
      "r342"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net number of share options (or share units) granted during the period.",
        "label": "Options granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r351"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Aggregate intrinsic value",
        "periodEndLabel": "Aggregate intrinsic value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ScheduleOfStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r339",
      "r351"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Number of Shares, Outstanding, Ending balance",
        "periodStartLabel": "Number of Shares, Outstanding, Beginning balance"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ScheduleOfStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r338"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Weighted Average Price Per Share, Outstanding, Ending balance",
        "periodStartLabel": "Weighted Average Price Per Share, Outstanding, Beginning balance"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ScheduleOfStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": {
     "auth_ref": [
      "r349"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod": {
     "auth_ref": [
      "r351"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued under share-based payment arrangement.",
        "label": "Number of Shares, Issued"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ScheduleOfStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward": {
     "auth_ref": [
      "r330",
      "r351"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares purchased for issuance under share-based payment arrangement.",
        "label": "Option purchase shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r330",
      "r335"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://propanc.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Weighted Average Price Per Share, Exercised",
        "verboseLabel": "Exercise price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://propanc.com/role/ScheduleOfStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.",
        "label": "Weighted Average Price Per Share, Expired"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ScheduleOfStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.",
        "label": "Weighted Average Price Per Share, Forfeited"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ScheduleOfStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Granted exercise price",
        "verboseLabel": "Weighted Average Price Per Share, Issued"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://propanc.com/role/ScheduleOfStockOptionActivityDetails",
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "auth_ref": [
      "r332",
      "r336"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.",
        "label": "Stock Based Compensation"
       }
      }
     },
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/NatureOfOperationsAndSummaryOfSignificantAccountingAndReportingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SharePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Price of a single share of a number of saleable stocks of a company.",
        "label": "Share Price",
        "verboseLabel": "Share price"
       }
      }
     },
     "localname": "SharePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/DerivativeFinancialInstrumentsAndFairValueMeasurementsDetailsNarrative",
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative",
      "http://propanc.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "auth_ref": [
      "r334"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Option term"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of non-vested options outstanding.",
        "label": "Number of shares not yet vested"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r349"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Weighted average remaining contractual term"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ScheduleOfStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchase price of common stock expressed as a percentage of its fair value.",
        "label": "Market price"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_SharesIssuedPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or per unit amount of equity securities issued.",
        "label": "Shares issued, price per share"
       }
      }
     },
     "localname": "SharesIssuedPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares, Outstanding",
        "periodEndLabel": "Ending balance, shares",
        "periodStartLabel": "Beginning balance, shares"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/StatementsOfChangesInStockholdersDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShortTermDebtLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Short-term Debt [Line Items]"
       }
      }
     },
     "localname": "ShortTermDebtLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ConvertibleNotesDetailsNarrative",
      "http://propanc.com/role/NatureOfOperationsAndSummaryOfSignificantAccountingAndReportingPoliciesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShortTermDebtTypeAxis": {
     "auth_ref": [
      "r38"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of short-term debt arrangement.",
        "label": "Short-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "ShortTermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ConvertibleNotesDetailsNarrative",
      "http://propanc.com/role/ScheduleOfFairValueMeasurementsRecurringAndNonrecurringValuationTechniquesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShortTermDebtTypeDomain": {
     "auth_ref": [
      "r37"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing."
       }
      }
     },
     "localname": "ShortTermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ConvertibleNotesDetailsNarrative",
      "http://propanc.com/role/ScheduleOfFairValueMeasurementsRecurringAndNonrecurringValuationTechniquesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r21",
      "r22",
      "r23",
      "r107",
      "r110",
      "r135",
      "r136",
      "r137",
      "r140",
      "r142",
      "r147",
      "r148",
      "r149",
      "r186",
      "r210",
      "r215",
      "r216",
      "r217",
      "r221",
      "r222",
      "r266",
      "r267",
      "r271",
      "r275",
      "r282",
      "r455",
      "r634"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/BalanceSheets",
      "http://propanc.com/role/BalanceSheetsParenthetical",
      "http://propanc.com/role/StatementsOfChangesInStockholdersDeficit",
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative",
      "http://propanc.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r2",
      "r51",
      "r69",
      "r70",
      "r71",
      "r117",
      "r118",
      "r119",
      "r121",
      "r128",
      "r130",
      "r146",
      "r190",
      "r282",
      "r289",
      "r356",
      "r357",
      "r358",
      "r389",
      "r390",
      "r442",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r475",
      "r586",
      "r587",
      "r588",
      "r643"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ConvertibleNotesDetailsNarrative",
      "http://propanc.com/role/StatementsOfChangesInStockholdersDeficit",
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative",
      "http://propanc.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/BalanceSheets",
      "http://propanc.com/role/BalanceSheetsParenthetical",
      "http://propanc.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://propanc.com/role/ScheduleOfIncomeTaxProvisionDetails",
      "http://propanc.com/role/StatementsOfChangesInStockholdersDeficit"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r117",
      "r118",
      "r119",
      "r146",
      "r527"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/BalanceSheets",
      "http://propanc.com/role/BalanceSheetsParenthetical",
      "http://propanc.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://propanc.com/role/ScheduleOfIncomeTaxProvisionDetails",
      "http://propanc.com/role/StatementsOfChangesInStockholdersDeficit"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssued1": {
     "auth_ref": [
      "r100",
      "r101",
      "r102"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value of stock issued in noncash financing activities.",
        "label": "Common stock issued for accrued services"
       }
      }
     },
     "localname": "StockIssued1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": {
     "auth_ref": [
      "r50",
      "r243",
      "r282",
      "r283",
      "r289"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities.",
        "label": "Issuance of common stock for conversion of convertible debt, conversion fee, and accrued interest, shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/StatementsOfChangesInStockholdersDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period to an employee benefit plan, such as a defined contribution or defined benefit plan.",
        "label": "Stock issued during the period for services, shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesEmployeeBenefitPlan",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.",
        "label": "Issuance of common stock for services and accrued expenses, shares",
        "verboseLabel": "Number of shares issued for services"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesIssuedForServices",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://propanc.com/role/StatementsOfChangesInStockholdersDeficit",
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r22",
      "r23",
      "r282",
      "r289"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Issuance of common stock for cash, shares",
        "verboseLabel": "Stock Issued During Period, Shares, New Issues"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/StatementsOfChangesInStockholdersDeficit",
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative",
      "http://propanc.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesOther": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued attributable to transactions classified as other.",
        "label": "Stock Issued During Period, Shares, Other"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross": {
     "auth_ref": [
      "r282",
      "r289"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.",
        "label": "Number of restricted stock, shares",
        "verboseLabel": "Restricted stock shares of common stock"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures": {
     "auth_ref": [
      "r22",
      "r23",
      "r282",
      "r289"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.",
        "label": "Vested restricted stock units, shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/StatementsOfChangesInStockholdersDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits": {
     "auth_ref": [
      "r282"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reduction in the number of shares during the period as a result of a reverse stock split.",
        "label": "Fractional difference due to the reverse stock-split, shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesReverseStockSplits",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/StatementsOfChangesInStockholdersDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r22",
      "r23",
      "r282",
      "r289",
      "r343"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Number of Shares, Exercised",
        "verboseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ScheduleOfStockOptionActivityDetails",
      "http://propanc.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": {
     "auth_ref": [
      "r51",
      "r282",
      "r289"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities.",
        "label": "Issuance of common stock for conversion of convertible debt, conversion fee, and accrued interest"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/StatementsOfChangesInStockholdersDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of shares issued during the period to an employee benefit plan, such as a defined contribution or defined benefit plan.",
        "label": "Stock Issued During Period, Value, Employee Benefit Plan"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueEmployeeBenefitPlan",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueIssuedForServices": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.",
        "label": "Issuance of common stock for services and accrued expenses",
        "verboseLabel": "Number of shares issued for services, value"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueIssuedForServices",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/StatementsOfChangesInStockholdersDeficit",
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [
      "r22",
      "r23",
      "r282",
      "r289"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.",
        "label": "Issuance of common stock for cash",
        "verboseLabel": "Stock Issued During Period, Value, New Issues"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/StatementsOfChangesInStockholdersDeficit",
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative",
      "http://propanc.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures": {
     "auth_ref": [
      "r282",
      "r289"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited.",
        "label": "Vested restricted stock units"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/StatementsOfChangesInStockholdersDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockOptionPlanExpense": {
     "auth_ref": [
      "r95"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for option under share-based payment arrangement.",
        "label": "Stock option expense"
       }
      }
     },
     "localname": "StockOptionPlanExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r23",
      "r27",
      "r28",
      "r110",
      "r182",
      "r186",
      "r455",
      "r512"
     ],
     "calculation": {
      "http://propanc.com/role/BalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "negatedLabel": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Ending balance, value",
        "periodStartLabel": "Beginning balance, value",
        "totalLabel": "TOTAL STOCKHOLDERS\u2019 DEFICIT"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/BalanceSheets",
      "http://propanc.com/role/GoingConcernDetailsNarrative",
      "http://propanc.com/role/StatementsOfChangesInStockholdersDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "STOCKHOLDERS\u2019 DEFICIT:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/BalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r108",
      "r267",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r281",
      "r289",
      "r294"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "STOCKHOLDERS\u2019 DEFICIT"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/StockholdersDeficit"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StockholdersEquityNoteSubscriptionsReceivable": {
     "auth_ref": [
      "r22",
      "r23",
      "r27",
      "r264"
     ],
     "calculation": {
      "http://propanc.com/role/BalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Note received instead of cash as contribution to equity. The transaction may be a sale of capital stock or a contribution to paid-in capital.",
        "label": "Stockholders' Equity Note, Subscriptions Receivable",
        "negatedLabel": "Subscription receivable"
       }
      }
     },
     "localname": "StockholdersEquityNoteSubscriptionsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/BalanceSheets",
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityReverseStockSplit": {
     "auth_ref": [
      "r290"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements.",
        "label": "Reverse stock",
        "verboseLabel": "Reverse stock split"
       }
      }
     },
     "localname": "StockholdersEquityReverseStockSplit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/NatureOfOperationsAndSummaryOfSignificantAccountingAndReportingPoliciesDetailsNarrative",
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.",
        "label": "Subsequent Event [Line Items]"
       }
      }
     },
     "localname": "SubsequentEventLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r476",
      "r514"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://propanc.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTable": {
     "auth_ref": [
      "r476",
      "r514"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.",
        "label": "Subsequent Event [Table]"
       }
      }
     },
     "localname": "SubsequentEventTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r476",
      "r514"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://propanc.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r476",
      "r514"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://propanc.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r513",
      "r515"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "SUBSEQUENT EVENTS"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/SubsequentEvents"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubstantialDoubtAboutGoingConcernTextBlock": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure when substantial doubt is raised about the ability to continue as a going concern. Includes, but is not limited to, principal conditions or events that raised substantial doubt about the ability to continue as a going concern, management's evaluation of the significance of those conditions or events in relation to the ability to meet its obligations, and management's plans that alleviated or are intended to mitigate the conditions or events that raise substantial doubt about the ability to continue as a going concern.",
        "label": "GOING CONCERN"
       }
      }
     },
     "localname": "SubstantialDoubtAboutGoingConcernTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/GoingConcern"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Disclosure of Cash Flow Information"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TreasuryStockMember": {
     "auth_ref": [
      "r49",
      "r291"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Treasury Stock [Member]"
       }
      }
     },
     "localname": "TreasuryStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/StatementsOfChangesInStockholdersDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockShares": {
     "auth_ref": [
      "r49",
      "r291"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.",
        "label": "Treasury stock, shares"
       }
      }
     },
     "localname": "TreasuryStockShares",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/BalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockValue": {
     "auth_ref": [
      "r49",
      "r291",
      "r292"
     ],
     "calculation": {
      "http://propanc.com/role/BalanceSheets": {
       "order": 8.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.",
        "label": "Treasury Stock, Value",
        "negatedLabel": "Treasury stock (1 share)"
       }
      }
     },
     "localname": "TreasuryStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TypeOfAdoptionMember": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r120",
      "r121",
      "r122",
      "r123",
      "r131",
      "r183",
      "r184",
      "r187",
      "r188",
      "r189",
      "r190",
      "r191",
      "r192",
      "r209",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r387",
      "r388",
      "r389",
      "r390",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r500",
      "r528",
      "r529",
      "r530",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r639",
      "r640",
      "r641",
      "r642",
      "r643"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amendment to accounting standards."
       }
      }
     },
     "localname": "TypeOfAdoptionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://propanc.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TypeOfArrangementAxis": {
     "auth_ref": [
      "r400"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]"
       }
      }
     },
     "localname": "TypeOfArrangementAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://propanc.com/role/ConvertibleNotesDetailsNarrative",
      "http://propanc.com/role/IncomeTaxesDetailsNarrative",
      "http://propanc.com/role/NatureOfOperationsAndSummaryOfSignificantAccountingAndReportingPoliciesDetailsNarrative",
      "http://propanc.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative",
      "http://propanc.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r366",
      "r373"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized tax benefits"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease": {
     "auth_ref": [
      "r373"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in unrecognized tax benefits attributable to uncertain tax positions taken in tax returns.",
        "label": "Changes in unrecognized tax benefits"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsPeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r150",
      "r151",
      "r152",
      "r153",
      "r157",
      "r158",
      "r159"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/NatureOfOperationsAndSummaryOfSignificantAccountingAndReportingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ValueAddedTaxReceivableCurrent": {
     "auth_ref": [
      "r52"
     ],
     "calculation": {
      "http://propanc.com/role/BalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of value added taxes due either from customers arising from sales on credit terms, or as previously overpaid to tax authorities. For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer.",
        "label": "GST tax receivable",
        "verboseLabel": "Value added tax receivable"
       }
      }
     },
     "localname": "ValueAddedTaxReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/BalanceSheets",
      "http://propanc.com/role/NatureOfOperationsAndSummaryOfSignificantAccountingAndReportingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_WarrantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.",
        "label": "Warrant [Member]"
       }
      }
     },
     "localname": "WarrantMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/ScheduleOfDilutiveSecuritiesExcludedFromComputationDetails",
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WarrantsAndRightsOutstandingMaturityDate": {
     "auth_ref": [
      "r449"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expiration date of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in YYYY-MM-DD format.",
        "label": "Warrant expiration date"
       }
      }
     },
     "localname": "WarrantsAndRightsOutstandingMaturityDate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_WarrantsAndRightsOutstandingTerm": {
     "auth_ref": [
      "r449"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Term of warrant"
       }
      }
     },
     "localname": "WarrantsAndRightsOutstandingTerm",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).",
        "label": "BASIC AND DILUTED WEIGHTED AVERAGE SHARES OUTSTANDING"
       }
      }
     },
     "localname": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://propanc.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 7
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6911-107765"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4304-108586"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4313-108586"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4332-108586"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e7018-107765"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "250",
   "URI": "http://asc.fasb.org/topic&trid=2122394"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1377-109256"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1278-109256"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2626-109256"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=124502072&loc=SL77927221-108306"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "http://asc.fasb.org/topic&trid=2134479"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226317&loc=d3e202-110218"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.CC)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=27011434&loc=d3e125687-122742"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "http://asc.fasb.org/topic&trid=2155823"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=27011672&loc=d3e149975-122751"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S65",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359872&loc=SL124427846-239511"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466302&loc=d3e4852-112606"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466302&loc=d3e4724-112606"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031898-161870"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123467658&loc=d3e12317-112629"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123467658&loc=d3e12355-112629"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=109262497&loc=d3e20148-110875"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(CFRR 211.02)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21553-112644"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21484-112644"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21488-112644"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.C)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187143-122770"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "50",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130561-203045"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130563-203045"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130563-203045"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130564-203045"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "710",
   "URI": "http://asc.fasb.org/extlink&oid=6409733&loc=d3e19524-108361"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "710",
   "URI": "http://asc.fasb.org/extlink&oid=6409733&loc=d3e19512-108361"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "10",
   "Topic": "710",
   "URI": "http://asc.fasb.org/extlink&oid=6409875&loc=d3e20015-108363"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "10",
   "Topic": "710",
   "URI": "http://asc.fasb.org/extlink&oid=6409875&loc=d3e20028-108363"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2410-114920"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2439-114920"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=123468992&loc=d3e4534-113899"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b),(f)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(4)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11149-113907"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11178-113907"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=109244661&loc=d3e17540-113929"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420387&loc=d3e23199-108380"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420387&loc=d3e23221-108380"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "51",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=124434304&loc=d3e34017-109320"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "808",
   "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569643-111683"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "http://asc.fasb.org/topic&trid=2197479"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624181-113959"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41641-113959"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41678-113959"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(2))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "182",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123421605&loc=SL5629052-113961"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "15",
   "Topic": "815",
   "URI": "http://asc.fasb.org/subtopic&trid=2229187"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90205-114008"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(5))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "815",
   "URI": "http://asc.fasb.org/topic&trid=2229140"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "60",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL120254526-165497"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL120254526-165497"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL122642865-165497"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL122642865-165497"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=120253306&loc=d3e28228-110885"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123602790&loc=d3e30226-110892"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=125521441&loc=d3e30690-110894"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=124440516&loc=d3e30840-110895"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.28,29)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6897108&loc=SL6897125-166521"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "830",
   "URI": "http://asc.fasb.org/topic&trid=2175825"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=123403832&loc=d3e34039-112682"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(Note 3)",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=123403562&loc=d3e38371-112697"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=123406913&loc=d3e41499-112717"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=123406913&loc=d3e41502-112717"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=123386454&loc=d3e45280-112737"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123341672&loc=SL77916155-209984"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918666-209980"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=124258985&loc=SL77919359-209981"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=124258985&loc=SL77919372-209981"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "http://asc.fasb.org/extlink&oid=122150657&loc=SL122150809-237846"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "850",
   "URI": "http://asc.fasb.org/topic&trid=2122745"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "http://asc.fasb.org/topic&trid=2122774"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.8)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(1)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(2)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=123384075&loc=d3e41242-110953"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15(1),(5))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15(5))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.14(b))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Subparagraph": "(a)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(15)(b)(2))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16)(a)(2))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16)(a))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.15(a))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.15)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04.4)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e637-108580"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(13))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401414&loc=d3e603758-122996"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "220",
   "Subparagraph": "(k)",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=124433917&loc=SL114874205-224268"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07.2(a),(b),(c),(d))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401555&loc=SL114874292-224272"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "40",
   "Topic": "205",
   "URI": "http://asc.fasb.org/subtopic&trid=51888271"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e681-108580"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=123364037&loc=d3e3115-115594"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=SL120174063-112916"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669686-108580"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r618": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12"
  },
  "r619": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r620": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r621": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r622": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r623": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g"
  },
  "r624": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d"
  },
  "r625": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r626": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r627": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d"
  },
  "r628": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r629": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r630": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r631": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r632": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r633": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r634": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402"
  },
  "r635": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r636": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r637": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r638": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "848"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "848"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Topic": "848"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e557-108580"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(4))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.3)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.6)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(b))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3000-108585"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4273-108586"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>72
<FILENAME>0001493152-22-000830-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001493152-22-000830-xbrl.zip
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M&Q%GX+K$<T]]QX&G[R3&/W"OAVS,AW3,AO[;#J"\9Z",=CK[_1W%MPQV+2@
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MP(Y<T51S,-8"-MV*HWJUL1:PKY8_.86-M8"ML^(FJ9BQ/N'?"UD<:?F,]9&
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MA>$)*))<9WCI>A"&)Z"^$6N7/\W7+@_0O#Q1Z?XTG5T21!JTA(B=#<(<.HA
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M[P,!W2>Q^-E@W2=A?.AQ@@]*+&V)+CI)&=IAEW\-:G)+V=)%Q).<V]46AGW
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ME7FZ%9(8J(_2:)B]H?4.=\1Y-C32<(<%G=(;Q]9]S;MV I)B8$FAM&JL-,+
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M@N*ICR91\*QZ^%X# _W;#J "_YZHNA[^79BRF/>/B91?/:?X,VC1K*::(4O
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MWQC.._@CU05WW5/ !N")*1A1^BYAD=VK!V$G?@=7NM0E5U@W.AK+X:O,*14
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M9$COB'SV,#O1_]MLDM&#7+QB?^45\\] +S3T0<,FF_.<G< $[#V"9O^Q]TC
MH0&J5/-%G;K)5DR,GY.D: ?=F,)73I(OB8M77+(VP>P*99)1I!;OZR:R&.[\
MWS=?!E>#^^O;_RA7U_?G@M\XXSOG%\R4P./':TOY"D:RVZ<-/3N[2K#52)G;
M::3\1-=.@ISQ:2)'_'.P8*,J\6Z4REW<+Z*K/G=[7>6G9(_*G^F#PUQT^OW1
M:\)NI8DUG*QVI?'GWIV?1@^A_M +MKZ)>H*;Z"5HIHKE%W$?1+FRGUF_[VZ/
M\>>= MZADFRZ.:,S5N3!7!Y:CP/.D3]!!Z5[T-GM=.C_*ZQ!<N@XQ?A)RY6Q
M,I:Z2;;V8U?YOYUWG4Y7F:B.\HSG96%\PAZ <0\K-S%-&J,$Y0)3962;N$H6
MM5RG_7UH69!CHY?H^2Z-K%5PC'3F_!F6J(+2 '!@Q4&O0PSG6SKJ8=OY@'ZK
M1\1+<1SR]^@+)]O$*;/V;O!;PC9F#IG6]81]=.-^*'*9KE%ZZ@^XQ$7.7P)"
ME.YA.-\9<H)AZ81YO !JUY],S."'$?K@+,.!MWB!T;65GXR?@U(\PD*&^&7!
ME,^C:V!9/D2KMS2!& EGM[/WCVCY<FBXN.]B2@!S+#S^P[>(TF=]?[N[Z)+/
M=Q ^/\5GW9&)1V7F[9O><7CU3\9LF O$9(SRGSYM1 6RN3C0?T8#]48.(7L@
M+-[(#48:C0"'"Z-8/MYY$6>C+3[<4]]Q<*K88,.W!6-^^^88F#O_ZC,(!]FK
MPS='WQPM?!-H:/@*],:$P=:<LK+,GXSGGP'Y/] 7<E"D%9N&APQ,- *-9/WM
MFRV1]>4CF%?C,RE\^\9V#'@NC:$U0 >H\UU:E0?_Z/AP.J]D#R'8I<K<(7"5
M2YB^AB#<-+Q0TI.:7,6-*-B%8E;%!=>A#!]W#F(V@=T%ZIP^D$I/M[.[O[]X
M3?!.JF]HG@K> $/SJ22\!,?5H6*9!"=*S(V(8;W;W>T==#(>_O9-[.G(>@SO
M\ST;8'G8WSW*?+2R^.1/RYX<<"1 _1I//UT][JT7C 7K^/;-S#Q2@7"#$A?F
MW!RP.<!!!\-__,AGNN6$8.=9TPR</03]! TK^W/!*"US:S #_DA(3(71@M,A
M)L1!+07Z;&^E/ILS>[2P)";R+ V)Y]ED.=(G@2.]W9-Z9:<7^;Y]0[WZ^9+Q
ML.1MR0R_4Q HZ@3/!:)ID43"=4B DA=X%D01!D1JS*7T#-82%#^'1@\=%^K8
M+G55MWSZ$N]>DN[J;6FZBZ5[B^:JDFFJ">6EH"15N8!IU&( [\7G7Y2 &[=$
M9WL5;\^_7'Z]O!K<_N?MFYO;Z[N;\]/[ASOE[N'3'_!)N;_&XP!NOIQC?V_E
M;'!_?J;\,;AZ@.N5\. 9I7D='9)\:.3R:)($NDZ:YH3$4DP&6W>GJ^@DR&L$
MBZ$L8Z>_4[X1^A5>AWDLM#IN8@?5JD7$=0XS,F++KIC42QUVN-N&KBZF#@T?
M;\  @AM0>VN&Q^*Z(764;>71GR[>B"NJUA2FR#%<W6!KEB\8F3-C3-\*\27U
ML8.'3W 9TP/7[5VS@-],M=7&OEMB#L!)/^ACF?O$(L:@?\#;-W=1L'C*@HD[
M&G=<NJY//9Z'"7QW_DH<S7"IOWKM>[2^)A%'?@OB2*&K,M4[ICL?YY650TQ6
MZ,%2SP:R#<LTZ+K#VS?P]<%\EB3!YUA0'L7BB<63.0Y'*RD:2WF:4\6>3<@[
MY5S51@O3\O8-1J!8RQ7.X\0QM/A2!CC-$'W :/_O/JYWQ'Y!)?MBF-B[96(X
MA&V@#5._-$6M6I:!(2O+K-&BFBB>"?G!MDNS!9SP>%5G0;?B &9#Q );//DN
M+&^9@UJPEF3[IHY96=_TPNQP]()=>. 3VW1"S1,,#6*\(099+#6+75&"I"V;
M2!T7>M!&[(*5M,C0P-(RY/&+A5,TMJF- $[NOSLY^1N.S?:=^ PD4RZSG5 L
M'6FY_G@<K%Q1N@QWMD^IDGA*_#KGM>]D@1_Q-</QG[[-LKML+>7Z_E3YYR>Z
M=8AXBCT)=C$$BV[XZU?ZDZM\!L(FS#;LQC:H0?3T V$\'3_:9BA/>$;HNW![
MS?7L4$66\^_MLG=KINVR="Z*B>H&]=[A_O%H<+B2B0N$_<B+,6B)%A:+F3XH
M"%H>J;JS&W4R1M1A^AJ1<QID5N^"7%LK$0#*^=)Z)BYUS7!]!!$1]\:>;?,9
MQ5$9&4\C4!4$#UZFQZ48[H]WRB<:E*(K1SM>@.<VNWM7F=H^X"M0 RI;_-4-
M5_.#@S.'"O9KP/[1]'$4A<;\<!83I0P(>(XJ7A8ND<,#E M5\VS'#4'T"&ZQ
M1;4#%J]BF-L[4D+AGED*P4F;<E=QKX@1;>5;[>^_?6/1W?-3A#V!AU'G&@.(
M. RT67Q K17VVGAF71A@.F=_#A?]>;ADHKHH9?XDD#-51Y.FT=Z/J@97PN>9
MSHU-BS* <8%X@WX"-12L\-JAOH9P!Y0#W:*H.<:8VC14V)9+JLO"B9?8>SJO
MM*R!J>J@HF&QP09..<PL92U:?H@T]2>"K\*NYT\6":YQ?0W+;T%N]@P+_L'4
MJNMA[+FK#!U[S-*AR'CX[VX0@R6D$HP]3-*S2C.DH5F@"M>-IU2CW"E&;[OX
MR]!X1;M.KZ1?6.3)]@QF[8-O$26>\@R3':E]=U:\NI"SQ6?ST=9<9Y/K=B<R
MJSBZ,6DPKIQA_&\\^B@DV>KOX"!%_5&+1]VG6-*":RS=LF)@;L/^1G#W!'@D
MZ&H[1"-TN_^L6P[,D4:([@9B&%M;S%A'##RP%/W ME<'H'E@X>)-\/C0Z6H<
M_QHZ[>B/OGT3$\!@*PR:LB<(;1RP9/ 76+5)/,Q:Z)T4=$9ZI_QGP<]*"CAM
M43:7)L22@:@.<1@L4!JT4<.8-J& 8$MA:P[4CV-^69B?FXU%<-)-HB:6IXI<
M=<POK_#5E7E7/2;_&_C*K-L2! ()-SY1@X>Q?X#&1Q99 [8=5FD)?UG!3I1@
MVU@ +%9C.$^4W)I2+L""X&&A]U#6:D$8//"-&##,C-P[8Q&"\)?G^-YHZ)M*
MN!618 IKPWBA8?/57)B!O<)BG<!@80[/HO]:J"F=56*GK*$%V(M]$ZL,MN.;
M '']R+/IBMI(!1<+W*VW;U1 D.W P&B4A+V^L="*66)J\:B"T@UJ9*ERFCG'
MRN4PO"FRW2FWP" ,BRI UYM[Q.[;-['L"//_@ <T2#:\W"MONU0$#3=>[<Y\
MP2 L= GYP5(SLQL?_>EN5!(?6W1C4LQ6V^@FP]ER&UN_"Y8SYY?=:.IX]8)G
M?+$3V$\C?]P/BG.O1B7_;(\H@P*XO6%I78HIPHK?)]7133SK([@[C )U8F+B
M>YIFP1AN@ $+OO1\NNF=@AG2QZ 7PVYL1S-,*JM2V@T2W.Q^F@FES8MH35KP
M3K;/E2(O6-Q57(-FWJFMI.GW)JZ<-7/YDB[/AQUB4V :IIW#DHIY![<11&;L
MFUQ6D]7?TIHLN04Q%W#7V8*XY9H&J\8'G[Z<OWUS?:&<7E_=GU_=W[5'T3>H
M&1R#:EK>WGEZ_*G7V=_M]8]W>P<'/]>DZ]&O$,0[V-GG?]3OG4YW!RMN AO%
MQG>'J]5XUH2:Z,"S>;^XSKL#PQ(-J'U1?:NR)_H;6Z"IX>SV=CYB0H:-+,C*
M<)Q7L3/9.RI_*ALALWT\>(XNQT2'*U_9'MTW #$+AF07MO,"'_>^V/8/EJT/
M\K'-F?V#GA3DV93O[WQ\<(/NGK'EE>;,9@5JN1&R?+#S\2S(2*JSHYFQX#+<
MK7J#R])RHALIMH>XHA[TB:"NU2Q])F>TZ:)[A"?MJ3.)C==)-&=V#Z2\LBE]
M9M$0*R\-.A;;#DW3)LM7+1T\+58V'*^2^JIZ,#<-,LG2O4X'00]!8*E/42,D
MMNL:QWDV6YI&& PLU9RZM)I;N8@2^*=A C^ 2I3#OXYR^,T!R;%4#X'&=R9,
MYY\9#J&!]"YND D.MKVF!]LZ;''FU'8F-EV ^HSK2XB+YCAPAR=2+61,_O'.
MQ]F,8U<&8KEJHZS]D;3V\1GM@KV_QQ[4JL:65NDB>VC<;T">X4O:GV]L>Z%T
MAUN'3K'NPS;#R^AOH6Y0+BV=3+ W5I-$'X]BEZ*?*OHG&,@%??ZN7RR8\I$Q
MH3N; C1\BO:-!;]3/,S\B.: 0.;=$BJBAPF:1,'LJ3HQ/)AGZOPW9U[[4K@S
MIACSZ;1X)BA70CWNJECB2E/FS"H,V$$#= \JX& P.W< ;YAY_Q@BF+;K.PW2
M^Q6X?'46^?V=C]]HI1H6OY_"2V!V09=CN?KEK!1-3F^3)?^9&77TTU[9T#P;
M73I:>$3=OYE(-W#U[&*O6\GI.;%"MB84##>TSCFK1\HN:X0PWTY<,>TGFS7P
M9$UJ/4?%'>G.#UJQZA+G&3>P!U\,4QZ@3B9$=8*=TW.%C:Q_7K"G; (:8IKZ
MC*"G^7SQL6JZ=MCWUXT-;)=]QG.D@JVDB5'2ZM;@O72_4_1B1J'M/*F6\1?+
MMKU3[FP32Z#9Z4+6,[$,#,QVXXR@&YEFKP0M01R'-:=(J3EF#*&>@>T'!RH#
MF([VHW,^]X][OP1="("81Q^WDMHN80_&M[MT_%CNC/MBV7E(=G2\TFY8.?V"
M>V59TXN@QP MUG:!']YNL ?A[9NA;YJXAXH>K>0%[1!BG0E-]667UB [QM/(
M<^G6U^"4&A*_SL;89?XU=(MO>"-[(Y[D%/$.#XR*,T\V2RI'#7#;ZQ! +6R&
M,L3-72\.:ZH5WY]%6WX]3A7?Y7(N0&+7A))OTP2.,T8:=H[&ZV@G;G5QCP[K
MA+:*>BU,V%+J(@FEX]-M^A!O]@)W@MLN'@W3\*8@>;;#5*L&LQH.U[)1='R'
M-@52HSY!P&!#93>"JMJ=)X9))%5@K*X_?!S<#@Q(V[F!3192FJ;1?0B)71GY
M&J$%'=2HOE7-F(K*WI%!]PNFU+JG;<) /:)3Y;;)]HK93N799KZW;_Z3W/*"
M[!^3F8[CMO4G0SAH/[J(9D8N/H?M!@C:9JC6ZGTH:"-T6_.IOYG4TYDTT#TG
MX4W9>%:*#C'8-K/RP?'YC#HQK#&A:CBET_6WQS!CM&I_3,AH; BU]=N,"]3?
M"^I4$!D!'?4^0 * 0MMG1;V^F +"S>/^(S@KB6;^<SO8L2^,#8Y+L(68;@N-
M"C-24$@U6(9"9 L#P=$7V(O$!P%PJ20YY$_?8 <5S&0GZ$7V8!FL/(#B*UHB
MP(YA1G"^1>*2MV]>1K9"#^0#9]!.C']1:L:^&V[XPT>-0>73S=F/\/S S7]$
M=SDR6$!]L,!!33QEK;T[:WL9;SX]U^4EZ*NTC'\16<$3DL0W3KBPU[01B9CQ
M,657Q?+=3OM;NMNIQ1VH*]VAE .0M8^PD ;Z,#RY.MAW$M P:T<-L<3#UZ^#
MV_\TD<*&QI" ++IK==:STF7;?VBG#Y,&_1F.)S%=$H0-2X*HU.P)&!;=)FX\
M/%-4TXR,4/R%L;WL8<,/?.:8GO2%OSKQ/A\ZT0R7[J-/[5P3$I?L$(JOI%VJ
M= )#,?'$IOA^^B _1;T-NHT[EB6>.:91SYMX4QP64 .9-.RB6:ZTJ&,WQM8Y
M9KY]LX*;"4HU"-@P%S2-> 4.P=C&D0=."AZ/QDS_F!4LAFT38V=>1!T0W7A;
ME[=O@AU$NV%CE^#'Q6HY;H5RX9MHTV_:P@6//UG!_]VPN5" D60GF%2$T#0D
MA0D-Y4.<91Q$%L5GM-5O>  +"S.BQ"'K;!3R*&5!:3 [C22VK!12/&!I1+SW
M,H)#N (=%!U<QL/P1SRU+<Q<1&VWC'*:CP1?&ECQX@4[_3BKJ;@!;)Z2'0!6
M?#=#^'V+9D+";C(P&":N+P9-&-,XP]V-IXX!=@$X7LB\./H+ @IB$WX5=?<+
M^M "B=/H\EB:+GG<:)C4IFT!668__(4."L>3E?&G\0B\#"*<H*<R*C4\"=30
M#=3%X8TW-_]1OMR?O6OD%#?5_#]^_!0D6=Z^N7[&-1;RTD3W2UBK_24JKX33
M9Q97^EB;J<?P3XWX-%JC+7!H-H\\$].>4+L'C@?\P5ID88=XFE"'W^FYN:P%
MMQ8<$ *.#QA0--&T(20UL&#=?'"+7);RI_E.& M827@CZB]B_35%<EB"$AA&
M//HP,-YL$0MSXAIV"L*C6&G(BNIO O=3-\GUPR0.?>?LX;O@"#ZKCJ%:@3D&
MYH*J1"KI UV6'F3410-!]>6H$]J(*]%]V]7H<A\;9SAHF,.Q;]).W08\_XDR
M$5X?)$J,H!_YHZU/=Q5Z_"?K"1_=3V"PL=;DP>A=FB!W29Q5X2U:X(P&*Q1*
M^/S(:PI/JM0)[1VFJ$]@Y5T/7!Y*=CFYE-:<JE0F/=?HF)KH/P(<=5_S$*FZ
MP18[;FYO=IG84E!3+XYVX[(C$*,?AV@,G>&HX^),S'8#;U1EI]!-J 1C:V7T
M"(-KWBGH9ZCAR0CPP\1V#7H]4?%<WV!YF4(\B+54RS/V D%EY_-$#:L\HHTL
M% X0@="_Q?P[T$>BYL[8*@\/0-5,PT(APNZ?$"P16B8'I+-FT>A?8_\K%$1D
M$IFHX3EYN B@A'<K>/.4+FKHSRJ].!A;J#;>*7?^XW_Q#$4\N]D-FMNRR!5W
M8>!%85A@/8$J@9%/L)4Q+H1A)TI*6M#O\DD-//"O!!A#&_?=!!-X9D/\@O$3
M&Q'6&-@N_([DS.ZVG4AZ/SFV-O(=$D8)>'0P#-XDEJX".O#4#*:WZ&B,<%70
MBOC".E0&;YLQB+;J=6=+KD''00V5N L/Q6YJL7('S !#M,6L@JD^!I4--$0"
MU/_D_HP-VLR@52;],<Z8:"+8+4%M0#13.*$_A3[B_6!V, F8'\-,1$E#PW&]
MB '*GSX]7!JP10^([@6J/6C<1@^ZO!\DGL,ZB#]BWC_\.?'HD6H.$:JTE1;,
M29B_!H2&;Z,9!7K$@[(  U:R,N,S7(EV .95<^>8!N\UO$!RGR%ZG$.AHQK4
M/,;/EXRPB-J;%@S3(:#?2S/%>/9%.)X( "I$AD#9WJ6U][L/>D?YZ>+R]Y]!
M@] 36B\?9](1&5&V*A[*"K7;"C/;8+;P[/H@WX])'E<=$@]D.7 =L#<$B:BE
M>H#>B6H YEQCA3PPX4:"M7&VSZ87X1T>1LI&B1K#GN#J-3VRE,TS#A<?]X)K
M%DIPB#@:;J(./>PE_8T$]3#(F,"9H<#$@:#$H%%EVFP//):GR,E@RWXD4&6V
M3Q,;8)"#A0R5*L; _5&I2AS#KRBO0WNF7;#G.S:U92N7D2L5O"-R*["7,IIV
M%VP\L=@Y+FVQ96VSS0 <MCJ/F@D4)P  T6%8_PUT8,R#1' %62)ZC@'B!J22
M>9;4U5;L2:CD E#,;@H@B BC"28J.[0KK#U^C!H\A!W8TWQI+$F;3D"9V$\D
M<'Y'T[$=^Y(]E7D9!-<"3<\ T9J9[G!<2&/H<\?KRT;&(QZ?QR0=6/]"JVI@
MX#:6CC$GU_5 Z%2F1X* 8.($AZ)X(WCTTRCR7B7R:TL/+JT'O?]I$MH81J;<
M";K^/[R[>Z=<V#9+?)XY_I,RT,=@[J(S'W^Z.!O\S&(G1-Y(U=FIUF +@DSG
MM3/!M6]Z\QF5FYF_0"M!0@&AV(_A/@AK6%U3$&+1/"XK(7K"$[_PD$ETDL"I
MQ6*D0*>SYLQA^ABN-<;,3R&,$'4&YYA\XG%GP -<;Y^ENN.C'VA,B&,5D4 ]
M5K<$SGE)Z]D2[6O0,WC[!A/C#.3,J@^87Z1<T\/5095CXIV=NA<&#K3>,1"&
M3[;JT,[AEQ:$93,G]"Y(( Q\E K34-E)[NQ0#7^"?ZG*?O_=P=_")*FFNJ.W
M;Y#H61-\W"#HL9?9X7AN_ZZ.)[^<X3%[&/&S[ %&+SH[CCQQS""ZBVB2F#?8
MG7?5:2 ";_H:FH2!JQ'ZH+=OSK!HY2Z,RX9H/SQBTR@AGLE9D%A:E941B,WG
M;^*^9S16ZFW/@D;PP9@S?X--CY2OJG8*!L<?*Z<T([@+<9CY"-Z>!6%SQ.UW
ML_FCP2^K3F%/IG*,Q9E6N+[&5FB8ZQ:18,6"(AB#ZZK3B%C0"E9,->+E08B=
MS+ !H:#M&.F!1QS+DM,0<&D&@!U<BQ5IEC^$5X#K&3D#0]2X(S*[.1Q<^ERW
M70LM+[ Y^$6YIDZ8^P%?=,?<N%^4?T&TLXWU-VEGIB9J<N+,#-GXBW(_G<#[
M!X[Z:&B_*%?JF#!67]G(P/U$&4UX%_[2LMJ>0 *D95V1W;RYONDJ_[4-*Y9W
MHH4<Z#AA#8%-JWQ!@8'?-D:?+(JA6"$_!BRX= 'C!9L9*31,#>#H0RNW1(>^
M>_OF6Y@$4XUQ8,C@0K1!)BY !,K<"\S<JF JV!$T'N/ILS 6WX47D5<:(M'S
MYF",8_A^EK=])-X+>+]OWYAV4.@1[ $")>([6GCH:]RFHFU4Z7-8+XFYO56&
M&QDQMFBCC< D$NN)>0 !I^&!--M$#[H!G?)HAV<M16G!!W8@;T3\'^K?_Z?7
M[__"2/\,SK2JJS3!0G4$78NFGDN0U_%>;':T;\HD)]ZI1'NC8]M HK=/D^_&
MPE9TW.,TLMJ8\/$SDQX9/81: *2VF[H&T_/KX\?KA]NW;RZN3Q]*:#XNIVI]
M>DZIZP[N)F[_<%E$'2W(AID<#+T=FM &@XL%W7_ZAO8#=^]86!M&EQVH'H"O
MPB.VPNU,N ?+>*([2UB$8X$FM[58(G_"JO!L6DY.CR?'S#HN6=&1@&;%^G<W
MEKVBHS2\Z!=@4'C^#3W'DP5+]&;0'$]X*#0^WJ9>]G_MQW EC;BHJN$J_!X/
MP7N:!B;)-(:TTLQZ>H<:S#1^X#8$!U4^Y<YN&/,P7@7)MBG;SQGL#$N,26JK
MVM(3'KH=9FUI2I<&DG1K'P:Y=#DAB,AF>&=160B5V:&)"6@@U'[@MEFV.99]
MB:4!M"PB.@L>L8K"Q0Y(AN!R9  >IV'1P&Q0:#)92A<C482;2O_"RDS3&TW#
MUX*4T+.:Z 'VFF_255ZVN8F)*#NQSPGV<]$!0.2)J\X.%K8RYXGEPUS#H<$.
MW<P1Y),EH&M+#_7*GVS,3%#%1Y/V 2A1,2711U/Y#']$]49,A87S'P)SILGH
M^@7-R\(_/RS[Q4*LS5T15MR \D1-_(-@4D4+CM&SZ5;[8+,=UN(BAU3<[$B1
M&PXXH86I&#D$ 1JH<KC5<)27_Y^]=VUNVTS2AK^K2O\![^YD2MJB&$D^Q(YG
MITJ194<9'U22DJE]OH'$31(Q"'!PD,SY]6]?W7T? %).,I%CBL%6[3B22. ^
M]O'JJXOR@V1B.$H\0>R83S*YL,/H97M4#-QA()##F"LX*9Q^572NDLU,<FJ&
M(UR^#IY#6',:ZCRM4/'5B*H8S\R\"'-#\(6X &T:S^?Q[DY: @H5WWO7X_XB
MW>=\[CP_?#U,M2KMV7'2DS*[C:6V54C<5ZZ10.*0$VR0W2#[ V%9NA5[Z= ,
M!XS2RP^":T#RGK'L^W2M7JZ_<'":Y&1+=;7@Q%ICM!=<6J[3W4)- . &N%NK
MN+R]KG$EO]^G:XA.$I5/X=-S.I_4B8CAM"]?[(_[QL[G&F@+86W)8SH.="I-
M%E"=*1"(/0).^PEN<6:R1<0L$--9W3ERP^A,HQWA4SG)0)^2IWC )6?8QG1,
M<-QI)'< ,'V&.;H(K9N[$)CF8S$NT]Q#,3U+C*DJ30;:$$.23G$MQ)JS Y7:
M\4D,> _3?7%-+UR9&6T(%W68&/P(H-.Y*(L)/9>>]T,Q P$D<D<"3!*L& )?
M7#.\B@3]90PH&M6V0* AS.76=D!N*E3[B&;LHA&&T955OG0F*I) V!/&PM8I
M/"*&\YD\*4H,E<=/1_W9(0UBMEQ KU4@F& SD@06G8F88U))7,<6L2MZTK]S
M>V[)MMWZ?^J5;^'#LR*?'D!Q.<7B$$[Q6H!*"Z@:P,G%O+P35&X+SA@TTU1&
M@0!R>M@@DP-EI8D#SC Z%MX-DOFPO,+W:_M;RP)P6X1AUWGZ4<DQHFH)GY_Q
M6NS!]:=T8^=S,F'0)M-85;"$-.I<E,MV0)K.;CIGGH%X#B).G( 90R8AGCQ<
MV2"0Y<#_=*Z^O>_%DO]=;6VWOC+NX'!XS!_]8H?C\_=6O'-R](>[$J1"$'DO
MK)3D5?X.NLF@6^'Q/1<Q=O;CGGHJWO\HGS_]YOG]#/,^QW5IV!F3L02>CL4P
MWJ2 ]X*I7:VZ=3&-UK24%7,CCMV&GK,_P\$ZRV<X3?9DX=3$"8Q?]=W!( 4.
ML!)%&$&A'"<HA:6G/U;]L5HY5@(C .8-H\D+9662$#M]"2FN,-0NZ2I$&;GP
M2ZWCJBEOTIL0\M4Z8I^+T;<W8G]77IP,S3XAOLGS<44A<!0!Q5QU(7^Y%D.<
MUE%QTXHZQ8J?9XC-:+F^Z 1I;_%+N>!L=X<]4PSBZ-NGMDJCLK8-_7I>5'60
MQ:F&T=G'&!%91RP3?4B3W"P'D=9.#R+@[ZH:_Y+G/6#*B9JQ5+ZB>A!E#<!3
M .\,=G>:VG (C3/V'UR-R]:'<S\-.'W:(TKO 5'ZI$>4/B#^FS]&4Z9_?VM
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M)QUMD?3<7C/W3"[C[LZ)PCD$D1]=P3 YQ>G:KBEOFVRU!11^OUBHE,#(U"Q
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M_>IM@C76ZX;?[C-LW(@V=*&>](?TRT45-FY$&[I0O23M42,/8[7ZD]K'"1_
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M(2"E?.LRRI*UR)VCBLR-!C+M%W1+0V)J3_&Y8*W6AIZU@%=0&W3N?84;;8R
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M)IZ3P<AL8S8L#HXTSXRB9'NJ=U8+S+7D&/0P-I_'R4$$8)0\3;K(:@)*2\[
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MJ#\V1AJS6M_4=OGUH)>NH%V).KOKXMDF+2,V!(HMF];(BR;A[27B]*LKL<9
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MK06SRQ7[0F3,:%&:GYN$7FF9^5TSP3(.JW@1=F&HM'?7K:8CNW6IZI&W,3/
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MT=+6H/&8:]+DVCH-7&^Q=O^1KA4E34PXLS)C5VZI/0*VYQ#_)U#H;WHH]'U
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MU=Z.]8#,YUN*S5V[1!"_6[3N6YO*XCW,)T 9&2@#%T79ATJBK6]Y;%-'.#K
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MEFDL0+ 7,$B3_47F(*N4*16.:GO5DO6#&_O)UEEJV=E\7C=(P$'[+\@8:.=
MC2_TJ&ZSX<9/A=8_N)YC7=UP[;M+EDW6+R:;>PCK[;#'.BVKO1WK =E<)S"E
ME6NNRXQ*0PUU46>YB?Q=U.C4-^Y^X^J'VQN0^T$WM2R%O%\%J+*.D\8S,M)(
M0,@X-OVL+.8T@F7>"#5+H<D++PK ]Q#OF14!,KHP3' & [V<! (.<]<<\EBG
M9;6W8ST@8^P<8*_0%YE@H#F[50%)EJ[)%OG"V\7(Y))_S)YQFI3%/_IBP=^&
M,54CCUI<:-_Y;I.9/(0E<MACG9;5WH[U$,WD9U:LH$NM250D!TIN^8?M$^U2
M-J8L@!JZN2Z30#]\6J\WP#B0_31R 08VD&N;LY^KF=>%_'2%^YF *LNV]IN\
MN751=^[.[5#O"DQ;]#-8<M/.AA(,'%X>6N!1Y^ABDG$LBB8':X'08"&;C6&V
MF:.<W=3D5!>Y$R_4)YEL_B&L]\,>Z[2L]G:L!V3S?V++JMZQX\HNVK8''8L7
ML\XV1<<%,?C+8#7DQDYN NV;^2H#UU7T';:JGCL6@$S%Z[,,MM)EL0W-&U!]
M9.<ZC,BT<UHCT,%6%"Q2%*+TY;Z@&0VHQN:0C)FZI0YB 1[V6*=EM;=C/2 C
M;'@)Y"&RI%UG99DW >1A+E[EED][*8VH :2WI=64+YBBNZS;GAE;/?Y6?%YD
M-"*-03+?=,/JW!')(H\A>5ZXOJC7D=V^^F>N5%U:FR/CO,F-V1 C\_6[35,#
M$K<3\7N3#%V>7.FFN)/L4M<Q<SV:F+EN@IGKX<3,=<--,?_R"&6RZ.M;:Y3_
MMOW^;_)9_CC3BQ6+_^_?LO__]NV[V(?\9&]?O/OK\=%/IT_/7K]]]\<_S/[S
MQIYXM'OIYI_MAM_3U^JY^F/QGR_X#.!CP>'D@K0Y'1%U>8&0@2N6Y'=#/0<'
M0U.T[T^2_Z[[I%VIKTYG%NL\ FE7("L$UQ_?:^EW[;PI9CGZ4\KZ$@SH=+11
M^)"U_"UI?2DJT$GR<</#Z9 &LH.FIP<IJGG9<SK^TQ!]>I@"X\U?JFH35OO?
M_^OQW;NW?WQ)Q]XY?QE_N//HQS9Y1@=KW[8%TU0NCH].<3"V!9^&/B_VM*XD
MVN&KO?4'YFMW8*9\CSL_&A$\Q2P%C_URE?/C J/#TY^,3/U)<H9Y 8JF@<$\
M/N+^P"L+J1@RPTFK@+1X:Z(UCEIES9KO,.O; JC,-)BON3U*:J<]D\CS$XD_
M<M[4E]TJ./*/CUZ AGZ^8C011I(&K4375,)E.!J]Q47O3RE')Z<^QN2%=7S$
M'/DT/PW 34SF+*#1O*4?T&)\7U&PR53Y/%GL'I%3)=.*+RSR?)T4:P<>S<JV
MY@%!,;IHHFD+W"%R>XHO;*>^6I?EW@^;S@Z<$>^.C]X^__GT[/FSY.QU<O:7
M%^^2US_]]/SMBU=_3DY?/4M>__KJ^=MW?WGQAOZ<O/[E;?+N^=-?WKXX>_'\
M*YPJT]L*3_KB/T_9AMO6A8G;59I5(WV9-4W&5IN,)8T0$0WM3Y@<UK.X"+ L
M)JE1U:RET0BQL!C()N_ZIC*:85BI<""Z;P]P-<BTVIHXT(?87A7<=_6)*X-.
MX8\M#*X !8N"#;Z/=#EG*3VT.#O"U4*_+^+3YD7\L[BU-M35$B='G:5%(BC;
M^#%C]\4\(Z:ZII-/_U:P4F&!QQC!8'W)=ZQ_+"JT<FBC^63*=,_]11+3[(+!
M'7#KD9<%%PUIS6F^/(.S'"YC+9'V]&)+O.2K))MSPB8) 'V#I3]9J=_T(7[!
MNSH^@FOZ\7>5]!OZS_P#2#ND)?0J7"2IKT /5@JWU-,%-VI1=M^";";*-<@@
M77^SD^273QT,63/8F@[)1)3$[2=BFGB .%!'EC+M ^"H,J5MZCH4;3Q)@01<
M: ](F+Z 8QC:%,M.0T)W*WP\F;???+,RD#DX8]M>SC .OQV:V%!R#B-QD97,
M5WB@>_R;,%3\ZA[<2Q\]N,W?H1__*?G57F6>T7;4]^5WG43G^3_ XDL;^+O[
MMT]NW_8(GOS#ANV=>&;="OF>[^_]D%SE&7 ^%;E;39LU5WP:LF@2-CF?:\NB
M:0&C))/A=CF,UM?9X]-^UC7]@GS*:XXKA%<"DFJ1$T.<E%299E5:\JD;D<W.
M/\Q7676>I\DO)^].$JO.ZUMW]F*D8<&6VO&1^+2!O]2MZKX33AE1@QGRRG#V
M+AQ&F5WZ1![;G*U3346W0OH&;CM;]/-\,5FHW_0A&'%XS4KTB;A_]+6NQ]=G
M3Y/_\R>*OY;7N5V?NXXIWA,"M8Y&;,N85V+NL2K!B9?&SLIPW<^NXGT1[ /Z
MS7K3"</2<#U3N$<+^B0Y19@@6=94M>HXKZT!,?\*:?8<J73+;NC-AF-)Z9-@
M+-=MR:3 -M3?'1_U58FTYF4>TSPA;S*R#^-*<Y5#VHY. H8(Y<VZZ"0G[*>L
MT8.'9H-3Y=CF.1Z^A!TX9T*K39E1*,X)6JL^9RV]0PP\7Y);*1@DCN@UG(_F
M?0O;&3BRH>U1"8^/6!KRM$$[$ PZ_T#KJTVO2R]<YENC6-1)6P_>LB8[I-F5
M?WB=Q_^YRSOYW-5]-2#Z<A,7V=;C(S6N94$OF,PIUR6<'=XZ"G:98= Y1._-
MGN^3WAM-QT=>W-#'4.FM;R>:^ A:X?&$5K@)M,*CWQE:X7 \Z7C+>0S#"'CA
MB_EB0'$IZE6R0@'F50NJ.,,;_P^ZI%(W!HPU7 P)TL<.+LMFL&BER2& Q-ZD
M#_O;SN.7"*P^R4;S2[PY.)\$,G0L[5@ =#9U65$:5,'7C5,C[G6Y%,8_N,*[
M0:RU?X9[:>(K("9GY^GN[;MW3XZ//(:!B>GFXB^Y'Q<57&Q<NJR9CLG$-D>Z
M;UP2H,HE*]AD.)&#APR&M^F;5@9W?.0*Y/#FP"52R^C(60AS2(!S:&E?/$7O
MWVW=R<ELZ"U1CG&?NUED4$7._B,]/-.7!E/-OD,'(&3;@8SDO)A+0K<M'"7J
M(N_@NU;T':0M!(GBG@<3<6*X#\9I8AM+(0>0CAFSJ_R!KH/A@O\DW/I!P8><
MF3:;!PK4?D1S6K%T:T6^8X* CO=(SMUW2]A).E?JU>0=YK2E%S+/I5CAEV08
M$ES0PN2W#I]R/L\W<MIC&EJFW1+I5GIL^B([W8ZVFM]:?%7!Z/>RZ&35\P;(
MT3#@7P8C-3!R;P)9784U5^@UT47)O4PV==MMZDJ6L\0_>=;,5^F6-G>9]14-
MQ@2Y^>TS:@<7*K@L2$]CZQ4[ S 7>AP%C<B+=@-D2&M1BT=)CGMU%;XSK>U9
MZ<Z:)W!WL-<4==\B(]Z356B8(G+6=[3Z-)<Z[N*G](J:T(VE+<MN$%X&;Z$=
MOV/7V5K<ZG!"]1Q),8TM7><J/&92T?-B8(RL-,7ST$P='P7IG6NJL>KAT]_Z
M:IE=U(UY[_V6 WYX1OTW=%5^3&;DF)^37:\6<*3KYC_@-W3YE_%AEMD\EZ>5
MRK7AX^A%OJIIF\EG3^N&]L5%T?2M_.'[IZ__]N+9K3M/?E"G1JQA'.\MBK;I
M-YT!R7GW\MH)-C"6?F"FN2LI'0#,%8'VA=)W8R_I*[R";\3]>1V=^2[WL4!I
M %8)T+DY%M3L2E(>3#CF<L>?ML:B Y\%L\IZ!G;';-[4.1G+>EW,CX_TVNEG
M7)G69L=!FE"9.>IUVP;Z($:HL\JSLEO%.$MI=N:C3Q<\@U:UBALN[IU[0&B%
MI2$/1EA/'IK;W<KK:?01W;EK"CIJZJ;U$F/.G2"C#O]REN>5]^QF;L#R>B[K
MYCWR8C,<"WE>M.LT^4>?(?>"M\L_C%GDJR1?;\KZ*L];!<V&621<+X7'I]Q#
M,O>B#$_>D?:LT'#]M$F/(3N"_F!&=^"&?<9JV61T_YZG(%6YAL1?"(P<@J=M
MZ''9^9 W=LO>9SC^D^29)5M1QU;8*AFP#BY6X)C*@A5@KG\_B3K/@3NNH)"=
M[TR+%[M>&],W.>%[OI1* /B=Q9X2>$]#L^NWFXJ#Q #?0>>.K0I9Y/@S37 ;
M.]5<K_GD/6333H\COIYM*AZU0W;1>[W5])5S'YA7$!^5-7FN#;N=6\\B(]%-
MG@][CP1FS#._QNZE^:@Z%#]3/35DW7#R6>U$LJ@O*T9Z2<860]1I6^1KOKPR
MN[C)9_2W6+)P4WMP-*="=V 1^2X8&P4H#4\/O&?>['Z(3H+ATZ9<<P_POY;+
M-N^P?2DVX,N;)=', N>M.L=CZQ/N6\N=W5E]R,^QSB@QZOO63>+.@S@* V\O
MA0ZM1VFGFIN6 !74ZG29Q>?=7O<AC<(AY'GW\(K,-Q03TDOW=4-ZPEIB/@DJ
MQ"[$]GU-\]@WNMC4EN _W7-%9E!6D"W;:*%\+LA>]F?64F15UI?M=J#+9MSS
MT2^B8KW^,;2G[AP:P:T/EU]@Z\D1R\OEK:*M2SN\W"9?TUMQH=?P/, ,VQ&@
M)LP=$3P6NCLZ.S2U__=Z%D:W?N*"8T0/2CTTX6'&FQ.[FTL=)5O;"J$<C3*G
M7>$2!^3; +Y9L=6FH\<L(**:HAO(E?BJP>\XJ?:;YUBW4?Z \?_TXM7IJZ<O
M3G].GKY^]>S%V8O7KP3O3Y^]>D[?^^GUV^3TF7R";YV^>7%V^O.4,-V?QY#8
MD^.&2%M(DY0,FCVO)<.&<Z)"KG"8)J][),#84_6"O&0J@67JZ "FT7".S.?'
M?#)N2J'?2 SYJYY&^I9:<)#VG22!/_'%SMA=<<=&:V>W*B"S$S=,6>.D&CBT
M. XX30W'S>>-@P0L!K+L$>&5I9U+00-7\BN%*F'*G2O<>H>0QXI.J (%=O5S
M%MG5K:Z^M8 O&\1YW:J7G[%KS^%%,!&+X-B7ASI)?K)$?(&>?@;8M0F%)O3E
M_^JK/+EW.T46_0X_;OB7V^H5+&@".ILC>L#O[J:W[SY(G]Q_)"G.[^ZGC^[?
M3A_=O9<:SKB@8_6*;MTW.-:Y#Y-^^"ZG<' ]H[/1[NGN\-W]!^GC.X^P%]E%
MP77Q=V9*G/?KGEVIXR-D<.<%.Y'?/7B</KY]/WWR\/')M,U^XU3-G[#;CH\8
M-B[9 <9;)5'%)G40%MY1UL K( "\==^.PL%Z4+="W-Y7NNVY0V8.6-"R+R65
MH9OK^"C"#CF/%_<3+$BHO20,0+QS:,/03I4@"T)W-*Y/0^"8O#KH-GJD(\A-
M1L%NC6 QL#=2\0#UAEB9T&U&7RYG&YC0?E70+S"()3V1V#KRU1WIG.;<%8A#
M?V0D#JR3%$<HRH&$,:(X8*R"!T#9H\OED-/Y,WME0Q'8C0Y9")PJAMGZ7_KD
M 8TD7^R*QP19U%?<&,L8NTN>73Q";+8O"@%AH4O@RE7<9OBQ3?*N$N568Z_4
MUAJ88JY,#3I[1SN@#P[K>*BHX<& KX,9/9E@1C<!,WH\P8SV=.OM0YB$$IT(
M:S%V(X]*;.;OD7&?YRJLA1H^V5T^* 4#(N02<^!+MW_Z$00(&>WCHRI'GM8.
M/>163$ F/@"GL.HSJXRCC_&.7Z9[D2[KAV;ID26P'4N\YFA(WG!R2<>WCP62
MZT*!U"^&\2CD^.BZ,"2.*DX_%DQDB84)0>PP#!F.C\YJ;BKRN4_X)N;/+;3)
M7X)%C4<N<@WUD?:KVVX[W!/0#<+!5G,'"!WA\6V:XH)EEL-<P==]_=_(*KZY
MQ^#]<'ST>M[56$AW;]]^Y%?#(K_@3I$@-X3"D0_R0UC9CNKKH-3FU;9I4*C2
M%: 6:)#89W01?AU<E7[56<4-PEDE^*1[8<6#-"SMA9=8A4T^Y]X6C2W^*ZOZ
MK+FZ]5,^:_ ?]%QW'LK%_9/>>7CKE)9DB?]\E%*TX#,N72-5=5[*7%&4L>9M
M$B39LZ3J>?O1(Y89>4VBTMUV_<)*:0NXY(P<PZI?"-Q4/I9DN_4$9P#&23$.
M$WUKCBW6A/5\FAX%$^4;!!8P)ZN>WG$"CA_X6DD'7AW T]C(K8O%+7XTO$]]
M(]C4]#H+\0=]]514;&H$1,='N#)W-(I"0[)H^G-; VP\V8QA/)B&7FH8C  3
ML-M27S;G#!-050F78O+GEV_"BJT]E7\2?8#C(SI>+U'Q.T?)A ;]NMFLZ/-G
M&,DSGCB^*7<H]*VO[_WT[)0O9Y?E/@URWSI;BK1O4,?K@ ;D*>8BT$M>N319
MC]'ATW($BR, L-,+U-=1[V!&J8Q33UC)?GGDR<N_O#U-OG^)L-/5\O_"Q2Z0
M=25OK)CRUFNYGY*9G5_]D/SRUU2[;HJVDRO*&\X$Z*#;1SH^G]J;/F,&I5-I
MU>"9^/[IV>D/D5_"?!R="]>Y@,N'#@?B\#I28\RRI9]M;U/D$[(%\\EST(C>
M$:@S9Y_D!S$:L-49T1(J0W4'Y^HUGA(W"C%\A-NG:(#G#8)MO&(&[PV6?QK'
MRKM1(72;]_2Q>R/9!FD/O@(%RS2"HEU)/4L-@B1  VIG*8^/82<"$<"%P\ON
MLF$,R5A2]%:KY-]B 1O3UE65EU\&[3>=E)_]&&?U\9%V7)MC7HKGM*:;1754
M;CSK,Z'H\UM&;":@J![_;/M-D,K!SC&&-\LZ*<(;N]FE^#3?Y3.!<D-THN7;
MVT*1Q7IA6^W!0A:<%,@"=9R79$(X.HG'JHE LDUR17<IVA]L$=9@M6!?DH=F
M1#U0?Y?<5'!PTI4!1W>XG]3-(*P43J[:(_EY,"[?:*XICDV 0 :YS;P2(,;.
MC")<^:5'7NO+E;K[.@S R!9=&I]>HQ"<1EOS'(>Z(!.4QRZHT C>7K.S@66X
MSCB9"Y2&ML-C#)I=Z<"OV9NWER9B'Y(*IXQ[)P^*O-I;+;CX/>ETT5EJ=U$@
M50X\.4X5I'#A!V)-*<O#K@0U@S8XW5XMU'/@;V$Q2VH!Z>0I9["/9PBYKF0&
M).D$MX$1HTL H<5&NO!+#=#X,I(R#0X6P2B)EQY$X 8)!"8/07NYQ"(B]_8V
M&[T0$^Y6DT>PXLYTD&@;,B]+<X>LR\K9+?;&LO4@EI-&D5E?E(Y"-G1\CH^V
M/1^U@$",VD^\&R[M10@_Y'IQ1!G839X9E\BXRCOK40&DL\0)5]8(LQ;YFIZ]
M\UF.P%Z/GJ8I?VOK2/5M1_3<Y_DM#G-H+@J*FX%%&S^"T>EMCF/@=(:1418X
M#AH\Z>,R5$R[D=0A]0'JE>N(=UC!'*\_U3.#YXO]5ZE;!^/PP%M/-X#+^^GP
ML<%V&/!"XPQN 0N/=\ER64@FE<MUAD8RWQTU&JA)=,:A"AE-/O@+"FW_7, S
MD#4HE(3HO5FQ[+6+*<A18H^>]TLC:]@Z]L&'ZY!KC!R0-^W\-T&W4* I%%Y,
MG9%QMP_6"H,PUAG#&; DM-9H +W "COSW7B#["$9,=B9&Y0,I*@[<KP-C[8\
MRJI,<Z>Q4N6BK-2?*NQ)"?O+W( 3#&X.H=]"V<OP6RU3)H(?;WDC"?#1^[+6
MJ\CM6H+QY, [,\.DI!;>/"SKN;BH_BM!E@!8;%%E0(SEEGN(T?\U$HT,UJ*U
MR&7!:&XB5)J.N:];Y[QW>ZISWD2=\\GOJLYYR%F,?0A14/?T?% -EZ>L;20$
MY.&3:U)S*4ZR"#@*4&@ "U3$T)"!!OG-*Q8> #1IBE+V;*F_0-K9T%A1OB*$
M8<82$1_+9#@D*3E,SBT>E(DX:G#U6-^^E+6TJ&CT5C$ED\GA$OL5WM4,&KR=
MCEX&%0U!PC&+ O)"Z)T3II#<.#C#AG!>PW#2E;":$]]8IG!&;"7[S1.MZ20O
MI$%NY?C64/6DW;#)2FG Q^!1-E763[V;W@$9J3+G8$=ZQ$R="J \':3V=N@/
MH^;U(; K98(!5K!B+)X0!_"H0@$)U[U#OF#7,:-:5Q\?<290TG-VB\I:\EP:
M,03N80(6+ +!(RSKK+*VQGG.Y.'7DH"?\:U\<9C"Q-K1Y+;OM=.KU2'A^07/
MJ/."$&\H8*@4,LM2"B*YX\C2YZ[]?/.E\'W%,^/IC591'S^CX.N<XP]FXW2S
M"D9.#CKU.1?;S\)6%;NHJM%[A&X?%;T5!8]@',&KMOM_RKNV=WAEBHX @1<7
MV<PQ@PWN%_V8+EV!=O2?>5/;Z#OR. ;L%@@.SRWJ"ANQLI)+@^TJUS0R%S(W
MF]S#)>/!MC%Q.VVN55'F=EADBG1 9%/6#4<(%UD#]@<*X6D+53P(+3SSPS&;
M')D;I"TJ2:'I]DJO.<$<GC624Z;P^@I1I\70\G1@5Z3'DY-2PS'!Y]9BE-0D
M>6:5F,0C1KFV9+>WS>J R"YX8THUNO7*\4?=BYICUJ!\2\XN2(VK+DRK7.FJ
M\3,P@:U9LR8WR <W\F:))Z2@>+;@$!??MJE?3('8GISDI[)_QX!"G _A+)4'
M:DM/3]^Y3)M0.89+@X6=PL/?3K042^"[!X_OIP]O/SX^^AZ;T7^+-JG1/)(#
ML"[Z]0\GR9N2:RFT(RU=R5^@9:S9ED_2CAI7BY+\UJA<5'*+_H[(*WD6$ V8
MAA1LQ5*:-D*9K&@I_([7\[Y$+UM&FY-382P2$H;UO)P-@R^P?.>XA?4Y2(95
M?"TF ;"ZWXS/CKFDOSB-EL(_Y(,'8!EWZ.S(2[L\>3*&HC ?>0J$]LQ\8J$I
MNH71;@9FB4_3TI,#L"</V(98,DZ'\@%?26=>6.:."B92ZK9BA2L<D /(E0,R
M8.)V(+,+ 34DO0%?V2XD8*&F"*4&^>.@HAY<),($#"^#JW!FVA.W;,&#>)-<
MAP :6>TVC0$9DEU7"8K<>%+42D*0&H>71NMA""16DEN1%Q5W1,;0FYT1:IAO
M/IU#3H-N5%ZY5BU M&64CIOM.BNS:PWX-JO(W_NH22);YVU2(I$#A6F-EOV4
M3.XZ4Y7LLE3J ^\T2,(K?053MV/NS*Y-'M^>F"PN[]I[U3,M:@CD@U-HT+&2
M&!6H19_ K4OA%6*E8M<KY1.%NQL4-PV IP053L :1Y_KD3/LWE8)5!A)A.@;
M:_%<HYB.P3?<+>@0>2#\HR>WU)#[J0G0[5R_ SB1X&K=3P5?:;=>"GFH7FN3
M=6P3-F'A3/H6QZW#=KZTKL;9:I%3<6T>$9Z'8S3$L]#=U![[T4N,DDNJY.88
MQ23VKU),/G?V7_H2'1NXCUS]?7S:+.Q&]'8%F1[(U.9!1JL13+<, NT'&< M
MW$G:&BIA[ Z*WKH$^J#DR<'PD/VCN=R@XY5F!D?">X2;95DCALBNM+VU=;5<
M?M/<9UTQ:%WU;_5D19YO.\;]2'R-YV;Q7) .^<2'T!DI.XPX!B-4POQK-,0R
M<Y/P14[XK#T('][2Z<H9I1&VW8AMSG-%N[RBOMO4,?,,FU^XCA^",QL@#D"$
MNS*Q+[D>+?M\OJKJLCY7MK/M#HDI(-BSTU7EZCBO!S!)@*07=#J2MPZ?&OJ)
M]G(]]T;D-X>'B";;Q&GTK?M&1ITQ6&)6: <$G6=*P6+DSZV!R&UQQU4Y1=@Z
MXEIVGNWB[D0MM:%%>4,]J7,I<D(*(*)#DGQY-N@10?)9K9HNG9/@ *IM)\FU
MWI[=C$S0(?94FO[VU9W 36%L?FS2P^]QL>(2',^K8A/47I;76&W/W4C;GVP\
M\SG(75H.I"R[S4>L:7.UD4Q&R"5=%O0<"WU7'DF=T[M"A5[YN;8H!F-QP)W#
MG;H#]N0Q/@?R<F>"O-P Y.7>[0GR,FW-3P)=S[J K$K".8N>4C;6? :JJG2(
M&5!-:['DCHR1>T3I&&?5)(9)JQ:%^X:"(CRJF+P]%D>@\YX!S2I0D"J(D8Z,
M'%-TKNDB/B0$,:G.(9B"^O5:\*U*[YF('I42R%==4Y>IRN@6%KO[JZ3'1WEU
MGIUKB@HH5ZD!TJ\]D:87L1@X$*FA7L>(_OV'.K* Q@B9SBL^JVF30&)M@9,9
MH$TZ AN=N471;D2<&Z%]V^:LM;96K3:[*I*6W/@8QJ>C(\;ZFM'Q;?TR;'2
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M)#9TGEMA:VND?OOI$-RS8-](AR;M23(M18NVHRJ(O1P8W-_XDJS'+;?5,(+
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M/]V]+@!!64IDAU2P+S.61 +KTJM77Y^G$Z(GZ;]DKZ8,9NDFMT/6OZ4:EW)
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MF"/2YU?I7"$WQC3I8F:4CS<$X)TG"R#O]J!#:<4+,R/E=?KT8SK^."(-$=.
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M#HC8.S<DZ^Y+G-+6TY0LM!*T'4>R35P[T<55Z^;0_F\SZ3P.?AJ>PV$>VYY
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M]ZSO'<)??RMH>@L' .&8<%1O=3DM?[2LAO&MH^++IS4C?K#J?*'\P*V2!)&
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M2L?,4^W=@BX/)9WEPH;A$^WVL)!&/O<0^H:N'8;YL4W<7H0;'_NPT22L?X/
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M31W((W/X.Z@?QS/B"#V@EK0HX=Y@5#3693K6SA";=!BYM#/'45.-I],74>2
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M7& O]U?>J0\=&%DG1,K/E".^',H1'Z(<\<50CKC68/T*VNWAGCUL]U>!L/;
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MQMX=%S^#ECJM,WCV*!/(#;B#I/J+73Y^F[S(SQ[A7'92:R0JX:1K)2O<='E
M9^P[5NQ[Q\$^*JG8.9)L\YH+QIC=4%Q8^@O_I"QM\"ZTX*)]9>0:4!:7NI-2
MP>:6_);23&S@#H&^-.>HR90D)@KB"F&X 2O3W=,_3-J]4_$UW]M'**T'BY3
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MJ\R-M)JHUOP0:OQS%UWC$L)@U?4)G,6_(1_N:584'QF0(WC?B*&7V*.SU2[
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M?C7%T;G!]X<K_ &TB:U=O56;'(E(<S%^GSS>1Y\<-S7\T"HZ$C':WOJQ+&[
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M&5T26-0O] <0W8K8#=@0B$(HCU[G[/L)>L7%,3=Z-$1<ITH"<5Q^TJ_^5%/
MI<4<_3C-]EW"29<,+K)@<;E%VM+V^O'6= R(RS,$5IZ%EV&2XY*\%FBULHO
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M\F04!8C6;?0FX?(:<'R0)ARL$>@*ED"EX&& B)6:<71HH_]"=P.P=L)N">!
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M91@E^0^\.,[W29J@QDH)X)W[B:88S )G<=D=0E,<_@G]!GV,0><"#!>(LR^
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MLG))JC'IV[ 30E;@<N/J9XT;W\P5LDV8#"FPXOD D:Q76Q6_7'S;0S1..3^
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M:&H#S?E=#:Q,%_4U3;-V=]ZF#NFWF!4LO-#]E,FTSCZW^IO;I)[#C2TOFQZ
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M(*$^?[@V:7_@@&_2B7ZRM&X4ZGM[6+:;WUT&,R$.8=-)D/R6%8OE],:3LF3
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M"WCR4J2(%"TO8@4 5I'D=4>]O?GSTDLS"S7A@S^X6- =B"2]@QO#YKY4%JF
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MXC!+?6>W<^ -G]6]3TB3+I]=3/9ZG8'?ZX_]WG#XO$'I4JVX![=1@Q?HP:R
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MHF<>Q-<\# '4JV#D09;=,&QO0:I)P276)!T%-VX>HB0UWW;AM,'SD1-_-HT
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M92[H]C'=\007SP^9%-%P&!\P#14V,I4VE(F]8*GD\H<LK'@^EAKAG_W@L&;
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MLQ#V31"*+*)#Z&<!C8 F*] DEK4N_\I*JGF+<!K/+J 1T&0?&J%O!30"FJQ
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M0+<*G1' V7'@8J#%S4>92H)!N?PKP>."S9&+6!&"<.>"\-1E),9(W$LU2E@
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ML-#-3V)#:9A%G'G$5UIVM'">M^^<1;+R[#E\6PD:H-[&D#T6HNFG1DP^4@,
M%A-26N2;^WA40R/>7=T2 Z,<4T4E0 .N[=4%!EXNDIYFKTMU,44;4-D1Y0&_
MA(,MWL+74T4"&MLK*?'&/WE6-HRJ),@ZJ,Q]^$*]!SBSWC:GN+L%L.,]BP_\
MQ.$'4$XY5'BMI?V=6DZFMTUXU2MX)#AD6PS8H "VP&Y ,/ 4QK6/:IRKX.$9
M/CPW76KX7%"9#MZ?[%=BK+RHT/?M$+:\&AR)*):N@:B@6#^F%MO0Q&H2??[T
MLUF<*'AZ[ 'APH=#%YPT?1X\S8N9#;EA:GL[#;"*901[<T0R;)M;0_R4U.%!
M]TQJ=B\NVKU>N]N1+KN]-L2E(:/5[IRV+CKMLW830]726?<*3/'/5_03D(%N
M]J7S=N.D?8X_[ZZ"I""DN._"/CKQRJ\O"XT@08&-:UY9;DM;*-8-:G1'.(&.
MNL=0%Z(J4V5,?.-DY.HZS#VA)\0P$AMBP..JX6%=QU+3FXCE@-2)O@+'_G*)
MPD;QH6\(0+%DNLO"Q0N#6>)!&\': -!.8!M3V48/--)4=ZCAAURFV.S@[7ZO
M68 #^@@Q3>4GZJ794D=*UIMILM%&0UF?CTGW^3_<F>+'S*DH0&FGFW-%=^:K
MQ8QHF,["M6<;5D%6J84UBZ+/BP]--1O'^[(R VELFBIL*X4")(O[[#BV#ZNC
M<% ?9OZG,.//H#83/D61OANLN?!6,W4_K46M.D'"6:"*;,,JR"JUL&9(,KH&
M%5?46V40SI3YU(NIJQHT6ALJFG[>QYC]!X$LUQI.%)N%V"RBXNQG\)\5V^O1
MQDBYGRNMEM;;[\D 65KR^9Z^1U!_!@@JV[ *LDHMK!D2JKZY&5[5@2/H65]K
MV.V6J">MP8(:*)J>0F4-*[3#6)^7QSF.IU$Q B*5<66VZF"*#=VRIPUM/PO-
M5E;SB5U8-4.UIT&!7 C^8BDEWU6'R3F,VD!RCD>9#P^B86;ID2AS]\GM#[B3
M( Y6<T!1B37!4+W,UI1@/[-AHWN$22SU\("^4PG(&OZ/ 2\%VTT\$P :XW68
MF#XSO:&X+(G/>07FHUOFD!"6F,09%G@VB=50VX2^%*J?;-=BSX7MUQ-%'[$L
M)998X\ME'R(YV-SG5P@H8Z]L&;X2Q+D52[-94SFF4"'_2C^#WP@FK2..A@I$
MBITY[T3'\6BP&-&KBJ(X9),V@FEM+);/+RIR_Q-MZKV'+1=?WN(1N=4]#L6G
M7@KT36]YD!/D^?E- HMIO*G8(RK,KG"R"BZW!X3,_@CE@GPJ:H0\0OD8?W.E
M:?F++OG8:!UK\?AL?!C9X)<L^BDIDY(HCD&(#*DAH3$0K,8/7DM/(WMM%>9,
M,Z*%P[)7$A@]+M0EC"&?!@DO5M<[,^G_SOD !"@A#;HU%HZ.E8A\/@U.;G(-
M N ,">BX_6CJ>J)\,"_*!S=0/EC/B?+!+,Q"2KCY\/8FEZO[K8=0NO&OU.]*
MS6ZGUSUOGS;ZK7!/<J]/?X&]S%D\^#94*&/>9GB\T9D_WB@HW\PXSG9> ?""
MN$-,B.%IE?$R7]D3TK&!CLU69&&#$\84(QP9Y_?SJ_&/BP<-E0+DP6#U[CON
M 9M$UR)JV$/CT1B>6;IA_(&&640<#QR\*+2U<E;(*Z(P"5/1(^&M1ZDAB;O>
M2M22FYB;N5YK/'A;R)7D0K$F%\KE=VF^Z3\4:4*]AC_?_!^.',CEW_S%6KU8
MF".8)G$53)/@_9&-8)K$F69-__A-B9<UF::8LZ-"<G+@.NUR8)$Z"F_^.E%T
M#!OU)H3X(QF71R^&?Y/;5](H)4<:698AQ6A3$H!-::3K]2^S\"R,Q[3(A!@V
M#*&&@.J42&_/3=M^Y[=/?,7IGJU'IGON*V65,R9TDN\T6*"Q4BR--8.Q3+U0
MM26OSY1.R4@;:HZ@KZ.*D%QQ5%4.455 5(H]D<YT\\X6A'-4S9A@2I):*CBD
M,>A<B0_J["<=U.+HP$^JIS\+]5[B5(<1BXRFTA8/\<?@K\\&'TA^>+!&P#%S
M ^/6N+;=!R(W5 +%6'GK(4H1C5QHAUKJAEJ)I_5"SH^'&),FGM>11ASR-Z3)
MGGA=$NA)V'Q],2=%3(V;7+X<]Z0PGX6D/L :&Z,)5D6L#-3D?7I,UFC9(#.=
M'17C3)'$R>2UQFI"=BDEELH2.00:_X5QF/X$!I)=T/=./*]G!35MP_5)VK0M
MUG=!4&F0.T_25O4)VGIF_.7GHJM23@BJ,#'5GB*FY;C+3T8P^9]5$"V02J'X
ME $4B</X5+7"ZTV/C?,:XHC+2R;?V+#M",QC19^%]]2804OF=W@K[Y=[+WU1
M=!=>(FI"%VI"SXY>4A6:STY1Z$MH/@YKD740R\L@7NBM)!9S7*2*=0Z@3<>2
M;0W_?*/!B".H_#C^-AN_D13=^?.-3\@3 GM1?Y=J^=F]3TR5:FYV_T;Z;3-8
MV&0$<H.N94QL-9GRWF1A7E@I O4]'O#^7[Y_C_R!U?]@-] S"X!2BY@DXOOK
MJL?UX/-Z8N+<)K!GX6\GWK+C4[_1S1QM=*C89L]TR6:='QZ<:.9LHEA3188
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ME:1LU_3?:_H@R@+6TLL-K\U5U>5<H9!Y=DB'S[;K=C8A%/9$*/QDB$P?1%G
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MV]R1OQ+%LMD)6X9*321OAO>^WF82U16"5]-RN_&:<T]XE9E@^WYQ^W*._23
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M:/8E\53#(GI==9@S[CY5I5TZ>+I>SQW&9U+I//M?:4]U^PW4&FHM[WJM:?[
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M2"HC8I-U+!/+.O;TQEKE^\_6\/N=66]4#GGI>7YCKD?G+]:&7=E\*57,H!^
M'/+(CYA<&K9>K#:N9E[9?!EZ)84\AQAY7;S4:SY=J0=3*SU?S>EKPA6_9*K]
M=.&?']:7_"&O^.MN-BO8;.ZG<J^]V403'9 T^8@=@&>WE8YJV52&M8[(%N'K
M22%/[,L!.@&!I-*3M *2@J22DS27!DE!TL0CMK^.]4M<YD(J4TKZ72'HMK8/
M\ARP!3DD$&631W[$0#O0+G8)03O0#K1+"HBRR2,_8J =:!>[A* =: ?:)05$
MV>21'S'0#K2+74+0#K0#[9("HFSRR(\8: ?:Q2XA: ?:@7:Q)D),NJUE.B2L
M-[HD+.%$-5F^R5SET:E/VG:-U1>9INI%LE)8AHH[E:)R2KI>U=*KHGRH$50/
M=4;?C?)P4/Q]KW_3GEY"I!ONT%0?WBF6;1%YFK.%F,T571D!;HKN$\6S%2T"
MW:0$BX/WA(9K+S(?(2<V3->-/S905'G%E5DV0 DHY9,-4 )*^60#E(!2/MD
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MX88BO(3DZ1NPG18^!&-_]S3,GUA /(?KFD4/C8NS2-F#D.7H0SE5RE827O<
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MFGS$)"Y%G0KMR]#5I5+.I\J9=,(K4*%;&UH T-4%))6>I.CJ I+*3M(<NKJ
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M0=+$(W:PCO?+XWWI5#I33*Y+C9Y,^R#/ 5N80P)1-GGD1PRT ^UBEQ"T ^U
MNZ2 *)L\\B,&VH%VL4L(VH%VH%U20)1-'OD1 ^U N]@E!.U .] N*2#*)H_\
MB(%VH%WL$H)VH!UHMVL0E_1D.NV0<1%N5?_INQZKUG7;]I),[9F\E.^&UY_D
MK9P1U?,=TAFE[PJ9\LG7D_JMFHP>3,]#?4&/I:'O*4.'# Q_H/A#VWIJ)7)\
MED)&6DMI#23+,XQ_C9&3.6NGN!9D3G$%V1)!-I@I,&?+9DKJ$EB0+1%D@YD"
M<[9LIDHP4R";-*B .8?%G+7-E-05XB!;(L@FI9E:4I$8!'G?;2K&*U??CTRJ
M5"Y(7:08:Z</.=5G35M=3$M=@PY;O5]DRX!L(-NNR)8%V4 V:5#95R_T /W+
MI+2]",G[(EW>P$,63</&'QMHE+SBRBP;H 24\LD&* &E?+(!2D IGVR $E#*
M)QN@!)3RR08HDP[EDGJ;6J3>9MP0ENBGOF-8-RWZ7%O_IIH^$;\^LQWZKEM#
M(VYG]/OF]%XOF,62;R:CJ&9;Q4V\AZZED7'1S=15@#W;4=P --3=Q2\A^GN#
M<8LE7/N83.H*'9!4"GGD1PR, ^,V:A:EK@@"2:60)P[$)A>2IQ_?[8AKG>>W
M.UN]6_SDO):_'5S>?_Y8'M\M'NXJ5FXHI+L3?'6>Q=,PW^7]WG/7>I?3A50Q
MGZR;1F V9)$P;HU:'+/9W6W=T_E*Y33T2 YYY$<,#A\8M]%=B=25=2"I%/+(
MC]@>NA<;JL&;28W.YE.E(MP-.>2)V_AGI"[5@_&70I[822IUB1](*H4\L9-4
MZM) D%0*>>1';'_<Z.<[R(54H91-N(.<E'I"N=@OFSP';"\."439Y)$?,= .
MM(M=0M .M /MD@*B;/+(CQAH!]K%+B%H!]J!=DD!439YY$<,M /M8I<0M /M
M0+ND@"B;//(C!MJ!=K%+"-J!=J!=K(D04VU]--_U[,'JKC[U>^)HADN:O>^J
MXZB6YW9&I\U,06_VO6P^(7=EQ]?6AP3PL3_>!0#")L0O(3()P;@E:7K19ZQ*
M=Y7ZVDB05 IYY$<,C /C-FH644P+DLJ(V*3%S]FC.Q_1X67!UF>K+7ZR-[U?
MOO?)^/&ULEZ+GT6;BX2T^VFU:B>K>_W,HQ]KLY]L)57.IA->$P'[D7BWZNGJ
MM"2,$U>GGVP%2B2%//(C!K</C-ODWB2+7@\@:?(1VSO?8BMM?DJE8BJ=D?L*
M5&C5SDP_FE. I-*3- >2@J2RDS0/DH*DB4=L7YSH%[G'^7S"W6,T^=D'>0[8
M6AP2B++)(S]BH!UH%[N$H!UH!]HE!439Y)$?,= .M(M=0M .M /MD@*B;/+(
MCQAH!]K%+B%H!]J!=DD!439YY$<,M /M8I<0M /M0+M8$R$F37XRDU+7L)*T
MV8N4<IW93DUU^R9Q%U6[CHC[LU[TS]7?HSP:_:QN]*,%,*+CCZ02(JD0C%N2
ML1=]QJK,UPHR7T'2Q",&QH%QFS2+.535@J0R(C;I^/.B;9#H +/=UC]_&S^^
MJ=;'AZLK?;W6/RNW&TGJ ?3<^8BU&5 ^E:E44I426IG((8_\B"5#M>+J"91/
M4;,*79)"'OD10^ 7M(M=0M .M$LV[?Z(TW784,L?EX+ROZ/CY/L3;Z!<6XA,
MH56%?/9,-GEB)VD!) 5)92=I$20%264G*6[D.?1..XOP",?R(DW;P$.V)-M"
M@LHKKLRR 4I *9]L@'*%;'*=E6-60'! "2@!): $E( 24$HIKLRRQ03EDOK!
MVB1Q]I20 =%/C5M#)Y9^/;2MJND1QU(]LJJ$L/ZU^;M>S-W5OA236T(HQJ[H
MP> 5GXY>4</A/U;[=TA,/991TJVAN&YD.I_9>D;(80$/^NZ4OO.7)P'X/0]E
M'=:$K*T)\S<T01-@R.-&<6WZSB?$ 7@9Z;LB-?=9^S 9+N3,53*I4GY1R9Q\
MDY(XPJQ*YMX%8RZ)IQH6T>NJ8QG6C;NA1.Z=<>:-G'19V[#/IS[!L.\$^#*
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MW*2031[Y$=L:XU84IF\XL"]#DX-")9TJI/.)NGL,:K>UM0'7YH"DTI,4U^:
MI-*3=+[/!D@:-REDDT=^Q [&RSYL_QG-7?9!G@,V)X<$HFSRR(\8: ?:Q2XA
M: ?:@79) 5$V>>1'#+0#[6*7$+0#[4"[I( HFSSR(P;:@7:Q2PC:@7:@75)
ME$T>^1$#[4"[V"4$[4 [T"[61(A)<Y=JAP19V.MU=[EB]YIV59?H-7LP)):K
ML@]=DM^^X1H>H<+<&AII49EL_9)H]HW%G_)--7W2&673]9^___Z6]X?]PV[W
M<L7ND15"<3#IGR=H*H;%,GLL(A*([@ROKXB+9^TA_\U-<)TYC$K<$B)3$8Q;
MD@88?<:*=-HB.K^ I,E'#(P#XS9J%M'Y!21-/F)@'!BW4;.(SB\@:?(1 ^/
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M.H)6,'*IA&SRR&_4D'8(VL4N(6@'VH%V20%1-GGD1PRT ^UBEQ"T ^U NZ2
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MG3S]:!D? ]EE*!.*<_V>)7O[AMMGZ>+"4UOE)NBUG_G?7XA^_>4&480%D\'
M#:('ED*FP WC"2G%(A[LG"0R[M#./:IXNXHE%-*I8CIIH03D#<@BH^PJLPW7
MH%A*9;97S!>C9U#OD/!V;@8V0_"*>)Y))A@_$CG(WU]W2?:?D\]J&9&#>3^@
M1Q%5W#&D\ )DE'$')JW5JIV\6Z%BNUK\\Y54+K/HEG>9)QZ+_U,C5M&'K+BD
MO)B9&X_4RG4L-^QKQ^UKD0WY55]UR(GJ$IU=QDDL5UV5G]<H7S2_G?3.>J2+
M'?B"*>"5*L$6?,CM+ZL4=(CK.8;&KND0U8'(WY-+QMV%ZQ>KVZZ6WW(V548!
MH$P2)0$U^75E*_'X=#J5SR3_(&N)#Y"/^ #\+NX+V])4MU\72],R!T!O7Y[7
MLS]&@^](T)\TUK.M8X9=>%;O$;;B8Y673,;=6:X%"K6S5+UBJI!.?L81% 6*
MLN5*_D(JO0>*LD;K]ZJF.80-;B8O,LPLKUIZD!?I-JQ;$C1O6Q5UM\TK/9T^
M_^=OA $6I_.'B(]S^8>^IPP%R#!SDLBXPX3D9VG@[OOP\BU/\FTBM I:]22M
MVFJ)?SE73)6R^<1KU1I%  V+SHCJDE,B_AMMK^NZQ(NVULUNM[7NRP,(DO33
M%64 [K@.0 #)SQ7.)YG_:),KBXSH4PKZ@7[RK5/IE>O4)=&(<:MV3<(VOKEE
M&]_"_?#GC]'0&%QBW[LH\>RJ+01UQG#",$@BXPX39U>JUZX"X=E49GL7RB#3
M3 [ $J$M&U:6K6Y6<ZE<+OD)(FL$Q>=A;SEDJ!KZ*>D1QR%Z<!Q1M71^2"&V
M7:M\@^N<IU8)^=THH8A]/#<!J%-MZ\3FU6:H*BJ'%6;OB19ES03;4AD)MG*N
M-O))E 34Y%FCUUDL8H@TIS*%I/F\S\I8FY^0JB:"_BWU@7E.;*%>E+_V\;)]
M,]2MWU_.3>S@%Y]<<QB%M$,!)BR>)#+&:?%F%&QG^6RE<BJ7R23>J$%O]D1O
MGAS[6D-QMNH5%"JI4BYI7L$ZU>-GD^KQ>=1#S^R26-ZJ7?M9J?3MXS?MU[_J
M=CO3)FK7'H(7!O,M%(O+(N.NBL57:]3.+IE)%2N%))LNZ,J>Z,I&567;(?S*
MWF:;E58& >J#H6D_$'))3-4C>B0_:ED\X&K0^E10S;.?^B_$ Q9,3(BHD+9+
M+-(SO''+V0>8.DEDC#,RL%SK=N8FY%*97/)M'C0(&K2&!FVEVKVPSSGJE=4Y
MZOS(9CI*4[5T5E[@K^5$G)W^*/W=^U[HYHK[&4,X[JD#PWQX]]CC^6==8T3"
MG/CYLCB?1146) ($1PU(!9!%QCCMX=H:N;-3B$(V52[B%$(BB9* FD2G$"]2
MJ:W&*RJI4CYI-:=K'D^L<#H:09>88"I$F]N%WL7#_<>,]SWW6?]J)"]$(5Y'
MO_.VP/R!'=?@^^$11MB39T.L6CBZW9F?KNWHQ!F_G7]1R*"XMFGHPA&3W8AN
M:Q1Q.B[S6KVSUG[I5*&\M<SM)>J<A!48NBKQ*.37U>VT'BJF\IFMI63$K:Q+
M_*%JQ!^B8-=4M]]R[%M#)_K)P[5+]&BW  K(;1ASR;1#M\B;N$4#M5:K7]9&
M-[UA9V3]&(ZT6NV;6MONQ4"K S!=V]2W/$$;"L3\U?UP40]*-6O5JT_*]57]
M5&E<*,U6_;+:;EQ\5*JU=N-;H]VH7_WU9W>KS$R^%8,M?N+V='WUWWD/I$PJ
MDR^DLL6MQ<)W:YTWDXP"S95Z%(G1W*W&D3*I<KY"-T%;NUXD1LV=<JF2$0.2
M;R\HGT3)V$&CO0SH)XF,H-\:APU+UN@SPU(M;6J-GK3CB[,9W]K[YIUND-F^
M6 A\=M[\?J6<73:_*&>-B^I%;7I__&YC&^2#)C8L1-PRRB=1$E #_=9:H$XB
M"Q1=F31"=)=M"FNVQ=>1KDF"Z]\S,X?@I=\_.J._SS\UN\/?=]>M;/(.P7?2
M9T= *J3EU[YJ$V25(?V%X;JV\Z!8ML>>8A%^&ZQ-"4O] E.A?_6)HH>]DWEF
MGOB=9KOHT".-C+L[,5NAI3O+Z\_NQR4=T!AHS(Z.EE/Y8H&N7,G7F37:^%Z2
MH?K F_HW>PO\B 4E_]R7*-U]4^_LUL5'([>?Z?K/F8 )ED)>ZANL<B!@W221
M<8=G/RO4;6?WQ^<2Z ^@(<!35]GH0Y:WMRRGBVAO&<<:G%NREV_0_:)J:829
MA\' MOAMZ,MV]">EC_56YN,_WU5LZ-?;T'M]HKC4+HJUF0&L\.OD85ZV9%[0
M/5=2%T@^B9* F@S;XH5+Q*XVQ_E".H'NX[.JW%N!IWYF.]1M]QVMK[H4] ;%
MPU#-EM\U#:W9Z]'W63>K]LIZ_\O7\ZOOO;/T=HO/$K57/B/A?6PJW1)K!NO9
MH-P97I^NS )2!,VWN3!G,EB8Y5QBY),H":C%%M%YRBJQJT6:'?DD[@[B=>K!
M3Y?LFK^KCJ-:7OV>.)KABHJG11MF<GVIG[9SI-CK)V_''%\=^)*-- G@9IOI
M.S$#FUFO42LA]2CBV?;,ZOBNXN6E4C&5SN])+1/*PN7TQ@M/\<:3H->;\M?C
M5H\ECDCM6;GBBPJQF5\R58A]?=MMC,B%>E:L)"&A7+Y"[-9E\UOCM'ZJG/Q8
MF&R.8FRX*9MU4]:W #MKMI=*%\IP6Z"T21M%4I1V.XF'Y4HZE=U>)[^XE18E
MV(@/2R$C2HQ /]!/ON/W:'^S>J]'-*_9J]]K?=6Z(9>J1YH66[+9_^J_?>.6
M+J.6YUX2UW,,S2,Z^T/5TJ=_$?EDP]),GZV IX8[M%W5_$B7C2']QBFKV;(\
MP_*)'O1AL2UW>E_^<?#OKT\W_:_I;WG)C_&W=8\-GY!Q:CL)YD6A:!%%_.PJ
MU,W2*.@P-9+(N#M_.GY]W?3F>N90-9O*%\L).U3%PB^5C(>NC2_9-<]H8RY5
M*6ZM5S-VQ$FR _))=-B6Z<" E$^B)* &^JVU(\Y&=L0O6KU;5 Q;GV_A'JSI
M43]!^ X=8W)4'=D&?U=;VNGY]UZK19)P/!W/.73CHG99KU[5E3].Z^*G-ZPU
M.#N>1J<SB63<89[P;I5WYSV_B_E4J9 T?QQ5Y;+(N+N-<?QZN(VC8ZI^Q4PN
M8>J'[3#V(Y+*B/T(Z ?ZR;(2+.[1O=.C8.-*;(:3L.>5(25[TOJ[VE9.ZA\;
M%Q<L"[MYIORH5R^1@BV7E4I^-F=\)UM5M]G;J"M?2J73>WNQ(30=FIYL36?;
M]PV5Z:=RE;TMT%BC]^QN';CZ#ARXM>,*S_;ELG'[<O6+TQUX<5D);#N70=%M
MOVL2"8S[?^(9P>$8]LU5WV69\N_*L*]O$:3SX*#ET')LU.14\UT=Q;RTW.%H
M\^'J#7E.NPZ\RB[V,ALCN]R)@3L10B846U#Y.6*OT?S^RA\.3<):**HF6^W/
M3/NN88FUF2ZGN[I>=?,[=XX[=21LX8R\H]X#]=U,PR([WKY'$1:#8MZ2:;N^
MPUOW,=05!KL2P1UIBA+)B.-@T _TDR4;0?X$@.5+CWRS*)]$4- # E(^B9*
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M*L7<\^F^DFX!%\L_5:@V)4?@*\R592_<7(N\0M]CRP-=>%^_ZK+Z.9W,3$R
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M"QK,UK$N=T'61IB',WUX-+V8A+?;L)6AE$]'%H;J9-O+MJ^"KDK 5N-#I$:
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M,9RX<O$MS9L/^Y@-RN>\;DZO8L)$C0@Y2R;<*]!'C!^(S>'(>PITL4*E,HX
MVI\!TIIU@P[\QWN]I/F<4+"A#G ,MN-*KMY7H?*8/Y^50=!_><CV]&#""UGB
MCBDLLCS<Z?->F_R6I6-@8@Q7F!'#%1I :<L^^)8]1DN$I?U^3S]O4B=NGF%9
MV//?@2*08[V-I.,2(/M!-C"$=<92B /@=/4>[3TWG]NB@X>LCO;*"DYSJ&Q9
M.#F[M-_Y*A9(NO7)G:"0P.YP9EZ5DA)K!DHHT2:J#3R%U^M!)80FT;J&8+MQ
M/H?]QB( %!^-;GH( [1- W32=8.)O_?2W\9;N'P O%-XV4O? #0 (L7Z"X5-
M\O3%]>"HV B)?/]#[F"\!30*HK7D331R=5MLT:,W97?B>GX*7)C>70.06!12
MD:K$9&NUS#NNH7'$:Z3V59JB2WDK@J],&PSQ#<6$A00\&&P<@" )A>,XOH#>
M>:1>]%YX=&FX'D %F4#E;>3M84J>;),C.0*@(8Y4PZF Q].DF<&9.67I[Z)_
MJV?(+M!F=X@1@4(;EA)ZQ(FE'_"V'9/.$7FHW2-VFU<+>W7RY+%XH#KPZ"D9
M!H ]' AA*BVS_[OD/]^@;-N!A[.U%5['NVW05B'RARIFE^!D@;PP=3=@:H)+
M 7XL] V$[+6/ P(M-S3^?D*:$Q*>JB;YC9^JT@+9.7HCUD2SS&.+%> K9]8:
M\NT;PA68[INK>[[SD^V.DM.$1 CDQEL?)OA>CQ.]"^9!D/T]Z!Y,0-N(7*UP
M-R+H+/42IL-CJ#* /]0;]D+"X=<-B,_W+2^J/&.X<ZGCPLR?1DTK0[Y@G+(D
M,C"(\CMHK$1C-'3I3ZPVK8" ?C_;<>@!#/HN 59!PZ+M"!CR/:F&R<@#@R@2
M:/X1Q85*O[?+T"D0BEG9''@J(:'7YX6/Z)1%SX^!75O$>1G3T:D2]-[ BAY
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M[21NPBL>N[_^.RG\N!E]_%C>VZ=,N*%S)HD+<KFP,O=RU<;)=R\9J% $/JN
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M#H9PJJ_K RRAY%)O&K_UX*D<?P5T',GT& -.!\R%JI,P&;Y08LD"Q$AW6-6
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M_CS2@HAW\6H9G( ]V-W<-?=[(+'% (F5!; [U^E9BF$\_?CYN#5 8C17#'/
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MJ>F;JWOZYD73-U?V],V9/8W=TS?OZ9OW],TK&^T=@"=@Y<"T\@)(G4L#8O7
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METX]S%Y/V-P]Y-N2(=\NB<L-"IW/%2E(6$/R\1\E#@"Y1W];_FA/\/"3[,:
MAD@71>)KDEC>X/KKU>?KY0=(6*N *B=-:-S%0'LG_<TJ'OAO>)6##+1N'B0<
MB]"]&_$G::'SX3[9H@P7,=_P'%.LJ9AX+?]V$%QXY148\@LOC-W6%&F#-W2F
M.5)*7XVM*,5J>J^#OP:%,;TU7H3=]M*P=-AI4R#2IL*53?,LG,3[?GI([V57
M?2O* 9E/YE(L9K9FN-G$="PDP960DY5IW6>PTA?$U4M'0*6$[M4/" !BK+B
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MOX@3PN [I3P@E,+G@_E<F@/"P_0'A"5EAK)-? <2/IA/^BICP!2/S=#Q8.E
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M2KV A: 8@[@ 8-K6B:?+.NS@=U!(R6M6$>UP))44KJ:3]R=^\Q +.9,:8P+
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MMB]<&W<[1]_&QF'QHE:;O_FV[E7!9"0,FZ_E-B!8R90[!@FC:$J=[.A]%?&
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MAEYA<A%:8"U4ETY.> I<Z(^;N(0ZIU10]X9@>88@J7.,*9G4)C$__"\*CRL
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ME"G4XUA/%:QBP=Y<GI/!\C%:>^;-/^KC[.C]?JF8J(?DJGP.<<S]^C37>#E
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M_S,D^Q@OX@!G*#J4\#<Y=+3H+M<WAUB\(I9BT]!'QM.[V>MC8 0' B2] &&
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M3Q +H5T2U#74[$.Q'/3O0BY01Y&PF\3,O^I\]D75T!O0?ZF7.=H.::BT#:(
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MW^BV#=M@=KD<,$]OXXL2<SP/E3U!)[VMJ;#50>G?V7@@$>0@:TG$8[;SZK:
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M<]O$9_U1IK:.SWX8KI[V6G6Y6CH?7PP2&Z)-*8,G)$H;K,OSN?!1VO"Y2\<
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M:1V;?I8";QUO S^'L;+A,:KY5KO#U:JU6N?/LQ=Q^.Z>=NT[# F%V?8QM']
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MP/PO@%33_7LO.K75:)_KW^A(I)?>>99LG50%D%-=/-4GS_V:JEQ;N" -L_/
M_>[ ^,SZBWV<<G26;#W*4RTR=*W@&P)+N0.=U-6:/1?Y' E8F87(KA:%G2/T
M7C'@W2&:,!O$$HS?%S(I@+;KW@T"B#"<L^NCN-+8JI&/<(_[QN]CO-+BX6[4
M+$^F@JN3D34;=WER<W-Y<G"X.2:"V;;(V".J'".M,-4:7:RXRTICH19[D3+E
M5Z,<4-:X<83%YB+EHY# 7C7'AZ6'6N%PY.!9LLQL5[)\% V^4_WQ(9BY6*#K
M'CFA6&XO5/TR8F;_ F;_;H3,I(XK2!FR*/QLFZ+PXZG5G8JZ#RM0R_4"7?8
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M]-^OBX8Y7[D=/@^6C0YGF01VL\[N4-G&RNQJIOJ=1X4M&T*/K1SQ/+X_,\Q
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M"JR-&TG3**;#&&N6$C-XG^M_1$U%17OB_@=$ N>*I0V7%2S4I>M:S?]C_\[
M0>0@R1&%61J!Y>/H &21;>]M0P'Z4!'N$KW:\$84F:AL.]Y@2DDLM(;+ZM"
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MNZDPTY%V]B#.7JK(N@)2U\".I%0_T@5+#!TKY0V[_LJC *>+9=@-Z?&)CF>
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M?,L\_W2KZ%F,R#C#) XG!_@=4-G8;-E(A>D4=LRW:N1KEQT,>K;3 3CX5;Y
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M0DZA4T['&[[1P5)YV8-E,Y+9_^,H;OL3<*_G:N5([_H[VOX2]50T*!<E1NU
M)<88[MU(9CQ;I;-_SY7\;^'@:,8SYU2$!K^9.EH_(*GA6<+#E!ON!+:7'#R?
MJ_*12BX1'2UIZ.@;M%]9</<+ARE SD%+WRS*+E]JXN\OW[X?AL$:/N47$Q_9
MS*+\R!^._/ LX4&*#W?\.Y$>+O8(.V<'O=D!#Q<UI,>R3A$ IHY>-H$3M:$)
M\U,XP[1$>XG-L6R@1^ZW-#0I7L"@GC6//RV;H4\,<::M=X(ME6&B)&/7]GM!
M::M #S,_^;CO[8Z^")*ZD=1Y,.=JO]O\JCR\H*43,9-T8DJ@UA8CXWN1NL@&
MLF2CW7MA[@\?50)NKWRN4(F'ZA"_]II1*"X^"$4\9/%1J,IZ4:B8$V/[*-26
M[+X'L:O2K[FE]FZ4:[ZVT]A5"$''QZ[B!<\KBFP="J(X'/\<1-DG77KS1B)5
MYZ\%$"%]4/4,NL!&2S:&BF; \D>4W_3)C36><C>?MVK_?NJ7A._%VL%E!K .
MVMD,GR= ;)[_$!"HM<(YZ!3]6X'G6_FG7V\^WK0O2(OMZ\9-_R?7OVE<]1K-
M?J=[U7/V>@<@_5>2,I'V-'JRBK6J9!-# D/0L8&*_:%D!#L!VV'ZLD14:8?8
M::P;;Q5!TT;5VB *M(1'&4I_G7()RBBB43N7$=2?(?F?-A8><23J4 'E7"1C
M&(%)HCW)ZOTN"KN2+V45#0.XZ+0LJT<:6FD:#8/ $7QP(Z<?O9^8M"=$5 #%
MX"D)MIQ-$9@MHH%EB<?;@B+NB41=:$ PY'#V"&"BI07Q<U$2^FSF_<6OW30M
M74>[7Q7/R?!:;'2ABCH9"C>"L3AT/L5'QBKKH>./J\UAZQGQ0TO \U_.E6,<
M+KB;"_O27F5?\J]L7_([WI=\KAZ-A\PA=&@*+P3E#]T@:$)--%6:<0I,B$I>
M8+]LQN8_<PQ2X'ZL629A2T0R46',V$\ABS<0% $. \JM@AG!V9QL<*IF$NL,
MAF%R W@:R&KN;4^2N"O-E+BRHS.0!<YF\%[\Q># ;,7$RG?IJZM'R;ZWDOW,
MHU*W+*FO>=@/% C&7(G)]Q6D!XP"F<8K.>1H!XQM5$2/?179GH[D*!9SQ5*T
MURM4HC=6WX\DY/J^[$=^)_N1SU6*]54EN4=UEIZGDFJ@,T601>!'%03M6%!&
MMG?,YD#/+4--GZ(C7P(! -.WIO"-85+M/-R9YLKLDB.SV=K3Y>#L];!_SF;8
M G-D9W<BR(]">X5IM$<C2D?9S*4PX\HD4[L2"V[VX)=I2$1BI7R Q%"F3^%<
M'\I3(!CI&70^?#C\-")096($7FDZ_/>SILMSH,]K(*@+4SS-@?!G5(E^6:"2
M'#Z1@ATO]5/N2C#'@BI+BC&'7RR=:[:[.:YYWF6)F_8ADJ-I-S*^;221UA_4
M24R^]YN5;.0D1V?!]YOW"#CL0JOI_N(9?4F?=$=-#1U^0Q/K7(KFS^<+DHU0
MR9?SY64N6[(0;!U@&6 5;$?IL/>@:^V1:=PXPNW]^Q^M'^_?EU<O?E.NO/DX
M@M4/UK^A_R1!/03=GLV0RDZXN RK3LYU^$)%J8&"5"#1,"09(_1HST<6X#)N
MX*8V%6J7LHJ9N3?D@4YXK'';<E:\2/(_MEO[I?$Q>"$]'X8S>[ODV>A6_%+I
M71K#]>JO1$\O- 6C<I(OG^2+SJ>RZUF.F W[?6',6QU1\#0XHNJY2H@1B%[9
MQ.D,7L@!184A@-:GFR2)A>H?>[7E"22-U7+%PF* /96=A1?FF(QGSCPCUJ?S
M2=-$ PQH%K[L"\_[) =^/E:>;_+-ZV_Y>JP'87$6^\_N+\_MI5@RV!E;I[J#
M"7!OKAR24I\6\^)Q?H]K0<Y_AD'@3.$9YX$U=Y:>_>UH&7YNF99N"TD&73#
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ML"&BX]#>.YAJ T9FJ?BD:UU3X>.0N.Z, .S/O:QG@B8'$L&XG>(,R-%6L"7
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M6#<DOUO^=(%@VR[!LH/K.PP5-E<RAKH\7:$^S_X<^P$'@\$]DJGD@$*<R;R
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MYY.Q#/.!%\&>%.3G@:X42J4R$ENMP!=<:CL0HCLR\ X9^&RO&;CP%S-P]<C
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M[AHL\ _P'"2"(0(6"]4/M/ ]?.9.3FS<E"@_K@X0#O3+J!#,X5K](U;K"K$
MM<37..#3(*34U*:AH"T7$K98=3;0A.+\Q+MV]JI]X)"QWW,-71C(PP_<%? G
M7=DK#9>P6/'>]1_[-OS)Q7?9V*[__@>6.FS5=4EX.!E(P)OP\"G9-F_?$KK(
M#DTZE(9?VQ0Q]3_=.R@<+1V0EU"V(?$#<<I&5A?>$#EU?=.];EPULYFS3O?Z
M<^/FLI'C.E?-4ZYQU>(0)=5I=1HW/]/%124]*82#];*9?I=K=J]ZW8M.J]%O
MM[CSSA5,M=.XX'I]^.*2XKX.:6((O,YF%EHL[02U=B ,LL.HDF".!14$DC'/
M9IH(D :93S2>QKTN232;<R=Q)O*E#'HG/C!_6BC+ZBL)/J4]C:Z:S32L>W@9
MJ!)AL2?"P"05"34U+GR;X=0UQ]P7@;S8I0KN+<)1"_D/GN_(-_R'=SFN.9:E
M$==^!DL1P>?93'<TDL%B(%S=DD'5-S7=]BFQX>1@\C"<P<SW&@''(9*RJF1X
MW%@V2* :XQA83XD.=Z"IEL$)3ONVD8P*,>G@QB9.VKAAD,Z3WI%#=11.6)JH
MA??Y8N3^\?FM%9R(=YS^M83UF]"^<7C=C40RO42N/9DJV@Q7%7;&66"1_'8I
MS#B^1$N<<V_QO6R!G0OMY3WEKBW=L 2X%=Z%5\*K)X8]7.?ZG&^ 3UAU"^B/
MV&9P'ZP,T ?&?E05PSW>%2/K"S8:,3Y0/:++BPLD"6"^>:^%M^*62,[4F'%'
MZ<9+;N0+@3.!*233^_ALACX_).[IJ7IV+>EXY(!RU!V=X?7=48,,_4PPI)Z@
M"/KL3IS>6; X$K, :[SMA*CQA42=$'@+O!_A$/=DL?T@%\_">[G*V1K',=4O
M=*Q_9T7#B@3-$8?$"G./\E+43GC>^518#?ZRVO#7<64S\_2DX+%/<:/>?"R$
MP#/_L5%1C+CL\"0E53 Q1!"=AL099.:V9X$T8O10)I(KR-,AI<)%<D:J!2:0
MQ%.NZ]B;3#!D,T'>(;(%&=KF2TK'C"FY2 HNKT?!4WF:#Y)QE;?AGM6$?6DW
MDH+"YUK0S5D?:-F@&V"<S;R_^&G[4O<L35J,\7-8J!:JQ3^%'Z6T&*-ZPM?M
M3TO==XPQPN;^ CQ370P-V"R3XX#JPWRVS@ZQH]AH>LY/O^OV[R.WK\]ZY;S]
MJ]>O+PT0A"W?(9+8DMH\M5)D#A\'%_DT% RAV<J)TSS7*XG=%KJN@9?C0-/S
MJ <DNZGZP>#.-%3B0)+:>J+A>QGY.5H5"E=B<R$Z93;C*I4FGC(XC06%, Y2
MO2X0R\-C-;[B:";)0G#WEL>4R\OAN#-0?Y572%M- N@%^D[%^;0B\/=EN<^.
M\9=S]4(MKM2V!RY.H_*15HN/=^CS73.-E*00,?59F$YU[1D&9TK*+)M9.$":
MWK05? I!1I"(B^PAZK^$E!],M3K[TY7[OW\[>>1D52A2;FG^B[. 49&A_2-8
MKT:2CX:F%",I%O1O2K4@^"5;71\JFH&?'8 A?LG(6"5_B P0>X_ <VJ",]I_
M GO;AL^BK&>>#I:0MPN(^M$UM86'\:NDSC1U=\Y%-H#_6R3_.^[H'CL;6_HI
MFN,RC(I2B>-LI'\&_8R]H0SWRJ"7<TP[1\?6"HY&]O0%'V,8>*GD@;UXQ@ZG
MR7"H@PPBQB8I0=)QCL/"ZD</'4K<J;/=N=C2Z1L6X32;XB(F;>M\D.\^E]N1
MN @*IHE;K9@#L&"?8\N7AET8F&-"R(J ;90OY"HABAG'.!AM(R ?@4[3]5!)
MW%B>8.<#^#'@@YXR$X88)'!DFPZV)M2)#.SW"#1N>+AF0/W1-G3")FOXRD?V
MBX[F10=X"-EO:N_$^V!?'3_4?G2^UD3K7APOS5I-S+[A]XM;PK-=BKE2(1]G
MS60S$4F*VYLR\:ADOR7S5TCMV7@\J'TMG;?N(QVK:YDI>TAWR9HD()7WU";Y
MRS7:Y$R17Y(".XY:8^B!ZZB1>P!]2 YN _.V-TI^':6AUC1!(M2KQ=WV^[H7
M?G8\WQ0HH1D2R R;I!S+Q?["]5S'A+I;DC'4Y2G5F%W0P)FD2B/9-+;3K.R1
ML-DW5-&>NSVW9,\PLB+V2Y,[R*Z4DESY*DKEIYKC@_.L&VU0YF 2!FSIWJQ0
MK2Y2M5I_Y=B-84NPY-SS&%!+J.'-QU@XR"+!^ID"3BY%X:9@%#@T*_BBZV@,
M%\IPD.:!O6Y;Y-0$%<T<Y_ N@B1FY^)(U@V$LY!["%"$7'?*=50'".Y_^02N
M=7 \DF<$#FP<-\B0158:&=4!L.W%1]G08&B&;0JQX#[B F:^6><X";@2GBBS
M(<)51,U$A$L [Y-#[9&<[S(LN&13$7Y#@DX^ % V$U%_I>)-CW%R/5"5QZ6B
M>HFK;6)9TH/BW/F9IE;+6N77#W6)V1\U^;CRHVEPVI;%6FKY6-LEHG!/T'1!
MT]KV"8@V1SKD&^9O:BXO%$9R ^!P)+\8H25O#XNVQ$]S_;P@S6X:2],V5UJ2
MU8J)OR#1+:;KE&*)+<1_1*527)@ZMMS::R*?+U_$L\NSJ_JW;\M#<"NMR=[3
MSW9"BU0>]4DM!+JM[$EI+_&D'!X!W=_\;/>:E=O? WE[Y\A>D<9NP[0+%:+9
MPP.>$D>'>IGP[=$+XO."4(4MFR&BD:.RD>@M=L!A)UZ/Y.;C]6X<."U%>C8H
M5H[(:2PWC%\A2Q&0<P@6N;66;9(T9GZ%XI">4755R1;+#6G:NIU\O_H=#Y)?
MV^)8'1 ?-JZ=V15A($E_+4=@4HH_=PSR$(/"ET%/31&"F)8,3_&-L)-[XWWK
M-,OC\DV[._S_[+UI<^+(TC;\O2/Z/^CX.7/'3(0\(['3/:<C6&VZ;<" E^XO
MA) *(UM(M!8O_/JG2D(@; $")%3"^3[ON8>VC925=>5265E7%:5YB6;V9F;V
MZHTGZOT$#1)Q]YBQ+9-RFR?G;5;..!5&IP*%$/8&&CEO0*;R61[.8VBEUO(]
M9;2._F^+=#[*$S [HZ*FEJXZE4K[\56(,$O?\>1+K(8>-!7WZ<_,;;6K&>/L
M2X.'6[YQ?=;B-Q*U!=Q_/.R\?N1^QZ-(F).2JZ42E*OUGK4YQ=*MKCW4)R_/
M[=3B(D3'KRT6%G:.XEI1[!G=7/J]'#V?R[&YW'NBKAWS.07="\JB0JR3NH&S
M=SF'EYUG/&NZ.5K/W'E!'F43=-&5$WA04Y<4Y5'A2[U<9HX:6VR;@VQ3H)@/
M,*),8%N O+\3;5T"X)_QY9*>\7EF]^*Q7$LUC2+WNM_5(%%G?.$X@K63O4.V
M]]ZX"VL.XTBT!03AQ;I]*#2%JIB-*>';;UK#3_@^?]HMXUMPH*4AYZ-J& U2
M-EUBJ MT54MAJQ2OF(Z(1S.818]T-%_$E=.=VU93?>W=A=P#4"05G*WM>R':
MODMUOLCF^97<Z]OD</8A%]*[8BDF:<T9>O?[Y]F<3;M.F"<^?W*K1F^8#I=(
M9U;@J+AKKE!<D+32 ZY?12N30Y5)]GEC'_U^V4+1P]]Z++ +G$-D-A2,* *$
M*O;,;'KX4C@/(8.(9:J#\K=[<HC/GW:N&A$O8K/L+MR/S0JR 1$!6D9\&HXH
M=2):8U"<U@8WM6DJNDZB.'S(^P-I?'KMZA)V;*,5VBG&?/[$%UE?NN)9#1#_
M2,3H(O>O$\X2<40Z; ][H. C3U1M.$2B0T7H%F>+ 4XI&XM)F[B3)BP?5CY#
M*GH2L SX<P?AP3PRYYI"2)6Q+ U5_'MQP),X9IN0[/,G[[?<)TM.QC@G4,?>
M>HPS/M+H3+C4ETD!EP?AE6+!Q*//[J.=IX_J[,:_^4UCBPL\!/O2"]^-X[>4
M-ZON\7 +#\5#,NWAQ7UOI%D&MKJ2*O6>\1^\ME2TL#;7V-Z1>'Q_>;8*WP?7
M-]70[P@IG&(E!(H%NXJ_^_'E-)OWN2T@FIM%'*[_!<9F!Y+GEX20SGR$M>U%
MO6UY6V2\LYY];7[JPVM:=J.^B85DA"%^IY,XR2^G]KD$0B<HDS.XLU,.-GGF
M:KMREF)K_L &@R"KY$Y>G&_)V*L1VGMRFF"E;;T]7KU V36&H(9U,B4]@LX3
M$FADO>]*]NKG\T\]&^AVO[7#3YZU'<S6_O[\::E.@-6D2O8%#!:.6 38*J%<
M=6^?GT>&=6@F%8M[_&\=6^ZSIC_:%S7,KF[ (6NB&<CXVZ4]Z)&X@C5$]/@Z
M7XYL>@6YNY2TQ:P[^[ ,B\O9*ZKX#7UI4>PNS/<\$F(80EWG\S?EUY:^N*=L
MXYFT0CR )]-I>TQ)>"5\?D@]66N[WDDZ>9L@IU8T!V]VKS9:!OC]QB*"D$('
MHZ^X-#6[$D;N+4\=_$WOHH\PKR864M)+W2RT;J]^3#8>[0^FC37;;#$A<5?"
M5!^^5-=S31RV(/QD=L86/ <7.9TXP$DRN;=FF:R2>%8O-'%F'3QE^<H,+'-V
M[A(G]O@5Y&X<IW$3ASE9">8W!P@_%,U[/FU6(_NHXRPC>N.-=<::$%(8442*
M>YJ2](WB!&FB(_P0HO._J5_('6#!N;BB)3)-1/CLQ1U4RBO+('?=ZU.28)W5
MX&&7OHSORA=;8."EKT]M98O5+[-V\>O36;GZ#ER_U6\Q=5">^=V#A?BS\E*\
MJ>?K!26"&S(#;M(?.A_/K4W(62;&]>KG3^Z"E=EFO;K>&)R<:OW?[+)J79U8
MK5VU)L8XSJU<MWO.YW/6QA;UG5>M]%K)6B-YLR$==*&Y 8.!UIK.&M=WD1G\
M6GK_!60QM;BM-"$8'13YVWRM+-2D5, %)$8<'P_V]EM OL?.JO.E?K6%=]].
M!?**/HM-G*2L6VVNONYZ\VHS@?B;/I1&/Z??Q^+WC4V=^ZTVXX-M>*O-&4#_
ML#?X#[_8M D6YZM-YOUB,Y@Q[+O>_/S)7G R[]:;25MC):GW,:QU]YK3I,OV
M[:&K2FXM[8S[GKUI3I5<;>AA%QN8V G,1T=EW7:=YZUZ97=<K\-NZ1!WY3CB
M:?@"1RB\#,_US-X.(_S9F-WMO;QSCJ6Q_XU7$"-[N>]8N7/WUM*2RN5!(E4P
M2R4.[_.GN1LD3,GV+>/.8GV@/;DWB<^:'Y>=(99!NW?<D'.]')9$<[R2O48U
M'$+EMYQCVK.3K(XTA;QJ_D*L#B]W&GDQZ]289Y=:,P1I1"=V9LOSW!^VSE+%
M/P@WCX2&LFJ74.9?7]1,_F9*LS6=3'(*/(U8'UC;IX0PS;DS;TFC> VFX6$3
MGST2L!:$=ZJUEZNV<E8Q;B3%NR3+%]J;78L[RV=]>>[%1PYFO>'3P:\3@G'X
MQ5:/9]XNLJTACW,XHF>O6%QSEN@="K';OJE7+IO#U_5]XRO&?CS[$>GL^PT)
M#/CP-X:]91PG2=,?[04Z0>RL%VF,!-7QW>X]B[,_QN[?J7IA#3"F+DCS)E1O
MZKDXVNE:@(G4^9_;H40>CY$D.WVG^/ODSQRF2@DII*+U:I=>!9)GSCI<%^SH
M?Y.?$M]NF'BNYO<\:CJZU_"_V"5+F]L8B2584-/ML9_5P?&WW4*S;;GR<-XI
M._L1B^50-/QW=CAQ0LD6U3V'9U242?4=1QG58:1<;DG!\0'')6$XE!6B$SQU
MZ,4IEZRKL]5^6SBYOL2Q3I,:6%K#)*!LX5?HQDB>>#R$W'A_#VI"'$3M^^]6
MQ^2G=Y6-K=Z!]4%]V\@&7U'\NU@\D+>8(5RSS+FQ+6%_OEGD"WZ[KN(FAPRY
M#<O4D<VIC%,CQSP,9.)46L*#'YBSK*O4K3 9G'/.,D--)Z]5EA? .B(_MQLD
M3<TDY6F_JG1Q$3S/!%DE\:%KO\\&QI $E28RDQL]KWBM-^8N>OG!RJJT'3W7
M##Y!$?1=6;K(L7SQ_2&92 QA8IENQI^8!OH$YM"K4N79EM3\'AQ$T&<[(;S"
M$BS%9)WBDE-"\U]=SE>4S[*=$I#BU5(B0E::^ OSWHLW--5.]6KV[J57KSM^
MM[K4V2,+RP0[GWK#[/S4;WH>+B^[(+(8+=GSG^F<#)BQ1YRX(LF[.3OY-H?2
M[+25-SXNP.?DG@[\G)K!##$+*+I;!ZD4CM_S4O"*M;M]9LM-4.UOR@9C&7AL
M&KEI7+<K _@A8]DTG313=.C1&$5XMBL)JEN:'<GW(^_[YP(M?1U_[6^F;NDD
MY\5I\$KCLRLH.+N^)TSM$Z0*BNG</Z7(."=S+IF2A#%92!"N&YFDU<8[-_IV
MT).Y117X3'_Z<]@KYU6SS)^E3RAU8?X.]S^GITQ=1HKTA6EC%7S%WR4 %A%^
M1:KPE;'/E>'/S.DI_@*#_[]_)?G)E65 \AS]=*"9&.&S-S'\WUDLFZ$ILN0.
M;?X7N8F)AV/:]7QR\\Z$>##UWHZ?Y-]8.-']]_([\& 486)@6=Q/7[&OE,P1
MT07WQU>&Z.74D*?(40YYC>X^PVY_P"FKJUE3FRRK6D%#^QN2^PWO+T6[UVCI
M=2??ZJ=>W;E:^\H0E_:%*>G"0!:_,DULNHYFFQI183KO_=8_[M?(K_[]QY3(
M_]')_R$*PO_%JO;3.LY3'T\'B*PJOS 3>]IF>L8#<Y4\#Z5S=)$?+[K%EI[N
M%8I(:PNT0S#V4YM7-.X=(C@?>)\.A;&LO'[9]+8W4QY]BH'_E/,;Y(XF:M]L
MT^ZTVJ5FY?.G<J/5/B]U+DLX,C4K?S.E9I7I7I>[C6JCU/D9]ITWX0]E?^$V
MHH?,\5O\V&#?#4'>?2*AS_'9DY5I^;)G&7RKM)K56K-;J^)%9JO9;5TTJJ5>
MK<J42Q=X,FM,][Q6ZW67)FU)/<LJ.J39K+*+8$[9C7IICNOS/-^?ZJ6TJ19?
MBHV[>^RRK3&6\]7^$^P4W0/1S"FID$E():<&\2<[-MB!MRPH-J-<=X20:>P0
M.H-%AQ/;SZT)"(Y:3UQWN"X.A*=XXN\7;[(?](S(I@F11\'!<S81\TFW(VNH
M[U^,%^N-_/A_)ZG%)&>*^<51^:DD78N/Y?/<<^-M;%X3_WU&%:I*YZT SDA<
M0ML5.O95J(^0'VJ.2XL+-*9(?1&NVV>56_1 T203KF**YY?D;('\BQ^QTZU#
M[#2?I$,A+R*(K0:Z3[I]*!L+-V'[\UH5+ G/FO374GS?2HPH-!#IC!YJ^KSO
ML3L(#O&B\ ?D]0ES5[MT4K1D&#CE*0T,D]2&^W*Y/WT<_7QZXMO\"Q).MO<D
M^OW@SQ2785/I IO*9O]:E<U(9'O"[G#[XFQJ*+**HG?BI6[7SH@!LI1"%F:#
MIMF@.:D G-"#$Y@-FF;#/^RGWX7]V=4PB^C/\3C^-UXD[N'[5?'J3(PF_D>;
ME%:N.YU:L\<XD?X+P)1:F,)LT#0;_D[#>RBP(ABCDBJ1_Y!&LB=!(9N<);,B
MZ/JKK-[;NW38B:0:_;%0F3YKM_UI>=KJ3,O7:H=/[^!,WF80;RLL1 ONKLNL
MT)HC==;=G0<>VPKMSYZ?VN?Q 5#KUHO_"-4I_G?]H/C\F]?MB^/U;8B!@+2.
MC';7=JA,EBWP*Z\;6:6<<*=BK8D?-<BRR0%9;@^0I4C>0QW&_-V[ETK/5DA)
MDI#4$UXZ2$189P,%S2\Z7/+KC[7[JV?93 FOPVB21#\7'Z*&SKH]QA1>2)?L
M;)R0FNQC;>O!$X4O3Q'T!#4S2&2/ "W[..4,F\[P=*#%WQ-[&V+;Y*BB+-5>
M)J19 0>Q%FDO7%JSOW''+YWN[^S5X")SGHLXS7ZKF_#WCF>C=Z1!C@X,NU?2
M.5GD=FP*MCZVV8.--JG:O$-]*$/>3I)H33T EJ.(#@4VG5UY[53 #?M#3=>Q
M8W7IBZ<&$D_EE].1C-T_?C;V?BGY9: KJ6PN_TYV"N!]2A-H]MJ/69-U0SIT
MM'4]F V:9L,_^2NOVIHA:5X/YWFFD^>1?._NXG=_6A.$U.NDJ^?1(,1\+]J-
MF5ZK5[I@EK=G *G[Y%:19U'9')OA8)%]Q.C89TV=8[/%'!W@@+PHF0B&O AF
M(V"G:A5--$,V#<>M-355G*=(?&.1&5U_-YZOQ3/QKI(Y<"5LK_,CXHP&TADD
M<\KH2"%GDQQ))H)NO@)Z]XF&J^ 3S=8$GUMY7REXN:/"R;X[Q6NNNHK?_Y:7
M-B6T"?:CKVU%4,V2*I%-]0DY5TGX@99]\*5PW7@8F(*>VV4W(J3-X2@V)AP-
M..*0#0GDZH E%.X?M+R;H*V(U0B.(@RD\?H(]B  I)&#=+^-\2VZE9*WYP%G
M4#[,$A)F@Z;9\$\H:^\V.DCJ.-OAL'-'\U>S.!Q\SQ6RN^QLA'/ZY'WJF-HS
M'-I['XXHOAL?JQSLON_=-0S;[V4DS1HHZ" ]PEM*<8C*>10I88Z4!G8.MZEX
M<T( (WU@W"?UX],LSP5NBHP%C)#[0;8!LY&TV=B\F7,A"P-9L0EG\1K7O@G!
MN5;&<"CJEPA)+M-W]S^LWU?EXBYG""DG)+EHE,J-BT:O4>O.\D-"N-AK57Z<
MMRZJM4YW1AO/5&OU1J71 ]A3"WN8#9IF U('P G,1M)FPS]UX/Q3!W_^DDQ'
MR8B_)C]J4Y1D_A)/8@ D)O0"%F:#IMGP=Q\Y;]59M.]V,]K.!2;OCE/F!*L_
M3:/BPV5%^EW)2,EI(G-'YEXVG%"8KBK*';#BY@N12$XIIG(L7X!6L2.'R%Y%
M6I;C4FS:Y_)+BAQL;;6#G9_X=:Z8>I^]O7&]UZ/V\ZM1+5IWCXDD%IF-T^?@
MNMO*:ZOE[;GUI)@>)5V:VX(L$C(I+L_F\Y38)2 H)@3MX]L+Q13+9ZFF)?&F
MSL[]PJ:,U65?-NWKOZ?EVPJ7^G$GUW9A#XTI=?:,S+V)%7OMI2,8;Z](M#M^
M[0O>9K=%.]^978 )[GTOX_1'6B0G7 L9-@='7#\$3O8ZZYK*L-E"X&[N.%QU
M=>FPW!!A74CD,FB<AMK;FFY,>_5WW.>IL?QR\7)]UWM(9.)=&P\0813S7E6O
M3<C '4F414@'H]O'Z()@*QI7S?(IJ)5\/-#LX[>SV"6EJ#YCM^2V+=33.D[:
MV1;TU562?&U\?<.U9/,QE9PL&X^.,35[(I&.\V8=B:8V*XO,#SS#6><0C&TE
MC"(YYI9BN3PE/"  E<BALH\W3J?9="8P_WI,]0[1,K#?/#V]T 0LHC:NV_ZJ
M.G-7'EV]OG'*5^G'<JU^95C379QR_!DT&3 SQ",&%QV9W;7;E?*7S<B*)'_&
MQ@=[C1\++WNESEDVRU&=.F<]J7-M/%&T5X1F6MFXSRBU'Q[E5/GBZ> \0>$3
M4[AC=\09(!4-97->\'CKJ=_*"D?^8S[ROQ&ZT>Q>YMA<)G X 'H*P.I>6-V+
MHX(OL-G@EWTDCZ4"&"@_8K,JS 9-L['+R0,//3=)*DER6;UX[$^?7^ZFP]QM
MYJ:L'):>._S<TL-<X7,R <(UW>'Z,+EDBDWG"FR^2#>/%, SP?#<J^K,<@6.
MS>7I7NQ  @DI"\Q&@F?#/X%,^R>0,\9<TTD82>)X<7?1GYK?RS7%D@?<%1]W
MXA@BY=GV"2-03<5!->7!)Y5I(O"? 2BI2P[IYT&#Y/ CIB,P&S3-AG]RF%DZ
M734>RR9A^B:4:!7\.NQED"HNDD4W2=0OLX5A3:GDJ[OPH<5S^9]G=/8YJ:7Q
M.;+\V46(:6HF8@I_?50D.ST#ZU_SE1PYFR@"%@>'*^2YH7;G .S]XNH+>G-\
MYMT0P;&!8X/,!" #LY'4V=A,UKJ.GM5F7,O]X,[TX7>.+^YR=#">A&0-Q2K0
MK=&+5I@-FF8CR*UQLX-_MA.Y$10+.8VXDPDWX0YU3&*/4<\'@+^,1\ RSI/<
MT1:YU,K1=D>"CHR298XT79XBJ2\W^B*I6''%-->?5M.C8>,F\\BIP@ECRB:1
M[-W;#/L9C#!_B#N4A0#5'03($0'2/\L5\?&NDF^FMQ-@PP56ZT0(H:[<:-8]
M13SG!=$(M45=T5\HGG30LQSG5_%>56VT__->[:P#\_^^G?W2RMEO"WI+[YJD
M3=.VNS;2;;G>P'!R\ZM6?'T2<\(:&$X$G7DB#WD/O_H> M@PU'[R]=[3RV6J
M+0838(N97B5"Z#"\[E;;NT!Q6P%WAJ170.YOWVL_UB-R/@.0'M$;D&$V:)H-
M__1HM<-\FQ[U1YXU&'81I'Q:400#>P/[[TLOLM'O+_X&"X+#VO(S+]%X@/3^
ME+\<O];3MZE:)5I*VWV69+;\3(F0:"U[_W=1+[]GU.N'I]B[%[$WZ;P6KX:I
MG>+GZO1MY5 6P3.\<4PDB8KHZTK;7R,L]1'Z((/8+XI_G=GR&S2F=US-A&A0
M?$7,_T#E//I1W&M=5-AQ712F;\AUT@,I<UV>CJA8846&RZA789$+[JS3_$X[
M;[E.^_K.I%;'*N?E#<.P(C2GG]FJ*%P*H\+SYC*#;(ORWI165W2<(;0LTS %
ME:0"D8UC+!2DUXQ:K6MHXSBTA3SO![/)Q;V=CY!]PH]LR^*D6B]SG=]Y/C:Y
M-M_Y"'D<UTAOE'_DK-_69EPMS\?6/L*9D80Y-L\<)$SR]>H^B#N.1-VT!9+M
M0HU_X'$\A$,RO]  (QB$FKB+)J8](B;-L0Q1@OV'WRT5S7^2T/)!_%= ^"S=
M#V3G9-L$K]J1'V?+"NQ!*>I8L!2R$TL&EC9W3T902"O[YSTH?_]P>_:0OI-V
M.:)SZ.W+64VM'*"FEHVAIK9"Q[=<-:^?&UDUE]FIIK9ZO1)L3RK$H4@WA?Q=
MFS.M/!V[6V]\AZ_42:NO13.(2.IKQ0/6UU8@\K5Y4VOS3_>-%WFO^MKJ?8SP
MZVLKAI(ZO[W+_SIO_%"'--;7PL/E@>MKX0L>0@?$^\K:ZH@5;F5M!?HN,H]7
MAOSK/'6]N2*UJI+#'[*RMF(<VIE15:93R;AZW*^RMNU\A.P-;GJ]ZU'CY4IL
M[#X?FYJI0JVLK1B'4JGR#_RE6*MM6^F,OK)&@TO;K;)&@^1;5]9H$'JWREKX
MD@=*QO:OJ7W8DEK04V!9;OM38/N63TZAA!7.W/$?9>[V;4WOCX5N;5HQS_O3
M\</=^%;IM)&UH(I>.H+YE8F\ /0F_L_QZ8X\&+X\?[U^LC?_H=\#:9)F\[$F
M<B194S=-_GUO8I;Y]-E4E&GMFW,&LK*N5_ ?<\#V\(>A]-PI60\I+3M/1I=?
MN*8.E]OUU79C.!*O^(>SS$OV1@GPZ@T7!6Y\>8PMX7M(%U8_^%ZEKG<+\YK_
MO&\Z$#/F!:MVU?LUE%?,]Y9=7^M>O<"9M_-Q\^N"3B0E!U]VD"B$4R^<LPF^
M2T>5XRK?%W^V@IA?X6?:$>[1_<5SJY/>,-^K:@-K7[FR4#,]2^5[HU*Q,[K+
MKW_O%FOY%2.F!60!5^A[B91)LX4,O^(.@_6>BZS8 H:JU86KZ=V3:$R%G^7A
MX'$W/-6#XFD+7Q4=AO9V"^%C:']/E6&Y;)9-%_TN]@U4GMZ[6, R^#$3A-_Q
MA!2X5&NO-HJW&7TX)(:K^B-L!Y2BHT$"H!(15+:C%EP%%=O/4')%YLI>&O?>
M0X]J2$00!LJ*I7'GH9C.HI>R>8D2T GC#9>VVR8#8_[TZ0Y?HP@G<+Q)\"[&
MO2D_J7-7C^G-B0!YRBIPVI>]K7QK9)E4"N?I*3:;*:X"Z*J$:0M%V1E3ZWS*
MZ<)Y]LISU/R BMH[7<BNUI CN(/@78/_AV6]"^&*1!\P1!O];:.APZ,G!RE!
MMRF*J8^]3>$],E;",9!@2U#:@BPUU(HPD4U!<:^S=(-QN5,3!S^F9^A7,3DW
MPB_&QDSPX$YEE1&=X244X)1DMRLP$\FMPEDVD\FPV> $VN ,DXR5O6X4QLN@
M?(;E>:J/%7A;\NR$8HGZD! 4=ZV!(>KRA$AN=)"(Y"=WE=1L]"6Y/S9<MWPW
M[,C5:::M%G=QR_'?">\=*DY6W:&"R:U_T9_K;6XK6$7AM?F5FS-1FV%2%SD!
M4]<\]\%35^\!AY(H6F/+OBBX98Z0CA=I$QV-D&K@]6Y#%;4QNM ,HXG,UK G
MO+Q-:7\W*W>U2J9CW0T3E-(NQLQH9-#8>CVC=L21[;$GU!)HR5NV U<D7I3E
M,T4V7<S3D<X A.*!T#XI,<]RA2R+<SPZ(+3Y#KL.,@5915)-T%7L1@V/#JMH
M*(NR^=:-/Z:5CBG*OT=")I$IL->C2\X0P>SV2G\W8RBDVBT>#$[6WBU#"VP!
M(ZJ8*T#^^X&PL^56[DKL\,4BF\G%L9O[5P!?[:4C[^E(,"S]=;G'^6V)(HM&
MW[__&@RTB)E!([B;?C:^V:;NN[W<_"I=^&[CMJXN7T:-QM18-#HOO\#=GGS?
MR979\"+_!JZ53U]K #[/CZGM;PM)]N_4VJ./]*W+?0M1N 8^\FO@-SCU]XXJ
MBN5:)L=F\H'7:M%? @^X/!Y<[K,&I!N7<,%;,O-HN(4 9B/@2=CWVU%DG=!;
M7#D[-MW%@O*SGN7'S:(@'/CNV0A6#ZU>Z<(19<UE<!"C*8_1[\$;:?$HQ::Y
M'(N7<K3&:\!HDC$:2I$JS7*Y/)O-^YUJH@*CD%-"%@.SD>#9V$S(>R$+ UF1
M3<)/K$J^&29/,DS3R3"GM6&E6?EY_;TSSL6=6*;"2RPO&J5RXZ+1:]2Z3*E9
M#2'1W%>X78.X_5Y&TJR!@D*-#*O8M[>4(MI.@4UHCJ)<F4NQ?,Z/-S,X3@Z7
M;@%,DPS3O3I8TBSORQY##TR=:(7_0]II\2?\>>(^>BSH]S)^*Q?>*R=O7D$>
MY6R!KG_05\81YM34)E@@HI?9#UQM.2=@]WB!5\\BPE#0@[YTYV X0I\_"2)I
M@A345\*-8*F")<FDFP:#44*J@3^IFDGH7G3$D'U5+->];I\)TDURE-(<(0/Y
M?@]_LE=S=G/.4%8%593Q%PV7@M7X^\VL./]O][FQU<%P?IKT45*0)Z^ #Q;R
M/Z>G3%U&BO2%:0OWV)%TT6\+J2+"CTT5OS+VA@3^S)R>NMY1DI^"+X#?S'/.
MGF?;1O"(%&5FJK;)DW]C\43WW\OOP$F8(DP,+(O[Z2OS+$OFB(R?^^,K8P/&
MD*=H?HI[]<(/X]#7'_BGMBZ(/:\[^58_]>K.U=I7IO<ZP1*4=.PDQ:],$[M.
M1[--C:@P7?!^ZQ_W:^17"S?B.I%__\&J]M.ZCH3'TP'"OA0_?&)/F]? '"6_
M]SX3#WW=9/GI7J&(M,YTQVW_>T ["8+_._C6[K3:I6;E\Z=RH]4^+W4N2RS3
M:%;^=A+YZW*W46V4.C___6?PC4GB".<]+$*?XW,G\X@]^%9I-:NU9K=6_?P)
M?^RV+AK54J]&5B_X/Y>U9J_+M.I,JUWKE'H-_ >V1BJMRW:G=HZ_U[BI$46U
M+FO,GQ>M;O<O^E04+'KY.:[!MS^OW4!D#^QHQN7:ZOLA!8L);AT@S67[/)_N
M3Z^4]F6V/;R^-,A-.=88C^#5_A/LD]T S9PR%6\,G__"YE!H39 NV,>A;.Z$
MI?YLQFG0QA#3#..OD^VU'BQXG;PM5.[,_/JV1@'E,<_R8%Y$*M;Z=K-<GN/[
M_45SWB_L=![RP[3^4SGQ$RK!M;3CF;HRF3!N/G6<,W6E40M]OQ5?S]7\L4W=
M;&&Y:1<C.J-?4^<\Y.X?]G#DQ_\[R;U=&JQ9?FRHS:Y<5 5?>>IH=M[N$G]M
M9# UO&R4EHEYMML0>R=R=%5U )0-J!1%@/*YVR%>O,!T;9@NCJKIHL"\(Y]^
MBN7]Z,/?S';204](M9!1&A@FJ>/WY7)_6KR^F!9O[GZV;B-B>0S3ZCJUFUKS
MNG94^?5QI<PP&S3-QF;ZN9E/J.O:N(+?1=S"K6R.*C;U)])K+Z)BD5A:,@R$
M_W_)X?'@YV2QK<;%=%PL]:>#.II<E.J_N=^/"3MF.%/!!^VRW&KC.[(&RZ#T
M.ZF<EPYGF^0OKDX)P$NL>,G3B1?HD(58#K.1X-G8?.IJMKFEWM=>)J2;97G9
M56\^/Q50+Y^_&QVV'W8/-<QVA)MG3.VN33:0NP!0:@$*LT'3;&QV%V=(Q?Y"
M*:E221K+JDQ\!;DW8.8][$47.:^9JYO]:2E=E-IZU30+NW"Z[,BY-=LUSV7^
M")DD?#%<374D03.7N6*N9I*D_H@VKW;;!,(=[UH4NJ]\J^-H^XHW8&^YK9B4
M"IRVXOPIQYM:",0=:9[-9P*?N(QO6@!P,0*.<P#G?-H';NE4FN7YP"WM!YL4
M_QCAO?"T)8H6_GOQM8G,Y8!0OZI4^>>GU\EEM-<8AYM/NL-9Y>\A@]G*JKSP
MB-IGY]E\FI(;SP G8>,D-%=;I)WZMK"T%6(@01='."I5T1-2M EI5/7-OR_*
MAI'5?]8FO5U.LX;$>1O%3HBC@=D]9RHAQ)TKXH/6NREBH=C$G+H&OI&G\#DV
MFPULZ;!% Y#=#;*A1:8LQQ8R@1.8V/>(_$D8WI68;=8%FW2!A*FQ,=^=/^^6
M7W-BIW8Y#'-W/D"Y.5)>KXT%:;!XRBS^'6(C#TR%',O1Q.8%D>EX<!I>2:J0
M9OG<SBP+T+( M0 :=[U@-FB:#?]\,N>73RXN1^K+))]T\\BQT+BH5UK3'I?J
M3R]XR4IEI5^7VB#I.24YQNY(4N^T+CU'WR%.QQVG-U!O^D V_)1R!0\G=;DE
M,,4>"USWR"Q7D<;2EF("92SD,S ;1S,;_MEER9-=-C556W9_L\7U4F.L@(;%
MU*-E3MN[G$>,J3&V=U[KS#F19K5(N F07K#";- T&_ZNH^YQ'0W"%8 ,[V9\
MT[GEL#)]T*?]Z?3NQ_G$,//I7#:1E]"Z W0[H0"M>Z79;_ 2]28#SQ790C;P
M=0P1KO@ *.$#);0J/Y\MLJE"X"780=9:"W];]/C;*O[:DT Z<L\$626KU):Z
M^)FW^]3VOH_\6:-5Y!74B?KL=X@ZJ8P$]1XQLLH,!5EGG@C;+J,-'3&D^6 9
M94&Z#<:VE[%M1-7!*G=IMAA+7R*XZ[UV97<#4&C^.Y=AB]D4S>VLWN4V49%!
M=(2PEFHO9-5MR<:(=%BUAE4T>./#T=@JBW>_Y,'%+@=2X\^@R7 9C!BT-%)'
M"FV(IW5@LHR*WK:Q@@6^M4#O%]<P*V0W,W' &IXJ[[G1(43K/3-%ME@(?-]-
M'-XSZ_&>=4U'^.452]>1*K[V=$$U'(G=T'.MZ@@+.$72LB.],'_<\8VN4!RG
M#IP,A[\O/M."(XTXTP5C+I3!W!.W"]N.<6\[KK?\;<!\B%H)GRK2LP\)#9D?
M L+A57'88HZBGH^=6/]6;L4M#A"06+;4[G7^6"Z-VRU9_WXHHM!#GR:P=_%F
MNW<LTZS!Y>"Q.X4-%:65.#Y<#QB;2Q7H\0;0 79<D V_#RR38M,%BDYJAM@&
M!C?P?)B6 9@-FF;#/^&L+#5PN.VN+M.TK%K8L2QN "O;=RHZ?]<37I!1>S%U
M 7MN617TUX:)Q@9VG<1%ZIJBV,[3V;JU3R@(E6EV\HH35T_"VGH=J>FBDDY+
MNQ1BPDE8]SR3P)1K]5:GQO1*=T"VN/=6?V00/%RV6>387#9PO@D[EQ\6?5$D
MCEDVFXFC@ \I8F*M E)$F(VM4D3L^6;KX3)2T5#&Z=V\TY=D>-/R?>XV=]/1
M"J5A-%G= 6J.P@LS<$8'Y9JXRS5!^QUR!3IOD@#0T R:(IV@@1P*HC;,1M)F
M8_.^;EO7<%*QX.V85<6$9N-B.KRY[$\SZ.7UMG!6L:H1=7E&6Q-KUGH,J8L!
M2/<J1BQ@ I4K ,M^8(%"$R1)%( 8DB28C35)4KJ/1/M*6W*V$8V15)6?9+Q:
MD[S)D9X_RSVWJB]W1D2EI5@ZW)SQ.K*XHX8*0MP5A!5!M]VNE+\L(_1@*1K/
M9]A"AMK6(( IQ86N?!8*79 U)#=K@-F@:38V'\]K(O,M1^T\C3-_7W1>AJWS
MYM,#16E<:L\@U:SU'$'LOK#23:EQ42I?U)A>BZFT+B];3:;;:U5^G+<NJK5.
M4-[:?87:-7+:[V4DS1HH*+[;Z5=+$74/N!>]!\OO<ER6S7*!^0M\L1)+?@<H
MI12EL=?^#HU12"<A@8'92-IL;$XG:X*N8C]BM)'>'0DZ*@N&+));R63%,I'4
MG\A2?_K0T'Y,<EGQ^XMX1'EEN=1M5!Q12LTJ4VU<7/=J5<;=:67:M0[3/2]U
M:A"L:0[6&Q <<I+9:-97A/"V_7;CY!OW-Z2:@-X(T;MK\AD(N_F=+TJ %!22
M'AJ2'I@-FF9C<PIZ:^=]2"IA:Q;N4=,:#Y#>&MHNJ669ABFHQ,^\S4RGS_F&
M\:OYT/K5B>@J<I^L-)(<="G]O*TUSL[QAUEB>E/KE,YJ3A[:95K7O6X/_W6C
M>?91P_KV6X31Q?;UH7TW7$>1K\Y#O1OF4WF6SZ38++\S&UGXP7ZK$QX ZV.
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M_(X>W8YD$P&9V3X2!()&K#*M\@>@*( /P ?@ _ !^%"D%8 /P ?@ _"A02:
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ML,Z<)O-%#SI8? (L'DCQ 3G1$D9F@7<9P 9N"I!#N9O*@)L"L(&; N30[::
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MX /PH4Q1\4M HU8 /@ ?@ _ AP:9 #X 'X /P ?@0YFBXI> 1JT ?  ^ !^
M#PTR?0#XK#@K5%^<%;)Y:QJ&82&I:NFR>N]0_=C\/GZ'A*Q1D=,ZNC[4E:0<
M$@I+O41+@BHB1Q)M2"A^QAIY#F'R&6IZA$>!CAFD%%@ST,P#<J+E7"P S3R
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M(L&1=PH?MZ+BEX!&K0!\ #X 'X /#3(!?  ^ !^ #\"',D7%+P&-6@'X 'P
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MG4 SDA0)CMS6CUM1\4M HU8 /@ ?@ _ AP:9 #X 'X /P ?@0YFBXI> 1JT
M?  ^ !^ #PTR 7P /@ ?@ _ AS)%Q2\!C5H!^ !\ #X 'QID^@#P64$SDO/0
MC+1U;2B;I&&C/TW_4&[OZQ.UGA:3PB(R$21)5N]/G;=]8?B_LY.=%=A$IB.)
M@M5!^E$8<X3P_W2$F#%^R,A@D"HA"?_]Q+0;_I@TQS*DB24<)(0ZF@ 0'6BZ
MA/3YZ\H*GBOGI8RA*;+TE:$ Q(>2FH;#MKX H-.5 E:3BM6@3?N9T%D( -X
M;W#%@%7 ZK:N.'2F!8 WP!M<,6 5L+JM*]Z.*@+@32%0/B"\P14#5I."U<"N
M.'0.%8 WP)L>>&]'TP+PIA H ._5\ Z=$P;@#?".'-X;B!$6^^E;DLQTD"G(
M*I)J@JYB9!@A,<ID4EDVFXF*%R%BBPN%:0:,+;G&%KG+A>@ @(TC^<GRD/P
MO!,'[Y"3'\AN_%LUH^N]!#*H$'!!HT^E,N6B3U'Q2T"C5@ ^ !^ #\"'!ID
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M !^ #\ 'X /PH4Q1\4M HU8 /@ ?@ _ AP:9 #X 'X /P ?@0YFBXI> 1JT
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M4?%+0*-6 #X 'X /P(<&F0 ^ !^ #\ 'X$.9HN*7@$:M 'P /@ ?@ \-,GT
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M@8DDP$0"^V-@N "P'0QL>0 ;@.U08$O0K15 89(4"8[<N(Y;4?%+0*-6 #X
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MT#EF()8 O.F!=^BL-@!O@'<R4B536R1+D W-I03RJ*1(0*=7_6"=T  ?@ _
MAQ*M 'P /@ ?@ \-,@%\ #X 'X /P(<R1<4O 8U: ?@ ?  ^ !\:9 +X 'P
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M=L%]]EFK8P,MWX+8W];. Q?L/MV 23A8N8 3,,C QV69K8[69S"1-FZ7 _.
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M5X-E@M)A14[DR']$1,P+(&XI<R'A)?X9F70\7Z21=/.$R5'50""F@YY'L$#
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M$V4K(+$Y3?B2\..8=FRY:[&VPD?M0()B<_>HJX.9PM,\J#II+991_(B(?8Y
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M6#B1'2[LHHP*V5 O;#4:&?$9[.<I)]<$LQV-+@+VYVT>R+_-NJ"V8<_JEN6
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MF9X\F<@G0EE%_.YH>'4RVLG)OO9>)"3Q/\@4I!B*ID8@FC@5>E<.;8RD:O1
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MXS%S?+49-BR!]]=#_I\9%"0O!'J2F*85<6R)74TTZ(A<*XKH&U(LBUT2_2J
M#<VESYD;'G,FCZY#!;E3^HPEK#@?,RD-)+''5#[%[AB'0NH]M#X,F"G0OUU:
M(0GZ-W8!^E['U7:!*-\FM>*Q>7I^2# .0$,;OP9V0;MI&%/FSA#.S0F*$*5!
M-P)2A=*0A;/AS7%PC@?/'P/,FV,^H @5<'+1\A #&1"#U\<=@M 9CR%UJ4$P
M2".&04>T_TBBTN3[WL$Q9V"?X/HCA2!"E$;"R+P0XQZJ'P157#!392R)0/'=
M 0TUJ3UH</3A->?.,1--R)YT^^((HL&Y#V&Q3>1D#N:2'TH0P&IK2!>>,_>:
M%P<1,G@S#.O'+21P9A$ E@OPU92:+)Y&B+:$H^>0,L&9!U!;2'S4"9PQ+>35
MS2S(.;.@+?,AVK** YE;TY2MP57SEG]O?C9#S3\24ET<A90*V8%C$L'6MO'T
M*S%K%GJ=QZ=LZ#X<4KZXF=)*QS%?C;_Q/@;7K[>3]^>G;O%U[?,(NW\]SB/R
M?71J_$RJ2]?C9&[%\UCYLB8GLM>+>O5%.\[@R%8>0.[$P2XZC-R[6KF_1;?&
M+]S%0\[_,![6R\(%#1>P=Y:,IH!\JB/GH !WT?YQ\LW6]<UV8L;C,@3,%ARN
M0> R,.,!7MD#,\L9#/#W5B["O)6%#]A)V0K8I,2>Q0TT@7;\XHLDW;16!6IY
MXWD3V(0#&QL9PHX""CN21\Q9:^J>?23D(W@I/OGF16G#8ZUQ&R<9@VWFDP41
MNL DQ>K\<%7ES*T;C\/ %KI9^P(VNNL;<Y5LV*2??XB?V\&LY'7,O=;EQ)TS
M=45<\ (\CV83'4415\ G<'@#T'\')KT\]7 '<7V5NLSB3G&I?:1(\*IK*A0L
M6,T 2]QVB'-]F0R79U V6[79DY2$]23H<B!(H.Y;\2B)?-P<TOE1HC/8\/%^
MWU]*[)01\X:2(>9P/$9E#JXZ=X<Q^9<A08D+=#KN%%SF=&2NQ4/=7SQV,T87
M)$>O6*09U7%_X*$.V;G\);VZ&;[?U\2^SU"N\GP9(_$QRU@5-W#M&>$8M$;\
M)ST2()NI+R2"-KA(9$>C2;,=BE.QW'K7PK+Q6]]&'FB!3:<SR ==[+MC*'_:
MERG4@+NL5IBUIE@#>&%+\&5D_GI,K0X;S>+&DBC9 F]/U6W @SB_F.&FAYQ5
M?S7EAQ?N[B*[&NY%P%I7 "6)]'3GTK>^>"0LH]%:=5PK'Y@,W_<!+349U\CH
MY>M9^B7WP1W2(6XVJW;E8P7?:X6A,0=SEORG\RS%"[XIYR<_,Q_YPSM+YU*C
M.$M?; F:)42?@^EZU)5V6T<VXJ&7DKW<-B1RJ&8=_KS[J3R\74E7*VK6U<"*
MHU&D03W_^0*;3_MVJ+/!D.N[1!4./9*W1Z$S$&\K4KB>C CO=^NGDV<3^8"!
M6P"\Y1";GBAZ0.&4;( &6W-<HH]&B)?H?RCZ^T-::76$2348Q,&]M'W8DD$P
M#FPRXU^B0@I6I[@[CHX0=0;QG'Z>-9\8?F-'8G \CC2@D%8Z$F*U$._0U4>;
M8B: )[]PQ.YLJ-J%%D @6I7V'M9[CH;0G1Q[^:;\5E;N<UUYB7QGR((/C1D2
M"9;+9_W8X1A[?0YLC2L@^B1LY4:A7_2VNCI^CT=5 &GK@U6H"K1YS54&./C3
MY/E7:5!*UL;&+]Y5G[$$LDN@9@S=UY+R8>9]%U:^=> @EE%$;#^0WD9BTSG!
MMO&P]"X(OBQ;.2#'Q8;4I@0HA="V.U$9&0+5FHZAP<8Z@/MA3$,6@Y)&A9_C
M&PT_@0%&*M]08!:$H["+8-F#=8,OXMWKIGA7RT]OCQ^/'?TFU.+?1L!LB35N
MUE=0R+&I1)[E.-^KC0D(FT';K/9! ]V]L3'6G/"B'9[B=A+1-3]M)EI)'ZTS
MCV_;5/&8)[X^;^Q>-(_H[MUA5@-.$FMGYZ NBM5Z0LS?0:6,$H\5QWWT>(9+
M.C,4!,'$PKR 7SEA<X-0M ,56&4XDM6I*%[@N@*C(?,*5;]YSE2_>2ZYO%%E
MNZ>695)71,N5T&5!>QR^E=!F3;/*+)R83V?3)GXG6YHEF!OI;(\M^VGO_!G'
M63\E3>WMM;6-U'62S8=T3MC*VJL\WJ6\@5X=51DC'4P"(I[!GDPX@^ &KAWS
M1SY=Z^9&4KH]#,7Z7W'5.SOBQ;A/.@1$"9^K>](ZV+X*(])M(*4"K93X["=2
MSVZ3J-3G6()$'"(SP;9RQC?U8?KY\?$UUT]9.J#JT&4+W-SE]4$DDA]JK1V@
MO+NH@0M_<#>C@/C&(/?!)WJ7(<K3X&&#SF)HG&I8[ Z-\(P3PV+UBE-N[F\X
M6\\[NP!8FG6U>FM"#]9O_7ZQW:V<X%Q2Q!]>U]$SI 6'VAUKP[IK*^>AYS]>
MIN\W9:G8\X2EHRVR5H?&LH!T>,5;/H%%A9IC"_X3XEF*#X;34+*JX])8,\-O
ME7F"_X*K56F)1Q\@BXCVI++G++)3 303K+)XC&)><3[S3/##SXB+A$07#&<K
M"!(8ZL5<=0'?*SF^MEF *Y@GI-;L,57*%XH_>VX991:7OY1T+JQ^-:<X2A9)
M!7'(>@,R7+%+;&#%8T$6EE/&BS;NEF_DSW%SF;=A"6;X;),%>KG/2GK8[_4J
M>1NXWS_FAD-[IML1BN&_P9[WQSC!QEH(IK>+/J=JZR/VGR\B]Y]Q 4E#4X5Q
MUZAK+>+0NF44#Q6E?[$BE8)8O,__O.FD==_,PFZ\7H_5;1:CS&;9;'8Q(0Z@
M[ZY:]/4X836/.1Z387MV_$O#L4T:%8,GX"L"'D?9R[8!Z$:6L-F9<)-]P218
MPF1?E[64="[W)DAOW"AT$.U&UG=4G#-G?"^"YD3$.L&V>WEYVWW=@ZD77^KZ
MQ:^+]_;;-FSQ]<_#8\1D/N_K!&UV"FP\MJPA3T4RQ3DU_M*6O</>\S#M8>K8
M.K;]Y9JV_;H\\WG528KE^F38>=V%L;YU'HI(E@\L(7RRVKP67U6<@^=]VS*"
MYL*M::05DH45A:^D*E#HBG3*O 2.AN^]CLA=_5+2N[+4"F?)@I<_Y+W$36.6
M7('-<?XUW2M87 2&WEJF._5HFUY0\@]]/*1S'[[EYA)W#(9RB;7051:TM'VV
MH-:CL<_\N2IY57UX[B=OAUSHM-,-0Z01,LVRM>-VF!0#1 5.*-S<UO(G\L^+
MCG!?F[05_75?X=&-J.]1Q)5FLUS W,*U8Z0@A;C$U1;?%4.A&&9@X:C3V[.7
M_,^]/7A^JUW=]GIZ:)5Y-!'.G9[RH57#[=;X607S/G/"O(\:\SY]PKP_8=Z?
M,.]/F/=SFSA^S'OIAPN:I^0L=;>J>$FMY.XQ/+CL>1(.[11?6"8K9(VLPBV$
MD,O#GJGWD1*HL06H5@OVR_$["Y=X'L(U'G-"M98=0*V.Y0 6+UI.9^IZ#:Z7
MQNUCI+F"&4@Z+HURQR))Z1_ G-'R[3FD'Y98?P"0X2@X@]90P-4E ]L(OHD3
M_<NCR,P)R.5<IYN6B'Y#8FZ2F:)XU)+ D!@'@9ZU"4SF,MWS4V2285RV@FO.
ME?5!QW2K.;@X@!ZS/'[K\ZQK@1,>6<"(XW 3'W3C\1J>(8A6J  RFI-BF+[(
M2<7V.=@OA+Q ((Q:YOPL>BL<B6AMS:Q@M2#J3)+A7_",@41!-)R/C\?(\STR
MDIRC.4K40%DCZZ7>NX#/UWM%O'1P3UJ\S&O3W\+H]Q@11PPIY OII7"0S2D3
M"QV"I;L2=U4:O]SS#O14:Y6P'6M?E,C@%C(Z7FMPPU3X7E=+8RZWI56B'K21
MZBSI<,^ ]+B[T,\W^X_)+B8X":$+GIOAH(W3A7/R&C @ >RFE=)S# I\B-A:
M% "W#L?0F*0IZLB@FI,&K"WPP#XJ:80SJ9@QOCR97XTG1](H,<^8.<X,P.:2
MSK*6IBB#,FCPFC%M(^[4"?GTBZGS+VYNO=<<&S.!'*)F]5OQXW;P(E?'EX/#
M8?7<&5<P?TI:X08O>NQ!"G)Y7R%@/3.LSMIT>EWJKD"0J_?SZ!CH/2&]I9_[
M]Z6"Q4"F4;!*R9T790Z3/X*:37,Y-I_VK[="'W*9  "_8=[^5FF&4S$26P-L
MFWC,-F[HB-CY%  I"@)@6&NZMO-E^,_^MH:WE<AZ&&VXEY5:;08H?=C&@L45
MAH=CHRJ43,P!&XG$&?OG7 *2I]-3X:?<,0C(J*&HO:>/P4MG*326Y<D28"AD
MK9]RAR$=%@ W6TCF5V@-"C#;7;Q-GF_[*3X), ]\BLQ\H!ZGFC :C.1@NJ-@
MM8>AE*@E=3'Q'#K+WMYJ0#YGY\SCO'H3T?<IY$/R;\=WXIW']]3UZTWJXE;>
M::;O0-0*A8G*LEPJ "9JBPT4C*M_PH4,LD:157;9I*&?_QL5G\Z2 [V4F_SB
MWBNA [Q6RR1Z>[$>:UB[XIU-%GQY(:I6"4<O:@CD402M$EL_[%^=ZY="0](_
M;GQQL+;9!;%UE@BSR@^P"^(4!%\B;W$K*E.HOSBE+ [^M*),691APMQ8EM Z
M" =8*0ORS_EL1:LKP82-GM0U!\N1H0&AZ0KZ](5,15A]=)$ C> 8ER3J)1M@
MTJL1MDR'(3AO3X==^(2V7%7PW-8Q+U=P6A]=8?:MV^!Q=%XO*D(#J5E--"AJ
M#2VX1/<!,38]7^2Z'<Q/D.C<JC9KH*&:_/Q5*1JI^L6='29"="*(+#0X[$39
M"KV(/&F\3&V:YR;-BJ8H[-3YHJ8DFPWP=R$D!,%5-RD$9+3#X$8/, 5[J!".
MP^"AU2:VHV=RRBS.<LA1A^2Y.J(Q@8% )J,K@EL0%A-8BXFUP(K2Z%K-VL R
M]9XM"7.\!Y)N"SJ5<[0A4\A-/KR;3K+<4TIX+>RLJMD'A6&Y%6]4Y)QBT\E
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M=D)"CBT "0MA61",S^NI=1C+M.)E0]04\ F@'$$6D5O@M+:22?/V+UIV^6*
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M\3;D<P>/F)W;]TR6K\-K7)3ZV8/95M?0L[N;#Z6M%C]>"T<'FIW;M^]V;+V
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M@$+@T(TU:[<LNC=%Z%E'+T'F]E@VT*^ZO#Y@>K(ZT6%=/40II*'1H]!5(DA
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MZKVJ(D@?DH#\>/<7+X 4]9Z):^$SG&<Y15]Z*FKU>CXO^N8&3<WA12!/XZ$
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MR&M1*F*>#-[_MJQG;9Z"\.5Y:]IE-U?1!R#XY[2?T3(=QC.$ Q%W2G_CT(5
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MABOQ&(_$7H%)B,1IM;I'_JJ]M"HL _][?]N&T3ZU8JM<_&F&3-"2W4 8&VS
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MI8W4O^$&B6F4VA8B#))%^%ZI#2"BDDXR(O 6A:2C=5%\ ]N5+@N9K08%.NU
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M,Q-5DP6[)QM#FCB0>ITU)1:T VY>0C^"<L AP"'RZE3+WR1Z]YQID#0IN'W
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M:SNPL-!F5 W='@HC:..^RYBV<.(LIKH7D0T#T"I,L2\JW2GV#!A]"-@<\$8
MYA@/<9A1(-;S"-D]XD*7I]V'XR-22&K,L#^CJ&3  T@%;6=!_P.U*P;ZU9>*
M/N^@":6,GO3!0R>0 S*NJ C7HH!HT"\22B/?,KPY)>VJ%5S_L;]G:O^G4E '
M(Z'/;Z5I)8+>%(XY6^A*J?R><;/1B\!U[X5R^MN/<J59?2RVJX\51UBO6FNU
MFP\XKH?CEY?%:I-Y+-X]5)C[2K'UT#1C?J?.E0,3T7^E'S9;QV.75GN#@\6_
M(Y$]U5L=RHFYLM7X*A-U<OFY,&-QLR67.4NC*P<=,H:T0E<,CO]5\*UBF7+U
M"?H5AOV#@V;IC4NJJIV]"9+-$G"EP7 C0*@P=-;^,/3.8% OG;20FNXANO)Q
MD2:NV$1N@XQO6&K0$0@%,G/@+[ (#<=F_F81F:=FSZGX*0X1C>AC;,:EW3#8
M4S3C'_A*YL'$',L&6B-=+0G6HBM:$$@'.\6ML,8?2<IB2X:KX11;!,BLI0.>
ML2V"_X[!Z6"@H$$PZPA8'?H7A@G61(P)9@'A5GLVNIT%:P>_L58J?I+J:_(Q
M1!W7Q\P2(%@@2\=3 ;HQF,[F6M%:=(;"F/R_]KZUN6TC6?N[JO0?\+J24_8I
M6 ; >[(G5=3%B1Q94B0YV>2+"R2'(F(0H'&13/_ZMWMF<"5 @B)( M)LG=UC
M2230,]/S]+T;TPBB=Z&S-=+AN4T>%G!$K7JCQ(C18C6"EJS=3"0+9S1,^+Q4
MEF(-'&M+D??,H#?%XV_M::,_'6N-J&W42>K(%I/Q&L6);9=)K'[7_^?/D?'5
M:*\J$%A:8I'JH,&_\SGSK9L7791":'L'A';SBD.RJT7":3LJ0@IYP[I')EDG
MP#-LM8A@0J_\X4&$-PDHM'W/]726D Y7O8A)_;P4^IH0GQ"<P$Q#[!; 92<V
MS)S2@XX0,FST$R"]P2W-'#[PW:#\X-BP["DJ47<.@>]\I&YXAJ9\SL[A0?$)
M.YD\)7.+&+N/.OJ("96PI?N,-D3,+<*1:2QA <Q/TYW.V9 R@,98N=-?L],+
MY>;ZWP\7T21)^F'INO 8IHQ!74\O<<J<M*4<*5H[#P)X?/1/&UW+*,'ER-,=
MM=:E RIH%AX@_=LQQFH-7K$E.91Q?)>YPP/FR9#F,5:)<U'\2*/< JI$@.Z+
MOHG(V\4<Z529X@WQ&2=%SGDD%'T%7W&<)P^WI-:15BQL)T^S"YIVD-BZ<;G4
M'T>=?+21,-N!P,\.IBZ&=X>^P]87>E5<.'Q*@7"_EV&GQT3HX0$*T2Q3NGQ_
MRGO@:9H%V'=!-T>7QT7$S!_I\9/1E76##("Q._C I6TYP8_'NFNX^'VJ:]YA
M<,?X"OAZAYR=XWCIQ2N8=_+^S]^-/\\>/S:___FKWMS<0U,7T;LE.I->I./&
MY^]?>L??NM\^:;\_C,/='1GNS-3G/X$JAG&CVY/?SDX_79P='ER]S_,AR=+-
MV<FGFYOSRU^IJ^GRZC+\A4P_3_NE2'=G)[]=GO_QZ>PV)_2T5@9J\>TMEJOZ
MBF9=+DE/93E4KX+DS&59J>7E6&'V:?0FOBUA.A=-ZBWU9='B8)/PU__W2DLG
M_2Y)+,[<B@UOA'K4Q7NQC;2\<,:<M,9_0MAR_S-PI'=@MZ!*!6^)- O^A[@J
MRI-Z4M)!JO#F@&IEK[<SZ7)?O@WQHE_^JT4%.)T7N7O6C[V,/NB1CK3%>V\"
M9U?^ZF707"HPQ;1CI#/*OBV.5!E$EGN"F*=?",6SA*QS/WBM*4U9:W1EK=5Z
MDX'T7%RTVC]N0'=DY.3L'7^+MLE+EK%7\C7JCYE%%UNY5\$KNZEW.L@0&[QT
MF0\TV>&#JZ:LV<?,9UY&8Y351B3R(J:_%#7KS?T(M:>CDPX<CSWU=^?/@7[_
MV(ZZ,9S2%C4AA3+OMLA*A@U\F!RK"G:+-VUH=U_]\C:M:BT]E]VS@F#R9\?D
MGV,>*]OQ[H@S1?(RGI?CG;=.3__\U?_8^/9[^\F7Y"EAU^)]@M(;42@J4&SW
MRG#-KRANUY3V47[OIIU"Q(_EB>^_F(V\U#K;D-JSP+]W$[KRD+NEUX;%!J6^
M26W>5J%M5WBV30P[SL4PW-@5\X^>@%C!">+3 [@9SG\CYY?'[N5Y;RVXX2.
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M07VR0 R+*H[=$'W-N]4='J "D#GJA;D20>7XJ,\SNH_2NLH,*[G3#=4:=)C
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MO!;=;@Y=_,K*/?Q4;S7UA2^1%EVB\-; OUG2-WX #D.3F_#*Y/24\$WQS 3
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M624 +M0"/P7 QVL#\$8-ZP4 "P 6 %P> (MJRRH!<*%>]2D /ED;@#?J+"\
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M&HP5%O*@OAA;)UI?%%NA/*A-V7!]N*IT<5!(Z3_1+>S!1=TTJQ3_5=':)PF
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M.AL<.G\YL2T7]4:L;-9- *=[Z7_TZ>SG -]DZ?JH?R1+AC4B,]!8\;,.]:T
M/(ZDF3\PC:&D#X>V;WFHSHX-9RI@3<":@+6BL/8BP^VEE QK2E-!3;!53!$L
M;X-BJ'FM>X[QW; Y;%YQA?""Z Z YP7W"9L^%B@;5JA*MH[0^N8;K&\_AIT3
M11GHPR_W#F#W"$- MO.3]#@Q/")B6[N215L+8Y5ZAY-QK/_=&*GJS]7OT:9C
M6U#T/Q/0F!X-;W)498];(KJ^T5.ZFM;<^#$?=4N_9ZUUAO E!'3)=N#?4U!&
M7=W#9F@SG/(.OZ3=']B']P.GU<\3VKZ-,?CE]>#-X<%[P]*MH:&;TJVG>^P
M;X<3,O)-XL(%&"RD%U5^:34]D;YI'AZXP=9+$_V!2 ,,2]A3PZ/.+C+4?9=(
M!*")..C;FL-5(I)EHZ7WU3? SI/#W^BS&1A\5'C;],.@U(QM9ZK30+OA2C8^
MY=& ![K$ W(<;W)X8+ HR#CD"C?@"I>&1!QB4L<;O %HQ"<0SSZJW5[7E$7@
MTI[#:1P>J.TCZ1/8^(ZG?\$R7'%/=T?VW80<'F ?(\>%5Y 1][+0AD9X'P9S
MR>='0]R?:K>\BEH!%="X8MJU5@L;H&PJ7\<LX:IX0.YL1@:&;F1IY#OHVL1
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MSZ&3=6H#>%)W6P(6!V#S$-VBI85+HKZ(WMP;%X-+%C*.%=8PMQ^\3 <CR;=
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MJ<-K/+4.K_P*M!7L1_GD/^\&]FA._S'QIN8O_Q]02P<(* $ X-_M!0 8SDH
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MVM4*QJ1EY^KEZFGGZL8DIRO,I&X)M7=!E %! 8B ) 0B*2#.!!&6A$A("@D
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MR<U@!5M:Z;7O,>[=;Z"RDET\@:]%=<X_)Q]3'=$R+!O*[8 ;COW&\2^!VDO
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M #(+?H"HGPQ 7>\!T$AQ 52S#'@-Z/>\J6$; (B59\BX_,/ND>E?7"M!B44
M3WOD90I 3D>/">KMX?.C#GE_ AW  0@!,H :8 !8@2L 'R (B %7@6N  G 3
MT 3T &/ '( "=H SX 'X D' 7> A$ D\ 9X!*4 FD ,4 "5 .5 #O .:@7:@
M&_@$C "3P"RP"'P'MH #X!0$ F&"\$&D(&H0(X@=Q ,2!(F#9$ *(#60#L@8
M=!MD"W(!>8."0/=!D: X4 HH"U0 *@.]!36#.D$#H''0'&@%M ,Z04%%P4,A
M0Z%'X4 !HXBC7$=11=%#N85BB^*.$H 2AA*#DHR2C5*,4HW2C-*-,H(RB_(=
M91\50,5%I4!E1N5#%4>50]5$-4&U0?5 #4&-0$U$S48M0:U#[4 =0IU%74,]
M1L- (T5C0N-#NXJFC*:/!D5S1PM!BT)+07N%5HW6BC:$-H>VA7:!CH].A\Z#
M+HFN@FZ$;HONB_X0/1$]#[T*O0U]!'T1_0 # X,"@Q-##$,9PQC# 2,0(PHC
M':,4XSW& ,8"QCXF)B8U)@^F-*8FIB6F%^9#S.>8Q9A-F(.8BYA'6+A8C%B"
M6(I8)E@N6/>P$K$*L1JQ!K&6L4ZQB;#9L26Q-;&ML?VQ8[%SL.NP^[$7L4]Q
MB'$X<:1Q]' <<.[B)..4X+3A?,'9Q<7%9<&5P-7&M<>]@YN,^P;W(^X<[C$>
M"1XWGAR>&9XW7@Q>/MY[O'&\77Q\? [\:_@F^%[X,?@%^"WXT_A'!*0$_ 0J
M!-8$H02I!-4$@P0;A-B$[(37"<T) P@3"2L(^PG7B+").(CDB"R)0HA2B=X2
MC1'M$Y,20X@UB9V)HX@+B3N)OY%@DG"0*)!8DX21O"1I(5D@125E)94CA9+>
M)\TA;2-=),,@XR13(7,@BR1[3=9'MD5.0BY,;D#N1YY*WD ^2X%*P4&A0N%$
M$4M13C%*<4))3WF=$D;YF+*$<I#RD(J6ZAH5C"J"JI1JA.J$FHE:@=J1^BEU
M#?44#1H--XTVC2]-!DT;S1HM&>U56BAM!&TY[00="ATWG0Y=(-U+NAZZ?7H&
M>B5Z-_KG]"WT:PP4#-<8'!@2&!H95AA)&648[1D3&)L85YG(F:XS.3$E,[4R
M;3'3,2LS>S-G,?<QG[)PLNBSW&,I99EBQ6$59[5A36#]P+K%QLBFSA;$5L0V
MP8[-+LYNQY[$WL%^R,')8<@1SE'#\8V3BE.%,X"SB//+%?PKLE?<KV1?&>;"
MX!+G<N1*Y_K$C<(MPFW'G<K=SX/"(\ICSY/.,\"+SBO!Z\*;S3O&A\=WG<^'
MKXAOCI^"7XW_'G\-_P:8#6P"?@KN %\(B @X">0(3$)((#<A]R!UD!U!;D&H
M8*K@L!"^D*)0J%"MT+8PCS!,.$/XLPBIB+I(N,@'D7-1,5$/T1+1%3$VL=MB
M:6)CXF3B6N)1XA\ET"5N2(1*O),XEA25])(LE]R\RG?5\6KAU6]2G%(PJ1RI
M!6D6:4OI+.E9&2:9VS(O9&9EF64M9;-EYZ^Q7K.^EG=M^3K7=8?KQ=<W;@C<
M\+A1=>-03E(N6.Z]/*J\DGR$?)\"B8*^0HK"M"*+HJUBD>*6DHA2H-)[971E
M5>6GRF,J]"I0E0*5K9MB-X-OMJKBJ>JJIJC.JW&K>:C5J:.HWU2/5_^BP:[A
MHE&C"6BJ:,9K3FEQ:KEKU6MC:&MIIVHOZ4!T@G0Z=$EU+70+=0_T;NC%ZDWJ
M7]'WUO]@0&A@9E!@<&@H;QAG.&L$-@HVZC:F,;8WKC7!-#$PR3/9-U4P?6:Z
M:"9B]M!L]!;G+;];G>8TYD[F#1:$%I86%;?1;QO>+KQ]9JEIF6VY;Z5BE6:U
M!96#)D&_6U^S3K!>@4G#XF#+-M(V<3;?;*5MXVU7[&3M$NW6[.7L4^RW'90=
M,AT.'34=\QTOG0R=2IVQG&\[OW4A<7%T:75E</5S'7#C<7OH-NLNZ?[,?<M#
MU2//$^1YR[/6BPSN3/5X7_%^X#WG(^.3ZG/D:^!;X4?LY^+7X\_M_]A_.4 Q
M(#<0+1 :^"&(.>ANT%SP]>"L$%"(5<B'4-;0L-#%.TIW7MW%N>MXM_>>P+VX
M>WOW#>_7A=&'W0E;>*#TH.@AP4./AV/A5\,S'Z$]LG_4]UCH\?/'%Q'6$5V1
M I&)D6=1T*BN:$AT<O1EC$U,7ZQH;,83C"<N3T:?RCY]%4<<%Q"W$*\>7YW
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M[0)40M>'CM$ZF\!?)#![0V4G9'.C54]Z"57 YW6A3,_%%D_#F8Y+ET^5_GB
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ML4I_W4%)IRJA!?X=FH5>#C14Y1WR!DB^X3NT>F(3)_JL'#4>YL'DPGA3T*#
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MJ=)B3%6A:LQ63AT(?M(%N/HIRC:"N6PL1,'A=?;&_-BQ[TRX[_KMFJUO?2F
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M;CWW(P XOK9+/9=5-J6+[3*OK'H4[;R34++AGLZS2R8X*G@/(1YVQH9OOM<
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M+E23SEP=IRS:#;Z]$B@6#^X%9$^*Y,U*9"6[=8R3;+,12N&&;_ISW_3F2%M
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M31^N5 2H#HR+YFSL:\KZU5DT#-HY=VNR3=R8T&ED^U2[=7I#'G1XCX=F5:"
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M)V=*[3G&N$C=MBA"1W:Q"G>L;@> 3\2$_S"#GP%,+1/*97NG>"^(?5AJ2V3
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MSRSMSC]N]W8[2A&#H*\%6$$BHB&=4W(S/812IACNH3YX.-*'N+'!TYTS!H5
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M<@K)H^]+:>18"41^VY0V(WE+:-Y-\!C?%6.W2V 3GU)- MDQ]=P)I:86E4B
MLJ!U @Y#X;#MV&4'LETXQ9BYV/P=.::WE_%?"?/BZD4_I.<27KXG"_[-?DYJ
MV62_:BBDI&<>(468-"()0F$K"$E);$&QJ?S@B23:XS98<\%1N$<O5!O";TGY
M_<>HSOPS(%+'6[;M]^S,$RSABG_2?";4^@U"Z+EI;JO"D&V#^.24' LMZT']
MS3>W+[KT++&Y?XM>8#AU'__$2JZI?\.Y?,)>+HC!K;7N#/4Q)/NTC>^B[G*S
MQ%,G>U0MDR-_XR!U?_9Z2'%OJF(E9!7RYC?/MV= :KA>I]V=_NDS0'(08J;
M7!>:E V"TEI%.%^,GGH=\1^XU&^/0:DU\'P<9;7TZM] E9E? CGM?M'G[_@]
ME6? 4FDZVJ%G^X&Q:U#RSC- *7-%^L:F"])UHNQ-U4KJUXP:K1OV81H1KIG=
M\ &E'XZ?WW"9:>__S?U%%W8^OK-*'_QZ3:WC&CE_F2X@;'P7=FI,F GX[ WO
MVC](0>M$S(XLC&RT/KP*N_]YCGWU]^"??Q+/DJC;K4%NRF*#S&*1>P$* S[L
M(8QHL3\# E@C'MK E,+7Q2=T\=/F >%6_J]>D<TMZKN(19>-RRSL1-S6^QB*
M+/DWB>!P$J9P!5*4RFL.$[ ZWZ5<1.;E%:;C;SJYNP=ZHP#67B*2:HANI/RK
M@WPP&'-5Z?5J/NJFMRI7UCE"+B)Z]]0;P)F4#& 5BZXC^5['*[C[EOWGO5G/
M/\,_GN>.KB-FXXM)GMY9Z5A?C,?B$_F;;H[*4V\EPY]6!9<6,TCML[-%:=WC
M7]=J:"&F\+4O%]TKSPA:J$W&$[8/Y4E]WVJSYO^O"X[0Z$C^G:Y:6:796"]Z
MAWR6Q __Y]OB,%AN20+,$G4[2=&)G:ZG/^0<$_M65,HUG(\\T(PT44@:>G(W
MJ2(M^5%Y"NQ?B8V/[:H><([$G26]W2N(Y172E;.H5;K*R55?&_&=)\):IDL!
M6Q@Q/H[YCIY7Y)3W<TM/#U+./-"#+B=3DZ%7R'OBDTH8Q2OTZ?NL*;[?R_OF
M/TQ]1KM@8V0?T@1*J1X*DJKE(%/&L:LK9-8XNIE'^1O\)#ZM)"\!V1;T]+HM
MC>I8 OI!,*A9N*#$!0URJ1*&E>:_$]+B*FAE<+A!^@G979_A3H?J]AF@('F8
MZKDV[I_ PQ_"7LF^?O"$ZV)>XH-Q\S\EQRCY;99%(R3E[\YM6"R-\(M>/09U
MNR6^:<GXE2VPM<LJ8H6I&)=XE,#-S@&SC#P%'>UZJD:8((KW<LP1$T2FK"&\
MD"GJ]+/,O<-;PZKB)4[6'J\MN8C!Z0>B%;JB3.N;V3F1KYC*,_T8G:@A!&#$
M:H\<;>0#T3%1,EI#/N.,^K 26'V^*N%7B1!)<=H>I>\'!^A^!YM/3)AQL[/3
MDR8[?6:S5N.Y[ZFTCH'* Z6J5J/^"XN&L(D[S1?*LUX]8=\'6-]^PJ);C/YR
M+=/&2F.J4LA)I)SD#.T43Q!8? 9H*$&11:^E?(DW6<;]VI'Z#V$=[?6QVX&&
M>N:321'^Q+.%[^<(Z%GV:^UG5HY<.(/2MI@,OT &:2FI"EFCAG<TVRCPF41M
M;RW8F<QP$U./F<6CU /[__I5ZL?"5OFYTVPJ?PY'IZ="I)@>> -6V3Y=; T*
M<]4?$)I\')1AA 1;._EV':V4&S9I^L3#9).J@DAM4F_DZ#R[@@9P.]Q2%O.]
M)*0M(R(N\9B*8#KLM=[1VQJ!(1J@L"81R1Q+BUQ:"\M(\G"O>(=?M*RAF-&M
MQM6<E%Z3L5NBU+TFF W\*R3IREV"G0J^V)'?SI/7F427>$-N$$BE9ELDC?<^
ME1+BW,D"\:2^FE(D<9N=\!,YE//GR8L4H=GT::N79D$T]&1Q23MD\)\!^CO#
MTK4Y(U74FY8E-@F,7@:KA@,VKT-[:?24 E'D1C'9;[O=C(5_$.GEJ%FHL]NY
M2+FPQH+<^\@<E/%LM-S3=?1D0ORE\ 5_@KS YD$]H1C#I,[1CL&]8LS+I9P;
MY<,25J@*#1$PUGI/7)$BPXA3W8Q6R^8 &PJVSC-$).3-L9$?(@EZ"UBN5VH%
M=9+*P> 1[1KVX8Y\$)5K?J.%%*ZO"+NOD*FXV0867A<]=UAU[5X)8VVL6_=2
MK7F,KW,1;J37]?=Q=8O0.BB/TA\AMC;\>]_E;%8.8+QY]+D_,7^G^"=3JP5M
MT$KA0FF&@A9]XL\<KO5( 0=ZZBM>:,NW5LSMG_WUV,C*T%4P3F6C=\0\QTKD
MB+QQIN^"**]^_JMPHF73D_84[:SS.*)_2(>-*NY'7\:VH1JN%3I=):)7LF2?
M4)ZPJ#P3Q5J)>_9V: QG7)1]6Z?THTT%AW4MK!>K?.O:Q$-3I$2H7JJB@*,H
MB_QFI!-QSV;I4&Z<9/ 9E(TY"6?3>$%!IP""R[,;'/" ULLR]C2S4S.P=RFR
M63[+I>7$JZJF]#4H_N-+,7>*AM%S'(3P)H41F;X[5KT&3UUE?#C4.,(1@A\<
MQ:R^G4PV? 9P(4 9:PYTZB[?N;"J %V"TW:-6HX1E(2J6_$>6K$Q1$?"X B0
MP\00;S%__DZ/2*>U7H@-2^50^G(5S%RKXF6SP*HCZ9,W=75[Y)+7\1ZP?=.&
MW\S5CUXGKD7)2(.E:^^GL(K%!D:QN#NIU[:P,C&S]W7=IK5#>_W%[AJOV+67
M%IT%[-^=W+OBD-^H%&#RWH\#JQH#7XCI8'^@:G 4R[W W+P7_<OVG:M=G*;5
MROO9P8TQ^>]H\*M;]U2'&&<_6A1ULJ5&/SH.H>)+AKF4_6K8(QJ:_"9*A\D1
M<QX%;V#6R_MUD>(TJ)L3"E4)'8J"^8VHY',DHT]:DDP>:X*UOH<[_NIS\=?(
M"^M(1A\37>4PV?(.KY/NINIHK$]2.B&*N\94%:+T+HP;W/+4R@[35D*5I0I7
M4R=89/=Y%164"-YP1.^^D3JL'7MGG]J9.M*.RQ:QQ0LME?!:,=EN[ ^E)WJ5
MEB:C;HQN] P83&#W)!^FJ57 ;7H&G(8[ S/68)8DZ*W)N!7AFI' T-*%:J7!
M@T_LM^FY=GP"JT 5/]6%PL.%8R+G,MR\D3;H"SZ0AP2DKIR8GC2]+EWE>K+A
M V+GUGS#F?MDG<'69MZQYL=1A38$><3 ]?D:4SY>;0:U+8JQTBEREM (3?YV
MA/#=$OINWX,[,]3)#3&7V)2;;E1B^&![^!F08W^!9#[=(N6%/'LG<P>,4,IM
M:E<HL.$ZK9OH^$K4^%;  )O_1N>'.L':?1PR5V'WLGKG1T%I<,8/<A["7?')
M?63ENM"1.,$,+FMMU$8L].PM[G "OUXEA6*.)65,E7P</"2VMOS)>B]4I[M:
M(V(<3%QS4P2@H:E7HC[8[]2O=U!Z<JJ@U@A? ")E(V4?O3:NLYM&_DY0"?/;
M8<=E@D:E3VR021NQ#M9(J<&N_*2Y8MNY,(Q9D^3,@F%\C&3PE9VEA.O:YN"?
MZIW9'+>P4T?P+F]]ZPOA9E3G156:^;8*^(&8^D1@'/8H1JDQ;<>5=MJEDW5[
MRI!\53'-OY=:$J<IGE^'5$E .JO-2R=P"Q28SUIB/<?U590VGYZ:_2 HWIC*
M2*(HV'+8JUUC;*,C(Z]E9VI]%KRN$$<L<. :I][?B' B;\7B5J#3HQL"JT3U
MT,B?(C'A]\A8VZZ#1Q;*I$Q:76(;Z93 =J/9D@0\N#[(;,7 ,R8+>IFLWH78
ME%VX:(&@'"-M&_(./QCV<I R?E=B(QCBV=DG&DC]'4KPM[?/':]K[S,&@O5W
M@FS/Y(""C#CIU:002#:W4UP*$5;$6LQW/\>-<P1+5O"VK>:JZ*6>78OA\J*,
M2[Q9DQLW?[OOE$) ]#,@2=K^1(*1BP[;[8T0 <4S0%$8CP?R"K8SIJ<!:LM.
MMFHE45VYDZ4W:_N^FF'9;'PZW?G$8=R]>KXQP,H11T5=LB$(/]G"8830:._L
MMG_$,;NGFU?WW1?S),6_D_GXMSU+IDD3^2TSYA0-78OWF7/,[U2TV,M+UC!!
M2>YB=" %ZV!ZCL#:(+,4+KL@ZYW,X%PE"=)=%"OPD,K)?;%4!8A$M(_9($;=
ML/-[.$G29'$1.$^FL66ZH&=7Q((1ZF0BYQ ?_:0!7YD.6FDHM*0!?X<VG"<V
MIXI]Y$9NC^" VS)]V-8N61+9+@V3;N$K/:L$NUA%:7B;4"3GK=GHAK&NJ+'1
M'[JEFYW_:N/7GK7#'O)OL<D8JDV;&2E1@48<%Y3:N7#<T;WLPU'2+&ZJ+)SR
M(H-1 3$;$&^1+";BT=@'115'2@;L)U(7BW-G*-<9_.O_FZ;D<%Y=[KN$!^0Z
MHYA]=ZP.OZ2<9T<^P>@U"?SL0^HT]*075VN^U"/4*A?E/USJP,D7\T++N%98
MH(7.S(PID5/:.]:TL2THJZ263#Y<JVH,7Q99W\.7C@S/I/M7V]F]S]ZD@R5:
M_[3K?0;(FT_69K.Q2RJCO_ERW"GJ01,_CM)WHM(L&N?ZP-<CG1\@^2#5W#1;
ME)L35S6@:$0\@X;5E7@R>C#Z27S5A]S?2YA&[_2=$P_'^Q(&4<,J<TBH-3$)
M*-=P1M4R6:"!?9CHS1-]W;3$8^!(\HB20F&7N2%#S4T8@W'JTM&3C5BA4>6,
MWP^E1!PE87]QNL[O%\&/\CE6XW.EF9P2@VYW'"YMB;<1>0"V,  [8IC^\#+*
M\- P:<Q3!ON<^WW,FZO%5[3N/W:-*>P0P\X-T7230R 72-8WCF,RB:3D$Q,(
MQ4VY1^FPV-EH6LLT9U-,T :%@_E 3VM*))%N0IFG"!V^43%\."WRH3%A/KN2
MY3L;0=LTJ+H,VV<T;=9 EI$JN%T"Z]#H).E1#/MC)/P!OSU8:+0YC K2_<4F
MJHXU,;XDH?>C0(D<">WQ%%\D6&%IHTEK))(@(/WGJ8,/(?M5.)EQHAM?"#V/
M).SWQA8^7RA[Q8^3U6/E.BE>6Y6=B:D_+*+R1QYP$$Q'44]#G2QI.0S'$63\
M@200=T'7]V/ ,9XB;EJ&Z0?U]#^VPVR]I %"]F_KG9/H+:*XX)FK]XN+9+]5
MR/[Y2Z9O5YMFY./6',UP"T$\.I4;Y \9;:0R9LFY6J3$4U/P$L%,SI*G1SWE
M1C\ADY=Y7:-X_+*)#]2'^P9VH9. AZ)['PG2%L^^(<(&%SH(AU0O%QI7^0Q'
MD^Z"X&Q-@C@Y"!/4,7PR'RQ8]4EQ,I^3#I&J4/$%BP5!>BU=.%=E:3GSIL5!
M&'WPPU\T^B5&!V^K;G/J6&>=N_N,^RMM:[JO(@0J(BI>JOQBO>0XK-@SKOF7
M::CX.BWDE6M5[Q-]U!/6@N)4(<<N/E6A'(,XEA&S6V9QC4G_8>QAF&/6[V33
MSWW&?0]&FU@7TY8]ZKWHW*HQ4RG4,\F1]R0VM^QWDGCIS??1=IJ/#712F>8O
M:P%9;=N29Y:M"F4W3,-,V<;UQK3@3;/CSATA7#R!I-!ZD4Z1=1.R!5^DE<'B
MF[Z_VU=(1E5(D'I]W/EE>---L"6-.Z?Q]$U:B- \AW-'QBQO&0;!<<M13IM2
MBFK!CXV:;R@0\AL:(6)#=CN G[=5'^30VF2^0BPM;6W26(]?0D+_Y-IT;H9"
M6U.W[ N?Q>?(U)#3_J\U#D$U\ 1CK#&D;BS'>[V$6SN\E:4\>^DQ__1PO.BA
M42^8"X[ ^?<% R[ZC#&FSK%([6$J;+R4K92J6U[/W-H-*%L8_O4QMF_*T0%A
M7=*"0U&-2K+$Y09"R,")&<^Y>[N4"-AL^^PL'G0!R2+DI\/EI# U]!!/51>?
M_RQ^'5*XSS&29)7;%E-,&]9M!ZBO9DH$KO(\>*:[\H:;9<J15"1.?M6 X.%'
MB,M-)H^T+EXBZ6V "DN*F&@C3H&Q(4LS'Z/\>G8<SSY%A56UHDJ]&\@W9KU)
M>+]?55=:33M<IR*I)HTJ,_$>2QJ?0%0[P]&4,KQE?3OZG!E?#B%;HY>-?.EX
MSB#7^E.XHDEYB5D@O-FBM2MU_$Y7[R,=5ZFFPB9W9ZY540OG34+PM;*[W@K.
M,)JPMGO<Z"HWUQ^!H3O>VTNS;K89 GVUBBZ9W1!7IFR9OZ=8!,>C4_+6,[43
MDPT-4E_9JUUSR2O[:8[.$Z,V6&7-)Z>WL$=UF!A'X2.6RUJC5-4S+5#3VF(T
MZ7O6+):U ,FK,<!J;S#/33$N+ JU#7>%B[GH%&\S(N=1B3DQK$7WA*76)3<O
MYT?A!TI:)KTN(>(0)T>W='*$OH>\>4@4<#"TVVK5+J>[I62*#Z0&HR-9<7F<
M?09\4RWVIZ%^_WD8QY-'"(WR_9F;8K"0*9,;7#V$1&N1 1P.;!8^T*@N&<.7
M-ZO1+OXXB8C^/'YT'3$!*H8\O4O6>7_Y,0(?+D5_>UB6&A*/>UKUJ[28H2B,
MC3WHKT%1DYB,'^[^UZ!@G!%44YO PVH?IK7\OBXDP_]?%YR0DB+AMKNJ6I5F
M7+PP'>@^)A;\GV^+PZ FV0G0HE=;293V'VD[N@/.?H'=ODBYIKCK!QJAA?PU
M*,CY%O54M#E:[;4/%5N4@N#N*;\\%&R3$2,_ S ./\"40G_[1RL5TO-T%'*[
MM#<+%6#DEE-D-K3#?_6DXGX&T*JM;SP2)\KWD#KHSU5;>K'-*CE&++:+7JI7
MS[P^^7O6#J>XQTB:BT=42ZP$/C'K8HK8&R8PL8O,R]<  [^E1;?-TWM9K-C_
M#,V64>;U$%8K /;M[!(C3!# [:JFLF*<"W@.FLY4G)<\E"B BG%<HG,*;.U3
M!3^[?EY"N%X:)*/N,XXK>B$=\%HO_(,N &C_HJ3_!^_F;%G:D%A,GSQJGLK@
M );C:?\$;6\35R%TT##SE<HY:%"Y6SZBOI5W/2JV3DDY=)E2\N#Y!L?(W1J[
MSGH5/:Z'8;Z$GWAH@%UE+Q3WV&/ISF6>.3W#)N97]VI4?YGT@Y>^F*=535JW
MMU[-/6XY2>'9;60N-RB)L!#>1L*AM"GAAE"#).AH@+4G00W;@ZWYG?]O,^Q6
M)@C8:&KV'I5?87']G2M1#WP7WEG(K;BNPR$#R]EY^$4\)@45(A^R7U56V[5[
MU/<909W-8PW%HZ.#GGB3U%NVK83/7@!->H^LCRKJ[*MCVIN3DTY+32M-2(26
M_!'*M *4ZFBF/C;!O+5K9]C\!G*\B!%@FL(<CH=99&?@75*CU3:"IVGB*5W/
MZ5#G]JU$SR+-E^+]%$..>&A><*>9PH("UAN$P'N;N%TQSO?8 Y+4V;%Y82@;
MN_!"8\\ N)IF\2F>8^(F6#BWE/]]V1+,A'Z_3$6IWY-:KBMQ;9!2R&'%_!E
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MA6'83S"6";?U7M3BT>PLC"2\5/&E+'=O&KZK';.VHW]343W_6^UL[CB&2=1
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M5C^QO962$IU<K"4F0]G'"1<EH_,;5KL62#3\JIR<"Q7^6>+; BC(BC3V53)
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MT1S2C&Y\_\'BL$[X(Z[RF=\JZ^):12X3.Q_0AI:6W9=[MCO1;(?6_6J&?B'
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M?'3,->I-OQ]GU$/<);)O&3?1[WL)("VJO8UM!;T7E("Y=^3,1+E#ZGW%P,"
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M3G];Y"DCY9(ZQ5MTA@2;M+Y^31".P,E";#6$!)MCHY058[INRI=#W*VGE.4
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MWN)6+OA_UD_E'Y&3A\/_ E!+ P04   (" #!A2I4#S@VC[ ;  #60P$ $0
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MJ2RR+T_&P/S<NR$L(+8!_U+'@E]"T$4(NX@P $EV'G/G;[Q8.!:A11 J A0
MB"78F=W"Y^W(\<CLUI^M_)"9GLU/"1'N"1'B9>?%)B&U5C!'ZDM*1&DEQ(<L
M$8.(>N;2)?PH &=U..P4X4I3,;">Z:)6 X)WOK%4IL&&N7!!E30[Y^ZPS;AY
M>1C$\TOH;F<KAW*>BT!Z?(=$&\D<IB@T0LD0).Q+ND5C:AS0>(.M:;I[J/L
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MX;HNGE#)1^DDZ6A[2W26.M92_=GQ^F048UC\(E7^/; :\VDGU5,;434,QL&
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MY-_SP -*(2XB'4_3">HW 8P\#F 5ACX/_JJVG0 QAR]0&#\#MOI?"=X29O.
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M>E,RG9U[7-JW.00]OB;4$:V6A_F'!Y0J6>H>*)7.WR.=JEQ!%M(ELU_M$ X
M^;&;PH*ZY ^4G)4! "YX+2Q82[Y!T7<9 ,P*)X8%;LDG8+@R@TA%K4_#PJ+D
M(S ]FP'P:&> 62B6O(I3S/ 0<N@\(#?Q0(<7:DH5(R\@G;&-O1IT2U['8OQ)
MGZRF5#]3GV]*-;2F_S[^- +.:J"Q"6NS40?!+"T30Q-?11X19B)<]DP*"&<H
M&C-B=%:WJ]0!-I>?8#<,HCZW]$_Z;$%$(=,VWT[-Q>*[8:E198OT*,8;0I=5
MA-:)-P5Z,,GPMN2_%,E08ZSTQ=*XI119+?3KU52; B4&%H4)]A*RW!?(24(:
M+$\?$4)NFK^RV28QG9&)?<DG*6(_,:8KNMP7^GAE&4NBR4#ZIZL)8'YMF;=4
M%%;+=%T,@'U'3EH&Z(P</1(25I.FY+GTX*YED&@[4'HD7C&\*$:!DA=T$&X<
M%GKVJF?*>#EXPE_A>V&6FSQ ,9U[1*0+Z#)S3=F])"=#5$-V$_(J5C'[R3ZA
M%N%3.05"@!3J'7L>O&V_K_,"__905M&S>/.R%LUZ9G<W@^RS]A9BT35Y.1E1
M@Y[[,?0VQPZ5MHP<I3V(0>(=-(FA5MI'BAT\#8MJU6&4&'JE/63-X90L7^(X
M)L3T(Y@[Q(H D0HNQ#3P[Y<HW+#SP0];R2W>=!?OXQ9C$(9GXL1OB#=?#S^[
MEVSWH(H'I:),?+35<P8.H5[Y=FJ:D)N76Q#E6&57V>:[,=L8!% P,QE\BB#"
M<>'R778=C_] E$!7V>E?0LP3), +6GC<VH7\GK)O#IRR[!K5)AS4^:UQ-#CN
M4RE$6^]E#.PX[<ZF:!)OQ DS_L ,LN[/JXAC_]E8'$83_T\^#R4%"PLY@>^
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MF6!@IR:#)F0+!-&PXZ2,F]E"Q[(&",LZF2\,.T$.@R@%85:,Q@8O TJ@!#(
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MK9H"NQGU!Y.E-K;[\3B@1U-A4S[Q9S'=;\*^1B^*=[B"E(J*=$B/8$WY#GE
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MK6:=96_A&J) :U/&OW )8#G2M=O^FA8,C< 8+3K45?& Q.<,T+Q)1PV78P9
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M.*  ,MO./QH*\5%-^"C@ )*XX0712]$,%ZC=UUB!5P7<IS%@27("NJ/,UU;
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M4;*&&0"E7=8?P)O565:2^ LAFC(@JI_.Z](HZ8L9 5$HZP&0V%LD=I7F2?F
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MP"2X )'2G%FQ2Z8'"O+T!J/%$47 PN'V:0P(DIR 0&C.-RK[/HE_J:XX2J/
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M$$5)I$?D@CNWX<.UZ-S:!.GZ1)O@O^[B=*H_3;@&;5G(#X2>Z<Q0A,"]]WA
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MJU;Q]#XCSIX&;!]$[^=8]SRZF38,N@V!+#N=_J[(&B*<M%I-4;#U_?$7PZL
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M+R\&Q9>MRE#QI>W4P'_I7P%?KF*[_KT.?+?ZO4P>!D/,0$HJW[\X*,>QP4F
MT_,BA3M5$4<H:)$N"J -D@BDH%!##HTG!)5%YV5J?6J'!G-3&G""EFD@ =JA
MP1PN#<30)#286Z;!S)0&G*!E&DB =F@P@TL#,30)#6;CTV#,6>GV17G%6D?&
M^JRT"X^;E98"SOFA0B6>E5*A*5:%3[GC(<V28)=A?Y/%N]^$@40C:_?F!@7<
M]B4- D$PC%&AXVO7E+*("4_=M=R0'X^1CWU]YR(5M=:]:,!6'8Q$SCDA#,!U
M^5!)6QMLW)*G)>%+$-WS];H4[#!2L\:4'DY4K#'0@<$@<Z#<]E:E*2JC-CFU
M>EV@!>&"+/,+L(!?<-7W JM)+ZR2+;%']]Y]?M.(GAT*87O+Z3K ]2*Z3!(&
M.W3PN 7S2MX>.XJ;"_+YV2SR5Q$V7ATQU[57AJ*G.W5Q"D-%&,SJB;9+M/=O
M437+IK<'O4/3K;V<D*PU?PCP?O&,=\<L>,*K_3[88?&FH%;:5L*6 >0R94LA
MZIQD9OBXWHUJH$H%%3K0UF\Z\\;;*,C2]>:VSZR]J^-P]BZ&KYC%MQ6<4ZT/
M2NVLGFFA;XE>^CMHM+LAT*^]1]6J85O$)JE$X)H<:OX.AC("4-P\G_P-49EI
MTUC:Q]%I!O7B[\<@>UF2%Q_16$AQJ 92/=0MCJ5Z.]483AGK.J?30,#\H.K=
MCRA70I468@2<>H;W> CCE]8\0S%J5TG;F^-I(=>3/*DH#.9H\7'3O$IABC6B
MD7JK9?1$.M=8/-R6"=GLL<0 FWU66\(Y692PNAPIA:8.'?0XHV1.)?C=6G@0
MP:H"0O-'YU]5AJC[07.1R0M[$)@OFP>\>\A47U4H9J\LAQQD776#EX'QJ>7
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M4&FD#$D<B>R7O%4<K@(PX36?Y0*?VO:=S[J8PW9JR:?*$O]&&A9+WYE ;Q3
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M^! G*@JUQ6PS1P2R2YBF#"B>"(!)Z9'+HES8(2O^\^@E&4["%RTQ.$G;W)!
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MU#=.SBXO)##;Q.@( 6*&&)F$&H4P8M*(B#LCQTT2/'K)RR;8:;H-7M N/61
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M*A% %!'A4E2Q25 IZXP/FT<O#,^/:1#A5-XI=:3L\D$(L<V'E@@@/HAP2?C
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M\[:TKDZ(_?.7-=[CA)YIV.+G[)P\[#?%S,- U_:LSMB=[B1/JPB"B'W1RJ:
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MS.+,"U7AM#=N;H]JL47L8,7M9G&!EM?"4Q6PN7L91%ZT&^',D-(0 "X;.&K
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MC%JA8/FF#PWPSFT>$FGGC#*&*.F;Z') J8'^6NK\-Q!^K9)[+RKN'2%];DJ
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ME 7FVLT+9)C^1,\,!MD+K0%DQ-:V@KM0+0(NCP=-::!A0 !1>$+ML9!C99=
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M\11G69C7=R#M98RT<=E";H*+[:\;''EAD_ZM%4.1F+VE63G(>@V6EW$>837
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MDZ#L2UKQ$GH5IY-##XLC5MN<"L!K;H?Z%VNQ/VT\_6MOKUK/_UG3".2O3%L
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MK('\ ;(LC@IJ=SSH-U/B.\\/X#04"^)U@0I)?Z#Q?,JT3),D$G4M>QA-IC;
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MV[=*VC #@AL -QECQ2LK$:Z^=R!TFGR=5#[0<BQ5?[,8T("5$I<:AF!:J\C
M]A2'1I)^$329K4OZ%+_%Y<J1XG)G(=CTN',+=!4+43W?_G<I3GE8OS.!G7OL
M8(>5>I?(WZ$-[8];1-A4:$5HWQ<_ 6W( PJ_%7_(3JC^.I7;H>'^7'>LC)>!
M2W6[-\#\4K?,R!-5 TU>HFWD12L?D$?FP((P(5ITQH.1'KZS+MI>QRE]^)X]
MK+*JB-(Y+^0.P2R4IO=T!H_98EK<,@VLV-K1A'1:8KKV)AJ7O>R]77H0OO@
M^?SW(_+YXZ>_DD824:)(+2MH/-EYM$PH]SLS<%=7IQ9;,)/ATJL3HU9W%8B)
MHCXBC#YP7)\R2J,I<KC764D'QZH/.RZ][83=/N9@O GM A,2I5IFFOCE0%.S
MIV"LAK"75ME-Y!.?EO^">%K^I4JV#ZLXA_9V.^&<W^/M8C1[D(G+7O;7H+ZI
M@&3RZ2=N)G_#;B9-RU6SAU8+/S:$RO;%;-0GUR62E>&7"B8WPS3WFN']6I'8
M%+ZG]NC&D%+RZ6?T@_N>0I:\$^5)LJC=2(5+DRZ(>H0$T)(3E?6_0*""4R\5
MG.)7@1FB106G.%1P1R&!0I3<+ SOZ43U]4YVRE8M=O6/VN?*=@8R:Y9Z1&3P
M5![R<[B,8I*VZMY3\5'Q$*MY\=@\>)Q7%'QPLW;ZT/K5%O]Z_Q$7KP *L9N1
MS(FFGGR%N9^MEE51&I>N5RWP>Y*+RP;WVRCMXIA+5WXXS(N]ZH?1>WE?1IQJ
MWW$_K_2*:$=_,RLSZ<3:TWG]U1)QJ7Q?S=$"%(1<\AG]&!_J@:&A/I+_;:G?
M;^#7RD8T\J^S9_@X]T1MS8W[.GKP[T,H+@/88XNTET!"=$Y^^HA^$E!8=YL"
M1G&CU/\HZ%9%8QK_ASU&67+@3/%17/8S88N#GEF/0F;\N:/Q^JG*"_%T)H72
M-06_C.5!Z _1RQV=T?@9VNQ(XKF3%&S6MGL3W.EHY'M\R0)FT?D689;#OT:.
M6R6#V =)\\5PL6;6$"LP<RK*0VX24R65<>RXC&$G['TKN( WEC$OWC6/%PLV
MUEE_JXD#C"(7DL34\J$ 66'#K LQJS9SF&&@VTAQ*7 0IS72NJBG]H8GB%8N
M4[:=C9)6B/$YV_',Y_#<6"$3SXC/F'$^\R#B.IZ<31U9SDB/K:FB]BL>E_8/
MTC:]6B+_2"]NF\H/M<Q'YB-@&P#UK2:(G^3R:R0*FZ9*9+I6D.7NJ=DMR8J0
MAK@D'S9<UC$*LS'?<DNW,\7>9)W;" $A)XW_H>DV2^_N'VTWF!8Z7(IR@[2-
M1T%.@#[H*?'+O2S5"9E:4V8N]F!;.RDNA0SBU)[;WZMZI42QA(^\;3DF>W<1
M7^[]G+$.-EP*&X79Z7IEF@SN=[F(\Z)T:*CW.RY5F,%I9P:@"M_3OT1I%>5;
M<4O+/?CB/^!_G8/$EQ&7;D:BUN++!#OYS&^D/G]$,5CDA6L_4+:.LC=E>G=>
M.(^7A$O)KVV&Y4KZTT?YY*>5 A_'Q</.^:G:>2JA$AJ<H_@!1_?Q[/T3N&SF
M8.WK&]/#BJI$_>P0R?W!1.2$G;63QT;-ER%W;)M.YJLF$7R^FQJ4S"$/=G-.
M19!9I+A,6</H/>MZWAIPJJ65R\4\DA^7'>T&WF0D74=RIN2*Y "0S!PDDT*)
MYCY&)KO[K#5,$C+-HZZ?@S027&JTXM/6AGHH+[EG'ZY]9%X?4D8OY/LJGJUD
M2DJ1@CY*4TC')W(\0!%83"Y_<5>F4DPWN0Y\??XV?ES:W0V\]LY4)>)N)7$(
M>L.GYZBP.3TI]WKRR@N&6KZO%H9+VWMHB8='6+AW8>9MS,'L"(X*<4,\E]]
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MJ1T::WHD&A&QN/*@=9S.;U+JEZK/EQ&7OD:B[JOO\T=2GS/!F_V)X$KQUXK
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MH0W0XU*='UA+#=,MML=?9W260\;+RU1<BYLN.#H$N)1A06>XJ.!DL.2("_U
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MDP*M4<I6[TSQ+FYR!#N@,2AM:C*SH1E6Y^M-DFTIE>]C6U<G?B/,SH]ZL'G
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M.!!KY:)'J& G3'\-(MD,B+T)9%@1.]DDR;Z#!7EMTG0VA/KR0>NU?:OY22T
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M'SP-N\.G(,JIM(?CZANRI'I<E)M[+R2ETU3B4<J"R$NV/ " O03%CJWB,.1
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MG,&J*&NXONE\"=:U(+@GNTT7_\WI6;W&SR\H[_Q6]04G S5F2/8+/)OHB*)
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M<>$'1$9>1B48+P\GFU3:6;Y>>\EVO)P%3Q%_PS7*R@FA@&-*-BQG4O0TB</
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MV?NQ2PW;SK3+#US+5M]"45L?Y_)C_.H3I*IQK6M!-XYKNHTM$$DG8#4I!<I
M%3KHR3 C:T6&2$A='$2:JBXT;*4B:/5F2XN$IDE6(9/^=$HD_=5/4S:3=E\"
M$5?T[Y4_7S<=Q[)4=H%. +\GZT>2*"#?%7 ,^C%J8D1W73T8=9>&]#-A+D&R
MZ#Z3Q%.#*RGJ+&SU%,0:Q$K9D.SB3S*J5O=GE6W;>X5; MH UMC%VHJGSCFK
M0PC3QKO'>SJ,@'<HE/OQ^K,4E?UXN0,?CMA5L8?[A^*AM_'\Q\&4'41-IH,?
M!Z,9<X2685Z_NQO/9K]_VZQ;D 7"](ADU"SS7I0"FC5T-1?-F@I8&]ZT>!$
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MC:L_UMX>?QATYN/.[7AZ/YAV^L/IH#<?3^D?IH/B<9Y)EXVZML:9Q.5SZ))
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M*E"/I1.((=+:6C]G9?)QEIR)/4JC4V%5!2C([9__ D#62WK!G;_Q/M_]KAX
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MM%K/.GZ1V_D&-+VE(%?2=9%[_X9[#+-\Y->:XUH"4)_^4DZ[LI+K.VX-*0<
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M%_W&>-I*]$N_/H[8C#5X81D=\R!=,2DE4X&\N.NK&2T/:ATN2(9G&UOKGSZ
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M\$L>9%NJ(YLXXLXMV)Y<7 W))K#!OEPL#Y+<?2>=TVW/)<61D -1O-,88+%
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M?U!+ 0(4 !0   @( ,&%*E1'>K(S] (  -D(   *
M  !E>#(S+3$N:'1M4$L! A0 %  (" @ QH4J5"@! .#?[04 &,Y*  T
M            ' ,  &9O<FUP;W-A;2YH=&U02P$"%  4   (" #!A2I4V6@L
M-+/6  "M#P$ #0                 V\04 :6UA9V5?,# Q+FIP9U!+ 0(4
M !0   @( ,&%*E0/.#:/L!L  -9# 0 1                 !3(!@!P<&-B
M+3(P,C$P.3,P+GAS9%!+ 0(4 !0   @( ,&%*E2S(^"MQQ<  ,,E 0 5
M             //C!@!P<&-B+3(P,C$P.3,P7V-A;"YX;6Q02P$"%  4   (
M" #!A2I40T;$.<53  #2)P4 %0                #M^P8 <'!C8BTR,#(Q
M,#DS,%]D968N>&UL4$L! A0 %   " @ P84J5-0W'=(_K   IZ8) !4
M            Y4\' '!P8V(M,C R,3 Y,S!?;&%B+GAM;%!+ 0(4 !0   @(
M ,&%*E3W(.Y+/V\  !\5!P 5                 %?\!P!P<&-B+3(P,C$P
A.3,P7W!R92YX;6Q02P4&      @ " #Y 0  R6L(

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
